
TTD - Therapeutic Targets Database Full Data Download File
Version 4.3.02 (2013.10.18)
Provided by BIDD - BioInformatic and Drug Design Group
                   Department of Pharmacy
                   National Unviersity of Singapore
                   http://bidd.nus.edu.sg/group/bidd.htm
Any question about data provided here, please contact with: Prof. Chen (csccyz@nus.edu.sg)


TTDS00001	Name	Muscarinic acetylcholine receptor
TTDS00001	Type of target	Successful target
TTDS00001	Synonyms	(m)AChR
TTDS00001	Synonyms	MAChR
TTDS00001	Disease	Alzheimer's disease
TTDS00001	Disease	Bronchospasm (histamine induced)
TTDS00001	Disease	Glaucoma
TTDS00001	Disease	Motion sickness
TTDS00001	Disease	Obstructive airway disease
TTDS00001	Disease	Organophosphate poisoning
TTDS00001	Disease	Schizophrenia
TTDS00001	Disease	Urinary incontinence
TTDS00001	Disease	Xerostomia
TTDS00001	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00001	Pathway	Calcium signaling pathway
TTDS00001	Pathway	Neuroactive ligand-receptor interaction
TTDS00001	Pathway	Regulation of actin cytoskeleton
TTDS00001	Related US Patent	6,211,204
TTDS00001	Related US Patent	6,323,194
TTDS00001	Related US Patent	6,369,081
TTDS00001	Related US Patent	6,376,675
TTDS00001	Related US Patent	6,423,842
TTDS00001	Related US Patent	6,451,797
TTDS00001	Related US Patent	6,455,552
TTDS00001	Related US Patent	6,458,812
TTDS00001	Related US Patent	6,555,550
TTDS00001	Related US Patent	6,602,891
TTDS00001	Target Validation	TTDS00001
TTDS00001	Drug(s)	961081
TTDS00001	Drug(s)	ANORATM ELLIPTATM
TTDS00001	Drug(s)	AZD8683
TTDS00001	Drug(s)	Aclidinium bromide
TTDS00001	Drug(s)	Anisodine
TTDS00001	Drug(s)	Anisotropine Methylbromide
TTDS00001	Drug(s)	Anoro
TTDS00001	Drug(s)	Bethanechol
TTDS00001	Drug(s)	CHF 5407
TTDS00001	Drug(s)	Cimetropium bromide
TTDS00001	Drug(s)	Cyclopentolate
TTDS00001	Drug(s)	Flavoxate
TTDS00001	Drug(s)	Flutropium bromide
TTDS00001	Drug(s)	GSK233705
TTDS00001	Drug(s)	Hyoscyamine
TTDS00001	Drug(s)	Ipratropium
TTDS00001	Drug(s)	Ispaghula
TTDS00001	Drug(s)	Mebeverine
TTDS00001	Drug(s)	Mepenzolate
TTDS00001	Drug(s)	Methantheline
TTDS00001	Drug(s)	NVA237
TTDS00001	Drug(s)	OrM3
TTDS00001	Drug(s)	Org-23366
TTDS00001	Drug(s)	Oxitropium bromide
TTDS00001	Drug(s)	Oxyphencyclimine
TTDS00001	Drug(s)	Pilocarpine
TTDS00001	Drug(s)	Procyclidine
TTDS00001	Drug(s)	Tridihexethyl
TTDS00001	Drug(s)	Trihexyphenidyl HCl
TTDS00001	Drug(s)	Trospium
TTDS00001	Drug(s)	Umeclidinium
TTDS00001	Antagonist	Aclidinium bromide
TTDS00001	Antagonist	Aprophen
TTDS00001	Antagonist	Benactyzine
TTDS00001	Antagonist	CHF 5407
TTDS00001	Antagonist	Cyclopentolate
TTDS00001	Antagonist	Flavoxate
TTDS00001	Antagonist	GSK233705
TTDS00001	Antagonist	Hyoscine
TTDS00001	Antagonist	Hyoscyamine
TTDS00001	Antagonist	Hyoscyamine sulfate
TTDS00001	Antagonist	Ipratropium
TTDS00001	Antagonist	Ipratropium bromide
TTDS00001	Antagonist	Ispaghula
TTDS00001	Antagonist	Mebeverine
TTDS00001	Antagonist	Mepenzolate
TTDS00001	Antagonist	Methantheline
TTDS00001	Antagonist	NVA237
TTDS00001	Antagonist	OrM3
TTDS00001	Antagonist	Org-23366
TTDS00001	Antagonist	Procyclidine
TTDS00001	Antagonist	Trihexyphenidyl HCl
TTDS00001	Antagonist	Trospium
TTDS00001	Agonist	Bethanechol
TTDS00001	Agonist	Muscarine
TTDS00001	Agonist	Pilocarpine
TTDS00001	Agonist	RS 86
TTDS00001	Binder	Anisotropine Methylbromide
TTDS00001	Binder	Oxyphencyclimine
TTDS00001	Binder	Tridihexethyl
TTDS00001	Multitarget	Org-23366
TTDS00002	UniProt ID	P11229
TTDS00002	Name	Muscarinic acetylcholine receptor M1
TTDS00002	Type of target	Successful target
TTDS00002	Synonyms	M1 receptor
TTDS00002	Disease	Alzheimer's disease
TTDS00002	Disease	Bronchospasm (histamine induced)
TTDS00002	Disease	Cognitive deficits
TTDS00002	Disease	Schizophrenia
TTDS00002	Function	The muscarinic acetylcholine receptor mediates various cellular responses, inclu
TTDS00002	Sequence	MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVNNYFLLSLACADLIIGTFSMN
TTDS00002	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00002	Pathway	Calcium signaling pathway
TTDS00002	Pathway	Neuroactive ligand-receptor interaction
TTDS00002	Pathway	Regulation of actin cytoskeleton
TTDS00002	Related US Patent	6,288,068
TTDS00002	Related US Patent	6,294,554
TTDS00002	Related US Patent	6,627,645
TTDS00002	Target Validation	TTDS00002
TTDS00002	Drug(s)	Benztropine
TTDS00002	Drug(s)	Biperiden
TTDS00002	Drug(s)	Clidinium
TTDS00002	Drug(s)	Cycrimine
TTDS00002	Drug(s)	Darotropium
TTDS00002	Drug(s)	Darotropium + 642444
TTDS00002	Drug(s)	Dicyclomine
TTDS00002	Drug(s)	Ethopropazine
TTDS00002	Drug(s)	GSK1034702
TTDS00002	Drug(s)	GSK573719
TTDS00002	Drug(s)	GSK961081
TTDS00002	Drug(s)	Glycopyrrolate
TTDS00002	Drug(s)	Oxyphenonium
TTDS00002	Drug(s)	Pirenzepine
TTDS00002	Drug(s)	Propantheline
TTDS00002	Drug(s)	Revatropate
TTDS00002	Drug(s)	Sabcomeline hydrochloride
TTDS00002	Drug(s)	Talsaclidine fumarate
TTDS00002	Drug(s)	Talsaclidine isomer
TTDS00002	Drug(s)	Trihexyphenidyl
TTDS00002	Drug(s)	Xanomeline tartrate
TTDS00002	Inhibitor	1'-Benzyl-3-phenyl-[3,4']bipiperidinyl-2,6-dione
TTDS00002	Inhibitor	1,1-diphenyl-2-(3-tropanyl)ethanol
TTDS00002	Inhibitor	1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea
TTDS00002	Inhibitor	2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one
TTDS00002	Inhibitor	2-(4-Diethylamino-but-2-ynyl)-isoindole-1,3-dione
TTDS00002	Inhibitor	2-Methyl-6-pyrrolidin-1-yl-hex-4-ynal oxime
TTDS00002	Inhibitor	3-(3-benzylamino)-piperidin-2-one
TTDS00002	Inhibitor	3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00002	Inhibitor	3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane
TTDS00002	Inhibitor	3alpha-(bis-chloro-phenylmethoxy)tropane
TTDS00002	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00002	Inhibitor	6-Dimethylamino-2-methyl-hex-4-ynal oxime
TTDS00002	Inhibitor	7-Dimethylamino-3-methyl-hept-5-yn-2-one
TTDS00002	Inhibitor	7-Dimethylamino-hept-5-yn-2-one
TTDS00002	Inhibitor	7-Dimethylamino-hept-5-yn-2-one oxime
TTDS00002	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00002	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one oxime
TTDS00002	Inhibitor	A-987306
TTDS00002	Inhibitor	ACECLIDINE
TTDS00002	Inhibitor	AMINOBENZTROPINE
TTDS00002	Inhibitor	Acetic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00002	Inhibitor	Arecoline
TTDS00002	Inhibitor	BI-1356
TTDS00002	Inhibitor	BRL-55473
TTDS00002	Inhibitor	Benzoic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00002	Inhibitor	Bo(15)PZ
TTDS00002	Inhibitor	CARAMIPEN
TTDS00002	Inhibitor	CREMASTRINE
TTDS00002	Inhibitor	DIFLUOROBENZTROPINE
TTDS00002	Inhibitor	FLUMEZAPINE
TTDS00002	Inhibitor	FM1-10
TTDS00002	Inhibitor	FM1-43
TTDS00002	Inhibitor	GNF-PF-5618
TTDS00002	Inhibitor	HIMBACINE
TTDS00002	Inhibitor	ISOCLOZAPINE
TTDS00002	Inhibitor	ISOLOXAPINE
TTDS00002	Inhibitor	N-(4-Dimethylamino-but-2-ynyl)-N-methyl-acetamide
TTDS00002	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl chloride
TTDS00002	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl fluoride
TTDS00002	Inhibitor	Propionic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00002	Inhibitor	R-dimethindene
TTDS00002	Inhibitor	RR(17)PZ
TTDS00002	Inhibitor	SB-202026
TTDS00002	Inhibitor	SULFOARECOLINE
TTDS00002	Inhibitor	Tiotropium Bromide
TTDS00002	Inhibitor	XANOMELINE
TTDS00002	Antagonist	Benztropine
TTDS00002	Antagonist	Biperiden
TTDS00002	Antagonist	Clidinium
TTDS00002	Antagonist	Dicyclomine
TTDS00002	Antagonist	Ethopropazine
TTDS00002	Antagonist	Glycopyrrolate
TTDS00002	Antagonist	Oxyphenonium
TTDS00002	Antagonist	Pirenzepine
TTDS00002	Antagonist	Propantheline
TTDS00002	Antagonist	Revatropate
TTDS00002	Antagonist	Trihexyphenidyl
TTDS00002	Agonist	77-LH-28-1
TTDS00002	Agonist	AC-260584
TTDS00002	Agonist	AC-42
TTDS00002	Agonist	AF150(S)
TTDS00002	Agonist	AF267B
TTDS00002	Agonist	Darotropium
TTDS00002	Agonist	Darotropium + 642444
TTDS00002	Agonist	GSK1034702
TTDS00002	Agonist	GSK573719
TTDS00002	Agonist	GSK961081
TTDS00002	Agonist	LY-593039
TTDS00002	Agonist	NGX-267
TTDS00002	Agonist	Sabcomeline
TTDS00002	Agonist	Sabcomeline hydrochloride
TTDS00002	Agonist	Talsaclidine fumarate
TTDS00002	Agonist	Talsaclidine isomer
TTDS00002	Agonist	WAY-132983
TTDS00002	Agonist	Xanomeline tartrate
TTDS00002	Binder	Cycrimine
TTDS00002	Multitarget	GSK961081
TTDS00002	Multitarget	Revatropate
TTDS00003	UniProt ID	P08172
TTDS00003	Name	Muscarinic acetylcholine receptor M2
TTDS00003	Type of target	Successful target
TTDS00003	Synonyms	M2 receptor
TTDS00003	Disease	Alzheimer's disease
TTDS00003	Disease	Analgesics
TTDS00003	Disease	Autoimmune cardiomyopathy
TTDS00003	Disease	Bronchoconstriction (cold air-induced)
TTDS00003	Disease	Chronic obstructive pulmonary disease, unspecified
TTDS00003	Disease	Hypothermia
TTDS00003	Disease	Neurogenic bladder
TTDS00003	Disease	Pain, unspecified
TTDS00003	Disease	Tremor, unspecified
TTDS00003	Function	The muscarinic acetylcholine receptor mediates various cellular responses, inclu
TTDS00003	Sequence	MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLY
TTDS00003	PDB Structure	1LUB; 3UON
TTDS00003	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00003	Pathway	Calcium signaling pathway
TTDS00003	Pathway	Neuroactive ligand-receptor interaction
TTDS00003	Pathway	Regulation of actin cytoskeleton
TTDS00003	Related US Patent	6,288,068
TTDS00003	Related US Patent	6,294,554
TTDS00003	Related US Patent	6,498,168
TTDS00003	Related US Patent	6,500,822
TTDS00003	Related US Patent	6,627,644
TTDS00003	Related US Patent	6,635,658
TTDS00003	Related US Patent	6,645,958
TTDS00003	Related US Patent	6,667,301
TTDS00003	Target Validation	TTDS00003
TTDS00003	Drug(s)	Gallamine Triethiodide
TTDS00003	Drug(s)	Methylscopolamine
TTDS00003	Drug(s)	Scopolamine
TTDS00003	Inhibitor	1'-Benzyl-3-phenyl-[3,4']bipiperidinyl-2,6-dione
TTDS00003	Inhibitor	1,1-diphenyl-2-(3-tropanyl)ethanol
TTDS00003	Inhibitor	1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea
TTDS00003	Inhibitor	2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one
TTDS00003	Inhibitor	2-(4-Diethylamino-but-2-ynyl)-isoindole-1,3-dione
TTDS00003	Inhibitor	2-Methyl-6-pyrrolidin-1-yl-hex-4-ynal oxime
TTDS00003	Inhibitor	3-(3-benzylamino)-piperidin-2-one
TTDS00003	Inhibitor	3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00003	Inhibitor	3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane
TTDS00003	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00003	Inhibitor	6-Dimethylamino-2-methyl-hex-4-ynal oxime
TTDS00003	Inhibitor	7-Dimethylamino-3-methyl-hept-5-yn-2-one
TTDS00003	Inhibitor	7-Dimethylamino-hept-5-yn-2-one
TTDS00003	Inhibitor	7-Dimethylamino-hept-5-yn-2-one oxime
TTDS00003	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00003	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one oxime
TTDS00003	Inhibitor	A-987306
TTDS00003	Inhibitor	ACECLIDINE
TTDS00003	Inhibitor	Acetic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00003	Inhibitor	BRL-55473
TTDS00003	Inhibitor	Benzoic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00003	Inhibitor	CARAMIPEN
TTDS00003	Inhibitor	FLUMEZAPINE
TTDS00003	Inhibitor	FM1-10
TTDS00003	Inhibitor	FM1-43
TTDS00003	Inhibitor	GNF-PF-5618
TTDS00003	Inhibitor	HIMBACINE
TTDS00003	Inhibitor	ISOCLOZAPINE
TTDS00003	Inhibitor	ISOLOXAPINE
TTDS00003	Inhibitor	METHACHOLINE
TTDS00003	Inhibitor	METHOCTRAMINE
TTDS00003	Inhibitor	METHOCTRAMINE HYDROCHLORIDE
TTDS00003	Inhibitor	N-(4-Dimethylamino-but-2-ynyl)-N-methyl-acetamide
TTDS00003	Inhibitor	N-DESMETHYLCLOZAPINE
TTDS00003	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl chloride
TTDS00003	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl fluoride
TTDS00003	Inhibitor	Propionic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00003	Inhibitor	SCH-211803
TTDS00003	Inhibitor	SULFOARECOLINE
TTDS00003	Inhibitor	Tiotropium Bromide
TTDS00003	Inhibitor	XANOMELINE
TTDS00003	Antagonist	(R)-4-[2-[3-(4-methoxy-benzoylamino)-benzyl]-piperidin-1-ylmethyl]piperidine-1-c
TTDS00003	Antagonist	AF-DX116
TTDS00003	Antagonist	Gallamine Triethiodide
TTDS00003	Antagonist	Methylscopolamine
TTDS00003	Antagonist	Otenzepad
TTDS00003	Antagonist	Scopolamine
TTDS00003	Agonist	CMI-1145
TTDS00003	Agonist	CMI-936
TTDS00003	Agonist	Oxotremorine
TTDS00003	Agonist	PTAC
TTDS00004	UniProt ID	P20309
TTDS00004	Name	Muscarinic acetylcholine receptor M3
TTDS00004	Type of target	Successful target
TTDS00004	Synonyms	M3 receptor
TTDS00004	Disease	Airway hyperreactivity
TTDS00004	Disease	Urge incontinence
TTDS00004	Function	The muscarinic acetylcholine receptor mediates various cellular responses, inclu
TTDS00004	Sequence	MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILAL
TTDS00004	PDB Structure	2CSA
TTDS00004	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00004	Pathway	Calcium signaling pathway
TTDS00004	Pathway	Neuroactive ligand-receptor interaction
TTDS00004	Pathway	Regulation of actin cytoskeleton
TTDS00004	Related US Patent	6,500,822
TTDS00004	Related US Patent	6,627,644
TTDS00004	Related US Patent	6,635,658
TTDS00004	Related US Patent	6,645,958
TTDS00004	Related US Patent	6,667,301
TTDS00004	Target Validation	TTDS00004
TTDS00004	QSAR Model	TTDS00004
TTDS00004	Drug(s)	Cevimeline
TTDS00004	Drug(s)	Darifenacin
TTDS00004	Drug(s)	Diphemanil Methylsulfate
TTDS00004	Drug(s)	LAS-34273
TTDS00004	Drug(s)	Oxybutynin
TTDS00004	Drug(s)	Revatropate
TTDS00004	Drug(s)	Solifenacin
TTDS00004	Drug(s)	Succinylcholine
TTDS00004	Drug(s)	Tiotropium
TTDS00004	Drug(s)	Tolterodine
TTDS00004	Inhibitor	1'-Benzyl-3-phenyl-[3,4']bipiperidinyl-2,6-dione
TTDS00004	Inhibitor	1,1-diphenyl-2-(3-tropanyl)ethanol
TTDS00004	Inhibitor	1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea
TTDS00004	Inhibitor	2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one
TTDS00004	Inhibitor	2-Methyl-6-pyrrolidin-1-yl-hex-4-ynal oxime
TTDS00004	Inhibitor	3-(3-benzylamino)-piperidin-2-one
TTDS00004	Inhibitor	3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00004	Inhibitor	3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane
TTDS00004	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00004	Inhibitor	6-Dimethylamino-2-methyl-hex-4-ynal oxime
TTDS00004	Inhibitor	7-Dimethylamino-3-methyl-hept-5-yn-2-one
TTDS00004	Inhibitor	7-Dimethylamino-hept-5-yn-2-one
TTDS00004	Inhibitor	7-Dimethylamino-hept-5-yn-2-one oxime
TTDS00004	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00004	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one oxime
TTDS00004	Inhibitor	A-987306
TTDS00004	Inhibitor	ACECLIDINE
TTDS00004	Inhibitor	Acetic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00004	Inhibitor	BRL-55473
TTDS00004	Inhibitor	Benzoic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00004	Inhibitor	CREMASTRINE
TTDS00004	Inhibitor	FLUMEZAPINE
TTDS00004	Inhibitor	FM1-10
TTDS00004	Inhibitor	FM1-43
TTDS00004	Inhibitor	GNF-PF-5618
TTDS00004	Inhibitor	ISOCLOZAPINE
TTDS00004	Inhibitor	ISOLOXAPINE
TTDS00004	Inhibitor	N-(4-Dimethylamino-but-2-ynyl)-N-methyl-acetamide
TTDS00004	Inhibitor	N-DESMETHYLCLOZAPINE
TTDS00004	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl chloride
TTDS00004	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl fluoride
TTDS00004	Inhibitor	NOCARDIMICIN A
TTDS00004	Inhibitor	Nocardimicin F
TTDS00004	Inhibitor	Noccardimicin E
TTDS00004	Inhibitor	Propionic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00004	Inhibitor	SULFOARECOLINE
TTDS00004	Inhibitor	Tiotropium Bromide
TTDS00004	Inhibitor	UCB-101333-3
TTDS00004	Inhibitor	XANOMELINE
TTDS00004	Inhibitor	nocardimicin C
TTDS00004	Inhibitor	nocardimicin D
TTDS00004	Antagonist	3-(1-carbamoyl-1,1-diphenylmethyl)-1-(4-methoxyphenylethyl)pyrrolidine (APP)
TTDS00004	Antagonist	4-DAMP
TTDS00004	Antagonist	Darifenacin
TTDS00004	Antagonist	Diphemanil Methylsulfate
TTDS00004	Antagonist	LAS-34273
TTDS00004	Antagonist	Olterodine
TTDS00004	Antagonist	Oxybutynin
TTDS00004	Antagonist	Oxybutynine
TTDS00004	Antagonist	PTAC
TTDS00004	Antagonist	Revatropate
TTDS00004	Antagonist	Solifenacin
TTDS00004	Antagonist	Succinylcholine
TTDS00004	Antagonist	Tiotropium
TTDS00004	Antagonist	Tolterodine
TTDS00004	Antagonist	Zamifenacin
TTDS00004	Agonist	Cevimeline
TTDS00004	Multitarget	Revatropate
TTDS00005	UniProt ID	P08173
TTDS00005	Name	Muscarinic acetylcholine receptor M4
TTDS00005	Type of target	Successful target
TTDS00005	Synonyms	M4 receptor
TTDS00005	Disease	Analgesics
TTDS00005	Disease	Manic disorder
TTDS00005	Disease	Neurologic and psychiatric diseases
TTDS00005	Disease	Pain, unspecified
TTDS00005	Disease	Parkinsonian symptoms
TTDS00005	Function	The muscarinic acetylcholine receptor mediates various cellular responses, inclu
TTDS00005	Sequence	MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGNILVMLSIKVNRQLQTVNNYFLFSLACADLI
TTDS00005	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00005	Pathway	Neuroactive ligand-receptor interaction
TTDS00005	Pathway	Regulation of actin cytoskeleton
TTDS00005	Related US Patent	6,251,916
TTDS00005	Related US Patent	6,500,837
TTDS00005	Related US Patent	6,559,171
TTDS00005	Related US Patent	6,627,645
TTDS00005	Target Validation	TTDS00005
TTDS00005	Drug(s)	Diphenidol
TTDS00005	Drug(s)	Tropicamide
TTDS00005	Inhibitor	1'-Benzyl-3-phenyl-[3,4']bipiperidinyl-2,6-dione
TTDS00005	Inhibitor	1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea
TTDS00005	Inhibitor	2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one
TTDS00005	Inhibitor	2-Methyl-6-pyrrolidin-1-yl-hex-4-ynal oxime
TTDS00005	Inhibitor	3-(3-benzylamino)-piperidin-2-one
TTDS00005	Inhibitor	3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00005	Inhibitor	3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane
TTDS00005	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00005	Inhibitor	6-Dimethylamino-2-methyl-hex-4-ynal oxime
TTDS00005	Inhibitor	7-Dimethylamino-3-methyl-hept-5-yn-2-one
TTDS00005	Inhibitor	7-Dimethylamino-hept-5-yn-2-one
TTDS00005	Inhibitor	7-Dimethylamino-hept-5-yn-2-one oxime
TTDS00005	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00005	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one oxime
TTDS00005	Inhibitor	A-987306
TTDS00005	Inhibitor	ACECLIDINE
TTDS00005	Inhibitor	Acetic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00005	Inhibitor	BRL-55473
TTDS00005	Inhibitor	Benzoic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00005	Inhibitor	CREMASTRINE
TTDS00005	Inhibitor	FLUMEZAPINE
TTDS00005	Inhibitor	FM1-10
TTDS00005	Inhibitor	FM1-43
TTDS00005	Inhibitor	GNF-PF-5618
TTDS00005	Inhibitor	ISOCLOZAPINE
TTDS00005	Inhibitor	ISOLOXAPINE
TTDS00005	Inhibitor	METHACHOLINE
TTDS00005	Inhibitor	N-(4-Dimethylamino-but-2-ynyl)-N-methyl-acetamide
TTDS00005	Inhibitor	N-DESMETHYLCLOZAPINE
TTDS00005	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl chloride
TTDS00005	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl fluoride
TTDS00005	Inhibitor	PF-3409409
TTDS00005	Inhibitor	Propionic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00005	Inhibitor	SULFOARECOLINE
TTDS00005	Inhibitor	VU10007
TTDS00005	Inhibitor	VU10010
TTDS00005	Inhibitor	XANOMELINE
TTDS00005	Antagonist	Diphenidol
TTDS00005	Antagonist	Tropicamide
TTDS00005	Agonist	CMI-1145
TTDS00005	Agonist	CMI-936
TTDS00005	Agonist	PTAC
TTDS00006	UniProt ID	P08912
TTDS00006	Name	Muscarinic acetylcholine receptor M5
TTDS00006	Type of target	Successful target
TTDS00006	Synonyms	M5 receptor
TTDS00006	Disease	Opioid dependence
TTDS00006	Disease	Schizophrenia
TTDS00006	Function	The muscarinic acetylcholine receptor mediates various cellular responses, inclu
TTDS00006	Sequence	MEGDSYHNATTVNGTPVNHQPLERHRLWEVITIAAVTAVVSLITIVGNVLVMISFKVNSQLKTVNNYYLLSLACADLIIG
TTDS00006	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00006	Pathway	Calcium signaling pathway
TTDS00006	Pathway	Neuroactive ligand-receptor interaction
TTDS00006	Pathway	Regulation of actin cytoskeleton
TTDS00006	Target Validation	TTDS00006
TTDS00006	Drug(s)	Atropine
TTDS00006	Drug(s)	Homatropine Methylbromide
TTDS00006	Drug(s)	Metixene
TTDS00006	Drug(s)	Promazine
TTDS00006	Inhibitor	1'-Benzyl-3-phenyl-[3,4']bipiperidinyl-2,6-dione
TTDS00006	Inhibitor	1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea
TTDS00006	Inhibitor	2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one
TTDS00006	Inhibitor	2-Methyl-6-pyrrolidin-1-yl-hex-4-ynal oxime
TTDS00006	Inhibitor	3-(3-benzylamino)-piperidin-2-one
TTDS00006	Inhibitor	3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00006	Inhibitor	3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane
TTDS00006	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00006	Inhibitor	6-Dimethylamino-2-methyl-hex-4-ynal oxime
TTDS00006	Inhibitor	7-Dimethylamino-3-methyl-hept-5-yn-2-one
TTDS00006	Inhibitor	7-Dimethylamino-hept-5-yn-2-one
TTDS00006	Inhibitor	7-Dimethylamino-hept-5-yn-2-one oxime
TTDS00006	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one
TTDS00006	Inhibitor	7-Pyrrolidin-1-yl-hept-5-yn-2-one oxime
TTDS00006	Inhibitor	ACECLIDINE
TTDS00006	Inhibitor	Acetic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00006	Inhibitor	BRL-55473
TTDS00006	Inhibitor	Benzoic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester
TTDS00006	Inhibitor	CREMASTRINE
TTDS00006	Inhibitor	FLUMEZAPINE
TTDS00006	Inhibitor	FM1-10
TTDS00006	Inhibitor	FM1-43
TTDS00006	Inhibitor	GNF-PF-5618
TTDS00006	Inhibitor	ISOCLOZAPINE
TTDS00006	Inhibitor	ISOLOXAPINE
TTDS00006	Inhibitor	N-(4-Dimethylamino-but-2-ynyl)-N-methyl-acetamide
TTDS00006	Inhibitor	N-DESMETHYLCLOZAPINE
TTDS00006	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl chloride
TTDS00006	Inhibitor	N-methoxyquinuclidine-3-carboximidoyl fluoride
TTDS00006	Inhibitor	PF-3409409
TTDS00006	Inhibitor	SULFOARECOLINE
TTDS00006	Inhibitor	VU0119498
TTDS00006	Inhibitor	VU0238429
TTDS00006	Inhibitor	XANOMELINE
TTDS00006	Antagonist	Atropine
TTDS00006	Antagonist	Homatropine Methylbromide
TTDS00006	Antagonist	Metixene
TTDS00006	Binder	Promazine
TTDS00007	UniProt ID	P17948
TTDS00007	Name	Vascular endothelial growth factor receptor 1
TTDS00007	Type of target	Successful target
TTDS00007	Synonyms	Flt-1
TTDS00007	Synonyms	Fms-like tyrosine kinase 1
TTDS00007	Synonyms	Tyrosine-protein kinase FRT
TTDS00007	Synonyms	Tyrosine-protein kinase receptor FLT
TTDS00007	Synonyms	VEGFR-1
TTDS00007	Synonyms	Vascular permeability factor receptor
TTDS00007	Disease	Angiogenesis
TTDS00007	Disease	Angiogenesis in metastatic and atherosclerotic processes
TTDS00007	Disease	Inflammatory diseases
TTDS00007	Function	Receptor for VEGF, VEGFB and PGF, and has a tyrosine-protein kinase activity. Th
TTDS00007	Sequence	MVSYWDTGVLLCALLSCLLLTGSSSGSKLKDPELSLKGTQHIMQAGQTLHLQCRGEAAHKWSLPEMVSKESERLSITKSA
TTDS00007	PDB Structure	1FLT; 1QSV; 1QSZ; 1QTY; 1RV6; 2XAC; 3HNG
TTDS00007	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00007	Pathway	Cytokine-cytokine receptor interaction
TTDS00007	Pathway	Focal adhesion
TTDS00007	EC Number	EC 2.7.1.112
TTDS00007	Target Validation	TTDS00007
TTDS00007	QSAR Model	TTDS00007
TTDS00007	Drug(s)	ASP4130
TTDS00007	Drug(s)	Brivanib
TTDS00007	Drug(s)	CEP-11981
TTDS00007	Drug(s)	LY3012212
TTDS00007	Drug(s)	Nintedanib
TTDS00007	Drug(s)	Ranibizumab
TTDS00007	Drug(s)	Sorafenib
TTDS00007	Drug(s)	Telbermin
TTDS00007	Drug(s)	X-82
TTDS00007	Inhibitor	AAL-993
TTDS00007	Inhibitor	Ranibizumab
TTDS00007	Inhibitor	SEMAXINIB
TTDS00007	Inhibitor	SU-11652
TTDS00007	Inhibitor	SU-5416
TTDS00007	Inhibitor	Sorafenib
TTDS00007	Activator	Telbermin
TTDS00007	Multitarget	Sorafenib
TTDS00008	UniProt ID	P35968
TTDS00008	Name	Vascular endothelial growth factor receptor 2
TTDS00008	Type of target	Successful target
TTDS00008	Synonyms	Fetal liver kinase 1
TTDS00008	Synonyms	Kinase NYK
TTDS00008	Synonyms	Kinase insert domain receptor
TTDS00008	Synonyms	Protein-tyrosine kinase receptor Flk-1
TTDS00008	Synonyms	VEGFR-2
TTDS00008	Disease	Angiogenesis
TTDS00008	Disease	Cancer, unspecific
TTDS00008	Function	Receptor for VEGF or VEGF-c, and has a tyrosine-protein kinase activity. the VEG
TTDS00008	Sequence	MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECS
TTDS00008	PDB Structure	1VR2; 1Y6A; 1Y6B; 1YWN; 2OH4; 2P2H; 2P2I; 2QU5; 2QU6; 2RL5; 2X1W; 2X1X; 2XIR; 3B
TTDS00008	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00008	Pathway	Cytokine-cytokine receptor interaction
TTDS00008	Pathway	Focal adhesion
TTDS00008	Pathway	VEGF signaling pathway
TTDS00008	EC Number	EC 2.7.1.112
TTDS00008	Target Validation	TTDS00008
TTDS00008	QSAR Model	TTDS00008
TTDS00008	Drug(s)	4SC-203
TTDS00008	Drug(s)	ASP4130
TTDS00008	Drug(s)	Aflibercept
TTDS00008	Drug(s)	Axitinib
TTDS00008	Drug(s)	BAY-57-9352
TTDS00008	Drug(s)	CEP-7055
TTDS00008	Drug(s)	CP-547632
TTDS00008	Drug(s)	CT-322
TTDS00008	Drug(s)	CYC116
TTDS00008	Drug(s)	Cabozantinib
TTDS00008	Drug(s)	Cediranib
TTDS00008	Drug(s)	E 7080
TTDS00008	Drug(s)	KRN633
TTDS00008	Drug(s)	Motesanib
TTDS00008	Drug(s)	Motesanib diphosphate
TTDS00008	Drug(s)	OSI-930
TTDS00008	Drug(s)	PF-00337210
TTDS00008	Drug(s)	PTK787/ZK 222584
TTDS00008	Drug(s)	Pazopanib
TTDS00008	Drug(s)	Pazopanib HCl
TTDS00008	Drug(s)	Pegdinetanib
TTDS00008	Drug(s)	Ramucirumab
TTDS00008	Drug(s)	Regorafenib
TTDS00008	Drug(s)	SU-14813
TTDS00008	Drug(s)	SU-6668
TTDS00008	Drug(s)	Sunitinib
TTDS00008	Drug(s)	Sunitinib malate
TTDS00008	Drug(s)	Vandetanib
TTDS00008	Drug(s)	XL647
TTDS00008	Drug(s)	XL880
TTDS00008	Drug(s)	XL999
TTDS00008	Inhibitor	(+)K-252a
TTDS00008	Inhibitor	(2-Methoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine
TTDS00008	Inhibitor	(3-Phenoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine
TTDS00008	Inhibitor	(4-Phenoxy-phenyl)-quinazolin-4-yl-amine
TTDS00008	Inhibitor	(5-Phenyl-oxazol-2-yl)-m-tolyl-amine
TTDS00008	Inhibitor	2-(1H-indazol-3-yl)-1H-benzo[d]imidazole
TTDS00008	Inhibitor	2-(5-Phenyl-oxazol-2-ylamino)-benzonitrile
TTDS00008	Inhibitor	2-(p-toluidino)-4-phenylpyrimidine-5-carbonitrile
TTDS00008	Inhibitor	2-(pyrimidin-4-ylamino)thiazole-5-carbonitrile
TTDS00008	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDS00008	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDS00008	Inhibitor	3,6-Di-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine
TTDS00008	Inhibitor	3-((3-bromothiophen-2-yl)methylene)indolin-2-one
TTDS00008	Inhibitor	3-(1H-Indol-2-yl)-1H-quinolin-2-one
TTDS00008	Inhibitor	3-(4-aminophenyl)thieno[3,2-c]pyridin-4-amine
TTDS00008	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDS00008	Inhibitor	3-(5-Phenyl-oxazol-2-ylamino)-benzonitrile
TTDS00008	Inhibitor	3-(5-Thiophen-3-yl-pyridin-3-yl)-1H-indole
TTDS00008	Inhibitor	3-Benzimidazol-2-ylhydroquinolin-2-one
TTDS00008	Inhibitor	3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide
TTDS00008	Inhibitor	3-phenyl-1,4-dihydroindeno[1,2-c]pyrazole
TTDS00008	Inhibitor	4-(4-aminophenyl)-1H-indazol-3yl-amine
TTDS00008	Inhibitor	4-(4-m-Tolylamino-phthalazin-1-yl)-benzamide
TTDS00008	Inhibitor	4-(4-p-Tolylamino-phthalazin-1-yl)-benzamide
TTDS00008	Inhibitor	4-(5-Phenyl-oxazol-2-ylamino)-benzenesulfonamide
TTDS00008	Inhibitor	4-(isoquinolin-5-yl)-N-m-tolylphthalazin-1-amine
TTDS00008	Inhibitor	4-(isoquinolin-5-yl)-N-o-tolylphthalazin-1-amine
TTDS00008	Inhibitor	4-Chloro-N-(2-chloro-benzoyl)-benzenesulfonamide
TTDS00008	Inhibitor	4-Chloro-N-(2-methyl-benzoyl)-benzenesulfonamide
TTDS00008	Inhibitor	4-Chloro-N-(3-chloro-benzoyl)-benzenesulfonamide
TTDS00008	Inhibitor	4-Chloro-N-(4-chloro-benzoyl)-benzenesulfonamide
TTDS00008	Inhibitor	4-Chloro-N-(4-nitro-benzoyl)-benzenesulfonamide
TTDS00008	Inhibitor	4-phenyl-2-(phenylamino)pyrimidine-5-carbonitrile
TTDS00008	Inhibitor	4SC-203
TTDS00008	Inhibitor	5-(4-Methoxy-phenyl)-1-phenyl-1H-benzoimidazole
TTDS00008	Inhibitor	6-(1H-Benzoimidazol-2-yl)-benzocyclohepten-7-one
TTDS00008	Inhibitor	6-o-tolylquinazolin-2-amine
TTDS00008	Inhibitor	8-methyl-4H,7H-indolo[6,5,4-cd]indol-5-one
TTDS00008	Inhibitor	AAL-993
TTDS00008	Inhibitor	AG1295
TTDS00008	Inhibitor	AZD-1152-HQPA;Barasertib
TTDS00008	Inhibitor	Aflibercept
TTDS00008	Inhibitor	Axitinib
TTDS00008	Inhibitor	BAY-57-9352
TTDS00008	Inhibitor	BMS-536924
TTDS00008	Inhibitor	BMS-540215
TTDS00008	Inhibitor	BMS-645737
TTDS00008	Inhibitor	CB-676475
TTDS00008	Inhibitor	CEP-5104
TTDS00008	Inhibitor	CEP-7055
TTDS00008	Inhibitor	CP-547632
TTDS00008	Inhibitor	CT-322
TTDS00008	Inhibitor	CYC116
TTDS00008	Inhibitor	Cabozantinib
TTDS00008	Inhibitor	Cediranib
TTDS00008	Inhibitor	E 7080
TTDS00008	Inhibitor	IM-023911
TTDS00008	Inhibitor	IM-094261
TTDS00008	Inhibitor	IM-094882
TTDS00008	Inhibitor	Isoindolinone Urea derivative
TTDS00008	Inhibitor	K-252a analogue
TTDS00008	Inhibitor	KRN633
TTDS00008	Inhibitor	L000021649
TTDS00008	Inhibitor	Motesanib
TTDS00008	Inhibitor	Motesanib diphosphate
TTDS00008	Inhibitor	N-(2,4-Dichloro-benzoyl)-benzenesulfonamide
TTDS00008	Inhibitor	N-(3-Bromo-benzoyl)-4-chloro-benzenesulfonamide
TTDS00008	Inhibitor	NERATINIB
TTDS00008	Inhibitor	OSI-930
TTDS00008	Inhibitor	PD-153035
TTDS00008	Inhibitor	PD-173074
TTDS00008	Inhibitor	PTK787/ZK 222584
TTDS00008	Inhibitor	Pazopanib
TTDS00008	Inhibitor	Pazopanib HCl
TTDS00008	Inhibitor	Phenyl-(5-phenyl-oxazol-2-yl)-amine
TTDS00008	Inhibitor	Ro-4396686
TTDS00008	Inhibitor	SEMAXINIB
TTDS00008	Inhibitor	SU-11652
TTDS00008	Inhibitor	SU-14813
TTDS00008	Inhibitor	SU-5402
TTDS00008	Inhibitor	SU-5416
TTDS00008	Inhibitor	SU-6668
TTDS00008	Inhibitor	Sunitinib
TTDS00008	Inhibitor	Sunitinib malate
TTDS00008	Inhibitor	TG-100435
TTDS00008	Inhibitor	VATALANIB
TTDS00008	Inhibitor	Vandetanib
TTDS00008	Inhibitor	WHI-P180
TTDS00008	Inhibitor	XL647
TTDS00008	Inhibitor	XL880
TTDS00008	Inhibitor	XL999
TTDS00008	Inhibitor	[3-(5-Phenyl-oxazol-2-ylamino)-phenyl]-methanol
TTDS00008	Antibody	IMC-1C11
TTDS00008	Multitarget	4SC-203
TTDS00008	Multitarget	Aflibercept
TTDS00008	Multitarget	Axitinib
TTDS00008	Multitarget	BAY-57-9352
TTDS00008	Multitarget	CEP-7055
TTDS00008	Multitarget	CYC116
TTDS00008	Multitarget	Cabozantinib
TTDS00008	Multitarget	Motesanib
TTDS00008	Multitarget	Motesanib diphosphate
TTDS00008	Multitarget	OSI-930
TTDS00008	Multitarget	Pazopanib
TTDS00008	Multitarget	Pazopanib HCl
TTDS00008	Multitarget	SU-6668
TTDS00008	Multitarget	Sunitinib
TTDS00008	Multitarget	Sunitinib malate
TTDS00008	Multitarget	Vandetanib
TTDS00008	Multitarget	XL647
TTDS00008	Multitarget	XL880
TTDS00010	Name	Dopamine receptor
TTDS00010	Type of target	Successful target
TTDS00010	Disease	Hypotension
TTDS00010	Disease	Nausea and vomiting
TTDS00010	Disease	Neuroleptic malignant syndrome
TTDS00010	Disease	Neurotensin-like immunoreactivity
TTDS00010	Disease	Schizophrenia
TTDS00010	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00010	Pathway	Calcium signaling pathway
TTDS00010	Pathway	Gap junction
TTDS00010	Pathway	Neuroactive ligand-receptor interaction
TTDS00010	Related US Patent	6,316,027
TTDS00010	Related US Patent	6,576,624
TTDS00010	Target Validation	TTDS00010
TTDS00010	Drug(s)	BIM23A760
TTDS00010	Drug(s)	BL-1020
TTDS00010	Drug(s)	Bromocryptine mesylate
TTDS00010	Drug(s)	DU-127090
TTDS00010	Drug(s)	Denopamine
TTDS00010	Drug(s)	Docarpamine
TTDS00010	Drug(s)	Domperidone
TTDS00010	Drug(s)	Dopexamine
TTDS00010	Drug(s)	Entacapone+levodopa+carbidopa
TTDS00010	Drug(s)	Fencamfamine
TTDS00010	Drug(s)	Ibopamine hci
TTDS00010	Drug(s)	Levodopa
TTDS00010	Drug(s)	Lisuride
TTDS00010	Drug(s)	Prolixin decanoate
TTDS00010	Drug(s)	Ropinirole HCl
TTDS00010	Drug(s)	SLV-308
TTDS00010	Drug(s)	Thiethylperazine
TTDS00010	Drug(s)	Thiothixene
TTDS00010	Antagonist	Anti-D
TTDS00010	Antagonist	BIM23A760
TTDS00010	Antagonist	BL-1020
TTDS00010	Antagonist	DU-127090
TTDS00010	Antagonist	Domperidone
TTDS00010	Antagonist	Prolixin decanoate
TTDS00010	Antagonist	SLV-308
TTDS00010	Antagonist	Thiethylperazine
TTDS00010	Antagonist	Thiothixene
TTDS00010	Agonist	Bromocryptine mesylate
TTDS00010	Agonist	Entacapone+levodopa+carbidopa
TTDS00010	Agonist	Fencamfamine
TTDS00010	Agonist	Levodopa
TTDS00010	Agonist	Lisuride
TTDS00010	Agonist	Ropinirole HCl
TTDS00010	Agonist	Rotigitine
TTDS00010	Multitarget	BL-1020
TTDS00010	Multitarget	DU-127090
TTDS00010	Multitarget	Entacapone+levodopa+carbidopa
TTDS00011	UniProt ID	P21728
TTDS00011	Name	Dopamine D1 receptor
TTDS00011	Type of target	Successful target
TTDS00011	Synonyms	D(1) dopamine receptor
TTDS00011	Synonyms	D(1A) dopamine receptor
TTDS00011	Disease	Parkinson's disease
TTDS00011	Function	This is one of the five types (D1 to D5) of receptors for dopamine, and the acti
TTDS00011	Sequence	MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPW
TTDS00011	PDB Structure	1OZ5
TTDS00011	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00011	Pathway	Calcium signaling pathway
TTDS00011	Pathway	Gap junction
TTDS00011	Pathway	Neuroactive ligand-receptor interaction
TTDS00011	Target Validation	TTDS00011
TTDS00011	Drug(s)	BSF-78438
TTDS00011	Drug(s)	D1 agonist D2 antagonist
TTDS00011	Drug(s)	Fenoldopam
TTDS00011	Drug(s)	Methylergonovine
TTDS00011	Drug(s)	Pergolide
TTDS00011	Inhibitor	(+)-(1R,1'S)-berbamunine hydrochloride
TTDS00011	Inhibitor	(+)-(1R,1'S)-thaligrisine hydrochloride
TTDS00011	Inhibitor	(+)-BUTACLAMOL
TTDS00011	Inhibitor	(+/-)-nantenine
TTDS00011	Inhibitor	(-)-(1S,1'R)-O,O-dimethylgrisbine hydrochloride
TTDS00011	Inhibitor	(R)-(+)-coclaurine
TTDS00011	Inhibitor	(R)-(-)-10-methyl-11-hydroxyaporphine
TTDS00011	Inhibitor	(R)-(-)-11-hydroxy-N-n-propylnoraporphine
TTDS00011	Inhibitor	(R)-(-)-2-methoxy-11-hydroxyaporphine
TTDS00011	Inhibitor	(R)-(-)-2-methoxy-N-npropylnorapomorphine
TTDS00011	Inhibitor	(R)-(-)-N-ethyl-2-methoxy-11-hydroxynoraporphine
TTDS00011	Inhibitor	(R)-(-)-N-propyl-2-methoxy-11-hydroxynoraporphine
TTDS00011	Inhibitor	(R)-11-Amino-2-methoxyaporphine
TTDS00011	Inhibitor	(R)-2,11-Diaminoaporphine
TTDS00011	Inhibitor	(R,S)-homoaromaline hydrochloride
TTDS00011	Inhibitor	(S)-BULBOCAPNINE
TTDS00011	Inhibitor	(S)APOMORPHINE
TTDS00011	Inhibitor	(S,S)-oxandrine hydrochloride
TTDS00011	Inhibitor	1,2,3,7,12,12a-hexahydro-1-aza-pleiaden-5-ol
TTDS00011	Inhibitor	1,2,3,7,12,12a-hexahydro-1-aza-pleiadene-5,6-diol
TTDS00011	Inhibitor	1,2-Bis-[R-(-)-apomorphine-2'-oxy]ethane
TTDS00011	Inhibitor	1-(4-(1H-pyrazol-1-yl)benzyl)-4-phenylpiperazine
TTDS00011	Inhibitor	1-Aminomethyl-3-cyclohexyl-isochroman-5,6-diol
TTDS00011	Inhibitor	1-Aminomethyl-3-phenyl-isochroman-5,6-diol
TTDS00011	Inhibitor	1-Aminomethyl-isochroman-5,6-diol
TTDS00011	Inhibitor	1-Aminomethyl-isochroman-5,6-diol; hydrobromide
TTDS00011	Inhibitor	1-Benzyl-4-(2-ethynyl-pyrrol-1-yl)-piperidine
TTDS00011	Inhibitor	1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine
TTDS00011	Inhibitor	1-Benzyl-4-(2-oxazol-5-yl-pyrrol-1-yl)-piperidine
TTDS00011	Inhibitor	1-Dibenzo[b,f]oxepin-10-yl-4-methyl-piperazine
TTDS00011	Inhibitor	1-[2-(2-Benzyl-phenoxy)-ethyl]-piperidine
TTDS00011	Inhibitor	1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine
TTDS00011	Inhibitor	1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine
TTDS00011	Inhibitor	11-Butyryloxy-N-n-propylnoraporphine
TTDS00011	Inhibitor	11-Heptanoyloxy-N-n-propylnoraporphine
TTDS00011	Inhibitor	11-Hexanoyloxy-N-n-propylnoraporphine
TTDS00011	Inhibitor	11-Propionyloxy-N-n-propylnoraporphine
TTDS00011	Inhibitor	11-valeryloxynoraporphine
TTDS00011	Inhibitor	2-Methyl-8-phenyl-1,2,3,4-tetrahydro-isoquinoline
TTDS00011	Inhibitor	2-methoxyapomorphine
TTDS00011	Inhibitor	2-{[R-(-)-Apomorphine-2'-oxy]ethoxy}-ethanol
TTDS00011	Inhibitor	3,8-dibromoboldine
TTDS00011	Inhibitor	3-(1-Propyl-piperidin-3-yl)-phenol
TTDS00011	Inhibitor	3-Chloroboldine
TTDS00011	Inhibitor	3-Iodoboldine
TTDS00011	Inhibitor	3-bromoboldine
TTDS00011	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00011	Inhibitor	4-[2-(2-Benzyl-phenoxy)-ethyl]-morpholine
TTDS00011	Inhibitor	5-(2-Amino-ethyl)-2-chloro-phenol; hydrobromide
TTDS00011	Inhibitor	6-(2-Amino-ethyl)-biphenyl-2,3,4'-triol
TTDS00011	Inhibitor	6-(2-Amino-ethyl)-biphenyl-2,3-diol
TTDS00011	Inhibitor	6-(2-Dipropylamino-ethyl)-biphenyl-2,3,4'-triol
TTDS00011	Inhibitor	6-(2-Dipropylamino-ethyl)-biphenyl-2,3-diol
TTDS00011	Inhibitor	9-Aminomethyl-9H-fluorene-2,5,6-triol
TTDS00011	Inhibitor	9-Aminomethyl-9H-fluorene-3,4-diol
TTDS00011	Inhibitor	A-70108
TTDS00011	Inhibitor	BOLDINE
TTDS00011	Inhibitor	BP-897
TTDS00011	Inhibitor	DIHYDREXIDINE
TTDS00011	Inhibitor	Ecopipam
TTDS00011	Inhibitor	Etoloxamine
TTDS00011	Inhibitor	FALCARINDIOL
TTDS00011	Inhibitor	FLUMEZAPINE
TTDS00011	Inhibitor	FLUTROLINE
TTDS00011	Inhibitor	GLAUCINE
TTDS00011	Inhibitor	IBZM
TTDS00011	Inhibitor	ISOCLOZAPINE
TTDS00011	Inhibitor	ISOLOXAPINE
TTDS00011	Inhibitor	L-745870
TTDS00011	Inhibitor	LE 300
TTDS00011	Inhibitor	MCL-516
TTDS00011	Inhibitor	MELOSMINE
TTDS00011	Inhibitor	N-(4-Dipropylaminobutyl)-4-biphenylcarboxamide
TTDS00011	Inhibitor	N-(4-Propylaminobutyl)-4-biphenylcarboxamide
TTDS00011	Inhibitor	NORSTEPHALAGINE
TTDS00011	Inhibitor	PREDICENTRINE
TTDS00011	Inhibitor	PUKATEINE
TTDS00011	Inhibitor	Phenyltoloxamine
TTDS00011	Inhibitor	QUINPIROLE
TTDS00011	Inhibitor	R-N-PROPYLNORAPOMORPHINE
TTDS00011	Inhibitor	Ro-21-7767
TTDS00011	Inhibitor	SB-271046
TTDS00011	Inhibitor	SCH-12679
TTDS00011	Inhibitor	SCH-24518
TTDS00011	Inhibitor	SK&F-38393;SK&F-383933;SK-38393;SK-383933
TTDS00011	Inhibitor	SK&F-89626;SK-89626
TTDS00011	Inhibitor	STEPHOLIDINE
TTDS00011	Inhibitor	TEPA (possesses cytotoxic activity)
TTDS00011	Inhibitor	[R-(-)-Apomorphine-2-yl]-(2'-hydroxy-ethyl)ether
TTDS00011	Inhibitor	dihydrexidine
TTDS00011	Antagonist	Methylergonovine
TTDS00011	Antagonist	SCH-23390
TTDS00011	Agonist	D1 agonist D2 antagonist
TTDS00011	Agonist	Fenoldopam
TTDS00011	Agonist	Pergolide
TTDS00011	Agonist	SKF 38393
TTDS00011	Binder	BSF-78438
TTDS00011	Multitarget	D1 agonist D2 antagonist
TTDS00011	Multitarget	Pergolide
TTDS00012	UniProt ID	P14416
TTDS00012	Name	D(2) dopamine receptor
TTDS00012	Type of target	Successful target
TTDS00012	Synonyms	Dopamine D2 receptor
TTDS00012	Synonyms	Dopamine receptor 2
TTDS00012	Disease	Anxiety disorder, unspecified
TTDS00012	Disease	Attention deficit hyperactivity disorder
TTDS00012	Disease	Cocaine dependence
TTDS00012	Disease	Cognitive deficits
TTDS00012	Disease	Delusional disorder
TTDS00012	Disease	Depression
TTDS00012	Disease	Disabling peak-dose dyskinesias
TTDS00012	Disease	Erectile dysfunction
TTDS00012	Disease	Gastric emptying disorders
TTDS00012	Disease	Gilles de la Tourette's disorder
TTDS00012	Disease	Nausea and vomiting
TTDS00012	Disease	Neuroleptic malignant syndrome
TTDS00012	Disease	Neurological diseases
TTDS00012	Disease	Parkinson's disease
TTDS00012	Disease	Psychiatric illness
TTDS00012	Disease	Respiratory diseases
TTDS00012	Disease	Schizophrenia
TTDS00012	Disease	Vomiting
TTDS00012	Function	This is one of the five types (D1 to D5) of receptors for dopamine, and the acti
TTDS00012	Sequence	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVAD
TTDS00012	PDB Structure	1I15
TTDS00012	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00012	Pathway	Gap junction
TTDS00012	Pathway	Neuroactive ligand-receptor interaction
TTDS00012	Related US Patent	6,277,875
TTDS00012	Related US Patent	6,300,365
TTDS00012	Target Validation	TTDS00012
TTDS00012	Drug(s)	(-)-3PPP, Maryland
TTDS00012	Drug(s)	(S)-amisulpride
TTDS00012	Drug(s)	1192U90
TTDS00012	Drug(s)	Abaperidone hydrochloride
TTDS00012	Drug(s)	Acetophenazine
TTDS00012	Drug(s)	Amisulpride
TTDS00012	Drug(s)	Aplindore fumarate
TTDS00012	Drug(s)	Aripiprazole
TTDS00012	Drug(s)	Asenapine
TTDS00012	Drug(s)	Bifeprunox
TTDS00012	Drug(s)	Blonanserin
TTDS00012	Drug(s)	Bromocriptine
TTDS00012	Drug(s)	Cabergoline
TTDS00012	Drug(s)	Carphenazine
TTDS00012	Drug(s)	Chlorpromazine
TTDS00012	Drug(s)	Chlorprothixene
TTDS00012	Drug(s)	Clozapine
TTDS00012	Drug(s)	D1 agonist D2 antagonist
TTDS00012	Drug(s)	Dapotum D
TTDS00012	Drug(s)	Dexamfetamine
TTDS00012	Drug(s)	Dihydroergotoxine
TTDS00012	Drug(s)	Domperidone maleate
TTDS00012	Drug(s)	Dopamine
TTDS00012	Drug(s)	Dopamine antags
TTDS00012	Drug(s)	Flupenthixol
TTDS00012	Drug(s)	Fluphenazine
TTDS00012	Drug(s)	Fluspirilene
TTDS00012	Drug(s)	GMC-283
TTDS00012	Drug(s)	HMR-2934
TTDS00012	Drug(s)	Haloperidol
TTDS00012	Drug(s)	Iloperidone
TTDS00012	Drug(s)	Lamectacin
TTDS00012	Drug(s)	Loxapine
TTDS00012	Drug(s)	Lurasidone hydrochloride
TTDS00012	Drug(s)	Mesoridazine
TTDS00012	Drug(s)	Methamfetamine
TTDS00012	Drug(s)	Metoclopramide
TTDS00012	Drug(s)	Molindone
TTDS00012	Drug(s)	N-0923
TTDS00012	Drug(s)	Nemonapride
TTDS00012	Drug(s)	Nomifensine
TTDS00012	Drug(s)	Ocaperidone
TTDS00012	Drug(s)	Olanzapine
TTDS00012	Drug(s)	Org-23366
TTDS00012	Drug(s)	PD-157695
TTDS00012	Drug(s)	PD-158771
TTDS00012	Drug(s)	PD-172760
TTDS00012	Drug(s)	Paliperidone
TTDS00012	Drug(s)	Pardoprunox
TTDS00012	Drug(s)	Pergolide
TTDS00012	Drug(s)	Perphenazine
TTDS00012	Drug(s)	Pimozide
TTDS00012	Drug(s)	Pramipexole
TTDS00012	Drug(s)	Prochlorperazine
TTDS00012	Drug(s)	Quetiapine
TTDS00012	Drug(s)	Quetiapine SR
TTDS00012	Drug(s)	Quinagolide
TTDS00012	Drug(s)	Quinagolide hydrochloride
TTDS00012	Drug(s)	Remoxipride
TTDS00012	Drug(s)	Risperidone
TTDS00012	Drug(s)	Risperidone Consta
TTDS00012	Drug(s)	Ropinirole
TTDS00012	Drug(s)	Rotigotine patch
TTDS00012	Drug(s)	S32504
TTDS00012	Drug(s)	SDZ-HDC-912
TTDS00012	Drug(s)	SDZ-MAR-327
TTDS00012	Drug(s)	SLV-310
TTDS00012	Drug(s)	SLV-313
TTDS00012	Drug(s)	SLV-319
TTDS00012	Drug(s)	SSR-181507
TTDS00012	Drug(s)	Sertindole
TTDS00012	Drug(s)	Sibenadet
TTDS00012	Drug(s)	Sulpiride
TTDS00012	Drug(s)	Sumanirole
TTDS00012	Drug(s)	Y-931
TTDS00012	Drug(s)	ZD-3638
TTDS00012	Drug(s)	Ziprasidone
TTDS00012	Drug(s)	Zuclopenthixol
TTDS00012	Antagonist	(S)-amisulpride
TTDS00012	Antagonist	1192U90
TTDS00012	Antagonist	Abaperidone hydrochloride
TTDS00012	Antagonist	Acetophenazine
TTDS00012	Antagonist	Amisulpride
TTDS00012	Antagonist	Asenapine
TTDS00012	Antagonist	Blonanserin
TTDS00012	Antagonist	Carphenazine
TTDS00012	Antagonist	Chlorpromazine
TTDS00012	Antagonist	Chlorprothixene
TTDS00012	Antagonist	Clozapine
TTDS00012	Antagonist	Dapotum D
TTDS00012	Antagonist	Domperidone maleate
TTDS00012	Antagonist	Flupenthixol
TTDS00012	Antagonist	Fluphenazine
TTDS00012	Antagonist	Fluspirilene
TTDS00012	Antagonist	GMC-283
TTDS00012	Antagonist	HMR-2934
TTDS00012	Antagonist	Haloperidol
TTDS00012	Antagonist	Iloperidone
TTDS00012	Antagonist	Lamectacin
TTDS00012	Antagonist	Loxapine
TTDS00012	Antagonist	Lurasidone hydrochloride
TTDS00012	Antagonist	Metoclopramide
TTDS00012	Antagonist	Nomifensine
TTDS00012	Antagonist	Ocaperidone
TTDS00012	Antagonist	Org-23366
TTDS00012	Antagonist	PD-157695
TTDS00012	Antagonist	PD-158771
TTDS00012	Antagonist	PD-172760
TTDS00012	Antagonist	Paliperidone
TTDS00012	Antagonist	Perphenazine
TTDS00012	Antagonist	Pimozide
TTDS00012	Antagonist	Prochlorperazine
TTDS00012	Antagonist	Quetiapine SR
TTDS00012	Antagonist	Remoxipride
TTDS00012	Antagonist	Risperidone
TTDS00012	Antagonist	Risperidone Consta
TTDS00012	Antagonist	SLV-310
TTDS00012	Antagonist	SLV-319
TTDS00012	Antagonist	Sertindole
TTDS00012	Antagonist	Sulpiride
TTDS00012	Antagonist	Zuclopenthixol
TTDS00012	Agonist	(-)-3PPP, Maryland
TTDS00012	Agonist	Aplindore fumarate
TTDS00012	Agonist	Aripiprazole
TTDS00012	Agonist	Bifeprunox
TTDS00012	Agonist	Bromocriptine
TTDS00012	Agonist	Cabergoline
TTDS00012	Agonist	Dexamfetamine
TTDS00012	Agonist	Dihydroergotoxine
TTDS00012	Agonist	Dopamine
TTDS00012	Agonist	Mesoridazine
TTDS00012	Agonist	Methamfetamine
TTDS00012	Agonist	N-0923
TTDS00012	Agonist	Nemonapride
TTDS00012	Agonist	Olanzapine
TTDS00012	Agonist	Pardoprunox
TTDS00012	Agonist	Pergolide
TTDS00012	Agonist	Pramipexole
TTDS00012	Agonist	Quetiapine
TTDS00012	Agonist	Quinagolide
TTDS00012	Agonist	Quinagolide hydrochloride
TTDS00012	Agonist	Ropinirole
TTDS00012	Agonist	Rotigotine patch
TTDS00012	Agonist	S32504
TTDS00012	Agonist	SDZ-MAR-327
TTDS00012	Agonist	SLV-313
TTDS00012	Agonist	Sibenadet
TTDS00012	Agonist	Sumanirole
TTDS00012	Agonist	Ziprasidone
TTDS00012	Binder	Dopamine antags
TTDS00012	Binder	Molindone
TTDS00012	Binder	SDZ-HDC-912
TTDS00012	Binder	SSR-181507
TTDS00012	Binder	Y-931
TTDS00012	Binder	ZD-3638
TTDS00012	Multitarget	1192U90
TTDS00012	Multitarget	Abaperidone hydrochloride
TTDS00012	Multitarget	Asenapine
TTDS00012	Multitarget	Bifeprunox
TTDS00012	Multitarget	Blonanserin
TTDS00012	Multitarget	Dexamfetamine
TTDS00012	Multitarget	GMC-283
TTDS00012	Multitarget	HMR-2934
TTDS00012	Multitarget	Iloperidone
TTDS00012	Multitarget	Lurasidone hydrochloride
TTDS00012	Multitarget	Ocaperidone
TTDS00012	Multitarget	Org-23366
TTDS00012	Multitarget	PD-157695
TTDS00012	Multitarget	PD-158771
TTDS00012	Multitarget	Pergolide
TTDS00012	Multitarget	Pramipexole
TTDS00012	Multitarget	Risperidone Consta
TTDS00012	Multitarget	Ropinirole
TTDS00012	Multitarget	SDZ-MAR-327
TTDS00012	Multitarget	SLV-310
TTDS00012	Multitarget	SLV-313
TTDS00012	Multitarget	SLV-319
TTDS00012	Multitarget	SSR-181507
TTDS00012	Multitarget	Sibenadet
TTDS00012	Multitarget	ZD-3638
TTDS00013	UniProt ID	P35462
TTDS00013	Name	D(3) dopamine receptor
TTDS00013	Type of target	Successful target
TTDS00013	Synonyms	Dopamine receptor 3
TTDS00013	Disease	Drug dependence
TTDS00013	Disease	Neurological diseases
TTDS00013	Disease	Psychiatric illness
TTDS00013	Disease	Respiratory diseases
TTDS00013	Disease	Schizophrenia
TTDS00013	Function	This is one of the five types (D1 to D5) of receptors for dopamine, and the acti
TTDS00013	Sequence	MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVAT
TTDS00013	PDB Structure	3PBL
TTDS00013	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00013	Pathway	Neuroactive ligand-receptor interaction
TTDS00013	Related US Patent	6,277,875
TTDS00013	Related US Patent	6,300,365
TTDS00013	Target Validation	TTDS00013
TTDS00013	Drug(s)	AVE-5997EF
TTDS00013	Drug(s)	BP4.879a
TTDS00013	Drug(s)	BTS-79018
TTDS00013	Drug(s)	GSK598809
TTDS00013	Drug(s)	GSK618334
TTDS00013	Drug(s)	PD-157533
TTDS00013	Drug(s)	PD-157695
TTDS00013	Drug(s)	PD-158771
TTDS00013	Drug(s)	PF-217830
TTDS00013	Drug(s)	PNU-177864
TTDS00013	Drug(s)	Pfizer 10
TTDS00013	Drug(s)	Pramipexole
TTDS00013	Drug(s)	RGH-1756
TTDS00013	Drug(s)	Ropinirole
TTDS00013	Drug(s)	S32504
TTDS00013	Drug(s)	SB-277011
TTDS00013	Drug(s)	Sarizotan
TTDS00013	Drug(s)	U-99194A
TTDS00013	Inhibitor	(+)-BUTACLAMOL
TTDS00013	Inhibitor	(+/-)-7-hydroxy-2-(N,N-di-n-propylamino)tetralin
TTDS00013	Inhibitor	(+/-)-nantenine
TTDS00013	Inhibitor	(-)-3-(1-Propyl-piperidin-3-yl)-benzonitrile
TTDS00013	Inhibitor	(-)-5-hydroxy-2-(dipropylamino)tetralin
TTDS00013	Inhibitor	(-)3-(1-Propyl-piperidin-3-yl)-phenol
TTDS00013	Inhibitor	(2-Benzyl-phenyl)-(2-pyrrolidin-1-yl-ethyl)-amine
TTDS00013	Inhibitor	(4-Dipropylamino-cyclohexylidene)-acetonitrile
TTDS00013	Inhibitor	(4-Phenylethynyl-cyclohex-3-enyl)-dipropyl-amine
TTDS00013	Inhibitor	(R)-(-)-2-Methyl-apomorphine hydrochloride
TTDS00013	Inhibitor	(R)-(-)-2-Phenyl-apomorphine hydrochloride
TTDS00013	Inhibitor	(R)-2-(Benzylamino-methyl)-chroman-7-ol
TTDS00013	Inhibitor	1-(4-(1H-pyrazol-1-yl)benzyl)-4-phenylpiperazine
TTDS00013	Inhibitor	1-(4-(4-phenyl-1-piperazinyl)butyl)indolin-2-one
TTDS00013	Inhibitor	1-Benzyl-4-(2-ethynyl-pyrrol-1-yl)-piperidine
TTDS00013	Inhibitor	1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine
TTDS00013	Inhibitor	1-Benzyl-4-(2-oxazol-5-yl-pyrrol-1-yl)-piperidine
TTDS00013	Inhibitor	1-Benzyl-4-(3-oxazol-5-yl-pyrrol-1-yl)-piperidine
TTDS00013	Inhibitor	1-Benzyl-4-pyrrol-1-yl-piperidine
TTDS00013	Inhibitor	1-Dibenzo[b,f]oxepin-10-yl-4-methyl-piperazine
TTDS00013	Inhibitor	1-Propyl-3-(3-trifluoromethyl-phenyl)-pyrrolidine
TTDS00013	Inhibitor	1-[2-(2-Benzyl-phenoxy)-ethyl]-piperidine
TTDS00013	Inhibitor	1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine
TTDS00013	Inhibitor	1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine
TTDS00013	Inhibitor	2-(4-Dipropylamino-cyclohexylidene)-malononitrile
TTDS00013	Inhibitor	3-(1-Propyl-piperidin-3-yl)-phenol
TTDS00013	Inhibitor	3-(1-Propyl-pyrrolidin-3-yl)-phenol
TTDS00013	Inhibitor	3-(2-Benzylamino-ethoxy)-phenol
TTDS00013	Inhibitor	3-(4-Benzyl-piperazin-1-yl)-phenol
TTDS00013	Inhibitor	3-(4-Methyl-piperidin-1-ylmethyl)-1H-indole
TTDS00013	Inhibitor	3-(4-Phenyl-piperazin-1-ylmethyl)-1H-indole
TTDS00013	Inhibitor	3-(4-Phenyl-piperidin-1-ylmethyl)-1H-indole
TTDS00013	Inhibitor	4-(2-Benzylamino-ethoxy)-1,3-dihydro-indol-2-one
TTDS00013	Inhibitor	4-(4-Benzyl-piperazin-1-yl)-1H-benzoimidazole
TTDS00013	Inhibitor	4-(4-Benzyl-piperazin-1-yl)-1H-indole
TTDS00013	Inhibitor	4-(4-Benzyl-piperazin-1-yl)-5-chloro-1H-indole
TTDS00013	Inhibitor	4-(4-Benzyl-piperazin-1-yl)-7-bromo-1H-indole
TTDS00013	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00013	Inhibitor	4-Dipropylamino-cyclohex-1-enecarbonitrile
TTDS00013	Inhibitor	4-ethynyl-N,N-dipropylcyclohex-3-enamine
TTDS00013	Inhibitor	A-437203
TTDS00013	Inhibitor	A-690344
TTDS00013	Inhibitor	A-706149
TTDS00013	Inhibitor	A-987306
TTDS00013	Inhibitor	Azaperone
TTDS00013	Inhibitor	BEFIRADOL
TTDS00013	Inhibitor	BP-897
TTDS00013	Inhibitor	Benzyl-[2-(1H-indazol-4-yloxy)-ethyl]-amine
TTDS00013	Inhibitor	Benzyl-[2-(1H-indol-4-yloxy)-ethyl]-amine
TTDS00013	Inhibitor	D-189
TTDS00013	Inhibitor	D-190
TTDS00013	Inhibitor	D-192
TTDS00013	Inhibitor	D-193
TTDS00013	Inhibitor	D-203
TTDS00013	Inhibitor	D-210
TTDS00013	Inhibitor	D-218
TTDS00013	Inhibitor	D-219
TTDS00013	Inhibitor	D-220
TTDS00013	Inhibitor	D-237
TTDS00013	Inhibitor	D-264
TTDS00013	Inhibitor	D-315
TTDS00013	Inhibitor	D-366
TTDS00013	Inhibitor	DIHYDREXIDINE
TTDS00013	Inhibitor	Etoloxamine
TTDS00013	Inhibitor	FLUMEZAPINE
TTDS00013	Inhibitor	FLUTROLINE
TTDS00013	Inhibitor	GR-218231
TTDS00013	Inhibitor	ISOCLOZAPINE
TTDS00013	Inhibitor	ISOLOXAPINE
TTDS00013	Inhibitor	L-741626
TTDS00013	Inhibitor	L-741742
TTDS00013	Inhibitor	L-745870
TTDS00013	Inhibitor	LE 300
TTDS00013	Inhibitor	MAZAPERTINE
TTDS00013	Inhibitor	N-(4-Dipropylaminobutyl)-4-biphenylcarboxamide
TTDS00013	Inhibitor	N-(4-Propylaminobutyl)-4-biphenylcarboxamide
TTDS00013	Inhibitor	PG-01037
TTDS00013	Inhibitor	PNU-95666E
TTDS00013	Inhibitor	QUINPIROLE
TTDS00013	Inhibitor	R-226161
TTDS00013	Inhibitor	SB-271046
TTDS00013	Inhibitor	SPIPERONE
TTDS00013	Inhibitor	ST-198
TTDS00013	Inhibitor	STEPHOLIDINE
TTDS00013	Inhibitor	UH-232
TTDS00013	Inhibitor	[2-(1H-Benzoimidazol-4-yloxy)-ethyl]-benzyl-amine
TTDS00013	Antagonist	AS-8112
TTDS00013	Antagonist	AS-9705
TTDS00013	Antagonist	AVE-5997EF
TTDS00013	Antagonist	BP4.879a
TTDS00013	Antagonist	GSK598809
TTDS00013	Antagonist	GSK618334
TTDS00013	Antagonist	PD-157533
TTDS00013	Antagonist	PD-157695
TTDS00013	Antagonist	PD-158771
TTDS00013	Antagonist	PF-217830
TTDS00013	Antagonist	PNU-177864
TTDS00013	Antagonist	RGH-1756
TTDS00013	Antagonist	SB-277011
TTDS00013	Agonist	Pfizer 10
TTDS00013	Agonist	Pramipexole
TTDS00013	Agonist	Ropinirole
TTDS00013	Agonist	Ropinirole CR
TTDS00013	Agonist	S32504
TTDS00013	Agonist	Sarizotan
TTDS00013	Binder	BTS-79018
TTDS00013	Binder	U-99194A
TTDS00013	Multitarget	BTS-79018
TTDS00013	Multitarget	PD-157695
TTDS00013	Multitarget	PD-158771
TTDS00013	Multitarget	Pramipexole
TTDS00013	Multitarget	Ropinirole
TTDS00013	Multitarget	Sarizotan
TTDS00015	UniProt ID	P21918
TTDS00015	Name	D(1B) dopamine receptor
TTDS00015	Type of target	Successful target
TTDS00015	Synonyms	D(5) dopamine receptor
TTDS00015	Synonyms	D(5)D(1B) dopamine receptor dopamine receptor
TTDS00015	Synonyms	D1beta dopamine receptor
TTDS00015	Synonyms	Dopamine receptor 5
TTDS00015	Disease	Respiratory diseases
TTDS00015	Function	This is one of the five types (D1 to D5) of receptors for dopamine, and the acti
TTDS00015	Sequence	MLPPGSNGTAYPGQFALYQQLAQGNAVGGSAGAPPLGPSQVVTACLLTLLIIWTLLGNVLVCAAIVRSRHLRANMTNVFI
TTDS00015	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00015	Pathway	Calcium signaling pathway
TTDS00015	Pathway	Neuroactive ligand-receptor interaction
TTDS00015	Target Validation	TTDS00015
TTDS00015	Drug(s)	Apomorphine
TTDS00015	Drug(s)	GMC-283
TTDS00015	Drug(s)	LE-300
TTDS00015	Drug(s)	ZD-3638
TTDS00015	Inhibitor	(+/-)-nantenine
TTDS00015	Inhibitor	1-(4-(4-phenyl-1-piperazinyl)butyl)indolin-2-one
TTDS00015	Inhibitor	1-Dibenzo[b,f]oxepin-10-yl-4-methyl-piperazine
TTDS00015	Inhibitor	1-[2-(2-Benzyl-phenoxy)-ethyl]-piperidine
TTDS00015	Inhibitor	1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine
TTDS00015	Inhibitor	1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine
TTDS00015	Inhibitor	3-(1-Propyl-piperidin-3-yl)-phenol
TTDS00015	Inhibitor	4-[2-(2-Benzyl-phenoxy)-ethyl]-morpholine
TTDS00015	Inhibitor	DIHYDREXIDINE
TTDS00015	Inhibitor	FLUMEZAPINE
TTDS00015	Inhibitor	FLUTROLINE
TTDS00015	Inhibitor	ISOCLOZAPINE
TTDS00015	Inhibitor	ISOLOXAPINE
TTDS00015	Inhibitor	LE 300
TTDS00015	Inhibitor	Phenyltoloxamine
TTDS00015	Inhibitor	STEPHOLIDINE
TTDS00015	Antagonist	GMC-283
TTDS00015	Antagonist	LE-300
TTDS00015	Agonist	Apomorphine
TTDS00015	Agonist	SKF 38393
TTDS00015	Binder	ZD-3638
TTDS00015	Multitarget	GMC-283
TTDS00015	Multitarget	ZD-3638
TTDS00016	Name	Dopamine reuptake
TTDS00016	Type of target	Successful target
TTDS00016	Synonyms	Dopamine re-uptake
TTDS00016	Disease	Depression
TTDS00016	Disease	Obesity
TTDS00016	Related US Patent	6,410,736
TTDS00016	Related US Patent	6,596,741
TTDS00016	Related US Patent	6,677,378
TTDS00016	Related US Patent	6,716,868
TTDS00016	Target Validation	TTDS00016
TTDS00016	Drug(s)	Amineptine
TTDS00016	Drug(s)	Brasofensine
TTDS00016	Drug(s)	Bupropion+naltrexone
TTDS00016	Drug(s)	Cocaine
TTDS00016	Drug(s)	DOV 21947
TTDS00016	Drug(s)	DOV-216303
TTDS00016	Drug(s)	DOV-21947
TTDS00016	Drug(s)	GSK372475
TTDS00016	Drug(s)	NS 2359
TTDS00016	Drug(s)	Phenmetrazine
TTDS00016	Drug(s)	Radafaxine
TTDS00016	Drug(s)	Radaxafine HCl
TTDS00016	Inhibitor	Amineptine
TTDS00016	Inhibitor	Brasofensine
TTDS00016	Inhibitor	Bupropion+naltrexone
TTDS00016	Inhibitor	Cocaine
TTDS00016	Inhibitor	DOV 21947
TTDS00016	Inhibitor	DOV-216303
TTDS00016	Inhibitor	DOV-21947
TTDS00016	Inhibitor	GSK372475
TTDS00016	Inhibitor	Hypericum (St John's Wort)
TTDS00016	Inhibitor	Indatraline
TTDS00016	Inhibitor	NS 2359
TTDS00016	Inhibitor	Phenmetrazine
TTDS00016	Inhibitor	Radafaxine
TTDS00016	Inhibitor	Radaxafine HCl
TTDS00016	Multitarget	Bupropion+naltrexone
TTDS00016	Multitarget	Cocaine
TTDS00016	Multitarget	DOV 21947
TTDS00016	Multitarget	DOV-216303
TTDS00016	Multitarget	DOV-21947
TTDS00016	Multitarget	GSK372475
TTDS00016	Multitarget	NS 2359
TTDS00016	Multitarget	Phenmetrazine
TTDS00016	Multitarget	Radafaxine
TTDS00016	Multitarget	Radaxafine HCl
TTDS00017	UniProt ID	Q01959
TTDS00017	Name	Sodium-dependent dopamine transporter
TTDS00017	Type of target	Successful target
TTDS00017	Synonyms	DA transporter
TTDS00017	Synonyms	DAT
TTDS00017	Synonyms	Dopamine transporter
TTDS00017	Disease	Parkinson's disease
TTDS00017	Function	Amine transporter, terminating the action of dopamine by its high affinity sodiu
TTDS00017	Sequence	MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNPRQSPVEAQDRETWGKKIDFLLSVIGFAVDL
TTDS00017	BioChemical Class	Transmembrane protein
TTDS00017	Pathway	Parkinson's disease
TTDS00017	Target Validation	TTDS00017
TTDS00017	Drug(s)	Ioflupane i-123
TTDS00017	Drug(s)	Methylphenidate
TTDS00017	Drug(s)	RTI-336
TTDS00017	Drug(s)	Vanoxerine
TTDS00017	Inhibitor	(2R,3R)-iodoreboxetine
TTDS00017	Inhibitor	(2S,3S)-iodoreboxetine
TTDS00017	Inhibitor	(R)-DULOXETINE
TTDS00017	Inhibitor	(R)-Norfluoxetine
TTDS00017	Inhibitor	(S)-Norfluoxetine
TTDS00017	Inhibitor	1-benzylpiperidine hydrochloride
TTDS00017	Inhibitor	10R-hydroxylobel-7-ene
TTDS00017	Inhibitor	10R-hydroxylobelane
TTDS00017	Inhibitor	10S-hydroxylobel-7-ene
TTDS00017	Inhibitor	10S-hydroxylobelane
TTDS00017	Inhibitor	1S,2R-milnacipran
TTDS00017	Inhibitor	8R-hydroxylobel-9-ene
TTDS00017	Inhibitor	8R-hydroxylobelane
TTDS00017	Inhibitor	8S-hydroxylobel-9-ene
TTDS00017	Inhibitor	8S-hydroxylobelane
TTDS00017	Inhibitor	AMINOBENZTROPINE
TTDS00017	Inhibitor	ANOLOBINE
TTDS00017	Inhibitor	ANONAINE
TTDS00017	Inhibitor	ANTIOQUINE
TTDS00017	Inhibitor	COCAINE.HCL
TTDS00017	Inhibitor	COCLAURINE
TTDS00017	Inhibitor	D-166A
TTDS00017	Inhibitor	D-211A
TTDS00017	Inhibitor	D-211B
TTDS00017	Inhibitor	D-254C
TTDS00017	Inhibitor	D-257A
TTDS00017	Inhibitor	D-257C
TTDS00017	Inhibitor	DEXMETHYLPHENIDATE
TTDS00017	Inhibitor	DEXMETHYLPHENIDATE HYDROCHLORIDE
TTDS00017	Inhibitor	DIFLUOROBENZTROPINE
TTDS00017	Inhibitor	DIMETHYLGRISABINE
TTDS00017	Inhibitor	FLUOXETINE HYDROCHLORIDE
TTDS00017	Inhibitor	GB-12819
TTDS00017	Inhibitor	GBR-12909
TTDS00017	Inhibitor	HOMOAROMOLINE
TTDS00017	Inhibitor	ISOPILINE
TTDS00017	Inhibitor	ISOTETRANDRINE
TTDS00017	Inhibitor	LITOXETINE
TTDS00017	Inhibitor	METHYLENEDIOXYAMPHETAMINE
TTDS00017	Inhibitor	METHYLENEDIOXYMETHAMPHETAMINE
TTDS00017	Inhibitor	N,Ndimethyl milnacipran
TTDS00017	Inhibitor	N-Benzylmethylphenidate
TTDS00017	Inhibitor	NISOXETINE
TTDS00017	Inhibitor	NORBOLDINE
TTDS00017	Inhibitor	NORSTEPHALAGINE
TTDS00017	Inhibitor	O-methyldauricine
TTDS00017	Inhibitor	OBABERINE
TTDS00017	Inhibitor	PF-18298;PF-184298
TTDS00017	Inhibitor	PF-3409409
TTDS00017	Inhibitor	PF-526014
TTDS00017	Inhibitor	PSEUDOCOCAINE
TTDS00017	Inhibitor	PYROVALERONE
TTDS00017	Inhibitor	R-226161
TTDS00017	Inhibitor	R-NORDULOXETINE
TTDS00017	Inhibitor	RTI-219
TTDS00017	Inhibitor	SECOCULARIDINE
TTDS00017	Inhibitor	WIN-35065
TTDS00017	Inhibitor	WIN-35065-2
TTDS00017	Inhibitor	WIN-35066-2
TTDS00017	Inhibitor	WIN_35428
TTDS00017	Inhibitor	methyl 2-(naphthalen-2-yl)benzoate
TTDS00017	Inhibitor	para-chloroamphetamine
TTDS00017	Antagonist	4-Methoxyamphetamine
TTDS00017	Blocker	Methylphenidate
TTDS00017	Blocker	RTI-336
TTDS00017	Blocker	Vanoxerine
TTDS00017	Modulator	3,4-Methylenedioxymethamphetamine
TTDS00017	Modulator	MMDA
TTDS00018	Name	Gamma-aminobutyric acid receptor
TTDS00018	Type of target	Successful target
TTDS00018	Synonyms	GABA receptor
TTDS00018	Disease	Anxiety disorder, unspecified
TTDS00018	Disease	Helminth infection
TTDS00018	Disease	Huntington's disease
TTDS00018	Disease	Hypertonia and apnoeic episodes
TTDS00018	Disease	Mood [affective] disorders
TTDS00018	Disease	Parkinson's disease
TTDS00018	BioChemical Class	Chloride channel
TTDS00018	Pathway	Neuroactive ligand-receptor interaction
TTDS00018	Target Validation	TTDS00018
TTDS00018	Drug(s)	BL-1020
TTDS00018	Drug(s)	Clonazepam
TTDS00018	Drug(s)	Dextofisopam
TTDS00018	Drug(s)	E-2007
TTDS00018	Drug(s)	Ganaxolone
TTDS00018	Drug(s)	Phenobarbital
TTDS00018	Drug(s)	Phentermine+topiramate
TTDS00018	Drug(s)	Phenylbutyrate
TTDS00018	Drug(s)	Piperazine
TTDS00018	Drug(s)	RG1662
TTDS00018	Inhibitor	(4R)-4-ammoniopentanoate
TTDS00018	Inhibitor	(4S)-4-ammoniopentanoate
TTDS00018	Inhibitor	AFLATREME
TTDS00018	Inhibitor	ALFAXALONE
TTDS00018	Inhibitor	ALLOPREGNANOLONE
TTDS00018	Inhibitor	ALPIDEM
TTDS00018	Inhibitor	AMENTOFLAVONE
TTDS00018	Inhibitor	ANDROSTERONE
TTDS00018	Inhibitor	BETA-CCM
TTDS00018	Inhibitor	BRL-54504AX
TTDS00018	Inhibitor	CGP-27492
TTDS00018	Inhibitor	CGS-13767
TTDS00018	Inhibitor	CGS-17867A
TTDS00018	Inhibitor	CGS-8216
TTDS00018	Inhibitor	CGS-9895
TTDS00018	Inhibitor	CGS-9896
TTDS00018	Inhibitor	CI-218872
TTDS00018	Inhibitor	DIAZEPAM HYDROCHLORIDE
TTDS00018	Inhibitor	Divaplon
TTDS00018	Inhibitor	ELTANOLONE
TTDS00018	Inhibitor	ETIOCHOLANOLONE
TTDS00018	Inhibitor	GABAZINE
TTDS00018	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDS00018	Inhibitor	GNF-PF-3645
TTDS00018	Inhibitor	GNF-PF-4421
TTDS00018	Inhibitor	NIPECOTIC ACID
TTDS00018	Inhibitor	NORHARMANE
TTDS00018	Inhibitor	NSC-19028
TTDS00018	Inhibitor	NSC-73613
TTDS00018	Inhibitor	NSC-93394
TTDS00018	Inhibitor	PITRAZEPINE
TTDS00018	Inhibitor	PNU-91571
TTDS00018	Inhibitor	Piperidine-4-carboxylic acid
TTDS00018	Inhibitor	Pyrrolidin-3-yl-acetic acid
TTDS00018	Inhibitor	RIPAZEPAM
TTDS00018	Inhibitor	RO-054520
TTDS00018	Inhibitor	RO-145974
TTDS00018	Inhibitor	RO-145975
TTDS00018	Inhibitor	RO-147437
TTDS00018	Inhibitor	RO-194603
TTDS00018	Inhibitor	RWJ-16979
TTDS00018	Inhibitor	RY-066
TTDS00018	Inhibitor	Ro-15-3505;Sarmazenil
TTDS00018	Inhibitor	Ro-151310
TTDS00018	Inhibitor	Ro-154513
TTDS00018	Inhibitor	Ro-16-6028
TTDS00018	Inhibitor	Ro-4882224
TTDS00018	Inhibitor	Ro-4938581
TTDS00018	Inhibitor	THIOCOLCHICOSIDE
TTDS00018	Inhibitor	TPA-023
TTDS00018	Inhibitor	Toluene-1-diazonium-3-sulfonic acid anion
TTDS00018	Inhibitor	U-78875
TTDS00018	Inhibitor	U-89267
TTDS00018	Inhibitor	WEDELOLACTONE
TTDS00018	Inhibitor	ZK-93423
TTDS00018	Inhibitor	ridine-5-carboxylic acid ethyl ester
TTDS00018	Antagonist	Bicuculline
TTDS00018	Antagonist	Clomethiazole
TTDS00018	Antagonist	Phenobarbital
TTDS00018	Antagonist	Piperazine
TTDS00018	Antagonist	SR95531
TTDS00018	Agonist	BL-1020
TTDS00018	Agonist	Clonazepam
TTDS00018	Agonist	Dextofisopam
TTDS00018	Agonist	E-2007
TTDS00018	Agonist	Muscimol
TTDS00018	Agonist	Phenylbutyrate
TTDS00018	Modulator	Gabapentin GR
TTDS00018	Modulator	Ganaxolone
TTDS00018	Modulator	Phentermine+topiramate
TTDS00018	Multitarget	BL-1020
TTDS00018	Multitarget	Dextofisopam
TTDS00018	Multitarget	Phentermine+topiramate
TTDS00018	Multitarget	Phenylbutyrate
TTDS00019	Name	Gamma-aminobutyric acid A receptor
TTDS00019	Type of target	Successful target
TTDS00019	Synonyms	GABA(A) receptor
TTDS00019	Synonyms	GABA-A receptor
TTDS00019	Disease	Alcoholism
TTDS00019	Disease	Anxiety disorder, unspecified
TTDS00019	Disease	Disorders of initiating and maintaining sleep [insomnias]
TTDS00019	Disease	Dyskinesia
TTDS00019	Disease	Epilepsy
TTDS00019	Disease	Hyperkinetic extrapyramidal movement disorders
TTDS00019	Disease	Neurological diseases
TTDS00019	Disease	Primary headache disorders
TTDS00019	BioChemical Class	Chloride channel
TTDS00019	Pathway	Neuroactive ligand-receptor interaction
TTDS00019	Target Validation	TTDS00019
TTDS00019	QSAR Model	TTDS00019
TTDS00019	Drug(s)	AZD6280
TTDS00019	Drug(s)	AZD7325
TTDS00019	Drug(s)	Acamprosate
TTDS00019	Drug(s)	Aprobarbital
TTDS00019	Drug(s)	Barbiturate
TTDS00019	Drug(s)	Bromazepam
TTDS00019	Drug(s)	Diazepam
TTDS00019	Drug(s)	Dihydroergotoxine
TTDS00019	Drug(s)	ELB-139
TTDS00019	Drug(s)	Fospropofol disodium
TTDS00019	Drug(s)	Gaboxadol
TTDS00019	Drug(s)	Heptabarbital
TTDS00019	Drug(s)	Isoflurane
TTDS00019	Drug(s)	Lindane
TTDS00019	Drug(s)	Ocinaplon
TTDS00019	Drug(s)	TP-023
TTDS00019	Drug(s)	TPT-43
TTDS00019	Drug(s)	Zolpidem
TTDS00019	Drug(s)	Zopiclone
TTDS00019	Antagonist	Bicuculline
TTDS00019	Antagonist	Heptabarbital
TTDS00019	Antagonist	Lindane
TTDS00019	Antagonist	N-methylbicuculline
TTDS00019	Agonist	4,5,6,7-tetrahydroisoxazolo-[5,4-c]-pyridin-3-ol
TTDS00019	Agonist	AZD6280
TTDS00019	Agonist	AZD7325
TTDS00019	Agonist	Acamprosate
TTDS00019	Agonist	Barbiturate
TTDS00019	Agonist	Diazepam
TTDS00019	Agonist	Dihydroergotoxine
TTDS00019	Agonist	GABA
TTDS00019	Agonist	Gaboxadol
TTDS00019	Agonist	Isoflurane
TTDS00019	Agonist	Isoguvacine
TTDS00019	Agonist	Muscimol
TTDS00019	Agonist	THIP
TTDS00019	Modulator	ELB-139
TTDS00019	Modulator	Ocinaplon
TTDS00019	Modulator	TP-023
TTDS00019	Modulator	TPT-43
TTDS00019	Binder	Aprobarbital
TTDS00019	Binder	Bromazepam
TTDS00019	Binder	Zolpidem
TTDS00019	Binder	Zopiclone
TTDS00022	Name	Gamma-aminobutyric acid B receptor
TTDS00022	Type of target	Successful target
TTDS00022	Synonyms	GABA B receptor
TTDS00022	Synonyms	GABA(B) receptor
TTDS00022	Synonyms	GABAB receptor
TTDS00022	Synonyms	Gamma-aminobutyric acid type b receptor
TTDS00022	Disease	Analgesics
TTDS00022	Disease	Anxiety disorder, unspecified
TTDS00022	Disease	Asthma
TTDS00022	Disease	Cognitive deficits
TTDS00022	Disease	Convulsions
TTDS00022	Disease	Depression
TTDS00022	Disease	Dyskinesia
TTDS00022	Disease	Epilepsy
TTDS00022	Disease	Gastroesophageal reflux disease
TTDS00022	Disease	Hyperkinetic extrapyramidal movement disorders
TTDS00022	Disease	Meige's disease
TTDS00022	Disease	Neurological diseases
TTDS00022	Disease	Nociceptive disorders
TTDS00022	Disease	Parkinson's disease
TTDS00022	Disease	Psychiatric illness
TTDS00022	BioChemical Class	Chloride channel
TTDS00022	Pathway	Neuroactive ligand-receptor interaction
TTDS00022	Related US Patent	6,664,069
TTDS00022	Target Validation	TTDS00022
TTDS00022	Drug(s)	AZD3355
TTDS00022	Drug(s)	Baclofen
TTDS00022	Drug(s)	Gabapentin
TTDS00022	Drug(s)	Progabide
TTDS00022	Drug(s)	SGS-742
TTDS00022	Drug(s)	SSTarbaclofen
TTDS00022	Drug(s)	STX209
TTDS00022	Inhibitor	((E)-3-Amino-propenyl)-methyl-phosphinic acid
TTDS00022	Inhibitor	((Z)-3-Amino-propenyl)-methyl-phosphinic acid
TTDS00022	Inhibitor	(3-Amino-1-ethyl-propyl)-methyl-phosphinic acid
TTDS00022	Inhibitor	(3-Amino-1-hydroxy-propyl)-methyl-phosphinic acid
TTDS00022	Inhibitor	(3-Amino-phenyl)-phosphonic acid diphenyl ester
TTDS00022	Inhibitor	(3-Amino-propyl)-difluoromethyl-phosphinic acid
TTDS00022	Inhibitor	(3-Amino-propyl)-hexyl-phosphinic acid
TTDS00022	Inhibitor	(3-Amino-propyl)-hydroxymethyl-phosphinic acid
TTDS00022	Inhibitor	(3-Amino-propyl)-phosphonic acid
TTDS00022	Inhibitor	(R)-4-Amino-3-(4-chloro-phenyl)-butyric acid
TTDS00022	Inhibitor	(R)-5-Amino-3-(4-chloro-phenyl)-pentanoic acid
TTDS00022	Inhibitor	3-Amino-propane-1-sulfonic acid
TTDS00022	Inhibitor	3-ammoniopropane-1-sulfinate
TTDS00022	Inhibitor	4-Amino-3-(2-chloro-phenyl)-butyric acid
TTDS00022	Inhibitor	4-Amino-3-(4-fluoro-phenyl)-butyric acid
TTDS00022	Inhibitor	4-Amino-3-(5-bromo-thiophen-2-yl)-butyric acid
TTDS00022	Inhibitor	4-Amino-3-(5-chloro-thiophen-2-yl)-butyric acid
TTDS00022	Inhibitor	4-Amino-3-(5-methyl-thiophen-2-yl)-butyric acid
TTDS00022	Inhibitor	4-Amino-3-benzofuran-2-yl-butyric acid
TTDS00022	Inhibitor	4-Amino-3-thiophen-2-yl-butyric acid
TTDS00022	Inhibitor	CGP-27492
TTDS00022	Inhibitor	CGP-34938
TTDS00022	Inhibitor	CGP-35024
TTDS00022	Inhibitor	CGP-35348
TTDS00022	Inhibitor	CGP-35582
TTDS00022	Inhibitor	CGP-36216
TTDS00022	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDS00022	Antagonist	Gabapentin
TTDS00022	Antagonist	Phaclofen
TTDS00022	Antagonist	SCH 50911
TTDS00022	Antagonist	SGS-742
TTDS00022	Agonist	(+/-)-baclofen
TTDS00022	Agonist	AZD3355
TTDS00022	Agonist	Baclofen
TTDS00022	Agonist	CGP-44532
TTDS00022	Agonist	Progabide
TTDS00022	Agonist	SKF-97541
TTDS00023	Name	Gamma-aminobutyric acid uptake
TTDS00023	Type of target	Successful target
TTDS00023	Synonyms	GABA uptake
TTDS00023	Disease	Convulsions
TTDS00023	Disease	Epilepsy
TTDS00023	Target Validation	TTDS00023
TTDS00023	Drug(s)	Tiagabine
TTDS00023	Inhibitor	(R)-nipecotic acid
TTDS00023	Inhibitor	Cis-4-hydroxynipecotic acid
TTDS00023	Inhibitor	Guvacine
TTDS00023	Inhibitor	NNC 05-2045
TTDS00023	Inhibitor	NNC 711
TTDS00023	Inhibitor	THPO
TTDS00023	Inhibitor	Tiagabine
TTDS00024	UniProt ID	P80404
TTDS00024	Name	4-aminobutyrate aminotransferase, mitochondrial
TTDS00024	Type of target	Successful target
TTDS00024	Synonyms	(S)-3-amino-2-methylpropionate transaminase
TTDS00024	Synonyms	GABA aminotransferase
TTDS00024	Synonyms	GABA transaminase
TTDS00024	Synonyms	GABA-AT
TTDS00024	Synonyms	GABA-T
TTDS00024	Synonyms	Gamma-amino-N-butyrate transaminase
TTDS00024	Synonyms	L-AIBAT
TTDS00024	Disease	Convulsions
TTDS00024	Disease	Epilepsy
TTDS00024	Disease	Huntington's disease
TTDS00024	Disease	Tardive dyskinesia
TTDS00024	Sequence	MASMLLAQRLACSFQHSYRLLVPGSRHISQAAAKVDVEFDYDGPLMKTEVPGPRSQELMKQLNIIQNAEAVHFFCNYEES
TTDS00024	BioChemical Class	Transferases transferring nitrogenous groups
TTDS00024	Pathway	Alanine, aspartate and glutamate metabolism
TTDS00024	Pathway	Butanoate metabolism
TTDS00024	Pathway	Metabolic pathways
TTDS00024	Pathway	Propanoate metabolism
TTDS00024	Pathway	Valine, leucine and isoleucine degradation
TTDS00024	Pathway	beta-Alanine metabolism
TTDS00024	EC Number	EC 2.6.1.19
TTDS00024	EC Number	EC 2.6.1.22
TTDS00024	Target Validation	TTDS00024
TTDS00024	Drug(s)	Divalproex sodium
TTDS00024	Drug(s)	L-Alanine
TTDS00024	Drug(s)	Pyridoxal Phosphate
TTDS00024	Drug(s)	Pyruvic acid
TTDS00024	Drug(s)	Vigabatrin
TTDS00024	Inhibitor	(4e)-4-Aminohex-4-Enoic Acid
TTDS00024	Inhibitor	1-(4-hydroxyphenyl)prop-2-en-1-one
TTDS00024	Inhibitor	3-chloro-1-(4-hydroxyphenyl)propan-1-one
TTDS00024	Inhibitor	4-Amino Hexanoic Acid
TTDS00024	Inhibitor	4-hydroxy-3-nitrobenzaldehyde
TTDS00024	Inhibitor	4-hydroxybenzaldehyde
TTDS00024	Inhibitor	4-hydroxybenzylamine
TTDS00024	Inhibitor	Acetate Ion
TTDS00024	Inhibitor	Divalproex sodium
TTDS00024	Inhibitor	Gamma-acetylenic GABA
TTDS00024	Inhibitor	L-Alanine
TTDS00024	Inhibitor	NIPECOTIC ACID
TTDS00024	Inhibitor	OXAMATE
TTDS00024	Inhibitor	Pyridoxal Phosphate
TTDS00024	Inhibitor	Pyruvic acid
TTDS00024	Inhibitor	Sodium valproate
TTDS00024	Inhibitor	VANILLIN
TTDS00024	Inhibitor	Vigabatrin
TTDS00026	Name	Alpha adrenergic receptor
TTDS00026	Type of target	Successful target
TTDS00026	Synonyms	Alpha-adrenoceptor
TTDS00026	Disease	Diabetes mellitus
TTDS00026	Disease	Hypertonicity of bladder
TTDS00026	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00026	Pathway	Calcium signaling pathway
TTDS00026	Pathway	Neuroactive ligand-receptor interaction
TTDS00026	Pathway	Vascular smooth muscle contraction
TTDS00026	Related US Patent	6,486,190
TTDS00026	Target Validation	TTDS00026
TTDS00026	Drug(s)	Bevantolol
TTDS00026	Drug(s)	Dapiprazole
TTDS00026	Drug(s)	Dihydroergotamine
TTDS00026	Drug(s)	Droperidol
TTDS00026	Drug(s)	Ephedrine
TTDS00026	Drug(s)	Ergonovine
TTDS00026	Drug(s)	Guanadrel Sulfate
TTDS00026	Drug(s)	Mephentermine
TTDS00026	Drug(s)	Metaraminol
TTDS00026	Drug(s)	Methyldopa
TTDS00026	Drug(s)	Naphazoline
TTDS00026	Drug(s)	Phenoxybenzamine
TTDS00026	Drug(s)	Phentolamine
TTDS00026	Drug(s)	Phenylephrine
TTDS00026	Drug(s)	Pseudoephedrine
TTDS00026	Drug(s)	Thioridazine
TTDS00026	Drug(s)	Tolazoline
TTDS00026	Antagonist	Bevantolol
TTDS00026	Antagonist	Dapiprazole
TTDS00026	Antagonist	Guanadrel Sulfate
TTDS00026	Antagonist	Phenoxybenzamine
TTDS00026	Antagonist	Phentolamine
TTDS00026	Antagonist	Thioridazine
TTDS00026	Antagonist	Tolazoline
TTDS00026	Agonist	Dihydroergotamine
TTDS00026	Agonist	Ephedrine
TTDS00026	Agonist	Ergonovine
TTDS00026	Agonist	Mephentermine
TTDS00026	Agonist	Metaraminol
TTDS00026	Agonist	Methyldopa
TTDS00026	Agonist	Naphazoline
TTDS00026	Agonist	Phenylephrine
TTDS00026	Stimulator	Pseudoephedrine
TTDS00026	Binder	Droperidol
TTDS00027	Name	Alpha-1 adrenergic receptor
TTDS00027	Type of target	Successful target
TTDS00027	Synonyms	Alpha1-adrenoceptor
TTDS00027	Disease	Benign prostate hyperplasia
TTDS00027	Disease	Chronic cardiac failure
TTDS00027	Disease	Erectile dysfunction
TTDS00027	Disease	Gastrointestinal disturbances
TTDS00027	Disease	Hyperlipidemia
TTDS00027	Disease	Hypertension
TTDS00027	Disease	Lower urinary tract symptoms associated with benign prostatic hyperplasia
TTDS00027	Disease	Nasal congestion
TTDS00027	Disease	Orthostatic hypotension
TTDS00027	Disease	Prostate cancer
TTDS00027	Disease	Shy-Drager syndrome
TTDS00027	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00027	Pathway	Calcium signaling pathway
TTDS00027	Pathway	Neuroactive ligand-receptor interaction
TTDS00027	Pathway	Vascular smooth muscle contraction
TTDS00027	Related US Patent	6,291,498
TTDS00027	Related US Patent	6,410,565
TTDS00027	Related US Patent	6,410,735
TTDS00027	Related US Patent	6,420,559
TTDS00027	Target Validation	TTDS00027
TTDS00027	QSAR Model	TTDS00027
TTDS00027	Drug(s)	Carvedilol
TTDS00027	Drug(s)	Ergotamine
TTDS00027	Drug(s)	Labetalol
TTDS00027	Drug(s)	Midodrine
TTDS00027	Drug(s)	Phenylpropanolamine
TTDS00027	Drug(s)	Prazosin
TTDS00027	Drug(s)	Tamsulosin
TTDS00027	Antagonist	Carvedilol
TTDS00027	Antagonist	DC-015
TTDS00027	Antagonist	Labetalol
TTDS00027	Antagonist	Metazosin
TTDS00027	Antagonist	Prazosin
TTDS00027	Antagonist	Tamsulosin
TTDS00027	Antagonist	Urapidil
TTDS00027	Agonist	Ergotamine
TTDS00027	Agonist	Midodrine
TTDS00027	Agonist	Phenylpropanolamine
TTDS00029	UniProt ID	P35368
TTDS00029	Name	Alpha-1B adrenergic receptor
TTDS00029	Type of target	Successful target
TTDS00029	Synonyms	Alpha 1B-adrenoceptor
TTDS00029	Synonyms	Alpha 1B-adrenoreceptor
TTDS00029	Disease	Shy-Drager syndrome
TTDS00029	Function	This alpha-adrenergic receptor mediates its action by association with g protein
TTDS00029	Sequence	MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPT
TTDS00029	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00029	Pathway	Calcium signaling pathway
TTDS00029	Pathway	Neuroactive ligand-receptor interaction
TTDS00029	Pathway	Vascular smooth muscle contraction
TTDS00029	Related US Patent	6,303,606
TTDS00029	Related US Patent	6,559,153
TTDS00029	Related US Patent	6,642,228
TTDS00029	Target Validation	TTDS00029
TTDS00029	Drug(s)	Dextroamphetamine
TTDS00029	Drug(s)	Lisdexamfetamine
TTDS00029	Drug(s)	Methamphetamine
TTDS00029	Drug(s)	Methoxamine
TTDS00029	Drug(s)	Phendimetrazine
TTDS00029	Drug(s)	Propericiazine
TTDS00029	Inhibitor	(+/-)-nantenine
TTDS00029	Inhibitor	(2,6-Dichloro-phenyl)-(1H-imidazol-2-yl)-amine
TTDS00029	Inhibitor	(2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine
TTDS00029	Inhibitor	2-Pyridin-4-yl-1,2,3,4-tetrahydro-isoquinoline
TTDS00029	Inhibitor	4-((E)-1-Naphthalen-1-yl-propenyl)-1H-imidazole
TTDS00029	Inhibitor	4-((Z)-1-Naphthalen-1-yl-propenyl)-1H-imidazole
TTDS00029	Inhibitor	4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole
TTDS00029	Inhibitor	4-(1-Naphthalen-1-yl-propyl)-1H-imidazole
TTDS00029	Inhibitor	4-(1-Naphthalen-1-yl-vinyl)-1H-imidazole
TTDS00029	Inhibitor	4-(2,3-Dihydro-1H-phenalen-1-yl)-1H-imidazole
TTDS00029	Inhibitor	4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinoline
TTDS00029	Inhibitor	4-(3-Hydroxy-piperidin-3-yl)-benzene-1,2-diol
TTDS00029	Inhibitor	4-(4-Isopropyl-morpholin-2-yl)-benzene-1,2-diol
TTDS00029	Inhibitor	4-(4-Methyl-indan-1-yl)-1H-imidazole
TTDS00029	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00029	Inhibitor	4-Benzo[b]thiophen-4-yl-1H-imidazole
TTDS00029	Inhibitor	4-Morpholin-2-yl-benzene-1,2-diol
TTDS00029	Inhibitor	6-fluoronorepinehprine
TTDS00029	Inhibitor	A-119637
TTDS00029	Inhibitor	A-123189
TTDS00029	Inhibitor	ABANOQUIL
TTDS00029	Inhibitor	AGN-192172
TTDS00029	Inhibitor	AGN-193080
TTDS00029	Inhibitor	BMY-7378
TTDS00029	Inhibitor	CORYNANTHEINE
TTDS00029	Inhibitor	FLUANISONE
TTDS00029	Inhibitor	ISOCLOZAPINE
TTDS00029	Inhibitor	Imidazolidin-2-ylidene-o-tolyl-amine
TTDS00029	Inhibitor	Imidazolidin-2-ylidene-quinoxalin-6-yl-amine
TTDS00029	Inhibitor	LEVONORDEFRIN
TTDS00029	Inhibitor	MAZAPERTINE
TTDS00029	Inhibitor	MEDETOMIDINE
TTDS00029	Inhibitor	N-(5-Bromo-quinoxalin-6-yl)-guanidine
TTDS00029	Inhibitor	NIGULDIPINE
TTDS00029	Inhibitor	OCTOCLOTHEPIN
TTDS00029	Inhibitor	RWJ-25730
TTDS00029	Inhibitor	RWJ-68157
TTDS00029	Inhibitor	RWJ-69736
TTDS00029	Inhibitor	RX-821002
TTDS00029	Inhibitor	SK&F-104078;SK-104078
TTDS00029	Inhibitor	SK&F-104856;SK-104856
TTDS00029	Inhibitor	SK&F-105854;SK-105854
TTDS00029	Inhibitor	SK&F-106686;SK-106686
TTDS00029	Inhibitor	SK&F-86466;SK-86466
TTDS00029	Inhibitor	SNAP-5089
TTDS00029	Inhibitor	SNAP-8719
TTDS00029	Inhibitor	Siramesine
TTDS00029	Inhibitor	TIOSPIRONE
TTDS00029	Inhibitor	UH-301
TTDS00029	Inhibitor	WAY-100135
TTDS00029	Inhibitor	WB-4101
TTDS00029	Inhibitor	sunepitron
TTDS00029	Antagonist	Cyclazosin
TTDS00029	Antagonist	Dextroamphetamine
TTDS00029	Antagonist	Lisdexamfetamine
TTDS00029	Antagonist	Methamphetamine
TTDS00029	Antagonist	Phendimetrazine
TTDS00029	Stimulator	Methoxamine
TTDS00029	Binder	Propericiazine
TTDS00030	UniProt ID	P25100
TTDS00030	Name	Alpha-1D adrenergic receptor
TTDS00030	Type of target	Successful target
TTDS00030	Synonyms	Alpha 1D-adrenoceptor
TTDS00030	Synonyms	Alpha 1D-adrenoreceptor
TTDS00030	Synonyms	Alpha adrenergic receptor 1a
TTDS00030	Synonyms	Alpha-1A adrenergic receptor
TTDS00030	Disease	Hypertension
TTDS00030	Function	This alpha-adrenergic receptor mediates its effect through the influx of extrace
TTDS00030	Sequence	MTFRDLLSVSFEGPRPDSSAGGSSAGGGGGSAGGAAPSEGPAVGGVPGGAGGGGGVVGAGSGEDNRSSAGEPGSAGAGGD
TTDS00030	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00030	Pathway	Calcium signaling pathway
TTDS00030	Pathway	Neuroactive ligand-receptor interaction
TTDS00030	Pathway	Vascular smooth muscle contraction
TTDS00030	Related US Patent	6,320,049
TTDS00030	Related US Patent	6,323,231
TTDS00030	Related US Patent	6,326,372
TTDS00030	Related US Patent	6,358,959
TTDS00030	Related US Patent	6,420,366
TTDS00030	Target Validation	TTDS00030
TTDS00030	Drug(s)	Alfuzosin
TTDS00030	Drug(s)	Doxazosin
TTDS00030	Drug(s)	Terazosin
TTDS00030	Inhibitor	(+/-)-nantenine
TTDS00030	Inhibitor	(2,6-Dichloro-phenyl)-(1H-imidazol-2-yl)-amine
TTDS00030	Inhibitor	(2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine
TTDS00030	Inhibitor	1',2',3',6'-Tetrahydro-[2,4']bipyridinyl
TTDS00030	Inhibitor	1-(2-Chloro-phenyl)-piperazine
TTDS00030	Inhibitor	1-(2-Methoxy-phenyl)-piperazine
TTDS00030	Inhibitor	1-(3-Fluoro-pyridin-2-yl)-4-methyl-piperazine
TTDS00030	Inhibitor	1-Pyridin-2-yl-piperazine
TTDS00030	Inhibitor	2-Pyridin-4-yl-1,2,3,4-tetrahydro-isoquinoline
TTDS00030	Inhibitor	4-((E)-1-Naphthalen-1-yl-propenyl)-1H-imidazole
TTDS00030	Inhibitor	4-((Z)-1-Naphthalen-1-yl-propenyl)-1H-imidazole
TTDS00030	Inhibitor	4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole
TTDS00030	Inhibitor	4-(1-Naphthalen-1-yl-propyl)-1H-imidazole
TTDS00030	Inhibitor	4-(1-Naphthalen-1-yl-vinyl)-1H-imidazole
TTDS00030	Inhibitor	4-(2,3-Dihydro-1H-phenalen-1-yl)-1H-imidazole
TTDS00030	Inhibitor	4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinoline
TTDS00030	Inhibitor	4-(3-Hydroxy-piperidin-3-yl)-benzene-1,2-diol
TTDS00030	Inhibitor	4-(4-Isopropyl-morpholin-2-yl)-benzene-1,2-diol
TTDS00030	Inhibitor	4-(4-Methyl-indan-1-yl)-1H-imidazole
TTDS00030	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00030	Inhibitor	4-(4-chlorobenzyl)-2-allylphthalazin-1(2H)-one
TTDS00030	Inhibitor	4-(4-chlorobenzyl)-2-methylphthalazin-1(2H)-one
TTDS00030	Inhibitor	4-(4-chlorobenzyl)phthalazin-1(2H)-one
TTDS00030	Inhibitor	4-Benzo[b]thiophen-4-yl-1H-imidazole
TTDS00030	Inhibitor	4-Morpholin-2-yl-benzene-1,2-diol
TTDS00030	Inhibitor	4-benzyl-2-methylphthalazin-1(2H)-one
TTDS00030	Inhibitor	5-Bromo-8-piperazin-1-yl-imidazo[1,2-a]pyrazine
TTDS00030	Inhibitor	6-hydroxy-3-(3',5'-dihydroxyphenyl)coumarin
TTDS00030	Inhibitor	8-Piperazin-1-yl-imidazo[1,2-a]pyrazine
TTDS00030	Inhibitor	ABANOQUIL
TTDS00030	Inhibitor	AGN-192172
TTDS00030	Inhibitor	AGN-193080
TTDS00030	Inhibitor	BMY-7378
TTDS00030	Inhibitor	BP-897
TTDS00030	Inhibitor	CORYNANTHEINE
TTDS00030	Inhibitor	FLUANISONE
TTDS00030	Inhibitor	INDORAMIN
TTDS00030	Inhibitor	ISOCLOZAPINE
TTDS00030	Inhibitor	Imidazolidin-2-ylidene-o-tolyl-amine
TTDS00030	Inhibitor	Imidazolidin-2-ylidene-quinoxalin-6-yl-amine
TTDS00030	Inhibitor	LEVONORDEFRIN
TTDS00030	Inhibitor	MAZAPERTINE
TTDS00030	Inhibitor	MEDETOMIDINE
TTDS00030	Inhibitor	N-(5-Bromo-quinoxalin-6-yl)-guanidine
TTDS00030	Inhibitor	NIGULDIPINE
TTDS00030	Inhibitor	OCTOCLOTHEPIN
TTDS00030	Inhibitor	RWJ-25730
TTDS00030	Inhibitor	RWJ-38063
TTDS00030	Inhibitor	RWJ-68157
TTDS00030	Inhibitor	RWJ-69736
TTDS00030	Inhibitor	RX-821002
TTDS00030	Inhibitor	SK&F-104078;SK-104078
TTDS00030	Inhibitor	SK&F-104856;SK-104856
TTDS00030	Inhibitor	SK&F-105854;SK-105854
TTDS00030	Inhibitor	SK&F-106686;SK-106686
TTDS00030	Inhibitor	SK&F-86466;SK-86466
TTDS00030	Inhibitor	SNAP-5089
TTDS00030	Inhibitor	SNAP-8719
TTDS00030	Inhibitor	Siramesine
TTDS00030	Inhibitor	TIOSPIRONE
TTDS00030	Inhibitor	UH-301
TTDS00030	Inhibitor	WAY-100135
TTDS00030	Inhibitor	WB-4101
TTDS00030	Inhibitor	sunepitron
TTDS00030	Antagonist	Alfuzosin
TTDS00030	Antagonist	Doxazosin
TTDS00030	Antagonist	Terazosin
TTDS00030	Agonist	4-Methoxyamphetamine
TTDS00031	Name	Alpha-2 adrenergic receptor
TTDS00031	Type of target	Successful target
TTDS00031	Synonyms	Alpha(2)-adrenoceptor
TTDS00031	Disease	Alzheimer's disease
TTDS00031	Disease	Analgesics
TTDS00031	Disease	Diabetes mellitus
TTDS00031	Disease	Erectile dysfunction
TTDS00031	Disease	Gastrointestinal disturbances
TTDS00031	Disease	Heart failure
TTDS00031	Disease	Hypertension
TTDS00031	Disease	Ischemic heart disease
TTDS00031	Disease	Mechanical allodynia associated with neuropathic pain of spinal origin
TTDS00031	Disease	Nasal congestion
TTDS00031	Disease	Open-angle glaucoma
TTDS00031	Disease	Peri-operative ischemia
TTDS00031	Disease	Prefrontal cognitive deficits
TTDS00031	Disease	Spasticity associated with cerebral or spinal damage
TTDS00031	Disease	Systemic sclerosis
TTDS00031	Disease	Tachycardia, unspecified
TTDS00031	Disease	Vasospastic attacks associated with idiopathic Raynaud's disease
TTDS00031	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00031	Pathway	Neuroactive ligand-receptor interaction
TTDS00031	Related US Patent	6,306,877
TTDS00031	Related US Patent	6,391,878
TTDS00031	Related US Patent	6,426,350
TTDS00031	Related US Patent	6,436,978
TTDS00031	Related US Patent	6,486,202
TTDS00031	Related US Patent	6,495,555
TTDS00031	Related US Patent	6,544,927
TTDS00031	Related US Patent	6,576,640
TTDS00031	Target Validation	TTDS00031
TTDS00031	Drug(s)	ADX415
TTDS00031	Drug(s)	Apraclonidine
TTDS00031	Drug(s)	Clonidine
TTDS00031	Drug(s)	Dexamfetamine
TTDS00031	Drug(s)	Dexmedetomidine
TTDS00031	Drug(s)	Ergoloid mesylate
TTDS00031	Drug(s)	Guanabenz
TTDS00031	Drug(s)	Guanfacine
TTDS00031	Drug(s)	Guanfacine extended release
TTDS00031	Drug(s)	Idazoxan
TTDS00031	Drug(s)	Lofexidine
TTDS00031	Drug(s)	Meperidine
TTDS00031	Drug(s)	Nicergoline
TTDS00031	Drug(s)	Oxymetazoline
TTDS00031	Drug(s)	Tizanidine
TTDS00031	Drug(s)	Yohimbine
TTDS00031	Antagonist	ADX415
TTDS00031	Antagonist	Atipamezole
TTDS00031	Antagonist	Ergoloid mesylate
TTDS00031	Antagonist	Fipamezole
TTDS00031	Antagonist	Idazoxan
TTDS00031	Antagonist	Nicergoline
TTDS00031	Antagonist	Rauwolscine
TTDS00031	Antagonist	Yohimbine
TTDS00031	Agonist	Apraclonidine
TTDS00031	Agonist	BHT-920
TTDS00031	Agonist	Brominide tartrate
TTDS00031	Agonist	Clonidine
TTDS00031	Agonist	Dexamfetamine
TTDS00031	Agonist	Dexmedetomidine
TTDS00031	Agonist	Guanabenz
TTDS00031	Agonist	Guanfacine
TTDS00031	Agonist	Guanfacine extended release
TTDS00031	Agonist	Lofexidine
TTDS00031	Agonist	Meperidine
TTDS00031	Agonist	Mivazerol
TTDS00031	Agonist	Oxymetazoline
TTDS00031	Agonist	Saline
TTDS00031	Agonist	Tizanidine
TTDS00031	Agonist	UK 14,304
TTDS00031	Multitarget	Dexamfetamine
TTDS00032	UniProt ID	P08913
TTDS00032	Name	Alpha-2A adrenergic receptor
TTDS00032	Type of target	Successful target
TTDS00032	Synonyms	Alpha-2A adrenoceptor
TTDS00032	Synonyms	Alpha-2A adrenoreceptor
TTDS00032	Synonyms	Alpha-2AAR subtype C10
TTDS00032	Disease	Heart failure
TTDS00032	Disease	Hypertension
TTDS00032	Disease	Ischemic heart disease
TTDS00032	Function	Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of ade
TTDS00032	Sequence	MGSLQPDAGNASWNGTEAPGGGARATPYSLQVTLTLVCLAGLLMLLTVFGNVLVIIAVFTSRALKAPQNLFLVSLASADI
TTDS00032	PDB Structure	1HLL; 1HO9; 1HOD; 1HOF
TTDS00032	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00032	Pathway	Neuroactive ligand-receptor interaction
TTDS00032	Target Validation	TTDS00032
TTDS00032	Drug(s)	Brimonidine
TTDS00032	Drug(s)	Connexyn
TTDS00032	Inhibitor	(+/-)-nantenine
TTDS00032	Inhibitor	(1,2,3,4-Tetrahydro-isoquinolin-3-yl)-methanol
TTDS00032	Inhibitor	(1H-Benzoimidazol-5-yl)-(1H-imidazol-2-yl)-amine
TTDS00032	Inhibitor	(1H-Imidazol-2-yl)-quinoxalin-6-yl-amine
TTDS00032	Inhibitor	(2,6-Dichloro-phenyl)-(1H-imidazol-2-yl)-amine
TTDS00032	Inhibitor	(2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine
TTDS00032	Inhibitor	(2-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine
TTDS00032	Inhibitor	(3-Ethyl-indol-1-yl)-propyl-pyridin-4-yl-amine
TTDS00032	Inhibitor	(3-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine
TTDS00032	Inhibitor	(R)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline
TTDS00032	Inhibitor	(S)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline
TTDS00032	Inhibitor	1',2',3',6'-Tetrahydro-[2,4']bipyridinyl
TTDS00032	Inhibitor	1,2,3,4,4a,5,10,10a-Octahydro-benzo[g]quinoline
TTDS00032	Inhibitor	1,2,3,4,5,6-Hexahydro-benzo[c]azocine
TTDS00032	Inhibitor	1,2,3,4-Tetrahydro-benzo[h]isoquinolin-8-ol
TTDS00032	Inhibitor	1,2,3,4-Tetrahydro-isoquinolin-7-ol
TTDS00032	Inhibitor	1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole
TTDS00032	Inhibitor	1,2,3,4-tetrahydroisoquinoline
TTDS00032	Inhibitor	1-((S)-2-aminopropyl)-1H-indazol-6-ol
TTDS00032	Inhibitor	1-(3-Fluoro-pyridin-2-yl)-4-methyl-piperazine
TTDS00032	Inhibitor	1-Pyridin-2-yl-piperazine
TTDS00032	Inhibitor	2,3,4,5-Tetrahydro-1H-benzo[c]azepine
TTDS00032	Inhibitor	2,3,4,5-Tetrahydro-1H-benzo[e][1,4]diazepine
TTDS00032	Inhibitor	2,3,4,5-Tetrahydro-benzo[f][1,4]oxazepine
TTDS00032	Inhibitor	2,3-Dihydro-1H-isoindole
TTDS00032	Inhibitor	2-Benzofuran-2-yl-4,5-dihydro-1H-imidazole
TTDS00032	Inhibitor	3-Fluoromethyl-1,2,3,4-tetrahydro-isoquinoline
TTDS00032	Inhibitor	3-Methoxymethyl-1,2,3,4-tetrahydro-isoquinoline
TTDS00032	Inhibitor	3-Methyl-1,2,3,4-tetrahydro-isoquinoline
TTDS00032	Inhibitor	3-Methyl-7-nitro-1,2,3,4-tetrahydro-isoquinoline
TTDS00032	Inhibitor	4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole
TTDS00032	Inhibitor	4-(4-Methyl-indan-1-yl)-1H-imidazole
TTDS00032	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00032	Inhibitor	4-Benzo[b]thiophen-4-yl-1H-imidazole
TTDS00032	Inhibitor	5-Aminomethyl-naphthalen-2-ol
TTDS00032	Inhibitor	6,7,8,9-Tetrahydro-5-thia-8-aza-benzocycloheptene
TTDS00032	Inhibitor	7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline
TTDS00032	Inhibitor	7-Nitro-1,2,3,4-tetrahydro-isoquinoline
TTDS00032	Inhibitor	8-Methoxy-1,2,3,4-tetrahydro-benzo[h]isoquinoline
TTDS00032	Inhibitor	A-80426
TTDS00032	Inhibitor	AKUAMMIGINE
TTDS00032	Inhibitor	AR-129330
TTDS00032	Inhibitor	ATC-0175
TTDS00032	Inhibitor	BP-897
TTDS00032	Inhibitor	Butyl-indol-1-yl-pyridin-4-yl-amine
TTDS00032	Inhibitor	C-(6-Methoxy-naphthalen-1-yl)-methylamine
TTDS00032	Inhibitor	C-Naphthalen-1-yl-methylamine
TTDS00032	Inhibitor	Ethyl-indol-1-yl-pyridin-4-yl-amine
TTDS00032	Inhibitor	GNF-PF-2857
TTDS00032	Inhibitor	GNF-PF-3427
TTDS00032	Inhibitor	GNF-PF-3878
TTDS00032	Inhibitor	Indol-1-yl-methyl-pyridin-4-yl-amine
TTDS00032	Inhibitor	Indol-1-yl-prop-2-ynyl-pyridin-4-yl-amine
TTDS00032	Inhibitor	Indol-1-yl-propyl-pyridin-4-yl-amine
TTDS00032	Inhibitor	Indol-1-yl-pyridin-4-yl-amine
TTDS00032	Inhibitor	MAZAPERTINE
TTDS00032	Inhibitor	MEDETOMIDINE
TTDS00032	Inhibitor	METHYLNORADRENALINE
TTDS00032	Inhibitor	MEZILAMINE
TTDS00032	Inhibitor	MOXONIDINE
TTDS00032	Inhibitor	PIPEROXAN
TTDS00032	Inhibitor	R-226161
TTDS00032	Inhibitor	RX-821002
TTDS00032	Inhibitor	S-34324
TTDS00032	Inhibitor	SK&F-104078;SK-104078
TTDS00032	Inhibitor	SK&F-29661;SK-29661
TTDS00032	Inhibitor	SK&F-64139;SK-64139
TTDS00032	Inhibitor	SNAP-5089
TTDS00032	Inhibitor	SNAP-5150
TTDS00032	Inhibitor	TRACIZOLINE
TTDS00032	Inhibitor	TRAMAZOLINE
TTDS00032	Inhibitor	TRYPTOLINE
TTDS00032	Inhibitor	WB-4101
TTDS00032	Inhibitor	Yohimbine Hydrochloride
TTDS00032	Antagonist	BRL 44408
TTDS00032	Antagonist	Ciproxifan
TTDS00032	Agonist	4-Methoxyamphetamine
TTDS00032	Agonist	Brimonidine
TTDS00032	Agonist	Chloroethylclonidine
TTDS00032	Agonist	Connexyn
TTDS00035	Name	Beta adrenergic receptor
TTDS00035	Type of target	Successful target
TTDS00035	Synonyms	Beta-Adrenoceptor
TTDS00035	Disease	Noninsulin-dependent diabetes mellitus
TTDS00035	Disease	Obesity
TTDS00035	Disease	Schizophrenia
TTDS00035	BioChemical Class	Transmembrane protein
TTDS00035	Pathway	Calcium signaling pathway
TTDS00035	Pathway	Neuroactive ligand-receptor interaction
TTDS00035	Related US Patent	6,297,382
TTDS00035	Related US Patent	6,316,443
TTDS00035	Related US Patent	6,352,992
TTDS00035	Related US Patent	6,399,605
TTDS00035	Related US Patent	6,414,030
TTDS00035	Related US Patent	6,441,181
TTDS00035	Target Validation	TTDS00035
TTDS00035	Drug(s)	Arbutamine
TTDS00035	Drug(s)	Bethanidine
TTDS00035	Drug(s)	Bretylium
TTDS00035	Drug(s)	Carteolol
TTDS00035	Drug(s)	Cryptenamine
TTDS00035	Drug(s)	Dipivefrin
TTDS00035	Drug(s)	Epinephrine
TTDS00035	Drug(s)	Isoetharine
TTDS00035	Drug(s)	Isoproterenol
TTDS00035	Drug(s)	Levobunolol
TTDS00035	Drug(s)	Metipranolol
TTDS00035	Drug(s)	Nadolol
TTDS00035	Drug(s)	Norepinephrine
TTDS00035	Drug(s)	Penbutolol
TTDS00035	Drug(s)	Pindolol
TTDS00035	Drug(s)	Propranolol
TTDS00035	Drug(s)	Ritodrine
TTDS00035	Drug(s)	Timolol
TTDS00035	Antagonist	(-)-propranolol
TTDS00035	Antagonist	Bethanidine
TTDS00035	Antagonist	Bretylium
TTDS00035	Antagonist	Cryptenamine
TTDS00035	Antagonist	Dipivefrin
TTDS00035	Antagonist	Levobunolol
TTDS00035	Antagonist	Metipranolol
TTDS00035	Antagonist	Nadolol
TTDS00035	Antagonist	Penbutolol
TTDS00035	Antagonist	Pindolol
TTDS00035	Antagonist	Propranolol
TTDS00035	Antagonist	Timolol
TTDS00035	Agonist	BRL 35135
TTDS00035	Agonist	Carazolol
TTDS00035	Agonist	Carteolol
TTDS00035	Agonist	Epinephrine
TTDS00035	Agonist	Isoetharine
TTDS00035	Agonist	Isoprenaline
TTDS00035	Agonist	Isoproterenol
TTDS00035	Agonist	Ritodrine
TTDS00035	Stimulator	Arbutamine
TTDS00035	Stimulator	Norepinephrine
TTDS00036	UniProt ID	P08588
TTDS00036	Name	Beta-1 adrenergic receptor
TTDS00036	Type of target	Successful target
TTDS00036	Synonyms	Beta-1 adrenoceptor
TTDS00036	Synonyms	Beta-1 adrenoreceptor
TTDS00036	Disease	Anxiety disorder, unspecified
TTDS00036	Disease	Asthma
TTDS00036	Disease	Cardiac arrhythmias
TTDS00036	Disease	Cardiovascular disease, unspecified
TTDS00036	Disease	Coronary heart disease
TTDS00036	Disease	Dilated cardiomyopathy
TTDS00036	Disease	Glaucoma
TTDS00036	Disease	Hypertension
TTDS00036	Function	Beta-adrenergic receptors mediate the catecholamine- induced activation of adeny
TTDS00036	Sequence	MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAGMGLLMALIVLLIVAGNVLVI
TTDS00036	PDB Structure	2LSQ
TTDS00036	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00036	Target Validation	TTDS00036
TTDS00036	Drug(s)	Acebutolol
TTDS00036	Drug(s)	Ajmalicine
TTDS00036	Drug(s)	Alprenolol
TTDS00036	Drug(s)	Anisodamine
TTDS00036	Drug(s)	Anisodine
TTDS00036	Drug(s)	Atenolol
TTDS00036	Drug(s)	Betaxolol
TTDS00036	Drug(s)	Bisoprolol
TTDS00036	Drug(s)	Dobutamine
TTDS00036	Drug(s)	Esmolol
TTDS00036	Drug(s)	Levobetaxolol
TTDS00036	Drug(s)	Metoprolol
TTDS00036	Drug(s)	Nebivolol
TTDS00036	Drug(s)	Oxprenolol
TTDS00036	Drug(s)	Practolol
TTDS00036	Drug(s)	Sotalol
TTDS00036	Inhibitor	(+/-)-nantenine
TTDS00036	Inhibitor	(R,R)-(-)-fenoterol
TTDS00036	Inhibitor	(R,S)-(-)-fenoterol
TTDS00036	Inhibitor	1-(1H-Indol-4-yloxy)-3-phenethylamino-propan-2-ol
TTDS00036	Inhibitor	1-(2-allylphenoxy)-3-morpholinopropan-2-ol
TTDS00036	Inhibitor	1-(2-isopropylphenoxy)-3-morpholinopropan-2-ol
TTDS00036	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00036	Inhibitor	BRL-37344
TTDS00036	Inhibitor	BUCINDOLOL
TTDS00036	Inhibitor	CGP-12177A
TTDS00036	Inhibitor	DICHLOROISOPROTERENOL
TTDS00036	Inhibitor	L-755507
TTDS00036	Inhibitor	L-796568
TTDS00036	Antagonist	Acebutolol
TTDS00036	Antagonist	Alprenolol
TTDS00036	Antagonist	Atenolol
TTDS00036	Antagonist	Betaxolol
TTDS00036	Antagonist	Bisoprolol
TTDS00036	Antagonist	CGP 20712A
TTDS00036	Antagonist	CGP 26505
TTDS00036	Antagonist	Cebutolol
TTDS00036	Antagonist	Esmolol
TTDS00036	Antagonist	Levobetaxolol
TTDS00036	Antagonist	Metoprolol
TTDS00036	Antagonist	Nebivolol
TTDS00036	Antagonist	Oxprenolol
TTDS00036	Antagonist	Practolol
TTDS00036	Antagonist	Sotalol
TTDS00036	Agonist	Dobutamine
TTDS00036	Agonist	Isoprenaline
TTDS00036	Agonist	Noradrenaline
TTDS00037	UniProt ID	P07550
TTDS00037	Name	Beta-2 adrenergic receptor
TTDS00037	Type of target	Successful target
TTDS00037	Synonyms	Beta-2 adrenoceptor
TTDS00037	Synonyms	Beta-2 adrenoreceptor
TTDS00037	Disease	Anxiety disorder, unspecified
TTDS00037	Disease	Asthma
TTDS00037	Disease	Cardiac arrhythmias
TTDS00037	Disease	Chronic obstructive pulmonary disease, unspecified
TTDS00037	Disease	Depression
TTDS00037	Disease	Glaucoma
TTDS00037	Disease	Hypertension
TTDS00037	Disease	Inflammation
TTDS00037	Disease	Multiple sclerosis
TTDS00037	Disease	Obstructive airway disease
TTDS00037	Disease	Respiratory distress syndrome
TTDS00037	Disease	Skeletal muscle wasting
TTDS00037	Disease	Skeletal muscle weakness
TTDS00037	Function	Beta-adrenergic receptors mediate the catecholamine- induced activation of adeny
TTDS00037	Sequence	MGQPGNGSAFLLAPNGSHAPDHDVTQQRDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADL
TTDS00037	PDB Structure	1GQ4; 2R4R; 2R4S; 2RH1; 3D4S; 3KJ6; 3NY8; 3NY9; 3NYA; 3P0G; 3PDS; 3SN6; 4GBR
TTDS00037	BioChemical Class	Transmembrane protein
TTDS00037	Pathway	Calcium signaling pathway
TTDS00037	Pathway	Neuroactive ligand-receptor interaction
TTDS00037	Related US Patent	6,576,793
TTDS00037	Related US Patent	6,593,497
TTDS00037	Related US Patent	6,653,323
TTDS00037	Related US Patent	6,670,376
TTDS00037	Related US Patent	6,747,043
TTDS00037	Target Validation	TTDS00037
TTDS00037	Drug(s)	961081
TTDS00037	Drug(s)	Albuterol sulfate
TTDS00037	Drug(s)	Anoro
TTDS00037	Drug(s)	Arformoterol
TTDS00037	Drug(s)	Bambuterol
TTDS00037	Drug(s)	Budesonide & formoterol fumarate dihydrate
TTDS00037	Drug(s)	Carmoterol
TTDS00037	Drug(s)	Clenbuterol
TTDS00037	Drug(s)	Fenoterol
TTDS00037	Drug(s)	Formoterol
TTDS00037	Drug(s)	GSK-159797
TTDS00037	Drug(s)	GSK159802
TTDS00037	Drug(s)	GSK642444
TTDS00037	Drug(s)	GSK961081
TTDS00037	Drug(s)	GW642444
TTDS00037	Drug(s)	Indacaterol
TTDS00037	Drug(s)	Milveterol
TTDS00037	Drug(s)	Milveterol+Fluticasone
TTDS00037	Drug(s)	Olodaterol
TTDS00037	Drug(s)	Orciprenaline
TTDS00037	Drug(s)	Pirbuterol
TTDS00037	Drug(s)	Procaterol
TTDS00037	Drug(s)	QMF149
TTDS00037	Drug(s)	QVA-149
TTDS00037	Drug(s)	RELVARTM or BREOTM ELLIPTATM
TTDS00037	Drug(s)	Relvar/Breo
TTDS00037	Drug(s)	Salbutamol
TTDS00037	Drug(s)	Salbutamol sulphate
TTDS00037	Drug(s)	Salmeterol
TTDS00037	Drug(s)	Salmeterol xinafoate
TTDS00037	Drug(s)	Sibenadet
TTDS00037	Drug(s)	Symbicort
TTDS00037	Drug(s)	TA-2005
TTDS00037	Drug(s)	Terbutaline
TTDS00037	Drug(s)	Vilanterol
TTDS00037	Inhibitor	(R,R)-(-)-fenoterol
TTDS00037	Inhibitor	(R,S)-(-)-fenoterol
TTDS00037	Inhibitor	(S,R)-(+)-fenoterol
TTDS00037	Inhibitor	1-(2-allylphenoxy)-3-morpholinopropan-2-ol
TTDS00037	Inhibitor	1-(2-isopropylphenoxy)-3-morpholinopropan-2-ol
TTDS00037	Inhibitor	2-fluoronorepinehprine
TTDS00037	Inhibitor	BRL-37344
TTDS00037	Inhibitor	BUCINDOLOL
TTDS00037	Inhibitor	CGP-12177A
TTDS00037	Inhibitor	DICHLOROISOPROTERENOL
TTDS00037	Inhibitor	GNF-PF-1694
TTDS00037	Inhibitor	ICI-118551
TTDS00037	Inhibitor	L-755507
TTDS00037	Inhibitor	L-796568
TTDS00037	Inhibitor	SDZ-201106
TTDS00037	Antagonist	Butoxamine
TTDS00037	Antagonist	ICI 118,551
TTDS00037	Antagonist	ICI 118.551
TTDS00037	Antagonist	Levalbuterol
TTDS00037	Agonist	Albuterol sulfate
TTDS00037	Agonist	Arformoterol
TTDS00037	Agonist	Bambuterol
TTDS00037	Agonist	Budesonide & formoterol fumarate dihydrate
TTDS00037	Agonist	Carmoterol
TTDS00037	Agonist	Clenbuterol
TTDS00037	Agonist	D 2343
TTDS00037	Agonist	Fenoterol
TTDS00037	Agonist	Formoterol
TTDS00037	Agonist	GSK-159797
TTDS00037	Agonist	GSK159802
TTDS00037	Agonist	GSK642444
TTDS00037	Agonist	GSK961081
TTDS00037	Agonist	GW642444
TTDS00037	Agonist	Indacaterol
TTDS00037	Agonist	Isoprenaline
TTDS00037	Agonist	Metaproterenol
TTDS00037	Agonist	Milveterol
TTDS00037	Agonist	Milveterol+Fluticasone
TTDS00037	Agonist	Orciprenaline
TTDS00037	Agonist	Pirbuterol
TTDS00037	Agonist	Procaterol
TTDS00037	Agonist	QVA-149
TTDS00037	Agonist	Salbutamol
TTDS00037	Agonist	Salbutamol sulphate
TTDS00037	Agonist	Salmeterol
TTDS00037	Agonist	Salmeterol xinafoate
TTDS00037	Agonist	Sibenadet
TTDS00037	Agonist	TA-2005
TTDS00037	Agonist	Terbutaline
TTDS00037	Multitarget	GSK961081
TTDS00037	Multitarget	Sibenadet
TTDS00038	Name	Noradrenergic re-uptake
TTDS00038	Type of target	Successful target
TTDS00038	Synonyms	Norepinephrine reuptake
TTDS00038	Disease	Depression
TTDS00038	Disease	Obesity
TTDS00038	Disease	Post-anaesthetic shivering
TTDS00038	Disease	St John's Wort
TTDS00038	Related US Patent	6,465,458
TTDS00038	Related US Patent	6,642,235
TTDS00038	Target Validation	TTDS00038
TTDS00038	Drug(s)	Amfepramone
TTDS00038	Drug(s)	Amitriptyline
TTDS00038	Drug(s)	Amoxapine
TTDS00038	Drug(s)	Atomoxetine
TTDS00038	Drug(s)	Bupropion
TTDS00038	Drug(s)	Cocaine
TTDS00038	Drug(s)	DOV 21947
TTDS00038	Drug(s)	DOV-216303
TTDS00038	Drug(s)	DOV-21947
TTDS00038	Drug(s)	Desipramine
TTDS00038	Drug(s)	Desvenalfaxine succinate
TTDS00038	Drug(s)	Desvenlafaxine
TTDS00038	Drug(s)	Desvenlafaxine SR
TTDS00038	Drug(s)	Diethylpropion
TTDS00038	Drug(s)	Duloxetine
TTDS00038	Drug(s)	GSK372475
TTDS00038	Drug(s)	Imipramine
TTDS00038	Drug(s)	Maprotiline
TTDS00038	Drug(s)	Mazindol
TTDS00038	Drug(s)	Milnacipran
TTDS00038	Drug(s)	NS 2359
TTDS00038	Drug(s)	Nortriptyline
TTDS00038	Drug(s)	Phenmetrazine
TTDS00038	Drug(s)	Phentermine
TTDS00038	Drug(s)	Protriptyline
TTDS00038	Drug(s)	R-sibutramine metabolite
TTDS00038	Drug(s)	Reboxetine
TTDS00038	Drug(s)	Sibutramine
TTDS00038	Drug(s)	Tapentadol hydrochloride
TTDS00038	Drug(s)	Trazodone
TTDS00038	Drug(s)	Trazodone CR
TTDS00038	Drug(s)	Trimipramine
TTDS00038	Drug(s)	Ultracet
TTDS00038	Drug(s)	Venlafaxine
TTDS00038	Inhibitor	Amfepramone
TTDS00038	Inhibitor	Amitriptyline
TTDS00038	Inhibitor	Amoxapine
TTDS00038	Inhibitor	Atomoxetine
TTDS00038	Inhibitor	Bupropion
TTDS00038	Inhibitor	Cocaine
TTDS00038	Inhibitor	DOV 21947
TTDS00038	Inhibitor	DOV-216303
TTDS00038	Inhibitor	DOV-21947
TTDS00038	Inhibitor	Desipramine
TTDS00038	Inhibitor	Desvenalfaxine succinate
TTDS00038	Inhibitor	Desvenlafaxine
TTDS00038	Inhibitor	Desvenlafaxine SR
TTDS00038	Inhibitor	Diethylpropion
TTDS00038	Inhibitor	Duloxetine
TTDS00038	Inhibitor	GSK372475
TTDS00038	Inhibitor	Hypericum
TTDS00038	Inhibitor	Imipramine
TTDS00038	Inhibitor	Maprotiline
TTDS00038	Inhibitor	Mazindol
TTDS00038	Inhibitor	Milnacipran
TTDS00038	Inhibitor	NS 2359
TTDS00038	Inhibitor	Nortriptyline
TTDS00038	Inhibitor	Phenmetrazine
TTDS00038	Inhibitor	Phentermine
TTDS00038	Inhibitor	Protriptyline
TTDS00038	Inhibitor	R-sibutramine metabolite
TTDS00038	Inhibitor	Reboxetine
TTDS00038	Inhibitor	Sibutramine
TTDS00038	Inhibitor	Trazodone
TTDS00038	Inhibitor	Trazodone CR
TTDS00038	Inhibitor	Trimipramine
TTDS00038	Inhibitor	Ultracet
TTDS00038	Inhibitor	Venlafaxine
TTDS00038	Multitarget	Amfepramone
TTDS00038	Multitarget	Amitriptyline
TTDS00038	Multitarget	Bupropion
TTDS00038	Multitarget	Cocaine
TTDS00038	Multitarget	DOV 21947
TTDS00038	Multitarget	DOV-216303
TTDS00038	Multitarget	DOV-21947
TTDS00038	Multitarget	Desvenlafaxine SR
TTDS00038	Multitarget	Diethylpropion
TTDS00038	Multitarget	Duloxetine
TTDS00038	Multitarget	GSK372475
TTDS00038	Multitarget	NS 2359
TTDS00038	Multitarget	Phenmetrazine
TTDS00038	Multitarget	R-sibutramine metabolite
TTDS00038	Multitarget	Sibutramine
TTDS00038	Multitarget	Trazodone
TTDS00038	Multitarget	Trazodone CR
TTDS00038	Multitarget	Ultracet
TTDS00038	Multitarget	Venlafaxine
TTDS00039	Name	Cyclooxygenase
TTDS00039	Type of target	Successful target
TTDS00039	Synonyms	Cyclooxygenase (COX1 and COX2)
TTDS00039	Synonyms	PHS
TTDS00039	Synonyms	Prostaglandin H2 synthase
TTDS00039	Synonyms	Prostaglandin synthase
TTDS00039	Disease	Cardiovascular disease, unspecified
TTDS00039	Disease	Inflammatory diseases
TTDS00039	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00039	Pathway	Arachidonic acid metabolism
TTDS00039	Pathway	Metabolic pathways
TTDS00039	Target Validation	TTDS00039
TTDS00039	QSAR Model	TTDS00039
TTDS00039	Drug(s)	Acetaminophen
TTDS00039	Drug(s)	Asasantin
TTDS00039	Drug(s)	Aspirin
TTDS00039	Drug(s)	Benzydamine
TTDS00039	Drug(s)	Diclofenac
TTDS00039	Drug(s)	Fenoprofen
TTDS00039	Drug(s)	Flurbiprofen
TTDS00039	Drug(s)	Fosfosal
TTDS00039	Drug(s)	Icosapent
TTDS00039	Drug(s)	Indomethacin
TTDS00039	Drug(s)	Ketorolac
TTDS00039	Drug(s)	Meclofenamic acid
TTDS00039	Drug(s)	NCX-4016
TTDS00039	Drug(s)	Oxaprozin
TTDS00039	Drug(s)	Pravigard
TTDS00039	Drug(s)	Sulindac sulfide
TTDS00039	Inhibitor	Acetaminophen
TTDS00039	Inhibitor	Asasantin
TTDS00039	Inhibitor	Aspirin
TTDS00039	Inhibitor	BN82451
TTDS00039	Inhibitor	Benzydamine
TTDS00039	Inhibitor	Diclofenac
TTDS00039	Inhibitor	Fenoprofen
TTDS00039	Inhibitor	Flurbiprofen
TTDS00039	Inhibitor	Indomethacin
TTDS00039	Inhibitor	Ketorolac
TTDS00039	Inhibitor	Meclofenamate
TTDS00039	Inhibitor	Meclofenamic acid
TTDS00039	Inhibitor	NCX-4016
TTDS00039	Inhibitor	Oxaprozin
TTDS00039	Inhibitor	Pravigard
TTDS00039	Inhibitor	Sulindac sulfide
TTDS00039	Binder	Icosapent
TTDS00039	Multitarget	Pravigard
TTDS00040	UniProt ID	P23219
TTDS00040	Name	Prostaglandin G/H synthase 1
TTDS00040	Type of target	Successful target
TTDS00040	Synonyms	COX-1
TTDS00040	Synonyms	Cyclooxygenase -1
TTDS00040	Synonyms	Cyclooxygenase-1
TTDS00040	Synonyms	PGH synthase 1
TTDS00040	Synonyms	PGHS-1
TTDS00040	Synonyms	PHS 1
TTDS00040	Synonyms	Prostaglandin H2 synthase 1
TTDS00040	Synonyms	Prostaglandin-endoperoxide synthase 1
TTDS00040	Disease	Cardiovascular disease, unspecified
TTDS00040	Disease	Chronic inflammatory diseases
TTDS00040	Function	May play an important role in regulating or promoting cell proliferation in some
TTDS00040	Sequence	MSRSLLLRFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNCTIPGLWTWLRNS
TTDS00040	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00040	Pathway	Arachidonic acid metabolism
TTDS00040	Pathway	Metabolic pathways
TTDS00040	EC Number	EC 1.14.99.1
TTDS00040	Target Validation	TTDS00040
TTDS00040	QSAR Model	TTDS00040
TTDS00040	Drug(s)	Balsalazide
TTDS00040	Drug(s)	Bromfenac
TTDS00040	Drug(s)	Gamma-Homolinolenic acid
TTDS00040	Drug(s)	Mesalazine
TTDS00040	Drug(s)	Salicyclic acid
TTDS00040	Drug(s)	Salsalate
TTDS00040	Drug(s)	Suprofen
TTDS00040	Inhibitor	(-)-3-O-acetylspectaline
TTDS00040	Inhibitor	(11H-Dibenzo[b,e][1,4]dioxepin-2-yl)-acetic acid
TTDS00040	Inhibitor	(11H-Dibenzo[b,e][1,4]dioxepin-7-yl)-acetic acid
TTDS00040	Inhibitor	(11H-Dibenzo[b,e][1,4]dioxepin-8-yl)-acetic acid
TTDS00040	Inhibitor	(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid
TTDS00040	Inhibitor	(R)-2-(4-Isobutyl-phenyl)-N-phenyl-propionamide
TTDS00040	Inhibitor	(S)-FLURBIPROFEN
TTDS00040	Inhibitor	(Z)-2'-des-methyl sulindac sulfide
TTDS00040	Inhibitor	1,2-dihydro-3-(2,3,4-trimethoxyphenyl)naphthalene
TTDS00040	Inhibitor	1-(4-(methylsulfonyl)phenyl)-3-p-tolylurea
TTDS00040	Inhibitor	1-(4-(methylsulfonyl)phenyl)-3-phenylurea
TTDS00040	Inhibitor	1-(4-aminosulfonylphenyl)-2-(2-pyridyl)acetylene
TTDS00040	Inhibitor	1-(4-aminosulfonylphenyl)-2-(4-pyridyl)acetylene
TTDS00040	Inhibitor	2'-epi-guianin
TTDS00040	Inhibitor	2,4'-Dimethoxy-5,3'-di-(2-propenyl)-biphenyl
TTDS00040	Inhibitor	2-(1,1'-Biphenyl-4-Yl)Propanoic Acid
TTDS00040	Inhibitor	2-(2,3,4-trimethoxyphenyl)-1H-indene
TTDS00040	Inhibitor	2-(2-(2,6-dimethylphenylamino)phenyl)acetic acid
TTDS00040	Inhibitor	2-(2-Methylpropanoyl)-1,3,5-benzenetriol
TTDS00040	Inhibitor	2-(2-methoxyphenyl)-1H-indene
TTDS00040	Inhibitor	2-(3'-Allyl-biphenyl-4-yl)-propionic acid
TTDS00040	Inhibitor	2-(3'-Ethyl-biphenyl-4-yl)-propionic acid
TTDS00040	Inhibitor	2-(3'-Ethylsulfanyl-biphenyl-4-yl)-propionic acid
TTDS00040	Inhibitor	2-(3'-Vinyl-biphenyl-4-yl)-propionic acid
TTDS00040	Inhibitor	2-(3-Phenyl-propyl)-1,2-dihydro-indazol-3-one
TTDS00040	Inhibitor	2-(N-(2-Ffuorophenyl)pyrrol-3-yl) acetic acid
TTDS00040	Inhibitor	2-(N-(2-fluorophenyl)pyrrol-2-yl) acetic acid
TTDS00040	Inhibitor	2-(p-Methylsulfonylbenzoyl)furan
TTDS00040	Inhibitor	2-Benzyl-1,2-dihydro-indazol-3-one
TTDS00040	Inhibitor	2-Bromoacetyl Group
TTDS00040	Inhibitor	2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one
TTDS00040	Inhibitor	2-Methyl-1,2-dihydro-indazol-3-one
TTDS00040	Inhibitor	2-Naphthalen-2-ylmethyl-1,2-dihydro-indazol-3-one
TTDS00040	Inhibitor	2-Phenethyl-1,2-dihydro-indazol-3-one
TTDS00040	Inhibitor	2-Phenyl-1,2-dihydro-indazol-3-one
TTDS00040	Inhibitor	2-[4-(1H-Indol-5-yl)-phenyl]-propionic acid
TTDS00040	Inhibitor	3 beta-O-acetyloleanolic acid
TTDS00040	Inhibitor	3-(4-Methanesulfonyl-phenyl)-1-phenyl-propynone
TTDS00040	Inhibitor	4'-Methoxy-5,3'-dipropyl-biphenyl-2ol
TTDS00040	Inhibitor	4,5-Bis(4-chlorophenyl)-1,2-selenazole
TTDS00040	Inhibitor	4,5-Bis(4-chlorophenyl)isothiazole
TTDS00040	Inhibitor	4,5-Bis(4-methoxyphenyl)-1,2-selenazole
TTDS00040	Inhibitor	4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiol-3-one
TTDS00040	Inhibitor	4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiole-3-thione
TTDS00040	Inhibitor	4,5-Bis(4-methoxyphenyl)isothiazole
TTDS00040	Inhibitor	4-(4-Chlorophenyl)-5-(4-methoxyphenyl)isothiazole
TTDS00040	Inhibitor	4-(4-Chlorophenyl)-5-p-tolyl-1,2-selenazole
TTDS00040	Inhibitor	4-(4-Chlorophenyl)-5-p-tolyl-3H-1,2-dithiol-3-one
TTDS00040	Inhibitor	4-(4-Chlorophenyl)-5-p-tolylisothiazole
TTDS00040	Inhibitor	4-(5-(4-Hydroxyphenyl)isothiazol-4-yl)phenol
TTDS00040	Inhibitor	4-amino-N-(2-chlorophenyl)benzenesulfonamide
TTDS00040	Inhibitor	4-amino-N-(4-chlorophenyl)benzenesulfonamide
TTDS00040	Inhibitor	4-amino-N-p-tolylbenzenesulfonamide
TTDS00040	Inhibitor	5,3'-Dipropyl-biphenyl-2,4'-diol
TTDS00040	Inhibitor	5-(2-1H-indenyl)-1,3-benzodioxole
TTDS00040	Inhibitor	5-(2-Imidazol-1-yl-ethyl)-7,8-dihydro-quinoline
TTDS00040	Inhibitor	5-(4-Chlorophenyl)-4-(4-methoxyphenyl)isothiazole
TTDS00040	Inhibitor	5-(4-Chlorophenyl)-4-p-tolyl-1,2-selenazole
TTDS00040	Inhibitor	5-(4-Chlorophenyl)-4-p-tolyl-3H-1,2-dithiol-3-one
TTDS00040	Inhibitor	5-(4-Chlorophenyl)-4-p-tolylisothiazole
TTDS00040	Inhibitor	5-(4-Methoxyphenyl)-4-p-tolyl-1,2-selenazole
TTDS00040	Inhibitor	5-(4-Methoxyphenyl)-4-p-tolylisothiazole
TTDS00040	Inhibitor	5-Ethyl-3,4-diphenyl-isoxazole
TTDS00040	Inhibitor	5-Methyl-3,4-diphenyl-isoxazole
TTDS00040	Inhibitor	5-Phenyl-pentanoic acid benzyl-hydroxy-amide
TTDS00040	Inhibitor	Acetic Acid Salicyloyl-Amino-Ester
TTDS00040	Inhibitor	Acetic acid 2-hept-2-ynylsulfanyl-phenyl ester
TTDS00040	Inhibitor	Acetic acid 2-hept-3-ynylsulfanyl-phenyl ester
TTDS00040	Inhibitor	Acetic acid 2-heptylselanyl-phenyl ester
TTDS00040	Inhibitor	Acetic acid 2-heptylsulfanyl-phenyl ester
TTDS00040	Inhibitor	Acetic acid 2-hex-2-ynylsulfanyl-phenyl ester
TTDS00040	Inhibitor	Acetic acid 2-hexylsulfanyl-phenyl ester
TTDS00040	Inhibitor	Acetic acid 2-pentylsulfanyl-phenyl ester
TTDS00040	Inhibitor	Alpha-D-Mannose
TTDS00040	Inhibitor	Arachidonic Acid
TTDS00040	Inhibitor	B-Octylglucoside
TTDS00040	Inhibitor	BW-755C
TTDS00040	Inhibitor	Balsalazide
TTDS00040	Inhibitor	Beta-D-Glucose
TTDS00040	Inhibitor	Beta-D-Mannose
TTDS00040	Inhibitor	Bromfenac
TTDS00040	Inhibitor	CATECHIN
TTDS00040	Inhibitor	CIMICOXIB
TTDS00040	Inhibitor	CURCUMIN
TTDS00040	Inhibitor	DEMETHOXYCURCUMIN
TTDS00040	Inhibitor	DOCOSAHEXAENOIC ACID
TTDS00040	Inhibitor	EPICATECHIN
TTDS00040	Inhibitor	FENBUFEN
TTDS00040	Inhibitor	Flufenamic Acid
TTDS00040	Inhibitor	Flurbiprofen Methyl Ester
TTDS00040	Inhibitor	Gamma-Homolinolenic acid
TTDS00040	Inhibitor	HONOKIOL
TTDS00040	Inhibitor	Heme
TTDS00040	Inhibitor	Hyperforin
TTDS00040	Inhibitor	IMRECOXIB
TTDS00040	Inhibitor	INDOPROFEN
TTDS00040	Inhibitor	IODOINDOMETHACIN
TTDS00040	Inhibitor	IODOSUPROFEN
TTDS00040	Inhibitor	L-745337
TTDS00040	Inhibitor	METHYLHONOKIOL
TTDS00040	Inhibitor	Mesalazine
TTDS00040	Inhibitor	N-(1H-indazol-5-yl)acetamide
TTDS00040	Inhibitor	N-(3-(phenylthio)pyridin-4-yl)methanesulfonamide
TTDS00040	Inhibitor	N-(3-phenoxy-4-pyridinyl)ethanesulfonamide
TTDS00040	Inhibitor	N-(3-phenoxy-4-pyridinyl)propanesulfonamide
TTDS00040	Inhibitor	N-(3-phenoxypyridin-4-yl)methanesulfonamide
TTDS00040	Inhibitor	N-(3-phenylamino-4-pyridinyl)methanesulfonamide
TTDS00040	Inhibitor	O-Acetylserine
TTDS00040	Inhibitor	Oxametacin
TTDS00040	Inhibitor	P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid
TTDS00040	Inhibitor	PHENIDONE
TTDS00040	Inhibitor	Phenacetin
TTDS00040	Inhibitor	Prifelone
TTDS00040	Inhibitor	Primary alcohol metabolite of celecoxib
TTDS00040	Inhibitor	Protoporphyrin Ix Containing Co
TTDS00040	Inhibitor	R-KETOPROFEN
TTDS00040	Inhibitor	RESORCINOL
TTDS00040	Inhibitor	Resveratrol
TTDS00040	Inhibitor	Resveratrol Potassium3-Sulfate
TTDS00040	Inhibitor	Resveratrol Potassium4,-Sulfate
TTDS00040	Inhibitor	SC-560
TTDS00040	Inhibitor	SC-58451
TTDS00040	Inhibitor	Salicyclic acid
TTDS00040	Inhibitor	Salsalate
TTDS00040	Inhibitor	Suprofen
TTDS00040	Inhibitor	TEBUFELONE
TTDS00040	Inhibitor	TENIDAP
TTDS00040	Inhibitor	alpha-Methyl-4-biphenyl-acetic acid
TTDS00040	Inhibitor	eicosapentaenoic acid
TTDS00041	UniProt ID	P35354
TTDS00041	Name	Prostaglandin G/H synthase 2
TTDS00041	Type of target	Successful target
TTDS00041	Synonyms	COX-2
TTDS00041	Synonyms	Cyclooxygenase -2
TTDS00041	Synonyms	Cyclooxygenase 2
TTDS00041	Synonyms	Cyclooxygenase-2
TTDS00041	Synonyms	Heme-protein prostaglandin G/H synthase
TTDS00041	Synonyms	PGH synthase 2
TTDS00041	Synonyms	PGHS-2
TTDS00041	Synonyms	PHS II
TTDS00041	Synonyms	Prostaglandin H2 synthase 2
TTDS00041	Synonyms	Prostaglandin-endoperoxide synthase 2
TTDS00041	Disease	Abdominal aortic aneurysm
TTDS00041	Disease	Adenomatous polyposis
TTDS00041	Disease	Alzheimer's disease
TTDS00041	Disease	Analgesics
TTDS00041	Disease	Arthritis
TTDS00041	Disease	Bladder cancer
TTDS00041	Disease	Breast cancer
TTDS00041	Disease	Cancer, unspecific
TTDS00041	Disease	Carcinoma in situ, unspecified
TTDS00041	Disease	Carpal tunnel syndrome
TTDS00041	Disease	Colorectal cancer
TTDS00041	Disease	Dysmenorrhea, unspecified
TTDS00041	Disease	Endometriosis
TTDS00041	Disease	Genitourinary tumors
TTDS00041	Disease	Gestational hypertension
TTDS00041	Disease	Inflammation
TTDS00041	Disease	Inflammatory diseases
TTDS00041	Disease	Lung cancer
TTDS00041	Disease	Malignant mesothelioma
TTDS00041	Disease	Meningioma
TTDS00041	Disease	Myocardial infarction
TTDS00041	Disease	Oropharyngeal squamous cell carcinoma
TTDS00041	Disease	Osteoarthritis
TTDS00041	Disease	Pain, unspecified
TTDS00041	Disease	Pathological angiogenesis
TTDS00041	Disease	Peutz-Jeghers syndrome
TTDS00041	Disease	Prostate cancer
TTDS00041	Disease	Pyresis
TTDS00041	Disease	Renal cell carcinoma
TTDS00041	Disease	Rheumatoid arthritis, unspecified
TTDS00041	Disease	Stroke
TTDS00041	Disease	Vascular lesion regression
TTDS00041	Function	May have a role as a major mediator of inflammation and/or a role for prostanoid
TTDS00041	Sequence	MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTH
TTDS00041	PDB Structure	1V0X
TTDS00041	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00041	Pathway	Arachidonic acid metabolism
TTDS00041	Pathway	Pathways in cancer
TTDS00041	Pathway	Small cell lung cancer
TTDS00041	Pathway	VEGF signaling pathway
TTDS00041	EC Number	EC 1.14.99.1
TTDS00041	Related US Patent	6,204,387
TTDS00041	Related US Patent	6,252,116
TTDS00041	Related US Patent	6,323,226
TTDS00041	Related US Patent	6,340,691
TTDS00041	Related US Patent	6,369,275
TTDS00041	Related US Patent	6,376,519
TTDS00041	Related US Patent	6,407,140
TTDS00041	Related US Patent	6,432,999
TTDS00041	Related US Patent	6,436,967
TTDS00041	Related US Patent	6,440,963
TTDS00041	Related US Patent	6,451,794
TTDS00041	Related US Patent	6,465,509
TTDS00041	Related US Patent	6,469,040
TTDS00041	Related US Patent	6,472,416
TTDS00041	Related US Patent	6,486,194
TTDS00041	Related US Patent	6,486,247
TTDS00041	Related US Patent	6,488,734
TTDS00041	Related US Patent	6,492,416
TTDS00041	Related US Patent	6,495,517
TTDS00041	Related US Patent	6,512,121
TTDS00041	Related US Patent	6,515,014
TTDS00041	Related US Patent	6,534,540
TTDS00041	Related US Patent	6,541,646
TTDS00041	Related US Patent	6,555,540
TTDS00041	Related US Patent	6,583,321
TTDS00041	Related US Patent	6,589,973
TTDS00041	Related US Patent	6,596,736
TTDS00041	Related US Patent	6,599,929
TTDS00041	Related US Patent	6,613,790
TTDS00041	Related US Patent	6,617,345
TTDS00041	Related US Patent	6,649,629
TTDS00041	Related US Patent	6,649,654
TTDS00041	Related US Patent	6,656,968
TTDS00041	Related US Patent	6,670,365
TTDS00041	Related US Patent	6,677,364
TTDS00041	Related US Patent	6,768,019
TTDS00041	Target Validation	TTDS00041
TTDS00041	QSAR Model	TTDS00041
TTDS00041	Drug(s)	Carprofen
TTDS00041	Drug(s)	Celecoxib
TTDS00041	Drug(s)	Diflunisal
TTDS00041	Drug(s)	Etodolac
TTDS00041	Drug(s)	Etoricoxib
TTDS00041	Drug(s)	GSK-644784
TTDS00041	Drug(s)	GW-406381
TTDS00041	Drug(s)	Ibuprofen
TTDS00041	Drug(s)	Ketoprofen
TTDS00041	Drug(s)	Lumiracoxib
TTDS00041	Drug(s)	Mefenamic acid
TTDS00041	Drug(s)	Meloxicam
TTDS00041	Drug(s)	Nabumetone
TTDS00041	Drug(s)	Naproxen
TTDS00041	Drug(s)	Niflumic Acid
TTDS00041	Drug(s)	Nimesulide
TTDS00041	Drug(s)	ONO-2506
TTDS00041	Drug(s)	Phenylbutazone
TTDS00041	Drug(s)	Piroxicam
TTDS00041	Drug(s)	RPR 200765A
TTDS00041	Drug(s)	Rofecoxib
TTDS00041	Drug(s)	Tenoxicam
TTDS00041	Drug(s)	Tiaprofenic acid
TTDS00041	Drug(s)	Tolmetin
TTDS00041	Drug(s)	Valdecoxib
TTDS00041	Inhibitor	2'-Hydroxychalcone
TTDS00041	Inhibitor	3,4-dihydroxyxanthone
TTDS00041	Inhibitor	B-Octylglucoside
TTDS00041	Inhibitor	BW-755C
TTDS00041	Inhibitor	Bimetopyrole
TTDS00041	Inhibitor	Carprofen
TTDS00041	Inhibitor	Celecoxib
TTDS00041	Inhibitor	DFU
TTDS00041	Inhibitor	Diflunisal
TTDS00041	Inhibitor	DuP-697
TTDS00041	Inhibitor	Etodolac
TTDS00041	Inhibitor	Etoricoxib
TTDS00041	Inhibitor	Firocoxib
TTDS00041	Inhibitor	Flufenamic Acid
TTDS00041	Inhibitor	GSK-644784
TTDS00041	Inhibitor	GW-406381
TTDS00041	Inhibitor	GW-637185X
TTDS00041	Inhibitor	Heme
TTDS00041	Inhibitor	Ibuprofen
TTDS00041	Inhibitor	Ketoprofen
TTDS00041	Inhibitor	L-745337
TTDS00041	Inhibitor	L-748780
TTDS00041	Inhibitor	L-761000
TTDS00041	Inhibitor	LM-4108
TTDS00041	Inhibitor	Lumiracoxib
TTDS00041	Inhibitor	MK-886
TTDS00041	Inhibitor	Mefenamic acid
TTDS00041	Inhibitor	Meloxicam
TTDS00041	Inhibitor	Microxine
TTDS00041	Inhibitor	NS-398
TTDS00041	Inhibitor	NS398
TTDS00041	Inhibitor	NSAIDs
TTDS00041	Inhibitor	NSC-27236
TTDS00041	Inhibitor	Nabumetone
TTDS00041	Inhibitor	Naproxen
TTDS00041	Inhibitor	Naproxene
TTDS00041	Inhibitor	Nectamazin C
TTDS00041	Inhibitor	Niflumic Acid
TTDS00041	Inhibitor	Nimesulide
TTDS00041	Inhibitor	ONO-2506
TTDS00041	Inhibitor	Oxametacin
TTDS00041	Inhibitor	Phenylbutazone
TTDS00041	Inhibitor	Piroxicam
TTDS00041	Inhibitor	Prifelone
TTDS00041	Inhibitor	Prostaglandin G2
TTDS00041	Inhibitor	RPR 200765A
TTDS00041	Inhibitor	RWJ-67657
TTDS00041	Inhibitor	Resveratrol
TTDS00041	Inhibitor	Rofecoxib
TTDS00041	Inhibitor	SB 202190
TTDS00041	Inhibitor	SB 203580
TTDS00041	Inhibitor	SB 239063
TTDS00041	Inhibitor	SC-558
TTDS00041	Inhibitor	SC-57666
TTDS00041	Inhibitor	SC-58125
TTDS00041	Inhibitor	SC-58451
TTDS00041	Inhibitor	Tenoxicam
TTDS00041	Inhibitor	Tiaprofenic acid
TTDS00041	Inhibitor	Tilmacoxib
TTDS00041	Inhibitor	Tolmetin
TTDS00041	Inhibitor	Valdecoxib
TTDS00041	UpRegulator	C-myb
TTDS00043	UniProt ID	P32239
TTDS00043	Name	Gastrin/cholecystokinin type B receptor
TTDS00043	Type of target	Successful target
TTDS00043	Synonyms	CCK-B receptor
TTDS00043	Synonyms	CCK-BR
TTDS00043	Disease	Acid-related diseases
TTDS00043	Disease	Anxiety disorder, unspecified
TTDS00043	Disease	Cocaine dependence
TTDS00043	Disease	Gastrin sensitive tumours
TTDS00043	Disease	Gastrointestinal adenocarcinomas
TTDS00043	Disease	Gastrointestinal motility disorders
TTDS00043	Disease	Malignant gliomas
TTDS00043	Disease	Medullary thyroid cancer
TTDS00043	Disease	Neuroendocrine tumors
TTDS00043	Disease	Small cell lung cancer
TTDS00043	Disease	Stromal ovarian tumors
TTDS00043	Function	Receptor for gastrin and cholecystokinin, and the ckk-b receptors occur througho
TTDS00043	Sequence	MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLG
TTDS00043	PDB Structure	1L4T
TTDS00043	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00043	Pathway	Calcium signaling pathway
TTDS00043	Pathway	Neuroactive ligand-receptor interaction
TTDS00043	Target Validation	TTDS00043
TTDS00043	QSAR Model	TTDS00043
TTDS00043	Drug(s)	Ceruletide
TTDS00043	Drug(s)	GG-8573
TTDS00043	Drug(s)	PD-170292
TTDS00043	Drug(s)	Pentagastrin
TTDS00043	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00043	Inhibitor	Asp-Tyr(OSO3H)-Met-Gly-Trp-Met-Asp-Phe
TTDS00043	Inhibitor	Boc-Asp-Tyr(So3-)-Nle-Gly-Trp-Asp-Phe-NH2
TTDS00043	Inhibitor	CI-988
TTDS00043	Inhibitor	Cholecystokinin-9
TTDS00043	Inhibitor	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-Bo
TTDS00043	Inhibitor	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-H
TTDS00043	Inhibitor	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-D-Trp-H
TTDS00043	Inhibitor	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-Trp-Ac
TTDS00043	Inhibitor	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-Trp-Boc
TTDS00043	Inhibitor	IQM-95333
TTDS00043	Inhibitor	L-365260
TTDS00043	Inhibitor	PD-134308
TTDS00043	Inhibitor	PD-135118
TTDS00043	Inhibitor	PD-135666
TTDS00043	Inhibitor	PD-136621
TTDS00043	Inhibitor	PD-137337
TTDS00043	Inhibitor	PD-137342
TTDS00043	Inhibitor	PD-138915
TTDS00043	Inhibitor	PD-138916
TTDS00043	Inhibitor	PD-138917
TTDS00043	Inhibitor	PD-140547
TTDS00043	Inhibitor	PD-140548
TTDS00043	Inhibitor	PD-140723
TTDS00043	Inhibitor	SINCALIDE
TTDS00043	Inhibitor	SNF-9007
TTDS00043	Inhibitor	Tetragastrin
TTDS00043	Inhibitor	Tyr-D-Ala-Gly-D-Trp-NMeNle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Ala-Gly-D-Trp-Nle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-NMeNle-D-Trp-Boc
TTDS00043	Inhibitor	Tyr-D-Ala-Gly-Trp-NMeNle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Ala-Gly-Trp-Nle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Nle-Gly-D-Trp-NMeNle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Nle-Gly-D-Trp-Nle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Nle-Gly-Trp-NMeNle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Nle-Gly-Trp-Nle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Phe-Gly-D-Trp-NMeNle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Phe-Gly-D-Trp-Nle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Phe-Gly-Trp-NMeNle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Phe-Gly-Trp-Nle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-D-Pro-Gly-Trp-NMeNle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-Gly-Gly-Trp-NMeNle-Asp-Phe-NH2
TTDS00043	Inhibitor	Tyr-Pro-Gly-Trp-NMeNle-Asp-Phe-NH2
TTDS00043	Antagonist	GG-8573
TTDS00043	Antagonist	GV-150013
TTDS00043	Antagonist	LY288513
TTDS00043	Antagonist	PD136450
TTDS00043	Antagonist	Spiroglumide
TTDS00043	Agonist	Ceruletide
TTDS00043	Agonist	PD-170292
TTDS00043	Agonist	Pentagastrin
TTDS00044	UniProt ID	P20648
TTDS00044	Name	Potassium-transporting ATPase alpha chain 1
TTDS00044	Type of target	Successful target
TTDS00044	Synonyms	Gastric H(+)/K(+)-ATPase
TTDS00044	Synonyms	Gastric H+/K+ ATPase alpha subunit
TTDS00044	Synonyms	Proton pump
TTDS00044	Disease	Acid-related diseases
TTDS00044	Disease	Gastric acid hypersecretion
TTDS00044	Disease	Gastric ulcer
TTDS00044	Disease	Gastroesophageal reflux disease
TTDS00044	Function	Catalyzes the hydrolysis of atp coupled with the exchange of h(+) and k(+) ions
TTDS00044	Sequence	MGKAENYELYSVELGPGPGGDMAAKMSKKKKAGGGGGKRKEKLENMKKEMEINDHQLSVAELEQKYQTSATKGLSASLAA
TTDS00044	BioChemical Class	Hydrolases acting on acid anhydrides
TTDS00044	Pathway	Oxidative phosphorylation
TTDS00044	EC Number	EC 3.6.3.10
TTDS00044	Related US Patent	6,303,644
TTDS00044	Related US Patent	6,316,481
TTDS00044	Related US Patent	6,328,993
TTDS00044	Related US Patent	6,353,005
TTDS00044	Related US Patent	6,362,202
TTDS00044	Related US Patent	6,380,222
TTDS00044	Related US Patent	6,420,384
TTDS00044	Related US Patent	6,544,556
TTDS00044	Related US Patent	6,548,518
TTDS00044	Related US Patent	6,552,045
TTDS00044	Related US Patent	6,559,167
TTDS00044	Related US Patent	6,599,927
TTDS00044	Target Validation	TTDS00044
TTDS00044	Drug(s)	Dexlansoprazole
TTDS00044	Drug(s)	Esomeprazole
TTDS00044	Drug(s)	Esomeprazole magnesium
TTDS00044	Drug(s)	Esomeprazole magnesium+Aspirin
TTDS00044	Drug(s)	Lansoprazole
TTDS00044	Drug(s)	Omeprazole
TTDS00044	Drug(s)	Pantoprazole
TTDS00044	Drug(s)	Rabeprazole
TTDS00044	Inhibitor	Dexlansoprazole
TTDS00044	Inhibitor	Esomeprazole
TTDS00044	Inhibitor	Esomeprazole magnesium
TTDS00044	Inhibitor	Esomeprazole magnesium+Aspirin
TTDS00044	Inhibitor	Lansoprazole
TTDS00044	Inhibitor	Omeprazole
TTDS00044	Inhibitor	Pantoprazole
TTDS00044	Inhibitor	Rabeprazole
TTDS00045	UniProt ID	P05023
TTDS00045	Name	Sodium/potassium-transporting ATPase alpha-1 chain
TTDS00045	Type of target	Successful target
TTDS00045	Synonyms	Na+/K+ ATPase 1
TTDS00045	Synonyms	Sodium pump 1
TTDS00045	Synonyms	Sodium/potassium-transporting ATPase alpha1
TTDS00045	Disease	Atrial fibrillation and flutter
TTDS00045	Disease	Heart failure
TTDS00045	Function	This is the catalytic component of the active enzyme, which catalyzes the hydrol
TTDS00045	Sequence	MGKGVGRDKYEPAAVSEQGDKKGKKGKKDRDMDELKKEVSMDDHKLSLDELHRKYGTDLSRGLTSARAAEILARDGPNAL
TTDS00045	BioChemical Class	Hydrolases acting on acid anhydrides
TTDS00045	Pathway	Cardiac muscle contraction
TTDS00045	EC Number	EC 3.6.3.9
TTDS00045	Target Validation	TTDS00045
TTDS00045	Drug(s)	Almitrine
TTDS00045	Drug(s)	Aluminium
TTDS00045	Drug(s)	Artemether
TTDS00045	Drug(s)	Chloroprocaine
TTDS00045	Drug(s)	Ciclopirox
TTDS00045	Drug(s)	Deslanoside
TTDS00045	Drug(s)	Lumefantrine
TTDS00045	Drug(s)	Ouabain
TTDS00045	Inhibitor	DIGITOXIGENIN
TTDS00045	Blocker	Chloroprocaine
TTDS00045	Binder	Almitrine
TTDS00045	Binder	Aluminium
TTDS00045	Binder	Artemether
TTDS00045	Binder	Ciclopirox
TTDS00045	Binder	Deslanoside
TTDS00045	Binder	Lumefantrine
TTDS00045	Binder	Ouabain
TTDS00046	Name	Sodium/potassium-transporting ATPase
TTDS00046	Type of target	Successful target
TTDS00046	Disease	Chronic renal failure
TTDS00046	Disease	Peptic ulcer
TTDS00046	BioChemical Class	Hydrolases acting on acid anhydrides
TTDS00046	Pathway	Cardiac muscle contraction
TTDS00046	EC Number	EC 3.6.3.9
TTDS00046	Target Validation	TTDS00046
TTDS00046	Drug(s)	Acetyldigitoxin
TTDS00046	Drug(s)	Digitoxin
TTDS00046	Drug(s)	Digoxin
TTDS00046	Inhibitor	Acetyldigitoxin
TTDS00046	Inhibitor	Digitoxin
TTDS00046	Inhibitor	Digoxin
TTDS00053	Name	Aldehyde dehydrogenase
TTDS00053	Type of target	Successful target
TTDS00053	Disease	Chronic alcoholism
TTDS00053	BioChemical Class	Oxidoreductases acting on the aldehyde or oxo group of donors
TTDS00053	Pathway	Glycine, serine and threonine metabolism
TTDS00053	EC Number	EC 1.2.1.8
TTDS00053	Target Validation	TTDS00053
TTDS00053	Drug(s)	Disulfiram
TTDS00053	Inhibitor	Disulfiram
TTDS00053	Inhibitor	NSC-527035
TTDS00053	Inhibitor	S-methyl 4-methyl-4-morpholinopent-2-ynethioate
TTDS00053	Inhibitor	aloe-emodin
TTDS00054	UniProt ID	P51649
TTDS00054	Name	Succinate semialdehyde dehydrogenase, mitochondrial
TTDS00054	Type of target	Successful target
TTDS00054	Synonyms	NAD(+)-dependent succinic semialdehyde dehydrogenase
TTDS00054	Synonyms	Succinic dehydrogenase
TTDS00054	Disease	Riboflavin deficiency
TTDS00054	Sequence	MATCIWLRSCGARRLGSTFPGCRLRPRAGGLVPASGPAPGPAQLRCYAGRLAGLSAALLRTDSFVGGRWLPAAATFPVQD
TTDS00054	PDB Structure	2W8N; 2W8O; 2W8P; 2W8Q; 2W8R
TTDS00054	BioChemical Class	Oxidoreductases acting on the aldehyde or oxo group of donors
TTDS00054	Pathway	Alanine, aspartate and glutamate metabolism
TTDS00054	Pathway	Butanoate metabolism
TTDS00054	Pathway	Metabolic pathways
TTDS00054	EC Number	EC 1.2.1.24
TTDS00054	Target Validation	TTDS00054
TTDS00054	Drug(s)	Chlormerodrin
TTDS00054	Drug(s)	Succinic acid
TTDS00054	Inhibitor	1-(4-hydroxyphenyl)prop-2-en-1-one
TTDS00054	Inhibitor	Chlormerodrin
TTDS00054	Inhibitor	Succinic acid
TTDS00054	Inhibitor	VANILLIN
TTDS00055	UniProt ID	P19871
TTDS00055	Name	3-beta-hydroxysteroid dehydrogenase
TTDS00055	Type of target	Successful target
TTDS00055	Disease	Female infertility (hyperprolactinemia)
TTDS00055	Disease	Polyendocrinopathies (autoimmune)
TTDS00055	Disease	Premature ovarian failure
TTDS00055	Disease	Primary aldosteronism
TTDS00055	Disease	Tumors (androgen sensitive)
TTDS00055	Sequence	MTNRLQGKVALVTGGASGVGLEVVKLLLGEGAKVAFSDINEAAGQQLAAELGERSMFVRHDVSSEADWTLVMAAVQRRLG
TTDS00055	PDB Structure	1HXH
TTDS00055	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00055	EC Number	EC 1.1.1.51
TTDS00055	Target Validation	TTDS00055
TTDS00055	Drug(s)	Trilostane
TTDS00055	Inhibitor	17 beta-N,N-diethylcarbamoyl-4-aza-5 alpha-androstan-3-one (4MA)
TTDS00055	Inhibitor	Trilostane
TTDS00056	UniProt ID	P47989
TTDS00056	Name	Xanthine dehydrogenase/oxidase
TTDS00056	Type of target	Successful target
TTDS00056	Synonyms	Xanthine oxidase
TTDS00056	Disease	Gout
TTDS00056	Function	This enzyme can be converted from the dehydrogenase form (d) to the oxidase form
TTDS00056	Sequence	MTADKLVFFVNGRKVVEKNADPETTLLAYLRRKLGLSGTKLGCGEGGCGACTVMLSKYDRLQNKIVHFSANACLAPICSL
TTDS00056	PDB Structure	2CKJ; 2E1Q
TTDS00056	Pathway	Caffeine metabolism
TTDS00056	Pathway	Drug metabolism - other enzymes
TTDS00056	Pathway	Metabolic pathways
TTDS00056	Pathway	Purine metabolism
TTDS00056	Related US Patent	6,589,573
TTDS00056	Target Validation	TTDS00056
TTDS00056	QSAR Model	TTDS00056
TTDS00056	Drug(s)	Allopurinol
TTDS00056	Drug(s)	Febuxostat
TTDS00056	Drug(s)	Leptin
TTDS00056	Inhibitor	1-(3-Cyano-phenyl)-1H-pyrazole-4-carboxylic acid
TTDS00056	Inhibitor	2-chloro-6(methylamino)purine
TTDS00056	Inhibitor	3,4'-(1H-1,2,4-triazole-3,5-diyl)dipyridine
TTDS00056	Inhibitor	3,5-bis(2-methylpyridin-4-yl)-1H-1,2,4-triazole
TTDS00056	Inhibitor	3,5-di(pyridin-4-yl)-1H-1,2,4-triazole
TTDS00056	Inhibitor	3-O-METHYLQUERCETIN
TTDS00056	Inhibitor	ACACETIN
TTDS00056	Inhibitor	AMENTOFLAVONE
TTDS00056	Inhibitor	Allopurinol
TTDS00056	Inhibitor	BAICALEIN
TTDS00056	Inhibitor	CHRYSOERIOL
TTDS00056	Inhibitor	CURCUMIN
TTDS00056	Inhibitor	DIHYDROKAEMPFEROL
TTDS00056	Inhibitor	FUKUGETIN
TTDS00056	Inhibitor	Febuxostat
TTDS00056	Inhibitor	Flavin-Adenine Dinucleotide
TTDS00056	Inhibitor	LIQUIRTIGENIN
TTDS00056	Inhibitor	Leptin
TTDS00056	Inhibitor	PERSICARIN
TTDS00056	Inhibitor	ROBINETIN
TTDS00056	Inhibitor	SCUTELLAREIN
TTDS00056	Inhibitor	WOGONIN
TTDS00056	Inhibitor	Y-700
TTDS00056	Inhibitor	dioxothiomolybdenum(VI) ion
TTDS00056	Inhibitor	pentagalloyl glucose
TTDS00058	UniProt ID	Q9NGT0
TTDS00058	Name	Glutamate dehydrogenase
TTDS00058	Type of target	Successful target
TTDS00058	Disease	Malaria
TTDS00058	Sequence	MDIDRRSALSCSPNNMECGFGSGHFSNNSITWKEKYEQTKELLKSYNLFSDHLINYSIDFYFNKLGFNKFHFEETSPELI
TTDS00058	BioChemical Class	Oxidoreductases acting on the CH-NH2 group of donors
TTDS00058	EC Number	EC 1.4.1.2
TTDS00058	Target Validation	TTDS00058
TTDS00058	Drug(s)	Chloroquine
TTDS00058	Drug(s)	Hexachlorophene
TTDS00058	Inhibitor	Chloroquine
TTDS00058	Inhibitor	Hexachlorophene
TTDS00059	UniProt ID	P05021
TTDS00059	UniProt ID	Q02127
TTDS00059	UniProt ID	Q08210
TTDS00059	UniProt ID	Q12610
TTDS00059	Name	Dihydroorotate dehydrogenase, mitochondrial
TTDS00059	Type of target	Successful target
TTDS00059	Synonyms	DHOD
TTDS00059	Synonyms	DHODH
TTDS00059	Synonyms	DHODase
TTDS00059	Synonyms	DHOdehase
TTDS00059	Synonyms	Dihydroorotate dehydrogenase
TTDS00059	Synonyms	Dihydroorotate oxidase
TTDS00059	Synonyms	Mitochondrially bound dihydroorotate-ubiqui oxidoreductase
TTDS00059	Disease	Arthritis
TTDS00059	Disease	Autoimmune diseases
TTDS00059	Disease	Bacterial infections
TTDS00059	Disease	Cancer, unspecific
TTDS00059	Disease	Fungal diseases
TTDS00059	Disease	Hepatocellular carcinoma
TTDS00059	Disease	Immunosuppression
TTDS00059	Disease	Inflammatory diseases
TTDS00059	Disease	Malaria
TTDS00059	Disease	Parasitic diseases
TTDS00059	Disease	Pneumocystis infections
TTDS00059	Disease	Proliferative diseases
TTDS00059	Disease	Rheumatoid arthritis, unspecified
TTDS00059	Disease	Tumors
TTDS00059	Sequence	MISKLKPQFMFLPKKHILSYCRKDVLNLFEQKFYYTSKRKESNNMKNESLLRLINYNRYYNKIDSNNYYNGGKILSNDRQ
TTDS00059	PDB Structure	1TV5; 3I65; 3I68; 3I6R; 3O8A; 3SFK
TTDS00059	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDS00059	Pathway	Pyrimidine metabolism
TTDS00059	EC Number	EC 1.3.3.1
TTDS00059	EC Number	EC 1.3.99.11
TTDS00059	Target Validation	TTDS00059
TTDS00059	QSAR Model	TTDS00059
TTDS00059	Drug(s)	Artemisinin
TTDS00059	Drug(s)	Atovaquone
TTDS00059	Drug(s)	Brequinar sodium
TTDS00059	Drug(s)	FK778
TTDS00059	Drug(s)	Leflunomide
TTDS00059	Drug(s)	Teriflunomide
TTDS00059	Drug(s)	Vidofludimus
TTDS00059	Inhibitor	1,4-Naphthoquinone
TTDS00059	Inhibitor	1-hydroxy-2-dodecyl-4(1H)quinolone
TTDS00059	Inhibitor	2-(2-bromo-2-naphthamido)benzoic acid
TTDS00059	Inhibitor	2-(2-naphthamido)benzoic acid
TTDS00059	Inhibitor	2-(3-(3,5-dichlorophenyl)ureido)benzoic acid
TTDS00059	Inhibitor	2-[(biphenyl-4-carbonyl)-amino]-benzoic acid
TTDS00059	Inhibitor	3,6,9,12,15-PENTAOXATRICOSAN-1-OL
TTDS00059	Inhibitor	3-hydroxy-2-phenylquinoline-4-carboxylic acid
TTDS00059	Inhibitor	5,8-hydroxy-naphthoquinone
TTDS00059	Inhibitor	5-Fluoro orotate
TTDS00059	Inhibitor	8-aminoquinolines
TTDS00059	Inhibitor	A77-1726 (monosodium salt)
TTDS00059	Inhibitor	Acetate Ion
TTDS00059	Inhibitor	Antimycin A
TTDS00059	Inhibitor	Antiproliferative Agent A771726
TTDS00059	Inhibitor	Artemisinin
TTDS00059	Inhibitor	Atovaquone
TTDS00059	Inhibitor	B-Octylglucoside
TTDS00059	Inhibitor	BREQUINAR
TTDS00059	Inhibitor	Brequinar Analog
TTDS00059	Inhibitor	Brequinar sodium
TTDS00059	Inhibitor	Cinchoninic acid
TTDS00059	Inhibitor	Cyanide
TTDS00059	Inhibitor	Decylamine-N,N-Dimethyl-N-Oxide
TTDS00059	Inhibitor	Dichloroally-lawsone
TTDS00059	Inhibitor	Dichloroallyl lawsone
TTDS00059	Inhibitor	Dihydroorotate
TTDS00059	Inhibitor	FK778
TTDS00059	Inhibitor	GNF-PF-85
TTDS00059	Inhibitor	HR325
TTDS00059	Inhibitor	Isoxazol
TTDS00059	Inhibitor	Juglon
TTDS00059	Inhibitor	LY214352
TTDS00059	Inhibitor	Lauryl Dimethylamine-N-Oxide
TTDS00059	Inhibitor	Leflunomide
TTDS00059	Inhibitor	N-(3,5-dichlorophenyl)-2-methyl-3-nitrobenzamide
TTDS00059	Inhibitor	N-(4-bromo-2-methylphenyl)-2-naphthamide
TTDS00059	Inhibitor	N-(Biphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide
TTDS00059	Inhibitor	NSC 665564
TTDS00059	Inhibitor	Orotate
TTDS00059	Inhibitor	Orotic Acid
TTDS00059	Inhibitor	Orotic acid
TTDS00059	Inhibitor	Plumbagin
TTDS00059	Inhibitor	Polyporic acid
TTDS00059	Inhibitor	RS-61980
TTDS00059	Inhibitor	Redoxal
TTDS00059	Inhibitor	Riboflavin Monophosphate
TTDS00059	Inhibitor	Salicylhydroxamic acid
TTDS00059	Inhibitor	Teriflunomide
TTDS00059	Inhibitor	Triazine
TTDS00059	Inhibitor	UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE
TTDS00059	Inhibitor	Vidofludimus
TTDS00059	Inhibitor	diethyl 2-((biphenyl-3-ylamino)methylene)malonate
TTDS00059	Inhibitor	ethyl 3-(biphenyl-3-ylamino)-2-cyanoacrylate
TTDS00059	Multitarget	Vidofludimus
TTDS00060	UniProt ID	P14550
TTDS00060	Name	Alcohol dehydrogenase
TTDS00060	Type of target	Successful target
TTDS00060	Synonyms	Aldehyde reductase
TTDS00060	Synonyms	Aldo-keto reductase family 1 member A1
TTDS00060	Disease	Methanol Poisoning
TTDS00060	Function	Catalyzes the nadph-dependent reduction of a variety of aldehydes to their corre
TTDS00060	Sequence	MAASCVLLHTGQKMPLIGLGTWKSEPGQVKAAVKYALSVGYRHIDCAAIYGNEPEIGEALKEDVGPGKAVPREELFVTSK
TTDS00060	PDB Structure	2ALR
TTDS00060	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00060	Pathway	Caprolactam degradation
TTDS00060	Pathway	Glycerolipid metabolism
TTDS00060	Pathway	Glycolysis / Gluconeogenesis
TTDS00060	Pathway	Metabolic pathways
TTDS00060	EC Number	EC 1.1.1.2
TTDS00060	Target Validation	TTDS00060
TTDS00060	Drug(s)	Fomepizole
TTDS00060	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDS00060	Inhibitor	3,5-dichlorosalicylic acid
TTDS00060	Inhibitor	Fomepizole
TTDS00060	Inhibitor	MINALRESTAT
TTDS00060	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDS00060	Inhibitor	Tolrestat
TTDS00060	Inhibitor	Trifluoroethanol
TTDS00060	Inhibitor	ZOPOLRESTAT
TTDS00062	UniProt ID	O96387
TTDS00062	UniProt ID	P06981
TTDS00062	UniProt ID	P49058
TTDS00062	UniProt ID	P50097
TTDS00062	Name	Inosine-5'-monophosphate dehydrogenase
TTDS00062	Type of target	Successful target
TTDS00062	Synonyms	IMP dehydrogenase
TTDS00062	Synonyms	IMPD
TTDS00062	Synonyms	IMPDH
TTDS00062	Synonyms	Inosine dehydrogenase
TTDS00062	Synonyms	NAD-dependent inosine monophosphate dehydrogenase
TTDS00062	Synonyms	Probable inosine-5'-monophosphate dehydrogenase IMD1
TTDS00062	Synonyms	SOI12
TTDS00062	Synonyms	Superoxide-inducible protein 12
TTDS00062	Disease	Cancer, unspecific
TTDS00062	Disease	Hepatitis C
TTDS00062	Disease	Immunosuppression
TTDS00062	Disease	Infections
TTDS00062	Disease	Influenza A virus infection
TTDS00062	Disease	Leukemia, unspecified
TTDS00062	Disease	Lung cancer
TTDS00062	Disease	Malaria
TTDS00062	Disease	Microbial infections
TTDS00062	Disease	Parasitic diseases
TTDS00062	Disease	Severe acute respiratory syndrome
TTDS00062	Disease	Trichomoniasis
TTDS00062	Disease	Tritrichomonial infection
TTDS00062	Disease	Viral infection, unspecified
TTDS00062	Sequence	MASGWKADEVFGGVMSYTYDVIICMPGYIDFALSDIDLTNNMTDNITLKTPVISSPMDTVTGHKMSIALALSGGLGVIHN
TTDS00062	PDB Structure	1AK5; 1LRT; 1ME7; 1ME8; 1ME9; 1MEH; 1MEI; 1MEW; 1PVN
TTDS00062	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00062	Pathway	Drug metabolism - other enzymes
TTDS00062	Pathway	Metabolic pathways
TTDS00062	Pathway	Purine metabolism
TTDS00062	EC Number	EC 1.1.1.205
TTDS00062	Related US Patent	6,395,763
TTDS00062	Related US Patent	6,498,178
TTDS00062	Related US Patent	6,541,496
TTDS00062	Related US Patent	6,617,323
TTDS00062	Related US Patent	6,653,309
TTDS00062	Target Validation	TTDS00062
TTDS00062	Drug(s)	Mercaptopurine
TTDS00062	Drug(s)	Mizoribine
TTDS00062	Drug(s)	Ribavirin
TTDS00062	Drug(s)	Tiazofurin
TTDS00062	Drug(s)	Viramidine
TTDS00062	Inhibitor	6-Cl-IMP
TTDS00062	Inhibitor	CellCept
TTDS00062	Inhibitor	Imidazo[4,5-e][1, 4]diazapine nucleotide (I)
TTDS00062	Inhibitor	Inosinic Acid
TTDS00062	Inhibitor	Mercaptopurine
TTDS00062	Inhibitor	Mizoribine
TTDS00062	Inhibitor	Mycophenolic acid
TTDS00062	Inhibitor	Mycophenolic acid glucuronide
TTDS00062	Inhibitor	Ribavirin
TTDS00062	Inhibitor	Selenazofurin
TTDS00062	Inhibitor	TAD
TTDS00062	Inhibitor	Tiazofurin
TTDS00062	Inhibitor	VX-148
TTDS00062	Inhibitor	VX-497
TTDS00062	Inhibitor	Viramidine
TTDS00063	UniProt ID	P12268
TTDS00063	Name	Inosine-5'-monophosphate dehydrogenase 2
TTDS00063	Type of target	Successful target
TTDS00063	Synonyms	IMP dehydrogenase 2
TTDS00063	Synonyms	IMPD 2
TTDS00063	Synonyms	IMPDH-II
TTDS00063	Disease	Leukemia, unspecified
TTDS00063	Function	Imp is the rate limiting enzyme in the de novo synthesis of guanine nucleotides
TTDS00063	Sequence	MADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAI
TTDS00063	PDB Structure	1B3O; 1NF7; 1NFB
TTDS00063	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00063	Pathway	Drug metabolism - other enzymes
TTDS00063	Pathway	Metabolic pathways
TTDS00063	Pathway	Purine metabolism
TTDS00063	EC Number	EC 1.1.1.205
TTDS00063	Target Validation	TTDS00063
TTDS00063	Drug(s)	Mycophenolate mofetil
TTDS00063	Drug(s)	Mycophenolic acid
TTDS00063	Inhibitor	1-(3-cyano-1-methyl-1H-indol-6-yl)-3-phenylurea
TTDS00063	Inhibitor	1-methoxy-3-(3-(pyridin-4-yl)-1H-indol-6-yl)urea
TTDS00063	Inhibitor	1-methyl-1H-indole-3-carbaldehyde
TTDS00063	Inhibitor	1-methyl-1H-indole-3-carbonitrile
TTDS00063	Inhibitor	1-methyl-1H-indole-3-carboxamide
TTDS00063	Inhibitor	2-Benzyl-6-methoxy-5-oxazol-5-yl-1H-indole
TTDS00063	Inhibitor	2-methyl-3-(pyridin-4-yl)-1H-indol-6-amine
TTDS00063	Inhibitor	2-methyl-3-(pyridin-4-yl)-1H-indole
TTDS00063	Inhibitor	3-(3-cyano-1H-indol-6-yl)-1-methyl-1-phenylurea
TTDS00063	Inhibitor	3-(furan-3-yl)-1-methyl-1H-indole
TTDS00063	Inhibitor	3-(furan-3-yl)-1H-indole
TTDS00063	Inhibitor	3-(pyridin-4-yl)-1H-indol-6-amine
TTDS00063	Inhibitor	3-(pyridin-4-yl)-1H-indol-7-amine
TTDS00063	Inhibitor	3-(pyridin-4-yl)-1H-indole
TTDS00063	Inhibitor	3-(thiophen-3-yl)-1H-indol-6-amine
TTDS00063	Inhibitor	3-methoxy-4-(oxazol-5-yl)aniline
TTDS00063	Inhibitor	6-Chloropurine Riboside, 5'-Monophosphate
TTDS00063	Inhibitor	6-Methoxy-5-oxazol-5-yl-2-phenyl-1H-indole
TTDS00063	Inhibitor	6-bromo-1-methyl-3-(pyridin-4-yl)-1H-indole
TTDS00063	Inhibitor	6-bromo-3-(pyridin-4-yl)-1H-indole
TTDS00063	Inhibitor	6-phenyl-3-(pyridin-4-yl)-1H-indole
TTDS00063	Inhibitor	C2-MAD
TTDS00063	Inhibitor	C4-MAD
TTDS00063	Inhibitor	Inosinic Acid
TTDS00063	Inhibitor	Mycophenolate mofetil
TTDS00063	Inhibitor	Mycophenolic acid
TTDS00063	Inhibitor	Mycophenolic bis(sulfonamide)
TTDS00063	Inhibitor	N-benzyl-9-oxo-9,10-dihydroacridine-3-carboxamide
TTDS00063	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDS00063	Inhibitor	Selenazole-4-Carboxyamide-Adenine Dinucleotide
TTDS00063	Inhibitor	ethyl 3-(pyridin-4-yl)-1H-indole-6-carboxylate
TTDS00063	Inhibitor	mycophenolic hydroxamic acid
TTDS00063	Inhibitor	tiazofurin adenine dinucleotide
TTDS00064	Name	Lipase
TTDS00064	Type of target	Successful target
TTDS00064	Disease	Acne
TTDS00064	Disease	Alzheimer's disease
TTDS00064	Disease	Dermatitis
TTDS00064	Disease	Hyperlipidemia
TTDS00064	Disease	Noninsulin-dependent diabetes mellitus
TTDS00064	Disease	Obesity
TTDS00064	Disease	Skin rash
TTDS00064	BioChemical Class	Hydrolases acting on ester bonds
TTDS00064	Related US Patent	6,251,421
TTDS00064	Related US Patent	6,461,601
TTDS00064	Related US Patent	6,558,690
TTDS00064	Target Validation	TTDS00064
TTDS00064	Drug(s)	Bisquaternary salt
TTDS00064	Drug(s)	Cetilistat
TTDS00064	Drug(s)	GT-389255
TTDS00064	Drug(s)	Orlistat
TTDS00064	Inhibitor	ApoC-III
TTDS00064	Inhibitor	Bisquaternary salt
TTDS00064	Inhibitor	Butylphosphonate
TTDS00064	Inhibitor	Cetilistat
TTDS00064	Inhibitor	GT-389255
TTDS00064	Inhibitor	Orlistat
TTDS00065	UniProt ID	P04054
TTDS00065	Name	Phospholipase A2
TTDS00065	Type of target	Successful target
TTDS00065	Synonyms	Group IB phospholipase A2
TTDS00065	Synonyms	Phosphatidylcholine 2-acylhydrolase
TTDS00065	Synonyms	Secreted phospholipase A(2)
TTDS00065	Disease	Arthritis
TTDS00065	Disease	Eicosanoid-mediated disorders
TTDS00065	Disease	Inflammation
TTDS00065	Function	Pa2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phos
TTDS00065	Sequence	MKLLVLAVLLTVAAADSGISPRAVWQFRKMIKCVIPGSDPFLEYNNYGCYCGLGGSGTPVDELDKCCQTHDNCYDQAKKL
TTDS00065	PDB Structure	1YSK; 3ELO
TTDS00065	BioChemical Class	Hydrolases acting on ester bonds
TTDS00065	Pathway	Arachidonic acid metabolism
TTDS00065	Pathway	Ether lipid metabolism
TTDS00065	Pathway	Fc epsilon RI signaling pathway
TTDS00065	Pathway	Glycerophospholipid metabolism
TTDS00065	Pathway	GnRH signaling pathway
TTDS00065	Pathway	Linoleic acid metabolism
TTDS00065	Pathway	Long-term depression
TTDS00065	Pathway	MAPK signaling pathway
TTDS00065	Pathway	Metabolic pathways
TTDS00065	Pathway	VEGF signaling pathway
TTDS00065	Pathway	Vascular smooth muscle contraction
TTDS00065	Pathway	alpha-Linolenic acid metabolism
TTDS00065	EC Number	EC 3.1.1.4
TTDS00065	Related US Patent	6,177,426
TTDS00065	Related US Patent	6,274,578
TTDS00065	Related US Patent	6,274,616
TTDS00065	Related US Patent	6,384,041
TTDS00065	Related US Patent	6,391,908
TTDS00065	Related US Patent	6,407,104
TTDS00065	Related US Patent	6,433,001
TTDS00065	Related US Patent	6,451,839
TTDS00065	Related US Patent	6,500,853
TTDS00065	Related US Patent	6,583,177
TTDS00065	Related US Patent	6,608,099
TTDS00065	Related US Patent	6,635,670
TTDS00065	Target Validation	TTDS00065
TTDS00065	Drug(s)	Clobetasol
TTDS00065	Drug(s)	Clocortolone
TTDS00065	Drug(s)	Desonide
TTDS00065	Drug(s)	Desoximetasone
TTDS00065	Drug(s)	Diflorasone
TTDS00065	Drug(s)	Halobetasol Propionate
TTDS00065	Drug(s)	Hydrocortamate
TTDS00065	Drug(s)	Miltefosine
TTDS00065	Drug(s)	Prednicarbate
TTDS00065	Drug(s)	Quinacrine
TTDS00065	Inhibitor	2-Methyl-2,4-Pentanediol
TTDS00065	Inhibitor	3,9-dihydroxy-2,10-diprenylpterocap-6a-ene
TTDS00065	Inhibitor	4'-hydroxy-6,3',5'-triprenylisoflavonone
TTDS00065	Inhibitor	ABYSSINONE V
TTDS00065	Inhibitor	Acetate Ion
TTDS00065	Inhibitor	Alpha-D-Mannose
TTDS00065	Inhibitor	BOLINAQUINONE
TTDS00065	Inhibitor	CACOSPONGIONOLIDE
TTDS00065	Inhibitor	CACOSPONGIONOLIDE B
TTDS00065	Inhibitor	Cholic Acid
TTDS00065	Inhibitor	Clobetasol
TTDS00065	Inhibitor	Desonide
TTDS00065	Inhibitor	Desoximetasone
TTDS00065	Inhibitor	Diflorasone
TTDS00065	Inhibitor	HELENAQUINONE
TTDS00065	Inhibitor	HYRTIOSULAWESINE
TTDS00065	Inhibitor	Halobetasol Propionate
TTDS00065	Inhibitor	Heptanoic Acid
TTDS00065	Inhibitor	Hexane-1,6-Diol
TTDS00065	Inhibitor	Hydrocortamate
TTDS00065	Inhibitor	LY178002
TTDS00065	Inhibitor	Lpc-Ether
TTDS00065	Inhibitor	MANOALIDE
TTDS00065	Inhibitor	Mepacrine
TTDS00065	Inhibitor	Miltefosine
TTDS00065	Inhibitor	N-Tridecanoic Acid
TTDS00065	Inhibitor	P-Anisic Acid
TTDS00065	Inhibitor	Petrosaspongiolide M
TTDS00065	Inhibitor	Petrosaspongiolide P
TTDS00065	Inhibitor	Pyruvoyl Group
TTDS00065	Inhibitor	Quinacrine
TTDS00065	Inhibitor	URSOLIC ACID
TTDS00065	Inhibitor	Varespladib sodium
TTDS00065	Inhibitor	cacospongionolide E
TTDS00065	Inhibitor	petrosaspongiolide M
TTDS00065	Inducer	Clocortolone
TTDS00065	Inducer	Prednicarbate
TTDS00065	Binder	LY256548
TTDS00066	UniProt ID	P06858
TTDS00066	Name	Lipoprotein lipase
TTDS00066	Type of target	Successful target
TTDS00066	Synonyms	LPL
TTDS00066	Disease	Dyslipidemia
TTDS00066	Function	The primary function of this lipase is the hydrolysis of triglycerides of circul
TTDS00066	Sequence	MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGVAESVATCHFNHSSKTFMVIH
TTDS00066	BioChemical Class	Hydrolases acting on ester bonds
TTDS00066	Pathway	Alzheimer's disease
TTDS00066	Pathway	Glycerolipid metabolism
TTDS00066	Pathway	PPAR signaling pathway
TTDS00066	EC Number	EC 3.1.1.34
TTDS00066	Target Validation	TTDS00066
TTDS00066	Drug(s)	Clofibrate
TTDS00066	Drug(s)	Gemfibrozil
TTDS00066	Activator	Clofibrate
TTDS00066	Activator	Gemfibrozil
TTDS00068	UniProt ID	P08185
TTDS00068	Name	Corticosteroid-binding globulin
TTDS00068	Type of target	Successful target
TTDS00068	Synonyms	CBG
TTDS00068	Synonyms	Transcortin
TTDS00068	Disease	Obesity [cortisol driven]
TTDS00068	Function	Major transport protein for glucocorticoids and progestins in the blood of almos
TTDS00068	Sequence	MPLLLYTCLLWLPTSGLWTVQAMDPNAAYVNMSNHHRGLASANVDFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLG
TTDS00068	PDB Structure	2VDX; 2VDY; 4BB2
TTDS00068	Target Validation	TTDS00068
TTDS00068	Drug(s)	Alclometasone
TTDS00068	Drug(s)	Beclomethasone
TTDS00068	Drug(s)	Ciclesonide
TTDS00068	Drug(s)	Flumethasone Pivalate
TTDS00068	Drug(s)	Fluocinolone Acetonide
TTDS00068	Drug(s)	Fluocinonide
TTDS00068	Drug(s)	Flurandrenolide
TTDS00068	Drug(s)	Paramethasone
TTDS00068	Drug(s)	Prednisolone
TTDS00068	Drug(s)	Rimexolone
TTDS00068	Drug(s)	Triamcinolone
TTDS00068	Binder	Alclometasone
TTDS00068	Binder	Beclomethasone
TTDS00068	Binder	Ciclesonide
TTDS00068	Binder	Flumethasone Pivalate
TTDS00068	Binder	Fluocinolone Acetonide
TTDS00068	Binder	Fluocinonide
TTDS00068	Binder	Flurandrenolide
TTDS00068	Binder	Paramethasone
TTDS00068	Binder	Prednisolone
TTDS00068	Binder	Rimexolone
TTDS00068	Binder	Triamcinolone
TTDS00072	Name	Retinoic acid receptor
TTDS00072	Type of target	Successful target
TTDS00072	Disease	Acne
TTDS00072	Disease	Immune disease
TTDS00072	Disease	Psoriasis
TTDS00072	Disease	Rheumatoid arthritis, unspecified
TTDS00072	Disease	Viral infection, unspecified
TTDS00072	BioChemical Class	Zinc-finger
TTDS00072	Pathway	Acute myeloid leukemia
TTDS00072	Pathway	Pathways in cancer
TTDS00072	Related US Patent	6,235,923
TTDS00072	Related US Patent	6,319,948
TTDS00072	Related US Patent	6,372,753
TTDS00072	Related US Patent	6,573,271
TTDS00072	Related US Patent	6,610,742
TTDS00072	Target Validation	TTDS00072
TTDS00072	Drug(s)	Adapalene
TTDS00072	Drug(s)	Isotretinoin
TTDS00072	Drug(s)	Tretinoin
TTDS00072	Drug(s)	Vitamin A
TTDS00072	Agonist	Isotretinoin
TTDS00072	Binder	Adapalene
TTDS00072	Binder	Tretinoin
TTDS00072	Binder	Vitamin A
TTDS00072	Multitarget	Vitamin A
TTDS00073	UniProt ID	P10276
TTDS00073	Name	Retinoic acid receptor alpha
TTDS00073	Type of target	Successful target
TTDS00073	Synonyms	RAR alpha
TTDS00073	Synonyms	RAR-alpha
TTDS00073	Disease	Acute promyelocytic leukemia
TTDS00073	Function	Nuclear receptor for retinoic acid. This metabolite has profound effects on vert
TTDS00073	Sequence	MASNSSSCPTPGGGHLNGYPVPPYAFFFPPMLGGLSPPGALTTLQHQLPVSGYSTPSPATIETQSSSSEEIVPSPPSPPP
TTDS00073	PDB Structure	1DKF; 1DSZ; 3A9E; 3KMR; 3KMZ; 4DQM
TTDS00073	BioChemical Class	Zinc-finger
TTDS00073	Pathway	Acute myeloid leukemia
TTDS00073	Pathway	Pathways in cancer
TTDS00073	Related US Patent	6,355,669
TTDS00073	Target Validation	TTDS00073
TTDS00073	Drug(s)	Alitretinoin
TTDS00073	Drug(s)	LG100268
TTDS00073	Drug(s)	Tamibarotene
TTDS00073	Agonist	Alitretinoin
TTDS00073	Agonist	LG100268
TTDS00073	Binder	Tamibarotene
TTDS00075	UniProt ID	P13631
TTDS00075	Name	Retinoic acid receptor gamma
TTDS00075	Type of target	Successful target
TTDS00075	Disease	Acne
TTDS00075	Disease	Emphysema
TTDS00075	Disease	Photoaging
TTDS00075	Disease	Psoriasis
TTDS00075	PDB Structure	1EXA; 1EXX; 1FCX; 1FCY; 1FCZ; 1FD0; 2LBD; 3LBD; 4LBD
TTDS00075	BioChemical Class	Zinc-finger
TTDS00075	Related US Patent	6,300,350
TTDS00075	Related US Patent	6,479,670
TTDS00075	Related US Patent	6,506,796
TTDS00075	Related US Patent	6,528,677
TTDS00075	Related US Patent	6,603,012
TTDS00075	Target Validation	TTDS00075
TTDS00075	Drug(s)	Tazarotene
TTDS00075	Inhibitor	BMS184394
TTDS00075	Inhibitor	CD564
TTDS00075	Inhibitor	Dodecyl-Alpha-D-Maltoside
TTDS00075	Inhibitor	SR11254
TTDS00075	Agonist	9-cis-retinoic acid
TTDS00075	Agonist	9-trans-retinoic acid
TTDS00075	Binder	Tazarotene
TTDS00076	UniProt ID	P10912
TTDS00076	Name	Growth hormone receptor
TTDS00076	Type of target	Successful target
TTDS00076	Synonyms	GH receptor
TTDS00076	Synonyms	Serum binding protein
TTDS00076	Synonyms	Somatotropin receptor
TTDS00076	Disease	Acromegaly and pituitary gigantism
TTDS00076	Function	This is a receptor for pituitary gland growth hormone.
TTDS00076	Sequence	MDLWQLLLTLALAGSSDAFSGSEATAAILSRAPWSLQSVNPGLKTNSSKEPKFTKCRSPERETFSCHWTDEVHHGTKNLG
TTDS00076	PDB Structure	1A22; 1AXI; 1HWG; 1HWH; 1KF9; 2AEW; 3HHR
TTDS00076	BioChemical Class	Transmembrane protein
TTDS00076	Pathway	Cytokine-cytokine receptor interaction
TTDS00076	Pathway	Jak-STAT signaling pathway
TTDS00076	Pathway	Neuroactive ligand-receptor interaction
TTDS00076	Related US Patent	6,495,589
TTDS00076	Target Validation	TTDS00076
TTDS00076	Drug(s)	AOD-9604
TTDS00076	Drug(s)	ATL-1103
TTDS00076	Drug(s)	BVT-A
TTDS00076	Drug(s)	EP-51216
TTDS00076	Drug(s)	EP-51389
TTDS00076	Drug(s)	Ibutamoren
TTDS00076	Drug(s)	Pegvisomant
TTDS00076	Drug(s)	Somatropin recombinant
TTDS00076	Antagonist	ATL-1103
TTDS00076	Antagonist	BVT-A
TTDS00076	Antagonist	Pegvisomant
TTDS00076	Antagonist	Somatostatin analogues
TTDS00076	Agonist	AOD-9604
TTDS00076	Agonist	EP-51216
TTDS00076	Agonist	EP-51389
TTDS00076	Binder	Ibutamoren
TTDS00076	Binder	Somatropin recombinant
TTDS00077	Name	Glycoprotein IIb/IIIa receptor
TTDS00077	Type of target	Successful target
TTDS00077	Synonyms	Alpha(IIb)beta(3) integrin receptor
TTDS00077	Synonyms	Fibrinogen receptor
TTDS00077	Synonyms	GPIIb-IIIa receptor
TTDS00077	Synonyms	Glycoprotein GP IIb/IIIa
TTDS00077	Synonyms	Glycoprotein IIb/IIIa
TTDS00077	Synonyms	Gp IIb/IIIa
TTDS00077	Synonyms	GpIIb/IIIa receptor
TTDS00077	Synonyms	Integrin IIb beta3
TTDS00077	Synonyms	Integrin IIbbeta3
TTDS00077	Synonyms	Integrin alpha IIb beta 3
TTDS00077	Synonyms	Integrin alphaIIbbeta3
TTDS00077	Synonyms	Platelet GPIIb-IIIa
TTDS00077	Synonyms	Platelet GPIIb/IIIa receptor
TTDS00077	Synonyms	Platelet glycoprotein IIb/IIIa fibrinogen receptor complex
TTDS00077	Synonyms	Platelet integrin IIbbeta3
TTDS00077	Disease	Acute coronary syndromes
TTDS00077	Disease	Atherothrombosis
TTDS00077	Disease	Cancer, unspecific
TTDS00077	Disease	Cardiovascular disease, unspecified
TTDS00077	Disease	Ischemic complications of nonurgent coronary stent implantation
TTDS00077	Disease	Myocardial infarction
TTDS00077	Disease	Platelet aggregation
TTDS00077	Disease	Thrombosis
TTDS00077	Related US Patent	6,448,269
TTDS00077	Related US Patent	6,455,560
TTDS00077	Related US Patent	6,476,226
TTDS00077	Related US Patent	6,489,333
TTDS00077	Related US Patent	6,495,545
TTDS00077	Related US Patent	6,518,244
TTDS00077	Related US Patent	6,630,488
TTDS00077	Related US Patent	6,677,360
TTDS00077	Target Validation	TTDS00077
TTDS00077	Drug(s)	Abciximab
TTDS00077	Drug(s)	Eptifibatide
TTDS00077	Drug(s)	Tirofiban
TTDS00077	Antagonist	Abciximab
TTDS00077	Antagonist	Accutin
TTDS00077	Antagonist	Eptifibatide
TTDS00077	Antagonist	Tirofiban
TTDS00077	Antagonist	XV454
TTDS00077	Antibody	AjvW2
TTDS00077	Antibody	Monoclonal antibodies
TTDS00077	Binder	Fibrinogen gamma-chain peptide ligands
TTDS00077	Binder	RGD
TTDS00078	UniProt ID	Q06278
TTDS00078	Name	Aldehyde oxidase
TTDS00078	Type of target	Successful target
TTDS00078	Disease	Acute leukaemia
TTDS00078	Disease	Psychiatric illness
TTDS00078	Sequence	MDRASELLFYVNGRKVIEKNVDPETMLLPYLRKKLRLTGTKYGCGGGGCGACTVMISRYNPITKRIRHHPANACLIPICS
TTDS00078	BioChemical Class	Oxidoreductases acting on the aldehyde or oxo group of donors
TTDS00078	Pathway	Drug metabolism - cytochrome P450
TTDS00078	Pathway	Metabolic pathways
TTDS00078	Pathway	Nicotinate and nicotinamide metabolism
TTDS00078	Pathway	Tryptophan metabolism
TTDS00078	Pathway	Tyrosine metabolism
TTDS00078	Pathway	Valine, leucine and isoleucine degradation
TTDS00078	Pathway	Vitamin B6 metabolism
TTDS00078	EC Number	EC 1.2.3.1
TTDS00078	Target Validation	TTDS00078
TTDS00078	Drug(s)	Isovanillin
TTDS00078	Drug(s)	Menadione
TTDS00078	Inhibitor	Benzamidine hydrochloride
TTDS00078	Inhibitor	Isovanillin
TTDS00078	Inhibitor	Menadione
TTDS00079	UniProt ID	P11387
TTDS00079	UniProt ID	Q00313
TTDS00079	Name	DNA topoisomerase I
TTDS00079	Type of target	Successful target
TTDS00079	Synonyms	Topoisomerase-I
TTDS00079	Disease	Brain tumors
TTDS00079	Disease	Breast cancer
TTDS00079	Disease	Cancer, unspecific
TTDS00079	Disease	Colorectal cancer
TTDS00079	Disease	Esophageal squamous cell cancer
TTDS00079	Disease	Fungal diseases
TTDS00079	Disease	Gastric cancer
TTDS00079	Disease	Lung cancer
TTDS00079	Disease	Lymphoblast tumor
TTDS00079	Disease	Ovarian cancer
TTDS00079	Function	The reaction catalyzed by topoisomerases leads to the conversion of one topologi
TTDS00079	Sequence	MSGDHLHNDSQIEADFRLNDSHKHKDKHKDREHRHKEHKKEKDREKSKHSNSEHKDSEKKHKEKEKTKHKDGSSEKHKDK
TTDS00079	PDB Structure	1A31; 1A35; 1A36; 1EJ9; 1K4S; 1K4T; 1LPQ; 1NH3; 1R49; 1RR8; 1RRJ; 1SC7; 1SEU; 1T
TTDS00079	BioChemical Class	Isomerases
TTDS00079	EC Number	EC 5.99.1.2
TTDS00079	Related US Patent	6,420,377
TTDS00079	Related US Patent	6,465,008
TTDS00079	Related US Patent	6,677,450
TTDS00079	Target Validation	TTDS00079
TTDS00079	QSAR Model	TTDS00079
TTDS00079	Drug(s)	Belotecan hydrocholoride
TTDS00079	Drug(s)	Beta-Lapachone
TTDS00079	Drug(s)	DS-8587
TTDS00079	Drug(s)	Irinotecan
TTDS00079	Drug(s)	Sphingosomal topotecan; Inx-0076
TTDS00079	Drug(s)	Topetecan
TTDS00079	Drug(s)	Topotecan
TTDS00079	Inhibitor	(5Z,9Z)-5,9-heptacosadienoic acid
TTDS00079	Inhibitor	10-hydroxycamptothecin
TTDS00079	Inhibitor	3,3'-(4-phenylpyridine-2,6-diyl)diphenol
TTDS00079	Inhibitor	3-(4-phenyl-2,4'-bipyridin-6-yl)phenol
TTDS00079	Inhibitor	3-(4-phenyl-6-(thiophen-2-yl)pyridin-2-yl)-phenol
TTDS00079	Inhibitor	3-(4-phenyl-6-(thiophen-3-yl)pyridin-2-yl)-phenol
TTDS00079	Inhibitor	3-(6-phenyl-2,4'-bipyridin-4-yl)phenol
TTDS00079	Inhibitor	4-(4,6-diphenylpyridin-2-yl)phenol
TTDS00079	Inhibitor	4-(6-phenyl-2,4'-bipyridin-4-yl)phenol
TTDS00079	Inhibitor	4-hydroxysaprothoquinone
TTDS00079	Inhibitor	Beta-Lapachone
TTDS00079	Inhibitor	CHO793076
TTDS00079	Inhibitor	CKD602
TTDS00079	Inhibitor	Camptothecin
TTDS00079	Inhibitor	Homocamptothecins (hCPTs)
TTDS00079	Inhibitor	Irinotecan
TTDS00079	Inhibitor	Luteolin
TTDS00079	Inhibitor	NSC-341622
TTDS00079	Inhibitor	ROSETTACIN
TTDS00079	Inhibitor	SN-38
TTDS00079	Inhibitor	TAS-103
TTDS00079	Inhibitor	TOPOSTATIN
TTDS00079	Inhibitor	Topetecan
TTDS00079	Inhibitor	Topotecan
TTDS00079	Activator	2,3-Dimethoxybenzo[i]phenanthridines
TTDS00079	Inducer	9-Nitrocamptothecin (9-NC)
TTDS00079	Inducer	KT6006
TTDS00079	Inducer	KT6528
TTDS00079	Ligand	5-hydroxy-1H-indole-3-acetic acid
TTDS00079	Ligand	7-amino-4-hydroxy-2-naphthalenesulfonic acid
TTDS00079	Ligand	Dibenzo-p-dioxin-2-carboxylic acid
TTDS00079	Ligand	Quinizarin
TTDS00080	UniProt ID	P0AES4
TTDS00080	UniProt ID	P0AES6
TTDS00080	UniProt ID	P11388
TTDS00080	UniProt ID	Q02880
TTDS00080	Name	DNA topoisomerase II
TTDS00080	Type of target	Successful target
TTDS00080	Synonyms	DNA gyrase
TTDS00080	Synonyms	Topo II
TTDS00080	Synonyms	Topoisomerase II
TTDS00080	Synonyms	Type II topoisomerase enzyme
TTDS00080	Disease	Acute promyelocytic leukemia
TTDS00080	Disease	Bacterial infections
TTDS00080	Disease	Cancer, unspecific
TTDS00080	Disease	Fungal diseases
TTDS00080	Disease	Herpes virus infection
TTDS00080	Disease	Leishmania infections
TTDS00080	Disease	Malaria
TTDS00080	Disease	Trichomoniasis
TTDS00080	Sequence	MEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTYIGSVELVTQQMWVYDEDVGINYREVTFVPG
TTDS00080	PDB Structure	3QX3
TTDS00080	BioChemical Class	Isomerases
TTDS00080	EC Number	EC 5.99.1.3
TTDS00080	Related US Patent	6,420,377
TTDS00080	Related US Patent	6,441,198
TTDS00080	Related US Patent	6,465,008
TTDS00080	Related US Patent	6,608,087
TTDS00080	Related US Patent	6,632,809
TTDS00080	Target Validation	TTDS00080
TTDS00080	QSAR Model	TTDS00080
TTDS00080	Drug(s)	2140944
TTDS00080	Drug(s)	AEZS-112
TTDS00080	Drug(s)	Aclarubicin
TTDS00080	Drug(s)	Amsacrine
TTDS00080	Drug(s)	Besifloxacin
TTDS00080	Drug(s)	Cinoxacin
TTDS00080	Drug(s)	Ciprofloxacin
TTDS00080	Drug(s)	Dexrazoxane
TTDS00080	Drug(s)	Dhaq diacetate
TTDS00080	Drug(s)	Doxorubicin
TTDS00080	Drug(s)	Enoxacin
TTDS00080	Drug(s)	Epirubicin
TTDS00080	Drug(s)	Etoposide
TTDS00080	Drug(s)	Fleroxacin
TTDS00080	Drug(s)	Fluoroquinolone
TTDS00080	Drug(s)	GSK945237
TTDS00080	Drug(s)	Garenoxacin
TTDS00080	Drug(s)	Gatifloxacin
TTDS00080	Drug(s)	Gemifloxacin
TTDS00080	Drug(s)	Iboctadekin + Doxil
TTDS00080	Drug(s)	Idarubicin
TTDS00080	Drug(s)	Levofloxacin
TTDS00080	Drug(s)	Lomefloxacin
TTDS00080	Drug(s)	Lucanthone
TTDS00080	Drug(s)	Mitoxantrone
TTDS00080	Drug(s)	Moxifloxacin
TTDS00080	Drug(s)	Nalidixic Acid
TTDS00080	Drug(s)	Norfloxacin
TTDS00080	Drug(s)	Novobiocin
TTDS00080	Drug(s)	Novobiocine
TTDS00080	Drug(s)	Ofloxacin
TTDS00080	Drug(s)	Pefloxacin
TTDS00080	Drug(s)	Quinolones
TTDS00080	Drug(s)	Rosoxacin
TTDS00080	Drug(s)	SNS-595
TTDS00080	Drug(s)	Salvicine
TTDS00080	Drug(s)	Sparfloxacin
TTDS00080	Drug(s)	TOP-53
TTDS00080	Drug(s)	Teniposide
TTDS00080	Drug(s)	Trovafloxacin
TTDS00080	Drug(s)	Valrubicin
TTDS00080	Drug(s)	ciprofloxacin
TTDS00080	Inhibitor	1,3,7-trihydroxyacridone
TTDS00080	Inhibitor	1-Methoxy-3-(oxiran-2-ylmethoxy)-9H-xanthen-9-one
TTDS00080	Inhibitor	2-(2-Aminoethyl)anthra[1,9-cd]pyrazol-6(2H)-one
TTDS00080	Inhibitor	2-(2-Hydroxyethyl)anthra[1,9-cd]pyrazol-6(2H)-one
TTDS00080	Inhibitor	3,3'-(4-phenylpyridine-2,6-diyl)diphenol
TTDS00080	Inhibitor	3-(2,6-diphenylpyridin-4-yl)phenol
TTDS00080	Inhibitor	3-(2-phenyl-6-(thiophen-2-yl)pyridin-4-yl)-phenol
TTDS00080	Inhibitor	3-(2-phenyl-6-(thiophen-3-yl)pyridin-4-yl)-phenol
TTDS00080	Inhibitor	3-(4-phenyl-6-(thiophen-2-yl)pyridin-2-yl)-phenol
TTDS00080	Inhibitor	3-(4-phenyl-6-(thiophen-3-yl)pyridin-2-yl)-phenol
TTDS00080	Inhibitor	3-(6-(furan-2-yl)-4-phenylpyridin-2-yl)-phenol
TTDS00080	Inhibitor	4'-Demethyl-4beta-amino-4-desoxypodophyllotoxin
TTDS00080	Inhibitor	4'-Demethyl-epipodophyllotoxin
TTDS00080	Inhibitor	4,4'-(4-phenylpyridine-2,6-diyl)diphenol
TTDS00080	Inhibitor	4-(furan-3-yl)-2,6-di(thiophen-2-yl)pyridine
TTDS00080	Inhibitor	7-chloro-1,3-dihydroxyacridone
TTDS00080	Inhibitor	A-62176
TTDS00080	Inhibitor	Aclarubicin
TTDS00080	Inhibitor	Amifloxacin
TTDS00080	Inhibitor	Amsacrine
TTDS00080	Inhibitor	Anthracycline
TTDS00080	Inhibitor	Cinoxacin
TTDS00080	Inhibitor	Ciprofloxacin
TTDS00080	Inhibitor	Clorobiocin
TTDS00080	Inhibitor	Coumermycin A1
TTDS00080	Inhibitor	DEMETHYLZEYLASTERONE
TTDS00080	Inhibitor	Dexrazoxane
TTDS00080	Inhibitor	Dhaq diacetate
TTDS00080	Inhibitor	Doxorubicin
TTDS00080	Inhibitor	ER-37328
TTDS00080	Inhibitor	Ellipticine
TTDS00080	Inhibitor	Enoxacin
TTDS00080	Inhibitor	Epirubicin
TTDS00080	Inhibitor	Etoposide
TTDS00080	Inhibitor	Fleroxacin
TTDS00080	Inhibitor	Fluoroquinolone
TTDS00080	Inhibitor	Fluoroquinolones
TTDS00080	Inhibitor	GSK945237
TTDS00080	Inhibitor	Garenoxacin
TTDS00080	Inhibitor	Gatifloxacin
TTDS00080	Inhibitor	Gemifloxacin
TTDS00080	Inhibitor	Genistein
TTDS00080	Inhibitor	Howiinol A (GHM-10)
TTDS00080	Inhibitor	ICRF-154
TTDS00080	Inhibitor	ICRF-193
TTDS00080	Inhibitor	Iboctadekin + Doxil
TTDS00080	Inhibitor	Idarubicin
TTDS00080	Inhibitor	LOSOXANTRONE
TTDS00080	Inhibitor	LUPEOL
TTDS00080	Inhibitor	Levofloxacin
TTDS00080	Inhibitor	Lomefloxacin
TTDS00080	Inhibitor	Lucanthone
TTDS00080	Inhibitor	Mitoxantrone
TTDS00080	Inhibitor	Moxifloxacin
TTDS00080	Inhibitor	Nalidixic Acid
TTDS00080	Inhibitor	Norfloxacin
TTDS00080	Inhibitor	Novobiocin
TTDS00080	Inhibitor	Ofloxacin
TTDS00080	Inhibitor	Olean-12-en-3beta,15alpha-diol
TTDS00080	Inhibitor	Oxolinic acid
TTDS00080	Inhibitor	PIROXANTRONE
TTDS00080	Inhibitor	Pefloxacin
TTDS00080	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDS00080	Inhibitor	Podophyllotoxin
TTDS00080	Inhibitor	Pumiliotoxin 251D
TTDS00080	Inhibitor	Quinolones
TTDS00080	Inhibitor	Ro-23-9424
TTDS00080	Inhibitor	Rosoxacin
TTDS00080	Inhibitor	SNS-595
TTDS00080	Inhibitor	Salvicine
TTDS00080	Inhibitor	Sparfloxacin
TTDS00080	Inhibitor	TOP-53
TTDS00080	Inhibitor	TOPOSTATIN
TTDS00080	Inhibitor	Teniposide
TTDS00080	Inhibitor	Trovafloxacin
TTDS00080	Inhibitor	Valrubicin
TTDS00080	Inhibitor	ciprofloxacin
TTDS00080	Inhibitor	makaluvamine N
TTDS00080	Binder	CBR-2092
TTDS00080	Binder	Ciprofloxacin+dexamethasone
TTDS00080	Binder	Novobiocine
TTDS00080	Binder	Ofloxacin otic
TTDS00080	Binder	Ro-23-9424
TTDS00080	Binder	Toll-like receptor 4 inhibition
TTDS00080	Multitarget	Ciprofloxacin
TTDS00080	Multitarget	Gatifloxacin
TTDS00080	Multitarget	Gemifloxacin
TTDS00080	Multitarget	Iboctadekin + Doxil
TTDS00080	Multitarget	Levofloxacin
TTDS00080	Multitarget	Moxifloxacin
TTDS00080	Multitarget	Sparfloxacin
TTDS00083	Name	Topoisomerase IV
TTDS00083	Type of target	Successful target
TTDS00083	Synonyms	Topo IV
TTDS00083	Disease	Bacterial infections
TTDS00083	BioChemical Class	Isomerases
TTDS00083	EC Number	EC 5.99.1.-
TTDS00083	Target Validation	TTDS00083
TTDS00083	Drug(s)	Besifloxacin
TTDS00083	Drug(s)	Gatifloxacin
TTDS00083	Drug(s)	Levofloxacin
TTDS00083	Drug(s)	Moxifloxacin
TTDS00083	Drug(s)	Sparfloxacin
TTDS00083	Drug(s)	ciprofloxacin
TTDS00083	Inhibitor	ABT-492
TTDS00083	Inhibitor	Gatifloxacin
TTDS00083	Inhibitor	Levofloxacin
TTDS00083	Inhibitor	Moxifloxacin
TTDS00083	Inhibitor	Premafloxacin
TTDS00083	Inhibitor	Sparfloxacin
TTDS00083	Inhibitor	ciprofloxacin
TTDS00083	Multitarget	Gatifloxacin
TTDS00083	Multitarget	Levofloxacin
TTDS00083	Multitarget	Moxifloxacin
TTDS00083	Multitarget	Sparfloxacin
TTDS00084	UniProt ID	P20082
TTDS00084	UniProt ID	P72525
TTDS00084	Name	Topoisomerase IV subunit A
TTDS00084	Type of target	Successful target
TTDS00084	Synonyms	DNA topoisomerase IV
TTDS00084	Disease	Bacterial infections
TTDS00084	Disease	Urinary tract infection
TTDS00084	Function	Topoisomerase iv is essential for chromosome segregation. It has relaxation of s
TTDS00084	Sequence	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDS
TTDS00084	PDB Structure	2NOV; 3FOE; 3FOF; 3K9F; 3KSA; 3KSB; 3LTN; 3RAD; 3RAE; 3RAF
TTDS00084	BioChemical Class	Isomerases
TTDS00084	EC Number	EC 5.99.1.-
TTDS00084	Target Validation	TTDS00084
TTDS00084	Drug(s)	Ciprofloxacin
TTDS00084	Drug(s)	Gemifloxacin
TTDS00084	Drug(s)	Grepafloxacin
TTDS00084	Inhibitor	Ciprofloxacin
TTDS00084	Inhibitor	Gemifloxacin
TTDS00084	Inhibitor	Grepafloxacin
TTDS00084	Inhibitor	Premafloxacin
TTDS00084	Inhibitor	Pumiliotoxin 251D
TTDS00084	Inhibitor	Ro-23-9424
TTDS00084	Multitarget	Ciprofloxacin
TTDS00084	Multitarget	Gemifloxacin
TTDS00085	Name	Histamine receptor
TTDS00085	Type of target	Successful target
TTDS00085	Disease	Schizophrenia
TTDS00085	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00085	Pathway	Calcium signaling pathway
TTDS00085	Pathway	Neuroactive ligand-receptor interaction
TTDS00085	Drug(s)	Histamine Phosphate
TTDS00085	Agonist	Histamine Phosphate
TTDS00086	UniProt ID	P35367
TTDS00086	Name	Histamine H1 receptor
TTDS00086	Type of target	Successful target
TTDS00086	Synonyms	H1 Histamine receptor
TTDS00086	Synonyms	Histamine receptor 1
TTDS00086	Disease	Acute lymphoblastic leukaemia (therapy-refractory)
TTDS00086	Disease	Allergic diseases
TTDS00086	Disease	Allergic rhinitis, unspecified
TTDS00086	Disease	Anxiety disorder, unspecified
TTDS00086	Disease	Chronic rhinitis
TTDS00086	Disease	Chronic urticaria
TTDS00086	Disease	Epidermal hyperplasia
TTDS00086	Disease	Epilepsy
TTDS00086	Disease	Hypotension
TTDS00086	Disease	Intimal hyperplasia
TTDS00086	Disease	Ischemia
TTDS00086	Disease	Motion sickness
TTDS00086	Disease	Nausea and vomiting
TTDS00086	Disease	Seasonal allergic rhinitis
TTDS00086	Disease	Systemic arterial vasodilation
TTDS00086	Function	In peripheral tissues, the h1 subclass of histamine receptors mediates the contr
TTDS00086	Sequence	MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVV
TTDS00086	PDB Structure	3RZE
TTDS00086	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00086	Pathway	Calcium signaling pathway
TTDS00086	Pathway	Neuroactive ligand-receptor interaction
TTDS00086	Related US Patent	6,506,756
TTDS00086	Related US Patent	6,509,353
TTDS00086	Related US Patent	6,518,287
TTDS00086	Related US Patent	6,525,070
TTDS00086	Related US Patent	6,528,522
TTDS00086	Related US Patent	6,605,302
TTDS00086	Related US Patent	6,613,357
TTDS00086	Related US Patent	6,649,602
TTDS00086	Target Validation	TTDS00086
TTDS00086	QSAR Model	TTDS00086
TTDS00086	Drug(s)	(S)-(+)-Dimethindene maleate
TTDS00086	Drug(s)	Aceprometazine
TTDS00086	Drug(s)	Acrivastine
TTDS00086	Drug(s)	Alcaftadine
TTDS00086	Drug(s)	Antazoline
TTDS00086	Drug(s)	Antazoline hydrochloride
TTDS00086	Drug(s)	Antazoline phosphate
TTDS00086	Drug(s)	Astemizole
TTDS00086	Drug(s)	Azatadine
TTDS00086	Drug(s)	Azelastine
TTDS00086	Drug(s)	Bepotastine
TTDS00086	Drug(s)	Bepotastine besilate
TTDS00086	Drug(s)	Bromodiphenhydramine
TTDS00086	Drug(s)	Brompheniramine
TTDS00086	Drug(s)	Buclizine
TTDS00086	Drug(s)	Carbinoxamine
TTDS00086	Drug(s)	Carebastine
TTDS00086	Drug(s)	Cetirizine
TTDS00086	Drug(s)	Chlophedianol
TTDS00086	Drug(s)	Chlorpheniramine
TTDS00086	Drug(s)	Cinnarizine
TTDS00086	Drug(s)	Clemastine
TTDS00086	Drug(s)	Cyclizine
TTDS00086	Drug(s)	Cyproheptadine
TTDS00086	Drug(s)	Desloratadine
TTDS00086	Drug(s)	Dexbrompheniramine
TTDS00086	Drug(s)	Dimenhydrinate
TTDS00086	Drug(s)	Dimethindene
TTDS00086	Drug(s)	Dimethindene maleate
TTDS00086	Drug(s)	Diphenhydramine
TTDS00086	Drug(s)	Diphenylpyraline
TTDS00086	Drug(s)	Doxepin
TTDS00086	Drug(s)	Doxylamine
TTDS00086	Drug(s)	Emedastine
TTDS00086	Drug(s)	Epinastine
TTDS00086	Drug(s)	Ergotidine
TTDS00086	Drug(s)	Fexofenadine
TTDS00086	Drug(s)	GSK1004723
TTDS00086	Drug(s)	GSK835726
TTDS00086	Drug(s)	Hydroxyzine
TTDS00086	Drug(s)	Ketotifen
TTDS00086	Drug(s)	Levocabastine
TTDS00086	Drug(s)	Levocetirizine dihydrochloride
TTDS00086	Drug(s)	Loratadine
TTDS00086	Drug(s)	Mepyramine
TTDS00086	Drug(s)	Mepyramine maleate
TTDS00086	Drug(s)	Mequitazine
TTDS00086	Drug(s)	Methdilazine
TTDS00086	Drug(s)	Mizolastine
TTDS00086	Drug(s)	Olopatadine
TTDS00086	Drug(s)	Oxatomide
TTDS00086	Drug(s)	Pemirolast
TTDS00086	Drug(s)	Phenindamine
TTDS00086	Drug(s)	Pheniramine
TTDS00086	Drug(s)	Promethazine
TTDS00086	Drug(s)	Propiomazine
TTDS00086	Drug(s)	Terfenadine
TTDS00086	Drug(s)	Tranilast
TTDS00086	Drug(s)	Trimeprazine
TTDS00086	Drug(s)	Tripelennamine
TTDS00086	Drug(s)	Triprolidine
TTDS00086	Inhibitor	ATC-0175
TTDS00086	Inhibitor	DIMEBOLIN
TTDS00086	Inhibitor	Doxepin
TTDS00086	Inhibitor	KF-A6
TTDS00086	Inhibitor	MDL-105212
TTDS00086	Inhibitor	MDL-28163
TTDS00086	Inhibitor	MIANSERIN HYDROCHLORIDE
TTDS00086	Inhibitor	OCTOCLOTHEPIN
TTDS00086	Inhibitor	R-226161
TTDS00086	Inhibitor	R-dimethindene
TTDS00086	Inhibitor	RUPATADINE
TTDS00086	Inhibitor	SCH-37370
TTDS00086	Inhibitor	VUF-10148
TTDS00086	Antagonist	(S)-(+)-Dimethindene maleate
TTDS00086	Antagonist	Aceprometazine
TTDS00086	Antagonist	Acrivastine
TTDS00086	Antagonist	Alcaftadine
TTDS00086	Antagonist	Antazoline
TTDS00086	Antagonist	Antazoline hydrochloride
TTDS00086	Antagonist	Antazoline phosphate
TTDS00086	Antagonist	Astemizole
TTDS00086	Antagonist	Azatadine
TTDS00086	Antagonist	Azelastine
TTDS00086	Antagonist	Bepotastine
TTDS00086	Antagonist	Bepotastine besilate
TTDS00086	Antagonist	Bromodiphenhydramine
TTDS00086	Antagonist	Brompheniramine
TTDS00086	Antagonist	Buclizine
TTDS00086	Antagonist	Carbinoxamine
TTDS00086	Antagonist	Carebastine
TTDS00086	Antagonist	Cetirizine
TTDS00086	Antagonist	Chlophedianol
TTDS00086	Antagonist	Chlorpheniramine
TTDS00086	Antagonist	Cinnarizine
TTDS00086	Antagonist	Clemastine
TTDS00086	Antagonist	Cyclizine
TTDS00086	Antagonist	Cyproheptadine
TTDS00086	Antagonist	Desloratadine
TTDS00086	Antagonist	Dexbrompheniramine
TTDS00086	Antagonist	Dimenhydrinate
TTDS00086	Antagonist	Dimethindene
TTDS00086	Antagonist	Dimethindene maleate
TTDS00086	Antagonist	Diphenhydramine
TTDS00086	Antagonist	Diphenylpyraline
TTDS00086	Antagonist	Doxylamine
TTDS00086	Antagonist	Emedastine
TTDS00086	Antagonist	Epinastine
TTDS00086	Antagonist	Fexofenadine
TTDS00086	Antagonist	GSK1004723
TTDS00086	Antagonist	GSK835726
TTDS00086	Antagonist	Hydroxyclemastine
TTDS00086	Antagonist	Hydroxyzine
TTDS00086	Antagonist	Ketotifen
TTDS00086	Antagonist	Levocabastine
TTDS00086	Antagonist	Levocetirizine dihydrochloride
TTDS00086	Antagonist	Loratadine
TTDS00086	Antagonist	Mepyramine
TTDS00086	Antagonist	Mepyramine maleate
TTDS00086	Antagonist	Mequitazine
TTDS00086	Antagonist	Methdilazine
TTDS00086	Antagonist	Mizolastine
TTDS00086	Antagonist	Olopatadine
TTDS00086	Antagonist	Oxatomide
TTDS00086	Antagonist	Pemirolast
TTDS00086	Antagonist	Phenindamine
TTDS00086	Antagonist	Pheniramine
TTDS00086	Antagonist	Promethazine
TTDS00086	Antagonist	Propiomazine
TTDS00086	Antagonist	Pyrilamine
TTDS00086	Antagonist	Pyrilamine Maleate
TTDS00086	Antagonist	Sch 37370
TTDS00086	Antagonist	Terfenadine
TTDS00086	Antagonist	Tranilast
TTDS00086	Antagonist	Trimeprazine
TTDS00086	Antagonist	Tripelennamine
TTDS00086	Antagonist	Triprolidine
TTDS00086	Agonist	8R-Lisuride
TTDS00086	Agonist	Ergotidine
TTDS00086	Multitarget	GSK1004723
TTDS00086	Multitarget	GSK835726
TTDS00087	UniProt ID	P25021
TTDS00087	Name	Histamine H2 receptor
TTDS00087	Type of target	Successful target
TTDS00087	Synonyms	Gastric receptor I
TTDS00087	Synonyms	H2R
TTDS00087	Synonyms	Histamine receptor 2
TTDS00087	Disease	Epidermal hyperplasia
TTDS00087	Disease	Lasting tachycardia
TTDS00087	Disease	Peptic ulcer
TTDS00087	Disease	Systemic arterial vasodilation
TTDS00087	Disease	Zollinger-Ellison syndrome
TTDS00087	Function	The H2 subclass of histamine receptors mediates gastric acid secretion and also
TTDS00087	Sequence	MAPNGTASSFCLDSTACKITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCFIVSLAITDLLLGLLVLPFSAIYQL
TTDS00087	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00087	Related US Patent	6,274,160
TTDS00087	Related US Patent	6,353,005
TTDS00087	Related US Patent	6,362,202
TTDS00087	Related US Patent	6,548,518
TTDS00087	Related US Patent	6,552,045
TTDS00087	Related US Patent	6,663,888
TTDS00087	Target Validation	TTDS00087
TTDS00087	Drug(s)	Betazole
TTDS00087	Drug(s)	Cimetidine
TTDS00087	Drug(s)	Famotidine
TTDS00087	Drug(s)	Nizatidine
TTDS00087	Drug(s)	Ranitidine
TTDS00087	Inhibitor	(+/-)-nantenine
TTDS00087	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00087	Inhibitor	MIANSERIN HYDROCHLORIDE
TTDS00087	Inhibitor	VUF-10148
TTDS00087	Inhibitor	WAY-207024
TTDS00087	Antagonist	Betazole
TTDS00087	Antagonist	Cimetidine
TTDS00087	Antagonist	Famotidine
TTDS00087	Antagonist	Gaster
TTDS00087	Antagonist	Metiamide
TTDS00087	Antagonist	Nizatidine
TTDS00087	Antagonist	Ranitidine
TTDS00087	Agonist	Dimaprit
TTDS00087	Agonist	Histamine
TTDS00089	UniProt ID	P50135
TTDS00089	Name	Histamine N-methyltransferase
TTDS00089	Type of target	Successful target
TTDS00089	Synonyms	HMT
TTDS00089	Synonyms	Histamine-N-methyltransferase
TTDS00089	Disease	Malaria
TTDS00089	Function	Inactivates histamine by n-methylation and plays an important role in degrading
TTDS00089	Sequence	MASSMRSLFSDHGKYVESFRRFLNHSTEHQCMQEFMDKKLPGIIGRIGDTKSEIKILSIGGGAGEIDLQILSKVQAQYPG
TTDS00089	PDB Structure	1ICZ; 1JQD; 1JQE; 2AOT; 2AOU; 2AOV; 2AOW; 2AOX
TTDS00089	BioChemical Class	Transferases transferring one-carbon groups
TTDS00089	EC Number	EC 2.1.1.8
TTDS00089	Target Validation	TTDS00089
TTDS00089	Drug(s)	Amodiaquine
TTDS00089	Inhibitor	4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE
TTDS00089	Inhibitor	Amodiaquine
TTDS00089	Inhibitor	METOPRINE, METHODICHLOROPHEN
TTDS00089	Inhibitor	N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE
TTDS00089	Inhibitor	S-Adenosyl-L-Homocysteine
TTDS00090	UniProt ID	P36888
TTDS00090	Name	FL cytokine receptor
TTDS00090	Type of target	Successful target
TTDS00090	Synonyms	CD135 antigen
TTDS00090	Synonyms	FLT3 tyrosine kinase
TTDS00090	Synonyms	Receptor tyrosine kinase FLT3
TTDS00090	Synonyms	STK-1
TTDS00090	Synonyms	Stem cell tyrosine kinase 1
TTDS00090	Synonyms	Tyrosine-protein kinase receptor FLT3
TTDS00090	Disease	Acute myeloid leukemia
TTDS00090	Disease	Autoimmune diseases
TTDS00090	Disease	MLL-rearranged acute lymphoblastic leukemias
TTDS00090	Function	Receptor for the fl cytokine, and has a tyrosine-protein kinase activity.
TTDS00090	Sequence	MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSSVGKSSSYPMVSESPEDLGCALRPQSSGTVYEAAA
TTDS00090	PDB Structure	1RJB; 3QS7; 3QS9
TTDS00090	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00090	Pathway	Acute myeloid leukemia
TTDS00090	Pathway	Cytokine-cytokine receptor interaction
TTDS00090	Pathway	Hematopoietic cell lineage
TTDS00090	Pathway	Pathways in cancer
TTDS00090	EC Number	EC 2.7.1.112
TTDS00090	Target Validation	TTDS00090
TTDS00090	Drug(s)	4SC-203
TTDS00090	Drug(s)	CDX-301
TTDS00090	Drug(s)	Midostaurin
TTDS00090	Drug(s)	PLX3397
TTDS00090	Drug(s)	Pacritinib
TTDS00090	Drug(s)	Ponatinib
TTDS00090	Drug(s)	Quizartinib
TTDS00090	Drug(s)	SU5614
TTDS00090	Drug(s)	Sunitinib
TTDS00090	Drug(s)	Sunitinib malate
TTDS00090	Drug(s)	Tandutinib
TTDS00090	Inhibitor	(1H-indol-2-yl)(5-methoxy-1H-indol-2-yl)methanone
TTDS00090	Inhibitor	(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone
TTDS00090	Inhibitor	(1H-indol-2-yl)(6-methoxy-1H-indol-2-yl)methanone
TTDS00090	Inhibitor	(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone
TTDS00090	Inhibitor	(5-hydroxy-1H-indol-2-yl)(1H-indol-2-yl)methanone
TTDS00090	Inhibitor	(benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone
TTDS00090	Inhibitor	2-(3,4-dimethoxybenzamido)thiophene-3-carboxamide
TTDS00090	Inhibitor	4-(4-aminophenyl)-1H-indazol-3yl-amine
TTDS00090	Inhibitor	4SC-203
TTDS00090	Inhibitor	AG1295
TTDS00090	Inhibitor	Bis-(5-hydroxy-1H-indol-2-yl)-methanone
TTDS00090	Inhibitor	Ki23819
TTDS00090	Inhibitor	MLN-518
TTDS00090	Inhibitor	Midostaurin
TTDS00090	Inhibitor	N-[4-(3-amino-1H-indazol-4-yl)phenyl]benzamide
TTDS00090	Inhibitor	PKC-412
TTDS00090	Inhibitor	SU5614
TTDS00090	Inhibitor	Sunitinib
TTDS00090	Inhibitor	Sunitinib malate
TTDS00090	Inhibitor	Tandutinib
TTDS00090	Inhibitor	bis(5-acetoxybenzo[b]furan-2-yl)methanone
TTDS00090	Inhibitor	bis(5-aminobenzo[b]furan-2-yl)methanone
TTDS00090	Inhibitor	bis(5-hydroxybenzo[b]furan-2-yl)methanone
TTDS00090	Inhibitor	bis(6-hydroxybenzo[b]furan-2-yl)methanone
TTDS00090	Inhibitor	bis(benzo[b]furan-2-yl)methanone
TTDS00090	Inhibitor	di(1H-indol-2-yl)methanone
TTDS00090	Multitarget	4SC-203
TTDS00090	Multitarget	Midostaurin
TTDS00090	Multitarget	Sunitinib
TTDS00090	Multitarget	Sunitinib malate
TTDS00091	UniProt ID	P20138
TTDS00091	Name	Myeloid cell surface antigen CD33
TTDS00091	Type of target	Successful target
TTDS00091	Synonyms	CD33
TTDS00091	Synonyms	Gp67
TTDS00091	Synonyms	Siglec-3
TTDS00091	Disease	Acute myeloid leukemia
TTDS00091	Function	Putative adhesion molecule of myelomonocytic-derived cells that mediates sialic-
TTDS00091	Sequence	MPLLLLLPLLWAGALAMDPNFWLQVQESVTVQEGLCVLVPCTFFHPIPYYDKNSPVHGYWFREGAIISRDSPVATNKLDQ
TTDS00091	BioChemical Class	Transmembrane protein
TTDS00091	Drug(s)	Gemtuzumab ozogamicin
TTDS00091	Antibody	Anti-CD33 antibody, P67.6
TTDS00091	Antibody	Gemtuzumab ozogamicin
TTDS00092	UniProt ID	P00813
TTDS00092	Name	Adenosine deaminase
TTDS00092	Type of target	Successful target
TTDS00092	Synonyms	Adenosine aminohydrolase
TTDS00092	Disease	Acute myeloid leukemia
TTDS00092	Disease	Chronic lymphocytic leukemia
TTDS00092	Disease	Chronic myeloid leukemia
TTDS00092	Disease	Hairy-cell leukemia
TTDS00092	Disease	Non-Hodgkin's lymphoma, unspecified type
TTDS00092	Disease	Peripheral and cutaneous T-cell lymphomas
TTDS00092	Sequence	MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIK
TTDS00092	PDB Structure	1M7M; 3IAR
TTDS00092	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDS00092	Pathway	Metabolic pathways
TTDS00092	Pathway	Primary immunodeficiency
TTDS00092	Pathway	Purine metabolism
TTDS00092	EC Number	EC 3.5.4.4
TTDS00092	Target Validation	TTDS00092
TTDS00092	Drug(s)	Cladribine
TTDS00092	Drug(s)	Dipyridamole
TTDS00092	Drug(s)	Fludarabine
TTDS00092	Drug(s)	Pentostatin
TTDS00092	Inhibitor	(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
TTDS00092	Inhibitor	1-Deaza-Adenosine
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-4-butoxy-butan-2-ol
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-4-p-tolyl-butan-2-ol
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-4-phenethyloxy-butan-2-ol
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-5-m-tolyl-pentan-2-ol
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-6-o-tolyl-hexan-2-ol
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-6-phenyl-hexan-2-ol
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-7-phenyl-heptan-2-ol
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-8-phenyl-octan-2-ol
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-non-5-en-2-ol
TTDS00092	Inhibitor	3-(6-Amino-purin-9-yl)-non-5-yn-2-ol
TTDS00092	Inhibitor	6-Hydroxy-1,6-Dihydro Purine Nucleoside
TTDS00092	Inhibitor	6-Hydroxy-7,8-Dihydro Purine Nucleoside
TTDS00092	Inhibitor	Cladribine
TTDS00092	Inhibitor	Dipyridamole
TTDS00092	Inhibitor	FR117016
TTDS00092	Inhibitor	FR221647
TTDS00092	Inhibitor	FR230513
TTDS00092	Inhibitor	FR233623
TTDS00092	Inhibitor	FR236913
TTDS00092	Inhibitor	FR239087
TTDS00092	Inhibitor	Fludarabine
TTDS00092	Inhibitor	Pentostatin
TTDS00092	Inhibitor	Purine Riboside
TTDS00093	UniProt ID	P27487
TTDS00093	Name	Dipeptidyl peptidase IV
TTDS00093	Type of target	Successful target
TTDS00093	Synonyms	ADABP
TTDS00093	Synonyms	Adenosine deaminase complexing protein-2
TTDS00093	Synonyms	DPP IV
TTDS00093	Synonyms	DPP-IV
TTDS00093	Synonyms	T-cell activation antigen CD26
TTDS00093	Synonyms	TP103
TTDS00093	Disease	Autoimmune diseases
TTDS00093	Disease	Diabetes mellitus
TTDS00093	Disease	Malignancies
TTDS00093	Disease	Noninsulin-dependent diabetes mellitus
TTDS00093	Disease	Obesity
TTDS00093	Function	Removes n-terminal dipeptides sequentially from polypeptides having unsubstitute
TTDS00093	Sequence	MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFN
TTDS00093	PDB Structure	1J2E; 1N1M; 1NU6; 1NU8; 1PFQ; 1R9M; 1R9N; 1RWQ; 1TK3; 1TKR; 1U8E; 1W1I; 1WCY; 1X
TTDS00093	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00093	EC Number	EC 3.4.14.5
TTDS00093	Related US Patent	6,380,398
TTDS00093	Related US Patent	6,395,767
TTDS00093	Related US Patent	6,573,287
TTDS00093	Related US Patent	6,645,995
TTDS00093	Related US Patent	6,710,040
TTDS00093	Target Validation	TTDS00093
TTDS00093	Drug(s)	ABT-279
TTDS00093	Drug(s)	ARI-2243
TTDS00093	Drug(s)	ASP8497
TTDS00093	Drug(s)	Alogliptin
TTDS00093	Drug(s)	Anagliptin
TTDS00093	Drug(s)	Denagliptin
TTDS00093	Drug(s)	ER-319711-15
TTDS00093	Drug(s)	IDDBCP161883
TTDS00093	Drug(s)	Isoleucine thiazolidide DPP IV
TTDS00093	Drug(s)	Kombiglyze XR/Komboglyze FDC
TTDS00093	Drug(s)	LY-2463665
TTDS00093	Drug(s)	Linagliptin
TTDS00093	Drug(s)	MK-3102
TTDS00093	Drug(s)	Melogliptin
TTDS00093	Drug(s)	NVP DPP728
TTDS00093	Drug(s)	R-1438
TTDS00093	Drug(s)	SSR-162369
TTDS00093	Drug(s)	SYR-472
TTDS00093	Drug(s)	SaxaDapa FDC
TTDS00093	Drug(s)	Saxagliptin
TTDS00093	Drug(s)	Sitagliptin
TTDS00093	Drug(s)	TAK-100
TTDS00093	Drug(s)	TAK-472
TTDS00093	Drug(s)	Teneligliptin
TTDS00093	Drug(s)	Vildagliptin
TTDS00093	Inhibitor	(+/-)-6-(2-chlorophenyl)cyclohex-3-enamine
TTDS00093	Inhibitor	(1-phenylcyclopentyl)methanamine
TTDS00093	Inhibitor	(1R,2R)-1,2-diphenylethane-1,2-diamine
TTDS00093	Inhibitor	(1R,2S)-1,2-diphenylethane-1,2-diamine
TTDS00093	Inhibitor	(2-(2-chlorophenyl)pyridin-3-yl)methanamine
TTDS00093	Inhibitor	(2-chloro-6-phenoxyphenyl)methanamine
TTDS00093	Inhibitor	(2s)-Pyrrolidin-2-Ylmethylamine
TTDS00093	Inhibitor	(3S,4R)-3-butyl-1-phenylpiperidin-4-amine
TTDS00093	Inhibitor	(5-phenyl-3H-benzo[d]imidazol-4-yl)methanamine
TTDS00093	Inhibitor	(R)-1-(2-aminoacetyl)pyrrolidin-2-ylboronic acid
TTDS00093	Inhibitor	(S)-2-Amino-1-azetidin-1-yl-2-cyclohexyl-ethanone
TTDS00093	Inhibitor	(S)-2-Amino-1-thiazolidin-3-yl-propane-1-thione
TTDS00093	Inhibitor	(S)-pyrrolidin-1-yl(pyrrolidin-2-yl)methanone
TTDS00093	Inhibitor	(S)-pyrrolidin-2-yl(thiazolidin-3-yl)methanone
TTDS00093	Inhibitor	1-(1-phenylcyclopentyl)methylamine
TTDS00093	Inhibitor	1-benzhydryl-3-butylpiperidin-4-amine
TTDS00093	Inhibitor	1-benzyl-4-(2,4-dichlorophenyl)pyrrolidin-3-amine
TTDS00093	Inhibitor	1-biphenyl-2-ylmethanamine
TTDS00093	Inhibitor	2-(2-chlorophenyl)-2-morpholinoethanamine
TTDS00093	Inhibitor	2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One
TTDS00093	Inhibitor	3-butyl-1-(naphthalen-1-yl)piperidin-4-amine
TTDS00093	Inhibitor	4-(2,4-dichlorophenyl)-1-phenylpyrrolidin-3-amine
TTDS00093	Inhibitor	4-(2,4-dichlorophenyl)-1-tosylpyrrolidin-3-amine
TTDS00093	Inhibitor	4-iodophenyl-alaninyl-(S)-2-cyano-pyrrolidine
TTDS00093	Inhibitor	ABT-279
TTDS00093	Inhibitor	ABT-341
TTDS00093	Inhibitor	ASP8497
TTDS00093	Inhibitor	Alogliptin
TTDS00093	Inhibitor	Alpha-D-Mannose
TTDS00093	Inhibitor	BI-1356
TTDS00093	Inhibitor	C-(2'-Chloro-biphenyl-2-yl)-methylamine
TTDS00093	Inhibitor	D-Val-L-boroPro
TTDS00093	Inhibitor	DIPROTIN A
TTDS00093	Inhibitor	DPP-4 inhibitor
TTDS00093	Inhibitor	Denagliptin
TTDS00093	Inhibitor	Diisopropylphosphono Group
TTDS00093	Inhibitor	ER-319711-15
TTDS00093	Inhibitor	FE 999011
TTDS00093	Inhibitor	Fucose
TTDS00093	Inhibitor	IDDBCP161883
TTDS00093	Inhibitor	Iodo-Phenylalanine
TTDS00093	Inhibitor	Isoleucine thiazolidide DPP IV
TTDS00093	Inhibitor	KR-62436
TTDS00093	Inhibitor	L-Ala-L-boroPro
TTDS00093	Inhibitor	L-Val-L-boroPro
TTDS00093	Inhibitor	LY-2463665
TTDS00093	Inhibitor	Linagliptin
TTDS00093	Inhibitor	Melogliptin
TTDS00093	Inhibitor	N-alkyl Gly-boro-Pro derivative
TTDS00093	Inhibitor	N-isoleucylthiazolidine
TTDS00093	Inhibitor	N4-(4-chlorobenzyl)-2,4-diaminobutanoylpiperidine
TTDS00093	Inhibitor	NVP DPP728
TTDS00093	Inhibitor	NVP-DPP728
TTDS00093	Inhibitor	P32/98
TTDS00093	Inhibitor	PF-00734200
TTDS00093	Inhibitor	R-1438
TTDS00093	Inhibitor	SSR-162369
TTDS00093	Inhibitor	SYR-472
TTDS00093	Inhibitor	Saxagliptin
TTDS00093	Inhibitor	Sitagliptin
TTDS00093	Inhibitor	TAK-100
TTDS00093	Inhibitor	Vildagliptin
TTDS00093	Inhibitor	cyclohexylglycine-(2S)-cyanopyrrolidine
TTDS00095	UniProt ID	Q13547
TTDS00095	Name	Histone deacetylase 1
TTDS00095	Type of target	Successful target
TTDS00095	Synonyms	HDAC1
TTDS00095	Disease	Cancer, unspecific
TTDS00095	Disease	Proliferative diseases
TTDS00095	Disease	Prostate cancer (hormone refractory)
TTDS00095	Function	Responsible for the deacetylation of lysine residues on the n-terminal part of t
TTDS00095	Sequence	MAQTQGTRRKVCYYYDGDVGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKANAEEMTKYHSDDYIKFLRSIR
TTDS00095	PDB Structure	1TYI
TTDS00095	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDS00095	Pathway	Cell cycle
TTDS00095	Pathway	Chronic myeloid leukemia
TTDS00095	Pathway	Huntington's disease
TTDS00095	Pathway	Notch signaling pathway
TTDS00095	Pathway	Pathways in cancer
TTDS00095	Target Validation	TTDS00095
TTDS00095	QSAR Model	TTDS00095
TTDS00095	Drug(s)	4SC-202
TTDS00095	Drug(s)	AN-9
TTDS00095	Drug(s)	CHAP-15
TTDS00095	Drug(s)	Chlamydocin
TTDS00095	Drug(s)	Depudecin
TTDS00095	Drug(s)	FFF1
TTDS00095	Drug(s)	FFF2
TTDS00095	Drug(s)	FFF3
TTDS00095	Drug(s)	FFF4
TTDS00095	Drug(s)	HC-Toxin
TTDS00095	Drug(s)	HDAC-42
TTDS00095	Drug(s)	ITF2357
TTDS00095	Drug(s)	JNS-16241199
TTDS00095	Drug(s)	LAQ824
TTDS00095	Drug(s)	M-carboxycinnamic acid bishydroxamide
TTDS00095	Drug(s)	MGCD-0103
TTDS00095	Drug(s)	MS-275
TTDS00095	Drug(s)	NVP-LAQ824
TTDS00095	Drug(s)	Oxamflatin
TTDS00095	Drug(s)	PDX-101
TTDS00095	Drug(s)	PXD101
TTDS00095	Drug(s)	Panobinostat
TTDS00095	Drug(s)	Phenylbutyrate
TTDS00095	Drug(s)	Pyroxamide
TTDS00095	Drug(s)	RG2833
TTDS00095	Drug(s)	Resminostat
TTDS00095	Drug(s)	Romidepsin
TTDS00095	Drug(s)	SB-623
TTDS00095	Drug(s)	SB-6241
TTDS00095	Drug(s)	SB-639
TTDS00095	Drug(s)	SK-7041
TTDS00095	Drug(s)	SK-7068
TTDS00095	Drug(s)	SNDX-275
TTDS00095	Drug(s)	Scriptaid
TTDS00095	Drug(s)	Sodium butyrate
TTDS00095	Drug(s)	Tacedinaline
TTDS00095	Drug(s)	Vorinostat
TTDS00095	Inhibitor	4SC-202
TTDS00095	Inhibitor	6-Phenoxy-hexane-1-thiol
TTDS00095	Inhibitor	6-phenylsulfanylhexanoic acid hydroxamide
TTDS00095	Inhibitor	ADS-100380
TTDS00095	Inhibitor	ADS-102550
TTDS00095	Inhibitor	AN-9
TTDS00095	Inhibitor	AZUMAMIDE B
TTDS00095	Inhibitor	AZUMAMIDE C
TTDS00095	Inhibitor	AZUMAMIDE E
TTDS00095	Inhibitor	Azithromycin-N-benzyltriazolyldecahydroxamic Acid
TTDS00095	Inhibitor	Azithromycin-N-benzyltriazolylhexahydroxamic Acid
TTDS00095	Inhibitor	Azithromycin-N-benzyltriazolylnonahydroxamic Acid
TTDS00095	Inhibitor	Azithromycin-N-benzyltriazolyloctahydroxamic Acid
TTDS00095	Inhibitor	Azithromycinarylalkylhydroxamic Acid
TTDS00095	Inhibitor	CHAP-15
TTDS00095	Inhibitor	CI-994
TTDS00095	Inhibitor	Chlamydocin
TTDS00095	Inhibitor	Cyclostellettamine derivative
TTDS00095	Inhibitor	DEPUDECIN
TTDS00095	Inhibitor	Depudecin
TTDS00095	Inhibitor	Desclasinose Azithromycinarylalkyl Hydroxamate
TTDS00095	Inhibitor	FFF1
TTDS00095	Inhibitor	FFF2
TTDS00095	Inhibitor	FFF3
TTDS00095	Inhibitor	FFF4
TTDS00095	Inhibitor	HC-Toxin
TTDS00095	Inhibitor	HDAC-42
TTDS00095	Inhibitor	ITF2357
TTDS00095	Inhibitor	JNS-16241199
TTDS00095	Inhibitor	LAQ824
TTDS00095	Inhibitor	LARGAZOLE
TTDS00095	Inhibitor	M-carboxycinnamic acid bishydroxamide
TTDS00095	Inhibitor	MGCD-0103
TTDS00095	Inhibitor	MS-275
TTDS00095	Inhibitor	NSC-746457
TTDS00095	Inhibitor	NVP-LAQ824
TTDS00095	Inhibitor	Octanedioic acid bis-hydroxyamide
TTDS00095	Inhibitor	Octanedioic acid hydroxyamide pyridin-2-ylamide
TTDS00095	Inhibitor	Octanedioic acid hydroxyamide pyridin-4-ylamide
TTDS00095	Inhibitor	Oxamflatin
TTDS00095	Inhibitor	PDX-101
TTDS00095	Inhibitor	PSAMMAPLIN A
TTDS00095	Inhibitor	PXD101
TTDS00095	Inhibitor	Panobinostat
TTDS00095	Inhibitor	Phenylbutyrate
TTDS00095	Inhibitor	Pyroxamide
TTDS00095	Inhibitor	RG2833
TTDS00095	Inhibitor	Resminostat
TTDS00095	Inhibitor	Romidepsin
TTDS00095	Inhibitor	SB-623
TTDS00095	Inhibitor	SB-6241
TTDS00095	Inhibitor	SB-639
TTDS00095	Inhibitor	SK-683
TTDS00095	Inhibitor	SK-7041
TTDS00095	Inhibitor	SK-7068
TTDS00095	Inhibitor	SNDX-275
TTDS00095	Inhibitor	ST-2986
TTDS00095	Inhibitor	ST-2987
TTDS00095	Inhibitor	ST-3050
TTDS00095	Inhibitor	Scriptaid
TTDS00095	Inhibitor	Sodium butyrate
TTDS00095	Inhibitor	Tacedinaline
TTDS00095	Inhibitor	Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester
TTDS00095	Inhibitor	Trichostatin
TTDS00095	Inhibitor	Vorinostat
TTDS00095	Inhibitor	gymnochrome E
TTDS00095	Multitarget	ITF2357
TTDS00095	Multitarget	Phenylbutyrate
TTDS00096	UniProt ID	P31358
TTDS00096	Name	CAMPATH-1 antigen
TTDS00096	Type of target	Successful target
TTDS00096	Synonyms	CD52
TTDS00096	Synonyms	CD52 antigen
TTDS00096	Synonyms	CDW52
TTDS00096	Synonyms	Cambridge pathology 1 antigen
TTDS00096	Synonyms	Epididymal secretory protein E5
TTDS00096	Disease	Acute promyelocytic leukemia
TTDS00096	Function	May play a role in carrying and orienting carbohydrate, as well as having a more
TTDS00096	Sequence	MKRFLFLLLTISLLVMVQIQTGLSGQNDTSQTSSPSASSNISGGIFLFFVANAIIHLFCFS
TTDS00096	BioChemical Class	Cell membrane protein
TTDS00096	Drug(s)	Alemtuzumab
TTDS00096	Antibody	Alemtuzumab
TTDS00097	Name	5-hydroxytryptamine receptor
TTDS00097	Type of target	Successful target
TTDS00097	Synonyms	5-HT receptor
TTDS00097	Disease	Cardiovascular disease, unspecified
TTDS00097	Disease	Chronic thromboembolic pulmonary hypertension
TTDS00097	Disease	Cushing's disease
TTDS00097	Disease	Diarrhea
TTDS00097	Disease	Gastrointestinal motility disorders
TTDS00097	Disease	Malabsorption (drug-induced)
TTDS00097	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00097	Pathway	Neuroactive ligand-receptor interaction
TTDS00097	Related US Patent	6,586,458
TTDS00097	Target Validation	TTDS00097
TTDS00097	Drug(s)	DU-127090
TTDS00097	Drug(s)	Fenfluramine
TTDS00097	Drug(s)	HMR-2934
TTDS00097	Drug(s)	Lu AA21004
TTDS00097	Drug(s)	Metergolin
TTDS00097	Drug(s)	NXN-188
TTDS00097	Drug(s)	Ramosetron
TTDS00097	Drug(s)	Tandospirone
TTDS00097	Antagonist	EpiCept
TTDS00097	Antagonist	Fenfluramine
TTDS00097	Antagonist	HMR-2934
TTDS00097	Antagonist	MCI
TTDS00097	Antagonist	NXN-188
TTDS00097	Antagonist	Ritanserin
TTDS00097	Antagonist	SB 203106
TTDS00097	Antagonist	SL65.0472
TTDS00097	Agonist	Bay x3702
TTDS00097	Agonist	DU-127090
TTDS00097	Modulator	Lu AA21004
TTDS00097	Multitarget	DU-127090
TTDS00097	Multitarget	HMR-2934
TTDS00097	Multitarget	NXN-188
TTDS00098	UniProt ID	P08908
TTDS00098	Name	5-hydroxytryptamine 1A receptor
TTDS00098	Type of target	Successful target
TTDS00098	Synonyms	5-HT-1A
TTDS00098	Synonyms	5-HT1A
TTDS00098	Synonyms	5-HT1A receptor
TTDS00098	Synonyms	5-hydroxytryptamine receptor 1A
TTDS00098	Synonyms	G-21
TTDS00098	Synonyms	Serotonin receptor
TTDS00098	Synonyms	Serotonin receptor 1A
TTDS00098	Disease	Anxiety disorder, unspecified
TTDS00098	Disease	Brain ischemia
TTDS00098	Disease	Cocaine dependence
TTDS00098	Disease	Depression
TTDS00098	Disease	Detrusor hyperreflexia
TTDS00098	Disease	Mood [affective] disorders
TTDS00098	Disease	Skeletal muscle associated spasticity
TTDS00098	Disease	Urinary incontinence
TTDS00098	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDS00098	Sequence	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAV
TTDS00098	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00098	Pathway	Neuroactive ligand-receptor interaction
TTDS00098	Related US Patent	6,346,622
TTDS00098	Related US Patent	6,448,268
TTDS00098	Related US Patent	6,656,951
TTDS00098	Related US Patent	6,664,274
TTDS00098	Target Validation	TTDS00098
TTDS00098	QSAR Model	TTDS00098
TTDS00098	Drug(s)	1192U90
TTDS00098	Drug(s)	Abaperidone hydrochloride
TTDS00098	Drug(s)	Adatanserin
TTDS00098	Drug(s)	BTS-79018
TTDS00098	Drug(s)	Bifeprunox
TTDS00098	Drug(s)	Buspirone
TTDS00098	Drug(s)	Flibanserin
TTDS00098	Drug(s)	GSK163090
TTDS00098	Drug(s)	Gepirone ER
TTDS00098	Drug(s)	MN-305
TTDS00098	Drug(s)	OPC-14523
TTDS00098	Drug(s)	PD-158771
TTDS00098	Drug(s)	PRX-00023
TTDS00098	Drug(s)	SDZ-MAR-327
TTDS00098	Drug(s)	SLV-313
TTDS00098	Drug(s)	SLV-319
TTDS00098	Drug(s)	SSR-181507
TTDS00098	Drug(s)	Sarizotan
TTDS00098	Drug(s)	TGBA01AD
TTDS00098	Drug(s)	Treximet
TTDS00098	Drug(s)	Vilazodone
TTDS00098	Drug(s)	Xaliproden
TTDS00098	Inhibitor	(R)-11-Amino-2-methoxyaporphine
TTDS00098	Inhibitor	(R)-2,11-Diaminoaporphine
TTDS00098	Inhibitor	1-(2-Butoxy-phenyl)-piperazine
TTDS00098	Inhibitor	1-(2-Chloro-phenyl)-piperazine
TTDS00098	Inhibitor	1-(2-Ethoxy-phenyl)-piperazine
TTDS00098	Inhibitor	1-(2-Fluoro-phenyl)-piperazine
TTDS00098	Inhibitor	1-(2-Methoxy-phenyl)-piperazine
TTDS00098	Inhibitor	1-(2-phenoxyphenyl)piperazine
TTDS00098	Inhibitor	1-(3-Fluoro-phenyl)-piperazine
TTDS00098	Inhibitor	1-(3-Nitro-phenyl)-piperazine
TTDS00098	Inhibitor	1-Methyl-1,3-dihydro-indol-2-one
TTDS00098	Inhibitor	1-Naphthalen-1-yl-piperazine
TTDS00098	Inhibitor	1-Naphthalen-2-yl-piperazine
TTDS00098	Inhibitor	2-Piperazin-1-yl-benzonitrile
TTDS00098	Inhibitor	2-Piperazin-1-yl-phenol
TTDS00098	Inhibitor	2-phenoxy-3-(piperidin-4-yl)pyridine
TTDS00098	Inhibitor	3-(1-Propyl-pyrrolidin-3-yl)-phenol
TTDS00098	Inhibitor	3-(2-Amino-propyl)-1H-indol-5-ol
TTDS00098	Inhibitor	3-(2-Benzylamino-ethoxy)-phenol
TTDS00098	Inhibitor	3-Naphthalen-1-yl-1-propyl-pyrrolidine
TTDS00098	Inhibitor	3-Naphthalen-1-yl-pyrrolidine
TTDS00098	Inhibitor	3-Phenyl-1-propyl-pyrrolidine
TTDS00098	Inhibitor	4-(2-(benzyloxy)phenyl)piperidine
TTDS00098	Inhibitor	4-(2-fluoro-6-phenoxyphenyl)piperidine
TTDS00098	Inhibitor	4-(2-phenoxyphenyl)piperidine
TTDS00098	Inhibitor	A-80426
TTDS00098	Inhibitor	A-987306
TTDS00098	Inhibitor	AGROCLAVINE
TTDS00098	Inhibitor	ATC-0175
TTDS00098	Inhibitor	BMY-7378
TTDS00098	Inhibitor	BP-897
TTDS00098	Inhibitor	Brolamfetamine
TTDS00098	Inhibitor	CGS-12066B
TTDS00098	Inhibitor	CHLOROPHENYLPIPERAZINE
TTDS00098	Inhibitor	CP-293019
TTDS00098	Inhibitor	ESCHOLTZINE
TTDS00098	Inhibitor	Etisulergine
TTDS00098	Inhibitor	GR-127935
TTDS00098	Inhibitor	JNJ-10392980
TTDS00098	Inhibitor	L-745870
TTDS00098	Inhibitor	LY-334370
TTDS00098	Inhibitor	LYSERGIC ACID DIETHYLAMIDE
TTDS00098	Inhibitor	MAZAPERTINE
TTDS00098	Inhibitor	MCL-516
TTDS00098	Inhibitor	N-methyllaurotetanine
TTDS00098	Inhibitor	PB-28
TTDS00098	Inhibitor	PG-01037
TTDS00098	Inhibitor	PHENYLPIPERAZINE
TTDS00098	Inhibitor	PNU-95666E
TTDS00098	Inhibitor	QUIPAZINE
TTDS00098	Inhibitor	RU-24969
TTDS00098	Inhibitor	RWJ-25730
TTDS00098	Inhibitor	SB-271046
TTDS00098	Inhibitor	SB-656104
TTDS00098	Inhibitor	SEROTONIN
TTDS00098	Inhibitor	SNAP-8719
TTDS00098	Inhibitor	SPIPERONE
TTDS00098	Inhibitor	TERTATOLOL
TTDS00098	Inhibitor	TIOSPIRONE
TTDS00098	Inhibitor	UH-232
TTDS00098	Inhibitor	UH-301
TTDS00098	Inhibitor	WAY-100135
TTDS00098	Inhibitor	WAY-466
TTDS00098	Inhibitor	WB-4101
TTDS00098	Inhibitor	sunepitron
TTDS00098	Antagonist	(S)-UH-301
TTDS00098	Antagonist	(S)-WAY 100135
TTDS00098	Antagonist	Abaperidone hydrochloride
TTDS00098	Antagonist	DU 125530
TTDS00098	Antagonist	GSK163090
TTDS00098	Antagonist	LY433221
TTDS00098	Antagonist	NAN-190
TTDS00098	Antagonist	P-MPPI
TTDS00098	Antagonist	PD-158771
TTDS00098	Antagonist	Robalzotan
TTDS00098	Antagonist	Robalzotan monohydrobromide
TTDS00098	Antagonist	SDZ 216-525
TTDS00098	Antagonist	SLV-319
TTDS00098	Antagonist	Treximet
TTDS00098	Antagonist	Vilazodone
TTDS00098	Antagonist	WAY 100135
TTDS00098	Antagonist	WAY-100635
TTDS00098	Antagonist	Xaliproden
TTDS00098	Agonist	1192U90
TTDS00098	Agonist	Adatanserin
TTDS00098	Agonist	Bifeprunox
TTDS00098	Agonist	Buspirone
TTDS00098	Agonist	Flibanserin
TTDS00098	Agonist	Gepirone
TTDS00098	Agonist	Gepirone ER
TTDS00098	Agonist	Ipsapirone
TTDS00098	Agonist	MN-305
TTDS00098	Agonist	OPC-14523
TTDS00098	Agonist	PRX-00023
TTDS00098	Agonist	SDZ-MAR-327
TTDS00098	Agonist	SLV-313
TTDS00098	Agonist	SUN N4057
TTDS00098	Agonist	Sarizotan
TTDS00098	Agonist	TGBA01AD
TTDS00098	Agonist	Urapidil
TTDS00098	Binder	BTS-79018
TTDS00098	Binder	SSR-181507
TTDS00098	Multitarget	1192U90
TTDS00098	Multitarget	Abaperidone hydrochloride
TTDS00098	Multitarget	Adatanserin
TTDS00098	Multitarget	BTS-79018
TTDS00098	Multitarget	Bifeprunox
TTDS00098	Multitarget	Flibanserin
TTDS00098	Multitarget	OPC-14523
TTDS00098	Multitarget	PD-158771
TTDS00098	Multitarget	PRX-00023
TTDS00098	Multitarget	SDZ-MAR-327
TTDS00098	Multitarget	SLV-313
TTDS00098	Multitarget	SLV-319
TTDS00098	Multitarget	SSR-181507
TTDS00098	Multitarget	Sarizotan
TTDS00098	Multitarget	TGBA01AD
TTDS00099	UniProt ID	P28222
TTDS00099	Name	5-hydroxytryptamine 1B receptor
TTDS00099	Type of target	Successful target
TTDS00099	Synonyms	5-HT-1B
TTDS00099	Synonyms	5-HT-1D-beta
TTDS00099	Synonyms	5-HT1B receptor
TTDS00099	Synonyms	S12
TTDS00099	Synonyms	Serotonin 1D beta receptor
TTDS00099	Synonyms	Serotonin receptor
TTDS00099	Synonyms	Serotonin receptor 1B
TTDS00099	Disease	Anxiety disorder, unspecified
TTDS00099	Disease	Migraine
TTDS00099	Disease	Obsessive-compulsive disorder
TTDS00099	Disease	Pulmonary hypertension
TTDS00099	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDS00099	Sequence	MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKL
TTDS00099	PDB Structure	2G1X; 4IAQ; 4IAR
TTDS00099	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00099	Pathway	Neuroactive ligand-receptor interaction
TTDS00099	Related US Patent	6,277,853
TTDS00099	Related US Patent	6,346,622
TTDS00099	Related US Patent	6,509,340
TTDS00099	Related US Patent	6,589,953
TTDS00099	Target Validation	TTDS00099
TTDS00099	Drug(s)	Almotriptan
TTDS00099	Drug(s)	Eletriptan
TTDS00099	Drug(s)	Elzasonan hydrochloride
TTDS00099	Drug(s)	Fluphenazine Decanoate
TTDS00099	Drug(s)	Frovatriptan
TTDS00099	Drug(s)	Naratriptan
TTDS00099	Drug(s)	Zolmitriptan
TTDS00099	Inhibitor	(+/-)-nantenine
TTDS00099	Inhibitor	1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine
TTDS00099	Inhibitor	1-(7-Methoxy-naphthalen-2-yl)-piperazine
TTDS00099	Inhibitor	1-Naphthalen-2-yl-piperazine
TTDS00099	Inhibitor	2-(5-Thiophen-2-yl-1H-indol-3-yl)-ethylamine
TTDS00099	Inhibitor	5-Ethyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole
TTDS00099	Inhibitor	5-Isopropyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole
TTDS00099	Inhibitor	5-amino-3-(N-methylpiperidin-4-yl)-1H-indole
TTDS00099	Inhibitor	A-987306
TTDS00099	Inhibitor	GR-127935
TTDS00099	Inhibitor	L-747201
TTDS00099	Inhibitor	L-775606
TTDS00099	Inhibitor	LY-334370
TTDS00099	Inhibitor	SB-224289
TTDS00099	Inhibitor	SEROTONIN
TTDS00099	Inhibitor	WAY-466
TTDS00099	Inhibitor	[2-(5-Ethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine
TTDS00099	Antagonist	Elzasonan hydrochloride
TTDS00099	Antagonist	Fluphenazine Decanoate
TTDS00099	Antagonist	GR55562
TTDS00099	Antagonist	SB 224289
TTDS00099	Agonist	Almotriptan
TTDS00099	Agonist	CP-94,253
TTDS00099	Agonist	Eletriptan
TTDS00099	Agonist	Frovatriptan
TTDS00099	Agonist	Naratriptan
TTDS00099	Agonist	SB 236057-A
TTDS00099	Agonist	Zolmitriptan
TTDS00099	Multitarget	Eletriptan
TTDS00099	Multitarget	Elzasonan hydrochloride
TTDS00099	Multitarget	Fluphenazine Decanoate
TTDS00099	Multitarget	Frovatriptan
TTDS00099	Multitarget	Zolmitriptan
TTDS00100	UniProt ID	P28221
TTDS00100	Name	5-hydroxytryptamine 1D receptor
TTDS00100	Type of target	Successful target
TTDS00100	Synonyms	5-HT-1D
TTDS00100	Synonyms	5-HT-1D-alpha
TTDS00100	Synonyms	5-HT1D receptor
TTDS00100	Synonyms	5-hydroxytryptamine receptor 1D
TTDS00100	Synonyms	5HT1D
TTDS00100	Synonyms	Serotonin receptor
TTDS00100	Synonyms	Serotonin receptor 1D
TTDS00100	Disease	Migraine
TTDS00100	Disease	Obsessive-compulsive disorder
TTDS00100	Disease	Vascular headache
TTDS00100	Disease	Vomiting
TTDS00100	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDS00100	Sequence	MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSL
TTDS00100	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00100	Pathway	Neuroactive ligand-receptor interaction
TTDS00100	Related US Patent	6,277,853
TTDS00100	Related US Patent	6,342,498
TTDS00100	Related US Patent	6,346,622
TTDS00100	Related US Patent	6,355,674
TTDS00100	Related US Patent	6,509,340
TTDS00100	Related US Patent	6,589,953
TTDS00100	Target Validation	TTDS00100
TTDS00100	Drug(s)	Almogran
TTDS00100	Drug(s)	Eletriptan
TTDS00100	Drug(s)	Elzasonan hydrochloride
TTDS00100	Drug(s)	Frovatriptan
TTDS00100	Drug(s)	Rizatriptan
TTDS00100	Drug(s)	Sumatriptan
TTDS00100	Drug(s)	Zolmitriptan
TTDS00100	Inhibitor	(+/-)-nantenine
TTDS00100	Inhibitor	(3-Chloro-phenyl)-piperazin-1-yl-methanone
TTDS00100	Inhibitor	1,2,3,4-Tetrahydro-naphthalen-2-ylamine
TTDS00100	Inhibitor	1-((S)-2-aminopropyl)-1H-indazol-6-ol
TTDS00100	Inhibitor	1-(2,5-Dimethoxy-4-methyl-phenyl)-piperazine
TTDS00100	Inhibitor	1-(2,5-Dimethoxy-phenyl)-piperazine
TTDS00100	Inhibitor	1-(2-Butoxy-phenyl)-piperazine
TTDS00100	Inhibitor	1-(2-Ethoxy-phenyl)-piperazine
TTDS00100	Inhibitor	1-(2-Fluoro-phenyl)-piperazine
TTDS00100	Inhibitor	1-(2-Isopropoxy-phenyl)-piperazine
TTDS00100	Inhibitor	1-(2-Methoxy-phenyl)-piperazine
TTDS00100	Inhibitor	1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine
TTDS00100	Inhibitor	1-(3-Fluoro-phenyl)-piperazine
TTDS00100	Inhibitor	1-(3-Nitro-phenyl)-piperazine
TTDS00100	Inhibitor	1-(3-Trifluoromethyl-phenyl)-piperazine
TTDS00100	Inhibitor	1-(4-Bromo-2,5-dimethoxy-phenyl)-piperazine
TTDS00100	Inhibitor	1-(7-Methoxy-naphthalen-2-yl)-piperazine
TTDS00100	Inhibitor	1-Naphthalen-1-yl-piperazine
TTDS00100	Inhibitor	1-Naphthalen-2-yl-piperazine
TTDS00100	Inhibitor	2-(2,5-Dimethoxy-phenyl)-1-methyl-ethylamine
TTDS00100	Inhibitor	2-(2,6-Dimethyl-benzyl)-4,5-dihydro-1H-imidazole
TTDS00100	Inhibitor	2-(2-Amino-propyl)-5-bromo-4-methoxy-phenol
TTDS00100	Inhibitor	2-(2-Methoxy-phenyl)-1-methyl-ethylamine
TTDS00100	Inhibitor	2-(3-Methoxy-phenyl)-1-methyl-ethylamine
TTDS00100	Inhibitor	2-(4-Bromo-2-methoxy-phenyl)-1-methyl-ethylamine
TTDS00100	Inhibitor	2-(4-Bromo-phenyl)-1-methyl-ethylamine
TTDS00100	Inhibitor	2-(4-tert-Butyl-phenyl)-4,5-dihydro-1H-imidazole
TTDS00100	Inhibitor	2-(5-Nonyloxy-1H-indol-3-yl)-ethylamine
TTDS00100	Inhibitor	2-(5-Thiophen-2-yl-1H-indol-3-yl)-ethylamine
TTDS00100	Inhibitor	2-Piperazin-1-yl-benzonitrile
TTDS00100	Inhibitor	2-Piperazin-1-yl-phenol
TTDS00100	Inhibitor	3-Amino-1-(2-amino-5-methoxy-phenyl)-propan-1-one
TTDS00100	Inhibitor	5,6-dichloro-3,4-dihydroquinazolin-2-amine
TTDS00100	Inhibitor	5-Ethyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole
TTDS00100	Inhibitor	5-Isopropyl-3-(2-pyrrolidin-1-yl-ethyl)-1H-indole
TTDS00100	Inhibitor	5-amino-3-(N-methylpiperidin-4-yl)-1H-indole
TTDS00100	Inhibitor	5-chloro-3,4-dihydroquinazolin-2-amine
TTDS00100	Inhibitor	5-chloro-4-methyl-3,4-dihydroquinazolin-2-amine
TTDS00100	Inhibitor	8-Methoxy-2-(4-methyl-piperazin-1-yl)-quinoline
TTDS00100	Inhibitor	8-Methoxy-2-piperazin-1-yl-quinoline
TTDS00100	Inhibitor	8-Methoxy-quinolin-2-ylamine
TTDS00100	Inhibitor	8-methoxy-4-methyl-3,4-dihydroquinazolin-2-amine
TTDS00100	Inhibitor	AGROCLAVINE
TTDS00100	Inhibitor	Brolamfetamine
TTDS00100	Inhibitor	CHLOROPHENYLPIPERAZINE
TTDS00100	Inhibitor	Etisulergine
TTDS00100	Inhibitor	GR-127935
TTDS00100	Inhibitor	L-741604
TTDS00100	Inhibitor	L-747201
TTDS00100	Inhibitor	L-760790
TTDS00100	Inhibitor	L-775606
TTDS00100	Inhibitor	LY-334370
TTDS00100	Inhibitor	PHENYLPIPERAZINE
TTDS00100	Inhibitor	QUIPAZINE
TTDS00100	Inhibitor	SB-224289
TTDS00100	Inhibitor	SEROTONIN
TTDS00100	Inhibitor	WAY-466
TTDS00100	Inhibitor	[2-(5-Ethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine
TTDS00100	Antagonist	Elzasonan hydrochloride
TTDS00100	Agonist	Almogran
TTDS00100	Agonist	Eletriptan
TTDS00100	Agonist	Frovatriptan
TTDS00100	Agonist	Rizatriptan
TTDS00100	Agonist	Sumatriptan
TTDS00100	Agonist	Zolmitriptan
TTDS00100	Multitarget	Eletriptan
TTDS00100	Multitarget	Elzasonan hydrochloride
TTDS00100	Multitarget	Frovatriptan
TTDS00100	Multitarget	Zolmitriptan
TTDS00102	Name	5-hydroxytryptamine 2 receptor
TTDS00102	Type of target	Successful target
TTDS00102	Synonyms	5-HT2 receptor
TTDS00102	Synonyms	5-HTB2
TTDS00102	Synonyms	Serotonin receptor 2
TTDS00102	Disease	Acute respiratory distress syndrome
TTDS00102	Disease	Cocaine dependence
TTDS00102	Disease	Detrusor hyperreflexia
TTDS00102	Disease	Hypertension
TTDS00102	Disease	Skeletal muscle associated spasticity
TTDS00102	Disease	Urinary incontinence
TTDS00102	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00102	Pathway	Calcium signaling pathway
TTDS00102	Pathway	Gap junction
TTDS00102	Pathway	Neuroactive ligand-receptor interaction
TTDS00102	Related US Patent	6,469,011
TTDS00102	Related US Patent	6,638,934
TTDS00102	Related US Patent	6,664,286
TTDS00102	Target Validation	TTDS00102
TTDS00102	Drug(s)	Cyclobenzaprine
TTDS00102	Drug(s)	E2101
TTDS00102	Drug(s)	Fluphenazine Decanoate
TTDS00102	Drug(s)	Ketanserin
TTDS00102	Drug(s)	Mianserin
TTDS00102	Antagonist	Cyclobenzaprine
TTDS00102	Antagonist	E2101
TTDS00102	Antagonist	Fluphenazine Decanoate
TTDS00102	Antagonist	Ketanserin
TTDS00102	Antagonist	Metrenperone
TTDS00102	Antagonist	Mianserin
TTDS00102	Antagonist	Ritanserin
TTDS00102	Binder	SB 206553 hydrochloride
TTDS00102	Multitarget	Fluphenazine Decanoate
TTDS00103	UniProt ID	P28223
TTDS00103	Name	5-hydroxytryptamine 2A receptor
TTDS00103	Type of target	Successful target
TTDS00103	Synonyms	5-HT-2
TTDS00103	Synonyms	5-HT-2A
TTDS00103	Synonyms	5-HT2A receptor
TTDS00103	Synonyms	5-hydroxytryptamine receptor 2A
TTDS00103	Synonyms	Serotonin receptor
TTDS00103	Synonyms	Serotonin receptor 2A
TTDS00103	Disease	Acute ureteric colic
TTDS00103	Disease	Anxiety disorder, unspecified
TTDS00103	Disease	Arterial embolism and thrombosis
TTDS00103	Disease	Cocaine dependence
TTDS00103	Disease	Depression
TTDS00103	Disease	Diabetic nephropathy
TTDS00103	Disease	Diabetic neuropathy
TTDS00103	Disease	Essential (primary) hypertension
TTDS00103	Disease	Migraine
TTDS00103	Disease	Schizophrenia
TTDS00103	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDS00103	Sequence	MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALL
TTDS00103	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00103	Pathway	Calcium signaling pathway
TTDS00103	Pathway	Gap junction
TTDS00103	Pathway	Neuroactive ligand-receptor interaction
TTDS00103	Related US Patent	6,143,792
TTDS00103	Related US Patent	6,316,468
TTDS00103	Related US Patent	6,576,670
TTDS00103	Related US Patent	6,638,934
TTDS00103	Related US Patent	6,664,274
TTDS00103	Target Validation	TTDS00103
TTDS00103	Drug(s)	1192U90
TTDS00103	Drug(s)	Abaperidone hydrochloride
TTDS00103	Drug(s)	Adatanserin
TTDS00103	Drug(s)	Asenapine
TTDS00103	Drug(s)	Blonanserin
TTDS00103	Drug(s)	Fananserin
TTDS00103	Drug(s)	Flibanserin
TTDS00103	Drug(s)	GMC-283
TTDS00103	Drug(s)	Iloperidone
TTDS00103	Drug(s)	LY367265
TTDS00103	Drug(s)	Lurasidone hydrochloride
TTDS00103	Drug(s)	Ocaperidone
TTDS00103	Drug(s)	Org-23366
TTDS00103	Drug(s)	Pimavanserin
TTDS00103	Drug(s)	Risperidone Consta
TTDS00103	Drug(s)	SR46349B
TTDS00103	Drug(s)	Sarpogrelate
TTDS00103	Drug(s)	TGBA01AD
TTDS00103	Drug(s)	YM-992
TTDS00103	Drug(s)	ZD-3638
TTDS00103	Inhibitor	(+/-)-nantenine
TTDS00103	Inhibitor	5-MEO-DMT
TTDS00103	Inhibitor	5-METHOXYTRYPTAMINE
TTDS00103	Inhibitor	6-bromoaplysinopsin
TTDS00103	Inhibitor	A-80426
TTDS00103	Inhibitor	A-987306
TTDS00103	Inhibitor	ALTANSERIN
TTDS00103	Inhibitor	APLYSINOPSIN
TTDS00103	Inhibitor	Aniracetam
TTDS00103	Inhibitor	BARETTIN
TTDS00103	Inhibitor	Brolamfetamine
TTDS00103	Inhibitor	CHLOROPHENYLPIPERAZINE
TTDS00103	Inhibitor	CINANSERIN
TTDS00103	Inhibitor	DOM
TTDS00103	Inhibitor	Dimethyltryptamine
TTDS00103	Inhibitor	EMD-281014
TTDS00103	Inhibitor	Etisulergine
TTDS00103	Inhibitor	FLUANISONE
TTDS00103	Inhibitor	GR-127935
TTDS00103	Inhibitor	ISOCLOZAPINE
TTDS00103	Inhibitor	L-745870
TTDS00103	Inhibitor	LY367265
TTDS00103	Inhibitor	LY433222
TTDS00103	Inhibitor	LYSERGIC ACID DIETHYLAMIDE
TTDS00103	Inhibitor	MAZAPERTINE
TTDS00103	Inhibitor	MDL-11939
TTDS00103	Inhibitor	MDL-28161
TTDS00103	Inhibitor	MESCALINE
TTDS00103	Inhibitor	N-3'-ethylaplysinopsin
TTDS00103	Inhibitor	NELOTANSERIN
TTDS00103	Inhibitor	PG-01037
TTDS00103	Inhibitor	PHENETHYLAMINE
TTDS00103	Inhibitor	PHENYLPIPERAZINE
TTDS00103	Inhibitor	PRUVANSERIN
TTDS00103	Inhibitor	PSILOCIN
TTDS00103	Inhibitor	QUIPAZINE
TTDS00103	Inhibitor	RP-68303
TTDS00103	Inhibitor	Racemic DOI
TTDS00103	Inhibitor	Racemic DOTFM
TTDS00103	Inhibitor	Ro-60-0175;Ro-600175
TTDS00103	Inhibitor	SB-243213
TTDS00103	Inhibitor	SB-271046
TTDS00103	Inhibitor	SEROTONIN
TTDS00103	Inhibitor	SPIPERONE
TTDS00103	Inhibitor	TIOSPIRONE
TTDS00103	Inhibitor	TRYPTAMINE
TTDS00103	Inhibitor	TRYPTOLINE
TTDS00103	Inhibitor	VER-2692
TTDS00103	Inhibitor	VER-3323
TTDS00103	Inhibitor	VER-5384
TTDS00103	Inhibitor	VER-5593
TTDS00103	Inhibitor	VOLINANSERIN
TTDS00103	Inhibitor	WAY-208466
TTDS00103	Inhibitor	YM-348
TTDS00103	Inhibitor	YM-992
TTDS00103	Inhibitor	ZOTEPINE
TTDS00103	Antagonist	1192U90
TTDS00103	Antagonist	Abaperidone hydrochloride
TTDS00103	Antagonist	Adatanserin
TTDS00103	Antagonist	Asenapine
TTDS00103	Antagonist	Blonanserin
TTDS00103	Antagonist	Fananserin
TTDS00103	Antagonist	GMC-283
TTDS00103	Antagonist	Iloperidone
TTDS00103	Antagonist	LY53857
TTDS00103	Antagonist	Lurasidone hydrochloride
TTDS00103	Antagonist	M100907
TTDS00103	Antagonist	Ocaperidone
TTDS00103	Antagonist	Org-23366
TTDS00103	Antagonist	Pimavanserin
TTDS00103	Antagonist	Risperidone Consta
TTDS00103	Antagonist	Ritanserin
TTDS00103	Antagonist	Sarpogrelate
TTDS00103	Agonist	DV-7028
TTDS00103	Agonist	Flibanserin
TTDS00103	Agonist	MMDA
TTDS00103	Agonist	TGBA01AD
TTDS00103	Binder	SR46349B
TTDS00103	Binder	ZD-3638
TTDS00103	Multitarget	1192U90
TTDS00103	Multitarget	Abaperidone hydrochloride
TTDS00103	Multitarget	Adatanserin
TTDS00103	Multitarget	Asenapine
TTDS00103	Multitarget	Blonanserin
TTDS00103	Multitarget	Flibanserin
TTDS00103	Multitarget	GMC-283
TTDS00103	Multitarget	Iloperidone
TTDS00103	Multitarget	Lurasidone hydrochloride
TTDS00103	Multitarget	Ocaperidone
TTDS00103	Multitarget	Org-23366
TTDS00103	Multitarget	Risperidone Consta
TTDS00103	Multitarget	SR46349B
TTDS00103	Multitarget	TGBA01AD
TTDS00103	Multitarget	ZD-3638
TTDS00104	UniProt ID	P41595
TTDS00104	Name	5-hydroxytryptamine 2B receptor
TTDS00104	Type of target	Successful target
TTDS00104	Synonyms	5-HT 2B
TTDS00104	Synonyms	5-HT-2B
TTDS00104	Synonyms	Serotonin receptor
TTDS00104	Synonyms	Serotonin receptor 2B
TTDS00104	Disease	Anxiety disorder, unspecified
TTDS00104	Disease	Migraine
TTDS00104	Disease	P-chloroamphetamine-induced hyperglycemia
TTDS00104	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDS00104	Sequence	MALSYRVSELQSTIPEHILQSTFVHVISSNWSGLQTESIPEEMKQIVEEQGNKLHWAALLILMVIIPTIGGNTLVILAVS
TTDS00104	PDB Structure	4IB4
TTDS00104	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00104	Pathway	Calcium signaling pathway
TTDS00104	Pathway	Gap junction
TTDS00104	Pathway	Neuroactive ligand-receptor interaction
TTDS00104	Related US Patent	6,444,477
TTDS00104	Related US Patent	6,638,953
TTDS00104	Target Validation	TTDS00104
TTDS00104	Drug(s)	Minaprine
TTDS00104	Drug(s)	PRX-08066
TTDS00104	Drug(s)	Triflupromazine
TTDS00104	Inhibitor	(+/-)-nantenine
TTDS00104	Inhibitor	(+/-)DOI
TTDS00104	Inhibitor	(5-methoxy-1H-indol-3-yl)methanamine
TTDS00104	Inhibitor	(S)-2-(6-methoxyindazol-1-yl)-1-methylethylamine
TTDS00104	Inhibitor	1-((R)-2-aminopropyl)-1H-indazol-6-ol
TTDS00104	Inhibitor	1-((S)-2-aminopropyl)-1H-indazol-6-ol
TTDS00104	Inhibitor	1-((S)-2-aminopropyl)-7-chloro-1H-indazol-6-ol
TTDS00104	Inhibitor	1-((S)-2-aminopropyl)-7-fluoro-1H-indazol-6-ol
TTDS00104	Inhibitor	1-((S)-2-aminopropyl)-7-iodo-1H-indazol-6-ol
TTDS00104	Inhibitor	1-((S)-2-aminopropyl)-7-methyl-1H-indazol-6-ol
TTDS00104	Inhibitor	1-(2-aminoethyl)-1H-indazol-6-ol
TTDS00104	Inhibitor	1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine
TTDS00104	Inhibitor	1-Butyl-3-(2-dimethylamino-ethyl)-1H-indol-4-ol
TTDS00104	Inhibitor	3-(2-Dimethylamino-ethyl)-1-methyl-1H-indol-4-ol
TTDS00104	Inhibitor	3-(2-Dimethylamino-ethyl)-1H-indol-6-ol
TTDS00104	Inhibitor	3-(2-Dimethylamino-propyl)-1H-indol-4-ol
TTDS00104	Inhibitor	3-(2-Pyrrolidin-1-yl-ethyl)-1H-indol-4-ol
TTDS00104	Inhibitor	3-(3-Dimethylamino-propyl)-1H-indol-4-ol
TTDS00104	Inhibitor	3-Dimethylaminomethyl-1-methyl-1H-indol-4-ol
TTDS00104	Inhibitor	3-Dimethylaminomethyl-1H-indol-4-ol
TTDS00104	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00104	Inhibitor	5-MEO-DMT
TTDS00104	Inhibitor	5-hydroxy-alpha-methyltryptamine
TTDS00104	Inhibitor	5-methoxy-alpha-methyltryptamine
TTDS00104	Inhibitor	6,7-dichloro-2,3,4,5-tetrahydro-1H-3-benzazepine
TTDS00104	Inhibitor	6-Fluoromelatonin
TTDS00104	Inhibitor	7,8,9,10-tetrahydro-6H-furo-[2,3-g][3]benzazepine
TTDS00104	Inhibitor	7,8,9,10-tetrahydro-6H-furo-[3,2-g][3]benzazepine
TTDS00104	Inhibitor	A-987306
TTDS00104	Inhibitor	ADRENOGLOMERULOTROPIN
TTDS00104	Inhibitor	ADS-103253
TTDS00104	Inhibitor	ADS-103274
TTDS00104	Inhibitor	ATC-0175
TTDS00104	Inhibitor	BP-897
TTDS00104	Inhibitor	CHLOROPHENYLPIPERAZINE
TTDS00104	Inhibitor	FENDILINE
TTDS00104	Inhibitor	Ro-60-0175;Ro-600175
TTDS00104	Inhibitor	SB-206553
TTDS00104	Inhibitor	SEROTONIN
TTDS00104	Inhibitor	VER-2692
TTDS00104	Inhibitor	VER-3323
TTDS00104	Inhibitor	VER-5384
TTDS00104	Inhibitor	VER-5593
TTDS00104	Inhibitor	WAY-181187
TTDS00104	Inhibitor	YM-348
TTDS00104	Inhibitor	[2-(4-Fluoro-1H-indol-3-yl)-ethyl]-dimethyl-amine
TTDS00104	Antagonist	LY53857
TTDS00104	Antagonist	MT-500
TTDS00104	Antagonist	Minaprine
TTDS00104	Antagonist	PRX-08066
TTDS00104	Antagonist	Ritanserin
TTDS00104	Antagonist	SB 206553
TTDS00104	Antagonist	Triflupromazine
TTDS00104	Agonist	3,4-Methylenedioxymethamphetamine
TTDS00105	UniProt ID	P28335
TTDS00105	Name	5-hydroxytryptamine 2C receptor
TTDS00105	Type of target	Successful target
TTDS00105	Synonyms	5-HT-2C
TTDS00105	Synonyms	5-HT2C receptor
TTDS00105	Synonyms	5HT-1C
TTDS00105	Synonyms	Serotonin receptor
TTDS00105	Synonyms	Serotonin receptor 2C
TTDS00105	Disease	Acute ureteric colic
TTDS00105	Disease	Cocaine dependence
TTDS00105	Disease	Motor disorder
TTDS00105	Disease	Schizophrenia
TTDS00105	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDS00105	Sequence	MVNLRNAVHSFLVHLIGLLVWQCDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSM
TTDS00105	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00105	Pathway	Calcium signaling pathway
TTDS00105	Pathway	Gap junction
TTDS00105	Pathway	Neuroactive ligand-receptor interaction
TTDS00105	Related US Patent	6,433,175
TTDS00105	Related US Patent	6,576,670
TTDS00105	Related US Patent	6,638,934
TTDS00105	Related US Patent	6,638,936
TTDS00105	Related US Patent	6,638,953
TTDS00105	Target Validation	TTDS00105
TTDS00105	Drug(s)	5-HT2C agonist
TTDS00105	Drug(s)	Lorcaserin
TTDS00105	Drug(s)	Methysergide
TTDS00105	Drug(s)	Mirtazapine
TTDS00105	Drug(s)	Nefazodone
TTDS00105	Drug(s)	PRX00933
TTDS00105	Drug(s)	SR46349B
TTDS00105	Inhibitor	(+/-)-nantenine
TTDS00105	Inhibitor	(2S)-1-(1H-furo[2,3-g]indazol-1-yl)propan-2-amine
TTDS00105	Inhibitor	(2S)-1-(5-fluoro-1H-indazol-1-yl)propan-2-amine
TTDS00105	Inhibitor	(2S)-1-(6-fluoro-1H-indazol-1-yl)propan-2-amine
TTDS00105	Inhibitor	(2S)-1-(6-methoxy-1H-indazol-1-yl)propan-2-amine
TTDS00105	Inhibitor	(E)-2-(4-fluorostyryl)-5-(phenylsulfinyl)pyridine
TTDS00105	Inhibitor	(R,S)-1-(5-bromo-1H-indol-1-yl)propan-2-amine
TTDS00105	Inhibitor	(R,S)-1-(5-chloro-1H-indol-1-yl)propan-2-amine
TTDS00105	Inhibitor	(R,S)-1-(5-fluoro-1H-indol-1-yl)propan-2-amine
TTDS00105	Inhibitor	(R,S)-1-(5-methyl-1H-indol-1-yl)propan-2-amine
TTDS00105	Inhibitor	(R,S)-1-(6-fluoro-1H-indol-1-yl)propan-2-amine
TTDS00105	Inhibitor	(S)-1-(5,6-difluoro-1H-indol-1-yl)propan-2-amine
TTDS00105	Inhibitor	1-((R)-2-aminopropyl)-1H-indazol-6-ol
TTDS00105	Inhibitor	1-((S)-2-aminopropyl)-1H-indazol-6-ol
TTDS00105	Inhibitor	1-((S)-2-aminopropyl)-7-chloro-1H-indazol-6-ol
TTDS00105	Inhibitor	1-((S)-2-aminopropyl)-7-fluoro-1H-indazol-6-ol
TTDS00105	Inhibitor	1-((S)-2-aminopropyl)-7-iodo-1H-indazol-6-ol
TTDS00105	Inhibitor	1-((S)-2-aminopropyl)-7-methyl-1H-indazol-6-ol
TTDS00105	Inhibitor	1-(2-Dimethylamino-ethyl)-1H-indol-4-ol
TTDS00105	Inhibitor	1-(2-aminoethyl)-1H-indazol-6-ol
TTDS00105	Inhibitor	1-(piperazin-1-yl)isoquinoline
TTDS00105	Inhibitor	1-Butyl-3-(2-dimethylamino-ethyl)-1H-indol-4-ol
TTDS00105	Inhibitor	2-(piperazin-1-yl)-5,6,7,8-tetrahydroquinoline
TTDS00105	Inhibitor	3-(2-Dimethylamino-ethyl)-1-methyl-1H-indol-4-ol
TTDS00105	Inhibitor	3-(2-Dimethylamino-ethyl)-1H-indol-6-ol
TTDS00105	Inhibitor	3-(2-Dimethylamino-ethyl)-2-methyl-1H-indol-4-ol
TTDS00105	Inhibitor	3-(2-Dimethylamino-propyl)-1H-indol-4-ol
TTDS00105	Inhibitor	3-(2-Pyrrolidin-1-yl-ethyl)-1H-indol-4-ol
TTDS00105	Inhibitor	3-(3-Dimethylamino-propyl)-1H-indol-4-ol
TTDS00105	Inhibitor	3-Dimethylaminomethyl-1-methyl-1H-indol-4-ol
TTDS00105	Inhibitor	3-Dimethylaminomethyl-1H-indol-4-ol
TTDS00105	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00105	Inhibitor	4-(piperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine
TTDS00105	Inhibitor	4-(piperazin-1-yl)furo[3,2-c]pyridine
TTDS00105	Inhibitor	4-(piperazin-1-yl)thieno[2,3-d]pyrimidine
TTDS00105	Inhibitor	4-(piperazin-1-yl)thieno[3,2-c]pyridine
TTDS00105	Inhibitor	4-(piperazin-1-yl)thieno[3,2-d]pyrimidine
TTDS00105	Inhibitor	5,6-dichloro-3,4-dihydroquinazolin-2-amine
TTDS00105	Inhibitor	5-MEO-DMT
TTDS00105	Inhibitor	5-chloro-3,4-dihydroquinazolin-2-amine
TTDS00105	Inhibitor	5-chloro-4-ethyl-3,4-dihydroquinazolin-2-amine
TTDS00105	Inhibitor	5-chloro-4-methyl-3,4-dihydroquinazolin-2-amine
TTDS00105	Inhibitor	5-chloro-N-(pyridin-3-yl)indoline-1-carboxamide
TTDS00105	Inhibitor	5-hydroxy-alpha-methyltryptamine
TTDS00105	Inhibitor	5-methoxy-alpha-methyltryptamine
TTDS00105	Inhibitor	6,7-dichloro-2,3,4,5-tetrahydro-1H-3-benzazepine
TTDS00105	Inhibitor	6-(piperazin-1-yl)-9-propyl-9H-purine
TTDS00105	Inhibitor	6-bromo-2'-de-N-methylaplysinopsin
TTDS00105	Inhibitor	6-bromo-8-(piperazin-1-yl)imidazo[1,2-a]pyrazine
TTDS00105	Inhibitor	6-bromoaplysinopsin
TTDS00105	Inhibitor	6-chloro-N-(pyridin-3-yl)indoline-1-carboxamide
TTDS00105	Inhibitor	6-methyl-4-(piperazin-1-yl)furo[2,3-d]pyrimidine
TTDS00105	Inhibitor	7,8,9,10-tetrahydro-6H-furo-[2,3-g][3]benzazepine
TTDS00105	Inhibitor	7,8,9,10-tetrahydro-6H-furo-[3,2-g][3]benzazepine
TTDS00105	Inhibitor	8-methoxy-4-methyl-3,4-dihydroquinazolin-2-amine
TTDS00105	Inhibitor	APLYSINOPSIN
TTDS00105	Inhibitor	BARETTIN
TTDS00105	Inhibitor	CHLOROPHENYLPIPERAZINE
TTDS00105	Inhibitor	EMD-281014
TTDS00105	Inhibitor	GR-127935
TTDS00105	Inhibitor	N-(6-phenoxypyridin-3-yl)-1H-indole-3-carboxamide
TTDS00105	Inhibitor	N-(pyridin-3-yl)indoline-1-carboxamide
TTDS00105	Inhibitor	N-3'-ethylaplysinopsin
TTDS00105	Inhibitor	NELOTANSERIN
TTDS00105	Inhibitor	OCTOCLOTHEPIN
TTDS00105	Inhibitor	PG-01037
TTDS00105	Inhibitor	PRUVANSERIN
TTDS00105	Inhibitor	RS-102,221
TTDS00105	Inhibitor	Ro-60-0175;Ro-600175
TTDS00105	Inhibitor	SB-243213
TTDS00105	Inhibitor	SB-271046
TTDS00105	Inhibitor	SEROTONIN
TTDS00105	Inhibitor	VER-2692
TTDS00105	Inhibitor	VER-3323
TTDS00105	Inhibitor	VER-5384
TTDS00105	Inhibitor	VER-5593
TTDS00105	Inhibitor	VOLINANSERIN
TTDS00105	Inhibitor	WAY-181187
TTDS00105	Inhibitor	WAY-208466
TTDS00105	Inhibitor	WAY-466
TTDS00105	Inhibitor	YM-348
TTDS00105	Inhibitor	[2-(4-Fluoro-1H-indol-3-yl)-ethyl]-dimethyl-amine
TTDS00105	Inhibitor	cyclo[(6-bromotryptophan)arginine]
TTDS00105	Antagonist	BVT 933
TTDS00105	Antagonist	LY53857
TTDS00105	Antagonist	Methysergide
TTDS00105	Antagonist	Mirtazapine
TTDS00105	Antagonist	Nefazodone
TTDS00105	Antagonist	Ritanserin
TTDS00105	Antagonist	SB 206553 hydrochloride
TTDS00105	Agonist	3,4-Methylenedioxymethamphetamine
TTDS00105	Agonist	5-HT2C agonist
TTDS00105	Agonist	Lorcaserin
TTDS00105	Agonist	PRX00933
TTDS00105	Agonist	SB 243213
TTDS00105	Binder	SR46349B
TTDS00105	Multitarget	SR46349B
TTDS00106	UniProt ID	P46098
TTDS00106	Name	5-hydroxytryptamine 3 receptor
TTDS00106	Type of target	Successful target
TTDS00106	Synonyms	5-HT-3
TTDS00106	Synonyms	5-HT3 receptor
TTDS00106	Synonyms	5-HT3R
TTDS00106	Synonyms	5-hydroxytryptamine receptor 3
TTDS00106	Synonyms	5-hydroxytryptamine receptor type 3
TTDS00106	Synonyms	Serotonin-gated ion channel receptor
TTDS00106	Disease	Alcohol dependence
TTDS00106	Disease	Alcoholism
TTDS00106	Disease	Irritable bowel syndrome
TTDS00106	Disease	Nausea and vomiting
TTDS00106	Disease	Pruritus
TTDS00106	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDS00106	Sequence	MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVRPVRDWRKPTTVSIDVIVYAILNVDEKNQVL
TTDS00106	BioChemical Class	Ion transport
TTDS00106	Related US Patent	6,333,328
TTDS00106	Related US Patent	6,384,042
TTDS00106	Related US Patent	6,440,453
TTDS00106	Related US Patent	6,451,808
TTDS00106	Related US Patent	6,462,065
TTDS00106	Related US Patent	6,552,057
TTDS00106	Related US Patent	6,555,546
TTDS00106	Related US Patent	6,770,655
TTDS00106	QSAR Model	TTDS00106
TTDS00106	Drug(s)	Granisetron
TTDS00106	Drug(s)	KB-6806
TTDS00106	Drug(s)	Lerisetron
TTDS00106	Drug(s)	Ondansetron
TTDS00106	Drug(s)	YM060
TTDS00106	Antagonist	BRL 43694A
TTDS00106	Antagonist	Ciproxifan
TTDS00106	Antagonist	Granisetron
TTDS00106	Antagonist	KB-6806
TTDS00106	Antagonist	LY278584
TTDS00106	Antagonist	Lerisetron
TTDS00106	Antagonist	Y-25130
TTDS00106	Agonist	Ondansetron
TTDS00107	UniProt ID	Q13639
TTDS00107	Name	5-hydroxytryptamine 4 receptor
TTDS00107	Type of target	Successful target
TTDS00107	Synonyms	5-HT-4
TTDS00107	Synonyms	5-HT4
TTDS00107	Synonyms	5-HT4 receptor
TTDS00107	Synonyms	Serotonin receptor
TTDS00107	Synonyms	Serotonin receptor 4
TTDS00107	Disease	Alzheimer's disease
TTDS00107	Disease	Cardiac arrhythmias
TTDS00107	Disease	Dementia
TTDS00107	Disease	Diarrhoea-predominant irritable bowel syndrome
TTDS00107	Disease	Drug dependence
TTDS00107	Disease	Irritable bowel syndrome
TTDS00107	Disease	Psychiatric illness
TTDS00107	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDS00107	Sequence	MDKLDANVSSEEGFGSVEKVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKIKTNYFIVSLAFADLLVSVLVMPFGAIE
TTDS00107	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00107	Pathway	Calcium signaling pathway
TTDS00107	Pathway	Neuroactive ligand-receptor interaction
TTDS00107	Target Validation	TTDS00107
TTDS00107	Drug(s)	5-HT4/D2 antagonists
TTDS00107	Drug(s)	Cisapride
TTDS00107	Drug(s)	Fluphenazine Decanoate
TTDS00107	Drug(s)	PRX-3140
TTDS00107	Drug(s)	Pumosetrag
TTDS00107	Drug(s)	Renzapride
TTDS00107	Drug(s)	TD-8954
TTDS00107	Drug(s)	Tegaserod
TTDS00107	Inhibitor	1-((S)-2-aminopropyl)-1H-indazol-6-ol
TTDS00107	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00107	Inhibitor	BARETTIN
TTDS00107	Inhibitor	GR-113808
TTDS00107	Inhibitor	ML-10302
TTDS00107	Inhibitor	Norcisapride
TTDS00107	Inhibitor	SB-207710
TTDS00107	Inhibitor	SEROTONIN
TTDS00107	Antagonist	5-HT4/D2 antagonists
TTDS00107	Antagonist	Fluphenazine Decanoate
TTDS00107	Antagonist	Piboserod
TTDS00107	Antagonist	SB 203186
TTDS00107	Antagonist	SB-207266A
TTDS00107	Antagonist	SDZ 205,557
TTDS00107	Agonist	Cisapride
TTDS00107	Agonist	HTF 919
TTDS00107	Agonist	Mosapride
TTDS00107	Agonist	Prucalopride
TTDS00107	Agonist	Pumosetrag
TTDS00107	Agonist	R0-93877
TTDS00107	Agonist	Renzapride
TTDS00107	Agonist	SL65.0155
TTDS00107	Agonist	TD-5108
TTDS00107	Agonist	Tegaserod
TTDS00107	Multitarget	Fluphenazine Decanoate
TTDS00107	Multitarget	Renzapride
TTDS00109	UniProt ID	P37288
TTDS00109	Name	Vasopressin V1a receptor
TTDS00109	Type of target	Successful target
TTDS00109	Synonyms	AVPR V1a
TTDS00109	Synonyms	Antidiuretic hormone receptor 1a
TTDS00109	Synonyms	V1a vasopressin receptor
TTDS00109	Synonyms	V1aR
TTDS00109	Synonyms	Vascular/hepatic-type arginine vasopressin receptor
TTDS00109	Disease	Congestive heart failure
TTDS00109	Disease	Dysmenorrhea, unspecified
TTDS00109	Disease	Hypertension
TTDS00109	Disease	Raynaud's syndrome
TTDS00109	Disease	Renal diseases
TTDS00109	Disease	Vasoconstriction
TTDS00109	Disease	Water-retaining diseases
TTDS00109	Function	Receptor for arginine vasopressin. The activity of this receptor is mediated by
TTDS00109	Sequence	MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTP
TTDS00109	PDB Structure	1YTV
TTDS00109	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00109	Pathway	Calcium signaling pathway
TTDS00109	Pathway	Neuroactive ligand-receptor interaction
TTDS00109	Pathway	Vascular smooth muscle contraction
TTDS00109	Related US Patent	6,235,900
TTDS00109	Related US Patent	6,521,611
TTDS00109	Related US Patent	6,610,680
TTDS00109	Related US Patent	6,627,649
TTDS00109	Target Validation	TTDS00109
TTDS00109	Drug(s)	Conivaptan
TTDS00109	Drug(s)	Felypressin
TTDS00109	Drug(s)	NOX-F37
TTDS00109	Drug(s)	RG7314
TTDS00109	Drug(s)	Terlipressin
TTDS00109	Inhibitor	1'-tosylspiro[indene-1,4'-piperidine]
TTDS00109	Inhibitor	A-987306
TTDS00109	Inhibitor	ARGENINE VASOPRESSIN
TTDS00109	Inhibitor	ATOSIBAN
TTDS00109	Inhibitor	Ac-Phe-[Orn-Pro-cha-Trp-Arg]
TTDS00109	Inhibitor	HO-LVA
TTDS00109	Inhibitor	Hoo-Phe-Orn-Pro-hle-Pff-Phe-NH2
TTDS00109	Inhibitor	L-368899;NCGC00094029-01
TTDS00109	Inhibitor	L-371257
TTDS00109	Inhibitor	L-372662
TTDS00109	Inhibitor	Mozavaptan
TTDS00109	Inhibitor	PF-3274167
TTDS00109	Inhibitor	Relcovaptan
TTDS00109	Inhibitor	SR-149415
TTDS00109	Inhibitor	VNA-932;WAY-VNA-932
TTDS00109	Inhibitor	Vasopressin Analogue
TTDS00109	Inhibitor	[HO1][Lys8(5/6C-Flu)]VT
TTDS00109	Inhibitor	[HO1][Orn8(5/6C-Flu)]VT
TTDS00109	Inhibitor	[HO1][Orn8(5/6C-Rhm)]VT
TTDS00109	Inhibitor	[HO1][Thr4,Lys8(5/6C-Flu)]VT
TTDS00109	Inhibitor	[HO1][Thr4,Orn8(5/6C-Flu)]VT
TTDS00109	Inhibitor	[Lys8(Alexa 488) ]PVA
TTDS00109	Inhibitor	[Lys8(Alexa 546) ]PVA
TTDS00109	Inhibitor	d(CH2)5[Tyr(Me)2,Thr4,Orn8(5/6C-Flu),Tyr-NH29]VT
TTDS00109	Inhibitor	d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr9-NH2]VT
TTDS00109	Inhibitor	dVDAVP
TTDS00109	Inhibitor	d[Arg4,Dab8]VP
TTDS00109	Inhibitor	d[Arg4,Lys8]VP
TTDS00109	Inhibitor	d[Arg4,Orn8]VP
TTDS00109	Inhibitor	d[Arg4]AVP
TTDS00109	Inhibitor	d[Cha4,Dab8]VP
TTDS00109	Inhibitor	d[Cha4,Dap8]VP
TTDS00109	Inhibitor	d[Cha4,Lys8]VP
TTDS00109	Inhibitor	d[Cha4,Orn8]VP
TTDS00109	Inhibitor	d[Cha4]AVP
TTDS00109	Inhibitor	d[D-3-Pal2]AVP
TTDS00109	Inhibitor	d[Leu4,Dab8]VP
TTDS00109	Inhibitor	d[Leu4,Dap8]VP
TTDS00109	Inhibitor	d[Leu4,Lys8]VP
TTDS00109	Inhibitor	d[Leu4,Orn8]VP
TTDS00109	Inhibitor	d[Leu4]AVP
TTDS00109	Inhibitor	d[Lys8(5/6-Flu)]VT
TTDS00109	Inhibitor	d[Orn4,Lys8]VP
TTDS00109	Inhibitor	d[Orn4,Orn8]VP
TTDS00109	Inhibitor	d[Orn4]AVP
TTDS00109	Inhibitor	d[Orn8(5/6C-Flu)]VT
TTDS00109	Inhibitor	d[Thr4,Lys8(5/6C-Flu)]VT
TTDS00109	Inhibitor	d[Thr4,Orn8(5/6C-Flu)]VT
TTDS00109	Inhibitor	d[Val4]AVP
TTDS00109	Inhibitor	desGly-NH2,d(CH2)5[D-Tyr2,Thr4,Orn8(5/6C-Flu)]VT
TTDS00109	Antagonist	CL-385004
TTDS00109	Antagonist	Conivaptan
TTDS00109	Antagonist	JTV-605
TTDS00109	Antagonist	NOX-F37
TTDS00109	Antagonist	OPC-21268
TTDS00109	Antagonist	OPC-31260
TTDS00109	Antagonist	SR 49059
TTDS00109	Antagonist	YM 087
TTDS00109	Antagonist	YM087
TTDS00109	Agonist	Felypressin
TTDS00109	Stimulator	Terlipressin
TTDS00109	Multitarget	Conivaptan
TTDS00111	UniProt ID	P30518
TTDS00111	Name	Vasopressin V2 receptor
TTDS00111	Type of target	Successful target
TTDS00111	Synonyms	AVPR V2
TTDS00111	Synonyms	Antidiuretic hormone receptor
TTDS00111	Synonyms	Renal-type arginine vasopressin receptor
TTDS00111	Disease	Cerebral edema
TTDS00111	Disease	Congestive heart failure
TTDS00111	Disease	Diabetes insipidus
TTDS00111	Disease	Glaucoma
TTDS00111	Disease	Hydronephrosis
TTDS00111	Disease	Hyponatremia
TTDS00111	Disease	Liver cirrhosis
TTDS00111	Disease	Nephrogenic diabetes insipidus
TTDS00111	Disease	Ocular hypertension
TTDS00111	Disease	Renal colic
TTDS00111	Disease	Renal diseases
TTDS00111	Disease	Syndrome of inappropriate secretion of antidiuretic hormone
TTDS00111	Disease	Von Willebrand's disease
TTDS00111	Disease	Water-retaining diseases
TTDS00111	Function	Receptor for arginine vasopressin. The activity of this receptor is mediated by
TTDS00111	Sequence	MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGH
TTDS00111	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00111	Pathway	Neuroactive ligand-receptor interaction
TTDS00111	Related US Patent	6,235,900
TTDS00111	Related US Patent	6,268,360
TTDS00111	Related US Patent	6,297,234
TTDS00111	Related US Patent	6,344,451
TTDS00111	Related US Patent	6,620,807
TTDS00111	Related US Patent	6,627,649
TTDS00111	Related US Patent	6,664,249
TTDS00111	Target Validation	TTDS00111
TTDS00111	Drug(s)	Conivaptan
TTDS00111	Drug(s)	Desmopressin
TTDS00111	Drug(s)	Lixivaptan
TTDS00111	Drug(s)	Satavaptan
TTDS00111	Drug(s)	Tolvaptan
TTDS00111	Drug(s)	Vasopressin
TTDS00111	Inhibitor	ARGENINE VASOPRESSIN
TTDS00111	Inhibitor	ATOSIBAN
TTDS00111	Inhibitor	GSK-221149A
TTDS00111	Inhibitor	L-368899;NCGC00094029-01
TTDS00111	Inhibitor	L-372662
TTDS00111	Inhibitor	Mozavaptan
TTDS00111	Inhibitor	SR-149415
TTDS00111	Inhibitor	VA-106483
TTDS00111	Inhibitor	VNA-932;WAY-VNA-932
TTDS00111	Inhibitor	YM-35278
TTDS00111	Inhibitor	d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr9-NH2]VT
TTDS00111	Inhibitor	dVDAVP
TTDS00111	Inhibitor	d[Arg4,Dab8]VP
TTDS00111	Inhibitor	d[Arg4,Lys8]VP
TTDS00111	Inhibitor	d[Arg4,Orn8]VP
TTDS00111	Inhibitor	d[Arg4]AVP
TTDS00111	Inhibitor	d[Cha4,Dab8]VP
TTDS00111	Inhibitor	d[Cha4,Dap8]VP
TTDS00111	Inhibitor	d[Cha4,Lys8]VP
TTDS00111	Inhibitor	d[Cha4,Orn8]VP
TTDS00111	Inhibitor	d[Cha4]AVP
TTDS00111	Inhibitor	d[D-3-Pal2]AVP
TTDS00111	Inhibitor	d[Leu4,Dab8]VP
TTDS00111	Inhibitor	d[Leu4,Dap8]VP
TTDS00111	Inhibitor	d[Leu4,Lys8]VP
TTDS00111	Inhibitor	d[Leu4,Orn8]VP
TTDS00111	Inhibitor	d[Leu4]AVP
TTDS00111	Inhibitor	d[Orn4,Lys8]VP
TTDS00111	Inhibitor	d[Orn4,Orn8]VP
TTDS00111	Inhibitor	d[Orn4]AVP
TTDS00111	Inhibitor	d[Val4]AVP
TTDS00111	Antagonist	CL-385004
TTDS00111	Antagonist	Conivaptan
TTDS00111	Antagonist	FR161282
TTDS00111	Antagonist	JTV-605
TTDS00111	Antagonist	Lixivaptan
TTDS00111	Antagonist	OPC-31260
TTDS00111	Antagonist	SR 121463 A
TTDS00111	Antagonist	SR121463
TTDS00111	Antagonist	SR121463B
TTDS00111	Antagonist	Satavaptan
TTDS00111	Antagonist	Satavaptan Lixivaptan
TTDS00111	Antagonist	Tolvaptan
TTDS00111	Antagonist	VP-343
TTDS00111	Antagonist	YM 087
TTDS00111	Agonist	DDAVP
TTDS00111	Agonist	Vasopressin
TTDS00111	Stimulator	Desmopressin
TTDS00111	Multitarget	Conivaptan
TTDS00112	UniProt ID	P09917
TTDS00112	Name	Arachidonate 5-lipoxygenase
TTDS00112	Type of target	Successful target
TTDS00112	Synonyms	5-LO
TTDS00112	Synonyms	5-LOX
TTDS00112	Synonyms	5-lipoxygenase
TTDS00112	Disease	Adult respiratory distress syndrome
TTDS00112	Disease	Allergic diseases
TTDS00112	Disease	Allergic rhinitis, unspecified
TTDS00112	Disease	Antigen-induced decrease in coronary flow and cardiac anaphylaxis
TTDS00112	Disease	Asthma
TTDS00112	Disease	Bronchiolar carcinoma
TTDS00112	Disease	Cerebral vasospasm
TTDS00112	Disease	Cervical cancer
TTDS00112	Disease	Chronic myeloid leukemia
TTDS00112	Disease	Dermatological disorders
TTDS00112	Disease	Gastrointestinal cancers
TTDS00112	Disease	Glomerulonephritis
TTDS00112	Disease	Inflammatory bowel disease
TTDS00112	Disease	Inflammatory lung disease
TTDS00112	Disease	Magnesium deficiency dermatitis
TTDS00112	Disease	Nephrosis
TTDS00112	Disease	Osteoarthritis
TTDS00112	Disease	Pancreatic cancer
TTDS00112	Disease	Polyarthritis, unspecified
TTDS00112	Disease	Prion diseases
TTDS00112	Disease	Psoriasis
TTDS00112	Disease	Pulmonary fibrosis
TTDS00112	Disease	Sjogren-Larsson syndrome
TTDS00112	Disease	Ulcerative colitis
TTDS00112	Disease	Urological cancers
TTDS00112	Disease	Vasospasm
TTDS00112	Sequence	MPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGAVDSYDVTVDEELGEIQLVRIEKRKYWLNDD
TTDS00112	PDB Structure	2ABV; 3O8Y; 3V92; 3V98; 3V99
TTDS00112	BioChemical Class	Oxidoreductases acting on single donors
TTDS00112	Pathway	Arachidonic acid metabolism
TTDS00112	Pathway	Linoleic acid metabolism
TTDS00112	Pathway	Metabolic pathways
TTDS00112	EC Number	EC 1.13.11.34
TTDS00112	Related US Patent	6,344,563
TTDS00112	Related US Patent	6,346,624
TTDS00112	Related US Patent	6,432,999
TTDS00112	Related US Patent	6,455,541
TTDS00112	Related US Patent	6,479,546
TTDS00112	Related US Patent	6,512,121
TTDS00112	Related US Patent	6,515,014
TTDS00112	Related US Patent	6,677,364
TTDS00112	Target Validation	TTDS00112
TTDS00112	QSAR Model	TTDS00112
TTDS00112	Drug(s)	ABT-761
TTDS00112	Drug(s)	CJ-13610
TTDS00112	Drug(s)	Diethylcarbamazine
TTDS00112	Drug(s)	Leukotriene antagonist
TTDS00112	Drug(s)	Licofelone
TTDS00112	Drug(s)	Linazolast
TTDS00112	Drug(s)	Linetastine
TTDS00112	Drug(s)	Lonapalene
TTDS00112	Drug(s)	MK-591
TTDS00112	Drug(s)	Masoprocol
TTDS00112	Drug(s)	Zileuton
TTDS00112	Inhibitor	A-78773
TTDS00112	Inhibitor	A-79175
TTDS00112	Inhibitor	AA-861
TTDS00112	Inhibitor	ABT-761
TTDS00112	Inhibitor	ACACETIN
TTDS00112	Inhibitor	ANTHRONE
TTDS00112	Inhibitor	Acanthus ilicifolius Linn
TTDS00112	Inhibitor	Azelastine hydrochloride
TTDS00112	Inhibitor	BAICALEIN
TTDS00112	Inhibitor	BUDDLEDIN A
TTDS00112	Inhibitor	BW A360C
TTDS00112	Inhibitor	BW A4C
TTDS00112	Inhibitor	BW B218C
TTDS00112	Inhibitor	BW B70C
TTDS00112	Inhibitor	BW-755C
TTDS00112	Inhibitor	BW755C
TTDS00112	Inhibitor	CGS 8515
TTDS00112	Inhibitor	CJ-13610
TTDS00112	Inhibitor	CV-6504
TTDS00112	Inhibitor	CV-6504 HCl
TTDS00112	Inhibitor	CYLINDOL A
TTDS00112	Inhibitor	Caffeic acid
TTDS00112	Inhibitor	Chebulagic acid
TTDS00112	Inhibitor	Diethylcarbamazine
TTDS00112	Inhibitor	ETH615
TTDS00112	Inhibitor	Fuscoside
TTDS00112	Inhibitor	Heme
TTDS00112	Inhibitor	Hyperforin
TTDS00112	Inhibitor	ICI 207968
TTDS00112	Inhibitor	Ibuproxam
TTDS00112	Inhibitor	JUGLONE
TTDS00112	Inhibitor	L-652,343
TTDS00112	Inhibitor	Leukotriene antagonist
TTDS00112	Inhibitor	Licofelone
TTDS00112	Inhibitor	Linazolast
TTDS00112	Inhibitor	Linetastine
TTDS00112	Inhibitor	Lonapalene
TTDS00112	Inhibitor	MK-591
TTDS00112	Inhibitor	MK-886
TTDS00112	Inhibitor	Masoprocol
TTDS00112	Inhibitor	NAFAZATROM
TTDS00112	Inhibitor	NAPHTHAZALIN
TTDS00112	Inhibitor	Nordihydroguaiaretic acid
TTDS00112	Inhibitor	PHENIDONE
TTDS00112	Inhibitor	PYROGALLOL
TTDS00112	Inhibitor	Quinacrine HCl
TTDS00112	Inhibitor	Quinacrine azide
TTDS00112	Inhibitor	Quinacrine dihydrochloride
TTDS00112	Inhibitor	R-68151
TTDS00112	Inhibitor	R-85355
TTDS00112	Inhibitor	REV-5901
TTDS00112	Inhibitor	SB 202235
TTDS00112	Inhibitor	SC41661A
TTDS00112	Inhibitor	SK&F 107649
TTDS00112	Inhibitor	SK&F 86002
TTDS00112	Inhibitor	Silymarin
TTDS00112	Inhibitor	TEBUFELONE
TTDS00112	Inhibitor	TZI-41127
TTDS00112	Inhibitor	Tepoxalin
TTDS00112	Inhibitor	ZM-211965
TTDS00112	Inhibitor	ZM-230487
TTDS00112	Inhibitor	Zileuton
TTDS00113	UniProt ID	Q9H244
TTDS00113	Name	P2Y purinoceptor 12
TTDS00113	Type of target	Successful target
TTDS00113	Synonyms	ADP-glucose receptor
TTDS00113	Synonyms	ADP-receptor
TTDS00113	Synonyms	ADPG-R
TTDS00113	Synonyms	Adenosine P2Y12 receptor
TTDS00113	Synonyms	Nucleotide P2Y(12) receptor
TTDS00113	Synonyms	P2T(AC)
TTDS00113	Synonyms	P2Y(AC)
TTDS00113	Synonyms	P2Y(ADP)
TTDS00113	Synonyms	P2Y(ADP)P2Y purinoceptor 12
TTDS00113	Synonyms	P2Y(cyc)
TTDS00113	Synonyms	P2Y12
TTDS00113	Synonyms	P2Y12 platelet ADP receptor
TTDS00113	Synonyms	SP1999
TTDS00113	Disease	Aggregation and activation of platelets
TTDS00113	Disease	Cardiovascular disease, unspecified
TTDS00113	Disease	Thrombosis
TTDS00113	Function	Receptor for adp and atp coupled to g-proteins that inhibit the adenylyl cyclase
TTDS00113	Sequence	MQAVDNLTSAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIFFQIRSKSNFIIFLKNTVISDLLMILTFPFK
TTDS00113	PDB Structure	1T78; 1VZ1; 1Y9C
TTDS00113	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00113	Target Validation	TTDS00113
TTDS00113	Drug(s)	AR-C69931 MX
TTDS00113	Drug(s)	Brilinta
TTDS00113	Drug(s)	Brilinta/Brilique
TTDS00113	Drug(s)	Clopidogrel
TTDS00113	Drug(s)	Prasugrel
TTDS00113	Drug(s)	Ticlopidine
TTDS00113	Inhibitor	ADENOSINETRIPHOSPHATE
TTDS00113	Inhibitor	PSB-0702
TTDS00113	Inhibitor	PSB-0739
TTDS00113	Inhibitor	Prasugrel
TTDS00113	Antagonist	AR-C69931 MX
TTDS00113	Antagonist	Adenosine triphosphate analogues
TTDS00113	Antagonist	Brilinta
TTDS00113	Antagonist	Clopidogrel
TTDS00113	Antagonist	Ticlopidine
TTDS00115	UniProt ID	P15121
TTDS00115	Name	Aldose reductase
TTDS00115	Type of target	Successful target
TTDS00115	Synonyms	AR
TTDS00115	Synonyms	Aldehyde reductase
TTDS00115	Disease	Analgesics
TTDS00115	Disease	Diabetic complications
TTDS00115	Disease	Diabetic neuropathy
TTDS00115	Disease	Diabetic retinopathy
TTDS00115	Disease	Neuropathic pain
TTDS00115	Disease	Noninsulin-dependent diabetes mellitus
TTDS00115	Function	Catalyzes the nadph-dependent reduction of a wide variety of carbonyl-containing
TTDS00115	Sequence	MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLW
TTDS00115	PDB Structure	1ABN; 1ADS; 1AZ1; 1AZ2; 1EF3; 1EL3; 1IEI; 1MAR; 1PWL; 1PWM; 1T40; 1T41; 1US0; 1X
TTDS00115	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00115	Pathway	Fructose and mannose metabolism
TTDS00115	Pathway	Galactose metabolism
TTDS00115	Pathway	Glycerolipid metabolism
TTDS00115	Pathway	Metabolic pathways
TTDS00115	Pathway	Pentose and glucuronate interconversions
TTDS00115	Pathway	Pyruvate metabolism
TTDS00115	EC Number	EC 1.1.1.21
TTDS00115	Related US Patent	6,337,327
TTDS00115	Related US Patent	6,380,200
TTDS00115	Related US Patent	6,509,499
TTDS00115	Related US Patent	6,555,540
TTDS00115	Related US Patent	6,579,879
TTDS00115	Related US Patent	6,610,890
TTDS00115	Related US Patent	6,649,622
TTDS00115	Related US Patent	6,670,380
TTDS00115	Target Validation	TTDS00115
TTDS00115	QSAR Model	TTDS00115
TTDS00115	Drug(s)	AS-3201
TTDS00115	Drug(s)	Epalrestat
TTDS00115	Drug(s)	Fidarestat
TTDS00115	Drug(s)	Sorbinil
TTDS00115	Drug(s)	Sulindac
TTDS00115	Drug(s)	Zenarestat
TTDS00115	Inhibitor	(4-Methyl-2-oxo-2H-quinolin-1-yl)-acetic acid
TTDS00115	Inhibitor	(6-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid
TTDS00115	Inhibitor	(6-Methoxy-2-oxo-2H-quinolin-1-yl)-acetic acid
TTDS00115	Inhibitor	(8-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid
TTDS00115	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDS00115	Inhibitor	2,3-dihydroxypropanal
TTDS00115	Inhibitor	2-(3,4-Dihydroxy-benzyl)-7-hydroxy-chromen-4-one
TTDS00115	Inhibitor	2-(3,4-Dihydroxy-phenyl)-7-hydroxy-chromen-4-one
TTDS00115	Inhibitor	2-(3-benzoyl-1H-pyrrol-1-yl)acetic acid
TTDS00115	Inhibitor	2-(4-aminophenylsulfonamido)acetic acid
TTDS00115	Inhibitor	2-(Phenylsulfonamido)acetic Acid
TTDS00115	Inhibitor	2-Benzhydryl-7-hydroxy-chromen-4-one
TTDS00115	Inhibitor	2-Benzyl-7-hydroxy-chromen-4-one
TTDS00115	Inhibitor	3,5-dichlorosalicylic acid
TTDS00115	Inhibitor	3-(3-Benzoyl-1H-pyrrol-1-yl)propanoic acid
TTDS00115	Inhibitor	3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid
TTDS00115	Inhibitor	4-(3-Benzoyl-1H-pyrrol-1-yl)butanoic acid
TTDS00115	Inhibitor	4-(3-Methoxy-phenyl)-isoxazolidine-3,5-dione
TTDS00115	Inhibitor	6,7-Dihydroxy-2-phenyl-chromen-4-one
TTDS00115	Inhibitor	6-(1H-Indole-2-sulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(2-Bromo-benzenesulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(2-Chloro-benzenesulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(2-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(3-Chloro-benzenesulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(4-Bromo-benzenesulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(4-Chloro-benzenesulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(4-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(4-Methoxy-benzenesulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(Benzofuran-2-sulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(Benzothiazole-2-sulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(Biphenyl-2-sulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(Naphthalene-1-sulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(Naphthalene-2-sulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-(Toluene-4-sulfonyl)-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-Benzenesulfonyl-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one
TTDS00115	Inhibitor	6-Phenylmethanesulfonyl-2H-pyridazin-3-one
TTDS00115	Inhibitor	6-methoxykaempferol 3-O-beta-D-robinobioside
TTDS00115	Inhibitor	7-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one
TTDS00115	Inhibitor	7-Hydroxy-2-(4-methoxy-benzyl)-chromen-4-one
TTDS00115	Inhibitor	7-Hydroxy-4-phenylcoumarin
TTDS00115	Inhibitor	7-Hydroxy-6-nitro-2-phenyl-chromen-4-one
TTDS00115	Inhibitor	APIGENIN
TTDS00115	Inhibitor	ASTRAGALIN
TTDS00115	Inhibitor	Alpha-D-Glucose-6-Phosphate
TTDS00115	Inhibitor	Alrestatin
TTDS00115	Inhibitor	CHRYSIN
TTDS00115	Inhibitor	CONTIGOSIDE B
TTDS00115	Inhibitor	DIADZEIN
TTDS00115	Inhibitor	EPALRESTATE
TTDS00115	Inhibitor	Epalrestat
TTDS00115	Inhibitor	Fidarestat
TTDS00115	Inhibitor	Fidarestat(Stereoisomer)
TTDS00115	Inhibitor	Hydroxydimethylarsine Oxide
TTDS00115	Inhibitor	IDD552
TTDS00115	Inhibitor	IDD594
TTDS00115	Inhibitor	IMIRESTAT
TTDS00115	Inhibitor	Inhibitor Idd 384
TTDS00115	Inhibitor	Isorhamnetin 3,7-disulfate
TTDS00115	Inhibitor	KAEMPFEROL
TTDS00115	Inhibitor	LIDORESTAT
TTDS00115	Inhibitor	MANGIFERIN
TTDS00115	Inhibitor	MINALRESTAT
TTDS00115	Inhibitor	N-Acetylalanine
TTDS00115	Inhibitor	NSC-94258
TTDS00115	Inhibitor	O5-Acetyl-O7-nitrooxyethyl chrysin
TTDS00115	Inhibitor	O7-Nitrooxyethyl chrysin
TTDS00115	Inhibitor	PALBINONE
TTDS00115	Inhibitor	Patuletin 3-O-beta-D-galactoside
TTDS00115	Inhibitor	Patuletin 3-O-beta-D-robinobioside
TTDS00115	Inhibitor	Ponalrestat
TTDS00115	Inhibitor	QUERCITRIN
TTDS00115	Inhibitor	SPR-210
TTDS00115	Inhibitor	Sorbinil
TTDS00115	Inhibitor	Sulindac
TTDS00115	Inhibitor	TINGENIN B
TTDS00115	Inhibitor	TINGENONE
TTDS00115	Inhibitor	TRIPTOCALLINE A
TTDS00115	Inhibitor	Tamarixetin 3-glucoside-7-sulfate
TTDS00115	Inhibitor	Tolrestat
TTDS00115	Inhibitor	ZOPOLRESTAT
TTDS00115	Inhibitor	Zenarestat
TTDS00115	Inhibitor	apigenin-7-O-beta-D-glucuronide
TTDS00115	Inhibitor	apigenin-7-O-beta-D-glucuronide methyl ester
TTDS00115	Inhibitor	isorhamnetin 3-O-rhamnoside
TTDS00115	Inhibitor	quercetin 3-O-neohesperidoside
TTDS00116	UniProt ID	Q13621
TTDS00116	Name	Solute carrier family 12 member 1
TTDS00116	Type of target	Successful target
TTDS00116	Synonyms	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2
TTDS00116	Synonyms	Bumetanide-sensitive sodium-(potassium)Solute carrier family 12 member 1-chlorid
TTDS00116	Synonyms	Kidney-specific Na-K-Cl symporter
TTDS00116	Synonyms	NKCC2
TTDS00116	Synonyms	Na+/K+/2CL- co-transporter
TTDS00116	Synonyms	Solute carrier family 12 member
TTDS00116	Disease	Congestive heart failure
TTDS00116	Disease	Hypertension
TTDS00116	Function	Electrically silent transporter system. mediates sodium and chloride reabsorptio
TTDS00116	Sequence	MSLNNSSNVFLDSVPSNTNRFQVSVINENHESSAAADDNTDPPHYEETSFGDEAQKRLRISFRPGNQECYDNFLQSGETA
TTDS00116	BioChemical Class	Ion transport
TTDS00116	Target Validation	TTDS00116
TTDS00116	Drug(s)	Bendroflumethiazide
TTDS00116	Drug(s)	Bumetanide
TTDS00116	Drug(s)	Chlorthalidone
TTDS00116	Drug(s)	Ethacrynic acid
TTDS00116	Drug(s)	Furosemide
TTDS00116	Drug(s)	Hydroflumethiazide
TTDS00116	Drug(s)	Methyclothiazide
TTDS00116	Drug(s)	Potassium Chloride
TTDS00116	Drug(s)	Torasemide
TTDS00116	Drug(s)	Trichlormethiazide
TTDS00116	Blocker	Bendroflumethiazide
TTDS00116	Blocker	Bumetanide
TTDS00116	Blocker	Chlorthalidone
TTDS00116	Blocker	Ethacrynic acid
TTDS00116	Blocker	Furosemide
TTDS00116	Blocker	Hydroflumethiazide
TTDS00116	Blocker	Methyclothiazide
TTDS00116	Blocker	Piretanide
TTDS00116	Blocker	Torasemide
TTDS00116	Blocker	Trichlormethiazide
TTDS00116	Binder	Potassium Chloride
TTDS00117	UniProt ID	P55017
TTDS00117	Name	Solute carrier family 12 member 3
TTDS00117	Type of target	Successful target
TTDS00117	Synonyms	Na-Cl symporter
TTDS00117	Synonyms	SLC12A3
TTDS00117	Synonyms	Thiazide-sensitive Na-Cl cotransporter
TTDS00117	Synonyms	Thiazide-sensitive sodium-chloride cotransporter
TTDS00117	Disease	Diabetic nephropathy
TTDS00117	Disease	Renal failure
TTDS00117	Function	Electrically silence transporter system and mediate sodium and chloride reabsorp
TTDS00117	Sequence	MAELPTTETPGDATLCSGRFTISTLLSSDEPSPPAAYDSSHPSHLTHSSTFCMRTFGYNTIDVVPTYEHYANSTQPGEPR
TTDS00117	BioChemical Class	Ion transport
TTDS00117	Target Validation	TTDS00117
TTDS00117	Drug(s)	Bendroflumethiazide
TTDS00117	Drug(s)	Hydrochlorothiazide
TTDS00117	Drug(s)	Metolazone
TTDS00117	Drug(s)	Polythiazide
TTDS00117	Blocker	Bendroflumethiazide
TTDS00117	Blocker	Hydrochlorothiazide
TTDS00117	Blocker	Metolazone
TTDS00117	Blocker	Polythiazide
TTDS00118	UniProt ID	Q05940
TTDS00118	Name	Synaptic vesicle amine transporter
TTDS00118	Type of target	Successful target
TTDS00118	Synonyms	Monoamine transporter
TTDS00118	Synonyms	Solute carrier family 18 member 2
TTDS00118	Synonyms	VAT
TTDS00118	Synonyms	VMAT
TTDS00118	Synonyms	Vesicular Monoamine Transporter
TTDS00118	Synonyms	Vesicular amine transporter
TTDS00118	Disease	Cocaine dependence
TTDS00118	Disease	Neurodegenerative diseases
TTDS00118	Function	Involved in the atp-dependent vesicular transport of biogenic amine neurotransmi
TTDS00118	Sequence	MALSELALVRWLQESRRSRKLILFIVFLALLLDNMLLTVVVPIIPSYLYSIKHEKNATEIQTARPVHTASISDSFQSIFS
TTDS00118	BioChemical Class	Transmembrane protein
TTDS00118	Pathway	Parkinson's disease
TTDS00118	Target Validation	TTDS00118
TTDS00118	Drug(s)	Alseroxylon
TTDS00118	Drug(s)	Reserpine
TTDS00118	Drug(s)	Tetrabenazine
TTDS00118	Inhibitor	Lobeline
TTDS00118	Inhibitor	Reserpine
TTDS00118	Inhibitor	Tetrabenazine
TTDS00118	Antagonist	3,4-Methylenedioxymethamphetamine
TTDS00118	Antagonist	4-Methoxyamphetamine
TTDS00118	Antagonist	MMDA
TTDS00118	Blocker	Alseroxylon
TTDS00118	Blocker	Reserpine
TTDS00118	Blocker	Tetrabenazine
TTDS00120	UniProt ID	Q9GQW8
TTDS00120	Name	Glutamate-gated chloride channel
TTDS00120	Type of target	Successful target
TTDS00120	Synonyms	GluCl
TTDS00120	Disease	Helminth infection
TTDS00120	Sequence	MFALILPFLLHFTRSEGFGYEKLLDEQKIIKHLLESPYSDYDWRVRPRGRLGPADDDDYDSEPVFITVNMYLRSISKVDD
TTDS00120	BioChemical Class	Ion transport
TTDS00120	Drug(s)	Ivermectin
TTDS00120	Activator	Ivermectin
TTDS00121	Name	Glutamate receptor AMPA subtype
TTDS00121	Type of target	Successful target
TTDS00121	Synonyms	AMPA receptor
TTDS00121	Synonyms	AMPA selective glutamate receptor
TTDS00121	Synonyms	GluR
TTDS00121	Synonyms	Glutamate receptor
TTDS00121	Synonyms	Glutamate receptor ionotropic, AMPA
TTDS00121	Disease	Stroke
TTDS00121	Related US Patent	6,268,366
TTDS00121	Related US Patent	6,306,864
TTDS00121	Related US Patent	6,407,094
TTDS00121	Related US Patent	6,562,810
TTDS00121	Related US Patent	6,600,036
TTDS00121	Target Validation	TTDS00121
TTDS00121	QSAR Model	TTDS00121
TTDS00121	Drug(s)	Becampanel
TTDS00121	Drug(s)	Bicifadine
TTDS00121	Drug(s)	CX-516
TTDS00121	Drug(s)	CX717
TTDS00121	Drug(s)	Desflurane
TTDS00121	Drug(s)	Enflurane
TTDS00121	Drug(s)	GSK729327
TTDS00121	Drug(s)	GYKI-47261
TTDS00121	Drug(s)	Halothane
TTDS00121	Drug(s)	NS 1209
TTDS00121	Drug(s)	S-18986
TTDS00121	Drug(s)	Sevoflurane
TTDS00121	Drug(s)	TRO-19622
TTDS00121	Drug(s)	Talampanel
TTDS00121	Inhibitor	(R,S)-AMPA
TTDS00121	Inhibitor	(S)-AMPA
TTDS00121	Inhibitor	(S)-WILLARDIINE
TTDS00121	Inhibitor	2-AMINO-3-(4-HYDROXY-1,2,5-OXADIAZOL-3-YL)PROPIONIC ACID (STRUCTURAL MIX)
TTDS00121	Inhibitor	6-cyano-7-nitroquinoxaline-2,3-dione
TTDS00121	Inhibitor	7-chloro-3-hydroxyquinazoline-2,4-dione
TTDS00121	Inhibitor	DNQX
TTDS00121	Inhibitor	GLUTAMATE
TTDS00121	Inhibitor	GYKI-52466
TTDS00121	Inhibitor	GYKI-53655
TTDS00121	Inhibitor	KAINATE
TTDS00121	Inhibitor	LY-293559
TTDS00121	Inhibitor	N-(4-hydroxyphenylpropanyl)-spermine
TTDS00121	Inhibitor	NBQX
TTDS00121	Inhibitor	Piriqualone
TTDS00121	Inhibitor	RPR-118723
TTDS00121	Inhibitor	YM-90K
TTDS00121	Inhibitor	ZK-200775
TTDS00121	Inhibitor	ZONAMPANEL
TTDS00121	Antagonist	Becampanel
TTDS00121	Antagonist	Bicifadine
TTDS00121	Antagonist	Desflurane
TTDS00121	Antagonist	GYKI-47261
TTDS00121	Antagonist	Halothane
TTDS00121	Antagonist	NS 1209
TTDS00121	Antagonist	Sevoflurane
TTDS00121	Antagonist	TRO-19622
TTDS00121	Antagonist	Talampanel
TTDS00121	Antagonist	YM872
TTDS00121	Suppressor	Enflurane
TTDS00121	Agonist	CX717
TTDS00121	Modulator	CX-516
TTDS00121	Modulator	GSK729327
TTDS00121	Modulator	S-18986
TTDS00121	Multitarget	Bicifadine
TTDS00122	UniProt ID	P39086
TTDS00122	Name	Glutamate receptor, ionotropic kainate 1
TTDS00122	Type of target	Successful target
TTDS00122	Synonyms	EAA3
TTDS00122	Synonyms	Excitatory amino acid receptor 3
TTDS00122	Synonyms	GluR-5
TTDS00122	Synonyms	GluR5
TTDS00122	Synonyms	GluR5 kainate receptor
TTDS00122	Synonyms	Glutamate receptor 5
TTDS00122	Disease	Analgesics
TTDS00122	Disease	Epilepsy
TTDS00122	Disease	Pain
TTDS00122	Function	L-glutamate acts as an excitatory neurotransmitter at many synapses in the centr
TTDS00122	Sequence	MEHGTLLAQPGLWTRDTSWALLYFLCYILPQTAPQVLRIGGIFETVENEPVNVEELAFKFAVTSINRNRTLMPNTTLTYD
TTDS00122	PDB Structure	2ZNS; 2ZNT; 2ZNU; 3FUZ; 3FV1; 3FV2; 3FVG; 3FVK; 3FVN; 3FVO
TTDS00122	BioChemical Class	Ion transport
TTDS00122	Pathway	Neuroactive ligand-receptor interaction
TTDS00122	Related US Patent	6,566,370
TTDS00122	Related US Patent	6,579,886
TTDS00122	Related US Patent	6,759,418
TTDS00122	Target Validation	TTDS00122
TTDS00122	Drug(s)	LY293558
TTDS00122	Drug(s)	Topiramate
TTDS00122	Inhibitor	(2S,4R)-4-(3-Methoxy-3-oxopropyl)glutamic Acid
TTDS00122	Inhibitor	(R,S)-AMPA
TTDS00122	Inhibitor	2-(3-(3-bromophenyl)ureido)-4-chlorobenzoic acid
TTDS00122	Inhibitor	2-(3-bromobenzoylamino)-4-chlorobenzoic acid
TTDS00122	Inhibitor	2-AMINO-3-(4-HYDROXY-1,2,5-OXADIAZOL-3-YL)PROPIONIC ACID (STRUCTURAL MIX)
TTDS00122	Inhibitor	2S,4R-4-METHYLGLUTAMATE
TTDS00122	Inhibitor	DIHYDROKAINATE
TTDS00122	Inhibitor	DNQX
TTDS00122	Inhibitor	GLUTAMATE
TTDS00122	Inhibitor	KAINATE
TTDS00122	Inhibitor	LY-293559
TTDS00122	Inhibitor	NBQX
TTDS00122	Inhibitor	QUISQUALATE
TTDS00122	Inhibitor	S-ATPO
TTDS00122	Inhibitor	TQX-173
TTDS00122	Inhibitor	UBP-302
TTDS00122	Inhibitor	YM-90K
TTDS00122	Inhibitor	domoric acid
TTDS00122	Antagonist	LY293558
TTDS00122	Antagonist	Topiramate
TTDS00123	UniProt ID	Q12879
TTDS00123	Name	Glutamate [NMDA] receptor subunit epsilon 1
TTDS00123	Type of target	Successful target
TTDS00123	Synonyms	HNR2A
TTDS00123	Synonyms	N-methyl D-aspartate receptor subtype 2A
TTDS00123	Synonyms	NMDA receptor NR2A
TTDS00123	Synonyms	NMDAR2A
TTDS00123	Synonyms	NR2A
TTDS00123	Disease	Analgesics
TTDS00123	Disease	Pain (anesthesia, neuropathic)
TTDS00123	Function	Nmda receptor subtype of glutamate-gated ion channels possesses high calcium per
TTDS00123	Sequence	MGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERELRTLWGPEQAAGLPLDVNVVALLMNRTDPK
TTDS00123	PDB Structure	3NFL
TTDS00123	BioChemical Class	Ion transport
TTDS00123	Pathway	Alzheimer's disease
TTDS00123	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDS00123	Pathway	Calcium signaling pathway
TTDS00123	Pathway	Long-term potentiation
TTDS00123	Pathway	Neuroactive ligand-receptor interaction
TTDS00123	Pathway	Systemic lupus erythematosus
TTDS00123	Target Validation	TTDS00123
TTDS00123	Drug(s)	Glycine
TTDS00123	Inhibitor	(D)-Ala-Pro-Glu
TTDS00123	Inhibitor	(R)-2-Amino-5-phosphono-pentanoic acid
TTDS00123	Inhibitor	(R)-2-Amino-7-phosphono-heptanoic acid
TTDS00123	Inhibitor	2-Methylamino-succinic acid(NMDA)
TTDS00123	Inhibitor	3-Benzoyl-7-chloro-4-hydroxy-1H-quinolin-2-one
TTDS00123	Inhibitor	3-Hydroxy-1H-benzo[b]azepine-2,5-dione
TTDS00123	Inhibitor	3-Hydroxy-6-methyl-1H-benzo[b]azepine-2,5-dione
TTDS00123	Inhibitor	3-Hydroxy-7-nitro-1H-benzo[b]azepine-2,5-dione
TTDS00123	Inhibitor	3-Hydroxy-8-methyl-1H-benzo[b]azepine-2,5-dione
TTDS00123	Inhibitor	3-phenyl-4-hydroxyquinolin-2(1H)-one
TTDS00123	Inhibitor	4,5,7-Trichloro-3-hydroxy-1H-quinolin-2-one
TTDS00123	Inhibitor	4,6-Dichloro-1H-indole-2-carboxylic acid
TTDS00123	Inhibitor	4-Bromo-3-hydroxy-1H-quinolin-2-one
TTDS00123	Inhibitor	4-Bromo-5,7-dichloro-3-hydroxy-1H-quinolin-2-one
TTDS00123	Inhibitor	4-Chloro-3-hydroxy-1H-quinolin-2-one
TTDS00123	Inhibitor	4-Phosphonomethyl-piperidine-2-carboxylic acid
TTDS00123	Inhibitor	4-[2-(4-Phenyl-butylamino)-ethyl]-phenol
TTDS00123	Inhibitor	4-[2-(5-Phenyl-pentylamino)-ethyl]-phenol
TTDS00123	Inhibitor	4-[2-(6-Phenyl-hexylamino)-ethyl]-phenol
TTDS00123	Inhibitor	4-[3-(4-Phenyl-butylamino)-propyl]-phenol
TTDS00123	Inhibitor	4-[3-(5-Phenyl-pentylamino)-propyl]-phenol
TTDS00123	Inhibitor	4-hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one
TTDS00123	Inhibitor	5,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione
TTDS00123	Inhibitor	5,7-Dichloro-4-hydroxy-3-phenyl-1H-quinolin-2-one
TTDS00123	Inhibitor	5,7-Dinitro-1,4-dihydro-quinoxaline-2,3-dione
TTDS00123	Inhibitor	6,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione
TTDS00123	Inhibitor	6-Chloro-1,4-dihydro-quinoxaline-2,3-dione
TTDS00123	Inhibitor	6-Nitro-1,4-dihydro-quinoxaline-2,3-dione
TTDS00123	Inhibitor	7-Chloro-3-nitro-3,4-dihydro-1H-quinolin-2-one
TTDS00123	Inhibitor	7-chloro-3-hydroxyquinazoline-2,4-dione
TTDS00123	Inhibitor	8-Bromo-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDS00123	Inhibitor	8-Chloro-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDS00123	Inhibitor	8-Ethyl-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDS00123	Inhibitor	8-Fluoro-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDS00123	Inhibitor	AP-7
TTDS00123	Inhibitor	Ala-Pro-Glu
TTDS00123	Inhibitor	CI-1041
TTDS00123	Inhibitor	DITOLYLGUANIDINE
TTDS00123	Inhibitor	DIZOCILPINE
TTDS00123	Inhibitor	DNQX
TTDS00123	Inhibitor	GLUTAMATE
TTDS00123	Inhibitor	Gly-Amp-Glu
TTDS00123	Inhibitor	Gly-Hyp-Glu
TTDS00123	Inhibitor	Gly-Pip-Glu
TTDS00123	Inhibitor	Gly-b7Pro-Glu
TTDS00123	Inhibitor	H-Gly-D-dmP-Glu-OH
TTDS00123	Inhibitor	H-Gly-PMe-Glu-OH
TTDS00123	Inhibitor	H-Gly-dmP-Glu-OH
TTDS00123	Inhibitor	L-687414
TTDS00123	Inhibitor	L-695902
TTDS00123	Inhibitor	L-698532
TTDS00123	Inhibitor	L-701324
TTDS00123	Inhibitor	MDL-105519
TTDS00123	Inhibitor	N,N'-Bis-(4-butoxy-phenyl)-guanidine
TTDS00123	Inhibitor	N,N'-Bis-(4-butyl-phenyl)-guanidine
TTDS00123	Inhibitor	N,N'-Bis-(4-ethyl-phenyl)-guanidine
TTDS00123	Inhibitor	N,N'-Bis-(4-hexyl-phenyl)-guanidine
TTDS00123	Inhibitor	N,N'-Bis-(4-isopropyl-phenyl)-guanidine
TTDS00123	Inhibitor	N,N'-Bis-(4-sec-butyl-phenyl)-guanidine
TTDS00123	Inhibitor	N-(2-methoxybenzyl)cinnamamidine
TTDS00123	Inhibitor	NBQX
TTDS00123	Inhibitor	Nle-Pro-Glu
TTDS00123	Inhibitor	PHENCYCLIDINE
TTDS00123	Inhibitor	Phe-Pro-Glu
TTDS00123	Inhibitor	RPR-104632
TTDS00123	Inhibitor	RPR-118723
TTDS00123	Inhibitor	SPERMINE
TTDS00123	Inhibitor	TRANSTORINE
TTDS00123	Inhibitor	YM-90K
TTDS00123	Inhibitor	benzyl 4-aminobutyl(3-aminopropyl)carbamate
TTDS00123	Inhibitor	conantokin-R
TTDS00123	Antagonist	Glycine
TTDS00123	Antagonist	MDL 100,453
TTDS00123	Antagonist	Tenocyclidine
TTDS00125	Name	Opioid receptor
TTDS00125	Type of target	Successful target
TTDS00125	Disease	Alcoholism
TTDS00125	Disease	Analgesics
TTDS00125	Disease	Drug dependence
TTDS00125	Disease	Eating disorders
TTDS00125	Disease	Irritable bowel syndrome
TTDS00125	Disease	Pain, unspecified
TTDS00125	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00125	Pathway	Neuroactive ligand-receptor interaction
TTDS00125	Related US Patent	6,395,705
TTDS00125	Related US Patent	6,495,155
TTDS00125	Related US Patent	6,512,009
TTDS00125	Related US Patent	6,569,449
TTDS00125	Target Validation	TTDS00125
TTDS00125	Drug(s)	Bupropion+naltrexone
TTDS00125	Drug(s)	Dextropropoxyphene
TTDS00125	Drug(s)	Levorphanol
TTDS00125	Drug(s)	Methadone
TTDS00125	Drug(s)	Methylnaltrexone bromide
TTDS00125	Drug(s)	Morphine
TTDS00125	Drug(s)	Nalmefene
TTDS00125	Drug(s)	Oravescent fentanyl
TTDS00125	Drug(s)	Pentazocine
TTDS00125	Drug(s)	S-297995
TTDS00125	Drug(s)	Sufentanil
TTDS00125	Drug(s)	Tapentadol hydrochloride
TTDS00125	Drug(s)	Tramadol
TTDS00125	Antagonist	Bupropion+naltrexone
TTDS00125	Antagonist	Cyprodine
TTDS00125	Antagonist	Nalmefene
TTDS00125	Antagonist	Pentazocine
TTDS00125	Antagonist	S-297995
TTDS00125	Antagonist	Sufentanil
TTDS00125	Agonist	Dextropropoxyphene
TTDS00125	Agonist	Levorphanol
TTDS00125	Agonist	Methadone
TTDS00125	Agonist	Morphine
TTDS00125	Agonist	Oravescent fentanyl
TTDS00125	Agonist	Tramadol
TTDS00125	Multitarget	Bupropion+naltrexone
TTDS00126	UniProt ID	P35372
TTDS00126	Name	Mu-type opioid receptor
TTDS00126	Type of target	Successful target
TTDS00126	Synonyms	MOR-1
TTDS00126	Synonyms	MOR1A
TTDS00126	Synonyms	Mu opioid receptor
TTDS00126	Disease	Analgesics
TTDS00126	Disease	Cough
TTDS00126	Disease	Diarrhea
TTDS00126	Disease	Dyspnea
TTDS00126	Disease	Opioid-induced bowel dysfunction
TTDS00126	Disease	Pain, unspecified
TTDS00126	Function	Inhibits neurotransmitter release by reducing calcium ion currents and increasin
TTDS00126	Sequence	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIV
TTDS00126	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00126	Pathway	Neuroactive ligand-receptor interaction
TTDS00126	Related US Patent	6,451,806
TTDS00126	Related US Patent	6,680,071
TTDS00126	Target Validation	TTDS00126
TTDS00126	QSAR Model	TTDS00126
TTDS00126	Drug(s)	Alfentanil
TTDS00126	Drug(s)	Alvimopan
TTDS00126	Drug(s)	Anileridine
TTDS00126	Drug(s)	Buprenex
TTDS00126	Drug(s)	Buprenorphine
TTDS00126	Drug(s)	Diphenoxylate
TTDS00126	Drug(s)	Fentanyl
TTDS00126	Drug(s)	GNTI
TTDS00126	Drug(s)	GSK1521498
TTDS00126	Drug(s)	LY-25582
TTDS00126	Drug(s)	Levomethadyl Acetate
TTDS00126	Drug(s)	Methadyl Acetate
TTDS00126	Drug(s)	Methylnaltrexone
TTDS00126	Drug(s)	Naloxone
TTDS00126	Drug(s)	Oxymorphone
TTDS00126	Drug(s)	Remifentanil
TTDS00126	Drug(s)	TD-1211
TTDS00126	Drug(s)	Tramadol ER
TTDS00126	Inhibitor	C6S
TTDS00126	Inhibitor	DC6S
TTDS00126	Inhibitor	DM3A6S
TTDS00126	Inhibitor	DM3B6S
TTDS00126	Inhibitor	DM6S
TTDS00126	Inhibitor	DPDPE
TTDS00126	Inhibitor	Dimepheptanol
TTDS00126	Inhibitor	Dynorphin(1-8)
TTDS00126	Inhibitor	FALCARINDIOL
TTDS00126	Inhibitor	FLUPERAMIDE
TTDS00126	Inhibitor	GBR-12909
TTDS00126	Inhibitor	ICI-199441
TTDS00126	Inhibitor	KNT-5
TTDS00126	Inhibitor	KNT-62
TTDS00126	Inhibitor	KNT-63
TTDS00126	Inhibitor	LY-255582
TTDS00126	Inhibitor	M3A6S
TTDS00126	Inhibitor	M3B6S
TTDS00126	Inhibitor	M3IBu6S
TTDS00126	Inhibitor	M3P6S
TTDS00126	Inhibitor	M3Pr6S
TTDS00126	Inhibitor	M3S
TTDS00126	Inhibitor	M6S
TTDS00126	Inhibitor	MC-CAM
TTDS00126	Inhibitor	MCL-117
TTDS00126	Inhibitor	MCL-139
TTDS00126	Inhibitor	MCL-144
TTDS00126	Inhibitor	MCL-145
TTDS00126	Inhibitor	MCL-147
TTDS00126	Inhibitor	MCL-149
TTDS00126	Inhibitor	MCL-154
TTDS00126	Inhibitor	MCL-182
TTDS00126	Inhibitor	MCL-183
TTDS00126	Inhibitor	MCL-428
TTDS00126	Inhibitor	MCL-429
TTDS00126	Inhibitor	MCL-431
TTDS00126	Inhibitor	MCL-432
TTDS00126	Inhibitor	MCL-433
TTDS00126	Inhibitor	MCL-434
TTDS00126	Inhibitor	MCL-435
TTDS00126	Inhibitor	MCL-443
TTDS00126	Inhibitor	MCL-444
TTDS00126	Inhibitor	MCL-445
TTDS00126	Inhibitor	MCL-446
TTDS00126	Inhibitor	MCL-447
TTDS00126	Inhibitor	MCL-448
TTDS00126	Inhibitor	MCL-449
TTDS00126	Inhibitor	MCL-450
TTDS00126	Inhibitor	MCL-451
TTDS00126	Inhibitor	MCL-457
TTDS00126	Inhibitor	MCL-458
TTDS00126	Inhibitor	MR-1029
TTDS00126	Inhibitor	MR-1526
TTDS00126	Inhibitor	MR-2034
TTDS00126	Inhibitor	MR-2266
TTDS00126	Inhibitor	NalBzOH
TTDS00126	Inhibitor	Naltrexone methiodide
TTDS00126	Inhibitor	Naltrexone semicarbazone
TTDS00126	Inhibitor	RTI-5989-31
TTDS00126	Inhibitor	SB-0304
TTDS00126	Inhibitor	SL-3111
TTDS00126	Inhibitor	SN-11
TTDS00126	Inhibitor	SN-23
TTDS00126	Inhibitor	SN-28
TTDS00126	Inhibitor	SNF-9007
TTDS00126	Inhibitor	TRK-820
TTDS00126	Inhibitor	U-69593
TTDS00126	Inhibitor	UFP-502
TTDS00126	Inhibitor	UFP-512
TTDS00126	Inhibitor	beta-funaltrexamine
TTDS00126	Antagonist	Alvimopan
TTDS00126	Antagonist	Beta-endorphin
TTDS00126	Antagonist	Diprenorphine
TTDS00126	Antagonist	GNTI
TTDS00126	Antagonist	LY-25582
TTDS00126	Antagonist	Methylnaltrexone
TTDS00126	Antagonist	Naloxone
TTDS00126	Agonist	Alfentanil
TTDS00126	Agonist	Anileridine
TTDS00126	Agonist	Buprenex
TTDS00126	Agonist	Buprenorphine
TTDS00126	Agonist	Carfentanil
TTDS00126	Agonist	DBO-11
TTDS00126	Agonist	DBO-17
TTDS00126	Agonist	Dihydromorphine
TTDS00126	Agonist	Dimethylthiambutene
TTDS00126	Agonist	Diphenoxylate
TTDS00126	Agonist	Ethylmorphine
TTDS00126	Agonist	Etorphine
TTDS00126	Agonist	Fentanyl
TTDS00126	Agonist	GSK1521498
TTDS00126	Agonist	Levomethadyl Acetate
TTDS00126	Agonist	Methadyl Acetate
TTDS00126	Agonist	Oxymorphone
TTDS00126	Agonist	Remifentanil
TTDS00126	Agonist	Tramadol ER
TTDS00126	Multitarget	Tramadol ER
TTDS00127	UniProt ID	P41145
TTDS00127	Name	Kappa-type opioid receptor
TTDS00127	Type of target	Successful target
TTDS00127	Synonyms	KOR
TTDS00127	Synonyms	KOR-1
TTDS00127	Synonyms	Kappa opioid receptor
TTDS00127	Synonyms	Opioid receptor Kappa
TTDS00127	Disease	Alcohol dependence
TTDS00127	Disease	Analgesics
TTDS00127	Disease	Behcet's disease
TTDS00127	Disease	Diarrhea
TTDS00127	Disease	Dyspnea
TTDS00127	Disease	Focal ischemia
TTDS00127	Disease	Immune disease
TTDS00127	Disease	Neurodegenerative diseases
TTDS00127	Disease	Pain, unspecified
TTDS00127	Function	Inhibits neurotransmitter release by reducing calcium ion currents and increasin
TTDS00127	Sequence	MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLV
TTDS00127	PDB Structure	2A0D; 2IQN; 4DJH
TTDS00127	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00127	Pathway	Neuroactive ligand-receptor interaction
TTDS00127	Related US Patent	6,156,769
TTDS00127	Related US Patent	6,294,557
TTDS00127	Related US Patent	6,294,569
TTDS00127	Related US Patent	6,303,602
TTDS00127	Related US Patent	6,307,061
TTDS00127	Related US Patent	6,310,061
TTDS00127	Related US Patent	6,313,302
TTDS00127	Related US Patent	6,391,910
TTDS00127	Related US Patent	6,476,063
TTDS00127	Related US Patent	6,486,165
TTDS00127	Related US Patent	6,492,351
TTDS00127	Related US Patent	6,500,824
TTDS00127	Related US Patent	6,525,062
TTDS00127	Related US Patent	6,528,518
TTDS00127	Related US Patent	6,624,313
TTDS00127	Related US Patent	R,E38,,13
TTDS00127	Target Validation	TTDS00127
TTDS00127	Drug(s)	Asimadoline
TTDS00127	Drug(s)	Dezocine
TTDS00127	Drug(s)	GNTI
TTDS00127	Inhibitor	(-)-cyclorphan
TTDS00127	Inhibitor	6-desoxonaltrexone
TTDS00127	Inhibitor	6beta-naltrexol HCl
TTDS00127	Inhibitor	ANISOCOUMARIN H
TTDS00127	Inhibitor	BUTORPHAN
TTDS00127	Inhibitor	BW-373U86;SNC-86
TTDS00127	Inhibitor	Benzyl derivative of M6G
TTDS00127	Inhibitor	CCDC 710249, HCl salt
TTDS00127	Inhibitor	CHLOROXINE
TTDS00127	Inhibitor	CLIOQUINOL
TTDS00127	Inhibitor	CYCLAZOCINE
TTDS00127	Inhibitor	CYCLORPHAN
TTDS00127	Inhibitor	DAMGO
TTDS00127	Inhibitor	DM6S
TTDS00127	Inhibitor	DPDPE
TTDS00127	Inhibitor	DYNORPHIN A
TTDS00127	Inhibitor	Dimepheptanol
TTDS00127	Inhibitor	Dynorphin(1-8)
TTDS00127	Inhibitor	ELAEOCARPENINE
TTDS00127	Inhibitor	ENDOMORPHIN 2
TTDS00127	Inhibitor	ENDOMORPHIN-1
TTDS00127	Inhibitor	ETONITAZENE
TTDS00127	Inhibitor	FALCARINDIOL
TTDS00127	Inhibitor	HERKINORIN
TTDS00127	Inhibitor	ICI-199441
TTDS00127	Inhibitor	ICI-204448
TTDS00127	Inhibitor	KETOCYCLAZOCINE
TTDS00127	Inhibitor	KNT-62
TTDS00127	Inhibitor	KNT-63
TTDS00127	Inhibitor	LOFENTANIL
TTDS00127	Inhibitor	LY-255582
TTDS00127	Inhibitor	M3A6S
TTDS00127	Inhibitor	M3IBu6S
TTDS00127	Inhibitor	M3P6S
TTDS00127	Inhibitor	M3Pr6S
TTDS00127	Inhibitor	M6S
TTDS00127	Inhibitor	MC-CAM
TTDS00127	Inhibitor	MCL-117
TTDS00127	Inhibitor	MCL-139
TTDS00127	Inhibitor	MCL-144
TTDS00127	Inhibitor	MCL-145
TTDS00127	Inhibitor	MCL-147
TTDS00127	Inhibitor	MCL-149
TTDS00127	Inhibitor	MCL-154
TTDS00127	Inhibitor	MCL-182
TTDS00127	Inhibitor	MCL-183
TTDS00127	Inhibitor	MCL-428
TTDS00127	Inhibitor	MCL-429
TTDS00127	Inhibitor	MCL-431
TTDS00127	Inhibitor	MCL-432
TTDS00127	Inhibitor	MCL-433
TTDS00127	Inhibitor	MCL-434
TTDS00127	Inhibitor	MCL-435
TTDS00127	Inhibitor	MCL-443
TTDS00127	Inhibitor	MCL-444
TTDS00127	Inhibitor	MCL-445
TTDS00127	Inhibitor	MCL-446
TTDS00127	Inhibitor	MCL-447
TTDS00127	Inhibitor	MCL-448
TTDS00127	Inhibitor	MCL-449
TTDS00127	Inhibitor	MCL-450
TTDS00127	Inhibitor	MCL-451
TTDS00127	Inhibitor	MCL-457
TTDS00127	Inhibitor	MCL-458
TTDS00127	Inhibitor	METAZOCINE
TTDS00127	Inhibitor	MK-1925
TTDS00127	Inhibitor	MORPHINE SULFATE
TTDS00127	Inhibitor	MR-1029
TTDS00127	Inhibitor	MR-1526
TTDS00127	Inhibitor	MR-2034
TTDS00127	Inhibitor	MR-2266
TTDS00127	Inhibitor	NALFURAFINE
TTDS00127	Inhibitor	NORBINALTORPHIMINE
TTDS00127	Inhibitor	NalBzOH
TTDS00127	Inhibitor	OXYMORPHINDOLE
TTDS00127	Inhibitor	PHENAZOCINE
TTDS00127	Inhibitor	RTI-5989-23
TTDS00127	Inhibitor	RTI-5989-25
TTDS00127	Inhibitor	RTI-5989-31
TTDS00127	Inhibitor	SALVINICIN B
TTDS00127	Inhibitor	SALVINORIN A
TTDS00127	Inhibitor	SALVINORIN B
TTDS00127	Inhibitor	SB-213698;TAN-67
TTDS00127	Inhibitor	SN-11
TTDS00127	Inhibitor	SN-23
TTDS00127	Inhibitor	SN-28
TTDS00127	Inhibitor	Salvinorin A (ester)
TTDS00127	Inhibitor	TRK-820
TTDS00127	Inhibitor	U-69593
TTDS00127	Inhibitor	ZYKLOPHIN
TTDS00127	Inhibitor	[Leu5]enkephalin
TTDS00127	Inhibitor	clocinnamox
TTDS00127	Inhibitor	salvinicin A
TTDS00127	Antagonist	7684380
TTDS00127	Antagonist	Beta-endorphin
TTDS00127	Antagonist	Dezocine
TTDS00127	Antagonist	Diprenorphine
TTDS00127	Antagonist	GNTI
TTDS00127	Antagonist	L-685,818
TTDS00127	Antagonist	Rapamycin
TTDS00127	Antagonist	[U-13C]ascomycin
TTDS00127	Agonist	3-Methylfentanyl
TTDS00127	Agonist	3-Methylthiofentanyl
TTDS00127	Agonist	Asimadoline
TTDS00127	Agonist	BRL 52537 hydrochloride
TTDS00127	Agonist	BRL 52974
TTDS00127	Agonist	Carfentanil
TTDS00127	Agonist	Dihydromorphine
TTDS00127	Agonist	Etorphine
TTDS00127	Agonist	Fedotozine
TTDS00127	Agonist	Nalorphine
TTDS00127	Agonist	U-50488H
TTDS00127	Agonist	U50,488H
TTDS00128	UniProt ID	P41143
TTDS00128	Name	Delta-type opioid receptor
TTDS00128	Type of target	Successful target
TTDS00128	Synonyms	DOR-1
TTDS00128	Synonyms	Delta opioid receptor
TTDS00128	Disease	Analgesics
TTDS00128	Disease	Cough
TTDS00128	Disease	Dyspnea
TTDS00128	Disease	Ischemia
TTDS00128	Disease	Pain, unspecified
TTDS00128	Disease	Parkinson's disease
TTDS00128	Function	Inhibits neurotransmitter release by reducing calcium ion currents and increasin
TTDS00128	Sequence	MEPAPSAGAELQPPLFANASDAYPSAFPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKM
TTDS00128	PDB Structure	1OZC; 2IQM
TTDS00128	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00128	Pathway	Neuroactive ligand-receptor interaction
TTDS00128	Related US Patent	6,630,462
TTDS00128	Related US Patent	6,680,318
TTDS00128	Related US Patent	6,790,854
TTDS00128	Target Validation	TTDS00128
TTDS00128	Drug(s)	BIO-306
TTDS00128	Drug(s)	Butorphanol
TTDS00128	Drug(s)	Codeine
TTDS00128	Drug(s)	Divers drug
TTDS00128	Drug(s)	Hydrocodone
TTDS00128	Drug(s)	Hydromorphone
TTDS00128	Drug(s)	Loperamide
TTDS00128	Drug(s)	Nalbuphine
TTDS00128	Drug(s)	Naltrexone
TTDS00128	Drug(s)	Oxycodone
TTDS00128	Inhibitor	(-)-cyclorphan
TTDS00128	Inhibitor	(-)-eseroline
TTDS00128	Inhibitor	(-)-isoelaeocarpiline
TTDS00128	Inhibitor	6-cinnamoylhernandine
TTDS00128	Inhibitor	6-desoxonaltrexone
TTDS00128	Inhibitor	6beta-naltrexol HCl
TTDS00128	Inhibitor	8-carboxamidocyclazocine
TTDS00128	Inhibitor	AKNADILACTAM
TTDS00128	Inhibitor	AMINOFENTANYL
TTDS00128	Inhibitor	BIPHALIN
TTDS00128	Inhibitor	BUTORPHAN
TTDS00128	Inhibitor	CARBOXYFENTANYL
TTDS00128	Inhibitor	CYCLAZOCINE
TTDS00128	Inhibitor	CYCLORPHAN
TTDS00128	Inhibitor	DAMGO
TTDS00128	Inhibitor	DELTORPHIN
TTDS00128	Inhibitor	DELTORPHIN-II
TTDS00128	Inhibitor	DERMORPHIN
TTDS00128	Inhibitor	Dimepheptanol
TTDS00128	Inhibitor	FALCARINDIOL
TTDS00128	Inhibitor	GUANIDINONALTRINDOLE
TTDS00128	Inhibitor	Grandisine C
TTDS00128	Inhibitor	Grandisine F
TTDS00128	Inhibitor	HERKINORIN
TTDS00128	Inhibitor	ICI-174864
TTDS00128	Inhibitor	ICI-199441
TTDS00128	Inhibitor	MC-CAM
TTDS00128	Inhibitor	MCL-117
TTDS00128	Inhibitor	MCL-139
TTDS00128	Inhibitor	MCL-144
TTDS00128	Inhibitor	MCL-145
TTDS00128	Inhibitor	MCL-147
TTDS00128	Inhibitor	MCL-149
TTDS00128	Inhibitor	MCL-153;MCL-154
TTDS00128	Inhibitor	MCL-154
TTDS00128	Inhibitor	MCL-182
TTDS00128	Inhibitor	MCL-183
TTDS00128	Inhibitor	MCL-428
TTDS00128	Inhibitor	MCL-429
TTDS00128	Inhibitor	MCL-431
TTDS00128	Inhibitor	MCL-432
TTDS00128	Inhibitor	MCL-433
TTDS00128	Inhibitor	MCL-434
TTDS00128	Inhibitor	MCL-435
TTDS00128	Inhibitor	MCL-443
TTDS00128	Inhibitor	MCL-444
TTDS00128	Inhibitor	MCL-445
TTDS00128	Inhibitor	MCL-446
TTDS00128	Inhibitor	MCL-447
TTDS00128	Inhibitor	MCL-448
TTDS00128	Inhibitor	MCL-449
TTDS00128	Inhibitor	MCL-450
TTDS00128	Inhibitor	MCL-451
TTDS00128	Inhibitor	MCL-458
TTDS00128	Inhibitor	RTI-5989-23
TTDS00128	Inhibitor	RTI-5989-25
TTDS00128	Inhibitor	RTI-5989-31
TTDS00128	Inhibitor	SALVINORIN A
TTDS00128	Inhibitor	SB-0304
TTDS00128	Inhibitor	SN-11
TTDS00128	Inhibitor	SN-23
TTDS00128	Inhibitor	SN-28
TTDS00128	Inhibitor	SNF-9007
TTDS00128	Inhibitor	UFP-502
TTDS00128	Inhibitor	UFP-512
TTDS00128	Inhibitor	[Leu5]enkephalin
TTDS00128	Inhibitor	clocinnamox
TTDS00128	Inhibitor	deltorphin C
TTDS00128	Inhibitor	grandisine D
TTDS00128	Antagonist	7-benzylidenenaltrexone
TTDS00128	Antagonist	Diprenorphine
TTDS00128	Antagonist	HS 378
TTDS00128	Antagonist	ICI 154129
TTDS00128	Antagonist	Nalbuphine
TTDS00128	Antagonist	Naltrexone
TTDS00128	Antagonist	Naltrindole
TTDS00128	Antagonist	TIP
TTDS00128	Antagonist	TIPP
TTDS00128	Agonist	3-Methylfentanyl
TTDS00128	Agonist	3-Methylthiofentanyl
TTDS00128	Agonist	BIO-306
TTDS00128	Agonist	BW 373U86
TTDS00128	Agonist	Beta-endorphin
TTDS00128	Agonist	Butorphanol
TTDS00128	Agonist	Carfentanil
TTDS00128	Agonist	Codeine
TTDS00128	Agonist	DADLE
TTDS00128	Agonist	Dihydromorphine
TTDS00128	Agonist	Dimethylthiambutene
TTDS00128	Agonist	Divers drug
TTDS00128	Agonist	Etorphine
TTDS00128	Agonist	Hydrocodone
TTDS00128	Agonist	Oxycodone
TTDS00128	Agonist	SB 227122
TTDS00128	Agonist	SNC-80
TTDS00128	Agonist	Tonazocine mesylate
TTDS00128	Binder	Hydromorphone
TTDS00128	Binder	Loperamide
TTDS00129	UniProt ID	Q99720
TTDS00129	Name	Sigma(1)-type opioid receptor
TTDS00129	Type of target	Successful target
TTDS00129	Synonyms	OPRS1 protein
TTDS00129	Synonyms	Opioid receptor, sigma 1, isoform 1
TTDS00129	Synonyms	SR31747 binding protein 1
TTDS00129	Disease	Neuropsychiatric disorders
TTDS00129	Sequence	MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQ
TTDS00129	BioChemical Class	Transmembrane protein
TTDS00129	Target Validation	TTDS00129
TTDS00129	QSAR Model	TTDS00129
TTDS00129	Drug(s)	ANAVEX 1-41
TTDS00129	Drug(s)	ANAVEX 1007
TTDS00129	Drug(s)	ANAVEX 2-73
TTDS00129	Drug(s)	Dextromethorphan
TTDS00129	Drug(s)	E-5842
TTDS00129	Drug(s)	E-6276
TTDS00129	Drug(s)	MS-377
TTDS00129	Drug(s)	NE-100
TTDS00129	Drug(s)	OPC-14523
TTDS00129	Drug(s)	PRX-00023
TTDS00129	Drug(s)	Rimcazole
TTDS00129	Drug(s)	SR-31742A
TTDS00129	Drug(s)	SSR-125047
TTDS00129	Drug(s)	Sigma antagonist
TTDS00129	Inhibitor	DITOLYLGUANIDINE
TTDS00129	Inhibitor	Dimethyltryptamine
TTDS00129	Antagonist	MS-377
TTDS00129	Antagonist	NE-100
TTDS00129	Antagonist	Rimcazole
TTDS00129	Antagonist	Sigma antagonist
TTDS00129	Agonist	ANAVEX 1-41
TTDS00129	Agonist	ANAVEX 1007
TTDS00129	Agonist	ANAVEX 2-73
TTDS00129	Agonist	Dextromethorphan
TTDS00129	Agonist	Dimemorfan
TTDS00129	Agonist	Igmesine
TTDS00129	Agonist	OPC-14523
TTDS00129	Agonist	PRX-00023
TTDS00129	Binder	E-5842
TTDS00129	Binder	E-6276
TTDS00129	Binder	SR-31742A
TTDS00129	Binder	SSR-125047
TTDS00129	Multitarget	ANAVEX 1007
TTDS00129	Multitarget	OPC-14523
TTDS00129	Multitarget	PRX-00023
TTDS00130	Name	Tryptase
TTDS00130	Type of target	Successful target
TTDS00130	Disease	Allergic airway inflammation
TTDS00130	Disease	Asthma
TTDS00130	Disease	Coagulative disorders
TTDS00130	Disease	Conjunctivitis
TTDS00130	Disease	Mast cell-mediated diseases
TTDS00130	Disease	Rhinitis
TTDS00130	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00130	EC Number	EC 3.4.21.59
TTDS00130	Related US Patent	6,469,036
TTDS00130	Related US Patent	6,489,327
TTDS00130	Related US Patent	6,613,769
TTDS00130	Related US Patent	6,630,505
TTDS00130	Related US Patent	6,642,252
TTDS00130	Related US Patent	6,673,786
TTDS00130	Target Validation	TTDS00130
TTDS00130	Drug(s)	Pentamidine
TTDS00130	Inhibitor	AMG-126737
TTDS00130	Inhibitor	APC-366
TTDS00130	Inhibitor	Actoferrin
TTDS00130	Inhibitor	BABIM
TTDS00130	Inhibitor	BMS-262084
TTDS00130	Inhibitor	GRASSYSTATIN A
TTDS00130	Inhibitor	Lactoferrin
TTDS00130	Inhibitor	MOL 6131
TTDS00130	Inhibitor	Pentamidine
TTDS00131	UniProt ID	P01375
TTDS00131	Name	Tumor necrosis factor
TTDS00131	Type of target	Successful target
TTDS00131	Synonyms	Cachectin
TTDS00131	Synonyms	TNF
TTDS00131	Synonyms	TNF alpha
TTDS00131	Synonyms	TNF-a
TTDS00131	Synonyms	TNF-alpha
TTDS00131	Synonyms	TNFalpha
TTDS00131	Synonyms	Tumor necrosis factor ligand superfamily member 2
TTDS00131	Synonyms	Tumor necrosis factor receptor 1
TTDS00131	Synonyms	Tumour necrosis factor
TTDS00131	Synonyms	Tumour necrosis factor alpha
TTDS00131	Disease	Asthma
TTDS00131	Disease	Behcet's disease
TTDS00131	Disease	Chronic inflammatory diseases
TTDS00131	Disease	Congestive heart failure
TTDS00131	Disease	Crohn's disease, unspecified
TTDS00131	Disease	Heart failure
TTDS00131	Disease	Hyperimmunoglobulinemia D
TTDS00131	Disease	Noninsulin-dependent diabetes mellitus
TTDS00131	Disease	Periodic fever syndrome
TTDS00131	Disease	Rheumatic diseases
TTDS00131	Disease	Rheumatoid arthritis, unspecified
TTDS00131	Disease	Solid tumor
TTDS00131	Function	Cytokine that binds to tnfrsf1a/tnfr1 and tnfrsf1b/tnfbr. It is mainly secreted
TTDS00131	Sequence	MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSS
TTDS00131	PDB Structure	1A8M; 1TNF; 2AZ5; 2E7A; 2TUN; 2ZJC; 2ZPX; 3ALQ; 3IT8; 3L9J; 4G3Y; 4TSV; 5TSW
TTDS00131	BioChemical Class	Transmembrane protein
TTDS00131	Pathway	Adipocytokine signaling pathway
TTDS00131	Pathway	Allograft rejection
TTDS00131	Pathway	Alzheimer's disease
TTDS00131	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDS00131	Pathway	Apoptosis
TTDS00131	Pathway	Asthma
TTDS00131	Pathway	Cytokine-cytokine receptor interaction
TTDS00131	Pathway	Fc epsilon RI signaling pathway
TTDS00131	Pathway	Graft-versus-host disease
TTDS00131	Pathway	Hematopoietic cell lineage
TTDS00131	Pathway	MAPK signaling pathway
TTDS00131	Pathway	Natural killer cell mediated cytotoxicity
TTDS00131	Pathway	Systemic lupus erythematosus
TTDS00131	Pathway	T cell receptor signaling pathway
TTDS00131	Pathway	TGF-beta signaling pathway
TTDS00131	Pathway	Toll-like receptor signaling pathway
TTDS00131	Pathway	Type I diabetes mellitus
TTDS00131	Pathway	Type II diabetes mellitus
TTDS00131	Related US Patent	6,162,830
TTDS00131	Related US Patent	6,376,665
TTDS00131	Related US Patent	6,379,666
TTDS00131	Related US Patent	6,419,944
TTDS00131	Related US Patent	6,423,321
TTDS00131	Related US Patent	6,432,962
TTDS00131	Related US Patent	6,455,520
TTDS00131	Related US Patent	6,489,324
TTDS00131	Related US Patent	6,495,548
TTDS00131	Related US Patent	6,495,565
TTDS00131	Related US Patent	6,541,670
TTDS00131	Related US Patent	6,555,710
TTDS00131	Related US Patent	6,566,543
TTDS00131	Related US Patent	6,566,554
TTDS00131	Related US Patent	6,635,250
TTDS00131	Related US Patent	6,642,255
TTDS00131	Target Validation	TTDS00131
TTDS00131	Drug(s)	AN0128
TTDS00131	Drug(s)	ART621
TTDS00131	Drug(s)	Adalimumab
TTDS00131	Drug(s)	CRx-191
TTDS00131	Drug(s)	CYT-609
TTDS00131	Drug(s)	Celastrol
TTDS00131	Drug(s)	Certolizumab
TTDS00131	Drug(s)	Certolizumab pegol
TTDS00131	Drug(s)	CytoFab
TTDS00131	Drug(s)	Etanercept
TTDS00131	Drug(s)	Genz29155
TTDS00131	Drug(s)	Golimumab
TTDS00131	Drug(s)	IP-751
TTDS00131	Drug(s)	Infliximab
TTDS00131	Drug(s)	Lenalidomide
TTDS00131	Drug(s)	Pentoxifylline
TTDS00131	Drug(s)	Pirfenidone
TTDS00131	Drug(s)	RDP-58
TTDS00131	Drug(s)	RDP58
TTDS00131	Drug(s)	Talactoferrin Alfa
TTDS00131	Drug(s)	TgAAC-94
TTDS00131	Drug(s)	Thalidomide
TTDS00131	Inhibitor	AN0128
TTDS00131	Inhibitor	ART621
TTDS00131	Inhibitor	BAICALEIN
TTDS00131	Inhibitor	CRx-191
TTDS00131	Inhibitor	Certolizumab
TTDS00131	Inhibitor	Genz29155
TTDS00131	Inhibitor	IK-682
TTDS00131	Inhibitor	IP-751
TTDS00131	Inhibitor	Isopropyl Alcohol
TTDS00131	Inhibitor	Lenalidomide
TTDS00131	Inhibitor	PKF-241-466
TTDS00131	Inhibitor	PKF-242-484;TNF-484
TTDS00131	Inhibitor	Pirfenidone
TTDS00131	Inhibitor	RDP-58
TTDS00131	Inhibitor	RDP58
TTDS00131	Inhibitor	SB-203580
TTDS00131	Inhibitor	Talactoferrin Alfa
TTDS00131	Inhibitor	TgAAC-94
TTDS00131	Inhibitor	Thalidomide
TTDS00131	Inhibitor	Y-39041
TTDS00131	Suppressor	Celastrol
TTDS00131	Antibody	Adalimumab
TTDS00131	Antibody	Certolizumab pegol
TTDS00131	Antibody	CytoFab
TTDS00131	Antibody	Etanercept
TTDS00131	Antibody	Golimumab
TTDS00131	Antibody	Infliximab
TTDS00131	Antibody	Monoclonal antibodies
TTDS00131	Antibody	Pentoxifylline
TTDS00131	Multitarget	CRx-191
TTDS00131	Multitarget	Pirfenidone
TTDS00132	Name	Immunoglobulin E
TTDS00132	Type of target	Successful target
TTDS00132	Synonyms	IgE
TTDS00132	Disease	Allergic diseases
TTDS00132	Disease	Allergic rhinitis, unspecified
TTDS00132	Disease	Asthma
TTDS00132	Drug(s)	MEDI4212
TTDS00132	Drug(s)	Omalizumab
TTDS00132	Drug(s)	RG7449
TTDS00132	Antibody	Omalizumab
TTDS00132	Antibody	Xolair
TTDS00132	Aptamer	D17.4
TTDS00132	Aptamer	IGEL1.2
TTDS00133	Name	Lyso-PAF: acetyl-CoA acetyltransferase
TTDS00133	Type of target	Successful target
TTDS00133	Synonyms	Acetyl-CoA: 1-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase
TTDS00133	Synonyms	LysoPAF acetyltransferase
TTDS00133	Disease	Allergic diseases
TTDS00133	Disease	Inflammatory diseases
TTDS00133	Target Validation	TTDS00133
TTDS00133	Drug(s)	Quercetin
TTDS00133	Inhibitor	Luteolin
TTDS00133	Inhibitor	Quercetin
TTDS00134	UniProt ID	P14735
TTDS00134	Name	Insulin-degrading Enzyme
TTDS00134	Type of target	Successful target
TTDS00134	Synonyms	IDE
TTDS00134	Synonyms	Insulin protease
TTDS00134	Synonyms	Insulinase
TTDS00134	Synonyms	Insulysin
TTDS00134	Disease	Alzheimer's disease
TTDS00134	Function	May play a role in the cellular processing of insulin. May be involved in interc
TTDS00134	Sequence	MRYRLAWLLHPALPSTFRSVLGARLPPPERLCGFQKKTYSKMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISD
TTDS00134	PDB Structure	2G47; 2G48; 2G49; 2G54; 2G56; 2JBU; 2JG4; 2WBY; 2WC0; 2WK3; 2YPU; 3CWW; 3E4A; 3E
TTDS00134	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00134	Pathway	Alzheimer's disease
TTDS00134	EC Number	EC 3.4.24.56
TTDS00134	Target Validation	TTDS00134
TTDS00134	Drug(s)	Bacitracin
TTDS00134	Inhibitor	Bacitracin
TTDS00134	Inhibitor	GNF-PF-4478
TTDS00135	Name	NMDA receptor
TTDS00135	Type of target	Successful target
TTDS00135	Disease	Alzheimer's disease
TTDS00135	Disease	Amyotrophic lateral sclerosis
TTDS00135	Disease	Analgesics
TTDS00135	Disease	Chronic pain
TTDS00135	Disease	Epilepsy
TTDS00135	Disease	Parkinson's disease
TTDS00135	Disease	Psychosis
TTDS00135	Disease	Stroke
TTDS00135	BioChemical Class	Ion transport
TTDS00135	Pathway	Alzheimer's disease
TTDS00135	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDS00135	Pathway	Calcium signaling pathway
TTDS00135	Pathway	Long-term potentiation
TTDS00135	Pathway	Neuroactive ligand-receptor interaction
TTDS00135	Pathway	Systemic lupus erythematosus
TTDS00135	Related US Patent	6,262,106
TTDS00135	Related US Patent	6,284,774
TTDS00135	Related US Patent	6,448,270
TTDS00135	Related US Patent	6,451,819
TTDS00135	Related US Patent	6,479,553
TTDS00135	Related US Patent	6,495,587
TTDS00135	Related US Patent	6,500,838
TTDS00135	Related US Patent	6,534,525
TTDS00135	Related US Patent	6,548,516
TTDS00135	Related US Patent	6,551,993
TTDS00135	Related US Patent	6,635,270
TTDS00135	Related US Patent	6,642,256
TTDS00135	Related US Patent	6,642,267
TTDS00135	Related US Patent	6,649,605
TTDS00135	Target Validation	TTDS00135
TTDS00135	Drug(s)	ADX-2 series
TTDS00135	Drug(s)	AZD6765
TTDS00135	Drug(s)	Amitriptyline+ketamine
TTDS00135	Drug(s)	Amphetamine
TTDS00135	Drug(s)	Benzphetamine
TTDS00135	Drug(s)	CHF-3381
TTDS00135	Drug(s)	CNS-5161
TTDS00135	Drug(s)	D-cycloserine
TTDS00135	Drug(s)	D-serine
TTDS00135	Drug(s)	Dexanabinol
TTDS00135	Drug(s)	Dextromethorphan+quinidine
TTDS00135	Drug(s)	EAA-090
TTDS00135	Drug(s)	Felbamate
TTDS00135	Drug(s)	Ketamine
TTDS00135	Drug(s)	L-Glutamic Acid
TTDS00135	Drug(s)	Magnesium
TTDS00135	Drug(s)	Magnesium Sulfate
TTDS00135	Drug(s)	Memantine
TTDS00135	Drug(s)	Neramexane
TTDS00135	Drug(s)	Nitrous oxide
TTDS00135	Drug(s)	Orphenadrine
TTDS00135	Drug(s)	Remacemide
TTDS00135	Antagonist	ACEA-1328
TTDS00135	Antagonist	ADX-2 series
TTDS00135	Antagonist	AZD-4282
TTDS00135	Antagonist	AZD6765
TTDS00135	Antagonist	Amitriptyline+ketamine
TTDS00135	Antagonist	Amphetamine
TTDS00135	Antagonist	Aptiganel HCl
TTDS00135	Antagonist	Benzphetamine
TTDS00135	Antagonist	C-101,606
TTDS00135	Antagonist	CHF-3381
TTDS00135	Antagonist	CNS-5161
TTDS00135	Antagonist	Dexanabinol
TTDS00135	Antagonist	Dextromethorphan+quinidine
TTDS00135	Antagonist	Dextrorphan
TTDS00135	Antagonist	EAA-090
TTDS00135	Antagonist	Felbamate
TTDS00135	Antagonist	Huperzine A
TTDS00135	Antagonist	Ketamine
TTDS00135	Antagonist	L-Glutamic Acid
TTDS00135	Antagonist	Magnesium
TTDS00135	Antagonist	Magnesium Sulfate
TTDS00135	Antagonist	Memantine
TTDS00135	Antagonist	Neramexane
TTDS00135	Antagonist	Nitrous oxide
TTDS00135	Antagonist	Orphenadrine
TTDS00135	Antagonist	Selfotel
TTDS00135	Agonist	D-cycloserine
TTDS00135	Agonist	Remacemide
TTDS00135	Modulator	D-serine
TTDS00135	Multitarget	CHF-3381
TTDS00135	Multitarget	Dextromethorphan+quinidine
TTDS00136	Name	Glycogen synthase kinase-3
TTDS00136	Type of target	Successful target
TTDS00136	Synonyms	GSK-3
TTDS00136	Synonyms	Glycogen synthase kinase 3
TTDS00136	Disease	Alzheimer's disease
TTDS00136	Disease	Bipolar affective disorder
TTDS00136	Disease	Cancer, unspecific
TTDS00136	Disease	Chronic inflammatory diseases
TTDS00136	Disease	Noninsulin-dependent diabetes mellitus
TTDS00136	Disease	Stroke
TTDS00136	Disease	Traumatic head injury
TTDS00136	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00136	Pathway	Alzheimer's disease
TTDS00136	Pathway	Axon guidance
TTDS00136	Pathway	B cell receptor signaling pathway
TTDS00136	Pathway	Basal cell carcinoma
TTDS00136	Pathway	Cell cycle
TTDS00136	Pathway	Chemokine signaling pathway
TTDS00136	Pathway	Colorectal cancer
TTDS00136	Pathway	Endometrial cancer
TTDS00136	Pathway	ErbB signaling pathway
TTDS00136	Pathway	Focal adhesion
TTDS00136	Pathway	Hedgehog signaling pathway
TTDS00136	Pathway	Insulin signaling pathway
TTDS00136	Pathway	Melanogenesis
TTDS00136	Pathway	Pathways in cancer
TTDS00136	Pathway	Prostate cancer
TTDS00136	Pathway	T cell receptor signaling pathway
TTDS00136	Pathway	Wnt signaling pathway
TTDS00136	EC Number	EC 2.7.1.37
TTDS00136	Related US Patent	6,608,063
TTDS00136	Related US Patent	6,610,677
TTDS00136	Related US Patent	6,613,776
TTDS00136	Related US Patent	6,638,926
TTDS00136	Related US Patent	6,653,300
TTDS00136	Related US Patent	6,653,301
TTDS00136	Related US Patent	6,656,939
TTDS00136	Related US Patent	6,660,731
TTDS00136	Related US Patent	6,664,247
TTDS00136	Target Validation	TTDS00136
TTDS00136	Drug(s)	LY2090314
TTDS00136	Drug(s)	Lithium
TTDS00136	Drug(s)	Valproate
TTDS00136	Inhibitor	6-bromoindirubin-3'-oxime (BIO)
TTDS00136	Inhibitor	AR-534
TTDS00136	Inhibitor	Benzofuran-3-yl-(indol-3-yl)maleimides
TTDS00136	Inhibitor	Lithium
TTDS00136	Inhibitor	Lithium chloride
TTDS00136	Inhibitor	NP12
TTDS00136	Inhibitor	SB216763
TTDS00136	Inhibitor	Valproate
TTDS00138	UniProt ID	P14778
TTDS00138	Name	Interleukin 1 receptor
TTDS00138	Type of target	Successful target
TTDS00138	Synonyms	IL-1R
TTDS00138	Disease	Rheumatoid arthritis, unspecified
TTDS00138	PDB Structure	1G0Y; 1IRA; 1ITB; 4DEP; 4GAF
TTDS00138	Pathway	Apoptosis
TTDS00138	Pathway	Cytokine-cytokine receptor interaction
TTDS00138	Pathway	Hematopoietic cell lineage
TTDS00138	Pathway	MAPK signaling pathway
TTDS00138	Related US Patent	6,497,870
TTDS00138	Related US Patent	6,541,623
TTDS00138	Related US Patent	6,573,366
TTDS00138	Related US Patent	6,623,736
TTDS00138	Target Validation	TTDS00138
TTDS00138	Drug(s)	Anakinra
TTDS00138	Drug(s)	MEDI-2338
TTDS00138	Drug(s)	MEDI8968
TTDS00138	Antagonist	Anakinra
TTDS00138	Antagonist	SB 203580
TTDS00139	UniProt ID	O15163
TTDS00139	UniProt ID	P01589
TTDS00139	UniProt ID	P14784
TTDS00139	Name	Interleukin-2 receptor
TTDS00139	Type of target	Successful target
TTDS00139	Synonyms	IL-2R
TTDS00139	Disease	Lymphoma
TTDS00139	Disease	Neoplastic diseases
TTDS00139	Sequence	IPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQKERKTTEMQ
TTDS00139	PDB Structure	1ILM; 1ILN; 2B5I; 2ERJ; 3QAZ; 4GS7
TTDS00139	Pathway	Cytokine-cytokine receptor interaction
TTDS00139	Pathway	Endocytosis
TTDS00139	Pathway	Hematopoietic cell lineage
TTDS00139	Pathway	Jak-STAT signaling pathway
TTDS00139	Target Validation	TTDS00139
TTDS00139	Drug(s)	Aldesleukin
TTDS00139	Drug(s)	Basiliximab
TTDS00139	Drug(s)	Daclizumab
TTDS00139	Drug(s)	Denileukin diftitox
TTDS00139	Drug(s)	Inolimomab
TTDS00139	Antagonist	Inolimomab
TTDS00139	Antibody	Basiliximab
TTDS00139	Antibody	Daclizumab
TTDS00139	Modulator	Aldesleukin
TTDS00139	Binder	Denileukin diftitox
TTDS00140	UniProt ID	P22303
TTDS00140	Name	Acetylcholinesterase
TTDS00140	Type of target	Successful target
TTDS00140	Synonyms	AChE
TTDS00140	Disease	Alzheimer's disease
TTDS00140	Disease	Cognitive deficits
TTDS00140	Disease	Hypoxic-ischemic encephalopathy
TTDS00140	Disease	Motor neurone disease
TTDS00140	Disease	Parkinson's disease
TTDS00140	Function	Rapidly hydrolyzes choline released into the synapse.
TTDS00140	Sequence	MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLP
TTDS00140	PDB Structure	1B41; 1F8U; 1PUV; 1PUW; 1VZJ; 2CLJ; 2X8B; 3LII; 4BDT; 4EY4; 4EY5; 4EY6; 4EY7; 4E
TTDS00140	BioChemical Class	Hydrolases acting on ester bonds
TTDS00140	Pathway	Glycerophospholipid metabolism
TTDS00140	EC Number	EC 3.1.1.7
TTDS00140	Target Validation	TTDS00140
TTDS00140	QSAR Model	TTDS00140
TTDS00140	Drug(s)	Ambenonium
TTDS00140	Drug(s)	Demecarium bromide
TTDS00140	Drug(s)	Donepezil
TTDS00140	Drug(s)	Edrophonium
TTDS00140	Drug(s)	Galantamine
TTDS00140	Drug(s)	Isoflurophate
TTDS00140	Drug(s)	Malathion
TTDS00140	Drug(s)	Neostigmine
TTDS00140	Drug(s)	Physostigmine
TTDS00140	Drug(s)	Pyridostigmine
TTDS00140	Drug(s)	Rivastigmine
TTDS00140	Drug(s)	Tacrine
TTDS00140	Drug(s)	YM443
TTDS00140	Inhibitor	(+/-)-huprineY hydrochloride
TTDS00140	Inhibitor	(-)-Cymserine
TTDS00140	Inhibitor	(-)-HUPERZINE B
TTDS00140	Inhibitor	(-)-Phenserine
TTDS00140	Inhibitor	(-)-Tolserine
TTDS00140	Inhibitor	(-)-huperzine B
TTDS00140	Inhibitor	(R)-tacrine(10)-hupyridone
TTDS00140	Inhibitor	(RS)-tacrine(10)-hupyridone
TTDS00140	Inhibitor	(S)-tacrine(10)-hupyridone
TTDS00140	Inhibitor	(S,S)-(-)-bis(10)-hupyridone
TTDS00140	Inhibitor	(S,S)-(-)-bis(12)-hupyridone
TTDS00140	Inhibitor	10-Hydroxy-infractopicrin
TTDS00140	Inhibitor	7-methoxytacrine
TTDS00140	Inhibitor	AP-2238
TTDS00140	Inhibitor	AP-2243
TTDS00140	Inhibitor	Ambenonium
TTDS00140	Inhibitor	BENZOQUINONE
TTDS00140	Inhibitor	BIS(12)-HUPERZINE B
TTDS00140	Inhibitor	BIS(16)-HUPERZINE B
TTDS00140	Inhibitor	BIS(18)-HUPERZINE B
TTDS00140	Inhibitor	BIS(20)-HUPERZINE B
TTDS00140	Inhibitor	BIS(8)-HUPERZINE B
TTDS00140	Inhibitor	BIS(9)-HUPERZINE B
TTDS00140	Inhibitor	BW-28C51
TTDS00140	Inhibitor	Bis(14)-Huperzine B
TTDS00140	Inhibitor	Bis-7-tacrine
TTDS00140	Inhibitor	But-3-enyl-trimethyl-ammonium; bromide
TTDS00140	Inhibitor	CAPROCTAMINE
TTDS00140	Inhibitor	CHF-2819
TTDS00140	Inhibitor	CHLORANIL
TTDS00140	Inhibitor	CHLORPYRIFOS
TTDS00140	Inhibitor	CHOLINE IODIDE
TTDS00140	Inhibitor	CLEBOPRIDE
TTDS00140	Inhibitor	CORONARIDINE
TTDS00140	Inhibitor	CRYPTADINE B
TTDS00140	Inhibitor	Caproctamine HCl
TTDS00140	Inhibitor	Chlorphrifos oxon
TTDS00140	Inhibitor	DECIDIUM
TTDS00140	Inhibitor	Demecarium bromide
TTDS00140	Inhibitor	Donepezil
TTDS00140	Inhibitor	EDROPHONIUM BROMIDE
TTDS00140	Inhibitor	ETHYLPHENSERINE
TTDS00140	Inhibitor	Edrophonium
TTDS00140	Inhibitor	Ethyl octylfluorophosphonate
TTDS00140	Inhibitor	Fucose
TTDS00140	Inhibitor	GALANTAMINE HYDROBROMIDE
TTDS00140	Inhibitor	GALLAMINE
TTDS00140	Inhibitor	GANSTIGMINE
TTDS00140	Inhibitor	GENESERINE
TTDS00140	Inhibitor	Galantamine
TTDS00140	Inhibitor	HALOXYSTEROL A
TTDS00140	Inhibitor	HALOXYSTEROL B
TTDS00140	Inhibitor	HEPTYPHYSOSTIGMINE
TTDS00140	Inhibitor	Hexyl-trimethyl-ammonium; iodide
TTDS00140	Inhibitor	Huperaine A
TTDS00140	Inhibitor	Huperzine A
TTDS00140	Inhibitor	Huprine Y
TTDS00140	Inhibitor	Huprine-Tacrine Heterodimer
TTDS00140	Inhibitor	INFRACTOPICRIN
TTDS00140	Inhibitor	Icopezil maleate
TTDS00140	Inhibitor	Isoflurophate
TTDS00140	Inhibitor	Isopropyl dodecylfluorophosphonate
TTDS00140	Inhibitor	Isosorbide-2-benzylcarbamate-5-tosylate
TTDS00140	Inhibitor	Isosorbide-di-(4-nitrophenyl carbamate)
TTDS00140	Inhibitor	Isosorbide-di-(benzylcarbamate)
TTDS00140	Inhibitor	Isosorbide-di-(ethylcarbamate)
TTDS00140	Inhibitor	Isosorbide-di-phenylcarbamate
TTDS00140	Inhibitor	LAWSARITOL
TTDS00140	Inhibitor	LIPOCRINE
TTDS00140	Inhibitor	LYSICAMINE
TTDS00140	Inhibitor	MEMOQUIN
TTDS00140	Inhibitor	MESUAGENIN A
TTDS00140	Inhibitor	MESUAGENIN B
TTDS00140	Inhibitor	MF268
TTDS00140	Inhibitor	Malathion
TTDS00140	Inhibitor	Mesuagenin D
TTDS00140	Inhibitor	Methyl Phosphinic Acid
TTDS00140	Inhibitor	Methylphosphonic Acid Ester Group
TTDS00140	Inhibitor	Monoisopropylphosphorylserine
TTDS00140	Inhibitor	N-(14-methylallyl)norgalanthamine
TTDS00140	Inhibitor	N-ALLYLNORGALANTHAMINE
TTDS00140	Inhibitor	N-allylnorlitebamine
TTDS00140	Inhibitor	N-benzylnorlitebamine
TTDS00140	Inhibitor	N-butylnorlitebamine
TTDS00140	Inhibitor	N-isobutylnorlitebamine
TTDS00140	Inhibitor	N-isopropylnorlitebamine
TTDS00140	Inhibitor	N-isopropylnorlitebamineN-methoiodide
TTDS00140	Inhibitor	N-propylnorlitebamine
TTDS00140	Inhibitor	NSC-23180
TTDS00140	Inhibitor	Neostigmine
TTDS00140	Inhibitor	OBIDOXIME
TTDS00140	Inhibitor	PARAOXON
TTDS00140	Inhibitor	PHENSERINE
TTDS00140	Inhibitor	Petrosamine
TTDS00140	Inhibitor	Physostigmine
TTDS00140	Inhibitor	Physostigmine salicylate
TTDS00140	Inhibitor	Propidium
TTDS00140	Inhibitor	Pyridostigmine
TTDS00140	Inhibitor	Pyridostigmine bromide
TTDS00140	Inhibitor	QUILOSTIGMINE
TTDS00140	Inhibitor	RIVASTIGMINE TARTRATE
TTDS00140	Inhibitor	Rivastigmine
TTDS00140	Inhibitor	TACRINE(8)-4-AMINOQUINOLINE
TTDS00140	Inhibitor	TASPINE
TTDS00140	Inhibitor	TERRITREM B
TTDS00140	Inhibitor	THIOCTIC ACID
TTDS00140	Inhibitor	TOLSERINE
TTDS00140	Inhibitor	TRIMEDOXIME
TTDS00140	Inhibitor	TURBINATINE
TTDS00140	Inhibitor	Tacrine
TTDS00140	Inhibitor	Tetraethylene Glycol
TTDS00140	Inhibitor	Trimethyl-(3-nitro-phenyl)-ammonium; iodide
TTDS00140	Inhibitor	Trimethyl-(4-oxo-pentyl)-ammonium; iodide
TTDS00140	Inhibitor	VELNACRINE
TTDS00140	Inhibitor	VOACANGINE
TTDS00140	Inhibitor	XANTHOSTIGMINE
TTDS00140	Inhibitor	beta-L-fucose
TTDS00140	Inhibitor	carinatumins B (2)
TTDS00140	Inhibitor	galanthamine derivative
TTDS00140	Inhibitor	haloxysterol C
TTDS00140	Inhibitor	haloxysterol D
TTDS00140	Inhibitor	huprine X
TTDS00140	Inhibitor	iso-OMPA
TTDS00140	Inhibitor	palmatine trifluoroacetate
TTDS00140	Inhibitor	pseudocolumbamine trifluoroacetate
TTDS00140	Inhibitor	pseudopalmatine trifluoroacetate
TTDS00141	UniProt ID	P43681
TTDS00141	Name	Neuronal acetylcholine receptor protein, alpha-4 chain
TTDS00141	Type of target	Successful target
TTDS00141	Synonyms	Alpha-4 nAChR
TTDS00141	Synonyms	Nicotinic acetylcholine receptor alpha4
TTDS00141	Disease	Alzheimer's disease
TTDS00141	Disease	Analgesics
TTDS00141	Disease	Drug dependence
TTDS00141	Disease	Frontal lobe epilepsy
TTDS00141	Disease	Neurodegenerative diseases
TTDS00141	Disease	Pain
TTDS00141	Function	After binding acetylcholine, the achr responds by an extensive change in conform
TTDS00141	Sequence	MELGGPGAPRLLPPLLLLLGTGLLRASSHVETRAHAEERLLKKLFSGYNKWSRPVANISDVVLVRFGLSIAQLIDVDEKN
TTDS00141	PDB Structure	2GVT; 2LLY
TTDS00141	BioChemical Class	Ion transport
TTDS00141	Target Validation	TTDS00141
TTDS00141	Drug(s)	ABT-894
TTDS00141	Drug(s)	AZD1446
TTDS00141	Drug(s)	Ispronicline
TTDS00141	Drug(s)	Pentolinium
TTDS00141	Drug(s)	TC-5619
TTDS00141	Drug(s)	Trimethaphan
TTDS00141	Drug(s)	Varenicline
TTDS00141	Inhibitor	(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol
TTDS00141	Inhibitor	(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol
TTDS00141	Inhibitor	3-[2-(N,N,N-trimethylammonium)ethoxy]pyridine
TTDS00141	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00141	Inhibitor	6'-methylepibatidine
TTDS00141	Inhibitor	BOLDINE
TTDS00141	Inhibitor	CMI-489
TTDS00141	Inhibitor	CYTISINE
TTDS00141	Inhibitor	HOMOEPIBATIDINE
TTDS00141	Inhibitor	N,N-dimethyl(pyridin-3-yl)methanamine
TTDS00141	Inhibitor	N,N-dimethyl-2-(pyridin-3-yloxy)ethanamine
TTDS00141	Inhibitor	N,N-dimethyl-4-(pyridin-3-yl)but-3-yn-1-amine
TTDS00141	Inhibitor	N-ethyl-N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine
TTDS00141	Inhibitor	N-methyl-2-(pyridin-3-yloxy)ethanamine
TTDS00141	Inhibitor	N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine
TTDS00141	Inhibitor	N-methyl-N-(pyridin-3-ylmethyl)ethanamine
TTDS00141	Inhibitor	N-methyllaurotetanine methiodide
TTDS00141	Inhibitor	boldine methiodide
TTDS00141	Inhibitor	glaucine methiodide
TTDS00141	Inhibitor	predicentrine methiodide
TTDS00141	Antagonist	Barbital
TTDS00141	Antagonist	Barbituric acid derivative
TTDS00141	Antagonist	Pentolinium
TTDS00141	Antagonist	Trimethaphan
TTDS00141	Agonist	ABT-418
TTDS00141	Agonist	ABT-594
TTDS00141	Agonist	ABT-894
TTDS00141	Agonist	AZD1446
TTDS00141	Agonist	Ispronicline
TTDS00141	Agonist	TC-5619
TTDS00141	Agonist	Varenicline
TTDS00141	Binder	Nicotine replacement
TTDS00141	Multitarget	ABT-894
TTDS00143	UniProt ID	P06276
TTDS00143	Name	Cholinesterase
TTDS00143	Type of target	Successful target
TTDS00143	Synonyms	Acylcholine acylhydrolase
TTDS00143	Synonyms	BuChE
TTDS00143	Synonyms	Butyrylcholine esterase
TTDS00143	Synonyms	Butyrylcholinesterase
TTDS00143	Synonyms	Choline esterase II
TTDS00143	Synonyms	Pseudocholinesterase
TTDS00143	Disease	Alzheimer's disease
TTDS00143	Disease	Schizophrenia
TTDS00143	Sequence	MHSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKW
TTDS00143	PDB Structure	1EHO; 1EHQ; 1KCJ; 1P0I; 1P0M; 1P0P; 1P0Q; 1XLU; 1XLV; 1XLW; 2J4C; 2PM8; 2WID; 2W
TTDS00143	BioChemical Class	Hydrolases acting on ester bonds
TTDS00143	EC Number	EC 3.1.1.8
TTDS00143	Related US Patent	6,498,255
TTDS00143	Target Validation	TTDS00143
TTDS00143	Drug(s)	Echothiophate Iodide
TTDS00143	Drug(s)	Hexafluronium bromide
TTDS00143	Inhibitor	(+/-)-DEBROMOFLUSTRAMINE B
TTDS00143	Inhibitor	(+/-)-huprineY hydrochloride
TTDS00143	Inhibitor	(-)-Cymserine
TTDS00143	Inhibitor	(-)-DEBROMOFLUSTRAMINE B
TTDS00143	Inhibitor	(-)-Phenethylcymserine
TTDS00143	Inhibitor	(-)-Phenserine
TTDS00143	Inhibitor	(-)-Tolserine
TTDS00143	Inhibitor	(1'H-Phenothiazin-1'-yl)(piperidin-1-yl)methanone
TTDS00143	Inhibitor	(10H-phenothiazin-10-yl)(m-tolyl)methanone
TTDS00143	Inhibitor	(10H-phenothiazin-10-yl)(o-tolyl)methanone
TTDS00143	Inhibitor	(10H-phenothiazin-10-yl)(p-tolyl)methanone
TTDS00143	Inhibitor	(10H-phenothiazin-10-yl)(phenyl)methanone
TTDS00143	Inhibitor	(1R)-MENTHYL HEXYL PHOSPHONATE GROUP
TTDS00143	Inhibitor	(1S)-MENTHYL HEXYL PHOSPHONATE GROUP
TTDS00143	Inhibitor	1,2-NAPHTHOQUINONE
TTDS00143	Inhibitor	1,2-indanedione
TTDS00143	Inhibitor	3-phenyl-cyclosal-d4TMP
TTDS00143	Inhibitor	3-sal-cyclosal-d4TMP
TTDS00143	Inhibitor	5-methyl-cyclosal-d4TMP
TTDS00143	Inhibitor	6-chlorotacrine hydrochloride
TTDS00143	Inhibitor	ACENAPHTHOQUINONE
TTDS00143	Inhibitor	AS-1397
TTDS00143	Inhibitor	Alpha-D-Mannose
TTDS00143	Inhibitor	BENZOQUINONE
TTDS00143	Inhibitor	Beta-D-Mannose
TTDS00143	Inhibitor	Bis-7-tacrine
TTDS00143	Inhibitor	Butanoic Acid
TTDS00143	Inhibitor	Butyrylthiocholine
TTDS00143	Inhibitor	CAPROCTAMINE
TTDS00143	Inhibitor	CHF-2819
TTDS00143	Inhibitor	CHLORANIL
TTDS00143	Inhibitor	Caproctamine HCl
TTDS00143	Inhibitor	Cymserine
TTDS00143	Inhibitor	DEMETHYLDEBROMOFLUSTRAMINE B
TTDS00143	Inhibitor	DODECANESULFONATE ION
TTDS00143	Inhibitor	Diethylphosphono Group
TTDS00143	Inhibitor	ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE
TTDS00143	Inhibitor	Echothiophate Iodide
TTDS00143	Inhibitor	Ethyl Dihydrogen Phosphate
TTDS00143	Inhibitor	Fucose
TTDS00143	Inhibitor	GALANTAMINE HYDROBROMIDE
TTDS00143	Inhibitor	HALOXYSTEROL A
TTDS00143	Inhibitor	HALOXYSTEROL B
TTDS00143	Inhibitor	HEPTYPHYSOSTIGMINE
TTDS00143	Inhibitor	Hexafluronium bromide
TTDS00143	Inhibitor	Huprine-Tacrine Heterodimer
TTDS00143	Inhibitor	LAWSARITOL
TTDS00143	Inhibitor	LIPOCRINE
TTDS00143	Inhibitor	MEMOQUIN
TTDS00143	Inhibitor	MEPTAZINOL
TTDS00143	Inhibitor	MF-8623
TTDS00143	Inhibitor	Methyl Phosphinic Acid
TTDS00143	Inhibitor	Monoisopropyl Ester Phosphonic Acid Group
TTDS00143	Inhibitor	Morpholino(1'H-phenothiazin-1'-yl)methanone
TTDS00143	Inhibitor	N-(Adamant-1-yl)-1'H-phenothiazine-1'-carboxamide
TTDS00143	Inhibitor	NOSTOCARBOLINE
TTDS00143	Inhibitor	NSC-23180
TTDS00143	Inhibitor	PHENSERINE
TTDS00143	Inhibitor	TOLSERINE
TTDS00143	Inhibitor	VAGANINE D
TTDS00143	Inhibitor	XANTHOSTIGMINE
TTDS00143	Inhibitor	anthracen-10-yl(10H-phenothiazin-10-yl)methanone
TTDS00143	Inhibitor	bis-cyclosal-d4TMP
TTDS00143	Inhibitor	cyclosal-d4TMP
TTDS00143	Inhibitor	haloxysterol C
TTDS00143	Inhibitor	haloxysterol D
TTDS00143	Inhibitor	huprine X
TTDS00143	Inhibitor	iso-OMPA
TTDS00143	Inhibitor	m-tolyl 10H-phenothiazine-10-carboxylate
TTDS00143	Inhibitor	methyl 10H-phenothiazine-10-carboxylate
TTDS00143	Inhibitor	p-tolyl 10H-phenothiazine-10-carboxylate
TTDS00143	Inhibitor	phenanthrene-9,10-dione
TTDS00143	Inhibitor	phenyl 10H-phenothiazine-10-carboxylate
TTDS00143	Inhibitor	tert-butyl 10H-phenothiazine-10-carboxylate
TTDS00144	UniProt ID	P19235
TTDS00144	Name	Erythropoietin Receptor
TTDS00144	Type of target	Successful target
TTDS00144	Synonyms	EPO-R
TTDS00144	Synonyms	Full-length form
TTDS00144	Disease	Anemia, unspecified
TTDS00144	Function	Receptor for erythropoietin. Mediates erythropoietin- induced erythroblast proli
TTDS00144	Sequence	MDHLGASLWPQVGSLCLLLAGAAWAPPPNLPDPKFESKAALLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGNYSFS
TTDS00144	PDB Structure	1CN4; 1EBA; 1EBP; 1EER; 1ERN; 2JIX
TTDS00144	BioChemical Class	Transmembrane protein
TTDS00144	Pathway	Cytokine-cytokine receptor interaction
TTDS00144	Pathway	Hematopoietic cell lineage
TTDS00144	Pathway	Jak-STAT signaling pathway
TTDS00144	Target Validation	TTDS00144
TTDS00144	Drug(s)	ARA 290
TTDS00144	Drug(s)	Darbepoetin alfa
TTDS00144	Drug(s)	Epoetin alfa
TTDS00144	Drug(s)	Hematide
TTDS00144	Inhibitor	3,5 DIBROMOTYROSINE
TTDS00144	Agonist	Darbepoetin alfa
TTDS00144	Agonist	Epoetin alfa
TTDS00144	Agonist	Erythropoietin
TTDS00144	Agonist	Hematide
TTDS00145	UniProt ID	O15554
TTDS00145	UniProt ID	Q12791
TTDS00145	Name	Calcium-activated potassium channel
TTDS00145	Type of target	Successful target
TTDS00145	Synonyms	Ca(2+)-activated potassium channel IKCa1
TTDS00145	Synonyms	Ca-activated K channel
TTDS00145	Synonyms	Gardos channel
TTDS00145	Synonyms	HSK4
TTDS00145	Synonyms	IK channel KCNN4
TTDS00145	Synonyms	IK1
TTDS00145	Synonyms	IKCa1
TTDS00145	Synonyms	IKCa1 Ca 2+ -activated K + channel
TTDS00145	Synonyms	Intermediate conductance calcium-activated potassium channel protein 4
TTDS00145	Synonyms	KCNN4
TTDS00145	Synonyms	KCa4
TTDS00145	Synonyms	Putative Gardos channel
TTDS00145	Synonyms	SK4
TTDS00145	Disease	Anemia, unspecified
TTDS00145	Disease	Autoimmune diseases
TTDS00145	Disease	Cystic fibrosis
TTDS00145	Disease	Diarrhea (secretory)
TTDS00145	Disease	Graft-versus-host disease, acute
TTDS00145	Disease	Graft-versus-host disease, chronic
TTDS00145	Disease	Sickle cell anemia
TTDS00145	Function	Forms a voltage-independent potassium channel that is activated by intracellular
TTDS00145	Sequence	MGGDLVLGLGALRRRKRLLEQEKSLAGWALVLAGTGIGLMVLHAEMLWFGGCSWALYLFLVKCTISISTFLLLCLIVAFH
TTDS00145	PDB Structure	2K44; 3MT5; 3NAF
TTDS00145	BioChemical Class	Ion transport
TTDS00145	Target Validation	TTDS00145
TTDS00145	QSAR Model	TTDS00145
TTDS00145	Drug(s)	AVE0118
TTDS00145	Drug(s)	Charybdotoxin
TTDS00145	Drug(s)	Chlorzoxazone
TTDS00145	Drug(s)	Halofantrine
TTDS00145	Drug(s)	ICA-17043
TTDS00145	Drug(s)	Quinine
TTDS00145	Inhibitor	(2-fluorophenyl)-(4-fluorophenyl)phenylacetamide
TTDS00145	Inhibitor	1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole
TTDS00145	Inhibitor	2,2,2-tris-(3-fluorophenyl)-acetamide
TTDS00145	Inhibitor	2,2,2-tris-(4-fluorophenyl)-acetamide
TTDS00145	Inhibitor	2,2-bis-(2-fluorophenyl)-2-phenylacetamide
TTDS00145	Inhibitor	2,2-bis-(3-fluorophenyl)-2-phenylacetamide
TTDS00145	Inhibitor	2-(2,4-difluorophenyl)-2,2-diphenylacetamide
TTDS00145	Inhibitor	2-(2-chlorophenyl)-2,2-diphenylethanamide
TTDS00145	Inhibitor	2-(3,4-Difluorophenyl)-2,2-diphenylacetamide
TTDS00145	Inhibitor	2-fluorophenyl-2,2-diphenylacetamide
TTDS00145	Inhibitor	2-trityl-4,5-dihydrooxazole
TTDS00145	Inhibitor	4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one
TTDS00145	Inhibitor	4-fluorophenyl-2,2-diphenylacetamide
TTDS00145	Inhibitor	5-tosyl-5H-dibenzo[b,d]azepin-7(6H)-one
TTDS00145	Inhibitor	N,N-dimethyl-2,2,2-triphenylacetamide
TTDS00145	Inhibitor	N-ethyl-2,2,2-triphenylacetamide
TTDS00145	Inhibitor	N-methyl-2,2,2-triphenylacetamide
TTDS00145	Inhibitor	TRIPHENYLMETHANAMINE
TTDS00145	Inhibitor	bis(4-fluorophenyl)-2-fluorophenylacetamide
TTDS00145	Inhibitor	bis(4-fluorophenyl)phenylacetamide
TTDS00145	Inhibitor	triphenylacetic acid methyl ester
TTDS00145	Blocker	AVE0118
TTDS00145	Blocker	Charybdotoxin
TTDS00145	Blocker	Halofantrine
TTDS00145	Blocker	ICA-17043
TTDS00145	Blocker	Quinine
TTDS00145	Activator	Chlorzoxazone
TTDS00145	Modulator	BMS-204352
TTDS00147	UniProt ID	Q12809
TTDS00147	Name	Potassium voltage-gated channel subfamily H member 2
TTDS00147	Type of target	Successful target
TTDS00147	Synonyms	Eag homolog
TTDS00147	Synonyms	Eag related protein 1
TTDS00147	Synonyms	Erg1
TTDS00147	Synonyms	Ether-a-go-go related gene potassium channel 1
TTDS00147	Synonyms	Ether-a-go-go related protein 1
TTDS00147	Synonyms	H-ERG
TTDS00147	Synonyms	HERG K+ channel
TTDS00147	Synonyms	Voltage-gated potassium channel subunit Kv11.1
TTDS00147	Disease	Cardiac arrhythmias
TTDS00147	Function	Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium chan
TTDS00147	Sequence	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAA
TTDS00147	PDB Structure	1BYW; 1UJL; 2L0W; 2L1M; 2L4R; 2LE7; 4HP9; 4HQA
TTDS00147	BioChemical Class	Voltage-gated channel
TTDS00147	Target Validation	TTDS00147
TTDS00147	Drug(s)	Amiodarone
TTDS00147	Drug(s)	Dofetilide
TTDS00147	Drug(s)	HP-184
TTDS00147	Drug(s)	Propafenone
TTDS00147	Inhibitor	(1R,5R)-30-OXO-19-OXA-2,6,10,12-TETRAAZAHEXACYCLO[18.6.2.1^{2,5}.1^{14,18}.0^{8,
TTDS00147	Inhibitor	(2R)-N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PY
TTDS00147	Inhibitor	(E)-2-(4-fluorostyryl)-5-(phenylsulfinyl)pyridine
TTDS00147	Inhibitor	(R)-3-(naphthalen-2-ylmethoxy)pyrrolidine
TTDS00147	Inhibitor	(R)-6-(2-(2-methylpyrrolidin-1-yl)ethyl)quinoline
TTDS00147	Inhibitor	(R)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide
TTDS00147	Inhibitor	(R)-ONDANSETRON
TTDS00147	Inhibitor	(S)-3-(naphthalen-2-ylmethoxy)pyrrolidine
TTDS00147	Inhibitor	1,6-bis(4-(3-chlorophenyl)piperazin-1-yl)hexane
TTDS00147	Inhibitor	1,6-bis(4-(3-methoxyphenyl)piperazin-1-yl)hexane
TTDS00147	Inhibitor	1,6-bis(4-m-tolylpiperazin-1-yl)hexane
TTDS00147	Inhibitor	1,6-bis(4-phenylpiperazin-1-yl)hexane
TTDS00147	Inhibitor	1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMER
TTDS00147	Inhibitor	1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMER
TTDS00147	Inhibitor	1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine
TTDS00147	Inhibitor	1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX)
TTDS00147	Inhibitor	1-(2-(6-fluoronaphthalen-2-yl)ethyl)piperazine
TTDS00147	Inhibitor	1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane
TTDS00147	Inhibitor	1-(4-p-Tolyl-butyl)-piperidine
TTDS00147	Inhibitor	2-Phenyl-3-piperidin-3-yl-1H-indole
TTDS00147	Inhibitor	2-Phenyl-3-piperidin-4-yl-1H-indole
TTDS00147	Inhibitor	2-[4-(2-Piperidin-1-ylethyl)phenoxy]benzothiazole
TTDS00147	Inhibitor	3 9-DIHYDRO-N-DESMETHYL-N-ISOPROPYLERYTHROMYCIN A
TTDS00147	Inhibitor	3-(1-Benzyl-piperidin-3-yl)-2-phenyl-1H-indole
TTDS00147	Inhibitor	3-(1-Methyl-piperidin-2-yl)-2-phenyl-1H-indole
TTDS00147	Inhibitor	3-(1-Methyl-piperidin-3-yl)-2-phenyl-1H-indole
TTDS00147	Inhibitor	3-(1-Phenethyl-piperidin-3-yl)-2-phenyl-1H-indole
TTDS00147	Inhibitor	3-(1-Phenethyl-piperidin-4-yl)-2-phenyl-1H-indole
TTDS00147	Inhibitor	3-(1H-indol-3-yl)-N-methyl-3-phenylpropan-1-amine
TTDS00147	Inhibitor	3-(benzo[b]thiophen-5-yl)-3-benzylpyrrolidine
TTDS00147	Inhibitor	3-(dimethylamino)-1-(4-heptylphenyl)propan-1-one
TTDS00147	Inhibitor	4-((naphthalen-2-yloxy)methyl)piperidine
TTDS00147	Inhibitor	4-(2-thienyl)benzene-1,2-diamine
TTDS00147	Inhibitor	4-(3-thienyl)benzene-1,2-diamine)
TTDS00147	Inhibitor	4-(Spiro[chromene-2,4'-piperidine]-4-yl)benzamide
TTDS00147	Inhibitor	4-(Spiro[chromene-2,4'-piperidine]-4-yl)phenol
TTDS00147	Inhibitor	4-(p-Tolyl)spiro[chromene-2,4'-piperidine]
TTDS00147	Inhibitor	4-Benzenesulfonyl-1-(3-phenyl-propyl)-piperidine
TTDS00147	Inhibitor	4-Benzenesulfonyl-1-phenethyl-piperidine
TTDS00147	Inhibitor	4-Phenylspiro[chromene-2,4'-piperidine]
TTDS00147	Inhibitor	5-(3-(4-fluorobenzyl)pyrrolidin-3-yl)-1H-indole
TTDS00147	Inhibitor	5-(3-BENZYLPYRROLIDIN-3-YL)-1H-INDOLE (STRUCTURAL MIX)
TTDS00147	Inhibitor	5-(3-benzylpyrrolidin-3-yl)-1-methyl-1H-indole
TTDS00147	Inhibitor	5-(3-butylpyrrolidin-3-yl)-1H-indole
TTDS00147	Inhibitor	5-Chloro-3-ethyl-1-(4-fluoro-phenyl)-1H-indole
TTDS00147	Inhibitor	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(HYDROXYMETHYL)-1,2,2-TRIMETHYL-1,2,
TTDS00147	Inhibitor	7-(piperidin-4-ylmethoxy)-2-naphthonitrile
TTDS00147	Inhibitor	8-azabicyclo[3.2.1]octan-3-yloxy-benzamide
TTDS00147	Inhibitor	ABT-229
TTDS00147	Inhibitor	ADS-103253
TTDS00147	Inhibitor	AZD-5438
TTDS00147	Inhibitor	BETRIXABAN
TTDS00147	Inhibitor	BI-1356
TTDS00147	Inhibitor	BMS-540215
TTDS00147	Inhibitor	BMS-645737
TTDS00147	Inhibitor	DESETHYL AMODIAQUINE
TTDS00147	Inhibitor	DESMETHEYLASTEMIZOLE
TTDS00147	Inhibitor	DESMETHYLOLANZAPINE
TTDS00147	Inhibitor	E-4031
TTDS00147	Inhibitor	EMD-281014
TTDS00147	Inhibitor	GSK-369796
TTDS00147	Inhibitor	GW-3430
TTDS00147	Inhibitor	ISOQUINE
TTDS00147	Inhibitor	JNJ-10392980
TTDS00147	Inhibitor	MDL-74156
TTDS00147	Inhibitor	MK-1925
TTDS00147	Inhibitor	MK-499
TTDS00147	Inhibitor	N-(4-(benzyloxy)phenethyl)pyridin-4-amine
TTDS00147	Inhibitor	N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[
TTDS00147	Inhibitor	N-(piperidin-4-yl)-N-propyl-2-naphthamide
TTDS00147	Inhibitor	N-DESMETHYLCLOZAPINE
TTDS00147	Inhibitor	N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[
TTDS00147	Inhibitor	NIFEVIROC
TTDS00147	Inhibitor	NITD609
TTDS00147	Inhibitor	NPS-2143;SB-262470A
TTDS00147	Inhibitor	PF-526014
TTDS00147	Inhibitor	R-dimethindene
TTDS00147	Inhibitor	RP-58866
TTDS00147	Inhibitor	RWJ-671818
TTDS00147	Inhibitor	TERIKALANT
TTDS00147	Inhibitor	VESNARINONE
TTDS00147	Inhibitor	VOLINANSERIN
TTDS00147	Inhibitor	ZIPRASIDONE HYDROCHLORIDE
TTDS00147	Inhibitor	[1-(4-p-Tolyl-butyl)-piperidin-4-yl]-methanol
TTDS00147	Blocker	Almokalant
TTDS00147	Blocker	Amiodarone
TTDS00147	Blocker	Desmethylastemizole
TTDS00147	Blocker	Dofetilide
TTDS00147	Blocker	HP-184
TTDS00147	Blocker	Norastemizole
TTDS00147	Blocker	Propafenone
TTDS00147	Multitarget	HP-184
TTDS00148	UniProt ID	P51787
TTDS00148	Name	Potassium voltage-gated channel subfamily KQT member 1
TTDS00148	Type of target	Successful target
TTDS00148	Synonyms	IKs producing slow voltage-gated potassium channel alpha subunit KvLQT1
TTDS00148	Synonyms	KCNQ1 channel
TTDS00148	Synonyms	KQT-like 1
TTDS00148	Synonyms	Kv7.1
TTDS00148	Synonyms	Voltage-gated potassium channel subunit Kv7.1
TTDS00148	Disease	Cardiac arrhythmias
TTDS00148	Function	Probably important in cardiac repolarization. associates with kcne1 (mink) to fo
TTDS00148	Sequence	MAAASSPPRAERKRWGWGRLPGARRGSAGLAKKCPFSLELAEGGPAGGALYAPIAPGAPGPAPPASPAAPAAPPVASDLG
TTDS00148	PDB Structure	3BJ4; 3HFC; 3HFE
TTDS00148	BioChemical Class	Voltage-gated channel
TTDS00148	Pathway	Vibrio cholerae infection
TTDS00148	Target Validation	TTDS00148
TTDS00148	Drug(s)	Indapamide
TTDS00148	Drug(s)	Nerispirdine
TTDS00148	Inhibitor	HMR-1556
TTDS00148	Inhibitor	L-365260
TTDS00148	Inhibitor	L-768673
TTDS00148	Inhibitor	N-(2-Diethylamino-ethyl)-4-hexyloxy-benzamide
TTDS00148	Inhibitor	N-(3,3-Dimethyl-butyl)-4-hexyloxy-benzamide
TTDS00148	Inhibitor	N-(3,3-Dimethyl-butyl)-4-indol-1-yl-benzamide
TTDS00148	Inhibitor	N-(3,3-Dimethyl-cyclopentyl)-4-hexyloxy-benzamide
TTDS00148	Blocker	Indapamide
TTDS00148	Blocker	L-735,821
TTDS00148	Blocker	Nerispirdine
TTDS00149	UniProt ID	P56696
TTDS00149	Name	Potassium voltage-gated channel subfamily KQT member 4
TTDS00149	Type of target	Successful target
TTDS00149	Synonyms	KQT-like 4
TTDS00149	Synonyms	Potassium channel alpha subunit KvLQT4
TTDS00149	Synonyms	Voltage-gated potassium channel subunit Kv7.4
TTDS00149	Disease	Convulsions
TTDS00149	Function	Probably important in the regulation of neuronal excitability. May underlie a po
TTDS00149	Sequence	MAEAPPRRLGLGPPPGDAPRAELVALTAVQSEQGEAGGGGSPRRLGLLGSPLPPGAPLPGPGSGSGSACGQRSSAAHKRY
TTDS00149	PDB Structure	2OVC; 4GOW
TTDS00149	BioChemical Class	Voltage-gated channel
TTDS00149	Target Validation	TTDS00149
TTDS00149	Drug(s)	Retigabine
TTDS00149	Activator	Retigabine
TTDS00150	UniProt ID	P48544
TTDS00150	Name	ATP-sensitive K+ channel
TTDS00150	Type of target	Successful target
TTDS00150	Synonyms	CIR
TTDS00150	Synonyms	Cardiac inward rectifier
TTDS00150	Synonyms	GIRK4
TTDS00150	Synonyms	Heart KATP channel
TTDS00150	Synonyms	Inward rectifier K+ channel Kir3.4
TTDS00150	Synonyms	KATP channel
TTDS00150	Synonyms	KATP-1
TTDS00150	Synonyms	Potassium channel, inwardly rectifying, subfamily J, member 5
TTDS00150	Disease	Hypertonicity of bladder
TTDS00150	Disease	Noninsulin-dependent diabetes mellitus
TTDS00150	Function	This potassium channel is controlled by G proteins. Inward rectifier potassium c
TTDS00150	Sequence	MAGDSRNAMNQDMEIGVTPWDPKKIPKQARDYVPIATDRTRLLAEGKKPRQRYMEKSGKCNVHHGNVQETYRYLSDLFTT
TTDS00150	BioChemical Class	Voltage-gated channel
TTDS00150	Related US Patent	6,610,746
TTDS00150	Target Validation	TTDS00150
TTDS00150	QSAR Model	TTDS00150
TTDS00150	Drug(s)	Dalfampridine
TTDS00150	Drug(s)	Glibenclamide
TTDS00150	Blocker	Dalfampridine
TTDS00150	Blocker	Glibenclamide
TTDS00150	Activator	Cromakalim
TTDS00150	Activator	Levcromakalim
TTDS00153	UniProt ID	P55011
TTDS00153	Name	Na-K-2Cl cotransporter
TTDS00153	Type of target	Successful target
TTDS00153	Synonyms	Basolateral Na-K-Cl symporter
TTDS00153	Synonyms	Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1
TTDS00153	Synonyms	NKCC1
TTDS00153	Synonyms	Na + K + -2Cl - cotransporter
TTDS00153	Disease	Hypertension
TTDS00153	Function	Electrically silent transporter system. Mediates sodium and chloride reabsorptio
TTDS00153	Sequence	MEPRPTAPSSGAPGLAGVGETPSAAALAAARVELPGTAVPSVPEDAAPASRDGGGVRDEGPAAAGDGLGRPLGPTPSQSR
TTDS00153	BioChemical Class	Ion transport
TTDS00153	Pathway	Vibrio cholerae infection
TTDS00153	Target Validation	TTDS00153
TTDS00153	Drug(s)	Aldosterone
TTDS00153	Blocker	Aldosterone
TTDS00155	Name	Sodium channel
TTDS00155	Type of target	Successful target
TTDS00155	Disease	Analgesics
TTDS00155	Disease	Cardiac dysrhythmias
TTDS00155	Disease	Epilepsy
TTDS00155	Disease	Pain, unspecified
TTDS00155	BioChemical Class	Sodium channel
TTDS00155	Target Validation	TTDS00155
TTDS00155	QSAR Model	TTDS00155
TTDS00155	Drug(s)	2339345
TTDS00155	Drug(s)	Benzocaine
TTDS00155	Drug(s)	Bupivacaine
TTDS00155	Drug(s)	Carbamazepine
TTDS00155	Drug(s)	Carisbamate
TTDS00155	Drug(s)	Eslicarbazepine acetate
TTDS00155	Drug(s)	GSK1014802
TTDS00155	Drug(s)	Levobupivacaine
TTDS00155	Drug(s)	Licarbazepine
TTDS00155	Drug(s)	Mepivacaine
TTDS00155	Drug(s)	Oxybuprocaine
TTDS00155	Drug(s)	Pachycarpine; (+)-sparteine
TTDS00155	Drug(s)	Permethrin
TTDS00155	Drug(s)	Phenylbutyrate
TTDS00155	Drug(s)	Phenytoin
TTDS00155	Drug(s)	Ralfinamide
TTDS00155	Drug(s)	Ropivacaine
TTDS00155	Drug(s)	Rufinamide
TTDS00155	Inhibitor	Enecadin
TTDS00155	Inhibitor	Indol-1-yl-propyl-pyridin-4-yl-amine(Besipirdine)
TTDS00155	Inhibitor	LOMERIZINE
TTDS00155	Inhibitor	LUBELUZOLE
TTDS00155	Inhibitor	PD-85639
TTDS00155	Inhibitor	SIPATRIGINE
TTDS00155	Blocker	BN82451
TTDS00155	Blocker	Benzocaine
TTDS00155	Blocker	Bupivacaine
TTDS00155	Blocker	Carbamazepine
TTDS00155	Blocker	Carisbamate
TTDS00155	Blocker	E-2070
TTDS00155	Blocker	Eslicarbazepine
TTDS00155	Blocker	Eslicarbazepine acetate
TTDS00155	Blocker	GSK1014802
TTDS00155	Blocker	Levobupivacaine
TTDS00155	Blocker	Licarbazepine
TTDS00155	Blocker	Mepivacaine
TTDS00155	Blocker	Oxybuprocaine
TTDS00155	Blocker	Permethrin
TTDS00155	Blocker	Phenylbutyrate
TTDS00155	Blocker	Phenytoin
TTDS00155	Blocker	Ralfinamide
TTDS00155	Blocker	Ropivacaine
TTDS00155	Blocker	Rufinamide
TTDS00155	Blocker	Saxitoxin
TTDS00155	Multitarget	Phenylbutyrate
TTDS00155	Multitarget	Ralfinamide
TTDS00156	UniProt ID	Q8NDX3
TTDS00156	Name	Voltage-gated sodium channel
TTDS00156	Type of target	Successful target
TTDS00156	Synonyms	Voltage-sensitive sodium channel
TTDS00156	Disease	Analgesics
TTDS00156	Disease	Epilepsy
TTDS00156	Disease	Injury to spine and spinal cord
TTDS00156	Disease	Pain, unspecified
TTDS00156	Sequence	MDDRCYPVIFPDERNFRPFTSDSLAAIEKRIAIQKEKKKSKDQTGEVPQPRPQLDLKASRKLPKLYGDIPRELIGKPLED
TTDS00156	BioChemical Class	Sodium channel
TTDS00156	Target Validation	TTDS00156
TTDS00156	Drug(s)	HP-184
TTDS00156	Drug(s)	Lacosamide
TTDS00156	Drug(s)	Lamotrigine
TTDS00156	Drug(s)	Lidocaine
TTDS00156	Drug(s)	Oxcarbazepine
TTDS00156	Drug(s)	Riluzole
TTDS00156	Blocker	E-2050
TTDS00156	Blocker	HP-184
TTDS00156	Blocker	Ia Quinidine
TTDS00156	Blocker	Ic Flecainide
TTDS00156	Blocker	Lamotrigine
TTDS00156	Blocker	Lidocaine
TTDS00156	Blocker	Oxcarbazepine
TTDS00156	Blocker	QX-314
TTDS00156	Blocker	Riluzole
TTDS00156	Blocker	SB-221420-A
TTDS00156	Enhancer	Lacosamide
TTDS00156	Multitarget	HP-184
TTDS00157	UniProt ID	Q9Y5Y9
TTDS00157	Name	Voltage-gated sodium channel subunit alpha Nav1.8
TTDS00157	Type of target	Successful target
TTDS00157	Synonyms	PN3
TTDS00157	Synonyms	SNS
TTDS00157	Synonyms	TTX-R sodium channel
TTDS00157	Synonyms	TTX-R/NaV1.8
TTDS00157	Synonyms	Transient tetrodotoxin-resistant Na+ current
TTDS00157	Synonyms	Voltage-gated sodium channel NaV1.8
TTDS00157	Disease	Analgesics
TTDS00157	Disease	Inflammatory diseases
TTDS00157	Disease	Neuropathic pain
TTDS00157	Disease	Pain, unspecified
TTDS00157	BioChemical Class	Sodium channel
TTDS00157	Target Validation	TTDS00157
TTDS00157	Drug(s)	SPI-860
TTDS00157	Drug(s)	Tetracaine
TTDS00157	Inhibitor	A-803467
TTDS00157	Inhibitor	Mu O-conotoxin
TTDS00157	Inhibitor	SPI-860
TTDS00157	Inhibitor	Tetracaine
TTDS00158	UniProt ID	P37088
TTDS00158	Name	Amiloride-sensitive sodium channel alpha-subunit
TTDS00158	Type of target	Successful target
TTDS00158	Synonyms	Alpha ENaC
TTDS00158	Synonyms	Alpha NaCH
TTDS00158	Synonyms	Epithelial Na+ channel alpha subunit
TTDS00158	Synonyms	Nonvoltage-gated sodium channel 1 alpha subunit
TTDS00158	Synonyms	SCNEA
TTDS00158	Disease	Analgesics
TTDS00158	Disease	Convulsions
TTDS00158	Disease	Depression
TTDS00158	Disease	Pain, unspecified
TTDS00158	Disease	Stroke
TTDS00158	Function	Sodium permeable non-voltage-sensitive ion channel inhibited by the diuretic ami
TTDS00158	Sequence	MEGNKLEEQDSSPPQSTPGLMKGNKREEQGLGPEPAAPQQPTAEEEALIEFHRSYRELFEFFCNNTTIHGAIRLVCSQHN
TTDS00158	BioChemical Class	Sodium channel
TTDS00158	Pathway	Taste transduction
TTDS00158	Target Validation	TTDS00158
TTDS00158	Drug(s)	Amiloride
TTDS00158	Drug(s)	Triamterene
TTDS00158	Blocker	Amiloride
TTDS00158	Blocker	Triamterene
TTDS00160	Name	Voltage-dependent L-type calcium channel
TTDS00160	Type of target	Successful target
TTDS00160	Synonyms	L-type Ca(2+) channel
TTDS00160	Synonyms	L-type Ca2+ channel
TTDS00160	Synonyms	L-type voltage-dependent Ca(2+) channel
TTDS00160	Disease	Analgesics
TTDS00160	Disease	Angina pectoris
TTDS00160	Disease	Bronchoconstriction
TTDS00160	Disease	Cardiac dysrhythmias
TTDS00160	Disease	Cardiovascular disease, unspecified
TTDS00160	Disease	Hypertension
TTDS00160	Disease	Iron-overload cardiomyopathy
TTDS00160	Disease	Pain, unspecified
TTDS00160	Disease	Psychiatric illness
TTDS00160	BioChemical Class	Voltage-gated channel
TTDS00160	Pathway	Calcium signaling pathway
TTDS00160	Pathway	MAPK signaling pathway
TTDS00160	Pathway	Type II diabetes mellitus
TTDS00160	Target Validation	TTDS00160
TTDS00160	Drug(s)	Bepridil
TTDS00160	Drug(s)	Cilnidipine
TTDS00160	Drug(s)	Pinaverium bromide
TTDS00160	Blocker	Ajinomoto 1
TTDS00160	Blocker	Ajinomoto 2
TTDS00160	Blocker	Ajinomoto 3
TTDS00160	Blocker	Bepridil
TTDS00160	Blocker	Cilnidipine
TTDS00160	Blocker	Clentiazem
TTDS00160	Blocker	Desmethoxyverapamil
TTDS00160	Blocker	Dihydropyridines
TTDS00160	Blocker	Euro-Celtique 1
TTDS00160	Blocker	Euro-Celtique 2
TTDS00160	Blocker	Euro-Celtique 3
TTDS00160	Blocker	Euro-Celtique 4
TTDS00160	Blocker	JZP-4
TTDS00160	Blocker	Methoxyverapamil
TTDS00160	Blocker	NMED-160
TTDS00160	Blocker	NS-7
TTDS00160	Blocker	Neuromed 2
TTDS00160	Blocker	Neuromed 5
TTDS00160	Blocker	Ono 1
TTDS00160	Blocker	Ono 2
TTDS00160	Blocker	Ono 3
TTDS00160	Blocker	Otilonium bromide
TTDS00160	Blocker	PD173212
TTDS00160	Blocker	PD176078
TTDS00160	Blocker	Parke-Davis 1
TTDS00160	Blocker	Parke-Davis 9
TTDS00160	Blocker	Pinaverium bromide
TTDS00160	Blocker	SQ32,910
TTDS00160	Activator	Bay K 8644
TTDS00160	Activator	S 202 791
TTDS00160	Multitarget	Cilnidipine
TTDS00161	UniProt ID	O43497
TTDS00161	UniProt ID	Q9P0X4
TTDS00161	Name	Voltage-dependent T-type calcium channel alpha-1G subunit
TTDS00161	Type of target	Successful target
TTDS00161	Synonyms	Cav
TTDS00161	Synonyms	Cav3.1c
TTDS00161	Synonyms	NBR13
TTDS00161	Synonyms	Voltage-dependent T-type calcium channel
TTDS00161	Synonyms	Voltage-gated calcium channel alpha subunit Cav3.1
TTDS00161	Disease	Analgesics
TTDS00161	Disease	Angina pectoris
TTDS00161	Disease	Cardiac dysrhythmias
TTDS00161	Disease	Cardiovascular disease, unspecified
TTDS00161	Disease	Epilepsy
TTDS00161	Disease	Heart failure
TTDS00161	Disease	Hypertension
TTDS00161	Disease	Hypoinsulinemia
TTDS00161	Disease	Neuropathic pain
TTDS00161	Function	Voltage-sensitive calcium channels (vscc) mediate the entry of calcium ions into
TTDS00161	Sequence	MDEEEDGAGAEESGQPRSFMRLNDLSGAGGRPGPGSAEKDPGSADSEAEGLPYPALAPVVFFYLSQDSRPRSWCLRTVCN
TTDS00161	BioChemical Class	Voltage-gated channel
TTDS00161	Pathway	Calcium signaling pathway
TTDS00161	Pathway	MAPK signaling pathway
TTDS00161	Pathway	Type II diabetes mellitus
TTDS00161	Target Validation	TTDS00161
TTDS00161	Drug(s)	Ethosuximide
TTDS00161	Drug(s)	Gabapentin enacarbil
TTDS00161	Drug(s)	Methsuximide
TTDS00161	Drug(s)	Mibefradil
TTDS00161	Drug(s)	PD-200390
TTDS00161	Drug(s)	Paramethadione
TTDS00161	Drug(s)	Pregabalin
TTDS00161	Drug(s)	Trimethadione
TTDS00161	Drug(s)	Verapamil
TTDS00161	Inhibitor	KKHT-10318
TTDS00161	Inhibitor	KKHT-10608
TTDS00161	Inhibitor	KKHT-10609
TTDS00161	Inhibitor	KKHT-10613
TTDS00161	Inhibitor	KKHT-10618
TTDS00161	Inhibitor	KKHT-11018
TTDS00161	Inhibitor	KKHT-20718
TTDS00161	Inhibitor	KKHT-20818
TTDS00161	Inhibitor	KKHT-20918
TTDS00161	Inhibitor	KYS-05001
TTDS00161	Inhibitor	KYS-05040
TTDS00161	Inhibitor	KYS-05041
TTDS00161	Inhibitor	KYS-05042
TTDS00161	Inhibitor	KYS-05050
TTDS00161	Inhibitor	KYS-05055
TTDS00161	Inhibitor	KYS-05056
TTDS00161	Inhibitor	KYS-05057
TTDS00161	Inhibitor	KYS-05064
TTDS00161	Inhibitor	KYS-05065
TTDS00161	Inhibitor	KYS-05070
TTDS00161	Inhibitor	KYS-05071
TTDS00161	Inhibitor	KYS-05074
TTDS00161	Inhibitor	KYS-05077
TTDS00161	Inhibitor	KYS-05080
TTDS00161	Inhibitor	KYS-05090
TTDS00161	Inhibitor	cis-N,5-dibenzyl-6-oxomorpholine-3-carboxamide
TTDS00161	Blocker	Alpha-methyl-alpha-phenylsuccinimide (MPS)
TTDS00161	Blocker	Diphenylbutylpiperidines pimozide
TTDS00161	Blocker	Ethosuximide
TTDS00161	Blocker	Methsuximide
TTDS00161	Blocker	Mibefradil
TTDS00161	Blocker	Nickel chloride
TTDS00161	Blocker	Paramethadione
TTDS00161	Blocker	Penfluridol
TTDS00161	Blocker	Trimethadione
TTDS00161	Blocker	Verapamil
TTDS00161	Modulator	Gabapentin enacarbil
TTDS00161	Modulator	PD-200390
TTDS00161	Modulator	Pregabalin
TTDS00163	Name	Calcium channel
TTDS00163	Type of target	Successful target
TTDS00163	Disease	Analgesics
TTDS00163	Disease	Cerebral ischemia
TTDS00163	Disease	Epilepsy
TTDS00163	Disease	Head injury, unspecified
TTDS00163	Disease	Hypertension
TTDS00163	Disease	Pain, unspecified
TTDS00163	Disease	Stroke
TTDS00163	Disease	Unstable angina
TTDS00163	BioChemical Class	Voltage-gated channel
TTDS00163	Pathway	Calcium signaling pathway
TTDS00163	Pathway	MAPK signaling pathway
TTDS00163	Pathway	Taste transduction
TTDS00163	Pathway	Type II diabetes mellitus
TTDS00163	Related US Patent	6,323,243
TTDS00163	Related US Patent	6,334,997
TTDS00163	Related US Patent	6,344,461
TTDS00163	Related US Patent	6,469,038
TTDS00163	Related US Patent	6,492,375
TTDS00163	Related US Patent	6,495,715
TTDS00163	Related US Patent	6,573,280
TTDS00163	Related US Patent	6,617,322
TTDS00163	Related US Patent	6,638,930
TTDS00163	Target Validation	TTDS00163
TTDS00163	QSAR Model	TTDS00163
TTDS00163	Drug(s)	Felodipine
TTDS00163	Drug(s)	MEM-1003
TTDS00163	Drug(s)	Nicardipine
TTDS00163	Drug(s)	Nimodipine
TTDS00163	Drug(s)	Nisoldipine
TTDS00163	Blocker	Felodipine
TTDS00163	Blocker	MEM-1003
TTDS00163	Blocker	Nicardipine
TTDS00163	Blocker	Nimodipine
TTDS00163	Blocker	Nisoldipine
TTDS00164	UniProt ID	P41180
TTDS00164	Name	Extracellular calcium-sensing receptor
TTDS00164	Type of target	Successful target
TTDS00164	Synonyms	CaSR
TTDS00164	Synonyms	Parathyroid Cell calcium-sensing receptor
TTDS00164	Synonyms	Parathyroid calcium receptor
TTDS00164	Synonyms	Parathyroid cell calcium receptor
TTDS00164	Disease	Hyperparathyroidism, unspecified
TTDS00164	Function	Senses changes in the extracellular concentration of calcium ions. The activity
TTDS00164	Sequence	MAFYSCCWVLLALTWHTSAYGPDQRAQKKGDIILGGLFPIHFGVAAKDQDLKSRPESVECIRYNFRGFRWLQAMIFAIEE
TTDS00164	BioChemical Class	G-protein coupled receptor (metabotropic glutamate family)
TTDS00164	Target Validation	TTDS00164
TTDS00164	Drug(s)	AMG 416
TTDS00164	Drug(s)	Cinacalcet
TTDS00164	Drug(s)	MK-5442
TTDS00164	Drug(s)	Ronacaleret
TTDS00164	Inhibitor	2-Furan-2-yl-3-phenethyl-3H-quinazolin-4-one
TTDS00164	Inhibitor	3-Phenethyl-2-phenyl-3H-quinazolin-4-one
TTDS00164	Inhibitor	NPS-2143;SB-262470A
TTDS00164	Antagonist	Ronacaleret
TTDS00164	Agonist	AMG 073
TTDS00164	Agonist	Cinacalcet
TTDS00164	Agonist	NPS 568
TTDS00164	Agonist	R-568
TTDS00165	UniProt ID	P21817
TTDS00165	UniProt ID	Q15413
TTDS00165	UniProt ID	Q92736
TTDS00165	Name	Ryanodine receptor
TTDS00165	Type of target	Successful target
TTDS00165	Synonyms	Brain ryanodine receptor-calcium release channel
TTDS00165	Synonyms	Brain-type ryanodine receptor
TTDS00165	Synonyms	Cardiac muscle ryanodine receptor-calcium release channel
TTDS00165	Synonyms	Cardiac muscle-type ryanodine receptor
TTDS00165	Synonyms	RyR
TTDS00165	Synonyms	Skeletal muscle calcium release channel
TTDS00165	Synonyms	Skeletal muscle-type ryanodine receptor
TTDS00165	Disease	Malignant hyperthermia
TTDS00165	Function	Communication between transverse-tubules and sarcoplasmic reticulum. contraction
TTDS00165	Sequence	MGDAEGEDEVQFLRTDDEVVLQCSATVLKEQLKLCLAAEGFGNRLCFLEPTSNAQNVPPDLAICCFVLEQSLSVRALQEM
TTDS00165	PDB Structure	4ERV
TTDS00165	BioChemical Class	Calcium channel
TTDS00165	Pathway	Calcium signaling pathway
TTDS00165	Pathway	Long-term depression
TTDS00165	Target Validation	TTDS00165
TTDS00165	Drug(s)	Dantrolene
TTDS00165	Inhibitor	(O10eq)-Benzyloxycarbonyl-beta-alanylryanodine
TTDS00165	Inhibitor	(O10eq)-beta-alanyl-anhydro-ryanodine
TTDS00165	Inhibitor	(O10eq)-beta-alanylryanodine
TTDS00165	Inhibitor	(O10eq)-beta-guanidinopropionylryanodine
TTDS00165	Inhibitor	(O10eq)-guanidino acetylryanodine
TTDS00165	Inhibitor	ANHYDRORYANIDINE
TTDS00165	Inhibitor	Benzyloxycarbonyl-glycylryanodine
TTDS00165	Inhibitor	Di-Benzyloxycarbonyl-guanidino acetylryanodine
TTDS00165	Inhibitor	GLYCYLRYANODINE
TTDS00165	Inhibitor	N-methyl ryanodine-succinamidate
TTDS00165	Antagonist	Dantrolene
TTDS00165	Antagonist	Ruthenium red
TTDS00165	Antagonist	Ryanodine
TTDS00165	Antagonist	Tetracaine
TTDS00167	UniProt ID	P54750
TTDS00167	UniProt ID	Q01064
TTDS00167	UniProt ID	Q14123
TTDS00167	Name	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1
TTDS00167	Type of target	Successful target
TTDS00167	Synonyms	61 kDa Cam-PDE
TTDS00167	Synonyms	Cam-PDE 1
TTDS00167	Synonyms	Cam-PDE 1A
TTDS00167	Synonyms	HCam-1
TTDS00167	Synonyms	PDE-I
TTDS00167	Disease	Cardiovascular disease, unspecified
TTDS00167	Disease	Erectile dysfunction
TTDS00167	Function	Has a higher affinity for cgmp than for camp.
TTDS00167	Sequence	MGSSATEIEELENTTFKYLTGEQTEKMWQRLKGILRCLVKQLERGDVNVVDLKKNIEYAASVLEAVYIDETRRLLDTEDE
TTDS00167	PDB Structure	1LXS
TTDS00167	BioChemical Class	Hydrolases acting on ester bonds
TTDS00167	Pathway	Calcium signaling pathway
TTDS00167	Pathway	Olfactory transduction
TTDS00167	Pathway	Purine metabolism
TTDS00167	Pathway	Taste transduction
TTDS00167	EC Number	EC 3.1.4.17
TTDS00167	Related US Patent	6,362,178
TTDS00167	Related US Patent	6,566,360
TTDS00167	Target Validation	TTDS00167
TTDS00167	Drug(s)	Vinpocetine
TTDS00167	Inhibitor	3-Isobutyl-1-methyl-3,7-dihydro-purine-2,6-dione
TTDS00167	Inhibitor	BUFROLIN
TTDS00167	Inhibitor	S,S-(2-Hydroxyethyl)Thiocysteine
TTDS00167	Inhibitor	Vinpocetine
TTDS00167	Inhibitor	ZAPRINAST
TTDS00168	UniProt ID	P43116
TTDS00168	Name	Prostaglandin E2 receptor, EP2 subtype
TTDS00168	Type of target	Successful target
TTDS00168	Synonyms	EP2 receptor
TTDS00168	Synonyms	PGE receptor, EP2 subtype
TTDS00168	Synonyms	Prostanoid EP2 receptor
TTDS00168	Disease	Cerebral oxidative damage
TTDS00168	Function	Receptor for prostaglandin e2 (pge2). The activity of this receptor is mediated
TTDS00168	Sequence	MGNASNDSQSEDCETRQWLPPGESPAISSVMFSAGVLGNLIALALLARRWRGDVGCSAGRRSSLSLFHVLVTELVFTDLL
TTDS00168	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00168	Pathway	Neuroactive ligand-receptor interaction
TTDS00168	Related US Patent	6,245,790
TTDS00168	Related US Patent	6,376,533
TTDS00168	Related US Patent	6,437,146
TTDS00168	Related US Patent	6,586,462
TTDS00168	Target Validation	TTDS00168
TTDS00168	Drug(s)	Alprostadil
TTDS00168	Drug(s)	CP-533536
TTDS00168	Drug(s)	Carboprost Tromethamine
TTDS00168	Drug(s)	Dinoprostone
TTDS00168	Drug(s)	Iloprost
TTDS00168	Drug(s)	Lipo-alprostadil
TTDS00168	Inhibitor	3-(2-((E)-3-phenylprop-1-enyl)phenyl)acrylic acid
TTDS00168	Inhibitor	3-(2-(4-methoxycinnamyl)phenyl)acrylic acid
TTDS00168	Inhibitor	3-(2-(naphthalen-2-ylmethyl)phenyl)acrylic acid
TTDS00168	Inhibitor	3-(2-cinnamylphenyl)acrylic acid
TTDS00168	Inhibitor	BUTAPROST
TTDS00168	Inhibitor	DG-041
TTDS00168	Inhibitor	LAROPIPRANT
TTDS00168	Antagonist	Alprostadil
TTDS00168	Antagonist	Dinoprostone
TTDS00168	Agonist	CP-533536
TTDS00168	Agonist	Iloprost
TTDS00168	Agonist	Lipo-alprostadil
TTDS00168	Binder	Carboprost Tromethamine
TTDS00169	UniProt ID	P43088
TTDS00169	Name	Prostaglandin F2-alpha receptor
TTDS00169	Type of target	Successful target
TTDS00169	Synonyms	FP prostaglandin receptor
TTDS00169	Synonyms	FP prostanoid receptor
TTDS00169	Synonyms	PGF receptor
TTDS00169	Synonyms	PGF2 alpha receptor
TTDS00169	Synonyms	Prostanoid FP receptor
TTDS00169	Disease	Bone disorders
TTDS00169	Disease	Dysmenorrhea, unspecified
TTDS00169	Disease	Glaucoma
TTDS00169	Disease	Inflammatory diseases
TTDS00169	Disease	Ocular hypertension
TTDS00169	Function	Receptor for prostaglandin f2-alpha (pgf2-alpha). The activity of this receptor
TTDS00169	Sequence	MSMNNSKQLVSPAAALLSNTTCQTENRLSVFFSVIFMTVGILSNSLAIAILMKAYQRFRQKSKASFLLLASGLVITDFFG
TTDS00169	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00169	Pathway	Calcium signaling pathway
TTDS00169	Pathway	Neuroactive ligand-receptor interaction
TTDS00169	Related US Patent	6,300,312
TTDS00169	Related US Patent	6,342,524
TTDS00169	Related US Patent	6,369,089
TTDS00169	Related US Patent	6,407,250
TTDS00169	Related US Patent	6,444,840
TTDS00169	Related US Patent	6,509,364
TTDS00169	Related US Patent	6,511,999
TTDS00169	Related US Patent	6,646,001
TTDS00169	Related US Patent	6,649,655
TTDS00169	Target Validation	TTDS00169
TTDS00169	Drug(s)	Bimatoprost
TTDS00169	Drug(s)	Latanoprost
TTDS00169	Drug(s)	Travoprost
TTDS00169	Inhibitor	AL- 16082
TTDS00169	Inhibitor	DINOPROST
TTDS00169	Inhibitor	LAROPIPRANT
TTDS00169	Agonist	Bimatoprost
TTDS00169	Agonist	Latanoprost
TTDS00169	Agonist	Travoprost
TTDS00170	UniProt ID	P43119
TTDS00170	Name	Prostacyclin receptor
TTDS00170	Type of target	Successful target
TTDS00170	Synonyms	IP prostanoid receptor
TTDS00170	Synonyms	PGI receptor
TTDS00170	Synonyms	Prostaglandin I2 receptor
TTDS00170	Synonyms	Prostanoid IP receptor
TTDS00170	Disease	Analgesics
TTDS00170	Disease	Diabetes mellitus
TTDS00170	Disease	Inflammatory pain
TTDS00170	Function	Receptor for prostacyclin (prostaglandin i2 or pgi2). The activity of this recep
TTDS00170	Sequence	MADSCRNLTYVRGSVGPATSTLMFVAGVVGNGLALGILSARRPARPSAFAVLVTGLAATDLLGTSFLSPAVFVAYARNSS
TTDS00170	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00170	Pathway	Neuroactive ligand-receptor interaction
TTDS00170	Pathway	Vascular smooth muscle contraction
TTDS00170	Related US Patent	6,417,186
TTDS00170	Related US Patent	6,569,860
TTDS00170	Target Validation	TTDS00170
TTDS00170	QSAR Model	TTDS00170
TTDS00170	Drug(s)	Dinoprost Tromethamine
TTDS00170	Drug(s)	Epoprostenol
TTDS00170	Drug(s)	Misoprostol
TTDS00170	Drug(s)	Treprostinil
TTDS00170	Drug(s)	YM533
TTDS00170	Inhibitor	AP-227
TTDS00170	Inhibitor	DG-041
TTDS00170	Inhibitor	FR-181157
TTDS00170	Inhibitor	FR-193262
TTDS00170	Inhibitor	LAROPIPRANT
TTDS00170	Antagonist	Dinoprost Tromethamine
TTDS00170	Antagonist	Misoprostol
TTDS00170	Agonist	Epoprostenol
TTDS00170	Agonist	Treprostinil
TTDS00171	UniProt ID	P21802
TTDS00171	Name	Fibroblast growth factor receptor 2
TTDS00171	Type of target	Successful target
TTDS00171	Synonyms	FGF-2 receptor
TTDS00171	Synonyms	FGFR-2
TTDS00171	Synonyms	Keratinocyte growth factor receptor 2
TTDS00171	Disease	Angiogenesis in metastatic and atherosclerotic processes
TTDS00171	Function	Receptor for acidic and basic fibroblast growth factors.
TTDS00171	Sequence	MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLG
TTDS00171	PDB Structure	1DJS; 1E0O; 1EV2; 1GJO; 1II4; 1IIL; 1NUN; 1OEC; 1WVZ; 2FDB; 2PSQ; 2PVF; 2PVY; 2P
TTDS00171	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00171	Pathway	MAPK signaling pathway
TTDS00171	Pathway	Pathways in cancer
TTDS00171	Pathway	Prostate cancer
TTDS00171	Pathway	Regulation of actin cytoskeleton
TTDS00171	EC Number	EC 2.7.1.112
TTDS00171	Target Validation	TTDS00171
TTDS00171	Drug(s)	AEE-788
TTDS00171	Drug(s)	Interferon Alfa-2a, Recombinant
TTDS00171	Drug(s)	Palifermin
TTDS00171	Drug(s)	Pentosan Polysulfate
TTDS00171	Drug(s)	Trafermin
TTDS00171	Inhibitor	AEE-788
TTDS00171	Inhibitor	PD-0183812
TTDS00171	Inhibitor	PD-173074
TTDS00171	Inhibitor	Pentosan Polysulfate
TTDS00171	Inhibitor	Platelet factor 4 (PF-4)
TTDS00171	Inhibitor	Ro-4396686
TTDS00171	Inhibitor	SU4984
TTDS00171	Inhibitor	TG-100435
TTDS00171	Activator	Trafermin
TTDS00171	Binder	Interferon Alfa-2a, Recombinant
TTDS00171	Binder	Interferon alfa (IFN-alpha)
TTDS00171	Binder	Palifermin
TTDS00171	Multitarget	AEE-788
TTDS00172	Name	Serotonin re-uptake
TTDS00172	Type of target	Successful target
TTDS00172	Synonyms	Serotonin reuptake
TTDS00172	Disease	Anxiety disorder, unspecified
TTDS00172	Disease	Depression
TTDS00172	Disease	Dysphoria
TTDS00172	Disease	Obesity
TTDS00172	Disease	Psychiatric illness
TTDS00172	Disease	Social phobias
TTDS00172	Related US Patent	6,239,129
TTDS00172	Related US Patent	6,316,469
TTDS00172	Related US Patent	6,342,498
TTDS00172	Related US Patent	6,372,763
TTDS00172	Related US Patent	6,380,200
TTDS00172	Related US Patent	6,384,281
TTDS00172	Related US Patent	6,399,608
TTDS00172	Related US Patent	6,410,736
TTDS00172	Related US Patent	6,492,366
TTDS00172	Related US Patent	6,509,340
TTDS00172	Related US Patent	6,552,014
TTDS00172	Related US Patent	6,596,741
TTDS00172	Related US Patent	6,664,274
TTDS00172	Related US Patent	6,677,338
TTDS00172	Related US Patent	6,677,378
TTDS00172	Related US Patent	6,787,560
TTDS00172	Target Validation	TTDS00172
TTDS00172	Drug(s)	(S)-Duloxetine
TTDS00172	Drug(s)	Amfepramone
TTDS00172	Drug(s)	Amitriptyline
TTDS00172	Drug(s)	Bicifadine
TTDS00172	Drug(s)	Bupropion
TTDS00172	Drug(s)	Citalopram
TTDS00172	Drug(s)	Clomipramine
TTDS00172	Drug(s)	Cocaine
TTDS00172	Drug(s)	DOV 21947
TTDS00172	Drug(s)	DOV-216303
TTDS00172	Drug(s)	DOV-21947
TTDS00172	Drug(s)	Desvenlafaxine SR
TTDS00172	Drug(s)	Dexfenfluramine
TTDS00172	Drug(s)	Diethylpropion
TTDS00172	Drug(s)	Duloxetine
TTDS00172	Drug(s)	Escitalopram
TTDS00172	Drug(s)	Fluoxetine
TTDS00172	Drug(s)	Fluvoxamine
TTDS00172	Drug(s)	GSK372475
TTDS00172	Drug(s)	Milnacipran HCl
TTDS00172	Drug(s)	NS 2359
TTDS00172	Drug(s)	OPC-14523
TTDS00172	Drug(s)	Paroxetine
TTDS00172	Drug(s)	R-sibutramine metabolite
TTDS00172	Drug(s)	Seroxat
TTDS00172	Drug(s)	Sertraline
TTDS00172	Drug(s)	Sibutramine
TTDS00172	Drug(s)	TGBA01AD
TTDS00172	Drug(s)	Tianeptine
TTDS00172	Drug(s)	Tramadol ER
TTDS00172	Drug(s)	Trazodone
TTDS00172	Drug(s)	Trazodone CR
TTDS00172	Drug(s)	Trimipramine
TTDS00172	Drug(s)	Ultracet
TTDS00172	Drug(s)	Venlafaxine
TTDS00172	Inhibitor	(S)-Duloxetine
TTDS00172	Inhibitor	Amfepramone
TTDS00172	Inhibitor	Amitriptyline
TTDS00172	Inhibitor	Bicifadine
TTDS00172	Inhibitor	Bupropion
TTDS00172	Inhibitor	Citalopram
TTDS00172	Inhibitor	Clomipramine
TTDS00172	Inhibitor	Cocaine
TTDS00172	Inhibitor	DOV 21947
TTDS00172	Inhibitor	DOV-216303
TTDS00172	Inhibitor	DOV-21947
TTDS00172	Inhibitor	Desvenlafaxine SR
TTDS00172	Inhibitor	Dexfenfluramine
TTDS00172	Inhibitor	Diethylpropion
TTDS00172	Inhibitor	Duloxetine
TTDS00172	Inhibitor	Escitalopram
TTDS00172	Inhibitor	Fluoxetine
TTDS00172	Inhibitor	Fluvoxamine
TTDS00172	Inhibitor	GSK372475
TTDS00172	Inhibitor	Hypericum (St John's Wort)
TTDS00172	Inhibitor	Milnacipran HCl
TTDS00172	Inhibitor	NS 2359
TTDS00172	Inhibitor	OPC-14523
TTDS00172	Inhibitor	Paroxetine
TTDS00172	Inhibitor	R-sibutramine metabolite
TTDS00172	Inhibitor	Seroxat
TTDS00172	Inhibitor	Sertraline
TTDS00172	Inhibitor	Sibutramine
TTDS00172	Inhibitor	TGBA01AD
TTDS00172	Inhibitor	Tianeptine
TTDS00172	Inhibitor	Tramadol ER
TTDS00172	Inhibitor	Trazodone
TTDS00172	Inhibitor	Trazodone CR
TTDS00172	Inhibitor	Trimipramine
TTDS00172	Inhibitor	Ultracet
TTDS00172	Inhibitor	Venlafaxine
TTDS00172	Multitarget	Amfepramone
TTDS00172	Multitarget	Amitriptyline
TTDS00172	Multitarget	Bicifadine
TTDS00172	Multitarget	Bupropion
TTDS00172	Multitarget	Cocaine
TTDS00172	Multitarget	DOV 21947
TTDS00172	Multitarget	DOV-216303
TTDS00172	Multitarget	DOV-21947
TTDS00172	Multitarget	Desvenlafaxine SR
TTDS00172	Multitarget	Diethylpropion
TTDS00172	Multitarget	Duloxetine
TTDS00172	Multitarget	GSK372475
TTDS00172	Multitarget	Milnacipran HCl
TTDS00172	Multitarget	NS 2359
TTDS00172	Multitarget	OPC-14523
TTDS00172	Multitarget	R-sibutramine metabolite
TTDS00172	Multitarget	Sibutramine
TTDS00172	Multitarget	TGBA01AD
TTDS00172	Multitarget	Tramadol ER
TTDS00172	Multitarget	Trazodone
TTDS00172	Multitarget	Trazodone CR
TTDS00172	Multitarget	Trimipramine
TTDS00172	Multitarget	Ultracet
TTDS00172	Multitarget	Venlafaxine
TTDS00174	UniProt ID	P06818
TTDS00174	UniProt ID	P29768
TTDS00174	Name	Neuraminidase
TTDS00174	Type of target	Successful target
TTDS00174	Synonyms	N-acylneuraminate glycohydrolase
TTDS00174	Synonyms	NANase
TTDS00174	Synonyms	STNA
TTDS00174	Synonyms	Sialidase
TTDS00174	Disease	Influenza, virus not identified
TTDS00174	Function	Cleaves the terminal sialic acid (n-acetyl neuraminic acid) from carbohydrate ch
TTDS00174	Sequence	MNPNQKIITIGSVSLTIATICFLMQIAILVTTVTLHFKQYECSSPPNNQVMPCEPIIIERNITEIVYLTNTTIDKEICPK
TTDS00174	PDB Structure	1DIL; 1DIM; 2SIL; 2SIM; 3SIL
TTDS00174	BioChemical Class	Glycosylases
TTDS00174	Pathway	Lysosome
TTDS00174	Pathway	Other glycan degradation
TTDS00174	Pathway	Sphingolipid metabolism
TTDS00174	EC Number	EC 3.2.1.18
TTDS00174	Related US Patent	6,509,359
TTDS00174	Related US Patent	6,518,299
TTDS00174	Related US Patent	6,548,476
TTDS00174	Related US Patent	6,562,861
TTDS00174	Related US Patent	6,593,314
TTDS00174	Target Validation	TTDS00174
TTDS00174	QSAR Model	TTDS00174
TTDS00174	Drug(s)	CS-8958
TTDS00174	Drug(s)	Oseltamivir
TTDS00174	Drug(s)	Peramivir
TTDS00174	Drug(s)	Zanamivir
TTDS00174	Inhibitor	(E,E)-1,7-Diphenyl-4,6-heptadien-3-one
TTDS00174	Inhibitor	(E,E)-5-Hydroxy-1,7-diphenyl-4,6-heptadien-3-one
TTDS00174	Inhibitor	(S)-1,7-Diphenyl-6(E)-hepten-3-ol
TTDS00174	Inhibitor	2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid
TTDS00174	Inhibitor	2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid
TTDS00174	Inhibitor	4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID
TTDS00174	Inhibitor	4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID
TTDS00174	Inhibitor	4-(Acetylamino)-3-Amino Benzoic Acid
TTDS00174	Inhibitor	4-(Acetylamino)-3-Guanidinobenzoic Acid
TTDS00174	Inhibitor	4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid
TTDS00174	Inhibitor	8-DEOXYGARTANIN
TTDS00174	Inhibitor	A-192558
TTDS00174	Inhibitor	A-315675
TTDS00174	Inhibitor	APIGENIN
TTDS00174	Inhibitor	Alpha-D-Mannose
TTDS00174	Inhibitor	BCX-1812
TTDS00174	Inhibitor	BCX-1827
TTDS00174	Inhibitor	BCX-1898
TTDS00174	Inhibitor	BCX-1923
TTDS00174	Inhibitor	Bcx-1812
TTDS00174	Inhibitor	Beta-D-Mannose
TTDS00174	Inhibitor	Beta-Sialic Acid
TTDS00174	Inhibitor	CALOPOCARPIN
TTDS00174	Inhibitor	CS-8958
TTDS00174	Inhibitor	CUDRATRICUSXANTHONE
TTDS00174	Inhibitor	Cudratricusxanthone F
TTDS00174	Inhibitor	Cudraxanthone D
TTDS00174	Inhibitor	Cudraxanthone L
TTDS00174	Inhibitor	Cudraxanthone M
TTDS00174	Inhibitor	Cyclopentane amide derivatives 1
TTDS00174	Inhibitor	Cyclopentane amide derivatives 2
TTDS00174	Inhibitor	Cyclopentane amide derivatives 3
TTDS00174	Inhibitor	Cyclopentane amide derivatives 4
TTDS00174	Inhibitor	DANA
TTDS00174	Inhibitor	DEMETHYLMEDICARPIN
TTDS00174	Inhibitor	ERYSTAGALLIN A
TTDS00174	Inhibitor	Erythribyssin D
TTDS00174	Inhibitor	Erythribyssin L
TTDS00174	Inhibitor	Erythribyssin M
TTDS00174	Inhibitor	Erythribyssin O
TTDS00174	Inhibitor	FANA
TTDS00174	Inhibitor	Fucose
TTDS00174	Inhibitor	GARCINONE D
TTDS00174	Inhibitor	GARTANIN
TTDS00174	Inhibitor	GOSSYPETIN
TTDS00174	Inhibitor	GS4071
TTDS00174	Inhibitor	HERBACETIN
TTDS00174	Inhibitor	ISONEORAUTENOL
TTDS00174	Inhibitor	KAEMPFEROL
TTDS00174	Inhibitor	KATSUMADAIN A
TTDS00174	Inhibitor	Lactose
TTDS00174	Inhibitor	MACLURAXANTHONE
TTDS00174	Inhibitor	MANGIFERIN
TTDS00174	Inhibitor	MANGOSTANIN
TTDS00174	Inhibitor	MANGOSTANOL
TTDS00174	Inhibitor	MANGOSTENONE F
TTDS00174	Inhibitor	MANGOSTENONE G
TTDS00174	Inhibitor	MANGOSTIN
TTDS00174	Inhibitor	NEORAUTENOL
TTDS00174	Inhibitor	O-Sialic Acid
TTDS00174	Inhibitor	OSELTAMIVIR ACID
TTDS00174	Inhibitor	Oseltamivir
TTDS00174	Inhibitor	PHASEOLIN
TTDS00174	Inhibitor	PHASEOLLIDIN
TTDS00174	Inhibitor	Peramivir
TTDS00174	Inhibitor	RHODIOLININ
TTDS00174	Inhibitor	SMEATHXANTHONE A
TTDS00174	Inhibitor	Zanamivir
TTDS00174	Inhibitor	cristacarpin
TTDS00174	Inhibitor	erysubin D
TTDS00174	Inhibitor	erysubin E
TTDS00174	Inhibitor	eryvarin D
TTDS00174	Inhibitor	gamma-mangostin
TTDS00175	UniProt ID	P06821
TTDS00175	UniProt ID	P63231
TTDS00175	Name	Influenza A virus M2 protein
TTDS00175	Type of target	Successful target
TTDS00175	Synonyms	M2 proton channel
TTDS00175	Synonyms	Matrix protein M2
TTDS00175	Disease	Influenza, influenza virus A-induced
TTDS00175	Sequence	MSLLTEVETPIRNEWGCRCNGSSDPLAIAANIIGILHLILWILDRLFFKCIYRRFKYGLKGGPSTEGVPKSMREEYRKEQ
TTDS00175	PDB Structure	1MP6; 2KIH; 2KWX; 2L0J; 2RLF
TTDS00175	Target Validation	TTDS00175
TTDS00175	Drug(s)	Amantadine
TTDS00175	Drug(s)	Rimantadine
TTDS00175	Inhibitor	2-(1-adamantyl) piperidine
TTDS00175	Inhibitor	2-(1-adamantyl) pyrrolidine
TTDS00175	Inhibitor	2-(1-adamantyl)-2-methyl-pyrrolidine
TTDS00175	Inhibitor	2-(2-adamantyl) piperidine
TTDS00175	Inhibitor	3-(2-adamantyl) pyrrolidine
TTDS00175	Inhibitor	Amantadine
TTDS00175	Inhibitor	B-Octylglucoside
TTDS00175	Inhibitor	Rimantadine
TTDS00175	Inhibitor	Rimantadine isomer 1
TTDS00175	Inhibitor	Rimantadine isomer 2
TTDS00175	Inhibitor	Spiro[cyclopropane-1,2-adamantan]-2-amine
TTDS00175	Inhibitor	Spiro[piperidine-2,2-adamantane]
TTDS00175	Inhibitor	Spiro[pyrrolidine-2,2-adamantane]
TTDS00177	UniProt ID	O00519
TTDS00177	Name	Fatty-acid amide hydrolase
TTDS00177	Type of target	Successful target
TTDS00177	Synonyms	Anandamide amidase
TTDS00177	Synonyms	Anandamide amidohydrolase
TTDS00177	Synonyms	Anandamide synthase
TTDS00177	Synonyms	Arachidonylethanolamide synthase
TTDS00177	Synonyms	FAAH
TTDS00177	Synonyms	Fatty acid amide hydrolase
TTDS00177	Synonyms	Oleamide hydrolase
TTDS00177	Disease	Analgesics
TTDS00177	Disease	Anesthetic
TTDS00177	Disease	Anxiety disorder, unspecified
TTDS00177	Disease	Pain
TTDS00177	Disease	Sedation
TTDS00177	Function	Degrades bioactive fatty acid amides like oleamide, the endogenous cannabinoid,
TTDS00177	Sequence	MVQYELWAALPGASGVALACCFVAAAVALRWSGRRTARGAVVRARQRQRAGLENMDRAAQRFRLQNPDLDSEALLALPLP
TTDS00177	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDS00177	EC Number	EC 3.5.1.4
TTDS00177	Related US Patent	6,562,846
TTDS00177	Related US Patent	6,579,900
TTDS00177	Target Validation	TTDS00177
TTDS00177	Drug(s)	Propofol
TTDS00177	Drug(s)	SSR411298
TTDS00177	Drug(s)	Thiopental
TTDS00177	Inhibitor	1,4-bis(malimido)xylene
TTDS00177	Inhibitor	1,8-bis-maleimidodiethyleneglycol
TTDS00177	Inhibitor	1-DODECANOL
TTDS00177	Inhibitor	2-arachidonoylglycerol
TTDS00177	Inhibitor	2-fluorophenylboronic acid
TTDS00177	Inhibitor	2-methoxyphenylboronic acid
TTDS00177	Inhibitor	3-cyanophenylboronic acid
TTDS00177	Inhibitor	3-methoxyphenylboronic acid
TTDS00177	Inhibitor	4-cyanophenylboronic acid
TTDS00177	Inhibitor	4-fluorophenylboronic acid
TTDS00177	Inhibitor	4-methoxyphenylboronic acid
TTDS00177	Inhibitor	4-nitrophenylboronic acid
TTDS00177	Inhibitor	4-nonylphenylboronic acid
TTDS00177	Inhibitor	6-fluoropyridin-3-ylboronic acid
TTDS00177	Inhibitor	AM-404
TTDS00177	Inhibitor	AMPEROZIDE
TTDS00177	Inhibitor	AR-C70484XX
TTDS00177	Inhibitor	ARACHIDONYL TRIFLUOROMETHYLKETONE
TTDS00177	Inhibitor	BMS-1
TTDS00177	Inhibitor	BTNP
TTDS00177	Inhibitor	Benzylcarbamic Acid Biphenyl-3-yl Ester
TTDS00177	Inhibitor	Biphenyl-3-ylcarbamic Acid Biphenyl-3-yl Ester
TTDS00177	Inhibitor	Chlorphrifos oxon
TTDS00177	Inhibitor	HTS-00798
TTDS00177	Inhibitor	Isopropyl dodecylfluorophosphonate
TTDS00177	Inhibitor	Isopropylcarbamic Acid Biphenyl-3-yl Ester
TTDS00177	Inhibitor	JNJ-1661010
TTDS00177	Inhibitor	LY-2183240
TTDS00177	Inhibitor	LY-2318912
TTDS00177	Inhibitor	Methoxy arachidonyl fluorophosphonate
TTDS00177	Inhibitor	N-(2-hydroxyethyl)linoleoylamide
TTDS00177	Inhibitor	N-(2-iodethyl)arachidonylamide
TTDS00177	Inhibitor	N-(2-iodoethyl)linoleoylamide
TTDS00177	Inhibitor	N-arachidonylmaleimide
TTDS00177	Inhibitor	NICARBAZIN
TTDS00177	Inhibitor	OL-135
TTDS00177	Inhibitor	OL-92
TTDS00177	Inhibitor	PARAOXON
TTDS00177	Inhibitor	PF-622
TTDS00177	Inhibitor	PHENMEDIPHAM
TTDS00177	Inhibitor	Phenethylcarbamic Acid Biphenyl-3-yl Ester
TTDS00177	Inhibitor	Phenylcarbamic Acid Biphenyl-3-yl Ester
TTDS00177	Inhibitor	Propofol
TTDS00177	Inhibitor	SSR411298
TTDS00177	Inhibitor	Thiopental
TTDS00177	Inhibitor	VER-156084
TTDS00177	Inhibitor	VER-24052
TTDS00177	Inhibitor	benzo[b]thiophen-2-ylboronic acid
TTDS00177	Inhibitor	benzofuran-2-ylboronic acid
TTDS00177	Inhibitor	biphenyl-3-ylboronic acid
TTDS00177	Inhibitor	biphenyl-3-ylcarbamic acid cyclohexyl ester
TTDS00177	Inhibitor	biphenyl-4-ylboronic acid
TTDS00177	Inhibitor	isopropyl 4-nitrophenyl dodecylphosphonate
TTDS00177	Inhibitor	n-Butylcarbamic Acid Biphenyl-3-yl Ester
TTDS00177	Inhibitor	n-Hexylcarbamic Acid Biphenyl-3-yl Ester
TTDS00177	Inhibitor	n-Octylcarbamic Acid Biphenyl-3-yl Ester
TTDS00177	Inhibitor	naphthalen-2-yl cyclohexylcarbamate
TTDS00177	Inhibitor	nicotinaldehyde O-4-butoxyphenylcarbamoyl oxime
TTDS00177	Inhibitor	nicotinaldehyde O-4-ethoxyphenylcarbamoyl oxime
TTDS00177	Inhibitor	nicotinaldehyde O-4-propoxyphenylcarbamoyl oxime
TTDS00177	Inhibitor	octane-1-sulfonyl fluoride
TTDS00177	Inhibitor	phenethylboronic acid
TTDS00177	Inhibitor	phenyl 1-(4-butoxyphenyl)propylcarbamate
TTDS00177	Inhibitor	phenyl 4-(decyloxy)phenylcarbamate
TTDS00177	Inhibitor	phenyl 4-(dodecyloxy)phenylcarbamate
TTDS00177	Inhibitor	phenyl 4-(heptyloxy)phenylcarbamate
TTDS00177	Inhibitor	phenyl 4-(hexyloxy)phenylcarbamate
TTDS00177	Inhibitor	phenyl 4-(octyloxy)phenylcarbamate
TTDS00177	Inhibitor	phenyl 4-(undecyloxy)phenylcarbamate
TTDS00177	Inhibitor	phenyl-1,4-bismaleimide
TTDS00177	Inhibitor	phenylboronic acid
TTDS00177	Inhibitor	pyridin-3-yl 4-butoxybenzylcarbamate
TTDS00179	Name	Prolyl 4-hydroxylase alpha subunit
TTDS00179	Type of target	Successful target
TTDS00179	Synonyms	4-PH alpha
TTDS00179	Synonyms	Procollagen-proline,2-oxoglutarate-4-dioxygenase alpha
TTDS00179	Synonyms	Prolyl hydroxylase
TTDS00179	Disease	Cardiovascular disease, unspecified
TTDS00179	Disease	Vitamin C deficiency
TTDS00179	EC Number	EC 1.14.11.2
TTDS00179	Target Validation	TTDS00179
TTDS00179	Drug(s)	1278863
TTDS00179	Drug(s)	Hydralazine
TTDS00179	Inhibitor	Hydralazine
TTDS00181	UniProt ID	P12821
TTDS00181	UniProt ID	P22966
TTDS00181	Name	Angiotensin-converting enzyme
TTDS00181	Type of target	Successful target
TTDS00181	Synonyms	ACE
TTDS00181	Synonyms	CD143 antigen
TTDS00181	Synonyms	Dipeptidyl carboxypeptidase I
TTDS00181	Synonyms	Kininase II
TTDS00181	Disease	Chronic obstructive pulmonary disease, unspecified
TTDS00181	Disease	Heart failure
TTDS00181	Disease	Hypertension
TTDS00181	Disease	Vascular disease
TTDS00181	Function	Converts angiotensin i to angiotensin ii by release of the terminal his-leu, thi
TTDS00181	Sequence	MGAASGRRGPGLLLPLPLLLLLPPQPALALDPGLQPGNFSADEAGAQLFAQSYNSSAEQVLFQSVAASWAHDTNITAENA
TTDS00181	PDB Structure	1O86; 1O8A; 1UZE; 1UZF; 2C6F; 2C6N; 2IUL; 2IUX; 2OC2; 2XY9; 2XYD; 2YDM; 3BKK; 3B
TTDS00181	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00181	Pathway	Renin-angiotensin system
TTDS00181	EC Number	EC 3.4.15.1
TTDS00181	Related US Patent	6,133,304
TTDS00181	Related US Patent	6,337,327
TTDS00181	Related US Patent	6,482,797
TTDS00181	Related US Patent	6,509,330
TTDS00181	Related US Patent	6,521,659
TTDS00181	Related US Patent	6,555,551
TTDS00181	Related US Patent	6,586,198
TTDS00181	Target Validation	TTDS00181
TTDS00181	Drug(s)	Alacepril
TTDS00181	Drug(s)	Benazepril
TTDS00181	Drug(s)	Captopril
TTDS00181	Drug(s)	Cilazapril
TTDS00181	Drug(s)	Delapril
TTDS00181	Drug(s)	Deserpidine
TTDS00181	Drug(s)	Enalapril
TTDS00181	Drug(s)	Enalapril maleate
TTDS00181	Drug(s)	Enalaprilat
TTDS00181	Drug(s)	Fosinopril
TTDS00181	Drug(s)	GSK 796406
TTDS00181	Drug(s)	Ilepatril
TTDS00181	Drug(s)	Imidapril hci
TTDS00181	Drug(s)	Lisinopril
TTDS00181	Drug(s)	M-100240
TTDS00181	Drug(s)	M100,240
TTDS00181	Drug(s)	Moexipril
TTDS00181	Drug(s)	Omapatrilat
TTDS00181	Drug(s)	Perindopril
TTDS00181	Drug(s)	Quinapril
TTDS00181	Drug(s)	Ramipril
TTDS00181	Drug(s)	Rescinnamine
TTDS00181	Drug(s)	Spirapril
TTDS00181	Drug(s)	Temocapril hydrochloride
TTDS00181	Drug(s)	Trandolapril
TTDS00181	Inhibitor	2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose
TTDS00181	Inhibitor	ASTRAGALIN
TTDS00181	Inhibitor	Acetate Ion
TTDS00181	Inhibitor	BUTEIN
TTDS00181	Inhibitor	Benazepril
TTDS00181	Inhibitor	CONTIGOSIDE B
TTDS00181	Inhibitor	Captopril
TTDS00181	Inhibitor	Cilazapril
TTDS00181	Inhibitor	Deserpidine
TTDS00181	Inhibitor	Enalapril
TTDS00181	Inhibitor	Enalaprilat
TTDS00181	Inhibitor	Fosinopril
TTDS00181	Inhibitor	GSK 796406
TTDS00181	Inhibitor	Ilepatril
TTDS00181	Inhibitor	LY-292223
TTDS00181	Inhibitor	Lisinopril
TTDS00181	Inhibitor	M100,240
TTDS00181	Inhibitor	Moexipril
TTDS00181	Inhibitor	N-Carboxymethyl-N-cyclopentyl-phthalamic acid
TTDS00181	Inhibitor	Omapatrilat
TTDS00181	Inhibitor	Perindopril
TTDS00181	Inhibitor	Perindopril erbumine
TTDS00181	Inhibitor	Quinapril
TTDS00181	Inhibitor	RIP
TTDS00181	Inhibitor	Ramipril
TTDS00181	Inhibitor	Rescinnamine
TTDS00181	Inhibitor	SCH-54470
TTDS00181	Inhibitor	SQ-26332;SQ-28603
TTDS00181	Inhibitor	Spirapril
TTDS00181	Inhibitor	Trandolapril
TTDS00181	Inhibitor	[Cyclopentyl-(2-nitro-benzoyl)-amino]-acetic acid
TTDS00181	Inhibitor	kaempferol-3-O-(2''-O-galloyl)-glucoside
TTDS00181	Multitarget	GSK 796406
TTDS00181	Multitarget	Ilepatril
TTDS00181	Multitarget	M-100240
TTDS00181	Multitarget	Omapatrilat
TTDS00182	UniProt ID	Q47746
TTDS00182	Name	D-alanyl-D-alanine carboxypeptidase
TTDS00182	Type of target	Successful target
TTDS00182	Synonyms	D-alanyl-D-alanine carboxypeptidase-transpeptidase
TTDS00182	Synonyms	DD-carboxypeptidase
TTDS00182	Synonyms	DD-peptidase
TTDS00182	Disease	Bacterial infections
TTDS00182	Function	Vancomycin-inducible, penicillin-resistant, dd- carboxypeptidase that hydrolyzes
TTDS00182	Sequence	MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATA
TTDS00182	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00182	EC Number	EC 3.4.16.4
TTDS00182	Related US Patent	6,608,046
TTDS00182	Target Validation	TTDS00182
TTDS00182	Drug(s)	B-Lactams
TTDS00182	Drug(s)	Cefalotin
TTDS00182	Drug(s)	Cefotaxime
TTDS00182	Drug(s)	Ceftobiprole
TTDS00182	Drug(s)	Ceftriaxone
TTDS00182	Drug(s)	Cephalosporin
TTDS00182	Inhibitor	2-[(Dioxidophosphino)Oxy]Benzoate
TTDS00182	Inhibitor	3-boronobenzoic acid
TTDS00182	Inhibitor	5-boronothiophene-2-carboxylic acid
TTDS00182	Inhibitor	B-Lactams
TTDS00182	Inhibitor	Cefalotin
TTDS00182	Inhibitor	Cefotaxime
TTDS00182	Inhibitor	Ceftriaxone
TTDS00182	Inhibitor	Cephalosporin Analog
TTDS00182	Inhibitor	Cephalosporin C
TTDS00182	Inhibitor	D-Alanine
TTDS00182	Inhibitor	Formaldehyde
TTDS00182	Inhibitor	Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanine
TTDS00182	Inhibitor	NITROCEFIN
TTDS00182	Inhibitor	Penicillin
TTDS00182	Inhibitor	Ro-23-9424
TTDS00182	Inhibitor	TD-1792
TTDS00182	Inhibitor	benzo[c][1,2]oxaborol-1(3H)-ol
TTDS00182	Inhibitor	phenylboronic acid
TTDS00182	Binder	Ceftobiprole
TTDS00182	Binder	Cephalosporin
TTDS00183	UniProt ID	Q9Y271
TTDS00183	Name	Cysteinyl leukotriene receptor 1
TTDS00183	Type of target	Successful target
TTDS00183	Synonyms	CysLTR1
TTDS00183	Synonyms	Cysteinyl leukotriene D4 receptor
TTDS00183	Synonyms	HG55
TTDS00183	Synonyms	HMTMF81
TTDS00183	Synonyms	LTD4 receptor
TTDS00183	Synonyms	Leukotriene D4-receptor
TTDS00183	Disease	Asthma
TTDS00183	Function	Receptor for cysteinyl leukotrienes mediating bronchoconstriction of individuals
TTDS00183	Sequence	MDETGNLTVSSATCHDTIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLIKTYHKKSAFQVYMINLAVADLLCVCTLPLRV
TTDS00183	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00183	Pathway	Calcium signaling pathway
TTDS00183	Pathway	Neuroactive ligand-receptor interaction
TTDS00183	Related US Patent	6,509,353
TTDS00183	Target Validation	TTDS00183
TTDS00183	Drug(s)	Cinalukast
TTDS00183	Drug(s)	Montelukast
TTDS00183	Drug(s)	Pranlukast
TTDS00183	Drug(s)	Zafirlukast
TTDS00183	Antagonist	5'-methylthioadenosine
TTDS00183	Antagonist	Cinalukast
TTDS00183	Antagonist	Montelukast
TTDS00183	Antagonist	Pranlukast
TTDS00183	Antagonist	Zafirlukast
TTDS00185	Name	Adenosine receptor
TTDS00185	Type of target	Successful target
TTDS00185	Disease	Tumors
TTDS00185	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00185	Pathway	Neuroactive ligand-receptor interaction
TTDS00185	Related US Patent	6,649,600
TTDS00185	Target Validation	TTDS00185
TTDS00185	Drug(s)	Theophylline
TTDS00185	Antagonist	8-sulfophenyl theophylline
TTDS00185	Antagonist	PD-116,948
TTDS00185	Antagonist	SPT
TTDS00185	Antagonist	Theophylline
TTDS00186	UniProt ID	P30542
TTDS00186	Name	Adenosine A1 receptor
TTDS00186	Type of target	Successful target
TTDS00186	Synonyms	A(1) adenosine receptor
TTDS00186	Disease	Analgesics
TTDS00186	Disease	Asthma
TTDS00186	Disease	Cardiac arrhythmias
TTDS00186	Disease	Chronic ileitis
TTDS00186	Disease	Inflammation
TTDS00186	Disease	Inflammatory bowel disease
TTDS00186	Disease	Insulin resistance (obesity-related)
TTDS00186	Disease	Noninsulin-dependent diabetes mellitus
TTDS00186	Disease	Pain
TTDS00186	Disease	Renal failure
TTDS00186	Function	Receptor for adenosine. The activity of this receptor is mediated by G proteins
TTDS00186	Sequence	MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTC
TTDS00186	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00186	Pathway	Neuroactive ligand-receptor interaction
TTDS00186	Related US Patent	6,495,687
TTDS00186	Related US Patent	6,576,620
TTDS00186	Related US Patent	6,586,413
TTDS00186	Related US Patent	6,605,600
TTDS00186	Related US Patent	6,605,601
TTDS00186	Related US Patent	6,638,914
TTDS00186	Target Validation	TTDS00186
TTDS00186	QSAR Model	TTDS00186
TTDS00186	Drug(s)	BAY 1067197
TTDS00186	Drug(s)	CVT-124
TTDS00186	Drug(s)	Caffeine
TTDS00186	Drug(s)	MK-7418
TTDS00186	Drug(s)	Rolofylline
TTDS00186	Drug(s)	SLV320
TTDS00186	Drug(s)	Tecadenoson
TTDS00186	Inhibitor	1-METHYLXANTHINE
TTDS00186	Inhibitor	2'-Me-tecadenoson
TTDS00186	Inhibitor	2,6-diphenyl-9H-purine
TTDS00186	Inhibitor	2-phenylpropoxyadenosine
TTDS00186	Inhibitor	2-tolyl-6-phenyl-9H-purine
TTDS00186	Inhibitor	9-Ethyl-9H-adenine
TTDS00186	Inhibitor	9-Propyl-9H-adenine
TTDS00186	Inhibitor	A-987306
TTDS00186	Inhibitor	ARISTEROMYCIN
TTDS00186	Inhibitor	Anthoptilide C
TTDS00186	Inhibitor	BRL-61063
TTDS00186	Inhibitor	CGS-15943
TTDS00186	Inhibitor	CGS-21680
TTDS00186	Inhibitor	CIRSIMARIN
TTDS00186	Inhibitor	CVT-6883
TTDS00186	Inhibitor	CYPROTERONE ACETATE
TTDS00186	Inhibitor	Ethyl 5-benzoyl-4-phenylthiazol-2-ylcarbamate
TTDS00186	Inhibitor	FK-453
TTDS00186	Inhibitor	FK-838
TTDS00186	Inhibitor	FR-166124
TTDS00186	Inhibitor	GNF-PF-2224
TTDS00186	Inhibitor	GNF-PF-2700
TTDS00186	Inhibitor	GW-328267
TTDS00186	Inhibitor	ISOGUANOSINE
TTDS00186	Inhibitor	ISTRADEFYLLINE
TTDS00186	Inhibitor	KF-17837
TTDS00186	Inhibitor	L-249313
TTDS00186	Inhibitor	LUF-5417
TTDS00186	Inhibitor	LUF-5433
TTDS00186	Inhibitor	LUF-5735
TTDS00186	Inhibitor	LUF-5737
TTDS00186	Inhibitor	LUF-5764
TTDS00186	Inhibitor	LUF-5767
TTDS00186	Inhibitor	LUF-5816
TTDS00186	Inhibitor	LUF-5853
TTDS00186	Inhibitor	LUF-5956
TTDS00186	Inhibitor	LUF-5957
TTDS00186	Inhibitor	LUF-5962
TTDS00186	Inhibitor	LUF-5978
TTDS00186	Inhibitor	LUF-5980
TTDS00186	Inhibitor	LUF-5981
TTDS00186	Inhibitor	LUF-6258
TTDS00186	Inhibitor	METHYLTHIOADENOSINE
TTDS00186	Inhibitor	METRIFUDIL
TTDS00186	Inhibitor	NECA
TTDS00186	Inhibitor	OSIP-339391
TTDS00186	Inhibitor	PD-115199
TTDS00186	Inhibitor	PD-81723
TTDS00186	Inhibitor	PSB-0788
TTDS00186	Inhibitor	PSB-1115
TTDS00186	Inhibitor	PSB-601
TTDS00186	Inhibitor	SB-298
TTDS00186	Inhibitor	SCH-442416
TTDS00186	Inhibitor	SCH-58261
TTDS00186	Inhibitor	SCH-63390
TTDS00186	Inhibitor	SLV-320
TTDS00186	Inhibitor	ST-1535
TTDS00186	Inhibitor	Tonapofylline
TTDS00186	Inhibitor	VCP-28
TTDS00186	Inhibitor	VUF-8507
TTDS00186	Inhibitor	ZM-241385
TTDS00186	Inhibitor	hexanoic Acid (2,6-diphenylpyrimidin-4-yl)amide
TTDS00186	Inhibitor	kuanoniamine D
TTDS00186	Inhibitor	p-IODOAMPHETAMINE
TTDS00186	Antagonist	CVT-124
TTDS00186	Antagonist	Caffeine
TTDS00186	Antagonist	MK-7418
TTDS00186	Antagonist	PD-116,948
TTDS00186	Antagonist	Rolofylline
TTDS00186	Antagonist	SLV320
TTDS00186	Agonist	CVT-2759
TTDS00186	Agonist	Tecadenoson
TTDS00186	Multitarget	Caffeine
TTDS00187	UniProt ID	P29274
TTDS00187	Name	Adenosine A2a receptor
TTDS00187	Type of target	Successful target
TTDS00187	Synonyms	A(2A) adenosine receptor
TTDS00187	Synonyms	A2a Adenosine receptor
TTDS00187	Synonyms	Adenosine receptor A2a
TTDS00187	Disease	Analgesics
TTDS00187	Disease	Brain injury
TTDS00187	Disease	Depression
TTDS00187	Disease	Dyskinesia
TTDS00187	Disease	Inflammation
TTDS00187	Disease	Ischemia reperfusion injuries
TTDS00187	Disease	Neurodegenerative diseases
TTDS00187	Disease	Neuropsychiatric disorders
TTDS00187	Disease	Oxygen-induced retinopathy
TTDS00187	Disease	Pain
TTDS00187	Disease	Parkinson's disease
TTDS00187	Disease	Renal diseases
TTDS00187	Function	Receptor for adenosine, and the activity of this receptor is mediated by G prote
TTDS00187	Sequence	MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFI
TTDS00187	PDB Structure	1MMH; 1UPE; 2YDO; 2YDV; 3EML; 3PWH; 3QAK; 3REY; 3RFM; 3UZA; 3UZC; 3VG9; 3VGA; 4E
TTDS00187	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00187	Pathway	Calcium signaling pathway
TTDS00187	Pathway	Neuroactive ligand-receptor interaction
TTDS00187	Pathway	Vascular smooth muscle contraction
TTDS00187	Related US Patent	6,440,948
TTDS00187	Related US Patent	6,448,235
TTDS00187	Related US Patent	6,555,545
TTDS00187	Related US Patent	6,579,868
TTDS00187	Related US Patent	6,583,156
TTDS00187	Related US Patent	6,586,413
TTDS00187	Related US Patent	6,608,085
TTDS00187	Related US Patent	6,630,475
TTDS00187	Related US Patent	6,642,210
TTDS00187	Related US Patent	6,653,315
TTDS00187	Target Validation	TTDS00187
TTDS00187	QSAR Model	TTDS00187
TTDS00187	Drug(s)	ATL-146e
TTDS00187	Drug(s)	Adenosine A(2A) receptor antagonist
TTDS00187	Drug(s)	BG-9928
TTDS00187	Drug(s)	BIIB014
TTDS00187	Drug(s)	Caffeine
TTDS00187	Drug(s)	Dexefaroxan
TTDS00187	Drug(s)	GW-493838
TTDS00187	Drug(s)	KW-3902
TTDS00187	Drug(s)	KW-6002
TTDS00187	Drug(s)	MRE-0094
TTDS00187	Drug(s)	Regadenoson
TTDS00187	Drug(s)	SCH 420814
TTDS00187	Drug(s)	T-62
TTDS00187	Inhibitor	(S)-DHPA
TTDS00187	Inhibitor	1-METHYLXANTHINE
TTDS00187	Inhibitor	2,6-diphenyl-9H-purine
TTDS00187	Inhibitor	2-phenylpropoxyadenosine
TTDS00187	Inhibitor	7-Isopropyl-7H-adenine
TTDS00187	Inhibitor	7-Propyl-7H-adenine
TTDS00187	Inhibitor	8-Br-adenine
TTDS00187	Inhibitor	9-Butyl-9H-adenine
TTDS00187	Inhibitor	9-Ethyl-9H-adenine
TTDS00187	Inhibitor	9-Isopropyl-9H-adenine
TTDS00187	Inhibitor	9-Propyl-9H-adenine
TTDS00187	Inhibitor	ALLOXAZINE
TTDS00187	Inhibitor	ARISTEROMYCIN
TTDS00187	Inhibitor	CGS-15943
TTDS00187	Inhibitor	CGS-21680
TTDS00187	Inhibitor	CVT-6883
TTDS00187	Inhibitor	FK-453
TTDS00187	Inhibitor	FK-838
TTDS00187	Inhibitor	FR-166124
TTDS00187	Inhibitor	GALANGIN
TTDS00187	Inhibitor	GNF-PF-2224
TTDS00187	Inhibitor	GNF-PF-2700
TTDS00187	Inhibitor	GW-328267
TTDS00187	Inhibitor	ISOGUANOSINE
TTDS00187	Inhibitor	ISTRADEFYLLINE
TTDS00187	Inhibitor	KF-17837
TTDS00187	Inhibitor	LUF-5417
TTDS00187	Inhibitor	LUF-5433
TTDS00187	Inhibitor	LUF-5437
TTDS00187	Inhibitor	LUF-5767
TTDS00187	Inhibitor	LUF-5956
TTDS00187	Inhibitor	LUF-5957
TTDS00187	Inhibitor	LUF-5962
TTDS00187	Inhibitor	LUF-5978
TTDS00187	Inhibitor	LUF-5980
TTDS00187	Inhibitor	LUF-5981
TTDS00187	Inhibitor	METHYLTHIOADENOSINE
TTDS00187	Inhibitor	METRIFUDIL
TTDS00187	Inhibitor	NECA
TTDS00187	Inhibitor	OSIP-339391
TTDS00187	Inhibitor	PD-115199
TTDS00187	Inhibitor	PSB-0788
TTDS00187	Inhibitor	PSB-09120
TTDS00187	Inhibitor	PSB-1115
TTDS00187	Inhibitor	PSB-601
TTDS00187	Inhibitor	SB-298
TTDS00187	Inhibitor	SCH-412348
TTDS00187	Inhibitor	SCH-442416
TTDS00187	Inhibitor	SCH-58261
TTDS00187	Inhibitor	SCH-63390
TTDS00187	Inhibitor	SLV-320
TTDS00187	Inhibitor	ST-1535
TTDS00187	Inhibitor	Tonapofylline
TTDS00187	Inhibitor	ZM-241385
TTDS00187	Inhibitor	kuanoniamine D
TTDS00187	Antagonist	Adenosine A(2A) receptor antagonist
TTDS00187	Antagonist	BG-9928
TTDS00187	Antagonist	BIIB014
TTDS00187	Antagonist	Caffeine
TTDS00187	Antagonist	KW-3902
TTDS00187	Antagonist	KW-6002
TTDS00187	Antagonist	SCH 420814
TTDS00187	Antagonist	SCH58261
TTDS00187	Antagonist	T-62
TTDS00187	Agonist	ATL-146e
TTDS00187	Agonist	CGS 21680
TTDS00187	Agonist	Dexefaroxan
TTDS00187	Agonist	GW-493838
TTDS00187	Agonist	MRE-0094
TTDS00187	Multitarget	Caffeine
TTDS00187	Multitarget	Dexefaroxan
TTDS00188	UniProt ID	P29275
TTDS00188	Name	Adenosine A2b receptor
TTDS00188	Type of target	Successful target
TTDS00188	Synonyms	A2b Adenosine receptor
TTDS00188	Synonyms	Adenosine receptor A2b
TTDS00188	Disease	Asthma
TTDS00188	Function	Receptor for adenosine. The activity of this receptor is mediated by G proteins
TTDS00188	Sequence	MLLETQDALYVALELVIAALSVAGNVLVCAAVGTANTLQTPTNYFLVSLAAADVAVGLFAIPFAITISLGFCTDFYGCLF
TTDS00188	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00188	Pathway	Calcium signaling pathway
TTDS00188	Pathway	Neuroactive ligand-receptor interaction
TTDS00188	Pathway	Vascular smooth muscle contraction
TTDS00188	Related US Patent	6,387,913
TTDS00188	Related US Patent	6,545,002
TTDS00188	Related US Patent	6,579,868
TTDS00188	Target Validation	TTDS00188
TTDS00188	Drug(s)	Enprofylline paradox
TTDS00188	Drug(s)	Xanthine
TTDS00188	Inhibitor	(1H-Imidazo[4,5-c]quinolin-4-yl)-phenyl-amine;HCl
TTDS00188	Inhibitor	1,3-Diallyl-3,7-dihydro-purine-2,6-dione
TTDS00188	Inhibitor	1,3-Diethyl-3,7-dihydro-purine-2,6-dione
TTDS00188	Inhibitor	1,3-Dipropyl-3,7-dihydro-purine-2,6-dione
TTDS00188	Inhibitor	1-Benzyl-3-methyl-3,7-dihydro-purine-2,6-dione
TTDS00188	Inhibitor	1-Butyl-8-phenyl-3,7-dihydro-purine-2,6-dione
TTDS00188	Inhibitor	1-METHYLXANTHINE
TTDS00188	Inhibitor	1-Propyl-3,7-dihydro-purine-2,6-dione
TTDS00188	Inhibitor	1H-Imidazo[4,5-c]quinolin-4-ylamine;HCl
TTDS00188	Inhibitor	2'-Me-tecadenoson
TTDS00188	Inhibitor	2,5'-dichloro-5'-deoxy-N6-cyclopentyladenosine
TTDS00188	Inhibitor	2,6-diphenyl-8-(1-ethylpropyl)-1-deazapurine
TTDS00188	Inhibitor	2-(6-amino-8-bromo-9H-purin-9-yl)ethanol
TTDS00188	Inhibitor	2-Amino-4,6-di-furan-2-yl-nicotinonitrile
TTDS00188	Inhibitor	2-Amino-4-furan-2-yl-6-phenyl-nicotinonitrile
TTDS00188	Inhibitor	2-Amino-6-furan-2-yl-4-phenyl-nicotinonitrile
TTDS00188	Inhibitor	2-Cyclopentyl-1H-imidazo[4,5-c]quinolin-4-ylamine
TTDS00188	Inhibitor	2-Phenyl-1H-imidazo[4,5-c]quinolin-4-ylamine
TTDS00188	Inhibitor	2-chloro-2'-C-methyl-tecadenoson
TTDS00188	Inhibitor	2-chloro-N6-cyclopentyladenosine
TTDS00188	Inhibitor	2-ethyl-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine
TTDS00188	Inhibitor	3-Isobutyl-1-methyl-3,9-dihydro-purine-2,6-dione
TTDS00188	Inhibitor	3-Methyl-1-phenethyl-3,7-dihydro-purine-2,6-dione
TTDS00188	Inhibitor	3-noradamantyl-1,3-dipropylxanthine
TTDS00188	Inhibitor	8-(3-Fluoro-phenyl)-9-methyl-9H-purin-6-ylamine
TTDS00188	Inhibitor	8-Bromo-9-(2,3-dihydroxypropyl)-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-(2-butyl)-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-(2-hydroxypropyl)-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-(3-hydroxypropyl)-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-(sec-butyl)-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-cyclobutyl-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-cyclopentyl-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-ethyl-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-isopropyl-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-methyl-9H-adenine
TTDS00188	Inhibitor	8-Bromo-9-propyl-9H-adenine
TTDS00188	Inhibitor	8-PHENYL THEOPHYLLINE
TTDS00188	Inhibitor	8-Phenyl-1-propyl-3,7-dihydro-purine-2,6-dione
TTDS00188	Inhibitor	8-bromo-9-isobutyl-9H-purin-6-amine
TTDS00188	Inhibitor	9-(sec-Butyl)-9H-adenine
TTDS00188	Inhibitor	9-Allyl-8-bromo-9H-adenine
TTDS00188	Inhibitor	9-Cyclobutyl-9H-adenine
TTDS00188	Inhibitor	9-Isopropyl-9H-adenine
TTDS00188	Inhibitor	9-Propyl-9H-adenine
TTDS00188	Inhibitor	ALLOXAZINE
TTDS00188	Inhibitor	BETA-HYDROXYETHYL THEOPHYLLINE;Etofylline
TTDS00188	Inhibitor	CGS-15943
TTDS00188	Inhibitor	CVT-6694
TTDS00188	Inhibitor	CVT-6883
TTDS00188	Inhibitor	CVT-7124
TTDS00188	Inhibitor	Ethyl 5-benzoyl-4-phenylthiazol-2-ylcarbamate
TTDS00188	Inhibitor	FK-453
TTDS00188	Inhibitor	GNF-PF-2224
TTDS00188	Inhibitor	GNF-PF-2700
TTDS00188	Inhibitor	GW-328267
TTDS00188	Inhibitor	ISOGUANOSINE
TTDS00188	Inhibitor	KF-17837
TTDS00188	Inhibitor	LUF-5816
TTDS00188	Inhibitor	LUF-5978
TTDS00188	Inhibitor	LUF-5980
TTDS00188	Inhibitor	LUF-5981
TTDS00188	Inhibitor	METHYLTHIOADENOSINE
TTDS00188	Inhibitor	N-(2-(furan-2-yl)-3,4'-bipyridin-6-yl)acetamide
TTDS00188	Inhibitor	N6-((+/-)-endo-norborn-2-yl)adenosine
TTDS00188	Inhibitor	N6-CYCLOPENTYLADENOSINE
TTDS00188	Inhibitor	NECA
TTDS00188	Inhibitor	OSIP-339391
TTDS00188	Inhibitor	PD-115199
TTDS00188	Inhibitor	PSB-0788
TTDS00188	Inhibitor	PSB-09120
TTDS00188	Inhibitor	PSB-1115
TTDS00188	Inhibitor	PSB-601
TTDS00188	Inhibitor	SB-298
TTDS00188	Inhibitor	SLV-320
TTDS00188	Inhibitor	ST-1535
TTDS00188	Inhibitor	Tonapofylline
TTDS00188	Inhibitor	ZM-241385
TTDS00188	Antagonist	Enprofylline paradox
TTDS00188	Antagonist	Xanthine
TTDS00189	UniProt ID	P33765
TTDS00189	Name	Adenosine A3 receptor
TTDS00189	Type of target	Successful target
TTDS00189	Synonyms	A3 Adenosine receptor
TTDS00189	Synonyms	A3AR
TTDS00189	Synonyms	Adenosine 3 receptor
TTDS00189	Synonyms	Adenosine receptor A3A
TTDS00189	Disease	Cancer, unspecific
TTDS00189	Disease	Chronic ileitis
TTDS00189	Disease	Depression
TTDS00189	Disease	Inflammatory bowel disease
TTDS00189	Disease	Myocardial ischemia and reperfusion injury
TTDS00189	Function	Receptor for adenosine. The activity of this receptor is mediated by G proteins
TTDS00189	Sequence	MPNNSTALSLANVTYITMEIFIGLCAIVGNVLVICVVKLNPSLQTTTFYFIVSLALADIAVGVLVMPLAIVVSLGITIHF
TTDS00189	PDB Structure	1OEA; 1R7N
TTDS00189	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00189	Pathway	Neuroactive ligand-receptor interaction
TTDS00189	Related US Patent	6,376,521
TTDS00189	Related US Patent	6,387,913
TTDS00189	Related US Patent	6,436,966
TTDS00189	Related US Patent	6,528,516
TTDS00189	Related US Patent	6,586,413
TTDS00189	Related US Patent	6,620,825
TTDS00189	Target Validation	TTDS00189
TTDS00189	QSAR Model	TTDS00189
TTDS00189	Drug(s)	Adenosine
TTDS00189	Drug(s)	CF101
TTDS00189	Drug(s)	CF102
TTDS00189	Drug(s)	CF502
TTDS00189	Drug(s)	CF602
TTDS00189	Inhibitor	(+)-BUTACLAMOL
TTDS00189	Inhibitor	(+)-NIGULDIPINE
TTDS00189	Inhibitor	(-)-NIGULDIPINE
TTDS00189	Inhibitor	8-PHENYL THEOPHYLLINE
TTDS00189	Inhibitor	9H-purine derivative
TTDS00189	Inhibitor	BEMESETRON
TTDS00189	Inhibitor	CGS-15943
TTDS00189	Inhibitor	CGS-21680
TTDS00189	Inhibitor	CIRSIMARITIN
TTDS00189	Inhibitor	CVT-6883
TTDS00189	Inhibitor	DIZOCILPINE
TTDS00189	Inhibitor	GALANGIN
TTDS00189	Inhibitor	GBR-12909
TTDS00189	Inhibitor	GLUTAMATE
TTDS00189	Inhibitor	GNF-PF-2224
TTDS00189	Inhibitor	GW-328267
TTDS00189	Inhibitor	ICI-118551
TTDS00189	Inhibitor	KAINATE
TTDS00189	Inhibitor	L-249313
TTDS00189	Inhibitor	LUF-5417
TTDS00189	Inhibitor	LUF-5433
TTDS00189	Inhibitor	LUF-5767
TTDS00189	Inhibitor	LUF-5816
TTDS00189	Inhibitor	LUF-5956
TTDS00189	Inhibitor	LUF-5957
TTDS00189	Inhibitor	LUF-5962
TTDS00189	Inhibitor	LUF-5978
TTDS00189	Inhibitor	LUF-5980
TTDS00189	Inhibitor	LUF-5981
TTDS00189	Inhibitor	MESULERGINE
TTDS00189	Inhibitor	METHOCTRAMINE
TTDS00189	Inhibitor	METHYLTHIOADENOSINE
TTDS00189	Inhibitor	METRIFUDIL
TTDS00189	Inhibitor	N6-CYCLOPENTYLADENOSINE
TTDS00189	Inhibitor	NECA
TTDS00189	Inhibitor	NIPECOTIC ACID
TTDS00189	Inhibitor	NITD609
TTDS00189	Inhibitor	NSC-19028
TTDS00189	Inhibitor	NSC-407228
TTDS00189	Inhibitor	OSIP-339391
TTDS00189	Inhibitor	REVERSINE
TTDS00189	Inhibitor	SB-298
TTDS00189	Inhibitor	SCH-442416
TTDS00189	Inhibitor	SEROTONIN
TTDS00189	Inhibitor	SLV-320
TTDS00189	Inhibitor	Tonapofylline
TTDS00189	Inhibitor	VUF-8504
TTDS00189	Inhibitor	VUF-8507
TTDS00189	Antagonist	MRS-1220
TTDS00189	Agonist	3-IB-MECA
TTDS00189	Agonist	Adenosine
TTDS00189	Agonist	CF101
TTDS00189	Agonist	CF102
TTDS00189	Agonist	CF502
TTDS00189	Agonist	CF602
TTDS00189	Agonist	Cl-IB-MECA
TTDS00189	Agonist	IB-MECA
TTDS00191	UniProt ID	P09874
TTDS00191	Name	Poly [ADP-ribose] polymerase-1
TTDS00191	Type of target	Successful target
TTDS00191	Synonyms	ADPRT
TTDS00191	Synonyms	NAD(+) ADP-ribosyltransferase-1
TTDS00191	Synonyms	NAD(+)Poly [ADP-ribose] polymerase-1 ADP-ribosyltransferase-1
TTDS00191	Synonyms	PARP-1
TTDS00191	Synonyms	Poly(ADP-ribose)polymerase-1
TTDS00191	Synonyms	Poly[ADP-ribose] synthetase-1
TTDS00191	Disease	Asthma
TTDS00191	Disease	Cancer, unspecific
TTDS00191	Disease	Chronic obstructive pulmonary disease
TTDS00191	Disease	Diabetic cardiovascular dysfunction
TTDS00191	Disease	Diabetic endothelial dysfunction
TTDS00191	Disease	Multiple sclerosis
TTDS00191	Disease	Traumatic brain injury
TTDS00191	Disease	Tumors
TTDS00191	Function	Involved in the base excision repair (ber) pathway, by catalysing the poly(adp-r
TTDS00191	Sequence	MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWD
TTDS00191	PDB Structure	1UK0; 1UK1; 1WOK; 2COK; 2CR9; 2CS2; 2DMJ; 2JVN; 2L30; 2L31; 2RCW; 2RD6; 2RIQ; 3G
TTDS00191	BioChemical Class	Glycosyltransferases
TTDS00191	Pathway	Base excision repair
TTDS00191	EC Number	EC 2.4.2.30
TTDS00191	Related US Patent	6,444,676
TTDS00191	Related US Patent	6,448,271
TTDS00191	Related US Patent	6,495,541
TTDS00191	Related US Patent	6,548,494
TTDS00191	Target Validation	TTDS00191
TTDS00191	Drug(s)	ABT-767
TTDS00191	Drug(s)	AG-14699
TTDS00191	Drug(s)	AG140699
TTDS00191	Drug(s)	BMN-673
TTDS00191	Drug(s)	BSI-201
TTDS00191	Drug(s)	CEP-9722
TTDS00191	Drug(s)	E7016
TTDS00191	Drug(s)	INO-1001
TTDS00191	Drug(s)	KU-0059436
TTDS00191	Drug(s)	MK-4827
TTDS00191	Drug(s)	MP-124
TTDS00191	Drug(s)	Nicotinamide
TTDS00191	Drug(s)	Olaparib
TTDS00191	Inhibitor	(E)-N-(4-Phenylthiazol-2-yl) cinnamamide
TTDS00191	Inhibitor	1,2,3,4,4a,5-hexahydrophenanthridin-6(10bH)-one
TTDS00191	Inhibitor	1,7,8,9-tetrahydro-1,5-diaza-trindene-4,6-dione
TTDS00191	Inhibitor	2,3-dihydro-1H-benzo[de]isoquinolin-1-one
TTDS00191	Inhibitor	2,8-Dimethyl-3H-quinazolin-4-one
TTDS00191	Inhibitor	2-(2-Chlorophenyl)-2H-indazole-7-carboxamide
TTDS00191	Inhibitor	2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide
TTDS00191	Inhibitor	2-(3-Chlorophenyl)-2H-indazole-7-carboxamide
TTDS00191	Inhibitor	2-(3-Piperidin-1-yl-propyl)-3H-quinazolin-4-one
TTDS00191	Inhibitor	2-(4-Amino-phenyl)-8-hydroxy-3H-quinazolin-4-one
TTDS00191	Inhibitor	2-(4-Amino-phenyl)-8-methyl-3H-quinazolin-4-one
TTDS00191	Inhibitor	2-(4-Azido-phenyl)-8-methoxy-3H-quinazolin-4-one
TTDS00191	Inhibitor	2-(4-Chlorophenyl)-2H-indazole-7-carboxamide
TTDS00191	Inhibitor	2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
TTDS00191	Inhibitor	2-(4-Hydroxy-phenyl)-8-methyl-3H-quinazolin-4-one
TTDS00191	Inhibitor	2-(4-Methoxy-phenyl)-8-methyl-3H-quinazolin-4-one
TTDS00191	Inhibitor	2-(4-methoxyphenyl)quinoline-8-carboxamide
TTDS00191	Inhibitor	2-Benzyl-2H-indazole-7-carboxamide
TTDS00191	Inhibitor	2-Methylquinoline-8-carboxamide
TTDS00191	Inhibitor	2-ethylquinoline-8-carboxamide
TTDS00191	Inhibitor	2-phenyl-2H-benzo[d][1,2,3]triazole-4-carboxamide
TTDS00191	Inhibitor	2-phenyl-2H-indazole-7-carboxamide
TTDS00191	Inhibitor	2-phenylpyrazolo-[1,5-a]pyridine-7-carboxamide
TTDS00191	Inhibitor	2-phenylquinoline-8-carboxamide
TTDS00191	Inhibitor	2H-Isoquinolin-1-one
TTDS00191	Inhibitor	3,4-Dihydro-5-Methyl-Isoquinolinone
TTDS00191	Inhibitor	3-(4-aminophenyl)quinoxaline-5-carboxamide
TTDS00191	Inhibitor	3-(4-cyanophenyl)quinoxaline-5-carboxamide
TTDS00191	Inhibitor	3-(4-methoxyphenyl)quinoxaline-5-carboxamide
TTDS00191	Inhibitor	3-Amino-benzamide
TTDS00191	Inhibitor	3-Ethenylquinoline-8-carboxamide
TTDS00191	Inhibitor	3-Ethylquinoline-8-carboxamide
TTDS00191	Inhibitor	3-Ethynylquinoline-8-carboxamide
TTDS00191	Inhibitor	3-Hydroxy-benzamide
TTDS00191	Inhibitor	3-Methoxybenzamide
TTDS00191	Inhibitor	3-Methylquinoline-8-carboxamide
TTDS00191	Inhibitor	3-Morpholin-4-ylmethyl-5H-phenanthridin-6-one
TTDS00191	Inhibitor	3-Phenylquinoline-8-carboxamide
TTDS00191	Inhibitor	3-Prop-1-ynylquinoline-8-carboxamide
TTDS00191	Inhibitor	3-aminobenzamide
TTDS00191	Inhibitor	3-aminobenzo[c][1,5]naphthyridin-6(5H)-one
TTDS00191	Inhibitor	4-(4-Morpholin-4-yl-butyl)-2H-phthalazin-1-one
TTDS00191	Inhibitor	4-(5-Morpholin-4-yl-pentyl)-2H-phthalazin-1-one
TTDS00191	Inhibitor	4-amino-1,8-naphthalimide
TTDS00191	Inhibitor	4-benzylphthalazin-1(2H)-one
TTDS00191	Inhibitor	4-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione
TTDS00191	Inhibitor	5-Chloro-2-methyl-3H-quinazolin-4-one
TTDS00191	Inhibitor	5-amino-3,4-dihydroisoquinolin-1(2H)-one
TTDS00191	Inhibitor	5-aminoisoquinolin-1(2H)-one
TTDS00191	Inhibitor	5-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione
TTDS00191	Inhibitor	6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
TTDS00191	Inhibitor	8-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one
TTDS00191	Inhibitor	8-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one
TTDS00191	Inhibitor	8-Hydroxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one
TTDS00191	Inhibitor	8-Hydroxy-2-phenyl-3H-quinazolin-4-one
TTDS00191	Inhibitor	8-Methoxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one
TTDS00191	Inhibitor	8-Methoxy-2-methyl-3H-quinazolin-4-one
TTDS00191	Inhibitor	8-Methoxy-2-phenyl-3H-quinazolin-4-one
TTDS00191	Inhibitor	8-Methyl-2-(4-nitro-phenyl)-3H-quinazolin-4-one
TTDS00191	Inhibitor	8-Methyl-2-phenyl-3H-quinazolin-4-one
TTDS00191	Inhibitor	8-Nitro-6H,11H-indeno[1,2-c]isoquinolin-5-one
TTDS00191	Inhibitor	9-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one
TTDS00191	Inhibitor	9-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one
TTDS00191	Inhibitor	ABT-888
TTDS00191	Inhibitor	AG-014376
TTDS00191	Inhibitor	AG-14699
TTDS00191	Inhibitor	AG140699
TTDS00191	Inhibitor	AZD-2281
TTDS00191	Inhibitor	BSI-201
TTDS00191	Inhibitor	BZ3
TTDS00191	Inhibitor	BZ5
TTDS00191	Inhibitor	BZ6
TTDS00191	Inhibitor	CEP-6800
TTDS00191	Inhibitor	Carba-Nicotinamide-Adenine-Dinucleotide
TTDS00191	Inhibitor	DR2313
TTDS00191	Inhibitor	EB-47
TTDS00191	Inhibitor	INO-1001
TTDS00191	Inhibitor	KU-0058948
TTDS00191	Inhibitor	KU-0059436
TTDS00191	Inhibitor	KU-58684
TTDS00191	Inhibitor	MK-4827
TTDS00191	Inhibitor	N-(4-Phenylthiazol-2-yl)isonicotinamide
TTDS00191	Inhibitor	NU-1025
TTDS00191	Inhibitor	NU1025
TTDS00191	Inhibitor	Olaparib
TTDS00191	Inhibitor	PD-128763
TTDS00191	Inhibitor	PJ34
TTDS00191	Inhibitor	Quinoline-8-carboxamide
TTDS00191	Inhibitor	TI1
TTDS00191	Inhibitor	TI3
TTDS00191	Inhibitor	TI4
TTDS00191	Inhibitor	Thieno-phenanthridin-6-one
TTDS00191	Inhibitor	benzo[c][1,5]naphthyridin-6(5H)-one
TTDS00191	Inhibitor	pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione
TTDS00191	Inhibitor	pyrrolo[3,4-e]indole-1,3(2H,6H)-dione
TTDS00191	Binder	Nicotinamide
TTDS00192	UniProt ID	P08515
TTDS00192	UniProt ID	P80894
TTDS00192	UniProt ID	Q8MU52
TTDS00192	Name	Glutathione S-transferase
TTDS00192	Type of target	Successful target
TTDS00192	Synonyms	GST class-alpha
TTDS00192	Synonyms	Glutathione-S-transferase
TTDS00192	Disease	Asthma
TTDS00192	Disease	Cancer, unspecific
TTDS00192	Disease	Helminth infection
TTDS00192	Disease	Malaria
TTDS00192	Disease	Multiple sclerosis
TTDS00192	Disease	Neurodegenerative diseases
TTDS00192	Disease	Schistosomiasis [bilharziasis]
TTDS00192	Disease	Tumors
TTDS00192	Function	Conjugation of reduced glutathione to a wide number of exogenous and endogenous
TTDS00192	Sequence	MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHN
TTDS00192	PDB Structure	1OKT; 1PA3; 1Q4J; 2AAW; 3FR3; 3FR6; 3FR9; 3FRC
TTDS00192	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDS00192	EC Number	EC 2.5.1.18
TTDS00192	Target Validation	TTDS00192
TTDS00192	Drug(s)	Praziquantel
TTDS00192	Inhibitor	Cibacron blue
TTDS00192	Inhibitor	Formic Acid
TTDS00192	Inhibitor	Glutathione Sulfonic Acid
TTDS00192	Inhibitor	Praziquantel
TTDS00192	Inhibitor	Protoporphyrin IX
TTDS00192	Inhibitor	S-Hexylglutathione
TTDS00192	Inhibitor	S-hexylglutathione
TTDS00194	UniProt ID	P25103
TTDS00194	Name	Substance-P receptor
TTDS00194	Type of target	Successful target
TTDS00194	Synonyms	NK-1 receptor
TTDS00194	Synonyms	NK-1R
TTDS00194	Synonyms	Neurokinin 1 receptor
TTDS00194	Synonyms	SPR
TTDS00194	Synonyms	Substance P receptor
TTDS00194	Synonyms	Tachykinin 1 receptor
TTDS00194	Synonyms	Tachykinin neurokinin 1 receptor
TTDS00194	Synonyms	Tachykinin receptor 1
TTDS00194	Disease	Analgesics
TTDS00194	Disease	Asthma
TTDS00194	Disease	Mood [affective] disorders
TTDS00194	Disease	Neuropathic pain
TTDS00194	Disease	Visceral pain
TTDS00194	Function	This is a receptor for the tachykinin neuropeptide substance p. It is probably a
TTDS00194	Sequence	MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEAS
TTDS00194	PDB Structure	2KS9; 2KSA; 2KSB
TTDS00194	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00194	Pathway	Calcium signaling pathway
TTDS00194	Pathway	Neuroactive ligand-receptor interaction
TTDS00194	Related US Patent	6,207,678
TTDS00194	Related US Patent	6,235,735
TTDS00194	Related US Patent	6,258,800
TTDS00194	Related US Patent	6,265,614
TTDS00194	Related US Patent	6,288,225
TTDS00194	Related US Patent	6,319,917
TTDS00194	Related US Patent	6,333,042
TTDS00194	Related US Patent	6,339,094
TTDS00194	Related US Patent	6,358,994
TTDS00194	Related US Patent	6,365,602
TTDS00194	Related US Patent	6,372,754
TTDS00194	Related US Patent	6,403,582
TTDS00194	Related US Patent	6,403,601
TTDS00194	Related US Patent	6,407,106
TTDS00194	Related US Patent	6,432,952
TTDS00194	Related US Patent	6,432,953
TTDS00194	Related US Patent	6,436,928
TTDS00194	Related US Patent	6,452,001
TTDS00194	Related US Patent	6,472,418
TTDS00194	Related US Patent	6,476,077
TTDS00194	Related US Patent	6,479,518
TTDS00194	Related US Patent	6,482,829
TTDS00194	Related US Patent	6,500,818
TTDS00194	Related US Patent	6,518,273
TTDS00194	Related US Patent	6,525,073
TTDS00194	Related US Patent	6,534,502
TTDS00194	Related US Patent	6,564,152
TTDS00194	Related US Patent	6,569,872
TTDS00194	Related US Patent	6,576,638
TTDS00194	Related US Patent	6,583,142
TTDS00194	Related US Patent	6,586,432
TTDS00194	Related US Patent	6,620,438
TTDS00194	Related US Patent	6,635,630
TTDS00194	Related US Patent	6,638,930
TTDS00194	Related US Patent	6,649,614
TTDS00194	Related US Patent	6,664,253
TTDS00194	Related US Patent	6,676,950
TTDS00194	Related US Patent	6,696,042
TTDS00194	Related US Patent	6,727,244
TTDS00194	Target Validation	TTDS00194
TTDS00194	Drug(s)	AZD2624
TTDS00194	Drug(s)	Aprepitant
TTDS00194	Drug(s)	CS-003
TTDS00194	Drug(s)	Casopitant
TTDS00194	Drug(s)	DA-5018
TTDS00194	Drug(s)	DNK-333
TTDS00194	Drug(s)	Ezlopitant
TTDS00194	Drug(s)	GSK 679769
TTDS00194	Drug(s)	GSK1144814
TTDS00194	Drug(s)	GSK424887
TTDS00194	Drug(s)	L-759274
TTDS00194	Drug(s)	Orvepitant
TTDS00194	Drug(s)	R 673
TTDS00194	Drug(s)	SLV-317
TTDS00194	Drug(s)	SLV-323
TTDS00194	Drug(s)	TAK-637
TTDS00194	Drug(s)	Vestipitant
TTDS00194	Drug(s)	Zunrisa/Rezonic
TTDS00194	Inhibitor	(D)-Phe-(D)-Phe-NH2
TTDS00194	Inhibitor	(D)-Phe-(L)-Phe-NH2
TTDS00194	Inhibitor	(L)-Phe-(D)-Phe-NH2
TTDS00194	Inhibitor	2-Phenyl-3-(1-phenyl-ethoxy)-piperidine
TTDS00194	Inhibitor	3,6-Diphenyl-1-oxa-7-aza-spiro[4.5]decane
TTDS00194	Inhibitor	3-Benzyloxy-2-phenyl-piperidine
TTDS00194	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00194	Inhibitor	7-METHYL-8-OXO-5-P-TOLYL-7,8-DIHYDRO-[1,7]NAPHTHYRIDINE-6-CARBOXYLIC ACID (3,5-B
TTDS00194	Inhibitor	7-METHYL-8-OXO-5-P-TOLYL-7,8-DIHYDRO-[1,7]NAPHTHYRIDINE-6-CARBOXYLIC ACID (S)-[(
TTDS00194	Inhibitor	7-METHYL-8-OXO-5-P-TOLYL-7,8-DIHYDRO-[1,7]NAPHTHYRIDINE-6-CARBOXYLIC ACID (S)-[(
TTDS00194	Inhibitor	Ac-Phe-Phe-NH2
TTDS00194	Inhibitor	Arg-Pro-Lys-Pro-Ala-Gln-Phe-Phe-Gly-Leu-Met-NH2
TTDS00194	Inhibitor	Arg-Pro-Lys-Pro-Ala-Ser-Phe-Phe-Gly-Leu-Met-NH2
TTDS00194	Inhibitor	Arg-Pro-Lys-Pro-Gln-Ser-Phe-Phe-Gly-Leu-Met-NH2
TTDS00194	Inhibitor	CP-96345
TTDS00194	Inhibitor	CP-99994
TTDS00194	Inhibitor	ENDOMORPHIN 2
TTDS00194	Inhibitor	H-Ala-Pro-Phe-Phe-NH2
TTDS00194	Inhibitor	H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-OH
TTDS00194	Inhibitor	H-Leu-Phe-NH2
TTDS00194	Inhibitor	H-Phe-NH2
TTDS00194	Inhibitor	H-Phe-Phe-NH2
TTDS00194	Inhibitor	H-Pro-Phe-Phe-NH2
TTDS00194	Inhibitor	H-Tyr(OMe)-Phe(2-Me)-NH2
TTDS00194	Inhibitor	H-Tyr-Ala-Phe-Phe-NH2
TTDS00194	Inhibitor	H-Tyr-D-Ala-Gly Phe-Pro-Leu-Trp-O-3,5-Bzl(CF3)2
TTDS00194	Inhibitor	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NH-3,5-Bzl(CF3)2
TTDS00194	Inhibitor	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NH-Bzl
TTDS00194	Inhibitor	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NMe-3,5-Bzl(CF3)2
TTDS00194	Inhibitor	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-NMe-Bzl
TTDS00194	Inhibitor	H-Tyr-D-Ala-Gly-Phe-Pro-Leu-Trp-O-Bzl
TTDS00194	Inhibitor	H-Tyr-Pro-Ala-Phe-NH2
TTDS00194	Inhibitor	H-Tyr-Pro-Phe-Ala-NH2
TTDS00194	Inhibitor	H-Tyr-Pro-Phe-Phe-OH
TTDS00194	Inhibitor	L-708568
TTDS00194	Inhibitor	L-732138
TTDS00194	Inhibitor	L-733060
TTDS00194	Inhibitor	L-736281
TTDS00194	Inhibitor	L-741671
TTDS00194	Inhibitor	MDL-28163
TTDS00194	Inhibitor	Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
TTDS00194	Inhibitor	R-226161
TTDS00194	Inhibitor	SCH-388714
TTDS00194	Inhibitor	SPANTIDE
TTDS00194	Inhibitor	SUBSTANCE P
TTDS00194	Inhibitor	Substance P
TTDS00194	Inhibitor	Tyr-D-Ala-Gly-Phe-Met-Pro-Leu-Trp-NH-Bzl
TTDS00194	Inhibitor	[Sar9,Met(O2)11]-SP
TTDS00194	Antagonist	AZD2624
TTDS00194	Antagonist	Aprepitant
TTDS00194	Antagonist	CI-1021
TTDS00194	Antagonist	CJ 11,974-01
TTDS00194	Antagonist	CP-100263
TTDS00194	Antagonist	CP-122721
TTDS00194	Antagonist	CP-99,994
TTDS00194	Antagonist	CS-003
TTDS00194	Antagonist	Casopitant
TTDS00194	Antagonist	DA-5018
TTDS00194	Antagonist	DNK-333
TTDS00194	Antagonist	Ezlopitant
TTDS00194	Antagonist	GSK 679769
TTDS00194	Antagonist	GSK1144814
TTDS00194	Antagonist	GSK424887
TTDS00194	Antagonist	L-759274
TTDS00194	Antagonist	MK-869
TTDS00194	Antagonist	Orvepitant
TTDS00194	Antagonist	R 673
TTDS00194	Antagonist	SLV-317
TTDS00194	Antagonist	SSR240600
TTDS00194	Antagonist	TAK-637
TTDS00194	Antagonist	Vestipitant
TTDS00194	Antagonist	Zunrisa/Rezonic
TTDS00194	Agonist	Septide
TTDS00194	Modulator	SLV-323
TTDS00194	Multitarget	CS-003
TTDS00194	Multitarget	DNK-333
TTDS00194	Multitarget	GSK1144814
TTDS00195	UniProt ID	P04035
TTDS00195	Name	3-hydroxy-3-methylglutaryl-coenzyme A reductase
TTDS00195	Type of target	Successful target
TTDS00195	Synonyms	HMG coA reductase
TTDS00195	Synonyms	HMG-CoA reductase
TTDS00195	Disease	Atherosclerosis
TTDS00195	Disease	Cardiovascular disease, unspecified
TTDS00195	Disease	Cervical cancer
TTDS00195	Disease	Coronary heart disease
TTDS00195	Disease	Dyslipidemia
TTDS00195	Disease	Head and neck squamous cell carcinomas
TTDS00195	Disease	Hypercholesterolemia
TTDS00195	Disease	Hypertriglyceridemia
TTDS00195	Disease	Myocardial infarction
TTDS00195	Function	This transmembrane glycoprotein is involved in the control of cholesterol biosyn
TTDS00195	Sequence	MLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYECPKFEEDVLSSDIIILTITRCIAILYIYFQF
TTDS00195	PDB Structure	1DQ8; 1DQ9; 1DQA; 1HW8; 1HW9; 1HWI; 1HWJ; 1HWK; 1HWL; 2Q1L; 2Q6B; 2Q6C; 2R4F; 3B
TTDS00195	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00195	Pathway	Biosynthesis of steroids
TTDS00195	Pathway	Metabolic pathways
TTDS00195	EC Number	EC 1.1.1.34
TTDS00195	Related US Patent	6,245,535
TTDS00195	Related US Patent	6,420,417
TTDS00195	Related US Patent	6,468,780
TTDS00195	Related US Patent	6,492,410
TTDS00195	Related US Patent	6,534,537
TTDS00195	Related US Patent	6,534,540
TTDS00195	Related US Patent	6,541,511
TTDS00195	Related US Patent	6,569,461
TTDS00195	Related US Patent	6,583,295
TTDS00195	Related US Patent	6,620,821
TTDS00195	Related US Patent	6,627,636
TTDS00195	Related US Patent	6,642,268
TTDS00195	Related US Patent	6,680,341
TTDS00195	Target Validation	TTDS00195
TTDS00195	QSAR Model	TTDS00195
TTDS00195	Drug(s)	Atorvastatin
TTDS00195	Drug(s)	BMS-180431
TTDS00195	Drug(s)	Crestor/TriLipix
TTDS00195	Drug(s)	Fluvastatin
TTDS00195	Drug(s)	HMG-CoA reductase inhibitor
TTDS00195	Drug(s)	Lovastatin
TTDS00195	Drug(s)	MK-0524B
TTDS00195	Drug(s)	Pitavastatin
TTDS00195	Drug(s)	Pravastatin
TTDS00195	Drug(s)	Pravigard
TTDS00195	Drug(s)	Rosuvastatin
TTDS00195	Drug(s)	Simvastatin
TTDS00195	Drug(s)	Simvistatin
TTDS00195	Drug(s)	Statins
TTDS00195	Inhibitor	(E)-5-octadecen-7,9-diynoic acid
TTDS00195	Inhibitor	(E)-octadecan-9-ynoic acid
TTDS00195	Inhibitor	(R)-Mevalonate
TTDS00195	Inhibitor	(Z)-5-octadecen-7,9-diynoic acid
TTDS00195	Inhibitor	(Z)-7-octedecan-9-ynoic acid
TTDS00195	Inhibitor	1,4-Dithiothreitol
TTDS00195	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDS00195	Inhibitor	3-(1,3 dodecadiynyl)-6-oxiranebutanoic acid
TTDS00195	Inhibitor	3-Hydroxy-3-Methyl-Glutaric Acid
TTDS00195	Inhibitor	6-hydroxy-7,9-octadecadiynoic acid
TTDS00195	Inhibitor	7,9-octadecadiynoic acid
TTDS00195	Inhibitor	7,9-tetradecadiynoic acid
TTDS00195	Inhibitor	9-octadecynoic acid
TTDS00195	Inhibitor	Adenosine-5'-Diphosphate
TTDS00195	Inhibitor	Atorvastatin
TTDS00195	Inhibitor	Cerivastatin
TTDS00195	Inhibitor	Coenzyme A
TTDS00195	Inhibitor	Crestor/TriLipix
TTDS00195	Inhibitor	F(4-Fluoro)VAE
TTDS00195	Inhibitor	Fluvastatin
TTDS00195	Inhibitor	GFPDGG
TTDS00195	Inhibitor	GFPEGG
TTDS00195	Inhibitor	GFPTGG
TTDS00195	Inhibitor	GLPTGG
TTDS00195	Inhibitor	HMG-CoA reductase inhibitor
TTDS00195	Inhibitor	Lovastatin
TTDS00195	Inhibitor	MK-0524B
TTDS00195	Inhibitor	Meglutol
TTDS00195	Inhibitor	NK-104
TTDS00195	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDS00195	Inhibitor	PF-3052334
TTDS00195	Inhibitor	PITAVASTATIN CALCIUM
TTDS00195	Inhibitor	Pitavastatin
TTDS00195	Inhibitor	Pravastatin
TTDS00195	Inhibitor	Pravigard
TTDS00195	Inhibitor	Rosuvastatin
TTDS00195	Inhibitor	Simvastatin
TTDS00195	Inhibitor	Simvistatin
TTDS00195	Inhibitor	Statins
TTDS00195	Inhibitor	atorvastatin calcium
TTDS00195	Inhibitor	rosuvastatin calcium
TTDS00195	Antagonist	Mevastatin
TTDS00195	Multitarget	Pravigard
TTDS00196	Name	Aldosterone receptor
TTDS00196	Type of target	Successful target
TTDS00196	Disease	Atherosclerosis
TTDS00196	Disease	Cardiovascular disease, unspecified
TTDS00196	Disease	Heart failure
TTDS00196	Disease	Hypertension
TTDS00196	Target Validation	TTDS00196
TTDS00196	Drug(s)	Eplerenone
TTDS00196	Drug(s)	PF-03882845
TTDS00196	Drug(s)	Spironolactone
TTDS00196	Antagonist	Eplerenone
TTDS00196	Antagonist	PF-03882845
TTDS00196	Antagonist	Spironolactone
TTDS00198	UniProt ID	P25101
TTDS00198	Name	Endothelin-1 receptor
TTDS00198	Type of target	Successful target
TTDS00198	Synonyms	ET-A
TTDS00198	Synonyms	ETA receptor
TTDS00198	Synonyms	ETA-R
TTDS00198	Synonyms	Endothelin A receptor
TTDS00198	Synonyms	Endothelin receptor A
TTDS00198	Synonyms	HET-AR
TTDS00198	Disease	Atopic asthma
TTDS00198	Disease	Cardiovascular disease, unspecified
TTDS00198	Disease	Chronic renal failure
TTDS00198	Disease	Hypertension
TTDS00198	Disease	Ovarian cancer
TTDS00198	Function	Receptor for endothelin-1. Mediates its action by association with G proteins th
TTDS00198	Sequence	METLCLRASFWLALVGCVISDNPERYSTNLSNHVDDFTTFRGTELSFLVTTHQPTNLVLPSNGSMHNYCPQQTKITSAFK
TTDS00198	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00198	Pathway	Calcium signaling pathway
TTDS00198	Pathway	Neuroactive ligand-receptor interaction
TTDS00198	Pathway	Vascular smooth muscle contraction
TTDS00198	Related US Patent	6,358,983
TTDS00198	Related US Patent	6,387,915
TTDS00198	Related US Patent	6,509,341
TTDS00198	Related US Patent	6,670,362
TTDS00198	Target Validation	TTDS00198
TTDS00198	Drug(s)	Ambrisentan
TTDS00198	Drug(s)	Atrasentan
TTDS00198	Drug(s)	Avosentan
TTDS00198	Drug(s)	Bosentan
TTDS00198	Drug(s)	PF-1228305
TTDS00198	Drug(s)	Sitaxsentan
TTDS00198	Drug(s)	Zibotentan
TTDS00198	Inhibitor	2-HYDROXY-3,5-DIIODOBENZOIC ACID
TTDS00198	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00198	Inhibitor	Ac-W-F-F-N-Y-Y-W
TTDS00198	Inhibitor	Ac-bhg-F-N-Y-Y-W
TTDS00198	Inhibitor	Ac-w-F-F-N-Y-Y-W
TTDS00198	Inhibitor	BMS-182874
TTDS00198	Inhibitor	BMS-187308
TTDS00198	Inhibitor	BMS-193884
TTDS00198	Inhibitor	BMS-248360
TTDS00198	Inhibitor	BOSENTAN SODIUM
TTDS00198	Inhibitor	PD-155080
TTDS00198	Inhibitor	PD-156707
TTDS00198	Inhibitor	PD-163140
TTDS00198	Inhibitor	Trp-Ile-Ile-Asp-Leu-Hisc(Cys-Ser-Val-Tyr-Phe-Cys)
TTDS00198	Inhibitor	Trp-Ile-Ile-Asp-Leu-Hisc(Cys-Val-Tyr-Phe-Cys)
TTDS00198	Inhibitor	W-F-F-N--Y-Y-W
TTDS00198	Inhibitor	asterric acid
TTDS00198	Inhibitor	bhg-F-N-Y-Y-W
TTDS00198	Inhibitor	endothelin-1
TTDS00198	Inhibitor	endothelin-2
TTDS00198	Antagonist	ABT-627
TTDS00198	Antagonist	Ambrisentan
TTDS00198	Antagonist	Atrasentan
TTDS00198	Antagonist	Avosentan
TTDS00198	Antagonist	BQ-123
TTDS00198	Antagonist	BQ610
TTDS00198	Antagonist	Bosentan
TTDS00198	Antagonist	FR139317
TTDS00198	Antagonist	LU302146
TTDS00198	Antagonist	LU302872
TTDS00198	Antagonist	PD142893
TTDS00198	Antagonist	PD156707
TTDS00198	Antagonist	PF-1228305
TTDS00198	Antagonist	Sitaxsentan
TTDS00198	Antagonist	TBC 11251 (TBC)
TTDS00198	Antagonist	Zibotentan
TTDS00198	Multitarget	Bosentan
TTDS00199	UniProt ID	P24530
TTDS00199	Name	Endothelin B receptor
TTDS00199	Type of target	Successful target
TTDS00199	Synonyms	ET-B
TTDS00199	Synonyms	Endothelin receptor B
TTDS00199	Synonyms	Endothelin receptor Non-selective type
TTDS00199	Disease	Atopic asthma
TTDS00199	Disease	Glial proliferation
TTDS00199	Disease	Melanoma
TTDS00199	Disease	Neuronal injury
TTDS00199	Function	Non-specific receptor for endothelin 1, 2, and 3. Mediates its action by associa
TTDS00199	Sequence	MQPPPSLCGRALVALVLACGLSRIWGEERGFPPDRATPLLQTAEIMTPPTKTLWPKGSNASLARSLAPAEVPKGDRTAGS
TTDS00199	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00199	Pathway	Calcium signaling pathway
TTDS00199	Pathway	Melanogenesis
TTDS00199	Pathway	Neuroactive ligand-receptor interaction
TTDS00199	Related US Patent	6,358,983
TTDS00199	Related US Patent	6,509,341
TTDS00199	Target Validation	TTDS00199
TTDS00199	Drug(s)	Bosentan
TTDS00199	Drug(s)	SPI-1620
TTDS00199	Inhibitor	Ac-W-F-F-N-Y-Y-W
TTDS00199	Inhibitor	Ac-bhg-F-N-Y-Y-W
TTDS00199	Inhibitor	Ac-w-F-F-N-Y-Y-W
TTDS00199	Inhibitor	BMS-193884
TTDS00199	Inhibitor	BOSENTAN SODIUM
TTDS00199	Inhibitor	Compound ET-3
TTDS00199	Inhibitor	Compound RES-701-1(1-10)/[A15]ET-1
TTDS00199	Inhibitor	Compound RES-701-1(1-10)/[A15]ET-3
TTDS00199	Inhibitor	Compound RES-701-1(1-10)/[A15]SRTX6b
TTDS00199	Inhibitor	Compound SRTX6b
TTDS00199	Inhibitor	Compound [S15]ET-1
TTDS00199	Inhibitor	ET-1
TTDS00199	Inhibitor	Endothelin-3
TTDS00199	Inhibitor	IRL-1722
TTDS00199	Inhibitor	IRL-1841
TTDS00199	Inhibitor	IRL-2500
TTDS00199	Inhibitor	PD-155080
TTDS00199	Inhibitor	PD-156707
TTDS00199	Inhibitor	PD-163140
TTDS00199	Inhibitor	RES-701-1
TTDS00199	Inhibitor	RES-701-1-C-terminal analogue
TTDS00199	Inhibitor	Trp-Ile-Ile-Asp-Leu-Hisc(Cys-Ser-Val-Tyr-Phe-Cys)
TTDS00199	Inhibitor	Trp-Ile-Ile-Asp-Leu-Hisc(Cys-Val-Tyr-Phe-Cys)
TTDS00199	Inhibitor	W-F-F-N--Y-Y-W
TTDS00199	Inhibitor	bhg-F-N-Y-Y-W
TTDS00199	Inhibitor	linear peptide of RES-701-1
TTDS00199	Antagonist	BQ788
TTDS00199	Antagonist	Bosentan
TTDS00199	Antagonist	Bosentan hydrate
TTDS00199	Antagonist	LU302872
TTDS00199	Antagonist	PD142893
TTDS00199	Antagonist	Sarafotoxin 6C
TTDS00199	Agonist	SPI-1620
TTDS00199	Multitarget	Bosentan
TTDS00200	Name	CGMP-inhibited 3',5'-cyclic phosphodiesterase
TTDS00200	Type of target	Successful target
TTDS00200	Synonyms	CAMP phosphodiesterase III
TTDS00200	Synonyms	CGI-PDE
TTDS00200	Synonyms	Cyclic AMP phosphodiesterase III
TTDS00200	Synonyms	Cyclic GMP inhibited phosphodiesterase
TTDS00200	Synonyms	PDE3
TTDS00200	Synonyms	Phosphodiesterase 3
TTDS00200	Synonyms	Phosphodiesterase III
TTDS00200	Disease	Asthma
TTDS00200	Disease	Atopic dermatitis
TTDS00200	Disease	Hepatic ischemia-reperfusion injury
TTDS00200	Disease	Malignant tumors
TTDS00200	Disease	Peripheral arterial disease
TTDS00200	Disease	Tumors
TTDS00200	Disease	Vascular disease
TTDS00200	EC Number	EC 3.1.4.17
TTDS00200	Related US Patent	6,255,303
TTDS00200	Related US Patent	6,403,597
TTDS00200	Related US Patent	6,498,173
TTDS00200	Related US Patent	6,541,487
TTDS00200	Related US Patent	6,610,746
TTDS00200	Target Validation	TTDS00200
TTDS00200	Drug(s)	Amrinone
TTDS00200	Drug(s)	Enoximone
TTDS00200	Drug(s)	Oxtriphylline
TTDS00200	Inhibitor	Amrinone
TTDS00200	Inhibitor	Cilostamide
TTDS00200	Inhibitor	Enoximone
TTDS00200	Inhibitor	Olprinone
TTDS00200	Inhibitor	Oxtriphylline
TTDS00200	Inhibitor	R 80122
TTDS00201	Name	CAMP-phosphodiesterase
TTDS00201	Type of target	Successful target
TTDS00201	Synonyms	3',5'-cyclic-nucleotide phosphodiesterase
TTDS00201	Synonyms	Cyclic Amp phosphodiesterase
TTDS00201	Disease	Atopic disease
TTDS00201	EC Number	EC 3.1.4.17
TTDS00201	Target Validation	TTDS00201
TTDS00201	Drug(s)	Inamrinone
TTDS00201	Inhibitor	Inamrinone
TTDS00201	Inhibitor	Iso-caffeine
TTDS00201	Inhibitor	Ro 20-1724
TTDS00201	Inhibitor	S(-)enantiomer of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP)
TTDS00201	Inhibitor	Trifluperidol
TTDS00202	UniProt ID	P00734
TTDS00202	Name	Thrombin
TTDS00202	Type of target	Successful target
TTDS00202	Synonyms	Coagulation factor II
TTDS00202	Synonyms	Prothrombin
TTDS00202	Disease	Coagulative disorders
TTDS00202	Disease	Coronary atherosclerosis
TTDS00202	Disease	Gliomas
TTDS00202	Disease	Heparin-induced thrombocytopenia type II
TTDS00202	Disease	Multiple organ failure
TTDS00202	Disease	Thromboembolic disorders
TTDS00202	Disease	Thrombosis
TTDS00202	Disease	Thrombotic disease
TTDS00202	Function	Thrombin, which cleaves bonds after arg and lys, converts fibrinogen to fibrin a
TTDS00202	Sequence	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTAT
TTDS00202	PDB Structure	1A2C; 1A3B; 1A3E; 1A46; 1A4W; 1A5G; 1A61; 1ABI; 1ABJ; 1AD8; 1AE8; 1AFE; 1AHT; 1A
TTDS00202	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00202	Pathway	Complement and coagulation cascades
TTDS00202	Pathway	Neuroactive ligand-receptor interaction
TTDS00202	Pathway	Regulation of actin cytoskeleton
TTDS00202	EC Number	EC 3.4.21.5
TTDS00202	Related US Patent	6,239,132
TTDS00202	Related US Patent	6,245,763
TTDS00202	Related US Patent	6,326,386
TTDS00202	Related US Patent	6,326,492
TTDS00202	Related US Patent	6,350,745
TTDS00202	Related US Patent	6,350,764
TTDS00202	Related US Patent	6,362,190
TTDS00202	Related US Patent	6,387,911
TTDS00202	Related US Patent	6,391,901
TTDS00202	Related US Patent	6,407,067
TTDS00202	Related US Patent	6,410,536
TTDS00202	Related US Patent	6,433,186
TTDS00202	Related US Patent	6,441,008
TTDS00202	Related US Patent	6,455,532
TTDS00202	Related US Patent	6,462,021
TTDS00202	Related US Patent	6,462,050
TTDS00202	Related US Patent	6,472,393
TTDS00202	Related US Patent	6,500,855
TTDS00202	Related US Patent	6,506,754
TTDS00202	Related US Patent	6,506,760
TTDS00202	Related US Patent	6,506,761
TTDS00202	Related US Patent	6,509,335
TTDS00202	Related US Patent	6,515,011
TTDS00202	Related US Patent	6,521,625
TTDS00202	Related US Patent	6,521,663
TTDS00202	Related US Patent	6,528,503
TTDS00202	Related US Patent	6,534,510
TTDS00202	Related US Patent	6,541,467
TTDS00202	Related US Patent	6,576,657
TTDS00202	Related US Patent	6,586,418
TTDS00202	Related US Patent	6,599,894
TTDS00202	Related US Patent	6,602,871
TTDS00202	Related US Patent	6,610,701
TTDS00202	Related US Patent	6,635,651
TTDS00202	Related US Patent	6,642,253
TTDS00202	Related US Patent	6,670,381
TTDS00202	Target Validation	TTDS00202
TTDS00202	Drug(s)	AZD0837
TTDS00202	Drug(s)	Argatroban
TTDS00202	Drug(s)	Bivalirudin
TTDS00202	Drug(s)	Dabigatran
TTDS00202	Drug(s)	Dermolastin
TTDS00202	Drug(s)	Lepirudin
TTDS00202	Drug(s)	SR-123781A
TTDS00202	Drug(s)	Ximelagatran
TTDS00202	Drug(s)	Ximelegatran
TTDS00202	Inhibitor	(3,4-dichlorophenyl)(1H-pyrazol-1-yl)methanone
TTDS00202	Inhibitor	(3-nitro-1H-pyrazol-1-yl)(p-tolyl)methanone
TTDS00202	Inhibitor	(3-nitro-1H-pyrazol-1-yl)(phenyl)methanone
TTDS00202	Inhibitor	(4-bromo-1H-pyrazol-1-yl)(p-tolyl)methanone
TTDS00202	Inhibitor	(4-nitro-1H-pyrazol-1-yl)(o-tolyl)methanone
TTDS00202	Inhibitor	(4-nitro-1H-pyrazol-1-yl)(phenyl)methanone
TTDS00202	Inhibitor	1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE
TTDS00202	Inhibitor	1-benzoyl-N-phenyl-1H-pyrazole-3-carboxamide
TTDS00202	Inhibitor	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine
TTDS00202	Inhibitor	2-NAPHTHALENESULFONIC ACID
TTDS00202	Inhibitor	2-nas-phe(3-am)-4-(2-guanidinoethyl)piperidine
TTDS00202	Inhibitor	3-(4-HYDROXY-PHENYL)PYRUVIC ACID
TTDS00202	Inhibitor	3-chlorophenyl 2-oxo-2H-chromene-3-carboxylate
TTDS00202	Inhibitor	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL
TTDS00202	Inhibitor	4-(3,4-Diethoxy-benzylamino)-benzamidine
TTDS00202	Inhibitor	4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine
TTDS00202	Inhibitor	4-Iodobenzo[B]Thiophene-2-Carboxamidine
TTDS00202	Inhibitor	4-TERT-BUTYLBENZENESULFONIC ACID
TTDS00202	Inhibitor	4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE
TTDS00202	Inhibitor	5-desgalloylstachyurin
TTDS00202	Inhibitor	6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE
TTDS00202	Inhibitor	AC-(D)PHE-PRO-BOROHOMOLYS-OH
TTDS00202	Inhibitor	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH
TTDS00202	Inhibitor	AC-(D)PHE-PRO-BOROLYS-OH
TTDS00202	Inhibitor	AZD0837
TTDS00202	Inhibitor	Argatroban
TTDS00202	Inhibitor	BCH-2763
TTDS00202	Inhibitor	BENZOTHIAZOLE
TTDS00202	Inhibitor	BIBR 1048
TTDS00202	Inhibitor	BMS-344577
TTDS00202	Inhibitor	BMS-740808
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-(EQKLISEEDL)-Gly-Hir
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-(SPH(pY)EKVS)-Gly-Hir
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-(SPHYEKVS)-Gly-Hir
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-S-(GS)1-Gly-Hir
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-S-(GS)11-Gly-Hir
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-S-(GS)13-Gly-Hir
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-S-(GS)3-Gly-Hir
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-S-(GS)5-Gly-Hir
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-S-(GS)7-Gly-Hir
TTDS00202	Inhibitor	Bbs-Arg-(D-Pip)-Gly-S-(GS)9-Gly-Hir
TTDS00202	Inhibitor	Beta-(2-Naphthyl)-Alanine
TTDS00202	Inhibitor	Bivalirudin
TTDS00202	Inhibitor	Bivalirudine
TTDS00202	Inhibitor	CASUARIIN
TTDS00202	Inhibitor	CHLORODYSINOSIN A
TTDS00202	Inhibitor	COCHINCHINENENE B
TTDS00202	Inhibitor	COCHINCHINENIN B
TTDS00202	Inhibitor	CRA_8696
TTDS00202	Inhibitor	D-Pro-Phe-Arg chloromethyl ketone
TTDS00202	Inhibitor	D-leucyl-N-(3-chlorobenzyl)-L-prolinamide
TTDS00202	Inhibitor	D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide
TTDS00202	Inhibitor	D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide
TTDS00202	Inhibitor	D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide
TTDS00202	Inhibitor	D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide
TTDS00202	Inhibitor	D-phenylalanyl-N-benzyl-L-prolinamide
TTDS00202	Inhibitor	DYSINOSIN A
TTDS00202	Inhibitor	Dabigatran
TTDS00202	Inhibitor	Dermolastin
TTDS00202	Inhibitor	Desirudine
TTDS00202	Inhibitor	DuP 714
TTDS00202	Inhibitor	DuP-714
TTDS00202	Inhibitor	Efegatran
TTDS00202	Inhibitor	Enoxaprin
TTDS00202	Inhibitor	GR-133686
TTDS00202	Inhibitor	Gamma-Carboxy-Glutamic Acid
TTDS00202	Inhibitor	H376/95
TTDS00202	Inhibitor	Hemi-Babim
TTDS00202	Inhibitor	Heparin-Cantithrombin III
TTDS00202	Inhibitor	Hirudin
TTDS00202	Inhibitor	Hirulog
TTDS00202	Inhibitor	INOGATRAN
TTDS00202	Inhibitor	L-370,518
TTDS00202	Inhibitor	L-374,087
TTDS00202	Inhibitor	L-375378
TTDS00202	Inhibitor	LB30057
TTDS00202	Inhibitor	LB30812
TTDS00202	Inhibitor	Lepirudin
TTDS00202	Inhibitor	Lepirudine
TTDS00202	Inhibitor	Licostinel
TTDS00202	Inhibitor	Lysophosphotidylserine
TTDS00202	Inhibitor	MELAGATRAN
TTDS00202	Inhibitor	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE
TTDS00202	Inhibitor	Melagatran dipeptide
TTDS00202	Inhibitor	Melogatran
TTDS00202	Inhibitor	N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE
TTDS00202	Inhibitor	OSCILLARIN
TTDS00202	Inhibitor	PEDUNCULAGIN
TTDS00202	Inhibitor	PPACK
TTDS00202	Inhibitor	RAZAXABAN
TTDS00202	Inhibitor	RAZAXABAN HYDROCHLORIDE
TTDS00202	Inhibitor	RWJ-50353
TTDS00202	Inhibitor	RWJ-671818
TTDS00202	Inhibitor	S-2238
TTDS00202	Inhibitor	SC-79407
TTDS00202	Inhibitor	SR-123781A
TTDS00202	Inhibitor	Ximelagatran
TTDS00202	Inhibitor	Ximelegatran
TTDS00202	Inhibitor	beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide
TTDS00202	Inhibitor	cyclotheonamide E
TTDS00202	Inhibitor	cyclotheonamide E4
TTDS00202	Inhibitor	cyclotheonamide E5
TTDS00202	Inhibitor	macrocyclic tripeptide motif
TTDS00202	Inhibitor	methyl L-phenylalaninate
TTDS00202	Inhibitor	penta-O-galloyl-beta-glucoside
TTDS00202	Inhibitor	tellimagrandin II
TTDS00202	Cofactor	Vitamin K
TTDS00202	Multitarget	Dermolastin
TTDS00202	Multitarget	SR-123781A
TTDS00203	UniProt ID	P00742
TTDS00203	Name	Coagulation factor Xa
TTDS00203	Type of target	Successful target
TTDS00203	Synonyms	Activated coagulation factor X
TTDS00203	Synonyms	Factor Xa
TTDS00203	Synonyms	Fxa
TTDS00203	Disease	Atrial fibrillation and flutter
TTDS00203	Disease	Cardiovascular disease, unspecified
TTDS00203	Disease	Coagulative disorders
TTDS00203	Disease	Thromboembolic disorders
TTDS00203	Disease	Thromboembolism
TTDS00203	Disease	Thrombosis
TTDS00203	Disease	Thrombotic disease
TTDS00203	Sequence	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEF
TTDS00203	PDB Structure	1C5M; 1EZQ; 1F0R; 1F0S; 1FAX; 1FJS; 1FXY; 1G2L; 1G2M; 1HCG; 1IOE; 1IQE; 1IQF; 1I
TTDS00203	Pathway	Complement and coagulation cascades
TTDS00203	EC Number	EC 3.4.21.6
TTDS00203	Related US Patent	6,297,233
TTDS00203	Related US Patent	6,337,344
TTDS00203	Related US Patent	6,376,515
TTDS00203	Related US Patent	6,399,627
TTDS00203	Related US Patent	6,399,644
TTDS00203	Related US Patent	6,407,256
TTDS00203	Related US Patent	6,410,536
TTDS00203	Related US Patent	6,426,346
TTDS00203	Related US Patent	6,429,205
TTDS00203	Related US Patent	6,436,985
TTDS00203	Related US Patent	6,469,026
TTDS00203	Related US Patent	6,469,029
TTDS00203	Related US Patent	6,472,393
TTDS00203	Related US Patent	6,486,154
TTDS00203	Related US Patent	6,492,368
TTDS00203	Related US Patent	6,500,855
TTDS00203	Related US Patent	6,506,771
TTDS00203	Related US Patent	6,509,335
TTDS00203	Related US Patent	6,511,973
TTDS00203	Related US Patent	6,521,663
TTDS00203	Related US Patent	6,525,076
TTDS00203	Related US Patent	6,534,535
TTDS00203	Related US Patent	6,541,488
TTDS00203	Related US Patent	6,544,981
TTDS00203	Related US Patent	6,545,054
TTDS00203	Related US Patent	6,545,055
TTDS00203	Related US Patent	6,548,512
TTDS00203	Related US Patent	6,548,517
TTDS00203	Related US Patent	6,548,525
TTDS00203	Related US Patent	6,552,042
TTDS00203	Related US Patent	6,555,542
TTDS00203	Related US Patent	6,569,874
TTDS00203	Related US Patent	6,586,418
TTDS00203	Related US Patent	6,599,926
TTDS00203	Related US Patent	6,602,871
TTDS00203	Related US Patent	6,602,895
TTDS00203	Related US Patent	6,630,468
TTDS00203	Related US Patent	6,630,505
TTDS00203	Related US Patent	6,632,815
TTDS00203	Related US Patent	6,638,980
TTDS00203	Related US Patent	6,642,252
TTDS00203	Related US Patent	6,660,739
TTDS00203	Related US Patent	6,667,332
TTDS00203	Related US Patent	6,673,810
TTDS00203	Related US Patent	6,673,817
TTDS00203	Related US Patent	6,686,368
TTDS00203	Related US Patent	6,747,158
TTDS00203	Target Validation	TTDS00203
TTDS00203	Drug(s)	AVE5026
TTDS00203	Drug(s)	Apixaban
TTDS00203	Drug(s)	Certoparin sodium
TTDS00203	Drug(s)	Coagulation Factor IX
TTDS00203	Drug(s)	DU-176b
TTDS00203	Drug(s)	Danaparoid
TTDS00203	Drug(s)	Enoxaparin
TTDS00203	Drug(s)	Fondaparinux sodium
TTDS00203	Drug(s)	GSK813893
TTDS00203	Drug(s)	Idraparinux
TTDS00203	Drug(s)	Lmw heparin
TTDS00203	Drug(s)	Nadroparin calcium
TTDS00203	Drug(s)	Octopamine
TTDS00203	Drug(s)	Otamixaban
TTDS00203	Drug(s)	PD-348292
TTDS00203	Drug(s)	Rivaroxaban
TTDS00203	Drug(s)	SR-123781A
TTDS00203	Drug(s)	TAK-442
TTDS00203	Inhibitor	AVE5026
TTDS00203	Inhibitor	Antistasin
TTDS00203	Inhibitor	Apixaban
TTDS00203	Inhibitor	CI-1031
TTDS00203	Inhibitor	Chloroaniline 1
TTDS00203	Inhibitor	DPC 423
TTDS00203	Inhibitor	DX-9065a
TTDS00203	Inhibitor	DX9065
TTDS00203	Inhibitor	Danaparoid
TTDS00203	Inhibitor	Enoxaparin
TTDS00203	Inhibitor	Fondaparinux
TTDS00203	Inhibitor	Fondaparinux sodium
TTDS00203	Inhibitor	Idraparinux
TTDS00203	Inhibitor	Lefaxin
TTDS00203	Inhibitor	M55113
TTDS00203	Inhibitor	M55551
TTDS00203	Inhibitor	Octopamine
TTDS00203	Inhibitor	Otamixaban
TTDS00203	Inhibitor	PD-348292
TTDS00203	Inhibitor	SC-83157
TTDS00203	Inhibitor	SF303
TTDS00203	Inhibitor	SK509
TTDS00203	Inhibitor	SK549
TTDS00203	Inhibitor	SK554
TTDS00203	Inhibitor	SN429
TTDS00203	Inhibitor	SR-123781A
TTDS00203	Inhibitor	T01312
TTDS00203	Inhibitor	TAK-442
TTDS00203	Inhibitor	Tick anticoagulant peptide
TTDS00203	Inhibitor	Tick anticoagulant peptide (TAP)
TTDS00203	Inhibitor	YM-96765
TTDS00203	Inhibitor	YM60828
TTDS00203	Activator	Coagulation Factor IX
TTDS00203	Multitarget	SR-123781A
TTDS00204	UniProt ID	P12259
TTDS00204	Name	Coagulation Factor Va
TTDS00204	Type of target	Successful target
TTDS00204	Synonyms	Factor Va
TTDS00204	Disease	Sepsis
TTDS00204	Sequence	MFPGCPRLWVLVVLGTSWVGWGSQGTEAAQLRQFYVAAQGISWSYRPEPTNSSLNLSVTSFKKIVYREYEPYFKKEKPQS
TTDS00204	PDB Structure	1CZS; 1CZT; 1CZV; 1FV4; 1Y61; 3P6Z; 3P70; 3S9C
TTDS00204	Pathway	Complement and coagulation cascades
TTDS00204	Target Validation	TTDS00204
TTDS00204	Drug(s)	Drotrecogin alfa
TTDS00204	Inhibitor	Drotrecogin alfa
TTDS00204	Inhibitor	Phenylmercury
TTDS00204	Inhibitor	RAZAXABAN
TTDS00204	Multitarget	Drotrecogin alfa
TTDS00205	UniProt ID	P00451
TTDS00205	Name	Coagulation Factor VIIIa
TTDS00205	Type of target	Successful target
TTDS00205	Synonyms	Factor VIIIa
TTDS00205	Disease	Sepsis
TTDS00205	Sequence	MQIELSTCFFLCLLRFCFSATRRYYLGAVELSWDYMQSDLGELPVDARFPPRVPKSFPFNTSVVYKKTLFVEFTDHLFNI
TTDS00205	PDB Structure	1CFG; 1D7P; 1FAC; 1IQD; 2R7E; 3CDZ; 3HNB; 3HNY; 3HOB; 4BDV
TTDS00205	Pathway	Complement and coagulation cascades
TTDS00205	Target Validation	TTDS00205
TTDS00205	Drug(s)	Drotrecogin alfa
TTDS00205	Inhibitor	Drotrecogin alfa
TTDS00205	Multitarget	Drotrecogin alfa
TTDS00206	UniProt ID	P08235
TTDS00206	Name	Mineralocorticoid receptor
TTDS00206	Type of target	Successful target
TTDS00206	Synonyms	Delta
TTDS00206	Synonyms	Inner ear mineralocorticoid receptor
TTDS00206	Synonyms	MR
TTDS00206	Disease	Autoimmune and sudden sensorineural hearing loss
TTDS00206	Disease	Brain injury
TTDS00206	Function	Receptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoid
TTDS00206	Sequence	METKGYHSLPEGLDMERRWGQVSQAVERSSLGPTERTDENNYMEIVNVSCVSGAIPNNSTQGSSKEKQELLPCLQQDNNR
TTDS00206	PDB Structure	1Y9R; 1YA3; 2A3I; 2AA2; 2AA5; 2AA6; 2AA7; 2AAX; 2AB2; 2ABI; 2OAX; 3VHU; 3VHV
TTDS00206	BioChemical Class	Zinc-finger
TTDS00206	Related US Patent	6,586,416
TTDS00206	Target Validation	TTDS00206
TTDS00206	Drug(s)	BAY 94-8862
TTDS00206	Drug(s)	CS-3150
TTDS00206	Drug(s)	Desoxycorticosterone Pivalate
TTDS00206	Drug(s)	Drospirenone
TTDS00206	Drug(s)	Fludrocortisone
TTDS00206	Drug(s)	LY2623091
TTDS00206	Drug(s)	XL550
TTDS00206	Inhibitor	(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE
TTDS00206	Inhibitor	AL-43
TTDS00206	Inhibitor	Aldosterone
TTDS00206	Inhibitor	B-Octylglucoside
TTDS00206	Inhibitor	EPIERENONE
TTDS00206	Inhibitor	LG-120838
TTDS00206	Inhibitor	LGD-5552
TTDS00206	Inhibitor	ONAPRISTONE
TTDS00206	Inhibitor	WAY-255348
TTDS00206	Antagonist	XL550
TTDS00206	Agonist	Fludrocortisone
TTDS00206	Binder	Desoxycorticosterone Pivalate
TTDS00206	Binder	Drospirenone
TTDS00208	UniProt ID	O33305
TTDS00208	UniProt ID	P00374
TTDS00208	UniProt ID	P00379
TTDS00208	UniProt ID	P0ABQ4
TTDS00208	UniProt ID	P13922
TTDS00208	UniProt ID	P16184
TTDS00208	UniProt ID	Q27793
TTDS00208	UniProt ID	Q8I372
TTDS00208	UniProt ID	Q9HBH1
TTDS00208	Name	Dihydrofolate reductase
TTDS00208	Type of target	Successful target
TTDS00208	Disease	Autoimmune diseases
TTDS00208	Disease	Bacterial infections
TTDS00208	Disease	Cancer, unspecific
TTDS00208	Disease	Chagas' disease
TTDS00208	Disease	Fungal diseases
TTDS00208	Disease	Inflammation
TTDS00208	Disease	Leishmania infections
TTDS00208	Disease	Leprosy, unspecified
TTDS00208	Disease	Malaria
TTDS00208	Disease	Microbial infections
TTDS00208	Disease	P. carinii pneumonia
TTDS00208	Disease	Parasitic diseases
TTDS00208	Disease	Toxoplasma infections
TTDS00208	Disease	Trypanosomatid infections
TTDS00208	Disease	Tuberculosis
TTDS00208	Sequence	MMEQVCDVFDIYAICACCKVESKNEGKKNEVFNNYTFRGLGNKGVLPWKCNSLDMKYFRAVTTYVNESKYEKLKYKRCKY
TTDS00208	PDB Structure	3G5K; 3G5P
TTDS00208	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDS00208	Pathway	Folate biosynthesis
TTDS00208	Pathway	Glyoxylate and dicarboxylate metabolism
TTDS00208	Pathway	Metabolic pathways
TTDS00208	Pathway	Methionine metabolism
TTDS00208	Pathway	One carbon pool by folate
TTDS00208	EC Number	EC 1.5.1.3
TTDS00208	Target Validation	TTDS00208
TTDS00208	QSAR Model	TTDS00208
TTDS00208	Drug(s)	Aminopterin
TTDS00208	Drug(s)	Chlorproguanil
TTDS00208	Drug(s)	Iclaprim
TTDS00208	Drug(s)	MCB-3837
TTDS00208	Drug(s)	Metoprine
TTDS00208	Drug(s)	Pralatrexate
TTDS00208	Drug(s)	Proguanil
TTDS00208	Drug(s)	Proquanil
TTDS00208	Drug(s)	Pyrimethamine
TTDS00208	Drug(s)	Trimethoprim
TTDS00208	Drug(s)	Trimetrexate
TTDS00208	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDS00208	Inhibitor	2'-Monophosphoadenosine-5'-Diphosphate
TTDS00208	Inhibitor	2,4-diamino triazine
TTDS00208	Inhibitor	2-(N-Morpholino)-Ethanesulfonic Acid
TTDS00208	Inhibitor	2-Allylthio-3-benzyl-6-nitro-quinazolin-4(3H)-one
TTDS00208	Inhibitor	2-Allylthio-6-amino-3-benzyl-quinazolin-4(3H)-one
TTDS00208	Inhibitor	3-Benzyl-2-ethylthio-6-nitro-quinazolin-4(3H)-one
TTDS00208	Inhibitor	3-Phenylsulfanylmethyl-quinoxaline-5,7-diamine
TTDS00208	Inhibitor	3-benzyl-2-mercapto-6-nitroquinazolin-4(3H)-one
TTDS00208	Inhibitor	4-(2,6-diamino-9H-purin-8-yl)-2,6-dimethoxyphenol
TTDS00208	Inhibitor	5,10-Dideazatetrahydrofolic Acid
TTDS00208	Inhibitor	5-((E)-Styryl)-quinazoline-2,4-diamine
TTDS00208	Inhibitor	5-(2-fluorobenzyloxy)quinazoline-2,4-diamine
TTDS00208	Inhibitor	5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine
TTDS00208	Inhibitor	5-Chloryl-2,4,6-Quinazolinetriamine
TTDS00208	Inhibitor	5-Formyl-6-Hydrofolic Acid
TTDS00208	Inhibitor	5-Phenethyl-quinazoline-2,4-diamine
TTDS00208	Inhibitor	5-Phenylsulfanyl-2,4-Quinazolinediamine
TTDS00208	Inhibitor	5-Phenylsulfanyl-quinazoline-2,4-diamine
TTDS00208	Inhibitor	5-p-Tolylsulfanyl-quinazoline-2,4-diamine
TTDS00208	Inhibitor	6,7-Diphenyl-pteridine-2,4-diamine
TTDS00208	Inhibitor	6-(2-Phenylsulfanyl-ethyl)-pteridine-2,4-diamine
TTDS00208	Inhibitor	6-Phenylaminomethyl-quinazoline-2,4-diamine
TTDS00208	Inhibitor	6-Phenylsulfanylmethyl-pteridine-2,4-diamine
TTDS00208	Inhibitor	6-m-Tolyl-pteridine-2,4,7-triamine
TTDS00208	Inhibitor	7-Methyl-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine
TTDS00208	Inhibitor	7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine
TTDS00208	Inhibitor	8-(2,3,4-trimethoxyphenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-(2,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-(2,4,6-trimethoxyphenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-(2,4-dimethoxyphenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-(2,5-dimethoxyphenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-(2,6-Dichloro-phenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-(3,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-(3,4-dichlorophenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-(3,4-dimethoxyphenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-(3,5-dimethoxyphenyl)-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-Pyridin-4-yl-9H-purine-2,6-diamine
TTDS00208	Inhibitor	8-benzyl-9H-purine-2,6-diamine
TTDS00208	Inhibitor	Aminopterin
TTDS00208	Inhibitor	Beta-Mercaptoethanol
TTDS00208	Inhibitor	Biopterin
TTDS00208	Inhibitor	Br-WR99210
TTDS00208	Inhibitor	Brodimoprim-4,6-Dicarboxylate
TTDS00208	Inhibitor	Bromo-WR99210
TTDS00208	Inhibitor	CB-3717
TTDS00208	Inhibitor	Chlorproguanil
TTDS00208	Inhibitor	Cycloguanil
TTDS00208	Inhibitor	Dihydrofolic Acid
TTDS00208	Inhibitor	Edatrexate
TTDS00208	Inhibitor	Epiroprim
TTDS00208	Inhibitor	Furo[2,3d]Pyrimidine Antifolate
TTDS00208	Inhibitor	GNF-PF-173
TTDS00208	Inhibitor	GNF-PF-607
TTDS00208	Inhibitor	MCB-3837
TTDS00208	Inhibitor	Methotrexate
TTDS00208	Inhibitor	Metoprine
TTDS00208	Inhibitor	N*6*-Benzyl-quinazoline-2,4,6-triamine
TTDS00208	Inhibitor	NB-3040
TTDS00208	Inhibitor	NB3178
TTDS00208	Inhibitor	NB3322
TTDS00208	Inhibitor	PDDF
TTDS00208	Inhibitor	PIRITREXIM
TTDS00208	Inhibitor	PREMETREXED
TTDS00208	Inhibitor	Pergularinine
TTDS00208	Inhibitor	Pralatrexate
TTDS00208	Inhibitor	Proguanil
TTDS00208	Inhibitor	Proquanil
TTDS00208	Inhibitor	Pyrimethamine
TTDS00208	Inhibitor	Sri-9439
TTDS00208	Inhibitor	Sri-9662
TTDS00208	Inhibitor	Trimethoprim
TTDS00208	Inhibitor	Trimetrexate
TTDS00208	Inhibitor	Tylophorinidine
TTDS00208	Inhibitor	WR-99210
TTDS00208	Inhibitor	WR99210
TTDS00208	Inhibitor	derivative of methotrexate
TTDS00208	Binder	Iclaprim
TTDS00209	Name	AMP-activated protein kinase
TTDS00209	Type of target	Successful target
TTDS00209	Synonyms	5'AMP-activated protein kinase
TTDS00209	Synonyms	AMPK
TTDS00209	Disease	Autoimmune inflammation
TTDS00209	Disease	Ischemia reperfusion injuries
TTDS00209	Disease	Noninsulin-dependent diabetes mellitus
TTDS00209	Disease	Obesity
TTDS00209	EC Number	EC 2.7.1.109
TTDS00209	Target Validation	TTDS00209
TTDS00209	Drug(s)	Phenformin
TTDS00209	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDS00209	Inhibitor	4-(3-bromopyrazolo[1,5-a]pyrimidin-6-yl)phenol
TTDS00209	Inhibitor	DORSOMORPHIN
TTDS00209	Inhibitor	GSK-690693
TTDS00209	Inhibitor	SU 6656
TTDS00209	Activator	Phenformin
TTDS00210	Name	Penicillin binding protein
TTDS00210	Type of target	Successful target
TTDS00210	Disease	Bacterial infections
TTDS00210	Target Validation	TTDS00210
TTDS00210	Drug(s)	Amoxicillin
TTDS00210	Drug(s)	Ampicillin
TTDS00210	Drug(s)	Azlocillin
TTDS00210	Drug(s)	Bacampicillin
TTDS00210	Drug(s)	Carbenicillin
TTDS00210	Drug(s)	Cefacetrile
TTDS00210	Drug(s)	Cefaclor
TTDS00210	Drug(s)	Cefadroxil
TTDS00210	Drug(s)	Cefamandole
TTDS00210	Drug(s)	Cefazolin
TTDS00210	Drug(s)	Cefdinir
TTDS00210	Drug(s)	Cefditoren
TTDS00210	Drug(s)	Cefepime
TTDS00210	Drug(s)	Cefixime
TTDS00210	Drug(s)	Cefonicid
TTDS00210	Drug(s)	Cefoperazone
TTDS00210	Drug(s)	Ceforanide
TTDS00210	Drug(s)	Cefotetan
TTDS00210	Drug(s)	Cefoxitin
TTDS00210	Drug(s)	Cefpiramide
TTDS00210	Drug(s)	Cefpodoxime
TTDS00210	Drug(s)	Cefprozil
TTDS00210	Drug(s)	Cefradine
TTDS00210	Drug(s)	Ceftazidime
TTDS00210	Drug(s)	Ceftibuten
TTDS00210	Drug(s)	Ceftizoxime
TTDS00210	Drug(s)	Cefuroxime
TTDS00210	Drug(s)	Cephalexin
TTDS00210	Drug(s)	Cephaloglycin
TTDS00210	Drug(s)	Cephapirin
TTDS00210	Drug(s)	Cloxacillin
TTDS00210	Drug(s)	Cyclacillin
TTDS00210	Drug(s)	Dicloxacillin
TTDS00210	Drug(s)	Ertapenem
TTDS00210	Drug(s)	Flucloxacillin
TTDS00210	Drug(s)	Hetacillin
TTDS00210	Drug(s)	Loracarbef
TTDS00210	Drug(s)	Meropenem
TTDS00210	Drug(s)	Meticillin
TTDS00210	Drug(s)	Nafcillin
TTDS00210	Drug(s)	Oxacillin
TTDS00210	Drug(s)	Penicillin G
TTDS00210	Drug(s)	Penicillin V
TTDS00210	Drug(s)	Piperacillin
TTDS00210	Drug(s)	Pivampicillin
TTDS00210	Drug(s)	Pivmecillinam
TTDS00210	Drug(s)	Ticarcillin
TTDS00210	Binder	Amoxicillin
TTDS00210	Binder	Ampicillin
TTDS00210	Binder	Azlocillin
TTDS00210	Binder	Bacampicillin
TTDS00210	Binder	Carbenicillin
TTDS00210	Binder	Cefacetrile
TTDS00210	Binder	Cefaclor
TTDS00210	Binder	Cefadroxil
TTDS00210	Binder	Cefamandole
TTDS00210	Binder	Cefazolin
TTDS00210	Binder	Cefdinir
TTDS00210	Binder	Cefditoren
TTDS00210	Binder	Cefepime
TTDS00210	Binder	Cefixime
TTDS00210	Binder	Cefonicid
TTDS00210	Binder	Cefoperazone
TTDS00210	Binder	Ceforanide
TTDS00210	Binder	Cefotetan
TTDS00210	Binder	Cefoxitin
TTDS00210	Binder	Cefpiramide
TTDS00210	Binder	Cefpodoxime
TTDS00210	Binder	Cefprozil
TTDS00210	Binder	Cefradine
TTDS00210	Binder	Ceftazidime
TTDS00210	Binder	Ceftibuten
TTDS00210	Binder	Ceftizoxime
TTDS00210	Binder	Cefuroxime
TTDS00210	Binder	Cephalexin
TTDS00210	Binder	Cephaloglycin
TTDS00210	Binder	Cephapirin
TTDS00210	Binder	Cloxacillin
TTDS00210	Binder	Cyclacillin
TTDS00210	Binder	Dicloxacillin
TTDS00210	Binder	Ertapenem
TTDS00210	Binder	Flucloxacillin
TTDS00210	Binder	Hetacillin
TTDS00210	Binder	Loracarbef
TTDS00210	Binder	Meropenem
TTDS00210	Binder	Meticillin
TTDS00210	Binder	Nafcillin
TTDS00210	Binder	Oxacillin
TTDS00210	Binder	Penicillin G
TTDS00210	Binder	Penicillin V
TTDS00210	Binder	Piperacillin
TTDS00210	Binder	Pivampicillin
TTDS00210	Binder	Pivmecillinam
TTDS00210	Binder	Ticarcillin
TTDS00211	UniProt ID	P08150
TTDS00211	UniProt ID	P0A3M5
TTDS00211	Name	Penicillin binding protein 2
TTDS00211	Type of target	Successful target
TTDS00211	Synonyms	PBP-2
TTDS00211	Disease	Gram-negative bacterial infection
TTDS00211	Function	Cell wall formation; PBP-2 is responsible for the determination of the rod shape
TTDS00211	Sequence	MKLQNSFRDYTAESALFVRRALVAFLGILLLTGVLIANLYNLQIVRFTDYQTRSNENRIKLVPIAPSRGIIYDRNGIPLA
TTDS00211	Target Validation	TTDS00211
TTDS00211	Drug(s)	Amdinocillin
TTDS00211	Drug(s)	Imipenem
TTDS00211	Inhibitor	Amdinocillin
TTDS00211	Binder	Imipenem
TTDS00212	UniProt ID	P04286
TTDS00212	UniProt ID	P0AD68
TTDS00212	UniProt ID	P45059
TTDS00212	Name	Penicillin binding protein 3
TTDS00212	Type of target	Successful target
TTDS00212	Synonyms	PBP 3
TTDS00212	Synonyms	PBP-3
TTDS00212	Synonyms	PSPB20
TTDS00212	Synonyms	Penicillin-binding protein 3
TTDS00212	Synonyms	Peptidoglycan glycosyltransferase 3
TTDS00212	Synonyms	Peptidoglycan synthetase ftsI
TTDS00212	Disease	Bacterial infections
TTDS00212	Function	Cell wall formation. essential for the formation of a septum of the murein saccu
TTDS00212	Sequence	MVKFNSSRKSGKSKKTIRKLTAPETVKQNKPQKVFEKCFMRGRYMLSTVLILLGLCALVARAAYVQSINADTLSNEADKR
TTDS00212	BioChemical Class	Glycosyltransferases
TTDS00212	Pathway	Peptidoglycan biosynthesis
TTDS00212	EC Number	EC 2.4.1.129
TTDS00212	Target Validation	TTDS00212
TTDS00212	Drug(s)	Aztreonam
TTDS00212	Drug(s)	Cefmenoxime
TTDS00212	Drug(s)	Cefmetazole
TTDS00212	Drug(s)	Cefotiam
TTDS00212	Drug(s)	Latamoxef
TTDS00212	Drug(s)	Mezlocillin
TTDS00212	Drug(s)	Sulopenem
TTDS00212	Drug(s)	Sulopenem IV
TTDS00212	Inhibitor	Sulopenem
TTDS00212	Inhibitor	Sulopenem IV
TTDS00212	Antagonist	Cephalosporin C
TTDS00212	Binder	Acylureido penicillin mezlocillin
TTDS00212	Binder	Aztreonam
TTDS00212	Binder	Benzylpenicillin
TTDS00212	Binder	Cefmenoxime
TTDS00212	Binder	Cefmetazole
TTDS00212	Binder	Cefotiam
TTDS00212	Binder	Latamoxef
TTDS00212	Binder	Mezlocillin
TTDS00213	Name	DNA
TTDS00213	Type of target	Successful target
TTDS00213	Disease	Bacterial infections
TTDS00213	Disease	Cancer, unspecific
TTDS00213	Disease	Human immunodeficiency virus [HIV] disease
TTDS00213	Disease	Tumors
TTDS00213	Target Validation	TTDS00213
TTDS00213	Drug(s)	ADVAX
TTDS00213	Drug(s)	Abetimus sodium
TTDS00213	Drug(s)	Adenine
TTDS00213	Drug(s)	Altretamine
TTDS00213	Drug(s)	Amrubicin hcl
TTDS00213	Drug(s)	Amrubicin hydrochloride; Sm-5887
TTDS00213	Drug(s)	Balofloxacin
TTDS00213	Drug(s)	Bendamustine hydrochloride
TTDS00213	Drug(s)	Bleomycin
TTDS00213	Drug(s)	Busulfan
TTDS00213	Drug(s)	Carboplatin
TTDS00213	Drug(s)	Carmustine
TTDS00213	Drug(s)	Chlorambucil
TTDS00213	Drug(s)	Ciprofloxacin XR
TTDS00213	Drug(s)	Cisplatin
TTDS00213	Drug(s)	Clofarabine
TTDS00213	Drug(s)	Clofazimine
TTDS00213	Drug(s)	Cyclophosphamide
TTDS00213	Drug(s)	Dacarbazine
TTDS00213	Drug(s)	Dactinomycin
TTDS00213	Drug(s)	Daunorubicin
TTDS00213	Drug(s)	Dornase Alfa
TTDS00213	Drug(s)	EP1090
TTDS00213	Drug(s)	EP1300
TTDS00213	Drug(s)	Elliptinium acetate
TTDS00213	Drug(s)	Elsamitrucin
TTDS00213	Drug(s)	Furazolidone
TTDS00213	Drug(s)	Glufosfamide
TTDS00213	Drug(s)	Hydroxystilbamidine Isethionate
TTDS00213	Drug(s)	Idoxuridine
TTDS00213	Drug(s)	Ifosfamide
TTDS00213	Drug(s)	Indol-3-carbinol
TTDS00213	Drug(s)	Lomustine
TTDS00213	Drug(s)	Mechlorethamine
TTDS00213	Drug(s)	Melphalan
TTDS00213	Drug(s)	Mercaptopurine
TTDS00213	Drug(s)	Methoxsalen
TTDS00213	Drug(s)	Metronidazole
TTDS00213	Drug(s)	Mitomycin
TTDS00213	Drug(s)	Mitomycin A
TTDS00213	Drug(s)	Mitomycin C
TTDS00213	Drug(s)	Nelarabine
TTDS00213	Drug(s)	Neocarzinostatin
TTDS00213	Drug(s)	Nitrofurantoin
TTDS00213	Drug(s)	Oxaliplatin
TTDS00213	Drug(s)	Oxamniquine
TTDS00213	Drug(s)	Pipobroman
TTDS00213	Drug(s)	Pirarubicin
TTDS00213	Drug(s)	Primaquine
TTDS00213	Drug(s)	Procarbazine
TTDS00213	Drug(s)	Proflavine
TTDS00213	Drug(s)	Streptozocin
TTDS00213	Drug(s)	TV-4710
TTDS00213	Drug(s)	Temozolomide
TTDS00213	Drug(s)	Thioguanine
TTDS00213	Drug(s)	Uracil mustard
TTDS00213	Drug(s)	Zinostatin stimalamer
TTDS00213	Inhibitor	2-(3,4-Dihydroxyphenyl)Acetic Acid
TTDS00213	Inhibitor	Abetimus sodium
TTDS00213	Inhibitor	Balofloxacin
TTDS00213	Inhibitor	Beta-D-Glucose
TTDS00213	Inhibitor	Ciprofloxacin XR
TTDS00213	Inhibitor	Glufosfamide
TTDS00213	Inhibitor	Lipid Fragment
TTDS00213	Inhibitor	Lomustine
TTDS00213	Inhibitor	Phosphomethylphosphonic Acid Adenosyl Ester
TTDS00213	Inhibitor	TV-4710
TTDS00213	Inhibitor	Thiamin Diphosphate
TTDS00213	Breaker	Altretamine
TTDS00213	Breaker	Bleomycin
TTDS00213	Breaker	Busulfan
TTDS00213	Breaker	Carboplatin
TTDS00213	Breaker	Carmustine
TTDS00213	Breaker	Cyclophosphamide
TTDS00213	Breaker	Dacarbazine
TTDS00213	Breaker	Dactinomycin
TTDS00213	Breaker	Dornase Alfa
TTDS00213	Breaker	Duocarmycin
TTDS00213	Breaker	Enediyne antibiotics
TTDS00213	Breaker	Ifosfamide
TTDS00213	Breaker	Mercaptopurine
TTDS00213	Breaker	Metronidazole
TTDS00213	Breaker	Nitracrine
TTDS00213	Breaker	Nitrofurantoin
TTDS00213	Breaker	Streptozocin
TTDS00213	Breaker	Talisomycin
TTDS00213	Breaker	Temozolomide
TTDS00213	Intercalator	Actinomycin D
TTDS00213	Intercalator	Adriamycin
TTDS00213	Intercalator	Ametantrone
TTDS00213	Intercalator	Chlorambucil
TTDS00213	Intercalator	Clofazimine
TTDS00213	Intercalator	Daunomycin
TTDS00213	Intercalator	Daunorubicin
TTDS00213	Intercalator	Elsamitrucin
TTDS00213	Intercalator	Ethidium
TTDS00213	Intercalator	Ethidium bromide
TTDS00213	Intercalator	Mechlorethamine
TTDS00213	Intercalator	Melphalan
TTDS00213	Intercalator	Nogalamycin
TTDS00213	Intercalator	Thioguanine
TTDS00213	Adduct	Anthramycin
TTDS00213	Adduct	Cis-[PtCl(NH3)2(N7-acyclovir)]+
TTDS00213	Adduct	Cisplatin
TTDS00213	Adduct	Ecteinascidins
TTDS00213	Adduct	JM216
TTDS00213	Adduct	Methylene blue
TTDS00213	Adduct	Mitomycin A
TTDS00213	Adduct	Mitomycin C
TTDS00213	Adduct	Naphthyridinomycin
TTDS00213	Adduct	Oxaliplatin
TTDS00213	Adduct	Primaquine
TTDS00213	Adduct	Procarbazine
TTDS00213	Adduct	Tallimustine
TTDS00213	Minor groove binder	Bisbenzimide (Hoechst 33258)
TTDS00213	Minor groove binder	Di-imidazole lexitropsin
TTDS00213	Minor groove binder	Distamycin A
TTDS00213	Minor groove binder	Netropsin
TTDS00213	Modulator	Uracil mustard
TTDS00213	Binder	Acriflavine
TTDS00213	Binder	Adenine
TTDS00213	Binder	Clofarabine
TTDS00213	Binder	Furazolidone
TTDS00213	Binder	Hydroxystilbamidine Isethionate
TTDS00213	Binder	Idoxuridine
TTDS00213	Binder	Indol-3-carbinol
TTDS00213	Binder	Methoxsalen
TTDS00213	Binder	Mitomycin
TTDS00213	Binder	Nelarabine
TTDS00213	Binder	Oxamniquine
TTDS00213	Binder	Pipobroman
TTDS00213	Binder	Proflavine
TTDS00213	Multitarget	Clofarabine
TTDS00216	Name	16S rRNA
TTDS00216	Type of target	Successful target
TTDS00216	Synonyms	Plastid 16S rRNA
TTDS00216	Synonyms	RrnS
TTDS00216	Disease	Bacterial infections
TTDS00216	Disease	Malaria
TTDS00216	Target Validation	TTDS00216
TTDS00216	Drug(s)	Framycetin
TTDS00216	Drug(s)	Tetracyclines
TTDS00216	Inhibitor	Aminodeoxykanamycin
TTDS00216	Inhibitor	Apramycin
TTDS00216	Inhibitor	Butirosin B
TTDS00216	Inhibitor	Geneticin
TTDS00216	Inhibitor	Hygromycin B
TTDS00216	Inhibitor	Neamine
TTDS00216	Inhibitor	Neomycin B
TTDS00216	Inhibitor	Oxazolidinones
TTDS00216	Inhibitor	Ribostamycin
TTDS00216	Adduct	GENTAMICIN C1A
TTDS00216	Binder	Framycetin
TTDS00216	Binder	Tetracyclines
TTDS00217	Name	23S rRNA
TTDS00217	Type of target	Successful target
TTDS00217	Synonyms	Plastid 23S rRNA
TTDS00217	Synonyms	RrnL
TTDS00217	Disease	Bacterial infections
TTDS00217	Disease	Malaria
TTDS00217	Target Validation	TTDS00217
TTDS00217	Drug(s)	Cethromycin
TTDS00217	Drug(s)	Evernimicin
TTDS00217	Drug(s)	Linezolid
TTDS00217	Drug(s)	Macrolides
TTDS00217	Drug(s)	Thiamphenicol
TTDS00217	Inhibitor	Cethromycin
TTDS00217	Inhibitor	Oxazolidinones
TTDS00217	Binder	Evernimicin
TTDS00217	Binder	Linezolid
TTDS00217	Binder	Macrolides
TTDS00217	Binder	Micrococcin
TTDS00217	Binder	Spiramycin
TTDS00217	Binder	Thiostrepton
TTDS00217	Binder	Zithromax
TTDS00219	Name	30S ribosomal subunit
TTDS00219	Type of target	Successful target
TTDS00219	Synonyms	30S ribosome subunit
TTDS00219	Disease	Bacterial infections
TTDS00219	Target Validation	TTDS00219
TTDS00219	Drug(s)	Amikacin
TTDS00219	Drug(s)	Clomocycline
TTDS00219	Drug(s)	Demeclocycline
TTDS00219	Drug(s)	Framycetin
TTDS00219	Drug(s)	Kanamycin
TTDS00219	Drug(s)	Lymecycline
TTDS00219	Drug(s)	Meclocycline
TTDS00219	Drug(s)	Methacycline
TTDS00219	Drug(s)	Minocycline
TTDS00219	Drug(s)	Neomycin
TTDS00219	Drug(s)	Netilmicin
TTDS00219	Drug(s)	Oxytetracycline
TTDS00219	Drug(s)	Paromomycin
TTDS00219	Drug(s)	Rolitetracycline
TTDS00219	Drug(s)	Spectinomycin
TTDS00219	Drug(s)	Streptomycin
TTDS00219	Drug(s)	Tetracycline
TTDS00219	Drug(s)	Tigecycline
TTDS00219	Binder	Amikacin
TTDS00219	Binder	Clomocycline
TTDS00219	Binder	Demeclocycline
TTDS00219	Binder	Framycetin
TTDS00219	Binder	Kanamycin
TTDS00219	Binder	Lymecycline
TTDS00219	Binder	Meclocycline
TTDS00219	Binder	Methacycline
TTDS00219	Binder	Minocycline
TTDS00219	Binder	Neomycin
TTDS00219	Binder	Netilmicin
TTDS00219	Binder	Oxytetracycline
TTDS00219	Binder	Paromomycin
TTDS00219	Binder	Rolitetracycline
TTDS00219	Binder	Spectinomycin
TTDS00219	Binder	Streptomycin
TTDS00219	Binder	Tetracycline
TTDS00219	Binder	Tigecycline
TTDS00220	Name	50S ribosomal subunit
TTDS00220	Type of target	Successful target
TTDS00220	Synonyms	50S ribosome subunit
TTDS00220	Disease	Bacterial infections
TTDS00220	Target Validation	TTDS00220
TTDS00220	Drug(s)	Azithromycin
TTDS00220	Drug(s)	Azithromycin/chloroquine
TTDS00220	Drug(s)	Chlornitromycin
TTDS00220	Drug(s)	Clarithromycin
TTDS00220	Drug(s)	Clindamycin
TTDS00220	Drug(s)	Dirithromycin
TTDS00220	Drug(s)	Erythromycin
TTDS00220	Drug(s)	Gentamicine sulfate
TTDS00220	Drug(s)	Josamycin
TTDS00220	Drug(s)	Lincomycin
TTDS00220	Drug(s)	Retapamulin
TTDS00220	Drug(s)	Roxithromycin
TTDS00220	Drug(s)	Telithromycin
TTDS00220	Drug(s)	Tobramycin
TTDS00220	Drug(s)	Troleandomycin
TTDS00220	Inhibitor	Lincomycin
TTDS00220	Inhibitor	Retapamulin
TTDS00220	Inhibitor	Roxithromycin
TTDS00220	Binder	Azithromycin
TTDS00220	Binder	Azithromycin/chloroquine
TTDS00220	Binder	Chlornitromycin
TTDS00220	Binder	Clarithromycin
TTDS00220	Binder	Clindamycin
TTDS00220	Binder	Dirithromycin
TTDS00220	Binder	Erythromycin
TTDS00220	Binder	Gentamicine sulfate
TTDS00220	Binder	Josamycin
TTDS00220	Binder	Telithromycin
TTDS00220	Binder	Tobramycin
TTDS00220	Binder	Troleandomycin
TTDS00221	Name	70S prokaryotic ribosome
TTDS00221	Type of target	Successful target
TTDS00221	Disease	Bacterial infections
TTDS00221	Drug(s)	Capreomycin
TTDS00221	Binder	Capreomycin
TTDS00222	UniProt ID	Q7X2I2
TTDS00222	Name	DNA-dependent RNA polymerase at the beta subunit
TTDS00222	Type of target	Successful target
TTDS00222	Disease	Bacterial infections
TTDS00222	Sequence	TVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQ
TTDS00222	Drug(s)	Rifabutin
TTDS00222	Inhibitor	Rifabutin
TTDS00223	UniProt ID	P00956
TTDS00223	UniProt ID	Q99UR8
TTDS00223	Name	Isoleucyl-tRNA synthetase (bacterial)
TTDS00223	Type of target	Successful target
TTDS00223	Synonyms	IRS
TTDS00223	Synonyms	IleRS
TTDS00223	Synonyms	Isoleucine--tRNA ligase
TTDS00223	Disease	Bacterial infections
TTDS00223	Disease	Microbial infections
TTDS00223	Sequence	MSDYKSTLNLPETGFPMRGDLAKREPGMLARWTDDDLYGIIRAAKKGKKTFILHDGPPYANGSIHIGHSVNKILKDIIVK
TTDS00223	BioChemical Class	Ligases forming carbon-oxygen bonds
TTDS00223	Pathway	Aminoacyl-tRNA biosynthesis
TTDS00223	Pathway	Valine, leucine and isoleucine biosynthesis
TTDS00223	EC Number	EC 6.1.1.5
TTDS00223	Target Validation	TTDS00223
TTDS00223	Drug(s)	Icofungipen
TTDS00223	Drug(s)	Mupirocin
TTDS00223	Inhibitor	Mupirocin
TTDS00223	Inhibitor	Reveromycin A
TTDS00223	Binder	Icofungipen
TTDS00225	Name	DNA-dependent RNA polymerase
TTDS00225	Type of target	Successful target
TTDS00225	Disease	Tuberculosis
TTDS00225	Drug(s)	Rifapentine
TTDS00225	Binder	CBR-2092
TTDS00225	Binder	Rifapentine
TTDS00226	UniProt ID	P00575
TTDS00226	UniProt ID	P0A8V2
TTDS00226	UniProt ID	P21421
TTDS00226	Name	Plastid RNA polymerase beta-subunit
TTDS00226	Type of target	Successful target
TTDS00226	Synonyms	DNA-directed RNA polymerase beta chain
TTDS00226	Synonyms	RNA polymerase beta subunit
TTDS00226	Synonyms	RNAP beta subunit
TTDS00226	Synonyms	RpoB
TTDS00226	Synonyms	Transcriptase beta chain
TTDS00226	Disease	Malaria
TTDS00226	Function	DNA-dependent rna polymerase catalyzes the transcription of dna into RNA using t
TTDS00226	Sequence	MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQSYSGNSELQYVSYRLGEPVF
TTDS00226	PDB Structure	3IYD; 3LTI; 3LU0; 3T72; 3TBI; 4IGC; 4JK1; 4JK2; 4KMU; 4KN4; 4KN7
TTDS00226	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00226	EC Number	EC 2.7.7.6
TTDS00226	Target Validation	TTDS00226
TTDS00226	Drug(s)	Rifaximin
TTDS00226	Inhibitor	Myxopyronin B
TTDS00226	Inhibitor	Rifaximin
TTDS00226	Inhibitor	Tagetitoxin
TTDS00227	Name	RNA polymerase
TTDS00227	Name	bacterial RNA polymerase switch region
TTDS00227	Type of target	Successful target
TTDS00227	Type of target	Successful target
TTDS00227	Disease	Cancer, unspecific
TTDS00227	Disease	Human cytomegalovirus infections
TTDS00227	Disease	Malaria
TTDS00227	Disease	Respiratory syncytial virus (RSV) infections
TTDS00227	Target Validation	TTDS00227
TTDS00227	Drug(s)	Fidaxomicin
TTDS00227	Drug(s)	Rifampicin
TTDS00227	Drug(s)	Rifampin
TTDS00227	Drug(s)	
TTDS00227	Inhibitor	Rifalazil
TTDS00227	Inhibitor	Rifampin
TTDS00227	Binder	Rifampicin
TTDS00228	UniProt ID	P00807
TTDS00228	UniProt ID	P00811
TTDS00228	Name	Beta-lactamase
TTDS00228	Type of target	Successful target
TTDS00228	Synonyms	Cephalosporinase
TTDS00228	Disease	Bacterial infections
TTDS00228	Function	This protein is a serine beta-lactamase with a substrate specificity for cephalo
TTDS00228	Sequence	MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGS
TTDS00228	PDB Structure	1C3B; 1FCM; 1FCN; 1FCO; 1FSW; 1FSY; 1GA9; 1I5Q; 1IEL; 1IEM; 1KDS; 1KDW; 1KE0; 1K
TTDS00228	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDS00228	Pathway	Two-component system
TTDS00228	EC Number	EC 3.5.2.6
TTDS00228	Related US Patent	6,417,174
TTDS00228	Related US Patent	6,426,342
TTDS00228	Related US Patent	6,436,398
TTDS00228	Related US Patent	6,448,238
TTDS00228	Related US Patent	6,472,406
TTDS00228	Related US Patent	6,482,818
TTDS00228	Related US Patent	6,599,889
TTDS00228	Related US Patent	6,608,046
TTDS00228	Related US Patent	6,630,510
TTDS00228	Target Validation	TTDS00228
TTDS00228	Drug(s)	CAZ AVI
TTDS00228	Drug(s)	CXL
TTDS00228	Drug(s)	Clavulanate
TTDS00228	Drug(s)	DA-7101
TTDS00228	Drug(s)	Tazobactam
TTDS00228	Inhibitor	(P-Iodophenylacetylamino)Methylphosphinic Acid
TTDS00228	Inhibitor	1-Aminopropane-1,2,3-tricarboxylic acid
TTDS00228	Inhibitor	2-(N-Morpholino)-Ethanesulfonic Acid
TTDS00228	Inhibitor	2-(Sulfanylmethyl)phenylphosphonic acid
TTDS00228	Inhibitor	2-Methyl-2,4-Pentanediol
TTDS00228	Inhibitor	2-mercaptophenylphosphonic acid
TTDS00228	Inhibitor	2-phenyl-1H-imidazole-4-carboxylic acid
TTDS00228	Inhibitor	3-Amino-3-(methoxycarbonyl)-1,5-pentandioic acid
TTDS00228	Inhibitor	3-Nitrophenylboronic Acid
TTDS00228	Inhibitor	3-ethoxycarbonylpyroglutamate
TTDS00228	Inhibitor	4,4'-Biphenyldiboronic Acid
TTDS00228	Inhibitor	4-(Carboxyvin-2-Yl)Phenylboronic Acid
TTDS00228	Inhibitor	4-Carboxyphenylboronic Acid
TTDS00228	Inhibitor	4-Methyl-3-(2-oxo-azetidin-1-yl)-benzoic acid
TTDS00228	Inhibitor	4-[(METHYLSULFONYL)AMINO]BENZOIC ACID
TTDS00228	Inhibitor	4-iodo-acetamido phenylboronic acid
TTDS00228	Inhibitor	5-Fluoro-2-sulfanyl-phenylphosphonic acid
TTDS00228	Inhibitor	5-hydroxymethylbenzo[b]thiophen-2-ylboronic acid
TTDS00228	Inhibitor	5-methyl-benzo[b]thiophen-2-ylboronic acid
TTDS00228	Inhibitor	Acetate Ion
TTDS00228	Inhibitor	Acylated Ceftazidime
TTDS00228	Inhibitor	Benzo[B]Thiophene-2-Boronic Acid
TTDS00228	Inhibitor	Carbamic Acid
TTDS00228	Inhibitor	Clavulanate
TTDS00228	Inhibitor	Clavulanate+Amoxicillin
TTDS00228	Inhibitor	DA-7101
TTDS00228	Inhibitor	Degraded Cephaloridine
TTDS00228	Inhibitor	Diisopropyl 2-(sulfanylmethyl)phenylphosphonate
TTDS00228	Inhibitor	Hydrolyzed Cephalothin
TTDS00228	Inhibitor	M-Aminophenylboronic Acid
TTDS00228	Inhibitor	N-2-Thiophen-2-Yl-Acetamide Boronic Acid
TTDS00228	Inhibitor	PCNOTAXIME GROUP
TTDS00228	Inhibitor	SULBACTAM
TTDS00228	Inhibitor	Sucrose
TTDS00228	Inhibitor	TAZOBACTAM SODIUM
TTDS00228	Inhibitor	Tazobactam
TTDS00228	Inhibitor	Tribenzyl 2-aminopropane-1,2,3-tricarboxylate
TTDS00228	Inhibitor	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate
TTDS00228	Inhibitor	alpha-Sulfanyl(2,4-dichlorobenzyl)phosphonic acid
TTDS00228	Inhibitor	alpha-Sulfanyl(2-methoxybenzyl)phosphonic acid
TTDS00228	Inhibitor	alpha-Sulfanyl(4-bromobenzyl)phosphonic acid
TTDS00228	Inhibitor	alpha-Sulfanyl(4-chlorobenzyl)phosphonic acid
TTDS00228	Inhibitor	alpha-Sulfanyl(4-fluorobenzyl)phosphonic acid
TTDS00228	Inhibitor	alpha-Sulfanylbenzylphosphonic acid
TTDS00228	Inhibitor	alpha-Sulfanylpropylphosphonic acid
TTDS00228	Inhibitor	benzo[b]thiophen-2-ylboronic acid
TTDS00228	Inhibitor	ceftazidime BATSI
TTDS00228	Inhibitor	diisopropyl 1-mercaptopropylphosphonate
TTDS00228	Inhibitor	diisopropyl mercapto(phenyl)methylphosphonate
TTDS00228	Inhibitor	thiophene-2-ylboronic acid
TTDS00228	Inhibitor	triethyl 2-aminopropane-1,2,3-tricarboxylate
TTDS00229	Name	Peptidyl tranferase
TTDS00229	Type of target	Successful target
TTDS00229	Disease	Bacterial infections
TTDS00229	Target Validation	TTDS00229
TTDS00229	Drug(s)	Chloramphenicol
TTDS00229	Binder	Chloramphenicol
TTDS00230	UniProt ID	P16444
TTDS00230	Name	Dehydropeptidase I
TTDS00230	Type of target	Successful target
TTDS00230	Synonyms	Dehydropeptidase-I
TTDS00230	Synonyms	MDP
TTDS00230	Synonyms	RDP
TTDS00230	Synonyms	Renal dipeptidase
TTDS00230	Disease	Bacterial infections
TTDS00230	Function	Hydrolyzes a wide range of dipeptides. Implicated in the renal metabolism of glu
TTDS00230	Sequence	MWSGWWLWPLVAVCTADFFRDEAERIMRDSPVIDGHNDLPWQLLDMFNNRLQDERANLTTLAGTHTNIPKLRAGFVGGQF
TTDS00230	PDB Structure	1ITQ; 1ITU
TTDS00230	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00230	EC Number	EC 3.4.13.19
TTDS00230	Target Validation	TTDS00230
TTDS00230	Drug(s)	Cilastatin
TTDS00230	Inhibitor	Cilastatin
TTDS00233	UniProt ID	P28909
TTDS00233	Name	UDP-N-acetylglucosamine 1-carboxyvinyltransferase
TTDS00233	Type of target	Successful target
TTDS00233	Synonyms	EPT
TTDS00233	Synonyms	Enoylpyruvate transferase
TTDS00233	Synonyms	MurA
TTDS00233	Synonyms	MurA protein
TTDS00233	Synonyms	UDP-GlcNAc enolpyruvyl transferase
TTDS00233	Synonyms	UDP-N-acetylglucosamine enolpyruvyl transferase
TTDS00233	Disease	Bacterial infections
TTDS00233	Function	Cell wall formation. Adds enolpyruvyl to UDP-n- acetylglucosamine. Target for th
TTDS00233	Sequence	MDKFRVQGPTKLQGEVTISGAKNAALPILFAALLAEEPVEIQNVPKLKDVDTSMKLLSQLGAKVERNGSVHIDARDVNVF
TTDS00233	PDB Structure	1A2N; 1UAE; 2Z2C
TTDS00233	EC Number	EC 2.5.1.7
TTDS00233	Target Validation	TTDS00233
TTDS00233	Drug(s)	Fosfomycin
TTDS00233	Drug(s)	Fosfomycin trometamol
TTDS00233	Inhibitor	1-Anilino-8-Naphthalene Sulfonate
TTDS00233	Inhibitor	Aminomethylcyclohexane
TTDS00233	Inhibitor	CNICIN
TTDS00233	Inhibitor	CYNAROPICRIN
TTDS00233	Inhibitor	Cyclohexylammonium Ion
TTDS00233	Inhibitor	EUPATORIOPICRIN
TTDS00233	Inhibitor	Fosfomycin
TTDS00233	Inhibitor	L-Iso-Aspartate
TTDS00233	Inhibitor	RWJ-140998
TTDS00233	Inhibitor	RWJ-3981
TTDS00233	Inhibitor	Uridine-Diphosphate-N-Acetylglucosamine
TTDS00234	UniProt ID	P11142
TTDS00234	Name	73-kDa molecular chaperone HSP73
TTDS00234	Type of target	Successful target
TTDS00234	Synonyms	HSP73
TTDS00234	Synonyms	Heat shock protein 73
TTDS00234	Disease	Bacterial infections
TTDS00234	Function	Chaperone. Isoform 2 may function as an endogenous inhibitory regulator of hsc70
TTDS00234	Sequence	MSKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDD
TTDS00234	PDB Structure	3AGY; 3AGZ; 3ESK; 3FZF; 3FZH; 3FZK; 3FZL; 3FZM; 3LDQ; 3M3Z; 4HWI
TTDS00234	Pathway	Antigen processing and presentation
TTDS00234	Pathway	MAPK signaling pathway
TTDS00234	Target Validation	TTDS00234
TTDS00234	Drug(s)	Gentamicin
TTDS00234	Inhibitor	ADENOSINETRIPHOSPHATE
TTDS00234	Inhibitor	Adenosine-5'-Diphosphate
TTDS00234	Inhibitor	Gentamicin
TTDS00234	Inhibitor	NSC-119911
TTDS00234	Inhibitor	NSC-119913
TTDS00235	UniProt ID	P0AEK4
TTDS00235	UniProt ID	P0AEK5
TTDS00235	UniProt ID	P0AEK6
TTDS00235	UniProt ID	Q965D5
TTDS00235	UniProt ID	Q9BH77
TTDS00235	Name	Enoyl-ACP reductase
TTDS00235	Type of target	Successful target
TTDS00235	Synonyms	Enoyl-ACP reductase FabI
TTDS00235	Synonyms	Enoyl-acyl carrier protein reductase
TTDS00235	Synonyms	Enoyl-acyl carrier reductase
TTDS00235	Synonyms	Enoyl-acyl-carrier protein reductase
TTDS00235	Synonyms	FABI
TTDS00235	Synonyms	NADH-dependent enoyl-ACP reductase
TTDS00235	Disease	Bacterial infections
TTDS00235	Disease	Malaria
TTDS00235	Sequence	MNKISQRLLFLFLHFYTTVCFIQNNTQKTFHNVLQNEQIRGKEKAFYRKEKRENIFIGNKMKHVHNMNNTHNNNHYMEKE
TTDS00235	PDB Structure	1NHG; 1NHW; 1NNU; 1VRW; 1ZW1; 2NQ8; 2O2Y; 2OL4; 2OOS; 2OP0; 2OP1
TTDS00235	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDS00235	Pathway	Fatty acid biosynthesis
TTDS00235	Pathway	Metabolic pathways
TTDS00235	EC Number	EC 1.3.1.9
TTDS00235	Related US Patent	6,372,752
TTDS00235	Related US Patent	6,503,903
TTDS00235	Target Validation	TTDS00235
TTDS00235	Drug(s)	Triclosan
TTDS00235	Inhibitor	(-)-CATECHINGALLATE
TTDS00235	Inhibitor	2-(2,4-dichlorophenoxy)-5-(2-methylbutyl)phenol
TTDS00235	Inhibitor	2-(2,4-dichlorophenoxy)-5-(3-phenylpropyl)phenol
TTDS00235	Inhibitor	2-(2,4-dichlorophenoxy)-5-ethylphenol
TTDS00235	Inhibitor	2-(2,4-dichlorophenoxy)-5-isobutylphenol
TTDS00235	Inhibitor	2-(2,4-dichlorophenoxy)-5-isopentylphenol
TTDS00235	Inhibitor	2-(2,4-dichlorophenoxy)-5-methylphenol
TTDS00235	Inhibitor	2-(2,4-dichlorophenoxy)-5-phenethylphenol
TTDS00235	Inhibitor	2-(2,4-dichlorophenoxy)-5-propylphenol
TTDS00235	Inhibitor	2-(2-((benzylamino)methyl)phenoxy)-5-chlorophenol
TTDS00235	Inhibitor	2-(4-amino-2-chlorophenoxy)-5-chlorophenol
TTDS00235	Inhibitor	2-(4-chloro-2-hydroxyphenoxy)benzenaminium
TTDS00235	Inhibitor	3,7-dihydroxy-flavone
TTDS00235	Inhibitor	3-chloro-4-(4-chloro-2-hydroxyphenoxy)benzamide
TTDS00235	Inhibitor	4-(2,4-dichloro-phenoxy)-2'-methyl-biphenyl-3-ol
TTDS00235	Inhibitor	4-(2,4-dichloro-phenoxy)-4'-fluoro-biphenyl-3-ol
TTDS00235	Inhibitor	4-(2,4-dichloro-phenoxy)-biphenyl-3-ol
TTDS00235	Inhibitor	4-(2,4-dichlorophenoxy)-3'-methylbiphenyl-3-ol
TTDS00235	Inhibitor	4-(2,4-dichlorophenoxy)-3-hydroxybenzonitrile
TTDS00235	Inhibitor	4-(2,4-dichlorophenoxy)-4'-methylbiphenyl-3-ol
TTDS00235	Inhibitor	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole
TTDS00235	Inhibitor	5-benzyl-2-(2,4-dichlorophenoxy)phenol
TTDS00235	Inhibitor	5-butyl-2-(2,4-dichlorophenoxy)phenol
TTDS00235	Inhibitor	5-chloro-2-(2-chloro-4-hydroxyphenoxy)phenol
TTDS00235	Inhibitor	5-chloro-2-(2-chloro-4-nitrophenoxy)phenol
TTDS00235	Inhibitor	BUTEIN
TTDS00235	Inhibitor	Beta-D-Glucose
TTDS00235	Inhibitor	Diazaborines
TTDS00235	Inhibitor	EPICATECHIN GALLATE
TTDS00235	Inhibitor	EPIGALLOCATECHIN
TTDS00235	Inhibitor	EPIGALOCATECHIN GALLATE
TTDS00235	Inhibitor	FISETIN
TTDS00235	Inhibitor	GALLOCATECHIN GALLATE
TTDS00235	Inhibitor	ISORHAMNETIN
TTDS00235	Inhibitor	Indole Naphthyridinone
TTDS00235	Inhibitor	MORIN
TTDS00235	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDS00235	Inhibitor	OROIDIN
TTDS00235	Inhibitor	TRICLOSAN
TTDS00235	Inhibitor	Thiolactomycin
TTDS00235	Binder	Triclosan
TTDS00235	Binder	WL-1001
TTDS00236	Name	1-deoxy-D-xylulose-5-phosphate reductoisomerase
TTDS00236	Type of target	Successful target
TTDS00236	Synonyms	1-deoxyxylulose-5-phosphate reductoisomerase
TTDS00236	Synonyms	2-C-Methyl-d-erythritol 4-phosphate synthase
TTDS00236	Synonyms	DOXP reductoisomerase
TTDS00236	Synonyms	DXP reductoisomerase
TTDS00236	Synonyms	DXR
TTDS00236	Synonyms	IspC
TTDS00236	Disease	Bacterial infections
TTDS00236	Disease	Malaria
TTDS00236	Function	Catalyzes the nadp-dependent rearrangement and reduction of 1-deoxy-d-xylulose-5
TTDS00236	EC Number	EC 1.1.1.267
TTDS00236	Target Validation	TTDS00236
TTDS00236	Drug(s)	Fosmidomycin
TTDS00236	Binder	Fosmidomycin
TTDS00237	UniProt ID	P26282
TTDS00237	UniProt ID	Q8IAU3
TTDS00237	UniProt ID	Q93RQ9
TTDS00237	UniProt ID	Q96W63
TTDS00237	UniProt ID	Q9BIX9
TTDS00237	Name	Dihydropteroate synthetase
TTDS00237	Type of target	Successful target
TTDS00237	Synonyms	DHPS
TTDS00237	Synonyms	Dihydropteroate pyrophosphorylase
TTDS00237	Synonyms	Dihydropteroate synthase
TTDS00237	Synonyms	H2Pte synthase
TTDS00237	Disease	Bacterial infections
TTDS00237	Disease	Malaria
TTDS00237	Function	Dhps catalyzes the formation of the immediate precursor of folic acid. It is imp
TTDS00237	Sequence	MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINAGATIIDVGGESTRPGAAEVSVEEELQRVIP
TTDS00237	PDB Structure	1AJ0; 1AJ2; 1AJZ
TTDS00237	EC Number	EC 2.5.1.15
TTDS00237	Target Validation	TTDS00237
TTDS00237	Drug(s)	Dapsone
TTDS00237	Drug(s)	Sulfacytine
TTDS00237	Drug(s)	Sulfadiazine
TTDS00237	Drug(s)	Sulfadoxine
TTDS00237	Drug(s)	Sulfamerazine
TTDS00237	Drug(s)	Sulfamethazine
TTDS00237	Drug(s)	Sulfamethizole
TTDS00237	Drug(s)	Sulfamethoxazole
TTDS00237	Drug(s)	Sulfametopyrazine
TTDS00237	Drug(s)	Sulfapyridine
TTDS00237	Drug(s)	Sulfisoxazole
TTDS00237	Drug(s)	Sulfonamides
TTDS00237	Drug(s)	Sulphadoxine
TTDS00237	Inhibitor	2,6-diamino-5-nitropyrimidin-4(3H)-one
TTDS00237	Inhibitor	2,6-diamino-5-nitrosopyrimidin-4(3H)-one
TTDS00237	Inhibitor	2-amino-8-methyl-7,8-dihydropteridin-4(3H)-one
TTDS00237	Inhibitor	6-Methylamino-5-Nitroisocytosine
TTDS00237	Inhibitor	Dapsone
TTDS00237	Inhibitor	Pterin-6-Yl-Methyl-Monophosphate
TTDS00237	Inhibitor	Pteroic Acid
TTDS00237	Inhibitor	Sulfacytine
TTDS00237	Inhibitor	Sulfadiazine
TTDS00237	Inhibitor	Sulfadoxine
TTDS00237	Inhibitor	Sulfamerazine
TTDS00237	Inhibitor	Sulfamethazine
TTDS00237	Inhibitor	Sulfamethizole
TTDS00237	Inhibitor	Sulfamethoxazole
TTDS00237	Inhibitor	Sulfametopyrazine
TTDS00237	Inhibitor	Sulfapyridine
TTDS00237	Inhibitor	Sulfisoxazole
TTDS00237	Inhibitor	[Pterin-6-Yl Methanyl]-Phosphonophosphate
TTDS00237	Binder	Sulfonamide
TTDS00237	Binder	Sulfonamides
TTDS00237	Binder	Sulphadoxine
TTDS00237	Binder	Sulphameth oxazole
TTDS00240	Name	5-alpha reductase
TTDS00240	Type of target	Successful target
TTDS00240	Synonyms	5 alpha-reductase
TTDS00240	Synonyms	Hepatic 5-alpha reductase
TTDS00240	Disease	Benign prostate hyperplasia
TTDS00240	Disease	Prostate cancer
TTDS00240	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDS00240	Pathway	Androgen and estrogen metabolism
TTDS00240	EC Number	EC 1.3.99.5
TTDS00240	Target Validation	TTDS00240
TTDS00240	QSAR Model	TTDS00240
TTDS00240	Drug(s)	Azelaic Acid
TTDS00240	Drug(s)	Dutasteride
TTDS00240	Drug(s)	Dutasteride & tamsulosin
TTDS00240	Drug(s)	Finasteride
TTDS00240	Inhibitor	Azelaic Acid
TTDS00240	Inhibitor	Dutasteride
TTDS00240	Inhibitor	Dutasteride & tamsulosin
TTDS00240	Inhibitor	Finasteride
TTDS00240	Multitarget	Dutasteride & tamsulosin
TTDS00241	UniProt ID	P05093
TTDS00241	Name	17 alpha-hydroxylase-C17, 20-lyase
TTDS00241	Type of target	Successful target
TTDS00241	Synonyms	17 alpha-Hydroxylase/C17-20-lyase
TTDS00241	Synonyms	CYP 17
TTDS00241	Synonyms	CYPXVII
TTDS00241	Synonyms	P450 17
TTDS00241	Synonyms	P450-C17
TTDS00241	Synonyms	P450c17
TTDS00241	Synonyms	Steroid 17-alpha-hydroxylase/17,20 lyase
TTDS00241	Disease	Benign prostate hyperplasia
TTDS00241	Disease	Prostate cancer
TTDS00241	Function	Conversion of pregnenolone and progesterone to their 17-alpha-hydroxylated produ
TTDS00241	Sequence	MWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQ
TTDS00241	PDB Structure	2C17; 3RUK; 3SWZ
TTDS00241	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00241	Pathway	C21-Steroid hormone metabolism
TTDS00241	Pathway	Metabolic pathways
TTDS00241	EC Number	EC 1.14.99.9
TTDS00241	Related US Patent	6,649,643
TTDS00241	Target Validation	TTDS00241
TTDS00241	Drug(s)	Progesterone
TTDS00241	Drug(s)	TAK-700
TTDS00241	Inhibitor	1-((9H-Fluoren-2-yl)ethyl)-1H-imidazole
TTDS00241	Inhibitor	1-((9H-Fluoren-2-yl)methyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-(4'-Ethylbiphenyl-4-yl)propyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-(4-thiophen-3-yl-phenyl)propyl)-1Himidazole
TTDS00241	Inhibitor	1-(1-(4-thiophen-3-ylphenyl)ethyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-(Biphenyl-4-yl)allyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-Biphenyl-4-yl-2-methyl-propyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-Biphenyl-4-yl-2-phenyl-ethyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-Biphenyl-4-yl-3-methyl-butyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-Biphenyl-4-yl-butyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-Biphenyl-4-yl-ethyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-Biphenyl-4-yl-pentyl)-1H-imidazole
TTDS00241	Inhibitor	1-(1-Biphenyl-4-yl-propyl)-1H-imidazole
TTDS00241	Inhibitor	1-(3,4-dichlorobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(3,4-difluorobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(3,5-bis(trifluoromethyl)benzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(3,5-dibromobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(3,5-dichlorobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(3,5-difluorobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(3-(4-chlorophenyl)propyl)-1H-imidazole
TTDS00241	Inhibitor	1-(3-(4-fluorophenyl)propyl)-1H-imidazole
TTDS00241	Inhibitor	1-(3-phenylpropyl)-1H-imidazole
TTDS00241	Inhibitor	1-(4-bromobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(4-bromophenethyl)-1H-imidazole
TTDS00241	Inhibitor	1-(4-chlorobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(4-chlorophenethyl)-1H-imidazole
TTDS00241	Inhibitor	1-(4-fluorobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(4-iodobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(4-methyl-benzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(4-nitrobenzyl)-1H-imidazole
TTDS00241	Inhibitor	1-(Bis-biphenyl-4-yl-methyl)-1H-imidazole
TTDS00241	Inhibitor	1-Ethyl-5-(imidazol-1-yl-phenyl-methyl)-1H-indole
TTDS00241	Inhibitor	1-Imidazol-1-ylmethyl-4-nitro-xanthen-9-one
TTDS00241	Inhibitor	1-Imidazol-1-ylmethylxanthen-9-one
TTDS00241	Inhibitor	2,3,4,5-Tetrafluoro-6-pentafluorophenylazo-phenol
TTDS00241	Inhibitor	2,3,5,6-Tetrafluoro-4-pentafluorophenylazo-phenol
TTDS00241	Inhibitor	2-(1-Imidazol-1-yl-ethyl)-9H-carbazole
TTDS00241	Inhibitor	3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine
TTDS00241	Inhibitor	3-(1-ethyl-3,4-dihydronaphthalen-2-yl)-pyridine
TTDS00241	Inhibitor	3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine
TTDS00241	Inhibitor	3-(6-Ethoxy-naphthalen-2-yl)-pyridine
TTDS00241	Inhibitor	3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine
TTDS00241	Inhibitor	3-(6-methoxynaphthalen-2-yl)pyridine
TTDS00241	Inhibitor	3-Fluoro-4'-(pyridin-4-ylmethyl)biphenyl-4-ol
TTDS00241	Inhibitor	3-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine
TTDS00241	Inhibitor	3-[4-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00241	Inhibitor	3-fluoro-4'-(1-(pyridin-4-yl)propyl)biphenyl-4-ol
TTDS00241	Inhibitor	4'-(1-(pyridin-4-yl)propyl)biphenyl-3-ol
TTDS00241	Inhibitor	4'-(2-methyl-1-(pyridin-4-yl)propyl)biphenyl-3-ol
TTDS00241	Inhibitor	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diamine
TTDS00241	Inhibitor	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diol
TTDS00241	Inhibitor	4'-(Pyridin-4-ylmethyl)biphenyl-3-amine
TTDS00241	Inhibitor	4'-(Pyridin-4-ylmethyl)biphenyl-4-amine
TTDS00241	Inhibitor	4'-(Pyridin-4-ylmethyl)biphenyl-4-carboxamide
TTDS00241	Inhibitor	4-((1H-imidazol-1-yl)methyl)benzonitrile
TTDS00241	Inhibitor	4-((1H-imidazol-1-yl)methyl)phenol
TTDS00241	Inhibitor	4-((3',4'-Difluorobiphenyl-4-yl)methyl)pyridine
TTDS00241	Inhibitor	4-(4'-Fluoro-biphenyl-4-ylmethyl)pyridine
TTDS00241	Inhibitor	4-(4-(thiophen-2-yl)benzyl)pyridine
TTDS00241	Inhibitor	4-(4-(thiophen-3-yl)benzyl)pyridine
TTDS00241	Inhibitor	4-Bromo-1-imidazol-1-ylmethyl-xanthen-9-one
TTDS00241	Inhibitor	4-Indan-(1Z)-ylidenemethyl-pyridine
TTDS00241	Inhibitor	4-[(3'-Hydroxybiphenyl-4-yl)methyl]pyridine
TTDS00241	Inhibitor	4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine
TTDS00241	Inhibitor	4-[1-(4'-Methoxybiphenyl-4-yl)propyl]pyridine
TTDS00241	Inhibitor	4-[4-(6-methoxynaphthalen-2-yl)benzyl]pyridine
TTDS00241	Inhibitor	4-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine
TTDS00241	Inhibitor	4-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00241	Inhibitor	4-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine
TTDS00241	Inhibitor	4-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00241	Inhibitor	4-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine
TTDS00241	Inhibitor	4-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00241	Inhibitor	5-[4-(Pyridin-4-ylmethyl)phenyl]-1H-indole
TTDS00241	Inhibitor	5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine
TTDS00241	Inhibitor	6-(3-(pyridin-4-yl)phenyl)naphthalen-2-ol
TTDS00241	Inhibitor	6-(pyridin-3-yl)-2-naphthonitrile
TTDS00241	Inhibitor	6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione
TTDS00241	Inhibitor	6-Pyridin-3-yl-naphthalen-2-ol
TTDS00241	Inhibitor	6-[4-(Pyridin-4-ylmethyl)phenyl]naphthalen-2-ol
TTDS00241	Inhibitor	7-(1-(1H-imidazol-1-yl)ethyl)-9H-fluoren-2-ol
TTDS00241	Inhibitor	ABIRATERONE
TTDS00241	Inhibitor	ISOCONAZOLE
TTDS00241	Inhibitor	N-(4'-Isonicotinoylbiphenyl-3-yl)acetamide
TTDS00241	Inhibitor	N-3-(4-bromophenyl)propyl imidazole
TTDS00241	Inhibitor	Pregnenolone
TTDS00241	Inhibitor	Progesterone
TTDS00241	Inhibitor	rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,4-diol
TTDS00241	Inhibitor	rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,5-diol
TTDS00241	Inhibitor	rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3-ol
TTDS00241	Inhibitor	rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-4-ol
TTDS00242	UniProt ID	P03372
TTDS00242	UniProt ID	Q13262
TTDS00242	Name	Estrogen receptor
TTDS00242	Type of target	Successful target
TTDS00242	Synonyms	ER
TTDS00242	Synonyms	ER-alpha
TTDS00242	Synonyms	ERalpha
TTDS00242	Synonyms	Estradiol receptor
TTDS00242	Synonyms	Estrogen receptor alpha
TTDS00242	Synonyms	Oestrogen receptor
TTDS00242	Synonyms	Oestrogen receptor alpha
TTDS00242	Disease	Brain injury
TTDS00242	Disease	Breast cancer
TTDS00242	Disease	Cardiovascular disease, unspecified
TTDS00242	Disease	Coronary atherosclerosis
TTDS00242	Disease	Endocrine independent cancer
TTDS00242	Disease	Neurodegenerative diseases
TTDS00242	Disease	Osteoporosis, unspecified
TTDS00242	Disease	Postmenopausal symptoms
TTDS00242	Function	Nuclear hormone receptor. The steroid hormones and their receptors are involved
TTDS00242	Sequence	MTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPAVYNYPEGAAYEFNAAAAANAQVYGQTGLPY
TTDS00242	PDB Structure	1A52; 1AKF; 1ERE; 1ERR; 1G50; 1GWQ; 1GWR; 1HCP; 1HCQ; 1L2I; 1PCG; 1QKT; 1QKU; 1R
TTDS00242	BioChemical Class	Zinc-finger
TTDS00242	Related US Patent	6,340,774
TTDS00242	Related US Patent	6,355,670
TTDS00242	Related US Patent	6,403,611
TTDS00242	Related US Patent	6,524,805
TTDS00242	Related US Patent	6,613,796
TTDS00242	Target Validation	TTDS00242
TTDS00242	QSAR Model	TTDS00242
TTDS00242	Drug(s)	Chlorotrianisene
TTDS00242	Drug(s)	Clomifene
TTDS00242	Drug(s)	Conjugated estrogens a
TTDS00242	Drug(s)	Conjugated estrogens b
TTDS00242	Drug(s)	Danazol
TTDS00242	Drug(s)	Dienestrol
TTDS00242	Drug(s)	Diethylstilbestrol
TTDS00242	Drug(s)	Estradiol
TTDS00242	Drug(s)	Estriol
TTDS00242	Drug(s)	Estrogen and selective estrogen receptor modulators
TTDS00242	Drug(s)	Estrone
TTDS00242	Drug(s)	Ethinyl Estradiol
TTDS00242	Drug(s)	Fosfestrol
TTDS00242	Drug(s)	Fulvestrant
TTDS00242	Drug(s)	GTx-758
TTDS00242	Drug(s)	Gestrinone
TTDS00242	Drug(s)	Lasofoxifene
TTDS00242	Drug(s)	Mestranol
TTDS00242	Drug(s)	Mitotane
TTDS00242	Drug(s)	Ospemifene
TTDS00242	Drug(s)	Quinestrol
TTDS00242	Drug(s)	Raloxifene
TTDS00242	Drug(s)	Tamoxifen
TTDS00242	Drug(s)	Toremifene
TTDS00242	Inhibitor	2,3-diphenyl-1H-indole
TTDS00242	Inhibitor	4-Naphthalen-2-yl-phenol
TTDS00242	Inhibitor	6-Phenyl-naphthalen-2-ol
TTDS00242	Inhibitor	7-Phenyl-naphthalen-2-ol
TTDS00242	Inhibitor	8-benzylnaringenin
TTDS00242	Inhibitor	8-methylnaringenin
TTDS00242	Inhibitor	8-n-heptylnaringenin
TTDS00242	Inhibitor	8-n-nonylnaringenin
TTDS00242	Inhibitor	8-n-pentylnaringenin
TTDS00242	Inhibitor	8-n-propylnaringenin
TTDS00242	Inhibitor	8-n-undecylnaringenin
TTDS00242	Inhibitor	ANDROSTENEDIOL
TTDS00242	Inhibitor	ARZOXIFENE
TTDS00242	Inhibitor	BITHIONOL
TTDS00242	Inhibitor	BROUSSONIN A
TTDS00242	Inhibitor	COUMESTROL
TTDS00242	Inhibitor	CP-394531
TTDS00242	Inhibitor	CP-409069
TTDS00242	Inhibitor	DIADZEIN
TTDS00242	Inhibitor	DIHYDRORALOXIFENE
TTDS00242	Inhibitor	EFFUSOL
TTDS00242	Inhibitor	GSK-5182
TTDS00242	Inhibitor	Genistein
TTDS00242	Inhibitor	HEXESTROL
TTDS00242	Inhibitor	ICI-164384
TTDS00242	Inhibitor	JNJ-17148066
TTDS00242	Inhibitor	JNJ-19398990
TTDS00242	Inhibitor	JNJ-26529126
TTDS00242	Inhibitor	JNJ-26529152
TTDS00242	Inhibitor	LTERHKILHRLLQEGSPSD
TTDS00242	Inhibitor	LY-117018
TTDS00242	Inhibitor	MPrP
TTDS00242	Inhibitor	NAFOXIDINE
TTDS00242	Inhibitor	ONAPRISTONE
TTDS00242	Inhibitor	Pipendoxifene
TTDS00242	Inhibitor	RALOXIFENE CORE
TTDS00242	Inhibitor	SOPHORAFLAVANONE B
TTDS00242	Inhibitor	Tamoxifen butyl bromide
TTDS00242	Inhibitor	Tamoxifen ethyl bromide
TTDS00242	Inhibitor	Tamoxifen isopropyl bromide
TTDS00242	Inhibitor	Tamoxifen methyl iodide
TTDS00242	Inhibitor	WAY-169916
TTDS00242	Inhibitor	ZK-119010
TTDS00242	Inhibitor	ZK-164015
TTDS00242	Antagonist	Danazol
TTDS00242	Antagonist	EM-800
TTDS00242	Antagonist	Fulvestrant
TTDS00242	Antagonist	GW7604
TTDS00242	Antagonist	Tamoxifen
TTDS00242	Antagonist	Trans-hydroxytamoxifen
TTDS00242	Agonist	Dienestrol
TTDS00242	Agonist	Diethylstilbestrol
TTDS00242	Agonist	Estradiol
TTDS00242	Agonist	Estriol
TTDS00242	Agonist	Estrogen
TTDS00242	Agonist	Estrone
TTDS00242	Agonist	Ethinyl Estradiol
TTDS00242	Agonist	Mestranol
TTDS00242	Modulator	Clomifene
TTDS00242	Modulator	Estrogen and selective estrogen receptor modulators
TTDS00242	Modulator	Lasofoxifene
TTDS00242	Modulator	Ospemifene
TTDS00242	Modulator	Quinestrol
TTDS00242	Modulator	Raloxifene
TTDS00242	Modulator	Toremifene
TTDS00242	Binder	Chlorotrianisene
TTDS00242	Binder	Mitotane
TTDS00244	Name	Leutinizing-hormone-releasing hormone
TTDS00244	Type of target	Successful target
TTDS00244	Disease	Breast cancer
TTDS00244	Drug(s)	Goserelin
TTDS00244	Drug(s)	Leuprolide
TTDS00244	Activator	Goserelin
TTDS00244	Activator	Leuprolide
TTDS00245	UniProt ID	P06401
TTDS00245	Name	Progesterone receptor
TTDS00245	Type of target	Successful target
TTDS00245	Synonyms	PR
TTDS00245	Disease	Breast cancer
TTDS00245	Function	The steroid hormones and their receptors are involved in the regulation of eukar
TTDS00245	Sequence	MTELKAKGPRAPHVAGGPPSPEVGSPLLCRPAAGPFPGSQTSDTLPEVSAIPISLDGLLFPRPCQGQDPSDEKTQDQQSL
TTDS00245	PDB Structure	1A28; 1E3K; 1SQN; 1SR7; 1ZUC; 2C7A; 2OVH; 2OVM; 2W8Y; 3D90; 3G8O; 3HQ5; 3KBA; 3Z
TTDS00245	BioChemical Class	Zinc-finger
TTDS00245	Related US Patent	6,451,780
TTDS00245	Related US Patent	6,608,074
TTDS00245	Target Validation	TTDS00245
TTDS00245	Drug(s)	Asoprisnil
TTDS00245	Drug(s)	Desogestrel
TTDS00245	Drug(s)	Dydrogesterone
TTDS00245	Drug(s)	Ethynodiol Diacetate
TTDS00245	Drug(s)	Etonogestrel
TTDS00245	Drug(s)	Levonorgestrel
TTDS00245	Drug(s)	Medroxyprogesterone
TTDS00245	Drug(s)	Medroxyprogesterone acetate
TTDS00245	Drug(s)	Megestrol
TTDS00245	Drug(s)	Mifepristone
TTDS00245	Drug(s)	Norethindrone
TTDS00245	Drug(s)	Norgestimate
TTDS00245	Drug(s)	Norgestrel
TTDS00245	Drug(s)	Ulipristal
TTDS00245	Inhibitor	1-Benzyl-3-phenylquinazoline-2,4(1H,3H)-dione
TTDS00245	Inhibitor	2,2,4-Trimethyl-6-phenyl-1,2-dihydro-quinoline
TTDS00245	Inhibitor	2-(4-Amino-3'-chloro-biphenyl-3-yl)-propan-2-ol
TTDS00245	Inhibitor	3,3-dimethyl-5-m-tolyl-2,3-dihydro-1H-inden-1-one
TTDS00245	Inhibitor	3-(3,3-dimethyl-2-oxoindolin-5-yl)benzonitrile
TTDS00245	Inhibitor	3-Phenyl-1-propylquinazoline-2,4(1H,3H)-dione
TTDS00245	Inhibitor	4-(2,4-diethyl-1H-pyrrol-3-yloxy)benzonitrile
TTDS00245	Inhibitor	5,N-Dihydroxythalidomide
TTDS00245	Inhibitor	5-(2-oxoindolin-5-yl)-1H-pyrrole-2-carbonitrile
TTDS00245	Inhibitor	6-(3-Nitro-phenyl)-3H-benzothiazol-2-one
TTDS00245	Inhibitor	AL-43
TTDS00245	Inhibitor	GSK-1564023A
TTDS00245	Inhibitor	GSK-325971A
TTDS00245	Inhibitor	LGD-5552
TTDS00245	Inhibitor	Lecanindole D
TTDS00245	Inhibitor	Methyltrienolone
TTDS00245	Inhibitor	ONAPRISTONE
TTDS00245	Inhibitor	PF-02367982
TTDS00245	Inhibitor	Tanaproget
TTDS00245	Inhibitor	ULIPRISTAL ACETATE
TTDS00245	Inhibitor	WAY-255348
TTDS00245	Inhibitor	ZK-230211
TTDS00245	Antagonist	Mifepristone
TTDS00245	Antagonist	Telaprevir
TTDS00245	Agonist	Dydrogesterone
TTDS00245	Agonist	Medroxyprogesterone
TTDS00245	Agonist	Norethindrone
TTDS00245	Agonist	Norgestimate
TTDS00245	Agonist	Norgestrel
TTDS00245	Modulator	Asoprisnil
TTDS00245	Modulator	Desogestrel
TTDS00245	Modulator	Ulipristal
TTDS00245	Binder	Ethynodiol Diacetate
TTDS00245	Binder	Etonogestrel
TTDS00245	Binder	Levonorgestrel
TTDS00245	Binder	Megestrol
TTDS00246	UniProt ID	P08543
TTDS00246	Name	Ribonucleoside-diphosphate reductase
TTDS00246	Type of target	Successful target
TTDS00246	Synonyms	Ribonucleoside diphosphate reductase
TTDS00246	Synonyms	Ribonucleotide reductase
TTDS00246	Disease	Breast cancer
TTDS00246	Disease	Cancer, unspecific
TTDS00246	Disease	Herpes Simplex Virus (HSV) infections
TTDS00246	Disease	Herpes virus infection
TTDS00246	Disease	Human immunodeficiency virus [HIV] disease
TTDS00246	Disease	Malaria
TTDS00246	Disease	Prostate cancer
TTDS00246	Disease	Retrovirus-induced immunodeficiency disease
TTDS00246	Disease	Tumors
TTDS00246	Sequence	MASRPAASSPVEARAPVGGQEAGGPSAATQGEAAGAPLAHGHHVYCQRVNGVMVLSDKTPGSASYRISDNNFVQCGSNCT
TTDS00246	BioChemical Class	Oxidoreductases acting on CH2 groups
TTDS00246	EC Number	EC 1.17.4.1
TTDS00246	Target Validation	TTDS00246
TTDS00246	Drug(s)	Clofarabine
TTDS00246	Drug(s)	Hydroxyurea
TTDS00246	Drug(s)	LOR-2040
TTDS00246	Inhibitor	Amidox
TTDS00246	Inhibitor	Clofarabine
TTDS00246	Inhibitor	Didox
TTDS00246	Inhibitor	Hydroxyurea
TTDS00246	Inhibitor	MDL 101,731
TTDS00246	Inhibitor	Resveratrol
TTDS00246	Inhibitor	Triapine
TTDS00246	Inhibitor	Trimidox
TTDS00246	Multitarget	Clofarabine
TTDS00247	UniProt ID	P12931
TTDS00247	Name	Proto-oncogene tyrosine-protein kinase SRC
TTDS00247	Type of target	Successful target
TTDS00247	Synonyms	C-SRC tyrosine kinase
TTDS00247	Synonyms	C-Src
TTDS00247	Synonyms	C-src TK
TTDS00247	Synonyms	P60-Src
TTDS00247	Synonyms	Pp60(src)
TTDS00247	Synonyms	Src tyrosine kinase
TTDS00247	Synonyms	Tyrosine kinase
TTDS00247	Synonyms	Tyrosine kinase (pp60(src))
TTDS00247	Disease	Breast cancer
TTDS00247	Disease	Cancer, unspecific
TTDS00247	Disease	Osteoporosis and other bone-related diseases
TTDS00247	Disease	Osteoporosis, unspecified
TTDS00247	Sequence	MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAG
TTDS00247	PDB Structure	1A07; 1A08; 1A09; 1A1A; 1A1B; 1A1C; 1A1E; 1FMK; 1HCS; 1HCT; 1KSW; 1O41; 1O42; 1O
TTDS00247	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00247	Pathway	Adherens junction
TTDS00247	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDS00247	Pathway	ErbB signaling pathway
TTDS00247	Pathway	Focal adhesion
TTDS00247	Pathway	Gap junction
TTDS00247	Pathway	GnRH signaling pathway
TTDS00247	Pathway	Tight junction
TTDS00247	Pathway	VEGF signaling pathway
TTDS00247	EC Number	EC 2.7.1.112
TTDS00247	Related US Patent	6,316,444
TTDS00247	Related US Patent	6,329,380
TTDS00247	Related US Patent	6,498,165
TTDS00247	Related US Patent	6,503,914
TTDS00247	Related US Patent	6,642,227
TTDS00247	Target Validation	TTDS00247
TTDS00247	QSAR Model	TTDS00247
TTDS00247	Drug(s)	AZD0530
TTDS00247	Drug(s)	Bosutinib
TTDS00247	Drug(s)	Dasatinib
TTDS00247	Drug(s)	Herbimycin A
TTDS00247	Drug(s)	KX01
TTDS00247	Inhibitor	2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
TTDS00247	Inhibitor	3-(3-aminobenzo[e][1,2,4]triazin-7-yl)phenol
TTDS00247	Inhibitor	4-Chloro-5,7-diphenyl-7H-pyrrolo[2,3-d]pyrimidine
TTDS00247	Inhibitor	5,7-Diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol
TTDS00247	Inhibitor	7-(naphthalen-2-yl)benzo[e][1,2,4]triazin-3-amine
TTDS00247	Inhibitor	A-420983
TTDS00247	Inhibitor	A-770041
TTDS00247	Inhibitor	AG-1879
TTDS00247	Inhibitor	AP-24163
TTDS00247	Inhibitor	AP-24226
TTDS00247	Inhibitor	AP22408
TTDS00247	Inhibitor	AZD-0530
TTDS00247	Inhibitor	AZD0530
TTDS00247	Inhibitor	Ac-Cys-Ile-Phe(4-NO2)-Lys-Phe(4-NO2)-Tyr
TTDS00247	Inhibitor	Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Phe(4-NO2)
TTDS00247	Inhibitor	Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Tyr
TTDS00247	Inhibitor	Ac-Cys-Ile-Tyr-Lys-Phe(4-CN)-Tyr
TTDS00247	Inhibitor	Ac-Cys-Ile-Tyr-Lys-Phe(4-Cl)-Tyr
TTDS00247	Inhibitor	Ac-Cys-Ile-Tyr-Lys-Phe(4-I)-Tyr
TTDS00247	Inhibitor	Ac-Cys-Ile-Tyr-Lys-Phe(4-N3)-Tyr
TTDS00247	Inhibitor	Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Phe(4-NO2)
TTDS00247	Inhibitor	Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Tyr-Phe
TTDS00247	Inhibitor	Ac-Cys-Ile-Tyr-Lys-Tyr-Phe(4-NO2)
TTDS00247	Inhibitor	Ac-Cys-Ile-cyclo[Phe-Lys]-Tyr-Tyr
TTDS00247	Inhibitor	BAS-00387275
TTDS00247	Inhibitor	BAS-00387328
TTDS00247	Inhibitor	BAS-00387347
TTDS00247	Inhibitor	BAS-00672722
TTDS00247	Inhibitor	BAS-01047341
TTDS00247	Inhibitor	BAS-01047655
TTDS00247	Inhibitor	BAS-01373578
TTDS00247	Inhibitor	BAS-0338868
TTDS00247	Inhibitor	BAS-0338872
TTDS00247	Inhibitor	BAS-09534324
TTDS00247	Inhibitor	BAS-450225
TTDS00247	Inhibitor	BAS-4844343
TTDS00247	Inhibitor	BMS-279700
TTDS00247	Inhibitor	Bosutinib
TTDS00247	Inhibitor	CGP 77675
TTDS00247	Inhibitor	CGP-191
TTDS00247	Inhibitor	CGP-62464
TTDS00247	Inhibitor	Cyclo[Ac-Cys-Ile-Phe]-Lys-Tyr-Tyr
TTDS00247	Inhibitor	Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Phe]
TTDS00247	Inhibitor	Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Tyr]
TTDS00247	Inhibitor	Cysteine Sulfenic Acid
TTDS00247	Inhibitor	DPI59
TTDS00247	Inhibitor	Dasatinib
TTDS00247	Inhibitor	Glu-Pro-Gln-F2Pmp-Glu-Glu-Ile-Pro-Ile-Tyr-Leu
TTDS00247	Inhibitor	Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu
TTDS00247	Inhibitor	Herbimycin A
TTDS00247	Inhibitor	ISO24
TTDS00247	Inhibitor	JNJ-10198409
TTDS00247	Inhibitor	Malonic acid
TTDS00247	Inhibitor	N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
TTDS00247	Inhibitor	N-Phenyl-5-phenylimidazo[1,5-a]pyrazin-8-amine
TTDS00247	Inhibitor	N6-Benzyl Adenosine-5'-Diphosphate
TTDS00247	Inhibitor	NM-PP1
TTDS00247	Inhibitor	Oxalic Acid
TTDS00247	Inhibitor	PAS219
TTDS00247	Inhibitor	PASBN
TTDS00247	Inhibitor	PD-0166326;PD-166326
TTDS00247	Inhibitor	PD-0173952
TTDS00247	Inhibitor	PD-0173955;PD-17395
TTDS00247	Inhibitor	PD-0173956
TTDS00247	Inhibitor	PD-0173958
TTDS00247	Inhibitor	PD-0179483
TTDS00247	Inhibitor	PD-0180970
TTDS00247	Inhibitor	PD-174265
TTDS00247	Inhibitor	PD166285
TTDS00247	Inhibitor	PD173074
TTDS00247	Inhibitor	Phenylphosphate
TTDS00247	Inhibitor	Phosphonotyrosine
TTDS00247	Inhibitor	Purvalanol A
TTDS00247	Inhibitor	RU78191
TTDS00247	Inhibitor	RU78262
TTDS00247	Inhibitor	RU78299
TTDS00247	Inhibitor	RU78300
TTDS00247	Inhibitor	RU78783
TTDS00247	Inhibitor	RU79072
TTDS00247	Inhibitor	RU79073
TTDS00247	Inhibitor	RU79256
TTDS00247	Inhibitor	RU81843
TTDS00247	Inhibitor	RU82129
TTDS00247	Inhibitor	RU82197
TTDS00247	Inhibitor	RU82209
TTDS00247	Inhibitor	RU83876
TTDS00247	Inhibitor	RU84687
TTDS00247	Inhibitor	RU85053
TTDS00247	Inhibitor	RU85493
TTDS00247	Inhibitor	RU90395
TTDS00247	Inhibitor	SB-203580
TTDS00247	Inhibitor	SKI-758
TTDS00247	Inhibitor	SKS-927
TTDS00247	Inhibitor	SU 6656
TTDS00247	Inhibitor	TG-100435
TTDS00247	Inhibitor	Y-c[D-Pen-(2')Nal-GSFC]KR-NH2
TTDS00247	Inhibitor	Y-c[D-Pen-(2R,3R)-2-Me-(2')Nal-GSFC]KR-NH2
TTDS00247	Inhibitor	Y-c[D-Pen-(2R,3S)-2-Me-(2')Nal-GSFC]KR-NH2
TTDS00247	Inhibitor	Y-c[D-Pen-(2S,3R)-2-Me-(2')Nal-GSFC]KR-NH2
TTDS00247	Inhibitor	Y-c[D-Pen-(2S,3S)-2-Me-(2')Nal-GSFC]KR-NH2
TTDS00247	Inhibitor	Y-c[D-Pen-(3,5-diI)Tyr-GSFC]KR-NH2
TTDS00247	Inhibitor	Y-c[D-Pen-(3-I)Tyr-GSFC]KR-NH2
TTDS00247	Inhibitor	Y-c[D-Pen-D-(2')Nal-GSFC]KR-NH2
TTDS00247	Multitarget	AZD0530
TTDS00247	Multitarget	Bosutinib
TTDS00247	Multitarget	Dasatinib
TTDS00249	UniProt ID	P04626
TTDS00249	Name	Receptor protein-tyrosine kinase erbB-2
TTDS00249	Type of target	Successful target
TTDS00249	Synonyms	C-erbB-2
TTDS00249	Synonyms	C-erbB-2 oncoprotein
TTDS00249	Synonyms	ERBB2
TTDS00249	Synonyms	Epidermal growth factor receptor 2
TTDS00249	Synonyms	Erb2
TTDS00249	Synonyms	HER-2
TTDS00249	Synonyms	HER2 (erbB2/neu)
TTDS00249	Synonyms	HER2/neu
TTDS00249	Synonyms	MLN 19
TTDS00249	Synonyms	NEU proto-oncogene
TTDS00249	Synonyms	P185erbB2
TTDS00249	Synonyms	Tyrosine kinase receptor ErbB2
TTDS00249	Synonyms	Tyrosine kinase-type cell surface receptor HER2
TTDS00249	Disease	Breast cancer
TTDS00249	Disease	Cancer, unspecific
TTDS00249	Disease	Colon cancer
TTDS00249	Disease	Ependymoma
TTDS00249	Disease	Ovarian cancer
TTDS00249	Function	Essential component of a neuregulin-receptor complex, althought neuregulins do n
TTDS00249	Sequence	MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEV
TTDS00249	PDB Structure	1MFG; 1MFL; 1MW4; 1N8Z; 1OVC; 1QR1; 1S78; 2A91; 2JWA; 2KS1; 2L4K; 3BE1; 3H3B; 3M
TTDS00249	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00249	Pathway	Adherens junction
TTDS00249	Pathway	Bladder cancer
TTDS00249	Pathway	Calcium signaling pathway
TTDS00249	Pathway	Endometrial cancer
TTDS00249	Pathway	ErbB signaling pathway
TTDS00249	Pathway	Focal adhesion
TTDS00249	Pathway	Non-small cell lung cancer
TTDS00249	Pathway	Pancreatic cancer
TTDS00249	Pathway	Pathways in cancer
TTDS00249	Pathway	Prostate cancer
TTDS00249	EC Number	EC 2.7.1.112
TTDS00249	Target Validation	TTDS00249
TTDS00249	Drug(s)	ARRY-380
TTDS00249	Drug(s)	AZD8931
TTDS00249	Drug(s)	BIBW 2992
TTDS00249	Drug(s)	BMS-599626
TTDS00249	Drug(s)	Bevacizumab+Trastuzumab
TTDS00249	Drug(s)	CI-1033
TTDS00249	Drug(s)	CP-724714
TTDS00249	Drug(s)	HKI-272
TTDS00249	Drug(s)	Lapatinib
TTDS00249	Drug(s)	MGAH22
TTDS00249	Drug(s)	MM-302
TTDS00249	Drug(s)	Pazopanib + Tyverb/Tykerb
TTDS00249	Drug(s)	Pertuzumab
TTDS00249	Drug(s)	RG1273
TTDS00249	Drug(s)	S-222611
TTDS00249	Drug(s)	TAK-285
TTDS00249	Drug(s)	TAK165
TTDS00249	Drug(s)	Trastuzumab
TTDS00249	Drug(s)	Trastuzumab-DM1
TTDS00249	Drug(s)	Tykerb
TTDS00249	Drug(s)	Tyverb/Tykerb
TTDS00249	Drug(s)	XL647
TTDS00249	Inhibitor	(1-Benzyl-1H-indazol-5-yl)-quinazolin-4-yl-amine
TTDS00249	Inhibitor	(1-Benzyl-1H-indol-5-yl)-quinazolin-4-yl-amine
TTDS00249	Inhibitor	AZD8931
TTDS00249	Inhibitor	BIBW 2992
TTDS00249	Inhibitor	BMS-599626
TTDS00249	Inhibitor	CI-1033
TTDS00249	Inhibitor	CP-724714
TTDS00249	Inhibitor	HKI-272
TTDS00249	Inhibitor	Lapatinib
TTDS00249	Inhibitor	Pazopanib + Tyverb/Tykerb
TTDS00249	Inhibitor	Pertuzumab
TTDS00249	Inhibitor	S-222611
TTDS00249	Inhibitor	TAK-285
TTDS00249	Inhibitor	TAK165
TTDS00249	Inhibitor	Tykerb
TTDS00249	Inhibitor	Tyverb/Tykerb
TTDS00249	Inhibitor	WAY-177820
TTDS00249	Inhibitor	XL647
TTDS00249	Inducer	RhuMAb HER2
TTDS00249	Antibody	Anti-ErbB-2 monoclonal antibody
TTDS00249	Antibody	Bevacizumab+Trastuzumab
TTDS00249	Antibody	Herceptin
TTDS00249	Antibody	Mini-antibody(scFv)
TTDS00249	Antibody	Trastuzumab
TTDS00249	Antibody	Trastuzumab-DM1
TTDS00249	Multitarget	BIBW 2992
TTDS00249	Multitarget	BMS-599626
TTDS00249	Multitarget	Bevacizumab+Trastuzumab
TTDS00249	Multitarget	CI-1033
TTDS00249	Multitarget	HKI-272
TTDS00249	Multitarget	Lapatinib
TTDS00249	Multitarget	Pazopanib + Tyverb/Tykerb
TTDS00249	Multitarget	S-222611
TTDS00249	Multitarget	TAK165
TTDS00249	Multitarget	Tykerb
TTDS00249	Multitarget	Tyverb/Tykerb
TTDS00249	Multitarget	XL647
TTDS00250	UniProt ID	Q92731
TTDS00250	Name	Estrogen receptor beta
TTDS00250	Type of target	Successful target
TTDS00250	Synonyms	Beta-1
TTDS00250	Synonyms	ER-beta
TTDS00250	Synonyms	Erbeta
TTDS00250	Synonyms	Oestrogen receptor beta
TTDS00250	Disease	Breast cancer
TTDS00250	Disease	Cardiovascular disease, unspecified
TTDS00250	Disease	ER beta-positive prostate tumors
TTDS00250	Disease	Neurodegenerative diseases
TTDS00250	Disease	Vascular injury response
TTDS00250	Function	Nuclear hormone receptor. binds estrogens with an affinity similar to that of es
TTDS00250	Sequence	MDIKNSPSSLNSPSSYNCSQSILPLEHGSIYIPSSYVDSHHEYPAMTFYSPAVMNYSIPSNVTNLEGGPGRQTTSPNVLW
TTDS00250	PDB Structure	1L2J; 1NDE; 1QKM; 1U3Q; 1U3R; 1U3S; 1U9E; 1X76; 1X78; 1X7B; 1X7J; 1YY4; 1YYE; 1Z
TTDS00250	BioChemical Class	Zinc-finger
TTDS00250	Related US Patent	6,355,670
TTDS00250	Related US Patent	6,403,611
TTDS00250	Related US Patent	6,613,796
TTDS00250	Related US Patent	6,630,508
TTDS00250	Target Validation	TTDS00250
TTDS00250	QSAR Model	TTDS00250
TTDS00250	Drug(s)	Conjugated Estrogens
TTDS00250	Inhibitor	1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
TTDS00250	Inhibitor	2-(3-hydroxyphenyl)-1,2'-spirobi[1H-indene]-5-ol
TTDS00250	Inhibitor	2-(3-hydroxyphenyl)-1,2'-spirobi[1H-indene]-6-ol
TTDS00250	Inhibitor	2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL
TTDS00250	Inhibitor	2-(4-Hydroxy-phenyl)-quinolin-6-ol
TTDS00250	Inhibitor	2-(4-hydroxyphenyl)-1,2'-spirobi[1H-indene]-5-ol
TTDS00250	Inhibitor	2-phenyl-1,2'-spirobi[1H-indene]-5'-ol
TTDS00250	Inhibitor	2-phenyl-1,2'-spirobi[1H-indene]-5-ol
TTDS00250	Inhibitor	3'-Methoxy-4'Hydroxyclomiphene
TTDS00250	Inhibitor	3-(4-Hydroxy-phenyl)-4H-chromen-7-ol
TTDS00250	Inhibitor	4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME
TTDS00250	Inhibitor	4-HYDROXYTAMOXIFEN
TTDS00250	Inhibitor	ANDROSTENEDIOL
TTDS00250	Inhibitor	ARZOXIFENE
TTDS00250	Inhibitor	Acetate Ion
TTDS00250	Inhibitor	BITHIONOL
TTDS00250	Inhibitor	BROUSSONIN A
TTDS00250	Inhibitor	COUMESTROL
TTDS00250	Inhibitor	CP-394531
TTDS00250	Inhibitor	CP-409069
TTDS00250	Inhibitor	DIADZEIN
TTDS00250	Inhibitor	DIHYDRORALOXIFENE
TTDS00250	Inhibitor	Doxorubicin-Formaldehyde Conjugate
TTDS00250	Inhibitor	EFFUSOL
TTDS00250	Inhibitor	Estrogen platinum(II) hybrid derivative
TTDS00250	Inhibitor	GNF-PF-3037
TTDS00250	Inhibitor	Genistein
TTDS00250	Inhibitor	HEXESTROL
TTDS00250	Inhibitor	ICI-164384
TTDS00250	Inhibitor	LY-117018
TTDS00250	Inhibitor	MORIN
TTDS00250	Inhibitor	NAFOXIDINE
TTDS00250	Inhibitor	NARINGENIN
TTDS00250	Inhibitor	ONAPRISTONE
TTDS00250	Inhibitor	Para-Mercury-Benzenesulfonic Acid
TTDS00250	Inhibitor	Pipendoxifene
TTDS00250	Inhibitor	SOPHORAFLAVANONE B
TTDS00250	Inhibitor	THIOGENISTEIN
TTDS00250	Inhibitor	TUPICHINOL C
TTDS00250	Inhibitor	WAY-169916
TTDS00250	Inhibitor	ZK-119010
TTDS00250	Inhibitor	ZK-164015
TTDS00250	Inhibitor	geldanamycin-estradiol hybrid
TTDS00250	Antagonist	Conjugated Estrogens
TTDS00250	Antagonist	EM-800
TTDS00250	Antagonist	Premarin
TTDS00250	Antagonist	Trans-hydroxytamoxifen
TTDS00250	Agonist	Estrogen
TTDS00250	Agonist	Estrogen receptor B agonist
TTDS00251	UniProt ID	P11473
TTDS00251	Name	Vitamin D receptor
TTDS00251	Type of target	Successful target
TTDS00251	Synonyms	1,25-dihydroxyvitamin D3 receptor
TTDS00251	Synonyms	Nuclear vitamin D receptor
TTDS00251	Synonyms	VDR
TTDS00251	Synonyms	Vitamin D(3) receptor
TTDS00251	Synonyms	Vitamin D3 receptor
TTDS00251	Disease	Breast cancer
TTDS00251	Disease	Colorectal cancer
TTDS00251	Disease	Kaposi's sarcoma
TTDS00251	Disease	Prostate cancer
TTDS00251	Disease	Vitamin D deficiency
TTDS00251	Function	Nuclear hormone receptor. Vdr mediates the action of vitamin d3 by controlling t
TTDS00251	Sequence	MEAMAASTSLPDPGDFDRNVPRICGVCGDRATGFHFNAMTCEGCKGFFRRSMKRKALFTCPFNGDCRITKDNRRHCQACR
TTDS00251	PDB Structure	1DB1; 1IE8; 1IE9; 1KB2; 1KB4; 1KB6; 1S0Z; 1S19; 1TXI; 1YNW; 2HAM; 2HAR; 2HAS; 2H
TTDS00251	BioChemical Class	Zinc-finger
TTDS00251	Target Validation	TTDS00251
TTDS00251	QSAR Model	TTDS00251
TTDS00251	Drug(s)	Calcidiol
TTDS00251	Drug(s)	Calcipotriol
TTDS00251	Drug(s)	Calcitriol
TTDS00251	Drug(s)	Cholecalciferol
TTDS00251	Drug(s)	Dihydrotachysterol
TTDS00251	Drug(s)	Doxercalciferol
TTDS00251	Drug(s)	Ergocalciferol
TTDS00251	Drug(s)	Paricalcitol
TTDS00251	Inhibitor	19-nor-14-epi-23-yne-1,25 dihydroxyvitamin D3
TTDS00251	Inhibitor	KSP-BCS-1-alpha-CHF2-1624F2-2
TTDS00251	Inhibitor	KSP-BCS-1-alpha-CHF2-20-epi-22-oxabishomo-26-OH
TTDS00251	Inhibitor	Seocalcitol
TTDS00251	Antagonist	Calcidiol
TTDS00251	Antagonist	Calcipotriol
TTDS00251	Antagonist	Calcitriol
TTDS00251	Antagonist	Dihydrotachysterol
TTDS00251	Antagonist	Doxercalciferol
TTDS00251	Antagonist	Ergocalciferol
TTDS00251	Agonist	1alpha,25 dihydroxyvitamin D(3)
TTDS00251	Agonist	Paricalcitol
TTDS00251	Binder	Cholecalciferol
TTDS00252	UniProt ID	P11511
TTDS00252	Name	Cytochrome P450 19
TTDS00252	Type of target	Successful target
TTDS00252	Synonyms	Aromatase
TTDS00252	Synonyms	CYPXIX
TTDS00252	Synonyms	Estrogen synthetase
TTDS00252	Synonyms	P-450AROM
TTDS00252	Disease	Breast cancer
TTDS00252	Disease	Endometriosis
TTDS00252	Disease	Estrogen disorders
TTDS00252	Disease	Male infertility
TTDS00252	Disease	McCune-Albright syndrome
TTDS00252	Disease	Neurodegenerative diseases
TTDS00252	Disease	Peripheral precocious puberty
TTDS00252	Function	Catalyzes the formation of aromatic c18 estrogens from c19 androgens.
TTDS00252	Sequence	MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRV
TTDS00252	PDB Structure	1TQA; 3EQM; 3S79; 3S7S; 4GL5; 4GL7
TTDS00252	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00252	Pathway	Androgen and estrogen metabolism
TTDS00252	Pathway	Metabolic pathways
TTDS00252	EC Number	EC 1.14.14.1
TTDS00252	Related US Patent	6,316,431
TTDS00252	Target Validation	TTDS00252
TTDS00252	QSAR Model	TTDS00252
TTDS00252	Drug(s)	Aminoglutethimide
TTDS00252	Drug(s)	Anastrozole
TTDS00252	Drug(s)	BGS649
TTDS00252	Drug(s)	Dextromethorphan+quinidine
TTDS00252	Drug(s)	Exemestane
TTDS00252	Drug(s)	Letrozole
TTDS00252	Drug(s)	Testolactone
TTDS00252	Inhibitor	ALBANOL A
TTDS00252	Inhibitor	ALPHA-NAPHTHOFLAVONE
TTDS00252	Inhibitor	ANDROSTENEDIONE
TTDS00252	Inhibitor	ANDROSTENEDONE
TTDS00252	Inhibitor	APIGENIN
TTDS00252	Inhibitor	Aminoglutethemide
TTDS00252	Inhibitor	Aminoglutethimide
TTDS00252	Inhibitor	Anastrozole
TTDS00252	Inhibitor	BIOCHANIN
TTDS00252	Inhibitor	CGS-18320B
TTDS00252	Inhibitor	CHRYSIN
TTDS00252	Inhibitor	COUMATE
TTDS00252	Inhibitor	DEHYDROLEUCODIN
TTDS00252	Inhibitor	Dextromethorphan+quinidine
TTDS00252	Inhibitor	Exemestane
TTDS00252	Inhibitor	FADROZOLE
TTDS00252	Inhibitor	FADROZOLE HCL
TTDS00252	Inhibitor	FORMESTANE
TTDS00252	Inhibitor	GARCINONE D
TTDS00252	Inhibitor	GOSSYPETIN
TTDS00252	Inhibitor	ISOLICOFLAVONOL
TTDS00252	Inhibitor	LIAROZOLE
TTDS00252	Inhibitor	LIQUIRTIGENIN
TTDS00252	Inhibitor	LUDARTIN
TTDS00252	Inhibitor	Letrozole
TTDS00252	Inhibitor	MDL-18962
TTDS00252	Inhibitor	MONODICTYOCHROMONE B
TTDS00252	Inhibitor	MORACHALCONE A
TTDS00252	Inhibitor	MR-16089
TTDS00252	Inhibitor	MR-20492
TTDS00252	Inhibitor	MR-20494
TTDS00252	Inhibitor	MR-20496
TTDS00252	Inhibitor	MR-20814
TTDS00252	Inhibitor	NARINGENIN
TTDS00252	Inhibitor	NSC-122427
TTDS00252	Inhibitor	NSC-12999
TTDS00252	Inhibitor	NSC-131736
TTDS00252	Inhibitor	NSC-19028
TTDS00252	Inhibitor	NSC-289311
TTDS00252	Inhibitor	NSC-356483
TTDS00252	Inhibitor	NSC-356781
TTDS00252	Inhibitor	NSC-368272
TTDS00252	Inhibitor	NSC-368280
TTDS00252	Inhibitor	NSC-369087
TTDS00252	Inhibitor	NSC-613604
TTDS00252	Inhibitor	NSC-625409
TTDS00252	Inhibitor	NSC-666292
TTDS00252	Inhibitor	NSC-683634
TTDS00252	Inhibitor	NSC-75308
TTDS00252	Inhibitor	NSC-93358
TTDS00252	Inhibitor	NSC-94258
TTDS00252	Inhibitor	NSC-94891
TTDS00252	Inhibitor	Rogletimide
TTDS00252	Inhibitor	Testolactone
TTDS00252	Inhibitor	VOROZOLE
TTDS00252	Inhibitor	YM-511
TTDS00252	Inhibitor	broussoflavonol F
TTDS00252	Inhibitor	docosapentaenoic acid
TTDS00252	Inhibitor	gamma-mangostin
TTDS00252	Inhibitor	isogemichalcone C
TTDS00252	Multitarget	Dextromethorphan+quinidine
TTDS00253	Name	Gonadotropin-releasing hormone
TTDS00253	Type of target	Successful target
TTDS00253	Synonyms	GnRH
TTDS00253	Synonyms	Gonadoliberin
TTDS00253	Synonyms	LH-RH
TTDS00253	Synonyms	LHRH
TTDS00253	Synonyms	Leutinizing-hormone-releasing hormone
TTDS00253	Synonyms	Luliberin
TTDS00253	Disease	Breast cancer
TTDS00253	Disease	Prostate cancer
TTDS00253	Related US Patent	6,172,080
TTDS00253	Related US Patent	6,180,642
TTDS00253	Related US Patent	6,214,798
TTDS00253	Related US Patent	6,288,078
TTDS00253	Related US Patent	6,346,534
TTDS00253	Related US Patent	6,384,017
TTDS00253	Related US Patent	6,540,979
TTDS00253	Related US Patent	6,569,863
TTDS00253	Related US Patent	6,583,153
TTDS00253	Related US Patent	6,620,824
TTDS00253	Related US Patent	6,627,609
TTDS00253	Related US Patent	6,765,011
TTDS00253	Target Validation	TTDS00253
TTDS00253	Drug(s)	ASP1707
TTDS00253	Drug(s)	ASP3550
TTDS00253	Drug(s)	Abarelix
TTDS00253	Drug(s)	MER-104
TTDS00253	Drug(s)	Ozarelix
TTDS00253	Drug(s)	Prostate cancer vaccine
TTDS00253	Inhibitor	Abarelix
TTDS00253	Inhibitor	Anti-GnRH Spiegelmer
TTDS00253	Inhibitor	Ozarelix
TTDS00254	UniProt ID	P22888
TTDS00254	Name	Lutropin-choriogonadotropic hormone receptor
TTDS00254	Type of target	Successful target
TTDS00254	Synonyms	LH/CG-R
TTDS00254	Synonyms	LHR
TTDS00254	Synonyms	LHRH receptor
TTDS00254	Synonyms	LSH-R
TTDS00254	Synonyms	Luteinizing hormone receptor
TTDS00254	Synonyms	Luteinizing hormone-releasing hormone receptor
TTDS00254	Disease	Benign prostate hyperplasia
TTDS00254	Disease	Breast cancer
TTDS00254	Disease	Endometriosis
TTDS00254	Disease	Prostate cancer
TTDS00254	Function	Receptor for lutropin-choriogonadotropic hormone. The activity of this receptor
TTDS00254	Sequence	MKQRFSALQLLKLLLLLQPPLPRALREALCPEPCNCVPDGALRCPGPTAGLTRLSLAYLPVKVIPSQAFRGLNEVIKIEI
TTDS00254	PDB Structure	1LUT; 1XUL
TTDS00254	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00254	Pathway	Calcium signaling pathway
TTDS00254	Pathway	Neuroactive ligand-receptor interaction
TTDS00254	Related US Patent	6,172,080
TTDS00254	Related US Patent	6,180,642
TTDS00254	Related US Patent	6,214,798
TTDS00254	Related US Patent	6,288,078
TTDS00254	Related US Patent	6,346,534
TTDS00254	Related US Patent	6,384,017
TTDS00254	Related US Patent	6,540,979
TTDS00254	Related US Patent	6,569,863
TTDS00254	Related US Patent	6,583,153
TTDS00254	Related US Patent	6,620,824
TTDS00254	Related US Patent	6,627,609
TTDS00254	Related US Patent	6,765,011
TTDS00254	Drug(s)	Lutropin alfa
TTDS00254	Binder	Lutropin alfa
TTDS00255	Name	Multidrug resistance protein
TTDS00255	Type of target	Successful target
TTDS00255	Synonyms	P-glycoprotein
TTDS00255	Disease	Acute leukaemia
TTDS00255	Disease	Allograft rejection
TTDS00255	Disease	Autoimmune diseases
TTDS00255	Disease	Cancer (multidrug resistant)
TTDS00255	Disease	Depression
TTDS00255	BioChemical Class	ABC transporter
TTDS00255	Drug(s)	Benzquinamide
TTDS00255	Drug(s)	CBT-1
TTDS00255	Drug(s)	Curcumin I
TTDS00255	Drug(s)	Ortataxel
TTDS00255	Drug(s)	Tariquidar
TTDS00255	Drug(s)	Valspodar
TTDS00255	Inhibitor	Benzquinamide
TTDS00255	Inhibitor	CBT-1
TTDS00255	Inhibitor	Chemosensitizers
TTDS00255	Inhibitor	Curcumin I
TTDS00255	Inhibitor	KP772
TTDS00255	Inhibitor	MM36
TTDS00255	Inhibitor	WK-X-34
TTDS00255	Modulator	Cyclosporin A
TTDS00255	Modulator	Ortataxel
TTDS00255	Modulator	Tariquidar
TTDS00255	Modulator	Valspodar
TTDS00256	UniProt ID	P05186
TTDS00256	Name	Alkaline phosphatase, tissue-nonspecific
TTDS00256	Type of target	Successful target
TTDS00256	Synonyms	AP-TNAP
TTDS00256	Synonyms	Liver/bone/kidney isozyme
TTDS00256	Synonyms	TNSALP
TTDS00256	Disease	Cancer, unspecific
TTDS00256	Function	This isozyme may play a role in skeletal mineralization.
TTDS00256	Sequence	MISPFLVLAIGTCLTNSLVPEKEKDPKYWRDQAQETLKYALELQKLNTNVAKNVIMFLGDGMGVSTVTAARILKGQLHHN
TTDS00256	BioChemical Class	Hydrolases acting on ester bonds
TTDS00256	Pathway	Folate biosynthesis
TTDS00256	Pathway	Metabolic pathways
TTDS00256	Pathway	gamma-Hexachlorocyclohexane degradation
TTDS00256	EC Number	EC 3.1.3.1
TTDS00256	Target Validation	TTDS00256
TTDS00256	Drug(s)	IAP Antagonist
TTDS00256	Drug(s)	Levamisole
TTDS00256	Inhibitor	IAP Antagonist
TTDS00256	Inhibitor	Levamisole
TTDS00258	UniProt ID	Q03431
TTDS00258	Name	Parathyroid hormone/parathyroid hormone-related peptide receptor
TTDS00258	Type of target	Successful target
TTDS00258	Synonyms	PTH/PTHr receptor
TTDS00258	Synonyms	PTH/PTHrP type I receptor
TTDS00258	Synonyms	Parathyroid hormone-related peptide (PTHRP)
TTDS00258	Disease	Cancer-associated morbidity
TTDS00258	Disease	Malignancy-associated hypercalcemia
TTDS00258	Function	This is a receptor for parathyroid hormone and for parathyroid hormone-related p
TTDS00258	Sequence	MGTARIAPGLALLLCCPVLSSAYALVDADDVMTKEEQIFLLHRAQAQCEKRLKEVLQRPASIMESDKGWTSASTSGKPRK
TTDS00258	PDB Structure	1BL1; 1ET2; 1ET3; 3C4M; 3H3G; 3KJ5; 3L2J
TTDS00258	BioChemical Class	G-protein coupled receptor (Secretin family)
TTDS00258	Pathway	Neuroactive ligand-receptor interaction
TTDS00258	Target Validation	TTDS00258
TTDS00258	Drug(s)	Teriparatide
TTDS00258	Binder	Teriparatide
TTDS00261	Name	Platelet-derived growth factor receptor
TTDS00261	Type of target	Successful target
TTDS00261	Synonyms	PDGF-R
TTDS00261	Synonyms	PDGFR kinase
TTDS00261	Synonyms	Platelet-derived growth factor receptor tyrosine kinase
TTDS00261	Disease	Cancer, unspecific
TTDS00261	Disease	Chronic myelomonocytic leukemia
TTDS00261	Disease	Glioblastoma multiforme
TTDS00261	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00261	Pathway	Calcium signaling pathway
TTDS00261	Pathway	Colorectal cancer
TTDS00261	Pathway	Cytokine-cytokine receptor interaction
TTDS00261	Pathway	Focal adhesion
TTDS00261	Pathway	Gap junction
TTDS00261	Pathway	Glioma
TTDS00261	Pathway	MAPK signaling pathway
TTDS00261	Pathway	Melanoma
TTDS00261	Pathway	Pathways in cancer
TTDS00261	Pathway	Prostate cancer
TTDS00261	Pathway	Regulation of actin cytoskeleton
TTDS00261	EC Number	EC 2.7.1.112
TTDS00261	Related US Patent	6,566,075
TTDS00261	Related US Patent	6,642,232
TTDS00261	Target Validation	TTDS00261
TTDS00261	QSAR Model	TTDS00261
TTDS00261	Drug(s)	Axitinib
TTDS00261	Drug(s)	BAY-57-9352
TTDS00261	Drug(s)	Becaplermin
TTDS00261	Drug(s)	CP-868596
TTDS00261	Drug(s)	CT-102
TTDS00261	Drug(s)	Imatinib
TTDS00261	Drug(s)	MP470
TTDS00261	Drug(s)	Motesanib
TTDS00261	Drug(s)	Motesanib diphosphate
TTDS00261	Drug(s)	Nilotinib
TTDS00261	Drug(s)	Nintedanib
TTDS00261	Drug(s)	Pazopanib
TTDS00261	Drug(s)	Pazopanib HCl
TTDS00261	Drug(s)	SU-6668
TTDS00261	Drug(s)	Sunitinib
TTDS00261	Drug(s)	Sunitinib malate
TTDS00261	Drug(s)	TKI258
TTDS00261	Drug(s)	X-82
TTDS00261	Inhibitor	Axitinib
TTDS00261	Inhibitor	BAY-57-9352
TTDS00261	Inhibitor	Becaplermin
TTDS00261	Inhibitor	CP-868596
TTDS00261	Inhibitor	Imatinib
TTDS00261	Inhibitor	MP470
TTDS00261	Inhibitor	Motesanib
TTDS00261	Inhibitor	Motesanib diphosphate
TTDS00261	Inhibitor	Nilotinib
TTDS00261	Inhibitor	Pazopanib
TTDS00261	Inhibitor	Pazopanib HCl
TTDS00261	Inhibitor	SU-6668
TTDS00261	Inhibitor	Sunitinib
TTDS00261	Inhibitor	Sunitinib malate
TTDS00261	Inhibitor	TKI258
TTDS00261	Inhibitor	Trapidil
TTDS00261	Activator	CT-102
TTDS00261	Activator	PDGF gene therapy
TTDS00261	Binder	Alkaloid staurosporin
TTDS00261	Multitarget	Axitinib
TTDS00261	Multitarget	BAY-57-9352
TTDS00261	Multitarget	Imatinib
TTDS00261	Multitarget	MP470
TTDS00261	Multitarget	Motesanib
TTDS00261	Multitarget	Motesanib diphosphate
TTDS00261	Multitarget	Nilotinib
TTDS00261	Multitarget	Pazopanib
TTDS00261	Multitarget	Pazopanib HCl
TTDS00261	Multitarget	SU-6668
TTDS00261	Multitarget	Sunitinib
TTDS00261	Multitarget	Sunitinib malate
TTDS00261	Multitarget	TKI258
TTDS00264	UniProt ID	P30559
TTDS00264	Name	Oxytocin receptor
TTDS00264	Type of target	Successful target
TTDS00264	Synonyms	OT-R
TTDS00264	Synonyms	OXTR
TTDS00264	Disease	Cancer, unspecific
TTDS00264	Function	Receptor for oxytocin. The activity of this receptor is mediated by G proteins w
TTDS00264	Sequence	MEGALAANWSAEAANASAAPPGAEGNRTAGPPRRNEALARVEVAVLCLILLLALSGNACVLLALRTTRQKHSRLFFFMKH
TTDS00264	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00264	Pathway	Calcium signaling pathway
TTDS00264	Pathway	Neuroactive ligand-receptor interaction
TTDS00264	Target Validation	TTDS00264
TTDS00264	Drug(s)	Carbetocin
TTDS00264	Drug(s)	GSK221149
TTDS00264	Drug(s)	Oxytocin
TTDS00264	Inhibitor	1'-tosylspiro[indene-1,4'-piperidine]
TTDS00264	Inhibitor	ARGENINE VASOPRESSIN
TTDS00264	Inhibitor	ATOSIBAN
TTDS00264	Inhibitor	GSK-221149A
TTDS00264	Inhibitor	L-368899;NCGC00094029-01
TTDS00264	Inhibitor	L-371257
TTDS00264	Inhibitor	L-372662
TTDS00264	Inhibitor	PF-3274167
TTDS00264	Inhibitor	SR-149415
TTDS00264	Inhibitor	VNA-932;WAY-VNA-932
TTDS00264	Inhibitor	[Aib7]OT
TTDS00264	Inhibitor	[D-Tic7]OT
TTDS00264	Inhibitor	[Gly(But)7]OT
TTDS00264	Inhibitor	[HO1][Lys8(5/6C-Flu)]VT
TTDS00264	Inhibitor	[HO1][Orn8(5/6C-Flu)]VT
TTDS00264	Inhibitor	[HO1][Orn8(5/6C-Rhm)]VT
TTDS00264	Inhibitor	[HO1][Thr4,Lys8(5/6C-Flu)]VT
TTDS00264	Inhibitor	[HO1][Thr4,Orn8(5/6C-Flu)]VT
TTDS00264	Inhibitor	[L-Tic7]OT
TTDS00264	Inhibitor	[Lys8(Alexa 488) ]PVA
TTDS00264	Inhibitor	[Lys8(Alexa 546) ]PVA
TTDS00264	Inhibitor	[Mpa1, D-Tic2, Aib7]OT
TTDS00264	Inhibitor	[Mpa1, D-Tic7]OT
TTDS00264	Inhibitor	[Mpa1, D-Tyr(Et)2, Aib7, D-Tic9]OT
TTDS00264	Inhibitor	[Mpa1, D-Tyr(Et)2, Aib7]OT
TTDS00264	Inhibitor	[Mpa1, D-Tyr(Et)2, D-Tic7, Aib9]OT
TTDS00264	Inhibitor	[Mpa1, D-Tyr(Et)2, D-Tic7, D-Tic9]OT
TTDS00264	Inhibitor	[Mpa1, D-Tyr(Et)2, D-Tic7]OT
TTDS00264	Inhibitor	[Mpa1, D-Tyr(Et)2, Gly(But)3, Gly(But)7]OT
TTDS00264	Inhibitor	[Mpa1, D-Tyr(Et)2, Gly(But)7]OT
TTDS00264	Inhibitor	[Mpa1, D-Tyr(Et)2, L-Tic7]OT
TTDS00264	Inhibitor	[Mpa1, D-Tyr(Et)2, Pip7]OT
TTDS00264	Inhibitor	[Mpa1, L-Tic7]OT
TTDS00264	Inhibitor	[Pip7]OT
TTDS00264	Inhibitor	d(CH2)5[Tyr(Me)2,Thr4,Orn8(5/6C-Flu),Tyr-NH29]VT
TTDS00264	Inhibitor	d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr9-NH2]VT
TTDS00264	Inhibitor	d[Arg4,Dab8]VP
TTDS00264	Inhibitor	d[Arg4,Lys8]VP
TTDS00264	Inhibitor	d[Arg4,Orn8]VP
TTDS00264	Inhibitor	d[Arg4]AVP
TTDS00264	Inhibitor	d[Cha4,Dab8]VP
TTDS00264	Inhibitor	d[Cha4,Dap8]VP
TTDS00264	Inhibitor	d[Cha4,Lys8]VP
TTDS00264	Inhibitor	d[Cha4,Orn8]VP
TTDS00264	Inhibitor	d[Cha4]AVP
TTDS00264	Inhibitor	d[Leu4,Dab8]VP
TTDS00264	Inhibitor	d[Leu4,Dap8]VP
TTDS00264	Inhibitor	d[Leu4,Lys8]VP
TTDS00264	Inhibitor	d[Leu4,Orn8]VP
TTDS00264	Inhibitor	d[Leu4]AVP
TTDS00264	Inhibitor	d[Lys8(5/6-Flu)]VT
TTDS00264	Inhibitor	d[Orn4,Lys8]VP
TTDS00264	Inhibitor	d[Orn4,Orn8]VP
TTDS00264	Inhibitor	d[Orn4]AVP
TTDS00264	Inhibitor	d[Orn8(5/6C-Flu)]VT
TTDS00264	Inhibitor	d[Thr4,Lys8(5/6C-Flu)]VT
TTDS00264	Inhibitor	d[Thr4,Orn8(5/6C-Flu)]VT
TTDS00264	Inhibitor	d[Val4]AVP
TTDS00264	Inhibitor	desGly-NH2,d(CH2)5[D-Tyr2,Thr4,Orn8(5/6C-Flu)]VT
TTDS00264	Antagonist	GSK221149
TTDS00264	Agonist	Carbetocin
TTDS00264	Agonist	Oxytocin
TTDS00265	UniProt ID	P42345
TTDS00265	Name	Serine/threonine-protein kinase mTOR
TTDS00265	Type of target	Successful target
TTDS00265	Synonyms	FK506-binding protein 12-rapamycin complex-associated protein 1
TTDS00265	Synonyms	FKBP-rapamycin associated protein
TTDS00265	Synonyms	FKBP12-rapamycin complex-associated protein
TTDS00265	Synonyms	FRAP
TTDS00265	Synonyms	FRAP1
TTDS00265	Synonyms	Mammalian target of rapamycin
TTDS00265	Synonyms	RAPT1
TTDS00265	Synonyms	Rapamycin target protein
TTDS00265	Synonyms	TOR kinase
TTDS00265	Synonyms	Target of rapamycin
TTDS00265	Synonyms	mTOR
TTDS00265	Disease	Cancer, unspecific
TTDS00265	Disease	Immunosuppression
TTDS00265	Function	Acts as the target for the cell-cycle arrest and immunosuppressive effects of th
TTDS00265	Sequence	MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDA
TTDS00265	PDB Structure	1AUE; 1FAP; 1NSG; 2FAP; 2GAQ; 2NPU; 2RSE; 3FAP; 4DRH; 4DRI; 4DRJ; 4FAP; 4JSN; 4J
TTDS00265	Pathway	Acute myeloid leukemia
TTDS00265	Pathway	Adipocytokine signaling pathway
TTDS00265	Pathway	ErbB signaling pathway
TTDS00265	Pathway	Glioma
TTDS00265	Pathway	Insulin signaling pathway
TTDS00265	Pathway	Pathways in cancer
TTDS00265	Pathway	Prostate cancer
TTDS00265	Pathway	Type II diabetes mellitus
TTDS00265	Pathway	mTOR signaling pathway
TTDS00265	Target Validation	TTDS00265
TTDS00265	Drug(s)	AP23573
TTDS00265	Drug(s)	AZD2014
TTDS00265	Drug(s)	AZD8055
TTDS00265	Drug(s)	BEZ235
TTDS00265	Drug(s)	BGT226
TTDS00265	Drug(s)	CC-223
TTDS00265	Drug(s)	DS-3078
TTDS00265	Drug(s)	DS-7423
TTDS00265	Drug(s)	Deforolimus
TTDS00265	Drug(s)	Everolimus
TTDS00265	Drug(s)	GDC-0980
TTDS00265	Drug(s)	GDC-0980/RG7422
TTDS00265	Drug(s)	GSK2126458
TTDS00265	Drug(s)	INK128
TTDS00265	Drug(s)	KD032
TTDS00265	Drug(s)	OSI-027
TTDS00265	Drug(s)	PF-04691502
TTDS00265	Drug(s)	PF-05212384
TTDS00265	Drug(s)	PI3 Kinase/mTOR Inhibitor
TTDS00265	Drug(s)	PWT33597
TTDS00265	Drug(s)	RG7422
TTDS00265	Drug(s)	Ridaforolimus
TTDS00265	Drug(s)	SAR245409/MSC1936369B combination therapy
TTDS00265	Drug(s)	Sirolimus
TTDS00265	Drug(s)	Temsirolimus
TTDS00265	Drug(s)	XL765
TTDS00265	Drug(s)	Zotarolimus; Abt-578
TTDS00265	Inhibitor	(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol
TTDS00265	Inhibitor	2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one
TTDS00265	Inhibitor	2-(6-morpholino-9H-purin-2-yl)phenol
TTDS00265	Inhibitor	2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one
TTDS00265	Inhibitor	2-chloro-N-(6-cyanopyridin-3-yl)propanamide
TTDS00265	Inhibitor	3-(6-morpholino-9H-purin-2-yl)phenol
TTDS00265	Inhibitor	4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine
TTDS00265	Inhibitor	4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine
TTDS00265	Inhibitor	4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine
TTDS00265	Inhibitor	4-(6-morpholino-9H-purin-2-yl)phenol
TTDS00265	Inhibitor	AP-21967
TTDS00265	Inhibitor	AP23573
TTDS00265	Inhibitor	AZD8055
TTDS00265	Inhibitor	BEZ235
TTDS00265	Inhibitor	BGT226
TTDS00265	Inhibitor	C-16-(S)-3-methylindolerapamycin
TTDS00265	Inhibitor	Deforolimus
TTDS00265	Inhibitor	Everolimus
TTDS00265	Inhibitor	GDC-0980
TTDS00265	Inhibitor	INK128
TTDS00265	Inhibitor	LY-293646
TTDS00265	Inhibitor	LY-294002
TTDS00265	Inhibitor	Macrolide derivative
TTDS00265	Inhibitor	OSI-027
TTDS00265	Inhibitor	Rapamycin
TTDS00265	Inhibitor	Rapamycin complexed with immunophilin FKBP12
TTDS00265	Inhibitor	Ridaforolimus
TTDS00265	Inhibitor	Sirolimus
TTDS00265	Inhibitor	Temsirolimus
TTDS00265	Inhibitor	XL765
TTDS00265	Multitarget	BEZ235
TTDS00265	Multitarget	BGT226
TTDS00265	Multitarget	GDC-0980
TTDS00265	Multitarget	XL765
TTDS00267	UniProt ID	P30556
TTDS00267	Name	Type-1 angiotensin II receptor
TTDS00267	Type of target	Successful target
TTDS00267	Synonyms	AT1
TTDS00267	Synonyms	AT1AR
TTDS00267	Synonyms	Angiotensin 1 receptor
TTDS00267	Synonyms	Angiotensin II receptor 1
TTDS00267	Disease	Cardiovascular disease, unspecified
TTDS00267	Disease	Heart failure
TTDS00267	Disease	Hypertension
TTDS00267	Disease	Ischemic stroke
TTDS00267	Disease	Parkinson's disease
TTDS00267	Function	Receptor for angiotensin II. Mediates its action by association with G proteins
TTDS00267	Sequence	MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLT
TTDS00267	PDB Structure	1ZV0
TTDS00267	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00267	Pathway	Calcium signaling pathway
TTDS00267	Pathway	Neuroactive ligand-receptor interaction
TTDS00267	Pathway	Renin-angiotensin system
TTDS00267	Pathway	Vascular smooth muscle contraction
TTDS00267	Related US Patent	6,300,356
TTDS00267	Related US Patent	6,544,968
TTDS00267	Related US Patent	6,589,547
TTDS00267	Related US Patent	6,638,937
TTDS00267	Related US Patent	6,641,811
TTDS00267	Related US Patent	6,767,905
TTDS00267	Target Validation	TTDS00267
TTDS00267	QSAR Model	TTDS00267
TTDS00267	Drug(s)	Candesartan
TTDS00267	Drug(s)	Eprosartan
TTDS00267	Drug(s)	Eprosartan mesylate
TTDS00267	Drug(s)	Forasartan
TTDS00267	Drug(s)	Irbesartan
TTDS00267	Drug(s)	Losartan
TTDS00267	Drug(s)	Olmesartan
TTDS00267	Drug(s)	Olmesartan medoxomil
TTDS00267	Drug(s)	S-474474
TTDS00267	Drug(s)	Saprisartan
TTDS00267	Drug(s)	TAK-591
TTDS00267	Drug(s)	Tasosartan
TTDS00267	Drug(s)	Telmisartan
TTDS00267	Drug(s)	Valsartan
TTDS00267	Inhibitor	4-(2-Butyl-benzoimidazol-1-ylmethyl)-phenol
TTDS00267	Inhibitor	ANGIOTENSIN II
TTDS00267	Inhibitor	BMS-248360
TTDS00267	Inhibitor	CV-11194
TTDS00267	Inhibitor	Carboxylic Acid Metabolite (E-3174)
TTDS00267	Inhibitor	GNF-PF-2307
TTDS00267	Inhibitor	GNF-PF-2812
TTDS00267	Inhibitor	GNF-PF-3832
TTDS00267	Inhibitor	HELENALIN
TTDS00267	Inhibitor	L-159093
TTDS00267	Inhibitor	L-159689
TTDS00267	Inhibitor	L-162313
TTDS00267	Inhibitor	L-162782
TTDS00267	Inhibitor	SARALASIN
TTDS00267	Inhibitor	TAK-536
TTDS00267	Inhibitor	[Bpa1]AngII
TTDS00267	Inhibitor	[Sar1,Bpa2]AngII
TTDS00267	Inhibitor	[Sar1,Bpa3]AngII
TTDS00267	Inhibitor	[Sar1,Bpa8]AngII
TTDS00267	Inhibitor	[Sar1,Tdf2]AngII
TTDS00267	Inhibitor	[Sar1,Tdf3]AngII
TTDS00267	Inhibitor	[Sar1,Tdf8]AngII
TTDS00267	Inhibitor	[Tdf1]AngII
TTDS00267	Antagonist	(E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n
TTDS00267	Antagonist	4-[(diphenylmethyl)amino]-2-phenylquinazoline
TTDS00267	Antagonist	4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone
TTDS00267	Antagonist	Candesartan
TTDS00267	Antagonist	Eprosartan
TTDS00267	Antagonist	Eprosartan mesylate
TTDS00267	Antagonist	Forasartan
TTDS00267	Antagonist	GBR-12935
TTDS00267	Antagonist	Irbesartan
TTDS00267	Antagonist	Losartan
TTDS00267	Antagonist	Olmesartan
TTDS00267	Antagonist	Olmesartan medoxomil
TTDS00267	Antagonist	RTI-76
TTDS00267	Antagonist	Saprisartan
TTDS00267	Antagonist	TAK-591
TTDS00267	Antagonist	Tasosartan
TTDS00267	Antagonist	Telmisartan
TTDS00267	Antagonist	Valsartan
TTDS00267	Blocker	S-474474
TTDS00267	Multitarget	TAK-591
TTDS00268	UniProt ID	P11836
TTDS00268	Name	B-lymphocyte antigen CD20
TTDS00268	Type of target	Successful target
TTDS00268	Synonyms	B-lymphocyte surface antigen B1
TTDS00268	Synonyms	Bp35
TTDS00268	Synonyms	CD20
TTDS00268	Synonyms	Leu-16
TTDS00268	Disease	B-cell lymphoma
TTDS00268	Disease	Cancer, unspecific
TTDS00268	Function	This protein may be involved in the regulation of b-cell activation and prolifer
TTDS00268	Sequence	MTTPRNSVNGTFPAEPMKGPIAMQSGPKPLFRRMSSLVGPTQSFFMRESKTLGAVQIMNGLFHIALGGLLMIPAGIYAPI
TTDS00268	PDB Structure	1S8B; 2OSL; 3BKY; 3PP4
TTDS00268	BioChemical Class	Transmembrane protein
TTDS00268	Pathway	Hematopoietic cell lineage
TTDS00268	Target Validation	TTDS00268
TTDS00268	Drug(s)	ATM AVI
TTDS00268	Drug(s)	Bevacizumab+Rituximab
TTDS00268	Drug(s)	DI-Leu16-IL2
TTDS00268	Drug(s)	GA101
TTDS00268	Drug(s)	Iboctadekin & rituximab
TTDS00268	Drug(s)	Ibritumomab
TTDS00268	Drug(s)	Ocrelizumab
TTDS00268	Drug(s)	Ofatumumab
TTDS00268	Drug(s)	R7159
TTDS00268	Drug(s)	RG7159
TTDS00268	Drug(s)	Rituxan Hemotalogy/oncology
TTDS00268	Drug(s)	Rituxan Immunology
TTDS00268	Drug(s)	Rituximab
TTDS00268	Drug(s)	Tositumomab
TTDS00268	Drug(s)	Veltuzumab
TTDS00268	Antibody	Bevacizumab+Rituximab
TTDS00268	Antibody	GA101
TTDS00268	Antibody	Iboctadekin & rituximab
TTDS00268	Antibody	Ibritumomab
TTDS00268	Antibody	Iodine-131-tositumomab
TTDS00268	Antibody	Ocrelizumab
TTDS00268	Antibody	Ofatumumab
TTDS00268	Antibody	R7159
TTDS00268	Antibody	Rituxan Hemotalogy/oncology
TTDS00268	Antibody	Rituxan Immunology
TTDS00268	Antibody	Rituximab
TTDS00268	Antibody	Tositumomab
TTDS00268	Multitarget	Bevacizumab+Rituximab
TTDS00268	Multitarget	Iboctadekin & rituximab
TTDS00269	UniProt ID	P08069
TTDS00269	Name	Insulin-like growth factor I receptor
TTDS00269	Type of target	Successful target
TTDS00269	Synonyms	CD221 antigen
TTDS00269	Synonyms	IGF-1 receptor
TTDS00269	Synonyms	IGF-1R
TTDS00269	Synonyms	IGF-IR
TTDS00269	Synonyms	Type 1 insulin-like growth factor receptor
TTDS00269	Disease	Cancer, unspecific
TTDS00269	Disease	Colorectal cancer
TTDS00269	Disease	Ewing's sarcoma
TTDS00269	Disease	Medulloblastoma
TTDS00269	Disease	Peripheral neuroectodermal tumor
TTDS00269	Disease	Tumors
TTDS00269	Function	This receptor binds insulin-like growth factor I (IGF I) with a high affinity an
TTDS00269	Sequence	MKSGSGGGSPTSLWGLLFLSAALSLWPTSGEICGPGIDIRNDYQQLKRLENCTVIEGYLHILLISKAEDYRSYRFPKLTV
TTDS00269	PDB Structure	1IGR; 1JQH; 1K3A; 1M7N; 1P4O; 2OJ9; 2ZM3; 3D94; 3F5P; 3I81; 3LVP; 3LW0; 3NW5; 3N
TTDS00269	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00269	Pathway	Adherens junction
TTDS00269	Pathway	Colorectal cancer
TTDS00269	Pathway	Focal adhesion
TTDS00269	Pathway	Glioma
TTDS00269	Pathway	Long-term depression
TTDS00269	Pathway	Melanoma
TTDS00269	Pathway	Pathways in cancer
TTDS00269	Pathway	Prostate cancer
TTDS00269	EC Number	EC 2.7.1.112
TTDS00269	Related US Patent	6,645,775
TTDS00269	Related US Patent	6,677,305
TTDS00269	Target Validation	TTDS00269
TTDS00269	Drug(s)	AEW-541
TTDS00269	Drug(s)	AMG 479
TTDS00269	Drug(s)	Cixutumumab
TTDS00269	Drug(s)	Figitumumab
TTDS00269	Drug(s)	MK-0646
TTDS00269	Drug(s)	Mecasermin
TTDS00269	Drug(s)	R1507
TTDS00269	Inhibitor	4-((1H-indazol-6-ylamino)methyl)benzene-1,2-diol
TTDS00269	Inhibitor	4-((naphthalen-2-ylamino)methyl)benzene-1,2-diol
TTDS00269	Inhibitor	AEW-541
TTDS00269	Inhibitor	AMG 479
TTDS00269	Inhibitor	Alpha-D-Mannose
TTDS00269	Inhibitor	BMS-536924
TTDS00269	Inhibitor	BMS-695735
TTDS00269	Inhibitor	Figitumumab
TTDS00269	Inhibitor	Fucose
TTDS00269	Inhibitor	JB-1
TTDS00269	Inhibitor	MK-0646
TTDS00269	Inhibitor	Mecasermin
TTDS00269	Inhibitor	NVP-ADW742
TTDS00269	Inhibitor	OSI-906
TTDS00269	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDS00269	Inhibitor	R1507
TTDS00270	UniProt ID	P10721
TTDS00270	Name	Mast/stem cell growth factor receptor
TTDS00270	Type of target	Successful target
TTDS00270	Synonyms	C-kit
TTDS00270	Synonyms	CD117 antigen
TTDS00270	Synonyms	KIT
TTDS00270	Synonyms	Proto-oncogene tyrosine-protein kinase Kit
TTDS00270	Synonyms	SCFR
TTDS00270	Disease	Cancer, unspecific
TTDS00270	Disease	Gastrointestinal stromal tumors
TTDS00270	Disease	Inflammation
TTDS00270	Disease	Malignant phyllodes tumours
TTDS00270	Disease	Ovarian cancer
TTDS00270	Disease	Phyllodes tumours
TTDS00270	Disease	Renal cell carcinoma
TTDS00270	Disease	Small cell lung cancer
TTDS00270	Function	This is the receptor for stem cell factor (mast cell growth factor). It has a ty
TTDS00270	Sequence	MRGARGAWDFLCVLLLLLRVQTGSSQPSVSPGEPSPPSIHPGKSDLIVRVGDEIRLLCTDPGFVKWTFEILDETNENKQN
TTDS00270	PDB Structure	1PKG; 1QZJ; 1QZK; 1R01; 1T45; 1T46; 2E9W; 2EC8; 2VIF; 3G0E; 3G0F; 4HVS
TTDS00270	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00270	Pathway	Acute myeloid leukemia
TTDS00270	Pathway	Cytokine-cytokine receptor interaction
TTDS00270	Pathway	Hematopoietic cell lineage
TTDS00270	Pathway	Melanogenesis
TTDS00270	Pathway	Pathways in cancer
TTDS00270	EC Number	EC 2.7.1.112
TTDS00270	Related US Patent	6,642,232
TTDS00270	Target Validation	TTDS00270
TTDS00270	Drug(s)	Imatinib
TTDS00270	Drug(s)	MP470
TTDS00270	Drug(s)	Motesanib
TTDS00270	Drug(s)	Motesanib diphosphate
TTDS00270	Drug(s)	Nilotinib
TTDS00270	Drug(s)	OSI-930
TTDS00270	Drug(s)	PLX3397
TTDS00270	Drug(s)	Pazopanib
TTDS00270	Drug(s)	Pazopanib HCl
TTDS00270	Drug(s)	Ponatinib
TTDS00270	Drug(s)	Regorafenib
TTDS00270	Drug(s)	Sunitinib
TTDS00270	Drug(s)	Sunitinib malate
TTDS00270	Inhibitor	4-(4-aminophenyl)-1H-indazol-3yl-amine
TTDS00270	Inhibitor	5,11-Dimethyl-6H-pyrido[4,3-b]carbazol-9-ol
TTDS00270	Inhibitor	9-Bromo-5,11-dimethyl-6H-pyrido[4,3-b]carbazole
TTDS00270	Inhibitor	9-Methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazole
TTDS00270	Inhibitor	AZD-0530
TTDS00270	Inhibitor	Adenosine-5'-Diphosphate
TTDS00270	Inhibitor	Bis-(5-hydroxy-1H-indol-2-yl)-methanone
TTDS00270	Inhibitor	ELLIPTINIUM
TTDS00270	Inhibitor	Imatinib
TTDS00270	Inhibitor	MP470
TTDS00270	Inhibitor	Motesanib
TTDS00270	Inhibitor	Motesanib diphosphate
TTDS00270	Inhibitor	Nilotinib
TTDS00270	Inhibitor	OSI-930
TTDS00270	Inhibitor	PD-0166326;PD-166326
TTDS00270	Inhibitor	PD-0173956
TTDS00270	Inhibitor	Pazopanib
TTDS00270	Inhibitor	Pazopanib HCl
TTDS00270	Inhibitor	Phosphonotyrosine
TTDS00270	Inhibitor	SEMAXINIB
TTDS00270	Inhibitor	Sunitinib
TTDS00270	Inhibitor	Sunitinib malate
TTDS00270	Multitarget	Imatinib
TTDS00270	Multitarget	MP470
TTDS00270	Multitarget	Motesanib
TTDS00270	Multitarget	Motesanib diphosphate
TTDS00270	Multitarget	Nilotinib
TTDS00270	Multitarget	OSI-930
TTDS00270	Multitarget	Pazopanib
TTDS00270	Multitarget	Pazopanib HCl
TTDS00270	Multitarget	Sti-571
TTDS00270	Multitarget	Sunitinib
TTDS00270	Multitarget	Sunitinib malate
TTDS00271	Name	Tubulin
TTDS00271	Type of target	Successful target
TTDS00271	Disease	Cancer, unspecific
TTDS00271	Disease	Helminth infection
TTDS00271	Disease	Leishmania infections
TTDS00271	Disease	Parasitic diseases
TTDS00271	Pathway	Gap junction
TTDS00271	Pathway	Pathogenic Escherichia coli infection
TTDS00271	Target Validation	TTDS00271
TTDS00271	Drug(s)	AEZS-112
TTDS00271	Drug(s)	ALB-109564a
TTDS00271	Drug(s)	BNC105
TTDS00271	Drug(s)	Brentuximab vedotin
TTDS00271	Drug(s)	Cabazitaxel
TTDS00271	Drug(s)	Colchicine
TTDS00271	Drug(s)	Docetaxel
TTDS00271	Drug(s)	E 7974
TTDS00271	Drug(s)	Epothilon
TTDS00271	Drug(s)	Eribulin
TTDS00271	Drug(s)	Indibulin
TTDS00271	Drug(s)	Ixabepilone
TTDS00271	Drug(s)	Larotaxel
TTDS00271	Drug(s)	Vincristine
TTDS00271	Drug(s)	Vinorelbine
TTDS00271	Inhibitor	2-(3-Chloro-phenyl)-1H-[1,8]naphthyridin-4-one
TTDS00271	Inhibitor	2-(4-Methoxy-phenyl)-1H-indole-3-carbaldehyde
TTDS00271	Inhibitor	2-Furan-2-yl-7-methyl-1H-[1,8]naphthyridin-4-one
TTDS00271	Inhibitor	2-Methoxy-5-(3,4,5-trimethoxy-benzyl)-phenol
TTDS00271	Inhibitor	2-Methoxy-5-(3,4,5-trimethoxy-phenoxy)-phenol
TTDS00271	Inhibitor	2-Methoxy-5-(5,6,7-trimethoxy-indan-1-yl)-phenol
TTDS00271	Inhibitor	2-Naphthalen-1-yl-1H-[1,8]naphthyridin-4-one
TTDS00271	Inhibitor	2-Naphthalen-2-yl-1H-[1,8]naphthyridin-4-one
TTDS00271	Inhibitor	2-m-Tolyl-1H-[1,8]naphthyridin-4-one
TTDS00271	Inhibitor	5,7-Dimethyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one
TTDS00271	Inhibitor	5-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one
TTDS00271	Inhibitor	6-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one
TTDS00271	Inhibitor	7-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one
TTDS00271	Inhibitor	ABT-751
TTDS00271	Inhibitor	BNC105
TTDS00271	Inhibitor	CENTAUREIDIN
TTDS00271	Inhibitor	COLCHINOL
TTDS00271	Inhibitor	COMBETASTATIN
TTDS00271	Inhibitor	COMBRETASTATIN
TTDS00271	Inhibitor	Cabazitaxel
TTDS00271	Inhibitor	DOLASTATIN-10
TTDS00271	Inhibitor	Docetaxel
TTDS00271	Inhibitor	E 7974
TTDS00271	Inhibitor	Epothilone B
TTDS00271	Inhibitor	Eribulin
TTDS00271	Inhibitor	GNF-PF-117
TTDS00271	Inhibitor	Larotaxel
TTDS00271	Inhibitor	MR-22388
TTDS00271	Inhibitor	MYOSEVERIN
TTDS00271	Inhibitor	NSC-106970
TTDS00271	Inhibitor	NSC-664171
TTDS00271	Inhibitor	NSC-679036
TTDS00271	Inhibitor	PHENSTATIN
TTDS00271	Inhibitor	RHIZOXIN
TTDS00271	Inhibitor	THIOCOLCHICINE
TTDS00271	Inhibitor	Vinorelbine
TTDS00271	Inhibitor	WR85915
TTDS00271	Inhibitor	isopropyl 3-(phenylthio)-1H-indole-2-carboxylate
TTDS00271	Inducer	Cryptophycin
TTDS00271	Inducer	Eleutherobin
TTDS00271	Inducer	Sarcodictyin A
TTDS00271	Inducer	Taxol
TTDS00271	Binder	Colchicine
TTDS00271	Binder	Vincristine
TTDS00271	Stablizer	Epothilon
TTDS00271	Stablizer	Indibulin
TTDS00271	Stablizer	Ixabepilone
TTDS00272	UniProt ID	Q96RI1
TTDS00272	Name	Bile acid receptor
TTDS00272	Type of target	Successful target
TTDS00272	Synonyms	Farnesoid X receptor
TTDS00272	Synonyms	Farnesoid X-activated receptor
TTDS00272	Synonyms	Farnesol receptor HRR-1
TTDS00272	Synonyms	Nuclear farnesoid X receptor
TTDS00272	Synonyms	RXR-interacting protein 14
TTDS00272	Synonyms	Retinoid X receptor-interacting protein 14
TTDS00272	Disease	Cancer, unspecific
TTDS00272	Disease	Hypercholesterolemia
TTDS00272	Disease	Intrahepatic cholestasis
TTDS00272	Function	Receptor for bile acids such as chenodeoxycholic acid, lithocholic acid and deox
TTDS00272	Sequence	MVMQFQGLENPIQISPHCSCTPSGFFMEMMSMKPAKGVLTEQVAGPLGQNLEVEPYSQYSNVQFPQVQPQISSSSYYSNL
TTDS00272	PDB Structure	1OSH; 1OSK; 3BEJ; 3DCT; 3DCU; 3FLI; 3FXV; 3GD2; 3HC5; 3HC6; 3L1B; 3OKH; 3OKI; 3O
TTDS00272	BioChemical Class	Zinc-finger
TTDS00272	Target Validation	TTDS00272
TTDS00272	Drug(s)	Guggulsterone
TTDS00272	Drug(s)	SB-756050
TTDS00272	Inhibitor	12-O-deacetyl-12-epi-19-deoxy-21-hydroxyscalarin
TTDS00272	Inhibitor	AGN-34
TTDS00272	Inhibitor	E-GUGGULSTERONE
TTDS00272	Inhibitor	Fexaramine
TTDS00272	Inhibitor	GW-4064
TTDS00272	Antagonist	Guggulsterone
TTDS00272	Antagonist	Lithocholate
TTDS00272	Agonist	1,1-bisphosphonate esters
TTDS00272	Agonist	Chenodeoxycholate
TTDS00272	Agonist	GW4065
TTDS00272	Agonist	SB-756050
TTDS00272	Agonist	SR-45023A (Apomine)
TTDS00272	Ligand	GW4064
TTDS00273	UniProt ID	P30968
TTDS00273	Name	Gonadotropin-releasing hormone receptor
TTDS00273	Type of target	Successful target
TTDS00273	Synonyms	GnRH receptor
TTDS00273	Synonyms	GnRH-R
TTDS00273	Synonyms	Gonadotrophin releasing hormone receptor
TTDS00273	Synonyms	Hypothalamic gonadotropin-releasing hormone receptor
TTDS00273	Disease	Cancer, unspecific
TTDS00273	Disease	Hypogonadotropic hypogonadism
TTDS00273	Disease	Reproductive disorder
TTDS00273	Function	Receptor for gonadotropin releasing hormone (gnrh) that mediate the action of gn
TTDS00273	Sequence	MANSASPEQNQNHCSAINNSIPLMQGNLPTLTLSGKIRVTVTFFLFLLSATFNASFLLKLQKWTQKKEKGKKLSRMKLLL
TTDS00273	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00273	Pathway	GnRH signaling pathway
TTDS00273	Pathway	Neuroactive ligand-receptor interaction
TTDS00273	Related US Patent	6,172,080
TTDS00273	Related US Patent	6,180,642
TTDS00273	Related US Patent	6,214,798
TTDS00273	Related US Patent	6,288,078
TTDS00273	Related US Patent	6,346,534
TTDS00273	Related US Patent	6,384,017
TTDS00273	Related US Patent	6,537,998
TTDS00273	Related US Patent	6,540,979
TTDS00273	Related US Patent	6,569,863
TTDS00273	Related US Patent	6,583,153
TTDS00273	Related US Patent	6,608,197
TTDS00273	Related US Patent	6,620,824
TTDS00273	Related US Patent	6,627,609
TTDS00273	Related US Patent	6,673,796
TTDS00273	Related US Patent	6,677,340
TTDS00273	Related US Patent	6,765,011
TTDS00273	Target Validation	TTDS00273
TTDS00273	Drug(s)	Cetrorelix
TTDS00273	Drug(s)	Ganirelix
TTDS00273	Drug(s)	Gonadorelin
TTDS00273	Drug(s)	Leuprorelin acetate
TTDS00273	Drug(s)	Nafarelin
TTDS00273	Drug(s)	TAK-385
TTDS00273	Inhibitor	ACYLINE
TTDS00273	Inhibitor	AZALINE B
TTDS00273	Inhibitor	Azaline B derivative
TTDS00273	Inhibitor	DEGARELIX
TTDS00273	Inhibitor	Degarelix analogue
TTDS00273	Inhibitor	LEUPRORELIN
TTDS00273	Inhibitor	LHRH
TTDS00273	Inhibitor	NBI-42902
TTDS00273	Inhibitor	T-98475
TTDS00273	Inhibitor	TAK-013
TTDS00273	Inhibitor	WAY-207024
TTDS00273	Inhibitor	[4Aph(CO-(C2H4O)3-C2H4-NH-CO-NH-OCH3)5]degarelix
TTDS00273	Inhibitor	[4Aph(CO-NH-(C2H4O)2-C2H5)5]degarelix
TTDS00273	Inhibitor	[4Aph(CO-NH-OCH3)5,D-4Aph(CO-NH-OCH3)6]degarelix
TTDS00273	Inhibitor	[4Aph(CO-NH-OCH3)5]degarelix
TTDS00273	Inhibitor	[4Aph(CO-NH-OH)5]degarelix
TTDS00273	Inhibitor	[D-4Aph(CO-NH-(C2H4O)2-C2H5)6]degarelix
TTDS00273	Inhibitor	[D-4Aph(CO-NH-OCH3)6]degarelix
TTDS00273	Inhibitor	[D-4Aph(CO-NH-OH)6]degarelix
TTDS00273	Inhibitor	[D-Dab(CO-NH-OCH3)3]degarelix
TTDS00273	Inhibitor	[D-Dab(CO-NH-OH)3]degarelix
TTDS00273	Inhibitor	[D-Dap(CO-NH-OCH3)3]degarelix
TTDS00273	Inhibitor	[D-Dap(CO-NH-OH)3]degarelix
TTDS00273	Inhibitor	[D-Gln3,D-Ncy(SO,isopropyl)7]acyline
TTDS00273	Inhibitor	[D-Gln3,D-Ncy(SO2,isopropyl)7]acyline
TTDS00273	Inhibitor	[D-Gln3,D-Ncy(isopropyl)7]acyline
TTDS00273	Inhibitor	[D-Gln3,Ncy(SO,isopropyl)7]acyline
TTDS00273	Inhibitor	[D-Gln3,Ncy(SO2,isopropyl)7]acyline
TTDS00273	Inhibitor	[D-Gln3,Ncy(isopropyl)7]acyline
TTDS00273	Inhibitor	[D-Ncy(2-naphthyl)1]acyline
TTDS00273	Inhibitor	[D-Ncy(SO,isopropyl)7]acyline
TTDS00273	Inhibitor	[D-Ncy(SO,methyl)10]acyline
TTDS00273	Inhibitor	[D-Ncy(SO,methyl)4]acyline
TTDS00273	Inhibitor	[D-Ncy(isopropyl)7]acyline
TTDS00273	Inhibitor	[D-Ncy(methyl)10] acyline
TTDS00273	Inhibitor	[D-Ncy(methyl)4]acyline
TTDS00273	Inhibitor	[Ncy(2-naphthyl)1]acyline
TTDS00273	Inhibitor	[Ncy(SO,isopropyl)7]acyline
TTDS00273	Inhibitor	[Ncy(SO,methyl)10]acyline
TTDS00273	Inhibitor	[Ncy(SO,methyl)4]acyline
TTDS00273	Inhibitor	[Ncy(isopropyl)7]acyline
TTDS00273	Inhibitor	[Ncy(methyl)10]acyline
TTDS00273	Inhibitor	[Ncy(methyl)4]acyline
TTDS00273	Inhibitor	pGlu-His-Trp-Ser-His-D-Tyr-Leu-Arg-Pro-Gly-NH2
TTDS00273	Inhibitor	pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2
TTDS00273	Antagonist	Cetrorelix
TTDS00273	Antagonist	Ganirelix
TTDS00273	Antagonist	TAK-385
TTDS00273	Agonist	Gonadorelin
TTDS00273	Agonist	Leuprorelin acetate
TTDS00273	Agonist	Nafarelin
TTDS00274	UniProt ID	P24724
TTDS00274	UniProt ID	Q8III6
TTDS00274	Name	Heat shock protein 90
TTDS00274	Type of target	Successful target
TTDS00274	Synonyms	HSP90
TTDS00274	Synonyms	HSP90 molecular chaperone
TTDS00274	Synonyms	Heat shock protein HSP 90
TTDS00274	Synonyms	Heat-shock protein 90 molecular chaperone
TTDS00274	Synonyms	Hsp90 chaperone
TTDS00274	Disease	Cancer, unspecific
TTDS00274	Disease	Inflammation
TTDS00274	Disease	Ischemia
TTDS00274	Disease	Malaria
TTDS00274	Disease	Viral infection, unspecified
TTDS00274	Function	Molecular chaperone. Has atpase activity (by similarity).
TTDS00274	Sequence	MSFSKFMKCSTQLSRRLSNFEGKGTFNKSAFYNCTREKCSIVCLRKKMNVELKKICEISKMNKRNYSSECENYEFKAETK
TTDS00274	Target Validation	TTDS00274
TTDS00274	Drug(s)	Amlexanox
TTDS00274	Drug(s)	CCT-018159
TTDS00274	Drug(s)	Cromoglicate
TTDS00274	Drug(s)	DS-2248
TTDS00274	Drug(s)	Debio 0932
TTDS00274	Drug(s)	Ganetespib
TTDS00274	Drug(s)	Geldanamycin
TTDS00274	Drug(s)	IPI-493
TTDS00274	Drug(s)	KW-2478
TTDS00274	Drug(s)	MEDI-561
TTDS00274	Drug(s)	NVP-AUY922
TTDS00274	Drug(s)	VER 49009
TTDS00274	Inhibitor	17-allylamino-17-demethoxygeldanamycin
TTDS00274	Inhibitor	17-allylamino-17-desmethoxy-geldanamycin
TTDS00274	Inhibitor	17-desmethoxy-17-aminogeldanamycin
TTDS00274	Inhibitor	17AAG
TTDS00274	Inhibitor	Amlexanox
TTDS00274	Inhibitor	Benzoquinone ansamycins
TTDS00274	Inhibitor	CCT-018159
TTDS00274	Inhibitor	Cromoglicate
TTDS00274	Inhibitor	Debio 0932
TTDS00274	Inhibitor	Disodium cromoglycate
TTDS00274	Inhibitor	GNF-PF-67
TTDS00274	Inhibitor	Geldanamycin
TTDS00274	Inhibitor	IPI-493
TTDS00274	Inhibitor	KOSN1559
TTDS00274	Inhibitor	MEDI-561
TTDS00274	Inhibitor	Macbecin
TTDS00274	Inhibitor	NVP-AUY922
TTDS00274	Inhibitor	PU-H58
TTDS00274	Inhibitor	PU24S
TTDS00274	Inhibitor	PU3
TTDS00274	Inhibitor	RHEIN
TTDS00274	Inhibitor	Radicicol
TTDS00274	Inhibitor	SNX-2112
TTDS00274	Inhibitor	VER 49009
TTDS00274	Inhibitor	VER 50589
TTDS00274	Inhibitor	VER-49009
TTDS00274	Inhibitor	ZEARALANONE
TTDS00274	Inhibitor	geldanamycin-estradiol hybrid
TTDS00275	UniProt ID	P40763
TTDS00275	Name	Signal transducer and activator of transcription 3
TTDS00275	Type of target	Successful target
TTDS00275	Synonyms	Stat3
TTDS00275	Synonyms	Transcription factor STAT3
TTDS00275	Disease	Cancer, unspecific
TTDS00275	Disease	Kidney disease induced by mesangial proliferation
TTDS00275	Function	Transcription factor that binds to the interleukin-6 (il-6)-responsive elements
TTDS00275	Sequence	MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQ
TTDS00275	Pathway	Acute myeloid leukemia
TTDS00275	Pathway	Adipocytokine signaling pathway
TTDS00275	Pathway	Chemokine signaling pathway
TTDS00275	Pathway	Jak-STAT signaling pathway
TTDS00275	Pathway	Pancreatic cancer
TTDS00275	Pathway	Pathways in cancer
TTDS00275	Target Validation	TTDS00275
TTDS00275	Drug(s)	AZD9150
TTDS00275	Drug(s)	Acitretin
TTDS00275	Drug(s)	Atiprimod
TTDS00275	Drug(s)	ISIS-STAT3Rx
TTDS00275	Drug(s)	RTA 402
TTDS00275	Inhibitor	Acitretin
TTDS00275	Inhibitor	Atiprimod
TTDS00275	Inhibitor	GNF-PF-1399;GNF-PF-2708;GNF-PF-4643
TTDS00275	Inhibitor	RTA 402
TTDS00276	UniProt ID	P46843
TTDS00276	UniProt ID	P61076
TTDS00276	UniProt ID	Q16881
TTDS00276	UniProt ID	Q25861
TTDS00276	UniProt ID	Q7Z7S3
TTDS00276	UniProt ID	Q8J0U0
TTDS00276	Name	Thioredoxin reductase, cytoplasmic
TTDS00276	Type of target	Successful target
TTDS00276	Synonyms	Cytosolic thioredoxin reductase
TTDS00276	Synonyms	TR
TTDS00276	Synonyms	TR1
TTDS00276	Synonyms	Thioredoxin reductase
TTDS00276	Synonyms	TrxR
TTDS00276	Disease	Amebiasis
TTDS00276	Disease	Bacterial infections
TTDS00276	Disease	Cancer, unspecific
TTDS00276	Disease	Human immunodeficiency virus [HIV] disease
TTDS00276	Disease	Leprosy, unspecified
TTDS00276	Disease	Malaria
TTDS00276	Disease	Malignancies
TTDS00276	Disease	Oxidative and free radical damage
TTDS00276	Disease	Parasitic diseases
TTDS00276	Disease	Pneumocystis infections
TTDS00276	Disease	Rheumatoid arthritis, unspecified
TTDS00276	Disease	Sjogren's syndrome
TTDS00276	Sequence	MNTTPSAHETIHEVIVIGSGPAGYTAALYAARAQLTPLVFEGTSFGGALMTTTEVENYPGFRNGITGPELMDDMREQALR
TTDS00276	PDB Structure	4B1B
TTDS00276	BioChemical Class	Oxidoreductases acting on a sulfur group of donors
TTDS00276	Pathway	Pyrimidine metabolism
TTDS00276	EC Number	EC 1.8.1.9
TTDS00276	Target Validation	TTDS00276
TTDS00276	Drug(s)	Auranofin
TTDS00276	Inhibitor	3-formyl-4-phenyl-1,2,5-oxadiazole 2-oxide
TTDS00276	Inhibitor	4,6-dinitrobenzo[c][1,2,5]thiadiazole
TTDS00276	Inhibitor	5,8-Dihydroxy-1,4-naphthoquinone
TTDS00276	Inhibitor	Auranofin
TTDS00276	Inhibitor	Flavin-Adenine Dinucleotide
TTDS00276	Inhibitor	Fotemustine
TTDS00276	Inhibitor	Spermidine
TTDS00276	Inhibitor	bis(2,4-dinitrophenyl)sulfane
TTDS00278	UniProt ID	O95342
TTDS00278	Name	Bile salt export pump
TTDS00278	Type of target	Successful target
TTDS00278	Synonyms	ATP-binding cassette, sub-family B, member 11
TTDS00278	Disease	Cholestasis
TTDS00278	Disease	Intrahepatic cholestasis
TTDS00278	Function	Involved in the atp-dependent secretion of bile salts into the canaliculus of he
TTDS00278	Sequence	MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQLFRFSSSTDIWLMFVGSLCAFLHGIAQPGVL
TTDS00278	BioChemical Class	ABC transporter
TTDS00278	Pathway	ABC transporters
TTDS00278	Drug(s)	Probucol
TTDS00278	Drug(s)	Quinidine barbiturate
TTDS00278	Inhibitor	Cyclosporin A
TTDS00278	Inhibitor	Probucol
TTDS00278	Inhibitor	Quinidine barbiturate
TTDS00280	UniProt ID	P27815
TTDS00280	Name	CAMP-specific 3',5'-cyclic phosphodiesterase 4A
TTDS00280	Type of target	Successful target
TTDS00280	Synonyms	DPDE2
TTDS00280	Synonyms	PDE46
TTDS00280	Synonyms	Type 4A cAMP phosphodiesterase
TTDS00280	Disease	Chronic lymphocytic leukemia
TTDS00280	Sequence	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLR
TTDS00280	PDB Structure	2QYK; 3I8V; 3TVX
TTDS00280	BioChemical Class	Hydrolases acting on ester bonds
TTDS00280	Pathway	Purine metabolism
TTDS00280	EC Number	EC 3.1.4.17
TTDS00280	Related US Patent	6,635,436
TTDS00280	Target Validation	TTDS00280
TTDS00280	Drug(s)	Cilomilast
TTDS00280	Drug(s)	Dyphylline
TTDS00280	Drug(s)	Enprofylline
TTDS00280	Drug(s)	GSK256066
TTDS00280	Inhibitor	(-)-ROLIPRAM
TTDS00280	Inhibitor	(2,5-Diphenyl-furan-3-yl)-phenyl-methanone
TTDS00280	Inhibitor	(R)-Rolipram
TTDS00280	Inhibitor	(S)-Rolipram
TTDS00280	Inhibitor	1-Butyl-3-methyl-3,7-dihydro-purine-2,6-dione
TTDS00280	Inhibitor	1-Methyl-3-propyl-3,7-dihydro-purine-2,6-dione
TTDS00280	Inhibitor	2,5-Bis-(3,4-dimethoxy-phenyl)-furan
TTDS00280	Inhibitor	2,5-Bis-(3-cyclopentyloxy-4-methoxy-phenyl)-furan
TTDS00280	Inhibitor	3-Isobutyl-1-methyl-3,7-dihydro-purine-2,6-dione
TTDS00280	Inhibitor	4-(2,5-Diphenyl-furan-3-yl)-morpholine
TTDS00280	Inhibitor	6-Azido-8-(3-iodo-phenyl)-quinoline
TTDS00280	Inhibitor	6-Imidazol-1-ylmethyl-8-phenyl-quinoline
TTDS00280	Inhibitor	8-(3-Azido-phenyl)-6-iodo-quinoline
TTDS00280	Inhibitor	8-(3-Azido-phenyl)-6-pyridin-4-ylmethyl-quinoline
TTDS00280	Inhibitor	8-(3-Nitro-phenyl)-6-phenyl-[1,7]naphthyridine
TTDS00280	Inhibitor	8-(3-Nitro-phenyl)-6-pyridin-4-ylmethyl-quinoline
TTDS00280	Inhibitor	Benzyl-(2-imidazol-1-yl-quinazolin-4-yl)-amine
TTDS00280	Inhibitor	Benzyl-(2-phenyl-quinazolin-4-yl)-amine
TTDS00280	Inhibitor	Benzyl-(2-pyridin-3-yl-quinazolin-4-yl)-amine
TTDS00280	Inhibitor	Benzyl-(2-pyridin-4-yl-quinazolin-4-yl)-amine
TTDS00280	Inhibitor	Benzyl-(2-thiophen-2-yl-quinazolin-4-yl)-amine
TTDS00280	Inhibitor	CC-1088
TTDS00280	Inhibitor	CDP840
TTDS00280	Inhibitor	CI-1018
TTDS00280	Inhibitor	CI-1044
TTDS00280	Inhibitor	Cilomilast
TTDS00280	Inhibitor	DENBUFYLLINE
TTDS00280	Inhibitor	Dyphylline
TTDS00280	Inhibitor	Enprofylline
TTDS00280	Inhibitor	GSK256066
TTDS00280	Inhibitor	KURAIDIN
TTDS00280	Inhibitor	KURARINOL
TTDS00280	Inhibitor	L-454560
TTDS00280	Inhibitor	L-791943
TTDS00280	Inhibitor	L-869298
TTDS00280	Inhibitor	NIS-62949
TTDS00280	Inhibitor	NITRAQUAZONE
TTDS00280	Inhibitor	Piclamilast
TTDS00280	Inhibitor	RO-201724
TTDS00280	Inhibitor	ROLIPRAM
TTDS00280	Inhibitor	RS-14491
TTDS00280	Inhibitor	SCH-351591
TTDS00280	Inhibitor	SCH-365351
TTDS00280	Inhibitor	SOPHOFLAVESCENOL
TTDS00280	Inhibitor	UCB-101333-3
TTDS00282	Name	Trypsin
TTDS00282	Type of target	Successful target
TTDS00282	Synonyms	Trypsinogen
TTDS00282	Disease	Chronic tendon injury
TTDS00282	Disease	Hemorrhage
TTDS00282	Disease	Pancreatitis
TTDS00282	EC Number	EC 3.4.21.4
TTDS00282	Related US Patent	6,583,177
TTDS00282	Target Validation	TTDS00282
TTDS00282	Drug(s)	Aprotinin
TTDS00282	Drug(s)	Dermolastin
TTDS00282	Inhibitor	1,3-Di-p-tolyl-[1,3]diazetidine-2,4-dione
TTDS00282	Inhibitor	1,3-Dibenzyl-[1,3]diazetidine-2,4-dione
TTDS00282	Inhibitor	1-(3-Amino-benzyl)-1H-indole-5-carboxamidine
TTDS00282	Inhibitor	1-(3-Nitro-benzyl)-1H-indole-5-carboxamidine
TTDS00282	Inhibitor	1-Benzyl-1H-indole-5-carboxamidine
TTDS00282	Inhibitor	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine
TTDS00282	Inhibitor	2-(2-Iodo-phenyl)-benzo[d][1,3]oxazin-4-one
TTDS00282	Inhibitor	2-Propionyl-1H-indole-6-carboxamidine
TTDS00282	Inhibitor	4-(3,4-Diethoxy-benzylamino)-benzamidine
TTDS00282	Inhibitor	4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine
TTDS00282	Inhibitor	4-(5-Nitro-indol-1-ylmethyl)-benzamidine
TTDS00282	Inhibitor	4-Indol-1-ylmethyl-benzamidine
TTDS00282	Inhibitor	6-Styryl-naphthalene-2-carboxamidine
TTDS00282	Inhibitor	8-Bromo-6-styryl-naphthalene-2-carboxamidine
TTDS00282	Inhibitor	8-Furan-3-yl-6-styryl-naphthalene-2-carboxamidine
TTDS00282	Inhibitor	Aprotinin
TTDS00282	Inhibitor	BMY-44621
TTDS00282	Inhibitor	Benzamidine
TTDS00282	Inhibitor	Benzamidrazone analogue
TTDS00282	Inhibitor	CVS-2139
TTDS00282	Inhibitor	CVS-2359
TTDS00282	Inhibitor	Dermolastin
TTDS00282	Inhibitor	GR-133686
TTDS00282	Inhibitor	GRASSYSTATIN A
TTDS00282	Inhibitor	INOGATRAN
TTDS00282	Inhibitor	L-370518
TTDS00282	Inhibitor	L-371912
TTDS00282	Inhibitor	L-375378
TTDS00282	Inhibitor	MELAGATRAN
TTDS00282	Inhibitor	P1 argininal derivative
TTDS00282	Inhibitor	Peptide boronate
TTDS00282	Inhibitor	Piperidine-1-carboxamidine
TTDS00282	Inhibitor	RWJ-50353
TTDS00282	Inhibitor	RWJ-56423
TTDS00282	Inhibitor	YM-60828
TTDS00282	Inhibitor	ZK-807834
TTDS00282	Inhibitor	macrocyclic tripeptide motif
TTDS00282	Inhibitor	tert-butyloxy carbonyl-D-Phe-pro-Arg-H
TTDS00282	Multitarget	Dermolastin
TTDS00283	UniProt ID	P04150
TTDS00283	Name	Glucocorticoid receptor
TTDS00283	Type of target	Successful target
TTDS00283	Synonyms	Alpha-A
TTDS00283	Synonyms	GR
TTDS00283	Disease	Cocaine dependence
TTDS00283	Disease	Drug dependence
TTDS00283	Disease	Major depressive disorder
TTDS00283	Function	Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription
TTDS00283	Sequence	MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAVASQSDSKQRRLLVDFPKGSVSNAQQPDLSK
TTDS00283	PDB Structure	1M2Z; 1NHZ; 1P93; 3BQD; 3CLD; 3E7C; 3H52; 3K22; 3K23; 4HN5; 4HN6
TTDS00283	BioChemical Class	Zinc-finger
TTDS00283	Pathway	Neuroactive ligand-receptor interaction
TTDS00283	Related US Patent	6,329,534
TTDS00283	Related US Patent	6,362,173
TTDS00283	Related US Patent	6,436,986
TTDS00283	Related US Patent	6,468,975
TTDS00283	Related US Patent	6,593,480
TTDS00283	Related US Patent	6,620,802
TTDS00283	Related US Patent	6,670,493
TTDS00283	Target Validation	TTDS00283
TTDS00283	Drug(s)	Amcinonide
TTDS00283	Drug(s)	Betamethasone
TTDS00283	Drug(s)	Budesonide
TTDS00283	Drug(s)	Dexamethasone
TTDS00283	Drug(s)	Flunisolide
TTDS00283	Drug(s)	Fluorometholone
TTDS00283	Drug(s)	Fluticasone
TTDS00283	Drug(s)	Fluticasone Propionate
TTDS00283	Drug(s)	GW685698X
TTDS00283	Drug(s)	GW870086X
TTDS00283	Drug(s)	ISIS-GCCRrx
TTDS00283	Drug(s)	Loteprednol Etabonate
TTDS00283	Drug(s)	Medrysone
TTDS00283	Drug(s)	Methylprednisolone
TTDS00283	Drug(s)	Mometasone
TTDS00283	Drug(s)	ORG 34517/34850
TTDS00283	Drug(s)	Prednisone
TTDS00283	Inhibitor	B-Octylglucoside
TTDS00283	Inhibitor	Hexane-1,6-Diol
TTDS00283	Inhibitor	ZK-230211
TTDS00283	Antagonist	Budesonide
TTDS00283	Antagonist	Fluticasone
TTDS00283	Antagonist	Fluticasone Propionate
TTDS00283	Antagonist	ORG 34517/34850
TTDS00283	Agonist	Amcinonide
TTDS00283	Agonist	Betamethasone
TTDS00283	Agonist	Dexamethasone
TTDS00283	Agonist	Flunisolide
TTDS00283	Agonist	GW685698X
TTDS00283	Agonist	GW870086X
TTDS00283	Agonist	Methylprednisolone
TTDS00283	Agonist	Mometasone
TTDS00283	Agonist	Prednisone
TTDS00283	Binder	Fluorometholone
TTDS00283	Binder	Loteprednol Etabonate
TTDS00283	Binder	Medrysone
TTDS00285	UniProt ID	P01009
TTDS00285	Name	Alpha-1-antitrypsin
TTDS00285	Type of target	Successful target
TTDS00285	Synonyms	Alpha-1 protease inhibitor
TTDS00285	Synonyms	Alpha-1-antiproteinase
TTDS00285	Synonyms	Alpha1-proteinase
TTDS00285	Synonyms	PRO0684/PRO2209
TTDS00285	Disease	Conformational diseases (polymer formation associated liver disease)
TTDS00285	Function	Inhibitor of serine proteases. Its primary target is elastase, but it also has a
TTDS00285	Sequence	MPSSVSWGILLLAGLCCLVPVSLAEDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVS
TTDS00285	PDB Structure	1ATU; 1D5S; 1EZX; 1HP7; 1IZ2; 1KCT; 1OO8; 1OPH; 1PSI; 1QLP; 1QMB; 2D26; 2QUG; 3C
TTDS00285	BioChemical Class	Protease
TTDS00285	Pathway	Complement and coagulation cascades
TTDS00285	Related US Patent	6,670,325
TTDS00285	Drug(s)	Alpha1-proteinase inhibitor
TTDS00285	Drug(s)	Alphagen
TTDS00285	Drug(s)	Zemaira
TTDS00285	Inhibitor	2-Sulfhydryl-Ethanol
TTDS00285	Inhibitor	Alpha1-proteinase inhibitor
TTDS00285	Inhibitor	Zemaira
TTDS00285	Modulator	Alphagen
TTDS00286	UniProt ID	Q01718
TTDS00286	Name	Adrenocorticotropic hormone receptor
TTDS00286	Type of target	Successful target
TTDS00286	Synonyms	ACTH receptor
TTDS00286	Synonyms	ACTH-R
TTDS00286	Synonyms	Adrenocorticotropin receptor
TTDS00286	Synonyms	MC2-R
TTDS00286	Synonyms	Melanocortin-2 receptor
TTDS00286	Disease	Cushing's syndrome (ACTH independent)
TTDS00286	Function	Receptor for acth. This receptor is mediated by G proteins (G(s)) which activate
TTDS00286	Sequence	MKHIINSYENINNTARNNSDCPRVVLPEEIFFTISIVGVLENLIVLLAVFKNKNLQAPMYFFICSLAISDMLGSLYKILE
TTDS00286	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00286	Pathway	Neuroactive ligand-receptor interaction
TTDS00286	Drug(s)	Cosyntropin
TTDS00286	Antagonist	Cosyntropin
TTDS00287	UniProt ID	P51788
TTDS00287	Name	Chloride channel protein 2
TTDS00287	Type of target	Successful target
TTDS00287	Synonyms	ClC-2
TTDS00287	Synonyms	ClC-2 Cl- channel
TTDS00287	Synonyms	ClC-2 chloride channel
TTDS00287	Disease	Cystic fibrosis
TTDS00287	Function	Voltage-gated chloride channel. chloride channels have several functions includi
TTDS00287	Sequence	MAAAAAEEGMEPRALQHEQTLMYGRYTQDLGAFAKEEAARIRLGGPEPWKGPPSSRAAPELLEYGRSRCARCRVCSVRCH
TTDS00287	BioChemical Class	Voltage-gated channel
TTDS00287	Drug(s)	Lubiprostone
TTDS00287	Activator	Acid-activated omeprazole
TTDS00287	Activator	Arachidonic acid
TTDS00287	Activator	Lubiprostone
TTDS00288	UniProt ID	P33527
TTDS00288	Name	Multidrug resistance-associated protein 1
TTDS00288	Type of target	Successful target
TTDS00288	Synonyms	Mrp1
TTDS00288	Synonyms	Multidrug resistance protein 1
TTDS00288	Disease	Cystic fibrosis
TTDS00288	Disease	Streptococcus pneumoniae infections
TTDS00288	Function	May participate directly in the active transport of drugs into subcellular organ
TTDS00288	Sequence	MALRGFCSADGSDPLWDWNVTWNTSNPDFTKCFQNTVLVWVPCFYLWACFPFYFLYLSRHDRGYIQMTPLNKTKTALGFL
TTDS00288	PDB Structure	2CBZ
TTDS00288	BioChemical Class	ABC transporter
TTDS00288	Related US Patent	6,673,809
TTDS00288	Target Validation	TTDS00288
TTDS00288	Drug(s)	Benzbromarone
TTDS00288	Drug(s)	Biricodar
TTDS00288	Drug(s)	Sulfinpyrazone
TTDS00288	Inhibitor	L-660771;MK-571
TTDS00288	Inhibitor	Pyrrolopyrimidine
TTDS00288	Inhibitor	XR-9456
TTDS00288	Inhibitor	XR-9504
TTDS00288	Inhibitor	XR-9544
TTDS00288	Inhibitor	XR-9577
TTDS00288	Stimulator	Benzbromarone
TTDS00288	Modulator	Biricodar
TTDS00288	Modulator	Sulfinpyrazone
TTDS00289	UniProt ID	P21397
TTDS00289	Name	Amine oxidase [flavin-containing] A
TTDS00289	Type of target	Successful target
TTDS00289	Synonyms	MAO-A
TTDS00289	Synonyms	Monoamine oxidase
TTDS00289	Synonyms	Monoamine oxidase A
TTDS00289	Disease	Depression
TTDS00289	Disease	Mood [affective] disorders
TTDS00289	Disease	Social phobias
TTDS00289	Function	Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has im
TTDS00289	Sequence	MENQEKASIAGHMFDVVVIGGGISGLSAAKLLTEYGVSVLVLEARDRVGGRTYTIRNEHVDYVDVGGAYVGPTQNRILRL
TTDS00289	PDB Structure	1H8Q; 2BXR; 2BXS; 2Z5X; 2Z5Y
TTDS00289	BioChemical Class	Oxidoreductases acting on the CH-NH2 group of donors
TTDS00289	Pathway	Arginine and proline metabolism
TTDS00289	Pathway	Drug metabolism - cytochrome P450
TTDS00289	Pathway	Glycine, serine and threonine metabolism
TTDS00289	Pathway	Histidine metabolism
TTDS00289	Pathway	Metabolic pathways
TTDS00289	Pathway	Phenylalanine metabolism
TTDS00289	Pathway	Tryptophan metabolism
TTDS00289	Pathway	Tyrosine metabolism
TTDS00289	EC Number	EC 1.4.3.4
TTDS00289	Related US Patent	6,432,991
TTDS00289	Related US Patent	6,569,470
TTDS00289	Related US Patent	6,635,667
TTDS00289	Target Validation	TTDS00289
TTDS00289	QSAR Model	TTDS00289
TTDS00289	Drug(s)	CHF-3381
TTDS00289	Drug(s)	Clorgyline
TTDS00289	Drug(s)	Isocarboxazid
TTDS00289	Drug(s)	Moclobemide
TTDS00289	Drug(s)	Tranylcypromine
TTDS00289	Inhibitor	CGS-19281A
TTDS00289	Inhibitor	CHF-3381
TTDS00289	Inhibitor	Clorgyline
TTDS00289	Inhibitor	DECYL(DIMETHYL)PHOSPHINE OXIDE
TTDS00289	Inhibitor	Flavin-Adenine Dinucleotide
TTDS00289	Inhibitor	HARMINE
TTDS00289	Inhibitor	HYDRAZINECARBOXAMIDE
TTDS00289	Inhibitor	IPRONIAZIDE
TTDS00289	Inhibitor	Isocarboxazid
TTDS00289	Inhibitor	Isopsoralen
TTDS00289	Inhibitor	MOFEGILINE
TTDS00289	Inhibitor	Moclobemide
TTDS00289	Inhibitor	NSC-656158
TTDS00289	Inhibitor	PIPERINE
TTDS00289	Inhibitor	PNU-22394
TTDS00289	Inhibitor	Psoralen
TTDS00289	Inhibitor	TOLOXATONE
TTDS00289	Inhibitor	TRACIZOLINE
TTDS00289	Inhibitor	TRYPTAMINE
TTDS00289	Inhibitor	TRYPTOLINE
TTDS00289	Inhibitor	Tranylcypromine
TTDS00289	Inhibitor	beta-methoxyamphetamine
TTDS00289	Inhibitor	cis-2-phenylcyclopropylamine
TTDS00289	Inhibitor	ethyl 4-(2-oxo-2H-chromene-3-carboxamido)benzoate
TTDS00289	Antagonist	MMDA
TTDS00289	Multitarget	CHF-3381
TTDS00289	Multitarget	Tranylcypromine
TTDS00291	UniProt ID	O43451
TTDS00291	Name	Maltase-glucoamylase, intestinal
TTDS00291	Type of target	Successful target
TTDS00291	Synonyms	Alpha-glucosidase
TTDS00291	Disease	Diabetes mellitus
TTDS00291	Function	May serve as an alternate pathway for starch digestion when luminal alpha-amylas
TTDS00291	Sequence	MARKKLKKFTTLEIVLSVLLLVLFIISIVLIVLLAKESLKSTAPDPGTTGTPDPGTTGTPDPGTTGTTHARTTGPPDPGT
TTDS00291	PDB Structure	2QLY; 2QMJ; 3CTT; 3L4T; 3L4U; 3L4V; 3L4W; 3L4X; 3L4Y; 3L4Z; 3TON; 3TOP
TTDS00291	BioChemical Class	Transmembrane protein
TTDS00291	Pathway	Galactose metabolism
TTDS00291	Pathway	Metabolic pathways
TTDS00291	Pathway	Starch and sucrose metabolism
TTDS00291	EC Number	EC 3.2.1.20
TTDS00291	Related US Patent	6,299,911
TTDS00291	Related US Patent	6,455,573
TTDS00291	Target Validation	TTDS00291
TTDS00291	Drug(s)	Acarbose
TTDS00291	Drug(s)	Miglitol
TTDS00291	Drug(s)	Voglibose
TTDS00291	Inhibitor	1,4-dideoxy-1,4-imino-D-arabinito
TTDS00291	Inhibitor	2,5-Dideoxy-2,5-imino-D-mannitol
TTDS00291	Inhibitor	2-Aminomethyl-pyrrolidine-3,4-diol
TTDS00291	Inhibitor	2-Cyclopentylaminomethyl-pyrrolidine-3,4-diol
TTDS00291	Inhibitor	3-(4-(4-hydroxyphenyl)phthalazin-1-ylamino)phenol
TTDS00291	Inhibitor	4'-(p-toluenesulfonamide)-3,4-dihydroxy chalcone
TTDS00291	Inhibitor	Acarbose
TTDS00291	Inhibitor	DEOXYNOJIRIMYCIN
TTDS00291	Inhibitor	Double Oxidized Cysteine
TTDS00291	Inhibitor	KOTALANOL
TTDS00291	Inhibitor	Maltose
TTDS00291	Inhibitor	Miglitol
TTDS00291	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDS00291	Inhibitor	PONKORANOL
TTDS00291	Inhibitor	SALACINOL
TTDS00291	Inhibitor	Voglibose
TTDS00291	Inhibitor	de-O-sulfonated kotalanol
TTDS00292	UniProt ID	P06213
TTDS00292	Name	Insulin receptor
TTDS00292	Type of target	Successful target
TTDS00292	Synonyms	CD220 antigen
TTDS00292	Synonyms	IR
TTDS00292	Disease	Diabetes mellitus
TTDS00292	Function	This receptor binds insulin and has a tyrosine-protein kinase activity.
TTDS00292	Sequence	MGTGGRRGAAAAPLLVAVAALLLGAAGHLYPGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPK
TTDS00292	PDB Structure	1GAG; 1I44; 1IR3; 1IRK; 1P14; 1RQQ; 2AUH; 2B4S; 2DTG; 2HR7; 2Z8C; 3BU3; 3BU5; 3B
TTDS00292	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00292	Pathway	Adherens junction
TTDS00292	Pathway	Insulin signaling pathway
TTDS00292	Pathway	Type II diabetes mellitus
TTDS00292	EC Number	EC 2.7.1.112
TTDS00292	Related US Patent	6,600,069
TTDS00292	Target Validation	TTDS00292
TTDS00292	Drug(s)	Insulin Glargine recombinant
TTDS00292	Drug(s)	Insulin Lyspro recombinant
TTDS00292	Drug(s)	Insulin recombinant
TTDS00292	Drug(s)	Insulin, porcine
TTDS00292	Drug(s)	Insulin-aspart
TTDS00292	Drug(s)	Insulin-detemir
TTDS00292	Drug(s)	Insulin-glargine
TTDS00292	Drug(s)	Insulin-glulisine
TTDS00292	Drug(s)	Insulin-lispro
TTDS00292	Drug(s)	Meglitinides
TTDS00292	Inhibitor	4-((1H-indazol-6-ylamino)methyl)benzene-1,2-diol
TTDS00292	Inhibitor	4-((naphthalen-2-ylamino)methyl)benzene-1,2-diol
TTDS00292	Inhibitor	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
TTDS00292	Inhibitor	NVP-AEW541
TTDS00292	Inhibitor	NVP-TAE684
TTDS00292	Stimulator	Meglitinides
TTDS00292	Binder	Humulin (Human insulin isophane)
TTDS00292	Binder	Insulin Glargine recombinant
TTDS00292	Binder	Insulin Lispro
TTDS00292	Binder	Insulin Lyspro recombinant
TTDS00292	Binder	Insulin lispro recombinant
TTDS00292	Binder	Insulin recombinant
TTDS00292	Binder	Insulin, porcine
TTDS00292	Binder	Insulin-aspart
TTDS00292	Binder	Insulin-detemir
TTDS00292	Binder	Insulin-glargine
TTDS00292	Binder	Insulin-glulisine
TTDS00292	Binder	Insulin-lispro
TTDS00293	Name	Omega 1 Benzodiazepine receptor
TTDS00293	Type of target	Successful target
TTDS00293	Synonyms	Omega-1 receptor situated on the alpha subunit of the GABA-A receptor complex
TTDS00293	Disease	Disorders of initiating and maintaining sleep [insomnias]
TTDS00293	Target Validation	TTDS00293
TTDS00293	Drug(s)	Indiplon
TTDS00293	Drug(s)	Zaleplon
TTDS00293	Agonist	Indiplon
TTDS00293	Agonist	Zaleplon
TTDS00295	UniProt ID	P49327
TTDS00295	Name	Fatty acid synthase
TTDS00295	Type of target	Successful target
TTDS00295	Synonyms	FAS
TTDS00295	Synonyms	Fatty acyl-CoA synthetase enzyme
TTDS00295	Synonyms	Fatty-acyl-CoA synthase
TTDS00295	Synonyms	Yeast fatty acid synthase
TTDS00295	Disease	Endometrial carcinoma
TTDS00295	Disease	Leukemia, unspecified
TTDS00295	Disease	Malaria
TTDS00295	Disease	Mesothelioma
TTDS00295	Disease	Metastatic osteosarcoma in the lung
TTDS00295	Disease	Obesity
TTDS00295	Disease	Prostate cancer
TTDS00295	Disease	Tumors
TTDS00295	Function	Fatty acid synthetase catalyzes the formation of long- chain fatty acids from ac
TTDS00295	Sequence	MEEVVIAGMSGKLPESENLQEFWDNLIGGVDMVTDDDRRWKAGLYGLPRRSGKLKDLSRFDASFFGVHPKQAHTMDPQLR
TTDS00295	PDB Structure	1XKT; 2CG5; 2JFD; 2JFK; 2PX6; 3HHD; 3TJM
TTDS00295	BioChemical Class	Acyltransferases
TTDS00295	Pathway	Fatty acid biosynthesis
TTDS00295	Pathway	Insulin signaling pathway
TTDS00295	Pathway	Metabolic pathways
TTDS00295	EC Number	EC 2.3.1.85
TTDS00295	EC Number	EC 2.3.1.86
TTDS00295	Target Validation	TTDS00295
TTDS00295	Drug(s)	Cerulenin
TTDS00295	Drug(s)	FAS1
TTDS00295	Drug(s)	FSA2
TTDS00295	Inhibitor	(-)-CATECHINGALLATE
TTDS00295	Inhibitor	2-Hexadecynoic acid
TTDS00295	Inhibitor	4-hydroxy-6-nitro-3-phenylquinolin-2(1H)-one
TTDS00295	Inhibitor	4-hydroxy-8-nitro-3-phenylquinolin-2(1H)-one
TTDS00295	Inhibitor	BIOCHANIN
TTDS00295	Inhibitor	C75
TTDS00295	Inhibitor	Cerulenin
TTDS00295	Inhibitor	EPICATECHIN GALLATE
TTDS00295	Inhibitor	EPIGALOCATECHIN GALLATE
TTDS00295	Inhibitor	FAS1
TTDS00295	Inhibitor	FISETIN
TTDS00295	Inhibitor	FSA2
TTDS00295	Inhibitor	GALLOCATECHIN GALLATE
TTDS00295	Inhibitor	MORIN
TTDS00295	Inhibitor	PA-824
TTDS00296	UniProt ID	O76074
TTDS00296	Name	CGMP-specific 3',5'-cyclic phosphodiesterase
TTDS00296	Type of target	Successful target
TTDS00296	Synonyms	CGB-PDE
TTDS00296	Synonyms	CGMP-binding cGMP-specific phosphodiesterase
TTDS00296	Synonyms	Phosphodiesterase 5
TTDS00296	Disease	Erectile dysfunction
TTDS00296	Disease	Injury to spine and spinal cord
TTDS00296	Disease	Pulmonary hypertension
TTDS00296	Disease	Vascular disease
TTDS00296	Function	Plays a role in signal transduction by regulating the intracellular concentratio
TTDS00296	Sequence	MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCS
TTDS00296	PDB Structure	1RKP; 1T9R; 1T9S; 1TBF; 1UDT; 1UDU; 1UHO; 1XOZ; 1XP0; 2CHM; 2H40; 2H42; 2H44; 2X
TTDS00296	BioChemical Class	Hydrolases acting on ester bonds
TTDS00296	Pathway	Purine metabolism
TTDS00296	EC Number	EC 3.1.4.17
TTDS00296	Related US Patent	6,316,438
TTDS00296	Related US Patent	6,338,862
TTDS00296	Related US Patent	6,362,178
TTDS00296	Related US Patent	6,384,080
TTDS00296	Related US Patent	6,403,597
TTDS00296	Related US Patent	6,451,807
TTDS00296	Related US Patent	6,458,951
TTDS00296	Related US Patent	6,462,047
TTDS00296	Related US Patent	6,469,016
TTDS00296	Related US Patent	6,476,037
TTDS00296	Related US Patent	6,492,371
TTDS00296	Related US Patent	6,548,508
TTDS00296	Related US Patent	6,566,360
TTDS00296	Related US Patent	6,576,644
TTDS00296	Related US Patent	6,582,351
TTDS00296	Related US Patent	6,608,065
TTDS00296	Related US Patent	6,635,638
TTDS00296	Related US Patent	6,642,244
TTDS00296	Related US Patent	6,656,945
TTDS00296	Target Validation	TTDS00296
TTDS00296	QSAR Model	TTDS00296
TTDS00296	Drug(s)	PF-00489791
TTDS00296	Drug(s)	Papaverine
TTDS00296	Drug(s)	Sildenafil
TTDS00296	Drug(s)	Tadalafil
TTDS00296	Drug(s)	UK-369003
TTDS00296	Drug(s)	Udenafil
TTDS00296	Drug(s)	Vardenafil
TTDS00296	Inhibitor	3,7-Bis(2-hydroxyethyl)icaritin
TTDS00296	Inhibitor	3-ISOBUTYL-1-METHYLXANTHINE
TTDS00296	Inhibitor	7-(2-Hydroxyethyl)-3-O-rhamnosylicariin
TTDS00296	Inhibitor	8-prenylapigenin
TTDS00296	Inhibitor	8-prenylquercetin
TTDS00296	Inhibitor	BRL-61063
TTDS00296	Inhibitor	Benzo[1,3]dioxol-5-ylmethyl-quinazolin-4-yl-amine
TTDS00296	Inhibitor	Cartazolate
TTDS00296	Inhibitor	Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine
TTDS00296	Inhibitor	Guanosine-5'-Monophosphate
TTDS00296	Inhibitor	ICARIIN
TTDS00296	Inhibitor	ICARITIN
TTDS00296	Inhibitor	IMAZODAN
TTDS00296	Inhibitor	Icariside II
TTDS00296	Inhibitor	KURAIDIN
TTDS00296	Inhibitor	KURARINOL
TTDS00296	Inhibitor	LORNEIC ACID A
TTDS00296	Inhibitor	Papaverine
TTDS00296	Inhibitor	ROLIPRAM
TTDS00296	Inhibitor	SCH-57726
TTDS00296	Inhibitor	SK&F-96321;SK-96321
TTDS00296	Inhibitor	SOPHOFLAVESCENOL
TTDS00296	Inhibitor	SOPHORAFLAVANONE B
TTDS00296	Inhibitor	Sildenafil
TTDS00296	Inhibitor	Tadalafil
TTDS00296	Inhibitor	Trequinsin
TTDS00296	Inhibitor	UK-343664
TTDS00296	Inhibitor	UK-369003
TTDS00296	Inhibitor	UK-371800
TTDS00296	Inhibitor	Udenafil
TTDS00296	Inhibitor	ZAPRINAST
TTDS00296	Binder	Vardenafil
TTDS00299	UniProt ID	P38631
TTDS00299	UniProt ID	P38678
TTDS00299	Name	1,3-Beta-Glucan synthase
TTDS00299	Type of target	Successful target
TTDS00299	Synonyms	(1,3)-beta-D-glucan synthase
TTDS00299	Synonyms	1,3-beta-D-glucan-UDP glucosyltransferase
TTDS00299	Synonyms	Beta-1,3-glucan synthase
TTDS00299	Synonyms	Beta-1,3-glucan synthetase
TTDS00299	Synonyms	CND1 protein
TTDS00299	Synonyms	CWN53 protein
TTDS00299	Synonyms	FKS1
TTDS00299	Synonyms	FKS1 protein
TTDS00299	Synonyms	Glucan synthase
TTDS00299	Synonyms	Papulacandin B sensitivity protein 1
TTDS00299	Synonyms	UDP-glucose-1,3-beta-D-glucan glucosyltransferase
TTDS00299	Disease	Fungal diseases
TTDS00299	Function	Involved in (1,3)beta-glucan synthase activity and cell- wall formation.
TTDS00299	Sequence	MNTDQQPYQGQTDYTQGPGNGQSQEQDYDQYGQPLYPSQADGYYDPNVAAGTEADMYGQQPPNESYDQDYTNGEYYGQPP
TTDS00299	BioChemical Class	Glycosyltransferases
TTDS00299	Pathway	MAPK signaling pathway - yeast
TTDS00299	Pathway	Starch and sucrose metabolism
TTDS00299	EC Number	EC 2.4.1.34
TTDS00299	Target Validation	TTDS00299
TTDS00299	Drug(s)	Anidulafungin
TTDS00299	Drug(s)	Caspofungin
TTDS00299	Drug(s)	Cilofungin
TTDS00299	Drug(s)	Eraxis/Vfend
TTDS00299	Drug(s)	Micafungin
TTDS00299	Inhibitor	ACULEACIN A
TTDS00299	Inhibitor	Anidulafungin
TTDS00299	Inhibitor	Caspofungin
TTDS00299	Inhibitor	Cilofungin
TTDS00299	Inhibitor	Eraxis/Vfend
TTDS00299	Inhibitor	L-692289
TTDS00299	Inhibitor	Macrocyclic lipopeptidolactone derivative
TTDS00299	Inhibitor	Micafungin
TTDS00299	Inhibitor	Pyridobenzimidazole
TTDS00299	Inhibitor	macrocyclic lipopeptidolactone derivative
TTDS00300	UniProt ID	Q16195
TTDS00300	Name	Human keratin
TTDS00300	Type of target	Successful target
TTDS00300	Disease	Fungal diseases
TTDS00300	Sequence	VTLARTDLEMQIEGLKEELAYLRKNHEEEMLALRGQTGGDVNVEMDAAPGVDLSRILNEMRDQYEQMAEKNRRDAETWFL
TTDS00300	Drug(s)	Griseofulvin
TTDS00300	Inducer	Griseofulvin
TTDS00301	UniProt ID	O02604
TTDS00301	UniProt ID	P04818
TTDS00301	UniProt ID	P13100
TTDS00301	UniProt ID	P13922
TTDS00301	Name	Thymidylate synthase
TTDS00301	Type of target	Successful target
TTDS00301	Synonyms	HrTS
TTDS00301	Synonyms	Human recombinant thymidylate synthase
TTDS00301	Synonyms	OK/SW-cl.29
TTDS00301	Synonyms	TS
TTDS00301	Synonyms	TSase
TTDS00301	Disease	Breast cancer
TTDS00301	Disease	Colorectal cancer
TTDS00301	Disease	Fungal diseases
TTDS00301	Disease	Gastric cancer
TTDS00301	Disease	Hepatocellular carcinoma
TTDS00301	Disease	Malaria
TTDS00301	Disease	Ovarian cancer
TTDS00301	Disease	Pancreatic cancer
TTDS00301	Disease	Proliferative diseases
TTDS00301	Sequence	MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVF
TTDS00301	PDB Structure	1J3I; 1J3J; 1J3K; 3DG8; 3DGA
TTDS00301	BioChemical Class	Transferases transferring one-carbon groups
TTDS00301	Pathway	Metabolic pathways
TTDS00301	Pathway	One carbon pool by folate
TTDS00301	Pathway	Pyrimidine metabolism
TTDS00301	EC Number	EC 2.1.1.45
TTDS00301	Related US Patent	6,143,776
TTDS00301	Target Validation	TTDS00301
TTDS00301	QSAR Model	TTDS00301
TTDS00301	Drug(s)	(+)-Irinotecan
TTDS00301	Drug(s)	Capecitabine
TTDS00301	Drug(s)	Floxuridine/5-fluorouracil
TTDS00301	Drug(s)	Flucytosine
TTDS00301	Drug(s)	Fluorouracil
TTDS00301	Drug(s)	Gemcitabine
TTDS00301	Drug(s)	LY231514
TTDS00301	Drug(s)	Leucovorin/5-fluorouracil
TTDS00301	Drug(s)	Pemetrexed
TTDS00301	Drug(s)	Plevitrexed
TTDS00301	Drug(s)	Plevitrexed (R)-isomer
TTDS00301	Drug(s)	Raltitrexed
TTDS00301	Drug(s)	Trifluridine
TTDS00301	Inhibitor	(+)-Irinotecan
TTDS00301	Inhibitor	(6s)-5,6,7,8-Tetrahydrofolate
TTDS00301	Inhibitor	1,3-propanediphosphonic acid
TTDS00301	Inhibitor	1,4-Dithiothreitol
TTDS00301	Inhibitor	10-Propargyl-5,8-Dideazafolic Acid
TTDS00301	Inhibitor	2'-5'dideoxyuridine
TTDS00301	Inhibitor	2'-Deoxycytidine-5'-Monophosphate
TTDS00301	Inhibitor	2'-Deoxyguanosine-5'-Monophosphate
TTDS00301	Inhibitor	2'-Deoxyuridine
TTDS00301	Inhibitor	2'-deoxyuridylic acid
TTDS00301	Inhibitor	2-bromophenol
TTDS00301	Inhibitor	3-Amino-5,6-dihydro-2H-benzo[f]quinazolin-1-one
TTDS00301	Inhibitor	3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE
TTDS00301	Inhibitor	3-Methyl-2H-benzo[f]quinazolin-1-one
TTDS00301	Inhibitor	4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN
TTDS00301	Inhibitor	5,10-Methylene-6-Hydrofolic Acid
TTDS00301	Inhibitor	5-Fluoro-2'-Deoxyuridine-5'-Monophosphate
TTDS00301	Inhibitor	5-Fluoroorotate
TTDS00301	Inhibitor	5-Fluorouracil
TTDS00301	Inhibitor	6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE
TTDS00301	Inhibitor	Beta-Mercaptoethanol
TTDS00301	Inhibitor	CB-3717
TTDS00301	Inhibitor	Capecitabine
TTDS00301	Inhibitor	Floxuridine/5-fluorouracil
TTDS00301	Inhibitor	Flucytosine
TTDS00301	Inhibitor	Fluorouracil
TTDS00301	Inhibitor	GW1843
TTDS00301	Inhibitor	Gemcitabine
TTDS00301	Inhibitor	LY231514
TTDS00301	Inhibitor	LY341770
TTDS00301	Inhibitor	Leucovorin/5-fluorouracil
TTDS00301	Inhibitor	Ly231514 Tetra Glu
TTDS00301	Inhibitor	N,O-Didansyl-L-Tyrosine
TTDS00301	Inhibitor	N-Carboxymethionine
TTDS00301	Inhibitor	N-[Tosyl-D-Prolinyl]Amino-Ethanethiol
TTDS00301	Inhibitor	PDDF
TTDS00301	Inhibitor	PREMETREXED
TTDS00301	Inhibitor	Pemetrexed
TTDS00301	Inhibitor	Plevitrexed
TTDS00301	Inhibitor	Plevitrexed (R)-isomer
TTDS00301	Inhibitor	Raltitrexed
TTDS00301	Inhibitor	S,S-(2-Hydroxyethyl)Thiocysteine
TTDS00301	Inhibitor	S-Oxymethionine
TTDS00301	Inhibitor	Sp-722
TTDS00301	Inhibitor	Sp-876
TTDS00301	Inhibitor	Thymidine-5'-Phosphate
TTDS00301	Inhibitor	Tosyl-D-Proline
TTDS00301	Inhibitor	Trifluridine
TTDS00301	Inhibitor	Uridine-5'-Monophosphate
TTDS00301	Inhibitor	ZD1604
TTDS00301	Inhibitor	ZD9331
TTDS00301	Ligand	NB1011
TTDS00302	UniProt ID	P32476
TTDS00302	UniProt ID	Q14534
TTDS00302	Name	Squalene monooxygenase
TTDS00302	Type of target	Successful target
TTDS00302	Synonyms	ERG1
TTDS00302	Synonyms	Oxidosqaulene cyclase
TTDS00302	Synonyms	SE
TTDS00302	Synonyms	Squalene epoxidase
TTDS00302	Disease	Fungal diseases
TTDS00302	Disease	Hypercholesterolemia
TTDS00302	Function	Catalyzes the first oxygenation step in sterol biosynthesis and is suggested to
TTDS00302	Sequence	MSAVNVAPELINADNTITYDAIVIGAGVIGPCVATGLARKGKKVLIVERDWAMPDRIVGELMQPGGVRALRSLGMIQSIN
TTDS00302	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00302	Pathway	Biosynthesis of steroids
TTDS00302	Pathway	Metabolic pathways
TTDS00302	Pathway	Terpenoid biosynthesis
TTDS00302	EC Number	EC 1.14.99.7
TTDS00302	Target Validation	TTDS00302
TTDS00302	Drug(s)	Butenafine
TTDS00302	Drug(s)	Naftifine
TTDS00302	Drug(s)	Terbinafine
TTDS00302	Drug(s)	Tolnaftate
TTDS00302	Inhibitor	1(beta)-O-galloylpedunculagin
TTDS00302	Inhibitor	1,2,3,4,6-penta-O-galloyl-beta-D-glucose
TTDS00302	Inhibitor	1,2,6-tri-O-galloyl-beta-D-glucose
TTDS00302	Inhibitor	Allylamines
TTDS00302	Inhibitor	Butenafine
TTDS00302	Inhibitor	CORILAGIN
TTDS00302	Inhibitor	ELLAGIC ACID
TTDS00302	Inhibitor	EPIGALOCATECHIN GALLATE
TTDS00302	Inhibitor	ETHYLGALLATE
TTDS00302	Inhibitor	EUGENIIN
TTDS00302	Inhibitor	FUROSIN
TTDS00302	Inhibitor	GERANIIN
TTDS00302	Inhibitor	Green tea
TTDS00302	Inhibitor	NB-598
TTDS00302	Inhibitor	Naftifine
TTDS00302	Inhibitor	OCTYL_GALLATE
TTDS00302	Inhibitor	PEDUNCULAGIN
TTDS00302	Inhibitor	THEASINENSIN A
TTDS00302	Inhibitor	Tellurium
TTDS00302	Inhibitor	Terbinafine
TTDS00302	Inhibitor	Thiocarbamate
TTDS00302	Inhibitor	Tolnaftate
TTDS00302	Inhibitor	Trisnorsqualene difluoromethylidene
TTDS00302	Inhibitor	chebulinic acid
TTDS00302	Inhibitor	mallotinic acid
TTDS00302	Inhibitor	mallotusinic acid
TTDS00302	Inhibitor	n-cetylgallate
TTDS00302	Inhibitor	n-dodecylgallate
TTDS00302	Inhibitor	procyanidin B-2 3,3'-di-O-gallate
TTDS00302	Inhibitor	sanguiin H-6
TTDS00302	Inhibitor	trisnorsqualene alcohol
TTDS00302	Inhibitor	trisnorsqualene cyclopropylamine
TTDS00303	Name	Nicotinic acetylcholine receptor
TTDS00303	Type of target	Successful target
TTDS00303	Synonyms	Nicotinergic acetylcholine receptor
TTDS00303	Synonyms	nAChR
TTDS00303	Disease	Alcoholism
TTDS00303	Disease	Alzheimer's disease
TTDS00303	Disease	Analgesics
TTDS00303	Disease	Cancer, unspecific
TTDS00303	Disease	Cognitive deficits
TTDS00303	Disease	Depression
TTDS00303	Disease	Drug dependence
TTDS00303	Disease	Gilles de la Tourette's disorder
TTDS00303	Disease	Helminth infection
TTDS00303	Disease	Mood [affective] disorders
TTDS00303	Disease	Neuropsychiatric disorders
TTDS00303	Disease	Pain
TTDS00303	Disease	Parkinson's disease
TTDS00303	BioChemical Class	Ion transport
TTDS00303	Related US Patent	6,277,855
TTDS00303	Related US Patent	6,448,276
TTDS00303	Target Validation	TTDS00303
TTDS00303	QSAR Model	TTDS00303
TTDS00303	Drug(s)	ABT-089
TTDS00303	Drug(s)	AZD0328
TTDS00303	Drug(s)	Atracurium
TTDS00303	Drug(s)	Benztropine mesylate
TTDS00303	Drug(s)	Cisatracurium Besylate
TTDS00303	Drug(s)	Cotinine
TTDS00303	Drug(s)	Dexefaroxan
TTDS00303	Drug(s)	Dianicline
TTDS00303	Drug(s)	Dianicline+rimonabant
TTDS00303	Drug(s)	Mecamylamine
TTDS00303	Drug(s)	NAChRs agonist
TTDS00303	Drug(s)	Nicotine
TTDS00303	Drug(s)	Pancuronium
TTDS00303	Drug(s)	TRIDMAC
TTDS00303	Drug(s)	Varenicline tartrate
TTDS00303	Inhibitor	PROTOSTEMODIOL
TTDS00303	Antagonist	Atracurium
TTDS00303	Antagonist	Benztropine mesylate
TTDS00303	Antagonist	Cisatracurium Besylate
TTDS00303	Antagonist	Hexamethonium
TTDS00303	Antagonist	Mecamylamine
TTDS00303	Antagonist	Nicotine
TTDS00303	Antagonist	Pancuronium
TTDS00303	Antagonist	TRIDMAC
TTDS00303	Agonist	A-85380
TTDS00303	Agonist	ABT-089
TTDS00303	Agonist	ABT-418
TTDS00303	Agonist	ABT-594
TTDS00303	Agonist	AZD0328
TTDS00303	Agonist	DBO-83
TTDS00303	Agonist	Dexefaroxan
TTDS00303	Agonist	Dianicline
TTDS00303	Agonist	Dianicline+rimonabant
TTDS00303	Agonist	Epibatidine
TTDS00303	Agonist	NAChRs agonist
TTDS00303	Agonist	RJR-2403
TTDS00303	Agonist	SIB-1508Y
TTDS00303	Agonist	SIB-1553A
TTDS00303	Agonist	SIB-1663
TTDS00303	Agonist	SIB-1765F
TTDS00303	Agonist	Varenicline tartrate
TTDS00303	Multitarget	Dexefaroxan
TTDS00304	Name	Carbonic anhydrase
TTDS00304	Type of target	Successful target
TTDS00304	Disease	Glaucoma
TTDS00304	Disease	Ocular hypertension
TTDS00304	BioChemical Class	Carbon-oxygen lyases
TTDS00304	Pathway	Nitrogen metabolism
TTDS00304	EC Number	EC 4.2.1.1
TTDS00304	Related US Patent	6,316,443
TTDS00304	Target Validation	TTDS00304
TTDS00304	QSAR Model	TTDS00304
TTDS00304	Drug(s)	Acetazolamide
TTDS00304	Drug(s)	Brinzolamide
TTDS00304	Drug(s)	Diazoxide
TTDS00304	Drug(s)	Dichlorphenamide
TTDS00304	Drug(s)	Ethoxzolamide
TTDS00304	Drug(s)	Methazolamide
TTDS00304	Drug(s)	Phentermine+topiramate
TTDS00304	Drug(s)	Quinethazone
TTDS00304	Inhibitor	(2-bromophenyl)difluoromethanesulfonamide
TTDS00304	Inhibitor	(4-bromophenyl)difluoromethanesulfonamide
TTDS00304	Inhibitor	1-(3,4-dichlorophenyl)-3-hydroxyurea
TTDS00304	Inhibitor	2,3-dihydro-1H-indene-5-sulfonamide
TTDS00304	Inhibitor	2,4-Disulfamyltrifluoromethylaniline
TTDS00304	Inhibitor	2,5-difluorophenol
TTDS00304	Inhibitor	2-acetamido-2,3-dihydro-1H-indene-5-sulfonic acid
TTDS00304	Inhibitor	2-amino-2,3-dihydro-1H-indene-5-sulfonamide
TTDS00304	Inhibitor	2-amino-2,3-dihydro-1H-indene-5-sulfonic acid
TTDS00304	Inhibitor	2-aminobenzenesulfonamide
TTDS00304	Inhibitor	2-hydrazinylbenzenesulfonamide
TTDS00304	Inhibitor	2-oxo-2H-chromene-3-carboxylic acid
TTDS00304	Inhibitor	2-oxo-2H-thiochromene-3-carboxylic acid
TTDS00304	Inhibitor	3,5-difluorophenol
TTDS00304	Inhibitor	3-(4-sulfamoylphenyl)propanoic acid
TTDS00304	Inhibitor	3-Amino-benzenesulfonamide
TTDS00304	Inhibitor	3-Nitro-benzenesulfonamide
TTDS00304	Inhibitor	3-bromophenyl-difluoromethanesulfonamide
TTDS00304	Inhibitor	4-(2-Amino-ethyl)-benzenesulfonamide
TTDS00304	Inhibitor	4-(2-Phenylacetamido)-3-bromobenzenesulfonamide
TTDS00304	Inhibitor	4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide
TTDS00304	Inhibitor	4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide
TTDS00304	Inhibitor	4-(2-Phenylacetamido)benzenesulfonamide
TTDS00304	Inhibitor	4-(2-Phenylacetamidoethyl)benzenesulfonamide
TTDS00304	Inhibitor	4-(2-Phenylacetamidomethyl)benzenesulfonamide
TTDS00304	Inhibitor	4-(2-Pyridin-2-ylacetamido)benzenesulfonamide
TTDS00304	Inhibitor	4-(2-Pyridin-4-ylacetamido)benzenesulfonamide
TTDS00304	Inhibitor	4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide
TTDS00304	Inhibitor	4-(2-hydroxyethyl)benzenesulfonamide
TTDS00304	Inhibitor	4-(hydroxymethyl)benzenesulfonamide
TTDS00304	Inhibitor	4-AMINOPHENOL
TTDS00304	Inhibitor	4-CYANOPHENOL
TTDS00304	Inhibitor	4-Nitro-benzenesulfonamide
TTDS00304	Inhibitor	4-Thiocyanato-benzenesulfonamide
TTDS00304	Inhibitor	4-[2-(2-Thienyl)acetamido]benzenesulfonamide
TTDS00304	Inhibitor	4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide
TTDS00304	Inhibitor	4-amino-3,5-dibromobenzenesulfonamide
TTDS00304	Inhibitor	4-amino-3-bromobenzenesulfonamide
TTDS00304	Inhibitor	4-amino-3-chlorobenzenesulfonamide
TTDS00304	Inhibitor	4-amino-3-fluoro-5-iodobenzenesulfonamide
TTDS00304	Inhibitor	4-amino-3-fluorobenzenesulfonamide
TTDS00304	Inhibitor	4-amino-3-iodobenzenesulfonamide
TTDS00304	Inhibitor	4-amino-6-chlorobenzene-1,3-disulfonamide
TTDS00304	Inhibitor	4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
TTDS00304	Inhibitor	4-azidobenzenesulfonamide
TTDS00304	Inhibitor	4-bromophenylboronic acid
TTDS00304	Inhibitor	4-butylphenylboronic acid
TTDS00304	Inhibitor	4-hydrazinylbenzenesulfonamide
TTDS00304	Inhibitor	4-methoxyphenylboronic acid
TTDS00304	Inhibitor	4-methylphenyl-difluoromethanesulfonamide
TTDS00304	Inhibitor	4-nitrophenyl phosphate
TTDS00304	Inhibitor	4-nitrophenyl-difluoromethanesulfonamide
TTDS00304	Inhibitor	4-phenoxyphenylboronic acid
TTDS00304	Inhibitor	5-amino-1,3,4-thiadiazole-2-sulfonamide
TTDS00304	Inhibitor	6-(aminomethyl)-2H-chromen-2-one
TTDS00304	Inhibitor	6-(hydroxymethyl)-2H-chromen-2-one
TTDS00304	Inhibitor	6-hydroxybenzo[d]thiazole-2-sulfonamide
TTDS00304	Inhibitor	6-methoxy-2-oxo-2H-chromene-3-carboxylic acid
TTDS00304	Inhibitor	6-methyl-2-oxo-2H-chromene-3-carboxylic acid
TTDS00304	Inhibitor	7-(benzyloxy)-2H-chromen-2-one
TTDS00304	Inhibitor	7-butoxy-2H-chromen-2-one
TTDS00304	Inhibitor	7-methoxy-2-oxo-2H-chromene-4-carboxylic acid
TTDS00304	Inhibitor	7-phenethoxy-2H-chromen-2-one
TTDS00304	Inhibitor	7-propoxy-2H-chromen-2-one
TTDS00304	Inhibitor	8-methoxy-2-oxo-2H-chromene-3-carboxylic acid
TTDS00304	Inhibitor	Acetazolamide
TTDS00304	Inhibitor	BENZOLAMIDE
TTDS00304	Inhibitor	Benzothiazole-2-sulfonic acid amide
TTDS00304	Inhibitor	Beta-Mercaptoethanol
TTDS00304	Inhibitor	Brinzolamide
TTDS00304	Inhibitor	CATECHIN
TTDS00304	Inhibitor	CATECHOL
TTDS00304	Inhibitor	CLIOQUINOL
TTDS00304	Inhibitor	COUMARIN
TTDS00304	Inhibitor	COUMATE
TTDS00304	Inhibitor	CURCUMIN
TTDS00304	Inhibitor	Carzenide;Para-Carboxybenzenesulfonamide (Weak Carbonic Anhydrase Inhibitor)
TTDS00304	Inhibitor	Diazoxide
TTDS00304	Inhibitor	Dichlorphenamide
TTDS00304	Inhibitor	ELLAGIC ACID
TTDS00304	Inhibitor	ETHOXYCOUMARIN
TTDS00304	Inhibitor	Ethoxzolamide
TTDS00304	Inhibitor	FERULIC ACID
TTDS00304	Inhibitor	GALLICACID
TTDS00304	Inhibitor	HERNIARIN
TTDS00304	Inhibitor	INDISULAM
TTDS00304	Inhibitor	MAFENIDE
TTDS00304	Inhibitor	Methazolamide
TTDS00304	Inhibitor	N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide
TTDS00304	Inhibitor	N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide
TTDS00304	Inhibitor	N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide
TTDS00304	Inhibitor	N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide
TTDS00304	Inhibitor	N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide
TTDS00304	Inhibitor	N1-(2-aminoethyl)ethane-1,2-diamine
TTDS00304	Inhibitor	N1-(naphthalen-1-yl)ethane-1,2-diamine
TTDS00304	Inhibitor	P-TOLUENESULFONAMIDE
TTDS00304	Inhibitor	PARABEN
TTDS00304	Inhibitor	PARAOXON
TTDS00304	Inhibitor	PHENOL
TTDS00304	Inhibitor	PHENYLDIFLUOROMETHANESULFONAMIDE
TTDS00304	Inhibitor	PHENYLMETHANESULFONAMIDE
TTDS00304	Inhibitor	PRONTOCIL
TTDS00304	Inhibitor	Phentermine+topiramate
TTDS00304	Inhibitor	Quinethazone
TTDS00304	Inhibitor	RESORCINOL
TTDS00304	Inhibitor	SACCHARIN
TTDS00304	Inhibitor	SALICYLATE
TTDS00304	Inhibitor	SPERMINE
TTDS00304	Inhibitor	SULFAMATE
TTDS00304	Inhibitor	SULFAMIDE
TTDS00304	Inhibitor	Syringic Acid
TTDS00304	Inhibitor	beta-naphthylboronic acid
TTDS00304	Inhibitor	biphenylboronic acid
TTDS00304	Inhibitor	decane-1,10-diyl disulfamate
TTDS00304	Inhibitor	decyl sulfamate
TTDS00304	Inhibitor	ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate
TTDS00304	Inhibitor	hexane-1,6-diamine
TTDS00304	Inhibitor	octane-1,8-diyl disulfamate
TTDS00304	Inhibitor	octyl sulfamate
TTDS00304	Inhibitor	p-Coumaric Acid
TTDS00304	Inhibitor	p-tolylboronic acid
TTDS00304	Inhibitor	pentane-1,5-diamine
TTDS00304	Inhibitor	phenylarsonic acid
TTDS00304	Inhibitor	phenylboronic acid
TTDS00304	Inhibitor	sodium maleate
TTDS00304	Multitarget	Phentermine+topiramate
TTDS00306	UniProt ID	P00918
TTDS00306	Name	Carbonic anhydrase II
TTDS00306	Type of target	Successful target
TTDS00306	Synonyms	CA-II
TTDS00306	Synonyms	Carbonate dehydratase II
TTDS00306	Synonyms	Carbonic anhydrase C
TTDS00306	Disease	Glaucoma
TTDS00306	Disease	Pancreatic cancer
TTDS00306	Disease	Renal failure
TTDS00306	Function	Reversible hydration of carbon dioxide.
TTDS00306	Sequence	MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLK
TTDS00306	PDB Structure	12CA; 1A42; 1AM6; 1AVN; 1BCD; 1BIC; 1BN1; 1BN3; 1BN4; 1BNM; 1BNN; 1BNQ; 1BNT; 1B
TTDS00306	BioChemical Class	Carbon-oxygen lyases
TTDS00306	Pathway	Nitrogen metabolism
TTDS00306	EC Number	EC 4.2.1.1
TTDS00306	Target Validation	TTDS00306
TTDS00306	QSAR Model	TTDS00306
TTDS00306	Drug(s)	Benzthiazide
TTDS00306	Drug(s)	Chlorothiazide
TTDS00306	Drug(s)	Cyclothiazide
TTDS00306	Drug(s)	Dorzolamide
TTDS00306	Drug(s)	Ethinamate
TTDS00306	Inhibitor	1,2,4-Triazole
TTDS00306	Inhibitor	2,6-di-t-butylphenol
TTDS00306	Inhibitor	4-CYANOPHENOL
TTDS00306	Inhibitor	4-Methylimidazole
TTDS00306	Inhibitor	ACETYLSULFANILAMIDE
TTDS00306	Inhibitor	AL4623
TTDS00306	Inhibitor	AL5300
TTDS00306	Inhibitor	AL5424
TTDS00306	Inhibitor	AL5927
TTDS00306	Inhibitor	AL6528
TTDS00306	Inhibitor	AL7099A
TTDS00306	Inhibitor	AL7182
TTDS00306	Inhibitor	Acetate Ion
TTDS00306	Inhibitor	Al7089a
TTDS00306	Inhibitor	Aminobenzolamide derivative
TTDS00306	Inhibitor	Azide
TTDS00306	Inhibitor	BENZOLAMIDE
TTDS00306	Inhibitor	BUTYLATEDHYDROXYTOLUENE
TTDS00306	Inhibitor	Benzthiazide
TTDS00306	Inhibitor	Beta-Mercaptoethanol
TTDS00306	Inhibitor	CATECHIN
TTDS00306	Inhibitor	CATECHOL
TTDS00306	Inhibitor	CGS-27023A
TTDS00306	Inhibitor	CHLORIDE
TTDS00306	Inhibitor	COUMARIN
TTDS00306	Inhibitor	COUMATE
TTDS00306	Inhibitor	CURCUMIN
TTDS00306	Inhibitor	Chlorothiazide
TTDS00306	Inhibitor	Cyanamide
TTDS00306	Inhibitor	Cyclothiazide
TTDS00306	Inhibitor	Dansylamide
TTDS00306	Inhibitor	Ditiocarb sodium
TTDS00306	Inhibitor	Dorzolamide
TTDS00306	Inhibitor	ELLAGIC ACID
TTDS00306	Inhibitor	EMATE
TTDS00306	Inhibitor	Ethinamate
TTDS00306	Inhibitor	FERULIC ACID
TTDS00306	Inhibitor	Formic Acid
TTDS00306	Inhibitor	GALLICACID
TTDS00306	Inhibitor	GUAIACOL
TTDS00306	Inhibitor	HYDROSULFIDE
TTDS00306	Inhibitor	INDISULAM
TTDS00306	Inhibitor	IODIDE
TTDS00306	Inhibitor	Indan-5-sulfonic acid amide
TTDS00306	Inhibitor	MAFENIDE
TTDS00306	Inhibitor	Mercuribenzoic Acid
TTDS00306	Inhibitor	Methyl Mercury Ion
TTDS00306	Inhibitor	Methyl-phosphonic acid
TTDS00306	Inhibitor	N-hydroxysulfamide
TTDS00306	Inhibitor	N-hydroxysulfonamides
TTDS00306	Inhibitor	NITRATE
TTDS00306	Inhibitor	NSC-654077
TTDS00306	Inhibitor	P-TOLUENESULFONAMIDE
TTDS00306	Inhibitor	PARABEN
TTDS00306	Inhibitor	PARAOXON
TTDS00306	Inhibitor	PHENOL
TTDS00306	Inhibitor	PHENYLDIFLUOROMETHANESULFONAMIDE
TTDS00306	Inhibitor	PHENYLMETHANESULFONAMIDE
TTDS00306	Inhibitor	PHENYLSULFAMATE
TTDS00306	Inhibitor	PHENYLSULFAMIDE
TTDS00306	Inhibitor	PRONTOCIL
TTDS00306	Inhibitor	Phenyl Boronic acid
TTDS00306	Inhibitor	Phenyl-phosphonic acid
TTDS00306	Inhibitor	RESORCINOL
TTDS00306	Inhibitor	SACCHARIN
TTDS00306	Inhibitor	SALICYLATE
TTDS00306	Inhibitor	SODIUM PERFLUOROHEXANESULFONAMIDE
TTDS00306	Inhibitor	SPARFOSIC ACID
TTDS00306	Inhibitor	SULFAMATE
TTDS00306	Inhibitor	SULFAMIDE
TTDS00306	Inhibitor	SULTHIAME
TTDS00306	Inhibitor	Sulfenamido-sulfonamides
TTDS00306	Inhibitor	Syringic Acid
TTDS00306	Inhibitor	Thioureido sulfonamide
TTDS00306	Inhibitor	beta-naphthylboronic acid
TTDS00306	Inhibitor	biphenylboronic acid
TTDS00306	Inhibitor	decyl sulfamate
TTDS00306	Inhibitor	di(2,6-di-t-butylphenol)
TTDS00306	Inhibitor	di(2,6-diisopropylphenol)
TTDS00306	Inhibitor	di(2,6-dimethylphenol)
TTDS00306	Inhibitor	indane-5-sulfonamide
TTDS00306	Inhibitor	octane-1,8-diyl disulfamate
TTDS00306	Inhibitor	octyl sulfamate
TTDS00306	Inhibitor	p-Coumaric Acid
TTDS00306	Inhibitor	p-tolylboronic acid
TTDS00306	Inhibitor	pentane-1,5-diamine
TTDS00306	Inhibitor	phenethylboronic acid
TTDS00306	Inhibitor	phenoxyarsonous acid
TTDS00306	Inhibitor	quinoline-8-sulfonamide
TTDS00306	Inhibitor	sodium trithiocarbonate
TTDS00306	Inhibitor	sulfanilamide derivative
TTDS00307	UniProt ID	O06913
TTDS00307	UniProt ID	P00363
TTDS00307	Name	Fumarate reductase flavoprotein subunit
TTDS00307	Type of target	Successful target
TTDS00307	Synonyms	FRDA
TTDS00307	Synonyms	Fumarate reductase
TTDS00307	Disease	Helicobacter pylori infection
TTDS00307	Function	Two distinct, membrane-bound, fad-containing enzymes are responsible for the cat
TTDS00307	Sequence	MKITYCDALIIGGGLAGLRASIACKQKGLNTIVLSLVPVRRSHSAAAQGGMQASLANAKKSEGDNEDLHFLDTVKGSDWG
TTDS00307	PDB Structure	1KF6; 1KFY; 1L0V; 2B76; 3CIR; 3P4P; 3P4Q; 3P4R; 3P4S
TTDS00307	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDS00307	Pathway	Benzoate degradation via CoA ligation
TTDS00307	Pathway	Butanoate metabolism
TTDS00307	Pathway	Citrate cycle (TCA cycle)
TTDS00307	Pathway	Metabolic pathways
TTDS00307	Pathway	Oxidative phosphorylation
TTDS00307	Pathway	Reductive carboxylate cycle (CO2 fixation)
TTDS00307	Pathway	Two-component system
TTDS00307	EC Number	EC 1.3.99.1
TTDS00307	Drug(s)	Morantel tartrate
TTDS00307	Drug(s)	Oxantel pamoate
TTDS00307	Drug(s)	Thiabendazole
TTDS00307	Inhibitor	2,3-DIMETHYL-1,4-NAPHTHOQUINONE
TTDS00307	Inhibitor	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE
TTDS00307	Inhibitor	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL
TTDS00307	Inhibitor	Citraconic acid
TTDS00307	Inhibitor	Flavin-Adenine Dinucleotide
TTDS00307	Inhibitor	Fumarate
TTDS00307	Inhibitor	Heme
TTDS00307	Inhibitor	Malate Like Intermediate
TTDS00307	Inhibitor	Morantel tartrate
TTDS00307	Inhibitor	Oxantel pamoate
TTDS00307	Inhibitor	Thiabendazole
TTDS00308	UniProt ID	P07437
TTDS00308	Name	Tubulin beta
TTDS00308	Type of target	Successful target
TTDS00308	Synonyms	Beta-tubulin
TTDS00308	Synonyms	Tubulin beta-1 chain
TTDS00308	Disease	Helminth infection
TTDS00308	Function	Tubulin is the major constituent of microtubules. It binds two moles of GTP, one
TTDS00308	Sequence	MREIVHIQAGQCGNQIGAKFWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGKYVPRAILVDLEPGTMDSVRSGP
TTDS00308	PDB Structure	3QNZ; 3QO0
TTDS00308	Pathway	Gap junction
TTDS00308	Pathway	Pathogenic Escherichia coli infection
TTDS00308	Target Validation	TTDS00308
TTDS00308	Drug(s)	2-Methoxyestradiol
TTDS00308	Drug(s)	Albendazole
TTDS00308	Drug(s)	Mebendazole
TTDS00308	Drug(s)	Paclitaxel
TTDS00308	Drug(s)	Tasidotin hydrochloride
TTDS00308	Drug(s)	Vindesine
TTDS00308	Inhibitor	2'-amino-3,4,4',5-tetramethoxy-(Z)-stillbene
TTDS00308	Inhibitor	2,3'-diamino-3,4,4',5-tetramethoxy-(Z)-stillbene
TTDS00308	Inhibitor	2-(3-Chloro-phenyl)-1H-[1,8]naphthyridin-4-one
TTDS00308	Inhibitor	2-(4-Methoxy-phenyl)-1H-indole-3-carbaldehyde
TTDS00308	Inhibitor	2-Furan-2-yl-7-methyl-1H-[1,8]naphthyridin-4-one
TTDS00308	Inhibitor	2-Methoxy-5-(3,4,5-trimethoxy-benzyl)-phenol
TTDS00308	Inhibitor	2-Methoxy-5-(3,4,5-trimethoxy-phenoxy)-phenol
TTDS00308	Inhibitor	2-Methoxy-5-(5,6,7-trimethoxy-indan-1-yl)-phenol
TTDS00308	Inhibitor	2-Naphthalen-1-yl-1H-[1,8]naphthyridin-4-one
TTDS00308	Inhibitor	2-Naphthalen-2-yl-1H-[1,8]naphthyridin-4-one
TTDS00308	Inhibitor	2-amino-3,4',5-trimethoxy-(Z)-stillbene
TTDS00308	Inhibitor	2-amino-3,4,4',5-tetramethoxy-(Z)-stillbene
TTDS00308	Inhibitor	2-m-Tolyl-1H-[1,8]naphthyridin-4-one
TTDS00308	Inhibitor	3,4',5-trimethoxy-(Z)-stilbene
TTDS00308	Inhibitor	3,4,4',5-tetramethoxy-(Z)-stilbene
TTDS00308	Inhibitor	3-bromo-4,4',5-trimethoxy-(Z)-stilbene
TTDS00308	Inhibitor	5,7-Dimethyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one
TTDS00308	Inhibitor	5-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one
TTDS00308	Inhibitor	6-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one
TTDS00308	Inhibitor	6-ile-ustiloxin
TTDS00308	Inhibitor	7-Methyl-2-m-tolyl-1H-[1,8]naphthyridin-4-one
TTDS00308	Inhibitor	ABT-751
TTDS00308	Inhibitor	CENTAUREIDIN
TTDS00308	Inhibitor	COLCHINOL
TTDS00308	Inhibitor	COMBETASTATIN
TTDS00308	Inhibitor	COMBRETASTATIN
TTDS00308	Inhibitor	DOLASTATIN-10
TTDS00308	Inhibitor	Epothilone B
TTDS00308	Inhibitor	Epothilone D
TTDS00308	Inhibitor	GNF-PF-117
TTDS00308	Inhibitor	MR-22388
TTDS00308	Inhibitor	MYOSEVERIN
TTDS00308	Inhibitor	N-(4-(3-(pyridin-2-yl)acryloyl)phenyl)acetamide
TTDS00308	Inhibitor	NSC-106970
TTDS00308	Inhibitor	NSC-664171
TTDS00308	Inhibitor	NSC-679036
TTDS00308	Inhibitor	PHENSTATIN
TTDS00308	Inhibitor	RHIZOXIN
TTDS00308	Inhibitor	THIOCOLCHICINE
TTDS00308	Inhibitor	USTILOXIN A
TTDS00308	Inhibitor	isopropyl 3-(phenylthio)-1H-indole-2-carboxylate
TTDS00308	Inhibitor	ustiloxin D
TTDS00308	Inhibitor	ustiloxin F
TTDS00308	Binder	2-Methoxyestradiol
TTDS00308	Binder	Albendazole
TTDS00308	Binder	Mebendazole
TTDS00308	Binder	Paclitaxel
TTDS00308	Binder	Tasidotin hydrochloride
TTDS00308	Binder	Vindesine
TTDS00309	UniProt ID	Q67889
TTDS00309	Name	HBV polymerase
TTDS00309	Type of target	Successful target
TTDS00309	Disease	Hepatitis B
TTDS00309	Sequence	MPLSYQHFRKLLLLDDGTGPLEEELPRLADEGLNRRVAEDLNLGNLNVSIPWTHKVGNFTGLYSSTVPVFNPHWKTPSFP
TTDS00309	BioChemical Class	DNA-directed DNA polymerase
TTDS00309	Related US Patent	6,528,252
TTDS00309	Target Validation	TTDS00309
TTDS00309	Drug(s)	Adefovir Dipivoxil
TTDS00309	Drug(s)	Entecavir
TTDS00309	Drug(s)	Lamivudine
TTDS00309	Drug(s)	Telbivudine
TTDS00309	Inhibitor	Adefovir Dipivoxil
TTDS00309	Inhibitor	Entecavir
TTDS00309	Inhibitor	Lamivudine
TTDS00309	Inhibitor	Telbivudine
TTDS00310	UniProt ID	O39644
TTDS00310	Name	DNA polymerase
TTDS00310	Type of target	Successful target
TTDS00310	Disease	Hepatitis B
TTDS00310	Disease	Herpes virus infection
TTDS00310	Disease	Parasitic diseases
TTDS00310	Disease	Viral infection, unspecified
TTDS00310	Sequence	MPLSYQHFRKLLLLDDEAGPLEEELPRLADEGLNRRVAEDLNLGDLNVSIPWTHKVGNFTGLYSSTVPVFNPEWQTPSFP
TTDS00310	BioChemical Class	DNA-directed DNA polymerase
TTDS00310	EC Number	EC 2.7.7.7
TTDS00310	Target Validation	TTDS00310
TTDS00310	Drug(s)	Aciclovir
TTDS00310	Drug(s)	Chloroquinium
TTDS00310	Drug(s)	Cidofovir
TTDS00310	Drug(s)	Cytarabine
TTDS00310	Drug(s)	Foscavir
TTDS00310	Drug(s)	Ganciclovir
TTDS00310	Drug(s)	Valaciclovir
TTDS00310	Drug(s)	Valganciclovir
TTDS00310	Drug(s)	Vidarabine
TTDS00310	Inhibitor	(+)-Myristinin A
TTDS00310	Inhibitor	(+)-Myristinin D
TTDS00310	Inhibitor	(24E)-3beta-hydroxy-7,24-euphadien-26-oic acid
TTDS00310	Inhibitor	2'-deoxythymidine triphosphate
TTDS00310	Inhibitor	3-Oximo-olean-12-en-29-oic acid
TTDS00310	Inhibitor	3-cis-p-coumaroyl maslinic acid
TTDS00310	Inhibitor	3-trans-p-coumaroyl maslinic acid
TTDS00310	Inhibitor	3alpha-O-trans-p-coumaroyl-7-labden-15-oic acid
TTDS00310	Inhibitor	3beta-hydroxyrus-12,19(29)-dien-28-oic acid
TTDS00310	Inhibitor	3beta-hydroxyrus-18,20(30)-dien-28-oic acid
TTDS00310	Inhibitor	5-propenyl-2'-deoxyuridine triphosphate
TTDS00310	Inhibitor	5-propenyl-arabinofuranosyluracil 5'-triphosphate
TTDS00310	Inhibitor	6-(3-Ethyl-phenylamino)-1H-pyrimidine-2,4-dione
TTDS00310	Inhibitor	6-(4-Bromo-phenylamino)-1H-pyrimidine-2,4-dione
TTDS00310	Inhibitor	6-(4-Chloro-phenylamino)-1H-pyrimidine-2,4-dione
TTDS00310	Inhibitor	Aciclovir
TTDS00310	Inhibitor	Actinomycin D
TTDS00310	Inhibitor	Acyclovir
TTDS00310	Inhibitor	BETULINIC ACID
TTDS00310	Inhibitor	Chloroquinium
TTDS00310	Inhibitor	Cidofovir
TTDS00310	Inhibitor	Cytarabine
TTDS00310	Inhibitor	EPICATECHIN
TTDS00310	Inhibitor	Foscavir
TTDS00310	Inhibitor	Ganciclovir
TTDS00310	Inhibitor	Guanosine
TTDS00310	Inhibitor	Guanosine-5'-Monophosphate
TTDS00310	Inhibitor	Mahureone D
TTDS00310	Inhibitor	OLEANOLIC_ACID
TTDS00310	Inhibitor	PENICILLIOL A
TTDS00310	Inhibitor	TALAROFLAVONE
TTDS00310	Inhibitor	URSOLIC ACID
TTDS00310	Inhibitor	Valaciclovir
TTDS00310	Inhibitor	Valganciclovir
TTDS00310	Inhibitor	Vidarabine
TTDS00310	Inhibitor	ZIDOVUDINE TRIPHOSPHATE
TTDS00310	Inhibitor	alpha,beta-methylene-dATP
TTDS00310	Inhibitor	alpha,beta-methylene-dCTP
TTDS00310	Inhibitor	alpha,beta-methylene-dGTP
TTDS00310	Inhibitor	alpha,beta-methylene-dTTP
TTDS00310	Inhibitor	ddCTP SODIUM
TTDS00310	Inhibitor	gallic acid 5,6-dihydroxy-3-carboxyphenylester
TTDS00311	UniProt ID	Q9NYK1
TTDS00311	Name	Toll-like receptor 7
TTDS00311	Type of target	Successful target
TTDS00311	Disease	Basal cell carcinoma
TTDS00311	Disease	Hepatitis C
TTDS00311	Disease	Skin cancer
TTDS00311	Function	Participates in the innate immune response to microbial agents. acts via myd88 a
TTDS00311	Sequence	MVFPMWTLKRQILILFNIILISKLLGARWFPKTLPCDVTLDVPKNHVIVDCTDKHLTEIPGGIPTNTTNLTLTINHIPDI
TTDS00311	BioChemical Class	Transmembrane protein
TTDS00311	Pathway	Toll-like receptor signaling pathway
TTDS00311	Target Validation	TTDS00311
TTDS00311	Drug(s)	2245035
TTDS00311	Drug(s)	ANA773
TTDS00311	Drug(s)	CPG 52364
TTDS00311	Drug(s)	Docosanol
TTDS00311	Drug(s)	GS-9620
TTDS00311	Drug(s)	Hydroxychloroquine
TTDS00311	Drug(s)	IMO-3100
TTDS00311	Drug(s)	Imiquimod
TTDS00311	Drug(s)	Isatoribine
TTDS00311	Drug(s)	Resiquimod
TTDS00311	Antagonist	CPG 52364
TTDS00311	Antagonist	Hydroxychloroquine
TTDS00311	Antagonist	IMO-3100
TTDS00311	Agonist	ANA773
TTDS00311	Agonist	Docosanol
TTDS00311	Agonist	Imiquimod
TTDS00311	Agonist	Isatoribine
TTDS00311	Agonist	Resiquimod
TTDS00311	Multitarget	CPG 52364
TTDS00311	Multitarget	IMO-3100
TTDS00312	UniProt ID	P11876
TTDS00312	Name	DNA (cytosine-5)-methyltransferase
TTDS00312	Type of target	Successful target
TTDS00312	Synonyms	DNA MTase
TTDS00312	Synonyms	DNA methyltransferase
TTDS00312	Synonyms	M.EcoDcm
TTDS00312	Disease	Hepatocellular carcinoma
TTDS00312	Disease	Leukemia, unspecified
TTDS00312	Disease	Solid tumor
TTDS00312	Function	This methylase recognizes the double-stranded sequence ccwgg, causes specific me
TTDS00312	Sequence	MQENISVTDSYSTGNAAQAMLEKLLQIYDVKTLVAQLNGVGENHWSAAILKRALANDSAWHRLSEKEFAHLQTLLPKPPA
TTDS00312	EC Number	EC 2.1.1.37
TTDS00312	EC Number	EC 2.1.1.73
TTDS00312	Target Validation	TTDS00312
TTDS00312	Drug(s)	Azacitidine
TTDS00312	Drug(s)	Decitabine
TTDS00312	Inhibitor	(L-)-S-adenosyl-L-homocysteine
TTDS00312	Inhibitor	Azacitidine
TTDS00312	Inhibitor	CURCUMIN
TTDS00312	Inhibitor	Decitabine
TTDS00312	Inhibitor	NSC-106084
TTDS00312	Inhibitor	NSC-137546
TTDS00312	Inhibitor	NSC-138419
TTDS00312	Inhibitor	NSC-154957
TTDS00312	Inhibitor	NSC-158324
TTDS00312	Inhibitor	NSC-319745
TTDS00312	Inhibitor	NSC-345763
TTDS00312	Inhibitor	NSC-348926
TTDS00312	Inhibitor	NSC-401077
TTDS00312	Inhibitor	NSC-54162
TTDS00312	Inhibitor	NSC-56071
TTDS00312	Inhibitor	NSC-57893
TTDS00312	Inhibitor	NSC-622444
TTDS00312	Inhibitor	NSC-622445
TTDS00312	Inhibitor	NSC-623548
TTDS00312	Inhibitor	S-Adenosylhomocysteine
TTDS00312	Inhibitor	S-tubercidinylhomocysteine
TTDS00313	UniProt ID	O15696
TTDS00313	UniProt ID	P07805
TTDS00313	UniProt ID	P11926
TTDS00313	Name	Ornithine decarboxylase
TTDS00313	Type of target	Successful target
TTDS00313	Synonyms	ODC
TTDS00313	Disease	African trypanosomiasis
TTDS00313	Disease	Hereditary polyposis syndromes
TTDS00313	Disease	Inflammation
TTDS00313	Disease	Malaria
TTDS00313	Disease	Sleeping sickness
TTDS00313	Sequence	MFMINYVFCEESNNMSKMVPDDDNNNYSSGKSCVYYQDLNKKEKEEYYRLNKKLRNDLFINSKQFYELHTFTERTVGFMR
TTDS00313	PDB Structure	1D7K; 2ON3; 2OO0
TTDS00313	BioChemical Class	Carbon-carbon lyases
TTDS00313	Pathway	Arginine and proline metabolism
TTDS00313	Pathway	Glutathione metabolism
TTDS00313	Pathway	Metabolic pathways
TTDS00313	EC Number	EC 4.1.1.17
TTDS00313	Target Validation	TTDS00313
TTDS00313	Drug(s)	Eflornithine
TTDS00313	Inhibitor	(2R,5R)-delta-methyl-alpha-acetylenic putrescine
TTDS00313	Inhibitor	1-Amino-3-(aminoxy)-2-propanol Dihydrochloride
TTDS00313	Inhibitor	3-(Aminooxy)propan-1-amine hydrochloride
TTDS00313	Inhibitor	3-aminooxy-1-aminopropane
TTDS00313	Inhibitor	3-methoxy-4-hydroxylonchocarpin
TTDS00313	Inhibitor	4-hydroxylonchocarpin
TTDS00313	Inhibitor	Alpha-Difluoromethylornithine
TTDS00313	Inhibitor	Alpha-monofluoromethyl-3,4-dehydroornithine
TTDS00313	Inhibitor	Alpha-monofluoromethyl-3,4-dehydroornithine ethyl ester
TTDS00313	Inhibitor	Alpha-monofluoromethyl-3,4-dehydroornithine methyl ester
TTDS00313	Inhibitor	DFMO
TTDS00313	Inhibitor	Difluoromethylornithine
TTDS00313	Inhibitor	Eflornithine
TTDS00313	Inhibitor	G418
TTDS00313	Inhibitor	LONCHOCARPUSONE
TTDS00313	Inhibitor	N'-Pyridoxyl-Lysine-5'-Monophosphate
TTDS00313	Inhibitor	N-Pyridoxyl-Glycine-5-Monophosphate
TTDS00313	Inhibitor	Putrescine
TTDS00313	Inhibitor	Pyridoxine-5'-Phosphate
TTDS00313	Inhibitor	ZAPOTIN
TTDS00314	UniProt ID	P49429
TTDS00314	Name	4-hydroxyphenylpyruvate dioxygenase
TTDS00314	Type of target	Successful target
TTDS00314	Synonyms	4HPPD
TTDS00314	Synonyms	F Alloantigen
TTDS00314	Synonyms	F protein
TTDS00314	Synonyms	HPD
TTDS00314	Synonyms	HPPDase
TTDS00314	Disease	Hereditary tyrosinemia type I
TTDS00314	Disease	Viral infection, unspecified
TTDS00314	Sequence	MTTYNNKGPKPERGRFLHFHSVTFWVGNAKQAASFYCNKMGFEPLAYRGLETGSREVVSHVIKQGKIVFVLCSALNPWNK
TTDS00314	BioChemical Class	Oxidoreductases acting on single donors
TTDS00314	Pathway	Metabolic pathways
TTDS00314	Pathway	Phenylalanine metabolism
TTDS00314	Pathway	Tyrosine metabolism
TTDS00314	EC Number	EC 1.13.11.27
TTDS00314	Target Validation	TTDS00314
TTDS00314	Drug(s)	BMS-433771
TTDS00314	Drug(s)	Nitisinone
TTDS00314	Inhibitor	(4-Hydroxy-phenoxy)-acetic acid
TTDS00314	Inhibitor	2-(2-Bromo-benzoyl)-cyclohexane-1,3-dione
TTDS00314	Inhibitor	2-(2-Chloro-benzoyl)-cyclohexane-1,3-dione
TTDS00314	Inhibitor	2-(2-Iodo-benzoyl)-cyclohexane-1,3-dione
TTDS00314	Inhibitor	2-(2-Methoxy-benzoyl)-cyclohexane-1,3-dione
TTDS00314	Inhibitor	2-(2-Methyl-benzoyl)-cyclohexane-1,3-dione
TTDS00314	Inhibitor	2-(2-Nitro-benzoyl)-cyclohexane-1,3-dione
TTDS00314	Inhibitor	2-Acetyl-cyclohexane-1,3-dione
TTDS00314	Inhibitor	2-Cyclopropanecarbonyl-cyclohexane-1,3-dione
TTDS00314	Inhibitor	2-Propionyl-cyclohexane-1,3-dione
TTDS00314	Inhibitor	2-acetyl-3-hydroxycyclohex-2-enone
TTDS00314	Inhibitor	3-Hydroxy-4-phenyl-5H-furan-2-one
TTDS00314	Inhibitor	3-hydroxy-2-propionylcyclohex-2-enone
TTDS00314	Inhibitor	Acetate Ion
TTDS00314	Inhibitor	BMS-433771
TTDS00314	Inhibitor	Diketonitrile
TTDS00314	Inhibitor	Nitisinone
TTDS00315	UniProt ID	P04293
TTDS00315	Name	DNA polymerase (HSV)
TTDS00315	Type of target	Successful target
TTDS00315	Synonyms	DNA polymerase
TTDS00315	Synonyms	Herpes simplex virus-specified DNA polymerase
TTDS00315	Disease	Herpes virus infection
TTDS00315	Disease	Viral infection, unspecified
TTDS00315	Sequence	MFSGGGGPLSPGGKSAARAASGFFAPAGPRGASRGPPPCLRQNFYNPYLAPVGTQQKPTGPTQRHTYYSECDEFRFIAPR
TTDS00315	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00315	Related US Patent	6,528,252
TTDS00315	Drug(s)	IDX136
TTDS00315	Drug(s)	Lobucavir
TTDS00315	Drug(s)	Penciclovir
TTDS00315	Inhibitor	Guanosine
TTDS00315	Inhibitor	Guanosine-5'-Monophosphate
TTDS00315	Inhibitor	IDX136
TTDS00315	Inhibitor	Lobucavir
TTDS00315	Inhibitor	PMEA
TTDS00315	Inhibitor	Penciclovir
TTDS00316	UniProt ID	P07918
TTDS00316	Name	DNA polymerase (HSV-2)
TTDS00316	Type of target	Successful target
TTDS00316	Synonyms	DNA polymerase
TTDS00316	Synonyms	Herpes simplex virus type 2 DNA polymerase
TTDS00316	Disease	Human cytomegalovirus infections
TTDS00316	Sequence	MFCAAGGPASPGGKSAARAASGFFAPHNPRGATQTAPPPCRRQNFYNPHLAQTGTQPKAPGPAQRHTYYSECDEFRFIAP
TTDS00316	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00316	Drug(s)	Famciclovir
TTDS00316	Inhibitor	Aphidicolin
TTDS00316	Inhibitor	Famciclovir
TTDS00316	Inhibitor	Guanosine
TTDS00316	Inhibitor	Guanosine-5'-Monophosphate
TTDS00317	UniProt ID	Q69617
TTDS00317	Name	HIV-1 reverse transcriptase
TTDS00317	Type of target	Successful target
TTDS00317	Synonyms	HIV-1 RT
TTDS00317	Synonyms	Human immunodeficiency virus type 1 reverse transcriptase
TTDS00317	Disease	Human immunodeficiency virus [HIV] disease
TTDS00317	Sequence	MEKEGKISKIGPENPYNTPVFAIKKKDSTRWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTV
TTDS00317	BioChemical Class	RNA-directed DNA polymerase
TTDS00317	EC Number	EC 2.7.7.49
TTDS00317	Related US Patent	6,492,423
TTDS00317	Related US Patent	6,492,515
TTDS00317	Related US Patent	6,569,897
TTDS00317	Related US Patent	6,610,714
TTDS00317	Related US Patent	6,673,791
TTDS00317	Related US Patent	6,759,533
TTDS00317	Target Validation	TTDS00317
TTDS00317	QSAR Model	TTDS00317
TTDS00317	Drug(s)	Abacavir/dolutegravir/lamivudine
TTDS00317	Drug(s)	Dapivirine
TTDS00317	Drug(s)	Delavirdine
TTDS00317	Drug(s)	Dolutegravir + abacavir sulphate + lamivudine
TTDS00317	Drug(s)	Efavirenz
TTDS00317	Drug(s)	Emtricitabine
TTDS00317	Drug(s)	Etravirine
TTDS00317	Drug(s)	IDX899
TTDS00317	Drug(s)	Nevirapine
TTDS00317	Drug(s)	Sorivudine
TTDS00317	Drug(s)	Tenofovir disoproxil
TTDS00317	Inhibitor	1-(1-Phenyl-propyl)-3-thiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-(2-Furan-2-yl-ethyl)-3-thiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-(2-Phenoxy-ethyl)-3-thiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-(2-Phenyl-propyl)-3-thiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-(2-Pyridin-2-yl-ethyl)-3-thiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-(3-Phenyl-propyl)-3-thiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-(4-Butyl-thiazol-2-yl)-3-phenethyl-thiourea
TTDS00317	Inhibitor	1-(4-Cyano-thiazol-2-yl)-3-phenethyl-thiourea
TTDS00317	Inhibitor	1-Adamantan-1-ylmethyl-3-thiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-Benzenesulfonyl-2-nitro-benzene
TTDS00317	Inhibitor	1-Benzothiazol-2-yl-3-phenethyl-thiourea
TTDS00317	Inhibitor	1-Benzyl-3-thiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-Furan-2-ylmethyl-3-thiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-Phenethyl-3-[1,3,4]thiadiazol-2-yl-thiourea
TTDS00317	Inhibitor	1-Thiazol-2-yl-3-(2-o-tolyl-ethyl)-thiourea
TTDS00317	Inhibitor	1-Thiazol-2-yl-3-(2-p-tolyl-ethyl)-thiourea
TTDS00317	Inhibitor	1-nitro-2-(2-nitrophenylsulfonyl)benzene
TTDS00317	Inhibitor	10-Allyl-10H-dibenzo[b,f][1,4]oxazepin-11-one
TTDS00317	Inhibitor	10-Ethyl-10H-dibenzo[b,f][1,4]oxazepin-11-one
TTDS00317	Inhibitor	10-Isopropyl-10H-dibenzo[b,f][1,4]oxazepin-11-one
TTDS00317	Inhibitor	10-Propyl-10H-dibenzo[b,f][1,4]oxazepin-11-one
TTDS00317	Inhibitor	10-Propyl-10H-dibenzo[b,f][1,4]thiazepin-11-one
TTDS00317	Inhibitor	2',3'-Dideoxyadenosine Triphosphate (Ddatp)
TTDS00317	Inhibitor	2'-3'-dideoxy-7-deaza-guaninetriphosphate
TTDS00317	Inhibitor	2-Amino-6-(2-bromo-benzenesulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(2-chloro-benzenesulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(2-chloro-phenylsulfanyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(2-cyano-benzenesulfinyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(2-cyano-benzenesulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(2-cyano-phenylsulfanyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(2-fluoro-benzenesulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(2-methoxy-phenylsulfanyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(3-bromo-benzenesulfinyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(3-bromo-benzenesulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(3-bromo-phenylsulfanyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(3-chloro-benzenesulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(3-chloro-phenylsulfanyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(3-cyano-benzenesulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(3-cyano-phenylsulfanyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(3-fluoro-phenylsulfanyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(3-methoxy-phenylsulfanyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(4-chloro-phenylsulfanyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(naphthalene-1-sulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(naphthalene-2-sulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(toluene-2-sulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(toluene-3-sulfinyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(toluene-3-sulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-(toluene-4-sulfonyl)-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-benzenesulfonyl-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-m-tolylsulfanyl-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-p-tolylsulfanyl-benzonitrile
TTDS00317	Inhibitor	2-Amino-6-phenylsulfanyl-benzonitrile
TTDS00317	Inhibitor	2-Benzylsulfanyl-6-chloro-pyrimidin-4-ylamine
TTDS00317	Inhibitor	3'thiacytidine
TTDS00317	Inhibitor	3-Benzylamino-5-ethyl-6-methyl-1H-pyridin-2-one
TTDS00317	Inhibitor	6-Benzyl-2-cyclohexylsulfanyl-3H-pyrimidin-4-one
TTDS00317	Inhibitor	6-Benzyl-2-cyclopentylsulfanyl-3H-pyrimidin-4-one
TTDS00317	Inhibitor	6-Benzyl-2-isobutylsulfanyl-3H-pyrimidin-4-one
TTDS00317	Inhibitor	6-Benzyl-2-sec-butylsulfanyl-3H-pyrimidin-4-one
TTDS00317	Inhibitor	ATEVIRDINE
TTDS00317	Inhibitor	ATEVIRDINE SULPHATE
TTDS00317	Inhibitor	Alovudine
TTDS00317	Inhibitor	Amdoxovir
TTDS00317	Inhibitor	Apricitabine
TTDS00317	Inhibitor	Benzimidazole 5-carboxamide
TTDS00317	Inhibitor	Benzothiadiazines
TTDS00317	Inhibitor	CORILAGIN
TTDS00317	Inhibitor	Cyclosporin A analogue
TTDS00317	Inhibitor	DEOXYTHYMIDINE_TRIPHOSPHATE
TTDS00317	Inhibitor	Dapivirine
TTDS00317	Inhibitor	DdC
TTDS00317	Inhibitor	DdI
TTDS00317	Inhibitor	Delavirdine
TTDS00317	Inhibitor	Deoxyfluorothymidine
TTDS00317	Inhibitor	Dideoxycytidine
TTDS00317	Inhibitor	Dihydropyrone
TTDS00317	Inhibitor	EMIVIRINE
TTDS00317	Inhibitor	EPIGALOCATECHIN GALLATE
TTDS00317	Inhibitor	Efavirenz
TTDS00317	Inhibitor	Elvucitabine
TTDS00317	Inhibitor	Emtricitabine
TTDS00317	Inhibitor	Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate
TTDS00317	Inhibitor	Ethyl 1-[(1H-benzimidazol-5(6)-yl)sulfonyl]-1H-pyrrole-2-carboxylate
TTDS00317	Inhibitor	Ethyl 1-[(1H-benzotriazol-5(6)-yl)sulfonyl]-1H-pyrrole-2-carboxylate
TTDS00317	Inhibitor	Etravirine
TTDS00317	Inhibitor	Fullerene Derivative
TTDS00317	Inhibitor	HEPT
TTDS00317	Inhibitor	HI-172
TTDS00317	Inhibitor	HI-236
TTDS00317	Inhibitor	HI-240
TTDS00317	Inhibitor	HI-241
TTDS00317	Inhibitor	HI-242
TTDS00317	Inhibitor	HI-244
TTDS00317	Inhibitor	HI-280
TTDS00317	Inhibitor	HI-281
TTDS00317	Inhibitor	HI-443
TTDS00317	Inhibitor	HI-445
TTDS00317	Inhibitor	IDX899
TTDS00317	Inhibitor	ISODISPAR B
TTDS00317	Inhibitor	Indole N -acetamide
TTDS00317	Inhibitor	L-697,661
TTDS00317	Inhibitor	L-697661
TTDS00317	Inhibitor	LY-73497
TTDS00317	Inhibitor	NSC-380292
TTDS00317	Inhibitor	Nevirapine
TTDS00317	Inhibitor	Opaviraline
TTDS00317	Inhibitor	PT-101
TTDS00317	Inhibitor	PT-102
TTDS00317	Inhibitor	PT-103
TTDS00317	Inhibitor	PT-104
TTDS00317	Inhibitor	PT-106
TTDS00317	Inhibitor	PT-108
TTDS00317	Inhibitor	PT-109
TTDS00317	Inhibitor	PT-110
TTDS00317	Inhibitor	PT-112
TTDS00317	Inhibitor	PT-113
TTDS00317	Inhibitor	PT-114
TTDS00317	Inhibitor	PT-115
TTDS00317	Inhibitor	PT-302
TTDS00317	Inhibitor	PT-304
TTDS00317	Inhibitor	PT-306
TTDS00317	Inhibitor	PT-307
TTDS00317	Inhibitor	PT-308
TTDS00317	Inhibitor	PT-309
TTDS00317	Inhibitor	PT-310
TTDS00317	Inhibitor	PT-311
TTDS00317	Inhibitor	PT-312
TTDS00317	Inhibitor	PT-313
TTDS00317	Inhibitor	PT-314
TTDS00317	Inhibitor	PT-315
TTDS00317	Inhibitor	PT-316
TTDS00317	Inhibitor	PT-317
TTDS00317	Inhibitor	PT-319
TTDS00317	Inhibitor	PT-320
TTDS00317	Inhibitor	PT-322
TTDS00317	Inhibitor	R-82150
TTDS00317	Inhibitor	R-82913
TTDS00317	Inhibitor	R-87027
TTDS00317	Inhibitor	RTI-20
TTDS00317	Inhibitor	Rilpivirine
TTDS00317	Inhibitor	TIBO
TTDS00317	Inhibitor	TRICIRIBINE
TTDS00317	Inhibitor	TROVIRDINE
TTDS00317	Inhibitor	TROVIRDINE HYDROCHLORIDE
TTDS00317	Inhibitor	Tenofovir disoproxil
TTDS00317	Inhibitor	Tetrahydroimidazo[4,5,1-jk]-[1,4]benzodiazepin-2(1H)-one
TTDS00317	Inhibitor	UK-129485
TTDS00317	Inhibitor	ZIDOVUDINE TRIPHOSPHATE
TTDS00317	Inhibitor	[(40-OH) MeLeu]4-CsA derivatives
TTDS00317	Inhibitor	[(40-OH)MeLeu]4-Cyclosporin A
TTDS00317	Inhibitor	[(D)MeSer]3-[(40-OH) MeLeu]4-Cyclosporin A
TTDS00317	Aptamer	Ligand 1.1
TTDS00318	Name	HIV reverse transcriptase
TTDS00318	Type of target	Successful target
TTDS00318	Disease	Human immunodeficiency virus [HIV] disease
TTDS00318	Related US Patent	6,265,406
TTDS00318	Related US Patent	6,303,630
TTDS00318	Related US Patent	6,303,780
TTDS00318	Related US Patent	6,348,616
TTDS00318	Related US Patent	6,380,190
TTDS00318	Related US Patent	6,420,359
TTDS00318	Related US Patent	6,423,718
TTDS00318	Related US Patent	6,462,037
TTDS00318	Related US Patent	6,489,320
TTDS00318	Related US Patent	6,545,152
TTDS00318	Related US Patent	6,555,686
TTDS00318	Related US Patent	6,593,337
TTDS00318	Related US Patent	6,596,729
TTDS00318	Related US Patent	6,706,706
TTDS00318	Target Validation	TTDS00318
TTDS00318	Drug(s)	Abacavir
TTDS00318	Drug(s)	Didanosine
TTDS00318	Drug(s)	Foscarnet
TTDS00318	Drug(s)	Stavudine
TTDS00318	Drug(s)	Tenofovir
TTDS00318	Drug(s)	Zalcitabine
TTDS00318	Drug(s)	Zidovudine
TTDS00318	Inhibitor	Abacavir
TTDS00318	Inhibitor	Didanosine
TTDS00318	Inhibitor	Foscarnet
TTDS00318	Inhibitor	Stavudine
TTDS00318	Inhibitor	Tenofovir
TTDS00318	Inhibitor	Zalcitabine
TTDS00318	Inhibitor	Zidovudine
TTDS00319	UniProt ID	O09807
TTDS00319	UniProt ID	O90777
TTDS00319	Name	HIV-1 protease
TTDS00319	Type of target	Successful target
TTDS00319	Synonyms	HIV-1 Retropepsin
TTDS00319	Synonyms	HIV-1 peptidase
TTDS00319	Synonyms	Retropepsin
TTDS00319	Disease	Human immunodeficiency virus [HIV] disease
TTDS00319	Sequence	PQITLWQRPVVIIKIEGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVKQYDQILVEICGHKAIGTVLVGPT
TTDS00319	BioChemical Class	Protease
TTDS00319	EC Number	EC 3.4.23.16
TTDS00319	Related US Patent	6,455,587
TTDS00319	Related US Patent	6,506,786
TTDS00319	Related US Patent	6,528,532
TTDS00319	Related US Patent	6,608,100
TTDS00319	Related US Patent	6,610,689
TTDS00319	Related US Patent	6,613,743
TTDS00319	Related US Patent	6,613,764
TTDS00319	Related US Patent	6,617,350
TTDS00319	Related US Patent	6,632,816
TTDS00319	Related US Patent	6,673,821
TTDS00319	Related US Patent	6,677,367
TTDS00319	Target Validation	TTDS00319
TTDS00319	QSAR Model	TTDS00319
TTDS00319	Drug(s)	Atazanavir
TTDS00319	Drug(s)	Darunavir
TTDS00319	Drug(s)	Fosamprenavir
TTDS00319	Drug(s)	Lopinavir
TTDS00319	Drug(s)	Nelfinavir
TTDS00319	Drug(s)	Tipranavir
TTDS00319	Inhibitor	Atazanavir
TTDS00319	Inhibitor	BMS-232632
TTDS00319	Inhibitor	Darunavir
TTDS00319	Inhibitor	Fosamprenavir
TTDS00319	Inhibitor	Lopinavir
TTDS00319	Inhibitor	Nelfinavir
TTDS00319	Inhibitor	Tipranavir
TTDS00320	Name	HIV protease
TTDS00320	Type of target	Successful target
TTDS00320	Disease	Human immunodeficiency virus [HIV] disease
TTDS00320	Related US Patent	6,214,861
TTDS00320	Related US Patent	6,281,367
TTDS00320	Related US Patent	6,313,117
TTDS00320	Related US Patent	6,316,496
TTDS00320	Related US Patent	6,316,625
TTDS00320	Related US Patent	6,329,524
TTDS00320	Related US Patent	6,335,460
TTDS00320	Related US Patent	6,372,905
TTDS00320	Related US Patent	6,380,188
TTDS00320	Related US Patent	6,380,400
TTDS00320	Related US Patent	6,384,036
TTDS00320	Related US Patent	6,388,132
TTDS00320	Related US Patent	6,391,919
TTDS00320	Related US Patent	6,392,067
TTDS00320	Related US Patent	6,403,585
TTDS00320	Related US Patent	6,403,799
TTDS00320	Related US Patent	6,407,134
TTDS00320	Related US Patent	6,407,285
TTDS00320	Related US Patent	6,417,387
TTDS00320	Related US Patent	6,440,659
TTDS00320	Related US Patent	6,444,678
TTDS00320	Related US Patent	6,451,999
TTDS00320	Related US Patent	6,458,785
TTDS00320	Related US Patent	6,465,661
TTDS00320	Related US Patent	6,469,207
TTDS00320	Related US Patent	6,472,407
TTDS00320	Related US Patent	6,472,534
TTDS00320	Related US Patent	6,500,832
TTDS00320	Related US Patent	6,506,759
TTDS00320	Related US Patent	6,512,135
TTDS00320	Related US Patent	6,515,024
TTDS00320	Related US Patent	6,515,162
TTDS00320	Related US Patent	6,525,215
TTDS00320	Related US Patent	6,528,252
TTDS00320	Related US Patent	6,534,493
TTDS00320	Related US Patent	6,538,006
TTDS00320	Related US Patent	6,552,203
TTDS00320	Related US Patent	6,555,558
TTDS00320	Related US Patent	6,562,848
TTDS00320	Related US Patent	6,569,882
TTDS00320	Related US Patent	6,570,027
TTDS00320	Related US Patent	6,605,721
TTDS00320	Related US Patent	6,646,010
TTDS00320	Related US Patent	6,649,651
TTDS00320	Related US Patent	6,649,761
TTDS00320	Related US Patent	6,667,307
TTDS00320	Related US Patent	6,673,822
TTDS00320	Target Validation	TTDS00320
TTDS00320	Drug(s)	ABT-450
TTDS00320	Drug(s)	ACH-1625
TTDS00320	Drug(s)	Amprenavir
TTDS00320	Drug(s)	BI 201335
TTDS00320	Drug(s)	BIT225
TTDS00320	Drug(s)	BMS 650032
TTDS00320	Drug(s)	Danoprevir
TTDS00320	Drug(s)	GS-9256
TTDS00320	Drug(s)	Indinavir
TTDS00320	Drug(s)	MK-5172
TTDS00320	Drug(s)	R7227
TTDS00320	Drug(s)	Ritonavir
TTDS00320	Drug(s)	Saquinavir
TTDS00320	Drug(s)	TMC435
TTDS00320	Drug(s)	VX-500
TTDS00320	Drug(s)	Vaniprevir
TTDS00320	Inhibitor	ABT-450
TTDS00320	Inhibitor	ACH-1625
TTDS00320	Inhibitor	Amprenavir
TTDS00320	Inhibitor	BI 201335
TTDS00320	Inhibitor	BIT225
TTDS00320	Inhibitor	BMS 650032
TTDS00320	Inhibitor	Danoprevir
TTDS00320	Inhibitor	GS-9256
TTDS00320	Inhibitor	Indinavir
TTDS00320	Inhibitor	MK-5172
TTDS00320	Inhibitor	R7227
TTDS00320	Inhibitor	Ritonavir
TTDS00320	Inhibitor	Saquinavir
TTDS00320	Inhibitor	TMC435
TTDS00320	Inhibitor	VX-500
TTDS00320	Inhibitor	Vaniprevir
TTDS00322	UniProt ID	P04612
TTDS00322	Name	HIV-1 Tat protein
TTDS00322	Type of target	Successful target
TTDS00322	Synonyms	TAT protein
TTDS00322	Synonyms	Transactivating regulatory protein
TTDS00322	Disease	Human immunodeficiency virus [HIV] disease
TTDS00322	Function	Transcriptional regulator that acts by binding to the trans-activating responsiv
TTDS00322	Sequence	MEPVDPRLEPWKHPGSQPKTACTTCYCKKCCFHCQVCFITKALGISYGRKKRRQRRRA
TTDS00322	Drug(s)	Penicillamine
TTDS00322	Inhibitor	CGP 40336A
TTDS00322	Inhibitor	D-penicillamine
TTDS00322	Inhibitor	Durhamycin A
TTDS00322	Inhibitor	Penicillamine
TTDS00323	UniProt ID	P05092
TTDS00323	UniProt ID	P62937
TTDS00323	Name	Peptidyl-prolyl cis-trans isomerase A
TTDS00323	Type of target	Successful target
TTDS00323	Synonyms	CyPA
TTDS00323	Synonyms	Cyclophilin A
TTDS00323	Synonyms	Cyclosporin A-binding protein
TTDS00323	Synonyms	PPIase
TTDS00323	Synonyms	Rotamase
TTDS00323	Disease	Human immunodeficiency virus [HIV] disease
TTDS00323	Function	Ppiases accelerate the folding of proteins. It catalyzes the cis-trans isomeriza
TTDS00323	Sequence	MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYG
TTDS00323	PDB Structure	1AK4; 1AWQ; 1AWR; 1AWS; 1AWT; 1AWU; 1AWV; 1BCK; 1CWA; 1CWB; 1CWC; 1CWF; 1CWH; 1C
TTDS00323	BioChemical Class	Cis-trans-Isomerases
TTDS00323	EC Number	EC 5.2.1.8
TTDS00323	Drug(s)	L-Proline
TTDS00323	Inhibitor	(3r)-1-Acetyl-3-Methylpiperidine
TTDS00323	Inhibitor	1-(3-benzyloxy-pyridin-2-yl)-3-phenyl-urea
TTDS00323	Inhibitor	3-[3-(3-benzyloxy-pyridin-2-yl)-ureido]-benzamide
TTDS00323	Inhibitor	4-[3-(3-benzyloxy-pyridin-2-yl)-ureido]-benzamide
TTDS00323	Inhibitor	7-AMINO-4-METHYL-CHROMEN-2-ONE
TTDS00323	Inhibitor	Ethyl Oxo(Piperidin-1-Yl)Acetate
TTDS00323	Binder	L-Proline
TTDS00325	UniProt ID	O40239
TTDS00325	Name	Transmembrane glycoprotein gp41
TTDS00325	Type of target	Successful target
TTDS00325	Synonyms	Glycoprotein gp41
TTDS00325	Synonyms	HIV-1 gp41
TTDS00325	Synonyms	HIV-1 gp41 envelope glycoprotein
TTDS00325	Disease	Human immunodeficiency virus [HIV] disease
TTDS00325	Sequence	WGIKQLQARVLAVERYLKDQQLLGIWGCSGKLICTTTVPWNASWSNKSLDDIWDNMTWMEWEREIDNYTDLIYTLIGKSQ
TTDS00325	BioChemical Class	Transmembrane protein
TTDS00325	Drug(s)	Enfuvirtide
TTDS00325	Inhibitor	Enfuvirtide
TTDS00325	Inhibitor	T-1249
TTDS00326	UniProt ID	P51681
TTDS00326	Name	C-C chemokine receptor type 5
TTDS00326	Type of target	Successful target
TTDS00326	Synonyms	C-C CKR-5
TTDS00326	Synonyms	CC-CKR-5
TTDS00326	Synonyms	CCR-5
TTDS00326	Synonyms	CCR5
TTDS00326	Synonyms	CD195 antigen
TTDS00326	Synonyms	CHEMR13
TTDS00326	Synonyms	Chemokine receptor CCR5
TTDS00326	Synonyms	HIV-1 fusion co-receptor
TTDS00326	Synonyms	HIV-1 fusion coreceptor
TTDS00326	Disease	Human immunodeficiency virus [HIV] disease
TTDS00326	Function	Receptor for a c-c type chemokine. Binds to MIP-1-alpha, MIP-1-beta and rantes a
TTDS00326	Sequence	MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKRLKSMTDIYLLNLAISDLFFL
TTDS00326	PDB Structure	1ND8; 1NE0; 1OPN; 1OPT; 1OPW; 2L87; 2RLL; 2RRS
TTDS00326	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00326	Pathway	Chemokine signaling pathway
TTDS00326	Pathway	Cytokine-cytokine receptor interaction
TTDS00326	Related US Patent	6,387,930
TTDS00326	Related US Patent	6,391,865
TTDS00326	Related US Patent	6,476,062
TTDS00326	Related US Patent	6,562,978
TTDS00326	Related US Patent	6,602,885
TTDS00326	Target Validation	TTDS00326
TTDS00326	QSAR Model	TTDS00326
TTDS00326	Drug(s)	AZD5672
TTDS00326	Drug(s)	AZD8566
TTDS00326	Drug(s)	Cenicriviroc
TTDS00326	Drug(s)	GW873140
TTDS00326	Drug(s)	INCB15050
TTDS00326	Drug(s)	INCB9471
TTDS00326	Drug(s)	Maraviroc
TTDS00326	Drug(s)	PRO 140
TTDS00326	Drug(s)	RAP101
TTDS00326	Drug(s)	SCH-C
TTDS00326	Drug(s)	SCH-D
TTDS00326	Drug(s)	Sch-351125
TTDS00326	Drug(s)	TAK-779
TTDS00326	Drug(s)	Tak-220
TTDS00326	Drug(s)	Vicriviroc
TTDS00326	Inhibitor	(2-(4-chlorobenzyloxy)-5-bromophenyl)methanamine
TTDS00326	Inhibitor	4-(2-(4-chlorobenzyloxy)-5-bromobenzyl)morpholine
TTDS00326	Inhibitor	ANIBAMINE
TTDS00326	Inhibitor	GT-1282;NIBR-1282
TTDS00326	Inhibitor	N-(2-(4-chlorobenzyloxy)-5-bromobenzyl)ethanamine
TTDS00326	Inhibitor	NIFEVIROC
TTDS00326	Inhibitor	SCH-210971
TTDS00326	Inhibitor	TAK-652
TTDS00326	Inhibitor	UK-427857
TTDS00326	Inhibitor	VARIECOLIN
TTDS00326	Antagonist	AZD5672
TTDS00326	Antagonist	AZD8566
TTDS00326	Antagonist	E-913
TTDS00326	Antagonist	INCB15050
TTDS00326	Antagonist	INCB9471
TTDS00326	Antagonist	Maraviroc
TTDS00326	Antagonist	SCH 351125
TTDS00326	Antagonist	SCH-D
TTDS00326	Antagonist	Sch-351125
TTDS00326	Antagonist	TAK-779
TTDS00326	Antagonist	Vicriviroc
TTDS00326	Antibody	Anti-CCR5 antibodies
TTDS00326	Antibody	PRO 140
TTDS00326	Binder	GW873140
TTDS00326	Binder	SCH-C
TTDS00326	Binder	Tak-220
TTDS00328	UniProt ID	Q9UHC9
TTDS00328	Name	Niemann-Pick C1-like protein 1
TTDS00328	Type of target	Successful target
TTDS00328	Synonyms	NPC1L1
TTDS00328	Synonyms	Niemann-Pick C1 Like 1
TTDS00328	Disease	Hypercholesterolemia
TTDS00328	Disease	Sitosterolemia
TTDS00328	Sequence	MAEAGLRGWLLWALLLRLAQSEPYTTIHQPGYCAFYDECGKNPELSGSLMTLSNVSCLSNTPARKITGDHLILLQKICPR
TTDS00328	PDB Structure	3QNT
TTDS00328	BioChemical Class	Transmembrane protein
TTDS00328	Target Validation	TTDS00328
TTDS00328	Drug(s)	Ezetimibe
TTDS00328	Inhibitor	Ezetimibe
TTDS00328	Inhibitor	ezetimibe-glucuronide
TTDS00331	Name	SUR1-type K(ATP) channel
TTDS00331	Type of target	Successful target
TTDS00331	Synonyms	Kir6.2/SUR1
TTDS00331	Disease	Noninsulin-dependent diabetes mellitus
TTDS00331	Target Validation	TTDS00331
TTDS00331	QSAR Model	TTDS00331
TTDS00331	Drug(s)	Gliclazide
TTDS00331	Drug(s)	Glimepiride
TTDS00331	Drug(s)	Repaglinide
TTDS00331	Drug(s)	Tolbutamide
TTDS00331	Blocker	Gliclazide
TTDS00331	Blocker	Glimepiride
TTDS00331	Blocker	Repaglinide
TTDS00331	Blocker	Tolbutamide
TTDS00331	Multitarget	Glimepiride
TTDS00331	Multitarget	Tolbutamide
TTDS00332	Name	SUR2-type K(ATP) channel
TTDS00332	Type of target	Successful target
TTDS00332	Synonyms	Kir6.2/SUR2
TTDS00332	Disease	Hypertension
TTDS00332	Disease	Noninsulin-dependent diabetes mellitus
TTDS00332	Disease	Unstable angina
TTDS00332	Target Validation	TTDS00332
TTDS00332	Drug(s)	Glimepiride
TTDS00332	Drug(s)	Nicorandil
TTDS00332	Drug(s)	Pinacidil
TTDS00332	Drug(s)	Repaglinide
TTDS00332	Drug(s)	Tolbutamide
TTDS00332	Blocker	Glimepiride
TTDS00332	Blocker	Meglitinide
TTDS00332	Blocker	Repaglinide
TTDS00332	Blocker	Tolbutamide
TTDS00332	Activator	Cromakalim
TTDS00332	Activator	Nicorandil
TTDS00332	Activator	Pinacidil
TTDS00332	Multitarget	Glimepiride
TTDS00332	Multitarget	Tolbutamide
TTDS00334	UniProt ID	P21554
TTDS00334	Name	Cannabinoid receptor 1
TTDS00334	Type of target	Successful target
TTDS00334	Synonyms	CANN6
TTDS00334	Synonyms	CB-R
TTDS00334	Synonyms	CB1
TTDS00334	Synonyms	Cannabinoid CB1 receptor
TTDS00334	Disease	Analgesics
TTDS00334	Disease	Inflammatory bowel disease
TTDS00334	Disease	Migraine
TTDS00334	Disease	Pain, unspecified
TTDS00334	Function	Involved in cannabinoid-induced cns effects. Acts by inhibiting adenylate cyclas
TTDS00334	Sequence	MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITE
TTDS00334	PDB Structure	1LVQ; 1LVR; 2B0Y; 2KOE
TTDS00334	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00334	Pathway	Neuroactive ligand-receptor interaction
TTDS00334	Related US Patent	6,509,367
TTDS00334	Related US Patent	6,525,087
TTDS00334	Related US Patent	6,642,258
TTDS00334	Target Validation	TTDS00334
TTDS00334	Drug(s)	AVE1625
TTDS00334	Drug(s)	AZD1175
TTDS00334	Drug(s)	AZD1704
TTDS00334	Drug(s)	AZD1940
TTDS00334	Drug(s)	AZD2207
TTDS00334	Drug(s)	CB1 antagonist
TTDS00334	Drug(s)	CBD cannabis derivative
TTDS00334	Drug(s)	CP-945598
TTDS00334	Drug(s)	Dianicline+rimonabant
TTDS00334	Drug(s)	JD-5037
TTDS00334	Drug(s)	KDS-2000
TTDS00334	Drug(s)	Marinol
TTDS00334	Drug(s)	Rimonabant
TTDS00334	Drug(s)	Rimonbant
TTDS00334	Drug(s)	SLV-319
TTDS00334	Drug(s)	TM38837
TTDS00334	Drug(s)	Taranabant
TTDS00334	Drug(s)	Tebipenem
TTDS00334	Drug(s)	ZY01
TTDS00334	Inhibitor	(1R,2R)-N-Arachidonoylcyclopropanolamide
TTDS00334	Inhibitor	(1R,2R)-N-Oleoylcyclopropanolamide
TTDS00334	Inhibitor	(1R,2S)-N-Arachidonoylcyclopropanolamide
TTDS00334	Inhibitor	2-Benzylbenzo[f]chromen-3-one
TTDS00334	Inhibitor	3,4-diarylpyrazoline derivative
TTDS00334	Inhibitor	4-cyanophenyl ethyl dodecylphosphonate
TTDS00334	Inhibitor	A-796260
TTDS00334	Inhibitor	AM-1241
TTDS00334	Inhibitor	AM-1710
TTDS00334	Inhibitor	AM-1714
TTDS00334	Inhibitor	AM-1715
TTDS00334	Inhibitor	AM-281
TTDS00334	Inhibitor	AM-404
TTDS00334	Inhibitor	AM-411
TTDS00334	Inhibitor	AM-4768
TTDS00334	Inhibitor	AM-630
TTDS00334	Inhibitor	CP-4497;CP-47497
TTDS00334	Inhibitor	CP-55940
TTDS00334	Inhibitor	DELTA 8-TETRAHYDROCANNOBINOL
TTDS00334	Inhibitor	HU-210
TTDS00334	Inhibitor	HU-210;HU-211
TTDS00334	Inhibitor	Isopropyl dodecylfluorophosphonate
TTDS00334	Inhibitor	JWH-120
TTDS00334	Inhibitor	JWH-133
TTDS00334	Inhibitor	JWH-145
TTDS00334	Inhibitor	JWH-146
TTDS00334	Inhibitor	JWH-147
TTDS00334	Inhibitor	JWH-150
TTDS00334	Inhibitor	JWH-156
TTDS00334	Inhibitor	JWH-229
TTDS00334	Inhibitor	JWH-243
TTDS00334	Inhibitor	JWH-244
TTDS00334	Inhibitor	JWH-245
TTDS00334	Inhibitor	JWH-246
TTDS00334	Inhibitor	JWH-268
TTDS00334	Inhibitor	JWH-292
TTDS00334	Inhibitor	JWH-293
TTDS00334	Inhibitor	JWH-297
TTDS00334	Inhibitor	JWH-307
TTDS00334	Inhibitor	JWH-308
TTDS00334	Inhibitor	JWH-309
TTDS00334	Inhibitor	JWH-324
TTDS00334	Inhibitor	JWH-325
TTDS00334	Inhibitor	JWH-337
TTDS00334	Inhibitor	JWH-342
TTDS00334	Inhibitor	JWH-344
TTDS00334	Inhibitor	JWH-345
TTDS00334	Inhibitor	JWH-346
TTDS00334	Inhibitor	JWH-347
TTDS00334	Inhibitor	JWH-348
TTDS00334	Inhibitor	JWH-363
TTDS00334	Inhibitor	JWH-364
TTDS00334	Inhibitor	JWH-365
TTDS00334	Inhibitor	JWH-366
TTDS00334	Inhibitor	JWH-367
TTDS00334	Inhibitor	JWH-368
TTDS00334	Inhibitor	JWH-369
TTDS00334	Inhibitor	JWH-370
TTDS00334	Inhibitor	JWH-371
TTDS00334	Inhibitor	JWH-372
TTDS00334	Inhibitor	JWH-373
TTDS00334	Inhibitor	JWH-385
TTDS00334	Inhibitor	JWH-392
TTDS00334	Inhibitor	JWH-401
TTDS00334	Inhibitor	JWH-402
TTDS00334	Inhibitor	JWH-403
TTDS00334	Inhibitor	JWH-404
TTDS00334	Inhibitor	JWH-405
TTDS00334	Inhibitor	JWH-406
TTDS00334	Inhibitor	JWH-407
TTDS00334	Inhibitor	JWH-440
TTDS00334	Inhibitor	JWH-442
TTDS00334	Inhibitor	KM-233
TTDS00334	Inhibitor	KM-233-M
TTDS00334	Inhibitor	MK-0364
TTDS00334	Inhibitor	N-(4-methoxybenzyl)oleamide
TTDS00334	Inhibitor	N-(4-methoxyphenethyl)oleamide
TTDS00334	Inhibitor	N-(4-methoxyphenyl)oleamide
TTDS00334	Inhibitor	N-(4-morpholinophenyl)docos-13-enamide
TTDS00334	Inhibitor	N-octadecyl-N'-propylsulfamide
TTDS00334	Inhibitor	NABILONE
TTDS00334	Inhibitor	NAPHTHYRIDINONE
TTDS00334	Inhibitor	OLEOYLETHANOLAMIDE
TTDS00334	Inhibitor	PARAOXON
TTDS00334	Inhibitor	PRAVADOLINE
TTDS00334	Inhibitor	RIMONABANT HYDROCHLORIDE
TTDS00334	Inhibitor	SCH-356036
TTDS00334	Inhibitor	SEMIPLENAMIDE A
TTDS00334	Inhibitor	SEMIPLENAMIDE B
TTDS00334	Inhibitor	SR-144,528
TTDS00334	Inhibitor	SR-147778
TTDS00334	Inhibitor	Semiplenamide G
TTDS00334	Inhibitor	TETRAHYDROLIPSTATIN
TTDS00334	Inhibitor	VER-156084
TTDS00334	Inhibitor	VER-156085
TTDS00334	Inhibitor	VER-24052
TTDS00334	Inhibitor	WIN-55212-2
TTDS00334	Inhibitor	cis-N-oleoylcyclopropanolamide
TTDS00334	Inhibitor	diethyl 3,5,6-trichloropyridin-2-yl phosphate
TTDS00334	Inhibitor	dodecane-1-sulfonyl fluoride
TTDS00334	Inhibitor	methyl icosylphosphonofluoridate
TTDS00334	Inhibitor	octane-1-sulfonyl fluoride
TTDS00334	Antagonist	AM-251
TTDS00334	Antagonist	AM251
TTDS00334	Antagonist	AVE1625
TTDS00334	Antagonist	AZD1175
TTDS00334	Antagonist	AZD1704
TTDS00334	Antagonist	AZD2207
TTDS00334	Antagonist	CB1 antagonist
TTDS00334	Antagonist	CBD cannabis derivative
TTDS00334	Antagonist	CP-945598
TTDS00334	Antagonist	Methanandamide
TTDS00334	Antagonist	Rimonabant
TTDS00334	Antagonist	Rimonbant
TTDS00334	Antagonist	SLV-319
TTDS00334	Antagonist	SR141716A
TTDS00334	Antagonist	TM38837
TTDS00334	Antagonist	Taranabant
TTDS00334	Antagonist	Tebipenem
TTDS00334	Antagonist	ZY01
TTDS00334	Agonist	ACEA
TTDS00334	Agonist	AZD1940
TTDS00334	Agonist	Anandamide
TTDS00334	Agonist	Delta(9)-tetrahydrocannabinol
TTDS00334	Agonist	Dianicline+rimonabant
TTDS00334	Agonist	HU210
TTDS00334	Agonist	JD-5037
TTDS00334	Agonist	KDS-2000
TTDS00334	Agonist	Marinol
TTDS00334	Multitarget	SLV-319
TTDS00336	UniProt ID	P02768
TTDS00336	Name	Serum albumin
TTDS00336	Type of target	Successful target
TTDS00336	Disease	Inflammatory diseases
TTDS00336	Function	Serum albumin, the main protein of plasma, has a good binding capacity for water
TTDS00336	Sequence	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVAD
TTDS00336	PDB Structure	1AO6; 1BJ5; 1BKE; 1BM0; 1E78; 1E7A; 1E7B; 1E7C; 1E7E; 1E7F; 1E7G; 1E7H; 1E7I; 1G
TTDS00336	Target Validation	TTDS00336
TTDS00336	Drug(s)	Bismuth
TTDS00336	Drug(s)	Ebselen
TTDS00336	Drug(s)	Gadobenate Dimeglumine
TTDS00336	Drug(s)	Iodipamide
TTDS00336	Drug(s)	Sodium lauryl sulfate
TTDS00336	Binder	Bismuth
TTDS00336	Binder	Ebselen
TTDS00336	Binder	Gadobenate Dimeglumine
TTDS00336	Binder	Iodipamide
TTDS00336	Binder	Sodium lauryl sulfate
TTDS00337	UniProt ID	P35228
TTDS00337	Name	Nitric oxide synthase, inducible
TTDS00337	Type of target	Successful target
TTDS00337	Synonyms	HEP-NOS
TTDS00337	Synonyms	Hepatocyte NOS
TTDS00337	Synonyms	INOS
TTDS00337	Synonyms	Inducible NOS
TTDS00337	Synonyms	Inducible nitric oxide synthase
TTDS00337	Synonyms	NOS, type II
TTDS00337	Disease	Ischemia reperfusion injuries
TTDS00337	Function	Produces nitric oxide (no) which is a messenger molecule with diverse functions
TTDS00337	Sequence	MACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLSKQQNESPQPLVETGKKSPESLVKLDATPLS
TTDS00337	PDB Structure	1NSI; 2LL6; 2NSI; 3E7G; 3EJ8; 3HR4; 4NOS
TTDS00337	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00337	Pathway	Alzheimer's disease
TTDS00337	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDS00337	Pathway	Arginine and proline metabolism
TTDS00337	Pathway	Calcium signaling pathway
TTDS00337	Pathway	Long-term depression
TTDS00337	Pathway	Metabolic pathways
TTDS00337	Pathway	Pathways in cancer
TTDS00337	Pathway	Small cell lung cancer
TTDS00337	EC Number	EC 1.14.13.39
TTDS00337	Related US Patent	6,225,305
TTDS00337	Related US Patent	6,297,276
TTDS00337	Related US Patent	6,344,473
TTDS00337	Related US Patent	6,344,483
TTDS00337	Related US Patent	6,355,689
TTDS00337	Related US Patent	6,362,195
TTDS00337	Related US Patent	6,372,733
TTDS00337	Related US Patent	6,391,887
TTDS00337	Related US Patent	6,403,830
TTDS00337	Related US Patent	6,410,542
TTDS00337	Related US Patent	6,451,821
TTDS00337	Related US Patent	6,465,518
TTDS00337	Related US Patent	6,465,686
TTDS00337	Related US Patent	6,495,544
TTDS00337	Related US Patent	6,495,606
TTDS00337	Related US Patent	6,525,051
TTDS00337	Related US Patent	6,545,170
TTDS00337	Related US Patent	6,552,052
TTDS00337	Related US Patent	6,576,780
TTDS00337	Related US Patent	6,579,883
TTDS00337	Related US Patent	6,586,471
TTDS00337	Related US Patent	6,586,474
TTDS00337	Related US Patent	6,620,848
TTDS00337	Related US Patent	6,670,473
TTDS00337	Target Validation	TTDS00337
TTDS00337	Drug(s)	Hydrocortisone
TTDS00337	Inhibitor	((E)-7-But-2-enyl)-azepan-(2Z)-ylideneamine
TTDS00337	Inhibitor	(4S,5R)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	(4S,5R)-4,5-Dimethyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	(4S,5R)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	(4S,5S)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	(4S,5S)-4,5-Dipropyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	(5-Imino-[1,4]thiazepan-3-yl)-methanol
TTDS00337	Inhibitor	(5S,6R)-[Octahydro-quinolin-(2E)-ylidene]amine
TTDS00337	Inhibitor	(5S,6S)-[Octahydro-quinolin-(2E)-ylidene]amine
TTDS00337	Inhibitor	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
TTDS00337	Inhibitor	(E)-4-Methyl-6-(prop-1-enyl)pyridin-2-amine
TTDS00337	Inhibitor	(R)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	(S)-2-Amino-5-(N-methyl-guanidino)-pentanoic acid
TTDS00337	Inhibitor	(S)-2-Amino-6-[(E)-ethylimino]-hexanoic acid
TTDS00337	Inhibitor	(S)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	(S)-6-Amino-2-(2-imino-ethylamino)-hexanoic acid
TTDS00337	Inhibitor	(S)-N-(1-phenylethyl)acetimidamide hydrobromide
TTDS00337	Inhibitor	1-(6-Amino-4-methylpyridin-2-yl)propan-2-ol
TTDS00337	Inhibitor	2-(2-Amino-ethyl)-7-imino-azepane
TTDS00337	Inhibitor	2-Amino-5-(N-nitro-guanidino)-pentanoic acid
TTDS00337	Inhibitor	2-Methyl-[1,4]thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	3,4-Dihydro-1H-quinolin-(2E)-ylideneamine
TTDS00337	Inhibitor	3,4-Dimethyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	3-(2-Amino-ethyl)-5-imino-[1,4]oxazepane
TTDS00337	Inhibitor	3-(2-Nitro-ethyl)-[1,4]oxazepan-(5Z)-ylideneamine
TTDS00337	Inhibitor	3-Bromo-1H-indazole-7-carbonitrile
TTDS00337	Inhibitor	3-Bromo-7-Nitroindazole
TTDS00337	Inhibitor	3-Butyl-[1,4]oxazepan-(5Z)-ylideneamine
TTDS00337	Inhibitor	3-Butyl-[1,4]thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	3-Ethyl-[1,4]thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	3-Isobutyl-[1,4]thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	3-Methyl-[1,4]thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	3-Methyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	3-Propyl-[1,4]thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	3-bromo-7-nitro-1H-indazole
TTDS00337	Inhibitor	4,5,6,7-tetrafluoro-3-methyl-1H-indazole
TTDS00337	Inhibitor	4,5,6,7-tetrafluoro-3-perfluorophenyl-1H-indazole
TTDS00337	Inhibitor	4,5-Dimethyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	4-(1H-IMIDAZOL-1-YL)PHENOL
TTDS00337	Inhibitor	4-Butyl-thiazolidin-(2E)-ylideneamine
TTDS00337	Inhibitor	4-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	4-Ethyl-5-methyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	4-Ethyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	4-Ethyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	4-Isopropyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	4-Methyl-5-propyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	4-Methyl-6-(2-methylprop-1-enyl)pyridin-2-amine
TTDS00337	Inhibitor	4-Methyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	4-Methyl-piperidin-(2E)-ylideneamine
TTDS00337	Inhibitor	4-Methyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	4-[(2-Methyl-1H-imidazol-1-yl)methyl]pyridine
TTDS00337	Inhibitor	4-methyl-6-propylpyridin-2-amine
TTDS00337	Inhibitor	4-methylpyridin-2-amine
TTDS00337	Inhibitor	4r-Fluoro-N6-Ethanimidoyl-L-Lysine
TTDS00337	Inhibitor	5-Bromomethyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	5-Ethyl-4-methyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	5-Ethyl-4-propyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	5-Ethyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	5-Methyl-4-propyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	5-Methyl-oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	5-Methyl-pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	5-Nitroindazole
TTDS00337	Inhibitor	6-(2-Fluoropropyl)-4-methylpyridin-2-amine
TTDS00337	Inhibitor	6-(3-Fluoropropyl)-4-methylpyridin-2-amine
TTDS00337	Inhibitor	6-(4-Fluorobutyl)-4-methylpyridin-2-amine
TTDS00337	Inhibitor	6-Nitroindazole
TTDS00337	Inhibitor	6-isobutyl-4-methylpyridin-2-amine
TTDS00337	Inhibitor	6-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine
TTDS00337	Inhibitor	7,8-Dihydro-L-Biopterin
TTDS00337	Inhibitor	7,8-dihydrobiopterin
TTDS00337	Inhibitor	7-(2-Nitro-ethyl)-azepan-(2Z)-ylideneamine
TTDS00337	Inhibitor	7-Butyl-azepan-(2Z)-ylideneamine
TTDS00337	Inhibitor	7-Methyl-[1,4]thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	7-Nitroindazole
TTDS00337	Inhibitor	7-nitro-1H-indazole
TTDS00337	Inhibitor	AMINOTHIAZOLINE
TTDS00337	Inhibitor	AR-C102222
TTDS00337	Inhibitor	AR-C133057XX
TTDS00337	Inhibitor	Aminoguanidine
TTDS00337	Inhibitor	Azepan-(2Z)-ylideneamine
TTDS00337	Inhibitor	Azocan-(2Z)-ylideneamine
TTDS00337	Inhibitor	Azonan-(2Z)-ylideneamine
TTDS00337	Inhibitor	B-Octylglucoside
TTDS00337	Inhibitor	CDDO
TTDS00337	Inhibitor	CURCUMIN
TTDS00337	Inhibitor	Ethylisothiourea
TTDS00337	Inhibitor	Heme
TTDS00337	Inhibitor	Hexahydro-cyclopenta[c]pyrrol-(1Z)-ylideneamine
TTDS00337	Inhibitor	Hydrocortisone
TTDS00337	Inhibitor	Imidazole
TTDS00337	Inhibitor	L-NIO
TTDS00337	Inhibitor	L-Nw-nitroarginine
TTDS00337	Inhibitor	L-Thiocitrulline
TTDS00337	Inhibitor	N,N-dimethylarginine
TTDS00337	Inhibitor	N-(3-(Aminomethyl)Benzyl)Acetamidine
TTDS00337	Inhibitor	N-(3-(aminomethyl)-benzyl)acetamidine
TTDS00337	Inhibitor	N-(5-Amino-6-oxo-heptyl)-acetamidine
TTDS00337	Inhibitor	N-Omega-Hydroxy-L-Arginine
TTDS00337	Inhibitor	N-Omega-Propyl-L-Arginine
TTDS00337	Inhibitor	N-benzylacetimidamide hydrobromide
TTDS00337	Inhibitor	N-omega-allyl-L-arginine
TTDS00337	Inhibitor	N-omega-propargyl-L-arginine
TTDS00337	Inhibitor	N5-(1-iminobut-3-enyl)-L-ornithine
TTDS00337	Inhibitor	N5-(1-iminobutyl)-L-ornithine
TTDS00337	Inhibitor	N5-(1-iminopropyl)-L-ornithine
TTDS00337	Inhibitor	ONO-1714
TTDS00337	Inhibitor	Octahydro-isoindol-(1Z)-ylideneamine
TTDS00337	Inhibitor	Oxazolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	Piperidin-(2E)-ylideneamine
TTDS00337	Inhibitor	Pyrrolidin-(2Z)-ylideneamine
TTDS00337	Inhibitor	Resveratrol Potassium4,-Sulfate
TTDS00337	Inhibitor	S-Ethylisothiourea
TTDS00337	Inhibitor	THIOCITRULLINE
TTDS00337	Inhibitor	Thiazolidin-(2E)-ylideneamine
TTDS00337	Inhibitor	Thiocoumarin
TTDS00337	Inhibitor	[1,3]Oxazinan-(2E)-ylideneamine
TTDS00337	Inhibitor	[1,3]Thiazinan-(2E)-ylideneamine
TTDS00337	Inhibitor	[1,4]Oxazepan-(3E)-ylideneamine
TTDS00337	Inhibitor	[1,4]Oxazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	[1,4]Thiazepan-(3E)-ylideneamine
TTDS00337	Inhibitor	[1,4]Thiazepan-(5E)-ylideneamine
TTDS00337	Inhibitor	[1,5]Thiazocan-(4E)-ylideneamine
TTDS00337	Inhibitor	l-NIL
TTDS00338	UniProt ID	P37231
TTDS00338	Name	Peroxisome proliferator activated receptor gamma
TTDS00338	Type of target	Successful target
TTDS00338	Synonyms	PPAR-gamma
TTDS00338	Synonyms	PPARgamma
TTDS00338	Synonyms	Transcription factor PPAR gamma receptor
TTDS00338	Disease	Adrenocorticotrophic hormone-secreting pituitary tumors
TTDS00338	Disease	Asthma
TTDS00338	Disease	Atherosclerosis
TTDS00338	Disease	Atopic dermatitis
TTDS00338	Disease	Autoimmune diseases
TTDS00338	Disease	Bladder cancer
TTDS00338	Disease	Chronic inflammatory diseases
TTDS00338	Disease	Crohn's disease, unspecified
TTDS00338	Disease	Diabetes mellitus
TTDS00338	Disease	Inflammation
TTDS00338	Disease	Inflammatory bowel disease
TTDS00338	Disease	Insulin resistance
TTDS00338	Disease	Ischemic heart disease
TTDS00338	Disease	Multiple sclerosis
TTDS00338	Disease	Obesity
TTDS00338	Disease	Pancreatic cancer
TTDS00338	Disease	Psoriasis
TTDS00338	Disease	Renal cell carcinoma
TTDS00338	Disease	Testicular cancer
TTDS00338	Disease	Thyroid follicular carcinoma
TTDS00338	Disease	Ulcerative colitis
TTDS00338	Function	Receptor that bind peroxisome proliferators such as hypolipidemic drugs and fatt
TTDS00338	Sequence	MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYED
TTDS00338	PDB Structure	1FM6; 1FM9; 1I7I; 1K74; 1KNU; 1NYX; 1PRG; 1RDT; 1WM0; 1ZEO; 1ZGY; 2ATH; 2F4B; 2F
TTDS00338	BioChemical Class	Zinc-finger
TTDS00338	Related US Patent	6,403,656
TTDS00338	Related US Patent	6,462,046
TTDS00338	Related US Patent	6,498,174
TTDS00338	Related US Patent	6,646,008
TTDS00338	Target Validation	TTDS00338
TTDS00338	QSAR Model	TTDS00338
TTDS00338	Drug(s)	CS-7017
TTDS00338	Drug(s)	DB 959
TTDS00338	Drug(s)	DS-6930
TTDS00338	Drug(s)	DSP-8658
TTDS00338	Drug(s)	GSK-677954
TTDS00338	Drug(s)	Genistein
TTDS00338	Drug(s)	INT131
TTDS00338	Drug(s)	Netoglitazone
TTDS00338	Drug(s)	Pioglitazone
TTDS00338	Drug(s)	Rosiglitazone
TTDS00338	Drug(s)	Rosiglitazone & metformin
TTDS00338	Drug(s)	Rosiglitazone & simvastatin
TTDS00338	Drug(s)	Rosiglitazone XR
TTDS00338	Drug(s)	Troglitazone
TTDS00338	Inhibitor	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid
TTDS00338	Inhibitor	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid
TTDS00338	Inhibitor	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid
TTDS00338	Inhibitor	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid
TTDS00338	Inhibitor	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid
TTDS00338	Inhibitor	2-chloro-5-nitro-N-phenylbenzamide
TTDS00338	Inhibitor	3-(5-methoxy-1H-indol-3-yl)propanoic acid
TTDS00338	Inhibitor	TESAGLITAZAR
TTDS00338	Agonist	15-deoxy-Delta(12, 14)-prostaglandin J(2)
TTDS00338	Agonist	Ciglitazone
TTDS00338	Agonist	GSK-677954
TTDS00338	Agonist	GW7845
TTDS00338	Agonist	Genistein
TTDS00338	Agonist	Glitazone
TTDS00338	Agonist	Netoglitazone
TTDS00338	Agonist	Pioglitazone
TTDS00338	Agonist	Rosiglitazone
TTDS00338	Agonist	Rosiglitazone & metformin
TTDS00338	Agonist	Rosiglitazone & simvastatin
TTDS00338	Agonist	Rosiglitazone XR
TTDS00338	Agonist	Thiazolidinedione
TTDS00338	Agonist	Troglitazone
TTDS00338	Ligand	PCG1
TTDS00338	Multitarget	GSK-677954
TTDS00338	Multitarget	Netoglitazone
TTDS00339	Name	Vascular endothelial growth factor
TTDS00339	Type of target	Successful target
TTDS00339	Synonyms	VEGF
TTDS00339	Synonyms	Vascular endothelial cell growth factor
TTDS00339	Disease	Breast cancer
TTDS00339	Disease	Cancer, unspecific
TTDS00339	Disease	Ischemic heart disease
TTDS00339	Disease	Joint disorders
TTDS00339	Disease	Proliferative retinopathy
TTDS00339	Disease	Renal cell carcinoma
TTDS00339	Disease	Rheumatoid arthritis, unspecified
TTDS00339	Disease	Superficial bladder tumors
TTDS00339	Pathway	Bladder cancer
TTDS00339	Pathway	Cytokine-cytokine receptor interaction
TTDS00339	Pathway	Focal adhesion
TTDS00339	Pathway	Pancreatic cancer
TTDS00339	Pathway	Pathways in cancer
TTDS00339	Pathway	Renal cell carcinoma
TTDS00339	Pathway	mTOR signaling pathway
TTDS00339	Target Validation	TTDS00339
TTDS00339	Drug(s)	AT001/r84
TTDS00339	Drug(s)	Avastin+/-Tarceva
TTDS00339	Drug(s)	Bevacizumab
TTDS00339	Drug(s)	Bevacizumab+Erlotinib
TTDS00339	Drug(s)	Bevacizumab+Rituximab
TTDS00339	Drug(s)	Bevacizumab+Trastuzumab
TTDS00339	Drug(s)	Cand 5
TTDS00339	Drug(s)	Erlotinib+Bevacizumab
TTDS00339	Drug(s)	PTC299
TTDS00339	Drug(s)	Pegaptanib
TTDS00339	Drug(s)	SU5416
TTDS00339	Drug(s)	TAK-593
TTDS00339	Drug(s)	VEGF Trap
TTDS00339	Drug(s)	Veglin
TTDS00339	Inhibitor	Avastin+/-Tarceva
TTDS00339	Inhibitor	BIBF100
TTDS00339	Inhibitor	Bevacizumab+Erlotinib
TTDS00339	Inhibitor	Bevacizumab+Rituximab
TTDS00339	Inhibitor	Bevacizumab+Trastuzumab
TTDS00339	Inhibitor	Cand 5
TTDS00339	Inhibitor	PTC299
TTDS00339	Inhibitor	SU5416
TTDS00339	Inhibitor	TAK-593
TTDS00339	Inhibitor	VEGF Trap
TTDS00339	Antibody	AT001/r84
TTDS00339	Antibody	Bevacizumab
TTDS00339	Antibody	Erlotinib+Bevacizumab
TTDS00339	Multitarget	Bevacizumab+Erlotinib
TTDS00339	Multitarget	Bevacizumab+Rituximab
TTDS00339	Multitarget	Bevacizumab+Trastuzumab
TTDS00339	Multitarget	Erlotinib+Bevacizumab
TTDS00339	Multitarget	TAK-593
TTDS00339	Aptamer	Pegaptanib
TTDS00340	UniProt ID	Q07869
TTDS00340	Name	Peroxisome proliferator activated receptor alpha
TTDS00340	Type of target	Successful target
TTDS00340	Synonyms	PPAR-alpha
TTDS00340	Synonyms	PPARalpha
TTDS00340	Synonyms	Peroxisome proliferater-activated receptor alpha
TTDS00340	Disease	Hyperglycemia
TTDS00340	Disease	Hyperinsulinemia
TTDS00340	Disease	Insulin resistance
TTDS00340	Disease	Lipid metabolic disorders
TTDS00340	Disease	Obesity
TTDS00340	Function	Receptor that bind peroxisome proliferators such as hypolipidemic drugs and fatt
TTDS00340	Sequence	MVDTESPLCPLSPLEAGDLESPLSEEFLQEMGNIQEISQSIGEDSSGSFGFTEYQYLGSCPGSDGSVITDTLSPASSPSS
TTDS00340	PDB Structure	1I7G; 1K7L; 1KKQ; 2NPA; 2P54; 2REW; 2ZNN; 3ET1; 3FEI; 3G8I; 3KDT; 3KDU; 3SP6; 3V
TTDS00340	BioChemical Class	Zinc-finger
TTDS00340	Pathway	Adipocytokine signaling pathway
TTDS00340	Pathway	PPAR signaling pathway
TTDS00340	Related US Patent	6,498,174
TTDS00340	Related US Patent	6,506,797
TTDS00340	Related US Patent	6,518,290
TTDS00340	Related US Patent	R,E37,,77
TTDS00340	Target Validation	TTDS00340
TTDS00340	QSAR Model	TTDS00340
TTDS00340	Drug(s)	AD-4833
TTDS00340	Drug(s)	AVE0897
TTDS00340	Drug(s)	Aleglitazar
TTDS00340	Drug(s)	Bezafibrate
TTDS00340	Drug(s)	Ciprofibrate
TTDS00340	Drug(s)	Fenofibrate
TTDS00340	Drug(s)	GSK-677954
TTDS00340	Drug(s)	Netoglitazone
TTDS00340	Drug(s)	SAR351034
TTDS00340	Inhibitor	(9Z,12E)-12-nitrooctadeca-9,12-dienoic acid
TTDS00340	Inhibitor	(E)-12-Nitrooctadec-12-enoic Acid
TTDS00340	Inhibitor	(E)-13-Nitrooctadec-12-enoic Acid
TTDS00340	Inhibitor	BMS-687453
TTDS00340	Inhibitor	Deoxy-Bigchap
TTDS00340	Inhibitor	FARGLITAZAR
TTDS00340	Inhibitor	GSK-9578
TTDS00340	Inhibitor	GW-501516
TTDS00340	Inhibitor	KRP-297
TTDS00340	Inhibitor	L-165461
TTDS00340	Inhibitor	L-796449
TTDS00340	Inhibitor	MURAGLITAZAR
TTDS00340	Inhibitor	PIRINIXIC ACID
TTDS00340	Inhibitor	Ragaglitazar
TTDS00340	Inhibitor	TESAGLITAZAR
TTDS00340	Agonist	AVE0897
TTDS00340	Agonist	Aleglitazar
TTDS00340	Agonist	Bezafibrate
TTDS00340	Agonist	Ciprofibrate
TTDS00340	Agonist	Fenofibrate
TTDS00340	Agonist	Fibrates
TTDS00340	Agonist	GSK-677954
TTDS00340	Agonist	GW9578
TTDS00340	Agonist	Netoglitazone
TTDS00340	Agonist	SAR351034
TTDS00340	Ligand	AD-4833
TTDS00340	Multitarget	GSK-677954
TTDS00340	Multitarget	Netoglitazone
TTDS00341	UniProt ID	P27338
TTDS00341	Name	Amine oxidase [flavin-containing] B
TTDS00341	Type of target	Successful target
TTDS00341	Synonyms	MAO-B
TTDS00341	Synonyms	Monoamine oxidase
TTDS00341	Synonyms	Monoamine oxidase B
TTDS00341	Disease	Major depressive disorder
TTDS00341	Disease	Neurological diseases
TTDS00341	Disease	Parkinson's disease
TTDS00341	Function	Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has im
TTDS00341	Sequence	MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETY
TTDS00341	PDB Structure	1GOS; 1H8R; 1OJ9; 1OJA; 1OJC; 1OJD; 1S2Q; 1S2Y; 1S3B; 1S3E; 2BK3; 2BK4; 2BK5; 2B
TTDS00341	BioChemical Class	Oxidoreductases acting on the CH-NH2 group of donors
TTDS00341	Pathway	Arginine and proline metabolism
TTDS00341	Pathway	Drug metabolism - cytochrome P450
TTDS00341	Pathway	Glycine, serine and threonine metabolism
TTDS00341	Pathway	Histidine metabolism
TTDS00341	Pathway	Metabolic pathways
TTDS00341	Pathway	Phenylalanine metabolism
TTDS00341	Pathway	Tryptophan metabolism
TTDS00341	Pathway	Tyrosine metabolism
TTDS00341	EC Number	EC 1.4.3.4
TTDS00341	Related US Patent	6,432,991
TTDS00341	Related US Patent	6,569,470
TTDS00341	Related US Patent	6,635,667
TTDS00341	Target Validation	TTDS00341
TTDS00341	Drug(s)	CHF-3381
TTDS00341	Drug(s)	PF9601N
TTDS00341	Drug(s)	Pargyline
TTDS00341	Drug(s)	Phenelzine
TTDS00341	Drug(s)	RG1577
TTDS00341	Drug(s)	Rasagiline
TTDS00341	Drug(s)	Safinamide
TTDS00341	Drug(s)	Selegiline
TTDS00341	Drug(s)	Tranylcypromine
TTDS00341	Inhibitor	(E)-5-Styrylisatin
TTDS00341	Inhibitor	(E)-6-Styrylisatin
TTDS00341	Inhibitor	(R/R)BEFLOXATONE
TTDS00341	Inhibitor	1H-Indole-2,3-dione
TTDS00341	Inhibitor	2-BFi
TTDS00341	Inhibitor	7-Methoxy-9H-beta-carboline
TTDS00341	Inhibitor	8-(3-Bromobenzyloxy)caffeine
TTDS00341	Inhibitor	8-(3-Chlorobenzyloxy)caffeine
TTDS00341	Inhibitor	8-(3-Fluorobenzyloxy)caffeine
TTDS00341	Inhibitor	8-(3-Methoxybenzyloxy)caffeine
TTDS00341	Inhibitor	8-(3-Methylbenzyloxy)caffeine
TTDS00341	Inhibitor	8-Benzyloxycaffeine
TTDS00341	Inhibitor	8-[(3-Trifluoromethyl)benzyloxy]caffeine
TTDS00341	Inhibitor	AS-605240
TTDS00341	Inhibitor	CGS-19281A
TTDS00341	Inhibitor	CHALCONE
TTDS00341	Inhibitor	CHF-3381
TTDS00341	Inhibitor	CORDOIN
TTDS00341	Inhibitor	Deprenyl
TTDS00341	Inhibitor	Farnesol
TTDS00341	Inhibitor	Flavin-Adenine Dinucleotide
TTDS00341	Inhibitor	HYDRAZINECARBOXAMIDE
TTDS00341	Inhibitor	Heptyl-methyl-prop-2-ynyl-amine; hydrochloride
TTDS00341	Inhibitor	IPRONIAZIDE
TTDS00341	Inhibitor	Isatin
TTDS00341	Inhibitor	Isopsoralen
TTDS00341	Inhibitor	L-136662
TTDS00341	Inhibitor	LAZEBEMIDE
TTDS00341	Inhibitor	Lauryl Dimethylamine-N-Oxide
TTDS00341	Inhibitor	MOFEGILINE
TTDS00341	Inhibitor	Methyl piperate
TTDS00341	Inhibitor	NSC-50187
TTDS00341	Inhibitor	NSC-50393
TTDS00341	Inhibitor	NSC-93405
TTDS00341	Inhibitor	PF9601N
TTDS00341	Inhibitor	PIPERINE
TTDS00341	Inhibitor	PNU-22394
TTDS00341	Inhibitor	Pargyline
TTDS00341	Inhibitor	Phenelzine
TTDS00341	Inhibitor	Psoralen
TTDS00341	Inhibitor	RS-1636
TTDS00341	Inhibitor	RS-1653
TTDS00341	Inhibitor	Rasagiline
TTDS00341	Inhibitor	Safinamide
TTDS00341	Inhibitor	Selegiline
TTDS00341	Inhibitor	TOLOXATONE
TTDS00341	Inhibitor	TRACIZOLINE
TTDS00341	Inhibitor	TRYPTAMINE
TTDS00341	Inhibitor	TRYPTOLINE
TTDS00341	Inhibitor	Tranylcypromine
TTDS00341	Inhibitor	Zydis selegiline
TTDS00341	Antagonist	4-Methoxyamphetamine
TTDS00341	Antagonist	MMDA
TTDS00341	Multitarget	CHF-3381
TTDS00341	Multitarget	Tranylcypromine
TTDS00342	UniProt ID	P13716
TTDS00342	Name	Delta-aminolevulinic acid dehydratase
TTDS00342	Type of target	Successful target
TTDS00342	Synonyms	ALAD
TTDS00342	Synonyms	ALADH
TTDS00342	Synonyms	Delta-aminolevulinate dehydratase
TTDS00342	Synonyms	Porphobilinogen synthase
TTDS00342	Disease	Malaria
TTDS00342	Sequence	MQPQSVLHSGYFHPLLRAWQTATTTLNASNLIYPIFVTDVPDDIQPITSLPGVARYGVKRLEEMLRPLVEEGLRCVLIFG
TTDS00342	PDB Structure	1E51; 1PV8
TTDS00342	BioChemical Class	Carbon-oxygen lyases
TTDS00342	Pathway	Metabolic pathways
TTDS00342	Pathway	Porphyrin and chlorophyll metabolism
TTDS00342	EC Number	EC 4.2.1.24
TTDS00342	Drug(s)	Aminolevulinic acid
TTDS00342	Inhibitor	3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid
TTDS00342	Inhibitor	4,7-Dioxosebacic Acid
TTDS00342	Inhibitor	4-Oxosebacic Acid
TTDS00342	Inhibitor	5-Fluorolevulinic Acid
TTDS00342	Inhibitor	5-hydroxyvaleric acid
TTDS00342	Inhibitor	Aminolevulinic acid
TTDS00342	Inhibitor	Beta-Mercaptoethanol
TTDS00342	Inhibitor	Delta-Amino Valeric Acid
TTDS00342	Inhibitor	Formic Acid
TTDS00342	Inhibitor	Laevulinic Acid
TTDS00342	Inhibitor	Levulinic Acid
TTDS00342	Inhibitor	Porphobilinogen
TTDS00342	Inhibitor	S,S-(2-Hydroxyethyl)Thiocysteine
TTDS00346	UniProt ID	P15056
TTDS00346	Name	B-Raf proto-oncogene serine/threonine-protein kinase
TTDS00346	Type of target	Successful target
TTDS00346	Synonyms	B-Raf
TTDS00346	Synonyms	B-raf protein
TTDS00346	Synonyms	BRAF
TTDS00346	Synonyms	BRAF serine/threonine kinase
TTDS00346	Synonyms	BRAF(V599E)
TTDS00346	Synonyms	P94
TTDS00346	Synonyms	V-Raf murine sarcoma viral oncogene homolog B1
TTDS00346	Disease	Malignant melanoma
TTDS00346	Disease	Melanoma
TTDS00346	Disease	Pancreatic cancer
TTDS00346	Function	Involved in the transduction of mitogenic signals from the cell membrane to the
TTDS00346	Sequence	MAALSGGGGGGAEPGQALFNGDMEPEAGAGAGAAASSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLE
TTDS00346	PDB Structure	1UWH; 1UWJ; 2FB8; 2L05; 3C4C; 3D4Q; 3IDP; 3II5; 3NY5; 3OG7; 3PPJ; 3PPK; 3PRF; 3P
TTDS00346	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00346	Pathway	Acute myeloid leukemia
TTDS00346	Pathway	Bladder cancer
TTDS00346	Pathway	Chemokine signaling pathway
TTDS00346	Pathway	Chronic myeloid leukemia
TTDS00346	Pathway	Colorectal cancer
TTDS00346	Pathway	Endometrial cancer
TTDS00346	Pathway	ErbB signaling pathway
TTDS00346	Pathway	Focal adhesion
TTDS00346	Pathway	Glioma
TTDS00346	Pathway	Insulin signaling pathway
TTDS00346	Pathway	Long-term depression
TTDS00346	Pathway	Long-term potentiation
TTDS00346	Pathway	MAPK signaling pathway
TTDS00346	Pathway	Melanoma
TTDS00346	Pathway	Natural killer cell mediated cytotoxicity
TTDS00346	Pathway	Non-small cell lung cancer
TTDS00346	Pathway	Pancreatic cancer
TTDS00346	Pathway	Pathways in cancer
TTDS00346	Pathway	Prostate cancer
TTDS00346	Pathway	Regulation of actin cytoskeleton
TTDS00346	Pathway	Renal cell carcinoma
TTDS00346	Pathway	Thyroid cancer
TTDS00346	Pathway	Vascular smooth muscle contraction
TTDS00346	Pathway	mTOR signaling pathway
TTDS00346	EC Number	EC 2.7.1.37
TTDS00346	Target Validation	TTDS00346
TTDS00346	Drug(s)	ARQ 736
TTDS00346	Drug(s)	BMS-908662
TTDS00346	Drug(s)	Dabrafenib
TTDS00346	Drug(s)	GSK2118436
TTDS00346	Drug(s)	PLX4032
TTDS00346	Drug(s)	R7204
TTDS00346	Drug(s)	RG7204
TTDS00346	Drug(s)	RG7256
TTDS00346	Drug(s)	RG7421+RG7204
TTDS00346	Drug(s)	Sorafenib
TTDS00346	Drug(s)	Trametinib + dabrafenib
TTDS00346	Drug(s)	Vemurafenib
TTDS00346	Inhibitor	BMS-908662
TTDS00346	Inhibitor	GSK2118436
TTDS00346	Inhibitor	R7204
TTDS00346	Inhibitor	Sorafenib
TTDS00346	Multitarget	Sorafenib
TTDS00347	UniProt ID	P33481
TTDS00347	UniProt ID	P35973
TTDS00347	UniProt ID	Q91MJ9
TTDS00347	Name	Fusion glycoprotein
TTDS00347	Type of target	Successful target
TTDS00347	Synonyms	F protein
TTDS00347	Synonyms	Fusion protein
TTDS00347	Synonyms	MV fusion protein
TTDS00347	Synonyms	Measles virus fusion protein
TTDS00347	Disease	Measles virus infections
TTDS00347	Function	This protein directs fusion of viral and cellular membranes.
TTDS00347	Sequence	MKAFPVICLGFAIFSSSICVNINILQQIGYIKQQVRQLSYYSQSSSSYVVVKLLPNIQPTDNSCEFKSVTQYNKTLSNLL
TTDS00347	BioChemical Class	Transmembrane protein
TTDS00347	Drug(s)	AC 165198
TTDS00347	Drug(s)	AMG 876
TTDS00347	Drug(s)	AZD9639
TTDS00347	Drug(s)	Motavizumab
TTDS00347	Drug(s)	Palivizumab
TTDS00347	Drug(s)	RFI-641
TTDS00347	Drug(s)	VP-14637
TTDS00347	Inhibitor	AZD9639
TTDS00347	Inhibitor	Motavizumab
TTDS00347	Inhibitor	RFI-641
TTDS00347	Inhibitor	VP-14637
TTDS00347	Antibody	Palivizumab
TTDS00348	UniProt ID	P07949
TTDS00348	Name	Proto-oncogene tyrosine-protein kinase receptor ret
TTDS00348	Type of target	Successful target
TTDS00348	Synonyms	C-ret
TTDS00348	Synonyms	RET receptor tyrosine kinase
TTDS00348	Disease	Medullary thyroid carcinoma
TTDS00348	Function	Probable receptor with tyrosine-protein kinase activity; Important for developme
TTDS00348	Sequence	MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRL
TTDS00348	PDB Structure	1XPD; 2IVS; 2IVT; 2IVU; 2IVV; 2X2K; 2X2L; 2X2M; 2X2U
TTDS00348	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00348	Pathway	Pathways in cancer
TTDS00348	Pathway	Thyroid cancer
TTDS00348	EC Number	EC 2.7.1.112
TTDS00348	Target Validation	TTDS00348
TTDS00348	Drug(s)	Sorafenib
TTDS00348	Drug(s)	Vandetanib
TTDS00348	Inhibitor	(E)-3-(4-hydroxybenzylidene)indolin-2-one
TTDS00348	Inhibitor	(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one
TTDS00348	Inhibitor	(Z)-5-Amino-3-(4-methoxybenzylidene)indolin-2-one
TTDS00348	Inhibitor	CEP-751
TTDS00348	Inhibitor	SEMAXINIB
TTDS00348	Inhibitor	SU-11248
TTDS00348	Inhibitor	SU-4984
TTDS00348	Inhibitor	SU-5614
TTDS00348	Inhibitor	SU-6656
TTDS00348	Inhibitor	SU-9516
TTDS00348	Inhibitor	Sorafenib
TTDS00348	Inhibitor	TG-100435
TTDS00348	Inhibitor	Vandetanib
TTDS00348	Multitarget	Sorafenib
TTDS00348	Multitarget	Vandetanib
TTDS00349	Name	Nicotinic acetylcholine receptor alpha subunit
TTDS00349	Type of target	Successful target
TTDS00349	Disease	Muscle contraction
TTDS00349	BioChemical Class	Ion transport
TTDS00349	Drug(s)	Doxacurium
TTDS00349	Antagonist	Doxacurium
TTDS00350	UniProt ID	P00519
TTDS00350	UniProt ID	P42684
TTDS00350	Name	Proto-oncogene tyrosine-protein kinase ABL1
TTDS00350	Type of target	Successful target
TTDS00350	Synonyms	C-ABL
TTDS00350	Synonyms	P150
TTDS00350	Disease	Myeloma disease
TTDS00350	Sequence	MGQQVGRVGEAPGLQQPQPRGIRGSSAARPSGRRRDPAGRTTETGFNIFTQHDHFASCVEDGFEGDKTGGSSPEALHRPY
TTDS00350	PDB Structure	2ECD; 2KK1; 2XYN; 3GVU; 3HMI; 3ULR; 4EIH
TTDS00350	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00350	Pathway	Axon guidance
TTDS00350	Pathway	Cell cycle
TTDS00350	Pathway	Chronic myeloid leukemia
TTDS00350	Pathway	ErbB signaling pathway
TTDS00350	Pathway	Pathogenic Escherichia coli infection
TTDS00350	Pathway	Pathways in cancer
TTDS00350	EC Number	EC 2.7.1.112
TTDS00350	Target Validation	TTDS00350
TTDS00350	Drug(s)	AZD0530
TTDS00350	Drug(s)	Adenosine triphosphate
TTDS00350	Drug(s)	Bosutinib
TTDS00350	Drug(s)	Dasatinib
TTDS00350	Drug(s)	Imatinib
TTDS00350	Drug(s)	Nilotinib
TTDS00350	Inhibitor	(E)-4-(3,5-dimethoxystyryl)phenol
TTDS00350	Inhibitor	3'',5''-dimethoxy-[1,1';2',1'']-terphenyl-4-ol
TTDS00350	Inhibitor	3'',5''-dimethoxy-[1,1';3',1'']-terphenyl-4-ol
TTDS00350	Inhibitor	4,3'',5''-trimethoxy-[1,1';2',1'']-terphenyl
TTDS00350	Inhibitor	4,3'',5''-trimethoxy-[1,1';3',1'']-terphenyl
TTDS00350	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDS00350	Inhibitor	AG-1879
TTDS00350	Inhibitor	AP-24163
TTDS00350	Inhibitor	AP-24226
TTDS00350	Inhibitor	AZD0530
TTDS00350	Inhibitor	Adenosine triphosphate
TTDS00350	Inhibitor	BAS-00387275
TTDS00350	Inhibitor	BAS-00387328
TTDS00350	Inhibitor	BAS-00387347
TTDS00350	Inhibitor	BAS-00672722
TTDS00350	Inhibitor	BAS-01373578
TTDS00350	Inhibitor	BAS-0338872
TTDS00350	Inhibitor	BAS-0338876
TTDS00350	Inhibitor	BAS-09534324
TTDS00350	Inhibitor	Bis-(5-hydroxy-1H-indol-2-yl)-methanone
TTDS00350	Inhibitor	Bosutinib
TTDS00350	Inhibitor	Dasatinib
TTDS00350	Inhibitor	Imatinib
TTDS00350	Inhibitor	JNJ-10198409
TTDS00350	Inhibitor	MYRISTIC ACID
TTDS00350	Inhibitor	Nilotinib
TTDS00350	Inhibitor	PD-0166326;PD-166326
TTDS00350	Inhibitor	PD-0173955;PD-17395
TTDS00350	Inhibitor	PD-0173956
TTDS00350	Inhibitor	SKI-758
TTDS00350	Inhibitor	TG-100435
TTDS00350	Inhibitor	TRISMETHOXYRESVERATROL
TTDS00350	Inhibitor	[1,1';2',1'']-terphenyl-4,3'',5''-triol
TTDS00350	Multitarget	AZD0530
TTDS00350	Multitarget	Bosutinib
TTDS00350	Multitarget	Dasatinib
TTDS00350	Multitarget	Imatinib
TTDS00350	Multitarget	Nilotinib
TTDS00351	UniProt ID	Q14994
TTDS00351	Name	Orphan nuclear receptor NR1I3
TTDS00351	Type of target	Successful target
TTDS00351	Synonyms	CAR
TTDS00351	Synonyms	Constitutive androstane receptor
TTDS00351	Synonyms	NR1I3
TTDS00351	Synonyms	Nuclear receptor CAR
TTDS00351	Synonyms	Orphan nuclear receptor CAR
TTDS00351	Synonyms	Orphan nuclear receptor MB67
TTDS00351	Disease	Neonatal jaundice
TTDS00351	Disease	Obesity
TTDS00351	Function	Binds and transactivates the retinoic acid response elements that control expres
TTDS00351	Sequence	MASREDELRNCVVCGDQATGYHFNALTCEGCKGFFRRTVSKSIGPTCPFAGSCEVSKTQRRHCPACRLQKCLDAGMRKDM
TTDS00351	PDB Structure	1XV9; 1XVP
TTDS00351	BioChemical Class	Zinc-finger
TTDS00351	Drug(s)	Meclizine
TTDS00351	Inhibitor	(5BETA)-PREGNANE-3,20-DIONE
TTDS00351	Inhibitor	16,17-Androstene-3-Ol
TTDS00351	Agonist	TCPOBOP
TTDS00351	Modulator	Meclizine
TTDS00354	Name	Retinoid X receptor
TTDS00354	Type of target	Successful target
TTDS00354	Synonyms	RXR
TTDS00354	Disease	Cancer, unspecific
TTDS00354	Disease	Noninsulin-dependent diabetes mellitus
TTDS00354	Related US Patent	6,316,404
TTDS00354	Related US Patent	6,521,633
TTDS00354	Related US Patent	6,586,455
TTDS00354	Target Validation	TTDS00354
TTDS00354	Drug(s)	Bexarotene
TTDS00354	Drug(s)	Vitamin A
TTDS00354	Agonist	Bexarotene
TTDS00354	Binder	Vitamin A
TTDS00354	Multitarget	Vitamin A
TTDS00355	UniProt ID	P00533
TTDS00355	Name	Epidermal growth factor receptor
TTDS00355	Type of target	Successful target
TTDS00355	Synonyms	EGFR
TTDS00355	Synonyms	EGFR-TK
TTDS00355	Synonyms	Epidermal growth factor receptor ErbB-1
TTDS00355	Synonyms	Epidermal growth factor receptor-tyrosine kinase
TTDS00355	Synonyms	Receptor protein-tyrosine kinase ErbB-1
TTDS00355	Disease	Breast cancer
TTDS00355	Disease	Cancer, unspecific
TTDS00355	Disease	Colorectal cancer
TTDS00355	Disease	Glioblastoma multiforme
TTDS00355	Disease	HCV infection
TTDS00355	Disease	Head and neck tumors
TTDS00355	Disease	Lymphangiomatosis
TTDS00355	Disease	Nonsmall cell lung cancer
TTDS00355	Disease	Ovarian cancer
TTDS00355	Disease	Pancreatic cancer
TTDS00355	Disease	Solid tumor
TTDS00355	Disease	Squamous cell carcinoma
TTDS00355	Disease	Tumors
TTDS00355	Function	Receptor for egf, but also for other members of the egf family, as tgf-alpha, am
TTDS00355	Sequence	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLK
TTDS00355	PDB Structure	1DNQ; 1DNR; 1IVO; 1M14; 1M17; 1MOX; 1NQL; 1XKK; 1YY9; 1Z9I; 2EB2; 2EB3; 2EXP; 2E
TTDS00355	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00355	Pathway	Adherens junction
TTDS00355	Pathway	Bladder cancer
TTDS00355	Pathway	Calcium signaling pathway
TTDS00355	Pathway	Colorectal cancer
TTDS00355	Pathway	Cytokine-cytokine receptor interaction
TTDS00355	Pathway	Endometrial cancer
TTDS00355	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDS00355	Pathway	ErbB signaling pathway
TTDS00355	Pathway	Focal adhesion
TTDS00355	Pathway	Gap junction
TTDS00355	Pathway	Glioma
TTDS00355	Pathway	GnRH signaling pathway
TTDS00355	Pathway	MAPK signaling pathway
TTDS00355	Pathway	Melanoma
TTDS00355	Pathway	Non-small cell lung cancer
TTDS00355	Pathway	Pancreatic cancer
TTDS00355	Pathway	Pathways in cancer
TTDS00355	Pathway	Prostate cancer
TTDS00355	Pathway	Regulation of actin cytoskeleton
TTDS00355	EC Number	EC 2.7.1.112
TTDS00355	Related US Patent	6,551,989
TTDS00355	Related US Patent	6,566,324
TTDS00355	Related US Patent	6,638,543
TTDS00355	Target Validation	TTDS00355
TTDS00355	QSAR Model	TTDS00355
TTDS00355	Drug(s)	ABT-806
TTDS00355	Drug(s)	AMG 595
TTDS00355	Drug(s)	AZD4769
TTDS00355	Drug(s)	Anti-HER3/EGFR DAF
TTDS00355	Drug(s)	BIBW 2992
TTDS00355	Drug(s)	BMS-599626
TTDS00355	Drug(s)	Bevacizumab+Erlotinib
TTDS00355	Drug(s)	CI-1033
TTDS00355	Drug(s)	CO-1686
TTDS00355	Drug(s)	Cetuximab
TTDS00355	Drug(s)	DE-766
TTDS00355	Drug(s)	DWP-401
TTDS00355	Drug(s)	Erlotinib
TTDS00355	Drug(s)	Erlotinib+Bevacizumab
TTDS00355	Drug(s)	Gefitinib
TTDS00355	Drug(s)	HEGF
TTDS00355	Drug(s)	HKI-272
TTDS00355	Drug(s)	Lapatinib
TTDS00355	Drug(s)	MEHD7945A
TTDS00355	Drug(s)	MM-151
TTDS00355	Drug(s)	Necitumumab
TTDS00355	Drug(s)	PF-299804
TTDS00355	Drug(s)	Panitumumab
TTDS00355	Drug(s)	Pazopanib + Tyverb/Tykerb
TTDS00355	Drug(s)	RG7160
TTDS00355	Drug(s)	RG7597
TTDS00355	Drug(s)	Rindopepimut
TTDS00355	Drug(s)	S-222611
TTDS00355	Drug(s)	TAK165
TTDS00355	Drug(s)	Tykerb
TTDS00355	Drug(s)	Tyverb/Tykerb
TTDS00355	Drug(s)	Vandetanib
TTDS00355	Drug(s)	XL647
TTDS00355	Inhibitor	AG-213
TTDS00355	Inhibitor	AG-490
TTDS00355	Inhibitor	AG-538
TTDS00355	Inhibitor	AZD-0530
TTDS00355	Inhibitor	AZD4769
TTDS00355	Inhibitor	BIBW 2992
TTDS00355	Inhibitor	BMS-599626
TTDS00355	Inhibitor	Bevacizumab+Erlotinib
TTDS00355	Inhibitor	CGP-53353
TTDS00355	Inhibitor	CI-1033
TTDS00355	Inhibitor	CL-387785
TTDS00355	Inhibitor	CP-358774
TTDS00355	Inhibitor	Erlotinib
TTDS00355	Inhibitor	Erlotinib+Bevacizumab
TTDS00355	Inhibitor	Flavopiridol
TTDS00355	Inhibitor	Gefitinib
TTDS00355	Inhibitor	HKI-272
TTDS00355	Inhibitor	HTS-00213
TTDS00355	Inhibitor	HTS-02876
TTDS00355	Inhibitor	HTS-05058
TTDS00355	Inhibitor	IMC-C225
TTDS00355	Inhibitor	LAVENDUSTIN A
TTDS00355	Inhibitor	Lapatinib
TTDS00355	Inhibitor	Lapatinib ditosylate
TTDS00355	Inhibitor	NERATINIB
TTDS00355	Inhibitor	OSI-75
TTDS00355	Inhibitor	PD-0166326;PD-166326
TTDS00355	Inhibitor	PD-0173956
TTDS00355	Inhibitor	PD-0180970
TTDS00355	Inhibitor	PD-153035
TTDS00355	Inhibitor	PD-158780
TTDS00355	Inhibitor	PD-168393
TTDS00355	Inhibitor	PD182905
TTDS00355	Inhibitor	PF-299804
TTDS00355	Inhibitor	PKI-166
TTDS00355	Inhibitor	Pazopanib + Tyverb/Tykerb
TTDS00355	Inhibitor	RG-50810
TTDS00355	Inhibitor	Ro-4396686
TTDS00355	Inhibitor	S-222611
TTDS00355	Inhibitor	SKI-758
TTDS00355	Inhibitor	TAK165
TTDS00355	Inhibitor	TYRPHOSTIN AG-1478
TTDS00355	Inhibitor	Tykerb
TTDS00355	Inhibitor	Tyverb/Tykerb
TTDS00355	Inhibitor	VATALANIB
TTDS00355	Inhibitor	Vandetanib
TTDS00355	Inhibitor	XL647
TTDS00355	Inhibitor	cochliobolic acid
TTDS00355	Suppressor	Panitumumab
TTDS00355	Activator	DWP-401
TTDS00355	Activator	HEGF
TTDS00355	Antibody	ABX-EGF
TTDS00355	Antibody	Anti-HER3/EGFR DAF
TTDS00355	Antibody	Cetuximab
TTDS00355	Antibody	EMD 55900
TTDS00355	Antibody	ICR 62
TTDS00355	Multitarget	Anti-HER3/EGFR DAF
TTDS00355	Multitarget	BIBW 2992
TTDS00355	Multitarget	BMS-599626
TTDS00355	Multitarget	Bevacizumab+Erlotinib
TTDS00355	Multitarget	CI-1033
TTDS00355	Multitarget	Erlotinib+Bevacizumab
TTDS00355	Multitarget	HKI-272
TTDS00355	Multitarget	Lapatinib
TTDS00355	Multitarget	Pazopanib + Tyverb/Tykerb
TTDS00355	Multitarget	S-222611
TTDS00355	Multitarget	TAK165
TTDS00355	Multitarget	Tykerb
TTDS00355	Multitarget	Tyverb/Tykerb
TTDS00355	Multitarget	Vandetanib
TTDS00355	Multitarget	XL647
TTDS00357	UniProt ID	O00763
TTDS00357	Name	Acetyl-CoA carboxylase 2
TTDS00357	Type of target	Successful target
TTDS00357	Synonyms	ACC-beta
TTDS00357	Synonyms	ACC2
TTDS00357	Synonyms	ACCbeta
TTDS00357	Synonyms	Acetyl CoA carboxylase beta
TTDS00357	Synonyms	Acetyl-Coenzyme A carboxylase beta
TTDS00357	Disease	Obesity
TTDS00357	Function	Acc-beta may be involved in the provision of malonyl-coa or in the regulation of
TTDS00357	Sequence	MVLLLCLSCLIFSCLTFSWLKIWGKMTDSKPITKSKSEANLIPSQEPFPASDNSGETPQRNGEGHTLPKTPSQAEPASHK
TTDS00357	PDB Structure	2DN8; 2HJW; 2KCC; 3FF6; 3GID; 3GLK; 3JRW; 3JRX; 3TDC
TTDS00357	BioChemical Class	Ligases forming carbon-carbon bonds
TTDS00357	Pathway	Adipocytokine signaling pathway
TTDS00357	Pathway	Fatty acid biosynthesis
TTDS00357	Pathway	Insulin signaling pathway
TTDS00357	Pathway	Metabolic pathways
TTDS00357	Pathway	Propanoate metabolism
TTDS00357	Pathway	Pyruvate metabolism
TTDS00357	EC Number	EC 6.4.1.2
TTDS00357	Target Validation	TTDS00357
TTDS00357	Drug(s)	Metformin
TTDS00357	Inhibitor	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid
TTDS00357	Inhibitor	A-80040
TTDS00357	Inhibitor	Axokine
TTDS00357	Inhibitor	CP-640186
TTDS00357	Inhibitor	Soraphen A
TTDS00357	Activator	Metformin
TTDS00359	UniProt ID	B3V1X5
TTDS00359	UniProt ID	P10613
TTDS00359	UniProt ID	Q16850
TTDS00359	UniProt ID	Q96W81
TTDS00359	Name	Fungal Cytochrome P450 51
TTDS00359	Type of target	Successful target
TTDS00359	Synonyms	CYPL1
TTDS00359	Synonyms	CYPLI
TTDS00359	Synonyms	Cyt P450 14DM
TTDS00359	Synonyms	Cytochrome P-450 lanosterol 14-alpha-demethylase
TTDS00359	Synonyms	Cytochrome P450-dependent lanosterol 14-demethylase
TTDS00359	Synonyms	Erg11p
TTDS00359	Synonyms	LDM
TTDS00359	Synonyms	Lanosterol 14 alpha-demethylase
TTDS00359	Synonyms	Lanosterol 14-alpha demethylase
TTDS00359	Synonyms	P450-14DM
TTDS00359	Synonyms	P450L1
TTDS00359	Synonyms	P450LI
TTDS00359	Synonyms	Sterol 14-alpha demethylase
TTDS00359	Synonyms	Sterol 14alpha-demethylase
TTDS00359	Disease	Oropharyngeal candidiasis
TTDS00359	Function	Catalyzes c14-demethylation of lanosterol; it transforms lanosterol into 4,4'-di
TTDS00359	Sequence	MLLLGLLQAGGSVLGQAMEKVTGGNLLSMLLIACAFTLSLVYLIRLAAGHLVQLPAGVKSPPYIFSPIPFLGHAIAFGKS
TTDS00359	PDB Structure	3JUS; 3JUV; 3LD6
TTDS00359	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00359	Pathway	Biosynthesis of steroids
TTDS00359	Pathway	Metabolic pathways
TTDS00359	EC Number	EC 1.14.13.70
TTDS00359	Target Validation	TTDS00359
TTDS00359	Drug(s)	Bifonazole
TTDS00359	Drug(s)	Butoconazole
TTDS00359	Drug(s)	Econazole
TTDS00359	Drug(s)	Fluconazole
TTDS00359	Drug(s)	Itraconazole
TTDS00359	Drug(s)	Ketoconazole
TTDS00359	Drug(s)	Miconazole
TTDS00359	Drug(s)	Oxiconazole
TTDS00359	Drug(s)	Posaconazole
TTDS00359	Drug(s)	Sertaconazole
TTDS00359	Drug(s)	Terconazole
TTDS00359	Drug(s)	Tioconazole
TTDS00359	Drug(s)	Voriconazole
TTDS00359	Inhibitor	ANALOGUE A
TTDS00359	Inhibitor	Bifonazole
TTDS00359	Inhibitor	Butoconazole
TTDS00359	Inhibitor	CP-320626
TTDS00359	Inhibitor	Econazole
TTDS00359	Inhibitor	Fluconazole
TTDS00359	Inhibitor	Itraconazole
TTDS00359	Inhibitor	Ketoconazole
TTDS00359	Inhibitor	Miconazole
TTDS00359	Inhibitor	Oxiconazole
TTDS00359	Inhibitor	Posaconazole
TTDS00359	Inhibitor	Sertaconazole
TTDS00359	Inhibitor	Terconazole
TTDS00359	Inhibitor	Tioconazole
TTDS00359	Inhibitor	Voriconazole
TTDS00359	Binder	FLC
TTDS00360	UniProt ID	Q13332
TTDS00360	Name	Receptor-type protein-tyrosine phosphatase S
TTDS00360	Type of target	Successful target
TTDS00360	Synonyms	Protein-tyrosine phosphatase sigma
TTDS00360	Synonyms	R-PTP-S
TTDS00360	Synonyms	R-PTP-sigma
TTDS00360	Disease	Osteoporosis, unspecified
TTDS00360	Disease	Paget's disease
TTDS00360	Function	Interacts with lar-interacting protein lip.1.
TTDS00360	Sequence	MAPTWGPGMVSVVGPMGLLVVLLVGGCAAEEPPRFIKEPKDQIGVSGGVASFVCQATGDPKPRVTWNKKGKKVNSQRFET
TTDS00360	PDB Structure	2FH7; 2YD2; 2YD3; 2YD9
TTDS00360	BioChemical Class	Hydrolases acting on ester bonds
TTDS00360	EC Number	EC 3.1.3.48
TTDS00360	Drug(s)	Alendronate
TTDS00360	Drug(s)	Etidronic acid
TTDS00360	Inhibitor	Alendronate
TTDS00360	Inhibitor	Etidronate
TTDS00360	Inhibitor	Etidronic acid
TTDS00360	Inhibitor	Orthovanadate
TTDS00361	UniProt ID	P20711
TTDS00361	Name	Aromatic-L-amino-acid decarboxylase
TTDS00361	Type of target	Successful target
TTDS00361	Synonyms	AADC
TTDS00361	Synonyms	DDC
TTDS00361	Synonyms	DOPA decarboxylase
TTDS00361	Disease	Parkinson's disease
TTDS00361	Function	Catalyzes the decarboxylation of l-3,4- dihydroxyphenylalanine (dopa) to dopamin
TTDS00361	Sequence	MNASEFRRRGKEMVDYVANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDVEKIIMPGVTHWHSPYFFAYF
TTDS00361	BioChemical Class	Carbon-carbon lyases
TTDS00361	Pathway	Alkaloid biosynthesis I
TTDS00361	Pathway	Histidine metabolism
TTDS00361	Pathway	Metabolic pathways
TTDS00361	Pathway	Phenylalanine metabolism
TTDS00361	Pathway	Tryptophan metabolism
TTDS00361	Pathway	Tyrosine metabolism
TTDS00361	EC Number	EC 4.1.1.28
TTDS00361	Target Validation	TTDS00361
TTDS00361	Drug(s)	Carbidopa
TTDS00361	Drug(s)	Patrome
TTDS00361	Drug(s)	Vitamin B6
TTDS00361	Inhibitor	Benserazide
TTDS00361	Inhibitor	Carbidopa
TTDS00361	Activator	Noradrenalone (arterenone)
TTDS00361	Cofactor	Vitamin B6
TTDS00362	UniProt ID	P21964
TTDS00362	Name	Catechol-O-methyl-transferase
TTDS00362	Type of target	Successful target
TTDS00362	Synonyms	COMT
TTDS00362	Synonyms	Catechol-O-methyltransferase
TTDS00362	Synonyms	MB-COMT
TTDS00362	Synonyms	S-COMT
TTDS00362	Disease	Parkinson's disease
TTDS00362	Function	Catalyzes the o-methylation, and thereby the inactivation, of catecholamine neur
TTDS00362	Sequence	MPEAPPLLLAAVLLGLVLLVVLLLLLRHWGWGLCLIGWNEFILQPIHNLLMGDTKEQRILNHVLQHAEPGNAQSVLEAID
TTDS00362	PDB Structure	3BWM; 3BWY
TTDS00362	BioChemical Class	Transferases transferring one-carbon groups
TTDS00362	Pathway	Metabolic pathways
TTDS00362	Pathway	Tyrosine metabolism
TTDS00362	EC Number	EC 2.1.1.6
TTDS00362	Target Validation	TTDS00362
TTDS00362	Drug(s)	Entacapone
TTDS00362	Drug(s)	Entacapone+levodopa+carbidopa
TTDS00362	Drug(s)	Tolcapone
TTDS00362	Inhibitor	(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE
TTDS00362	Inhibitor	1-(3,4-dihydroxy-2-nitrophenyl)-2-phenylethanone
TTDS00362	Inhibitor	1-(3,4-dihydroxy-5-nitrophenyl)-2-phenoxyethanone
TTDS00362	Inhibitor	3,5-Dinitrocatechol
TTDS00362	Inhibitor	5,6-dihydroxy-7-nitro-2,3-dihydroinden-1-one
TTDS00362	Inhibitor	6,7-dihydroxy-8-nitro-1-tetralone
TTDS00362	Inhibitor	7,8-dihydroxy-4-phenyl-2H-chromen-2-one
TTDS00362	Inhibitor	BIA
TTDS00362	Inhibitor	BIA 3-202
TTDS00362	Inhibitor	Entacapone
TTDS00362	Inhibitor	Entacapone+levodopa+carbidopa
TTDS00362	Inhibitor	NEBICAPONE
TTDS00362	Inhibitor	Tolcapone
TTDS00362	Multitarget	Entacapone+levodopa+carbidopa
TTDS00363	Name	Calcineurin
TTDS00363	Type of target	Successful target
TTDS00363	Synonyms	Serine/threonine protein phosphatase
TTDS00363	Disease	Fungal diseases
TTDS00363	Disease	Parkinson's disease
TTDS00363	Disease	Traumatic brain injury
TTDS00363	EC Number	EC 3.1.3.16
TTDS00363	Target Validation	TTDS00363
TTDS00363	Drug(s)	Cyclosporin A
TTDS00363	Drug(s)	Cyclosporine
TTDS00363	Drug(s)	Pimecrolimus
TTDS00363	Drug(s)	Tacrolimus
TTDS00363	Drug(s)	Voclosporin
TTDS00363	Inhibitor	Cyclosporin A
TTDS00363	Inhibitor	Cyclosporine
TTDS00363	Inhibitor	L-685,818
TTDS00363	Inhibitor	Pimecrolimus
TTDS00363	Inhibitor	Tacrolimus
TTDS00363	Inhibitor	Voclosporin
TTDS00364	Name	Collagenase
TTDS00364	Type of target	Successful target
TTDS00364	Disease	Periodontal disease
TTDS00364	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00364	Pathway	Bladder cancer
TTDS00364	Pathway	Leukocyte transendothelial migration
TTDS00364	Pathway	Pathways in cancer
TTDS00364	QSAR Model	TTDS00364
TTDS00365	UniProt ID	P07101
TTDS00365	Name	Tyrosine 3-monooxygenase
TTDS00365	Type of target	Successful target
TTDS00365	Synonyms	TH
TTDS00365	Synonyms	Tyrosine 3-hydroxylase
TTDS00365	Disease	Pheochromocytoma
TTDS00365	Function	Plays an important role in the physiology of adrenergic neurones.
TTDS00365	Sequence	MPTPDATTPQAKGFRRAVSELDAKQAEAIMVRGQGAPGPSLTGSPWPGTAAPAASYTPTPRSPRFIGRRQSLIEDARKER
TTDS00365	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00365	Pathway	Metabolic pathways
TTDS00365	Pathway	Parkinson's disease
TTDS00365	Pathway	Tyrosine metabolism
TTDS00365	EC Number	EC 1.14.16.2
TTDS00365	Drug(s)	L-Phenylalanine
TTDS00365	Drug(s)	L-Tyrosine
TTDS00365	Drug(s)	Metyrosine
TTDS00365	Drug(s)	Tetrahydrobiopterin
TTDS00365	Inhibitor	7,8-dihydrobiopterin
TTDS00365	Inhibitor	Meta-Tyrosine
TTDS00365	Binder	L-Phenylalanine
TTDS00365	Binder	L-Tyrosine
TTDS00365	Binder	Metyrosine
TTDS00365	Cofactor	Tetrahydrobiopterin
TTDS00367	UniProt ID	P10275
TTDS00367	Name	Androgen receptor
TTDS00367	Type of target	Successful target
TTDS00367	Synonyms	Dihydrotestosterone receptor
TTDS00367	Synonyms	Testosterone receptor
TTDS00367	Disease	Prostate cancer
TTDS00367	Disease	Spinal and bulbar muscular atrophy
TTDS00367	Function	The steroid hormones and their receptors are involved in the regulation of eukar
TTDS00367	Sequence	MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQQQQQQQQQQQQQQQQQQQET
TTDS00367	PDB Structure	1E3G; 1GS4; 1T5Z; 1T63; 1T65; 1XJ7; 1XOW; 1XQ3
TTDS00367	BioChemical Class	Zinc-finger
TTDS00367	Pathway	Pathways in cancer
TTDS00367	Pathway	Prostate cancer
TTDS00367	Target Validation	TTDS00367
TTDS00367	Drug(s)	2849466
TTDS00367	Drug(s)	APC-100
TTDS00367	Drug(s)	Bicalutamide
TTDS00367	Drug(s)	Cyproterone
TTDS00367	Drug(s)	Dromostanolone
TTDS00367	Drug(s)	Enzalutamide
TTDS00367	Drug(s)	Fluoxymesterone
TTDS00367	Drug(s)	Flutamide
TTDS00367	Drug(s)	Hydroxyflutamide
TTDS00367	Drug(s)	MDV3100
TTDS00367	Drug(s)	Nandrolone
TTDS00367	Drug(s)	Nilutamide
TTDS00367	Drug(s)	ODM-201
TTDS00367	Drug(s)	Ostarine
TTDS00367	Drug(s)	Oxandrolone
TTDS00367	Drug(s)	Testosterone
TTDS00367	Inhibitor	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane
TTDS00367	Inhibitor	11-methyl-6,11-dihydro-5H-benzo[a]carbazol-9-ol
TTDS00367	Inhibitor	6,11-dihydrothiochromeno[4,3-b]indol-8-ol
TTDS00367	Inhibitor	9alpha-Fluorocortisol
TTDS00367	Inhibitor	APC-100
TTDS00367	Inhibitor	CYPROTERONE ACETATE
TTDS00367	Inhibitor	Calusterone
TTDS00367	Inhibitor	Dihydrotestosterone
TTDS00367	Inhibitor	Flufenamic Acid
TTDS00367	Inhibitor	Methyltrienolone
TTDS00367	Inhibitor	Mibolerone
TTDS00367	Inhibitor	OXENDLONE
TTDS00367	Inhibitor	Palodesangren C
TTDS00367	Inhibitor	Palodesangren D
TTDS00367	Inhibitor	Palodesangren E
TTDS00367	Inhibitor	RU-59063
TTDS00367	Inhibitor	WIN-49596
TTDS00367	Inhibitor	ZANOTERONE
TTDS00367	Antagonist	ARN34
TTDS00367	Antagonist	Alpha-estradiol
TTDS00367	Antagonist	Bicalutamide
TTDS00367	Antagonist	Cyproterone
TTDS00367	Antagonist	Flutamide
TTDS00367	Antagonist	Hydroxyflutamide
TTDS00367	Antagonist	Nilutamide
TTDS00367	Agonist	Boldenone
TTDS00367	Agonist	Delta1-dihydrotestosterone
TTDS00367	Agonist	Fluoxymesterone
TTDS00367	Agonist	Nandrolone
TTDS00367	Agonist	Oxandrolone
TTDS00367	Agonist	Testosterone
TTDS00367	Modulator	Ostarine
TTDS00367	Binder	Dromostanolone
TTDS00368	UniProt ID	P06729
TTDS00368	Name	T-cell surface antigen CD2
TTDS00368	Type of target	Successful target
TTDS00368	Synonyms	CD2
TTDS00368	Synonyms	Erythrocyte receptor
TTDS00368	Synonyms	LFA-2
TTDS00368	Synonyms	LFA-3 receptor
TTDS00368	Synonyms	Rosette receptor
TTDS00368	Synonyms	T-cell surface antigen T11/Leu-5
TTDS00368	Disease	Psoriasis
TTDS00368	Function	Cd2 interacts with lymphocyte function-associated antigen (lfa-3) and cd48/bcm1
TTDS00368	Sequence	MSFPCKFVASFLLIFNVSSKGAVSKEITNALETWGALGQDINLDIPSFQMSDDIDDIKWEKTSDKKKIAQFRKEKETFKE
TTDS00368	PDB Structure	1CDB; 1GYA; 1HNF; 1L2Z; 1QA9; 2J6O; 2J7I
TTDS00368	BioChemical Class	Transmembrane protein
TTDS00368	Pathway	Cell adhesion molecules (CAMs)
TTDS00368	Pathway	Hematopoietic cell lineage
TTDS00368	Drug(s)	Alefacept
TTDS00368	Drug(s)	Siplizumab
TTDS00368	Inhibitor	Alefacept
TTDS00368	Inhibitor	Alpha-D-Mannose
TTDS00368	Inhibitor	Pen(Acm)AQFRKEKETFC(Acm)-OH
TTDS00368	Inhibitor	cyclo(1,10)EIYDPGDDIK
TTDS00368	Inhibitor	cyclo(1,10)H-EIYDPGDDIK-OH
TTDS00368	Inhibitor	cyclo(1,11)H-ESIYDPGDDIK-OH
TTDS00368	Inhibitor	cyclo(1,12)PenIYDTKGKNVLC-OH
TTDS00368	Antibody	Siplizumab
TTDS00372	UniProt ID	P14324
TTDS00372	UniProt ID	Q86C09
TTDS00372	Name	Farnesyl pyrophosphate synthetase
TTDS00372	Type of target	Successful target
TTDS00372	Synonyms	FPP synthase
TTDS00372	Synonyms	FPP synthetase
TTDS00372	Synonyms	FPPS
TTDS00372	Synonyms	FPS
TTDS00372	Synonyms	Farnesyl diphosphate synthase
TTDS00372	Synonyms	Farnesyl diphosphate synthetase
TTDS00372	Synonyms	Farnesyl pyrophosphate synthase
TTDS00372	Disease	Cancer, unspecific
TTDS00372	Disease	Chagas' disease
TTDS00372	Disease	Hypercholesterolemia
TTDS00372	Disease	Leishmania infections
TTDS00372	Disease	Myeloma disease
TTDS00372	Disease	Osteoporosis, unspecified
TTDS00372	Disease	Skeletal disorders
TTDS00372	Disease	Toxoplasma infections
TTDS00372	Disease	Trypanosomatid infections
TTDS00372	Function	Catalyzes the sequential condensation of isopentenyl pyrophosphate with the ally
TTDS00372	Sequence	MPLSRWLRSVGVFLLPAPYWAPRERWLGSLRRPSLVHGYPVLAWHSARCWCQAWTEEPRALCSSLRMNGDQNSDVYAQEK
TTDS00372	PDB Structure	1YQ7; 1YV5; 1ZW5; 2F7M; 3DYF; 3DYG; 3DYH; 3EFQ
TTDS00372	Pathway	Biosynthesis of steroids
TTDS00372	Pathway	Metabolic pathways
TTDS00372	Pathway	Terpenoid biosynthesis
TTDS00372	EC Number	EC 2.5.1.1
TTDS00372	EC Number	EC 2.5.1.10
TTDS00372	Target Validation	TTDS00372
TTDS00372	Drug(s)	Alendronate
TTDS00372	Drug(s)	Ibandronate
TTDS00372	Drug(s)	Pamidronate
TTDS00372	Drug(s)	Pamidronate disodium
TTDS00372	Drug(s)	Risedronate
TTDS00372	Drug(s)	Zoledronate
TTDS00372	Drug(s)	Zoledronic acid
TTDS00372	Inhibitor	(1-hydroxy-1-phosphono-heptyl)-phosphonic acid
TTDS00372	Inhibitor	(biphenyl-3-ylamino)methylenediphosphonic acid
TTDS00372	Inhibitor	1-(but-2-ylamino)ethyl 1,I-bisphosphonic acid
TTDS00372	Inhibitor	1-[(cyclohexylamino)ethyl]-1,1-bisphosphonicacid
TTDS00372	Inhibitor	1-[(n-but-1-ylamino)ethyl]-1,1-bisphosphonic acid
TTDS00372	Inhibitor	1-[(n-hex-1-ylamino)ethyl]-1,1-bisphosphonic acid
TTDS00372	Inhibitor	1-[(n-oct-1-ylamino)ethyl]-1,1-bisphosphonic acid
TTDS00372	Inhibitor	1-[(prop-1-ylamino)ethyl]-1,1-bisphosphonic acid
TTDS00372	Inhibitor	1-[(prop-2-ylamino)ethyl]-1,1-bisphosphonicacid
TTDS00372	Inhibitor	1-[(tert-butylamino)ethyl]-1,1-bisphosphonicacid
TTDS00372	Inhibitor	Alendronate
TTDS00372	Inhibitor	Bisphosphonates
TTDS00372	Inhibitor	Bisphosphonates alendronate
TTDS00372	Inhibitor	Dimethylallyl Diphosphate
TTDS00372	Inhibitor	FARNESYL DIPHOSPHATE
TTDS00372	Inhibitor	Farnesyl pyrophosphate
TTDS00372	Inhibitor	GERANYLGERANYL DIPHOSPHATE
TTDS00372	Inhibitor	Geranyl Diphosphate
TTDS00372	Inhibitor	Homorisedronate
TTDS00372	Inhibitor	ISOPENTENYL PYROPHOSPHATE
TTDS00372	Inhibitor	Ibandronate
TTDS00372	Inhibitor	Incadronate
TTDS00372	Inhibitor	Isopentyl Pyrophosphate
TTDS00372	Inhibitor	Minodronate
TTDS00372	Inhibitor	NE-10575
TTDS00372	Inhibitor	NE21650
TTDS00372	Inhibitor	NERIDRONIC ACID
TTDS00372	Inhibitor	Pamidronate
TTDS00372	Inhibitor	Pamidronate disodium
TTDS00372	Inhibitor	Piridronic acid
TTDS00372	Inhibitor	RIS
TTDS00372	Inhibitor	Risedronate
TTDS00372	Inhibitor	YM-175
TTDS00372	Inhibitor	Zoledronate
TTDS00372	Inhibitor	Zoledronic acid
TTDS00372	Inhibitor	[2-(6-Chloro-purin-9-yl)ethyl]-bisphosphonic acid
TTDS00372	Inhibitor	[2-(Benzoimidazol-1-yl)ethyl]-bisphosphonic acid
TTDS00372	Inhibitor	[2-(Imidazol-1-yl)ethyl]-bisphosphonic acid
TTDS00372	Inhibitor	[2-(Imidazol-2-yl-thio)ethyl]-bisphosphonic acid
TTDS00372	Inhibitor	[2-(Purin-9-yl)ethyl]-bisphosphonic acid
TTDS00372	Inhibitor	[2-(Pyrazol-1-yl)ethyl]-bisphosphonic acid
TTDS00373	UniProt ID	P14679
TTDS00373	Name	Tyrosine oxidase
TTDS00373	Type of target	Successful target
TTDS00373	Synonyms	LB24-AB
TTDS00373	Synonyms	Monophenol monooxygenase
TTDS00373	Synonyms	SK29-AB
TTDS00373	Synonyms	Tumor rejection antigen AB
TTDS00373	Synonyms	Tyrosinase
TTDS00373	Disease	Skin diseases
TTDS00373	Function	This is a copper-containing oxidase that functions in the formation of pigments
TTDS00373	Sequence	MLLAVLYCLLWSFQTSAGHFPRACVSSKNLMEKECCPPWSGDRSPCGQLSGRGSCQNILLSNAPLGPQFPFTGVDDRESW
TTDS00373	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00373	Pathway	Alkaloid biosynthesis I
TTDS00373	Pathway	Melanogenesis
TTDS00373	Pathway	Metabolic pathways
TTDS00373	Pathway	Riboflavin metabolism
TTDS00373	Pathway	Tyrosine metabolism
TTDS00373	EC Number	EC 1.10.3.1
TTDS00373	EC Number	EC 1.14.18.1
TTDS00373	Related US Patent	6,521,267
TTDS00373	Target Validation	TTDS00373
TTDS00373	Drug(s)	Monobenzone
TTDS00373	Inhibitor	(+/-)-Daedalin A
TTDS00373	Inhibitor	1'-(4-Methyl-benzyl)-[1,4']bipiperidinyl
TTDS00373	Inhibitor	1-(1,4-diacetylphenyl)dithiosemicarbazide
TTDS00373	Inhibitor	1-(1-(4-bromophenyl)ethylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(1-(4-fluorophenyl)ethylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(1-(pyrazin-2-yl)ethylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(1-(pyridin-3-yl)ethylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(1-(thiophen-2-yl)ethylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(1-p-tolylethylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(1-phenylethylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(2,5-Dimethyl-1H-pyrrol-1-yl)thiourea
TTDS00373	Inhibitor	1-(3-Methylbutylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(3-Oxocyclohexylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(3-Phenylallylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(3-phenoxypropyl)-4-(piperidin-1-yl)piperidine
TTDS00373	Inhibitor	1-(4-(benzyloxy)phenyl)-3-hydroxyurea
TTDS00373	Inhibitor	1-(4-Methylpent-3-en-2-ylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(4-bromophenyl)-3-hydroxyurea
TTDS00373	Inhibitor	1-(But-2-enylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(Butan-2-ylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-(Propan-2-ylidene)thiosemicarbazide
TTDS00373	Inhibitor	1-Cyclohexylidenethiosemicarbazide
TTDS00373	Inhibitor	1-Cyclopentylidenethiosemicarbazide
TTDS00373	Inhibitor	1-Ethylidenethiosemicarbazide
TTDS00373	Inhibitor	1-Propylidenethiosemicarbazide
TTDS00373	Inhibitor	1-hydroxy-3-(4-(trifluoromethyl)phenyl)urea
TTDS00373	Inhibitor	1-hydroxy-3-(4-nitrophenyl)urea
TTDS00373	Inhibitor	1-hydroxy-3-phenylurea
TTDS00373	Inhibitor	2,2',4,4',6'-pentahydroxychalcone
TTDS00373	Inhibitor	2,2',4,4'-tetrahydroxy-6'-methoxychalcone
TTDS00373	Inhibitor	2,2',4,4'-tetrahydroxychalcone
TTDS00373	Inhibitor	2,2'-bi(1,3,4-thiadiazole)-5,5'(4H,4'H)-dithione
TTDS00373	Inhibitor	2,4,3',5'-tetrahydroxybibenzyl
TTDS00373	Inhibitor	2-(butylthiomethyl)-5-hydroxy-4H-pyran-4-one
TTDS00373	Inhibitor	2-(cyclohexylthiomethyl)-5-hydroxy-4H-pyran-4-one
TTDS00373	Inhibitor	2-(ethylthiomethyl)-5-hydroxy-4H-pyran-4-one
TTDS00373	Inhibitor	2-(heptylthiomethyl)-5-hydroxy-4H-pyran-4-one
TTDS00373	Inhibitor	2-(hexylthiomethyl)-5-hydroxy-4H-pyran-4-one
TTDS00373	Inhibitor	2-hydroxy-3-isopropyl-2,4,6-cycloheptatrien-1-one
TTDS00373	Inhibitor	2-hydroxy-5-isopropyl-2,4,6-cycloheptatrien-1-one
TTDS00373	Inhibitor	2-hydroxyphenethyl 3,4,5-trihydroxybenzoate
TTDS00373	Inhibitor	3,4-dihydroxybenzaldehyde-O-ethyloxime
TTDS00373	Inhibitor	3-(2,4-dihydroxyphenyl)-propionic acid ethylester
TTDS00373	Inhibitor	3-(2,4-dihydroxyphenyl)-propionic acid octylester
TTDS00373	Inhibitor	3-(2,4-dihydroxyphenyl)propionic acid
TTDS00373	Inhibitor	3-hydroxyphenethyl 3,4,5-trihydroxybenzoate
TTDS00373	Inhibitor	3hydroxy-1-methyl-1-phenylurea
TTDS00373	Inhibitor	4',4-Dihydroxychalcone
TTDS00373	Inhibitor	4'-(4-Aminobenzensulfonamide)-4-hydroxychalcone
TTDS00373	Inhibitor	4'-(4-Fluorobenzensulfonamide)-4-hydroxychalcone
TTDS00373	Inhibitor	4'-(4-Nitrobenzensulfonamide)-4-hydroxychalcone
TTDS00373	Inhibitor	4'-(Benzensulfonamide)-4-hydroxychalcone
TTDS00373	Inhibitor	4'-(p-Toluenesulfonamide)-4-hydroxychalcone
TTDS00373	Inhibitor	4'-Amino-4-hydroxychalcone
TTDS00373	Inhibitor	4,4'-(ethane-1,2-diyl)dibenzene-1,3-diol
TTDS00373	Inhibitor	4-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol
TTDS00373	Inhibitor	4-adamantyl resorcinol
TTDS00373	Inhibitor	4-hexyl resorcinol
TTDS00373	Inhibitor	4-hydroxyphenethyl 3,4,5-trihydroxybenzoate
TTDS00373	Inhibitor	5,5'-methylenebis(1,3,4-oxadiazole-2(3H)-thione)
TTDS00373	Inhibitor	5,5'-methylenebis(1,3,4-thiadiazole-2(3H)-thione)
TTDS00373	Inhibitor	5-(3-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-(4-hydroxyphenyl)-1,3,4-oxadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol
TTDS00373	Inhibitor	5-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol
TTDS00373	Inhibitor	5-(pyridin-4-yl)-1,3,4-oxadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-(pyridin-4-yl)-1,3,4-thiadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-benzhydryl-1,3,4-oxadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-benzhydryl-1,3,4-thiadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-benzyl-1,3,4-oxadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-cyclohexyl-1,3,4-oxadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-hydroxy-2-(pentylthiomethyl)-4H-pyran-4-one
TTDS00373	Inhibitor	5-hydroxy-2-(propylthiomethyl)-4H-pyran-4-one
TTDS00373	Inhibitor	5-phenyl-1,3,4-oxadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-phenyl-1,3,4-thiadiazole-2(3H)-thione
TTDS00373	Inhibitor	5-{8(Z),-pentadecenyl}resorcinol
TTDS00373	Inhibitor	5-{8(Z),11(Z),14-pentadecatrienyl}resorcinol
TTDS00373	Inhibitor	5-{8(Z),11(Z)-pentadecadienyl}resorcinol
TTDS00373	Inhibitor	6-(3-hydroxyphenyl)naphthalen-2-ol
TTDS00373	Inhibitor	7,3',4'-trihydroxyisoflavone
TTDS00373	Inhibitor	7,8,4'-trihydroxyisoflavone
TTDS00373	Inhibitor	7-(3,5-dihydroxyphenyl)naphthalene-1,3-diol
TTDS00373	Inhibitor	ASKENDOSIDE B
TTDS00373	Inhibitor	Crocusatin-K
TTDS00373	Inhibitor	DAEDALIN A
TTDS00373	Inhibitor	ETHISTERONE
TTDS00373	Inhibitor	HINOKITIOL
TTDS00373	Inhibitor	Hydroquinone
TTDS00373	Inhibitor	KAZINOL S
TTDS00373	Inhibitor	KOJIC ACID
TTDS00373	Inhibitor	Kojic acid-phenylalanine amide
TTDS00373	Inhibitor	Monobenzone
TTDS00373	Inhibitor	N-(2,4-dihydroxybenzyl)-3,4,5-trihydroxybenzamide
TTDS00373	Inhibitor	N-(2,4-dihydroxybenzyl)-3,4-dihydroxybenzamide
TTDS00373	Inhibitor	N-(2,4-dihydroxybenzyl)-3,5-dihydroxybenzamide
TTDS00373	Inhibitor	N-butylresorcinol
TTDS00373	Inhibitor	OXYRESVERATROL
TTDS00373	Inhibitor	PHENYLTHIOUREA
TTDS00373	Inhibitor	ROSMARINIC ACID
TTDS00373	Inhibitor	S-2-(o-toluidino)-2-oxoethyl carbamothioate
TTDS00373	Inhibitor	SODIUM ZINC DIHYDROLIPOYLHISTIDINATE
TTDS00373	Inhibitor	SRI-224
TTDS00373	Inhibitor	TROPOLONE
TTDS00373	Inhibitor	broussonin C
TTDS00373	Inhibitor	kazinol C
TTDS00373	Inhibitor	kazinol F
TTDS00374	Name	Benzodiazepine receptor
TTDS00374	Type of target	Successful target
TTDS00374	Disease	Anxiety disorder, unspecified
TTDS00374	Disease	Disorders of initiating and maintaining sleep [insomnias]
TTDS00374	Disease	Sleeping sickness
TTDS00374	BioChemical Class	Transmembrane protein
TTDS00374	Pathway	Neuroactive ligand-receptor interaction
TTDS00374	QSAR Model	TTDS00374
TTDS00374	Drug(s)	Alprazolam
TTDS00374	Drug(s)	Chlordiazepoxide
TTDS00374	Drug(s)	Clorazepate
TTDS00374	Drug(s)	Clotiazepam
TTDS00374	Drug(s)	Estazolam
TTDS00374	Drug(s)	Eszopiclone
TTDS00374	Drug(s)	Fludiazepam
TTDS00374	Drug(s)	Flunitrazepam
TTDS00374	Drug(s)	Flurazepam
TTDS00374	Drug(s)	Lorazepam
TTDS00374	Drug(s)	Midazolam
TTDS00374	Drug(s)	Oxazepam
TTDS00374	Drug(s)	Temazepam
TTDS00374	Drug(s)	Triazolam
TTDS00374	Agonist	Alprazolam
TTDS00374	Agonist	Chlordiazepoxide
TTDS00374	Agonist	Clorazepate
TTDS00374	Agonist	Clotiazepam
TTDS00374	Agonist	Diazemuls
TTDS00374	Agonist	Estazolam
TTDS00374	Agonist	Eszopiclone
TTDS00374	Agonist	Fludiazepam
TTDS00374	Agonist	Flunitrazepam
TTDS00374	Agonist	Flurazepam
TTDS00374	Agonist	Lorazepam
TTDS00374	Agonist	Midazolam
TTDS00374	Agonist	Oxazepam
TTDS00374	Agonist	Temazepam
TTDS00374	Agonist	Triazolam
TTDS00377	UniProt ID	Q16739
TTDS00377	Name	Ceramide glucosyltransferase
TTDS00377	Type of target	Successful target
TTDS00377	Synonyms	GCS
TTDS00377	Synonyms	GLCT-1
TTDS00377	Synonyms	Glucosylceramide synthase
TTDS00377	Synonyms	UDP-glucose ceramide glucosyltransferase
TTDS00377	Synonyms	UDP-glucose:N-acylsphingosine D-glucosyltransferase
TTDS00377	Disease	Sphingolipid storage disorders
TTDS00377	Function	May serve as a "flippase" as well as a glucosyltransferase that transfers glucos
TTDS00377	Sequence	MALLDLALEGMAVFGFVLFLVLWLMHFMAIIYTRLHLNKKATDKQPYSKLPGVSLLKPLKGVDPNLINNLETFFELDYPK
TTDS00377	BioChemical Class	Glycosyltransferases
TTDS00377	Pathway	Metabolic pathways
TTDS00377	Pathway	Sphingolipid metabolism
TTDS00377	EC Number	EC 2.4.1.80
TTDS00377	Target Validation	TTDS00377
TTDS00377	Drug(s)	GZ402671
TTDS00377	Drug(s)	Miglustat
TTDS00377	Inhibitor	Miglustat
TTDS00377	Inhibitor	N-butylgalactonojirimycin
TTDS00378	UniProt ID	P05546
TTDS00378	Name	Heparin cofactor II
TTDS00378	Type of target	Successful target
TTDS00378	Synonyms	HC-II
TTDS00378	Synonyms	HLS2
TTDS00378	Synonyms	Protease inhibitor leuserpin 2
TTDS00378	Disease	Thrombosis
TTDS00378	Function	Thrombin inhibitor activated by the glycosaminoglycans, heparin or dermatan sulf
TTDS00378	Sequence	MKHSLNALLIFLIITSAWGGSKGPLDQLEKGGETAQSADPQWEQLNNKNLSMPLLPADFHKENTVTNDWIPEGEEDDDYL
TTDS00378	PDB Structure	1JMJ; 1JMO
TTDS00378	Pathway	Complement and coagulation cascades
TTDS00378	Related US Patent	6,518,244
TTDS00378	Drug(s)	Ardeparin
TTDS00378	Inhibitor	Alpha-D-Mannose
TTDS00378	Binder	Ardeparin
TTDS00380	UniProt ID	P07202
TTDS00380	Name	Thyroid peroxidase
TTDS00380	Type of target	Successful target
TTDS00380	Synonyms	TPO
TTDS00380	Synonyms	Thyroperoxidase
TTDS00380	Disease	Thyrotoxicosis [hyperthyroidism]
TTDS00380	Function	Iodination and coupling of the hormonogenic tyrosines in thyroglobulin to yield
TTDS00380	Sequence	MRALAVLSVTLVMACTEAFFPFISRGKELLWGKPEESRVSSVLEESKRLVDTAMYATMQRNLKKRGILSPAQLLSFSKLP
TTDS00380	BioChemical Class	Oxidoreductases acting on a peroxide as acceptor
TTDS00380	Pathway	Autoimmune thyroid disease
TTDS00380	Pathway	Cytokine-cytokine receptor interaction
TTDS00380	Pathway	Hematopoietic cell lineage
TTDS00380	Pathway	Jak-STAT signaling pathway
TTDS00380	Pathway	Metabolic pathways
TTDS00380	Pathway	Tyrosine metabolism
TTDS00380	EC Number	EC 1.11.1.8
TTDS00380	Target Validation	TTDS00380
TTDS00380	Drug(s)	Carbimazole
TTDS00380	Drug(s)	Methimazole
TTDS00380	Drug(s)	Propylthiouracil
TTDS00380	Inhibitor	Carbimazole
TTDS00380	Inhibitor	Methimazole
TTDS00380	Inhibitor	Propyl thiouracile
TTDS00380	Inhibitor	Propylthiouracil
TTDS00380	Inhibitor	Thiamazole
TTDS00381	UniProt ID	P10827
TTDS00381	Name	Thyroid hormone receptor alpha
TTDS00381	Type of target	Successful target
TTDS00381	Synonyms	C-erbA-1
TTDS00381	Synonyms	C-erbA-alpha
TTDS00381	Synonyms	EAR-7
TTDS00381	Synonyms	EAR7
TTDS00381	Disease	Thyrotoxicosis [hyperthyroidism]
TTDS00381	Function	Nuclear hormone receptor. High affinity receptor for triiodothyronine.
TTDS00381	Sequence	MEQKPSKVECGSDPEENSARSPDGKRKRKNGQCSLKTSMSGYIPSYLDKDEQCVVCGDKATGYHYRCITCEGCKGFFRRT
TTDS00381	PDB Structure	1NAV; 2H79
TTDS00381	BioChemical Class	Zinc-finger
TTDS00381	Pathway	Neuroactive ligand-receptor interaction
TTDS00381	Target Validation	TTDS00381
TTDS00381	Drug(s)	Levothyroxine
TTDS00381	Drug(s)	Liothyronine
TTDS00381	Inhibitor	(3,5-Dibromo-4-hexyloxy-phenyl)-acetic acid
TTDS00381	Inhibitor	(E)-1-(4-heptylphenyl)but-2-en-1-one
TTDS00381	Inhibitor	(Z)-4-(4-hexylphenylamino)-4-oxobut-2-enoic acid
TTDS00381	Inhibitor	1-(4-hexylphenyl)-3-morpholinopropan-1-one
TTDS00381	Inhibitor	3-(3,5-Dibromo-4-hexyloxy-phenyl)-propionic acid
TTDS00381	Inhibitor	3-(4-(benzyloxy)-3,5-dibromophenyl)propanoic acid
TTDS00381	Inhibitor	3-(dibutylamino)-1-(4-hexylphenyl)propan-1-one
TTDS00381	Inhibitor	3-(dimethylamino)-1-(4-hexylphenyl)propan-1-one
TTDS00381	Inhibitor	3-bromo-1-(4-hexylphenyl)propan-1-one
TTDS00381	Inhibitor	4-(4-hexylphenyl)-4-oxobut-2-enoic acid
TTDS00381	Inhibitor	4-hexylphenyl propiolate
TTDS00381	Inhibitor	Detrothyronine
TTDS00381	Inhibitor	MB-07344
TTDS00381	Antagonist	Levothyroxine
TTDS00381	Antagonist	Liothyronine
TTDS00383	Name	Probable arabinosyltransferase
TTDS00383	Type of target	Successful target
TTDS00383	Disease	Tuberculosis
TTDS00383	Target Validation	TTDS00383
TTDS00383	Drug(s)	Ethambutol
TTDS00383	Inhibitor	Ethambutol
TTDS00384	UniProt ID	P0A5Y6
TTDS00384	UniProt ID	P46533
TTDS00384	Name	Enoyl-[acyl-carrier-protein] reductase [NADH]
TTDS00384	Type of target	Successful target
TTDS00384	Synonyms	InhA
TTDS00384	Synonyms	NADH-dependent enoyl-ACP reductase
TTDS00384	Disease	Tuberculosis
TTDS00384	Function	Involved in the resistance against the antituberculosis drugs isoniazid and ethi
TTDS00384	Sequence	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTE
TTDS00384	PDB Structure	1BVR; 1ENY; 1ENZ; 1P44; 1P45; 1ZID; 2AQ8; 2AQH
TTDS00384	EC Number	EC 1.3.1.9
TTDS00384	Target Validation	TTDS00384
TTDS00384	Drug(s)	Ethionamide
TTDS00384	Drug(s)	Isoniazid
TTDS00384	Drug(s)	Prothionamide
TTDS00384	Inhibitor	(4-benzylpiperidin-1-yl)(2-fluorophenyl)methanone
TTDS00384	Inhibitor	(4-benzylpiperidin-1-yl)(3-chlorophenyl)methanone
TTDS00384	Inhibitor	(4-benzylpiperidin-1-yl)(m-tolyl)methanone
TTDS00384	Inhibitor	(4-benzylpiperidin-1-yl)(p-tolyl)methanone
TTDS00384	Inhibitor	(4-phenylpiperazin-1-yl)(p-tolyl)methanone
TTDS00384	Inhibitor	2-(2-aminophenoxy)-5-hexylphenol
TTDS00384	Inhibitor	2-(3-aminophenoxy)-5-hexylphenol
TTDS00384	Inhibitor	2-(4,6-dimethoxypyrimidin-2-yloxy)-5-hexylphenol
TTDS00384	Inhibitor	2-(4-aminophenoxy)-5-hexylphenol
TTDS00384	Inhibitor	2-(4-hexyl-2-methoxyphenoxy)pyrimidine
TTDS00384	Inhibitor	2-Hexadecynoic acid
TTDS00384	Inhibitor	2-bromo-4-methylphenyl 2-nitrobenzoate
TTDS00384	Inhibitor	2-nitro-N-(2,4,5-trichlorophenyl)benzamide
TTDS00384	Inhibitor	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole
TTDS00384	Inhibitor	4-chloro-N-(2,5-dichlorophenyl)-3-nitrobenzamide
TTDS00384	Inhibitor	5-PENTYL-2-PHENOXYPHENOL
TTDS00384	Inhibitor	5-hexyl-2-(2-nitrophenoxy)phenol
TTDS00384	Inhibitor	5-hexyl-2-(3-nitrophenoxy)phenol
TTDS00384	Inhibitor	5-hexyl-2-(4-nitrophenoxy)phenol
TTDS00384	Inhibitor	5-hexyl-2-(pyrazin-2-yloxy)phenol
TTDS00384	Inhibitor	5-hexyl-2-(pyridin-2-yloxy)phenol
TTDS00384	Inhibitor	5-hexyl-2-(pyridin-3-yloxy)phenol
TTDS00384	Inhibitor	5-hexyl-2-(pyridin-4-yloxy)phenol
TTDS00384	Inhibitor	5-hexyl-2-(pyrimidin-2-yloxy)phenol
TTDS00384	Inhibitor	5-hexyl-2-phenoxyphenol
TTDS00384	Inhibitor	5-octyl-2-phenoxyphenol
TTDS00384	Inhibitor	Beta-D-Glucose
TTDS00384	Inhibitor	C16-Fatty-Acyl-Substrate-Mimic
TTDS00384	Inhibitor	Diclosan
TTDS00384	Inhibitor	Ethionamide
TTDS00384	Inhibitor	Genz-10850
TTDS00384	Inhibitor	Indole Naphthyridinone
TTDS00384	Inhibitor	Isoniazid
TTDS00384	Inhibitor	N-(2,4-dichlorophenyl)-2-nitrobenzamide
TTDS00384	Inhibitor	N-(2,4-dichlorophenyl)-4-methyl-3-nitrobenzamide
TTDS00384	Inhibitor	N-(2,4-dimethylphenyl)-2-nitrobenzamide
TTDS00384	Inhibitor	N-(2,5-dichlorophenyl)-4-methoxy-3-nitrobenzamide
TTDS00384	Inhibitor	N-(2-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide
TTDS00384	Inhibitor	N-(3,5-dichlorophenyl)-2-nitrobenzamide
TTDS00384	Inhibitor	N-(3,5-dichlorophenyl)-4-methoxy-3-nitrobenzamide
TTDS00384	Inhibitor	N-(3,5-dimethoxyphenyl)-4-methyl-2-nitrobenzamide
TTDS00384	Inhibitor	N-(3-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide
TTDS00384	Inhibitor	N-(4-(4-hexyl-2-hydroxyphenoxy)phenyl)acetamide
TTDS00384	Inhibitor	N-(4-(diethylamino)phenyl)-2-nitrobenzamide
TTDS00384	Inhibitor	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE
TTDS00384	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDS00384	Inhibitor	Prothionamide
TTDS00384	Inhibitor	TRICLOSAN
TTDS00386	UniProt ID	P34229
TTDS00386	UniProt ID	P34731
TTDS00386	Name	Fatty acid synthase subunit beta
TTDS00386	Type of target	Successful target
TTDS00386	Synonyms	Fatty acid synthetase I
TTDS00386	Disease	Tuberculosis
TTDS00386	Function	Fatty acid synthetase catalyzes the formation of long-chain fatty acids from ace
TTDS00386	Sequence	MYPTTGVNTPQSAASLRPLVLSHGQTEHSLLVPTSLYINCTTLRDQFYASLPPATEDKADDDEPSSSTELLAAFLGFTAK
TTDS00386	BioChemical Class	Acyltransferases
TTDS00386	Pathway	Fatty acid biosynthesis
TTDS00386	Pathway	Metabolic pathways
TTDS00386	EC Number	EC 2.3.1.86
TTDS00386	Target Validation	TTDS00386
TTDS00386	QSAR Model	TTDS00386
TTDS00386	Drug(s)	Pyrazinamide
TTDS00386	Inhibitor	Pyrazinamide
TTDS00389	UniProt ID	P05217
TTDS00389	Name	Tubulin beta-2 chain
TTDS00389	Type of target	Successful target
TTDS00389	Synonyms	Beta(II) isotype of Tubulin
TTDS00389	Synonyms	Beta(II)-Tubulin
TTDS00389	Synonyms	BetaII-Tubulin
TTDS00389	Disease	Tumors
TTDS00389	Function	Tubulin is the major constituent of microtubules. It binds two moles of gtp, one
TTDS00389	Sequence	MREIVHLQAGQCGNQIGAKFWEVISDEHGIDPTGTYHGDSDLQLERINVYYNEATGGKYVPRAVLVDLEPGTMDSVRSGP
TTDS00389	Target Validation	TTDS00389
TTDS00389	Drug(s)	Vinblastine
TTDS00389	Inhibitor	2'-amino-3,4,4',5-tetramethoxy-(Z)-stillbene
TTDS00389	Inhibitor	2,3'-diamino-3,4,4',5-tetramethoxy-(Z)-stillbene
TTDS00389	Inhibitor	2-amino-3,4',5-trimethoxy-(Z)-stillbene
TTDS00389	Inhibitor	2-amino-3,4,4',5-tetramethoxy-(Z)-stillbene
TTDS00389	Inhibitor	3,4',5-trimethoxy-(Z)-stilbene
TTDS00389	Inhibitor	3,4,4',5-tetramethoxy-(Z)-stilbene
TTDS00389	Inhibitor	3-bromo-4,4',5-trimethoxy-(Z)-stilbene
TTDS00389	Inhibitor	6-ile-ustiloxin
TTDS00389	Inhibitor	COMBRETASTATIN
TTDS00389	Inhibitor	DOLASTATIN-10
TTDS00389	Inhibitor	N-(4-(3-(pyridin-2-yl)acryloyl)phenyl)acetamide
TTDS00389	Inhibitor	Taxol
TTDS00389	Inhibitor	USTILOXIN A
TTDS00389	Inhibitor	Vinblastine
TTDS00389	Inhibitor	ustiloxin D
TTDS00389	Inhibitor	ustiloxin F
TTDS00390	UniProt ID	Q14432
TTDS00390	Name	CGMP-inhibited 3',5'-cyclic phosphodiesterase A
TTDS00390	Type of target	Successful target
TTDS00390	Synonyms	CGI-PDE A
TTDS00390	Synonyms	Cyclic GMP inhibited phosphodiesterase A
TTDS00390	Synonyms	Phosphodiesterase  3A
TTDS00390	Disease	Bronchial asthma
TTDS00390	Disease	Chronic myeloid leukemia
TTDS00390	Disease	Vascular disease
TTDS00390	Function	Hydrolyzes both cyclic amp (camp) and cyclic gmp (cgmp) (by similarity).
TTDS00390	Sequence	MAVPGDAARVRDKPVHSGVSQAPTAGRDCHHRADPASPRDSGCRGCWGDLVLQPLRSSRKLSSALCAGSLSFLLALLVRL
TTDS00390	PDB Structure	1LRC
TTDS00390	BioChemical Class	Hydrolases acting on ester bonds
TTDS00390	Pathway	Insulin signaling pathway
TTDS00390	Pathway	Purine metabolism
TTDS00390	EC Number	EC 3.1.4.17
TTDS00390	Target Validation	TTDS00390
TTDS00390	Drug(s)	Aminophylline
TTDS00390	Drug(s)	Anagrelide
TTDS00390	Drug(s)	Cilostazol
TTDS00390	Drug(s)	Milrinone
TTDS00390	Inhibitor	1,3,9,9a-Tetrahydro-imidazo[4,5-b]quinolin-2-one
TTDS00390	Inhibitor	1,3-Dihydro-imidazo[4,5-b]quinolin-2-one
TTDS00390	Inhibitor	1,3-Dihydro-naphtho[2,3-d]imidazol-2-one
TTDS00390	Inhibitor	1,5-Dihydro-imidazo[2,1-b]quinazolin-2-one
TTDS00390	Inhibitor	2-morpholino-7-(2-phenylethynyl)-4H-chromen-4-one
TTDS00390	Inhibitor	2-morpholino-7-phenyl-4H-chromen-4-one
TTDS00390	Inhibitor	2-morpholino-8-(2-phenylethynyl)-4H-chromen-4-one
TTDS00390	Inhibitor	3-Isobutyl-1-methyl-3,7-dihydro-purine-2,6-dione
TTDS00390	Inhibitor	5-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one
TTDS00390	Inhibitor	6-(2-Imidazol-1-yl-vinyl)-1H-quinolin-2-one
TTDS00390	Inhibitor	6-Imidazol-1-yl-3,4-dihydro-1H-quinolin-2-one
TTDS00390	Inhibitor	6-Pyridin-3-yl-3,4-dihydro-1H-quinolin-2-one
TTDS00390	Inhibitor	7-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one
TTDS00390	Inhibitor	7-Ethoxy-1,3-dihydro-imidazo[4,5-b]quinolin-2-one
TTDS00390	Inhibitor	7-Fluoro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one
TTDS00390	Inhibitor	7-Iodo-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one
TTDS00390	Inhibitor	7-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one
TTDS00390	Inhibitor	8-Chloro-1,3-dihydro-imidazo[4,5-b]quinolin-2-one
TTDS00390	Inhibitor	8-Methyl-1,3-dihydro-imidazo[4,5-b]quinolin-2-one
TTDS00390	Inhibitor	8-methyl-2-morpholino-7-phenoxy-4H-chromen-4-one
TTDS00390	Inhibitor	8-methyl-2-morpholino-7-phenyl-4H-chromen-4-one
TTDS00390	Inhibitor	Aminophylline
TTDS00390	Inhibitor	Anagrelide
TTDS00390	Inhibitor	BENZOYLENUREA
TTDS00390	Inhibitor	BMY-20844
TTDS00390	Inhibitor	CI-930
TTDS00390	Inhibitor	Cilostazol
TTDS00390	Inhibitor	FENOXIMONE
TTDS00390	Inhibitor	IMAZODAN
TTDS00390	Inhibitor	KURAIDIN
TTDS00390	Inhibitor	KURARINOL
TTDS00390	Inhibitor	Milrinone
TTDS00390	Inhibitor	OPC-13013
TTDS00390	Inhibitor	RO-201724
TTDS00390	Inhibitor	SOPHOFLAVESCENOL
TTDS00390	Inhibitor	TETRAHYDROBENXIMIDAZOLE
TTDS00390	Inhibitor	VESNARINONE
TTDS00392	UniProt ID	P00747
TTDS00392	Name	Plasminogen
TTDS00392	Type of target	Successful target
TTDS00392	Synonyms	PLG
TTDS00392	Synonyms	Plasmin
TTDS00392	Disease	Excessive postoperative bleeding
TTDS00392	Disease	Hemorrhage
TTDS00392	Sequence	MEHKEVVLLLLLFLKSGQGEPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFTCRAFQYHSKEQQCVIMAENR
TTDS00392	PDB Structure	1B2I; 1BML; 1BUI; 1CEA; 1CEB; 1DDJ; 1HPJ; 1HPK
TTDS00392	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00392	Pathway	Complement and coagulation cascades
TTDS00392	Pathway	Neuroactive ligand-receptor interaction
TTDS00392	EC Number	EC 3.4.21.7
TTDS00392	Target Validation	TTDS00392
TTDS00392	Drug(s)	Alteplase
TTDS00392	Drug(s)	Aminocaproic Acid
TTDS00392	Drug(s)	Anistreplase
TTDS00392	Drug(s)	Reteplase
TTDS00392	Drug(s)	Streptokinase
TTDS00392	Drug(s)	Tenecteplase
TTDS00392	Drug(s)	Tranexamic Acid
TTDS00392	Drug(s)	Urokinase
TTDS00392	Inhibitor	1-(2-Oxo-2-p-tolyl-ethyl)-1H-indole-2,3-dione
TTDS00392	Inhibitor	1-(3,3-Dimethyl-2-oxo-butyl)-1H-indole-2,3-dione
TTDS00392	Inhibitor	1-guanidino-7-isoquinolinesulphonamide
TTDS00392	Inhibitor	1-guanidino-N-phenyl-7-isoquinolinesulphonamide
TTDS00392	Inhibitor	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine
TTDS00392	Inhibitor	Aminocaproic Acid
TTDS00392	Inhibitor	Bicine
TTDS00392	Inhibitor	GRASSYSTATIN A
TTDS00392	Inhibitor	MELAGATRAN
TTDS00392	Inhibitor	N-(4-Chloro-7-p-tolyl-isoquinolin-1-yl)-guanidine
TTDS00392	Inhibitor	Tranexamic Acid
TTDS00392	Activator	Alteplase
TTDS00392	Activator	Anistreplase
TTDS00392	Activator	Reteplase
TTDS00392	Activator	Streptokinase
TTDS00392	Activator	Tenecteplase
TTDS00392	Activator	Urokinase
TTDS00393	UniProt ID	P48039
TTDS00393	Name	Melatonin receptor type 1A
TTDS00393	Type of target	Successful target
TTDS00393	Disease	Chronic Primary Insomnia
TTDS00393	Disease	Insomnia
TTDS00393	Disease	Major Depressive Disorder
TTDS00393	Sequence	MQGNGSALPNASQPVLRGDGARPSWLASALACVLIFTIVVDILGNLLVILSVYRNKKLRNAGNIFVVSLAVADLVVAIYP
TTDS00393	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00393	Pathway	Neuroactive ligand-receptor interaction
TTDS00393	Target Validation	TTDS00393
TTDS00393	QSAR Model	TTDS00393
TTDS00393	Drug(s)	Agomelatine
TTDS00393	Drug(s)	LY-156735
TTDS00393	Drug(s)	Melatonin
TTDS00393	Drug(s)	Ramelteon
TTDS00393	Drug(s)	VEC-162
TTDS00393	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00393	Inhibitor	5-methoxycarbonylamino-N-acetyltryptamine
TTDS00393	Inhibitor	IODOMELATONIN
TTDS00393	Inhibitor	N-(2,3,4,9-Tetrahydro-1H-carbazol-3-yl)-acetamide
TTDS00393	Inhibitor	N-(2,3-Dihydro-1H-phenalen-2-yl)-acetamide
TTDS00393	Inhibitor	N-(2-(5-methoxybenzofuran-3-yl)ethyl)acetamide
TTDS00393	Inhibitor	N-(3-(2,5-dimethoxyphenyl)propyl)acetamide
TTDS00393	Inhibitor	N-(3-(2-ethoxy-5-methoxyphenyl)propyl)acetamide
TTDS00393	Inhibitor	N-(3-(2-hydroxy-5-methoxyphenyl)propyl)acetamide
TTDS00393	Inhibitor	N-(3-(3-methoxyphenyl)-3-phenylallyl)acetamide
TTDS00393	Inhibitor	N-(3-(3-methoxyphenyl)propyl)acetamide
TTDS00393	Inhibitor	N-(3-(3-methoxyphenyl)propyl)propionamide
TTDS00393	Inhibitor	N-(3-(4-hydroxy-3-methoxyphenyl)propyl)acetamide
TTDS00393	Inhibitor	N-(3-(5-methoxy-2-propoxyphenyl)propyl)acetamide
TTDS00393	Inhibitor	N-[2-(5-Hydroxy-1H-indol-3-yl)-ethyl]-acetamide
TTDS00393	Inhibitor	UCM-454
TTDS00393	Inhibitor	beta,beta-dimethylmelatonin
TTDS00393	Inhibitor	beta-methylmelatonin
TTDS00393	Agonist	Agomelatine
TTDS00393	Agonist	LY-156735
TTDS00393	Agonist	Ramelteon
TTDS00393	Agonist	VEC-162
TTDS00393	Binder	Melatonin
TTDS00393	Multitarget	Ramelteon
TTDS00394	UniProt ID	P30874
TTDS00394	Name	Somatostatin receptor type 2
TTDS00394	Type of target	Successful target
TTDS00394	Synonyms	SRIF-1
TTDS00394	Synonyms	SS2R
TTDS00394	Synonyms	Somatostatin receptor 2
TTDS00394	Synonyms	Sst(2)
TTDS00394	Disease	Cancer, unspecified
TTDS00394	Disease	Cushing's disease
TTDS00394	Disease	Neuroblastoma
TTDS00394	Function	Receptor for somatostatins-14 and -28. This receptor is coupled via pertussis to
TTDS00394	Sequence	MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITNI
TTDS00394	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00394	Pathway	Neuroactive ligand-receptor interaction
TTDS00394	Related US Patent	6,387,932
TTDS00394	Target Validation	TTDS00394
TTDS00394	Drug(s)	BIM23A760
TTDS00394	Drug(s)	Lanreotide Autogel
TTDS00394	Drug(s)	Octreotide
TTDS00394	Drug(s)	Pasireotide
TTDS00394	Inhibitor	Ala11-SRIF-14-amide
TTDS00394	Inhibitor	Ala6-SRIF-14-amide
TTDS00394	Inhibitor	Ala7-SRIF-14-amide
TTDS00394	Inhibitor	CytotoxinPeptide Conjugate
TTDS00394	Inhibitor	D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Asp-NH2
TTDS00394	Inhibitor	Des-AA1,2,4,12,13-[D-Trp8]SRIF
TTDS00394	Inhibitor	Des-AA1,2,4,13-[D-Trp8]SRIF
TTDS00394	Inhibitor	Des-AA1,2,4,5,11,12,13-[D-Trp8]SRIF
TTDS00394	Inhibitor	Des-AA1,2,4,5,13-[D-Trp8]-SRIF
TTDS00394	Inhibitor	Des-AA1,2,4,5,6,12,13-[D-Trp8]SRIF
TTDS00394	Inhibitor	Des-AA1,2,4,5-[D-Trp8]SRIF
TTDS00394	Inhibitor	Des-AA1,2,5,12,13-[D-Trp8]SRIF
TTDS00394	Inhibitor	Des-AA1,2,5-[D-Trp8,Tyr11]SRIF
TTDS00394	Inhibitor	Des-AA5-[D-Trp8]SRIF
TTDS00394	Inhibitor	Edotreotide
TTDS00394	Inhibitor	H-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2
TTDS00394	Inhibitor	H-D-Phe-c[Cys-Ala-D-Trp-Lys-Thr-Cys]-Thr-NH2
TTDS00394	Inhibitor	H-DPhe-c[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-NH2
TTDS00394	Inhibitor	H-c[Cys-Phe-DTrp-Lys-Thr-Cys]-OH
TTDS00394	Inhibitor	L-363377
TTDS00394	Inhibitor	ODT-8
TTDS00394	Inhibitor	Pyz11-D-Trp8-SRIF
TTDS00394	Inhibitor	Pyz6-D-Trp8-SRIF
TTDS00394	Inhibitor	Radiolabeled octreotide derivative
TTDS00394	Inhibitor	SOMATOSTATIN
TTDS00394	Inhibitor	SRIF-28
TTDS00394	Inhibitor	Somatostatin Analogue
TTDS00394	Antagonist	BIM23A760
TTDS00394	Agonist	L-054852
TTDS00394	Agonist	Pasireotide
TTDS00394	Binder	Lanreotide Autogel
TTDS00394	Binder	Octreotide
TTDS00394	Multitarget	Pasireotide
TTDS00395	UniProt ID	P21731
TTDS00395	Name	Thromboxane A2 receptor
TTDS00395	Type of target	Successful target
TTDS00395	Synonyms	Prostanoid TP receptor
TTDS00395	Synonyms	TXA2 receptor
TTDS00395	Synonyms	TXA2-R
TTDS00395	Disease	Platelet adhesion
TTDS00395	Function	Receptor for thromboxane a2 (txa2), a potent stimulator of platelet aggregation.
TTDS00395	Sequence	MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLV
TTDS00395	PDB Structure	1LBN
TTDS00395	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00395	Pathway	Calcium signaling pathway
TTDS00395	Pathway	Neuroactive ligand-receptor interaction
TTDS00395	Related US Patent	6,469,011
TTDS00395	Target Validation	TTDS00395
TTDS00395	Drug(s)	BIBV 308
TTDS00395	Drug(s)	Ifetroban sodium
TTDS00395	Drug(s)	Ramatroban
TTDS00395	Drug(s)	Ridogrel
TTDS00395	Drug(s)	Seratrodast
TTDS00395	Inhibitor	BM-573
TTDS00395	Inhibitor	DALTROBAN
TTDS00395	Inhibitor	L-657925;L-657926
TTDS00395	Inhibitor	LAROPIPRANT
TTDS00395	Inhibitor	SQ-29548
TTDS00395	Inhibitor	U-44069
TTDS00395	Antagonist	BIBV 308
TTDS00395	Antagonist	Ifetroban sodium
TTDS00395	Antagonist	Ramatroban
TTDS00395	Antagonist	Seratrodast
TTDS00395	Binder	Ridogrel
TTDS00397	UniProt ID	P04746
TTDS00397	Name	Pancreatic alpha-amylase
TTDS00397	Type of target	Successful target
TTDS00397	Synonyms	1,4-alpha-D-glucan glucanohydrolase
TTDS00397	Synonyms	AMY2A
TTDS00397	Synonyms	PA
TTDS00397	Disease	Hypoglycemia
TTDS00397	Disease	Pancreatic disease
TTDS00397	Sequence	MKFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPV
TTDS00397	PDB Structure	1KBK; 1KGU; 1KGW; 1KGX; 1U2Y; 1U30; 1U33; 1XCW
TTDS00397	BioChemical Class	Glycosylases
TTDS00397	Pathway	Metabolic pathways
TTDS00397	Pathway	Starch and sucrose metabolism
TTDS00397	EC Number	EC 3.2.1.1
TTDS00397	Inhibitor	4,6-Dideoxy-4-Amino-Alpha-D-Glucose
TTDS00397	Inhibitor	5-Hydroxymethyl-Chonduritol
TTDS00397	Inhibitor	6-Deoxy-Alpha-D-Glucose
TTDS00397	Inhibitor	Acarbose Derived Hexasaccharide
TTDS00397	Inhibitor	Acarviostatin III03
TTDS00397	Inhibitor	Acarviostatin IV03
TTDS00397	Inhibitor	Alpha-acarviosinyl-(1-->7)-3-alpha-D-glucopyranosylpropen
TTDS00397	Inhibitor	Alpha-acarviosinyl-(1-->9)-3-alpha-D-glucopyranosylpropen
TTDS00397	Inhibitor	Beta-D-Glucose
TTDS00397	Inhibitor	Hydroxycitric acid
TTDS00397	Inhibitor	Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam
TTDS00397	Inhibitor	Pyroglutamic Acid
TTDS00398	UniProt ID	Q9BQB6
TTDS00398	Name	Vitamin K epoxide reductase complex subunit 1
TTDS00398	Type of target	Successful target
TTDS00398	Synonyms	MSTP134
TTDS00398	Synonyms	MSTP576
TTDS00398	Synonyms	UNQ308/PRO351
TTDS00398	Synonyms	VKOR
TTDS00398	Synonyms	VKORC1
TTDS00398	Synonyms	Vitamin K1 2,3-epoxide reductase subunit 1
TTDS00398	Disease	Thromboembolic disease
TTDS00398	Sequence	MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSN
TTDS00398	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00398	Pathway	Biosynthesis of steroids
TTDS00398	Pathway	Metabolic pathways
TTDS00398	EC Number	EC 1.1.4.1
TTDS00398	Target Validation	TTDS00398
TTDS00398	Drug(s)	Acenocoumarol
TTDS00398	Drug(s)	Dicumarol
TTDS00398	Drug(s)	Phenindione
TTDS00398	Drug(s)	Phenprocoumon
TTDS00398	Drug(s)	Warfarin
TTDS00398	Inhibitor	Acenocoumarol
TTDS00398	Inhibitor	Dicumarol
TTDS00398	Inhibitor	Phenindione
TTDS00398	Inhibitor	Phenprocoumon
TTDS00398	Inhibitor	Warfarin
TTDS00399	UniProt ID	P46098
TTDS00399	Name	5-hydroxytryptamine receptor 3A
TTDS00399	Type of target	Successful target
TTDS00399	Synonyms	5-HT-3
TTDS00399	Synonyms	5-HT3A
TTDS00399	Synonyms	5-HT3R
TTDS00399	Synonyms	5HT3R
TTDS00399	Synonyms	HTR3
TTDS00399	Synonyms	HTR3A
TTDS00399	Synonyms	Serotonin receptor 3A
TTDS00399	Synonyms	Serotonin-gated ion channel receptor
TTDS00399	Disease	Chemotherapy-induced nausea and vomiting
TTDS00399	Disease	Diarrhea
TTDS00399	Disease	Irritable bowel syndrome
TTDS00399	Disease	Postoperative nausea and vomiting
TTDS00399	Sequence	MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVRPVRDWRKPTTVSIDVIVYAILNVDEKNQVL
TTDS00399	BioChemical Class	Ion transport
TTDS00399	Target Validation	TTDS00399
TTDS00399	Drug(s)	ATI-17000
TTDS00399	Drug(s)	Alosetron
TTDS00399	Drug(s)	Arverapamil
TTDS00399	Drug(s)	DDP-225
TTDS00399	Drug(s)	Dolasetron
TTDS00399	Drug(s)	Levetriacetam
TTDS00399	Drug(s)	Palonosetron
TTDS00399	Drug(s)	Procaine
TTDS00399	Drug(s)	Renzapride
TTDS00399	Drug(s)	Tropisetron
TTDS00399	Inhibitor	(4-Quinolin-2-ylpiperazin-1-yl)acetic Acid
TTDS00399	Inhibitor	1-(biphenyl-4-yl)-3-(4-(piperidin-1-yl)butyl)urea
TTDS00399	Inhibitor	10,11-dihydro-5H-dibenzo[b,f]azepine
TTDS00399	Inhibitor	2-(1H-Imidazol-4-ylmethyl)-4-phenyl-thiazole
TTDS00399	Inhibitor	2-(4-Benzyl-piperazin-1-yl)-benzothiazole
TTDS00399	Inhibitor	2-(4-Methyl-piperazin-1-yl)-quinoline
TTDS00399	Inhibitor	3-(2-Amino-ethyl)-2-methyl-1H-indol-5-ol
TTDS00399	Inhibitor	3alpha-(1'-Methyl-2'-Indolecarbonyloxy)-tropane
TTDS00399	Inhibitor	3alpha-(2'-Indolecarbonyloxy)-nortropane
TTDS00399	Inhibitor	4-((naphthalen-2-yloxy)methyl)piperidine
TTDS00399	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDS00399	Inhibitor	4-Benzoxazo-2-yl-1,4-diazabicyclo[3.2.2]nonane
TTDS00399	Inhibitor	5,6-dichloro-3,4-dihydroquinazolin-2-amine
TTDS00399	Inhibitor	5-chloro-3,4-dihydroquinazolin-2-amine
TTDS00399	Inhibitor	6-(4-Methyl-piperazin-1-yl)-phenanthridine
TTDS00399	Inhibitor	7-(piperidin-4-ylmethoxy)-2-naphthonitrile
TTDS00399	Inhibitor	A-987306
TTDS00399	Inhibitor	BEMESETRON
TTDS00399	Inhibitor	BRL-24682
TTDS00399	Inhibitor	BRL-46470
TTDS00399	Inhibitor	CP-810123
TTDS00399	Inhibitor	FLUPENTIXOLE
TTDS00399	Inhibitor	MESULERGINE
TTDS00399	Inhibitor	ML-10302
TTDS00399	Inhibitor	Norcisapride
TTDS00399	Inhibitor	PH-709829
TTDS00399	Inhibitor	PHA-543613
TTDS00399	Inhibitor	QUIPAZINE
TTDS00399	Inhibitor	SC-52491
TTDS00399	Inhibitor	SC-53116
TTDS00399	Inhibitor	SDZ-205557
TTDS00399	Inhibitor	SEROTONIN
TTDS00399	Inhibitor	ZACOPRIDE
TTDS00399	Antagonist	AS-8112
TTDS00399	Antagonist	ATI-17000
TTDS00399	Antagonist	Alosetron
TTDS00399	Antagonist	Arverapamil
TTDS00399	Antagonist	CR-3124
TTDS00399	Antagonist	DDP-225
TTDS00399	Antagonist	Dolasetron
TTDS00399	Antagonist	Levetriacetam
TTDS00399	Antagonist	Palonosetron
TTDS00399	Antagonist	Procaine
TTDS00399	Antagonist	Renzapride
TTDS00399	Antagonist	Tropisetron
TTDS00399	Multitarget	Renzapride
TTDS00400	UniProt ID	Q15822
TTDS00400	Name	Neuronal acetylcholine receptor subunit alpha-2
TTDS00400	Type of target	Successful target
TTDS00400	Synonyms	CHRNA2
TTDS00400	Disease	Anesthesia
TTDS00400	Disease	Postoperative residual curarisation
TTDS00400	Sequence	MGPSCPVFLSFTKLSLWWLLLTPAGGEEAKRPPPRAPGDPLSSPSPTALPQGGSHTETEDRLFKHLFRGYNRWARPVPNT
TTDS00400	BioChemical Class	Ion transport
TTDS00400	Target Validation	TTDS00400
TTDS00400	Drug(s)	Carbachol
TTDS00400	Drug(s)	Decamethonium
TTDS00400	Drug(s)	Doxacurium chloride
TTDS00400	Drug(s)	Levallorphan
TTDS00400	Drug(s)	Metocurine
TTDS00400	Drug(s)	Metocurine Iodide
TTDS00400	Drug(s)	Mivacurium
TTDS00400	Drug(s)	Pipecuronium
TTDS00400	Drug(s)	Rocuronium
TTDS00400	Drug(s)	Tubocurarine
TTDS00400	Drug(s)	Vecuronium
TTDS00400	Inhibitor	(S)-3-(azetidin-2-ylmethoxy)-2-fluoropyridine
TTDS00400	Inhibitor	1,1-Dimethyl-4-phenyl-piperazin-1-ium; iodide
TTDS00400	Inhibitor	1-(piperidin-3-ylmethyl)pyridin-2(1H)-one
TTDS00400	Inhibitor	1-(piperidin-4-ylmethyl)pyridin-2(1H)-one
TTDS00400	Inhibitor	2-Pyridin-3-yl-7-aza-bicyclo[2.2.1]heptane
TTDS00400	Inhibitor	3-((S)-Azetidin-2-yloxy)-5-iodo-pyridine
TTDS00400	Inhibitor	5-(1-Methyl-pyrrolidin-2-yl)-2-phenethyl-pyridine
TTDS00400	Inhibitor	ACETYLCHOLINE CHLORIDE
TTDS00400	Inhibitor	CHOLINE
TTDS00400	Inhibitor	CYTISINE
TTDS00400	Antagonist	Carbachol
TTDS00400	Antagonist	Cisatracurium
TTDS00400	Antagonist	Decamethonium
TTDS00400	Antagonist	Doxacurium chloride
TTDS00400	Antagonist	Levallorphan
TTDS00400	Antagonist	Metocurine
TTDS00400	Antagonist	Metocurine Iodide
TTDS00400	Antagonist	Mivacurium
TTDS00400	Antagonist	Pipecuronium
TTDS00400	Antagonist	Rocuronium
TTDS00400	Antagonist	Tubocurarine
TTDS00400	Antagonist	Vecuronium
TTDS00401	UniProt ID	P20839
TTDS00401	Name	Inosine-5'-monophosphate dehydrogenase 1
TTDS00401	Type of target	Successful target
TTDS00401	Synonyms	IMP dehydrogenase 1
TTDS00401	Synonyms	IMPD 1
TTDS00401	Synonyms	IMPD1
TTDS00401	Synonyms	IMPDH-I
TTDS00401	Synonyms	IMPDH1
TTDS00401	Disease	Inflammatory bowel disease
TTDS00401	Sequence	MADYLISGGTGYVPEDGLTAQQLFASADGLTYNDFLILPGFIDFIADEVDLTSALTRKITLKTPLISSPMDTVTEADMAI
TTDS00401	PDB Structure	1JCN
TTDS00401	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00401	EC Number	EC 1.1.1.205
TTDS00401	Target Validation	TTDS00401
TTDS00401	Drug(s)	Azathioprine
TTDS00401	Inhibitor	6-Chloropurine Riboside, 5'-Monophosphate
TTDS00401	Inhibitor	Azathioprine
TTDS00401	Inhibitor	Mycophenolic bis(sulfonamide)
TTDS00401	Inhibitor	mycophenolic hydroxamic acid
TTDS00401	Inhibitor	tiazofurin adenine dinucleotide
TTDS00402	UniProt ID	Q14524
TTDS00402	Name	Sodium channel protein type 5 subunit alpha
TTDS00402	Type of target	Successful target
TTDS00402	Synonyms	HH1
TTDS00402	Synonyms	SCN5A
TTDS00402	Synonyms	Sodium channel protein cardiac muscle subunit alpha
TTDS00402	Synonyms	Sodium channel protein type V subunit alpha
TTDS00402	Synonyms	Voltage-gated sodium channel subunit alpha Nav1.5
TTDS00402	Disease	Analgesics
TTDS00402	Disease	Cardiac dysrhythmias
TTDS00402	Disease	Epileptic seizures
TTDS00402	Disease	Pain
TTDS00402	Disease	Refractory partial epilepsy
TTDS00402	Disease	Sustained ventricular tachycardia
TTDS00402	Sequence	MANFLLPRGTSSFRRFTRESLAAIEKRMAEKQARGSTTLQESREGLPEEEAPRPQLDLQASKKLPDLYGNPPQELIGEPL
TTDS00402	PDB Structure	2KBI
TTDS00402	BioChemical Class	Voltage-gated channel
TTDS00402	Target Validation	TTDS00402
TTDS00402	Drug(s)	Benzonatate
TTDS00402	Drug(s)	Dibucaine
TTDS00402	Drug(s)	Disopyramide
TTDS00402	Drug(s)	Dyclonine
TTDS00402	Drug(s)	Encainide
TTDS00402	Drug(s)	Ethotoin
TTDS00402	Drug(s)	Flecainide
TTDS00402	Drug(s)	Fosphenytoin
TTDS00402	Drug(s)	Hexylcaine
TTDS00402	Drug(s)	Indecainide
TTDS00402	Drug(s)	Mephenytoin
TTDS00402	Drug(s)	Mexiletine
TTDS00402	Drug(s)	Moricizine
TTDS00402	Drug(s)	Prilocaine
TTDS00402	Drug(s)	Procainamide
TTDS00402	Drug(s)	Proparacaine
TTDS00402	Drug(s)	Quinidine
TTDS00402	Drug(s)	Tetrodotoxin
TTDS00402	Drug(s)	Tocainide
TTDS00402	Inhibitor	1-[5-(4-Chlorophenyl)-2-furoyl]piperazine
TTDS00402	Inhibitor	Enecadin
TTDS00402	Inhibitor	Indol-1-yl-propyl-pyridin-4-yl-amine(Besipirdine)
TTDS00402	Inhibitor	KC-12291
TTDS00402	Inhibitor	LOMERIZINE
TTDS00402	Inhibitor	LUBELUZOLE
TTDS00402	Inhibitor	N-(4-Methyl-benzoyl)-N'-phenethyl-guanidine
TTDS00402	Inhibitor	N-Butyl-N'-(4-methyl-benzoyl)-guanidine
TTDS00402	Inhibitor	PD-85639
TTDS00402	Inhibitor	SIPATRIGINE
TTDS00402	Blocker	Acetylprocainamide
TTDS00402	Blocker	Benzonatate
TTDS00402	Blocker	Dibucaine
TTDS00402	Blocker	Disopyramide
TTDS00402	Blocker	Dyclonine
TTDS00402	Blocker	Encainide
TTDS00402	Blocker	Ethotoin
TTDS00402	Blocker	Flecainide
TTDS00402	Blocker	Fosphenytoin
TTDS00402	Blocker	Hexylcaine
TTDS00402	Blocker	Indecainide
TTDS00402	Blocker	Mephenytoin
TTDS00402	Blocker	Mexiletine
TTDS00402	Blocker	Moricizine
TTDS00402	Blocker	Prilocaine
TTDS00402	Blocker	Procainamide
TTDS00402	Blocker	Proparacaine
TTDS00402	Blocker	Quinidine
TTDS00402	Blocker	Tetrodotoxin
TTDS00402	Blocker	Tocainide
TTDS00403	UniProt ID	P14867
TTDS00403	Name	Gamma-aminobutyric acid receptor subunit alpha-1
TTDS00403	Type of target	Successful target
TTDS00403	Synonyms	GABA(A) receptor subunit alpha-1
TTDS00403	Synonyms	GABRA1
TTDS00403	Disease	Anxiety disorders
TTDS00403	Disease	Insomnia
TTDS00403	Sequence	MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLLDGYDNRLRPGLGERVTEVKTDIFVTSFGPV
TTDS00403	BioChemical Class	Chloride channel
TTDS00403	Pathway	Neuroactive ligand-receptor interaction
TTDS00403	Target Validation	TTDS00403
TTDS00403	Drug(s)	Amobarbital
TTDS00403	Drug(s)	Barbital
TTDS00403	Drug(s)	Barbituric acid
TTDS00403	Drug(s)	Butabarbital
TTDS00403	Drug(s)	Butalbital
TTDS00403	Drug(s)	Butethal
TTDS00403	Drug(s)	Clobazam
TTDS00403	Drug(s)	Ethanol
TTDS00403	Drug(s)	Ethchlorvynol
TTDS00403	Drug(s)	Etomidate
TTDS00403	Drug(s)	Flumazenil
TTDS00403	Drug(s)	Halazepam
TTDS00403	Drug(s)	Hexobarbital
TTDS00403	Drug(s)	Meprobamate
TTDS00403	Drug(s)	Metharbital
TTDS00403	Drug(s)	Methohexital
TTDS00403	Drug(s)	Methoxyflurane
TTDS00403	Drug(s)	Methylphenobarbital
TTDS00403	Drug(s)	Methyprylon
TTDS00403	Drug(s)	Nitrazepam
TTDS00403	Drug(s)	Pentobarbital
TTDS00403	Drug(s)	Picrotoxin
TTDS00403	Drug(s)	Prazepam
TTDS00403	Drug(s)	Primidone
TTDS00403	Drug(s)	Quazepam
TTDS00403	Drug(s)	Secobarbital
TTDS00403	Drug(s)	Talbutal
TTDS00403	Drug(s)	Thiamylal
TTDS00403	Inhibitor	(4R)-4-ammoniopentanoate
TTDS00403	Inhibitor	(4S)-4-ammoniopentanoate
TTDS00403	Inhibitor	ALLOPREGNANOLONE
TTDS00403	Inhibitor	AMENTOFLAVONE
TTDS00403	Inhibitor	BETA-CCM
TTDS00403	Inhibitor	Barbital
TTDS00403	Inhibitor	Barbituric acid derivative
TTDS00403	Inhibitor	CGP-27492
TTDS00403	Inhibitor	CGS-13767
TTDS00403	Inhibitor	CGS-8216
TTDS00403	Inhibitor	CGS-9895
TTDS00403	Inhibitor	CGS-9896
TTDS00403	Inhibitor	CI-218872
TTDS00403	Inhibitor	Divaplon
TTDS00403	Inhibitor	ELTANOLONE
TTDS00403	Inhibitor	GABAZINE
TTDS00403	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDS00403	Inhibitor	GNF-PF-3645
TTDS00403	Inhibitor	GNF-PF-4421
TTDS00403	Inhibitor	NORHARMANE
TTDS00403	Inhibitor	NSC-19028
TTDS00403	Inhibitor	NSC-73613
TTDS00403	Inhibitor	NSC-93394
TTDS00403	Inhibitor	PNU-91571
TTDS00403	Inhibitor	RIPAZEPAM
TTDS00403	Inhibitor	RO-054520
TTDS00403	Inhibitor	RO-145974
TTDS00403	Inhibitor	RO-145975
TTDS00403	Inhibitor	RO-147437
TTDS00403	Inhibitor	RO-194603
TTDS00403	Inhibitor	RWJ-16979
TTDS00403	Inhibitor	RY-066
TTDS00403	Inhibitor	Ro-151310
TTDS00403	Inhibitor	Ro-154513
TTDS00403	Inhibitor	Ro-4882224
TTDS00403	Inhibitor	Ro-4938581
TTDS00403	Inhibitor	THIOCOLCHICOSIDE
TTDS00403	Inhibitor	TPA-023
TTDS00403	Inhibitor	U-78875
TTDS00403	Inhibitor	U-89267
TTDS00403	Inhibitor	ZK-93423
TTDS00403	Antagonist	Amobarbital
TTDS00403	Antagonist	Barbital
TTDS00403	Antagonist	Barbituric acid
TTDS00403	Antagonist	Butabarbital
TTDS00403	Antagonist	Butalbital
TTDS00403	Antagonist	Butethal
TTDS00403	Antagonist	Clobazam
TTDS00403	Antagonist	Ethanol
TTDS00403	Antagonist	Ethchlorvynol
TTDS00403	Antagonist	Etomidate
TTDS00403	Antagonist	Flumazenil
TTDS00403	Antagonist	Halazepam
TTDS00403	Antagonist	Hexobarbital
TTDS00403	Antagonist	Meprobamate
TTDS00403	Antagonist	Metharbital
TTDS00403	Antagonist	Methohexital
TTDS00403	Antagonist	Methoxyflurane
TTDS00403	Antagonist	Methylphenobarbital
TTDS00403	Antagonist	Methyprylon
TTDS00403	Antagonist	Nitrazepam
TTDS00403	Antagonist	Pentobarbital
TTDS00403	Antagonist	Picrotoxin
TTDS00403	Antagonist	Prazepam
TTDS00403	Antagonist	Primidone
TTDS00403	Antagonist	Quazepam
TTDS00403	Antagonist	Secobarbital
TTDS00403	Antagonist	Talbutal
TTDS00403	Antagonist	Thiamylal
TTDS00404	UniProt ID	P35498
TTDS00404	Name	Sodium channel protein type 1 subunit alpha
TTDS00404	Type of target	Successful target
TTDS00404	Synonyms	NAC1
TTDS00404	Synonyms	SCN1
TTDS00404	Synonyms	SCN1A
TTDS00404	Synonyms	Sodium channel protein type I subunit alpha
TTDS00404	Synonyms	Sodium channel protein, brain I subunit alpha
TTDS00404	Synonyms	Voltage-gated sodium channel subunit alpha Nav1.1
TTDS00404	Disease	Analgesics
TTDS00404	Disease	Local anesthesia
TTDS00404	Disease	Pain
TTDS00404	Disease	Seizures
TTDS00404	Sequence	MEQTVLVPPGPDSFNFFTRESLAAIERRIAEEKAKNPKPDKKDDDENGPKPNSDLEAGKNLPFIYGDIPPEMVSEPLEDL
TTDS00404	BioChemical Class	Voltage-gated channel
TTDS00404	Target Validation	TTDS00404
TTDS00404	Drug(s)	Levetiracetam
TTDS00404	Drug(s)	Phenacemide
TTDS00404	Drug(s)	Zonisamide
TTDS00404	Inhibitor	2-(1-Pentyl-hexyl)-4-phenyl-1H-imidazole
TTDS00404	Inhibitor	2-Hexyl-4-(4-isobutyl-phenyl)-1H-imidazole
TTDS00404	Inhibitor	2-Hydroxy-2-phenyl-nonanoic acid amide
TTDS00404	Inhibitor	4-Biphenyl-4-yl-2-(1-pentyl-hexyl)-1H-imidazole
TTDS00404	Inhibitor	4-Biphenyl-4-yl-2-(1-propyl-butyl)-1H-imidazole
TTDS00404	Inhibitor	4-Biphenyl-4-yl-2-cyclohexylmethyl-1H-imidazole
TTDS00404	Inhibitor	4-Biphenyl-4-yl-2-hexyl-1H-imidazole
TTDS00404	Inhibitor	4-Biphenyl-4-yl-2-methyl-1H-imidazole
TTDS00404	Inhibitor	5-Ethyl-3-methyl-5-phenyl-oxazolidine-2,4-dione
TTDS00404	Inhibitor	5-Heptyl-5-phenyl-imidazolidine-2,4-dione
TTDS00404	Inhibitor	5-Hexyl-5-phenyl-imidazolidine-2,4-dione
TTDS00404	Inhibitor	5-Nonyl-5-phenyl-imidazolidine-2,4-dione
TTDS00404	Inhibitor	BW-202W92
TTDS00404	Inhibitor	L-741742
TTDS00404	Inhibitor	LIDOFLAZINE
TTDS00404	Inhibitor	LIFARIZINE
TTDS00404	Inhibitor	LUBELUZOLE
TTDS00404	Inhibitor	PD-85639
TTDS00404	Inhibitor	SIPATRIGINE
TTDS00404	Inhibitor	U-92032
TTDS00404	Blocker	Levetiracetam
TTDS00404	Blocker	Phenacemide
TTDS00404	Blocker	Zonisamide
TTDS00405	UniProt ID	P12235
TTDS00405	Name	Adenine nucleotide translocator 1
TTDS00405	Type of target	Successful target
TTDS00405	Synonyms	ADP,ATP carrier protein 1
TTDS00405	Synonyms	ADP,ATP carrier protein, heart/skeletal muscle isoform T1
TTDS00405	Synonyms	ADP/ATP translocase 1
TTDS00405	Synonyms	ANT 1
TTDS00405	Synonyms	ANT1
TTDS00405	Synonyms	SLC25A4
TTDS00405	Synonyms	Solute carrier family 25 member 4
TTDS00405	Disease	Hypercalcemia of malignancy
TTDS00405	Disease	Osteolysis
TTDS00405	Sequence	MGDHAWSFLKDFLAGGVAAAVSKTAVAPIERVKLLLQVQHASKQISAEKQYKGIIDCVVRIPKEQGFLSFWRGNLANVIR
TTDS00405	BioChemical Class	Transmembrane protein
TTDS00405	Pathway	Calcium signaling pathway
TTDS00405	Pathway	Huntington's disease
TTDS00405	Pathway	Parkinson's disease
TTDS00405	Drug(s)	Clodronate
TTDS00405	Inhibitor	Carboxyatractyloside
TTDS00405	Inhibitor	Cardiolipin
TTDS00405	Inhibitor	Clodronate
TTDS00405	Inhibitor	Di-Stearoyl-3-Sn-Phosphatidylcholine
TTDS00406	UniProt ID	P06241
TTDS00406	Name	Proto-oncogene tyrosine-protein kinase Fyn
TTDS00406	Type of target	Successful target
TTDS00406	Synonyms	FYN
TTDS00406	Synonyms	Protooncogene Syn
TTDS00406	Synonyms	SLK
TTDS00406	Synonyms	p59-Fyn
TTDS00406	Disease	Philadelphia-positive leukemia
TTDS00406	Sequence	MGCVQCKDKEATKLTEERDGSLNQSSGYRYGTDPTPQHYPSFGVTSIPNYNNFHAAGGQGLTVFGGVNSSSHTGTLRTRG
TTDS00406	PDB Structure	1AZG; 1EFN; 1FYN; 1G83; 1M27; 1NYF; 1NYG; 1SHF
TTDS00406	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00406	Pathway	Adherens junction
TTDS00406	Pathway	Axon guidance
TTDS00406	Pathway	Fc epsilon RI signaling pathway
TTDS00406	Pathway	Focal adhesion
TTDS00406	Pathway	Natural killer cell mediated cytotoxicity
TTDS00406	Pathway	Pathogenic Escherichia coli infection
TTDS00406	Pathway	T cell receptor signaling pathway
TTDS00406	Target Validation	TTDS00406
TTDS00406	Drug(s)	Dasatinib
TTDS00406	Inhibitor	1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane
TTDS00406	Inhibitor	CEP-5104
TTDS00406	Inhibitor	CEP-6331
TTDS00406	Inhibitor	Dasatinib
TTDS00406	Inhibitor	JNJ-10198409
TTDS00406	Inhibitor	Ro-4396686
TTDS00406	Multitarget	Dasatinib
TTDS00407	UniProt ID	P06239
TTDS00407	Name	Proto-oncogene tyrosine-protein kinase LCK
TTDS00407	Type of target	Successful target
TTDS00407	Synonyms	FYN
TTDS00407	Synonyms	Protooncogene Syn
TTDS00407	Synonyms	SLK
TTDS00407	Synonyms	p59-Fyn
TTDS00407	Disease	Philadelphia-positive leukemia
TTDS00407	Sequence	MGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVTYEGSNPPASPLQDNLVIALHSYEPSHDGDL
TTDS00407	PDB Structure	1FBZ; 1H92; 1IJR; 1KIK; 1LCJ; 1LCK; 1LKK; 1LKL
TTDS00407	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00407	Pathway	Natural killer cell mediated cytotoxicity
TTDS00407	Pathway	Primary immunodeficiency
TTDS00407	Pathway	T cell receptor signaling pathway
TTDS00407	Target Validation	TTDS00407
TTDS00407	QSAR Model	TTDS00407
TTDS00407	Drug(s)	Dasatinib
TTDS00407	Drug(s)	VX-680
TTDS00407	Inhibitor	(4-Phenoxy-phenyl)-quinazolin-4-yl-amine
TTDS00407	Inhibitor	2-(3,4,5-Trihydroxy-benzylidene)-malononitrile
TTDS00407	Inhibitor	3-(4-(o-toluidino)pyrimidin-2-ylamino)benzamide
TTDS00407	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDS00407	Inhibitor	4-(3-Chloro-phenoxy)-6,7-dimethoxy-quinazoline
TTDS00407	Inhibitor	4-Phenylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine
TTDS00407	Inhibitor	6-o-tolylquinazolin-2-amine
TTDS00407	Inhibitor	A-420983
TTDS00407	Inhibitor	A-641359
TTDS00407	Inhibitor	A-770041
TTDS00407	Inhibitor	AG-1879
TTDS00407	Inhibitor	AZD-0530
TTDS00407	Inhibitor	AZD-1152-HQPA;Barasertib
TTDS00407	Inhibitor	BIRB796
TTDS00407	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDS00407	Inhibitor	BMS-536924
TTDS00407	Inhibitor	CEP-5104
TTDS00407	Inhibitor	CGP-57380
TTDS00407	Inhibitor	CI-1040;PD-18435;PD-184352
TTDS00407	Inhibitor	Dasatinib
TTDS00407	Inhibitor	GF-109203
TTDS00407	Inhibitor	GW-788388
TTDS00407	Inhibitor	Go-6976
TTDS00407	Inhibitor	JNJ-10198409
TTDS00407	Inhibitor	KN-62
TTDS00407	Inhibitor	L-779450
TTDS00407	Inhibitor	LAVENDUSTIN A
TTDS00407	Inhibitor	LY-294002
TTDS00407	Inhibitor	NM-PP1
TTDS00407	Inhibitor	PD-0166326;PD-166326
TTDS00407	Inhibitor	PD-0173952
TTDS00407	Inhibitor	PD-0173955;PD-17395
TTDS00407	Inhibitor	PD-0173956
TTDS00407	Inhibitor	PD-0173958
TTDS00407	Inhibitor	PD-0179483
TTDS00407	Inhibitor	PD-0180970
TTDS00407	Inhibitor	PD-98059
TTDS00407	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDS00407	Inhibitor	RO-316233
TTDS00407	Inhibitor	RPR-108518A
TTDS00407	Inhibitor	SB-202190
TTDS00407	Inhibitor	SB-203580
TTDS00407	Inhibitor	STAUROSPORINONE
TTDS00407	Inhibitor	SU 6656
TTDS00407	Inhibitor	Staurosporine
TTDS00407	Inhibitor	TG-100435
TTDS00407	Inhibitor	U-0126
TTDS00407	Inhibitor	VX-680
TTDS00407	Inhibitor	Y-c[D-Pen-(3,5-diI)Tyr-GSFC]KR-NH2
TTDS00407	Inhibitor	Y-c[D-Pen-(3-I)Tyr-GSFC]KR-NH2
TTDS00407	Inhibitor	ZM-336372
TTDS00407	Multitarget	Dasatinib
TTDS00407	Multitarget	VX-680
TTDS00408	UniProt ID	P07947
TTDS00408	Name	Proto-oncogene tyrosine-protein kinase Yes
TTDS00408	Type of target	Successful target
TTDS00408	Synonyms	FYN
TTDS00408	Synonyms	Protooncogene Syn
TTDS00408	Synonyms	SLK
TTDS00408	Synonyms	p59-Fyn
TTDS00408	Disease	Philadelphia-positive leukemia
TTDS00408	Sequence	MGCIKSKENKSPAIKYRPENTPEPVSTSVSHYGAEPTTVSPCPSSSAKGTAVNFSSLSMTPFGGSSGVTPFGGASSSFSV
TTDS00408	PDB Structure	2HDA
TTDS00408	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00408	Pathway	Adherens junction
TTDS00408	Pathway	Tight junction
TTDS00408	Target Validation	TTDS00408
TTDS00408	Inhibitor	AZD-0530
TTDS00408	Inhibitor	CGP77675
TTDS00408	Inhibitor	TG-100435
TTDS00409	UniProt ID	P63316
TTDS00409	Name	Troponin C
TTDS00409	Type of target	Successful target
TTDS00409	Synonyms	TN-C
TTDS00409	Synonyms	TNNC
TTDS00409	Synonyms	TNNC1
TTDS00409	Synonyms	Troponin C, slow skeletal and cardiac muscles
TTDS00409	Disease	Biventricular heart failure
TTDS00409	Disease	Chronic heart failure
TTDS00409	Sequence	MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVM
TTDS00409	PDB Structure	1AP4; 1IH0; 1J1D; 1J1E; 1LXF; 1MXL; 1OZS; 1SPY
TTDS00409	Pathway	Calcium signaling pathway
TTDS00409	Pathway	Cardiac muscle contraction
TTDS00409	Target Validation	TTDS00409
TTDS00409	Drug(s)	Dihydroxyaluminium
TTDS00409	Drug(s)	Levosimendan
TTDS00409	Stimulator	Dihydroxyaluminium
TTDS00409	Stimulator	Levosimendan
TTDS00410	UniProt ID	P47870
TTDS00410	Name	Gamma-aminobutyric acid receptor subunit beta-2
TTDS00410	Type of target	Successful target
TTDS00410	Synonyms	GABA(A) receptor subunit beta-2
TTDS00410	Synonyms	GABRB2
TTDS00410	Disease	Insomnia
TTDS00410	Sequence	MWRVRKRGYFGIWSFPLIIAAVCAQSVNDPSNMSLVKETVDRLLKGYDIRLRPDFGGPPVAVGMNIDIASIDMVSEVNMD
TTDS00410	BioChemical Class	Chloride channel
TTDS00410	Pathway	Neuroactive ligand-receptor interaction
TTDS00410	Target Validation	TTDS00410
TTDS00410	Drug(s)	Ethchlorvynol
TTDS00410	Inhibitor	(2E,4S)-4-ammoniopent-2-enoate
TTDS00410	Inhibitor	(4R)-4-ammoniopentanoate
TTDS00410	Inhibitor	(4S)-4-ammoniopentanoate
TTDS00410	Inhibitor	(9-Benzyl-9H-purin-6-yl)-cyclopropyl-amine
TTDS00410	Inhibitor	1,1-Dimethyl-5-oxa-spiro[2.4]heptan-4-one
TTDS00410	Inhibitor	1-(4-chlorophenyl)-4-phenyl-1H-imidazole
TTDS00410	Inhibitor	1-Methyl-5-oxa-spiro[2.4]heptan-4-one
TTDS00410	Inhibitor	2-(4-chlorophenyl)-5-phenyl-4-isoxazolin-3-one
TTDS00410	Inhibitor	2-(9-Benzyl-9H-purin-6-ylamino)-ethanol
TTDS00410	Inhibitor	2-Isoxazol-5-yl-3H-imidazo[4,5-c]quinoline
TTDS00410	Inhibitor	2-Oxa-spiro[4.4]nonan-1-one
TTDS00410	Inhibitor	2-Thiophen-2-yl-3H-imidazo[4,5-c]quinoline
TTDS00410	Inhibitor	3,3-Diethyl-dihydro-furan-2-one
TTDS00410	Inhibitor	3,3-Diisopropyl-dihydro-furan-2-one
TTDS00410	Inhibitor	3-Ethyl-3-isopropyl-dihydro-furan-2-one
TTDS00410	Inhibitor	3-Ethyl-3-methyl-dihydro-furan-2-one
TTDS00410	Inhibitor	3-Isopropyl-3-methyl-dihydro-furan-2-one
TTDS00410	Inhibitor	3-Isothiocyanato-9H-beta-carboline
TTDS00410	Inhibitor	3-Methyl-9H-beta-carboline
TTDS00410	Inhibitor	3-amino-3-demethoxythiocolchicine
TTDS00410	Inhibitor	3-butoxycarbonyl-4-quinolone
TTDS00410	Inhibitor	3-butoxycarbonyl-6-ethyl-4-quinolone
TTDS00410	Inhibitor	3-butylaminocarbonyl-6-ethyl-4-quinolone
TTDS00410	Inhibitor	3-carboxy-6-ethyl-4-quinolone
TTDS00410	Inhibitor	3-cyclopentoxycarbonyl-6-ethyl-4-quinolone
TTDS00410	Inhibitor	3-demethoxy-3-D-lyxopyranosylaminothiocolchicine
TTDS00410	Inhibitor	3-demethoxy-3-D-mannopyranosylaminothiocolchicine
TTDS00410	Inhibitor	3-demethoxy-3-D-xylopyranosylaminothiocolchicine
TTDS00410	Inhibitor	3-demethoxy-3-L-fucopyranosylaminothiocolchicine
TTDS00410	Inhibitor	3-demethoxy-3D-glucopyranosylaminothiocolchicine
TTDS00410	Inhibitor	3-ethoxycarbonyl-4-quinolone
TTDS00410	Inhibitor	3-ethoxycarbonyl-6-ethyl-2-methyl-4-quinolone
TTDS00410	Inhibitor	3-ethoxycarbonyl-6-propyl-4-quinolone
TTDS00410	Inhibitor	3-tert-Butyl-3-ethyl-dihydro-furan-2-one
TTDS00410	Inhibitor	4-(2-aminoethyl)-1,2,5-oxadiazol-3-ol
TTDS00410	Inhibitor	4-(4-chlorophenyl)-1-pyrid-2-yl-pyrazole
TTDS00410	Inhibitor	4-(biphenyl-3-yl)-5-(piperidin-4-yl)isoxazol-3-ol
TTDS00410	Inhibitor	4-Benzyl-5-piperidin-4-yl-isoxazol-3-ol
TTDS00410	Inhibitor	4-Naphthalen-1-yl-5-piperidin-4-yl-isoxazol-3-ol
TTDS00410	Inhibitor	4-Naphthalen-2-yl-5-piperidin-4-yl-isoxazol-3-ol
TTDS00410	Inhibitor	4-Phenyl-5-piperidin-4-yl-isoxazol-3-ol
TTDS00410	Inhibitor	5-Piperidin-4-yl-isoxazol-3-ol
TTDS00410	Inhibitor	5-[(1R)-1-ammonioethyl]isoxazol-3-olate
TTDS00410	Inhibitor	5-[(1S)-1-ammonioethyl]isoxazol-3-olate
TTDS00410	Inhibitor	6,6-Dimethyl-2-oxa-spiro[4.4]nonan-1-one
TTDS00410	Inhibitor	6,9-Dimethyl-2-oxa-spiro[4.4]nonan-1-one
TTDS00410	Inhibitor	6-Methyl-2-oxa-spiro[4.4]nonan-1-one
TTDS00410	Inhibitor	6-benzyl-3-ethoxycarbonyl-4-quinolone
TTDS00410	Inhibitor	6-benzyl-3-propoxycarbonyl-4-quinolone
TTDS00410	Inhibitor	6-benzyl-3-propylaminocarbonyl-4-quinolone
TTDS00410	Inhibitor	6-bromo-3-ethoxycarbonyl-2-methyl-4-quinolone
TTDS00410	Inhibitor	6-bromo-3-ethoxycarbonyl-4-quinolone
TTDS00410	Inhibitor	6-ethyl-3-(2-ethylbutoxycarbonyl)-4-quinolone
TTDS00410	Inhibitor	6-ethyl-3-(2-methylbutoxycarbonyl)-4-quinolone
TTDS00410	Inhibitor	6-ethyl-3-(3-methylbutoxycarbonyl)-4-quinolone
TTDS00410	Inhibitor	6-ethyl-3-(3-pentoxycarbonyl)-4-quinolone
TTDS00410	Inhibitor	6-ethyl-3-i-propoxycarbonyl-4-quinolone
TTDS00410	Inhibitor	6-ethyl-3-pentoxycarbonyl-4-quinolone
TTDS00410	Inhibitor	6-ethyl-3-propoxycarbonyl-4-quinolone
TTDS00410	Inhibitor	6-ethyl-3-propylaminocarbonyl-4-quinolone
TTDS00410	Inhibitor	ALLOPREGNANOLONE
TTDS00410	Inhibitor	AMENTOFLAVONE
TTDS00410	Inhibitor	BETA-CCM
TTDS00410	Inhibitor	CGS-13767
TTDS00410	Inhibitor	CGS-8216
TTDS00410	Inhibitor	CGS-9896
TTDS00410	Inhibitor	CI-218872
TTDS00410	Inhibitor	ELTANOLONE
TTDS00410	Inhibitor	GABAZINE
TTDS00410	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDS00410	Inhibitor	GNF-PF-3645
TTDS00410	Inhibitor	GNF-PF-4421
TTDS00410	Inhibitor	N-(p-methylbenzyl)-5-nitroindol-3-ylglyoxylamide
TTDS00410	Inhibitor	N-Indan-1-yl-2-(1H-indol-3-yl)-2-oxo-acetamide
TTDS00410	Inhibitor	N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide
TTDS00410	Inhibitor	N-benzyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide
TTDS00410	Inhibitor	N-butyl-2-(1H-indol-3-yl)-2-oxoacetamide
TTDS00410	Inhibitor	N-butyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide
TTDS00410	Inhibitor	PNU-91571
TTDS00410	Inhibitor	RO-145974
TTDS00410	Inhibitor	RO-145975
TTDS00410	Inhibitor	RO-147437
TTDS00410	Inhibitor	RO-194603
TTDS00410	Inhibitor	Ro-151310
TTDS00410	Inhibitor	Ro-154513
TTDS00410	Inhibitor	THIOCOLCHICOSIDE
TTDS00410	Inhibitor	U-78875
TTDS00410	Inhibitor	U-89267
TTDS00410	Inhibitor	ZK-93423
TTDS00410	Inhibitor	ridine-5-carboxylic acid ethyl ester
TTDS00410	Antagonist	Ethchlorvynol
TTDS00411	UniProt ID	P07333
TTDS00411	UniProt ID	Q99062
TTDS00411	Name	Macrophage colony-stimulating factor receptor
TTDS00411	Type of target	Successful target
TTDS00411	Synonyms	CD115
TTDS00411	Synonyms	CSF-1-R
TTDS00411	Synonyms	CSF1R
TTDS00411	Synonyms	FMS
TTDS00411	Synonyms	Fms proto-oncogene
TTDS00411	Synonyms	c-fms
TTDS00411	Disease	Bone marrow transplant
TTDS00411	Disease	Febrile neutropenia
TTDS00411	Disease	Non-myeloid cancer
TTDS00411	Sequence	MGPGVLLLLLVATAWHGQGIPVIEPSVPELVVKPGATVTLRCVGNGSVEWDGPPSPHWTLYSDGSSSILSTNNATFQNTG
TTDS00411	PDB Structure	2I0V; 2I0Y; 2I1M; 2OGV; 3BEA; 3DPK; 1AZ7; 2D9Q
TTDS00411	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDS00411	Pathway	Cytokine-cytokine receptor interaction
TTDS00411	Pathway	Hematopoietic cell lineage
TTDS00411	Pathway	Jak-STAT signaling pathway
TTDS00411	Pathway	Pathways in cancer
TTDS00411	Target Validation	TTDS00411
TTDS00411	Drug(s)	AMG 820
TTDS00411	Drug(s)	CSF-1R Monoclonal Antibody
TTDS00411	Drug(s)	Filgrastim
TTDS00411	Drug(s)	IMC-CS4
TTDS00411	Drug(s)	JNJ-40346527
TTDS00411	Drug(s)	PLX3397
TTDS00411	Drug(s)	PLX5622
TTDS00411	Drug(s)	Pegfilgrastim
TTDS00411	Drug(s)	RG7155
TTDS00411	Inhibitor	MLN-518
TTDS00411	Inhibitor	N-(2-morpholinophenyl)-5-nitrofuran-2-carboxamide
TTDS00411	Inhibitor	PKC-412
TTDS00411	Binder	Filgrastim
TTDS00411	Binder	Pegfilgrastim
TTDS00412	UniProt ID	Q9UK17
TTDS00412	Name	Potassium voltage-gated channel subfamily D member 3
TTDS00412	Type of target	Successful target
TTDS00412	Synonyms	KCND3
TTDS00412	Synonyms	Voltage-gated potassium channel subunit Kv4.3
TTDS00412	Disease	Analgesics
TTDS00412	Disease	Migraine
TTDS00412	Disease	Occlusive peripheral vascular disease
TTDS00412	Disease	Pain
TTDS00412	Disease	Vertigo of central and peripheral origin
TTDS00412	Sequence	MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLERYPDTLLGSTEKEFFFNEDTK
TTDS00412	PDB Structure	1S1G; 2NZ0
TTDS00412	BioChemical Class	Voltage-gated channel
TTDS00412	Drug(s)	Sodium bicarbonate
TTDS00412	Blocker	Sodium bicarbonate
TTDS00413	UniProt ID	O95180
TTDS00413	Name	Voltage-dependent T-type calcium channel subunit alpha-1H
TTDS00413	Type of target	Successful target
TTDS00413	Synonyms	KCND3
TTDS00413	Synonyms	Voltage-gated potassium channel subunit Kv4.3
TTDS00413	Disease	Analgesics
TTDS00413	Disease	Migraine
TTDS00413	Disease	Occlusive peripheral vascular disease
TTDS00413	Disease	Pain
TTDS00413	Disease	Vertigo of central and peripheral origin
TTDS00413	Sequence	MTEGARAADEVRVPLGAPPPGPAALVGASPESPGAPGREAERGSELGVSPSESPAAERGAELGADEEQRVPYPALAATVF
TTDS00413	BioChemical Class	Voltage-gated channel
TTDS00413	Pathway	Calcium signaling pathway
TTDS00413	Pathway	MAPK signaling pathway
TTDS00413	Target Validation	TTDS00413
TTDS00413	Drug(s)	Flunarizine
TTDS00413	Drug(s)	Sodium bicarbonate
TTDS00413	Inhibitor	BELFOSDIL
TTDS00413	Inhibitor	GNF-PF-1967
TTDS00413	Inhibitor	GNF-PF-4599
TTDS00413	Inhibitor	KYS-05001
TTDS00413	Inhibitor	KYS-05040
TTDS00413	Inhibitor	KYS-05041
TTDS00413	Inhibitor	KYS-05042
TTDS00413	Inhibitor	KYS-05050
TTDS00413	Inhibitor	KYS-05077
TTDS00413	Inhibitor	KYS-05080
TTDS00413	Inhibitor	U-92032
TTDS00413	Inhibitor	cis-N,5-dibenzyl-6-oxomorpholine-3-carboxamide
TTDS00413	Blocker	Flunarizine
TTDS00413	Blocker	Sodium bicarbonate
TTDS00414	UniProt ID	Q13936
TTDS00414	Name	Voltage-dependent L-type calcium channel subunit alpha-1C
TTDS00414	Type of target	Successful target
TTDS00414	Synonyms	CACH2
TTDS00414	Synonyms	CACN2
TTDS00414	Synonyms	CACNA1C
TTDS00414	Synonyms	CACNL1A1
TTDS00414	Synonyms	CCHL1A1
TTDS00414	Synonyms	Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle
TTDS00414	Synonyms	Voltage-gated calcium channel subunit alpha Cav1.2
TTDS00414	Disease	Heart Disease
TTDS00414	Disease	Heart transplant
TTDS00414	Sequence	MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTPGAALSWQAAIDAARQAKLMGSAGNATISTVSSTQ
TTDS00414	PDB Structure	1T0J; 2BE6; 2F3Y; 2F3Z; 3G43
TTDS00414	BioChemical Class	Voltage-gated channel
TTDS00414	Pathway	Alzheimer's disease
TTDS00414	Pathway	Calcium signaling pathway
TTDS00414	Pathway	Cardiac muscle contraction
TTDS00414	Pathway	GnRH signaling pathway
TTDS00414	Pathway	Long-term potentiation
TTDS00414	Pathway	MAPK signaling pathway
TTDS00414	Pathway	Type II diabetes mellitus
TTDS00414	Pathway	Vascular smooth muscle contraction
TTDS00414	Target Validation	TTDS00414
TTDS00414	Drug(s)	Ibutilide
TTDS00414	Inhibitor	(+)-NIGULDIPINE
TTDS00414	Inhibitor	(-)-NIGULDIPINE
TTDS00414	Inhibitor	CGS-27830
TTDS00414	Inhibitor	CORYNANTHEINE
TTDS00414	Inhibitor	CV-4093
TTDS00414	Inhibitor	MEBUDIPINE
TTDS00414	Inhibitor	NIGULDIPINE
TTDS00414	Inhibitor	NILVADIPINE
TTDS00414	Inhibitor	PD-32577
TTDS00414	Inhibitor	R-56865
TTDS00414	Inhibitor	RAUWOLFIA SERPENTINA ROOT
TTDS00414	Inhibitor	SNAP-5089
TTDS00414	Activator	Ibutilide
TTDS00415	UniProt ID	P54289
TTDS00415	UniProt ID	Q06432
TTDS00415	Name	Voltage-dependent calcium channel subunit alpha-2/delta-1
TTDS00415	Type of target	Successful target
TTDS00415	Synonyms	CACNA2D1
TTDS00415	Synonyms	CACNL2A
TTDS00415	Synonyms	CCHL2A
TTDS00415	Synonyms	MHS3
TTDS00415	Synonyms	Voltage-dependent calcium channel subunit alpha-2-1
TTDS00415	Synonyms	Voltage-dependent calcium channel subunit delta-1
TTDS00415	Synonyms	Voltage-gated calcium channel subunit alpha-2/delta-1
TTDS00415	Disease	Analgesics
TTDS00415	Disease	Chronic stable angina
TTDS00415	Disease	Heart transplant
TTDS00415	Disease	Hypertension
TTDS00415	Disease	Vasospastic angina
TTDS00415	Sequence	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVE
TTDS00415	BioChemical Class	Voltage-gated channel
TTDS00415	Target Validation	TTDS00415
TTDS00415	Drug(s)	Amlodipine
TTDS00415	Drug(s)	Diltiazem
TTDS00415	Drug(s)	Isradipine
TTDS00415	Drug(s)	Lercanidipine
TTDS00415	Drug(s)	Nifedipine
TTDS00415	Drug(s)	Nitrendipine
TTDS00415	Inhibitor	(R)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid
TTDS00415	Inhibitor	(S)-2-amino-2-cyclohexylacetic acid
TTDS00415	Inhibitor	(S)-2-amino-2-o-tolylacetic acid
TTDS00415	Inhibitor	(S)-2-amino-2-p-tolylacetic acid
TTDS00415	Inhibitor	(S)-2-amino-2-phenylpropanoic acid
TTDS00415	Inhibitor	(S)-2-amino-3-(benzylthio)propanoic acid
TTDS00415	Inhibitor	(S)-2-amino-3-cyclohexylpropanoic acid
TTDS00415	Inhibitor	(S)-2-amino-4-(benzylthio)butanoic acid
TTDS00415	Inhibitor	(S)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid
TTDS00415	Inhibitor	(S)-phenylglycine
TTDS00415	Inhibitor	1-benzhydryl-4-(3,3-diphenylpropyl)piperazine
TTDS00415	Inhibitor	1-benzhydryl-4-(4,4-diphenylbutyl)piperazine
TTDS00415	Inhibitor	2-(1-(aminomethyl)-3-butylcyclopentyl)acetic acid
TTDS00415	Inhibitor	2-(1-(aminomethyl)-3-ethylcyclopentyl)acetic acid
TTDS00415	Inhibitor	2-amino-2-(2,3-difluorophenyl)acetic acid
TTDS00415	Inhibitor	2-amino-2-(2,4-difluorophenyl)acetic acid
TTDS00415	Inhibitor	2-amino-2-(2-fluorophenyl)acetic acid
TTDS00415	Inhibitor	2-amino-2-(3-bromophenyl)acetic acid
TTDS00415	Inhibitor	2-amino-2-(3-chloro-4-fluorophenyl)acetic acid
TTDS00415	Inhibitor	2-amino-2-(3-chlorophenyl)acetic acid
TTDS00415	Inhibitor	2-amino-2-(thiophen-2-yl)acetic acid
TTDS00415	Inhibitor	2-amino-4-(2-methyl-benzylsulfanyl)-butyric acid
TTDS00415	Inhibitor	3-(aminomethyl)-4-(furan-2-yl)butanoic acid
TTDS00415	Inhibitor	3-(aminomethyl)-4-(furan-3-yl)butanoic acid
TTDS00415	Inhibitor	3-(aminomethyl)-4-(thiophen-2-yl)butanoic acid
TTDS00415	Inhibitor	3-(aminomethyl)-4-(thiophen-3-yl)butanoic acid
TTDS00415	Inhibitor	3-Aminomethyl-5-methyl-hexanoic acid
TTDS00415	Inhibitor	4-(2,3-dichlorobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(2,5-dichlorobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(2-bromobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(2-cyanobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(2-methoxybenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(2-nitrobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3,4-dichlorobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3,4-dimethylbenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3,5-dichlorobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3,5-dimethylbenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3-bromobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3-chlorobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3-cyanobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3-fluorobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3-methoxybenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(3-nitrobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(4-bromobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(4-chlorobenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	4-(4-tert-butylbenzylthio)-2-aminobutanoic acid
TTDS00415	Inhibitor	ETHIONINE
TTDS00415	Inhibitor	Gababutin
TTDS00415	Inhibitor	LOMERIZINE
TTDS00415	Inhibitor	N'-Acridin-9-yl-N,N-diethyl-butane-1,4-diamine
TTDS00415	Inhibitor	N,4-dibenzhydrylpiperazine-1-carboxamide
TTDS00415	Inhibitor	NP-118809
TTDS00415	Inhibitor	PD-144550
TTDS00415	Inhibitor	PHENYLALANINE
TTDS00415	Inhibitor	rac-2-amino-4-phenylbutanoic acid
TTDS00415	Inhibitor	rac-2-amino-5-cyclohexylpentanoic acid
TTDS00415	Inhibitor	trans-dimethyl gababutin
TTDS00415	Blocker	Amlodipine
TTDS00415	Blocker	Diltiazem
TTDS00415	Blocker	Isradipine
TTDS00415	Blocker	Lercanidipine
TTDS00415	Blocker	Nifedipine
TTDS00415	Blocker	Nitrendipine
TTDS00416	UniProt ID	P35499
TTDS00416	Name	Sodium channel protein type 4 subunit alpha
TTDS00416	Type of target	Successful target
TTDS00416	Synonyms	SCN4A
TTDS00416	Synonyms	SkM1
TTDS00416	Synonyms	Sodium channel protein skeletal muscle subunit alpha
TTDS00416	Synonyms	Sodium channel protein type IV subunit alpha
TTDS00416	Synonyms	Voltage-gated sodium channel subunit alpha Nav1.4
TTDS00416	Disease	Analgesics
TTDS00416	Disease	Pain
TTDS00416	Disease	Seizures in epilepsy
TTDS00416	Disease	Seizures of Lennox-Gastaut syndrome
TTDS00416	Sequence	MARPSLCTLVPLGPECLRPFTRESLAAIEQRAVEEEARLQRNKQMEIEEPERKPRSDLEAGKNLPMIYGDPPPEVIGIPL
TTDS00416	BioChemical Class	Voltage-gated channel
TTDS00416	Target Validation	TTDS00416
TTDS00416	QSAR Model	TTDS00416
TTDS00416	Inhibitor	3-(4-Phenoxy-phenyl)-1H-pyrazole
TTDS00416	Inhibitor	3-[4-(4-Fluoro-phenoxy)-phenyl]-1H-pyrazole
TTDS00416	Inhibitor	BW-202W92
TTDS00416	Inhibitor	CCACSSKWCRDHSRCC
TTDS00416	Inhibitor	CCNCASKWCRDHSRCC
TTDS00416	Inhibitor	CCNCSAKWCRDHSRCC
TTDS00416	Inhibitor	CCNCSSKWCRAHSRCC
TTDS00416	Inhibitor	CCNCSSKWCRDHARCC
TTDS00416	Inhibitor	CCNCSSKWCRDHSRCC
TTDS00416	Inhibitor	SIPATRIGINE
TTDS00416	Inhibitor	V-102862
TTDS00416	Inhibitor	ZNCCNCSSKWCRDHSRCC
TTDS00416	Inhibitor	ZRCCNCSSKWCRDHSRCC
TTDS00417	UniProt ID	P23284
TTDS00417	Name	Peptidyl-prolyl cis-trans isomerase B
TTDS00417	Type of target	Successful target
TTDS00417	Synonyms	CYP-S1
TTDS00417	Synonyms	CYPB
TTDS00417	Synonyms	Cyclophilin B
TTDS00417	Synonyms	PPIB
TTDS00417	Synonyms	PPIase
TTDS00417	Synonyms	Rotamase
TTDS00417	Synonyms	S-cyclophilin
TTDS00417	Synonyms	SCYLP
TTDS00417	Disease	Heart disease
TTDS00417	Sequence	MLRLSERNMKVLLAAALIAGSVFFLLLPGPSAADEKKKGPKVTVKVYFDLRIGDEDVGRVIFGLFGKTVPKTVDNFVALA
TTDS00417	PDB Structure	1CYN
TTDS00417	BioChemical Class	Cis-trans-Isomerases
TTDS00417	EC Number	EC 5.2.1.8
TTDS00417	Drug(s)	L-Proline
TTDS00417	Inhibitor	1,4-Dithiothreitol
TTDS00417	Binder	L-Proline
TTDS00418	UniProt ID	P08684
TTDS00418	Name	Cytochrome P450 3A4
TTDS00418	Type of target	Successful target
TTDS00418	Synonyms	Albendazole monooxygenase
TTDS00418	Synonyms	Albendazole sulfoxidase
TTDS00418	Synonyms	CYP3A3
TTDS00418	Synonyms	CYP3A4
TTDS00418	Synonyms	CYPIIIA3
TTDS00418	Synonyms	CYPIIIA4
TTDS00418	Synonyms	Cytochrome P450 3A3
TTDS00418	Synonyms	HLp
TTDS00418	Synonyms	NF-25
TTDS00418	Synonyms	Nifedipine oxidase
TTDS00418	Synonyms	P450-PCN1
TTDS00418	Synonyms	Quinine 3-monooxygenase
TTDS00418	Synonyms	Taurochenodeoxycholate 6-alpha-hydroxylase
TTDS00418	Disease	Hypothalamic-pituitary ACTH function
TTDS00418	Sequence	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQP
TTDS00418	PDB Structure	1TQN; 1W0E; 1W0F; 1W0G; 2J0D; 2V0M
TTDS00418	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00418	Pathway	Drug metabolism - cytochrome P450
TTDS00418	Pathway	Drug metabolism - other enzymes
TTDS00418	Pathway	Linoleic acid metabolism
TTDS00418	Pathway	Metabolic pathways
TTDS00418	Pathway	Metabolism of xenobiotics by cytochrome P450
TTDS00418	Pathway	Retinol metabolism
TTDS00418	Pathway	gamma-Hexachlorocyclohexane degradation
TTDS00418	EC Number	EC 1.14.13.32
TTDS00418	EC Number	EC 1.14.13.67
TTDS00418	EC Number	EC 1.14.13.97
TTDS00418	Target Validation	TTDS00418
TTDS00418	QSAR Model	TTDS00418
TTDS00418	Drug(s)	Clotrimazole
TTDS00418	Inhibitor	(-)-clusin
TTDS00418	Inhibitor	(-)-cubebin
TTDS00418	Inhibitor	(-)-cubebinin
TTDS00418	Inhibitor	(-)-cubebininolide
TTDS00418	Inhibitor	(-)-dihydroclusin
TTDS00418	Inhibitor	(-)-thujaplicatintrimethyl ether
TTDS00418	Inhibitor	(-)-yatein
TTDS00418	Inhibitor	(5-pyridin-3-yl-furan-2-yl)methanethiol
TTDS00418	Inhibitor	(8R,8'R)-4-hydroxycubebinone
TTDS00418	Inhibitor	(8R,8'R,9'S)-5-methoxyclusin
TTDS00418	Inhibitor	1,1':4',1''-terphenyl-3,3''-diol
TTDS00418	Inhibitor	1,2-Diacetoxylycorine
TTDS00418	Inhibitor	1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERI
TTDS00418	Inhibitor	1-(4-Butoxy-phenyl)-1H-imidazole
TTDS00418	Inhibitor	1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC M
TTDS00418	Inhibitor	1-Acetoxy-2-tert-butyldimethylsilyl-oxylycorine
TTDS00418	Inhibitor	1-Acetoxylycorine
TTDS00418	Inhibitor	1H-1,2,3-benzotriazol-1-amine
TTDS00418	Inhibitor	2,5-bis(4-hydroxybenzylidene)cyclopentanone
TTDS00418	Inhibitor	2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole
TTDS00418	Inhibitor	2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine
TTDS00418	Inhibitor	2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol
TTDS00418	Inhibitor	2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine
TTDS00418	Inhibitor	2-fluoro-5-(3-methylthiophen-2-yl)pyridine
TTDS00418	Inhibitor	2-tert-Butyldimethylsilyloxylycorine
TTDS00418	Inhibitor	3,3-(1,3-Thiazole-2,5-diyl)diphenol
TTDS00418	Inhibitor	3-(3-methylthiophen-2-yl)pyridine
TTDS00418	Inhibitor	3-(5-((methylthio)methyl)furan-2-yl)pyridine
TTDS00418	Inhibitor	3-(5-[1,3]dithiolan-2-yl-furan-2-yl)pyridine
TTDS00418	Inhibitor	3-(pyridin-3-yl)prop-2-yn-1-amine
TTDS00418	Inhibitor	3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine
TTDS00418	Inhibitor	3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine
TTDS00418	Inhibitor	3-[5-(4-Hydroxyphenyl)-3-thienyl]phenol
TTDS00418	Inhibitor	3-methoxy-5-(6-methoxynaphthalen-2-yl)pyridine
TTDS00418	Inhibitor	4-(6-Methoxynaphthalen-2-yl)isoquinoline
TTDS00418	Inhibitor	4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine
TTDS00418	Inhibitor	4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine
TTDS00418	Inhibitor	4-[5-(3-Hydroxyphenyl)-2-thienyl)-2-methyl]phenol
TTDS00418	Inhibitor	4-[5-(3-Hydroxyphenyl)-3-thienyl]-2-methylphenol
TTDS00418	Inhibitor	5-(2-phenethylpiperazin-1-yl)-1H-indazole
TTDS00418	Inhibitor	5-Pyridin-3-yl-thiophene-2-carbaldehyde oxime
TTDS00418	Inhibitor	6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE
TTDS00418	Inhibitor	6-(3-hydroxyphenyl)-2-naphthol
TTDS00418	Inhibitor	6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one
TTDS00418	Inhibitor	Ac-Phe-[Orn-Pro-cha-Trp-Arg]
TTDS00418	Inhibitor	Alpha-Hydroxy-Midazolam
TTDS00418	Inhibitor	BERGAPTOL
TTDS00418	Inhibitor	BMS-536924
TTDS00418	Inhibitor	BMS-540215
TTDS00418	Inhibitor	CEP-18770
TTDS00418	Inhibitor	CURCUMIN
TTDS00418	Inhibitor	Clotrimazole
TTDS00418	Inhibitor	DG-041
TTDS00418	Inhibitor	DIETHOXYFLOURESCEIN
TTDS00418	Inhibitor	DIHYDROCUBEBIN
TTDS00418	Inhibitor	ETHOXYCLUSIN
TTDS00418	Inhibitor	GSK-1070916
TTDS00418	Inhibitor	GSK-8062
TTDS00418	Inhibitor	Go-Y026
TTDS00418	Inhibitor	HINOKININ
TTDS00418	Inhibitor	Heme
TTDS00418	Inhibitor	JATRORRHIZINE
TTDS00418	Inhibitor	MEDIORESINOL
TTDS00418	Inhibitor	ML-3163
TTDS00418	Inhibitor	ML-3375
TTDS00418	Inhibitor	ML-3403
TTDS00418	Inhibitor	Methyl-(5-pyridin-3-yl-thiophen-2-yl)-amine
TTDS00418	Inhibitor	PALMATINE
TTDS00418	Inhibitor	SB-203580
TTDS00418	Inhibitor	SK&F-96365;SK-96365
TTDS00418	Inhibitor	TILIROSIDE
TTDS00418	Inhibitor	alpha-methylcubebin
TTDS00418	Inhibitor	geranylcoumarin
TTDS00419	UniProt ID	P05108
TTDS00419	Name	Cytochrome P450 11A1, mitochondrial
TTDS00419	Type of target	Successful target
TTDS00419	Synonyms	CYP11A
TTDS00419	Synonyms	CYP11A1
TTDS00419	Synonyms	CYPXIA1
TTDS00419	Synonyms	Cholesterol desmolase
TTDS00419	Synonyms	Cytochrome P450 11A1
TTDS00419	Synonyms	P450(scc)
TTDS00419	Disease	Adrenocortical tumour
TTDS00419	Disease	Cushing's syndrome
TTDS00419	Sequence	MLAKGLPPRSVLVKGCQTFLSAPREGLGRLRVPTGEGAGISTRSPRPFNEIPSPGDNGWLNLYHFWRETGTHKVHLHHVQ
TTDS00419	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00419	Pathway	C21-Steroid hormone metabolism
TTDS00419	Pathway	Metabolic pathways
TTDS00419	EC Number	EC 1.14.15.6
TTDS00419	Drug(s)	Aminoglutethimide
TTDS00419	Inhibitor	3-(4-Amino-phenyl)-3-butyl-piperidine-2,6-dione
TTDS00419	Inhibitor	3-(4-Amino-phenyl)-3-pentyl-piperidine-2,6-dione
TTDS00419	Inhibitor	Aminoglutethimide
TTDS00420	UniProt ID	P15538
TTDS00420	Name	Cytochrome P450 11B1, mitochondrial
TTDS00420	Type of target	Successful target
TTDS00420	Synonyms	CYP11B1
TTDS00420	Synonyms	CYPXIB1
TTDS00420	Synonyms	P-450c11
TTDS00420	Synonyms	P450C11
TTDS00420	Synonyms	S11BH
TTDS00420	Synonyms	Steroid 11-beta-hydroxylase
TTDS00420	Disease	Adrenocortical tumour
TTDS00420	Disease	Cushing's syndrome
TTDS00420	Sequence	MALRAKAEVCMAVPWLSLQRAQALGTRAARVPRTVLPFEAMPRRPGNRWLRLLQIWREQGYEDLHLEVHQTFQELGPIFR
TTDS00420	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00420	Pathway	Androgen and estrogen metabolism
TTDS00420	Pathway	C21-Steroid hormone metabolism
TTDS00420	Pathway	Metabolic pathways
TTDS00420	EC Number	EC 1.14.15.4
TTDS00420	Target Validation	TTDS00420
TTDS00420	Drug(s)	Metyrapone
TTDS00420	Inhibitor	(3-((1H-imidazol-1-yl)methyl)phenyl)methanol
TTDS00420	Inhibitor	(4-((1H-imidazol-1-yl)methyl)phenyl)methanol
TTDS00420	Inhibitor	1-(2-Phenoxy-ethyl)-1H-imidazole
TTDS00420	Inhibitor	1-(3,4-dihydronaphthalen-2-yl)-1H-imidazole
TTDS00420	Inhibitor	1-(3-Bromobenzyl)-1H-imidazole
TTDS00420	Inhibitor	1-(3-Chlorobenzyl)-1H-imidazole
TTDS00420	Inhibitor	1-(3-Fluorobenzyl)-1H-imidazole
TTDS00420	Inhibitor	1-(3-Methoxy-naphthalen-2-yl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Aminobenzyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Bromobenzyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Bromobenzyl)-5-phenyl-1H-imidazole
TTDS00420	Inhibitor	1-(4-Chlorobenzyl)-5-phenyl-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-(2-fluorophenyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-(2-methylphenyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-(3-fluorophenyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-(3-methylphenyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-(4-fluorophenyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-(4-methylphenyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-(4-pyridyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-bromo-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-formyl-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-hydroxymethyl-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-methyl-1H-imidazole
TTDS00420	Inhibitor	1-(4-Cyanobenzyl)-5-phenyl-1H-imidazole
TTDS00420	Inhibitor	1-(4-Fluorobenzyl)-1H-imidazole
TTDS00420	Inhibitor	1-(4-Fluorobenzyl)-5-phenyl-1H-imidazole
TTDS00420	Inhibitor	1-(4-Methoxybenzyl)-5-phenyl-1H-imidazole
TTDS00420	Inhibitor	1-(6-Methoxy-naphthalen-2-yl)-1H-imidazole
TTDS00420	Inhibitor	1-Benzyl-5-phenyl-1H-imidazole
TTDS00420	Inhibitor	1-Ethyl-3-imidazol-1-ylmethyl-1H-indole
TTDS00420	Inhibitor	1-Naphthalen-2-yl-1H-imidazole
TTDS00420	Inhibitor	1-Phenyl-2-pyridin-3-yl-propan-1-one
TTDS00420	Inhibitor	2-Methyl-1,2-di-pyridin-3-yl-1-methoxypropane
TTDS00420	Inhibitor	2-Methyl-1,2-di-pyridin-3-yl-propan-1-one oxime
TTDS00420	Inhibitor	2-Methyl-1,2-di-pyridin-3-yl-propane
TTDS00420	Inhibitor	2-Methyl-1,2-di-pyridin-3-yl-propylchloride
TTDS00420	Inhibitor	2-Methyl-1,2-di-pyridin-3-yl-propyliodide
TTDS00420	Inhibitor	2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-ol
TTDS00420	Inhibitor	2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-one
TTDS00420	Inhibitor	3-((1H-imidazol-1-yl)methyl)aniline
TTDS00420	Inhibitor	3-(1,1-Dimethyl-2-phenyl-ethyl)-pyridine
TTDS00420	Inhibitor	3-(1,2-dihydroacenaphthylen-3-yl)pyridine
TTDS00420	Inhibitor	3-(1,2-dihydroacenaphthylen-5-yl)pyridine
TTDS00420	Inhibitor	3-(1-Benzyl-1H-imidazol-5-yl)-1-propanol
TTDS00420	Inhibitor	3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine
TTDS00420	Inhibitor	3-(1-ethyl-3,4-dihydronaphthalen-2-yl)-pyridine
TTDS00420	Inhibitor	3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine
TTDS00420	Inhibitor	3-(1H-inden-2-yl)pyridine
TTDS00420	Inhibitor	3-(2,3-Dihydro-1,4-benzodioxin-6-yl)pyridine
TTDS00420	Inhibitor	3-(2-Chloro-1,1-dimethyl-2-phenyl-ethyl)-pyridine
TTDS00420	Inhibitor	3-(3,4-dihydronaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(3-Benzyl-6-methoxynaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(3-Benzylnaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(4-ethyl-3,4-dihydronaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(4-methyl-3,4-dihydronaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(5,6,7,8-Tetrahydronaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(5-Bromo-6-methoxy-naphthalen-2-yl)-pyridine
TTDS00420	Inhibitor	3-(5-Chloro-6-methoxy-naphthalen-2-yl)-pyridine
TTDS00420	Inhibitor	3-(5-methoxy-1H-inden-2-yl)pyridine
TTDS00420	Inhibitor	3-(6-Bromo-naphthalen-2-yl)-pyridine
TTDS00420	Inhibitor	3-(6-Ethoxy-naphthalen-2-yl)-pyridine
TTDS00420	Inhibitor	3-(6-Methoxy-3-methylnaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(6-Methoxynaphthalen-2-yl)-4-methylpyridine
TTDS00420	Inhibitor	3-(6-Methoxynaphthalen-2-yl)-5-phenylpyridine
TTDS00420	Inhibitor	3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine
TTDS00420	Inhibitor	3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(6-methoxynaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-(naphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-Ethoxy-5-(6-methoxynaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	3-Fluoro-4'-(pyridin-4-ylmethyl)biphenyl-4-ol
TTDS00420	Inhibitor	3-Imidazol-1-yl-quinoline
TTDS00420	Inhibitor	3-Imidazol-1-ylmethyl-1H-indole
TTDS00420	Inhibitor	3-Imidazol-1-ylmethyl-2-isopropyl-1H-indole
TTDS00420	Inhibitor	3-Indan-(1E)-ylidenemethyl-pyridine
TTDS00420	Inhibitor	3-Indan-(1Z)-ylidenemethyl-pyridine
TTDS00420	Inhibitor	3-MeSO2-DDE
TTDS00420	Inhibitor	3-Phenanthren-9-yl-pyridine
TTDS00420	Inhibitor	3-[(Z)-2-phenylvinyl]pyridine
TTDS00420	Inhibitor	3-[1-(4-Bromobenzyl)-1H-imidazol-5-yl]-1-propanol
TTDS00420	Inhibitor	3-[1-(4-Cyanobenzyl)-1H-imidazol-5-yl]-1-propanol
TTDS00420	Inhibitor	3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine
TTDS00420	Inhibitor	3-[4-Chloro-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[4-Chloro-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[4-Fluoro-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[4-Methyl-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Ethoxy-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Ethoxy-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-[7-Methoxy-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	3-methoxy-5-(6-methoxynaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diamine
TTDS00420	Inhibitor	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diol
TTDS00420	Inhibitor	4'-(Pyridin-4-ylmethyl)biphenyl-3-amine
TTDS00420	Inhibitor	4'-(Pyridin-4-ylmethyl)biphenyl-4-amine
TTDS00420	Inhibitor	4-((3',4'-Difluorobiphenyl-4-yl)methyl)pyridine
TTDS00420	Inhibitor	4-(2-Imidazol-1-yl-ethoxy)-benzamide
TTDS00420	Inhibitor	4-(4'-Fluoro-biphenyl-4-ylmethyl)pyridine
TTDS00420	Inhibitor	4-(4-(thiophen-2-yl)benzyl)pyridine
TTDS00420	Inhibitor	4-(4-(thiophen-3-yl)benzyl)pyridine
TTDS00420	Inhibitor	4-(6-Methoxy-3-methylnaphthalen-2-yl)isoquinoline
TTDS00420	Inhibitor	4-(6-Methoxynaphthalen-2-yl)isoquinoline
TTDS00420	Inhibitor	4-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine
TTDS00420	Inhibitor	4-Indan-(1Z)-ylidenemethyl-pyridine
TTDS00420	Inhibitor	4-[(3'-Hydroxybiphenyl-4-yl)methyl]pyridine
TTDS00420	Inhibitor	4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine
TTDS00420	Inhibitor	4-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	4-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	4-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	4-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	4-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	4-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine
TTDS00420	Inhibitor	5-(6-Methoxynaphthalen-2-yl)pyridin-3-ol
TTDS00420	Inhibitor	5-Indan-(1E)-ylidenemethyl-1H-imidazole
TTDS00420	Inhibitor	5-Indan-(1Z)-ylidenemethyl-1H-imidazole
TTDS00420	Inhibitor	5-Naphthalen-2-yl-1H-imidazole
TTDS00420	Inhibitor	5-Naphthalen-2-yl-oxazole
TTDS00420	Inhibitor	5-Pyridin-3-yl-1,3-dihydro-2H-indol-2-one
TTDS00420	Inhibitor	5-Pyridin-3-yl-2,3-dihydro-1H-inden-1-one
TTDS00420	Inhibitor	5-[4-(Pyridin-4-ylmethyl)phenyl]-1H-indole
TTDS00420	Inhibitor	5-[5-Bromo-indan-(1E)-ylidenemethyl]-1H-imidazole
TTDS00420	Inhibitor	5-[5-Bromo-indan-(1Z)-ylidenemethyl]-1H-imidazole
TTDS00420	Inhibitor	5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine
TTDS00420	Inhibitor	6-(4-Methylpyridin-3-yl)-2-naphthonitrile
TTDS00420	Inhibitor	6-(pyridin-3-yl)-2-naphthonitrile
TTDS00420	Inhibitor	6-Isoquinolin-4-yl-3,4-dihydroquinolin-2(1H)-one
TTDS00420	Inhibitor	6-Pyridin-3-yl-1,2,3,4-tetrahydronaphthalen-2-ol
TTDS00420	Inhibitor	6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one
TTDS00420	Inhibitor	6-Pyridin-3-yl-3,4-dihydroquinolin-2(1H)-on
TTDS00420	Inhibitor	6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione
TTDS00420	Inhibitor	6-Pyridin-3-yl-naphthalen-2-ol
TTDS00420	Inhibitor	6-[4-(Pyridin-4-ylmethyl)phenyl]naphthalen-2-ol
TTDS00420	Inhibitor	7-(1-(1H-imidazol-1-yl)ethyl)-9H-fluoren-2-ol
TTDS00420	Inhibitor	7-Pyridin-3-yl-2H-1,4-benzothiazin-3(4H)-one
TTDS00420	Inhibitor	ABIRATERONE
TTDS00420	Inhibitor	BENZYLIMIDAZOLE
TTDS00420	Inhibitor	FADROZOLE
TTDS00420	Inhibitor	FADROZOLE HCL
TTDS00420	Inhibitor	METYRAPOL
TTDS00420	Inhibitor	Methyl 3-(1-Benzyl-1H-imidazol-5-yl)-propanoate
TTDS00420	Inhibitor	Metyrapone
TTDS00420	Inhibitor	N-(4'-Isonicotinoylbiphenyl-3-yl)acetamide
TTDS00420	Inhibitor	R-fadrozole
TTDS00420	Inhibitor	SL125
TTDS00421	UniProt ID	P31350
TTDS00421	Name	Ribonucleoside-diphosphate reductase subunit M2
TTDS00421	Type of target	Successful target
TTDS00421	Synonyms	RR2
TTDS00421	Synonyms	RRM2
TTDS00421	Synonyms	Ribonucleotide reductase small chain
TTDS00421	Synonyms	Ribonucleotide reductase small subunit
TTDS00421	Disease	Cancers
TTDS00421	Sequence	MLSLRVPLAPITDPQQLQLSPLKGLSLVDKENTPPALSGTRVLASKTARRIFQEPTEPKTKAAAPGVEDEPLLRENPRRF
TTDS00421	PDB Structure	2UW2; 3OLJ; 3VPM; 3VPN; 3VPO
TTDS00421	BioChemical Class	Oxidoreductases acting on CH2 groups
TTDS00421	Pathway	Glutathione metabolism
TTDS00421	Pathway	Metabolic pathways
TTDS00421	Pathway	Purine metabolism
TTDS00421	Pathway	Pyrimidine metabolism
TTDS00421	Pathway	p53 signaling pathway
TTDS00421	EC Number	EC 1.17.4.1
TTDS00421	Target Validation	TTDS00421
TTDS00421	Drug(s)	Motexafin gadolinium
TTDS00421	Inhibitor	Motexafin gadolinium
TTDS00422	UniProt ID	P49286
TTDS00422	Name	Melatonin receptor type 1B
TTDS00422	Type of target	Successful target
TTDS00422	Synonyms	MTNR1B
TTDS00422	Synonyms	Mel-1B-R
TTDS00422	Synonyms	Mel1b melatonin receptor
TTDS00422	Disease	Insomnia
TTDS00422	Sequence	MSENGSFANCCEAGGWAVRPGWSGAGSARPSRTPRPPWVAPALSAVLIVTTAVDVVGNLLVILSVLRNRKLRNAGNLFLV
TTDS00422	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00422	Pathway	Neuroactive ligand-receptor interaction
TTDS00422	Target Validation	TTDS00422
TTDS00422	QSAR Model	TTDS00422
TTDS00422	Drug(s)	Ramelteon
TTDS00422	Inhibitor	5-methoxycarbonylamino-N-acetyltryptamine
TTDS00422	Inhibitor	IODOMELATONIN
TTDS00422	Inhibitor	N-(2,3,4,9-Tetrahydro-1H-carbazol-3-yl)-acetamide
TTDS00422	Inhibitor	N-(2-(5-methoxybenzofuran-3-yl)ethyl)acetamide
TTDS00422	Inhibitor	N-(3-(2,5-dimethoxyphenyl)propyl)acetamide
TTDS00422	Inhibitor	N-(3-(2-ethoxy-5-methoxyphenyl)propyl)acetamide
TTDS00422	Inhibitor	N-(3-(2-hydroxy-5-methoxyphenyl)propyl)acetamide
TTDS00422	Inhibitor	N-(3-(3-methoxyphenyl)-3-phenylallyl)acetamide
TTDS00422	Inhibitor	N-(3-(3-methoxyphenyl)propyl)acetamide
TTDS00422	Inhibitor	N-(3-(3-methoxyphenyl)propyl)propionamide
TTDS00422	Inhibitor	N-(3-(4-hydroxy-3-methoxyphenyl)propyl)acetamide
TTDS00422	Inhibitor	N-(3-(5-methoxy-2-propoxyphenyl)propyl)acetamide
TTDS00422	Inhibitor	N-(3-Benzooxazol-7-yl-propyl)-acetamide
TTDS00422	Inhibitor	N-(3-Benzooxazol-7-yl-propyl)-butyramide
TTDS00422	Inhibitor	N-(3-Benzooxazol-7-yl-propyl)-propionamide
TTDS00422	Inhibitor	N-[3-(2-Ethyl-benzooxazol-7-yl)-propyl]-acetamide
TTDS00422	Inhibitor	UCM-454
TTDS00422	Inhibitor	beta,beta-dimethylmelatonin
TTDS00422	Inhibitor	beta-methylmelatonin
TTDS00422	Agonist	Ramelteon
TTDS00422	Multitarget	Ramelteon
TTDS00423	UniProt ID	P14060
TTDS00423	UniProt ID	P26439
TTDS00423	Name	3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
TTDS00423	Type of target	Successful target
TTDS00423	Synonyms	3-beta-HSD
TTDS00423	Synonyms	3-beta-hydroxy-5-ene steroid dehydrogenase
TTDS00423	Synonyms	3-beta-hydroxy-Delta(5)-steroid dehydrogenase
TTDS00423	Synonyms	3BH
TTDS00423	Synonyms	Delta-5-3-ketosteroid isomerase
TTDS00423	Synonyms	HSD3B1
TTDS00423	Synonyms	HSDB3A
TTDS00423	Synonyms	Progesterone reductase
TTDS00423	Synonyms	Steroid Delta-isomerase
TTDS00423	Synonyms	Trophoblast antigen FDO161G
TTDS00423	Disease	Cushing's syndrome
TTDS00423	Sequence	MTGWSCLVTGAGGFLGQRIIRLLVKEKELKEIRVLDKAFGPELREEFSKLQNKTKLTVLEGDILDEPFLKRACQDVSVII
TTDS00423	BioChemical Class	Transmembrane protein
TTDS00423	Pathway	Androgen and estrogen metabolism
TTDS00423	Pathway	C21-Steroid hormone metabolism
TTDS00423	Pathway	Metabolic pathways
TTDS00423	EC Number	EC 1.1.1.145
TTDS00423	EC Number	EC 5.3.3.1
TTDS00423	Inhibitor	3-Beta-Hydroxy-5-Androsten-17-One
TTDS00423	Inhibitor	4-MA
TTDS00423	Inhibitor	5alpha-Androstan-3,17-Dione
TTDS00423	Inhibitor	Beta-Mercaptoethanol
TTDS00423	Inhibitor	Epostane
TTDS00423	Inhibitor	Equilenin
TTDS00423	Agonist	4-Androstenedione
TTDS00424	UniProt ID	Q02153
TTDS00424	Name	Guanylate cyclase soluble subunit beta-1
TTDS00424	Type of target	Successful target
TTDS00424	Synonyms	GCS-beta-1
TTDS00424	Synonyms	GCS-beta-3
TTDS00424	Synonyms	GUC1B3
TTDS00424	Synonyms	GUCSB3
TTDS00424	Synonyms	GUCY1B1
TTDS00424	Synonyms	GUCY1B3
TTDS00424	Synonyms	Soluble guanylate cyclase small subunit
TTDS00424	Disease	Heart failure
TTDS00424	Sequence	MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQE
TTDS00424	PDB Structure	2WZ1; 3UVJ
TTDS00424	BioChemical Class	Phosphorus-oxygen lyases
TTDS00424	Pathway	Gap junction
TTDS00424	Pathway	Long-term depression
TTDS00424	Pathway	Purine metabolism
TTDS00424	Pathway	Vascular smooth muscle contraction
TTDS00424	EC Number	EC 4.6.1.2
TTDS00424	Activator	Cinaciguat
TTDS00426	UniProt ID	P49895
TTDS00426	Name	Type I iodothyronine deiodinase
TTDS00426	Type of target	Successful target
TTDS00426	Synonyms	5DI
TTDS00426	Synonyms	DIO1
TTDS00426	Synonyms	DIOI
TTDS00426	Synonyms	ITDI1
TTDS00426	Synonyms	TXDI1
TTDS00426	Synonyms	Type 1 DI
TTDS00426	Synonyms	Type-I 5'-deiodinase
TTDS00426	Disease	Massive metastatic follicular thyroid carcinoma
TTDS00426	Sequence	MGLPQPGLWLKRLWVLLEVAVHVVVGKVLLILFPDRVKRNILAMGEKTGMTRNPHFSHDNWIPTFFSTQYFWFVLKVRWQ
TTDS00426	EC Number	EC 1.97.1.10
TTDS00426	Drug(s)	Propylthiouracil
TTDS00426	Inhibitor	Propylthiouracil
TTDS00427	UniProt ID	P38606
TTDS00427	Name	Vacuolar ATP synthase catalytic subunit A
TTDS00427	Type of target	Successful target
TTDS00427	Synonyms	ATP6A1
TTDS00427	Synonyms	ATP6V1A
TTDS00427	Synonyms	ATP6V1A1
TTDS00427	Synonyms	V-ATPase 69 kDa subunit
TTDS00427	Synonyms	V-ATPase subunit A
TTDS00427	Synonyms	VPP2
TTDS00427	Synonyms	Vacuolar ATPase isoform VA68
TTDS00427	Synonyms	Vacuolar proton pump subunit alpha
TTDS00427	Disease	Net blotch
TTDS00427	Sequence	MDFSKLPKILDEDKESTFGYVHGVSGPVVTACDMAGAAMYELVRVGHSELVGEIIRLEGDMATIQVYEETSGVSVGDPVL
TTDS00427	BioChemical Class	Hydrolases acting on acid anhydrides
TTDS00427	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDS00427	Pathway	Metabolic pathways
TTDS00427	Pathway	Oxidative phosphorylation
TTDS00427	Pathway	Vibrio cholerae infection
TTDS00427	EC Number	EC 3.6.3.14
TTDS00427	Drug(s)	Cruentaren
TTDS00427	Inhibitor	Cruentaren
TTDS00428	UniProt ID	P18507
TTDS00428	Name	Gamma-aminobutyric acid receptor subunit gamma-2
TTDS00428	Type of target	Successful target
TTDS00428	Synonyms	GABA(A) receptor subunit gamma-2
TTDS00428	Synonyms	GABRG2
TTDS00428	Disease	Brain injury
TTDS00428	Sequence	MSSPNIWSTGSSVYSTPVFSQKMTVWILLLLSLYPGFTSQKSDDDYEDYASNKTWVLTPKVPEGDVTVILNNLLEGYDNK
TTDS00428	BioChemical Class	Chloride channel
TTDS00428	Pathway	Neuroactive ligand-receptor interaction
TTDS00428	Target Validation	TTDS00428
TTDS00428	Inhibitor	(2E,4S)-4-ammoniopent-2-enoate
TTDS00428	Inhibitor	(4R)-4-ammoniopentanoate
TTDS00428	Inhibitor	(4S)-4-ammoniopentanoate
TTDS00428	Inhibitor	(9-Benzyl-9H-purin-6-yl)-cyclopropyl-amine
TTDS00428	Inhibitor	(beta-CCE)9H-beta-Carboline-3-carboxylic acid
TTDS00428	Inhibitor	1,1-Dimethyl-5-oxa-spiro[2.4]heptan-4-one
TTDS00428	Inhibitor	1,3-Diphenyl-1H-chromeno[4,3-c]pyrazol-4-one
TTDS00428	Inhibitor	1-(4-chlorophenyl)-4-phenyl-1H-imidazole
TTDS00428	Inhibitor	1-Methyl-5-oxa-spiro[2.4]heptan-4-one
TTDS00428	Inhibitor	2-(1H-Indol-3-yl)-2-oxo-N-phenethyl-acetamide
TTDS00428	Inhibitor	2-(4-chlorophenyl)-5-phenyl-4-isoxazolin-3-one
TTDS00428	Inhibitor	2-(9-Benzyl-9H-purin-6-ylamino)-ethanol
TTDS00428	Inhibitor	2-Isoxazol-5-yl-3H-imidazo[4,5-c]quinoline
TTDS00428	Inhibitor	2-Oxa-spiro[4.4]nonan-1-one
TTDS00428	Inhibitor	2-Thiophen-2-yl-3H-imidazo[4,5-c]quinoline
TTDS00428	Inhibitor	3,3-Diethyl-dihydro-furan-2-one
TTDS00428	Inhibitor	3,3-Diisopropyl-dihydro-furan-2-one
TTDS00428	Inhibitor	3-(benzyloxy)-9H-pyrido[3,4-b]indole
TTDS00428	Inhibitor	3-(hexa-1,3-dienyloxy)-9H-pyrido[3,4-b]indole
TTDS00428	Inhibitor	3-(isopentyloxy)-9H-pyrido[3,4-b]indole
TTDS00428	Inhibitor	3-Ethoxy-9H-beta-carboline
TTDS00428	Inhibitor	3-Ethyl-3-isopropyl-dihydro-furan-2-one
TTDS00428	Inhibitor	3-Ethyl-3-methyl-dihydro-furan-2-one
TTDS00428	Inhibitor	3-Isopropyl-3-methyl-dihydro-furan-2-one
TTDS00428	Inhibitor	3-Isothiocyanato-9H-beta-carboline
TTDS00428	Inhibitor	3-Methyl-1-phenyl-1H-chromeno[4,3-c]pyrazol-4-one
TTDS00428	Inhibitor	3-Methyl-2-phenyl-2H-chromeno[4,3-c]pyrazol-4-one
TTDS00428	Inhibitor	3-Methyl-9H-beta-carboline
TTDS00428	Inhibitor	3-amino-3-demethoxythiocolchicine
TTDS00428	Inhibitor	3-butoxy-9H-pyrido[3,4-b]indole
TTDS00428	Inhibitor	3-butoxycarbonyl-4-quinolone
TTDS00428	Inhibitor	3-butoxycarbonyl-6-ethyl-4-quinolone
TTDS00428	Inhibitor	3-butylaminocarbonyl-6-ethyl-4-quinolone
TTDS00428	Inhibitor	3-carboxy-6-ethyl-4-quinolone
TTDS00428	Inhibitor	3-cyclopentoxycarbonyl-6-ethyl-4-quinolone
TTDS00428	Inhibitor	3-demethoxy-3-D-lyxopyranosylaminothiocolchicine
TTDS00428	Inhibitor	3-demethoxy-3-D-mannopyranosylaminothiocolchicine
TTDS00428	Inhibitor	3-demethoxy-3-D-xylopyranosylaminothiocolchicine
TTDS00428	Inhibitor	3-demethoxy-3-L-fucopyranosylaminothiocolchicine
TTDS00428	Inhibitor	3-demethoxy-3D-glucopyranosylaminothiocolchicine
TTDS00428	Inhibitor	3-ethoxy-9H-pyrido[3,4-b]indole
TTDS00428	Inhibitor	3-ethoxycarbonyl-4-quinolone
TTDS00428	Inhibitor	3-ethoxycarbonyl-6-ethyl-2-methyl-4-quinolone
TTDS00428	Inhibitor	3-ethoxycarbonyl-6-propyl-4-quinolone
TTDS00428	Inhibitor	3-isobutoxy-9H-pyrido[3,4-b]indole
TTDS00428	Inhibitor	3-propoxy-9H-pyrido[3,4-b]indole
TTDS00428	Inhibitor	3-tert-Butyl-3-ethyl-dihydro-furan-2-one
TTDS00428	Inhibitor	4-(2-aminoethyl)-1,2,5-oxadiazol-3-ol
TTDS00428	Inhibitor	4-(4-chlorophenyl)-1-pyrid-2-yl-pyrazole
TTDS00428	Inhibitor	4-(biphenyl-3-yl)-5-(piperidin-4-yl)isoxazol-3-ol
TTDS00428	Inhibitor	4-Benzyl-5-piperidin-4-yl-isoxazol-3-ol
TTDS00428	Inhibitor	4-Methyl-5-(4-piperidyl)isothiazol-3-ol
TTDS00428	Inhibitor	4-Naphthalen-1-yl-5-piperidin-4-yl-isoxazol-3-ol
TTDS00428	Inhibitor	4-Naphthalen-2-yl-5-piperidin-4-yl-isoxazol-3-ol
TTDS00428	Inhibitor	4-Phenyl-5-piperidin-4-yl-isoxazol-3-ol
TTDS00428	Inhibitor	4-benzyl-5-(4-piperidyl)isothiazol-3-ol
TTDS00428	Inhibitor	5-(4-piperidyl)-4-propylisothiazol-3-ol
TTDS00428	Inhibitor	5-(piperidin-4-yl)isothiazol-3-ol
TTDS00428	Inhibitor	5-Piperidin-4-yl-isoxazol-3-ol
TTDS00428	Inhibitor	5-[(1R)-1-ammonioethyl]isoxazol-3-olate
TTDS00428	Inhibitor	5-[(1S)-1-ammonioethyl]isoxazol-3-olate
TTDS00428	Inhibitor	6,6-Dimethyl-2-oxa-spiro[4.4]nonan-1-one
TTDS00428	Inhibitor	6,9-Dimethyl-2-oxa-spiro[4.4]nonan-1-one
TTDS00428	Inhibitor	6-Methyl-2-oxa-spiro[4.4]nonan-1-one
TTDS00428	Inhibitor	6-Nitro-2-(3-nitro-phenyl)-chromen-4-one
TTDS00428	Inhibitor	6-Nitro-2-(4-nitro-phenyl)-chromen-4-one
TTDS00428	Inhibitor	6-benzyl-3-ethoxycarbonyl-4-quinolone
TTDS00428	Inhibitor	6-benzyl-3-propoxycarbonyl-4-quinolone
TTDS00428	Inhibitor	6-benzyl-3-propylaminocarbonyl-4-quinolone
TTDS00428	Inhibitor	6-bromo-3-ethoxycarbonyl-2-methyl-4-quinolone
TTDS00428	Inhibitor	6-bromo-3-ethoxycarbonyl-4-quinolone
TTDS00428	Inhibitor	6-ethyl-3-(2-ethylbutoxycarbonyl)-4-quinolone
TTDS00428	Inhibitor	6-ethyl-3-(2-methylbutoxycarbonyl)-4-quinolone
TTDS00428	Inhibitor	6-ethyl-3-(3-methylbutoxycarbonyl)-4-quinolone
TTDS00428	Inhibitor	6-ethyl-3-(3-pentoxycarbonyl)-4-quinolone
TTDS00428	Inhibitor	6-ethyl-3-i-propoxycarbonyl-4-quinolone
TTDS00428	Inhibitor	6-ethyl-3-pentoxycarbonyl-4-quinolone
TTDS00428	Inhibitor	6-ethyl-3-propoxycarbonyl-4-quinolone
TTDS00428	Inhibitor	6-ethyl-3-propylaminocarbonyl-4-quinolone
TTDS00428	Inhibitor	9H-beta-Carboline-3-carboxylic acid butyl ester
TTDS00428	Inhibitor	9H-beta-Carboline-3-carboxylic acid ethyl ester
TTDS00428	Inhibitor	9H-beta-Carboline-3-carboxylic acid propyl ester
TTDS00428	Inhibitor	ALLOPREGNANOLONE
TTDS00428	Inhibitor	AMENTOFLAVONE
TTDS00428	Inhibitor	BETA-CCM
TTDS00428	Inhibitor	CGS-13767
TTDS00428	Inhibitor	CGS-17867A
TTDS00428	Inhibitor	CGS-8216
TTDS00428	Inhibitor	CGS-9895
TTDS00428	Inhibitor	CGS-9896
TTDS00428	Inhibitor	CI-218872
TTDS00428	Inhibitor	ELTANOLONE
TTDS00428	Inhibitor	Ethyl 9H-pyrido[3,4-b]indole-3-carboxylate
TTDS00428	Inhibitor	GABAZINE
TTDS00428	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDS00428	Inhibitor	GNF-PF-3645
TTDS00428	Inhibitor	GNF-PF-4421
TTDS00428	Inhibitor	L-655708;NCGC00025115-02
TTDS00428	Inhibitor	N-(p-methylbenzyl)-5-nitroindol-3-ylglyoxylamide
TTDS00428	Inhibitor	N-Indan-1-yl-2-(1H-indol-3-yl)-2-oxo-acetamide
TTDS00428	Inhibitor	N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide
TTDS00428	Inhibitor	N-benzyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide
TTDS00428	Inhibitor	N-butyl-2-(1H-indol-3-yl)-2-oxoacetamide
TTDS00428	Inhibitor	N-butyl-2-(5-nitro-1H-indol-3-yl)-2-oxoacetamide
TTDS00428	Inhibitor	PNU-91571
TTDS00428	Inhibitor	RO-145974
TTDS00428	Inhibitor	RO-145975
TTDS00428	Inhibitor	RO-147437
TTDS00428	Inhibitor	RO-194603
TTDS00428	Inhibitor	RY-066
TTDS00428	Inhibitor	Ro-151310
TTDS00428	Inhibitor	Ro-154513
TTDS00428	Inhibitor	Ro-4882224
TTDS00428	Inhibitor	Ro-4938581
TTDS00428	Inhibitor	THIOCOLCHICOSIDE
TTDS00428	Inhibitor	TPA-023
TTDS00428	Inhibitor	U-78875
TTDS00428	Inhibitor	U-89267
TTDS00428	Inhibitor	ZK-93423
TTDS00428	Inhibitor	beta-Carboline-3-carboxylic acid t-butyl ester
TTDS00428	Inhibitor	ethyl 6-iodo-9H-pyrido[3,4-b]indole-3-carboxylate
TTDS00428	Inhibitor	ridine-5-carboxylic acid ethyl ester
TTDS00428	Inhibitor	sec-butyl 9H-pyrido[3,4-b]indole-3-carboxylate
TTDS00429	UniProt ID	P07098
TTDS00429	Name	Gastric triacylglycerol lipase
TTDS00429	Type of target	Successful target
TTDS00429	Synonyms	GL
TTDS00429	Synonyms	Gastric lipase
TTDS00429	Synonyms	LIPF
TTDS00429	Disease	Gastric disease
TTDS00429	Sequence	MWLLLTMASLISVLGTTHGLFGKLHPGSPEVTMNISQMITYWGYPNEEYEVVTEDGYILEVNRIPYGKKNSGNTGQRPVV
TTDS00429	PDB Structure	1HLG
TTDS00429	BioChemical Class	Hydrolases acting on ester bonds
TTDS00429	Pathway	Glycerolipid metabolism
TTDS00429	Pathway	Metabolic pathways
TTDS00429	EC Number	EC 3.1.1.3
TTDS00429	Inhibitor	B-Octylglucoside
TTDS00429	Inhibitor	Undecyl-Phosphinic Acid Butyl Ester
TTDS00430	UniProt ID	Q99808
TTDS00430	UniProt ID	Q9NIH7
TTDS00430	Name	Equilibrative nucleoside transporter 1
TTDS00430	Type of target	Successful target
TTDS00430	Synonyms	ENT1
TTDS00430	Synonyms	Equilibrative NBMPR-sensitive nucleoside transporter
TTDS00430	Synonyms	Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporte
TTDS00430	Synonyms	Nucleoside transporter 1
TTDS00430	Synonyms	Nucleoside transporter, es-type
TTDS00430	Synonyms	Solute carrier family 29 member 1
TTDS00430	Disease	Malaria
TTDS00430	Function	Mediates both influx and efflux of nucleosides across the membrane (equilibrativ
TTDS00430	Sequence	MTTSHQPQDRYKAVWLIFFMLGLGTLLPWNFFMTATQYFTNRLDMSQNVSLVTAELSKDAQASAAPAAPLPERNSLSAIF
TTDS00430	BioChemical Class	Transmembrane protein
TTDS00430	Target Validation	TTDS00430
TTDS00430	Inhibitor	6-(4-Nitro-benzylsulfanyl)-9-phenethyl-9H-purine
TTDS00430	Inhibitor	9-Benzyl-6-(4-nitro-benzylsulfanyl)-9H-purine
TTDS00430	Inhibitor	Dilazep
TTDS00430	Inhibitor	Dipyridamole
TTDS00430	Inhibitor	LIDOFLAZINE
TTDS00430	Inhibitor	N6-CYCLOPENTYLADENOSINE
TTDS00430	Inhibitor	Nitrobenzylthioinosine
TTDS00430	Inhibitor	S6-nitrobenzyl mercaptopurine riboside
TTDS00431	UniProt ID	P78508
TTDS00431	Name	ATP-sensitive inward rectifier potassium channel 10
TTDS00431	Type of target	Successful target
TTDS00431	Synonyms	ATP dependent K+ channel
TTDS00431	Synonyms	ATP-dependent inwardly rectifying potassium channel Kir4.1
TTDS00431	Synonyms	ATP-sensitive potassium channel
TTDS00431	Synonyms	Inward rectifier K+ channel Kir1.2
TTDS00431	Synonyms	Potassium channel, inwardly rectifying, subfamily J, member 10
TTDS00431	Disease	Analgesics
TTDS00431	Disease	Cardiac arrhythmias
TTDS00431	Disease	Pain
TTDS00431	Disease	Sudden cardiac death
TTDS00431	Disease	Unstable angina
TTDS00431	Function	May be responsible for potassium buffering action of glial cells in the brain. I
TTDS00431	Sequence	MTSVAKVYYSQTTQTESRPLMGPGIRRRRVLTKDGRSNVRMEHIADKRFLYLKDLWTTFIDMQWRYKLLLFSATFAGTWF
TTDS00431	BioChemical Class	Voltage-gated channel
TTDS00431	QSAR Model	TTDS00431
TTDS00431	Drug(s)	Acetohexamide
TTDS00431	Drug(s)	Chlorpropamide
TTDS00431	Drug(s)	Glipizide
TTDS00431	Drug(s)	Gliquidone
TTDS00431	Drug(s)	Glisoxepide
TTDS00431	Drug(s)	Glycodiazine
TTDS00431	Drug(s)	Minoxidil
TTDS00431	Drug(s)	Mitiglinide
TTDS00431	Drug(s)	Nateglinide
TTDS00431	Drug(s)	Tolazamide
TTDS00431	Blocker	Chlorpropamide
TTDS00431	Blocker	Glipizide
TTDS00431	Blocker	Glisoxepide
TTDS00431	Blocker	HMR1098
TTDS00431	Blocker	HMR1883
TTDS00431	Blocker	Mitiglinide
TTDS00431	Blocker	Nateglinide
TTDS00431	Blocker	Sulfonylthioureas
TTDS00431	Blocker	Tolazamide
TTDS00431	Binder	Acetohexamide
TTDS00431	Binder	Gliquidone
TTDS00431	Binder	Glycodiazine
TTDS00431	Opener	Minoxidil
TTDS00432	UniProt ID	P02593
TTDS00432	Name	Calmodulin
TTDS00432	Type of target	Successful target
TTDS00432	Disease	Atopic asthma
TTDS00432	Disease	Cancer, unspecific
TTDS00432	Function	Calmodulin mediates the control of a large number of enzymes by ca(2+). Among th
TTDS00432	Sequence	MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDT
TTDS00432	PDB Structure	1CMF; 1CMG; 1DEG; 1FW4; 1LIN; 1PRW; 1QIV; 1QIW
TTDS00432	Target Validation	TTDS00432
TTDS00432	Drug(s)	Aprindine
TTDS00432	Drug(s)	Trifluoperazine
TTDS00432	Inhibitor	2-Methyl-2,4-Pentanediol
TTDS00432	Inhibitor	2-Methyl-2-Propanol
TTDS00432	Inhibitor	Acetate Ion
TTDS00432	Inhibitor	Aprindine
TTDS00432	Inhibitor	Cacodylate Ion
TTDS00432	Inhibitor	MYRISTIC ACID
TTDS00432	Inhibitor	N-Trimethyllysine
TTDS00432	Inhibitor	Trifluoperazine
TTDS00433	UniProt ID	P50416
TTDS00433	UniProt ID	Q92523
TTDS00433	Name	Carnitine O-palmitoyltransferase I
TTDS00433	Type of target	Successful target
TTDS00433	Synonyms	CPT
TTDS00433	Synonyms	CPT I
TTDS00433	Synonyms	CPT-1
TTDS00433	Synonyms	CPTI-L
TTDS00433	Synonyms	Carnitine o-palmitoyltransferase-1
TTDS00433	Synonyms	Carnitine palmitoyl-transferase I
TTDS00433	Synonyms	Carnitine palmitoyltransferase I
TTDS00433	Disease	Noninsulin-dependent diabetes mellitus
TTDS00433	Disease	Obesity
TTDS00433	Sequence	MAEAHQAVAFQFTVTPDGIDLRLSHEALRQIYLSGLHSWKKKFIRFKNGIITGVYPASPSSWLIVVVGVMTTMYAKIDPS
TTDS00433	PDB Structure	2LE3
TTDS00433	BioChemical Class	Acyltransferases
TTDS00433	Pathway	Adipocytokine signaling pathway
TTDS00433	Pathway	Fatty acid metabolism
TTDS00433	Pathway	PPAR signaling pathway
TTDS00433	EC Number	EC 2.3.1.21
TTDS00433	Target Validation	TTDS00433
TTDS00433	Drug(s)	L-Carnitine
TTDS00433	Drug(s)	Perhexiline
TTDS00433	Inhibitor	Etomoxir
TTDS00433	Inhibitor	Perhexiline
TTDS00433	Activator	C75
TTDS00433	Activator	L-Carnitine
TTDS00434	Name	Collagen
TTDS00434	Type of target	Successful target
TTDS00434	Disease	Dermal ulcers
TTDS00434	Disease	Dupuytren's disease
TTDS00434	Disease	Skin burns
TTDS00434	Disease	Vitamin C deficiency
TTDS00434	Drug(s)	Collagenase
TTDS00434	Drug(s)	Vitamin C
TTDS00434	Activator	Vitamin C
TTDS00434	Breaker	Collagenase
TTDS00434	Binder	Clostridial collagenase
TTDS00435	UniProt ID	P01031
TTDS00435	Name	Complement C5
TTDS00435	Type of target	Successful target
TTDS00435	Disease	Rheumatoid arthritis, unspecified
TTDS00435	Function	Activation of c5 by a c5 convertase initiates the spontaneous assembly of the la
TTDS00435	Sequence	MGLLGILCFLIFLGKTWGQEQTYVISAPKIFRVGASENIVIQVYGYTEAFDATISIKSYPDKKFSYSSGHVHLSSENKFQ
TTDS00435	PDB Structure	1CFA; 1KJS; 1XWE; 3CU7; 3HQA; 3HQB; 3KLS; 3KM9; 3PRX; 3PVM; 4A5W; 4E0S
TTDS00435	Pathway	Complement and coagulation cascades
TTDS00435	Pathway	Systemic lupus erythematosus
TTDS00435	Target Validation	TTDS00435
TTDS00435	Drug(s)	Eculizumab
TTDS00435	Antibody	Eculizumab
TTDS00436	UniProt ID	P02996
TTDS00436	UniProt ID	P0A6M8
TTDS00436	UniProt ID	Q97SQ3
TTDS00436	Name	Elongation factor G
TTDS00436	Type of target	Successful target
TTDS00436	Synonyms	EF-G
TTDS00436	Disease	Streptococcus pneumoniae infections
TTDS00436	Function	This protein promotes the gtp-dependent translocation of the nascent protein cha
TTDS00436	Sequence	MARTTPIARYRNIGISAHIDAGKTTTTERILFYTGVNHKIGEVHDGAATMDWMEQEQERGITITSAATTAFWSGMAKQYE
TTDS00436	PDB Structure	2RDO; 3J0E
TTDS00436	EC Number	EC 3.6.5.3
TTDS00436	Drug(s)	Fusidic Acid
TTDS00436	Inhibitor	Fusidic Acid
TTDS00436	Inhibitor	Guanosine-5'-Diphosphate
TTDS00437	UniProt ID	P22830
TTDS00437	Name	Ferrochelatase
TTDS00437	Type of target	Successful target
TTDS00437	Synonyms	Heme synthetase
TTDS00437	Synonyms	Protoheme ferro-lyase
TTDS00437	Disease	Cancer, unspecific
TTDS00437	Disease	Photodynamic therapy
TTDS00437	Function	Catalyzes the ferrous insertion into protoporphyrin ix.
TTDS00437	Sequence	MRSLGANMAAALRAAGVLLRDPLASSSWRVCQPWRWKSGAAAAAVTTETAQHAQGAKPQVQPQKRKPKTGILMLNMGGPE
TTDS00437	PDB Structure	1HRK; 2HRC; 2HRE; 2PNJ; 2PO5; 2PO7; 2QD1; 2QD2; 2QD3; 2QD4; 2QD5; 3AQI; 3HCN; 3H
TTDS00437	Pathway	Metabolic pathways
TTDS00437	Pathway	Porphyrin and chlorophyll metabolism
TTDS00437	EC Number	EC 4.99.1.1
TTDS00437	Drug(s)	Methyl aminolevulinate
TTDS00437	Inhibitor	Cholic Acid
TTDS00437	Inhibitor	Lead acetate
TTDS00437	Inhibitor	N-Methylmesoporphyrin
TTDS00437	Inhibitor	N-Methylmesoporphyrin Containing Copper
TTDS00437	Activator	Methyl aminolevulinate
TTDS00438	UniProt ID	P23945
TTDS00438	Name	Follicle stimulating hormone receptor
TTDS00438	Type of target	Successful target
TTDS00438	Synonyms	FSH-R
TTDS00438	Synonyms	Follitropin receptor
TTDS00438	Disease	Psychosis
TTDS00438	Disease	Respiratory diseases
TTDS00438	Disease	Viral infection, unspecified
TTDS00438	Function	Receptor for follicle stimulating hormone. The activity of this receptor is medi
TTDS00438	Sequence	MALLLVSLLAFLSLGSGCHHRICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN
TTDS00438	PDB Structure	1XUN; 1XWD; 4AY9
TTDS00438	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00438	Pathway	Neuroactive ligand-receptor interaction
TTDS00438	Related US Patent	6,355,633
TTDS00438	Related US Patent	6,583,179
TTDS00438	Target Validation	TTDS00438
TTDS00438	QSAR Model	TTDS00438
TTDS00438	Drug(s)	Choriogonadotropin alfa
TTDS00438	Drug(s)	Follitropin beta
TTDS00438	Drug(s)	Menotropins
TTDS00438	Drug(s)	Suramin
TTDS00438	Drug(s)	Urofollitropin
TTDS00438	Antagonist	Suramin
TTDS00438	Binder	Choriogonadotropin alfa
TTDS00438	Binder	Follitropin beta
TTDS00438	Binder	Menotropins
TTDS00438	Binder	Urofollitropin
TTDS00439	UniProt ID	P47871
TTDS00439	Name	Glucagon receptor
TTDS00439	Type of target	Successful target
TTDS00439	Disease	Hyperglycemia
TTDS00439	Disease	Insulin-dependent diabetes mellitus
TTDS00439	Disease	Lipid metabolic disorders
TTDS00439	Disease	Noninsulin-dependent diabetes mellitus
TTDS00439	Disease	Obesity
TTDS00439	Function	This is a receptor for glucagon which plays a central role in regulating the lev
TTDS00439	Sequence	MPPCQPQRPLLLLLLLLACQPQVPSAQVMDFLFEKWKLYGDQCHHNLSLLPPPTELVCNRTFDKYSCWPDTPANTTANIS
TTDS00439	PDB Structure	3CZF; 4ERS
TTDS00439	BioChemical Class	G-protein coupled receptor (Secretin family)
TTDS00439	Pathway	Neuroactive ligand-receptor interaction
TTDS00439	Related US Patent	6,503,949
TTDS00439	Related US Patent	6,562,807
TTDS00439	Related US Patent	6,649,641
TTDS00439	Target Validation	TTDS00439
TTDS00439	Drug(s)	DwLIP-GCGRrx
TTDS00439	Drug(s)	Glucagon recombinant
TTDS00439	Drug(s)	ISIS-GCGRrx
TTDS00439	Drug(s)	LY2409021
TTDS00439	Drug(s)	ZP2929
TTDS00439	Inhibitor	BI-32169
TTDS00439	Inhibitor	Des-His1[Glu9]glucagon-NH2
TTDS00439	Inhibitor	[des-His1,Tyr5,Glu9,D-Ala10]glucagon-NH2
TTDS00439	Inhibitor	[des-His1,Tyr5,Glu9,D-Phe10]glucagon-NH2
TTDS00439	Inhibitor	[des-His1,Tyr5,Glu9,D-Tyr10]glucagon-NH2
TTDS00439	Inhibitor	[des-His1,Tyr5,Glu9]glucagon-NH2
TTDS00439	Agonist	ZP2929
TTDS00439	Binder	DwLIP-GCGRrx
TTDS00439	Binder	Glucagon recombinant
TTDS00439	Multitarget	ZP2929
TTDS00440	UniProt ID	P43220
TTDS00440	Name	Glucagon-like peptide 1 receptor
TTDS00440	Type of target	Successful target
TTDS00440	Synonyms	GLP-1 receptor
TTDS00440	Synonyms	GLP-1-R
TTDS00440	Synonyms	GLP-1R
TTDS00440	Disease	Central nervous system diseases
TTDS00440	Disease	Diabetic neuropathy
TTDS00440	Disease	Noninsulin-dependent diabetes mellitus
TTDS00440	Disease	Obesity
TTDS00440	Function	This is a receptor for glucagon-like peptide 1. The activity of this receptor is
TTDS00440	Sequence	MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSF
TTDS00440	PDB Structure	3C59; 3C5T; 3IOL
TTDS00440	BioChemical Class	G-protein coupled receptor (Secretin family)
TTDS00440	Pathway	Neuroactive ligand-receptor interaction
TTDS00440	Related US Patent	6,469,021
TTDS00440	Target Validation	TTDS00440
TTDS00440	Drug(s)	Bydureon Dual Chamber Pen
TTDS00440	Drug(s)	CVX 096
TTDS00440	Drug(s)	Exenatide
TTDS00440	Drug(s)	GTP-010
TTDS00440	Drug(s)	Liraglutide
TTDS00440	Drug(s)	NN9924
TTDS00440	Drug(s)	PB-1023
TTDS00440	Drug(s)	Pramlintide
TTDS00440	Drug(s)	TT-401
TTDS00440	Drug(s)	TTP054
TTDS00440	Drug(s)	ZP2929
TTDS00440	Drug(s)	ZYOG1
TTDS00440	Inhibitor	GLP-17-(7-36) derivative
TTDS00440	Inhibitor	Glu20-Lys24][Gly8][GLP-1(7-37)-NH2
TTDS00440	Inhibitor	HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG-NH2
TTDS00440	Inhibitor	HAEGTFTSDVSSYLEGQAAKEIFAWLVKGR
TTDS00440	Inhibitor	NH2-HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-CONH2
TTDS00440	Inhibitor	[Gly8, aib22]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	[Gly8,Glu22]GLP-1(7,37)-NH2
TTDS00440	Inhibitor	[Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Asp22-Lys26][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Cpa19-Lys26][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Glu18-Lys22][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Glu19-Lys23][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Glu21-Lys25][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Glu21-Lys26][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Glu22-Lys26][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Glu22-Orn26][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Glu23-Lys27][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Glu24-Lys28][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[Glu26-Lys30][Gly8]GLP-1(7-37)-NH2
TTDS00440	Inhibitor	c[hGlu22-Lys26][Gly8]GLP-1(7-37)-NH2
TTDS00440	Agonist	Exendin-4
TTDS00440	Agonist	GTP-010
TTDS00440	Agonist	Liraglutide
TTDS00440	Agonist	Pramlintide
TTDS00440	Agonist	ZP2929
TTDS00440	Agonist	ZYOG1
TTDS00440	Binder	Exenatide
TTDS00440	Multitarget	ZP2929
TTDS00441	UniProt ID	Q04609
TTDS00441	Name	Glutamate carboxypeptidase II
TTDS00441	Type of target	Successful target
TTDS00441	Synonyms	FGCP
TTDS00441	Synonyms	Folate hydrolase 1
TTDS00441	Synonyms	Folylpoly-gamma-glutamate carboxypeptidase
TTDS00441	Synonyms	MGCP
TTDS00441	Synonyms	Membrane glutamate carboxypeptidase
TTDS00441	Synonyms	N-acetylated-alpha-linked acidic dipeptidase I
TTDS00441	Synonyms	NAALADase I
TTDS00441	Synonyms	PSM
TTDS00441	Synonyms	PSMA
TTDS00441	Synonyms	Prostate-specific membrane antigen
TTDS00441	Synonyms	Pteroylpoly-gamma-glutamate carboxypeptidase
TTDS00441	Disease	Amyotrophic lateral sclerosis
TTDS00441	Disease	Prostate cancer
TTDS00441	Disease	Stroke
TTDS00441	Function	Has both folate hydrolase and n-acetylated-alpha-linked- acidic dipeptidase (naa
TTDS00441	Sequence	MWNLLHETDSAVATARRPRWLCAGALVLAGGFFLLGFLFGWFIKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQI
TTDS00441	PDB Structure	1Z8L; 2C6C; 2C6G; 2C6P; 2CIJ; 2JBJ; 2JBK; 2OOT; 2OR4; 2PVV; 2PVW; 2XEF; 2XEG; 2X
TTDS00441	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00441	EC Number	EC 3.4.17.21
TTDS00441	Related US Patent	6,376,478
TTDS00441	Related US Patent	6,479,470
TTDS00441	Related US Patent	6,528,499
TTDS00441	Related US Patent	6,586,623
TTDS00441	Target Validation	TTDS00441
TTDS00441	Drug(s)	Capromab
TTDS00441	Drug(s)	GPI-16072
TTDS00441	Inhibitor	2-(2-Hydroxycarbamoyl-ethyl)-pentanedioic acid
TTDS00441	Inhibitor	2-(2-Mercapto-ethyl)-pentanedioic acid
TTDS00441	Inhibitor	2-(2-Phosphonooxy-ethyl)-pentanedioic acid
TTDS00441	Inhibitor	2-(2-carboxy-5-mercaptopentyl)benzoic acid
TTDS00441	Inhibitor	2-(2-carboxy-7-mercaptoheptyl)benzoic acid
TTDS00441	Inhibitor	2-(3-Hydroxycarbamoyl-propyl)-pentanedioic acid
TTDS00441	Inhibitor	2-(3-Mercapto-propyl)-pentanedioic acid
TTDS00441	Inhibitor	2-(3-Methylsulfanyl-propyl)-pentanedioic acid
TTDS00441	Inhibitor	2-(3-carbamoylbenzyl)-5-mercaptopentanoic acid
TTDS00441	Inhibitor	2-(3-carboxybenzyl)succinic acid
TTDS00441	Inhibitor	2-(3-cyanobenzyl)-5-mercaptopentanoic acid
TTDS00441	Inhibitor	2-(4-Mercapto-butyl)-pentanedioic acid
TTDS00441	Inhibitor	2-(5-Mercapto-pentyl)-pentanedioic acid
TTDS00441	Inhibitor	2-(phosphonomethyl)pentanedioic acid
TTDS00441	Inhibitor	2-Hydroxycarbamoyl-pentanedioic acid
TTDS00441	Inhibitor	2-Hydroxycarbamoylmethyl-pentanedioic acid
TTDS00441	Inhibitor	2-Mercapto-pentanedioic acid
TTDS00441	Inhibitor	2-Mercaptomethyl-pentanedioic acid
TTDS00441	Inhibitor	2-PMPA
TTDS00441	Inhibitor	2-Phosphonooxy-pentanedioic acid
TTDS00441	Inhibitor	2-benzyl-5-mercaptopentanoic acid
TTDS00441	Inhibitor	3-(1-carboxy-4-mercaptobutoxy)benzoic acid
TTDS00441	Inhibitor	3-(2-carbamoyl-5-mercaptopentyl)benzoic acid
TTDS00441	Inhibitor	3-(2-carboxy-3-mercaptopropyl)benzoic acid
TTDS00441	Inhibitor	3-(2-carboxy-3-phosphonopropyl)benzoic acid
TTDS00441	Inhibitor	3-(2-carboxy-4-mercaptobutyl)benzoic acid
TTDS00441	Inhibitor	3-(2-carboxy-5-mercaptopentyl)benzoic acid
TTDS00441	Inhibitor	3-(2-carboxy-6-mercaptohexyl)benzoic acid
TTDS00441	Inhibitor	3-[(1-carboxy-4-mercaptobutyl)thio]benzoic acid
TTDS00441	Inhibitor	4-(2-carboxy-5-mercaptopentyl)benzoic acid
TTDS00441	Inhibitor	5-Mercapto-pentanoic acid
TTDS00441	Inhibitor	GPI-16072
TTDS00441	Inhibitor	QUISQUALATE
TTDS00441	Antibody	Capromab
TTDS00442	UniProt ID	P15509
TTDS00442	Name	Granulocyte-macrophage colony-stimulating factor receptor alpha chain
TTDS00442	Type of target	Successful target
TTDS00442	Synonyms	CD116 antigen
TTDS00442	Synonyms	CDw116
TTDS00442	Synonyms	GM-CSF-R-alpha
TTDS00442	Synonyms	GM-CSFR
TTDS00442	Synonyms	GMR
TTDS00442	Disease	Leukemia, unspecified
TTDS00442	Disease	Solid tumor
TTDS00442	Function	Low affinity receptor for granulocyte-macrophage colony- stimulating factor. Tra
TTDS00442	Sequence	MLLLVTSLLLCELPHPAFLLIPEKSDLRTVAPASSLNVRFDSRTMNLSWDCQENTTFSKCFLTDKKNRVVEPRLSNNECS
TTDS00442	PDB Structure	3CXE
TTDS00442	BioChemical Class	Transmembrane protein
TTDS00442	Pathway	Cytokine-cytokine receptor interaction
TTDS00442	Pathway	Hematopoietic cell lineage
TTDS00442	Pathway	Jak-STAT signaling pathway
TTDS00442	Pathway	Pathways in cancer
TTDS00442	Drug(s)	Mavrilimumab
TTDS00442	Drug(s)	Sargramostim
TTDS00442	Antibody	Mavrilimumab
TTDS00442	Binder	Sargramostim
TTDS00443	Name	Guanylate cyclase
TTDS00443	Type of target	Successful target
TTDS00443	Synonyms	Guanylyl Cyclase
TTDS00443	Disease	Angina pectoris
TTDS00443	Disease	Atherosclerosis
TTDS00443	Disease	Cardiac insufficiency
TTDS00443	Disease	Cardiovascular disease, unspecified
TTDS00443	Disease	Hypertension
TTDS00443	Disease	Thrombosis
TTDS00443	BioChemical Class	Phosphorus-oxygen lyases
TTDS00443	Pathway	Gap junction
TTDS00443	Pathway	Long-term depression
TTDS00443	Pathway	Purine metabolism
TTDS00443	Pathway	Vascular smooth muscle contraction
TTDS00443	Related US Patent	6,548,547
TTDS00443	Target Validation	TTDS00443
TTDS00443	Drug(s)	Erythrityl Tetranitrate
TTDS00443	Drug(s)	Isosorbide Dinitrate
TTDS00443	Drug(s)	Isosorbide Mononitrate
TTDS00443	Drug(s)	Nitric Oxide
TTDS00443	Drug(s)	Nitroglycerin
TTDS00443	Inhibitor	Methylene blue
TTDS00443	Stimulator	Erythrityl Tetranitrate
TTDS00443	Stimulator	Isosorbide Dinitrate
TTDS00443	Stimulator	Isosorbide Mononitrate
TTDS00443	Stimulator	Nitric Oxide
TTDS00443	Stimulator	Nitroglycerin
TTDS00444	UniProt ID	P20701
TTDS00444	UniProt ID	Q9UBC8
TTDS00444	Name	Lymphocyte function-associated antigen 1
TTDS00444	Type of target	Successful target
TTDS00444	Synonyms	CD11a
TTDS00444	Synonyms	Integrin alpha-L
TTDS00444	Synonyms	LFA-1
TTDS00444	Synonyms	LFA-1A
TTDS00444	Synonyms	Leukocyte adhesion glycoprotein LFA-1 alpha chain
TTDS00444	Synonyms	Leukocyte function associated molecule 1, alpha chain
TTDS00444	Synonyms	Lymphocyte Function-associated Antigen-1
TTDS00444	Disease	Inflammatory diseases
TTDS00444	Sequence	MKDSCITVMAMALLSGFFFFAPASSYNLDVRGARSFSPPRAGRHFGYRVLQVGNGVIVGAPGEGNSTGSLYQCQSGTGHC
TTDS00444	PDB Structure	1CQP; 1DGQ; 1IJ4; 1LFA; 1MJN; 1MQ8; 1MQ9; 1MQA; 1RD4; 1T0P; 1XDD; 1XDG; 1XUO; 1Z
TTDS00444	Related US Patent	6,630,492
TTDS00444	Related US Patent	6,652,855
TTDS00444	Related US Patent	6,667,318
TTDS00444	Target Validation	TTDS00444
TTDS00444	Drug(s)	Efalizumab
TTDS00444	Inhibitor	A-286982
TTDS00444	Inhibitor	BMS-587101;BMS-688521
TTDS00444	Inhibitor	LFA703
TTDS00444	Antibody	Efalizumab
TTDS00445	UniProt ID	P13612
TTDS00445	Name	Integrin alpha-4
TTDS00445	Type of target	Successful target
TTDS00445	Synonyms	CD49d
TTDS00445	Synonyms	Integrin alpha 4 beta 1
TTDS00445	Synonyms	Integrin alpha-IV
TTDS00445	Synonyms	VLA-4
TTDS00445	Synonyms	Very late antigen 4
TTDS00445	Disease	Allergic rhinitis, unspecified
TTDS00445	Disease	Allergy, unspecified
TTDS00445	Disease	Asthma
TTDS00445	Disease	Chronic experimental allergic encephalomyelitis
TTDS00445	Disease	Diabetes mellitus
TTDS00445	Disease	Inflammatory bowel disease
TTDS00445	Disease	Multiple sclerosis
TTDS00445	Disease	Predominantly eosinophil mediated disease states
TTDS00445	Disease	Rheumatoid arthritis, unspecified
TTDS00445	Function	Integrins alpha-4/beta-1 (vla-4) and alpha-4/beta-7 are receptors for fibronecti
TTDS00445	Sequence	MAWEARREPGPRRAAVRETVMLLLCLGVPTGRPYNVDTESALLYQGPHNTLFGYSVVLHSHGANRWLLVGAPTANWLANA
TTDS00445	PDB Structure	3V4P; 3V4V
TTDS00445	BioChemical Class	Transmembrane protein
TTDS00445	Pathway	Cell adhesion molecules (CAMs)
TTDS00445	Pathway	ECM-receptor interaction
TTDS00445	Pathway	Focal adhesion
TTDS00445	Pathway	Hematopoietic cell lineage
TTDS00445	Pathway	Leukocyte transendothelial migration
TTDS00445	Pathway	Regulation of actin cytoskeleton
TTDS00445	Related US Patent	6,432,923
TTDS00445	Related US Patent	6,596,752
TTDS00445	Related US Patent	6,668,527
TTDS00445	Target Validation	TTDS00445
TTDS00445	QSAR Model	TTDS00445
TTDS00445	Drug(s)	ATL/TV1102
TTDS00445	Drug(s)	CDP323
TTDS00445	Drug(s)	Firategrast
TTDS00445	Drug(s)	GSK683699
TTDS00445	Drug(s)	Natalizumab
TTDS00445	Drug(s)	R1295
TTDS00445	Drug(s)	SB-683699
TTDS00445	Drug(s)	Vedolizmab
TTDS00445	Antagonist	BIO-1211
TTDS00445	Antagonist	CDP323
TTDS00445	Antagonist	CT301
TTDS00445	Antagonist	Firategrast
TTDS00445	Antagonist	R1295
TTDS00445	Antagonist	SB-683699
TTDS00445	Antagonist	Vedolizmab
TTDS00445	Antibody	Antegren
TTDS00445	Antibody	Natalizumab
TTDS00445	Binder	ATL/TV1102
TTDS00445	Binder	GSK683699
TTDS00445	Multitarget	Vedolizmab
TTDS00446	UniProt ID	Q02643
TTDS00446	Name	Growth hormone-releasing hormone receptor
TTDS00446	Type of target	Successful target
TTDS00446	Synonyms	GHRH receptor
TTDS00446	Synonyms	GRF receptor
TTDS00446	Synonyms	GRFR
TTDS00446	Disease	Chronic Renal Failure
TTDS00446	Disease	Growth Hormone Deficiencies/Abnormalities
TTDS00446	Disease	Hormone Deficiencies
TTDS00446	Disease	Lipodystrophy
TTDS00446	Sequence	MDRRMWGAHVFCVLSPLPTVLGHMHPECDFITQLREDESACLQAAEEMPNTTLGCPATWDGLLCWPTAGSGEWVTLPCPD
TTDS00446	PDB Structure	2XDG
TTDS00446	Pathway	Neuroactive ligand-receptor interaction
TTDS00446	Drug(s)	GHRH analog
TTDS00446	Drug(s)	Ipamorelin
TTDS00446	Drug(s)	Sermorelin
TTDS00446	Drug(s)	Tesamorelin
TTDS00446	Antagonist	Ipamorelin
TTDS00446	Agonist	GHRH analog
TTDS00446	Agonist	Mutated growth hormone
TTDS00446	Binder	Sermorelin
TTDS00446	Binder	Tesamorelin
TTDS00447	UniProt ID	P01584
TTDS00447	Name	Interleukin-1 beta
TTDS00447	Type of target	Successful target
TTDS00447	Synonyms	Catabolin
TTDS00447	Synonyms	IL-1 beta
TTDS00447	Synonyms	IL-1beta
TTDS00447	Disease	Acne
TTDS00447	Disease	Atopic Dermatitis
TTDS00447	Disease	Chronic hepatitis C
TTDS00447	Disease	Pediatric
TTDS00447	Disease	Psoriasis and Psoriatic Disorders
TTDS00447	Function	Produced by activated macrophages, il-1 stimulates thymocyte proliferation by in
TTDS00447	Sequence	MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVP
TTDS00447	PDB Structure	1HIB; 1I1B; 1IOB; 1ITB; 1L2H; 1S0L; 1T4Q; 1TOO; 1TP0; 1TWE; 1TWM; 21BI; 2I1B; 2K
TTDS00447	Pathway	Alzheimer's disease
TTDS00447	Pathway	Apoptosis
TTDS00447	Pathway	Cytokine-cytokine receptor interaction
TTDS00447	Pathway	Graft-versus-host disease
TTDS00447	Pathway	Hematopoietic cell lineage
TTDS00447	Pathway	MAPK signaling pathway
TTDS00447	Pathway	Toll-like receptor signaling pathway
TTDS00447	Pathway	Type I diabetes mellitus
TTDS00447	Related US Patent	6,432,962
TTDS00447	Related US Patent	6,541,670
TTDS00447	Related US Patent	6,555,710
TTDS00447	Related US Patent	6,566,554
TTDS00447	Target Validation	TTDS00447
TTDS00447	Drug(s)	Canakinumab
TTDS00447	Drug(s)	Celastrol
TTDS00447	Drug(s)	Gallium nitrate
TTDS00447	Drug(s)	Glucosamine
TTDS00447	Drug(s)	Ibudilast
TTDS00447	Inhibitor	Diacerein
TTDS00447	Inhibitor	Gallium nitrate
TTDS00447	Inhibitor	Glucosamine
TTDS00447	Inhibitor	Ibudilast
TTDS00447	Suppressor	Celastrol
TTDS00447	Antibody	Canakinumab
TTDS00447	Multitarget	Ibudilast
TTDS00448	UniProt ID	P08246
TTDS00448	Name	Leukocyte elastase
TTDS00448	Type of target	Successful target
TTDS00448	Synonyms	Bone marrow serine protease
TTDS00448	Synonyms	Medullasin
TTDS00448	Synonyms	Neutrophil elastase
TTDS00448	Synonyms	PMN elastase
TTDS00448	Disease	Adult respiratory distress syndrome
TTDS00448	Disease	Allergic rhinitis, unspecified
TTDS00448	Disease	Asthma
TTDS00448	Disease	Attenuated coronary flow reserve and myocardial dysfunction
TTDS00448	Disease	Chronic bronchitis
TTDS00448	Disease	Chronic obstructive pulmonary disease, unspecified
TTDS00448	Disease	Cystic fibrosis
TTDS00448	Disease	Emphysema
TTDS00448	Disease	Intestinal ischemia-reperfusion associated with lung injury and the acute respir
TTDS00448	Disease	Mucociliary dysfunction
TTDS00448	Disease	Pulmonary edema (thrombin-induced)
TTDS00448	Function	Medullasin modifies the functions of natural killer cells, monocytes and granulo
TTDS00448	Sequence	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAV
TTDS00448	PDB Structure	1B0F; 1H1B; 1HNE; 1PPF; 1PPG; 2RG3; 2Z7F; 3Q76; 3Q77
TTDS00448	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00448	Pathway	Systemic lupus erythematosus
TTDS00448	EC Number	EC 3.4.21.37
TTDS00448	Related US Patent	6,215,002
TTDS00448	Related US Patent	6,228,853
TTDS00448	Related US Patent	6,375,926
TTDS00448	Related US Patent	6,548,638
TTDS00448	Related US Patent	6,608,175
TTDS00448	Related US Patent	6,656,911
TTDS00448	Target Validation	TTDS00448
TTDS00448	Drug(s)	AZD9668
TTDS00448	Drug(s)	Alpha-1-proteinase inhibitor
TTDS00448	Drug(s)	BAY 85-8501
TTDS00448	Drug(s)	DX-890
TTDS00448	Drug(s)	Dermolastin
TTDS00448	Drug(s)	Sivelestat sodium hydrate
TTDS00448	Inhibitor	(1H-pyrazol-1-yl)(o-tolyl)methanone
TTDS00448	Inhibitor	(3,4-dichlorophenyl)(1H-pyrazol-1-yl)methanone
TTDS00448	Inhibitor	(3-nitro-1H-pyrazol-1-yl)(p-tolyl)methanone
TTDS00448	Inhibitor	(3-nitro-1H-pyrazol-1-yl)(phenyl)methanone
TTDS00448	Inhibitor	(4-bromo-1H-pyrazol-1-yl)(m-tolyl)methanone
TTDS00448	Inhibitor	(4-bromo-1H-pyrazol-1-yl)(o-tolyl)methanone
TTDS00448	Inhibitor	(4-bromo-1H-pyrazol-1-yl)(p-tolyl)methanone
TTDS00448	Inhibitor	(4-chloro-1H-pyrazol-1-yl)(o-tolyl)methanone
TTDS00448	Inhibitor	(4-nitro-1H-pyrazol-1-yl)(o-tolyl)methanone
TTDS00448	Inhibitor	(4-nitro-1H-pyrazol-1-yl)(phenyl)methanone
TTDS00448	Inhibitor	1-(3,3-Dimethyl-2-oxo-butyl)-1H-indole-2,3-dione
TTDS00448	Inhibitor	1-benzoyl-N-phenyl-1H-pyrazole-3-carboxamide
TTDS00448	Inhibitor	1-benzyl-3,3-diethylazetidine-2,4-dione
TTDS00448	Inhibitor	1-benzyl-3,3-dimethylazetidine-2,4-dione
TTDS00448	Inhibitor	2-methylbut-3-yn-2-yl 4-methoxybenzoate
TTDS00448	Inhibitor	3,3-Diethyl-1-(pyridin-3-yl)azetidine-2,4-dione
TTDS00448	Inhibitor	3,3-Diethyl-1-o-tolylazetidine-2,4-dione
TTDS00448	Inhibitor	3,3-diethyl-1-phenylazetidine-2,4-dione
TTDS00448	Inhibitor	3,4-dichloroisocoumarin
TTDS00448	Inhibitor	3-Benzyl-3-ethyl-1-phenylazetidine-2,4-dione
TTDS00448	Inhibitor	3-Benzyl-3-methyl-1-phenylazetidine-2,4-dione
TTDS00448	Inhibitor	3-Decanoyl-4-hydroxy-6-nonyl-pyran-2-one
TTDS00448	Inhibitor	3-Ethyl-3-isobutyl-1-phenylazetidine-2,4-dione
TTDS00448	Inhibitor	3-butyl-3-ethyl-1-phenylazetidine-2,4-dione
TTDS00448	Inhibitor	4-Hydroxy-3-nonanoyl-6-octyl-pyran-2-one
TTDS00448	Inhibitor	4-methoxy-N'-(2-phenylacetyl)benzohydrazide
TTDS00448	Inhibitor	6-Heptyl-4-hydroxy-3-octanoyl-pyran-2-one
TTDS00448	Inhibitor	AE-3763
TTDS00448	Inhibitor	AZD9668
TTDS00448	Inhibitor	Ac-Ala-Pro-Val-(2-benzoxazole)
TTDS00448	Inhibitor	Alpha-1-proteinase inhibitor
TTDS00448	Inhibitor	CE-1037
TTDS00448	Inhibitor	CEP-18770
TTDS00448	Inhibitor	Cbz-Val-Pro-Val-(2-benzoxazole)
TTDS00448	Inhibitor	DX-890
TTDS00448	Inhibitor	Dermolastin
TTDS00448	Inhibitor	E-6-O-p-methoxycinnamoyl scandoside methyl ester
TTDS00448	Inhibitor	EPIGALOCATECHIN GALLATE
TTDS00448	Inhibitor	FK-706
TTDS00448	Inhibitor	FR-901277
TTDS00448	Inhibitor	FR-901451
TTDS00448	Inhibitor	Fucose
TTDS00448	Inhibitor	GW-311616
TTDS00448	Inhibitor	ICI 200,355
TTDS00448	Inhibitor	ICI 200,880
TTDS00448	Inhibitor	ICI-200355
TTDS00448	Inhibitor	ICI-200880
TTDS00448	Inhibitor	L-658,758
TTDS00448	Inhibitor	L-658758
TTDS00448	Inhibitor	L-694,458
TTDS00448	Inhibitor	MR-889
TTDS00448	Inhibitor	Mdl 101,146
TTDS00448	Inhibitor	N,N-bis(cyanomethyl)-3,4-dimethoxybenzamide
TTDS00448	Inhibitor	ONO-6818
TTDS00448	Inhibitor	Secretory leukocyte protease inhibitor
TTDS00448	Inhibitor	Sivelestat
TTDS00448	Inhibitor	Sivelestat sodium hydrate
TTDS00448	Inhibitor	TEI-8362
TTDS00448	Inhibitor	Ulinastatin
TTDS00448	Inhibitor	WIN-63395
TTDS00448	Inhibitor	ZD-0892
TTDS00448	Inhibitor	ZD-8321
TTDS00448	Inhibitor	ZK-814048
TTDS00448	Inhibitor	bornyl (3,4,5-trihydroxy)-cinnamate
TTDS00448	Multitarget	Dermolastin
TTDS00448	Aptamer	DD7
TTDS00448	Aptamer	ED1
TTDS00448	Aptamer	ED45
TTDS00449	UniProt ID	P08473
TTDS00449	Name	Neprilysin
TTDS00449	Type of target	Successful target
TTDS00449	Synonyms	CALLA
TTDS00449	Synonyms	CD10
TTDS00449	Synonyms	Common acute lymphocytic leukemia antigen
TTDS00449	Synonyms	Enkephalinase
TTDS00449	Synonyms	NEP
TTDS00449	Synonyms	Neutral endopeptidase
TTDS00449	Synonyms	Neutral endopeptidase 24.11
TTDS00449	Disease	Congestive Heart Failure
TTDS00449	Disease	Hypertension
TTDS00449	Disease	Prostate cancer (early stage hormone sensitive)
TTDS00449	Function	Thermolysin-like specificity, but is almost confined on acting on polypeptides o
TTDS00449	Sequence	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPC
TTDS00449	PDB Structure	1DL9; 1DMT; 1QVD; 1R1H; 1R1I; 1R1J; 1Y8J; 2QPJ; 2YB9
TTDS00449	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00449	Pathway	Alzheimer's disease
TTDS00449	Pathway	Hematopoietic cell lineage
TTDS00449	Pathway	Renin-angiotensin system
TTDS00449	EC Number	EC 3.4.24.11
TTDS00449	Related US Patent	6,509,330
TTDS00449	Related US Patent	6,660,756
TTDS00449	Target Validation	TTDS00449
TTDS00449	Drug(s)	Candoxatril
TTDS00449	Drug(s)	Debio 0827
TTDS00449	Drug(s)	GSK 796406
TTDS00449	Drug(s)	Ilepatril
TTDS00449	Drug(s)	LCZ696
TTDS00449	Drug(s)	M100,240
TTDS00449	Drug(s)	Omapatrilat
TTDS00449	Drug(s)	Pfizer 4
TTDS00449	Drug(s)	SLV 306
TTDS00449	Inhibitor	9-Mercaptomethyl-10-oxo-azecane-2-carboxylic acid
TTDS00449	Inhibitor	CGS-26303
TTDS00449	Inhibitor	CGS-314447
TTDS00449	Inhibitor	Candoxatril
TTDS00449	Inhibitor	Debio 0827
TTDS00449	Inhibitor	GSK 796406
TTDS00449	Inhibitor	Ilepatril
TTDS00449	Inhibitor	M100,240
TTDS00449	Inhibitor	NEP inhibitor
TTDS00449	Inhibitor	Omapatrilat
TTDS00449	Inhibitor	Pfizer 4
TTDS00449	Inhibitor	Phosphoramidon
TTDS00449	Inhibitor	SCH-54470
TTDS00449	Inhibitor	SLV 306
TTDS00449	Inhibitor	SQ-26332;SQ-28603
TTDS00449	Inhibitor	Thiorphan
TTDS00449	Inhibitor	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala
TTDS00449	Multitarget	GSK 796406
TTDS00449	Multitarget	Ilepatril
TTDS00449	Multitarget	M100,240
TTDS00449	Multitarget	Omapatrilat
TTDS00450	UniProt ID	P00946
TTDS00450	UniProt ID	P34948
TTDS00450	UniProt ID	P34949
TTDS00450	Name	Mannose-6-phosphate isomerase
TTDS00450	Type of target	Successful target
TTDS00450	Synonyms	PMI
TTDS00450	Synonyms	Phosphohexomutase
TTDS00450	Synonyms	Phosphomannose isomerase
TTDS00450	Disease	Fungal diseases
TTDS00450	Function	Involved in the synthesis of the gdp-mannose and dolichol-phosphate-mannose requ
TTDS00450	Sequence	MSSEKLFRIQCGYQNYDWGKIGSSSAVAQFVHNSDPSITIDETKPYAELWMGTHPSVPSKAIDLNNQTLRDLVTAKPQEY
TTDS00450	PDB Structure	1PMI
TTDS00450	BioChemical Class	Intramolecular oxidoreductases
TTDS00450	Pathway	Amino sugar and nucleotide sugar metabolism
TTDS00450	Pathway	Fructose and mannose metabolism
TTDS00450	Pathway	Metabolic pathways
TTDS00450	EC Number	EC 5.3.1.8
TTDS00450	Target Validation	TTDS00450
TTDS00450	Drug(s)	Sulfacetamide
TTDS00450	Drug(s)	Sulfanilamide
TTDS00450	Drug(s)	Sulfoxone
TTDS00450	Inhibitor	Acetate Ion
TTDS00450	Inhibitor	Formic Acid
TTDS00450	Inhibitor	GNF-PF-2272
TTDS00450	Inhibitor	GNF-PF-5134
TTDS00450	Inhibitor	NSC-66209
TTDS00450	Inhibitor	Sulfacetamide
TTDS00450	Inhibitor	Sulfanilamide
TTDS00450	Inhibitor	Sulfoxone
TTDS00451	UniProt ID	P00797
TTDS00451	Name	Renin, renal
TTDS00451	Type of target	Successful target
TTDS00451	Synonyms	Angiotensinogenase
TTDS00451	Synonyms	Renin
TTDS00451	Disease	Cancer, unspecific
TTDS00451	Disease	Hypertension
TTDS00451	Function	Renin is a highly specific endopeptidase, whose only known function is to genera
TTDS00451	Sequence	MDGWRRMPRWGLLLLLWGSCTFGLPTDTTTFKRIFLKRMPSIRESLKERGVDMARLGPEWSQPMKRLTLGNTTSSVILTN
TTDS00451	PDB Structure	1BBS; 1BIL; 1BIM; 1HRN; 1RNE; 2BKS; 2BKT; 2FS4; 2G1N; 2G1O; 2G1R; 2G1S; 2G1Y; 2G
TTDS00451	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00451	Pathway	Renin-angiotensin system
TTDS00451	EC Number	EC 3.4.23.15
TTDS00451	Related US Patent	6,376,672
TTDS00451	Related US Patent	6,673,931
TTDS00451	Target Validation	TTDS00451
TTDS00451	QSAR Model	TTDS00451
TTDS00451	Drug(s)	Aliskiren
TTDS00451	Drug(s)	Remikiren
TTDS00451	Drug(s)	TAK-272
TTDS00451	Inhibitor	(H-261)Boc-His-Pro-Phe-His-Leu(OH)-Val-Ile-His-OH
TTDS00451	Inhibitor	1-Hydroxy-2-Amino-3-Cyclohexylpropane
TTDS00451	Inhibitor	1-Hydroxy-3-Methylbutane
TTDS00451	Inhibitor	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine
TTDS00451	Inhibitor	2-Cyclopropylmethylenepropanal
TTDS00451	Inhibitor	2-Methyl-3-(2-Aminothiazolo)Propanal
TTDS00451	Inhibitor	3-Phenyl-1,2-Propandiol
TTDS00451	Inhibitor	Aliskiren
TTDS00451	Inhibitor	CP-305202
TTDS00451	Inhibitor	CP-80794
TTDS00451	Inhibitor	Dimethylformamide
TTDS00451	Inhibitor	Enalkiren
TTDS00451	Inhibitor	Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro
TTDS00451	Inhibitor	Iva-His-Pro-Phe-His-ACHPA-Leu-Phe-NH2
TTDS00451	Inhibitor	Iva-His-Pro-Phe-His-AHPPA-Leu-Phe-NH2
TTDS00451	Inhibitor	Iva-His-Pro-Phe-His-Sta-Leu-Phe-NH2
TTDS00451	Inhibitor	N-Methyl-N-(Methylbenzyl)Formamide
TTDS00451	Inhibitor	PEPSTATIN A
TTDS00451	Inhibitor	PP1-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)
TTDS00451	Inhibitor	PP2-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)
TTDS00451	Inhibitor	Pro-His-Pro-His-Leu-Phe-Val-Tyr
TTDS00451	Inhibitor	Pro-His-Pro-His-Phe-Phe-Val-Tyr
TTDS00451	Inhibitor	Pro-His-Pro-His-Phe-Phe-Val-Tyr-Lys
TTDS00451	Inhibitor	Pro-His-Pro-Phe-His-Leu(CH2NH)Val-Ile-His-Lys
TTDS00451	Inhibitor	Remikiren
TTDS00451	Inhibitor	Ro-65-7219
TTDS00451	Inhibitor	Ro-66-1168
TTDS00451	Inhibitor	Sul-Pro-Phe-N-MeHis-LVA-Ile-Amp
TTDS00451	Inhibitor	Sul-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)
TTDS00451	Inhibitor	ZANKIREN
TTDS00452	UniProt ID	P16473
TTDS00452	Name	Thyrotropin receptor
TTDS00452	Type of target	Successful target
TTDS00452	Synonyms	TSH receptor
TTDS00452	Synonyms	TSH-R
TTDS00452	Synonyms	Thyroid stimulating hormone receptor
TTDS00452	Disease	Graves' disease
TTDS00452	Function	Receptor for thyrothropin. Plays a central role in controlling thyroid cell meta
TTDS00452	Sequence	MRPADLLQLVLLLDLPRDLGGMGCSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISR
TTDS00452	PDB Structure	1XUM; 2XWT; 3G04
TTDS00452	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00452	Pathway	Autoimmune thyroid disease
TTDS00452	Pathway	Neuroactive ligand-receptor interaction
TTDS00452	Drug(s)	Thyrotropin Alfa
TTDS00452	Binder	Thyrotropin Alfa
TTDS00453	UniProt ID	P33681
TTDS00453	Name	T-lymphocyte activation antigen CD80
TTDS00453	Type of target	Successful target
TTDS00453	Synonyms	Activation B7-1 antigen
TTDS00453	Synonyms	B7
TTDS00453	Synonyms	BB1
TTDS00453	Synonyms	CD28LG
TTDS00453	Synonyms	CD28LG1
TTDS00453	Synonyms	CD80
TTDS00453	Synonyms	CTLA-4 counter-receptor B7.1
TTDS00453	Synonyms	LAB7
TTDS00453	Disease	Rheumatoid arthritis
TTDS00453	Sequence	MGHTRRQGTSPSKCPYLNFFQLLVLAGLSHFCSGVIHVTKEVKEVATLSCGHNVSVEELAQTRIYWQKEKKMVLTMMSGD
TTDS00453	PDB Structure	1DR9; 1I8L
TTDS00453	Pathway	Allograft rejection
TTDS00453	Pathway	Autoimmune thyroid disease
TTDS00453	Pathway	Cell adhesion molecules (CAMs)
TTDS00453	Pathway	Graft-versus-host disease
TTDS00453	Pathway	Systemic lupus erythematosus
TTDS00453	Pathway	Toll-like receptor signaling pathway
TTDS00453	Pathway	Type I diabetes mellitus
TTDS00453	Target Validation	TTDS00453
TTDS00453	Drug(s)	Abatacept
TTDS00453	Drug(s)	RhuDex
TTDS00453	Inhibitor	RhuDex
TTDS00453	Binder	Abatacept
TTDS00453	Multitarget	Abatacept
TTDS00454	UniProt ID	P30536
TTDS00454	Name	Peripheral-type benzodiazepine receptor
TTDS00454	Type of target	Successful target
TTDS00454	Synonyms	Mitochondrial benzodiazepine receptor
TTDS00454	Synonyms	PBR
TTDS00454	Synonyms	PKBS
TTDS00454	Synonyms	Peripheral benzodiazepine receptor
TTDS00454	Synonyms	Translocator protein
TTDS00454	Disease	Angina pectoris
TTDS00454	Disease	Autoimmune diseases
TTDS00454	Disease	Brain tumors
TTDS00454	Disease	Breast cancer
TTDS00454	Disease	Cancer, unspecific
TTDS00454	Disease	Colorectal cancer
TTDS00454	Disease	Dementia
TTDS00454	Disease	Melanoma
TTDS00454	Disease	Myocardial ischemia
TTDS00454	Disease	Neurodegenerative diseases
TTDS00454	Disease	Neurological diseases
TTDS00454	Disease	Photodynamic tumor
TTDS00454	Disease	Porphyrin-derived photocytotoxicity
TTDS00454	Disease	Viral infection, unspecified
TTDS00454	Function	Responsible for the manifestation of peripheral-type benzodiazepine recognition
TTDS00454	Sequence	MAPPWVPAMGFTLAPSLGCFVGSRFVHGEGLRWYAGLQKPSWHPPHWVLGPVWGTLYSAMGYGSYLVWKELGGFTEKAVV
TTDS00454	BioChemical Class	Transmembrane protein
TTDS00454	Pathway	Neuroactive ligand-receptor interaction
TTDS00454	Target Validation	TTDS00454
TTDS00454	Drug(s)	Adinazolam
TTDS00454	Drug(s)	Chlormezanone
TTDS00454	Drug(s)	Cinolazepam
TTDS00454	Drug(s)	Dextofisopam
TTDS00454	Drug(s)	Emapunil
TTDS00454	Inhibitor	(R)PK-11195
TTDS00454	Inhibitor	2-(2-Phenyl-1H-indol-3-yl)-N,N-dipropyl-acetamide
TTDS00454	Inhibitor	4-Methoxy-5-phenyl-6-thia-10b-aza-benzo[e]azulene
TTDS00454	Inhibitor	5-Phenyl-6-thia-10b-aza-benzo[e]azulen-4-one
TTDS00454	Inhibitor	5-Phenyl-6-thia-10b-aza-benzo[e]azulene
TTDS00454	Inhibitor	6-Thia-10b-aza-benzo[e]azulen-4-one
TTDS00454	Inhibitor	ALPIDEM
TTDS00454	Inhibitor	N,N-Diethyl-2-(2-phenyl-1H-indol-3-yl)-acetamide
TTDS00454	Inhibitor	N,N-Dihexyl-2-(2-phenyl-1H-indol-3-yl)-acetamide
TTDS00454	Inhibitor	N,N-Dimethyl-2-(2-phenyl-1H-indol-3-yl)-acetamide
TTDS00454	Inhibitor	N-Hexyl-2-(2-phenyl-1H-indol-3-yl)-acetamide
TTDS00454	Inhibitor	PK-11195
TTDS00454	Inhibitor	Ro-5-4864
TTDS00454	Suppressor	Ginkgolide B (GKB)
TTDS00454	Agonist	Adinazolam
TTDS00454	Agonist	Chlormezanone
TTDS00454	Agonist	Dextofisopam
TTDS00454	Agonist	Emapunil
TTDS00454	Agonist	S-8510
TTDS00454	Binder	Cinolazepam
TTDS00454	Ligand	FGIN-1-27
TTDS00454	Ligand	PK 11195
TTDS00454	Ligand	PK11195
TTDS00454	Ligand	Ro 5-4864
TTDS00454	Multitarget	Dextofisopam
TTDS00455	Name	Parasitic pyruvate:ferredoxin oxidoreductase
TTDS00455	Type of target	Successful target
TTDS00455	Disease	Diarrhea
TTDS00455	BioChemical Class	Oxidoreductases acting on iron-sulfur proteins as donors
TTDS00455	Drug(s)	Nitazoxanide
TTDS00455	Inhibitor	Nitazoxanide
TTDS00456	Name	Peptidyl-transferase domain of the bacterial ribosome
TTDS00456	Type of target	Successful target
TTDS00456	Disease	Bacterial infections
TTDS00456	Drug(s)	Dalfopristin
TTDS00456	Binder	Dalfopristin
TTDS00457	Name	Peripheral carotid chemoreceptor
TTDS00457	Type of target	Successful target
TTDS00457	Disease	Respiratory stimulant
TTDS00457	Drug(s)	Doxapram
TTDS00457	Stimulator	Doxapram
TTDS00458	Name	TAG-72 antigen
TTDS00458	Type of target	Successful target
TTDS00458	Disease	Tumor imaging
TTDS00458	Drug(s)	Satumomab Pendetide
TTDS00458	Binder	Satumomab Pendetide
TTDS00459	Name	Estramustine binding protein
TTDS00459	Type of target	Successful target
TTDS00459	Disease	Prostate cancer
TTDS00459	Drug(s)	Estramustine
TTDS00459	Binder	Estramustine
TTDS00460	Name	Food vacuoles
TTDS00460	Type of target	Successful target
TTDS00460	Disease	Malaria
TTDS00460	Drug(s)	Mefloquine
TTDS00460	Binder	Mefloquine
TTDS00461	Name	26S proteasome
TTDS00461	Type of target	Successful target
TTDS00461	Disease	Multiple myeloma
TTDS00461	BioChemical Class	Protease
TTDS00461	Target Validation	TTDS00461
TTDS00461	Drug(s)	Bortezomib
TTDS00461	Inhibitor	Bortezomib
TTDS00462	Name	Bacterial outer membrane
TTDS00462	Type of target	Successful target
TTDS00462	Disease	Bacterial infections
TTDS00462	Target Validation	TTDS00462
TTDS00462	Drug(s)	Candicidin
TTDS00462	Drug(s)	Cefozopran
TTDS00462	Drug(s)	Chlorhexidine
TTDS00462	Drug(s)	Colistimethate
TTDS00462	Drug(s)	Colistin
TTDS00462	Drug(s)	Daptomycin
TTDS00462	Drug(s)	Doripenem
TTDS00462	Drug(s)	Faropenem
TTDS00462	Drug(s)	Gramicidin D
TTDS00462	Drug(s)	Oritavancin
TTDS00462	Drug(s)	Polymyxin B Sulfate
TTDS00462	Drug(s)	SUN13834
TTDS00462	Drug(s)	Silver sulfadiazine
TTDS00462	Drug(s)	Vancomycin
TTDS00462	Inhibitor	Cefozopran
TTDS00462	Inhibitor	Doripenem
TTDS00462	Inhibitor	Ethylene diamine
TTDS00462	Inhibitor	Faropenem
TTDS00462	Inhibitor	HKI-9924129
TTDS00462	Inhibitor	Oritavancin
TTDS00462	Inhibitor	SUN13834
TTDS00462	Breaker	Chlorhexidine
TTDS00462	Binder	Candicidin
TTDS00462	Binder	Colistimethate
TTDS00462	Binder	Colistin
TTDS00462	Binder	Daptomycin
TTDS00462	Binder	Gramicidin D
TTDS00462	Binder	Polymyxin B Sulfate
TTDS00462	Binder	Silver sulfadiazine
TTDS00462	Binder	Vancomycin
TTDS00463	Name	Fungal outer membrane
TTDS00463	Type of target	Successful target
TTDS00463	Disease	Athlete's foot
TTDS00463	Disease	Fungal infections
TTDS00463	Drug(s)	Amphotericin B
TTDS00463	Drug(s)	Haloprogin
TTDS00463	Drug(s)	Natamycin
TTDS00463	Drug(s)	Nystatin
TTDS00463	Binder	Amphotericin B
TTDS00463	Binder	Haloprogin
TTDS00463	Binder	Natamycin
TTDS00463	Binder	Nystatin
TTDS00464	Name	Malignant cancer cells
TTDS00464	Type of target	Successful target
TTDS00464	Disease	Leukemias
TTDS00464	Drug(s)	Arsenic trioxide
TTDS00464	Inhibitor	Arsenic trioxide
TTDS00465	UniProt ID	O75762
TTDS00465	Name	Transient receptor potential cation channel subfamily A member 1
TTDS00465	Type of target	Successful target
TTDS00465	Synonyms	ANKTM1
TTDS00465	Synonyms	Ankyrin-like with transmembrane domains protein 1
TTDS00465	Synonyms	TRPA1
TTDS00465	Synonyms	Transformation-sensitive protein p120
TTDS00465	Disease	Analgesics
TTDS00465	Disease	Irritation
TTDS00465	Disease	Pain
TTDS00465	Function	Has a central role in the pain response to endogenous inflammatory mediators and
TTDS00465	Sequence	MKRSLRKMWRPGEKKEPQGVVYEDVPDDTEDFKESLKVVFEGSAYGLQNFNKQKKLKRCDDMDTFFLHYAAAEGQIELME
TTDS00465	PDB Structure	1UOH
TTDS00465	BioChemical Class	Voltage-gated channel
TTDS00465	Target Validation	TTDS00465
TTDS00465	Drug(s)	Menthol
TTDS00465	Inhibitor	2-methyl-1-(pyridin-3-yl)pent-1-en-3-one oxime
TTDS00465	Inhibitor	2-methyl-1-(pyridin-4-yl)pent-1-en-3-one oxime
TTDS00465	Inhibitor	2-methyl-1-(thiophen-2-yl)pent-1-en-3-one oxime
TTDS00465	Inhibitor	2-methyl-1-(thiophen-3-yl)pent-1-en-3-one oxime
TTDS00465	Inhibitor	3-Methyl-4-phenylbut-3-en-2-one oxime
TTDS00465	Inhibitor	AMG-2504
TTDS00465	Inhibitor	AMG-5445
TTDS00465	Inhibitor	AMG-7160
TTDS00465	Inhibitor	AMG-9090
TTDS00465	Inhibitor	AP18 5
TTDS00465	Activator	Menthol
TTDS00466	UniProt ID	O75907
TTDS00466	Name	Diglyceride acyltransferase
TTDS00466	Type of target	Successful target
TTDS00466	Synonyms	ACAT-related gene product 1
TTDS00466	Synonyms	AGRP1
TTDS00466	Synonyms	DGAT
TTDS00466	Synonyms	DGAT1
TTDS00466	Synonyms	Diacylglycerol O-acyltransferase 1
TTDS00466	Disease	Lowering cholesterol
TTDS00466	Function	Catalyzes the terminal and only committed step in triacylglycerol synthesis by u
TTDS00466	Sequence	MGDRGSSRRRRTGSRPSSHGGGGPAAAEEEVRDAAAGPDVGAAGDAPAPAPNKDGDAGVGSGHWELRCHRLQDSLFSSDS
TTDS00466	BioChemical Class	Acyltransferases
TTDS00466	Pathway	Metabolic pathways
TTDS00466	Pathway	Retinol metabolism
TTDS00466	EC Number	EC 2.3.1.20
TTDS00466	Drug(s)	AZD7687
TTDS00466	Drug(s)	DS-7250
TTDS00466	Drug(s)	Hesperetin
TTDS00466	Drug(s)	LCQ908
TTDS00466	Drug(s)	PF-04620110
TTDS00466	Inhibitor	AZD7687
TTDS00466	Inhibitor	Hesperetin
TTDS00466	Inhibitor	PF-04620110
TTDS00467	UniProt ID	P01008
TTDS00467	Name	Antithrombin-III
TTDS00467	Type of target	Successful target
TTDS00467	Synonyms	AT3
TTDS00467	Synonyms	ATIII
TTDS00467	Synonyms	SERPINC1
TTDS00467	Disease	Thrombosis
TTDS00467	Function	Most important serine protease inhibitor in plasma that regulates the blood coag
TTDS00467	Sequence	MYSNVIGTVTSGKRKVYLLSLLLIGFWDCVTCHGSPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRV
TTDS00467	PDB Structure	1ANT; 1ATH; 1AZX; 1BR8; 1DZG; 1DZH; 1E03; 1E04; 1E05; 1JVQ; 1LK6; 1NQ9; 1OYH; 1R
TTDS00467	Drug(s)	Heparin
TTDS00467	Drug(s)	Sulodexide
TTDS00467	Drug(s)	Tinzaparin
TTDS00467	Inhibitor	Alpha-D-Mannose
TTDS00467	Inhibitor	Heparin Pentasaccharide
TTDS00467	Inhibitor	N-Formylmethionine
TTDS00467	Activator	Sulodexide
TTDS00467	Cofactor	Heparin
TTDS00467	Cofactor	Tinzaparin
TTDS00469	UniProt ID	P03886
TTDS00469	UniProt ID	P03891
TTDS00469	UniProt ID	P03897
TTDS00469	Name	NADH dehydrogenase
TTDS00469	Type of target	Successful target
TTDS00469	Synonyms	MT-ND
TTDS00469	Synonyms	MTND
TTDS00469	Synonyms	NADH
TTDS00469	Synonyms	NADH-ubiquinone oxidoreductase
TTDS00469	Synonyms	ND
TTDS00469	Disease	Parkinson's disease
TTDS00469	Function	Core subunit of the mitochondrial membrane respiratory chain nadh dehydrogenase
TTDS00469	Sequence	MPMANLLLLIVPILIAMAFLMLTERKILGYMQLRKGPNVVGPYGLLQPFADAMKLFTKEPLKPATSTITLYITAPTLALT
TTDS00469	BioChemical Class	Oxidoreductases acting on NADH or NADPH
TTDS00469	Pathway	Metabolic pathways
TTDS00469	Pathway	Parkinson's disease
TTDS00469	EC Number	EC 1.6.5.3
TTDS00469	Target Validation	TTDS00469
TTDS00469	Drug(s)	NADH
TTDS00469	Inhibitor	6-Thiophen-2-yl-imidazo[2,1-b]thiazole
TTDS00469	Inhibitor	6-Thiophen-3-yl-imidazo[2,1-b]thiazole
TTDS00469	Inhibitor	N-Formylmethionine
TTDS00469	Inhibitor	Riboflavin Monophosphate
TTDS00469	Binder	NADH
TTDS00470	UniProt ID	P04070
TTDS00470	Name	Vitamin K-dependent protein C
TTDS00470	Type of target	Successful target
TTDS00470	Synonyms	Activation peptide
TTDS00470	Synonyms	Anticoagulant protein C
TTDS00470	Synonyms	Autoprothrombin IIA
TTDS00470	Synonyms	Blood coagulation factor XIV
TTDS00470	Synonyms	PROC
TTDS00470	Synonyms	Vitamin K-dependent protein C heavy chain
TTDS00470	Synonyms	Vitamin K-dependent protein C light chain
TTDS00470	Disease	Varicose and spider veins of the leg
TTDS00470	Function	Protein c is a vitamin k-dependent serine protease that regulates blood coagulat
TTDS00470	Sequence	MWQLTSLLLFVATWGISGTPAPLDSVFSSSERAHQVLRIRKRANSFLEELRHSSLERECIEEICDFEEAKEIFQNVDDTL
TTDS00470	PDB Structure	1AUT; 1LQV; 1PCU; 2PCT; 3F6U; 3JTC; 4DT7
TTDS00470	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDS00470	EC Number	EC 3.4.21.69
TTDS00470	Target Validation	TTDS00470
TTDS00470	Drug(s)	Sodium Tetradecyl Sulfate
TTDS00470	Inhibitor	RAZAXABAN HYDROCHLORIDE
TTDS00470	Inhibitor	RPR-118071
TTDS00470	Inhibitor	RPR-120844
TTDS00470	Inhibitor	Sodium Tetradecyl Sulfate
TTDS00471	UniProt ID	P04229
TTDS00471	Name	HLA class II histocompatibility antigen, DRB1-1
TTDS00471	Type of target	Successful target
TTDS00471	Synonyms	DR-1
TTDS00471	Synonyms	DR1
TTDS00471	Synonyms	HLA-DRB1
TTDS00471	Synonyms	MHC class I antigen DRB1*1
TTDS00471	Disease	Relapsing-remitting multiple sclerosis
TTDS00471	Sequence	MVCLKLPGGSCMTALTVTLMVLSSPLALAGDTRPRFLWQLKFECHFFNGTERVRLLERCIYNQEESVRFDSDVGEYRAVT
TTDS00471	PDB Structure	1AQD; 1DLH; 1FYT; 1HXY; 1JWM; 1JWS; 1JWU; 1KG0; 1KLG; 1KLU; 1LO5; 1PYW; 1R5I; 1S
TTDS00471	Drug(s)	Glatiramer Acetate
TTDS00471	Binder	Glatiramer Acetate
TTDS00472	UniProt ID	P06126
TTDS00472	Name	T-cell surface glycoprotein CD1a
TTDS00472	Type of target	Successful target
TTDS00472	Synonyms	CD1a
TTDS00472	Synonyms	T-cell surface antigen T6/Leu-6
TTDS00472	Synonyms	hTa1 thymocyte antigen
TTDS00472	Disease	Renal transplant rejection
TTDS00472	Function	Antigen-presenting protein that binds self and non-self lipid and glycolipid ant
TTDS00472	Sequence	MLFLLLPLLAVLPGDGNADGLKEPLSFHVIWIASFYNHSWKQNLVSGWLSDLQTHTWDSNSSTIVFLWPWSRGNFSNEEW
TTDS00472	PDB Structure	1ONQ; 1XZ0
TTDS00472	Drug(s)	Antithymocyte globulin
TTDS00472	Binder	Antithymocyte globulin
TTDS00473	UniProt ID	P07766
TTDS00473	Name	T-cell surface glycoprotein CD3 epsilon chain
TTDS00473	Type of target	Successful target
TTDS00473	Synonyms	CD3e
TTDS00473	Synonyms	T-cell surface antigen T3/Leu-4 epsilon chain
TTDS00473	Synonyms	T3E
TTDS00473	Disease	Organ rejection
TTDS00473	Function	The cd3 complex mediates signal transduction.
TTDS00473	Sequence	MQSGTHWRVLGLCLLSVGVWGQDGNEEMGGITQTPYKVSISGTTVILTCPQYPGSEILWQHNDKNIGGDEDDKNIGSDED
TTDS00473	PDB Structure	1A81; 1SY6; 1XIW; 2ROL
TTDS00473	Pathway	Primary immunodeficiency
TTDS00473	Pathway	T cell receptor signaling pathway
TTDS00473	Target Validation	TTDS00473
TTDS00473	Drug(s)	Muromonab
TTDS00473	Drug(s)	Otelixizumab
TTDS00473	Drug(s)	TRX4
TTDS00473	Antibody	Otelixizumab
TTDS00473	Antibody	TRX4
TTDS00473	Binder	Muromonab
TTDS00474	UniProt ID	P0A6J8
TTDS00474	Name	D-alanine-D-alanine ligase A
TTDS00474	Type of target	Successful target
TTDS00474	Synonyms	D-Ala-D-Ala ligase A
TTDS00474	Synonyms	D-alanylalanine synthetase A
TTDS00474	Synonyms	ddlA
TTDS00474	Disease	Tuberculosis
TTDS00474	Function	Cell wall formation.
TTDS00474	Sequence	MEKLRVGIVFGGKSAEHEVSLQSAKNIVDAIDKSRFDVVLLGIDKQGQWHVSDASNYLLNADDPAHIALRPSATSLAQVP
TTDS00474	PDB Structure	1E4E
TTDS00474	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDS00474	Pathway	Peptidoglycan biosynthesis
TTDS00474	EC Number	EC 6.3.2.4
TTDS00474	Target Validation	TTDS00474
TTDS00474	Drug(s)	Cycloserine
TTDS00474	Inhibitor	Cycloserine
TTDS00475	UniProt ID	P10635
TTDS00475	Name	Cytochrome P450 2D6
TTDS00475	Type of target	Successful target
TTDS00475	Synonyms	CYP2D6
TTDS00475	Synonyms	CYP2DL1
TTDS00475	Synonyms	CYPIID6
TTDS00475	Synonyms	Debrisoquine 4-hydroxylase
TTDS00475	Synonyms	P450-DB1
TTDS00475	Disease	Insomnia
TTDS00475	Function	Responsible for the metabolism of many drugs and environmental chemicals that it
TTDS00475	Sequence	MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVV
TTDS00475	PDB Structure	2F9Q; 3QM4; 3TBG; 3TDA
TTDS00475	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00475	EC Number	EC 1.14.14.1
TTDS00475	Target Validation	TTDS00475
TTDS00475	Drug(s)	Glutethimide
TTDS00475	Inhibitor	(2-hydroxy-3-phenoxypropyl)(propan-2-yl)amine
TTDS00475	Inhibitor	(5-(pyridin-3-yl)furan-2-yl)methanamine
TTDS00475	Inhibitor	(5-phenylfuran-2-yl)methanamine
TTDS00475	Inhibitor	(5-pyridin-3-yl-furan-2-yl)methanethiol
TTDS00475	Inhibitor	1,5-bis(4-hydroxyphenyl)penta-1,4-dien-3-one
TTDS00475	Inhibitor	1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERI
TTDS00475	Inhibitor	1-(4-Butoxy-phenyl)-1H-imidazole
TTDS00475	Inhibitor	1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC M
TTDS00475	Inhibitor	1H-1,2,3-benzotriazol-1-amine
TTDS00475	Inhibitor	2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole
TTDS00475	Inhibitor	2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine
TTDS00475	Inhibitor	2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol
TTDS00475	Inhibitor	2-Hexyloxy-5-imidazol-1-yl-pyridine
TTDS00475	Inhibitor	2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine
TTDS00475	Inhibitor	3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine
TTDS00475	Inhibitor	3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine
TTDS00475	Inhibitor	4-(3-Pent-1-ynyl-benzyl)-1H-imidazole
TTDS00475	Inhibitor	4-(3-Phenylethynyl-benzyl)-1H-imidazole
TTDS00475	Inhibitor	4-(Spiro[chromene-2,4'-piperidine]-4-yl)benzamide
TTDS00475	Inhibitor	4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine
TTDS00475	Inhibitor	4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine
TTDS00475	Inhibitor	4-[5-(3-Hydroxyphenyl)-2-thienyl)-2-methyl]phenol
TTDS00475	Inhibitor	4-[5-(3-Hydroxyphenyl)-3-thienyl]-2-methylphenol
TTDS00475	Inhibitor	4-methylaminomethyl-7-methoxycoumarin
TTDS00475	Inhibitor	6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE
TTDS00475	Inhibitor	BMS-694153
TTDS00475	Inhibitor	BS 7581
TTDS00475	Inhibitor	BS 7840
TTDS00475	Inhibitor	BS 9106
TTDS00475	Inhibitor	BUCINDOLOL
TTDS00475	Inhibitor	Bis-(5-pyridin-3-yl-thiophen-2-ylmethyl)-amine
TTDS00475	Inhibitor	DESETHYL AMODIAQUINE
TTDS00475	Inhibitor	DIHYDROCUBEBIN
TTDS00475	Inhibitor	GB-12819
TTDS00475	Inhibitor	GBR 12530
TTDS00475	Inhibitor	GBR-12289
TTDS00475	Inhibitor	GNF-PF-2094
TTDS00475	Inhibitor	GNF-PF-4292
TTDS00475	Inhibitor	GNF-PF-5411
TTDS00475	Inhibitor	GSK-1070916
TTDS00475	Inhibitor	GSK-369796
TTDS00475	Inhibitor	Go-Y022
TTDS00475	Inhibitor	ICI-199441
TTDS00475	Inhibitor	ISOQUINE
TTDS00475	Inhibitor	ML-3163
TTDS00475	Inhibitor	Methyl-(5-pyridin-3-yl-thiophen-2-yl)-amine
TTDS00475	Inhibitor	Prodipine
TTDS00475	Inhibitor	QUINIDINE SULFATE
TTDS00475	Inhibitor	SB-203580
TTDS00475	Inhibitor	SB-210313
TTDS00475	Inhibitor	desethyl isoquine
TTDS00475	Inhibitor	kaempferol-3-O-methyl ether
TTDS00475	Inducer	Glutethimide
TTDS00476	UniProt ID	P14902
TTDS00476	Name	Indoleamine 2,3-dioxygenase
TTDS00476	Type of target	Successful target
TTDS00476	Synonyms	INDO
TTDS00476	Synonyms	IDO
TTDS00476	Synonyms	Indoleamine-pyrrole 2,3-dioxygenase
TTDS00476	Disease	Depression
TTDS00476	Function	Catalyzes the cleavage of the pyrrol ring of tryptophan and incorporates both at
TTDS00476	Sequence	MAHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLAR
TTDS00476	PDB Structure	2D0T; 2D0U
TTDS00476	BioChemical Class	Oxidoreductases acting on single donors
TTDS00476	Pathway	Metabolic pathways
TTDS00476	EC Number	EC 1.13.11.52
TTDS00476	Target Validation	TTDS00476
TTDS00476	Drug(s)	INCB24360
TTDS00476	Drug(s)	L-Tryptophan
TTDS00476	Inhibitor	1,2-NAPHTHOQUINONE
TTDS00476	Inhibitor	1,4-naphtho-quinone
TTDS00476	Inhibitor	1-methyltryptophan
TTDS00476	Inhibitor	1H-indole-4,7-dione
TTDS00476	Inhibitor	2,2-dimethyl-2H-benzo[g]chromene-5,10-dione
TTDS00476	Inhibitor	2,3-dichloro-1,4-naphthoquinone
TTDS00476	Inhibitor	2,3-dihydrobenzo[d]thiazole-2-thiol
TTDS00476	Inhibitor	2,4-Dichlorobenzenemethanethiol
TTDS00476	Inhibitor	2-(1H-Imidazol-4-yl)benzene-1,3-diol
TTDS00476	Inhibitor	2-(1H-Imidazol-4-yl)phenol
TTDS00476	Inhibitor	2-Chlorobenzenemethanethiol
TTDS00476	Inhibitor	2-HYDROXYGARVIN A
TTDS00476	Inhibitor	2-hydroxygarveatin E
TTDS00476	Inhibitor	2-methoxy-1,4-naphthoquinone
TTDS00476	Inhibitor	3,4-Dichlorobenzenemethanethiol
TTDS00476	Inhibitor	3-(1H-Imidazol-4-yl)benzenethiol
TTDS00476	Inhibitor	3-(4H-Imidazol-4-yl)benzenethiol
TTDS00476	Inhibitor	4-(1H-1,2,3-triazol-5-yl)pyridine
TTDS00476	Inhibitor	4-(2-(diethylamino)ethylamino)-1-naphthol
TTDS00476	Inhibitor	4-(2-Hydroxyethoxy)-1-naphthol
TTDS00476	Inhibitor	4-(Benzylamino)-1-naphthol
TTDS00476	Inhibitor	4-(Cyclohexylamino)-1-naphthol
TTDS00476	Inhibitor	4-(Isopropylamino)-1-naphthol
TTDS00476	Inhibitor	4-(Pent-3-ylamino)-1-naphthol
TTDS00476	Inhibitor	4-(ethylamino)naphthalen-1-ol
TTDS00476	Inhibitor	4-(methylamino)naphthalen-1-ol
TTDS00476	Inhibitor	4-(propylamino)naphthalen-1-ol
TTDS00476	Inhibitor	4-(tert-butylamino)naphthalen-1-ol
TTDS00476	Inhibitor	4-Chlorobenzenemethanethiol
TTDS00476	Inhibitor	4-Fluorobenzenemethanethiol
TTDS00476	Inhibitor	4-Methoxybenzenemethanethiol
TTDS00476	Inhibitor	4-Methylbenzenemethanethiol
TTDS00476	Inhibitor	4-Phenylimidazole
TTDS00476	Inhibitor	4-amino-1,2,5-oxadiazole-3-carboximidamide
TTDS00476	Inhibitor	4-aminonaphthalen-1-ol
TTDS00476	Inhibitor	4-methoxynaphthalen-1-amine
TTDS00476	Inhibitor	4-phenylthiazole-2-thiol
TTDS00476	Inhibitor	5-(isopropylamino)quinolin-8-ol
TTDS00476	Inhibitor	5-aminoquinolin-8-ol
TTDS00476	Inhibitor	5-phenyl-1H-1,2,3-triazole
TTDS00476	Inhibitor	ANNULIN A
TTDS00476	Inhibitor	ANNULIN B
TTDS00476	Inhibitor	ANNULIN C
TTDS00476	Inhibitor	BENZENEMETHANETHIOL
TTDS00476	Inhibitor	EXIGUAMINE B
TTDS00476	Inhibitor	Exiguamine A
TTDS00476	Inhibitor	Exiguamine A hydrochloride
TTDS00476	Inhibitor	GARVEATIN A
TTDS00476	Inhibitor	INCB24360
TTDS00476	Inhibitor	JUGLONE
TTDS00476	Inhibitor	N-[2-(Indol-3-yl)ethyl]-S-benzyl-dithiocarbamate
TTDS00476	Inhibitor	S-(2,4-Dichlorobenzyl)isothiourea hydrobromide
TTDS00476	Inhibitor	S-(2-Chlorobenzyl)isothiourea hydrochloride
TTDS00476	Inhibitor	S-(3,4-Dichlorobenzyl)isothiourea hydrochloride
TTDS00476	Inhibitor	S-(3-Chlorobenzyl)isothiourea hydrochloride
TTDS00476	Inhibitor	S-(4-Bromobenzyl)isothiourea hydrobromide
TTDS00476	Inhibitor	S-(4-Chlorobenzyl)isothiourea hydrochloride
TTDS00476	Inhibitor	S-(4-Cyanobenzyl)isothiourea hydrobromide
TTDS00476	Inhibitor	S-(4-Ethylbenzyl)isothiourea hydrochloride
TTDS00476	Inhibitor	S-(4-Fluorobenzyl)isothiourea hydrochloride
TTDS00476	Inhibitor	S-(4-Methoxybenzyl)isothiourea hydrochloride
TTDS00476	Inhibitor	S-(4-Methylbenzyl)isothiourea hydrochloride
TTDS00476	Inhibitor	S-(4-Nitrobenzyl)isothiourea hydrochloride
TTDS00476	Inhibitor	S-Benzyl-brassinin
TTDS00476	Inhibitor	Seco-exiguamine
TTDS00476	Inhibitor	garveatin C
TTDS00476	Inhibitor	garveatin E
TTDS00476	Inhibitor	naphthalene-1,4-diol
TTDS00476	Binder	L-Tryptophan
TTDS00477	UniProt ID	P15260
TTDS00477	UniProt ID	P38484
TTDS00477	Name	Interferon-gamma receptor
TTDS00477	Type of target	Successful target
TTDS00477	Synonyms	CD119
TTDS00477	Synonyms	CDw119
TTDS00477	Synonyms	IFN-gamma-R
TTDS00477	Synonyms	IFNGR
TTDS00477	Disease	Idiopathic pulmonary fibrosis
TTDS00477	Function	Receptor for interferon gamma. Two receptors bind one interferon gamma dimer.
TTDS00477	Sequence	MALLFLLPLVMQGVSRAEMGTADLGPSSVPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINI
TTDS00477	PDB Structure	1FG9; 1FYH; 1JRH
TTDS00477	Pathway	Jak-STAT signaling pathway
TTDS00477	Pathway	Natural killer cell mediated cytotoxicity
TTDS00477	Target Validation	TTDS00477
TTDS00477	Drug(s)	Interferon gamma-1b
TTDS00477	Binder	Interferon gamma-1b
TTDS00478	UniProt ID	P16066
TTDS00478	Name	Atrial natriuretic peptide receptor A
TTDS00478	Type of target	Successful target
TTDS00478	Synonyms	ANP-A
TTDS00478	Synonyms	ANPRA
TTDS00478	Synonyms	Atrial natriuretic peptide A-type receptor
TTDS00478	Synonyms	GC-A
TTDS00478	Synonyms	Guanylate cyclase
TTDS00478	Synonyms	NPR-A
TTDS00478	Synonyms	NPR1
TTDS00478	Disease	Acutely decompensated congestive heart failure
TTDS00478	Function	Receptor for atrial natriuretic peptide. Has guanylate cyclase activity on bindi
TTDS00478	Sequence	MPGPRRPAGSRLRLLLLLLLPPLLLLLRGSHAGNLTVAVVLPLANTSYPWSWARVGPAVELALAQVKARPDLLPGWTVRT
TTDS00478	PDB Structure	1DP4
TTDS00478	BioChemical Class	Phosphorus-oxygen lyases
TTDS00478	Pathway	Vascular smooth muscle contraction
TTDS00478	EC Number	EC 4.6.1.2
TTDS00478	Drug(s)	Ataciguat
TTDS00478	Drug(s)	Cenderitide
TTDS00478	Drug(s)	Nesiritide
TTDS00478	Activator	Ataciguat
TTDS00478	Agonist	Cenderitide
TTDS00478	Binder	Nesiritide
TTDS00479	UniProt ID	P18314
TTDS00479	Name	Urease
TTDS00479	Type of target	Successful target
TTDS00479	Synonyms	Urea amidohydrolase
TTDS00479	Synonyms	ureC
TTDS00479	Disease	Urinary tract infections
TTDS00479	Sequence	MSNISRQAYADMFGPTVGDKVRLADTELWIEVEDDLTTYGEEVKFGGGKVIRDGMGQGQMLAADCVDLVLTNALIVDHWG
TTDS00479	PDB Structure	1A5K; 1A5L; 1A5M; 1A5N; 1A5O; 1EF2; 1EJR; 1EJS; 1EJT; 1EJU; 1EJV; 1EJW; 1EJX; 1F
TTDS00479	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDS00479	EC Number	EC 3.5.1.5
TTDS00479	Target Validation	TTDS00479
TTDS00479	Drug(s)	Acetohydroxamic Acid
TTDS00479	Inhibitor	1-cyclohexyl-1-isopropyl-3,3-dimethylselenourea
TTDS00479	Inhibitor	3-(4-bromobenzyl)-1,1-dimethylselenourea
TTDS00479	Inhibitor	3-(4-bromophenyl)-1,1-dimethylthiourea
TTDS00479	Inhibitor	3-dodecyl-1,1-dimethylthiourea
TTDS00479	Inhibitor	Acetohydroxamic Acid
TTDS00479	Inhibitor	N-glycylglycinehydroxamic acid
TTDS00480	UniProt ID	P20273
TTDS00480	Name	B-cell receptor CD22
TTDS00480	Type of target	Successful target
TTDS00480	Synonyms	B-lymphocyte cell adhesion molecule
TTDS00480	Synonyms	BL-CAM
TTDS00480	Synonyms	CD22
TTDS00480	Synonyms	Leu-14
TTDS00480	Synonyms	Sialic acid-binding Ig-like lectin 2
TTDS00480	Synonyms	Siglec-2
TTDS00480	Disease	Lyme disease
TTDS00480	Function	Mediates b-cell b-cell interactions. May be involved in the localization of b-ce
TTDS00480	Sequence	MHLLGPWLLLLVLEYLAFSDSSKWVFEHPETLYAWEGACVWIPCTYRALDGDLESFILFHNPEYNKNTSKFDGTRLYEST
TTDS00480	Pathway	B cell receptor signaling pathway
TTDS00480	Pathway	Hematopoietic cell lineage
TTDS00480	Target Validation	TTDS00480
TTDS00480	Drug(s)	Anti-CD22
TTDS00480	Drug(s)	Anti-CD22/CD19 mAb-toxin conjugate
TTDS00480	Drug(s)	Epratuzumab
TTDS00480	Drug(s)	Moxetumomab
TTDS00480	Drug(s)	Moxetumomab Pasudotox
TTDS00480	Drug(s)	OspA lipoprotein
TTDS00480	Drug(s)	RG7159
TTDS00480	Drug(s)	RG7593
TTDS00480	Antibody	Anti-CD22
TTDS00480	Antibody	Epratuzumab
TTDS00480	Antibody	Moxetumomab Pasudotox
TTDS00480	Binder	OspA lipoprotein
TTDS00481	UniProt ID	P20645
TTDS00481	Name	Mannose-6-phosphate receptor
TTDS00481	Type of target	Successful target
TTDS00481	Synonyms	46 kDa mannose 6-phosphate receptor
TTDS00481	Synonyms	CD Man-6-P receptor
TTDS00481	Synonyms	CD-MPR
TTDS00481	Synonyms	M6PR
TTDS00481	Synonyms	MPR 46
TTDS00481	Synonyms	MPR46
TTDS00481	Synonyms	MPRD
TTDS00481	Disease	Glycogen storage disease type II
TTDS00481	Disease	Mucopolysaccharidosis VI.
TTDS00481	Function	Transport of phosphorylated lysosomal enzymes from the golgi complex and the cel
TTDS00481	Sequence	MFPFYSCWRTGLLLLLLAVAVRESWQTEEKTCDLVGEKGKESEKELALVKRLKPLFNKSFESTVGQGSDTYIYIFRVCRE
TTDS00481	PDB Structure	1M6P
TTDS00481	Drug(s)	Alglucosidase alfa
TTDS00481	Drug(s)	Galsulfase
TTDS00481	Inhibitor	1-3 Sugar Ring of Pentamannosyl 6-Phosphate
TTDS00481	Inhibitor	Alpha-D-Mannose-6-Phosphate
TTDS00481	Binder	Alglucosidase alfa
TTDS00481	Binder	Galsulfase
TTDS00482	UniProt ID	P22033
TTDS00482	Name	Methylmalonyl-CoA mutase
TTDS00482	Type of target	Successful target
TTDS00482	Synonyms	MCM
TTDS00482	Synonyms	MUT
TTDS00482	Synonyms	Methylmalonyl-CoA isomerase
TTDS00482	Disease	B12 deficiency
TTDS00482	Function	Involved in the degradation of several amino acids, odd-chain fatty acids and ch
TTDS00482	Sequence	MLRAKNQLFLLSPHYLRQVKESSGSRLIQQRLLHQQQPLHPEWAALAKKQLKGKNPEDLIWHTPEGISIKPLYSKRDTMD
TTDS00482	PDB Structure	2XIJ; 2XIQ; 3BIC
TTDS00482	BioChemical Class	Intramolecular transferases
TTDS00482	Pathway	Metabolic pathways
TTDS00482	Pathway	Propanoate metabolism
TTDS00482	EC Number	EC 5.4.99.2
TTDS00482	Target Validation	TTDS00482
TTDS00482	Drug(s)	Hydroxocobalamin
TTDS00482	Cofactor	Hydroxocobalamin
TTDS00483	UniProt ID	P23763
TTDS00483	UniProt ID	P63027
TTDS00483	Name	Vesicle-associated membrane protein
TTDS00483	Type of target	Successful target
TTDS00483	Synonyms	SYB1
TTDS00483	Synonyms	Synaptobrevin-1
TTDS00483	Synonyms	VAMP-1
TTDS00483	Synonyms	VAMP1
TTDS00483	Disease	Parkinson's disease
TTDS00483	Function	Involved in the targeting and/or fusion of transport vesicles to their target me
TTDS00483	Sequence	MSAPAQPPAEGTEGTAPGGGPPGPPPNMTSNRRLQQTQAQVEEVVDIIRVNVDKVLERDQKLSELDDRADALQAGASQFE
TTDS00483	PDB Structure	3FIE; 3FII; 3RK2; 3RK3; 3RL0
TTDS00483	Drug(s)	Botulinum Toxin Type B
TTDS00483	Binder	Botulinum Toxin Type B
TTDS00484	UniProt ID	P12319
TTDS00484	UniProt ID	P30273
TTDS00484	Name	High affinity immunoglobulin epsilon receptor
TTDS00484	Type of target	Successful target
TTDS00484	Synonyms	FCER1G
TTDS00484	Synonyms	Fc-epsilon RI-gamma
TTDS00484	Synonyms	FceRI gamma
TTDS00484	Synonyms	IgE Fc receptor subunit gamma
TTDS00484	Disease	Risk of administering penicillin
TTDS00484	Function	Associates with a variety of fcr alpha chains to form a functional signaling com
TTDS00484	Sequence	MIPAVVLLLLLLVEQAAALGEPQLCYILDAILFLYGIVLTLLYCRLKIQVRKAAITSYEKSDGVYTGLSTRNQETYETLK
TTDS00484	PDB Structure	1ALS; 1ALT; 1F2Q; 1F6A; 1J86; 1J87; 1J88; 1J89; 1RPQ; 2Y7Q
TTDS00484	Pathway	Asthma
TTDS00484	Pathway	Fc epsilon RI signaling pathway
TTDS00484	Drug(s)	Benzylpenicilloyl Polylysine
TTDS00484	Inhibitor	Alpha-D-Mannose
TTDS00484	Inhibitor	Fucose
TTDS00484	Binder	Benzylpenicilloyl Polylysine
TTDS00485	UniProt ID	P30988
TTDS00485	Name	Calcitonin receptor
TTDS00485	Type of target	Successful target
TTDS00485	Synonyms	CALCR
TTDS00485	Synonyms	CT-R
TTDS00485	Disease	Post-menopausal osteoporosis
TTDS00485	Function	This is a receptor for calcitonin. The activity of this receptor is mediated by
TTDS00485	Sequence	MRFTFTSRCLALFLLLNHPTPILPAFSNQTYPTIEPKPFLYVVGRKKMMDAQYKCYDRMQQLPAYQGEGPYCNRTWDGWL
TTDS00485	Target Validation	TTDS00485
TTDS00485	Drug(s)	Salmon Calcitonin
TTDS00485	Inhibitor	CGNLSTCBLGTYTQDFNKFHZYPQTAIGVGAP-amide
TTDS00485	Inhibitor	CGNLSTCBLGTYTQDF[DKFHO]YPQTAIGVGAP-amide
TTDS00485	Inhibitor	CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-amide
TTDS00485	Inhibitor	CGNLSTCMLGTYTQDFNKPHTFPQTAIGVGAP-amide
TTDS00485	Inhibitor	CGNLSTCMLGTYTQDFNPFHTFPQTAIGVGAP-amide
TTDS00485	Inhibitor	CGNLSTCMLGTYTQDFNPKHTFPQTAIGVGAP-amide
TTDS00485	Inhibitor	CGNLSTCMLGTYTQDFc[DKFHK]FPQTAIGVGAP-amide
TTDS00485	Inhibitor	CGNLSTCMLGTYTQDFc[DKFHO]FPQTAIGVGAP-amide
TTDS00485	Inhibitor	CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-amide
TTDS00485	Inhibitor	CSNLSTCVLGKLSQELNKLHBYPRTNTGSGTP-amide
TTDS00485	Inhibitor	CSNLSTCVLGKLSQELc[DKLHK]YPRTNTGSGTP-amide
TTDS00485	Inhibitor	CSNLSTCVLGKLSQELc[DKLHO]YPRTNTGSGTP-amide
TTDS00485	Inhibitor	CSNLSTCVLGKLSQELc[DKLQK]YPRTNTGSGTP-amide
TTDS00485	Binder	Salmon Calcitonin
TTDS00486	UniProt ID	P38435
TTDS00486	Name	Vitamin K-dependent gamma-carboxylase
TTDS00486	Type of target	Successful target
TTDS00486	Synonyms	GC
TTDS00486	Synonyms	GGCX
TTDS00486	Synonyms	Gamma-glutamyl carboxylase
TTDS00486	Synonyms	Vitamin K gamma glutamyl carboxylase
TTDS00486	Disease	Anticoagulant
TTDS00486	Disease	Haemorrhagic conditions
TTDS00486	Function	Mediates the vitamin k-dependent carboxylation of glutamate residues to calcium
TTDS00486	Sequence	MAVSAGSARTSPSSDKVQKDKAELISGPRQDSRIGKLLGFEWTDLSSWRRLVTLLNRPTDPASLAVFRFLFGFLMVLDIP
TTDS00486	BioChemical Class	Ligases forming carbon-carbon bonds
TTDS00486	EC Number	EC 6.4.-.-
TTDS00486	Drug(s)	Anisindione
TTDS00486	Drug(s)	Phytonadione
TTDS00486	Inhibitor	Anisindione
TTDS00486	Cofactor	Phytonadione
TTDS00487	UniProt ID	P40198
TTDS00487	Name	Carcinoembryonic antigen
TTDS00487	Type of target	Successful target
TTDS00487	Synonyms	CD66d
TTDS00487	Synonyms	CEACAM3
TTDS00487	Synonyms	CGM1
TTDS00487	Synonyms	Carcinoembryonic antigen CGM1
TTDS00487	Disease	Imaging colorectal tumors
TTDS00487	Function	Major granulocyte receptor mediating recognition and efficient opsonin-independe
TTDS00487	Sequence	MGPPSASPHRECIPWQGLLLTASLLNFWNPPTTAKLTIESMPLSVAEGKEVLLLVHNLPQHLFGYSWYKGERVDGNSLIV
TTDS00487	PDB Structure	1L6Z
TTDS00487	Drug(s)	Arcitumomab
TTDS00487	Antibody	Arcitumomab
TTDS00489	UniProt ID	P14207
TTDS00489	UniProt ID	P41439
TTDS00489	Name	Folate receptor
TTDS00489	Type of target	Successful target
TTDS00489	Synonyms	FOLR
TTDS00489	Synonyms	FR
TTDS00489	Disease	Dietary shortage
TTDS00489	Disease	Folic acid deficiency
TTDS00489	Function	Binds to folate and reduced folic acid derivatives and mediates delivery of 5-me
TTDS00489	Sequence	MAWQMMQLLLLALVTAAGSAQPRSARARTDLLNVCMNAKHHKTQPSPEDELYGQCSPWKKNACCTASTSQELHKDTSRLY
TTDS00489	Drug(s)	Farletuzumab
TTDS00489	Drug(s)	Folic Acid
TTDS00489	Drug(s)	Tetrahydrofolic acid
TTDS00489	Antagonist	Farletuzumab
TTDS00489	Binder	Folic Acid
TTDS00489	Binder	Tetrahydrofolic acid
TTDS00490	UniProt ID	P42081
TTDS00490	Name	T-lymphocyte activation antigen CD86
TTDS00490	Type of target	Successful target
TTDS00490	Synonyms	Activation B7-2 antigen
TTDS00490	Synonyms	B70
TTDS00490	Synonyms	BU63
TTDS00490	Synonyms	CD28LG2
TTDS00490	Synonyms	CD86
TTDS00490	Synonyms	CTLA-4 counter-receptor B7.2
TTDS00490	Synonyms	FUN-1
TTDS00490	Disease	Rheumatoid arthritis
TTDS00490	Function	Receptor involved in the costimulatory signal essential for t-lymphocyte prolife
TTDS00490	Sequence	MDPQCTMGLSNILFVMAFLLSGAAPLKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHS
TTDS00490	PDB Structure	1I85; 1NCN
TTDS00490	Pathway	Allograft rejection
TTDS00490	Pathway	Autoimmune thyroid disease
TTDS00490	Pathway	Graft-versus-host disease
TTDS00490	Pathway	Systemic lupus erythematosus
TTDS00490	Pathway	Toll-like receptor signaling pathway
TTDS00490	Pathway	Type I diabetes mellitus
TTDS00490	Target Validation	TTDS00490
TTDS00490	Drug(s)	Abatacept
TTDS00490	Binder	Abatacept
TTDS00490	Multitarget	Abatacept
TTDS00491	UniProt ID	P47872
TTDS00491	Name	Secretin receptor
TTDS00491	Type of target	Successful target
TTDS00491	Synonyms	SCT-R
TTDS00491	Synonyms	SCTR
TTDS00491	Disease	Diagnosis of pancreatic exocrine dysfunction and gastrinoma
TTDS00491	Function	This is a receptor for secretin. The activity of this receptor is mediated by G
TTDS00491	Sequence	MRPHLSPPLQQLLLPVLLACAAHSTGALPRLCDVLQVLWEEQDQCLQELSREQTGDLGTEQPVPGCEGMWDNISCWPSSV
TTDS00491	Drug(s)	Secretin
TTDS00491	Binder	Secretin
TTDS00492	UniProt ID	P17181
TTDS00492	UniProt ID	P48551
TTDS00492	Name	Interferon-alpha/beta receptor
TTDS00492	Type of target	Successful target
TTDS00492	Synonyms	IFN-R
TTDS00492	Synonyms	IFN-alpha-REC
TTDS00492	Synonyms	Interferon alpha/beta receptor
TTDS00492	Synonyms	Type I interferon receptor
TTDS00492	Disease	AIDS-related Kaposi's sarcoma
TTDS00492	Disease	Chronic hepatitis C
TTDS00492	Disease	Hairy cell leukemia
TTDS00492	Disease	Malignant melanoma
TTDS00492	Disease	Multiple sclerosis
TTDS00492	Function	Receptor for interferons alpha and beta. Isoform 1 and isoform 3 are directly in
TTDS00492	Sequence	MLLSQNAFIFRSLNLVLMVYISLVFGISYDSPDYTDESCTFKISLRNFRSILSWELKNHSIVPTHYTLLYTIMSKPEDLK
TTDS00492	PDB Structure	1N6U; 1N6V; 2HYM; 2KZ1; 2LAG; 3S8W; 3S9D; 3SE3; 3SE4
TTDS00492	Pathway	Jak-STAT signaling pathway
TTDS00492	Pathway	Natural killer cell mediated cytotoxicity
TTDS00492	Pathway	Toll-like receptor signaling pathway
TTDS00492	Drug(s)	Alfa-interferon
TTDS00492	Drug(s)	Anti-IFN alfa
TTDS00492	Drug(s)	Interferon Alfa-2b, Recombinant
TTDS00492	Drug(s)	Interferon alfa-n1
TTDS00492	Drug(s)	Interferon alfa-n3
TTDS00492	Drug(s)	Interferon alfacon-1
TTDS00492	Drug(s)	Interferon beta-1a
TTDS00492	Drug(s)	Interferon beta-1b
TTDS00492	Drug(s)	Peginterferon alfa-2a
TTDS00492	Drug(s)	Peginterferon alfa-2b
TTDS00492	Drug(s)	RhuMAb IFN alpha
TTDS00492	Drug(s)	Sifalimumab
TTDS00492	Antagonist	Anti-IFN alfa
TTDS00492	Stimulator	Alfa-interferon
TTDS00492	Antibody	RhuMAb IFN alpha
TTDS00492	Antibody	Sifalimumab
TTDS00492	Modulator	IFN-alpha
TTDS00492	Binder	Interferon Alfa-2b, Recombinant
TTDS00492	Binder	Interferon alfa-n1
TTDS00492	Binder	Interferon alfa-n3
TTDS00492	Binder	Interferon alfacon-1
TTDS00492	Binder	Interferon beta-1a
TTDS00492	Binder	Interferon beta-1b
TTDS00492	Binder	Peginterferon alfa-2a
TTDS00492	Binder	Peginterferon alfa-2b
TTDS00494	UniProt ID	P53004
TTDS00494	Name	Biliverdin reductase A
TTDS00494	Type of target	Successful target
TTDS00494	Synonyms	BLVR
TTDS00494	Synonyms	BLVRA
TTDS00494	Synonyms	BVR
TTDS00494	Synonyms	BVR A
TTDS00494	Synonyms	Biliverdin-IX alpha-reductase
TTDS00494	Disease	Primary biliary cirrhosis
TTDS00494	Function	Reduces the gamma-methene bridge of the open tetrapyrrole, biliverdin ix alpha,
TTDS00494	Sequence	MNAEPERKFGVVVVGVGRAGSVRMRDLRNPHPSSAFLNLIGFVSRRELGSIDGVQQISLEDALSSQEVEVAYICSESSSH
TTDS00494	PDB Structure	2H63
TTDS00494	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDS00494	EC Number	EC 1.3.1.24
TTDS00494	Drug(s)	Ursodeoxycholic acid
TTDS00494	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDS00494	Activator	Ursodeoxycholic acid
TTDS00495	UniProt ID	P54802
TTDS00495	Name	Alpha-N-acetylglucosaminidase
TTDS00495	Type of target	Successful target
TTDS00495	Synonyms	Alpha-N-acetylglucosaminidase 77 kDa form
TTDS00495	Synonyms	Alpha-N-acetylglucosaminidase 82 kDa form
TTDS00495	Synonyms	N-acetyl-alpha-glucosaminidase
TTDS00495	Synonyms	NAG
TTDS00495	Synonyms	NAGLU
TTDS00495	Synonyms	UFHSD1
TTDS00495	Disease	Osteoarthritis
TTDS00495	Function	Involved in the degradation of heparan sulfate.
TTDS00495	Sequence	MEAVAVAAAVGVLLLAGAGGAAGDEAREAAAVRALVARLLGPGPAADFSVSVERALAAKPGLDTYSLGGGGAARVRVRGS
TTDS00495	BioChemical Class	Glycosylases
TTDS00495	Pathway	Lysosome
TTDS00495	Pathway	Metabolic pathways
TTDS00495	EC Number	EC 3.2.1.50
TTDS00495	Target Validation	TTDS00495
TTDS00495	Drug(s)	N-Acetyl-D-glucosamine
TTDS00495	Activator	N-Acetyl-D-glucosamine
TTDS00496	UniProt ID	P60880
TTDS00496	Name	Synaptosomal-associated protein 25
TTDS00496	Type of target	Successful target
TTDS00496	Synonyms	SNAP
TTDS00496	Synonyms	SNAP-25
TTDS00496	Synonyms	SNAP25
TTDS00496	Synonyms	SUP
TTDS00496	Synonyms	Super protein
TTDS00496	Synonyms	Synaptosomal-associated 25 kDa protein
TTDS00496	Disease	Blepharospasm
TTDS00496	Function	T-snare involved in the molecular regulation of neurotransmitter release. May pl
TTDS00496	Sequence	MAEDADMRNELEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLERIEEGMDQINKDMKEAEKNLTD
TTDS00496	PDB Structure	1KIL; 1XTG; 3RK2; 3RK3; 3RL0
TTDS00496	Drug(s)	Botulinum Toxin Type A
TTDS00496	Inhibitor	Botulinum Toxin Type A
TTDS00497	UniProt ID	P61278
TTDS00497	Name	Somatostatin
TTDS00497	Type of target	Successful target
TTDS00497	Synonyms	Growth hormone release-inhibiting factor
TTDS00497	Synonyms	SST
TTDS00497	Synonyms	Somatostatin-14
TTDS00497	Synonyms	Somatostatin-28
TTDS00497	Disease	Disorders of cystine excretion
TTDS00497	Function	Somatostatin inhibits the release of somatotropin.
TTDS00497	Sequence	MLSCRLQCALAALSIVLALGCVTGAPSDPRLRQFLQKSLAAAAGKQELAKYFLAELLSEPNQTENDALEPEDLSQAAEQD
TTDS00497	PDB Structure	1P2W
TTDS00497	Drug(s)	Cysteamine
TTDS00497	Activator	Somatoprim
TTDS00497	Binder	Cysteamine
TTDS00498	UniProt ID	P68871
TTDS00498	UniProt ID	P69905
TTDS00498	Name	Hemoglobin
TTDS00498	Type of target	Successful target
TTDS00498	Synonyms	Beta-globin
TTDS00498	Synonyms	HBB
TTDS00498	Synonyms	Hemoglobin beta chain
TTDS00498	Synonyms	LVV-hemorphin-7
TTDS00498	Disease	Documented iron deficiency
TTDS00498	Disease	Iron-deficiency anemia
TTDS00498	Function	Involved in oxygen transport from the lung to the various peripheral tissues. Lv
TTDS00498	Sequence	MVHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLD
TTDS00498	PDB Structure	1A00; 1A01; 1A0U; 1A0Z; 1A3N; 1A3O; 1A9W; 1ABW; 1ABY; 1AJ9; 1B86; 1BAB; 1BBB; 1B
TTDS00498	Target Validation	TTDS00498
TTDS00498	Drug(s)	Iron
TTDS00498	Drug(s)	Iron Dextran
TTDS00498	Inhibitor	1,3,5-BENZENETRICARBOXYLIC ACID
TTDS00498	Inhibitor	2,6-DICARBOXYNAPHTHALENE
TTDS00498	Inhibitor	2-[(2-methoxy-5-methylphenoxy)methyl]pyridine
TTDS00498	Inhibitor	4-Carboxycinnamic Acid
TTDS00498	Inhibitor	4-[(5-methoxy-2-methylphenoxy)methyl]pyridine
TTDS00498	Inhibitor	Heme
TTDS00498	Inhibitor	SEBACIC ACID
TTDS00498	Activator	Iron
TTDS00498	Activator	Iron Dextran
TTDS00499	UniProt ID	Q08499
TTDS00499	Name	Type IV phosphodiesterase
TTDS00499	Type of target	Successful target
TTDS00499	Synonyms	DPDE3
TTDS00499	Synonyms	PDE43
TTDS00499	Synonyms	PDE4D
TTDS00499	Disease	Asthma
TTDS00499	Function	Regulates the levels of camp in the cell.
TTDS00499	Sequence	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPP
TTDS00499	PDB Structure	1E9K; 1MKD; 1OYN; 1PTW; 1Q9M; 1TB7; 1TBB; 1XOM; 1XON; 1XOQ; 1XOR; 1Y2B; 1Y2C; 1Y
TTDS00499	BioChemical Class	Hydrolases acting on ester bonds
TTDS00499	EC Number	EC 3.1.4.17
TTDS00499	Target Validation	TTDS00499
TTDS00499	Drug(s)	Oxtriphylline
TTDS00499	Inhibitor	(-)-ROLIPRAM
TTDS00499	Inhibitor	(R)-Rolipram
TTDS00499	Inhibitor	(S)-Rolipram
TTDS00499	Inhibitor	1-(3,4-DIMETHOXYBENZYL)-6,7-DIMETHOXYISOQUINOLINE
TTDS00499	Inhibitor	1-Butyl-3-methyl-3,7-dihydro-purine-2,6-dione
TTDS00499	Inhibitor	1-Methyl-3-propyl-3,7-dihydro-purine-2,6-dione
TTDS00499	Inhibitor	3-ISOBUTYL-1-METHYLXANTHINE
TTDS00499	Inhibitor	3-Isobutyl-1-methyl-3,7-dihydro-purine-2,6-dione
TTDS00499	Inhibitor	CC-1088
TTDS00499	Inhibitor	CDP840
TTDS00499	Inhibitor	CI-1018
TTDS00499	Inhibitor	DENBUFYLLINE
TTDS00499	Inhibitor	L-454560
TTDS00499	Inhibitor	L-869298
TTDS00499	Inhibitor	Oxtriphylline
TTDS00499	Inhibitor	Piclamilast
TTDS00499	Inhibitor	RO-201724
TTDS00499	Inhibitor	ROLIPRAM
TTDS00499	Inhibitor	SCH-351591
TTDS00499	Inhibitor	SCH-365351
TTDS00499	Inhibitor	UCB-101333-3
TTDS00499	Inhibitor	ZAPRINAST
TTDS00499	Inhibitor	ZARDAVERINE
TTDS00500	UniProt ID	Q08828
TTDS00500	Name	Adenylate cyclase type 1
TTDS00500	Type of target	Successful target
TTDS00500	Synonyms	ADCY1
TTDS00500	Synonyms	ATP pyrophosphate-lyase 1
TTDS00500	Synonyms	Adenylate cyclase type I
TTDS00500	Synonyms	Adenylyl cyclase 1
TTDS00500	Synonyms	Ca(2+)/calmodulin-activated adenylyl cyclase
TTDS00500	Disease	Dietary shortage
TTDS00500	Function	This is a calmodulin-sensitive adenylyl cyclase. May be involved in regulatory p
TTDS00500	Sequence	MAGAPRGGGGGGGGAGEPGGAERAAGTSRRRGLRACDEEFACPELEALFRGYTLRLEQAATLKALAVLSLLAGALALAEL
TTDS00500	PDB Structure	1CUL
TTDS00500	BioChemical Class	Phosphorus-oxygen lyases
TTDS00500	Pathway	Calcium signaling pathway
TTDS00500	Pathway	Chemokine signaling pathway
TTDS00500	Pathway	Gap junction
TTDS00500	Pathway	GnRH signaling pathway
TTDS00500	Pathway	Long-term potentiation
TTDS00500	Pathway	Melanogenesis
TTDS00500	Pathway	Vascular smooth muscle contraction
TTDS00500	EC Number	EC 4.6.1.1
TTDS00500	Target Validation	TTDS00500
TTDS00500	Drug(s)	Adenosine monophosphate
TTDS00500	Binder	Adenosine monophosphate
TTDS00501	UniProt ID	Q14626
TTDS00501	Name	Interleukin-11 receptor alpha chain
TTDS00501	Type of target	Successful target
TTDS00501	Synonyms	IL-11R-alpha
TTDS00501	Synonyms	IL-11RA
TTDS00501	Synonyms	IL11RA
TTDS00501	Disease	Chemotherapy-induced thrombocytopenia
TTDS00501	Function	Receptor for interleukin-11. The receptor systems for il6, lif, osm, cntf, il11
TTDS00501	Sequence	MSSSCSGLSRVLVAVATALVSASSPCPQAWGPPGVQYGQPGRSVKLCCPGVTAGDPVSWFRDGEPKLLQGPDSGLGHELV
TTDS00501	PDB Structure	1N26
TTDS00501	Pathway	Hematopoietic cell lineage
TTDS00501	Pathway	Jak-STAT signaling pathway
TTDS00501	Drug(s)	Oprelvekin
TTDS00501	Binder	Oprelvekin
TTDS00502	UniProt ID	Q14571
TTDS00502	UniProt ID	Q14573
TTDS00502	UniProt ID	Q14643
TTDS00502	Name	Inositol 1,4,5-trisphosphate receptor
TTDS00502	Type of target	Successful target
TTDS00502	Synonyms	IP3 receptor isoform 1
TTDS00502	Synonyms	IP3R
TTDS00502	Synonyms	ITPR1
TTDS00502	Synonyms	InsP3R1
TTDS00502	Synonyms	Type 1 InsP3 receptor
TTDS00502	Synonyms	Type 1 inositol 1,4,5-trisphosphate receptor
TTDS00502	Disease	Hypertension
TTDS00502	Function	Intracellular channel that mediates calcium release from the endoplasmic reticul
TTDS00502	Sequence	MSDKMSSFLHIGDICSLYAEGSTNGFISTLGLVDDRCVVQPETGDLNNPPKKFRDCLFKLCPMNRYSAQKQFWKAAKPGA
TTDS00502	PDB Structure	1N4K
TTDS00502	Pathway	Alzheimer's disease
TTDS00502	Pathway	Gap junction
TTDS00502	Pathway	GnRH signaling pathway
TTDS00502	Pathway	Huntington's disease
TTDS00502	Pathway	Long-term depression
TTDS00502	Pathway	Long-term potentiation
TTDS00502	Pathway	Phosphatidylinositol signaling system
TTDS00502	Pathway	Vascular smooth muscle contraction
TTDS00502	Target Validation	TTDS00502
TTDS00502	Drug(s)	Nitroprusside
TTDS00502	Inhibitor	5'-Deoxy-5'-phenyladenophostin A
TTDS00502	Inhibitor	ADENOPHOSTIN A
TTDS00502	Inhibitor	D-Myo-Inositol-1,4,5-Triphosphate
TTDS00502	Inhibitor	D-myo-inositol 1,4,5-trisphosphate
TTDS00502	Inhibitor	Glycerol
TTDS00502	Antagonist	Nitroprusside
TTDS00503	UniProt ID	Q15858
TTDS00503	Name	Voltage-gated sodium channel subunit alpha Nav1.7
TTDS00503	Type of target	Successful target
TTDS00503	Synonyms	Neuroendocrine sodium channel
TTDS00503	Synonyms	Peripheral sodium channel 1
TTDS00503	Synonyms	Sodium channel protein type 9 subunit alpha
TTDS00503	Synonyms	Sodium channel protein type IX subunit alpha
TTDS00503	Synonyms	hNE-Na
TTDS00503	Disease	Analgesics
TTDS00503	Disease	Chronic angina pectoris
TTDS00503	Disease	Pain
TTDS00503	Function	Mediates the voltage-dependent sodium ion permeability of excitable membranes. A
TTDS00503	Sequence	MAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLPFIYGDIPPGMVSEPLEDLDP
TTDS00503	PDB Structure	1BYY
TTDS00503	Target Validation	TTDS00503
TTDS00503	Drug(s)	Ranolazine
TTDS00503	Inhibitor	4-(2'-(trifluoromethoxy)biphenyl-3-yl)oxazole
TTDS00503	Inhibitor	4-(2'-(trifluoromethoxy)biphenyl-3-yl)thiazole
TTDS00503	Inhibitor	4-(2'-(trifluoromethyl)biphenyl-3-yl)oxazole
TTDS00503	Inhibitor	SIPATRIGINE
TTDS00503	Inhibitor	V-102862
TTDS00503	Blocker	Ranolazine
TTDS00503	Multitarget	Ranolazine
TTDS00504	UniProt ID	Q4U2R8
TTDS00504	Name	Organic anion transporter 1
TTDS00504	Type of target	Successful target
TTDS00504	Synonyms	OAT1
TTDS00504	Synonyms	PAH transporter
TTDS00504	Synonyms	PAHT
TTDS00504	Synonyms	Renal organic anion transporter 1
TTDS00504	Synonyms	SLC22A6
TTDS00504	Synonyms	Solute carrier family 22 member 6
TTDS00504	Synonyms	hOAT1
TTDS00504	Synonyms	hPAHT
TTDS00504	Synonyms	hROAT1
TTDS00504	Disease	Gout
TTDS00504	Function	Involved in the renal elimination of endogenous and exogenous organic anions. Fu
TTDS00504	Sequence	MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCRPPADANLSKNGGLEVWLPRDRQGQPESCLR
TTDS00504	Target Validation	TTDS00504
TTDS00504	Drug(s)	Buproprion+zonisamide
TTDS00504	Drug(s)	Probenecid
TTDS00504	Inhibitor	3R14S-OCHRATOXIN A
TTDS00504	Inhibitor	ADIPATE
TTDS00504	Inhibitor	AMINOHIPPURIC ACID
TTDS00504	Inhibitor	FLUORESCEIN
TTDS00504	Inhibitor	GLUTARATE
TTDS00504	Inhibitor	HEPTANOATE
TTDS00504	Blocker	Buproprion+zonisamide
TTDS00504	Blocker	Probenecid
TTDS00505	UniProt ID	Q4WQY4
TTDS00505	Name	Mannitol 2-dehydrogenase
TTDS00505	Type of target	Successful target
TTDS00505	Synonyms	M2DH
TTDS00505	Synonyms	MDH
TTDS00505	Disease	Renal failure
TTDS00505	Function	Catalyzes the nad(h)-dependent interconversion of d-fructose and d-mannitol in t
TTDS00505	Sequence	MAPLKLNSRNLSQIAAAGGALVKIPTYQRGRAVKEGIVHIGVGGFHRAHLAVYIDQLMQKHGVNDYAICGVGLQPFDSAM
TTDS00505	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00505	Pathway	Bisphenol A degradation
TTDS00505	Pathway	Butanoate metabolism
TTDS00505	Pathway	Linoleic acid metabolism
TTDS00505	Pathway	Metabolic pathways
TTDS00505	EC Number	EC 1.1.1.67
TTDS00505	Drug(s)	Mannitol
TTDS00505	Activator	Mannitol
TTDS00506	UniProt ID	Q4X1A4
TTDS00506	Name	Mannitol-1-phosphate 5-dehydrogenase
TTDS00506	Type of target	Successful target
TTDS00506	Synonyms	M1PDH
TTDS00506	Synonyms	MPD
TTDS00506	Synonyms	MPDH
TTDS00506	Synonyms	mpdA
TTDS00506	Disease	Renal failure
TTDS00506	Function	Catalyzes the nad(h)-dependent interconversion of d-fructose 6-phosphate and d-m
TTDS00506	Sequence	MGKKAIQFGGGNIGRGFVAEFLHEAGYEVVFIDVVDKIIDALKSTPSYEVTEVSEEGEKTKTITNYRAINSKTNEEDVVK
TTDS00506	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDS00506	EC Number	EC 1.1.1.17
TTDS00506	Drug(s)	Mannitol
TTDS00506	Activator	Mannitol
TTDS00507	UniProt ID	Q7Z2W7
TTDS00507	Name	Transient receptor potential cation channel subfamily M member 8
TTDS00507	Type of target	Successful target
TTDS00507	Synonyms	LTrpC6
TTDS00507	Synonyms	Long transient receptor potential channel 6
TTDS00507	Synonyms	TRPM8
TTDS00507	Synonyms	TRPP8
TTDS00507	Synonyms	Transient receptor potential-p8
TTDS00507	Synonyms	Trp-p8
TTDS00507	Disease	Analgesics
TTDS00507	Disease	Irritation
TTDS00507	Disease	Pain
TTDS00507	Function	Receptor-activated non-selective cation channel involved in detection of sensati
TTDS00507	Sequence	MSFRAARLSMRNRRNDTLDSTRTLYSSASRSTDLSYSESDLVNFIQANFKKRECVFFTKDSKATENVCKCGYAQSQHMEG
TTDS00507	Target Validation	TTDS00507
TTDS00507	Drug(s)	Menthol
TTDS00507	Inhibitor	2-(5-fluoro-1H-indol-3-yl)ethanamine
TTDS00507	Inhibitor	2-(7-(benzyloxy)-1H-indol-3-yl)ethanamine
TTDS00507	Inhibitor	5-Benzyloxytryptamine
TTDS00507	Inhibitor	5-METHOXYTRYPTAMINE
TTDS00507	Inhibitor	PERILLALDEHYDE
TTDS00507	Activator	Menthol
TTDS00510	UniProt ID	Q9CDQ3
TTDS00510	Name	Integral membrane protein LmrP
TTDS00510	Type of target	Successful target
TTDS00510	Synonyms	lmrP
TTDS00510	Disease	Bacterial infections
TTDS00510	Sequence	MKEFWNLDKNLQLRLGIVFLGAFSYGTVFSSMTIYYNQHLGSAITGILLALSAVATFVAGILSGFFADRNGRKPVMVFGT
TTDS00510	Drug(s)	Quinupristin
TTDS00510	Modulator	Quinupristin
TTDS00511	UniProt ID	Q9F0I5
TTDS00511	Name	Cycloinulo-oligosaccharide fructanotransferase
TTDS00511	Type of target	Successful target
TTDS00511	Synonyms	cft
TTDS00511	Disease	Measure kidney function
TTDS00511	Sequence	MRKVKRGKCWISGMVIWAMVLQLVVPGISVASENRTVAGETLIPKNDVKSSVTDAIYQIKNIPQNDMGLSVTDSVYQIRN
TTDS00511	Drug(s)	Inulin
TTDS00511	Binder	Inulin
TTDS00512	UniProt ID	Q9HAB3
TTDS00512	Name	Gamma-hydroxybutyrate receptor
TTDS00512	Type of target	Successful target
TTDS00512	Synonyms	GPR172A
TTDS00512	Synonyms	PAR1
TTDS00512	Synonyms	PERV-A receptor 1
TTDS00512	Synonyms	Protein GPR172A
TTDS00512	Disease	Alcoholism
TTDS00512	Disease	Depression
TTDS00512	Disease	Insomnia
TTDS00512	Disease	Narcolepsy
TTDS00512	Function	Acts as cell surface receptor for porcine endogenous retrovirus (perv-a).
TTDS00512	Sequence	MAAPTPARPVLTHLLVALFGMGSWAAVNGIWVELPVVVKELPEGWSLPSYVSVLVALGNLGLLVVTLWRRLAPGKDEQVP
TTDS00512	Target Validation	TTDS00512
TTDS00512	Drug(s)	Gamma Hydroxybutyric Acid
TTDS00512	Drug(s)	Sodium oxybate
TTDS00512	Inhibitor	4-Cyclohexyl-4-hydroxy-but-2-enoic acid
TTDS00512	Inhibitor	4-Hydroxy-3-methyl-but-2-enoic acid
TTDS00512	Inhibitor	4-Hydroxy-3-methyl-butyric acid
TTDS00512	Inhibitor	4-Hydroxy-4-phenyl-but-2-enoic acid
TTDS00512	Inhibitor	4-Hydroxy-4-phenyl-butyric acid
TTDS00512	Inhibitor	4-Hydroxy-pent-2-enoic acid
TTDS00512	Inhibitor	4-Hydroxy-pentanoic acid
TTDS00512	Inhibitor	Sodium; 4-hydroxy-but-2-enoate
TTDS00512	Inhibitor	Sodium; 5-hydroxy-pentanoate
TTDS00512	Agonist	Gamma Hydroxybutyric Acid
TTDS00512	Agonist	Sodium oxybate
TTDS00513	UniProt ID	Q9UGH3
TTDS00513	Name	Sodium-dependent vitamin C transporter 2
TTDS00513	Type of target	Successful target
TTDS00513	Synonyms	KIAA0238
TTDS00513	Synonyms	NBTL1
TTDS00513	Synonyms	Na(+)/L-ascorbic acid transporter 2
TTDS00513	Synonyms	Nucleobase transporter-like 1 protein
TTDS00513	Synonyms	SLC23A1
TTDS00513	Synonyms	SLC23A2
TTDS00513	Synonyms	SVCT2
TTDS00513	Synonyms	Solute carrier family 23 member 2
TTDS00513	Synonyms	YSPL2
TTDS00513	Synonyms	Yolk sac permease-like molecule 2
TTDS00513	Synonyms	hSVCT2
TTDS00513	Disease	Primary biliary cirrhosis
TTDS00513	Function	Sodium/ascorbate cotransporter. Mediates electrogenic uptake of vitamin c, with
TTDS00513	Sequence	MMGIGKNTTSKSMEAGSSTEGKYEDEAKHPAFFTLPVVINGGATSSGEQDNEDTELMAIYTTENGIAEKSSLAETLDSTG
TTDS00513	Drug(s)	Ursodeoxycholic acid
TTDS00513	Activator	Ursodeoxycholic acid
TTDS00514	UniProt ID	Q9Y5Y9
TTDS00514	Name	Sodium channel protein type 10 subunit alpha
TTDS00514	Type of target	Successful target
TTDS00514	Synonyms	Peripheral nerve sodium channel 3
TTDS00514	Synonyms	Sodium channel protein type X subunit alpha
TTDS00514	Synonyms	Voltage-gated sodium channel subunit alpha Nav1.8
TTDS00514	Synonyms	hPN3
TTDS00514	Disease	Analgesics
TTDS00514	Disease	Chronic angina pectoris
TTDS00514	Disease	Pain
TTDS00514	Function	This protein mediates the voltage-dependent sodium ion permeability of excitable
TTDS00514	Sequence	MEFPIGSLETNNFRRFTPESLVEIEKQIAAKQGTKKAREKHREQKDQEEKPRPQLDLKACNQLPKFYGELPAELIGEPLE
TTDS00514	PDB Structure	1BYY
TTDS00514	Target Validation	TTDS00514
TTDS00514	Drug(s)	Ranolazine
TTDS00514	Inhibitor	1-[5-(4-Chlorophenyl)-2-furoyl]piperazine
TTDS00514	Inhibitor	5-(4-chlorophenyl)-N-(2-methylbenzyl)nicotinamide
TTDS00514	Inhibitor	BW-202W92
TTDS00514	Inhibitor	N-(2-chlorobenzyl)-5-(4-chlorophenyl)nicotinamide
TTDS00514	Inhibitor	N-benzyl-5-(4-chlorophenyl)nicotinamide
TTDS00514	Inhibitor	SCH-725737
TTDS00514	Inhibitor	SCH-725739
TTDS00514	Inhibitor	SIPATRIGINE
TTDS00514	Blocker	Ranolazine
TTDS00514	Multitarget	Ranolazine
TTDS00515	UniProt ID	P12318
TTDS00515	Name	Low affinity immunoglobulin gamma Fc region receptor II-A
TTDS00515	Type of target	Successful target
TTDS00515	Synonyms	CD32
TTDS00515	Synonyms	CDw32
TTDS00515	Synonyms	Fc-gamma RII-a
TTDS00515	Synonyms	Fc-gamma-RIIa
TTDS00515	Synonyms	FcRII-a
TTDS00515	Synonyms	FcgammaRIIa
TTDS00515	Synonyms	IgG Fc receptor II-a
TTDS00515	Disease	Systemic lupus erythematosus
TTDS00515	Function	Binds to the fc region of immunoglobulins gamma. Low affinity receptor. By bindi
TTDS00515	Sequence	MTMETQMSQNVCPRNLWLLQPLTVLLLLASADSQAAAPPKAVLKLEPPWINVLQEDSVTLTCQGARSPESDSIQWFHNGN
TTDS00515	PDB Structure	1FCG; 1H9V; 3D5O; 3RY4; 3RY5; 3RY6
TTDS00515	BioChemical Class	Transmembrane protein
TTDS00515	Pathway	Systemic lupus erythematosus
TTDS00515	Target Validation	TTDS00515
TTDS00515	Drug(s)	SM-101
TTDS00515	Antagonist	SM-101
TTDS00516	UniProt ID	O00767
TTDS00516	UniProt ID	Q6MWZ3
TTDS00516	Name	Acyl-CoA desaturase
TTDS00516	Type of target	Successful target
TTDS00516	Synonyms	9 stearoyl-desaturase
TTDS00516	Synonyms	Delta(9)-desaturase
TTDS00516	Synonyms	Delta-9-stearoyl desaturase
TTDS00516	Synonyms	Des A3
TTDS00516	Synonyms	DesA3
TTDS00516	Synonyms	Fatty acid desaturase
TTDS00516	Synonyms	Membrane-bound 9 desaturase
TTDS00516	Synonyms	SCD
TTDS00516	Synonyms	Stearoyl-CoA desaturase
TTDS00516	Synonyms	Stearoyl-coenzyme A (Delta9) desaturase
TTDS00516	Disease	Cardiovascular disease, unspecified
TTDS00516	Disease	Hyperlipidemia
TTDS00516	Disease	Tuberculosis
TTDS00516	Function	Terminal component of the liver microsomal stearyl-coa desaturase system, that u
TTDS00516	Sequence	MPAHLLQDDISSSYTTTTTITAPPSRVLQNGGDKLETMPLYLEDDIRPDIKDDIYDPTYKDKEGPSPKVEYVWRNIILMS
TTDS00516	BioChemical Class	Oxidoreductases acting on paired donors
TTDS00516	Pathway	Biosynthesis of unsaturated fatty acids
TTDS00516	Pathway	Linoleic acid metabolism
TTDS00516	Pathway	Metabolic pathways
TTDS00516	Pathway	PPAR signaling pathway
TTDS00516	EC Number	EC 1.14.19.1
TTDS00516	Target Validation	TTDS00516
TTDS00516	Drug(s)	Isoxyl
TTDS00516	Inhibitor	CVT-12012
TTDS00516	Inhibitor	MF-152
TTDS00516	Inhibitor	Sterculic acid
TTDS00516	Inhibitor	Thiocarlide
TTDS00516	Antisense	ISIS 147919
TTDS00516	Binder	Isoxyl
TTDS00517	Name	Sarcoplasmic/endoplasmic reticulum calcium ATPase
TTDS00517	Type of target	Successful target
TTDS00517	Synonyms	ATP4
TTDS00517	Synonyms	Ca(2+)-ATPase
TTDS00517	Synonyms	Ca2+-ATPase
TTDS00517	Synonyms	Calcium pump
TTDS00517	Synonyms	Calcium-transporting ATPase
TTDS00517	Synonyms	SERCA
TTDS00517	Synonyms	SERCA pump
TTDS00517	Synonyms	SR Ca(2+)-ATPase
TTDS00517	Disease	Heart failure
TTDS00517	Disease	Malaria
TTDS00517	EC Number	EC 3.6.3.8
TTDS00517	Target Validation	TTDS00517
TTDS00517	Drug(s)	Artemisinin
TTDS00517	Drug(s)	Artemisinin SP
TTDS00517	Drug(s)	Artesunate
TTDS00517	Drug(s)	Dihydroartemisinin
TTDS00517	Drug(s)	OZ277
TTDS00517	Drug(s)	Piperaquine
TTDS00517	Drug(s)	Pyronaridine
TTDS00517	Inhibitor	Artemisinin
TTDS00517	Inhibitor	Artemisinin SP
TTDS00517	Inhibitor	Artesunate
TTDS00517	Inhibitor	Cyclopiazonic acid
TTDS00517	Inhibitor	Dihydroartemisinin
TTDS00517	Inhibitor	OZ277
TTDS00517	Inhibitor	Piperaquine
TTDS00517	Inhibitor	Pyronaridine
TTDS00517	Inhibitor	THAPSIGARGIN
TTDS00517	Inhibitor	Vanadate
TTDS00518	Name	Fc gamma receptor III
TTDS00518	Type of target	Successful target
TTDS00518	Synonyms	CD16
TTDS00518	Synonyms	Fc-gamma RIII
TTDS00518	Synonyms	FcR-10
TTDS00518	Synonyms	FcRIII
TTDS00518	Synonyms	FcgammaRIIIb
TTDS00518	Synonyms	IgG FC receptor III
TTDS00518	Synonyms	Low affinity immunoglobulin gamma Fc region receptor III
TTDS00518	Disease	Anaphylactic reaction
TTDS00518	Disease	Cancer, unspecific
TTDS00518	Disease	Inflammatory diseases
TTDS00518	Disease	Rheumatoid arthritis, unspecified
TTDS00518	Target Validation	TTDS00518
TTDS00518	Drug(s)	GMA-161
TTDS00518	Antagonist	GMA-161
TTDS00518	Antibody	Chemically linked bispecific antibodies
TTDS00519	UniProt ID	O56072
TTDS00519	Name	HIV-1 integrase
TTDS00519	Type of target	Successful target
TTDS00519	Synonyms	HIV 1 Integrase
TTDS00519	Synonyms	HIV Integration Protein
TTDS00519	Synonyms	Integrase, HIV-1
TTDS00519	Synonyms	Integration Protein, HIV
TTDS00519	Disease	Human immunodeficiency virus [HIV] disease
TTDS00519	Sequence	IPAETGQETAYFLLKLAGKWPVKVVHTDNGSNFTSATVKAACWWAGIKQEFEIPYNPQSQGVVKSINKELKKIIGQVRDQ
TTDS00519	EC Number	EC 2.7.7.-
TTDS00519	Related US Patent	6,638,921
TTDS00519	QSAR Model	TTDS00519
TTDS00519	Drug(s)	Abacavir/dolutegravir/lamivudine
TTDS00519	Drug(s)	BI-224436
TTDS00519	Drug(s)	Dolutegravir
TTDS00519	Drug(s)	Raltegravir
TTDS00519	Drug(s)	S/GSK1265744
TTDS00519	Inhibitor	AR177
TTDS00519	Inhibitor	Elvitegravir
TTDS00519	Inhibitor	L-708,906
TTDS00519	Inhibitor	L-731,988
TTDS00519	Inhibitor	L17
TTDS00519	Inhibitor	Purpurin
TTDS00519	Inhibitor	Quinalizarin
TTDS00519	Inhibitor	Raltegravir
TTDS00519	Inhibitor	V-165
TTDS00520	UniProt ID	P36544
TTDS00520	Name	Neuronal acetylcholine receptor protein, alpha-7 chain
TTDS00520	Type of target	Successful target
TTDS00520	Synonyms	Alpha(7) nicotinic receptor
TTDS00520	Synonyms	Alpha-7 nAChR
TTDS00520	Synonyms	Alpha7 nAChR
TTDS00520	Synonyms	Alpha7 nicotinic receptor
TTDS00520	Synonyms	Nicotinic acetylcholine receptor alpha7
TTDS00520	Synonyms	Nicotinic acetylcholine receptor subunit alpha 7
TTDS00520	Disease	Alzheimer's disease
TTDS00520	Disease	Analgesics
TTDS00520	Disease	Drug dependence
TTDS00520	Disease	Neuropsychiatric disorders
TTDS00520	Disease	Pain
TTDS00520	Disease	Schizophrenia
TTDS00520	Function	After binding acetylcholine, the achr responds by an extensive change in conform
TTDS00520	Sequence	MRCSPGGVWLALAASLLHVSLQGEFQRKLYKELVKNYNPLERPVANDSQPLTVYFSLSLLQIMDVDEKNQVLTTNIWLQM
TTDS00520	BioChemical Class	Ion transport
TTDS00520	Pathway	Calcium signaling pathway
TTDS00520	Target Validation	TTDS00520
TTDS00520	Drug(s)	EVP-6124
TTDS00520	Drug(s)	MEM-3454
TTDS00520	Drug(s)	PNU-282987
TTDS00520	Drug(s)	R3487
TTDS00520	Drug(s)	R4996
TTDS00520	Drug(s)	RMG-40083
TTDS00520	Drug(s)	TC-1698
TTDS00520	Drug(s)	TC-5280
TTDS00520	Inhibitor	3,8-dibromoboldine
TTDS00520	Inhibitor	3-bromoboldine
TTDS00520	Inhibitor	ALCURONIUM
TTDS00520	Inhibitor	CP-810123
TTDS00520	Inhibitor	CYTISINE
TTDS00520	Inhibitor	GCCSHPACAGNNQHIC*
TTDS00520	Inhibitor	GCCSNPVCHLEHSNLC*
TTDS00520	Inhibitor	N-methyllaurotetanine methiodide
TTDS00520	Inhibitor	PH-709829
TTDS00520	Inhibitor	PHA-543613
TTDS00520	Inhibitor	TOXIFERINE
TTDS00520	Inhibitor	boldine methiodide
TTDS00520	Inhibitor	glaucine methiodide
TTDS00520	Antagonist	Barbital
TTDS00520	Antagonist	Barbituric acid derivative
TTDS00520	Antagonist	Laudanosine
TTDS00520	Antagonist	MEM-3454
TTDS00520	Antagonist	Methyllycaconitine
TTDS00520	Antagonist	PNU-282987
TTDS00520	Antagonist	RMG-40083
TTDS00520	Agonist	GTS-21
TTDS00520	Agonist	R3487
TTDS00520	Agonist	R4996
TTDS00520	Binder	TC-1698
TTDS00520	Binder	TC-5280
TTDS00521	UniProt ID	P08887
TTDS00521	UniProt ID	P40189
TTDS00521	Name	Interleukin-6 receptor
TTDS00521	Type of target	Successful target
TTDS00521	Synonyms	CD126
TTDS00521	Synonyms	IL-6R
TTDS00521	Synonyms	IL6R
TTDS00521	Synonyms	Membrane glycoprotein 80
TTDS00521	Synonyms	gp80
TTDS00521	Disease	Rheumatoid arthritis, unspecified
TTDS00521	Function	Part of the receptor for interleukin 6. Binds to IL6 with low affinity, but does
TTDS00521	Sequence	MLAVGCALLAALLAAPGAALAPRRCPAQEVARGVLTSLPGDSVTLTCPGVEPEDNATVHWVLRKPAAGSHPSRWAGMGRR
TTDS00521	PDB Structure	1BJ8; 1BQU; 1I1R; 1N2Q; 1P9M; 1PVH; 3L5H; 3L5I; 3L5J
TTDS00521	Pathway	Cytokine-cytokine receptor interaction
TTDS00521	Pathway	Hematopoietic cell lineage
TTDS00521	Pathway	Jak-STAT signaling pathway
TTDS00521	Related US Patent	6,599,875
TTDS00521	Target Validation	TTDS00521
TTDS00521	Drug(s)	CHU
TTDS00521	Drug(s)	SAR153191
TTDS00521	Drug(s)	Tocilizumab
TTDS00521	Inhibitor	Alpha-D-Mannose
TTDS00521	Antagonist	SAR153191
TTDS00521	Antagonist	Sant7
TTDS00521	Antibody	Tocilizumab
TTDS00522	Name	Noradrenaline uptake
TTDS00522	Type of target	Successful target
TTDS00522	Disease	Depression
TTDS00522	Related US Patent	6,403,645
TTDS00522	Target Validation	TTDS00522
TTDS00522	Drug(s)	AD-337
TTDS00522	Drug(s)	Bicifadine
TTDS00522	Drug(s)	Bupropion+naltrexone
TTDS00522	Drug(s)	Edivoxetine
TTDS00522	Drug(s)	Radafaxine
TTDS00522	Drug(s)	Radaxafine HCl
TTDS00522	Drug(s)	Tramadol ER
TTDS00522	Drug(s)	Trimipramine
TTDS00522	Inhibitor	AD-337
TTDS00522	Inhibitor	Bicifadine
TTDS00522	Inhibitor	Bupropion+naltrexone
TTDS00522	Inhibitor	Radafaxine
TTDS00522	Inhibitor	Radaxafine HCl
TTDS00522	Inhibitor	Tramadol ER
TTDS00522	Inhibitor	Trimipramine
TTDS00522	Multitarget	Bicifadine
TTDS00522	Multitarget	Bupropion+naltrexone
TTDS00522	Multitarget	Radafaxine
TTDS00522	Multitarget	Radaxafine HCl
TTDS00522	Multitarget	Tramadol ER
TTDS00522	Multitarget	Trimipramine
TTDS00524	UniProt ID	P40238
TTDS00524	Name	Thrombopoietin Receptor
TTDS00524	Type of target	Successful target
TTDS00524	Synonyms	C-mpl
TTDS00524	Synonyms	CD110 antigen
TTDS00524	Synonyms	MPL
TTDS00524	Synonyms	Myeloproliferative leukemia protein
TTDS00524	Synonyms	TPO-R
TTDS00524	Synonyms	TPOR
TTDS00524	Disease	Thrombocytopenia
TTDS00524	Sequence	MPSWALFMVTSCLLLAPQNLAQVSSQDVSLLASDSEPLKCFSRTFEDLTCFWDEEEAAPSGTYQLLYAYPREKPRACPLS
TTDS00524	Pathway	Cytokine-cytokine receptor interaction
TTDS00524	Pathway	Jak-STAT signaling pathway
TTDS00524	Target Validation	TTDS00524
TTDS00524	Drug(s)	AKR-501
TTDS00524	Drug(s)	Eltrombopag
TTDS00524	Drug(s)	LGD-4665
TTDS00524	Drug(s)	Revolade/Promacta
TTDS00524	Drug(s)	RhTPO
TTDS00524	Drug(s)	SB-559448
TTDS00524	Drug(s)	Thrombopoietin
TTDS00524	Drug(s)	Totrombopag
TTDS00524	Agonist	AKR-501
TTDS00524	Agonist	Eltrombopag
TTDS00524	Agonist	LGD-4665
TTDS00524	Agonist	Revolade/Promacta
TTDS00524	Agonist	RhTPO
TTDS00524	Agonist	SB-559448
TTDS00524	Agonist	Thrombopoietin
TTDS00524	Agonist	Totrombopag
TTDS00525	UniProt ID	P50052
TTDS00525	Name	Type-2 angiotensin II receptor
TTDS00525	Type of target	Successful target
TTDS00525	Synonyms	AT2
TTDS00525	Synonyms	Angiotensin II receptor 2
TTDS00525	Disease	Hypertension
TTDS00525	Function	Receptor for angiotensin ii. May have a role in cell morphogenesis and related e
TTDS00525	Sequence	MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSS
TTDS00525	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDS00525	Pathway	Neuroactive ligand-receptor interaction
TTDS00525	Pathway	Renin-angiotensin system
TTDS00525	Related US Patent	6,300,356
TTDS00525	Related US Patent	6,444,646
TTDS00525	Related US Patent	6,544,968
TTDS00525	Related US Patent	6,589,547
TTDS00525	Related US Patent	6,638,937
TTDS00525	Related US Patent	6,641,811
TTDS00525	Target Validation	TTDS00525
TTDS00525	QSAR Model	TTDS00525
TTDS00525	Drug(s)	Azilsartan
TTDS00525	Drug(s)	Azilsartan medoxomil
TTDS00525	Drug(s)	Candesartan cilexetil
TTDS00525	Drug(s)	PS433540
TTDS00525	Drug(s)	TAK-491
TTDS00525	Drug(s)	TAK-591
TTDS00525	Inhibitor	ANGIOTENSIN II
TTDS00525	Inhibitor	L-158282;MK-996
TTDS00525	Inhibitor	L-158809
TTDS00525	Inhibitor	L-159093
TTDS00525	Inhibitor	L-159689
TTDS00525	Inhibitor	L-162234
TTDS00525	Inhibitor	L-162313
TTDS00525	Inhibitor	Macrocyclic Quinazolinone analogue
TTDS00525	Inhibitor	PD-123319
TTDS00525	Inhibitor	SARALASIN
TTDS00525	Inhibitor	SC-50560
TTDS00525	Inhibitor	SC-51895
TTDS00525	Inhibitor	SC-52458
TTDS00525	Inhibitor	SC-52892
TTDS00525	Inhibitor	SC-55634
TTDS00525	Inhibitor	Sar-Arg-Val-Tyr-Ile-His-Pro-Ala
TTDS00525	Inhibitor	Sar-Arg-Val-Tyr-Ile-His-Pro-Ile
TTDS00525	Inhibitor	Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
TTDS00525	Antagonist	Azilsartan
TTDS00525	Antagonist	Azilsartan medoxomil
TTDS00525	Antagonist	Candesartan cilexetil
TTDS00525	Antagonist	PS433540
TTDS00525	Antagonist	TAK-491
TTDS00525	Antagonist	TAK-591
TTDS00525	Multitarget	TAK-591
TTDS00526	Name	mRNA of IE2 region of cytomegalovirus
TTDS00526	Type of target	Successful target
TTDS00526	Disease	CMV retinitis
TTDS00526	Drug(s)	Fomivirsen sodium
TTDS00526	Antisense	Fomivirsen sodium
TTDS00526	Antisense	ISIS 12659
TTDS00526	Antisense	ISIS 12660
TTDS00526	Antisense	ISIS 2918
TTDS00526	Antisense	ISIS 2919
TTDS00526	Antisense	ISIS 2920
TTDS00526	Antisense	ISIS 2921
TTDS00526	Antisense	ISIS 2922
TTDS00526	Antisense	ISIS 2922 + Ganciclovir
TTDS00526	Antisense	ISIS 2922 + foscarnet 3' -azido-3'-deoxythymidine 2'-3'-dideoxycytidine
TTDS00526	Antisense	ISIS 3246
TTDS00526	Antisense	ISIS 3300
TTDS00527	Name	Adrenergic neuron
TTDS00527	Type of target	Successful target
TTDS00527	Disease	Hypertension
TTDS00527	Drug(s)	Debrisoquin
TTDS00527	Drug(s)	Guanethidine
TTDS00527	Blocker	Debrisoquin
TTDS00527	Blocker	Guanethidine
TTDS00528	Name	5-aminoimidazole-4-carboxamidoribonucleotide (AICAR) transformylase
TTDS00528	Type of target	Successful target
TTDS00528	Disease	Inflammatory bowel dieaseas and rheumatoid arthritis
TTDS00528	Target Validation	TTDS00528
TTDS00528	Drug(s)	Sulfasalazine
TTDS00528	Inhibitor	Sulfasalazine
TTDS00529	UniProt ID	Q00975
TTDS00529	Name	Voltage-dependent N-type calcium channel
TTDS00529	Type of target	Successful target
TTDS00529	Synonyms	BIII
TTDS00529	Synonyms	Brain calcium channel III
TTDS00529	Synonyms	Calcium channel, L type, alpha-1 polypeptide isoform 5
TTDS00529	Synonyms	N-type Ca2+ channel
TTDS00529	Synonyms	Voltage-dependent N-type calcium channel alpha-1B subunit
TTDS00529	Synonyms	Voltage-gated calcium channel alpha subunit Cav2.2
TTDS00529	Disease	Analgesics
TTDS00529	Disease	Cardiovascular disease, unspecified
TTDS00529	Disease	Cerebral ischemia
TTDS00529	Disease	Malignant pain
TTDS00529	Disease	Neuropathic pain
TTDS00529	Function	Voltage-sensitive calcium channels (vscc) mediate the entry of calcium ions into
TTDS00529	Sequence	MVRFGDELGGRYGGPGGGERARGGGAGGAGGPGPGGLQPGQRVLYKQSIAQRARTMALYNPIPVKQNCFTVNRSLFVFSE
TTDS00529	PDB Structure	2LCM
TTDS00529	BioChemical Class	Voltage-gated channel
TTDS00529	Pathway	Calcium signaling pathway
TTDS00529	Pathway	MAPK signaling pathway
TTDS00529	Pathway	Taste transduction
TTDS00529	Pathway	Type II diabetes mellitus
TTDS00529	Target Validation	TTDS00529
TTDS00529	QSAR Model	TTDS00529
TTDS00529	Drug(s)	Cilnidipine
TTDS00529	Drug(s)	Ralfinamide
TTDS00529	Drug(s)	Ziconotide
TTDS00529	Inhibitor	GNF-PF-3464
TTDS00529	Inhibitor	HESPERIDINE
TTDS00529	Inhibitor	KYS-05090
TTDS00529	Inhibitor	LOMERIZINE
TTDS00529	Inhibitor	NSC-180246
TTDS00529	Inhibitor	NSC-87509
TTDS00529	Inhibitor	PD-151307
TTDS00529	Inhibitor	PD-157667
TTDS00529	Inhibitor	PD-167341
TTDS00529	Inhibitor	PD-29361
TTDS00529	Inhibitor	PD-32577
TTDS00529	Blocker	AM336
TTDS00529	Blocker	Cilnidipine
TTDS00529	Blocker	Conotoxin
TTDS00529	Blocker	JZP-4
TTDS00529	Blocker	N,N-dialkyl-dipeptidylamines
TTDS00529	Blocker	Ralfinamide
TTDS00529	Blocker	SNX-111
TTDS00529	Blocker	Ziconotide
TTDS00529	Multitarget	Cilnidipine
TTDS00529	Multitarget	Ralfinamide
TTDS00530	UniProt ID	P06958
TTDS00530	Name	Pyruvate decarboxylase
TTDS00530	Type of target	Successful target
TTDS00530	Synonyms	Pyruvate decarboxylase E1 component
TTDS00530	Disease	Vitamin B1 deficiency
TTDS00530	Function	The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate
TTDS00530	Sequence	MSERFPNDVDPIETRDWLQAIESVIREEGVERAQYLIDQLLAEARKGGVNVAAGTGISNYINTIPVEEQPEYPGNLELER
TTDS00530	PDB Structure	1L8A; 1RP7; 2G25; 2G28; 2G67; 2IEA; 2QTA; 2QTC
TTDS00530	EC Number	EC 1.2.4.1
TTDS00530	Drug(s)	Vitamin B1
TTDS00530	Cofactor	Vitamin B1
TTDS00531	UniProt ID	Q96PD7
TTDS00531	Name	Diacylglycerol O-acyltransferase 2
TTDS00531	Type of target	Successful target
TTDS00531	Synonyms	DGAT2
TTDS00531	Synonyms	Diglyceride acyltransferase 2
TTDS00531	Disease	Dyslipidemia
TTDS00531	Disease	Lipid disorders, cardiovascular disease
TTDS00531	Function	Essential acyltransferase that catalyzes the terminal and only committed step in
TTDS00531	Sequence	MKTLIAAYSGVLRGERQAEADRSQRSHGGPALSREGSGRWGTGSSILSALQDLFSVTWLNRSKVEKQLQVISVLQWVLSF
TTDS00531	Drug(s)	ARI-3037MO
TTDS00531	Drug(s)	Vitamin B3
TTDS00531	Inhibitor	ARI-3037MO
TTDS00531	Inhibitor	Vitamin B3
TTDS00531	Multitarget	ARI-3037MO
TTDS00531	Multitarget	Vitamin B3
TTDS00532	Name	Corynebacterium diphtheriae CRM197 protein
TTDS00532	Type of target	Successful target
TTDS00532	Disease	Disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V,
TTDS00532	Disease	Meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-
TTDS00532	Drug(s)	Meningococcal groups A, C, Y and W-135 conjugate vaccine
TTDS00532	Drug(s)	Pneumococcal 13-valent conjugate vaccine
TTDS00532	Binder	Meningococcal groups A, C, Y and W-135 conjugate vaccine
TTDS00532	Binder	Pneumococcal 13-valent conjugate vaccine
TTDS00533	UniProt ID	P31327
TTDS00533	Name	Carbamoyl-phosphate synthetase I
TTDS00533	Type of target	Successful target
TTDS00533	Synonyms	CPS1
TTDS00533	Synonyms	CPSase I
TTDS00533	Synonyms	Carbamoyl-phosphate synthase [ammonia], mitochondrial
TTDS00533	Disease	Acute hyperammonaemia
TTDS00533	Function	Involved in the urea cycle of ureotelic animals where the enzyme plays an import
TTDS00533	Sequence	MTRILTAFKVVRTLKTGFGFTNVTAHQKWKFSRPGIRLLSVKAQTAHIVLEDGTKMKGYSFGHPSSVAGEVVFNTGLGGY
TTDS00533	PDB Structure	2YVQ
TTDS00533	Drug(s)	Carglumic acid
TTDS00533	Activator	Carglumic acid
TTDS00534	UniProt ID	Q9NPF7
TTDS00534	Name	Interleukin-23
TTDS00534	Type of target	Successful target
TTDS00534	Synonyms	IL-23
TTDS00534	Synonyms	Interleukin 23
TTDS00534	Synonyms	P40 subunit of interleukin-23
TTDS00534	Disease	Crohn's Disease, Inflammatory bowel disease
TTDS00534	Disease	Moderate-to-severe plaque psoriasis
TTDS00534	Disease	Psoriasis
TTDS00534	Function	Associates with IL12B to form the IL-23 interleukin, an heterodimeric cytokine w
TTDS00534	Sequence	MLGSRAVMLLLLLPWTAQGRAVPGGSSPAWTQCQQLSQKLCTLAWSAHPLVGHMDLREEGDEETTNDVPHIQCGDGCDPQ
TTDS00534	PDB Structure	3D85; 3D87; 3DUH; 3QWR
TTDS00534	Drug(s)	MEDI2070
TTDS00534	Drug(s)	MK-3222/SCH 900222
TTDS00534	Drug(s)	Ustekinumab
TTDS00534	Antibody	Ustekinumab
TTDS00534	Multitarget	Ustekinumab
TTDC00001	UniProt ID	P87764
TTDC00001	Name	RNA-dependent RNA polymerase
TTDC00001	Type of target	Clinical trial target
TTDC00001	Synonyms	NI-b
TTDC00001	Synonyms	NIb
TTDC00001	Synonyms	NS5B
TTDC00001	Synonyms	Nonstructural protein 5b
TTDC00001	Synonyms	Nuclear inclusion protein B
TTDC00001	Synonyms	P66
TTDC00001	Synonyms	P70
TTDC00001	Synonyms	RNA-directed RNA polymerase
TTDC00001	Synonyms	RdRp
TTDC00001	Synonyms	Virus-encoded nonstructural protein 5B
TTDC00001	Disease	Hepatitis C
TTDC00001	Disease	Influenza A virus infection
TTDC00001	Disease	Severe acute respiratory syndrome
TTDC00001	Sequence	XXXXXDXAPEARQAIRSLTERLYXGGPLTNSKGQNCGYRRCRASGVLTTSCXNTLTCYLKASAACRAAKLQDCT
TTDC00001	EC Number	EC 2.7.7.48
TTDC00001	Related US Patent	6,448,281
TTDC00001	Related US Patent	6,479,508
TTDC00001	Related US Patent	6,492,423
TTDC00001	Target Validation	TTDC00001
TTDC00001	QSAR Model	TTDC00001
TTDC00001	Drug(s)	P70/AKT inhibitor
TTDC00001	Drug(s)	T-705
TTDC00001	Inhibitor	ANX-201
TTDC00001	Inhibitor	FdG
TTDC00001	Inhibitor	Flutimide
TTDC00001	Inhibitor	Guanosine-5'-Triphosphate
TTDC00001	Inhibitor	Pyrimidinyl acylthiourea
TTDC00001	Inhibitor	Pyrophosphate 2-
TTDC00001	Inhibitor	T-1105
TTDC00001	Inhibitor	T-1106
TTDC00001	Inhibitor	T-705
TTDC00001	Inhibitor	Thiadiazolo[2,3-a]pyrimidine
TTDC00002	UniProt ID	P03437
TTDC00002	Name	Hemagglutinin
TTDC00002	Type of target	Clinical trial target
TTDC00002	Synonyms	HA
TTDC00002	Synonyms	Hemagglutinin HA1 chain
TTDC00002	Synonyms	Hemagglutinin HA2 chain
TTDC00002	Disease	Influenza A virus infection
TTDC00002	Function	Binds to sialic acid-containing receptors on the cell surface, bringing about th
TTDC00002	Sequence	MKTIIALSYIFCLALGQDLPGNDNSTATLCLGHHAVPNGTLVKTITDDQIEVTNATELVQSSSTGKICNNPHRILDGIDC
TTDC00002	PDB Structure	1EO8; 1FYT; 1HA0; 1HGG; 1HTM; 1J8H; 1QU1; 2HMG; 2VIR; 2VIS; 2VIT; 2VIU; 2YPG; 3E
TTDC00002	Target Validation	TTDC00002
TTDC00002	Drug(s)	Arbidol
TTDC00002	Inhibitor	2-tert-butylbenzene-1,4-diol
TTDC00002	Inhibitor	Alpha-D-Mannose
TTDC00002	Inhibitor	Arbidol
TTDC00002	Inhibitor	BMY-27709
TTDC00002	Inhibitor	CL 385319
TTDC00002	Inhibitor	Stachyflin
TTDC00002	Inhibitor	TBHQ
TTDC00005	UniProt ID	O14757
TTDC00005	Name	Serine/threonine-protein kinase Chk1
TTDC00005	Type of target	Clinical trial target
TTDC00005	Synonyms	Chk1
TTDC00005	Disease	Solid tumors
TTDC00005	Sequence	MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ
TTDC00005	PDB Structure	1IA8; 1NVQ; 1NVR; 1NVS; 1ZLT; 1ZYS; 2AYP; 2BR1; 2BRB; 2BRG; 2BRH; 2BRM; 2BRN; 2B
TTDC00005	Pathway	Cell cycle
TTDC00005	Pathway	p53 signaling pathway
TTDC00005	EC Number	EC 2.7.11.1
TTDC00005	Target Validation	TTDC00005
TTDC00005	Drug(s)	7-hydroxystaurosporine
TTDC00005	Drug(s)	AZD7762
TTDC00005	Drug(s)	Chk1 inhibitor
TTDC00005	Drug(s)	GDC-0425
TTDC00005	Drug(s)	GDC-0575
TTDC00005	Drug(s)	LY2603618
TTDC00005	Drug(s)	LY2606368
TTDC00005	Drug(s)	PF-477736
TTDC00005	Drug(s)	RG7602
TTDC00005	Drug(s)	RG7741
TTDC00005	Drug(s)	UCN-01
TTDC00005	Drug(s)	XL844
TTDC00005	Inhibitor	2-(cyclohexylamino)benzoic acid
TTDC00005	Inhibitor	3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE
TTDC00005	Inhibitor	3-(1H-indol-2-yl)quinolin-2(1H)-one
TTDC00005	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDC00005	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDC00005	Inhibitor	6-(3-aminopropyl)benzo[h]isoquinolin-1(2H)-one
TTDC00005	Inhibitor	6-MORPHOLIN-4-YL-9H-PURINE
TTDC00005	Inhibitor	7-hydroxystaurosporine
TTDC00005	Inhibitor	9-chlorobenzo[h]isoquinolin-1(2H)-one
TTDC00005	Inhibitor	9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione
TTDC00005	Inhibitor	A-432411
TTDC00005	Inhibitor	AZD7762
TTDC00005	Inhibitor	BIS-IMIDE A
TTDC00005	Inhibitor	CI-1040;PD-18435;PD-184352
TTDC00005	Inhibitor	DEBROMOHYMENIALDISINE
TTDC00005	Inhibitor	GF-109203
TTDC00005	Inhibitor	GRANULATIMIDE
TTDC00005	Inhibitor	ISOGRANULATIMIDE
TTDC00005	Inhibitor	KN-62
TTDC00005	Inhibitor	LY-294002
TTDC00005	Inhibitor	N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE
TTDC00005	Inhibitor	NU-6102
TTDC00005	Inhibitor	PD-98059
TTDC00005	Inhibitor	PF-477736
TTDC00005	Inhibitor	RO-316233
TTDC00005	Inhibitor	SB-202190
TTDC00005	Inhibitor	SB-203580
TTDC00005	Inhibitor	U-0126
TTDC00005	Inhibitor	UCN-01
TTDC00005	Inhibitor	XL844
TTDC00005	Multitarget	7-hydroxystaurosporine
TTDC00005	Multitarget	XL844
TTDC00006	UniProt ID	O14965
TTDC00006	Name	Aurora kinase A
TTDC00006	Type of target	Clinical trial target
TTDC00006	Synonyms	Aurora-A
TTDC00006	Synonyms	Aurora-related kinase 1
TTDC00006	Synonyms	Aurora/IPL1-related kinase 1
TTDC00006	Synonyms	Breast tumor-amplified kinase
TTDC00006	Synonyms	Serine/threonine kinase 15
TTDC00006	Synonyms	Serine/threonine-protein kinase 6
TTDC00006	Synonyms	hARK1
TTDC00006	Disease	Colorectal Cancer
TTDC00006	Disease	Lymphoma, Unspecified
TTDC00006	Disease	Solid tumors
TTDC00006	Sequence	MDRSKENCISGPVKATAPVGGPKRVLVTQQFPCQNPLPVNSGQAQRVLCPSNSSQRVPLQAQKLVSSHKPVQNQKQKQLQ
TTDC00006	PDB Structure	1MQ4; 1MUO; 1OL5; 1OL6; 1OL7; 2BMC; 2C6D; 2C6E; 2DWB; 2J4Z; 2J50; 2NP8; 2W1C; 2W
TTDC00006	EC Number	EC 2.7.11.1
TTDC00006	Target Validation	TTDC00006
TTDC00006	Drug(s)	ABT-348
TTDC00006	Drug(s)	AMG 900
TTDC00006	Drug(s)	AT-9283
TTDC00006	Drug(s)	AT9283
TTDC00006	Drug(s)	AZD1152
TTDC00006	Drug(s)	CYC-116
TTDC00006	Drug(s)	CYC116
TTDC00006	Drug(s)	ENMD-2076
TTDC00006	Drug(s)	MK-5108
TTDC00006	Drug(s)	MK-5108/VX-689
TTDC00006	Drug(s)	MLN8054
TTDC00006	Drug(s)	MLN8237
TTDC00006	Drug(s)	PF-03814735
TTDC00006	Drug(s)	PHA-739358
TTDC00006	Drug(s)	R763
TTDC00006	Drug(s)	SNS-314
TTDC00006	Drug(s)	SU-6668
TTDC00006	Drug(s)	VX-680
TTDC00006	Drug(s)	VX-689
TTDC00006	Inhibitor	2-(1H-pyrazol-3-yl)-1H-benzimidazole
TTDC00006	Inhibitor	4-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine
TTDC00006	Inhibitor	6-bromoindirubin-3-oxime
TTDC00006	Inhibitor	7-fluoroindirubin-3-oxime
TTDC00006	Inhibitor	AT-9283
TTDC00006	Inhibitor	AT9283
TTDC00006	Inhibitor	AZD-1152-HQPA;Barasertib
TTDC00006	Inhibitor	AZD1152
TTDC00006	Inhibitor	Adenosine-5'-Diphosphate
TTDC00006	Inhibitor	CYC-116
TTDC00006	Inhibitor	CYC116
TTDC00006	Inhibitor	ENMD-2076
TTDC00006	Inhibitor	GSK-1070916
TTDC00006	Inhibitor	MK-5108
TTDC00006	Inhibitor	MLN8054
TTDC00006	Inhibitor	MLN8237
TTDC00006	Inhibitor	PF-03814735
TTDC00006	Inhibitor	PHA-680632
TTDC00006	Inhibitor	PHA-739358
TTDC00006	Inhibitor	Phosphonothreonine
TTDC00006	Inhibitor	R763
TTDC00006	Inhibitor	SNS-314
TTDC00006	Inhibitor	SU-6668
TTDC00006	Inhibitor	VX-680
TTDC00006	Inhibitor	VX-689
TTDC00006	Inhibitor	ZM-447439
TTDC00006	Inhibitor	indirubin-3-acetoxime
TTDC00006	Inhibitor	indirubin-3-methoxime
TTDC00006	Inhibitor	indirubin-3-oxime
TTDC00006	Multitarget	AT-9283
TTDC00006	Multitarget	AT9283
TTDC00006	Multitarget	AZD1152
TTDC00006	Multitarget	CYC-116
TTDC00006	Multitarget	CYC116
TTDC00006	Multitarget	MK-5108
TTDC00006	Multitarget	PF-03814735
TTDC00006	Multitarget	PHA-739358
TTDC00006	Multitarget	R763
TTDC00006	Multitarget	SNS-314
TTDC00006	Multitarget	SU-6668
TTDC00006	Multitarget	VX-680
TTDC00006	Multitarget	VX-689
TTDC00007	UniProt ID	O15455
TTDC00007	Name	Toll-like receptor 3
TTDC00007	Type of target	Discontinued target
TTDC00007	Synonyms	CD283
TTDC00007	Synonyms	TLR3
TTDC00007	Disease	HPV-related Diseases
TTDC00007	Disease	HPV-related high-grade anal intraepithelial neoplasia (AIN)
TTDC00007	Disease	Human Papillomavirus (HPV) Infections
TTDC00007	Sequence	MRQTLPCIYFWGGLLPFGMLCASSTTKCTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSL
TTDC00007	PDB Structure	1ZIW; 2A0Z; 3ULU; 3ULV
TTDC00007	Pathway	Toll-like receptor signaling pathway
TTDC00007	Target Validation	TTDC00007
TTDC00007	Drug(s)	HspE7 (TLR3 agonist adjuvant)
TTDC00007	Agonist	HspE7 (TLR3 agonist adjuvant)
TTDC00009	UniProt ID	O95264
TTDC00009	Name	5-hydroxy-tryptamine 3B receptor
TTDC00009	Type of target	Clinical trial target
TTDC00009	Synonyms	5-HT-3B
TTDC00009	Synonyms	5-HT3B
TTDC00009	Synonyms	5-hydroxytryptamine receptor 3B
TTDC00009	Synonyms	HTR3B
TTDC00009	Synonyms	Serotonin receptor 3B
TTDC00009	Disease	Diarrhea
TTDC00009	Disease	Irritable Bowel Syndrome (IBS)
TTDC00009	Sequence	MLSSVMAPLWACILVAAGILATDTHHPQDSALYHLSKQLLQKYHKEVRPVYNWTKATTVYLDLFVHAILDVDAENQILKT
TTDC00009	Target Validation	TTDC00009
TTDC00009	Drug(s)	Cilansetron
TTDC00009	Inhibitor	2-(1H-Imidazol-4-ylmethyl)-4-phenyl-thiazole
TTDC00009	Inhibitor	2-(4-Benzyl-piperazin-1-yl)-benzothiazole
TTDC00009	Inhibitor	2-(4-Methyl-piperazin-1-yl)-quinoline
TTDC00009	Inhibitor	3-(2-Amino-ethyl)-2-methyl-1H-indol-5-ol
TTDC00009	Inhibitor	6-(4-Methyl-piperazin-1-yl)-phenanthridine
TTDC00009	Inhibitor	BEMESETRON
TTDC00009	Inhibitor	BRL-24682
TTDC00009	Inhibitor	BRL-46470
TTDC00009	Inhibitor	MESULERGINE
TTDC00009	Inhibitor	ML-10302
TTDC00009	Inhibitor	PHA-543613
TTDC00009	Inhibitor	QUIPAZINE
TTDC00009	Inhibitor	SC-52491
TTDC00009	Inhibitor	SC-53116
TTDC00009	Inhibitor	SDZ-205557
TTDC00009	Inhibitor	SEROTONIN
TTDC00009	Inhibitor	ZACOPRIDE
TTDC00009	Antagonist	Cilansetron
TTDC00010	UniProt ID	O96017
TTDC00010	Name	Serine/threonine-protein kinase Chk2
TTDC00010	Type of target	Discontinued target
TTDC00010	Synonyms	CHEK2
TTDC00010	Synonyms	CHK2
TTDC00010	Synonyms	Cds1
TTDC00010	Synonyms	RAD53
TTDC00010	Disease	Solid tumors
TTDC00010	Sequence	MSRESDVEAQQSHGSSACSQPHGSVTQSQGSSSQSQGISSSSTSTMPNSSQSSHSSSGTLSSLETVSTQELYSIPEDQEP
TTDC00010	PDB Structure	1GXC; 2CN5; 2CN8; 2W0J; 2W7X; 2WTC; 2WTD; 2WTI; 2WTJ; 2XBJ; 2XK9; 2XM8; 2XM9; 2Y
TTDC00010	Pathway	Cell cycle
TTDC00010	Pathway	p53 signaling pathway
TTDC00010	EC Number	EC 2.7.11.1
TTDC00010	Target Validation	TTDC00010
TTDC00010	Drug(s)	XL844
TTDC00010	Inhibitor	2-(4-Phenoxy-phenyl)-1H-benzoimidazol-5-ylamine
TTDC00010	Inhibitor	5-Nitro-2-(4-phenoxy-phenyl)-1H-benzoimidazole
TTDC00010	Inhibitor	DEBROMOHYMENIALDISINE
TTDC00010	Inhibitor	XL844
TTDC00010	Multitarget	XL844
TTDC00012	UniProt ID	P02751
TTDC00012	Name	Fibronectin
TTDC00012	Type of target	Clinical trial target
TTDC00012	Synonyms	CIG
TTDC00012	Synonyms	Cold-insoluble globulin
TTDC00012	Synonyms	FN
TTDC00012	Synonyms	FN1
TTDC00012	Synonyms	Ugl-Y1
TTDC00012	Synonyms	Ugl-Y2
TTDC00012	Synonyms	Ugl-Y3
TTDC00012	Disease	Kidney Cancer
TTDC00012	Disease	Melanoma
TTDC00012	Sequence	MLRGPGPGLLLLAVQCLGTAVPSTGASKSKRQAQQMVQPQSPVAVSQSKPGCYDNGKHYQINQQWERTYLGNALVCTCYG
TTDC00012	PDB Structure	1E88; 1E8B; 1FBR; 1FNA; 1FNF; 1FNH; 1J8K; 1O9A; 1OWW; 1Q38; 1QGB; 1QO6; 1TTF; 1T
TTDC00012	Pathway	ECM-receptor interaction
TTDC00012	Pathway	Focal adhesion
TTDC00012	Pathway	Pathways in cancer
TTDC00012	Pathway	Regulation of actin cytoskeleton
TTDC00012	Pathway	Small cell lung cancer
TTDC00012	Target Validation	TTDC00012
TTDC00012	Drug(s)	AS1409
TTDC00012	Binder	AS1409
TTDC00013	UniProt ID	P03952
TTDC00013	Name	Plasma kallikrein
TTDC00013	Type of target	Successful target
TTDC00013	Synonyms	Fletcher factor
TTDC00013	Synonyms	KLK3
TTDC00013	Synonyms	KLKB1
TTDC00013	Synonyms	Kininogenin
TTDC00013	Synonyms	Plasma kallikrein heavy chain
TTDC00013	Synonyms	Plasma kallikrein light chain
TTDC00013	Synonyms	Plasma prekallikrein
TTDC00013	Disease	Hereditary Angioedema (HAE)
TTDC00013	Sequence	MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLK
TTDC00013	PDB Structure	2ANW; 2ANY
TTDC00013	Pathway	Complement and coagulation cascades
TTDC00013	EC Number	EC 3.4.21.34
TTDC00013	Target Validation	TTDC00013
TTDC00013	Drug(s)	Ecallantide
TTDC00013	Inhibitor	(3,4-dichlorophenyl)(1H-pyrazol-1-yl)methanone
TTDC00013	Inhibitor	(3-nitro-1H-pyrazol-1-yl)(p-tolyl)methanone
TTDC00013	Inhibitor	(3-nitro-1H-pyrazol-1-yl)(phenyl)methanone
TTDC00013	Inhibitor	(4-bromo-1H-pyrazol-1-yl)(p-tolyl)methanone
TTDC00013	Inhibitor	1-benzoyl-N-phenyl-1H-pyrazole-3-carboxamide
TTDC00013	Inhibitor	D-Pro-Phe-Arg chloromethyl ketone
TTDC00013	Inhibitor	Ecallantide
TTDC00013	Inhibitor	ZK-810388
TTDC00013	Inhibitor	ZK-813039
TTDC00013	Inhibitor	ZK-814048
TTDC00014	UniProt ID	P04062
TTDC00014	Name	Glucosylceramidase
TTDC00014	Type of target	Clinical trial target
TTDC00014	Synonyms	Acid beta-glucosidase
TTDC00014	Synonyms	Alglucerase
TTDC00014	Synonyms	Beta-glucocerebrosidase
TTDC00014	Synonyms	D-glucosyl-N-acylsphingosine glucohydrolase
TTDC00014	Synonyms	Imiglucerase
TTDC00014	Disease	Metabolic Disease
TTDC00014	Sequence	MEFSSPSREECPKPLSRVSIMAGSLTGLLLLQAVSWASGARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYE
TTDC00014	PDB Structure	1OGS; 1Y7V; 2F61; 2J25; 2NSX; 2NT0; 2NT1; 2V3D; 2V3E; 2V3F; 2VT0; 2WCG; 2WKL; 2X
TTDC00014	Pathway	Lysosome
TTDC00014	Pathway	Metabolic pathways
TTDC00014	Pathway	Other glycan degradation
TTDC00014	Pathway	Sphingolipid metabolism
TTDC00014	EC Number	EC 3.2.1.45
TTDC00014	Target Validation	TTDC00014
TTDC00014	Drug(s)	Isofagomine tartrate
TTDC00014	Inhibitor	(2R,3S,4S,5R)-2-hexylpiperidine-3,4,5-triol
TTDC00014	Inhibitor	(2R,3S,4S,5R)-2-nonylpiperidine-3,4,5-triol
TTDC00014	Inhibitor	(2R,3S,4S,5R)-2-propylpiperidine-3,4,5-triol
TTDC00014	Inhibitor	1,5-Dideoxy-1,5-imino-D-xylitol
TTDC00014	Inhibitor	2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose
TTDC00014	Inhibitor	ISOFAGOMINE
TTDC00014	Inhibitor	Isofagomine tartrate
TTDC00014	Inhibitor	L-Isofagomine
TTDC00014	Inhibitor	Myo-Inositol
TTDC00014	Inhibitor	N-(Propylamide-acetophenone)-1-deoxynojirimycin
TTDC00014	Inhibitor	N-(Propylamide-benzophenone)-1-deoxynojirimycin
TTDC00015	UniProt ID	P05129
TTDC00015	Name	Protein kinase C gamma type
TTDC00015	Type of target	Clinical trial target
TTDC00015	Synonyms	PKC-gamma
TTDC00015	Synonyms	PKCG
TTDC00015	Synonyms	PRKCG
TTDC00015	Disease	Cancers unspecified
TTDC00015	Disease	Myeloid Leukemia
TTDC00015	Sequence	MAGLGPGVGDSEGGPRPLFCRKGALRQKVVHEVKSHKFTARFFKQPTFCSHCTDFIWGIGKQGLQCQVCSFVVHRRCHEF
TTDC00015	PDB Structure	2E73; 2UZP
TTDC00015	Pathway	Calcium signaling pathway
TTDC00015	Pathway	ErbB signaling pathway
TTDC00015	Pathway	Focal adhesion
TTDC00015	Pathway	Gap junction
TTDC00015	Pathway	Glioma
TTDC00015	Pathway	Leukocyte transendothelial migration
TTDC00015	Pathway	Long-term depression
TTDC00015	Pathway	Long-term potentiation
TTDC00015	Pathway	MAPK signaling pathway
TTDC00015	Pathway	Melanogenesis
TTDC00015	Pathway	Natural killer cell mediated cytotoxicity
TTDC00015	Pathway	Non-small cell lung cancer
TTDC00015	Pathway	Pathways in cancer
TTDC00015	Pathway	Phosphatidylinositol signaling system
TTDC00015	Pathway	Tight junction
TTDC00015	Pathway	VEGF signaling pathway
TTDC00015	Pathway	Vascular smooth muscle contraction
TTDC00015	Pathway	Vibrio cholerae infection
TTDC00015	Pathway	Wnt signaling pathway
TTDC00015	EC Number	EC 2.7.11.13
TTDC00015	Target Validation	TTDC00015
TTDC00015	Drug(s)	Midostaurin
TTDC00015	Inhibitor	(-)-Cercosporamide
TTDC00015	Inhibitor	2,3,3-Triphenyl-acrylonitrile
TTDC00015	Inhibitor	2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile
TTDC00015	Inhibitor	3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile
TTDC00015	Inhibitor	3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile
TTDC00015	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDC00015	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDC00015	Inhibitor	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile
TTDC00015	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00015	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00015	Inhibitor	4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol
TTDC00015	Inhibitor	4-cycloheptyliden(4-hydroxyphenyl)methylphenol
TTDC00015	Inhibitor	4-cyclohexyliden(4-hydroxyphenyl)methylphenol
TTDC00015	Inhibitor	4-cyclopentyliden(4-hydroxyphenyl)methylphenol
TTDC00015	Inhibitor	8-Octyl-benzolactam-V9
TTDC00015	Inhibitor	BALANOL
TTDC00015	Inhibitor	GF-109203
TTDC00015	Inhibitor	Indolocarbazole analogue
TTDC00015	Inhibitor	LY-317644
TTDC00015	Inhibitor	LY-326449
TTDC00015	Inhibitor	Midostaurin
TTDC00015	Inhibitor	Monoctanoin component C
TTDC00015	Inhibitor	PROSTRATIN
TTDC00015	Inhibitor	RO-316233
TTDC00015	Inhibitor	RO-320432
TTDC00015	Inhibitor	Ro-32-0557
TTDC00015	Inhibitor	[2,2';5',2'']Terthiophen-4-yl-methanol
TTDC00015	Inhibitor	[2,2';5',2'']Terthiophene-4,5''-dicarbaldehyde
TTDC00015	Inhibitor	[2,2';5',2'']Terthiophene-4-carbaldehyde
TTDC00015	Multitarget	Midostaurin
TTDC00016	UniProt ID	P06280
TTDC00016	Name	Alpha-galactosidase A
TTDC00016	Type of target	Clinical trial target
TTDC00016	Synonyms	Agalsidase
TTDC00016	Synonyms	Alpha-D-galactosidase A
TTDC00016	Synonyms	Alpha-D-galactoside galactohydrolase
TTDC00016	Synonyms	Melibiase
TTDC00016	Disease	Fabry Disease
TTDC00016	Sequence	MQLRNPELHLGCALALRFLALVSWDIPGARALDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEG
TTDC00016	PDB Structure	1R46; 1R47; 3GXN; 3GXP; 3GXT; 3HG2; 3HG3; 3HG4; 3HG5; 3LX9; 3LXA; 3LXB; 3LXC; 3S
TTDC00016	Pathway	Galactose metabolism
TTDC00016	Pathway	Glycerolipid metabolism
TTDC00016	Pathway	Glycosphingolipid biosynthesis - globo series
TTDC00016	Pathway	Lysosome
TTDC00016	Pathway	Sphingolipid metabolism
TTDC00016	EC Number	EC 3.2.1.22
TTDC00016	Target Validation	TTDC00016
TTDC00016	Drug(s)	Migalastat
TTDC00016	Inhibitor	(+)-5-deoxyadeenophorine
TTDC00016	Inhibitor	1-deoxygalactonojirimycin
TTDC00016	Inhibitor	2,5-dideoxy-2,5-imino-D-altritol
TTDC00016	Inhibitor	Alpha-D-Mannose
TTDC00016	Inhibitor	CALYSTEGINE B2
TTDC00016	Inhibitor	DEOXYGALACTONOJIRIMYCIN
TTDC00016	Inhibitor	Fucose
TTDC00016	Inhibitor	beta-1-C-Butyl-1-deoxygalactonojirimycin
TTDC00016	Inhibitor	beta-1-C-butenyl-1-deoxygalactonojirimycin
TTDC00016	Modulator	Migalastat
TTDC00017	UniProt ID	P06881
TTDC00017	Name	Calcitonin gene-related peptide 1
TTDC00017	Type of target	Clinical trial target
TTDC00017	Synonyms	Alpha-type CGRP
TTDC00017	Synonyms	CALC1
TTDC00017	Synonyms	CALCA
TTDC00017	Synonyms	CGRP-I
TTDC00017	Synonyms	Calcitonin gene-related peptide I
TTDC00017	Disease	Migraine and Cluster Headaches
TTDC00017	Sequence	MGFQKFSPFLALSILVLLQAGSLHAAPFRSALESSPADPATLSEDEARLLLAALVQDYVQMKASELEQEQEREGSRIIAQ
TTDC00017	PDB Structure	1LS7
TTDC00017	Target Validation	TTDC00017
TTDC00017	Drug(s)	Cizolirtine
TTDC00017	Drug(s)	Olcegepant
TTDC00017	Inhibitor	Ac-VTHRLAGLLSRSGGVVKNNFVPTDVGPFAF-NH2
TTDC00017	Inhibitor	Ac-VTHRLAGLLSRSGGVVRKNFVPTDVGPFAF-NH2
TTDC00017	Inhibitor	Ac-WVEHRLKGELSRKGGVV[hArg]KNFVPTDVGPFAF-NH2
TTDC00017	Inhibitor	Ac-WVTHQLAGLLSQSGGVVRKNFVPTDVGPFAF-NH2
TTDC00017	Inhibitor	Ac-WVTHRLAGLLSRSGGVVRKNFVPTDVGPFAF-NH2
TTDC00017	Inhibitor	Ac-WVTHRLAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2
TTDC00017	Inhibitor	Ac-WVTH[Cit]LAGLLSRSGGVVRKNFVPTDVGPFAF-NH2
TTDC00017	Inhibitor	Ac-WVTH[Cit]LAGLLS[Cit]SGGVVRKNFVPTDVGPFAF-NH2
TTDC00017	Inhibitor	Ac-WVTH[hArg]LAGLLS[hArg]SGGVVRKNFVPTDVGPFAF-NH2
TTDC00017	Inhibitor	Cizolirtine
TTDC00017	Inhibitor	Olcegepant
TTDC00017	Inhibitor	VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2
TTDC00017	Inhibitor	WVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2
TTDC00017	Inhibitor	[Aib29,Asp31,Pro34,Phe35]CGRP(27-37)
TTDC00018	UniProt ID	P07900
TTDC00018	Name	Heat shock protein HSP 90
TTDC00018	Type of target	Clinical trial target
TTDC00018	Synonyms	HSP 86
TTDC00018	Synonyms	HSP90A
TTDC00018	Synonyms	HSP90AA1
TTDC00018	Synonyms	HSPC1
TTDC00018	Synonyms	HSPCA
TTDC00018	Synonyms	Renal carcinoma antigen NY-REN-38
TTDC00018	Disease	Breast cancer
TTDC00018	Disease	Chronic Myelogenous Leukemia (CML)
TTDC00018	Disease	Gastrointestinal Stromal Tumors (GIST)
TTDC00018	Disease	HER2-positive Metastatic Breast Cancer
TTDC00018	Disease	Hematological Malignancies
TTDC00018	Disease	Melanoma
TTDC00018	Disease	Multiple Myeloma
TTDC00018	Disease	Non-small Cell Lung Cancer
TTDC00018	Disease	Ovarian cancer
TTDC00018	Disease	Prostate cancer
TTDC00018	Disease	Refractory Hematological Malignancies
TTDC00018	Disease	Solid tumors
TTDC00018	Sequence	MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINL
TTDC00018	PDB Structure	1BYQ; 1OSF; 1UY6; 1UY7; 1UY8; 1UY9; 1UYC; 1UYD; 1UYE; 1UYF; 1UYG; 1UYH; 1UYI; 1U
TTDC00018	Target Validation	TTDC00018
TTDC00018	Drug(s)	AT13387
TTDC00018	Drug(s)	Alvespimycin hydrochloride
TTDC00018	Drug(s)	CNF1010
TTDC00018	Drug(s)	IPI-504
TTDC00018	Drug(s)	SNX-5422
TTDC00018	Drug(s)	STA-9090
TTDC00018	Drug(s)	Tanespimycin
TTDC00018	Inhibitor	17-Dmag
TTDC00018	Inhibitor	2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
TTDC00018	Inhibitor	2-Methyl-2,4-Pentanediol
TTDC00018	Inhibitor	4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
TTDC00018	Inhibitor	6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
TTDC00018	Inhibitor	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
TTDC00018	Inhibitor	9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
TTDC00018	Inhibitor	9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
TTDC00018	Inhibitor	AT13387
TTDC00018	Inhibitor	Adenosine-5'-Diphosphate
TTDC00018	Inhibitor	Alvespimycin hydrochloride
TTDC00018	Inhibitor	CNF1010
TTDC00018	Inhibitor	GNF-PF-67
TTDC00018	Inhibitor	Geldanamycin
TTDC00018	Inhibitor	IPI-504
TTDC00018	Inhibitor	RHEIN
TTDC00018	Inhibitor	SNX-5422
TTDC00018	Inhibitor	STA-9090
TTDC00018	Inhibitor	Tanespimycin
TTDC00018	Inhibitor	VER-49009
TTDC00018	Inhibitor	ZEARALANONE
TTDC00018	Inhibitor	geldanamycin-estradiol hybrid
TTDC00019	UniProt ID	P08311
TTDC00019	Name	Cathepsin G
TTDC00019	Type of target	Clinical trial target
TTDC00019	Synonyms	CG
TTDC00019	Synonyms	CTSG
TTDC00019	Disease	Alpha 1 Antitrypsin Deficiency
TTDC00019	Disease	Atopic Dermatitis
TTDC00019	Disease	Chronic Obstructive Pulmonary Disease (COPD)
TTDC00019	Sequence	MQPLLLLLAFLLPTGAEAGEIIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQ
TTDC00019	PDB Structure	1AU8; 1CGH; 1KYN; 1T32
TTDC00019	Pathway	Lysosome
TTDC00019	Pathway	Neuroactive ligand-receptor interaction
TTDC00019	Pathway	Renin-angiotensin system
TTDC00019	Pathway	Systemic lupus erythematosus
TTDC00019	EC Number	EC 3.4.21.20
TTDC00019	Target Validation	TTDC00019
TTDC00019	Drug(s)	Dermolastin
TTDC00019	Inhibitor	Aloxistatin
TTDC00019	Inhibitor	Bis-Napthyl Beta-Ketophosphonic Acid
TTDC00019	Inhibitor	CEP-18770
TTDC00019	Inhibitor	Dermolastin
TTDC00019	Inhibitor	JNJ-10311795
TTDC00019	Multitarget	Dermolastin
TTDC00020	UniProt ID	P08648
TTDC00020	Name	Integrin alpha-5
TTDC00020	Type of target	Clinical trial target
TTDC00020	Synonyms	CD49e antigen
TTDC00020	Synonyms	FNRA
TTDC00020	Synonyms	Fibronectin receptor subunit alpha
TTDC00020	Synonyms	ITGA5
TTDC00020	Synonyms	Integrin alpha-5 heavy chain
TTDC00020	Synonyms	Integrin alpha-5 light chain
TTDC00020	Synonyms	Integrin alpha-F
TTDC00020	Synonyms	VLA-5
TTDC00020	Disease	Macular Degeneration
TTDC00020	Sequence	MGSRTPESPLHAVQLRWGPRRRPPLLPLLLLLLPPPPRVGGFNLDAEAPAVLSGPPGSFFGFSVEFYRPGTDGVSVLVGA
TTDC00020	PDB Structure	3VI3; 3VI4
TTDC00020	Pathway	ECM-receptor interaction
TTDC00020	Pathway	Focal adhesion
TTDC00020	Pathway	Hematopoietic cell lineage
TTDC00020	Pathway	Regulation of actin cytoskeleton
TTDC00020	Target Validation	TTDC00020
TTDC00020	Drug(s)	JSM 6427
TTDC00020	Inhibitor	c(-GRGDfL-)
TTDC00020	Antagonist	JSM 6427
TTDC00020	Multitarget	JSM 6427
TTDC00022	UniProt ID	P10242
TTDC00022	Name	mRNA of Myb proto-oncogene protein
TTDC00022	Type of target	Clinical trial target
TTDC00022	Synonyms	C-myb
TTDC00022	Synonyms	MYB
TTDC00022	Disease	Cancer, unspecific
TTDC00022	Disease	Leukemia, Myeloid
TTDC00022	Sequence	MARRPRHSIYSSDEDDEDFEMCDHDYDGLLPKSGKRHLGKTRWTREEDEKLKKLVEQNGTDDWKVIANYLPNRTDVQCQH
TTDC00022	Target Validation	TTDC00022
TTDC00022	Drug(s)	LR3001
TTDC00022	Antisense	LR3001
TTDC00023	UniProt ID	P10253
TTDC00023	Name	Lysosomal alpha-glucosidase
TTDC00023	Type of target	Clinical trial target
TTDC00023	Synonyms	Acid maltase
TTDC00023	Synonyms	Aglucosidase alfa
TTDC00023	Disease	Cardiovascular Disorders (CVD)
TTDC00023	Disease	Diabetes Mellitus Type 2
TTDC00023	Disease	Hepatitis, Viral, C
TTDC00023	Sequence	MGVRHPPCSHRLLAVCALVSLATAALLGHILLHDFLLVPRELSGSSPVLEETHPAHQQGASRPGPRDAQAHPGRPRAVPT
TTDC00023	Pathway	Galactose metabolism
TTDC00023	Pathway	Lysosome
TTDC00023	Pathway	Metabolic pathways
TTDC00023	Pathway	Starch and sucrose metabolism
TTDC00023	EC Number	EC 3.2.1.20
TTDC00023	Target Validation	TTDC00023
TTDC00023	QSAR Model	TTDC00023
TTDC00023	Drug(s)	Celgosivir
TTDC00023	Drug(s)	Glucobay
TTDC00023	Inhibitor	(-)-uniflorine A
TTDC00023	Inhibitor	(R)-2,6-Bis-hydroxymethyl-piperidine-3,4,5-triol
TTDC00023	Inhibitor	2,5-imino-2,5,6-trideoxy-D-manno-heptitol
TTDC00023	Inhibitor	7-O-b-D-Glucopyranosyl-a-homonojirimycin
TTDC00023	Inhibitor	Celgosivir
TTDC00023	Inhibitor	DEOXYNOJIRIMYCIN
TTDC00023	Inhibitor	Glucobay
TTDC00023	Inhibitor	KOTALANOL
TTDC00023	Inhibitor	N-adamantanemethyloxypentyl-1-deoxynojirimycin
TTDC00023	Inhibitor	SALACINOL
TTDC00023	Inhibitor	UNIFLORINE B
TTDC00023	Inhibitor	VALIOLAMINE
TTDC00023	Inhibitor	alpha-7-Deoxyhomonojirimycin
TTDC00023	Inhibitor	alpha-Homonojirimycin
TTDC00024	UniProt ID	P11362
TTDC00024	Name	Basic fibroblast growth factor receptor 1
TTDC00024	Type of target	Clinical trial target
TTDC00024	Synonyms	CD331 antigen
TTDC00024	Synonyms	FGFR-1
TTDC00024	Synonyms	Fms-like tyrosine kinase 2
TTDC00024	Synonyms	bFGF-R
TTDC00024	Synonyms	c-fgr
TTDC00024	Disease	Peripheral Vascular Disease
TTDC00024	Disease	Severe Coronary Heart Disease
TTDC00024	Disease	Solid tumors
TTDC00024	Disease	Ulcers
TTDC00024	Sequence	MWSWKCLLFWAVLVTATLCTARPSPTLPEQAQPWGAPVEVESFLVHPGDLLQLRCRLRDDVQSINWLRDGVQLAESNRTR
TTDC00024	PDB Structure	1AGW; 1CVS; 1EVT; 1FGI; 1FGK; 1FQ9; 1XR0; 2CR3; 2FGI; 3C4F; 3GQI; 3GQL; 3JS2; 3K
TTDC00024	Pathway	Adherens junction
TTDC00024	Pathway	MAPK signaling pathway
TTDC00024	Pathway	Melanoma
TTDC00024	Pathway	Pathways in cancer
TTDC00024	Pathway	Prostate cancer
TTDC00024	Pathway	Regulation of actin cytoskeleton
TTDC00024	EC Number	EC 2.7.10.1
TTDC00024	Target Validation	TTDC00024
TTDC00024	QSAR Model	TTDC00024
TTDC00024	Drug(s)	AZD4547
TTDC00024	Drug(s)	BGJ398
TTDC00024	Drug(s)	Brivanib
TTDC00024	Drug(s)	FGF-1
TTDC00024	Drug(s)	JNJ-42756493
TTDC00024	Drug(s)	Nintedanib
TTDC00024	Drug(s)	SU-6668
TTDC00024	Inhibitor	2-(1H-indazol-3-yl)-1H-benzo[d]imidazole
TTDC00024	Inhibitor	3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine
TTDC00024	Inhibitor	3-Benzimidazol-2-ylhydroquinolin-2-one
TTDC00024	Inhibitor	AAL-993
TTDC00024	Inhibitor	BMS-540215
TTDC00024	Inhibitor	BMS-695735
TTDC00024	Inhibitor	NP-506
TTDC00024	Inhibitor	PD-0166326;PD-166326
TTDC00024	Inhibitor	PD-0173952
TTDC00024	Inhibitor	PD-0173955;PD-17395
TTDC00024	Inhibitor	PD-0173956
TTDC00024	Inhibitor	PD-0173958
TTDC00024	Inhibitor	PD-0179483
TTDC00024	Inhibitor	PD-0180970
TTDC00024	Inhibitor	PD-0183812
TTDC00024	Inhibitor	PD-173074
TTDC00024	Inhibitor	Ro-4396686
TTDC00024	Inhibitor	SEMAXINIB
TTDC00024	Inhibitor	SU-5402
TTDC00024	Inhibitor	SU-6668
TTDC00024	Inhibitor	SU4984
TTDC00024	Binder	FGF-1
TTDC00024	Multitarget	SU-6668
TTDC00025	UniProt ID	P14555
TTDC00025	Name	Phospholipase A2, membrane associated
TTDC00025	Type of target	Clinical trial target
TTDC00025	Synonyms	GIIC sPLA2
TTDC00025	Synonyms	Group IIA phospholipase A2
TTDC00025	Synonyms	NPS-PLA2
TTDC00025	Synonyms	Non-pancreatic secretory phospholipase A2
TTDC00025	Synonyms	PLA2B
TTDC00025	Synonyms	PLA2G2A
TTDC00025	Synonyms	PLA2L
TTDC00025	Synonyms	Phosphatidylcholine 2-acylhydrolase
TTDC00025	Synonyms	RASF-A
TTDC00025	Disease	Atherosclerosis
TTDC00025	Disease	Coronary Artery Disease
TTDC00025	Sequence	MKTLLLLAVIMIFGLLQAHGNLVNFHRMIKLTTGKEAALSYGFYGCHCGVGGRGSPKDATDRCCVTHDCCYKRLEKRGCG
TTDC00025	PDB Structure	1AYP; 1BBC; 1DB4; 1DB5; 1DCY; 1J1A; 1KQU; 1KVO; 1N28; 1N29; 1POD; 1POE; 2GNY; 3U
TTDC00025	Pathway	Arachidonic acid metabolism
TTDC00025	Pathway	Ether lipid metabolism
TTDC00025	Pathway	Fc epsilon RI signaling pathway
TTDC00025	Pathway	Glycerophospholipid metabolism
TTDC00025	Pathway	GnRH signaling pathway
TTDC00025	Pathway	Linoleic acid metabolism
TTDC00025	Pathway	Long-term depression
TTDC00025	Pathway	MAPK signaling pathway
TTDC00025	Pathway	Metabolic pathways
TTDC00025	Pathway	VEGF signaling pathway
TTDC00025	Pathway	Vascular smooth muscle contraction
TTDC00025	Pathway	alpha-Linolenic acid metabolism
TTDC00025	EC Number	EC 3.1.1.4
TTDC00025	Target Validation	TTDC00025
TTDC00025	Drug(s)	Varespladib
TTDC00025	Inhibitor	1,4-Butanediol
TTDC00025	Inhibitor	2-(4-phenoxyphenoxy)ethanamine
TTDC00025	Inhibitor	B-Octylglucoside
TTDC00025	Inhibitor	BOLINAQUINONE
TTDC00025	Inhibitor	CACOSPONGIONOLIDE
TTDC00025	Inhibitor	CACOSPONGIONOLIDE B
TTDC00025	Inhibitor	DIDODECANOYLPHLOROGLUCINOL
TTDC00025	Inhibitor	DYSIDINE
TTDC00025	Inhibitor	Elaidoylamide
TTDC00025	Inhibitor	Isopropyl Alcohol
TTDC00025	Inhibitor	LUFFARIELLOLIDE
TTDC00025	Inhibitor	Lauric Acid
TTDC00025	Inhibitor	MANOALIDE
TTDC00025	Inhibitor	N-Tridecanoic Acid
TTDC00025	Inhibitor	OCHNAFLAVONE
TTDC00025	Inhibitor	Varespladib
TTDC00025	Inhibitor	Varespladib sodium
TTDC00025	Inhibitor	YM-26734
TTDC00025	Inhibitor	cacospongionolide E
TTDC00026	UniProt ID	P14784
TTDC00026	Name	Interleukin-2 receptor subunit beta
TTDC00026	Type of target	Clinical trial target
TTDC00026	Synonyms	CD122
TTDC00026	Synonyms	High affinity IL-2 receptor subunit beta
TTDC00026	Synonyms	IL-2 receptor
TTDC00026	Synonyms	IL2RB
TTDC00026	Synonyms	P70-75
TTDC00026	Synonyms	p75
TTDC00026	Disease	Head and Neck Cancer
TTDC00026	Disease	Lymphoma, Non-Hodgkin's
TTDC00026	Disease	Solid tumors
TTDC00026	Sequence	MAAPALSWRLPLLILLLPLATSWASAAVNGTSQFTCFYNSRANISCVWSQDGALQDTSCQVHAWPDRRRWNQTCELLPVS
TTDC00026	PDB Structure	1ILM; 1ILN; 2B5I; 2ERJ; 3QAZ; 4GS7
TTDC00026	Pathway	Cytokine-cytokine receptor interaction
TTDC00026	Pathway	Jak-STAT signaling pathway
TTDC00026	Target Validation	TTDC00026
TTDC00026	Drug(s)	Medusa IL-2
TTDC00026	Agonist	Medusa IL-2
TTDC00027	UniProt ID	P19113
TTDC00027	Name	Histidine decarboxylase
TTDC00027	Type of target	Clinical trial target
TTDC00027	Synonyms	HDC
TTDC00027	Disease	Skin Infections/Disorders
TTDC00027	Sequence	MMEPEEYRERGREMVDYICQYLSTVRERRVTPDVQPGYLRAQLPESAPEDPDSWDSIFGDIERIIMPGVVHWQSPHMHAY
TTDC00027	PDB Structure	4E1O
TTDC00027	Pathway	Histidine metabolism
TTDC00027	Pathway	Metabolic pathways
TTDC00027	EC Number	EC 4.1.1.22
TTDC00027	Target Validation	TTDC00027
TTDC00027	Drug(s)	BF-Derm1
TTDC00027	Inhibitor	BF-Derm1
TTDC00028	UniProt ID	P20151
TTDC00028	Name	Tissue kallikrein
TTDC00028	Type of target	Clinical trial target
TTDC00028	Synonyms	Glandular kallikrein
TTDC00028	Synonyms	KLK
TTDC00028	Synonyms	Kallikrein
TTDC00028	Synonyms	hGK
TTDC00028	Disease	Alpha 1 Antitrypsin Deficiency
TTDC00028	Disease	Atopic Dermatitis
TTDC00028	Disease	Chronic Obstructive Pulmonary Disease (COPD)
TTDC00028	Sequence	MWDLVLSIALSVGCTGAVPLIQSRIVGGWECEKHSQPWQVAVYSHGWAHCGGVLVHPQWVLTAAHCLKKNSQVWLGRHNL
TTDC00028	EC Number	EC 3.4.21.35
TTDC00028	Target Validation	TTDC00028
TTDC00028	Drug(s)	Dermolastin
TTDC00028	Inhibitor	Dermolastin
TTDC00028	Multitarget	Dermolastin
TTDC00029	UniProt ID	P20594
TTDC00029	Name	Atrial natriuretic peptide receptor B
TTDC00029	Type of target	Clinical trial target
TTDC00029	Synonyms	ANP-B
TTDC00029	Synonyms	ANPRB
TTDC00029	Synonyms	Atrial natriuretic peptide B-type receptor
TTDC00029	Synonyms	GC-B
TTDC00029	Synonyms	Guanylate cyclase B
TTDC00029	Synonyms	NPR-B
TTDC00029	Disease	Crohn's Disease
TTDC00029	Disease	Heart Disease
TTDC00029	Disease	Inflammatory Bowel Disease
TTDC00029	Disease	Myocardial infarction
TTDC00029	Disease	Ulcerative colitis
TTDC00029	Sequence	MALPSLLLLVAALAGGVRPPGARNLTLAVVLPEHNLSYAWAWPRVGPAVALAVEALGRALPVDLRFVSSELEGACSEYLA
TTDC00029	Pathway	Purine metabolism
TTDC00029	Pathway	Vascular smooth muscle contraction
TTDC00029	EC Number	EC 4.6.1.2
TTDC00029	Target Validation	TTDC00029
TTDC00029	Drug(s)	CD-NP
TTDC00029	Activator	CD-NP
TTDC00030	UniProt ID	P21439
TTDC00030	Name	P-glycoprotein
TTDC00030	Type of target	Clinical trial target
TTDC00030	Synonyms	ABCB4
TTDC00030	Synonyms	ATP-binding cassette sub-family B member 4
TTDC00030	Synonyms	MDR3
TTDC00030	Synonyms	Multidrug resistance protein
TTDC00030	Synonyms	P-gp
TTDC00030	Synonyms	PGY3
TTDC00030	Disease	Acute Myeloid Leukemia (AML)
TTDC00030	Sequence	MDLEAAKNGTAWRPTSAEGDFELGISSKQKRKKTKTVKMIGVLTLFRYSDWQDKLFMSLGTIMAIAHGSGLPLMMIVFGE
TTDC00030	EC Number	EC 3.6.3.44
TTDC00030	Target Validation	TTDC00030
TTDC00030	Drug(s)	LY335979
TTDC00030	Inhibitor	LY335979
TTDC00031	UniProt ID	P26010
TTDC00031	Name	Integrin beta-7
TTDC00031	Type of target	Clinical trial target
TTDC00031	Synonyms	Gut homing receptor beta subunit
TTDC00031	Synonyms	ITGB7
TTDC00031	Disease	Rheumatoid arthritis
TTDC00031	Sequence	MVALPMVLVLLLVLSRGESELDAKIPSTGDATEWRNPHLSMLGSCQPAPSCQKCILSHPSCAWCKQLNFTASGEAEARRC
TTDC00031	PDB Structure	2BRQ; 3V4P; 3V4V
TTDC00031	Pathway	Cell adhesion molecules (CAMs)
TTDC00031	Pathway	ECM-receptor interaction
TTDC00031	Pathway	Focal adhesion
TTDC00031	Pathway	Regulation of actin cytoskeleton
TTDC00031	Target Validation	TTDC00031
TTDC00031	Drug(s)	RG7413
TTDC00031	Drug(s)	RhuMAb Beta7
TTDC00031	Drug(s)	Vedolizmab
TTDC00031	Inhibitor	TR-14035
TTDC00031	Antagonist	Vedolizmab
TTDC00031	Antibody	RhuMAb Beta7
TTDC00031	Multitarget	Vedolizmab
TTDC00032	UniProt ID	P29350
TTDC00032	Name	Tyrosine-protein phosphatase non-receptor type 6
TTDC00032	Type of target	Clinical trial target
TTDC00032	Synonyms	Hematopoietic cell protein-tyrosine phosphatase
TTDC00032	Synonyms	PTP-1C
TTDC00032	Synonyms	Protein-tyrosine phosphatase 1C
TTDC00032	Synonyms	Protein-tyrosine phosphatase SHP-1
TTDC00032	Synonyms	SH-PTP1
TTDC00032	Disease	Solid tumors
TTDC00032	Sequence	MVRWFHRDLSGLDAETLLKGRGVHGSFLARPSRKNQGDFSLSVRVGDQVTHIRIQNSGDFYDLYGGEKFATLTELVEYYT
TTDC00032	PDB Structure	1FPR; 1GWZ; 1X6C; 2B3O; 2RMX; 2YU7; 3PS5; 4GRY; 4GRZ; 4GS0; 4HJP; 4HJQ
TTDC00032	Pathway	Adherens junction
TTDC00032	Pathway	B cell receptor signaling pathway
TTDC00032	Pathway	Jak-STAT signaling pathway
TTDC00032	Pathway	Natural killer cell mediated cytotoxicity
TTDC00032	Pathway	T cell receptor signaling pathway
TTDC00032	EC Number	EC 3.1.3.48
TTDC00032	Target Validation	TTDC00032
TTDC00032	Drug(s)	Sodium stibogluconate
TTDC00032	Inhibitor	Sodium stibogluconate
TTDC00033	UniProt ID	P29459
TTDC00033	Name	Interleukin-12
TTDC00033	Type of target	Successful target
TTDC00033	Synonyms	CLMF p35
TTDC00033	Synonyms	Cytotoxic lymphocyte maturation factor 35 kDa subunit
TTDC00033	Synonyms	IL-12
TTDC00033	Synonyms	NK cell stimulatory factor
TTDC00033	Synonyms	NKSF
TTDC00033	Disease	Autoimmune diseases
TTDC00033	Disease	Crohn's Disease
TTDC00033	Disease	Guillain-Barre syndrome
TTDC00033	Disease	Inflammatory diseases
TTDC00033	Disease	Lupus erythematosus
TTDC00033	Disease	Psoriasis and Psoriatic Disorders
TTDC00033	Disease	Rheumatoid arthritis, unspecified
TTDC00033	Sequence	MCPARSLLLVATLVLLDHLSLARNLPVATPDPGMFPCLHHSQNLLRAVSNMLQKARQTLEFYPCTSEEIDHEDITKDKTS
TTDC00033	PDB Structure	1F45; 3HMX
TTDC00033	Pathway	Allograft rejection
TTDC00033	Pathway	Cytokine-cytokine receptor interaction
TTDC00033	Pathway	Jak-STAT signaling pathway
TTDC00033	Pathway	Toll-like receptor signaling pathway
TTDC00033	Pathway	Type I diabetes mellitus
TTDC00033	Related US Patent	6,338,848
TTDC00033	Target Validation	TTDC00033
TTDC00033	Drug(s)	ABT-874
TTDC00033	Drug(s)	STA-5326
TTDC00033	Drug(s)	Ustekinumab
TTDC00033	Inhibitor	STA-5326
TTDC00033	Antibody	ABT-874
TTDC00033	Antibody	Ustekinumab
TTDC00033	Multitarget	Ustekinumab
TTDC00034	UniProt ID	P31391
TTDC00034	Name	Somatostatin receptor type 4
TTDC00034	Type of target	Clinical trial target
TTDC00034	Synonyms	SS4R
TTDC00034	Synonyms	SSTR4
TTDC00034	Disease	Solid tumors
TTDC00034	Sequence	MSAPSTLPPGGEEGLGTAWPSAANASSAPAEAEEAVAGPGDARAAGMVAIQCIYALVCLVGLVGNALVIFVILRYAKMKT
TTDC00034	Pathway	Neuroactive ligand-receptor interaction
TTDC00034	Target Validation	TTDC00034
TTDC00034	Drug(s)	CAP-232
TTDC00034	Inhibitor	Ala11-SRIF-14-amide
TTDC00034	Inhibitor	Ala6-SRIF-14-amide
TTDC00034	Inhibitor	CytotoxinPeptide Conjugate
TTDC00034	Inhibitor	D-Trp8-SRIF-14
TTDC00034	Inhibitor	Des-AA1,2,4,12,13-[D-Trp8]SRIF
TTDC00034	Inhibitor	Des-AA1,2,4,13-[D-Trp8]SRIF
TTDC00034	Inhibitor	Des-AA1,2,4,5,10,12,13-[D-Trp8]SRIF
TTDC00034	Inhibitor	Des-AA1,2,4,5,13-[D-Trp8]-SRIF
TTDC00034	Inhibitor	Des-AA1,2,4,5,6,12,13-[D-Trp8]SRIF
TTDC00034	Inhibitor	Des-AA1,2,4,5-[D-Trp8]SRIF
TTDC00034	Inhibitor	Des-AA1,2,5,12,13-[D-Trp8,IAmp9]SRIF
TTDC00034	Inhibitor	Des-AA1,2,5,12,13-[D-Trp8]SRIF
TTDC00034	Inhibitor	Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Thr12]SRIF
TTDC00034	Inhibitor	Des-AA1,2,5-[D-Trp8,(NalphaMe)IAmp9]SRIF
TTDC00034	Inhibitor	Des-AA1,2,5-[D-Trp8,Tyr11]SRIF
TTDC00034	Inhibitor	Des-AA1,2,5-[IAmp9,Tyr11]-SRIF
TTDC00034	Inhibitor	Des-AA1,5-[Tyr2,D-Trp8,(NalphaMe)IAmp9]Cbm-SRIF
TTDC00034	Inhibitor	Des-AA1,5-[Tyr2,D-Trp8,(NalphaMe)IAmp9]SRIF
TTDC00034	Inhibitor	Des-AA5-[D-Trp8]SRIF
TTDC00034	Inhibitor	ODT-8
TTDC00034	Inhibitor	Pyz11-D-Trp8-SRIF
TTDC00034	Inhibitor	Pyz6-D-Trp8-SRIF
TTDC00034	Inhibitor	Pyz7-D-Trp8-SRIF
TTDC00034	Inhibitor	Radiolabeled octreotide derivative
TTDC00034	Inhibitor	SOMATOSTATIN
TTDC00034	Inhibitor	SRIF-28
TTDC00034	Inhibitor	Somatostatin Analogue
TTDC00034	Agonist	CAP-232
TTDC00034	Multitarget	CAP-232
TTDC00037	UniProt ID	P43115
TTDC00037	Name	Prostaglandin E2 receptor EP3 subtype
TTDC00037	Type of target	Clinical trial target
TTDC00037	Synonyms	PGE receptor, EP3 subtype
TTDC00037	Synonyms	PGE2-R
TTDC00037	Synonyms	Prostanoid EP3 receptor
TTDC00037	Disease	Peripheral Vascular Disease
TTDC00037	Sequence	MKETRGYGGDAPFCTRLNHSYTGMWAPERSAEARGNLTRPPGSGEDCGSVSVAFPITMLLTGFVGNALAMLLVSRSYRRR
TTDC00037	Pathway	Calcium signaling pathway
TTDC00037	Pathway	Neuroactive ligand-receptor interaction
TTDC00037	Target Validation	TTDC00037
TTDC00037	Drug(s)	DG041
TTDC00037	Inhibitor	3-(2-((E)-3-phenylprop-1-enyl)phenyl)acrylic acid
TTDC00037	Inhibitor	3-(2-(4-methoxycinnamyl)phenyl)acrylic acid
TTDC00037	Inhibitor	3-(2-(naphthalen-2-ylmethyl)phenyl)acrylic acid
TTDC00037	Inhibitor	3-(2-cinnamylphenyl)acrylic acid
TTDC00037	Inhibitor	DG-041
TTDC00037	Inhibitor	DINOPROST
TTDC00037	Inhibitor	FR-181157
TTDC00037	Inhibitor	LAROPIPRANT
TTDC00037	Antagonist	DG041
TTDC00038	UniProt ID	P45880
TTDC00038	Name	Voltage-dependent anion-selective channel protein 2
TTDC00038	Type of target	Clinical trial target
TTDC00038	Synonyms	Outer mitochondrial membrane protein porin 2
TTDC00038	Synonyms	VDAC-2
TTDC00038	Synonyms	hVDAC2
TTDC00038	Disease	Solid tumors
TTDC00038	Sequence	MATHGQTCARPMCIPPSYADLGKAARDIFNKGFGFGLVKLDVKTKSCSGVEFSTSGSSNTDTGKVTGTLETKYKWCEYGL
TTDC00038	Pathway	Calcium signaling pathway
TTDC00038	Pathway	Huntington's disease
TTDC00038	Pathway	Parkinson's disease
TTDC00038	Target Validation	TTDC00038
TTDC00038	Drug(s)	PRLX 93936
TTDC00038	Activator	PRLX 93936
TTDC00038	Multitarget	PRLX 93936
TTDC00039	UniProt ID	P48167
TTDC00039	Name	Glycine receptor
TTDC00039	Type of target	Discontinued target
TTDC00039	Synonyms	GLR
TTDC00039	Synonyms	Glycine receptor 58 kDa subunit
TTDC00039	Disease	Tobacco Dependence
TTDC00039	Sequence	MKFLLTTAFLILISLWVEEAYSKEKSSKKGKGKKKQYLCPSQQSAEDLARVPANSTSNILNRLLVSYDPRIRPNFKGIPV
TTDC00039	Pathway	Neuroactive ligand-receptor interaction
TTDC00039	Target Validation	TTDC00039
TTDC00039	Drug(s)	GW 468816
TTDC00039	Drug(s)	GW468816
TTDC00039	Inhibitor	(12E,20Z,18S)-8-hydroxyvariabilin
TTDC00039	Inhibitor	10-methoxy-ginkgolide C
TTDC00039	Inhibitor	3,14-DIDEHYDROGINKGOLIDE A
TTDC00039	Inhibitor	3-demethoxy-3-D-lyxopyranosylaminothiocolchicine
TTDC00039	Inhibitor	3-demethoxy-3-D-mannopyranosylaminothiocolchicine
TTDC00039	Inhibitor	3-demethoxy-3-D-xylopyranosylaminothiocolchicine
TTDC00039	Inhibitor	3-demethoxy-3-L-fucopyranosylaminothiocolchicine
TTDC00039	Inhibitor	3-demethoxy-3D-glucopyranosylaminothiocolchicine
TTDC00039	Inhibitor	GINKGOLIDE A
TTDC00039	Inhibitor	GINKOLIDE B
TTDC00039	Inhibitor	ORG-25543
TTDC00039	Inhibitor	PICROTIN
TTDC00039	Inhibitor	STRYCHNINE
TTDC00039	Inhibitor	THIOCOLCHICOSIDE
TTDC00039	Inhibitor	ginkgolide C
TTDC00039	Inhibitor	ginkgolide J
TTDC00039	Inhibitor	ginkgolide M
TTDC00039	Antagonist	GW 468816
TTDC00039	Antagonist	GW468816
TTDC00039	Antagonist	Gavestinel
TTDC00040	UniProt ID	P49146
TTDC00040	Name	Neuropeptide Y receptor type 2
TTDC00040	Type of target	Clinical trial target
TTDC00040	Synonyms	NPY-Y2 receptor
TTDC00040	Synonyms	NPY2-R
TTDC00040	Synonyms	NPY2R
TTDC00040	Synonyms	Y2 receptor
TTDC00040	Disease	Obesity
TTDC00040	Sequence	MGPIGAEADENQTVEEMKVEQYGPQTTPRGELVPDPEPELIDSTKLIEVQVVLILAYCSIILLGVIGNSLVIHVVIKFKS
TTDC00040	PDB Structure	2IK3
TTDC00040	Pathway	Neuroactive ligand-receptor interaction
TTDC00040	Target Validation	TTDC00040
TTDC00040	Drug(s)	AC-162352
TTDC00040	Drug(s)	BIBO-3304
TTDC00040	Drug(s)	BMS-192548
TTDC00040	Drug(s)	PYY3-36
TTDC00040	Drug(s)	TM30338
TTDC00040	Inhibitor	AcNPY(25-36)
TTDC00040	Inhibitor	AcPYY(22-36)
TTDC00040	Inhibitor	AcPYY(25-36)
TTDC00040	Inhibitor	AcPYY(26-36)
TTDC00040	Inhibitor	Adp[-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00040	Inhibitor	ECONAZOLE NITRATE
TTDC00040	Inhibitor	H-[Trp-Arg-Nva-Arg-Tyr]2-NH2
TTDC00040	Inhibitor	H-[Trp-Arg-Nva-Arg-Tyr]3-NH2
TTDC00040	Inhibitor	LRHYLNLLTRQRY-NH2
TTDC00040	Inhibitor	NEUROPEPTIDE-Y
TTDC00040	Inhibitor	PYY(22-36)
TTDC00040	Inhibitor	PYY(25-36)
TTDC00040	Inhibitor	PYY(3-36)
TTDC00040	Inhibitor	Pim[-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00040	Inhibitor	Sub[-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00040	Inhibitor	Sub[-Tyr-Arg-Leu-Arg-Tyr-NH2]2
TTDC00040	Antagonist	BIBO-3304
TTDC00040	Antagonist	BMS-192548
TTDC00040	Agonist	AC-162352
TTDC00040	Agonist	PYY3-36
TTDC00040	Agonist	TM30338
TTDC00040	Multitarget	TM30338
TTDC00041	UniProt ID	P49190
TTDC00041	Name	Parathyroid hormone receptor
TTDC00041	Type of target	Clinical trial target
TTDC00041	Synonyms	PTH2 receptor
TTDC00041	Synonyms	PTH2R
TTDC00041	Synonyms	PTHR2
TTDC00041	Disease	Menopause
TTDC00041	Disease	Osteoporosis
TTDC00041	Disease	Psoriasis and Psoriatic Disorders
TTDC00041	Sequence	MAGLGASLHVWGWLMLGSCLLARAQLDSDGTITIEEQIVLVLKAKVQCELNITAQLQEGEGNCFPEWDGLICWPRGTVGK
TTDC00041	Pathway	Neuroactive ligand-receptor interaction
TTDC00041	Target Validation	TTDC00041
TTDC00041	Drug(s)	GSK768974
TTDC00041	Drug(s)	Ostabolin-C
TTDC00041	Drug(s)	PTH 1-34
TTDC00041	Agonist	Ostabolin-C
TTDC00041	Agonist	PTH 1-34
TTDC00042	UniProt ID	P50281
TTDC00042	Name	Matrix metalloproteinase-14
TTDC00042	Type of target	Discontinued target
TTDC00042	Synonyms	MMP-14
TTDC00042	Synonyms	MMP-X1
TTDC00042	Synonyms	MMP14
TTDC00042	Synonyms	MT-MMP 1
TTDC00042	Synonyms	MT1-MMP
TTDC00042	Synonyms	MT1MMP
TTDC00042	Synonyms	MTMMP1
TTDC00042	Synonyms	Membrane-type matrix metalloproteinase 1
TTDC00042	Synonyms	Membrane-type-1 matrix metalloproteinase
TTDC00042	Disease	Brain Cancer
TTDC00042	Disease	Hormone-refractory Prostate cancer
TTDC00042	Disease	Kaposi's Sarcoma
TTDC00042	Disease	Lung Cancer
TTDC00042	Disease	Myocardial infarction (MI)
TTDC00042	Disease	Non-small Cell Lung Cancer
TTDC00042	Disease	Osteoarthritis
TTDC00042	Disease	Pancreatic Cancer
TTDC00042	Disease	Prostate cancer
TTDC00042	Sequence	MSPAPRPSRCLLLPLLTLGTALASLGSAQSSSFSPEAWLQQYGYLPPGDLRTHTQRSPQSLSAAIAAMQKFYGLQVTGKA
TTDC00042	PDB Structure	1BQQ; 1BUV; 3C7X; 3MA2
TTDC00042	Pathway	GnRH signaling pathway
TTDC00042	EC Number	EC 3.4.24.80
TTDC00042	Target Validation	TTDC00042
TTDC00042	Inhibitor	2-(4-bromophenylsulfonamido)-N-hydroxyacetamide
TTDC00042	Inhibitor	2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide
TTDC00042	Inhibitor	2-(biphenyl-4-ylsulfonamido)-N-hydroxyacetamide
TTDC00042	Inhibitor	CGS-27023A
TTDC00042	Inhibitor	EPIGALOCATECHIN GALLATE
TTDC00042	Inhibitor	IK-682
TTDC00042	Inhibitor	ILOMASTAT
TTDC00042	Inhibitor	N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide
TTDC00042	Inhibitor	N-hydroxy-2-(4-methoxyphenylsulfonamido)acetamide
TTDC00042	Inhibitor	SR-973
TTDC00042	Inhibitor	UK-356618
TTDC00042	Inhibitor	[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid
TTDC00043	UniProt ID	P50391
TTDC00043	Name	Neuropeptide Y receptor type 4
TTDC00043	Type of target	Clinical trial target
TTDC00043	Synonyms	NPY4-R
TTDC00043	Synonyms	NPY4R
TTDC00043	Synonyms	PP1
TTDC00043	Synonyms	PPYR1
TTDC00043	Synonyms	Pancreatic polypeptide receptor 1
TTDC00043	Disease	Obesity
TTDC00043	Disease	Schizophrenia and Schizoaffective Disorders
TTDC00043	Sequence	MNTSHLLALLLPKSPQGENRSKPLGTPYNFSEHCQDSVDVMVFIVTSYSIETVVGVLGNLCLMCVTVRQKEKANVTNLLI
TTDC00043	PDB Structure	2IK5
TTDC00043	Pathway	Neuroactive ligand-receptor interaction
TTDC00043	Target Validation	TTDC00043
TTDC00043	Drug(s)	TM30338
TTDC00043	Drug(s)	TM30339
TTDC00043	Inhibitor	Adp[-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00043	Inhibitor	H-[Trp-Arg-Nva-Arg-Tyr]2-NH2
TTDC00043	Inhibitor	H-[Trp-Arg-Nva-Arg-Tyr]3-NH2
TTDC00043	Inhibitor	Pim[-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00043	Inhibitor	Sub[-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00043	Inhibitor	Sub[-Tyr-Arg-Leu-Arg-Tyr-NH2]2
TTDC00043	Inhibitor	[Cys-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00043	Agonist	TM30338
TTDC00043	Agonist	TM30339
TTDC00043	Multitarget	TM30338
TTDC00044	UniProt ID	P53778
TTDC00044	Name	MAP kinase p38
TTDC00044	Type of target	Clinical trial target
TTDC00044	Synonyms	ERK-6
TTDC00044	Synonyms	ERK5
TTDC00044	Synonyms	ERK6
TTDC00044	Synonyms	Extracellular signal-regulated kinase 6
TTDC00044	Synonyms	MAP kinase p38 gamma
TTDC00044	Synonyms	MAPK12
TTDC00044	Synonyms	Mitogen-activated protein kinase 12
TTDC00044	Synonyms	Mitogen-activated protein kinase p38 gamma
TTDC00044	Synonyms	SAPK3
TTDC00044	Synonyms	Stress-activated protein kinase 3
TTDC00044	Disease	Analgesics
TTDC00044	Disease	Cancer, unspecific
TTDC00044	Disease	Cardiovascular Disorders
TTDC00044	Disease	Coronary Artery Disease
TTDC00044	Disease	Inflammatory Bowel Disease
TTDC00044	Disease	Inflammatory Disorders, Unspecified
TTDC00044	Disease	Neurologic Disorders
TTDC00044	Disease	Oral Facial Pain
TTDC00044	Disease	Pain, Acute or Chronic
TTDC00044	Disease	Psoriasis and Psoriatic Disorders
TTDC00044	Disease	Rheumatoid arthritis
TTDC00044	Sequence	MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH
TTDC00044	PDB Structure	1CM8
TTDC00044	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDC00044	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDC00044	Pathway	Fc epsilon RI signaling pathway
TTDC00044	Pathway	GnRH signaling pathway
TTDC00044	Pathway	Leukocyte transendothelial migration
TTDC00044	Pathway	MAPK signaling pathway
TTDC00044	Pathway	T cell receptor signaling pathway
TTDC00044	Pathway	Toll-like receptor signaling pathway
TTDC00044	Pathway	VEGF signaling pathway
TTDC00044	EC Number	EC 2.7.11.24
TTDC00044	Target Validation	TTDC00044
TTDC00044	Drug(s)	ARRY-797
TTDC00044	Drug(s)	BIRB 796
TTDC00044	Drug(s)	GSK-681323
TTDC00044	Drug(s)	KC706
TTDC00044	Drug(s)	R1503
TTDC00044	Drug(s)	SB681323
TTDC00044	Drug(s)	SCIO-469
TTDC00044	Drug(s)	SMP-534
TTDC00044	Drug(s)	VX-702
TTDC00044	Drug(s)	VX-745
TTDC00044	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDC00044	Inhibitor	ARRY-797
TTDC00044	Inhibitor	BIRB 796
TTDC00044	Inhibitor	BIRB796
TTDC00044	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDC00044	Inhibitor	CI-1040;PD-18435;PD-184352
TTDC00044	Inhibitor	GF-109203
TTDC00044	Inhibitor	GSK-681323
TTDC00044	Inhibitor	Go-6976
TTDC00044	Inhibitor	KC706
TTDC00044	Inhibitor	KN-62
TTDC00044	Inhibitor	KT-5720
TTDC00044	Inhibitor	LY-294002
TTDC00044	Inhibitor	ML-3163
TTDC00044	Inhibitor	ML-3375
TTDC00044	Inhibitor	ML-3403
TTDC00044	Inhibitor	PD-98059
TTDC00044	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDC00044	Inhibitor	Phosphonothreonine
TTDC00044	Inhibitor	R1503
TTDC00044	Inhibitor	RO-316233
TTDC00044	Inhibitor	RWJ-68354
TTDC00044	Inhibitor	SB-202190
TTDC00044	Inhibitor	SB-203580
TTDC00044	Inhibitor	SB681323
TTDC00044	Inhibitor	SCIO-469
TTDC00044	Inhibitor	SK&F-86002;SK-86002
TTDC00044	Inhibitor	SMP-534
TTDC00044	Inhibitor	STAUROSPORINONE
TTDC00044	Inhibitor	U-0126
TTDC00044	Inhibitor	VK-19911
TTDC00044	Inhibitor	VX-702
TTDC00044	Inhibitor	VX-745
TTDC00045	UniProt ID	P54760
TTDC00045	Name	Ephrin type-B receptor 4
TTDC00045	Type of target	Clinical trial target
TTDC00045	Synonyms	Tyrosine-protein kinase TYRO11
TTDC00045	Synonyms	Tyrosine-protein kinase receptor HTK
TTDC00045	Disease	Lung Cancer
TTDC00045	Disease	Solid tumors
TTDC00045	Sequence	MELRVLLCWASLAAALEETLLNTKLETADLKWVTFPQVDGQWEELSGLDEEQHSVRTYEVCDVQRAPGQAHWLRTGWVPR
TTDC00045	PDB Structure	2BBA; 2E7H; 2HLE; 2QKQ; 2VWU; 2VWV; 2VWW; 2VWX; 2VWY; 2VWZ; 2VX0; 2VX1; 2X9F; 2X
TTDC00045	Pathway	Axon guidance
TTDC00045	EC Number	EC 2.7.10.1
TTDC00045	Target Validation	TTDC00045
TTDC00045	Drug(s)	XL647
TTDC00045	Inhibitor	TG-100435
TTDC00045	Inhibitor	XL647
TTDC00045	Multitarget	XL647
TTDC00046	UniProt ID	Q00653
TTDC00046	Name	Nuclear factor NF-kappa-B
TTDC00046	Type of target	Clinical trial target
TTDC00046	Synonyms	DNA-binding factor KBF2
TTDC00046	Synonyms	H2TF1
TTDC00046	Synonyms	Lymphocyte translocation chromosome 10
TTDC00046	Synonyms	Lyt10
TTDC00046	Synonyms	NFKB2
TTDC00046	Synonyms	Nuclear factor NF-kappa-B p52 subunit
TTDC00046	Synonyms	Oncogene Lyt-10
TTDC00046	Disease	Cancer, unspecific
TTDC00046	Disease	Cystic Fibrosis
TTDC00046	Disease	Kidney Cancer
TTDC00046	Disease	Lymphoma, Unspecified
TTDC00046	Disease	Multiple Myeloma
TTDC00046	Disease	Pediatric
TTDC00046	Disease	Prostate cancer
TTDC00046	Disease	Solid tumors
TTDC00046	Sequence	MESCYNPGLDGIIEYDDFKLNSSIVEPKEPAPETADGPYLVIVEQPKQRGFRFRYGCEGPSHGGLPGASSEKGRKTYPTV
TTDC00046	PDB Structure	1A3Q; 2D96; 3DO7
TTDC00046	Pathway	MAPK signaling pathway
TTDC00046	Pathway	Pathways in cancer
TTDC00046	Target Validation	TTDC00046
TTDC00046	Drug(s)	Curaxin CBLC102
TTDC00046	Drug(s)	GMX1777
TTDC00046	Drug(s)	PG-490-88
TTDC00046	Drug(s)	Sulfasalizine
TTDC00046	Drug(s)	Tyloxapol
TTDC00046	Inhibitor	15-ACETOXY-EREMANTHOLIDE B
TTDC00046	Inhibitor	15-DEOXYBUDLEIN A
TTDC00046	Inhibitor	ACHP
TTDC00046	Inhibitor	AS602868
TTDC00046	Inhibitor	ATRIPLICIOLIDTIGLATE
TTDC00046	Inhibitor	BAY11-7082
TTDC00046	Inhibitor	BUDLEIN A
TTDC00046	Inhibitor	Curaxin CBLC102
TTDC00046	Inhibitor	GMX1777
TTDC00046	Inhibitor	HELENALIN
TTDC00046	Inhibitor	ISOGOIAZENSOLIDE
TTDC00046	Inhibitor	MOLEPHANTIN
TTDC00046	Inhibitor	MOLEPHANTININ
TTDC00046	Inhibitor	PG-490-88
TTDC00046	Inhibitor	SCANDENOLIDE
TTDC00046	Inhibitor	Tyloxapol
TTDC00046	Activator	PS-1145
TTDC00046	Activator	Sulfasalizine
TTDC00046	Multitarget	Curaxin CBLC102
TTDC00048	UniProt ID	Q07820
TTDC00048	Name	Induced myeloid leukemia cell differentiation protein Mcl-1
TTDC00048	Type of target	Clinical trial target
TTDC00048	Synonyms	Bcl-2-related protein EAT/mcl1
TTDC00048	Synonyms	mcl1/EAT
TTDC00048	Disease	Leukemia, Lymphoid
TTDC00048	Disease	Lymphoma, Non-Hodgkin's
TTDC00048	Disease	Prostate cancer
TTDC00048	Sequence	MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPP
TTDC00048	PDB Structure	2KBW; 2NL9; 2NLA; 2PQK; 3D7V; 3IO9; 3KJ0; 3KJ1; 3KJ2; 3KZ0; 3MK8; 3PK1; 3TWU; 4H
TTDC00048	Target Validation	TTDC00048
TTDC00048	Drug(s)	AT-101
TTDC00048	Inhibitor	ALTENUSIN
TTDC00048	Inhibitor	AMENTOFLAVONE
TTDC00048	Inhibitor	AT-101
TTDC00048	Inhibitor	BITHIONOL
TTDC00048	Inhibitor	CEPHALOCHROMIN
TTDC00048	Inhibitor	GNF-PF-1591
TTDC00048	Inhibitor	GNF-PF-3955
TTDC00048	Inhibitor	GNF-PF-5134
TTDC00048	Inhibitor	LIOTHYRONINE SODIUM
TTDC00048	Inhibitor	MORIN
TTDC00048	Inhibitor	NSC-180246
TTDC00048	Inhibitor	NSC-66209
TTDC00048	Inhibitor	QEDIIRNIARHLAQVGDSMDR
TTDC00048	Inhibitor	ROSMARINIC ACID
TTDC00048	Inhibitor	SULFURETIN
TTDC00048	Inhibitor	TW-37
TTDC00048	Multitarget	AT-101
TTDC00049	UniProt ID	Q8NER1
TTDC00049	Name	Transient receptor potential cation channel subfamily V member 1
TTDC00049	Type of target	Clinical trial target
TTDC00049	Synonyms	Capsaicin receptor
TTDC00049	Synonyms	OTRPC1
TTDC00049	Synonyms	Osm-9-like TRP channel 1
TTDC00049	Synonyms	TrpV1
TTDC00049	Synonyms	Vanilloid receptor 1
TTDC00049	Disease	Acute migraine
TTDC00049	Disease	Analgesics
TTDC00049	Disease	Chronic pathological pain
TTDC00049	Disease	Osteoarthritis pain
TTDC00049	Disease	Pain, Acute or Chronic
TTDC00049	Disease	Urinary incontinence
TTDC00049	Sequence	MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSP
TTDC00049	Pathway	Neuroactive ligand-receptor interaction
TTDC00049	Target Validation	TTDC00049
TTDC00049	QSAR Model	TTDC00049
TTDC00049	Drug(s)	A-425619
TTDC00049	Drug(s)	A-993610
TTDC00049	Drug(s)	ABT-102
TTDC00049	Drug(s)	AMG-517
TTDC00049	Drug(s)	AMG-8562
TTDC00049	Drug(s)	AMG-8563
TTDC00049	Drug(s)	AZD1386
TTDC00049	Drug(s)	BCTC
TTDC00049	Drug(s)	Capsaicin
TTDC00049	Drug(s)	GRC-6211
TTDC00049	Drug(s)	NGD-8243
TTDC00049	Drug(s)	Resiniferatoxin
TTDC00049	Drug(s)	SB-705498
TTDC00049	Inhibitor	(5E,8E,11E,14E)-Icosa-5,8,11,14-tetraenal
TTDC00049	Inhibitor	(E)-3-(4-tert-Butyl-phenyl)-N-phenyl-acrylamide
TTDC00049	Inhibitor	(E)-Octadec-9-enal
TTDC00049	Inhibitor	(R)-1-(1H-indazol-4-yl)-3-(1-p-tolylethyl)urea
TTDC00049	Inhibitor	(S)-1-(1H-indazol-4-yl)-3-(1-p-tolylethyl)urea
TTDC00049	Inhibitor	1,3-dibenzyl urea
TTDC00049	Inhibitor	1-(4-Bromo-benzyl)-3-quinazolin-8-yl-urea
TTDC00049	Inhibitor	1-(isoquinolin-5-yl)-3-(1-phenylpropyl)urea
TTDC00049	Inhibitor	1-(isoquinolin-5-yl)-3-(4-morpholinobenzyl)urea
TTDC00049	Inhibitor	1-benzhydryl-3-(isoquinolin-5-yl)urea
TTDC00049	Inhibitor	2-(4-pentylphenyl)-N-(pyridin-3-yl)acetamide
TTDC00049	Inhibitor	4-(3-methylpyridin-2-yl)-N-p-tolylbenzamide
TTDC00049	Inhibitor	4-(butyl(methyl)amino)-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-(cyclohexylamino)-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-(hexyl(methyl)amino)-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-(methyl(nonyl)amino)-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-(methyl(octyl)amino)-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-Pyridin-2-yl-piperazine-1-carboxylic acid amide
TTDC00049	Inhibitor	4-butyl-N-(7-hydroxynaphthalen-1-yl)benzamide
TTDC00049	Inhibitor	4-butyl-N-(isoquinolin-5-yl)benzamide
TTDC00049	Inhibitor	4-butyl-N-(pyridin-3-yl)benzamide
TTDC00049	Inhibitor	4-butyl-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-butyl-N-phenylbenzamide
TTDC00049	Inhibitor	4-decyl-N-(pyridin-3-yl)benzamide
TTDC00049	Inhibitor	4-heptyl-N-(pyridin-3-yl)benzamide
TTDC00049	Inhibitor	4-heptyl-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-hexyl-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-nonyl-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-octyl-N-(pyridin-3-yl)benzamide
TTDC00049	Inhibitor	4-octyl-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-pentyl-N-pyridin-3-yl benzamide
TTDC00049	Inhibitor	4-propyl-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	4-tert-butyl-N-(quinolin-3-yl)benzamide
TTDC00049	Inhibitor	6'-Iodononivamide
TTDC00049	Inhibitor	A-795614
TTDC00049	Inhibitor	AMG-628
TTDC00049	Inhibitor	ATC-120
TTDC00049	Inhibitor	CAPSAZEPINE
TTDC00049	Inhibitor	IODORESINIFERATOXIN
TTDC00049	Inhibitor	JNJ-17203212
TTDC00049	Inhibitor	MK-056
TTDC00049	Inhibitor	N-(4-iodophenyl)-4-(trifluoromethoxy)benzamide
TTDC00049	Inhibitor	N-(4-iodophenyl)-4-(trifluoromethyl)benzamide
TTDC00049	Inhibitor	N-(4-tert-butylphenyl)-4-(pyridin-2-yl)benzamide
TTDC00049	Inhibitor	N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]lauramide
TTDC00049	Inhibitor	N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]linoleamide
TTDC00049	Inhibitor	N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]undecanamide
TTDC00049	Inhibitor	N-methyl-4-pentyl-N-(pyridin-3-yl)benzamide
TTDC00049	Inhibitor	Pyrrolidin-1-yl-thiourea
TTDC00049	Inhibitor	SB-782443
TTDC00049	Inhibitor	SC-0030;SC0030
TTDC00049	Blocker	A-425619
TTDC00049	Blocker	A-993610
TTDC00049	Blocker	ABT-102
TTDC00049	Blocker	AMG-517
TTDC00049	Blocker	AMG-8562
TTDC00049	Blocker	AMG-8563
TTDC00049	Blocker	AZD1386
TTDC00049	Blocker	BCTC
TTDC00049	Blocker	GRC-6211
TTDC00049	Blocker	NGD-8243
TTDC00049	Blocker	SB-705498
TTDC00049	Activator	Capsaicin
TTDC00049	Activator	Resiniferatoxin
TTDC00050	UniProt ID	Q8TDV5
TTDC00050	Name	Glucose-dependent insulinotropic receptor
TTDC00050	Type of target	Clinical trial target
TTDC00050	Synonyms	G-protein coupled receptor 119
TTDC00050	Disease	Diabetes Mellitus Type 2
TTDC00050	Sequence	MESSFSFGVILAVLASLIIATNTLVAVAVLLLIHKNDGVSLCFTLNLAVADTLIGVAISGLLTDQLSSPSRPTQKTLCSL
TTDC00050	Target Validation	TTDC00050
TTDC00050	Drug(s)	APD668
TTDC00050	Drug(s)	PSN821
TTDC00050	Agonist	APD668
TTDC00050	Agonist	PSN821
TTDC00051	UniProt ID	Q8WW43
TTDC00051	Name	Gamma-secretase
TTDC00051	Type of target	Clinical trial target
TTDC00051	Synonyms	APH
TTDC00051	Synonyms	Aph-1beta
TTDC00051	Synonyms	PSFL
TTDC00051	Synonyms	Presenilin-stabilization factor-like
TTDC00051	Disease	Alzheimer's Disease
TTDC00051	Sequence	MTAAVFFGCAFIAFGPALALYVFTIATEPLRIIFLIAGAFFWLVSLLISSLVWFMARVIIDNKDGPTQKYLLIFGAFVSV
TTDC00051	Target Validation	TTDC00051
TTDC00051	Drug(s)	E2012
TTDC00051	Inhibitor	(2S,3R)-2-(benzyloxy)-3-methoxycyclohexanone
TTDC00051	Inhibitor	(5R,6S)-5,6-bis(benzyloxy)cyclohex-2-enone
TTDC00051	Inhibitor	(5R,6S)-6-(benzyloxy)-5-methoxycyclohex-2-enone
TTDC00051	Inhibitor	(S)-FLURBIPROFEN
TTDC00051	Inhibitor	1-benzoyl-2-benzyl-1,2-dihydropyridin-3(6H)-one
TTDC00051	Inhibitor	311383
TTDC00051	Inhibitor	311440
TTDC00051	Inhibitor	311951
TTDC00051	Inhibitor	311952
TTDC00051	Inhibitor	R-flurbiprofen
TTDC00051	Modulator	E2012
TTDC00052	UniProt ID	Q96EB6
TTDC00052	Name	NAD-dependent deacetylase sirtuin-1
TTDC00052	Type of target	Clinical trial target
TTDC00052	Synonyms	SIR2-like protein 1
TTDC00052	Synonyms	SIR2L1
TTDC00052	Synonyms	SIRT1
TTDC00052	Synonyms	hSIR2
TTDC00052	Synonyms	hSIRT1
TTDC00052	Disease	Diabetes Mellitus Type 2
TTDC00052	Disease	Neurologic Disorders
TTDC00052	Sequence	MADEAALALQPGGSPSAAGADREAASSPAGEPLRKRPRRDGPGLERSPGEPGGAAPEREVPAAARGCPGAAAAALWREAE
TTDC00052	PDB Structure	4I5I
TTDC00052	EC Number	EC 3.5.1.-
TTDC00052	Target Validation	TTDC00052
TTDC00052	Drug(s)	2245840
TTDC00052	Drug(s)	GSK184072
TTDC00052	Drug(s)	GSK2245840
TTDC00052	Drug(s)	SRT2104
TTDC00052	Drug(s)	SRT2379
TTDC00052	Drug(s)	SRT3025
TTDC00052	Drug(s)	SRT501
TTDC00052	Inhibitor	(R)-sirtinol
TTDC00052	Inhibitor	(S)-sirtinol
TTDC00052	Inhibitor	2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide
TTDC00052	Inhibitor	2H-chromeno[2,3-d]pyrimidine-2,4(3H)-dione
TTDC00052	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDC00052	Inhibitor	CAMBINOL
TTDC00052	Inhibitor	RO-316233
TTDC00052	Inhibitor	meta-sirtinol
TTDC00052	Inhibitor	para-sirtinol
TTDC00052	Activator	GSK184072
TTDC00052	Activator	GSK2245840
TTDC00052	Binder	SRT501
TTDC00053	UniProt ID	Q96IY4
TTDC00053	Name	Carboxypeptidase B2
TTDC00053	Type of target	Discontinued target
TTDC00053	Synonyms	CPU
TTDC00053	Synonyms	Carboxypeptidase U
TTDC00053	Synonyms	Plasma carboxypeptidase B
TTDC00053	Synonyms	TAFI
TTDC00053	Synonyms	Thrombin-activable fibrinolysis inhibitor
TTDC00053	Synonyms	pCPB
TTDC00053	Disease	Thrombosis
TTDC00053	Sequence	MKLCSLAVLVPIVLFCEQHVFAFQSGQVLAALPRTSRQVQVLQNLTTTYEIVLWQPVTADLIVKKKQVHFFVNASDVDNV
TTDC00053	PDB Structure	3D66; 3D67; 3D68; 3LMS
TTDC00053	Pathway	Complement and coagulation cascades
TTDC00053	EC Number	EC 3.4.17.20
TTDC00053	Target Validation	TTDC00053
TTDC00053	Drug(s)	AZD-9684
TTDC00053	Inhibitor	(+/-)-5-amino-2-(mercaptomethyl)pentanoic acid
TTDC00053	Inhibitor	2-(3-aminophenyl)-3-mercaptopropanoic acid
TTDC00053	Inhibitor	2-(3-guanidinophenyl)-3-mercaptopropanoic acid
TTDC00053	Inhibitor	2-(4-benzoylpiperidine-1-carbonyl)benzoic acid
TTDC00053	Inhibitor	3-mercapto-2-(piperidin-3-yl)propanoic acid
TTDC00053	Inhibitor	3-mercapto-2-(piperidin-4-yl)propanoic acid
TTDC00053	Inhibitor	6-Amino-2-(1H-imidazol-4-yl)-hexanoic acid
TTDC00053	Inhibitor	AZD-9684
TTDC00053	Inhibitor	DL-benzylsuccinic acid
TTDC00053	Inhibitor	DL-guanidinoethylmercaptosuccinic acid
TTDC00053	Inhibitor	SQ-24798
TTDC00053	Inhibitor	UK-396082
TTDC00054	UniProt ID	Q96KS0
TTDC00054	Name	Hypoxia-inducible factor-prolyl hydroxylase
TTDC00054	Type of target	Clinical trial target
TTDC00054	Synonyms	EGLN2
TTDC00054	Synonyms	EIT6
TTDC00054	Synonyms	Egl nine homolog 2
TTDC00054	Synonyms	Estrogen-induced tag 6
TTDC00054	Synonyms	HIF-PH
TTDC00054	Synonyms	HIF-PH1
TTDC00054	Synonyms	HIF-prolyl hydroxylase 1
TTDC00054	Synonyms	HPH-3
TTDC00054	Synonyms	Hypoxia-inducible factor prolyl hydroxylase 1
TTDC00054	Synonyms	PHD1
TTDC00054	Synonyms	Prolyl hydroxylase domain-containing protein 1
TTDC00054	Disease	Anemia
TTDC00054	Disease	Kidney Disease
TTDC00054	Sequence	MDSPCQPQPLSQALPQLPGSSSEPLEPEPGRARMGVESYLPCPLLPSYHCPGVPSEASAGSGTPRATATSTTASPLRDGF
TTDC00054	EC Number	EC 1.14.11.-
TTDC00054	Target Validation	TTDC00054
TTDC00054	Drug(s)	BAY 85-3934
TTDC00054	Drug(s)	FG-2216
TTDC00054	Drug(s)	FG-4592
TTDC00054	Drug(s)	GSK1278863
TTDC00054	Inhibitor	2-(carboxymethylamino)-2-oxoacetic acid
TTDC00054	Inhibitor	FG-2216
TTDC00054	Inhibitor	FG-4592
TTDC00054	Inhibitor	GSK1278863
TTDC00054	Inhibitor	pyridine-2,4-dicarboxylic acid
TTDC00055	UniProt ID	Q99973
TTDC00055	Name	Telomerase protein component 1
TTDC00055	Type of target	Clinical trial target
TTDC00055	Synonyms	Telomerase protein 1
TTDC00055	Synonyms	Telomerase-associated protein 1
TTDC00055	Synonyms	p240
TTDC00055	Synonyms	p80 telomerase homolog
TTDC00055	Disease	Leukemia, Lymphoid
TTDC00055	Disease	Multiple Myeloma
TTDC00055	Disease	Solid tumors
TTDC00055	Sequence	MEKLHGHVSAHPDILSLENRCLAMLPDLQPLEKLHQHVSTHSDILSLKNQCLATLPDLKTMEKPHGYVSAHPDILSLENQ
TTDC00055	Target Validation	TTDC00055
TTDC00055	Drug(s)	GRN163L
TTDC00055	Inhibitor	GRN163L
TTDC00056	UniProt ID	Q9NR97
TTDC00056	Name	Toll-like receptor 8
TTDC00056	Type of target	Clinical trial target
TTDC00056	Synonyms	CD288 antigen
TTDC00056	Synonyms	TLR8
TTDC00056	Disease	Genital warts
TTDC00056	Disease	Systemic Lupus Erythematosus (SLE)
TTDC00056	Sequence	MENMFLQSSMLTCIFLLISGSCELCAEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITN
TTDC00056	PDB Structure	3W3G; 3W3J; 3W3K; 3W3L; 3W3M; 3W3N
TTDC00056	Pathway	Toll-like receptor signaling pathway
TTDC00056	Target Validation	TTDC00056
TTDC00056	Drug(s)	CPG 52364
TTDC00056	Drug(s)	Resiquimod
TTDC00056	Antagonist	CPG 52364
TTDC00056	Agonist	Resiquimod
TTDC00056	Multitarget	CPG 52364
TTDC00057	UniProt ID	Q9NXE4
TTDC00057	Name	Sphingomyelin phosphodiesterase 4
TTDC00057	Type of target	Clinical trial target
TTDC00057	Synonyms	KIAA1418
TTDC00057	Synonyms	Neutral sphingomyelinase 3
TTDC00057	Synonyms	Neutral sphingomyelinase III
TTDC00057	Synonyms	SMPD4
TTDC00057	Synonyms	nSMase-3
TTDC00057	Synonyms	nSMase3
TTDC00057	Disease	Depression
TTDC00057	Sequence	MAFPHLQQPSFLLASLKADSINKPFAQQCQDLVKVIEDFPAKELHTIFPWLVESIFGSLDGVLVGWNLRCLQGRVNPVEY
TTDC00057	Pathway	Metabolic pathways
TTDC00057	Pathway	Sphingolipid metabolism
TTDC00057	EC Number	EC 3.1.4.12
TTDC00057	Target Validation	TTDC00057
TTDC00057	Drug(s)	ND1251
TTDC00057	Inhibitor	ND1251
TTDC00058	UniProt ID	Q9NYA1
TTDC00058	UniProt ID	Q9NRA0
TTDC00058	Name	Sphingosine kinase
TTDC00058	Name	Sphingosine kinase 2
TTDC00058	Type of target	Clinical trial target
TTDC00058	Type of target	Clinical trial target
TTDC00058	Synonyms	SK
TTDC00058	Synonyms	SPHK
TTDC00058	Synonyms	SPK
TTDC00058	Synonyms	SK 2; SPK 2; SPHK2;
TTDC00058	Disease	Late-Stage Ovarian cancer
TTDC00058	Disease	Prostate cancer
TTDC00058	Function	Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SP
TTDC00058	Sequence	MDPAGGPRGVLPRPCRVLVLLNPRGGKGKALQLFRSHVQPLLAEAEISFTLMLTERRNHARELVRSEELGRWDALVVMSG
TTDC00058	PDB Structure	3VZB; 3VZC; 3VZD
TTDC00058	EC Number	EC 2.7.1.91
TTDC00058	EC Number	EC 2.7.1.91
TTDC00058	Target Validation	TTDC00058
TTDC00058	Drug(s)	Phenoxodiol
TTDC00058	Drug(s)	
TTDC00058	Inhibitor	(R)-2-amino-3-(4-octylphenylamino)propan-1-ol
TTDC00058	Inhibitor	(R)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide
TTDC00058	Inhibitor	(S)-2-amino-4-hydroxy-N-(4-octylphenyl)butanamide
TTDC00058	Inhibitor	(S)-2-amino-6-hydroxy-N-(4-octylphenyl)hexanamide
TTDC00058	Inhibitor	DIMETHYLSPINGOSINE
TTDC00058	Inhibitor	Phenoxodiol
TTDC00059	UniProt ID	Q9UQB9
TTDC00059	Name	Serine/threonine-protein kinase 13
TTDC00059	Type of target	Clinical trial target
TTDC00059	Synonyms	Aurora-C
TTDC00059	Synonyms	Aurora/Ipl1-related kinase 3
TTDC00059	Synonyms	Aurora/Ipl1/Eg2 protein 2
TTDC00059	Disease	Leukemia, Myeloid
TTDC00059	Disease	Solid tumors
TTDC00059	Sequence	MSSPRAVVQLGKAQPAGEELATANQTAQQPSSPAMRRLTVDDFEIGRPLGKGKFGNVYLARLKESHFIVALKVLFKSQIE
TTDC00059	EC Number	EC 2.7.11.1
TTDC00059	Target Validation	TTDC00059
TTDC00059	Drug(s)	AMG 900
TTDC00059	Drug(s)	GSK1070916
TTDC00059	Drug(s)	GSK1070916A
TTDC00059	Drug(s)	SNS-314
TTDC00059	Inhibitor	6-bromoindirubin-3-oxime
TTDC00059	Inhibitor	7-bromoindirubin-3-acetoxime
TTDC00059	Inhibitor	7-bromoindirubin-3-oxime
TTDC00059	Inhibitor	7-chloroindirubin-3-oxime
TTDC00059	Inhibitor	7-fluoroindirubin-3-acetoxime
TTDC00059	Inhibitor	7-fluoroindirubin-3-oxime
TTDC00059	Inhibitor	7-iodoindirubin-3-oxime
TTDC00059	Inhibitor	AZD-1152-HQPA;Barasertib
TTDC00059	Inhibitor	GSK-1070916
TTDC00059	Inhibitor	GSK1070916
TTDC00059	Inhibitor	PHA-680632
TTDC00059	Inhibitor	SNS-314
TTDC00059	Inhibitor	SU 6656
TTDC00059	Inhibitor	indirubin-3-acetoxime
TTDC00059	Inhibitor	indirubin-3-methoxime
TTDC00059	Inhibitor	indirubin-3-oxime
TTDC00059	Multitarget	GSK1070916
TTDC00059	Multitarget	SNS-314
TTDC00060	UniProt ID	Q9Y251
TTDC00060	Name	Heparanase
TTDC00060	Type of target	Successful target
TTDC00060	Synonyms	Endo-glucoronidase
TTDC00060	Synonyms	HEP
TTDC00060	Synonyms	HPA
TTDC00060	Synonyms	HPR1
TTDC00060	Synonyms	HPSE
TTDC00060	Synonyms	HPSE1
TTDC00060	Synonyms	HSE1
TTDC00060	Synonyms	Heparanase 50 kDa subunit
TTDC00060	Synonyms	Heparanase 8 kDa subunit
TTDC00060	Synonyms	Heparanase-1
TTDC00060	Synonyms	Hpa1
TTDC00060	Disease	Hepatocellular Cancer Following Curative Resection
TTDC00060	Disease	Lung Cancer
TTDC00060	Disease	Prostate cancer
TTDC00060	Sequence	MLLRSKPALPPPLMLLLLGPLGPLSPGALPRPAQAQDVVDLDFFTQEPLHLVSPSFLSVTIDANLATDPRFLILLGSPKL
TTDC00060	Pathway	Glycosaminoglycan degradation
TTDC00060	Pathway	Metabolic pathways
TTDC00060	EC Number	EC 3.2.-.-
TTDC00060	Target Validation	TTDC00060
TTDC00060	Drug(s)	PI-88
TTDC00060	Inhibitor	PI-88
TTDC00061	UniProt ID	Q9Y277
TTDC00061	Name	Voltage-dependent anion-selective channel protein 3
TTDC00061	Type of target	Clinical trial target
TTDC00061	Synonyms	Outer mitochondrial membrane protein porin 3
TTDC00061	Synonyms	VDAC-3
TTDC00061	Synonyms	VDAC3
TTDC00061	Synonyms	hVDAC3
TTDC00061	Disease	Solid tumors
TTDC00061	Sequence	MCNTPTYCDLGKAAKDVFNKGYGFGMVKIDLKTKSCSGVEFSTSGHAYTDTGKASGNLETKYKVCNYGLTFTQKWNTDNT
TTDC00061	Pathway	Calcium signaling pathway
TTDC00061	Pathway	Huntington's disease
TTDC00061	Pathway	Parkinson's disease
TTDC00061	Target Validation	TTDC00061
TTDC00061	Drug(s)	PRLX 93936
TTDC00061	Activator	PRLX 93936
TTDC00061	Multitarget	PRLX 93936
TTDC00062	UniProt ID	P20292
TTDC00062	Name	5-lipoxygenase activating protein
TTDC00062	Type of target	Clinical trial target
TTDC00062	Synonyms	FLAP
TTDC00062	Synonyms	MK-886-binding protein
TTDC00062	Disease	Arthritis
TTDC00062	Disease	Asthma
TTDC00062	Disease	Cardiovascular Disorders
TTDC00062	Disease	Coronary Artery Disease and Heart Attack
TTDC00062	Disease	Inflammatory Disorders, Unspecified
TTDC00062	Disease	Psoriasis
TTDC00062	Function	Seems to be required for the activation of 5-lo (5- lipoxygenase). Flap could pl
TTDC00062	Sequence	MDQETVGNVVLLAIVTLISVVQNGFFAHKVEHESRTQNGRSFQRTGTLAFERVYTANQNCVDAYPTFLAVLWSAGLLCSQ
TTDC00062	PDB Structure	2Q7M; 2Q7R
TTDC00062	BioChemical Class	Transmembrane protein
TTDC00062	Target Validation	TTDC00062
TTDC00062	Drug(s)	2190915
TTDC00062	Drug(s)	AM103
TTDC00062	Drug(s)	AM803
TTDC00062	Drug(s)	DG031
TTDC00062	Drug(s)	GSK2190915
TTDC00062	Inhibitor	AM103
TTDC00062	Inhibitor	AM803
TTDC00062	Inhibitor	DG031
TTDC00062	Inhibitor	GSK2190915
TTDC00062	Inhibitor	L-671,480
TTDC00062	Inhibitor	L-674,573
TTDC00062	Inhibitor	L-689,037
TTDC00062	Inhibitor	MK-886
TTDC00063	UniProt ID	P29475
TTDC00063	Name	Nitric-oxide synthase, brain
TTDC00063	Type of target	Clinical trial target
TTDC00063	Synonyms	BNOS
TTDC00063	Synonyms	Constitutive NOS
TTDC00063	Synonyms	N-NOS
TTDC00063	Synonyms	NC-NOS
TTDC00063	Synonyms	NNOS
TTDC00063	Synonyms	NOS, type I
TTDC00063	Synonyms	Neuronal NOS
TTDC00063	Disease	Helminth infection
TTDC00063	Disease	Migraine and Cluster Headaches
TTDC00063	Disease	Schizophrenia
TTDC00063	Function	Produces nitric oxide (no) which is a messenger molecule with diverse functions
TTDC00063	Sequence	MEDHMFGVQQIQPNVISVRLFKRKVGGLGFLVKERVSKPPVIISDLIRGGAAEQSGLIQAGDIILAVNGRPLVDLSYDSA
TTDC00063	BioChemical Class	Oxidoreductases acting on paired donors
TTDC00063	Pathway	Alzheimer's disease
TTDC00063	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDC00063	Pathway	Arginine and proline metabolism
TTDC00063	Pathway	Calcium signaling pathway
TTDC00063	Pathway	Long-term depression
TTDC00063	Pathway	Metabolic pathways
TTDC00063	Pathway	Pathways in cancer
TTDC00063	Pathway	Small cell lung cancer
TTDC00063	EC Number	EC 1.14.13.39
TTDC00063	Related US Patent	6,225,305
TTDC00063	Related US Patent	6,297,276
TTDC00063	Related US Patent	6,344,473
TTDC00063	Related US Patent	6,344,483
TTDC00063	Related US Patent	6,355,689
TTDC00063	Related US Patent	6,362,195
TTDC00063	Related US Patent	6,372,733
TTDC00063	Related US Patent	6,391,887
TTDC00063	Related US Patent	6,403,830
TTDC00063	Related US Patent	6,410,542
TTDC00063	Related US Patent	6,451,821
TTDC00063	Related US Patent	6,465,518
TTDC00063	Related US Patent	6,465,686
TTDC00063	Related US Patent	6,495,606
TTDC00063	Related US Patent	6,525,051
TTDC00063	Related US Patent	6,545,170
TTDC00063	Related US Patent	6,552,052
TTDC00063	Related US Patent	6,576,780
TTDC00063	Related US Patent	6,579,883
TTDC00063	Related US Patent	6,586,471
TTDC00063	Related US Patent	6,586,474
TTDC00063	Related US Patent	6,620,848
TTDC00063	Related US Patent	6,670,473
TTDC00063	Target Validation	TTDC00063
TTDC00063	Drug(s)	NXN-188
TTDC00063	Inhibitor	((E)-7-But-2-enyl)-azepan-(2Z)-ylideneamine
TTDC00063	Inhibitor	(+/-)-2-Methyl-1-(1-phenylethyl)-1H-imidazole
TTDC00063	Inhibitor	(4S,5R)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	(4S,5R)-4,5-Dimethyl-oxazolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	(4S,5S)-4,5-Diethyl-oxazolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	(5-Imino-[1,4]thiazepan-3-yl)-methanol
TTDC00063	Inhibitor	(5S,6R)-[Octahydro-quinolin-(2E)-ylidene]amine
TTDC00063	Inhibitor	(5S,6S)-[Octahydro-quinolin-(2E)-ylidene]amine
TTDC00063	Inhibitor	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
TTDC00063	Inhibitor	(R)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	(S)-2-Amino-5-(N-methyl-guanidino)-pentanoic acid
TTDC00063	Inhibitor	(S)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	(S)-6-Amino-2-(2-imino-ethylamino)-hexanoic acid
TTDC00063	Inhibitor	1-(2-amino-benzothiazol-5-yl)-2-ethyl-isothiourea
TTDC00063	Inhibitor	1-(2-amino-benzothiazol-6-yl)-2-ethyl-isothiourea
TTDC00063	Inhibitor	1-(Benzhydrylamino)ethaniminium bromide
TTDC00063	Inhibitor	1-Benzyl-2-methyl-1H-imidazole
TTDC00063	Inhibitor	1-[(3-Methoxybenzyl)amino]ethaniminium chloride
TTDC00063	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDC00063	Inhibitor	2-(2-Amino-ethyl)-7-imino-azepane
TTDC00063	Inhibitor	2-Amino-5-(N-nitro-guanidino)-pentanoic acid
TTDC00063	Inhibitor	2-Methyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	2-amino-4,6-dimethylpyridine
TTDC00063	Inhibitor	2-aminopyridine
TTDC00063	Inhibitor	3,4-Dihydro-1H-quinolin-(2E)-ylideneamine
TTDC00063	Inhibitor	3,4-Dimethyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	3-(2-Amino-ethyl)-5-imino-[1,4]oxazepane
TTDC00063	Inhibitor	3-(2-Nitro-ethyl)-[1,4]oxazepan-(5Z)-ylideneamine
TTDC00063	Inhibitor	3-Bromo-1H-indazole-7-carbonitrile
TTDC00063	Inhibitor	3-Bromo-7-Nitroindazole
TTDC00063	Inhibitor	3-Butyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	3-Ethyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	3-Isobutyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	3-Methyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	3-Methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	3-Propyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	3-bromo-7-nitro-1H-indazole
TTDC00063	Inhibitor	4,5,6,7-tetrafluoro-3-methyl-1H-indazole
TTDC00063	Inhibitor	4,5-Dimethyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	4-Butyl-thiazolidin-(2E)-ylideneamine
TTDC00063	Inhibitor	4-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	4-Ethyl-5-methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	4-Ethyl-oxazolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	4-Ethyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	4-Isopropyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	4-Methyl-5-propyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	4-Methyl-oxazolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	4-Methyl-piperidin-(2E)-ylideneamine
TTDC00063	Inhibitor	4-Methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	4-[(2-Methyl-1H-imidazol-1-yl)methyl]pyridine
TTDC00063	Inhibitor	4-bromo-1H-indazole
TTDC00063	Inhibitor	4-chloro-1H-indazole
TTDC00063	Inhibitor	4-iodo-1H-indazole
TTDC00063	Inhibitor	4-methyl-6-propylpyridin-2-amine
TTDC00063	Inhibitor	4-methylpyridin-2-amine
TTDC00063	Inhibitor	5-Bromomethyl-oxazolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	5-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	5-Ethyl-4-methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	5-Ethyl-4-propyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	5-Ethyl-oxazolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	5-Methyl-oxazolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	5-Methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	5-N-Allyl-Arginine
TTDC00063	Inhibitor	5-bromo-1H-indazole
TTDC00063	Inhibitor	5-chloro-1H-indazole
TTDC00063	Inhibitor	5-iodo-1H-indazole
TTDC00063	Inhibitor	6-(2-Fluoropropyl)-4-methylpyridin-2-amine
TTDC00063	Inhibitor	6-(3-Fluoropropyl)-4-methylpyridin-2-amine
TTDC00063	Inhibitor	6-bromo-1H-indazole
TTDC00063	Inhibitor	6-chloro-1H-indazole
TTDC00063	Inhibitor	6-isobutyl-4-methylpyridin-2-amine
TTDC00063	Inhibitor	7-(2-Nitro-ethyl)-azepan-(2Z)-ylideneamine
TTDC00063	Inhibitor	7-Butyl-azepan-(2Z)-ylideneamine
TTDC00063	Inhibitor	7-Methoxy-1H-indazole
TTDC00063	Inhibitor	7-Methyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	7-bromo-1H-indazole
TTDC00063	Inhibitor	7-chloro-1H-indazole
TTDC00063	Inhibitor	7-nitro-1H-indazole
TTDC00063	Inhibitor	AR-C102222
TTDC00063	Inhibitor	AR-C133057XX
TTDC00063	Inhibitor	Acetate Ion
TTDC00063	Inhibitor	Alpha-D-Mannose
TTDC00063	Inhibitor	Azepan-(2Z)-ylideneamine
TTDC00063	Inhibitor	Azocan-(2Z)-ylideneamine
TTDC00063	Inhibitor	Azonan-(2Z)-ylideneamine
TTDC00063	Inhibitor	EUSYNSTYELAMIDE B
TTDC00063	Inhibitor	Eusynstyelamide C
TTDC00063	Inhibitor	Flavin-Adenine Dinucleotide
TTDC00063	Inhibitor	Formic Acid
TTDC00063	Inhibitor	Heme
TTDC00063	Inhibitor	Hexahydro-cyclopenta[b]pyrrol-(2Z)-ylideneamine
TTDC00063	Inhibitor	Hexahydro-cyclopenta[c]pyrrol-(1Z)-ylideneamine
TTDC00063	Inhibitor	Hexahydro-pyrrolizin-(3E)-ylideneamine
TTDC00063	Inhibitor	L-NIO
TTDC00063	Inhibitor	L-Nw-nitroarginine
TTDC00063	Inhibitor	N*1*-(5-Methyl-2-nitro-phenyl)-butane-1,4-diamine
TTDC00063	Inhibitor	N-(3-(Aminomethyl)Benzyl)Acetamidine
TTDC00063	Inhibitor	N-(3-(aminomethyl)-benzyl)acetamidine
TTDC00063	Inhibitor	N-(5-Amino-6-oxo-heptyl)-acetamidine
TTDC00063	Inhibitor	N-Butyl-N'-Hydroxyguanidine
TTDC00063	Inhibitor	N-Isopropyl-N'-Hydroxyguanidine
TTDC00063	Inhibitor	N-Omega-Hydroxy-L-Arginine
TTDC00063	Inhibitor	N-Omega-Propyl-L-Arginine
TTDC00063	Inhibitor	N-omega-allyl-L-arginine
TTDC00063	Inhibitor	N-omega-propargyl-L-arginine
TTDC00063	Inhibitor	N5-(1-Imino-3-Butenyl)-L-Ornithine
TTDC00063	Inhibitor	N5-(1-iminobut-3-enyl)-L-ornithine
TTDC00063	Inhibitor	N5-(1-iminobutyl)-L-ornithine
TTDC00063	Inhibitor	N5-(1-iminopent-3-enyl)-L-ornithine
TTDC00063	Inhibitor	N5-(1-iminopropyl)-L-ornithine
TTDC00063	Inhibitor	NXN-188
TTDC00063	Inhibitor	Nitroarginine
TTDC00063	Inhibitor	ONO-1714
TTDC00063	Inhibitor	Octahydro-isoindol-(1Z)-ylideneamine
TTDC00063	Inhibitor	Piperidin-(2E)-ylideneamine
TTDC00063	Inhibitor	Pyrrolidin-(2Z)-ylideneamine
TTDC00063	Inhibitor	Riboflavin Monophosphate
TTDC00063	Inhibitor	S-Ethyl-N-Phenyl-Isothiourea
TTDC00063	Inhibitor	S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea
TTDC00063	Inhibitor	THIOCITRULLINE
TTDC00063	Inhibitor	Tetrahydro-pyrimidin-2-ylideneamine
TTDC00063	Inhibitor	Thiazolidin-(2E)-ylideneamine
TTDC00063	Inhibitor	[1,3]Oxazinan-(2E)-ylideneamine
TTDC00063	Inhibitor	[1,3]Thiazinan-(2E)-ylideneamine
TTDC00063	Inhibitor	[1,4]Oxazepan-(3E)-ylideneamine
TTDC00063	Inhibitor	[1,4]Oxazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	[1,4]Thiazepan-(3E)-ylideneamine
TTDC00063	Inhibitor	[1,4]Thiazepan-(5E)-ylideneamine
TTDC00063	Inhibitor	l-NIL
TTDC00063	Multitarget	NXN-188
TTDC00064	UniProt ID	Q02224
TTDC00064	Name	Centromeric protein E
TTDC00064	Type of target	Discontinued target
TTDC00064	Synonyms	CENP-E
TTDC00064	Synonyms	Centromere-associated protein E
TTDC00064	Disease	Cancer, unspecific
TTDC00064	Disease	Solid tumors
TTDC00064	Function	Minus-end directed microtubule motor. Probable kinetochore motor. Accumulates ju
TTDC00064	Sequence	MAEEGAVAVCVRVRPLNSREESLGETAQVYWKTDNNVIYQVDGSKSFNFDRVFHGNETTKNVYEEIAAPIIDSAIQGYNG
TTDC00064	PDB Structure	1T5C
TTDC00064	Target Validation	TTDC00064
TTDC00064	Drug(s)	GSK-923295
TTDC00064	Drug(s)	GSK923295
TTDC00064	Inhibitor	GSK-923295
TTDC00064	Inhibitor	GSK923295
TTDC00065	UniProt ID	P49354
TTDC00065	UniProt ID	Q8IHP6
TTDC00065	Name	Farnesyltransferase
TTDC00065	Type of target	Discontinued target
TTDC00065	Synonyms	CAAX farnesyltransferase
TTDC00065	Synonyms	CAAX farnesyltransferase alpha subunit
TTDC00065	Synonyms	FTase
TTDC00065	Synonyms	FTase-alpha
TTDC00065	Synonyms	GGTase-I-alpha
TTDC00065	Synonyms	Protein farnesyltransferase alpha subunit
TTDC00065	Synonyms	RAS proteins prenyltransferase
TTDC00065	Synonyms	RAS proteins prenyltransferase alpha
TTDC00065	Synonyms	Type I protein geranyl-geranyltransferase alpha subunit
TTDC00065	Disease	Acute myeloid leukemia (AML)
TTDC00065	Disease	Amebiasis
TTDC00065	Disease	Bladder cancer
TTDC00065	Disease	Breast cancer
TTDC00065	Disease	Cancer, unspecific
TTDC00065	Disease	Colorectal Cancer
TTDC00065	Disease	Malaria
TTDC00065	Disease	Non-small cell lung cancer (NSCLC)
TTDC00065	Disease	Pancreatic Cancer
TTDC00065	Disease	Solid tumors
TTDC00065	Function	Catalyzes the transfer of a farnesyl or geranyl-geranyl moiety from farnesyl or
TTDC00065	Sequence	MAATEGVGEAAQGGEPGQPAQPPPQPHPPPPQQQHKEEMAAEAGEAVASPMDDGFVSLDSPSYVLYRDRAEWADIDPVPQ
TTDC00065	PDB Structure	1JCQ; 1LD7; 1LD8; 1MZC; 1S63; 1SA4; 1TN6; 2F0Y; 2H6F; 2H6G; 2H6H; 2H6I; 2IEJ; 3E
TTDC00065	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDC00065	EC Number	EC 2.5.1.-
TTDC00065	EC Number	EC 2.5.1.58
TTDC00065	EC Number	EC 2.5.1.59
TTDC00065	Related US Patent	6,143,766
TTDC00065	Related US Patent	6,218,375
TTDC00065	Related US Patent	6,335,343
TTDC00065	Related US Patent	6,376,496
TTDC00065	Target Validation	TTDC00065
TTDC00065	Drug(s)	AZD3409
TTDC00065	Drug(s)	BMS214662
TTDC00065	Drug(s)	CP-609,754
TTDC00065	Drug(s)	Lonafarnib
TTDC00065	Drug(s)	Zarnestra
TTDC00065	Inhibitor	(Z)-2-Methyl-3-tetradecyl-but-2-enedioic acid
TTDC00065	Inhibitor	ABT-839
TTDC00065	Inhibitor	ACTINOPLANIC ACID A
TTDC00065	Inhibitor	ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID
TTDC00065	Inhibitor	AZD3409
TTDC00065	Inhibitor	BMS-214662
TTDC00065	Inhibitor	BMS-404683
TTDC00065	Inhibitor	BMS214662
TTDC00065	Inhibitor	CLAVARINONE
TTDC00065	Inhibitor	CP-609,754
TTDC00065	Inhibitor	FARNESYL
TTDC00065	Inhibitor	FARNESYL DIPHOSPHATE
TTDC00065	Inhibitor	GERANYLGERANYL DIPHOSPHATE
TTDC00065	Inhibitor	L-731735
TTDC00065	Inhibitor	L-745631
TTDC00065	Inhibitor	L-778123
TTDC00065	Inhibitor	Lonafarnib
TTDC00065	Inhibitor	MANUMYCIN A
TTDC00065	Inhibitor	PB-27
TTDC00065	Inhibitor	PB-80
TTDC00065	Inhibitor	PB-81
TTDC00065	Inhibitor	PD-83176
TTDC00065	Inhibitor	Pseudopeptide derivative
TTDC00065	Inhibitor	RPR-113829
TTDC00065	Inhibitor	RPR-114334
TTDC00065	Inhibitor	SCH-44342
TTDC00065	Inhibitor	SCH66336
TTDC00065	Inhibitor	Zarnestra
TTDC00065	Binder	Human PFT inhibitor
TTDC00066	UniProt ID	Q02156
TTDC00066	Name	Protein kinase C, epsilon type
TTDC00066	Type of target	Clinical trial target
TTDC00066	Synonyms	NPKC-epsilon
TTDC00066	Synonyms	PKC epsilon
TTDC00066	Synonyms	Protein Kinase C epsilon
TTDC00066	Disease	Anxiety disorder, unspecified
TTDC00066	Disease	Astroglial brain tumors
TTDC00066	Disease	Immune disease
TTDC00066	Disease	Inflammation
TTDC00066	Disease	Ischemic Reperfusion Injury
TTDC00066	Disease	Myocardial hypertrophy
TTDC00066	Function	This is calcium-independent, phospholipid-dependent, serine- and threonine-speci
TTDC00066	Sequence	MVVFNGLLKIKICEAVSLKPTAWSLRHAVGPRPQTFLLDPYIALNVDDSRIGQTATKQKTNSPAWHDEFVTDVCNGRKIE
TTDC00066	PDB Structure	2WH0
TTDC00066	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00066	Pathway	Fc epsilon RI signaling pathway
TTDC00066	Pathway	Tight junction
TTDC00066	Pathway	Type II diabetes mellitus
TTDC00066	Pathway	Vascular smooth muscle contraction
TTDC00066	EC Number	EC 2.7.1.-
TTDC00066	Target Validation	TTDC00066
TTDC00066	Drug(s)	KAI-1455
TTDC00066	Inhibitor	2,3,3-Triphenyl-acrylonitrile
TTDC00066	Inhibitor	2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile
TTDC00066	Inhibitor	3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile
TTDC00066	Inhibitor	3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile
TTDC00066	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDC00066	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDC00066	Inhibitor	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile
TTDC00066	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00066	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00066	Inhibitor	4-HYDROXYTAMOXIFEN
TTDC00066	Inhibitor	4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol
TTDC00066	Inhibitor	4-cycloheptyliden(4-hydroxyphenyl)methylphenol
TTDC00066	Inhibitor	4-cyclohexyliden(4-hydroxyphenyl)methylphenol
TTDC00066	Inhibitor	Indolocarbazole analogue
TTDC00066	Inhibitor	LY-317644
TTDC00066	Inhibitor	LY-326449
TTDC00066	Inhibitor	RO-316233
TTDC00066	Inhibitor	RO-320432
TTDC00066	Inhibitor	Ro-32-0557
TTDC00066	Inhibitor	[2,2';5',2'']Terthiophen-4-yl-methanol
TTDC00066	Inhibitor	[2,2';5',2'']Terthiophene-4,5''-dicarbaldehyde
TTDC00066	Inhibitor	[2,2';5',2'']Terthiophene-4-carbaldehyde
TTDC00066	Activator	13-acetate
TTDC00066	Activator	Bryostatin-1
TTDC00066	Activator	KAI-1455
TTDC00066	Activator	Phorbol 12-myristate
TTDC00067	UniProt ID	P25774
TTDC00067	Name	Cathepsin S
TTDC00067	Type of target	Discontinued target
TTDC00067	Synonyms	Cysteine protease cathepsin S
TTDC00067	Disease	Autoimmune diseases
TTDC00067	Disease	Psoriasis and Psoriatic Disorders
TTDC00067	Function	Thiol protease. The bond-specificity of this proteinase is in part similar to th
TTDC00067	Sequence	MKRLVCVLLVCSSAVAQLHKDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMGMHSYDLGMNHL
TTDC00067	PDB Structure	1BXF; 1GLO; 1MS6; 1NPZ; 1NQC; 2C0Y; 2F1G; 2FQ9; 2FRA; 2FRQ; 2FT2; 2FUD; 2FYE; 2G
TTDC00067	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00067	Pathway	Antigen processing and presentation
TTDC00067	Pathway	Lysosome
TTDC00067	EC Number	EC 3.4.22.27
TTDC00067	Related US Patent	6,313,119
TTDC00067	Related US Patent	6,420,364
TTDC00067	Related US Patent	6,455,502
TTDC00067	Related US Patent	6,476,026
TTDC00067	Related US Patent	6,492,362
TTDC00067	Related US Patent	6,506,733
TTDC00067	Related US Patent	6,525,036
TTDC00067	Related US Patent	6,525,052
TTDC00067	Related US Patent	6,576,630
TTDC00067	Related US Patent	6,593,327
TTDC00067	Related US Patent	6,608,057
TTDC00067	Related US Patent	6,635,621
TTDC00067	Related US Patent	6,649,642
TTDC00067	Related US Patent	6,730,671
TTDC00067	Target Validation	TTDC00067
TTDC00067	Drug(s)	CRA-028129
TTDC00067	Drug(s)	SAR114137
TTDC00067	Inhibitor	2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL
TTDC00067	Inhibitor	4-cycloheptyl-6-propylpyrimidine-2-carbonitrile
TTDC00067	Inhibitor	4-cyclooctyl-6-propylpyrimidine-2-carbonitrile
TTDC00067	Inhibitor	4-propyl-6-m-tolylpyrimidine-2-carbonitrile
TTDC00067	Inhibitor	6-(3-(trifluoromethyl)phenyl)picolinonitrile
TTDC00067	Inhibitor	Ac-hPhe-Leu-Ala-LeuVSMe
TTDC00067	Inhibitor	Ac-hPhe-Leu-Gly-LeuVSMe
TTDC00067	Inhibitor	Ac-hPhe-Leu-Phe-LeuVSMe
TTDC00067	Inhibitor	BOCEPREVIR
TTDC00067	Inhibitor	CRA-028129
TTDC00067	Inhibitor	Cbz-Glu(OtBu)-Ala-LeuVSMe
TTDC00067	Inhibitor	Cbz-Ile-Leu-Ala-LeuVSMe
TTDC00067	Inhibitor	Cbz-Ile-MetO2-Ala-LeuVSMe
TTDC00067	Inhibitor	Cbz-Ile-Phe-Ala-LeuVSMe
TTDC00067	Inhibitor	Cbz-Ile-Pro-Ala-LeuVSMe
TTDC00067	Inhibitor	Cbz-Ile-hPhe-Ala-LeuVSMe
TTDC00067	Inhibitor	Cbz-Ile-t-ButylGln-Ala-LeuVSMe
TTDC00067	Inhibitor	Cbz-Ile-t-ButylhomoGlu-Ala-LeuVSMe
TTDC00067	Inhibitor	Clik60
TTDC00067	Inhibitor	E-64
TTDC00067	Inhibitor	Fucose
TTDC00067	Inhibitor	GNF-PF-5434
TTDC00067	Inhibitor	L-006235-1
TTDC00067	Inhibitor	L-873724
TTDC00067	Inhibitor	N-(1-oxobutan-2-yl)-3-(trifluoromethyl)benzamide
TTDC00067	Inhibitor	N-(2-naphthylsulfonyl)-glycyl-glycine-nitrile
TTDC00067	Inhibitor	N-(4-phenylbenzoyl)-phenylalanyl-glycine-nitrile
TTDC00067	Inhibitor	N-(benzyloxycarbonyl)-leucyl-glycine-nitrile
TTDC00067	Inhibitor	N-(tert-butoxycarbonyl)-isoleucyl-glycine-nitrile
TTDC00067	Inhibitor	N-(tert-butoxycarbonyl)-leucyl-glycine-nitrile
TTDC00067	Inhibitor	N-(tert-butoxycarbonyl)-methionyl-glycine-nitrile
TTDC00067	Inhibitor	N-(tert-butoxycarbonyl)-norleucyl-glycine-nitrile
TTDC00067	Inhibitor	N-(tert-butoxycarbonyl)-norvalyl-glycine-nitrile
TTDC00067	Inhibitor	N-(tert-butoxycarbonyl)-tyrosyl-glycine-nitrile
TTDC00067	Inhibitor	N-(tert-butoxycarbonyl)-valyl-glycine-nitrile
TTDC00067	Inhibitor	N-acetyl-phenylalanyl-glycine-nitrile
TTDC00067	Inhibitor	N-benzoyl-phenylalanyl-glycine-nitrile
TTDC00067	Inhibitor	P2,P3 Ketoamide derivative
TTDC00068	UniProt ID	P43235
TTDC00068	Name	Cathepsin K
TTDC00068	Type of target	Clinical trial target
TTDC00068	Synonyms	Cathepsin O
TTDC00068	Synonyms	Cathepsin O2
TTDC00068	Synonyms	Cathepsin X
TTDC00068	Disease	Bone Metastases
TTDC00068	Disease	Cancer, unspecific
TTDC00068	Disease	Osteoporosis
TTDC00068	Disease	Postmenopausal Women with Osteoporosis
TTDC00068	Disease	Rheumatoid arthritis
TTDC00068	Function	Closely involved in osteoclastic bone resorption and may participate partially i
TTDC00068	Sequence	MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLGVHTYELAMNHLGD
TTDC00068	PDB Structure	1ATK; 1AU0; 1AU2; 1AU3; 1AU4; 1AYU; 1AYV; 1AYW; 1BGO; 1BY8; 1MEM; 1NL6; 1NLJ; 1Q
TTDC00068	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00068	Pathway	Lysosome
TTDC00068	EC Number	EC 3.4.22.38
TTDC00068	Related US Patent	6,284,777
TTDC00068	Related US Patent	6,313,119
TTDC00068	Related US Patent	6,331,542
TTDC00068	Related US Patent	6,420,364
TTDC00068	Related US Patent	6,455,502
TTDC00068	Related US Patent	6,462,076
TTDC00068	Related US Patent	6,476,026
TTDC00068	Related US Patent	6,492,362
TTDC00068	Related US Patent	6,506,733
TTDC00068	Related US Patent	6,518,267
TTDC00068	Related US Patent	6,525,036
TTDC00068	Related US Patent	6,525,052
TTDC00068	Related US Patent	6,534,498
TTDC00068	Related US Patent	6,562,842
TTDC00068	Related US Patent	6,566,373
TTDC00068	Related US Patent	6,576,630
TTDC00068	Related US Patent	6,583,137
TTDC00068	Related US Patent	6,586,466
TTDC00068	Related US Patent	6,593,327
TTDC00068	Related US Patent	6,596,715
TTDC00068	Related US Patent	6,608,057
TTDC00068	Related US Patent	6,635,621
TTDC00068	Related US Patent	6,642,239
TTDC00068	Related US Patent	6,649,642
TTDC00068	Target Validation	TTDC00068
TTDC00068	Drug(s)	Balicatib
TTDC00068	Drug(s)	MIV-701
TTDC00068	Drug(s)	MK-0822
TTDC00068	Drug(s)	Odanacatib
TTDC00068	Drug(s)	Relacatib
TTDC00068	Drug(s)	SAR114137
TTDC00068	Inhibitor	(S)-1-benzylcyclopentyl 1-oxohexan-2-ylcarbamate
TTDC00068	Inhibitor	(S)-tert-butyl 1-oxohexan-2-ylcarbamate
TTDC00068	Inhibitor	(S)-tert-butyl 4-methyl-1-oxopentan-2-ylcarbamate
TTDC00068	Inhibitor	2-cyclohexylamino-pyridine-2-carbonitrile
TTDC00068	Inhibitor	2-cyclohexylamino-pyrimidine-4-carbonitrile
TTDC00068	Inhibitor	3-Amino-5-Phenylpentane
TTDC00068	Inhibitor	4-cycloheptyl-6-propylpyrimidine-2-carbonitrile
TTDC00068	Inhibitor	4-cyclohexyl-6-propylpyrimidine-2-carbonitrile
TTDC00068	Inhibitor	4-cyclohexylamino-pyrimidine-2-carbonitrile
TTDC00068	Inhibitor	4-cyclooctyl-6-propylpyrimidine-2-carbonitrile
TTDC00068	Inhibitor	4-phenyl-6-propylpyrimidine-2-carbonitrile
TTDC00068	Inhibitor	4-propyl-6-m-tolylpyrimidine-2-carbonitrile
TTDC00068	Inhibitor	BOCEPREVIR
TTDC00068	Inhibitor	Balicatib
TTDC00068	Inhibitor	Boc-Agly-Val-Agly-OEt
TTDC00068	Inhibitor	GNF-PF-5434
TTDC00068	Inhibitor	L-006235-1
TTDC00068	Inhibitor	L-873724
TTDC00068	Inhibitor	MIV-701
TTDC00068	Inhibitor	MK-0822
TTDC00068	Inhibitor	MK-1256
TTDC00068	Inhibitor	N-(1-((cyanomethyl)carbamoyl)cyclohexyl)benzamide
TTDC00068	Inhibitor	N-(4-phenylbenzoyl)-phenylalanyl-glycine-nitrile
TTDC00068	Inhibitor	N-(benzyloxycarbonyl)-leucyl-glycine-nitrile
TTDC00068	Inhibitor	N-(cyanomethyl)cyclohex-1-ene-1-carboxamide
TTDC00068	Inhibitor	N-(tert-butoxycarbonyl)-isoleucyl-glycine-nitrile
TTDC00068	Inhibitor	N-(tert-butoxycarbonyl)-leucyl-glycine-nitrile
TTDC00068	Inhibitor	N-(tert-butoxycarbonyl)-methionyl-glycine-nitrile
TTDC00068	Inhibitor	N-(tert-butoxycarbonyl)-norleucyl-glycine-nitrile
TTDC00068	Inhibitor	N-(tert-butoxycarbonyl)-norvalyl-glycine-nitrile
TTDC00068	Inhibitor	N-(tert-butoxycarbonyl)-valyl-glycine-nitrile
TTDC00068	Inhibitor	N-acetyl-phenylalanyl-glycine-nitrile
TTDC00068	Inhibitor	N-benzoyl-phenylalanyl-glycine-nitrile
TTDC00068	Inhibitor	Odanacatib
TTDC00068	Inhibitor	P2,P3 Ketoamide derivative
TTDC00068	Inhibitor	Peptide aldehydes
TTDC00068	Inhibitor	Pyrrolidine-1-carbonitrile
TTDC00068	Inhibitor	Relacatib
TTDC00068	Inhibitor	TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE
TTDC00068	Inhibitor	Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate
TTDC00068	Inhibitor	Z-Ala-Leu-His-Agly-Ile-Val-OMe
TTDC00068	Inhibitor	Z-Ala-Leu-Nal-Agly-Ile-Val-OMe
TTDC00068	Inhibitor	Z-Ala-Leu-Phe-Agly-Ile-Val-OMe
TTDC00068	Inhibitor	Z-Ala-Leu-Tyr(Me)-Agly-Ile-Val-OMe
TTDC00068	Inhibitor	Z-Ala-Leu-lle-Agly-Ile-Val-NHBzl
TTDC00068	Inhibitor	Z-Ala-Leu-lle-Agly-Ile-Val-OMe
TTDC00068	Inhibitor	Z-Arg-Leu-Val-Agly-Ala-Gly-NH2
TTDC00068	Inhibitor	Z-Arg-Leu-Val-Agly-Ile-Val-Trp-NH2
TTDC00068	Inhibitor	Z-Arg-Leu-Val-Agly-Ileu-Val-OMe
TTDC00068	Inhibitor	Z-Arg-Leu-Val-Agly-Trp-Val-Ala-NH2
TTDC00068	Inhibitor	Z-Arg-Leu-Val-Agly-Val-Ala-NH2
TTDC00068	Inhibitor	Z-leu-Val-Agly-Val-OBzl
TTDC00068	Inhibitor	tert-butyl (2S)-1-cyanopyrrolidine-2-carboxylate
TTDC00069	UniProt ID	Q03181
TTDC00069	Name	Peroxisome proliferator activated receptor delta
TTDC00069	Type of target	Clinical trial target
TTDC00069	Synonyms	NUC1
TTDC00069	Synonyms	NUCI
TTDC00069	Synonyms	Nuclear hormone receptor 1
TTDC00069	Synonyms	PPAR-beta
TTDC00069	Synonyms	PPAR-delta
TTDC00069	Synonyms	PPARdelta
TTDC00069	Synonyms	Peroxisome proliferator activated receptor beta/delta
TTDC00069	Synonyms	Peroxisome proliferator-activated receptor beta
TTDC00069	Disease	Atherosclerosis
TTDC00069	Disease	Hyperlipidemia
TTDC00069	Disease	Inflammation
TTDC00069	Disease	Metabolic Disease
TTDC00069	Disease	Metabolic syndrome X
TTDC00069	Disease	Noninsulin-dependent diabetes mellitus
TTDC00069	Disease	Obesity
TTDC00069	Disease	Skin diseases
TTDC00069	Function	Receptor that bind peroxisome proliferators such as hypolipidemic drugs and fatt
TTDC00069	Sequence	MEQPQEEAPEVREEEEKEEVAEAEGAPELNGGPQHALPSSSYTDLSRSSSPPSLLDQLQMGCDGASCGSLNMECRVCGDK
TTDC00069	PDB Structure	1GWX; 1Y0S; 2AWH; 2B50; 2BAW; 2ENV; 2GWX; 2J14; 2Q5G; 2XYJ; 2XYW; 2XYX; 2ZNP; 2Z
TTDC00069	BioChemical Class	Zinc-finger
TTDC00069	Pathway	Acute myeloid leukemia
TTDC00069	Pathway	PPAR signaling pathway
TTDC00069	Pathway	Pathways in cancer
TTDC00069	Pathway	Wnt signaling pathway
TTDC00069	Related US Patent	6,723,740
TTDC00069	Related US Patent	6,787,552
TTDC00069	Target Validation	TTDC00069
TTDC00069	Drug(s)	GSK-677954
TTDC00069	Drug(s)	KD-3020
TTDC00069	Drug(s)	KD3010
TTDC00069	Drug(s)	MBX-8025
TTDC00069	Drug(s)	Netoglitazone
TTDC00069	Inhibitor	(11E)-OCTADEC-11-ENOIC ACID
TTDC00069	Inhibitor	GSK-0660
TTDC00069	Inhibitor	GSK-3787
TTDC00069	Inhibitor	GW-501516
TTDC00069	Inhibitor	Heptyl-Beta-D-Glucopyranoside
TTDC00069	Inhibitor	L-165461
TTDC00069	Inhibitor	L-796449
TTDC00069	Agonist	GSK-677954
TTDC00069	Agonist	KD-3020
TTDC00069	Agonist	KD3010
TTDC00069	Agonist	MBX-8025
TTDC00069	Agonist	Netoglitazone
TTDC00069	Multitarget	GSK-677954
TTDC00069	Multitarget	Netoglitazone
TTDC00070	UniProt ID	P28845
TTDC00070	Name	Corticosteroid 11-beta-dehydrogenase, isozyme 1
TTDC00070	Type of target	Clinical trial target
TTDC00070	Synonyms	11 beta-hydroxysteroid dehydrogenase type 1
TTDC00070	Synonyms	11-DH
TTDC00070	Synonyms	11-beta-HSD1
TTDC00070	Synonyms	11-beta-hydroxysteroid dehydrogenase 1
TTDC00070	Synonyms	11HSD1
TTDC00070	Synonyms	11beta-HSD1A
TTDC00070	Synonyms	11beta-HSD2
TTDC00070	Disease	Cognitive deficits (age- and dementia-associated)
TTDC00070	Disease	Diabetes Mellitus Type 2
TTDC00070	Disease	Metabolic disorder, unspecified
TTDC00070	Disease	Neurodegenerative diseases
TTDC00070	Disease	Noninsulin-dependent diabetes mellitus
TTDC00070	Disease	Obesity
TTDC00070	Function	Catalyzes reversibly the conversion of cortisol to the inactive metabolite corti
TTDC00070	Sequence	MAFMKKYLLPILGLFMAYYYYSANEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLE
TTDC00070	PDB Structure	1XU7; 1XU9; 2BEL; 2ILT; 2IRW; 2RBE; 3BYZ; 3BZU; 3CH6; 3CZR; 3D3E; 3D4N; 3D5Q; 3E
TTDC00070	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDC00070	Pathway	Androgen and estrogen metabolism
TTDC00070	Pathway	C21-Steroid hormone metabolism
TTDC00070	Pathway	Metabolic pathways
TTDC00070	EC Number	EC 1.1.1.146
TTDC00070	Related US Patent	6,730,690
TTDC00070	Target Validation	TTDC00070
TTDC00070	Drug(s)	AZD4017
TTDC00070	Drug(s)	AZD8329
TTDC00070	Drug(s)	BI-135585
TTDC00070	Drug(s)	BMS-770767
TTDC00070	Drug(s)	INCB13739
TTDC00070	Drug(s)	LY2409021
TTDC00070	Drug(s)	LY2523199
TTDC00070	Drug(s)	RG4929
TTDC00070	Inhibitor	(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE
TTDC00070	Inhibitor	(4-methoxyphenyl)(4-phenylazepan-1-yl)methanone
TTDC00070	Inhibitor	1,1-diphenyl-3-(phenylsulfonyl)propan-2-one
TTDC00070	Inhibitor	1-(1-phenyl-1H-tetrazol-5-ylthio)propan-2-one
TTDC00070	Inhibitor	1-(2-adamantyl)-3-benzylpyrrolidin-2-one
TTDC00070	Inhibitor	1-(3,4-dichlorophenyl)-2-(phenylsulfonyl)ethanone
TTDC00070	Inhibitor	1-(3,5-dimethylphenyl)-2-(phenylsulfonyl)ethanone
TTDC00070	Inhibitor	1-(3-chloropyridin-2-yl)-4-tosylpiperazine
TTDC00070	Inhibitor	1-(3-methoxyphenyl)-2-(phenylsulfonyl)ethanone
TTDC00070	Inhibitor	1-(3-methylpyridin-2-yl)-4-tosylpiperazine
TTDC00070	Inhibitor	1-(3-nitropyridin-2-yl)-4-tosylpiperazine
TTDC00070	Inhibitor	1-(4-chlorophenyl)-2-(phenylsulfonyl)ethanone
TTDC00070	Inhibitor	1-(4-chlorophenylsulfonyl)-4-phenylazepan-4-ol
TTDC00070	Inhibitor	1-(4-ethylphenylsulfonyl)-4-phenylazepan-4-ol
TTDC00070	Inhibitor	1-(4-ethylpiperazin-1-yl)-2-phenylethanone
TTDC00070	Inhibitor	1-(4-fluorophenyl)-2-(phenylsulfonyl)ethanone
TTDC00070	Inhibitor	1-(4-fluorophenyl)-3-(phenylsulfonyl)propan-1-one
TTDC00070	Inhibitor	1-(4-methoxyphenyl)-2-(phenylsulfonyl)ethanone
TTDC00070	Inhibitor	1-(4-methoxyphenylsulfonyl)-4-phenylazepan-4-ol
TTDC00070	Inhibitor	1-(4-nitrophenyl)-2-(phenylsulfonyl)ethanone
TTDC00070	Inhibitor	1-(4-tert-butylphenylsulfonyl)-4-methoxyazepane
TTDC00070	Inhibitor	1-(4-tert-butylphenylsulfonyl)azepan-4-ol
TTDC00070	Inhibitor	1-(phenylsulfonyl)butan-2-one
TTDC00070	Inhibitor	1-phenyl-2-(1-phenyl-1H-tetrazol-5-yloxy)ethanone
TTDC00070	Inhibitor	1-phenyl-3-(phenylsulfonyl)propan-1-one
TTDC00070	Inhibitor	1-phenyl-4-(1-phenyl-1H-tetrazol-5-yl)butan-2-one
TTDC00070	Inhibitor	11-keto-beta-boswellicacid
TTDC00070	Inhibitor	11-keto-ursolic acid
TTDC00070	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDC00070	Inhibitor	2-(2-chlorophenylamino)-5-methylthiazol-4(5H)-one
TTDC00070	Inhibitor	2-(4-tosylpiperazin-1-yl)nicotinonitrile
TTDC00070	Inhibitor	2-(N-Morpholino)-Ethanesulfonic Acid
TTDC00070	Inhibitor	2-(adamantan-1-ylamino)-5,5-diethyl-oxazol-4-one
TTDC00070	Inhibitor	2-(benzylamino)-5,5-diethyloxazol-4(5H)-one
TTDC00070	Inhibitor	2-(cyclooctylamino)-5,5-diethyloxazol-4(5H)-one
TTDC00070	Inhibitor	2-(o-toluidino)-5-ethylthiazol-4(5H)-one
TTDC00070	Inhibitor	2-(o-toluidino)-5-isopropylthiazol-4(5H)-one
TTDC00070	Inhibitor	2-(phenylsulfonyl)-1-(thiophen-3-yl)ethanone
TTDC00070	Inhibitor	2-(phenylsulfonyl)-1-p-tolylethanone
TTDC00070	Inhibitor	3-acetyl-11-keto-beta-boswellic acid
TTDC00070	Inhibitor	3-acetyl-11-keto-ursolic acid
TTDC00070	Inhibitor	3-benzyl-1-cyclohexylpyrrolidin-2-one
TTDC00070	Inhibitor	3-epicorosolic acid methyl ester
TTDC00070	Inhibitor	5,5-diethyl-2-(phenethylamino)oxazol-4(5H)-one
TTDC00070	Inhibitor	5-isopropyl-2-(phenylamino)thiazol-4(5H)-one
TTDC00070	Inhibitor	AMG-221
TTDC00070	Inhibitor	AZD4017
TTDC00070	Inhibitor	AZD8329
TTDC00070	Inhibitor	Abietic acid
TTDC00070	Inhibitor	BVT-14225
TTDC00070	Inhibitor	BVT.2733
TTDC00070	Inhibitor	Carbenoxolone
TTDC00070	Inhibitor	Corosolic acid
TTDC00070	Inhibitor	Enoxolone
TTDC00070	Inhibitor	FIG 1
TTDC00070	Inhibitor	Flavanone
TTDC00070	Inhibitor	GLYCYRRHIZIN
TTDC00070	Inhibitor	INCB13739
TTDC00070	Inhibitor	MERCK-544
TTDC00070	Inhibitor	N-benzyl-N-(phenylsulfonyl)benzamide
TTDC00070	Inhibitor	PF-877423
TTDC00070	Inhibitor	PF-915275
TTDC00070	Inhibitor	Piperidine-1-carboxylic acid adamantan-2-yl ester
TTDC00070	Inhibitor	Piperidine-1-carboxylic acid adamantan-2-ylamide
TTDC00070	Inhibitor	Tormentic acid methyl ester
TTDC00070	Inhibitor	URSOLIC ACID
TTDC00070	Inhibitor	adamantan-1-yl-(4-ethyl-piperazin-1-yl)-methanone
TTDC00070	Inhibitor	adamantan-1-yl-piperazin-1-yl-methanone
TTDC00070	Inhibitor	adamantan-1-yl-piperidin-1-yl-methanone
TTDC00070	Inhibitor	adamantan-1-yl-pyrrolidin-1-yl-methanone
TTDC00070	Inhibitor	adamantan-2-yl-piperidin-1-yl-methanone
TTDC00070	Inhibitor	glycyrrhizic acid
TTDC00071	UniProt ID	P25116
TTDC00071	Name	Proteinase activated receptor 1
TTDC00071	Type of target	Clinical trial target
TTDC00071	Synonyms	Coagulation factor II receptor
TTDC00071	Synonyms	PAR-1
TTDC00071	Synonyms	Protease activated receptor 1
TTDC00071	Synonyms	Protease-activated receptor-1
TTDC00071	Synonyms	Thrombin receptor
TTDC00071	Disease	Acute Coronary Syndrome
TTDC00071	Disease	Analgesics
TTDC00071	Disease	Cardiovascular Disorders
TTDC00071	Disease	Inflammation
TTDC00071	Disease	Ischemic Stroke
TTDC00071	Disease	Pain, unspecified
TTDC00071	Disease	Vascular disease
TTDC00071	Function	High affinity receptor for activated thrombin coupled to G proteins that stimula
TTDC00071	Sequence	MGPRRLLLVAACFSLCGPLLSARTRARRPESKATNATLDPRSFLLRNPNDKYEPFWEDEEKNESGLTEYRLVSINKSSPL
TTDC00071	PDB Structure	1NRN; 1NRO; 1NRP; 1NRQ; 1NRR; 3BEF; 3HKI; 3HKJ; 3LU9; 3VW7
TTDC00071	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00071	Pathway	Calcium signaling pathway
TTDC00071	Pathway	Complement and coagulation cascades
TTDC00071	Pathway	Neuroactive ligand-receptor interaction
TTDC00071	Pathway	Regulation of actin cytoskeleton
TTDC00071	Related US Patent	6,326,380
TTDC00071	Related US Patent	6,365,617
TTDC00071	Related US Patent	6,399,581
TTDC00071	Related US Patent	6,403,612
TTDC00071	Related US Patent	6,515,023
TTDC00071	Related US Patent	6,544,982
TTDC00071	Related US Patent	6,630,451
TTDC00071	Related US Patent	6,645,987
TTDC00071	Target Validation	TTDC00071
TTDC00071	Drug(s)	SCH-530348
TTDC00071	Inhibitor	SCH-205831
TTDC00071	Antagonist	SCH-530348
TTDC00072	UniProt ID	P32245
TTDC00072	Name	Melanocortin-4 receptor
TTDC00072	Type of target	Clinical trial target
TTDC00072	Synonyms	MC4-R
TTDC00072	Disease	Erectile Dysfunction
TTDC00072	Disease	Obesity
TTDC00072	Disease	Sexual Dysfunction, Female
TTDC00072	Function	Receptor specific to the heptapeptide core common to adrenocorticotropic hormone
TTDC00072	Sequence	MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMY
TTDC00072	PDB Structure	2IQP; 2IQR; 2IQS; 2IQU; 2IQV; 2IQW
TTDC00072	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00072	Pathway	Neuroactive ligand-receptor interaction
TTDC00072	Related US Patent	6,350,760
TTDC00072	Related US Patent	6,376,509
TTDC00072	Related US Patent	6,472,398
TTDC00072	Related US Patent	6,600,015
TTDC00072	Related US Patent	6,767,915
TTDC00072	Target Validation	TTDC00072
TTDC00072	QSAR Model	TTDC00072
TTDC00072	Drug(s)	Bremelanotide
TTDC00072	Drug(s)	CHIR-01020
TTDC00072	Drug(s)	IDDBCP-150101
TTDC00072	Drug(s)	MC-4 agonist
TTDC00072	Drug(s)	Melanotetan II
TTDC00072	Drug(s)	PT-15
TTDC00072	Drug(s)	RM-493
TTDC00072	Drug(s)	Ro-27-3225
TTDC00072	Inhibitor	1-Benzyl-4-methyl-piperazine
TTDC00072	Inhibitor	1-Methyl-4-(1-phenyl-ethyl)-piperazine
TTDC00072	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDC00072	Inhibitor	AC-Nle-c[Asp-His-DPhe-Pro-Trp-Lys]-NH2
TTDC00072	Inhibitor	AEKKDEGPYRMEHFRWGSPPKD
TTDC00072	Inhibitor	Ac-His-D-Phe-Arg-2-Nal-NHCH3
TTDC00072	Inhibitor	Ac-His-DPhe-Arg-Trp-NH2
TTDC00072	Inhibitor	Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
TTDC00072	Inhibitor	Ac-Nle-c[Asp-His-DNaI(2')-Pro-Trp-Lys]-NH2
TTDC00072	Inhibitor	Ac-Nle-c[Asp-His-DNal(2')-Pro-Trp-Lys]-NH2
TTDC00072	Inhibitor	Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2
TTDC00072	Inhibitor	Ac-Phe-[Orn-Pro-cha-Trp-Arg]
TTDC00072	Inhibitor	Ac-R[CEHdFRWC]-NH2
TTDC00072	Inhibitor	Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3
TTDC00072	Inhibitor	Ac-YCit[CEHdFRWC]-NH2
TTDC00072	Inhibitor	Ac-YK[CEHdFRWC]-NH2
TTDC00072	Inhibitor	Ac-YRC(Me)*EHdFRWC(Me)NH2
TTDC00072	Inhibitor	Ac-YRMEHdFRWG-NH2
TTDC00072	Inhibitor	Ac-YRMEHdFRWGSPPKD-NH2
TTDC00072	Inhibitor	Ac-YR[CE(1-Me-H)dFRWC]-NH2
TTDC00072	Inhibitor	Ac-YR[CEH(d-2alpha-Nal)RWC]-NH2
TTDC00072	Inhibitor	Ac-YR[CEH(pCl-dF)RWC]-NH2
TTDC00072	Inhibitor	Ac-YR[CEH(pF-dF)RWC]-NH2
TTDC00072	Inhibitor	Ac-YR[CEHFRWC]-NH2
TTDC00072	Inhibitor	Ac-YR[CEHdFRWC]-NH2
TTDC00072	Inhibitor	Ac-YR[CEHdFRWC]SPPKD-NH2
TTDC00072	Inhibitor	Ac-[CEHdFRWC]-NH2
TTDC00072	Inhibitor	Ac-dR[CEHdFRWC]-NH2
TTDC00072	Inhibitor	Alpha-MSH
TTDC00072	Inhibitor	D-Phe-Arg-2-Nal-NHCH3
TTDC00072	Inhibitor	GPYRMEHFRWGSPPKD-NH2
TTDC00072	Inhibitor	His-DPhe-Arg-Trp
TTDC00072	Inhibitor	Hoo-Phe-Orn-Pro-hle-Pff-Phe-NH2
TTDC00072	Inhibitor	MCL-129
TTDC00072	Inhibitor	MK-10
TTDC00072	Inhibitor	MK-11
TTDC00072	Inhibitor	ML-253764
TTDC00072	Inhibitor	NDP-SYSMEHFRWGKPVG
TTDC00072	Inhibitor	NDP-alpha-MSH
TTDC00072	Inhibitor	Ser-Tyr-Ser-Nle-Glu-His-Dphe-Arg
TTDC00072	Inhibitor	Tic-D-Phe-Arg-2-Nal-NHCH3
TTDC00072	Inhibitor	c(his-D-phe-arg-trp-Abu)
TTDC00072	Inhibitor	c(his-D-phe-arg-trp-Ahp)
TTDC00072	Inhibitor	c(his-D-phe-arg-trp-Ahx)
TTDC00072	Inhibitor	c(his-D-phe-arg-trp-Aoc)
TTDC00072	Inhibitor	c(his-L-phe-arg-trp-Aoc)
TTDC00072	Inhibitor	c[CO-(CH2)2-CO-Nle-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDC00072	Inhibitor	c[CO-(CH2)2-CO-Nle-D-Phe-Arg-Trp-Lys]-NH2
TTDC00072	Inhibitor	c[CO-(CH2)3-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDC00072	Inhibitor	c[CO-o-C6H4-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDC00072	Inhibitor	c[CO-o-C6H4-CO-Pro-D-Phe-Arg-Trp-Lys]-NH2
TTDC00072	Inhibitor	c[Nle-Arg-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Arg-D-Phe-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Asp-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Asp-D-Phe-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Gln-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Glu-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-His-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-His-D-Phe-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Nle-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Nle-D-Phe-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Pro-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Pro-D-Phe-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Val-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Nle-Val-D-Phe-Arg-Trp-Glu]-NH2
TTDC00072	Inhibitor	c[Ser-Tyr-Thr-His-Dphe-Arg-Trp-Thr-Ile-Pro]
TTDC00072	Inhibitor	c[Thr-Tyr-Thr-His-DNaf-Arg-Trp-Thr-Ile-Pro]
TTDC00072	Antagonist	HS014
TTDC00072	Antagonist	Melanocortin-4 Receptor antagonist
TTDC00072	Agonist	AMSH
TTDC00072	Agonist	Amylin
TTDC00072	Agonist	Bremelanotide
TTDC00072	Agonist	CHIR-01020
TTDC00072	Agonist	IDDBCP-150101
TTDC00072	Agonist	MC-4 agonist
TTDC00072	Agonist	MTII Melanotan-II
TTDC00072	Agonist	Melanotetan II
TTDC00072	Agonist	PT-15
TTDC00072	Agonist	RM-493
TTDC00072	Agonist	Ro-27-3225
TTDC00072	Multitarget	Melanotetan II
TTDC00073	UniProt ID	P34998
TTDC00073	Name	Corticotropin releasing factor receptor 1
TTDC00073	Type of target	Clinical trial target
TTDC00073	Synonyms	CRF receptor
TTDC00073	Synonyms	CRF-1 receptor
TTDC00073	Synonyms	CRF-R
TTDC00073	Synonyms	CRF-R1
TTDC00073	Synonyms	CRF1
TTDC00073	Synonyms	CRH-R 1
TTDC00073	Synonyms	Corticotropin-releasing hormone receptor 1
TTDC00073	Synonyms	Corticotropin-releasing hormone type 1 receptor
TTDC00073	Disease	Anxiety Disorders
TTDC00073	Disease	Depression
TTDC00073	Disease	Innate anxiety
TTDC00073	Disease	Irritable Bowel Syndrome (IBS)
TTDC00073	Disease	Obesity
TTDC00073	Disease	Stress-related disorders
TTDC00073	Function	This is a receptor for corticotropin releasing factor. Shows high-affinity crf b
TTDC00073	Sequence	MGGHPQLRLVKALLLLGLNPVSASLQDQHCESLSLASNISGLQCNASVDLIGTCWPRSPAGQLVVRPCPAFFYGVRYNTT
TTDC00073	PDB Structure	2L27; 3EHS; 3EHT; 3EHU
TTDC00073	BioChemical Class	G-protein coupled receptor (Secretin family)
TTDC00073	Pathway	Long-term depression
TTDC00073	Pathway	Neuroactive ligand-receptor interaction
TTDC00073	Related US Patent	6,440,960
TTDC00073	Related US Patent	6,500,839
TTDC00073	Related US Patent	6,515,005
TTDC00073	Related US Patent	6,541,469
TTDC00073	Related US Patent	6,583,143
TTDC00073	Target Validation	TTDC00073
TTDC00073	Drug(s)	CP-316,311
TTDC00073	Drug(s)	CRF-1 antagonist
TTDC00073	Drug(s)	GSK561679
TTDC00073	Drug(s)	GSK586529
TTDC00073	Drug(s)	GW876008
TTDC00073	Drug(s)	NBI-34041
TTDC00073	Drug(s)	NBI-37582
TTDC00073	Drug(s)	Pexacerfont
TTDC00073	Drug(s)	SSR125543
TTDC00073	Inhibitor	BMS-561388
TTDC00073	Inhibitor	CP-316311
TTDC00073	Inhibitor	CP-376395
TTDC00073	Inhibitor	DMP-696
TTDC00073	Inhibitor	N-mesityl-4,6-dimethyl-3-tosylpyridin-2-amine
TTDC00073	Inhibitor	N-mesityl-6-methyl-3-tosylpyridin-2-amine
TTDC00073	Inhibitor	PD-171729
TTDC00073	Inhibitor	R-121919
TTDC00073	Inhibitor	SR-125543A
TTDC00073	Antagonist	Antalarmin
TTDC00073	Antagonist	CP-154526
TTDC00073	Antagonist	CP-316,311
TTDC00073	Antagonist	CP154,526
TTDC00073	Antagonist	CRA1000
TTDC00073	Antagonist	CRA1001
TTDC00073	Antagonist	CRF-1 antagonist
TTDC00073	Antagonist	DMP-695/696
TTDC00073	Antagonist	GSK561679
TTDC00073	Antagonist	GSK586529
TTDC00073	Antagonist	GW876008
TTDC00073	Antagonist	NBI-27914
TTDC00073	Antagonist	NBI-34041
TTDC00073	Antagonist	NBI-37582
TTDC00073	Antagonist	Pexacerfont
TTDC00073	Antagonist	R121919
TTDC00073	Antagonist	SSR125543
TTDC00073	Antagonist	SSR125543A
TTDC00073	Antagonist	Telavancin
TTDC00074	UniProt ID	Q13324
TTDC00074	Name	Corticotropin releasing factor receptor 2
TTDC00074	Type of target	Clinical trial target
TTDC00074	Synonyms	CRF-R 2
TTDC00074	Synonyms	CRF2
TTDC00074	Synonyms	CRH-R 2
TTDC00074	Synonyms	CRH2 receptor
TTDC00074	Synonyms	Corticotropin-releasing hormone receptor 2
TTDC00074	Disease	Angiogenesis
TTDC00074	Disease	Congestive Heart Failure
TTDC00074	Disease	Eating disorders
TTDC00074	Disease	Obesity
TTDC00074	Disease	Stress-related disorders
TTDC00074	Function	This is a receptor for corticotropin releasing factor. Shows high-affinity crf b
TTDC00074	Sequence	MDAALLHSLLEANCSLALAEELLLDGWGPPLDPEGPYSYCNTTLDQIGTCWPRSAAGALVERPCPEYFNGVKYNTTRNAY
TTDC00074	PDB Structure	3N93; 3N95; 3N96
TTDC00074	BioChemical Class	G-protein coupled receptor (Secretin family)
TTDC00074	Pathway	Neuroactive ligand-receptor interaction
TTDC00074	Related US Patent	6,440,960
TTDC00074	Related US Patent	6,500,839
TTDC00074	Related US Patent	6,541,469
TTDC00074	Related US Patent	6,583,143
TTDC00074	Target Validation	TTDC00074
TTDC00074	Drug(s)	CRF-R2 antagonists
TTDC00074	Drug(s)	Urocortin 2
TTDC00074	Antagonist	CRF-R2 antagonists
TTDC00074	Antagonist	Urocortin 2
TTDC00075	UniProt ID	P10599
TTDC00075	Name	Thioredoxin
TTDC00075	Type of target	Clinical trial target
TTDC00075	Synonyms	ADF
TTDC00075	Synonyms	ATL-derived factor
TTDC00075	Synonyms	SASP
TTDC00075	Synonyms	Surface associated sulphydryl protein
TTDC00075	Disease	Cancer, unspecific
TTDC00075	Disease	Gastric Cancer
TTDC00075	Disease	Pancreatic Cancer
TTDC00075	Function	Participates in various redox reactions through the reversible oxidation of its
TTDC00075	Sequence	MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFF
TTDC00075	PDB Structure	1AIU; 1AUC; 1CQG; 1CQH; 1ERT; 1ERU; 1ERV; 1ERW; 1M7T; 1MDI; 1MDJ; 1MDK; 1TRS; 1T
TTDC00075	Target Validation	TTDC00075
TTDC00075	Drug(s)	PX-12
TTDC00075	Inhibitor	Acetate Ion
TTDC00075	Inhibitor	Cacodylate Ion
TTDC00075	Inhibitor	PX-12
TTDC00076	UniProt ID	P14780
TTDC00076	Name	92 kDa type IV collagenase
TTDC00076	Type of target	Discontinued target
TTDC00076	Synonyms	92 kDa gelatinase
TTDC00076	Synonyms	GELB
TTDC00076	Synonyms	Gelatinase B
TTDC00076	Synonyms	MMP-9
TTDC00076	Synonyms	Matrix metalloproteinase 9
TTDC00076	Synonyms	Matrix metalloproteinase-9
TTDC00076	Disease	Advanced lung cancer
TTDC00076	Disease	Atherosclerosis
TTDC00076	Disease	Brain Cancer
TTDC00076	Disease	Guillain-Barre syndrome
TTDC00076	Disease	Hormone-refractory Prostate cancer
TTDC00076	Disease	Kaposi's Sarcoma
TTDC00076	Disease	Lung Cancer
TTDC00076	Disease	Multiple sclerosis
TTDC00076	Disease	Non-small Cell Lung Cancer
TTDC00076	Disease	Osteoarthritis
TTDC00076	Disease	Pancreatic Cancer
TTDC00076	Disease	Prostate cancer
TTDC00076	Disease	Renal Cell Carcinoma
TTDC00076	Disease	Restenosis
TTDC00076	Disease	Rheumatoid arthritis, unspecified
TTDC00076	Function	Could play a role in bone osteoclastic resorption.
TTDC00076	Sequence	MSLWQPLVLVLLVLGCCFAAPRQRQSTLVLFPGDLRTNLTDRQLAEEYLYRYGYTRVAEMRGESKSLGPALLLLQKQLSL
TTDC00076	PDB Structure	1GKC; 1GKD; 1ITV; 1L6J; 1LKG; 2OVX; 2OVZ; 2OW0; 2OW1; 2OW2; 4H1Q; 4H2E; 4H3X; 4H
TTDC00076	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00076	Pathway	Bladder cancer
TTDC00076	Pathway	Leukocyte transendothelial migration
TTDC00076	Pathway	Pathways in cancer
TTDC00076	EC Number	EC 3.4.24.35
TTDC00076	Related US Patent	6,310,084
TTDC00076	Related US Patent	6,541,489
TTDC00076	Related US Patent	6,624,144
TTDC00076	Related US Patent	6,630,501
TTDC00076	Related US Patent	6,667,388
TTDC00076	Target Validation	TTDC00076
TTDC00076	QSAR Model	TTDC00076
TTDC00076	Drug(s)	GS-5745
TTDC00076	Drug(s)	Neovastat
TTDC00076	Drug(s)	PG-116800
TTDC00076	Inhibitor	(+/-)5-(biphenyl-4-yl)-3-hydroxypentanoic acid
TTDC00076	Inhibitor	2-(4'-chloro-biphenyl-4-sulfonyl)-pentanoic acid
TTDC00076	Inhibitor	2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide
TTDC00076	Inhibitor	2-(biphenyl-4-ylsulfonamido)pentanedioic acid
TTDC00076	Inhibitor	2-Amino-N,3,3-Trimethylbutanamide
TTDC00076	Inhibitor	3-(4-(2-phenylethynyl)benzoyl)pentanoic acid
TTDC00076	Inhibitor	3-(4-Phenylethynylbenzoyl)nonanoic acid
TTDC00076	Inhibitor	4-amino-3-(4-(hexyloxy)phenyl)-4-oxobutanoic acid
TTDC00076	Inhibitor	5-(4-Phenoxy-phenyl)-pyrimidine-2,4,6-trione
TTDC00076	Inhibitor	5-Biphenyl-4-yl-5-ethyl-pyrimidine-2,4,6-trione
TTDC00076	Inhibitor	5-Biphenyl-4-yl-5-hexyl-pyrimidine-2,4,6-trione
TTDC00076	Inhibitor	5-Hexyl-5-phenyl-pyrimidine-2,4,6-trione
TTDC00076	Inhibitor	5-Methyl-5-phenyl-pyrimidine-2,4,6-trione
TTDC00076	Inhibitor	BAY-12-9566
TTDC00076	Inhibitor	CGS-27023A
TTDC00076	Inhibitor	CIPEMASTAT
TTDC00076	Inhibitor	CURCUMIN
TTDC00076	Inhibitor	IK-682
TTDC00076	Inhibitor	ILOMASTAT
TTDC00076	Inhibitor	N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide
TTDC00076	Inhibitor	N-hydroxy-2,3-bis(phenylsulfonamido)propanamide
TTDC00076	Inhibitor	N-hydroxy-3-(2-oxo-2H-chromen-3-yl)propanamide
TTDC00076	Inhibitor	N-hydroxy-3-(6-methoxy-2-oxo-2H-chromen-3-yl)
TTDC00076	Inhibitor	Neovastat
TTDC00076	Inhibitor	PG-116800
TTDC00076	Inhibitor	RO-319790
TTDC00076	Inhibitor	RS-130830
TTDC00076	Inhibitor	Ro 28-2653
TTDC00076	Inhibitor	Ro-32-3555
TTDC00076	Inhibitor	Ro-37-9790
TTDC00076	Inhibitor	Roche 28-2653
TTDC00076	Inhibitor	SC-44463
TTDC00076	Inhibitor	SR-973
TTDC00076	Inhibitor	UK-356618
TTDC00076	Inhibitor	[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid
TTDC00076	Inhibitor	carboxylated glucosamine
TTDC00076	Inhibitor	folate gamma-hydroxamic acid
TTDC00076	Inhibitor	methotrexate gamma-L-phenylalaninehydroxamic acid
TTDC00076	Inhibitor	methotrexate gamma-L-proline-hydroxamic acid
TTDC00076	Inhibitor	methotrexate gamma-hydroxamic acid
TTDC00076	Multitarget	Neovastat
TTDC00076	Multitarget	PG-116800
TTDC00077	UniProt ID	Q05655
TTDC00077	Name	Protein kinase C, delta type
TTDC00077	Type of target	Clinical trial target
TTDC00077	Synonyms	NPKC-delta
TTDC00077	Synonyms	Protein Kinase C delta
TTDC00077	Disease	Cancer, unspecific
TTDC00077	Disease	Head and neck squamous cell carcinomas
TTDC00077	Disease	Melanoma metastasis
TTDC00077	Disease	Reperfusion Injury associated with Heart Attacks, or Acute Myocardial Infarction
TTDC00077	Function	This is calcium-independent, phospholipid-dependent, serine- and threonine-speci
TTDC00077	Sequence	MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEP
TTDC00077	PDB Structure	1YRK; 2YUU
TTDC00077	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00077	Pathway	Chemokine signaling pathway
TTDC00077	Pathway	Fc epsilon RI signaling pathway
TTDC00077	Pathway	GnRH signaling pathway
TTDC00077	Pathway	Tight junction
TTDC00077	Pathway	Type II diabetes mellitus
TTDC00077	Pathway	Vascular smooth muscle contraction
TTDC00077	EC Number	EC 2.7.1.-
TTDC00077	EC Number	EC 3.4.21.22
TTDC00077	Target Validation	TTDC00077
TTDC00077	Drug(s)	KAI-9803
TTDC00077	Inhibitor	13-Acetylphorbol
TTDC00077	Inhibitor	2,3,3-Triphenyl-acrylonitrile
TTDC00077	Inhibitor	2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile
TTDC00077	Inhibitor	3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile
TTDC00077	Inhibitor	3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile
TTDC00077	Inhibitor	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile
TTDC00077	Inhibitor	4-HYDROXYTAMOXIFEN
TTDC00077	Inhibitor	4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol
TTDC00077	Inhibitor	4-cycloheptyliden(4-hydroxyphenyl)methylphenol
TTDC00077	Inhibitor	4-cyclohexyliden(4-hydroxyphenyl)methylphenol
TTDC00077	Inhibitor	INDOLACTUM
TTDC00077	Inhibitor	Indolocarbazole analogue
TTDC00077	Inhibitor	Ingenol-3-bezoate
TTDC00077	Inhibitor	KAI-9803
TTDC00077	Inhibitor	LY-317644
TTDC00077	Inhibitor	LY-326449
TTDC00077	Inhibitor	PROSTRATIN
TTDC00077	Inhibitor	RO-316233
TTDC00077	Inhibitor	RO-320432
TTDC00077	Inhibitor	Ro-32-0557
TTDC00077	Inhibitor	THYMELEATOXIN
TTDC00077	Inhibitor	[2,2';5',2'']Terthiophen-4-yl-methanol
TTDC00077	Inhibitor	[2,2';5',2'']Terthiophene-4,5''-dicarbaldehyde
TTDC00077	Inhibitor	[2,2';5',2'']Terthiophene-4-carbaldehyde
TTDC00077	Inhibitor	phorbol 12,13-butyrate
TTDC00077	Activator	AD 198
TTDC00078	UniProt ID	P00740
TTDC00078	Name	Coagulation factor IX
TTDC00078	Type of target	Clinical trial target
TTDC00078	Synonyms	Christmas factor
TTDC00078	Synonyms	Factor IX
TTDC00078	Synonyms	PTC
TTDC00078	Synonyms	Plasma thromboplastin component
TTDC00078	Disease	Blood, Blood Forming Organ Disorders, Unspecified
TTDC00078	Disease	Cardiac Surgery
TTDC00078	Disease	Coronary Artery Disease
TTDC00078	Disease	Thrombosis
TTDC00078	Disease	Vascular Diseases
TTDC00078	Disease	Venous Thromboembolism
TTDC00078	Function	Factor ix is a vitamin k-dependent plasma protein that participates in the intri
TTDC00078	Sequence	MQRVNMIMAESPGLITICLLGYLLSAECTVFLDHENANKILNRPKRYNSGKLEEFVQGNLERECMEEKCSFEEAREVFEN
TTDC00078	PDB Structure	1CFH; 1CFI; 1EDM; 1IXA; 1MGX; 1NL0; 1RFN; 2WPH; 2WPI; 2WPJ; 2WPK; 2WPL; 2WPM; 3K
TTDC00078	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00078	Pathway	Complement and coagulation cascades
TTDC00078	EC Number	EC 3.4.21.22
TTDC00078	Target Validation	TTDC00078
TTDC00078	Drug(s)	RB-006
TTDC00078	Drug(s)	TTP889
TTDC00078	Inhibitor	2-amidino-4-iodobenzothiophene
TTDC00078	Inhibitor	4-Benzyloxybenzo[b]thiophene-2-carboxamidine
TTDC00078	Inhibitor	4-Phenyl-benzo[b]thiophene-2-carboxamidine
TTDC00078	Inhibitor	5-Benzyloxy-benzo[b]thiophene-2-carboxamidine
TTDC00078	Inhibitor	6-Benzyloxybenzo[b]thiophene-2-carboxamidine
TTDC00078	Inhibitor	Gamma-Carboxy-Glutamic Acid
TTDC00078	Inhibitor	RAZAXABAN
TTDC00078	Inhibitor	RAZAXABAN HYDROCHLORIDE
TTDC00078	Inhibitor	RB-006
TTDC00078	Inhibitor	SN-429
TTDC00078	Inhibitor	TTP889
TTDC00079	UniProt ID	Q9Y5N1
TTDC00079	Name	Histamine H3 receptor
TTDC00079	Type of target	Clinical trial target
TTDC00079	Synonyms	G protein-coupled receptor 97
TTDC00079	Synonyms	HH3R
TTDC00079	Synonyms	Histamine receptor 3
TTDC00079	Disease	Acid-related diseases
TTDC00079	Disease	Allergic rhinitis, unspecified
TTDC00079	Disease	Alzheimer's disease
TTDC00079	Disease	Attention-deficit hyperactivity disorder
TTDC00079	Disease	Central nervous system diseases
TTDC00079	Disease	Inflammatory diseases
TTDC00079	Disease	Schizophrenia
TTDC00079	Function	The h3 subclass of histamine receptors could mediate the histamine signals in cn
TTDC00079	Sequence	MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISD
TTDC00079	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00079	Pathway	Neuroactive ligand-receptor interaction
TTDC00079	Related US Patent	6,436,939
TTDC00079	Related US Patent	6,506,756
TTDC00079	Related US Patent	6,518,287
TTDC00079	Related US Patent	6,528,522
TTDC00079	Related US Patent	6,559,140
TTDC00079	Target Validation	TTDC00079
TTDC00079	QSAR Model	TTDC00079
TTDC00079	Drug(s)	239512
TTDC00079	Drug(s)	ABT-239
TTDC00079	Drug(s)	ABT-652
TTDC00079	Drug(s)	AZD5213
TTDC00079	Drug(s)	Cipralisant
TTDC00079	Drug(s)	GSK1004723
TTDC00079	Drug(s)	GSK239512
TTDC00079	Drug(s)	GSK835726
TTDC00079	Drug(s)	HPP404
TTDC00079	Drug(s)	SAR110894
TTDC00079	Inhibitor	(1H-indol-2-yl)(piperazin-1-yl)methanone
TTDC00079	Inhibitor	(1R,2R)-2-(1H-Imidazol-4-yl)-1-methyl-propylamine
TTDC00079	Inhibitor	(1R,2S)-2-(1H-Imidazol-4-yl)-1-methyl-propylamine
TTDC00079	Inhibitor	(1S,2S)-2-(1H-Imidazol-4-yl)-cyclopentylamine
TTDC00079	Inhibitor	(R)-1-(2-methoxyphenethyl)-2-methylpyrrolidine
TTDC00079	Inhibitor	(R)-1-(3-methoxyphenethyl)-2-methylpyrrolidine
TTDC00079	Inhibitor	(R)-1-(4-methoxyphenethyl)-2-methylpyrrolidine
TTDC00079	Inhibitor	(R)-1-(4-nitrophenethyl)-2-methylpyrrolidine
TTDC00079	Inhibitor	(R)-2-(1H-Imidazol-4-yl)-1-methyl-ethylamine
TTDC00079	Inhibitor	(R)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)phenol
TTDC00079	Inhibitor	(R)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine
TTDC00079	Inhibitor	(R)-2-methyl-1-(2-m-tolyl-ethyl)-pyrrolidine
TTDC00079	Inhibitor	(R)-2-methyl-1-(2-p-tolyl-ethyl)-pyrrolidine
TTDC00079	Inhibitor	(R)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate
TTDC00079	Inhibitor	(R)-3-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine
TTDC00079	Inhibitor	(R)-4-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine
TTDC00079	Inhibitor	(R)-6-(2-(2-methylpyrrolidin-1-yl)ethyl)quinoline
TTDC00079	Inhibitor	(S)-1-(2-methoxyphenethyl)-2-methylpyrrolidine
TTDC00079	Inhibitor	(S)-1-(3-methoxyphenethyl)-2-methylpyrrolidine
TTDC00079	Inhibitor	(S)-1-(4-methoxyphenethyl)-2-methylpyrrolidine
TTDC00079	Inhibitor	(S)-1-(4-nitrophenethyl)-2-methylpyrrolidine
TTDC00079	Inhibitor	(S)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)phenol
TTDC00079	Inhibitor	(S)-2-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine
TTDC00079	Inhibitor	(S)-2-methyl-1-(2-m-tolyl-ethyl)-pyrrolidine
TTDC00079	Inhibitor	(S)-2-methyl-1-(2-p-tolyl-ethyl)-pyrrolidine
TTDC00079	Inhibitor	(S)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate
TTDC00079	Inhibitor	(S)-4-(2-(2-methylpyrrolidin-1-yl)ethyl)pyridine
TTDC00079	Inhibitor	1-(2-(naphthalen-2-yl)ethyl)pyrrolidine
TTDC00079	Inhibitor	1-(2-m-tolyl-ethyl)-pyrrolidine
TTDC00079	Inhibitor	1-(2-methoxyphenethyl)pyrrolidine
TTDC00079	Inhibitor	1-(2-p-tolyl-ethyl)-pyrrolidine
TTDC00079	Inhibitor	1-(3-(2-(3-methoxyphenoxy)ethoxy)propyl)azepane
TTDC00079	Inhibitor	1-(3-(3-phenylpropoxy)propyl)piperidine
TTDC00079	Inhibitor	1-(3-(4-(2-fluoroethyl)phenoxy)propyl)piperidine
TTDC00079	Inhibitor	1-(3-(4-(fluoromethyl)phenoxy)propyl)piperidine
TTDC00079	Inhibitor	1-(3-methoxyphenethyl)pyrrolidine
TTDC00079	Inhibitor	1-(4-(benzyloxy)phenethyl)pyrrolidine
TTDC00079	Inhibitor	1-(4-methoxyphenethyl)pyrrolidine
TTDC00079	Inhibitor	1-(4-nitrophenethyl)pyrrolidine
TTDC00079	Inhibitor	1-[2-(2,4,6-trimethyl-phenyl)-ethyl]-pyrrolidine
TTDC00079	Inhibitor	2-((1H-imidazol-4-yl)methyl)pyridine
TTDC00079	Inhibitor	2-((2-ethoxyphenoxy)methyl)-4-isopropylmorpholine
TTDC00079	Inhibitor	2-(1,4'-bipiperidin-1'-yl)thiazolo[4,5-b]pyridine
TTDC00079	Inhibitor	2-(1,4'-bipiperidin-1'-yl)thiazolo[4,5-c]pyridine
TTDC00079	Inhibitor	2-(1H-Imidazol-4-yl)-cyclopropylamine
TTDC00079	Inhibitor	2-(2-(pyrrolidin-1-yl)ethyl)-1H-indole
TTDC00079	Inhibitor	2-(2-(pyrrolidin-1-yl)ethyl)phenol
TTDC00079	Inhibitor	2-(2-(pyrrolidin-1-yl)ethyl)pyridine
TTDC00079	Inhibitor	2-(3-Methyl-3H-imidazol-4-yl)-ethylamine
TTDC00079	Inhibitor	2-(4-Cyclopentyl-piperazin-1-yl)-quinoline
TTDC00079	Inhibitor	2-(4-Cyclopropyl-piperazin-1-yl)-quinoline
TTDC00079	Inhibitor	2-(4-Isopropyl-piperazin-1-yl)-quinoline
TTDC00079	Inhibitor	2-(4-Methyl-piperazin-1-yl)-quinoline
TTDC00079	Inhibitor	2-(4-Propyl-piperazin-1-yl)-quinoline
TTDC00079	Inhibitor	2-(ethoxycarbonyl)-1H-indole-5-carboxylic acid
TTDC00079	Inhibitor	2-[2-(1H-Imidazol-4-yl)-cyclopropyl]-ethylamine
TTDC00079	Inhibitor	2-[4-(1-Ethyl-propyl)-piperazin-1-yl]-quinoline
TTDC00079	Inhibitor	3-((1H-imidazol-4-yl)methyl)pyridine
TTDC00079	Inhibitor	4-((1H-Imidazol-4-yl)methyl)-1-phenylpiperidine
TTDC00079	Inhibitor	4-((1H-imidazol-4-yl)methyl)-1-heptylpiperidine
TTDC00079	Inhibitor	4-((2R,3S)-2-Methyl-pyrrolidin-3-yl)-1H-imidazole
TTDC00079	Inhibitor	4-((2S,3R)-2-Methyl-pyrrolidin-3-yl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(3,4-Dimethylphenylamino)ethyl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(3-tert-Butylphenylamino)ethyl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(4-Cyclohexylphenylamino)ethyl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(4-Methoxyphenylamino)ethyl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(4-Methylphenylamino)ethyl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(4-tert-Butylphenylamino)ethyl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(40-tert-butylphenylthio)ethyl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(Cyclohexylamino)ethyl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(Phenylamino)ethyl)-1H-imidazole
TTDC00079	Inhibitor	4-(2-(pyrrolidin-1-yl)ethyl)pyridine
TTDC00079	Inhibitor	4-(3-Phenoxy-propyl)-1H-imidazole
TTDC00079	Inhibitor	4-(4-Phenyl-butyl)-1H-imidazole
TTDC00079	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDC00079	Inhibitor	4-(6-Cyclohexyl-hex-3-ynyl)-1H-imidazole
TTDC00079	Inhibitor	4-(6-Cyclopentyl-hex-3-ynyl)-1H-imidazole
TTDC00079	Inhibitor	4-(7,7-Dimethyl-oct-3-ynyl)-1H-imidazole
TTDC00079	Inhibitor	4-(7-Methyl-oct-3-ynyl)-1H-imidazole
TTDC00079	Inhibitor	4-(8-Phenyl-oct-3-ynyl)-1H-imidazole
TTDC00079	Inhibitor	4-Benzyl-1-[3-phenylpropoxy)propyl]piperidine
TTDC00079	Inhibitor	4-Butyl-1-[3-(phenylpropoxy)propyl]piperidine
TTDC00079	Inhibitor	4-Hept-3-ynyl-1H-imidazole
TTDC00079	Inhibitor	4-Hex-3-ynyl-1H-imidazole
TTDC00079	Inhibitor	4-Propyl-1-[3-(phenylpropoxy)propyl]piperidine
TTDC00079	Inhibitor	4-[3-(4-Butyl-phenoxy)-propyl]-1H-imidazole
TTDC00079	Inhibitor	4-[3-(4-Ethynyl-phenoxy)-propyl]-1H-imidazole
TTDC00079	Inhibitor	4-[3-(4-Methoxy-phenoxy)-propyl]-1H-imidazole
TTDC00079	Inhibitor	4-isopropyl-2-(phenoxymethyl)morpholine
TTDC00079	Inhibitor	5-(2-(pyrrolidin-1-yl)ethyl)isothiazole
TTDC00079	Inhibitor	5-ethyl-2-(2-(pyrrolidin-1-yl)ethyl)pyridine
TTDC00079	Inhibitor	5-methoxy-2-(2-(pyrrolidin-1-yl)ethyl)-1H-indole
TTDC00079	Inhibitor	5-phenyl-2-(4-(piperidin-1-yl)butyl)oxazole
TTDC00079	Inhibitor	A-349821
TTDC00079	Inhibitor	APLYSAMINE
TTDC00079	Inhibitor	C-[2-(1H-Imidazol-4-yl)-cyclopropyl]-methylamine
TTDC00079	Inhibitor	CARCININE
TTDC00079	Inhibitor	CONESSINE
TTDC00079	Inhibitor	GR-175737
TTDC00079	Inhibitor	GSK-189254
TTDC00079	Inhibitor	GT-2016
TTDC00079	Inhibitor	IODOPROXYFAN
TTDC00079	Inhibitor	JNJ-28583867
TTDC00079	Inhibitor	JNJ-7777120
TTDC00079	Inhibitor	N-alpha-methylhistamine
TTDC00079	Inhibitor	N-benzyl-4-cyclopentylpiperazine-1-carboxamide
TTDC00079	Inhibitor	N-methyl-2-(pyridin-2-yl)ethanamine
TTDC00079	Inhibitor	ST-1025
TTDC00079	Inhibitor	ST-1093
TTDC00079	Inhibitor	TIPROLISANT
TTDC00079	Inhibitor	UCL-1972
TTDC00079	Inhibitor	UCL-2138
TTDC00079	Inhibitor	VERONGAMINE
TTDC00079	Inhibitor	VUF-10214
TTDC00079	Inhibitor	VUF-5296
TTDC00079	Inhibitor	VUF-5297
TTDC00079	Inhibitor	aerophobin-1
TTDC00079	Inhibitor	des-bromoaplysamine-1
TTDC00079	Antagonist	A-317920
TTDC00079	Antagonist	A-331440
TTDC00079	Antagonist	ABT-239
TTDC00079	Antagonist	Ciproxifan
TTDC00079	Antagonist	Clobenpropit
TTDC00079	Antagonist	FUB 649
TTDC00079	Antagonist	GSK1004723
TTDC00079	Antagonist	GSK189254A
TTDC00079	Antagonist	GSK239512
TTDC00079	Antagonist	GSK835726
TTDC00079	Antagonist	HPP404
TTDC00079	Antagonist	JNJ-10181457
TTDC00079	Antagonist	JNJ-5207852
TTDC00079	Antagonist	NNC 0038-0000-1202
TTDC00079	Antagonist	Proxyfan
TTDC00079	Antagonist	SAR110894
TTDC00079	Antagonist	SCH79687
TTDC00079	Antagonist	Thioperamide
TTDC00079	Antagonist	UCL-1390
TTDC00079	Antagonist	UCL1972
TTDC00079	Antagonist	VUF 5681
TTDC00079	Antagonist	VUF5391
TTDC00079	Agonist	(R)-alpha-methylhistamine
TTDC00079	Agonist	Imetit
TTDC00079	Agonist	Immepip
TTDC00079	Agonist	Immethridine
TTDC00079	Agonist	Methimepip
TTDC00079	Ligand	Cipralisant
TTDC00079	Multitarget	GSK1004723
TTDC00079	Multitarget	GSK835726
TTDC00080	UniProt ID	P05231
TTDC00080	Name	Interleukin-6
TTDC00080	Type of target	Clinical trial target
TTDC00080	Synonyms	B-cell stimulatory factor 2
TTDC00080	Synonyms	BSF-2
TTDC00080	Synonyms	CDF
TTDC00080	Synonyms	CTL differentiation factor
TTDC00080	Synonyms	Hybridoma growth factor
TTDC00080	Synonyms	IL-6
TTDC00080	Synonyms	Interferon beta-2
TTDC00080	Disease	Cachexia
TTDC00080	Disease	Glioblastoma multiforme
TTDC00080	Disease	Hyperinflammatory provoked organ injury
TTDC00080	Disease	Inflammatory Disorders, Unspecified
TTDC00080	Disease	Multiple myeloma
TTDC00080	Disease	Osteoporosis, unspecified
TTDC00080	Disease	Systemic-onset juvenile idiopathic arthritis
TTDC00080	Function	Il-6 is a cytokine with a wide variety of biological functions: it plays an esse
TTDC00080	Sequence	MNSFSTSAFGPVAFSLGLLLVLPAAFPAPVPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCES
TTDC00080	PDB Structure	1ALU; 1IL6; 1N2Q; 1P9M; 2IL6
TTDC00080	BioChemical Class	Growth factor
TTDC00080	Pathway	Cytokine-cytokine receptor interaction
TTDC00080	Pathway	Graft-versus-host disease
TTDC00080	Pathway	Hematopoietic cell lineage
TTDC00080	Pathway	Jak-STAT signaling pathway
TTDC00080	Pathway	Pathways in cancer
TTDC00080	Pathway	Toll-like receptor signaling pathway
TTDC00080	Related US Patent	6,419,944
TTDC00080	Related US Patent	6,455,520
TTDC00080	Target Validation	TTDC00080
TTDC00080	Drug(s)	BMS-945429
TTDC00080	Drug(s)	C326
TTDC00080	Drug(s)	Ibudilast
TTDC00080	Drug(s)	Sirukumab
TTDC00080	Inhibitor	C326
TTDC00080	Inhibitor	Ibudilast
TTDC00080	Multitarget	Ibudilast
TTDC00081	UniProt ID	P24394
TTDC00081	Name	Interleukin-4 receptor alpha chain
TTDC00081	Type of target	Clinical trial target
TTDC00081	Synonyms	CD124 antigen
TTDC00081	Synonyms	IL-4R
TTDC00081	Synonyms	IL-4R-alpha
TTDC00081	Disease	Asthma
TTDC00081	Disease	Brain Cancer
TTDC00081	Disease	Cancer, unspecific
TTDC00081	Disease	Gastric carcinoma
TTDC00081	Disease	Kidney Cancer
TTDC00081	Disease	Lung Cancer
TTDC00081	Function	This is a receptor for interleukin 4. A soluble form of the il4 receptor may rep
TTDC00081	Sequence	MGWLCSGLLFPVSCLVLLQVASSGNMKVLQEPTCVSDYMSISTCEWKMNGPTNCSTELRLLYQLVFLLSEAHTCIPENNG
TTDC00081	PDB Structure	1IAR; 1IRS; 1ITE; 3BPL; 3BPN; 3BPO
TTDC00081	BioChemical Class	Transmembrane protein
TTDC00081	Pathway	Cytokine-cytokine receptor interaction
TTDC00081	Pathway	Hematopoietic cell lineage
TTDC00081	Pathway	Jak-STAT signaling pathway
TTDC00081	Related US Patent	6,376,524
TTDC00081	Target Validation	TTDC00081
TTDC00081	Drug(s)	AMG 317
TTDC00081	Drug(s)	Aerovant
TTDC00081	Drug(s)	PRX-321
TTDC00081	Drug(s)	SAR231893
TTDC00081	Antagonist	AMG 317
TTDC00081	Antagonist	Aerovant
TTDC00081	Agonist	PRX-321
TTDC00082	UniProt ID	P32238
TTDC00082	Name	Cholecystokinin type A receptor
TTDC00082	Type of target	Clinical trial target
TTDC00082	Synonyms	CCK-A receptor
TTDC00082	Synonyms	CCK-AR
TTDC00082	Disease	Acid-related diseases
TTDC00082	Disease	Alcoholism
TTDC00082	Disease	Gastroesophageal Reflux Disease (GERD)
TTDC00082	Disease	Gastrointestinal Diseases and Disorders, miscellaneous
TTDC00082	Disease	Gastrointestinal motility disorders
TTDC00082	Disease	Irritable Bowel Syndrome (IBS)
TTDC00082	Disease	Obesity
TTDC00082	Disease	Pancreatic Cancer
TTDC00082	Function	Receptor for cholecystokinin. Has a 1000-fold higher affinity for cck rather tha
TTDC00082	Sequence	MDVVDSLLVNGSNITPPCELGLENETLFCLDQPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFL
TTDC00082	PDB Structure	1D6G; 1HZN; 1PB2
TTDC00082	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00082	Pathway	Calcium signaling pathway
TTDC00082	Pathway	Neuroactive ligand-receptor interaction
TTDC00082	Target Validation	TTDC00082
TTDC00082	QSAR Model	TTDC00082
TTDC00082	Drug(s)	A-71378
TTDC00082	Drug(s)	A-74498
TTDC00082	Drug(s)	AR-R-1589
TTDC00082	Drug(s)	Dexloxiglumide
TTDC00082	Drug(s)	FPL-14294
TTDC00082	Drug(s)	GG-8573
TTDC00082	Drug(s)	GI 181771
TTDC00082	Drug(s)	GI-181771
TTDC00082	Drug(s)	Lintitript
TTDC00082	Drug(s)	PD-170292
TTDC00082	Drug(s)	Tarazepide
TTDC00082	Drug(s)	UCL-2000 and butabindide
TTDC00082	Inhibitor	1-(3,3-Diphenyl-allyl)-3-m-tolyl-urea
TTDC00082	Inhibitor	1-(4-Chloro-phenyl)-3-(3,3-diphenyl-allyl)-urea
TTDC00082	Inhibitor	1-(4-Chloro-phenyl)-3-(3-pentyl-oct-2-enyl)-urea
TTDC00082	Inhibitor	3,4-Dichloro-N-(3,3-diphenyl-allyl)-benzamide
TTDC00082	Inhibitor	Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
TTDC00082	Inhibitor	Asp-Tyr(SO3Na)-Met-Gly-Trp-Met-Asp-Phe-NH2
TTDC00082	Inhibitor	Boc-Asp-Tyr(So3-)-Nle-Gly-Trp-Asp-Phe-NH2
TTDC00082	Inhibitor	Boc-D-Glu-Tyr(SO3H)-Nle-D-Lys-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	Boc-D-Glu-Tyr(SO3H)-Nle-D-Nle-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	Boc-Glu-Tyr(SO3H)-Nle-D-Lys-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	Boc-Tyr(SO3H)-Nle-Gly-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	Boc-cyclo-(Glu-Tyr-Nle-D-Lys)-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	CI-988
TTDC00082	Inhibitor	CR-1795
TTDC00082	Inhibitor	CR-2345
TTDC00082	Inhibitor	FR-175985
TTDC00082	Inhibitor	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-H
TTDC00082	Inhibitor	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-D-Trp-H
TTDC00082	Inhibitor	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-Trp-Boc
TTDC00082	Inhibitor	H-Tyr-D-Ala-Gly-Phe-NH-NH-Trp-D-Nle-D-Asp-D-Phe-H
TTDC00082	Inhibitor	IQM-95333
TTDC00082	Inhibitor	L-365260
TTDC00082	Inhibitor	L-708474
TTDC00082	Inhibitor	L-740093
TTDC00082	Inhibitor	PD-135118
TTDC00082	Inhibitor	PD-135666
TTDC00082	Inhibitor	PD-136621
TTDC00082	Inhibitor	PD-137337
TTDC00082	Inhibitor	PD-137342
TTDC00082	Inhibitor	PD-138915
TTDC00082	Inhibitor	PD-138916
TTDC00082	Inhibitor	PD-140547
TTDC00082	Inhibitor	PD-140548
TTDC00082	Inhibitor	PD-140723
TTDC00082	Inhibitor	Pranazepide
TTDC00082	Inhibitor	SINCALIDE
TTDC00082	Inhibitor	SNF-9007
TTDC00082	Inhibitor	Tetragastrin
TTDC00082	Inhibitor	Tyr-D-Ala-Gly-D-Trp-NMeNle-Asp-Phe-NH2
TTDC00082	Inhibitor	Tyr-D-Ala-Gly-D-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-NMeNle-D-Trp-Boc
TTDC00082	Inhibitor	Tyr-D-Ala-Gly-Trp-NMeNle-Asp-Phe-NH2
TTDC00082	Inhibitor	Tyr-D-Ala-Gly-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	Tyr-D-Nle-Gly-D-Trp-NMeNle-Asp-Phe-NH2
TTDC00082	Inhibitor	Tyr-D-Nle-Gly-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	Tyr-D-Phe-Gly-D-Trp-NMeNle-Asp-Phe-NH2
TTDC00082	Inhibitor	Tyr-D-Phe-Gly-D-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	Tyr-D-Phe-Gly-Trp-NMeNle-Asp-Phe-NH2
TTDC00082	Inhibitor	Tyr-D-Phe-Gly-Trp-Nle-Asp-Phe-NH2
TTDC00082	Inhibitor	VL-0395
TTDC00082	Inhibitor	VL-0494
TTDC00082	Inhibitor	VL-0699
TTDC00082	Inhibitor	VL-1499
TTDC00082	Inhibitor	VL-2799
TTDC00082	Antagonist	Asperlicin
TTDC00082	Antagonist	Devazepide
TTDC00082	Antagonist	Dexloxiglumide
TTDC00082	Antagonist	L-364,718
TTDC00082	Antagonist	Lintitript
TTDC00082	Antagonist	Lorglumide
TTDC00082	Antagonist	Loxiglumide
TTDC00082	Antagonist	Tarazepide
TTDC00082	Agonist	A-71378
TTDC00082	Agonist	A-74498
TTDC00082	Agonist	AR-R-1589
TTDC00082	Agonist	FPL-14294
TTDC00082	Agonist	GG-8573
TTDC00082	Agonist	GI 181771
TTDC00082	Agonist	GI-181771
TTDC00082	Agonist	PD-170292
TTDC00082	Agonist	UCL-2000 and butabindide
TTDC00082	Multitarget	UCL-2000 and butabindide
TTDC00084	UniProt ID	P52333
TTDC00084	Name	Tyrosine-protein kinase JAK3
TTDC00084	Type of target	Successful target
TTDC00084	Synonyms	JAK-3
TTDC00084	Synonyms	Janus kinase 3
TTDC00084	Synonyms	L-JAK
TTDC00084	Synonyms	Leukocyte janus kinase
TTDC00084	Disease	Acute graft-versus-host disease
TTDC00084	Disease	Chronic graft-versus-host disease
TTDC00084	Disease	Immunosuppression
TTDC00084	Disease	Rheumatoid-arthritis
TTDC00084	Function	Tyrosine kinase of the non-receptor type, involved in the interleukin-2 and inte
TTDC00084	Sequence	MAPPSEETPLIPQRSCSLLSTEAGALHVLLPARGPGPPQRLSFSFGDHLAEDLCVQAAKASGILPVYHSLFALATEDLSC
TTDC00084	PDB Structure	1YVJ; 3LXK; 3LXL; 3PJC; 4HVD; 4HVG; 4HVH; 4HVI
TTDC00084	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00084	Pathway	Chemokine signaling pathway
TTDC00084	Pathway	Jak-STAT signaling pathway
TTDC00084	Pathway	Primary immunodeficiency
TTDC00084	EC Number	EC 2.7.1.112
TTDC00084	Related US Patent	6,313,130
TTDC00084	Related US Patent	6,326,373
TTDC00084	Related US Patent	6,452,005
TTDC00084	Target Validation	TTDC00084
TTDC00084	Drug(s)	CP-690,550
TTDC00084	Drug(s)	R348
TTDC00084	Drug(s)	Tofacitinib
TTDC00084	Inhibitor	6-o-tolylquinazolin-2-amine
TTDC00084	Inhibitor	AG490
TTDC00084	Inhibitor	CP-690,550
TTDC00084	Inhibitor	CP-690550
TTDC00084	Inhibitor	NC1153
TTDC00084	Inhibitor	PNU156804
TTDC00084	Inhibitor	R348
TTDC00084	Inhibitor	atropisomer 1
TTDC00085	UniProt ID	P09871
TTDC00085	Name	Complement C1s component
TTDC00085	Type of target	Successful target
TTDC00085	Synonyms	C1 esterase
TTDC00085	Synonyms	C1-esterase
TTDC00085	Disease	Hereditary Angioedema
TTDC00085	Disease	Inflammation
TTDC00085	Function	C1s b chain is a serine protease that combines with c1q and c1s to form c1, the
TTDC00085	Sequence	MWCIVLFSLLAWVYAEPTMYGEILSPNYPQAYPSEVEKSWDIEVPEGYGIHLYFTHLDIELSENCAYDSVQIISGDTEEG
TTDC00085	PDB Structure	1ELV; 1NZI; 4J1Y
TTDC00085	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00085	Pathway	Complement and coagulation cascades
TTDC00085	Pathway	Systemic lupus erythematosus
TTDC00085	EC Number	EC 3.4.21.42
TTDC00085	Target Validation	TTDC00085
TTDC00085	Drug(s)	C1-INH
TTDC00085	Drug(s)	Cinryze
TTDC00085	Drug(s)	Recombinant human C1 inhibitor
TTDC00085	Drug(s)	Rhucin
TTDC00085	Drug(s)	Romiplostim
TTDC00085	Drug(s)	Tanaproget
TTDC00085	Inhibitor	C1-INH
TTDC00085	Inhibitor	Cinryze
TTDC00085	Inhibitor	Fucose
TTDC00085	Inhibitor	Recombinant human C1 inhibitor
TTDC00085	Inhibitor	Rhucin
TTDC00085	Inhibitor	Romiplostim
TTDC00085	Inhibitor	Tanaproget
TTDC00086	UniProt ID	P24557
TTDC00086	Name	Thromboxane-A synthase
TTDC00086	Type of target	Clinical trial target
TTDC00086	Synonyms	TS
TTDC00086	Synonyms	TXA synthase
TTDC00086	Synonyms	TXS
TTDC00086	Synonyms	Thromboxane A2 synthase
TTDC00086	Disease	Asthma
TTDC00086	Disease	Cardiovascular disease, unspecified
TTDC00086	Disease	Cerebral circulatory disorders
TTDC00086	Disease	Inflammatory Bowel Disease
TTDC00086	Disease	Ischemic heart disease
TTDC00086	Disease	Peripheral Vascular Disease
TTDC00086	Disease	Thromboembolic disorders
TTDC00086	Sequence	MEALGFLKLEVNGPMVTVALSVALLALLKWYSTSAFSRLEKLGLRHPKPSPFIGNLTFFRQGFWESQMELRKLYGPLCGY
TTDC00086	BioChemical Class	Intramolecular oxidoreductases
TTDC00086	Pathway	Arachidonic acid metabolism
TTDC00086	Pathway	Metabolic pathways
TTDC00086	EC Number	EC 5.3.99.5
TTDC00086	Target Validation	TTDC00086
TTDC00086	Drug(s)	NM-702
TTDC00086	Drug(s)	NV-52
TTDC00086	Inhibitor	2-(10-Imidazol-1-yl-decyl)-isoindole-1,3-dione
TTDC00086	Inhibitor	2-(6-Imidazol-1-yl-hexyl)-isoindole-1,3-dione
TTDC00086	Inhibitor	2-(8-Imidazol-1-yl-octyl)-isoindole-1,3-dione
TTDC00086	Inhibitor	4-Methyl-pyridine
TTDC00086	Inhibitor	5-(2-Imidazol-1-yl-ethyl)-7,8-dihydro-quinoline
TTDC00086	Inhibitor	5-Imidazol-1-yl-5,6,7,8-tetrahydro-quinoline
TTDC00086	Inhibitor	6-Imidazol-1-yl-isoquinoline
TTDC00086	Inhibitor	CGS-13080
TTDC00086	Inhibitor	CGS-22652
TTDC00086	Inhibitor	Dazoxiben
TTDC00086	Inhibitor	NM-702
TTDC00086	Inhibitor	NV-52
TTDC00086	Inhibitor	ONO-1581
TTDC00086	Inhibitor	Ozagrel
TTDC00086	Inhibitor	Ozagrel hydrochloride
TTDC00086	Inhibitor	PYRIDINE
TTDC00086	Multitarget	NM-702
TTDC00087	UniProt ID	P25025
TTDC00087	Name	High affinity interleukin-8 receptor B
TTDC00087	Type of target	Clinical trial target
TTDC00087	Synonyms	CDw128b
TTDC00087	Synonyms	CXCR-2
TTDC00087	Synonyms	GRO/MGSA receptor
TTDC00087	Synonyms	IL-8 receptor type 2
TTDC00087	Synonyms	IL-8R B
TTDC00087	Synonyms	Interleukin-8 receptor B
TTDC00087	Disease	Acute respiratory distress syndrome
TTDC00087	Disease	Asthma
TTDC00087	Disease	Chronic Obstructive Pulmonary Disease (COPD)
TTDC00087	Disease	Colorectal cancer
TTDC00087	Disease	Lung injury
TTDC00087	Function	Receptor to interleukin-8, which is a powerful neutrophils chemotactic factor. B
TTDC00087	Sequence	MEDFNMESDSFEDFWKGEDLSNYSYSSTLPPFLLDAAPCEPESLEINKYFVVIIYALVFLLSLLGNSLVMLVILYSRVGR
TTDC00087	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00087	Pathway	Chemokine signaling pathway
TTDC00087	Pathway	Cytokine-cytokine receptor interaction
TTDC00087	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDC00087	Target Validation	TTDC00087
TTDC00087	Drug(s)	1325756
TTDC00087	Drug(s)	AZD5069
TTDC00087	Drug(s)	PS-938285
TTDC00087	Drug(s)	Reparixin
TTDC00087	Drug(s)	SB-265610
TTDC00087	Drug(s)	SB-656933
TTDC00087	Drug(s)	SCH-527123
TTDC00087	Inhibitor	(R)-2-(4-Isobutyl-phenyl)-N-methoxy-propionamide
TTDC00087	Inhibitor	(R)-2-(4-Isobutyl-phenyl)-propionamide
TTDC00087	Inhibitor	(R)-3-(4-Isobutyl-phenyl)-butan-2-one
TTDC00087	Inhibitor	(R)-N-Hydroxy-2-(4-isobutyl-phenyl)-propionamide
TTDC00087	Inhibitor	1-(2-Hydroxy-3-nitro-phenyl)-3-phenyl-urea
TTDC00087	Inhibitor	1-(2-Hydroxy-5-nitro-phenyl)-3-phenyl-urea
TTDC00087	Inhibitor	1-(2-bromophenyl)-3-(4-cyano-2-hydroxyphenyl)urea
TTDC00087	Inhibitor	1-(2-hydroxy-4-nitrophenyl)-3-phenylurea
TTDC00087	Inhibitor	1-(3-cyano-2-hydroxyphenyl)-3-phenylurea
TTDC00087	Inhibitor	1-(4-cyano-2-hydroxyphenyl)-3-phenylurea
TTDC00087	Inhibitor	1-(5-chloro-2-hydroxy-4-nitrophenyl)-3-phenylurea
TTDC00087	Inhibitor	2-(3-Isobutyl-phenyl)-propionic acid
TTDC00087	Inhibitor	2-(3-Isopropyl-phenyl)-propionic acid
TTDC00087	Inhibitor	2-[3-(1-Hydroxy-propyl)-phenyl]-propionic acid
TTDC00087	Inhibitor	2-[3-(1-Phenyl-ethyl)-phenyl]-propionic acid
TTDC00087	Inhibitor	2-[3-(2-Methyl-butyl)-phenyl]-propionic acid
TTDC00087	Inhibitor	5-(pentylthio)thiazolo[4,5-d]pyrimidin-7-ol
TTDC00087	Inhibitor	IBUPROPHEN
TTDC00087	Inhibitor	INDOPROFEN
TTDC00087	Inhibitor	R-KETOPROFEN
TTDC00087	Inhibitor	RAPARIXIN
TTDC00087	Antagonist	N-(3-(aminosulfonyl)-4-chloro-2-hydroxyphenyl)-N'-(2,3-dichlorophenyl) urea
TTDC00087	Antagonist	PS-938285
TTDC00087	Antagonist	Reparixin
TTDC00087	Antagonist	SB 225002
TTDC00087	Antagonist	SB 265610
TTDC00087	Antagonist	SB 272844
TTDC00087	Antagonist	SB-225002
TTDC00087	Antagonist	SB-265610
TTDC00087	Antagonist	SB-332235
TTDC00087	Antagonist	SB-656933
TTDC00087	Antagonist	SCH-527123
TTDC00087	Agonist	Il-8((3-73))K11R
TTDC00087	Multitarget	Reparixin
TTDC00087	Multitarget	SCH-527123
TTDC00088	UniProt ID	P24941
TTDC00088	Name	Cell division protein kinase 2
TTDC00088	Type of target	Clinical trial target
TTDC00088	Synonyms	CDK2
TTDC00088	Synonyms	Cyclin-dependent kinase 2
TTDC00088	Synonyms	P33 protein kinase
TTDC00088	Synonyms	SIN3-associated protein
TTDC00088	Synonyms	Sin3 associated polypeptide
TTDC00088	Disease	Acute lymphoblastic leukemia (ALL)
TTDC00088	Disease	Acute myeloid leukemia (AML)
TTDC00088	Disease	Advanced Solid tumors
TTDC00088	Disease	B-cell malignancies
TTDC00088	Disease	Cancer, unspecific
TTDC00088	Disease	Cardiovascular disease, unspecified
TTDC00088	Disease	Chronic lymphocytic leukemia (CLL)
TTDC00088	Disease	Hepatocellular Carcinoma (HCC)
TTDC00088	Disease	Nasopharyngeal Cancer (NPC)
TTDC00088	Disease	Non-Hodgkin's Lymphoma
TTDC00088	Disease	Non-small Cell Lung Cancer
TTDC00088	Disease	Solid tumors
TTDC00088	Disease	Viral infection, unspecified
TTDC00088	Function	Probably involved in the control of the cell cycle. Interacts with cyclins a, d,
TTDC00088	Sequence	MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF
TTDC00088	PDB Structure	1AQ1; 1B38; 1B39; 1BUH; 1CKP; 1DI8; 1DM2; 1E1V; 1E1X; 1E9H; 1F5Q; 1FIN; 1FQ1; 1F
TTDC00088	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00088	Pathway	Cell cycle
TTDC00088	Pathway	Pathways in cancer
TTDC00088	Pathway	Prostate cancer
TTDC00088	Pathway	Small cell lung cancer
TTDC00088	Pathway	p53 signaling pathway
TTDC00088	EC Number	EC 2.7.1.-
TTDC00088	EC Number	EC 2.7.1.37
TTDC00088	Related US Patent	6,387,919
TTDC00088	Related US Patent	6,465,507
TTDC00088	Related US Patent	6,541,503
TTDC00088	Related US Patent	6,635,640
TTDC00088	Target Validation	TTDC00088
TTDC00088	Drug(s)	AG-024322
TTDC00088	Drug(s)	AT7519
TTDC00088	Drug(s)	Capridine-beta
TTDC00088	Drug(s)	Flavopiridol
TTDC00088	Drug(s)	R-roscovitine
TTDC00088	Drug(s)	R547
TTDC00088	Drug(s)	Ro 31-7453
TTDC00088	Drug(s)	SCH 727965
TTDC00088	Drug(s)	SNS-032
TTDC00088	Drug(s)	Seliciclib
TTDC00088	Drug(s)	ZK 304709
TTDC00088	Inhibitor	(2'Z,3'E)-5-Chloro-5'-chloro-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Chloro-5'-fluoro-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Chloro-5'-hydroxy-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Chloro-5'-methyl-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-chloro-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-fluoro-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-hydroxy-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-methoxy-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-methyl-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Nitro-5'-chloro-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Nitro-5'-fluoro-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Nitro-5'-hydroxy-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Nitro-5'-methoxy-indirubin-3'-oxime
TTDC00088	Inhibitor	(2'Z,3'E)-5-Nitro-5'-methyl-indirubin-3'-oxime
TTDC00088	Inhibitor	1-Amino-6-Cyclohex-3-Enylmethyloxypurine
TTDC00088	Inhibitor	2-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol
TTDC00088	Inhibitor	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE
TTDC00088	Inhibitor	2-Amino-6-Chloropyrazine
TTDC00088	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDC00088	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDC00088	Inhibitor	3-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol
TTDC00088	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00088	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00088	Inhibitor	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
TTDC00088	Inhibitor	4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)-phenol
TTDC00088	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDC00088	Inhibitor	4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide
TTDC00088	Inhibitor	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
TTDC00088	Inhibitor	5-hydroxynaphthalene-1-sulfonamide
TTDC00088	Inhibitor	5-nitroindirubin-3'-oxime
TTDC00088	Inhibitor	6-(3-Amino-benzyloxy)-9H-purin-2-ylamine
TTDC00088	Inhibitor	6-(3-Methyl-benzyloxy)-9H-purin-2-ylamine
TTDC00088	Inhibitor	6-(Cyclohex-3-enylmethoxy)-9H-purin-2-ylamine
TTDC00088	Inhibitor	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE
TTDC00088	Inhibitor	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE
TTDC00088	Inhibitor	6-Cyclohexylmethoxy-pyrimidine-2,4,5-triamine
TTDC00088	Inhibitor	6-O-Cyclohexylmethyl Guanine
TTDC00088	Inhibitor	AG-024322
TTDC00088	Inhibitor	AT7519
TTDC00088	Inhibitor	AZD-0530
TTDC00088	Inhibitor	Alsterpaullone
TTDC00088	Inhibitor	Aminopurvalanol
TTDC00088	Inhibitor	BMS-536924
TTDC00088	Inhibitor	BOHEMINE
TTDC00088	Inhibitor	Benzyl-(9-isopropyl-9H-purin-6-yl)-amine
TTDC00088	Inhibitor	Capridine-beta
TTDC00088	Inhibitor	Double Oxidized Cysteine
TTDC00088	Inhibitor	Flavopiridol
TTDC00088	Inhibitor	GW-8510
TTDC00088	Inhibitor	Hymenialdisine
TTDC00088	Inhibitor	Indirubin-3'-Monoxime
TTDC00088	Inhibitor	Indirubin-3'-monoxime
TTDC00088	Inhibitor	Indirubin-5-sulfonate
TTDC00088	Inhibitor	JNJ-7706621
TTDC00088	Inhibitor	Lysine Nz-Carboxylic Acid
TTDC00088	Inhibitor	MERIOLIN 1
TTDC00088	Inhibitor	MERIOLIN 2
TTDC00088	Inhibitor	MERIOLIN 3
TTDC00088	Inhibitor	MERIOLIN 4
TTDC00088	Inhibitor	MERIOLIN 5
TTDC00088	Inhibitor	MERIOLIN 6
TTDC00088	Inhibitor	MERIOLIN 8
TTDC00088	Inhibitor	N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE
TTDC00088	Inhibitor	N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide
TTDC00088	Inhibitor	N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide
TTDC00088	Inhibitor	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide
TTDC00088	Inhibitor	N-phenyl-1H-pyrazole-3-carboxamide
TTDC00088	Inhibitor	NU-2058
TTDC00088	Inhibitor	NU-6027
TTDC00088	Inhibitor	NU-6086
TTDC00088	Inhibitor	NU-6094
TTDC00088	Inhibitor	NU-6102
TTDC00088	Inhibitor	OLOMOUCINE II
TTDC00088	Inhibitor	Olomoucine
TTDC00088	Inhibitor	Oxindole 95
TTDC00088	Inhibitor	PD-0183812
TTDC00088	Inhibitor	PF-228
TTDC00088	Inhibitor	PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE
TTDC00088	Inhibitor	PURVALANOLA
TTDC00088	Inhibitor	PYRAZOLOPYRIDAZINE 1
TTDC00088	Inhibitor	PYRAZOLOPYRIDAZINE 2
TTDC00088	Inhibitor	Purvalanol
TTDC00088	Inhibitor	Purvalanol B
TTDC00088	Inhibitor	R-roscovitine
TTDC00088	Inhibitor	R547
TTDC00088	Inhibitor	RESCOVITINE
TTDC00088	Inhibitor	Ro 31-7453
TTDC00088	Inhibitor	Roscovitine
TTDC00088	Inhibitor	SB-216763
TTDC00088	Inhibitor	SCH 727965
TTDC00088	Inhibitor	SNS-032
TTDC00088	Inhibitor	SU9516
TTDC00088	Inhibitor	Seliciclib
TTDC00088	Inhibitor	Staurosporine
TTDC00088	Inhibitor	TRIAZOLOPYRIMIDINE
TTDC00088	Inhibitor	ZK 304709
TTDC00088	Multitarget	AG-024322
TTDC00088	Multitarget	Capridine-beta
TTDC00088	Multitarget	R-roscovitine
TTDC00088	Multitarget	R547
TTDC00088	Multitarget	Ro 31-7453
TTDC00088	Multitarget	SCH 727965
TTDC00088	Multitarget	SNS-032
TTDC00088	Multitarget	ZK 304709
TTDC00089	UniProt ID	Q15761
TTDC00089	Name	Neuropeptide Y receptor type 5
TTDC00089	Type of target	Clinical trial target
TTDC00089	Synonyms	NPY-Y5 receptor
TTDC00089	Synonyms	NPY5-R
TTDC00089	Synonyms	NPYY5
TTDC00089	Synonyms	Neuropeptide Y (NPY) Y(5) receptor
TTDC00089	Synonyms	Neuropeptide Y receptor Y5
TTDC00089	Synonyms	Y5 receptor
TTDC00089	Disease	Epilepsy
TTDC00089	Disease	Obesity
TTDC00089	Disease	Opioid dependence
TTDC00089	Disease	Temporal lobe epilepsy
TTDC00089	Function	Receptor for neuropeptide y and peptide yy. The activity of this receptor is med
TTDC00089	Sequence	MDLELDEYYNKTLATENNTAATRNSDFPVWDDYKSSVDDLQYFLIGLYTFVSLLGFMGNLLILMALMKKRNQKTTVNFLI
TTDC00089	PDB Structure	2HE6
TTDC00089	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00089	Pathway	Neuroactive ligand-receptor interaction
TTDC00089	Related US Patent	6,313,298
TTDC00089	Related US Patent	6,399,631
TTDC00089	Related US Patent	6,444,687
TTDC00089	Related US Patent	6,495,559
TTDC00089	Related US Patent	6,569,856
TTDC00089	Related US Patent	6,632,828
TTDC00089	Related US Patent	6,638,942
TTDC00089	Related US Patent	6,667,319
TTDC00089	Target Validation	TTDC00089
TTDC00089	QSAR Model	TTDC00089
TTDC00089	Drug(s)	Axovan-3
TTDC00089	Drug(s)	CGP71683A
TTDC00089	Drug(s)	FR-79620
TTDC00089	Drug(s)	GW-594884A
TTDC00089	Drug(s)	NPY antagonist
TTDC00089	Drug(s)	NPY5RA-972
TTDC00089	Drug(s)	S-234462
TTDC00089	Drug(s)	Velneperit
TTDC00089	Inhibitor	2,4,4-triphenylimidazoline
TTDC00089	Inhibitor	AR-129330
TTDC00089	Inhibitor	ATC-0175
TTDC00089	Inhibitor	CGP-71683A
TTDC00089	Inhibitor	FR-226928
TTDC00089	Inhibitor	FR-230481
TTDC00089	Inhibitor	FR-233118
TTDC00089	Inhibitor	FR-73966
TTDC00089	Inhibitor	PYY(3-36)
TTDC00089	Antagonist	Axovan-3
TTDC00089	Antagonist	CGP71683A
TTDC00089	Antagonist	FR-79620
TTDC00089	Antagonist	GW-594884A
TTDC00089	Antagonist	NPY antagonist
TTDC00089	Antagonist	NPY-5 receptor antagonist
TTDC00089	Antagonist	NPY5RA-972
TTDC00089	Antagonist	S-19528
TTDC00089	Antagonist	S-234462
TTDC00089	Antagonist	S-25585
TTDC00089	Antagonist	Velneperit
TTDC00089	Agonist	Bis(31/31')[[Cys(31), Nva(34)]NPY(27-36)-NH(2)]
TTDC00090	UniProt ID	P21452
TTDC00090	Name	Substance-K receptor
TTDC00090	Type of target	Clinical trial target
TTDC00090	Synonyms	NK-2 receptor
TTDC00090	Synonyms	NK-2R
TTDC00090	Synonyms	Neurokinin A receptor
TTDC00090	Synonyms	SKR
TTDC00090	Synonyms	Tachykinin neurokinin 2 receptor
TTDC00090	Synonyms	Tachykinin receptor 2
TTDC00090	Disease	Analgesics
TTDC00090	Disease	Anxiety Disorders
TTDC00090	Disease	Asthma
TTDC00090	Disease	Depression
TTDC00090	Disease	Generalized Anxiety Disorders (GAD)
TTDC00090	Disease	Pain, Acute or Chronic
TTDC00090	Disease	Urinary incontinence
TTDC00090	Function	This is a receptor for the tachykinin neuropeptide substance k (neurokinin a). I
TTDC00090	Sequence	MGTCDIVTEANISSGPESNTTGITAFSMPSWQLALWATAYLALVLVAVTGNAIVIWIILAHRRMRTVTNYFIVNLALADL
TTDC00090	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00090	Related US Patent	6,207,678
TTDC00090	Related US Patent	6,235,735
TTDC00090	Related US Patent	6,265,614
TTDC00090	Related US Patent	6,319,917
TTDC00090	Related US Patent	6,339,094
TTDC00090	Related US Patent	6,358,994
TTDC00090	Related US Patent	6,365,602
TTDC00090	Related US Patent	6,372,754
TTDC00090	Related US Patent	6,403,582
TTDC00090	Related US Patent	6,403,601
TTDC00090	Related US Patent	6,407,106
TTDC00090	Related US Patent	6,432,952
TTDC00090	Related US Patent	6,432,953
TTDC00090	Related US Patent	6,479,518
TTDC00090	Related US Patent	6,500,818
TTDC00090	Related US Patent	6,534,502
TTDC00090	Related US Patent	6,569,872
TTDC00090	Related US Patent	6,583,142
TTDC00090	Related US Patent	6,638,930
TTDC00090	Related US Patent	6,664,253
TTDC00090	Related US Patent	6,676,950
TTDC00090	Related US Patent	6,780,875
TTDC00090	Target Validation	TTDC00090
TTDC00090	Drug(s)	CS-003
TTDC00090	Drug(s)	DNK-333
TTDC00090	Drug(s)	Nepadutant
TTDC00090	Drug(s)	SLV-332
TTDC00090	Drug(s)	SR 144190
TTDC00090	Drug(s)	Saredutant
TTDC00090	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDC00090	Inhibitor	A-987306
TTDC00090	Inhibitor	Ac-Phe-[Orn-Pro-cha-Trp-Arg]
TTDC00090	Inhibitor	Hoo-Phe-Orn-Pro-hle-Pff-Phe-NH2
TTDC00090	Inhibitor	L-732138
TTDC00090	Inhibitor	MEN-14933
TTDC00090	Inhibitor	WAY-207024
TTDC00090	Antagonist	CS-003
TTDC00090	Antagonist	DNK-333
TTDC00090	Antagonist	MEN13510
TTDC00090	Antagonist	Nepadutant
TTDC00090	Antagonist	SLV-332
TTDC00090	Antagonist	SR 144190
TTDC00090	Antagonist	SR48,968
TTDC00090	Antagonist	Saredutant
TTDC00090	Multitarget	CS-003
TTDC00090	Multitarget	DNK-333
TTDC00091	UniProt ID	P00491
TTDC00091	UniProt ID	Q6Y2E4
TTDC00091	UniProt ID	Q8T9Z7
TTDC00091	UniProt ID	Q9BMI9
TTDC00091	Name	Purine nucleoside phosphorylase
TTDC00091	Type of target	Clinical trial target
TTDC00091	Synonyms	Inosine phosphorylase
TTDC00091	Synonyms	PNP
TTDC00091	Synonyms	Purine-nucleoside phosphorylase
TTDC00091	Disease	B cell acute lymphoblastic leukemia (B-ALL)
TTDC00091	Disease	Cutaneous T-cell Lymphoma
TTDC00091	Disease	Malaria
TTDC00091	Disease	Moderate to Severe Plaque Psoriasis
TTDC00091	Disease	Psoriasis
TTDC00091	Disease	Refractory Cutaneous T-cell Lymphoma (CTCL)
TTDC00091	Disease	Schistosomiasis [bilharziasis]
TTDC00091	Disease	T-cell proliferation
TTDC00091	Disease	Trypanosomatid infections
TTDC00091	Disease	Tumors
TTDC00091	Sequence	MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYGEIPNFPRSTVPGHAGRLVFGFLNGRACVM
TTDC00091	PDB Structure	1TCU; 1TCV; 1TD1; 3DJF; 3E0Q; 3E9R; 3E9Z; 3F8W; 3FAZ; 3FB1; 3FNQ; 3IEX
TTDC00091	BioChemical Class	Glycosyltransferases
TTDC00091	Pathway	Metabolic pathways
TTDC00091	Pathway	Nicotinate and nicotinamide metabolism
TTDC00091	Pathway	Purine metabolism
TTDC00091	Pathway	Pyrimidine metabolism
TTDC00091	EC Number	EC 2.4.2.1
TTDC00091	Related US Patent	6,387,923
TTDC00091	Target Validation	TTDC00091
TTDC00091	Drug(s)	BCX-34
TTDC00091	Drug(s)	BCX-4208
TTDC00091	Drug(s)	Forodesine
TTDC00091	Inhibitor	(+/-)-5'-deoxy-4'-fluoro-5'-methylthio-DADMe-ImmH
TTDC00091	Inhibitor	2'3'-Dideoxyinosine
TTDC00091	Inhibitor	2,8-Diamino-9-benzyl-1,9-dihydro-purin-6-one
TTDC00091	Inhibitor	2-Hydroxymethyl-Pyrrolidine-3,4-Diol
TTDC00091	Inhibitor	3-((2-Pyrrolidine-1-yl)-ethyl)uracil
TTDC00091	Inhibitor	3-Deoxyguanosine
TTDC00091	Inhibitor	5'-Methylthio-ImmH
TTDC00091	Inhibitor	5'-deoxy-4'-hydroxy-5'-methylthio-DADMe-ImmH
TTDC00091	Inhibitor	5'-methylthio-immucillin-H
TTDC00091	Inhibitor	5'-phenylthio-ImmH
TTDC00091	Inhibitor	8-AMINOGUANINE
TTDC00091	Inhibitor	8-Azaguanine
TTDC00091	Inhibitor	8-Iodo-Guanine
TTDC00091	Inhibitor	8-amino-5'-deoxy-5'-chloroguanosine
TTDC00091	Inhibitor	8-amino-9-benzylguanine
TTDC00091	Inhibitor	8-aminoguanosine
TTDC00091	Inhibitor	8-aza-DADMe-ImmH
TTDC00091	Inhibitor	9-(5',5'-difluoro-5'-phosphonopentyl)guanine
TTDC00091	Inhibitor	9-(5,5-Difluoro-5-Phosphonopentyl)Guanine
TTDC00091	Inhibitor	9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE
TTDC00091	Inhibitor	9-Deazahypoxanthine
TTDC00091	Inhibitor	9-Deazainosine
TTDC00091	Inhibitor	ACYCLOVIR DIPHOSPHATE
TTDC00091	Inhibitor	Acyclovir
TTDC00091	Inhibitor	Aza-C-nucleosides
TTDC00091	Inhibitor	BCX-34
TTDC00091	Inhibitor	BCX-3408;R-3421
TTDC00091	Inhibitor	BCX-4208
TTDC00091	Inhibitor	CI-972
TTDC00091	Inhibitor	DADMe-ImmG
TTDC00091	Inhibitor	DADMe-ImmH
TTDC00091	Inhibitor	Forodesine
TTDC00091	Inhibitor	GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE
TTDC00091	Inhibitor	GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE
TTDC00091	Inhibitor	Guanine
TTDC00091	Inhibitor	Guanosine
TTDC00091	Inhibitor	Hypoxanthine
TTDC00091	Inhibitor	Immucillin-G
TTDC00091	Inhibitor	Immucillin-H
TTDC00091	Inhibitor	MT-Immucillin-H
TTDC00091	Inhibitor	Peldesine
TTDC00091	Inhibitor	Ribose-1-Phosphate
TTDC00092	UniProt ID	P56817
TTDC00092	Name	Beta-secretase
TTDC00092	Type of target	Clinical trial target
TTDC00092	Synonyms	ASP2
TTDC00092	Synonyms	Asp 2
TTDC00092	Synonyms	Aspartyl protease 2
TTDC00092	Synonyms	BACE
TTDC00092	Synonyms	BACE1
TTDC00092	Synonyms	Beta-site APP cleaving enzyme
TTDC00092	Synonyms	Beta-site APP cleaving enzyme 1
TTDC00092	Synonyms	Beta-site AbetaPP-cleaving enzyme
TTDC00092	Synonyms	Beta-site amyloid precursor protein cleaving enzyme
TTDC00092	Synonyms	Beta-site amyloid precursor protein cleaving enzyme 1
TTDC00092	Synonyms	Memapsin-2
TTDC00092	Synonyms	Membrane-associated aspartic protease 2
TTDC00092	Synonyms	Transmembrane aspartic protease
TTDC00092	Disease	Alzheimer's disease
TTDC00092	Function	Responsible for the proteolytic processing of the amyloid precursor protein (app
TTDC00092	Sequence	MAQALPWLLLWMGAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMT
TTDC00092	PDB Structure	1FKN; 1M4H; 1PY1; 1SGZ; 1TQF; 1UJJ; 1UJK; 1W50; 1W51; 1XN2; 1XN3; 1XS7; 1YM2; 1Y
TTDC00092	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00092	Pathway	Alzheimer's disease
TTDC00092	EC Number	EC 3.4.23.46
TTDC00092	Related US Patent	6,326,393
TTDC00092	Related US Patent	6,432,933
TTDC00092	Related US Patent	6,562,783
TTDC00092	Target Validation	TTDC00092
TTDC00092	Drug(s)	(-)-CATECHINGALLATE
TTDC00092	Drug(s)	(2S)-2'-methoxy kurarinone
TTDC00092	Drug(s)	(S)-FLURBIPROFEN
TTDC00092	Drug(s)	4-(2-aminoethyl)-2-cyclohexylphenol
TTDC00092	Drug(s)	4-(2-aminoethyl)-2-ethylphenol
TTDC00092	Drug(s)	4-(4-FLUOROBENZYL)PIPERIDINE
TTDC00092	Drug(s)	6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE
TTDC00092	Drug(s)	7-Phloroethol
TTDC00092	Drug(s)	AP-2243
TTDC00092	Drug(s)	AZD3293
TTDC00092	Drug(s)	CTS-21166
TTDC00092	Drug(s)	Carbocyclic Peptidomimetic
TTDC00092	Drug(s)	DIECKOL
TTDC00092	Drug(s)	DIOXINODEHYDROECKOL
TTDC00092	Drug(s)	E2609
TTDC00092	Drug(s)	Eckol
TTDC00092	Drug(s)	GRL-7234
TTDC00092	Drug(s)	GSK-188909
TTDC00092	Drug(s)	Glu-Leu-Asp-Leu-(CHOH-CH2)-Ala-Ala-Glu-Phe
TTDC00092	Drug(s)	HPP-854
TTDC00092	Drug(s)	KMI-172
TTDC00092	Drug(s)	KMI-494
TTDC00092	Drug(s)	KMI-538
TTDC00092	Drug(s)	KMI-596
TTDC00092	Drug(s)	KURARINONE
TTDC00092	Drug(s)	KUSHENOL A
TTDC00092	Drug(s)	LEACHIANONE A
TTDC00092	Drug(s)	MK-8931
TTDC00092	Drug(s)	MMI-175
TTDC00092	Drug(s)	N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide
TTDC00092	Drug(s)	N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE
TTDC00092	Drug(s)	N~3~-BENZYLPYRIDINE-2,3-DIAMINE
TTDC00092	Drug(s)	OM00-3
TTDC00092	Drug(s)	Oxalyl-DAP derivative
TTDC00092	Drug(s)	PHLOROFUCOFUROECKOL A
TTDC00092	Drug(s)	R-flurbiprofen
TTDC00092	Drug(s)	RG7129
TTDC00092	Drug(s)	TRIPHLOROETHOL A
TTDC00092	Drug(s)	bis(7)-tacrine
TTDC00092	Drug(s)	sophoraflavanone G
TTDC00092	Inhibitor	(-)-CATECHINGALLATE
TTDC00092	Inhibitor	(2S)-2'-methoxy kurarinone
TTDC00092	Inhibitor	(S)-FLURBIPROFEN
TTDC00092	Inhibitor	4-(2-aminoethyl)-2-ethylphenol
TTDC00092	Inhibitor	4-(4-FLUOROBENZYL)PIPERIDINE
TTDC00092	Inhibitor	5,5-Diphenyl-2-iminohydantoin
TTDC00092	Inhibitor	6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE
TTDC00092	Inhibitor	7-Phloroethol
TTDC00092	Inhibitor	AP-2243
TTDC00092	Inhibitor	CTS-21166
TTDC00092	Inhibitor	Carbocyclic Peptidomimetic
TTDC00092	Inhibitor	DIECKOL
TTDC00092	Inhibitor	DIOXINODEHYDROECKOL
TTDC00092	Inhibitor	Eckol
TTDC00092	Inhibitor	GRL-7234
TTDC00092	Inhibitor	GSK-188909
TTDC00092	Inhibitor	Glu-Leu-Asp-Leu-(CHOH-CH2)-Ala-Ala-Glu-Phe
TTDC00092	Inhibitor	KMI-172
TTDC00092	Inhibitor	KMI-494
TTDC00092	Inhibitor	KMI-538
TTDC00092	Inhibitor	KMI-596
TTDC00092	Inhibitor	KURARINONE
TTDC00092	Inhibitor	KUSHENOL A
TTDC00092	Inhibitor	LEACHIANONE A
TTDC00092	Inhibitor	MMI-175
TTDC00092	Inhibitor	N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide
TTDC00092	Inhibitor	N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE
TTDC00092	Inhibitor	N~3~-BENZYLPYRIDINE-2,3-DIAMINE
TTDC00092	Inhibitor	OM00-3
TTDC00092	Inhibitor	Oxalyl-DAP derivative
TTDC00092	Inhibitor	PHLOROFUCOFUROECKOL A
TTDC00092	Inhibitor	R-flurbiprofen
TTDC00092	Inhibitor	TRIPHLOROETHOL A
TTDC00092	Inhibitor	bis(7)-tacrine
TTDC00092	Inhibitor	sophoraflavanone G
TTDC00093	UniProt ID	Q16602
TTDC00093	Name	Calcitonin gene-related peptide type 1 receptor
TTDC00093	Type of target	Clinical trial target
TTDC00093	Synonyms	CGRP receptor 1
TTDC00093	Synonyms	CGRP type 1 receptor
TTDC00093	Synonyms	Calcitonin gene-related peptide 1 receptor
TTDC00093	Synonyms	Calcitonin receptor-like receptor
TTDC00093	Disease	Cluster Headaches
TTDC00093	Disease	Diabetes mellitus
TTDC00093	Disease	Migraine
TTDC00093	Disease	Opioid dependence
TTDC00093	Function	This is a receptor for calcitonin gene-related peptide type 1. The activity of t
TTDC00093	Sequence	MEKKCTLNFLVLLPFFMILVTAELEESPEDSIQLGVTRNKIMTAQYECYQKIMQDPIQQAEGVYCNRTWDGWLCWNDVAA
TTDC00093	PDB Structure	3AQF; 3N7P; 3N7R; 3N7S
TTDC00093	BioChemical Class	G-protein coupled receptor (Secretin family)
TTDC00093	Pathway	Neuroactive ligand-receptor interaction
TTDC00093	Pathway	Vascular smooth muscle contraction
TTDC00093	Target Validation	TTDC00093
TTDC00093	Drug(s)	Telcagepant
TTDC00093	Inhibitor	BMS-694153
TTDC00093	Inhibitor	EPIMER A
TTDC00093	Inhibitor	FV-Aib-TDVGPFAF
TTDC00093	Inhibitor	FV-Hyp-TDVGPFAF
TTDC00093	Inhibitor	FV-Tic-TDVGPFAF
TTDC00093	Inhibitor	FVATDVGPFAF
TTDC00093	Inhibitor	FVPTDVG-Tic-FAF-Tic
TTDC00093	Inhibitor	FVPTDVGAFAF
TTDC00093	Inhibitor	FVPTDVGPFAF
TTDC00093	Inhibitor	ISOMER A
TTDC00093	Inhibitor	hCGRPalpha
TTDC00093	Antagonist	BIBN4096BS
TTDC00093	Antagonist	Telcagepant
TTDC00094	UniProt ID	P50613
TTDC00094	Name	Cell division protein kinase 7
TTDC00094	Type of target	Clinical trial target
TTDC00094	Synonyms	39 kDa protein kinase
TTDC00094	Synonyms	CAK
TTDC00094	Synonyms	CAK1
TTDC00094	Synonyms	CDK-activating kinase
TTDC00094	Synonyms	CDK7
TTDC00094	Synonyms	Cyclin-dependent kinase 7
TTDC00094	Synonyms	P39 Mo15
TTDC00094	Synonyms	STK1
TTDC00094	Synonyms	TFIIH basal transcription factor complex kinase subunit
TTDC00094	Disease	B-cell malignancies
TTDC00094	Disease	Cancer, unspecific
TTDC00094	Disease	Solid tumors
TTDC00094	Function	Cyclin-dependent kinases (cdks) are activated by the binding to a cyclin and med
TTDC00094	Sequence	MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA
TTDC00094	PDB Structure	1LG3; 1PA8; 1UA2; 2HIC
TTDC00094	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00094	Pathway	Cell cycle
TTDC00094	Pathway	Nucleotide excision repair
TTDC00094	EC Number	EC 2.7.1.-
TTDC00094	EC Number	EC 2.7.1.37
TTDC00094	Target Validation	TTDC00094
TTDC00094	Drug(s)	R-roscovitine
TTDC00094	Drug(s)	R547
TTDC00094	Drug(s)	SNS-032
TTDC00094	Drug(s)	ZK 304709
TTDC00094	Inhibitor	2,5-dichloro-N-p-tolylthiophene-3-sulfonamide
TTDC00094	Inhibitor	Flavopiridol
TTDC00094	Inhibitor	PF-228
TTDC00094	Inhibitor	Phosphonothreonine
TTDC00094	Inhibitor	R-roscovitine
TTDC00094	Inhibitor	R547
TTDC00094	Inhibitor	SNS-032
TTDC00094	Inhibitor	ZK 304709
TTDC00094	Multitarget	R-roscovitine
TTDC00094	Multitarget	R547
TTDC00094	Multitarget	SNS-032
TTDC00094	Multitarget	ZK 304709
TTDC00095	UniProt ID	P50750
TTDC00095	Name	Cell division protein kinase 9
TTDC00095	Type of target	Clinical trial target
TTDC00095	Synonyms	C-2K
TTDC00095	Synonyms	CDC2-related kinase
TTDC00095	Synonyms	Cyclin-dependent kinase 9
TTDC00095	Synonyms	Cyclin-dependent protein kinase Cdk9
TTDC00095	Synonyms	Serine/threonine-protein kinase PITALRE
TTDC00095	Synonyms	Similar to cyclin-dependent kinase 9
TTDC00095	Disease	Cancer, unspecific
TTDC00095	Disease	Heart disease, unspecified
TTDC00095	Disease	Leukemia, Unspecified
TTDC00095	Disease	Lymphoma, Unspecified
TTDC00095	Disease	Multiple Myeloma
TTDC00095	Disease	Solid tumors
TTDC00095	Function	Member of the cyclin-dependent kinase pair (cdk9/cyclin t) complex, also called
TTDC00095	Sequence	MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN
TTDC00095	PDB Structure	1PF6; 3BLH; 3BLQ; 3BLR; 3LQ5; 3MI9; 3MIA; 3MY1; 3TN8; 3TNH; 3TNI; 4BCF; 4BCG; 4B
TTDC00095	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00095	EC Number	EC 2.7.1.-
TTDC00095	EC Number	EC 2.7.1.37
TTDC00095	Target Validation	TTDC00095
TTDC00095	Drug(s)	P276-00
TTDC00095	Drug(s)	SCH 727965
TTDC00095	Drug(s)	SNS-032
TTDC00095	Drug(s)	ZK 304709
TTDC00095	Inhibitor	3-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol
TTDC00095	Inhibitor	4-(phenyldiazenyl)-1H-pyrazole-3,5-diamine
TTDC00095	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDC00095	Inhibitor	Flavopiridol
TTDC00095	Inhibitor	MERIOLIN 1
TTDC00095	Inhibitor	MERIOLIN 2
TTDC00095	Inhibitor	MERIOLIN 3
TTDC00095	Inhibitor	MERIOLIN 4
TTDC00095	Inhibitor	MERIOLIN 5
TTDC00095	Inhibitor	MERIOLIN 6
TTDC00095	Inhibitor	MERIOLIN 7
TTDC00095	Inhibitor	MERIOLIN 8
TTDC00095	Inhibitor	P276-00
TTDC00095	Inhibitor	SCH 727965
TTDC00095	Inhibitor	SNS-032
TTDC00095	Inhibitor	ZK 304709
TTDC00095	Binder	Deschloroflavopiridol
TTDC00095	Multitarget	P276-00
TTDC00095	Multitarget	SCH 727965
TTDC00095	Multitarget	SNS-032
TTDC00095	Multitarget	ZK 304709
TTDC00096	UniProt ID	P01579
TTDC00096	Name	Interferon gamma
TTDC00096	Type of target	Clinical trial target
TTDC00096	Synonyms	IFN-gamma
TTDC00096	Synonyms	Immune interferon
TTDC00096	Disease	Multiple sclerosis
TTDC00096	Disease	Psoriasis and Psoriatic Disorders
TTDC00096	Function	Produced by lymphocytes activated by specific antigens or mitogens. Ifn-gamma, i
TTDC00096	Sequence	MKYTSYILAFQLCIVLGSLGCYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLF
TTDC00096	PDB Structure	1EKU; 1FG9; 1FYH; 1HIG; 3BES
TTDC00096	Pathway	Allograft rejection
TTDC00096	Pathway	Cytokine-cytokine receptor interaction
TTDC00096	Pathway	Graft-versus-host disease
TTDC00096	Pathway	Jak-STAT signaling pathway
TTDC00096	Pathway	Natural killer cell mediated cytotoxicity
TTDC00096	Pathway	Proteasome
TTDC00096	Pathway	Regulation of autophagy
TTDC00096	Pathway	Systemic lupus erythematosus
TTDC00096	Pathway	T cell receptor signaling pathway
TTDC00096	Pathway	TGF-beta signaling pathway
TTDC00096	Pathway	Type I diabetes mellitus
TTDC00096	Target Validation	TTDC00096
TTDC00096	Drug(s)	AMG 811
TTDC00096	Drug(s)	CRx-191
TTDC00096	Drug(s)	Fontolizumab
TTDC00096	Drug(s)	Fumaric acid
TTDC00096	Inhibitor	CRx-191
TTDC00096	Antibody	Fontolizumab
TTDC00096	Binder	Fumaric acid
TTDC00096	Multitarget	CRx-191
TTDC00096	Aptamer	2'-NH2-30-ligand
TTDC00097	UniProt ID	P29474
TTDC00097	Name	Nitric-oxide synthase, endothelial
TTDC00097	Type of target	Clinical trial target
TTDC00097	Synonyms	CNOS
TTDC00097	Synonyms	Constitutive NOS
TTDC00097	Synonyms	EC-NOS
TTDC00097	Synonyms	ENOS
TTDC00097	Synonyms	Endothelial NOS
TTDC00097	Synonyms	Endothelial nitric oxide synthase
TTDC00097	Synonyms	NOS, type III
TTDC00097	Synonyms	NOSIII
TTDC00097	Disease	Angina
TTDC00097	Disease	Cardiovascular disease, unspecified
TTDC00097	Disease	Colon cancer
TTDC00097	Disease	Coronary Artery Disease
TTDC00097	Disease	Helminth infection
TTDC00097	Disease	Hypertension, Angina
TTDC00097	Disease	Inflammation
TTDC00097	Disease	Schizophrenia
TTDC00097	Disease	Sepsis
TTDC00097	Function	Produces nitric oxide (no) which is implicated in vascular smooth muscle relaxat
TTDC00097	Sequence	MGNLKSVAQEPGPPCGLGLGLGLGLCGKQGPATPAPEPSRAPASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSIT
TTDC00097	PDB Structure	1M9J; 1M9K; 1M9M; 1M9Q; 1M9R; 2LL7; 3EAH; 3NOS
TTDC00097	BioChemical Class	Oxidoreductases acting on paired donors
TTDC00097	EC Number	EC 1.14.13.39
TTDC00097	Related US Patent	6,225,305
TTDC00097	Related US Patent	6,297,276
TTDC00097	Related US Patent	6,344,473
TTDC00097	Related US Patent	6,344,483
TTDC00097	Related US Patent	6,355,689
TTDC00097	Related US Patent	6,362,195
TTDC00097	Related US Patent	6,372,733
TTDC00097	Related US Patent	6,391,887
TTDC00097	Related US Patent	6,403,830
TTDC00097	Related US Patent	6,410,542
TTDC00097	Related US Patent	6,451,821
TTDC00097	Related US Patent	6,465,518
TTDC00097	Related US Patent	6,465,686
TTDC00097	Related US Patent	6,495,606
TTDC00097	Related US Patent	6,525,051
TTDC00097	Related US Patent	6,545,170
TTDC00097	Related US Patent	6,552,052
TTDC00097	Related US Patent	6,576,780
TTDC00097	Related US Patent	6,579,883
TTDC00097	Related US Patent	6,586,471
TTDC00097	Related US Patent	6,586,474
TTDC00097	Related US Patent	6,620,848
TTDC00097	Related US Patent	6,670,473
TTDC00097	Target Validation	TTDC00097
TTDC00097	Drug(s)	ACCLAIM
TTDC00097	Drug(s)	L-NAME
TTDC00097	Drug(s)	L-NMMA
TTDC00097	Inhibitor	(5-Imino-[1,4]thiazepan-3-yl)-methanol
TTDC00097	Inhibitor	(5S,6R)-[Octahydro-quinolin-(2E)-ylidene]amine
TTDC00097	Inhibitor	(5S,6S)-[Octahydro-quinolin-(2E)-ylidene]amine
TTDC00097	Inhibitor	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin
TTDC00097	Inhibitor	(S)-2-Amino-5-(N-methyl-guanidino)-pentanoic acid
TTDC00097	Inhibitor	(S)-3-Propyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00097	Inhibitor	(S)-6-Amino-2-(2-imino-ethylamino)-hexanoic acid
TTDC00097	Inhibitor	1,2,4-Triazole-Carboxamidine
TTDC00097	Inhibitor	1-(2-amino-benzothiazol-5-yl)-2-ethyl-isothiourea
TTDC00097	Inhibitor	1-(2-amino-benzothiazol-6-yl)-2-ethyl-isothiourea
TTDC00097	Inhibitor	2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine
TTDC00097	Inhibitor	2-Amino-5-(N-nitro-guanidino)-pentanoic acid
TTDC00097	Inhibitor	2-Aminothiazoline
TTDC00097	Inhibitor	2-Methyl-2,4-Pentanediol
TTDC00097	Inhibitor	2-Methyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00097	Inhibitor	2-Propanol, Isopropanol
TTDC00097	Inhibitor	3,4-Dimethyl-pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	3-Bromo-1H-indazole-7-carbonitrile
TTDC00097	Inhibitor	3-Bromo-7-Nitroindazole
TTDC00097	Inhibitor	3-Ethyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00097	Inhibitor	3-Methyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00097	Inhibitor	3-Methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	3-bromo-7-nitro-1H-indazole
TTDC00097	Inhibitor	4,5-Dimethyl-pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	4-Ethyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine
TTDC00097	Inhibitor	4-Ethyl-5-methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	4-Ethyl-pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	4-Methyl-3,6-dihydro-1H-pyridin-(2Z)-ylideneamine
TTDC00097	Inhibitor	4-Methyl-5,6-dihydro-1H-pyridin-(2Z)-ylideneamine
TTDC00097	Inhibitor	4-Methyl-piperidin-(2E)-ylideneamine
TTDC00097	Inhibitor	4-Methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	4-methyl-6-propylpyridin-2-amine
TTDC00097	Inhibitor	4-methylpyridin-2-amine
TTDC00097	Inhibitor	5,6-Cyclic-Tetrahydropteridine
TTDC00097	Inhibitor	5-Ethyl-3-methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	5-Ethyl-4-methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	5-Methyl-pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	5-Nitroindazole
TTDC00097	Inhibitor	6-(2-Fluoropropyl)-4-methylpyridin-2-amine
TTDC00097	Inhibitor	6-(3-Fluoropropyl)-4-methylpyridin-2-amine
TTDC00097	Inhibitor	6-Nitroindazole
TTDC00097	Inhibitor	6-isobutyl-4-methylpyridin-2-amine
TTDC00097	Inhibitor	6s-5,6,7,8-Tetrahydrobiopterin
TTDC00097	Inhibitor	7-(2-Nitro-ethyl)-azepan-(2Z)-ylideneamine
TTDC00097	Inhibitor	7-Methyl-[1,4]thiazepan-(5E)-ylideneamine
TTDC00097	Inhibitor	7-Nitroindazole
TTDC00097	Inhibitor	7-Nitroindazole-2-Carboxamidine
TTDC00097	Inhibitor	AP-Cav
TTDC00097	Inhibitor	Acetate Ion
TTDC00097	Inhibitor	Azepan-(2Z)-ylideneamine
TTDC00097	Inhibitor	Cacodylate Ion
TTDC00097	Inhibitor	Ethylisothiourea
TTDC00097	Inhibitor	Heme
TTDC00097	Inhibitor	Hexahydro-cyclopenta[c]pyrrol-(1Z)-ylideneamine
TTDC00097	Inhibitor	Hydroxydimethylarsine Oxide
TTDC00097	Inhibitor	L-2-Amino-4-(Guanidinooxy)Butyric Acid
TTDC00097	Inhibitor	L-Homoarginine
TTDC00097	Inhibitor	L-NAME
TTDC00097	Inhibitor	L-NG-nitroarginine methyl ester
TTDC00097	Inhibitor	L-NIO
TTDC00097	Inhibitor	L-NMMA
TTDC00097	Inhibitor	L-Nw-nitroarginine
TTDC00097	Inhibitor	N,N-dimethylarginine
TTDC00097	Inhibitor	N-(3-(Aminomethyl)Benzyl)Acetamidine
TTDC00097	Inhibitor	N-(5-Amino-6-oxo-heptyl)-acetamidine
TTDC00097	Inhibitor	N-(Chlorophenyl)-N'-Hydroxyguanidine
TTDC00097	Inhibitor	N-Omega-Hydroxy-L-Arginine
TTDC00097	Inhibitor	N-omega-allyl-L-arginine
TTDC00097	Inhibitor	N-omega-propargyl-L-arginine
TTDC00097	Inhibitor	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane
TTDC00097	Inhibitor	N5-(1-iminobut-3-enyl)-L-ornithine
TTDC00097	Inhibitor	N5-(1-iminobutyl)-L-ornithine
TTDC00097	Inhibitor	N5-(1-iminopropyl)-L-ornithine
TTDC00097	Inhibitor	N5-Iminoethyl-L-Ornithine
TTDC00097	Inhibitor	Nitroarginine
TTDC00097	Inhibitor	Piperidin-(2E)-ylideneamine
TTDC00097	Inhibitor	Pyrrolidin-(2Z)-ylideneamine
TTDC00097	Inhibitor	S-(Dimethylarsenic)Cysteine
TTDC00097	Inhibitor	S-Ethyl-N-Phenyl-Isothiourea
TTDC00097	Inhibitor	S-Isopropyl-Isothiourea
TTDC00097	Inhibitor	Se-Ethyl-Isoselenourea
TTDC00097	Inhibitor	THIOCITRULLINE
TTDC00097	Inhibitor	Thiazolidin-(2E)-ylideneamine
TTDC00097	Inhibitor	[1,3]Oxazinan-(2E)-ylideneamine
TTDC00097	Inhibitor	[1,3]Thiazinan-(2E)-ylideneamine
TTDC00097	Inhibitor	[1,4]Oxazepan-(3E)-ylideneamine
TTDC00097	Inhibitor	[1,4]Thiazepan-(3E)-ylideneamine
TTDC00097	Inhibitor	[1,4]Thiazepan-(5E)-ylideneamine
TTDC00097	Inhibitor	l-NIL
TTDC00097	Stimulator	ACCLAIM
TTDC00098	UniProt ID	P16581
TTDC00098	Name	E-selectin
TTDC00098	Type of target	Clinical trial target
TTDC00098	Synonyms	CD62E
TTDC00098	Synonyms	CD62E antigen
TTDC00098	Synonyms	ELAM-1
TTDC00098	Synonyms	Endothelial leukocyte adhesion molecule 1
TTDC00098	Synonyms	LECAM2
TTDC00098	Synonyms	Leukocyte-endothelial cell adhesion molecule 2
TTDC00098	Disease	Asthma
TTDC00098	Disease	Atopic Dermatitis
TTDC00098	Disease	Chronic Obstructive Pulmonary Disease (COPD)
TTDC00098	Disease	Inflammatory skin disorder
TTDC00098	Disease	Ischemic stroke
TTDC00098	Disease	Psoriasis and Psoriatic Disorders
TTDC00098	Function	Expressed on cytokine induced endothelial cells and mediates their binding to le
TTDC00098	Sequence	MIASQFLSALTLVLLIKESGAWSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNV
TTDC00098	PDB Structure	1ESL; 1G1T; 1KJA
TTDC00098	BioChemical Class	Growth factor
TTDC00098	Pathway	Cell adhesion molecules (CAMs)
TTDC00098	Target Validation	TTDC00098
TTDC00098	Drug(s)	Bimosiamose
TTDC00098	Inhibitor	1na
TTDC00098	Inhibitor	Bimosiamose
TTDC00098	Inhibitor	Efomycine M
TTDC00098	Inhibitor	Fucose
TTDC00098	Inhibitor	O-Sialic Acid
TTDC00098	Antibody	Monoclonal antibodies
TTDC00099	UniProt ID	P11217
TTDC00099	Name	Glycogen phosphorylase, muscle form
TTDC00099	Type of target	Discontinued target
TTDC00099	Synonyms	Glycogen phosphorylase b
TTDC00099	Synonyms	Muscle glycogen phosphorylase
TTDC00099	Disease	Diabetes Mellitus Type 2
TTDC00099	Disease	Noninsulin-dependent diabetes mellitus
TTDC00099	Function	Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzy
TTDC00099	Sequence	MAKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCP
TTDC00099	PDB Structure	1Z8D
TTDC00099	BioChemical Class	Glycosyltransferases
TTDC00099	Pathway	Insulin signaling pathway
TTDC00099	Pathway	Starch and sucrose metabolism
TTDC00099	EC Number	EC 2.4.1.1
TTDC00099	Related US Patent	6,277,877
TTDC00099	Related US Patent	6,399,601
TTDC00099	Related US Patent	6,576,653
TTDC00099	Related US Patent	6,649,634
TTDC00099	Related US Patent	6,696,574
TTDC00099	Target Validation	TTDC00099
TTDC00099	Drug(s)	PSN357
TTDC00099	Inhibitor	1-D-glucopyranosyl cytosine
TTDC00099	Inhibitor	1-D-glucopyranosyl uracil
TTDC00099	Inhibitor	1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose
TTDC00099	Inhibitor	1-N-Acetyl-Beta-D-Glucosamine
TTDC00099	Inhibitor	2-Deoxy-Glucose-6-Phosphate
TTDC00099	Inhibitor	2-Hydroxyiminoolean-12-en-28-oic acid
TTDC00099	Inhibitor	2-Hydroxyiminours-12-en-28-oic acid
TTDC00099	Inhibitor	2-Oxoolean-12-en-28-oic acid
TTDC00099	Inhibitor	2-isooleanolic acid
TTDC00099	Inhibitor	2-isoursolic acid
TTDC00099	Inhibitor	23-hydroxybetulinic acid
TTDC00099	Inhibitor	2alpha-Hydroxyolean-12-en-28-oic acid
TTDC00099	Inhibitor	2alpha-Hydroxyurs-12-en-28-oic acid
TTDC00099	Inhibitor	2beta,3alpha-dihydroxyolean-12-en-28-oic acid
TTDC00099	Inhibitor	2beta,3alpha-dihydroxyurs-12-en-28-oic acid
TTDC00099	Inhibitor	3-Oxoolean-12-en-28-oic Acid
TTDC00099	Inhibitor	3alpha-Hydroxyurs-12-en-28-oic Acid
TTDC00099	Inhibitor	4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
TTDC00099	Inhibitor	ASIATIC ACID
TTDC00099	Inhibitor	Acurea
TTDC00099	Inhibitor	Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide
TTDC00099	Inhibitor	Alpha-D-Glucose-1-Phosphate
TTDC00099	Inhibitor	Alpha-D-Glucose-6-Phosphate
TTDC00099	Inhibitor	BETULIN
TTDC00099	Inhibitor	Benzyl 2-hydroxyiminoolean-12-en-28-oate
TTDC00099	Inhibitor	Beta-D-Glucopyranose Spirohydantoin
TTDC00099	Inhibitor	Beta-D-Glucose
TTDC00099	Inhibitor	Bzurea
TTDC00099	Inhibitor	C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide
TTDC00099	Inhibitor	C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide
TTDC00099	Inhibitor	Ethyl 2beta-hydroxyolean-12-en-28-oate
TTDC00099	Inhibitor	Flavopiridol
TTDC00099	Inhibitor	Fluoro-Phosphite Ion
TTDC00099	Inhibitor	Heptulose-2-Phosphate
TTDC00099	Inhibitor	ISOFAGOMINE
TTDC00099	Inhibitor	Indirubin-5-Sulphonate
TTDC00099	Inhibitor	Inosinic Acid
TTDC00099	Inhibitor	N'-Pyridoxyl-Lysine-5'-Monophosphate
TTDC00099	Inhibitor	N-Acetyl-N'-Beta-D-Glucopyranosyl Urea
TTDC00099	Inhibitor	N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea
TTDC00099	Inhibitor	Nojirimycine Tetrazole
TTDC00099	Inhibitor	OLEANOLIC_ACID
TTDC00099	Inhibitor	PSN357
TTDC00099	Inhibitor	Phosphonoserine
TTDC00099	Inhibitor	URSOLIC ACID
TTDC00099	Inhibitor	n-Butyl 2beta-hydroxyolean-12-en-28-oate
TTDC00100	UniProt ID	P41594
TTDC00100	Name	Metabotropic glutamate receptor 5
TTDC00100	Type of target	Clinical trial target
TTDC00100	Synonyms	5b
TTDC00100	Synonyms	Glutamate receptor mGLU5
TTDC00100	Synonyms	mGluR5
TTDC00100	Disease	Analgesics
TTDC00100	Disease	Anxiety Disorders
TTDC00100	Disease	Convulsions
TTDC00100	Disease	Depression
TTDC00100	Disease	Drug dependence
TTDC00100	Disease	Gastroesophageal Reflux Disease (GERD)
TTDC00100	Disease	Inflammatory pain
TTDC00100	Disease	Migraine and Cluster Headaches
TTDC00100	Disease	Neuronal injury
TTDC00100	Disease	Parkinson's disease
TTDC00100	Function	Receptor for glutamate. The activity of this receptor is mediated by a g-protein
TTDC00100	Sequence	MVLLLILSVLLLKEDVRGSAQSSERRVVAHMPGDIIIGALFSVHHQPTVDKVHERKCGAVREQYGIQRVEAMLHTLERIN
TTDC00100	PDB Structure	3LMK
TTDC00100	BioChemical Class	G-protein coupled receptor (metabotropic glutamate family)
TTDC00100	Pathway	Calcium signaling pathway
TTDC00100	Pathway	Gap junction
TTDC00100	Pathway	Huntington's disease
TTDC00100	Pathway	Long-term depression
TTDC00100	Pathway	Long-term potentiation
TTDC00100	Pathway	Neuroactive ligand-receptor interaction
TTDC00100	Related US Patent	6,660,753
TTDC00100	Target Validation	TTDC00100
TTDC00100	Drug(s)	ADX-48621
TTDC00100	Drug(s)	ADX10059
TTDC00100	Drug(s)	AFQ056
TTDC00100	Drug(s)	AZD2066
TTDC00100	Drug(s)	AZD2516
TTDC00100	Drug(s)	LY467711
TTDC00100	Drug(s)	LY525327
TTDC00100	Drug(s)	MGluRIII agonist and mGlu5 antagonist
TTDC00100	Drug(s)	McN3377
TTDC00100	Drug(s)	RG7090
TTDC00100	Drug(s)	STX107
TTDC00100	Inhibitor	GLUTAMATE
TTDC00100	Inhibitor	N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
TTDC00100	Inhibitor	N-(1,4-diphenyl-1H-pyrazol-5-yl)benzamide
TTDC00100	Inhibitor	N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide
TTDC00100	Inhibitor	N-(3-(3-cyanobenzamido)phenyl)-2-methoxybenzamide
TTDC00100	Inhibitor	N-(3-acetamidophenyl)-3-chlorobenzamide
TTDC00100	Inhibitor	N-(3-bromophenyl)-6-chloroquinazolin-4-amine
TTDC00100	Inhibitor	N-(3-bromophenyl)-6-fluoroquinazolin-4-amine
TTDC00100	Inhibitor	N-(3-chlorophenyl)-3-cyano-5-fluorobenzamide
TTDC00100	Inhibitor	N-(3-chlorophenyl)-6-fluoroquinazolin-4-amine
TTDC00100	Inhibitor	N-(3-chlorophenyl)-6-methoxyquinazolin-4-amine
TTDC00100	Inhibitor	N-(3-chlorophenyl)-6-nitroquinazolin-4-amine
TTDC00100	Inhibitor	N-(6-methylpyridin-2-yl)-5-phenylpicolinamide
TTDC00100	Inhibitor	N-(6-methylpyridin-2-yl)-6-phenylnicotinamide
TTDC00100	Inhibitor	N-(6-methylpyridin-2-yl)biphenyl-3-carboxamide
TTDC00100	Inhibitor	N-[4-(3-pyridylethynyl)-2-thiazolyl]acetamide
TTDC00100	Inhibitor	N-cyclopentyl-6-(2-phenylethynyl)nicotinamide
TTDC00100	Inhibitor	QUISQUALATE
TTDC00100	Inhibitor	SIB-1757
TTDC00100	Inhibitor	SIB-1893
TTDC00100	Antagonist	AZD2066
TTDC00100	Antagonist	AZD2516
TTDC00100	Antagonist	LY467711
TTDC00100	Antagonist	LY525327
TTDC00100	Antagonist	MGluRIII agonist and mGlu5 antagonist
TTDC00100	Modulator	ADX-48621
TTDC00100	Modulator	ADX10059
TTDC00100	Modulator	McN3377
TTDC00101	UniProt ID	Q16665
TTDC00101	Name	Hypoxia-inducible factor 1 alpha
TTDC00101	Type of target	Clinical trial target
TTDC00101	Synonyms	ARNT interacting protein
TTDC00101	Synonyms	HIF-1
TTDC00101	Synonyms	HIF-1 alpha
TTDC00101	Synonyms	HIF-1alpha
TTDC00101	Synonyms	HIF1 alpha
TTDC00101	Synonyms	Hypoxia inducible factor 1
TTDC00101	Synonyms	Hypoxia-inducible factor 1
TTDC00101	Synonyms	Hypoxia-inducible transcription factor (HIF)-1
TTDC00101	Synonyms	MOP1
TTDC00101	Synonyms	Member of PAS protein 1
TTDC00101	Synonyms	Transcription factor HIF-1
TTDC00101	Disease	Cancer, unspecific
TTDC00101	Disease	Chronic lung diseases
TTDC00101	Disease	Heart disease, unspecified
TTDC00101	Disease	Lymphoma, Unspecified
TTDC00101	Disease	Renal cancer
TTDC00101	Disease	Solid tumors
TTDC00101	Disease	Stroke
TTDC00101	Disease	Tumors
TTDC00101	Function	Functions as a master transcriptional regulator of the adaptive response to hypo
TTDC00101	Sequence	MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNVSSHLDKASVMRLTISYLRVRKLLDAGDLDI
TTDC00101	PDB Structure	1D7G; 1H2K; 1H2L; 1H2M; 1L3E; 1L8C; 1LM8; 1LQB; 2ILM; 3HQR; 3HQU; 4AJY; 4H6J
TTDC00101	Pathway	Pathways in cancer
TTDC00101	Pathway	Renal cell carcinoma
TTDC00101	Pathway	mTOR signaling pathway
TTDC00101	Target Validation	TTDC00101
TTDC00101	Drug(s)	HIF-1alpha
TTDC00101	Drug(s)	PX-478
TTDC00101	Inhibitor	HIF-1alpha
TTDC00101	Inhibitor	PX-478
TTDC00102	UniProt ID	P45983
TTDC00102	Name	Mitogen-activated protein kinase 8
TTDC00102	Type of target	Clinical trial target
TTDC00102	Synonyms	C-Jun N-terminal kinase 1
TTDC00102	Synonyms	JNK-46
TTDC00102	Synonyms	JNK1
TTDC00102	Synonyms	Stress-activated protein kinase JNK1
TTDC00102	Disease	Cancer, unspecific
TTDC00102	Disease	Crohn's disease, unspecified
TTDC00102	Disease	Hearing Loss
TTDC00102	Disease	Inflammatory Disorders, Unspecified
TTDC00102	Disease	Insulin resistance
TTDC00102	Disease	Obesity
TTDC00102	Function	Responds to activation by environmental stress and pro- inflammatory cytokines b
TTDC00102	Sequence	MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV
TTDC00102	PDB Structure	1UKH; 1UKI; 2G01; 2GMX; 2H96; 2NO3; 2XRW; 2XS0; 3ELJ; 3O17; 3O2M; 3PZE; 3V3V; 3V
TTDC00102	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00102	Pathway	Adipocytokine signaling pathway
TTDC00102	Pathway	Colorectal cancer
TTDC00102	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDC00102	Pathway	ErbB signaling pathway
TTDC00102	Pathway	Fc epsilon RI signaling pathway
TTDC00102	Pathway	Focal adhesion
TTDC00102	Pathway	GnRH signaling pathway
TTDC00102	Pathway	Insulin signaling pathway
TTDC00102	Pathway	MAPK signaling pathway
TTDC00102	Pathway	Pancreatic cancer
TTDC00102	Pathway	Pathways in cancer
TTDC00102	Pathway	Toll-like receptor signaling pathway
TTDC00102	Pathway	Type II diabetes mellitus
TTDC00102	Pathway	Wnt signaling pathway
TTDC00102	EC Number	EC 2.7.1.37
TTDC00102	Target Validation	TTDC00102
TTDC00102	Drug(s)	AM-111
TTDC00102	Drug(s)	CC-401
TTDC00102	Inhibitor	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One
TTDC00102	Inhibitor	2-(2-(butylamino)pyrimidin-4-ylamino)benzoic acid
TTDC00102	Inhibitor	2-(2-(pentyloxy)pyrimidin-4-ylamino)benzoic acid
TTDC00102	Inhibitor	2-(2-(phenylamino)pyrimidin-4-ylamino)benzamide
TTDC00102	Inhibitor	2-(2-butoxypyrimidin-4-ylamino)benzoic acid
TTDC00102	Inhibitor	2-(2-phenoxypyrimidin-4-ylamino)benzoic acid
TTDC00102	Inhibitor	2-(2-propoxypyrimidin-4-ylamino)benzoic acid
TTDC00102	Inhibitor	2-(2-sec-butoxypyrimidin-4-ylamino)benzoic acid
TTDC00102	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDC00102	Inhibitor	AM-111
TTDC00102	Inhibitor	AS-601245
TTDC00102	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDC00102	Inhibitor	CC-401
TTDC00102	Inhibitor	CEP-1347
TTDC00102	Inhibitor	CI-1040;PD-18435;PD-184352
TTDC00102	Inhibitor	GF-109203
TTDC00102	Inhibitor	Go-6976
TTDC00102	Inhibitor	KN-62
TTDC00102	Inhibitor	KT-5720
TTDC00102	Inhibitor	LY-294002
TTDC00102	Inhibitor	N-(4-amino-5-cyano-6-ethoxypyridin-2-yl)acetamide
TTDC00102	Inhibitor	N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide
TTDC00102	Inhibitor	N-(4-amino-6-butoxy-5-cyanopyridin-2-yl)acetamide
TTDC00102	Inhibitor	N-(6-ethoxypyridin-2-yl)acetamide
TTDC00102	Inhibitor	NM-PP1
TTDC00102	Inhibitor	PD-98059
TTDC00102	Inhibitor	RO-316233
TTDC00102	Inhibitor	SB-202190
TTDC00102	Inhibitor	SB-203580
TTDC00102	Inhibitor	SP-600125
TTDC00102	Inhibitor	STAUROSPORINONE
TTDC00102	Inhibitor	U-0126
TTDC00103	UniProt ID	P14174
TTDC00103	Name	Macrophage migration inhibitory factor
TTDC00103	Type of target	Clinical trial target
TTDC00103	Synonyms	GIF
TTDC00103	Synonyms	Glycosylation-inhibiting factor
TTDC00103	Synonyms	MIF
TTDC00103	Synonyms	Phenylpyruvate tautomerase
TTDC00103	Disease	Cancer, unspecific
TTDC00103	Disease	Glomerulonephritis
TTDC00103	Disease	Inflammation
TTDC00103	Disease	Inflammatory lung disease
TTDC00103	Disease	Inflammatory neurological disease
TTDC00103	Disease	Inflammatory response in alcoholic liver disease
TTDC00103	Disease	Rheumatoid arthritis, unspecified
TTDC00103	Disease	Sepsis
TTDC00103	Disease	Septic shock
TTDC00103	Disease	Systemic lupus erythematosus
TTDC00103	Disease	Ulcerative colitis
TTDC00103	Function	The expression of mif at sites of inflammation suggest a role for the mediator i
TTDC00103	Sequence	MPMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLL
TTDC00103	PDB Structure	1CA7; 1CGQ; 1GCZ; 1GD0; 1GIF; 1LJT; 1MIF; 1P1G; 2OOH; 2OOW; 2OOZ; 3B9S; 3CE4; 3D
TTDC00103	BioChemical Class	Intramolecular oxidoreductases
TTDC00103	Pathway	Phenylalanine metabolism
TTDC00103	Pathway	Tyrosine metabolism
TTDC00103	EC Number	EC 5.3.2.1
TTDC00103	Related US Patent	6,492,428
TTDC00103	Related US Patent	6,599,938
TTDC00103	Target Validation	TTDC00103
TTDC00103	Drug(s)	COR100140
TTDC00103	Inhibitor	3,4-Dihydroxycinnamic Acid
TTDC00103	Inhibitor	3-(4-HYDROXY-PHENYL)PYRUVIC ACID
TTDC00103	Inhibitor	4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME
TTDC00103	Inhibitor	6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE
TTDC00103	Inhibitor	AVP-13546
TTDC00103	Inhibitor	AVP-13748
TTDC00103	Inhibitor	COR100140
TTDC00103	Inhibitor	ISO-1
TTDC00103	Inhibitor	NAPQI
TTDC00104	UniProt ID	P08253
TTDC00104	Name	72 kDa type IV collagenase
TTDC00104	Type of target	Discontinued target
TTDC00104	Synonyms	72 kDa gelatinase
TTDC00104	Synonyms	Gelatinase A
TTDC00104	Synonyms	MMP-2
TTDC00104	Synonyms	Matrix metalloproteinase 2
TTDC00104	Synonyms	Matrix metalloproteinase-2
TTDC00104	Synonyms	TBE-1
TTDC00104	Disease	Brain Cancer
TTDC00104	Disease	Breast cancer
TTDC00104	Disease	Cancer, unspecific
TTDC00104	Disease	Hepatocellular carcinoma
TTDC00104	Disease	Hormone-refractory Prostate cancer
TTDC00104	Disease	Kaposi's Sarcoma
TTDC00104	Disease	Lung Cancer
TTDC00104	Disease	Non-small Cell Lung Cancer
TTDC00104	Disease	Osteoarthritis
TTDC00104	Disease	Pancreatic Cancer
TTDC00104	Disease	Prostate cancer
TTDC00104	Disease	Renal Cell Carcinoma
TTDC00104	Disease	Smooth muscle hyperplasia
TTDC00104	Sequence	MEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTDKELAVQYLNTFYGCPKESCNLFVLKDTLKKMQKF
TTDC00104	PDB Structure	1CK7; 1CXW; 1EAK; 1GEN; 1GXD; 1HOV; 1J7M; 1KS0; 1QIB; 1RTG; 3AYU
TTDC00104	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00104	EC Number	EC 3.4.24.24
TTDC00104	Related US Patent	6,265,432
TTDC00104	Related US Patent	6,297,247
TTDC00104	Related US Patent	6,307,089
TTDC00104	Related US Patent	6,310,084
TTDC00104	Related US Patent	6,350,885
TTDC00104	Related US Patent	6,399,612
TTDC00104	Related US Patent	6,420,408
TTDC00104	Related US Patent	6,492,422
TTDC00104	Related US Patent	6,541,489
TTDC00104	Related US Patent	6,624,144
TTDC00104	Related US Patent	6,624,196
TTDC00104	Related US Patent	6,630,501
TTDC00104	Target Validation	TTDC00104
TTDC00104	QSAR Model	TTDC00104
TTDC00104	Drug(s)	BB-3644
TTDC00104	Drug(s)	BMS 275291
TTDC00104	Drug(s)	Batimastat
TTDC00104	Drug(s)	Marimastat
TTDC00104	Drug(s)	Metastat
TTDC00104	Drug(s)	Neovastat
TTDC00104	Drug(s)	PG-116800
TTDC00104	Drug(s)	Prinomastat
TTDC00104	Drug(s)	RO-26-2853
TTDC00104	Drug(s)	Tanomastat
TTDC00104	Inhibitor	(+/-)5-(biphenyl-4-yl)-3-hydroxypentanoic acid
TTDC00104	Inhibitor	2-(4'-chloro-biphenyl-4-sulfonyl)-pentanoic acid
TTDC00104	Inhibitor	2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide
TTDC00104	Inhibitor	3-(4-(2-phenylethynyl)benzoyl)pentanoic acid
TTDC00104	Inhibitor	3-(4-Phenylethynylbenzoyl)nonanoic acid
TTDC00104	Inhibitor	4-(4-(dec-1-ynyl)phenyl)-4-oxobutanoic acid
TTDC00104	Inhibitor	5-(4-Phenoxy-phenyl)-pyrimidine-2,4,6-trione
TTDC00104	Inhibitor	5-Biphenyl-4-yl-5-ethyl-pyrimidine-2,4,6-trione
TTDC00104	Inhibitor	5-Biphenyl-4-yl-5-hexyl-pyrimidine-2,4,6-trione
TTDC00104	Inhibitor	5-Hexyl-5-phenyl-pyrimidine-2,4,6-trione
TTDC00104	Inhibitor	AG3340
TTDC00104	Inhibitor	BAY-12-9566
TTDC00104	Inhibitor	BB-1101
TTDC00104	Inhibitor	BB-3644
TTDC00104	Inhibitor	BMS 275291
TTDC00104	Inhibitor	Batimastat
TTDC00104	Inhibitor	CGS-27023A
TTDC00104	Inhibitor	CIPEMASTAT
TTDC00104	Inhibitor	Clinopodic acid C
TTDC00104	Inhibitor	EPIGALOCATECHIN GALLATE
TTDC00104	Inhibitor	IK-682
TTDC00104	Inhibitor	ILOMASTAT
TTDC00104	Inhibitor	L-696418
TTDC00104	Inhibitor	MMI270
TTDC00104	Inhibitor	Marimastat
TTDC00104	Inhibitor	Metastat
TTDC00104	Inhibitor	N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide
TTDC00104	Inhibitor	N-hydroxy-3-(2-oxo-2H-chromen-3-yl)propanamide
TTDC00104	Inhibitor	N-hydroxy-3-(6-methoxy-2-oxo-2H-chromen-3-yl)
TTDC00104	Inhibitor	Neovastat
TTDC00104	Inhibitor	PD-169469
TTDC00104	Inhibitor	PG-116800
TTDC00104	Inhibitor	PNU-107859
TTDC00104	Inhibitor	PNU-142372
TTDC00104	Inhibitor	Prinomastat
TTDC00104	Inhibitor	RO-26-2853
TTDC00104	Inhibitor	RS-130830
TTDC00104	Inhibitor	Ro-32-3555
TTDC00104	Inhibitor	Ro-37-9790
TTDC00104	Inhibitor	Roche 28-2653
TTDC00104	Inhibitor	SC-44463
TTDC00104	Inhibitor	SC-74020
TTDC00104	Inhibitor	SR-973
TTDC00104	Inhibitor	Tanomastat
TTDC00104	Inhibitor	UK-356618
TTDC00104	Inhibitor	[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid
TTDC00104	Inhibitor	cis-2-aminocyclohexylcarbamoylphosphonic acid
TTDC00104	Inhibitor	folate gamma-L-proline-hydroxamic acid
TTDC00104	Inhibitor	folate gamma-hydroxamic acid
TTDC00104	Inhibitor	lithospermic acid
TTDC00104	Inhibitor	methotrexate gamma-L-proline-hydroxamic acid
TTDC00104	Inhibitor	methotrexate gamma-hydroxamic acid
TTDC00104	Multitarget	BB-3644
TTDC00104	Multitarget	BMS 275291
TTDC00104	Multitarget	Batimastat
TTDC00104	Multitarget	Marimastat
TTDC00104	Multitarget	Neovastat
TTDC00104	Multitarget	PG-116800
TTDC00104	Multitarget	Prinomastat
TTDC00105	UniProt ID	P08254
TTDC00105	Name	Stromelysin-1
TTDC00105	Type of target	Discontinued target
TTDC00105	Synonyms	MMP-3
TTDC00105	Synonyms	Matrix metalloproteinase 3
TTDC00105	Synonyms	Matrix metalloproteinase-3
TTDC00105	Synonyms	SL-1
TTDC00105	Synonyms	Transin-1
TTDC00105	Disease	Brain Cancer
TTDC00105	Disease	Cancer, unspecific
TTDC00105	Disease	Lung Cancer
TTDC00105	Disease	Myocardial infarction (MI)
TTDC00105	Disease	Osteoarthritis
TTDC00105	Disease	Ovarian cancer
TTDC00105	Disease	Pancreatic Cancer
TTDC00105	Disease	Prostate cancer
TTDC00105	Function	Can degrade fibronectin, laminin, gelatins of type i, iii, iv, and v; collagens
TTDC00105	Sequence	MKSLPILLLLCVAVCSAYPLDGAARGEDTSMNLVQKYLENYYDLKKDVKQFVRRKDSGPVVKKIREMQKFLGLEVTGKLD
TTDC00105	PDB Structure	1B3D; 1B8Y; 1BIW; 1BM6; 1BQO; 1C3I; 1C8T; 1CAQ; 1CIZ; 1CQR; 1D5J; 1D7X; 1D8F; 1D
TTDC00105	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00105	EC Number	EC 3.4.24.17
TTDC00105	Related US Patent	6,265,432
TTDC00105	Related US Patent	6,297,247
TTDC00105	Related US Patent	6,307,089
TTDC00105	Related US Patent	6,350,885
TTDC00105	Related US Patent	6,350,907
TTDC00105	Related US Patent	6,399,612
TTDC00105	Related US Patent	6,420,408
TTDC00105	Related US Patent	6,492,422
TTDC00105	Related US Patent	6,624,196
TTDC00105	Target Validation	TTDC00105
TTDC00105	QSAR Model	TTDC00105
TTDC00105	Drug(s)	Galardin
TTDC00105	Drug(s)	PG-116800
TTDC00105	Drug(s)	PG-530742
TTDC00105	Inhibitor	1-Methyloxy-4-Sulfone-Benzene
TTDC00105	Inhibitor	3-Methylpyridine
TTDC00105	Inhibitor	5-Biphenyl-4-yl-5-ethyl-pyrimidine-2,4,6-trione
TTDC00105	Inhibitor	8-chloro-quinoline-3-carbonitrile
TTDC00105	Inhibitor	AM-2S
TTDC00105	Inhibitor	BAY-12-9566
TTDC00105	Inhibitor	BB-1101
TTDC00105	Inhibitor	CGS-27023A
TTDC00105	Inhibitor	CIPEMASTAT
TTDC00105	Inhibitor	FUTOENONE
TTDC00105	Inhibitor	Galardin
TTDC00105	Inhibitor	Hydroxyaminovaline
TTDC00105	Inhibitor	IK-682
TTDC00105	Inhibitor	ILOMASTAT
TTDC00105	Inhibitor	L-696418
TTDC00105	Inhibitor	MMI270
TTDC00105	Inhibitor	PD-169469
TTDC00105	Inhibitor	PG-116800
TTDC00105	Inhibitor	PG-530742
TTDC00105	Inhibitor	PKF-242-484;TNF-484
TTDC00105	Inhibitor	PNU-107859
TTDC00105	Inhibitor	PNU-142372
TTDC00105	Inhibitor	RO-319790
TTDC00105	Inhibitor	RS-130830
TTDC00105	Inhibitor	RS-39066
TTDC00105	Inhibitor	Ro-32-3555
TTDC00105	Inhibitor	Ro-37-9790
TTDC00105	Inhibitor	SC-44463
TTDC00105	Inhibitor	UK-356618
TTDC00105	Multitarget	PG-116800
TTDC00106	UniProt ID	P37268
TTDC00106	Name	Farnesyl-diphosphate farnesyltransferase
TTDC00106	Type of target	Discontinued target
TTDC00106	Synonyms	FPP:FPP farnesyltransferase
TTDC00106	Synonyms	SQS
TTDC00106	Synonyms	SS
TTDC00106	Synonyms	Squalene synthase
TTDC00106	Synonyms	Squalene synthetase
TTDC00106	Disease	Hypercholesterolemia
TTDC00106	Disease	Hyperlipidemia
TTDC00106	Disease	Hypocholesterolemia
TTDC00106	Sequence	MEFVKCLGHPEEFYNLVRFRIGGKRKVMPKMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALD
TTDC00106	PDB Structure	1EZF; 3ASX; 3LEE; 3Q2Z; 3Q30; 3V66; 3VJ8; 3VJ9; 3VJA; 3VJB; 3VJC
TTDC00106	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDC00106	Pathway	Biosynthesis of steroids
TTDC00106	Pathway	Metabolic pathways
TTDC00106	Pathway	Terpenoid biosynthesis
TTDC00106	EC Number	EC 2.5.1.21
TTDC00106	Target Validation	TTDC00106
TTDC00106	Drug(s)	Lapaquistat acetate
TTDC00106	Inhibitor	(Z)-3-[2-(9H-fluoren-2-yloxy)ethylidene]-quinuclidine hydrochloride 31
TTDC00106	Inhibitor	2-[4-(2-Thienyl)phenyl]-4-methylmorpholin-2-ol
TTDC00106	Inhibitor	3-[1'-{4'-(Benzyloxy)-phenyl}]-quinuclidine-2-ene
TTDC00106	Inhibitor	3-[7'-(Methoxy)-napht-2'-yl]-quinuclidine-2-ene
TTDC00106	Inhibitor	A-87049
TTDC00106	Inhibitor	BMS-187745
TTDC00106	Inhibitor	ER-119884
TTDC00106	Inhibitor	Lapaquistat acetate
TTDC00106	Inhibitor	N-hydroxyglycine derivative
TTDC00106	Inhibitor	SQ-34919
TTDC00106	Inhibitor	ZARAGOZIC ACID B
TTDC00106	Inhibitor	ZARAGOZIC ACIDS A
TTDC00106	Inhibitor	Zaragozic Acid C
TTDC00106	Inhibitor	Zaragozic Acid D
TTDC00106	Inhibitor	Zaragozic Acid D2
TTDC00106	Inhibitor	Zwitterionic sulfobetaine derivative
TTDC00106	Inhibitor	zaragozic acid C
TTDC00107	UniProt ID	Q9NR96
TTDC00107	Name	Toll-like receptor 9
TTDC00107	Type of target	Clinical trial target
TTDC00107	Synonyms	TLR-9
TTDC00107	Disease	Autoimmune diseases
TTDC00107	Disease	Colorectal Cancer
TTDC00107	Disease	Rheumatoid arthritis, unspecified
TTDC00107	Disease	Systemic Lupus Erythematosus
TTDC00107	Function	Participates in the innate immune response to microbial agents. Detects the unme
TTDC00107	Sequence	MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHD
TTDC00107	BioChemical Class	Transmembrane protein
TTDC00107	Pathway	Toll-like receptor signaling pathway
TTDC00107	Target Validation	TTDC00107
TTDC00107	Drug(s)	AVE0675
TTDC00107	Drug(s)	Agatolimod
TTDC00107	Drug(s)	CPG 52364
TTDC00107	Drug(s)	GNKG-168
TTDC00107	Drug(s)	IMO-2055
TTDC00107	Drug(s)	IMO-2125
TTDC00107	Drug(s)	IMO-2134
TTDC00107	Drug(s)	IMO-3100
TTDC00107	Drug(s)	TLR9 agonist
TTDC00107	Antagonist	CPG 52364
TTDC00107	Antagonist	IMO-3100
TTDC00107	Agonist	AVE0675
TTDC00107	Agonist	Agatolimod
TTDC00107	Agonist	IMO-2055
TTDC00107	Agonist	IMO-2125
TTDC00107	Agonist	IMO-2134
TTDC00107	Agonist	TLR9 agonist
TTDC00107	Multitarget	CPG 52364
TTDC00107	Multitarget	IMO-3100
TTDC00108	UniProt ID	P04275
TTDC00108	Name	Von Willebrand factor
TTDC00108	Type of target	Clinical trial target
TTDC00108	Synonyms	VWF
TTDC00108	Disease	Cardiovascular Disorders
TTDC00108	Disease	Thrombosis
TTDC00108	Function	Important in the maintenance of homeostasis, it participates in platelet-vessel
TTDC00108	Sequence	MIPARFAGVLLALALILPGTLCAEGTRGRSSTARCSLFGSDFVNTFDGSMYSFAGYCSYLLAGGCQKRSFSIIGDFQNGK
TTDC00108	PDB Structure	1AO3; 1ATZ; 1AUQ; 1FE8; 1FNS; 1IJB; 1IJK; 1M10; 1OAK; 1SQ0; 1U0N; 1UEX; 2ADF; 3G
TTDC00108	Pathway	Complement and coagulation cascades
TTDC00108	Pathway	ECM-receptor interaction
TTDC00108	Pathway	Focal adhesion
TTDC00108	Target Validation	TTDC00108
TTDC00108	Drug(s)	ALX-0081
TTDC00108	Inhibitor	Auryntricarboxylic acid (ATA)
TTDC00108	Inhibitor	Flavone-8-acetic acid
TTDC00108	Binder	ALX-0081
TTDC00110	UniProt ID	P08581
TTDC00110	Name	Hepatocyte growth factor receptor
TTDC00110	Type of target	Successful target
TTDC00110	Synonyms	C-Met receptor tyrosine kinase
TTDC00110	Synonyms	C-met
TTDC00110	Synonyms	HGF receptor
TTDC00110	Synonyms	HGF-SF receptor
TTDC00110	Synonyms	Met proto-oncogene tyrosine kinase
TTDC00110	Disease	Gastric Cancer
TTDC00110	Disease	Hepatocellular carcinoma
TTDC00110	Disease	Lung cancer
TTDC00110	Disease	Pancreatic Cancer
TTDC00110	Disease	Prostate cancer (metastatic)
TTDC00110	Disease	Renal Cell Carcinoma
TTDC00110	Disease	Small cell lung cancer
TTDC00110	Disease	Solid tumors
TTDC00110	Function	Receptor for hepatocyte growth factor. Has a tyrosine- protein kinase activity.
TTDC00110	Sequence	MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQNVILHEHHIFLGATNYIYVLNEEDLQK
TTDC00110	PDB Structure	1FYR; 1R0P; 1R1W; 1SHY; 1SSL; 1UX3; 2G15; 2RFN; 2RFS; 2UZX; 2UZY; 2WD1; 2WGJ; 2W
TTDC00110	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00110	Pathway	Adherens junction
TTDC00110	Pathway	Axon guidance
TTDC00110	Pathway	Colorectal cancer
TTDC00110	Pathway	Cytokine-cytokine receptor interaction
TTDC00110	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDC00110	Pathway	Focal adhesion
TTDC00110	Pathway	Melanoma
TTDC00110	Pathway	Pathways in cancer
TTDC00110	Pathway	Renal cell carcinoma
TTDC00110	EC Number	EC 2.7.1.112
TTDC00110	Related US Patent	6,468,529
TTDC00110	Target Validation	TTDC00110
TTDC00110	Drug(s)	ABT-700
TTDC00110	Drug(s)	AMG 208
TTDC00110	Drug(s)	AMG 337
TTDC00110	Drug(s)	ARQ 197
TTDC00110	Drug(s)	Anti-cMet
TTDC00110	Drug(s)	C-Met inhibitor
TTDC00110	Drug(s)	Cabozantinib
TTDC00110	Drug(s)	Crizotinib
TTDC00110	Drug(s)	EMD-1214063
TTDC00110	Drug(s)	INC280
TTDC00110	Drug(s)	INCB28060
TTDC00110	Drug(s)	LY2801653
TTDC00110	Drug(s)	LY2875358
TTDC00110	Drug(s)	MK-8033
TTDC00110	Drug(s)	MP470
TTDC00110	Drug(s)	MetMAb
TTDC00110	Drug(s)	Mteron-F1
TTDC00110	Drug(s)	RG3638
TTDC00110	Drug(s)	SAR125844
TTDC00110	Drug(s)	SGX523
TTDC00110	Drug(s)	TAK-701
TTDC00110	Drug(s)	Volitinib
TTDC00110	Drug(s)	XL880
TTDC00110	Inhibitor	1-(2-nitrophenethyl)-1H-pyrrolo[3,2-b]pyridine
TTDC00110	Inhibitor	1-(phenylsulfonyl)-1H-pyrrolo[3,2-b]pyridine
TTDC00110	Inhibitor	1-benzyl-1H-pyrrolo[3,2-b]pyridine
TTDC00110	Inhibitor	3-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
TTDC00110	Inhibitor	ARQ 197
TTDC00110	Inhibitor	BMS-536924
TTDC00110	Inhibitor	BMS-777607
TTDC00110	Inhibitor	Cabozantinib
TTDC00110	Inhibitor	K-252a
TTDC00110	Inhibitor	MK-8033
TTDC00110	Inhibitor	MP470
TTDC00110	Inhibitor	SGX523
TTDC00110	Inhibitor	XL880
TTDC00110	Stimulator	Mteron-F1
TTDC00110	Antibody	Anti-cMet
TTDC00110	Antibody	MetMAb
TTDC00110	Antibody	TAK-701
TTDC00110	Multitarget	Cabozantinib
TTDC00110	Multitarget	MP470
TTDC00110	Multitarget	XL880
TTDC00111	UniProt ID	P30411
TTDC00111	Name	B2 bradykinin receptor
TTDC00111	Type of target	Clinical trial target
TTDC00111	Synonyms	B2R
TTDC00111	Synonyms	BK B(2) receptor
TTDC00111	Synonyms	BK-2 receptor
TTDC00111	Synonyms	Bradykinin B2 receptor
TTDC00111	Disease	Alzheimer's disease
TTDC00111	Disease	Analgesics
TTDC00111	Disease	Arthritis
TTDC00111	Disease	Asthma
TTDC00111	Disease	Brain Cancer
TTDC00111	Disease	Cardiac hypertrophy
TTDC00111	Disease	Cardiovascular disease, unspecified
TTDC00111	Disease	Cerebral edema
TTDC00111	Disease	Chronic rhinitis
TTDC00111	Disease	Colitis
TTDC00111	Disease	Diabetic disorders
TTDC00111	Disease	Diabetic nephropathy
TTDC00111	Disease	Hepatorenal syndrome
TTDC00111	Disease	Hereditary Angioedema (HAE)
TTDC00111	Disease	Hypertension
TTDC00111	Disease	Liver Disease
TTDC00111	Disease	Lung cancer
TTDC00111	Disease	Myocardial infarction
TTDC00111	Disease	Pancreatitis
TTDC00111	Disease	Pediatric
TTDC00111	Disease	Restenosis
TTDC00111	Disease	Sepsis
TTDC00111	Disease	Tissue injury
TTDC00111	Disease	Traumatic brain injuries
TTDC00111	Disease	Visceral pain
TTDC00111	Function	Receptor for bradykinin. It is associated with G proteins that activate a phosph
TTDC00111	Sequence	MFSPWKISMFLSVREDSVPTTASFSADMLNVTLQGPTLNGTFAQSKCPQVEWLGWLNTIQPPFLWVLFVLATLENIFVLS
TTDC00111	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00111	Pathway	Calcium signaling pathway
TTDC00111	Pathway	Complement and coagulation cascades
TTDC00111	Pathway	Neuroactive ligand-receptor interaction
TTDC00111	Pathway	Regulation of actin cytoskeleton
TTDC00111	Related US Patent	6,479,515
TTDC00111	Related US Patent	6,500,831
TTDC00111	Related US Patent	6,531,480
TTDC00111	Target Validation	TTDC00111
TTDC00111	Drug(s)	Anatibant
TTDC00111	Drug(s)	Icatibant
TTDC00111	Drug(s)	Labradimil
TTDC00111	Inhibitor	(D)Arg-Arg-Pro-Hyp-Gly-Phe-Ser-(d)Phe-Phe-Arg
TTDC00111	Inhibitor	(D)Arg-Arg-Pro-Hyp-Gly-Thi-Cys-(D)Phe-Phe-Cys-Arg
TTDC00111	Inhibitor	(D)Arg-Arg-Pro-Hyp-Gly-Thi-Ser-(D)Tic-Aoc-Arg
TTDC00111	Inhibitor	(D)Arg-Arg-Pro-Hyp-Gly-Thi-Ser-(D)Tic-Tic-Arg
TTDC00111	Inhibitor	BRADYKININ
TTDC00111	Inhibitor	FR-173657
TTDC00111	Inhibitor	H-DArg-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH(JMV1638)
TTDC00111	Inhibitor	H-DArg-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-OH(JMV1431)
TTDC00111	Inhibitor	H-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH(JMV1645)
TTDC00111	Inhibitor	H-Lys-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-OH(JMV1669)
TTDC00111	Inhibitor	NPC-567
TTDC00111	Inhibitor	Quinapril analogue
TTDC00111	Antagonist	Anatibant
TTDC00111	Antagonist	Icatibant
TTDC00111	Agonist	Labradimil
TTDC00112	UniProt ID	P30872
TTDC00112	Name	Somatostatin receptor type 1
TTDC00112	Type of target	Clinical trial target
TTDC00112	Synonyms	SRIF-2
TTDC00112	Synonyms	SS1R
TTDC00112	Synonyms	Somatostatin receptor 1
TTDC00112	Synonyms	Sst(1)
TTDC00112	Disease	Cushing's disease
TTDC00112	Disease	Neuroblastoma
TTDC00112	Disease	Refractory Renal Cell Carcinoma
TTDC00112	Function	Receptor for somatostatin with higher affinity for somatostatin-14 than -28. Thi
TTDC00112	Sequence	MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVI
TTDC00112	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00112	Pathway	Neuroactive ligand-receptor interaction
TTDC00112	Target Validation	TTDC00112
TTDC00112	Drug(s)	CAP-232
TTDC00112	Drug(s)	Pasireotide
TTDC00112	Inhibitor	CytotoxinPeptide Conjugate
TTDC00112	Inhibitor	Des-AA1,2,4,12,13-[D-Trp8]SRIF
TTDC00112	Inhibitor	Des-AA1,2,4,13-[D-Trp8]SRIF
TTDC00112	Inhibitor	Des-AA1,2,4,5,13-[D-Trp8]-SRIF
TTDC00112	Inhibitor	Des-AA1,2,4,5-[D-Trp8]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5,12,13-[D-Trp8,IAmp9]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5,12,13-[D-Trp8]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[(NalphaMe)Cys3,D-Nal8,IAmp9]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[(NalphaMe)Cys3,D-Trp8,IAmp9]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[(NalphaMe)D-Nal8,IAmp9]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[(NalphaMe)Lys4,D-Nal8,IAmp9]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Nal8,(NalphaMe)IAmp9,Tyr11]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Nal8,(NalphaMe)IAmp9]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Cys14]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Phe11]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Ser13]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Nal8,IAmp9,(NalphaMe)Thr12]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Nal8,IAmp9]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Trp8,(NalphaMe)IAmp9,Tyr11]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Trp8,(NalphaMe)IAmp9]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Trp8,IAmp9,(NalphaMe)Cys14]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Trp8,IAmp9,(NalphaMe)Ser13]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Trp8,IAmp9,(NalphaMe)Thr12]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Trp8,IAmp9,Tyr11]Cbm-SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Trp8,IAmp9,m-I-Tyr11]Cbm-SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Trp8,IAmp9]SRIF CH-275
TTDC00112	Inhibitor	Des-AA1,2,5-[D-Trp8,Tyr11]SRIF
TTDC00112	Inhibitor	Des-AA1,2,5-[IAmp9,Tyr11]-SRIF
TTDC00112	Inhibitor	Des-AA1,4,5,13-[Tyr2,D-Trp8]-SRIF
TTDC00112	Inhibitor	Des-AA1,5-[Tyr2,D-Trp8,(NalphaMe)IAmp9]Cbm-SRIF
TTDC00112	Inhibitor	Des-AA1,5-[Tyr2,D-Trp8,(NalphaMe)IAmp9]SRIF
TTDC00112	Inhibitor	Des-AA1,5-[Tyr2,D-Trp8,IAmp9]Cbm-SRIF
TTDC00112	Inhibitor	Des-AA1,5-[Tyr2,D-Trp8,IAmp9]SRIF CH-288
TTDC00112	Inhibitor	Des-AA5-[D-Trp8]SRIF
TTDC00112	Inhibitor	ODT-8
TTDC00112	Inhibitor	SOMATOSTATIN
TTDC00112	Inhibitor	SRIF-28
TTDC00112	Inhibitor	Somatostatin Analogue
TTDC00112	Agonist	CAP-232
TTDC00112	Agonist	Pasireotide
TTDC00112	Multitarget	CAP-232
TTDC00112	Multitarget	Pasireotide
TTDC00113	UniProt ID	P42224
TTDC00113	Name	STAT-1 transcription factor
TTDC00113	Type of target	Clinical trial target
TTDC00113	Synonyms	P91
TTDC00113	Synonyms	STAT-1
TTDC00113	Synonyms	Signal transducers and activators of transcription factor
TTDC00113	Disease	Inflammatory Disorders, Unspecified
TTDC00113	Disease	Ischemic injury
TTDC00113	Disease	Myocardial ischemia and reperfusion injury
TTDC00113	Disease	Skin Infections/Disorders
TTDC00113	Function	Transcription factor that binds to the ifn-stimulated response element (isre) an
TTDC00113	Sequence	MSQWYELQQLDSKFLEQVHQLYDDSFPMEIRQYLAQWLEKQDWEHAANDVSFATIRFHDLLSQLDDQYSRFSLENNFLLQ
TTDC00113	PDB Structure	1BF5; 1YVL; 2KA6
TTDC00113	Pathway	Chemokine signaling pathway
TTDC00113	Pathway	Jak-STAT signaling pathway
TTDC00113	Pathway	Pancreatic cancer
TTDC00113	Pathway	Pathways in cancer
TTDC00113	Pathway	Toll-like receptor signaling pathway
TTDC00113	Target Validation	TTDC00113
TTDC00113	Drug(s)	AVT-02 UE
TTDC00113	Inhibitor	AVT-02 UE
TTDC00114	UniProt ID	Q15303
TTDC00114	Name	Receptor protein-tyrosine kinase erbB-4
TTDC00114	Type of target	Discontinued target
TTDC00114	Synonyms	ERBB4
TTDC00114	Synonyms	P180erbB4
TTDC00114	Synonyms	Tyrosine kinase-type cell surface receptor HER4
TTDC00114	Disease	Dermatologic Complications
TTDC00114	Disease	Ependymoma
TTDC00114	Disease	Metastatic (Stage IV) Breast Cancer
TTDC00114	Function	Specifically binds and is activated by neuregulins, nrg- 2, nrg-3, heparin-bindi
TTDC00114	Sequence	MKPATGLWVWVSLLVAAGTVQPSDSQSVCAGTENKLSSLSDLEQQYRALRKYYENCEVVMGNLEITSIEHNRDLSFLRSV
TTDC00114	PDB Structure	2AHX; 2L2T; 2LCX; 2R4B; 3BBT; 3BBW; 3BCE; 3U2P; 3U7U; 3U9U
TTDC00114	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00114	Pathway	Calcium signaling pathway
TTDC00114	Pathway	ErbB signaling pathway
TTDC00114	EC Number	EC 2.7.1.112
TTDC00114	Target Validation	TTDC00114
TTDC00114	Drug(s)	CI-1033
TTDC00114	Inhibitor	CI-1033
TTDC00114	Multitarget	CI-1033
TTDC00116	UniProt ID	Q13093
TTDC00116	Name	Platelet-activating factor acetylhydrolase
TTDC00116	Type of target	Clinical trial target
TTDC00116	Synonyms	1-alkyl-2-acetylglycerophosphocholine esterase
TTDC00116	Synonyms	2-acetyl-1-alkylglycerophosphocholine esterase
TTDC00116	Synonyms	LDL-PLA(2)
TTDC00116	Synonyms	LDL-associated phospholipase A2
TTDC00116	Synonyms	Lipoprotein-associated phospholipase A2
TTDC00116	Synonyms	PAF 2-acylhydrolase
TTDC00116	Synonyms	PAF acetylhydrolase
TTDC00116	Disease	Atherosclerosis
TTDC00116	Disease	Cardiovascular Disorders
TTDC00116	Disease	Coronary atherosclerosis
TTDC00116	Function	Modulates the action of platelet-activating factor (paf) by hydrolyzing the sn-2
TTDC00116	Sequence	MVPPKLHVLFCLCGCLAVVYPFDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTF
TTDC00116	PDB Structure	3D59; 3D5E; 3F96; 3F97; 3F98; 3F9C
TTDC00116	BioChemical Class	Hydrolases acting on ester bonds
TTDC00116	Pathway	Ether lipid metabolism
TTDC00116	EC Number	EC 3.1.1.47
TTDC00116	Target Validation	TTDC00116
TTDC00116	Drug(s)	Darapladib
TTDC00116	Drug(s)	GSK 659032
TTDC00116	Drug(s)	GSK568859
TTDC00116	Drug(s)	Rilapladib
TTDC00116	Inhibitor	(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE
TTDC00116	Inhibitor	(E)-(thiophen-2-ylmethylidene)amino benzoate
TTDC00116	Inhibitor	3,4-difluorobenzaldehyde O-benzoyloxime
TTDC00116	Inhibitor	4-fluorobenzaldehyde O-benzoyloxime
TTDC00116	Inhibitor	Darapladib
TTDC00116	Inhibitor	GSK 659032
TTDC00116	Inhibitor	Rilapladib
TTDC00116	Inhibitor	SB-381320
TTDC00116	Inhibitor	benzaldehyde O-benzoyloxime
TTDC00117	UniProt ID	P29371
TTDC00117	Name	Nigral tachykinin NK(3) receptor
TTDC00117	Type of target	Clinical trial target
TTDC00117	Synonyms	NK-3 receptor
TTDC00117	Synonyms	NK-3R
TTDC00117	Synonyms	NKR
TTDC00117	Synonyms	Neurokinin B receptor
TTDC00117	Synonyms	Neurokinin-3 receptor
TTDC00117	Synonyms	Neuromedin K receptor
TTDC00117	Synonyms	Tachykinin receptor 3
TTDC00117	Disease	Arterial hypertension
TTDC00117	Disease	Depression
TTDC00117	Disease	Irritable Bowel Syndrome (IBS)
TTDC00117	Disease	Parkinson's disease
TTDC00117	Disease	Schizophrenia and Schizoaffective Disorders
TTDC00117	Function	This is a receptor for the tachykinin neuropeptide neuromedin k (neurokinin b).
TTDC00117	Sequence	MATLPAAETWIDGGGGVGADAVNLTASLAAGAATGAVETGWLQLLDQAGNLSSSPSALGLPVASPAPSQPWANLTNQFVQ
TTDC00117	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00117	Pathway	Calcium signaling pathway
TTDC00117	Pathway	Neuroactive ligand-receptor interaction
TTDC00117	Related US Patent	6,235,735
TTDC00117	Related US Patent	6,265,614
TTDC00117	Related US Patent	6,339,094
TTDC00117	Related US Patent	6,358,994
TTDC00117	Related US Patent	6,365,602
TTDC00117	Related US Patent	6,372,754
TTDC00117	Related US Patent	6,407,106
TTDC00117	Related US Patent	6,432,952
TTDC00117	Related US Patent	6,432,953
TTDC00117	Related US Patent	6,432,977
TTDC00117	Related US Patent	6,465,489
TTDC00117	Related US Patent	6,479,518
TTDC00117	Related US Patent	6,500,818
TTDC00117	Related US Patent	6,569,872
TTDC00117	Related US Patent	6,583,142
TTDC00117	Related US Patent	6,638,930
TTDC00117	Related US Patent	6,664,253
TTDC00117	Related US Patent	6,676,950
TTDC00117	Related US Patent	6,780,875
TTDC00117	Target Validation	TTDC00117
TTDC00117	Drug(s)	CS-003
TTDC00117	Drug(s)	GSK1144814
TTDC00117	Drug(s)	Osanetant
TTDC00117	Drug(s)	SB222200
TTDC00117	Drug(s)	Talnetant
TTDC00117	Inhibitor	2-phenyl-N-(1-phenylethyl)quinoline-4-carboxamide
TTDC00117	Inhibitor	3-methoxy-N',2-diphenylquinoline-4-carbohydrazide
TTDC00117	Inhibitor	N-phenethyl-2-phenylquinoline-4-carboxamide
TTDC00117	Inhibitor	NEUROKININ B
TTDC00117	Inhibitor	PD-157672
TTDC00117	Inhibitor	PD-160946
TTDC00117	Inhibitor	PD-161182
TTDC00117	Inhibitor	SB-222200
TTDC00117	Antagonist	CS-003
TTDC00117	Antagonist	GSK1144814
TTDC00117	Antagonist	Osanetant
TTDC00117	Antagonist	R-820
TTDC00117	Antagonist	SB222200
TTDC00117	Antagonist	Talnetant
TTDC00117	Agonist	Senktide
TTDC00117	Multitarget	CS-003
TTDC00117	Multitarget	GSK1144814
TTDC00118	UniProt ID	P04637
TTDC00118	Name	Cellular tumor antigen p53
TTDC00118	Type of target	Clinical trial target
TTDC00118	Synonyms	Antigen NY-CO-13
TTDC00118	Synonyms	P53
TTDC00118	Synonyms	Phosphoprotein p53
TTDC00118	Synonyms	Tumor suppressor p53
TTDC00118	Disease	Bladder cancer
TTDC00118	Disease	Cancer, unspecific
TTDC00118	Disease	Hepatocellular carcinoma
TTDC00118	Disease	Kidney Cancer
TTDC00118	Disease	Prostate cancer
TTDC00118	Function	Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptos
TTDC00118	Sequence	MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPRVAPAPAAP
TTDC00118	PDB Structure	1A1U; 1AIE; 1C26; 1DT7; 1GZH; 1H26; 1HS5; 1JSP; 1KZY; 1MA3; 1OLG; 1OLH; 1PES; 1P
TTDC00118	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDC00118	Pathway	Apoptosis
TTDC00118	Pathway	Basal cell carcinoma
TTDC00118	Pathway	Bladder cancer
TTDC00118	Pathway	Cell cycle
TTDC00118	Pathway	Chronic myeloid leukemia
TTDC00118	Pathway	Colorectal cancer
TTDC00118	Pathway	Endometrial cancer
TTDC00118	Pathway	Glioma
TTDC00118	Pathway	Huntington's disease
TTDC00118	Pathway	MAPK signaling pathway
TTDC00118	Pathway	Melanoma
TTDC00118	Pathway	Non-small cell lung cancer
TTDC00118	Pathway	Pancreatic cancer
TTDC00118	Pathway	Pathways in cancer
TTDC00118	Pathway	Prostate cancer
TTDC00118	Pathway	Small cell lung cancer
TTDC00118	Pathway	Thyroid cancer
TTDC00118	Pathway	Wnt signaling pathway
TTDC00118	Pathway	p53 signaling pathway
TTDC00118	Related US Patent	6,593,353
TTDC00118	Target Validation	TTDC00118
TTDC00118	Drug(s)	Curaxin CBLC102
TTDC00118	Drug(s)	SAR405838
TTDC00118	Inhibitor	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
TTDC00118	Inhibitor	NU-8231
TTDC00118	Inhibitor	NUTLIN-3
TTDC00118	Activator	Curaxin CBLC102
TTDC00118	Multitarget	Curaxin CBLC102
TTDC00119	UniProt ID	P05412
TTDC00119	Name	Transcription factor AP-1
TTDC00119	Type of target	Clinical trial target
TTDC00119	Synonyms	AP-1 transcription factor
TTDC00119	Synonyms	AP1
TTDC00119	Synonyms	Activator protein 1
TTDC00119	Synonyms	Activator protein-1
TTDC00119	Synonyms	C-jun proto-oncogene
TTDC00119	Synonyms	P39
TTDC00119	Synonyms	Proto-oncogene c-jun
TTDC00119	Synonyms	V-jun avian sarcoma virus 17 oncogene homolog
TTDC00119	Disease	Allergic airway inflammation
TTDC00119	Disease	Breast cancer
TTDC00119	Disease	Cancer (multidrug resistant)
TTDC00119	Disease	Cancer, unspecific
TTDC00119	Disease	Melanoma
TTDC00119	Disease	Rheumatoid arthritis
TTDC00119	Disease	Vascular disease
TTDC00119	Function	Transcription factor that recognizes and binds to the enhancer heptamer motif 5'
TTDC00119	Sequence	MTAKMETTFYDDALNASFLPSESGPYGYSNPKILKQSMTLNLADPVGSLKPHLRAKNSDLLTSPDVGLLKLASPELERLI
TTDC00119	PDB Structure	1A02; 1FOS; 1JNM; 1JUN; 1S9K; 1T2K
TTDC00119	Pathway	B cell receptor signaling pathway
TTDC00119	Pathway	Colorectal cancer
TTDC00119	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDC00119	Pathway	ErbB signaling pathway
TTDC00119	Pathway	Focal adhesion
TTDC00119	Pathway	GnRH signaling pathway
TTDC00119	Pathway	MAPK signaling pathway
TTDC00119	Pathway	Pathways in cancer
TTDC00119	Pathway	Renal cell carcinoma
TTDC00119	Pathway	T cell receptor signaling pathway
TTDC00119	Pathway	Toll-like receptor signaling pathway
TTDC00119	Pathway	Wnt signaling pathway
TTDC00119	Related US Patent	6,384,065
TTDC00119	Target Validation	TTDC00119
TTDC00119	Drug(s)	T-5224
TTDC00119	Inhibitor	PNRI-299
TTDC00119	Inhibitor	T-5224
TTDC00119	Inhibitor	TAM-67
TTDC00119	Inhibitor	TWS-119
TTDC00120	UniProt ID	P21980
TTDC00120	Name	Protein-glutamine gamma-glutamyltransferase
TTDC00120	Type of target	Clinical trial target
TTDC00120	Synonyms	TG(C)
TTDC00120	Synonyms	TG(C)Protein-glutamine gamma-glutamyltransferase
TTDC00120	Synonyms	TGC
TTDC00120	Synonyms	TGase C
TTDC00120	Synonyms	TGase-H
TTDC00120	Synonyms	TTg
TTDC00120	Synonyms	Tissue transglutaminase
TTDC00120	Synonyms	Tranglutaminase 2
TTDC00120	Synonyms	Transglutaminase 2
TTDC00120	Disease	Burns and Burn Infections
TTDC00120	Disease	Coeliac disease
TTDC00120	Disease	Fibrosis
TTDC00120	Disease	Neurodegenerative diseases
TTDC00120	Disease	Renal fibrosis
TTDC00120	Disease	Scar Tissue
TTDC00120	Function	Catalyzes the cross-linking of proteins and the conjugation of polyamines to pro
TTDC00120	Sequence	MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLR
TTDC00120	PDB Structure	1FAU; 1KV3; 2Q3Z; 3LY6; 3S3J; 3S3P; 3S3S
TTDC00120	BioChemical Class	Acyltransferases
TTDC00120	Pathway	Huntington's disease
TTDC00120	EC Number	EC 2.3.2.13
TTDC00120	Target Validation	TTDC00120
TTDC00120	Drug(s)	Fibrostat
TTDC00120	Inhibitor	Fibrostat
TTDC00120	Inhibitor	Guanosine-5'-Diphosphate
TTDC00121	UniProt ID	P30991
TTDC00121	UniProt ID	P61073
TTDC00121	Name	C-X-C chemokine receptor type 4
TTDC00121	Type of target	Successful target
TTDC00121	Synonyms	CD184 antigen
TTDC00121	Synonyms	CXC-R4
TTDC00121	Synonyms	CXCR-4
TTDC00121	Synonyms	CXCR4
TTDC00121	Synonyms	Chemokine receptor CXCR4
TTDC00121	Synonyms	FB22
TTDC00121	Synonyms	Fusin
TTDC00121	Synonyms	HM89
TTDC00121	Synonyms	LCR1
TTDC00121	Synonyms	LESTR
TTDC00121	Synonyms	Leukocyte-derived seven transmembrane domain receptor
TTDC00121	Synonyms	NPYRL
TTDC00121	Synonyms	SDF-1 receptor
TTDC00121	Synonyms	Stromal cell-derived factor 1 receptor
TTDC00121	Disease	Breast cancer
TTDC00121	Disease	HIV Infection
TTDC00121	Disease	Human immunodeficiency virus [HIV] disease
TTDC00121	Disease	Late-stage Solid tumors
TTDC00121	Disease	Multiple Myeloma
TTDC00121	Disease	Non-Hodgkin's Lymphoma
TTDC00121	Disease	Ovarian cancer
TTDC00121	Disease	Prostate cancer (metastatic)
TTDC00121	Function	Receptor for the c-x-c chemokine sdf-1. Transduces a signal by increasing the in
TTDC00121	Sequence	MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHL
TTDC00121	PDB Structure	2K03; 2K04; 2K05; 3ODU; 3OE0; 3OE6; 3OE8; 3OE9
TTDC00121	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00121	Pathway	Axon guidance
TTDC00121	Pathway	Chemokine signaling pathway
TTDC00121	Pathway	Cytokine-cytokine receptor interaction
TTDC00121	Pathway	Leukocyte transendothelial migration
TTDC00121	Target Validation	TTDC00121
TTDC00121	Drug(s)	AMD-070
TTDC00121	Drug(s)	AMD-3100
TTDC00121	Drug(s)	BMS-936564
TTDC00121	Drug(s)	KRH-2731
TTDC00121	Drug(s)	LY2510924
TTDC00121	Drug(s)	MSX-122
TTDC00121	Drug(s)	Plerixafor
TTDC00121	Inhibitor	TN-14003
TTDC00121	Inhibitor	cyclo(-D-Ala-D-Arg-L-Arg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-MeTyr-D-Arg-L-Arg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-MeTyr-L-Arg-L-Arg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-Arg-Arg-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-Ala-L-Arg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-Arg-L-Arg-L-MeNal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-D-Ala-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-L-Ala-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-L-Pic-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-Sar-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-beta-Ala-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-Arg-L-MeArg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-D-MeArg-L-Arg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-L-Ala-L-Arg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-L-Arg-L-Arg-L-Ala-Sar-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-L-Arg-L-Arg-L-MeNal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-D-Ala-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-L-Ala-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-beta-Ala-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-L-Arg-L-MeArg-L-Nal-Gly-)
TTDC00121	Inhibitor	cyclo(-D-Tyr-L-MeArg-L-Arg-L-Nal-Gly-)
TTDC00121	Antagonist	AMD-070
TTDC00121	Antagonist	AMD-3100
TTDC00121	Antagonist	MSX-122
TTDC00121	Antagonist	Plerixafor
TTDC00121	Antibody	Anti-CXCR4 monoclonal antibody 12G5
TTDC00121	Binder	KRH-2731
TTDC00122	UniProt ID	P41597
TTDC00122	Name	C-C chemokine receptor type 2
TTDC00122	Type of target	Clinical trial target
TTDC00122	Synonyms	C-C CKR-2
TTDC00122	Synonyms	CC-CKR-2
TTDC00122	Synonyms	CCR-2
TTDC00122	Synonyms	CCR2
TTDC00122	Synonyms	Chemokine receptor CCR2B
TTDC00122	Synonyms	MCP-1-R
TTDC00122	Synonyms	Monocyte chemoattractant protein 1 receptor
TTDC00122	Disease	Inflammatory demyelination
TTDC00122	Disease	Multiple Sclerosis (MS)
TTDC00122	Disease	Obese Insulin-resistant Subjects
TTDC00122	Disease	Rheumatoid arthritis
TTDC00122	Function	Receptor for the mcp-1, mcp-3 and mcp-4 chemokines. Transduces a signal by incre
TTDC00122	Sequence	MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIY
TTDC00122	PDB Structure	1KAD; 1KP1
TTDC00122	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00122	Pathway	Chemokine signaling pathway
TTDC00122	Pathway	Cytokine-cytokine receptor interaction
TTDC00122	Related US Patent	6,288,103
TTDC00122	Related US Patent	6,316,449
TTDC00122	Target Validation	TTDC00122
TTDC00122	Drug(s)	CCX915
TTDC00122	Drug(s)	INCB-3284
TTDC00122	Drug(s)	INCB3284
TTDC00122	Drug(s)	INCB8696
TTDC00122	Drug(s)	MCP-1
TTDC00122	Drug(s)	MLN1202
TTDC00122	Drug(s)	RS-504393
TTDC00122	Inhibitor	(R)-3-(1'-Adamantanecarbonyl)amino-caprolactam
TTDC00122	Inhibitor	(S)-3-(1'-Adamantanecarbonyl)amino-caprolactam
TTDC00122	Inhibitor	(S)-3-(2',2'-Dimethyl-propionyl)amino-caprolactam
TTDC00122	Inhibitor	BMS-639623
TTDC00122	Inhibitor	NSC-651016
TTDC00122	Inhibitor	RP-23618
TTDC00122	Inhibitor	TAK-652
TTDC00122	Antagonist	CCX915
TTDC00122	Antagonist	INCB-3284
TTDC00122	Antagonist	INCB3284
TTDC00122	Antagonist	INCB8696
TTDC00122	Antagonist	MCP-1
TTDC00122	Antagonist	MLN1202
TTDC00122	Antagonist	RS-504393
TTDC00122	Multitarget	MCP-1
TTDC00122	Multitarget	RS-504393
TTDC00123	UniProt ID	P55157
TTDC00123	Name	Microsomal triglyceride transfer protein, large subunit
TTDC00123	Type of target	Clinical trial target
TTDC00123	Disease	Atherosclerosis
TTDC00123	Disease	Cardiovascular disease, unspecified
TTDC00123	Disease	Hyperlipidemia
TTDC00123	Function	Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid bet
TTDC00123	Sequence	MILLAVLFLCFISSYSASVKGHTTGLSLNNDRLYKLTYSTEVLLDRGKGKLQDSVGYRISSNVDVALLWRNPDGDDDQLI
TTDC00123	Target Validation	TTDC00123
TTDC00123	Drug(s)	BMS-201038
TTDC00123	Drug(s)	Implitapide
TTDC00123	Inhibitor	BMS-201038
TTDC00123	Inhibitor	DIRLOTAPIDE
TTDC00123	Inhibitor	Implitapide
TTDC00124	UniProt ID	P11597
TTDC00124	Name	Cholesteryl ester transfer protein
TTDC00124	Type of target	Clinical trial target
TTDC00124	Synonyms	CETP
TTDC00124	Synonyms	Cholesterol ester transfer protein
TTDC00124	Synonyms	Lipid transfer protein I
TTDC00124	Disease	Atherosclerosis
TTDC00124	Disease	Coronary atherosclerosis
TTDC00124	Disease	Hypercholesterolemia
TTDC00124	Disease	Hyperlipidemia
TTDC00124	Disease	Peripheral Vascular Disease
TTDC00124	Function	Involved in the transfer of insoluble cholesteryl esters in the reverse transpor
TTDC00124	Sequence	MLAATVLTLALLGNAHACSKGTSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQ
TTDC00124	PDB Structure	2OBD; 4EWS; 4F2A
TTDC00124	Related US Patent	6,387,929
TTDC00124	Related US Patent	6,562,976
TTDC00124	Related US Patent	6,573,383
TTDC00124	Related US Patent	6,600,045
TTDC00124	Related US Patent	6,706,881
TTDC00124	Target Validation	TTDC00124
TTDC00124	Drug(s)	Anacetrapib
TTDC00124	Drug(s)	CP-800569
TTDC00124	Drug(s)	DS-1442
TTDC00124	Drug(s)	Dalcetrapib
TTDC00124	Drug(s)	PF-3185043
TTDC00124	Drug(s)	R7232
TTDC00124	Drug(s)	Torcetrapib
TTDC00124	Inhibitor	Anacetrapib
TTDC00124	Inhibitor	CP-800569
TTDC00124	Inhibitor	Dalcetrapib
TTDC00124	Inhibitor	NSC-40331
TTDC00124	Inhibitor	NSC-89508
TTDC00124	Inhibitor	PF-3185043
TTDC00124	Inhibitor	R7232
TTDC00124	Inhibitor	SC-795
TTDC00124	Inhibitor	TETRAHYDROQUINOLINE A
TTDC00124	Inhibitor	TETRAHYDROQUINOLINE B
TTDC00124	Inhibitor	Torcetrapib
TTDC00125	UniProt ID	P49682
TTDC00125	Name	C-X-C chemokine receptor type 3
TTDC00125	Type of target	Discontinued target
TTDC00125	Synonyms	CD183 antigen
TTDC00125	Synonyms	CKR-L2
TTDC00125	Synonyms	CXC-R3
TTDC00125	Synonyms	CXCR-3
TTDC00125	Synonyms	CXCR3/IP-10
TTDC00125	Synonyms	Chemokine receptor CXCR3
TTDC00125	Synonyms	Chemokine receptor CXCR3/interferon-inducible protein-10
TTDC00125	Synonyms	Interferon-inducible protein 10 receptor
TTDC00125	Disease	Autoimmune diseases
TTDC00125	Disease	Focal stroke
TTDC00125	Disease	Inflammatory Disorders, Unspecified
TTDC00125	Disease	Insulin-dependent diabetes mellitus
TTDC00125	Disease	Multiple sclerosis
TTDC00125	Disease	Psoriasis and Psoriatic Disorders
TTDC00125	Function	Receptor for scyb9/mig, scyb10/inp10 and scyb11/itac.
TTDC00125	Sequence	MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLS
TTDC00125	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00125	Pathway	Chemokine signaling pathway
TTDC00125	Pathway	Cytokine-cytokine receptor interaction
TTDC00125	Target Validation	TTDC00125
TTDC00125	QSAR Model	TTDC00125
TTDC00125	Drug(s)	T487
TTDC00125	Inhibitor	AMG-487
TTDC00125	Antagonist	T487
TTDC00126	UniProt ID	Q14832
TTDC00126	Name	Metabotropic glutamate receptor 3
TTDC00126	Type of target	Clinical trial target
TTDC00126	Synonyms	Group III metabotropic glutamate receptor
TTDC00126	Synonyms	mGLUR3
TTDC00126	Disease	Alzheimer's disease
TTDC00126	Disease	Analgesics
TTDC00126	Disease	Epilepsy
TTDC00126	Disease	Pain
TTDC00126	Disease	Psychosis
TTDC00126	Disease	Schizophrenia and Schizoaffective Disorders
TTDC00126	Disease	Traumatic brain injury
TTDC00126	Function	Receptor for glutamate. The activity of this receptor is mediated by a g-protein
TTDC00126	Sequence	MKMLTRLQVLTLALFSKGFLLSLGDHNFLRREIKIEGDLVLGGLFPINEKGTGTEECGRINEDRGIQRLEAMLFAIDEIN
TTDC00126	PDB Structure	1S8M; 3SM9
TTDC00126	BioChemical Class	G-protein coupled receptor (metabotropic glutamate family)
TTDC00126	Pathway	Neuroactive ligand-receptor interaction
TTDC00126	Target Validation	TTDC00126
TTDC00126	Drug(s)	BCI-632
TTDC00126	Drug(s)	BCI-838
TTDC00126	Drug(s)	LY-544344
TTDC00126	Drug(s)	LY354740
TTDC00126	Drug(s)	LY404039
TTDC00126	Drug(s)	MGluRIII agonist and mGlu5 antagonist
TTDC00126	Drug(s)	RG1578
TTDC00126	Inhibitor	LY-341495
TTDC00126	Inhibitor	LY-354740
TTDC00126	Inhibitor	LY-379268
TTDC00126	Inhibitor	LY-389795
TTDC00126	Inhibitor	QUISQUALATE
TTDC00126	Agonist	LY-544344
TTDC00126	Agonist	LY354740
TTDC00126	Agonist	LY404039
TTDC00126	Agonist	MGluRIII agonist and mGlu5 antagonist
TTDC00127	UniProt ID	Q92847
TTDC00127	Name	Growth hormone secretagogue receptor type 1
TTDC00127	Type of target	Clinical trial target
TTDC00127	Synonyms	GH-releasing peptide receptor
TTDC00127	Synonyms	GHRP
TTDC00127	Synonyms	GHS-R
TTDC00127	Synonyms	Ghrelin receptor
TTDC00127	Synonyms	Growth hormone secretagogue receptor
TTDC00127	Disease	Anorexia
TTDC00127	Disease	Cachexia
TTDC00127	Disease	Cardiovascular disease, unspecified
TTDC00127	Disease	Gastrointestinal Diseases and Disorders, miscellaneous
TTDC00127	Disease	Gastroparesis
TTDC00127	Disease	Ileus
TTDC00127	Disease	Noninsulin-dependent diabetes mellitus
TTDC00127	Function	Receptor for ghrelin, coupled to g-alpha-11 proteins. Stimulates growth hormone
TTDC00127	Sequence	MWNATPSEEPGFNLTLADLDWDASPGNDSLGDELLQLFPAPLLAGVTATCVALFVVGIAGNLLTMLVVSRFRELRTTTNL
TTDC00127	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00127	Pathway	Neuroactive ligand-receptor interaction
TTDC00127	Target Validation	TTDC00127
TTDC00127	Drug(s)	AEZS-123
TTDC00127	Drug(s)	Anamorelin
TTDC00127	Drug(s)	CYT-009-GhrQb
TTDC00127	Drug(s)	EP-01492
TTDC00127	Drug(s)	SUN-11031
TTDC00127	Drug(s)	TZP-101
TTDC00127	Drug(s)	TZP-301
TTDC00127	Inhibitor	4-(3-hexylureido)-N-phenylbenzenesulfonamide
TTDC00127	Inhibitor	AwFwLL-NH2
TTDC00127	Inhibitor	CP-424391-18
TTDC00127	Inhibitor	DprwFwLL-NH2
TTDC00127	Inhibitor	DwFwLL-NH2
TTDC00127	Inhibitor	GHRELIN
TTDC00127	Inhibitor	HwFwLL-NH2
TTDC00127	Inhibitor	KwFwLL-NH2
TTDC00127	Inhibitor	QwFwLL-NH2
TTDC00127	Inhibitor	RwFwLL-NH2
TTDC00127	Inhibitor	rPKPfQwFwLL-NH2
TTDC00127	Inhibitor	wFwGG-NH2
TTDC00127	Inhibitor	wFwLL-NH2
TTDC00127	Antagonist	AEZS-123
TTDC00127	Antagonist	CYT-009-GhrQb
TTDC00127	Antagonist	EP-01492
TTDC00127	Antagonist	TZP-301
TTDC00127	Agonist	GHRP-2
TTDC00127	Agonist	SUN-11031
TTDC00127	Agonist	TZP-101
TTDC00127	Stimulator	Anamorelin
TTDC00128	UniProt ID	O43525
TTDC00128	Name	Potassium voltage-gated channel subfamily KQT member 3
TTDC00128	Type of target	Clinical trial target
TTDC00128	Synonyms	K+ channel KCNQ3
TTDC00128	Synonyms	KQT-like 3
TTDC00128	Synonyms	Potassium channel KQT-like 3
TTDC00128	Synonyms	Potassium channel alpha subunit KvLQT3
TTDC00128	Synonyms	Voltage-gated potassium channel subunit Kv7.3
TTDC00128	Disease	Analgesics
TTDC00128	Disease	Epilepsy
TTDC00128	Disease	Pain
TTDC00128	Function	Probably important in the regulation of neuronal excitability. Associates with k
TTDC00128	Sequence	MGLKARRAAGAAGGGGDGGGGGGGAANPAGGDAAAAGDEERKVGLAPGDVEQVTLALGAGADKDGTLLLEGGGRDEGQRR
TTDC00128	BioChemical Class	Voltage-gated channel
TTDC00128	Target Validation	TTDC00128
TTDC00128	Drug(s)	ICA-105665
TTDC00128	Inhibitor	PD-32577
TTDC00128	Activator	ICA-105665
TTDC00129	UniProt ID	Q15722
TTDC00129	Name	Leukotriene B4 receptor 1
TTDC00129	Type of target	Clinical trial target
TTDC00129	Synonyms	Chemoattractant receptor-like 1
TTDC00129	Synonyms	LTB4-R
TTDC00129	Synonyms	LTB4-R 1
TTDC00129	Synonyms	Leukotriene B(4) receptor BLT1
TTDC00129	Synonyms	P2Y purinoceptor 7
TTDC00129	Synonyms	P2Y7
TTDC00129	Disease	Adverse Effects, Chemotherapy
TTDC00129	Disease	Asthma
TTDC00129	Disease	Cancer
TTDC00129	Disease	Chronic Obstructive Pulmonary Disease (COPD)
TTDC00129	Disease	Cystic Fibrosis
TTDC00129	Disease	Immunological disorders
TTDC00129	Disease	Inflammation
TTDC00129	Disease	Renal Cell Carcinoma
TTDC00129	Disease	Rheumatoid arthritis
TTDC00129	Function	Receptor for extracellular atp > utp and adp. The activity of this receptor is m
TTDC00129	Sequence	MNTTSSAAPPSLGVEFISLLAIILLSVALAVGLPGNSFVVWSILKRMQKRSVTALMVLNLALADLAVLLTAPFFLHFLAQ
TTDC00129	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00129	Pathway	Neuroactive ligand-receptor interaction
TTDC00129	Related US Patent	6,133,286
TTDC00129	Related US Patent	6,160,012
TTDC00129	Related US Patent	6,291,531
TTDC00129	Related US Patent	6,340,706
TTDC00129	Related US Patent	6,576,669
TTDC00129	Related US Patent	6,583,177
TTDC00129	Related US Patent	6,617,345
TTDC00129	Target Validation	TTDC00129
TTDC00129	Drug(s)	Amelubant
TTDC00129	Drug(s)	Biomed 101
TTDC00129	Drug(s)	LTB 019
TTDC00129	Drug(s)	LY-293111
TTDC00129	Drug(s)	LY293111
TTDC00129	Inhibitor	(3S,4R)-3-Benzyl-7-isopropyl-chroman-4-ol
TTDC00129	Inhibitor	(LTB4-(Csa)4)2-Glu-H Conjugate
TTDC00129	Inhibitor	CP-105696
TTDC00129	Inhibitor	DTPA Conjugate
TTDC00129	Inhibitor	HYNIC Analogue
TTDC00129	Inhibitor	HYNIC Conjugate
TTDC00129	Inhibitor	LEUCETTAMIDINE
TTDC00129	Inhibitor	LEUCETTAMINE A
TTDC00129	Inhibitor	LEUKOTRIENE_B4
TTDC00129	Inhibitor	LY-255283
TTDC00129	Inhibitor	LY-282210
TTDC00129	Inhibitor	LY-292728
TTDC00129	Inhibitor	SB-201146
TTDC00129	Inhibitor	SB-201993
TTDC00129	Inhibitor	SB-209247;Ticolubant
TTDC00129	Inhibitor	SC-41390
TTDC00129	Inhibitor	SC-48928
TTDC00129	Inhibitor	SC-50073
TTDC00129	Inhibitor	SC-50135
TTDC00129	Inhibitor	SC-50676
TTDC00129	Inhibitor	SC-51146
TTDC00129	Inhibitor	SC-52073
TTDC00129	Inhibitor	SC-52569
TTDC00129	Inhibitor	SC-53228
TTDC00129	Inhibitor	SC-53229
TTDC00129	Antagonist	Amelubant
TTDC00129	Antagonist	LTB 019
TTDC00129	Antagonist	LY-293111
TTDC00129	Antagonist	LY293111
TTDC00129	Antagonist	U 75302
TTDC00129	Binder	Biomed 101
TTDC00130	UniProt ID	P09960
TTDC00130	Name	Leukotriene A-4 hydrolase
TTDC00130	Type of target	Clinical trial target
TTDC00130	Synonyms	LTA-4 hydrolase
TTDC00130	Synonyms	LTA-H
TTDC00130	Synonyms	LTA4H
TTDC00130	Synonyms	Leukotriene A(4) hydrolase
TTDC00130	Synonyms	Leukotriene A(4)Leukotriene A-4 hydrolase hydrolase
TTDC00130	Synonyms	Leukotriene A4 hydrolase
TTDC00130	Disease	Inflammation
TTDC00130	Disease	Leukemia, Myeloid
TTDC00130	Disease	Myocardial infarction
TTDC00130	Disease	Oesophageal cancer
TTDC00130	Disease	Solid tumors
TTDC00130	Function	Hydrolyzes an epoxide moiety of leukotriene a4 (lta-4) to form leukotriene b4 (l
TTDC00130	Sequence	MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQ
TTDC00130	PDB Structure	1GW6; 1H19; 1HS6; 1SQM; 2R59; 2VJ8; 3B7R; 3B7S; 3B7T; 3B7U; 3CHO; 3CHP; 3CHQ; 3C
TTDC00130	BioChemical Class	Hydrolases acting on ether bonds
TTDC00130	Pathway	Arachidonic acid metabolism
TTDC00130	Pathway	Metabolic pathways
TTDC00130	EC Number	EC 3.3.2.6
TTDC00130	Related US Patent	6,407,140
TTDC00130	Related US Patent	6,436,973
TTDC00130	Target Validation	TTDC00130
TTDC00130	Drug(s)	DG051
TTDC00130	Inhibitor	(4-(thiophen-2-yl)phenyl)methanamine
TTDC00130	Inhibitor	(4-fluorophenyl)(pyridin-4-yl)methanone
TTDC00130	Inhibitor	(R)-2-((4-benzylphenoxy)methyl)piperidine
TTDC00130	Inhibitor	(R)-2-((4-phenoxyphenoxy)methyl)piperidine
TTDC00130	Inhibitor	(R)-2-(4-Benzylphenoxymethyl)pyrrolidine
TTDC00130	Inhibitor	(R)-N-benzyl-4-(pyrrolidin-2-ylmethoxy)aniline
TTDC00130	Inhibitor	(R/S)-2-((4-benzylphenoxy)methyl)piperazine
TTDC00130	Inhibitor	(R/S)-2-((4-benzylphenoxy)methyl)piperidine
TTDC00130	Inhibitor	(R/S)-2-((4-phenoxyphenoxy)methyl)piperidine
TTDC00130	Inhibitor	(S)-2-((4-phenoxyphenoxy)methyl)piperidine
TTDC00130	Inhibitor	1-(2,2'-bithiophen-5-yl)methanamine
TTDC00130	Inhibitor	1-(4-Phenoxyphenyl)piperazine
TTDC00130	Inhibitor	1-(4-thiophen-2-ylphenyl)methanamine
TTDC00130	Inhibitor	1-(pentyloxy)-4-phenoxybenzene
TTDC00130	Inhibitor	1-[4-(4-Iodophenoxy)phenyl]piperazine
TTDC00130	Inhibitor	1-[4-(Benzothiazol-2-yloxy)benzyl]piperidin-4-ol
TTDC00130	Inhibitor	1-butoxy-4-phenoxybenzene
TTDC00130	Inhibitor	2-(4-Piperidin-1-ylmethylphenoxy)benzothiazole
TTDC00130	Inhibitor	2-(4-benzylphenoxy)ethanamine
TTDC00130	Inhibitor	2-(4-phenoxyphenoxy)ethanamine
TTDC00130	Inhibitor	2-(7-(benzyloxy)-1H-indol-3-yl)ethanamine
TTDC00130	Inhibitor	2-Amino-N-[4-(phenylmethoxy)phenyl]-acetamide
TTDC00130	Inhibitor	2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzooxazole
TTDC00130	Inhibitor	2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzothiazole
TTDC00130	Inhibitor	2-[4-(2-Morpholin-4-ylethoxy)phenoxy]benzooxazole
TTDC00130	Inhibitor	2-[4-(2-Piperidin-1-ylethyl)phenoxy]benzothiazole
TTDC00130	Inhibitor	3-(Benzyloxy)Pyridin-2-Amine
TTDC00130	Inhibitor	4-(2-amino-1,3-thiazol-4-yl)phenol
TTDC00130	Inhibitor	4-(4-(pentyloxy)phenoxy)phenol
TTDC00130	Inhibitor	4-(4-butoxyphenoxy)phenol
TTDC00130	Inhibitor	4-(4-propoxyphenoxy)phenol
TTDC00130	Inhibitor	4-Amino-N-[4-(phenylmethoxy)phenyl]butanamide
TTDC00130	Inhibitor	4-[2-(4-Benzylphenoxy)ethyl]pyridine
TTDC00130	Inhibitor	4-amino-N-[4-(benzyloxy)phenyl]butanamide
TTDC00130	Inhibitor	4S-4,5-Diamino-N-(4-phenoxyphenyl)pentanamide
TTDC00130	Inhibitor	5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole
TTDC00130	Inhibitor	5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol
TTDC00130	Inhibitor	8(S)-amino-2(R)-methyl-7-oxononanoic acid
TTDC00130	Inhibitor	Acetate Ion
TTDC00130	Inhibitor	Bestatin
TTDC00130	Inhibitor	DG051
TTDC00130	Inhibitor	Imidazole
TTDC00130	Inhibitor	JNJ-10392980
TTDC00130	Inhibitor	N-(pyridin-3-ylmethyl)aniline
TTDC00130	Inhibitor	N-[4-(benzyloxy)phenyl]glycinamide
TTDC00130	Inhibitor	N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline
TTDC00130	Inhibitor	N-methyl-1-(2-thiophen-2-ylphenyl)methanamine
TTDC00130	Inhibitor	N1-[4-(Phenylmethoxy)phenyl]-D-aspartamine
TTDC00130	Inhibitor	N1-[4-(Phenylmethoxy)phenyl]-D-glutamine
TTDC00130	Inhibitor	N1-[4-(Phenylmethoxy)phenyl]-L-aspartamine
TTDC00130	Inhibitor	N1-[4-(Phenylmethoxy)phenyl]-L-glutamine
TTDC00130	Inhibitor	N4-[4-(Phenylmethoxy)phenyl]-L-aspartamine
TTDC00130	Inhibitor	N5-(4-Phenoxyphenyl)-L-glutamine
TTDC00130	Inhibitor	N5-[(4-Phenoxy)-3-pyridyl]-L-glutamamide
TTDC00130	Inhibitor	N5-[4-(1H-pyrrol-1-yl)phenyl]-L-glutamamide
TTDC00130	Inhibitor	N5-[4-(2-Oxo-3-phenylpropoxy)phenyl]-L-glutamine
TTDC00130	Inhibitor	N5-[4-(2-methylphenoxy)phenyl]-L-glutamamide
TTDC00130	Inhibitor	N5-[4-(2-phenylethoxy)phenyl]-L-glutamine
TTDC00130	Inhibitor	N5-[4-(3-Phenylpropoxy)phenyl]-L-glutamine
TTDC00130	Inhibitor	N5-[4-(3-methylphenoxy)phenyl]-L-glutamamide
TTDC00130	Inhibitor	N5-[4-(4-(3-Furyl)phenoxy)phenyl]-L-glutamamide
TTDC00130	Inhibitor	N5-[4-(4-methylphenoxy)phenyl]-L-glutamamide
TTDC00130	Inhibitor	N5-[4-(N-Phenylamino)phenyl]-L-glutamine
TTDC00130	Inhibitor	N5-[4-(Phenylmethoxy)phenyl]-D-glutamine
TTDC00130	Inhibitor	N5-[4-(Phenylmethoxy)phenyl]-L-glutamamide
TTDC00130	Inhibitor	N5-[4-(Phenylmethoxy)phenyl]-L-glutamine
TTDC00130	Inhibitor	N5-[4-Benzylphenyl]-L-glutamamide
TTDC00130	Inhibitor	N6-[4-(4-methylphenoxy)phenyl]-L-homoglutamine
TTDC00130	Inhibitor	SA-6541
TTDC00131	UniProt ID	P22607
TTDC00131	Name	Fibroblast growth factor receptor 3
TTDC00131	Type of target	Clinical trial target
TTDC00131	Synonyms	FGFR-3
TTDC00131	Synonyms	FGFR3
TTDC00131	Disease	Achondroplasia
TTDC00131	Disease	Multiple Myeloma
TTDC00131	Disease	Osteopenic disorders
TTDC00131	Disease	Skeletal disorders
TTDC00131	Disease	Solid tumors
TTDC00131	Disease	T(4;14) myeloma
TTDC00131	Function	Receptor for acidic and basic fibroblast growth factors. Preferentially binds fg
TTDC00131	Sequence	MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLVFGSGDAVELSCPPPGGGPMGPTVWVKDGTG
TTDC00131	PDB Structure	1RY7
TTDC00131	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00131	Pathway	Bladder cancer
TTDC00131	Pathway	MAPK signaling pathway
TTDC00131	Pathway	Pathways in cancer
TTDC00131	Pathway	Regulation of actin cytoskeleton
TTDC00131	EC Number	EC 2.7.1.112
TTDC00131	Target Validation	TTDC00131
TTDC00131	Drug(s)	AEE-788
TTDC00131	Drug(s)	Anti-FGFR3
TTDC00131	Drug(s)	BMS-582664
TTDC00131	Drug(s)	TKI258
TTDC00131	Inhibitor	5,11-Dimethyl-6H-pyrido[4,3-b]carbazol-9-ol
TTDC00131	Inhibitor	AEE-788
TTDC00131	Inhibitor	BMS-582664
TTDC00131	Inhibitor	ELLIPTINIUM
TTDC00131	Inhibitor	PD-0183812
TTDC00131	Inhibitor	PD-173074
TTDC00131	Inhibitor	Ro-4396686
TTDC00131	Inhibitor	SU10991
TTDC00131	Inhibitor	SU5402
TTDC00131	Inhibitor	TKI258
TTDC00131	Antibody	Anti-FGFR3
TTDC00131	Multitarget	AEE-788
TTDC00131	Multitarget	TKI258
TTDC00132	UniProt ID	P31749
TTDC00132	UniProt ID	P31749
TTDC00132	UniProt ID	P31751
TTDC00132	UniProt ID	Q9Y243
TTDC00132	Name	RAC-alpha serine/threonine kinase
TTDC00132	Name	AkT
TTDC00132	Type of target	Clinical trial target
TTDC00132	Type of target	Clinical trial target
TTDC00132	Synonyms	Akt
TTDC00132	Synonyms	C-AKT
TTDC00132	Synonyms	PKB
TTDC00132	Synonyms	Protein kinase B
TTDC00132	Synonyms	RAC-PK-alpha
TTDC00132	Synonyms	Serine/threonine protein kinase PKB
TTDC00132	Disease	Advanced, Relapsed/Refractory Multiple Myeloma
TTDC00132	Disease	Brain ischemic insult
TTDC00132	Disease	Breast cancer
TTDC00132	Disease	Cancer, unspecific
TTDC00132	Disease	Diabetes mellitus
TTDC00132	Disease	Glioblastoma Multiforme (GBM)
TTDC00132	Disease	Huntington's disease
TTDC00132	Disease	Non-Hodgkin's Lymphoma
TTDC00132	Disease	Non-small Cell Lung Cancer
TTDC00132	Disease	Parkinson's disease
TTDC00132	Disease	Recurrent Malignant Glioma
TTDC00132	Disease	Refractory, Rare Sarcoma's
TTDC00132	Disease	Seizure
TTDC00132	Disease	Solid tumors
TTDC00132	Disease	Stroke
TTDC00132	Function	General protein kinase capable of phosphorylating several known proteins.
TTDC00132	Sequence	MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQW
TTDC00132	PDB Structure	1H10; 1UNP; 1UNQ; 1UNR; 2UVM; 2UZR; 2UZS; 3CQU; 3CQW; 3MV5; 3MVH; 3O96; 3OCB; 3O
TTDC00132	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00132	Pathway	Acute myeloid leukemia
TTDC00132	Pathway	Adipocytokine signaling pathway
TTDC00132	Pathway	Apoptosis
TTDC00132	Pathway	B cell receptor signaling pathway
TTDC00132	Pathway	Chemokine signaling pathway
TTDC00132	Pathway	Chronic myeloid leukemia
TTDC00132	Pathway	Colorectal cancer
TTDC00132	Pathway	Endometrial cancer
TTDC00132	Pathway	ErbB signaling pathway
TTDC00132	Pathway	Fc epsilon RI signaling pathway
TTDC00132	Pathway	Focal adhesion
TTDC00132	Pathway	Glioma
TTDC00132	Pathway	Insulin signaling pathway
TTDC00132	Pathway	Jak-STAT signaling pathway
TTDC00132	Pathway	MAPK signaling pathway
TTDC00132	Pathway	Melanoma
TTDC00132	Pathway	Non-small cell lung cancer
TTDC00132	Pathway	Pancreatic cancer
TTDC00132	Pathway	Pathways in cancer
TTDC00132	Pathway	Prostate cancer
TTDC00132	Pathway	Renal cell carcinoma
TTDC00132	Pathway	Small cell lung cancer
TTDC00132	Pathway	T cell receptor signaling pathway
TTDC00132	Pathway	Tight junction
TTDC00132	Pathway	Toll-like receptor signaling pathway
TTDC00132	Pathway	VEGF signaling pathway
TTDC00132	Pathway	mTOR signaling pathway
TTDC00132	EC Number	EC 2.7.1.-
TTDC00132	EC Number	EC 2.7.1.37
TTDC00132	Related US Patent	6,649,640
TTDC00132	Target Validation	TTDC00132
TTDC00132	Drug(s)	2110183
TTDC00132	Drug(s)	AR-12
TTDC00132	Drug(s)	ARQ 092
TTDC00132	Drug(s)	AZD5363
TTDC00132	Drug(s)	CI-1033
TTDC00132	Drug(s)	Enzastaurin
TTDC00132	Drug(s)	GDC-0068
TTDC00132	Drug(s)	GSK2110183
TTDC00132	Drug(s)	GSK2141795
TTDC00132	Drug(s)	MK-2206
TTDC00132	Drug(s)	MK2206
TTDC00132	Drug(s)	P70 S6 Kinase/AKT Dual Inhibitor
TTDC00132	Drug(s)	P70/AKT inhibitor
TTDC00132	Drug(s)	Perifosine
TTDC00132	Drug(s)	RG7440
TTDC00132	Drug(s)	RX-0201
TTDC00132	Drug(s)	Rigosertib
TTDC00132	Drug(s)	TCN-P
TTDC00132	Drug(s)	Trametinib + 2141795
TTDC00132	Drug(s)	VQD-002
TTDC00132	Drug(s)	XL418
TTDC00132	Drug(s)	
TTDC00132	Inhibitor	(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one
TTDC00132	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDC00132	Inhibitor	4,5,6-trihydroxy-3-methylphthalide
TTDC00132	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDC00132	Inhibitor	A-443654;A-4436554
TTDC00132	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDC00132	Inhibitor	BMS-536924
TTDC00132	Inhibitor	BMS-754807
TTDC00132	Inhibitor	BX-517
TTDC00132	Inhibitor	CI-1033
TTDC00132	Inhibitor	CI-1040;PD-18435;PD-184352
TTDC00132	Inhibitor	Enzastaurin
TTDC00132	Inhibitor	GDC-0068
TTDC00132	Inhibitor	GF-109203
TTDC00132	Inhibitor	GSK-690693
TTDC00132	Inhibitor	GSK690693
TTDC00132	Inhibitor	Go-6976
TTDC00132	Inhibitor	Inositol 1,3,4,5-Tetrakisphosphate
TTDC00132	Inhibitor	KN-62
TTDC00132	Inhibitor	LY-294002
TTDC00132	Inhibitor	Lactoquinomycin
TTDC00132	Inhibitor	MK-2206
TTDC00132	Inhibitor	MK2206
TTDC00132	Inhibitor	MYRIOCIN
TTDC00132	Inhibitor	PD-98059
TTDC00132	Inhibitor	Perifosine
TTDC00132	Inhibitor	RO-316233
TTDC00132	Inhibitor	RX-0201
TTDC00132	Inhibitor	SB-202190
TTDC00132	Inhibitor	SB-203580
TTDC00132	Inhibitor	SB-747651A
TTDC00132	Inhibitor	STAUROSPORINONE
TTDC00132	Inhibitor	U-0126
TTDC00132	Inhibitor	VQD-002
TTDC00132	Inhibitor	XL418
TTDC00132	Inhibitor	ZARAGOZIC ACIDS A
TTDC00132	Multitarget	CI-1033
TTDC00132	Multitarget	Enzastaurin
TTDC00132	Multitarget	XL418
TTDC00133	UniProt ID	Q99705
TTDC00133	Name	Melanin-concentrating hormone receptor 1
TTDC00133	Type of target	Discontinued target
TTDC00133	Synonyms	G protein coupled receptor 24
TTDC00133	Synonyms	MCH receptor 1
TTDC00133	Synonyms	MCH(1) receptor
TTDC00133	Synonyms	MCH-1R
TTDC00133	Synonyms	MCH-R1
TTDC00133	Synonyms	MCH1R
TTDC00133	Synonyms	MCHR
TTDC00133	Synonyms	MCHR-1
TTDC00133	Synonyms	MCHR1
TTDC00133	Synonyms	Melanin-concentrating hormone receptor subtype 1
TTDC00133	Synonyms	SLC-1
TTDC00133	Synonyms	Somatostatin receptor-like protein
TTDC00133	Disease	Obesity
TTDC00133	Disease	Social anxiety disorder
TTDC00133	Disease	Vitiligo
TTDC00133	Function	Receptor for melanin-concentrating hormone, coupled to both G proteins that inhi
TTDC00133	Sequence	MSVGAMKKGVGRAVGLGGGSGCQATEEDPLPNCGACAPGQGGRRWRLPQPAWVEGSSARLWEQATGTGWMDLEASLLPTG
TTDC00133	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00133	Pathway	Neuroactive ligand-receptor interaction
TTDC00133	Target Validation	TTDC00133
TTDC00133	Drug(s)	ALB-127158(a)
TTDC00133	Drug(s)	AMG 076
TTDC00133	Drug(s)	BMS-830216
TTDC00133	Drug(s)	MCH antagonist
TTDC00133	Drug(s)	NGD-4715
TTDC00133	Drug(s)	SNAP-7941
TTDC00133	Drug(s)	T-226293
TTDC00133	Drug(s)	T-226296
TTDC00133	Inhibitor	2-phenyl-N,N-bis(o-tolylthiomethyl)ethanamine
TTDC00133	Inhibitor	8-(1,2-Dimethyl-propoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(1,3,3-Trimethyl-butoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(1-Ethyl-propoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(1-Methyl-butoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(2-Cyclopropyl-ethoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(2-Ethoxy-1-methyl-ethoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(2-Ethyl-1-methyl-butoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(2-Methoxy-1-methyl-ethoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(2-Methyl-butoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(2-Methyl-cyclohexyloxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(3,3,3-trifluoropropoxy)quinolin-2-amine
TTDC00133	Inhibitor	8-(3,3-Dimethyl-butoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(3-Methoxy-3-methyl-butoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(3-Methyl-butoxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(3-Methyl-cyclohexyloxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(3-Methyl-cyclopentyloxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-(4-Methyl-cyclohexyloxy)-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Butoxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Cyclobutylmethoxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Cycloheptyloxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Cyclohexyloxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Cyclopentylmethoxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Hexyloxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Isopropoxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Methoxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Pentyloxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-Propoxy-quinolin-2-ylamine
TTDC00133	Inhibitor	8-sec-Butoxy-quinolin-2-ylamine
TTDC00133	Inhibitor	A-224940
TTDC00133	Inhibitor	ADS-102891
TTDC00133	Inhibitor	ADS-103168
TTDC00133	Inhibitor	ADS-103214
TTDC00133	Inhibitor	ADS-103253
TTDC00133	Inhibitor	ADS-103254
TTDC00133	Inhibitor	ADS-103274
TTDC00133	Inhibitor	ADS-103293
TTDC00133	Inhibitor	ADS-103294
TTDC00133	Inhibitor	ADS-103316
TTDC00133	Inhibitor	AR-129330
TTDC00133	Inhibitor	ATC-0175
TTDC00133	Inhibitor	GNF-PF-1550
TTDC00133	Inhibitor	GNF-PF-2322
TTDC00133	Inhibitor	N,N-bis(tosylmethyl)hexan-1-amine
TTDC00133	Inhibitor	N-(1-benzylpiperidin-4-yl)-3,5-dimethoxybenzamide
TTDC00133	Inhibitor	N-(4-amino-2-propylquinolin-6-yl)cinnamamide
TTDC00133	Inhibitor	phenyl-N,N-bis(tosylmethyl)methanamine
TTDC00133	Antagonist	ALB-127158(a)
TTDC00133	Antagonist	AMG 076
TTDC00133	Antagonist	BMS-830216
TTDC00133	Antagonist	MCH antagonist
TTDC00133	Antagonist	NGD-4715
TTDC00133	Antagonist	SNAP-7941
TTDC00133	Antagonist	T-226293
TTDC00133	Antagonist	T-226296
TTDC00134	UniProt ID	P09601
TTDC00134	Name	Heme oxygenase 1
TTDC00134	Type of target	Clinical trial target
TTDC00134	Synonyms	HO-1
TTDC00134	Synonyms	Heme Oxygenase-1
TTDC00134	Disease	Atherosclerosis
TTDC00134	Disease	Cardiovascular disease, unspecified
TTDC00134	Disease	Cerebral vasospasm
TTDC00134	Disease	Chronic myeloid leukemia
TTDC00134	Disease	Crohn's Disease
TTDC00134	Disease	Ischemic injury of the liver
TTDC00134	Disease	Kaposi's sarcoma
TTDC00134	Disease	Neonatal Hyperbilirubinemia, jaundice
TTDC00134	Disease	Oxidative tissue injuries
TTDC00134	Disease	Ulcerative colitis
TTDC00134	Disease	Vascular disease
TTDC00134	Function	Heme oxygenase cleaves the heme ring at the alpha methene bridge to form biliver
TTDC00134	Sequence	MERPQPDSMPQDLSEALKEATKEVHTQAENAEFMRNFQKGQVTRDGFKLVMASLYHIYVALEEEIERNKESPVFAPVYFP
TTDC00134	PDB Structure	1N3U; 1N45; 1NI6; 1OYK; 1OYL; 1OZE; 1OZL; 1OZR; 1OZW; 1S13; 1S8C; 1T5P; 1TWN; 1T
TTDC00134	BioChemical Class	Oxidoreductases acting on paired donors
TTDC00134	Pathway	Porphyrin and chlorophyll metabolism
TTDC00134	EC Number	EC 1.14.99.3
TTDC00134	Target Validation	TTDC00134
TTDC00134	Drug(s)	Stannsoporfin
TTDC00134	Inhibitor	1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone
TTDC00134	Inhibitor	12-Phenylheme
TTDC00134	Inhibitor	2-Phenylheme
TTDC00134	Inhibitor	2-Propanol, Isopropanol
TTDC00134	Inhibitor	AZALANSTAT
TTDC00134	Inhibitor	Biliverdine Ix Alpha
TTDC00134	Inhibitor	Formic Acid
TTDC00134	Inhibitor	Heme
TTDC00134	Inhibitor	Stannsoporfin
TTDC00134	Inhibitor	Tin protoporphyrin
TTDC00134	Inhibitor	Verdoheme
TTDC00135	UniProt ID	P15391
TTDC00135	Name	B-lymphocyte antigen CD19
TTDC00135	Type of target	Clinical trial target
TTDC00135	Synonyms	B-lymphocyte surface antigen B4
TTDC00135	Synonyms	CD19
TTDC00135	Synonyms	Differentiation antigen CD19
TTDC00135	Synonyms	Leu-12
TTDC00135	Disease	Lymphoma, Non-Hodgkin's
TTDC00135	Disease	Multiple myeloma
TTDC00135	Function	May be involved in growth regulation of b-cells.
TTDC00135	Sequence	MPPPRLLFFLLFLTPMEVRPEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKPFLKLSLGLPGLGIHMRPLAI
TTDC00135	BioChemical Class	Transmembrane protein
TTDC00135	Pathway	B cell receptor signaling pathway
TTDC00135	Pathway	Hematopoietic cell lineage
TTDC00135	Pathway	Primary immunodeficiency
TTDC00135	Target Validation	TTDC00135
TTDC00135	Drug(s)	AMG 729
TTDC00135	Drug(s)	Anti-CD22/CD19 mAb-toxin conjugate
TTDC00135	Drug(s)	Blinatumomab
TTDC00135	Drug(s)	CTL019
TTDC00135	Drug(s)	MEDI-551
TTDC00135	Drug(s)	MOR208
TTDC00135	Drug(s)	SAR3419
TTDC00135	Drug(s)	SGN-19A
TTDC00135	Drug(s)	XmAb 5871
TTDC00135	Antibody	MEDI-551
TTDC00135	Antibody	SAR3419
TTDC00135	Antibody	SGN-19A
TTDC00136	UniProt ID	P16871
TTDC00136	Name	Interleukin-7 receptor alpha chain
TTDC00136	Type of target	Clinical trial target
TTDC00136	Synonyms	CD127 antigen
TTDC00136	Synonyms	CDw127
TTDC00136	Synonyms	IL-7R alpha chain
TTDC00136	Synonyms	IL-7R-alpha
TTDC00136	Disease	Acquired Immune Deficiency Syndrome (AIDS) and AIDS-Related Infections
TTDC00136	Disease	Cancer, unspecific
TTDC00136	Disease	Immunodeficiency
TTDC00136	Disease	Tumors
TTDC00136	Function	Receptor for interleukin-7.
TTDC00136	Sequence	MTILGTTFGMVFSLLQVVSGESGYAQNGDLEDAELDDYSFSCYSQLEVNGSQHSLTCAFEDPDVNTTNLEFEICGALVEV
TTDC00136	PDB Structure	3DI2; 3DI3; 3UP1
TTDC00136	BioChemical Class	Transmembrane protein
TTDC00136	Pathway	Cytokine-cytokine receptor interaction
TTDC00136	Pathway	Hematopoietic cell lineage
TTDC00136	Pathway	Jak-STAT signaling pathway
TTDC00136	Pathway	Primary immunodeficiency
TTDC00136	Target Validation	TTDC00136
TTDC00136	Drug(s)	CYT 99007
TTDC00136	Binder	CYT 99007
TTDC00137	UniProt ID	P19022
TTDC00137	Name	Neural-cadherin
TTDC00137	Type of target	Clinical trial target
TTDC00137	Synonyms	Cadherin-2
TTDC00137	Synonyms	N-cadherin
TTDC00137	Disease	Breast cancer
TTDC00137	Disease	Cancer/Tumors (Unspecified)
TTDC00137	Disease	Melanoma
TTDC00137	Disease	Ovarian cancer
TTDC00137	Disease	Restenosis
TTDC00137	Disease	Solid tumors
TTDC00137	Disease	Vascular bypass graft failure
TTDC00137	Function	Cadherins are calcium dependent cell adhesion proteins. They preferentially inte
TTDC00137	Sequence	MCRIAGALRTLLPLLAALLQASVEASGEIALCKTGFPEDVYSAVLSKDVHEGQPLLNVKFSNCNGKRKVQYESSEPADFK
TTDC00137	BioChemical Class	Transmembrane protein
TTDC00137	Pathway	Cell adhesion molecules (CAMs)
TTDC00137	Target Validation	TTDC00137
TTDC00137	Drug(s)	Exherin
TTDC00137	Binder	Exherin
TTDC00138	UniProt ID	P16083
TTDC00138	UniProt ID	Q6LFA2
TTDC00138	Name	NRH dehydrogenase [quinone] 2
TTDC00138	Type of target	Clinical trial target
TTDC00138	Synonyms	NAD(P)H qui oxidoreductase 2
TTDC00138	Synonyms	NQO2
TTDC00138	Synonyms	NRH:qui oxidoreductase 2
TTDC00138	Synonyms	NRH:quinone oxidoreductase 2
TTDC00138	Synonyms	QR2
TTDC00138	Synonyms	Qui reductase 2
TTDC00138	Synonyms	Quinone oxidoreductase 2
TTDC00138	Synonyms	Quinone reductase 2
TTDC00138	Disease	Cancer, unspecific
TTDC00138	Disease	Malaria
TTDC00138	Disease	Tumors
TTDC00138	Function	The enzyme apparently serves as a quinone reductase in connection with conjugati
TTDC00138	Sequence	MICVKNILKRYKNSPLNELRNNRKYYEGSFVKSIKFSTSNYGSNEKKPNDIEKNKNVSINLNEGNILQSEIYDTVVIGGG
TTDC00138	PDB Structure	1QR2; 1SG0; 1XI2; 1ZX1; 2BZS; 2QMY; 2QMZ; 2QR2; 2QWX; 2QX4; 2QX6; 2QX8; 2QX9; 3F
TTDC00138	BioChemical Class	Oxidoreductases acting on diphenols as donors
TTDC00138	EC Number	EC 1.6.99.-
TTDC00138	EC Number	EC 1.6.99.2
TTDC00138	Target Validation	TTDC00138
TTDC00138	Drug(s)	CB1954/EP-0152R, NQO2 prodrug therapy
TTDC00138	Drug(s)	Prolarix
TTDC00138	Inhibitor	1,4-Dimethylquinolin-2(1H)-one
TTDC00138	Inhibitor	10-Propargyl-5,8-Dideazafolic Acid
TTDC00138	Inhibitor	3,4,5-Trimethoxy-4'-amino-trans-stilbene
TTDC00138	Inhibitor	3,5-Dimethoxy-4'-amino-trans-stilbene
TTDC00138	Inhibitor	5,6,8-Trimethoxy-1,4-dimethylquinolin-2(1H)-one
TTDC00138	Inhibitor	5,6,8-Trimethoxy-4-methylquinolin-2(1H)-one
TTDC00138	Inhibitor	5,8-Dimethoxy-4-methylquinolin-2(1H)-one
TTDC00138	Inhibitor	5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one
TTDC00138	Inhibitor	6,7,8-Trimethoxy-1,4-dimethylquinolin-2(1H)-one
TTDC00138	Inhibitor	6,7,8-Trimethoxy-4-methylquinolin-2(1H)-one
TTDC00138	Inhibitor	6,8-Dimethoxy-1,4-dimethylquinolin-2(1H)-one
TTDC00138	Inhibitor	6,8-Dimethoxy-4-methylquinolin-2(1H)-one
TTDC00138	Inhibitor	6-Methyl-[1,3]dioxolo[4,5-h]quinolin-8(9H)-one
TTDC00138	Inhibitor	7,8-Dimethoxy-1,4-dimethylquinolin-2(1H)-one
TTDC00138	Inhibitor	8-Methoxy-1,4-dimethylquinolin-2(1H)-one
TTDC00138	Inhibitor	CB1954
TTDC00138	Inhibitor	CB1954/EP-0152R, NQO2 prodrug therapy
TTDC00138	Inhibitor	Flavin-Adenine Dinucleotide
TTDC00138	Inhibitor	IODOMELATONIN
TTDC00138	Inhibitor	N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide
TTDC00138	Inhibitor	NSC-106080
TTDC00138	Inhibitor	NSC-115890
TTDC00138	Inhibitor	NSC-180969
TTDC00138	Inhibitor	NSC-204996
TTDC00138	Inhibitor	NSC-238146
TTDC00138	Inhibitor	NSC-300853
TTDC00138	Inhibitor	NSC-306843
TTDC00138	Inhibitor	NSC-356819
TTDC00138	Inhibitor	NSC-356820
TTDC00138	Inhibitor	NSC-359466
TTDC00138	Inhibitor	NSC-381864
TTDC00138	Inhibitor	NSC-637991
TTDC00138	Inhibitor	NSC-637992
TTDC00138	Inhibitor	NSC-637993
TTDC00138	Inhibitor	NSC-637994
TTDC00138	Inhibitor	NSC-640353
TTDC00138	Inhibitor	NSC-640556
TTDC00138	Inhibitor	NSC-640558
TTDC00138	Inhibitor	NSC-640559
TTDC00138	Inhibitor	NSC-640566
TTDC00138	Inhibitor	NSC-640583
TTDC00138	Inhibitor	NSC-640584
TTDC00138	Inhibitor	NSC-645808
TTDC00138	Inhibitor	NSC-645809
TTDC00138	Inhibitor	NSC-645811
TTDC00138	Inhibitor	NSC-645812
TTDC00138	Inhibitor	NSC-645831
TTDC00138	Inhibitor	NSC-645833
TTDC00138	Inhibitor	NSC-645834
TTDC00138	Inhibitor	NSC-645835
TTDC00138	Inhibitor	NSC-645836
TTDC00138	Inhibitor	NSC-649091
TTDC00138	Inhibitor	NSC-660838
TTDC00138	Inhibitor	NSC-660839
TTDC00138	Inhibitor	NSC-660840
TTDC00138	Inhibitor	NSC-660841
TTDC00138	Inhibitor	NSC-665126
TTDC00138	Inhibitor	NSC-669977
TTDC00138	Inhibitor	NSC-676468
TTDC00138	Inhibitor	NSC-677939
TTDC00138	Inhibitor	NSC-693571
TTDC00138	Inhibitor	NSC-720622
TTDC00138	Inhibitor	NSC-77833
TTDC00138	Inhibitor	NSC-78017
TTDC00138	Inhibitor	NSC-78021
TTDC00138	Inhibitor	NSC-86715
TTDC00138	Inhibitor	NSC-97374
TTDC00138	Inhibitor	NSC-99495
TTDC00138	Inhibitor	NSC-99528
TTDC00138	Inhibitor	Resveratrol
TTDC00138	Activator	Prolarix
TTDC00139	UniProt ID	Q96GD4
TTDC00139	Name	Serine/threonine protein kinase 12
TTDC00139	Type of target	Clinical trial target
TTDC00139	Synonyms	AIM-1
TTDC00139	Synonyms	Aurora- and Ipl1-like midbody-associated protein 1
TTDC00139	Synonyms	Aurora-2
TTDC00139	Synonyms	Aurora-2 kinase
TTDC00139	Synonyms	Aurora-B
TTDC00139	Synonyms	Aurora-related kinase 2
TTDC00139	Synonyms	Aurora/IPL1-related kinase 2
TTDC00139	Synonyms	STK-1
TTDC00139	Disease	Cancer, unspecific
TTDC00139	Disease	Pancreatic cancer
TTDC00139	Disease	Solid tumors
TTDC00139	Function	May be directly involved in regulating the cleavage of polar spindle microtubule
TTDC00139	Sequence	MAQKENSYPWPYGRQTAPSGLSTLPQRVLRKEPVTPSALVLMSRSNVQPTAAPGQKVMENSSGTPDILTRHFTIDDFEIG
TTDC00139	PDB Structure	4AF3
TTDC00139	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00139	EC Number	EC 2.7.1.37
TTDC00139	Related US Patent	6,610,677
TTDC00139	Related US Patent	6,613,776
TTDC00139	Related US Patent	6,638,926
TTDC00139	Related US Patent	6,653,300
TTDC00139	Related US Patent	6,653,301
TTDC00139	Related US Patent	6,656,939
TTDC00139	Related US Patent	6,660,731
TTDC00139	Related US Patent	6,664,247
TTDC00139	Target Validation	TTDC00139
TTDC00139	Drug(s)	AMG 900
TTDC00139	Drug(s)	AT-9283
TTDC00139	Drug(s)	AT9283
TTDC00139	Drug(s)	AZD1152
TTDC00139	Drug(s)	BI-811283
TTDC00139	Drug(s)	CYC-116
TTDC00139	Drug(s)	CYC116
TTDC00139	Drug(s)	GSK1070916
TTDC00139	Drug(s)	GSK1070916A
TTDC00139	Drug(s)	MK-5108
TTDC00139	Drug(s)	PF-03814735
TTDC00139	Drug(s)	PHA-739358
TTDC00139	Drug(s)	R763
TTDC00139	Drug(s)	SNS-314
TTDC00139	Drug(s)	SU-6668
TTDC00139	Drug(s)	TAK-901
TTDC00139	Drug(s)	VX-680
TTDC00139	Drug(s)	VX-689
TTDC00139	Inhibitor	AT-9283
TTDC00139	Inhibitor	AT9283
TTDC00139	Inhibitor	AZD1152
TTDC00139	Inhibitor	CYC-116
TTDC00139	Inhibitor	CYC116
TTDC00139	Inhibitor	GSK1070916
TTDC00139	Inhibitor	MK-5108
TTDC00139	Inhibitor	PF-03814735
TTDC00139	Inhibitor	PHA-739358
TTDC00139	Inhibitor	R763
TTDC00139	Inhibitor	SNS-314
TTDC00139	Inhibitor	SU-6668
TTDC00139	Inhibitor	TAK-901
TTDC00139	Inhibitor	VX-680
TTDC00139	Inhibitor	VX-689
TTDC00139	Multitarget	AT-9283
TTDC00139	Multitarget	AT9283
TTDC00139	Multitarget	AZD1152
TTDC00139	Multitarget	CYC-116
TTDC00139	Multitarget	CYC116
TTDC00139	Multitarget	GSK1070916
TTDC00139	Multitarget	MK-5108
TTDC00139	Multitarget	PF-03814735
TTDC00139	Multitarget	PHA-739358
TTDC00139	Multitarget	R763
TTDC00139	Multitarget	SNS-314
TTDC00139	Multitarget	SU-6668
TTDC00139	Multitarget	VX-680
TTDC00139	Multitarget	VX-689
TTDC00140	UniProt ID	P48736
TTDC00140	Name	Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, gamma isoform
TTDC00140	Type of target	Clinical trial target
TTDC00140	Synonyms	PI3-kinase p110 subunit gamma
TTDC00140	Synonyms	PI3K
TTDC00140	Synonyms	PI3Kgamma
TTDC00140	Synonyms	Phosphoinositide 3-Kinase gamma
TTDC00140	Synonyms	PtdIns-3-kinase p110
TTDC00140	Disease	Angioedema
TTDC00140	Disease	Cancer, unspecific
TTDC00140	Disease	Heart failure
TTDC00140	Disease	Myocardial infarction
TTDC00140	Disease	Solid tumors
TTDC00140	Function	3-phosphorylates the cellular phosphoinositide ptdins-4,5-biphosphate (ptdins(4,
TTDC00140	Sequence	MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALE
TTDC00140	PDB Structure	1E8Y; 1E8Z; 1HE8; 2A4Z; 2A5U; 2CHW; 2CHX; 2CHZ; 2V4L; 3APC; 3APD; 3APF; 3CSF; 3C
TTDC00140	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00140	Pathway	Acute myeloid leukemia
TTDC00140	Pathway	Apoptosis
TTDC00140	Pathway	B cell receptor signaling pathway
TTDC00140	Pathway	Chemokine signaling pathway
TTDC00140	Pathway	Chronic myeloid leukemia
TTDC00140	Pathway	Colorectal cancer
TTDC00140	Pathway	Endometrial cancer
TTDC00140	Pathway	ErbB signaling pathway
TTDC00140	Pathway	Fc epsilon RI signaling pathway
TTDC00140	Pathway	Focal adhesion
TTDC00140	Pathway	Glioma
TTDC00140	Pathway	Inositol phosphate metabolism
TTDC00140	Pathway	Insulin signaling pathway
TTDC00140	Pathway	Jak-STAT signaling pathway
TTDC00140	Pathway	Leukocyte transendothelial migration
TTDC00140	Pathway	Melanoma
TTDC00140	Pathway	Natural killer cell mediated cytotoxicity
TTDC00140	Pathway	Non-small cell lung cancer
TTDC00140	Pathway	Pancreatic cancer
TTDC00140	Pathway	Pathways in cancer
TTDC00140	Pathway	Phosphatidylinositol signaling system
TTDC00140	Pathway	Prostate cancer
TTDC00140	Pathway	Regulation of actin cytoskeleton
TTDC00140	Pathway	Renal cell carcinoma
TTDC00140	Pathway	Small cell lung cancer
TTDC00140	Pathway	T cell receptor signaling pathway
TTDC00140	Pathway	Toll-like receptor signaling pathway
TTDC00140	Pathway	Type II diabetes mellitus
TTDC00140	Pathway	VEGF signaling pathway
TTDC00140	Pathway	mTOR signaling pathway
TTDC00140	EC Number	EC 2.7.1.153
TTDC00140	Target Validation	TTDC00140
TTDC00140	Drug(s)	2636771
TTDC00140	Drug(s)	AR-12
TTDC00140	Drug(s)	AZD6482
TTDC00140	Drug(s)	BAY 1082439
TTDC00140	Drug(s)	BAY 80-6946
TTDC00140	Drug(s)	BEZ235
TTDC00140	Drug(s)	BGT226
TTDC00140	Drug(s)	BKM120
TTDC00140	Drug(s)	BYL719
TTDC00140	Drug(s)	CAL-101
TTDC00140	Drug(s)	CHU
TTDC00140	Drug(s)	CUDC-907
TTDC00140	Drug(s)	DS-7423
TTDC00140	Drug(s)	GDC-0032
TTDC00140	Drug(s)	GDC-0980
TTDC00140	Drug(s)	GDC-0980/RG7422
TTDC00140	Drug(s)	GDC0941
TTDC00140	Drug(s)	GSK1059615
TTDC00140	Drug(s)	GSK2126458
TTDC00140	Drug(s)	LY294002
TTDC00140	Drug(s)	PF-04691502
TTDC00140	Drug(s)	PF-05212384
TTDC00140	Drug(s)	PI3K alpha
TTDC00140	Drug(s)	PX-866
TTDC00140	Drug(s)	RG7422
TTDC00140	Drug(s)	SAR245408/MSC1936369B combination therapy
TTDC00140	Drug(s)	SAR245409/MSC1936369B combination therapy
TTDC00140	Drug(s)	SF1126
TTDC00140	Drug(s)	TG100-115
TTDC00140	Drug(s)	XL147
TTDC00140	Drug(s)	XL765
TTDC00140	Inhibitor	2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One
TTDC00140	Inhibitor	3-(4-morpholinothieno[3,2-d]pyrimidin-2-yl)phenol
TTDC00140	Inhibitor	5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE
TTDC00140	Inhibitor	AZD6482
TTDC00140	Inhibitor	BAG956
TTDC00140	Inhibitor	BEZ235
TTDC00140	Inhibitor	BGT226
TTDC00140	Inhibitor	BKM120
TTDC00140	Inhibitor	CAL-101
TTDC00140	Inhibitor	GDC-0980
TTDC00140	Inhibitor	GDC0941
TTDC00140	Inhibitor	GSK1059615
TTDC00140	Inhibitor	LY-292223
TTDC00140	Inhibitor	LY-293646
TTDC00140	Inhibitor	LY-294002
TTDC00140	Inhibitor	LY294002
TTDC00140	Inhibitor	Myricetin
TTDC00140	Inhibitor	PI-103
TTDC00140	Inhibitor	PI3K alpha
TTDC00140	Inhibitor	PKI-402
TTDC00140	Inhibitor	PX-866
TTDC00140	Inhibitor	Quercetin
TTDC00140	Inhibitor	SF1126
TTDC00140	Inhibitor	Staurosporine
TTDC00140	Inhibitor	TG100-115
TTDC00140	Inhibitor	Wortmannin
TTDC00140	Inhibitor	XL147
TTDC00140	Inhibitor	XL765
TTDC00140	Inhibitor	ZSTK474
TTDC00140	Multitarget	BEZ235
TTDC00140	Multitarget	BGT226
TTDC00140	Multitarget	GDC-0980
TTDC00140	Multitarget	XL765
TTDC00141	UniProt ID	P35557
TTDC00141	Name	Hexokinase D
TTDC00141	Type of target	Clinical trial target
TTDC00141	Synonyms	GCK
TTDC00141	Synonyms	Glucokinase
TTDC00141	Synonyms	HK IV
TTDC00141	Synonyms	HK4
TTDC00141	Synonyms	Hexokinase type IV
TTDC00141	Disease	Benign prostatic hyperplasia
TTDC00141	Disease	Diabetes Mellitus Type 1 and 2
TTDC00141	Disease	Noninsulin-dependent diabetes mellitus
TTDC00141	Disease	Prostate Disorders
TTDC00141	Function	Catalyzes the initial step in utilization of glucose by the beta-cell and liver
TTDC00141	Sequence	MLDDRARMEAAKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLG
TTDC00141	PDB Structure	1GLK; 1V4S; 1V4T; 3A0I; 3F9M; 3FGU; 3FR0; 3GOI; 3H1V; 3ID8; 3IDH; 3IMX; 3QIC; 3S
TTDC00141	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00141	Pathway	Amino sugar and nucleotide sugar metabolism
TTDC00141	Pathway	Glycolysis / Gluconeogenesis
TTDC00141	Pathway	Insulin signaling pathway
TTDC00141	Pathway	Maturity onset diabetes of the young
TTDC00141	Pathway	Metabolic pathways
TTDC00141	Pathway	Starch and sucrose metabolism
TTDC00141	Pathway	Type II diabetes mellitus
TTDC00141	EC Number	EC 2.7.1.1
TTDC00141	Related US Patent	6,320,050
TTDC00141	Related US Patent	6,353,111
TTDC00141	Related US Patent	6,369,232
TTDC00141	Related US Patent	6,384,220
TTDC00141	Related US Patent	6,388,071
TTDC00141	Related US Patent	6,388,088
TTDC00141	Related US Patent	6,433,188
TTDC00141	Related US Patent	6,441,180
TTDC00141	Related US Patent	6,441,184
TTDC00141	Related US Patent	6,448,399
TTDC00141	Related US Patent	6,482,951
TTDC00141	Related US Patent	6,486,184
TTDC00141	Related US Patent	6,489,485
TTDC00141	Related US Patent	6,545,155
TTDC00141	Related US Patent	6,583,288
TTDC00141	Related US Patent	6,608,218
TTDC00141	Related US Patent	6,610,846
TTDC00141	Target Validation	TTDC00141
TTDC00141	Drug(s)	AMG 151
TTDC00141	Drug(s)	AZD1656
TTDC00141	Drug(s)	AZD5658
TTDC00141	Drug(s)	AZD6370
TTDC00141	Drug(s)	DS-7309
TTDC00141	Drug(s)	GK1-399
TTDC00141	Drug(s)	Lonidamine
TTDC00141	Drug(s)	PSN-101
TTDC00141	Drug(s)	R7201
TTDC00141	Drug(s)	TAK-329
TTDC00141	Drug(s)	TTP355
TTDC00141	Inhibitor	Beta-D-Glucose
TTDC00141	Inhibitor	Lonidamine
TTDC00141	Activator	AZD1656
TTDC00141	Activator	AZD5658
TTDC00141	Activator	AZD6370
TTDC00141	Activator	GKA1
TTDC00141	Activator	GKA2
TTDC00141	Activator	PSN-101
TTDC00141	Activator	R7201
TTDC00142	UniProt ID	P10909
TTDC00142	Name	mRNA of Clusterin
TTDC00142	Type of target	Clinical trial target
TTDC00142	Synonyms	Apo-J
TTDC00142	Synonyms	Apolipoprotein J
TTDC00142	Synonyms	CLI
TTDC00142	Synonyms	Complement cytolysis inhibitor
TTDC00142	Synonyms	Complement-associated protein SP-40,40
TTDC00142	Synonyms	NA1/NA2
TTDC00142	Synonyms	TRPM-2
TTDC00142	Synonyms	Testosterone-repressed prostate message 2
TTDC00142	Disease	Advanced lung cancer
TTDC00142	Disease	Breast cancer
TTDC00142	Disease	Lung Cancer
TTDC00142	Disease	Prostate cancer
TTDC00142	Function	Not yet clear. It is known to be expressed in a variety of tissues and it seems
TTDC00142	Sequence	MMKTLLLFVGLLLTWESGQVLGDQTVSDNELQEMSNQGSKYVNKEIQNAVNGVKQIKTLIEKTNEERKTLLSNLEEAKKK
TTDC00142	Target Validation	TTDC00142
TTDC00142	Drug(s)	OGX-011
TTDC00142	Antisense	OGX-011
TTDC00143	UniProt ID	P52732
TTDC00143	Name	Kinesin-like protein KIF11
TTDC00143	Type of target	Clinical trial target
TTDC00143	Synonyms	Eg5
TTDC00143	Synonyms	Kinesin-like protein 1
TTDC00143	Synonyms	Kinesin-like spindle protein HKSP
TTDC00143	Synonyms	Kinesin-related motor protein Eg5
TTDC00143	Synonyms	TRIP5
TTDC00143	Synonyms	Thyroid receptor interacting protein 5
TTDC00143	Disease	Cancer, unspecific
TTDC00143	Disease	Head and Neck Cancer
TTDC00143	Disease	Lung Cancer
TTDC00143	Disease	Lymphoma, Non-Hodgkin's
TTDC00143	Disease	Ovarian cancer
TTDC00143	Disease	Pediatric
TTDC00143	Disease	Renal Cell Carcinoma
TTDC00143	Disease	Solid tumors
TTDC00143	Function	Motor protein required for establishing a bipolar spindle. Blocking of eg5 preve
TTDC00143	Sequence	MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQID
TTDC00143	PDB Structure	1II6; 1Q0B; 1X88; 1YRS; 2FKY; 2FL2; 2FL6; 2FME; 2G1Q; 2GM1; 2IEH; 2PG2; 2Q2Y; 2Q
TTDC00143	Target Validation	TTDC00143
TTDC00143	Drug(s)	4SC-205
TTDC00143	Drug(s)	ARQ 621
TTDC00143	Drug(s)	ARRY-520
TTDC00143	Drug(s)	BQS481
TTDC00143	Drug(s)	Ispinesib
TTDC00143	Drug(s)	SB-743921
TTDC00143	Inhibitor	4SC-205
TTDC00143	Inhibitor	ARRY-520
TTDC00143	Inhibitor	Adenosine-5'-Diphosphate
TTDC00143	Inhibitor	Ispinesib
TTDC00143	Inhibitor	Monastrol
TTDC00143	Inhibitor	SB-743921
TTDC00144	UniProt ID	P30989
TTDC00144	Name	Neurotensin receptor type 1
TTDC00144	Type of target	Clinical trial target
TTDC00144	Synonyms	High-affinity levocabastine-insensitive neurotensin receptor
TTDC00144	Synonyms	NT-R-1
TTDC00144	Synonyms	NT-R1
TTDC00144	Synonyms	NTR subtype 1
TTDC00144	Synonyms	NTR1
TTDC00144	Synonyms	NTRH
TTDC00144	Disease	Analgesics
TTDC00144	Disease	Colorectal Cancer
TTDC00144	Disease	Depression
TTDC00144	Disease	Lung Cancer
TTDC00144	Disease	NTR-positive tumors
TTDC00144	Disease	Pain, Acute or Chronic
TTDC00144	Disease	Pancreatic cancer
TTDC00144	Disease	Prostate cancer
TTDC00144	Disease	Psychosis
TTDC00144	Disease	Schizophrenia and Schizoaffective Disorders
TTDC00144	Function	Receptor for the tridecapeptide neurotensin. It is associated with G proteins th
TTDC00144	Sequence	MRLNSSAPGTPGTPAADPFQRAQAGLEEALLAPGFGNASGNASERVLAAPSSELDVNTDIYSKVLVTAVYLALFVVGTVG
TTDC00144	PDB Structure	2LYW
TTDC00144	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00144	Pathway	Calcium signaling pathway
TTDC00144	Pathway	Neuroactive ligand-receptor interaction
TTDC00144	Target Validation	TTDC00144
TTDC00144	Drug(s)	CGX-1160
TTDC00144	Drug(s)	Meclinertant
TTDC00144	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDC00144	Inhibitor	Arg-Arg-Pro-Tyr-Ile-Leu-OH
TTDC00144	Inhibitor	Demotensin 1
TTDC00144	Inhibitor	Demotensin 2
TTDC00144	Inhibitor	Demotensin 3
TTDC00144	Inhibitor	Demotensin 4
TTDC00144	Inhibitor	H-Arg-Arg-Pro-Tyr-Ile-Aac-OH
TTDC00144	Inhibitor	H-Arg-Arg-Pro-Tyr-Ile-N-Me-Leu-OH
TTDC00144	Inhibitor	H-Arg-Arg-Pro-Tyr-N-Me-Ile-Leu-OH
TTDC00144	Inhibitor	H-Arg-N-Me-Arg-Pro-Tyr-Ile-Leu-OH
TTDC00144	Inhibitor	NEUROTENSIN
TTDC00144	Inhibitor	Neurotensin(8-13)
TTDC00144	Inhibitor	SR-48692
TTDC00144	Antagonist	Meclinertant
TTDC00144	Agonist	CGX-1160
TTDC00145	UniProt ID	P23443
TTDC00145	Name	Ribosomal protein S6 kinase
TTDC00145	Type of target	Discontinued target
TTDC00145	Synonyms	P70-S6K
TTDC00145	Synonyms	S6K
TTDC00145	Disease	Cancer, unspecific
TTDC00145	Disease	Solid tumors
TTDC00145	Function	Phosphorylates specifically ribosomal protein s6.
TTDC00145	Sequence	MRRRRRRDGFYPAPDFRDREAEDMAGVFDIDLDQPEDAGSEDELEEGGQLNESMDHGGVGPYELGMEHCEKFEISETSVN
TTDC00145	PDB Structure	3A60; 3A61; 3A62
TTDC00145	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00145	Pathway	Acute myeloid leukemia
TTDC00145	Pathway	ErbB signaling pathway
TTDC00145	Pathway	Insulin signaling pathway
TTDC00145	Pathway	TGF-beta signaling pathway
TTDC00145	Pathway	mTOR signaling pathway
TTDC00145	EC Number	EC 2.7.1.-
TTDC00145	EC Number	EC 2.7.1.37
TTDC00145	Target Validation	TTDC00145
TTDC00145	Drug(s)	XL418
TTDC00145	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDC00145	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDC00145	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDC00145	Inhibitor	CI-1040;PD-18435;PD-184352
TTDC00145	Inhibitor	KN-62
TTDC00145	Inhibitor	KT-5720
TTDC00145	Inhibitor	LY-294002
TTDC00145	Inhibitor	PD-98059
TTDC00145	Inhibitor	PHA-767491
TTDC00145	Inhibitor	RO-316233
TTDC00145	Inhibitor	SB-202190
TTDC00145	Inhibitor	SB-203580
TTDC00145	Inhibitor	SB-415286
TTDC00145	Inhibitor	SB-747651A
TTDC00145	Inhibitor	STAUROSPORINONE
TTDC00145	Inhibitor	U-0126
TTDC00145	Inhibitor	XL418
TTDC00145	Multitarget	XL418
TTDC00147	UniProt ID	P03956
TTDC00147	Name	Interstitial collagenase
TTDC00147	Type of target	Discontinued target
TTDC00147	Synonyms	Fibroblast collagenase
TTDC00147	Synonyms	MMP-1
TTDC00147	Synonyms	Matrix metalloproteinase-1
TTDC00147	Disease	Cancer, unspecific
TTDC00147	Disease	Chondrosarcoma
TTDC00147	Disease	Emphysema
TTDC00147	Disease	Hormone-refractory Prostate cancer
TTDC00147	Disease	Kaposi's Sarcoma
TTDC00147	Disease	Lung Cancer
TTDC00147	Disease	Myocardial infarction (MI)
TTDC00147	Disease	Non-small Cell Lung Cancer
TTDC00147	Disease	Osteoarthritis
TTDC00147	Disease	Pancreatic Cancer
TTDC00147	Function	Cleaves collagens of types i, ii, and iii at one site in the helical domain. Als
TTDC00147	Sequence	MHSFPPLLLLLFWGVVSHSFPATLETQEQDVDLVQKYLEKYYNLKNDGRQVEKRRNSGPVVEKLKQMQEFFGLKVTGKPD
TTDC00147	PDB Structure	1AYK; 1CGE; 1CGF; 1CGL; 1HFC; 1SU3; 2AYK; 2CLT; 2J0T; 2TCL; 3AYK; 3SHI; 4AUO; 4A
TTDC00147	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00147	Pathway	Bladder cancer
TTDC00147	Pathway	PPAR signaling pathway
TTDC00147	Pathway	Pathways in cancer
TTDC00147	EC Number	EC 3.4.24.7
TTDC00147	Related US Patent	6,608,112
TTDC00147	Target Validation	TTDC00147
TTDC00147	QSAR Model	TTDC00147
TTDC00147	Drug(s)	BB-3644
TTDC00147	Drug(s)	BMS 275291
TTDC00147	Drug(s)	Batimastat
TTDC00147	Drug(s)	Marimastat
TTDC00147	Drug(s)	Prinomastat
TTDC00147	Drug(s)	XL784
TTDC00147	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-cyclohexanethiol
TTDC00147	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-hexane-1-thiol
TTDC00147	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-pentane-1-thiol
TTDC00147	Inhibitor	3-(4-Phenoxy-benzenesulfonyl)-cyclohexanethiol
TTDC00147	Inhibitor	3-(4-Phenoxy-benzenesulfonyl)-propane-1-thiol
TTDC00147	Inhibitor	3-Benzenesulfinyl-heptanoic acid hydroxyamide
TTDC00147	Inhibitor	3-Benzenesulfonyl-heptanoic acid hydroxyamide
TTDC00147	Inhibitor	3-Cyclohexanesulfonyl-heptanoic acid hydroxyamide
TTDC00147	Inhibitor	4-(4-Butoxy-phenyl)-N-hydroxy-4-oxo-butyramide
TTDC00147	Inhibitor	4-(4-Methoxy-benzenesulfonyl)-butane-2-thiol
TTDC00147	Inhibitor	4-Butoxy-N-hydroxycarbamoylmethyl-benzamide
TTDC00147	Inhibitor	BB-1101
TTDC00147	Inhibitor	BB-3644
TTDC00147	Inhibitor	BMS 275291
TTDC00147	Inhibitor	Batimastat
TTDC00147	Inhibitor	CGS-27023A
TTDC00147	Inhibitor	CIPEMASTAT
TTDC00147	Inhibitor	ILOMASTAT
TTDC00147	Inhibitor	L-696418
TTDC00147	Inhibitor	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID
TTDC00147	Inhibitor	Marimastat
TTDC00147	Inhibitor	N-(Ethylphosphoryl)-L-isoleucyl-L-Trp-NHCH3
TTDC00147	Inhibitor	N-Hydroxy-4-(4-methoxy-phenyl)-4-oxo-butyramide
TTDC00147	Inhibitor	N-Hydroxy-4-oxo-4-(4-phenoxy-phenyl)-butyramide
TTDC00147	Inhibitor	N-Hydroxycarbamoylmethyl-4-methoxy-benzamide
TTDC00147	Inhibitor	N-Hydroxycarbamoylmethyl-4-phenoxy-benzamide
TTDC00147	Inhibitor	PKF-242-484;TNF-484
TTDC00147	Inhibitor	Prinomastat
TTDC00147	Inhibitor	RO-319790
TTDC00147	Inhibitor	RS-130830
TTDC00147	Inhibitor	RS-39066
TTDC00147	Inhibitor	Ro-31-4724
TTDC00147	Inhibitor	Ro-32-3555
TTDC00147	Inhibitor	Ro-37-9790
TTDC00147	Inhibitor	SC-44463
TTDC00147	Inhibitor	SR-973
TTDC00147	Inhibitor	TMI-05
TTDC00147	Inhibitor	XL784
TTDC00147	Multitarget	BB-3644
TTDC00147	Multitarget	BMS 275291
TTDC00147	Multitarget	Batimastat
TTDC00147	Multitarget	Marimastat
TTDC00147	Multitarget	Prinomastat
TTDC00148	UniProt ID	P05556
TTDC00148	Name	Integrin beta-1
TTDC00148	Type of target	Clinical trial target
TTDC00148	Synonyms	Beta(1) integrin
TTDC00148	Synonyms	CD29 antigen
TTDC00148	Synonyms	Fibronectin receptor beta subunit
TTDC00148	Synonyms	Integrin VLA-4 beta subunit
TTDC00148	Disease	Asthma
TTDC00148	Disease	Macular Degeneration
TTDC00148	Disease	Rheumatoid arthritis
TTDC00148	Disease	Tumors
TTDC00148	Function	Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta- 1 and alpha-11/beta-1 a
TTDC00148	Sequence	MNLQPIFWIGLISSVCCVFAQTDENRCLKANAKSCGECIQAGPNCGWCTNSTFLQEGMPTSARCDDLEALKKKGCPPDDI
TTDC00148	PDB Structure	1K11; 1LHA; 3G9W; 3T9K; 3VI3; 3VI4; 4DX9
TTDC00148	BioChemical Class	Transmembrane protein
TTDC00148	Target Validation	TTDC00148
TTDC00148	Drug(s)	JSM 6427
TTDC00148	Drug(s)	R411
TTDC00148	Inhibitor	MK-0668
TTDC00148	Inhibitor	SB-265123
TTDC00148	Inhibitor	TR-14035
TTDC00148	Inhibitor	c(-GRGDfL-)
TTDC00148	Antagonist	JSM 6427
TTDC00148	Antagonist	R411
TTDC00148	Multitarget	JSM 6427
TTDC00149	UniProt ID	P08842
TTDC00149	Name	Steryl-sulfatase
TTDC00149	Type of target	Clinical trial target
TTDC00149	Synonyms	ASC
TTDC00149	Synonyms	Arylsulfatase C
TTDC00149	Synonyms	Estrone sulfatase
TTDC00149	Synonyms	STS
TTDC00149	Synonyms	Steroid sulfatase
TTDC00149	Synonyms	Steryl-sulfate sulfohydrolase
TTDC00149	Disease	Androgen-dependent diseases
TTDC00149	Disease	Breast cancer
TTDC00149	Disease	Breast cancer (hormone-sensitive)
TTDC00149	Disease	Estrogen disorders
TTDC00149	Disease	Tumors
TTDC00149	Function	Conversion of sulfated steroid precursors to estrogens during pregnancy.
TTDC00149	Sequence	MPLRKMKIPFLLLFFLWEAESHAASRPNIILVMADDLGIGDPGCYGNKTIRTPNIDRLASGGVKLTQHLAASPLCTPSRA
TTDC00149	PDB Structure	1P49
TTDC00149	BioChemical Class	Hydrolases acting on ester bonds
TTDC00149	Pathway	Androgen and estrogen metabolism
TTDC00149	EC Number	EC 3.1.6.2
TTDC00149	Related US Patent	6,376,687
TTDC00149	Related US Patent	6,399,595
TTDC00149	Related US Patent	6,436,918
TTDC00149	Related US Patent	6,585,954
TTDC00149	Related US Patent	6,642,397
TTDC00149	Related US Patent	6,670,353
TTDC00149	Related US Patent	6,677,325
TTDC00149	Target Validation	TTDC00149
TTDC00149	Drug(s)	STX 64
TTDC00149	Inhibitor	2',4'-dicyanobiphenyl-4-yl sulfamate
TTDC00149	Inhibitor	2-(4-cyclohexylthiosemicarbazono)methyl-phenol
TTDC00149	Inhibitor	2-Adamantan-2-ylidenemethyl-benzooxazol-6-ol
TTDC00149	Inhibitor	2-Amino-3-Oxo-4-Sulfo-Butyric Acid
TTDC00149	Inhibitor	2-ethylestradiol 3,17-O,O-bis-sulfamate
TTDC00149	Inhibitor	2-methoxyestradiol 3,17-O,O-bis-sulfamate
TTDC00149	Inhibitor	2-methylsulfanylestradiol 3,17-O,O-bis-sulfamate
TTDC00149	Inhibitor	3-(4-cyclohexylthiosemicarbazono)methyl-phenol
TTDC00149	Inhibitor	3-(4-hexylthiosemicarbazono)methyl-benzoic acid
TTDC00149	Inhibitor	3-{3-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate
TTDC00149	Inhibitor	3-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate
TTDC00149	Inhibitor	4-(4-cyclohexylthiosemicarbazono)methyl-phenol
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid butyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid cycloheptyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid cyclohexyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid cyclooctyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid cyclopentyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid heptyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid hexyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid nonyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid octyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid pentyl ester
TTDC00149	Inhibitor	4-Sulfamoyloxy-benzoic acid propyl ester
TTDC00149	Inhibitor	4-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate
TTDC00149	Inhibitor	667COUMATE
TTDC00149	Inhibitor	B-Octylglucoside
TTDC00149	Inhibitor	Benzomate
TTDC00149	Inhibitor	COUMATE
TTDC00149	Inhibitor	EMATE
TTDC00149	Inhibitor	MHL cyclohexylthiosemicarbazone
TTDC00149	Inhibitor	Nortropinyl-arylsulfonylurea 3
TTDC00149	Inhibitor	STX 64
TTDC00149	Inhibitor	Steroidal and non-steroidal inhibitors
TTDC00149	Inhibitor	Sulfamic acid 2-nonyl-4-oxo-4H-chromen-6-yl ester
TTDC00149	Inhibitor	Sulfamic acid 3-(3-hydroxy-benzoyl)-phenyl ester
TTDC00149	Inhibitor	Sulfamic acid 3-(3-methoxy-benzoyl)-phenyl ester
TTDC00149	Inhibitor	Sulfamic acid 3-(4-hydroxy-benzoyl)-phenyl ester
TTDC00149	Inhibitor	Sulfamic acid 3-(4-methoxy-benzoyl)-phenyl ester
TTDC00149	Inhibitor	Sulfamic acid 3-benzoyl-phenyl ester
TTDC00149	Inhibitor	Sulfamic acid 4-(2-hydroxy-benzoyl)-phenyl ester
TTDC00149	Inhibitor	Sulfamic acid 4-(2-methoxy-benzoyl)-phenyl ester
TTDC00149	Inhibitor	Sulfamic acid 4-(3-methoxy-benzoyl)-phenyl ester
TTDC00149	Inhibitor	Sulfamic acid 4-benzoyl-phenyl ester
TTDC00149	Inhibitor	estradiol 17-O-sulfamate
TTDC00149	Inhibitor	estradiol 3,17-O,O-bis-sulfamate
TTDC00150	UniProt ID	P45452
TTDC00150	Name	Collagenase 3
TTDC00150	Type of target	Discontinued target
TTDC00150	Synonyms	Collagenase-3
TTDC00150	Synonyms	MMP-13
TTDC00150	Synonyms	Matrix metalloproteinase 13
TTDC00150	Synonyms	Matrix metalloproteinase-13
TTDC00150	Disease	Brain Cancer
TTDC00150	Disease	Hormone-refractory Prostate cancer
TTDC00150	Disease	Kaposi's Sarcoma
TTDC00150	Disease	Lung Cancer
TTDC00150	Disease	Myocardial infarction (MI)
TTDC00150	Disease	Non-small Cell Lung Cancer
TTDC00150	Disease	Osteoarthritis
TTDC00150	Disease	Prostate cancer
TTDC00150	Disease	Squamous cell carcinoma
TTDC00150	Function	Degrades collagen type i. Does not act on gelatin or casein. Could have a role i
TTDC00150	Sequence	MHPGVLAAFLFLSWTHCRALPLPSGGDEDDLSEEDLQFAERYLRSYYHPTNLAGILKENAASSMTERLREMQSFFGLEVT
TTDC00150	PDB Structure	1EUB; 1FLS; 1FM1; 1PEX; 1UC1; 1XUC; 1XUD; 1XUR; 1YOU; 1ZTQ; 2D1N; 2E2D; 2OW9; 2O
TTDC00150	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00150	EC Number	EC 3.4.24.-
TTDC00150	Related US Patent	6,265,432
TTDC00150	Related US Patent	6,350,885
TTDC00150	Related US Patent	6,350,907
TTDC00150	Related US Patent	6,399,612
TTDC00150	Related US Patent	6,420,408
TTDC00150	Related US Patent	6,492,422
TTDC00150	Related US Patent	6,541,489
TTDC00150	Related US Patent	6,624,196
TTDC00150	Related US Patent	6,656,932
TTDC00150	Target Validation	TTDC00150
TTDC00150	QSAR Model	TTDC00150
TTDC00150	Inhibitor	(+/-)5-(biphenyl-4-yl)-3-hydroxypentanoic acid
TTDC00150	Inhibitor	1-(4-Methoxy-benzenesulfonyl)-heptane-3-thiol
TTDC00150	Inhibitor	1-Methyloxy-4-Sulfone-Benzene
TTDC00150	Inhibitor	2-(2-(biphenyl-4-yl)ethylsulfonyl)acetic acid
TTDC00150	Inhibitor	2-(4-methoxybenzylthio)-6-methylpyrimidin-4-ol
TTDC00150	Inhibitor	2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide
TTDC00150	Inhibitor	2-(biphenyl-4-ylsulfonamido)pentanedioic acid
TTDC00150	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-cyclohexanethiol
TTDC00150	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-cyclopentanethiol
TTDC00150	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-hexane-1-thiol
TTDC00150	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-pentane-1-thiol
TTDC00150	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-propane-1-thiol
TTDC00150	Inhibitor	3-(4-Phenoxy-benzenesulfonyl)-cyclohexanethiol
TTDC00150	Inhibitor	3-(4-Phenoxy-benzenesulfonyl)-propane-1-thiol
TTDC00150	Inhibitor	3-Benzenesulfonyl-heptanoic acid hydroxyamide
TTDC00150	Inhibitor	3-Cyclohexanesulfonyl-heptanoic acid hydroxyamide
TTDC00150	Inhibitor	3-Methylpyridine
TTDC00150	Inhibitor	4-(2,2'-bithiophen-5-ylmethyleneamino)phenol
TTDC00150	Inhibitor	4-(4-Methoxy-benzenesulfonyl)-butane-2-thiol
TTDC00150	Inhibitor	4-(methyl(4-phenylthiazol-2-yl)amino)phenol
TTDC00150	Inhibitor	4-amino-3-(4-(hexyloxy)phenyl)-4-oxobutanoic acid
TTDC00150	Inhibitor	5-(4'-cyanobiphenyl-4-yl)-3-hydroxypentanoic acid
TTDC00150	Inhibitor	CGS-27023A
TTDC00150	Inhibitor	CIPEMASTAT
TTDC00150	Inhibitor	CURCUMIN
TTDC00150	Inhibitor	Hydroxyaminovaline
TTDC00150	Inhibitor	IK-682
TTDC00150	Inhibitor	ILOMASTAT
TTDC00150	Inhibitor	N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide
TTDC00150	Inhibitor	N1,N3-bis(3-methoxybenzyl)isophthalamide
TTDC00150	Inhibitor	N4,N6-dibenzylpyrimidine-4,6-dicarboxamide
TTDC00150	Inhibitor	PKF-242-484;TNF-484
TTDC00150	Inhibitor	RS-130830
TTDC00150	Inhibitor	Ro-32-3555
TTDC00150	Inhibitor	Ro-37-9790
TTDC00150	Inhibitor	SR-973
TTDC00150	Inhibitor	TMI-05
TTDC00150	Inhibitor	UK-356618
TTDC00150	Inhibitor	WAY-151693
TTDC00150	Inhibitor	[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid
TTDC00150	Inhibitor	ethyl 2-cyano-2-(quinoxalin-2(1H)-ylidene)acetate
TTDC00151	UniProt ID	P35408
TTDC00151	Name	Prostaglandin E2 receptor, EP4 subtype
TTDC00151	Type of target	Discontinued target
TTDC00151	Synonyms	EP sub 4 receptor
TTDC00151	Synonyms	PGE receptor, EP4 subtype
TTDC00151	Synonyms	Prostanoid EP4 receptor
TTDC00151	Disease	Dry eye
TTDC00151	Disease	Osteoporosis, unspecified
TTDC00151	Disease	Renal failure
TTDC00151	Disease	Ulcerative colitis
TTDC00151	Function	Receptor for prostaglandin e2 (pge2). The activity of this receptor is mediated
TTDC00151	Sequence	MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATY
TTDC00151	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00151	Pathway	Neuroactive ligand-receptor interaction
TTDC00151	Related US Patent	6,344,477
TTDC00151	Related US Patent	6,552,067
TTDC00151	Related US Patent	6,610,719
TTDC00151	Related US Patent	6,642,266
TTDC00151	Target Validation	TTDC00151
TTDC00151	Drug(s)	ONO-4819
TTDC00151	Inhibitor	3-(2-((E)-3-phenylprop-1-enyl)phenyl)acrylic acid
TTDC00151	Inhibitor	3-(2-(4-methoxycinnamyl)phenyl)acrylic acid
TTDC00151	Inhibitor	3-(2-(naphthalen-2-ylmethyl)phenyl)acrylic acid
TTDC00151	Inhibitor	3-(2-cinnamylphenyl)acrylic acid
TTDC00151	Inhibitor	8-aza-11-deoxyprostaglandin E1
TTDC00151	Inhibitor	DG-041
TTDC00151	Inhibitor	DINOPROST
TTDC00151	Inhibitor	FR-181157
TTDC00151	Agonist	ONO-4819
TTDC00152	UniProt ID	P09467
TTDC00152	Name	Fructose-1,6-bisphosphatase
TTDC00152	Type of target	Clinical trial target
TTDC00152	Synonyms	D-fructose-1,6-bisphosphate 1-phosphohydrolase
TTDC00152	Synonyms	FBP1
TTDC00152	Synonyms	FBPase
TTDC00152	Synonyms	Fructose 1,6-bisphosphatase
TTDC00152	Disease	Diabetes Mellitus Type 2
TTDC00152	Sequence	MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSND
TTDC00152	PDB Structure	1FTA; 2FHY; 2FIE; 2FIX; 2JJK; 2VT5; 2WBB; 2WBD; 2Y5K; 2Y5L; 3A29; 3KBZ; 3KC0; 3K
TTDC00152	BioChemical Class	Hydrolases acting on ester bonds
TTDC00152	Pathway	Fructose and mannose metabolism
TTDC00152	Pathway	Glycolysis / Gluconeogenesis
TTDC00152	Pathway	Insulin signaling pathway
TTDC00152	Pathway	Metabolic pathways
TTDC00152	Pathway	Pentose phosphate pathway
TTDC00152	EC Number	EC 3.1.3.11
TTDC00152	Related US Patent	6,294,672
TTDC00152	Related US Patent	6,399,782
TTDC00152	Target Validation	TTDC00152
TTDC00152	Drug(s)	MB07803
TTDC00152	Inhibitor	1-(2-mercaptoethyl)-3-(m-tolylsulfonyl)urea
TTDC00152	Inhibitor	1-(4-aminophenylsulfonyl)-3-(2-mercaptoethyl)urea
TTDC00152	Inhibitor	2,5-Anhydroglucitol-1,6-Biphosphate
TTDC00152	Inhibitor	2-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol
TTDC00152	Inhibitor	3-(4-(4-Hydroxyphenyl)thiazol-2-ylamino)phenol
TTDC00152	Inhibitor	4-(2-Aminothiazol-4-yl)phenol
TTDC00152	Inhibitor	4-(4-(4-Nitrophenyl)thiazol-2-ylamino)phenol
TTDC00152	Inhibitor	Adenosine Monophosphate (Amp);Adenosine phosphate
TTDC00152	Inhibitor	Fructose-6-Phosphate
TTDC00152	Inhibitor	MB07803
TTDC00152	Inhibitor	Mdl-29951
TTDC00152	Inhibitor	N-(5-chlorobenzo[d]oxazol-2-yl)benzenesulfonamide
TTDC00153	UniProt ID	O43613
TTDC00153	Name	Orexin receptor type 1
TTDC00153	Type of target	Clinical trial target
TTDC00153	Synonyms	7-transmembrane G-protein coupled neuropeptide receptor
TTDC00153	Synonyms	HFGAN72 receptor
TTDC00153	Synonyms	Hypocretin receptor type 1
TTDC00153	Synonyms	Orexin-1 receptor
TTDC00153	Synonyms	Ox1r
TTDC00153	Disease	Gastrointestinal motility disorders
TTDC00153	Disease	Insomnia
TTDC00153	Disease	Insulin disorders
TTDC00153	Disease	Nausea and vomiting
TTDC00153	Disease	Nutritional disorders
TTDC00153	Disease	Sleep Disorders
TTDC00153	Disease	Sleeping sickness
TTDC00153	Function	Moderately selective excitatory receptor for orexin-a and, with a lower affinity
TTDC00153	Sequence	MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTV
TTDC00153	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00153	Pathway	Neuroactive ligand-receptor interaction
TTDC00153	Related US Patent	6,410,529
TTDC00153	Related US Patent	6,506,774
TTDC00153	Related US Patent	6,677,354
TTDC00153	Target Validation	TTDC00153
TTDC00153	Drug(s)	Almorexant
TTDC00153	Drug(s)	Orexin-1 antagonist
TTDC00153	Drug(s)	SB-649868
TTDC00153	Inhibitor	MK-4305
TTDC00153	Antagonist	Almorexant
TTDC00153	Antagonist	Orexin-1 antagonist
TTDC00153	Antagonist	SB-649868
TTDC00155	UniProt ID	O43193
TTDC00155	Name	Motilin receptor
TTDC00155	Type of target	Clinical trial target
TTDC00155	Disease	Eating disorders
TTDC00155	Disease	Gastroesophageal Reflux Disease (GERD)
TTDC00155	Disease	Gastrointestinal Diseases and Disorders, miscellaneous
TTDC00155	Disease	Gastrointestinal reflux disorders
TTDC00155	Disease	Gastroparesis
TTDC00155	Disease	Irritable Bowel Syndrome (IBS)
TTDC00155	Disease	Obesity
TTDC00155	Function	Receptor for motilin.
TTDC00155	Sequence	MGSPWNGSDGPEGAREPPWPALPPCDERRCSPFPLGALVPVTAVCLCLFVVGVSGNVVTVMLIGRYRDMRTTTNLYLGSM
TTDC00155	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00155	Pathway	Neuroactive ligand-receptor interaction
TTDC00155	Related US Patent	6,384,031
TTDC00155	Related US Patent	6,392,040
TTDC00155	Related US Patent	6,423,714
TTDC00155	Related US Patent	6,511,980
TTDC00155	Related US Patent	6,624,165
TTDC00155	Related US Patent	6,667,309
TTDC00155	Target Validation	TTDC00155
TTDC00155	Drug(s)	Camicinal
TTDC00155	Drug(s)	GSK-326416
TTDC00155	Drug(s)	GSK962040
TTDC00155	Drug(s)	KOS-2187
TTDC00155	Drug(s)	Mitemcinal
TTDC00155	Drug(s)	Mitemcinal fumarate
TTDC00155	Inhibitor	MOTILIN
TTDC00155	Agonist	GSK-326416
TTDC00155	Agonist	GSK962040
TTDC00155	Agonist	KOS-2187
TTDC00155	Agonist	Mitemcinal
TTDC00155	Agonist	Mitemcinal fumarate
TTDC00156	UniProt ID	P43405
TTDC00156	Name	Tyrosine-protein kinase SYK
TTDC00156	Type of target	Clinical trial target
TTDC00156	Synonyms	Spleen tyrosine kinase
TTDC00156	Disease	Allergic Reaction
TTDC00156	Disease	Asthma
TTDC00156	Disease	Inflammatory diseases
TTDC00156	Disease	Lymphoma, Non-Hodgkin's
TTDC00156	Disease	Obstructive airway disease
TTDC00156	Disease	Rheumatoid arthritis
TTDC00156	Disease	Thrombocytopenia
TTDC00156	Function	Positive effector of bcr-stimulated responses. Couples the b cell antigen recept
TTDC00156	Sequence	MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGR
TTDC00156	PDB Structure	1A81; 1CSY; 1CSZ; 1XBA; 1XBB; 1XBC; 3BUW; 3EMG; 3FQE; 3FQH; 3FQS; 3SRV; 3TUB; 3T
TTDC00156	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00156	EC Number	EC 2.7.1.112
TTDC00156	Related US Patent	6,589,950
TTDC00156	Target Validation	TTDC00156
TTDC00156	Drug(s)	Fostamatinib
TTDC00156	Drug(s)	GS-9973
TTDC00156	Drug(s)	PRT6207
TTDC00156	Drug(s)	R-788
TTDC00156	Drug(s)	R343
TTDC00156	Drug(s)	R788
TTDC00156	Inhibitor	ELLAGIC ACID
TTDC00156	Inhibitor	N-Benzyl-4-(2,5-dihydroxy-benzylamino)-benzamide
TTDC00156	Inhibitor	R-788
TTDC00156	Inhibitor	R343
TTDC00156	Inhibitor	R788
TTDC00156	Inhibitor	Staurosporine
TTDC00156	Inhibitor	Sti-571
TTDC00157	UniProt ID	P39900
TTDC00157	Name	Macrophage metalloelastase
TTDC00157	Type of target	Clinical trial target
TTDC00157	Synonyms	HME
TTDC00157	Synonyms	ME
TTDC00157	Synonyms	MMP-12
TTDC00157	Synonyms	Macrophage elastase
TTDC00157	Synonyms	Matrix metalloproteinase-12
TTDC00157	Disease	Atherosclerosis
TTDC00157	Disease	Crohn's disease, unspecified
TTDC00157	Disease	Emphysema
TTDC00157	Disease	Gastro-intestinal ulcers
TTDC00157	Disease	Non-small Cell Lung Cancer (NSCLC)
TTDC00157	Disease	Prostate cancer
TTDC00157	Disease	Renal Cell Carcinoma
TTDC00157	Disease	Ulcerative colitis
TTDC00157	Function	May be involved in tissue injury and remodeling. Has significant elastolytic act
TTDC00157	Sequence	MKFLLILLLQATASGALPLNSSTSLEKNNVLFGERYLEKFYGLEINKLPVTKMKYSGNLMKEKIQEMQHFLGLKVTGQLD
TTDC00157	PDB Structure	1JIZ; 1JK3; 1OS2; 1OS9; 1RMZ; 1ROS; 1UTT; 1UTZ; 1Y93; 1YCM; 1Z3J; 2HU6; 2JXY; 2K
TTDC00157	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00157	EC Number	EC 3.4.24.65
TTDC00157	Related US Patent	6,350,907
TTDC00157	Target Validation	TTDC00157
TTDC00157	Drug(s)	AZD1236
TTDC00157	Drug(s)	Neovastat
TTDC00157	Drug(s)	V85546
TTDC00157	Inhibitor	(+/-)5-(biphenyl-4-yl)-3-hydroxypentanoic acid
TTDC00157	Inhibitor	2-(2-(biphenyl-4-yl)ethylsulfinyl)acetic acid
TTDC00157	Inhibitor	2-(2-(biphenyl-4-yl)ethylsulfonyl)acetic acid
TTDC00157	Inhibitor	2-(2-(biphenyl-4-yl)ethylthio)acetic acid
TTDC00157	Inhibitor	2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide
TTDC00157	Inhibitor	3-(4-(2-phenylethynyl)benzoyl)pentanoic acid
TTDC00157	Inhibitor	3-(4-Phenylethynylbenzoyl)nonanoic acid
TTDC00157	Inhibitor	3-Benzenesulfonyl-heptanoic acid hydroxyamide
TTDC00157	Inhibitor	3-Cyclohexanesulfonyl-heptanoic acid hydroxyamide
TTDC00157	Inhibitor	4-(4-(dec-1-ynyl)phenyl)-4-oxobutanoic acid
TTDC00157	Inhibitor	5-(3'-cyanobiphenyl-4-yl)-3-hydroxypentanoic acid
TTDC00157	Inhibitor	5-(4'-cyanobiphenyl-4-yl)-3-hydroxypentanoic acid
TTDC00157	Inhibitor	5-(biphenyl-4-yl)-3-methoxypentanoic acid
TTDC00157	Inhibitor	5-(biphenyl-4-yl)-3-oxopentanoic acid
TTDC00157	Inhibitor	AGELADINE A
TTDC00157	Inhibitor	AZD1236
TTDC00157	Inhibitor	Acetate Ion
TTDC00157	Inhibitor	Batimastat
TTDC00157	Inhibitor	CP-271485
TTDC00157	Inhibitor	ILOMASTAT
TTDC00157	Inhibitor	N-(biphenyl-4-ylsulfonyl)-D-leucine
TTDC00157	Inhibitor	N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine
TTDC00157	Inhibitor	N-Hydroxy-2-(4-methoxy-benzenesulfonyl)benzamide
TTDC00157	Inhibitor	N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide
TTDC00157	Inhibitor	N-[(4-methoxyphenyl)sulfonyl]-D-alanine
TTDC00157	Inhibitor	N-oxo-2-(phenylsulfonylamino)ethanamide
TTDC00157	Inhibitor	N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide
TTDC00157	Inhibitor	Neovastat
TTDC00157	Inhibitor	PF-00356231
TTDC00157	Inhibitor	V85546
TTDC00157	Inhibitor	[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid
TTDC00157	Multitarget	Neovastat
TTDC00158	UniProt ID	P31639
TTDC00158	Name	Sodium/glucose cotransporter 2
TTDC00158	Type of target	Successful target
TTDC00158	Synonyms	Low affinity sodium-glucose cotransporter
TTDC00158	Synonyms	Na(+)/glucose cotransporter 2
TTDC00158	Synonyms	SGLT2
TTDC00158	Synonyms	Sodium dependent glucose transporter 2
TTDC00158	Disease	Atherosclerosis
TTDC00158	Disease	Diabetes Mellitus Type 2
TTDC00158	Disease	Hyperglycemia
TTDC00158	Disease	Hyperinsulinemia
TTDC00158	Disease	Noninsulin-dependent diabetes mellitus
TTDC00158	Disease	Obesity
TTDC00158	Function	Sodium-dependent glucose transporter. Has a na+ to glucose coupling ratio of 1:1
TTDC00158	Sequence	MEEHTEAGSAPEMGAQKALIDNPADILVIAAYFLLVIGVGLWSMCRTNRGTVGGYFLAGRSMVWWPVGASLFASNIGSGH
TTDC00158	BioChemical Class	Ion transport
TTDC00158	Related US Patent	6,414,126
TTDC00158	Related US Patent	6,515,117
TTDC00158	Related US Patent	6,555,519
TTDC00158	Target Validation	TTDC00158
TTDC00158	Drug(s)	ASP1941
TTDC00158	Drug(s)	CHU
TTDC00158	Drug(s)	Canagliflozin
TTDC00158	Drug(s)	Dapagliflozin
TTDC00158	Drug(s)	EGT-0001442
TTDC00158	Drug(s)	EGT-0001474
TTDC00158	Drug(s)	Empagliflozin
TTDC00158	Drug(s)	Ertugliflozin/PF-04971729
TTDC00158	Drug(s)	ISIS-5GLT2rx
TTDC00158	Drug(s)	LIK066
TTDC00158	Drug(s)	RG7201
TTDC00158	Drug(s)	Remogliflozin etabonate
TTDC00158	Drug(s)	SaxaDapa FDC
TTDC00158	Drug(s)	Tofogliflozin
TTDC00158	Blocker	Canagliflozin
TTDC00158	Blocker	Dapagliflozin
TTDC00158	Blocker	ISIS-5GLT2rx
TTDC00158	Blocker	Remogliflozin etabonate
TTDC00159	UniProt ID	P56524
TTDC00159	Name	Histone deacetylase 4
TTDC00159	Type of target	Clinical trial target
TTDC00159	Synonyms	HDAC4
TTDC00159	Disease	Acne
TTDC00159	Disease	Basal cell carcinoma
TTDC00159	Disease	Bladder cancer
TTDC00159	Disease	Colorectal Cancer
TTDC00159	Disease	Cutaneous T-Cell Lymphoma
TTDC00159	Disease	Leukemia, Lymphoid
TTDC00159	Disease	Leukemia, Myeloid
TTDC00159	Disease	Liver Cancer
TTDC00159	Disease	Lymphoma, Unspecified
TTDC00159	Disease	Melanoma; Prostate cancer
TTDC00159	Disease	Mesothelioma
TTDC00159	Disease	Multiple Myeloma
TTDC00159	Disease	Myelodysplastic Syndrome
TTDC00159	Disease	Ovarian cancer
TTDC00159	Disease	Pancreatic Cancer
TTDC00159	Disease	Prostate cancer
TTDC00159	Disease	Prostate cancer (hormone refractory)
TTDC00159	Disease	Renal Cell Carcinoma
TTDC00159	Disease	Sarcoma
TTDC00159	Disease	Skin cancer
TTDC00159	Disease	Solid tumors
TTDC00159	Function	Responsible for the deacetylation of lysine residues on the n-terminal part of t
TTDC00159	Sequence	MSSQSHPDGLSGRDQPVELLNPARVNHMPSTVDVATALPLQVAPSAVPMDLRLDHQFSLPVAEPALREQQLQQELLALKQ
TTDC00159	PDB Structure	2H8N; 2O94; 2VQJ; 2VQM; 2VQO; 2VQQ; 2VQV; 2VQW; 3UXG; 3UZD; 3V31
TTDC00159	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDC00159	Target Validation	TTDC00159
TTDC00159	Drug(s)	FK-228
TTDC00159	Inhibitor	(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one
TTDC00159	Inhibitor	2,2-bis(3-fluorophenyl)-N-hydroxyacetamide
TTDC00159	Inhibitor	2,2-bis(4-chlorophenyl)-N-hydroxyacetamide
TTDC00159	Inhibitor	2,2-bis(4-fluorophenyl)-N-hydroxyacetamide
TTDC00159	Inhibitor	2-(methylsulfonylthio)ethyl 2-propylpentanoate
TTDC00159	Inhibitor	4-Benzoylamino-N-hydroxy-benzamide
TTDC00159	Inhibitor	4-Butyrylamino-N-hydroxy-benzamide
TTDC00159	Inhibitor	4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDC00159	Inhibitor	4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide
TTDC00159	Inhibitor	4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDC00159	Inhibitor	5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide
TTDC00159	Inhibitor	5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione
TTDC00159	Inhibitor	5-Mercapto-pentanoic acid phenylamide
TTDC00159	Inhibitor	6-(2-Bromo-acetylamino)-hexanoic acid phenylamide
TTDC00159	Inhibitor	6-Mercapto-hexanoic acid phenylamide
TTDC00159	Inhibitor	6-Phenoxy-hexane-1-thiol
TTDC00159	Inhibitor	6-benzenesulfinylhexanoic acid hydroxamide
TTDC00159	Inhibitor	6-benzenesulfonylhexanoic acid hydroxamide
TTDC00159	Inhibitor	6-phenylsulfanylhexanoic acid hydroxamide
TTDC00159	Inhibitor	7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDC00159	Inhibitor	7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one
TTDC00159	Inhibitor	7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDC00159	Inhibitor	7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDC00159	Inhibitor	7-Mercapto-heptanoic acid benzothiazol-2-ylamide
TTDC00159	Inhibitor	7-Mercapto-heptanoic acid biphenyl-3-ylamide
TTDC00159	Inhibitor	7-Mercapto-heptanoic acid biphenyl-4-ylamide
TTDC00159	Inhibitor	7-Mercapto-heptanoic acid phenylamide
TTDC00159	Inhibitor	7-Mercapto-heptanoic acid pyridin-3-ylamide
TTDC00159	Inhibitor	7-Mercapto-heptanoic acid quinolin-3-ylamide
TTDC00159	Inhibitor	7-mercapto-N-(4-phenylthiazol-2-yl)heptanamide
TTDC00159	Inhibitor	8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one
TTDC00159	Inhibitor	8-Mercapto-octanoic acid phenylamide
TTDC00159	Inhibitor	8-Oxo-8-phenyl-octanoic acid
TTDC00159	Inhibitor	8-Oxo-8-phenyl-octanoic acid hydroxyamide
TTDC00159	Inhibitor	9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide
TTDC00159	Inhibitor	9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one
TTDC00159	Inhibitor	AZUMAMIDE B
TTDC00159	Inhibitor	AZUMAMIDE C
TTDC00159	Inhibitor	AZUMAMIDE E
TTDC00159	Inhibitor	Cyclostellettamine derivative
TTDC00159	Inhibitor	FK-228
TTDC00159	Inhibitor	LARGAZOLE
TTDC00159	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide
TTDC00159	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-succinamide
TTDC00159	Inhibitor	N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide
TTDC00159	Inhibitor	N-(6-Hydroxycarbamoyl-hexyl)-benzamide
TTDC00159	Inhibitor	N-(6-Mercapto-hexyl)-benzamide
TTDC00159	Inhibitor	N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide
TTDC00159	Inhibitor	N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide
TTDC00159	Inhibitor	N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide
TTDC00159	Inhibitor	N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide
TTDC00159	Inhibitor	N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide
TTDC00159	Inhibitor	N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide
TTDC00159	Inhibitor	N-Hydroxy-4-(pentanoylamino-methyl)-benzamide
TTDC00159	Inhibitor	N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide
TTDC00159	Inhibitor	N-Hydroxy-4-phenylacetylamino-benzamide
TTDC00159	Inhibitor	N-hydroxy-2,2-diphenylacetamide
TTDC00159	Inhibitor	N-hydroxy-2,2-diphenylpropanamide
TTDC00159	Inhibitor	N-hydroxy-9,10-dihydroanthracene-9-carboxamide
TTDC00159	Inhibitor	N-hydroxy-9H-xanthene-9-carboxamide
TTDC00159	Inhibitor	Octanedioic acid bis-hydroxyamide
TTDC00159	Inhibitor	Octanedioic acid hydroxyamide pyridin-2-ylamide
TTDC00159	Inhibitor	Octanedioic acid hydroxyamide pyridin-4-ylamide
TTDC00159	Inhibitor	PSAMMAPLIN A
TTDC00159	Inhibitor	ST-2987
TTDC00159	Inhibitor	ST-3050
TTDC00159	Inhibitor	Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ph4-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ph5-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Phe-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Phg-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ser(Bzl)-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ser-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-L-2MePhe-L-Ala-D-Pro-)
TTDC00159	Inhibitor	cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-)
TTDC00160	UniProt ID	P53350
TTDC00160	Name	Serine/threonine-protein kinase PLK1
TTDC00160	Type of target	Clinical trial target
TTDC00160	Synonyms	Mitotic serine-threonine kinase polo-like kinase 1
TTDC00160	Synonyms	PLK-1
TTDC00160	Synonyms	Plk1
TTDC00160	Synonyms	Polo-like kinase 1
TTDC00160	Synonyms	STPK13
TTDC00160	Synonyms	Serine-threonine protein kinase 13
TTDC00160	Disease	Acute myeloid leukemia
TTDC00160	Disease	Advanced or metastatic non-small cell lung cancer
TTDC00160	Disease	Advanced solid tumor
TTDC00160	Disease	Cancer, unspecific
TTDC00160	Disease	Metastatic hormone refractory Prostate cancer
TTDC00160	Disease	Non-Hodgkins Lymphoma
TTDC00160	Disease	Pancreatic cancer
TTDC00160	Disease	Pancreatic, prostate and a number of other cancers
TTDC00160	Function	May be required for cell division and may have a role during g1 or s phase.
TTDC00160	Sequence	MSAAVTAGKLARAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFA
TTDC00160	PDB Structure	1Q4K; 1Q4O; 1UMW; 2OGQ; 2OJX; 2OU7; 2OWB; 2RKU; 2V5Q; 2YAC; 3BZI; 3C5L; 3FC2; 3F
TTDC00160	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00160	Pathway	Cell cycle
TTDC00160	EC Number	EC 2.7.1.37
TTDC00160	Target Validation	TTDC00160
TTDC00160	Drug(s)	BI 2536
TTDC00160	Drug(s)	BI 6727
TTDC00160	Drug(s)	CYC-800
TTDC00160	Drug(s)	DAP-81
TTDC00160	Drug(s)	GSK461364
TTDC00160	Drug(s)	HMN-214
TTDC00160	Drug(s)	LC-445
TTDC00160	Drug(s)	NMS-1
TTDC00160	Drug(s)	ON 019190.Na
TTDC00160	Drug(s)	Rigosertib
TTDC00160	Drug(s)	TAK-960
TTDC00160	Drug(s)	Volasertib
TTDC00160	Drug(s)	ZK-thiazolidinone
TTDC00160	Inhibitor	BI 2536
TTDC00160	Inhibitor	BI 6727
TTDC00160	Inhibitor	CYC-800
TTDC00160	Inhibitor	DAP-81
TTDC00160	Inhibitor	GSK461364
TTDC00160	Inhibitor	HMN-214
TTDC00160	Inhibitor	LC-445
TTDC00160	Inhibitor	LY-294002
TTDC00160	Inhibitor	NMS-1
TTDC00160	Inhibitor	ON 019190.Na
TTDC00160	Inhibitor	ZK-thiazolidinone
TTDC00161	UniProt ID	Q02763
TTDC00161	Name	Angiopoietin 1 receptor
TTDC00161	Type of target	Discontinued target
TTDC00161	Synonyms	CD202b antigen
TTDC00161	Synonyms	Endothelial Cell-Specific Receptor TIE-2
TTDC00161	Synonyms	P140 TEK
TTDC00161	Synonyms	Tunica interna endothelial cell kinase
TTDC00161	Synonyms	Tyrosine-protein kinase receptor TEK
TTDC00161	Synonyms	Tyrosine-protein kinase receptor TIE-2
TTDC00161	Disease	Tumors
TTDC00161	Function	This protein is a protein tyrosine-kinase transmembrane receptor for angiopoieti
TTDC00161	Sequence	MDSLASLVLCGVSLLLSGTVEGAMDLILINSLPLVSDAETSLTCIASGWRPHEPITIGRDFEALMNQHQDPLEVTQDVTR
TTDC00161	PDB Structure	1FVR; 2GY5; 2GY7; 2OO8; 2OSC; 2P4I; 2WQB; 3BEA; 3L8P; 4K0V
TTDC00161	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00161	EC Number	EC 2.7.1.112
TTDC00161	Related US Patent	6,413,932
TTDC00161	Related US Patent	6,521,424
TTDC00161	Target Validation	TTDC00161
TTDC00161	Drug(s)	CEP-7055
TTDC00161	Inhibitor	(4-Phenoxy-phenyl)-quinazolin-4-yl-amine
TTDC00161	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDC00161	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDC00161	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00161	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00161	Inhibitor	A-420983
TTDC00161	Inhibitor	CEP-7055
TTDC00161	Multitarget	CEP-7055
TTDC00162	UniProt ID	P49841
TTDC00162	Name	Glycogen synthase kinase-3 beta
TTDC00162	Type of target	Clinical trial target
TTDC00162	Synonyms	GSK-3 beta
TTDC00162	Disease	Alzheimer's disease
TTDC00162	Disease	Bipolar affective disorder
TTDC00162	Disease	Brain injury
TTDC00162	Disease	Immunodeficiency
TTDC00162	Disease	Ischemia
TTDC00162	Disease	Noninsulin-dependent diabetes mellitus
TTDC00162	Function	Participates in the wnt signaling pathway. Implicated in the hormonal control of
TTDC00162	Sequence	MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE
TTDC00162	PDB Structure	1GNG; 1H8F; 1I09; 1J1B; 1J1C; 1O9U; 1PYX; 1Q3D; 1Q3W; 1Q41; 1Q4L; 1Q5K; 1R0E; 1U
TTDC00162	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00162	Pathway	Alzheimer's disease
TTDC00162	Pathway	Axon guidance
TTDC00162	Pathway	B cell receptor signaling pathway
TTDC00162	Pathway	Basal cell carcinoma
TTDC00162	Pathway	Cell cycle
TTDC00162	Pathway	Chemokine signaling pathway
TTDC00162	Pathway	Colorectal cancer
TTDC00162	Pathway	Endometrial cancer
TTDC00162	Pathway	ErbB signaling pathway
TTDC00162	Pathway	Focal adhesion
TTDC00162	Pathway	Hedgehog signaling pathway
TTDC00162	Pathway	Insulin signaling pathway
TTDC00162	Pathway	Melanogenesis
TTDC00162	Pathway	Pathways in cancer
TTDC00162	Pathway	Prostate cancer
TTDC00162	Pathway	T cell receptor signaling pathway
TTDC00162	Pathway	Wnt signaling pathway
TTDC00162	EC Number	EC 2.7.1.37
TTDC00162	Related US Patent	6,479,490
TTDC00162	Target Validation	TTDC00162
TTDC00162	QSAR Model	TTDC00162
TTDC00162	Drug(s)	Enzastaurin
TTDC00162	Drug(s)	LY2090314
TTDC00162	Inhibitor	(2'Z,3'E)-7-Azaindirubin-3'-oxime
TTDC00162	Inhibitor	(E)-N-(6-(prop-1-enyl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	12,13-DEHYDRO-8-O-ACETYLMANZAMINE A
TTDC00162	Inhibitor	12,13-DEHYDROMANZAMINE A
TTDC00162	Inhibitor	3-(6-(phenylamino)-9H-purin-8-yl)benzonitrile
TTDC00162	Inhibitor	3-phenyl-4-(phenylamino)-1H-pyrrole-2,5-dione
TTDC00162	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDC00162	Inhibitor	4-(5-bromo-1H-indol-3-yl)pyrimidin-2-amine
TTDC00162	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDC00162	Inhibitor	6-deoxymanzamine X
TTDC00162	Inhibitor	6-hydroxymanzamine A
TTDC00162	Inhibitor	8-O-(4-bromobenzenesulfonyl)manzamine F
TTDC00162	Inhibitor	8-O-(4-chlorobenzenesulfonyl)manzamine F
TTDC00162	Inhibitor	8-O-(4-toluenesulfonyl)manzamine A
TTDC00162	Inhibitor	8-OH-MANZAMINE A
TTDC00162	Inhibitor	9-N-ETHYL-8-ETHOXY-MANZAMINE A
TTDC00162	Inhibitor	9-N-METHYL-8-METHOXY-MANZAMINE A
TTDC00162	Inhibitor	AR-A014418
TTDC00162	Inhibitor	AS-601245
TTDC00162	Inhibitor	AZAKENPAULLONE
TTDC00162	Inhibitor	Adenosine-5'-Diphosphate
TTDC00162	Inhibitor	Alsterpaullone
TTDC00162	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDC00162	Inhibitor	CHIR-98023;CT-98014
TTDC00162	Inhibitor	CI-1040;PD-18435;PD-184352
TTDC00162	Inhibitor	CT-98024
TTDC00162	Inhibitor	ELLAGIC ACID
TTDC00162	Inhibitor	Enzastaurin
TTDC00162	Inhibitor	GF-109203
TTDC00162	Inhibitor	GSK-690693
TTDC00162	Inhibitor	I-5
TTDC00162	Inhibitor	Indirubin-3'-Monoxime
TTDC00162	Inhibitor	KENPAULLONE
TTDC00162	Inhibitor	L-779450
TTDC00162	Inhibitor	LEUCETTAMINE B
TTDC00162	Inhibitor	LY-294002
TTDC00162	Inhibitor	MANZAMINE A
TTDC00162	Inhibitor	N,8-diphenyl-9H-purin-6-amine
TTDC00162	Inhibitor	N-(6-(2-chlorophenyl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-(3-hydroxyphenyl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-(4-aminophenyl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-(4-fluorophenyl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-(4-hydroxyphenyl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-(furan-3-yl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-(pyridin-3-yl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-(pyridin-4-yl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-(thiophen-3-yl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-(trifluoromethyl)-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-benzyl-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-bromo-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-chloro-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-chloro-5-p-tolyl-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-chloro-5-phenyl-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-phenethyl-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(6-phenyl-1H-indazol-3-yl)butyramide
TTDC00162	Inhibitor	N-(8-(3-cyanophenyl)-9H-purin-6-yl)pentanamide
TTDC00162	Inhibitor	NU-6102
TTDC00162	Inhibitor	Neo-kauluamine
TTDC00162	Inhibitor	PAULLONE
TTDC00162	Inhibitor	PD-98059
TTDC00162	Inhibitor	PF-228
TTDC00162	Inhibitor	PYRAZOLOPYRIDAZINE 1
TTDC00162	Inhibitor	PYRAZOLOPYRIDAZINE 2
TTDC00162	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDC00162	Inhibitor	RO-320432
TTDC00162	Inhibitor	SB-202190
TTDC00162	Inhibitor	SB-203580
TTDC00162	Inhibitor	SB-216763
TTDC00162	Inhibitor	SB-415286
TTDC00162	Inhibitor	STAUROSPORINONE
TTDC00162	Inhibitor	Staurosporine
TTDC00162	Inhibitor	TWS-119
TTDC00162	Inhibitor	Thieno analogue of kenpaullone
TTDC00162	Inhibitor	U-0126
TTDC00162	Inhibitor	manzamine E
TTDC00162	Inhibitor	manzamine Y
TTDC00162	Multitarget	Enzastaurin
TTDC00163	UniProt ID	P05771
TTDC00163	Name	Protein kinase C, beta type
TTDC00163	Type of target	Clinical trial target
TTDC00163	Synonyms	PKC-B
TTDC00163	Synonyms	PKC-beta
TTDC00163	Synonyms	Protein Kinase C beta
TTDC00163	Disease	B-lineage malignancies
TTDC00163	Disease	Diabetes mellitus
TTDC00163	Disease	Diabetic retinopathy
TTDC00163	Disease	Macular edema
TTDC00163	Function	This is a calcium-activated, phospholipid-dependent, serine- and threonine-speci
TTDC00163	Sequence	MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHE
TTDC00163	PDB Structure	2I0E
TTDC00163	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00163	Pathway	B cell receptor signaling pathway
TTDC00163	Pathway	Calcium signaling pathway
TTDC00163	Pathway	Chemokine signaling pathway
TTDC00163	Pathway	ErbB signaling pathway
TTDC00163	Pathway	Fc epsilon RI signaling pathway
TTDC00163	Pathway	Focal adhesion
TTDC00163	Pathway	Gap junction
TTDC00163	Pathway	Glioma
TTDC00163	Pathway	GnRH signaling pathway
TTDC00163	Pathway	Leukocyte transendothelial migration
TTDC00163	Pathway	Long-term depression
TTDC00163	Pathway	Long-term potentiation
TTDC00163	Pathway	MAPK signaling pathway
TTDC00163	Pathway	Melanogenesis
TTDC00163	Pathway	Natural killer cell mediated cytotoxicity
TTDC00163	Pathway	Non-small cell lung cancer
TTDC00163	Pathway	Pathways in cancer
TTDC00163	Pathway	Phosphatidylinositol signaling system
TTDC00163	Pathway	Tight junction
TTDC00163	Pathway	VEGF signaling pathway
TTDC00163	Pathway	Vascular smooth muscle contraction
TTDC00163	Pathway	Vibrio cholerae infection
TTDC00163	Pathway	Wnt signaling pathway
TTDC00163	EC Number	EC 2.7.1.37
TTDC00163	Related US Patent	6,486,179
TTDC00163	Target Validation	TTDC00163
TTDC00163	Drug(s)	Enzastaurin
TTDC00163	Drug(s)	Ruboxistaurin
TTDC00163	Drug(s)	Sotrastaurin acetate
TTDC00163	Inhibitor	(-)-Cercosporamide
TTDC00163	Inhibitor	2,3,3-Triphenyl-acrylonitrile
TTDC00163	Inhibitor	2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile
TTDC00163	Inhibitor	3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile
TTDC00163	Inhibitor	3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile
TTDC00163	Inhibitor	3-(1H-Indol-3-yl)-4-phenylamino-pyrrole-2,5-dione
TTDC00163	Inhibitor	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile
TTDC00163	Inhibitor	4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol
TTDC00163	Inhibitor	4-cycloheptyliden(4-hydroxyphenyl)methylphenol
TTDC00163	Inhibitor	4-cyclohexyliden(4-hydroxyphenyl)methylphenol
TTDC00163	Inhibitor	4-cyclopentyliden(4-hydroxyphenyl)methylphenol
TTDC00163	Inhibitor	BALANOL
TTDC00163	Inhibitor	Beta specific inhibitors
TTDC00163	Inhibitor	Enzastaurin
TTDC00163	Inhibitor	GSK-690693
TTDC00163	Inhibitor	Indolocarbazole analogue
TTDC00163	Inhibitor	LY-317644
TTDC00163	Inhibitor	LY-326449
TTDC00163	Inhibitor	LY333531
TTDC00163	Inhibitor	O-Phosphoethanolamine
TTDC00163	Inhibitor	PROSTRATIN
TTDC00163	Inhibitor	PUNICAFOLIN
TTDC00163	Inhibitor	RO-316233
TTDC00163	Inhibitor	RO-320432
TTDC00163	Inhibitor	Ro-32-0557
TTDC00163	Inhibitor	Ruboxistaurin
TTDC00163	Inhibitor	Sotrastaurin acetate
TTDC00163	Inhibitor	TANNIN
TTDC00163	Inhibitor	TANNIN analogue
TTDC00163	Inhibitor	[2,2';5',2'']Terthiophen-4-yl-methanol
TTDC00163	Inhibitor	[2,2';5',2'']Terthiophene-4,5''-dicarbaldehyde
TTDC00163	Inhibitor	[2,2';5',2'']Terthiophene-4-carbaldehyde
TTDC00163	Multitarget	Enzastaurin
TTDC00163	Multitarget	Sotrastaurin acetate
TTDC00164	Name	Dual specificity mitogen-activated protein kinase kinase
TTDC00164	Type of target	Clinical trial target
TTDC00164	Synonyms	ERK activator kinase
TTDC00164	Synonyms	MAP kinase kinase
TTDC00164	Synonyms	MAPKK
TTDC00164	Synonyms	MEK
TTDC00164	Disease	Cancer, unspecific
TTDC00164	Disease	Heart failure
TTDC00164	Disease	Immunodeficiency
TTDC00164	Disease	Inflammation
TTDC00164	Disease	Proliferative diseases
TTDC00164	Disease	Psoriasis
TTDC00164	Disease	Restenosis
TTDC00164	Disease	Stroke
TTDC00164	Related US Patent	6,310,060
TTDC00164	Related US Patent	6,440,966
TTDC00164	Related US Patent	6,455,582
TTDC00164	Related US Patent	6,469,004
TTDC00164	Related US Patent	6,506,798
TTDC00164	Related US Patent	6,638,945
TTDC00164	Target Validation	TTDC00164
TTDC00164	Drug(s)	ARRY-162
TTDC00164	Drug(s)	ARRY-300
TTDC00164	Drug(s)	AZD6244
TTDC00164	Drug(s)	AZD8330
TTDC00164	Drug(s)	Anti-Mek
TTDC00164	Drug(s)	BAY 86-9766
TTDC00164	Drug(s)	E6201
TTDC00164	Drug(s)	GDC-0623
TTDC00164	Drug(s)	GDC-0973
TTDC00164	Drug(s)	GSK1120212
TTDC00164	Drug(s)	MEK-Inhibitor
TTDC00164	Drug(s)	MEK162
TTDC00164	Drug(s)	MSC2015103B
TTDC00164	Drug(s)	PD-0325901
TTDC00164	Drug(s)	RG7167
TTDC00164	Drug(s)	RG7304
TTDC00164	Drug(s)	RG7420
TTDC00164	Drug(s)	RG7421+RG7204
TTDC00164	Drug(s)	SAR245408/MSC1936369B combination therapy
TTDC00164	Drug(s)	SAR245409/MSC1936369B combination therapy
TTDC00164	Drug(s)	TAK-733
TTDC00164	Inhibitor	AZD6244
TTDC00164	Inhibitor	AZD8330
TTDC00164	Inhibitor	Anti-Mek
TTDC00164	Inhibitor	GDC-0623
TTDC00164	Inhibitor	GDC-0973
TTDC00164	Inhibitor	GSK1120212
TTDC00164	Inhibitor	PD-0325901
TTDC00164	Inhibitor	U-0126
TTDC00165	UniProt ID	P11802
TTDC00165	Name	Cell division protein kinase 4
TTDC00165	Type of target	Clinical trial target
TTDC00165	Synonyms	CDK4
TTDC00165	Synonyms	Cyclin-dependent kinase 4
TTDC00165	Synonyms	PSK-J3
TTDC00165	Disease	Cancer, unspecific
TTDC00165	Disease	Insulin-dependent diabetes mellitus
TTDC00165	Disease	Squamous cell carcinoma
TTDC00165	Function	Probably involved in the control of the cell cycle.
TTDC00165	Sequence	MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT
TTDC00165	PDB Structure	1LD2; 2W96; 2W99; 2W9F; 2W9Z; 3G33
TTDC00165	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00165	Pathway	Bladder cancer
TTDC00165	Pathway	Cell cycle
TTDC00165	Pathway	Chronic myeloid leukemia
TTDC00165	Pathway	Glioma
TTDC00165	Pathway	Melanoma
TTDC00165	Pathway	Non-small cell lung cancer
TTDC00165	Pathway	Pancreatic cancer
TTDC00165	Pathway	Pathways in cancer
TTDC00165	Pathway	Small cell lung cancer
TTDC00165	Pathway	T cell receptor signaling pathway
TTDC00165	Pathway	Tight junction
TTDC00165	Pathway	p53 signaling pathway
TTDC00165	EC Number	EC 2.7.1.37
TTDC00165	Related US Patent	6,630,464
TTDC00165	Target Validation	TTDC00165
TTDC00165	Drug(s)	AG-024322
TTDC00165	Drug(s)	Capridine-beta
TTDC00165	Drug(s)	LEE011
TTDC00165	Drug(s)	LY2835219
TTDC00165	Drug(s)	P1446A-05
TTDC00165	Drug(s)	P276-00
TTDC00165	Drug(s)	PD-0332991
TTDC00165	Drug(s)	PD-332991
TTDC00165	Drug(s)	R547
TTDC00165	Drug(s)	Ro 31-7453
TTDC00165	Drug(s)	ZK 304709
TTDC00165	Inhibitor	1-(1H-Indazol-6-yl)-3-pyridin-2-yl-urea
TTDC00165	Inhibitor	1-(7-Hydroxy-naphthalen-1-yl)-3-pyridin-2-yl-urea
TTDC00165	Inhibitor	1-(9-Oxo-9H-fluoren-4-yl)-3-pyridin-2-yl-urea
TTDC00165	Inhibitor	1-Pyridin-2-yl-3-quinolin-5-yl-urea
TTDC00165	Inhibitor	10-hydroxy-18-methoxybetaenone
TTDC00165	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDC00165	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDC00165	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00165	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00165	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDC00165	Inhibitor	AG-024322
TTDC00165	Inhibitor	Capridine-beta
TTDC00165	Inhibitor	Fascaplysin
TTDC00165	Inhibitor	Flavopiridol
TTDC00165	Inhibitor	N-(2-(1H-Indol-3-yl)ethyl)biphenyl-4-carboxamide
TTDC00165	Inhibitor	NU-6102
TTDC00165	Inhibitor	P1446A-05
TTDC00165	Inhibitor	P276-00
TTDC00165	Inhibitor	PD-0332991
TTDC00165	Inhibitor	PD-332991
TTDC00165	Inhibitor	PD0183813
TTDC00165	Inhibitor	PYRAZOLOPYRIDAZINE 1
TTDC00165	Inhibitor	PYRAZOLOPYRIDAZINE 2
TTDC00165	Inhibitor	Purvalanol
TTDC00165	Inhibitor	R547
TTDC00165	Inhibitor	Ro 31-7453
TTDC00165	Inhibitor	ZK 304709
TTDC00165	Multitarget	AG-024322
TTDC00165	Multitarget	Capridine-beta
TTDC00165	Multitarget	P276-00
TTDC00165	Multitarget	PD-0332991
TTDC00165	Multitarget	R547
TTDC00165	Multitarget	Ro 31-7453
TTDC00165	Multitarget	ZK 304709
TTDC00166	UniProt ID	P06493
TTDC00166	UniProt ID	Q6LFL1
TTDC00166	Name	Cell division control protein 2 homolog
TTDC00166	Type of target	Clinical trial target
TTDC00166	Synonyms	CDK1
TTDC00166	Synonyms	Cyclin-dependent kinase 1
TTDC00166	Synonyms	P34 protein kinase
TTDC00166	Disease	Cancer, unspecific
TTDC00166	Disease	Malaria
TTDC00166	Function	Plays a key role in the control of the eukaryotic cell cycle. It is required in
TTDC00166	Sequence	MESGVYFSLYEDFFKDAKIFLNTIESKNKILDVSNSSTTSSSISSDEVDDISSNNDTEKYDDNYNSTGRYLDYYLNMENN
TTDC00166	PDB Structure	1LC9
TTDC00166	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00166	EC Number	EC 2.7.1.-
TTDC00166	EC Number	EC 2.7.1.37
TTDC00166	Target Validation	TTDC00166
TTDC00166	Drug(s)	AG-024322
TTDC00166	Drug(s)	P276-00
TTDC00166	Drug(s)	R-roscovitine
TTDC00166	Drug(s)	R547
TTDC00166	Drug(s)	Ro 31-7453
TTDC00166	Drug(s)	SCH 727965
TTDC00166	Drug(s)	Terameprocol
TTDC00166	Drug(s)	ZK 304709
TTDC00166	Inhibitor	(2,6-Diamino-pyridin-3-yl)-phenyl-methanone
TTDC00166	Inhibitor	(R)-roscovitine
TTDC00166	Inhibitor	2-(p-toluidino)-4-phenylpyrimidine-5-carbonitrile
TTDC00166	Inhibitor	3,4-bis(indol-3-yl)maleimide derivative
TTDC00166	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDC00166	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDC00166	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00166	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00166	Inhibitor	4-(Quinolin-3-yl)-N-p-tolylpyrimidin-2-amine
TTDC00166	Inhibitor	4-(Quinolin-4-yl)-N-p-tolylpyrimidin-2-amine
TTDC00166	Inhibitor	4-phenyl-2-(phenylamino)pyrimidine-5-carbonitrile
TTDC00166	Inhibitor	AG-024322
TTDC00166	Inhibitor	AZAKENPAULLONE
TTDC00166	Inhibitor	Alsterpaullone
TTDC00166	Inhibitor	CGP-60474
TTDC00166	Inhibitor	Flavopiridol
TTDC00166	Inhibitor	GF-109203
TTDC00166	Inhibitor	Hymenialdisine
TTDC00166	Inhibitor	Indirubin-5-Sulphonate
TTDC00166	Inhibitor	JNJ-7706621
TTDC00166	Inhibitor	KENPAULLONE
TTDC00166	Inhibitor	Microxine
TTDC00166	Inhibitor	P276-00
TTDC00166	Inhibitor	PF-228
TTDC00166	Inhibitor	PHA-767491
TTDC00166	Inhibitor	Purvalanol
TTDC00166	Inhibitor	Purvalanol A
TTDC00166	Inhibitor	R-roscovitine
TTDC00166	Inhibitor	R547
TTDC00166	Inhibitor	RO-316233
TTDC00166	Inhibitor	Ro 31-7453
TTDC00166	Inhibitor	SCH 727965
TTDC00166	Inhibitor	Terameprocol
TTDC00166	Inhibitor	Thieno analogue of kenpaullone
TTDC00166	Inhibitor	ZK 304709
TTDC00166	Binder	10Z-Hymenialdisine
TTDC00166	Binder	IN1535
TTDC00166	Binder	Indirubin-3'-Monoxime
TTDC00166	Binder	Indirubin-3'-monoxime
TTDC00166	Binder	Indirubin-5-sulfonate
TTDC00166	Binder	Olomoucine
TTDC00166	Binder	Purvalanol B
TTDC00166	Binder	SU9516
TTDC00166	Multitarget	AG-024322
TTDC00166	Multitarget	P276-00
TTDC00166	Multitarget	R-roscovitine
TTDC00166	Multitarget	R547
TTDC00166	Multitarget	Ro 31-7453
TTDC00166	Multitarget	SCH 727965
TTDC00166	Multitarget	Terameprocol
TTDC00166	Multitarget	ZK 304709
TTDC00168	UniProt ID	Q07817
TTDC00168	Name	Antiapoptotic protein BCL-XL
TTDC00168	Type of target	Clinical trial target
TTDC00168	Synonyms	Bcl-XL
TTDC00168	Disease	Anaplastic Large Cell Lymphomas
TTDC00168	Disease	Colorectal cancer
TTDC00168	Disease	Mesothelioma
TTDC00168	Function	Potent inhibitor of cell death. Isoform bcl-x(l) anti- apoptotic activity is inh
TTDC00168	Sequence	MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREV
TTDC00168	PDB Structure	1BXL; 1G5J; 1LXL; 1MAZ; 1R2D; 1R2E; 1R2G; 1R2H; 1R2I; 1YSG; 1YSI; 1YSN; 2B48; 2L
TTDC00168	BioChemical Class	Transmembrane protein
TTDC00168	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDC00168	Pathway	Apoptosis
TTDC00168	Pathway	Chronic myeloid leukemia
TTDC00168	Pathway	Jak-STAT signaling pathway
TTDC00168	Pathway	Pancreatic cancer
TTDC00168	Pathway	Pathways in cancer
TTDC00168	Pathway	Small cell lung cancer
TTDC00168	Target Validation	TTDC00168
TTDC00168	Drug(s)	ABT-263
TTDC00168	Drug(s)	AT-101
TTDC00168	Inhibitor	4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID
TTDC00168	Inhibitor	ABT-263
TTDC00168	Inhibitor	AT-101
TTDC00168	Multitarget	ABT-263
TTDC00168	Multitarget	AT-101
TTDC00169	UniProt ID	Q00534
TTDC00169	Name	Cell division protein kinase 6
TTDC00169	Type of target	Clinical trial target
TTDC00169	Synonyms	CDK6
TTDC00169	Synonyms	Cyclin-dependent kinase 6
TTDC00169	Synonyms	Serine/threonine protein kinase PLSTIRE
TTDC00169	Synonyms	Serine/threonine-protein kinase PLSTIRE
TTDC00169	Disease	Cancer, unspecific
TTDC00169	Function	Probably involved in the control of the cell cycle. Interacts with d-type g1 cyc
TTDC00169	Sequence	MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF
TTDC00169	PDB Structure	1BI7; 1BI8; 1BLX; 1G3N; 1JOW; 1XO2; 2EUF; 2F2C; 3NUP; 3NUX; 4AUA; 4EZ5
TTDC00169	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00169	Pathway	Cell cycle
TTDC00169	Pathway	Chronic myeloid leukemia
TTDC00169	Pathway	Glioma
TTDC00169	Pathway	Melanoma
TTDC00169	Pathway	Non-small cell lung cancer
TTDC00169	Pathway	Pancreatic cancer
TTDC00169	Pathway	Pathways in cancer
TTDC00169	Pathway	Small cell lung cancer
TTDC00169	Pathway	p53 signaling pathway
TTDC00169	EC Number	EC 2.7.1.37
TTDC00169	Target Validation	TTDC00169
TTDC00169	Drug(s)	Capridine-beta
TTDC00169	Drug(s)	LEE011
TTDC00169	Drug(s)	LY2835219
TTDC00169	Drug(s)	PD-0332991
TTDC00169	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDC00169	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDC00169	Inhibitor	3,7,3',4'-TETRAHYDROXYFLAVONE
TTDC00169	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00169	Inhibitor	APIGENIN
TTDC00169	Inhibitor	CHRYSIN
TTDC00169	Inhibitor	Capridine-beta
TTDC00169	Inhibitor	Deschloroflavopiridol
TTDC00169	Inhibitor	FISETIN
TTDC00169	Inhibitor	Fascaplysin
TTDC00169	Inhibitor	Flavopiridol
TTDC00169	Inhibitor	PD-0332991
TTDC00169	Inhibitor	PD0183813
TTDC00169	Multitarget	Capridine-beta
TTDC00169	Multitarget	PD-0332991
TTDC00170	UniProt ID	Q86V67
TTDC00170	UniProt ID	P27815
TTDC00170	UniProt ID	Q07343
TTDC00170	UniProt ID	Q08493
TTDC00170	UniProt ID	Q08499
TTDC00170	Name	Phosphodiesterase isozyme 4
TTDC00170	Name	PDE4
TTDC00170	Type of target	Clinical trial target
TTDC00170	Type of target	Clinical trial target
TTDC00170	Synonyms	PDE4
TTDC00170	Synonyms	Phosphodiesterase 4
TTDC00170	Disease	Asthma
TTDC00170	Disease	Chronic obstructive pulmonary disease
TTDC00170	Disease	Osteosarcoma
TTDC00170	Sequence	MVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASV
TTDC00170	EC Number	EC 3.1.4.17
TTDC00170	Related US Patent	6,162,830
TTDC00170	Related US Patent	6,180,650
TTDC00170	Related US Patent	6,200,993
TTDC00170	Related US Patent	6,255,303
TTDC00170	Related US Patent	6,258,843
TTDC00170	Related US Patent	6,294,561
TTDC00170	Related US Patent	6,297,257
TTDC00170	Related US Patent	6,303,789
TTDC00170	Related US Patent	6,313,156
TTDC00170	Related US Patent	6,316,472
TTDC00170	Related US Patent	6,329,370
TTDC00170	Related US Patent	6,340,684
TTDC00170	Related US Patent	6,348,602
TTDC00170	Related US Patent	6,358,973
TTDC00170	Related US Patent	6,362,213
TTDC00170	Related US Patent	6,372,777
TTDC00170	Related US Patent	6,399,636
TTDC00170	Related US Patent	6,403,597
TTDC00170	Related US Patent	6,410,547
TTDC00170	Related US Patent	6,410,563
TTDC00170	Related US Patent	6,423,710
TTDC00170	Related US Patent	6,436,971
TTDC00170	Related US Patent	6,444,671
TTDC00170	Related US Patent	6,448,274
TTDC00170	Related US Patent	6,455,562
TTDC00170	Related US Patent	6,458,787
TTDC00170	Related US Patent	6,486,186
TTDC00170	Related US Patent	6,492,360
TTDC00170	Related US Patent	6,498,160
TTDC00170	Related US Patent	6,500,856
TTDC00170	Related US Patent	6,525,055
TTDC00170	Related US Patent	6,528,527
TTDC00170	Related US Patent	6,541,480
TTDC00170	Related US Patent	6,544,993
TTDC00170	Related US Patent	6,545,025
TTDC00170	Related US Patent	6,545,158
TTDC00170	Related US Patent	6,555,572
TTDC00170	Related US Patent	6,559,168
TTDC00170	Related US Patent	6,569,885
TTDC00170	Related US Patent	6,569,890
TTDC00170	Related US Patent	6,589,951
TTDC00170	Related US Patent	6,602,890
TTDC00170	Related US Patent	6,613,794
TTDC00170	Related US Patent	6,639,077
TTDC00170	Related US Patent	6,649,633
TTDC00170	Related US Patent	6,677,351
TTDC00170	Related US Patent	6,680,336
TTDC00170	Related US Patent	6,756,392
TTDC00170	Target Validation	TTDC00170
TTDC00170	Drug(s)	AN2728
TTDC00170	Drug(s)	Apremilast
TTDC00170	Drug(s)	Arofylline
TTDC00170	Drug(s)	CC-10004
TTDC00170	Drug(s)	Cilomilast
TTDC00170	Drug(s)	E6005
TTDC00170	Drug(s)	GW842470X
TTDC00170	Drug(s)	IC-485
TTDC00170	Drug(s)	ONO-6126
TTDC00170	Drug(s)	Roflumilast
TTDC00170	Drug(s)	
TTDC00170	Inhibitor	(R)-Rolipram
TTDC00170	Inhibitor	(S)-Rolipram
TTDC00170	Inhibitor	Apremilast
TTDC00170	Inhibitor	Arofylline
TTDC00170	Inhibitor	CC-10004
TTDC00170	Inhibitor	Cilomilast
TTDC00170	Inhibitor	GW842470X
TTDC00170	Inhibitor	IC-485
TTDC00170	Inhibitor	ONO-6126
TTDC00170	Inhibitor	Roflumilast
TTDC00171	UniProt ID	P25092
TTDC00171	Name	Guanylyl cyclase C
TTDC00171	Type of target	Clinical trial target
TTDC00171	Synonyms	GC-C
TTDC00171	Synonyms	GCC
TTDC00171	Synonyms	HSTAR
TTDC00171	Synonyms	Intestinal guanylate cyclase
TTDC00171	Synonyms	STA receptor
TTDC00171	Disease	Colorectal cancer
TTDC00171	Function	Receptor for the e.coli heat-stable enterotoxin (e.coli enterotoxin markedly sti
TTDC00171	Sequence	MKTLLLDLALWSLLFQPGWLSFSSQVSQNCHNGSYEISVLMMGNSAFAEPLKNLEDAVNEGLEIVRGRLQNAGLNVTVNA
TTDC00171	BioChemical Class	Phosphorus-oxygen lyases
TTDC00171	Pathway	Purine metabolism
TTDC00171	EC Number	EC 4.6.1.2
TTDC00171	Target Validation	TTDC00171
TTDC00171	Drug(s)	Guanilib
TTDC00171	Drug(s)	ISIS-GCCRRx
TTDC00171	Drug(s)	ISIS-GCGRRx
TTDC00171	Drug(s)	Linaclotide
TTDC00171	Drug(s)	MD-1100
TTDC00171	Drug(s)	MLN0264
TTDC00171	Activator	Guanilib
TTDC00171	Activator	Linaclotide
TTDC00171	Activator	MD-1100
TTDC00176	UniProt ID	P49763
TTDC00176	Name	Placenta growth factor
TTDC00176	Type of target	Clinical trial target
TTDC00176	Synonyms	PlGF-131
TTDC00176	Disease	Angiogenesis
TTDC00176	Disease	Cancer, unspecific
TTDC00176	Disease	Inflammatory diseases
TTDC00176	Disease	Myocardial infarction
TTDC00176	Disease	Myocardial ischemia
TTDC00176	Function	Growth factor active in angiogenesis, and endothelial cell growth, stimulating t
TTDC00176	Sequence	MPVMRLFPCFLQLLAGLALPAVPPQQWALSAGNGSSEVEVVPFQEVWGRSYCRALERLVDVVSEYPSEVEHMFSPSCVSL
TTDC00176	PDB Structure	1FZV; 1RV6
TTDC00176	BioChemical Class	Growth factor
TTDC00176	Pathway	Bladder cancer
TTDC00176	Pathway	Focal adhesion
TTDC00176	Pathway	Pancreatic cancer
TTDC00176	Pathway	Pathways in cancer
TTDC00176	Pathway	Renal cell carcinoma
TTDC00176	Pathway	mTOR signaling pathway
TTDC00176	Target Validation	TTDC00176
TTDC00176	Drug(s)	R7334
TTDC00176	Inhibitor	2-Methyl-2,4-Pentanediol
TTDC00176	Antibody	R7334
TTDC00177	UniProt ID	P35225
TTDC00177	Name	Interleukin-13
TTDC00177	Type of target	Clinical trial target
TTDC00177	Synonyms	IL-13
TTDC00177	Disease	Airway hyperreactivity in asthma
TTDC00177	Disease	Allergy, unspecified
TTDC00177	Disease	Asthma
TTDC00177	Disease	Atopic disease
TTDC00177	Disease	Inflammatory diseases
TTDC00177	Disease	Ocular allergy
TTDC00177	Disease	Parasitic infections of the eye
TTDC00177	Disease	Rheumatoid arthritis, unspecified
TTDC00177	Function	Cytokine. Inhibits inflammatory cytokine production. Synergizes with il2 in regu
TTDC00177	Sequence	MHPLLNPLLLALGLMALLLTTVIALTCLGGFASPGPVPPSTALRELIEELVNITQNQKAPLCNGSMVWSINLTAGMYCAA
TTDC00177	PDB Structure	1GA3; 1IJZ; 1IK0; 1J9U; 3BPO; 3G6D; 3ITR; 3ITS; 3L5W; 3L5X; 3L5Y; 3LB6; 4I77
TTDC00177	Target Validation	TTDC00177
TTDC00177	Drug(s)	ABT-308
TTDC00177	Drug(s)	Anti-IL13
TTDC00177	Drug(s)	CAT-354
TTDC00177	Drug(s)	RG3637
TTDC00177	Drug(s)	Tralokinumab
TTDC00177	Inhibitor	Anti-IL13
TTDC00177	Antibody	CAT-354
TTDC00178	UniProt ID	Q04759
TTDC00178	Name	Protein kinase C, theta type
TTDC00178	Type of target	Clinical trial target
TTDC00178	Synonyms	NPKC-theta
TTDC00178	Synonyms	Protein kinase C theta
TTDC00178	Disease	Immune disease
TTDC00178	Disease	T cell leukemias
TTDC00178	Function	This is calcium-independent, phospholipid-dependent, serine- and threonine-speci
TTDC00178	Sequence	MSPFLRIGLSNFDCGSCQSCQGEAVNPYCAVLVKEYVESENGQMYIQKKPTMYPPWDSTFDAHINKGRVMQIIVKGKNVD
TTDC00178	PDB Structure	1XJD; 2ENJ; 2ENN; 2ENZ; 2JED
TTDC00178	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00178	Pathway	Adipocytokine signaling pathway
TTDC00178	Pathway	T cell receptor signaling pathway
TTDC00178	Pathway	Tight junction
TTDC00178	Pathway	Vascular smooth muscle contraction
TTDC00178	EC Number	EC 2.7.1.-
TTDC00178	Target Validation	TTDC00178
TTDC00178	Drug(s)	Sotrastaurin acetate
TTDC00178	Inhibitor	2,3,3-Triphenyl-acrylonitrile
TTDC00178	Inhibitor	2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile
TTDC00178	Inhibitor	3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile
TTDC00178	Inhibitor	3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile
TTDC00178	Inhibitor	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile
TTDC00178	Inhibitor	4-HYDROXYTAMOXIFEN
TTDC00178	Inhibitor	4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol
TTDC00178	Inhibitor	4-cycloheptyliden(4-hydroxyphenyl)methylphenol
TTDC00178	Inhibitor	4-cyclohexyliden(4-hydroxyphenyl)methylphenol
TTDC00178	Inhibitor	Indolocarbazole analogue
TTDC00178	Inhibitor	LY-317644
TTDC00178	Inhibitor	LY-326449
TTDC00178	Inhibitor	Phosphonoserine
TTDC00178	Inhibitor	Phosphonothreonine
TTDC00178	Inhibitor	RO-316233
TTDC00178	Inhibitor	RO-320432
TTDC00178	Inhibitor	Ro-32-0557
TTDC00178	Inhibitor	Sotrastaurin acetate
TTDC00178	Inhibitor	Staurosporine
TTDC00178	Inhibitor	[2,2';5',2'']Terthiophen-4-yl-methanol
TTDC00178	Inhibitor	[2,2';5',2'']Terthiophene-4,5''-dicarbaldehyde
TTDC00178	Inhibitor	[2,2';5',2'']Terthiophene-4-carbaldehyde
TTDC00178	Multitarget	Sotrastaurin acetate
TTDC00179	UniProt ID	P41231
TTDC00179	Name	P2Y purinoceptor 2
TTDC00179	Type of target	Clinical trial target
TTDC00179	Synonyms	ATP receptor
TTDC00179	Synonyms	Adenosine P2Y2 receptor
TTDC00179	Synonyms	P2U nucleotide receptor
TTDC00179	Synonyms	P2U purinoceptor 1
TTDC00179	Synonyms	P2U receptor
TTDC00179	Synonyms	P2U1
TTDC00179	Synonyms	P2Y2
TTDC00179	Synonyms	Purinergic receptor
TTDC00179	Disease	Cystic fibrosis
TTDC00179	Disease	Dry eye
TTDC00179	Disease	Glaucoma
TTDC00179	Disease	Oesophageal cancer
TTDC00179	Function	Receptor for atp and utp coupled to g-proteins that activate a phosphatidylinosi
TTDC00179	Sequence	MAADLGPWNDTINGTWDGDELGYRCRFNEDFKYVLLPVSYGVVCVLGLCLNAVALYIFLCRLKTWNASTTYMFHLAVSDA
TTDC00179	PDB Structure	1Z8E
TTDC00179	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00179	Pathway	Neuroactive ligand-receptor interaction
TTDC00179	Target Validation	TTDC00179
TTDC00179	Drug(s)	Diquafosol
TTDC00179	Drug(s)	INS-37217
TTDC00179	Inhibitor	PSB-0963
TTDC00179	Inhibitor	PSB-716
TTDC00179	Inhibitor	RB 2
TTDC00179	Inhibitor	SB-416
TTDC00179	Inhibitor	Urea derivative
TTDC00179	Inhibitor	acid blue 25
TTDC00179	Agonist	ATP
TTDC00179	Agonist	Diquafosol
TTDC00179	Agonist	INS-37217
TTDC00179	Agonist	UTP
TTDC00180	UniProt ID	P05067
TTDC00180	Name	Amyloid beta A4 protein
TTDC00180	Type of target	Successful target
TTDC00180	Synonyms	ABPP
TTDC00180	Synonyms	APP
TTDC00180	Synonyms	APPI
TTDC00180	Synonyms	Alzheimer's disease amyloid protein
TTDC00180	Synonyms	Amyloid beta precursor protein
TTDC00180	Synonyms	Amyloid precursor protein
TTDC00180	Synonyms	Beta-amyloid peptide
TTDC00180	Synonyms	CVAP
TTDC00180	Synonyms	Cerebral vascular amyloid peptide
TTDC00180	Synonyms	Gamma-Secretase
TTDC00180	Synonyms	PN-II
TTDC00180	Synonyms	PreA4
TTDC00180	Synonyms	Protease nexin-II
TTDC00180	Synonyms	Vascular beta-amyloid
TTDC00180	Disease	Alzheimer's disease
TTDC00180	Disease	Dementia
TTDC00180	Disease	Pancreatic cancer
TTDC00180	Function	Functions as a cell surface receptor and performs physiological functions on the
TTDC00180	Sequence	MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPEL
TTDC00180	PDB Structure	1AAP; 1AMB; 1AMC; 1AML; 1BA4; 1BA6; 1BJB; 1BJC; 1BRC; 1CA0; 1HZ3; 1IYT; 1MWP; 1O
TTDC00180	BioChemical Class	Transmembrane protein
TTDC00180	Pathway	Alzheimer's disease
TTDC00180	Target Validation	TTDC00180
TTDC00180	Drug(s)	933776
TTDC00180	Drug(s)	AAB-002
TTDC00180	Drug(s)	AAB-003/PF-05236812
TTDC00180	Drug(s)	Anti-Abeta
TTDC00180	Drug(s)	BAN2401
TTDC00180	Drug(s)	BIIB037
TTDC00180	Drug(s)	CAD106
TTDC00180	Drug(s)	Crenezumab
TTDC00180	Drug(s)	ELND005
TTDC00180	Drug(s)	Florbetapir F-18
TTDC00180	Drug(s)	GSK933776A
TTDC00180	Drug(s)	R1450
TTDC00180	Drug(s)	RG1450
TTDC00180	Drug(s)	RG7412
TTDC00180	Drug(s)	Solanezumab
TTDC00180	Drug(s)	UB-311
TTDC00180	Inhibitor	1,6-Bis(4'-hydroxyphenyl)-hexa-1,3,5-triene
TTDC00180	Inhibitor	1,6-bis(4'-aminophenyl)-hexa-1,3,5-triene
TTDC00180	Inhibitor	1,6-bis(4'-dimethylaminophenyl)-hexa-1,3,5-triene
TTDC00180	Inhibitor	1,6-bis(4'-methylaminophenyl)-hexa-1,3,5-triene
TTDC00180	Inhibitor	1,6-bis(4'-nitrophenyl)-hexa-1,3,5-triene
TTDC00180	Inhibitor	2,5-bis(2-methoxyphenyl)thiophene
TTDC00180	Inhibitor	2,5-bis(4-Hydroxyphenyl)thiophene
TTDC00180	Inhibitor	2,5-bis(4-methoxyphenyl)thiophene
TTDC00180	Inhibitor	2,5-bis(4-nitrophenyl)thiophene
TTDC00180	Inhibitor	2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol
TTDC00180	Inhibitor	2-(4-nitrophenyl)-5-(4-methoxyphenyl)thiophene
TTDC00180	Inhibitor	4-(5-(4-(methylamino)phenyl)thiophen-2-yl)phenol
TTDC00180	Inhibitor	4-(5-(4-aminophenyl)thiophen-2-yl)benzenamine
TTDC00180	Inhibitor	4-(5-(4-aminophenyl)thiophen-2-yl)phenol
TTDC00180	Inhibitor	4-(5-(4-methoxyphenyl)thiophen-2-yl)benzenamine
TTDC00180	Inhibitor	4-(5-(4-methoxyphenyl)thiophen-2-yl)phenol
TTDC00180	Inhibitor	5-hydroxy-2-(4-aminophenyl)benzofuran
TTDC00180	Inhibitor	5-hydroxy-2-(4-dimethylaminophenyl)benzofuran
TTDC00180	Inhibitor	5-hydroxy-2-(4-methylaminophenyl)benzofuran
TTDC00180	Inhibitor	5-methoxy-2-(4-aminophenyl)benzofuran
TTDC00180	Inhibitor	5-methoxy-2-(4-dimethylaminophenyl)benzofuran
TTDC00180	Inhibitor	5-methoxy-2-(4-methylaminophenyl)benzofuran
TTDC00180	Inhibitor	6-iodo-4'-dimethyaminoflavone
TTDC00180	Inhibitor	6-iodo-4'-hydroxyflavone
TTDC00180	Inhibitor	6-iodo-4'-methoxyflavone
TTDC00180	Inhibitor	6-iodo-4'-methylaminoflavone
TTDC00180	Inhibitor	CURCUMIN
TTDC00180	Inhibitor	DEHYDROZINGERONE
TTDC00180	Inhibitor	Methionine Sulfoxide
TTDC00180	Inhibitor	SB-13
TTDC00180	Inhibitor	SR-973
TTDC00180	Inhibitor	chrysamine -G
TTDC00180	Antibody	Anti-Abeta
TTDC00180	Antibody	Gelsolin
TTDC00180	Antibody	R1450
TTDC00181	Name	Protein kinase C
TTDC00181	Type of target	Clinical trial target
TTDC00181	Disease	Amyotrophic lateral sclerosis
TTDC00181	Disease	Cancer, unspecific
TTDC00181	Disease	Proteinuria-induced tubular injury
TTDC00181	Disease	Vascular disease
TTDC00181	EC Number	EC 2.7.1.-
TTDC00181	Related US Patent	6,306,383
TTDC00181	Related US Patent	6,492,409
TTDC00181	Target Validation	TTDC00181
TTDC00181	Drug(s)	AEB07
TTDC00181	Drug(s)	AEB071
TTDC00181	Drug(s)	HO-0303
TTDC00181	Drug(s)	Rottlerin
TTDC00181	Inhibitor	AEB07
TTDC00181	Inhibitor	Calphostin C
TTDC00181	Inhibitor	Go6850
TTDC00181	Inhibitor	Go6976
TTDC00181	Inhibitor	Rottlerin
TTDC00181	Inhibitor	Staurosporine
TTDC00181	Binder	Selenocompounds
TTDC00182	UniProt ID	P17252
TTDC00182	Name	Protein kinase C, alpha type
TTDC00182	Type of target	Clinical trial target
TTDC00182	Synonyms	PKC-A
TTDC00182	Synonyms	PKC-alpha
TTDC00182	Synonyms	PKCalpha
TTDC00182	Synonyms	Protein Kinase C alpha
TTDC00182	Disease	Leukemia, unspecified
TTDC00182	Disease	Prostate cancer
TTDC00182	Function	This is a calcium-activated, phospholipid-dependent, serine- and threonine-speci
TTDC00182	Sequence	MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHE
TTDC00182	PDB Structure	2ELI; 3IW4; 4DNL
TTDC00182	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00182	Pathway	Calcium signaling pathway
TTDC00182	Pathway	ErbB signaling pathway
TTDC00182	Pathway	Fc epsilon RI signaling pathway
TTDC00182	Pathway	Focal adhesion
TTDC00182	Pathway	Gap junction
TTDC00182	Pathway	Glioma
TTDC00182	Pathway	GnRH signaling pathway
TTDC00182	Pathway	Leukocyte transendothelial migration
TTDC00182	Pathway	Long-term depression
TTDC00182	Pathway	Long-term potentiation
TTDC00182	Pathway	MAPK signaling pathway
TTDC00182	Pathway	Melanogenesis
TTDC00182	Pathway	Natural killer cell mediated cytotoxicity
TTDC00182	Pathway	Non-small cell lung cancer
TTDC00182	Pathway	Pathogenic Escherichia coli infection
TTDC00182	Pathway	Pathways in cancer
TTDC00182	Pathway	Phosphatidylinositol signaling system
TTDC00182	Pathway	Tight junction
TTDC00182	Pathway	VEGF signaling pathway
TTDC00182	Pathway	Vascular smooth muscle contraction
TTDC00182	Pathway	Vibrio cholerae infection
TTDC00182	Pathway	Wnt signaling pathway
TTDC00182	EC Number	EC 2.7.1.37
TTDC00182	Target Validation	TTDC00182
TTDC00182	Drug(s)	Sotrastaurin acetate
TTDC00182	Inhibitor	(-)-Cercosporamide
TTDC00182	Inhibitor	1,2-dioctanoyl-sn-glycerol
TTDC00182	Inhibitor	2,3,3-Triphenyl-acrylonitrile
TTDC00182	Inhibitor	2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile
TTDC00182	Inhibitor	3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile
TTDC00182	Inhibitor	3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile
TTDC00182	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDC00182	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDC00182	Inhibitor	3-(1H-Indol-3-yl)-4-phenylamino-pyrrole-2,5-dione
TTDC00182	Inhibitor	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile
TTDC00182	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00182	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDC00182	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDC00182	Inhibitor	4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol
TTDC00182	Inhibitor	4-cycloheptyliden(4-hydroxyphenyl)methylphenol
TTDC00182	Inhibitor	4-cyclohexyliden(4-hydroxyphenyl)methylphenol
TTDC00182	Inhibitor	4-cyclopentyliden(4-hydroxyphenyl)methylphenol
TTDC00182	Inhibitor	ACETOSIDE
TTDC00182	Inhibitor	BALANOL
TTDC00182	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDC00182	Inhibitor	CALCEOLARIOSIDE A
TTDC00182	Inhibitor	CALCEOLARIOSIDE B
TTDC00182	Inhibitor	CI-1040;PD-18435;PD-184352
TTDC00182	Inhibitor	Dequalinium Analogue
TTDC00182	Inhibitor	FORSYTHIASIDE
TTDC00182	Inhibitor	Indolocarbazole analogue
TTDC00182	Inhibitor	KN-62
TTDC00182	Inhibitor	KT-5720
TTDC00182	Inhibitor	LEUCOSCEPTOSIDE A
TTDC00182	Inhibitor	LY-294002
TTDC00182	Inhibitor	LY-317644
TTDC00182	Inhibitor	LY-326449
TTDC00182	Inhibitor	PD-98059
TTDC00182	Inhibitor	PROSTRATIN
TTDC00182	Inhibitor	PUNICAFOLIN
TTDC00182	Inhibitor	Plantainoside D
TTDC00182	Inhibitor	RO-316233
TTDC00182	Inhibitor	RO-320432
TTDC00182	Inhibitor	Ro-32-0557
TTDC00182	Inhibitor	SB-202190
TTDC00182	Inhibitor	SB-203580
TTDC00182	Inhibitor	STAUROSPORINONE
TTDC00182	Inhibitor	Sotrastaurin acetate
TTDC00182	Inhibitor	TANNIN
TTDC00182	Inhibitor	TANNIN analogue
TTDC00182	Inhibitor	U-0126
TTDC00182	Inhibitor	[2,2';5',2'']Terthiophen-4-yl-methanol
TTDC00182	Inhibitor	[2,2';5',2'']Terthiophene-4,5''-dicarbaldehyde
TTDC00182	Inhibitor	[2,2';5',2'']Terthiophene-4-carbaldehyde
TTDC00182	Inhibitor	diheptan-3-yl 5-(hydroxymethyl)isophthalate
TTDC00182	Inhibitor	dihexan-3-yl 5-(hydroxymethyl)isophthalate
TTDC00182	Multitarget	Sotrastaurin acetate
TTDC00183	UniProt ID	O14786
TTDC00183	Name	Neuropilin-1
TTDC00183	Type of target	Clinical trial target
TTDC00183	Synonyms	Membrane-bound
TTDC00183	Synonyms	Platelet-derived endothelial cell growth factor receptor
TTDC00183	Synonyms	Vascular endothelial cell growth factor 165 receptor
TTDC00183	Disease	Cancer, unspecific
TTDC00183	Function	The membrane-bound isoform 1 is a receptor involved in the development of the ca
TTDC00183	Sequence	MERGLPLLCAVLALVLAPAGAFRNDKCGDTIKIESPGYLTSPGYPHSYHPSEKCEWLIQAPDPYQRIMINFNPHFDLEDR
TTDC00183	PDB Structure	1KEX; 2QQI; 2QQM; 2QQN; 3I97; 4DEQ
TTDC00183	BioChemical Class	Transmembrane protein
TTDC00183	Target Validation	TTDC00183
TTDC00183	Drug(s)	Anti-NRP1
TTDC00183	Drug(s)	RG7347
TTDC00183	Inhibitor	Anti-NRP1
TTDC00183	Inhibitor	H-KPPR-OH
TTDC00184	UniProt ID	P13945
TTDC00184	Name	Beta-3 adrenergic receptor
TTDC00184	Type of target	Successful target
TTDC00184	Synonyms	Beta-3 adrenoceptor
TTDC00184	Synonyms	Beta-3 adrenoreceptor
TTDC00184	Synonyms	Beta3-AR
TTDC00184	Synonyms	Beta3AR
TTDC00184	Disease	Cardiac arrhythmias
TTDC00184	Disease	Erectile dysfunction
TTDC00184	Disease	Gain weight in patients with morbid obesity
TTDC00184	Disease	Hypertension
TTDC00184	Disease	Hypertonicity of bladder
TTDC00184	Disease	Noninsulin-dependent diabetes mellitus
TTDC00184	Disease	Obesity
TTDC00184	Disease	Overactive bladder disorder
TTDC00184	Function	Beta-adrenergic receptors mediate the catecholamine- induced activation of adeny
TTDC00184	Sequence	MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLA
TTDC00184	PDB Structure	2CDW
TTDC00184	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00184	Pathway	Calcium signaling pathway
TTDC00184	Pathway	Neuroactive ligand-receptor interaction
TTDC00184	Related US Patent	6,124,457
TTDC00184	Related US Patent	6,232,337
TTDC00184	Related US Patent	6,265,581
TTDC00184	Related US Patent	6,291,491
TTDC00184	Related US Patent	6,310,050
TTDC00184	Related US Patent	6,395,762
TTDC00184	Related US Patent	6,410,734
TTDC00184	Related US Patent	6,413,991
TTDC00184	Related US Patent	6,436,914
TTDC00184	Related US Patent	6,444,685
TTDC00184	Related US Patent	6,451,814
TTDC00184	Related US Patent	6,458,817
TTDC00184	Related US Patent	6,465,501
TTDC00184	Related US Patent	6,498,170
TTDC00184	Related US Patent	6,506,901
TTDC00184	Related US Patent	6,509,358
TTDC00184	Related US Patent	6,514,991
TTDC00184	Related US Patent	6,525,202
TTDC00184	Related US Patent	6,537,994
TTDC00184	Related US Patent	6,566,377
TTDC00184	Related US Patent	6,569,873
TTDC00184	Related US Patent	6,583,140
TTDC00184	Related US Patent	6,593,341
TTDC00184	Related US Patent	6,596,734
TTDC00184	Related US Patent	6,605,618
TTDC00184	Related US Patent	6,649,603
TTDC00184	Related US Patent	6,660,752
TTDC00184	Related US Patent	6,689,800
TTDC00184	Related US Patent	6,689,888
TTDC00184	Related US Patent	6,706,743
TTDC00184	Target Validation	TTDC00184
TTDC00184	QSAR Model	TTDC00184
TTDC00184	Drug(s)	AZ-40140
TTDC00184	Drug(s)	Amibegron
TTDC00184	Drug(s)	Beta3-adrenoceptor agonist
TTDC00184	Drug(s)	CL-314698
TTDC00184	Drug(s)	CP-114271
TTDC00184	Drug(s)	GCR-1087
TTDC00184	Drug(s)	GW-427353
TTDC00184	Drug(s)	L-742791
TTDC00184	Drug(s)	L-751250
TTDC00184	Drug(s)	LY-362884
TTDC00184	Drug(s)	Mirabegron
TTDC00184	Drug(s)	N-5984
TTDC00184	Inhibitor	1-(1H-Indol-4-yloxy)-3-phenethylamino-propan-2-ol
TTDC00184	Inhibitor	1-(2-allylphenoxy)-3-morpholinopropan-2-ol
TTDC00184	Inhibitor	1-(2-isopropylphenoxy)-3-morpholinopropan-2-ol
TTDC00184	Inhibitor	BMS-196085
TTDC00184	Inhibitor	BRL-37344
TTDC00184	Inhibitor	BUCINDOLOL
TTDC00184	Agonist	AZ-40140
TTDC00184	Agonist	Amibegron
TTDC00184	Agonist	BRL 26830A
TTDC00184	Agonist	BRL 37344
TTDC00184	Agonist	Beta3-adrenoceptor agonist
TTDC00184	Agonist	CGP 12177
TTDC00184	Agonist	CL-314698
TTDC00184	Agonist	CL-316,243
TTDC00184	Agonist	CP-114271
TTDC00184	Agonist	Carazolol
TTDC00184	Agonist	FR149175
TTDC00184	Agonist	GCR-1087
TTDC00184	Agonist	GW-427353
TTDC00184	Agonist	L-742791
TTDC00184	Agonist	L-751250
TTDC00184	Agonist	LY-362884
TTDC00184	Agonist	N-5984
TTDC00184	Agonist	SM 11044
TTDC00184	Agonist	SWR-0342SA
TTDC00184	Agonist	Trecadrine
TTDC00184	Agonist	Trimetoquinol
TTDC00184	Agonist	ZD2079
TTDC00184	Agonist	ZD7114
TTDC00185	UniProt ID	P50406
TTDC00185	Name	5-hydroxytryptamine 6 receptor
TTDC00185	Type of target	Clinical trial target
TTDC00185	Synonyms	5-HT-6
TTDC00185	Synonyms	5-HT6 receptor
TTDC00185	Synonyms	Serotonin receptor
TTDC00185	Synonyms	Serotonin receptor 6
TTDC00185	Disease	Irritable bowel syndrome
TTDC00185	Disease	Nausea and vomiting
TTDC00185	Disease	Pruritus in chronic liver disease
TTDC00185	Disease	Schizophrenia
TTDC00185	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDC00185	Sequence	MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVM
TTDC00185	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00185	Pathway	Calcium signaling pathway
TTDC00185	Pathway	Neuroactive ligand-receptor interaction
TTDC00185	Related US Patent	6,380,199
TTDC00185	Related US Patent	6,627,661
TTDC00185	Target Validation	TTDC00185
TTDC00185	QSAR Model	TTDC00185
TTDC00185	Drug(s)	742457
TTDC00185	Drug(s)	AVN 101
TTDC00185	Drug(s)	AVN 211
TTDC00185	Drug(s)	AVN 322
TTDC00185	Drug(s)	SB-742457
TTDC00185	Inhibitor	(+/-)-nantenine
TTDC00185	Inhibitor	1-(2-Methoxy-phenyl)-piperazine
TTDC00185	Inhibitor	1-(3-(benzyloxy)-2-methylphenyl)piperazine
TTDC00185	Inhibitor	1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine
TTDC00185	Inhibitor	1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole
TTDC00185	Inhibitor	1-Benzenesulfonyl-3-piperidin-3-yl-1H-indole
TTDC00185	Inhibitor	1-Benzenesulfonyl-3-piperidin-4-yl-1H-indole
TTDC00185	Inhibitor	1-Naphthalen-1-yl-piperazine
TTDC00185	Inhibitor	1-phenylthio-N,N-dimethyltryptamine
TTDC00185	Inhibitor	2-(1-(phenylsulfonyl)-1H-indol-3-yl)ethanamine
TTDC00185	Inhibitor	2-(1-benzyl-1H-inden-3-yl)-N,N-dimethylethanamine
TTDC00185	Inhibitor	2-(1-benzyl-1H-indol-3-yl)-N,N-dimethylethanamine
TTDC00185	Inhibitor	2-(1-tosyl-1H-indol-3-yl)ethanamine
TTDC00185	Inhibitor	2-(3-(phenylsulfonyl)-1H-indol-1-yl)ethanamine
TTDC00185	Inhibitor	2-(3-benzenesulfonyl)phenyl-1-aminoethane
TTDC00185	Inhibitor	2-(3-phenylthio)phenyl)-1-aminoethane
TTDC00185	Inhibitor	2-(4-(benzenesulfonyl)phenyl)-1-aminoethane
TTDC00185	Inhibitor	2-Benzyl-4-piperazin-1-yl-1H-benzimidazole
TTDC00185	Inhibitor	2-Ethyl-5-methoxy-3-piperidin-4-yl-1H-indole
TTDC00185	Inhibitor	3-(phenylsulfonyl)-1-(piperidin-3-yl)-1H-indole
TTDC00185	Inhibitor	3-(phenylsulfonyl)-1-(piperidin-4-yl)-1H-indole
TTDC00185	Inhibitor	3-(phenylsulfonyl)-1-(pyrrolidin-3-yl)-1H-indole
TTDC00185	Inhibitor	4-((1H-indol-1-yl)methyl)benzenamine
TTDC00185	Inhibitor	4-(1H-Inden-1-ylmethyl)-phenylamine
TTDC00185	Inhibitor	4-(1H-Indol-3-ylmethyl)-phenylamine
TTDC00185	Inhibitor	4-(1H-indol-1-ylsulfonyl)benzenamine
TTDC00185	Inhibitor	4-(2-benzenesulfonylphenyl)piperazine
TTDC00185	Inhibitor	4-(3-Methyl-indole-1-sulfonyl)-phenylamine
TTDC00185	Inhibitor	4-(3-benzenesulfonamidophenyl)piperazine
TTDC00185	Inhibitor	4-(3-benzenesulfonylphenyl)piperazine
TTDC00185	Inhibitor	4-(3H-Inden-1-ylmethyl)-phenylamine
TTDC00185	Inhibitor	4-(4,6-dinitro-1H-indol-1-ylsulfonyl)benzenamine
TTDC00185	Inhibitor	4-(4-benzenesulfonamidophenyl)piperazine
TTDC00185	Inhibitor	4-(4-benzenesulfonylphenyl)piperazine
TTDC00185	Inhibitor	4-(4-methoxy-1H-indol-1-ylsulfonyl)benzenamine
TTDC00185	Inhibitor	4-(6-methoxy-1H-indol-1-ylsulfonyl)benzenamine
TTDC00185	Inhibitor	4-(Indan-1-ylsulfanyl)-phenylamine
TTDC00185	Inhibitor	4-(Indane-1-sulfonyl)-phenylamine
TTDC00185	Inhibitor	4-(Naphthalene-1-sulfonyl)-phenylamine
TTDC00185	Inhibitor	4-(piperazin-1-yl)-1H-indole
TTDC00185	Inhibitor	4-(piperazin-1-yl)-3-tosyl-1H-indazole
TTDC00185	Inhibitor	4-Indan-1-ylmethyl-phenylamine
TTDC00185	Inhibitor	4-Inden-(1E)-ylidenemethyl-phenylamine
TTDC00185	Inhibitor	5,6-dichloro-3,4-dihydroquinazolin-2-amine
TTDC00185	Inhibitor	5-(4-Methylpiperazin-1-yl)-3-tosyl-1H-indazole
TTDC00185	Inhibitor	5-MEO-DMT
TTDC00185	Inhibitor	5-METHOXYTRYPTAMINE
TTDC00185	Inhibitor	6-(piperazin-1-yl)-3-tosyl-1H-indazole
TTDC00185	Inhibitor	6-tosyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole
TTDC00185	Inhibitor	CHLOROPHENYLPIPERAZINE
TTDC00185	Inhibitor	DIMEBOLIN
TTDC00185	Inhibitor	Dimethyltryptamine
TTDC00185	Inhibitor	E-6837
TTDC00185	Inhibitor	EDMT
TTDC00185	Inhibitor	HTR5A3-(2-Amino-ethyl)-2-methyl-1H-indol-5-ol
TTDC00185	Inhibitor	L-745870
TTDC00185	Inhibitor	METHIOTHEPIN
TTDC00185	Inhibitor	N,N-diethyl-2-(1H-indol-3-yl)ethanamine
TTDC00185	Inhibitor	N,N-dimethyl-2-(1-tosyl-1H-indol-3-yl)ethanamine
TTDC00185	Inhibitor	N-(3-(2-aminoethyl)phenyl)benzenesulfonamide
TTDC00185	Inhibitor	N-(3-(3-aminopropyl)phenyl)benzenesulfonamide
TTDC00185	Inhibitor	N-(3-(aminomethyl)phenyl)benzenesulfonamide
TTDC00185	Inhibitor	N-(3-aminophenyl)benzenesulfonamide
TTDC00185	Inhibitor	N-(4-(2-aminoethyl)phenyl)benzenesulfonamide
TTDC00185	Inhibitor	N-phenyl-3-(2-aminoethyl)benzenesulfonamide
TTDC00185	Inhibitor	OCTOCLOTHEPIN
TTDC00185	Inhibitor	QUIPAZINE
TTDC00185	Inhibitor	RU-24969
TTDC00185	Inhibitor	Ro-04-6790
TTDC00185	Inhibitor	Ro-63-0563
TTDC00185	Inhibitor	SB-243213
TTDC00185	Inhibitor	SB-258585
TTDC00185	Inhibitor	SB-271046
TTDC00185	Inhibitor	SB-357134
TTDC00185	Inhibitor	SEROTONIN
TTDC00185	Inhibitor	SPIPERONE
TTDC00185	Inhibitor	WAY-181187
TTDC00185	Inhibitor	WAY-208466
TTDC00185	Inhibitor	WAY-466
TTDC00185	Inhibitor	[2-(3-Benzyl-3H-inden-1-yl)-ethyl]-methyl-amine
TTDC00185	Inhibitor	[2-(3-Benzyl-3H-indol-1-yl)-ethyl]-dimethyl-amine
TTDC00185	Inhibitor	[2-(3-Benzyl-indol-1-yl)-ethyl]-dimethyl-amine
TTDC00185	Inhibitor	[2-(3H-Indol-1-yl)-ethyl]-dimethyl-amine
TTDC00185	Antagonist	SB 258585
TTDC00185	Antagonist	SB-742457
TTDC00185	Antagonist	[125I]SB-258585
TTDC00186	UniProt ID	P15248
TTDC00186	Name	Interleukin-9
TTDC00186	Type of target	Clinical trial target
TTDC00186	Synonyms	IL-9
TTDC00186	Synonyms	P40 cytokine
TTDC00186	Synonyms	T-cell growth factor P40
TTDC00186	Disease	Asthma
TTDC00186	Function	Supports il-2 independent and il-4 independent growth of helper t-cells.
TTDC00186	Sequence	MLLAMVLTSALLLCSVAGQGCPTLAGILDINFLINKMQEDPASKCHCSANVTSCLCLGIPSDNCTRPCFSERLSQMTNTT
TTDC00186	BioChemical Class	Growth factor
TTDC00186	Pathway	Asthma
TTDC00186	Pathway	Cytokine-cytokine receptor interaction
TTDC00186	Pathway	Jak-STAT signaling pathway
TTDC00186	Target Validation	TTDC00186
TTDC00186	Drug(s)	MEDI-528
TTDC00186	Inhibitor	MEDI-528
TTDC00187	UniProt ID	O60674
TTDC00187	Name	Tyrosine-protein kinase JAK2
TTDC00187	Type of target	Clinical trial target
TTDC00187	Synonyms	JAK-2
TTDC00187	Synonyms	Janus kinase 2
TTDC00187	Disease	Hodgkin's disease, unspecified
TTDC00187	Disease	Leukemia, unspecified
TTDC00187	Disease	Vascular disease
TTDC00187	Function	Tyrosine kinase of the non-receptor type, involved in interleukin 3 signal trans
TTDC00187	Sequence	MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPV
TTDC00187	PDB Structure	2B7A; 2W1I; 2XA4; 3E62; 3E63; 3E64; 3FUP; 3IO7; 3IOK; 3JY9; 3KCK; 3KRR; 3LPB; 3Q
TTDC00187	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00187	Pathway	Adipocytokine signaling pathway
TTDC00187	Pathway	Chemokine signaling pathway
TTDC00187	Pathway	Jak-STAT signaling pathway
TTDC00187	EC Number	EC 2.7.1.112
TTDC00187	Target Validation	TTDC00187
TTDC00187	Drug(s)	AC430
TTDC00187	Drug(s)	AZD1480
TTDC00187	Drug(s)	BMS-911543
TTDC00187	Drug(s)	Baricitinib
TTDC00187	Drug(s)	INCB018424
TTDC00187	Drug(s)	INCB18424
TTDC00187	Drug(s)	INCB28050
TTDC00187	Drug(s)	ITF2357
TTDC00187	Drug(s)	JAK2 inhibitor
TTDC00187	Drug(s)	LY2784544
TTDC00187	Drug(s)	NS-018
TTDC00187	Drug(s)	Pacritinib
TTDC00187	Drug(s)	Ruxolitinib
TTDC00187	Drug(s)	SAR302503
TTDC00187	Drug(s)	SB1578
TTDC00187	Drug(s)	TG101348
TTDC00187	Drug(s)	XL019
TTDC00187	Inhibitor	5-phenyl-1H-indazol-3-amine
TTDC00187	Inhibitor	AG490
TTDC00187	Inhibitor	CP-690550
TTDC00187	Inhibitor	INCB018424
TTDC00187	Inhibitor	INCB18424
TTDC00187	Inhibitor	INCB28050
TTDC00187	Inhibitor	ITF2357
TTDC00187	Inhibitor	NSC-1771;Thiram
TTDC00187	Inhibitor	TG101348
TTDC00187	Inhibitor	Tyrphostin AG490
TTDC00187	Inhibitor	XL019
TTDC00187	Inhibitor	atropisomer 1
TTDC00187	Multitarget	INCB18424
TTDC00187	Multitarget	INCB28050
TTDC00187	Multitarget	ITF2357
TTDC00188	UniProt ID	P25942
TTDC00188	Name	Tumor necrosis factor receptor superfamily member 5
TTDC00188	Type of target	Clinical trial target
TTDC00188	Synonyms	B-cell surface antigen CD40
TTDC00188	Synonyms	Bp50
TTDC00188	Synonyms	CD40
TTDC00188	Synonyms	CD40L receptor
TTDC00188	Synonyms	CDw40
TTDC00188	Disease	Cancer, unspecific
TTDC00188	Disease	Inflammation
TTDC00188	Disease	Nonsmall cell lung cancer
TTDC00188	Function	Receptor for tnfsf5/cd40l.
TTDC00188	Sequence	MVRLPLQCVLWGCLLTAVHPEPPTACREKQYLINSQCCSLCQPGQKLVSDCTEFTETECLPCGESEFLDTWNRETHCHQH
TTDC00188	PDB Structure	1CDF; 1CZZ; 1D00; 1FLL; 1LB6; 3QD6
TTDC00188	BioChemical Class	Transmembrane protein
TTDC00188	Pathway	Allograft rejection
TTDC00188	Pathway	Asthma
TTDC00188	Pathway	Autoimmune thyroid disease
TTDC00188	Pathway	Cell adhesion molecules (CAMs)
TTDC00188	Pathway	Cytokine-cytokine receptor interaction
TTDC00188	Pathway	Primary immunodeficiency
TTDC00188	Pathway	Systemic lupus erythematosus
TTDC00188	Pathway	Toll-like receptor signaling pathway
TTDC00188	Target Validation	TTDC00188
TTDC00188	Drug(s)	ASKP1240
TTDC00188	Drug(s)	Dacetuzumab
TTDC00188	Antibody	Dacetuzumab
TTDC00188	Ligand	CD154
TTDC00188	Ligand	RhuCD40L
TTDC00189	UniProt ID	P08138
TTDC00189	Name	Tumor necrosis factor receptor superfamily member 16
TTDC00189	Type of target	Clinical trial target
TTDC00189	Synonyms	75kD-neurotrophin receptor
TTDC00189	Synonyms	Gp80-LNGFR
TTDC00189	Synonyms	Low affinity neurotrophin receptor p75NTR
TTDC00189	Synonyms	Low-affinity nerve growth factor receptor
TTDC00189	Synonyms	NGF receptor
TTDC00189	Synonyms	NGF-P75 receptor
TTDC00189	Synonyms	P75 ICD
TTDC00189	Synonyms	P75 neurotrophin receptor (p75(NTR))
TTDC00189	Synonyms	P75NTR
TTDC00189	Disease	Alzheimer's disease
TTDC00189	Disease	Analgesics
TTDC00189	Disease	Cancer, unspecific
TTDC00189	Disease	Neurodegenerative diseases
TTDC00189	Disease	Neuropathic pain
TTDC00189	Disease	Traumatic neuroma formation
TTDC00189	Function	Low affinity receptor which can bind to ngf, bdnf, nt-3, and nt-4. Can mediate c
TTDC00189	Sequence	MGAGATGRAMDGPRLLLLLLLGVSLGGAKEACPTGLYTHSGECCKACNLGEGVAQPCGANQTVCEPCLDSVTFSDVVSAT
TTDC00189	BioChemical Class	Transmembrane protein
TTDC00189	Pathway	Cytokine-cytokine receptor interaction
TTDC00189	Target Validation	TTDC00189
TTDC00189	Drug(s)	PF-4383119
TTDC00189	Drug(s)	SAR164877
TTDC00189	Antagonist	PF-4383119
TTDC00189	Antagonist	SAR164877
TTDC00189	Antagonist	TrkA-IgG
TTDC00190	UniProt ID	P25024
TTDC00190	Name	High affinity interleukin-8 receptor A
TTDC00190	Type of target	Clinical trial target
TTDC00190	Synonyms	CDw128a
TTDC00190	Synonyms	CXCR-1
TTDC00190	Synonyms	IL-8 receptor type 1
TTDC00190	Synonyms	IL-8R A
TTDC00190	Synonyms	Interleukin-8 receptor A
TTDC00190	Disease	Acute respiratory distress syndrome
TTDC00190	Disease	Asthma
TTDC00190	Disease	Human cytomegalovirus infections
TTDC00190	Disease	Lung injury
TTDC00190	Function	Receptor to interleukin-8, which is a powerful neutrophils chemotactic factor. B
TTDC00190	Sequence	MSNITDPQMWDFDDLNFTGMPPADEDYSPCMLETETLNKYVVIIAYALVFLLSLLGNSLVMLVILYSRVGRSVTDVYLLN
TTDC00190	PDB Structure	1ILP; 1ILQ
TTDC00190	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00190	Pathway	Chemokine signaling pathway
TTDC00190	Pathway	Cytokine-cytokine receptor interaction
TTDC00190	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDC00190	Target Validation	TTDC00190
TTDC00190	Drug(s)	Reparixin
TTDC00190	Drug(s)	SCH-527123
TTDC00190	Inhibitor	(R)-2-(4-Isobutyl-phenyl)-N-methoxy-propionamide
TTDC00190	Inhibitor	(R)-2-(4-Isobutyl-phenyl)-propionamide
TTDC00190	Inhibitor	(R)-3-(4-Isobutyl-phenyl)-butan-2-one
TTDC00190	Inhibitor	(R)-N-Hydroxy-2-(4-isobutyl-phenyl)-propionamide
TTDC00190	Inhibitor	1-(2-Bromo-phenyl)-3-(2,4-dihydroxy-phenyl)-urea
TTDC00190	Inhibitor	1-(2-Hydroxy-4-nitro-phenyl)-3-phenyl-urea
TTDC00190	Inhibitor	2-(3-Isobutyl-phenyl)-propionic acid
TTDC00190	Inhibitor	2-(3-Isopropyl-phenyl)-propionic acid
TTDC00190	Inhibitor	2-[3-(1-Hydroxy-propyl)-phenyl]-propionic acid
TTDC00190	Inhibitor	2-[3-(1-Phenyl-ethyl)-phenyl]-propionic acid
TTDC00190	Inhibitor	2-[3-(2-Methyl-butyl)-phenyl]-propionic acid
TTDC00190	Inhibitor	IBUPROPHEN
TTDC00190	Inhibitor	INDOPROFEN
TTDC00190	Inhibitor	R-KETOPROFEN
TTDC00190	Inhibitor	RAPARIXIN
TTDC00190	Antagonist	Reparixin
TTDC00190	Antagonist	SCH-527123
TTDC00190	Agonist	Il-8((3-73))K11R
TTDC00190	Multitarget	Reparixin
TTDC00190	Multitarget	SCH-527123
TTDC00191	UniProt ID	P18031
TTDC00191	Name	mRNA of Protein-tyrosine phosphatase, non-receptor type 1
TTDC00191	Type of target	Clinical trial target
TTDC00191	Synonyms	PTP-1B
TTDC00191	Synonyms	PTP1B
TTDC00191	Synonyms	Protein tyrosine phosphatase 1B
TTDC00191	Synonyms	Protein tyrosine phosphatase-1B
TTDC00191	Synonyms	Protein-tyrosine phosphatase 1B
TTDC00191	Synonyms	Tyrosine phosphatase 1B
TTDC00191	Disease	Cancer, unspecific
TTDC00191	Disease	Noninsulin-dependent diabetes mellitus
TTDC00191	Disease	Obesity
TTDC00191	Sequence	MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRS
TTDC00191	PDB Structure	1A5Y; 1AAX; 1BZC; 1BZH; 1BZJ; 1C83; 1C84; 1C85
TTDC00191	BioChemical Class	Hydrolases acting on ester bonds
TTDC00191	Pathway	Adherens junction
TTDC00191	Pathway	Insulin signaling pathway
TTDC00191	EC Number	EC 3.1.3.48
TTDC00191	Related US Patent	6,365,592
TTDC00191	Related US Patent	6,448,429
TTDC00191	Related US Patent	6,465,444
TTDC00191	Related US Patent	6,472,545
TTDC00191	Related US Patent	6,486,141
TTDC00191	Related US Patent	6,486,142
TTDC00191	Related US Patent	6,498,151
TTDC00191	Related US Patent	6,583,126
TTDC00191	Related US Patent	6,627,767
TTDC00191	Related US Patent	6,642,381
TTDC00191	Target Validation	TTDC00191
TTDC00191	Drug(s)	ISIS 113715
TTDC00191	Drug(s)	ISIS-PTP1BRx
TTDC00191	Drug(s)	ISIS-PTP1Brx
TTDC00191	Inhibitor	1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE
TTDC00191	Inhibitor	1-Iodyl-3-nitro-benzene
TTDC00191	Inhibitor	1-Iodyl-4-nitro-benzene
TTDC00191	Inhibitor	1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID
TTDC00191	Inhibitor	2-(Oxalyl-Amino)-Benzoic Acid
TTDC00191	Inhibitor	2-Methyl-2,4-Pentanediol
TTDC00191	Inhibitor	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid
TTDC00191	Inhibitor	3-Iodyl-benzoic acid
TTDC00191	Inhibitor	4-Iodyl-benzoic acid
TTDC00191	Inhibitor	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid
TTDC00191	Inhibitor	Acetate Ion
TTDC00191	Inhibitor	B-Octylglucoside
TTDC00191	Inhibitor	Compound 15
TTDC00191	Inhibitor	Compound 19
TTDC00191	Inhibitor	Compound 9
TTDC00191	Inhibitor	Cysteine Sulfenic Acid
TTDC00191	Inhibitor	Cysteinesulfonic Acid
TTDC00191	Inhibitor	Double Oxidized Cysteine
TTDC00191	Inhibitor	Hydrogen peroxide
TTDC00191	Inhibitor	ISOTHIAZOLIDINONE ANALOG
TTDC00191	Inhibitor	Iodyl-benzene
TTDC00191	Inhibitor	KR61639
TTDC00191	Inhibitor	Novo Nordisk a/S Compound
TTDC00191	Inhibitor	PARA-(BENZOYL)-PHENYLALANINE
TTDC00191	Inhibitor	PNU177836
TTDC00191	Inhibitor	Selective inhibitors of PTP1B
TTDC00191	Inhibitor	Sp7343-Sp7964
TTDC00191	Inhibitor	[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,
TTDC00191	Antisense	ISIS 107772
TTDC00191	Antisense	ISIS 107773
TTDC00191	Antisense	ISIS 107774
TTDC00191	Antisense	ISIS 107775
TTDC00191	Antisense	ISIS 107776
TTDC00191	Antisense	ISIS 107791
TTDC00191	Antisense	ISIS 107792
TTDC00191	Antisense	ISIS 113715
TTDC00192	UniProt ID	P05362
TTDC00192	Name	mRNA of Intercellular adhesion molecule-1
TTDC00192	Type of target	Clinical trial target
TTDC00192	Synonyms	CD54 antigen
TTDC00192	Synonyms	ICAM-1
TTDC00192	Synonyms	Major group rhinovirus receptor
TTDC00192	Disease	Asthma
TTDC00192	Disease	Autoimmune diseases
TTDC00192	Disease	Inflammation
TTDC00192	Disease	Multiple sclerosis
TTDC00192	Function	Icam proteins are ligands for the leukocyte adhesion lfa-1 protein (integrin alp
TTDC00192	Sequence	MAPSSPRPALPALLVLLGALFPGPGNAQTSVSPSKVILPRGGSVLVTCSTSCDQPKLLGIETPLPKKELLLPGNNRKVYE
TTDC00192	PDB Structure	1D3L; 1IAM; 1IC1; 1IJ4; 1MQ8; 1P53; 1Z7Z; 2OZ4
TTDC00192	BioChemical Class	Transmembrane protein
TTDC00192	Pathway	Cell adhesion molecules (CAMs)
TTDC00192	Pathway	Leukocyte transendothelial migration
TTDC00192	Pathway	Natural killer cell mediated cytotoxicity
TTDC00192	Target Validation	TTDC00192
TTDC00192	Drug(s)	Alicaforsen
TTDC00192	Inhibitor	A-286982
TTDC00192	Inhibitor	Dehydropipernonaline
TTDC00192	Inhibitor	PIPERNONALINE
TTDC00192	Inhibitor	PIPERROLEIN B
TTDC00192	Inhibitor	Pellitorin
TTDC00192	Antisense	Alicaforsen
TTDC00192	Antisense	ISIS 11158
TTDC00192	Antisense	ISIS 11159
TTDC00192	Antisense	ISIS 11665
TTDC00192	Antisense	ISIS 1570
TTDC00192	Antisense	ISIS 1931
TTDC00192	Antisense	ISIS 1939
TTDC00192	Antisense	ISIS 2302
TTDC00192	Antisense	ISIS 2974
TTDC00192	Antisense	ISIS 3067
TTDC00192	Antisense	ISIS 3224
TTDC00193	UniProt ID	P25929
TTDC00193	Name	Neuropeptide Y receptor type 1
TTDC00193	Type of target	Clinical trial target
TTDC00193	Synonyms	NPY1-R
TTDC00193	Synonyms	Neuropeptide Y Y(1) receptor
TTDC00193	Synonyms	Neuropeptide Y receptor Y1
TTDC00193	Synonyms	Neuropeptide Y-Y1 receptor
TTDC00193	Disease	Analgesics
TTDC00193	Disease	Anxiety disorder, unspecified
TTDC00193	Disease	Cardiovascular disease, unspecified
TTDC00193	Disease	Convulsions
TTDC00193	Disease	Drug dependence
TTDC00193	Disease	Metabolic disorder, unspecified
TTDC00193	Disease	Obesity
TTDC00193	Disease	Pain, unspecified
TTDC00193	Disease	Rhinitis
TTDC00193	Function	Receptor for neuropeptide y and peptide yy. The rank order of affinity of this r
TTDC00193	Sequence	MNSTLFSQVENHSVHSNFSEKNAQLLAFENDDCHLPLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTNILIV
TTDC00193	PDB Structure	2F1U; 2IIL
TTDC00193	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00193	Pathway	Neuroactive ligand-receptor interaction
TTDC00193	Target Validation	TTDC00193
TTDC00193	Drug(s)	Benzylamine derivative
TTDC00193	Drug(s)	GI-264879A
TTDC00193	Drug(s)	PD-160170
TTDC00193	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDC00193	Inhibitor	AcPYY(22-36)
TTDC00193	Inhibitor	Adp[-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00193	Inhibitor	BIBP-3226
TTDC00193	Inhibitor	BMS-189323
TTDC00193	Inhibitor	BMS-245782
TTDC00193	Inhibitor	ECONAZOLE NITRATE
TTDC00193	Inhibitor	H-[Trp-Arg-Nva-Arg-Tyr]2-NH2
TTDC00193	Inhibitor	H-[Trp-Arg-Nva-Arg-Tyr]3-NH2
TTDC00193	Inhibitor	LRHYLNLLTRQRY-NH2
TTDC00193	Inhibitor	N-arylpiperazine derivative
TTDC00193	Inhibitor	NEUROPEPTIDE-Y
TTDC00193	Inhibitor	PYY(22-36)
TTDC00193	Inhibitor	PYY(3-36)
TTDC00193	Inhibitor	Pim[-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00193	Inhibitor	Sub[-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00193	Inhibitor	Sub[-Tyr-Arg-Leu-Arg-Tyr-NH2]2
TTDC00193	Inhibitor	[Cys-Trp-Arg-Nva-Arg-Tyr-NH2]2
TTDC00193	Inhibitor	neuropeptide Y
TTDC00193	Antagonist	BIBO3304
TTDC00193	Antagonist	BIBP 3226
TTDC00193	Antagonist	BMS-193885
TTDC00193	Antagonist	Benzylamine derivative
TTDC00193	Antagonist	GI-264879A
TTDC00193	Antagonist	J-104870
TTDC00193	Antagonist	NPY-1 antagonist
TTDC00193	Antagonist	PD-160170
TTDC00193	Antagonist	S-19528
TTDC00193	Antagonist	S-25585
TTDC00193	Antagonist	SR 120819A
TTDC00194	UniProt ID	P14210
TTDC00194	Name	Hepatocyte growth factor
TTDC00194	Type of target	Clinical trial target
TTDC00194	Synonyms	HGF
TTDC00194	Synonyms	Hepatopoeitin A
TTDC00194	Synonyms	SF
TTDC00194	Synonyms	Scatter factor
TTDC00194	Disease	Renal fibrosis
TTDC00194	Function	Hgf is a potent mitogen for mature parenchymal hepatocyte cells, seems to be an
TTDC00194	Sequence	MWVTKLLPALLLQHVLLHLLLLPIAIPYAEGQRKRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGL
TTDC00194	PDB Structure	1BHT; 1GMN; 1GMO; 1GP9; 1NK1; 1SHY; 1SI5; 2HGF
TTDC00194	BioChemical Class	Growth factor
TTDC00194	Pathway	Cytokine-cytokine receptor interaction
TTDC00194	Pathway	Focal adhesion
TTDC00194	Pathway	Melanoma
TTDC00194	Pathway	Pathways in cancer
TTDC00194	Pathway	Renal cell carcinoma
TTDC00194	Related US Patent	6,432,406
TTDC00194	Target Validation	TTDC00194
TTDC00194	Drug(s)	Rilotumumab
TTDC00194	Inhibitor	N,O6-Disulfo-Glucosamine
TTDC00194	Inhibitor	O2-Sulfo-Glucuronic Acid
TTDC00194	Antibody	Rilotumumab
TTDC00195	UniProt ID	Q37967
TTDC00195	Name	Telomerase
TTDC00195	Type of target	Clinical trial target
TTDC00195	Disease	Barrett's esophageal adenocarcinoma
TTDC00195	Disease	Cancer, unspecific
TTDC00195	Disease	Malaria
TTDC00195	Disease	Multiple myeloma
TTDC00195	Sequence	MSKVKIGELINTLVNEVEAIDASDRPQGDKTKRIKAAAARYKNALFNDKRKFRGKGLQKRITANTFNAYMSRARKRFDDK
TTDC00195	Related US Patent	6,452,014
TTDC00195	Related US Patent	6,518,268
TTDC00195	Target Validation	TTDC00195
TTDC00195	QSAR Model	TTDC00195
TTDC00195	Drug(s)	GRN163
TTDC00195	Drug(s)	Imetelstat
TTDC00195	Inhibitor	2,3,7-trichloro-5-nitroquinoxaline (TNQX)
TTDC00195	Inhibitor	Berberine
TTDC00195	Inhibitor	GRN163
TTDC00195	Inhibitor	PPA
TTDC00195	Inhibitor	TMPyP4
TTDC00195	Inhibitor	Telomestatin
TTDC00196	UniProt ID	Q9Y275
TTDC00196	Name	Tumor necrosis factor ligand superfamily member 13B
TTDC00196	Type of target	Clinical trial target
TTDC00196	Synonyms	B cell-activating factor
TTDC00196	Synonyms	B lymphocyte stimulator
TTDC00196	Synonyms	BAFF
TTDC00196	Synonyms	BLyS
TTDC00196	Synonyms	Dendritic cell-derived TNF-like molecule
TTDC00196	Synonyms	TALL-1
TTDC00196	Synonyms	TNF-and APOL-related leukocyte expressed ligand 1
TTDC00196	Synonyms	UNQ401/PRO738
TTDC00196	Disease	Autoimmune diseases
TTDC00196	Disease	Rheumatic diseases
TTDC00196	Disease	Systemic lupus erythematosus
TTDC00196	Function	Cytokine that binds to tnfrsf13b/taci and tnfrsf17/bcma. Tnfsf13/april binds to
TTDC00196	Sequence	MDDSTEREQSRLTSCLKKREEMKLKECVSILPRKESPSVRSSKDGKLLAATLLLALLSCCLTVVSFYQVAALQGDLASLR
TTDC00196	PDB Structure	1JH5; 1KD7; 1KXG; 1OQD; 1OQE; 1OSG; 1OTZ
TTDC00196	BioChemical Class	Transmembrane protein
TTDC00196	Pathway	Cytokine-cytokine receptor interaction
TTDC00196	Target Validation	TTDC00196
TTDC00196	Drug(s)	AMG 623
TTDC00196	Drug(s)	Atacicept
TTDC00196	Drug(s)	Atacicept EMD Serono
TTDC00196	Drug(s)	BR3-Fc
TTDC00196	Drug(s)	Belimumab
TTDC00196	Drug(s)	LymphoStat B
TTDC00196	Drug(s)	Tabalumab
TTDC00196	Inhibitor	1,4-Diethylene Dioxide
TTDC00196	Inhibitor	AMG 623
TTDC00196	Inhibitor	Atacicept
TTDC00196	Inhibitor	BR3-Fc
TTDC00196	Inhibitor	LymphoStat B
TTDC00196	Antibody	Anti-BAFF antibody
TTDC00196	Antibody	Belimumab
TTDC00196	Antibody	Receptor-Fc fusion proteins
TTDC00197	UniProt ID	P16109
TTDC00197	Name	P-selectin
TTDC00197	Type of target	Clinical trial target
TTDC00197	Synonyms	CD62P
TTDC00197	Synonyms	GMP-140
TTDC00197	Synonyms	Granule membrane protein 140
TTDC00197	Synonyms	LECAM3
TTDC00197	Synonyms	Leukocyte-endothelial cell adhesion molecule 3
TTDC00197	Synonyms	PADGEM
TTDC00197	Disease	Inflammatory skin disorder
TTDC00197	Disease	Stroke
TTDC00197	Function	Ca(2+)-dependent receptor for myeloid cells that binds to carbohydrates on neutr
TTDC00197	Sequence	MANCQIAILYQRFQRVVFGISQLLCFSALISELTNQKEVAAWTYHYSTKAYSWNISRKYCQNRYTDLVAIQNKNEIDYLN
TTDC00197	PDB Structure	1FSB; 1G1Q; 1G1R; 1G1S; 1HES; 1KJD
TTDC00197	BioChemical Class	Growth factor
TTDC00197	Target Validation	TTDC00197
TTDC00197	Drug(s)	RPSGL-Ig
TTDC00197	Drug(s)	SelG1
TTDC00197	Inhibitor	1na
TTDC00197	Inhibitor	2,3,4-trihydroxybenzoic acid
TTDC00197	Inhibitor	2-Methyl-2,4-Pentanediol
TTDC00197	Inhibitor	BAICALEIN
TTDC00197	Inhibitor	Efomycine M
TTDC00197	Inhibitor	Fucose
TTDC00197	Inhibitor	GALLICACID
TTDC00197	Inhibitor	O-Sialic Acid
TTDC00197	Inhibitor	PURPUROGALLIN
TTDC00197	Inhibitor	RPSGL-Ig
TTDC00197	Antibody	Monoclonal antibodies
TTDC00197	Antibody	SelG1
TTDC00198	UniProt ID	Q68929
TTDC00198	Name	HCV polymerase
TTDC00198	Type of target	Clinical trial target
TTDC00198	Disease	Hepatitis C
TTDC00198	Sequence	CGNTITCYLKASAACRAAKLQDCTMLVCGDDLVVICESAGTQEDAASLRVFTEAMTRYSAPPGDPPQPEYDLELITSCSS
TTDC00198	BioChemical Class	RNA-directed RNA polymerase
TTDC00198	EC Number	EC 3.4.22.-
TTDC00198	Related US Patent	6,528,252
TTDC00198	Target Validation	TTDC00198
TTDC00198	Drug(s)	ABT-072
TTDC00198	Drug(s)	ABT-333
TTDC00198	Drug(s)	BI 207127
TTDC00198	Drug(s)	BMS 791325
TTDC00198	Drug(s)	Filibuvir
TTDC00198	Drug(s)	HCV-796
TTDC00198	Drug(s)	IDX-189
TTDC00198	Drug(s)	IDX375
TTDC00198	Drug(s)	MK-3281
TTDC00198	Drug(s)	PSI-7977
TTDC00198	Drug(s)	PSI-938
TTDC00198	Drug(s)	R7128
TTDC00198	Drug(s)	RG7128
TTDC00198	Drug(s)	Setrobuvir
TTDC00198	Drug(s)	TMC649128
TTDC00198	Drug(s)	Tegobuvir
TTDC00198	Drug(s)	VX-222
TTDC00198	Drug(s)	VX-759
TTDC00198	Drug(s)	VX-916
TTDC00198	Drug(s)	XTL-2125
TTDC00198	Inhibitor	ABT-072
TTDC00198	Inhibitor	ABT-333
TTDC00198	Inhibitor	BI 207127
TTDC00198	Inhibitor	BMS 791325
TTDC00198	Inhibitor	Filibuvir
TTDC00198	Inhibitor	HCV-796
TTDC00198	Inhibitor	IDX-189
TTDC00198	Inhibitor	IDX375
TTDC00198	Inhibitor	MK-3281
TTDC00198	Inhibitor	PSI-7977
TTDC00198	Inhibitor	PSI-938
TTDC00198	Inhibitor	R7128
TTDC00198	Inhibitor	RG7128
TTDC00198	Inhibitor	Setrobuvir
TTDC00198	Inhibitor	TMC649128
TTDC00198	Inhibitor	Tegobuvir
TTDC00198	Inhibitor	VX-222
TTDC00198	Inhibitor	VX-759
TTDC00198	Inhibitor	VX-916
TTDC00198	Inhibitor	XTL-2125
TTDC00199	UniProt ID	P05164
TTDC00199	Name	Myeloperoxidase
TTDC00199	Type of target	Clinical trial target
TTDC00199	Synonyms	MPO
TTDC00199	Disease	Alzheimer's disease
TTDC00199	Disease	Atherosclerosis
TTDC00199	Disease	Lung cancer
TTDC00199	Disease	Multiple sclerosis
TTDC00199	Function	Part of the host defense system of polymorphonuclear leukocytes. It is responsib
TTDC00199	Sequence	MGVPFFSSLRCMVDLGPCWAGGLTAEMKLLLALAGLLAILATPQPSEGAAPAVLGEVDTSLVLSSMEEAKQLVDKAYKER
TTDC00199	PDB Structure	1CXP; 1D2V; 1D5L; 1D7W; 1DNU; 1DNW; 1MHL; 1MYP
TTDC00199	BioChemical Class	Oxidoreductases acting on a peroxide as acceptor
TTDC00199	EC Number	EC 1.11.1.7
TTDC00199	Target Validation	TTDC00199
TTDC00199	Drug(s)	AZD3241
TTDC00199	Drug(s)	AZD5904
TTDC00199	Inhibitor	AZD3241
TTDC00199	Inhibitor	AZD5904
TTDC00200	UniProt ID	P15559
TTDC00200	Name	NAD(P)H dehydrogenase [quinone] 1
TTDC00200	Type of target	Clinical trial target
TTDC00200	Synonyms	Azoreductase
TTDC00200	Synonyms	DT-diaphorase
TTDC00200	Synonyms	DT-diaphorase 1
TTDC00200	Synonyms	DTD
TTDC00200	Synonyms	Menadione reductase
TTDC00200	Synonyms	NAD(P)H:quinone oxidoreductase 1
TTDC00200	Synonyms	NQO1
TTDC00200	Synonyms	Phylloqui reductase
TTDC00200	Synonyms	Phylloquinone reductase
TTDC00200	Synonyms	QR1
TTDC00200	Synonyms	Qui reductase 1
TTDC00200	Synonyms	Quinone reductase 1
TTDC00200	Disease	Cancer, unspecific
TTDC00200	Disease	Nonsmall cell lung cancer
TTDC00200	Function	The enzyme apparently serves as a quinone reductase in connection with conjugati
TTDC00200	Sequence	MVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDITGKLKDPANFQYPAESVLAYKEGH
TTDC00200	PDB Structure	1D4A; 1DXO; 1GG5; 1H66; 1H69; 1KBO; 1KBQ; 1QBG
TTDC00200	BioChemical Class	Oxidoreductases acting on NADH or NADPH
TTDC00200	Pathway	Biosynthesis of steroids
TTDC00200	Pathway	Metabolic pathways
TTDC00200	EC Number	EC 1.6.99.2
TTDC00200	Target Validation	TTDC00200
TTDC00200	Drug(s)	Apaziquone
TTDC00200	Inhibitor	2-Benzyl-1-hydroxy-3H-benzo[f]chromen-3-one
TTDC00200	Inhibitor	3-(3,4-Dimethylbenzyl)-4-hydroxy-2H-chromen-2-one
TTDC00200	Inhibitor	3-Benzyl-4-hydroxy-2H-benzo[h]chromen-2-one
TTDC00200	Inhibitor	3-Benzyl-4-hydroxy-2H-chromen-2-one
TTDC00200	Inhibitor	3-Benzyl-4-hydroxy-6,7-dimethyl-2H-chromen-2-one
TTDC00200	Inhibitor	4-Hydroxy-3-(1-naphthylmethyl)-2H-chromen-2-one
TTDC00200	Inhibitor	4-Hydroxy-3-(2-naphthylmethyl)-2H-chromen-2-one
TTDC00200	Inhibitor	4-amino-2H-chromen-2-one
TTDC00200	Inhibitor	Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]
TTDC00200	Inhibitor	Cibacron Blue
TTDC00200	Inhibitor	Duroquinone
TTDC00200	Inhibitor	ES-936
TTDC00200	Inhibitor	Ethyl Bis(4-hydroxy-2-oxo-2H-chromen-3-yl)acetate
TTDC00200	Inhibitor	Flavin-Adenine Dinucleotide
TTDC00200	Inhibitor	NSC-106080
TTDC00200	Inhibitor	NSC-106547
TTDC00200	Inhibitor	NSC-2113
TTDC00200	Inhibitor	NSC-224124
TTDC00200	Inhibitor	NSC-275420
TTDC00200	Inhibitor	NSC-316158
TTDC00200	Inhibitor	NSC-339580
TTDC00200	Inhibitor	NSC-339583
TTDC00200	Inhibitor	NSC-354279
TTDC00200	Inhibitor	NSC-621351
TTDC00200	Inhibitor	NSC-645808
TTDC00200	Inhibitor	NSC-645827
TTDC00200	Inhibitor	NSC-65069
TTDC00200	Inhibitor	NSC-73410
TTDC00200	Inhibitor	NSC-99528
TTDC00200	Inhibitor	Quinones
TTDC00200	Activator	Apaziquone
TTDC00201	UniProt ID	Q16539
TTDC00201	Name	Mitogen-activated protein kinase 14
TTDC00201	Type of target	Clinical trial target
TTDC00201	Synonyms	CRK1
TTDC00201	Synonyms	CSAID binding protein
TTDC00201	Synonyms	CSBP
TTDC00201	Synonyms	Cytokine suppressive anti-inflammatory drug binding protein
TTDC00201	Synonyms	MAP kinase MXI2
TTDC00201	Synonyms	MAP kinase p38
TTDC00201	Synonyms	MAP kinase p38alpha
TTDC00201	Synonyms	MAX-interacting protein 2
TTDC00201	Synonyms	Mitogen-activated protein kinase p38
TTDC00201	Synonyms	Mitogen-activated protein kinase p38 alpha
TTDC00201	Synonyms	P38 Mitogen-activated protein kinase alpha
TTDC00201	Synonyms	P38 mitogen activated protein kinase
TTDC00201	Synonyms	SAPK2A
TTDC00201	Disease	Adult respiratory distress syndrome
TTDC00201	Disease	Alzheimer's disease
TTDC00201	Disease	Crescentic glomerulonephritis
TTDC00201	Disease	Crohn's disease, unspecified
TTDC00201	Disease	Cytokine-mediated diseases
TTDC00201	Disease	Endotoxemia
TTDC00201	Disease	Inflammation
TTDC00201	Disease	Insulin resistance
TTDC00201	Disease	Multiple myeloma
TTDC00201	Disease	Psoriasis
TTDC00201	Disease	Rheumatoid arthritis, unspecified
TTDC00201	Disease	Skin diseases
TTDC00201	Disease	Thrombosis
TTDC00201	Function	Responds to activation by environmental stress, pro- inflammatory cytokines and
TTDC00201	Sequence	MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH
TTDC00201	PDB Structure	1A9U; 1DI9; 1M7Q; 1OZ1; 1W82; 1WBO; 1WBW; 1ZZ2
TTDC00201	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00201	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDC00201	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDC00201	Pathway	Fc epsilon RI signaling pathway
TTDC00201	Pathway	GnRH signaling pathway
TTDC00201	Pathway	Leukocyte transendothelial migration
TTDC00201	Pathway	MAPK signaling pathway
TTDC00201	Pathway	T cell receptor signaling pathway
TTDC00201	Pathway	Toll-like receptor signaling pathway
TTDC00201	Pathway	VEGF signaling pathway
TTDC00201	EC Number	EC 2.7.1.37
TTDC00201	Related US Patent	6,541,477
TTDC00201	Target Validation	TTDC00201
TTDC00201	Drug(s)	Dilmapimod
TTDC00201	Drug(s)	GSK610677
TTDC00201	Drug(s)	Losmapimod
TTDC00201	Inhibitor	(5-amino-1-phenyl-1H-pyrazol-4-yl)phenylmethanone
TTDC00201	Inhibitor	2-Chlorophenol
TTDC00201	Inhibitor	3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE
TTDC00201	Inhibitor	3-(Benzyloxy)Pyridin-2-Amine
TTDC00201	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDC00201	Inhibitor	4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-pyridine
TTDC00201	Inhibitor	4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE
TTDC00201	Inhibitor	4-Phenylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine
TTDC00201	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDC00201	Inhibitor	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE
TTDC00201	Inhibitor	6-(4-Fluoro-phenylsulfanyl)-9H-purine
TTDC00201	Inhibitor	6-Benzylsulfanyl-9H-purine
TTDC00201	Inhibitor	6-Phenylsulfanyl-9H-purine
TTDC00201	Inhibitor	6-o-tolylquinazolin-2-amine
TTDC00201	Inhibitor	9-(4-Fluoro-benzyl)-6-phenylsulfanyl-9H-purine
TTDC00201	Inhibitor	9-Benzyl-6-(4-fluoro-phenylsulfanyl)-9H-purine
TTDC00201	Inhibitor	9-Benzyl-6-phenylsulfanyl-9H-purine
TTDC00201	Inhibitor	B-Octylglucoside
TTDC00201	Inhibitor	BIRB796
TTDC00201	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDC00201	Inhibitor	BMS-640994
TTDC00201	Inhibitor	CI-1040;PD-18435;PD-184352
TTDC00201	Inhibitor	CNI-1493
TTDC00201	Inhibitor	CP-808844
TTDC00201	Inhibitor	Dihydro-quinolinone
TTDC00201	Inhibitor	Dilmapimod
TTDC00201	Inhibitor	FR167653
TTDC00201	Inhibitor	GF-109203
TTDC00201	Inhibitor	GSK610677
TTDC00201	Inhibitor	GW-788388
TTDC00201	Inhibitor	Go-6976
TTDC00201	Inhibitor	IN-1130
TTDC00201	Inhibitor	IN-1166
TTDC00201	Inhibitor	Inhibitor of P38 Kinase
TTDC00201	Inhibitor	KN-62
TTDC00201	Inhibitor	KT-5720
TTDC00201	Inhibitor	L-779450
TTDC00201	Inhibitor	LY-294002
TTDC00201	Inhibitor	Losmapimod
TTDC00201	Inhibitor	ML-3163
TTDC00201	Inhibitor	ML-3375
TTDC00201	Inhibitor	ML-3403
TTDC00201	Inhibitor	N-(3-(trifluoromethoxy)benzyl)-4-phenoxybenzamide
TTDC00201	Inhibitor	N-(3-(trifluoromethyl)benzyl)-4-phenoxybenzamide
TTDC00201	Inhibitor	N-(4-(trifluoromethyl)benzyl)-4-phenoxybenzamide
TTDC00201	Inhibitor	N-(4-fluorobenzyl)-N-(pyridin-4-yl)-2-naphthamide
TTDC00201	Inhibitor	N-(4-methyl-benzyl)-4-phenoxy-benzamide
TTDC00201	Inhibitor	PAMAPIMOD
TTDC00201	Inhibitor	PD-0166326;PD-166326
TTDC00201	Inhibitor	PD-0173956
TTDC00201	Inhibitor	PD-98059
TTDC00201	Inhibitor	Phenyl-(3-phenyl-1H-indazol-6-yl)-amine
TTDC00201	Inhibitor	Pyridinyl imidazole compounds
TTDC00201	Inhibitor	RO-316233
TTDC00201	Inhibitor	RWJ-68354
TTDC00201	Inhibitor	Ro-3201195
TTDC00201	Inhibitor	SB 202190
TTDC00201	Inhibitor	SB 203580
TTDC00201	Inhibitor	SB 235699
TTDC00201	Inhibitor	SB-202190
TTDC00201	Inhibitor	SB-203580
TTDC00201	Inhibitor	SB-216995
TTDC00201	Inhibitor	SB-218655
TTDC00201	Inhibitor	SB-220025
TTDC00201	Inhibitor	SB-227931
TTDC00201	Inhibitor	SB-242235
TTDC00201	Inhibitor	SB220025
TTDC00201	Inhibitor	SCIO469
TTDC00201	Inhibitor	SK&F-86002;SK-86002
TTDC00201	Inhibitor	STAUROSPORINONE
TTDC00201	Inhibitor	TYRPHOSTIN AG-1478
TTDC00201	Inhibitor	Triazolopyridine
TTDC00201	Inhibitor	U-0126
TTDC00201	Inhibitor	VK-19911
TTDC00201	Inhibitor	Vertex 745 (VX745)
TTDC00201	Inhibitor	ZM-336372
TTDC00201	Inhibitor	talmapimod
TTDC00202	UniProt ID	Q13464
TTDC00202	Name	Rho-associated protein kinase 1
TTDC00202	Type of target	Clinical trial target
TTDC00202	Synonyms	Let-502 kinase
TTDC00202	Synonyms	P160 ROCK-1
TTDC00202	Synonyms	P160(rock)
TTDC00202	Synonyms	P160ROCK
TTDC00202	Synonyms	ROCK
TTDC00202	Synonyms	Rho kinase
TTDC00202	Synonyms	Rho-associated kinase
TTDC00202	Synonyms	Rho-associated protein kinase
TTDC00202	Synonyms	Rho-associated, coiled-coil containing protein kinase
TTDC00202	Synonyms	Rho-associated, coiled-coil containing protein kinase 1
TTDC00202	Synonyms	Rok
TTDC00202	Disease	Asthma
TTDC00202	Disease	Atherosclerotic cardiovascular disease
TTDC00202	Disease	Cardiac allograft vasculopathy
TTDC00202	Disease	Glaucoma
TTDC00202	Disease	Hepatic fibrosis
TTDC00202	Disease	Hypertensive vascular disease
TTDC00202	Disease	Intimal hyperplasia
TTDC00202	Disease	Liver fibrogenesis
TTDC00202	Disease	Primary pulmonary hypertension
TTDC00202	Disease	Pulmonary hypertension
TTDC00202	Disease	Restenosis
TTDC00202	Disease	Vascular disease
TTDC00202	Disease	Ventricular hypertrophy
TTDC00202	Sequence	MSTGDSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVK
TTDC00202	PDB Structure	1S1C; 2ESM; 2ETK; 2ETR; 2V55; 3D9V
TTDC00202	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00202	Pathway	Axon guidance
TTDC00202	Pathway	Chemokine signaling pathway
TTDC00202	Pathway	Focal adhesion
TTDC00202	Pathway	Leukocyte transendothelial migration
TTDC00202	Pathway	Pathogenic Escherichia coli infection
TTDC00202	Pathway	Regulation of actin cytoskeleton
TTDC00202	Pathway	TGF-beta signaling pathway
TTDC00202	Pathway	Vascular smooth muscle contraction
TTDC00202	Pathway	Wnt signaling pathway
TTDC00202	EC Number	EC 2.7.1.37
TTDC00202	EC Number	EC 2.7.10.-
TTDC00202	Related US Patent	6,451,825
TTDC00202	Target Validation	TTDC00202
TTDC00202	Drug(s)	Cethrin
TTDC00202	Drug(s)	Rho-kinase inhibitor
TTDC00202	Drug(s)	SAR407899
TTDC00202	Inhibitor	(4-Fluoro-phenyl)-(9H-purin-6-yl)-amine
TTDC00202	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDC00202	Inhibitor	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE
TTDC00202	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDC00202	Inhibitor	CI-1040;PD-18435;PD-184352
TTDC00202	Inhibitor	Cethrin
TTDC00202	Inhibitor	Fasudil
TTDC00202	Inhibitor	GF-109203
TTDC00202	Inhibitor	GSK-690693
TTDC00202	Inhibitor	H-1152P
TTDC00202	Inhibitor	HYDROXYFASUDIL
TTDC00202	Inhibitor	Hydroxyfasudil
TTDC00202	Inhibitor	KN-62
TTDC00202	Inhibitor	KT-5720
TTDC00202	Inhibitor	LY-294002
TTDC00202	Inhibitor	PD-98059
TTDC00202	Inhibitor	RO-316233
TTDC00202	Inhibitor	Rho-kinase inhibitor
TTDC00202	Inhibitor	SAR407899
TTDC00202	Inhibitor	SB-202190
TTDC00202	Inhibitor	SB-203580
TTDC00202	Inhibitor	SB-747651A
TTDC00202	Inhibitor	U-0126
TTDC00202	Inhibitor	Y-27632
TTDC00203	Name	Transforming growth factor-beta
TTDC00203	Type of target	Clinical trial target
TTDC00203	Synonyms	TGF-beta
TTDC00203	Disease	Brain tumors
TTDC00203	Disease	Breast cancer
TTDC00203	Disease	Diabetic nephropathy
TTDC00203	Disease	Malignant gliomas
TTDC00203	Disease	Ovarian cancer
TTDC00203	Disease	Renal fibrosis
TTDC00203	Target Validation	TTDC00203
TTDC00203	Drug(s)	ACE-011
TTDC00203	Drug(s)	ACE-536
TTDC00203	Drug(s)	Fresolimumab
TTDC00203	Drug(s)	GC-1008
TTDC00203	Drug(s)	Pirfenidone
TTDC00203	Inhibitor	ACE-011
TTDC00203	Inhibitor	GC-1008
TTDC00203	Inhibitor	Pirfenidone
TTDC00203	Multitarget	Pirfenidone
TTDC00204	UniProt ID	P32241
TTDC00204	Name	Vasoactive intestinal polypeptide receptor 1
TTDC00204	Type of target	Clinical trial target
TTDC00204	Synonyms	PACAP type II receptor
TTDC00204	Synonyms	PACAP-R-2
TTDC00204	Synonyms	Pituitary adenylate cyclase activating polypeptide type II receptor
TTDC00204	Synonyms	VIP-R-1
TTDC00204	Synonyms	VPAC-1
TTDC00204	Synonyms	VPAC1
TTDC00204	Synonyms	Vasoactive intestinal peptide receptor 1
TTDC00204	Synonyms	Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide
TTDC00204	Disease	Autoimmune diseases
TTDC00204	Disease	Human immunodeficiency virus [HIV] disease
TTDC00204	Function	This is a receptor for vip. The activity of this receptor is mediated by G prote
TTDC00204	Sequence	MRPPSPLPARWLCVLAGALAWALGPAGGQAARLQEECDYVQMIEVQHKQCLEEAQLENETIGCSKMWDNLTCWPATPRGQ
TTDC00204	PDB Structure	1OF2; 1OGT; 3B3I
TTDC00204	BioChemical Class	G-protein coupled receptor (Secretin family)
TTDC00204	Pathway	Neuroactive ligand-receptor interaction
TTDC00204	Target Validation	TTDC00204
TTDC00204	Drug(s)	Vasoactive intestinal peptide
TTDC00204	Inhibitor	VIP
TTDC00204	Antagonist	Vasoactive intestinal peptide
TTDC00205	UniProt ID	P41521
TTDC00205	Name	Glucagon-like peptide 1
TTDC00205	Type of target	Successful target
TTDC00205	Synonyms	GLP
TTDC00205	Synonyms	GLP-1
TTDC00205	Synonyms	Glucagon-like peptide-1(7-36)-amide
TTDC00205	Disease	Alzheimer's disease
TTDC00205	Disease	Obesity
TTDC00205	Sequence	HAEGTYTSDVSSYLQDQAAKEFVSWLKTGR
TTDC00205	Target Validation	TTDC00205
TTDC00205	Drug(s)	2374697
TTDC00205	Drug(s)	AVE0010
TTDC00205	Drug(s)	Albiglutide
TTDC00205	Drug(s)	CJC-1134-PC
TTDC00205	Drug(s)	Lixisenatide
TTDC00205	Drug(s)	Lixisenatide + Lantus
TTDC00205	Drug(s)	NN9926
TTDC00205	Drug(s)	RG7685
TTDC00205	Drug(s)	RG7697
TTDC00205	Drug(s)	VRS-859
TTDC00205	Activator	AVE0010
TTDC00205	Activator	Albiglutide
TTDC00206	UniProt ID	Q00987
TTDC00206	Name	Ubiquitin-protein ligase E3 Mdm2
TTDC00206	Type of target	Successful target
TTDC00206	Synonyms	Double minute 2 protein
TTDC00206	Synonyms	Hdm2
TTDC00206	Synonyms	MDM2
TTDC00206	Synonyms	MDM2 protein
TTDC00206	Synonyms	Oncoprotein Mdm2
TTDC00206	Synonyms	P53-binding protein Mdm2
TTDC00206	Disease	Breast cancer
TTDC00206	Disease	Cancer, unspecific
TTDC00206	Disease	Lymphoma
TTDC00206	Disease	Osteosarcoma
TTDC00206	Disease	Ovarian cancer
TTDC00206	Function	Inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its tr
TTDC00206	Sequence	MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSND
TTDC00206	PDB Structure	1RV1; 1T4E; 1T4F; 1YCR; 1Z1M; 2AXI; 2C6A; 2C6B
TTDC00206	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDC00206	Pathway	Bladder cancer
TTDC00206	Pathway	Cell cycle
TTDC00206	Pathway	Chronic myeloid leukemia
TTDC00206	Pathway	Glioma
TTDC00206	Pathway	Melanoma
TTDC00206	Pathway	Pathways in cancer
TTDC00206	Pathway	Prostate cancer
TTDC00206	Pathway	Ubiquitin mediated proteolysis
TTDC00206	Pathway	p53 signaling pathway
TTDC00206	EC Number	EC 6.3.2.-
TTDC00206	Target Validation	TTDC00206
TTDC00206	Drug(s)	JNJ-26854165
TTDC00206	Drug(s)	MK-8242
TTDC00206	Drug(s)	R7112
TTDC00206	Drug(s)	RG7112
TTDC00206	Drug(s)	RG7388
TTDC00206	Drug(s)	SAR405838
TTDC00206	Inhibitor	R7112
TTDC00206	Binder	Antisense oligodeoxynucleotides (ODNs)
TTDC00207	UniProt ID	P51677
TTDC00207	Name	C-C chemokine receptor type 3
TTDC00207	Type of target	Clinical trial target
TTDC00207	Synonyms	C-C CKR-3
TTDC00207	Synonyms	CC-CKR-3
TTDC00207	Synonyms	CCR-3
TTDC00207	Synonyms	CCR3
TTDC00207	Synonyms	CKR3
TTDC00207	Synonyms	Chemokine receptor CCR3
TTDC00207	Synonyms	Eosinophil eotaxin receptor
TTDC00207	Disease	Allergic diseases
TTDC00207	Function	Receptor for a c-c type chemokine. Binds to eotaxin, eotaxin-3, mcp-3, mcp-4, ra
TTDC00207	Sequence	MTTSLDTVETFGTTSYYDDVGLLCEKADTRALMAQFVPPLYSLVFTVGLLGNVVVVMILIKYRRLRIMTNIYLLNLAISD
TTDC00207	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00207	Pathway	Chemokine signaling pathway
TTDC00207	Pathway	Cytokine-cytokine receptor interaction
TTDC00207	Related US Patent	6,420,424
TTDC00207	Related US Patent	6,552,028
TTDC00207	Related US Patent	6,670,379
TTDC00207	Target Validation	TTDC00207
TTDC00207	Drug(s)	Bertilimumab??
TTDC00207	Drug(s)	GW766994
TTDC00207	Drug(s)	YM-344031
TTDC00207	Drug(s)	YM-355179
TTDC00207	Inhibitor	BMS-639623
TTDC00207	Inhibitor	TAK-652
TTDC00207	Antagonist	Bertilimumab??
TTDC00207	Antagonist	YM-344031
TTDC00207	Antagonist	YM-355179
TTDC00208	UniProt ID	P10747
TTDC00208	Name	T-cell-specific surface glycoprotein CD28
TTDC00208	Type of target	Successful target
TTDC00208	Synonyms	CD28-S2
TTDC00208	Synonyms	TP44
TTDC00208	Disease	Lung mucosal allergic inflammation
TTDC00208	Function	Involved in t-cell activation, the induction of cell proliferation and cytokine
TTDC00208	Sequence	MLRLLLALNLFPSIQVTGNKILVKQSPMLVAYDNAVNLSCKYSYNLFSREFRASLHKGLDSAVEVCVVYGNYSQQLQVYS
TTDC00208	PDB Structure	1YJD
TTDC00208	BioChemical Class	Transmembrane protein
TTDC00208	Pathway	Allograft rejection
TTDC00208	Pathway	Autoimmune thyroid disease
TTDC00208	Pathway	Cell adhesion molecules (CAMs)
TTDC00208	Pathway	Graft-versus-host disease
TTDC00208	Pathway	Systemic lupus erythematosus
TTDC00208	Pathway	T cell receptor signaling pathway
TTDC00208	Pathway	Type I diabetes mellitus
TTDC00208	Target Validation	TTDC00208
TTDC00208	Drug(s)	Belatacept
TTDC00208	Inhibitor	Belatacept
TTDC00209	UniProt ID	O00206
TTDC00209	Name	Toll-like receptor 4
TTDC00209	Type of target	Discontinued target
TTDC00209	Synonyms	HToll
TTDC00209	Synonyms	TLR-4
TTDC00209	Disease	LPS-induced left ventricular dysfunction
TTDC00209	Function	Cooperates with ly96 and cd14 to mediate the innate immune response to bacterial
TTDC00209	Sequence	MMSASRLAGTLIPAMAFLSCVRPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPEL
TTDC00209	PDB Structure	2Z62; 2Z63; 2Z65; 2Z66; 3FXI
TTDC00209	BioChemical Class	Transmembrane protein
TTDC00209	Pathway	Pathogenic Escherichia coli infection
TTDC00209	Pathway	Toll-like receptor signaling pathway
TTDC00209	Target Validation	TTDC00209
TTDC00209	Drug(s)	CS-4771
TTDC00209	Drug(s)	Resatorvid
TTDC00209	Inhibitor	3-Hydroxy-Myristic Acid
TTDC00209	Inhibitor	6-(2-aminophenoxy)benzo[d]isothiazol-3-amine
TTDC00209	Inhibitor	CRX-526
TTDC00209	Inhibitor	ERITORAN
TTDC00209	Inhibitor	Lauric Acid
TTDC00209	Inhibitor	MYRISTIC ACID
TTDC00209	Antagonist	Resatorvid
TTDC00210	UniProt ID	O15123
TTDC00210	Name	Angiopoietin-2
TTDC00210	Type of target	Clinical trial target
TTDC00210	Synonyms	ANG-2
TTDC00210	Disease	Breast cancer
TTDC00210	Function	Binds to tie2 receptor and counteracts blood vessel maturation/stability mediate
TTDC00210	Sequence	MWQIVFFTLSCDLVLAAAYNNFRKSMDSIGKKQYQVQHGSCSYTFLLPEMDNCRSSSSPYVSNAVQRDAPLEYDDSVQRL
TTDC00210	PDB Structure	1Z3S; 1Z3U; 2GY7
TTDC00210	Target Validation	TTDC00210
TTDC00210	Drug(s)	AMG 386
TTDC00210	Drug(s)	CVX-060
TTDC00210	Drug(s)	MEDI3617
TTDC00210	Drug(s)	RG7221
TTDC00210	Drug(s)	SAR307746
TTDC00210	Inhibitor	AMG 386
TTDC00210	Antibody	CVX-060
TTDC00210	Antibody	MEDI3617
TTDC00210	Multitarget	AMG 386
TTDC00211	UniProt ID	O56072
TTDC00211	Name	HIV integrase
TTDC00211	Type of target	Successful target
TTDC00211	Disease	Human immunodeficiency virus [HIV] disease
TTDC00211	Sequence	IPAETGQETAYFLLKLAGKWPVKVVHTDNGSNFTSATVKAACWWAGIKQEFEIPYNPQSQGVVKSINKELKKIIGQVRDQ
TTDC00211	EC Number	EC 2.7.7.-
TTDC00211	Related US Patent	6,245,806
TTDC00211	Related US Patent	6,395,743
TTDC00211	Related US Patent	6,541,515
TTDC00211	Related US Patent	6,548,546
TTDC00211	Related US Patent	6,638,921
TTDC00211	Target Validation	TTDC00211
TTDC00211	Drug(s)	1265744
TTDC00211	Drug(s)	Dolutegravir
TTDC00211	Drug(s)	Dolutegravir + abacavir sulphate + lamivudine
TTDC00211	Drug(s)	GSK1265744
TTDC00211	Drug(s)	GSK1349572
TTDC00211	Drug(s)	S-265744 LAP
TTDC00211	Drug(s)	S-349572
TTDC00211	Inhibitor	Dicaffeoylquinic acids
TTDC00211	Inhibitor	Dicaffeoyltartaric acids
TTDC00211	Inhibitor	GSK1265744
TTDC00211	Inhibitor	GSK1349572
TTDC00211	Inhibitor	S-265744 LAP
TTDC00211	Inhibitor	S-349572
TTDC00212	Name	Cyclin-dependent kinase
TTDC00212	Type of target	Discontinued target
TTDC00212	Synonyms	Cell division protein kinase
TTDC00212	Synonyms	Cyclin-dependent protein kinase
TTDC00212	Disease	Stroke
TTDC00212	EC Number	EC 2.7.1.-
TTDC00212	Related US Patent	6,214,852
TTDC00212	Related US Patent	6,448,264
TTDC00212	Related US Patent	6,482,842
TTDC00212	Related US Patent	6,500,846
TTDC00212	Related US Patent	6,515,004
TTDC00212	Related US Patent	6,521,759
TTDC00212	Related US Patent	6,559,152
TTDC00212	Related US Patent	6,593,356
TTDC00212	Related US Patent	6,610,684
TTDC00212	Related US Patent	6,610,724
TTDC00212	Related US Patent	6,627,633
TTDC00212	Related US Patent	6,677,345
TTDC00212	Target Validation	TTDC00212
TTDC00212	Drug(s)	Alvocidib
TTDC00212	Inhibitor	Alvocidib
TTDC00212	Inhibitor	Purvalanol
TTDC00213	UniProt ID	P29279
TTDC00213	Name	Connective tissue growth factor
TTDC00213	Type of target	Clinical trial target
TTDC00213	Synonyms	CCN2
TTDC00213	Synonyms	CTGF
TTDC00213	Synonyms	Hypertrophic chondrocyte-specific protein 24
TTDC00213	Synonyms	Long
TTDC00213	Disease	Atherosclerosis
TTDC00213	Disease	Fibrotic disease
TTDC00213	Disease	Fibrotic renal disease
TTDC00213	Disease	Lung fibrosis
TTDC00213	Disease	Rhabdomyosarcoma
TTDC00213	Disease	Scleroderma
TTDC00213	Disease	Tubulointerstitial fibrosis
TTDC00213	Function	Major connective tissue mitoattractant secreted by vascular endothelial cells. P
TTDC00213	Sequence	MTAASMGPVRVAFVVLLALCSRPAVGQNCSGPCRCPDEPAPRCPAGVSLVLDGCGCCRVCAKQLGELCTERDPCDPHKGL
TTDC00213	Target Validation	TTDC00213
TTDC00213	Drug(s)	FG-3019
TTDC00213	Inhibitor	FG-3019
TTDC00214	UniProt ID	Q16552
TTDC00214	Name	Interleukin-17
TTDC00214	Type of target	Clinical trial target
TTDC00214	Synonyms	CTLA-8
TTDC00214	Synonyms	Cytotoxic T lymphocyte-associated antigen 8
TTDC00214	Synonyms	IL-17
TTDC00214	Synonyms	IL-17A
TTDC00214	Disease	Allograft rejection
TTDC00214	Disease	Neutrophilic airway inflammation
TTDC00214	Disease	Rheumatoid arthritis, unspecified
TTDC00214	Function	Induces stromal cells to produce proinflammatory and hematopoietic cytokines. En
TTDC00214	Sequence	MTPGKTSLVSLLLLLSLEAIVKAGITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNE
TTDC00214	Pathway	Cytokine-cytokine receptor interaction
TTDC00214	Target Validation	TTDC00214
TTDC00214	Drug(s)	AIN457
TTDC00214	Drug(s)	Ixekizumab
TTDC00214	Drug(s)	MCAF5352A
TTDC00214	Drug(s)	RG4934
TTDC00214	Drug(s)	RG7624
TTDC00214	Drug(s)	SCH-900117
TTDC00214	Drug(s)	Vidofludimus
TTDC00214	Inhibitor	AIN457
TTDC00214	Inhibitor	Vidofludimus
TTDC00214	Multitarget	Vidofludimus
TTDC00215	UniProt ID	P32246
TTDC00215	Name	C-C chemokine receptor type 1
TTDC00215	Type of target	Clinical trial target
TTDC00215	Synonyms	C-C CKR-1
TTDC00215	Synonyms	CC-CKR-1
TTDC00215	Synonyms	CCR-1
TTDC00215	Synonyms	CCR1
TTDC00215	Synonyms	Chemokine receptor CCR1
TTDC00215	Synonyms	HM145
TTDC00215	Synonyms	LD78 receptor
TTDC00215	Synonyms	MIP-1alpha-R
TTDC00215	Synonyms	Macrophage inflammatory protein-1 alpha receptor
TTDC00215	Synonyms	RANTES-R
TTDC00215	Disease	Autoimmune diseases
TTDC00215	Disease	Chronic inflammatory diseases
TTDC00215	Disease	Ovarian cancer
TTDC00215	Disease	Renal fibrosis
TTDC00215	Function	Receptor for a c-c type chemokine. Binds to mip-1-alpha, mip-1 delta, rantes, an
TTDC00215	Sequence	METPNTTEDYDTTTEFDYGDATPCQKVNERAFGAQLLPPLYSLVFVIGLVGNILVVLVLVQYKRLKNMTSIYLLNLAISD
TTDC00215	PDB Structure	1Y5D
TTDC00215	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00215	Pathway	Chemokine signaling pathway
TTDC00215	Pathway	Cytokine-cytokine receptor interaction
TTDC00215	Related US Patent	6,403,587
TTDC00215	Related US Patent	6,555,105
TTDC00215	Target Validation	TTDC00215
TTDC00215	Drug(s)	AVE1701
TTDC00215	Drug(s)	AZD4818
TTDC00215	Drug(s)	BMS-817399
TTDC00215	Drug(s)	MLN3897
TTDC00215	Inhibitor	A-987306
TTDC00215	Inhibitor	BX-471
TTDC00215	Inhibitor	BX-471;BX-741
TTDC00215	Inhibitor	COSALANE
TTDC00215	Inhibitor	Cosalane derivative
TTDC00215	Inhibitor	RP-23618
TTDC00215	Antagonist	AVE1701
TTDC00215	Antagonist	AZD4818
TTDC00215	Antagonist	BX 471
TTDC00215	Antagonist	MLN3897
TTDC00216	UniProt ID	P02741
TTDC00216	Name	mRNA of C-reactive protein
TTDC00216	Type of target	Clinical trial target
TTDC00216	Synonyms	CRP
TTDC00216	Disease	Atherosclerosis
TTDC00216	Disease	Cardiovascular disease, unspecified
TTDC00216	Function	Displays several functions associated with host defense: it promotes agglutinati
TTDC00216	Sequence	MEKLLCFLVLTSLSHAFGQTDMSRKAFVFPKESDTSYVSLKAPLTKPLKAFTVCLHFYTELSSTRGYSIFSYATKRQDNE
TTDC00216	PDB Structure	1B09; 1CRV; 1GNH; 1LJ7
TTDC00216	Target Validation	TTDC00216
TTDC00216	Drug(s)	ISIS-CRP
TTDC00216	Drug(s)	ISIS-CRPRx
TTDC00216	Inhibitor	Phosphocholine
TTDC00216	Antisense	ISIS-CRP
TTDC00217	UniProt ID	Q14633
TTDC00217	Name	Interleukin-5 receptor
TTDC00217	Type of target	Clinical trial target
TTDC00217	Synonyms	IL-5R
TTDC00217	Disease	Eosinophilia associated with chronic allergic disease
TTDC00217	Sequence	MIIVAHVLLILLGATEILQADLLPDEKISLLPPVNFTIKVTGLAQVLLQWKPNPDQEQRNVNLEYQVKINAPKEDDYETR
TTDC00217	PDB Structure	1OBX; 1OBZ
TTDC00217	Pathway	Cytokine-cytokine receptor interaction
TTDC00217	Pathway	Hematopoietic cell lineage
TTDC00217	Pathway	Jak-STAT signaling pathway
TTDC00217	Target Validation	TTDC00217
TTDC00217	Drug(s)	Benralizumab
TTDC00217	Drug(s)	MEDI-563
TTDC00217	Drug(s)	Mepolizumab
TTDC00217	Antibody	MEDI-563
TTDC00217	Antibody	Mepolizumab
TTDC00218	UniProt ID	Q99572
TTDC00218	Name	P2X purinoceptor 7
TTDC00218	Type of target	Discontinued target
TTDC00218	Synonyms	ATP receptor
TTDC00218	Synonyms	Adenosine P2X7 receptor
TTDC00218	Synonyms	P2X7
TTDC00218	Synonyms	P2Z receptor
TTDC00218	Synonyms	Purinergic receptor
TTDC00218	Disease	Analgesics
TTDC00218	Disease	Diseases characterized by increased osteoclast number and excessive bone turnove
TTDC00218	Disease	Osteoporosis, unspecified
TTDC00218	Disease	Pain
TTDC00218	Function	Receptor for atp that acts as a ligand gated ion channel. Responsible for atp-de
TTDC00218	Sequence	MPACCSCSDVFQYETNKVTRIQSMNYGTIKWFFHVIIFSYVCFALVSDKLYQRKEPVISSVHTKVKGIAEVKEEIVENGV
TTDC00218	BioChemical Class	Ion transport
TTDC00218	Pathway	Calcium signaling pathway
TTDC00218	Pathway	Neuroactive ligand-receptor interaction
TTDC00218	Target Validation	TTDC00218
TTDC00218	Drug(s)	AZD9056
TTDC00218	Drug(s)	GSK1482160
TTDC00218	Inhibitor	A-740003
TTDC00218	Inhibitor	ISOPPADS
TTDC00218	Inhibitor	KN-62
TTDC00218	Inhibitor	STYLISSADINE A
TTDC00218	Inhibitor	STYLISSADINE B
TTDC00218	Inhibitor	[3H]A-804598
TTDC00218	Antagonist	AZD9056
TTDC00218	Antagonist	GSK1482160
TTDC00219	UniProt ID	P43489
TTDC00219	Name	Tumor necrosis factor receptor superfamily member 4
TTDC00219	Type of target	Clinical trial target
TTDC00219	Synonyms	ACT35 antigen
TTDC00219	Synonyms	CD134 antigen
TTDC00219	Synonyms	Cell surface receptor OX40
TTDC00219	Synonyms	OX40 antigen
TTDC00219	Synonyms	OX40L receptor
TTDC00219	Synonyms	TAX-transcriptionally activated glycoprotein 1 receptor
TTDC00219	Disease	Autoimmune diseases
TTDC00219	Function	Receptor for tnfsf4/ox40l/gp34.
TTDC00219	Sequence	MCVGARRLGRGPCAALLLLGLGLSTVTGLHCVGDTYPSNDRCCHECRPGNGMVSRCSRSQNTVCRPCGPGFYNDVVSSKP
TTDC00219	PDB Structure	1D0A; 2HEV; 2HEY
TTDC00219	BioChemical Class	Transmembrane protein
TTDC00219	Pathway	Cytokine-cytokine receptor interaction
TTDC00219	Target Validation	TTDC00219
TTDC00219	Drug(s)	Anti-oxLDL
TTDC00219	Drug(s)	HuMAb OX40L
TTDC00219	Drug(s)	R4930
TTDC00219	Antagonist	Anti-oxLDL
TTDC00219	Antagonist	HuMAb OX40L
TTDC00219	Antagonist	R4930
TTDC00220	UniProt ID	Q13255
TTDC00220	Name	Metabotropic glutamate receptor 1
TTDC00220	Type of target	Clinical trial target
TTDC00220	Synonyms	Glutamate receptor mGLU1
TTDC00220	Synonyms	mGLUR1
TTDC00220	Disease	Analgesics
TTDC00220	Disease	Convulsions
TTDC00220	Disease	Neuronal injury
TTDC00220	Disease	Pain
TTDC00220	Function	Receptor for glutamate. The activity of this receptor is mediated by a g-protein
TTDC00220	Sequence	MVGLLLFFFPAIFLEVSLLPRSPGRKVLLAGASSQRSVARMDGDVIIGALFSVHHQPPAEKVPERKCGEIREQYGIQRVE
TTDC00220	BioChemical Class	G-protein coupled receptor (metabotropic glutamate family)
TTDC00220	Pathway	Calcium signaling pathway
TTDC00220	Pathway	Gap junction
TTDC00220	Pathway	Long-term depression
TTDC00220	Pathway	Long-term potentiation
TTDC00220	Pathway	Neuroactive ligand-receptor interaction
TTDC00220	Related US Patent	6,482,824
TTDC00220	Target Validation	TTDC00220
TTDC00220	Drug(s)	AZD-9272
TTDC00220	Drug(s)	AZD8529
TTDC00220	Drug(s)	PF-1913539
TTDC00220	Inhibitor	(3,4-dimethylphenyl)(4-phenoxyphenyl)methanone
TTDC00220	Inhibitor	(E)-1-Adamantan-1-yl-3-quinolin-3-yl-propenone
TTDC00220	Inhibitor	(E)-4,4-Dimethyl-1-quinolin-3-yl-pent-1-en-3-one
TTDC00220	Inhibitor	2-methyl-6-(phenylethynyl)pyridine
TTDC00220	Inhibitor	4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid
TTDC00220	Inhibitor	4-(cyclohexyloxy)quinazoline
TTDC00220	Inhibitor	6-bromo-N-(3-chlorophenyl)quinazolin-4-amine
TTDC00220	Inhibitor	GLUTAMATE
TTDC00220	Inhibitor	JNJ-16259685
TTDC00220	Inhibitor	N-(2,3-dihydro-1H-inden-2-yl)isoquinolin-1-amine
TTDC00220	Inhibitor	N-(2,3-dihydro-1H-inden-2-yl)quinazolin-4-amine
TTDC00220	Inhibitor	N-(2-methyl-2-phenylpropyl)pyrazine-2-carboxamide
TTDC00220	Inhibitor	N-(2-phenylpropyl)quinoxaline-2-carboxamide
TTDC00220	Inhibitor	N-(3-bromophenyl)-6-chloroquinazolin-4-amine
TTDC00220	Inhibitor	N-(3-bromophenyl)-6-fluoroquinazolin-4-amine
TTDC00220	Inhibitor	N-cyclohexylquinazolin-4-amine
TTDC00220	Inhibitor	N-cyclohexylquinolin-4-amine
TTDC00220	Inhibitor	N-phenethylquinoxaline-2-carboxamide
TTDC00220	Inhibitor	QUISQUALATE
TTDC00220	Inhibitor	VU0080241
TTDC00220	Inhibitor	pyrazine-2-carboxylic acid adamantan-1-ylamide
TTDC00220	Inhibitor	quinoline-2-carboxylic acid adamantan-1-ylamide
TTDC00220	Inhibitor	quinoline-3-carboxylic acid adamantan-1-ylamide
TTDC00220	Inhibitor	quinoxaline-2-carboxylic acid adamantan-1-ylamide
TTDC00220	Antagonist	PF-1913539
TTDC00220	Agonist	AZD8529
TTDC00220	Modulator	AZD-9272
TTDC00221	UniProt ID	Q14116
TTDC00221	Name	Interleukin-18
TTDC00221	Type of target	Clinical trial target
TTDC00221	Synonyms	IFN-gamma-inducing factor
TTDC00221	Synonyms	IL-1 gamma
TTDC00221	Synonyms	IL-18
TTDC00221	Synonyms	Interferon-gamma inducing factor
TTDC00221	Synonyms	Interleukin-1 gamma
TTDC00221	Disease	Autoimmune diseases
TTDC00221	Disease	Group B streptococci induced septic arthritis
TTDC00221	Disease	Group B streptococci infection
TTDC00221	Disease	Inflammatory arthritis
TTDC00221	Disease	Pancreatic necrosis and systemic complications
TTDC00221	Function	Augments natural killer cell activity in spleen cells and stimulates interferon
TTDC00221	Sequence	MAAEPVEDNCINFVAMKFIDNTLYFIAEDDENLESDYFGKLESKLSVIRNLNDQVLFIDQGNRPLFEDMTDSDCRDNAPR
TTDC00221	PDB Structure	1J0S; 3F62
TTDC00221	Pathway	Cytokine-cytokine receptor interaction
TTDC00221	Target Validation	TTDC00221
TTDC00221	Drug(s)	1070806
TTDC00221	Drug(s)	GSK1070806
TTDC00221	Drug(s)	Gevokizumab
TTDC00221	Drug(s)	IL-18BP
TTDC00221	Drug(s)	Iboctadekin & rituximab
TTDC00221	Drug(s)	Iboctadekin + Doxil
TTDC00221	Drug(s)	MEDI-2338
TTDC00221	Modulator	Iboctadekin & rituximab
TTDC00221	Modulator	Iboctadekin + Doxil
TTDC00221	Binder	IL-18BP
TTDC00221	Multitarget	Iboctadekin & rituximab
TTDC00221	Multitarget	Iboctadekin + Doxil
TTDC00222	UniProt ID	O14920
TTDC00222	UniProt ID	O15111
TTDC00222	UniProt ID	Q14164
TTDC00222	Name	Inhibitor of nuclear factor kappa-B kinase
TTDC00222	Type of target	Discontinued target
TTDC00222	Synonyms	I kappa B kinase
TTDC00222	Synonyms	IKK
TTDC00222	Synonyms	IkBK
TTDC00222	Disease	Analgesics
TTDC00222	Disease	Herpes virus infection
TTDC00222	Disease	Inflammation
TTDC00222	Disease	Inflammatory diseases
TTDC00222	Disease	Pain, unspecified
TTDC00222	Disease	Rheumatoid arthritis, unspecified
TTDC00222	Sequence	MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVP
TTDC00222	PDB Structure	3BRT; 3BRV
TTDC00222	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00222	Pathway	Acute myeloid leukemia
TTDC00222	Pathway	Adipocytokine signaling pathway
TTDC00222	Pathway	Apoptosis
TTDC00222	Pathway	B cell receptor signaling pathway
TTDC00222	Pathway	Chemokine signaling pathway
TTDC00222	Pathway	Chronic myeloid leukemia
TTDC00222	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDC00222	Pathway	Insulin signaling pathway
TTDC00222	Pathway	MAPK signaling pathway
TTDC00222	Pathway	Pancreatic cancer
TTDC00222	Pathway	Pathways in cancer
TTDC00222	Pathway	Prostate cancer
TTDC00222	Pathway	Small cell lung cancer
TTDC00222	Pathway	T cell receptor signaling pathway
TTDC00222	Pathway	Toll-like receptor signaling pathway
TTDC00222	Pathway	Type II diabetes mellitus
TTDC00222	EC Number	EC 2.7.1.-
TTDC00222	Related US Patent	6,649,654
TTDC00222	Target Validation	TTDC00222
TTDC00222	Drug(s)	MLN0415
TTDC00222	Drug(s)	SAR113945
TTDC00222	Inhibitor	4-hydroxy-2-nonenal
TTDC00222	Inhibitor	5-Bromo-6-methoxy-9H-beta-carboline
TTDC00222	Inhibitor	Arsenite
TTDC00222	Inhibitor	BMS-345541
TTDC00222	Inhibitor	MLN0415
TTDC00222	Inhibitor	PS-1145
TTDC00222	Inhibitor	S1627
TTDC00224	UniProt ID	O14788
TTDC00224	Name	Tumor necrosis factor ligand superfamily member 11
TTDC00224	Type of target	Successful target
TTDC00224	Synonyms	ODF
TTDC00224	Synonyms	OPGL
TTDC00224	Synonyms	Osteoclast differentiation factor
TTDC00224	Synonyms	Osteoprotegerin ligand
TTDC00224	Synonyms	RANKL
TTDC00224	Synonyms	Receptor activator of nuclear factor kappa B ligand
TTDC00224	Synonyms	TNF-related activation-induced cytokine
TTDC00224	Synonyms	TRANCE
TTDC00224	Disease	Arthritis
TTDC00224	Disease	Osteolytic metastatic cancer
TTDC00224	Disease	Osteoporosis, unspecified
TTDC00224	Disease	Periodontitis
TTDC00224	Function	Cytokine that binds to tnfrsf11b/opg and to tnfrsf11a/rank. Osteoclast different
TTDC00224	Sequence	MRRASRDYTKYLRGSEEMGGGPGAPHEGPLHAPPPPAPHQPPAASRSMFVALLGLGLGQVVCSVALFFYFRAQMDPNRIS
TTDC00224	BioChemical Class	Transmembrane protein
TTDC00224	Pathway	Cytokine-cytokine receptor interaction
TTDC00224	Target Validation	TTDC00224
TTDC00224	Drug(s)	Denosumab
TTDC00224	Antibody	Denosumab
TTDC00225	UniProt ID	P19875
TTDC00225	Name	Macrophage inflammatory protein-2-alpha
TTDC00225	Type of target	Clinical trial target
TTDC00225	Synonyms	CXCL2
TTDC00225	Synonyms	Gro-beta
TTDC00225	Synonyms	Growth regulated protein beta
TTDC00225	Synonyms	MIP2-alpha
TTDC00225	Synonyms	Macrophage inflammatory protein 2
TTDC00225	Disease	Influenza virus pneumonia
TTDC00225	Function	Produced by activated monocytes and neutrophils and expressed at sites of inflam
TTDC00225	Sequence	MARATLSAAPSNPRLLRVALLLLLLVAASRRAAGAPLATELRCQCLQTLQGIHLKNIQSVKVKSPGPHCAQTEVIATLKN
TTDC00225	PDB Structure	1QNK
TTDC00225	Pathway	Chemokine signaling pathway
TTDC00225	Pathway	Cytokine-cytokine receptor interaction
TTDC00225	Target Validation	TTDC00225
TTDC00225	Drug(s)	Laquinamod
TTDC00225	Modulator	Laquinamod
TTDC00226	UniProt ID	P51679
TTDC00226	Name	C-C chemokine receptor type 4
TTDC00226	Type of target	Clinical trial target
TTDC00226	Synonyms	C-C CKR-4
TTDC00226	Synonyms	CC chemokine receptor 4
TTDC00226	Synonyms	CC-CKR-4
TTDC00226	Synonyms	CCR-4
TTDC00226	Synonyms	CCR4
TTDC00226	Synonyms	K5-5
TTDC00226	Disease	Asthma
TTDC00226	Function	High affinity receptor for the c-c type chemokines tarc/scya17 and mdc/scya22. T
TTDC00226	Sequence	MNPTDIADTTLDESIYSNYYLYESIPKPCTKEGIKAFGELFLPPLYSLVFVFGLLGNSVVVLVLFKYKRLRSMTDVYLLN
TTDC00226	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00226	Pathway	Chemokine signaling pathway
TTDC00226	Pathway	Cytokine-cytokine receptor interaction
TTDC00226	Target Validation	TTDC00226
TTDC00226	Drug(s)	AMG 761
TTDC00226	Drug(s)	AT008
TTDC00226	Drug(s)	GSK2239633
TTDC00226	Inhibitor	4-isopropyl-N-(naphthalen-1-yl)thiazol-2-amine
TTDC00226	Inhibitor	4-methyl-N-(naphthalen-1-yl)thiazol-2-amine
TTDC00226	Inhibitor	4-tert-butyl-N-(2-isopropylphenyl)thiazol-2-amine
TTDC00226	Inhibitor	4-tert-butyl-N-(naphthalen-1-yl)oxazol-2-amine
TTDC00226	Inhibitor	4-tert-butyl-N-(naphthalen-1-yl)thiazol-2-amine
TTDC00226	Inhibitor	4-tert-butyl-N-m-tolylthiazol-2-amine
TTDC00226	Inhibitor	4-tert-butyl-N-o-tolylthiazol-2-amine
TTDC00226	Inhibitor	4-tert-butyl-N-phenylthiazol-2-amine
TTDC00226	Inhibitor	C-014C
TTDC00226	Inhibitor	N-(4-tert-butylthiazol-2-yl)-1H-indol-4-amine
TTDC00226	Inhibitor	N-(4-tert-butylthiazol-2-yl)isoquinolin-5-amine
TTDC00226	Inhibitor	N-(4-tert-butylthiazol-2-yl)quinolin-5-amine
TTDC00226	Inhibitor	N-(naphthalen-1-yl)-4-neopentylthiazol-2-amine
TTDC00226	Inhibitor	N-(naphthalen-1-yl)-4-phenylthiazol-2-amine
TTDC00226	Inhibitor	TAK-652
TTDC00226	Antibody	AMG 761
TTDC00226	Antibody	AT008
TTDC00227	UniProt ID	P48067
TTDC00227	Name	Sodium- and chloride-dependent glycine transporter 1
TTDC00227	Type of target	Clinical trial target
TTDC00227	Synonyms	GlyT-1
TTDC00227	Synonyms	GlyT1
TTDC00227	Synonyms	Glycine transporter type 1
TTDC00227	Synonyms	Glycine type-1 transporter
TTDC00227	Disease	Disorders associated with NMDAR hypofunction
TTDC00227	Function	Terminates the action of glycine by its high affinity sodium-dependent reuptake
TTDC00227	Sequence	MAAAHGPVAPSSPEQVTLLPVQRSFFLPPFSGATPSTSLAESVLKVWHGAYNSGLLPQLMAQHSLAMAQNGAVPSEATKR
TTDC00227	BioChemical Class	Transmembrane protein
TTDC00227	Related US Patent	6,506,780
TTDC00227	Related US Patent	6,566,550
TTDC00227	Related US Patent	6,645,973
TTDC00227	Related US Patent	6,667,336
TTDC00227	Related US Patent	6,784,299
TTDC00227	Target Validation	TTDC00227
TTDC00227	Drug(s)	ALX-5407
TTDC00227	Drug(s)	AMG 747
TTDC00227	Drug(s)	GSK1018921
TTDC00227	Drug(s)	Gliatech
TTDC00227	Drug(s)	Org-24461
TTDC00227	Drug(s)	Organon
TTDC00227	Drug(s)	Organon-2
TTDC00227	Drug(s)	Organon-3
TTDC00227	Drug(s)	R1678
TTDC00227	Drug(s)	SSR-103800
TTDC00227	Drug(s)	SSR-504734
TTDC00227	Blocker	ALX-5407
TTDC00227	Blocker	GSK1018921
TTDC00227	Blocker	Gliatech
TTDC00227	Blocker	NFPS
TTDC00227	Blocker	Org-24461
TTDC00227	Blocker	Organon
TTDC00227	Blocker	Organon-2
TTDC00227	Blocker	Organon-3
TTDC00227	Blocker	R1678
TTDC00227	Blocker	SSR-103800
TTDC00227	Blocker	SSR-504734
TTDC00228	UniProt ID	P06730
TTDC00228	Name	mRNA of Eukaryotic translation initiation factor 4E
TTDC00228	Type of target	Clinical trial target
TTDC00228	Synonyms	EIF-4E
TTDC00228	Synonyms	EIF-4F 25 kDa subunit
TTDC00228	Synonyms	EIF4E
TTDC00228	Synonyms	MRNA cap-binding protein
TTDC00228	Disease	Cancer, unspecific
TTDC00228	Function	Recognizes and binds the 7-methylguanosine-containing mrna cap during an early s
TTDC00228	Sequence	MATVEPETTPTPNPPTTEEEKTESNQEVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQ
TTDC00228	PDB Structure	1IPB; 1IPC; 1WKW; 2GPQ; 2V8W; 2V8X; 2V8Y
TTDC00228	Target Validation	TTDC00228
TTDC00228	Drug(s)	ISIS-EIF4ERx
TTDC00228	Drug(s)	LY2275796
TTDC00228	Inhibitor	7-Methyl-Gpppa
TTDC00228	Inhibitor	7-Methyl-Guanosine-5'-Triphosphate
TTDC00228	Inhibitor	7n-Methyl-8-Hydroguanosine-5'-Diphosphate
TTDC00228	Antisense	LY2275796
TTDC00230	UniProt ID	P30550
TTDC00230	Name	Gastrin-releasing peptide receptor
TTDC00230	Type of target	Clinical trial target
TTDC00230	Synonyms	Bombesin/gastrin-releasing peptide receptor
TTDC00230	Synonyms	GRP-R
TTDC00230	Synonyms	GRP-preferring bombesin receptor
TTDC00230	Disease	Small cell lung cancer
TTDC00230	Function	Receptor for gastrin releasing peptide (grp). This receptor mediates its action
TTDC00230	Sequence	MALNDCFLLNLEVDHFMHCNISSHSADLPVNDDWSHPGILYVIPAVYGVIILIGLIGNITLIKIFCTVKSMRNVPNLFIS
TTDC00230	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00230	Pathway	Calcium signaling pathway
TTDC00230	Pathway	Neuroactive ligand-receptor interaction
TTDC00230	Target Validation	TTDC00230
TTDC00230	Drug(s)	GSK1292263
TTDC00230	Inhibitor	(CH3)CCO-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2
TTDC00230	Inhibitor	(D)Phe-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2
TTDC00230	Inhibitor	Ac-His-Trp-Ala-Val-Ala-His-Leu-Met-NH2
TTDC00230	Inhibitor	Ac-His-Trp-Ala-Val-D-Ala-His-Leu-Met-NH2
TTDC00230	Inhibitor	Ac-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2
TTDC00230	Inhibitor	JMV 1535
TTDC00230	Inhibitor	JMV 1693
TTDC00230	Inhibitor	JMV 1719
TTDC00230	Inhibitor	JMV 1799
TTDC00230	Inhibitor	JMV 1801
TTDC00230	Inhibitor	JMV 1802
TTDC00230	Inhibitor	JMV 1803
TTDC00230	Inhibitor	JMV 1813
TTDC00230	Inhibitor	Universal ligand
TTDC00230	Inhibitor	[(N4-Bzdig)0,Nle14]BB(7-14)
TTDC00230	Inhibitor	[(N4-Bzdig)0]BB(7-14)
TTDC00230	Inhibitor	[N40,Pro1,Tyr4,Nle 14]BB
TTDC00230	Inhibitor	[N40,Pro1,Tyr4]BB
TTDC00230	Inhibitor	[Tyr4]Bombesin
TTDC00230	Agonist	GSK1292263
TTDC00231	UniProt ID	Q969F8
TTDC00231	Name	G-protein coupled receptor 54
TTDC00231	Type of target	Clinical trial target
TTDC00231	Synonyms	GPR54
TTDC00231	Synonyms	KiSS-1 receptor GPR54
TTDC00231	Disease	Human reproductive syndromes
TTDC00231	Sequence	MHTVATSGPNASWGAPANASGCPGCGANASDGPVPSPRAVDAWLVPLFFAALMLLGLVGNSLVIYVICRHKPMRTVTNFY
TTDC00231	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00231	Pathway	Neuroactive ligand-receptor interaction
TTDC00231	Target Validation	TTDC00231
TTDC00231	Drug(s)	TAK-448
TTDC00231	Drug(s)	TAK-683
TTDC00231	Inhibitor	4-fluorobenzoyl-Phe-Gly-Leu-Arg-Trp-NH2
TTDC00231	Inhibitor	H-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2
TTDC00231	Agonist	TAK-448
TTDC00231	Agonist	TAK-683
TTDC00232	UniProt ID	O43174
TTDC00232	Name	Cytochrome P450 26
TTDC00232	Type of target	Clinical trial target
TTDC00232	Synonyms	Cytochrome P450RAI
TTDC00232	Synonyms	HP450RAI
TTDC00232	Synonyms	P450 retinoic acid-inactivating 1
TTDC00232	Synonyms	P450RAI
TTDC00232	Synonyms	Retinoic acid 4-hydroxylase
TTDC00232	Synonyms	Retinoic acid inducible enzyme
TTDC00232	Synonyms	Retinoic acid-metabolizing cytochrome
TTDC00232	Disease	Cardiovascular disease, unspecified
TTDC00232	Disease	Eye diseases
TTDC00232	Disease	Hyperproliferative disorders
TTDC00232	Disease	Inflammatory diseases
TTDC00232	Disease	Neurodegenerative diseases
TTDC00232	Disease	Noninsulin-dependent diabetes mellitus
TTDC00232	Disease	Skin diseases
TTDC00232	Function	Plays a key role in retinoic acid metabolism. Acts on retinoids, including all-t
TTDC00232	Sequence	MGLPALLASALCTFVLPLLLFLAAIKLWDLYCVSGRDRSCALPLPPGTMGFPFFGETLQMVLQRRKFLQMKRRKYGFIYK
TTDC00232	BioChemical Class	Oxidoreductases acting on paired donors
TTDC00232	EC Number	EC 1.14.-.-
TTDC00232	Related US Patent	6,252,090
TTDC00232	Related US Patent	6,291,677
TTDC00232	Related US Patent	6,303,785
TTDC00232	Related US Patent	6,313,107
TTDC00232	Related US Patent	6,359,135
TTDC00232	Related US Patent	6,369,225
TTDC00232	Related US Patent	6,369,261
TTDC00232	Related US Patent	6,380,256
TTDC00232	Related US Patent	6,387,892
TTDC00232	Related US Patent	6,387,951
TTDC00232	Related US Patent	6,399,774
TTDC00232	Related US Patent	6,495,552
TTDC00232	Related US Patent	6,531,599
TTDC00232	Related US Patent	6,603,019
TTDC00232	Related US Patent	6,713,647
TTDC00232	Target Validation	TTDC00232
TTDC00232	Drug(s)	Rambazole
TTDC00232	Inhibitor	4-((+/-)-(1H-imidazol-1-yl)-(E)-methylretinoate
TTDC00232	Inhibitor	4-((+/-)-(1H-imidazol-1-yl)-(E)-retinoic acid
TTDC00232	Inhibitor	LIAROZOLE
TTDC00232	Inhibitor	R-115866
TTDC00232	Inhibitor	Rambazole
TTDC00233	Name	Gamma secretase
TTDC00233	Type of target	Clinical trial target
TTDC00233	Disease	Alzheimer's disease
TTDC00233	Related US Patent	6,448,229
TTDC00233	Target Validation	TTDC00233
TTDC00233	QSAR Model	TTDC00233
TTDC00233	Drug(s)	BMS-932481
TTDC00233	Drug(s)	MK-0752
TTDC00233	Drug(s)	PF-03084014
TTDC00233	Drug(s)	R4733
TTDC00233	Inhibitor	MK-0752
TTDC00233	Inhibitor	R4733
TTDC00234	UniProt ID	P27930
TTDC00234	Name	Interleukin-1 receptor, type II
TTDC00234	Type of target	Clinical trial target
TTDC00234	Synonyms	Antigen CDw121b
TTDC00234	Synonyms	IL-1R-2
TTDC00234	Synonyms	IL-1R-beta
TTDC00234	Synonyms	Interleukin 1 receptor type II
TTDC00234	Disease	Allergy, unspecified
TTDC00234	Disease	Arthritis
TTDC00234	Disease	Inflammation
TTDC00234	Disease	Inflammatory bowel disease
TTDC00234	Function	Receptor for interleukin-1 alpha (il-1a), beta (il-1b), and interleukin-1 recept
TTDC00234	Sequence	MLRLYVLVMGVSAFTLQPAAHTGAARSCRFRGRHYKREFRLEGEPVALRCPQVPYWLWASVSPRINLTWHKNDSARTVPG
TTDC00234	BioChemical Class	Transmembrane protein
TTDC00234	Pathway	Cytokine-cytokine receptor interaction
TTDC00234	Pathway	Hematopoietic cell lineage
TTDC00234	Pathway	MAPK signaling pathway
TTDC00234	Related US Patent	6,399,573
TTDC00234	Target Validation	TTDC00234
TTDC00234	Drug(s)	AMG 108
TTDC00234	Antagonist	AMG 108
TTDC00236	Name	mRNA of ApoB-100
TTDC00236	Type of target	Clinical trial target
TTDC00236	Disease	Cardiovascular disease, unspecified
TTDC00236	Target Validation	TTDC00236
TTDC00236	Drug(s)	ISIS 301012
TTDC00236	Drug(s)	Mipomersen
TTDC00236	Antisense	ISIS 301012
TTDC00236	Antisense	Mipomersen
TTDC00237	UniProt ID	Q9Y5Y4
TTDC00237	Name	Putative G-protein coupled receptor 44
TTDC00237	Type of target	Clinical trial target
TTDC00237	Synonyms	CD294
TTDC00237	Synonyms	Chemoattractant receptor-homologous molecule expressed on Th2 cells
TTDC00237	Disease	Asthma
TTDC00237	Disease	Chronic obstructive pulmonary disease
TTDC00237	Function	Orphan receptor.
TTDC00237	Sequence	MSANATLKPLCPILEQMSRLQSHSNTSIRYIDHAAVLLHGLASLLGLVENGVILFVVGCRMRQTVVTTWVLHLALSDLLA
TTDC00237	Target Validation	TTDC00237
TTDC00237	Drug(s)	AM211
TTDC00237	Drug(s)	AMG 853
TTDC00237	Drug(s)	ARRY-502
TTDC00237	Drug(s)	AZD1981
TTDC00237	Drug(s)	AZD5985
TTDC00237	Drug(s)	AZD8075
TTDC00237	Drug(s)	RG7185
TTDC00237	Inhibitor	2-(2,4-diphenylthiazol-5-yl)acetic acid
TTDC00237	Inhibitor	2-(2-acetyl-4-bromophenoxy)acetic acid
TTDC00237	Inhibitor	2-(2-allyl-4-chlorophenoxy)acetic acid
TTDC00237	Inhibitor	2-(2-benzhydryl-4-phenylthiazol-5-yl)acetic acid
TTDC00237	Inhibitor	2-(2-benzoyl-4-bromophenoxy)acetic acid
TTDC00237	Inhibitor	2-(2-cyclohexyl-4-fluorophenoxy)acetic acid
TTDC00237	Inhibitor	2-(2-cyclohexyl-4-methoxyphenoxy)acetic acid
TTDC00237	Inhibitor	2-(2-cyclohexyl-4-methylphenoxy)acetic acid
TTDC00237	Inhibitor	2-(2-cyclohexylphenoxy)acetic acid
TTDC00237	Inhibitor	2-(2-formylphenoxy)acetic acid
TTDC00237	Inhibitor	2-(4-bromo-2-(hydroxymethyl)phenoxy)acetic acid
TTDC00237	Inhibitor	2-(4-bromo-2-cyclohexylphenoxy)acetic acid
TTDC00237	Inhibitor	2-(4-bromo-2-formylphenoxy)acetic acid
TTDC00237	Inhibitor	2-(4-bromo-2-tert-butylphenoxy)acetic acid
TTDC00237	Inhibitor	2-(4-chloro-2-cycloheptylphenoxy)acetic acid
TTDC00237	Inhibitor	2-(4-chloro-2-cyclohexylphenoxy)acetic acid
TTDC00237	Inhibitor	2-(4-chloro-2-cyclopentylphenoxy)acetic acid
TTDC00237	Inhibitor	2-(4-cyano-2-cyclohexylphenoxy)acetic acid
TTDC00237	Inhibitor	3-(4-chloro-2-cyclohexylphenoxy)propanoic acid
TTDC00237	Inhibitor	4-(4-chloro-2-cyclohexylphenoxy)butanoic acid
TTDC00237	Inhibitor	L-888607
TTDC00237	Inhibitor	LAROPIPRANT
TTDC00237	Inhibitor	methyl 2-(4-chloro-2-cyclohexylphenoxy)acetate
TTDC00237	Antagonist	AZD1981
TTDC00237	Antagonist	AZD5985
TTDC00237	Antagonist	AZD8075
TTDC00238	UniProt ID	Q9UHF1
TTDC00238	Name	EGF-like domain-containing protein 7
TTDC00238	Type of target	Clinical trial target
TTDC00238	Synonyms	Multiple EGF-like domain protein 7
TTDC00238	Synonyms	Multiple epidermal growth factor-like domain protein 7
TTDC00238	Synonyms	NOTCH4-like protein
TTDC00238	Synonyms	VE-statin
TTDC00238	Synonyms	Vascular endothelial statin
TTDC00238	Synonyms	ZNEU1
TTDC00238	Disease	Cancers
TTDC00238	Function	Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth facto
TTDC00238	Sequence	MRGSQEVLLMWLLVLAVGGTEHAYRPGRRVCAVRAHGDPVSESFVQRVYQPFLTTCDGHRACSTYRTIYRTAYRRSPGLA
TTDC00238	Target Validation	TTDC00238
TTDC00238	Drug(s)	Anti-EGFL7
TTDC00238	Drug(s)	RG7414
TTDC00238	Antibody	Anti-EGFL7
TTDC00239	UniProt ID	Q9UGM1
TTDC00239	Name	Neuronal acetylcholine receptor subunit alpha-9
TTDC00239	Type of target	Clinical trial target
TTDC00239	Synonyms	NACHR alpha 9
TTDC00239	Synonyms	Nicotinic acetylcholine receptor subunit alpha 9
TTDC00239	Disease	Analgesics
TTDC00239	Disease	Neuropathic pain
TTDC00239	Function	Ionotropic receptor with a probable role in the modulation of auditory stimuli.
TTDC00239	Sequence	MNWSHSCISFCWIYFAASRLRAAETADGKYAQKLFNDLFEDYSNALRPVEDTDKVLNVTLQITLSQIKDMDERNQILTAY
TTDC00239	Target Validation	TTDC00239
TTDC00239	Drug(s)	ACV-1
TTDC00239	Antagonist	ACV-1
TTDC00239	Multitarget	ACV-1
TTDC00240	UniProt ID	Q9NY47
TTDC00240	Name	Voltage-dependent calcium channel subunit alpha-2/delta-2
TTDC00240	Type of target	Clinical trial target
TTDC00240	Synonyms	Voltage-dependent calcium channel subunit alpha-2-2
TTDC00240	Synonyms	Voltage-dependent calcium channel subunit delta-2
TTDC00240	Synonyms	Voltage-gated calcium channel subunit alpha-2/delta-2
TTDC00240	Disease	Analgesics
TTDC00240	Disease	Pain
TTDC00240	Disease	Postherpetic neuralgia
TTDC00240	Function	The alpha-2/delta subunit of voltage-dependent calcium channels regulates calciu
TTDC00240	Sequence	MAVPARTCGASRPGPARTARPWPGCGPHPGPGTRRPTSGPPRPLWLLLPLLPLLAAPGASAYSFPQQHTMQHWARRLEQE
TTDC00240	Pathway	Cardiac muscle contraction
TTDC00240	Pathway	MAPK signaling pathway
TTDC00240	Target Validation	TTDC00240
TTDC00240	Drug(s)	Gabapentin ER
TTDC00240	Inhibitor	3-Aminomethyl-5-methyl-hexanoic acid
TTDC00240	Inhibitor	PD-144550
TTDC00240	Blocker	Gabapentin ER
TTDC00241	UniProt ID	Q9NX09
TTDC00241	Name	mRNA of HIF-1 responsive protein RTP801
TTDC00241	Type of target	Clinical trial target
TTDC00241	Synonyms	DNA-damage-inducible transcript 4 protein
TTDC00241	Synonyms	Protein regulated in development and DNA damage response 1
TTDC00241	Synonyms	REDD-1
TTDC00241	Disease	Age-Related Macular Degeneration
TTDC00241	Disease	Diabetic Macular Degeneration
TTDC00241	Function	Inhibits cell growth by regulating the FRAP1 pathway upstream of the TSC1-TSC2 c
TTDC00241	Sequence	MPSLWDRFSSSSTSSSPSSLPRTPTPDRPPRSAWGSATREEGFDRSTSLESSDCESLDSSNSGFGPEEDTAYLDGVSLPD
TTDC00241	Pathway	mTOR signaling pathway
TTDC00241	Target Validation	TTDC00241
TTDC00241	Drug(s)	PF-4523655
TTDC00241	siRNA	PF-4523655
TTDC00242	UniProt ID	Q9GZZ6
TTDC00242	Name	Neuronal acetylcholine receptor subunit alpha-10
TTDC00242	Type of target	Clinical trial target
TTDC00242	Synonyms	NACHR alpha 10
TTDC00242	Synonyms	Nicotinic acetylcholine receptor subunit alpha 10
TTDC00242	Disease	Analgesics
TTDC00242	Disease	Neuropathic pain
TTDC00242	Function	Ionotropic receptor with a probable role in the modulation of auditory stimuli.
TTDC00242	Sequence	MGLRSHHLSLGLLLLFLLPAECLGAEGRLALKLFRDLFANYTSALRPVADTDQTLNVTLEVTLSQIIDMDERNQVLTLYL
TTDC00242	Target Validation	TTDC00242
TTDC00242	Drug(s)	ACV-1
TTDC00242	Antagonist	ACV-1
TTDC00242	Multitarget	ACV-1
TTDC00243	UniProt ID	Q96S37
TTDC00243	Name	Solute carrier family 22 member 12
TTDC00243	Type of target	Clinical trial target
TTDC00243	Synonyms	Organic anion transporter 4-like protein
TTDC00243	Synonyms	RST
TTDC00243	Synonyms	Renal-specific transporter
TTDC00243	Synonyms	Urate anion exchanger 1
TTDC00243	Disease	Gout
TTDC00243	Function	Required for efficient urate re-absorption in the kidney. Regulates blood urate
TTDC00243	Sequence	MAFSELLDLVGGLGRFQVLQTMALMVSIMWLCTQSMLENFSAAVPSHRCWAPLLDNSTAQASILGSLSPEALLAISIPPG
TTDC00243	Target Validation	TTDC00243
TTDC00243	Drug(s)	Lesinurad
TTDC00243	Drug(s)	RDEA 594
TTDC00243	Drug(s)	RDEA3170
TTDC00243	Inhibitor	MORIN
TTDC00243	Blocker	RDEA 594
TTDC00244	UniProt ID	Q92843
TTDC00244	Name	Bcl-2-like protein 2
TTDC00244	Type of target	Clinical trial target
TTDC00244	Synonyms	Apoptosis regulator Bcl-W
TTDC00244	Synonyms	Bcl2-L-2
TTDC00244	Disease	Chronic lymphocytic leukemia
TTDC00244	Disease	Hematologic malignancies
TTDC00244	Disease	Lymphoid malignancies
TTDC00244	Disease	Small cell lung cancer
TTDC00244	Function	Promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates surviva
TTDC00244	Sequence	MATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRTFSDLAAQLHVTPGSAQQRFT
TTDC00244	PDB Structure	1MK3; 1O0L; 1ZY3
TTDC00244	Target Validation	TTDC00244
TTDC00244	Drug(s)	ABT-263
TTDC00244	Inhibitor	ABT-263
TTDC00244	Multitarget	ABT-263
TTDC00245	UniProt ID	Q8TBC4
TTDC00245	Name	NEDD8-activating enzyme E1 catalytic subunit
TTDC00245	Type of target	Clinical trial target
TTDC00245	Synonyms	NEDD8-activating enzyme E1C
TTDC00245	Synonyms	Ubiquitin-activating enzyme 3
TTDC00245	Synonyms	Ubiquitin-activating enzyme E1C
TTDC00245	Synonyms	Ubiquitin-like modifier-activating enzyme 3
TTDC00245	Disease	Advanced malignancies
TTDC00245	Function	Catalytic subunit of the dimeric UBA3-NAE1 E1 enzyme. E1 activates NEDD8 by firs
TTDC00245	Sequence	MADGEEPEKKRRRIEELLAEKMAVDGGCGDTGDWEGRWNHVKKFLERSGPFTHPDFEPSTESLQFLLDTCKVLVIGAGGL
TTDC00245	PDB Structure	1R4M; 1R4N; 2NVU; 3DBR; 3FN1
TTDC00245	Pathway	Ubiquitin mediated proteolysis
TTDC00245	EC Number	EC 6.3.2.-
TTDC00245	Target Validation	TTDC00245
TTDC00245	Drug(s)	MLN4924
TTDC00245	Inhibitor	MLN4924
TTDC00246	UniProt ID	Q7L0J3
TTDC00246	Name	Synaptic vesicle glycoprotein 2A
TTDC00246	Type of target	Clinical trial target
TTDC00246	Disease	Epilepsy
TTDC00246	Function	Plays a role in the control of regulated secretion in neural and endocrine cells
TTDC00246	Sequence	MEEGFRDRAAFIRGAKDIAKEVKKHAAKKVVKGLDRVQDEYSRRSYSRFEEEDDDDDFPAPSDGYYRGEGTQDEEEGGAS
TTDC00246	Pathway	ECM-receptor interaction
TTDC00246	Target Validation	TTDC00246
TTDC00246	Drug(s)	Brivaracetam
TTDC00246	Drug(s)	Seletracetam
TTDC00246	Inhibitor	Brivaracetam
TTDC00246	Binder	Seletracetam
TTDC00247	UniProt ID	Q15389
TTDC00247	Name	Angiopoietin-1
TTDC00247	Type of target	Clinical trial target
TTDC00247	Synonyms	ANG-1
TTDC00247	Disease	Cancers
TTDC00247	Function	Binds and activates TIE2 receptor by inducing its tyrosine phosphorylation. Impl
TTDC00247	Sequence	MTVFLSFAFLAAILTHIGCSNQRRSPENSGRRYNRIQHGQCAYTFILPEHDGNCRESTTDQYNTNALQRDAPHVEPDFSS
TTDC00247	Target Validation	TTDC00247
TTDC00247	Drug(s)	AMG 386
TTDC00247	Inhibitor	AMG 386
TTDC00247	Multitarget	AMG 386
TTDC00248	UniProt ID	Q13477
TTDC00248	Name	Mucosal addressin cell adhesion molecule 1
TTDC00248	Type of target	Clinical trial target
TTDC00248	Synonyms	MAdCAM-1
TTDC00248	Synonyms	hMAdCAM-1
TTDC00248	Disease	Inflammatory bowel disease
TTDC00248	Function	Cell adhesion leukocyte receptor expressed by mucosal venules, helps to direct l
TTDC00248	Sequence	MDFGLALLLAGLLGLLLGQSLQVKPLQVEPPEPVVAVALGASRQLTCRLACADRGASVQWRGLDTSLGAVQSDTGRSVLT
TTDC00248	PDB Structure	1BQS; 1GSM
TTDC00248	Pathway	Cell adhesion molecules (CAMs)
TTDC00248	Target Validation	TTDC00248
TTDC00248	Drug(s)	PF-00547659
TTDC00248	Antibody	PF-00547659
TTDC00249	UniProt ID	P55786
TTDC00249	Name	Puromycin-sensitive aminopeptidase
TTDC00249	Type of target	Clinical trial target
TTDC00249	Synonyms	PSA
TTDC00249	Disease	Solid Tumors
TTDC00249	Function	Aminopeptidase with broad substrate specificity to several peptides. Involved in
TTDC00249	Sequence	MWLAAAAPSLARRLLFLGPPPPPLLLLVFSRSSRRRLHSLGLAAMPEKRPFERLPADVSPINYSLCLKPDLLDFTFEGKL
TTDC00249	PDB Structure	2GAQ; 2NPU; 3FAP; 2FAP
TTDC00249	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00249	Pathway	Acute myeloid leukemia
TTDC00249	Pathway	Adipocytokine signaling pathway
TTDC00249	Pathway	ErbB signaling pathway
TTDC00249	Pathway	Glioma
TTDC00249	Pathway	Insulin signaling pathway
TTDC00249	Pathway	Pathways in cancer
TTDC00249	Pathway	Prostate cancer
TTDC00249	Pathway	Type II diabetes mellitus
TTDC00249	Pathway	mTOR signaling pathway
TTDC00249	EC Number	EC 3.4.11.-
TTDC00249	Target Validation	TTDC00249
TTDC00249	Drug(s)	CHR-2797
TTDC00249	Inhibitor	CHR-2797
TTDC00250	UniProt ID	P42261
TTDC00250	Name	Glutamate receptor 1
TTDC00250	Type of target	Clinical trial target
TTDC00250	Synonyms	AMPA-selective glutamate receptor 1
TTDC00250	Synonyms	GluR-1
TTDC00250	Synonyms	GluR-A
TTDC00250	Synonyms	GluR-K1
TTDC00250	Synonyms	Glutamate receptor ionotropic, AMPA 1
TTDC00250	Disease	Schizophrenia
TTDC00250	Function	Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitte
TTDC00250	Sequence	MQHIFAFFCTGFLGAVVGANFPNNIQIGGLFPNQQSQEHAAFRFALSQLTEPPKLLPQIDIVNISDSFEMTYRFCSQFSK
TTDC00250	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDC00250	Pathway	Long-term depression
TTDC00250	Pathway	Long-term potentiation
TTDC00250	Pathway	Neuroactive ligand-receptor interaction
TTDC00250	Target Validation	TTDC00250
TTDC00250	Drug(s)	Farampator
TTDC00250	Inhibitor	(R,S)-AMPA
TTDC00250	Inhibitor	(S)-AMPA
TTDC00250	Inhibitor	(S)-WILLARDIINE
TTDC00250	Inhibitor	6-cyano-7-nitroquinoxaline-2,3-dione
TTDC00250	Inhibitor	7-chloro-3-hydroxyquinazoline-2,4-dione
TTDC00250	Inhibitor	Argiotoxin-636
TTDC00250	Inhibitor	DNQX
TTDC00250	Inhibitor	GLUTAMATE
TTDC00250	Inhibitor	GYKI-52466
TTDC00250	Inhibitor	GYKI-53655
TTDC00250	Inhibitor	KAINATE
TTDC00250	Inhibitor	LY-293559
TTDC00250	Inhibitor	N-(4-hydroxyphenylpropanyl)-spermine
TTDC00250	Inhibitor	NBQX
TTDC00250	Inhibitor	Philanthotoxin-343
TTDC00250	Inhibitor	Piriqualone
TTDC00250	Inhibitor	RPR-118723
TTDC00250	Inhibitor	YM-90K
TTDC00250	Inhibitor	ZONAMPANEL
TTDC00250	Binder	Farampator
TTDC00251	UniProt ID	P40933
TTDC00251	Name	Interleukin-15
TTDC00251	Type of target	Clinical trial target
TTDC00251	Synonyms	IL-15
TTDC00251	Disease	Rheumatoid arthritis
TTDC00251	Function	Cytokine that stimulates the proliferation of T-lymphocytes. Stimulation by IL-1
TTDC00251	Sequence	MRISKPHLRSISIQCYLCLLLNSHFLTEAGIHVFILGCFSAGLPKTEANWVNVISDLKKIEDLIQSMHIDATLYTESDVH
TTDC00251	PDB Structure	2Z3Q; 2Z3R
TTDC00251	Pathway	Cytokine-cytokine receptor interaction
TTDC00251	Pathway	Jak-STAT signaling pathway
TTDC00251	Target Validation	TTDC00251
TTDC00251	Drug(s)	AMG 714
TTDC00251	Drug(s)	AMG-714
TTDC00251	Inhibitor	AMG 714
TTDC00251	Antibody	AMG-714
TTDC00252	UniProt ID	P36955
TTDC00252	Name	Pigment epithelium-derived factor
TTDC00252	Type of target	Clinical trial target
TTDC00252	Synonyms	EPC-1
TTDC00252	Synonyms	PEDF
TTDC00252	Synonyms	Serpin-F1
TTDC00252	Disease	Exudative age-related macular degeneration
TTDC00252	Function	Neurotrophic protein; induces extensive neuronal differentiation in retinoblasto
TTDC00252	Sequence	MQALVLLLCIGALLGHSSCQNPASPPEEGSPDPDSTGALVEEEDPFFKVPVNKLAAAVSNFGYDLYRVRSSMSPTTNVLL
TTDC00252	PDB Structure	1IMV
TTDC00252	Target Validation	TTDC00252
TTDC00252	Drug(s)	AdPEDR
TTDC00252	Inhibitor	AdPEDR
TTDC00253	UniProt ID	P35346
TTDC00253	Name	Somatostatin receptor type 5
TTDC00253	Type of target	Clinical trial target
TTDC00253	Synonyms	SS5R
TTDC00253	Disease	Cushing's disease
TTDC00253	Function	Receptor for somatostatin 28 and to a lesser extent for somatostatin-14. The act
TTDC00253	Sequence	MEPLFPASTPSWNASSPGAASGGGDNRTLVGPAPSAGARAVLVPVLYLLVCAAGLGGNTLVIYVVLRFAKMKTVTNIYIL
TTDC00253	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00253	Pathway	Neuroactive ligand-receptor interaction
TTDC00253	Target Validation	TTDC00253
TTDC00253	Drug(s)	Pasireotide
TTDC00253	Inhibitor	CytotoxinPeptide Conjugate
TTDC00253	Inhibitor	D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Asp-NH2
TTDC00253	Inhibitor	Des-AA1,2,4,12,13-[D-Trp8]SRIF
TTDC00253	Inhibitor	Des-AA1,2,4,13-[D-Trp8]SRIF
TTDC00253	Inhibitor	Des-AA1,2,4,5,13-[D-Trp8]-SRIF
TTDC00253	Inhibitor	Des-AA1,2,4,5-[D-Trp8]SRIF
TTDC00253	Inhibitor	Des-AA1,2,5,12,13-[D-Trp8]SRIF
TTDC00253	Inhibitor	Des-AA1,2,5-[D-Trp8,Tyr11]SRIF
TTDC00253	Inhibitor	Des-AA5-[D-Trp8]SRIF
TTDC00253	Inhibitor	Edotreotide
TTDC00253	Inhibitor	H-D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2
TTDC00253	Inhibitor	H-D-Phe-c[Cys-Ala-D-Trp-Lys-Thr-Cys]-Thr-NH2
TTDC00253	Inhibitor	H-DPhe-c[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-NH2
TTDC00253	Inhibitor	ODT-8
TTDC00253	Inhibitor	PTR-3046
TTDC00253	Inhibitor	Radiolabeled octreotide derivative
TTDC00253	Inhibitor	SOMATOSTATIN
TTDC00253	Inhibitor	SRIF-28
TTDC00253	Inhibitor	Somatostatin Analogue
TTDC00253	Agonist	Pasireotide
TTDC00253	Multitarget	Pasireotide
TTDC00254	UniProt ID	P32745
TTDC00254	Name	Somatostatin receptor type 3
TTDC00254	Type of target	Clinical trial target
TTDC00254	Synonyms	SS3R
TTDC00254	Synonyms	SSR-28
TTDC00254	Disease	Cushing's disease
TTDC00254	Function	Receptor for somatostatins-14 and -28. This receptor is coupled via pertussis to
TTDC00254	Sequence	MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTN
TTDC00254	Pathway	Neuroactive ligand-receptor interaction
TTDC00254	Target Validation	TTDC00254
TTDC00254	Drug(s)	Pasireotide
TTDC00254	Inhibitor	CytotoxinPeptide Conjugate
TTDC00254	Inhibitor	Des-AA1,2,4,12,13-[D-Trp8]SRIF
TTDC00254	Inhibitor	Des-AA1,2,4,13-[D-Trp8]SRIF
TTDC00254	Inhibitor	Des-AA1,2,4,5,10,12,13-[D-Trp8]SRIF
TTDC00254	Inhibitor	Des-AA1,2,4,5,13-[D-Trp8]-SRIF
TTDC00254	Inhibitor	Des-AA1,2,4,5-[D-Trp8]SRIF
TTDC00254	Inhibitor	Des-AA1,2,5,12,13-[D-Trp8,IAmp9]SRIF
TTDC00254	Inhibitor	Des-AA1,2,5,12,13-[D-Trp8]SRIF
TTDC00254	Inhibitor	Des-AA1,2,5-[D-Trp8,(NalphaMe)IAmp9]SRIF
TTDC00254	Inhibitor	Des-AA1,2,5-[D-Trp8,IAmp9,m-I-Tyr11]Cbm-SRIF
TTDC00254	Inhibitor	Des-AA1,2,5-[D-Trp8,IAmp9]SRIF CH-275
TTDC00254	Inhibitor	Des-AA1,2,5-[D-Trp8,Tyr11]SRIF
TTDC00254	Inhibitor	Des-AA1,4,5,13-[Tyr2,D-Trp8]-SRIF
TTDC00254	Inhibitor	Des-AA1,5-[Tyr2,D-Trp8,IAmp9]Cbm-SRIF
TTDC00254	Inhibitor	Des-AA5-[D-Trp8]SRIF
TTDC00254	Inhibitor	Edotreotide
TTDC00254	Inhibitor	H-D-Phe-c[Cys-Ala-D-Trp-Lys-Thr-Cys]-Thr-NH2
TTDC00254	Inhibitor	H-DPhe-c[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-NH2
TTDC00254	Inhibitor	ODT-8
TTDC00254	Inhibitor	Radiolabeled octreotide derivative
TTDC00254	Inhibitor	SOMATOSTATIN
TTDC00254	Inhibitor	SRIF-28
TTDC00254	Inhibitor	Somatostatin Analogue
TTDC00254	Agonist	Pasireotide
TTDC00254	Multitarget	Pasireotide
TTDC00255	UniProt ID	P31645
TTDC00255	Name	Sodium-dependent serotonin transporter
TTDC00255	Type of target	Clinical trial target
TTDC00255	Synonyms	5HT transporter
TTDC00255	Synonyms	5HTT
TTDC00255	Synonyms	Solute carrier family 6 member 4
TTDC00255	Disease	Schizophrenia
TTDC00255	Function	Terminates the action of serotonin by its high affinity sodium-dependent reuptak
TTDC00255	Sequence	METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTRHSIPATTTTLVAELHQGERE
TTDC00255	Target Validation	TTDC00255
TTDC00255	Drug(s)	LY367265
TTDC00255	Drug(s)	SLV-310
TTDC00255	Drug(s)	Vilazodone
TTDC00255	Drug(s)	YM-992
TTDC00255	Inhibitor	(+/-)-nantenine
TTDC00255	Inhibitor	(2R,3R)-iodoreboxetine
TTDC00255	Inhibitor	(2S,3S)-iodoreboxetine
TTDC00255	Inhibitor	(R)-DULOXETINE
TTDC00255	Inhibitor	(R)-Norfluoxetine
TTDC00255	Inhibitor	(S)-NORDULOXETINE
TTDC00255	Inhibitor	(S)-Norfluoxetine
TTDC00255	Inhibitor	(S,S)-reboxetine
TTDC00255	Inhibitor	1-(1,2-diphenylethyl)piperazine
TTDC00255	Inhibitor	1-(1,3-diphenylpropyl)piperazine
TTDC00255	Inhibitor	1-(1,4-diphenylbutan-2-yl)piperazine
TTDC00255	Inhibitor	1-benzylpiperidine hydrochloride
TTDC00255	Inhibitor	10R-hydroxylobel-7-ene
TTDC00255	Inhibitor	10R-hydroxylobelane
TTDC00255	Inhibitor	10S-hydroxylobel-7-ene
TTDC00255	Inhibitor	10S-hydroxylobelane
TTDC00255	Inhibitor	1S,2R-milnacipran
TTDC00255	Inhibitor	6-nitroquipazine
TTDC00255	Inhibitor	8R-hydroxylobel-9-ene
TTDC00255	Inhibitor	8R-hydroxylobelane
TTDC00255	Inhibitor	8S-hydroxylobel-9-ene
TTDC00255	Inhibitor	8S-hydroxylobelane
TTDC00255	Inhibitor	A-80426
TTDC00255	Inhibitor	COCAINE.HCL
TTDC00255	Inhibitor	D-166A
TTDC00255	Inhibitor	D-211A
TTDC00255	Inhibitor	D-211B
TTDC00255	Inhibitor	D-254C
TTDC00255	Inhibitor	D-257A
TTDC00255	Inhibitor	D-257C
TTDC00255	Inhibitor	DIFLUOROBENZTROPINE
TTDC00255	Inhibitor	ESCITALOPRAM OXALATE
TTDC00255	Inhibitor	FLUOXETINE HYDROCHLORIDE
TTDC00255	Inhibitor	GBR-12909
TTDC00255	Inhibitor	Irindalone
TTDC00255	Inhibitor	JNJ-28583867
TTDC00255	Inhibitor	KF-A5
TTDC00255	Inhibitor	KF-A6
TTDC00255	Inhibitor	LITOXETINE
TTDC00255	Inhibitor	LY367265
TTDC00255	Inhibitor	MDL-28618
TTDC00255	Inhibitor	METHYLENEDIOXYAMPHETAMINE
TTDC00255	Inhibitor	METHYLENEDIOXYMETHAMPHETAMINE
TTDC00255	Inhibitor	NISOXETINE
TTDC00255	Inhibitor	O-DESMETHYL TRAMADOL
TTDC00255	Inhibitor	PF-18298;PF-184298
TTDC00255	Inhibitor	PF-3409409
TTDC00255	Inhibitor	PF-526014
TTDC00255	Inhibitor	PYROVALERONE
TTDC00255	Inhibitor	QUIPAZINE
TTDC00255	Inhibitor	R-226161
TTDC00255	Inhibitor	R-NORDULOXETINE
TTDC00255	Inhibitor	RTI-219
TTDC00255	Inhibitor	S-34324
TTDC00255	Inhibitor	S33005
TTDC00255	Inhibitor	TEFLUDAZINE
TTDC00255	Inhibitor	Vilazodone
TTDC00255	Inhibitor	WIN-35065
TTDC00255	Inhibitor	WIN-35065-2
TTDC00255	Inhibitor	WIN-35066-2
TTDC00255	Inhibitor	WIN_35428
TTDC00255	Inhibitor	YM-992
TTDC00255	Inhibitor	ZIMELIDINE
TTDC00255	Inhibitor	para-Methoxyamphetamine
TTDC00255	Inhibitor	para-chloroamphetamine
TTDC00255	Antagonist	4-Methoxyamphetamine
TTDC00255	Blocker	SLV-310
TTDC00255	Modulator	MMDA
TTDC00255	Multitarget	SLV-310
TTDC00256	UniProt ID	P30291
TTDC00256	Name	Wee1-like protein kinase
TTDC00256	Type of target	Clinical trial target
TTDC00256	Synonyms	WEE1hu
TTDC00256	Synonyms	Wee1A kinase
TTDC00256	Disease	Cancer
TTDC00256	Function	May act as a negative regulator of entry into mitosis (G2 to M transition) by pr
TTDC00256	Sequence	MSFLSRQQPPPPRRAGAACTLRQKLIFSPCSDCEEEEEEEEEEGSGHSTGEDSAFQEPDSPLPPARSPTEPGPERRRSPG
TTDC00256	PDB Structure	1X8B; 2IN6; 2Z2W; 3CQE; 3CR0
TTDC00256	Pathway	Cell cycle
TTDC00256	EC Number	EC 2.7.10.2
TTDC00256	Target Validation	TTDC00256
TTDC00256	Drug(s)	MK-1775
TTDC00256	Inhibitor	9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione
TTDC00256	Inhibitor	MK-1775
TTDC00257	UniProt ID	P26992
TTDC00257	Name	Ciliary neurotrophic factor receptor alpha
TTDC00257	Type of target	Clinical trial target
TTDC00257	Synonyms	CNTFR alpha
TTDC00257	Disease	Obesity
TTDC00257	Function	Binds to CNTF. The alpha chain provides the receptor specificity.
TTDC00257	Sequence	MAAPVPWACCAVLAAAAAVVYAQRHSPQEAPHVQYERLGSDVTLPCGTANWDAAVTWRVNGTDLAPDLLNGSQLVLHGLE
TTDC00257	PDB Structure	1UC6
TTDC00257	Pathway	Cytokine-cytokine receptor interaction
TTDC00257	Pathway	Jak-STAT signaling pathway
TTDC00257	Target Validation	TTDC00257
TTDC00257	Drug(s)	CNTF
TTDC00257	Drug(s)	PegCNTF
TTDC00257	Agonist	CNTF
TTDC00257	Agonist	PegCNTF
TTDC00258	UniProt ID	P21453
TTDC00258	Name	Sphingosine 1-phosphate receptor 1
TTDC00258	Type of target	Successful target
TTDC00258	Synonyms	Endothelial differentiation G-protein coupled receptor 1
TTDC00258	Synonyms	S1P receptor 1
TTDC00258	Synonyms	S1P receptor Edg-1
TTDC00258	Synonyms	S1P1
TTDC00258	Synonyms	Sphingosine 1-phosphate receptor Edg-1
TTDC00258	Disease	Autoimmune diseases
TTDC00258	Function	Receptor for the lysosphingolipid sphingosine 1-phosphate (S1P). S1P is a bioact
TTDC00258	Sequence	MGPTSVPLVKAHRSSVSDYVNYDIIVRHYNYTGKLNISADKENSIKLTSVVFILICCFIILENIFVLLTIWKTKKFHRPM
TTDC00258	Pathway	Neuroactive ligand-receptor interaction
TTDC00258	Target Validation	TTDC00258
TTDC00258	Drug(s)	ACT-128800
TTDC00258	Drug(s)	BAF312
TTDC00258	Drug(s)	CS-0777
TTDC00258	Drug(s)	FTY720
TTDC00258	Drug(s)	Fingolimod
TTDC00258	Drug(s)	Gilenia
TTDC00258	Drug(s)	R3477
TTDC00258	Inhibitor	(3-Tetradecylamino-cyclohexyl)-phosphonic acid
TTDC00258	Inhibitor	(3-Tetradecylamino-cyclopentyl)-phosphonic acid
TTDC00258	Inhibitor	(S)-FTY720P
TTDC00258	Inhibitor	1-(4-nonylbenzyl)azetidine-3-carboxylic acid
TTDC00258	Inhibitor	1-(4-nonylbenzyl)pyrrolidin-3-ylphosphonic acid
TTDC00258	Inhibitor	1-(4-nonylbenzyl)pyrrolidine-3-carboxylic acid
TTDC00258	Inhibitor	3-(N-alkylamino) propylphosphonic acid derivative
TTDC00258	Inhibitor	3-(tetradecylamino)propylphosphonic acid
TTDC00258	Inhibitor	3-amino-5-(4-octylphenyl)pentanoic acid
TTDC00258	Inhibitor	4-amino-6-(4-octylphenyl)hexanoic acid
TTDC00258	Inhibitor	GNF-PF-78
TTDC00258	Inhibitor	GNF-PF-826
TTDC00258	Inhibitor	Gilenia
TTDC00258	Inhibitor	[3-(4-Nonyl-benzylamino)-propyl]-phosphonic acid
TTDC00258	Inhibitor	sphingosine-1-phosphate
TTDC00258	Agonist	R3477
TTDC00258	Modulator	FTY720
TTDC00258	Modulator	Fingolimod
TTDC00259	UniProt ID	P16410
TTDC00259	Name	Cytotoxic T-lymphocyte protein 4
TTDC00259	Type of target	Successful target
TTDC00259	Synonyms	CD152
TTDC00259	Synonyms	CTLA-4
TTDC00259	Synonyms	Cytotoxic T-lymphocyte-associated antigen 4
TTDC00259	Disease	Cell Carcinoma
TTDC00259	Disease	Colorectal Cancer
TTDC00259	Disease	Gastrointestinal Cancers
TTDC00259	Disease	Melanoma
TTDC00259	Function	Possibly involved in T-cell activation. Binds to B7-1 (CD80) and B7-2 (CD86).
TTDC00259	Sequence	MACLGFQRHKAQLNLATRTWPCTLLFFLLFIPVFCKAMHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQ
TTDC00259	PDB Structure	1AH1; 1H6E; 1I85; 3BX7
TTDC00259	Pathway	Autoimmune thyroid disease
TTDC00259	Pathway	Cell adhesion molecules (CAMs)
TTDC00259	Pathway	T cell receptor signaling pathway
TTDC00259	Target Validation	TTDC00259
TTDC00259	Drug(s)	CP-675206
TTDC00259	Drug(s)	Ipilimumab
TTDC00259	Drug(s)	Tremelimumab
TTDC00259	Inhibitor	Alpha-D-Mannose
TTDC00259	Inhibitor	Fucose
TTDC00259	Antibody	CP-675206
TTDC00259	Antibody	Ipilimumab
TTDC00259	Aptamer	Del 60 tetramer
TTDC00260	UniProt ID	P13866
TTDC00260	Name	Sodium/glucose cotransporter 1
TTDC00260	Type of target	Clinical trial target
TTDC00260	Synonyms	High affinity sodium-glucose cotransporter
TTDC00260	Synonyms	Na(+)/glucose cotransporter 1
TTDC00260	Synonyms	Solute carrier family 5 member 1
TTDC00260	Disease	Diabetes
TTDC00260	Function	Actively transports glucose into cells by Na+ cotransport with a Na+ to glucose
TTDC00260	Sequence	MDSSTWSPKTTAVTRPVETHELIRNAADISIIVIYFVVVMAVGLWAMFSTNRGTVGGFFLAGRSMVWWPIGASLFASNIG
TTDC00260	Target Validation	TTDC00260
TTDC00260	Drug(s)	GSK1614235
TTDC00260	Inhibitor	10-methoxy-N(1)-methylburnamine-17-O-veratrate
TTDC00260	Inhibitor	ACEROGENIN B
TTDC00260	Inhibitor	Alstiphyllanine D
TTDC00260	Inhibitor	Alstiphyllanine E
TTDC00260	Inhibitor	Alstiphyllanine F
TTDC00260	Inhibitor	Burnamine-17-O-3',4',5'-trimethoxybenzoate
TTDC00260	Inhibitor	KURAIDIN
TTDC00260	Inhibitor	KURARINONE
TTDC00260	Inhibitor	O-spiroketal glucoside
TTDC00260	Inhibitor	PHLORIZIN
TTDC00260	Inhibitor	QCP
TTDC00260	Inhibitor	QCPac
TTDC00260	Inhibitor	QNEQCPQVSac
TTDC00260	Inhibitor	QSPac
TTDC00260	Inhibitor	acerogenin A
TTDC00260	Inhibitor	kushenol N
TTDC00260	Inhibitor	sophoraflavanone G
TTDC00260	Blocker	GSK1614235
TTDC00263	UniProt ID	P09603
TTDC00263	Name	Macrophage colony-stimulating factor 1
TTDC00263	Type of target	Clinical trial target
TTDC00263	Synonyms	CSF-1
TTDC00263	Synonyms	Lanimostim
TTDC00263	Synonyms	M-CSF
TTDC00263	Synonyms	MCSF
TTDC00263	Synonyms	Processed macrophage colony-stimulating factor 1
TTDC00263	Disease	Myelodisplastic syndrome
TTDC00263	Function	Granulocyte/macrophage colony-stimulating factors are cytokines that act in hema
TTDC00263	Sequence	MTAPGAAGRCPPTTWLGSLLLLVCLLASRSITEEVSEYCSHMIGSGHLQSLQRLIDSQMETSCQITFEFVDQEQLKDPVC
TTDC00263	PDB Structure	1HMC
TTDC00263	Pathway	Cytokine-cytokine receptor interaction
TTDC00263	Pathway	Hematopoietic cell lineage
TTDC00263	Target Validation	TTDC00263
TTDC00263	Drug(s)	ABT-869
TTDC00263	Drug(s)	Axitinib
TTDC00263	Inhibitor	ABT-869
TTDC00263	Inhibitor	Axitinib
TTDC00263	Multitarget	Axitinib
TTDC00264	UniProt ID	P02749
TTDC00264	Name	Beta-2-glycoprotein 1
TTDC00264	Type of target	Clinical trial target
TTDC00264	Synonyms	APC inhibitor
TTDC00264	Synonyms	Activated protein C-binding protein
TTDC00264	Synonyms	Anticardiolipin cofactor
TTDC00264	Synonyms	Apo-H
TTDC00264	Synonyms	Apolipoprotein H
TTDC00264	Synonyms	B2GPI
TTDC00264	Synonyms	Beta(2)GPI
TTDC00264	Synonyms	Beta-2-glycoprotein I
TTDC00264	Disease	Antiphospholipid syndrome
TTDC00264	Function	Binds to various kinds of negatively charged substances such as heparin, phospho
TTDC00264	Sequence	MISPVLILFSSFLCHVAIAGRTCPKPDDLPFSTVVPLKTFYEPGEEITYSCKPGYVSRGGMRKFICPLTGLWPINTLKCT
TTDC00264	PDB Structure	1C1Z; 1G4F; 1G4G; 1QUB
TTDC00264	Target Validation	TTDC00264
TTDC00264	Drug(s)	LJP-1082
TTDC00264	Inhibitor	Alpha-D-Mannose
TTDC00264	Inhibitor	LJP-1082
TTDC00265	UniProt ID	P01730
TTDC00265	Name	T-cell surface glycoprotein CD4
TTDC00265	Type of target	Clinical trial target
TTDC00265	Synonyms	CD4
TTDC00265	Synonyms	T-cell surface antigen T4/Leu-3
TTDC00265	Disease	Rheumatoid arthritis
TTDC00265	Function	Accessory protein for MHC class-II antigen/T-cell receptor interaction. May regu
TTDC00265	Sequence	MNRGVPFRHLLLVLQLALLPAATQGKKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRA
TTDC00265	PDB Structure	1CDH; 1G9N; 1OPT; 2NXZ; 3CD4
TTDC00265	Pathway	Antigen processing and presentation
TTDC00265	Pathway	Cell adhesion molecules (CAMs)
TTDC00265	Pathway	Hematopoietic cell lineage
TTDC00265	Pathway	Primary immunodeficiency
TTDC00265	Pathway	T cell receptor signaling pathway
TTDC00265	Target Validation	TTDC00265
TTDC00265	Drug(s)	Anti-CD4
TTDC00265	Drug(s)	Blinatumomab
TTDC00265	Drug(s)	TNX-355
TTDC00265	Antibody	Anti-CD4
TTDC00265	Binder	TNX-355
TTDC00265	Aptamer	CD4 specific aptamer 14
TTDC00266	UniProt ID	O14763
TTDC00266	Name	Tumor necrosis factor receptor superfamily member 10B
TTDC00266	Type of target	Clinical trial target
TTDC00266	Synonyms	CD262
TTDC00266	Synonyms	Death receptor 5
TTDC00266	Synonyms	TNF-related apoptosis-inducing ligand receptor 2
TTDC00266	Synonyms	TRAIL receptor 2
TTDC00266	Synonyms	TRAIL-R2
TTDC00266	Disease	Colorectal cancer
TTDC00266	Function	Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recru
TTDC00266	Sequence	MEQRGQNAPAASGARKRHGPGPREARGARPGPRVPKTLVLVVAAVLLLVSAESALITQQDLAPQQRAAPQQKRSSPSEGL
TTDC00266	PDB Structure	1D0G; 1DU3; 2H9G
TTDC00266	Pathway	Apoptosis
TTDC00266	Pathway	Cytokine-cytokine receptor interaction
TTDC00266	Pathway	Natural killer cell mediated cytotoxicity
TTDC00266	Pathway	p53 signaling pathway
TTDC00266	Target Validation	TTDC00266
TTDC00266	Drug(s)	Apomab
TTDC00266	Drug(s)	Conatumumab
TTDC00266	Drug(s)	Dulanermin
TTDC00266	Drug(s)	RhApo2L/TRAIL
TTDC00266	Agonist	Apomab
TTDC00266	Agonist	Conatumumab
TTDC00266	Agonist	Dulanermin
TTDC00266	Agonist	RhApo2L/TRAIL
TTDC00266	Multitarget	Dulanermin
TTDC00266	Multitarget	RhApo2L/TRAIL
TTDC00267	UniProt ID	O00220
TTDC00267	Name	Tumor necrosis factor receptor superfamily member 10A
TTDC00267	Type of target	Clinical trial target
TTDC00267	Synonyms	CD261
TTDC00267	Synonyms	Death receptor 4
TTDC00267	Synonyms	TNF-related apoptosis-inducing ligand receptor 1
TTDC00267	Synonyms	TRAIL receptor 1
TTDC00267	Synonyms	TRAIL-R1
TTDC00267	Disease	Cancers
TTDC00267	Function	Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recru
TTDC00267	Sequence	MAPPPARVHLGAFLAVTPNPGSAASGTEAAAATPSKVWGSSAGRIEPRGGGRGALPTSMGQHGPSARARAGRAPGPRPAR
TTDC00267	Pathway	Apoptosis
TTDC00267	Pathway	Cytokine-cytokine receptor interaction
TTDC00267	Pathway	Natural killer cell mediated cytotoxicity
TTDC00267	Target Validation	TTDC00267
TTDC00267	Drug(s)	Dulanermin
TTDC00267	Drug(s)	RhApo2L/TRAIL
TTDC00267	Agonist	Dulanermin
TTDC00267	Agonist	RhApo2L/TRAIL
TTDC00267	Multitarget	Dulanermin
TTDC00267	Multitarget	RhApo2L/TRAIL
TTDC00268	Name	mRNA of TNF alpha
TTDC00268	Type of target	Discontinued target
TTDC00268	Disease	Inflammatory bowel disease
TTDC00268	Disease	Psoriasis
TTDC00268	Disease	Rheumatoid arthritis, unspecified
TTDC00268	Target Validation	TTDC00268
TTDC00268	Drug(s)	ISIS 104838
TTDC00268	Antisense	ISIS 104838
TTDC00268	Antisense	ISIS 25302
TTDC00269	UniProt ID	P04792
TTDC00269	Name	mRNA of Heat shock 27 kDa protein
TTDC00269	Type of target	Clinical trial target
TTDC00269	Synonyms	28 kDa heat shock protein
TTDC00269	Synonyms	Estrogen-regulated 24 kDa protein
TTDC00269	Synonyms	HSP 27
TTDC00269	Synonyms	Heat shock protein 27
TTDC00269	Synonyms	HspB1
TTDC00269	Synonyms	SRP27
TTDC00269	Synonyms	Stress-responsive protein 27
TTDC00269	Disease	Colon adenocarcinoma
TTDC00269	Function	Involved in stress resistance and actin organization.
TTDC00269	Sequence	MTERRVPFSLLRGPSWDPFRDWYPHSRLFDQAFGLPRLPEEWSQWLGGSSWPGYVRPLPPAAIESPAVAAPAYSRALSRQ
TTDC00269	Pathway	MAPK signaling pathway
TTDC00269	Pathway	VEGF signaling pathway
TTDC00269	Target Validation	TTDC00269
TTDC00269	Drug(s)	OGX-427
TTDC00269	Inhibitor	BIRB796
TTDC00269	Inhibitor	SB-242235
TTDC00269	Antisense	OGX-427
TTDC00269	Antisense	OGX-427 + Paclitaxel
TTDC00270	Name	HCV internal ribosome entry site (IRES)
TTDC00270	Type of target	Discontinued target
TTDC00270	Disease	Hepatitis C
TTDC00270	Target Validation	TTDC00270
TTDC00270	Drug(s)	ISIS 14803
TTDC00270	Inhibitor	Catalytic ribozymes
TTDC00270	Antisense	Antisense molecules
TTDC00270	Antisense	ISIS 14803
TTDC00271	UniProt ID	P01106
TTDC00271	Name	Myc proto-oncogene protein
TTDC00271	Type of target	Clinical trial target
TTDC00271	Synonyms	C-myc
TTDC00271	Synonyms	C-myc oncogene
TTDC00271	Disease	Advanced melanoma
TTDC00271	Disease	Cancer, unspecific
TTDC00271	Disease	Hepatocellular carcinoma
TTDC00271	Disease	Restenosis
TTDC00271	Function	Participates in the regulation of gene transcription. Binds dna both in a non-sp
TTDC00271	Sequence	MPLNVSFTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPAPSEDIWKKFELLPTPPLSPSRRSGLCSPSYVAVTPF
TTDC00271	PDB Structure	1A93; 1EE4; 1MV0; 1NKP; 2A93
TTDC00271	Pathway	Acute myeloid leukemia
TTDC00271	Pathway	Bladder cancer
TTDC00271	Pathway	Chronic myeloid leukemia
TTDC00271	Pathway	Colorectal cancer
TTDC00271	Pathway	Endometrial cancer
TTDC00271	Pathway	ErbB signaling pathway
TTDC00271	Pathway	Jak-STAT signaling pathway
TTDC00271	Pathway	MAPK signaling pathway
TTDC00271	Pathway	Pathways in cancer
TTDC00271	Pathway	Small cell lung cancer
TTDC00271	Pathway	TGF-beta signaling pathway
TTDC00271	Pathway	Thyroid cancer
TTDC00271	Pathway	Wnt signaling pathway
TTDC00271	Target Validation	TTDC00271
TTDC00271	Drug(s)	AVI4126
TTDC00271	Inhibitor	TWS-119
TTDC00271	Antisense	AVI4126
TTDC00272	UniProt ID	P61812
TTDC00272	Name	Transforming growth factor beta 2
TTDC00272	Type of target	Clinical trial target
TTDC00272	Synonyms	BSC-1 cell growth inhibitor
TTDC00272	Synonyms	Cetermin
TTDC00272	Synonyms	G-TSF
TTDC00272	Synonyms	Glioblastoma-derived T-cell suppressor factor
TTDC00272	Synonyms	Polyergin
TTDC00272	Synonyms	TGF-beta 2
TTDC00272	Disease	Cataract
TTDC00272	Disease	Post-operative scarring in patients undergoing surgery for glaucoma (trabulectom
TTDC00272	Sequence	MHYCVLSAFLILHLVTVALSLSTCSTLDMDQFMRKRIEAIRGQILSKLKLTSPPEDYPEPEEVPPEVISIYNSTRDLLQE
TTDC00272	PDB Structure	1TFG; 2TGI
TTDC00272	BioChemical Class	Growth factor
TTDC00272	Target Validation	TTDC00272
TTDC00272	Drug(s)	AP12009
TTDC00272	Antisense	AP12009
TTDC00272	Antibody	Lerdelimumab
TTDC00273	UniProt ID	O15392
TTDC00273	Name	Baculoviral IAP repeat-containing protein 5
TTDC00273	Type of target	Clinical trial target
TTDC00273	Synonyms	Apoptosis inhibitor 4
TTDC00273	Synonyms	Apoptosis inhibitor survivin
TTDC00273	Synonyms	Survivin
TTDC00273	Disease	Astrocytic tumors
TTDC00273	Disease	B-cell lymphoma
TTDC00273	Disease	Brain tumors
TTDC00273	Disease	Cancer, unspecific
TTDC00273	Disease	Gastric cancer
TTDC00273	Disease	Inflammatory diseases
TTDC00273	Disease	Lung cancer
TTDC00273	Disease	Melanoma
TTDC00273	Disease	Mesothelioma
TTDC00273	Disease	Non-Hodgkin's lymphoma, unspecified type
TTDC00273	Disease	Prostate cancer (androgen-independent)
TTDC00273	Disease	Prostate carcinoma
TTDC00273	Function	May play a role in neoplasia. May counteract a default induction of apoptosis in
TTDC00273	Sequence	MGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKH
TTDC00273	PDB Structure	1E31; 1F3H; 1XOX; 2QFA; 2RAW; 2RAX
TTDC00273	Pathway	Colorectal cancer
TTDC00273	Pathway	Pathways in cancer
TTDC00273	Target Validation	TTDC00273
TTDC00273	Drug(s)	DPX-Survivac
TTDC00273	Drug(s)	Terameprocol
TTDC00273	Inhibitor	Terameprocol
TTDC00273	Multitarget	Terameprocol
TTDC00273	Vaccine	DPX-Survivac
TTDC00274	Name	mRNA of HIV Tar and Tat/Rev
TTDC00274	Type of target	Clinical trial target
TTDC00274	Disease	AIDS
TTDC00274	Target Validation	TTDC00274
TTDC00274	Drug(s)	HGTV43
TTDC00274	Antisense	HGTV43
TTDC00275	Name	HCV genome conserved portion (unspecified)
TTDC00275	Type of target	Clinical trial target
TTDC00275	Disease	Hepatitis C
TTDC00275	Target Validation	TTDC00275
TTDC00275	Drug(s)	AVI-4065
TTDC00275	Drug(s)	Merck drug
TTDC00275	Antisense	AVI-4065
TTDC00275	Antisense	Merck drug
TTDC00277	Name	mRNA of E1 region of human papillomavirus
TTDC00277	Type of target	Clinical trial target
TTDC00277	Disease	Cancer
TTDC00277	Target Validation	TTDC00277
TTDC00277	Drug(s)	MBI 1121
TTDC00277	Antisense	MBI 1121
TTDC00278	Name	mRNA of Inflammatory cytokines
TTDC00278	Type of target	Clinical trial target
TTDC00278	Disease	Asthma
TTDC00278	Target Validation	TTDC00278
TTDC00278	Drug(s)	TPI ASM8
TTDC00278	Antisense	TPI ASM8
TTDC00279	UniProt ID	P03349
TTDC00279	UniProt ID	P15130
TTDC00279	Name	mRNA of respiratory syncytial virus nucleocapsid protein
TTDC00279	Type of target	Clinical trial target
TTDC00279	Synonyms	N structural protein
TTDC00279	Synonyms	NC
TTDC00279	Disease	Viral infection, unspecified
TTDC00279	Function	Major structural component of virions that associates with genomic rna to form a
TTDC00279	Sequence	MGARASVLSGGELDKWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGLLETSEGCRQILGQLQPSLQTGSEELRSLYN
TTDC00279	BioChemical Class	Zinc-finger
TTDC00279	Target Validation	TTDC00279
TTDC00279	Drug(s)	ALN-RSV01
TTDC00279	siRNA	ALN-RSV01
TTDC00280	UniProt ID	P98170
TTDC00280	Name	mRNA of Inhibitor of apoptosis protein
TTDC00280	Type of target	Clinical trial target
TTDC00280	Synonyms	Baculoviral IAP repeat-containing protein 4
TTDC00280	Synonyms	HILP
TTDC00280	Synonyms	IAP-like protein
TTDC00280	Synonyms	Inhibitor of apoptosis protein 3
TTDC00280	Synonyms	X-linked IAP
TTDC00280	Synonyms	X-linked inhibitor of apoptosis
TTDC00280	Synonyms	X-linked inhibitor of apoptosis protein
TTDC00280	Synonyms	XIAP
TTDC00280	Disease	Hepatocellular carcinoma
TTDC00280	Disease	Neoplasms
TTDC00280	Disease	Ovarian cancer
TTDC00280	Function	Apoptotic suppressor. Inhibitor of caspase-3, -7 and -9.
TTDC00280	Sequence	MTFNSFEGSKTCVPADINKEEEFVEEFNRLKTFANFPSGSPVSASTLARAGFLYTGEGDTVRCFSCHAAVDRWQYGDSAV
TTDC00280	PDB Structure	1G3F; 1KMC; 1NW9; 1TFQ; 1TFT; 2ECG; 2JK7; 2OPY
TTDC00280	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDC00280	Pathway	Apoptosis
TTDC00280	Pathway	Focal adhesion
TTDC00280	Pathway	Pathways in cancer
TTDC00280	Pathway	Small cell lung cancer
TTDC00280	Pathway	Ubiquitin mediated proteolysis
TTDC00280	Target Validation	TTDC00280
TTDC00280	Drug(s)	AEG35156
TTDC00280	Inhibitor	ARPFAQK-FAM
TTDC00280	Inhibitor	AVPIAQKSEK-FAM
TTDC00280	Inhibitor	EMBELIN
TTDC00280	Inhibitor	SM-122
TTDC00280	Inhibitor	SM-131
TTDC00280	Inhibitor	SM-337
TTDC00280	siRNA	AEG35156
TTDC00281	UniProt ID	P27448
TTDC00281	Name	MARK3
TTDC00281	Type of target	Clinical trial target
TTDC00281	Synonyms	C-TAK1
TTDC00281	Synonyms	Cdc25C-associated protein kinase 1
TTDC00281	Synonyms	MAP/microtubule affinity-regulating kinase 3
TTDC00281	Synonyms	Protein kinase STK10)
TTDC00281	Synonyms	Ser/Thr protein kinase PAR-1
TTDC00281	Synonyms	Serine/threonine-protein kinase p78
TTDC00281	Synonyms	cTAK1
TTDC00281	Disease	Leukaemia
TTDC00281	Disease	RCC
TTDC00281	Function	Involved in the specific phosphorylation of microtubule-associated proteins for
TTDC00281	Sequence	MSTRTPLPTVNERDTENHTSHGDGRQEVTSRTSRSGARCRNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGR
TTDC00281	PDB Structure	2QNJ; 3FE3
TTDC00281	EC Number	EC 2.7.11.1
TTDC00281	Target Validation	TTDC00281
TTDC00281	Drug(s)	7-hydroxystaurosporine
TTDC00281	Inhibitor	7-hydroxystaurosporine
TTDC00281	Multitarget	7-hydroxystaurosporine
TTDC00282	Name	mRNA of Integrin alpha V
TTDC00282	Type of target	Clinical trial target
TTDC00282	Disease	Medulloblastoma
TTDC00282	Target Validation	TTDC00282
TTDC00282	Drug(s)	TV-1102
TTDC00282	Antisense	TV-1102
TTDC00283	Name	mRNA of HIV-1 envelope protein
TTDC00283	Type of target	Clinical trial target
TTDC00283	Disease	HIV infection
TTDC00283	Target Validation	TTDC00283
TTDC00283	Drug(s)	VRX496
TTDC00283	Antisense	VRX496
TTDC00284	Name	mRNA of HIV reverse transcriptase
TTDC00284	Type of target	Clinical trial target
TTDC00284	Disease	HIV infection
TTDC00284	Target Validation	TTDC00284
TTDC00284	Drug(s)	Antisense TAR and RevM10
TTDC00284	Antisense	Antisense TAR and RevM10
TTDC00284	Multitarget	Antisense TAR and RevM10
TTDC00285	Name	mRNA of Survivin
TTDC00285	Type of target	Clinical trial target
TTDC00285	Disease	Cancers
TTDC00285	Target Validation	TTDC00285
TTDC00285	Drug(s)	EZN-3042
TTDC00285	Drug(s)	LY2181308
TTDC00285	Antisense	EZN-3042
TTDC00285	Antisense	ISIS 23705
TTDC00285	Antisense	ISIS 23707
TTDC00285	Antisense	ISIS 23718
TTDC00285	Antisense	ISIS 23722
TTDC00285	Antisense	LY2181308
TTDC00285	siRNA	ISIS 341881
TTDC00285	siRNA	ISIS 343867
TTDC00286	Name	mRNA of Glucagon receptor
TTDC00286	Type of target	Clinical trial target
TTDC00286	Disease	Type 2 diabetes
TTDC00286	Target Validation	TTDC00286
TTDC00286	Drug(s)	ISIS 325568
TTDC00286	Drug(s)	ISIS-GCGR
TTDC00286	Antisense	ISIS 325568
TTDC00286	Antisense	ISIS-GCGR
TTDC00287	Name	mRNA of PKC-alpha
TTDC00287	Type of target	Discontinued target
TTDC00287	Disease	Cancers
TTDC00287	Target Validation	TTDC00287
TTDC00287	Drug(s)	Affinitak
TTDC00287	Antisense	Affinitak
TTDC00287	Antisense	Affinitak + Cisplatin
TTDC00287	Antisense	Affinitak + Gemcitabine
TTDC00287	Antisense	ISIS 3521
TTDC00287	Antisense	ISIS 4189
TTDC00287	Antisense	ISIS 9606
TTDC00288	Name	mRNA of Vascular endothelial growth factor receptor
TTDC00288	Type of target	Clinical trial target
TTDC00288	Disease	Choroid neovascularization and age-related macular degeneration
TTDC00288	Target Validation	TTDC00288
TTDC00288	Drug(s)	AGN211745
TTDC00288	siRNA	AGN211745
TTDC00289	Name	mRNA of Vascular endothelial growth factor A165 isoform
TTDC00289	Type of target	Discontinued target
TTDC00289	Disease	Exudative age-related macular degeneration
TTDC00289	Target Validation	TTDC00289
TTDC00289	Drug(s)	Bevasiranib
TTDC00289	siRNA	Bevasiranib
TTDC00290	UniProt ID	P35916
TTDC00290	Name	Vascular endothelial growth factor receptor 3
TTDC00290	Type of target	Successful target
TTDC00290	Synonyms	Tyrosine-protein kinase receptor FLT4
TTDC00290	Synonyms	VEGFR-3
TTDC00290	Disease	Angiogenesis in metastatic and atherosclerotic processes
TTDC00290	Function	Receptor for VEGF-c, and has a tyrosine-protein kinase activity.
TTDC00290	Sequence	MQRGAALCLRLWLCLGLLDGLVSGYSMTPPTLNITEESHVIDTGDSLSISCRGQHPLEWAWPGAQEAPATGDKDSEDTGV
TTDC00290	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00290	Pathway	Cytokine-cytokine receptor interaction
TTDC00290	Pathway	Focal adhesion
TTDC00290	EC Number	EC 2.7.1.112
TTDC00290	Target Validation	TTDC00290
TTDC00290	Inhibitor	(2-Methoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine
TTDC00290	Inhibitor	(5-Phenyl-oxazol-2-yl)-m-tolyl-amine
TTDC00290	Inhibitor	2-(5-Phenyl-oxazol-2-ylamino)-benzonitrile
TTDC00290	Inhibitor	3,6-Di-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine
TTDC00290	Inhibitor	3-(5-Phenyl-oxazol-2-ylamino)-benzonitrile
TTDC00290	Inhibitor	4-(5-Phenyl-oxazol-2-ylamino)-benzenesulfonamide
TTDC00290	Inhibitor	4-Chloro-N-(2-chloro-benzoyl)-benzenesulfonamide
TTDC00290	Inhibitor	4-Chloro-N-(2-methyl-benzoyl)-benzenesulfonamide
TTDC00290	Inhibitor	4-Chloro-N-(3-chloro-benzoyl)-benzenesulfonamide
TTDC00290	Inhibitor	4-Chloro-N-(4-chloro-benzoyl)-benzenesulfonamide
TTDC00290	Inhibitor	4-Chloro-N-(4-nitro-benzoyl)-benzenesulfonamide
TTDC00290	Inhibitor	CB-676475
TTDC00290	Inhibitor	CEP-6331
TTDC00290	Inhibitor	N-(2,4-Dichloro-benzoyl)-benzenesulfonamide
TTDC00290	Inhibitor	N-(3-Bromo-benzoyl)-4-chloro-benzenesulfonamide
TTDC00290	Inhibitor	PD-173074
TTDC00290	Inhibitor	Phenyl-(5-phenyl-oxazol-2-yl)-amine
TTDC00290	Inhibitor	SU-5416
TTDC00290	Inhibitor	VATALANIB
TTDC00290	Inhibitor	[3-(5-Phenyl-oxazol-2-ylamino)-phenyl]-methanol
TTDC00291	UniProt ID	P21917
TTDC00291	Name	D(4) dopamine receptor
TTDC00291	Type of target	Clinical trial target
TTDC00291	Synonyms	D(2C)D(4) dopamine receptor dopamine receptor
TTDC00291	Synonyms	Dopamine D4 receptor
TTDC00291	Disease	Parkinson's disease
TTDC00291	Disease	Psychiatric illness
TTDC00291	Disease	Respiratory diseases
TTDC00291	Function	This is one of the five types (D1 to D5) of receptors for dopamine, and the acti
TTDC00291	Sequence	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAAD
TTDC00291	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00291	Pathway	Neuroactive ligand-receptor interaction
TTDC00291	Related US Patent	6,479,491
TTDC00291	Target Validation	TTDC00291
TTDC00291	Drug(s)	Belaperidone
TTDC00291	Drug(s)	HMR-2934
TTDC00291	Drug(s)	NGD 94-1
TTDC00291	Drug(s)	PD-165167
TTDC00291	Drug(s)	SPI-376
TTDC00291	Drug(s)	Sarizotan
TTDC00291	Drug(s)	Sonepiprazole
TTDC00291	Drug(s)	U-99363E
TTDC00291	Inhibitor	(+/-)-nantenine
TTDC00291	Inhibitor	(-)3-(1-Propyl-piperidin-3-yl)-phenol
TTDC00291	Inhibitor	(4-Ethynyl-cyclohex-3-enyl)-dipropyl-amine
TTDC00291	Inhibitor	(4-Phenylethynyl-cyclohex-3-enyl)-dipropyl-amine
TTDC00291	Inhibitor	1-(4-(1H-pyrazol-1-yl)benzyl)-4-phenylpiperazine
TTDC00291	Inhibitor	1-Benzyl-4-(2-ethynyl-pyrrol-1-yl)-piperidine
TTDC00291	Inhibitor	1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine
TTDC00291	Inhibitor	1-Benzyl-4-(2-oxazol-5-yl-pyrrol-1-yl)-piperidine
TTDC00291	Inhibitor	1-Benzyl-4-(3-oxazol-5-yl-pyrrol-1-yl)-piperidine
TTDC00291	Inhibitor	1-Benzyl-4-pyrrol-1-yl-piperidine
TTDC00291	Inhibitor	1-Dibenzo[b,f]oxepin-10-yl-4-methyl-piperazine
TTDC00291	Inhibitor	1-[2-(2-Benzyl-phenoxy)-ethyl]-piperidine
TTDC00291	Inhibitor	1-[2-(2-Benzyl-phenoxy)-ethyl]-pyrrolidine
TTDC00291	Inhibitor	1-[3-(2-Benzyl-phenoxy)-propyl]-pyrrolidine
TTDC00291	Inhibitor	3-(1-Propyl-piperidin-3-yl)-phenol
TTDC00291	Inhibitor	3-(2-Benzylamino-ethoxy)-phenol
TTDC00291	Inhibitor	3-(4-Methyl-piperidin-1-ylmethyl)-1H-indole
TTDC00291	Inhibitor	3-(4-Phenyl-piperazin-1-ylmethyl)-1H-indole
TTDC00291	Inhibitor	3-(4-Phenyl-piperidin-1-ylmethyl)-1H-indole
TTDC00291	Inhibitor	4-(2-Benzylamino-ethoxy)-1,3-dihydro-indol-2-one
TTDC00291	Inhibitor	4-(4-Benzyl-piperazin-1-yl)-1H-benzoimidazole
TTDC00291	Inhibitor	4-(4-Benzyl-piperazin-1-yl)-1H-indole
TTDC00291	Inhibitor	4-(4-Benzyl-piperazin-1-yl)-5-chloro-1H-indole
TTDC00291	Inhibitor	4-(4-Benzyl-piperazin-1-yl)-7-bromo-1H-indole
TTDC00291	Inhibitor	4-[2-(2-Benzyl-phenoxy)-ethyl]-morpholine
TTDC00291	Inhibitor	A-425444
TTDC00291	Inhibitor	A-80426
TTDC00291	Inhibitor	ABT-670
TTDC00291	Inhibitor	BP-897
TTDC00291	Inhibitor	Benzyl-[2-(1H-indazol-4-yloxy)-ethyl]-amine
TTDC00291	Inhibitor	Benzyl-[2-(1H-indol-4-yloxy)-ethyl]-amine
TTDC00291	Inhibitor	DIHYDREXIDINE
TTDC00291	Inhibitor	FLUMEZAPINE
TTDC00291	Inhibitor	FLUTROLINE
TTDC00291	Inhibitor	ISOCLOZAPINE
TTDC00291	Inhibitor	ISOLOXAPINE
TTDC00291	Inhibitor	JL-18;NCGC00094013-01
TTDC00291	Inhibitor	L-741626
TTDC00291	Inhibitor	L-741742
TTDC00291	Inhibitor	L-745870
TTDC00291	Inhibitor	N-(4-Dipropylaminobutyl)-4-biphenylcarboxamide
TTDC00291	Inhibitor	N-(4-Propylaminobutyl)-4-biphenylcarboxamide
TTDC00291	Inhibitor	PG-01037
TTDC00291	Inhibitor	Phenyltoloxamine
TTDC00291	Inhibitor	QUINPIROLE
TTDC00291	Inhibitor	SB-271046
TTDC00291	Inhibitor	SPIPERONE
TTDC00291	Inhibitor	STEPHOLIDINE
TTDC00291	Inhibitor	UH-232
TTDC00291	Inhibitor	[2-(1H-Benzoimidazol-4-yloxy)-ethyl]-benzyl-amine
TTDC00291	Antagonist	A-381393
TTDC00291	Antagonist	Belaperidone
TTDC00291	Antagonist	FAUC 113
TTDC00291	Antagonist	HMR-2934
TTDC00291	Antagonist	L-745,870
TTDC00291	Antagonist	NGD 94-1
TTDC00291	Antagonist	PD-165167
TTDC00291	Agonist	Sarizotan
TTDC00291	Binder	SPI-376
TTDC00291	Binder	Sonepiprazole
TTDC00291	Binder	U-99363E
TTDC00291	Multitarget	HMR-2934
TTDC00291	Multitarget	Sarizotan
TTDC00292	UniProt ID	P35348
TTDC00292	Name	Alpha-1A adrenergic receptor
TTDC00292	Type of target	Clinical trial target
TTDC00292	Synonyms	Alpha 1A-adrenoceptor
TTDC00292	Synonyms	Alpha 1A-adrenoreceptor
TTDC00292	Synonyms	Alpha adrenergic receptor 1c
TTDC00292	Synonyms	Alpha-1C adrenergic receptor
TTDC00292	Disease	Benign prostate hyperplasia
TTDC00292	Disease	Hypertrophic vascular disease
TTDC00292	Function	This alpha-adrenergic receptor mediates its action by association with g protein
TTDC00292	Sequence	MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVL
TTDC00292	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00292	Pathway	Calcium signaling pathway
TTDC00292	Pathway	Neuroactive ligand-receptor interaction
TTDC00292	Pathway	Vascular smooth muscle contraction
TTDC00292	Target Validation	TTDC00292
TTDC00292	Drug(s)	Dutasteride & tamsulosin
TTDC00292	Drug(s)	Xatral
TTDC00292	Inhibitor	(+)-NIGULDIPINE
TTDC00292	Inhibitor	(+/-)-nantenine
TTDC00292	Inhibitor	(-)-SNAP-5089
TTDC00292	Inhibitor	(-)-SNAP-5399;SNAP-5399
TTDC00292	Inhibitor	(2,6-Dichloro-phenyl)-(1H-imidazol-2-yl)-amine
TTDC00292	Inhibitor	(2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine
TTDC00292	Inhibitor	1',2',3',6'-Tetrahydro-[2,4']bipyridinyl
TTDC00292	Inhibitor	1-(2-Chloro-phenyl)-piperazine
TTDC00292	Inhibitor	1-(2-Methoxy-phenyl)-piperazine
TTDC00292	Inhibitor	1-(3-Fluoro-pyridin-2-yl)-4-methyl-piperazine
TTDC00292	Inhibitor	1-Pyridin-2-yl-piperazine
TTDC00292	Inhibitor	2-(4-tert-Butyl-phenyl)-4,5-dihydro-1H-imidazole
TTDC00292	Inhibitor	2-Pyridin-4-yl-1,2,3,4-tetrahydro-isoquinoline
TTDC00292	Inhibitor	4-((E)-1-Naphthalen-1-yl-propenyl)-1H-imidazole
TTDC00292	Inhibitor	4-((Z)-1-Naphthalen-1-yl-propenyl)-1H-imidazole
TTDC00292	Inhibitor	4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole
TTDC00292	Inhibitor	4-(1-Naphthalen-1-yl-propyl)-1H-imidazole
TTDC00292	Inhibitor	4-(1-Naphthalen-1-yl-vinyl)-1H-imidazole
TTDC00292	Inhibitor	4-(2,3-Dihydro-1H-phenalen-1-yl)-1H-imidazole
TTDC00292	Inhibitor	4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinoline
TTDC00292	Inhibitor	4-(3-Hydroxy-piperidin-3-yl)-benzene-1,2-diol
TTDC00292	Inhibitor	4-(4-Isopropyl-morpholin-2-yl)-benzene-1,2-diol
TTDC00292	Inhibitor	4-(4-Methyl-indan-1-yl)-1H-imidazole
TTDC00292	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDC00292	Inhibitor	4-(4-chlorobenzyl)-2-allylphthalazin-1(2H)-one
TTDC00292	Inhibitor	4-(4-chlorobenzyl)-2-methylphthalazin-1(2H)-one
TTDC00292	Inhibitor	4-(4-chlorobenzyl)phthalazin-1(2H)-one
TTDC00292	Inhibitor	4-Benzo[b]thiophen-4-yl-1H-imidazole
TTDC00292	Inhibitor	4-Morpholin-2-yl-benzene-1,2-diol
TTDC00292	Inhibitor	4-benzyl-2-methylphthalazin-1(2H)-one
TTDC00292	Inhibitor	5-Bromo-8-piperazin-1-yl-imidazo[1,2-a]pyrazine
TTDC00292	Inhibitor	8-Piperazin-1-yl-imidazo[1,2-a]pyrazine
TTDC00292	Inhibitor	A-119637
TTDC00292	Inhibitor	A-123189
TTDC00292	Inhibitor	A-131701
TTDC00292	Inhibitor	A-315456
TTDC00292	Inhibitor	ABANOQUIL
TTDC00292	Inhibitor	AGN-192172
TTDC00292	Inhibitor	AGN-193080
TTDC00292	Inhibitor	ATC-0175
TTDC00292	Inhibitor	BMY-7378
TTDC00292	Inhibitor	BP-897
TTDC00292	Inhibitor	CORYNANTHEINE
TTDC00292	Inhibitor	FLUANISONE
TTDC00292	Inhibitor	ISOCLOZAPINE
TTDC00292	Inhibitor	Imidazolidin-2-ylidene-o-tolyl-amine
TTDC00292	Inhibitor	Imidazolidin-2-ylidene-quinoxalin-6-yl-amine
TTDC00292	Inhibitor	L-765314
TTDC00292	Inhibitor	L-771688
TTDC00292	Inhibitor	LEVONORDEFRIN
TTDC00292	Inhibitor	MAZAPERTINE
TTDC00292	Inhibitor	MEDETOMIDINE
TTDC00292	Inhibitor	N-(5-Bromo-quinoxalin-6-yl)-guanidine
TTDC00292	Inhibitor	NAFTOPIDIL
TTDC00292	Inhibitor	NIGULDIPINE
TTDC00292	Inhibitor	OCTOCLOTHEPIN
TTDC00292	Inhibitor	R-226161
TTDC00292	Inhibitor	RS-100329
TTDC00292	Inhibitor	RS-17053
TTDC00292	Inhibitor	RS-513815
TTDC00292	Inhibitor	RWJ-25730
TTDC00292	Inhibitor	RWJ-38063
TTDC00292	Inhibitor	RWJ-68141
TTDC00292	Inhibitor	RWJ-68157
TTDC00292	Inhibitor	RWJ-69736
TTDC00292	Inhibitor	RX-821002
TTDC00292	Inhibitor	Ro-11-04253
TTDC00292	Inhibitor	Ro-700004;RS-100975
TTDC00292	Inhibitor	SILODOSIN
TTDC00292	Inhibitor	SK&F-104078;SK-104078
TTDC00292	Inhibitor	SK&F-104856;SK-104856
TTDC00292	Inhibitor	SK&F-105854;SK-105854
TTDC00292	Inhibitor	SK&F-106686;SK-106686
TTDC00292	Inhibitor	SK&F-86466;SK-86466
TTDC00292	Inhibitor	SNAP-5036
TTDC00292	Inhibitor	SNAP-5089
TTDC00292	Inhibitor	SNAP-5150
TTDC00292	Inhibitor	SNAP-6201
TTDC00292	Inhibitor	SNAP-7915
TTDC00292	Inhibitor	SNAP-8719
TTDC00292	Inhibitor	SNAP-94847
TTDC00292	Inhibitor	SPIPERONE
TTDC00292	Inhibitor	Siramesine
TTDC00292	Inhibitor	TIOSPIRONE
TTDC00292	Inhibitor	UH-301
TTDC00292	Inhibitor	UPIDOSIN
TTDC00292	Inhibitor	WAY-100135
TTDC00292	Inhibitor	WB-4101
TTDC00292	Inhibitor	sunepitron
TTDC00292	Antagonist	Dutasteride & tamsulosin
TTDC00292	Antagonist	REC2615
TTDC00292	Antagonist	Xatral
TTDC00292	Agonist	4-Methoxyamphetamine
TTDC00292	Binder	KMD-3213
TTDC00292	Multitarget	Dutasteride & tamsulosin
TTDC00293	UniProt ID	P18089
TTDC00293	Name	Alpha-2B adrenergic receptor
TTDC00293	Type of target	Clinical trial target
TTDC00293	Synonyms	Alpha-2B adrenoceptor
TTDC00293	Synonyms	Alpha-2B adrenoreceptor
TTDC00293	Synonyms	Subtype C2
TTDC00293	Disease	Heart failure
TTDC00293	Disease	Hypertension
TTDC00293	Disease	Ischemic heart disease
TTDC00293	Function	Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of ade
TTDC00293	Sequence	MDHQDPYSVQATAAIAAAITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADILVATLIIPFSLANELLGYWYF
TTDC00293	PDB Structure	2CVA
TTDC00293	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00293	Pathway	Neuroactive ligand-receptor interaction
TTDC00293	Target Validation	TTDC00293
TTDC00293	Drug(s)	AGN-199981
TTDC00293	Inhibitor	(+/-)-nantenine
TTDC00293	Inhibitor	(1,2,3,4-Tetrahydro-isoquinolin-3-yl)-methanol
TTDC00293	Inhibitor	(2-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine
TTDC00293	Inhibitor	(3-Ethyl-indol-1-yl)-propyl-pyridin-4-yl-amine
TTDC00293	Inhibitor	(3-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine
TTDC00293	Inhibitor	(R)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline
TTDC00293	Inhibitor	(S)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline
TTDC00293	Inhibitor	1',2',3',6'-Tetrahydro-[2,4']bipyridinyl
TTDC00293	Inhibitor	1,2,3,4,4a,5,10,10a-Octahydro-benzo[g]quinoline
TTDC00293	Inhibitor	1,2,3,4,5,6-Hexahydro-benzo[c]azocine
TTDC00293	Inhibitor	1,2,3,4-Tetrahydro-benzo[h]isoquinolin-8-ol
TTDC00293	Inhibitor	1,2,3,4-Tetrahydro-isoquinolin-7-ol
TTDC00293	Inhibitor	1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole
TTDC00293	Inhibitor	1,2,3,4-tetrahydroisoquinoline
TTDC00293	Inhibitor	1-(3-Fluoro-pyridin-2-yl)-4-methyl-piperazine
TTDC00293	Inhibitor	1-Pyridin-2-yl-piperazine
TTDC00293	Inhibitor	2,3,4,5-Tetrahydro-1H-benzo[c]azepine
TTDC00293	Inhibitor	2,3,4,5-Tetrahydro-1H-benzo[e][1,4]diazepine
TTDC00293	Inhibitor	2,3,4,5-Tetrahydro-benzo[f][1,4]oxazepine
TTDC00293	Inhibitor	2,3-Dihydro-1H-isoindole
TTDC00293	Inhibitor	2-Benzofuran-2-yl-4,5-dihydro-1H-imidazole
TTDC00293	Inhibitor	3-Fluoromethyl-1,2,3,4-tetrahydro-isoquinoline
TTDC00293	Inhibitor	3-Methoxymethyl-1,2,3,4-tetrahydro-isoquinoline
TTDC00293	Inhibitor	3-Methyl-1,2,3,4-tetrahydro-isoquinoline
TTDC00293	Inhibitor	4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole
TTDC00293	Inhibitor	4-(4-Methyl-indan-1-yl)-1H-imidazole
TTDC00293	Inhibitor	4-Benzo[b]thiophen-4-yl-1H-imidazole
TTDC00293	Inhibitor	5-Aminomethyl-naphthalen-2-ol
TTDC00293	Inhibitor	6,7,8,9-Tetrahydro-5-thia-8-aza-benzocycloheptene
TTDC00293	Inhibitor	7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline
TTDC00293	Inhibitor	8-Methoxy-1,2,3,4-tetrahydro-benzo[h]isoquinoline
TTDC00293	Inhibitor	A-80426
TTDC00293	Inhibitor	Butyl-indol-1-yl-pyridin-4-yl-amine
TTDC00293	Inhibitor	C-(6-Methoxy-naphthalen-1-yl)-methylamine
TTDC00293	Inhibitor	C-Naphthalen-1-yl-methylamine
TTDC00293	Inhibitor	Ethyl-indol-1-yl-pyridin-4-yl-amine
TTDC00293	Inhibitor	GNF-PF-2857
TTDC00293	Inhibitor	GNF-PF-3427
TTDC00293	Inhibitor	GNF-PF-3878
TTDC00293	Inhibitor	INDORAMIN
TTDC00293	Inhibitor	Indol-1-yl-methyl-pyridin-4-yl-amine
TTDC00293	Inhibitor	Indol-1-yl-prop-2-ynyl-pyridin-4-yl-amine
TTDC00293	Inhibitor	Indol-1-yl-propyl-pyridin-4-yl-amine
TTDC00293	Inhibitor	Indol-1-yl-pyridin-4-yl-amine
TTDC00293	Inhibitor	MAZAPERTINE
TTDC00293	Inhibitor	MEDETOMIDINE
TTDC00293	Inhibitor	METHYLNORADRENALINE
TTDC00293	Inhibitor	MEZILAMINE
TTDC00293	Inhibitor	MOXONIDINE
TTDC00293	Inhibitor	PIPEROXAN
TTDC00293	Inhibitor	R-226161
TTDC00293	Inhibitor	RX-821002
TTDC00293	Inhibitor	S-34324
TTDC00293	Inhibitor	SK&F-104078;SK-104078
TTDC00293	Inhibitor	SK&F-64139;SK-64139
TTDC00293	Inhibitor	SNAP-5089
TTDC00293	Inhibitor	SNAP-5150
TTDC00293	Inhibitor	TRACIZOLINE
TTDC00293	Inhibitor	TRAMAZOLINE
TTDC00293	Inhibitor	TRYPTOLINE
TTDC00293	Inhibitor	WB-4101
TTDC00293	Antagonist	ARC-239
TTDC00293	Agonist	AGN-199981
TTDC00295	UniProt ID	P16233
TTDC00295	Name	Triacylglycerol lipase, pancreatic
TTDC00295	Type of target	Clinical trial target
TTDC00295	Synonyms	PL
TTDC00295	Synonyms	Pancreatic lipase
TTDC00295	Disease	Obesity
TTDC00295	Sequence	MLPLWTLSLLLGAVAGKEVCYERLGCFSDDSPWSGITERPLHILPWSPKDVNTRFLLYTNENPNNFQEVAADSSSISGSN
TTDC00295	PDB Structure	1GPL; 1LPA; 1LPB; 1N8S
TTDC00295	BioChemical Class	Hydrolases acting on ester bonds
TTDC00295	Pathway	Glycerolipid metabolism
TTDC00295	Pathway	Metabolic pathways
TTDC00295	EC Number	EC 3.1.1.3
TTDC00295	Target Validation	TTDC00295
TTDC00295	Drug(s)	Dalbavancin
TTDC00295	Inhibitor	(Hydroxyethyloxy)Tri(Ethyloxy)Octane
TTDC00295	Inhibitor	B-Nonylglucoside
TTDC00295	Inhibitor	B-Octylglucoside
TTDC00295	Inhibitor	Daio-Orengedokuto (DOT)
TTDC00295	Inhibitor	Dalbavancin
TTDC00295	Inhibitor	METHOXYUNDECYLPHOSPHINIC ACID
TTDC00297	Name	Histone deacetylase
TTDC00297	Type of target	Successful target
TTDC00297	Synonyms	HD
TTDC00297	Synonyms	HDAC
TTDC00297	Disease	Acute myeloid leukemia
TTDC00297	Disease	Cancer, unspecific
TTDC00297	Disease	Hematologic malignancies
TTDC00297	Function	Responsible for the deacetylation of lysine residues on the n-terminal part of t
TTDC00297	Sequence	MDTGGNSLASGPDGVKRKVCYFYDPEVGNYYYGQGHPMKPHRIRMTHALLAHYGLLQHMQVLKPFPARDRDLCRFHADDY
TTDC00297	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDC00297	EC Number	EC 3.5.1.-
TTDC00297	Related US Patent	6,495,719
TTDC00297	Related US Patent	6,511,990
TTDC00297	Related US Patent	6,541,661
TTDC00297	Related US Patent	6,552,065
TTDC00297	Related US Patent	6,638,530
TTDC00297	Target Validation	TTDC00297
TTDC00297	Drug(s)	ACY-1215
TTDC00297	Drug(s)	Abexinostat
TTDC00297	Drug(s)	CUDC-907
TTDC00297	Drug(s)	HBI-8000
TTDC00297	Drug(s)	JNJ-26481585
TTDC00297	Drug(s)	Pracinostat
TTDC00297	Drug(s)	SHP-141
TTDC00297	Drug(s)	Valproic Acid
TTDC00297	Inhibitor	(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one
TTDC00297	Inhibitor	2,2-bis(3-fluorophenyl)-N-hydroxyacetamide
TTDC00297	Inhibitor	2,2-bis(4-chlorophenyl)-N-hydroxyacetamide
TTDC00297	Inhibitor	2,2-bis(4-fluorophenyl)-N-hydroxyacetamide
TTDC00297	Inhibitor	2-(methylsulfonylthio)ethyl 2-propylpentanoate
TTDC00297	Inhibitor	4-Benzoylamino-N-hydroxy-benzamide
TTDC00297	Inhibitor	4-Butyrylamino-N-hydroxy-benzamide
TTDC00297	Inhibitor	4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDC00297	Inhibitor	4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide
TTDC00297	Inhibitor	4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDC00297	Inhibitor	4-Phenylbutyrohydroxamic acid
TTDC00297	Inhibitor	5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide
TTDC00297	Inhibitor	5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione
TTDC00297	Inhibitor	5-Mercapto-pentanoic acid phenylamide
TTDC00297	Inhibitor	6-(2-Bromo-acetylamino)-hexanoic acid phenylamide
TTDC00297	Inhibitor	6-Mercapto-hexanoic acid phenylamide
TTDC00297	Inhibitor	6-Phenoxy-hexane-1-thiol
TTDC00297	Inhibitor	6-benzenesulfinylhexanoic acid hydroxamide
TTDC00297	Inhibitor	6-benzenesulfonylhexanoic acid hydroxamide
TTDC00297	Inhibitor	6-phenylsulfanylhexanoic acid hydroxamide
TTDC00297	Inhibitor	7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDC00297	Inhibitor	7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one
TTDC00297	Inhibitor	7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDC00297	Inhibitor	7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDC00297	Inhibitor	7-Mercapto-heptanoic acid benzothiazol-2-ylamide
TTDC00297	Inhibitor	7-Mercapto-heptanoic acid biphenyl-3-ylamide
TTDC00297	Inhibitor	7-Mercapto-heptanoic acid biphenyl-4-ylamide
TTDC00297	Inhibitor	7-Mercapto-heptanoic acid phenylamide
TTDC00297	Inhibitor	7-Mercapto-heptanoic acid pyridin-3-ylamide
TTDC00297	Inhibitor	7-Mercapto-heptanoic acid quinolin-3-ylamide
TTDC00297	Inhibitor	8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one
TTDC00297	Inhibitor	8-Mercapto-octanoic acid phenylamide
TTDC00297	Inhibitor	8-Oxo-8-phenyl-octanoic acid
TTDC00297	Inhibitor	8-Oxo-8-phenyl-octanoic acid hydroxyamide
TTDC00297	Inhibitor	9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide
TTDC00297	Inhibitor	9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one
TTDC00297	Inhibitor	Apicidin
TTDC00297	Inhibitor	Azelaic bishydroxamic acid
TTDC00297	Inhibitor	CG-1521
TTDC00297	Inhibitor	CHAP1
TTDC00297	Inhibitor	CHAP31
TTDC00297	Inhibitor	CI-994
TTDC00297	Inhibitor	Cyclostellettamine derivative
TTDC00297	Inhibitor	DEPUDECIN
TTDC00297	Inhibitor	LBH539
TTDC00297	Inhibitor	N-(2,3-Dimethylphenyl)-N'-hydroxyoctanediamide
TTDC00297	Inhibitor	N-(2,4-Dimethylphenyl)-N'-hydroxyoctanediamide
TTDC00297	Inhibitor	N-(2,5-Dimethylphenyl)-N'-hydroxyoctanediamide
TTDC00297	Inhibitor	N-(2,6-Dimethylphenyl)-N'-hydroxyoctanediamide
TTDC00297	Inhibitor	N-(2-Ethylphenyl)-N'-hydroxyoctanediamide
TTDC00297	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide
TTDC00297	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-succinamide
TTDC00297	Inhibitor	N-(2-amino-5-(thiophen-2-yl)phenyl)nicotinamide
TTDC00297	Inhibitor	N-(2-aminophenyl)-4-methoxybenzamide
TTDC00297	Inhibitor	N-(2-aminophenyl)nicotinamide
TTDC00297	Inhibitor	N-(3,4-Dimethylphenyl)-N'-hydroxyoctanediamide
TTDC00297	Inhibitor	N-(3,5-Dimethylphenyl)-N'-hydroxyoctanediamide
TTDC00297	Inhibitor	N-(3-Ethylphenyl)-N'-hydroxyoctanediamide
TTDC00297	Inhibitor	N-(4-Ethylphenyl)-N'-hydroxyoctanediamide
TTDC00297	Inhibitor	N-(4-aminobiphenyl-3-yl)nicotinamide
TTDC00297	Inhibitor	N-(5-Hydroxycarbamoyl-pentyl)-4-methoxy-benzamide
TTDC00297	Inhibitor	N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide
TTDC00297	Inhibitor	N-(5-Hydroxycarbamoyl-pentyl)-benzamide
TTDC00297	Inhibitor	N-(6-Hydroxycarbamoyl-hexyl)-benzamide
TTDC00297	Inhibitor	N-(6-Mercapto-hexyl)-benzamide
TTDC00297	Inhibitor	N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide
TTDC00297	Inhibitor	N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide
TTDC00297	Inhibitor	N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide
TTDC00297	Inhibitor	N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide
TTDC00297	Inhibitor	N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide
TTDC00297	Inhibitor	N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide
TTDC00297	Inhibitor	N-Hydroxy-4-(pentanoylamino-methyl)-benzamide
TTDC00297	Inhibitor	N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide
TTDC00297	Inhibitor	N-Hydroxy-4-phenylacetylamino-benzamide
TTDC00297	Inhibitor	N-Hydroxy-N'-(2-methylphenyl)octanediamide
TTDC00297	Inhibitor	N-Hydroxy-N'-(3-methylphenyl)octanediamide
TTDC00297	Inhibitor	N-Hydroxy-N'-(4-methoxyphenyl)octanediamide
TTDC00297	Inhibitor	N-Hydroxy-N'-(4-methylphenyl)octanediamide
TTDC00297	Inhibitor	N-hydroxy-2,2-diphenylacetamide
TTDC00297	Inhibitor	N-hydroxy-2,2-diphenylpropanamide
TTDC00297	Inhibitor	N-hydroxy-9,10-dihydroanthracene-9-carboxamide
TTDC00297	Inhibitor	N-hydroxy-9H-xanthene-9-carboxamide
TTDC00297	Inhibitor	N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide
TTDC00297	Inhibitor	Octanedioic acid hydroxyamide pyridin-2-ylamide
TTDC00297	Inhibitor	Octanedioic acid hydroxyamide pyridin-4-ylamide
TTDC00297	Inhibitor	PSAMMAPLIN A
TTDC00297	Inhibitor	ST-2986
TTDC00297	Inhibitor	ST-2987
TTDC00297	Inhibitor	ST-3050
TTDC00297	Inhibitor	ST-5732
TTDC00297	Inhibitor	Suberic bishydroxamic acid
TTDC00297	Inhibitor	Suberohydroxamic acid
TTDC00297	Inhibitor	Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester
TTDC00297	Inhibitor	Trapoxin
TTDC00297	Inhibitor	Trapoxin A
TTDC00297	Inhibitor	Trichostatin A
TTDC00297	Inhibitor	Trifluoromethylketone
TTDC00297	Inhibitor	Valproic Acid
TTDC00298	UniProt ID	P47901
TTDC00298	Name	Vasopressin V1b receptor
TTDC00298	Type of target	Clinical trial target
TTDC00298	Synonyms	AVPR V1b
TTDC00298	Synonyms	AVPR V3
TTDC00298	Synonyms	Antidiuretic hormone receptor 1b
TTDC00298	Synonyms	V1bR
TTDC00298	Synonyms	Vasopressin V(1b) Receptor
TTDC00298	Synonyms	Vasopressin V3 receptor
TTDC00298	Disease	Adrenocorticotrophic hormone-secreting tumors
TTDC00298	Disease	Emotional diseases
TTDC00298	Disease	Stress-related disorders
TTDC00298	Function	Receptor for arginine vasopressin. The activity of this receptor is mediated by
TTDC00298	Sequence	MDSGPLWDANPTPRGTLSAPNATTPWLGRDEELAKVEIGVLATVLVLATGGNLAVLLTLGQLGRKRSRMHLFVLHLALTD
TTDC00298	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00298	Pathway	Calcium signaling pathway
TTDC00298	Pathway	Neuroactive ligand-receptor interaction
TTDC00298	Pathway	Vascular smooth muscle contraction
TTDC00298	Target Validation	TTDC00298
TTDC00298	Drug(s)	ABT-436
TTDC00298	Drug(s)	SSR149415
TTDC00298	Inhibitor	ARGENINE VASOPRESSIN
TTDC00298	Inhibitor	ATOSIBAN
TTDC00298	Inhibitor	Mozavaptan
TTDC00298	Inhibitor	SR-149415
TTDC00298	Inhibitor	[HO1][Lys8(5/6C-Flu)]VT
TTDC00298	Inhibitor	[HO1][Orn8(5/6C-Flu)]VT
TTDC00298	Inhibitor	[HO1][Thr4,Lys8(5/6C-Flu)]VT
TTDC00298	Inhibitor	[HO1][Thr4,Orn8(5/6C-Flu)]VT
TTDC00298	Inhibitor	[Lys8(Alexa 488) ]PVA
TTDC00298	Inhibitor	d[Arg4,Dab8]VP
TTDC00298	Inhibitor	d[Arg4,Lys8]VP
TTDC00298	Inhibitor	d[Arg4,Orn8]VP
TTDC00298	Inhibitor	d[Arg4]AVP
TTDC00298	Inhibitor	d[Cha4,Dab8]VP
TTDC00298	Inhibitor	d[Cha4,Dap8]VP
TTDC00298	Inhibitor	d[Cha4,Lys8]VP
TTDC00298	Inhibitor	d[Cha4,Orn8]VP
TTDC00298	Inhibitor	d[Cha4]AVP
TTDC00298	Inhibitor	d[D-3-Pal2]AVP
TTDC00298	Inhibitor	d[Leu4,Dab8]VP
TTDC00298	Inhibitor	d[Leu4,Dap8]VP
TTDC00298	Inhibitor	d[Leu4,Lys8]VP
TTDC00298	Inhibitor	d[Leu4,Orn8]VP
TTDC00298	Inhibitor	d[Leu4]AVP
TTDC00298	Inhibitor	d[Lys8(5/6-Flu)]VT
TTDC00298	Inhibitor	d[Orn4,Lys8]VP
TTDC00298	Inhibitor	d[Orn4,Orn8]VP
TTDC00298	Inhibitor	d[Orn4]AVP
TTDC00298	Inhibitor	d[Orn8(5/6C-Flu)]VT
TTDC00298	Inhibitor	d[Thr4,Lys8(5/6C-Flu)]VT
TTDC00298	Inhibitor	d[Thr4,Orn8(5/6C-Flu)]VT
TTDC00298	Inhibitor	d[Val4]AVP
TTDC00298	Antagonist	SSR149415
TTDC00299	UniProt ID	Q13224
TTDC00299	Name	Glutamate [NMDA] receptor subunit epsilon 2
TTDC00299	Type of target	Clinical trial target
TTDC00299	Synonyms	Glutamate receptor NR2B subunit
TTDC00299	Synonyms	HNR3
TTDC00299	Synonyms	N-methyl D-aspartate receptor subtype 2B
TTDC00299	Synonyms	N-methyl-D-aspartate receptor subunit 3
TTDC00299	Synonyms	NMDA NR2B receptor
TTDC00299	Synonyms	NMDA receptor NR2B
TTDC00299	Synonyms	NMDA receptor subunit 2B
TTDC00299	Synonyms	NMDAR2B
TTDC00299	Synonyms	NR2B
TTDC00299	Synonyms	NR3
TTDC00299	Disease	Alcohol dependence
TTDC00299	Disease	Alcoholism
TTDC00299	Disease	Analgesics
TTDC00299	Disease	Chronic pain
TTDC00299	Disease	Convulsions
TTDC00299	Disease	Dementia
TTDC00299	Disease	Drug-induced dyskinesias
TTDC00299	Disease	Pain (anesthesia, neuropathic)
TTDC00299	Disease	Parkinson's disease
TTDC00299	Disease	Stroke
TTDC00299	Disease	Traumatic head injury
TTDC00299	Function	Nmda receptor subtype of glutamate-gated ion channels with high calcium permeabi
TTDC00299	Sequence	MKPRAECCSPKFWLVLAVLAVSGSRARSQKSPPSIGIAVILVGTSDEVAIKDAHEKDDFHHLSVVPRVELVAMNETDPKS
TTDC00299	PDB Structure	1S11; 1S2S; 2IPV
TTDC00299	BioChemical Class	Ion transport
TTDC00299	Pathway	Alzheimer's disease
TTDC00299	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDC00299	Pathway	Huntington's disease
TTDC00299	Pathway	Long-term potentiation
TTDC00299	Pathway	Neuroactive ligand-receptor interaction
TTDC00299	Pathway	Systemic lupus erythematosus
TTDC00299	Related US Patent	6,291,499
TTDC00299	Related US Patent	6,316,474
TTDC00299	Related US Patent	6,362,196
TTDC00299	Related US Patent	6,369,076
TTDC00299	Related US Patent	6,376,530
TTDC00299	Related US Patent	6,380,205
TTDC00299	Related US Patent	6,432,976
TTDC00299	Related US Patent	6,432,985
TTDC00299	Related US Patent	6,440,976
TTDC00299	Related US Patent	6,476,041
TTDC00299	Related US Patent	6,495,561
TTDC00299	Related US Patent	6,538,008
TTDC00299	Related US Patent	6,713,490
TTDC00299	Target Validation	TTDC00299
TTDC00299	Drug(s)	Besonprodil
TTDC00299	Drug(s)	EVT-101
TTDC00299	Drug(s)	RGH-896
TTDC00299	Drug(s)	Traxoprodil
TTDC00299	Inhibitor	(D)-Ala-Pro-Glu
TTDC00299	Inhibitor	(R)-2-Amino-5-phosphono-pentanoic acid
TTDC00299	Inhibitor	(R)-2-Amino-7-phosphono-heptanoic acid
TTDC00299	Inhibitor	2-(4-Phenoxy-benzyl)-1H-benzoimidazole
TTDC00299	Inhibitor	2-(4-Phenoxy-benzyl)-3H-benzoimidazol-4-ol
TTDC00299	Inhibitor	2-(4-Phenoxy-benzyl)-3H-benzoimidazol-5-ol
TTDC00299	Inhibitor	2-(4-Phenoxy-benzyl)-3H-benzoimidazol-5-ylamine
TTDC00299	Inhibitor	2-(4-benzyl-piperidin-1-ylmethyl)-1H-indol-6-ol
TTDC00299	Inhibitor	2-Methylamino-succinic acid(NMDA)
TTDC00299	Inhibitor	2-Pyridin-4-yl-1,2,3,4-tetrahydro-isoquinoline
TTDC00299	Inhibitor	3-Benzoyl-7-chloro-4-hydroxy-1H-quinolin-2-one
TTDC00299	Inhibitor	3-Hydroxy-1H-benzo[b]azepine-2,5-dione
TTDC00299	Inhibitor	3-Hydroxy-6-methyl-1H-benzo[b]azepine-2,5-dione
TTDC00299	Inhibitor	3-Hydroxy-7-nitro-1H-benzo[b]azepine-2,5-dione
TTDC00299	Inhibitor	3-Hydroxy-8-methyl-1H-benzo[b]azepine-2,5-dione
TTDC00299	Inhibitor	3-phenyl-4-hydroxyquinolin-2(1H)-one
TTDC00299	Inhibitor	4,5,7-Trichloro-3-hydroxy-1H-quinolin-2-one
TTDC00299	Inhibitor	4,6-Dichloro-1H-indole-2-carboxylic acid
TTDC00299	Inhibitor	4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinoline
TTDC00299	Inhibitor	4-Benzyl-1-(2-phenoxy-ethyl)-piperidine
TTDC00299	Inhibitor	4-Benzyl-1-phenethyl-piperidine; hydrochloride
TTDC00299	Inhibitor	4-Bromo-3-hydroxy-1H-quinolin-2-one
TTDC00299	Inhibitor	4-Bromo-5,7-dichloro-3-hydroxy-1H-quinolin-2-one
TTDC00299	Inhibitor	4-Chloro-3-hydroxy-1H-quinolin-2-one
TTDC00299	Inhibitor	4-Phosphonomethyl-piperidine-2-carboxylic acid
TTDC00299	Inhibitor	4-[2-(3-Phenyl-propylamino)-ethyl]-phenol
TTDC00299	Inhibitor	4-[2-(4-Benzyl-piperidin-1-yl)-ethoxy]-phenol
TTDC00299	Inhibitor	4-[2-(4-Phenyl-butoxy)-ethyl]-phenol
TTDC00299	Inhibitor	4-[2-(4-Phenyl-butylamino)-ethyl]-phenol
TTDC00299	Inhibitor	4-[2-(4-Phenyl-piperidin-1-yl)-ethoxy]-phenol
TTDC00299	Inhibitor	4-[2-(5-Phenyl-pentylamino)-ethyl]-phenol
TTDC00299	Inhibitor	4-[2-(6-Phenyl-hexylamino)-ethyl]-phenol
TTDC00299	Inhibitor	4-[3-(4-Phenyl-butylamino)-propyl]-phenol
TTDC00299	Inhibitor	4-[3-(5-Phenyl-pentylamino)-propyl]-phenol
TTDC00299	Inhibitor	4-hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one
TTDC00299	Inhibitor	4-{2-[Ethyl-(4-phenyl-butyl)-amino]-ethyl}-phenol
TTDC00299	Inhibitor	5,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione
TTDC00299	Inhibitor	5,7-Dichloro-4-hydroxy-3-phenyl-1H-quinolin-2-one
TTDC00299	Inhibitor	5,7-Dinitro-1,4-dihydro-quinoxaline-2,3-dione
TTDC00299	Inhibitor	6,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione
TTDC00299	Inhibitor	6-Chloro-1,4-dihydro-quinoxaline-2,3-dione
TTDC00299	Inhibitor	6-Methoxy-2-(4-phenoxy-benzyl)-1H-benzoimidazole
TTDC00299	Inhibitor	6-Nitro-1,4-dihydro-quinoxaline-2,3-dione
TTDC00299	Inhibitor	6-Nitro-2-(4-phenoxy-benzyl)-1H-benzoimidazole
TTDC00299	Inhibitor	7-Chloro-3-nitro-3,4-dihydro-1H-quinolin-2-one
TTDC00299	Inhibitor	7-chloro-3-hydroxyquinazoline-2,4-dione
TTDC00299	Inhibitor	8-Bromo-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDC00299	Inhibitor	8-Chloro-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDC00299	Inhibitor	8-Ethyl-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDC00299	Inhibitor	8-Fluoro-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDC00299	Inhibitor	AP-7
TTDC00299	Inhibitor	Ala-Pro-Glu
TTDC00299	Inhibitor	CI-1041
TTDC00299	Inhibitor	DITOLYLGUANIDINE
TTDC00299	Inhibitor	DIZOCILPINE
TTDC00299	Inhibitor	DNQX
TTDC00299	Inhibitor	ELIPRODIL
TTDC00299	Inhibitor	GLUTAMATE
TTDC00299	Inhibitor	Gly-Amp-Glu
TTDC00299	Inhibitor	Gly-Hyp-Glu
TTDC00299	Inhibitor	Gly-Pip-Glu
TTDC00299	Inhibitor	Gly-b7Pro-Glu
TTDC00299	Inhibitor	H-Gly-D-dmP-Glu-OH
TTDC00299	Inhibitor	H-Gly-PMe-Glu-OH
TTDC00299	Inhibitor	H-Gly-dmP-Glu-OH
TTDC00299	Inhibitor	L-687414
TTDC00299	Inhibitor	L-695902
TTDC00299	Inhibitor	L-698532
TTDC00299	Inhibitor	L-701324
TTDC00299	Inhibitor	MDL-105519
TTDC00299	Inhibitor	N,N'-Bis-(4-butoxy-phenyl)-guanidine
TTDC00299	Inhibitor	N,N'-Bis-(4-butyl-phenyl)-guanidine
TTDC00299	Inhibitor	N,N'-Bis-(4-ethyl-phenyl)-guanidine
TTDC00299	Inhibitor	N,N'-Bis-(4-hexyl-phenyl)-guanidine
TTDC00299	Inhibitor	N,N'-Bis-(4-isopropyl-phenyl)-guanidine
TTDC00299	Inhibitor	N,N'-Bis-(4-sec-butyl-phenyl)-guanidine
TTDC00299	Inhibitor	N-(2-methoxybenzyl)cinnamamidine
TTDC00299	Inhibitor	N-(3-phenethoxybenzyl)-4-hydroxybenzamide
TTDC00299	Inhibitor	N-(4-(benzyloxy)phenethyl)pyridin-4-amine
TTDC00299	Inhibitor	NBQX
TTDC00299	Inhibitor	Nle-Pro-Glu
TTDC00299	Inhibitor	PHENCYCLIDINE
TTDC00299	Inhibitor	Phe-Pro-Glu
TTDC00299	Inhibitor	Phenethyl-(3-phenyl-propyl)-amine
TTDC00299	Inhibitor	Phenethyl-(4-phenyl-butyl)-amine
TTDC00299	Inhibitor	RPR-104632
TTDC00299	Inhibitor	RPR-118723
TTDC00299	Inhibitor	TRANSTORINE
TTDC00299	Inhibitor	YM-90K
TTDC00299	Inhibitor	benzyl 4-aminobutyl(3-aminopropyl)carbamate
TTDC00299	Inhibitor	conantokin-G
TTDC00299	Inhibitor	conantokin-R
TTDC00299	Antagonist	Besonprodil
TTDC00299	Antagonist	CP-101,606
TTDC00299	Antagonist	Co 101244
TTDC00299	Antagonist	Conantokins G
TTDC00299	Antagonist	Conantokins T
TTDC00299	Antagonist	EVT-101
TTDC00299	Antagonist	Ifenprodil
TTDC00299	Antagonist	RGH-896
TTDC00299	Antagonist	RO-25-6981
TTDC00299	Antagonist	Ro 63-1908
TTDC00299	Antagonist	Tenocyclidine
TTDC00299	Antagonist	Traxoprodil
TTDC00300	Name	Interleukin-1
TTDC00300	Type of target	Successful target
TTDC00300	Synonyms	IL-1
TTDC00300	Disease	Alzheimer's disease
TTDC00300	Disease	Chronic arthritis
TTDC00300	Disease	Chronic inflammatory diseases
TTDC00300	Disease	Head injury, unspecified
TTDC00300	Disease	Multiple sclerosis
TTDC00300	Disease	Neurodegenerative diseases
TTDC00300	Disease	Parkinson's disease
TTDC00300	Disease	Stroke
TTDC00300	Pathway	Alzheimer's disease
TTDC00300	Pathway	Apoptosis
TTDC00300	Pathway	Cytokine-cytokine receptor interaction
TTDC00300	Pathway	Graft-versus-host disease
TTDC00300	Pathway	Hematopoietic cell lineage
TTDC00300	Pathway	MAPK signaling pathway
TTDC00300	Pathway	Toll-like receptor signaling pathway
TTDC00300	Pathway	Type I diabetes mellitus
TTDC00300	Related US Patent	6,419,944
TTDC00300	Related US Patent	6,423,321
TTDC00300	Related US Patent	6,455,520
TTDC00300	Target Validation	TTDC00300
TTDC00300	Drug(s)	AMG108
TTDC00300	Drug(s)	IL-1 ?Monoclonal Antibody
TTDC00300	Drug(s)	K-832
TTDC00300	Drug(s)	Rilonacept
TTDC00300	Inhibitor	K-832
TTDC00300	Antibody	AMG108
TTDC00300	Binder	Rilonacept
TTDC00301	UniProt ID	P17787
TTDC00301	Name	Neuronal acetylcholine receptor protein, beta-2 chain
TTDC00301	Type of target	Discontinued target
TTDC00301	Synonyms	Beta-2 nAChR
TTDC00301	Synonyms	Nicotinic acetylcholine receptor beta 2-subunit protein
TTDC00301	Synonyms	Nicotinic acetylcholine receptor beta2
TTDC00301	Disease	Alzheimer's disease
TTDC00301	Disease	Analgesics
TTDC00301	Disease	Drug dependence
TTDC00301	Disease	Frontal lobe epilepsy
TTDC00301	Disease	Neurodegenerative diseases
TTDC00301	Disease	Pain, unspecified
TTDC00301	Disease	Parkinson's disease
TTDC00301	Function	After binding acetylcholine, the achr responds by an extensive change in conform
TTDC00301	Sequence	MARRCGPVALLLGFGLLRLCSGVWGTDTEERLVEHLLDPSRYNKLIRPATNGSELVTVQLMVSLAQLISVHEREQIMTTN
TTDC00301	PDB Structure	2GVT; 2K58; 2K59
TTDC00301	BioChemical Class	Ion transport
TTDC00301	Target Validation	TTDC00301
TTDC00301	Drug(s)	ABT-894
TTDC00301	Inhibitor	(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol
TTDC00301	Inhibitor	(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol
TTDC00301	Inhibitor	3-[2-(N,N,N-trimethylammonium)ethoxy]pyridine
TTDC00301	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDC00301	Inhibitor	6'-methylepibatidine
TTDC00301	Inhibitor	BOLDINE
TTDC00301	Inhibitor	CMI-489
TTDC00301	Inhibitor	CYTISINE
TTDC00301	Inhibitor	GCCSHPACAGNNQHIC*
TTDC00301	Inhibitor	GCCSNPVCHLEHSNLC*
TTDC00301	Inhibitor	HOMOEPIBATIDINE
TTDC00301	Inhibitor	N,N-dimethyl(pyridin-3-yl)methanamine
TTDC00301	Inhibitor	N,N-dimethyl-2-(pyridin-3-yloxy)ethanamine
TTDC00301	Inhibitor	N,N-dimethyl-4-(pyridin-3-yl)but-3-yn-1-amine
TTDC00301	Inhibitor	N-ethyl-N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine
TTDC00301	Inhibitor	N-methyl-2-(pyridin-3-yloxy)ethanamine
TTDC00301	Inhibitor	N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine
TTDC00301	Inhibitor	N-methyl-N-(pyridin-3-ylmethyl)ethanamine
TTDC00301	Inhibitor	N-methyllaurotetanine methiodide
TTDC00301	Inhibitor	boldine methiodide
TTDC00301	Inhibitor	glaucine methiodide
TTDC00301	Inhibitor	predicentrine methiodide
TTDC00301	Antagonist	Laudanosine
TTDC00301	Antagonist	Volatile anesthetics
TTDC00301	Agonist	ABT-418
TTDC00301	Agonist	ABT-594
TTDC00301	Agonist	ABT-894
TTDC00301	Agonist	SIB-1508Y
TTDC00301	Binder	Nicotine replacement
TTDC00301	Multitarget	ABT-894
TTDC00303	UniProt ID	P22460
TTDC00303	Name	Potassium voltage-gated channel subfamily A member 5
TTDC00303	Type of target	Clinical trial target
TTDC00303	Synonyms	02-Sensitive Potassium Channel Kv1.5
TTDC00303	Synonyms	HK2
TTDC00303	Synonyms	HPCN1
TTDC00303	Synonyms	Potassium channel Kv1.5
TTDC00303	Synonyms	Voltage-gated potassium channel subunit Kv1.5
TTDC00303	Disease	Vascular disease
TTDC00303	Function	Mediates the voltage-dependent potassium ion permeability of excitable membranes
TTDC00303	Sequence	MEIALVPLENGGAMTVRGGDEARAGCGQATGGELQCPPTAGLSDGPKEPAPKGRGAQRDADSGVRPLPPLPDPGVRPLPP
TTDC00303	BioChemical Class	Voltage-gated channel
TTDC00303	Target Validation	TTDC00303
TTDC00303	Drug(s)	4-Aminopyridine
TTDC00303	Drug(s)	Azimilide
TTDC00303	Drug(s)	Dronedarone
TTDC00303	Inhibitor	2-amino-2-phenyl-1,1-di(pyridin-3-yl)ethanol
TTDC00303	Inhibitor	2-morpholino-1,1,2-triphenylethanol
TTDC00303	Inhibitor	2-morpholino-1,1-di(pyridin-3-yl)hexan-1-ol
TTDC00303	Inhibitor	2-morpholino-1,1-di(pyridin-3-yl)octan-1-ol
TTDC00303	Inhibitor	2-morpholino-2-phenyl-1,1-di(pyridin-3-yl)ethanol
TTDC00303	Inhibitor	2-phenoxy-1-(2-p-tolylthiazolidin-3-yl)ethanone
TTDC00303	Inhibitor	2-phenyl-1,1-di(pyridin-3-yl)ethanol
TTDC00303	Inhibitor	3-(4-methoxybenzyloxy)-2-phenylthiazolidin-4-one
TTDC00303	Inhibitor	3-(benzyloxy)-2-(4-chlorophenyl)thiazolidin-4-one
TTDC00303	Inhibitor	3-methyl-2-morpholino-1,1-diphenylbutan-1-ol
TTDC00303	Inhibitor	4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one
TTDC00303	Inhibitor	N-Benzyl-2-(toluene-4-sulfonylamino)-benzamide
TTDC00303	Inhibitor	N-Phenethyl-2-(toluene-4-sulfonylamino)-benzamide
TTDC00303	Blocker	4-Aminopyridine
TTDC00303	Blocker	AVE-0118
TTDC00303	Blocker	Azimilide
TTDC00303	Blocker	Dronedarone
TTDC00303	Blocker	NIP-142
TTDC00303	Blocker	RS-100302
TTDC00303	Blocker	S-20951
TTDC00303	Blocker	S-9947
TTDC00304	UniProt ID	P23975
TTDC00304	Name	Sodium-dependent noradrenaline transporter
TTDC00304	Type of target	Successful target
TTDC00304	Synonyms	NET
TTDC00304	Synonyms	Norepinephrine transporter
TTDC00304	Disease	Depression
TTDC00304	Function	Amine transporter. Terminates the action of noradrenaline by its high affinity s
TTDC00304	Sequence	MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRDGDAQPRETWGKKIDFLLSVVGFAVDLANVW
TTDC00304	BioChemical Class	Transmembrane protein
TTDC00304	Target Validation	TTDC00304
TTDC00304	Drug(s)	Esreboxetine
TTDC00304	Drug(s)	LY367265
TTDC00304	Drug(s)	Milnacipran HCl
TTDC00304	Drug(s)	NERI IV
TTDC00304	Inhibitor	((3R,4R)-4-(o-tolyloxy)chroman-3-yl)methanamine
TTDC00304	Inhibitor	(+/-)-3-((naphthalen-2-yloxy)methyl)pyrrolidine
TTDC00304	Inhibitor	(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol
TTDC00304	Inhibitor	(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol
TTDC00304	Inhibitor	(R)-1-((S)-morpholin-2-yl)-1,2-diphenylethanol
TTDC00304	Inhibitor	(R)-2-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol
TTDC00304	Inhibitor	(R)-3-(naphthalen-2-ylmethoxy)pyrrolidine
TTDC00304	Inhibitor	(R)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile
TTDC00304	Inhibitor	(R)-DULOXETINE
TTDC00304	Inhibitor	(R)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide
TTDC00304	Inhibitor	(R)-N-isopropyl-N-(pyrrolidin-3-yl)-2-naphthamide
TTDC00304	Inhibitor	(R)-Norfluoxetine
TTDC00304	Inhibitor	(S)-3-(naphthalen-2-ylmethoxy)pyrrolidine
TTDC00304	Inhibitor	(S)-6-(pyrrolidin-3-ylmethoxy)-2-naphthonitrile
TTDC00304	Inhibitor	(S)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide
TTDC00304	Inhibitor	(S)-NORDULOXETINE
TTDC00304	Inhibitor	(S)-Norfluoxetine
TTDC00304	Inhibitor	(S,S)-reboxetine
TTDC00304	Inhibitor	1-(1,2-diphenylethyl)piperazine
TTDC00304	Inhibitor	1-(1,4-diphenylbutan-2-yl)piperazine
TTDC00304	Inhibitor	1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMER
TTDC00304	Inhibitor	1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMER
TTDC00304	Inhibitor	1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine
TTDC00304	Inhibitor	1-(1-phenyl-2-o-tolylethyl)piperazine
TTDC00304	Inhibitor	1-(2,3-Dihydro-1H-indol-5-ylmethyl)-propylamine
TTDC00304	Inhibitor	1-(2-((3-fluorophenoxy)methyl)phenyl)piperazine
TTDC00304	Inhibitor	1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX)
TTDC00304	Inhibitor	1-(2-(2-bromophenyl)-1-phenylethyl)piperazine
TTDC00304	Inhibitor	1-(2-(2-chlorophenoxy)pyridin-3-yl)piperazine
TTDC00304	Inhibitor	1-(2-(2-chlorophenyl)-1-phenylethyl)piperazine
TTDC00304	Inhibitor	1-(2-(2-ethoxyphenyl)-1-phenylethyl)piperazine
TTDC00304	Inhibitor	1-(2-(2-ethylphenyl)-1-phenylethyl)piperazine
TTDC00304	Inhibitor	1-(2-(2-fluorobenzyloxy)phenyl)piperazine
TTDC00304	Inhibitor	1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine
TTDC00304	Inhibitor	1-(2-(3-chlorophenyl)-1-phenylethyl)piperazine
TTDC00304	Inhibitor	1-(2-(3-fluorophenoxy)phenyl)piperazine
TTDC00304	Inhibitor	1-(2-(3-methoxyphenyl)-1-phenylethyl)piperazine
TTDC00304	Inhibitor	1-(2-(4-fluorophenoxy)phenyl)piperazine
TTDC00304	Inhibitor	1-(2-(6-fluoronaphthalen-2-yl)ethyl)piperazine
TTDC00304	Inhibitor	1-(2-(benzyloxy)phenyl)piperazine
TTDC00304	Inhibitor	1-(2-(phenoxymethyl)phenyl)piperazine
TTDC00304	Inhibitor	1-(2-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one
TTDC00304	Inhibitor	1-(2-phenoxyphenyl)piperazine
TTDC00304	Inhibitor	1-(3,4-Dichloro-phenyl)-3-diethylamino-indan-5-ol
TTDC00304	Inhibitor	1-(3,4-Dichloro-phenyl)-3-methylamino-indan-5-ol
TTDC00304	Inhibitor	1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane
TTDC00304	Inhibitor	1-(3-bromophenyl)-2-(tert-butylamino)propan-1-one
TTDC00304	Inhibitor	1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one
TTDC00304	Inhibitor	1-(3-chlorophenyl)-2-(piperidin-1-yl)propan-1-one
TTDC00304	Inhibitor	1-(3-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one
TTDC00304	Inhibitor	1-(3-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one
TTDC00304	Inhibitor	1-(4-bromophenyl)-2-(tert-butylamino)propan-1-one
TTDC00304	Inhibitor	1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one
TTDC00304	Inhibitor	1-(4-fluorophenyl)-2-pyrrolidin-1-yl-pentan-1-one
TTDC00304	Inhibitor	1-(4-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one
TTDC00304	Inhibitor	1-(4-nitrophenyl)-2-pyrrolidin-1-yl-pentan-1-one
TTDC00304	Inhibitor	1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one
TTDC00304	Inhibitor	1S,2R-milnacipran
TTDC00304	Inhibitor	2-((2-iodophenoxy)(phenyl)methyl)morpholine
TTDC00304	Inhibitor	2-((3-iodophenyl)(o-tolyloxy)methyl)morpholine
TTDC00304	Inhibitor	2-(2'-Aminoethyl)-5-benzyltetrahydrofuran
TTDC00304	Inhibitor	2-(2,3-Dihydro-1H-indol-5-yl)-1-methyl-ethylamine
TTDC00304	Inhibitor	2-(2-chlorophenoxy)-3-(piperidin-4-yl)pyridine
TTDC00304	Inhibitor	2-(2-fluorophenoxy)-3-(piperidin-4-yl)pyridine
TTDC00304	Inhibitor	2-(2-methoxyphenoxy)-3-(piperidin-4-yl)pyridine
TTDC00304	Inhibitor	2-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile
TTDC00304	Inhibitor	2-(Aminomethyl)-5-(1'-naphthethyl)tetrahydrofuran
TTDC00304	Inhibitor	2-(Aminomethyl)-5-(1'-naphthyl)tetrahydrofuran
TTDC00304	Inhibitor	2-(Aminomethyl)-5-(2'-naphthyl)tetrahydrofuran
TTDC00304	Inhibitor	2-(Aminomethyl)-5-phenethyltetrahydrofuran
TTDC00304	Inhibitor	2-(N,N-Diethylamino)-3'-chloropropiophenone
TTDC00304	Inhibitor	2-(N-Cyclopentylamino)-3'-bromopropiophenone
TTDC00304	Inhibitor	2-(N-Cyclopentylamino)-3'-chloropropiophenone
TTDC00304	Inhibitor	2-(N-Cyclopentylamino)-3'-fluoropropiophenone
TTDC00304	Inhibitor	2-(N-Cyclopentylamino)-3'-methoxypropiophenone
TTDC00304	Inhibitor	2-(N-Cyclopentylamino)-3'-methylpropiophenone
TTDC00304	Inhibitor	2-(N-Cyclopropylamino)-3-chloropropiophenone
TTDC00304	Inhibitor	2-(N-Pyrrolidinyl)-3'-bromopropiophenone
TTDC00304	Inhibitor	2-(N-Pyrrolidinyl)-3'-fluoropropiophenone
TTDC00304	Inhibitor	2-(N-Pyrrolidinyl)-3'-methoxypropiophenone
TTDC00304	Inhibitor	2-(N-Pyrrolidinyl)-3'-methylpropiophenone
TTDC00304	Inhibitor	2-(N-Pyrrolidinyl)-3'-nitropropiophenone
TTDC00304	Inhibitor	2-(N-tert-Butylamino)-3',4'-dichloropropiophenone
TTDC00304	Inhibitor	2-(N-tert-Butylamino)-3'-chloroheptanophenone
TTDC00304	Inhibitor	2-(N-tert-Butylamino)-3'-chlorohexanophenone
TTDC00304	Inhibitor	2-(N-tert-Butylamino)-3'-chlorooctanophenone
TTDC00304	Inhibitor	2-(N-tert-Butylamino)-3'-chloropentanophenone
TTDC00304	Inhibitor	2-(N-tert-Butylamino)propiophenone
TTDC00304	Inhibitor	2-(tert-Butylamino)-3',4'-dichlorobutyrophenone
TTDC00304	Inhibitor	2-(tert-Butylamino)-3',4'-dichloropentanophenone
TTDC00304	Inhibitor	2-(tert-butylamino)-1-(3-chlorophenyl)butan-1-one
TTDC00304	Inhibitor	2-(tert-butylamino)-1-m-tolylpropan-1-one
TTDC00304	Inhibitor	2-(tert-butylamino)-1-p-tolylpropan-1-one
TTDC00304	Inhibitor	2-Amino-1-(4-methylthiophenyl)propane
TTDC00304	Inhibitor	2-Aminomethyl-5-(p-bromophenyl)tetrahydrofuran
TTDC00304	Inhibitor	2-Aminomethyl-5-(p-chlorophenyl)tetrahydrofuran
TTDC00304	Inhibitor	2-Aminomethyl-5-(p-methoxyphenyl)tetrahydrofuran
TTDC00304	Inhibitor	2-Aminomethyl-5-(p-t-butylphenyl)tetrahydrofuran
TTDC00304	Inhibitor	2-Aminomethyl-5-(phenyl)tetrahydrofuran
TTDC00304	Inhibitor	2-phenoxy-3-(piperidin-4-yl)pyridine
TTDC00304	Inhibitor	2pyrrolidin-1-yl-1-phenylpentan-1-one
TTDC00304	Inhibitor	3-(1H-indol-1-yl)-N-methyl-3-phenylpropan-1-amine
TTDC00304	Inhibitor	3-(2-phenyl-2-(piperazin-1-yl)ethyl)benzonitrile
TTDC00304	Inhibitor	3-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol
TTDC00304	Inhibitor	3-(3'-furyl)-aniline
TTDC00304	Inhibitor	3-(piperidin-4-yl)-2-(o-tolyloxy)pyridine
TTDC00304	Inhibitor	3-p-Tolyl-8-aza-bicyclo[3.2.1]octane
TTDC00304	Inhibitor	3alpha-(bis-chloro-phenylmethoxy)tropane
TTDC00304	Inhibitor	4-((naphthalen-2-yloxy)methyl)piperidine
TTDC00304	Inhibitor	4-(1H-indol-3-yl)-N,N-dimethylcyclohex-3-enamine
TTDC00304	Inhibitor	4-(2-((3-fluorophenoxy)methyl)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-(2-fluoro-5-methylphenoxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-(2-fluorobenzyloxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-(3-chlorophenoxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-(3-fluorophenoxy)-4-methylphenyl)piperidine
TTDC00304	Inhibitor	4-(2-(3-fluorophenoxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-(4-fluorobenzyloxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-(4-fluorophenoxy)-4-methylphenyl)piperidine
TTDC00304	Inhibitor	4-(2-(4-fluorophenoxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-(benzyloxy)-3-fluorophenyl)piperidine
TTDC00304	Inhibitor	4-(2-(benzyloxy)-6-fluorophenyl)piperidine
TTDC00304	Inhibitor	4-(2-(benzyloxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-(phenoxymethyl)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-fluoro-6-(2-fluorophenoxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-fluoro-6-(3-fluorophenoxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-fluoro-6-(4-fluorophenoxy)phenyl)piperidine
TTDC00304	Inhibitor	4-(2-fluoro-6-phenoxyphenyl)piperidine
TTDC00304	Inhibitor	4-(2-phenoxyphenyl)piperidine
TTDC00304	Inhibitor	4-(3'-furyl)-aniline
TTDC00304	Inhibitor	4-(3-fluoro-2-phenoxyphenyl)piperidine
TTDC00304	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDC00304	Inhibitor	6-(piperidin-4-ylmethoxy)-2-naphthonitrile
TTDC00304	Inhibitor	7-(piperidin-4-ylmethoxy)-2-naphthonitrile
TTDC00304	Inhibitor	8-Methyl-3-p-tolyl-8-aza-bicyclo[3.2.1]octane
TTDC00304	Inhibitor	AMIFLAMINE
TTDC00304	Inhibitor	Biphenyl-2-ylmethyl-(S)-pyrrolidin-3-yl-amine
TTDC00304	Inhibitor	D-166A
TTDC00304	Inhibitor	D-211A
TTDC00304	Inhibitor	D-211B
TTDC00304	Inhibitor	D-254C
TTDC00304	Inhibitor	D-257A
TTDC00304	Inhibitor	D-257C
TTDC00304	Inhibitor	DIFLUOROBENZTROPINE
TTDC00304	Inhibitor	KF-A5
TTDC00304	Inhibitor	LITOXETINE
TTDC00304	Inhibitor	LY367265
TTDC00304	Inhibitor	MDL-28618
TTDC00304	Inhibitor	METHYLENEDIOXYAMPHETAMINE
TTDC00304	Inhibitor	METHYLENEDIOXYMETHAMPHETAMINE
TTDC00304	Inhibitor	Milnacipran HCl
TTDC00304	Inhibitor	N,N-dimethyl(2-phenoxyphenyl)methanamine
TTDC00304	Inhibitor	N-(2-oxazolemethyl)milnacipran
TTDC00304	Inhibitor	N-benzyl-N-isobutylpiperidin-4-amine
TTDC00304	Inhibitor	NISOXETINE
TTDC00304	Inhibitor	PF-18298;PF-184298
TTDC00304	Inhibitor	PF-3409409
TTDC00304	Inhibitor	PF-526014
TTDC00304	Inhibitor	POLYGALATENOSIDE B
TTDC00304	Inhibitor	PYROVALERONE
TTDC00304	Inhibitor	R-NORDULOXETINE
TTDC00304	Inhibitor	RTI-219
TTDC00304	Inhibitor	S-34324
TTDC00304	Inhibitor	S33005
TTDC00304	Inhibitor	WAY-256805
TTDC00304	Inhibitor	WIN-35065-2
TTDC00304	Inhibitor	WIN-35066-2
TTDC00304	Inhibitor	WIN_35428
TTDC00304	Inhibitor	[3-(3,4-Dichloro-phenyl)-indan-1-yl]-methyl-amine
TTDC00304	Inhibitor	cis-3-phenoxy-2,3-dihydro-1H-inden-1-amine
TTDC00304	Inhibitor	isobutyl-(4-methyl-benzyl)-piperidin-4-yl-amine
TTDC00304	Inhibitor	para-chloroamphetamine
TTDC00304	Inhibitor	trans-3-(o-tolyloxy)-2,3-dihydro-1H-inden-1-amine
TTDC00304	Inhibitor	{2-[3-(Phenylsulfonyl)-1H-indol-4-yl]ethyl}amine
TTDC00304	Blocker	Esreboxetine
TTDC00304	Blocker	NERI IV
TTDC00304	Blocker	Oxaprotiline
TTDC00304	Modulator	3,4-Methylenedioxymethamphetamine
TTDC00304	Modulator	MMDA
TTDC00304	Multitarget	Milnacipran HCl
TTDC00307	UniProt ID	P20071
TTDC00307	Name	FK506-binding protein 1A
TTDC00307	Type of target	Clinical trial target
TTDC00307	Synonyms	12 kDa FKBP
TTDC00307	Synonyms	FK-binding protein 12
TTDC00307	Synonyms	FKBP-12
TTDC00307	Synonyms	Immunophilin FKBP12
TTDC00307	Synonyms	Immunophillin FKBP
TTDC00307	Synonyms	PPIase
TTDC00307	Synonyms	Peptidyl-prolyl cis-trans isomerase
TTDC00307	Synonyms	Rotamase
TTDC00307	Disease	Autoimmune diseases
TTDC00307	Function	May play a role in modulation of ryanodine receptor isoform-1 (RYR-1), a compone
TTDC00307	Sequence	MGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPD
TTDC00307	PDB Structure	1A7X; 1B6C; 1BKF; 1BL4; 1D6O; 1D7H; 1D7I; 1D7J
TTDC00307	EC Number	EC 5.2.1.8
TTDC00307	Related US Patent	6,495,549
TTDC00307	Related US Patent	6,509,464
TTDC00307	Related US Patent	6,562,964
TTDC00307	Target Validation	TTDC00307
TTDC00307	Drug(s)	GPI-1485
TTDC00307	Inhibitor	4-Hydroxy-2-Butanone
TTDC00307	Inhibitor	FKB-001
TTDC00307	Inhibitor	Gpi-1046
TTDC00307	Inhibitor	Heptyl-Beta-D-Glucopyranoside
TTDC00307	Inhibitor	L-709,587
TTDC00307	Inhibitor	MYRISTIC ACID
TTDC00307	Inhibitor	Methyl Methylsulfinylmethyl Sulfide
TTDC00307	Inhibitor	Rapamycin Immunosuppressant Drug
TTDC00307	Binder	Rapamycin
TTDC00307	Ligand	GPI-1485
TTDC00308	Name	mRNA of HIV-1 TAR
TTDC00308	Type of target	Clinical trial target
TTDC00308	Disease	Human immunodeficiency virus [HIV] disease
TTDC00308	Target Validation	TTDC00308
TTDC00308	Drug(s)	Antisense TAR and RevM10
TTDC00308	Antisense	Antisense TAR and RevM10
TTDC00308	Multitarget	Antisense TAR and RevM10
TTDC00310	UniProt ID	P04049
TTDC00310	Name	mRNA of RAF proto-oncogene serine/threonine-protein kinase
TTDC00310	Type of target	Clinical trial target
TTDC00310	Synonyms	C-RAF
TTDC00310	Synonyms	CRaf
TTDC00310	Synonyms	Raf kinase
TTDC00310	Synonyms	Raf-1
TTDC00310	Disease	Cancer, unspecific
TTDC00310	Function	Involved in the transduction of mitogenic signals from the cell membrane to the
TTDC00310	Sequence	MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHD
TTDC00310	PDB Structure	1C1Y; 1FAQ; 1FAR; 1GUA; 1RFA; 3CU8
TTDC00310	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00310	Pathway	Acute myeloid leukemia
TTDC00310	Pathway	B cell receptor signaling pathway
TTDC00310	Pathway	Bladder cancer
TTDC00310	Pathway	Chemokine signaling pathway
TTDC00310	Pathway	Chronic myeloid leukemia
TTDC00310	Pathway	Colorectal cancer
TTDC00310	Pathway	Endometrial cancer
TTDC00310	Pathway	ErbB signaling pathway
TTDC00310	Pathway	Fc epsilon RI signaling pathway
TTDC00310	Pathway	Focal adhesion
TTDC00310	Pathway	Gap junction
TTDC00310	Pathway	Glioma
TTDC00310	Pathway	GnRH signaling pathway
TTDC00310	Pathway	Insulin signaling pathway
TTDC00310	Pathway	Long-term depression
TTDC00310	Pathway	Long-term potentiation
TTDC00310	Pathway	MAPK signaling pathway
TTDC00310	Pathway	Melanogenesis
TTDC00310	Pathway	Melanoma
TTDC00310	Pathway	Natural killer cell mediated cytotoxicity
TTDC00310	Pathway	Non-small cell lung cancer
TTDC00310	Pathway	Pancreatic cancer
TTDC00310	Pathway	Pathways in cancer
TTDC00310	Pathway	Prostate cancer
TTDC00310	Pathway	Regulation of actin cytoskeleton
TTDC00310	Pathway	Renal cell carcinoma
TTDC00310	Pathway	T cell receptor signaling pathway
TTDC00310	Pathway	VEGF signaling pathway
TTDC00310	Pathway	Vascular smooth muscle contraction
TTDC00310	EC Number	EC 2.7.1.37
TTDC00310	Related US Patent	6,268,391
TTDC00310	Target Validation	TTDC00310
TTDC00310	Drug(s)	LGX8 18
TTDC00310	Drug(s)	LGX818
TTDC00310	Drug(s)	MLN2480
TTDC00310	Drug(s)	RAF265
TTDC00310	Drug(s)	RG7304
TTDC00310	Drug(s)	iCo-007
TTDC00310	Inhibitor	5-(4-hydroxy-2,6-dimethylstyryl)nicotinic acid
TTDC00310	Inhibitor	6-Benzylsulfanyl-9H-purine
TTDC00310	Inhibitor	6-[(E)-2-(4-Fluoro-phenyl)-vinyl]-9H-purine
TTDC00310	Inhibitor	BIRB796
TTDC00310	Inhibitor	DEBROMOHYMENIALDISINE
TTDC00310	Inhibitor	GW-5074
TTDC00310	Inhibitor	L-790070
TTDC00310	Inhibitor	PD-98059
TTDC00310	Inhibitor	SB-203580
TTDC00310	Inhibitor	U-0126
TTDC00310	Inhibitor	ZM-336372
TTDC00310	Antisense	ISIS 10707
TTDC00310	Antisense	ISIS 11061
TTDC00310	Antisense	ISIS 15770
TTDC00310	Antisense	ISIS 5132
TTDC00310	Antisense	ISIS 6717
TTDC00310	Antisense	ISIS 6720
TTDC00310	Antisense	ISIS 6729
TTDC00310	Antisense	ISIS 7847
TTDC00310	Antisense	ISIS 7848
TTDC00310	Antisense	ISIS 7849
TTDC00310	Antisense	ISIS 7851
TTDC00310	Antisense	ISIS 7853
TTDC00310	Antisense	ISIS 7855
TTDC00310	Antisense	ISIS 9058
TTDC00310	Antisense	iCo-007
TTDC00311	UniProt ID	P16234
TTDC00311	Name	Alpha platelet-derived growth factor receptor
TTDC00311	Type of target	Discontinued target
TTDC00311	Synonyms	CD140a antigen
TTDC00311	Synonyms	PDGF-R-alpha
TTDC00311	Synonyms	Platelet-derived growth factor receptor alpha
TTDC00311	Disease	Hypereosinophilic syndrome
TTDC00311	Disease	Lung cancer
TTDC00311	Function	Receptor that binds both pdgfa and pdgfb and has a tyrosine-protein kinase activ
TTDC00311	Sequence	MGTSHPAFLVLGCLLTGLSLILCQLSLPSILPNENEKVVQLNSSFSLRCFGESEVSWQYPMSEEESSDVEIRNEENNSGL
TTDC00311	PDB Structure	1GQ5
TTDC00311	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00311	Pathway	Calcium signaling pathway
TTDC00311	Pathway	Colorectal cancer
TTDC00311	Pathway	Cytokine-cytokine receptor interaction
TTDC00311	Pathway	Focal adhesion
TTDC00311	Pathway	Gap junction
TTDC00311	Pathway	Glioma
TTDC00311	Pathway	MAPK signaling pathway
TTDC00311	Pathway	Melanoma
TTDC00311	Pathway	Pathways in cancer
TTDC00311	Pathway	Prostate cancer
TTDC00311	Pathway	Regulation of actin cytoskeleton
TTDC00311	EC Number	EC 2.7.1.112
TTDC00311	Target Validation	TTDC00311
TTDC00311	Drug(s)	MEDI-575
TTDC00311	Drug(s)	Olaratumab
TTDC00311	Drug(s)	TAK-593
TTDC00311	Inhibitor	(1H-indol-2-yl)(5-methoxy-1H-indol-2-yl)methanone
TTDC00311	Inhibitor	(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone
TTDC00311	Inhibitor	(1H-indol-2-yl)(6-methoxy-1H-indol-2-yl)methanone
TTDC00311	Inhibitor	(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone
TTDC00311	Inhibitor	(5-hydroxy-1H-indol-2-yl)(1H-indol-2-yl)methanone
TTDC00311	Inhibitor	1-Phenyl-1H-benzoimidazol-5-ol
TTDC00311	Inhibitor	1-Phenyl-1H-benzoimidazole
TTDC00311	Inhibitor	3-((E)-Styryl)-quinoline
TTDC00311	Inhibitor	3-(1H-Indol-3-yl)-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-(1H-Indol-3-yl)-quinoline
TTDC00311	Inhibitor	3-(2-Cyclohexyl-ethyl)-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-(3,4-Dichloro-phenyl)-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-(3,4-Difluoro-phenyl)-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-(3,4-Dimethoxy-phenyl)-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-(3-Fluoro-phenyl)-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-(4-Fluoro-phenyl)-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-Benzyloxy-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-Cyclohexylethynyl-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-Cyclopent-1-enyl-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-Cyclopentyl-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	3-Pyridin-3-yl-quinoline-6,7-diol
TTDC00311	Inhibitor	3-Pyridin-4-yl-quinolin-7-ol
TTDC00311	Inhibitor	3-Pyridin-4-yl-quinoline
TTDC00311	Inhibitor	3-Pyridin-4-yl-quinoline-5,7-diol
TTDC00311	Inhibitor	3-Thiophen-3-yl-quinoline
TTDC00311	Inhibitor	4-(3,4-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline
TTDC00311	Inhibitor	4-(5-Methoxy-benzoimidazol-1-yl)-phenylamine
TTDC00311	Inhibitor	4-(6,7-Dimethoxy-quinolin-3-yl)-benzoic acid
TTDC00311	Inhibitor	4-(6,7-Dimethoxy-quinolin-3-yl)-phenol
TTDC00311	Inhibitor	4-Benzoimidazol-1-yl-phenylamine
TTDC00311	Inhibitor	5,11-Dimethyl-6H-pyrido[4,3-b]carbazol-9-ol
TTDC00311	Inhibitor	5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline
TTDC00311	Inhibitor	5,7-Dimethoxy-3-pyridin-4-yl-quinoline
TTDC00311	Inhibitor	5,7-Dimethoxy-3-thiophen-3-yl-quinoline
TTDC00311	Inhibitor	5,7-Dimethyl-3-thiophen-3-yl-quinoline
TTDC00311	Inhibitor	5-(6,7-Dimethoxy-quinolin-3-yl)-1H-pyridin-2-one
TTDC00311	Inhibitor	5-Fluoro-3-thiophen-3-yl-quinoline
TTDC00311	Inhibitor	5-Methoxy-1-phenyl-1H-benzoimidazole
TTDC00311	Inhibitor	6,7-Dichloro-3-thiophen-3-yl-quinoline
TTDC00311	Inhibitor	6,7-Difluoro-3-thiophen-3-yl-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-((E)-styryl)-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-(2-methoxy-phenyl)-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-(3-methoxy-phenyl)-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-(4-methoxy-phenyl)-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-(4-nitro-phenyl)-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-p-tolyl-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-phenyl-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-phenylethynyl-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-pyridin-3-yl-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-pyridin-4-yl-quinoline
TTDC00311	Inhibitor	6,7-Dimethoxy-3-thiophen-2-yl-quinoline
TTDC00311	Inhibitor	6-Methoxy-3-pyridin-4-yl-quinoline
TTDC00311	Inhibitor	6-Methoxy-3-thiophen-3-yl-quinoline
TTDC00311	Inhibitor	7-Chloro-3-pyridin-4-yl-quinoline
TTDC00311	Inhibitor	7-Fluoro-3-thiophen-3-yl-quinoline
TTDC00311	Inhibitor	7-Methoxy-3-pyridin-4-yl-quinoline
TTDC00311	Inhibitor	7-Methoxy-3-thiophen-3-yl-quinoline
TTDC00311	Inhibitor	7-Thiophen-3-yl-[1,3]dioxolo[4,5-g]quinoline
TTDC00311	Inhibitor	AG1295
TTDC00311	Inhibitor	AZD-0530
TTDC00311	Inhibitor	BMS-536924
TTDC00311	Inhibitor	Benzyl-(6,7-dimethoxy-quinolin-3-yl)-amine
TTDC00311	Inhibitor	Bis-(5-hydroxy-1H-indol-2-yl)-methanone
TTDC00311	Inhibitor	ELLIPTINIUM
TTDC00311	Inhibitor	JNJ-10198409
TTDC00311	Inhibitor	PD-0166326;PD-166326
TTDC00311	Inhibitor	PD-0173952
TTDC00311	Inhibitor	PD-0173955;PD-17395
TTDC00311	Inhibitor	PD-0173956
TTDC00311	Inhibitor	PD-0173958
TTDC00311	Inhibitor	PD-0179483
TTDC00311	Inhibitor	PD-0180970
TTDC00311	Inhibitor	PD-173074
TTDC00311	Inhibitor	RG-13022
TTDC00311	Inhibitor	RPR-101511
TTDC00311	Inhibitor	RPR-108514A
TTDC00311	Inhibitor	Ro-4396686
TTDC00311	Inhibitor	SEMAXINIB
TTDC00311	Inhibitor	SU-11652
TTDC00311	Inhibitor	TAK-593
TTDC00311	Inhibitor	di(1H-indol-2-yl)methanone
TTDC00311	Antibody	MEDI-575
TTDC00311	Multitarget	TAK-593
TTDC00312	UniProt ID	P00749
TTDC00312	Name	Urokinase-type plasminogen activator
TTDC00312	Type of target	Clinical trial target
TTDC00312	Synonyms	U-plasminogen activator
TTDC00312	Synonyms	UPA
TTDC00312	Disease	Cancer, unspecific
TTDC00312	Disease	Melanoma
TTDC00312	Function	Potent plasminogen activator and is clinically used for therapy of thrombolytic
TTDC00312	Sequence	MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRG
TTDC00312	PDB Structure	1C5W; 1C5X; 1C5Y; 1C5Z; 1EJN; 1F5K; 1F5L; 1F92
TTDC00312	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDC00312	Pathway	Complement and coagulation cascades
TTDC00312	EC Number	EC 3.4.21.73
TTDC00312	Related US Patent	6,207,701
TTDC00312	Related US Patent	6,248,738
TTDC00312	Related US Patent	6,274,619
TTDC00312	Related US Patent	6,465,503
TTDC00312	Related US Patent	6,495,562
TTDC00312	Related US Patent	6,504,031
TTDC00312	Related US Patent	6,528,619
TTDC00312	Related US Patent	6,562,840
TTDC00312	Related US Patent	6,583,162
TTDC00312	Related US Patent	6,624,169
TTDC00312	Related US Patent	6,673,789
TTDC00312	Related US Patent	6,680,320
TTDC00312	Target Validation	TTDC00312
TTDC00312	Drug(s)	Amediplase
TTDC00312	Inhibitor	(2R)-1-(2,6-dimethylphenoxy)propan-2-amine
TTDC00312	Inhibitor	(3,4-dichlorophenyl)(1H-pyrazol-1-yl)methanone
TTDC00312	Inhibitor	(3-nitro-1H-pyrazol-1-yl)(p-tolyl)methanone
TTDC00312	Inhibitor	(4-bromo-1H-pyrazol-1-yl)(p-tolyl)methanone
TTDC00312	Inhibitor	(4-guanidino-benzyl)-carbamic acid benzyl ester
TTDC00312	Inhibitor	(4-nitro-1H-pyrazol-1-yl)(o-tolyl)methanone
TTDC00312	Inhibitor	(4-nitro-1H-pyrazol-1-yl)(phenyl)methanone
TTDC00312	Inhibitor	1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine
TTDC00312	Inhibitor	1-benzoyl-N-phenyl-1H-pyrazole-3-carboxamide
TTDC00312	Inhibitor	1-guanidino-7-isoquinolinesulphonamide
TTDC00312	Inhibitor	1-guanidino-N-phenyl-7-isoquinolinesulphonamide
TTDC00312	Inhibitor	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine
TTDC00312	Inhibitor	2-Amino-5-Hydroxy-Benzimidazole
TTDC00312	Inhibitor	2-nas-phe(3-am)-4-(2-guanidinoethyl)piperidine
TTDC00312	Inhibitor	4-Iodo-benzo[b]thiophene-2-carboxamidine
TTDC00312	Inhibitor	4-Iodobenzo[B]Thiophene-2-Carboxamidine
TTDC00312	Inhibitor	4-chloro-1-guanidino-7-isoquinolinesulphonamide
TTDC00312	Inhibitor	4-iodobenzo[b]thiophene 2-carboxamidine
TTDC00312	Inhibitor	4-methoxy-N'-(2-phenylacetyl)benzohydrazide
TTDC00312	Inhibitor	5-Methylsulfanyl-thiophene-2-carboxamidine
TTDC00312	Inhibitor	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine
TTDC00312	Inhibitor	Benzamidine
TTDC00312	Inhibitor	CRA_10655
TTDC00312	Inhibitor	CRA_8696
TTDC00312	Inhibitor	Fucose
TTDC00312	Inhibitor	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea
TTDC00312	Inhibitor	PAI-1
TTDC00312	Inhibitor	PAI-2
TTDC00312	Inhibitor	Thieno[2,3-B]Pyridine-2-Carboxamidine
TTDC00312	Activator	Amediplase
TTDC00313	UniProt ID	P24752
TTDC00313	Name	Acetyl-CoA acetyltransferase, mitochondrial
TTDC00313	Type of target	Discontinued target
TTDC00313	Synonyms	Acetoacetyl-CoA thiolase
TTDC00313	Synonyms	T2
TTDC00313	Disease	Hypercholesterolemia
TTDC00313	Function	Plays a major role in ketone body metabolism.
TTDC00313	Sequence	MAVLAALLRSGARSRSPLLRRLVQEIRYVERSYVSKPTLKEVVIVSATRTPIGSFLGSLSLLPATKLGSIAIQGAIEKAG
TTDC00313	PDB Structure	2F2S; 2IB7; 2IB8; 2IB9; 2IBU; 2IBW; 2IBY
TTDC00313	BioChemical Class	Acyltransferases
TTDC00313	Pathway	Benzoate degradation via CoA ligation
TTDC00313	Pathway	Butanoate metabolism
TTDC00313	Pathway	Fatty acid metabolism
TTDC00313	Pathway	Lysine degradation
TTDC00313	Pathway	Metabolic pathways
TTDC00313	Pathway	Propanoate metabolism
TTDC00313	Pathway	Pyruvate metabolism
TTDC00313	Pathway	Synthesis and degradation of ketone bodies
TTDC00313	Pathway	Tryptophan metabolism
TTDC00313	Pathway	Valine, leucine and isoleucine degradation
TTDC00313	EC Number	EC 2.3.1.9
TTDC00313	Target Validation	TTDC00313
TTDC00313	Drug(s)	Benoxaprofen
TTDC00313	Inhibitor	(Z)-2,6-diisopropyl-N-phenyloctadec-9-enamide
TTDC00313	Inhibitor	Benoxaprofen
TTDC00313	Inhibitor	Nordihydroguaiaretic acid
TTDC00313	Inhibitor	nonanoic acid biphenyl-2-ylamide
TTDC00313	Inhibitor	octanoic acid biphenyl-2-ylamide
TTDC00314	UniProt ID	P34972
TTDC00314	Name	Cannabinoid receptor 2
TTDC00314	Type of target	Clinical trial target
TTDC00314	Synonyms	CB-2
TTDC00314	Synonyms	CB2
TTDC00314	Synonyms	CX5
TTDC00314	Synonyms	Cannabinoid CB2 receptor
TTDC00314	Disease	Analgesics
TTDC00314	Disease	Pain, unspecified
TTDC00314	Function	Involved in cannabinoid-induced cns effects through G-protein mediated inhibitio
TTDC00314	Sequence	MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGAD
TTDC00314	PDB Structure	2KI9
TTDC00314	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDC00314	Pathway	Neuroactive ligand-receptor interaction
TTDC00314	Target Validation	TTDC00314
TTDC00314	QSAR Model	TTDC00314
TTDC00314	Drug(s)	S-777469
TTDC00314	Inhibitor	A-796260
TTDC00314	Inhibitor	AM-1241
TTDC00314	Inhibitor	AM-1710
TTDC00314	Inhibitor	AM-1714
TTDC00314	Inhibitor	AM-1715
TTDC00314	Inhibitor	AM-281
TTDC00314	Inhibitor	AM-404
TTDC00314	Inhibitor	AM-411
TTDC00314	Inhibitor	AM-4768
TTDC00314	Inhibitor	AM-630
TTDC00314	Inhibitor	CP-55940
TTDC00314	Inhibitor	GNF-PF-5188
TTDC00314	Inhibitor	HU-210
TTDC00314	Inhibitor	HU-210;HU-211
TTDC00314	Inhibitor	JWH-120
TTDC00314	Inhibitor	JWH-133
TTDC00314	Inhibitor	JWH-145
TTDC00314	Inhibitor	JWH-146
TTDC00314	Inhibitor	JWH-147
TTDC00314	Inhibitor	JWH-150
TTDC00314	Inhibitor	JWH-151
TTDC00314	Inhibitor	JWH-156
TTDC00314	Inhibitor	JWH-167
TTDC00314	Inhibitor	JWH-201
TTDC00314	Inhibitor	JWH-202
TTDC00314	Inhibitor	JWH-203
TTDC00314	Inhibitor	JWH-204
TTDC00314	Inhibitor	JWH-205
TTDC00314	Inhibitor	JWH-206
TTDC00314	Inhibitor	JWH-207
TTDC00314	Inhibitor	JWH-208
TTDC00314	Inhibitor	JWH-209
TTDC00314	Inhibitor	JWH-229
TTDC00314	Inhibitor	JWH-237
TTDC00314	Inhibitor	JWH-243
TTDC00314	Inhibitor	JWH-244
TTDC00314	Inhibitor	JWH-245
TTDC00314	Inhibitor	JWH-246
TTDC00314	Inhibitor	JWH-248
TTDC00314	Inhibitor	JWH-249
TTDC00314	Inhibitor	JWH-250
TTDC00314	Inhibitor	JWH-251
TTDC00314	Inhibitor	JWH-252
TTDC00314	Inhibitor	JWH-253
TTDC00314	Inhibitor	JWH-268
TTDC00314	Inhibitor	JWH-292
TTDC00314	Inhibitor	JWH-293
TTDC00314	Inhibitor	JWH-294
TTDC00314	Inhibitor	JWH-295
TTDC00314	Inhibitor	JWH-296
TTDC00314	Inhibitor	JWH-297
TTDC00314	Inhibitor	JWH-302
TTDC00314	Inhibitor	JWH-303
TTDC00314	Inhibitor	JWH-305
TTDC00314	Inhibitor	JWH-306
TTDC00314	Inhibitor	JWH-307
TTDC00314	Inhibitor	JWH-308
TTDC00314	Inhibitor	JWH-309
TTDC00314	Inhibitor	JWH-311
TTDC00314	Inhibitor	JWH-312
TTDC00314	Inhibitor	JWH-313
TTDC00314	Inhibitor	JWH-314
TTDC00314	Inhibitor	JWH-315
TTDC00314	Inhibitor	JWH-323
TTDC00314	Inhibitor	JWH-324
TTDC00314	Inhibitor	JWH-325
TTDC00314	Inhibitor	JWH-337
TTDC00314	Inhibitor	JWH-342
TTDC00314	Inhibitor	JWH-343
TTDC00314	Inhibitor	JWH-344
TTDC00314	Inhibitor	JWH-345
TTDC00314	Inhibitor	JWH-346
TTDC00314	Inhibitor	JWH-347
TTDC00314	Inhibitor	JWH-348
TTDC00314	Inhibitor	JWH-363
TTDC00314	Inhibitor	JWH-364
TTDC00314	Inhibitor	JWH-365
TTDC00314	Inhibitor	JWH-366
TTDC00314	Inhibitor	JWH-367
TTDC00314	Inhibitor	JWH-368
TTDC00314	Inhibitor	JWH-369
TTDC00314	Inhibitor	JWH-370
TTDC00314	Inhibitor	JWH-371
TTDC00314	Inhibitor	JWH-372
TTDC00314	Inhibitor	JWH-373
TTDC00314	Inhibitor	JWH-385
TTDC00314	Inhibitor	JWH-392
TTDC00314	Inhibitor	JWH-401
TTDC00314	Inhibitor	JWH-402
TTDC00314	Inhibitor	JWH-403
TTDC00314	Inhibitor	JWH-404
TTDC00314	Inhibitor	JWH-405
TTDC00314	Inhibitor	JWH-406
TTDC00314	Inhibitor	JWH-407
TTDC00314	Inhibitor	JWH-440
TTDC00314	Inhibitor	JWH-441
TTDC00314	Inhibitor	JWH-442
TTDC00314	Inhibitor	KM-233
TTDC00314	Inhibitor	KM-233-M
TTDC00314	Inhibitor	NABILONE
TTDC00314	Inhibitor	NAPHTHYRIDINONE
TTDC00314	Inhibitor	PRAVADOLINE
TTDC00314	Inhibitor	RIMONABANT HYDROCHLORIDE
TTDC00314	Inhibitor	SCH-225336
TTDC00314	Inhibitor	SCH-356036
TTDC00314	Inhibitor	SR-144,528
TTDC00314	Inhibitor	SR-147778
TTDC00314	Inhibitor	VER-156084
TTDC00314	Inhibitor	VER-156085
TTDC00314	Inhibitor	WIN-55212-2
TTDC00314	Antagonist	SR144528
TTDC00314	Agonist	JWH-015
TTDC00314	Agonist	Palmitoylethanolamide
TTDC00314	Agonist	S-777469
TTDC00315	UniProt ID	Q08497
TTDC00315	Name	Phosphodiesterase
TTDC00315	Type of target	Clinical trial target
TTDC00315	Disease	Silent brain infarction
TTDC00315	Disease	Thrombosis
TTDC00315	Sequence	RPRGLGRIPELQLVAFPVAVAAEDEAFLPEPLAPRAPRRPRSPPSSPVFFASPSPTFRRRLRLLRSCQDLGRQAWAGAGF
TTDC00315	Related US Patent	6,462,044
TTDC00315	Related US Patent	6,476,078
TTDC00315	Related US Patent	6,492,358
TTDC00315	Target Validation	TTDC00315
TTDC00315	Drug(s)	NM-702
TTDC00315	Inhibitor	NM-702
TTDC00315	Multitarget	NM-702
TTDC00316	Name	Tyrosine-protein kinase
TTDC00316	Type of target	Clinical trial target
TTDC00316	Synonyms	PTK
TTDC00316	Synonyms	Protein-tyrosine kinase
TTDC00316	Disease	Chronic myeloid leukemia (CML)
TTDC00316	EC Number	EC 2.7.1.112
TTDC00316	Related US Patent	6,239,133
TTDC00316	Related US Patent	6,350,754
TTDC00316	Related US Patent	6,498,176
TTDC00316	Related US Patent	6,541,504
TTDC00316	Related US Patent	6,548,496
TTDC00316	Related US Patent	6,559,173
TTDC00316	Related US Patent	6,579,897
TTDC00316	Related US Patent	6,596,746
TTDC00316	Related US Patent	6,608,048
TTDC00316	Related US Patent	6,653,308
TTDC00316	Related US Patent	6,656,940
TTDC00316	Target Validation	TTDC00316
TTDC00316	Drug(s)	INCB18424
TTDC00316	Drug(s)	INCB28050
TTDC00316	Inhibitor	INCB18424
TTDC00316	Inhibitor	INCB28050
TTDC00316	Multitarget	INCB18424
TTDC00316	Multitarget	INCB28050
TTDC00317	UniProt ID	P49019
TTDC00317	UniProt ID	Q8TDS4
TTDC00317	Name	Nicotinic acid receptor
TTDC00317	Type of target	Successful target
TTDC00317	Synonyms	G-protein coupled receptor 109A
TTDC00317	Synonyms	G-protein coupled receptor HM74A
TTDC00317	Synonyms	GPR109A
TTDC00317	Synonyms	HM74A
TTDC00317	Synonyms	NIACR1
TTDC00317	Synonyms	Niacin receptor 1
TTDC00317	Disease	Type IV and V hyperlipidemia
TTDC00317	Function	Acts as a high affinity receptor for both nicotinic acid (also known as niacin)
TTDC00317	Sequence	MNRHHLQDHFLEIDKKNCCVFRDDFIVKVLPPVLGLEFIFGLLGNGLALWIFCFHLKSWKSSRIFLFNLAVADFLLIICL
TTDC00317	Target Validation	TTDC00317
TTDC00317	Drug(s)	GSK256073
TTDC00317	Drug(s)	INCB19602
TTDC00317	Drug(s)	MBX-2982
TTDC00317	Drug(s)	Vitamin B3
TTDC00317	Inhibitor	1H-Pyrazole-3-carboxylic acid
TTDC00317	Inhibitor	2-(2-(4-tert-butylphenoxy)acetamido)benzoic acid
TTDC00317	Inhibitor	2-(3-(naphthalen-2-yl)propanamido)benzoic acid
TTDC00317	Inhibitor	2-(3-biphenyl-4-yl-propionylamino)-benzoic acid
TTDC00317	Inhibitor	2-(4-phenylbutyl)pyrido[2,3-d]pyrimidin-4(3H)-one
TTDC00317	Inhibitor	2-(6-phenylhexyl)pyrido[2,3-d]pyrimidin-4(3H)-one
TTDC00317	Inhibitor	2-(cinnamyloxy)pyrido[2,3-d]pyrimidin-4(3H)-one
TTDC00317	Inhibitor	4,5,6,7-Tetrahydro-1H-indazole-3-carboxylic acid
TTDC00317	Inhibitor	5-(3-Chloro-benzyl)-1H-pyrazole-3-carboxylic acid
TTDC00317	Inhibitor	5-(3-Phenyl-propyl)-1H-pyrazole-3-carboxylic acid
TTDC00317	Inhibitor	5-(4-Chloro-benzyl)-1H-pyrazole-3-carboxylic acid
TTDC00317	Inhibitor	5-Benzyl-1H-pyrazole-3-carboxylic acid
TTDC00317	Inhibitor	5-Butyl-1H-pyrazole-3-carboxylic acid
TTDC00317	Inhibitor	5-Isopropyl-1H-pyrazole-3-carboxylic acid
TTDC00317	Inhibitor	5-Phenethyl-1H-pyrazole-3-carboxylic acid
TTDC00317	Inhibitor	5-Propyl-1H-pyrazole-3-carboxylic acid
TTDC00317	Inhibitor	ISONICOTINIC ACID
TTDC00317	Inhibitor	MK-0354
TTDC00317	Agonist	GSK256073
TTDC00317	Agonist	INCB19602
TTDC00317	Agonist	Vitamin B3
TTDC00317	Multitarget	Vitamin B3
TTDC00318	UniProt ID	P04629
TTDC00318	Name	High affinity nerve growth factor receptor
TTDC00318	Type of target	Successful target
TTDC00318	Synonyms	NGF-trk receptor type A
TTDC00318	Synonyms	NTRK1
TTDC00318	Synonyms	P140-TrkA
TTDC00318	Synonyms	TRK1 transforming tyrosine kinase protein
TTDC00318	Synonyms	Trk-A
TTDC00318	Disease	Acute myeloid leukemia (AML)
TTDC00318	Disease	Analgesics
TTDC00318	Disease	Cancer, unspecific
TTDC00318	Disease	Neurodegenerative diseases
TTDC00318	Disease	Pain, unspecified
TTDC00318	Disease	Pancreatic Cancer
TTDC00318	Disease	Prostate cancer
TTDC00318	Function	Required for high-affinity binding to nerve growth factor (ngf), neurotrophin-3
TTDC00318	Sequence	MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ
TTDC00318	PDB Structure	1HE7; 1SHC; 1WWA; 1WWW; 2IFG
TTDC00318	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDC00318	Pathway	Apoptosis
TTDC00318	Pathway	MAPK signaling pathway
TTDC00318	Pathway	Pathways in cancer
TTDC00318	Pathway	Thyroid cancer
TTDC00318	EC Number	EC 2.7.1.112
TTDC00318	Target Validation	TTDC00318
TTDC00318	Drug(s)	AZD6918
TTDC00318	Drug(s)	Lestaurtinib
TTDC00318	Inhibitor	(+)K-252a
TTDC00318	Inhibitor	AZD6918
TTDC00318	Inhibitor	CEP-5104
TTDC00318	Inhibitor	CEP-6331
TTDC00318	Inhibitor	GW-5074
TTDC00318	Inhibitor	K-252a analogue
TTDC00318	Inhibitor	Lestaurtinib
TTDC00319	UniProt ID	P10415
TTDC00319	Name	Apoptosis regulator Bcl-2
TTDC00319	Type of target	Clinical trial target
TTDC00319	Synonyms	Bcl-2
TTDC00319	Disease	Chronic lymphocytic leukemia
TTDC00319	Disease	Prostate cancer (hormone refractory)
TTDC00319	Disease	Waldenstrom's macroglobulinemia
TTDC00319	Function	Suppresses apoptosis in a variety of cell systems including factor-dependent lym
TTDC00319	Sequence	MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGA
TTDC00319	PDB Structure	1G5M; 1GJH; 1YSW; 2O21; 2O22; 2O2F; 2W3L
TTDC00319	BioChemical Class	Transmembrane protein
TTDC00319	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDC00319	Pathway	Apoptosis
TTDC00319	Pathway	Colorectal cancer
TTDC00319	Pathway	Focal adhesion
TTDC00319	Pathway	Pathways in cancer
TTDC00319	Pathway	Prostate cancer
TTDC00319	Pathway	Small cell lung cancer
TTDC00319	Target Validation	TTDC00319
TTDC00319	Drug(s)	ABT-199/GDC-0199
TTDC00319	Drug(s)	ABT-199/GDC-0199/RG7601
TTDC00319	Drug(s)	ABT-263
TTDC00319	Drug(s)	AT-101
TTDC00319	Drug(s)	GDC-0199
TTDC00319	Drug(s)	MCI-186
TTDC00319	Drug(s)	Oblimersen
TTDC00319	Drug(s)	PNT2258
TTDC00319	Drug(s)	RG7601
TTDC00319	Inhibitor	2,3,4-trihydroxy-5-isopropyl-N-phenyl-benzamide
TTDC00319	Inhibitor	4,5-dibenzylbenzene-1,2-diol
TTDC00319	Inhibitor	5,10-Dioxy-2-phenyl-benzo[g]pteridin-4-ylamine
TTDC00319	Inhibitor	ABT-263
TTDC00319	Inhibitor	ABT-737
TTDC00319	Inhibitor	AT-101
TTDC00319	Inhibitor	N-phenyl-2,3,4-trihydroxy-5-benzyl-benzamide
TTDC00319	Inhibitor	Oblimersen
TTDC00319	Inhibitor	QEDIIRNIARHLAQVGDSMDR
TTDC00319	Inhibitor	TW-37
TTDC00319	Regulator	Gossypol
TTDC00319	UpRegulator	MCI-186
TTDC00319	Multitarget	ABT-263
TTDC00319	Multitarget	AT-101
TTDC00320	Name	G protein-coupled receptor 110A niacin receptor
TTDC00320	Type of target	Clinical trial target
TTDC00320	Disease	Dyslipidemia
TTDC00320	Drug(s)	ARI-3037MO
TTDC00320	Agonist	ARI-3037MO
TTDC00320	Multitarget	ARI-3037MO
TTDC00321	Name	HCV NS4B protein
TTDC00321	Type of target	Clinical trial target
TTDC00321	Disease	Hepatitis C
TTDC00321	Drug(s)	Clemizole
TTDC00321	Inhibitor	Clemizole
TTDC00322	UniProt ID	K7X7T4
TTDC00322	Name	HCV NS5A protein
TTDC00322	Name	NS5A protein
TTDC00322	Type of target	Clinical trial target
TTDC00322	Type of target	Clinical trial target
TTDC00322	Synonyms	NS5A;
TTDC00322	Disease	Hepatitis C
TTDC00322	Drug(s)	BMS 790052
TTDC00322	Drug(s)	BMS-824383
TTDC00322	Drug(s)	GS-5816
TTDC00322	Drug(s)	IDX719
TTDC00322	Drug(s)	PPI-461
TTDC00322	Drug(s)	Single Tablet Regimen of sofosbuvir and ledipasvir (
TTDC00322	Drug(s)	
TTDC00322	Inhibitor	BMS 790052
TTDC00322	Inhibitor	BMS-824383
TTDC00322	Inhibitor	PPI-461
TTDC00323	Name	M1 prime segment of membrane IgE
TTDC00323	Type of target	Clinical trial target
TTDC00323	Disease	Asthma
TTDC00323	Drug(s)	Anti-M1 prime
TTDC00323	Antibody	Anti-M1 prime
TTDC00324	Name	MicroRNA miR-122
TTDC00324	Type of target	Clinical trial target
TTDC00324	Disease	Hepatitis C infection
TTDC00324	Drug(s)	Miravirsen
TTDC00324	Inhibitor	Miravirsen
TTDC00325	UniProt ID	P00441
TTDC00325	Name	mRNA of copper zinc superoxide dismutase 1
TTDC00325	Type of target	Clinical trial target
TTDC00325	Synonyms	mRNA of Superoxide dismutase 1
TTDC00325	Synonyms	mRNA of Superoxide dismutase [Cu-Zn]
TTDC00325	Disease	Amyotrophic lateral sclerosis
TTDC00325	Function	Destroys radicals which are normally produced within the cells and which are tox
TTDC00325	Sequence	MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEER
TTDC00325	PDB Structure	1AZV; 1BA9; 1DSW; 1FUN; 1HL4; 1HL5; 1KMG; 1L3N; 1MFM; 1N18; 1N19; 1OEZ; 1OZT; 1O
TTDC00325	Drug(s)	ISIS-SOD1
TTDC00325	Antisense	ISIS-SOD1
TTDC00326	UniProt ID	P00746
TTDC00326	Name	Complement factor D
TTDC00326	Type of target	Clinical trial target
TTDC00326	Synonyms	Adipsin
TTDC00326	Synonyms	C3 convertase activator
TTDC00326	Synonyms	Properdin factor D
TTDC00326	Disease	Geographic atrophy associated with age-related macular degeneration
TTDC00326	Function	Factor D cleaves factor B when the latter is complexed with factor C3b, activati
TTDC00326	Sequence	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLL
TTDC00326	PDB Structure	1BIO; 1DFP; 1DIC; 1DST; 1DSU; 1FDP; 1HFD; 2XW9; 2XWA; 2XWB
TTDC00326	Drug(s)	Anti-Factor D
TTDC00326	Drug(s)	FCFD4514S
TTDC00326	Antibody	Anti-Factor D
TTDC00327	UniProt ID	P01374
TTDC00327	Name	Lymphotoxin alpha
TTDC00327	Type of target	Clinical trial target
TTDC00327	Synonyms	LT-alpha
TTDC00327	Synonyms	Lymphotoxin-alpha
TTDC00327	Synonyms	TNF-beta
TTDC00327	Synonyms	Tumor necrosis factor ligand superfamily member 1
TTDC00327	Disease	Rheumatoid arthritis
TTDC00327	Function	Cytokine that in its homotrimeric form binds to TNFRSF1A/TNFR1, TNFRSF1B/TNFBR a
TTDC00327	Sequence	MTPPERLFLPRVCGTTLHLLLLGLLLVLLPGAQGLPGVGLTPSAAQTARQHPKMHLAHSTLKPAAHLIGDPSKQNSLLWR
TTDC00327	PDB Structure	1TNR
TTDC00327	Drug(s)	Anti-LT alpha
TTDC00327	Drug(s)	RG7416
TTDC00327	Antibody	Anti-LT alpha
TTDC00328	UniProt ID	P02656
TTDC00328	Name	mRNA of ApoC-III
TTDC00328	Type of target	Clinical trial target
TTDC00328	Synonyms	mRNA of Apo-CIII
TTDC00328	Synonyms	mRNA of ApoC-III
TTDC00328	Synonyms	mRNA of Apolipoprotein C3
TTDC00328	Disease	Inflammation, high triglycerides, atherosclerosis, metabolic syndrome
TTDC00328	Function	Inhibits lipoprotein lipase and hepatic lipase and decreases the uptake of lymph
TTDC00328	Sequence	MQPRVLLVVALLALLASARASEAEDASLLSFMQGYMKHATKTAKDALSSVQESQVAQQARGWVTDGFSSLKDYWSTVKDK
TTDC00328	PDB Structure	2JQ3
TTDC00328	Drug(s)	ISIS-APOCIII
TTDC00328	Antisense	ISIS-APOCIII
TTDC00329	UniProt ID	P02766
TTDC00329	Name	mRNA of transthyretin
TTDC00329	Type of target	Clinical trial target
TTDC00329	Synonyms	mRNA of ATTR
TTDC00329	Synonyms	mRNA of Prealbumin
TTDC00329	Synonyms	mRNA of TBPA
TTDC00329	Disease	Amyloidosis
TTDC00329	Function	Thyroid hormone-binding protein. Probably transports thyroxine from the bloodstr
TTDC00329	Sequence	MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTT
TTDC00329	PDB Structure	1BM7; 1BMZ; 1BZ8; 1BZD; 1BZE; 1DVQ; 1DVS; 1DVT; 1DVU; 1DVX; 1DVY; 1DVZ; 1E3F; 1E
TTDC00329	Drug(s)	ALN-TTR01
TTDC00329	Drug(s)	ISIS-TTR
TTDC00329	Antisense	ISIS-TTR
TTDC00329	RNAi	ALN-TTR01
TTDC00330	UniProt ID	P03951
TTDC00330	Name	mRNA of Factor XI
TTDC00330	Type of target	Clinical trial target
TTDC00330	Synonyms	mRNA of Coagulation factor XI
TTDC00330	Synonyms	mRNA of FXI
TTDC00330	Synonyms	mRNA of PTA
TTDC00330	Synonyms	mRNA of Plasma thromboplastin antecedent
TTDC00330	Disease	Clotting Disorders
TTDC00330	Function	Factor XI triggers the middle phase of the intrinsic pathway of blood coagulatio
TTDC00330	Sequence	MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFTFTAESPSEDPTRWFTCVLKD
TTDC00330	PDB Structure	1XX9; 1XXD; 1XXF; 1ZHM; 1ZHP; 1ZHR; 1ZJD; 1ZLR; 1ZMJ; 1ZML; 1ZMN; 1ZOM; 1ZPB; 1Z
TTDC00330	Drug(s)	ISIS-FXI
TTDC00330	Antisense	ISIS-FXI
TTDC00331	UniProt ID	P04114
TTDC00331	Name	Apolipoprotein B-100
TTDC00331	Type of target	Successful target
TTDC00331	Synonyms	Apo B-100
TTDC00331	Disease	High cholesterol
TTDC00331	Function	Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48), LDL
TTDC00331	Drug(s)	KYNAMRO
TTDC00331	Drug(s)	SPC4955
TTDC00331	Inhibitor	SPC4955
TTDC00332	UniProt ID	P10275
TTDC00332	Name	mRNA of androgen receptor
TTDC00332	Type of target	Clinical trial target
TTDC00332	Synonyms	mRNA of Dihydrotestosterone receptor
TTDC00332	Synonyms	mRNA of Nuclear receptor subfamily 3 group C member 4
TTDC00332	Disease	Prostate cancer
TTDC00332	Function	Steroid hormone receptors are ligand-activated transcription factors that regula
TTDC00332	Sequence	MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQQQQQQQQQQQQQQQQQQQET
TTDC00332	PDB Structure	1E3G; 1GS4; 1T5Z; 1T63; 1T65; 1XJ7; 1XOW; 1XQ3; 1Z95; 2AM9; 2AMA; 2AMB; 2AO6; 2A
TTDC00332	Target Validation	TTDC00332
TTDC00332	Drug(s)	EZN-4176
TTDC00332	Inhibitor	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane
TTDC00332	Inhibitor	2'-Hydroxy-3-methoxy-biphenyl-4-carbonitrile
TTDC00332	Inhibitor	2-chloro-4-(o-tolyloxy)benzonitrile
TTDC00332	Inhibitor	2-methoxy-4-(2-methoxyphenylthio)benzonitrile
TTDC00332	Inhibitor	2-methoxy-4-(m-tolyloxy)benzonitrile
TTDC00332	Inhibitor	2-methoxy-4-(o-tolyloxy)benzonitrile
TTDC00332	Inhibitor	2-methoxy-4-(p-tolyloxy)benzonitrile
TTDC00332	Inhibitor	2-methoxy-4-(propylthio)benzonitrile
TTDC00332	Inhibitor	3,2'-bis-trifluoromethyl-biphenyl-4-carbonitrile
TTDC00332	Inhibitor	3-chloro-4-(o-tolyloxy)benzonitrile
TTDC00332	Inhibitor	3-chloro-4-(o-tolylthio)benzonitrile
TTDC00332	Inhibitor	3-methoxy-4-(m-tolyloxy)benzonitrile
TTDC00332	Inhibitor	3-methoxy-4-(o-tolyloxy)benzonitrile
TTDC00332	Inhibitor	3-methoxy-4-(p-tolyloxy)benzonitrile
TTDC00332	Inhibitor	4-(2,6-dimethylphenylthio)-2-methoxybenzonitrile
TTDC00332	Inhibitor	4-(butylthio)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	4-(butylthio)-2-methoxybenzonitrile
TTDC00332	Inhibitor	4-(cyclobutylmethylthio)-2-methoxybenzonitrile
TTDC00332	Inhibitor	4-(cyclopropylmethylthio)-2-methoxybenzonitrile
TTDC00332	Inhibitor	4-(isopentylthio)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	4-(isopentylthio)-2-methoxybenzonitrile
TTDC00332	Inhibitor	4-(isopropylthio)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	4-(isopropylthio)-2-methoxybenzonitrile
TTDC00332	Inhibitor	4-(m-tolyloxy)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	4-(mesityloxy)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	4-(mesitylthio)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	4-(mesitylthio)-2-methoxybenzonitrile
TTDC00332	Inhibitor	4-(o-tolyloxy)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	4-(o-tolylthio)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	4-(p-tolyloxy)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	4-(propylthio)-2-(trifluoromethyl)benzonitrile
TTDC00332	Inhibitor	5-Methoxyflavone
TTDC00332	Inhibitor	6-Hydroxyflavanone
TTDC00332	Inhibitor	6-N-propyl -4-trifluoromethylquinolin-2(1H)-one
TTDC00332	Inhibitor	6-amino-4-trifluoromethylquinolin-2(1H)-one
TTDC00332	Inhibitor	AL-43
TTDC00332	Inhibitor	APIGENIN
TTDC00332	Inhibitor	BMS-564929
TTDC00332	Inhibitor	CP-394531
TTDC00332	Inhibitor	CP-409069
TTDC00332	Inhibitor	Doxorubicin-Formaldehyde Conjugate
TTDC00332	Inhibitor	EPIERENONE
TTDC00332	Inhibitor	EUGENOL
TTDC00332	Inhibitor	KAEMPFEROL
TTDC00332	Inhibitor	LG-120838
TTDC00332	Inhibitor	LG-121071;LGD-121071
TTDC00332	Inhibitor	LGD-2226
TTDC00332	Inhibitor	LGD-5552
TTDC00332	Inhibitor	NSC-19028
TTDC00332	Inhibitor	NSC-26745
TTDC00332	Inhibitor	ONAPRISTONE
TTDC00332	Inhibitor	PF-0998425
TTDC00332	Inhibitor	RU-43044
TTDC00332	Inhibitor	RU-56187
TTDC00332	Inhibitor	RU-58841
TTDC00332	Inhibitor	TESTOSTERONE PROPIONATE
TTDC00332	Inhibitor	WAY-252623
TTDC00332	Inhibitor	WAY-255348
TTDC00332	Inhibitor	YM-175735
TTDC00332	Inhibitor	ZK-230211
TTDC00332	Antisense	EZN-4176
TTDC00333	UniProt ID	P16471
TTDC00333	Name	Prolactin receptor
TTDC00333	Type of target	Clinical trial target
TTDC00333	Synonyms	PRL-R
TTDC00333	Disease	Breast cancer, prostate cancer
TTDC00333	Function	This is a receptor for the anterior pituitary hormone prolactin (PRL). Isoform 4
TTDC00333	Sequence	MKENVASATVFTLLLFLNTCLLNGQLPPGKPEIFKCRSPNKETFTCWWRPGTDGGLPTNYSLTYHREGETLMHECPDYIT
TTDC00333	PDB Structure	1BP3; 3D48; 3MZG; 3N06; 3N0P; 3NCB; 3NCC; 3NCE; 3NCF
TTDC00333	Drug(s)	LFA102
TTDC00333	Antibody	LFA102
TTDC00334	UniProt ID	P17948
TTDC00334	Name	mRNA of VEGFR1
TTDC00334	Type of target	Clinical trial target
TTDC00334	Synonyms	mRNA of FLT-1
TTDC00334	Synonyms	mRNA of FLT1
TTDC00334	Synonyms	mRNA of Fms-like tyrosine kinase 1
TTDC00334	Synonyms	mRNA of Tyrosine-protein kinase FRT
TTDC00334	Synonyms	mRNA of Tyrosine-protein kinase receptor FLT
TTDC00334	Synonyms	mRNA of VEGFR-1
TTDC00334	Synonyms	mRNA of Vascular endothelial growth factor receptor 1
TTDC00334	Synonyms	mRNA of Vascular permeability factor receptor
TTDC00334	Disease	Exudative age-related macular degeneration
TTDC00334	Disease	Neovascular Age-Related Macular Degeneration
TTDC00334	Function	Receptor for VEGF, VEGFB and PGF. Has a tyrosine-protein kinase activity. The VE
TTDC00334	Sequence	MVSYWDTGVLLCALLSCLLLTGSSSGSKLKDPELSLKGTQHIMQAGQTLHLQCRGEAAHKWSLPEMVSKESERLSITKSA
TTDC00334	PDB Structure	1FLT; 1QSV; 1QSZ; 1QTY; 1RV6; 2XAC; 3HNG
TTDC00334	Target Validation	TTDC00334
TTDC00334	Drug(s)	Sirna-027
TTDC00334	Inhibitor	(2-Methoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine
TTDC00334	Inhibitor	(5-Phenyl-oxazol-2-yl)-m-tolyl-amine
TTDC00334	Inhibitor	2-(1H-indazol-3-yl)-1H-benzo[d]imidazole
TTDC00334	Inhibitor	2-(5-Phenyl-oxazol-2-ylamino)-benzonitrile
TTDC00334	Inhibitor	3,6-Di-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine
TTDC00334	Inhibitor	3-(5-Phenyl-oxazol-2-ylamino)-benzonitrile
TTDC00334	Inhibitor	4-(5-Phenyl-oxazol-2-ylamino)-benzenesulfonamide
TTDC00334	Inhibitor	4-(isoquinolin-5-yl)-N-m-tolylphthalazin-1-amine
TTDC00334	Inhibitor	4-(isoquinolin-5-yl)-N-o-tolylphthalazin-1-amine
TTDC00334	Inhibitor	4-Chloro-N-(2-chloro-benzoyl)-benzenesulfonamide
TTDC00334	Inhibitor	4-Chloro-N-(2-methyl-benzoyl)-benzenesulfonamide
TTDC00334	Inhibitor	4-Chloro-N-(3-chloro-benzoyl)-benzenesulfonamide
TTDC00334	Inhibitor	4-Chloro-N-(4-chloro-benzoyl)-benzenesulfonamide
TTDC00334	Inhibitor	4-Chloro-N-(4-nitro-benzoyl)-benzenesulfonamide
TTDC00334	Inhibitor	AAL-993
TTDC00334	Inhibitor	BMS-540215
TTDC00334	Inhibitor	CB-676475
TTDC00334	Inhibitor	IM-094261
TTDC00334	Inhibitor	IM-094882
TTDC00334	Inhibitor	LYCOGARUBIN B
TTDC00334	Inhibitor	N-(2,4-Dichloro-benzoyl)-benzenesulfonamide
TTDC00334	Inhibitor	N-(3-Bromo-benzoyl)-4-chloro-benzenesulfonamide
TTDC00334	Inhibitor	N3-GHQMFYYPra-NH2
TTDC00334	Inhibitor	PD-173074
TTDC00334	Inhibitor	Phenyl-(5-phenyl-oxazol-2-yl)-amine
TTDC00334	Inhibitor	SEMAXINIB
TTDC00334	Inhibitor	VATALANIB
TTDC00334	Inhibitor	[3-(5-Phenyl-oxazol-2-ylamino)-phenyl]-methanol
TTDC00334	Inhibitor	c[YYAEGLEE]-NH2
TTDC00334	Inhibitor	c[YYDEGLEE]-NH2
TTDC00334	Inhibitor	c[YYDEKLEE]-NH2
TTDC00334	Inhibitor	c[homoPhe-Hca-Glu-Gly-Leu-Glu-Glu]-NH2
TTDC00334	siRNA	Sirna-027
TTDC00335	UniProt ID	P29279
TTDC00335	Name	mRNA of connective tissue growth factor
TTDC00335	Type of target	Clinical trial target
TTDC00335	Synonyms	mRNA of CCN family member 2
TTDC00335	Synonyms	mRNA of CCN2
TTDC00335	Synonyms	mRNA of CTGF
TTDC00335	Synonyms	mRNA of Hypertrophic chondrocyte-specific protein 24
TTDC00335	Synonyms	mRNA of IBP-8
TTDC00335	Synonyms	mRNA of IGF-binding protein 8
TTDC00335	Synonyms	mRNA of IGFBP-8
TTDC00335	Synonyms	mRNA of Insulin-like growth factor-binding protein 8
TTDC00335	Disease	Fibrosis
TTDC00335	Function	Major connective tissue mitoattractant secreted by vascular endothelial cells. P
TTDC00335	Sequence	MTAASMGPVRVAFVVLLALCSRPAVGQNCSGPCRCPDEPAPRCPAGVSLVLDGCGCCRVCAKQLGELCTERDPCDPHKGL
TTDC00335	Drug(s)	EXC 001
TTDC00335	Antisense	EXC 001
TTDC00336	UniProt ID	P31639
TTDC00336	Name	mRNA of sodium-glucose transporter-2
TTDC00336	Type of target	Clinical trial target
TTDC00336	Synonyms	mRNA of Low affinity sodium-glucose cotransporter
TTDC00336	Synonyms	mRNA of Na(+)/glucose cotransporter 2
TTDC00336	Synonyms	mRNA of SGLT2
TTDC00336	Synonyms	mRNA of SLC5A2
TTDC00336	Synonyms	mRNA of Sodium/glucose cotransporter 2
TTDC00336	Synonyms	mRNA of Solute carrier family 5 member 2
TTDC00336	Disease	Type 2 Diabetes
TTDC00336	Function	Sodium-dependent glucose transporter. Has a Na(+) to glucose coupling ratio of 1
TTDC00336	Sequence	MEEHTEAGSAPEMGAQKALIDNPADILVIAAYFLLVIGVGLWSMCRTNRGTVGGYFLAGRSMVWWPVGASLFASNIGSGH
TTDC00336	Target Validation	TTDC00336
TTDC00336	Drug(s)	ISIS-SGLT2
TTDC00336	Inhibitor	10-methoxy-N(1)-methylburnamine-17-O-veratrate
TTDC00336	Inhibitor	ACEROGENIN B
TTDC00336	Inhibitor	Alstiphyllanine D
TTDC00336	Inhibitor	Alstiphyllanine E
TTDC00336	Inhibitor	Alstiphyllanine F
TTDC00336	Inhibitor	Burnamine-17-O-3',4',5'-trimethoxybenzoate
TTDC00336	Inhibitor	FORMONONETIN
TTDC00336	Inhibitor	KURAIDIN
TTDC00336	Inhibitor	KURARINONE
TTDC00336	Inhibitor	MAACKIAIN
TTDC00336	Inhibitor	O-spiroketal glucoside
TTDC00336	Inhibitor	PHLORIZIN
TTDC00336	Inhibitor	SERGLIFLOZIN A
TTDC00336	Inhibitor	acerogenin C
TTDC00336	Inhibitor	kushenol N
TTDC00336	Inhibitor	remogliflozin
TTDC00336	Inhibitor	sophoraflavanone G
TTDC00336	Antisense	ISIS-SGLT2
TTDC00337	UniProt ID	P32970
TTDC00337	Name	CD70
TTDC00337	Type of target	Clinical trial target
TTDC00337	Synonyms	CD27 ligand
TTDC00337	Synonyms	CD27-L
TTDC00337	Synonyms	CD70 antigen
TTDC00337	Synonyms	Tumor necrosis factor ligand superfamily member 7
TTDC00337	Disease	Autoimmune disease
TTDC00337	Disease	Renal cell carcinoma, non-Hodgkin lymphoma
TTDC00337	Function	Cytokine that binds to CD27. Plays a role in T-cell activation. Induces the prol
TTDC00337	Sequence	MPEEGSGCSVRRRPYGCVLRAALVPLVAGLVICLVVCIQRFAQAQQQLPLESLGWDVAELQLNHTGPQQDPRLYWQGGPA
TTDC00337	Drug(s)	AMG 172
TTDC00337	Drug(s)	BMS-936561
TTDC00337	Drug(s)	SGN-70
TTDC00337	Drug(s)	SGN-75
TTDC00337	Antibody	SGN-70
TTDC00337	Antibody	SGN-75
TTDC00338	UniProt ID	P37023
TTDC00338	Name	Activin receptor-like kinase-1
TTDC00338	Type of target	Clinical trial target
TTDC00338	Synonyms	ACVRL1
TTDC00338	Synonyms	ACVRLK1
TTDC00338	Synonyms	ALK-1
TTDC00338	Synonyms	Activin receptor-like kinase 1
TTDC00338	Synonyms	SKR3
TTDC00338	Synonyms	Serine/threonine-protein kinase receptor R3
TTDC00338	Synonyms	TGF-B superfamily receptor type I
TTDC00338	Synonyms	TSR-I
TTDC00338	Disease	Advanced cancers, age-related macular degeneration
TTDC00338	Function	On ligand binding, forms a receptor complex consisting of two type II and two ty
TTDC00338	Sequence	MTLGSPRKGLLMLLMALVTQGDPVKPSRGPLVTCTCESPHCKGPTCRGAWCTVVLVREEGRHPQEHRGCGNLHRELCRGR
TTDC00338	PDB Structure	3MY0
TTDC00338	Drug(s)	ACE-041
TTDC00338	Drug(s)	PF-03446962
TTDC00338	Inhibitor	ACE-041
TTDC00339	UniProt ID	P52732
TTDC00339	Name	mRNA of kinesin spindle protein
TTDC00339	Type of target	Clinical trial target
TTDC00339	Synonyms	mRNA of KIF11
TTDC00339	Synonyms	mRNA of Kinesin-like protein 1
TTDC00339	Synonyms	mRNA of Kinesin-like protein KIF11
TTDC00339	Synonyms	mRNA of Kinesin-like spindle protein HKSP
TTDC00339	Synonyms	mRNA of Kinesin-related motor protein Eg5
TTDC00339	Synonyms	mRNA of TR-interacting protein 5
TTDC00339	Synonyms	mRNA of TRIP-5
TTDC00339	Synonyms	mRNA of Thyroid receptor-interacting protein 5
TTDC00339	Disease	Liver cancers
TTDC00339	Function	Motor protein required for establishing a bipolar spindle. Blocking of KIF11 pre
TTDC00339	Sequence	MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQID
TTDC00339	PDB Structure	1II6; 1Q0B; 1X88; 1YRS; 2FKY; 2FL2; 2FL6; 2FME; 2G1Q; 2GM1; 2IEH; 2PG2; 2Q2Y; 2Q
TTDC00339	Drug(s)	ALN-VSP
TTDC00339	RNAi	ALN-VSP
TTDC00340	UniProt ID	Q53GD3
TTDC00340	Name	Choline transporter-like protein 4
TTDC00340	Type of target	Clinical trial target
TTDC00340	Synonyms	SLC44A4
TTDC00340	Synonyms	Solute carrier family 44 member 4
TTDC00340	Disease	Pancreatic cancer, Prostate cancer
TTDC00340	Sequence	MGGKQRDEDDEAYGKPVKYDPSFRGPIKNRSCTDVICCVLFLLFILGYIVVGIVAWLYGDPRQVLYPRNSTGAYCGMGEN
TTDC00340	Drug(s)	ASG-5ME
TTDC00340	Antibody	ASG-5ME
TTDC00341	UniProt ID	Q96C86
TTDC00341	Name	Scavenger decapping enzyme DcpS
TTDC00341	Type of target	Clinical trial target
TTDC00341	Synonyms	DCPS
TTDC00341	Synonyms	DCS-1
TTDC00341	Synonyms	HINT-5
TTDC00341	Synonyms	Hint-related 7meGMP-directed hydrolase
TTDC00341	Synonyms	Histidine triad protein member 5
TTDC00341	Synonyms	Scavenger mRNA-decapping enzyme DcpS
TTDC00341	Disease	Spinal Muscular Atrophy
TTDC00341	Function	Necessary for the complete degradation of mRNAs, both in normal mRNA turnover an
TTDC00341	Sequence	MADAAPQLGKRKRELDVEEAHAASTEEKEAGVGNGTCAPVRLPFSGFRLQKVLRESARDKIIFLHGKVNEASGDGDGEDA
TTDC00341	PDB Structure	1ST0; 1ST4; 1XML; 1XMM; 3BL7; 3BL9; 3BLA
TTDC00341	Drug(s)	RG3039
TTDC00341	Inhibitor	RG3039
TTDC00342	UniProt ID	Q96D31
TTDC00342	Name	Calcium-release activated calcium channel
TTDC00342	Type of target	Clinical trial target
TTDC00342	Synonyms	Calcium release-activated calcium channel protein 1
TTDC00342	Synonyms	ORAI1
TTDC00342	Synonyms	Protein orai-1
TTDC00342	Synonyms	Transmembrane protein 142A
TTDC00342	Disease	Psoriasis
TTDC00342	Function	Ca(2+) release-activated Ca(2+) (CRAC) channel subunit which mediates Ca(2+) inf
TTDC00342	Sequence	MHPEPAPPPSRSSPELPPSGGSTTSGSRRSRRRSGDGEPPGAPPPPPSAVTYPDWIGQSYSEVMSLNEHSMQALSWRKLY
TTDC00342	Drug(s)	CM2489
TTDC00342	Inhibitor	CM2489
TTDC00343	UniProt ID	Q96NY8
TTDC00343	Name	Nectin-4
TTDC00343	Type of target	Clinical trial target
TTDC00343	Synonyms	Ig superfamily receptor LNIR
TTDC00343	Synonyms	Poliovirus receptor-related protein 4
TTDC00343	Disease	Solid tumors
TTDC00343	Function	Seems to be involved in cell adhesion through trans- homophilic and -heterophili
TTDC00343	Sequence	MPLSLGAEMWGPEAWLLLLLLLASFTGRCPAGELETSDVVTVVLGQDAKLPCFYRGDSGEQVGQVAWARVDAGEGAQELA
TTDC00343	Drug(s)	ASG-22ME
TTDC00343	Antibody	ASG-22ME
TTDC00344	UniProt ID	Q99835
TTDC00344	Name	Smoothened
TTDC00344	Type of target	Clinical trial target
TTDC00344	Synonyms	Protein Gx
TTDC00344	Synonyms	SMO
TTDC00344	Synonyms	Smoothened homolog
TTDC00344	Disease	Cancers
TTDC00344	Function	G protein-coupled receptor that probably associates with the patched protein (PT
TTDC00344	Sequence	MAAARPARGPELPLLGLLLLLLLGDPGRGAASSGNATGPGPRSAGGSARRSAAVTGPPPPLSHCGRAAPCEPLRYNVCLG
TTDC00344	Target Validation	TTDC00344
TTDC00344	Drug(s)	BMS-833923
TTDC00344	Drug(s)	LEQ506
TTDC00344	Drug(s)	LY2940680
TTDC00344	Inhibitor	1-Benzyl-4-(4-phenylpiperazin-1-yl)phthalazine
TTDC00344	Inhibitor	BMS-833923
TTDC00344	Inhibitor	CYCLOPAMINE
TTDC00345	UniProt ID	P10912
TTDC00345	Name	mRNA of growth hormone receptor
TTDC00345	Type of target	Clinical trial target
TTDC00345	Synonyms	mRNA of GH receptor
TTDC00345	Synonyms	mRNA of GHR
TTDC00345	Synonyms	mRNA of Somatotropin receptor
TTDC00345	Disease	Acromegally
TTDC00345	Function	Receptor for pituitary gland growth hormone involved in regulating postnatal bod
TTDC00345	Sequence	MDLWQLLLTLALAGSSDAFSGSEATAAILSRAPWSLQSVNPGLKTNSSKEPKFTKCRSPERETFSCHWTDEVHHGTKNLG
TTDC00345	PDB Structure	1A22; 1AXI; 1HWG; 1HWH; 1KF9; 2AEW; 3HHR
TTDC00345	Drug(s)	ATL1103
TTDC00345	Antisense	ATL1103
TTDNC00348	UniProt ID	Q13233
TTDNC00348	Name	MEKK-1 kinase
TTDNC00348	Type of target	Clinical trial target
TTDNC00348	Function	Component of a protein kinase signal transduction cascade. Activates the ERK and
TTDNC00348	Sequence	MAAAAGNRASSSGFPGARATSPEAGGGGGALKASSAPAAAAGLLREAGSGGRERADWRRRQLRKVRSVELDQLPEQPLFL
TTDNC00348	EC Number	EC 2.7.11.25
TTDNC00348	Drug(s)	E6201
TTDNC00350	UniProt ID	Q9HCU0
TTDNC00350	Name	endosialin
TTDNC00350	Type of target	Clinical trial target
TTDNC00350	Function	May play a role in tumor angiogenesis.
TTDNC00350	Sequence	MLLRLLLAWAAAGPTLGQDPWAAEPRAACGPSSCYALFPRRRTFLEAWRACRELGGDLATPRTPEEAQRVDSLVGAGPAS
TTDNC00350	Drug(s)	MORAb-004
TTDNC00351	UniProt ID	Q9HCU0
TTDNC00351	Name	Tumor Endothelial Marker 1 (TEM-1)
TTDNC00351	Type of target	Clinical trial target
TTDNC00351	Function	May play a role in tumor angiogenesis.
TTDNC00351	Sequence	MLLRLLLAWAAAGPTLGQDPWAAEPRAACGPSSCYALFPRRRTFLEAWRACRELGGDLATPRTPEEAQRVDSLVGAGPAS
TTDNC00351	Drug(s)	MORAb-004
TTDNC00352	Name	PK
TTDNC00352	Type of target	Successful target
TTDNC00352	Drug(s)	Cobicistat
TTDNC00352	Drug(s)	Cobicistat/darunavir
TTDNC00356	Name	Inhaled steroid
TTDNC00356	Type of target	Successful target
TTDNC00356	Drug(s)	Symbicort
TTDNC00358	Name	Afferent nerve
TTDNC00358	Type of target	Clinical trial target
TTDNC00358	Drug(s)	ASP3652
TTDNC00361	Name	Hedgehog Signaling Pathway
TTDNC00361	Type of target	Successful target
TTDNC00361	Drug(s)	LDE225
TTDNC00361	Drug(s)	LY2940680
TTDNC00361	Drug(s)	RG3616
TTDNC00361	Drug(s)	TAK-441
TTDNC00362	Name	Synthetic, peptide-based erythropoiesis
TTDNC00362	Type of target	Successful target
TTDNC00362	Drug(s)	Peginesatide
TTDNC00364	Name	Influenza vaccine
TTDNC00364	Type of target	Clinical trial target
TTDNC00364	Drug(s)	ASP7373
TTDNC00366	Name	JAK
TTDNC00366	Type of target	Clinical trial target
TTDNC00366	Drug(s)	ASP015K
TTDNC00366	Drug(s)	Momelotinib
TTDNC00370	UniProt ID	O94907
TTDNC00370	Name	DKK1 protein
TTDNC00370	Type of target	Clinical trial target
TTDNC00370	Function	Antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt an
TTDNC00370	Sequence	MMALGAAGATRVFVAMVAAALGGHPLLGVSATLNSVLNSNAIKNLPPPLGGAAGHPGSAVSAAPGILYPGGNKYQTIDNY
TTDNC00370	PDB Structure	3S2K; 3S8V
TTDNC00370	Drug(s)	PF-04840082
TTDNC00371	UniProt ID	Q9HBE4
TTDNC00371	Name	IL-21
TTDNC00371	Type of target	Clinical trial target
TTDNC00371	Function	Cytokine with immunoregulatory activity. May promote the transition between inna
TTDNC00371	Sequence	MERIVICLMVIFLGTLVHKSSSQGQDRHMIRMRQLIDIVDQLKNYVNDLVPEFLPAPEDVETNCEWSAFSCFQKAQLKSA
TTDNC00371	PDB Structure	2OQP; 3TGX
TTDNC00371	Drug(s)	NN8828
TTDNC00372	UniProt ID	P56199
TTDNC00372	Name	VLA-1
TTDNC00372	Type of target	Clinical trial target
TTDNC00372	Function	Integrin alpha-1/beta-1 is a receptor for laminin and collagen. It recognizes th
TTDNC00372	Sequence	MAPRPRARPGVAVACCWLLTVVLRCCVSFNVDVKNSMTFSGPVEDMFGYTVQQYENEEGKWVLIGSPLVGQPKNRTGDVY
TTDNC00372	PDB Structure	1PT6; 1QC5; 1QCY; 2L8S; 4A0Q
TTDNC00372	Drug(s)	SAN-300
TTDNC00373	UniProt ID	P17181
TTDNC00373	Name	IFN-alphaR
TTDNC00373	Type of target	Clinical trial target
TTDNC00373	Function	Associates with IFNAR2 to form the type I interferon receptor. Receptor for inte
TTDNC00373	Sequence	MMVVLLGATTLVLVAVAPWVLSAAAGGKNLKSPQKVEVDIIDDNFILRWNRSDESVGNVTFSFDYQKTGMDNWIKLSGCQ
TTDNC00373	PDB Structure	3S98; 3SE3; 3SE4
TTDNC00373	Drug(s)	MEDI-546
TTDNC00375	Name	OxLDL
TTDNC00375	Type of target	Clinical trial target
TTDNC00375	Drug(s)	RG7418
TTDNC00376	UniProt ID	P36544
TTDNC00376	Name	A-7 nicotinic
TTDNC00376	Type of target	Clinical trial target
TTDNC00376	Function	After binding acetylcholine, the AChR responds by an extensive change in conform
TTDNC00376	Sequence	MRCSPGGVWLALAASLLHVSLQGEFQRKLYKELVKNYNPLERPVANDSQPLTVYFSLSLLQIMDVDEKNQVLTTNIWLQM
TTDNC00376	Drug(s)	ABT-126
TTDNC00376	Drug(s)	BMS-933043
TTDNC00377	Name	secretase
TTDNC00377	Type of target	Clinical trial target
TTDNC00377	Drug(s)	LY2886721
TTDNC00377	Drug(s)	Secretase inhibitor
TTDNC00378	Name	Amyloid precursor protein secretase
TTDNC00378	Type of target	Clinical trial target
TTDNC00378	Drug(s)	CHF-5074
TTDNC00378	Drug(s)	E2212
TTDNC00378	Drug(s)	EVP-0962
TTDNC00380	UniProt ID	O15155
TTDNC00380	Name	BET protein
TTDNC00380	Type of target	Clinical trial target
TTDNC00380	Function	Required for vesicular transport from the ER to the Golgi complex. Functions as
TTDNC00380	Sequence	MRRAGLGEGVPPGNYGNYGYANSGYSACEEENERLTESLRSKVTAIKSLSIEIGHEVKTQNKLLAEMDSQFDSTTGFLGK
TTDNC00380	PDB Structure	3EGX
TTDNC00380	Drug(s)	RVX-208
TTDNC00381	UniProt ID	P43681
TTDNC00381	Name	Alpha-4 beta-2 nicotinic   receptor
TTDNC00381	Type of target	Clinical trial target
TTDNC00381	Function	After binding acetylcholine, the AChR responds by an extensive change in conform
TTDNC00381	Sequence	MELGGPGAPRLLPPLLLLLGTGLLRASSHVETRAHAEERLLKKLFSGYNKWSRPVANISDVVLVRFGLSIAQLIDVDEKN
TTDNC00381	PDB Structure	2GVT; 2LLY
TTDNC00381	Drug(s)	ABT-560
TTDNC00385	UniProt ID	P49767
TTDNC00385	Name	VEGF-C
TTDNC00385	Type of target	Clinical trial target
TTDNC00385	Function	Growth factor active in angiogenesis, and endothelial cell growth, stimulating t
TTDNC00385	Sequence	MHLLGFFSVACSLLAAALLPGPREAPAAAAAFESGLDLSDAEPDAGEATAYASKDLEEQLRSVSSVDELMTVLYPEYWKM
TTDNC00385	PDB Structure	2X1W; 2X1X
TTDNC00385	Drug(s)	VGX-100
TTDNC00386	Name	catenin
TTDNC00386	Type of target	Clinical trial target
TTDNC00386	Drug(s)	PRI-724
TTDNC00387	UniProt ID	Q92793
TTDNC00387	Name	CBP
TTDNC00387	Type of target	Clinical trial target
TTDNC00387	Function	Acetylates histones, giving a specific tag for transcriptional activation. Also
TTDNC00387	Sequence	MAENLLDGPPNPKRAKLSSPGFSANDSTDFGSLFDLENDLPDELIPNGGELGLLNSGNLVPDAASKHKQLSELLRGGSGS
TTDNC00387	PDB Structure	1JSP; 1LIQ; 1RDT; 1WO3; 1WO4; 1WO5; 1WO6; 1WO7; 1ZOQ; 2D82; 2KJE; 2KWF; 2L84; 2L
TTDNC00387	EC Number	EC 2.3.1.48
TTDNC00387	Drug(s)	PRI-724
TTDNC00388	UniProt ID	O00443
TTDNC00388	Name	PI3K alpha
TTDNC00388	Type of target	Clinical trial target
TTDNC00388	Function	Generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3
TTDNC00388	Sequence	MAQISSNSGFKECPSSHPEPTRAKDVDKEEALQMEAEALAKLQKDRQVTDNQRGFELSSSTRKKAQVYNKQDYDLMVFPE
TTDNC00388	PDB Structure	2AR5; 2IWL; 2REA; 2RED
TTDNC00388	EC Number	EC 2.7.1.154
TTDNC00388	Drug(s)	BYL719
TTDNC00388	Drug(s)	INK1117
TTDNC00388	Drug(s)	MLN1117
TTDNC00388	Drug(s)	PWT33597
TTDNC00388	Drug(s)	RG7321
TTDNC00389	UniProt ID	O95180
TTDNC00389	Name	T-type calcium channel
TTDNC00389	Type of target	Clinical trial target
TTDNC00389	Function	Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into
TTDNC00389	Sequence	MTEGARAADEVRVPLGAPPPGPAALVGASPESPGAPGREAERGSELGVSPSESPAAERGAELGADEEQRVPYPALAATVF
TTDNC00389	Drug(s)	ABT-639
TTDNC00390	Name	HER
TTDNC00390	Type of target	Clinical trial target
TTDNC00390	Drug(s)	AC480
TTDNC00391	Name	Pim kinase
TTDNC00391	Type of target	Clinical trial target
TTDNC00391	Drug(s)	AZD1208
TTDNC00392	UniProt ID	Q6UUV9
TTDNC00392	Name	TORC1
TTDNC00392	Type of target	Clinical trial target
TTDNC00392	Function	Transcriptional coactivator for CREB1 which activates transcription through both
TTDNC00392	Sequence	MATSNNPRKFSEKIALHNQKQAEETAAFEEVMKDLSLTRAARLQLQKSQYLQLGPSRGQYYGGSLPNVNQIGSGTMDLPF
TTDNC00392	Drug(s)	MLN0128
TTDNC00393	UniProt ID	Q53ET0
TTDNC00393	Name	TORC2
TTDNC00393	Type of target	Clinical trial target
TTDNC00393	Function	Transcriptional coactivator for CREB1 which activates transcription through both
TTDNC00393	Sequence	MATSGANGPGSATASASNPRKFSEKIALQKQRQAEETAAFEEVMMDIGSTRLQAQKLRLAYTRSSHYGGSLPNVNQIGSG
TTDNC00393	PDB Structure	4HTM
TTDNC00393	Drug(s)	MLN0128
TTDNC00395	UniProt ID	Q9Y5S8
TTDNC00395	Name	NADH oxidase
TTDNC00395	Type of target	Clinical trial target
TTDNC00395	Function	NOH-1S is a voltage-gated proton channel that mediates the H(+) currents of rest
TTDNC00395	Sequence	MGNWVVNHWFSVLFLVVWLGLNVFLFVDAFLKYEKADKYYYTRKILGSTLACARASALCLNFNSTLILLPVCRNLLSFLR
TTDNC00395	EC Number	EC 1.-.-.-
TTDNC00395	Drug(s)	ME-143
TTDNC00397	UniProt ID	Q9NR61
TTDNC00397	Name	Delta-like 4
TTDNC00397	Type of target	Clinical trial target
TTDNC00397	Function	Involved in angiogenesis; negatively regulates endothelial cell proliferation an
TTDNC00397	Sequence	MAAASRSASGWALLLLVALWQQRAAGSGVFQLQLQEFINERGVLASGRPCEPGCRTFFRVCLKHFQAVVSPGPCTFGTVS
TTDNC00397	Drug(s)	MEDI0639
TTDNC00397	Drug(s)	OMP-21M18
TTDNC00397	Drug(s)	SAR153192
TTDNC00397	Drug(s)	SAR153192
TTDNC00398	UniProt ID	Q5ZPR3
TTDNC00398	Name	B7-H3
TTDNC00398	Type of target	Clinical trial target
TTDNC00398	Function	May participate in the regulation of T-cell-mediated immune response. May play a
TTDNC00398	Sequence	MLRRRGSPGMGVHVGAALGALWFCLTGALEVQVPEDPVVALVGTDATLCCSFSPEPGFSLAQLNLIWQLTDTKQLVHSFA
TTDNC00398	Drug(s)	MGA271
TTDNC00400	UniProt ID	P39104
TTDNC00400	Name	PIK-1
TTDNC00400	Type of target	Clinical trial target
TTDNC00400	Function	Acts on phosphatidylinositol (PI) in the first committed step in the production
TTDNC00400	Sequence	MHKASSSKKSFDDTIELKKNEQLLKLINSSEFTLHNCVELLCKHSENIGIHYYLCQKLATFPHSELQFYIPQLVQVLVTM
TTDNC00400	PDB Structure	2JU0
TTDNC00400	EC Number	EC 2.7.1.67
TTDNC00400	Drug(s)	NMS-1286937
TTDNC00405	Name	Sonic hedgehog pathway
TTDNC00405	Type of target	Clinical trial target
TTDNC00405	Drug(s)	PF-04449913
TTDNC00406	UniProt ID	Q07011
TTDNC00406	Name	CD137 antigen
TTDNC00406	Type of target	Clinical trial target
TTDNC00406	Function	Receptor for TNFSF9/4-1BBL. Possibly active during T cell activation.
TTDNC00406	Sequence	MGNSCYNIVATLLLVLNFERTRSLQDPCSNCPAGTFCDNNRNQICSPCPPNSFSSAGGQRTCDICRQCKGVFRTRKECSS
TTDNC00406	Drug(s)	PF-05082566
TTDNC00407	UniProt ID	P16949
TTDNC00407	Name	Stathim
TTDNC00407	Type of target	Clinical trial target
TTDNC00407	Function	Involved in the regulation of the microtubule (MT) filament system by destabiliz
TTDNC00407	Sequence	MASSDIQVKELEKRASGQAFELILSPRSKESVPEFPLSPPKKKDLSLEEIQKKLEAAEERRKSHEAEVLKQLAEKREHEK
TTDNC00407	Drug(s)	StMN1 Lp
TTDNC00408	UniProt ID	Q14872
TTDNC00408	Name	MTF-1
TTDNC00408	Type of target	Clinical trial target
TTDNC00408	Function	Activates the metallothionein I promoter. Binds to the metal responsive element
TTDNC00408	Sequence	MGEHSPDNNIIYFEAEEDELTPDDKMLRFVDKNGLVPSSSGTVYDRTTVLIEQDPGTLEDEDDDGQCGEHLPFLVGGEEG
TTDNC00408	Drug(s)	LOR 253
TTDNC00409	Name	Stemness
TTDNC00409	Type of target	Clinical trial target
TTDNC00409	Drug(s)	BBI503
TTDNC00409	Drug(s)	BBI608
TTDNC00410	UniProt ID	P36888
TTDNC00410	Name	Fms-like tyrosine kinase 3
TTDNC00410	Type of target	Clinical trial target
TTDNC00410	Function	Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine FLT3
TTDNC00410	Sequence	MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSSVGKSSSYPMVSESPEDLGCALRPQSSGTVYEAAA
TTDNC00410	PDB Structure	1RJB; 3QS7; 3QS9
TTDNC00410	EC Number	EC 2.7.10.1
TTDNC00410	Drug(s)	CDX-301
TTDNC00411	UniProt ID	Q01094
TTDNC00411	Name	E2F1
TTDNC00411	Type of target	Clinical trial target
TTDNC00411	Function	Transcription activator that binds DNA cooperatively with DP proteins through th
TTDNC00411	Sequence	MALAGAPAGGPCAPALEALLGAGALRLLDSSQIVIISAAQDASAPPAPTGPAAPAAGPCDPDLLLFATPQAPRPTPSAPR
TTDNC00411	PDB Structure	1H24; 1O9K; 2AZE
TTDNC00411	Drug(s)	ARQ 761
TTDNC00412	UniProt ID	P29597
TTDNC00412	Name	TYK2
TTDNC00412	Type of target	Clinical trial target
TTDNC00412	Function	Probably involved in intracellular signal transduction by being involved in the
TTDNC00412	Sequence	MPLRHWGMARGSKPVGDGAQPMAAMGGLKVLLHWAGPGGGEPWVTFSESSLTAEEVCIHIAHKVGITPPCFNLFALFDAQ
TTDNC00412	PDB Structure	3LXN; 3LXP; 3NYX; 3NZ0; 3ZON; 4GII; 4GJ2; 4GJ3
TTDNC00412	EC Number	EC 2.7.10.2
TTDNC00412	Drug(s)	BI-853520
TTDNC00413	UniProt ID	P55040
TTDNC00413	Name	KIR
TTDNC00413	Type of target	Clinical trial target
TTDNC00413	Function	Could be a regulatory protein, possibly participating in receptor-mediated signa
TTDNC00413	Sequence	MTLNNVTMRQGTVGMQPQQQRWSIPADGRHLMVQKEPHQYSHRNRHSATPEDHCRRSWSSDSTDSVISSESGNTYYRVVL
TTDNC00413	PDB Structure	2CJW; 2G3Y; 2HT6
TTDNC00413	Drug(s)	BMS-986015
TTDNC00413	Drug(s)	Lirilumab
TTDNC00414	UniProt ID	P18627
TTDNC00414	Name	LAG3
TTDNC00414	Type of target	Clinical trial target
TTDNC00414	Function	Involved in lymphocyte activation. Binds to HLA class-II antigens.
TTDNC00414	Sequence	MWEAQFLGLLFLQPLWVAPVKPLQPGAEVPVVWAQEGAPAQLPCSPTIPLQDLSLLRRAGVTWQHQPDSGPPAAAPGHPL
TTDNC00414	Drug(s)	BMS-986016
TTDNC00415	UniProt ID	P46531
TTDNC00415	Name	Notch
TTDNC00415	Type of target	Clinical trial target
TTDNC00415	Function	Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 t
TTDNC00415	Sequence	MPPLLAPLLCLALLPALAARGPRCSQPGETCLNGGKCEAANGTEACVCGGAFVGPRCQDPNPCLSTPCKNAGTCHVVDRR
TTDNC00415	PDB Structure	1PB5; 1TOZ; 1YYH; 2F8X; 2F8Y; 2HE0; 2VJ3; 3ETO; 3I08; 3L95; 3NBN; 3V79
TTDNC00415	Drug(s)	BMS-906024
TTDNC00415	Drug(s)	Notch inhibitor
TTDNC00418	UniProt ID	Q04912
TTDNC00418	Name	RON
TTDNC00418	Type of target	Clinical trial target
TTDNC00418	Function	Receptor tyrosine kinase that transduces signals from the extracellular matrix i
TTDNC00418	Sequence	MELLPPLPQSFLLLLLLPAKPAAGEDWQCPRTPYAASRDFDVKYVVPSFSAGGLVQAMVTYEGDRNESAVFVAIRNRLHV
TTDNC00418	PDB Structure	3PLS; 4FWW
TTDNC00418	EC Number	EC 2.7.10.1
TTDNC00418	Drug(s)	RON Monoclonal Antibody
TTDNC00419	UniProt ID	Q15389
TTDNC00419	Name	Angioprotein
TTDNC00419	Type of target	Clinical trial target
TTDNC00419	Function	Binds and activates TEK/TIE2 receptor by inducing its dimerization and tyrosine
TTDNC00419	Sequence	MTVFLSFAFLAAILTHIGCSNQRRSPENSGRRYNRIQHGQCAYTFILPEHDGNCRESTTDQYNTNALQRDAPHVEPDFSS
TTDNC00419	PDB Structure	4EPU; 4JYO; 4K0V
TTDNC00419	Drug(s)	AMG 780
TTDNC00420	UniProt ID	Q99075
TTDNC00420	Name	HB-EGF
TTDNC00420	Type of target	Clinical trial target
TTDNC00420	Function	Growth factor that mediates its effects via EGFR, ERBB2 and ERBB4. Required for
TTDNC00420	Sequence	MKLLPSVVLKLFLAAVLSALVTGESLERLRRGLAAGTSNPDPPTVSTDQLLPLGGGRDRKVRDLQEADLDLLRVTLSSKP
TTDNC00420	PDB Structure	1XDT
TTDNC00420	Drug(s)	U3-1565
TTDNC00421	UniProt ID	P43489
TTDNC00421	Name	OX40
TTDNC00421	Type of target	Clinical trial target
TTDNC00421	Function	Receptor for TNFSF4/OX40L/GP34.
TTDNC00421	Sequence	MCVGARRLGRGPCAALLLLGLGLSTVTGLHCVGDTYPSNDRCCHECRPGNGMVSRCSRSQNTVCRPCGPGFYNDVVSSKP
TTDNC00421	PDB Structure	1D0A; 2HEV; 2HEY
TTDNC00421	Drug(s)	Anti-OX40 mAb
TTDNC00422	UniProt ID	P11387
TTDNC00422	Name	Toposisomerase-1
TTDNC00422	Type of target	Clinical trial target
TTDNC00422	Function	Releases the supercoiling and torsional tension of DNA introduced during the DNA
TTDNC00422	Sequence	MSGDHLHNDSQIEADFRLNDSHKHKDKHKDREHRHKEHKKEKDREKSKHSNSEHKDSEKKHKEKEKTKHKDGSSEKHKDK
TTDNC00422	PDB Structure	1A31; 1A35; 1A36; 1EJ9; 1K4S; 1K4T; 1LPQ; 1NH3; 1R49; 1RR8; 1RRJ; 1SC7; 1SEU; 1T
TTDNC00422	EC Number	EC 5.99.1.2
TTDNC00422	Drug(s)	Genz644282
TTDNC00423	Name	DS6
TTDNC00423	Type of target	Clinical trial target
TTDNC00423	Drug(s)	SAR566658
TTDNC00424	UniProt ID	P28907
TTDNC00424	Name	CD38
TTDNC00424	Type of target	Clinical trial target
TTDNC00424	Function	Synthesizes cyclic ADP-ribose, a second messenger for glucose-induced insulin se
TTDNC00424	Sequence	MANCEFSPVSGDKPCCRLSRRAQLCLGVSILVLILVVVLAVVVPRWRQQWSGPGTTKRFPETVLARCVKYTEIHPEMRHV
TTDNC00424	PDB Structure	1YH3; 1ZVM; 2EF1; 2HCT; 2I65; 2I66; 2I67; 2O3Q; 2O3R; 2O3S; 2O3T; 2O3U; 2PGJ; 2P
TTDNC00424	EC Number	EC 3.2.2.5
TTDNC00424	Drug(s)	SAR650984
TTDNC00424	Drug(s)	SAR650984
TTDNC00425	UniProt ID	P68400
TTDNC00425	Name	CK2
TTDNC00425	Type of target	Clinical trial target
TTDNC00425	Function	Catalytic subunit of a constitutively active serine/threonine-protein kinase com
TTDNC00425	Sequence	MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR
TTDNC00425	PDB Structure	1JWH; 1NA7; 1PJK; 2PVR; 2ZJW; 3AMY; 3AT2; 3AT3; 3AT4; 3AXW; 3BQC; 3C13; 3FWQ; 3H
TTDNC00425	EC Number	EC 2.7.11.1
TTDNC00425	Drug(s)	CX-4945
TTDNC00426	UniProt ID	P08648
TTDNC00426	Name	a5? integrin
TTDNC00426	Type of target	Clinical trial target
TTDNC00426	Function	Integrin alpha-5/beta-1 is a receptor for fibronectin and fibrinogen. It recogni
TTDNC00426	Sequence	MGSRTPESPLHAVQLRWGPRRRPPLLPLLLLLLPPPPRVGGFNLDAEAPAVLSGPPGSFFGFSVEFYRPGTDGVSVLVGA
TTDNC00426	PDB Structure	3VI3; 3VI4
TTDNC00426	Drug(s)	PF-04605412
TTDNC00427	UniProt ID	Q7Z2W7
TTDNC00427	Name	TRPM8 protein
TTDNC00427	Type of target	Clinical trial target
TTDNC00427	Function	Receptor-activated non-selective cation channel involved in detection of sensati
TTDNC00427	Sequence	MSFRAARLSMRNRRNDTLDSTRTLYSSASRSTDLSYSESDLVNFIQANFKKRECVFFTKDSKATENVCKCGYAQSQHMEG
TTDNC00427	Drug(s)	D-3263
TTDNC00429	Name	WNT signaling pathway
TTDNC00429	Type of target	Clinical trial target
TTDNC00429	Drug(s)	LGK974
TTDNC00433	UniProt ID	O00750
TTDNC00433	Name	PI3K beta
TTDNC00433	Type of target	Clinical trial target
TTDNC00433	Function	Phosphorylates PtdIns and PtdIns4P with a preference for PtdIns. Does not phosph
TTDNC00433	Sequence	MSSTQGNGEHWKSLESVGISRKELAMAEALQMEYDALSRLRHDKEENRAKQNADPSLISWDEPGVDFYSKPAGRRTDLKL
TTDNC00433	EC Number	EC 2.7.1.154
TTDNC00433	Drug(s)	GSK2636771
TTDNC00433	Drug(s)	SAR260301
TTDNC00434	Name	CDK
TTDNC00434	Type of target	Clinical trial target
TTDNC00434	Drug(s)	BAY 1000394
TTDNC00435	Name	HIF-1 pathway
TTDNC00435	Type of target	Clinical trial target
TTDNC00435	Drug(s)	BAY 87-2243
TTDNC00437	UniProt ID	Q6P1X5
TTDNC00437	Name	CIF
TTDNC00437	Type of target	Clinical trial target
TTDNC00437	Function	Transcription factor TFIID is one of the general factors required for accurate a
TTDNC00437	Sequence	MPLTGVEPARMNRKKGDKGFESPRPYKLTHQVVCINNINFQRKSVVGFVELTIFPTVANLNRIKLNSKQCRIYRVRINDL
TTDNC00437	Drug(s)	RG7167
TTDNC00438	Name	MAP
TTDNC00438	Type of target	Clinical trial target
TTDNC00438	Drug(s)	RG7304
TTDNC00439	UniProt ID	P20039
TTDNC00439	Name	DR5
TTDNC00439	Type of target	Clinical trial target
TTDNC00439	Function	Binds peptides derived from antigens that access the endocytic route of antigen
TTDNC00439	Sequence	MVCLRLPGGSCMAVLTVTLMVLSSPLALAGDTRPRFLEYSTSECHFFNGTERVRFLDRYFYNQEEYVRFDSDVGEFRAVT
TTDNC00439	Drug(s)	CS-1008
TTDNC00439	Drug(s)	Tigatuzumab
TTDNC00441	UniProt ID	P13866
TTDNC00441	Name	SGLT1
TTDNC00441	Type of target	Clinical trial target
TTDNC00441	Function	Actively transports glucose into cells by Na(+) cotransport with a Na(+) to gluc
TTDNC00441	Sequence	MDSSTWSPKTTAVTRPVETHELIRNAADISIIVIYFVVVMAVGLWAMFSTNRGTVGGFFLAGRSMVWWPIGASLFASNIG
TTDNC00441	Drug(s)	LIK066
TTDNC00442	UniProt ID	Q12908
TTDNC00442	Name	Ileal bile acid transfer
TTDNC00442	Type of target	Clinical trial target
TTDNC00442	Function	Plays a critical role in the sodium-dependent reabsorption of bile acids from th
TTDNC00442	Sequence	MNDPNSCVDNATVCSGASCVVPESNFNNILSVVLSTVLTILLALVMFSMGCNVEIKKFLGHIKRPWGICVGFLCQFGIMP
TTDNC00442	Drug(s)	1614235  + 2330672
TTDNC00442	Drug(s)	GSK2330672
TTDNC00443	UniProt ID	P10997
TTDNC00443	Name	Human pro-islet peptide
TTDNC00443	Type of target	Clinical trial target
TTDNC00443	Function	Selectively inhibits insulin-stimulated glucose utilization and glycogen deposit
TTDNC00443	Sequence	MGILKLQVFLIVLSVALNHLKATPIESHQVEKRKCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTYGKRNAVEVLK
TTDNC00443	PDB Structure	1KUW; 2G48; 2KB8; 2L86; 3FPO; 3FR1; 3FTH; 3FTK; 3FTL; 3FTR; 3G7V; 3G7W; 3HGZ
TTDNC00443	Drug(s)	HIP-2B
TTDNC00444	UniProt ID	Q99943
TTDNC00444	Name	Lysophosphatidic acid transferase
TTDNC00444	Type of target	Clinical trial target
TTDNC00444	Function	Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an
TTDNC00444	Sequence	MDLWPGAWMLLLLLFLLLLFLLPTLWFCSPSAKYFFKMAFYNGWILFLAVLAIPVCAVRGRNVENMKILRLMLLHIKYLY
TTDNC00444	EC Number	EC 2.3.1.51
TTDNC00444	Drug(s)	Lisofylline
TTDNC00446	UniProt ID	Q12913
TTDNC00446	Name	HPTP
TTDNC00446	Type of target	Clinical trial target
TTDNC00446	Function	Tyrosine phosphatase which dephosphorylates or contributes to the dephosphorylat
TTDNC00446	Sequence	MKPAAREARLPPRSPGLRWALPLLLLLLRLGQILCAGGTPSPIPDPSVATVATGENGITQISSTAESFHKQNGTGTPQVE
TTDNC00446	PDB Structure	2CFV; 2DLE; 2NZ6
TTDNC00446	EC Number	EC 3.1.3.48
TTDNC00446	Drug(s)	AKB-9778
TTDNC00447	UniProt ID	Q02763
TTDNC00447	Name	TIE2
TTDNC00447	Type of target	Clinical trial target
TTDNC00447	Function	Tyrosine-protein kinase that acts as cell-surface receptor for ANGPT1, ANGPT2 an
TTDNC00447	Sequence	MDSLASLVLCGVSLLLSGTVEGAMDLILINSLPLVSDAETSLTCIASGWRPHEPITIGRDFEALMNQHQDPLEVTQDVTR
TTDNC00447	PDB Structure	1FVR; 2GY5; 2GY7; 2OO8; 2OSC; 2P4I; 2WQB; 3BEA; 3L8P; 4K0V
TTDNC00447	EC Number	EC 2.7.10.1
TTDNC00447	Drug(s)	AKB-9778
TTDNC00447	Drug(s)	ARRY-614
TTDNC00447	Drug(s)	CEP-11981
TTDNC00448	UniProt ID	P10619
TTDNC00448	Name	Cathepsin A
TTDNC00448	Type of target	Clinical trial target
TTDNC00448	Function	Protective protein appears to be essential for both the activity of beta-galacto
TTDNC00448	Sequence	MIRAAPPPLFLLLLLLLLLVSWASRGEAAPDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVL
TTDNC00448	PDB Structure	1IVY; 3BP4; 3BP7; 3BXN; 4AZ0; 4AZ3
TTDNC00448	EC Number	EC 3.4.16.5
TTDNC00448	Drug(s)	SAR164653
TTDNC00449	Name	protease
TTDNC00449	Type of target	Clinical trial target
TTDNC00449	Drug(s)	Cobicistat/darunavir
TTDNC00451	Name	MAG pDNA
TTDNC00451	Type of target	Clinical trial target
TTDNC00451	Drug(s)	HIV vaccine
TTDNC00453	Name	Triple reuptake
TTDNC00453	Type of target	Clinical trial target
TTDNC00453	Drug(s)	BMS-820836
TTDNC00453	Drug(s)	EB-1020
TTDNC00454	UniProt ID	P08908
TTDNC00454	Name	Serotonin-1A
TTDNC00454	Type of target	Clinical trial target
TTDNC00454	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDNC00454	Sequence	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAV
TTDNC00454	Drug(s)	AV965
TTDNC00455	Name	Vasopressin-1 receptor
TTDNC00455	Type of target	Clinical trial target
TTDNC00455	Drug(s)	RG7314
TTDNC00456	UniProt ID	Q9Y233
TTDNC00456	Name	Phosphodiesterase 10A (PDE10A)
TTDNC00456	Type of target	Clinical trial target
TTDNC00456	Function	Plays a role in signal transduction by regulating the intracellular concentratio
TTDNC00456	Sequence	MRIEERKSQHLTGLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNS
TTDNC00456	PDB Structure	1LRB; 2OUN; 2OUP; 2OUQ; 2OUR; 2OUS; 2OUU; 2OUV; 2OUY; 2WEY; 2Y0J; 2ZMF; 3SN7; 3S
TTDNC00456	EC Number	EC 3.1.4.17
TTDNC00456	Drug(s)	AMG 579
TTDNC00456	Drug(s)	RG7203
TTDNC00456	Drug(s)	TAK-063
TTDNC00457	Name	Recombinant fusion protein
TTDNC00457	Type of target	Clinical trial target
TTDNC00457	Drug(s)	VAX-102
TTDNC00457	Drug(s)	VAX-125
TTDNC00457	Drug(s)	VAX-128
TTDNC00460	UniProt ID	Q969D9
TTDNC00460	Name	Thymic stromal lymphopoietin
TTDNC00460	Type of target	Clinical trial target
TTDNC00460	Function	Cytokine that induces the release of T-cell-attracting chemokines from monocytes
TTDNC00460	Sequence	MFPFALLYVLSVSFRKIFILQLVGLVLTYDFTNCDFEKIKAAYLSTISKDLITYMSGTKSTEFNNTVSCSNRPHCLTEIQ
TTDNC00460	Drug(s)	AMG 157
TTDNC00461	UniProt ID	Q9BQB4
TTDNC00461	Name	Sclerostin
TTDNC00461	Type of target	Clinical trial target
TTDNC00461	Function	Negative regulator of bone growth that acts through inhibition of Wnt signaling
TTDNC00461	Sequence	MQLPLALCLVCLLVHTAFRVVEGQGWQAFKNDATEIIPELGEYPEPPPELENNKTMNRAENGGRPPHHPFETKDVSEYSC
TTDNC00461	PDB Structure	2K8P
TTDNC00461	Drug(s)	AMG 167
TTDNC00461	Drug(s)	AMG 785
TTDNC00461	Drug(s)	
TTDNC00462	UniProt ID	Q16602
TTDNC00462	Name	Receptor for Calcitonin Gene-Related Peptide (CGRP)
TTDNC00462	Type of target	Clinical trial target
TTDNC00462	Function	Receptor for calcitonin-gene-related peptide (CGRP) together with RAMP1 and rece
TTDNC00462	Sequence	MEKKCTLNFLVLLPFFMILVTAELEESPEDSIQLGVTRNKIMTAQYECYQKIMQDPIQQAEGVYCNRTWDGWLCWNDVAA
TTDNC00462	PDB Structure	3AQF; 3N7P; 3N7R; 3N7S
TTDNC00462	Drug(s)	AMG 334
TTDNC00463	UniProt ID	O75144
TTDNC00463	Name	B7RP1
TTDNC00463	Type of target	Clinical trial target
TTDNC00463	Function	Ligand for the T-cell-specific cell surface receptor ICOS. Acts as a costimulato
TTDNC00463	Sequence	MRLGSPGLLFLLFSSLRADTQEKEVRAMVGSDVELSCACPEGSRFDLNDVYVYWQTSESKTVVTYHIPQNSSLENVDSRY
TTDNC00463	Drug(s)	AMG 557
TTDNC00463	Drug(s)	MEDI5872
TTDNC00464	UniProt ID	P31994
TTDNC00464	Name	CD32b
TTDNC00464	Type of target	Clinical trial target
TTDNC00464	Function	Receptor for the Fc region of complexed or aggregated immunoglobulins gamma. Low
TTDNC00464	Sequence	MGILSFLPVLATESDWADCKSPQPWGHMLLWTAVLFLAPVAGTPAAPPKAVLKLEPQWINVLQEDSVTLTCRGTHSPESD
TTDNC00464	PDB Structure	2FCB
TTDNC00464	Drug(s)	AMG 729
TTDNC00464	Drug(s)	XmAb 5871
TTDNC00466	Name	BL
TTDNC00466	Type of target	Clinical trial target
TTDNC00466	Drug(s)	ATM AVI
TTDNC00468	UniProt ID	Q9NZQ7
TTDNC00468	Name	Programmed cell death? ligand 1 (PD-L1)
TTDNC00468	Type of target	Clinical trial target
TTDNC00468	Function	Involved in the costimulatory signal, essential for T- cell proliferation and pr
TTDNC00468	Sequence	MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSS
TTDNC00468	PDB Structure	3BIK; 3BIS; 3FN3; 3SBW
TTDNC00468	Drug(s)	MEDI4736
TTDNC00468	Drug(s)	MPDL-3280A
TTDNC00470	Name	Murine anti-OX40 Mab
TTDNC00470	Type of target	Clinical trial target
TTDNC00470	Drug(s)	MEDI6469
TTDNC00471	Name	Inhaled TLR7
TTDNC00471	Type of target	Clinical trial target
TTDNC00471	Drug(s)	AZD8848
TTDNC00472	Name	Inhaled SGRM
TTDNC00472	Type of target	Clinical trial target
TTDNC00472	Drug(s)	AZD5423
TTDNC00472	Drug(s)	AZD7594
TTDNC00473	Name	C5
TTDNC00473	Type of target	Clinical trial target
TTDNC00473	Drug(s)	MEDI7814
TTDNC00474	UniProt ID	P01031
TTDNC00474	Name	C5a
TTDNC00474	Type of target	Clinical trial target
TTDNC00474	Function	Activation of C5 by a C5 convertase initiates the spontaneous assembly of the la
TTDNC00474	Sequence	MGLLGILCFLIFLGKTWGQEQTYVISAPKIFRVGASENIVIQVYGYTEAFDATISIKSYPDKKFSYSSGHVHLSSENKFQ
TTDNC00474	PDB Structure	1CFA; 1KJS; 1XWE; 3CU7; 3HQA; 3HQB; 3KLS; 3KM9; 3PRX; 3PVM; 4A5W; 4E0S
TTDNC00474	Drug(s)	MEDI7814
TTDNC00475	UniProt ID	Q969D9
TTDNC00475	Name	TSLP
TTDNC00475	Type of target	Clinical trial target
TTDNC00475	Function	Cytokine that induces the release of T-cell-attracting chemokines from monocytes
TTDNC00475	Sequence	MFPFALLYVLSVSFRKIFILQLVGLVLTYDFTNCDFEKIKAAYLSTISKDLITYMSGTKSTEFNNTVSCSNRPHCLTEIQ
TTDNC00475	Drug(s)	MEDI9929
TTDNC00477	UniProt ID	Q13421
TTDNC00477	Name	Mesothelin-ADC
TTDNC00477	Type of target	Clinical trial target
TTDNC00477	Function	Membrane-anchored forms may play a role in cellular adhesion.
TTDNC00477	Sequence	MALPTARPLLGSCGTPALGSLLFLLFSLGWVQPSRTLAGETGQEAAPLDGVLANPPNISSLSPRQLLGFPCAEVSGLSTE
TTDNC00477	PDB Structure	4F3F
TTDNC00477	Drug(s)	BAY 94-9343
TTDNC00479	Name	S-PRAnt
TTDNC00479	Type of target	Clinical trial target
TTDNC00479	Drug(s)	BAY 1002670
TTDNC00480	Name	Mitotic checkpoint
TTDNC00480	Type of target	Clinical trial target
TTDNC00480	Drug(s)	
TTDNC00481	Name	DNAPKi
TTDNC00481	Type of target	Clinical trial target
TTDNC00481	Drug(s)	CC-115
TTDNC00483	UniProt ID	P78358
TTDNC00483	Name	NY-ESO-1
TTDNC00483	Type of target	Clinical trial target
TTDNC00483	Sequence	MQAEGRGTGGSTGDADGPGGPGIPDGPGGNAGGPGEAGATGGRGPRGAGAARASGPGGGAPRGPHGGAASGLNGCCRCGA
TTDNC00483	PDB Structure	2BNQ; 2BNR; 2F53; 2F54; 2P5E; 2P5W; 2PYE; 3KLA
TTDNC00483	Drug(s)	CDX-1401
TTDNC00484	UniProt ID	P26842
TTDNC00484	Name	CD27
TTDNC00484	Type of target	Clinical trial target
TTDNC00484	Function	Receptor for CD70/CD27L. May play a role in survival of activated T-cells. May p
TTDNC00484	Sequence	MARPHPWWLCVLGTLVGLSATPAPKSCPERHYWAQGKLCCQMCEPGTFLVKDCDQHRKAAQCDPCIPGVSFSPDHHTRPH
TTDNC00484	Drug(s)	CDX-1127
TTDNC00485	UniProt ID	Q8TDV5
TTDNC00485	Name	GPR119
TTDNC00485	Type of target	Clinical trial target
TTDNC00485	Function	Receptor for the endogenous fatty-acid ethanolamide oleoylethanolamide (OEA) and
TTDNC00485	Sequence	MESSFSFGVILAVLASLIIATNTLVAVAVLLLIHKNDGVSLCFTLNLAVADTLIGVAISGLLTDQLSSPSRPTQKTLCSL
TTDNC00485	Drug(s)	DS-8500
TTDNC00486	UniProt ID	Q96IY4
TTDNC00486	Name	TAFIa
TTDNC00486	Type of target	Clinical trial target
TTDNC00486	Function	Cleaves C-terminal arginine or lysine residues from biologically active peptides
TTDNC00486	Sequence	MKLCSLAVLVPIVLFCEQHVFAFQSGQVLAALPRTSRQVQVLQNLTTTYEIVLWQPVTADLIVKKKQVHFFVNASDVDNV
TTDNC00486	PDB Structure	3D66; 3D67; 3D68; 3LMS
TTDNC00486	EC Number	EC 3.4.17.20
TTDNC00486	Drug(s)	DS-1040
TTDNC00486	Drug(s)	SAR126119
TTDNC00488	Name	Second-generation proteasome
TTDNC00488	Type of target	Clinical trial target
TTDNC00488	Drug(s)	MLN9708
TTDNC00489	UniProt ID	Q15116
TTDNC00489	Name	PD-1
TTDNC00489	Type of target	Clinical trial target
TTDNC00489	Function	Inhibitory cell surface receptor involved in the regulation of T-cell function d
TTDNC00489	Sequence	MQIPQAPWPVVWAVLQLGWRPGWFLDSPDRPWNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLA
TTDNC00489	PDB Structure	2M2D; 3RRQ
TTDNC00489	Drug(s)	BMS-936558
TTDNC00489	Drug(s)	Nivolumab
TTDNC00490	UniProt ID	Q15303
TTDNC00490	Name	Proto oncogene protein-c mdm2
TTDNC00490	Type of target	Clinical trial target
TTDNC00490	Function	Tyrosine-protein kinase that plays an essential role as cell surface receptor fo
TTDNC00490	Sequence	MKPATGLWVWVSLLVAAGTVQPSDSQSVCAGTENKLSSLSDLEQQYRALRKYYENCEVVMGNLEITSIEHNRDLSFLRSV
TTDNC00490	PDB Structure	2AHX; 2L2T; 2LCX; 2R4B; 3BBT; 3BBW; 3BCE; 3U2P; 3U7U; 3U9U
TTDNC00490	EC Number	EC 2.7.10.1
TTDNC00490	Drug(s)	RG7388
TTDNC00491	Name	Multi-IAP
TTDNC00491	Type of target	Clinical trial target
TTDNC00491	Drug(s)	AT-406
TTDNC00492	UniProt ID	Q8TEK3
TTDNC00492	Name	DOT1L
TTDNC00492	Type of target	Clinical trial target
TTDNC00492	Function	Histone methyltransferase. Methylates 'Lys-79' of histone H3. Nucleosomes are pr
TTDNC00492	Sequence	MGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNR
TTDNC00492	PDB Structure	1NW3; 3QOW; 3QOX; 3SR4; 3SX0; 3UWP; 4EK9; 4EKG; 4EKI; 4EQZ; 4ER0; 4ER3; 4ER5; 4E
TTDNC00492	EC Number	EC 2.1.1.43
TTDNC00492	Drug(s)	EPZ-5676
TTDNC00493	Name	Cell-cycle
TTDNC00493	Type of target	Clinical trial target
TTDNC00493	Drug(s)	DFP-10917
TTDNC00493	Drug(s)	PM01183
TTDNC00494	Name	PKC
TTDNC00494	Type of target	Clinical trial target
TTDNC00494	Drug(s)	AEB071
TTDNC00497	UniProt ID	Q9UBU2
TTDNC00497	Name	DKK2 protein
TTDNC00497	Type of target	Clinical trial target
TTDNC00497	Function	Antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt an
TTDNC00497	Sequence	MAALMRSKDSSCCLLLLAAVLMVESSQIGSSRAKLNSIKSSLGGETPGQAANRSAGMYQGLAFGGSKKGKNLGQAYPCSS
TTDNC00497	Drug(s)	DKN-01
TTDNC00498	UniProt ID	P11309
TTDNC00498	Name	Proto-oncogene pim-1
TTDNC00498	Type of target	Clinical trial target
TTDNC00498	Function	Proto-oncogene with serine/threonine kinase activity involved in cell survival a
TTDNC00498	Sequence	MPHEPHEPLTPPFSALPDPAGAPSRRQSRQRPQLSSDSPSAFRASRSHSRNATRSHSHSHSPRHSLRHSPGSGSCGSSSG
TTDNC00498	PDB Structure	1XQZ; 1XR1; 1XWS; 1YHS; 1YI3; 1YI4; 1YWV; 1YXS; 1YXT; 1YXU; 1YXV; 1YXX; 2BIK; 2B
TTDNC00498	EC Number	EC 2.7.11.1
TTDNC00498	Drug(s)	LGH447
TTDNC00499	UniProt ID	Q9UHE8
TTDNC00499	Name	STEAP1
TTDNC00499	Type of target	Clinical trial target
TTDNC00499	Function	Metalloreductase that has the ability to reduce both Fe(3+) to Fe(2+) and Cu(2+)
TTDNC00499	Sequence	MESRKDITNQEELWKMKPRRNLEEDDYLHKDTGETSMLKRPVLLHLHQTAHADEFDCPSELQHTQELFPQWHLPIKIAAI
TTDNC00499	EC Number	EC 1.16.1.-
TTDNC00499	Drug(s)	DSTP-3086S
TTDNC00499	Drug(s)	RG7450
TTDNC00500	Name	Nucleotide reverse transcriptase
TTDNC00500	Type of target	Clinical trial target
TTDNC00500	Drug(s)	Tenofovir Alafenamide
TTDNC00501	Name	Tarmogen T cell immunity
TTDNC00501	Type of target	Clinical trial target
TTDNC00501	Drug(s)	GS-4774
TTDNC00502	UniProt ID	P19438
TTDNC00502	Name	Tumour necrosis factor receptor-1 (TNFR1)
TTDNC00502	Type of target	Clinical trial target
TTDNC00502	Function	Receptor for TNFSF2/TNF-alpha and homotrimeric TNFSF1/lymphotoxin-alpha. The ada
TTDNC00502	Sequence	MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCTKCHKGTYLYNDCPGPGQDTD
TTDNC00502	PDB Structure	1EXT; 1FT4; 1ICH; 1NCF; 1TNR
TTDNC00502	Drug(s)	1995057
TTDNC00504	UniProt ID	P09693
TTDNC00504	Name	CD3
TTDNC00504	Type of target	Clinical trial target
TTDNC00504	Function	The CD3 complex mediates signal transduction.
TTDNC00504	Sequence	MEQGKGLAVLILAIILLQGTLAQSIKGNHLVKVYDYQEDGSVLLTCDAEAKNITWFKDGKMIGFLTEDKKKWNLGSNAKD
TTDNC00504	PDB Structure	1SY6
TTDNC00504	Drug(s)	Blinatumomab
TTDNC00506	UniProt ID	P13866
TTDNC00506	Name	Sodium dependent glucose transport (SGLT1)
TTDNC00506	Type of target	Clinical trial target
TTDNC00506	Function	Actively transports glucose into cells by Na(+) cotransport with a Na(+) to gluc
TTDNC00506	Sequence	MDSSTWSPKTTAVTRPVETHELIRNAADISIIVIYFVVVMAVGLWAMFSTNRGTVGGFFLAGRSMVWWPIGASLFASNIG
TTDNC00506	Drug(s)	1614235  + 2330672
TTDNC00508	Name	Endogenous gut peptide
TTDNC00508	Type of target	Clinical trial target
TTDNC00508	Drug(s)	2890457
TTDNC00510	Name	cephalosporin
TTDNC00510	Type of target	Clinical trial target
TTDNC00510	Drug(s)	2696266
TTDNC00510	Drug(s)	CAZ AVI
TTDNC00510	Drug(s)	CXL
TTDNC00511	UniProt ID	P27815
TTDNC00511	Name	Phoshodiesterase 4
TTDNC00511	Type of target	Clinical trial target
TTDNC00511	Function	Hydrolyzes the second messenger cAMP, which is a key regulator of many important
TTDNC00511	Sequence	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLR
TTDNC00511	PDB Structure	2QYK; 3I8V; 3TVX
TTDNC00511	EC Number	EC 3.1.4.17
TTDNC00511	Drug(s)	356278
TTDNC00512	UniProt ID	Q13093
TTDNC00512	Name	Lp-PLA2
TTDNC00512	Type of target	Clinical trial target
TTDNC00512	Function	Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2
TTDNC00512	Sequence	MVPPKLHVLFCLCGCLAVVYPFDWQYINPVAHMKSSAWVNKIQVLMAAASFGQTKIPRGNGPYSVGCTDLMFDHTNKGTF
TTDNC00512	PDB Structure	3D59; 3D5E; 3F96; 3F97; 3F98; 3F9C
TTDNC00512	EC Number	EC 3.1.1.47
TTDNC00512	Drug(s)	2647544
TTDNC00513	Name	Bromodomain
TTDNC00513	Type of target	Clinical trial target
TTDNC00513	Drug(s)	525762
TTDNC00515	UniProt ID	P04150
TTDNC00515	Name	Glucocortoid
TTDNC00515	Type of target	Successful target
TTDNC00515	Function	Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription
TTDNC00515	Sequence	MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAVASQSDSKQRRLLVDFPKGSVSNAQQPDLSK
TTDNC00515	PDB Structure	1M2Z; 1NHZ; 1P93; 3BQD; 3CLD; 3E7C; 3H52; 3K22; 3K23; 4HN5; 4HN6
TTDNC00515	Drug(s)	GSK870086
TTDNC00515	Drug(s)	Relvar/Breo
TTDNC00518	UniProt ID	P21730
TTDNC00518	Name	C5aR
TTDNC00518	Type of target	Clinical trial target
TTDNC00518	Function	Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a. This re
TTDNC00518	Sequence	MDSFNYTTPDYGHYDDKDTLDLNTPVDKTSNTLRVPDILALVIFAVVFLVGVLGNALVVWVTAFEAKRTINAIWFLNLAV
TTDNC00518	Drug(s)	NN8209
TTDNC00518	Drug(s)	NN8210
TTDNC00520	UniProt ID	P26715
TTDNC00520	Name	NKG2A
TTDNC00520	Type of target	Clinical trial target
TTDNC00520	Function	Plays a role as a receptor for the recognition of MHC class I HLA-E molecules by
TTDNC00520	Sequence	MDNQGVIYSDLNLPPNPKRQQRKPKGNKNSILATEQEITYAELNLQKASQDFQGNDKTYHCKDLPSAPEKLIVGILGIIC
TTDNC00520	PDB Structure	2RMX; 2YU7; 3BDW; 3CDG; 3CII
TTDNC00520	Drug(s)	NN8765
TTDNC00521	UniProt ID	E9PEK4
TTDNC00521	Name	Colony stimulating factor-1 receptor (CSF-1R)
TTDNC00521	Type of target	Clinical trial target
TTDNC00521	Sequence	MGPGVLLLLLVATAWHGQGIPVIEPSVPELVVKPGATVTLRCVGNGSVEWDGPPSPHWTLYSDGSSSILSTNNATFQNTG
TTDNC00521	Drug(s)	RG7155
TTDNC00522	UniProt ID	Q4ACW9
TTDNC00522	Name	TWEAK
TTDNC00522	Type of target	Clinical trial target
TTDNC00522	Sequence	MAARRSQRRRGRRGEPGTALLVPLALGLGLALACLGLLLAVVSLGSRASLSAQEPAQEELVAEEDQDPSELNPQTEESQD
TTDNC00522	Drug(s)	ANTI-TWEAK
TTDNC00522	Drug(s)	RG7212
TTDNC00524	Name	Coagulation factor VIII
TTDNC00524	Type of target	Clinical trial target
TTDNC00524	Drug(s)	CHU
TTDNC00525	UniProt ID	P11387
TTDNC00525	Name	Non-camptothecin topo1
TTDNC00525	Type of target	Clinical trial target
TTDNC00525	Function	Releases the supercoiling and torsional tension of DNA introduced during the DNA
TTDNC00525	Sequence	MSGDHLHNDSQIEADFRLNDSHKHKDKHKDREHRHKEHKKEKDREKSKHSNSEHKDSEKKHKEKEKTKHKDGSSEKHKDK
TTDNC00525	PDB Structure	1A31; 1A35; 1A36; 1EJ9; 1K4S; 1K4T; 1LPQ; 1NH3; 1R49; 1RR8; 1RRJ; 1SC7; 1SEU; 1T
TTDNC00525	EC Number	EC 5.99.1.2
TTDNC00525	Drug(s)	GZ402674
TTDNC00526	Name	P75 receptor
TTDNC00526	Type of target	Clinical trial target
TTDNC00526	Drug(s)	SAR127963
TTDNC00527	UniProt ID	P25024
TTDNC00527	Name	CXCRS
TTDNC00527	Type of target	Clinical trial target
TTDNC00527	Function	Receptor to interleukin-8, which is a powerful neutrophils chemotactic factor. B
TTDNC00527	Sequence	MSNITDPQMWDFDDLNFTGMPPADEDYSPCMLETETLNKYVVIIAYALVFLLSLLGNSLVMLVILYSRVGRSVTDVYLLN
TTDNC00527	PDB Structure	1ILP; 1ILQ; 2LNL
TTDNC00527	Drug(s)	SAR113244
TTDNC00528	Name	MTORC1
TTDNC00528	Type of target	Clinical trial target
TTDNC00528	Drug(s)	MLN0128
TTDNC00529	UniProt ID	Q9BPZ7
TTDNC00529	Name	MTORC2
TTDNC00529	Type of target	Clinical trial target
TTDNC00529	Function	Subunit of mTORC2, which regulates cell growth and survival in response to hormo
TTDNC00529	Sequence	MAFLDNPTIILAHIRQSHVTSDDTGMCEMVLIDHDVDLEKIHPPSMPGDSGSEIQGSNGETQGYVYAQSVDITSSWDFGI
TTDNC00529	PDB Structure	3VOQ
TTDNC00529	Drug(s)	MLN0128
TTDNC00531	UniProt ID	O18696
TTDNC00531	Name	PDE1
TTDNC00531	Type of target	Clinical trial target
TTDNC00531	Sequence	MNRARKTSSCGCFRSAFCLLKPSTSSASEEHGDSDKKLLSVQLITPRDEEEQTSSRSIKIPPLDLNGLDCKKNAVAARRA
TTDNC00531	EC Number	EC 3.1.4.17
TTDNC00531	Drug(s)	ITI-214
TTDNC00532	UniProt ID	Q9NP59
TTDNC00532	Name	Ferroportin
TTDNC00532	Type of target	Clinical trial target
TTDNC00532	Function	May be involved in iron export from duodenal epithelial cell and also in transfe
TTDNC00532	Sequence	MTRAGDHNRQRGCCGSLADYLTSAKFLLYLGHSLSTWGDRMWHFAVSVFLVELYGNSLLLTAVYGLVVAGSVLVLGAIIG
TTDNC00532	Drug(s)	Ferroportin Monoclonal Antibody
TTDNC00533	Name	p70 S6 Kinase
TTDNC00533	Type of target	Clinical trial target
TTDNC00533	Drug(s)	P70 S6 Kinase/AKT Dual Inhibitor
TTDNC00536	Name	IgG1
TTDNC00536	Type of target	Clinical trial target
TTDNC00536	Drug(s)	TRC093
TTDNC00537	Name	Ultra-rapid-acting recombinant human insulin
TTDNC00537	Type of target	Clinical trial target
TTDNC00537	Drug(s)	BIOD-123
TTDNC00539	UniProt ID	P22607
TTDNC00539	Name	FGF-3 receptor
TTDNC00539	Type of target	Clinical trial target
TTDNC00539	Function	Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth
TTDNC00539	Sequence	MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLVFGSGDAVELSCPPPGGGPMGPTVWVKDGTG
TTDNC00539	PDB Structure	1RY7
TTDNC00539	EC Number	EC 2.7.10.1
TTDNC00539	Drug(s)	MFGR-1877S
TTDNC00540	UniProt ID	P11049
TTDNC00540	Name	CD37
TTDNC00540	Type of target	Clinical trial target
TTDNC00540	Sequence	MSAQESCLSLIKYFLFVFNLFFFVLGSLIFCFGIWILIDKTSFVSFVGLAFVPLQIWSKVLAISGIFTMGIALLGCVGAL
TTDNC00540	Drug(s)	TRU-016
TTDNC00541	Name	Angiogenesis
TTDNC00541	Type of target	Clinical trial target
TTDNC00541	Drug(s)	JI-101
TTDNC00542	UniProt ID	Q9UBN7
TTDNC00542	Name	HDAC6
TTDNC00542	Type of target	Clinical trial target
TTDNC00542	Function	Responsible for the deacetylation of lysine residues on the N-terminal part of t
TTDNC00542	Sequence	MTSTGQDSTTTRQRRSRQNPQSPPQDSSVTSKRNIKKGAVPRSIPNLAEVKKKGKMKKLGQAMEEDLIVGLQGMDLNLEA
TTDNC00542	PDB Structure	3C5K; 3GV4; 3PHD
TTDNC00542	EC Number	EC 3.5.1.98
TTDNC00542	Drug(s)	ACY-1215
TTDNC00543	UniProt ID	Q96CG0
TTDNC00543	Name	ENG protein
TTDNC00543	Type of target	Clinical trial target
TTDNC00543	Sequence	MDRGTLPLAVALLLASCSLSPTSLAETVHCDLQPVGPERDEVTYTTSQVSKGCVAQAPNAILEVHVLFLEFPTGPSQLEL
TTDNC00543	Drug(s)	TRC 105
TTDNC00544	Name	DNMT
TTDNC00544	Type of target	Clinical trial target
TTDNC00544	Drug(s)	SGI110
TTDNC00546	Name	Folate-binding protein E39
TTDNC00546	Type of target	Clinical trial target
TTDNC00546	Drug(s)	FBP vaccine
TTDNC00547	Name	Pan-DAC
TTDNC00547	Type of target	Clinical trial target
TTDNC00547	Drug(s)	AR-42
TTDNC00549	UniProt ID	Q7KZ06
TTDNC00549	Name	Ras
TTDNC00549	Type of target	Clinical trial target
TTDNC00549	Sequence	MTEYKLVVVGAGGVGKSALTIQLIQNHFVDDYDPTLE
TTDNC00549	Drug(s)	KD032
TTDNC00550	Name	HepB
TTDNC00550	Type of target	Clinical trial target
TTDNC00550	Drug(s)	MB07133
TTDNC00553	UniProt ID	Q05655
TTDNC00553	Name	PKC-Delta
TTDNC00553	Type of target	Clinical trial target
TTDNC00553	Function	Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/thr
TTDNC00553	Sequence	MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEP
TTDNC00553	PDB Structure	1YRK; 2YUU
TTDNC00553	EC Number	EC 2.7.11.13
TTDNC00553	Drug(s)	KAI-9803/ BMS-875944
TTDNC00554	Name	Cholesterol absorption
TTDNC00554	Type of target	Clinical trial target
TTDNC00554	Drug(s)	MD-0727
TTDNC00560	Name	Neurotransmitter receptor
TTDNC00560	Type of target	Clinical trial target
TTDNC00560	Drug(s)	ABT-288
TTDNC00561	Name	M1 prime
TTDNC00561	Type of target	Clinical trial target
TTDNC00561	Drug(s)	RG7449
TTDNC00567	UniProt ID	O43653
TTDNC00567	Name	PSCA
TTDNC00567	Type of target	Clinical trial target
TTDNC00567	Function	May be involved in the regulation of cell proliferation. Has a cell-proliferatio
TTDNC00567	Sequence	MKAVLLALLMAGLALQPGTALLCYSCKAQVSNEDCLQVENCTQLGEQCWTARIRAVGLLTVISKGCSLNCVDDSQDYYVG
TTDNC00567	Drug(s)	Anti-PSCA mAb
TTDNC00569	UniProt ID	Q04609
TTDNC00569	Name	PMSA
TTDNC00569	Type of target	Clinical trial target
TTDNC00569	Function	Has both folate hydrolase and N-acetylated-alpha-linked- acidic dipeptidase (NAA
TTDNC00569	Sequence	MWNLLHETDSAVATARRPRWLCAGALVLAGGFFLLGFLFGWFIKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQI
TTDNC00569	PDB Structure	1Z8L; 2C6C; 2C6G; 2C6P; 2CIJ; 2JBJ; 2JBK; 2OOT; 2OR4; 2PVV; 2PVW; 2XEF; 2XEG; 2X
TTDNC00569	EC Number	EC 3.4.17.21
TTDNC00569	Drug(s)	J 591 Lu-177
TTDNC00572	UniProt ID	P19099
TTDNC00572	Name	Aldosterone synthase
TTDNC00572	Type of target	Clinical trial target
TTDNC00572	Function	Preferentially catalyzes the conversion of 11- deoxycorticosterone to aldosteron
TTDNC00572	Sequence	MALRAKAEVCVAAPWLSLQRARALGTRAARAPRTVLPFEAMPQHPGNRWLRLLQIWREQGYEHLHLEMHQTFQELGPIFR
TTDNC00572	PDB Structure	4DVQ; 4FDH
TTDNC00572	EC Number	EC 1.14.15.4
TTDNC00572	Drug(s)	LCI699
TTDNC00574	UniProt ID	P41597
TTDNC00574	Name	CCR2b
TTDNC00574	Type of target	Clinical trial target
TTDNC00574	Function	Receptor for the MCP-1, MCP-3 and MCP-4 chemokines. Transduces a signal by incre
TTDNC00574	Sequence	MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIY
TTDNC00574	PDB Structure	1KAD; 1KP1
TTDNC00574	Drug(s)	AZD2423
TTDNC00576	UniProt ID	P01308
TTDNC00576	Name	insulin
TTDNC00576	Type of target	Clinical trial target
TTDNC00576	Function	Insulin decreases blood glucose concentration. It increases cell permeability to
TTDNC00576	Sequence	MALWMRLLPLLALLALWGPDPAAAFVNQHLCGSHLVEALYLVCGERGFFYTPKTRREAEDLQVGQVELGGGPGAGSLQPL
TTDNC00576	PDB Structure	1A7F; 1AI0; 1AIY; 1B9E; 1BEN; 1EFE; 1EV3; 1EV6; 1EVR; 1FU2; 1FUB; 1G7A; 1G7B; 1G
TTDNC00576	Drug(s)	BGP-15
TTDNC00577	UniProt ID	P27487
TTDNC00577	Name	CD26 antigen
TTDNC00577	Type of target	Clinical trial target
TTDNC00577	Function	Cell surface glycoprotein receptor involved in the costimulatory signal essentia
TTDNC00577	Sequence	MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFN
TTDNC00577	PDB Structure	1J2E; 1N1M; 1NU6; 1NU8; 1PFQ; 1R9M; 1R9N; 1RWQ; 1TK3; 1TKR; 1U8E; 1W1I; 1WCY; 1X
TTDNC00577	EC Number	EC 3.4.14.5
TTDNC00577	Drug(s)	KRP-104
TTDNC00578	UniProt ID	P13866
TTDNC00578	Name	SLGT1
TTDNC00578	Type of target	Clinical trial target
TTDNC00578	Function	Actively transports glucose into cells by Na(+) cotransport with a Na(+) to gluc
TTDNC00578	Sequence	MDSSTWSPKTTAVTRPVETHELIRNAADISIIVIYFVVVMAVGLWAMFSTNRGTVGGFFLAGRSMVWWPIGASLFASNIG
TTDNC00578	Drug(s)	LX-4211
TTDNC00579	UniProt ID	P31639
TTDNC00579	Name	SLGT2
TTDNC00579	Type of target	Clinical trial target
TTDNC00579	Function	Sodium-dependent glucose transporter. Has a Na(+) to glucose coupling ratio of 1
TTDNC00579	Sequence	MEEHTEAGSAPEMGAQKALIDNPADILVIAAYFLLVIGVGLWSMCRTNRGTVGGYFLAGRSMVWWPVGASLFASNIGSGH
TTDNC00579	Drug(s)	LX-4211
TTDNC00581	UniProt ID	P55157
TTDNC00581	Name	MTP
TTDNC00581	Type of target	Clinical trial target
TTDNC00581	Function	Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid bet
TTDNC00581	Sequence	MILLAVLFLCFISSYSASVKGHTTGLSLNNDRLYKLTYSTEVLLDRGKGKLQDSVGYRISSNVDVALLWRNPDGDDDQLI
TTDNC00581	Drug(s)	SLX-4090
TTDNC00582	Name	Intranasal dopamine-receptor
TTDNC00582	Type of target	Clinical trial target
TTDNC00582	Drug(s)	EVK-001
TTDNC00584	UniProt ID	P13232
TTDNC00584	Name	Recombinant human interleukin-7
TTDNC00584	Type of target	Clinical trial target
TTDNC00584	Function	Hematopoietic growth factor capable of stimulating the proliferation of lymphoid
TTDNC00584	Sequence	MFHVSFRYIFGLPPLILVLLPVASSDCDIEGKDGKQYESVLMVSIDQLLDSMKEIGSNCLNNEFNFFKRHICDANKEGMF
TTDNC00584	PDB Structure	1IL7; 3DI2; 3DI3
TTDNC00584	Drug(s)	CYT107
TTDNC00585	UniProt ID	Q96F46
TTDNC00585	Name	IL-17 receptor
TTDNC00585	Type of target	Clinical trial target
TTDNC00585	Function	Receptor for IL17A, IL17F and, in dimer with IL17RE, for IL17C. Binds its IL17A
TTDNC00585	Sequence	MGAARSPPSAVPGPLLGLLLLLLGVLAPGGASLRLLDHRALVCSQPGLNCTVKNSTCLDDSWIHPRNLTPSSPKDLQIQL
TTDNC00585	PDB Structure	3JVF; 4HSA
TTDNC00585	Drug(s)	Brodalumab
TTDNC00586	UniProt ID	Q14896
TTDNC00586	Name	Cardiac myosin
TTDNC00586	Type of target	Clinical trial target
TTDNC00586	Function	Thick filament-associated protein located in the crossbridge region of vertebrat
TTDNC00586	Sequence	MPEPGKKPVSAFSKKPRSVEVAAGSPAVFEAETERAGVKVRWQRGGSDISASNKYGLATEGTRHTLTVREVGPADQGSYA
TTDNC00586	PDB Structure	1GXE; 1PD6; 2AVG; 2K1M; 2V6H; 3CX2
TTDNC00586	Drug(s)	Omecamtiv mecarbil
TTDNC00587	Name	Oxazolidinone anti-bacterial
TTDNC00587	Type of target	Clinical trial target
TTDNC00587	Drug(s)	AZD5847
TTDNC00588	Name	MABA
TTDNC00588	Type of target	Clinical trial target
TTDNC00588	Drug(s)	AZD2115
TTDNC00589	UniProt ID	P13612
TTDNC00589	Name	A4b7
TTDNC00589	Type of target	Clinical trial target
TTDNC00589	Function	Integrins alpha-4/beta-1 (VLA-4) and alpha-4/beta-7 are receptors for fibronecti
TTDNC00589	Sequence	MAWEARREPGPRRAAVRETVMLLLCLGVPTGRPYNVDTESALLYQGPHNTLFGYSVVLHSHGANRWLLVGAPTANWLANA
TTDNC00589	PDB Structure	3V4P; 3V4V
TTDNC00589	Drug(s)	MEDI7183
TTDNC00591	Name	TOPKi
TTDNC00591	Type of target	Clinical trial target
TTDNC00591	Drug(s)	CC-223
TTDNC00593	UniProt ID	Q96F58
TTDNC00593	Name	GPNMB
TTDNC00593	Type of target	Clinical trial target
TTDNC00593	Sequence	MECLYYFLGFLLLAARLPLDAAKRFHDVLGNERPSAYMREHNQLNGWSSDENDWNEKLYPVWKRGDMRWKNSWKGGRVQA
TTDNC00593	Drug(s)	CDX-011
TTDNC00595	Name	a2d ligand
TTDNC00595	Type of target	Clinical trial target
TTDNC00595	Drug(s)	DS-5565
TTDNC00596	Name	BFGF signaling system
TTDNC00596	Type of target	Clinical trial target
TTDNC00596	Drug(s)	SUN13837
TTDNC00597	UniProt ID	P26358
TTDNC00597	Name	DNMT1
TTDNC00597	Type of target	Clinical trial target
TTDNC00597	Function	Methylates CpG residues. Preferentially methylates hemimethylated DNA. Associate
TTDNC00597	Sequence	MPARTAPARVPTLAVPAISLPDDVRRRLKDLERDSLTEKECVKEKLNLLHEFLQTEIKNQLCDLETKLRKEELSEEGYLA
TTDNC00597	PDB Structure	3EPZ; 3PTA; 3SWR
TTDNC00597	EC Number	EC 2.1.1.37
TTDNC00597	Drug(s)	SGI110
TTDNC00599	UniProt ID	Q9UHF1
TTDNC00599	Name	Epidermal growth factor domain-like-7 (EGFL7)
TTDNC00599	Type of target	Clinical trial target
TTDNC00599	Function	Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth facto
TTDNC00599	Sequence	MRGSQEVLLMWLLVLAVGGTEHAYRPGRRVCAVRAHGDPVSESFVQRVYQPFLTTCDGHRACSTYRTIYRTAYRRSPGLA
TTDNC00599	Drug(s)	MEGF0444A
TTDNC00600	Name	Non-nucleoside NS5B
TTDNC00600	Type of target	Clinical trial target
TTDNC00600	Drug(s)	GS-9669
TTDNC00602	UniProt ID	Q9BYF1
TTDNC00602	Name	Recombinant human angiotensin converting enzyme 2
TTDNC00602	Type of target	Clinical trial target
TTDNC00602	Function	Carboxypeptidase which converts angiotensin I to angiotensin 1-9, a peptide of u
TTDNC00602	Sequence	MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLA
TTDNC00602	PDB Structure	1R42; 1R4L; 1XJP; 2AJF; 3D0G; 3D0H; 3D0I; 3KBH; 3SCI; 3SCJ
TTDNC00602	EC Number	EC 3.4.17.23
TTDNC00602	Drug(s)	2586881
TTDNC00604	UniProt ID	O00220
TTDNC00604	Name	Tumor necrosis factorrelated apoptosis-inducing ligand receptor 1 (TRAIL-R1)
TTDNC00604	Type of target	Clinical trial target
TTDNC00604	Function	Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recru
TTDNC00604	Sequence	MAPPPARVHLGAFLAVTPNPGSAASGTEAAAATPSKVWGSSAGRIEPRGGGRGALPTSMGQHGPSARARAGRAPGPRPAR
TTDNC00604	Drug(s)	Mapatumumab
TTDNC00605	UniProt ID	Q3LIF4
TTDNC00605	Name	Neurite outgrowth inhibitor (NOGO-A)
TTDNC00605	Type of target	Clinical trial target
TTDNC00605	Sequence	KEPENINAALQETEAPYISIACDLIKETKLSAEPAPDFSDYSEMAKVEQPVPDHSELVEDSSPDSEPVDLFSDDSIPDVP
TTDNC00605	Drug(s)	Ozanezumab
TTDNC00606	Name	Oxytocin
TTDNC00606	Type of target	Clinical trial target
TTDNC00606	Drug(s)	Retosiban
TTDNC00608	UniProt ID	P32246
TTDNC00608	Name	CCR1 chemokine receptor
TTDNC00608	Type of target	Clinical trial target
TTDNC00608	Function	Receptor for a C-C type chemokine. Binds to MIP-1-alpha, MIP-1-delta, RANTES, an
TTDNC00608	Sequence	METPNTTEDYDTTTEFDYGDATPCQKVNERAFGAQLLPPLYSLVFVIGLVGNILVVLVLVQYKRLKNMTSIYLLNLAISD
TTDNC00608	PDB Structure	1Y5D
TTDNC00608	Drug(s)	2941266
TTDNC00609	Name	Hepatitis C virus
TTDNC00609	Type of target	Clinical trial target
TTDNC00609	Drug(s)	2336805
TTDNC00610	Name	8-aminoquinoline
TTDNC00610	Type of target	Clinical trial target
TTDNC00610	Drug(s)	Tafenoquine
TTDNC00613	UniProt ID	P36507
TTDNC00613	Name	MEK2
TTDNC00613	Type of target	Successful target
TTDNC00613	Function	Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue
TTDNC00613	Sequence	MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQKKRLEAFLTQKAKVGELKDDDFERISELGA
TTDNC00613	PDB Structure	1S9I; 4H3Q
TTDNC00613	EC Number	EC 2.7.12.2
TTDNC00613	Drug(s)	Trametinib
TTDNC00613	Drug(s)	Trametinib + dabrafenib
TTDNC00613	Drug(s)	Trametinib + 2141795
TTDNC00616	UniProt ID	P02656
TTDNC00616	Name	ApoCIII
TTDNC00616	Type of target	Clinical trial target
TTDNC00616	Function	Inhibits lipoprotein lipase and hepatic lipase and decreases the uptake of lymph
TTDNC00616	Sequence	MQPRVLLVVALLALLASARASEAEDASLLSFMQGYMKHATKTAKDALSSVQESQVAQQARGWVTDGFSSLKDYWSTVKDK
TTDNC00616	PDB Structure	2JQ3
TTDNC00616	Drug(s)	ISIS-APOCIIIRx
TTDNC00617	Name	Factor XI
TTDNC00617	Type of target	Clinical trial target
TTDNC00617	Drug(s)	ISIS-FXIRx
TTDNC00618	UniProt ID	I2E4T0
TTDNC00618	Name	SMN2
TTDNC00618	Type of target	Clinical trial target
TTDNC00618	Sequence	NTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQEPGLKF
TTDNC00618	Drug(s)	ISIS-SMNRx
TTDNC00621	UniProt ID	P22455
TTDNC00621	Name	FGFR4
TTDNC00621	Type of target	Clinical trial target
TTDNC00621	Function	Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth
TTDNC00621	Sequence	MRLLLALLGVLLSVPGPPVLSLEASEEVELEPCLAPSLEQQEQELTVALGQPVRLCCGRAERGGHWYKEGSRLAPAGRVR
TTDNC00621	PDB Structure	1QCT
TTDNC00621	EC Number	EC 2.7.10.1
TTDNC00621	Drug(s)	ISIS-FGFR4Rx
TTDNC00623	Name	Aminoglycoside
TTDNC00623	Type of target	Clinical trial target
TTDNC00623	Drug(s)	Plazomicin
TTDNC00625	UniProt ID	P27037
TTDNC00625	Name	Activin receptor type II
TTDNC00625	Type of target	Clinical trial target
TTDNC00625	Function	On ligand binding, forms a receptor complex consisting of two type II and two ty
TTDNC00625	Sequence	MGAAAKLAFAVFLISCSSGAILGRSETQECLFFNANWEKDRTNQTGVEPCYGDKDKRRHCFATWKNISGSIEIVKQGCWL
TTDNC00625	PDB Structure	3Q4T; 3SOC; 4ASX
TTDNC00625	EC Number	EC 2.7.11.30
TTDNC00625	Drug(s)	BYM338
TTDNC00628	UniProt ID	P0CE47
TTDNC00628	Name	Bacterial elongation factor Tu (EFTu)
TTDNC00628	Type of target	Clinical trial target
TTDNC00628	Function	This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site
TTDNC00628	Sequence	MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHV
TTDNC00628	PDB Structure	1D8T; 1EFC; 1ETU; 1MJ1; 2FX3; 2HCJ; 2HDN; 3EP2; 3EQ3; 3EQ4; 3U2Q; 3U6B; 3U6K; 4G
TTDNC00628	Drug(s)	LFF571
TTDNC00629	Name	Integrin
TTDNC00629	Type of target	Clinical trial target
TTDNC00629	Drug(s)	AS101
TTDNC00629	Drug(s)	EMD-525797
TTDNC00630	UniProt ID	P04629
TTDNC00630	Name	Trk kinase
TTDNC00630	Type of target	Clinical trial target
TTDNC00630	Function	Receptor tyrosine kinase involved in the development and the maturation of the c
TTDNC00630	Sequence	MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ
TTDNC00630	PDB Structure	1HE7; 1SHC; 1WWA; 1WWW; 2IFG; 4AOJ; 4F0I; 4GT5
TTDNC00630	EC Number	EC 2.7.10.1
TTDNC00630	Drug(s)	CT 327
TTDNC00631	Name	Immune suppressant
TTDNC00631	Type of target	Clinical trial target
TTDNC00631	Drug(s)	DPIV/CD26
TTDNC00632	Name	Proprietary
TTDNC00632	Type of target	Clinical trial target
TTDNC00632	Drug(s)	LEO 90100
TTDNC00633	UniProt ID	Q8IXJ6
TTDNC00633	Name	Sirtuin
TTDNC00633	Type of target	Clinical trial target
TTDNC00633	Function	NAD-dependent protein deacetylase, which deacetylates internal lysines on histon
TTDNC00633	Sequence	MAEPDPSHPLETQAGKVQEAQDSDSDSEGGAAGGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVI
TTDNC00633	PDB Structure	1J8F; 3ZGO; 3ZGV
TTDNC00633	EC Number	EC 3.5.1.-
TTDNC00633	Drug(s)	SRT2104
TTDNC00634	UniProt ID	P40259
TTDNC00634	Name	CD79b
TTDNC00634	Type of target	Clinical trial target
TTDNC00634	Function	Required in cooperation with CD79A for initiation of the signal transduction cas
TTDNC00634	Sequence	MARLALSPVPSHWMVALLLLLSAEPVPAARSEDRYRNPKGSACSRIWQSPRFIARKRGFTVKMHCYMNSASGNVSWLWKQ
TTDNC00634	PDB Structure	3KG5
TTDNC00634	Drug(s)	RG7596
TTDNC00636	Name	Factor D Fab
TTDNC00636	Type of target	Clinical trial target
TTDNC00636	Drug(s)	RG7417
TTDNC00645	UniProt ID	P23560
TTDNC00645	Name	Neurotrophic factor production
TTDNC00645	Type of target	Clinical trial target
TTDNC00645	Function	During development, promotes the survival and differentiation of selected neuron
TTDNC00645	Sequence	MTILFLTMVISYFGCMKAAPMKEANIRGQGGLAYPGVRTHGTLESVNGPKAGSRGLTSLADTFEHVIEELLDEDQKVRPN
TTDNC00645	PDB Structure	1B8M; 1BND
TTDNC00645	Drug(s)	TAK-428
TTDNC00646	Name	Proteasome
TTDNC00646	Type of target	Clinical trial target
TTDNC00646	Drug(s)	MLN9708
TTDNC00647	Name	Transforming growth factor
TTDNC00647	Type of target	Clinical trial target
TTDNC00647	Drug(s)	LY2382770
TTDNC00648	UniProt ID	P52732
TTDNC00648	Name	Mitotic kinesin Eg5
TTDNC00648	Type of target	Clinical trial target
TTDNC00648	Function	Motor protein required for establishing a bipolar spindle. Blocking of KIF11 pre
TTDNC00648	Sequence	MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQID
TTDNC00648	PDB Structure	1II6; 1Q0B; 1X88; 1YRS; 2FKY; 2FL2; 2FL6; 2FME; 2G1Q; 2GM1; 2IEH; 2PG2; 2Q2Y; 2Q
TTDNC00648	Drug(s)	LY2523355
TTDNC00650	UniProt ID	O75888
TTDNC00650	Name	APRIL
TTDNC00650	Type of target	Clinical trial target
TTDNC00650	Function	Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. May be implicated in
TTDNC00650	Sequence	MPASSPFLLAPKGPPGNMGGPVREPALSVALWLSWGAALGAVACAMALLTQQTELQSLRREVSRLQGTGGPSQNGEGYPW
TTDNC00651	UniProt ID	Q13258
TTDNC00651	Name	D-prostanoid receptor
TTDNC00651	Type of target	Clinical trial target
TTDNC00651	Function	Receptor for prostaglandin D2 (PGD2). The activity of this receptor is mainly me
TTDNC00651	Sequence	MKSPFYRCQNTTSVEKGNSAVMGGVLFSTGLLGNLLALGLLARSGLGWCSRRPLRPLPSVFYMLVCGLTVTDLLGKCLLS
TTDNC00651	Drug(s)	AMG 853
TTDNC00652	Name	SSKI
TTDNC00652	Type of target	Clinical trial target
TTDNC00652	Drug(s)	KD019
TTDNC00653	UniProt ID	O14842
TTDNC00653	Name	GPR40
TTDNC00653	Type of target	Clinical trial target
TTDNC00653	Function	Receptor for medium and long chain saturated and unsaturated fatty acids. Bindin
TTDNC00653	Sequence	MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCP
TTDNC00653	Drug(s)	TAK-875
TTDNC00655	Name	Proprotein Convertase Subtilisin
TTDNC00655	Type of target	Clinical trial target
TTDNC00655	Drug(s)	AMG 145
TTDNC00657	Name	Extended spectrum cephalosporin with affinity to penicillin-binding proteins
TTDNC00657	Type of target	Clinical trial target
TTDNC00657	Drug(s)	Zinforo
TTDNC00658	UniProt ID	P35372
TTDNC00658	Name	Peripherally-acting muopioid receptor
TTDNC00658	Type of target	Clinical trial target
TTDNC00658	Function	Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor
TTDNC00658	Sequence	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIV
TTDNC00658	Drug(s)	Naloxegol
TTDNC00659	Name	LCS 16
TTDNC00659	Type of target	Clinical trial target
TTDNC00659	Drug(s)	LCS 16
TTDNC00662	Name	Triple angiokinase
TTDNC00662	Type of target	Clinical trial target
TTDNC00662	Drug(s)	Nintedanib
TTDNC00663	Name	Anti-fibrotic kinase
TTDNC00663	Type of target	Clinical trial target
TTDNC00663	Drug(s)	Nintedanib
TTDNC00667	UniProt ID	P51686
TTDNC00667	Name	CCR9 chemokine receptor
TTDNC00667	Type of target	Clinical trial target
TTDNC00667	Function	Receptor for chemokine SCYA25/TECK. Subsequently transduces a signal by increasi
TTDNC00667	Sequence	MTPTDFTSPIPNMADDYGSESTSSMEDYVNFNFTDFYCEKNNVRQFASHFLPPLYWLVFIVGALGNSLVILVYWYCTRVK
TTDNC00667	Drug(s)	Vercirnon
TTDNC00668	Name	Dopamine precursor
TTDNC00668	Type of target	Clinical trial target
TTDNC00668	Drug(s)	Patrome
TTDNC00670	UniProt ID	P02766
TTDNC00670	Name	TTR
TTDNC00670	Type of target	Clinical trial target
TTDNC00670	Function	Thyroid hormone-binding protein. Probably transports thyroxine from the bloodstr
TTDNC00670	Sequence	MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTT
TTDNC00670	PDB Structure	1BM7; 1BMZ; 1BZ8; 1BZD; 1BZE; 1DVQ; 1DVS; 1DVT; 1DVU; 1DVX; 1DVY; 1DVZ; 1E3F; 1E
TTDNC00670	Drug(s)	ISIS-TTRRx
TTDNC00671	UniProt ID	P10909
TTDNC00671	Name	Clusterin
TTDNC00671	Type of target	Clinical trial target
TTDNC00671	Function	Isoform 1 functions as extracellular chaperone that prevents aggregation of nonn
TTDNC00671	Sequence	MMKTLLLFVGLLLTWESGQVLGDQTVSDNELQEMSNQGSKYVNKEIQNAVNGVKQIKTLIEKTNEERKTLLSNLEEAKKK
TTDNC00671	Drug(s)	Custirsen
TTDNC00676	UniProt ID	O15181
TTDNC00676	Name	CD21
TTDNC00676	Type of target	Clinical trial target
TTDNC00676	Sequence	LITPGILKYQFVKKAASHLLGSTMVVIQVENTVFFVSGMTVDYTCDPGYLLVGNKSIHCMPSGNWSPSAP
TTDNC00676	Drug(s)	RG7159
TTDNC00677	UniProt ID	Q16739
TTDNC00677	Name	Glucosylceramide synthetase
TTDNC00677	Type of target	Clinical trial target
TTDNC00677	Function	Catalyzes the first glycosylation step in glycosphingolipid biosynthesis, the tr
TTDNC00677	Sequence	MALLDLALEGMAVFGFVLFLVLWLMHFMAIIYTRLHLNKKATDKQPYSKLPGVSLLKPLKGVDPNLINNLETFFELDYPK
TTDNC00677	EC Number	EC 2.4.1.80
TTDNC00677	Drug(s)	Eliglustat  tartrate
TTDNC00678	Name	Non-steroidal androgen synthesis
TTDNC00678	Type of target	Clinical trial target
TTDNC00678	Drug(s)	TAK-700
TTDNC00679	Name	Potassium-competitive acid
TTDNC00679	Type of target	Clinical trial target
TTDNC00679	Drug(s)	TAK-438
TTDNC00687	Name	H5N1 inactivated split ?monovalent (Quebec)
TTDNC00687	Type of target	Successful target
TTDNC00687	Drug(s)	Flu
TTDNC00691	Name	Azole antifungal
TTDNC00691	Type of target	Clinical trial target
TTDNC00691	Drug(s)	Isavuconazole
TTDNR00633	UniProt ID	Q15120
TTDNR00633	Name	[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial
TTDNR00633	Type of target	Research target
TTDNR00633	Synonyms	Pyruvate dehydrogenase kinase isoform 3; PDK3; PDK3;
TTDNR00633	Function	Inhibits pyruvate dehydrogenase activity by phosphorylation of the E1 subunit PD
TTDNR00633	PDB Structure	1Y8N; 1Y8O; 1Y8P; 2PNR; 2Q8I
TTDNR00633	EC Number	EC 2.7.11.2
TTDNR00633	Drug(s)	
TTDNR00634	UniProt ID	Q9BZP6
TTDNR00634	Name	Acidic mammalian chitinase
TTDNR00634	Type of target	Research target
TTDNR00634	Synonyms	AMCase; Lung-specific protein TSA1902; CHIA;
TTDNR00634	Function	Degrades chitin and chitotriose. May participate in the defense against nematode
TTDNR00634	PDB Structure	2YBT; 2YBU; 3FXY; 3FY1; 3RM4; 3RM8; 3RM9; 3RME
TTDNR00634	EC Number	EC 3.2.1.14
TTDNR00634	Drug(s)	
TTDNR00635	UniProt ID	Q7Z4H4
TTDNR00635	Name	ADM2
TTDNR00635	Type of target	Research target
TTDNR00635	Synonyms	Intermedin; ADM2; ADM2;
TTDNR00635	Function	IMDL and IMDS may play a role as physiological regulators of gastrointestinal, c
TTDNR00635	Drug(s)	
TTDNR00636	UniProt ID	P84077
TTDNR00636	Name	ADP-ribosylation factor 1
TTDNR00636	Type of target	Research target
TTDNR00636	Synonyms	ARF1;
TTDNR00636	Function	GTP-binding protein that functions as an allosteric activator of the cholera tox
TTDNR00636	PDB Structure	1HUR; 1RE0; 1U81; 3O47; 4HMY
TTDNR00636	Drug(s)	
TTDNR00637	UniProt ID	Q9Y2D8
TTDNR00637	Name	Afadin- and alpha-actinin-binding protein
TTDNR00637	Type of target	Research target
TTDNR00637	Synonyms	ADIP; Afadin DIL domain-interacting protein; SSX2-interacting protein; SSX2IP; S
TTDNR00637	Function	Belongs to an adhesion system, which plays a role in the organization of homotyp
TTDNR00637	Drug(s)	
TTDNR00639	UniProt ID	P63531
TTDNR00639	Name	Alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase
TTDNR00639	Type of target	Research target
TTDNR00639	Synonyms	GMPMT; (1->4)-alpha-D-glucan:maltose-1-phosphate alpha-D-maltosyltransferase; (1
TTDNR00639	Function	Essential maltosyltransferase that uses maltose 1- phosphate (M1P) as the sugar
TTDNR00639	EC Number	EC 2.4.99.16
TTDNR00639	Drug(s)	
TTDNR00640	UniProt ID	P02489
TTDNR00640	Name	Alpha-crystallin A chain
TTDNR00640	Type of target	Research target
TTDNR00640	Synonyms	Heat shock protein beta-4; HspB4; CRYAA; CRYAA;
TTDNR00640	Function	May contribute to the transparency and refractive index of the lens. Has chapero
TTDNR00640	Drug(s)	
TTDNR00641	UniProt ID	O76080
TTDNR00641	Name	AN1-type zinc finger protein 5
TTDNR00641	Type of target	Research target
TTDNR00641	Synonyms	Zinc finger A20 domain-containing protein 2; Zinc finger protein 216; ZFAND5; ZF
TTDNR00641	Function	Involved in protein degradation via the ubiquitin- proteasome system. May act by
TTDNR00641	Drug(s)	
TTDNR00642	UniProt ID	Q9Y5C1
TTDNR00642	Name	Angiopoietin-related protein 3
TTDNR00642	Type of target	Research target
TTDNR00642	Synonyms	Angiopoietin-5; ANG-5; Angiopoietin-like protein 3; ANGPTL3; ANGPTL3;
TTDNR00642	Drug(s)	
TTDNR00643	UniProt ID	P01019
TTDNR00643	Name	Angiotensinogen
TTDNR00643	Type of target	Research target
TTDNR00643	Synonyms	Serpin A8; AGT; AGT;
TTDNR00643	Function	Angiotensin-3: stimulates aldosterone release.
TTDNR00643	PDB Structure	1N9U; 1N9V; 2JP8; 2WXW; 2X0B; 4AA1; 4APH; 4FYS
TTDNR00643	Drug(s)	
TTDNR00644	UniProt ID	P07355
TTDNR00644	Name	Annexin A2
TTDNR00644	Type of target	Research target
TTDNR00644	Synonyms	Annexin II; Annexin-2; Calpactin I heavy chain; Calpactin-1 heavy chain; Chromob
TTDNR00644	Function	Calcium-regulated membrane-binding protein whose affinity for calcium is greatly
TTDNR00644	PDB Structure	1W7B; 1XJL; 2HYU; 2HYV; 2HYW; 4DRW; 4HRH
TTDNR00644	Drug(s)	
TTDNR00645	UniProt ID	Q5GS83
TTDNR00645	Name	ATP-dependent Clp protease proteolytic subunit
TTDNR00645	Type of target	Research target
TTDNR00645	Synonyms	Endopeptidase Clp; clpP;
TTDNR00645	Function	Cleaves peptides in various proteins in a process that requires ATP hydrolysis.
TTDNR00645	EC Number	EC 3.4.21.92
TTDNR00645	Drug(s)	
TTDNR00646	UniProt ID	Q6PIL6
TTDNR00646	UniProt ID	Q9NS61
TTDNR00646	UniProt ID	Q9NZI2
TTDNR00646	UniProt ID	Q9Y2W7
TTDNR00646	Name	A-type K(+) channels
TTDNR00646	Type of target	Research target
TTDNR00646	Drug(s)	
TTDNR00648	UniProt ID	P35613
TTDNR00648	Name	Basigin
TTDNR00648	Type of target	Research target
TTDNR00648	Synonyms	5F7; Collagenase stimulatory factor; Extracellular matrix metalloproteinase indu
TTDNR00648	Function	Plays pivotal roles in spermatogenesis, embryo implantation, neural network form
TTDNR00648	PDB Structure	3B5H; 3I84; 3I85; 3QQN; 3QR2
TTDNR00648	Drug(s)	
TTDNR00649	UniProt ID	Q16620
TTDNR00649	Name	BDNF/NT-3 growth factors receptor
TTDNR00649	Type of target	Research target
TTDNR00649	Synonyms	GP145-TrkB; Trk-B; Neurotrophic tyrosine kinase receptor type 2; TrkB tyrosine k
TTDNR00649	Function	Receptor tyrosine kinase involved in the development and the maturation of the c
TTDNR00649	PDB Structure	1HCF; 1WWB; 4ASZ; 4AT3; 4AT4; 4AT5
TTDNR00649	EC Number	EC 2.7.10.1
TTDNR00649	Drug(s)	
TTDNR00650	UniProt ID	Q86Z14
TTDNR00650	Name	Beta-klotho
TTDNR00650	Type of target	Research target
TTDNR00650	Synonyms	BKL; BetaKlotho; Klotho beta-like protein; KLB;
TTDNR00650	Function	Contributes to the transcriptional repression of cholesterol 7-alpha-hydroxylase
TTDNR00650	Drug(s)	
TTDNR00651	UniProt ID	O60732
TTDNR00651	UniProt ID	Q8TD91
TTDNR00651	Name	Cancer/Testis Antigen MAGE-C1/CT7
TTDNR00651	Type of target	Research target
TTDNR00651	Drug(s)	
TTDNR00652	UniProt ID	Q16619
TTDNR00652	Name	Cardiotrophin-1
TTDNR00652	Type of target	Research target
TTDNR00652	Synonyms	CT-1; CTF1;
TTDNR00652	Function	Induces cardiac myocyte hypertrophy in vitro. Binds to and activates the ILST/gp
TTDNR00652	Drug(s)	
TTDNR00653	UniProt ID	P32248
TTDNR00653	Name	C-C chemokine receptor type 7
TTDNR00653	Type of target	Research target
TTDNR00653	Synonyms	C-C CKR-7; CC-CKR-7; CCR-7; BLR2; CDw197; Epstein-Barr virus-induced G-protein c
TTDNR00653	Function	Receptor for the MIP-3-beta chemokine. Probable mediator of EBV effects on B-lym
TTDNR00653	Drug(s)	
TTDNR00654	UniProt ID	O00585
TTDNR00654	Name	C-C motif chemokine 21
TTDNR00654	Type of target	Research target
TTDNR00654	Synonyms	6Ckine; Beta-chemokine exodus-2; Secondary lymphoid-tissue chemokine; SLC; Small
TTDNR00654	Function	Inhibits hemopoiesis and stimulates chemotaxis. Chemotactic in vitro for thymocy
TTDNR00654	PDB Structure	2L4N
TTDNR00654	Drug(s)	
TTDNR00656	UniProt ID	Q92187
TTDNR00656	Name	CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase
TTDNR00656	Type of target	Research target
TTDNR00656	Synonyms	Alpha-2,8-sialyltransferase 8D; Polysialyltransferase-1; Sialyltransferase 8D; S
TTDNR00656	Function	Catalyzes the polycondensation of alpha-2,8-linked sialic acid required for the
TTDNR00656	EC Number	EC 2.4.99.-
TTDNR00656	Drug(s)	
TTDNR00657	UniProt ID	Q9UGN4
TTDNR00657	Name	CMRF35-like molecule 8
TTDNR00657	Type of target	Research target
TTDNR00657	Synonyms	CLM-8; CD300 antigen-like family member A; CMRF-35-H9; CMRF35-H9; CMRF35-H; IRC1
TTDNR00657	Function	Inhibitory receptor which may contribute to the down- regulation of cytolytic ac
TTDNR00657	PDB Structure	2Q87
TTDNR00657	Drug(s)	
TTDNR00659	UniProt ID	P98187
TTDNR00659	UniProt ID	Q6NT55
TTDNR00659	UniProt ID	Q9HBI6
TTDNR00659	UniProt ID	Q9HCS2
TTDNR00659	Name	Cytochrome P4504f
TTDNR00659	Type of target	Research target
TTDNR00659	Drug(s)	
TTDNR00660	UniProt ID	Q9UP65
TTDNR00660	Name	Cytosolic phospholipase A2 gamma
TTDNR00660	Type of target	Research target
TTDNR00660	Synonyms	cPLA2-gamma; Phospholipase A2 group IVC; PLA2G4C;
TTDNR00660	Function	Has a preference for arachidonic acid at the sn-2 position of phosphatidylcholin
TTDNR00660	EC Number	EC 3.1.1.4
TTDNR00660	Drug(s)	
TTDNR00661	UniProt ID	Q16832
TTDNR00661	Name	Discoidin domain-containing receptor 2
TTDNR00661	Type of target	Research target
TTDNR00661	Synonyms	Discoidin domain receptor 2; CD167 antigen-like family member B; Discoidin domai
TTDNR00661	Function	Tyrosine kinase that functions as cell surface receptor for fibrillar collagen a
TTDNR00661	PDB Structure	2WUH; 2Z4F
TTDNR00661	EC Number	EC 2.7.10.1
TTDNR00661	Drug(s)	
TTDNR00662	UniProt ID	Q9Y6W6
TTDNR00662	Name	Dual specificity protein phosphatase 10
TTDNR00662	Type of target	Research target
TTDNR00662	Synonyms	Mitogen-activated protein kinase phosphatase 5; MAP kinase phosphatase 5; MKP-5;
TTDNR00662	Function	Protein phosphatase involved in the inactivation of MAP kinases. Has a specifici
TTDNR00662	PDB Structure	1ZZW; 2OUC; 2OUD; 3TG1
TTDNR00662	EC Number	EC 3.1.3.163.1.3.48
TTDNR00662	Drug(s)	
TTDNR00663	UniProt ID	Q96J02
TTDNR00663	Name	E3 ubiquitin-protein ligase Itchy homolog
TTDNR00663	Type of target	Research target
TTDNR00663	Synonyms	Itch; Atrophin-1-interacting protein 4; AIP4; NFE2-associated polypeptide 1; NAP
TTDNR00663	Function	Acts as an E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiqui
TTDNR00663	PDB Structure	2DMV; 2KYK; 2NQ3; 2P4R; 2YSF; 3TUG
TTDNR00663	EC Number	EC 6.3.2.-
TTDNR00663	Drug(s)	
TTDNR00664	UniProt ID	Q8IIR7
TTDNR00664	Name	Endoplasmic reticulum-resident calcium binding protein
TTDNR00664	Type of target	Research target
TTDNR00664	Synonyms	ERC;
TTDNR00664	Drug(s)	
TTDNR00665	UniProt ID	P0A898
TTDNR00665	Name	Endoribonuclease YbeY
TTDNR00665	Type of target	Research target
TTDNR00665	Synonyms	ybeY;
TTDNR00665	Function	Single strand-specific metallo-endoribonuclease involved in late-stage 70S ribos
TTDNR00665	PDB Structure	1XM5
TTDNR00665	EC Number	EC 3.1.-.-
TTDNR00665	Drug(s)	
TTDNR00666	UniProt ID	Q14511
TTDNR00666	Name	Enhancer of filamentation 1
TTDNR00666	Type of target	Research target
TTDNR00666	Synonyms	hEF1; CRK-associated substrate-related protein; CAS-L; CasL; Cas scaffolding pro
TTDNR00666	Function	Docking protein which plays a central coordinating role for tyrosine-kinase-base
TTDNR00666	PDB Structure	2L81
TTDNR00666	Drug(s)	
TTDNR00667	UniProt ID	P98073
TTDNR00667	Name	Enteropeptidase
TTDNR00667	Type of target	Research target
TTDNR00667	Synonyms	Enterokinase; Serine protease 7; Transmembrane protease serine 15; TMPRSS15; TMP
TTDNR00667	Function	Responsible for initiating activation of pancreatic proteolytic proenzymes (tryp
TTDNR00667	PDB Structure	4DGJ
TTDNR00667	EC Number	EC 3.4.21.9
TTDNR00667	Drug(s)	
TTDNR00668	UniProt ID	Q8IUX8
TTDNR00668	Name	Epidermal growth factor-like protein 6
TTDNR00668	Type of target	Research target
TTDNR00668	Synonyms	EGF-like protein 6; MAM and EGF domains-containing gene protein; EGFL6; EGFL6;
TTDNR00668	Function	May bind integrin alpha-8/beta-1 and play a role in hair follicle morphogenesis.
TTDNR00668	Drug(s)	
TTDNR00669	UniProt ID	Q13541
TTDNR00669	Name	Eukaryotic translation initiation factor 4E-binding protein 1
TTDNR00669	Type of target	Research target
TTDNR00669	Synonyms	4E-BP1; eIF4E-binding protein 1; Phosphorylated heat- and acid-stable protein re
TTDNR00669	Function	Regulates eIF4E activity by preventing its assembly into the eIF4F complex. Medi
TTDNR00669	PDB Structure	1WKW; 2JGB; 2JGC; 2V8W; 2V8X; 2V8Y; 3HXG; 3HXI; 3M93; 3M94; 3U7X
TTDNR00669	Drug(s)	
TTDNR00670	UniProt ID	P43004
TTDNR00670	Name	Excitatory amino acid transporter 2
TTDNR00670	Type of target	Research target
TTDNR00670	Synonyms	Glutamate/aspartate transporter II; Sodium-dependent glutamate/aspartate transpo
TTDNR00670	Function	Transports L-glutamate and also L- and D-aspartate. Essential for terminating th
TTDNR00670	Drug(s)	
TTDNR00671	UniProt ID	O14980
TTDNR00671	Name	Exportin-1
TTDNR00671	Type of target	Research target
TTDNR00671	Synonyms	Exp1; Chromosome region maintenance 1 protein homolog; XPO1; XPO1;
TTDNR00671	Function	Mediates the nuclear export of cellular proteins (cargos) bearing a leucine-rich
TTDNR00671	PDB Structure	1W9C; 2L1L; 3GB8
TTDNR00671	Drug(s)	
TTDNR00672	UniProt ID	P55060
TTDNR00672	Name	Exportin-2
TTDNR00672	Type of target	Research target
TTDNR00672	Synonyms	Exp2; Cellular apoptosis susceptibility protein; Chromosome segregation 1-like p
TTDNR00672	Function	Export receptor for importin-alpha. Mediates importin- alpha re-export from the
TTDNR00672	Drug(s)	
TTDNR00673	Name	FAP48
TTDNR00673	Type of target	Research target
TTDNR00673	Drug(s)	
TTDNR00674	UniProt ID	O95864
TTDNR00674	Name	Fatty acid desaturase 2
TTDNR00674	Type of target	Research target
TTDNR00674	Synonyms	Delta(6) fatty acid desaturase; D6D; Delta(6) desaturase; Delta-6 desaturase; FA
TTDNR00674	Function	Component of a lipid metabolic pathway that catalyzes biosynthesis of highly uns
TTDNR00674	EC Number	EC 1.14.19.-
TTDNR00674	Drug(s)	
TTDNR00675	UniProt ID	Q6GMR7
TTDNR00675	Name	Fatty-acid amide hydrolase 2
TTDNR00675	Type of target	Research target
TTDNR00675	Synonyms	Amidase domain-containing protein; Anandamide amidohydrolase 2; Oleamide hydrola
TTDNR00675	Function	Degrades bioactive fatty acid amides like oleamide, the endogenous cannabinoid,
TTDNR00675	EC Number	EC 3.5.1.99
TTDNR00675	Drug(s)	
TTDNR00676	Name	flavivirus NS5 capping enzyme
TTDNR00676	Type of target	Research target
TTDNR00676	Drug(s)	
TTDNR00677	UniProt ID	Q12948
TTDNR00677	Name	Forkhead box protein C1
TTDNR00677	Type of target	Research target
TTDNR00677	Synonyms	Forkhead-related protein FKHL7; Forkhead-related transcription factor 3; FREAC-3
TTDNR00677	Function	Binding of FREAC-3 and FREAC-4 to their cognate sites results in bending of the
TTDNR00677	Drug(s)	
TTDNR00679	UniProt ID	Q96T53
TTDNR00679	Name	Ghrelin O-acyltransferase
TTDNR00679	Type of target	Research target
TTDNR00679	Synonyms	Membrane-bound O-acyltransferase domain-containing protein 4; O-acyltransferase
TTDNR00679	Function	Mediates the octanoylation of ghrelin at 'Ser-3'. Can use a variety of fatty aci
TTDNR00679	EC Number	EC 2.3.1.-
TTDNR00679	Drug(s)	
TTDNR00680	UniProt ID	P06744
TTDNR00680	Name	Glucose-6-phosphate isomerase
TTDNR00680	Type of target	Research target
TTDNR00680	Synonyms	GPI; Autocrine motility factor; AMF; Neuroleukin; NLK; Phosphoglucose isomerase;
TTDNR00680	Function	Besides it's role as a glycolytic enzyme, mammalian GPI can function as a tumor-
TTDNR00680	PDB Structure	1IAT; 1IRI; 1JIQ; 1JLH; 1NUH
TTDNR00680	EC Number	EC 5.3.1.9
TTDNR00680	Drug(s)	
TTDNR00681	UniProt ID	O75311
TTDNR00681	UniProt ID	P23415
TTDNR00681	UniProt ID	P23416
TTDNR00681	UniProt ID	P48167
TTDNR00681	UniProt ID	Q5JXX5
TTDNR00681	Name	glycine receptor chloride channel
TTDNR00681	Type of target	Research target
TTDNR00681	Drug(s)	
TTDNR00682	UniProt ID	Q99527
TTDNR00682	Name	G-protein coupled estrogen receptor 1
TTDNR00682	Type of target	Research target
TTDNR00682	Synonyms	Chemoattractant receptor-like 2; Flow-induced endothelial G-protein coupled rece
TTDNR00682	Function	Receptor for estrogen.
TTDNR00682	Drug(s)	
TTDNR00683	UniProt ID	Q9Y2T6
TTDNR00683	Name	G-protein coupled receptor 55
TTDNR00683	Type of target	Research target
TTDNR00683	Synonyms	GPR55;
TTDNR00683	Function	May be involved in hyperalgesia associated with inflammatory and neuropathic pai
TTDNR00683	Drug(s)	
TTDNR00684	UniProt ID	O00165
TTDNR00684	Name	HCLS1-associated protein X-1
TTDNR00684	Type of target	Research target
TTDNR00684	Synonyms	HS1-associating protein X-1; HAX-1; HS1-binding protein 1; HSP1BP-1; HAX1; HAX1;
TTDNR00684	Function	Promotes cell survival. Potentiates GNA13-mediated cell migration. Involved in t
TTDNR00684	Drug(s)	
TTDNR00685	UniProt ID	P04792
TTDNR00685	UniProt ID	Q12988
TTDNR00685	Name	Heat shock protein 27
TTDNR00685	Type of target	Research target
TTDNR00685	Drug(s)	
TTDNR00686	UniProt ID	Q8TDQ0
TTDNR00686	Name	Hepatitis A virus cellular receptor 2
TTDNR00686	Type of target	Research target
TTDNR00686	Synonyms	HAVcr-2; T-cell immunoglobulin and mucin domain-containing protein 3; TIMD-3; T-
TTDNR00686	Function	Regulates macrophage activation. Inhibits T-helper type 1 lymphocyte (Th1)-media
TTDNR00686	Drug(s)	
TTDNR00687	Name	Hepatitis C virus p7 protein
TTDNR00687	Type of target	Research target
TTDNR00687	Drug(s)	
TTDNR00688	UniProt ID	P17096
TTDNR00688	Name	High mobility group protein HMG-I/HMG-Y
TTDNR00688	Type of target	Research target
TTDNR00688	Synonyms	HMG-I(Y); High mobility group AT-hook protein 1; High mobility group protein A1;
TTDNR00688	Function	HMG-I/Y bind preferentially to the minor groove of A+T rich regions in double st
TTDNR00688	PDB Structure	2EZD; 2EZE; 2EZF; 2EZG
TTDNR00688	Drug(s)	
TTDNR00689	UniProt ID	Q08446
TTDNR00689	UniProt ID	Q9US49
TTDNR00689	Name	Hsp90 co-chaperone Sgt1
TTDNR00689	Type of target	Research target
TTDNR00689	Drug(s)	
TTDNR00690	UniProt ID	P20577
TTDNR00690	Name	Indole-3-glycerol phosphate synthase
TTDNR00690	Type of target	Research target
TTDNR00690	Synonyms	IGPS; trpC;
TTDNR00690	EC Number	EC 4.1.1.48
TTDNR00690	Drug(s)	
TTDNR00691	Name	influenza virus  nucleoprotein
TTDNR00691	Type of target	Research target
TTDNR00691	Drug(s)	
TTDNR00692	UniProt ID	P53708
TTDNR00692	Name	Integrin alpha-8
TTDNR00692	Type of target	Research target
TTDNR00692	Synonyms	ITGA8;
TTDNR00692	Function	Integrin alpha-8/beta-1 functions in the genesis of kidney and probably of other
TTDNR00692	Drug(s)	
TTDNR00693	UniProt ID	P26012
TTDNR00693	Name	Integrin beta-8
TTDNR00693	Type of target	Research target
TTDNR00693	Synonyms	ITGB8;
TTDNR00693	Function	Integrin alpha-V/beta-8 is a receptor for fibronectin.
TTDNR00693	Drug(s)	
TTDNR00694	UniProt ID	P19525
TTDNR00694	Name	Interferon-induced, double-stranded RNA-activated protein kinase
TTDNR00694	Type of target	Research target
TTDNR00694	Synonyms	Eukaryotic translation initiation factor 2-alpha kinase 2; eIF-2A protein kinase
TTDNR00694	Function	IFN-induced dsRNA-dependent serine/threonine-protein kinase which plays a key ro
TTDNR00694	PDB Structure	1QU6; 2A19; 2A1A; 3UIU
TTDNR00694	EC Number	EC 2.7.11.12.7.10.2
TTDNR00694	Drug(s)	
TTDNR00695	UniProt ID	Q14005
TTDNR00695	UniProt ID	Q9UME6
TTDNR00695	Name	Interleukin-16  (pro-IL-16 & IL-16)
TTDNR00695	Type of target	Research target
TTDNR00695	Drug(s)	
TTDNR00696	UniProt ID	Q9UHD0
TTDNR00696	Name	Interleukin-19
TTDNR00696	Type of target	Research target
TTDNR00696	Synonyms	IL-19; Melanoma differentiation-associated protein-like protein; NG.1; IL19; IL1
TTDNR00696	Function	May play some important roles in inflammatory responses. Up-regulates IL-6 and T
TTDNR00696	PDB Structure	1N1F
TTDNR00696	Drug(s)	
TTDNR00697	UniProt ID	P0A5H3
TTDNR00697	Name	Isocitrate lyase
TTDNR00697	Type of target	Research target
TTDNR00697	Synonyms	ICL; Isocitrase; Isocitratase; icl;
TTDNR00697	Function	Catalyzes the formation of succinate and glyoxylate from isocitrate, a key step
TTDNR00697	PDB Structure	1F61; 1F8I; 1F8M
TTDNR00697	EC Number	EC 4.1.3.1
TTDNR00697	Drug(s)	
TTDNR00698	UniProt ID	Q9Y624
TTDNR00698	Name	Junctional adhesion molecule A
TTDNR00698	Type of target	Research target
TTDNR00698	Synonyms	JAM-A; Junctional adhesion molecule 1; JAM-1; Platelet F11 receptor; Platelet ad
TTDNR00698	Function	Seems to play a role in epithelial tight junction formation. Appears early in pr
TTDNR00698	PDB Structure	1NBQ; 3EOY; 3TSZ
TTDNR00698	Drug(s)	
TTDNR00699	UniProt ID	Q04695
TTDNR00699	Name	Keratin, type I cytoskeletal 17
TTDNR00699	Type of target	Research target
TTDNR00699	Synonyms	39.1; Cytokeratin-17; CK-17; Keratin-17; K17; KRT17;
TTDNR00699	Function	May play a role in the formation and maintenance of various skin appendages, spe
TTDNR00699	Drug(s)	
TTDNR00700	Name	LEDGF/p75
TTDNR00700	Type of target	Research target
TTDNR00700	Drug(s)	
TTDNR00701	UniProt ID	P36776
TTDNR00701	Name	Lon protease homolog, mitochondrial
TTDNR00701	Type of target	Research target
TTDNR00701	Synonyms	LONHs; Lon protease-like protein; LONP; Mitochondrial ATP-dependent protease Lon
TTDNR00701	Function	ATP-dependent serine protease that mediates the selective degradation of misfold
TTDNR00701	PDB Structure	2X36
TTDNR00701	EC Number	EC 3.4.21.-
TTDNR00701	Drug(s)	
TTDNR00702	UniProt ID	O75581
TTDNR00702	Name	Low-density lipoprotein receptor-related protein 6
TTDNR00702	Type of target	Research target
TTDNR00702	Synonyms	LRP-6; LRP6;
TTDNR00702	Function	Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling
TTDNR00702	PDB Structure	3S2K; 3S8V; 3S8Z; 3S94; 3SOB; 3SOQ; 3SOV; 4A0P; 4DG6
TTDNR00702	Drug(s)	
TTDNR00703	UniProt ID	P29375
TTDNR00703	Name	Lysine-specific demethylase 5A
TTDNR00703	Type of target	Research target
TTDNR00703	Synonyms	Histone demethylase JARID1A; Jumonji/ARID domain-containing protein 1A; Retinobl
TTDNR00703	Function	Histone demethylase that specifically demethylates 'Lys- 4' of histone H3, there
TTDNR00703	PDB Structure	2JXJ; 2KGG; 2KGI; 3GL6
TTDNR00703	EC Number	EC 1.14.11.-
TTDNR00703	Drug(s)	
TTDNR00704	Name	MicroRNA 486
TTDNR00704	Type of target	Research target
TTDNR00704	Drug(s)	
TTDNR00705	Name	Mitochondrial fumarate reductase
TTDNR00705	Type of target	Research target
TTDNR00705	Drug(s)	
TTDNR00706	UniProt ID	O43318
TTDNR00706	Name	Mitogen-activated protein kinase kinase kinase 7
TTDNR00706	Type of target	Research target
TTDNR00706	Synonyms	Transforming growth factor-beta-activated kinase 1; TGF-beta-activated kinase 1;
TTDNR00706	Function	Serine/threonine kinase which acts as an essential component of the MAP kinase s
TTDNR00706	PDB Structure	2EVA; 2YIY; 4GS6
TTDNR00706	EC Number	EC 2.7.11.25
TTDNR00706	Drug(s)	
TTDNR00707	UniProt ID	Q92918
TTDNR00707	Name	Mitogen-activated protein kinase kinase kinase kinase 1
TTDNR00707	Type of target	Research target
TTDNR00707	Synonyms	Hematopoietic progenitor kinase; MAPK/ERK kinase kinase kinase 1; MEK kinase kin
TTDNR00707	Function	May play a role in the response to environmental stress. Appears to act upstream
TTDNR00707	EC Number	EC 2.7.11.1
TTDNR00707	Drug(s)	
TTDNR00708	Name	mRNA of Tau
TTDNR00708	Type of target	Research target
TTDNR00708	Drug(s)	
TTDNR00709	UniProt ID	O95631
TTDNR00709	Name	Netrin-1
TTDNR00709	Type of target	Research target
TTDNR00709	Synonyms	Epididymis tissue protein Li 131P; NTN1; NTN1;
TTDNR00709	Function	Netrins control guidance of CNS commissural axons and peripheral motor axons. It
TTDNR00709	Drug(s)	
TTDNR00710	UniProt ID	Q9NPD7
TTDNR00710	Name	Neuritin
TTDNR00710	Type of target	Research target
TTDNR00710	Synonyms	NRN1; NRN1;
TTDNR00710	Function	Promotes neurite outgrowth and especially branching of neuritic processes in pri
TTDNR00710	Drug(s)	
TTDNR00711	UniProt ID	P80188
TTDNR00711	Name	Neutrophil gelatinase-associated lipocalin
TTDNR00711	Type of target	Research target
TTDNR00711	Synonyms	NGAL; 25 kDa alpha-2-microglobulin-related subunit of MMP-9; Lipocalin-2; Oncoge
TTDNR00711	Function	Iron-trafficking protein involved in multiple processes such as apoptosis, innat
TTDNR00711	PDB Structure	1DFV; 1L6M; 1NGL; 1QQS; 1X71; 1X89; 1X8U; 3BY0; 3CBC; 3CMP; 3DSZ; 3DTQ; 3FW4; 3F
TTDNR00711	Drug(s)	
TTDNR00712	UniProt ID	Q9Y2I1
TTDNR00712	Name	Nischarin
TTDNR00712	Type of target	Research target
TTDNR00712	Synonyms	Imidazoline receptor 1; I-1; IR1; Imidazoline receptor antisera-selected protein
TTDNR00712	Function	Acts either as the functional imidazoline-1 receptor (I1R) candidate or as a mem
TTDNR00712	PDB Structure	3P0C
TTDNR00712	Drug(s)	
TTDNR00714	UniProt ID	Q16236
TTDNR00714	Name	Nuclear factor erythroid 2-related factor 2
TTDNR00714	Type of target	Research target
TTDNR00714	Synonyms	NF-E2-related factor 2; NFE2-related factor 2; HEBP1; Nuclear factor, erythroid
TTDNR00714	Function	Transcription activator that binds to antioxidant response (ARE) elements in the
TTDNR00714	PDB Structure	2FLU; 2LZ1
TTDNR00714	Drug(s)	
TTDNR00715	UniProt ID	P22736
TTDNR00715	Name	Nuclear receptor subfamily 4 group A member 1
TTDNR00715	Type of target	Research target
TTDNR00715	Synonyms	Early response protein NAK1; Nuclear hormone receptor NUR/77; Nur77; Orphan nucl
TTDNR00715	Function	Orphan nuclear receptor. May act concomitantly with NURR1 in regulating the expr
TTDNR00715	PDB Structure	2QW4; 3V3E; 3V3Q
TTDNR00715	Drug(s)	
TTDNR00716	UniProt ID	Q96RE7
TTDNR00716	Name	Nucleus accumbens-associated protein 1
TTDNR00716	Type of target	Research target
TTDNR00716	Synonyms	NAC-1; BTB/POZ domain-containing protein 14B; NACC1; NACC1;
TTDNR00716	Function	Functions as a transcriptional repressor. Seems to function as a transcriptional
TTDNR00716	PDB Structure	3GA1
TTDNR00716	Drug(s)	
TTDNR00717	UniProt ID	Q99650
TTDNR00717	Name	Oncostatin-M-specific receptor subunit beta
TTDNR00717	Type of target	Research target
TTDNR00717	Synonyms	Interleukin-31 receptor subunit beta; IL-31 receptor subunit beta; IL-31R subuni
TTDNR00717	Function	Associates with IL31RA to form the IL31 receptor. Binds IL31 to activate STAT3 a
TTDNR00717	Drug(s)	
TTDNR00718	UniProt ID	Q96GU1
TTDNR00718	Name	P antigen family member 5
TTDNR00718	Type of target	Research target
TTDNR00718	Synonyms	PAGE-5; Cancer/testis antigen 16.1; CT16.1; G antigen family E member 1; Prostat
TTDNR00718	Drug(s)	
TTDNR00719	UniProt ID	P51812
TTDNR00719	UniProt ID	Q15349
TTDNR00719	UniProt ID	Q15418
TTDNR00719	UniProt ID	Q9UK32
TTDNR00719	Name	p90RSK
TTDNR00719	Type of target	Research target
TTDNR00719	Drug(s)	
TTDNR00721	UniProt ID	O43511
TTDNR00721	Name	Pendrin
TTDNR00721	Type of target	Research target
TTDNR00721	Synonyms	Sodium-independent chloride/iodide transporter; Solute carrier family 26 member
TTDNR00721	Function	Sodium-independent transporter of chloride and iodide.
TTDNR00721	Drug(s)	
TTDNR00722	UniProt ID	Q13451
TTDNR00722	Name	Peptidyl-prolyl cis-trans isomerase FKBP5
TTDNR00722	Type of target	Research target
TTDNR00722	Synonyms	PPIase FKBP5; 51 kDa FK506-binding protein; 51 kDa FKBP; FKBP-51; 54 kDa progest
TTDNR00722	Function	Interacts with functionally mature heterooligomeric progesterone receptor comple
TTDNR00722	PDB Structure	1KT0; 3O5D; 3O5E; 3O5F; 3O5G; 3O5I; 3O5J; 3O5K; 3O5L; 3O5M; 3O5O; 3O5P; 3O5Q; 3O
TTDNR00722	EC Number	EC 5.2.1.8
TTDNR00722	Drug(s)	
TTDNR00723	UniProt ID	A5U8B7
TTDNR00723	Name	Phosphoglucosamine mutase
TTDNR00723	Type of target	Research target
TTDNR00723	Synonyms	glmM;
TTDNR00723	Function	Catalyzes the conversion of glucosamine-6-phosphate to glucosamine-1-phosphate (
TTDNR00723	EC Number	EC 5.4.2.10
TTDNR00723	Drug(s)	
TTDNR00724	UniProt ID	O33336
TTDNR00724	Name	Phosphopantetheinyl transferase
TTDNR00724	Type of target	Research target
TTDNR00724	Synonyms	pptT;
TTDNR00724	Drug(s)	
TTDNR00725	UniProt ID	Q96BK5
TTDNR00725	Name	PIN2/TERF1-interacting telomerase inhibitor 1
TTDNR00725	Type of target	Research target
TTDNR00725	Synonyms	Liver-related putative tumor suppressor; Pin2-interacting protein X1; Protein 67
TTDNR00725	Function	Microtubule-binding protein essential for faithful chromosome segregation. Media
TTDNR00725	Drug(s)	
TTDNR00726	UniProt ID	P16671
TTDNR00726	Name	Platelet glycoprotein 4
TTDNR00726	Type of target	Research target
TTDNR00726	Synonyms	Fatty acid translocase; FAT; Glycoprotein IIIb; GPIIIB; Leukocyte differentiatio
TTDNR00726	Function	Seems to have numerous potential physiological functions. Binds to collagen, thr
TTDNR00726	Drug(s)	
TTDNR00727	UniProt ID	Q8IUK5
TTDNR00727	Name	Plexin domain-containing protein 1
TTDNR00727	Type of target	Research target
TTDNR00727	Synonyms	Tumor endothelial marker 3; Tumor endothelial marker 7; PLXDC1; PLXDC1;
TTDNR00727	Function	Plays a critical role in endothelial cell capillary morphogenesis (By similarity
TTDNR00727	Drug(s)	
TTDNR00728	UniProt ID	P35226
TTDNR00728	Name	Polycomb complex protein BMI-1
TTDNR00728	Type of target	Research target
TTDNR00728	Synonyms	Polycomb group RING finger protein 4; RING finger protein 51; BMI1; BMI1;
TTDNR00728	Function	Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex c
TTDNR00728	PDB Structure	2H0D; 3RPG
TTDNR00728	Drug(s)	
TTDNR00729	Name	Polycomb repressor complex-2
TTDNR00729	Type of target	Research target
TTDNR00729	Drug(s)	
TTDNR00730	UniProt ID	P03540
TTDNR00730	Name	Pre-glycoprotein polyprotein GP complex
TTDNR00730	Type of target	Research target
TTDNR00730	Synonyms	Pre-GP-C; GPC; GPC;
TTDNR00730	Function	Glycoprotein G2 is a viral fusion protein. Membrane fusion is mediated by confor
TTDNR00730	Drug(s)	
TTDNR00731	UniProt ID	O00622
TTDNR00731	Name	Protein CYR61
TTDNR00731	Type of target	Research target
TTDNR00731	Synonyms	CCN family member 1; Cysteine-rich angiogenic inducer 61; Insulin-like growth fa
TTDNR00731	Function	Promotes cell proliferation, chemotaxis, angiogenesis and cell adhesion. Appears
TTDNR00731	Drug(s)	
TTDNR00732	UniProt ID	P80370
TTDNR00732	Name	Protein delta homolog 1
TTDNR00732	Type of target	Research target
TTDNR00732	Synonyms	DLK-1; pG2; DLK1; DLK1;
TTDNR00732	Function	May have a role in neuroendocrine differentiation.
TTDNR00732	Drug(s)	
TTDNR00733	UniProt ID	Q5T0W9
TTDNR00733	Name	Protein FAM83B
TTDNR00733	Type of target	Research target
TTDNR00733	Synonyms	FAM83B; FAM83B;
TTDNR00733	Drug(s)	
TTDNR00734	UniProt ID	Q86UE4
TTDNR00734	Name	Protein LYRIC
TTDNR00734	Type of target	Research target
TTDNR00734	Synonyms	3D3/LYRIC; Astrocyte elevated gene-1 protein; AEG-1; Lysine-rich CEACAM1 co-isol
TTDNR00734	Function	Downregulates SLC1A2/EAAT2 promoter activity when expressed ectopically. Activat
TTDNR00734	Drug(s)	
TTDNR00735	UniProt ID	P27392
TTDNR00735	Name	Protein P16
TTDNR00735	Type of target	Research target
TTDNR00735	Synonyms	GpS; Protein S; XVI; XVI;
TTDNR00735	Function	protein of the infection vertex complex, which increases the vertex stability. A
TTDNR00735	PDB Structure	1W8X
TTDNR00735	Drug(s)	
TTDNR00736	UniProt ID	Q5VTY9
TTDNR00736	Name	Protein-cysteine N-palmitoyltransferase HHAT
TTDNR00736	Type of target	Research target
TTDNR00736	Synonyms	Hedgehog acyltransferase; Melanoma antigen recognized by T-cells 2; MART-2; Skin
TTDNR00736	Function	Catalyzes N-terminal palmitoylation of SHH; which is required for SHH signaling
TTDNR00736	EC Number	EC 2.3.1.-
TTDNR00736	Drug(s)	
TTDNR00737	UniProt ID	Q9A1S9
TTDNR00737	Name	Putative pyrroline carboxylate reductase
TTDNR00737	Type of target	Research target
TTDNR00737	Synonyms	proC;
TTDNR00737	PDB Structure	2AHR; 2AMF
TTDNR00737	EC Number	EC 1.5.1.2
TTDNR00737	Drug(s)	
TTDNR00738	Name	PvSERA4
TTDNR00738	Type of target	Research target
TTDNR00738	Drug(s)	
TTDNR00739	UniProt ID	Q15311
TTDNR00739	Name	RalA-binding protein 1
TTDNR00739	Type of target	Research target
TTDNR00739	Synonyms	RalBP1; 76 kDa Ral-interacting protein; Dinitrophenyl S-glutathione ATPase; DNP-
TTDNR00739	Function	Can activate specifically hydrolysis of GTP bound to RAC1 and CDC42, but not RAL
TTDNR00739	PDB Structure	2KWH; 2KWI
TTDNR00739	Drug(s)	
TTDNR00740	UniProt ID	P51149
TTDNR00740	Name	Ras-related protein Rab-7a
TTDNR00740	Type of target	Research target
TTDNR00740	Synonyms	RAB7A; RAB7A;
TTDNR00740	Function	Key regulator in endo-lysosomal trafficking. Governs early-to-late endosomal mat
TTDNR00740	PDB Structure	1T91; 1YHN; 3LAW
TTDNR00740	Drug(s)	
TTDNR00741	UniProt ID	Q06330
TTDNR00741	Name	Recombining binding protein suppressor of hairless
TTDNR00741	Type of target	Research target
TTDNR00741	Synonyms	CBF-1; J kappa-recombination signal-binding protein; RBP-J kappa; RBP-J; RBP-JK;
TTDNR00741	Function	Transcriptional regulator that plays a central role in Notch signaling, a signal
TTDNR00741	PDB Structure	2F8X; 3NBN; 3V79
TTDNR00741	Drug(s)	
TTDNR00742	UniProt ID	P41220
TTDNR00742	Name	Regulator of G-protein signaling 2
TTDNR00742	Type of target	Research target
TTDNR00742	Synonyms	RGS2; Cell growth-inhibiting gene 31 protein; G0/G1 switch regulatory protein 8;
TTDNR00742	Function	Inhibits signal transduction by increasing the GTPase activity of G protein alph
TTDNR00742	PDB Structure	2AF0; 2V4Z; 4EKC; 4EKD
TTDNR00742	Drug(s)	
TTDNR00743	UniProt ID	P49758
TTDNR00743	Name	Regulator of G-protein signaling 6
TTDNR00743	Type of target	Research target
TTDNR00743	Synonyms	RGS6; S914; RGS6;
TTDNR00743	Function	Inhibits signal transduction by increasing the GTPase activity of G protein alph
TTDNR00743	PDB Structure	2ES0
TTDNR00743	Drug(s)	
TTDNR00744	UniProt ID	P0C6X7
TTDNR00744	Name	Replicase polyprotein 1ab
TTDNR00744	Type of target	Research target
TTDNR00744	Synonyms	pp1ab; ORF1ab polyprotein; rep;
TTDNR00744	Function	Nsp9 is a ssRNA-binding protein.
TTDNR00744	PDB Structure	1O5S; 1P76; 1P9T; 1PA5; 1PUK; 1Q1X; 1Q2W; 1QZ8; 1SXF; 1UJ1; 1UK2; 1UK3; 1UK4; 1U
TTDNR00744	Drug(s)	
TTDNR00745	Name	retrovirus-K envelope protein
TTDNR00745	Type of target	Research target
TTDNR00745	Drug(s)	
TTDNR00746	UniProt ID	Q9P1W9
TTDNR00746	Name	Serine/threonine-protein kinase pim-2
TTDNR00746	Type of target	Research target
TTDNR00746	Synonyms	Pim-2h; PIM2;
TTDNR00746	Function	Proto-oncogene with serine/threonine kinase activity involved in cell survival a
TTDNR00746	PDB Structure	2IWI
TTDNR00746	EC Number	EC 2.7.11.1
TTDNR00746	Drug(s)	
TTDNR00747	UniProt ID	O00141
TTDNR00747	UniProt ID	Q96BR1
TTDNR00747	UniProt ID	Q9HBY8
TTDNR00747	Name	serum- and glucocorticoid-inducible kinase SGK
TTDNR00747	Type of target	Research target
TTDNR00747	Drug(s)	
TTDNR00748	UniProt ID	P48995
TTDNR00748	Name	Short transient receptor potential channel 1
TTDNR00748	Type of target	Research target
TTDNR00748	Synonyms	TrpC1; Transient receptor protein 1; TRP-1; TRPC1; TRPC1;
TTDNR00748	Function	Thought to form a receptor-activated non-selective calcium permeant cation chann
TTDNR00748	Drug(s)	
TTDNR00749	UniProt ID	Q10789
TTDNR00749	Name	Signal peptidase I
TTDNR00749	Type of target	Research target
TTDNR00749	Synonyms	SPase I; Leader peptidase I; lepB;
TTDNR00749	EC Number	EC 3.4.21.89
TTDNR00749	Drug(s)	
TTDNR00750	UniProt ID	P42226
TTDNR00750	Name	Signal transducer and activator of transcription 6
TTDNR00750	Type of target	Research target
TTDNR00750	Synonyms	IL-4 Stat; STAT6;
TTDNR00750	Function	Carries out a dual function: signal transduction and activation of transcription
TTDNR00750	PDB Structure	1OJ5
TTDNR00750	Drug(s)	
TTDNR00751	UniProt ID	O15554
TTDNR00751	UniProt ID	Q92952
TTDNR00751	UniProt ID	Q9H2S1
TTDNR00751	UniProt ID	Q9UGI6
TTDNR00751	Name	SK channel
TTDNR00751	Type of target	Research target
TTDNR00751	Drug(s)	
TTDNR00753	UniProt ID	Q8WWQ8
TTDNR00753	Name	Stabilin-2
TTDNR00753	Type of target	Research target
TTDNR00753	Synonyms	FAS1 EGF-like and X-link domain-containing adhesion molecule 2; Fasciclin, EGF-l
TTDNR00753	Function	Phosphatidylserine receptor that enhances the engulfment of apoptotic cells. Hya
TTDNR00753	Drug(s)	
TTDNR00754	UniProt ID	O76061
TTDNR00754	Name	Stanniocalcin-2
TTDNR00754	Type of target	Research target
TTDNR00754	Synonyms	STC-2; Stanniocalcin-related protein; STC-related protein; STCRP; STC2;
TTDNR00754	Function	Has an anti-hypocalcemic action on calcium and phosphate homeostasis.
TTDNR00754	Drug(s)	
TTDNR00755	Name	Staphylococcus aureus  Pmt ABC transporter
TTDNR00755	Type of target	Research target
TTDNR00755	Drug(s)	
TTDNR00756	UniProt ID	O95347
TTDNR00756	Name	Structural maintenance of chromosomes protein 2
TTDNR00756	Type of target	Research target
TTDNR00756	Synonyms	SMC protein 2; SMC-2; Chromosome-associated protein E; hCAP-E; XCAP-E homolog; S
TTDNR00756	Function	Central component of the condensin complex, a complex required for conversion of
TTDNR00756	Drug(s)	
TTDNR00757	UniProt ID	P34741
TTDNR00757	Name	Syndecan-2
TTDNR00757	Type of target	Research target
TTDNR00757	Synonyms	SYND2; Fibroglycan; Heparan sulfate proteoglycan core protein; HSPG; SDC2; SDC2;
TTDNR00757	Function	Cell surface proteoglycan that bears heparan sulfate. Regulates dendritic arbor
TTDNR00757	Drug(s)	
TTDNR00758	UniProt ID	Q08629
TTDNR00758	Name	Testican-1
TTDNR00758	Type of target	Research target
TTDNR00758	Synonyms	Protein SPOCK; SPOCK1; SPOCK1;
TTDNR00758	Function	May play a role in cell-cell and cell-matrix interactions. May contribute to var
TTDNR00758	Drug(s)	
TTDNR00759	UniProt ID	B5THG7
TTDNR00759	Name	Thioredoxin glutathione reductase
TTDNR00759	Type of target	Research target
TTDNR00759	Synonyms	TGR;
TTDNR00759	Drug(s)	
TTDNR00760	UniProt ID	P62328
TTDNR00760	Name	Thymosin beta-4
TTDNR00760	Type of target	Research target
TTDNR00760	Synonyms	T beta-4; Fx; TMSB4X; TMSB4X;
TTDNR00760	Function	Plays an important role in the organization of the cytoskeleton (By similarity).
TTDNR00760	PDB Structure	1UY5; 3TU5
TTDNR00760	Drug(s)	
TTDNR00761	UniProt ID	Q9HBG7
TTDNR00761	Name	T-lymphocyte surface antigen Ly-9
TTDNR00761	Type of target	Research target
TTDNR00761	Synonyms	Cell surface molecule Ly-9; Lymphocyte antigen 9; SLAM family member 3; SLAMF3;
TTDNR00761	Function	May participate in adhesion reactions between T lymphocytes and accessory cells
TTDNR00761	Drug(s)	
TTDNR00762	UniProt ID	P48431
TTDNR00762	Name	Transcription factor SOX-2
TTDNR00762	Type of target	Research target
TTDNR00762	Synonyms	SOX2;
TTDNR00762	Function	Transcription factor that forms a trimeric complex with OCT4 on DNA and controls
TTDNR00762	PDB Structure	1O4X; 2LE4
TTDNR00762	Drug(s)	
TTDNR00763	UniProt ID	Q12888
TTDNR00763	Name	Tumor suppressor p53-binding protein 1
TTDNR00763	Type of target	Research target
TTDNR00763	Synonyms	53BP1; p53-binding protein 1; p53BP1; TP53BP1;
TTDNR00763	Function	Plays a key role in the response to DNA damage. May have a role in checkpoint si
TTDNR00763	PDB Structure	1GZH; 1KZY; 1XNI; 2G3R; 2IG0; 2LVM; 3LGF; 3LGL; 3LH0
TTDNR00763	Drug(s)	
TTDNR00764	UniProt ID	P30530
TTDNR00764	Name	Tyrosine-protein kinase receptor UFO
TTDNR00764	Type of target	Research target
TTDNR00764	Synonyms	AXL oncogene; AXL; AXL;
TTDNR00764	Function	Receptor tyrosine kinase that transduces signals from the extracellular matrix i
TTDNR00764	PDB Structure	2C5D
TTDNR00764	EC Number	EC 2.7.10.1
TTDNR00764	Drug(s)	
TTDNR00765	UniProt ID	O95551
TTDNR00765	Name	Tyrosyl-DNA phosphodiesterase 2
TTDNR00765	Type of target	Research target
TTDNR00765	Synonyms	Tyr-DNA phosphodiesterase 2; hTDP2; 5'-tyrosyl-DNA phosphodiesterase; 5'-Tyr-DNA
TTDNR00765	Function	DNA repair enzyme that can remove a variety of covalent adducts from DNA through
TTDNR00765	EC Number	EC 3.1.4.-
TTDNR00765	Drug(s)	
TTDNR00766	UniProt ID	Q13488
TTDNR00766	Name	V-type proton ATPase 116 kDa subunit a isoform 3
TTDNR00766	Type of target	Research target
TTDNR00766	Synonyms	V-ATPase 116 kDa isoform a3; Osteoclastic proton pump 116 kDa subunit; OC-116 kD
TTDNR00766	Function	Part of the proton channel of V-ATPases (By similarity). Seems to be directly in
TTDNR00766	Drug(s)	
TTDNR00767	UniProt ID	O95388
TTDNR00767	Name	WNT1-inducible-signaling pathway protein 1
TTDNR00767	Type of target	Research target
TTDNR00767	Synonyms	WISP-1; CCN family member 4; Wnt-1-induced secreted protein; WISP1; WISP1;
TTDNR00767	Function	Downstream regulator in the Wnt/Frizzled-signaling pathway. Associated with cell
TTDNR00767	Drug(s)	
TTDNS00535	Name	Nucleotide NS5B
TTDNS00535	Type of target	Successful target
TTDNS00535	Drug(s)	Sofosbuvir
TTDNS00535	Drug(s)	Single Tablet Regimen of sofosbuvir and ledipasvir (
TTDNS00536	UniProt ID	Q99835
TTDNS00536	Name	smoothened receptor
TTDNS00536	Type of target	Successful target
TTDNS00536	Function	G protein-coupled receptor that probably associates with the patched protein (PT
TTDNS00536	Sequence	MAAARPARGPELPLLGLLLLLLLGDPGRGAASSGNATGPGPRSAGGSARRSAAVTGPPPPLSHCGRAAPCEPLRYNVCLG
TTDNS00536	PDB Structure	4JKV
TTDNS00536	Drug(s)	Vismodegib
TTDNS00536	Drug(s)	Vismodegib
TTDNS00536	Drug(s)	LDE225
TTDNS00537	UniProt ID	P43088
TTDNS00537	Name	prostaglandin F prostanoid receptor
TTDNS00537	Type of target	Successful target
TTDNS00537	Function	Receptor for prostaglandin F2-alpha (PGF2-alpha). The activity of this receptor
TTDNS00537	Sequence	MSMNNSKQLVSPAAALLSNTTCQTENRLSVFFSVIFMTVGILSNSLAIAILMKAYQRFRQKSKASFLLLASGLVITDFFG
TTDNS00537	Drug(s)	Tafluprost
TTDNS00537	Drug(s)	Tafluprost
TTDNS00538	Name	ostatin receptor 5
TTDNS00538	Type of target	Successful target
TTDNS00538	Drug(s)	Pasireotide diaspartate
TTDNS00538	Drug(s)	Pasireotide diaspartate
TTDNS00539	Name	ribosome A site
TTDNS00539	Type of target	Successful target
TTDNS00539	Drug(s)	Arbekacin
TTDNS00539	Drug(s)	Omacetaxine mepesuccinate
TTDNS00539	Drug(s)	Omacetaxine mepesuccinate
TTDNS00539	Drug(s)	Viomycin sulfate
TTDNS00541	UniProt ID	Q07326
TTDNS00541	Name	PIGF
TTDNS00541	Type of target	Successful target
TTDNS00541	Function	Involved in GPI-anchor biosynthesis through the transfer of ethanolamine phospha
TTDNS00541	Sequence	MKDNDIKRLLYTHLLCIFSIILSVFIPSLFLENFSILETHLTWLCICSGFVTAVNLVLYLVVKPNTSSKRSSLSHKVTGF
TTDNS00541	Drug(s)	Ziv-aflibercept
TTDNS00541	Drug(s)	Ziv-aflibercept
TTDNS00542	UniProt ID	P15692
TTDNS00542	Name	VEGFA
TTDNS00542	Type of target	Successful target
TTDNS00542	Function	Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth
TTDNS00542	Sequence	MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPL
TTDNS00542	PDB Structure	1BJ1; 1CZ8; 1FLT; 1KAT; 1KMX; 1MJV; 1MKG; 1MKK; 1QTY; 1TZH; 1TZI; 1VGH; 1VPF; 1V
TTDNS00542	Drug(s)	Ziv-aflibercept
TTDNS00542	Drug(s)	Ziv-aflibercept
TTDNS00542	Drug(s)	RG7221
TTDNS00544	UniProt ID	O95838
TTDNS00544	Name	Glucagon-like peptide 2 receptor
TTDNS00544	Type of target	Successful target
TTDNS00544	Function	This is a receptor for glucagon-like peptide 2. The activity of this receptor is
TTDNS00544	Sequence	MKLGSSRAGPGRGSAGLLPGVHELPMGIPAPWGTSPLSFHRKCSLWAPGRPFLTLVLLVSIKQVTGSLLEETTRKWAQYK
TTDNS00544	Drug(s)	Teduglutide
TTDNS00544	Drug(s)	Teduglutide
TTDNS00545	Name	anthrax protective antigen
TTDNS00545	Type of target	Successful target
TTDNS00545	Drug(s)	Raxibacumab
TTDNS00552	Name	Kinase
TTDNS00552	Type of target	Clinical trial target
TTDNS00552	Drug(s)	BMS-582949
TTDNS00552	Drug(s)	CC-115
TTDNS00559	Name	Glutamine receptor
TTDNS00559	Type of target	Successful target
TTDNS00559	Drug(s)	L-alanyl-l-glutamine
TTDNS00563	Name	GABA
TTDNS00563	Type of target	Clinical trial target
TTDNS00563	Drug(s)	RG1662
TTDNS00564	UniProt ID	P49913
TTDNS00564	Name	upregulating cAMP
TTDNS00564	Type of target	Successful target
TTDNS00564	Function	Binds to bacterial lipopolysaccharides (LPS), has antibacterial activity.
TTDNS00564	Sequence	MKTQRDGHSLGRWSLVLLLLGLVMPLAIIAQVLSYKEAVLRAIDGINQRSSDANLYRLLDLDPRPTMDGDPDTPKPVSFT
TTDNS00564	PDB Structure	2FBS; 2FBU; 2FCG; 2K6O; 2LMF; 4EYC
TTDNS00564	Drug(s)	Colforsin daropate hci
TTDNS00566	Name	adrenergic receptor
TTDNS00566	Type of target	Successful target
TTDNS00566	Drug(s)	Befunolol hci
TTDNS00566	Drug(s)	Celiprolol hcl
TTDNS00566	Drug(s)	Terbutyline
TTDNS00570	Name	sodium pump
TTDNS00570	Type of target	Successful target
TTDNS00570	Drug(s)	Alpha-acetyldigoxin
TTDNS00570	Drug(s)	Beta-acetyldigoxin
TTDNS00575	Name	Na+-K+-ATPase transmembrane protein
TTDNS00575	Type of target	Successful target
TTDNS00575	Drug(s)	Sanguinarine
TTDNS00579	Name	taste receptor
TTDNS00579	Type of target	Successful target
TTDNS00579	Drug(s)	Cynarin
TTDNS00582	UniProt ID	P11229
TTDNS00582	Name	muscarinic receptor
TTDNS00582	Type of target	Successful target
TTDNS00582	Function	The muscarinic acetylcholine receptor mediates various cellular responses, inclu
TTDNS00582	Sequence	MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVNNYFLLSLACADLIIGTFSMN
TTDNS00582	Drug(s)	Fesoterodine fumarate
TTDNS00584	Name	RNA synthesis
TTDNS00584	Type of target	Successful target
TTDNS00584	Drug(s)	Plicamycin
TTDNS00588	Name	DNA intercalative bis-alkylating agents
TTDNS00588	Type of target	Successful target
TTDNS00588	Drug(s)	Carzinophilin
TTDNS00592	UniProt ID	P00519
TTDNS00592	Name	Abl
TTDNS00592	Type of target	Successful target
TTDNS00592	Function	Non-receptor tyrosine-protein kinase that plays a role in many key processes lin
TTDNS00592	Sequence	MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTL
TTDNS00592	PDB Structure	1AB2; 1ABL; 1AWO; 1BBZ; 1JU5; 1OPL; 1ZZP; 2ABL; 2E2B; 2F4J; 2FO0; 2G1T; 2G2F; 2G
TTDNS00592	EC Number	EC 2.7.10.2
TTDNS00592	Drug(s)	Ponatinib
TTDNS00593	UniProt ID	P07949
TTDNS00593	Name	RET
TTDNS00593	Type of target	Successful target
TTDNS00593	Function	Receptor tyrosine-protein kinase involved in numerous cellular mechanisms includ
TTDNS00593	Sequence	MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRL
TTDNS00593	PDB Structure	1XPD; 2IVS; 2IVT; 2IVU; 2IVV; 2X2K; 2X2L; 2X2M; 2X2U
TTDNS00593	EC Number	EC 2.7.10.1
TTDNS00593	Drug(s)	Ponatinib
TTDNS00593	Drug(s)	Regorafenib
TTDNS00596	Name	ALK
TTDNS00596	Type of target	Successful target
TTDNS00596	Drug(s)	Crizotinib
TTDNS00596	Drug(s)	ASP3026
TTDNS00596	Drug(s)	LDK378
TTDNS00596	Drug(s)	RG7853
TTDNS00597	UniProt ID	P08922
TTDNS00597	Name	ROS1
TTDNS00597	Type of target	Successful target
TTDNS00597	Function	Orphan receptor tyrosine kinase (RTK) that plays a role in epithelial cell diffe
TTDNS00597	Sequence	MKNIYCLIPKLVNFATLGCLWISVVQCTVLNSCLKSCVTNLGQQLDLGTPHNLSEPCIQGCHFWNSVDQKNCALKCRESC
TTDNS00597	PDB Structure	3ZBF
TTDNS00597	EC Number	EC 2.7.10.1
TTDNS00597	Drug(s)	Crizotinib
TTDNS00605	UniProt ID	P13569
TTDNS00605	Name	cystic fibrosis transmembrane conductance regulator
TTDNS00605	Type of target	Successful target
TTDNS00605	Function	Involved in the transport of chloride ions. May regulate bicarbonate secretion a
TTDNS00605	Sequence	MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWR
TTDNS00605	PDB Structure	1NBD; 1XMI; 1XMJ; 2BBO; 2BBS; 2BBT; 2LOB; 2PZE; 2PZF; 2PZG; 3GD7; 3ISW
TTDNS00605	EC Number	EC 3.6.3.49
TTDNS00605	Drug(s)	Crofelemer
TTDNS00605	Drug(s)	Crofelemer
TTDNS00605	Drug(s)	Ivacaftor
TTDNS00606	UniProt ID	Q5XXA6
TTDNS00606	Name	calcium activated channel anoctamin 1
TTDNS00606	Type of target	Successful target
TTDNS00606	Function	Calcium-activated chloride channel (CaCC) which plays a role in transepithelial
TTDNS00606	Sequence	MRVNEKYSTLPAEDRSVHIINICAIEDIGYLPSEGTLLNSLSVDPDAECKYGLYFRDGRRKVDYILVYHHKRPSGNRTLV
TTDNS00606	Drug(s)	Crofelemer
TTDNS00610	Name	endothelium of blood vessels
TTDNS00610	Type of target	Successful target
TTDNS00610	Drug(s)	Polidocanol
TTDNS00611	UniProt ID	P23458
TTDNS00611	Name	JAK1
TTDNS00611	Type of target	Clinical trial target
TTDNS00611	Function	Tyrosine kinase of the non-receptor type, involved in the IFN-alpha/beta/gamma s
TTDNS00611	Sequence	MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFAL
TTDNS00611	PDB Structure	3EYG; 3EYH; 4E4L; 4E4N; 4E5W; 4EHZ; 4EI4; 4FK6; 4GS0; 4I5C; 4IVB; 4IVC; 4IVD
TTDNS00611	EC Number	EC 2.7.10.2
TTDNS00611	Drug(s)	2586184
TTDNS00611	Drug(s)	AZD1480
TTDNS00611	Drug(s)	Baricitinib
TTDNS00611	Drug(s)	INCB39110
TTDNS00611	Drug(s)	Ruxolitinib
TTDNS00612	Name	L-type  calcium channel
TTDNS00612	Type of target	Successful target
TTDNS00612	Drug(s)	Clevidipine butyrate
TTDNS00614	Name	mycobacteria proton pump
TTDNS00614	Type of target	Successful target
TTDNS00614	Drug(s)	Bedaquiline
TTDNS00615	UniProt ID	O76074
TTDNS00615	Name	PDE5
TTDNS00615	Type of target	Successful target
TTDNS00615	Function	Plays a role in signal transduction by regulating the intracellular concentratio
TTDNS00615	Sequence	MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCS
TTDNS00615	PDB Structure	1RKP; 1T9R; 1T9S; 1TBF; 1UDT; 1UDU; 1UHO; 1XOZ; 1XP0; 2CHM; 2H40; 2H42; 2H44; 2X
TTDNS00615	EC Number	EC 3.1.4.35
TTDNS00615	Drug(s)	Avanafil
TTDNS00628	Name	Multi-kinase
TTDNS00628	Type of target	Clinical trial target
TTDNS00628	Drug(s)	MGCD265
TTDNS00628	Drug(s)	TG02
TTDNS00628	Drug(s)	Tabalumab
TTDNS00629	Name	Inactivated split ?quadrivalent
TTDNS00629	Type of target	Successful target
TTDNS00629	Drug(s)	Flu vaccine
TTDNS00630	Name	IV iron
TTDNS00630	Type of target	Successful target
TTDNS00630	Drug(s)	Feraheme/ Rienso
TTDR00001	Name	Alpha-amylase
TTDR00001	Type of target	Research target
TTDR00001	Synonyms	Alpha-glucosidase
TTDR00001	Disease	Pancreatic disease
TTDR00001	Target Validation	TTDR00001
TTDR00001	Inhibitor	4,6-Dideoxyglucose
TTDR00001	Inhibitor	6-Deoxy-Alpha-D-Glucose
TTDR00001	Inhibitor	Beta-D-Glucose
TTDR00001	Inhibitor	DEOXYNOJIRIMYCIN
TTDR00001	Inhibitor	Double Oxidized Cysteine
TTDR00001	Inhibitor	Maltose
TTDR00001	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00001	Inhibitor	Tendamistat
TTDR00003	Name	K(ATP) channels
TTDR00003	Type of target	Research target
TTDR00003	Disease	Noninsulin-dependent diabetes mellitus
TTDR00004	Name	Prokaryotic primase
TTDR00004	Type of target	Research target
TTDR00004	Synonyms	Primase
TTDR00004	Disease	Bacterial infections
TTDR00005	Name	Kallikrein
TTDR00005	Type of target	Research target
TTDR00005	Disease	Clotting disorders
TTDR00005	Related US Patent	6,472,393
TTDR00005	Target Validation	TTDR00005
TTDR00005	Inhibitor	Peptide boronate
TTDR00006	Name	Follicle stimulating hormone
TTDR00006	Type of target	Research target
TTDR00006	Disease	Psychosis
TTDR00006	Disease	Respiratory diseases
TTDR00006	Disease	Viral infection, unspecified
TTDR00006	Related US Patent	6,355,633
TTDR00006	Related US Patent	6,583,179
TTDR00007	UniProt ID	P08183
TTDR00007	Name	Multidrug resistance protein 1
TTDR00007	Type of target	Research target
TTDR00007	Synonyms	CD243 antigen
TTDR00007	Synonyms	P-glycoprotein 1
TTDR00007	Disease	Cancer, unspecific
TTDR00007	Function	Energy-dependent efflux pump responsible for decreased drug accumulation in mult
TTDR00007	Sequence	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAIIHGAGLPLMMLVFGEMTDIFA
TTDR00007	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00007	Pathway	ABC transporters
TTDR00007	Target Validation	TTDR00007
TTDR00007	Inhibitor	4,3'',5''-trimethoxy-[1,1';2',1'']-terphenyl
TTDR00007	Inhibitor	6-(3,5-dimethoxy-phenyl)-naphthalen-2-ol
TTDR00007	Inhibitor	BRECANAVIR
TTDR00007	Inhibitor	ELACRIDAR
TTDR00007	Inhibitor	TRISMETHOXYRESVERATROL
TTDR00007	Inhibitor	XR-9456
TTDR00007	Inhibitor	XR-9504
TTDR00007	Inhibitor	XR-9544
TTDR00007	Inhibitor	XR-9577
TTDR00007	Inhibitor	[1,1';2',1'']-terphenyl-4,3'',5''-triol
TTDR00008	UniProt ID	P11413
TTDR00008	Name	Glucose-6-phosphate dehydrogenase
TTDR00008	Type of target	Research target
TTDR00008	Synonyms	G6PD
TTDR00008	Disease	Systemic lupus erythematosus
TTDR00008	Function	Produces pentose sugars for nucleic acid synthesis and main producer of nadph re
TTDR00008	Sequence	MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADI
TTDR00008	PDB Structure	1QKI; 2BH9; 2BHL
TTDR00008	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00008	Pathway	Glutathione metabolism
TTDR00008	Pathway	Metabolic pathways
TTDR00008	Pathway	Pentose phosphate pathway
TTDR00008	EC Number	EC 1.1.1.49
TTDR00008	Target Validation	TTDR00008
TTDR00008	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDR00008	Inhibitor	EPIANDROSTERONE
TTDR00008	Inhibitor	Hydroxyacetic Acid
TTDR00008	Inhibitor	Metazamide
TTDR00008	Inhibitor	Prasterone
TTDR00009	Name	Histidine decarboxylase
TTDR00009	Type of target	Research target
TTDR00009	Synonyms	HDC
TTDR00009	Disease	Hyaline Membrane Disease
TTDR00009	EC Number	EC 4.1.1.22
TTDR00009	Inhibitor	Brocresine
TTDR00010	UniProt ID	P19801
TTDR00010	Name	Diamine oxidase
TTDR00010	Type of target	Research target
TTDR00010	Synonyms	ABP
TTDR00010	Synonyms	Amiloride-binding protein
TTDR00010	Synonyms	DAO
TTDR00010	Synonyms	Histaminase
TTDR00010	Synonyms	KAO
TTDR00010	Synonyms	Kidney amine oxidase
TTDR00010	Disease	Diabetic nephropathy
TTDR00010	Function	Catalyzes the degradation of compounds such as putrescine, histamine, spermine,
TTDR00010	Sequence	MPALGWAVAAILMLQTAMAEPSPGTLPRKAGVFSDLSNQELKAVHSFLWSKKELRLQPSSTTTMAKNTVFLIEMLLPKKY
TTDR00010	BioChemical Class	Oxidoreductases acting on the CH-NH2 group of donors
TTDR00010	Pathway	Arginine and proline metabolism
TTDR00010	Pathway	Histidine metabolism
TTDR00010	Pathway	Tryptophan metabolism
TTDR00010	EC Number	EC 1.4.3.6
TTDR00010	Inhibitor	Diminazene
TTDR00010	Inhibitor	Pimagedine
TTDR00011	UniProt ID	P21462
TTDR00011	Name	FMLP receptor
TTDR00011	Type of target	Research target
TTDR00011	Synonyms	FPR
TTDR00011	Synonyms	N-formyl peptide receptor
TTDR00011	Synonyms	N-formylpeptide chemoattractant receptor
TTDR00011	Disease	Gastric ulcer
TTDR00011	Function	High affinity receptor for n-formyl-methionyl peptides, which are powerful neutr
TTDR00011	Sequence	METNSSLPTNISGGTPAVSAGYLFLDIITYLVFAVTFVLGVLGNGLVIWVAGFRMTHTVTTISYLNLAVADFCFTSTLPF
TTDR00011	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00011	Pathway	Neuroactive ligand-receptor interaction
TTDR00011	Target Validation	TTDR00011
TTDR00011	Inhibitor	N-formyl-methionyl-leucyl-phenylalanine
TTDR00011	Antagonist	Rebamipide
TTDR00012	UniProt ID	P26951
TTDR00012	Name	Interleukin 3 receptor
TTDR00012	Type of target	Research target
TTDR00012	Synonyms	CD123 antigen
TTDR00012	Synonyms	IL-3R-alpha
TTDR00012	Disease	Acute myeloid leukemia
TTDR00012	Function	This is a receptor for interleukin 3.
TTDR00012	Sequence	MVLLWLTLLLIALPCLLQTKEDPNPPITNLRMKAKAQQLTWDLNRNVTDIECVKDADYSMPAVNNSYCQFGAISLCEVTN
TTDR00012	BioChemical Class	Transmembrane protein
TTDR00012	Pathway	Apoptosis
TTDR00012	Pathway	Cytokine-cytokine receptor interaction
TTDR00012	Pathway	Hematopoietic cell lineage
TTDR00012	Pathway	Jak-STAT signaling pathway
TTDR00012	Agonist	Daniplestim
TTDR00013	Name	1,3-beta-D-glucan-UDP glucosyltransferase
TTDR00013	Type of target	Research target
TTDR00013	Synonyms	CND1 protein
TTDR00013	Synonyms	CWN53 protein
TTDR00013	Synonyms	FKS1 protein
TTDR00013	Synonyms	Papulacandin B sensitivity protein 1
TTDR00013	Disease	Fungal diseases
TTDR00013	EC Number	EC 2.4.1.34
TTDR00014	Name	Carnitine O-acetyltransferase
TTDR00014	Type of target	Research target
TTDR00014	Synonyms	CAT
TTDR00014	Synonyms	Carnitine acetylase
TTDR00014	Disease	Alzheimer Disease
TTDR00014	Function	Carnitine acetylase is specific for short chain fatty acids. Carnitine acetylase
TTDR00014	EC Number	EC 2.3.1.7
TTDR00014	Inhibitor	Coenzyme A
TTDR00015	UniProt ID	P48147
TTDR00015	Name	Prolyl endopeptidase
TTDR00015	Type of target	Research target
TTDR00015	Synonyms	PE
TTDR00015	Synonyms	Post-proline cleaving enzyme
TTDR00015	Disease	Dementia
TTDR00015	Disease	Neurological diseases
TTDR00015	Function	Cleaves peptide bonds on the c-terminal side of prolyl residues within peptides
TTDR00015	Sequence	MLSLQYPDVYRDETAVQDYHGHKICDPYAWLEDPDSEQTKAFVEAQNKITVPFLEQCPIRGLYKERMTELYDYPKYSCHF
TTDR00015	PDB Structure	3DDU
TTDR00015	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00015	EC Number	EC 3.4.21.26
TTDR00015	Target Validation	TTDR00015
TTDR00015	Inhibitor	1-Hydroxy-1-Thio-Glycerol
TTDR00015	Inhibitor	BAICALEIN
TTDR00015	Inhibitor	BAICALIN
TTDR00015	Inhibitor	Double Oxidized Cysteine
TTDR00015	Inhibitor	Monothioglycerol
TTDR00015	Inhibitor	S-Oxy Cysteine
TTDR00015	Inhibitor	SUAM-1221
TTDR00015	Inhibitor	Y-29794
TTDR00015	Inhibitor	Z-Pro-Prolinal
TTDR00017	Name	Growth hormone-releasing hormone receptor
TTDR00017	Type of target	Research target
TTDR00017	Synonyms	GHRH receptor
TTDR00017	Synonyms	GRF receptor
TTDR00017	Synonyms	GRFR
TTDR00017	Disease	Cardiovascular disorders
TTDR00017	Function	Receptor for grf, coupled to G proteins which activate adenylyl cyclase. Stimula
TTDR00018	UniProt ID	Q15392
TTDR00018	Name	3-beta-hydroxysterol delta-24-reductase
TTDR00018	Type of target	Research target
TTDR00018	Synonyms	Diminuto/dwarf1 homolog
TTDR00018	Synonyms	Seladin-1
TTDR00018	Disease	Hypercholesterolaemia
TTDR00018	Function	Catalyzes the reduction of the delta-24 double bond of sterol intermediates. Pro
TTDR00018	Sequence	MEPAVSLAVCALLFLLWVRLKGLEFVLIHQRWVFVCLFLLPLSLIFDIYYYVRAWVVFKLSSAPRLHEQRVRDIQKQVRE
TTDR00018	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDR00018	Pathway	Biosynthesis of steroids
TTDR00018	Pathway	Metabolic pathways
TTDR00018	EC Number	EC 1.3.1.-
TTDR00018	Inhibitor	Diazacholesterol
TTDR00018	Inhibitor	Triparanol
TTDR00019	UniProt ID	Q24803
TTDR00019	Name	Alcohol dehydrogenase 2
TTDR00019	Type of target	Research target
TTDR00019	Disease	Amoebiasis
TTDR00019	Disease	Giardiasis infections
TTDR00019	Function	This enzyme has two nad(+)-dependent activities: adh and acdh. May be a critical
TTDR00019	Sequence	MSTQQTMTVDEHINQLVRKAQVALKEYLKPEYTQEKIDYIVKKASVAALDQHCALAAAAVEETGRGIFEDKATKNIFACE
TTDR00019	EC Number	EC 1.1.1.1
TTDR00019	Inhibitor	Cyclobutyl
TTDR00019	Inhibitor	Cyclopropyl
TTDR00020	UniProt ID	Q92887
TTDR00020	Name	Multidrug resistance-associated protein 2
TTDR00020	Type of target	Research target
TTDR00020	Synonyms	ATP-binding cassette, sub-family C, member 2
TTDR00020	Synonyms	Canalicular multidrug resistance protein
TTDR00020	Disease	Cancer, unspecific
TTDR00020	Function	Mediates hepatobiliary excretion of numerous organic anions. May function as a c
TTDR00020	Sequence	MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGFLWLLAPWQLLHVYKSRTKRSSTTKLYLAKQVFVGFLLILAA
TTDR00020	BioChemical Class	ABC transporter
TTDR00020	Pathway	ABC transporters
TTDR00020	Target Validation	TTDR00020
TTDR00020	Inhibitor	MK-571
TTDR00021	UniProt ID	Q99YI8
TTDR00021	Name	Glycerol-3-phosphate oxidase
TTDR00021	Type of target	Research target
TTDR00021	Synonyms	GPO
TTDR00021	Disease	Trypanosomiasis
TTDR00021	Sequence	MEFSRETRRLALQKMQERDLDLLIIGGGITGAGVALQAAASGLDTGLIEMQDFAQGTSSRSTKLVHGGLRYLKQFDVEVV
TTDR00021	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00021	Pathway	Glycerophospholipid metabolism
TTDR00021	EC Number	EC 1.1.3.21
TTDR00022	UniProt ID	P17579
TTDR00022	UniProt ID	Q9JZ55
TTDR00022	Name	3-Deoxy-D-manno-octulosonate 8-phosphate synthase
TTDR00022	Type of target	Research target
TTDR00022	Synonyms	2-dehydro-3-deoxyphosphooctonate aldolase
TTDR00022	Synonyms	3-Deoxy-d-manno-2-octulosonate-8-phosphate synthase
TTDR00022	Synonyms	3-deoxy-D-manno-octulosonic acid 8-phosphate synthetase
TTDR00022	Synonyms	KDO 8-P synthase
TTDR00022	Synonyms	KDO-8-phosphate synthetase
TTDR00022	Synonyms	KDO8P synthase
TTDR00022	Synonyms	KDO8PS
TTDR00022	Synonyms	KDOP synthase
TTDR00022	Synonyms	KDOPS
TTDR00022	Synonyms	Phospho-2-dehydro-3-deoxyoctonate aldolase
TTDR00022	Disease	Bacterial infections
TTDR00022	Function	Synthesis of kdo 8-p which is required for lipid a maturation and cellular growt
TTDR00022	Sequence	MKQKVVSIGDINVANDLPFVLFGGMNVLESRDLAMRICEHYVTVTQKLGIPYVFKASFDKANRSSIHSYRGPGLEEGMKI
TTDR00022	PDB Structure	1D9E; 1G7U; 1G7V; 1GG0; 1PHQ; 2QKF; 3FYO; 3FYP
TTDR00022	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR00022	Pathway	Lipopolysaccharide biosynthesis
TTDR00022	Pathway	Metabolic pathways
TTDR00022	EC Number	EC 2.5.1.55
TTDR00022	Inhibitor	1-Deoxy-Ribofuranose-5'-Phosphate
TTDR00022	Inhibitor	2-(Phosphonooxy)Butanoic Acid
TTDR00022	Inhibitor	2-Phosphoglyceric Acid
TTDR00022	Inhibitor	3-Fluoro-2-(Phosphonooxy)Propanoic Acid
TTDR00022	Inhibitor	Arabinose-5-Phosphate
TTDR00022	Inhibitor	Erythose-4-Phosphate
TTDR00022	Inhibitor	Phosphoenolpyruvate
TTDR00022	Inhibitor	Ribose-5-Phosphate
TTDR00023	UniProt ID	O06330
TTDR00023	Name	DTDP-4-dehydrorhamnose 3,5-epimerase rmlC
TTDR00023	Type of target	Research target
TTDR00023	Synonyms	DTDP-4-KETO-6-DEOXYGLUCOSE 3,5-EPIMERASE
TTDR00023	Synonyms	DTDP-4-keto-6-deoxyglucose epimerase
TTDR00023	Synonyms	DTDP-L-RHAMNOSE SYNTHETASE
TTDR00023	Synonyms	THYMIDINE DIPHOSPHO-4-KETO-RHAMNOSE 3,5-EPIMERASE
TTDR00023	Disease	Bacterial infections
TTDR00023	Sequence	MKARELDVPGAWEITPTIHVDSRGLFFEWLTDHGFRAFAGHSLDVRQVNCSVSSAGVLRGLHFAQLPPSQAKYVTCVSGS
TTDR00023	PDB Structure	1PM7; 1UPI; 2IXC
TTDR00023	BioChemical Class	Racemases and Epimerases
TTDR00023	Pathway	Metabolic pathways
TTDR00023	Pathway	Polyketide sugar unit biosynthesis
TTDR00023	Pathway	Streptomycin biosynthesis
TTDR00023	EC Number	EC 5.1.3.13
TTDR00023	Inhibitor	S,S-(2-Hydroxyethyl)Thiocysteine
TTDR00024	UniProt ID	O06414
TTDR00024	Name	Probable naphthoate synthase menB
TTDR00024	Type of target	Research target
TTDR00024	Synonyms	1,4-dihydroxy-2-naphthoyl-CoA synthase
TTDR00024	Synonyms	DHNA SYNTHETASE
TTDR00024	Synonyms	DIHYDROXYNAPHTHOIC ACID SYNTHETASE
TTDR00024	Disease	Bacterial infections
TTDR00024	Sequence	MVAPAGEQGRSSTALSDNPFDAKAWRLVDGFDDLTDITYHRHVDDATVRVAFNRPEVRNAFRPHTVDELYRVLDHARMSP
TTDR00024	PDB Structure	1Q51; 1Q52; 1RJM; 1RJN
TTDR00024	BioChemical Class	Carbon-carbon lyases
TTDR00024	Pathway	Metabolic pathways
TTDR00024	Pathway	Ubiquinone and menaquinone biosynthesis
TTDR00024	EC Number	EC 4.1.3.36
TTDR00024	Inhibitor	Acetoacetyl-Coenzyme A
TTDR00024	Inhibitor	Coenzyme A
TTDR00025	UniProt ID	O15851
TTDR00025	Name	Cdc2-related kinase 3
TTDR00025	Type of target	Research target
TTDR00025	Synonyms	CRK3
TTDR00025	Synonyms	CRK3 cyclin-dependent kinase
TTDR00025	Disease	Leishmania infections
TTDR00025	Sequence	MSSFGRVTARSGDAGTRDSLDRYNRLDVLGEGTYGVVYRAVDKITGQYVALKKVRLDRTEEGIPQTALREVSILQEFDHP
TTDR00026	UniProt ID	O15910
TTDR00026	Name	Ribonucleoside-diphosphate reductase small chain
TTDR00026	Type of target	Research target
TTDR00026	Synonyms	Ribonucleotide reductase R2 subunit
TTDR00026	Disease	Parasitic diseases
TTDR00026	Function	Provides the precursors necessary for dna synthesis.
TTDR00026	Sequence	MPPKSHKCSRKEGEVEEPLLTENPDRYVIFPIKYPDIWQKYKEAESSIWTVEEIDLGNDMTDWEKLDDGERHFIKHVLAF
TTDR00026	BioChemical Class	Oxidoreductases acting on CH2 groups
TTDR00026	EC Number	EC 1.17.4.1
TTDR00027	UniProt ID	O33253
TTDR00027	UniProt ID	P13079
TTDR00027	Name	Possible RNA methyltransferase
TTDR00027	Type of target	Research target
TTDR00027	Synonyms	RNA methyltransferase
TTDR00027	Disease	Bacterial infections
TTDR00027	Sequence	MSATGPFSIGERVQLTDAKGRRYTMSLTPGAEFHTHRGSIAHDAVIGLEQGSVVKSSNGALFLVLRPLLVDYVMSMPRGP
TTDR00027	PDB Structure	1I9G
TTDR00027	BioChemical Class	Transferases transferring one-carbon groups
TTDR00027	Inhibitor	Sinefungin
TTDR00028	UniProt ID	P00546
TTDR00028	Name	Cell division control protein 28
TTDR00028	Type of target	Research target
TTDR00028	Disease	Bacterial infections
TTDR00028	Function	This protein is essential for the completion of the start, the controlling event
TTDR00028	Sequence	MSGELANYKRLEKVGEGTYGVVYKALDLRPGQGQRVVALKKIRLESEDEGVPSTAIREISLLKELKDDNIVRLYDIVHSD
TTDR00028	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00028	Pathway	Cell cycle - yeast
TTDR00028	EC Number	EC 2.7.1.-
TTDR00028	Inhibitor	Borrelidin
TTDR00029	UniProt ID	P09237
TTDR00029	Name	Matrilysin
TTDR00029	Type of target	Discontinued target
TTDR00029	Synonyms	MMP-7
TTDR00029	Synonyms	Matrin
TTDR00029	Synonyms	Matrix metalloproteinase-7
TTDR00029	Synonyms	Pump-1 protease
TTDR00029	Synonyms	Uterine metalloproteinase
TTDR00029	Disease	Cancer, unspecific
TTDR00029	Disease	Inflammation
TTDR00029	Function	Degrades casein, gelatins of types i, iii, iv, and v, and fibronectin. Activates
TTDR00029	Sequence	MRLTVLCAVCLLPGSLALPLPQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIE
TTDR00029	PDB Structure	1MMP; 1MMQ; 1MMR; 2DDY
TTDR00029	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00029	Pathway	Wnt signaling pathway
TTDR00029	EC Number	EC 3.4.24.23
TTDR00029	Related US Patent	6,310,084
TTDR00029	Target Validation	TTDR00029
TTDR00029	Drug(s)	BB-3644
TTDR00029	Drug(s)	BMS 275291
TTDR00029	Drug(s)	Batimastat
TTDR00029	Drug(s)	Marimastat
TTDR00029	Drug(s)	Prinomastat
TTDR00029	Inhibitor	3-Benzenesulfonyl-heptanoic acid hydroxyamide
TTDR00029	Inhibitor	3-Cyclohexanesulfonyl-heptanoic acid hydroxyamide
TTDR00029	Inhibitor	BB-3644
TTDR00029	Inhibitor	BMS 275291
TTDR00029	Inhibitor	Batimastat
TTDR00029	Inhibitor	CGS-27023A
TTDR00029	Inhibitor	IK-682
TTDR00029	Inhibitor	Marimastat
TTDR00029	Inhibitor	N-hydroxy-2,3-bis(phenylsulfonamido)propanamide
TTDR00029	Inhibitor	Prinomastat
TTDR00029	Inhibitor	RS-39066
TTDR00029	Inhibitor	SC-44463
TTDR00029	Inhibitor	SR-973
TTDR00029	Inhibitor	folate gamma-L-phenylalaninehydroxamic acid
TTDR00029	Inhibitor	folate gamma-L-proline-hydroxamic acid
TTDR00029	Inhibitor	folate gamma-hydroxamic acid
TTDR00029	Multitarget	BB-3644
TTDR00029	Multitarget	BMS 275291
TTDR00029	Multitarget	Batimastat
TTDR00029	Multitarget	Marimastat
TTDR00029	Multitarget	Prinomastat
TTDR00030	UniProt ID	P17443
TTDR00030	Name	Glycosyltransferase MurG
TTDR00030	Type of target	Research target
TTDR00030	Synonyms	MurG
TTDR00030	Synonyms	Undecaprenyl-PP-MurNAc-pentapeptide-UDPGlcNAc GlcNAc transferase
TTDR00030	Disease	Bacterial infections
TTDR00030	Function	Cell wall formation. Catalyzes the transfer of a glcnac subunit on undecaprenyl-
TTDR00030	Sequence	MSGQGKRLMVMAGGTGGHVFPGLAVAHHLMAQGWQVRWLGTADRMEADLVPKHGIEIDFIRISGLRGKGIKALIAAPLRI
TTDR00030	PDB Structure	1F0K; 1NLM
TTDR00030	BioChemical Class	Glycosyltransferases
TTDR00030	Pathway	Metabolic pathways
TTDR00030	Pathway	Peptidoglycan biosynthesis
TTDR00030	EC Number	EC 2.4.1.227
TTDR00030	Inhibitor	Uridine-Diphosphate-N-Acetylgalactosamine
TTDR00031	Name	Synthesis of leukotrienes
TTDR00031	Type of target	Research target
TTDR00031	Disease	Coronary Heart Disease
TTDR00031	Inhibitor	MK0886
TTDR00032	UniProt ID	P26441
TTDR00032	Name	Ciliary neurotrophic factor
TTDR00032	Type of target	Research target
TTDR00032	Synonyms	CNTF
TTDR00032	Disease	Amyotrophic lateral sclerosis
TTDR00032	Function	Cntf is a survival factor for various neuronal cell types. Seems to prevent the
TTDR00032	Sequence	MAFTEHSPLTPHRRDLCSRSIWLARKIRSDLTALTESYVKHQGLNKNINLDSADGMPVASTDQWSELTEAERLQENLQAY
TTDR00032	PDB Structure	1CNT
TTDR00032	BioChemical Class	Growth factor
TTDR00032	Pathway	Cytokine-cytokine receptor interaction
TTDR00032	Pathway	Jak-STAT signaling pathway
TTDR00033	UniProt ID	P42330
TTDR00033	Name	Aldo-keto reductase family 1 member C3
TTDR00033	Type of target	Research target
TTDR00033	Synonyms	3-alpha-hydroxysteroid dehydrogenase
TTDR00033	Synonyms	3alpha-HSD
TTDR00033	Synonyms	AKR1C3
TTDR00033	Synonyms	Chlordecone reductase homolog HAKRb
TTDR00033	Synonyms	DD3
TTDR00033	Synonyms	Dihydrodiol dehydrogenase 3
TTDR00033	Synonyms	Dihydrodiol dehydrogenase, type I
TTDR00033	Synonyms	HA1753
TTDR00033	Synonyms	HPGFS
TTDR00033	Synonyms	Human prostaglandin F synthase
TTDR00033	Synonyms	Prostaglandin F synthase
TTDR00033	Synonyms	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase
TTDR00033	Disease	Cancer, unspecific
TTDR00033	Disease	Head and neck cancer
TTDR00033	Function	Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the red
TTDR00033	Sequence	MDSKQQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIF
TTDR00033	PDB Structure	1RY0; 1RY8; 1S1P; 1S1R; 1S2A; 1S2C; 1XF0; 1ZQ5
TTDR00033	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00033	Pathway	Arachidonic acid metabolism
TTDR00033	Pathway	Metabolism of xenobiotics by cytochrome P450
TTDR00033	EC Number	EC 1.1.1.-
TTDR00033	EC Number	EC 1.1.1.188
TTDR00033	EC Number	EC 1.3.1.20
TTDR00033	Target Validation	TTDR00033
TTDR00033	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDR00033	Inhibitor	2,2-Dibenzylcyclopentanol
TTDR00033	Inhibitor	2-(4-Chlorobenzylidene)cyclopentanone
TTDR00033	Inhibitor	2-(4-chlorobenzylidene)cyclopentyl ethyl ether
TTDR00033	Inhibitor	2-(4-chlorobenzylidene)cyclopentylmethyl ether
TTDR00033	Inhibitor	2-Methyl-2,4-Pentanediol
TTDR00033	Inhibitor	2-[(2,2-diphenylacetyl)amino]benzoic acid
TTDR00033	Inhibitor	3-Bromo-5-phenylsalicylc acid
TTDR00033	Inhibitor	3-Phenylcyclopentanecarboxylic acid
TTDR00033	Inhibitor	4-ANDROSTENE-3-17-DIONE
TTDR00033	Inhibitor	Acetate Ion
TTDR00033	Inhibitor	DICLOFENAC SODIUM
TTDR00033	Inhibitor	EM-1424
TTDR00033	Inhibitor	EM1396
TTDR00033	Inhibitor	Flufenamic Acid
TTDR00033	Inhibitor	M-Phenoxybenzoic Acid For Cis-Isomer
TTDR00033	Inhibitor	Rutin
TTDR00033	Agonist	4-Androstenedione
TTDR00034	Name	Prostaglandin E2 receptor, EP3 subtype
TTDR00034	Type of target	Research target
TTDR00034	Synonyms	PGE receptor, EP3 subtype
TTDR00034	Synonyms	Prostanoid EP3 receptor
TTDR00034	Disease	Asthma
TTDR00034	Function	Receptor for prostaglandin e2 (pge2); the ep3 receptor may be involved in inhibi
TTDR00034	Target Validation	TTDR00034
TTDR00034	Inhibitor	DG-041
TTDR00035	UniProt ID	P48764
TTDR00035	Name	Sodium/hydrogen exchanger 3
TTDR00035	Type of target	Clinical trial target
TTDR00035	Synonyms	NHE-3
TTDR00035	Synonyms	Na(+)/H(+) exchanger 3
TTDR00035	Disease	Renal inflammation
TTDR00035	Function	Involved in ph regulation to eliminate acids generated by active metabolism or t
TTDR00035	Sequence	MWGLGARGPDRGLLLALALGGLARAGGVEVEPGGAHGESGGFQVVTFEWAHVQDPYVIALWILVASLAKIGFHLSHKVTS
TTDR00035	BioChemical Class	Ion transport
TTDR00035	Target Validation	TTDR00035
TTDR00035	Inhibitor	CARIPORIDE
TTDR00035	Inhibitor	ENIPORIDE
TTDR00035	Inhibitor	HOE-694
TTDR00035	Inhibitor	N-(3-Methanesulfonyl-4-methoxy-benzoyl)-guanidine
TTDR00035	Inhibitor	N-(3-Methanesulfonyl-4-methyl-benzoyl)-guanidine
TTDR00035	Inhibitor	N-(4-Bromo-3-methanesulfonyl-benzoyl)-guanidine
TTDR00035	Inhibitor	N-(4-Chloro-3-methanesulfonyl-benzoyl)-guanidine
TTDR00035	Inhibitor	N-(4-Cyano-3-methanesulfonyl-benzoyl)-guanidine
TTDR00035	Inhibitor	N-(5-Methanesulfonyl-2-methyl-benzoyl)-guanidine
TTDR00036	UniProt ID	P51151
TTDR00036	Name	Ras-related protein Rab-9A
TTDR00036	Type of target	Research target
TTDR00036	Disease	Viral infection, unspecified
TTDR00036	Function	Involved in the transport of proteins between the endosomes and the trans golgi
TTDR00036	Sequence	MAGKSSLFKVILLGDGGVGKSSLMNRYVTNKFDTQLFHTIGVEFLNKDLEVDGHFVTMQIWDTAGQERFRSLRTPFYRGS
TTDR00036	PDB Structure	1WMS
TTDR00036	BioChemical Class	Cell membrane protein
TTDR00036	Inhibitor	Benzoic Acid
TTDR00036	Inhibitor	Guanosine-5'-Diphosphate
TTDR00037	UniProt ID	P56221
TTDR00037	Name	Scytalone dehydratase
TTDR00037	Type of target	Research target
TTDR00037	Disease	Fungal diseases
TTDR00037	Function	Catalyzes two steps in melanin biosynthesis. From scytalone they are two dehydra
TTDR00037	Sequence	MGSQVQKSDEITFSDYLGLMTCVYEWADSYDSKDWDRLRKVIAPTLRIDYRSFLDKLWEAMPAEEFVGMVSSKQVLGDPT
TTDR00037	PDB Structure	1IDP; 1STD; 2STD; 3STD; 4STD; 5STD; 6STD; 7STD
TTDR00037	BioChemical Class	Carbon-oxygen lyases
TTDR00037	Target Validation	TTDR00037
TTDR00037	Inhibitor	(3-Phenyl-propyl)-quinazolin-4-yl-amine
TTDR00037	Inhibitor	2-Hydroxy-N-(3-phenyl-propyl)-benzamide
TTDR00037	Inhibitor	5-Fluoro-2-hydroxy-N-isopropyl-benzamide
TTDR00037	Inhibitor	Carpropamid
TTDR00037	Inhibitor	Isoquinolin-1-yl-(3-phenyl-propyl)-amine
TTDR00038	UniProt ID	P72538
TTDR00038	Name	Manganese ABC transporter substrate-binding lipoprotein
TTDR00038	Type of target	Research target
TTDR00038	Synonyms	PsaA
TTDR00038	Disease	Pneumococcal disease
TTDR00038	Function	Part of an atp-driven transport system for manganese. Also act as an adhesin whi
TTDR00038	Sequence	MKKLGTLLVLFLSAIILVACASGKKDTTSGQKLKVVATNSIIADITKNIAGDKIDLHSIVPIGQDPHEYEPLPEDVKKTS
TTDR00038	PDB Structure	1PSZ
TTDR00039	UniProt ID	Q11155
TTDR00039	Name	Sensor-like histidine kinase senX3
TTDR00039	Type of target	Research target
TTDR00039	Disease	Tuberculosis
TTDR00039	Function	Probably forms part of a two-component regulatory system senx3/regx3. Phosphoryl
TTDR00039	Sequence	MTVFSALLLAGVLSALALAVGGAVGMRLTSRVVEQRQRVATEWSGITVSQMLQCIVTLMPLGAAVVDTHRDVVYLNERAK
TTDR00040	UniProt ID	Q12778
TTDR00040	Name	Forkhead box protein O1A
TTDR00040	Type of target	Research target
TTDR00040	Synonyms	FOXO1a
TTDR00040	Disease	Cancer, unspecific
TTDR00040	Function	Probable transcription factor.
TTDR00040	Sequence	MAEAPQVVEIDPDFEPLPRPRSCTWPLPRPEFSQSNSATSSPAPSGSAAANPDAAAGLPSASAAAVSADFMSNLSLLEES
TTDR00040	PDB Structure	3CO6; 3CO7; 3COA
TTDR00040	Pathway	Insulin signaling pathway
TTDR00040	Pathway	Pathways in cancer
TTDR00040	Pathway	Prostate cancer
TTDR00041	Name	S-adenosyl-L-methionine-C-24-delta-sterol-methyltransferase
TTDR00041	Type of target	Research target
TTDR00041	Synonyms	S-adenosyl-L-methionine-C-24-delta-sterol-methyltransferase A
TTDR00041	Synonyms	S-adenosyl-L-methionine:C-24 sterol methyl transferase
TTDR00041	Synonyms	S-adenosyl-L-methionine:sterol C-24 methyl transferase
TTDR00041	Synonyms	SAM:SMT
TTDR00041	Disease	Pneumocystis infections
TTDR00041	EC Number	EC 2.1.1.41
TTDR00042	UniProt ID	Q8I6T4
TTDR00042	Name	Beta-hydroxyacyl-acp dehydratase
TTDR00042	Type of target	Research target
TTDR00042	Synonyms	FabZ
TTDR00042	Disease	Malaria
TTDR00042	Sequence	MRFLIIHIAVIVLPFVLMIDVKRENSFFLRHSPKRLYKKADYNNMYDKIIKKQQNRIYDVSSQINQDNINGQNISFNLTF
TTDR00042	BioChemical Class	Carbon-oxygen lyases
TTDR00042	Pathway	Fatty acid biosynthesis
TTDR00042	Pathway	Metabolic pathways
TTDR00042	EC Number	EC 4.2.1.-
TTDR00042	Target Validation	TTDR00042
TTDR00042	Inhibitor	(-)-CATECHINGALLATE
TTDR00042	Inhibitor	2-Hexadecynoic acid
TTDR00042	Inhibitor	BIOCHANIN
TTDR00042	Inhibitor	EPICATECHIN GALLATE
TTDR00042	Inhibitor	EPIGALOCATECHIN GALLATE
TTDR00042	Inhibitor	FISETIN
TTDR00042	Inhibitor	GALLOCATECHIN GALLATE
TTDR00042	Inhibitor	MORIN
TTDR00043	UniProt ID	Q937U6
TTDR00043	Name	Class 1 lysyl-tRNA synthetase
TTDR00043	Type of target	Research target
TTDR00043	Synonyms	LysRS1
TTDR00043	Disease	Bacterial infections
TTDR00043	Sequence	DFYAKKIIEEKGEKEQYTVASGITPSGTVHIGNFREVISVDLVARALKDAGRNVRFIYSWDNYDVFRKVPKNMPNQELLT
TTDR00043	BioChemical Class	Ligases forming carbon-oxygen bonds
TTDR00043	EC Number	EC 6.1.1.6
TTDR00044	UniProt ID	Q9BLW4
TTDR00044	Name	GDP-mannose pyrophosphorylase
TTDR00044	Type of target	Research target
TTDR00044	Synonyms	GDP-MP
TTDR00044	Disease	Leishmania infections
TTDR00044	Sequence	MSASDGQGMRAVILVGGFGTRLRPLTLTTPKPLVPFCNKPMIIHQIEALKAVGVTEVILAVAYRPEAMKEQMDEWSRKLG
TTDR00044	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00045	UniProt ID	Q9NWZ3
TTDR00045	Name	Interleukin-1 receptor-associated kinase-4
TTDR00045	Type of target	Research target
TTDR00045	Synonyms	IRAK-4
TTDR00045	Synonyms	NY-REN-64 antigen
TTDR00045	Disease	Autoimmune diseases
TTDR00045	Disease	Inflammation
TTDR00045	Disease	Sepsis
TTDR00045	Sequence	MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCT
TTDR00045	PDB Structure	2NRU; 2NRY; 2O8Y; 2OIB; 2OIC; 2OID
TTDR00045	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00045	Pathway	Apoptosis
TTDR00045	Pathway	Toll-like receptor signaling pathway
TTDR00045	EC Number	EC 2.7.1.-
TTDR00046	UniProt ID	Q9UBF6
TTDR00046	Name	RING-box protein 2
TTDR00046	Type of target	Research target
TTDR00046	Synonyms	CKBBP1
TTDR00046	Synonyms	CKII beta-binding protein 1
TTDR00046	Synonyms	RING finger protein 7
TTDR00046	Synonyms	Rbx2
TTDR00046	Synonyms	Regulator of cullins 2
TTDR00046	Synonyms	Sensitive to apoptosis gene protein
TTDR00046	Disease	Cancer, unspecific
TTDR00046	Disease	Inflammation
TTDR00046	Function	Probable component of the scf (skp1-cul1-f-box protein) e3 ubiquitin ligase comp
TTDR00046	Sequence	MADVEDGEETCALASHSGSSGSKSGGDKMFSLKKWNAVAMWSWDVECDTCAICRVQVMDACLRCQAENKQEDCVVVWGEC
TTDR00046	PDB Structure	2ECL
TTDR00046	BioChemical Class	Zinc-finger
TTDR00046	Pathway	Ubiquitin mediated proteolysis
TTDR00047	UniProt ID	Q9WJB2
TTDR00047	Name	Papain-like cysteine protease
TTDR00047	Type of target	Research target
TTDR00047	Disease	Arthritis
TTDR00047	Disease	Cancer, unspecific
TTDR00047	Disease	Osteoporosis, unspecified
TTDR00047	Disease	Vascular disease
TTDR00047	Sequence	MSGILDRCTCTPNARVFMAEGQVYCTRCLSARSLLPLNLQVSELGVLGLFYRPEEPLRWTLPRAFPTVECSPAGACWLSA
TTDR00047	BioChemical Class	Protease
TTDR00048	UniProt ID	Q9Z0Y8
TTDR00048	Name	Voltage-dependent T-type calcium channel alpha-1I subunit
TTDR00048	Type of target	Research target
TTDR00048	Synonyms	Alpha1I
TTDR00048	Synonyms	CaVT.3
TTDR00048	Synonyms	Voltage-gated calcium channel alpha subunit Cav3.3
TTDR00048	Disease	Analgesics
TTDR00048	Disease	Epilepsy
TTDR00048	Disease	Pain
TTDR00048	Function	Voltage-sensitive calcium channels (vscc) mediate the entry of calcium ions into
TTDR00048	Sequence	MADSNLPPSSAAAPAPEPGITEQPGPRSPPPSPPGLEEPLEGTNPDVPHPDLAPVAFFCLRQTTSPRNWCIKMVCNPWFE
TTDR00048	BioChemical Class	Voltage-gated channel
TTDR00048	Pathway	Calcium signaling pathway
TTDR00048	Pathway	MAPK signaling pathway
TTDR00048	Target Validation	TTDR00048
TTDR00048	Inhibitor	BELFOSDIL
TTDR00048	Inhibitor	U-92032
TTDR00049	Name	5-HT-moduline
TTDR00049	Type of target	Research target
TTDR00049	Synonyms	5-HT moduline
TTDR00049	Synonyms	5-HTm
TTDR00049	Disease	Mood [affective] disorders
TTDR00050	Name	ATP-independent DNA topoisomerase II
TTDR00050	Type of target	Research target
TTDR00050	Disease	Trypanosomiasis
TTDR00050	EC Number	EC 5.99.1.3
TTDR00051	Name	CGMP-dependent protein kinase
TTDR00051	Type of target	Research target
TTDR00051	Disease	Intestinal parasites infections
TTDR00051	EC Number	EC 2.7.1.37
TTDR00051	Target Validation	TTDR00051
TTDR00051	Inhibitor	ARC-1028
TTDR00051	Inhibitor	GSK-690693
TTDR00051	Inhibitor	Go-6976
TTDR00051	Inhibitor	STAUROSPORINONE
TTDR00051	Inhibitor	TENELLONE A
TTDR00051	Inhibitor	TENELLONE B
TTDR00052	Name	Growth arrest and DNA-damage-inducible protein GADD45
TTDR00052	Type of target	Research target
TTDR00052	Disease	Cancer, unspecific
TTDR00053	UniProt ID	P26664
TTDR00053	Name	HCV polyprotein
TTDR00053	Type of target	Research target
TTDR00053	Disease	Hepatitis C
TTDR00053	Sequence	MSTNPKPQKKNKRNTNRRPQDVKFPGGGQIVGGVYLLPRRGPRLGVRATRKTSERSQPRGRRQPIPKARRPEGRTWAQPG
TTDR00053	PDB Structure	1RTL; 2A4G; 2GVF; 3EYD
TTDR00053	BioChemical Class	Protease
TTDR00054	Name	HIV-1 peptidase
TTDR00054	Type of target	Research target
TTDR00054	Disease	Human immunodeficiency virus [HIV] disease
TTDR00055	Name	HIV-1 Tat protein-TAR RNA
TTDR00055	Type of target	Research target
TTDR00055	Disease	Human immunodeficiency virus [HIV] disease
TTDR00055	Inhibitor	2'-O-Methyl G-Clamp Containing Oligonucleotides
TTDR00055	Aptamer	DNA aptamer with consensus sequences complementary to the TAR apical loop (5-C
TTDR00055	Aptamer	DNA aptamer with consensus sequences targeted to the stem 3-strand (5-CCCTAG
TTDR00056	UniProt ID	P33334
TTDR00056	UniProt ID	Q6BQU7
TTDR00056	Name	Pre-mRNA splicing factor PRP8
TTDR00056	Type of target	Research target
TTDR00056	Synonyms	Intein (PRP8)
TTDR00056	Synonyms	Prp8 intein
TTDR00056	Disease	Fungal diseases
TTDR00056	Function	Involved in pre-mrna splicing. U5 snrnp protein. Appears to contact the pre-mrna
TTDR00056	Sequence	MSGLPPPPPGFEEDSDLALPPPPPPPPGYEIEELDNPMVPSSVNEDTFLPPPPPPPSNFEINAEEIVDFTLPPPPPPPGL
TTDR00056	PDB Structure	2OG4; 3E66; 3E9O; 3E9P
TTDR00057	Name	Melanocortin receptor
TTDR00057	Type of target	Research target
TTDR00057	Disease	Obesity
TTDR00057	Related US Patent	6,410,548
TTDR00057	Related US Patent	6,458,790
TTDR00057	Target Validation	TTDR00057
TTDR00057	Inhibitor	AEKKDEGPYRMEHFRWGSPPKD
TTDR00057	Inhibitor	Ac-His-DNal(2)-Arg-Trp-NH2
TTDR00057	Inhibitor	Ac-His-DPhe(3,4-diCl)-Arg-Trp-NH2
TTDR00057	Inhibitor	Ac-His-DPhe(pBr)-Arg-Trp-NH2
TTDR00057	Inhibitor	Ac-His-DPhe(pCF3)-Arg-Trp-NH2
TTDR00057	Inhibitor	Ac-His-DPhe(pI)-Arg-Trp-NH2
TTDR00057	Inhibitor	Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
TTDR00057	Inhibitor	Ac-Nle-c[Asp-His-DNal(2')-Pro-Trp-Lys]-NH2
TTDR00057	Inhibitor	Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2
TTDR00057	Inhibitor	Ac-YRC(Me)*EHdFRWC(Me)NH2
TTDR00057	Inhibitor	Ac-YRMEHdFRWG-NH2
TTDR00057	Inhibitor	Ac-YRMEHdFRWGSPPKD-NH2
TTDR00057	Inhibitor	Ac-YR[CEH(d-2alpha-Nal)RWC]-NH2
TTDR00057	Inhibitor	Ac-YR[CEH(pCl-dF)RWC]-NH2
TTDR00057	Inhibitor	Ac-YR[CEH(pF-dF)RWC]-NH2
TTDR00057	Inhibitor	Alpha-MSH
TTDR00057	Inhibitor	GPYRMEHFRWGSPPKD-NH2
TTDR00057	Inhibitor	MK-10
TTDR00057	Inhibitor	MK-11
TTDR00057	Inhibitor	NDP-SYSMEHFRWGKPVG
TTDR00057	Inhibitor	c[CO-(CH2)2-CO-Nle-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00057	Inhibitor	c[CO-(CH2)2-CO-Nle-D-Phe-Arg-Trp-Lys]-NH2
TTDR00057	Inhibitor	c[CO-(CH2)3-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00057	Inhibitor	c[CO-(CH2)3-CO-Pro-D-Phe-Arg-Trp-Lys]-NH2
TTDR00057	Inhibitor	c[CO-2,3-pyrazine-CO-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00057	Inhibitor	c[CO-o-C6H4-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00057	Inhibitor	c[Nle-Arg-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Arg-D-Phe-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Asp-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Gln-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Gln-D-Phe-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Glu-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Glu-D-Phe-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-His-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-His-D-Phe-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Nle-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Nle-D-Phe-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Pro-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Pro-D-Phe-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Val-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00057	Inhibitor	c[Nle-Val-D-Phe-Arg-Trp-Glu]-NH2
TTDR00058	Name	P16 gene
TTDR00058	Type of target	Research target
TTDR00058	Disease	Multiple myeloma
TTDR00059	Name	P2X receptor (bacterial)
TTDR00059	Type of target	Research target
TTDR00059	Disease	Schistosomiasis [bilharziasis]
TTDR00060	Name	Protease resistant isoform
TTDR00060	Type of target	Research target
TTDR00060	Disease	Prion diseases
TTDR00061	Name	Rnase P protein
TTDR00061	Type of target	Research target
TTDR00061	Synonyms	Protein C5
TTDR00061	Synonyms	RNaseP protein
TTDR00061	Synonyms	Ribonuclease P protein component
TTDR00061	Synonyms	Rnase P
TTDR00061	Disease	Bacterial infections
TTDR00061	EC Number	EC 3.1.26.5
TTDR00062	Name	Voltage-gated calcium channel
TTDR00062	Type of target	Research target
TTDR00062	Disease	Epilepsy
TTDR00063	Name	Wld(S) protein
TTDR00063	Type of target	Research target
TTDR00063	Synonyms	Neuroprotective gene Wld(S)
TTDR00063	Synonyms	Wld S protein
TTDR00063	Synonyms	Wld s fusion protein
TTDR00063	Synonyms	Wld(S)
TTDR00063	Disease	Axon death in CNS and PNS disease
TTDR00063	Disease	Neurological diseases
TTDR00064	UniProt ID	P08546
TTDR00064	Name	HCMV DNA polymerase
TTDR00064	Type of target	Research target
TTDR00064	Synonyms	DNA polymerase
TTDR00064	Disease	Cytomegalovirus retinitis
TTDR00064	Disease	GCV-resistant HCMV
TTDR00064	Sequence	MFFNPYLSGGVTGGAVAGGRRQRSQPGSAQGSGKRPPQKQFLQIVPRGVMFDGQTGLIKHKTGRLPLMFYREIKHLLSHD
TTDR00064	PDB Structure	1YYP
TTDR00064	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00064	Inhibitor	Guanosine
TTDR00064	Inhibitor	Guanosine-5'-Monophosphate
TTDR00065	Name	Aspartyl protease (Candida albicans secreted)
TTDR00065	Type of target	Research target
TTDR00065	Disease	Fungal diseases
TTDR00065	EC Number	EC 3.4.23.-
TTDR00066	UniProt ID	Q6GKS9
TTDR00066	Name	DnaB-like helicase
TTDR00066	Type of target	Research target
TTDR00066	Synonyms	DnaC
TTDR00066	Synonyms	DnaC helicase
TTDR00066	Disease	Bacterial infections
TTDR00066	Sequence	MDRMYEQNQMPHNNEAEQSVLGSIIIDPELINTTQEVLLPESFYRGAHQHIFRAMMHLNEDNKEIDVVTLMDQLSTEGTL
TTDR00066	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00066	Pathway	DNA replication
TTDR00067	Name	Ribosomal ATPase RbbA
TTDR00067	Type of target	Research target
TTDR00067	Synonyms	RbbA
TTDR00067	Synonyms	RbbA protein
TTDR00067	Disease	Bacterial infections
TTDR00067	Disease	Fungal diseases
TTDR00067	Inhibitor	Hygromycin B
TTDR00068	UniProt ID	P10192
TTDR00068	Name	DNA helicase/primase complex associated protein
TTDR00068	Type of target	Research target
TTDR00068	Synonyms	DNA replication protein UL8
TTDR00068	Synonyms	HSV-1 UL8 DNA replication protein
TTDR00068	Synonyms	Herpes simplex virus type 1 UL8 DNA replication protein
TTDR00068	Synonyms	UL8 protein
TTDR00068	Disease	Herpes virus infection
TTDR00068	Function	Probably involved in dna replication.
TTDR00068	Sequence	MDTADIVWVEESVSAITLYAVWLPPRAREYFHALVYFVCRNAAGEGRARFAEVSVTATELRDFYGSADVSVQAVVAAARA
TTDR00069	Name	Stromelysin
TTDR00069	Type of target	Research target
TTDR00069	Disease	Connective tissue disorders
TTDR00069	Disease	Inflammatory diseases
TTDR00069	Disease	Tumors
TTDR00069	Related US Patent	6,310,084
TTDR00069	Related US Patent	6,337,411
TTDR00070	Name	Cysteine protease
TTDR00070	Type of target	Research target
TTDR00070	Disease	Chagas' disease
TTDR00070	Related US Patent	6,329,377
TTDR00070	Related US Patent	6,342,531
TTDR00070	Related US Patent	6,468,977
TTDR00070	Related US Patent	6,500,802
TTDR00070	Related US Patent	6,569,847
TTDR00070	Target Validation	TTDR00070
TTDR00070	Inhibitor	ALLICIN
TTDR00070	Inhibitor	K-777
TTDR00070	Inhibitor	MELARSOPROL
TTDR00070	Inhibitor	N-methyl-Pip-F-homoF-vinyl sulfonyl phenyl (N-methyl-Pip-F-hF-VS phi)
TTDR00070	Inhibitor	S-benzyl phenylmethanesulfinothioate
TTDR00070	Inhibitor	S-hexyl hexane-1-sulfinothioate
TTDR00070	Inhibitor	S-isopentyl 3-methylbutane-1-sulfinothioate
TTDR00070	Inhibitor	S-propyl propane-1-sulfinothioate
TTDR00071	UniProt ID	Q14721
TTDR00071	Name	Potassium voltage-gated channel subfamily B member 1
TTDR00071	Type of target	Research target
TTDR00071	Synonyms	H-DRK1
TTDR00071	Synonyms	Potassium channel Kv2.1
TTDR00071	Synonyms	Rectifier potassium channel Kv2.1
TTDR00071	Synonyms	Voltage-gated potassium channel subunit Kv2.1
TTDR00071	Disease	Noninsulin-dependent diabetes mellitus
TTDR00071	Function	Mediates the voltage-dependent potassium ion permeability of excitable membranes
TTDR00071	Sequence	MPAGMTKHGSRSTSSLPPEPMEIVRSKACSRRVRLNVGGLAHEVLWRTLDRLPRTRLGKLRDCNTHDSLLEVCDDYSLDD
TTDR00071	BioChemical Class	Voltage-gated channel
TTDR00071	Pathway	Taste transduction
TTDR00071	Related US Patent	6,589,934
TTDR00072	Name	Metalloproteinase-4
TTDR00072	Type of target	Research target
TTDR00072	Disease	Arthritis
TTDR00072	Disease	Cancer, unspecific
TTDR00072	Related US Patent	6,544,761
TTDR00073	Name	Vascular endothelial growth factor receptor
TTDR00073	Type of target	Research target
TTDR00073	Disease	Cancer, unspecific
TTDR00073	Disease	Leukemia, unspecified
TTDR00073	Disease	Retinopathy
TTDR00073	Related US Patent	6,448,277
TTDR00073	Related US Patent	6,624,174
TTDR00073	Related US Patent	6,642,232
TTDR00073	Aptamer	SU5416
TTDR00074	UniProt ID	Q8I5S7
TTDR00074	Name	Choline transporter
TTDR00074	Type of target	Research target
TTDR00074	Disease	Malaria
TTDR00074	Sequence	MPDFYFLIRWLCKVIVKSVFRDVNVINPENVPLYGSVIFVGNHNNQFIDACVLIANIPRQVKFIVAEKSMRRAVIGKLAS
TTDR00074	Blocker	G-25
TTDR00075	UniProt ID	Q6LFD5
TTDR00075	UniProt ID	Q8I1U9
TTDR00075	Name	Apicoplast ribosome
TTDR00075	Type of target	Research target
TTDR00075	Disease	Malaria
TTDR00075	Sequence	MFIKKINIKYLSFSLLVYFIYNAYVYNTIKLQKCFNYEHKKGNFLVSSLVLDGKDIKGRRNKGIINFIRSNIITTNKFKL
TTDR00075	Inhibitor	Antibiotics
TTDR00076	UniProt ID	Q8I0X3
TTDR00076	UniProt ID	Q8I528
TTDR00076	Name	DNA gyrase
TTDR00076	Type of target	Research target
TTDR00076	Disease	Malaria
TTDR00076	Sequence	MSFKFSIVFVLYLLFLLKFNKRFIFLKSEKITSYINTQIPNYSSSPPFFLKKEAKNNIKKCYFIKREGYRNIGTKNASNA
TTDR00077	UniProt ID	Q02766
TTDR00077	Name	Cytochrome c oxidoreductase
TTDR00077	Type of target	Research target
TTDR00077	Disease	Malaria
TTDR00077	Sequence	MVLNRYSLITNCNHKTLGLYYLWFSFLFGSYGFLLSVILRTELYSSSLRIIAQENVNLYNMIFTIHGIIMIFFNIMPGLF
TTDR00079	Name	New permeability pathways
TTDR00079	Type of target	Research target
TTDR00079	Synonyms	NPPs
TTDR00079	Disease	Malaria
TTDR00079	Inhibitor	5-nitro-2-(3-phenylpropylamino) benzoic acid
TTDR00079	Inhibitor	Decyltrimethylammonium
TTDR00079	Inhibitor	Hemicholinium
TTDR00081	UniProt ID	P47900
TTDR00081	Name	P2Y purinoceptor 1
TTDR00081	Type of target	Research target
TTDR00081	Synonyms	ATP receptor
TTDR00081	Synonyms	Adenosine P2Y1 receptor
TTDR00081	Synonyms	P2Y(1) receptor
TTDR00081	Synonyms	P2Y1
TTDR00081	Synonyms	Purinergic receptor
TTDR00081	Disease	Thrombosis
TTDR00081	Function	Receptor for extracellular adenine nucleotides such as atp and adp. In platelets
TTDR00081	Sequence	MTEVLWPAVPNGTDAAFLAGPGSSWGNSTVASTAAVSSSFKCALTKTGFQFYYLPAVYILVFIIGFLGNSVAIWMFVFHM
TTDR00081	PDB Structure	1Y36
TTDR00081	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00081	Pathway	Neuroactive ligand-receptor interaction
TTDR00081	Target Validation	TTDR00081
TTDR00081	Inhibitor	1-(3,4-dichlorophenyl)-3-(3,5-dichlorophenyl)urea
TTDR00081	Inhibitor	Urea derivative
TTDR00081	Antagonist	MRS-2179
TTDR00081	Antagonist	N:(6)-methyl-2'-deoxyadenosine-3':5'-bisphosphate
TTDR00082	UniProt ID	P25874
TTDR00082	Name	Mitochondrial brown fat uncoupling protein 1
TTDR00082	Type of target	Research target
TTDR00082	Synonyms	Mitochondrial uncoupling protein 1
TTDR00082	Synonyms	Thermogenin
TTDR00082	Synonyms	UCP 1
TTDR00082	Disease	Noninsulin-dependent diabetes mellitus
TTDR00082	Disease	Obesity
TTDR00082	Function	Ucp are mitochondrial transporter proteins that create proton leaks across the i
TTDR00082	Sequence	MGGLTASDVHPTLGVQLFSAGIAACLADVITFPLDTAKVRLQVQGECPTSSVIRYKGVLGTITAVVKTEGRMKLYSGLPA
TTDR00082	BioChemical Class	Transmembrane protein
TTDR00082	Pathway	Huntington's disease
TTDR00082	Pathway	PPAR signaling pathway
TTDR00082	Inducer	CL-316,243
TTDR00082	Inducer	NC-2100
TTDR00082	Stimulator	Beta 3-adrenoceptor agonists
TTDR00083	UniProt ID	P55851
TTDR00083	Name	Mitochondrial uncoupling protein 2
TTDR00083	Type of target	Research target
TTDR00083	Synonyms	UCP 2
TTDR00083	Synonyms	UCP2
TTDR00083	Synonyms	UCPH
TTDR00083	Disease	Obesity
TTDR00083	Function	Ucp are mitochondrial transporter proteins that create proton leaks across the i
TTDR00083	Sequence	MVGFKATDVPPTATVKFLGAGTAACIADLITFPLDTAKVRLQIQGESQGPVRATASAQYRGVMGTILTMVRTEGPRSLYN
TTDR00083	BioChemical Class	Transmembrane protein
TTDR00083	Inducer	CL-316,243
TTDR00083	Inducer	NC-2100
TTDR00083	Stimulator	Beta 3-adrenoceptor
TTDR00084	UniProt ID	P55916
TTDR00084	Name	Mitochondrial uncoupling protein 3
TTDR00084	Type of target	Research target
TTDR00084	Synonyms	Mitochondrial uncoupling protein 1
TTDR00084	Synonyms	UCP 3
TTDR00084	Synonyms	UCP3
TTDR00084	Disease	Diabetes mellitus
TTDR00084	Disease	Noninsulin-dependent diabetes mellitus
TTDR00084	Disease	Obesity
TTDR00084	Function	Ucp are mitochondrial transporter proteins that create proton leaks across the i
TTDR00084	Sequence	MVGLKPSDVPPTMAVKFLGAGTAACFADLVTFPLDTAKVRLQIQGENQAVQTARLVQYRGVLGTILTMVRTEGPCSPYNG
TTDR00084	BioChemical Class	Transmembrane protein
TTDR00084	Inducer	CL-316,243
TTDR00084	Stimulator	Beta 3-adrenoceptor
TTDR00085	UniProt ID	P28562
TTDR00085	Name	Dual specificity protein phosphatase 1
TTDR00085	Type of target	Research target
TTDR00085	Synonyms	Dual specificity protein phosphatase hVH1
TTDR00085	Synonyms	MAP kinase phosphatase-1
TTDR00085	Synonyms	MKP-1
TTDR00085	Synonyms	Protein-tyrosine phosphatase CL100
TTDR00085	Disease	Inflammation
TTDR00085	Disease	Parkinson's disease
TTDR00085	Function	Dual specificity phosphatase that dephosphorylates map kinase erk2 on both thr-1
TTDR00085	Sequence	MVMEVGTLDAGGLRALLGERAAQCLLLDCRSFFAFNAGHIAGSVNVRFSTIVRRRAKGAMGLEHIVPNAELRGRLLAGAY
TTDR00085	BioChemical Class	Hydrolases acting on ester bonds
TTDR00085	Pathway	MAPK signaling pathway
TTDR00085	EC Number	EC 3.1.3.16
TTDR00085	EC Number	EC 3.1.3.48
TTDR00085	Target Validation	TTDR00085
TTDR00085	Inhibitor	4-ethoxynaphthalene-1,2-dione
TTDR00085	Inhibitor	ADOCIAQUINONE B
TTDR00085	Inhibitor	JUGLONE
TTDR00085	Inhibitor	Okadaic acid
TTDR00086	UniProt ID	P05112
TTDR00086	Name	Interleukin-4
TTDR00086	Type of target	Research target
TTDR00086	Synonyms	B-cell stimulatory factor 1
TTDR00086	Synonyms	BSF-1
TTDR00086	Synonyms	IL-4
TTDR00086	Synonyms	Lymphocyte stimulatory factor 1
TTDR00086	Disease	Allergic diseases
TTDR00086	Disease	Asthma
TTDR00086	Disease	Ocular allergy
TTDR00086	Disease	Parasitic infections of the eye
TTDR00086	Disease	Rheumatoid arthritis, unspecified
TTDR00086	Disease	Type I hypersensitivity
TTDR00086	Function	Participates in at least several b-cell activation processes as well as of other
TTDR00086	Sequence	MGLTSQLLPPLFFLLACAGNFVHGHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFY
TTDR00086	PDB Structure	1ITE; 1ITI; 1ITL; 1ITM; 1RCB; 2B8U; 2B8X; 2B8Y
TTDR00086	BioChemical Class	Growth factor
TTDR00086	Pathway	Allograft rejection
TTDR00086	Pathway	Asthma
TTDR00086	Pathway	Autoimmune thyroid disease
TTDR00086	Pathway	Cytokine-cytokine receptor interaction
TTDR00086	Pathway	Fc epsilon RI signaling pathway
TTDR00086	Pathway	Hematopoietic cell lineage
TTDR00086	Pathway	Jak-STAT signaling pathway
TTDR00086	Pathway	T cell receptor signaling pathway
TTDR00086	Related US Patent	6,376,524
TTDR00086	Inhibitor	Antagonistic site II mutants of human IL-4
TTDR00086	Inhibitor	IL-4R
TTDR00086	Inhibitor	Nuvance
TTDR00086	Inhibitor	SIL-4R
TTDR00088	UniProt ID	P05113
TTDR00088	Name	Interleukin-5
TTDR00088	Type of target	Research target
TTDR00088	Synonyms	B cell differentiation factor I
TTDR00088	Synonyms	Eosinophil differentiation factor
TTDR00088	Synonyms	IL-5
TTDR00088	Synonyms	T-cell replacing factor
TTDR00088	Synonyms	TRF
TTDR00088	Disease	Allergic inflammation
TTDR00088	Disease	Asthma
TTDR00088	Disease	Asthmatic bronchial mucosal inflammation
TTDR00088	Function	Factor that induces terminal differentiation of late- developing b-cells to immu
TTDR00088	Sequence	MRMLLHLSLLALGAAYVYAIPTEIPTSALVKETLALLSTHRTLLIANETLRIPVPVHKNHQLCTEEIFQGIGTLESQTVQ
TTDR00088	PDB Structure	1HUL
TTDR00088	BioChemical Class	Growth factor
TTDR00088	Pathway	Allograft rejection
TTDR00088	Pathway	Asthma
TTDR00088	Pathway	Autoimmune thyroid disease
TTDR00088	Pathway	Cytokine-cytokine receptor interaction
TTDR00088	Pathway	Fc epsilon RI signaling pathway
TTDR00088	Pathway	Hematopoietic cell lineage
TTDR00088	Pathway	Jak-STAT signaling pathway
TTDR00088	Pathway	T cell receptor signaling pathway
TTDR00088	Target Validation	TTDR00088
TTDR00088	Inhibitor	SOPHORICOSIDE
TTDR00089	UniProt ID	P54694
TTDR00089	Name	D-amino acid aminotransferase
TTDR00089	Type of target	Research target
TTDR00089	Synonyms	D-alanine aminotransferase
TTDR00089	Synonyms	D-amino acid transaminase
TTDR00089	Synonyms	D-aspartate aminotransferase
TTDR00089	Synonyms	DAAT
TTDR00089	Disease	Bacterial infections
TTDR00089	Disease	Vitamin B6 deficiency
TTDR00089	Function	Acts on the d-isomers of alanine, leucine, aspartate, glutamate, aminobutyrate,
TTDR00089	Sequence	MTKVFINGEFIDQNEAKVSYEDRGYVFGDGIYEYIRAYDGKLFTVTEHFERFIRSASEIQLDLGYTVEELIDVVRELLKV
TTDR00089	BioChemical Class	Transferases transferring nitrogenous groups
TTDR00089	EC Number	EC 2.6.1.21
TTDR00089	Inhibitor	Acetate Ion
TTDR00089	Inhibitor	Pyridoxamine-5'-Phosphate
TTDR00090	Name	mRNA of intercellular adhesion molecule 1
TTDR00090	Type of target	Research target
TTDR00090	Synonyms	mRNA of ICAM-1
TTDR00090	Disease	Crohn's disease, unspecified
TTDR00092	Name	mRNA of the major immediate-early region protein
TTDR00092	Type of target	Research target
TTDR00092	Disease	Cytomegalovirus retinitis
TTDR00093	Name	Penicillin binding protein 1
TTDR00093	Type of target	Research target
TTDR00093	Synonyms	PBP1
TTDR00093	Disease	Bacterial infections
TTDR00093	Binder	Benzylpenicillin
TTDR00094	UniProt ID	P29401
TTDR00094	Name	Transketolase
TTDR00094	Type of target	Research target
TTDR00094	Synonyms	TK
TTDR00094	Disease	Thiamine deficiency
TTDR00094	Sequence	MESYHKPDQQKLQALKDTANRLRISSIQATTAAGSGHPTSCCSAAEIMAVLFFHTMRYKSQDPRNPHNDRFVLSKGHAAP
TTDR00094	BioChemical Class	Transferases transferring aldehyde or ketone residues
TTDR00094	Pathway	Metabolic pathways
TTDR00094	Pathway	Pentose phosphate pathway
TTDR00094	EC Number	EC 2.2.1.1
TTDR00094	Inhibitor	1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane
TTDR00096	UniProt ID	O00253
TTDR00096	Name	Agouti-related protein
TTDR00096	Type of target	Clinical trial target
TTDR00096	Synonyms	AGRP
TTDR00096	Synonyms	Agouti related protein
TTDR00096	Synonyms	Agouti-related peptide
TTDR00096	Disease	Anorexia nervosa
TTDR00096	Disease	Obesity
TTDR00096	Disease	Obesity-associated disorders
TTDR00096	Function	Plays a role in weight homeostasis. May play a role in the regulation of melanoc
TTDR00096	Sequence	MLTAAVLSCALLLALPATRGAQMGLAPMEGIRRPDQALLPELPGLGLRAPLKKTTAEQAEEDLLQEAQALAEVLDLQDRE
TTDR00096	PDB Structure	1HYK; 1MR0; 2IQV
TTDR00096	Pathway	Adipocytokine signaling pathway
TTDR00096	Drug(s)	TTP435
TTDR00096	Inhibitor	TTP435
TTDR00098	Name	Monoamine uptake
TTDR00098	Type of target	Research target
TTDR00098	Disease	Depression
TTDR00098	Disease	Mood [affective] disorders
TTDR00098	Inhibitor	Desmethylclomipramine
TTDR00098	Inhibitor	Luvox
TTDR00098	Inhibitor	Norzimelidine
TTDR00099	UniProt ID	P01100
TTDR00099	Name	Proto-oncogene protein c-fos
TTDR00099	Type of target	Research target
TTDR00099	Synonyms	C-fos
TTDR00099	Synonyms	Cellular oncogene fos
TTDR00099	Synonyms	G0/G1 switch regulatory protein 7
TTDR00099	Disease	Breast cancer
TTDR00099	Disease	Neurological symptom
TTDR00099	Function	Nuclear phosphoprotein which forms a tight but non- covalently linked complex wi
TTDR00099	Sequence	MMFSGFNADYEASSSRCSSASPAGDSLSYYHSPADSFSSMGSPVNAQDFCTDLAVSSANFIPTVTAISTSPDLQWLVQPA
TTDR00099	PDB Structure	1A02; 1FOS; 1S9K
TTDR00099	Pathway	B cell receptor signaling pathway
TTDR00099	Pathway	Colorectal cancer
TTDR00099	Pathway	MAPK signaling pathway
TTDR00099	Pathway	Pathways in cancer
TTDR00099	Pathway	T cell receptor signaling pathway
TTDR00099	Pathway	Toll-like receptor signaling pathway
TTDR00101	UniProt ID	P00495
TTDR00101	UniProt ID	Q8N0R1
TTDR00101	Name	Orotate phosphoribosyltransferase
TTDR00101	Type of target	Research target
TTDR00101	Synonyms	OPRtase
TTDR00101	Synonyms	Oprt
TTDR00101	Synonyms	Orotidylic acid phosphorylase
TTDR00101	Disease	Bladder cancer
TTDR00101	Disease	Malaria
TTDR00101	Sequence	MTTIKENEFLCDEEIYKSFVHLKDKICEERKKKELVNNNIDNVNFNDDDDNNYDDDGNSYSSYIKEMKKLLKVVLLKYKA
TTDR00101	PDB Structure	1ORO
TTDR00101	BioChemical Class	Glycosyltransferases
TTDR00101	EC Number	EC 2.4.2.10
TTDR00101	Inhibitor	Alpha-Phosphoribosylpyrophosphoric Acid
TTDR00101	Inhibitor	Orotic Acid
TTDR00102	UniProt ID	P26664
TTDR00102	UniProt ID	Q81562
TTDR00102	Name	Hepatitis C Virus Serine Protease NS3/4A
TTDR00102	Type of target	Research target
TTDR00102	Synonyms	Cpro-2
TTDR00102	Synonyms	Hepacivirin
TTDR00102	Synonyms	Hepatitis c virus NS3/4a protease
TTDR00102	Synonyms	NS3-4A serine proteinase complex
TTDR00102	Synonyms	NS3/4A complex
TTDR00102	Synonyms	NS3/4A serine protease
TTDR00102	Disease	Hepatitis C
TTDR00102	Sequence	MSTNPKPQKKNKRNTNRRPQDVKFPGGGQIVGGVYLLPRRGPRLGVRATRKTSERSQPRGRRQPIPKARRPEGRTWAQPG
TTDR00102	PDB Structure	1RTL; 2A4G; 2GVF; 3EYD
TTDR00102	BioChemical Class	Protease
TTDR00102	EC Number	EC 3.4.21.98
TTDR00102	Related US Patent	6,599,738
TTDR00103	UniProt ID	P06591
TTDR00103	UniProt ID	P26664
TTDR00103	Name	Nonstructural protein NS3
TTDR00103	Type of target	Clinical trial target
TTDR00103	Synonyms	HCV NS3 RNA helicase
TTDR00103	Synonyms	Hepacivirin
TTDR00103	Synonyms	Hepatitis C Virus RNA Helicase
TTDR00103	Synonyms	Hepatitis C virus NS3 serine proteinase
TTDR00103	Synonyms	NS3
TTDR00103	Synonyms	NS3 protease
TTDR00103	Synonyms	NS3 protein
TTDR00103	Synonyms	Nonstructural protein 3
TTDR00103	Synonyms	ORF-C
TTDR00103	Synonyms	P70
TTDR00103	Synonyms	Protease/helicase NS3
TTDR00103	Synonyms	RNA helicase
TTDR00103	Synonyms	Ribonucleic acid (RNA) helicase
TTDR00103	Synonyms	SM protein
TTDR00103	Disease	Hepatitis C
TTDR00103	Disease	Viral infection, unspecified
TTDR00103	Sequence	APITAYAQQTRGLLGCIITSLTGRDKNQVEGEVQIVSTAAQTFLATCINGVCWTVYHGAGTRTIASPKGPVIQMYTNVDQ
TTDR00103	PDB Structure	1RTL; 2A4G; 2GVF; 3EYD
TTDR00103	BioChemical Class	Protease
TTDR00103	EC Number	EC 3.4.21.98
TTDR00103	Related US Patent	6,608,067
TTDR00103	Related US Patent	6,617,309
TTDR00103	Related US Patent	6,642,204
TTDR00103	Related US Patent	6,653,295
TTDR00103	Target Validation	TTDR00103
TTDR00103	Inhibitor	2,4,6-Trihydroxy-3-nitro-N-tridecyl-benzamide
TTDR00103	Inhibitor	Ac-Glu-Cha-Cys
TTDR00103	Inhibitor	AcAsp-D-Gla-Leu-Ile-Cha-Cys
TTDR00103	Inhibitor	AcAsp-D-Glu-Leu-Glu-Cha-Cys
TTDR00103	Inhibitor	AcAsp-Gla-Leu-Ile-Cha-Cys
TTDR00103	Inhibitor	AcAsp-Glu-Cha-Val-Prb-Cpg
TTDR00103	Inhibitor	AcAsp-Glu-Cha-Val-Prb-Cys
TTDR00103	Inhibitor	AcAsp-Glu-Dif-Glu-Cha-Cys
TTDR00103	Inhibitor	AcAsp-Glu-Dif-Glu-Cha-Fab
TTDR00103	Inhibitor	AcAsp-Glu-Dif-Ile-Cha-Cys
TTDR00103	Inhibitor	AcAsp-Glu-Dif-Ile-Cha-Cys-Iqc-Nle-Thr-TyrNH2
TTDR00103	Inhibitor	AcAsp-Glu-Dif-Ile-Cha-Cys-Pro-Cha-Asp-ValNH2
TTDR00103	Inhibitor	AcAsp-Glu-Dif-Ile-Cha-Cys-Pro-Nle-Asp-ValNH2
TTDR00103	Inhibitor	AcAsp-Glu-Dif-Lys-Cha-Cys
TTDR00103	Inhibitor	AcAsp-Glu-Leu-Glu-Cha-Cys
TTDR00103	Inhibitor	AcAsp-Glu-Met-Glu-Cha-Cys
TTDR00103	Inhibitor	AcAsp-Glu-Met-Glu-Glu-Cys
TTDR00103	Inhibitor	AcAsp-Glu-Met-Glu-Nal-Cyse
TTDR00103	Inhibitor	AcDif-Glu-Cha-Cys
TTDR00103	Inhibitor	AcDif-Ile-Cha-Cys
TTDR00103	Inhibitor	AcGlu-Asp-Val-Val-Leu-Cys-Iqc-Nle-Thr-TyrNH2
TTDR00103	Inhibitor	AcGlu-Dif-Glu-Cha-Cys
TTDR00103	Inhibitor	AcGlu-Dif-Ile-Cha-Cys
TTDR00103	Inhibitor	Asp-D-Glu-Leu-Glu-Cha-Cys
TTDR00103	Inhibitor	Azapeptide
TTDR00103	Inhibitor	Azapeptide derivative
TTDR00103	Inhibitor	BILN-2061
TTDR00103	Inhibitor	Boc-Ile-Leu-L-(difluoro)aminobutyric aid
TTDR00103	Inhibitor	Cbz-Ile-Leu-L-(difluoro)aminobutyric acid
TTDR00103	Inhibitor	GNF-PF-3464
TTDR00103	Inhibitor	PATULIN
TTDR00103	Inhibitor	Peptide Boronic Acid analogue
TTDR00103	Inhibitor	SCH-68631
TTDR00103	Aptamer	SE RNA
TTDR00104	UniProt ID	P06721
TTDR00104	Name	Cystathionine beta-lyase
TTDR00104	Type of target	Research target
TTDR00104	Synonyms	Beta-cystathionase
TTDR00104	Synonyms	CBL
TTDR00104	Synonyms	Cysteine lyase
TTDR00104	Disease	Vitamin B6 deficiency
TTDR00104	Sequence	MADKKLDTQLVNAGRSKKYTLGAVNSVIQRASSLVFDSVEAKKHATRNRANGELFYGRRGTLTHFSLQQAMCELEGGAGC
TTDR00104	PDB Structure	1CL1; 1CL2; 2FQ6; 2GQN
TTDR00104	BioChemical Class	Carbon-sulfur lyases
TTDR00104	Pathway	Cysteine metabolism
TTDR00104	Pathway	Metabolic pathways
TTDR00104	Pathway	Methionine metabolism
TTDR00104	Pathway	Nitrogen metabolism
TTDR00104	Pathway	Selenoamino acid metabolism
TTDR00104	Pathway	Sulfur metabolism
TTDR00104	EC Number	EC 4.4.1.8
TTDR00105	Name	Peroxisome proliferator activated receptor
TTDR00105	Type of target	Clinical trial target
TTDR00105	Synonyms	PPAR
TTDR00105	Disease	Bladder cancer
TTDR00105	Disease	Diabetes mellitus
TTDR00105	Disease	Diabetic nephropathy
TTDR00105	Disease	Glomerulosclerosis
TTDR00105	Disease	Kidney tumors
TTDR00105	Disease	Prostate cancer
TTDR00105	Related US Patent	6,506,781
TTDR00106	UniProt ID	P46925
TTDR00106	Name	Plasmepsin 2
TTDR00106	Type of target	Research target
TTDR00106	Synonyms	Aspartic hemoglobinase II
TTDR00106	Synonyms	PFAPD
TTDR00106	Synonyms	Plasmepsin II
TTDR00106	Disease	Human immunodeficiency virus [HIV] disease
TTDR00106	Disease	Malaria
TTDR00106	Disease	Parasitic diseases
TTDR00106	Sequence	MDITVREHDFKHGFIKSNSTFDGLNIDNSKNKKKIQKGFQILYVLLFCSVMCGLFYYVYENVWLQRDNEMNEILKNSEHL
TTDR00106	PDB Structure	1J8J; 1LEE; 1LF2; 1LF3; 1LF4; 1M43; 1ME6; 1PFZ
TTDR00106	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00106	EC Number	EC 3.4.23.39
TTDR00106	Related US Patent	6,326,393
TTDR00106	Related US Patent	6,432,933
TTDR00106	Target Validation	TTDR00106
TTDR00106	Inhibitor	E-64
TTDR00106	Inhibitor	KNI-10006
TTDR00106	Inhibitor	KNI-10033
TTDR00106	Inhibitor	KNI-10061
TTDR00106	Inhibitor	KNI-10062
TTDR00106	Inhibitor	KNI-10074
TTDR00106	Inhibitor	KNI-10079
TTDR00106	Inhibitor	KNI-10080
TTDR00106	Inhibitor	KNI-10081
TTDR00106	Inhibitor	KNI-10087
TTDR00106	Inhibitor	KNI-10088
TTDR00106	Inhibitor	KNI-10092
TTDR00106	Inhibitor	KNI-10093
TTDR00106	Inhibitor	KNI-10094
TTDR00106	Inhibitor	KNI-10095
TTDR00106	Inhibitor	KNI-10106
TTDR00106	Inhibitor	KNI-10113
TTDR00106	Inhibitor	KNI-10124
TTDR00106	Inhibitor	KNI-10125
TTDR00106	Inhibitor	KNI-10152
TTDR00106	Inhibitor	KNI-10155
TTDR00106	Inhibitor	KNI-10216
TTDR00106	Inhibitor	KNI-10217
TTDR00106	Inhibitor	KNI-10232
TTDR00106	Inhibitor	KNI-10255
TTDR00106	Inhibitor	KNI-10256
TTDR00106	Inhibitor	KNI-10260
TTDR00106	Inhibitor	KNI-10265
TTDR00106	Inhibitor	KNI-10266
TTDR00106	Inhibitor	KNI-10282
TTDR00106	Inhibitor	KNI-10283
TTDR00106	Inhibitor	KNI-10313
TTDR00106	Inhibitor	KNI-10314
TTDR00106	Inhibitor	KNI-10315
TTDR00106	Inhibitor	KNI-10316
TTDR00106	Inhibitor	KNI-10332
TTDR00106	Inhibitor	KNI-10341
TTDR00106	Inhibitor	KNI-10342
TTDR00106	Inhibitor	KNI-10368
TTDR00106	Inhibitor	KNI-10369
TTDR00106	Inhibitor	KNI-10372
TTDR00106	Inhibitor	KNI-10526
TTDR00106	Inhibitor	KNI-10527
TTDR00106	Inhibitor	KNI-10529
TTDR00106	Inhibitor	KNI-10538
TTDR00106	Inhibitor	KNI-10539
TTDR00106	Inhibitor	KNI-10541
TTDR00106	Inhibitor	KNI-10737
TTDR00106	Inhibitor	KNI-10740
TTDR00106	Inhibitor	KNI-10741
TTDR00106	Inhibitor	KNI-10742
TTDR00106	Inhibitor	KNI-10743
TTDR00106	Inhibitor	KNI-10758
TTDR00106	Inhibitor	KNI-10759
TTDR00106	Inhibitor	KNI-10760
TTDR00106	Inhibitor	KNI-10761
TTDR00106	Inhibitor	KNI-10762
TTDR00106	Inhibitor	KNI-10763
TTDR00106	Inhibitor	KNI-1293
TTDR00106	Inhibitor	KNI-227
TTDR00106	Inhibitor	KNI-272
TTDR00106	Inhibitor	KNI-727
TTDR00106	Inhibitor	KNI-764
TTDR00106	Inhibitor	Leupeptin
TTDR00106	Inhibitor	N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)
TTDR00106	Inhibitor	PEPSTATIN A
TTDR00106	Inhibitor	PS-154636-1;PS-154636-2
TTDR00106	Inhibitor	PS-222036
TTDR00106	Inhibitor	PS-444035
TTDR00106	Inhibitor	PS-662477
TTDR00106	Inhibitor	PS-725074
TTDR00106	Inhibitor	PS-777621
TTDR00106	Inhibitor	Pepstatin
TTDR00107	UniProt ID	P39898
TTDR00107	Name	Plasmepsin 1
TTDR00107	Type of target	Research target
TTDR00107	Synonyms	Aspartic hemoglobinase I
TTDR00107	Synonyms	PFAPG
TTDR00107	Synonyms	Plasmepsin I
TTDR00107	Disease	Malaria
TTDR00107	Function	Participates in the digestion of the host hemoglobin. Initial cleavage at the hi
TTDR00107	Sequence	MALSIKEDFSSAFAKNESAVNSSTFNNNMKTWKIQKRFQILYVFFFLLITGALFYYLIDNVLFPKNKKINEIMNTSKHVI
TTDR00107	PDB Structure	1LCR; 1LDU
TTDR00107	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00107	EC Number	EC 3.4.23.38
TTDR00107	Related US Patent	6,326,393
TTDR00107	Related US Patent	6,432,933
TTDR00107	Target Validation	TTDR00107
TTDR00107	Inhibitor	E-64
TTDR00107	Inhibitor	KNI-10006
TTDR00107	Inhibitor	L-mannitol derivative
TTDR00107	Inhibitor	Leupeptin
TTDR00107	Inhibitor	PS-777621
TTDR00107	Inhibitor	Pepstatin
TTDR00107	Inhibitor	SC-5003
TTDR00108	UniProt ID	P21246
TTDR00108	Name	Pleiotrophin
TTDR00108	Type of target	Research target
TTDR00108	Synonyms	HB-GAM
TTDR00108	Synonyms	HBGF-8
TTDR00108	Synonyms	HBNF-1
TTDR00108	Synonyms	Heparin-binding growth factor 8
TTDR00108	Synonyms	Heparin-binding growth-associated molecule
TTDR00108	Synonyms	Heparin-binding neurite outgrowth promoting factor 1
TTDR00108	Synonyms	OSF-1
TTDR00108	Synonyms	Osteoblast specific factor 1
TTDR00108	Synonyms	PTN
TTDR00108	Disease	Breast cancer
TTDR00108	Disease	Cancer, unspecific
TTDR00108	Function	Heparin binding mitogenic protein. Has neurite extension activity.
TTDR00108	Sequence	MQAQQYQQQRRKFAAAFLAFIFILAAVDTAEAGKKEKPEKKVKKSDCGEWQWSVCVPTSGDCGLGTREGTRTGAECKQTM
TTDR00108	BioChemical Class	Growth factor
TTDR00109	UniProt ID	P55085
TTDR00109	Name	Proteinase activated receptor 2
TTDR00109	Type of target	Research target
TTDR00109	Synonyms	Coagulation factor II receptor-like 1
TTDR00109	Synonyms	PAR-2
TTDR00109	Synonyms	PAR2
TTDR00109	Synonyms	Protease activated receptor 2
TTDR00109	Synonyms	Proteinase-activated receptor-2
TTDR00109	Synonyms	Thrombin receptor-like 1
TTDR00109	Disease	Coronary atherosclerotic lesions
TTDR00109	Disease	Inflammation
TTDR00109	Disease	Inflammatory skin disorder
TTDR00109	Disease	Neurogenic inflammation
TTDR00109	Disease	Pruritus
TTDR00109	Disease	Rheumatoid arthritis, unspecified
TTDR00109	Disease	Tissue injury
TTDR00109	Function	Receptor for trypsin and trypsin-like enzymes coupled to G proteins that stimula
TTDR00109	Sequence	MRSPSAAWLLGAAILLAASLSCSGTIQGTNRSSKGRSLIGKVDGTSHVTGKGVTVETVFSVDEFSASVLTGKLTTVFLPI
TTDR00109	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00109	Pathway	Neuroactive ligand-receptor interaction
TTDR00109	Agonist	ASKH95
TTDR00110	UniProt ID	O00254
TTDR00110	Name	Proteinase activated receptor 3
TTDR00110	Type of target	Research target
TTDR00110	Synonyms	Coagulation factor II receptor-like 2
TTDR00110	Synonyms	PAR-3
TTDR00110	Synonyms	Protease activated receptor 3
TTDR00110	Synonyms	Thrombin receptor-like 2
TTDR00110	Disease	Inflammation
TTDR00110	Function	Receptor for activated thrombin coupled to G proteins that stimulate phosphoinos
TTDR00110	Sequence	MKALIFAAAGLLLLLPTFCQSGMENDTNNLAKPTLPIKTFRGAPPNSFEEFPFSALEGWTGATITVKIKCPEESASHLHV
TTDR00110	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00110	Pathway	Neuroactive ligand-receptor interaction
TTDR00111	UniProt ID	Q96RI0
TTDR00111	Name	Proteinase activated receptor 4
TTDR00111	Type of target	Research target
TTDR00111	Synonyms	Coagulation factor II receptor-like 3
TTDR00111	Synonyms	PAR-4
TTDR00111	Synonyms	Protease activated receptor 4
TTDR00111	Synonyms	Thrombin receptor-like 3
TTDR00111	Disease	Brain inflammation
TTDR00111	Disease	Inflammation
TTDR00111	Function	Receptor for activated thrombin or trypsin coupled to G proteins that stimulate
TTDR00111	Sequence	MWGRLLLWPLVLGFSLSGGTQTPSVYDESGSTGGGDDSTPSILPAPRGYPGQVCANDSDTLELPDSSRALLLGWVPTRLV
TTDR00111	PDB Structure	2ZPK
TTDR00111	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00111	Pathway	Neuroactive ligand-receptor interaction
TTDR00111	Target Validation	TTDR00111
TTDR00111	Inhibitor	SC-47643
TTDR00111	Inhibitor	ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate
TTDR00113	UniProt ID	P12283
TTDR00113	UniProt ID	Q9U8D3
TTDR00113	Name	Adenylosuccinate synthetase
TTDR00113	Type of target	Research target
TTDR00113	Synonyms	AMPSase
TTDR00113	Synonyms	AdSS
TTDR00113	Synonyms	Adenylosuccinate synthase
TTDR00113	Synonyms	IMP--aspartate ligase
TTDR00113	Disease	Malaria
TTDR00113	Function	Plays an important role in the de novo pathway of purine nucleotide biosynthesis
TTDR00113	Sequence	MGNNVVVLGTQWGDEGKGKIVDLLTERAKYVVRYQGGHNAGHTLVINGEKTVLHLIPSGILRENVTSIIGNGVVLSPAAL
TTDR00113	PDB Structure	1ADE; 1ADI; 1CG0; 1CG1; 1CG3; 1CG4; 1CH8; 1P9B
TTDR00113	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00113	EC Number	EC 6.3.4.4
TTDR00113	Inhibitor	(C8-R)-Hydantocidin 5'-Phosphate
TTDR00113	Inhibitor	(C8-S)-Hydantocidin 5'-Phosphate
TTDR00113	Inhibitor	(Carboxyhydroxyamino)Ethanoic Acid
TTDR00113	Inhibitor	6-O-Phosphoryl Inosine Monophosphate
TTDR00113	Inhibitor	Alanosine
TTDR00113	Inhibitor	Beta-Mercaptoethanol
TTDR00113	Inhibitor	Diphosphate
TTDR00113	Inhibitor	Guanosine-5'-Diphosphate
TTDR00113	Inhibitor	Hadacidin
TTDR00113	Inhibitor	Hydantocidin-5'-Monophosphate
TTDR00113	Inhibitor	Hydantocidin-5'-Phosphate
TTDR00113	Inhibitor	Inosinic Acid
TTDR00114	Name	Vasoactive intestinal polypeptide receptor
TTDR00114	Type of target	Research target
TTDR00114	Synonyms	VIP receptor
TTDR00114	Synonyms	VIP-R
TTDR00114	Disease	Breast cancer
TTDR00114	Related US Patent	6,630,124
TTDR00114	Target Validation	TTDR00114
TTDR00114	Inhibitor	Ac-HSDAVFTDQYTRLRKQVAAKKYLQSIKQKRYC
TTDR00115	UniProt ID	O97071
TTDR00115	UniProt ID	P30793
TTDR00115	Name	GTP cyclohydrolase I
TTDR00115	Type of target	Research target
TTDR00115	Synonyms	GTP-CH-I
TTDR00115	Synonyms	Guanosine triphosphate cyclohydrolase I
TTDR00115	Disease	Lesch-Nyhan syndrome
TTDR00115	Disease	Malaria
TTDR00115	Disease	Parkinson's disease
TTDR00115	Function	Isoform gch-1 is the functional enzyme, the potential function of the enzymatica
TTDR00115	Sequence	MYKYTSINKSDKIYETHNMEEKKKKGNNNNFSGLLNNEIDDNNKKEKLKNSISKMYSNHKNRENFNECEKEDLVVIDEKD
TTDR00115	PDB Structure	1FB1
TTDR00115	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDR00115	Pathway	Folate biosynthesis
TTDR00115	Pathway	Metabolic pathways
TTDR00115	EC Number	EC 3.5.4.16
TTDR00115	Inhibitor	8-hydroxyguanine
TTDR00115	Inhibitor	ATP
TTDR00115	Inhibitor	BH4
TTDR00115	Inhibitor	Guanine
TTDR00115	Inhibitor	Guanosine-5'-Triphosphate
TTDR00115	Inhibitor	Isopropyl Alcohol
TTDR00116	UniProt ID	P30305
TTDR00116	Name	M-phase inducer phosphatase 2
TTDR00116	Type of target	Research target
TTDR00116	Synonyms	Cdc25B phosphatase
TTDR00116	Synonyms	Dual specificity phosphatase Cdc25B
TTDR00116	Disease	Cancer, unspecific
TTDR00116	Function	Functions as a dosage-dependent inducer in mitotic control. It is a tyrosine pro
TTDR00116	Sequence	MEVPQPEPAPGSALSPAGVCGGAQRPGHLPGLLLGSHGLLGSPVRAAASSPVTTLTQTMHDLAGLGSETPKSQVGTLLFR
TTDR00116	PDB Structure	1CWR; 1CWS; 1CWT; 1QB0; 1YM9; 1YMD; 1YMK; 1YML
TTDR00116	BioChemical Class	Hydrolases acting on ester bonds
TTDR00116	EC Number	EC 3.1.3.48
TTDR00116	Target Validation	TTDR00116
TTDR00116	Inhibitor	3-isopropyl-4-(phenylamino)naphthalene-1,2-dione
TTDR00116	Inhibitor	3-isopropyl-4-(phenylthio)naphthalene-1,2-dione
TTDR00116	Inhibitor	3-isopropyl-4-phenylnaphthalene-1,2-dione
TTDR00116	Inhibitor	4-(p-toluidino)-3-isopropylnaphthalene-1,2-dione
TTDR00116	Inhibitor	4-ethoxynaphthalene-1,2-dione
TTDR00116	Inhibitor	5,6,7,8-tetrahydroanthracene-1,4-dione
TTDR00116	Inhibitor	6,7-dibromoquinoline-5,8-dione
TTDR00116	Inhibitor	ADOCIAQUINONE B
TTDR00116	Inhibitor	ANTHRAQUINONE
TTDR00116	Inhibitor	Beta-Mercaptoethanol
TTDR00116	Inhibitor	Cysteine Sulfenic Acid
TTDR00116	Inhibitor	Cysteinesulfonic Acid
TTDR00116	Inhibitor	Double Oxidized Cysteine
TTDR00116	Inhibitor	JUGLONE
TTDR00116	Inhibitor	Methyl Mercury Ion
TTDR00116	Inhibitor	NSC-95397
TTDR00117	UniProt ID	Q13233
TTDR00117	Name	Mitogen-activated protein kinase kinase kinase 1
TTDR00117	Type of target	Research target
TTDR00117	Synonyms	MAPK/ERK kinase 1
TTDR00117	Synonyms	MAPK/ERK kinase kinase 1
TTDR00117	Synonyms	MEK kinase 1
TTDR00117	Synonyms	MEKK 1
TTDR00117	Disease	Cancer, unspecific
TTDR00117	Disease	Heart disease, unspecified
TTDR00117	Function	Can phosphorylate and activate mapkk 1 and mapkk 2 (mek1/mek2) which leads to ph
TTDR00117	Sequence	MAAAAGNRASSSGFPGARATSPEAGGGGGALKASSAPAAAAGLLREAGSGGRERADWRRRQLRKVRSVELDQLPEQPLFL
TTDR00117	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00117	Pathway	GnRH signaling pathway
TTDR00117	Pathway	MAPK signaling pathway
TTDR00117	Pathway	Ubiquitin mediated proteolysis
TTDR00117	EC Number	EC 2.7.1.-
TTDR00117	Inhibitor	LLZ16406
TTDR00117	Inhibitor	PD184352
TTDR00117	Inhibitor	PD98059
TTDR00117	Inhibitor	Ro092210
TTDR00117	Inhibitor	U0126
TTDR00118	UniProt ID	P32247
TTDR00118	Name	Bombesin receptor subtype-3
TTDR00118	Type of target	Research target
TTDR00118	Synonyms	BRS-3
TTDR00118	Synonyms	Bombesin
TTDR00118	Synonyms	Orphan receptor bombesin receptor subtype 3
TTDR00118	Disease	Cancer, unspecific
TTDR00118	Disease	Obesity
TTDR00118	Function	Role in sperm cell division, maturation, or function. This receptor mediates its
TTDR00118	Sequence	MAQRQPHSPNQTLISITNDTESSSSVVSNDNTNKGWSGDNSPGIEALCAIYITYAVIISVGILGNAILIKVFFKTKSMQT
TTDR00118	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00118	Pathway	Neuroactive ligand-receptor interaction
TTDR00118	Target Validation	TTDR00118
TTDR00118	Inhibitor	Universal ligand
TTDR00118	Inhibitor	[(N4-Bzdig)0]BB(7-14)
TTDR00119	UniProt ID	O43612
TTDR00119	Name	Orexin
TTDR00119	Type of target	Clinical trial target
TTDR00119	Synonyms	Hcrt
TTDR00119	Synonyms	Hypocretin
TTDR00119	Disease	Obesity
TTDR00119	Function	Neuropeptides that play a significant role in the regulation of food intake and
TTDR00119	Sequence	MNLPSTKVSWAAVTLLLLLLLLPPALLSSGAAAQPLPDCCRQKTCSCRLYELLHGAGNHAAGILTLGKRRSGPPGLQGRL
TTDR00119	PDB Structure	1CQ0; 1R02; 1UVQ; 1WSO
TTDR00119	Inhibitor	Pyroglutamic Acid
TTDR00120	Name	Dopamine D2-like receptor
TTDR00120	Type of target	Research target
TTDR00120	Disease	Erectile dysfunction
TTDR00120	Disease	Parkinson's disease
TTDR00120	Agonist	A 77636
TTDR00120	Agonist	Indolophenanthridine
TTDR00120	Agonist	Quinelorane
TTDR00120	Agonist	SKF 38393
TTDR00122	Name	Cyclophilin
TTDR00122	Type of target	Clinical trial target
TTDR00122	Synonyms	Cyclosporin A-binding protein
TTDR00122	Synonyms	PPIase
TTDR00122	Synonyms	Peptidyl-prolyl cis-trans isomerase
TTDR00122	Synonyms	Peptidylprolyl isomerase
TTDR00122	Synonyms	Rotamase
TTDR00122	Disease	Cancer, unspecific
TTDR00122	EC Number	EC 5.2.1.8
TTDR00122	Drug(s)	DEB025
TTDR00122	Drug(s)	Debio 025
TTDR00122	Drug(s)	SCY-635
TTDR00122	Drug(s)	SCY-641
TTDR00122	Inhibitor	Debio 025
TTDR00122	Inhibitor	SCY-635
TTDR00122	Inhibitor	SCY-641
TTDR00123	Name	mRNA of Protein kinase C, alpha type
TTDR00123	Type of target	Research target
TTDR00123	Disease	Cancer, unspecific
TTDR00123	Antisense	ISIS 3521
TTDR00124	Name	mRNA of bcl2
TTDR00124	Type of target	Research target
TTDR00124	Disease	Cancer, unspecific
TTDR00124	Antisense	G3139
TTDR00124	Antisense	G3139 + Dacarbazine
TTDR00124	Antisense	G3139 + Dexamethasone
TTDR00124	Antisense	G3139 + Fludarabine
TTDR00124	Antisense	G3139 + G-CSF
TTDR00124	Antisense	G3139 + Irinotecan
TTDR00124	Antisense	G3139 + Paclitaxel
TTDR00124	Antisense	G3139 + Thalidomide
TTDR00124	Antisense	G3139 + cytarabine (ARA-C)
TTDR00128	Name	mRNA of protein kinase C
TTDR00128	Type of target	Research target
TTDR00128	Disease	Cancer, unspecific
TTDR00128	Inhibitor	ISIS 3521
TTDR00129	Name	mRNA of Raf
TTDR00129	Type of target	Research target
TTDR00129	Disease	Lung cancer
TTDR00129	Inhibitor	ISIS 5132
TTDR00129	Inhibitor	ISIS 5132 (CGP 69846A)
TTDR00131	Name	Melanin-concentrating hormone receptor
TTDR00131	Type of target	Research target
TTDR00131	Synonyms	MCH receptor
TTDR00131	Disease	Obesity
TTDR00131	Related US Patent	6,472,394
TTDR00131	Related US Patent	6,664,273
TTDR00131	Drug(s)	IDDB-41331
TTDR00131	Antagonist	IDDB-41331
TTDR00133	UniProt ID	P13774
TTDR00133	UniProt ID	Q07251
TTDR00133	Name	L-lactate dehydrogenase
TTDR00133	Type of target	Research target
TTDR00133	Synonyms	LDH
TTDR00133	Synonyms	LDH1
TTDR00133	Synonyms	Lactate dehydrogenase
TTDR00133	Disease	Malaria
TTDR00133	Disease	Toxoplasmic encephalitis
TTDR00133	Sequence	MKISLTSARQLARDILAAQQVPADIADDVAEHLVESDRCGYISHGLSILPNYRTALDGHSVNPQGRAKCVLDQGTLMVFD
TTDR00133	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00133	Pathway	Cysteine metabolism
TTDR00133	Pathway	Glycolysis / Gluconeogenesis
TTDR00133	Pathway	Propanoate metabolism
TTDR00133	Pathway	Pyruvate metabolism
TTDR00133	EC Number	EC 1.1.1.27
TTDR00133	Inhibitor	3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID
TTDR00133	Inhibitor	3-Hydroxyisoxazole-4-Carboxylic Acid
TTDR00133	Inhibitor	4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid
TTDR00133	Inhibitor	4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid
TTDR00133	Inhibitor	Naphthalene-2,6-disulfonic acid
TTDR00133	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00133	Inhibitor	Oxalate Ion
TTDR00133	Inhibitor	Oxamic Acid
TTDR00134	Name	P185HER-2
TTDR00134	Type of target	Research target
TTDR00134	Disease	Breast cancer
TTDR00134	Disease	Ovarian cancer
TTDR00134	Binder	TA1-RTA
TTDR00135	UniProt ID	P42892
TTDR00135	Name	Endothelin-converting enzyme 1
TTDR00135	Type of target	Research target
TTDR00135	Synonyms	ECE-1
TTDR00135	Disease	Alzheimer's disease
TTDR00135	Disease	Cardiovascular disease, unspecified
TTDR00135	Function	Converts big endothelin-1 to endothelin-1.
TTDR00135	Sequence	MRGVWPPPVSALLSALGMSTYKRATLDEEDLVDSLSEGDAYPNGLQVNFHSPRSGQRCWAARTQVEKRLVVLVVLLAAGL
TTDR00135	PDB Structure	3DWB
TTDR00135	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00135	EC Number	EC 3.4.24.71
TTDR00135	Target Validation	TTDR00135
TTDR00135	Inhibitor	5-(2-hydroxyethyl)nonane-1,9-diol
TTDR00135	Inhibitor	CGS 35066
TTDR00135	Inhibitor	LY-292223
TTDR00135	Inhibitor	PO3 2-Ile-Trp-O-3K
TTDR00135	Inhibitor	PO3 2-Leu-Nal-O-3K
TTDR00135	Inhibitor	PO3 2-Leu-Trp-O-3K
TTDR00135	Inhibitor	PO3 2-Nle-Trp-O-3K
TTDR00135	Inhibitor	SCH-54470
TTDR00135	Inhibitor	SLV306
TTDR00136	UniProt ID	O60344
TTDR00136	Name	Endothelin-converting enzyme 2
TTDR00136	Type of target	Research target
TTDR00136	Synonyms	ECE-2
TTDR00136	Disease	Cardiovascular disease, unspecified
TTDR00136	Function	Converts big endothelin-1 to endothelin-1 (by similarity).
TTDR00136	Sequence	MASPGAGRAPPELPERNCGYREVEYWDQRYQGAADSAPYDWFGDFSSFRALLEPELRPEDRILVLGCGNSALSYELFLGG
TTDR00136	PDB Structure	2PXX
TTDR00136	BioChemical Class	Protease
TTDR00136	EC Number	EC 3.4.24.71
TTDR00136	Inhibitor	CGS 35066
TTDR00136	Inhibitor	SLV306
TTDR00137	UniProt ID	P04968
TTDR00137	Name	Threonine deaminase
TTDR00137	Type of target	Research target
TTDR00137	Synonyms	Putative threonine dehydratase
TTDR00137	Disease	Vitamin B6 deficiency
TTDR00137	Function	Catalyzes the formation of alpha-ketobutyrate from threonine in a two-step react
TTDR00137	Sequence	MADSQPLSGAPEGAEYLRAVLRAPVYEAAQVTPLQKMEKLSSRLDNVILVKREDRQPVHSFKLRGAYAMMAGLTEEQKAH
TTDR00137	PDB Structure	1TDJ
TTDR00137	BioChemical Class	Carbon-nitrogen lyases
TTDR00137	Pathway	Glycine, serine and threonine metabolism
TTDR00137	Pathway	Metabolic pathways
TTDR00137	Pathway	Valine, leucine and isoleucine biosynthesis
TTDR00137	EC Number	EC 4.3.1.19
TTDR00138	UniProt ID	P22301
TTDR00138	Name	Interleukin-10
TTDR00138	Type of target	Research target
TTDR00138	Synonyms	CSIF
TTDR00138	Synonyms	Cytokine synthesis inhibitory factor
TTDR00138	Synonyms	IL-10
TTDR00138	Disease	Group B Streptococcus arthritis
TTDR00138	Disease	Inflammatory diseases
TTDR00138	Disease	Lupus erythematosus
TTDR00138	Disease	Osteoarthritis
TTDR00138	Disease	Systemic lupus erythematosus
TTDR00138	Function	Inhibits the synthesis of a number of cytokines, including ifn-gamma, il-2, il-3
TTDR00138	Sequence	MHSSALLCCLVLLTGVRASPGQGTQSENSCTHFPGNLPNMLRDLRDAFSRVKTFFQMKDQLDNLLLKESLLEDFKGYLGC
TTDR00138	PDB Structure	1ILK; 1INR; 1J7V; 1LK3; 1Y6K; 2H24; 2ILK
TTDR00138	Pathway	Allograft rejection
TTDR00138	Pathway	Asthma
TTDR00138	Pathway	Autoimmune thyroid disease
TTDR00138	Pathway	Cytokine-cytokine receptor interaction
TTDR00138	Pathway	Jak-STAT signaling pathway
TTDR00138	Pathway	Systemic lupus erythematosus
TTDR00138	Pathway	T cell receptor signaling pathway
TTDR00138	Activator	Ankinara
TTDR00138	Antibody	Anti-interleukin-10 antibodies
TTDR00141	UniProt ID	P01585
TTDR00141	Name	Interleukin-2
TTDR00141	Type of target	Research target
TTDR00141	Synonyms	Aldesleukin
TTDR00141	Synonyms	IL-2
TTDR00141	Synonyms	T-cell growth factor
TTDR00141	Synonyms	TCGF
TTDR00141	Disease	Rheumatoid arthritis, unspecified
TTDR00141	Function	Produced by t-cells in response to antigenic or mitogenic stimulation, this prot
TTDR00141	Sequence	MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLE
TTDR00141	PDB Structure	1ILM; 1ILN; 1IRL; 1M47; 1M48; 1M49; 1M4A; 1M4B
TTDR00141	Inhibitor	SP2456
TTDR00141	Inhibitor	SP4160
TTDR00142	Name	DNA topoisomerase
TTDR00142	Type of target	Research target
TTDR00142	Synonyms	TraE
TTDR00142	Disease	Cancer, unspecific
TTDR00142	EC Number	EC 5.99.1.2
TTDR00142	Target Validation	TTDR00142
TTDR00142	Inhibitor	2-Amino-6-(indan-5-ylamino)-3H-pyrimidin-4-one
TTDR00142	Inhibitor	3-(9-Acridinylamino)-5-(hydroxymethyl)aniline (AHMA)
TTDR00142	Inhibitor	5-Bromo-6-p-tolylamino-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	6-(3-Bromo-phenylamino)-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	6-(3-Ethyl-phenylamino)-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	6-(3-Iodo-phenylamino)-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	6-(Indan-5-ylamino)-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	6-(Naphthalen-2-ylamino)-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	6-Benzylamino-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	6-Benzylamino-5-bromo-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	6-Benzylamino-5-iodo-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	6-p-Tolylamino-1H-pyrimidine-2,4-dione
TTDR00142	Inhibitor	AHMA
TTDR00142	Inhibitor	N*4*-Benzyl-6-chloro-pyrimidine-2,4-diamine
TTDR00142	Inhibitor	TOPOSTATIN
TTDR00145	Name	Prostaglandin E receptor
TTDR00145	Type of target	Research target
TTDR00145	Synonyms	EP
TTDR00145	Disease	Erectile dysfunction
TTDR00145	Related US Patent	6,462,080
TTDR00145	Related US Patent	6,545,045
TTDR00145	Related US Patent	6,627,656
TTDR00146	UniProt ID	Q9Y6R4
TTDR00146	Name	Mitogen-activated protein kinase kinase kinase 4
TTDR00146	Type of target	Research target
TTDR00146	Synonyms	MAP three kinase 1
TTDR00146	Synonyms	MAPK/ERK kinase kinase 4
TTDR00146	Synonyms	MEK kinase 4
TTDR00146	Synonyms	MEKK 4
TTDR00146	Disease	Breast cancer
TTDR00146	Disease	Melanoma
TTDR00146	Disease	Ovarian cancer
TTDR00146	Disease	Pancreatic cancer
TTDR00146	Disease	Prostate cancer
TTDR00146	Function	Activates the csbp2, p38 and jnk mapk pathways, but not the erk pathway. Specifi
TTDR00146	Sequence	MREAAAALVPPPAFAVTPAAAMEEPPPPPPPPPPPPEPETESEPECCLAARQEGTLGDSACKSPESDLEDFSDETNTENL
TTDR00146	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00146	Pathway	GnRH signaling pathway
TTDR00146	Pathway	MAPK signaling pathway
TTDR00146	EC Number	EC 2.7.1.-
TTDR00147	UniProt ID	O14733
TTDR00147	Name	Dual specificity mitogen-activated protein kinase kinase 7
TTDR00147	Type of target	Research target
TTDR00147	Synonyms	C-Jun N-terminal kinase kinase 2
TTDR00147	Synonyms	JNK activating kinase 2
TTDR00147	Synonyms	JNK kinase 2
TTDR00147	Synonyms	JNKK 2
TTDR00147	Synonyms	MAP kinase kinase 7
TTDR00147	Synonyms	MAPK/ERK kinase 7
TTDR00147	Synonyms	MAPKK 7
TTDR00147	Synonyms	MKK7
TTDR00147	Synonyms	Mitogen-activated protein kinase kinase 7
TTDR00147	Disease	Cancer, unspecific
TTDR00147	Disease	Inflammatory diseases
TTDR00147	Disease	Prostate cancer
TTDR00147	Function	Dual specificity kinase that activates the jun kinases mapk8 (jnk1) and mapk9 (j
TTDR00147	Sequence	MAASSLEQKLSRLEAKLKQENREARRRIDLNLDISPQRPRPTLQLPLANDGGSRSPSSESSPQHPTPPARPRHMLGLPST
TTDR00147	PDB Structure	2DYL
TTDR00147	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00147	Pathway	ErbB signaling pathway
TTDR00147	Pathway	Fc epsilon RI signaling pathway
TTDR00147	Pathway	GnRH signaling pathway
TTDR00147	Pathway	MAPK signaling pathway
TTDR00147	Pathway	T cell receptor signaling pathway
TTDR00147	Pathway	Toll-like receptor signaling pathway
TTDR00147	EC Number	EC 2.7.1.-
TTDR00147	Inhibitor	U-0126
TTDR00148	UniProt ID	Q02750
TTDR00148	Name	Dual specificity mitogen-activated protein kinase kinase 1
TTDR00148	Type of target	Successful target
TTDR00148	Synonyms	ERK activator kinase 1
TTDR00148	Synonyms	MAP kinase kinase 1
TTDR00148	Synonyms	MAPK/ERK kinase 1
TTDR00148	Synonyms	MAPKK 1
TTDR00148	Synonyms	MEK1
TTDR00148	Synonyms	Mitogen-activated protein kinase kinase 1
TTDR00148	Disease	Breast cancer
TTDR00148	Disease	Prostate cancer
TTDR00148	Function	Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue
TTDR00148	Sequence	MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGG
TTDR00148	PDB Structure	1S9J; 2P55; 3EQB; 3EQC; 3EQD; 3EQF; 3EQG; 3EQH
TTDR00148	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00148	Pathway	Acute myeloid leukemia
TTDR00148	Pathway	B cell receptor signaling pathway
TTDR00148	Pathway	Bladder cancer
TTDR00148	Pathway	Chemokine signaling pathway
TTDR00148	Pathway	Chronic myeloid leukemia
TTDR00148	Pathway	Colorectal cancer
TTDR00148	Pathway	Endometrial cancer
TTDR00148	Pathway	ErbB signaling pathway
TTDR00148	Pathway	Fc epsilon RI signaling pathway
TTDR00148	Pathway	Focal adhesion
TTDR00148	Pathway	Gap junction
TTDR00148	Pathway	Glioma
TTDR00148	Pathway	GnRH signaling pathway
TTDR00148	Pathway	Insulin signaling pathway
TTDR00148	Pathway	Long-term depression
TTDR00148	Pathway	Long-term potentiation
TTDR00148	Pathway	MAPK signaling pathway
TTDR00148	Pathway	Melanogenesis
TTDR00148	Pathway	Melanoma
TTDR00148	Pathway	Natural killer cell mediated cytotoxicity
TTDR00148	Pathway	Non-small cell lung cancer
TTDR00148	Pathway	Pancreatic cancer
TTDR00148	Pathway	Pathways in cancer
TTDR00148	Pathway	Prostate cancer
TTDR00148	Pathway	Regulation of actin cytoskeleton
TTDR00148	Pathway	Renal cell carcinoma
TTDR00148	Pathway	T cell receptor signaling pathway
TTDR00148	Pathway	Thyroid cancer
TTDR00148	Pathway	Toll-like receptor signaling pathway
TTDR00148	Pathway	VEGF signaling pathway
TTDR00148	Pathway	Vascular smooth muscle contraction
TTDR00148	EC Number	EC 2.7.1.-
TTDR00148	Related US Patent	6,319,955
TTDR00148	Target Validation	TTDR00148
TTDR00148	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDR00148	Inhibitor	4,5-Dibromo-1H-pyrrole-2-carboxylic acid amide
TTDR00148	Inhibitor	5-phenylamino-4-cyano-3-hydroxy-isothiazole
TTDR00148	Inhibitor	ALDISIN
TTDR00148	Inhibitor	AZD-0530
TTDR00148	Inhibitor	DEBROMOHYMENIALDISINE
TTDR00148	Inhibitor	K-252a
TTDR00148	Inhibitor	OROIDIN
TTDR00148	Inhibitor	PD-98059
TTDR00148	Inhibitor	REVERSINE
TTDR00148	Inhibitor	U-0126
TTDR00149	UniProt ID	Q13163
TTDR00149	Name	Dual specificity mitogen-activated protein kinase kinase 5
TTDR00149	Type of target	Research target
TTDR00149	Synonyms	MAP kinase kinase 5
TTDR00149	Synonyms	MAPK/ERK kinase 5
TTDR00149	Synonyms	MAPKK 5
TTDR00149	Synonyms	Mitogen-activated protein kinase kinase 5
TTDR00149	Disease	Breast cancer
TTDR00149	Function	Interacts specifically with erk5, and not with another map kinase like p38. Is n
TTDR00149	Sequence	MLWLALGPFPAMENQVLVIRIKIPNSGAVDWTVHSGPQLLFRDVLDVIGQVLPEATTTAFEYEDEDGDRITVRSDEEMKA
TTDR00149	PDB Structure	2NPT; 2O2V
TTDR00149	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00149	Pathway	Gap junction
TTDR00149	Pathway	MAPK signaling pathway
TTDR00149	EC Number	EC 2.7.1.-
TTDR00150	Name	Mitogen-activated protein kinase kinase
TTDR00150	Type of target	Research target
TTDR00150	Disease	Breast cancer
TTDR00150	Disease	Lung cancer
TTDR00150	EC Number	EC 2.7.1.-
TTDR00150	Inhibitor	PD98059
TTDR00150	Inhibitor	U0126
TTDR00151	UniProt ID	P00742
TTDR00151	Name	Coagulation factor X
TTDR00151	Type of target	Research target
TTDR00151	Synonyms	Factor X
TTDR00151	Synonyms	Stuart factor
TTDR00151	Synonyms	Stuart-Prower factor
TTDR00151	Disease	Thrombosis
TTDR00151	Disease	Thrombotic disease
TTDR00151	Function	Factor xa is a vitamin k-dependent glycoprotein that converts prothrombin to thr
TTDR00151	Sequence	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEF
TTDR00151	PDB Structure	1C5M; 1EZQ; 1F0R; 1F0S; 1FAX; 1FJS; 1FXY; 1G2L
TTDR00151	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00151	Pathway	Complement and coagulation cascades
TTDR00151	EC Number	EC 3.4.21.6
TTDR00151	Target Validation	TTDR00151
TTDR00151	Inhibitor	3-chlorophenyl 2-oxo-2H-chromene-3-carboxylate
TTDR00151	Inhibitor	4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine
TTDR00151	Inhibitor	5-desgalloylstachyurin
TTDR00151	Inhibitor	Azaphenylalanine derivative
TTDR00151	Inhibitor	BAY-59-7939
TTDR00151	Inhibitor	BMS-269223
TTDR00151	Inhibitor	BMS-344577
TTDR00151	Inhibitor	BMS-740808
TTDR00151	Inhibitor	Beta-Hydroxy Aspartic Acid
TTDR00151	Inhibitor	CASUARIIN
TTDR00151	Inhibitor	D-Pro-Phe-Arg chloromethyl ketone
TTDR00151	Inhibitor	ERIBAXABAN
TTDR00151	Inhibitor	Gamma-Carboxy-Glutamic Acid
TTDR00151	Inhibitor	MELAGATRAN
TTDR00151	Inhibitor	PEDUNCULAGIN
TTDR00151	Inhibitor	PhSO2-Gly-(Me-Gly)-Arg-(2-thiazole)
TTDR00151	Inhibitor	RAZAXABAN
TTDR00151	Inhibitor	RAZAXABAN HYDROCHLORIDE
TTDR00151	Inhibitor	RWJ-671818
TTDR00151	Inhibitor	SN-429
TTDR00151	Inhibitor	Tissue factor pathway inhibitor (TFPI)
TTDR00151	Inhibitor	ZK-810388
TTDR00151	Inhibitor	ZK-813039
TTDR00151	Inhibitor	ZK-814048
TTDR00151	Inhibitor	penta-O-galloyl-beta-glucoside
TTDR00151	Inhibitor	tellimagrandin II
TTDR00152	UniProt ID	P14635
TTDR00152	Name	G2/mitotic-specific cyclin B1
TTDR00152	Type of target	Research target
TTDR00152	Synonyms	Cyclin B1
TTDR00152	Disease	Cardiovascular disease, unspecified
TTDR00152	Function	Essential for the control of the cell cycle at the g2/m (mitosis) transition.
TTDR00152	Sequence	MALRVTRNSKINAENKAKINMAGAKRVPTAPAATSKPGLRPRTALGDIGNKVSEQLQAKMPMKKEAKPSATGKVIDKKLP
TTDR00152	PDB Structure	2B9R; 2JGZ
TTDR00152	Pathway	Cell cycle
TTDR00152	Pathway	p53 signaling pathway
TTDR00152	Target Validation	TTDR00152
TTDR00152	Inhibitor	3,4-bis(indol-3-yl)maleimide derivative
TTDR00152	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDR00152	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDR00152	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDR00152	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDR00152	Inhibitor	4-(Quinolin-3-yl)-N-p-tolylpyrimidin-2-amine
TTDR00152	Inhibitor	4-(Quinolin-4-yl)-N-p-tolylpyrimidin-2-amine
TTDR00152	Inhibitor	AZAKENPAULLONE
TTDR00152	Inhibitor	GF-109203
TTDR00152	Inhibitor	KENPAULLONE
TTDR00152	Inhibitor	RO-316233
TTDR00152	Inhibitor	Thieno analogue of kenpaullone
TTDR00154	UniProt ID	P09848
TTDR00154	Name	Lactase-phlorizin hydrolase
TTDR00154	Type of target	Research target
TTDR00154	Synonyms	Glycosyl-hydrolase
TTDR00154	Synonyms	Lactase-glycosylceramidase
TTDR00154	Disease	Bacterial infections
TTDR00154	Function	Lph splits lactose in the small intestine.
TTDR00154	Sequence	MELSWHVVFIALLSFSCWGSDWESDRNFISTAGPLTNDLLHNLSGLLGDQSSNFVAGDKDMYVCHQPLPTFLPEYFSSLH
TTDR00154	BioChemical Class	Transmembrane protein
TTDR00154	Pathway	Galactose metabolism
TTDR00154	Target Validation	TTDR00154
TTDR00154	Inhibitor	2,5-dideoxy-2,5-imino-D-altritol
TTDR00154	Inhibitor	2,5-dideoxy-2,5-imino-dl-glycero-D-manno-heptitol
TTDR00154	Inhibitor	2-Deoxy-2fluoro-Glucose
TTDR00154	Inhibitor	Alpha-D-Mannose
TTDR00154	Inhibitor	D-Gluconhydroximo-1,5-Lactam
TTDR00154	Inhibitor	ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE
TTDR00154	Inhibitor	Fucose
TTDR00154	Inhibitor	Gluconolactone
TTDR00154	Inhibitor	Hyacinthacine B3
TTDR00154	Inhibitor	Nojirimycine Tetrazole
TTDR00154	Inhibitor	Xylopyranose
TTDR00155	Name	5-hydroxytryptamine 1 receptor
TTDR00155	Type of target	Research target
TTDR00155	Synonyms	5-HT 1 receptor
TTDR00155	Synonyms	5-HT1 receptor
TTDR00155	Synonyms	5-hydroxytryptamine receptor 1
TTDR00155	Synonyms	Serotonin receptor
TTDR00155	Synonyms	Serotonin receptor 1
TTDR00155	Disease	Migraine
TTDR00155	Related US Patent	6,380,233
TTDR00155	Related US Patent	6,387,941
TTDR00155	Related US Patent	6,410,739
TTDR00155	Related US Patent	6,423,731
TTDR00155	Related US Patent	6,436,957
TTDR00155	Related US Patent	6,448,268
TTDR00155	Related US Patent	6,465,500
TTDR00155	Antagonist	Cyanopindolol
TTDR00155	Agonist	8-OH-DPAT
TTDR00155	Agonist	RU 24969
TTDR00155	Agonist	Sumatriptan
TTDR00157	UniProt ID	P34969
TTDR00157	Name	5-hydroxytryptamine 7 receptor
TTDR00157	Type of target	Research target
TTDR00157	Synonyms	5-HT-7
TTDR00157	Synonyms	5-HT-X
TTDR00157	Synonyms	5-HT7 receptor
TTDR00157	Synonyms	5HT7
TTDR00157	Synonyms	Serotonin receptor
TTDR00157	Synonyms	Serotonin receptor 7
TTDR00157	Disease	Migraine
TTDR00157	Disease	Neuropsychiatric disorders
TTDR00157	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDR00157	Sequence	MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVE
TTDR00157	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00157	Pathway	Calcium signaling pathway
TTDR00157	Pathway	Neuroactive ligand-receptor interaction
TTDR00157	Related US Patent	6,440,988
TTDR00157	Related US Patent	6,486,173
TTDR00157	Related US Patent	6,630,469
TTDR00157	Related US Patent	6,660,751
TTDR00157	Target Validation	TTDR00157
TTDR00157	Inhibitor	(+/-)-nantenine
TTDR00157	Inhibitor	(2-biphenyl-3-yl-ethyl)-dimethyl-amine
TTDR00157	Inhibitor	(R)-8-phenyl-N,N-dipropylchroman-3-amine
TTDR00157	Inhibitor	1-(3-(pentafluorosulfanyl)phenyl)propan-2-amine
TTDR00157	Inhibitor	1-Naphthalen-1-yl-piperazine
TTDR00157	Inhibitor	2-(1-o-tolyl-1H-pyrrol-3-yl)ethanamine
TTDR00157	Inhibitor	2-(2'-methyl-biphenyl-3-yl)-ethylamine
TTDR00157	Inhibitor	2-(2-Bromophenoxy)-N,N-dimethylethanamine
TTDR00157	Inhibitor	2-(2-Bromophenylthio)-N,N-dimethylethanamine
TTDR00157	Inhibitor	2-(Biphenyl-2-yloxy)-N,N-dimethylethanamine
TTDR00157	Inhibitor	2-(Biphenyl-2-ylthio)-N,N-dimethylethanamine
TTDR00157	Inhibitor	2-[1-(2-Chloro-phenyl)-1H-pyrrol-2-yl]-ethylamine
TTDR00157	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDR00157	Inhibitor	5,6-dichloro-3,4-dihydroquinazolin-2-amine
TTDR00157	Inhibitor	5-chloro-3,4-dihydroquinazolin-2-amine
TTDR00157	Inhibitor	5-chloro-4-ethyl-3,4-dihydroquinazolin-2-amine
TTDR00157	Inhibitor	5-chloro-4-methyl-3,4-dihydroquinazolin-2-amine
TTDR00157	Inhibitor	8-methoxy-4-methyl-3,4-dihydroquinazolin-2-amine
TTDR00157	Inhibitor	Disulergine
TTDR00157	Inhibitor	FALCARINDIOL
TTDR00157	Inhibitor	IMPERATORIN
TTDR00157	Inhibitor	L-745870
TTDR00157	Inhibitor	MESULERGINE
TTDR00157	Inhibitor	METHIOTHEPIN
TTDR00157	Inhibitor	N,N-dimethyl-2-(2'-methylbiphenyl-3-yl)ethanamine
TTDR00157	Inhibitor	SB-258719
TTDR00157	Inhibitor	SB-258741
TTDR00157	Inhibitor	SB-269970
TTDR00157	Inhibitor	SB-271046
TTDR00157	Inhibitor	SB-656104
TTDR00157	Inhibitor	SEROTONIN
TTDR00157	Inhibitor	SPIPERONE
TTDR00157	Inhibitor	UCM-5600
TTDR00157	Inhibitor	WAY-181187
TTDR00157	Inhibitor	WAY-208466
TTDR00157	Inhibitor	WAY-466
TTDR00157	Inhibitor	p-hydroxyphenethyl trans-ferulate
TTDR00157	Antagonist	SB 269970-A
TTDR00157	Antagonist	SB 656104-A
TTDR00158	UniProt ID	A0QSR6
TTDR00158	UniProt ID	P29743
TTDR00158	UniProt ID	P94967
TTDR00158	Name	Alanine racemase, biosynthetic
TTDR00158	Type of target	Research target
TTDR00158	Synonyms	AlaR
TTDR00158	Synonyms	Alanine racemase
TTDR00158	Synonyms	Alr
TTDR00158	Synonyms	D-alanine racemase
TTDR00158	Disease	Bacterial infections
TTDR00158	Disease	Tuberculosis
TTDR00158	Disease	Vitamin B6 deficiency
TTDR00158	Function	Provides the d-alanine required for cell wall biosynthesis.
TTDR00158	Sequence	MQAATVVINRRALRHNLQRLRELAPASKMVAVVKANAYGHGLLETARTLPDADAFGVARLEEALRLRAGGITKPVLLLEG
TTDR00158	PDB Structure	2RJG; 2RJH; 3B8T; 3B8U; 3B8V; 3B8W
TTDR00158	BioChemical Class	Racemases and Epimerases
TTDR00158	EC Number	EC 5.1.1.1
TTDR00158	Inhibitor	(R)-4-Amino-Isoxazolidin-3-One
TTDR00158	Inhibitor	3-fluorovinylglycine
TTDR00158	Inhibitor	Acetate Ion
TTDR00158	Inhibitor	Lysine Nz-Carboxylic Acid
TTDR00158	Inhibitor	N-(5'-Phosphopyridoxyl)-D-Alanine
TTDR00158	Inhibitor	Propanoic Acid
TTDR00158	Inhibitor	Propionate
TTDR00158	Inhibitor	Pyridoxamine-5'-Phosphate
TTDR00158	Inhibitor	Pyridoxyl-Alanine-5-Phosphate
TTDR00158	Inhibitor	Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate
TTDR00158	Cofactor	Pyridoxal 5'-phosphate
TTDR00159	UniProt ID	P41252
TTDR00159	Name	Isoleucyl-tRNA synthetase, cytoplasmic (human)
TTDR00159	Type of target	Research target
TTDR00159	Synonyms	IRS
TTDR00159	Synonyms	IleRS
TTDR00159	Synonyms	Isoleucine--tRNA ligase
TTDR00159	Disease	Autoimmune diseases
TTDR00159	Sequence	MLQQVPENINFPAEEEKILEFWTEFNCFQECLKQSKHKPKFTFYDGPPFATGLPHYGHILAGTIKDIVTRYAHQSGFHVD
TTDR00159	BioChemical Class	Ligases forming carbon-oxygen bonds
TTDR00159	EC Number	EC 6.1.1.5
TTDR00159	Inhibitor	Reveromycin A
TTDR00161	UniProt ID	Q8DZJ7
TTDR00161	Name	Platelet activating factor
TTDR00161	Type of target	Research target
TTDR00161	Synonyms	PAF
TTDR00161	Disease	Acute pancreatitis
TTDR00161	Disease	Allergic diseases
TTDR00161	Disease	Allergic rhinitis, unspecified
TTDR00161	Disease	Asthma
TTDR00161	Disease	Cerebral edema
TTDR00161	Disease	Cerebral ischemia
TTDR00161	Disease	Gut barrier dysfunction
TTDR00161	Disease	Hepatic warm ischemic injury
TTDR00161	Disease	Hypotension
TTDR00161	Disease	Inflammatory diseases
TTDR00161	Disease	Ischemia reperfusion injuries
TTDR00161	Disease	Male infertility (asthenospermia)
TTDR00161	Disease	Mild pancreatitis
TTDR00161	Disease	Myocardial ischemia and reperfusion injury
TTDR00161	Disease	Necrotizing enterocolitis
TTDR00161	Disease	Ocular inflammation
TTDR00161	Disease	Rheumatoid arthritis, unspecified
TTDR00161	Disease	Septic shock
TTDR00161	Disease	Shock (hemorrhagic)
TTDR00161	Disease	Stroke
TTDR00161	Sequence	MLEVIDKALRDYQMKREQFFEINNQTVQEGAIVFTGDSIVEFFPLKKHLGRDYPLVNRGVAGSDTYWLLENLRTQVWELL
TTDR00161	Inhibitor	ABT-491
TTDR00161	Inhibitor	BN 50730
TTDR00161	Inhibitor	BN50727
TTDR00161	Inhibitor	BN50739
TTDR00161	Inhibitor	BN52021
TTDR00161	Inhibitor	CL-184005
TTDR00161	Inhibitor	CV 6209
TTDR00161	Inhibitor	E-6123
TTDR00161	Inhibitor	F-0401
TTDR00161	Inhibitor	Lexipafant
TTDR00161	Inhibitor	Pinusolide
TTDR00161	Inhibitor	SCH 44643
TTDR00161	Inhibitor	SRI 63-441
TTDR00161	Inhibitor	Sch 37370
TTDR00161	Inhibitor	TCV-309
TTDR00161	Inhibitor	UR-12670
TTDR00161	Inhibitor	WEB 2086
TTDR00164	UniProt ID	P30926
TTDR00164	Name	Neuronal acetylcholine receptor protein, beta-4 chain
TTDR00164	Type of target	Research target
TTDR00164	Synonyms	Beta-4 nAChR
TTDR00164	Disease	Specific cognitive deficits associated with aging and neurological diseases
TTDR00164	Function	After binding acetylcholine, the achr responds by an extensive change in conform
TTDR00164	Sequence	MRRAPSLVLFFLVALCGRGNCRVANAEEKLMDDLLNKTRYNNLIRPATSSSQLISIKLQLSLAQLISVNEREQIMTTNVW
TTDR00164	PDB Structure	2ASG
TTDR00164	BioChemical Class	Ion transport
TTDR00164	Target Validation	TTDR00164
TTDR00164	Inhibitor	(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol
TTDR00164	Inhibitor	(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol
TTDR00164	Inhibitor	15-nor-18-Methoxycornaridine
TTDR00164	Inhibitor	18-Dimethylaminocoronaridine
TTDR00164	Inhibitor	18-Methylaminocoronaridine
TTDR00164	Inhibitor	18-methoxycoronaridinate 2-Hydroxyethylamide
TTDR00164	Inhibitor	18-methoxycoronaridinate 2-methoxyethylamide
TTDR00164	Inhibitor	2-Acetylaminoethyl 18-methoxycoronaridinate
TTDR00164	Inhibitor	2-Hydroxyethyl 18-methoxycoronaridinate
TTDR00164	Inhibitor	2-Methoxyethyl 18-methoxycoronaridinate
TTDR00164	Inhibitor	CYTISINE
TTDR00164	Inhibitor	GCCSNPVCHLEHSNLC*
TTDR00164	Inhibitor	HOMOEPIBATIDINE
TTDR00164	Inhibitor	N,N-Dimethylaminoethyl 18-methoxycoronaridinate
TTDR00164	Agonist	SIB-1553A
TTDR00165	UniProt ID	P95114
TTDR00165	Name	D-alanine--D-alanine ligase
TTDR00165	Type of target	Research target
TTDR00165	Synonyms	D-Ala-D-Ala ligase
TTDR00165	Synonyms	D-alanine:D-alanine ligase
TTDR00165	Synonyms	D-alanylalanine synthetase
TTDR00165	Disease	Bacterial infections
TTDR00165	Function	Cell wall formation (by similarity).
TTDR00165	Sequence	MSANDRRDRRVRVAVVFGGRSNEHAISCVSAGSILRNLDSRRFDVIAVGITPAGSWVLTDANPDALTITNRELPQVKSGS
TTDR00165	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00165	Pathway	D-Alanine metabolism
TTDR00165	Pathway	Peptidoglycan biosynthesis
TTDR00165	EC Number	EC 6.3.2.4
TTDR00165	Inhibitor	Adenosine-5'-Diphosphate
TTDR00165	Binder	Glycopeptides
TTDR00166	UniProt ID	P23893
TTDR00166	Name	Glutamate-1-semialdehyde aminomutase
TTDR00166	Type of target	Research target
TTDR00166	Synonyms	GSA
TTDR00166	Synonyms	GSA-AT
TTDR00166	Synonyms	Glutamate-1-semialdehyde aminotransferase
TTDR00166	Disease	Bacterial infections
TTDR00166	Disease	Vitamin B6 deficiency
TTDR00166	Sequence	MSKSENLYSAARELIPGGVNSPVRAFTGVGGTPLFIEKADGAYLYDVDGKAYIDYVGSWGPMVLGHNHPAIRNAVIEAAE
TTDR00166	BioChemical Class	Intramolecular transferases
TTDR00166	Pathway	Metabolic pathways
TTDR00166	Pathway	Porphyrin and chlorophyll metabolism
TTDR00166	EC Number	EC 5.4.3.8
TTDR00166	Inhibitor	Diaminopropyl sulfate
TTDR00166	Inhibitor	Gabaculine
TTDR00166	Binder	Vitamin B6
TTDR00167	UniProt ID	P05020
TTDR00167	UniProt ID	Q8IKA9
TTDR00167	Name	Dihydroorotase
TTDR00167	Type of target	Research target
TTDR00167	Synonyms	DHOase
TTDR00167	Disease	Malaria
TTDR00167	Sequence	MTAPSQVLKIRRPDDWHLHLRDGDMLKTVVPYTSEIYGRAIVMPNLAPPVTTVEAAVAYRQRILDAVPAGHDFTPLMTCY
TTDR00167	PDB Structure	2EG6; 2EG7; 2EG8; 2Z24; 2Z25; 2Z26; 2Z27; 2Z28
TTDR00167	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDR00167	Pathway	Metabolic pathways
TTDR00167	Pathway	Pyrimidine metabolism
TTDR00167	EC Number	EC 3.5.2.3
TTDR00167	Inhibitor	5-Fluoro orotate
TTDR00167	Inhibitor	5-amino orotate
TTDR00167	Inhibitor	5-bromo orotate
TTDR00167	Inhibitor	5-iodo orotate
TTDR00167	Inhibitor	5-methyl orotate
TTDR00167	Inhibitor	Dihydroorotic Acid
TTDR00167	Inhibitor	Lysine Nz-Carboxylic Acid
TTDR00167	Inhibitor	N-Carbamoyl-L-Aspartate
TTDR00167	Inhibitor	Orotate
TTDR00167	Inhibitor	Orotic Acid
TTDR00168	Name	Cannabinoid receptor
TTDR00168	Type of target	Research target
TTDR00168	Disease	Atherosclerosis
TTDR00168	Disease	Essential (primary) hypertension
TTDR00168	Disease	Heart failure
TTDR00168	Disease	Pulmonary hypertension
TTDR00168	Disease	Subarachnoid hemorrhage
TTDR00168	Binder	Cannabidiol
TTDR00169	UniProt ID	P04475
TTDR00169	Name	Heat shock protein 70
TTDR00169	Type of target	Research target
TTDR00169	Synonyms	Chaperone protein dnaK
TTDR00169	Synonyms	HSP70
TTDR00169	Synonyms	Heat shock 70 kDa protein
TTDR00169	Synonyms	Molecular chaperone Hsp70
TTDR00169	Disease	Arthritis
TTDR00169	Disease	Inflammation
TTDR00169	Disease	Polyglutamine diseases
TTDR00169	Function	Plays an essential role in the initiation of phage lambda dna replication, where
TTDR00169	Sequence	MGKIIGIDLGTTNSCVAIMDGTTPRVLENAEGDRTTPSIIAYTQDGETLVGQPAKRQAVTNPQNTLFAIKRLIGRRFQDE
TTDR00169	PDB Structure	1DKX; 1DKY; 1DKZ; 1Q5L; 2BPR; 2KHO; 3DPO; 3DPP
TTDR00169	Target Validation	TTDR00169
TTDR00169	Inhibitor	ADENOSINETRIPHOSPHATE
TTDR00169	Inhibitor	ELLAGIC ACID
TTDR00169	Inhibitor	NSC-119910
TTDR00169	Inhibitor	NSC-119911
TTDR00169	Inhibitor	NSC-119913
TTDR00170	UniProt ID	Q9BZJ3
TTDR00170	Name	Putative tryptase delta
TTDR00170	Type of target	Research target
TTDR00170	Synonyms	Delta tryptase
TTDR00170	Synonyms	HmMCP-3-like tryptase III
TTDR00170	Synonyms	Mast cell mMCP-7-like
TTDR00170	Disease	Asthma
TTDR00170	Function	Tryptase is the major neutral protease present in mast cells and is secreted upo
TTDR00170	Sequence	MLLLAPQMLSLLLLALPVLASPAYVAPAPGQALQQTGIVGGQEAPRSKWPWQVSLRVRGPYWMHFCGGSLIHPQWVLTAA
TTDR00170	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00170	EC Number	EC 3.4.21.59
TTDR00170	Target Validation	TTDR00170
TTDR00170	Inhibitor	BMS-262084
TTDR00171	UniProt ID	P27708
TTDR00171	Name	CAD protein
TTDR00171	Type of target	Research target
TTDR00171	Synonyms	CAD
TTDR00171	Disease	Cancer, unspecific
TTDR00171	Function	This protein is a "fusion" protein encoding four enzymatic activities of the pyr
TTDR00171	Sequence	MAALVLEDGSVLRGQPFGAAVSTAGEVVFQTGMVGYPEALTDPSYKAQILVLTYPLIGNYGIPPDEMDEFGLCKWFESSG
TTDR00171	Pathway	Alanine, aspartate and glutamate metabolism
TTDR00171	Pathway	Metabolic pathways
TTDR00171	Pathway	Pyrimidine metabolism
TTDR00171	Inhibitor	N-(Phosphonacetyl)-L-Aspartic Acid
TTDR00171	Inhibitor	N-phosphonacetyl-L-aspartate
TTDR00172	UniProt ID	P13259
TTDR00172	UniProt ID	P49587
TTDR00172	Name	Cholinephosphate cytidylyltransferase
TTDR00172	Type of target	Research target
TTDR00172	Synonyms	CCT
TTDR00172	Synonyms	CT
TTDR00172	Synonyms	CTP:phosphocholine cytidylyltransferase
TTDR00172	Synonyms	Phosphorylcholine transferase
TTDR00172	Disease	Cancer, unspecific
TTDR00172	Disease	Malaria
TTDR00172	Sequence	MANPTTGKSSIRAKLSNSSLSNLFKKNKNKRQREETEEQDNEDKDESKNQDENKDTQLTPRKRRRLTKEFEEKEARYTNE
TTDR00172	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00172	Pathway	Aminophosphonate metabolism
TTDR00172	Pathway	Glycerophospholipid metabolism
TTDR00172	Pathway	Metabolic pathways
TTDR00172	EC Number	EC 2.7.7.15
TTDR00172	Inhibitor	Sphingosine
TTDR00172	Activator	Cholesterol
TTDR00173	UniProt ID	Q08462
TTDR00173	Name	Adenylate cyclase, type II
TTDR00173	Type of target	Research target
TTDR00173	Synonyms	ATP pyrophosphate-lyase
TTDR00173	Synonyms	Adenylyl cyclase
TTDR00173	Disease	Erectile dysfunction
TTDR00173	Disease	Heart failure
TTDR00173	Disease	Vascular disease
TTDR00173	Function	This is a membrane-bound, calmodulin-insensitive adenylyl cyclase.
TTDR00173	Sequence	MWQEAMRRRRYLRDRSEEAAGGGDGLPRSRDWLYESYYCMSQQHPLIVFLLLIVMGSCLALLAVFFALGLEVEDHVAFLI
TTDR00173	BioChemical Class	Phosphorus-oxygen lyases
TTDR00173	Pathway	Calcium signaling pathway
TTDR00173	Pathway	Chemokine signaling pathway
TTDR00173	Pathway	Gap junction
TTDR00173	Pathway	GnRH signaling pathway
TTDR00173	Pathway	Melanogenesis
TTDR00173	Pathway	Purine metabolism
TTDR00173	Pathway	Vascular smooth muscle contraction
TTDR00173	EC Number	EC 4.6.1.1
TTDR00173	Inhibitor	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
TTDR00173	Inhibitor	A1-adenosine receptor
TTDR00173	Inhibitor	Forskolin
TTDR00174	Name	Potassium channel
TTDR00174	Type of target	Clinical trial target
TTDR00174	Disease	Cerebral vasospasm
TTDR00174	Disease	Diabetes mellitus
TTDR00174	Related US Patent	6,395,730
TTDR00174	Related US Patent	6,417,207
TTDR00174	Related US Patent	6,458,794
TTDR00174	Related US Patent	6,511,977
TTDR00174	Related US Patent	6,566,380
TTDR00174	Related US Patent	6,620,849
TTDR00174	QSAR Model	TTDR00174
TTDR00174	Binder	Tetraethylammonium (TEA)
TTDR00175	UniProt ID	P05106
TTDR00175	Name	Integrin beta-3
TTDR00175	Type of target	Research target
TTDR00175	Synonyms	CD61 antigen
TTDR00175	Synonyms	GPIIIa
TTDR00175	Synonyms	Platelet membrane glycoprotein IIIa
TTDR00175	Disease	Platelet adhesion
TTDR00175	Function	Integrin alpha-v/beta-3 is a receptor for cytotactin, fibronectin, laminin, matr
TTDR00175	Sequence	MRARPRPRPLWATVLALGALAGVGVGGPNICTTRGVSSCQQCLAVSPMCAWCSDEALPLGSPRCDLKENLLKDNCAPESI
TTDR00175	PDB Structure	1S4X; 1TYE; 1U8C; 2INI; 2K9J; 2Q6W; 2RMZ; 2RN0
TTDR00175	BioChemical Class	Transmembrane protein
TTDR00175	Pathway	ECM-receptor interaction
TTDR00175	Pathway	Focal adhesion
TTDR00175	Pathway	Hematopoietic cell lineage
TTDR00175	Pathway	Regulation of actin cytoskeleton
TTDR00176	Name	Vasopressin V1 receptor
TTDR00176	Type of target	Research target
TTDR00176	Synonyms	ADH V1 receptor
TTDR00176	Disease	Syndrome of inappropriate secretion of antidiuretic hormone
TTDR00176	Antagonist	OPC-21268
TTDR00176	Antagonist	OPC-31260
TTDR00176	Agonist	Triglycyl-lysine-vasopressin
TTDR00177	Name	Immunoglobulin A
TTDR00177	Type of target	Research target
TTDR00177	Disease	Arthritis
TTDR00178	UniProt ID	P09097
TTDR00178	UniProt ID	P48372
TTDR00178	Name	DNA gyrase A subunit
TTDR00178	Type of target	Research target
TTDR00178	Synonyms	DNA gyrase subunit A
TTDR00178	Synonyms	GyrA
TTDR00178	Disease	Bacterial infections
TTDR00178	Disease	Urinary tract infection
TTDR00178	Function	Dna gyrase negatively supercoils closed circular double- stranded dna in an atp-
TTDR00178	Sequence	MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPH
TTDR00178	PDB Structure	1AB4; 1X75; 1ZI0
TTDR00178	BioChemical Class	Isomerases
TTDR00178	EC Number	EC 5.99.1.3
TTDR00178	Target Validation	TTDR00178
TTDR00178	Inhibitor	ACH-702
TTDR00179	Name	V beta 3 T-cell receptor
TTDR00179	Type of target	Research target
TTDR00179	Disease	Arthritis
TTDR00179	Disease	Autoimmune diseases
TTDR00180	Name	Transforming growth factor receptor b
TTDR00180	Type of target	Research target
TTDR00180	Disease	Gastric cancer
TTDR00180	Disease	Liver cancer
TTDR00181	UniProt ID	P01135
TTDR00181	Name	Transforming growth factor alpha
TTDR00181	Type of target	Research target
TTDR00181	Synonyms	EGF-like TGF
TTDR00181	Synonyms	ETGF
TTDR00181	Synonyms	TGF type 1
TTDR00181	Synonyms	TGF-alpha
TTDR00181	Disease	Tumors
TTDR00181	Function	Tgf alpha is a mitogenic polypeptide that is able to bind to the egf receptor an
TTDR00181	Sequence	MVPSAGQLALFALGIVLAACQALENSTSPLSADPPVAAAVVSHFNDCPDSHTQFCFHGTCRFLVQEDKPACVCHSGYVGA
TTDR00181	PDB Structure	1GK5; 1MOX; 1YUF; 1YUG; 2TGF; 3TGF; 4TGF
TTDR00181	BioChemical Class	Growth factor
TTDR00182	UniProt ID	P04435
TTDR00182	Name	T-cell receptor beta chain V region CTL-L17
TTDR00182	Type of target	Research target
TTDR00182	Synonyms	V beta 17 T-cell receptor
TTDR00182	Disease	Arthritis
TTDR00182	Disease	Rheumatoid arthritis, unspecified
TTDR00182	Sequence	MGTSLLCWMALCLLGADHADTGVSQNPRHNITKRGQNVTFRCDPISEHNRLYWYRQTLGQGPEFLTYFQNEAQLEKSRLL
TTDR00183	UniProt ID	Q9XZW0
TTDR00183	Name	Gamma-aminobutyric acid gated chloride channel
TTDR00183	Type of target	Research target
TTDR00183	Synonyms	GABA gated chloride channel
TTDR00183	Synonyms	GABA-gated chloride channel
TTDR00183	Disease	Convulsions
TTDR00183	Disease	Dermacentor variabilis infection
TTDR00183	Sequence	MHTSRPRGVHSIALVLSLAIAWLPHADHAAGAGGGGMFGDVNISAILDSLSVSYDKRVRPNYGGPPVDVGVTMYVLSISS
TTDR00183	BioChemical Class	Ion transport
TTDR00183	Blocker	Fipronil
TTDR00183	Blocker	Picrotoxinin
TTDR00184	UniProt ID	P47211
TTDR00184	Name	Galanin receptor type 1
TTDR00184	Type of target	Research target
TTDR00184	Synonyms	GAL1-R
TTDR00184	Synonyms	GALR1
TTDR00184	Disease	Convulsions
TTDR00184	Disease	Obesity
TTDR00184	Function	Receptor for the hormone galanin. The activity of this receptor is mediated by G
TTDR00184	Sequence	MELAVGNLSEGNASCPEPPAPEPGPLFGIGVENFVTLVVFGLIFALGVLGNSLVITVLARSKPGKPRSTTNLFILNLSIA
TTDR00184	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00184	Pathway	Neuroactive ligand-receptor interaction
TTDR00184	Related US Patent	6,407,136
TTDR00184	Target Validation	TTDR00184
TTDR00184	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-MPEG4)K
TTDR00184	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-decanoyl)K
TTDR00184	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-lauroyl)K
TTDR00184	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-myristoyl)K
TTDR00184	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-octanoyl)K
TTDR00184	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-palmitoyl)K
TTDR00184	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-stearoyl)K
TTDR00184	Inhibitor	(Sar)WTLNSAGYLLGPKKKK
TTDR00184	Inhibitor	GALANIN
TTDR00184	Inhibitor	GALANTIDE
TTDR00184	Inhibitor	GWTLNSAGYLLGPHAV-NH2
TTDR00184	Inhibitor	GWTLNSAGYLLGPPPALALA-CONH2
TTDR00184	Inhibitor	GWTLNSAGYLLGPPPGFSPFR-CONH2
TTDR00184	Inhibitor	GWTLNSAGYLLGPRHYINLITRQRY-CONH2
TTDR00184	Inhibitor	GWTLNSAGYLLGPrPKPQQwFwLL-CONH2
TTDR00184	Inhibitor	Gal-B5
TTDR00184	Inhibitor	GalB2
TTDR00184	Inhibitor	GwTLNSAGYLLGPHAVGNHRSFSDKNGLTS-CONH2
TTDR00184	Inhibitor	WTLNSAGYLL-CONH2
TTDR00184	Inhibitor	WTLNSAGYLLGPHAVGNHPSFSDKNGLTS-CONH2
TTDR00184	Inhibitor	[N-Ac,des-Sar]Gal-B2
TTDR00184	Inhibitor	[N-Me,des-Sar]Gal-B2
TTDR00184	Inhibitor	[Sar1Ala]GAL-B2
TTDR00184	Inhibitor	[Sar1Gly]GAL-B2
TTDR00184	Agonist	Galnon
TTDR00184	Agonist	NAX-5055
TTDR00185	UniProt ID	P04198
TTDR00185	Name	N-myc proto-oncogene protein
TTDR00185	Type of target	Research target
TTDR00185	Synonyms	N-myc
TTDR00185	Disease	Cancer, unspecific
TTDR00185	Function	May function as a transcription factor.
TTDR00185	Sequence	MPSCSTSTMPGMICKNPDLEFDSLQPCFYPDEDDFYFGGPDSTPPGEDIWKKFELLPTPPLSPSRGFAEHSSEPPSWVTE
TTDR00186	Name	Soluble guanylate cyclase
TTDR00186	Type of target	Clinical trial target
TTDR00186	Synonyms	SGC
TTDR00186	Disease	Cardiovascular disease, unspecified
TTDR00186	Disease	Erectile dysfunction
TTDR00186	Disease	Heart failure
TTDR00186	Disease	Unstable angina
TTDR00186	Disease	Vascular disease
TTDR00186	EC Number	EC 4.6.1.2
TTDR00186	Activator	Nitroglycerine
TTDR00186	Activator	Sodium nitroprusside
TTDR00186	Activator	YC-1
TTDR00186	Stimulator	Endothelium-derived relaxing factor (EDRF)
TTDR00188	Name	HIV-2 reverse transcriptase
TTDR00188	Type of target	Research target
TTDR00188	Synonyms	HIV-2 RT
TTDR00188	Synonyms	Human immunodeficiency virus type 2 reverse transcriptase
TTDR00188	Disease	Human immunodeficiency virus [HIV] disease
TTDR00188	Disease	Viral infection, unspecified
TTDR00188	EC Number	EC 2.7.7.49
TTDR00188	Related US Patent	6,492,423
TTDR00188	Related US Patent	6,492,515
TTDR00190	Name	Tumor necrosis factor receptor
TTDR00190	Type of target	Research target
TTDR00190	Disease	Crohn's disease, unspecified
TTDR00190	Disease	Rheumatoid arthritis, unspecified
TTDR00190	Related US Patent	6,428,787
TTDR00190	Related US Patent	6,663,865
TTDR00190	Antagonist	Enbrel
TTDR00190	Antibody	CDP571
TTDR00192	UniProt ID	P28908
TTDR00192	Name	Tumor necrosis factor receptor superfamily member 8
TTDR00192	Type of target	Clinical trial target
TTDR00192	Synonyms	CD30
TTDR00192	Synonyms	CD30L receptor
TTDR00192	Synonyms	KI-1 antigen
TTDR00192	Synonyms	Lymphocyte activation antigen CD30
TTDR00192	Disease	Cancer, unspecific
TTDR00192	Disease	Hodgkin's disease, unspecified
TTDR00192	Function	Receptor for tnfsf8/cd30l. May play a role in the regulation of cellular growth
TTDR00192	Sequence	MRVLLAALGLLFLGALRAFPQDRPFEDTCHGNPSHYYDKAVRRCCYRCPMGLFPTQQCPQRPTDCRKQCEPDYYLDEADR
TTDR00192	PDB Structure	1D01
TTDR00192	BioChemical Class	Transmembrane protein
TTDR00192	Pathway	Cytokine-cytokine receptor interaction
TTDR00192	Related US Patent	6,652,854
TTDR00192	Antibody	Ber-H2/saporin
TTDR00192	Antibody	H22xKi-4
TTDR00193	UniProt ID	O00300
TTDR00193	Name	Tumor necrosis factor receptor superfamily member 11B
TTDR00193	Type of target	Research target
TTDR00193	Synonyms	Osteoclastogenesis inhibitory factor
TTDR00193	Synonyms	Osteoprotegerin
TTDR00193	Disease	Osteoporosis, unspecified
TTDR00193	Function	Acts as decoy receptor for rankl and thereby neutralizes its function in osteocl
TTDR00193	Sequence	MNKLLCCALVFLDISIKWTTQETFPPKYLHYDEETSHQLLCDKCPPGTYLKQHCTAKWKTVCAPCPDHYYTDSWHTSDEC
TTDR00193	Pathway	Cytokine-cytokine receptor interaction
TTDR00194	Name	Phosphotransketolase
TTDR00194	Type of target	Research target
TTDR00194	Disease	Thiamine deficiency
TTDR00195	Name	Nicotinic acetylcholine receptor alpha2 / alpha3
TTDR00195	Type of target	Research target
TTDR00195	Disease	Alzheimer's disease
TTDR00195	Disease	Analgesics
TTDR00195	Disease	Drug dependence
TTDR00195	Disease	Pain, unspecified
TTDR00195	Antagonist	18-Methoxycoronaridine
TTDR00195	Antagonist	Ibogaine
TTDR00195	Antagonist	Laudanosine
TTDR00195	Antagonist	Volatile anesthetics
TTDR00195	Agonist	SIB-1533A
TTDR00196	UniProt ID	P13795
TTDR00196	Name	Synaptosomal-associated protein 25
TTDR00196	Type of target	Research target
TTDR00196	Synonyms	SNAP-25
TTDR00196	Synonyms	SUP
TTDR00196	Synonyms	Super protein
TTDR00196	Disease	Attention deficit hyperactivity disorder
TTDR00196	Disease	Involuntary muscle spasms
TTDR00196	Disease	Neurological symptom
TTDR00196	Function	Tsnare involved in the molecular regulation of neurotransmitter release. May pla
TTDR00196	Sequence	MAEDADMRNELEEMQRRADQLADESLESTRRMLQLVEESKDAGIRTLVMLDEQGEQLERIEEGMDQINKDMKEAEKNLTD
TTDR00196	PDB Structure	1KIL; 1XTG; 2BU0; 1JTH; 1N7S; 1SFC; 1URQ
TTDR00196	Antigen	Synaptosomal membrane antigen D3
TTDR00197	UniProt ID	P23946
TTDR00197	Name	Chymase
TTDR00197	Type of target	Research target
TTDR00197	Synonyms	Mast cell protease I
TTDR00197	Disease	Asthma
TTDR00197	Disease	Atopic dermatitis
TTDR00197	Disease	Cardiovascular disease, unspecified
TTDR00197	Disease	Inflammation
TTDR00197	Disease	Myocardial infarction
TTDR00197	Function	Major secreted protease of mast cells with suspected roles in vasoactive peptide
TTDR00197	Sequence	MLLLPLPLLLFLLCSRAEAGEIIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHN
TTDR00197	PDB Structure	1KLT; 1NN6; 1PJP; 1T31; 2HVX
TTDR00197	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00197	Pathway	Renin-angiotensin system
TTDR00197	EC Number	EC 3.4.21.39
TTDR00197	Related US Patent	6,500,835
TTDR00197	Related US Patent	6,677,344
TTDR00197	Target Validation	TTDR00197
TTDR00197	Inhibitor	2-(N-Morpholino)-Ethanesulfonic Acid
TTDR00197	Inhibitor	BCEAB
TTDR00197	Inhibitor	BOCEPREVIR
TTDR00197	Inhibitor	Benzylsulfinic Acid
TTDR00197	Inhibitor	CEP-18770
TTDR00197	Inhibitor	CHYMOSTATIN
TTDR00197	Inhibitor	JNJ-10311795
TTDR00197	Inhibitor	NK3201
TTDR00197	Inhibitor	Phenylalanylmethane
TTDR00197	Inhibitor	SUN-C8257
TTDR00197	Inhibitor	Y-40613
TTDR00197	Inhibitor	rac-2q
TTDR00198	UniProt ID	P14921
TTDR00198	Name	C-ets-1 protein
TTDR00198	Type of target	Research target
TTDR00198	Synonyms	P54
TTDR00198	Disease	Cancer, unspecific
TTDR00198	Function	Transcription factor.
TTDR00198	Sequence	MKAAVDLKPTLTIIKTEKVDLELFPSPDMECADVPLLTPSSKEMMSQALKATFSGFTKEQQRLGIPKDPRQWTETHVRDW
TTDR00198	PDB Structure	1GVJ; 2NNY; 2STT; 2STW
TTDR00198	Pathway	Pathways in cancer
TTDR00198	Pathway	Renal cell carcinoma
TTDR00199	UniProt ID	O00555
TTDR00199	Name	Voltage-dependent P/Q-type calcium channel alpha-1A subunit
TTDR00199	Type of target	Research target
TTDR00199	Synonyms	BI
TTDR00199	Synonyms	Brain calcium channel I
TTDR00199	Synonyms	Calcium channel, L type, alpha-1 polypeptide isoform 4
TTDR00199	Synonyms	Calcium channel, L type, alpha-1 polypeptide, isoform 4
TTDR00199	Synonyms	RAT brain class A
TTDR00199	Synonyms	RBA-I
TTDR00199	Synonyms	Voltage-dependent P/Q-type calcium channel
TTDR00199	Synonyms	Voltage-gated calcium channel alpha subunit Cav2.1
TTDR00199	Disease	Analgesics
TTDR00199	Disease	Cerebral ischemia
TTDR00199	Disease	Migraine
TTDR00199	Disease	Neurogenic inflammation
TTDR00199	Disease	Pain, unspecified
TTDR00199	Function	Voltage-sensitive calcium channels (vscc) mediate the entry of calcium ions into
TTDR00199	Sequence	MARFGDEMPARYGGGGSGAAAGVVVGSGGGRGAGGSRQGGQPGAQRMYKQSMAQRARTMALYNPIPVRQNCLTVNRSLFL
TTDR00199	PDB Structure	3BXK; 3BXL
TTDR00199	BioChemical Class	Voltage-gated channel
TTDR00199	Pathway	Calcium signaling pathway
TTDR00199	Pathway	Long-term depression
TTDR00199	Pathway	MAPK signaling pathway
TTDR00199	Pathway	Taste transduction
TTDR00199	Pathway	Type II diabetes mellitus
TTDR00199	Blocker	Alpha-eudesmol
TTDR00200	UniProt ID	Q15878
TTDR00200	Name	Voltage-dependent R-type calcium channel alpha-1E subunit
TTDR00200	Type of target	Research target
TTDR00200	Synonyms	BII
TTDR00200	Synonyms	Brain calcium channel II
TTDR00200	Synonyms	Calcium channel, L type, alpha-1 polypeptide, isoform 6
TTDR00200	Synonyms	Class E voltage-gated calcium channel
TTDR00200	Synonyms	R-type voltage-gated calcium channel
TTDR00200	Synonyms	Voltage-dependent R-type calcium channel
TTDR00200	Synonyms	Voltage-gated calcium channel alpha subunit Cav2.3
TTDR00200	Disease	Analgesics
TTDR00200	Disease	Pain, unspecified
TTDR00200	Function	Voltage-sensitive calcium channels (vscc) mediate the entry of calcium ions into
TTDR00200	Sequence	MARFGEAVVARPGSGDGDSDQSRNRQGTPVPASGQAAAYKQTKAQRARTMALYNPIPVRQNCFTVNRSLFIFGEDNIVRK
TTDR00200	BioChemical Class	Voltage-gated channel
TTDR00200	Pathway	Calcium signaling pathway
TTDR00200	Pathway	MAPK signaling pathway
TTDR00200	Pathway	Type II diabetes mellitus
TTDR00200	Related US Patent	6,653,460
TTDR00201	UniProt ID	P31650
TTDR00201	Name	Gamma-aminobutyric acid transporter 4
TTDR00201	Type of target	Research target
TTDR00201	Synonyms	GABA transporter 4
TTDR00201	Synonyms	GAT4
TTDR00201	Synonyms	Sodium- and chloride-dependent GABA transporter 4
TTDR00201	Disease	Convulsions
TTDR00201	Function	Terminates the action of gaba by its high affinity sodium-dependent reuptake int
TTDR00201	Sequence	MTAEQALPLGNGKAAEEARGSETLGGGGGGAAGTREARDKAVHERGHWNNKVEFVLSVAGEIIGLGNVWRFPYLCYKNGG
TTDR00201	BioChemical Class	Transmembrane protein
TTDR00201	Blocker	SNAP-5114
TTDR00202	UniProt ID	P30304
TTDR00202	Name	M-phase inducer phosphatase 1
TTDR00202	Type of target	Research target
TTDR00202	Synonyms	Cdc25A phosphatase
TTDR00202	Synonyms	Dual specificity phosphatase Cdc25A
TTDR00202	Disease	Breast cancer
TTDR00202	Disease	Cancer, unspecific
TTDR00202	Function	Functions as a dosage-dependent inducer in mitotic control. It is a tyrosine pro
TTDR00202	Sequence	MELGPEPPHRRRLLFACSPPPASQPVVKALFGASAAGGLSPVTNLTVTMDQLQGLGSDYEQPLEVKNNSNLQRMGSSEST
TTDR00202	PDB Structure	1C25
TTDR00202	BioChemical Class	Hydrolases acting on ester bonds
TTDR00202	Pathway	Cell cycle
TTDR00202	EC Number	EC 3.1.3.48
TTDR00202	Target Validation	TTDR00202
TTDR00202	Inhibitor	(E)-2-(1-decyl-2-oxoindolin-3-ylidene)acetic acid
TTDR00202	Inhibitor	(Z)-2-(1-decyl-2-oxoindolin-3-ylidene)acetic acid
TTDR00202	Inhibitor	1-dodecylindoline-2,3-dione
TTDR00202	Inhibitor	2-(1-dodecyl-1H-indol-3-yl)acetic acid
TTDR00202	Inhibitor	3-isopropyl-4-(phenylamino)naphthalene-1,2-dione
TTDR00202	Inhibitor	3-isopropyl-4-(phenylthio)naphthalene-1,2-dione
TTDR00202	Inhibitor	3-isopropyl-4-phenylnaphthalene-1,2-dione
TTDR00202	Inhibitor	3-isopropylnaphthalene-1,2-dione
TTDR00202	Inhibitor	4-(p-toluidino)-3-isopropylnaphthalene-1,2-dione
TTDR00202	Inhibitor	NSC-95397
TTDR00202	Inhibitor	Naphthoquinone analogs
TTDR00202	Inhibitor	Vitamin K3
TTDR00204	Name	Tar rRNA
TTDR00204	Type of target	Research target
TTDR00204	Disease	Human immunodeficiency virus [HIV] disease
TTDR00204	Inhibitor	2,4-diaminoquinozalines and quinoxaline-2,3-diones
TTDR00204	Inhibitor	Chimeric small nucleolar RNA-TAR decoy
TTDR00204	Inhibitor	Neomycin B
TTDR00204	Inhibitor	Neomycin B-arginine conjugate
TTDR00205	UniProt ID	P10145
TTDR00205	Name	Interleukin-8
TTDR00205	Type of target	Research target
TTDR00205	Synonyms	CXCL8
TTDR00205	Synonyms	Emoctakin
TTDR00205	Synonyms	GCP-1
TTDR00205	Synonyms	Granulocyte chemotactic protein 1
TTDR00205	Synonyms	IL-8
TTDR00205	Synonyms	LYNAP
TTDR00205	Synonyms	Lymphocyte-derived neutrophil-activating factor
TTDR00205	Synonyms	MDNCF
TTDR00205	Synonyms	MONAP
TTDR00205	Synonyms	Monocyte derived neutrophil activating peptide
TTDR00205	Synonyms	Monocyte-derived neutrophil chemotactic factor
TTDR00205	Synonyms	NAF
TTDR00205	Synonyms	NAP-1
TTDR00205	Synonyms	Neutrophil-activating factor
TTDR00205	Synonyms	Neutrophil-activating protein 1
TTDR00205	Synonyms	Protein 3-10C
TTDR00205	Synonyms	T-cell chemotactic factor
TTDR00205	Disease	Angiogenesis in metastatic and atherosclerotic processes
TTDR00205	Disease	Arthritis
TTDR00205	Disease	Human cytomegalovirus infections
TTDR00205	Disease	Inflammation
TTDR00205	Disease	Mechanical nociceptor hypersensitivity
TTDR00205	Disease	Meningitis
TTDR00205	Function	Il-8 is a chemotactic factor that attracts neutrophils, basophils, and t-cells,
TTDR00205	Sequence	MTSKLAVALLAAFLISAALCEGAVLPRSAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDP
TTDR00205	PDB Structure	1ICW; 1IKL; 1IKM; 1IL8; 1ILP; 1ILQ; 1QE6; 1ROD
TTDR00205	Pathway	Bladder cancer
TTDR00205	Pathway	Chemokine signaling pathway
TTDR00205	Pathway	Cytokine-cytokine receptor interaction
TTDR00205	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR00205	Pathway	Pathways in cancer
TTDR00205	Pathway	Toll-like receptor signaling pathway
TTDR00205	Related US Patent	6,419,944
TTDR00205	Related US Patent	6,455,520
TTDR00205	Related US Patent	6,579,880
TTDR00205	Target Validation	TTDR00205
TTDR00205	Inhibitor	2-(2-(2,5-dichlorophenylamino)phenyl)acetic acid
TTDR00205	Inhibitor	2-(2-(2-chlorophenoxy)phenyl)acetic acid
TTDR00205	Inhibitor	2-(2-(2-chlorophenylamino)phenyl)acetic acid
TTDR00205	Inhibitor	2-(2-(2-fluorophenoxy)phenyl)acetic acid
TTDR00205	Inhibitor	2-(2-(2-fluorophenylamino)phenyl)acetic acid
TTDR00205	Inhibitor	IBUPROPHEN
TTDR00205	Inhibitor	R-KETOPROFEN
TTDR00205	Antibody	ABX-IL8
TTDR00207	UniProt ID	Q12840
TTDR00207	Name	Neuronal kinesin heavy chain
TTDR00207	Type of target	Research target
TTDR00207	Synonyms	Kinesin heavy chain isoform 5A
TTDR00207	Synonyms	Kinesin heavy chain neuron-specific 1
TTDR00207	Synonyms	NKHC
TTDR00207	Disease	Neurological symptom
TTDR00207	Function	Kinesin is a microtubule-associated force-producing protein that may play a role
TTDR00207	Sequence	MAETNNECSIKVLCRFRPLNQAEILRGDKFIPIFQGDDSVVIGGKPYVFDRVFPPNTTQEQVYHACAMQIVKDVLAGYNG
TTDR00208	UniProt ID	P30307
TTDR00208	Name	M-phase inducer phosphatase 3
TTDR00208	Type of target	Research target
TTDR00208	Synonyms	Cdc25C phosphatase
TTDR00208	Synonyms	Dual specificity phosphatase Cdc25C
TTDR00208	Disease	Cancer, unspecific
TTDR00208	Function	Functions as a dosage-dependent inducer in mitotic control. It is a tyrosine pro
TTDR00208	Sequence	MSTELFSSTREEGSSGSGPSFRSNQRKMLNLLLERDTSFTVCPDVPRTPVGKFLGDSANLSILSGGTPKRCLDLSNLSSG
TTDR00208	PDB Structure	3BZI
TTDR00208	BioChemical Class	Hydrolases acting on ester bonds
TTDR00208	Pathway	Cell cycle
TTDR00208	EC Number	EC 3.1.3.48
TTDR00208	Target Validation	TTDR00208
TTDR00208	Inhibitor	BN-82002
TTDR00208	Inhibitor	BN-82685
TTDR00208	Inhibitor	NSC-663284
TTDR00209	UniProt ID	P22748
TTDR00209	Name	Carbonic anhydrase IV
TTDR00209	Type of target	Research target
TTDR00209	Synonyms	CA-IV
TTDR00209	Synonyms	Carbonate dehydratase IV
TTDR00209	Disease	Glaucoma
TTDR00209	Disease	Pancreatic cancer
TTDR00209	Disease	Renal failure
TTDR00209	Disease	Salivary glands cancer
TTDR00209	Function	Reversible hydration of carbon dioxide.
TTDR00209	Sequence	MRMLLALLALSAARPSASAESHWCYEVQAESSNYPCLVPVKWGGNCQKDRQSPINIVTTKAKVDKKLGRFFFSGYDKKQT
TTDR00209	PDB Structure	1ZNC
TTDR00209	BioChemical Class	Carbon-oxygen lyases
TTDR00209	Pathway	Nitrogen metabolism
TTDR00209	EC Number	EC 4.2.1.1
TTDR00209	Target Validation	TTDR00209
TTDR00209	QSAR Model	TTDR00209
TTDR00209	Inhibitor	1-(3,4-dichlorophenyl)-3-hydroxyurea
TTDR00209	Inhibitor	2,4-Disulfamyltrifluoromethylaniline
TTDR00209	Inhibitor	2-Propyl-pentanoic acid 4-sulfamoyl-benzyl ester
TTDR00209	Inhibitor	2-Propyl-pentanoic acid 4-sulfamoyl-benzylamide
TTDR00209	Inhibitor	2-oxo-2H-chromene-3-carboxylic acid
TTDR00209	Inhibitor	3-Amino-benzenesulfonamide
TTDR00209	Inhibitor	4-(2-Amino-ethyl)-benzenesulfonamide
TTDR00209	Inhibitor	4-Amino-3-bromo-benzenesulfonamide
TTDR00209	Inhibitor	4-Amino-3-chloro-benzenesulfonamide
TTDR00209	Inhibitor	4-Amino-3-fluoro-benzenesulfonamide
TTDR00209	Inhibitor	4-Amino-3-iodo-benzenesulfonamide
TTDR00209	Inhibitor	4-Hydrazino-benzenesulfonamide
TTDR00209	Inhibitor	5-amino-1,3,4-thiadiazole-2-sulfonamide
TTDR00209	Inhibitor	6-(aminomethyl)-2H-chromen-2-one
TTDR00209	Inhibitor	6-(hydroxymethyl)-2H-chromen-2-one
TTDR00209	Inhibitor	6-methyl-2-oxo-2H-chromene-3-carboxylic acid
TTDR00209	Inhibitor	7-(benzyloxy)-2H-chromen-2-one
TTDR00209	Inhibitor	BENZOLAMIDE
TTDR00209	Inhibitor	CATECHIN
TTDR00209	Inhibitor	CATECHOL
TTDR00209	Inhibitor	COUMARIN
TTDR00209	Inhibitor	COUMATE
TTDR00209	Inhibitor	CURCUMIN
TTDR00209	Inhibitor	Carbamoyl phosphate; di sodium
TTDR00209	Inhibitor	Ditiocarb sodium
TTDR00209	Inhibitor	ELLAGIC ACID
TTDR00209	Inhibitor	FERULIC ACID
TTDR00209	Inhibitor	GALLICACID
TTDR00209	Inhibitor	HERNIARIN
TTDR00209	Inhibitor	MAFENIDE
TTDR00209	Inhibitor	N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-benzamide
TTDR00209	Inhibitor	N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide
TTDR00209	Inhibitor	N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide
TTDR00209	Inhibitor	N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide
TTDR00209	Inhibitor	N-1,3,4-thiadiazol-2-ylsulfamide
TTDR00209	Inhibitor	N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide
TTDR00209	Inhibitor	N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide
TTDR00209	Inhibitor	N-hydroxysulfonamides
TTDR00209	Inhibitor	N1-(naphthalen-1-yl)ethane-1,2-diamine
TTDR00209	Inhibitor	PARABEN
TTDR00209	Inhibitor	PHENOL
TTDR00209	Inhibitor	PYRUVATE SODIUM
TTDR00209	Inhibitor	Phenyl-phosphonic acid
TTDR00209	Inhibitor	Phenylarsonic acid
TTDR00209	Inhibitor	SALICYLATE
TTDR00209	Inhibitor	SODIUM CITRATE
TTDR00209	Inhibitor	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
TTDR00209	Inhibitor	SPARFOSIC ACID
TTDR00209	Inhibitor	SPERMINE
TTDR00209	Inhibitor	SULFAMATE
TTDR00209	Inhibitor	SULFAMIDE
TTDR00209	Inhibitor	Sodium; Malonate
TTDR00209	Inhibitor	Sodium; Oxalate
TTDR00209	Inhibitor	Sulfenamido-sulfonamides
TTDR00209	Inhibitor	Syringic Acid
TTDR00209	Inhibitor	[Cu(CN)2]-
TTDR00209	Inhibitor	[Fe(CN)6]4-
TTDR00209	Inhibitor	aminocarbonyl dihydrogen phosphate
TTDR00209	Inhibitor	decane-1,10-diyl disulfamate
TTDR00209	Inhibitor	decyl sulfamate
TTDR00209	Inhibitor	ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate
TTDR00209	Inhibitor	hexane-1,6-diamine
TTDR00209	Inhibitor	octane-1,8-diyl disulfamate
TTDR00209	Inhibitor	octyl sulfamate
TTDR00209	Inhibitor	p-Coumaric Acid
TTDR00209	Inhibitor	pentane-1,5-diamine
TTDR00209	Inhibitor	phenylboronic acid
TTDR00209	Inhibitor	sodium phenylarsonate
TTDR00209	Inhibitor	sodium sulfamate
TTDR00209	Inhibitor	sodium trithiocarbonate
TTDR00209	Inhibitor	trisodium phosphate
TTDR00210	UniProt ID	P23280
TTDR00210	Name	Carbonic anhydrase VI
TTDR00210	Type of target	Research target
TTDR00210	Synonyms	CA-VI
TTDR00210	Synonyms	Carbonate dehydratase VI
TTDR00210	Synonyms	Salivary carbonic anhydrase
TTDR00210	Synonyms	Secreted carbonic anhydrase
TTDR00210	Disease	Pancreatic cancer
TTDR00210	Disease	Salivary glands cancer
TTDR00210	Function	Reversible hydration of carbon dioxide. Its role in saliva is unknown.
TTDR00210	Sequence	MRALVLLLSLFLLGGQAQHVSDWTYSEGALDEAHWPQHYPACGGQRQSPINLQRTKVRYNPSLKGLNMTGYETQAGEFPM
TTDR00210	PDB Structure	3FE4
TTDR00210	BioChemical Class	Carbon-oxygen lyases
TTDR00210	Pathway	Nitrogen metabolism
TTDR00210	EC Number	EC 4.2.1.1
TTDR00210	Target Validation	TTDR00210
TTDR00210	Inhibitor	2,4-Disulfamyltrifluoromethylaniline
TTDR00210	Inhibitor	2-aminobenzenesulfonamide
TTDR00210	Inhibitor	2-hydrazinylbenzenesulfonamide
TTDR00210	Inhibitor	4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide
TTDR00210	Inhibitor	4-(2-hydroxyethyl)benzenesulfonamide
TTDR00210	Inhibitor	4-(hydroxymethyl)benzenesulfonamide
TTDR00210	Inhibitor	4-CYANOPHENOL
TTDR00210	Inhibitor	4-amino-3-bromobenzenesulfonamide
TTDR00210	Inhibitor	4-amino-3-chlorobenzenesulfonamide
TTDR00210	Inhibitor	4-amino-3-fluorobenzenesulfonamide
TTDR00210	Inhibitor	4-amino-3-iodobenzenesulfonamide
TTDR00210	Inhibitor	4-amino-6-chlorobenzene-1,3-disulfonamide
TTDR00210	Inhibitor	4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide
TTDR00210	Inhibitor	4-hydrazinylbenzenesulfonamide
TTDR00210	Inhibitor	5-amino-1,3,4-thiadiazole-2-sulfonamide
TTDR00210	Inhibitor	6-(aminomethyl)-2H-chromen-2-one
TTDR00210	Inhibitor	6-(hydroxymethyl)-2H-chromen-2-one
TTDR00210	Inhibitor	6-hydroxybenzo[d]thiazole-2-sulfonamide
TTDR00210	Inhibitor	7-butoxy-2H-chromen-2-one
TTDR00210	Inhibitor	7-propoxy-2H-chromen-2-one
TTDR00210	Inhibitor	BENZOLAMIDE
TTDR00210	Inhibitor	CATECHIN
TTDR00210	Inhibitor	COUMARIN
TTDR00210	Inhibitor	COUMATE
TTDR00210	Inhibitor	CURCUMIN
TTDR00210	Inhibitor	Carzenide;Para-Carboxybenzenesulfonamide (Weak Carbonic Anhydrase Inhibitor)
TTDR00210	Inhibitor	ELLAGIC ACID
TTDR00210	Inhibitor	FERULIC ACID
TTDR00210	Inhibitor	GALLICACID
TTDR00210	Inhibitor	HERNIARIN
TTDR00210	Inhibitor	INDISULAM
TTDR00210	Inhibitor	MAFENIDE
TTDR00210	Inhibitor	N1-(2-aminoethyl)ethane-1,2-diamine
TTDR00210	Inhibitor	N1-(naphthalen-1-yl)ethane-1,2-diamine
TTDR00210	Inhibitor	P-TOLUENESULFONAMIDE
TTDR00210	Inhibitor	PARABEN
TTDR00210	Inhibitor	SALICYLATE
TTDR00210	Inhibitor	SPERMINE
TTDR00210	Inhibitor	Syringic Acid
TTDR00210	Inhibitor	decane-1,10-diyl disulfamate
TTDR00210	Inhibitor	decyl sulfamate
TTDR00210	Inhibitor	ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate
TTDR00210	Inhibitor	hexane-1,6-diamine
TTDR00210	Inhibitor	octane-1,8-diyl disulfamate
TTDR00210	Inhibitor	octyl sulfamate
TTDR00210	Inhibitor	p-Coumaric Acid
TTDR00210	Inhibitor	pentane-1,5-diamine
TTDR00211	UniProt ID	Q16790
TTDR00211	Name	Carbonic anhydrase IX
TTDR00211	Type of target	Research target
TTDR00211	Synonyms	CA-IX
TTDR00211	Synonyms	CAIX
TTDR00211	Synonyms	Carbonate dehydratase IX
TTDR00211	Synonyms	G250 antigen (MN/CA IX/G250)
TTDR00211	Synonyms	Membrane antigen MN
TTDR00211	Synonyms	P54/58N
TTDR00211	Synonyms	PMW1
TTDR00211	Synonyms	RCC-associated antigen G250
TTDR00211	Synonyms	Renal cell carcinoma-associated antigen G250
TTDR00211	Disease	Bladder cancer
TTDR00211	Disease	Head and neck squamous cell carcinomas
TTDR00211	Disease	Pancreatic cancer
TTDR00211	Disease	Renal cell carcinoma
TTDR00211	Function	Reversible hydration of carbon dioxide. May be involved in the control of cell p
TTDR00211	Sequence	MAPLCPSPWLPLLIPAPAPGLTVQLLLSLLLLVPVHPQRLPRMQEDSPLGGGSSGEDDPLGEEDLPSEEDSPREEDPPGE
TTDR00211	PDB Structure	2HKF
TTDR00211	BioChemical Class	Carbon-oxygen lyases
TTDR00211	Pathway	Nitrogen metabolism
TTDR00211	EC Number	EC 4.2.1.1
TTDR00211	Target Validation	TTDR00211
TTDR00211	QSAR Model	TTDR00211
TTDR00211	Inhibitor	1-acetamido-5-sulfonamidoindane
TTDR00211	Inhibitor	2-acetamido-5-sulfonamidoindane
TTDR00211	Inhibitor	4-azidobenzenesulfonamide
TTDR00211	Inhibitor	4-ethynyl benzene sulfonamide
TTDR00211	Inhibitor	ACETYLSULFANILAMIDE
TTDR00211	Inhibitor	Aminobenzolamide derivative
TTDR00211	Inhibitor	Azide
TTDR00211	Inhibitor	BENZOLAMIDE
TTDR00211	Inhibitor	BICARBONATE
TTDR00211	Inhibitor	CATECHIN
TTDR00211	Inhibitor	CGS-27023A
TTDR00211	Inhibitor	COUMARIN
TTDR00211	Inhibitor	COUMATE
TTDR00211	Inhibitor	CURCUMIN
TTDR00211	Inhibitor	ELLAGIC ACID
TTDR00211	Inhibitor	EMATE
TTDR00211	Inhibitor	ETHOXYCOUMARIN
TTDR00211	Inhibitor	FERULIC ACID
TTDR00211	Inhibitor	GALLICACID
TTDR00211	Inhibitor	HERNIARIN
TTDR00211	Inhibitor	HYDROSULFIDE
TTDR00211	Inhibitor	INDISULAM
TTDR00211	Inhibitor	MAFENIDE
TTDR00211	Inhibitor	N-hydroxysulfamide
TTDR00211	Inhibitor	N1-(2-aminoethyl)ethane-1,2-diamine
TTDR00211	Inhibitor	N1-(naphthalen-1-yl)ethane-1,2-diamine
TTDR00211	Inhibitor	NSC-654077
TTDR00211	Inhibitor	PARABEN
TTDR00211	Inhibitor	PHENOL
TTDR00211	Inhibitor	PHENYLDIFLUOROMETHANESULFONAMIDE
TTDR00211	Inhibitor	PHENYLMETHANESULFONAMIDE
TTDR00211	Inhibitor	PHENYLSULFAMATE
TTDR00211	Inhibitor	Pentanoic acid (4-sulfamoyl-phenyl)-amide
TTDR00211	Inhibitor	SACCHARIN
TTDR00211	Inhibitor	SPERMINE
TTDR00211	Inhibitor	SULFAMATE
TTDR00211	Inhibitor	SULFAMIDE
TTDR00211	Inhibitor	Sodium N-methylphenylaminomethanesulfonate
TTDR00211	Inhibitor	Sodium phenylaminomethanesulfonate
TTDR00211	Inhibitor	Syringic Acid
TTDR00211	Inhibitor	UMBELLIFERONE
TTDR00211	Inhibitor	decyl sulfamate
TTDR00211	Inhibitor	hexane-1,6-diamine
TTDR00211	Inhibitor	octyl sulfamate
TTDR00211	Inhibitor	p-Coumaric Acid
TTDR00211	Inhibitor	pentane-1,5-diamine
TTDR00212	UniProt ID	O43570
TTDR00212	Name	Carbonic anhydrase XII
TTDR00212	Type of target	Research target
TTDR00212	Synonyms	CA-XII
TTDR00212	Synonyms	Carbonate dehydratase XII
TTDR00212	Synonyms	Tumor antigen HOM-RCC-3.1.3
TTDR00212	Disease	Colorectal cancer
TTDR00212	Disease	Gastrointestinal cancers
TTDR00212	Disease	Pancreatic cancer
TTDR00212	Disease	Renal failure
TTDR00212	Function	Reversible hydration of carbon dioxide.
TTDR00212	Sequence	MPRRSLHAAAVLLLVILKEQPSSPAPVNGSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYN
TTDR00212	PDB Structure	1JCZ; 1JD0
TTDR00212	BioChemical Class	Carbon-oxygen lyases
TTDR00212	Pathway	Nitrogen metabolism
TTDR00212	EC Number	EC 4.2.1.1
TTDR00212	Target Validation	TTDR00212
TTDR00212	Inhibitor	1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide
TTDR00212	Inhibitor	1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide
TTDR00212	Inhibitor	2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide
TTDR00212	Inhibitor	2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide
TTDR00212	Inhibitor	2,3-dihydro-1H-indene-5-sulfonamide
TTDR00212	Inhibitor	2,4-Disulfamyltrifluoromethylaniline
TTDR00212	Inhibitor	2-Amino-benzenesulfonamide
TTDR00212	Inhibitor	2-Hydrazino-benzenesulfonamide
TTDR00212	Inhibitor	2-acetamido-2,3-dihydro-1H-indene-5-sulfonic acid
TTDR00212	Inhibitor	2-amino-2,3-dihydro-1H-indene-5-sulfonamide
TTDR00212	Inhibitor	2-amino-2,3-dihydro-1H-indene-5-sulfonic acid
TTDR00212	Inhibitor	2-oxo-2H-chromene-3-carboxylic acid
TTDR00212	Inhibitor	2-oxo-2H-thiochromene-3-carboxylic acid
TTDR00212	Inhibitor	3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide
TTDR00212	Inhibitor	3-(3-Phenyl-ureido)-benzenesulfonamide
TTDR00212	Inhibitor	3-(4'-Aminophenyl)diazenylbenzenesulfonamide
TTDR00212	Inhibitor	3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide
TTDR00212	Inhibitor	3-Amino-benzenesulfonamide
TTDR00212	Inhibitor	4,4'-thiodipyridine-3-sulfonamide
TTDR00212	Inhibitor	4-(2-Amino-ethyl)-benzenesulfonamide
TTDR00212	Inhibitor	4-(2-Hydroxy-ethyl)-benzenesulfonamide
TTDR00212	Inhibitor	4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-(2-Propynylthio)pyridine-3-sulfonamide
TTDR00212	Inhibitor	4-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide
TTDR00212	Inhibitor	4-(4'-N-Methylphenyl)diazenylbenzenesulfonamide
TTDR00212	Inhibitor	4-(4-Cyanophenoxy)-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-(4-Fluorophenoxy)-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-(Allylamino)-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-(Carbamolymethylthio)pyridine-3-sulfonamide
TTDR00212	Inhibitor	4-(Cyanomethylthio)pyridine-3-sulfonamide
TTDR00212	Inhibitor	4-(Methylhydrazino)-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-(N-Methyl-hydrazino)-benzenesulfonamide
TTDR00212	Inhibitor	4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide
TTDR00212	Inhibitor	4-(Quinolinoxy)-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-Amino-3-bromo-benzenesulfonamide
TTDR00212	Inhibitor	4-Amino-3-chloro-benzenesulfonamide
TTDR00212	Inhibitor	4-Amino-3-fluoro-benzenesulfonamide
TTDR00212	Inhibitor	4-Amino-3-iodo-benzenesulfonamide
TTDR00212	Inhibitor	4-Benzenesulfonylamino-benzenesulfonamide
TTDR00212	Inhibitor	4-Benzythiopyridine-3-sulfonamide
TTDR00212	Inhibitor	4-CYANOPHENOL
TTDR00212	Inhibitor	4-Ethoxy-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-Hydrazino-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-Hydrazino-benzenesulfonamide
TTDR00212	Inhibitor	4-Hydroxymethyl-benzenesulfonamide
TTDR00212	Inhibitor	4-Methanesulfonylamino-benzenesulfonamide
TTDR00212	Inhibitor	4-Methoxy-3-pyridinesulfonamide
TTDR00212	Inhibitor	4-Methylamino-benzenesulfonamide
TTDR00212	Inhibitor	4-Methylthiopyridine-3-sulfonamide
TTDR00212	Inhibitor	4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide
TTDR00212	Inhibitor	5-amino-1,3,4-thiadiazole-2-sulfonamide
TTDR00212	Inhibitor	6-(aminomethyl)-2H-chromen-2-one
TTDR00212	Inhibitor	6-(hydroxymethyl)-2H-chromen-2-one
TTDR00212	Inhibitor	6-Hydroxy-benzothiazole-2-sulfonic acid amide
TTDR00212	Inhibitor	6-methoxy-2-oxo-2H-chromene-3-carboxylic acid
TTDR00212	Inhibitor	6-methyl-2-oxo-2H-chromene-3-carboxylic acid
TTDR00212	Inhibitor	7-(benzyloxy)-2H-chromen-2-one
TTDR00212	Inhibitor	7-butoxy-2H-chromen-2-one
TTDR00212	Inhibitor	7-methoxy-2-oxo-2H-chromene-4-carboxylic acid
TTDR00212	Inhibitor	7-phenethoxy-2H-chromen-2-one
TTDR00212	Inhibitor	7-propoxy-2H-chromen-2-one
TTDR00212	Inhibitor	8-methoxy-2-oxo-2H-chromene-3-carboxylic acid
TTDR00212	Inhibitor	ACETYLSULFANILAMIDE
TTDR00212	Inhibitor	BENZOLAMIDE
TTDR00212	Inhibitor	CATECHIN
TTDR00212	Inhibitor	CATECHOL
TTDR00212	Inhibitor	COUMARIN
TTDR00212	Inhibitor	COUMATE
TTDR00212	Inhibitor	CURCUMIN
TTDR00212	Inhibitor	Carzenide;Para-Carboxybenzenesulfonamide (Weak Carbonic Anhydrase Inhibitor)
TTDR00212	Inhibitor	ELLAGIC ACID
TTDR00212	Inhibitor	ETHOXYCOUMARIN
TTDR00212	Inhibitor	FERULIC ACID
TTDR00212	Inhibitor	GALLICACID
TTDR00212	Inhibitor	HERNIARIN
TTDR00212	Inhibitor	INDISULAM
TTDR00212	Inhibitor	MAFENIDE
TTDR00212	Inhibitor	N-(4-Sulfamoyl-phenyl)-benzamide
TTDR00212	Inhibitor	N-(4-Sulfamoyl-phenyl)-butyramide
TTDR00212	Inhibitor	N-(4-Sulfamoyl-phenyl)-isobutyramide
TTDR00212	Inhibitor	N-(4-Sulfamoyl-phenyl)-propionamide
TTDR00212	Inhibitor	N-(4-cyanophenyl)sulfamide
TTDR00212	Inhibitor	N-(pentafluorophenyl)sulfamide
TTDR00212	Inhibitor	N-hydroxysulfamide
TTDR00212	Inhibitor	N-propynyl amidebenzenesulphonide
TTDR00212	Inhibitor	N1-(2-aminoethyl)ethane-1,2-diamine
TTDR00212	Inhibitor	N1-(naphthalen-1-yl)ethane-1,2-diamine
TTDR00212	Inhibitor	O-propynylamide benzenesulphonamide
TTDR00212	Inhibitor	P-TOLUENESULFONAMIDE
TTDR00212	Inhibitor	PARABEN
TTDR00212	Inhibitor	PHENOL
TTDR00212	Inhibitor	Pentanoic acid (4-sulfamoyl-phenyl)-amide
TTDR00212	Inhibitor	RESORCINOL
TTDR00212	Inhibitor	SACCHARIN
TTDR00212	Inhibitor	SALICYLATE
TTDR00212	Inhibitor	Sodium N-methylphenylaminomethanesulfonate
TTDR00212	Inhibitor	Sodium phenylaminomethanesulfonate
TTDR00212	Inhibitor	Syringic Acid
TTDR00212	Inhibitor	Thioureido sulfonamide
TTDR00212	Inhibitor	decane-1,10-diyl disulfamate
TTDR00212	Inhibitor	decyl sulfamate
TTDR00212	Inhibitor	ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate
TTDR00212	Inhibitor	hexane-1,6-diamine
TTDR00212	Inhibitor	octane-1,8-diyl disulfamate
TTDR00212	Inhibitor	octyl sulfamate
TTDR00212	Inhibitor	p-Coumaric Acid
TTDR00212	Inhibitor	pentane-1,5-diamine
TTDR00212	Inhibitor	sulfanilamide derivative
TTDR00213	UniProt ID	Q9ULX7
TTDR00213	Name	Carbonic anhydrase XIV
TTDR00213	Type of target	Research target
TTDR00213	Synonyms	CA-XIV
TTDR00213	Synonyms	Carbonate dehydratase XIV
TTDR00213	Synonyms	UNQ690/PRO1335
TTDR00213	Disease	Renal failure
TTDR00213	Function	Reversible hydration of carbon dioxide.
TTDR00213	Sequence	MLFSALLLEVIWILAADGGQHWTYEGPHGQDHWPASYPECGNNAQSPIDIQTDSVTFDPDLPALQPHGYDQPGTEPLDLH
TTDR00213	BioChemical Class	Carbon-oxygen lyases
TTDR00213	Pathway	Nitrogen metabolism
TTDR00213	EC Number	EC 4.2.1.1
TTDR00213	Target Validation	TTDR00213
TTDR00213	Inhibitor	2,3-dihydro-1H-indene-5-sulfonamide
TTDR00213	Inhibitor	2,4-Disulfamyltrifluoromethylaniline
TTDR00213	Inhibitor	2-Amino-benzenesulfonamide
TTDR00213	Inhibitor	2-acetamido-2,3-dihydro-1H-indene-5-sulfonic acid
TTDR00213	Inhibitor	2-amino-2,3-dihydro-1H-indene-5-sulfonamide
TTDR00213	Inhibitor	2-amino-2,3-dihydro-1H-indene-5-sulfonic acid
TTDR00213	Inhibitor	2-oxo-2H-chromene-3-carboxylic acid
TTDR00213	Inhibitor	2-oxo-2H-thiochromene-3-carboxylic acid
TTDR00213	Inhibitor	3-Amino-benzenesulfonamide
TTDR00213	Inhibitor	4,4'-thiodipyridine-3-sulfonamide
TTDR00213	Inhibitor	4-(2-Amino-ethyl)-benzenesulfonamide
TTDR00213	Inhibitor	4-(2-Hydroxy-ethyl)-benzenesulfonamide
TTDR00213	Inhibitor	4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide
TTDR00213	Inhibitor	4-(2-Propynylthio)pyridine-3-sulfonamide
TTDR00213	Inhibitor	4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide
TTDR00213	Inhibitor	4-(Allylamino)-3-pyridinesulfonamide
TTDR00213	Inhibitor	4-(Carbamolymethylthio)pyridine-3-sulfonamide
TTDR00213	Inhibitor	4-(Cyanomethylthio)pyridine-3-sulfonamide
TTDR00213	Inhibitor	4-(Methylhydrazino)-3-pyridinesulfonamide
TTDR00213	Inhibitor	4-(Quinolinoxy)-3-pyridinesulfonamide
TTDR00213	Inhibitor	4-AMINOPHENOL
TTDR00213	Inhibitor	4-Amino-3-bromo-benzenesulfonamide
TTDR00213	Inhibitor	4-Amino-3-chloro-benzenesulfonamide
TTDR00213	Inhibitor	4-Amino-3-fluoro-benzenesulfonamide
TTDR00213	Inhibitor	4-Amino-3-iodo-benzenesulfonamide
TTDR00213	Inhibitor	4-Benzythiopyridine-3-sulfonamide
TTDR00213	Inhibitor	4-Ethoxy-3-pyridinesulfonamide
TTDR00213	Inhibitor	4-Hydrazino-3-pyridinesulfonamide
TTDR00213	Inhibitor	4-Hydrazino-benzenesulfonamide
TTDR00213	Inhibitor	4-Hydroxymethyl-benzenesulfonamide
TTDR00213	Inhibitor	4-Methylthiopyridine-3-sulfonamide
TTDR00213	Inhibitor	5-amino-1,3,4-thiadiazole-2-sulfonamide
TTDR00213	Inhibitor	6-(aminomethyl)-2H-chromen-2-one
TTDR00213	Inhibitor	6-(hydroxymethyl)-2H-chromen-2-one
TTDR00213	Inhibitor	6-Hydroxy-benzothiazole-2-sulfonic acid amide
TTDR00213	Inhibitor	6-methoxy-2-oxo-2H-chromene-3-carboxylic acid
TTDR00213	Inhibitor	6-methyl-2-oxo-2H-chromene-3-carboxylic acid
TTDR00213	Inhibitor	7-(benzyloxy)-2H-chromen-2-one
TTDR00213	Inhibitor	7-butoxy-2H-chromen-2-one
TTDR00213	Inhibitor	7-methoxy-2-oxo-2H-chromene-4-carboxylic acid
TTDR00213	Inhibitor	7-phenethoxy-2H-chromen-2-one
TTDR00213	Inhibitor	7-propoxy-2H-chromen-2-one
TTDR00213	Inhibitor	8-methoxy-2-oxo-2H-chromene-3-carboxylic acid
TTDR00213	Inhibitor	BENZOLAMIDE
TTDR00213	Inhibitor	Beta-D-Mannose
TTDR00213	Inhibitor	CATECHIN
TTDR00213	Inhibitor	COUMARIN
TTDR00213	Inhibitor	COUMATE
TTDR00213	Inhibitor	CURCUMIN
TTDR00213	Inhibitor	Carzenide;Para-Carboxybenzenesulfonamide (Weak Carbonic Anhydrase Inhibitor)
TTDR00213	Inhibitor	ELLAGIC ACID
TTDR00213	Inhibitor	ETHOXYCOUMARIN
TTDR00213	Inhibitor	FERULIC ACID
TTDR00213	Inhibitor	GALLICACID
TTDR00213	Inhibitor	HERNIARIN
TTDR00213	Inhibitor	INDISULAM
TTDR00213	Inhibitor	MAFENIDE
TTDR00213	Inhibitor	N-propynyl amidebenzenesulphonide
TTDR00213	Inhibitor	N1-(2-aminoethyl)ethane-1,2-diamine
TTDR00213	Inhibitor	N1-(naphthalen-1-yl)ethane-1,2-diamine
TTDR00213	Inhibitor	O-propynylamide benzenesulphonamide
TTDR00213	Inhibitor	PARABEN
TTDR00213	Inhibitor	PHENOL
TTDR00213	Inhibitor	RESORCINOL
TTDR00213	Inhibitor	SPERMINE
TTDR00213	Inhibitor	Syringic Acid
TTDR00213	Inhibitor	TRIENTINE
TTDR00213	Inhibitor	decane-1,10-diyl disulfamate
TTDR00213	Inhibitor	decyl sulfamate
TTDR00213	Inhibitor	ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate
TTDR00213	Inhibitor	hexane-1,6-diamine
TTDR00213	Inhibitor	octane-1,8-diyl disulfamate
TTDR00213	Inhibitor	octyl sulfamate
TTDR00213	Inhibitor	p-Coumaric Acid
TTDR00213	Inhibitor	pentane-1,5-diamine
TTDR00214	UniProt ID	P50993
TTDR00214	Name	Sodium/potassium-transporting ATPase alpha-2 chain
TTDR00214	Type of target	Research target
TTDR00214	Synonyms	Alpha(+)Sodium/potassium-transporting ATPase alpha-2 chain
TTDR00214	Synonyms	Na+/K+ ATPase 2
TTDR00214	Synonyms	Sodium pump 2
TTDR00214	Synonyms	Sodium/potassium-transporting ATPase alpha2
TTDR00214	Disease	Atrial fibrillation and flutter
TTDR00214	Disease	Heart failure
TTDR00214	Function	This is the catalytic component of the active enzyme, which catalyzes the hydrol
TTDR00214	Sequence	MGRGAGREYSPAATTAENGGGKKKQKEKELDELKKEVAMDDHKLSLDELGRKYQVDLSKGLTNQRAQDVLARDGPNALTP
TTDR00214	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00214	Pathway	Cardiac muscle contraction
TTDR00214	EC Number	EC 3.6.3.9
TTDR00217	Name	mRNA of VLA-4
TTDR00217	Type of target	Clinical trial target
TTDR00217	Disease	Allergy, unspecified
TTDR00217	Disease	Multiple sclerosis
TTDR00217	Drug(s)	ATL1102
TTDR00217	Antisense	ATL1102
TTDR00217	Antisense	ISIS 107248
TTDR00218	UniProt ID	O23733
TTDR00218	Name	O-acetylserine sulfhydrylase
TTDR00218	Type of target	Research target
TTDR00218	Synonyms	CSase
TTDR00218	Synonyms	Cysteine synthase
TTDR00218	Synonyms	O-acetylserine (Thiol)-lyase
TTDR00218	Synonyms	OAS-TL
TTDR00218	Synonyms	OAS-TL4
TTDR00218	Disease	Vitamin B6 deficiency
TTDR00218	Sequence	MASRIAKDVTELIGNTPLVYLNNVAEGCVGRVAAKLEMMEPCSSVKDRIGFSMISDAEQKGLIKPGESVLIEPTSGNTGV
TTDR00218	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR00218	EC Number	EC 2.5.1.47
TTDR00218	Activator	Vitamin B6
TTDR00219	UniProt ID	P00492
TTDR00219	UniProt ID	P20035
TTDR00219	UniProt ID	P43152
TTDR00219	UniProt ID	Q27796
TTDR00219	Name	Hypoxanthine-guanine phosphoribosyltransferase
TTDR00219	Type of target	Research target
TTDR00219	Synonyms	GPRT
TTDR00219	Synonyms	Guanine phosphoribosyltransferase
TTDR00219	Synonyms	HGPRT
TTDR00219	Synonyms	HGPRTase
TTDR00219	Synonyms	HPRT
TTDR00219	Synonyms	Hypoxanthine phosphoribosyltransferase
TTDR00219	Disease	Chagas' disease
TTDR00219	Disease	Giardiasis infections
TTDR00219	Disease	Leishmania infections
TTDR00219	Disease	Malaria
TTDR00219	Disease	Parasitic diseases
TTDR00219	Disease	Schistosomiasis [bilharziasis]
TTDR00219	Disease	Sleeping sickness
TTDR00219	Sequence	MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLD
TTDR00219	PDB Structure	1BZY; 1D6N; 1HMP; 1CJB; 2VFA; 1P18; 1P19; 1TC1
TTDR00219	BioChemical Class	Glycosyltransferases
TTDR00219	Pathway	Drug metabolism - other enzymes
TTDR00219	Pathway	Metabolic pathways
TTDR00219	Pathway	Purine metabolism
TTDR00219	EC Number	EC 2.4.2.8
TTDR00219	Target Validation	TTDR00219
TTDR00219	Inhibitor	3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol
TTDR00219	Inhibitor	5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine
TTDR00219	Inhibitor	7-Hydroxy-Pyrazolo[4,3-D]Pyrimidine
TTDR00219	Inhibitor	9-Deazaguanine
TTDR00219	Inhibitor	9-[2-(1-Phosphonobutan-2-yloxy)ethyl]guanine
TTDR00219	Inhibitor	9-[2-(1-Phosphonobutan-2-yloxy)ethyl]hypoxanthine
TTDR00219	Inhibitor	9-[2-(1-Phosphonopropan-2-yloxy)ethyl]guanine
TTDR00219	Inhibitor	Acetate Ion
TTDR00219	Inhibitor	Alpha-Phosphoribosylpyrophosphoric Acid
TTDR00219	Inhibitor	Formic Acid
TTDR00219	Inhibitor	Formycin B
TTDR00219	Inhibitor	Inosinic Acid
TTDR00219	Inhibitor	Pyrophosphate 2-
TTDR00220	Name	Vasopeptidase
TTDR00220	Type of target	Research target
TTDR00220	Disease	Heart failure
TTDR00220	Disease	Hypertension
TTDR00220	Related US Patent	6,140,319
TTDR00220	Related US Patent	6,586,198
TTDR00220	Inhibitor	Fasidotril
TTDR00220	Inhibitor	Gemopatrilat
TTDR00220	Inhibitor	Sampatrilat
TTDR00221	UniProt ID	P08100
TTDR00221	Name	Rhodopsin
TTDR00221	Type of target	Research target
TTDR00221	Synonyms	Opsin 2
TTDR00221	Disease	Vitamin A deficiency
TTDR00221	Function	Visual pigments are the light-absorbing molecules that mediate vision. They cons
TTDR00221	Sequence	MNGTEGPNFYVPFSNATGVVRSPFEYPQYYLAEPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTPLNYILLNLA
TTDR00221	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00221	Target Validation	TTDR00221
TTDR00221	Inhibitor	(Hydroxyethyloxy)Tri(Ethyloxy)Octane
TTDR00221	Inhibitor	Alpha-D-Mannose
TTDR00221	Inhibitor	B-2-Octylglucoside
TTDR00221	Inhibitor	B-Nonylglucoside
TTDR00221	Inhibitor	B-Octylglucoside
TTDR00221	Inhibitor	Beta-D-Mannose
TTDR00221	Inhibitor	Heptane-1,2,3-Triol
TTDR00221	Inhibitor	Heptyl 1-Thiohexopyranoside
TTDR00221	Inhibitor	Hexadecanal
TTDR00221	Inhibitor	Lauryl Dimethylamine-N-Oxide
TTDR00221	Inhibitor	N-Acetylmethionine
TTDR00221	Inhibitor	NSC-88915
TTDR00221	Inhibitor	Palmitic Acid
TTDR00221	Inhibitor	Phosphonoserine
TTDR00221	Inhibitor	Phosphonothreonine
TTDR00221	Activator	Vitamin A
TTDR00222	UniProt ID	P17174
TTDR00222	Name	Aspartate aminotransferase, cytoplasmic
TTDR00222	Type of target	Research target
TTDR00222	Synonyms	Glutamate oxaloacetate transaminase-1
TTDR00222	Synonyms	Transaminase A
TTDR00222	Disease	Vitamin B6 deficiency
TTDR00222	Sequence	MAPPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQKIANDNSLNHEYLPILGLAEF
TTDR00222	BioChemical Class	Transferases transferring nitrogenous groups
TTDR00222	Pathway	Alanine, aspartate and glutamate metabolism
TTDR00222	Pathway	Alkaloid biosynthesis I
TTDR00222	Pathway	Arginine and proline metabolism
TTDR00222	Pathway	Cysteine metabolism
TTDR00222	Pathway	Metabolic pathways
TTDR00222	Pathway	Phenylalanine metabolism
TTDR00222	Pathway	Phenylalanine, tyrosine and tryptophan biosynthesis
TTDR00222	Pathway	Tyrosine metabolism
TTDR00222	EC Number	EC 2.6.1.1
TTDR00222	Inhibitor	Aminooxyacetate
TTDR00222	Inhibitor	Maleic Acid
TTDR00222	Activator	Vitamin B6
TTDR00223	UniProt ID	P28269
TTDR00223	Name	Omega-amino acid:pyruvate aminotransferase
TTDR00223	Type of target	Research target
TTDR00223	Synonyms	Beta-alanine--pyruvate aminotransferase
TTDR00223	Synonyms	Omega-APT
TTDR00223	Disease	Vitamin B6 deficiency
TTDR00223	Function	Catalyzes transamination between a variety of omega- amino acids, mono and diami
TTDR00223	Sequence	NMPEHAGASLASQLKLDAHWMPYTANRNFLRDPRLIVAAEGSWLVDDKGRKVYDSLSGLWTCGAGHTRKEIQEAVAKQLS
TTDR00223	BioChemical Class	Transferases transferring nitrogenous groups
TTDR00223	EC Number	EC 2.6.1.18
TTDR00223	Activator	Vitamin B6
TTDR00224	UniProt ID	P12004
TTDR00224	UniProt ID	P20248
TTDR00224	Name	Cyclin-A2
TTDR00224	Name	Proliferating cell nuclear antigen
TTDR00224	Type of target	Research target
TTDR00224	Synonyms	Cyclin
TTDR00224	Synonyms	Cyclin-A; CCNA2; CCNA2;
TTDR00224	Synonyms	PCNA
TTDR00224	Disease	Cardiovascular disease, unspecified
TTDR00224	Function	Essential for the control of the cell cycle at the G1/S (start) and the G2/M (mi
TTDR00224	Function	This protein is an auxiliary protein of dna polymerase delta and is involved in
TTDR00224	Sequence	MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILK
TTDR00224	PDB Structure	1AXC; 1U76; 1U7B; 1UL1; 1VYJ; 1VYM; 1W60; 2ZVK
TTDR00224	PDB Structure	1E9H; 1FIN; 1FVV; 1GY3; 1H1P; 1H1Q; 1H1R; 1H1S; 1H24; 1H25; 1H26; 1H27; 1H28; 1J
TTDR00224	Pathway	Base excision repair
TTDR00224	Pathway	Cell cycle
TTDR00224	Pathway	DNA replication
TTDR00224	Pathway	Mismatch repair
TTDR00224	Pathway	Nucleotide excision repair
TTDR00224	Target Validation	TTDR00224
TTDR00224	Drug(s)	
TTDR00224	Inhibitor	2,5-dichloro-N-p-tolylthiophene-3-sulfonamide
TTDR00224	Inhibitor	3-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol
TTDR00224	Inhibitor	4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)-phenol
TTDR00224	Inhibitor	4-(phenyldiazenyl)-1H-pyrazole-3,5-diamine
TTDR00224	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDR00224	Inhibitor	6-(3-Amino-benzyloxy)-9H-purin-2-ylamine
TTDR00224	Inhibitor	6-(3-Methyl-benzyloxy)-9H-purin-2-ylamine
TTDR00224	Inhibitor	6-(Cyclohex-3-enylmethoxy)-9H-purin-2-ylamine
TTDR00224	Inhibitor	6-Cyclohexylmethoxy-pyrimidine-2,4,5-triamine
TTDR00224	Inhibitor	GW-8510
TTDR00224	Inhibitor	MERIOLIN 1
TTDR00224	Inhibitor	MERIOLIN 2
TTDR00224	Inhibitor	MERIOLIN 3
TTDR00224	Inhibitor	MERIOLIN 4
TTDR00224	Inhibitor	MERIOLIN 5
TTDR00224	Inhibitor	MERIOLIN 6
TTDR00224	Inhibitor	MERIOLIN 7
TTDR00224	Inhibitor	MERIOLIN 8
TTDR00224	Inhibitor	NU-2058
TTDR00224	Inhibitor	NU-6027
TTDR00224	Inhibitor	PD-0183812
TTDR00224	Inhibitor	PURVALANOLA
TTDR00224	Inhibitor	RESCOVITINE
TTDR00224	Inhibitor	SB-216763
TTDR00225	UniProt ID	P01130
TTDR00225	Name	Low-density lipoprotein receptor
TTDR00225	Type of target	Research target
TTDR00225	Synonyms	LDL receptor
TTDR00225	Disease	Parkinson's disease
TTDR00225	Function	Binds ldl, the major cholesterol-carrying lipoprotein of plasma, and transports
TTDR00225	Sequence	MGPWGWKLRWTVALLLAAAGTAVGDRCERNEFQCQDGKCISYKWVCDGSAECQDGSDESQETCLSVTCKSGDFSCGGRVN
TTDR00225	PDB Structure	1HZ8; 1I0U; 1IJQ; 1LDL; 1LDR; 1LRX; 1N7D; 1XFE
TTDR00225	BioChemical Class	Growth factor
TTDR00225	Inhibitor	Alpha-D-Mannose
TTDR00226	UniProt ID	P34897
TTDR00226	UniProt ID	Q8I566
TTDR00226	Name	Serine hydroxymethyltransferase, mitochondrial
TTDR00226	Type of target	Research target
TTDR00226	Synonyms	Glycine hydroxymethyltransferase
TTDR00226	Synonyms	SHMT
TTDR00226	Synonyms	Serine methylase
TTDR00226	Disease	Cancer, unspecific
TTDR00226	Disease	Malaria
TTDR00226	Function	Interconversion of serine and glycine.
TTDR00226	Sequence	MLYFSLFWAARPLQRCGQLVRMAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFC
TTDR00226	PDB Structure	2A7V
TTDR00226	BioChemical Class	Transferases transferring one-carbon groups
TTDR00226	Pathway	Cyanoamino acid metabolism
TTDR00226	Pathway	Glycine, serine and threonine metabolism
TTDR00226	Pathway	Metabolic pathways
TTDR00226	Pathway	Methane metabolism
TTDR00226	Pathway	One carbon pool by folate
TTDR00226	EC Number	EC 2.1.2.1
TTDR00226	Inhibitor	Mimosine
TTDR00228	UniProt ID	P06982
TTDR00228	UniProt ID	Q6A1Q1
TTDR00228	Name	DNA gyrase B subunit
TTDR00228	Type of target	Research target
TTDR00228	Disease	Bacterial infections
TTDR00228	Function	Dna gyrase negatively supercoils closed circular double- stranded dna in an atp-
TTDR00228	Sequence	MSNSYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGHCKEIIVTIHADNSVSVQDDGRGIPT
TTDR00228	PDB Structure	1AJ6; 1EI1; 1KZN
TTDR00228	BioChemical Class	Isomerases
TTDR00228	EC Number	EC 5.99.1.3
TTDR00228	Inhibitor	BAY 50-7952
TTDR00228	Inhibitor	Coumermycin
TTDR00229	UniProt ID	P18898
TTDR00229	Name	Geranylgeranyltransferase I
TTDR00229	Type of target	Research target
TTDR00229	Synonyms	GGTase-I-beta
TTDR00229	Synonyms	PGGT
TTDR00229	Synonyms	RAS proteins geranylgeranyltransferase beta subunit
TTDR00229	Synonyms	Type I protein geranyl-geranyltransferase beta subunit
TTDR00229	Disease	Cancer, unspecific
TTDR00229	Disease	Fungal diseases
TTDR00229	Function	Catalyzes the transfer of a geranyl-geranyl moiety from geranyl-geranyl pyrophos
TTDR00229	Sequence	MCQATNGPSRVVTKKHRKFFERHLQLLPSSHQGHDVNRMAIIFYSISGLSIFDVNVSAKYGDHLGWMRKHYIKTVLDDTE
TTDR00229	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR00229	EC Number	EC 2.5.1.-
TTDR00229	EC Number	EC 2.5.1.59
TTDR00229	Related US Patent	6,355,643
TTDR00229	Related US Patent	6,387,903
TTDR00229	Inhibitor	GGTI-298
TTDR00229	Inhibitor	J-109,390
TTDR00229	Inhibitor	L-269,289
TTDR00230	UniProt ID	Q9UNI1
TTDR00230	Name	Elastase 1
TTDR00230	Type of target	Research target
TTDR00230	Synonyms	Elastase
TTDR00230	Disease	Arthritis
TTDR00230	Disease	Emphysema
TTDR00230	Function	Acts upon elastin.
TTDR00230	Sequence	MLVLYGHSTQDLPETNARVVGGTEAGRNSWPSQISLQYRSGGSRYHTCGGTLIRQNWVMTAAHCVDYQKTFRVVAGDHNL
TTDR00230	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00230	EC Number	EC 3.4.21.36
TTDR00230	Related US Patent	6,265,381
TTDR00230	Related US Patent	6,509,368
TTDR00230	Target Validation	TTDR00230
TTDR00230	Inhibitor	(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE
TTDR00230	Inhibitor	(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine
TTDR00230	Inhibitor	Acetate Ion
TTDR00230	Inhibitor	Acetyl-Ala-Ala-Pro-Ala-trifluromethane
TTDR00230	Inhibitor	Acetyl-Pro-Ala-Pro-Ala-trifluoro methane
TTDR00230	Inhibitor	Alpha 1-PI
TTDR00230	Inhibitor	Dimethylformamide
TTDR00230	Inhibitor	GRASSYSTATIN A
TTDR00230	Inhibitor	MOLASSAMIDE
TTDR00230	Inhibitor	Mdl 101,146
TTDR00230	Inhibitor	ONO-6818
TTDR00230	Inhibitor	Para-Isopropylaniline
TTDR00230	Inhibitor	Sivelestat
TTDR00231	UniProt ID	P08244
TTDR00231	UniProt ID	P11172
TTDR00231	Name	Orotidine 5'-monophosphate decarboxylase
TTDR00231	Type of target	Research target
TTDR00231	Synonyms	OMP decarboxylase
TTDR00231	Synonyms	OMPDCase
TTDR00231	Synonyms	OMPdecase
TTDR00231	Synonyms	Orotidine decarboxylase
TTDR00231	Disease	Viral infection, unspecified
TTDR00231	Sequence	MTLTASSSSRAVTNSPVVVALDYHNRDDALAFVDKIDPRDCRLKVGKEMFTLFGPQFVRELQQRGFDIFLDLKFHDIPNT
TTDR00231	PDB Structure	1EIX; 1JJK; 1L2U; 2QCC; 2QCD; 2QCE; 2QCF; 2QCG
TTDR00231	BioChemical Class	Carbon-carbon lyases
TTDR00231	Pathway	Drug metabolism - other enzymes
TTDR00231	Pathway	Metabolic pathways
TTDR00231	Pathway	Pyrimidine metabolism
TTDR00231	EC Number	EC 4.1.1.23
TTDR00231	Target Validation	TTDR00231
TTDR00231	Inhibitor	5-Fluoro-6-ethyluridine-5'-O-monophosphate
TTDR00231	Inhibitor	5-fluoro-6-amino-UMP
TTDR00231	Inhibitor	5-fluoro-6-azido-UMP
TTDR00231	Inhibitor	5-fluoro-6-iodo-UMP
TTDR00231	Inhibitor	6-Hydroxyuridine-5'-Phosphate
TTDR00231	Inhibitor	Pyrazofurin
TTDR00232	UniProt ID	Q16873
TTDR00232	Name	Leukotriene C4 synthase
TTDR00232	Type of target	Research target
TTDR00232	Synonyms	LTC4 synthase
TTDR00232	Synonyms	Leukotriene-C(4) synthase
TTDR00232	Synonyms	Leukotriene-C(4)Leukotriene C4 synthase synthase
TTDR00232	Disease	Asthma
TTDR00232	Function	Catalyzes the conjugation of leukotriene a4 with reduced glutathione to form leu
TTDR00232	Sequence	MKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAA
TTDR00232	PDB Structure	2PNO; 2UUH; 2UUI
TTDR00232	BioChemical Class	Carbon-sulfur lyases
TTDR00232	Pathway	Arachidonic acid metabolism
TTDR00232	Pathway	Metabolic pathways
TTDR00232	EC Number	EC 2.5.1.37
TTDR00232	EC Number	EC 4.4.1.20
TTDR00233	UniProt ID	Q06187
TTDR00233	Name	Tyrosine-protein kinase BTK
TTDR00233	Type of target	Clinical trial target
TTDR00233	Synonyms	ATK
TTDR00233	Synonyms	Agammaglobulinaemia tyrosine kinase
TTDR00233	Synonyms	B cell progenitor kinase
TTDR00233	Synonyms	BPK
TTDR00233	Synonyms	Bruton's tyrosine kinase
TTDR00233	Disease	Acute lymphoblastic leukaemia
TTDR00233	Disease	B cell immunodeficiency
TTDR00233	Function	Plays a crucial role in b-cell ontogeny. Transiently phosphorylates gtf2i on tyr
TTDR00233	Sequence	MAAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIP
TTDR00233	PDB Structure	1AWW; 1B55; 1BTK; 1BWN; 1K2P; 1QLY; 2GE9; 2Z0P
TTDR00233	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00233	Pathway	B cell receptor signaling pathway
TTDR00233	Pathway	Fc epsilon RI signaling pathway
TTDR00233	Pathway	Primary immunodeficiency
TTDR00233	EC Number	EC 2.7.1.112
TTDR00233	Related US Patent	6,294,575
TTDR00233	Related US Patent	6,365,626
TTDR00233	Target Validation	TTDR00233
TTDR00233	Inhibitor	Inositol 1,3,4,5-Tetrakisphosphate
TTDR00233	Inhibitor	Inositol-(1,3,4,5)-Tetrakisphosphate
TTDR00233	Inhibitor	LFM-A13
TTDR00234	UniProt ID	O15296
TTDR00234	UniProt ID	P16050
TTDR00234	Name	Arachidonate 15-lipoxygenase
TTDR00234	Type of target	Research target
TTDR00234	Synonyms	15-LOX
TTDR00234	Synonyms	15-Lipoxygenase
TTDR00234	Synonyms	Arachidonate omega-6 lipoxygenase
TTDR00234	Disease	Atherosclerosis
TTDR00234	Disease	Prostate cancer
TTDR00234	Disease	Vascular disease
TTDR00234	Function	Converts arachidonic acid to 15s- hydroperoxyeicosatetraenoic acid. Also acts on
TTDR00234	Sequence	MGLYRIRVSTGASLYAGSNNQVQLWLVGQHGEAALGKRLWPARGKETELKVEVPEYLGPLLFVKLRKRHLLKDDAWFCNW
TTDR00234	PDB Structure	2ABT
TTDR00234	BioChemical Class	Oxidoreductases acting on single donors
TTDR00234	Pathway	Arachidonic acid metabolism
TTDR00234	Pathway	Linoleic acid metabolism
TTDR00234	Pathway	Metabolic pathways
TTDR00234	EC Number	EC 1.13.11.33
TTDR00234	Related US Patent	6,479,546
TTDR00234	Target Validation	TTDR00234
TTDR00234	Inhibitor	(+)-(5S,8S,10S)-20-methoxy-9,15-ene-puupehenol
TTDR00234	Inhibitor	(+)-(5S,8S,10S)-20-methoxypuupehenol
TTDR00234	Inhibitor	(+)-(5S,8S,9R,10S)-20-methoxypuupehenone
TTDR00234	Inhibitor	(+)-3,3'-bisdemethyltanegool
TTDR00234	Inhibitor	(-)-3,3'-bisdemethylpinoresinol
TTDR00234	Inhibitor	(-)-pinoresinol
TTDR00234	Inhibitor	(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID
TTDR00234	Inhibitor	2,3,4,5-Tetrabromo-6-(2,4-dibromo-phenoxy)-phenol
TTDR00234	Inhibitor	3,4,6-Tribromo-2-(2,4-dibromo-phenoxy)-phenol
TTDR00234	Inhibitor	3,4-Dibromo-2-(5-bromo-2-hydroxy-phenoxy)-phenol
TTDR00234	Inhibitor	3,6,8-Tribromo-dibenzo[1,4]dioxin-1-ol
TTDR00234	Inhibitor	Benzothiopyranoindole
TTDR00234	Inhibitor	CHLOROPUUPEHENONE
TTDR00234	Inhibitor	DYSIDENIN
TTDR00234	Inhibitor	IGERNELLIN
TTDR00234	Inhibitor	ISOSCOPOLETIN
TTDR00234	Inhibitor	JASPAQUINOL
TTDR00234	Inhibitor	KAEMPFEROL
TTDR00234	Inhibitor	NSC-172033
TTDR00234	Inhibitor	NSC-30552
TTDR00234	Inhibitor	NSC-661755
TTDR00234	Inhibitor	Nonsteroidal anti-inflammatory drugs (NSAIDs)
TTDR00234	Inhibitor	PD-146176
TTDR00234	Inhibitor	PUUPEHEDIONE
TTDR00234	Inhibitor	PUUPEHENONE
TTDR00234	Inhibitor	SCOPOLETIN
TTDR00234	Inhibitor	SPONGIADIOXIN A
TTDR00234	Inhibitor	dimethylnordihydroguarierate acid
TTDR00234	Inhibitor	halisulfate 1
TTDR00234	Inhibitor	hydrohalisulfate 1
TTDR00234	Inhibitor	isojaspic acid
TTDR00234	Inhibitor	jaspic acid
TTDR00234	Inhibitor	polybrominated diphenyl ether derivative
TTDR00234	Inhibitor	subersic acid
TTDR00236	UniProt ID	P23008
TTDR00236	UniProt ID	P33515
TTDR00236	Name	Genome polyprotein
TTDR00236	Name	Rhinovirus coat protein
TTDR00236	Type of target	Research target
TTDR00236	Disease	Acute nasopharyngitis [common cold]
TTDR00236	Function	Serine protease NS3 displays three enzymatic activities: serine protease, NTPase
TTDR00236	Sequence	MGAGVSRQNVGTHSTQNSVSNGSSLNYFNINYFKDAASSGASRLDSPSVEACGYSDRIMQITRGDSTISSDDVANAVVGY
TTDR00236	PDB Structure	1AYM; 1AYN; 1R1A; 2HWD; 2HWE; 2HWF
TTDR00236	Drug(s)	
TTDR00236	Inhibitor	Lauric Acid
TTDR00236	Inhibitor	MYRISTIC ACID
TTDR00237	UniProt ID	Q62968
TTDR00237	Name	PN3 Na+ channel
TTDR00237	Type of target	Research target
TTDR00237	Disease	Analgesics
TTDR00237	Disease	Bladder pain
TTDR00237	Sequence	MELPFASVGTTNFRRFTPESLAEIEKQIAAHRAAKKARTKHRGQEDKGEKPRPQLDLKACNQLPKFYGELPAELVGEPLE
TTDR00237	BioChemical Class	Voltage-gated channel
TTDR00237	Target Validation	TTDR00237
TTDR00237	Inhibitor	1-[5-(4-Chlorophenyl)-2-furoyl]piperazine
TTDR00237	Inhibitor	5-(4-chlorophenyl)-N-(2-methylbenzyl)nicotinamide
TTDR00237	Inhibitor	N-(2-chlorobenzyl)-5-(4-chlorophenyl)nicotinamide
TTDR00237	Inhibitor	N-benzyl-5-(4-chlorophenyl)nicotinamide
TTDR00237	Inhibitor	PD-32577
TTDR00237	Binder	New analgesic drugs
TTDR00238	UniProt ID	P48357
TTDR00238	Name	Leptin receptor
TTDR00238	Type of target	Research target
TTDR00238	Synonyms	HuB219
TTDR00238	Synonyms	LEP-R
TTDR00238	Synonyms	OB receptor
TTDR00238	Synonyms	OB-R
TTDR00238	Disease	Obesity
TTDR00238	Function	Receptor for obesity factor (leptin). Involved in the regulation of fat metaboli
TTDR00238	Sequence	MICQKFCVVLLHWEFIYVITAFNLSYPITPWRFKLSCMPPNSTYDYFLLPAGLSKNTSNSNGHYETAVEPKFNSSGTHFS
TTDR00238	BioChemical Class	Transmembrane protein
TTDR00238	Pathway	Adipocytokine signaling pathway
TTDR00238	Pathway	Cytokine-cytokine receptor interaction
TTDR00238	Pathway	Jak-STAT signaling pathway
TTDR00238	Pathway	Neuroactive ligand-receptor interaction
TTDR00239	UniProt ID	P18054
TTDR00239	Name	Arachidonate 12-lipoxygenase, 12S-type
TTDR00239	Type of target	Research target
TTDR00239	Synonyms	12-LOX
TTDR00239	Synonyms	12-lipoxygenase
TTDR00239	Synonyms	Platelet-type lipoxygenase 12
TTDR00239	Disease	Alzheimer's disease
TTDR00239	Disease	Melanoma
TTDR00239	Function	Oxygenase and 14,15-leukotriene a4 synthase activity.
TTDR00239	Sequence	MGRYRIRVATGAWLFSGSYNRVQLWLVGTRGEAELELQLRPARGEEEEFDHDVAEDLGLLQFVRLRKHHWLVDDAWFCDR
TTDR00239	PDB Structure	2ABU; 3D3L
TTDR00239	BioChemical Class	Oxidoreductases acting on single donors
TTDR00239	Pathway	Arachidonic acid metabolism
TTDR00239	Pathway	Metabolic pathways
TTDR00239	EC Number	EC 1.13.11.31
TTDR00239	Related US Patent	6,479,546
TTDR00239	Target Validation	TTDR00239
TTDR00239	Inhibitor	(+)-(5S,8S,10S)-20-methoxy-9,15-ene-puupehenol
TTDR00239	Inhibitor	(+)-(5S,8S,10S)-20-methoxypuupehenol
TTDR00239	Inhibitor	(+)-(5S,8S,9R,10S)-20-methoxypuupehenone
TTDR00239	Inhibitor	(-)-7-N-methyldibromophakellin
TTDR00239	Inhibitor	2,3,4,5-Tetrabromo-6-(2,4-dibromo-phenoxy)-phenol
TTDR00239	Inhibitor	3,4,6-Tribromo-2-(2,4-dibromo-phenoxy)-phenol
TTDR00239	Inhibitor	CGS-23885
TTDR00239	Inhibitor	CHLOROPUUPEHENONE
TTDR00239	Inhibitor	DYSIDENIN
TTDR00239	Inhibitor	NEODYSIDENIN
TTDR00239	Inhibitor	NSC-125034
TTDR00239	Inhibitor	NSC-172033
TTDR00239	Inhibitor	NSC-292213
TTDR00239	Inhibitor	NSC-30552
TTDR00239	Inhibitor	NSC-661755
TTDR00239	Inhibitor	PUUPEHEDIONE
TTDR00239	Inhibitor	PUUPEHENONE
TTDR00239	Inhibitor	dimethylnordihydroguarierate acid
TTDR00239	Inhibitor	isojaspic acid
TTDR00239	Inhibitor	jaspic acid
TTDR00239	Inhibitor	polybrominated diphenyl ether derivative
TTDR00240	UniProt ID	P03950
TTDR00240	Name	Angiogenin
TTDR00240	Type of target	Research target
TTDR00240	Synonyms	RNase 5
TTDR00240	Synonyms	Ribonuclease 5
TTDR00240	Disease	Cancer, unspecific
TTDR00240	Function	May function as a trna-specific ribonuclease that binds to actin on the surface
TTDR00240	Sequence	MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAI
TTDR00240	PDB Structure	1H52; 1H53; 1HBY; 1K58; 1K59; 1K5A; 1K5B; 1UN3
TTDR00240	BioChemical Class	Hydrolases acting on ester bonds
TTDR00240	EC Number	EC 3.1.27.-
TTDR00240	Inhibitor	Oltipraz
TTDR00240	Inhibitor	Pyroglutamic Acid
TTDR00240	Inhibitor	Pyrophosphate 2-
TTDR00241	Name	2-oxoglutarate decarboxylase
TTDR00241	Type of target	Research target
TTDR00241	Synonyms	Alpha-ketoglutarate decarboxylase
TTDR00241	Synonyms	Alpha-ketoglutarate-decarboxylase
TTDR00241	Synonyms	Alpha-ketoglutaric acid decarboxylase
TTDR00241	Synonyms	KDC
TTDR00241	Disease	Thiamine deficiency
TTDR00241	EC Number	EC 4.1.1.71
TTDR00242	UniProt ID	Q16678
TTDR00242	Name	Cytochrome P450 1B1
TTDR00242	Type of target	Research target
TTDR00242	Synonyms	CYP1B1
TTDR00242	Synonyms	CYPIB1
TTDR00242	Disease	Breast cancer
TTDR00242	Disease	Colon adenocarcinoma
TTDR00242	Disease	Prostate cancer
TTDR00242	Function	Cytochromes p450 are a group of heme-thiolate monooxygenases. In liver microsome
TTDR00242	Sequence	MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSAPPGPFAWPLIGNAAAVGQAAHLSFARLARR
TTDR00242	BioChemical Class	Oxidoreductases acting on paired donors
TTDR00242	Pathway	Metabolism of xenobiotics by cytochrome P450
TTDR00242	Pathway	Tryptophan metabolism
TTDR00242	EC Number	EC 1.14.14.1
TTDR00242	Target Validation	TTDR00242
TTDR00242	Inhibitor	2-[2-(3,5-Dimethoxy-phenyl)-vinyl]-thiophene
TTDR00242	Inhibitor	3-[2-(3,5-Dimethoxy-phenyl)-vinyl]-furan
TTDR00242	Inhibitor	4-[2-(3,5-Dimethoxy-phenyl)-vinyl]-pyridine
TTDR00242	Inhibitor	ACACETIN
TTDR00242	Inhibitor	APIGENIN
TTDR00242	Inhibitor	CHRYSIN
TTDR00242	Inhibitor	CHRYSOERIOL
TTDR00242	Inhibitor	DIOSMETIN
TTDR00242	Inhibitor	ERIODICTYOL
TTDR00242	Inhibitor	GALANGIN
TTDR00242	Inhibitor	HOMOERIODICTYOL
TTDR00242	Inhibitor	ISORHAMNETIN
TTDR00242	Inhibitor	ISOSAKUTANETIN
TTDR00242	Inhibitor	KAEMPFERIDE
TTDR00242	Inhibitor	KAEMPFEROL
TTDR00242	Inhibitor	N-(2,4-Dimethoxy-phenyl)-3,5-dimethoxy-benzamide
TTDR00242	Inhibitor	NARINGENIN
TTDR00242	Inhibitor	PINOCEMBRIN
TTDR00242	Inhibitor	TAMARIXETIN
TTDR00242	Inhibitor	TRISMETHOXYRESVERATROL
TTDR00243	Name	Oncogenic GTP-binding protein
TTDR00243	Type of target	Research target
TTDR00243	Disease	Cancer, unspecific
TTDR00244	Name	Integrin alpha V beta 3
TTDR00244	Type of target	Research target
TTDR00244	Synonyms	Alpha v beta 3 integrin
TTDR00244	Synonyms	Alpha(v)beta(3) Integrin
TTDR00244	Synonyms	Integrin alpha-v beta-3
TTDR00244	Synonyms	Integrin alphaVbeta3
TTDR00244	Synonyms	Vitronectin Receptor
TTDR00244	Disease	Angiogenesis
TTDR00244	Disease	Kaposi's sarcoma
TTDR00244	Disease	Rheumatoid arthritis, unspecified
TTDR00244	Disease	Tumor angiogenesis
TTDR00244	Related US Patent	6,191,304
TTDR00244	Related US Patent	6,268,378
TTDR00244	Related US Patent	6,387,895
TTDR00244	Related US Patent	6,399,620
TTDR00244	Related US Patent	6,458,784
TTDR00244	Related US Patent	6,458,814
TTDR00244	Related US Patent	6,482,821
TTDR00244	Related US Patent	6,492,356
TTDR00244	Related US Patent	6,495,545
TTDR00244	Related US Patent	6,495,560
TTDR00244	Related US Patent	6,511,649
TTDR00244	Related US Patent	6,566,366
TTDR00244	Related US Patent	6,569,402
TTDR00244	Related US Patent	6,576,643
TTDR00244	Related US Patent	6,586,187
TTDR00244	Related US Patent	6,620,820
TTDR00244	Related US Patent	6,660,728
TTDR00244	Antagonist	Cilengitide
TTDR00244	Antagonist	IS20I
TTDR00244	Antagonist	Vitaxin
TTDR00247	UniProt ID	Q99707
TTDR00247	Name	5-methyltetrahydrofolate--homocysteine methyltransferase
TTDR00247	Type of target	Research target
TTDR00247	Synonyms	5-methyltetrahydrofolate homocysteine methyltransferase
TTDR00247	Synonyms	5-methyltetrahydrofolate-homocysteine methyltransferase
TTDR00247	Synonyms	5-methyltetrahydrofolate:homocysteine methyltransferase
TTDR00247	Synonyms	B12 dependent methionine synthetase
TTDR00247	Synonyms	Cobalamin-dependent methionine synthase
TTDR00247	Synonyms	MS
TTDR00247	Synonyms	Methionine synthase, vitamin-B12 dependent
TTDR00247	Disease	Cancer, unspecific
TTDR00247	Disease	Myeloneuropathy
TTDR00247	Disease	Vitamin B12 deficiency
TTDR00247	Sequence	MSPALQDLSQPEGLKKTLRDEINAILQKRIMVLDGGMGTMIQREKLNEEHFRGQEFKDHARPLKGNNDILSITQPDVIYQ
TTDR00247	PDB Structure	2O2K
TTDR00247	BioChemical Class	Transferases transferring one-carbon groups
TTDR00247	Pathway	Metabolic pathways
TTDR00247	Pathway	Methionine metabolism
TTDR00247	Pathway	One carbon pool by folate
TTDR00247	EC Number	EC 2.1.1.13
TTDR00248	Name	V beta 14 T-cell receptor
TTDR00248	Type of target	Research target
TTDR00248	Disease	Arthritis
TTDR00249	UniProt ID	P04181
TTDR00249	Name	Ornithine aminotransferase, mitochondrial
TTDR00249	Type of target	Research target
TTDR00249	Synonyms	Ornithine--oxo-acid aminotransferase
TTDR00249	Disease	Hyperammonemia
TTDR00249	Sequence	MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFD
TTDR00249	PDB Structure	1GBN; 1OAT; 2BYJ; 2BYL; 2CAN; 2OAT
TTDR00249	BioChemical Class	Transferases transferring nitrogenous groups
TTDR00249	Pathway	Arginine and proline metabolism
TTDR00249	Pathway	Metabolic pathways
TTDR00249	EC Number	EC 2.6.1.13
TTDR00249	Inhibitor	Canaline
TTDR00249	Inhibitor	Gabaculine
TTDR00249	Inhibitor	L-canaline
TTDR00250	UniProt ID	Q04206
TTDR00250	UniProt ID	Q9GLG5
TTDR00250	Name	Nuclear factor NF-kappa-B
TTDR00250	Type of target	Research target
TTDR00250	Synonyms	NF-kappa B
TTDR00250	Synonyms	NF-kappaB
TTDR00250	Synonyms	NFKB
TTDR00250	Synonyms	Nuclear factor kappaB
TTDR00250	Synonyms	Nuclear factor-kappaB
TTDR00250	Disease	Atherosclerosis
TTDR00250	Disease	Autoimmune diseases
TTDR00250	Disease	B-cell lymphoma
TTDR00250	Disease	Breast cancer
TTDR00250	Disease	Cachexia
TTDR00250	Disease	Cancer, unspecific
TTDR00250	Disease	Cardiovascular disease, unspecified
TTDR00250	Disease	Chronic inflammatory diseases
TTDR00250	Disease	Chronic myeloid leukemia
TTDR00250	Disease	Embolic focal cerebral ischemia
TTDR00250	Disease	Eosinophilic diseases
TTDR00250	Disease	Gammaherpesvirus-related malignancies
TTDR00250	Disease	Gastric cancer
TTDR00250	Disease	Graft-versus-host disease (acute) (chronic)
TTDR00250	Disease	Human immunodeficiency virus [HIV] disease
TTDR00250	Disease	Inflammatory bowel disease
TTDR00250	Disease	Inflammatory diseases
TTDR00250	Disease	Ischemic renal injury
TTDR00250	Disease	Migraine
TTDR00250	Disease	Multiple myeloma
TTDR00250	Disease	Myocardial hypertrophy
TTDR00250	Disease	Neutrophil-mediated disorders
TTDR00250	Disease	Prostate cancer
TTDR00250	Disease	Prostate cancer (hormone refractory)
TTDR00250	Disease	Pulmonary fibrosis
TTDR00250	Disease	Restenosis
TTDR00250	Disease	Rheumatoid arthritis, unspecified
TTDR00250	Disease	Shock (endotoxin)
TTDR00250	Disease	Solid tumor
TTDR00250	Disease	Systemic inflammatory response syndrome
TTDR00250	Disease	Thrombosis
TTDR00250	Disease	Vascular inflammatory reaction
TTDR00250	Sequence	MDELFPLIFPAEPAQASGPYVEIIEQPKQRGMRFRYKCEGRSAGSIPGERSTDTTKTHPTIKINGYTGPGTVRISLVTKD
TTDR00250	PDB Structure	1NFI; 2O61
TTDR00250	Pathway	Acute myeloid leukemia
TTDR00250	Pathway	Adipocytokine signaling pathway
TTDR00250	Pathway	Apoptosis
TTDR00250	Pathway	B cell receptor signaling pathway
TTDR00250	Pathway	Chemokine signaling pathway
TTDR00250	Pathway	Chronic myeloid leukemia
TTDR00250	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR00250	Pathway	MAPK signaling pathway
TTDR00250	Pathway	Pancreatic cancer
TTDR00250	Pathway	Pathways in cancer
TTDR00250	Pathway	Prostate cancer
TTDR00250	Pathway	Small cell lung cancer
TTDR00250	Pathway	T cell receptor signaling pathway
TTDR00250	Pathway	Toll-like receptor signaling pathway
TTDR00250	Related US Patent	6,479,635
TTDR00250	Related US Patent	6,492,425
TTDR00250	Related US Patent	6,610,745
TTDR00250	Related US Patent	6,673,897
TTDR00250	Target Validation	TTDR00250
TTDR00250	QSAR Model	TTDR00250
TTDR00250	Inhibitor	15-ACETOXY-EREMANTHOLIDE B
TTDR00250	Inhibitor	15-DEOXYBUDLEIN A
TTDR00250	Inhibitor	15-deoxygoiazensolide
TTDR00250	Inhibitor	15-isobutyrylmiguanin
TTDR00250	Inhibitor	1beta-methoxy-miller-9Z-enolide
TTDR00250	Inhibitor	2-amino-N-(quinolin-8-yl)benzenesulfonamide
TTDR00250	Inhibitor	2-nitro-N-(quinolin-8-yl)benzenesulfonamide
TTDR00250	Inhibitor	2-oxoguaia-1,4(15), 11(13)-trien-12,8beta-olide
TTDR00250	Inhibitor	2-oxoguaia-1,4,11(13)-trien-12,8alpha-olide
TTDR00250	Inhibitor	2beta-methoxy-2-deethoxyphantomolin
TTDR00250	Inhibitor	3,4-epoxydehydroleucodin
TTDR00250	Inhibitor	4,5-ISOBUDLEIN A
TTDR00250	Inhibitor	4-nitro-N-(quinolin-8-yl)benzenesulfonamide
TTDR00250	Inhibitor	4beta,15-epoxy-miller-9E-enolide
TTDR00250	Inhibitor	4beta,15-epoxy-miller-9Z-enolide
TTDR00250	Inhibitor	5-bromo-N-(quinolin-8-yl)thiophene-2-sulfonamide
TTDR00250	Inhibitor	5-chloro-N-(quinolin-8-yl)thiophene-2-sulfonamide
TTDR00250	Inhibitor	5H-6-thia-4,5-diaza-chrysene 6,6-dioxide
TTDR00250	Inhibitor	7-hydroxycostunolide
TTDR00250	Inhibitor	9-chloro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide
TTDR00250	Inhibitor	9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide
TTDR00250	Inhibitor	9-methyl-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide
TTDR00250	Inhibitor	9alpha-acetoxy-miller-1(10)Z-enolide
TTDR00250	Inhibitor	ARTOBILOXANTHONE
TTDR00250	Inhibitor	ARTORIGIDIN A
TTDR00250	Inhibitor	ATRIPLICIOLIDTIGLATE
TTDR00250	Inhibitor	BAY-11-7082
TTDR00250	Inhibitor	BUDLEIN A
TTDR00250	Inhibitor	CENTRATHERIN
TTDR00250	Inhibitor	Caffeic acid phenethyl ester
TTDR00250	Inhibitor	DTD
TTDR00250	Inhibitor	ENHYDRIN
TTDR00250	Inhibitor	Gliotoxin
TTDR00250	Inhibitor	Go6976
TTDR00250	Inhibitor	HELENALIN
TTDR00250	Inhibitor	HELENALINMETHACRYLATE
TTDR00250	Inhibitor	ISOGOIAZENSOLIDE
TTDR00250	Inhibitor	IkappaB-alphaM
TTDR00250	Inhibitor	Isohelenin
TTDR00250	Inhibitor	MOLEPHANTIN
TTDR00250	Inhibitor	MOLEPHANTININ
TTDR00250	Inhibitor	N-(quinolin-8-yl)thiophene-2-sulfonamide
TTDR00250	Inhibitor	N-acetylcysteine
TTDR00250	Inhibitor	PS-341
TTDR00250	Inhibitor	PS-519
TTDR00250	Inhibitor	Parthenolide
TTDR00250	Inhibitor	Pycnogenol
TTDR00250	Inhibitor	Pyrrolidine dithiocarbamate
TTDR00250	Inhibitor	ROCAGLAMIDE
TTDR00250	Inhibitor	SCANDENOLIDE
TTDR00250	Inhibitor	Triptolide
TTDR00250	Inhibitor	helenalin-2-methylbutyrate
TTDR00250	Inhibitor	miller-9E-enolide
TTDR00250	Inhibitor	miller-9Z-enolide
TTDR00250	Activator	Act1
TTDR00251	UniProt ID	P19971
TTDR00251	Name	Thymidine phosphorylase
TTDR00251	Type of target	Research target
TTDR00251	Synonyms	Gliostatin
TTDR00251	Synonyms	PD-ECGF
TTDR00251	Synonyms	PDECGF
TTDR00251	Synonyms	Platelet-derived endothelial cell growth factor
TTDR00251	Synonyms	TP
TTDR00251	Synonyms	TdRPase
TTDR00251	Disease	Angiogenesis
TTDR00251	Disease	Breast cancer
TTDR00251	Disease	Lung adenocarcinomas
TTDR00251	Disease	Renal cell carcinoma
TTDR00251	Function	May have a role in maintaining the integrity of the blood vessels. Has growth pr
TTDR00251	Sequence	MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRL
TTDR00251	PDB Structure	1UOU; 2J0F
TTDR00251	BioChemical Class	Glycosyltransferases
TTDR00251	Pathway	Bladder cancer
TTDR00251	Pathway	Drug metabolism - other enzymes
TTDR00251	Pathway	Metabolic pathways
TTDR00251	Pathway	Pyrimidine metabolism
TTDR00251	EC Number	EC 2.4.2.4
TTDR00251	Target Validation	TTDR00251
TTDR00251	Inhibitor	1-(cyclohexyl)methyl-5'-O-tritylinosine
TTDR00251	Inhibitor	1-(cyclopropyl)methyl-5'-O-tritylinosine
TTDR00251	Inhibitor	1-allyl-5'-O-tritylinosine
TTDR00251	Inhibitor	1-benzyl-5'-O-tritylinosine
TTDR00251	Inhibitor	1-propyl-5'-O-tritylinosine
TTDR00251	Inhibitor	2'-aminoimidazolylmethyluracils
TTDR00251	Inhibitor	5-benzyl-6-chloropyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	5-bromo-6-(cyclopropylamino)uracil hydrochloride
TTDR00251	Inhibitor	5-bromo-6-hydrazinouracil hydrochloride
TTDR00251	Inhibitor	5-butyl-6-chloropyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	5-chloro-6-hydrazinouracil hydrochloride
TTDR00251	Inhibitor	5-fluoro-6-[(2-aminoimidazol-1-yl)methyl]uracil
TTDR00251	Inhibitor	6-amino-5-bromouracil
TTDR00251	Inhibitor	6-amino-5-chlorouracil hydrochloride
TTDR00251	Inhibitor	6-bromo-5-phenylpyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	6-chloro-5-(2-thienyl)pyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	6-chloro-5-heptylpyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	6-chloro-5-hexylpyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	6-chloro-5-pentylpyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	6-chloro-5-phenylpyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	6-chloro-5-propylpyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	6-fluoro-5-phenylpyrimidine-2,4(1H,3H)-dione
TTDR00251	Inhibitor	Thymine
TTDR00251	Inhibitor	Uridine
TTDR00252	UniProt ID	P01344
TTDR00252	Name	Insulin-like growth factor II
TTDR00252	Type of target	Research target
TTDR00252	Synonyms	IGF-II
TTDR00252	Synonyms	IGF2
TTDR00252	Synonyms	Insulin-like growth factor 2
TTDR00252	Synonyms	Somatomedin A
TTDR00252	Disease	Colorectal cancer
TTDR00252	Disease	Medulloblastoma
TTDR00252	Disease	Ovarian cancer
TTDR00252	Disease	Rhabdomyosarcoma
TTDR00252	Function	The insulin-like growth factors possess growth-promoting activity. In vitro, the
TTDR00252	Sequence	MGIPMGKSMLVLLTFLAFASCCIAAYRPSETLCGGELVDTLQFVCGDRGFYFSRPASRVSRRSRGIVEECCFRSCDLALL
TTDR00252	PDB Structure	1GF2; 1IGL; 2V5P
TTDR00252	BioChemical Class	Growth factor
TTDR00252	Related US Patent	6,645,775
TTDR00252	Related US Patent	6,677,305
TTDR00252	Related US Patent	6,680,298
TTDR00253	Name	Ras proteins
TTDR00253	Type of target	Research target
TTDR00253	Synonyms	Oncogenic Ras proteins
TTDR00253	Disease	Cancer, unspecific
TTDR00253	Related US Patent	6,350,755
TTDR00253	Related US Patent	6,380,228
TTDR00253	Related US Patent	6,387,903
TTDR00253	Related US Patent	6,462,086
TTDR00254	UniProt ID	P00478
TTDR00254	UniProt ID	Q9S6L8
TTDR00254	Name	Aspartate carbamoyltransferase
TTDR00254	Type of target	Research target
TTDR00254	Synonyms	ACTase
TTDR00254	Synonyms	ATCase
TTDR00254	Synonyms	Aspartate transcarbamylase
TTDR00254	Synonyms	L-aspartate transcarbamoylase
TTDR00254	Synonyms	L-aspartic acid transcarbamylase
TTDR00254	Synonyms	PYRB
TTDR00254	Disease	Cancer, unspecific
TTDR00254	Disease	Colon cancer
TTDR00254	Disease	Intracerebral tumor
TTDR00254	Disease	Lewis lung carcinoma
TTDR00254	Disease	Neurological diseases
TTDR00254	Disease	Proliferative diseases
TTDR00254	Disease	Pseudomonas infection
TTDR00254	Function	Involved in allosteric regulation of aspartate carbamoyltransferase.
TTDR00254	Sequence	MTHDNKLQVEAIKRGTVIDHIPAQIGFKLLSLFKLTETDQRITIGLNLPSGEMGRKDLIKIENTFLSEDQVDQLALYAPQ
TTDR00254	PDB Structure	1ACM; 1AT1; 1D09; 1EZZ; 1F1B; 1I5O; 1NBE; 1Q95
TTDR00254	EC Number	EC 2.1.3.2
TTDR00254	Inhibitor	N-(phosphonacetyl)-L-aspartate
TTDR00254	Inhibitor	N-(phosphonacetyl)-L-aspartate (PALA)
TTDR00254	Inhibitor	PALA
TTDR00255	UniProt ID	O15111
TTDR00255	Name	Inhibitor of nuclear factor kappa-B kinase alpha subunit
TTDR00255	Type of target	Research target
TTDR00255	Synonyms	Conserved helix-loop-helix ubiquitous kinase
TTDR00255	Synonyms	I kappa-B kinase alpha
TTDR00255	Synonyms	I-kappa-B kinase 1
TTDR00255	Synonyms	IKK-A
TTDR00255	Synonyms	IKK-alpha
TTDR00255	Synonyms	IKK1
TTDR00255	Synonyms	IkBKA
TTDR00255	Synonyms	IkappaB kinase
TTDR00255	Synonyms	Inhibitory kappa B kinase a
TTDR00255	Synonyms	NFKBIKA
TTDR00255	Synonyms	Nuclear factor NFkappaB inhibitor kinase alpha
TTDR00255	Disease	Asthma
TTDR00255	Function	Phosphorylates inhibitors of nf-kappa-b thus leading to the dissociation of the
TTDR00255	Sequence	MERPPGLRPGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLELSTKNRERWCHEIQIMKKLNHANVVKACDVP
TTDR00255	PDB Structure	3BRT
TTDR00255	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00255	Pathway	Acute myeloid leukemia
TTDR00255	Pathway	Adipocytokine signaling pathway
TTDR00255	Pathway	Apoptosis
TTDR00255	Pathway	B cell receptor signaling pathway
TTDR00255	Pathway	Chemokine signaling pathway
TTDR00255	Pathway	Chronic myeloid leukemia
TTDR00255	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR00255	Pathway	MAPK signaling pathway
TTDR00255	Pathway	Pancreatic cancer
TTDR00255	Pathway	Pathways in cancer
TTDR00255	Pathway	Prostate cancer
TTDR00255	Pathway	Small cell lung cancer
TTDR00255	Pathway	T cell receptor signaling pathway
TTDR00255	Pathway	Toll-like receptor signaling pathway
TTDR00255	EC Number	EC 2.7.1.-
TTDR00256	UniProt ID	O00408
TTDR00256	Name	CGMP-dependent 3',5'-cyclic phosphodiesterase
TTDR00256	Type of target	Research target
TTDR00256	Synonyms	CGS-PDE
TTDR00256	Synonyms	CGSPDE
TTDR00256	Synonyms	Cyclic GMP stimulated phosphodiesterase
TTDR00256	Synonyms	Cyclic-GMP phosphodiesterase
TTDR00256	Synonyms	PDE-II
TTDR00256	Synonyms	PDE2A
TTDR00256	Disease	Colorectal cancer
TTDR00256	Disease	Erectile dysfunction
TTDR00256	Function	Hydrolyzes both cyclic amp (camp) and cyclic gmp (cgmp).
TTDR00256	Sequence	MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVET
TTDR00256	PDB Structure	1Z1L
TTDR00256	BioChemical Class	Hydrolases acting on ester bonds
TTDR00256	Pathway	Purine metabolism
TTDR00256	EC Number	EC 3.1.4.17
TTDR00256	Related US Patent	6,362,178
TTDR00256	Related US Patent	6,566,360
TTDR00256	Target Validation	TTDR00256
TTDR00256	Inhibitor	2-Morpholin-4-yl-8-phenylethynyl-chromen-4-one
TTDR00256	Inhibitor	3-(6-Amino-purin-9-yl)-nonan-2-ol
TTDR00256	Inhibitor	3-ISOBUTYL-1-METHYLXANTHINE
TTDR00256	Inhibitor	3-Isobutyl-1-methyl-3,7-dihydro-purine-2,6-dione
TTDR00256	Inhibitor	BAY-60-7550
TTDR00256	Inhibitor	Benzyl-(2-pyridin-3-yl-quinazolin-4-yl)-amine
TTDR00256	Inhibitor	Benzyl-(2-pyridin-4-yl-quinazolin-4-yl)-amine
TTDR00256	Inhibitor	CP-461
TTDR00256	Inhibitor	Cyclic Guanosine Monophosphate
TTDR00256	Inhibitor	IMAZODAN
TTDR00257	UniProt ID	P19138
TTDR00257	Name	Casein kinase II, alpha chain
TTDR00257	Type of target	Clinical trial target
TTDR00257	Synonyms	CK II
TTDR00257	Synonyms	Protein kinase CK2
TTDR00257	Disease	Breast cancer
TTDR00257	Disease	Cancer, unspecific
TTDR00257	Function	Casein kinases are operationally defined by their preferential utilization of ac
TTDR00257	Sequence	MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR
TTDR00257	PDB Structure	1JWH; 1NA7; 1PJK; 2PVR; 2ZJW; 3BQC; 3BW5; 3C13
TTDR00257	EC Number	EC 2.7.1.37
TTDR00257	Target Validation	TTDR00257
TTDR00257	Inhibitor	4,5,6,7-tetrabromo-1H-benzimidazole
TTDR00257	Inhibitor	4,5,6,7-tetrabromo-1H-benzo[d][1,2,3]triazole
TTDR00257	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDR00257	Inhibitor	5,6,8-trichloroquinoline-4-one-3-carboxylic acid
TTDR00257	Inhibitor	5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole
TTDR00257	Inhibitor	7,8-dichloroquinoline-4-one-3-carboxylic acid
TTDR00257	Inhibitor	APIGENIN
TTDR00257	Inhibitor	AdoC(Dpr)2AlaArg6
TTDR00257	Inhibitor	BALANOL
TTDR00257	Inhibitor	CGP-029482
TTDR00257	Inhibitor	ELLAGIC ACID
TTDR00257	Inhibitor	EMODIN
TTDR00257	Inhibitor	Resveratrol
TTDR00258	Name	Carbamoyl-phosphate synthase II
TTDR00258	Type of target	Research target
TTDR00258	Synonyms	CPSASEII
TTDR00258	Synonyms	Carbamoyl-phosphate synthetase 2
TTDR00258	Synonyms	Carbamyl phosphate synthetase II
TTDR00258	Disease	Visceral leishmaniasis
TTDR00258	EC Number	EC 6.3.5.5
TTDR00258	Inhibitor	Acivicin
TTDR00260	UniProt ID	Q56921
TTDR00260	Name	Protein kinase A
TTDR00260	Type of target	Research target
TTDR00260	Synonyms	CAMP-dependent protein kinase
TTDR00260	Synonyms	PKA
TTDR00260	Disease	Cancer, unspecific
TTDR00260	Disease	Obesity
TTDR00260	Disease	Parasitic diseases
TTDR00260	Sequence	MKIMGTMSPSISLAKAHERISKHWQNPVGELNIEGKRYRIIDNQVVRLNPHSGFSLFREGVGKIFSGKMFSFSIARNLTD
TTDR00260	EC Number	EC 2.7.1.37
TTDR00260	Target Validation	TTDR00260
TTDR00260	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDR00260	Inhibitor	BALANOL
TTDR00260	Inhibitor	Ro-4396686
TTDR00260	Inhibitor	Rp-adenosine 3',5'-cyclic monophosphothioate triethylamine (Rp-cAMPS)
TTDR00261	UniProt ID	P01189
TTDR00261	Name	Corticotropin-lipotropin
TTDR00261	Type of target	Research target
TTDR00261	Synonyms	POMC
TTDR00261	Synonyms	Pro-opiomelanocortin
TTDR00261	Disease	Obesity
TTDR00261	Function	Acth stimulates the adrenal glands to release cortisol.msh (melanocyte-stimulati
TTDR00261	Sequence	MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPDLSAETPMFPGNGDEQPLTENPRKYVMG
TTDR00261	Pathway	Adipocytokine signaling pathway
TTDR00261	Pathway	Melanogenesis
TTDR00261	Inhibitor	Etorphine
TTDR00261	Agonist	Dihydromorphine
TTDR00262	UniProt ID	P01185
TTDR00262	Name	Arginine vasopressin
TTDR00262	Type of target	Research target
TTDR00262	Disease	Febrile convulsions
TTDR00262	Disease	Heart failure
TTDR00262	Disease	Temporal lobe epilepsy
TTDR00262	Disease	Vasodilatory shock
TTDR00262	Function	Neurophysin 2 specifically binds vasopressin.vasopressin has a direct antidiuret
TTDR00262	Sequence	MPDTMLPACFLGLLAFSSACYFQNCPRGGKRAMSDLELRQCLPCGPGGKGRCFGPSICCADELGCFVGTAEALRCQEENY
TTDR00262	Inhibitor	Niravoline
TTDR00264	UniProt ID	O40473
TTDR00264	Name	HIV envelope protein gp120
TTDR00264	Type of target	Clinical trial target
TTDR00264	Disease	Human immunodeficiency virus [HIV] disease
TTDR00264	Sequence	EVVIRSENFSQNAKTIIVQLNESVVINCIRPNNNTRKSIHLGQGRAWYTTGNIIGDIRQAHCNLSRTDWEKTLKRIVIK
TTDR00264	Target Validation	TTDR00264
TTDR00264	Drug(s)	BMS-488043
TTDR00264	Drug(s)	Pro 542
TTDR00264	Binder	BMS-488043
TTDR00264	Binder	Pro 542
TTDR00265	UniProt ID	P00441
TTDR00265	Name	Superoxide dismutase [Cu-Zn]
TTDR00265	Type of target	Research target
TTDR00265	Synonyms	Superoxide dismutase
TTDR00265	Disease	Cancer, unspecific
TTDR00265	Disease	Ischemic injury of the liver
TTDR00265	Function	Destroys radicals which are normally produced within the cells and which are tox
TTDR00265	Sequence	MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEER
TTDR00265	PDB Structure	1AZV; 1BA9; 1DSW; 1FUN; 1HL4; 1HL5; 1KMG; 1L3N
TTDR00265	BioChemical Class	Oxidoreductases acting on superoxide as acceptor
TTDR00265	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDR00265	Pathway	Huntington's disease
TTDR00265	EC Number	EC 1.15.1.1
TTDR00265	Inhibitor	Acetate Ion
TTDR00265	Inhibitor	Methoxyestradiol
TTDR00265	Inhibitor	S-Oxy Cysteine
TTDR00266	UniProt ID	Q9NQ74
TTDR00266	Name	Vanilloid receptor 1
TTDR00266	Type of target	Research target
TTDR00266	Synonyms	VR(1)
TTDR00266	Synonyms	VR1 receptor
TTDR00266	Disease	Analgesics
TTDR00266	Disease	Detrusor hyperreflexia
TTDR00266	Disease	Hypertonicity of bladder
TTDR00266	Disease	Inflammatory hyperalgesia
TTDR00266	Disease	Neuropathic pain
TTDR00266	Disease	Nociceptive disorders
TTDR00266	Disease	Uremic pruritus
TTDR00266	Sequence	MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFPVDCPHEEGELDSCPTITVSP
TTDR00266	Pathway	Neuroactive ligand-receptor interaction
TTDR00266	Antagonist	KJM429
TTDR00267	UniProt ID	P27251
TTDR00267	UniProt ID	Q9HBH1
TTDR00267	Name	Peptide deformylase
TTDR00267	Type of target	Clinical trial target
TTDR00267	Synonyms	PDF
TTDR00267	Synonyms	Polypeptide deformylase
TTDR00267	Disease	Bacterial infections
TTDR00267	Disease	Malaria
TTDR00267	Function	Removes the formyl group from the n-terminal met of newly synthesized proteins.
TTDR00267	Sequence	MSVLQVLHIPDERLRKVAKPVEEVNAEIQRIVDDMFETMYAEEGIGLAATQVDIHQRIIVIDVSENRDERLVLINPELLE
TTDR00267	PDB Structure	1BS4; 1BS5; 1BS6; 1BS7; 1BS8; 1BSJ; 3G5K; 3G5P
TTDR00267	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDR00267	EC Number	EC 3.5.1.88
TTDR00267	QSAR Model	TTDR00267
TTDR00267	Inhibitor	2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE
TTDR00267	Inhibitor	3-Sulfinoalanine
TTDR00267	Inhibitor	Actinonin
TTDR00267	Inhibitor	BB-3497
TTDR00267	Inhibitor	Bb-3497
TTDR00267	Inhibitor	Cysteinesulfonic Acid
TTDR00267	Inhibitor	Double Oxidized Cysteine
TTDR00267	Inhibitor	Formic Acid
TTDR00267	Inhibitor	HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE
TTDR00267	Inhibitor	N-(2-Acetamido)Iminodiacetic Acid
TTDR00267	Inhibitor	N-alkyl urea hydroxamic acids
TTDR00267	Inhibitor	NVP-PDF386 (VRC4887)
TTDR00267	Inhibitor	VRC3375
TTDR00267	Inhibitor	[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL
TTDR00267	Binder	Hydroxamates
TTDR00268	UniProt ID	P20823
TTDR00268	Name	Hepatocyte nuclear factor 1-alpha
TTDR00268	Type of target	Research target
TTDR00268	Synonyms	HNF-1 alpha
TTDR00268	Synonyms	HNF-1A
TTDR00268	Synonyms	LFB1
TTDR00268	Synonyms	Liver specific transcription factor LF-B1
TTDR00268	Synonyms	Liver-specific transcription factor LF-B1
TTDR00268	Synonyms	TCF-1
TTDR00268	Synonyms	Transcription factor-1
TTDR00268	Disease	Noninsulin-dependent diabetes mellitus
TTDR00268	Function	Required for the expression of several liver specific genes. Binds to the invert
TTDR00268	Sequence	MVSKLSQLQTELLAALLESGLSKEALIQALGEPGPYLLAGEGPLDKGESCGGGRGELAELPNGLGETRGSEDETDDDGED
TTDR00268	PDB Structure	1IC8; 2GYP
TTDR00268	Pathway	Maturity onset diabetes of the young
TTDR00268	Inhibitor	Norleucine
TTDR00269	UniProt ID	P41235
TTDR00269	Name	Hepatocyte nuclear factor 4-alpha
TTDR00269	Type of target	Research target
TTDR00269	Synonyms	HNF-4-alpha
TTDR00269	Synonyms	Transcription factor 14
TTDR00269	Synonyms	Transcription factor HNF-4
TTDR00269	Disease	Noninsulin-dependent diabetes mellitus
TTDR00269	Function	Transcriptionally controlled transcription factor. Binds to dna sites required f
TTDR00269	Sequence	MRLSKTLVDMDMADYSAALDPAYTTLEFENVQVLTMGNDTSPSEGTNLNAPNSLGVSALCAICGDRATGKHYGASSCDGC
TTDR00269	PDB Structure	1PZL; 3CBB
TTDR00269	BioChemical Class	Zinc-finger
TTDR00269	Pathway	Maturity onset diabetes of the young
TTDR00269	Inhibitor	Lauric Acid
TTDR00269	Inhibitor	MYRISTIC ACID
TTDR00270	UniProt ID	P11474
TTDR00270	Name	Steroid hormone receptor ERR1
TTDR00270	Type of target	Research target
TTDR00270	Synonyms	ERR-alpha
TTDR00270	Synonyms	ERRalpha
TTDR00270	Synonyms	Estrogen receptor-like 1
TTDR00270	Synonyms	Estrogen-related receptor alpha
TTDR00270	Synonyms	Estrogen-related receptor, alpha
TTDR00270	Disease	Breast cancer
TTDR00270	Disease	Diabetes mellitus
TTDR00270	Disease	Metabolic disorder, unspecified
TTDR00270	Disease	Obesity
TTDR00270	Function	Binds to an err-alpha response element (erre) containing a single consensus half
TTDR00270	Sequence	MSSQVVGIEPLYIKAEPASPDSPKGSSETETEPPVALAPGPAPTRCLPGHKEEEDGEGAGPGEQGGGKLVLSSLPKRLCL
TTDR00270	PDB Structure	1XB7; 2PJL; 3D24
TTDR00270	BioChemical Class	Zinc-finger
TTDR00270	Target Validation	TTDR00270
TTDR00270	Inhibitor	2-(4-hydroxyphenyl)-4-vinylquinolin-6-ol
TTDR00270	Inhibitor	4-bromo-2-(4-hydroxyphenyl)quinolin-6-ol
TTDR00270	Inhibitor	4-chloro-2-(4-hydroxyphenyl)quinolin-6-ol
TTDR00270	Inhibitor	4-ethyl-2-(4-hydroxyphenyl)quinolin-6-ol
TTDR00270	Inhibitor	4-ethynyl-2-(4-hydroxyphenyl)quinolin-6-ol
TTDR00270	Inhibitor	7-bromo-6H-chromeno[4,3-b]quinoline-3,9-diol
TTDR00270	Inhibitor	7-chloro-6H-chromeno[4,3-b]quinoline-3,9-diol
TTDR00270	Inhibitor	7-ethyl-6H-chromeno[4,3-b]quinoline-3,9-diol
TTDR00270	Inhibitor	7-ethynyl-6H-chromeno[4,3-b]quinoline-3,9-diol
TTDR00270	Inhibitor	7-vinyl-6H-chromeno[4,3-b]quinoline-3,9-diol
TTDR00271	UniProt ID	P51843
TTDR00271	Name	Orphan nuclear receptor DAX-1
TTDR00271	Type of target	Research target
TTDR00271	Synonyms	DSS-AHC critical region on the X chromosome protein 1
TTDR00271	Synonyms	Nuclear receptor DAX-1
TTDR00271	Disease	Hypogonadotropic hypogonadism
TTDR00271	Disease	X-linked congenital adrenal hypoplasia
TTDR00271	Function	Receptor that may be a component of a cascade required for development of steroi
TTDR00271	Sequence	MAGENHQWQGSILYNMLMSAKQTRAAPEAPETRLVDQCWGCSCGDEPGVGREGLLGGRNVALLYRCCFCGKDHPRQGSIL
TTDR00272	Name	Thyroid hormone receptor
TTDR00272	Type of target	Research target
TTDR00272	Disease	Nonthyroidal illness syndrome
TTDR00272	Disease	Thyrotoxicosis [hyperthyroidism]
TTDR00272	Antagonist	DIBRT
TTDR00272	Antagonist	GC-14
TTDR00272	Antagonist	NH-3
TTDR00272	Antagonist	NH-4
TTDR00273	UniProt ID	O15530
TTDR00273	Name	3-phosphoinositide dependent protein kinase-1
TTDR00273	Type of target	Research target
TTDR00273	Synonyms	3'-phosphoinositide dependent kinase 1
TTDR00273	Synonyms	3-Phosphoinositide-dependent kinase-1
TTDR00273	Synonyms	HPDK1
TTDR00273	Disease	Cancer, unspecific
TTDR00273	Disease	Diabetes mellitus
TTDR00273	Function	Phosphorylates and activates not only pkb/akt, but also pka, pkc-zeta, p70s6k an
TTDR00273	Sequence	MARTTSQLYDAVPIQSSVVLCSCPSPSMVRTQTESSTPPGIPGGSRQGPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPE
TTDR00273	PDB Structure	1H1W; 1OKY; 1OKZ; 1UU3; 1UU7; 1UU8; 1UU9; 1UVR
TTDR00273	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00273	Pathway	Endometrial cancer
TTDR00273	Pathway	Focal adhesion
TTDR00273	Pathway	Insulin signaling pathway
TTDR00273	Pathway	Non-small cell lung cancer
TTDR00273	Pathway	PPAR signaling pathway
TTDR00273	Pathway	Prostate cancer
TTDR00273	Pathway	mTOR signaling pathway
TTDR00273	EC Number	EC 2.7.1.37
TTDR00273	Inhibitor	7-Hydroxystaurosporine
TTDR00273	Inhibitor	Inositol-(1,3,4,5)-Tetrakisphosphate
TTDR00273	Inhibitor	Phosphonoserine
TTDR00273	Inhibitor	Rbt205 Inhibitor
TTDR00273	Inhibitor	Staurosporine
TTDR00274	UniProt ID	P23141
TTDR00274	Name	Liver carboxylesterase
TTDR00274	Type of target	Research target
TTDR00274	Synonyms	ACAT
TTDR00274	Synonyms	Acyl coenzyme A:cholesterol acyltransferase
TTDR00274	Synonyms	Brain carboxylesterase hBr1
TTDR00274	Synonyms	HCE1
TTDR00274	Synonyms	HMSE
TTDR00274	Synonyms	Human carboxylesterase 1
TTDR00274	Synonyms	Monocyte/macrophage serine esterase
TTDR00274	Synonyms	Serine esterase 1
TTDR00274	Disease	Alzheimer's disease
TTDR00274	Disease	Atherosclerosis
TTDR00274	Disease	Cardiovascular disease, unspecified
TTDR00274	Disease	Cocaine overdose
TTDR00274	Disease	Hypercholesterolaemia
TTDR00274	Disease	Protection against chemical weapons like Sarin, Soman and VX gas
TTDR00274	Function	Involved in the detoxification of xenobiotics and in the activation of ester and
TTDR00274	Sequence	MWLRAFILATLSASAAWGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIFLGIPFAKPPLGPLRFTPPQPAEPWSFVKNA
TTDR00274	PDB Structure	1MX1; 1MX5; 1MX9; 1YA4; 1YA8; 1YAH; 1YAJ; 2DQY
TTDR00274	BioChemical Class	Hydrolases acting on ester bonds
TTDR00274	Pathway	Alkaloid biosynthesis II
TTDR00274	Pathway	Drug metabolism - other enzymes
TTDR00274	EC Number	EC 3.1.1.1
TTDR00274	Related US Patent	6,444,691
TTDR00274	Target Validation	TTDR00274
TTDR00274	Inhibitor	(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE
TTDR00274	Inhibitor	(E)-Octadec-9-enoic acid phenylamide
TTDR00274	Inhibitor	1,1,1-trifluoro-3-(hexylsulfinyl)propan-2-one
TTDR00274	Inhibitor	1,1,1-trifluoro-3-(hexylsulfonyl)propan-2-one
TTDR00274	Inhibitor	1,1,1-trifluoro-3-(hexylthio)propan-2-one
TTDR00274	Inhibitor	1,1,1-trifluoro-3-(octylsulfinyl)propan-2-one
TTDR00274	Inhibitor	1,1,1-trifluoro-3-(octylsulfonyl)propan-2-one
TTDR00274	Inhibitor	1,1,1-trifluoro-3-(octylthio)propan-2-one
TTDR00274	Inhibitor	1,1,1-trifluorododecan-2-one
TTDR00274	Inhibitor	1,10-phenanthroline-5,6-dione
TTDR00274	Inhibitor	1,2-Bis-(2-chloro-phenyl)-ethane-1,2-dione
TTDR00274	Inhibitor	1,2-Bis-(3-methoxy-phenyl)-ethane-1,2-dione
TTDR00274	Inhibitor	1,2-Bis-(3-nitro-phenyl)-ethane-1,2-dione
TTDR00274	Inhibitor	1,2-Bis-(4-bromo-phenyl)-ethane-1,2-dione
TTDR00274	Inhibitor	1,2-Bis-(4-chloro-phenyl)-ethane-1,2-dione
TTDR00274	Inhibitor	1,2-Bis-(4-methoxy-phenyl)-ethane-1,2-dione
TTDR00274	Inhibitor	1,2-Di-naphthalen-2-yl-ethane-1,2-dione
TTDR00274	Inhibitor	1,2-Di-p-tolyl-ethane-1,2-dione
TTDR00274	Inhibitor	1,2-NAPHTHOQUINONE
TTDR00274	Inhibitor	1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(2,3,4-trifluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(2,3,5-trifluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(2,3,5-trifluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(2,3,6-trifluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(2,3-difluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(2,3-fluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(2,4-difluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(2,4-difluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(2,5-difluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(2,5-difluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(2,6-difluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(2,6-difluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(2-fluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(2-fluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(3,4,5-trifluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(3,4,5-trifluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(3,4-difluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(3,4-difluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(3,5-difluorophenyl)-2-hydroxyethanone
TTDR00274	Inhibitor	1,2-bis(3,5-difluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(3-fluorophenyl)-2-hydroxyethanon
TTDR00274	Inhibitor	1,2-bis(3-fluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-bis(4-fluorophenyl)ethane-1,2-dione
TTDR00274	Inhibitor	1,2-dicyclohexylethane-1,2-dione
TTDR00274	Inhibitor	1,2-indanedione
TTDR00274	Inhibitor	1-(2-bromoethyl)-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-(2-iodoethyl)-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-(3,4-Dimethyl-phenyl)-2-phenyl-ethane-1,2-dione
TTDR00274	Inhibitor	1-(3,4-dichlorobenzyl)-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-(4-Chloro-phenyl)-2-p-tolyl-ethane-1,2-dione
TTDR00274	Inhibitor	1-(4-Chloro-phenyl)-2-phenyl-ethane-1,2-dione
TTDR00274	Inhibitor	1-(4-Methoxy-phenyl)-2-phenyl-ethane-1,2-dione
TTDR00274	Inhibitor	1-(4-Nitro-phenyl)-2-phenyl-ethane-1,2-dione
TTDR00274	Inhibitor	1-(4-chlorobenzyl)-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-Phenyl-2-p-tolyl-ethane-1,2-dione
TTDR00274	Inhibitor	1-Phenyl-propane-1,2-dione
TTDR00274	Inhibitor	1-benzyl-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-butyryl-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-dodecyl-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-hexadecyl-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-methyl-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-phenyl-1H-indole-2,3-dione
TTDR00274	Inhibitor	1-propionyl-1H-indole-2,3-dione
TTDR00274	Inhibitor	11,12-dihydro-dibenzo[a,e]cyclooctene-5,6-dione
TTDR00274	Inhibitor	2,2-Dimethoxy-1,2-diphenyl-ethanone
TTDR00274	Inhibitor	2,2-dimethyl-3-methyleneheptadecane
TTDR00274	Inhibitor	2-methoxy-3,4-methylenedioxybenzophenone
TTDR00274	Inhibitor	3,4,5,6-Tetrachloro-[1,2]benzoquinone
TTDR00274	Inhibitor	3,5-Di-tert-butyl-[1,2]benzoquinone
TTDR00274	Inhibitor	3-(butylsulfinyl)-1,1,1-trifluoropropan-2-one
TTDR00274	Inhibitor	3-(butylthio)-1,1,1-trifluoropropan-2-one
TTDR00274	Inhibitor	3-(decylsulfinyl)-1,1,1-trifluoropropan-2-one
TTDR00274	Inhibitor	3-(decylsulfonyl)-1,1,1-trifluoropropan-2-one
TTDR00274	Inhibitor	3-(decylthio)-1,1,1-trifluoropropan-2-one
TTDR00274	Inhibitor	3-(dodecylsulfinyl)-1,1,1-trifluoropropan-2-one
TTDR00274	Inhibitor	3-(dodecylsulfonyl)-1,1,1-trifluoropropan-2-one
TTDR00274	Inhibitor	4,5-dichloro-1H-indole-2,3-dione
TTDR00274	Inhibitor	4,6-dichloro-1H-indole-2,3-dione
TTDR00274	Inhibitor	4,7-dichloro-1H-indole-2,3-dione
TTDR00274	Inhibitor	4-(2-Oxo-2-phenyl-acetyl)-benzoic acid
TTDR00274	Inhibitor	4-Piperidino-Piperidine
TTDR00274	Inhibitor	4-chloro-1H-indole-2,3-dione
TTDR00274	Inhibitor	4-chloro-7-methyl-1H-indole-2,3-dione
TTDR00274	Inhibitor	5,6-dinitroacenaphthoquinone
TTDR00274	Inhibitor	5,7-dichloro-1H-indole-2,3-dione
TTDR00274	Inhibitor	5-(trifluoromethoxy)-1H-indole-2,3-dione
TTDR00274	Inhibitor	5-chloro-1H-indole-2,3-dione
TTDR00274	Inhibitor	6,7-dichloro-1H-indole-2,3-dione
TTDR00274	Inhibitor	6-bromo-5-methyl-1H-indole-2,3-dione
TTDR00274	Inhibitor	7-(trifluoromethyl)-1H-indole-2,3-dione
TTDR00274	Inhibitor	7-chloro-1H-indole-2,3-dione
TTDR00274	Inhibitor	ACENAPHTHOQUINONE
TTDR00274	Inhibitor	Alpha-D-Mannose
TTDR00274	Inhibitor	Avasimibe
TTDR00274	Inhibitor	BENZIL
TTDR00274	Inhibitor	BENZOIN
TTDR00274	Inhibitor	CHLORANIL
TTDR00274	Inhibitor	CI-976
TTDR00274	Inhibitor	Cholic Acid
TTDR00274	Inhibitor	Dibutyl 2,2,2-trifluoro-1-phenylethyl phosphate
TTDR00274	Inhibitor	Diethyl 2,2,2-trifluoro-1-phenylethyl phosphate
TTDR00274	Inhibitor	Dimethyl 2,2,2-trifluoro-1-phenylethyl phosphate
TTDR00274	Inhibitor	Heptane-2,3-dione
TTDR00274	Inhibitor	N-Methylnaloxonium
TTDR00274	Inhibitor	NSC-23180
TTDR00274	Inhibitor	O-Sialic Acid
TTDR00274	Inhibitor	Oleic Acid Anilide
TTDR00274	Inhibitor	PACTIMIBE
TTDR00274	Inhibitor	PYRIPYROPENE A
TTDR00274	Inhibitor	SCH-48375;SCH-48678
TTDR00274	Inhibitor	SM-32504
TTDR00274	Inhibitor	Thenoyltrifluoroacetone
TTDR00274	Inhibitor	acenanthrene-9,10-dione
TTDR00274	Inhibitor	phenanthrene-9,10-dione
TTDR00274	Inhibitor	thieno[3,2-e][1]benzothiophene-4,5-dione
TTDR00275	UniProt ID	Q13085
TTDR00275	UniProt ID	Q9U752
TTDR00275	Name	Acetyl-CoA carboxylase 1
TTDR00275	Type of target	Research target
TTDR00275	Synonyms	ACC-alpha
TTDR00275	Synonyms	ACC1
TTDR00275	Synonyms	Acetyl-CoA carboxylase
TTDR00275	Disease	Bacterial infections
TTDR00275	Disease	Malaria
TTDR00275	Function	Catalyzes the rate-limiting reaction in the biogenesis of long-chain fatty acids
TTDR00275	Sequence	MDEPSPLAQPLELNQHSRFIIGSVSEDNSEDEISNLVKLDLLEEKEGSLSPASVGSDTLSDLGISSLQDGLALHIRSSMS
TTDR00275	BioChemical Class	Ligases forming carbon-carbon bonds
TTDR00275	Pathway	Fatty acid biosynthesis
TTDR00275	Pathway	Insulin signaling pathway
TTDR00275	Pathway	Metabolic pathways
TTDR00275	Pathway	Propanoate metabolism
TTDR00275	Pathway	Pyruvate metabolism
TTDR00275	EC Number	EC 6.4.1.2
TTDR00275	Target Validation	TTDR00275
TTDR00275	Inhibitor	A-80040
TTDR00275	Inhibitor	CP-640186
TTDR00275	Binder	Clodinafop
TTDR00275	Binder	Haloxyfop
TTDR00275	Binder	Quizalofop
TTDR00276	UniProt ID	P17301
TTDR00276	Name	Integrin alpha-2
TTDR00276	Type of target	Clinical trial target
TTDR00276	Synonyms	Adhesive platelet receptor alpha1 beta2
TTDR00276	Synonyms	Alpha 2 beta 1 integrin
TTDR00276	Synonyms	CD49b
TTDR00276	Synonyms	Collagen receptor
TTDR00276	Synonyms	GPIa
TTDR00276	Synonyms	GPIa/IIa
TTDR00276	Synonyms	Glycoprotein Ia-IIa
TTDR00276	Synonyms	Integrin alpha(2)beta(1)
TTDR00276	Synonyms	Integrin alpha2beta 1
TTDR00276	Synonyms	Platelet glycoprotein Ia/IIa
TTDR00276	Synonyms	Platelet membrane glycoprotein Ia
TTDR00276	Synonyms	VLA-2
TTDR00276	Synonyms	VLA-2 alpha chain
TTDR00276	Disease	Thrombosis
TTDR00276	Function	Integrin alpha-2/beta-1 is a receptor for laminin, collagen, collagen c-propepti
TTDR00276	Sequence	MGPERTGAAPLPLLLVLALSQGILNCCLAYNVGLPEAKIFSGPSSEQFGYAVQQFINPKGNWLLVGSPWSGFPENRMGDV
TTDR00276	PDB Structure	1AOX; 1DZI; 1PQB; 1V7P
TTDR00276	BioChemical Class	Transmembrane protein
TTDR00276	Pathway	ECM-receptor interaction
TTDR00276	Pathway	Focal adhesion
TTDR00276	Pathway	Hematopoietic cell lineage
TTDR00276	Pathway	Pathways in cancer
TTDR00276	Pathway	Regulation of actin cytoskeleton
TTDR00276	Pathway	Small cell lung cancer
TTDR00276	Target Validation	TTDR00276
TTDR00276	Inhibitor	3-(3-(benzamido)-5-nitrobenzamido)propanoic acid
TTDR00276	Inhibitor	3-(3-(carbamoyl)benzamido)-3-phenylpropanoic acid
TTDR00276	Inhibitor	3-(3-(carbamoyl)benzamido)propanoic acid
TTDR00276	Inhibitor	MAGGIEMYCIN
TTDR00277	Name	Alpha v beta 3 integrin receptor
TTDR00277	Type of target	Research target
TTDR00277	Synonyms	Alpha v beta 3 integrin
TTDR00277	Synonyms	Alpha(v)beta(3) Integrin
TTDR00277	Synonyms	Alpha(v)beta(3) integrin receptor
TTDR00277	Synonyms	Integrin alpha V beta 3
TTDR00277	Synonyms	Integrin alpha-v beta-3
TTDR00277	Synonyms	Integrin alphaVbeta3
TTDR00277	Synonyms	Vitronectin Receptor
TTDR00277	Disease	Angiogenesis
TTDR00277	Disease	Cancer, unspecific
TTDR00277	Disease	Kaposi's sarcoma
TTDR00277	Disease	Rheumatoid arthritis, unspecified
TTDR00277	Disease	Tumor angiogenesis
TTDR00277	Related US Patent	6,191,304
TTDR00277	Related US Patent	6,232,308
TTDR00277	Related US Patent	6,268,378
TTDR00277	Related US Patent	6,274,620
TTDR00277	Related US Patent	6,344,484
TTDR00277	Related US Patent	6,358,970
TTDR00277	Related US Patent	6,358,976
TTDR00277	Related US Patent	6,387,895
TTDR00277	Related US Patent	6,399,620
TTDR00277	Related US Patent	6,407,241
TTDR00277	Related US Patent	6,410,526
TTDR00277	Related US Patent	6,413,955
TTDR00277	Related US Patent	6,420,558
TTDR00277	Related US Patent	6,429,214
TTDR00277	Related US Patent	6,437,094
TTDR00277	Related US Patent	6,451,800
TTDR00277	Related US Patent	6,451,972
TTDR00277	Related US Patent	6,458,784
TTDR00277	Related US Patent	6,458,814
TTDR00277	Related US Patent	6,472,403
TTDR00277	Related US Patent	6,482,821
TTDR00277	Related US Patent	6,486,174
TTDR00277	Related US Patent	6,489,333
TTDR00277	Related US Patent	6,492,356
TTDR00277	Related US Patent	6,495,545
TTDR00277	Related US Patent	6,495,560
TTDR00277	Related US Patent	6,509,347
TTDR00277	Related US Patent	6,511,649
TTDR00277	Related US Patent	6,531,494
TTDR00277	Related US Patent	6,545,029
TTDR00277	Related US Patent	6,566,366
TTDR00277	Related US Patent	6,569,402
TTDR00277	Related US Patent	6,576,643
TTDR00277	Related US Patent	6,586,187
TTDR00277	Related US Patent	6,589,972
TTDR00277	Related US Patent	6,620,820
TTDR00277	Related US Patent	6,645,991
TTDR00277	Related US Patent	6,660,728
TTDR00277	Related US Patent	6,677,360
TTDR00277	Antagonist	IS20I
TTDR00277	Antagonist	Vitaxin
TTDR00277	Binder	Cilengitide
TTDR00278	UniProt ID	P56373
TTDR00278	Name	P2X purinoceptor 3
TTDR00278	Type of target	Research target
TTDR00278	Synonyms	ATP receptor
TTDR00278	Synonyms	ATP-gated ion channel P2X(3)
TTDR00278	Synonyms	P2X3
TTDR00278	Synonyms	P2X3 receptor
TTDR00278	Synonyms	Purinergic receptor
TTDR00278	Disease	Analgesics
TTDR00278	Disease	Dysmotility
TTDR00278	Disease	Hypertonicity of bladder
TTDR00278	Disease	Inflammatory bowel disease
TTDR00278	Disease	Pain, unspecified
TTDR00278	Function	Receptor for atp that acts as a ligand gated ion channel.
TTDR00278	Sequence	MNCISDFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDY
TTDR00278	BioChemical Class	Ion transport
TTDR00278	Pathway	Calcium signaling pathway
TTDR00278	Pathway	Neuroactive ligand-receptor interaction
TTDR00278	Target Validation	TTDR00278
TTDR00278	Inhibitor	AVVYPWT
TTDR00278	Inhibitor	ISOPPADS
TTDR00278	Inhibitor	LAVYPWT
TTDR00278	Inhibitor	LVAYPWT
TTDR00278	Inhibitor	LVVAPWT
TTDR00278	Inhibitor	LVVYPWT
TTDR00278	Inhibitor	cyclic LVVYPWT
TTDR00278	Antagonist	A-317491
TTDR00280	UniProt ID	P25098
TTDR00280	Name	Beta-adrenergic receptor kinase 1
TTDR00280	Type of target	Research target
TTDR00280	Synonyms	Beta ARK1
TTDR00280	Synonyms	Beta-ARK-1
TTDR00280	Synonyms	BetaARK1
TTDR00280	Synonyms	G-protein coupled receptor kinase 2
TTDR00280	Synonyms	GRK2
TTDR00280	Disease	Congestive heart failure
TTDR00280	Disease	Heart failure
TTDR00280	Disease	Hypertension
TTDR00280	Disease	Ventricular dysfunction
TTDR00280	Function	Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and
TTDR00280	Sequence	MADLEAVLADVSYLMAMEKSKATPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEAR
TTDR00280	PDB Structure	1BAK; 3CIK
TTDR00280	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00280	Pathway	Chemokine signaling pathway
TTDR00280	EC Number	EC 2.7.1.126
TTDR00280	Inhibitor	BetaARKct
TTDR00281	Name	CAP-dependent endonuclease
TTDR00281	Type of target	Research target
TTDR00281	Disease	Influenza, influenza virus A-induced
TTDR00281	Disease	Viral infection, unspecified
TTDR00281	Inhibitor	4-substituted 2,4-dioxobutanoic acids
TTDR00281	Inhibitor	Flutimide
TTDR00283	UniProt ID	P08571
TTDR00283	Name	Monocyte differentiation antigen CD14
TTDR00283	Type of target	Research target
TTDR00283	Synonyms	CD14
TTDR00283	Synonyms	Myeloid cell-specific leucine-rich glycoprotein
TTDR00283	Disease	Sepsis
TTDR00283	Disease	Systemic inflammatory response syndrome
TTDR00283	Function	Cooperates with md-2 and tlr4 to mediate the innate immune response to bacterial
TTDR00283	Sequence	MERASCLLLLLLPLVHVSATTPEPCELDDEDFRCVCNFSEPQPDWSEAFQCVSAVEVEIHAGGLNLEPFLKRVDADADPR
TTDR00283	BioChemical Class	Cell membrane protein
TTDR00283	Pathway	Hematopoietic cell lineage
TTDR00283	Pathway	MAPK signaling pathway
TTDR00283	Pathway	Pathogenic Escherichia coli infection
TTDR00283	Pathway	Regulation of actin cytoskeleton
TTDR00283	Pathway	Toll-like receptor signaling pathway
TTDR00283	Antibody	Anti CD14 antibodies
TTDR00284	UniProt ID	P29965
TTDR00284	Name	Tumor necrosis factor ligand superfamily member 5
TTDR00284	Type of target	Research target
TTDR00284	Synonyms	CD154 antigen
TTDR00284	Synonyms	CD40 ligand
TTDR00284	Synonyms	CD40-L
TTDR00284	Synonyms	CD40L
TTDR00284	Synonyms	T cell antigen Gp39
TTDR00284	Synonyms	TNF-related activation protein
TTDR00284	Synonyms	TRAP
TTDR00284	Disease	Arthritis
TTDR00284	Disease	Atherosclerosis
TTDR00284	Disease	Autoimmune diseases
TTDR00284	Disease	Cancer, unspecific
TTDR00284	Disease	Lupus erythematosus
TTDR00284	Disease	Lupus nephritis
TTDR00284	Function	Mediates b-cell proliferation in the absence of co- stimulus as well as ige prod
TTDR00284	Sequence	MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLS
TTDR00284	PDB Structure	1ALY; 1I9R
TTDR00284	BioChemical Class	Transmembrane protein
TTDR00284	Pathway	Allograft rejection
TTDR00284	Pathway	Asthma
TTDR00284	Pathway	Autoimmune thyroid disease
TTDR00284	Pathway	Cell adhesion molecules (CAMs)
TTDR00284	Pathway	Cytokine-cytokine receptor interaction
TTDR00284	Pathway	Primary immunodeficiency
TTDR00284	Pathway	Systemic lupus erythematosus
TTDR00284	Pathway	T cell receptor signaling pathway
TTDR00285	UniProt ID	Q9HF08
TTDR00285	Name	Large subunit Cp complex Cdc68p
TTDR00285	Type of target	Research target
TTDR00285	Synonyms	CDC68
TTDR00285	Synonyms	Cdc68p
TTDR00285	Disease	Fungal diseases
TTDR00285	Sequence	MSEVNIDAGLFYKRLSIFQKQLTANNIPQALIIVGARSDDNTYKKSTVLQNWLLGYEFIHTAIYITDKKCIFITSEGKSK
TTDR00286	Name	Calcitonin gene-related peptide type 2 receptor
TTDR00286	Type of target	Research target
TTDR00286	Synonyms	Beta-type CGRP
TTDR00286	Synonyms	CGRP receptor 2
TTDR00286	Synonyms	Calcitonin gene-related peptide 2 receptor
TTDR00286	Disease	Migraine
TTDR00286	Disease	Opioid dependence
TTDR00286	Antagonist	BIBN4096BS
TTDR00287	UniProt ID	P32302
TTDR00287	Name	C-X-C chemokine receptor type 5
TTDR00287	Type of target	Research target
TTDR00287	Synonyms	Burkitt'S lymphoma receptor 1
TTDR00287	Synonyms	CXC-R5
TTDR00287	Synonyms	CXCR-5
TTDR00287	Synonyms	Chemokine receptor CCR5
TTDR00287	Synonyms	Chemokine receptor CXCR5
TTDR00287	Synonyms	MDR15
TTDR00287	Synonyms	Monocyte-derived receptor 15
TTDR00287	Disease	Human immunodeficiency virus [HIV] disease
TTDR00287	Disease	Inflammatory demyelination
TTDR00287	Function	Cytokine receptor that binds to blc. Blr1 exerts possibly a regulatory function
TTDR00287	Sequence	MNYPLTLEMDLENLEDLFWELDRLDNYNDTSLVENHLCPATEGPLMASFKAVFVPVAYSLIFLLGVIGNVLVLVILERHR
TTDR00287	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00287	Pathway	Chemokine signaling pathway
TTDR00287	Pathway	Cytokine-cytokine receptor interaction
TTDR00288	UniProt ID	O95477
TTDR00288	Name	ATP-binding cassette, sub-family A, member 1
TTDR00288	Type of target	Clinical trial target
TTDR00288	Synonyms	ABC-1
TTDR00288	Synonyms	ABCA1
TTDR00288	Synonyms	ATP-binding cassette 1
TTDR00288	Synonyms	ATP-binding cassette transporter (ABCA1) transmembrane protein
TTDR00288	Synonyms	ATP-binding cassette transporter 1
TTDR00288	Synonyms	ATP-binding cassette transporter A1
TTDR00288	Synonyms	Cholesterol efflux regulatory protein
TTDR00288	Synonyms	Cholesterol mobilizing transporter ABCA1
TTDR00288	Disease	Atherosclerotic cardiovascular disease
TTDR00288	Disease	Cardiovascular disease, unspecified
TTDR00288	Disease	Hypercholesterolemia
TTDR00288	Disease	Low high density lipoprotein syndromes
TTDR00288	Function	Camp-dependent and sulfonylurea-sensitive anion transporter. Key gatekeeper infl
TTDR00288	Sequence	MACWPQLRLLLWKNLTFRRRQTCQLLLEVAWPLFIFLILISVRLSYPPYEQHECHFPNKAMPSAGTLPWVQGIICNANNP
TTDR00288	BioChemical Class	ABC transporter
TTDR00288	Pathway	ABC transporters
TTDR00289	Name	C-Jun N-terminal kinase
TTDR00289	Type of target	Clinical trial target
TTDR00289	Synonyms	C-Jun-N-terminal kinase
TTDR00289	Synonyms	JNK
TTDR00289	Synonyms	Mitogen-activated protein kinase
TTDR00289	Synonyms	Stress-activated protein kinase JNK
TTDR00289	Disease	Alzheimer's disease
TTDR00289	Disease	Diabetes mellitus
TTDR00289	Disease	Rheumatoid arthritis, unspecified
TTDR00289	Disease	Skin diseases
TTDR00289	EC Number	EC 2.7.1.37
TTDR00289	Related US Patent	6,642,227
TTDR00289	Inhibitor	SP600125
TTDR00291	UniProt ID	P14926
TTDR00291	Name	Beta-ketoacyl-ACP synthase I
TTDR00291	Type of target	Research target
TTDR00291	Synonyms	3-oxoacyl-[acyl-carrier-protein] synthase I
TTDR00291	Synonyms	Condensing enzyme FabB
TTDR00291	Synonyms	KAS I
TTDR00291	Disease	Bacterial infections
TTDR00291	Function	Catalyzes the condensation reaction of fatty acid synthesis by the addition to a
TTDR00291	Sequence	MKRAVITGLGIVSSIGNNQQEVLASLREGRSGITFSQELKDSGMRSHVWGNVKLDTTGLIDRKVVRFMSDASIYAFLSME
TTDR00291	PDB Structure	1DD8; 1EK4; 1F91; 1FJ4; 1FJ8; 1G5X; 1H4F; 2AQ7
TTDR00291	EC Number	EC 2.3.1.41
TTDR00291	Binder	Thiolactomycin
TTDR00292	UniProt ID	P39435
TTDR00292	UniProt ID	Q10525
TTDR00292	Name	3-oxoacyl-[acyl-carrier-protein] synthase II
TTDR00292	Type of target	Research target
TTDR00292	Synonyms	3-oxoacyl-[acyl-carrier-protein] synthase 2
TTDR00292	Synonyms	Beta-ketoacyl-ACP synthase 2
TTDR00292	Synonyms	Beta-ketoacyl-ACP synthase II
TTDR00292	Synonyms	Beta-ketoacyl-acyl carrier protein synthase B
TTDR00292	Synonyms	Condensing enzyme FabF
TTDR00292	Synonyms	FabF
TTDR00292	Synonyms	KAS 2
TTDR00292	Synonyms	KAS II
TTDR00292	Synonyms	KASB
TTDR00292	Disease	Bacterial infections
TTDR00292	Disease	Tuberculosis
TTDR00292	Function	Catalyzes the condensation reaction of fatty acid synthesis by the addition to a
TTDR00292	Sequence	MSKRRVVVTGLGMLSPVGNTVESTWKALLAGQSGISLIDHFDTSAYATKFAGLVKDFNCEDIISRKEQRKMDAFIQYGIV
TTDR00292	PDB Structure	1B3N; 1KAS; 2GFV; 2GFW; 2GFX; 2GFY; 3G0Y; 2GP6
TTDR00292	EC Number	EC 2.3.1.41
TTDR00292	Inhibitor	Lauric Acid
TTDR00292	Inhibitor	PLATENSIMYCIN
TTDR00292	Inhibitor	Platensimycin
TTDR00292	Binder	Thiolactomycin
TTDR00293	UniProt ID	P17302
TTDR00293	Name	Gap junction alpha-1 protein
TTDR00293	Type of target	Research target
TTDR00293	Synonyms	Connexin 43
TTDR00293	Synonyms	Cx43
TTDR00293	Synonyms	Gap junction 43 kDa heart protein
TTDR00293	Disease	Heart disease, unspecified
TTDR00293	Function	One gap junction consists of a cluster of closely packed pairs of transmembrane
TTDR00293	Sequence	MGDWSALGKLLDKVQAYSTAGGKVWLSVLFIFRILLLGTAVESAWGDEQSAFRCNTQQPGCENVCYDKSFPISHVRFWVL
TTDR00293	BioChemical Class	Transmembrane protein
TTDR00293	Pathway	Gap junction
TTDR00296	UniProt ID	Q00535
TTDR00296	Name	Cell division protein kinase 5
TTDR00296	Type of target	Research target
TTDR00296	Synonyms	Cyclin-dependent kinase 5
TTDR00296	Synonyms	Cyclin-dependent kinase 5 (CDK5)
TTDR00296	Synonyms	PDPK
TTDR00296	Synonyms	Proline-directed protein kinase 33 kDa subunit
TTDR00296	Synonyms	Proline-directed protein kinase F(A) (PDPK F(A))
TTDR00296	Synonyms	Serine/threonine protein kinase PSSALRE
TTDR00296	Synonyms	Serine/threonine-protein kinase PSSALRE
TTDR00296	Synonyms	TPKII catalytic subunit
TTDR00296	Synonyms	Tau protein kinase II catalytic subunit
TTDR00296	Disease	Alzheimer's disease
TTDR00296	Disease	Bladder cancer
TTDR00296	Function	Probably involved in the control of the cell cycle. Interacts with d1 and d3-typ
TTDR00296	Sequence	MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF
TTDR00296	PDB Structure	1H4L; 1LFR; 1UNG; 1UNH; 1UNL
TTDR00296	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00296	Pathway	Alzheimer's disease
TTDR00296	Pathway	Axon guidance
TTDR00296	EC Number	EC 2.7.1.-
TTDR00296	EC Number	EC 2.7.1.37
TTDR00296	Target Validation	TTDR00296
TTDR00296	Inhibitor	(R)-roscovitine
TTDR00296	Inhibitor	1-phenyl-3-(2-(pyridin-4-yl)thiazol-4-yl)urea
TTDR00296	Inhibitor	3-(2-phenylthiazol-4-yl)quinolin-2(1H)-one
TTDR00296	Inhibitor	6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE
TTDR00296	Inhibitor	9-Nitropaullone
TTDR00296	Inhibitor	AZAKENPAULLONE
TTDR00296	Inhibitor	Alsterpaullone
TTDR00296	Inhibitor	Aminopurvalanol (NG97)
TTDR00296	Inhibitor	Flavopiridol
TTDR00296	Inhibitor	Hymenialdisine
TTDR00296	Inhibitor	Indirubin-3'-Monoxime
TTDR00296	Inhibitor	Indirubin-3'-monoxime
TTDR00296	Inhibitor	Indirubin-5-sulfonate
TTDR00296	Inhibitor	KENPAULLONE
TTDR00296	Inhibitor	MANZAMINE A
TTDR00296	Inhibitor	Olomoucine
TTDR00296	Inhibitor	Oxindole 16 (compound 3)
TTDR00296	Inhibitor	Oxindole 95
TTDR00296	Inhibitor	Purvalanol B
TTDR00296	Inhibitor	SU9516
TTDR00296	Inhibitor	Thieno analogue of kenpaullone
TTDR00298	UniProt ID	P49336
TTDR00298	Name	Cell division protein kinase 8
TTDR00298	Type of target	Research target
TTDR00298	Synonyms	CDK8
TTDR00298	Synonyms	Cyclin-dependent kinase 8
TTDR00298	Synonyms	Protein kinase K35
TTDR00298	Disease	Cancer, unspecific
TTDR00298	Function	Probably involved in the control of the cell cycle. May play a role in transcrip
TTDR00298	Sequence	MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVIS
TTDR00298	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00298	EC Number	EC 2.7.1.-
TTDR00298	EC Number	EC 2.7.1.37
TTDR00298	Inhibitor	Flavopiridol
TTDR00298	Inhibitor	Oxindole 16 (compound 3)
TTDR00298	Inhibitor	Oxindole 94
TTDR00299	UniProt ID	Q07785
TTDR00299	Name	Cyclin-dependent protein kinase PfPK5
TTDR00299	Type of target	Research target
TTDR00299	Synonyms	Cell division control protein 2 homolog
TTDR00299	Disease	Malaria
TTDR00299	Function	Plays a key role in the control of the eukaryotic cell cycle. It is required in
TTDR00299	Sequence	MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE
TTDR00299	PDB Structure	1LCH; 1OB3; 1V0B; 1V0O; 1V0P
TTDR00299	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00299	EC Number	EC 2.7.1.-
TTDR00299	Inhibitor	Alsterpaullone
TTDR00299	Inhibitor	Aminopurvalanol
TTDR00299	Inhibitor	Flavopiridol
TTDR00299	Inhibitor	Hymenialdisine
TTDR00299	Inhibitor	Indirubin-5-Sulphonate
TTDR00299	Inhibitor	Purvalanol
TTDR00299	Binder	Indirubin-3'-Monoxime
TTDR00299	Binder	Olomoucine
TTDR00299	Binder	SU9516
TTDR00300	UniProt ID	Q8IDW1
TTDR00300	Name	Cyclin-dependent protein kinase PfPK6
TTDR00300	Type of target	Research target
TTDR00300	Synonyms	CDK-related protein kinase 6
TTDR00300	Disease	Malaria
TTDR00300	Sequence	MNRIDISNFDFLYVIGKGTYGIVYKALDKKENNFVAIKKIINLCDENYGISKCILRELTILQKIKHKNIINLKYVFYGKD
TTDR00300	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00300	EC Number	EC 2.7.1.123
TTDR00300	EC Number	EC 2.7.1.37
TTDR00301	UniProt ID	P90584
TTDR00301	Name	Cyclin-dependent protein kinase Pfmrk
TTDR00301	Type of target	Research target
TTDR00301	Synonyms	MO15-related protein kinase Pfmrk
TTDR00301	Disease	Malaria
TTDR00301	Sequence	MENNSTERYIFKPNFLGEGSYGKVYKAYDTILKKEVAIKKMKLNEISNYIDDCGINFVLLREIKIMKEIKHKNIMSALDL
TTDR00301	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00301	EC Number	EC 2.7.1.37
TTDR00301	Target Validation	TTDR00301
TTDR00301	Inhibitor	(E)-1-(4-Nitro-phenyl)-3-pyridin-2-yl-propenone
TTDR00301	Inhibitor	2,5-dichloro-N-p-tolylthiophene-3-sulfonamide
TTDR00301	Inhibitor	2,5-dichloro-N-phenylthiophene-3-sulfonamide
TTDR00301	Inhibitor	2-chloro-N-(o-tolylcarbamoyl)benzamide
TTDR00301	Inhibitor	3-[3-(2-Hydroxy-ethoxy)-phenyl]-1H-quinolin-2-one
TTDR00301	Inhibitor	5-Nitro-1H-indole-2,3-dione
TTDR00301	Inhibitor	5-chloro-4-nitrothiophene-2-sulfonamide
TTDR00301	Inhibitor	APIGENIN
TTDR00301	Inhibitor	KENPAULLONE
TTDR00301	Inhibitor	N'-(2-fluorobenzoyl)-2-naphthohydrazide
TTDR00301	Inhibitor	N-(2-aminoethyl)isoquinoline-5-sulfonamide
TTDR00301	Inhibitor	Oxindole derivative
TTDR00301	Inhibitor	Oxindole derivatives
TTDR00301	Inhibitor	Thiophene sulfonamide
TTDR00301	Inhibitor	WR-080539
TTDR00301	Inhibitor	WR-089120
TTDR00301	Inhibitor	WR-190706
TTDR00301	Inhibitor	WR-203581
TTDR00301	Inhibitor	WR-289009
TTDR00301	Inhibitor	WR-289010
TTDR00301	Inhibitor	WR-289012
TTDR00301	Inhibitor	WR-289016
TTDR00302	Name	Cyclosporine receptor
TTDR00302	Type of target	Research target
TTDR00302	Disease	Inflammation
TTDR00302	Binder	D-43787
TTDR00303	UniProt ID	P58380
TTDR00303	Name	Enoyl-[acyl-carrier-protein] reductase [NADH] 1
TTDR00303	Type of target	Research target
TTDR00303	Synonyms	Enoyl-ACP reductase I
TTDR00303	Synonyms	NADH-dependent enoyl-ACP reductase 1
TTDR00303	Disease	Bacterial infections
TTDR00303	Sequence	MAQASGLMNGKRGVIMGVANNRSIAWGIAKALAEAGAEIALTWQGDALKKRVEPLAQELGAFMAGHCDVTDLATIDAVFS
TTDR00303	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDR00303	Pathway	Fatty acid biosynthesis
TTDR00303	Pathway	Metabolic pathways
TTDR00303	EC Number	EC 1.3.1.9
TTDR00303	Inhibitor	Diazaborines
TTDR00304	UniProt ID	P58381
TTDR00304	Name	Enoyl-[acyl-carrier-protein] reductase [NADH] 2
TTDR00304	Type of target	Research target
TTDR00304	Synonyms	Enoyl-ACP reductase II
TTDR00304	Synonyms	NADH-dependent enoyl-ACP reductase 2
TTDR00304	Disease	Bacterial infections
TTDR00304	Sequence	MNGLMNGKRGLIMGVANSHSIAWGIAKSLAAQGAELAFTYQGEALGKRVKPLAAEVNSDFLLPCDVEDIGSVDAVVDAIK
TTDR00304	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDR00304	Pathway	Fatty acid biosynthesis
TTDR00304	Pathway	Metabolic pathways
TTDR00304	EC Number	EC 1.3.1.9
TTDR00304	Inhibitor	Diazaborines
TTDR00306	UniProt ID	P14304
TTDR00306	Name	FemA factor
TTDR00306	Type of target	Research target
TTDR00306	Synonyms	Factor essential for expression of methicillin resistance
TTDR00306	Disease	Bacterial infections
TTDR00306	Function	May be involved in cell wall or membrane metabolism, or it might be a control el
TTDR00306	Sequence	MKFTNLTAKEFGAFTDSMPYSHFTQTVGHYELKLAEGYETHLVGIKNNNNEVIAACLLTAVPVMKVFKYFYSNRGPVIDY
TTDR00306	PDB Structure	1LRZ
TTDR00307	UniProt ID	P14305
TTDR00307	Name	FemB factor
TTDR00307	Type of target	Research target
TTDR00307	Synonyms	ORF 419
TTDR00307	Synonyms	Possible protein femB
TTDR00307	Disease	Bacterial infections
TTDR00307	Function	Its function is unknown but its expression is needed for attaining the full leve
TTDR00307	Sequence	MKFTELTVTEFDNFVQNPSLESHYFQVKENIVTRENDGFEVVLLGIKDDNNKVIAASLFSKIPTMGSYVYYSNRGPVMDF
TTDR00308	UniProt ID	Q6GEH2
TTDR00308	UniProt ID	Q9EY50
TTDR00308	Name	FemX factor
TTDR00308	Type of target	Research target
TTDR00308	Disease	Bacterial infections
TTDR00308	Sequence	MEKMHITNQEHDAFVKSNPNGDLLQLTKWAETKKLTGWYARRIAVGRDGEIQGVAQLLFKKVPKLPYTLCYISRGFVVDY
TTDR00308	PDB Structure	1NE9; 1P4N; 1XE4; 1XF8; 1XIX
TTDR00308	BioChemical Class	Acyltransferases
TTDR00309	UniProt ID	Q01469
TTDR00309	Name	Fatty acid-binding protein, epidermal
TTDR00309	Type of target	Research target
TTDR00309	Synonyms	E-FABP
TTDR00309	Synonyms	Fatty Acid Binding Protein mal1
TTDR00309	Synonyms	PA-FABP
TTDR00309	Synonyms	Psoriasis-associated fatty acid-binding protein homolog
TTDR00309	Disease	Insulin resistance
TTDR00309	Disease	Obesity
TTDR00309	Function	High specificity for fatty acids. Highest affinity for c18 chain length. Decreas
TTDR00309	Sequence	MATVQQLEGRWRLVDSKGFDEYMKELGVGIALRKMGAMAKPDCIITCDGKNLTIKTESTLKTTQFSCTLGEKFEETTADG
TTDR00309	PDB Structure	1B56; 1JJJ
TTDR00309	Pathway	PPAR signaling pathway
TTDR00309	Target Validation	TTDR00309
TTDR00309	Inhibitor	2-(2,3-bis(2-chlorobenzyloxy)phenyl)acetic acid
TTDR00309	Inhibitor	2-(Carbazole-9-sulfonyl)-benzoic acid
TTDR00309	Inhibitor	4-Carbazol-9-yl-butyric acid
TTDR00309	Inhibitor	5-Carbazol-9-yl-pentanoic acid
TTDR00309	Inhibitor	BMS-480404
TTDR00309	Inhibitor	Hexadecanoic acid
TTDR00310	UniProt ID	P24071
TTDR00310	Name	Immunoglobulin alpha Fc receptor
TTDR00310	Type of target	Research target
TTDR00310	Synonyms	CD89
TTDR00310	Synonyms	CD89 antigen
TTDR00310	Synonyms	IgA Fc receptor
TTDR00310	Disease	Cancer, unspecific
TTDR00310	Function	Binds to the fc region of immunoglobulins alpha. Mediates several functions incl
TTDR00310	Sequence	MDPKQTTLLCLVLCLGQRIQAQEGDFPMPFISAKSSPVIPLDGSVKIQCQAIREAYLTQLMIIKNSTYREIGRRLKFWNE
TTDR00310	PDB Structure	1OVZ; 1OW0; 1UCT
TTDR00310	BioChemical Class	Transmembrane protein
TTDR00310	Antibody	Chemically linked bispecific antibodies
TTDR00311	UniProt ID	P12314
TTDR00311	Name	Fc gamma receptor I
TTDR00311	Type of target	Research target
TTDR00311	Synonyms	CD64
TTDR00311	Synonyms	CD64 antigen
TTDR00311	Synonyms	Fc-gamma RI
TTDR00311	Synonyms	FcRI
TTDR00311	Synonyms	IgG Fc receptor I
TTDR00311	Disease	Cancer, unspecific
TTDR00311	Disease	Invasive candidiasis
TTDR00311	Function	Binds to the fc region of immunoglobulins gamma. High affinity receptor.
TTDR00311	Sequence	MWFLTTLLLWVPVDGQVDTTKAVITLQPPWVSVFQEETVTLHCEVLHLPGSSSTQWFLNGTATQTSTPSYRITSASVNDS
TTDR00311	BioChemical Class	Transmembrane protein
TTDR00311	Pathway	Hematopoietic cell lineage
TTDR00311	Pathway	Systemic lupus erythematosus
TTDR00311	Antibody	Chemically linked bispecific antibodies
TTDR00313	UniProt ID	Q14512
TTDR00313	Name	Heparin binding protein
TTDR00313	Type of target	Research target
TTDR00313	Synonyms	FGF-BP
TTDR00313	Synonyms	FGF-binding protein HBp17
TTDR00313	Synonyms	Fibroblast growth factor binding protein 1
TTDR00313	Synonyms	HBP17 heparin-binding and FGF-binding protein
TTDR00313	Synonyms	HBp17
TTDR00313	Disease	Prostate cancer
TTDR00313	Sequence	MKICSLTLLSFLLLAAQVLLVEGKKKVKNGLHSKVVSEQKDTLGNTQIKQKSRPGNKGKFVTKDQANCRWAATEQEEGIS
TTDR00313	BioChemical Class	Cell membrane protein
TTDR00314	Name	Fibroblast growth factor receptor
TTDR00314	Type of target	Clinical trial target
TTDR00314	Synonyms	FGF receptor
TTDR00314	Disease	Angiogenesis
TTDR00314	Disease	Cancer, unspecific
TTDR00314	Antagonist	PD166866
TTDR00314	Antagonist	PD173074
TTDR00314	Antagonist	SU4984
TTDR00314	Antagonist	SU5403
TTDR00315	UniProt ID	Q65037
TTDR00315	Name	Foot-and-mouth disease virus capsid protein VP1
TTDR00315	Type of target	Research target
TTDR00315	Disease	Foot and mouth disease
TTDR00315	Sequence	TTATGESADPVTTTVENYGGETQVQRRHHTDVGFIMDRFVKINSLSPTHVIDLMHTHKHGIVGALLRAATYYFSDLEIVV
TTDR00315	Antibody	Anti-FMDV antibodies
TTDR00316	UniProt ID	Q65035
TTDR00316	Name	Foot-and-mouth disease virus capsid protein VP2
TTDR00316	Type of target	Research target
TTDR00316	Disease	Foot and mouth disease
TTDR00316	Sequence	DKKTEETTLLEDRILTTRNGHTTSTTQSSVGVTYGYSTEEDHVAGPNTSGLETRVVQAERFFKKFLFDWTTDKPFGHLTK
TTDR00316	Antibody	Anti-FMDV antibodies
TTDR00317	UniProt ID	Q65036
TTDR00317	Name	Foot-and-mouth disease virus capsid protein VP3
TTDR00317	Type of target	Research target
TTDR00317	Disease	Foot and mouth disease
TTDR00317	Sequence	GIFPVACADGYGGLVTTDPKTADPVYGKVYNPPRTNYPGRFTNLLDVAEACPTFLCFDDGKPYVVTRTDDTRLLAKFDVS
TTDR00317	Antibody	Anti-FMDV antibodies
TTDR00319	UniProt ID	Q9HCN5
TTDR00319	Name	Glycoprotein VI
TTDR00319	Type of target	Research target
TTDR00319	Disease	Thrombosis
TTDR00319	Sequence	MSPSPTALFCL
TTDR00319	Antibody	Monoclonal antibodies
TTDR00320	UniProt ID	P07203
TTDR00320	Name	Glutathione peroxidase
TTDR00320	Type of target	Research target
TTDR00320	Synonyms	Cellular glutathione peroxidase
TTDR00320	Synonyms	GSHPx-1
TTDR00320	Disease	Oxidative and free radical damage
TTDR00320	Disease	Selenium deficiency
TTDR00320	Function	Protects the hemoglobin in erythrocytes from oxidative breakdown.
TTDR00320	Sequence	MCAARLAAAAAQSVYAFSARPLAGGEPVSLGSLRGKVLLIENVASLUGTTVRDYTQMNELQRRLGPRGLVVLGFPCNQFG
TTDR00320	PDB Structure	2F8A
TTDR00320	BioChemical Class	Oxidoreductases acting on a peroxide as acceptor
TTDR00320	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDR00320	Pathway	Arachidonic acid metabolism
TTDR00320	Pathway	Glutathione metabolism
TTDR00320	Pathway	Huntington's disease
TTDR00320	EC Number	EC 1.11.1.9
TTDR00321	UniProt ID	Q14416
TTDR00321	Name	Metabotropic glutamate receptor 2
TTDR00321	Type of target	Clinical trial target
TTDR00321	Synonyms	Glutamate receptor mGLU2
TTDR00321	Synonyms	Group II metabotropic glutamate receptor
TTDR00321	Synonyms	mGLUR2
TTDR00321	Disease	Alzheimer's disease
TTDR00321	Disease	Analgesics
TTDR00321	Disease	Anxiety disorder, unspecified
TTDR00321	Disease	Epilepsy
TTDR00321	Disease	Pain, unspecified
TTDR00321	Disease	Traumatic brain injury
TTDR00321	Function	Receptor for glutamate. The activity of this receptor is mediated by a g-protein
TTDR00321	Sequence	MGSLLALLALLLLWGAVAEGPAKKVLTLEGDLVLGGLFPVHQKGGPAEDCGPVNEHRGIQRLEAMLFALDRINRDPHLLP
TTDR00321	BioChemical Class	G-protein coupled receptor (metabotropic glutamate family)
TTDR00321	Pathway	Neuroactive ligand-receptor interaction
TTDR00321	Target Validation	TTDR00321
TTDR00321	Drug(s)	ADX71149
TTDR00321	Drug(s)	BCI-632
TTDR00321	Drug(s)	BCI-838
TTDR00321	Drug(s)	LY-544344
TTDR00321	Drug(s)	MGluR2 agonist
TTDR00321	Drug(s)	RG1578
TTDR00321	Inhibitor	GLUTAMATE
TTDR00321	Inhibitor	LY-341495
TTDR00321	Inhibitor	LY-354740
TTDR00321	Inhibitor	LY-379268
TTDR00321	Inhibitor	LY-389795
TTDR00321	Inhibitor	QUISQUALATE
TTDR00321	Antagonist	LY341495
TTDR00321	Agonist	(2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate
TTDR00321	Agonist	2R,4R-APDC
TTDR00321	Agonist	DCG IV
TTDR00321	Agonist	LY-544344
TTDR00321	Agonist	MGluR2 agonist
TTDR00322	UniProt ID	P04141
TTDR00322	Name	Granulocyte-macrophage colony-stimulating factor
TTDR00322	Type of target	Clinical trial target
TTDR00322	Synonyms	CSF
TTDR00322	Synonyms	Colony-stimulating factor
TTDR00322	Synonyms	GM-CSF
TTDR00322	Synonyms	Molgramostin
TTDR00322	Synonyms	Sargramostim
TTDR00322	Disease	Experimental autoimmune encephalomyelitis
TTDR00322	Disease	Inflammation
TTDR00322	Function	Cytokine that stimulates the growth and differentiation of hematopoietic precurs
TTDR00322	Sequence	MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYK
TTDR00322	PDB Structure	1CSG; 2GMF; 3CXE
TTDR00322	BioChemical Class	Growth factor
TTDR00322	Pathway	Cytokine-cytokine receptor interaction
TTDR00322	Pathway	Fc epsilon RI signaling pathway
TTDR00322	Pathway	Hematopoietic cell lineage
TTDR00322	Pathway	Jak-STAT signaling pathway
TTDR00322	Pathway	Natural killer cell mediated cytotoxicity
TTDR00322	Pathway	T cell receptor signaling pathway
TTDR00323	UniProt ID	P26664
TTDR00323	Name	HCV helicase
TTDR00323	Type of target	Research target
TTDR00323	Disease	Hepatitis C
TTDR00323	Sequence	MSTNPKPQKKNKRNTNRRPQDVKFPGGGQIVGGVYLLPRRGPRLGVRATRKTSERSQPRGRRQPIPKARRPEGRTWAQPG
TTDR00323	PDB Structure	1RTL; 2A4G; 2GVF; 3EYD
TTDR00323	BioChemical Class	Protease
TTDR00323	EC Number	EC 3.6.1.-
TTDR00326	UniProt ID	P10236
TTDR00326	Name	Herpes simplex virus helicase-primase
TTDR00326	Type of target	Research target
TTDR00326	Synonyms	DNA helicase/primase complex protein
TTDR00326	Synonyms	DNA replication protein UL52
TTDR00326	Synonyms	Helicase-primase complex
TTDR00326	Synonyms	Herpesvirus helicase primase enzyme
TTDR00326	Disease	Herpes virus infection
TTDR00326	Function	Involved in dna replication.
TTDR00326	Sequence	MGQEDGNRGERRAAGTPVEVTALYATDGCVITSSIALLTNSLLGAEPVYIFSYDAYTHDGRADGPTEQDRFEESRALYQA
TTDR00326	Related US Patent	6,323,202
TTDR00326	Inhibitor	BAY 57-1293
TTDR00326	Inhibitor	BILS 179 BS
TTDR00327	UniProt ID	Q9WWI2
TTDR00327	Name	Histidine kinase AlgR1
TTDR00327	Type of target	Research target
TTDR00327	Disease	Bacterial infections
TTDR00327	Sequence	MNVLIVDDEPLARERLSRMVNEIEGYRVLEPSASNGEEALALIETHKPDVVLLDIRMPGLDGLQVAARLCEREAPPAVVF
TTDR00327	EC Number	EC 2.7.-.-
TTDR00328	UniProt ID	P15275
TTDR00328	Name	Histidine kinase AlgR2
TTDR00328	Type of target	Research target
TTDR00328	Disease	Bacterial infections
TTDR00328	Function	The promoter for a critical alginate biosynthetic gene, algd, encoding gdp-manno
TTDR00328	Sequence	MLESCRNAQERWGGVHQLIDRWLHERQQLVQAFDALSGIQAPAPNAEELQHFCQLLLDYVSAGHFEVYEQLTAEGKAFGD
TTDR00328	EC Number	EC 2.7.-.-
TTDR00328	Inhibitor	LY266500
TTDR00329	UniProt ID	O07382
TTDR00329	Name	Histidine kinase KinA
TTDR00329	Type of target	Research target
TTDR00329	Disease	Bacterial infections
TTDR00329	Sequence	MKKLFTFNKKKETVEESSAKRSIMLRWAFANTVFCFITFTLFATLTYQLTISSFIKEEQRLLTGSMDSAEEVLEQADAPL
TTDR00329	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00329	Inhibitor	Closantel 6
TTDR00329	Inhibitor	RWJ-49815
TTDR00329	Inhibitor	RWJ-49968
TTDR00329	Inhibitor	RWJ-61907
TTDR00329	Inhibitor	Tetrachlorosalicylanilide
TTDR00330	UniProt ID	P03378
TTDR00330	Name	HIV-1 gp160
TTDR00330	Type of target	Research target
TTDR00330	Synonyms	Envelope polyprotein GP160
TTDR00330	Disease	Human immunodeficiency virus [HIV] disease
TTDR00330	Sequence	MKVKGTRRNYQHLWRWGTLLLGMLMICSATEKLWVTVYYGVPVWKEATTTLFCASDARAYDTEVHNVWATHACVPTDPNP
TTDR00330	BioChemical Class	Transmembrane protein
TTDR00330	Antibody	HIV-1 vaccine
TTDR00331	UniProt ID	P24224
TTDR00331	Name	Holo-ACP synthase
TTDR00331	Type of target	Research target
TTDR00331	Synonyms	4'-phosphopantetheinyl transferase acpS
TTDR00331	Synonyms	Holo-[acyl-carrier protein] synthase
TTDR00331	Disease	Bacterial infections
TTDR00331	Function	Transfers the 4'-phosphopantetheine moiety from coenzyme a to the ser-36 of acyl
TTDR00331	Sequence	MAILGLGTDIVEIARIEAVIARSGDRLARRVLSDNEWAIWKTHHQPVRFLAKRFAVKEAAAKAFGTGIRNGLAFNQFEVF
TTDR00331	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00331	Pathway	Pantothenate and CoA biosynthesis
TTDR00331	EC Number	EC 2.7.8.7
TTDR00332	Name	Interferon alpha
TTDR00332	Type of target	Clinical trial target
TTDR00332	Synonyms	B-cell interferon
TTDR00332	Synonyms	Buffy coat interferon
TTDR00332	Synonyms	Foreign cell-induced interferon
TTDR00332	Synonyms	IFN-alpha
TTDR00332	Synonyms	Leukocyte interferon
TTDR00332	Synonyms	Lymphoblast interferon
TTDR00332	Synonyms	Lymphoblastoid interferon
TTDR00332	Synonyms	Namalwa interferon
TTDR00332	Synonyms	PH2-stable interferon
TTDR00332	Synonyms	RSV-induced factor
TTDR00332	Synonyms	Type-1 interferon
TTDR00332	Disease	Hepatitis C
TTDR00332	Disease	Inflammation
TTDR00332	Disease	Systemic lupus erythematosus
TTDR00332	Drug(s)	MEDI-545
TTDR00332	Drug(s)	MEDI-546
TTDR00332	Drug(s)	Rontalizumab
TTDR00332	Antibody	Rontalizumab
TTDR00333	UniProt ID	P08833
TTDR00333	Name	Insulin-like growth factor binding protein 1
TTDR00333	Type of target	Research target
TTDR00333	Synonyms	IBP-1
TTDR00333	Synonyms	IGF-binding protein 1
TTDR00333	Synonyms	IGFBP-1
TTDR00333	Synonyms	Insulin-like growth factor I
TTDR00333	Synonyms	PP12
TTDR00333	Synonyms	Placental protein 12
TTDR00333	Disease	Colorectal cancer
TTDR00333	Disease	Maturity-onset diabetes of the young
TTDR00333	Function	Igf-bindinG proteins prolong the half-life of the igfs and have been shown to ei
TTDR00333	Sequence	MSEVPVARVWLVLLLLTVQVGVTAGAPWQCAPCSAEKLALCPPVSASCSEVTRSAGCGCCPMCALPLGAACGVATARCAR
TTDR00333	PDB Structure	1ZT3; 1ZT5; 2DSQ
TTDR00333	Related US Patent	6,680,298
TTDR00334	UniProt ID	P45984
TTDR00334	Name	Mitogen-activated protein kinase 9
TTDR00334	Type of target	Research target
TTDR00334	Synonyms	C-Jun N-terminal kinase 2
TTDR00334	Synonyms	C-jun-amino-terminal kinase interacting protein 2
TTDR00334	Synonyms	IB-2
TTDR00334	Synonyms	Islet-brain-2
TTDR00334	Synonyms	JIP-2
TTDR00334	Synonyms	JNK MAP kinase scaffold protein 2
TTDR00334	Synonyms	JNK-55
TTDR00334	Synonyms	JNK-interacting protein 2
TTDR00334	Synonyms	JNK2
TTDR00334	Synonyms	Jun-N-terminal kinase 2
TTDR00334	Synonyms	Mitogen-activated protein kinase 8-interacting protein 2
TTDR00334	Synonyms	Stress-activated protein kinase JNK2
TTDR00334	Disease	Cancer, unspecific
TTDR00334	Disease	Crohn's disease, unspecified
TTDR00334	Disease	Inflammation
TTDR00334	Disease	Obesity
TTDR00334	Function	Responds to activation by environmental stress and pro- inflammatory cytokines b
TTDR00334	Sequence	MSDSKCDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV
TTDR00334	PDB Structure	3E7O
TTDR00334	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00334	EC Number	EC 2.7.1.37
TTDR00334	Inhibitor	SP600125
TTDR00335	UniProt ID	P25791
TTDR00335	Name	Rhombotin-2
TTDR00335	Type of target	Research target
TTDR00335	Synonyms	Cysteine rich protein TTG-2
TTDR00335	Synonyms	Cysteine-rich protein TTG-2
TTDR00335	Synonyms	LIM-domain protein Lmo2
TTDR00335	Synonyms	LIM-only protein 2
TTDR00335	Synonyms	T-cell translocation protein 2
TTDR00335	Disease	Cancer, unspecific
TTDR00335	Function	Binds to the basic helix-loop-helix protein tal-1. This interaction seems to be
TTDR00335	Sequence	MSSAIERKSLDPSEEPVDEVLQIPPSLLTCGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLC
TTDR00336	UniProt ID	P55058
TTDR00336	Name	Phospholipid transfer protein
TTDR00336	Type of target	Research target
TTDR00336	Synonyms	Lipid II precursor
TTDR00336	Synonyms	Lipid transfer protein II
TTDR00336	Synonyms	PLTP
TTDR00336	Synonyms	Plasma phospholipid transfer protein
TTDR00336	Disease	Coronary heart disease
TTDR00336	Disease	Diabetes mellitus
TTDR00336	Disease	Hyperlipidemia
TTDR00336	Disease	Obesity
TTDR00336	Function	Converts hdl into larger and smaller particles. May play a key role in extracell
TTDR00336	Sequence	MALFGALFLALLAGAHAEFPGCKIRVTSKALELVKQEGLRFLEQELETITIPDLRGKEGHFYYNISEVKVTELQLTSSEL
TTDR00336	Pathway	PPAR signaling pathway
TTDR00337	UniProt ID	Q9Y2U5
TTDR00337	Name	Mitogen-activated protein kinase kinase kinase 2
TTDR00337	Type of target	Research target
TTDR00337	Synonyms	MAPK/ERK kinase 2
TTDR00337	Synonyms	MAPK/ERK kinase kinase 2
TTDR00337	Synonyms	MEK kinase 2
TTDR00337	Synonyms	MEKK 2
TTDR00337	Disease	Cancer, unspecific
TTDR00337	Function	Preferentially activates the jnk/sapk group of map kinases.
TTDR00337	Sequence	MDDQQALNSIMQDLAVLHKASRPALSLQETRKAKSSSPKKQNDVRVKFEHRGEKRILQFPRPVKLEDLRSKAKIAFGQSM
TTDR00337	PDB Structure	2CU1; 2NPT
TTDR00337	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00337	Pathway	Gap junction
TTDR00337	Pathway	GnRH signaling pathway
TTDR00337	Pathway	MAPK signaling pathway
TTDR00337	EC Number	EC 2.7.1.-
TTDR00337	Inhibitor	LLZ16407
TTDR00337	Inhibitor	PD184352
TTDR00337	Inhibitor	PD98059
TTDR00337	Inhibitor	Ro092210
TTDR00337	Inhibitor	U0126
TTDR00338	UniProt ID	Q8NG02
TTDR00338	Name	Matrix metalloproteinase
TTDR00338	Type of target	Research target
TTDR00338	Synonyms	MMP
TTDR00338	Synonyms	MMP-21
TTDR00338	Disease	Atherosclerosis
TTDR00338	Disease	Leukemia, unspecified
TTDR00338	Disease	Osteoarthritis
TTDR00338	Disease	Rheumatoid arthritis, unspecified
TTDR00338	Sequence	MLAASIFRPTLLLCWLAAPWPTQPESLFHSRDRSDLEPSPLRQAKPIADLHAAQRFLSRYGWSGVWAAWGPSPEGPPETP
TTDR00338	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00338	EC Number	EC 3.4.24.-
TTDR00338	Related US Patent	6,133,304
TTDR00338	Related US Patent	6,197,770
TTDR00338	Related US Patent	6,235,786
TTDR00338	Related US Patent	6,271,262
TTDR00338	Related US Patent	6,277,876
TTDR00338	Related US Patent	6,288,086
TTDR00338	Related US Patent	6,294,539
TTDR00338	Related US Patent	6,294,573
TTDR00338	Related US Patent	6,306,892
TTDR00338	Related US Patent	6,329,373
TTDR00338	Related US Patent	6,331,563
TTDR00338	Related US Patent	6,339,092
TTDR00338	Related US Patent	6,339,160
TTDR00338	Related US Patent	6,342,508
TTDR00338	Related US Patent	6,358,980
TTDR00338	Related US Patent	6,358,987
TTDR00338	Related US Patent	6,376,489
TTDR00338	Related US Patent	6,376,665
TTDR00338	Related US Patent	6,387,901
TTDR00338	Related US Patent	6,387,931
TTDR00338	Related US Patent	6,399,598
TTDR00338	Related US Patent	6,417,229
TTDR00338	Related US Patent	6,441,021
TTDR00338	Related US Patent	6,441,023
TTDR00338	Related US Patent	6,441,189
TTDR00338	Related US Patent	6,444,704
TTDR00338	Related US Patent	6,448,250
TTDR00338	Related US Patent	6,455,570
TTDR00338	Related US Patent	6,462,042
TTDR00338	Related US Patent	6,462,073
TTDR00338	Related US Patent	6,465,474
TTDR00338	Related US Patent	6,465,508
TTDR00338	Related US Patent	6,469,000
TTDR00338	Related US Patent	6,479,502
TTDR00338	Related US Patent	6,486,193
TTDR00338	Related US Patent	6,486,203
TTDR00338	Related US Patent	6,489,324
TTDR00338	Related US Patent	6,492,367
TTDR00338	Related US Patent	6,495,548
TTDR00338	Related US Patent	6,495,565
TTDR00338	Related US Patent	6,495,582
TTDR00338	Related US Patent	6,498,167
TTDR00338	Related US Patent	6,503,892
TTDR00338	Related US Patent	6,509,368
TTDR00338	Related US Patent	6,511,993
TTDR00338	Related US Patent	6,521,606
TTDR00338	Related US Patent	6,531,499
TTDR00338	Related US Patent	6,534,491
TTDR00338	Related US Patent	6,544,980
TTDR00338	Related US Patent	6,545,038
TTDR00338	Related US Patent	6,548,667
TTDR00338	Related US Patent	6,555,535
TTDR00338	Related US Patent	6,559,142
TTDR00338	Related US Patent	6,562,963
TTDR00338	Related US Patent	6,566,381
TTDR00338	Related US Patent	6,569,855
TTDR00338	Related US Patent	6,579,982
TTDR00338	Related US Patent	6,600,057
TTDR00338	Related US Patent	6,620,823
TTDR00338	Related US Patent	6,642,255
TTDR00338	Related US Patent	6,645,477
TTDR00338	Related US Patent	6,677,355
TTDR00338	Related US Patent	6,762,198
TTDR00338	Related US Patent	6,784,169
TTDR00338	Target Validation	TTDR00338
TTDR00338	Inhibitor	2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide
TTDR00338	Inhibitor	3-(4-(2-phenylethynyl)benzoyl)pentanoic acid
TTDR00338	Inhibitor	IK-682
TTDR00338	Inhibitor	ILOMASTAT
TTDR00338	Inhibitor	N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide
TTDR00338	Inhibitor	N-hydroxy-2,3-bis(phenylsulfonamido)propanamide
TTDR00338	Inhibitor	SR-973
TTDR00338	Inhibitor	[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid
TTDR00339	UniProt ID	P80192
TTDR00339	Name	Mitogen-activated protein kinase kinase kinase 9
TTDR00339	Type of target	Research target
TTDR00339	Synonyms	Mixed lineage kinase 1
TTDR00339	Disease	Cancer, unspecific
TTDR00339	Sequence	MEPSRALLGCLASAAAAAPPGEDGAGAGAEEEEEEEEEAAAAVGPGELGCDAPLPYWTAVFEYEAAGEDELTLRLGDVVE
TTDR00339	PDB Structure	3DTC
TTDR00339	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00339	EC Number	EC 2.7.1.-
TTDR00339	EC Number	EC 2.7.1.37
TTDR00339	Target Validation	TTDR00339
TTDR00339	Inhibitor	CEP-5104
TTDR00339	Inhibitor	CEP-6331
TTDR00339	Inhibitor	CEP1347
TTDR00340	UniProt ID	Q02779
TTDR00340	Name	Mitogen-activated protein kinase kinase kinase 10
TTDR00340	Type of target	Research target
TTDR00340	Synonyms	Mixed lineage kinase 2
TTDR00340	Synonyms	Protein kinase MST
TTDR00340	Disease	Cancer, unspecific
TTDR00340	Sequence	MEEEEGAVAKEWGTTPAGPVWTAVFDYEAAGDEELTLRRGDRVQVLSQDCAVSGDEGWWTGQLPSGRVGVFPSNYVAPGA
TTDR00340	PDB Structure	2RF0
TTDR00340	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00340	EC Number	EC 2.7.1.37
TTDR00340	Target Validation	TTDR00340
TTDR00340	Inhibitor	(+)K-252a
TTDR00340	Inhibitor	CEP-5104
TTDR00340	Inhibitor	CEP-6331
TTDR00340	Inhibitor	CEP1348
TTDR00341	UniProt ID	Q9JJ15
TTDR00341	Name	Mitogen-activated protein kinase kinase kinase 11
TTDR00341	Type of target	Research target
TTDR00341	Synonyms	MLK3
TTDR00341	Synonyms	Mixed lineage kinase 3
TTDR00341	Synonyms	Mixed-lineage protein kinase 3
TTDR00341	Synonyms	Protein-tyrosine kinase PTK1
TTDR00341	Synonyms	SH3 domain-containing proline-rich kinase
TTDR00341	Disease	Cancer, unspecific
TTDR00341	Disease	Neurodegenerative diseases involving neuronal apoptosis
TTDR00341	Sequence	MEPLKNLFLKSPLGSWNGSGSGGGGGTGGVRPEGSPKATAAYANPVWTALFDYEPNGQDELALRKGDRVEVLSRDAAISG
TTDR00341	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00341	Pathway	MAPK signaling pathway
TTDR00341	EC Number	EC 2.7.1.112
TTDR00341	Target Validation	TTDR00341
TTDR00341	Inhibitor	CEP-5104
TTDR00341	Inhibitor	CEP-6331
TTDR00341	Inhibitor	CEP1349
TTDR00342	Name	mRNA of adenosine A1 receptor
TTDR00342	Type of target	Research target
TTDR00342	Disease	Asthma
TTDR00342	Antisense	EPI-2010
TTDR00343	Name	mRNA of EGFR
TTDR00343	Type of target	Research target
TTDR00343	Disease	Prostate cancer
TTDR00343	Antisense	21-mer antisense phosphorothioate oligonucleotide
TTDR00343	Antisense	Antisense EGFR oligodeoxynucleotide enveloped in Lipofectin
TTDR00344	Name	mRNA of protein kinase A Rialpha subunit
TTDR00344	Type of target	Research target
TTDR00344	Disease	Cancer, unspecific
TTDR00344	Antisense	(35)S-labeled oligonucleotide
TTDR00347	UniProt ID	P19634
TTDR00347	Name	Sodium/hydrogen exchanger 1
TTDR00347	Type of target	Research target
TTDR00347	Synonyms	APNH
TTDR00347	Synonyms	Myocardial Na+/H+ exchanger
TTDR00347	Synonyms	NHE-1
TTDR00347	Synonyms	Na(+)/H(+) exchanger 1
TTDR00347	Synonyms	Na(+)Sodium/hydrogen exchanger 1/H(+) exchanger 1
TTDR00347	Synonyms	Na+/H+ antiporter, amiloride-sensitive
TTDR00347	Disease	Heart failure
TTDR00347	Disease	Myocardial ischemia and reperfusion injury
TTDR00347	Function	Involved in ph regulation to eliminate acids generated by active metabolism or t
TTDR00347	Sequence	MVLRSGICGLSPHRIFPSLLVVVALVGLLPVLRSHGLQLSPTASTIRSSEPPRERSIGDVTTAPPEVTPESRPVNHSVTD
TTDR00347	PDB Structure	1Y4E; 2BEC; 2E30; 2HTG; 2KBV
TTDR00347	BioChemical Class	Ion transport
TTDR00347	Pathway	Cardiac muscle contraction
TTDR00347	Pathway	Regulation of actin cytoskeleton
TTDR00347	Related US Patent	6,348,476
TTDR00347	Related US Patent	6,441,176
TTDR00347	Related US Patent	6,462,024
TTDR00347	Related US Patent	6,593,352
TTDR00347	Related US Patent	6,627,643
TTDR00347	Related US Patent	6,630,506
TTDR00347	Target Validation	TTDR00347
TTDR00347	Inhibitor	5'-(N-ethyl-N-isopropyl)amiloride
TTDR00347	Inhibitor	CARIPORIDE
TTDR00347	Inhibitor	CARIPORIDE METHYLSULFONATE
TTDR00347	Inhibitor	ENIPORIDE
TTDR00347	Inhibitor	HOE-694
TTDR00347	Inhibitor	Homoserine Lactone
TTDR00347	Inhibitor	N-(3-Methanesulfonyl-4-methoxy-benzoyl)-guanidine
TTDR00347	Inhibitor	N-(3-Methanesulfonyl-4-methyl-benzoyl)-guanidine
TTDR00347	Inhibitor	N-(4-Bromo-3-methanesulfonyl-benzoyl)-guanidine
TTDR00347	Inhibitor	N-(4-Chloro-3-methanesulfonyl-benzoyl)-guanidine
TTDR00347	Inhibitor	N-(4-Cyano-3-methanesulfonyl-benzoyl)-guanidine
TTDR00347	Inhibitor	N-(5-Methanesulfonyl-2-methyl-benzoyl)-guanidine
TTDR00347	Inhibitor	N-(5-Phenyl-furan-2-carbonyl)-guanidine
TTDR00347	Inhibitor	N-(5-m-Tolyl-furan-2-carbonyl)-guanidine
TTDR00347	Inhibitor	N-(5-o-Tolyl-furan-2-carbonyl)-guanidine
TTDR00347	Inhibitor	N-[2-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine
TTDR00347	Inhibitor	N-[4-(1H-benzoimidazol-2-yl)-benzoyl]-guanidine
TTDR00347	Inhibitor	N-[5-(2-Ethyl-phenyl)-furan-2-carbonyl]-guanidine
TTDR00347	Inhibitor	N-[5-(2-Nitro-phenyl)-furan-2-carbonyl]-guanidine
TTDR00348	UniProt ID	P52085
TTDR00348	Name	Nicotinate-nucleotide adenylyltransferase
TTDR00348	Type of target	Research target
TTDR00348	Synonyms	Deamido-NAD(+) diphosphorylase
TTDR00348	Synonyms	Deamido-NAD(+) pyrophosphorylase
TTDR00348	Synonyms	Deamido-NAD(+)Nicotinate-nucleotide adenylyltransferase pyrophosphorylase
TTDR00348	Synonyms	NaMN adenylyltransferase
TTDR00348	Synonyms	Nicotinate mononucleotide adenylyltransferase
TTDR00348	Disease	Bacterial infections
TTDR00348	Function	Catalyzes the reversible adenylation of nicotinate mononucleotide (namn) to nico
TTDR00348	Sequence	MKSLQALFGGTFDPVHYGHLKPVETLANLIGLTRVTIIPNNVPPHRPQPEANSVQRKHMLELAIADKPLFTLDERELKRN
TTDR00348	PDB Structure	1K4K; 1K4M
TTDR00348	EC Number	EC 2.7.7.18
TTDR00348	Inhibitor	Deamido-Nad+
TTDR00348	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00348	Binder	Deamido-NAD
TTDR00349	UniProt ID	Q9BZR6
TTDR00349	Name	Reticulon 4 receptor
TTDR00349	Type of target	Research target
TTDR00349	Synonyms	NgR
TTDR00349	Synonyms	Nogo receptor
TTDR00349	Synonyms	Nogo-66 receptor
TTDR00349	Synonyms	UNQ330/PRO526
TTDR00349	Disease	Cancer, unspecific
TTDR00349	Disease	Central nervous system injury
TTDR00349	Disease	Neurodegenerative diseases
TTDR00349	Function	Receptor for rtn4, omg and mag. Mediates axonal growth inhibition and may play a
TTDR00349	Sequence	MKRASAGGSRLLAWVLWLQAWQVAAPCPGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRAC
TTDR00349	PDB Structure	1OZN; 1P8T
TTDR00349	BioChemical Class	Cell membrane protein
TTDR00349	Inhibitor	Alpha-D-Mannose
TTDR00350	UniProt ID	Q9H1D0
TTDR00350	Name	Transient receptor potential channel 6, subfamily V
TTDR00350	Type of target	Research target
TTDR00350	Synonyms	CaT1
TTDR00350	Synonyms	Calcium channel CAT1
TTDR00350	Synonyms	Calcium transport protein CaT1
TTDR00350	Synonyms	ECaC2
TTDR00350	Synonyms	HTRP8
TTDR00350	Synonyms	TRPV6
TTDR00350	Synonyms	Transient receptor potential cation channel subfamily V, member 6
TTDR00350	Disease	Inflammation
TTDR00350	Disease	Prostate cancer
TTDR00350	Sequence	MGLSLPKEKGLILCLWSKFCRWFQRRESWAQSRDEQNLLQQKRIWESPLLLAAKDNDVQALNKLLKYEDCKVHQRGAMGE
TTDR00350	BioChemical Class	Calcium channel
TTDR00352	UniProt ID	Q15759
TTDR00352	Name	Mitogen-activated protein kinase 11
TTDR00352	Type of target	Research target
TTDR00352	Synonyms	MAP kinase p38 beta
TTDR00352	Synonyms	Mitogen-activated protein kinase p38 beta
TTDR00352	Synonyms	P38 Mitogen-activated protein kinase beta
TTDR00352	Synonyms	P38-2
TTDR00352	Synonyms	P38b
TTDR00352	Synonyms	Stress-activated protein kinase-2
TTDR00352	Disease	Inflammation
TTDR00352	Disease	Psoriasis
TTDR00352	Disease	Rheumatoid arthritis, unspecified
TTDR00352	Function	Kinase involved in a signal transduction pathway that is activated by changes in
TTDR00352	Sequence	MSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKH
TTDR00352	PDB Structure	3GP0
TTDR00352	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00352	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDR00352	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR00352	Pathway	Fc epsilon RI signaling pathway
TTDR00352	Pathway	GnRH signaling pathway
TTDR00352	Pathway	Leukocyte transendothelial migration
TTDR00352	Pathway	MAPK signaling pathway
TTDR00352	Pathway	T cell receptor signaling pathway
TTDR00352	Pathway	Toll-like receptor signaling pathway
TTDR00352	Pathway	VEGF signaling pathway
TTDR00352	EC Number	EC 2.7.1.37
TTDR00352	Target Validation	TTDR00352
TTDR00352	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDR00352	Inhibitor	BIRB796
TTDR00352	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDR00352	Inhibitor	BMS-640994
TTDR00352	Inhibitor	CI-1040;PD-18435;PD-184352
TTDR00352	Inhibitor	GF-109203
TTDR00352	Inhibitor	Go-6976
TTDR00352	Inhibitor	KN-62
TTDR00352	Inhibitor	KT-5720
TTDR00352	Inhibitor	L-779450
TTDR00352	Inhibitor	LY-294002
TTDR00352	Inhibitor	ML-3163
TTDR00352	Inhibitor	ML-3375
TTDR00352	Inhibitor	ML-3403
TTDR00352	Inhibitor	PD-98059
TTDR00352	Inhibitor	RO-316233
TTDR00352	Inhibitor	RWJ-68354
TTDR00352	Inhibitor	SB 235699
TTDR00352	Inhibitor	SB-202190
TTDR00352	Inhibitor	SB-203580
TTDR00352	Inhibitor	SCIO469
TTDR00352	Inhibitor	SK&F-86002;SK-86002
TTDR00352	Inhibitor	STAUROSPORINONE
TTDR00352	Inhibitor	U-0126
TTDR00352	Inhibitor	VK-19911
TTDR00352	Inhibitor	Vertex 745 (VX745)
TTDR00353	Name	P42/p44 mitogen-activated protein kinase
TTDR00353	Type of target	Research target
TTDR00353	Disease	Neurodegenerative diseases
TTDR00353	Disease	Proliferative diseases
TTDR00353	EC Number	EC 2.7.1.-
TTDR00353	Inhibitor	Purvalanol
TTDR00354	UniProt ID	P15044
TTDR00354	Name	Pantothenate kinase
TTDR00354	Type of target	Research target
TTDR00354	Synonyms	Pantothenic acid kinase
TTDR00354	Synonyms	Rts protein
TTDR00354	Disease	Bacterial infections
TTDR00354	Sequence	MSIKEQTLMTPYLQFDRNQWAALRDSVPMTLSEDEIARLKGINEDLSLEEVAEIYLPLSRLLNFYISSNLRRQAVLEQFL
TTDR00354	PDB Structure	1ESM; 1ESN; 1SQ5
TTDR00354	EC Number	EC 2.7.1.33
TTDR00354	Inhibitor	Adenosine-5'-Diphosphate
TTDR00354	Inhibitor	Coenzyme A
TTDR00354	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDR00355	UniProt ID	Q13526
TTDR00355	Name	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1
TTDR00355	Type of target	Research target
TTDR00355	Synonyms	PPIase Pin1
TTDR00355	Synonyms	Peptidyl prolyl cis/trans isomerase Pin1
TTDR00355	Synonyms	Prolyl isomerase Pin1
TTDR00355	Synonyms	Rotamase Pin1
TTDR00355	Disease	Alzheimer's disease
TTDR00355	Disease	Cancer, unspecific
TTDR00355	Disease	Hepatocellular carcinoma
TTDR00355	Function	Essential ppiase that regulates mitosis presumably by interacting with nima and
TTDR00355	Sequence	MADEEKLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITR
TTDR00355	PDB Structure	1F8A; 1I8G; 1I8H; 1NMV; 1PIN; 1ZCN; 2F21
TTDR00355	BioChemical Class	Cis-trans-Isomerases
TTDR00355	EC Number	EC 5.2.1.8
TTDR00355	Target Validation	TTDR00355
TTDR00355	Inhibitor	(R)-2-(2-naphthamido)-3-m-tolylpropanoic acid
TTDR00355	Inhibitor	(R)-2-(2-naphthamido)-3-p-tolylpropanoic acid
TTDR00355	Inhibitor	(R)-2-(2-naphthamido)-5-phenylpent-4-ynoic acid
TTDR00355	Inhibitor	(R)-3-(2-naphthamido)-4-m-tolylbutanoic acid
TTDR00355	Inhibitor	(R,)-2-(2-naphthamido)-5-phenylpent-4-enoic acid
TTDR00355	Inhibitor	3,6,9,12,15,18-HEXAOXAICOSANE
TTDR00355	Inhibitor	Ac-Bth-Thr(PO3H2)-Pip-Nal-Gln-NH2
TTDR00355	Inhibitor	Ac-Phe-D-Thr(PO3H2)-Pip-Nal-Gln-NH2
TTDR00355	Inhibitor	Ac-Phe-Thr(PO3H2)-Pip-Nal-Gln-NH2
TTDR00355	Inhibitor	Beta-(2-Naphthyl)-Alanine
TTDR00356	UniProt ID	O00443
TTDR00356	Name	Phosphoinositide 3 kinase
TTDR00356	Type of target	Clinical trial target
TTDR00356	Synonyms	PI 3-kinase
TTDR00356	Synonyms	PI3K
TTDR00356	Synonyms	Phosphoinositol-3 kinase
TTDR00356	Disease	Autoimmune diseases
TTDR00356	Disease	Cancer, unspecific
TTDR00356	Disease	Respiratory diseases
TTDR00356	Sequence	MAQISSNSGFKECPSSHPEPTRAKDVDKEEALQMEAEALAKLQKDRQVTDNQRGFELSSSTRKKAQVYNKQDYDLMVFPE
TTDR00356	PDB Structure	2AR5; 2IWL; 2REA; 2RED
TTDR00356	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00356	Pathway	Inositol phosphate metabolism
TTDR00356	Pathway	Metabolic pathways
TTDR00356	Pathway	Phosphatidylinositol signaling system
TTDR00356	EC Number	EC 2.7.1.137
TTDR00357	UniProt ID	P08839
TTDR00357	UniProt ID	P51183
TTDR00357	Name	Phosphoenolpyruvate transferase
TTDR00357	Type of target	Research target
TTDR00357	Synonyms	Phosphoenolpyruvate-protein phosphotransferase
TTDR00357	Synonyms	Phosphotransferase system, enzyme I
TTDR00357	Disease	Bacterial infections
TTDR00357	Function	This is a component of the phosphoenolpyruvate-dependent sugar phosphotransferas
TTDR00357	Sequence	MISGILASPGIAFGKALLLKEDEIVIDRKKISADQVDQEVERFLSGRAKASAQLETIKTKAGETFGEEKEAIFEGHIMLL
TTDR00357	PDB Structure	1EZD; 1ZYM; 2EZA; 2EZB; 2EZC; 2HWG; 3EZA; 3EZB
TTDR00357	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00357	Pathway	Phosphotransferase system (PTS)
TTDR00357	EC Number	EC 2.7.3.9
TTDR00357	Inhibitor	1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE
TTDR00358	Name	Phospholipase D
TTDR00358	Type of target	Research target
TTDR00358	Synonyms	Choline phosphatase
TTDR00358	Synonyms	PLD
TTDR00358	Synonyms	PLD-A
TTDR00358	Disease	Colon cancer
TTDR00358	Disease	Inflammation
TTDR00358	Disease	Systemic inflammatory response syndrome (cardiopulmonary bypass-induced)
TTDR00358	EC Number	EC 3.1.4.4
TTDR00358	Target Validation	TTDR00358
TTDR00358	Inhibitor	4-HYDROXYTAMOXIFEN
TTDR00358	Inhibitor	HALOPEMIDE
TTDR00359	UniProt ID	P04720
TTDR00359	UniProt ID	Q00080
TTDR00359	Name	Elongation factor 1-alpha 1
TTDR00359	Type of target	Research target
TTDR00359	Synonyms	EEF1A-1
TTDR00359	Synonyms	EF-1-alpha-1
TTDR00359	Synonyms	EF-Tu
TTDR00359	Synonyms	Elongation factor 1 A-1
TTDR00359	Synonyms	Elongation factor Tu
TTDR00359	Disease	Malaria
TTDR00359	Function	This protein promotes the gtp-dependent binding of aminoacyl-trna to the a-site
TTDR00359	Sequence	MGKEKTHINIVVIGHVDSGKSTTTGHLIYKCGGIDKRTIEKFEKEAAEMGKGSFKYAWVLDKLKAERERGITIDISLWKF
TTDR00359	PDB Structure	1SYW
TTDR00359	EC Number	EC 3.6.5.3
TTDR00359	Inhibitor	Ge2270a
TTDR00359	Inhibitor	Guanosine-5'-Diphosphate
TTDR00359	Binder	Amythiamicin
TTDR00360	UniProt ID	Q9YEK9
TTDR00360	Name	5-enopyruvyl shikimate 3-phosphate synthase
TTDR00360	Type of target	Research target
TTDR00360	Synonyms	5-enolpyruvylshikimate-3-phosphate synthase
TTDR00360	Synonyms	EPSP synthase
TTDR00360	Synonyms	EPSPS
TTDR00360	Synonyms	Probable 3-phosphoshikimate 1-carboxyvinyltransferase
TTDR00360	Disease	Malaria
TTDR00360	Sequence	MVWLRAPDRVVVHPSTVEGRVEAPPSKSYTHRMLFLALLARGRSVVRRPLVSNDTLATLNAVALLGGKPRLGRGVAEVEG
TTDR00360	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR00360	Pathway	Metabolic pathways
TTDR00360	Pathway	Phenylalanine, tyrosine and tryptophan biosynthesis
TTDR00360	EC Number	EC 2.5.1.19
TTDR00360	Inhibitor	Glyphosate
TTDR00361	UniProt ID	O77078
TTDR00361	UniProt ID	P24249
TTDR00361	Name	Beta-ketoacyl-ACP synthase III
TTDR00361	Type of target	Research target
TTDR00361	Synonyms	3-oxoacyl-[acyl-carrier-protein] synthase III
TTDR00361	Synonyms	Acetoacetyl-ACP synthase
TTDR00361	Synonyms	Acetoacetyl-acyl carrier protein synthase
TTDR00361	Synonyms	Beta-ketoacyl-acyl carrier protein synthase III
TTDR00361	Synonyms	Condensing enzyme FabH
TTDR00361	Synonyms	EcFabH
TTDR00361	Synonyms	FabH
TTDR00361	Synonyms	KAS III
TTDR00361	Disease	Bacterial infections
TTDR00361	Disease	Malaria
TTDR00361	Function	Catalyzes the condensation reaction of fatty acid synthesis by the addition to a
TTDR00361	Sequence	MFLYFITYLCIFHNNIYSVELIKNNKYNFINNVHNIKYRTKIRAIYGKTGGKIIGHGHSYPSTEIYNDELKKYVDTNDEW
TTDR00361	PDB Structure	1EBL; 1HN9; 1HND; 1HNH; 1HNJ; 1HNK; 1MZS; 2EFT
TTDR00361	EC Number	EC 2.3.1.41
TTDR00361	Related US Patent	6,498,187
TTDR00361	Related US Patent	6,559,179
TTDR00361	Related US Patent	6,608,059
TTDR00361	Related US Patent	6,670,388
TTDR00361	Related US Patent	6,723,749
TTDR00361	Target Validation	TTDR00361
TTDR00361	QSAR Model	TTDR00361
TTDR00361	Inhibitor	2-(3-Phenoxy-benzoylamino)-benzoic acid
TTDR00361	Inhibitor	2-(4-Bromo-3-phenoxy-benzoylamino)-benzoic acid
TTDR00361	Inhibitor	2-(4-Fluoro-3-phenoxy-benzoylamino)-benzoic acid
TTDR00361	Inhibitor	2-(4-chlorophenylsulfonyl)naphthalene-1,4-diol
TTDR00361	Inhibitor	2-(4-propylphenylsulfonyl)naphthalene-1,4-diol
TTDR00361	Inhibitor	2-(methylsulfonyl)naphthalene-1,4-diol
TTDR00361	Inhibitor	2-(naphthalen-2-ylsulfonyl)naphthalene-1,4-diol
TTDR00361	Inhibitor	2-(p-tolylthio)naphthalene-1,4-dione
TTDR00361	Inhibitor	2-(phenylsulfonyl)naphthalene-1,4-diol
TTDR00361	Inhibitor	2-Fluoro-6-(3-phenoxy-benzoylamino)-benzoic acid
TTDR00361	Inhibitor	2-Hydroxy-6-(3-phenoxy-benzoylamino)-benzoic acid
TTDR00361	Inhibitor	2-Tosylnaphthalene-1,4-diol
TTDR00361	Inhibitor	2-[3-(Pyridin-4-yloxy)-benzoylamino]-benzoic acid
TTDR00361	Inhibitor	2-tosylanthracene-1,4-diol
TTDR00361	Inhibitor	2-tosylbenzene-1,4-diol
TTDR00361	Inhibitor	2-tosylnaphthalene
TTDR00361	Inhibitor	2-tosylnaphthalene-1,4-dione
TTDR00361	Binder	Thiolactomycin
TTDR00362	Name	20S proteasome
TTDR00362	Type of target	Successful target
TTDR00362	Synonyms	MCP
TTDR00362	Synonyms	Multicatalytic protease
TTDR00362	Disease	Cancer, unspecific
TTDR00362	EC Number	EC 3.4.25.1
TTDR00362	Related US Patent	6,310,057
TTDR00362	Inhibitor	PS-341
TTDR00363	UniProt ID	Q15172
TTDR00363	Name	Serine/threonine protein phosphatase 2A, 56 kDa regulatory subunit, alpha isofor
TTDR00363	Type of target	Research target
TTDR00363	Synonyms	PP2A, B subunit, B' alpha isoform
TTDR00363	Synonyms	PP2A, B subunit, B56 alpha isoform
TTDR00363	Synonyms	PP2A, B subunit, PR61 alpha isoform
TTDR00363	Synonyms	PP2A, B subunit, R5 alpha isoform
TTDR00363	Synonyms	Protein phosphatase-2A
TTDR00363	Disease	Alzheimer's disease
TTDR00363	Function	The b regulatory subunit might modulate substrate selectivity and catalytic acti
TTDR00363	Sequence	MSSSSPPAGAASAAISASEKVDGFTRKSVRKAQRQKRSQGSSQFRSQGSQAELHPLPQLKDATSNEQQELFCQKLQQCCI
TTDR00363	Pathway	Wnt signaling pathway
TTDR00363	Inhibitor	NORCANTHARIDIN
TTDR00365	Name	Stress kinase p38
TTDR00365	Type of target	Clinical trial target
TTDR00365	Synonyms	MAP kinase p38
TTDR00365	Synonyms	Mitogen-activated protein kinase p38
TTDR00365	Synonyms	P38 MAP kinase
TTDR00365	Synonyms	P38 MAPK
TTDR00365	Synonyms	Stress-activated protein kinase
TTDR00365	Disease	Skin diseases
TTDR00365	EC Number	EC 2.7.1.37
TTDR00365	Related US Patent	6,335,336
TTDR00365	Related US Patent	6,423,713
TTDR00365	Related US Patent	6,444,696
TTDR00365	Related US Patent	6,479,507
TTDR00365	Related US Patent	6,503,930
TTDR00365	Related US Patent	6,509,361
TTDR00365	Related US Patent	6,509,363
TTDR00365	Related US Patent	6,525,059
TTDR00365	Related US Patent	6,528,508
TTDR00365	Related US Patent	6,552,019
TTDR00365	Related US Patent	6,579,873
TTDR00365	Related US Patent	6,602,896
TTDR00365	Related US Patent	6,617,324
TTDR00365	Related US Patent	6,630,485
TTDR00365	Related US Patent	6,632,945
TTDR00365	Related US Patent	6,635,644
TTDR00365	Related US Patent	6,759,535
TTDR00366	Name	Sulfur mustard-stimulated protease
TTDR00366	Type of target	Research target
TTDR00366	Disease	Vesication
TTDR00366	Inhibitor	Ca(2+) chelator
TTDR00366	Inhibitor	EGTA
TTDR00369	UniProt ID	Q03405
TTDR00369	Name	Urokinase plasminogen activator surface receptor
TTDR00369	Type of target	Research target
TTDR00369	Synonyms	CD87 antigen
TTDR00369	Synonyms	Monocyte activation antigen Mo3
TTDR00369	Synonyms	U-PAR
TTDR00369	Synonyms	UPAR
TTDR00369	Synonyms	Urokinase plasminogen activator receptor
TTDR00369	Synonyms	Urokinase-type plasminogen activator receptor
TTDR00369	Disease	Autoimmune diseases
TTDR00369	Disease	Breast cancer
TTDR00369	Disease	Cancer, unspecific
TTDR00369	Disease	Myocardial infarction
TTDR00369	Function	Acts as a receptor for urokinase plasminogen activator. Plays a role in localizi
TTDR00369	Sequence	MGHPPLLPLLLLLHTCVPASWGLRCMQCKTNGDCRVEECALGQDLCRTTIVRLWEEGEELELVEKSCTHSEKTNRTLSYR
TTDR00369	PDB Structure	1YWH; 2FD6; 2I9B; 3BT1; 3BT2
TTDR00369	BioChemical Class	Cell membrane protein
TTDR00369	Pathway	Complement and coagulation cascades
TTDR00369	Related US Patent	6,586,011
TTDR00370	Name	Vasopressin receptor
TTDR00370	Type of target	Clinical trial target
TTDR00370	Disease	Congestive heart failure
TTDR00370	Disease	Diabetes mellitus
TTDR00370	Disease	Dysmenorrhea, unspecified
TTDR00370	Disease	Hypertension
TTDR00370	Disease	Liver cirrhosis
TTDR00370	Disease	Nephrotic syndrome
TTDR00370	Related US Patent	6,420,358
TTDR00370	Related US Patent	6,489,321
TTDR00370	Related US Patent	6,495,542
TTDR00370	Related US Patent	6,653,478
TTDR00372	UniProt ID	P28482
TTDR00372	Name	Mitogen-activated protein kinase 1
TTDR00372	Type of target	Research target
TTDR00372	Synonyms	ERK-2
TTDR00372	Synonyms	ERT1
TTDR00372	Synonyms	Extracellular signal-regulated kinase 2
TTDR00372	Synonyms	MAP kinase 2
TTDR00372	Synonyms	MAPK 2
TTDR00372	Synonyms	Mitogen-activated protein kinase 2
TTDR00372	Synonyms	P42 Mitogen-activated protein kinase
TTDR00372	Synonyms	P42-MAPK
TTDR00372	Disease	Neurodegenerative diseases
TTDR00372	Disease	Proliferative diseases
TTDR00372	Function	Phosphorylates microtubule-associated protein-2 (map2). Myelin basic protein (mb
TTDR00372	Sequence	MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH
TTDR00372	PDB Structure	1PME; 1TVO; 1WZY; 2E14; 2OJG; 2OJI; 2OJJ; 3D42
TTDR00372	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00372	Pathway	Acute myeloid leukemia
TTDR00372	Pathway	Adherens junction
TTDR00372	Pathway	Alzheimer's disease
TTDR00372	Pathway	Axon guidance
TTDR00372	Pathway	B cell receptor signaling pathway
TTDR00372	Pathway	Bladder cancer
TTDR00372	Pathway	Chemokine signaling pathway
TTDR00372	Pathway	Chronic myeloid leukemia
TTDR00372	Pathway	Colorectal cancer
TTDR00372	Pathway	Endometrial cancer
TTDR00372	Pathway	ErbB signaling pathway
TTDR00372	Pathway	Fc epsilon RI signaling pathway
TTDR00372	Pathway	Focal adhesion
TTDR00372	Pathway	Gap junction
TTDR00372	Pathway	Glioma
TTDR00372	Pathway	GnRH signaling pathway
TTDR00372	Pathway	Insulin signaling pathway
TTDR00372	Pathway	Long-term depression
TTDR00372	Pathway	Long-term potentiation
TTDR00372	Pathway	MAPK signaling pathway
TTDR00372	Pathway	Melanogenesis
TTDR00372	Pathway	Melanoma
TTDR00372	Pathway	Natural killer cell mediated cytotoxicity
TTDR00372	Pathway	Non-small cell lung cancer
TTDR00372	Pathway	Pancreatic cancer
TTDR00372	Pathway	Pathways in cancer
TTDR00372	Pathway	Prostate cancer
TTDR00372	Pathway	Regulation of actin cytoskeleton
TTDR00372	Pathway	Renal cell carcinoma
TTDR00372	Pathway	T cell receptor signaling pathway
TTDR00372	Pathway	TGF-beta signaling pathway
TTDR00372	Pathway	Thyroid cancer
TTDR00372	Pathway	Toll-like receptor signaling pathway
TTDR00372	Pathway	Type II diabetes mellitus
TTDR00372	Pathway	VEGF signaling pathway
TTDR00372	Pathway	Vascular smooth muscle contraction
TTDR00372	Pathway	mTOR signaling pathway
TTDR00372	EC Number	EC 2.7.1.37
TTDR00372	Target Validation	TTDR00372
TTDR00372	Inhibitor	(4-Fluoro-phenyl)-(9-methyl-9H-purin-6-yl)-amine
TTDR00372	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDR00372	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDR00372	Inhibitor	BISINDOLYLMALEIMIDE IX
TTDR00372	Inhibitor	BMS-536924
TTDR00372	Inhibitor	CI-1040;PD-18435;PD-184352
TTDR00372	Inhibitor	DEBROMOHYMENIALDISINE
TTDR00372	Inhibitor	FR-180204
TTDR00372	Inhibitor	GF-109203
TTDR00372	Inhibitor	KN-62
TTDR00372	Inhibitor	KT-5720
TTDR00372	Inhibitor	LY-294002
TTDR00372	Inhibitor	Olomoucine
TTDR00372	Inhibitor	PD-98059
TTDR00372	Inhibitor	Phosphonothreonine
TTDR00372	Inhibitor	Purvalanol
TTDR00372	Inhibitor	RO-316233
TTDR00372	Inhibitor	Ro-4396686
TTDR00372	Inhibitor	SB-202190
TTDR00372	Inhibitor	SB-203580
TTDR00372	Inhibitor	SB220025
TTDR00372	Inhibitor	U-0126
TTDR00373	UniProt ID	P27361
TTDR00373	Name	Mitogen-activated protein kinase 3
TTDR00373	Type of target	Research target
TTDR00373	Synonyms	ERK-1
TTDR00373	Synonyms	ERT2
TTDR00373	Synonyms	Extracellular signal-regulated kinase 1
TTDR00373	Synonyms	Insulin-stimulated MAP2 kinase
TTDR00373	Synonyms	MAP kinase 1
TTDR00373	Synonyms	MAPK 1
TTDR00373	Synonyms	Microtubule-associated protein-2 kinase
TTDR00373	Synonyms	P44 Mitogen-activated protein kinase
TTDR00373	Synonyms	P44-ERK1
TTDR00373	Synonyms	P44-MAPK
TTDR00373	Disease	Neurodegenerative diseases
TTDR00373	Disease	Proliferative diseases
TTDR00373	Disease	Traumatic brain injury
TTDR00373	Function	Involved in both the initiation and regulation of meiosis, mitosis, and postmito
TTDR00373	Sequence	MAAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQT
TTDR00373	PDB Structure	2ZOQ
TTDR00373	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00373	EC Number	EC 2.7.1.37
TTDR00373	Inhibitor	5-iodotubercidin
TTDR00373	Inhibitor	6-[(E)-2-(4-Fluoro-phenyl)-vinyl]-9H-purine
TTDR00373	Inhibitor	Purvalanol
TTDR00374	UniProt ID	Q13393
TTDR00374	Name	Phospholipase D1
TTDR00374	Type of target	Research target
TTDR00374	Synonyms	Choline phosphatase 1
TTDR00374	Synonyms	HPLD1
TTDR00374	Synonyms	PLD 1
TTDR00374	Synonyms	Phosphatidylcholine-hydrolyzing phospholipase D1
TTDR00374	Disease	Inflammation
TTDR00374	Function	Implicated as a critical step in numerous cellular pathways, including signal tr
TTDR00374	Sequence	MSLKNEPRVNTSALQKIAADMSNIIENLDTRELHFEGEEVDYDVSPSDPKIQEVYIPFSAIYNTQGFKEPNIQTYLSGCP
TTDR00374	BioChemical Class	Hydrolases acting on ester bonds
TTDR00374	EC Number	EC 3.1.4.4
TTDR00374	Target Validation	TTDR00374
TTDR00374	Inhibitor	1-(pyridin-2-yl)piperazine
TTDR00374	Inhibitor	1-(pyridin-4-yl)piperazine
TTDR00374	Inhibitor	4-HYDROXYTAMOXIFEN
TTDR00374	Inhibitor	HALOPEMIDE
TTDR00375	UniProt ID	P41968
TTDR00375	Name	Melanocortin-3 receptor
TTDR00375	Type of target	Research target
TTDR00375	Synonyms	MC3-R
TTDR00375	Disease	Chronic inflammatory diseases
TTDR00375	Disease	Gouty arthritis
TTDR00375	Disease	Obesity
TTDR00375	Function	Receptor for msh (alpha, beta and gamma) and acth. This receptor is mediated by
TTDR00375	Sequence	MSIQKTYLEGDFVFPVSSSSFLRTLLEPQLGSALLTAMNASCCLPSVQPTLPNGSEHLQAPFFSNQSSSAFCEQVFIKPE
TTDR00375	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00375	Pathway	Neuroactive ligand-receptor interaction
TTDR00375	Target Validation	TTDR00375
TTDR00375	Drug(s)	Melanotetan II
TTDR00375	Inhibitor	AEKKDEGPYRMEHFRWGSPPKD
TTDR00375	Inhibitor	Ac-His-D-Phe-Arg-2-Nal-NHCH3
TTDR00375	Inhibitor	Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
TTDR00375	Inhibitor	Ac-Nle-c[Asp-His-DNal(2')-Pro-Trp-Lys]-NH2
TTDR00375	Inhibitor	Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2
TTDR00375	Inhibitor	Ac-R[CEHdFRWC]-NH2
TTDR00375	Inhibitor	Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3
TTDR00375	Inhibitor	Ac-YCit[CEHdFRWC]-NH2
TTDR00375	Inhibitor	Ac-YK[CEHdFRWC]-NH2
TTDR00375	Inhibitor	Ac-YRC(Me)*EHdFRWC(Me)NH2
TTDR00375	Inhibitor	Ac-YRMEHdFRWG-NH2
TTDR00375	Inhibitor	Ac-YRMEHdFRWGSPPKD-NH2
TTDR00375	Inhibitor	Ac-YR[CEH(d-2alpha-Nal)RWC]-NH2
TTDR00375	Inhibitor	Ac-YR[CEH(pCl-dF)RWC]-NH2
TTDR00375	Inhibitor	Ac-YR[CEH(pF-dF)RWC]-NH2
TTDR00375	Inhibitor	Ac-YR[CEHdFRWC]-NH2
TTDR00375	Inhibitor	Ac-YR[CEHdFRWC]SPPKD-NH2
TTDR00375	Inhibitor	Ac-[CEHdFRWC]-NH2
TTDR00375	Inhibitor	Ac-dR[CEHdFRWC]-NH2
TTDR00375	Inhibitor	Alpha-MSH
TTDR00375	Inhibitor	GPYRMEHFRWGSPPKD-NH2
TTDR00375	Inhibitor	MK-10
TTDR00375	Inhibitor	MK-11
TTDR00375	Inhibitor	MK-9
TTDR00375	Inhibitor	NDP-SYSMEHFRWGKPVG
TTDR00375	Inhibitor	Tic-D-Phe-Arg-2-Nal-NHCH3
TTDR00375	Inhibitor	c[CO-(CH2)2-CO-Nle-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00375	Inhibitor	c[CO-(CH2)2-CO-Nle-D-Phe-Arg-Trp-Lys]-NH2
TTDR00375	Inhibitor	c[CO-(CH2)3-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00375	Inhibitor	c[CO-(CH2)3-CO-Pro-D-Phe-Arg-Trp-Lys]-NH2
TTDR00375	Inhibitor	c[CO-2,3-pyrazine-CO-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00375	Inhibitor	c[CO-2,3-pyrazine-CO-D-Phe-Arg-Trp-Lys]-NH2
TTDR00375	Inhibitor	c[CO-o-C6H4-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00375	Inhibitor	c[Nle-Arg-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Arg-D-Phe-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Asp-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Gln-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Gln-D-Phe-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Glu-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Glu-D-Phe-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-His-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-His-D-Phe-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Nle-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Nle-D-Phe-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Pro-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Pro-D-Phe-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Val-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00375	Inhibitor	c[Nle-Val-D-Phe-Arg-Trp-Glu]-NH2
TTDR00375	Antagonist	SHU9119
TTDR00375	Agonist	Melanotetan II
TTDR00375	Multitarget	Melanotetan II
TTDR00377	UniProt ID	P06307
TTDR00377	Name	Cholecystokinin
TTDR00377	Type of target	Research target
TTDR00377	Synonyms	CCK
TTDR00377	Synonyms	Procholecystokinin
TTDR00377	Disease	Acute pancreatitis
TTDR00377	Disease	Obesity
TTDR00377	Function	This peptide hormone induces gall bladder contraction and the release of pancrea
TTDR00377	Sequence	MNSGVCLCVLMAVLAAGALTQPVPPADPAGSGLQRAEEAPRRQLRVSQRTDGESRAHLGALLARYIQQARKAPSGRMSIV
TTDR00378	Name	mRNA of protein kinase A1
TTDR00378	Type of target	Research target
TTDR00378	Disease	Cancer, unspecific
TTDR00378	Antisense	GEM 231
TTDR00380	Name	3-hydroxysteroid dehydrogenase
TTDR00380	Type of target	Research target
TTDR00380	Disease	Primary aldosteronism
TTDR00381	UniProt ID	P54868
TTDR00381	Name	Hydroxymethylglutaryl-CoA synthase, mitochondrial
TTDR00381	Type of target	Research target
TTDR00381	Synonyms	3-hydroxy-3-methylglutaryl coenzyme A synthase
TTDR00381	Synonyms	HMG-CoA synthase
TTDR00381	Disease	Hypercholesterolemia
TTDR00381	Function	This enzyme condenses acetyl-coa with acetoacetyl-coa to form hmg-coa, which is
TTDR00381	Sequence	MQRLLTPVKRILQLTRAVQETSLTPARLLPVAHQRFSTASAVPLAKTDTWPKDVGILALEVYFPAQYVDQTDLEKYNNVE
TTDR00381	PDB Structure	2V4W
TTDR00381	BioChemical Class	Acyltransferases
TTDR00381	Pathway	Butanoate metabolism
TTDR00381	Pathway	Metabolic pathways
TTDR00381	Pathway	PPAR signaling pathway
TTDR00381	Pathway	Synthesis and degradation of ketone bodies
TTDR00381	Pathway	Valine, leucine and isoleucine degradation
TTDR00381	EC Number	EC 2.3.3.10
TTDR00381	Inhibitor	3-Sulfinoalanine
TTDR00381	Inhibitor	Acetoacetyl-Coenzyme A
TTDR00382	Name	Low-density lipoprotein
TTDR00382	Type of target	Research target
TTDR00382	Synonyms	LDL
TTDR00382	Disease	Coronary heart disease
TTDR00383	Name	Low-density lipoprotein receptor-related protein
TTDR00383	Type of target	Research target
TTDR00383	Synonyms	LDL receptor-related protein
TTDR00383	Synonyms	LRP
TTDR00383	Disease	Glioblastoma multiforme
TTDR00384	UniProt ID	Q8WTV0
TTDR00384	Name	Scavenger receptor class B member 1
TTDR00384	Type of target	Research target
TTDR00384	Synonyms	CD36 and LIMPII analogous 1
TTDR00384	Synonyms	CD36 antigen-like 1
TTDR00384	Synonyms	CLA-1
TTDR00384	Synonyms	Collagen type I receptor, thrombospondin receptor-like 1
TTDR00384	Synonyms	High-density lipoprotein receptor SR-BI
TTDR00384	Synonyms	SR-BI
TTDR00384	Synonyms	SRB1
TTDR00384	Synonyms	Scavenger receptor class B type I
TTDR00384	Disease	Atherosclerosis
TTDR00384	Disease	Atherosclerotic cardiovascular disease
TTDR00384	Disease	Cardiovascular disease, unspecified
TTDR00384	Disease	Hypercholesterolemia
TTDR00384	Disease	Reproductive disorder
TTDR00384	Function	Receptor for different ligands such as phospholipids, cholesterol ester, lipopro
TTDR00384	Sequence	MGCSAKARWAAGALGVAGLLCAVLGAVMIVMVPSLIKQQVLKNVRIDPSSLSFNMWKEIPIPFYLSVYFFDVMNPSEILK
TTDR00384	BioChemical Class	Transmembrane protein
TTDR00384	Related US Patent	6,472,504
TTDR00385	UniProt ID	P21333
TTDR00385	Name	Filamin A
TTDR00385	Type of target	Research target
TTDR00385	Synonyms	ABP-280
TTDR00385	Synonyms	Alpha-filamin
TTDR00385	Synonyms	Endothelial actin cytoskeleton
TTDR00385	Synonyms	Endothelial actin-binding protein
TTDR00385	Synonyms	Filamin 1
TTDR00385	Synonyms	Nonmuscle filamin
TTDR00385	Disease	Ischemic stroke
TTDR00385	Function	Promotes orthogonal branching of actin filaments and links actin filaments to me
TTDR00385	Sequence	MSSSHSRAGQSAAGAAPGGGVDTRDAEMPATEKDLAEDAPWKKIQQNTFTRWCNEHLKCVSKRIANLQTDLSDGLRLIAL
TTDR00385	PDB Structure	2AAV; 2BP3; 2BRQ; 2J3S; 2JF1; 2K3T; 2W0P; 3CNK
TTDR00385	Pathway	Focal adhesion
TTDR00385	Pathway	MAPK signaling pathway
TTDR00386	UniProt ID	P24387
TTDR00386	Name	Corticotropin-releasing factor binding protein
TTDR00386	Type of target	Research target
TTDR00386	Synonyms	CRF-BP
TTDR00386	Synonyms	CRF-binding protein
TTDR00386	Synonyms	CRH-BP
TTDR00386	Synonyms	Corticotropin-releasing hormone-binding protein
TTDR00386	Disease	Excessive weight gain associated with obesity of multiple etiology
TTDR00386	Function	Binds crf and inactivates it. May prevent innapropriate pituitary-adrenal stimul
TTDR00386	Sequence	MSPNFKLQCHFILIFLTALRGESRYLELREAADYDPFLLFSANLKRELAGEQPYRRALRCLDMLSLQGQFTFTADRPQLH
TTDR00387	UniProt ID	P06850
TTDR00387	Name	Corticoliberin
TTDR00387	Type of target	Research target
TTDR00387	Synonyms	Adrenocorticotropic hormone
TTDR00387	Synonyms	CRF
TTDR00387	Synonyms	Corticotropin
TTDR00387	Synonyms	Corticotropin releasing hormone
TTDR00387	Synonyms	Corticotropin-releasing factor
TTDR00387	Disease	Childhood seizure disorders
TTDR00387	Disease	Multiple sclerosis
TTDR00387	Disease	West's syndrome
TTDR00387	Function	This hormone from hypothalamus regulates the release of corticotropin from pitui
TTDR00387	Sequence	MRLPLLVSAGVLLVALLPCPPCRALLSRGPVPGARQAPQHPQPLDFFQPPPQSEQPQQPQARPVLLRMGEEYFLRLGNLN
TTDR00387	PDB Structure	3EHT; 3EHU
TTDR00387	Pathway	Long-term depression
TTDR00387	Related US Patent	6,384,039
TTDR00387	Related US Patent	6,387,894
TTDR00387	Related US Patent	6,432,989
TTDR00387	Related US Patent	6,521,636
TTDR00387	Related US Patent	6,525,056
TTDR00387	Related US Patent	6,531,475
TTDR00387	Related US Patent	6,579,876
TTDR00387	Related US Patent	6,589,947
TTDR00387	Related US Patent	6,589,958
TTDR00387	Related US Patent	6,630,476
TTDR00387	Related US Patent	6,734,185
TTDR00387	Related US Patent	6,777,404
TTDR00387	Inhibitor	Alpha-Aminoisobutyric Acid
TTDR00387	Inhibitor	D-Phenylalanine
TTDR00388	UniProt ID	Q13772
TTDR00388	Name	Nuclear receptor coactivator 4
TTDR00388	Type of target	Research target
TTDR00388	Synonyms	70 kDa AR-activator
TTDR00388	Synonyms	70 kDa androgen receptor coactivator
TTDR00388	Synonyms	ARA70 (dARA70N)
TTDR00388	Synonyms	NCoA-4
TTDR00388	Synonyms	Ret-activating protein ELE1
TTDR00388	Disease	Prostate cancer
TTDR00388	Function	Enhances the androgen receptor transcriptional activity in Prostate cancer cells
TTDR00388	Sequence	MNTFQDQSGSSSNREPLLRCSDARRDLELAIGGVLRAEQQIKDNLREVKAQIHSCISRHLECLRSREVWLYEQVDLIYQL
TTDR00388	PDB Structure	1T5Z
TTDR00388	Pathway	Pathways in cancer
TTDR00388	Pathway	Thyroid cancer
TTDR00389	UniProt ID	P01215
TTDR00389	Name	Glycoprotein hormones alpha chain
TTDR00389	Type of target	Research target
TTDR00389	Synonyms	CG-alpha
TTDR00389	Synonyms	Choriogonadotropin alpha chain
TTDR00389	Synonyms	Chorionic gonadotrophin alpha subunit
TTDR00389	Synonyms	FSH-alpha
TTDR00389	Synonyms	Follicle-stimulating hormone alpha chain
TTDR00389	Synonyms	Follitropin alpha chain
TTDR00389	Synonyms	LSH-alpha
TTDR00389	Synonyms	Luteinizing hormone alpha chain
TTDR00389	Synonyms	Lutropin alpha chain
TTDR00389	Synonyms	TSH-alpha
TTDR00389	Synonyms	Thyroid-stimulating hormone alpha chain
TTDR00389	Synonyms	Thyrotropin alpha chain
TTDR00389	Disease	ER alpha-positive prostate tumors
TTDR00389	Disease	Prostate cancer (metastatic)
TTDR00389	Sequence	MDYYRKYAAIFLVTLSVFLHVLHSAPDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSE
TTDR00389	PDB Structure	1DZ7; 1E9J; 1FL7; 1HCN; 1HD4; 1HRP; 1QFW; 1XUL
TTDR00389	Pathway	Autoimmune thyroid disease
TTDR00389	Pathway	GnRH signaling pathway
TTDR00389	Pathway	Neuroactive ligand-receptor interaction
TTDR00389	Inhibitor	Alpha-D-Mannose
TTDR00390	UniProt ID	Q9H1R7
TTDR00390	Name	Supervillin
TTDR00390	Type of target	Research target
TTDR00390	Synonyms	205-kDa actin-binding protein
TTDR00390	Synonyms	F-actin binding protein
TTDR00390	Disease	Prostate cancer
TTDR00390	Sequence	MKRKERIARRLEGIENDTQPILLQSCTGLVTHRLLEEDTPRYMRASDPASPHIGRSNEEEETSDSSLEKQTRSKYCTETS
TTDR00391	UniProt ID	Q96L73
TTDR00391	Name	Nuclear receptor binding SET domain containing protein 1
TTDR00391	Type of target	Research target
TTDR00391	Synonyms	ARA267
TTDR00391	Synonyms	Androgen receptor associated coregulator 267
TTDR00391	Synonyms	Androgen receptor-associated coregulator 267
TTDR00391	Synonyms	Hypothetical protein FLJ22263 similar to nuclear receptor-binding SET-domain pro
TTDR00391	Synonyms	NR-binding SET domain containing protein
TTDR00391	Disease	Prostate cancer
TTDR00391	Function	Transcriptional intermediary factor capable of both negatively or positively inf
TTDR00391	Sequence	MDQTCELPRRNCLLPFSNPVNLDAPEDKDSPFGNGQSNFSEPLNGCTMQLSTVSGTSQNAYGQDSPSCYIPLRRLQDLAS
TTDR00391	BioChemical Class	Transferases transferring one-carbon groups
TTDR00391	Pathway	Lysine degradation
TTDR00392	UniProt ID	O43653
TTDR00392	Name	Prostate stem cell antigen
TTDR00392	Type of target	Research target
TTDR00392	Disease	Prostate cancer
TTDR00392	Sequence	MKAVLLALLMAGLALQPGTALLCYSCKAQVSNEDCLQVENCTQLGEQCWTARIRAVGLLTVISKGCSLNCVDDSQDYYVG
TTDR00392	BioChemical Class	Cell membrane protein
TTDR00393	UniProt ID	P23457
TTDR00393	Name	3-alpha-hydroxysteroid dehydrogenase
TTDR00393	Type of target	Research target
TTDR00393	Synonyms	3 alpha-HSD
TTDR00393	Synonyms	3 alpha-hydroxysteroid dehydrogenase
TTDR00393	Synonyms	3-alpha-HSD
TTDR00393	Synonyms	Hydroxyprostaglandin dehydrogenase
TTDR00393	Disease	Androgen-dependent diseases
TTDR00393	Disease	Inflammation
TTDR00393	Function	Besides being a 3-alpha-hydroxysteroid dehydrogenase, the enzyme can accomplish
TTDR00393	Sequence	MDSISLRVALNDGNFIPVLGFGTTVPEKVAKDEVIKATKIAIDNGFRHFDSAYLYEVEEEVGQAIRSKIEDGTVKREDIF
TTDR00393	PDB Structure	1AFS; 1LWI; 1RAL
TTDR00393	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00393	EC Number	EC 1.1.1.50
TTDR00394	UniProt ID	P30825
TTDR00394	Name	High-affinity cationic amino acid transporter-1
TTDR00394	Type of target	Research target
TTDR00394	Synonyms	CAT-1
TTDR00394	Synonyms	CAT1
TTDR00394	Synonyms	ERR
TTDR00394	Synonyms	Ecotropic retroviral leukemia receptor homolog
TTDR00394	Synonyms	Ecotropic retrovirus receptor homolog
TTDR00394	Synonyms	System Y+ basic amino acid transporter
TTDR00394	Disease	Prostate cancer
TTDR00394	Function	High-affinity, low capacity permease involved in the transport of the cationic a
TTDR00394	Sequence	MGCKVLLNIGQQMLRRKVVDCSREETRLSRCLNTFDLVALGVGSTLGAGVYVLAGAVARENAGPAIVISFLIAALASVLA
TTDR00394	BioChemical Class	Transmembrane protein
TTDR00395	UniProt ID	P07204
TTDR00395	Name	Thrombomodulin
TTDR00395	Type of target	Research target
TTDR00395	Synonyms	CD141 antigen
TTDR00395	Synonyms	Fetomodulin
TTDR00395	Synonyms	TM
TTDR00395	Disease	Radiation enteropathy
TTDR00395	Disease	Thrombosis
TTDR00395	Function	Thrombomodulin is a specific endothelial cell receptor that forms a 1:1 stoichio
TTDR00395	Sequence	MLGVLVLGALALAGLGFPAPAEPQPGGSQCVEHDCFALYPGPATFLNASQICDGLRGHLMTVRSSVAADVISLLLNGDGG
TTDR00395	PDB Structure	1DX5; 1EGT; 1FGD; 1FGE; 1HLT; 1TMR; 1ZAQ; 2ADX
TTDR00395	BioChemical Class	Growth factor
TTDR00395	Pathway	Complement and coagulation cascades
TTDR00396	UniProt ID	P13726
TTDR00396	Name	Tissue factor
TTDR00396	Type of target	Research target
TTDR00396	Synonyms	CD142 antigen
TTDR00396	Synonyms	Coagulation factor III
TTDR00396	Synonyms	TF
TTDR00396	Synonyms	Thromboplastin
TTDR00396	Disease	Atherosclerosis
TTDR00396	Disease	Coronary syndromes
TTDR00396	Disease	Disseminated intravascular coagulation
TTDR00396	Disease	Gliomas
TTDR00396	Disease	Over-expression of TF
TTDR00396	Disease	Sepsis
TTDR00396	Disease	Thrombotic disease
TTDR00396	Function	Initiates blood coagulation by forming a complex with circulating factor vii or
TTDR00396	Sequence	METPAWPRVPRPETAVARTLLLGWVFAQVAGASGTTNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSK
TTDR00396	PDB Structure	1AHW; 1BOY; 1DAN; 1FAK; 1J9C; 1JPS; 1NL8; 1O5D
TTDR00396	BioChemical Class	Transmembrane protein
TTDR00396	Pathway	Complement and coagulation cascades
TTDR00396	Related US Patent	6,472,393
TTDR00396	Related US Patent	6,608,066
TTDR00396	Target Validation	TTDR00396
TTDR00396	Inhibitor	D-Pro-Phe-Arg chloromethyl ketone
TTDR00397	UniProt ID	P24385
TTDR00397	Name	G1/S-specific cyclin D1
TTDR00397	Type of target	Clinical trial target
TTDR00397	Synonyms	BCL-1 oncogene
TTDR00397	Synonyms	Cyclin D1
TTDR00397	Synonyms	PRAD1 oncogene
TTDR00397	Disease	Breast cancer
TTDR00397	Disease	Cancer, unspecific
TTDR00397	Function	Essential for the control of the cell cycle at the g1/s (start) transition.
TTDR00397	Sequence	MEHQLLCCEVETIRRAYPDANLLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPL
TTDR00397	PDB Structure	2W96; 2W99; 2W9F; 2W9Z
TTDR00397	Pathway	Acute myeloid leukemia
TTDR00397	Pathway	Bladder cancer
TTDR00397	Pathway	Cell cycle
TTDR00397	Pathway	Chronic myeloid leukemia
TTDR00397	Pathway	Colorectal cancer
TTDR00397	Pathway	Endometrial cancer
TTDR00397	Pathway	Focal adhesion
TTDR00397	Pathway	Glioma
TTDR00397	Pathway	Jak-STAT signaling pathway
TTDR00397	Pathway	Melanoma
TTDR00397	Pathway	Non-small cell lung cancer
TTDR00397	Pathway	Pancreatic cancer
TTDR00397	Pathway	Pathways in cancer
TTDR00397	Pathway	Prostate cancer
TTDR00397	Pathway	Small cell lung cancer
TTDR00397	Pathway	Thyroid cancer
TTDR00397	Pathway	Wnt signaling pathway
TTDR00397	Pathway	p53 signaling pathway
TTDR00397	Target Validation	TTDR00397
TTDR00397	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDR00397	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDR00397	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDR00397	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDR00397	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDR00397	Inhibitor	7-hydroxycoumarin
TTDR00399	UniProt ID	P31678
TTDR00399	UniProt ID	Q9HEP0
TTDR00399	Name	Trehalose-phosphatase
TTDR00399	Type of target	Research target
TTDR00399	Synonyms	TPP
TTDR00399	Synonyms	TPS2
TTDR00399	Synonyms	Trehalose 6-phosphate phosphatase
TTDR00399	Synonyms	Trehalose-6-phosphate phosphatase
TTDR00399	Disease	Fungal diseases
TTDR00399	Sequence	MAPQQVNAFSANGSIPSPKEFEGKGKLKLSGRILNVMTSLPLQIISDYDNKTGQYYWDVETVRGNSALYSSQHFLAENKE
TTDR00399	BioChemical Class	Hydrolases acting on ester bonds
TTDR00399	Pathway	Starch and sucrose metabolism
TTDR00399	EC Number	EC 3.1.3.12
TTDR00400	Name	Coagulation factor VIIa
TTDR00400	Type of target	Clinical trial target
TTDR00400	Synonyms	Factor VIIa
TTDR00400	Disease	Thrombosis
TTDR00400	EC Number	EC 3.4.21.21
TTDR00400	Related US Patent	6,472,393
TTDR00400	Related US Patent	6,500,803
TTDR00400	Related US Patent	6,509,335
TTDR00400	Related US Patent	6,642,252
TTDR00401	UniProt ID	P22897
TTDR00401	Name	Macrophage mannose receptor
TTDR00401	Type of target	Research target
TTDR00401	Synonyms	CD206 antigen
TTDR00401	Synonyms	MMR
TTDR00401	Disease	Leukemia, unspecified
TTDR00401	Function	Mediates the endocytosis of glycoproteins by macrophages, in several recognition
TTDR00401	Sequence	MRLPLLLVFASVIPGAVLLLDTRQFLIYNEDHKRCVDAVSPSAVQTAACNQDAESQKFRWVSESQIMSVAFKLCLGVPSK
TTDR00401	PDB Structure	1EGG; 1EGI
TTDR00401	BioChemical Class	Transmembrane protein
TTDR00402	UniProt ID	Q8B6C3
TTDR00402	Name	Outer capsid glycoprotein VP7
TTDR00402	Type of target	Research target
TTDR00402	Disease	Viral infection, unspecified
TTDR00402	Sequence	MVCTTLYTVCAILFILFIYILFFRKMFHLITDTLIVMLILSNCVEWSQCQMFIDDIYYNGNVETIINSTDPFNVESLCIY
TTDR00403	Name	Serine proteinase alpha-thrombin
TTDR00403	Type of target	Research target
TTDR00403	Synonyms	Hydrolase(Serine Proteinase) Alpha-thrombin
TTDR00403	Disease	Haemostatic disorders
TTDR00403	EC Number	EC 3.4.21.5
TTDR00404	UniProt ID	P21741
TTDR00404	Name	Midkine
TTDR00404	Type of target	Research target
TTDR00404	Synonyms	ARAP
TTDR00404	Synonyms	Amphiregulin-associated protein
TTDR00404	Synonyms	MK
TTDR00404	Synonyms	Midgestation and kidney protein
TTDR00404	Synonyms	Neurite outgrowth-promoting factor 2
TTDR00404	Synonyms	Neurite outgrowth-promoting protein
TTDR00404	Disease	Cancer, unspecific
TTDR00404	Function	Has heparin binding activity, and growth promoting activity for pc12 cells.
TTDR00404	Sequence	MQHRGFLLLTLLALLALTSAVAKKKDKVKKGGPGSECAEWAWGPCTPSSKDCGVGFREGTCGAQTQRIRCRVPCNWKKEF
TTDR00404	PDB Structure	1MKC; 1MKN
TTDR00404	BioChemical Class	Growth factor
TTDR00405	UniProt ID	P46663
TTDR00405	Name	B1 bradykinin receptor
TTDR00405	Type of target	Clinical trial target
TTDR00405	Synonyms	B1R
TTDR00405	Synonyms	BK-1 receptor
TTDR00405	Synonyms	Bradykinin subtype 1 receptor
TTDR00405	Disease	Diabetic nephropathy
TTDR00405	Disease	Inflammatory diseases
TTDR00405	Disease	Ischemic vascular disease
TTDR00405	Disease	Prostate cancer
TTDR00405	Function	This is a receptor for bradykinin. Could be a factor in chronic pain and inflamm
TTDR00405	Sequence	MASSWPPLELQSSNQSQLFPQNATACDNAPEAWDLLHRVLPTFIISICFFGLLGNLFVLLVFLLPRRQLNVAEIYLANLA
TTDR00405	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00405	Pathway	Calcium signaling pathway
TTDR00405	Pathway	Complement and coagulation cascades
TTDR00405	Pathway	Neuroactive ligand-receptor interaction
TTDR00405	Pathway	Regulation of actin cytoskeleton
TTDR00405	Related US Patent	6,479,515
TTDR00405	Related US Patent	6,500,831
TTDR00405	Related US Patent	6,531,480
TTDR00405	Target Validation	TTDR00405
TTDR00405	Inhibitor	H-DArg-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH(JMV1638)
TTDR00405	Inhibitor	H-DArg-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-OH(JMV1431)
TTDR00405	Inhibitor	H-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH(JMV1645)
TTDR00405	Inhibitor	H-Lys-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-OH(JMV1669)
TTDR00405	Inhibitor	des-Arg10-Kallidin
TTDR00405	Inhibitor	des-Arg10-Leu9-Kallidin
TTDR00405	Antagonist	B-9958
TTDR00405	Antagonist	Des-Arg(9)-[Leu(8)]-BK
TTDR00406	UniProt ID	P01042
TTDR00406	Name	Kininogen
TTDR00406	Type of target	Research target
TTDR00406	Synonyms	Bradykinin
TTDR00406	Disease	Cardiovascular disease, unspecified
TTDR00406	Disease	Lung cancers with neuroendocrine features
TTDR00406	Function	(1) kininogens are inhibitors of thiol proteases; (2) hmw-kininogen plays an imp
TTDR00406	Sequence	MKLITILFLCSRLLLSLTQESQSEEIDCNDKDLFKAVDAALKKYNSQNQSNNQFVLYRITEATKTVGSDTFYSFKYEIKE
TTDR00406	Pathway	Complement and coagulation cascades
TTDR00406	Related US Patent	6,344,462
TTDR00406	Related US Patent	6,444,677
TTDR00406	Related US Patent	6,509,468
TTDR00406	Related US Patent	6,653,313
TTDR00406	Inhibitor	CU201 (B9870)
TTDR00407	UniProt ID	P97583
TTDR00407	Name	Kinin B1 receptor
TTDR00407	Type of target	Research target
TTDR00407	Synonyms	B(1) receptor
TTDR00407	Synonyms	B1 bradykinin receptor
TTDR00407	Synonyms	B1R
TTDR00407	Synonyms	BK-1 receptor
TTDR00407	Synonyms	KB1
TTDR00407	Synonyms	Kinin B(1) receptor
TTDR00407	Disease	Analgesics
TTDR00407	Disease	Inflammatory diseases
TTDR00407	Disease	Inflammatory pain
TTDR00407	Disease	Pain, unspecified
TTDR00407	Function	This is a receptor for bradykinin. Could be a factor in chronic pain and inflamm
TTDR00407	Sequence	MASEVLLELQPSNRSLQAPANITSCESALEDWDLLYRVLPGFVITICFFGLLGNLLVLSFFLLPWRQWWWQQRQRQQRLT
TTDR00407	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00407	Pathway	Calcium signaling pathway
TTDR00407	Pathway	Complement and coagulation cascades
TTDR00407	Pathway	Neuroactive ligand-receptor interaction
TTDR00407	Pathway	Regulation of actin cytoskeleton
TTDR00407	Related US Patent	6,479,515
TTDR00407	Related US Patent	6,500,831
TTDR00407	Related US Patent	6,531,480
TTDR00407	Antagonist	Ac-Lys-[Leu(8)]-des-Arg(9)-BK
TTDR00407	Antagonist	B-9858
TTDR00408	Name	Kinin B2 receptor
TTDR00408	Type of target	Research target
TTDR00408	Disease	Analgesics
TTDR00408	Disease	Pain, unspecified
TTDR00408	Disease	Salt-sensitive hypertension
TTDR00409	Name	Vanilloid receptor
TTDR00409	Type of target	Research target
TTDR00409	Disease	Analgesics
TTDR00409	Disease	Pain, unspecified
TTDR00409	Disease	Skin inflammation
TTDR00409	Related US Patent	6,476,076
TTDR00409	Target Validation	TTDR00409
TTDR00409	Inhibitor	1,3-dibenzyl urea
TTDR00409	Inhibitor	4-Pyridin-2-yl-piperazine-1-carboxylic acid amide
TTDR00409	Inhibitor	6'-Iodononivamide
TTDR00409	Inhibitor	A-795614
TTDR00409	Inhibitor	AMG-628
TTDR00409	Inhibitor	ATC-120
TTDR00409	Inhibitor	CAPSAZEPINE
TTDR00409	Inhibitor	IODORESINIFERATOXIN
TTDR00409	Inhibitor	JNJ-17203212
TTDR00409	Inhibitor	MK-056
TTDR00409	Inhibitor	N-(4-tert-butylphenyl)-4-(pyridin-2-yl)benzamide
TTDR00409	Inhibitor	Pyrrolidin-1-yl-thiourea
TTDR00409	Inhibitor	SC-0030;SC0030
TTDR00411	UniProt ID	P02649
TTDR00411	Name	Apolipoprotein E
TTDR00411	Type of target	Research target
TTDR00411	Disease	Alzheimer's disease
TTDR00411	Disease	Amyloidosis
TTDR00411	Disease	Brain tumors
TTDR00411	Function	Mediates the binding, internalization, and catabolism of lipoprotein particles.
TTDR00411	Sequence	MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRA
TTDR00411	PDB Structure	1LE2; 1LE4; 1LPE; 1NFN; 1NFO; 1OEF; 1OEG; 1OR2
TTDR00411	Pathway	Alzheimer's disease
TTDR00412	UniProt ID	P05305
TTDR00412	Name	Endothelin-1
TTDR00412	Type of target	Research target
TTDR00412	Synonyms	ET-1
TTDR00412	Synonyms	PPET1
TTDR00412	Synonyms	Preproendothelin-1
TTDR00412	Disease	Cardiovascular disease, unspecified
TTDR00412	Disease	Congestive heart failure
TTDR00412	Function	Endothelins are endothelium-derived vasoconstrictor peptides.
TTDR00412	Sequence	MDYLLMIFSLLFVACQGAPETAVLGAELSAVGENGGEKPTPSPPWRLRRSKRCSCSSLMDKECVYFCHLDIIWVNTPEHV
TTDR00412	PDB Structure	1EDN; 1EDP; 1T7H; 1V6R
TTDR00412	Pathway	Melanogenesis
TTDR00412	Related US Patent	6,440,962
TTDR00412	Related US Patent	6,545,150
TTDR00413	UniProt ID	P53602
TTDR00413	Name	Diphosphomevalonate decarboxylase
TTDR00413	Type of target	Research target
TTDR00413	Synonyms	Mevalonate (diphospho)Diphosphomevalonate decarboxylasedecarboxylase
TTDR00413	Synonyms	Mevalonate (diphospho)decarboxylase
TTDR00413	Synonyms	Mevalonate pyrophosphate decarboxylase
TTDR00413	Disease	Hypercholesterolemia
TTDR00413	Function	Performs the first committed step in the biosynthesis of isoprenes.
TTDR00413	Sequence	MASEKPLAAVTCTAPVNIAVIKYWGKRDEELVLPINSSLSVTLHQDQLKTTTTAVISKDFTEDRIWLNGREEDVGQPRLQ
TTDR00413	PDB Structure	3D4J
TTDR00413	BioChemical Class	Carbon-carbon lyases
TTDR00413	Pathway	Biosynthesis of steroids
TTDR00413	Pathway	Metabolic pathways
TTDR00413	EC Number	EC 4.1.1.33
TTDR00414	UniProt ID	P17707
TTDR00414	Name	S-adenosylmethionine decarboxylase proenzyme
TTDR00414	Type of target	Research target
TTDR00414	Synonyms	AdoMetDC
TTDR00414	Synonyms	S-adenosylmethionine decarboxylase
TTDR00414	Synonyms	SamDC
TTDR00414	Disease	Cancer, unspecific
TTDR00414	Disease	Parasitic diseases
TTDR00414	Disease	Proliferative diseases
TTDR00414	Sequence	MEAAHFFEGTEKLLEVWFSRQQPDANQGSGDLRTIPRSEWDILLKDVQCSIISVTKTDKQEAYVLSESSMFVSKRRFILK
TTDR00414	PDB Structure	1I72; 1I79; 1I7B; 1I7C; 1I7M; 1JEN; 1JL0; 1MSV
TTDR00414	BioChemical Class	Carbon-carbon lyases
TTDR00414	EC Number	EC 4.1.1.50
TTDR00414	Target Validation	TTDR00414
TTDR00414	Inhibitor	5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine
TTDR00414	Inhibitor	5'-Deoxy-5'-(N,N-dimethylamino)-8-methyladenosine
TTDR00414	Inhibitor	5'-Deoxy-5'-(N,N-dimethylamino)adenosine
TTDR00414	Inhibitor	5'-Deoxy-5'-dimethylsulfonioadenosine chloride
TTDR00414	Inhibitor	5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine
TTDR00414	Inhibitor	Guanylhydrazone
TTDR00414	Inhibitor	Hydroxyalanine
TTDR00414	Inhibitor	MGBG
TTDR00414	Inhibitor	Methylglyoxal (bis) guanylhydrazone
TTDR00414	Inhibitor	Methylglyoxal bis(guanylhydrazone)
TTDR00414	Inhibitor	Putrescine
TTDR00414	Inhibitor	SAM486A
TTDR00414	Inhibitor	Tris(Hydroxymethyl)Aminomethane
TTDR00414	Inhibitor	[(2-aminooxyethyl)methylamino]-5'-deoxyadenosine
TTDR00415	UniProt ID	Q9UNP4
TTDR00415	Name	Lactosylceramide alpha-2,3-sialyltransferase
TTDR00415	Type of target	Research target
TTDR00415	Synonyms	CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase
TTDR00415	Synonyms	Ganglioside GM3 synthase
TTDR00415	Synonyms	ST3Gal V
TTDR00415	Synonyms	Sialyltransferase 9
TTDR00415	Synonyms	UNQ2510/PRO5998
TTDR00415	Disease	Noninsulin-dependent diabetes mellitus
TTDR00415	Function	Catalyses the formation of ganglioside gm3 (alpha-n- acetylneuraminyl-2,3-beta-d
TTDR00415	Sequence	MRTKAAGCAERRPLQPRTEAAAAPAGRAMPSEYTYVKLRSDCSRPSLQWYTRAQSKMRRPSLLLKDILKCTLLVFGVWIL
TTDR00415	BioChemical Class	Glycosyltransferases
TTDR00415	Pathway	Glycosphingolipid biosynthesis - ganglio series
TTDR00415	Pathway	Metabolic pathways
TTDR00415	EC Number	EC 2.4.99.9
TTDR00415	Inhibitor	5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine
TTDR00416	Name	Endothelin converting enzyme
TTDR00416	Type of target	Research target
TTDR00416	Synonyms	ECE
TTDR00416	Disease	Cardiovascular disease, unspecified
TTDR00416	Disease	Coronary atherosclerosis
TTDR00416	Disease	Renal diseases
TTDR00416	Disease	Vein graft disease
TTDR00416	EC Number	EC 3.4.24.71
TTDR00416	Related US Patent	6,423,727
TTDR00416	Related US Patent	6,426,354
TTDR00416	Related US Patent	6,469,056
TTDR00416	Related US Patent	6,613,782
TTDR00416	Inhibitor	Phosphoramidon
TTDR00417	UniProt ID	O75473
TTDR00417	Name	Leucine-rich repeat-containing G protein-coupled receptor 5
TTDR00417	Type of target	Research target
TTDR00417	Synonyms	G protein-coupled receptor 49
TTDR00417	Synonyms	Gpr49
TTDR00417	Synonyms	Orphan G protein-coupled receptor HG38
TTDR00417	Disease	Hepatocellular carcinoma
TTDR00417	Function	Orphan receptor. It may be an important receptor for signals controlling growth
TTDR00417	Sequence	MDTSRLGVLLSLPVLLQLATGGSSPRSGVLLRGCPTHCHCEPDGRMLLRVDCSDLGLSELPSNLSVFTSYLDLSMNNISQ
TTDR00417	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00418	UniProt ID	P01236
TTDR00418	Name	Prolactin
TTDR00418	Type of target	Research target
TTDR00418	Synonyms	PRL
TTDR00418	Disease	Breast cancer
TTDR00418	Function	Prolactin acts primarily on the mammary gland by promoting lactation.
TTDR00418	Sequence	MNIKGSPWKGSLLLLLVSNLLLCQSVAPLPICPGGAARCQVTLRDLFDRAVVLSHYIHNLSSEMFSEFDKRYTHGRGFIT
TTDR00418	PDB Structure	1N9D; 1RW5; 2Q98; 3D48
TTDR00418	Pathway	Cytokine-cytokine receptor interaction
TTDR00418	Pathway	Jak-STAT signaling pathway
TTDR00418	Pathway	Neuroactive ligand-receptor interaction
TTDR00419	UniProt ID	P17676
TTDR00419	Name	CCAAT/enhancer binding protein beta
TTDR00419	Type of target	Research target
TTDR00419	Synonyms	C/EBP beta
TTDR00419	Synonyms	Nuclear factor NF-IL6
TTDR00419	Synonyms	Transcription factor 5
TTDR00419	Synonyms	Transcription factor CCAAT/enhancer-binding protein beta
TTDR00419	Disease	Kaposi's sarcoma
TTDR00419	Disease	Noninsulin-dependent diabetes mellitus
TTDR00419	Disease	Obesity
TTDR00419	Function	Important transcriptional activator in the regulation of genes involved in immun
TTDR00419	Sequence	MQRLVAWDPACLPLPPPPPAFKSMEVANFYYEADCLAAAYGGKAAPAAPPAARPGPRPPAGELGSIGDHERAIDFSPYLE
TTDR00419	PDB Structure	1GTW; 1GU4; 1GU5; 1H88; 1H89; 1H8A; 1HJB; 1IO4
TTDR00420	UniProt ID	Q13133
TTDR00420	Name	Oxysterols receptor LXR-alpha
TTDR00420	Type of target	Research target
TTDR00420	Synonyms	LXRalpha
TTDR00420	Synonyms	Liver X receptor alpha
TTDR00420	Synonyms	Nuclear orphan receptor LXR-alpha
TTDR00420	Synonyms	Nuclear receptor LXRalpha
TTDR00420	Disease	Atherosclerosis
TTDR00420	Disease	Cancer, unspecific
TTDR00420	Function	Orphan receptor. Interaction with rxr shifts rxr from its role as a silent dna-b
TTDR00420	Sequence	MSLWLGAPVPDIPPDSAVELWKPGAQDASSQAQGGSSCILREEARMPHSAGGTAGVGLEAAEPTALLTRAEPPSEPTEIR
TTDR00420	PDB Structure	1UHL
TTDR00420	BioChemical Class	Zinc-finger
TTDR00420	Pathway	PPAR signaling pathway
TTDR00420	Target Validation	TTDR00420
TTDR00420	Inhibitor	12,17-dehydroxyriccardin C
TTDR00420	Inhibitor	12-dehydroxyriccardin C
TTDR00420	Inhibitor	17-dehydroxyriccardin C
TTDR00420	Inhibitor	2-(2-hexylphenyl)isoindoline-1,3-dione
TTDR00420	Inhibitor	2-(2-phenethylphenyl)isoindoline-1,3-dione
TTDR00420	Inhibitor	2-Benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazole
TTDR00420	Inhibitor	2-benzyl-4,5,6,7-tetrachloroisoindoline-1,3-dione
TTDR00420	Inhibitor	4,12,17-dehydroxyriccardin C
TTDR00420	Inhibitor	4,17-dehydroxyriccardin C
TTDR00420	Inhibitor	4-dehydroxyriccardin C
TTDR00420	Inhibitor	5-chloro-2-(4-phenylbutyl)isoindoline-1,3-dione
TTDR00420	Inhibitor	GSK-9772
TTDR00420	Inhibitor	GW-3965
TTDR00420	Inhibitor	Guttiferone I
TTDR00420	Inhibitor	N-{4-[2-(3-Hydroxyphenyl)ethyl]phenyl}phthalimide
TTDR00420	Inhibitor	N-{4-[2-(3-Methoxyphenyl)ethyl]phenyl}phthalimide
TTDR00420	Inhibitor	N-{4-[2-(4-Hydroxyphenyl)ethyl]phenyl}phthalimide
TTDR00420	Inhibitor	N-{4-[2-(4-Methoxyphenyl)ethyl]phenyl}phthalimide
TTDR00420	Inhibitor	WAY-214950
TTDR00420	Inhibitor	WAY-252623
TTDR00420	Inhibitor	WAY-254011
TTDR00420	Inhibitor	riccardin C
TTDR00421	UniProt ID	P55055
TTDR00421	Name	Oxysterols receptor LXR-beta
TTDR00421	Type of target	Research target
TTDR00421	Synonyms	LXRbeta
TTDR00421	Synonyms	Liver X receptor beta
TTDR00421	Synonyms	Nuclear orphan receptor LXR-beta
TTDR00421	Synonyms	Nuclear receptor NER
TTDR00421	Synonyms	Ubiquitously-expressed nuclear receptor
TTDR00421	Disease	Atherosclerosis
TTDR00421	Disease	Dyslipidemia
TTDR00421	Function	Orphan receptor. Binds preferentially to double-stranded oligonucleotide direct
TTDR00421	Sequence	MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDWVIPDPEEEPERKRKKGPAPK
TTDR00421	PDB Structure	1P8D; 1PQ6; 1PQ9; 1PQC; 1UPV; 1UPW
TTDR00421	BioChemical Class	Zinc-finger
TTDR00421	Target Validation	TTDR00421
TTDR00421	Inhibitor	12,17-dehydroxyriccardin C
TTDR00421	Inhibitor	12-dehydroxyriccardin C
TTDR00421	Inhibitor	17-dehydroxyriccardin C
TTDR00421	Inhibitor	2-Benzyl-3-phenyl-7-(trifluoromethyl)-2H-indazole
TTDR00421	Inhibitor	2-Propanol, Isopropanol
TTDR00421	Inhibitor	2-benzyl-4,5,6,7-tetrachloroisoindoline-1,3-dione
TTDR00421	Inhibitor	4,17-dehydroxyriccardin C
TTDR00421	Inhibitor	4-dehydroxyriccardin C
TTDR00421	Inhibitor	Benzenesulfonyl
TTDR00421	Inhibitor	GSK-9772
TTDR00421	Inhibitor	GW-3965
TTDR00421	Inhibitor	N-{4-[2-(3-Methoxyphenyl)ethyl]phenyl}phthalimide
TTDR00421	Inhibitor	WAY-214950
TTDR00421	Inhibitor	WAY-252623
TTDR00421	Inhibitor	WAY-254011
TTDR00421	Inhibitor	riccardin C
TTDR00422	UniProt ID	P15018
TTDR00422	Name	Leukemia inhibitory factor
TTDR00422	Type of target	Research target
TTDR00422	Synonyms	D factor
TTDR00422	Synonyms	Differentiation-stimulating factor
TTDR00422	Synonyms	LIF
TTDR00422	Synonyms	MLPLI
TTDR00422	Synonyms	Melanoma-derived LPL inhibitor
TTDR00422	Disease	Osteoporosis, unspecified
TTDR00422	Disease	Rheumatoid arthritis, unspecified
TTDR00422	Function	Lif has the capacity to induce terminal differentiation in leukemic cells. Its a
TTDR00422	Sequence	MKVLAAGVVPLLLVLHWKHGAGSPLPITPVNATCAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDK
TTDR00422	PDB Structure	1A7M; 1EMR; 1PVH; 2Q7N
TTDR00422	BioChemical Class	Growth factor
TTDR00422	Pathway	Cytokine-cytokine receptor interaction
TTDR00422	Pathway	Jak-STAT signaling pathway
TTDR00423	UniProt ID	P11678
TTDR00423	Name	Eosinophil peroxidase
TTDR00423	Type of target	Research target
TTDR00423	Synonyms	EPO
TTDR00423	Disease	Allergen-triggered inflammatory tissue injury
TTDR00423	Sequence	MHLLPALAGVLATLVLAQPCEGTDPASPGAVETSVLRDCIAEAKLLVDAAYNWTQKSIKQRLRSGSASPMDLLSYFKQPV
TTDR00423	BioChemical Class	Oxidoreductases acting on a peroxide as acceptor
TTDR00423	Pathway	Asthma
TTDR00423	EC Number	EC 1.11.1.7
TTDR00426	Name	Chemokine receptor
TTDR00426	Type of target	Clinical trial target
TTDR00426	Disease	Sjogren's syndrome
TTDR00426	Related US Patent	6,506,751
TTDR00427	UniProt ID	P10914
TTDR00427	Name	Interferon regulatory factor 1
TTDR00427	Type of target	Research target
TTDR00427	Synonyms	IRF-1
TTDR00427	Disease	Ischemic stroke
TTDR00427	Function	Specifically binds to the upstream regulatory region of type i ifn and ifn-induc
TTDR00427	Sequence	MPITRMRMRPWLEMQINSNQIPGLIWINKEEMIFQIPWKHAAKHGWDINKDACLFRSWAIHTGRYKAGEKEPDPKTWKAN
TTDR00428	Name	Class II cytokine receptor
TTDR00428	Type of target	Research target
TTDR00428	Synonyms	Cytokine class II receptor
TTDR00428	Disease	Vascular injury
TTDR00428	Ligand	IFN
TTDR00428	Ligand	IL-10
TTDR00430	UniProt ID	Q08722
TTDR00430	Name	Leukocyte surface antigen CD47
TTDR00430	Type of target	Clinical trial target
TTDR00430	Synonyms	Antigenic surface determinant protein OA3
TTDR00430	Synonyms	CD47
TTDR00430	Synonyms	IAP
TTDR00430	Synonyms	Integrin associated protein
TTDR00430	Synonyms	MER6
TTDR00430	Disease	Allograft rejection
TTDR00430	Disease	Anergy
TTDR00430	Disease	Autoimmune diseases
TTDR00430	Disease	Graft-versus-host disease (acute) (chronic)
TTDR00430	Disease	Inflammatory disease of mucosal surfaces
TTDR00430	Function	Receptor for ptpns1. May play a role in membrane transport and/or signal transdu
TTDR00430	Sequence	MWPLVAALLLGSACCGSAQLLFNKTKSVEFTFCNDTVVIPCFVTNMEAQNTTEVYVKWKFKGRDIYTFDGALNKSTVPTD
TTDR00430	PDB Structure	2JJS; 2JJT; 2VSC
TTDR00430	BioChemical Class	Transmembrane protein
TTDR00430	Pathway	ECM-receptor interaction
TTDR00431	Name	Monokine
TTDR00431	Type of target	Research target
TTDR00431	Disease	Autoimmune inflammation
TTDR00431	Disease	Cancer, unspecific
TTDR00431	Disease	Inflammatory diseases
TTDR00432	UniProt ID	P09681
TTDR00432	Name	Gastric inhibitory polypeptide
TTDR00432	Type of target	Clinical trial target
TTDR00432	Synonyms	GIP
TTDR00432	Synonyms	Glucose-dependent insulinotropic polypeptide
TTDR00432	Disease	Noninsulin-dependent diabetes mellitus
TTDR00432	Disease	Obesity
TTDR00432	Function	Potent stimulator of insulin secretion and relatively poor inhibitor of gastric
TTDR00432	Sequence	MVATKTFALLLLSLFLAVGLGEKKEGHFSALPSLPVGSHAKVSSPQPRGPRYAEGTFISDYSIAMDKIHQQDFVNWLLAQ
TTDR00432	PDB Structure	1T5Q; 2B4N; 2OBU; 2QKH
TTDR00433	UniProt ID	Q14790
TTDR00433	Name	Caspase-8
TTDR00433	Type of target	Research target
TTDR00433	Synonyms	Apoptotic cysteine protease
TTDR00433	Synonyms	Apoptotic protease Mch-5
TTDR00433	Synonyms	CAP4
TTDR00433	Synonyms	FADD-homologous ICE/CED-3-like protease
TTDR00433	Synonyms	FADD-like ICE
TTDR00433	Synonyms	FLICE
TTDR00433	Synonyms	ICE-like apoptotic protease 5
TTDR00433	Synonyms	MACH
TTDR00433	Synonyms	MORT1-associated CED-3 homolog
TTDR00433	Disease	Neurodegenerative diseases
TTDR00433	Function	Most upstream protease of the activation cascade of caspases responsible for the
TTDR00433	Sequence	MDFSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEESNLSFLKELLFRINRLDLLITYLN
TTDR00433	PDB Structure	1F9E; 1I4E; 1QDU; 1QTN; 2C2Z; 2FUN; 2K7Z; 3H11
TTDR00433	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00433	Pathway	Alzheimer's disease
TTDR00433	Pathway	Apoptosis
TTDR00433	Pathway	Huntington's disease
TTDR00433	Pathway	Pathways in cancer
TTDR00433	Pathway	Toll-like receptor signaling pathway
TTDR00433	Pathway	p53 signaling pathway
TTDR00433	EC Number	EC 3.4.22.-
TTDR00433	Related US Patent	6,489,353
TTDR00433	Related US Patent	6,515,173
TTDR00433	Related US Patent	6,525,024
TTDR00433	Related US Patent	6,528,506
TTDR00433	Related US Patent	6,531,467
TTDR00433	Related US Patent	6,544,951
TTDR00433	Related US Patent	6,610,683
TTDR00433	Related US Patent	6,632,962
TTDR00433	Inhibitor	Acetyl-Ile-Glu-Thr-Asp-aldehyde
TTDR00434	UniProt ID	P29466
TTDR00434	Name	Interleukin-1 beta convertase
TTDR00434	Type of target	Research target
TTDR00434	Synonyms	CASP-1
TTDR00434	Synonyms	Caspase-1
TTDR00434	Synonyms	ICE
TTDR00434	Synonyms	IL-1 beta converting enzyme
TTDR00434	Synonyms	IL-1BC
TTDR00434	Synonyms	Interleukin-1 beta converting enzyme
TTDR00434	Synonyms	P45
TTDR00434	Disease	Brain inflammation
TTDR00434	Disease	Cerebral ischemia
TTDR00434	Disease	Diabetic retinopathy
TTDR00434	Disease	Inflammation
TTDR00434	Function	Thiol protease that cleaves il-1 beta between an asp and an ala, releasing the m
TTDR00434	Sequence	MADKVLKEKRKLFIRSMGEGTINGLLDELLQTRVLNKEEMEKVKRENATVMDKTRALIDSVIPKGAQACQICITYICEED
TTDR00434	PDB Structure	1BMQ; 1IBC; 1ICE; 1RWK; 1RWM; 1RWN; 1RWO; 1RWP
TTDR00434	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00434	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDR00434	EC Number	EC 3.4.22.36
TTDR00434	Related US Patent	6,407,080
TTDR00434	Related US Patent	6,423,840
TTDR00434	Related US Patent	6,426,413
TTDR00434	Related US Patent	6,528,506
TTDR00434	Related US Patent	6,531,467
TTDR00434	Related US Patent	6,531,474
TTDR00434	Related US Patent	6,573,259
TTDR00434	Related US Patent	6,610,683
TTDR00434	Target Validation	TTDR00434
TTDR00434	Inhibitor	L-709049
TTDR00434	Inhibitor	PRALNACASAN
TTDR00434	Inhibitor	YVAD
TTDR00434	Inhibitor	Z-VAD-CHO
TTDR00434	Inhibitor	Z-YVAD-CHO
TTDR00435	Name	Common lymphatic endothelial and vascular endothelial receptor-1
TTDR00435	Type of target	Research target
TTDR00435	Synonyms	CLEVER-1
TTDR00435	Disease	Inflammation
TTDR00436	Name	Mitogen-activated protein kinase
TTDR00436	Type of target	Research target
TTDR00436	Synonyms	ERK
TTDR00436	Synonyms	Extracellular signal-regulated kinase
TTDR00436	Synonyms	MAPK
TTDR00436	Disease	Chronic myeloid leukemia
TTDR00436	Disease	Reperfusion injury after brain ischemia
TTDR00436	Disease	Traumatic brain injury
TTDR00436	Related US Patent	6,495,568
TTDR00436	Related US Patent	6,528,509
TTDR00436	Related US Patent	6,593,357
TTDR00436	Related US Patent	6,649,640
TTDR00436	Inhibitor	U0126
TTDR00437	Name	Cytokine
TTDR00437	Type of target	Research target
TTDR00437	Disease	Inflammatory diseases
TTDR00437	Disease	Sepsis
TTDR00438	UniProt ID	O97600
TTDR00438	Name	Serum amyloid A-activating factor 1
TTDR00438	Type of target	Research target
TTDR00438	Synonyms	SAF-1
TTDR00438	Disease	Osteoarthritis
TTDR00438	Sequence	MFPVFPCTLIAPPFPVLGLESRGRPSNWSSFIFQGHAQNPLQVGAELQSRFFASQGCAQSPFQAAPAPPPTPQAPAAEPF
TTDR00439	Name	Endotoxin
TTDR00439	Type of target	Research target
TTDR00439	Disease	Septic shock
TTDR00440	UniProt ID	P42574
TTDR00440	Name	Apopain
TTDR00440	Type of target	Research target
TTDR00440	Synonyms	CASP-3
TTDR00440	Synonyms	CPP-32
TTDR00440	Synonyms	Caspase 3
TTDR00440	Synonyms	Caspase-3
TTDR00440	Synonyms	Cysteine protease CPP32
TTDR00440	Synonyms	SCA-1
TTDR00440	Synonyms	SREBP cleavage activity 1
TTDR00440	Synonyms	Yama protein
TTDR00440	Disease	Chronic experimental allergic encephalomyelitis
TTDR00440	Disease	Dysregulation of apoptosis
TTDR00440	Disease	Multiple sclerosis
TTDR00440	Disease	Neurodegenerative diseases
TTDR00440	Function	Involved in the activation cascade of caspases responsible for apoptosis executi
TTDR00440	Sequence	MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRN
TTDR00440	PDB Structure	1CP3; 1GFW; 1I3O; 1NME; 1NMQ; 1NMS; 1PAU; 1QX3
TTDR00440	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00440	Pathway	Alzheimer's disease
TTDR00440	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDR00440	Pathway	Apoptosis
TTDR00440	Pathway	Colorectal cancer
TTDR00440	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR00440	Pathway	Huntington's disease
TTDR00440	Pathway	MAPK signaling pathway
TTDR00440	Pathway	Natural killer cell mediated cytotoxicity
TTDR00440	Pathway	Parkinson's disease
TTDR00440	Pathway	Pathways in cancer
TTDR00440	Pathway	p53 signaling pathway
TTDR00440	EC Number	EC 3.4.22.-
TTDR00440	Related US Patent	6,225,288
TTDR00440	Related US Patent	6,525,025
TTDR00440	Target Validation	TTDR00440
TTDR00440	Inhibitor	2-(4-fluoro-benzyl)isoquinoline-1,3,4-trione
TTDR00440	Inhibitor	2-(4-methoxy-benzyl)isoquinoline-1,3,4-trione
TTDR00440	Inhibitor	2-allylisoquinoline-1,3,4-trione
TTDR00440	Inhibitor	2-benzylisoquinoline-1,3,4-trione
TTDR00440	Inhibitor	2-methylisoquinoline-1,3,4-trione
TTDR00440	Inhibitor	2-phenethylisoquinoline-1,3,4-trione
TTDR00440	Inhibitor	5-(azepan-1-ylsulfonyl)indoline-2,3-dione
TTDR00440	Inhibitor	5-(azetidin-1-ylsulfonyl)indoline-2,3-dione
TTDR00440	Inhibitor	5-(piperidin-1-ylsulfonyl)indoline-2,3-dione
TTDR00440	Inhibitor	5-(pyrrolidin-1-ylsulfonyl)indoline-2,3-dione
TTDR00440	Inhibitor	Ac-Asp-Glu-Val-Asp-CHO
TTDR00440	Inhibitor	Ac-DEVD-CHO
TTDR00440	Inhibitor	PRALNACASAN
TTDR00440	Inhibitor	isoquinoline-1,3,4(2H)-trione
TTDR00441	UniProt ID	P02652
TTDR00441	Name	Apolipoprotein A-II
TTDR00441	Type of target	Research target
TTDR00441	Synonyms	Apo-AII
TTDR00441	Synonyms	ApoA-II
TTDR00441	Disease	Amyloidosis
TTDR00441	Function	May stabilize hdl (high density lipoprotein) structure by its association with l
TTDR00441	Sequence	MKLLAATVLLLTICSLEGALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAG
TTDR00441	PDB Structure	1L6L; 2OU1
TTDR00441	Pathway	PPAR signaling pathway
TTDR00441	Inhibitor	B-Octylglucoside
TTDR00442	UniProt ID	P53379
TTDR00442	Name	Glycosylphosphatidylinositol-anchored aspartyl protease
TTDR00442	Type of target	Research target
TTDR00442	Synonyms	GPI-anchored aspartyl protease
TTDR00442	Synonyms	Glycosylphosphatidylinositol-anchored protein
TTDR00442	Synonyms	Yapsin 2
TTDR00442	Disease	Alzheimer's disease
TTDR00442	Sequence	MKLSVLTFVVDALLVCSSIVDAGVTDFPSLPSNEVYVKMNFQKKYGSSFENALDDTKGRTRLMTRDDDYELVELTNQNSF
TTDR00442	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00442	EC Number	EC 3.4.23.41
TTDR00443	UniProt ID	P47712
TTDR00443	Name	Cytosolic phospholipase A2
TTDR00443	Type of target	Research target
TTDR00443	Synonyms	CPLA2
TTDR00443	Synonyms	Phospholipase A2 group IVA
TTDR00443	Disease	Atherosclerosis
TTDR00443	Disease	Cancer, unspecific
TTDR00443	Disease	Diabetes mellitus
TTDR00443	Disease	Lipid metabolic disorders
TTDR00443	Disease	Neurodegenerative diseases
TTDR00443	Disease	Obesity
TTDR00443	Function	Selectively hydrolyzes arachidonyl phospholipids in the sn-2 position releasing
TTDR00443	Sequence	MSFIDPYQHIIVEHQYSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPDSRKRTRHFNNDINPVWNETFEFILD
TTDR00443	PDB Structure	1BCI; 1CJY; 1RLW
TTDR00443	Pathway	Arachidonic acid metabolism
TTDR00443	Pathway	Ether lipid metabolism
TTDR00443	Pathway	Fc epsilon RI signaling pathway
TTDR00443	Pathway	Glycerophospholipid metabolism
TTDR00443	Pathway	GnRH signaling pathway
TTDR00443	Pathway	Linoleic acid metabolism
TTDR00443	Pathway	Long-term depression
TTDR00443	Pathway	MAPK signaling pathway
TTDR00443	Pathway	Metabolic pathways
TTDR00443	Pathway	VEGF signaling pathway
TTDR00443	Pathway	Vascular smooth muscle contraction
TTDR00443	Pathway	alpha-Linolenic acid metabolism
TTDR00443	Related US Patent	6,350,892
TTDR00443	Related US Patent	6,414,179
TTDR00443	Related US Patent	6,492,550
TTDR00443	Related US Patent	6,630,496
TTDR00443	Target Validation	TTDR00443
TTDR00443	Inhibitor	(S)-Ethyl 6-(2-oxohexadecanamido)decanoate
TTDR00443	Inhibitor	(S)-Methyl 4-(2-oxohexadecanamido)octanoate
TTDR00443	Inhibitor	(S)-tert-Butyl 4-(2-oxohexadecanamido)pentanoate
TTDR00443	Inhibitor	(Z)-1,1,1,2,2,3,3-heptafluorohenicos-12-en-4-one
TTDR00443	Inhibitor	1,1,1,2,2,3,3,5-octafluoro-8-phenyloctan-4-one
TTDR00443	Inhibitor	1,1,1,2,2,3,3-heptafluoro-8-phenyloctan-4-ol
TTDR00443	Inhibitor	1,1,1,2,2,4-hexafluoro-7-phenylheptan-3-one
TTDR00443	Inhibitor	1,1,1,2,2-Pentafluoro-8-phenyl-octan-3-one
TTDR00443	Inhibitor	1,1,1,2,2-Pentafluoro-9-phenyl-nonan-3-one
TTDR00443	Inhibitor	1,1,1,3-Tetrafluoro-6-phenylhexan-2-one
TTDR00443	Inhibitor	1,1,1,3-Tetrafluoro-7-phenylheptan-2-one
TTDR00443	Inhibitor	1,1,1,3-Tetrafluoro-heptadecan-2-one
TTDR00443	Inhibitor	1,1,1-Trifluoro-4-(4-hexyloxy-phenyl)-butan-2-one
TTDR00443	Inhibitor	1,1,1-Trifluoro-5-(4-octylphenoxy)pentan-2-one
TTDR00443	Inhibitor	1,1,1-Trifluoro-6-(4-hexyloxy-phenyl)-hexan-2-one
TTDR00443	Inhibitor	1,1,1-Trifluoro-6-(naphthalen-2-yl)hexan-2-one
TTDR00443	Inhibitor	1,1,1-Trifluoro-7-phenylheptan-2-one
TTDR00443	Inhibitor	1,1,1-Trifluoro-8-phenyloctan-2-one
TTDR00443	Inhibitor	1,1,1-trifluoroheptadecan-2-one
TTDR00443	Inhibitor	1-Imidazol-1-yl-3-(4-octylphenoxy)propan-2-one
TTDR00443	Inhibitor	4-(2-oxohexadecanamido)butanoic acid
TTDR00443	Inhibitor	4-(4-Decyloxy-phenyl)-1,1,1-trifluoro-butan-2-one
TTDR00443	Inhibitor	6-(4-Decyloxy-phenyl)-1,1,1-trifluoro-hexan-2-one
TTDR00443	Inhibitor	AR-C70484XX
TTDR00443	Inhibitor	ARACHIDONYL TRIFLUOROMETHYLKETONE
TTDR00443	Inhibitor	AX-006
TTDR00443	Inhibitor	AX-048
TTDR00443	Inhibitor	Allyl 4-(2-oxohexadecanamido)butanoate
TTDR00443	Inhibitor	Arachidonyltrifluoromethyl ketone
TTDR00443	Inhibitor	ECOPLADIB
TTDR00443	Inhibitor	EFIPLADIB
TTDR00443	Inhibitor	Ethyl 2-(2-oxohexadecanamido)acetate
TTDR00443	Inhibitor	Ethyl 4-(2-oxohexadecanamido)benzoate
TTDR00443	Inhibitor	Methyl 2-(2-oxo-8-phenyloctanamido)acetate
TTDR00443	Inhibitor	Methyl 2-(2-oxohexadecanamido)acetate
TTDR00443	Inhibitor	Methyl arachidonyl fluorophosphonate
TTDR00443	Inhibitor	N-(4-Ethoxybutyl)-2-oxohexadecanamide
TTDR00443	Inhibitor	WAY-196025
TTDR00443	Inhibitor	[3,4''']biflavone
TTDR00443	Inhibitor	[4',4''']-biflavone
TTDR00443	Inhibitor	[6,3''']biflavone
TTDR00443	Inhibitor	[6,4''']biflavone
TTDR00443	Inhibitor	tert-Butyl 2-(2-oxohexadecanamido)acetate
TTDR00443	Inhibitor	tert-Butyl 3-(2-oxo-8-phenyloctanamido)propanoate
TTDR00443	Inhibitor	tert-Butyl 3-(2-oxohexadecanamido)propanoate
TTDR00443	Inhibitor	tert-Butyl 5-(2-oxohexadecanamido)pentanoate
TTDR00444	UniProt ID	P49768
TTDR00444	Name	Presenilin 1
TTDR00444	Type of target	Research target
TTDR00444	Synonyms	PS-1
TTDR00444	Synonyms	PS1
TTDR00444	Synonyms	S182 protein
TTDR00444	Disease	Familial Alzheimer's disease
TTDR00444	Function	Probable catalytic subunit of the gamma-secretase complex, an endoprotease compl
TTDR00444	Sequence	MTELPAPLSYFQNAQMSEDNHLSNTVRSQNDNRERQEHNDRRSLGHPEPLSNGRPQGNSRQVVEQDEEEDEELTLKYGAK
TTDR00444	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00444	Pathway	Alzheimer's disease
TTDR00444	Pathway	Notch signaling pathway
TTDR00444	Pathway	Wnt signaling pathway
TTDR00444	Target Validation	TTDR00444
TTDR00444	Inhibitor	(2S,3R)-2-(benzyloxy)-3-methoxycyclohexanone
TTDR00444	Inhibitor	(5R,6S)-5,6-bis(benzyloxy)cyclohex-2-enone
TTDR00444	Inhibitor	(5R,6S)-6-(benzyloxy)-5-methoxycyclohex-2-enone
TTDR00444	Inhibitor	(S)-FLURBIPROFEN
TTDR00444	Inhibitor	1-Chloro-4-(1-phenyl-cyclohexanesulfonyl)-benzene
TTDR00444	Inhibitor	1-benzoyl-2-benzyl-1,2-dihydropyridin-3(6H)-one
TTDR00444	Inhibitor	311383
TTDR00444	Inhibitor	311440
TTDR00444	Inhibitor	311951
TTDR00444	Inhibitor	311952
TTDR00444	Inhibitor	R-flurbiprofen
TTDR00445	UniProt ID	P49810
TTDR00445	Name	Presenilin 2
TTDR00445	Type of target	Research target
TTDR00445	Synonyms	AD3LP
TTDR00445	Synonyms	AD5
TTDR00445	Synonyms	E5-1
TTDR00445	Synonyms	PS-2
TTDR00445	Synonyms	PS2
TTDR00445	Synonyms	STM-2
TTDR00445	Disease	Familial Alzheimer's disease
TTDR00445	Function	Probable catalytic subunit of the gamma-secretase complex, an endoprotease compl
TTDR00445	Sequence	MLTFMASDSEEEVCDERTSLMSAESPTPRSCQEGRQGPEDGENTAQWRSQENEEDGEEDPDRYVCSGVPGRPPGLEEELT
TTDR00445	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00445	Pathway	Alzheimer's disease
TTDR00445	Pathway	Notch signaling pathway
TTDR00445	Target Validation	TTDR00445
TTDR00445	Inhibitor	(2S,3R)-2-(benzyloxy)-3-methoxycyclohexanone
TTDR00445	Inhibitor	(5R,6S)-5,6-bis(benzyloxy)cyclohex-2-enone
TTDR00445	Inhibitor	(5R,6S)-6-(benzyloxy)-5-methoxycyclohex-2-enone
TTDR00445	Inhibitor	(S)-FLURBIPROFEN
TTDR00445	Inhibitor	1-Chloro-4-(1-phenyl-cyclohexanesulfonyl)-benzene
TTDR00445	Inhibitor	1-benzoyl-2-benzyl-1,2-dihydropyridin-3(6H)-one
TTDR00445	Inhibitor	311383
TTDR00445	Inhibitor	311440
TTDR00445	Inhibitor	311951
TTDR00445	Inhibitor	311952
TTDR00445	Inhibitor	R-flurbiprofen
TTDR00446	UniProt ID	P02743
TTDR00446	Name	Serum amyloid P-component
TTDR00446	Type of target	Research target
TTDR00446	Synonyms	9.5S alpha-1-glycoprotein
TTDR00446	Synonyms	SAP
TTDR00446	Disease	Alzheimer's disease
TTDR00446	Disease	Amyloidosis
TTDR00446	Disease	Transmissible spongiform encephalopathies
TTDR00446	Function	Can interact with dna and histones and may scavenge nuclear material released fr
TTDR00446	Sequence	MNKPLLWISVLTSLLEAFAHTDLSGKVFVFPRESVTDHVNLITPLEKPLQNFTLCFRAYSDLSRAYSLFSYNTQGRDNEL
TTDR00446	PDB Structure	1GYK; 1LGN; 1SAC; 2A3W; 2A3X; 2A3Y; 2W08; 3D5O; 3KQR
TTDR00447	UniProt ID	P07339
TTDR00447	Name	Cathepsin D
TTDR00447	Type of target	Research target
TTDR00447	Synonyms	CD
TTDR00447	Disease	Alzheimer's disease
TTDR00447	Disease	Breast cancer
TTDR00447	Function	Acid protease active in intracellular protein breakdown. Involved in the pathoge
TTDR00447	Sequence	MQPSSLLPLALCLLAAPASALVRIPLHKFTSIRRTMSEVGGSVEDLIAKGPVSKYSQAVPAVTEGPIPEVLKNYMDAQYY
TTDR00447	PDB Structure	1LYA; 1LYB; 1LYW
TTDR00447	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00447	Pathway	Lysosome
TTDR00447	EC Number	EC 3.4.23.5
TTDR00447	Related US Patent	6,326,393
TTDR00447	Related US Patent	6,432,933
TTDR00447	Target Validation	TTDR00447
TTDR00447	Inhibitor	1h-Benoximidazole-2-Carboxylic Acid
TTDR00447	Inhibitor	Alpha-D-Mannose
TTDR00447	Inhibitor	CI-992
TTDR00447	Inhibitor	Carbocyclic Peptidomimetic
TTDR00447	Inhibitor	GRASSYSTATIN A
TTDR00447	Inhibitor	GRL-7234
TTDR00447	Inhibitor	KNI-10006
TTDR00447	Inhibitor	N-Aminoethylmorpholine
TTDR00447	Inhibitor	PEPSTATIN A
TTDR00447	Inhibitor	S-Methylcysteine
TTDR00448	UniProt ID	Q07762
TTDR00448	Name	Ribonuclease H
TTDR00448	Type of target	Research target
TTDR00448	Synonyms	RNase H
TTDR00448	Synonyms	Retroviral ribonuclease H
TTDR00448	Disease	Human immunodeficiency virus [HIV] disease
TTDR00448	Function	This enzyme is an endonuclease that degrades the rna of rna-dna hybrids specific
TTDR00448	Sequence	MRRVALSVLFQSSRVLHFTDLRDKQIALCNAAPGHTVQFHQHRRHSSAPVSSVGGQNTFSCLGASCAGLLHPSRVRFANR
TTDR00448	BioChemical Class	Hydrolases acting on ester bonds
TTDR00448	EC Number	EC 3.1.26.4
TTDR00448	Target Validation	TTDR00448
TTDR00448	Inhibitor	2-hydroxyisoquinoline-1,3(2H,4H)-dione
TTDR00448	Inhibitor	3-hydroxyquinazoline-2,4(1H,3H)-dione
TTDR00449	UniProt ID	P17936
TTDR00449	Name	Insulin-like growth factor binding protein 3
TTDR00449	Type of target	Research target
TTDR00449	Synonyms	IBP-3
TTDR00449	Synonyms	IGF-binding protein 3
TTDR00449	Synonyms	IGFBP-3
TTDR00449	Disease	Angiogenesis
TTDR00449	Disease	Hepatocellular carcinoma
TTDR00449	Function	Igf-bindinG proteins prolong the half-life of the igfs and have been shown to ei
TTDR00449	Sequence	MQRARPTLWAAALTLLVLLRGPPVARAGASSAGLGPVVRCEPCDARALAQCAPPPAVCAELVREPGCGCCLTCALSEGQP
TTDR00449	Pathway	p53 signaling pathway
TTDR00450	UniProt ID	Q8NFT2
TTDR00450	Name	Six-transmembrane epithelial antigen of the prostate 2
TTDR00450	Type of target	Research target
TTDR00450	Synonyms	STEAP2
TTDR00450	Disease	Prostate cancer
TTDR00450	Sequence	MESISMMGSPKSLSETCLPNGINGIKDARKVTVGVIGSGDFAKSLTIRLIRCGYHVVIGSRNPKFASEFFPHVVDVTHHE
TTDR00451	UniProt ID	P13500
TTDR00451	Name	C-C motif chemokine 2
TTDR00451	Type of target	Research target
TTDR00451	Synonyms	CCL2
TTDR00451	Synonyms	HC11
TTDR00451	Synonyms	MCAF
TTDR00451	Synonyms	MCP-1
TTDR00451	Synonyms	MCP1
TTDR00451	Synonyms	Monocyte Chemoattractant Protein 1
TTDR00451	Synonyms	Monocyte chemoattractant protein-1
TTDR00451	Synonyms	Monocyte chemotactic and activating factor
TTDR00451	Synonyms	Monocyte chemotactic protein 1
TTDR00451	Synonyms	Monocyte secretory protein JE
TTDR00451	Synonyms	SCYA2
TTDR00451	Synonyms	Small-inducible cytokine A2
TTDR00451	Disease	Acute coronary syndromes
TTDR00451	Disease	Atherosclerosis
TTDR00451	Disease	Chronic obstructive pulmonary disease, unspecified
TTDR00451	Disease	Inflammatory diseases associated with hypoxia
TTDR00451	Disease	Peyronie's disease
TTDR00451	Disease	Renal ischemia-reperfusion injury
TTDR00451	Disease	Rheumatoid arthritis, unspecified
TTDR00451	Function	Chemotactic factor that attracts monocytes and basophils but not neutrophils or
TTDR00451	Sequence	MKVSAALLCLLLIAATFIPQGLAQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQ
TTDR00451	PDB Structure	1DOK; 1DOL; 1DOM; 1DON; 1MCA; 1ML0; 2BDN; 2NZ1; 3IFD; 4DN4
TTDR00451	Pathway	Chemokine signaling pathway
TTDR00451	Pathway	Cytokine-cytokine receptor interaction
TTDR00451	Related US Patent	6,348,487
TTDR00451	Related US Patent	6,441,004
TTDR00451	Related US Patent	6,479,527
TTDR00451	Related US Patent	6,534,521
TTDR00451	Related US Patent	6,613,760
TTDR00451	Related US Patent	6,670,364
TTDR00451	Related US Patent	6,677,365
TTDR00451	Target Validation	TTDR00451
TTDR00451	Drug(s)	MCP-1
TTDR00451	Drug(s)	RS-504393
TTDR00451	Inhibitor	MCP-1
TTDR00451	Inhibitor	RS-504393
TTDR00451	Multitarget	MCP-1
TTDR00451	Multitarget	RS-504393
TTDR00452	UniProt ID	Q9JKE2
TTDR00452	Name	Triggering receptor expressed on myeloid cells 1
TTDR00452	Type of target	Research target
TTDR00452	Synonyms	TREM-1
TTDR00452	Disease	Septic shock
TTDR00452	Sequence	MRKAGLWGLLCVFFVSEVKAAIVLEEERYDLVEGQTLTVKCPFNIMKYANSQKAWQRLPDGKEPLTLVVTQRPFTRPSEV
TTDR00452	PDB Structure	1U9K
TTDR00452	BioChemical Class	Transmembrane protein
TTDR00452	Inhibitor	D-tartaric acid
TTDR00453	UniProt ID	P19320
TTDR00453	Name	Vascular cell adhesion protein 1
TTDR00453	Type of target	Research target
TTDR00453	Synonyms	CD106 antigen
TTDR00453	Synonyms	INCAM-100
TTDR00453	Synonyms	V-CAM 1
TTDR00453	Synonyms	VCAM-1
TTDR00453	Synonyms	Vascular cell adhesion molecule 1
TTDR00453	Disease	Endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction
TTDR00453	Function	Important in cell-cell recognition. Appears to function in leukocyte-endothelial
TTDR00453	Sequence	MPGKMVVILGASNILWIMFAASQAFKIETTPESRYLAQIGDSVSLTCSTTGCESPFFSWRTQIDSPLNGKVTNEGTTSTL
TTDR00453	PDB Structure	1IJ9; 1VCA; 1VSC
TTDR00453	BioChemical Class	Transmembrane protein
TTDR00453	Pathway	Cell adhesion molecules (CAMs)
TTDR00453	Pathway	Leukocyte transendothelial migration
TTDR00453	QSAR Model	TTDR00453
TTDR00455	UniProt ID	P70343
TTDR00455	Name	Caspase-11
TTDR00455	Type of target	Research target
TTDR00455	Synonyms	ICH-3 protease
TTDR00455	Disease	Septic shock
TTDR00455	Function	Involved in the activation cascade of caspases responsible for apoptosis executi
TTDR00455	Sequence	MAENKHPDKPLKVLEQLGKEVLTEYLEKLVQSNVLKLKEEDKQKFNNAERSDKRWVFVDAMKKKHSKVGEMLLQTFFSVD
TTDR00455	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00455	EC Number	EC 3.4.22.-
TTDR00455	Target Validation	TTDR00455
TTDR00455	Inhibitor	GRASSYSTATIN A
TTDR00456	UniProt ID	P03402
TTDR00456	Name	Virion infectivity factor
TTDR00456	Type of target	Research target
TTDR00456	Synonyms	HIV-1 Vif protein
TTDR00456	Synonyms	HIV-1 encoded Vif protein
TTDR00456	Synonyms	Human immunodeficiency virus type 1-encoded Vif protein
TTDR00456	Synonyms	SOR protein
TTDR00456	Synonyms	Vif
TTDR00456	Synonyms	Vif protein
TTDR00456	Disease	Human immunodeficiency virus [HIV] disease
TTDR00456	Function	Determines virus infectivity.
TTDR00456	Sequence	MENRWQVMIVWQVDRMRIRTWKSLVKHHMYISKKAKGWFYRHHYESTHPRVSSEVHIPLGDAKLVITTYWGLHTGEREWH
TTDR00456	BioChemical Class	Cell membrane protein
TTDR00457	UniProt ID	P49862
TTDR00457	Name	Kallikrein 7
TTDR00457	Type of target	Research target
TTDR00457	Synonyms	HSCCE
TTDR00457	Synonyms	Stratum corneum chymotryptic enzyme
TTDR00457	Disease	Ovarian cancer
TTDR00457	Function	May catalyze the degradation of intercellular cohesive structures in the cornifi
TTDR00457	Sequence	MARSLLLPLQILLLSLALETAGEEAQGDKIIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHCKMNEYTVHL
TTDR00457	PDB Structure	2QXG; 2QXH; 2QXI; 2QXJ; 3BSQ
TTDR00457	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00457	EC Number	EC 3.4.21.-
TTDR00457	Inhibitor	Antileukoprotease (ALP)
TTDR00458	UniProt ID	P13725
TTDR00458	Name	Oncostatin M
TTDR00458	Type of target	Research target
TTDR00458	Synonyms	OSM
TTDR00458	Disease	Liver injury
TTDR00458	Disease	Rheumatoid arthritis, unspecified
TTDR00458	Function	Growth regulator. Inhibits the proliferation of a number of tumor cell lines. It
TTDR00458	Sequence	MGVLLTQRTLLSLVLALLFPSMASMAAIGSCSKEYRVLLGQLQKQTDLMQDTSRLLDPYIRIQGLDVPKLREHCRERPGA
TTDR00458	PDB Structure	1EVS
TTDR00458	Pathway	Cytokine-cytokine receptor interaction
TTDR00458	Pathway	Jak-STAT signaling pathway
TTDR00458	Aptamer	ADR58
TTDR00459	UniProt ID	O14746
TTDR00459	Name	mRNA of Telomerase reverse transcriptase
TTDR00459	Type of target	Research target
TTDR00459	Synonyms	TP2
TTDR00459	Synonyms	Telomerase catalytic subunit
TTDR00459	Synonyms	Telomerase-associated protein 2
TTDR00459	Synonyms	hEST2
TTDR00459	Synonyms	hTERT
TTDR00459	Disease	Cancer, unspecific
TTDR00459	Disease	Lung cancer
TTDR00459	Disease	Prostate carcinoma
TTDR00459	Disease	Tumors
TTDR00459	Function	Telomerase is a ribonucleoprotein enzyme essential for the replication of chromo
TTDR00459	Sequence	MPRAPRCRAVRSLLRSHYREVLPLATFVRRLGPQGWRLVQRGDPAAFRALVAQCLVCVPWDARPPPAAPSFRQVSCLKEL
TTDR00459	PDB Structure	2BCK
TTDR00459	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00459	EC Number	EC 2.7.7.-
TTDR00459	Target Validation	TTDR00459
TTDR00459	Inhibitor	1,3-bis(3,4-dihydroxyphenyl)prop-2-en-1-one
TTDR00459	Inhibitor	2,3-Dimethylnaphtho[2,3-f]quinoxaline-7,12-dione
TTDR00459	Inhibitor	2,7-Bis(3-chloropropionamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(4-chlorobutyramido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(acetamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(benzoamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(butyramido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(chloroacetamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(cyclohexanecarbonamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(cyclopentanecarbonamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(cyclopropanecarbonamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(phenylacetamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(phenylpropionamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis(propionamido)anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(butylamino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(diethylamino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(dimethylamino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(ethylamino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(isobutylamino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(isopropylamino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(piperazino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(piperidino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(propylamino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[2-(pyrrolidino)acetamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[3-(butylamino)propionamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[3-(ethylamino)propionamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[3-(piperazino)propionamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[3-(piperidino)propionamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[3-(propylamino)propionamido]anthraquinone
TTDR00459	Inhibitor	2,7-Bis[3-(pyrrolidino)propionamido]anthraquinone
TTDR00459	Inhibitor	2,7-Dinitroantraquinone
TTDR00459	Inhibitor	2,7-diaminoanthraquinone
TTDR00459	Inhibitor	2-Butyl-1(3)H-anthra[1,2-d]imidazole-6,11-dione
TTDR00459	Inhibitor	2-Heptyl-1(3)H-anthra[1,2-d]imidazole-6,11-dione
TTDR00459	Inhibitor	2-Methyl-1(3)H-anthrasimidazole-6,11-dione
TTDR00459	Inhibitor	7,8,3',4'-tetrahydroxyflavone
TTDR00459	Inhibitor	AURASPERONE A
TTDR00459	Inhibitor	HOE-33258
TTDR00459	Inhibitor	LIVIDOMYCIN A
TTDR00459	Inhibitor	NSC-745794
TTDR00459	Inhibitor	NSC-745795
TTDR00459	Inhibitor	NSC-745796
TTDR00459	Inhibitor	NSC-745797
TTDR00459	Inhibitor	NSC-745798
TTDR00459	Inhibitor	NSC-745799
TTDR00459	Inhibitor	NSC-745883
TTDR00459	Inhibitor	NSC-745884
TTDR00459	Inhibitor	NSC-745885
TTDR00459	Inhibitor	NSC-745886
TTDR00459	Inhibitor	NSC-745887
TTDR00459	Inhibitor	NSC-745888
TTDR00459	Antisense	Cantide + 5-FU
TTDR00459	Antisense	Cantide + Cisplatin
TTDR00459	Antisense	Cantide + adriamycin
TTDR00460	UniProt ID	O60890
TTDR00460	Name	Oligophrenin 1
TTDR00460	Type of target	Research target
TTDR00460	Disease	Colorectal cancer
TTDR00460	Function	Stimulates gtp hydrolysis of members of the rho family. Could activates gtpase t
TTDR00460	Sequence	MGHPPLEFSDCYLDSPDFRERLKCYEQELERTNKFIKDVIKDGNALISAMRNYSSAVQKFSQTLQSFQFDFIGDTLTDDE
TTDR00461	UniProt ID	O60259
TTDR00461	Name	Neuropsin
TTDR00461	Type of target	Research target
TTDR00461	Synonyms	KLK8 (neuropsin/ovasin)
TTDR00461	Synonyms	Kallikrein 8
TTDR00461	Synonyms	NP
TTDR00461	Synonyms	Neuropsin (M(r) 25032)
TTDR00461	Synonyms	Ovasin
TTDR00461	Synonyms	Serine protease TADG-14
TTDR00461	Synonyms	Tumor-associated differentially expressed gene-14 protein
TTDR00461	Synonyms	UNQ283/PRO322
TTDR00461	Disease	Epilepsy
TTDR00461	Disease	Ovarian cancer
TTDR00461	Function	Suggested to be involved in kindling epileptogenesis and hippocampal plasticity.
TTDR00461	Sequence	MGRPRPRAAKTWMFLLLLGGAWAGHSRAQEDKVLGGHECQPHSQPWQAALFQGQQLLCGGVLVGGNWVLTAAHCKKPKYT
TTDR00461	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00461	EC Number	EC 3.4.21.-
TTDR00462	UniProt ID	P48023
TTDR00462	Name	Tumor necrosis factor ligand superfamily member 6
TTDR00462	Type of target	Research target
TTDR00462	Synonyms	APTL
TTDR00462	Synonyms	Apoptosis antigen ligand
TTDR00462	Synonyms	CD178 antigen
TTDR00462	Synonyms	FAS antigen ligand
TTDR00462	Synonyms	Fas ligand
TTDR00462	Disease	Hypoxia-induced EC injury
TTDR00462	Function	Cytokine that binds to tnfrsf6/fas, a receptor that transduces the apoptotic sig
TTDR00462	Sequence	MQQPFNYPYPQIYWVDSSASSPWAPPGTVLPCPTSVPRRPGQRRPPPPPPPPPLPPPPPPPPLPPLPLPPLKKRGNHSTG
TTDR00462	PDB Structure	1BZI
TTDR00462	BioChemical Class	Transmembrane protein
TTDR00462	Pathway	Allograft rejection
TTDR00462	Pathway	Apoptosis
TTDR00462	Pathway	Autoimmune thyroid disease
TTDR00462	Pathway	Cytokine-cytokine receptor interaction
TTDR00462	Pathway	Graft-versus-host disease
TTDR00462	Pathway	MAPK signaling pathway
TTDR00462	Pathway	Natural killer cell mediated cytotoxicity
TTDR00462	Pathway	Pathways in cancer
TTDR00462	Pathway	Type I diabetes mellitus
TTDR00464	UniProt ID	Q02548
TTDR00464	Name	Paired box protein Pax-5
TTDR00464	Type of target	Research target
TTDR00464	Synonyms	B-cell specific transcription factor
TTDR00464	Synonyms	BSAP
TTDR00464	Synonyms	PAX5
TTDR00464	Disease	Transitional cell carcinoma
TTDR00464	Function	May play an important role in b-cell differentiation as well as neural developme
TTDR00464	Sequence	MDLEKNYPTPRTSRTGHGGVNQLGGVFVNGRPLPDVVRQRIVELAHQGVRPCDISRQLRVSHGCVSKILGRYYETGSIKP
TTDR00464	PDB Structure	1K78; 1MDM
TTDR00465	UniProt ID	O60262
TTDR00465	Name	Guanine nucleotide-binding protein G(I)/G(S)/G(O) gamma-7 subunit
TTDR00465	Type of target	Research target
TTDR00465	Synonyms	G protein gamma 7
TTDR00465	Disease	Cancer, unspecific
TTDR00465	Function	Guanine nucleotide-bindinG proteins (G proteins) are involved as a modulator or
TTDR00465	Sequence	MSATNNIAQARKLVEQLRIEAGIERIKVSKAASDLMSYCEQHARNDPLLVGVPASENPFKDKKPCIIL
TTDR00465	BioChemical Class	Cell membrane protein
TTDR00465	Pathway	Chemokine signaling pathway
TTDR00466	UniProt ID	Q07343
TTDR00466	Name	CAMP-specific 3',5'-cyclic phosphodiesterase 4B
TTDR00466	Type of target	Research target
TTDR00466	Synonyms	DPDE4
TTDR00466	Synonyms	PDE32
TTDR00466	Synonyms	Type 4 cyclic adenosine monophosphate phosphodiesterase (type 4 PDE)
TTDR00466	Synonyms	Type 4B cAMP phosphodiesterase
TTDR00466	Disease	Asthma
TTDR00466	Disease	Chronic lymphocytic leukemia
TTDR00466	Function	May be involved in mediating central nervous system effects of therapeutic agent
TTDR00466	Sequence	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLT
TTDR00466	PDB Structure	1F0J; 1JP1; 1JP2; 1RO6; 1RO9; 1ROR; 1TB5; 1XLX; 1XLZ; 1XM4; 1XM6; 1XMU; 1XMY; 1X
TTDR00466	BioChemical Class	Hydrolases acting on ester bonds
TTDR00466	Pathway	Purine metabolism
TTDR00466	EC Number	EC 3.1.4.17
TTDR00466	Target Validation	TTDR00466
TTDR00466	Inhibitor	(-)-ROLIPRAM
TTDR00466	Inhibitor	(R)-Mesopram
TTDR00466	Inhibitor	(R)-Rolipram
TTDR00466	Inhibitor	(S)-Rolipram
TTDR00466	Inhibitor	3-(2-Bromophenyl)-2-thioxo-(1H )-quinazolin-4-one
TTDR00466	Inhibitor	3-Isobutyl-1-methyl-3,7-dihydro-purine-2,6-dione
TTDR00466	Inhibitor	8-(3-Nitro-phenyl)-6-phenyl-[1,7]naphthyridine
TTDR00466	Inhibitor	8-Bromo-Adenosine-5'-Monophosphate
TTDR00466	Inhibitor	Benzyl-(2-imidazol-1-yl-quinazolin-4-yl)-amine
TTDR00466	Inhibitor	Benzyl-(2-phenyl-quinazolin-4-yl)-amine
TTDR00466	Inhibitor	Benzyl-(2-pyridin-3-yl-quinazolin-4-yl)-amine
TTDR00466	Inhibitor	Benzyl-(2-pyridin-4-yl-quinazolin-4-yl)-amine
TTDR00466	Inhibitor	Benzyl-(2-thiophen-2-yl-quinazolin-4-yl)-amine
TTDR00466	Inhibitor	CC-1088
TTDR00466	Inhibitor	CDP840
TTDR00466	Inhibitor	CI-1018
TTDR00466	Inhibitor	CI-1044
TTDR00466	Inhibitor	DENBUFYLLINE
TTDR00466	Inhibitor	Filaminast
TTDR00466	Inhibitor	KURAIDIN
TTDR00466	Inhibitor	KURARINOL
TTDR00466	Inhibitor	L-454560
TTDR00466	Inhibitor	L-869298
TTDR00466	Inhibitor	NITRAQUAZONE
TTDR00466	Inhibitor	Piclamilast
TTDR00466	Inhibitor	RO-201724
TTDR00466	Inhibitor	ROLIPRAM
TTDR00466	Inhibitor	RS-14491
TTDR00466	Inhibitor	S,S-(2-Hydroxyethyl)Thiocysteine
TTDR00466	Inhibitor	SCH-351591
TTDR00466	Inhibitor	SCH-365351
TTDR00466	Inhibitor	SOPHOFLAVESCENOL
TTDR00466	Inhibitor	UCB-101333-3
TTDR00466	Inhibitor	[R]-Mesopram
TTDR00468	UniProt ID	P41159
TTDR00468	Name	Leptin
TTDR00468	Type of target	Research target
TTDR00468	Synonyms	Obese protein
TTDR00468	Synonyms	Obesity factor
TTDR00468	Disease	Epilepsy
TTDR00468	Disease	Multiple sclerosis
TTDR00468	Function	May function as part of a signaling pathway that acts to regulate the size of th
TTDR00468	Sequence	MHWGTLCGFLWLWPYLFYVQAVPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQKVTGLDFIPGLHPILTLSKMDQTLA
TTDR00468	PDB Structure	1AX8
TTDR00468	Pathway	Adipocytokine signaling pathway
TTDR00468	Pathway	Cytokine-cytokine receptor interaction
TTDR00468	Pathway	Jak-STAT signaling pathway
TTDR00468	Pathway	Neuroactive ligand-receptor interaction
TTDR00469	UniProt ID	P35568
TTDR00469	Name	Insulin receptor substrate-1
TTDR00469	Type of target	Research target
TTDR00469	Synonyms	IRS-1
TTDR00469	Disease	Insulin resistance
TTDR00469	Disease	Solid tumor
TTDR00469	Function	May mediate the control of various cellular processes by insulin. When phosphory
TTDR00469	Sequence	MASPPESDGFSDVRKVGYLRKPKSMHKRFFVLRAASEAGGPARLEYYENEKKWRHKSSAPKRSIPLESCFNINKRADSKN
TTDR00469	PDB Structure	1IRS; 1K3A; 1QQG; 2Z8C
TTDR00469	Pathway	Adipocytokine signaling pathway
TTDR00469	Pathway	Insulin signaling pathway
TTDR00469	Pathway	Type II diabetes mellitus
TTDR00470	UniProt ID	P46108
TTDR00470	Name	Proto-oncogene C-crk
TTDR00470	Type of target	Clinical trial target
TTDR00470	Synonyms	Adapter molecule crk
TTDR00470	Synonyms	P38
TTDR00470	Disease	Insulin resistance
TTDR00470	Function	The crk-i and crk-ii forms differ in their biological activities. Crk-ii has les
TTDR00470	Sequence	MAGNFDSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGDYVLSVSENSRVSHYIINSSGPRPPVPPSPAQPPP
TTDR00470	PDB Structure	1JU5; 2DVJ; 2EYV; 2EYW; 2EYX; 2EYY; 2EYZ
TTDR00470	BioChemical Class	Cell membrane protein
TTDR00470	Pathway	Chemokine signaling pathway
TTDR00470	Pathway	Chronic myeloid leukemia
TTDR00470	Pathway	ErbB signaling pathway
TTDR00470	Pathway	Focal adhesion
TTDR00470	Pathway	Insulin signaling pathway
TTDR00470	Pathway	MAPK signaling pathway
TTDR00470	Pathway	Pathways in cancer
TTDR00470	Pathway	Regulation of actin cytoskeleton
TTDR00470	Pathway	Renal cell carcinoma
TTDR00471	UniProt ID	P02765
TTDR00471	Name	Fetuin
TTDR00471	Type of target	Research target
TTDR00471	Synonyms	Alpha-2-HS-glycoprotein
TTDR00471	Synonyms	Alpha-2-Z-globulin
TTDR00471	Synonyms	Alpha2-HS glycoprotein
TTDR00471	Synonyms	Ba-alpha-2-glycoprotein
TTDR00471	Synonyms	Fetuin-A
TTDR00471	Synonyms	PRO2743
TTDR00471	Disease	Noninsulin-dependent diabetes mellitus
TTDR00471	Disease	Obesity
TTDR00471	Function	Promotes endocytosis, possesses opsonic properties and influences the mineral ph
TTDR00471	Sequence	MKSLVLLLCLAQLWGCHSAPHGPGLIYRQPNCDDPETEEAALVAIDYINQNLPWGYKHTLNQIDEVKVWPQQPSGELFEI
TTDR00473	UniProt ID	P06756
TTDR00473	Name	Integrin alpha-V
TTDR00473	Type of target	Research target
TTDR00473	Synonyms	CD51 antigen
TTDR00473	Synonyms	Vitronectin receptor alpha subunit
TTDR00473	Disease	Brain tumors
TTDR00473	Function	The alpha-v integrins are receptors for vitronectin, cytotactin, fibronectin, fi
TTDR00473	Sequence	MAFPPRRRLRLGPRGLPLLLSGLLLPLCRAFNLDVDSPAEYSGPEGSYFGFAVDFFVPSASSRMFLLVGAPKANTTQPGI
TTDR00473	PDB Structure	1JV2; 1L5G; 1M1X; 1U8C; 3IJE; 4G1E; 4G1M
TTDR00473	BioChemical Class	Transmembrane protein
TTDR00473	Pathway	Cell adhesion molecules (CAMs)
TTDR00473	Pathway	ECM-receptor interaction
TTDR00473	Pathway	Focal adhesion
TTDR00473	Pathway	Pathways in cancer
TTDR00473	Pathway	Regulation of actin cytoskeleton
TTDR00473	Pathway	Small cell lung cancer
TTDR00473	Related US Patent	6,426,353
TTDR00473	Target Validation	TTDR00473
TTDR00473	Inhibitor	Ac-Asp-Arg-Leu-Asp-Ser-OH
TTDR00473	Inhibitor	AcDRGDS
TTDR00473	Inhibitor	CYCLORGDFV
TTDR00473	Inhibitor	E[c(RGDyK)]2
TTDR00473	Inhibitor	E[c(RGDyK)]2-PTX conjugate
TTDR00473	Inhibitor	G(D-Pen)-G-H-R-G-D-L-R-C-A
TTDR00473	Inhibitor	Gly-Arg-Gly-Asp-Ser
TTDR00473	Inhibitor	Gly-Arg-Gly-Asp-Ser-Pro-Lys
TTDR00473	Inhibitor	ISONIPECOTAMIDE
TTDR00473	Inhibitor	N-(3,5-dichlorophenyl)imidodicarbonimidic diamide
TTDR00473	Inhibitor	NAVPNLRGDLQVLAQKVART
TTDR00473	Inhibitor	RGDechi
TTDR00473	Inhibitor	SB-223245
TTDR00473	Inhibitor	SB-265123
TTDR00473	Inhibitor	ST-1646
TTDR00473	Inhibitor	TR-14035
TTDR00473	Inhibitor	c(-GRGDfL-)
TTDR00473	Inhibitor	c(Arg-Gly-Asp-D-Phe-Val)
TTDR00473	Inhibitor	c(RGDfF)
TTDR00473	Inhibitor	c(RGDfMeF)
TTDR00473	Inhibitor	c(RGDfV)
TTDR00473	Inhibitor	c-[-Arg-Gly-Asp-Acpca30-]
TTDR00473	Inhibitor	c-[-Arg-Gly-Asp-Acpca31-]
TTDR00473	Inhibitor	c-[-Arg-Gly-Asp-Acpca32-]
TTDR00473	Inhibitor	c-[-Arg-Gly-Asp-Acpca33-]
TTDR00473	Inhibitor	c[-Arg-Gly-Asp-Acpca19-]
TTDR00473	Inhibitor	c[-Arg-Gly-Asp-Acpca20-]
TTDR00473	Inhibitor	c[-Arg-Gly-Asp-Acpca21-]
TTDR00473	Inhibitor	c[-Arg-Gly-Asp-Acpca22-]
TTDR00473	Inhibitor	c[-Arg-Gly-Asp-Acpca34-]
TTDR00473	Inhibitor	c[-Arg-Gly-Asp-Acpca35-]
TTDR00473	Inhibitor	c[-Arg-Gly-Asp-Acpca36-]
TTDR00473	Inhibitor	c[RGD-(R)-alpha-TfmfV]
TTDR00473	Inhibitor	c[RGD-(S)-alpha-TfmfV]
TTDR00473	Inhibitor	c[RGDf-(3R)-Carboxymorpholine]
TTDR00473	Inhibitor	c[RGDf-(3S)-Carboxymorpholine]
TTDR00473	Inhibitor	c[RGDf-(R)-N-Me-alpha-TfmF]
TTDR00473	Inhibitor	c[RGDf-(R)-alpha-TfmF]
TTDR00473	Inhibitor	c[RGDf-(R)-alpha-TfmV]
TTDR00473	Inhibitor	c[RGDf-(S)-N-Me-alpha-TfmF]
TTDR00473	Inhibitor	c[RGDf-(S)-alpha-TfmF]
TTDR00473	Inhibitor	c[RGDf-(S)-alpha-TfmV]
TTDR00473	Inhibitor	c[RGDf-(S,R)-alpha-Dfm-F]
TTDR00473	Inhibitor	cyclo(RGDfV) (control)
TTDR00473	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp21-]
TTDR00473	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp22-]
TTDR00473	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp23-]
TTDR00473	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp24-]
TTDR00473	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp25-]
TTDR00473	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp26-]
TTDR00473	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp27-]
TTDR00473	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp28-]
TTDR00473	Inhibitor	cyclo[RGDfK(cypate)]
TTDR00473	Inhibitor	cypate-[(RGD)2-NH2]1
TTDR00473	Inhibitor	cypate-[(RGD)2-NH2]2
TTDR00473	Inhibitor	cypate-[(RGD)3-NH2]1
TTDR00473	Inhibitor	cypate-[(RGD)3-NH2]2
TTDR00473	Inhibitor	cypate-[(RGD)4-NH2]1
TTDR00473	Inhibitor	cypate-[(RGD)4-NH2]2
TTDR00474	UniProt ID	P35575
TTDR00474	Name	Glucose-6-phosphatase
TTDR00474	Type of target	Research target
TTDR00474	Synonyms	G-6-Pase
TTDR00474	Synonyms	G6Pase
TTDR00474	Disease	Hyperglycemia
TTDR00474	Function	May be a single membrane channel protein acting both as a hydrolase and a transl
TTDR00474	Sequence	MEEGMNVLHDFGIQSTHYLQVNYQDSQDWFILVSVIADLRNAFYVLFPIWFHLQEAVGIKLLWVAVIGDWLNLVFKWILF
TTDR00474	BioChemical Class	Hydrolases acting on ester bonds
TTDR00474	Pathway	Adipocytokine signaling pathway
TTDR00474	Pathway	Galactose metabolism
TTDR00474	Pathway	Glycolysis / Gluconeogenesis
TTDR00474	Pathway	Insulin signaling pathway
TTDR00474	Pathway	Metabolic pathways
TTDR00474	Pathway	Starch and sucrose metabolism
TTDR00474	EC Number	EC 3.1.3.9
TTDR00475	UniProt ID	P49918
TTDR00475	Name	Cyclin-dependent kinase inhibitor 1C
TTDR00475	Type of target	Research target
TTDR00475	Synonyms	Cyclin-dependent kinase inhibitor p57
TTDR00475	Synonyms	P57(KIP2)
TTDR00475	Synonyms	P57KIP2
TTDR00475	Disease	Beta-cell failure observed in diabetes
TTDR00475	Function	Potent tight-binding inhibitor of several g1 cyclin/cdk complexes (cyclin e-cdk2
TTDR00475	Sequence	MSDASLRSTSTMERLVARGTFPVLVRTSACRSLFGPVDHEELSRELQARLAELNAEDQNRWDYDFQQDMPLRGPGRLQWT
TTDR00475	Pathway	Cell cycle
TTDR00476	UniProt ID	P15090
TTDR00476	Name	Fatty acid-binding protein, adipocyte
TTDR00476	Type of target	Research target
TTDR00476	Synonyms	A-FABP
TTDR00476	Synonyms	AFABP
TTDR00476	Synonyms	ALBP
TTDR00476	Synonyms	AP2
TTDR00476	Synonyms	Adipocyte fatty binding protein
TTDR00476	Synonyms	Adipocyte fatty-acid-binding protein
TTDR00476	Synonyms	Adipocyte lipid-binding protein
TTDR00476	Disease	Atherosclerosis
TTDR00476	Function	Lipid transport protein in adipocytes. Binds both long chain fatty acid and reti
TTDR00476	Sequence	MCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRK
TTDR00476	PDB Structure	1TOU; 1TOW; 2HNX; 2NNQ; 3FR2; 3FR4; 3FR5; 3P6C; 3P6D; 3P6E; 3P6F; 3P6G; 3P6H; 3Q
TTDR00476	Pathway	PPAR signaling pathway
TTDR00476	Related US Patent	6,548,529
TTDR00476	Related US Patent	6,649,622
TTDR00476	Related US Patent	6,670,380
TTDR00476	Target Validation	TTDR00476
TTDR00476	Inhibitor	1-benzyl-2,3-dimethyl-1H-indole-7-carboxylic acid
TTDR00476	Inhibitor	2-(2,3-bis(2-chlorobenzyloxy)phenyl)acetic acid
TTDR00476	Inhibitor	2-(3-Methyl-indole-1-sulfonyl)-benzoic acid
TTDR00476	Inhibitor	2-(4-Fluoro-indole-1-sulfonyl)-benzoic acid
TTDR00476	Inhibitor	2-(4-Methyl-indole-1-sulfonyl)-benzoic acid
TTDR00476	Inhibitor	2-(5-Bromo-indole-1-sulfonyl)-benzoic acid
TTDR00476	Inhibitor	2-(6-Methoxy-indole-1-sulfonyl)-benzoic acid
TTDR00476	Inhibitor	2-(Carbazole-9-sulfonyl)-benzoic acid
TTDR00476	Inhibitor	3-Carbazol-9-yl-propionic acid
TTDR00476	Inhibitor	4-Carbazol-9-yl-butyric acid
TTDR00476	Inhibitor	5-Carbazol-9-yl-pentanoic acid
TTDR00476	Inhibitor	BMS-480404
TTDR00476	Inhibitor	Hexadecanoic acid
TTDR00476	Inhibitor	LINOLEIC ACID
TTDR00476	Inhibitor	OLEIC ACID
TTDR00477	UniProt ID	P22413
TTDR00477	Name	Ectonucleotide pyrophosphatase/phosphodiesterase 1
TTDR00477	Type of target	Research target
TTDR00477	Synonyms	E-NPP 1
TTDR00477	Synonyms	PC-1
TTDR00477	Synonyms	Phosphodiesterase I/nucleotide pyrophosphatase 1
TTDR00477	Synonyms	Plasma-cell membrane glycoprotein PC-1
TTDR00477	Disease	Diabetes mellitus
TTDR00477	Disease	Disorders of bone mineralization
TTDR00477	Function	Has a broad specificity and cleaves a variety of substrates, including phosphodi
TTDR00477	Sequence	MERDGCAGGGSRGGEGGRAPREGPAGNGRDRGRSHAAEAPGDPQAAASLLAPMDVGEEPLEKAARARTAKDPNTYKVLSL
TTDR00477	PDB Structure	2YS0
TTDR00477	BioChemical Class	Transmembrane protein
TTDR00477	Pathway	Metabolic pathways
TTDR00477	Pathway	Nicotinate and nicotinamide metabolism
TTDR00477	Pathway	Pantothenate and CoA biosynthesis
TTDR00477	Pathway	Purine metabolism
TTDR00477	Pathway	Riboflavin metabolism
TTDR00477	Pathway	Starch and sucrose metabolism
TTDR00478	UniProt ID	P20783
TTDR00478	Name	Neurotrophin-3
TTDR00478	Type of target	Research target
TTDR00478	Synonyms	HDNF
TTDR00478	Synonyms	NGF-2
TTDR00478	Synonyms	NT-3
TTDR00478	Synonyms	Nerve growth factor 2
TTDR00478	Synonyms	Neurotrophic factor
TTDR00478	Disease	Analgesics
TTDR00478	Disease	Diabetic neuropathy
TTDR00478	Disease	Pain
TTDR00478	Function	Seems to promotes the survival of visceral and proprioceptive sensory neurons.
TTDR00478	Sequence	MSILFYVIFLAYLRGIQGNNMDQRSLPEDSLNSLIIKLIQADILKNKLSKQMVDVKENYQSTLPKAEAPREPERGGPAKS
TTDR00478	PDB Structure	1B8K; 1BND; 1NT3; 3BUK
TTDR00478	BioChemical Class	Growth factor
TTDR00478	Pathway	MAPK signaling pathway
TTDR00479	Name	I1-imidazoline receptor
TTDR00479	Type of target	Research target
TTDR00479	Synonyms	I1-IR
TTDR00479	Disease	Cardiovascular disease, unspecified
TTDR00479	Disease	Metabolic syndromes
TTDR00480	UniProt ID	Q9UL17
TTDR00480	Name	T-box transcription factor TBX21
TTDR00480	Type of target	Research target
TTDR00480	Synonyms	T-bet
TTDR00480	Synonyms	T-box protein 21
TTDR00480	Synonyms	T-cell-specific T-box transcription factor T-bet
TTDR00480	Synonyms	Transcription factor TBLYM
TTDR00480	Disease	Autoimmune diseases
TTDR00480	Disease	Chronic inflammatory diseases
TTDR00480	Function	Transcription factor that controls the expression of the th1 cytokine, interfero
TTDR00480	Sequence	MGIVEPGCGDMLTGTEPMPGSDEGRAPGADPQHRYFYPEPGAQDADERRGGGSLGSPYPGGALVPAPPSRFLGAYAYPPR
TTDR00481	Name	Sigma receptor
TTDR00481	Type of target	Research target
TTDR00481	Disease	Disorders resulting from noradrenergic imbalance in hippocampus
TTDR00482	UniProt ID	P55899
TTDR00482	Name	IgG receptor FcRN large subunit P51
TTDR00482	Type of target	Research target
TTDR00482	Synonyms	FcRn
TTDR00482	Synonyms	IgG Fc fragment receptor transporter, alpha chain
TTDR00482	Synonyms	MHC class I family-like Fc receptor
TTDR00482	Synonyms	Neonatal Fc receptor
TTDR00482	Synonyms	Neonatal FcR
TTDR00482	Disease	Autoimmune diseases
TTDR00482	Function	Binds to the fc region of monomeric immunoglobulins gamma. Mediates the uptake o
TTDR00482	Sequence	MGVPRPQPWALGLLLFLLPGSLGAESHLSLLYHLTAVSSPAPGTPAFWVSGWLGPQQYLSYNSLRGEAEPCGAWVWENQV
TTDR00482	PDB Structure	1EXU; 3M17; 3M1B
TTDR00482	BioChemical Class	Transmembrane protein
TTDR00482	Target Validation	TTDR00482
TTDR00482	Inhibitor	SYN-1327
TTDR00483	Name	L523S
TTDR00483	Type of target	Research target
TTDR00483	Disease	Lung cancer
TTDR00484	UniProt ID	P10451
TTDR00484	Name	Osteopontin
TTDR00484	Type of target	Research target
TTDR00484	Synonyms	Bone sialoprotein 1
TTDR00484	Synonyms	Nephropontin
TTDR00484	Synonyms	SPP-1
TTDR00484	Synonyms	Secreted phosphoprotein 1
TTDR00484	Synonyms	Urinary stone protein
TTDR00484	Synonyms	Uropontin
TTDR00484	Disease	Hepatocellular carcinoma (metastatic)
TTDR00484	Disease	Multiple sclerosis
TTDR00484	Function	Binds tightly to hydroxyapatite. Appears to form an integral part of the mineral
TTDR00484	Sequence	MRIAVICFCLLGITCAIPVKQADSGSSEEKQLYNKYPDAVATWLNPDPSQKQNLLAPQNAVSSEETNDFKQETLPSKSNE
TTDR00484	PDB Structure	3CXD; 3DSF
TTDR00484	Pathway	ECM-receptor interaction
TTDR00484	Pathway	Focal adhesion
TTDR00484	Pathway	Toll-like receptor signaling pathway
TTDR00485	UniProt ID	Q13418
TTDR00485	Name	Integrin-linked protein kinase 1
TTDR00485	Type of target	Research target
TTDR00485	Synonyms	59 kDa serine/threonine protein kinase
TTDR00485	Synonyms	59 kDa serine/threonine-protein kinase
TTDR00485	Synonyms	Beta-integrin-linked kinase
TTDR00485	Synonyms	ILK
TTDR00485	Synonyms	ILK-1
TTDR00485	Synonyms	Integrin-linked kinase
TTDR00485	Synonyms	Integrin-linked protein kinase
TTDR00485	Synonyms	P59ILK
TTDR00485	Disease	Inflammation
TTDR00485	Disease	Solid tumor
TTDR00485	Function	Receptor-proximal protein kinase regulating integrin- mediated signal transducti
TTDR00485	Sequence	MDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHR
TTDR00485	PDB Structure	2KBX; 3F6Q; 3IXE; 3KMU; 3KMW; 3REP
TTDR00485	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00485	Pathway	Endometrial cancer
TTDR00485	Pathway	Focal adhesion
TTDR00485	Pathway	PPAR signaling pathway
TTDR00485	EC Number	EC 2.7.1.-
TTDR00485	EC Number	EC 2.7.1.37
TTDR00486	UniProt ID	O00633
TTDR00486	Name	Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase PTEN
TTDR00486	Type of target	Research target
TTDR00486	Synonyms	Mutated in multiple advanced cancers 1
TTDR00486	Synonyms	PTEN
TTDR00486	Synonyms	Tumor suppressor phosphatase PTEN
TTDR00486	Disease	Neurodegenerative diseases
TTDR00486	Disease	Noninsulin-dependent diabetes mellitus
TTDR00486	Disease	Stroke
TTDR00486	Function	Potential tumor suppressor. Acts as a phosphoinositide 3-phosphatase by regulati
TTDR00486	Sequence	MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNIDDVVRFLDSKHKNHYKIYNLCAERHYDTAK
TTDR00486	PDB Structure	1D5R
TTDR00486	EC Number	EC 3.1.3.67
TTDR00487	UniProt ID	P17811
TTDR00487	Name	Plasminogen activator
TTDR00487	Type of target	Research target
TTDR00487	Synonyms	Coagulase/fibrinolysin
TTDR00487	Disease	Kawasaki disease related coronary artery lesions
TTDR00487	Function	Seems to play an essential role in plague transmission by mediating flea blockag
TTDR00487	Sequence	MKKSSIVATIITILSGSANAASSQLIPNISPDSFTVAASTGMLSGKSHEMLYDAETGRKISQLDWKIKNVAILKGDISWD
TTDR00487	PDB Structure	2X4M; 2X55; 2X56; 4DCB
TTDR00487	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00487	EC Number	EC 3.4.23.48
TTDR00488	UniProt ID	P43694
TTDR00488	Name	Transcription factor GATA-4
TTDR00488	Type of target	Research target
TTDR00488	Synonyms	GATA binding factor-4
TTDR00488	Synonyms	GATA-4
TTDR00488	Disease	Pulmonary hypertension
TTDR00488	Function	Transcriptional activator. Binds to the consensus sequence 5'-agatag-3'. May reg
TTDR00488	Sequence	MYQSLAMAANHGPPPGAYEAGGPGAFMHGAGAASSPVYVPTPRVPSSVLGLSYLQGGGAGSASGGASGGSSGGAASGAGP
TTDR00488	BioChemical Class	Zinc-finger
TTDR00489	UniProt ID	Q9Y6Q9
TTDR00489	Name	Nuclear receptor coactivator 3
TTDR00489	Type of target	Research target
TTDR00489	Synonyms	ACTR
TTDR00489	Synonyms	AIB-1
TTDR00489	Synonyms	AIB1 (SRC-3)
TTDR00489	Synonyms	Amplified in breast cancer-1 protein
TTDR00489	Synonyms	CBP-interacting protein
TTDR00489	Synonyms	NCoA-3
TTDR00489	Synonyms	PCIP
TTDR00489	Synonyms	RAC-3
TTDR00489	Synonyms	Receptor-associated coactivator 3
TTDR00489	Synonyms	SRC-3
TTDR00489	Synonyms	Steroid receptor coactivator protein 3
TTDR00489	Synonyms	TRAM-1
TTDR00489	Synonyms	Thyroid hormone receptor activator molecule 1
TTDR00489	Disease	Breast cancer
TTDR00489	Function	Nuclear receptor coactivator that directly binds nuclear receptors and stimulate
TTDR00489	Sequence	MSGLGENLDPLASDSRKRKLPCDTPGQGLTCSGEKRRREQESKYIEELAELISANLSDIDNFNVKPDKCAILKETVRQIR
TTDR00489	PDB Structure	1KBH; 3L3X; 3L3Z
TTDR00489	BioChemical Class	Acyltransferases
TTDR00489	EC Number	EC 2.3.1.48
TTDR00489	Target Validation	TTDR00489
TTDR00489	Inhibitor	GNF-PF-78
TTDR00489	Inhibitor	GNF-PF-826
TTDR00490	UniProt ID	Q14913
TTDR00490	Name	Sodium/calcium exchanger
TTDR00490	Type of target	Research target
TTDR00490	Synonyms	Mitochondrial sodium-calcium exchanger
TTDR00490	Synonyms	Na(+)/Ca(2+) exchanger
TTDR00490	Synonyms	NaCaX
TTDR00490	Disease	Noninsulin-dependent diabetes mellitus
TTDR00490	Disease	Ventricular arrhythmias
TTDR00490	Sequence	KIITIRIFDREEYEKECSLSLVLEEPKWIRRGMKGGFTIT
TTDR00490	QSAR Model	TTDR00490
TTDR00491	UniProt ID	Q14566
TTDR00491	Name	DNA replication licensing factor MCM6
TTDR00491	Type of target	Research target
TTDR00491	Synonyms	Minichromosome maintenance protein 6
TTDR00491	Disease	Proliferative vascular diseases
TTDR00491	Function	May be involved in the control of a single round of dna replication during s pha
TTDR00491	Sequence	MDLAAAAEPGAGSQHLEVRDEVAEKCQKLFLDFLEEFQSSDGEIKYLQLAEELIRPERNTLVVSFVDLEQFNQQLSTTIQ
TTDR00491	PDB Structure	2KLQ; 2LE8
TTDR00491	Pathway	Cell cycle
TTDR00491	Pathway	DNA replication
TTDR00492	UniProt ID	P33993
TTDR00492	Name	DNA replication licensing factor MCM7
TTDR00492	Type of target	Research target
TTDR00492	Synonyms	CDC47 homolog
TTDR00492	Synonyms	Minichromosome maintenance protein 7
TTDR00492	Synonyms	P1.1-MCM3
TTDR00492	Disease	Proliferative vascular diseases
TTDR00492	Function	Acts as a factor that allows the dna to undergo a single round of replication pe
TTDR00492	Sequence	MALKDYALEKEKVKKFLQEFYQDDELGKKQFKYGNQLVRLAHREQVALYVDLDDVAEDDPELVDSICENARRYAKLFADA
TTDR00492	Pathway	Cell cycle
TTDR00492	Pathway	DNA replication
TTDR00493	UniProt ID	O15524
TTDR00493	Name	Suppressor of cytokine signaling 1
TTDR00493	Type of target	Research target
TTDR00493	Synonyms	JAB
TTDR00493	Synonyms	JAK-binding protein
TTDR00493	Synonyms	SOCS-1
TTDR00493	Synonyms	SSI-1
TTDR00493	Synonyms	STAT induced STAT inhibitor 1
TTDR00493	Synonyms	TIP-3
TTDR00493	Synonyms	Tec-interacting protein 3
TTDR00493	Disease	Enterovirus-induced cardiac injury
TTDR00493	Function	Socs family proteins form part of a classical negative feedback system that regu
TTDR00493	Sequence	MVAHNQVAADNAVSTAAEPRRRPEPSSSSSSSPAAPARPRPCPAVPAPAPGDTHFRTFRSHADYRRITRASALLDACGFY
TTDR00493	Pathway	Insulin signaling pathway
TTDR00493	Pathway	Jak-STAT signaling pathway
TTDR00493	Pathway	Type II diabetes mellitus
TTDR00493	Pathway	Ubiquitin mediated proteolysis
TTDR00494	UniProt ID	O94992
TTDR00494	Name	Hexamethylene bisacetamide-inducible protein 1
TTDR00494	Type of target	Research target
TTDR00494	Synonyms	CLP1
TTDR00494	Synonyms	HEXIM1
TTDR00494	Synonyms	HIS1 protein
TTDR00494	Synonyms	Likely ortholog of mouse cardiac lineage protein 1
TTDR00494	Synonyms	MAQ1
TTDR00494	Synonyms	Menage a quatre 1
TTDR00494	Disease	Atherogenesis
TTDR00494	Disease	Restenosis
TTDR00494	Sequence	MAEPFLSEYQHQPQTSNCTGAAAVQEELNPERPPGAEERVPEEDSRWQSRAFPQLGGRPGPEGEGSLESQPPPLQTQACP
TTDR00494	PDB Structure	2GD7; 3S9G
TTDR00495	UniProt ID	O95151
TTDR00495	Name	Calcium-dependent chloride channel-1
TTDR00495	Type of target	Research target
TTDR00495	Synonyms	Bclca1
TTDR00495	Synonyms	Ca2+-activated Cl- channel
TTDR00495	Synonyms	Calcium-activated chloride channel
TTDR00495	Synonyms	HCLCA1
TTDR00495	Disease	Asthma
TTDR00495	Disease	Cystic fibrosis
TTDR00495	Disease	Mucus overproduction in chronic pulmonary disorders
TTDR00495	Sequence	MGPFKSSVFILILHLLEGALSNSLIQLNNNGYEGIVVAIDPNVPEDETLIQQIKDMVTQASLYLLEATGKRFYFKNVAIL
TTDR00495	Pathway	Olfactory transduction
TTDR00495	Blocker	MSI-1956
TTDR00496	Name	4-aminopyridine sensitive K(+) channels
TTDR00496	Type of target	Research target
TTDR00496	Disease	Neuronal damage after brain ischemia
TTDR00497	UniProt ID	P50548
TTDR00497	Name	ETS-domain transcription factor ERF
TTDR00497	Type of target	Research target
TTDR00497	Synonyms	Ets2 repressor factor
TTDR00497	Synonyms	Transcription factor Ets2
TTDR00497	Disease	Cancer, unspecific
TTDR00497	Function	Potent transcriptional repressor that binds to the h1 element of the ets2 promot
TTDR00497	Sequence	MKTPADTGFAFPDWAYKPESSPGSRQIQLWHFILELLRKEEYQGVIAWQGDYGEFVIKDPDEVARLWGVRKCKPQMNYDK
TTDR00498	UniProt ID	P02778
TTDR00498	Name	Small inducible cytokine B10
TTDR00498	Type of target	Research target
TTDR00498	Synonyms	10 kDa interferon-gamma induced protein
TTDR00498	Synonyms	CXCL10
TTDR00498	Synonyms	Gamma-IP10
TTDR00498	Synonyms	IP-10
TTDR00498	Synonyms	Interferon-gamma induced protein
TTDR00498	Disease	Inflammatory bowel disease
TTDR00498	Function	Chemotactic for monocytes and t lymphocytes. Binds to cxcr3.
TTDR00498	Sequence	MNQTAILICCLIFLTLSGIQGVPLSRTVRCTCISISNQPVNPRSLEKLEIIPASQFCPRVEIIATMKKKGEKRCLNPESK
TTDR00498	PDB Structure	1LV9; 1O7Y; 1O7Z; 1O80
TTDR00498	Pathway	Chemokine signaling pathway
TTDR00498	Pathway	Cytokine-cytokine receptor interaction
TTDR00498	Pathway	Toll-like receptor signaling pathway
TTDR00498	Inhibitor	N-Methylleucine
TTDR00499	UniProt ID	P21580
TTDR00499	Name	Zinc finger protein A20
TTDR00499	Type of target	Research target
TTDR00499	Synonyms	A20
TTDR00499	Synonyms	Putative DNA binding protein A20
TTDR00499	Synonyms	Tumor necrosis factor, alpha-induced protein 3
TTDR00499	Disease	Chronic allograft rejection
TTDR00499	Function	Interacts with naf1 and inhibits tnf-induced nf-kappa-b- dependent gene expressi
TTDR00499	Sequence	MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQ
TTDR00499	PDB Structure	2EQE; 2EQF; 2EQG; 2VFJ; 3DKB; 3OJ3; 3OJ4; 3VUW; 3VUX; 3VUY; 3ZJD; 3ZJE; 3ZJF; 3Z
TTDR00499	EC Number	EC 3.-.-.-
TTDR00500	UniProt ID	P23331
TTDR00500	UniProt ID	Q69085
TTDR00500	Name	Thymidine kinase
TTDR00500	Type of target	Research target
TTDR00500	Disease	Bladder cancer
TTDR00500	Disease	Cancer, unspecific
TTDR00500	Disease	Herpes virus infection
TTDR00500	Disease	Renal cell carcinoma
TTDR00500	Disease	Trichomoniasis
TTDR00500	Disease	Viral infection, unspecified
TTDR00500	Function	Phosphorylates both thymidine and deoxyuridine.
TTDR00500	Sequence	MAQLYFYYSAMNAGKSTALLQSSYNYQERGMRTVVYTAEIDDRFGAGKVSSRIGLSSPAKLFNQNSSLFDEIRAEHEQQA
TTDR00500	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00500	Pathway	Drug metabolism - other enzymes
TTDR00500	Pathway	Metabolic pathways
TTDR00500	Pathway	Pyrimidine metabolism
TTDR00500	EC Number	EC 2.7.1.21
TTDR00500	Target Validation	TTDR00500
TTDR00500	QSAR Model	TTDR00500
TTDR00500	Inhibitor	(South)-Methanocarba-Thymidine
TTDR00500	Inhibitor	1-[(Z)-4-(triphenylmethoxy)-2-butenyl]thymine
TTDR00500	Inhibitor	1-[2-(2-triphenylmethoxyethoxy)ethyl]thymine
TTDR00500	Inhibitor	1-[5-(triphenylmethoxy)pentyl]thymine
TTDR00500	Inhibitor	1-[6-(triphenylmethoxy)hexyl]thymine
TTDR00500	Inhibitor	1-[7-(triphenylmethoxy)heptyl]thymine
TTDR00500	Inhibitor	2-phenylamino-9-(4-hydroxy-butyl)-6-oxopurine
TTDR00500	Inhibitor	3'-(1,2,3-Triazol-1-yl)-3'-deoxy-beta-D-thymidine
TTDR00500	Inhibitor	3-(2-propyn-1-yl)thymidine
TTDR00500	Inhibitor	5-Bromothienyldeoxyuridine
TTDR00500	Inhibitor	5-Bromovinyldeoxyuridine
TTDR00500	Inhibitor	5-Iodo-2'-Deoxyuridine-5'-Monophosphate
TTDR00500	Inhibitor	5-Iododeoxyuridine
TTDR00500	Inhibitor	5-propyl-2'-deoxyuridine
TTDR00500	Inhibitor	6-(Dihydroxy-Isobutyl)-Thymine
TTDR00500	Inhibitor	6-Hydroxypropylthymine
TTDR00500	Inhibitor	9-(4-Hydroxy-3-(Hydroxymethyl)but-1-Yl)Guanine
TTDR00500	Inhibitor	9-(4-Hydroxybutyl)-N2-Phenylguanine
TTDR00500	Inhibitor	9-Hydroxypropyladenine, R-Isomer
TTDR00500	Inhibitor	9-Hydroxypropyladenine, S-Isomer
TTDR00500	Inhibitor	Adenosine-5'-Diphosphate
TTDR00500	Inhibitor	BVDU-MP
TTDR00500	Inhibitor	DEOXYCYTIDINE
TTDR00500	Inhibitor	DEOXYURIDINE
TTDR00500	Inhibitor	Deoxythymidine
TTDR00500	Inhibitor	Edoxudine
TTDR00500	Inhibitor	ITdU
TTDR00500	Inhibitor	L-5-(bromovinyl)deoxyuridine
TTDR00500	Inhibitor	L-5-iodo-2'-deoxyuridine
TTDR00500	Inhibitor	MTdU
TTDR00500	Inhibitor	N2-(3-trifluoromethylphenyl)guanine
TTDR00500	Inhibitor	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate
TTDR00500	Inhibitor	Thymidine-5'-Phosphate
TTDR00500	Inhibitor	Thymidine-5'-Triphosphate
TTDR00503	UniProt ID	P07288
TTDR00503	Name	Prostate specific antigen
TTDR00503	Type of target	Research target
TTDR00503	Synonyms	Gamma-seminoprotein
TTDR00503	Synonyms	Kallikrein 3
TTDR00503	Synonyms	P-30 antigen
TTDR00503	Synonyms	PSA
TTDR00503	Synonyms	Prostate-specific antigen
TTDR00503	Synonyms	Semenogelase
TTDR00503	Synonyms	Seminin
TTDR00503	Disease	Prostate cancer
TTDR00503	Function	Presumably hydrolyze the high molecular mass seminal vesicle protein thus leadin
TTDR00503	Sequence	MWVPVVFLTLSVTWIGAAPLILSRIVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKSVILLGRHSL
TTDR00503	PDB Structure	1PFA; 2PSA; 2ZCH; 2ZCK; 2ZCL; 3QUM
TTDR00503	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00503	Pathway	Pathways in cancer
TTDR00503	Pathway	Prostate cancer
TTDR00503	EC Number	EC 3.4.21.77
TTDR00504	UniProt ID	P09486
TTDR00504	Name	Osteonectin
TTDR00504	Type of target	Research target
TTDR00504	Synonyms	Basement membrane protein BM-40
TTDR00504	Synonyms	ON
TTDR00504	Synonyms	Secreted protein acidic and rich in cysteine
TTDR00504	Disease	Glioma cell proliferation
TTDR00504	Function	Appears to regulate cell growth through interactions with the extracellular matr
TTDR00504	Sequence	MRAWIFFLLCLAGRALAAPQQEALPDETEVVEETVAEVTEVSVGANPVQVEVGEFDDGAEETEEEVVAENPCQNHHCKHG
TTDR00504	PDB Structure	1BMO; 1NUB; 1SRA; 2V53
TTDR00505	Name	Calpain
TTDR00505	Type of target	Clinical trial target
TTDR00505	Synonyms	CANP
TTDR00505	Synonyms	Calcium-activated neutral proteinase
TTDR00505	Disease	Cerebral vasospasm
TTDR00505	Disease	Huntington's Disease
TTDR00505	Disease	Inflammatory diseases
TTDR00505	Disease	Injury to spine and spinal cord
TTDR00505	Disease	Malaria
TTDR00505	Disease	Neurodegenerative diseases
TTDR00505	Disease	Renal failure
TTDR00505	Disease	Stroke
TTDR00505	EC Number	EC 3.4.22.52
TTDR00505	EC Number	EC 3.4.22.53
TTDR00505	Related US Patent	6,511,959
TTDR00505	Related US Patent	6,562,827
TTDR00505	Target Validation	TTDR00505
TTDR00505	Inhibitor	(1-Benzyl-2-oxo-ethyl)-carbamic acid benzyl ester
TTDR00505	Inhibitor	3-(1H-Pyrrol-3-yl)-propionamide
TTDR00505	Inhibitor	AW-00430
TTDR00505	Inhibitor	Aloxistatin
TTDR00505	Inhibitor	BITHIONOL
TTDR00505	Inhibitor	Calpastatin
TTDR00505	Inhibitor	DIHYDROXANTHOHUMOL
TTDR00505	Inhibitor	GNF-PF-4453
TTDR00505	Inhibitor	MDL-2170;MDL-28170
TTDR00505	Inhibitor	MDL-28170
TTDR00505	Inhibitor	N-(1-Benzyl-2-oxo-ethyl)-benzamide
TTDR00505	Inhibitor	SJA-6017
TTDR00505	Inhibitor	SNJ-1715
TTDR00506	UniProt ID	Q9UBM1
TTDR00506	Name	Phosphatidylethanolamine N-methyltransferase
TTDR00506	Type of target	Research target
TTDR00506	Synonyms	PEAMT
TTDR00506	Synonyms	PEMT
TTDR00506	Synonyms	PEMT2
TTDR00506	Disease	Cardiovascular disease, unspecified
TTDR00506	Disease	Hyperhomocysteinemia
TTDR00506	Function	Catalyzes three sequential methylation of phosphatidylethanolamine (pe) by adome
TTDR00506	Sequence	MTRLLGYVDPLDPSFVAAVITITFNPLYWNVVARWEHKTRKLSRAFGSPYLACYSLSVTILLLNFLRSHCFTQAMLSQPR
TTDR00506	BioChemical Class	Transferases transferring one-carbon groups
TTDR00506	Pathway	Glycerophospholipid metabolism
TTDR00506	Pathway	Metabolic pathways
TTDR00506	EC Number	EC 2.1.1.17
TTDR00507	UniProt ID	P04839
TTDR00507	Name	Cytochrome B-245 heavy chain
TTDR00507	Type of target	Research target
TTDR00507	Synonyms	CGD91-PHOX
TTDR00507	Synonyms	Cytochrome B(558) beta chain
TTDR00507	Synonyms	GP91-1
TTDR00507	Synonyms	GP91-PHOX
TTDR00507	Synonyms	Gp91(phox) NAD(P)H oxidase
TTDR00507	Synonyms	Heme binding membrane glycoprotein GP91PHOX
TTDR00507	Synonyms	NAD(P)H oxidase
TTDR00507	Synonyms	NADPH oxidase 2
TTDR00507	Synonyms	NOX2
TTDR00507	Synonyms	Neutrophil cytochrome B, 91 kDa polypeptide
TTDR00507	Synonyms	P22 phagocyte B-cytochrome
TTDR00507	Synonyms	Superoxide-generating NADPH oxidase heavy chain subunit
TTDR00507	Disease	Angiogenesis
TTDR00507	Disease	Atherosclerosis
TTDR00507	Disease	Cardiovascular disease, unspecified
TTDR00507	Disease	Hypertension
TTDR00507	Disease	Neutrophil-mediated liver injury
TTDR00507	Function	Critical component of the membrane-bound oxidase of phagocytes that generates su
TTDR00507	Sequence	MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLR
TTDR00507	PDB Structure	3A1F
TTDR00507	Pathway	Leukocyte transendothelial migration
TTDR00508	UniProt ID	Q06643
TTDR00508	Name	Lymphotoxin-beta
TTDR00508	Type of target	Research target
TTDR00508	Synonyms	LT-beta
TTDR00508	Synonyms	TNF-C
TTDR00508	Synonyms	Tumor necrosis factor C
TTDR00508	Synonyms	Tumor necrosis factor ligand superfamily member 3
TTDR00508	Disease	Infections
TTDR00508	Disease	Inflammatory diseases
TTDR00508	Function	Cytokine that binds to ltbr/tnfrsf3. May play a specific role in immune response
TTDR00508	Sequence	MGALGLEGRGGRLQGRGSLLLAVAGATSLVTLLLAVPITVLAVLALVPQDQGGLVTETADPGAQAQQGLGFQKLPEEEPE
TTDR00508	BioChemical Class	Transmembrane protein
TTDR00508	Pathway	Cytokine-cytokine receptor interaction
TTDR00509	UniProt ID	P01117
TTDR00509	Name	Transforming protein p21
TTDR00509	Type of target	Research target
TTDR00509	Synonyms	K-Ras
TTDR00509	Synonyms	Ki-Ras
TTDR00509	Disease	Colorectal cancer
TTDR00509	Sequence	MTEYKLVVVGASGVGKSALTIQLIQNHFVDEYDPTIQDSYRKQVVIDGETCLLDILDTTGQEEYSAMRDQYMRTGEGFLC
TTDR00509	BioChemical Class	Cell membrane protein
TTDR00510	UniProt ID	P05981
TTDR00510	Name	Serine protease hepsin
TTDR00510	Type of target	Research target
TTDR00510	Synonyms	HEPSIN
TTDR00510	Synonyms	Transmembrane protease, serine 1
TTDR00510	Disease	Prostate cancer
TTDR00510	Function	Plays an essential role in cell growth and maintenance of cell morphology.
TTDR00510	Sequence	MAQKEGGRTVPCCSRPKVAALTAGTLLLLTAIGAASWAIVAVLLRSDQEPLYPVQVSSADARLMVFDKTEGTWRLLCSSR
TTDR00510	PDB Structure	1O5E; 1O5F; 1P57; 1Z8G; 3T2N
TTDR00510	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00510	EC Number	EC 3.4.21.-
TTDR00510	Inhibitor	Benzylsulfinic Acid
TTDR00510	Inhibitor	CRA_1144
TTDR00511	UniProt ID	P01137
TTDR00511	Name	Transforming growth factor beta 1
TTDR00511	Type of target	Research target
TTDR00511	Synonyms	TGF-beta 1
TTDR00511	Synonyms	TGF-beta1
TTDR00511	Disease	Prostate cancer
TTDR00511	Disease	Renal cell carcinoma
TTDR00511	Function	Multifunctional peptide that controls proliferation, differentiation, and other
TTDR00511	Sequence	MPPSGLRLLLLLLPLLWLLVLTPGRPAAGLSTCKTIDMELVKRKRIEAIRGQILSKLRLASPPSQGEVPPGPLPEAVLAL
TTDR00511	PDB Structure	1KLA; 1KLC; 1KLD; 3KFD
TTDR00511	BioChemical Class	Growth factor
TTDR00511	Pathway	Cell cycle
TTDR00511	Pathway	Chronic myeloid leukemia
TTDR00511	Pathway	Colorectal cancer
TTDR00511	Pathway	Cytokine-cytokine receptor interaction
TTDR00511	Pathway	MAPK signaling pathway
TTDR00511	Pathway	Pancreatic cancer
TTDR00511	Pathway	Pathways in cancer
TTDR00511	Pathway	Renal cell carcinoma
TTDR00511	Pathway	TGF-beta signaling pathway
TTDR00511	Related US Patent	6,509,318
TTDR00512	UniProt ID	P28300
TTDR00512	Name	Protein-lysine 6-oxidase
TTDR00512	Type of target	Research target
TTDR00512	Synonyms	Lysyl oxidase
TTDR00512	Disease	Fibrotic renal disease
TTDR00512	Disease	Prostate cancer
TTDR00512	Function	Responsible for the posttranslational oxidative deamination of peptidyl lysine r
TTDR00512	Sequence	MRFAWTVLLLGPLQLCALVHCAPPAAGQQQPPREPPAAPGAWRQQIQWENNGQVFSLLSLGSQYQPQRRRDPGAAVPGAA
TTDR00512	BioChemical Class	Oxidoreductases acting on the CH-NH2 group of donors
TTDR00512	EC Number	EC 1.4.3.13
TTDR00513	UniProt ID	P16615
TTDR00513	Name	Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
TTDR00513	Type of target	Research target
TTDR00513	Synonyms	Calcium pump 2
TTDR00513	Synonyms	Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal mu
TTDR00513	Synonyms	Cardiac Ca2+ ATPase (SERCA2a)
TTDR00513	Synonyms	Cardiac sarcoplasmic reticulum calcium ATPase
TTDR00513	Synonyms	Endoplasmic reticulum class 1/2 Ca(2+) ATPase
TTDR00513	Synonyms	SERCA2
TTDR00513	Synonyms	SR Ca(2+) pump
TTDR00513	Synonyms	SR Ca(2+)-ATPase
TTDR00513	Synonyms	SR Ca(2+)-ATPase 2
TTDR00513	Synonyms	SR Ca(2+)Sarcoplasmic/endoplasmic reticulum calcium ATPase 2-ATPase 2
TTDR00513	Disease	Diabetes mellitus
TTDR00513	Disease	Myocardial hypertrophy
TTDR00513	Function	This magnesium-dependent enzyme catalyzes the hydrolysis of atp coupled with the
TTDR00513	Sequence	MENAHTKTVEEVLGHFGVNESTGLSLEQVKKLKERWGSNELPAEEGKTLLELVIEQFEDLLVRILLLAACISFVLAWFEE
TTDR00513	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00513	EC Number	EC 3.6.3.8
TTDR00513	Inhibitor	Gallopamil
TTDR00514	UniProt ID	P16949
TTDR00514	Name	Stathmin
TTDR00514	Type of target	Research target
TTDR00514	Synonyms	Leukemia-associated phosphoprotein p18
TTDR00514	Synonyms	Metablastin
TTDR00514	Synonyms	Oncoprotein 18
TTDR00514	Synonyms	Op18
TTDR00514	Synonyms	Phosphoprotein p19
TTDR00514	Synonyms	Pp17
TTDR00514	Synonyms	Pp19
TTDR00514	Synonyms	Pr22 protein
TTDR00514	Synonyms	Prosolin
TTDR00514	Disease	Cancer, unspecific
TTDR00514	Disease	Lung adenocarcinomas
TTDR00514	Disease	Osteosarcoma
TTDR00514	Function	Involved in the regulation of the microtubule (mt) filament system by destabiliz
TTDR00514	Sequence	MASSDIQVKELEKRASGQAFELILSPRSKESVPEFPLSPPKKKDLSLEEIQKKLEAAEERRKSHEAEVLKQLAEKREHEK
TTDR00514	Pathway	MAPK signaling pathway
TTDR00515	UniProt ID	Q66550
TTDR00515	UniProt ID	Q69133
TTDR00515	Name	Latent membrane protein 2A
TTDR00515	Type of target	Research target
TTDR00515	Synonyms	LMP2A
TTDR00515	Disease	Epstein-Barr virus latent infections and associated proliferative disorders
TTDR00515	Sequence	MGSLEMVPMGAGPPNPGGDPDGDDGGNNSQYPSASGSSGNTPTPPNDEERESNEEPPPPYEDPYWGNGDRHSDYQPLGTQ
TTDR00516	Name	Voltage-gated potassium channel
TTDR00516	Type of target	Research target
TTDR00516	Synonyms	Voltage-gated K(+) channel
TTDR00516	Disease	Cardiac dysrhythmias
TTDR00516	Target Validation	TTDR00516
TTDR00516	Inhibitor	(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE
TTDR00516	Inhibitor	E-4031
TTDR00516	Inhibitor	HMR-1556
TTDR00516	Inhibitor	Tetrabutylammonium Ion
TTDR00516	Blocker	Fampridine
TTDR00517	UniProt ID	P18847
TTDR00517	Name	Cyclic-AMP-dependent transcription factor ATF-3
TTDR00517	Type of target	Research target
TTDR00517	Synonyms	ATF3
TTDR00517	Synonyms	Activating transcription factor 3
TTDR00517	Disease	Doxorubicin-induced apoptosis
TTDR00517	Function	This protein binds the camp response element (cre) (consensus: 5'-gtgacgt[ac][ag
TTDR00517	Sequence	MMLQHPGQVSASEVSASAIVPCLSPPGSLVFEDFANLTPFVKEELRFAIQNKHLCHRMSSALESVTVSDRPLGVSITKAE
TTDR00518	UniProt ID	P09429
TTDR00518	Name	High mobility group protein 1
TTDR00518	Type of target	Research target
TTDR00518	Synonyms	HMG-1
TTDR00518	Synonyms	High mobility group box chromosomal protein 1
TTDR00518	Disease	Arthritis
TTDR00518	Disease	Endotoxin lethality
TTDR00518	Disease	Lethal systemic inflammatory diseases
TTDR00518	Disease	Synovitis and tenosynovitis
TTDR00518	Function	Binds preferentially single-stranded dna and unwinds double stranded dna.
TTDR00518	Sequence	MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSAKEKGKFEDMAKADKARYEREMKTYIP
TTDR00518	PDB Structure	2LY4; 2YRQ
TTDR00518	Pathway	Base excision repair
TTDR00518	Related US Patent	6,448,223
TTDR00518	Related US Patent	6,468,533
TTDR00518	Inhibitor	Beta-Mercaptoethanol
TTDR00519	UniProt ID	P20809
TTDR00519	Name	Interleukin-11
TTDR00519	Type of target	Research target
TTDR00519	Synonyms	AGIF
TTDR00519	Synonyms	Adipogenesis inhibitory factor
TTDR00519	Synonyms	IL-11
TTDR00519	Synonyms	Oprelvekin
TTDR00519	Disease	Senile osteoporosis
TTDR00519	Function	Directly stimulates the proliferation of hematopoietic stem cells and megakaryoc
TTDR00519	Sequence	MNCVCRLVLVVLSLWPDTAVAPGPPPGPPRVSPDPRAELDSTVLLTRSLLADTRQLAAQLRDKFPADGDHNLDSLPTLAM
TTDR00519	BioChemical Class	Growth factor
TTDR00519	Pathway	Cytokine-cytokine receptor interaction
TTDR00519	Pathway	Hematopoietic cell lineage
TTDR00519	Pathway	Jak-STAT signaling pathway
TTDR00521	Name	Cell adhesion molecules
TTDR00521	Type of target	Research target
TTDR00521	Disease	Inflammatory diseases
TTDR00524	UniProt ID	P78423
TTDR00524	Name	Fractalkine
TTDR00524	Type of target	Research target
TTDR00524	Synonyms	CX3C membrane-anchored chemokine
TTDR00524	Synonyms	CX3CL1
TTDR00524	Synonyms	Neurotactin
TTDR00524	Synonyms	Small inducible cytokine D1
TTDR00524	Disease	Acute allograft rejection
TTDR00524	Disease	Central nervous system diseases
TTDR00524	Function	The soluble form is chemotactic for t cells and monocytes, but not for neutrophi
TTDR00524	Sequence	MAPISLSWLLRLATFCHLTVLLAGQHHGVTKCNITCSKMTSKIPVALLIHYQQNQASCGKRAIILETRQHRLFCADPKEQ
TTDR00524	PDB Structure	1B2T; 1F2L; 3ONA
TTDR00524	BioChemical Class	Transmembrane protein
TTDR00524	Pathway	Chemokine signaling pathway
TTDR00524	Pathway	Cytokine-cytokine receptor interaction
TTDR00525	UniProt ID	P16070
TTDR00525	Name	CD44 antigen
TTDR00525	Type of target	Clinical trial target
TTDR00525	Synonyms	CD44
TTDR00525	Synonyms	CDw44
TTDR00525	Synonyms	ECMR-III
TTDR00525	Synonyms	Epican
TTDR00525	Synonyms	Extracellular matrix receptor-III
TTDR00525	Synonyms	GP90 lymphocyte homing/adhesion receptor
TTDR00525	Synonyms	HUTCH-I
TTDR00525	Synonyms	Heparan sulfate proteoglycan
TTDR00525	Synonyms	Hermes antigen
TTDR00525	Synonyms	Hyaluronate receptor
TTDR00525	Synonyms	PGP-1
TTDR00525	Synonyms	Phagocytic glycoprotein I
TTDR00525	Disease	Autoimmune diseases
TTDR00525	Disease	Insulin-dependent diabetes mellitus
TTDR00525	Disease	Systemic sclerosis
TTDR00525	Disease	Tumors
TTDR00525	Function	Receptor for hyaluronic acid (ha). Mediates cell-cell and cell-matrix interactio
TTDR00525	Sequence	MDKFWWHAAWGLCLVPLSLAQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYG
TTDR00525	PDB Structure	1POZ; 1UUH; 2I83
TTDR00525	BioChemical Class	Transmembrane protein
TTDR00525	Pathway	ECM-receptor interaction
TTDR00525	Pathway	Hematopoietic cell lineage
TTDR00526	UniProt ID	P35520
TTDR00526	Name	Cystathionine beta-synthase
TTDR00526	Type of target	Research target
TTDR00526	Synonyms	Beta-thionase
TTDR00526	Synonyms	Serine sulfhydrase
TTDR00526	Disease	Homocysteine-related vascular disease
TTDR00526	Disease	Homocystinuria
TTDR00526	Disease	Myeloma disease
TTDR00526	Sequence	MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDI
TTDR00526	PDB Structure	1JBQ; 1M54
TTDR00526	BioChemical Class	Carbon-oxygen lyases
TTDR00526	Pathway	Glycine, serine and threonine metabolism
TTDR00526	Pathway	Metabolic pathways
TTDR00526	Pathway	Methionine metabolism
TTDR00526	Pathway	Selenoamino acid metabolism
TTDR00526	EC Number	EC 4.2.1.22
TTDR00526	Inhibitor	Heme
TTDR00527	UniProt ID	Q03135
TTDR00527	Name	Caveolin-1
TTDR00527	Type of target	Research target
TTDR00527	Synonyms	Cav-1
TTDR00527	Disease	Atherosclerosis
TTDR00527	Disease	Prostate cancer (androgen-independent)
TTDR00527	Disease	Psoriasis
TTDR00527	Disease	Vascular impairment associated with diabetes
TTDR00527	Function	May act as a scaffolding protein within caveolar membranes. Interacts directly w
TTDR00527	Sequence	MSGGKYVDSEGHLYTVPIREQGNIYKPNNKAMADELSEKQVYDAHTKEIDLVNRDPKHLNDDVVKIDFEDVIAEPEGTHS
TTDR00527	BioChemical Class	Transmembrane protein
TTDR00527	Pathway	Focal adhesion
TTDR00529	UniProt ID	P55263
TTDR00529	Name	Adenosine kinase
TTDR00529	Type of target	Research target
TTDR00529	Synonyms	AK
TTDR00529	Synonyms	Adenosine 5'-phosphotransferase
TTDR00529	Disease	Analgesics
TTDR00529	Disease	Central and peripheral nervous system diseases
TTDR00529	Disease	Epilepsy
TTDR00529	Disease	Inflammation
TTDR00529	Disease	Inflammatory bowel disease
TTDR00529	Disease	Pain, unspecified
TTDR00529	Disease	Toxoplasmosis
TTDR00529	Function	Atp dependent phosphorylation of adenosine and other related nucleoside analogs
TTDR00529	Sequence	MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAG
TTDR00529	PDB Structure	1BX4; 2I6A; 2I6B
TTDR00529	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00529	Pathway	Metabolic pathways
TTDR00529	Pathway	Purine metabolism
TTDR00529	EC Number	EC 2.7.1.20
TTDR00529	Target Validation	TTDR00529
TTDR00529	Inhibitor	5'-iodotubercidin
TTDR00529	Inhibitor	5-iodo,5'-deoxytubercidin
TTDR00529	Inhibitor	6-Benzylthioinosine
TTDR00529	Inhibitor	GP515
TTDR00529	Inhibitor	Iodotubercidin
TTDR00530	UniProt ID	Q01726
TTDR00530	Name	Melanocyte stimulating hormone receptor
TTDR00530	Type of target	Research target
TTDR00530	Synonyms	MC1-R
TTDR00530	Synonyms	MSH-R
TTDR00530	Synonyms	Melanocortin-1 receptor
TTDR00530	Synonyms	Melanotropin receptor
TTDR00530	Disease	Melanoma
TTDR00530	Disease	Obesity
TTDR00530	Function	Receptor for msh (alpha, beta and gamma) and acth. The activity of this receptor
TTDR00530	Sequence	MAVQGSQRRLLGSLNSTPTAIPQLGLAANQTGARCLEVSISDGLFLSLGLVSLVENALVVATIAKNRNLHSPMYCFICCL
TTDR00530	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00530	Pathway	Melanogenesis
TTDR00530	Pathway	Neuroactive ligand-receptor interaction
TTDR00530	Target Validation	TTDR00530
TTDR00530	Inhibitor	AEKKDEGPYRMEHFRWGSPPKD
TTDR00530	Inhibitor	Ac-His-D-Phe-Arg-2-Nal-NHCH3
TTDR00530	Inhibitor	Ac-His-DPhe-Arg-Trp-NH2
TTDR00530	Inhibitor	Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
TTDR00530	Inhibitor	Ac-Nle-c[Asp-His-DNaI(2')-Pro-Trp-Lys]-NH2
TTDR00530	Inhibitor	Ac-Nle-c[Asp-His-DNal(2')-Pro-Trp-Lys]-NH2
TTDR00530	Inhibitor	Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2
TTDR00530	Inhibitor	Ac-R[CEHdFRWC]-NH2
TTDR00530	Inhibitor	Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3
TTDR00530	Inhibitor	Ac-YCit[CEHdFRWC]-NH2
TTDR00530	Inhibitor	Ac-YK[CEHdFRWC]-NH2
TTDR00530	Inhibitor	Ac-YRC(Me)*EHdFRWC(Me)NH2
TTDR00530	Inhibitor	Ac-YRMEHdFRWG-NH2
TTDR00530	Inhibitor	Ac-YRMEHdFRWGSPPKD-NH2
TTDR00530	Inhibitor	Ac-YR[CEH(d-2alpha-Nal)RWC]-NH2
TTDR00530	Inhibitor	Ac-YR[CEH(pCl-dF)RWC]-NH2
TTDR00530	Inhibitor	Ac-YR[CEH(pF-dF)RWC]-NH2
TTDR00530	Inhibitor	Ac-YR[CEHFRWC]-NH2
TTDR00530	Inhibitor	Ac-YR[CEHdFRWC]-NH2
TTDR00530	Inhibitor	Ac-YR[CEHdFRWC]SPPKD-NH2
TTDR00530	Inhibitor	Ac-[CEHdFRWC]-NH2
TTDR00530	Inhibitor	Ac-dR[CEHdFRWC]-NH2
TTDR00530	Inhibitor	D-Phe-Arg-2-Nal-NHCH3
TTDR00530	Inhibitor	GPYRMEHFRWGSPPKD-NH2
TTDR00530	Inhibitor	NDP-SYSMEHFRWGKPVG
TTDR00530	Inhibitor	Tic-D-Phe-Arg-2-Nal-NHCH3
TTDR00530	Inhibitor	c[CO-(CH2)2-CO-Nle-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00530	Inhibitor	c[CO-2,3-pyrazine-CO-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00530	Inhibitor	c[CO-2,3-pyrazine-CO-D-Phe-Arg-Trp-Lys]-NH2
TTDR00530	Inhibitor	c[CO-o-C6H4-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2
TTDR00530	Inhibitor	c[Nle-Arg-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00530	Inhibitor	c[Nle-Arg-D-Phe-Arg-Trp-Glu]-NH2
TTDR00530	Inhibitor	c[Nle-Gln-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00530	Inhibitor	c[Nle-Gln-D-Phe-Arg-Trp-Glu]-NH2
TTDR00530	Inhibitor	c[Nle-Nle-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00530	Inhibitor	c[Nle-Val-D-Nal(2')-Arg-Trp-Glu]-NH2
TTDR00531	UniProt ID	Q07075
TTDR00531	Name	Glutamyl aminopeptidase
TTDR00531	Type of target	Research target
TTDR00531	Synonyms	APA
TTDR00531	Synonyms	Aminopeptidase A
TTDR00531	Synonyms	Differentiation antigen gp160
TTDR00531	Synonyms	EAP
TTDR00531	Disease	Hypertension
TTDR00531	Function	Appears to have a role in the catabolic pathway of the renin-angiotensin system.
TTDR00531	Sequence	MNFAEREGSKRYCIQTKHVAILCAVVVGVGLIVGLAVGLTRSCDSSGDGGPGTAPAPSHLPSSTASPSGPPAQDQDICPA
TTDR00531	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00531	Pathway	Renin-angiotensin system
TTDR00531	EC Number	EC 3.4.11.7
TTDR00531	Related US Patent	6,340,708
TTDR00531	Target Validation	TTDR00531
TTDR00531	Inhibitor	EC33
TTDR00531	Inhibitor	KELATORPHAN
TTDR00532	UniProt ID	P16220
TTDR00532	Name	CAMP response element binding protein
TTDR00532	Type of target	Research target
TTDR00532	Synonyms	CAMP-response element binding protein
TTDR00532	Synonyms	CREB
TTDR00532	Synonyms	Cyclic AMP response element-binding protein
TTDR00532	Disease	Atherosclerotic cardiovascular disease
TTDR00532	Disease	Depression
TTDR00532	Function	This protein binds the camp response element (cre), a sequence present in many v
TTDR00532	Sequence	MTMESGAENQQSGDAAVTEAENQQMTVQAQPQIATLAQVSMPAAHATSSAPTVTLVQLPNGQTVQVHGVIQAAQPSVIQS
TTDR00532	PDB Structure	2LXT
TTDR00532	Pathway	Antigen processing and presentation
TTDR00532	Pathway	Huntington's disease
TTDR00532	Pathway	Melanogenesis
TTDR00532	Pathway	Prostate cancer
TTDR00533	UniProt ID	Q9GZS9
TTDR00533	Name	Intestinal GlcNAc-6-sulfotransferase
TTDR00533	Type of target	Research target
TTDR00533	Synonyms	Carbohydrate sulfotransferase GST-3
TTDR00533	Synonyms	GlcNAc 6-O-sulfotransferase
TTDR00533	Synonyms	HEC-GlcNAc6ST
TTDR00533	Synonyms	High endothelial cell GlcNAc 6-O-sulfotransferase
TTDR00533	Synonyms	Intestinal N-acetylglucosamine-6-O-sulfotransferase
TTDR00533	Synonyms	L-selectin ligand sulfotransferase
TTDR00533	Synonyms	L-selectin ligand sulfotransferase GST-3
TTDR00533	Synonyms	LSST
TTDR00533	Synonyms	N-acetylglucosamine 6-O-sulfotransferase
TTDR00533	Synonyms	N-acetylglucosamine-6-O-sulfotransferase
TTDR00533	Disease	Cancer, unspecific
TTDR00533	Disease	Chronic inflammatory diseases
TTDR00533	Disease	Inflammation
TTDR00533	Disease	Viral infection, unspecified
TTDR00533	Sequence	MGMRARVPKVAHSTRRPPAARMWLPRFSSKTVTVLLLAQTTCLLLFIISRPGPSSPAGGEDRVHVLVLSSWRSGSSFLGQ
TTDR00533	BioChemical Class	Transferases transferring sulfur-containing groups
TTDR00533	EC Number	EC 2.5.1.18
TTDR00534	UniProt ID	O00574
TTDR00534	Name	C-X-C chemokine receptor type 6
TTDR00534	Type of target	Research target
TTDR00534	Synonyms	CXC-R6
TTDR00534	Synonyms	CXCR-6
TTDR00534	Synonyms	Chemokine receptor CXCR6
TTDR00534	Synonyms	G protein-coupled receptor STRL33
TTDR00534	Synonyms	G protein-coupled receptor bonzo
TTDR00534	Disease	Human immunodeficiency virus [HIV] disease
TTDR00534	Function	Receptor for the c-x-c chemokine cxcl16. Used as a coreceptor by sivs and by str
TTDR00534	Sequence	MAEHDYHEDYGFSSFNDSSQEEHQDFLQFSKVFLPCMYLVVFVCGLVGNSLVLVISIFYHKLQSLTDVFLVNLPLADLVF
TTDR00534	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00534	Pathway	Chemokine signaling pathway
TTDR00534	Pathway	Cytokine-cytokine receptor interaction
TTDR00534	Antagonist	AMD3101
TTDR00535	UniProt ID	O60494
TTDR00535	Name	Intrinsic factor-B12 receptor
TTDR00535	Type of target	Research target
TTDR00535	Synonyms	CUBN
TTDR00535	Synonyms	Cubilin
TTDR00535	Synonyms	Intrinsic factor-vitamin B12 receptor
TTDR00535	Disease	Renal diseases
TTDR00535	Sequence	MMNMSLPFLWSLLTLLIFAEVNGEAGELELQRQKRSINLQQPRMATERGNLVFLTGSAQNIEFRTGSLGKIKLNDEDLSE
TTDR00535	PDB Structure	3KQ4
TTDR00535	BioChemical Class	Growth factor
TTDR00536	Name	Cyclophilin receptor
TTDR00536	Type of target	Research target
TTDR00536	Disease	Inflammation
TTDR00536	Binder	D-43787
TTDR00537	UniProt ID	P49961
TTDR00537	Name	Ectonucleoside triphosphate diphosphohydrolase 1
TTDR00537	Type of target	Research target
TTDR00537	Synonyms	ATPDase
TTDR00537	Synonyms	CD39 antigen
TTDR00537	Synonyms	Ecto-ATP diphosphohydrolase
TTDR00537	Synonyms	Ecto-apyrase
TTDR00537	Synonyms	Ecto-nucleotidase CD-39
TTDR00537	Synonyms	Lymphoid cell activation antigen
TTDR00537	Synonyms	NTPDase1
TTDR00537	Disease	Platelet aggregation
TTDR00537	Function	In the nervous system, could hydrolyze atp and other nucleotides to regulate pur
TTDR00537	Sequence	MEDTKESNVKTFCSKNILAILGFSSIIAVIALLAVGLTQNKALPENVKYGIVLDAGSSHTSLYIYKWPAEKENDTGVVHQ
TTDR00537	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00537	Pathway	Purine metabolism
TTDR00537	Pathway	Pyrimidine metabolism
TTDR00537	EC Number	EC 3.6.1.5
TTDR00537	Target Validation	TTDR00537
TTDR00537	Inhibitor	PSB-0963
TTDR00537	Inhibitor	PSB-6426
TTDR00538	UniProt ID	Q9WVF5
TTDR00538	Name	Epidermal growth factor receptor III
TTDR00538	Type of target	Research target
TTDR00538	Synonyms	Epidermal growth factor receptor isoform 3
TTDR00538	Synonyms	Mus musculus adult male liver cDNA, RIKEN full-length enriched library, clone:13
TTDR00538	Synonyms	Mus musculus adult male liver cDNA, RIKEN full-length enriched library, clone:13
TTDR00538	Synonyms	Mus musculus adult male liver cDNA, RIKEN full-length enriched library, clone:13
TTDR00538	Disease	Brain tumors
TTDR00538	Sequence	MRPSGTARTTLLVLLTALCAAGGALEEKKVCQGTSNRLTQLGTFEDHFLSLQRMYNNCEVVLGNLEITYVQRNYDLSFLK
TTDR00538	Pathway	Adherens junction
TTDR00538	Pathway	Bladder cancer
TTDR00538	Pathway	Calcium signaling pathway
TTDR00538	Pathway	Colorectal cancer
TTDR00538	Pathway	Cytokine-cytokine receptor interaction
TTDR00538	Pathway	Endometrial cancer
TTDR00538	Pathway	ErbB signaling pathway
TTDR00538	Pathway	Focal adhesion
TTDR00538	Pathway	Gap junction
TTDR00538	Pathway	Glioma
TTDR00538	Pathway	GnRH signaling pathway
TTDR00538	Pathway	MAPK signaling pathway
TTDR00538	Pathway	Melanoma
TTDR00538	Pathway	Non-small cell lung cancer
TTDR00538	Pathway	Pancreatic cancer
TTDR00538	Pathway	Pathways in cancer
TTDR00538	Pathway	Prostate cancer
TTDR00538	Pathway	Regulation of actin cytoskeleton
TTDR00539	UniProt ID	Q05932
TTDR00539	UniProt ID	Q9U738
TTDR00539	Name	Folylpolyglutamate synthase, mitochondrial
TTDR00539	Type of target	Research target
TTDR00539	Synonyms	FPGS
TTDR00539	Synonyms	Folylpoly-gamma-glutamate synthetase
TTDR00539	Synonyms	Folylpolyglutamate synthetase
TTDR00539	Disease	Cancer, unspecific
TTDR00539	Disease	Malaria
TTDR00539	Function	Conversion of folates to polyglutamate derivatives. This allows tissues to conce
TTDR00539	Sequence	MSRARSHLRAALFLAAASARGITTQVAARRGLSAWPVPQEPSMEYQDAVRMLNTLQTNAGYLEQVKRQRGDPQTQLEAME
TTDR00539	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00539	Pathway	Folate biosynthesis
TTDR00539	Pathway	Metabolic pathways
TTDR00539	EC Number	EC 6.3.2.17
TTDR00540	UniProt ID	P25090
TTDR00540	Name	FMLP-related receptor I
TTDR00540	Type of target	Research target
TTDR00540	Synonyms	FMLP-R-I
TTDR00540	Synonyms	FPRL1
TTDR00540	Synonyms	Formyl peptide receptor-like 1
TTDR00540	Synonyms	G-protein-coupled receptor FPR-Like-1
TTDR00540	Synonyms	HM63
TTDR00540	Synonyms	LXA4 receptor
TTDR00540	Synonyms	Lipoxin A4 receptor
TTDR00540	Synonyms	RFP
TTDR00540	Disease	Alzheimer's disease
TTDR00540	Function	Low affinity receptor to n-formyl-methionyl peptides, which are powerful neutrop
TTDR00540	Sequence	METNFSTPLNEYEEVSYESAGYTVLRILPLVVLGVTFVLGVLGNGLVIWVAGFRMTRTVTTICYLNLALADFSFTATLPF
TTDR00540	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00540	Pathway	Neuroactive ligand-receptor interaction
TTDR00541	UniProt ID	Q57679
TTDR00541	Name	HCV nucleoside triphosphatase
TTDR00541	Type of target	Research target
TTDR00541	Synonyms	NTPase
TTDR00541	Synonyms	Nucleoside triphosphate phosphohydrolase
TTDR00541	Synonyms	Nucleoside-triphosphatase
TTDR00541	Disease	Hepatitis C
TTDR00541	Function	Can efficiently hydrolyze nonstandard nucleotides such as xtp to xmp or itp to i
TTDR00541	Sequence	MQRTLGEIMKIYFATGNPNKIKEANIILKDLKDVEIEQIKISYPEIQGTLEEVAEFGAKWVYNILKKPVIVEDSGFFVEA
TTDR00541	PDB Structure	1B78; 2MJP
TTDR00541	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00541	Pathway	Metabolic pathways
TTDR00541	Pathway	Purine metabolism
TTDR00541	Pathway	Thiamine metabolism
TTDR00541	EC Number	EC 3.6.1.15
TTDR00542	Name	Interleukin-13 receptor
TTDR00542	Type of target	Research target
TTDR00542	Synonyms	IL-13R
TTDR00542	Disease	Glioblastoma multiforme
TTDR00542	Disease	Prostate cancer
TTDR00543	Name	Solute carrier family 12 member
TTDR00543	Type of target	Research target
TTDR00543	Synonyms	Electroneutral potassium-chloride cotransporter
TTDR00543	Synonyms	K(+)-Cl(-)-cotransporter
TTDR00543	Synonyms	K-Cl cotransporter
TTDR00543	Disease	Hepatocellular carcinoma
TTDR00543	Disease	Sickle cell anemia
TTDR00543	Blocker	Calyculin-A
TTDR00544	UniProt ID	O43526
TTDR00544	Name	Potassium voltage-gated channel subfamily KQT member 2
TTDR00544	Type of target	Research target
TTDR00544	Synonyms	K+ channel KCNQ2
TTDR00544	Synonyms	KQT-like 2
TTDR00544	Synonyms	Neuroblastoma-specific potassium channel KQT-like 2
TTDR00544	Synonyms	Neuroblastoma-specific potassium channel alpha subunit KvLQT2
TTDR00544	Synonyms	Voltage-gated potassium channel subunit Kv7.2
TTDR00544	Disease	Analgesics
TTDR00544	Disease	Epilepsy
TTDR00544	Disease	Pain
TTDR00544	Function	Probably important in the regulation of neuronal excitability. Associates with k
TTDR00544	Sequence	MVQKSRNGGVYPGPSGEKKLKVGFVGLDPGAPDSTRDGALLIAGSEAPKRGSILSKPRAGGAGAGKPPKRNAFYRKLQNF
TTDR00544	BioChemical Class	Voltage-gated channel
TTDR00544	Inhibitor	PD-32577
TTDR00545	UniProt ID	Q9NPC1
TTDR00545	Name	Leukotriene B4 receptor 2
TTDR00545	Type of target	Research target
TTDR00545	Synonyms	LTB4 receptor JULF2
TTDR00545	Synonyms	LTB4-R2
TTDR00545	Synonyms	Leukotriene B(4) receptor BLT2
TTDR00545	Synonyms	Leukotriene B4 receptor BLT2
TTDR00545	Synonyms	Seven transmembrane receptor BLTR2
TTDR00545	Disease	Immunological disorders
TTDR00545	Disease	Inflammation
TTDR00545	Function	Low-affinity receptor for leukotrienes including leukotriene b4. Mediates chemot
TTDR00545	Sequence	MAPSHRASQVGFCPTPERPLWRLPPTCRPRRMSVCYRPPGNETLLSWKTSRATGTAFLLLAALLGLPGNGFVVWSLAGWR
TTDR00545	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00545	Pathway	Calcium signaling pathway
TTDR00545	Pathway	Neuroactive ligand-receptor interaction
TTDR00545	Related US Patent	6,133,286
TTDR00545	Related US Patent	6,160,012
TTDR00545	Related US Patent	6,291,531
TTDR00545	Related US Patent	6,340,706
TTDR00545	Related US Patent	6,576,669
TTDR00545	Related US Patent	6,583,177
TTDR00545	Related US Patent	6,617,345
TTDR00545	Target Validation	TTDR00545
TTDR00545	QSAR Model	TTDR00545
TTDR00545	Inhibitor	(3S,4R)-3-Benzyl-7-isopropyl-chroman-4-ol
TTDR00545	Inhibitor	CP-105696
TTDR00545	Inhibitor	LEUKOTRIENE_B4
TTDR00545	Inhibitor	LY-255283
TTDR00545	Inhibitor	LY-282210
TTDR00545	Inhibitor	LY-292728
TTDR00545	Inhibitor	SC-41390
TTDR00546	UniProt ID	P98164
TTDR00546	Name	Low-density lipoprotein receptor-related protein 2
TTDR00546	Type of target	Research target
TTDR00546	Synonyms	Glycoprotein 330
TTDR00546	Synonyms	Gp330
TTDR00546	Synonyms	Megalin
TTDR00546	Disease	Renal diseases
TTDR00546	Function	Binds specifically clusterin with high affinity, but also ligands in common with
TTDR00546	Sequence	MDRGPAAVACTLLLALVACLAPASGQECDSAHFRCGSGHCIPADWRCDGTKDCSDDADEIGCAVVTCQQGYFKCQSEGQC
TTDR00546	PDB Structure	2M0P
TTDR00546	BioChemical Class	Growth factor
TTDR00546	Pathway	Hedgehog signaling pathway
TTDR00547	Name	mRNA of 3-phosphoinositide-dependent kinase-1
TTDR00547	Type of target	Research target
TTDR00547	Disease	Cancer, unspecific
TTDR00547	Binder	miR-375
TTDR00548	Name	mRNA of Htert
TTDR00548	Type of target	Research target
TTDR00548	Disease	Cancer, unspecific
TTDR00548	Antisense	Antisense hTERT mRNA oligodeoxynucleotide
TTDR00549	Name	mRNA of H-ras
TTDR00549	Type of target	Research target
TTDR00549	Disease	Cancer, unspecific
TTDR00549	Antisense	ISIS 2503
TTDR00549	Antisense	ISIS 2570
TTDR00550	Name	mRNA of Ki-ras
TTDR00550	Type of target	Research target
TTDR00550	Disease	Colorectal cancer
TTDR00550	Antisense	ISIS 6957
TTDR00550	Antisense	ISIS 6958
TTDR00550	Antisense	ISIS 7453
TTDR00551	Name	mRNA of telomerase
TTDR00551	Type of target	Research target
TTDR00551	Disease	Cancer, unspecific
TTDR00551	Antisense	2-5A-anti-hTR
TTDR00552	Name	mRNA of protein kinase A alpha subunit
TTDR00552	Type of target	Research target
TTDR00552	Disease	Cancer, unspecific
TTDR00552	Antisense	(35)S-labeled oligonucleotide
TTDR00553	UniProt ID	P30894
TTDR00553	Name	Nerve growth factor
TTDR00553	Type of target	Clinical trial target
TTDR00553	Synonyms	NGF
TTDR00553	Disease	Alzheimer's disease
TTDR00553	Disease	Analgesics
TTDR00553	Disease	Neurodegenerative diseases
TTDR00553	Disease	Pain
TTDR00553	Function	Nerve growth factor is important for the development and maintenance of the symp
TTDR00553	Sequence	HPVHNQGEFSVCDSVSVWVANKTTATDMRGNVVTVMVDVNLNNNVYKQYFFETKCKNPNPVPSGCRGIDAKHWNSYCTTT
TTDR00553	BioChemical Class	Growth factor
TTDR00553	Drug(s)	AMG 403
TTDR00553	Drug(s)	MEDI-578
TTDR00553	Drug(s)	TAK-428
TTDR00553	Antibody	MEDI-578
TTDR00554	UniProt ID	P43354
TTDR00554	Name	Orphan nuclear receptor NURR1
TTDR00554	Type of target	Research target
TTDR00554	Synonyms	Immediate-early response protein NOT
TTDR00554	Synonyms	Transcriptionally inducible nuclear receptor
TTDR00554	Disease	Parkinson's disease
TTDR00554	Function	Probable nuclear receptor. May function as a general coactivator of gene transcr
TTDR00554	Sequence	MPCVQAQYGSSPQGASPASQSYSYHSSGEYSSDFLTPEFVKFSMDLTNTEITATTSLPSFSTFMDNYSTGYDVKPPCLYQ
TTDR00554	PDB Structure	1OVL
TTDR00554	BioChemical Class	Zinc-finger
TTDR00555	UniProt ID	P36664
TTDR00555	Name	Acid phosphatase surE
TTDR00555	Type of target	Research target
TTDR00555	Synonyms	Acid Phosphatase
TTDR00555	Synonyms	Acid Phosphomonoesterase
TTDR00555	Synonyms	Glycerophosphatase
TTDR00555	Synonyms	Phosphomonoesterase
TTDR00555	Synonyms	Stationary-phase survival protein surE
TTDR00555	Disease	Bipolar affective disorder
TTDR00555	Function	This protein is essential for the survival of e.coli in stationary phase and for
TTDR00555	Sequence	MRILLSNDDGVHAPGIQTLAKALREFADVQVVAPDRNRSGASNSLTLESSLRTFTFENGDIAVQMGTPTDCVYLGVNALM
TTDR00555	EC Number	EC 3.1.3.2
TTDR00556	UniProt ID	P05121
TTDR00556	Name	Plasminogen activator inhibitor-1
TTDR00556	Type of target	Research target
TTDR00556	Synonyms	Endothelial plasminogen activator inhibitor
TTDR00556	Synonyms	PAI
TTDR00556	Synonyms	PAI-1
TTDR00556	Synonyms	Plasminogen activator inhibitor type 1
TTDR00556	Disease	Age-related macular degeneration
TTDR00556	Disease	Asthma
TTDR00556	Disease	Cancer, unspecific
TTDR00556	Disease	Coagulative disorders
TTDR00556	Disease	Diabetic retinopathy
TTDR00556	Disease	Inflammation
TTDR00556	Disease	Renal fibrosis
TTDR00556	Disease	Thrombotic disease
TTDR00556	Function	This inhibitor acts as "bait" for tissue plasminogen activator, urokinase, and p
TTDR00556	Sequence	MQMSPALTCLVLGLALVFGEGSAVHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQ
TTDR00556	PDB Structure	1A7C; 1B3K; 1C5G; 1DB2; 1DVM; 1DVN; 1LJ5; 1OC0; 3CVM; 3EOX; 3PB1; 3Q02; 3Q03; 3R
TTDR00556	Pathway	Complement and coagulation cascades
TTDR00556	Pathway	p53 signaling pathway
TTDR00556	Related US Patent	6,586,453
TTDR00556	Related US Patent	6,589,970
TTDR00556	Related US Patent	6,599,925
TTDR00556	Related US Patent	6,677,473
TTDR00556	Target Validation	TTDR00556
TTDR00556	Inhibitor	AR-HO29953XX
TTDR00556	Inhibitor	SIDEROXYLONAL A
TTDR00556	Inhibitor	SIDEROXYLONAL B
TTDR00556	Inhibitor	XR-5118
TTDR00556	Inhibitor	sideroxylonal C
TTDR00557	UniProt ID	Q05513
TTDR00557	Name	Protein kinase C, zeta type
TTDR00557	Type of target	Research target
TTDR00557	Synonyms	NPKC-zeta
TTDR00557	Synonyms	Protein kinase C zeta
TTDR00557	Disease	Cancer, unspecific
TTDR00557	Function	This is a calcium-independent, phospholipid-dependent, serine- and threonine-spe
TTDR00557	Sequence	MPSRTGPKMEGSGGRVRLKAHYGGDIFITSVDAATTFEELCEEVRDMCRLHQQHPLTLKWVDSEGDPCTVSSQMELEEAF
TTDR00557	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00557	Pathway	Chemokine signaling pathway
TTDR00557	Pathway	Insulin signaling pathway
TTDR00557	Pathway	Tight junction
TTDR00557	Pathway	Type II diabetes mellitus
TTDR00557	EC Number	EC 2.7.1.37
TTDR00557	Target Validation	TTDR00557
TTDR00557	Inhibitor	2,3,3-Triphenyl-acrylonitrile
TTDR00557	Inhibitor	2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile
TTDR00557	Inhibitor	3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile
TTDR00557	Inhibitor	3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile
TTDR00557	Inhibitor	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile
TTDR00557	Inhibitor	4-HYDROXYTAMOXIFEN
TTDR00557	Inhibitor	4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol
TTDR00557	Inhibitor	4-cycloheptyliden(4-hydroxyphenyl)methylphenol
TTDR00557	Inhibitor	4-cyclohexyliden(4-hydroxyphenyl)methylphenol
TTDR00557	Inhibitor	Bisindolylmaleimide-I
TTDR00557	Inhibitor	Go6976
TTDR00557	Inhibitor	Indolocarbazole analogue
TTDR00557	Inhibitor	LY-317644
TTDR00557	Inhibitor	LY-326449
TTDR00557	Inhibitor	RO-316233
TTDR00557	Inhibitor	RO-320432
TTDR00557	Inhibitor	Ro-32-0557
TTDR00557	Inhibitor	[2,2';5',2'']Terthiophen-4-yl-methanol
TTDR00557	Inhibitor	[2,2';5',2'']Terthiophene-4,5''-dicarbaldehyde
TTDR00557	Inhibitor	[2,2';5',2'']Terthiophene-4-carbaldehyde
TTDR00558	UniProt ID	P25736
TTDR00558	Name	RNA endonuclease
TTDR00558	Type of target	Research target
TTDR00558	Synonyms	Endo I
TTDR00558	Synonyms	Endonuclease I
TTDR00558	Disease	Influenza, virus not identified
TTDR00558	Function	Has double-strand break activity.
TTDR00558	Sequence	MYRYLSIAAVVLSAAFSGPALAEGINSFSQAKAAAVKVHADAPGTFYCGCKINWQGKKGVVDLQSCGYQVRKNENRASRV
TTDR00558	BioChemical Class	Hydrolases acting on ester bonds
TTDR00558	EC Number	EC 3.1.21.1
TTDR00559	UniProt ID	Q99RA7
TTDR00559	Name	Sortase
TTDR00559	Type of target	Research target
TTDR00559	Disease	Bacterial infections
TTDR00559	Sequence	MKKWTNRLMTIAGVVLILVAAYLFAKPHIDNYLHDKDKDEKIEQYDKNVKEQASKDNKQQAKPQIPKDKSKVAGYIEIPD
TTDR00559	Target Validation	TTDR00559
TTDR00559	Inhibitor	(-)-Discorhabdin Z
TTDR00560	UniProt ID	Q8D7G2
TTDR00560	Name	Trypsin-like serine protease
TTDR00560	Type of target	Research target
TTDR00560	Disease	Asthma
TTDR00560	Disease	Coagulative disorders
TTDR00560	Sequence	MAGEVESRIVNGTVVDVNRYASFASLFYDSLEYDGGYYSGASCGATILDVDHVLTAAHCVEELGSLALFLVVVPQLQDEN
TTDR00560	BioChemical Class	Protease
TTDR00560	Related US Patent	6,225,302
TTDR00560	Related US Patent	6,281,206
TTDR00560	Related US Patent	6,313,096
TTDR00560	Related US Patent	6,472,399
TTDR00560	Related US Patent	6,476,016
TTDR00560	Related US Patent	6,514,978
TTDR00560	Related US Patent	6,518,310
TTDR00560	Related US Patent	6,566,379
TTDR00560	Related US Patent	6,635,637
TTDR00560	Related US Patent	6,638,931
TTDR00560	Related US Patent	6,706,021
TTDR00560	Related US Patent	6,706,765
TTDR00560	Related US Patent	6,730,783
TTDR00560	Inhibitor	Peptide alpha-keto-beta-aldehyde-based inhibitors
TTDR00561	UniProt ID	Q91280
TTDR00561	Name	UDP-glucuronosyltransferase
TTDR00561	Type of target	Research target
TTDR00561	Synonyms	UDPGT
TTDR00561	Synonyms	Uridine diphosphate glucuronosyltransferase
TTDR00561	Disease	Autoimmune hepatitis
TTDR00561	Disease	Inflammatory liver diseases
TTDR00561	Function	Udpgt is of major importance in the conjugation and subsequent elimination of po
TTDR00561	Sequence	LVPESSLFMHQSEDYETEVYPVSFTTEEMDATHKQLKDGLFLKQPDWTEYYVNIMRFVNFTSIHLRGCENLLENQPLMSR
TTDR00561	BioChemical Class	Glycosyltransferases
TTDR00561	EC Number	EC 2.4.1.17
TTDR00561	Target Validation	TTDR00561
TTDR00561	Inhibitor	Autoantibody LKM-3
TTDR00561	Inhibitor	ISOLONGIFOLOL
TTDR00562	UniProt ID	Q9UKP6
TTDR00562	Name	Urotensin II receptor
TTDR00562	Type of target	Research target
TTDR00562	Synonyms	G protein coupled receptor 14
TTDR00562	Synonyms	UR-II-R
TTDR00562	Synonyms	Urotensin-II receptor GPR14
TTDR00562	Disease	Congestive heart failure
TTDR00562	Disease	Myocardial infarction
TTDR00562	Function	High afinity receptor for urotensin ii. The activity of this receptor is mediate
TTDR00562	Sequence	MALTPESPSSFPGLAATGSSVPEPPGGPNATLNSSWASPTEPSSLEDLVATGTIGTLLSAMGVVGVVGNAYTLVVTCRSL
TTDR00562	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00562	Pathway	Neuroactive ligand-receptor interaction
TTDR00562	Related US Patent	6,514,970
TTDR00562	Related US Patent	6,544,992
TTDR00562	Target Validation	TTDR00562
TTDR00562	Inhibitor	AGTAD[CFWKYC]V
TTDR00562	Inhibitor	Ac-FWKY-NH2
TTDR00562	Inhibitor	Ac-SFWKYS-NH2
TTDR00562	Inhibitor	Ac-WKY-NH2
TTDR00562	Inhibitor	Ac-[CFWKFC]-NH2
TTDR00562	Inhibitor	Ac-[CFWKYC]-NH2
TTDR00562	Inhibitor	Ac-[CFWKyC]-NH2
TTDR00562	Inhibitor	Ac-[CFWkYC]-NH2
TTDR00562	Inhibitor	Ac-[CFwKYC]-NH2
TTDR00562	Inhibitor	Ac-[CfWKYC]-NH2
TTDR00562	Inhibitor	ICI-199441
TTDR00562	Inhibitor	JNJ-28318706
TTDR00562	Inhibitor	PALOSURAN
TTDR00562	Inhibitor	SB-328872
TTDR00562	Inhibitor	SB-436811
TTDR00562	Inhibitor	SB-706375
TTDR00563	UniProt ID	O96703
TTDR00563	Name	Vacuolar-type (H+)-ATPase
TTDR00563	Type of target	Research target
TTDR00563	Synonyms	V-ATPase
TTDR00563	Synonyms	Vacuolar ATPase
TTDR00563	Synonyms	Vacuolar-ATPase
TTDR00563	Disease	Cancer, unspecific
TTDR00563	Disease	Lytic bone diseases
TTDR00563	Disease	Osteoporosis, unspecified
TTDR00563	Disease	Tumor invasion and metastasis
TTDR00563	Sequence	MGVNMEIARFFKQDFEENGSMENVSLFLNLANDPTIERIITPRIALTTAEYMAYQCEKHVLVILTDMSSYAEALREVSAA
TTDR00563	EC Number	EC 3.6.3.14
TTDR00563	Inhibitor	FR167356
TTDR00563	Inhibitor	Lobatamide A
TTDR00563	Inhibitor	Lobatamide B
TTDR00563	Inhibitor	Lobatamide C
TTDR00563	Inhibitor	Lobatamide D
TTDR00563	Inhibitor	Lobatamide F
TTDR00563	Inhibitor	Oximidine I
TTDR00563	Inhibitor	Oximidine II
TTDR00563	Inhibitor	Salicylihalamide A
TTDR00564	UniProt ID	P28566
TTDR00564	Name	5-hydroxytryptamine 1E receptor
TTDR00564	Type of target	Research target
TTDR00564	Synonyms	5-HT 1E
TTDR00564	Synonyms	5-HT-1E
TTDR00564	Synonyms	5-HT1E
TTDR00564	Synonyms	S31
TTDR00564	Synonyms	Serotonin receptor
TTDR00564	Synonyms	Serotonin receptor 1E
TTDR00564	Disease	Neurologic and psychiatric diseases
TTDR00564	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDR00564	Sequence	MNITNCTTEASMAIRPKTITEKMLICMTLVVITTLTTLLNLAVIMAIGTTKKLHQPANYLICSLAVTDLLVAVLVMPLSI
TTDR00564	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00564	Pathway	Neuroactive ligand-receptor interaction
TTDR00564	Agonist	B173
TTDR00564	Agonist	BRL54443
TTDR00565	UniProt ID	P47898
TTDR00565	Name	5-hydroxytryptamine 5A receptor
TTDR00565	Type of target	Research target
TTDR00565	Synonyms	5-HT 5A
TTDR00565	Synonyms	5-HT-5
TTDR00565	Synonyms	5-HT-5A
TTDR00565	Synonyms	Serotonin receptor
TTDR00565	Synonyms	Serotonin receptor 5A
TTDR00565	Disease	Bipolar affective disorder
TTDR00565	Disease	Depression
TTDR00565	Disease	Schizophrenia
TTDR00565	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDR00565	Sequence	MDLPVNLTSFSLSTPSPLETNHSLGKDDLRPSSPLLSVFGVLILTLLGFLVAATFAWNLLVLATILRVRTFHRVPHNLVA
TTDR00565	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00565	Pathway	Calcium signaling pathway
TTDR00565	Pathway	Neuroactive ligand-receptor interaction
TTDR00565	Target Validation	TTDR00565
TTDR00565	Inhibitor	(+/-)-nantenine
TTDR00565	Inhibitor	3,4-dihydroquinazolin-2-amine hydrobromide
TTDR00565	Inhibitor	4-ethyl-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	4-methyl-N-propyl-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	4-propyl-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	5,6-dichloro-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	5-chloro-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	5-chloro-4-ethyl-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	5-chloro-4-methyl-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	8-chloro-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	8-methoxy-4-methyl-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	METHIOTHEPIN
TTDR00565	Inhibitor	N,4-dimethyl-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	N,N-dimethyl-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	N-butyl-4-methyl-3,4-dihydroquinazolin-2-amine
TTDR00565	Inhibitor	SEROTONIN
TTDR00565	Inhibitor	ZACOPRIDE
TTDR00565	Antagonist	SB-699551-A
TTDR00566	Name	CCK receptor
TTDR00566	Type of target	Research target
TTDR00566	Disease	Acute pancreatitis
TTDR00566	Disease	Analgesics
TTDR00566	Disease	Biliary colic
TTDR00566	Disease	Pancreatic cancer
TTDR00566	Antagonist	Loxiglumide
TTDR00567	UniProt ID	P09038
TTDR00567	Name	Heparin-binding growth factor 2
TTDR00567	Type of target	Research target
TTDR00567	Synonyms	BFGF
TTDR00567	Synonyms	Basic fibroblast growth factor
TTDR00567	Synonyms	FGF-2
TTDR00567	Synonyms	FGF2
TTDR00567	Synonyms	Fibroblast growth factor 2
TTDR00567	Synonyms	HBGF-2
TTDR00567	Synonyms	Prostatropin
TTDR00567	Disease	Hepatic fibrosis
TTDR00567	Disease	Rheumatoid arthritis, unspecified
TTDR00567	Function	The heparin-binding growth factors are angiogenic agents in vivo and are potent
TTDR00567	Sequence	MGDRGRGRALPGGRLGGRGRGRAPERVGGRGRGRGTAAPRAAPAARGSRPGPAGTMAAGSITTLPALPEDGGSGAFPPGH
TTDR00567	PDB Structure	1BAS; 1BFB; 1BFC; 1BFF; 1BFG; 1BLA; 1BLD; 1CVS; 1EV2; 1FGA; 1FQ9; 1II4; 1IIL; 2B
TTDR00567	BioChemical Class	Growth factor
TTDR00567	Pathway	MAPK signaling pathway
TTDR00567	Pathway	Melanoma
TTDR00567	Pathway	Pathways in cancer
TTDR00567	Pathway	Regulation of actin cytoskeleton
TTDR00567	Related US Patent	6,485,920
TTDR00567	Inhibitor	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
TTDR00567	Inhibitor	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
TTDR00567	Inhibitor	BIBF100
TTDR00567	Inhibitor	Beta-Mercaptoethanol
TTDR00567	Inhibitor	N,O6-Disulfo-Glucosamine
TTDR00568	UniProt ID	P42339
TTDR00568	Name	Phosphatidylinositol 3-kinase
TTDR00568	Type of target	Research target
TTDR00568	Synonyms	ATVPS34
TTDR00568	Synonyms	PI3-kinase
TTDR00568	Synonyms	PI3K
TTDR00568	Synonyms	PtdIns-3-kinase
TTDR00568	Disease	Breast cancer
TTDR00568	Disease	Tumor vascular endothelium
TTDR00568	Sequence	MGANEFRFFLSCDINSPVTFRIEKLDGNLPVKKSSDSGVVSIAEEKKPELYIECALYIDGAPFGLPMRTRLKTTGPPYCW
TTDR00568	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00568	Pathway	Inositol phosphate metabolism
TTDR00568	Pathway	Metabolic pathways
TTDR00568	Pathway	Phosphatidylinositol signaling system
TTDR00568	Pathway	Regulation of autophagy
TTDR00568	EC Number	EC 2.7.1.137
TTDR00570	UniProt ID	P05793
TTDR00570	Name	Ketol-acid reductoisomerase
TTDR00570	Type of target	Research target
TTDR00570	Synonyms	Acetohydroxy acid isomeroreductase
TTDR00570	Synonyms	Acetohydroxy-acid isomeroreductase
TTDR00570	Synonyms	Alpha-keto-beta-hydroxylacil reductoisomerase
TTDR00570	Disease	Fungal diseases
TTDR00570	Sequence	MANYFNTLNLRQQLAQLGKCRFMGRDEFADGASYLQGKKVVIVGCGAQGLNQGLNMRDSGLDISYALRKEAIAEKRASWR
TTDR00570	PDB Structure	1YRL; 3ULK
TTDR00570	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00570	Pathway	Metabolic pathways
TTDR00570	Pathway	Pantothenate and CoA biosynthesis
TTDR00570	Pathway	Valine, leucine and isoleucine biosynthesis
TTDR00570	EC Number	EC 1.1.1.86
TTDR00571	UniProt ID	P53634
TTDR00571	Name	Dipeptidyl-peptidase I
TTDR00571	Type of target	Research target
TTDR00571	Synonyms	Cathepsin C
TTDR00571	Synonyms	Cathepsin J
TTDR00571	Synonyms	Cysteine protease dipeptidyl peptidase I
TTDR00571	Synonyms	DPP-I
TTDR00571	Synonyms	DPPI
TTDR00571	Synonyms	Dipeptidyl peptidase I
TTDR00571	Synonyms	Dipeptidyl transferase
TTDR00571	Disease	Alzheimer's disease
TTDR00571	Disease	Sepsis
TTDR00571	Function	Thiol protease. Has dipeptidylpeptidase activity. Can act as both an exopeptidas
TTDR00571	Sequence	MGAGPSLLLAALLLLLSGDGAVRCDTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGN
TTDR00571	PDB Structure	1K3B; 2DJF; 2DJG; 3PDF
TTDR00571	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00571	EC Number	EC 3.4.14.1
TTDR00571	Target Validation	TTDR00571
TTDR00571	Inhibitor	(S)-2-amino-N-(1-cyano-2-phenylethyl)acetamide
TTDR00571	Inhibitor	GNF-PF-5434
TTDR00572	UniProt ID	Q92820
TTDR00572	Name	Gamma-glutamyl hydrolase
TTDR00572	Type of target	Research target
TTDR00572	Synonyms	Conjugase
TTDR00572	Synonyms	GH
TTDR00572	Synonyms	Gamma-Glu-X carboxypeptidase
TTDR00572	Synonyms	Human glutamyl hydrolase
TTDR00572	Disease	Cancer, unspecific
TTDR00572	Function	Hydrolyzes the polyglutamate sidechains of pteroylpolyglutamates. Progressively
TTDR00572	Sequence	MASPGCLLCVLGLLLCGAASLELSRPHGDTAKKPIIGILMQKCRNKVMKNYGRYYIAASYVKYLESAGARVVPVRLDLTE
TTDR00572	PDB Structure	1L9X
TTDR00572	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00572	Pathway	Folate biosynthesis
TTDR00572	EC Number	EC 3.4.19.9
TTDR00573	Name	Endothelin
TTDR00573	Type of target	Research target
TTDR00573	Disease	Cardiovascular disease, unspecified
TTDR00573	Disease	Heart failure
TTDR00573	Related US Patent	6,252,070
TTDR00573	Related US Patent	6,271,248
TTDR00573	Related US Patent	6,352,992
TTDR00573	Related US Patent	6,380,195
TTDR00573	Related US Patent	6,380,241
TTDR00573	Related US Patent	6,573,285
TTDR00573	Related US Patent	6,608,054
TTDR00574	UniProt ID	O95399
TTDR00574	Name	Urotensin II
TTDR00574	Type of target	Research target
TTDR00574	Synonyms	HU-II
TTDR00574	Synonyms	U-II
TTDR00574	Synonyms	UII
TTDR00574	Synonyms	Urotensin-II
TTDR00574	Disease	Cardiorenal disease
TTDR00574	Disease	Cardiovascular disease, unspecified
TTDR00574	Function	Highly potent vasoconstrictor.
TTDR00574	Sequence	MYKLASCCLLFIGFLNPLLSLPLLDSREISFQLSAPHEDARLTPEELERASLLQILPEMLGAERGDILRKADSSTNIFNP
TTDR00575	UniProt ID	P19338
TTDR00575	Name	Nucleolin
TTDR00575	Type of target	Research target
TTDR00575	Synonyms	Protein C23
TTDR00575	Disease	Cancer, unspecific
TTDR00575	Function	Nucleolin is the major nucleolar protein of growing eukaryotic cells. It is foun
TTDR00575	Sequence	MVKLAKAGKNQGDPKKMAPPPKEVEEDSEDEEMSEDEEDDSSGEEVVIPQKKGKKAAATSAKKVVVSPTKKVAVATPAKK
TTDR00575	PDB Structure	2FC8; 2FC9; 2KRR
TTDR00575	Pathway	Pathogenic Escherichia coli infection
TTDR00576	Name	Epidermal growth factor receptor deltaEGFR
TTDR00576	Type of target	Research target
TTDR00576	Synonyms	De2-7 EGFR
TTDR00576	Synonyms	Deletion-mutant epidermal growth factor receptor
TTDR00576	Synonyms	DeltaEGFR
TTDR00576	Synonyms	EGFRvIII
TTDR00576	Synonyms	Epidermal growth factor receptor EGFRvIII
TTDR00576	Disease	Breast cancer
TTDR00576	Disease	Glioblastoma multiforme
TTDR00577	UniProt ID	Q8TAA9
TTDR00577	Name	Vang-like protein 1
TTDR00577	Type of target	Research target
TTDR00577	Synonyms	LPP2
TTDR00577	Synonyms	Loop-tail protein 2 homolog
TTDR00577	Synonyms	Strabismus 2
TTDR00577	Synonyms	VANGL1
TTDR00577	Synonyms	Van Gogh-like protein 1
TTDR00577	Synonyms	Vang (Van Gogh, Drosophila)-like 1
TTDR00577	Disease	Hepatocellular carcinoma
TTDR00577	Sequence	MDTESTYSGYSYYSSHSKKSHRQGERTRERHKSPRNKDGRGSEKSVTIQPPTGEPLLGNDSTRTEEVQDDNWGETTTAIT
TTDR00577	BioChemical Class	Transmembrane protein
TTDR00577	Pathway	Wnt signaling pathway
TTDR00578	Name	14-3-3 proteins
TTDR00578	Type of target	Research target
TTDR00578	Disease	Cancer, unspecific
TTDR00579	Name	EPAS-1/HIF-2alpha mRNA
TTDR00579	Type of target	Research target
TTDR00579	Disease	Bladder cancer
TTDR00580	UniProt ID	Q92633
TTDR00580	Name	Lysophosphatidic acid receptor Edg-2
TTDR00580	Type of target	Research target
TTDR00580	Synonyms	EDG 2 receptor
TTDR00580	Synonyms	LPA receptor 1
TTDR00580	Synonyms	LPA-1
TTDR00580	Disease	Multiple sclerosis
TTDR00580	Function	Receptor for lysophosphatidic acid (lpa), a mediator of diverse cellular activit
TTDR00580	Sequence	MAAISTSIPVISQPQFTAMNEPQCFYNESIAFFYNRSGKHLATEWNTVSKLVMGLGITVCIFIMLANLLVMVAIYVNRRF
TTDR00580	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00580	Pathway	Gap junction
TTDR00580	Pathway	Neuroactive ligand-receptor interaction
TTDR00580	Related US Patent	6,380,177
TTDR00580	Target Validation	TTDR00580
TTDR00580	Inhibitor	(1,1-Difluoro-pentadecyl)-phosphonic acid
TTDR00580	Inhibitor	Decyl-phosphonic acid
TTDR00580	Inhibitor	Dodecyl-phosphonic acid
TTDR00580	Inhibitor	Phosphoric acid mono-((E)-dec-4-enyl) ester
TTDR00580	Inhibitor	Phosphoric acid mono-((E)-dodec-9-enyl) ester
TTDR00580	Inhibitor	Phosphoric acid mono-((E)-tetradec-11-enyl) ester
TTDR00580	Inhibitor	Phosphoric acid mono-((E)-tetradec-9-enyl) ester
TTDR00580	Inhibitor	Phosphoric acid monodec-9-enyl ester
TTDR00580	Inhibitor	Phosphoric acid monododecyl ester
TTDR00580	Inhibitor	Phosphoric acid monotetradecyl ester
TTDR00580	Inhibitor	Tetradecyl-phosphonic acid
TTDR00580	Inhibitor	Thiophosphoric acid (E)-dodec-9-enyl ester
TTDR00580	Inhibitor	Thiophosphoric acid (E)-tetradec-9-enyl ester
TTDR00580	Inhibitor	Thiophosphoric acid dec-9-enyl ester
TTDR00580	Inhibitor	Thiophosphoric acid decyl ester
TTDR00580	Inhibitor	Thiophosphoric acid dodecyl ester
TTDR00582	UniProt ID	Q9Y5P9
TTDR00582	Name	Endocytic receptor Endo180
TTDR00582	Type of target	Research target
TTDR00582	Synonyms	C-type lectin receptor Endo180
TTDR00582	Disease	Breast cancer
TTDR00582	Sequence	MGPGRPAPAPWPRHLLRCVLLLGCLHLGRPGAPGDAALPEPNVFLIFSHGLQGCLEAQGGQVRVTPACNTSLPAQRWKWV
TTDR00583	UniProt ID	Q9UBU3
TTDR00583	Name	Ghrelin
TTDR00583	Type of target	Clinical trial target
TTDR00583	Synonyms	Gastric peptide ghrelin
TTDR00583	Synonyms	Growth hormone releasing peptide
TTDR00583	Synonyms	Growth hormone secretagogue
TTDR00583	Synonyms	M46 protein
TTDR00583	Synonyms	Motilin-related peptide
TTDR00583	Synonyms	UNQ524/PRO1066
TTDR00583	Disease	Anorexia nervosa
TTDR00583	Disease	Cachexia
TTDR00583	Disease	Noninsulin-dependent diabetes mellitus
TTDR00583	Disease	Obesity
TTDR00583	Function	Specific ligand for the growth hormone secretagogue receptor type 1 (ghsr) induc
TTDR00583	Sequence	MPSPGTVCSLLLLGMLWLDLAMAGSSFLSPEHQRVQQRKESKKPPAKLQPRALAGWLRPEDGGQAEGAEDELEVRFNAPF
TTDR00583	PDB Structure	1P7X
TTDR00584	UniProt ID	O00626
TTDR00584	Name	Small inducible cytokine A22
TTDR00584	Type of target	Research target
TTDR00584	Synonyms	CC chemokine STCP-1
TTDR00584	Synonyms	CCL22
TTDR00584	Synonyms	MDC(1-69)
TTDR00584	Synonyms	Macrophage-derived chemokine
TTDR00584	Synonyms	Stimulated T cell chemotactic protein 1
TTDR00584	Disease	Crescentic glomerulonephritis
TTDR00584	Function	May play a role in the trafficking of activated/effector t lymphocytes to inflam
TTDR00584	Sequence	MARLQTALLVVLVLLAVALQATEAGPYGANMEDSVCCRDYVRYRLPLRVVKHFYWTSDSCPRPGVVLLTFRDKEICADPR
TTDR00584	Pathway	Chemokine signaling pathway
TTDR00584	Pathway	Cytokine-cytokine receptor interaction
TTDR00585	UniProt ID	P39051
TTDR00585	Name	Trypanothione reductase
TTDR00585	Type of target	Research target
TTDR00585	Synonyms	N(1),N(8)-bis(glutathionyl)spermidine reductase
TTDR00585	Synonyms	Parasite-specific trypanothione reductase
TTDR00585	Synonyms	TR
TTDR00585	Synonyms	TRYR
TTDR00585	Disease	African trypanosomiasis
TTDR00585	Disease	Chagas' disease
TTDR00585	Disease	Leishmania infections
TTDR00585	Disease	Parasitic diseases
TTDR00585	Disease	Sleeping sickness
TTDR00585	Disease	Trypanolytic infections
TTDR00585	Disease	Trypanosomatid infections
TTDR00585	Function	Trypanothione is the parasite analog of glutathione; this enzyme is the equivale
TTDR00585	Sequence	MSKIFDLVVIGAGSGGLEAGWNAATLYKKRVAVIDVQTHHGPPHYAALGGTCVNVGCVPKKLMVTGAQYMDHLRESAGFG
TTDR00585	PDB Structure	2WBA
TTDR00585	BioChemical Class	Oxidoreductases acting on a sulfur group of donors
TTDR00585	EC Number	EC 1.8.1.12
TTDR00585	Target Validation	TTDR00585
TTDR00585	Inhibitor	1-(2'-chlorophenyl)penta-1,4-dien-3-one
TTDR00585	Inhibitor	8-Methoxy-naphtho[2,3-b]thiophen-4,9-quinone
TTDR00585	Inhibitor	CEPHARANTINE
TTDR00585	Inhibitor	CONESSINE
TTDR00585	Inhibitor	Flavin-Adenine Dinucleotide
TTDR00585	Inhibitor	Maleic Acid
TTDR00585	Inhibitor	N-(5-chloro-2-(phenylthio)phenyl)butyramide
TTDR00585	Inhibitor	N1,N2-bis(dihydrocaffeoyl)spermine
TTDR00585	Inhibitor	Trypanothione
TTDR00585	Binder	Tricyclics
TTDR00586	UniProt ID	P24592
TTDR00586	Name	Insulin-like growth factor binding protein 6
TTDR00586	Type of target	Research target
TTDR00586	Synonyms	IBP-6
TTDR00586	Synonyms	IGF-binding protein 6
TTDR00586	Synonyms	IGFBP-6
TTDR00586	Disease	Cancer, unspecific
TTDR00586	Function	Igf-bindinG proteins prolong the half-life of the igfs and have been shown to ei
TTDR00586	Sequence	MTPHRLLPPLLLLLALLLAASPGGALARCPGCGQGVQAGCPGGCVEEEDGGSPAEGCAEAEGCLRREGQECGVYTPNCAP
TTDR00586	PDB Structure	1RMJ
TTDR00587	UniProt ID	P14061
TTDR00587	Name	Estradiol 17 beta-dehydrogenase 1
TTDR00587	Type of target	Research target
TTDR00587	Synonyms	17-beta-HSD 1
TTDR00587	Synonyms	17-beta-Hydroxysteroid dehydrogenase type 1
TTDR00587	Synonyms	20 alpha-hydroxysteroid dehydrogenase
TTDR00587	Synonyms	20-alpha-HSD
TTDR00587	Synonyms	E2DH
TTDR00587	Synonyms	Placental 17-beta-hydroxysteroid dehydrogenase
TTDR00587	Disease	Breast cancer (hormone-sensitive)
TTDR00587	Function	Favors the reduction of estrogens and androgens. Also has 20-alpha-hsd activity.
TTDR00587	Sequence	MARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLETLQLDVRDSKSVAAARERV
TTDR00587	PDB Structure	1A27; 1BHS; 1DHT; 1EQU; 1FDS; 1FDT; 1FDU; 1FDV; 1FDW; 1I5R; 1IOL; 1JTV; 1QYV; 1Q
TTDR00587	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00587	Pathway	Androgen and estrogen metabolism
TTDR00587	Pathway	Metabolic pathways
TTDR00587	EC Number	EC 1.1.1.62
TTDR00587	Target Validation	TTDR00587
TTDR00587	QSAR Model	TTDR00587
TTDR00587	Inhibitor	1,1':4',1''-terphenyl-3,3''-diol
TTDR00587	Inhibitor	1,1':4',1''-terphenyl-3,4''-diol
TTDR00587	Inhibitor	1-Bromo-6-(3-hydroxyphenyl)-2-naphthol
TTDR00587	Inhibitor	16-(2',2'-Dimethyl)-propylidene-estradiol
TTDR00587	Inhibitor	16-(2',2'-Dimethyl)-propylidene-estrone
TTDR00587	Inhibitor	16-(4-cyano-benzylidene)-estradiol
TTDR00587	Inhibitor	16-(4-dimethylamino-benzylidene)-estradiol
TTDR00587	Inhibitor	16-(4-dimethylamino-benzylidene)-estrone
TTDR00587	Inhibitor	16-(pyridin-2-yl)methyl-estradiol
TTDR00587	Inhibitor	16-(pyridin-2-yl)methylene-estradiol
TTDR00587	Inhibitor	16-(pyridin-3-yl)methyl-estradiol
TTDR00587	Inhibitor	16-(pyridin-3-yl)methylene-estradiol
TTDR00587	Inhibitor	16-(pyridin-4-yl)methyl-estradiol
TTDR00587	Inhibitor	16-(pyridin-4-yl)methylene-estradiol
TTDR00587	Inhibitor	16-(thiophen-2-yl)methylene-estrone
TTDR00587	Inhibitor	16-beta-ethoxymethyl-estrone
TTDR00587	Inhibitor	16-beta-hydroxymethyl-estradiol
TTDR00587	Inhibitor	16-isobutylidene-estradiol
TTDR00587	Inhibitor	16-isobutylidene-estrone
TTDR00587	Inhibitor	16beta-cyano-estradiol
TTDR00587	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDR00587	Inhibitor	2-(3-hydroxyphenyl)quinolin-6-ol
TTDR00587	Inhibitor	2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol
TTDR00587	Inhibitor	2-Fluoro-4-[5-(3-hydroxyphenyl)-3-thienyl]phenol
TTDR00587	Inhibitor	2-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol
TTDR00587	Inhibitor	2-Hydroxy-N,6-bis(3-hydroxyphenyl)-1-naphthamide
TTDR00587	Inhibitor	3'-(1-Benzothien-2-yl)biphenyl-3-ol
TTDR00587	Inhibitor	3'-(5-Chloro-2-thienyl)biphenyl-3-ol
TTDR00587	Inhibitor	3,3',3''-Thiene-2,3,5-triyltriphenol
TTDR00587	Inhibitor	3,3'-(1,2,4,5-tetrazine-3,6-diyl)diphenol
TTDR00587	Inhibitor	3,3'-(1,2,4-Thiadiazol-2,5-diyl)diphenol
TTDR00587	Inhibitor	3,3'-(1,2,4-thiadiazole-3,5-diyl)diphenol
TTDR00587	Inhibitor	3,3'-(1,3-Thiazol-2,4-diyl)diphenol
TTDR00587	Inhibitor	3,3'-(3-Methylthiene-2,5-diyl]diphenol
TTDR00587	Inhibitor	3,3'-(3-Phenylthiene-2,5-diyl)diphenol
TTDR00587	Inhibitor	3,3'-Pyridine-2,5-diyldiphenol
TTDR00587	Inhibitor	3,3'-Thiene-2,4-diyldiphenol
TTDR00587	Inhibitor	3,3'-pyrazine-2,5-diyldiphenol
TTDR00587	Inhibitor	3,3'-thiene-2,5-diyldiphenol
TTDR00587	Inhibitor	3,3-(1,3-Thiazole-2,5-diyl)diphenol
TTDR00587	Inhibitor	3,4'-(thiophene-2,4-diyl)diphenol
TTDR00587	Inhibitor	3-(2-naphthyl)phenol
TTDR00587	Inhibitor	3-(3-hydroxyphenyl)quinolin-7-ol
TTDR00587	Inhibitor	3-(5-phenyl-2-thienyl)phenol
TTDR00587	Inhibitor	3-(6-hydroxy-2-naphthyl)benzoic acid
TTDR00587	Inhibitor	3-Beta-Hydroxy-5-Androsten-17-One
TTDR00587	Inhibitor	3-Fluoro-5-[5-(4-hydroxyphenyl)-2-thienyl]phenol
TTDR00587	Inhibitor	3-Hydroxy-7-(3-hydroxyphenyl)-1-naphthonitrile
TTDR00587	Inhibitor	3-[2-(5-Chloro-2-thienyl)pyridin-4-yl]phenol
TTDR00587	Inhibitor	3-[3-(4-hydroxyphenyl)isoxazol-5-yl]phenol
TTDR00587	Inhibitor	3-[4-(4-Hydroxyphenyl)-1,3-oxazol-2-yl]phenol
TTDR00587	Inhibitor	3-[4-(5-Chloro-2-thienyl)pyridin-2-yl]phenol
TTDR00587	Inhibitor	3-[5-(3,4-Difluorophenyl)-2-thienyl]phenol
TTDR00587	Inhibitor	3-[5-(3-Fluorophenyl)-2-thienyl]phenol
TTDR00587	Inhibitor	3-[5-(4-Fluorophenyl)-2-thienyl]phenol
TTDR00587	Inhibitor	3-[5-(4-Hydroxyphenyl)-2-thienyl]-5-methylphenol
TTDR00587	Inhibitor	3-[5-(4-Hydroxyphenyl)-3-thienyl]phenol
TTDR00587	Inhibitor	3-[5-(4-hydroxyphenyl)-1,3-oxazol-2-yl]phenol
TTDR00587	Inhibitor	3-[5-(4-hydroxyphenyl)-1,3-thiazol-2-yl]phenol
TTDR00587	Inhibitor	3-[5-(4-hydroxyphenyl)-2-thienyl]phenol
TTDR00587	Inhibitor	3-[6-(5-Chloro-2-thienyl)pyridin-2-yl]phenol
TTDR00587	Inhibitor	4'-(5-Chloro-2-thienyl)biphenyl-3-ol
TTDR00587	Inhibitor	4'-(6-Methoxypyridin-3-yl)biphenyl-3-ol
TTDR00587	Inhibitor	4-ANDROSTENE-3-17-DIONE
TTDR00587	Inhibitor	4-Fluoro-1,1':4',1''-terphenyl-3,3''-diol
TTDR00587	Inhibitor	4-Methyl-1,1':4',1''-terphenyl-3,4''-diol
TTDR00587	Inhibitor	4-[5-(3-Hydroxyphenyl)-2-thienyl)-2-methyl]phenol
TTDR00587	Inhibitor	4-[5-(3-Hydroxyphenyl)-2-thienyl]benzene-1,2-diol
TTDR00587	Inhibitor	4-[5-(3-Hydroxyphenyl)-3-thienyl]-2-methylphenol
TTDR00587	Inhibitor	5-(6-hydroxy-2-naphthyl)pyridin-3-ol
TTDR00587	Inhibitor	5alpha-Androstan-3,17-Dione
TTDR00587	Inhibitor	6-(3-Hydroxyphenyl)-1-phenyl-2-naphthol
TTDR00587	Inhibitor	6-(3-hydroxyphenyl)-2-naphthol
TTDR00587	Inhibitor	6-(4-hydroxyphenyl)-1-naphthol
TTDR00587	Inhibitor	6-oxo-16-formyl-estrone
TTDR00587	Inhibitor	6-oxo-estrone
TTDR00587	Inhibitor	7-(3-hydroxyphenyl)-2-naphthol
TTDR00587	Inhibitor	7-Hydroxy-3-(3-hydroxyphenyl)-1-naphthonitrile
TTDR00587	Inhibitor	APIGENIN
TTDR00587	Inhibitor	BVT-14225
TTDR00587	Inhibitor	BVT-2733
TTDR00587	Inhibitor	Dihydrotestosterone
TTDR00587	Inhibitor	EM-1745
TTDR00587	Inhibitor	Equilin
TTDR00587	Inhibitor	KAEMPFEROL
TTDR00587	Inhibitor	N(1'-Phenyl-ethyl) estradiol-16-carboxamide
TTDR00587	Inhibitor	N(4'-methyl-piperazinyl) estradiol-16-carboxamide
TTDR00587	Inhibitor	N(furan-2-ylmethyl)-estrone-16-methyl carboxamide
TTDR00587	Inhibitor	N(pyridin-3-ylmethyl) estradiol-16-carboxamide
TTDR00587	Inhibitor	N(pyridin-4-ylmethyl) estradiol-16-carboxamide
TTDR00587	Inhibitor	N,N-diethyl estrone-16-methyl carboxamide
TTDR00587	Inhibitor	N-(furan-2-ylmethyl)estradiol-16-carboxamide
TTDR00587	Inhibitor	N-N-diethyl estradiol-16-methyl carboxamide
TTDR00587	Inhibitor	N-ethyl estradiol-16-methyl carboxamide
TTDR00587	Inhibitor	N-ethyl estrone-16-methyl carboxamide
TTDR00587	Inhibitor	N-isopropyl estradiol-16-carboxamide
TTDR00587	Inhibitor	N-isopropyl estradiol-16-methyl carboxamide
TTDR00587	Inhibitor	N-isopropyl estrone-16-methyl carboxamide
TTDR00587	Inhibitor	N-methoxyethyl estrone-16-methyl carboxamide
TTDR00587	Inhibitor	N-methyl estradiol-16-methyl carboxamide
TTDR00587	Inhibitor	N-methyl estrone-16-methyl carboxamide
TTDR00587	Inhibitor	N-methyl-N-ethyl estradiol-16-carboxamide
TTDR00587	Inhibitor	N-methyl-N-ethyl estrone-16-methyl carboxamide
TTDR00587	Inhibitor	NARINGENIN
TTDR00587	Inhibitor	NSC-94258
TTDR00587	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00587	Inhibitor	[1,1';4',1'']Terphenyl-3,3''-diol
TTDR00587	Inhibitor	ethyl estrone-16-methylcarboxylate
TTDR00587	Inhibitor	methyl estradiol-16-beta-carboxylate
TTDR00587	Agonist	4-Androstenedione
TTDR00588	UniProt ID	Q8IWY7
TTDR00588	Name	Tubulin associated unit Tau
TTDR00588	Type of target	Research target
TTDR00588	Synonyms	Tau kinase
TTDR00588	Disease	Alzheimer's disease
TTDR00588	Sequence	MESVEKDWGWGLWRNLRCLGHAHQGKCCTEGGISSTTKTSSENGSCCFEKAARKDHVCRFIGCGRNDRFNYVVMQLQGRN
TTDR00588	EC Number	EC 2.7.1.-
TTDR00589	UniProt ID	P16788
TTDR00589	Name	Ganciclovir kinase
TTDR00589	Type of target	Research target
TTDR00589	Synonyms	HSRF3 protein
TTDR00589	Synonyms	Human cytomegalovirus UL97 protein kinase
TTDR00589	Disease	Viral infection, unspecified
TTDR00589	Function	Phosphorylates the antiviral nucleoside analog ganciclovir.
TTDR00589	Sequence	MSSALRSRARSASLGTTTQGWDPPPLRRPSRARRRQWMREAAQAAAQAAVQAAQAAAAQVAQAHVDENEVVDLMADEAGG
TTDR00589	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00589	EC Number	EC 2.7.1.-
TTDR00589	Inhibitor	Maribavir
TTDR00590	UniProt ID	P16753
TTDR00590	Name	Human cytomegalovirus protease
TTDR00590	Type of target	Research target
TTDR00590	Synonyms	Assemblin
TTDR00590	Synonyms	Capsid protein P40
TTDR00590	Disease	Viral infection, unspecified
TTDR00590	Function	The capsid assembly protein is a component of the capsid core involved in proces
TTDR00590	Sequence	MTMDEQQSQAVAPVYVGGFLARYDQSPDEAELLLPRDVVEHWLHAQGQGQPSLSVALPLNINHDDTAVVGHVAAMQSVRD
TTDR00590	PDB Structure	1CMV; 1ID4; 1IEC; 1IED; 1IEF; 1IEG; 1JQ6; 1JQ7; 1LAY; 1NJT; 1NJU; 1NKK; 1NKM; 1W
TTDR00590	BioChemical Class	Protease
TTDR00590	EC Number	EC 3.4.21.97
TTDR00590	Inhibitor	Monoisopropyl Ester Phosphonic Acid Group
TTDR00590	Inhibitor	N-(1-PHENYL-PROPYL)-FORMAMIDE
TTDR00590	Inhibitor	O-Benzylsulfonyl-Serine
TTDR00590	Inhibitor	S-(Dimethylarsenic)Cysteine
TTDR00591	UniProt ID	P24247
TTDR00591	Name	MTA/SAH nucleosidase
TTDR00591	Type of target	Research target
TTDR00591	Synonyms	5'-Methylthioadenosine/S-adenosylhomocysteine (MTA/AdoHcy) nucleosidase
TTDR00591	Synonyms	5'-methylthioadenosine nucleosidase
TTDR00591	Synonyms	P46
TTDR00591	Synonyms	S-adenosylhomocysteine nucleosidase
TTDR00591	Disease	Bacterial infections
TTDR00591	Function	Responsible for cleavage of the glycosidic bond in both 5'-methylthioadenosine (
TTDR00591	Sequence	MKIGIIGAMEEEVTLLRDKIENRQTISLGGCEIYTGQLNGTEVALLKSGIGKVAAALGATLLLEHCKPDVIINTGSAGGL
TTDR00591	PDB Structure	3DF9; 1JYS; 1NC1; 1NC3; 1Y6Q; 1Y6R; 1Z5N; 1Z5O
TTDR00591	EC Number	EC 3.2.2.16
TTDR00591	EC Number	EC 3.2.2.9
TTDR00591	Inhibitor	5'-Deoxy-5'-(Methylthio)-Tubercidin
TTDR00591	Inhibitor	Formycin
TTDR00592	UniProt ID	P14743
TTDR00592	UniProt ID	P30418
TTDR00592	UniProt ID	P34763
TTDR00592	Name	Glycylpeptide N-tetradecanoyltransferase
TTDR00592	Type of target	Research target
TTDR00592	Synonyms	Myristoyl-CoA:protein N-myristoyltransferase
TTDR00592	Synonyms	NMT
TTDR00592	Synonyms	Peptide N-myristoyltransferase
TTDR00592	Disease	Fungal diseases
TTDR00592	Disease	Human immunodeficiency virus [HIV] disease
TTDR00592	Disease	Kinetoplastida parasite infection
TTDR00592	Disease	Neoplastic diseases
TTDR00592	Disease	Viral infection, unspecified
TTDR00592	Function	Adds a myristoyl group to the n-terminal glycine residue of certain cellular pro
TTDR00592	Sequence	MSEEDKAKKLENLLKLLQLNNDDTSKFTQEQKKAMKDHKFWRTQPVKDFDEKVVEEGPIDKPKTPEDISDKPLPLLSSFE
TTDR00592	PDB Structure	1IYK; 1IYL; 1NMT
TTDR00592	BioChemical Class	Acyltransferases
TTDR00592	EC Number	EC 2.3.1.97
TTDR00592	Target Validation	TTDR00592
TTDR00592	Inhibitor	(S-(2-oxo)pentadecyl-CoA)
TTDR00592	Inhibitor	Myristoyl-Coa
TTDR00592	Inhibitor	SC-58272
TTDR00593	UniProt ID	P35398
TTDR00593	Name	Nuclear receptor ROR-alpha
TTDR00593	Type of target	Research target
TTDR00593	Synonyms	Nuclear receptor RZR-alpha
TTDR00593	Synonyms	Retinoic acid-related orphan receptor alpha
TTDR00593	Disease	Cholesterol-related diseases
TTDR00593	Disease	Chronic inflammatory diseases
TTDR00593	Function	Orphan nuclear receptor. Binds dna as a monomer to hormone response elements (hr
TTDR00593	Sequence	MNEGAPGDSDLETEARVPWSIMGHCLRTGQARMSATPTPAGEGARRDELFGILQILHQCILSSGDAFVLTGVCCSWRQNG
TTDR00593	PDB Structure	1N83; 1S0X
TTDR00593	BioChemical Class	Zinc-finger
TTDR00593	Inhibitor	Cholesterol
TTDR00593	Inhibitor	Cholesterol-Sulfate
TTDR00594	UniProt ID	P97175
TTDR00594	Name	Immunogenic protein MPT63/MPB63
TTDR00594	Type of target	Research target
TTDR00594	Synonyms	16 kDa immunoprotective extracellular protein
TTDR00594	Synonyms	Antigen MPT63/MPB63
TTDR00594	Synonyms	MPT63
TTDR00594	Disease	Tuberculosis
TTDR00594	Sequence	MKLTTMIKTAVAVVAMAAIATFAAPVALAAYPITGKLGSELTMTDTVGQVVLGWKVSDLKSSTAVIPGYPVAGQVWEATA
TTDR00594	PDB Structure	1LMI
TTDR00595	UniProt ID	P96966
TTDR00595	Name	Kgp protease
TTDR00595	Type of target	Research target
TTDR00595	Disease	P. gingivalis infections
TTDR00595	Sequence	MRKLLLLIAASLLGVGLYAQSAKIKLDAPTTRTTCTNNSFKQFDASFSFNEVELTKVETKGGTFASVSIPGAFPTGEVGS
TTDR00595	BioChemical Class	Protease
TTDR00596	UniProt ID	P03195
TTDR00596	UniProt ID	P06968
TTDR00596	UniProt ID	P33316
TTDR00596	Name	Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial
TTDR00596	Type of target	Research target
TTDR00596	Synonyms	DUTP pyrophosphatase
TTDR00596	Synonyms	DUTPase
TTDR00596	Synonyms	Deoxyuridine 5'-triphosphate nucleotidohydrolase
TTDR00596	Synonyms	Deoxyuridine triphosphate nucleotidohydrolase
TTDR00596	Disease	Cancer, unspecific
TTDR00596	Disease	Herpes virus infection
TTDR00596	Disease	Viral infection, unspecified
TTDR00596	Function	This enzyme is involved in nucleotide metabolism: it produces dump, the immediat
TTDR00596	Sequence	MEACPHIRYAFQNDKLLLQQASVGRLTLVNKTTILLRPMKTTTVDLGLYARPPEGHGLMLWGSTSRPVTSHVGIIDPGYT
TTDR00596	PDB Structure	1Q5H; 1Q5U; 2HQU; 3ARA; 3ARN; 3EHW
TTDR00596	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00596	Pathway	Metabolic pathways
TTDR00596	Pathway	Pyrimidine metabolism
TTDR00596	EC Number	EC 3.6.1.23
TTDR00596	Target Validation	TTDR00596
TTDR00596	Inhibitor	1-(3-tritylaminopropyl)uracil
TTDR00596	Inhibitor	1-[(Z)-4-trityloxy-2-butenyl]uracil
TTDR00596	Inhibitor	1-[2-(trityloxy)ethoxymethyl]uracil
TTDR00596	Inhibitor	1-[4-hydroxy-3-(tritylaminomethyl)butyl]uracil
TTDR00596	Inhibitor	2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate
TTDR00596	Inhibitor	2'-deoxyuridine 5'-alpha,beta-imido-diphosphate
TTDR00596	Inhibitor	2'-deoxyuridylic acid
TTDR00596	Inhibitor	Acetate Ion
TTDR00596	Inhibitor	Deoxyuridine-5'-Diphosphate
TTDR00596	Inhibitor	Deoxyuridine-5'-Triphosphate
TTDR00597	UniProt ID	Q8I8A4
TTDR00597	UniProt ID	Q9Y2B2
TTDR00597	Name	N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase
TTDR00597	Type of target	Research target
TTDR00597	Synonyms	GlcNAc-PI de-N-acetylase
TTDR00597	Synonyms	PIG-L
TTDR00597	Synonyms	Phosphatidylinositol-glycan biosynthesis, class L protein
TTDR00597	Disease	African trypanosomiasis
TTDR00597	Function	Involved in the second step of gpi biosynthesis. De-n- acetylation of n-acetylgl
TTDR00597	Sequence	MHSITVVCISVVLALLLLLWMKISNLAGTSVRSDVLFVFAHPDDEAMFFTPLLHSLRTQRVTVHFLCLSNGNYAGMGKER
TTDR00597	BioChemical Class	Hydrolases acting on ester bonds
TTDR00597	Pathway	Glycosylphosphatidylinositol(GPI)-anchor
TTDR00597	Pathway	Metabolic pathways
TTDR00597	EC Number	EC 3.5.1.89
TTDR00598	UniProt ID	O97467
TTDR00598	UniProt ID	Q9P3U6
TTDR00598	Name	Hexose transporter 1
TTDR00598	Type of target	Research target
TTDR00598	Synonyms	Hexose transporter
TTDR00598	Synonyms	Putative sugar transporter
TTDR00598	Disease	Malaria
TTDR00598	Function	High-affinity glucose transporter.
TTDR00598	Sequence	MTKSSKDICSENEGKKNGKSGFFSTSFKYVLSACIASFIFGYQVSVLNTIKNFIVVEFEWCKGEKDRLNCSNNTIQSSFL
TTDR00598	PDB Structure	1LVI
TTDR00598	BioChemical Class	Transmembrane protein
TTDR00598	Blocker	O-3-hexose derivatives
TTDR00598	Binder	Glucose analogue
TTDR00599	UniProt ID	P90582
TTDR00599	Name	Histidine-rich protein II
TTDR00599	Type of target	Research target
TTDR00599	Synonyms	HRP-2
TTDR00599	Synonyms	Histidine-rich protein 2
TTDR00599	Disease	Malaria
TTDR00599	Sequence	MVSFSKNKVLSAAVFASVLLLDNNNSAFNNNLCSKNAKGLNLNKRLLHETQAHVDDAHHAHHVADAHHAHHAADAHHAHH
TTDR00600	UniProt ID	Q27733
TTDR00600	Name	Delta-aminolevulinic acid synthetase
TTDR00600	Type of target	Research target
TTDR00600	Synonyms	Delta-aminolaevulinate synthase
TTDR00600	Disease	Malaria
TTDR00600	Sequence	MRKKRTLKVSINEIKKYCPFVKNIQFLYNTNEKKNNLVLSVMSDLCPVGKAINEKHFIIIDNKSKINIIKILKQANMQSK
TTDR00600	BioChemical Class	Acyltransferases
TTDR00600	EC Number	EC 2.3.1.37
TTDR00601	UniProt ID	Q43445
TTDR00601	UniProt ID	Q6RW42
TTDR00601	UniProt ID	Q96WX4
TTDR00601	Name	S-adenosyl-L-methionine:C-24 sterol methyl transferase
TTDR00601	Type of target	Research target
TTDR00601	Synonyms	S-adenosyl-L-methionine-C-24-delta-sterol-methyltransferase
TTDR00601	Synonyms	S-adenosyl-L-methionine:sterol C-24 methyl transferase
TTDR00601	Synonyms	SAM:SMT
TTDR00601	Disease	Pneumocystis infections
TTDR00601	Sequence	MQKKKKNRNEVVLCSAEGTGGCSRLAAMDLASNLGGKIDKAEVLSAVQKYEKYHVCYGGQEEERKANYTDMVNKYYDLVT
TTDR00601	BioChemical Class	Transferases transferring one-carbon groups
TTDR00601	EC Number	EC 2.1.1.41
TTDR00601	Target Validation	TTDR00601
TTDR00601	Inhibitor	24-thiacycloartanol
TTDR00602	UniProt ID	P44308
TTDR00602	Name	Haemophilus influenzae NadR protein
TTDR00602	Type of target	Research target
TTDR00602	Synonyms	Transcriptional regulator nadR
TTDR00602	Disease	Infections
TTDR00602	Function	Nadr is bifunctional; it interacts with pnuc at low internal nad levels, permitt
TTDR00602	Sequence	MGFTTGREFHPALRMRAKYNAKYLGTKSEREKYFHLAYNKHTQFLRYQEQIMSKTKEKKVGVIFGKFYPVHTGHINMIYE
TTDR00602	PDB Structure	1LW7
TTDR00602	Pathway	Metabolic pathways
TTDR00602	Pathway	Nicotinate and nicotinamide metabolism
TTDR00602	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00603	Name	CAMP-specific 3',5'-cyclic phosphodiesterase 2C
TTDR00603	Type of target	Research target
TTDR00603	Synonyms	CAMP-specific phosphodiesterase PDE2C
TTDR00603	Synonyms	Cyclic Amp phosphodiesterase
TTDR00603	Disease	Trypanolytic infections
TTDR00603	EC Number	EC 3.1.4.17
TTDR00604	UniProt ID	P42771
TTDR00604	Name	Cyclin-dependent kinase 4 inhibitor A
TTDR00604	Type of target	Research target
TTDR00604	Synonyms	CDK4I
TTDR00604	Synonyms	MTS1
TTDR00604	Synonyms	Multiple tumor suppressor 1
TTDR00604	Synonyms	P16 gene
TTDR00604	Synonyms	P16-INK4
TTDR00604	Synonyms	P16-INK4a
TTDR00604	Synonyms	Tumour suppressor gene p16
TTDR00604	Disease	Multiple myeloma
TTDR00604	Function	Interacts strongly with cdk4 and cdk6. Inhibits their ability to interact with c
TTDR00604	Sequence	MEPAAGSSMEPSADWLATAAARGRVEEVRALLEAGALPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCADPATLTR
TTDR00604	PDB Structure	1A5E; 1BI7; 1DC2; 2A5E
TTDR00604	Pathway	Bladder cancer
TTDR00604	Pathway	Cell cycle
TTDR00604	Pathway	Chronic myeloid leukemia
TTDR00604	Pathway	Glioma
TTDR00604	Pathway	Melanoma
TTDR00604	Pathway	Non-small cell lung cancer
TTDR00604	Pathway	Pancreatic cancer
TTDR00604	Pathway	Pathways in cancer
TTDR00604	Pathway	p53 signaling pathway
TTDR00605	UniProt ID	Q9NRA2
TTDR00605	Name	Protein HP59
TTDR00605	Type of target	Research target
TTDR00605	Synonyms	AST
TTDR00605	Synonyms	Membrane glycoprotein HP59
TTDR00605	Synonyms	Sodium/sialic acid cotransporter
TTDR00605	Synonyms	Solute carrier family 17 member 5
TTDR00605	Disease	Tumor angiogenesis
TTDR00605	Sequence	MRSPVRDLARNDGEESTDRTPLLPGAPRAEAAPVCCSARYNLAILAFFGFFIVYALRVNLSVALVDMVDSNTTLEDNRTS
TTDR00605	BioChemical Class	Transmembrane protein
TTDR00605	Pathway	Lysosome
TTDR00606	UniProt ID	Q8I6U5
TTDR00606	Name	Cysteine protease falcipain-2
TTDR00606	Type of target	Research target
TTDR00606	Synonyms	Falcipain-2
TTDR00606	Disease	Malaria
TTDR00606	Sequence	MDYHMDYIPNEVISHQGERFVDKYVDRKILKNKKSLLVIISLSVLSVVGFILFYFTPNFRKSDLFKNSSVENNNDDYIIN
TTDR00606	BioChemical Class	Protease
TTDR00606	Target Validation	TTDR00606
TTDR00606	Inhibitor	FITC-LMNNAEHINQFYMFI
TTDR00606	Inhibitor	Leupeptin
TTDR00606	Inhibitor	MDL-2170;MDL-28170
TTDR00606	Inhibitor	Pepstatin
TTDR00606	Binder	Vinylsulphones
TTDR00607	UniProt ID	Q8IIL0
TTDR00607	Name	Falcipain-3
TTDR00607	Type of target	Research target
TTDR00607	Disease	Malaria
TTDR00607	Sequence	MEYHMEYSPNEVIKQEREVFVGKEKSGSKFKRKRSIFIVLTVSICFMFALMLFYFTRNENNKTLFTNSLSNNINDDYIIN
TTDR00607	Inhibitor	Leupeptin
TTDR00607	Inhibitor	Pepstatin
TTDR00608	UniProt ID	O43768
TTDR00608	Name	Alpha-endosulfine
TTDR00608	Type of target	Research target
TTDR00608	Disease	Alzheimer's disease
TTDR00608	Function	Endogenous ligand for sulfonylurea receptor. By inhibiting sulfonylurea from bin
TTDR00608	Sequence	MSQKQEEENPAEETGEEKQDTQEKEGILPERAEEAKLKAKYPSLGQKPGGSDFLMKRLQKGQKYFDSGDYNMAKAKMKNK
TTDR00609	UniProt ID	O13297
TTDR00609	UniProt ID	O93803
TTDR00609	Name	RNA triphosphatase
TTDR00609	Type of target	Research target
TTDR00609	Synonyms	CET1
TTDR00609	Synonyms	MRNA 5'-triphosphatase
TTDR00609	Synonyms	MRNA capping enzyme beta subunit
TTDR00609	Synonyms	Polynucleotide 5'-triphosphatase
TTDR00609	Synonyms	TPase
TTDR00609	Disease	Fungal diseases
TTDR00609	Disease	Malaria
TTDR00609	Function	First step of mrna capping. Converts the 5'- triphosphate end of a nascent mrna
TTDR00609	Sequence	MSYTDNPPQTKRALSLDDLVNHDENEKVKLQKLSEAANGSRPFAENLESDINQTETGQAAPIDNYKESTGHGSHSQKPKS
TTDR00609	PDB Structure	1D8H; 1D8I; 3KYH
TTDR00609	BioChemical Class	Hydrolases acting on ester bonds
TTDR00609	EC Number	EC 3.1.3.33
TTDR00610	UniProt ID	O15564
TTDR00610	UniProt ID	P13254
TTDR00610	Name	Methionine gamma-lyase
TTDR00610	Type of target	Research target
TTDR00610	Synonyms	L-methioninase
TTDR00610	Disease	Prokaryotic and eukaryotic anaerobic pathogens infections
TTDR00610	Sequence	MSHERMTPATACIHANPQKDQFGAAIPPIYQTSTFVFDNCQQGGNRFAGQESGYIYTRLGNPTVSNLEGKIAFLEKTEAC
TTDR00610	PDB Structure	1GC0; 1GC2; 1PG8; 1UKJ; 2O7C; 3VK2; 3VK3; 3VK4
TTDR00610	BioChemical Class	Carbon-sulfur lyases
TTDR00610	EC Number	EC 4.4.1.11
TTDR00610	Inhibitor	N'-Pyridoxyl-Lysine-5'-Monophosphate
TTDR00610	Inhibitor	Trifluoromethionine
TTDR00611	UniProt ID	P08575
TTDR00611	Name	Leukocyte common antigen
TTDR00611	Type of target	Research target
TTDR00611	Synonyms	CD45
TTDR00611	Synonyms	CD45 antigen
TTDR00611	Synonyms	L-CA
TTDR00611	Synonyms	T200
TTDR00611	Disease	Alzheimer's disease
TTDR00611	Function	Required for t-cell activation through the antigen receptor. The first ptpase do
TTDR00611	Sequence	MYLWLKLLAFGFAFLDTEVFVTGQSPTPSPTGLTTAKMPSVPLSSDPLPTHTTAFSPASTFERENDFSETTTSLSPDNTS
TTDR00611	PDB Structure	1YGR; 1YGU
TTDR00611	BioChemical Class	Hydrolases acting on ester bonds
TTDR00611	Pathway	Cell adhesion molecules (CAMs)
TTDR00611	Pathway	Primary immunodeficiency
TTDR00611	Pathway	T cell receptor signaling pathway
TTDR00611	EC Number	EC 3.1.3.48
TTDR00611	Target Validation	TTDR00611
TTDR00611	Inhibitor	Asp-BrPmp-Leu
TTDR00612	UniProt ID	Q969V1
TTDR00612	Name	Melanin-concentrating hormone receptor 2
TTDR00612	Type of target	Research target
TTDR00612	Synonyms	G protein coupled receptor 145
TTDR00612	Synonyms	GPRv17
TTDR00612	Synonyms	MCH receptor 2
TTDR00612	Synonyms	MCH(2) receptor
TTDR00612	Synonyms	MCH-2R
TTDR00612	Synonyms	MCH-R2
TTDR00612	Synonyms	MCH2
TTDR00612	Synonyms	MCH2R
TTDR00612	Synonyms	MCHR-2
TTDR00612	Disease	Obesity
TTDR00612	Disease	Social anxiety disorder
TTDR00612	Function	Receptor for melanin-concentrating hormone, coupled to G proteins that activate
TTDR00612	Sequence	MNPFHASCWNTSAELLNKSWNKEFAYQTASVVDTVILPSMIGIICSTGLVGNILIVFTIIRSRKKTVPDIYICNLAVADL
TTDR00612	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00612	Pathway	Neuroactive ligand-receptor interaction
TTDR00613	UniProt ID	P31952
TTDR00613	Name	Mycobacterium tuberculosis 30 kDa major secretory protein
TTDR00613	Type of target	Research target
TTDR00613	Synonyms	30 kDa extracellular protein
TTDR00613	Synonyms	85B
TTDR00613	Synonyms	Ag85B
TTDR00613	Synonyms	Antigen 85 complex B
TTDR00613	Synonyms	Antigen 85B
TTDR00613	Synonyms	Extracellular alpha-antigen
TTDR00613	Synonyms	Fibronectin-binding protein B
TTDR00613	Synonyms	Mycolyl transferase 85B
TTDR00613	Disease	Tuberculosis
TTDR00613	Function	Proteins of the antigen 85 complex are responsible for the high affinity of myco
TTDR00613	Sequence	MTDVSRKIRAWGRRLMIGTAAAVVLPGLVGLAGGAATAGAFSRPGLPVEYLQVPSPSMGRDIKVQFQSGGNNSPAVYLLD
TTDR00613	PDB Structure	1F0N; 1F0P
TTDR00613	EC Number	EC 2.3.1.-
TTDR00614	UniProt ID	O93796
TTDR00614	Name	Elongation factor 3
TTDR00614	Type of target	Research target
TTDR00614	Synonyms	EF-3
TTDR00614	Disease	Fungal diseases
TTDR00614	Function	The main role of ef-3 may be to transduce nucleoside triphosphate energy into me
TTDR00614	Sequence	MTDSDQSLKVLEELFKNLSVATADNRVEAAQEVASFLNGNIIEHDIPEKFFEELAKAVKDKKTSANFLEAVAHIANEANL
TTDR00614	BioChemical Class	ABC transporter
TTDR00615	UniProt ID	P48507
TTDR00615	UniProt ID	Q26820
TTDR00615	UniProt ID	Q9UB86
TTDR00615	Name	Glutamate--cysteine ligase regulatory subunit
TTDR00615	Type of target	Research target
TTDR00615	Synonyms	GCS
TTDR00615	Synonyms	GCS light chain
TTDR00615	Synonyms	Gamma-ECS
TTDR00615	Synonyms	Gamma-GCS
TTDR00615	Synonyms	Gamma-glutamylcysteine synthetase
TTDR00615	Synonyms	Glutamate cysteine ligase
TTDR00615	Synonyms	Glutamate--cysteine ligase
TTDR00615	Synonyms	Glutamate--cysteine ligase modifier subunit
TTDR00615	Disease	Lung cancer
TTDR00615	Disease	Malaria
TTDR00615	Disease	Parasitic diseases
TTDR00615	Disease	Trypanosomiasis
TTDR00615	Sequence	MGFLKIGTPLSWDDVQDVKSLIRLYGILQFVHVXKLNKDRYDENIMFGDEIEYIIIRNDESLKESSALLCASDLIDEMMN
TTDR00615	Pathway	Glutathione metabolism
TTDR00615	Pathway	Metabolic pathways
TTDR00615	EC Number	EC 6.3.2.2
TTDR00615	Inhibitor	Adenosine-5'-Diphosphate
TTDR00615	Inhibitor	BSO
TTDR00615	Inhibitor	Buthionine sulfoximine
TTDR00615	Inhibitor	Cystamine
TTDR00615	Inhibitor	N-Formylmethionine
TTDR00617	UniProt ID	Q99WJ1
TTDR00617	UniProt ID	Q9U6Y2
TTDR00617	Name	Xanthine phosphoribosyltransferase
TTDR00617	Type of target	Research target
TTDR00617	Synonyms	XPRT
TTDR00617	Disease	Parasitic diseases
TTDR00617	Sequence	MLPTHSCKGFVDAQGRVFVDGREYPMASGIVATEDVIQTNIKAMAHTIAKDYKSLSHRDARLSPSTAETAEAAEAAEAPI
TTDR00617	BioChemical Class	Glycosyltransferases
TTDR00617	Pathway	Metabolic pathways
TTDR00617	Pathway	Purine metabolism
TTDR00617	EC Number	EC 2.4.2.22
TTDR00617	Inhibitor	Carboxylic PRPP
TTDR00617	Inhibitor	Guanine
TTDR00617	Inhibitor	Guanosine-5',3'-Tetraphosphate
TTDR00617	Inhibitor	Guanosine-5'-Monophosphate
TTDR00617	Inhibitor	Xanthine
TTDR00618	UniProt ID	P07833
TTDR00618	UniProt ID	P20035
TTDR00618	Name	Hypoxanthine-guanine-xanthine phosphoribosyltransferase
TTDR00618	Type of target	Research target
TTDR00618	Synonyms	HGPRT
TTDR00618	Synonyms	HGXPRT
TTDR00618	Synonyms	HGXPRTase
TTDR00618	Synonyms	LACZ
TTDR00618	Disease	Malaria
TTDR00618	Disease	Parasitic diseases
TTDR00618	Disease	Trichomoniasis
TTDR00618	Function	Works with guanine, hypoxanthine and xanthine.
TTDR00618	Sequence	MPIPNNPGAGENAFDPVFVNDDDGYDLDSFMIPAHYKKYLTKVLVPNGVIKNRIEKLAYDIKKVYNNEEFHILCLLKGSR
TTDR00618	PDB Structure	1CJB; 2VFA; 3OZF; 3OZG
TTDR00618	BioChemical Class	Glycosyltransferases
TTDR00618	EC Number	EC 2.4.2.-
TTDR00618	Inhibitor	Immucillin-H
TTDR00618	Inhibitor	Pyrophosphate 2-
TTDR00619	UniProt ID	O53752
TTDR00619	UniProt ID	P05313
TTDR00619	Name	Isocitrate lyase
TTDR00619	Type of target	Research target
TTDR00619	Synonyms	ICL
TTDR00619	Synonyms	Isocitrase
TTDR00619	Synonyms	Isocitratase
TTDR00619	Disease	Tuberculosis
TTDR00619	Sequence	MSVVGTPKSAEQIQQEWDTNPRWKDVTRTYSAEDVVALQGSVVEEHTLARRGAEVLWEQLHDLEWVNALGALTGNMAVQQ
TTDR00619	PDB Structure	1F61; 1F8I; 1F8M; 1IGW
TTDR00619	EC Number	EC 4.1.3.1
TTDR00619	Target Validation	TTDR00619
TTDR00619	Inhibitor	2,2',3-Tribromo-4,4',5,5'-tetrahydroxybibenzyl
TTDR00619	Inhibitor	3-bromopyruvate
TTDR00619	Inhibitor	3-nitropropionate
TTDR00619	Inhibitor	5,5'-methylenebis(3,4-dibromobenzene-1,2-diol)
TTDR00619	Inhibitor	Bis(2,3-dibromo-4,5-dihydroxyphenyl)ether
TTDR00619	Inhibitor	Bis(3-bromo-4,5-dihydroxyphenyl)methanone
TTDR00619	Inhibitor	Glyoxalate, Glyoxylate
TTDR00619	Inhibitor	halisulfate 1
TTDR00619	Inhibitor	hydrohalisulfate 1
TTDR00620	UniProt ID	Q01668
TTDR00620	Name	Voltage-dependent L-type calcium channel alpha-1D subunit
TTDR00620	Type of target	Research target
TTDR00620	Synonyms	Calcium channel, L type, alpha-1 polypeptide, isoform 2
TTDR00620	Synonyms	Voltage-gated L-type Ca2+ channel alpha1D
TTDR00620	Synonyms	Voltage-gated calcium channel alpha subunit Cav1.3
TTDR00620	Disease	Hepatitis, virus not identified
TTDR00620	Disease	Sinoatrial node dysfunction
TTDR00620	Function	Voltage-sensitive calcium channels (vscc) mediate the entry of calcium ions into
TTDR00620	Sequence	MMMMMMMKKMQHQRQQQADHANEANYARGTRLPLSGEGPTSQPNSSKQTVLSWQAAIDAARQAKAAQTMSTSAPPPVGSL
TTDR00620	PDB Structure	3LV3
TTDR00620	BioChemical Class	Voltage-gated channel
TTDR00620	Pathway	Alzheimer's disease
TTDR00620	Pathway	Calcium signaling pathway
TTDR00620	Pathway	Cardiac muscle contraction
TTDR00620	Pathway	GnRH signaling pathway
TTDR00620	Pathway	MAPK signaling pathway
TTDR00620	Pathway	Type II diabetes mellitus
TTDR00620	Pathway	Vascular smooth muscle contraction
TTDR00620	Target Validation	TTDR00620
TTDR00620	Inhibitor	(+)-NIGULDIPINE
TTDR00620	Inhibitor	(-)-NIGULDIPINE
TTDR00620	Inhibitor	BELFOSDIL
TTDR00620	Inhibitor	CGS-27830
TTDR00620	Inhibitor	CV-4093
TTDR00620	Inhibitor	MEBUDIPINE
TTDR00620	Inhibitor	N,N'-Di-acenaphthen-5-yl-guanidine
TTDR00620	Inhibitor	NILVADIPINE
TTDR00620	Inhibitor	PD-32577
TTDR00620	Inhibitor	SIPATRIGINE
TTDR00620	Inhibitor	SNAP-5089
TTDR00621	Name	Synapsin
TTDR00621	Type of target	Research target
TTDR00621	Disease	Cyclosporine A-induced hypertension
TTDR00622	UniProt ID	O14735
TTDR00622	UniProt ID	P96282
TTDR00622	Name	CDP-diacylglycerol--inositol 3-phosphatidyltransferase
TTDR00622	Type of target	Research target
TTDR00622	Synonyms	PI synthase
TTDR00622	Synonyms	Phosphatidylinositol synthase
TTDR00622	Synonyms	PtdIns synthase
TTDR00622	Disease	Tuberculosis
TTDR00622	Function	Catalyzes the biosynthesis of phosphatidylinositol (ptdins) as well as ptdins:in
TTDR00622	Sequence	MIGKPRGRRGVNLQILPSAMTVLSICAGLTAIKFALEHQPKAAMALIAAAAILDGLDGRVARILDAQSRMGAEIDSLADA
TTDR00622	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00622	Pathway	Glycerophospholipid metabolism
TTDR00622	Pathway	Glycine, serine and threonine metabolism
TTDR00622	Pathway	Inositol phosphate metabolism
TTDR00622	Pathway	Metabolic pathways
TTDR00622	Pathway	Phosphatidylinositol signaling system
TTDR00622	EC Number	EC 2.7.8.11
TTDR00622	Inhibitor	Epi-inositol
TTDR00622	Inhibitor	Myo-Inositol
TTDR00622	Inhibitor	Myo-inositol
TTDR00622	Inhibitor	Scyllo-inositol
TTDR00622	Inhibitor	Zn2+
TTDR00623	UniProt ID	P21695
TTDR00623	Name	Glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic
TTDR00623	Type of target	Research target
TTDR00623	Synonyms	GPD-C
TTDR00623	Synonyms	GPDH-C
TTDR00623	Synonyms	Glycerol-3-phosphate dehydrogenase [NAD+]
TTDR00623	Synonyms	NAD-dependent glycerol-3-phosphate dehydrogenase
TTDR00623	Disease	Chagas' disease
TTDR00623	Disease	Parasitic diseases
TTDR00623	Disease	Sleeping sickness
TTDR00623	Sequence	MASKKVCIVGSGNWGSAIAKIVGGNAAQLAQFDPRVTMWVFEEDIGGKKLTEIINTQHENVKYLPGHKLPPNVVAVPDVV
TTDR00623	PDB Structure	1WPQ; 1X0V; 1X0X
TTDR00623	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00623	Pathway	Glycerophospholipid metabolism
TTDR00623	EC Number	EC 1.1.1.8
TTDR00624	UniProt ID	P16455
TTDR00624	Name	Methylated-DNA--protein-cysteine methyltransferase
TTDR00624	Type of target	Research target
TTDR00624	Synonyms	6-O-methylguanine-DNA methyltransferase
TTDR00624	Synonyms	Human O(6)-alkylguanine-DNA alkyltransferase
TTDR00624	Synonyms	MGMT
TTDR00624	Synonyms	O-6-methylguanine-DNA-alkyltransferase
TTDR00624	Disease	Cancer, unspecific
TTDR00624	Function	Repair of alkylated guanine in dna by stoichiometrically transferring the alkyl
TTDR00624	Sequence	MDKDCEMKRTTLDSPLGKLELSGCEQGLHEIKLLGKGTSAADAVEVPAPAAVLGGPEPLMQCTAWLNAYFHQPEAIEEFP
TTDR00624	PDB Structure	1EH6; 1EH7; 1EH8; 1QNT; 1T38; 1T39; 1YFH
TTDR00624	BioChemical Class	Transferases transferring one-carbon groups
TTDR00624	EC Number	EC 2.1.1.63
TTDR00624	Target Validation	TTDR00624
TTDR00624	Inhibitor	6-Allyloxy-9H-purin-2-ylamine
TTDR00624	Inhibitor	6-Benzyloxy-5-nitro-pyrimidine-2,4-diamine
TTDR00624	Inhibitor	6-Benzyloxy-5-nitroso-pyrimidine-2,4-diamine
TTDR00624	Inhibitor	6-Benzyloxy-9H-purin-2-ylamine
TTDR00624	Inhibitor	Benzylcysteine
TTDR00624	Inhibitor	S-Methylcysteine
TTDR00625	UniProt ID	P19582
TTDR00625	Name	Homoserine dehydrogenase
TTDR00625	Type of target	Research target
TTDR00625	Synonyms	HDH
TTDR00625	Synonyms	HSD
TTDR00625	Disease	Fungal diseases
TTDR00625	Sequence	MKAIRVGLLGLGTVGSGVVKIIQDHQDKLMHQVGCPVTIKKVLVKDLEKKREVDLPKEVLTTEVYDVIDDPDVDVVIEVI
TTDR00625	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00625	Pathway	Glycine, serine and threonine metabolism
TTDR00625	Pathway	Lysine biosynthesis
TTDR00625	Pathway	Metabolic pathways
TTDR00625	EC Number	EC 1.1.1.3
TTDR00626	UniProt ID	Q01650
TTDR00626	Name	Large neutral amino acids transporter small subunit 1
TTDR00626	Type of target	Research target
TTDR00626	Synonyms	4F2 LC
TTDR00626	Synonyms	4F2 light chain
TTDR00626	Synonyms	4F2LC
TTDR00626	Synonyms	CD98 light chain
TTDR00626	Synonyms	HLAT1
TTDR00626	Synonyms	Integral membrane protein E16
TTDR00626	Synonyms	L-type amino acid transporter 1
TTDR00626	Synonyms	L-type amino acid transporter LAT1
TTDR00626	Disease	Tumors
TTDR00626	Function	Sodium-independent, high-affinity transport of large neutral amino acids. Involv
TTDR00626	Sequence	MAGAGPKRRALAAPAAEEKEEAREKMLAAKSADGSAPAGEGEGVTLQRNITLLNGVAIIVGTIIGSGIFVTPTGVLKEAG
TTDR00626	BioChemical Class	Transmembrane protein
TTDR00626	Target Validation	TTDR00626
TTDR00626	Inhibitor	(+/-)-2-Amino-1,2,3,4-tetrahydro-2-naphthoic acid
TTDR00626	Inhibitor	(+/-)-2-Aminoindane-2-carboxylic acid
TTDR00626	Blocker	BCH
TTDR00627	UniProt ID	P26678
TTDR00627	Name	Cardiac phospholamban
TTDR00627	Type of target	Research target
TTDR00627	Synonyms	PLB
TTDR00627	Synonyms	Phospholamban
TTDR00627	Disease	Heart failure
TTDR00627	Function	Phospholamban has been postulated to regulate the activity of the calcium pump o
TTDR00627	Sequence	MEKVQYLTRSAIRRASTIEMPQQARQKLQNLFINFCLILICLLLICIIVMLL
TTDR00627	PDB Structure	1K9N; 1KCH; 1PLN; 1PLP; 1PSL; 1ZLL; 2HYN
TTDR00627	BioChemical Class	Transmembrane protein
TTDR00627	Pathway	Calcium signaling pathway
TTDR00628	UniProt ID	P53697
TTDR00628	Name	MNN9 protein
TTDR00628	Type of target	Research target
TTDR00628	Synonyms	C. albicans MNN9
TTDR00628	Disease	Fungal diseases
TTDR00628	Function	Required for complex glycosylation of secreted proteins. Required for the additi
TTDR00628	Sequence	MVHYRNRYLNYIRRKPLALLAPITLLVVIYFYFFSAHGFSSNKQKYNYNKKSRGWFYKNRDTVILKDLPKNHISHYDLNK
TTDR00628	BioChemical Class	Transmembrane protein
TTDR00629	UniProt ID	P49238
TTDR00629	Name	CX3C chemokine receptor 1
TTDR00629	Type of target	Research target
TTDR00629	Synonyms	Beta chemokine receptor-like 1
TTDR00629	Synonyms	C-X3-C CKR-1
TTDR00629	Synonyms	CMK-BRL-1
TTDR00629	Synonyms	CMKBLR1
TTDR00629	Synonyms	CX3CR1
TTDR00629	Synonyms	Fractalkine receptor
TTDR00629	Synonyms	Fractalkine receptor CX3CR1
TTDR00629	Synonyms	GPR13
TTDR00629	Synonyms	V28
TTDR00629	Disease	Endothelium-related inflammatory diseases
TTDR00629	Function	Receptor for the cx3c chemokine fractalkine and mediates both its adhesive and m
TTDR00629	Sequence	MDQFPESVTENFEYDDLAEACYIGDIVVFGTVFLSIFYSVIFAIGLVGNLLVVFALTNSKKPKSVTDIYLLNLALSDLLF
TTDR00629	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00629	Pathway	Chemokine signaling pathway
TTDR00629	Pathway	Cytokine-cytokine receptor interaction
TTDR00630	UniProt ID	O14684
TTDR00630	Name	Prostaglandin E synthase
TTDR00630	Type of target	Research target
TTDR00630	Synonyms	MGST1-L1
TTDR00630	Synonyms	MPGES-1
TTDR00630	Synonyms	Microsomal glutathione S-transferase 1-like 1
TTDR00630	Synonyms	Microsomal prostaglandin E synthase 1
TTDR00630	Synonyms	P53-induced apoptosis protein 12
TTDR00630	Synonyms	PGE synthase
TTDR00630	Disease	Inflammation
TTDR00630	Disease	Rheumatoid arthritis, unspecified
TTDR00630	Sequence	MPAHSLVMSSPALPAFLLCSTLLVIKMYVVAIITGQVRLRKKAFANPEDALRHGGPQYCRSDPDVERCLRAHRNDMETIY
TTDR00630	PDB Structure	3DWW; 4AL0; 4AL1
TTDR00630	BioChemical Class	Intramolecular oxidoreductases
TTDR00630	Pathway	Arachidonic acid metabolism
TTDR00630	Pathway	Metabolic pathways
TTDR00630	EC Number	EC 5.3.99.3
TTDR00630	Target Validation	TTDR00630
TTDR00630	Inhibitor	L-655240
TTDR00631	UniProt ID	P42363
TTDR00631	Name	Metal-transporter protein PsaA
TTDR00631	Type of target	Research target
TTDR00631	Synonyms	Manganese ABC transporter substrate-binding lipoprotein
TTDR00631	Synonyms	Pneumococcal surface adhesin A
TTDR00631	Disease	Streptococcus pneumoniae infections
TTDR00631	Function	Part of an atp-driven transport system for manganese. Also act as an adhesin whi
TTDR00631	Sequence	MKKIASVLALFVALLFGLLACSKGTSSKSSSDKLKVVTTNSILADITKNIAGDKIELHSIVPVGQDPHEYEPLPEDVKKT
TTDR00631	BioChemical Class	Cell membrane protein
TTDR00632	Name	Beta-ketoacyl-ACP synthase
TTDR00632	Type of target	Research target
TTDR00632	Synonyms	3-oxoacyl-ACP synthase
TTDR00632	Synonyms	Beta ketoacyl-acyl carrier protein synthase
TTDR00632	Synonyms	Beta-ketoacyl-acyl carrier protein synthase
TTDR00632	Synonyms	KAS
TTDR00632	Disease	Cancer, unspecific
TTDR00632	Disease	Tuberculosis
TTDR00632	EC Number	EC 2.3.1.41
TTDR00633	UniProt ID	O06594
TTDR00633	UniProt ID	P30011
TTDR00633	Name	Nicotinate-nucleotide pyrophosphorylase [carboxylating]
TTDR00633	Type of target	Research target
TTDR00633	Synonyms	QAPRTase
TTDR00633	Synonyms	Quinolinate phosphoribosyltransferase [decarboxylating]
TTDR00633	Synonyms	Quinolinic acid phosphoribosyltransferase
TTDR00633	Disease	Tuberculosis
TTDR00633	Sequence	MGLSDWELAAARAAIARGLDEDLRYGPDVTTLATVPASATTTASLVTREAGVVAGLDVALLTLNEVLGTNGYRVLDRVED
TTDR00633	PDB Structure	1QPN; 1QPO; 1QPQ; 1QPR
TTDR00633	BioChemical Class	Glycosyltransferases
TTDR00633	Pathway	Metabolic pathways
TTDR00633	Pathway	Nicotinate and nicotinamide metabolism
TTDR00633	EC Number	EC 2.4.2.19
TTDR00633	Target Validation	TTDR00633
TTDR00633	Inhibitor	5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate
TTDR00633	Inhibitor	Namn
TTDR00633	Inhibitor	Phthalic Acid
TTDR00633	Inhibitor	Quinolinic Acid
TTDR00634	UniProt ID	O45035
TTDR00634	UniProt ID	P07148
TTDR00634	Name	Fatty acid-binding protein, liver
TTDR00634	Type of target	Research target
TTDR00634	Synonyms	14 kDa selenium-binding protein
TTDR00634	Synonyms	14-kDa fatty-acid binding protein
TTDR00634	Synonyms	L-FABP
TTDR00634	Disease	Schistosomiasis [bilharziasis]
TTDR00634	Function	This protein binds free fatty acids and their coenzyme a derivatives, bilirubin,
TTDR00634	Sequence	MSSFLGKWKLSETHNFDAVMSKLGVSWPIRQMGNTVTPTVTFTMDGDTMTMLTESTFKNLSVTFKFGEEFDEKTSDGRNV
TTDR00634	PDB Structure	2F73; 2L67; 2L68; 2LKK; 2PY1; 3B2H; 3B2I; 3B2J; 3B2K; 3B2L; 3STK; 3STM; 3STN; 3V
TTDR00634	Pathway	PPAR signaling pathway
TTDR00634	Target Validation	TTDR00634
TTDR00634	Inhibitor	1-anilinonaphthalene-8-sulfonic acid
TTDR00634	Inhibitor	FENOFIBRIC ACID
TTDR00634	Inhibitor	INDOPROFEN
TTDR00634	Inhibitor	OLEIC ACID
TTDR00635	UniProt ID	Q41140
TTDR00635	Name	Pyrophosphate-dependent phosphofructokinase
TTDR00635	Type of target	Research target
TTDR00635	Synonyms	6-phosphofructokinase, pyrophosphate dependent
TTDR00635	Synonyms	PFP
TTDR00635	Synonyms	PPi-PFK
TTDR00635	Synonyms	Pyrophosphate--fructose 6-phosphate 1-phosphotransferase alpha subunit
TTDR00635	Synonyms	Pyrophosphate-dependent 6-phosphofructose-1-kinase
TTDR00635	Disease	Parasitic diseases
TTDR00635	Function	The alpha subunit may be involved in the regulation of pfp by fru-2,6-p (by simi
TTDR00635	Sequence	MDSDFGIPRELSDLQKLRSLYKPELPPCLQGTTVRVELGDGTTACSEAGAHTISRSFPHTYGQPLAHFLRATAKVADAHI
TTDR00635	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00635	EC Number	EC 2.7.1.90
TTDR00635	Target Validation	TTDR00635
TTDR00635	Inhibitor	POLYSIN
TTDR00636	UniProt ID	Q12570
TTDR00636	Name	Laccase
TTDR00636	Type of target	Research target
TTDR00636	Synonyms	Benzenediol:oxygen oxidoreductase
TTDR00636	Synonyms	Diphenol oxidase
TTDR00636	Synonyms	Fragment
TTDR00636	Synonyms	Urishiol oxidase
TTDR00636	Disease	Cryptococcosis
TTDR00636	Function	Lignin degradation and detoxification of lignin-derived products (by similarity)
TTDR00636	Sequence	MKNSFFSSLAKFASLSLAFALPTAEVIPSALEERQSCANTATTRSCWGQYSASTNSYTTVPKTGYWLVVQNTTLSADGVS
TTDR00636	BioChemical Class	Oxidoreductases acting on diphenols as donors
TTDR00636	EC Number	EC 1.10.3.2
TTDR00637	UniProt ID	P04790
TTDR00637	UniProt ID	Q07412
TTDR00637	Name	Triosephosphate isomerase (bacterial)
TTDR00637	Type of target	Research target
TTDR00637	Synonyms	TIM
TTDR00637	Synonyms	Triose-phosphate isomerase
TTDR00637	Disease	Malaria
TTDR00637	Disease	Trypanosomiasis
TTDR00637	Sequence	MARKYFVAANWKCNGTLESIKSLTNSFNNLDFDPSKLDVVVFPVSVHYDHTRKLLQSKFSTGIQNVSKFGNGSYTGEVSA
TTDR00637	PDB Structure	1LYX; 1LZO; 1M7O; 1M7P; 1O5X; 1VGA; 1WOA; 1WOB; 1YDV; 2FI6; 2VFD; 2VFE; 2VFF; 2V
TTDR00637	BioChemical Class	Intramolecular oxidoreductases
TTDR00637	EC Number	EC 5.3.1.1
TTDR00637	Inhibitor	2-Phosphoglyceric Acid
TTDR00637	Inhibitor	2-Phosphoglycolic Acid
TTDR00637	Inhibitor	3-Hydroxypyruvic Acid
TTDR00637	Inhibitor	3-Phosphoglyceric Acid
TTDR00637	Inhibitor	3-Phosphoglycerol
TTDR00637	Inhibitor	Glycerol-2-Phosphate
TTDR00638	UniProt ID	P10226
TTDR00638	Name	DNA polymerase processivity factor
TTDR00638	Type of target	Research target
TTDR00638	Synonyms	DNA-binding protein UL42
TTDR00638	Synonyms	PAP
TTDR00638	Synonyms	Polymerase accessory protein
TTDR00638	Synonyms	Protein UL42
TTDR00638	Disease	Herpes virus infection
TTDR00638	Function	Accessory subunit of the dna polymerase that acts to increase the processivity o
TTDR00638	Sequence	MTDSPGGVAPASPVEDASDASLGQPEEGAPCQVVLQGAELNGILQAFAPLRTSLLDSLLVMGDRGILIHNTIFGEQVFLP
TTDR00638	PDB Structure	1DML
TTDR00640	UniProt ID	P11604
TTDR00640	UniProt ID	P14223
TTDR00640	Name	Fructose-bisphosphate aldolase
TTDR00640	Type of target	Research target
TTDR00640	Synonyms	Aldolase
TTDR00640	Synonyms	FBP aldolase
TTDR00640	Disease	Malaria
TTDR00640	Sequence	MSKIFDFVKPGVITGDDVQKVFQVAKENNFALPAVNCVGTDSINAVLETAAKVKAPVIVQFSNGGASFIAGKGVKSDVPQ
TTDR00640	PDB Structure	1A5C; 2EPH; 2PC4
TTDR00640	BioChemical Class	Carbon-carbon lyases
TTDR00640	EC Number	EC 4.1.2.13
TTDR00640	Target Validation	TTDR00640
TTDR00640	Inhibitor	PHOSPHOGLYCOLOHYDROXAMATE
TTDR00641	UniProt ID	O00145
TTDR00641	Name	SH2 containing inositol-5-phosphatase
TTDR00641	Type of target	Research target
TTDR00641	Synonyms	SHIP gene
TTDR00641	Disease	Leukemia, unspecified
TTDR00641	Sequence	MVPCWNHGNITRSKAEELLSRTGKDGSFLVRASESISRAYALCVLYRNCVYTYRILPNEDDKFTVQASEGVSMRFFTKLD
TTDR00641	PDB Structure	2YSX
TTDR00641	BioChemical Class	Hydrolases acting on ester bonds
TTDR00641	Pathway	B cell receptor signaling pathway
TTDR00641	Pathway	Fc epsilon RI signaling pathway
TTDR00641	Pathway	Insulin signaling pathway
TTDR00641	Pathway	Phosphatidylinositol signaling system
TTDR00642	UniProt ID	P17813
TTDR00642	Name	Endoglin
TTDR00642	Type of target	Research target
TTDR00642	Synonyms	CD105
TTDR00642	Synonyms	CD105 antigen
TTDR00642	Disease	Cancer, unspecific
TTDR00642	Function	Major glycoprotein of vascular endothelium. May play a critical role in the bind
TTDR00642	Sequence	MDRGTLPLAVALLLASCSLSPTSLAETVHCDLQPVGPERGEVTYTTSQVSKGCVAQAPNAILEVHVLFLEFPTGPSQLEL
TTDR00642	BioChemical Class	Transmembrane protein
TTDR00644	UniProt ID	Q9Y5Y6
TTDR00644	Name	Suppressor of tumorigenicity 14
TTDR00644	Type of target	Research target
TTDR00644	Synonyms	MT-SP1
TTDR00644	Synonyms	Matriptase
TTDR00644	Synonyms	Membrane type serine protease 1
TTDR00644	Synonyms	Membrane-type serine protease 1
TTDR00644	Synonyms	Prostamin
TTDR00644	Synonyms	Serine protease TADG-15
TTDR00644	Synonyms	Tumor associated differentially-expressed gene-15 protein
TTDR00644	Disease	Breast cancer
TTDR00644	Function	Degrades extracellular matrix. Proposed to play a role in breast cancer invasion
TTDR00644	Sequence	MGSDRARKGGGGPKDFGAGLKYNSRHEKVNGLEEGVEFLPVNNVKKVEKHGPGRWVVLAAVLIGLLLVLLGIGFLVWHLQ
TTDR00644	PDB Structure	1EAW; 1EAX; 2FMV; 2GV6; 2GV7; 3BN9; 3NCL; 3NPS; 3P8F; 3P8G; 3SO3; 4IS5; 4ISL; 4I
TTDR00644	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00644	EC Number	EC 3.4.21.-
TTDR00644	Related US Patent	6,677,377
TTDR00644	Target Validation	TTDR00644
TTDR00644	Inhibitor	2-nas-phe(3-am)-4-(2-guanidinoethyl)piperidine
TTDR00644	Inhibitor	3-tapap
TTDR00644	Inhibitor	Benzamidine
TTDR00646	UniProt ID	Q9LDH0
TTDR00646	Name	Beta 1, 2-Xylosyltransferase
TTDR00646	Type of target	Research target
TTDR00646	Synonyms	Beta-(1,2)-xylosyltransferase
TTDR00646	Disease	Allergy, unspecified
TTDR00646	Function	Catalyzes beta-1,2 glycosidic linkages.
TTDR00646	Sequence	MSKRNPKILKIFLYMLLLNSLFLIIYFVFHSSSFSPEQSQPPHIYHVSVNNQSAIQKPWPILPSYLPWTPPQRNLPTGSC
TTDR00646	BioChemical Class	Glycosyltransferases
TTDR00646	Pathway	N-Glycan biosynthesis
TTDR00646	EC Number	EC 2.4.2.38
TTDR00647	Name	Phospholipase C gamma
TTDR00647	Type of target	Research target
TTDR00647	Synonyms	PLC-gamma
TTDR00647	Synonyms	PLCgamma
TTDR00647	Synonyms	Phospholipase cgamma
TTDR00647	Disease	Inflammatory bowel disease
TTDR00647	Disease	Prostate cancer
TTDR00647	Disease	Tumors
TTDR00647	EC Number	EC 3.1.4.11
TTDR00648	Name	CoA-independent transacylase
TTDR00648	Type of target	Research target
TTDR00648	Synonyms	1-alkylglycerophosphocholine Acyltransferase
TTDR00648	Synonyms	CoA-IT
TTDR00648	Synonyms	Coenzyme A-independent transacylase
TTDR00648	Synonyms	Glycerophospholipid arachidonoyl-transferase (CoA-independent)
TTDR00648	Disease	Proliferative diseases
TTDR00648	EC Number	EC 2.3.1.147
TTDR00650	Name	Alpha 4 beta 7 integrin receptor
TTDR00650	Type of target	Clinical trial target
TTDR00650	Synonyms	Alpha 4 beta 7 integrin
TTDR00650	Disease	Inflammatory bowel disease
TTDR00650	Related US Patent	6,410,781
TTDR00650	Related US Patent	6,545,160
TTDR00651	UniProt ID	P23229
TTDR00651	Name	Integrin alpha-6
TTDR00651	Type of target	Research target
TTDR00651	Synonyms	Alpha6 beta1 integrin
TTDR00651	Synonyms	CD49f
TTDR00651	Synonyms	VLA-6
TTDR00651	Synonyms	VLA-6 integrin
TTDR00651	Disease	Tumors
TTDR00651	Function	Integrin alpha-6/beta-1 is a receptor for laminin on platelets. Integrin alpha-6
TTDR00651	Sequence	MAAAGQLCLLYLSAGLLSRLGAAFNLDTREDNVIRKYGDPGSLFGFSLAMHWQLQPEDKRLLLVGAPRAEALPLQRANRT
TTDR00651	BioChemical Class	Transmembrane protein
TTDR00651	Pathway	Cell adhesion molecules (CAMs)
TTDR00651	Pathway	ECM-receptor interaction
TTDR00651	Pathway	Focal adhesion
TTDR00651	Pathway	Hematopoietic cell lineage
TTDR00651	Pathway	Pathways in cancer
TTDR00651	Pathway	Regulation of actin cytoskeleton
TTDR00651	Pathway	Small cell lung cancer
TTDR00653	UniProt ID	P53985
TTDR00653	Name	Monocarboxylate transporter 1
TTDR00653	Type of target	Research target
TTDR00653	Synonyms	MCT 1
TTDR00653	Synonyms	MCT1
TTDR00653	Disease	Neoplasms (CNS)
TTDR00653	Function	Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across
TTDR00653	Sequence	MPPAVGGPVGYTPPDGGWGWAVVIGAFISIGFSYAFPKSITVFFKEIEGIFHATTSEVSWISSIMLAVMYGGGPISSILV
TTDR00653	BioChemical Class	Transmembrane protein
TTDR00654	UniProt ID	O15297
TTDR00654	Name	Protein phosphatase 2C delta isoform
TTDR00654	Type of target	Research target
TTDR00654	Synonyms	P53-induced protein phosphatase 1
TTDR00654	Synonyms	PP2C-delta
TTDR00654	Synonyms	PPM1D
TTDR00654	Synonyms	Protein phosphatase magnesium-dependent 1 delta
TTDR00654	Disease	Neuroblastoma
TTDR00654	Function	Might contribute to growth inhibitory pathways activated in response to dna dama
TTDR00654	Sequence	MAGLYSLGVSVFSDQGGRKYMEDVTQIVVEPEPTAEEKPSPRRSLSQPLPPRPSPAALPGGEVSGKGPAVAAREARDPLP
TTDR00654	BioChemical Class	Hydrolases acting on ester bonds
TTDR00654	Pathway	p53 signaling pathway
TTDR00654	EC Number	EC 3.1.3.16
TTDR00655	UniProt ID	P24223
TTDR00655	Name	Pyridoxal phosphate biosynthetic protein pdxJ
TTDR00655	Type of target	Research target
TTDR00655	Synonyms	PNP synthase
TTDR00655	Synonyms	Pyridoxine 5'-phosphate synthase
TTDR00655	Disease	Bacterial infections
TTDR00655	Disease	Vitamin B6 deficiency
TTDR00655	Function	Catalyzes the condensation of 1-deoxy-d-xylulose-5- phosphate (dxp) and 1-amino-
TTDR00655	Sequence	MAELLLGVNIDHIATLRNARGTAYPDPVQAAFIAEQAGADGITVHLREDRRHITDRDVRILRQTLDTRMNLEMAVTEEML
TTDR00655	PDB Structure	1HO1; 1HO4; 1IXN; 1IXO; 1IXP; 1IXQ; 1M5W
TTDR00655	Inhibitor	1-Deoxy-D-Xylulose-5-Phosphate
TTDR00655	Inhibitor	3-Phosphoglycerol
TTDR00655	Inhibitor	Pyridoxine-5'-Phosphate
TTDR00656	UniProt ID	Q16653
TTDR00656	Name	Myelin-oligodendrocyte glycoprotein
TTDR00656	Type of target	Research target
TTDR00656	Synonyms	MOG
TTDR00656	Disease	Multiple sclerosis
TTDR00656	Function	Minor component of the myelin sheath. May be involved in completion and/or maint
TTDR00656	Sequence	MASLSRPSLPSCLCSFLLLLLLQVSSSYAGQFRVIGPRHPIRALVGDEVELPCRISPGKNATGMEVGWYRPPFSRVVHLY
TTDR00656	PDB Structure	1Q70
TTDR00656	BioChemical Class	Transmembrane protein
TTDR00657	UniProt ID	P25716
TTDR00657	UniProt ID	Q965D6
TTDR00657	Name	3-oxoacyl-[acyl-carrier protein] reductase
TTDR00657	Type of target	Research target
TTDR00657	Synonyms	3-ketoacyl-acyl carrier protein reductase
TTDR00657	Synonyms	Beta-ketoacyl-ACP reductase (FabG)
TTDR00657	Disease	Malaria
TTDR00657	Sequence	MSVLHRFYLFFLFTKFFHCYKISYVLKNAKLAPNHAIKNINSLNLLSENKKENYYYCGENKVALVTGAGRGIGREIAKML
TTDR00657	PDB Structure	1I01; 1Q7B; 1Q7C; 2CF2
TTDR00657	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00657	EC Number	EC 1.1.1.100
TTDR00657	Target Validation	TTDR00657
TTDR00657	Inhibitor	(-)-CATECHINGALLATE
TTDR00657	Inhibitor	2-Hexadecynoic acid
TTDR00657	Inhibitor	CHRYSIN
TTDR00657	Inhibitor	EPICATECHIN GALLATE
TTDR00657	Inhibitor	EPIGALOCATECHIN GALLATE
TTDR00657	Inhibitor	FISETIN
TTDR00657	Inhibitor	GALLOCATECHIN GALLATE
TTDR00657	Inhibitor	ISORHAMNETIN
TTDR00657	Inhibitor	KAEMPFEROL
TTDR00657	Inhibitor	MORIN
TTDR00657	Cofactor	NADPH
TTDR00658	Name	Actin
TTDR00658	Type of target	Research target
TTDR00658	Disease	Inflammation
TTDR00659	UniProt ID	P49789
TTDR00659	Name	Bis(5'-adenosyl)-triphosphatase
TTDR00659	Type of target	Research target
TTDR00659	Synonyms	AP3A hydrolase
TTDR00659	Synonyms	AP3AASE
TTDR00659	Synonyms	Diadenosine 5',5'''-P1,P3-triphosphate hydrolase
TTDR00659	Synonyms	Dinucleosidetriphosphatase
TTDR00659	Synonyms	Fragile histidine triad (FHIT) gene
TTDR00659	Synonyms	Fragile histidine triad protein
TTDR00659	Disease	Prostate carcinoma
TTDR00659	Function	Cleaves a-5'-ppp-5'a to yield amp and adp. Possible tumor suppressor for specifi
TTDR00659	Sequence	MSFRFGQHLIKPSVVFLKTELSFALVNRKPVVPGHVLVCPLRPVERFHDLRPDEVADLFQTTQRVGTVVEKHFHGTSLTF
TTDR00659	PDB Structure	1FHI; 1FIT; 2FHI; 2FIT; 3FIT; 4FIT; 5FIT; 6FIT
TTDR00659	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00659	Pathway	Non-small cell lung cancer
TTDR00659	Pathway	Purine metabolism
TTDR00659	Pathway	Small cell lung cancer
TTDR00659	EC Number	EC 3.6.1.29
TTDR00659	Inhibitor	Adenosine Monotungstate
TTDR00659	Inhibitor	Ado-P-Ch2-P-Ps-Ado
TTDR00659	Inhibitor	Fructose
TTDR00660	Name	Ly-6K antigen
TTDR00660	Type of target	Research target
TTDR00660	Disease	Head and neck squamous cell carcinomas
TTDR00661	UniProt ID	Q99798
TTDR00661	Name	Aconitate hydratase, mitochondrial
TTDR00661	Type of target	Research target
TTDR00661	Synonyms	Aconitase
TTDR00661	Synonyms	Citrate hydro-lyase
TTDR00661	Disease	Acute cardiac allograft rejection
TTDR00661	Sequence	MAPYSLLVTRLQKALGVRQYHVASVLCQRAKVAMSHFEPNEYIHYDLLEKNINIVRKRLNRPLTLSEKIVYGHLDDPASQ
TTDR00661	BioChemical Class	Carbon-oxygen lyases
TTDR00661	Pathway	Citrate cycle (TCA cycle)
TTDR00661	Pathway	Glyoxylate and dicarboxylate metabolism
TTDR00661	Pathway	Metabolic pathways
TTDR00661	Pathway	Reductive carboxylate cycle (CO2 fixation)
TTDR00661	EC Number	EC 4.2.1.3
TTDR00661	Inhibitor	4-Hydroxy-Aconitate Ion
TTDR00661	Inhibitor	Aconitate Ion
TTDR00661	Inhibitor	Alpha-Methylisocitric Acid
TTDR00661	Inhibitor	Isocitric Acid
TTDR00661	Inhibitor	Tricarballylic Acid
TTDR00662	UniProt ID	Q14376
TTDR00662	UniProt ID	Q8T8E9
TTDR00662	Name	UDP-glucose 4-epimerase
TTDR00662	Type of target	Research target
TTDR00662	Synonyms	Galactowaldenase
TTDR00662	Synonyms	UDP-galactose 4'-epimerase
TTDR00662	Synonyms	UDP-galactose 4-epimerase
TTDR00662	Disease	Trypanolytic infections
TTDR00662	Function	Catalyzes two distinct but analogous reactions: the epimerization of udp-glucose
TTDR00662	Sequence	MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKY
TTDR00662	PDB Structure	1GY8; 2CNB
TTDR00662	BioChemical Class	Racemases and Epimerases
TTDR00662	Pathway	Amino sugar and nucleotide sugar metabolism
TTDR00662	Pathway	Galactose metabolism
TTDR00662	Pathway	Metabolic pathways
TTDR00662	EC Number	EC 5.1.3.2
TTDR00662	Target Validation	TTDR00662
TTDR00662	Inhibitor	Glucose-Uridine-C1,5'-Diphosphate
TTDR00662	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00662	Inhibitor	PSAMMAPLIN A
TTDR00662	Inhibitor	Phenyl-Uridine-5'-Diphosphate
TTDR00662	Inhibitor	Tetramethylammonium Ion
TTDR00662	Inhibitor	Uridine Diphosphate Galactose
TTDR00662	Inhibitor	Uridine-5'-Diphosphate
TTDR00662	Inhibitor	Uridine-5'-Diphosphate-Mannose
TTDR00662	Inhibitor	Uridine-Diphosphate-N-Acetylgalactosamine
TTDR00662	Inhibitor	Uridine-Diphosphate-N-Acetylglucosamine
TTDR00663	UniProt ID	P10809
TTDR00663	Name	60 kDa heat shock protein, mitochondrial
TTDR00663	Type of target	Research target
TTDR00663	Synonyms	60 kDa chaperonin
TTDR00663	Synonyms	CPN60
TTDR00663	Synonyms	HSP-60
TTDR00663	Synonyms	Heat shock protein 60
TTDR00663	Synonyms	Hsp60
TTDR00663	Synonyms	HuCHA60
TTDR00663	Synonyms	Mitochondrial matrix protein P1
TTDR00663	Synonyms	P60 lymphocyte protein
TTDR00663	Disease	Schizophrenia
TTDR00663	Function	Implicated in mitochondrial protein import and macromolecular assembly. May faci
TTDR00663	Sequence	MLRLPTVFRQMRPVSRVLAPHLTRAYAKDVKFGADARALMLQGVDLLADAVAVTMGPKGRTVIIEQSWGSPKVTKDGVTV
TTDR00663	Pathway	Type I diabetes mellitus
TTDR00665	Name	520 kDa MYC-binding protein
TTDR00665	Type of target	Research target
TTDR00665	Synonyms	PAM
TTDR00665	Disease	Schizophrenia
TTDR00666	UniProt ID	O70038
TTDR00666	UniProt ID	P02919
TTDR00666	Name	Penicillin-binding protein 1B
TTDR00666	Type of target	Research target
TTDR00666	Synonyms	Murein polymerase
TTDR00666	Synonyms	PBP 1b
TTDR00666	Synonyms	PBP-1b
TTDR00666	Synonyms	PBP1b
TTDR00666	Disease	Bacterial infections
TTDR00666	Function	Cell wall formation. Synthesis of cross-linked peptidoglycan from the lipid inte
TTDR00666	Sequence	MQNQLNELKRKMLEFFQQKQKNKKSARPGKKGSSTKKSKTLDKSAIFPAILLSIKALFNLLFVLGFLGGMLGAGIALGYG
TTDR00666	PDB Structure	3FWL; 3VMA
TTDR00666	BioChemical Class	Transmembrane protein
TTDR00666	Pathway	Peptidoglycan biosynthesis
TTDR00666	EC Number	EC 2.3.2.-
TTDR00666	Inhibitor	N-BENZOYL-D-ALANINE
TTDR00666	Antagonist	Cephalosporin C
TTDR00667	UniProt ID	P38936
TTDR00667	Name	Cyclin-dependent kinase inhibitor 1
TTDR00667	Type of target	Research target
TTDR00667	Synonyms	CDK-interacting protein 1
TTDR00667	Synonyms	MDA-6
TTDR00667	Synonyms	Melanoma differentiation associated protein 6
TTDR00667	Synonyms	P21
TTDR00667	Synonyms	P21(WAF1)
TTDR00667	Disease	Leukemia, unspecified
TTDR00667	Function	May be the important intermediate by which p53 mediates its role as an inhibitor
TTDR00667	Sequence	MSEPAGDVRQNPCGSKACRRLFGPVDSEQLSRDCDALMAGCIQEARERWNFDFVTETPLEGDFAWERVRGLGLPKLYLPT
TTDR00667	PDB Structure	1AXC; 2ZVV; 2ZVW
TTDR00667	BioChemical Class	Zinc-finger
TTDR00667	Pathway	Bladder cancer
TTDR00667	Pathway	Cell cycle
TTDR00667	Pathway	Chronic myeloid leukemia
TTDR00667	Pathway	ErbB signaling pathway
TTDR00667	Pathway	Glioma
TTDR00667	Pathway	Melanoma
TTDR00667	Pathway	Pathways in cancer
TTDR00667	Pathway	Prostate cancer
TTDR00667	Pathway	p53 signaling pathway
TTDR00668	UniProt ID	Q02297
TTDR00668	Name	Pro-neuregulin-1
TTDR00668	Type of target	Research target
TTDR00668	Synonyms	Alpha
TTDR00668	Synonyms	Heregulin
TTDR00668	Synonyms	Pro-NRG1
TTDR00668	Disease	Breast cancer
TTDR00668	Function	Direct ligand for erbb3 and erbb4 tyrosine kinase receptors. Concomitantly recru
TTDR00668	Sequence	MSERKEGRGKGKGKKKERGSGKKPESAAGSQSPALPPRLKEMKSQESAAGSKLVLRCETSSEYSSLRFKWFKNGNELNRK
TTDR00668	PDB Structure	1HAE; 1HAF; 1HRE; 1HRF; 3U7U
TTDR00668	BioChemical Class	Growth factor
TTDR00668	Pathway	ErbB signaling pathway
TTDR00669	UniProt ID	P38134
TTDR00669	Name	Focal adhesion kinase
TTDR00669	Type of target	Clinical trial target
TTDR00669	Synonyms	FADK
TTDR00669	Synonyms	FAK
TTDR00669	Synonyms	Protein-tyrosine kinase 2
TTDR00669	Disease	Cancer, unspecific
TTDR00669	Disease	Gliomas
TTDR00669	Disease	Ovarian cancer
TTDR00669	Disease	Pancreatic cancer
TTDR00669	Sequence	MTTKNMNTPPGSTQENEIDLLRLVGELWDHRKFIISVTALFTLIAVAYSLLSTPIYQADTLVQVEQKQGNAILSGLSDMI
TTDR00669	PDB Structure	3CIO
TTDR00669	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00669	EC Number	EC 2.7.1.112
TTDR00669	Target Validation	TTDR00669
TTDR00669	Inhibitor	BMS-536924
TTDR00669	Inhibitor	PF-228
TTDR00670	UniProt ID	P19429
TTDR00670	Name	Troponin I, cardiac muscle
TTDR00670	Type of target	Research target
TTDR00670	Disease	Cardiac diseases
TTDR00670	Function	Troponin i is the inhibitory subunit of troponin, the thin filament regulatory c
TTDR00670	Sequence	MADGSSDAAREPRPAPAPIRRRSSNYRAYATEPHAKKKSKISASRKLQLKTLLLQIAKQELEREAEERRGEKGRALSTRC
TTDR00670	PDB Structure	1J1D; 1J1E; 1LXF; 1MXL; 1OZS; 2KGB; 2KRD; 2L1R
TTDR00670	Pathway	Cardiac muscle contraction
TTDR00673	UniProt ID	P34995
TTDR00673	Name	Prostaglandin E2 receptor, EP1 subtype
TTDR00673	Type of target	Research target
TTDR00673	Synonyms	EP1 receptor
TTDR00673	Synonyms	PGE receptor, EP1 subtype
TTDR00673	Synonyms	Prostanoid EP1 receptor
TTDR00673	Disease	Analgesics
TTDR00673	Disease	Visceral pain
TTDR00673	Function	Receptor for prostaglandin e2 (pge2). The activity of this receptor is mediated
TTDR00673	Sequence	MSPCGPLNLSLAGEATTCAAPWVPNTSAVPPSGASPALPIFSMTLGAVSNLLALALLAQAAGRLRRRRSAATFLLFVASL
TTDR00673	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00673	Pathway	Calcium signaling pathway
TTDR00673	Pathway	Neuroactive ligand-receptor interaction
TTDR00673	Target Validation	TTDR00673
TTDR00673	Inhibitor	DINOPROST
TTDR00673	Inhibitor	GSK-345931A
TTDR00673	Inhibitor	LAROPIPRANT
TTDR00673	Antagonist	ZD6416
TTDR00674	UniProt ID	P53674
TTDR00674	Name	Beta crystallin B1
TTDR00674	Type of target	Research target
TTDR00674	Synonyms	Beta B1-crystallin
TTDR00674	Disease	Inflammation
TTDR00674	Function	Crystallins are the dominant structural components of the vertebrate eye lens.
TTDR00674	Sequence	MSQAAKASASATVAVNPGPDTKGKGAPPAGTSPSPGTTLAPTTVPITSAKAAELPPGNYRLVVFELENFQGRRAEFSGEC
TTDR00674	PDB Structure	1OKI
TTDR00674	Inhibitor	Double Oxidized Cysteine
TTDR00675	Name	Opioid-insensitive Ca2+ channel
TTDR00675	Type of target	Research target
TTDR00675	Disease	Acute pain
TTDR00675	Disease	Analgesics
TTDR00676	UniProt ID	P04951
TTDR00676	UniProt ID	P44490
TTDR00676	Name	3-deoxy-manno-octulosonate cytidylyltransferase
TTDR00676	Type of target	Research target
TTDR00676	Synonyms	3-deoxy-D-manno-octulosonate cytidylytransferase
TTDR00676	Synonyms	CKS
TTDR00676	Synonyms	CMP-2-keto-3-deoxyoctulosonic acid synthetase
TTDR00676	Synonyms	CMP-KDO synthetase
TTDR00676	Disease	Bacterial infections
TTDR00676	Function	Activates kdo (a required 8-carbon sugar) for incorporation into bacterial lipop
TTDR00676	Sequence	MSFVVIIPARYASTRLPGKPLVDINGKPMIVHVLERARESGAERIIVATDHEDVARAVEAAGGEVCMTRADHQSGTERLA
TTDR00676	PDB Structure	1VH3; 1VIC; 3DUV
TTDR00676	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00676	Pathway	Lipopolysaccharide biosynthesis
TTDR00676	Pathway	Metabolic pathways
TTDR00676	EC Number	EC 2.7.7.38
TTDR00676	Inhibitor	Cmp-2-Keto-3-Deoxy-Octulosonic Acid
TTDR00676	Inhibitor	Cytidine-5'-Diphosphate
TTDR00676	Inhibitor	Cytidine-5'-Monophosphate
TTDR00676	Inhibitor	Cytidine-5'-Triphosphate
TTDR00676	Inhibitor	O-Sialic Acid (Chair Conformation)
TTDR00677	UniProt ID	Q14627
TTDR00677	Name	Interleukin-13 receptor alpha-2 chain
TTDR00677	Type of target	Research target
TTDR00677	Synonyms	IL-13R alpha-2 chain
TTDR00677	Synonyms	Interleukin-13 binding protein
TTDR00677	Disease	Localized cancer
TTDR00677	Function	Binds as a monomer with high affinity to interleukin 13 (il13), but not to il4.
TTDR00677	Sequence	MAFVCLAIGCLYTFLISTTFGCTSSSDTEIKVNPPQDFEIVDPGYLGYLYLQWQPPLSLDHFKECTVEYELKYRNIGSET
TTDR00677	PDB Structure	3LB6
TTDR00677	BioChemical Class	Transmembrane protein
TTDR00677	Pathway	Jak-STAT signaling pathway
TTDR00678	UniProt ID	Q910P5
TTDR00678	Name	Glycoprotein coupled receptor
TTDR00678	Type of target	Research target
TTDR00678	Synonyms	Chemokine receptor US28
TTDR00678	Disease	Cytomegalovirus-accelerated vascular disease
TTDR00678	Sequence	MTPTTTTAELTTEFDYDEDATPCVFTDVLNQSKPVTLFLYGVVFLFGSIGNFLVIFTITWRRRIQCSGDVYFINLAAADL
TTDR00678	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00679	UniProt ID	P02771
TTDR00679	Name	Alpha-fetoprotein
TTDR00679	Type of target	Research target
TTDR00679	Synonyms	Alpha-1-fetoprotein
TTDR00679	Synonyms	Alpha-fetoglobulin
TTDR00679	Disease	Hepatocellular carcinoma
TTDR00679	Function	Binds copper, nickel, and fatty acids as well as, and bilirubin less well than,
TTDR00679	Sequence	MKWVESIFLIFLLNFTESRTLHRNEYGIASILDSYQCTAEISLADLATIFFAQFVQEATYKEVSKMVKDALTAIEKPTGD
TTDR00679	PDB Structure	3MRK
TTDR00680	UniProt ID	P09543
TTDR00680	Name	2',3'-cyclic nucleotide 3'-phosphodiesterase
TTDR00680	Type of target	Research target
TTDR00680	Synonyms	CNP
TTDR00680	Synonyms	CNPase
TTDR00680	Disease	Multiple sclerosis
TTDR00680	Sequence	MNRGFSRKSHTFLPKIFFRKMSSSGAKDKPELQFPFLQDEDTVATLLECKTLFILRGLPGSGKSTLARVIVDKYRDGTKM
TTDR00680	PDB Structure	1WOJ
TTDR00680	BioChemical Class	Hydrolases acting on ester bonds
TTDR00680	EC Number	EC 3.1.4.37
TTDR00681	UniProt ID	P06731
TTDR00681	Name	Carcinoembryonic antigen-related cell adhesion molecule 5
TTDR00681	Type of target	Clinical trial target
TTDR00681	Synonyms	CD66e antigen
TTDR00681	Synonyms	CEA
TTDR00681	Synonyms	Carcinoembryonic antigen
TTDR00681	Synonyms	Meconium antigen 100
TTDR00681	Disease	Colon cancer
TTDR00681	Disease	Head and neck cancer
TTDR00681	Disease	Tumors
TTDR00681	Sequence	MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLVHNLPQHLFGYSWYKGERVDGNRQII
TTDR00681	PDB Structure	1E07; 2QSQ; 2QST; 2VER
TTDR00681	BioChemical Class	Cell membrane protein
TTDR00682	UniProt ID	Q08431
TTDR00682	Name	Lactadherin
TTDR00682	Type of target	Research target
TTDR00682	Synonyms	Breast epithelial antigen BA46
TTDR00682	Synonyms	HMFG
TTDR00682	Synonyms	Human milk fat globule membrane protein BA46
TTDR00682	Synonyms	MFG-E8
TTDR00682	Synonyms	MFGM
TTDR00682	Synonyms	Milk fat globule-EGF factor 8
TTDR00682	Disease	Breast cancer
TTDR00682	Function	May be involved in phospholipid binding. Binds specifically to rotavirus and inh
TTDR00682	Sequence	MPRPRLLAALCGALLCAPSLLVALDICSKNPCHNGGLCEEISQEVRGDVFPSYTCTCLKGYAGNHCETKCVEPLGMENGN
TTDR00682	BioChemical Class	Growth factor
TTDR00683	UniProt ID	P24821
TTDR00683	Name	Tenascin
TTDR00683	Type of target	Research target
TTDR00683	Synonyms	Cytotactin
TTDR00683	Synonyms	GMEM
TTDR00683	Synonyms	GP 150-225
TTDR00683	Synonyms	Glioma-associated-extracellular matrix antigen
TTDR00683	Synonyms	Hexabrachion
TTDR00683	Synonyms	JI
TTDR00683	Synonyms	Miotendinous antigen
TTDR00683	Synonyms	Neuronectin
TTDR00683	Synonyms	TN
TTDR00683	Synonyms	TN-C
TTDR00683	Synonyms	Tenascin-C
TTDR00683	Disease	Meningioma
TTDR00683	Function	Sam (substrate-adhesion molecule) that appears to inhibit cell migration. May pl
TTDR00683	Sequence	MGAMTQLLAGVFLAFLALATEGGVLKKVIRHKRQSGVNATLPEENQPVVFNHVYNIKLPVGSQCSVDLESASGEKDLAPP
TTDR00683	PDB Structure	1TEN; 2RB8; 2RBL
TTDR00683	BioChemical Class	Growth factor
TTDR00684	UniProt ID	P27169
TTDR00684	Name	Serum paraoxonase/arylesterase 1
TTDR00684	Type of target	Research target
TTDR00684	Synonyms	A-esterase 1
TTDR00684	Synonyms	Aromatic esterase 1
TTDR00684	Synonyms	K-45
TTDR00684	Synonyms	PON 1
TTDR00684	Synonyms	Serum aryldiakylphosphatase 1
TTDR00684	Synonyms	Serum aryldialkylphosphatase 1
TTDR00684	Synonyms	Serum paraoxonase
TTDR00684	Disease	Cardiovascular disease, unspecified
TTDR00684	Function	Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides.
TTDR00684	Sequence	MAKLIALTLLGMGLALFRNHQSSYQTRLNALREVQPVELPNCNLVKGIETGSEDMEILPNGLAFISSGLKYPGIKSFNPN
TTDR00684	PDB Structure	1V04; 1XHR
TTDR00684	BioChemical Class	Hydrolases acting on ester bonds
TTDR00684	EC Number	EC 3.1.1.2
TTDR00684	EC Number	EC 3.1.8.1
TTDR00685	UniProt ID	Q8IXA6
TTDR00685	Name	Hepatocellular carcinoma-associated protein
TTDR00685	Type of target	Research target
TTDR00685	Synonyms	HCCA1
TTDR00685	Disease	Hepatocellular carcinoma
TTDR00685	Sequence	MEEEASRSAAATNPGSRLTRWPPPDKREGSAVDPGKRRSLAATPSSSLPCTLIALGLRHEKEANELMEDLFETFQDEMGF
TTDR00686	Name	CAMP-dependent protein kinase A type I
TTDR00686	Type of target	Research target
TTDR00686	Synonyms	CAMP-dependent protein kinase type I
TTDR00686	Synonyms	Cyclic AMP-dependent protein kinase A type I
TTDR00686	Synonyms	PKA type I
TTDR00686	Synonyms	Protein kinase A type I
TTDR00686	Disease	HIV-induced T cell dysfunction
TTDR00686	Disease	Immune disease
TTDR00686	EC Number	EC 2.7.1.37
TTDR00687	UniProt ID	P14207
TTDR00687	Name	Folate receptor beta
TTDR00687	Type of target	Research target
TTDR00687	Synonyms	FBP
TTDR00687	Synonyms	FR-beta
TTDR00687	Synonyms	Folate receptor 2
TTDR00687	Synonyms	Folate receptor type-beta
TTDR00687	Synonyms	Folate receptor, fetal/placental
TTDR00687	Synonyms	Placental folate-binding protein
TTDR00687	Disease	Acute myeloid leukemia
TTDR00687	Function	Binds to folate and reduced folic acid derivatives and mediates delivery of 5-me
TTDR00687	Sequence	MVWKWMPLLLLLVCVATMCSAQDRTDLLNVCMDAKHHKTKPGPEDKLHDQCSPWKKNACCTASTSQELHKDTSRLYNFNW
TTDR00687	BioChemical Class	Cell membrane protein
TTDR00688	UniProt ID	P19544
TTDR00688	Name	Wilms' tumor protein
TTDR00688	Type of target	Clinical trial target
TTDR00688	Synonyms	WT1
TTDR00688	Synonyms	WT1 protein
TTDR00688	Synonyms	WT33
TTDR00688	Synonyms	Wilms' tumour 1 protein
TTDR00688	Disease	Colon cancer
TTDR00688	Disease	Leukemia, unspecified
TTDR00688	Disease	Solid tumor
TTDR00688	Function	Potential role in transcriptional regulation. Recognizes and binds to the dna se
TTDR00688	Sequence	MGSDVRDLNALLPAVPSLGGGGGCALPVSGAAQWAPVLDFAPPGASAYGSLGGPAPPPAPPPPPPPPPHSFIKQEPSWGG
TTDR00688	PDB Structure	1LU6; 1XF7; 2G7T; 2G7V; 2G7W; 2G7X; 2JP9; 2JPA; 2PRT; 3HPJ; 3MYJ
TTDR00688	BioChemical Class	Zinc-finger
TTDR00689	UniProt ID	P45379
TTDR00689	Name	Troponin T, cardiac muscle isoforms
TTDR00689	Type of target	Research target
TTDR00689	Synonyms	CTnT
TTDR00689	Synonyms	Cardiac troponin C (cTnC)
TTDR00689	Synonyms	TnTC
TTDR00689	Disease	Heart failure
TTDR00689	Function	Troponin t is the tropomyosin-binding subunit of troponin, the thin filament reg
TTDR00689	Sequence	MSDIEEVVEEYEEEEQEEAAVEEEEDWREDEDEQEEAAEEDAEAEAETEETRAEEDEEEEEAKEAEDGPMEESKPKPRSF
TTDR00689	PDB Structure	1J1D; 1J1E
TTDR00689	Pathway	Cardiac muscle contraction
TTDR00690	UniProt ID	P31055
TTDR00690	UniProt ID	Q9Z7E9
TTDR00690	Name	Dihydroneopterin aldolase
TTDR00690	Type of target	Research target
TTDR00690	Synonyms	7,8-Dihydroneopterin aldolase
TTDR00690	Synonyms	DHNA
TTDR00690	Synonyms	FOLB
TTDR00690	Disease	Microbial infections
TTDR00690	Disease	Parasitic diseases
TTDR00690	Function	Catalyzes the conversion of 7,8-dihydroneopterin to 6- hydroxymethyl-7,8-dihydro
TTDR00690	Sequence	MDIVFIEQLSVITTIGVYDWEQTIEQKLVFDIEMAWDNRKAAKSDDVADCLSYADIAETVVSHVEGARFALVERVAEEVA
TTDR00690	PDB Structure	2O90
TTDR00690	BioChemical Class	Carbon-carbon lyases
TTDR00690	Pathway	Folate biosynthesis
TTDR00690	Pathway	Metabolic pathways
TTDR00690	EC Number	EC 4.1.2.25
TTDR00690	Inhibitor	2-Amino-5-Bromo-6-Phenylpyrimidin-4-Ol
TTDR00690	Inhibitor	6-Hydroxymethyl-7,8-Dihydropterin
TTDR00690	Inhibitor	7,8-Dihydroneopterin
TTDR00690	Inhibitor	7,8-dihydrobiopterin
TTDR00690	Inhibitor	8-Amino-1,3-Dimethyl-3,7-Dihydropurine-2,6-Dione
TTDR00690	Inhibitor	9-Methylguanine
TTDR00691	UniProt ID	O94907
TTDR00691	Name	Dickkopf related protein-1
TTDR00691	Type of target	Research target
TTDR00691	Synonyms	Dickkopf-1
TTDR00691	Synonyms	Dkk-1
TTDR00691	Synonyms	HDkk-1
TTDR00691	Synonyms	SK
TTDR00691	Synonyms	UNQ492/PRO1008
TTDR00691	Disease	Osteoporosis, unspecified
TTDR00691	Function	Inhibitor of wnt signaling pathway.
TTDR00691	Sequence	MMALGAAGATRVFVAMVAAALGGHPLLGVSATLNSVLNSNAIKNLPPPLGGAAGHPGSAVSAAPGILYPGGNKYQTIDNY
TTDR00691	PDB Structure	3S2K; 3S8V
TTDR00691	Pathway	Wnt signaling pathway
TTDR00692	UniProt ID	P19835
TTDR00692	Name	Bile-salt-activated lipase
TTDR00692	Type of target	Research target
TTDR00692	Synonyms	BAL
TTDR00692	Synonyms	BSSL
TTDR00692	Synonyms	Bile-salt-stimulated lipase
TTDR00692	Synonyms	Carboxyl ester lipase
TTDR00692	Synonyms	Cholesterol esterase
TTDR00692	Synonyms	Pancreatic cholesterol esterase
TTDR00692	Synonyms	Pancreatic lysophospholipase
TTDR00692	Synonyms	Sterol esterase
TTDR00692	Disease	Hypercholesterolemia
TTDR00692	Function	Catalyzes fat and vitamin absorption. Acts in concert with pancreatic lipase and
TTDR00692	Sequence	MGRLQLVVLGLTCCWAVASAAKLGAVYTEGGFVEGVNKKLGLLGDSVDIFKGIPFAAPTKALENPQPHPGWQGTLKAKNF
TTDR00692	PDB Structure	1F6W; 1JMY
TTDR00692	BioChemical Class	Hydrolases acting on ester bonds
TTDR00692	EC Number	EC 3.1.1.13
TTDR00692	EC Number	EC 3.1.1.3
TTDR00692	Inhibitor	Taurocholic Acid
TTDR00693	UniProt ID	Q9UJ72
TTDR00693	Name	Annexin A10
TTDR00693	Type of target	Research target
TTDR00693	Synonyms	Annexin 14
TTDR00693	Disease	Hepatocellular carcinoma
TTDR00693	Sequence	MFCGDYVQGTIFPAPNFNPIMDAQMLGGALQGFDCDKDMLINILTQRCNAQRMMIAEAYQSMYGRDLIGDMREQLSDHFK
TTDR00694	Name	Tumor-associated carbohydrate antigen KH-1
TTDR00694	Type of target	Research target
TTDR00694	Disease	Adenocarcinoma
TTDR00695	Name	Rab geranylgeranyltransferase
TTDR00695	Type of target	Research target
TTDR00695	Synonyms	RabGGTase
TTDR00695	Disease	Thrombocytosis
TTDR00695	EC Number	EC 2.5.1.-
TTDR00696	UniProt ID	O75173
TTDR00696	Name	ADAMTS-4
TTDR00696	Type of target	Research target
TTDR00696	Synonyms	A disintegrin and metalloproteinase with thrombospondin motifs 4
TTDR00696	Synonyms	ADAM-TS 4
TTDR00696	Synonyms	ADAM-TS4
TTDR00696	Synonyms	ADMP-1
TTDR00696	Synonyms	Aggrecanase 1
TTDR00696	Disease	Osteoarthritis
TTDR00696	Function	Cleaves aggrecan, a cartilage proteoglycan, and may be involved in its turnover.
TTDR00696	Sequence	MSQTGSHPGRGLAGRWLWGAQPCLLLPIVPLSWLVWLLLLLLASLLPSARLASPLPREEEIVFPEKLNGSVLPGSGAPAR
TTDR00696	PDB Structure	2RJP; 3B2Z
TTDR00696	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00696	EC Number	EC 3.4.24.82
TTDR00696	Related US Patent	6,376,665
TTDR00696	Related US Patent	6,495,548
TTDR00696	Target Validation	TTDR00696
TTDR00696	Inhibitor	(R)-2-(biphenyl-4-sulfonylamino)-propionic acid
TTDR00696	Inhibitor	BB-16
TTDR00696	Inhibitor	CGS-27023A
TTDR00696	Inhibitor	SC-44463
TTDR00697	UniProt ID	Q9UNA0
TTDR00697	Name	ADAMTS-5
TTDR00697	Type of target	Research target
TTDR00697	Synonyms	A disintegrin and metalloproteinase with thrombospondin motifs 5
TTDR00697	Synonyms	ADAM-TS 11
TTDR00697	Synonyms	ADAM-TS 5
TTDR00697	Synonyms	ADAM-TS5
TTDR00697	Synonyms	ADMP-2
TTDR00697	Synonyms	Aggrecanase-2
TTDR00697	Disease	Osteoarthritis
TTDR00697	Function	Cleaves aggrecan, a cartilage proteoglycan, and may be involved in its turnover.
TTDR00697	Sequence	MLLGWASLLLCAFRLPLAAVGPAATPAQDKAGQPPTAAAAAQPRRRQGEEVQERAEPPGHPHPLAQRRRSKGLVQNIDQL
TTDR00697	PDB Structure	2RJQ; 3B8Z; 3HY7; 3HY9; 3HYG; 3LJT
TTDR00697	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00697	EC Number	EC 3.4.24.-
TTDR00697	Related US Patent	6,376,665
TTDR00697	Related US Patent	6,495,548
TTDR00697	Target Validation	TTDR00697
TTDR00697	Inhibitor	BB-16
TTDR00697	Inhibitor	Batimastat
TTDR00697	Inhibitor	SC-44463
TTDR00698	UniProt ID	P16284
TTDR00698	Name	Platelet endothelial cell adhesion molecule
TTDR00698	Type of target	Research target
TTDR00698	Synonyms	CD31 antigen
TTDR00698	Synonyms	ECAM
TTDR00698	Synonyms	EndoCAM
TTDR00698	Synonyms	Ep-CAM
TTDR00698	Synonyms	Epithelial cell adhesion molecule
TTDR00698	Synonyms	GPIIA'
TTDR00698	Synonyms	PECAM-1
TTDR00698	Disease	Colorectal cancer
TTDR00698	Disease	Lung cancer
TTDR00698	Function	This protein is a cell adhesion molecule expressed on platelets and at endotheli
TTDR00698	Sequence	MQPRWAQGATMWLGVLLTLLLCSSLEGQENSFTINSVDMKSLPDWTVQNGKNLTLQCFADVSTTSHVKPQHQMLFYKDDV
TTDR00698	PDB Structure	2KY5
TTDR00698	BioChemical Class	Transmembrane protein
TTDR00698	Pathway	Cell adhesion molecules (CAMs)
TTDR00698	Pathway	Leukocyte transendothelial migration
TTDR00699	UniProt ID	P11215
TTDR00699	Name	Integrin alpha-M
TTDR00699	Type of target	Research target
TTDR00699	Synonyms	CD11b
TTDR00699	Synonyms	CR-3 alpha chain
TTDR00699	Synonyms	Cell surface glycoprotein MAC-1 alpha subunit
TTDR00699	Synonyms	Cell surface glycoprotein Mac-1
TTDR00699	Synonyms	Leukocyte adhesion receptor MO1
TTDR00699	Synonyms	Neutrophil adherence receptor
TTDR00699	Disease	Closed head injury
TTDR00699	Function	Integrin alpha-m/beta-2 is implicated in various adhesive interactions of monocy
TTDR00699	Sequence	MALRVLLLTALTLCHGFNLDTENAMTFQENARGFGQSVVQLQGSRVVVGAPQEIVAANQRGSLYQCDYSTGSCEPIRLQV
TTDR00699	PDB Structure	1A8X; 1BHO; 1BHQ; 1IDN; 1IDO; 1JLM; 1M1U; 1MF7; 1N9Z; 1NA5; 2LKE; 2LKJ; 3Q3G; 3Q
TTDR00699	BioChemical Class	Transmembrane protein
TTDR00699	Pathway	Cell adhesion molecules (CAMs)
TTDR00699	Pathway	Hematopoietic cell lineage
TTDR00699	Pathway	Leukocyte transendothelial migration
TTDR00699	Pathway	Regulation of actin cytoskeleton
TTDR00700	UniProt ID	O76075
TTDR00700	Name	DNA fragmentation factor 40 kDa subunit
TTDR00700	Type of target	Research target
TTDR00700	Synonyms	CAD
TTDR00700	Synonyms	CPAN
TTDR00700	Synonyms	Caspase-activated DNase
TTDR00700	Synonyms	Caspase-activated deoxyribonuclease
TTDR00700	Synonyms	Caspase-activated nuclease
TTDR00700	Synonyms	DFF-40
TTDR00700	Disease	Colon cancer
TTDR00700	Function	Nuclease that induces dna fragmentation and chromatin condensation during apopto
TTDR00700	Sequence	MLQKPKSVKLRALRSPRKFGVAGRSCQEVLRKGCLRFQLPERGSRLCLYEDGTELTEDYFPSVPDNAELVLLTLGQAWQG
TTDR00700	PDB Structure	1IBX
TTDR00700	Pathway	Apoptosis
TTDR00700	EC Number	EC 3.-.-.-
TTDR00701	UniProt ID	P42782
TTDR00701	Name	Immunoglobulin A1 protease
TTDR00701	Type of target	Research target
TTDR00701	Synonyms	IGA1 protease
TTDR00701	Disease	Infections caused by nontypeable H influenza
TTDR00701	Function	Virulence factor; cleaves host immunoglobulin a producing intact fc and fab frag
TTDR00701	Sequence	MLNKKFKLNFIALTVAYALTPYTEAALVRDDVDYQIFRDFAENKGKFSVGATNVLVKDKNNKDLGTALPNGIPMIDFSVV
TTDR00701	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00701	EC Number	EC 3.4.21.72
TTDR00701	EC Number	EC 3.4.24.13
TTDR00702	UniProt ID	Q57353
TTDR00702	Name	Alkylhydroperoxidase AhpD
TTDR00702	Type of target	Research target
TTDR00702	Synonyms	AhpD protein
TTDR00702	Disease	Tuberculosis
TTDR00702	Sequence	MSIEKLKAALPEYAKDIKLNLSSITRSSVLDQEQLWGTLLASAAATRNPQVLADIGAEATDHLSAAARHAALGAAAIMGM
TTDR00702	PDB Structure	1GU9; 1KNC; 1LW1; 1ME5
TTDR00703	UniProt ID	P42332
TTDR00703	Name	Bacitracin transport ATP-binding protein bcrA
TTDR00703	Type of target	Research target
TTDR00703	Synonyms	BCRA
TTDR00703	Disease	Cystic fibrosis
TTDR00703	Function	Part of the binding-protein-dependent transport system for bacitracin that confe
TTDR00703	Sequence	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIG
TTDR00703	BioChemical Class	ABC transporter
TTDR00704	Name	Plasmepsin 4
TTDR00704	Type of target	Research target
TTDR00704	Synonyms	Plasmepsin IV
TTDR00704	Disease	Parasitic diseases
TTDR00705	UniProt ID	Q14118
TTDR00705	Name	Dystroglycan
TTDR00705	Type of target	Research target
TTDR00705	Synonyms	Alpha-dystroglycan
TTDR00705	Synonyms	Dystrophin-associated glycoprotein 1
TTDR00705	Disease	Congenital muscular dystrophy
TTDR00705	Disease	Lissencephaly
TTDR00705	Disease	Ocular abnormalities
TTDR00705	Function	Forms part of the dystrophin-associated protein complex (dapc) which may link th
TTDR00705	Sequence	MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEAVPTVVGIPDGTAVVGRSFRV
TTDR00705	PDB Structure	1EG4
TTDR00705	BioChemical Class	Transmembrane protein
TTDR00706	UniProt ID	P25398
TTDR00706	Name	40S ribosomal protein S12
TTDR00706	Type of target	Research target
TTDR00706	Synonyms	Protein S12 gene
TTDR00706	Synonyms	Ribosomal protein S12 gene
TTDR00706	Synonyms	RpS12
TTDR00706	Disease	Cancer, unspecific
TTDR00706	Sequence	MAEEGIAAGGVMDVNTALQEVLKTALIHDGLARGIREAAKALDKRQAHLCVLASNCDEPMYVKLVEALCAEHQINLIKVD
TTDR00706	PDB Structure	3J3A
TTDR00707	UniProt ID	P01233
TTDR00707	Name	Choriogonadotropin beta chain
TTDR00707	Type of target	Research target
TTDR00707	Synonyms	CG-beta
TTDR00707	Synonyms	Chorionic gonadotrophin beta subunit
TTDR00707	Synonyms	Chorionic gonadotropin beta subunit
TTDR00707	Disease	Cancer, unspecific
TTDR00707	Function	Stimulates the ovaries to synthesize the steroids that are essential for the mai
TTDR00707	Sequence	MEMFQGLLLLLLLSMGGTWASKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPTMTRVLQGVLPALPQVVCNYR
TTDR00707	PDB Structure	1HCN; 1HRP; 1QFW; 1XUL
TTDR00708	UniProt ID	Q8ITL2
TTDR00708	Name	65 kD membrane-associated NADH-fumarate reductase
TTDR00708	Type of target	Research target
TTDR00708	Synonyms	Fumarate reductase (NADH)
TTDR00708	Synonyms	NADH-dependent fumarate reductase
TTDR00708	Disease	Leishmania infections
TTDR00708	Sequence	MVDGRSSASIVAVDPERAARERDAAARALLQDSPLHTTMQYATSGLELTVPYALKVVASADTFDRAKEVADEVLRCAWQL
TTDR00708	EC Number	EC 1.3.1.6
TTDR00709	UniProt ID	P49441
TTDR00709	Name	Inositol polyphosphate 1-phosphatase
TTDR00709	Type of target	Research target
TTDR00709	Synonyms	IPP
TTDR00709	Synonyms	IPPase
TTDR00709	Synonyms	Inositol 1,4-bisphosphate phosphatase
TTDR00709	Synonyms	RnPIP
TTDR00709	Disease	Bipolar affective disorder
TTDR00709	Sequence	MSDILRELLCVSEKAANIARACRQQEALFQLLIEEKKEGEKNKKFAVDFKTLADVLVQEVIKQNMENKFPGLEKNIFGEE
TTDR00709	BioChemical Class	Hydrolases acting on ester bonds
TTDR00709	Pathway	Inositol phosphate metabolism
TTDR00709	Pathway	Metabolic pathways
TTDR00709	Pathway	Phosphatidylinositol signaling system
TTDR00709	EC Number	EC 3.1.3.57
TTDR00710	UniProt ID	O95989
TTDR00710	Name	Diphosphoinositol polyphosphate phosphohydrolase 2
TTDR00710	Type of target	Research target
TTDR00710	Synonyms	DIPP2
TTDR00710	Synonyms	Diphosphoinositol polyphosphate phosphohydrolase
TTDR00710	Disease	Bipolar affective disorder
TTDR00710	Sequence	MMKLKSNQTRTYDGDGYKKRAACLCFRSESEEEVLLVSSSRHPDRWIVPGGGMEPEEEPSVAAVREVCEEAGVKGTLGRL
TTDR00710	PDB Structure	2FVV; 2Q9P
TTDR00710	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00710	EC Number	EC 3.6.1.52
TTDR00711	Name	Gene A1
TTDR00711	Type of target	Research target
TTDR00711	Disease	Allergic diseases
TTDR00712	UniProt ID	Q14703
TTDR00712	Name	Membrane-bound transcription factor site-1 protease
TTDR00712	Type of target	Research target
TTDR00712	Synonyms	SKI-1
TTDR00712	Synonyms	Site-1 protease
TTDR00712	Synonyms	Subtilisin/kexin-isozyme-1
TTDR00712	Disease	Hyperlipidemia
TTDR00712	Function	Catalyzes the first step in the proteolytic activation of the sterol regulatory
TTDR00712	Sequence	MKLVNIWLLLLVVLLCGKKHLGDRLEKKSFEKAPCPGCSHLTLKVEFSSTVVEYEYIVAFNGYFTAKARNSFISSALKSS
TTDR00712	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00712	EC Number	EC 3.4.21.-
TTDR00712	Target Validation	TTDR00712
TTDR00712	Inhibitor	PF-429242
TTDR00713	UniProt ID	P35222
TTDR00713	Name	Beta-catenin
TTDR00713	Type of target	Research target
TTDR00713	Synonyms	PRO2286
TTDR00713	Disease	Colorectal cancer
TTDR00713	Function	Involved in the regulation of cell adhesion and in signal transduction through t
TTDR00713	Sequence	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVA
TTDR00713	PDB Structure	1G3J; 1JDH; 1JPW; 1LUJ; 1P22; 1QZ7; 1T08; 1TH1; 2G57; 2GL7; 2Z6H; 3DIW; 3FQN; 3F
TTDR00713	Pathway	Adherens junction
TTDR00713	Pathway	Basal cell carcinoma
TTDR00713	Pathway	Colorectal cancer
TTDR00713	Pathway	Endometrial cancer
TTDR00713	Pathway	Focal adhesion
TTDR00713	Pathway	Leukocyte transendothelial migration
TTDR00713	Pathway	Melanogenesis
TTDR00713	Pathway	Pathogenic Escherichia coli infection
TTDR00713	Pathway	Pathways in cancer
TTDR00713	Pathway	Prostate cancer
TTDR00713	Pathway	Thyroid cancer
TTDR00713	Pathway	Tight junction
TTDR00713	Pathway	Wnt signaling pathway
TTDR00714	UniProt ID	Q13641
TTDR00714	Name	5T4 ONCOFETAL antigen
TTDR00714	Type of target	Research target
TTDR00714	Synonyms	Trophoblast glycoprotein
TTDR00714	Disease	Breast cancer
TTDR00714	Disease	Lung cancer
TTDR00714	Sequence	MPGGCSRGPAAGDGRLRLARLALVLLGWVSSSSPTSSASSFSSSAPFLASAVSAQPPLPDQCPALCECSEAARTVKCVNR
TTDR00714	BioChemical Class	Transmembrane protein
TTDR00715	Name	Glycosylphosphatidylinositol phosphoethanolamine transferase
TTDR00715	Type of target	Research target
TTDR00715	Synonyms	GPI-PET
TTDR00715	Synonyms	GPI-phosphoethanolamine transferase
TTDR00715	Disease	Parasitic diseases
TTDR00715	Inhibitor	YW3548
TTDR00716	UniProt ID	Q76L89
TTDR00716	UniProt ID	Q76L90
TTDR00716	UniProt ID	Q9U1N4
TTDR00716	Name	Farnesyl-protein transferase
TTDR00716	Type of target	Research target
TTDR00716	Synonyms	FPTase
TTDR00716	Synonyms	FT
TTDR00716	Synonyms	FTase
TTDR00716	Synonyms	Farnesyl Protein Transferase
TTDR00716	Synonyms	Farnesyltransferase
TTDR00716	Synonyms	Protein farnesyltransferase
TTDR00716	Synonyms	Ras protein farnesyltransferase
TTDR00716	Disease	Amebiasis
TTDR00716	Disease	Cancer, unspecific
TTDR00716	Disease	Parasitic diseases
TTDR00716	Sequence	MEIEEVEVETVTSIDQYECQNTVEKEKAYTRYIIRHNFLTYSFNPEIHIKWLTLSIHKPLPSGFMSLDSSTPWILYWTLN
TTDR00716	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR00716	EC Number	EC 2.5.1.-
TTDR00716	EC Number	EC 2.5.1.21
TTDR00716	Related US Patent	6,265,422
TTDR00716	Related US Patent	6,335,343
TTDR00716	Related US Patent	6,342,765
TTDR00716	Related US Patent	6,358,968
TTDR00716	Related US Patent	6,369,034
TTDR00716	Related US Patent	6,376,496
TTDR00716	Related US Patent	6,387,903
TTDR00716	Related US Patent	6,399,615
TTDR00716	Related US Patent	6,410,539
TTDR00716	Related US Patent	6,429,203
TTDR00716	Related US Patent	6,436,960
TTDR00716	Related US Patent	6,440,989
TTDR00716	Related US Patent	6,451,812
TTDR00716	Related US Patent	6,458,783
TTDR00716	Related US Patent	6,458,935
TTDR00716	Related US Patent	6,492,410
TTDR00716	Related US Patent	6,498,152
TTDR00716	Related US Patent	6,511,978
TTDR00716	Related US Patent	6,528,523
TTDR00716	Related US Patent	6,528,535
TTDR00716	Related US Patent	6,541,491
TTDR00716	Related US Patent	6,545,020
TTDR00716	Related US Patent	6,602,883
TTDR00716	Related US Patent	6,624,157
TTDR00716	Related US Patent	6,632,818
TTDR00716	Related US Patent	6,645,966
TTDR00716	Inhibitor	Tipifarnib
TTDR00717	UniProt ID	P08129
TTDR00717	Name	Serine/threonine protein phosphatase PP1-alpha 1 catalytic subunit
TTDR00717	Type of target	Research target
TTDR00717	Synonyms	PP-1A
TTDR00717	Synonyms	Protein phosphatase 1alpha
TTDR00717	Disease	Cancer, unspecific
TTDR00717	Function	Protein phosphatase 1 (pp1) is essential for cell division, and participates in
TTDR00717	Sequence	MSDSEKLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGG
TTDR00717	PDB Structure	3E7A; 3E7B; 1FJM
TTDR00717	EC Number	EC 3.1.3.16
TTDR00717	Target Validation	TTDR00717
TTDR00717	Inhibitor	CANTHARIDIC_ACID
TTDR00717	Inhibitor	CANTHARIDIN
TTDR00717	Inhibitor	DEMETHYL-CANTHARIDIN
TTDR00717	Inhibitor	MICROCYSTIN-LR
TTDR00717	Inhibitor	NORCANTHARIDIN
TTDR00717	Inhibitor	PALASONIN
TTDR00717	Inhibitor	TAUTOMYCIN
TTDR00718	Name	HPIV-1 hemagglutinin-neuraminidase glycoprotein
TTDR00718	Type of target	Research target
TTDR00718	Synonyms	HANA Glycoprotein
TTDR00718	Synonyms	HPIV-1 HN
TTDR00718	Synonyms	Hemagglutinin Neuraminidase Glycoprotein
TTDR00718	Disease	Viral infection, unspecified
TTDR00720	UniProt ID	Q97S61
TTDR00720	Name	UPF0090 protein SP0552
TTDR00720	Type of target	Research target
TTDR00720	Synonyms	Hypothetical protein SP14.3
TTDR00720	Synonyms	SP14.3
TTDR00720	Disease	Streptococcus pneumoniae infections
TTDR00720	Sequence	MDAIATIVELVREVVEPVIEAPFELVDIEYGKIGSDMILSIFVDKPEGITLNDTADLTEIISPVLDTIKPDPFPEQYFLE
TTDR00720	PDB Structure	1IB8
TTDR00721	UniProt ID	P50579
TTDR00721	UniProt ID	Q8SR45
TTDR00721	Name	Methionine aminopeptidase 2
TTDR00721	Type of target	Clinical trial target
TTDR00721	Synonyms	(MetAP)-2
TTDR00721	Synonyms	Initiation factor 2 associated 67 kDa glycoprotein
TTDR00721	Synonyms	MetAP 2
TTDR00721	Synonyms	P67
TTDR00721	Synonyms	P67eIF2
TTDR00721	Synonyms	Peptidase M 2
TTDR00721	Disease	Bacterial infections
TTDR00721	Disease	Cancer, unspecific
TTDR00721	Disease	Mesothelioma
TTDR00721	Function	Removes the amino-terminal methionine from nascent proteins.
TTDR00721	Sequence	MAGVEEVAASGSHLNGDLDPDDREEGAASTAEEAAKKKRRKKKKSKGPSAAGEQEPDKESGASVDEVARQLERSALEDKE
TTDR00721	PDB Structure	3FM3; 3FMQ; 3FMR
TTDR00721	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00721	EC Number	EC 3.4.11.18
TTDR00721	Related US Patent	6,566,541
TTDR00721	Target Validation	TTDR00721
TTDR00721	Drug(s)	ZGN-433
TTDR00721	Inhibitor	2-(4-fluorophenylsulfonamido)-1-naphthoic acid
TTDR00721	Inhibitor	2-(phenylsulfonamido)-1-naphthoic acid
TTDR00721	Inhibitor	2-(phenylsulfonamido)-5-propylbenzoic acid
TTDR00721	Inhibitor	2-(pyridin-2-yl)-1H-benzo[d]imidazol-5-amine
TTDR00721	Inhibitor	2-(pyridin-2-yl)-1H-benzo[d]imidazole
TTDR00721	Inhibitor	2-(pyridin-2-yl)-1H-imidazo[4,5-c]pyridine
TTDR00721	Inhibitor	2-(thiazol-4-yl)-1H-benzo[d]imidazol-5-amine
TTDR00721	Inhibitor	2-Methyl-2-Propanol
TTDR00721	Inhibitor	3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium
TTDR00721	Inhibitor	3,5-dimethyl-2-(phenylsulfonamido)benzoic acid
TTDR00721	Inhibitor	3-anilino-5-benzylthio-1,2,4-triazole
TTDR00721	Inhibitor	5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID
TTDR00721	Inhibitor	5-bromo-2-(4-chlorophenylsulfonamido)benzoic acid
TTDR00721	Inhibitor	5-butyl-2-(phenylsulfonamido)benzoic acid
TTDR00721	Inhibitor	5-chloro-2-(pyridin-2-yl)-1H-benzo[d]imidazole
TTDR00721	Inhibitor	5-ethyl-2-(phenylsulfonamido)benzoic acid
TTDR00721	Inhibitor	5-fluoro-2-(pyridin-2-yl)-1H-benzo[d]imidazole
TTDR00721	Inhibitor	5-methyl-2-(phenylsulfonamido)benzoic acid
TTDR00721	Inhibitor	5-methyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole
TTDR00721	Inhibitor	5-p-Tolyl-1H-[1,2,3]triazole
TTDR00721	Inhibitor	A-357300
TTDR00721	Inhibitor	D-Methionine
TTDR00721	Inhibitor	OXYQUINOLINE
TTDR00721	Inhibitor	Ovalicin
TTDR00721	Inhibitor	TNP-470
TTDR00721	Inhibitor	ZGN-433
TTDR00721	Ligand	Fumagillin
TTDR00722	UniProt ID	P14151
TTDR00722	Name	L-selectin
TTDR00722	Type of target	Research target
TTDR00722	Synonyms	CD62L
TTDR00722	Synonyms	Gp90-MEL
TTDR00722	Synonyms	LAM-1
TTDR00722	Synonyms	LECAM1
TTDR00722	Synonyms	Leukocyte adhesion molecule-1
TTDR00722	Synonyms	Leukocyte surface antigen Leu-8
TTDR00722	Synonyms	Leukocyte-endothelial cell adhesion molecule 1
TTDR00722	Synonyms	Lymph node homing receptor
TTDR00722	Synonyms	TQ1
TTDR00722	Disease	Asthma
TTDR00722	Function	Cell surface adhesion protein. Mediate the adherence of lymphocytes to endotheli
TTDR00722	Sequence	MIFPWKCQSTQRDLWNIFKLWGWTMLCCDFLAHHGTDCWTYHYSEKPMNWQRARRFCRDNYTDLVAIQNKAEIEYLEKTL
TTDR00722	PDB Structure	1KJB; 2LGF; 3CFW
TTDR00722	BioChemical Class	Growth factor
TTDR00722	Pathway	Cell adhesion molecules (CAMs)
TTDR00722	Target Validation	TTDR00722
TTDR00722	Inhibitor	2,3,4-trihydroxybenzoic acid
TTDR00722	Inhibitor	BAICALEIN
TTDR00722	Inhibitor	PURPUROGALLIN
TTDR00722	Aptamer	LD201t1
TTDR00723	UniProt ID	P36663
TTDR00723	UniProt ID	P62368
TTDR00723	Name	2C-Methyl-D-erythritol 2,4-cyclodiphosphate synthase
TTDR00723	Type of target	Research target
TTDR00723	Synonyms	MECDP-synthase
TTDR00723	Synonyms	MECPS
TTDR00723	Disease	Malaria
TTDR00723	Function	Converts 4-diphosphocytidyl-2c-methyl-d-erythritol 2- phosphate into 2c-methyl-d
TTDR00723	Sequence	MRIGHGFDVHAFGGEGPIIIGGVRIPYEKGLLAHSDGDVALHALTDALLGAAALGDIGKLFPDTDPAFKGADSRELLREA
TTDR00723	PDB Structure	1GX1; 1H47; 1H48; 1JY8; 1KNJ; 1KNK; 1U3L; 1U3P
TTDR00723	BioChemical Class	Phosphorus-oxygen lyases
TTDR00723	Pathway	Biosynthesis of steroids
TTDR00723	Pathway	Metabolic pathways
TTDR00723	EC Number	EC 4.6.1.12
TTDR00725	Name	DNA: NF2 gene promoter
TTDR00725	Type of target	Research target
TTDR00725	Disease	Schwannoma
TTDR00726	UniProt ID	O07344
TTDR00726	UniProt ID	P00803
TTDR00726	Name	Signal peptidase I
TTDR00726	Type of target	Research target
TTDR00726	Synonyms	Leader peptidase I
TTDR00726	Synonyms	SPase I
TTDR00726	Disease	Bacterial infections
TTDR00726	Sequence	MANMFALILVIATLVTGILWCVDKFFFAPKRRERQAAAQAAAGDSLDKATLKKVAPKPGWLETGASVFPVLAIVLIVRSF
TTDR00726	PDB Structure	1B12; 1KN9; 1T7D; 3IIQ; 3S04
TTDR00726	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00726	Pathway	Protein export
TTDR00726	EC Number	EC 3.4.21.89
TTDR00727	UniProt ID	O60240
TTDR00727	Name	Perilipin
TTDR00727	Type of target	Research target
TTDR00727	Synonyms	Lipid droplet-associated protein
TTDR00727	Synonyms	PERI
TTDR00727	Disease	Obesity
TTDR00727	Function	Modulator of adipocyte lipid metabolism, it coats lipid storage droplets to prot
TTDR00727	Sequence	MAVNKGLTLLDGDLPEQENVLQRVLQLPVVSGTCECFQKTYTSTKEAHPLVASVCNAYEKGVQSASSLAAWSMEPVVRRL
TTDR00727	Pathway	PPAR signaling pathway
TTDR00728	UniProt ID	Q02246
TTDR00728	Name	Contactin 2
TTDR00728	Type of target	Research target
TTDR00728	Synonyms	Axonal glycoprotein TAG-1
TTDR00728	Synonyms	Axonin-1
TTDR00728	Synonyms	TAX-1
TTDR00728	Synonyms	TAX-1 gene
TTDR00728	Synonyms	Transient axonal glycoprotein 1
TTDR00728	Disease	Malignant gliomas
TTDR00728	Function	May play a role in the initial growth and guidance of axons. May be involved in
TTDR00728	Sequence	MGTATRRKPHLLLVAAVALVSSSAWSSALGSQTTFGPVFEDQPLSVLFPEESTEEQVLLACRARASPPATYRWKMNGTEM
TTDR00728	PDB Structure	2OM5
TTDR00728	BioChemical Class	Cell membrane protein
TTDR00728	Pathway	Cell adhesion molecules (CAMs)
TTDR00729	Name	DNA: squamous cell carcinoma antigen SCCA1 promoter
TTDR00729	Type of target	Research target
TTDR00729	Disease	Squamous cell carcinoma
TTDR00730	UniProt ID	P15941
TTDR00730	Name	Mucin 1
TTDR00730	Type of target	Clinical trial target
TTDR00730	Synonyms	Breast carcinoma-associated antigen DF3
TTDR00730	Synonyms	CD227 antigen
TTDR00730	Synonyms	Carcinoma-associated mucin
TTDR00730	Synonyms	EMA
TTDR00730	Synonyms	Episialin
TTDR00730	Synonyms	H23AG
TTDR00730	Synonyms	MUC-1
TTDR00730	Synonyms	MUC1
TTDR00730	Synonyms	PEM
TTDR00730	Synonyms	PEMT
TTDR00730	Synonyms	PUM
TTDR00730	Synonyms	Peanut-reactive urinary mucin
TTDR00730	Synonyms	Polymorphic epithelial mucin
TTDR00730	Synonyms	Tumor-associated epithelial membrane antigen
TTDR00730	Synonyms	Tumor-associated mucin
TTDR00730	Synonyms	Tumour-associated antigen mucin 1
TTDR00730	Disease	Breast cancer
TTDR00730	Disease	Cancer, unspecific
TTDR00730	Disease	Immune disease
TTDR00730	Disease	Papillary thyroid carcinomas
TTDR00730	Function	May play a role in adhesive functions and in cell-cell interactions, metastasis
TTDR00730	Sequence	MTPGTQSPFFLLLLLTVLTVVTGSGHASSTPGGEKETSATQRSSVPSSTEKNAVSMTSSVLSSHSPGSGSSTTQGQDVTL
TTDR00730	PDB Structure	2ACM; 2FO4
TTDR00730	BioChemical Class	Transmembrane protein
TTDR00731	UniProt ID	Q15077
TTDR00731	Name	P2Y purinoceptor 6
TTDR00731	Type of target	Research target
TTDR00731	Synonyms	Adenosine P2Y6 receptor
TTDR00731	Synonyms	P2Y6
TTDR00731	Disease	Cystic fibrosis gallbladder disease
TTDR00731	Function	Receptor for extracellular udp > utp > atp. The activity of this receptor is med
TTDR00731	Sequence	MEWDNGTGQALGLPPTTCVYRENFKQLLLPPVYSAVLAAGLPLNICVITQICTSRRALTRTAVYTLNLALADLLYACSLP
TTDR00731	PDB Structure	2B6R
TTDR00731	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00731	Pathway	Neuroactive ligand-receptor interaction
TTDR00731	Target Validation	TTDR00731
TTDR00731	Inhibitor	PSB-0952
TTDR00731	Inhibitor	RB 2
TTDR00732	UniProt ID	P78540
TTDR00732	Name	Arginase II, mitochondrial
TTDR00732	Type of target	Research target
TTDR00732	Synonyms	Arginase II
TTDR00732	Synonyms	Human penile arginase
TTDR00732	Synonyms	Kidney-type arginase
TTDR00732	Synonyms	Non-hepatic arginase
TTDR00732	Disease	Erectile dysfunction
TTDR00732	Disease	Sexual arousal disorders
TTDR00732	Function	May play a role in the regulation of extra-urea cycle arginine metabolism and al
TTDR00732	Sequence	MSLRGSLSRLLQTRVHSILKKSVHSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDD
TTDR00732	PDB Structure	1PQ3; 4HZE; 4I06; 4IE2; 4IE3
TTDR00732	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDR00732	Pathway	Arginine and proline metabolism
TTDR00732	Pathway	Metabolic pathways
TTDR00732	EC Number	EC 3.5.3.1
TTDR00732	Inhibitor	Difluoromethylornithine
TTDR00732	Inhibitor	N-hydroxy-nor-L-arginine
TTDR00732	Inhibitor	S-(2-boronoethyl)-L-cysteine
TTDR00732	Inhibitor	S-2-(Boronoethyl)-L-Cysteine
TTDR00733	UniProt ID	O15393
TTDR00733	Name	Transmembrane protease, serine 2
TTDR00733	Type of target	Research target
TTDR00733	Synonyms	TMPRSS2 protease
TTDR00733	Disease	Prostate cancer
TTDR00733	Sequence	MALNSGSPPAIGPYYENHGYQPENPYPAQPTVVPTVYEVHPAQYYPSPVPQYAPRVLTQASNPVVCTQPKSPSGTVCTSK
TTDR00733	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00733	EC Number	EC 3.4.21.-
TTDR00734	UniProt ID	P17927
TTDR00734	Name	Complement receptor type 1
TTDR00734	Type of target	Research target
TTDR00734	Synonyms	C3b/C4b receptor
TTDR00734	Synonyms	CD35 antigen
TTDR00734	Disease	Malaria
TTDR00734	Function	Mediates cellular binding of particles and immune complexes that have activated
TTDR00734	Sequence	MGASSPRSPEPVGPPAPGLPFCCGGSLLAVVVLLALPVAWGQCNAPEWLPFARPTNLTDEFEFPIGTYLNYECRPGYSGR
TTDR00734	PDB Structure	1GKG; 1GKN; 1GOP; 1PPQ; 2Q7Z
TTDR00734	BioChemical Class	Transmembrane protein
TTDR00734	Pathway	Complement and coagulation cascades
TTDR00734	Pathway	Hematopoietic cell lineage
TTDR00735	UniProt ID	Q92213
TTDR00735	Name	Phosphatidylinositol 3-kinase CaVps34p
TTDR00735	Type of target	Research target
TTDR00735	Synonyms	PI3-kinase
TTDR00735	Synonyms	PI3K
TTDR00735	Synonyms	Phosphatidylinositol 3-kinase VPS34
TTDR00735	Synonyms	PtdIns-3-kinase
TTDR00735	Synonyms	Vacuolar sorting protein 34
TTDR00735	Disease	Fungal diseases
TTDR00735	Function	Phosphatidylinositol 3-kinase homolog required for vacuolar sorting and segregat
TTDR00735	Sequence	MATLSQPQSALPKTKIATTFGLSKDLKSPISVKVCYLECTRNNVSLVPLSTKFEDPTVFKKLSQIYKNSDLFVEIRVYDG
TTDR00735	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00735	EC Number	EC 2.7.1.137
TTDR00736	Name	Macrophage scavenger receptor class B type I
TTDR00736	Type of target	Research target
TTDR00736	Disease	Atherosclerosis
TTDR00737	UniProt ID	O60825
TTDR00737	Name	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
TTDR00737	Type of target	Research target
TTDR00737	Synonyms	6PF-2-K/Fru-2,6-P2ASE heart-type isozyme
TTDR00737	Synonyms	PFK-2/FBPase-2
TTDR00737	Disease	Neoplasms
TTDR00737	Function	Synthesis and degradation of fructose 2,6-bisphosphate.
TTDR00737	Sequence	MSGASSSEQNNNSYETKTPNLRMSEKKCSWASYMTNSPTLIVMIGLPARGKTYVSKKLTRYLNWIGVPTKVFNLGVYRRE
TTDR00737	Pathway	Fructose and mannose metabolism
TTDR00737	EC Number	EC 3.1.3.46
TTDR00738	UniProt ID	Q82443
TTDR00738	Name	Human T-cell leukemia virus type-1 proteinase
TTDR00738	Type of target	Research target
TTDR00738	Synonyms	HTLV-1 protease
TTDR00738	Disease	Human t-lymphotropic virus infections
TTDR00738	Sequence	KEFNMGGGLTSPPTLQQVLLNQDPASILPVIPLDPARRPVIKAQVDTQTSHPKTIEALLDTGADMTVLPIALFSSNTPLK
TTDR00738	BioChemical Class	Protease
TTDR00739	UniProt ID	P00448
TTDR00739	Name	Superoxide dismutase [Mn]
TTDR00739	Type of target	Research target
TTDR00739	Synonyms	Manganese superoxide dismutase
TTDR00739	Synonyms	Mn-SOD
TTDR00739	Synonyms	MnSOD
TTDR00739	Disease	Cancer, unspecific
TTDR00739	Disease	Colon cancer
TTDR00739	Function	Destroys radicals which are normally produced within the cells and which are tox
TTDR00739	Sequence	MSYTLPSLPYAYDALEPHFDKQTMEIHHTKHHQTYVNNANAALESLPEFANLPVEELITKLDQLPADKKTVLRNNAGGHA
TTDR00739	PDB Structure	1D5N; 1EN4; 1EN5; 1EN6; 1I08; 1I0H; 1IX9; 1IXB; 1MMM; 1VEW; 1ZLZ; 3K9S; 3OT7
TTDR00739	BioChemical Class	Oxidoreductases acting on superoxide as acceptor
TTDR00739	EC Number	EC 1.15.1.1
TTDR00740	UniProt ID	P13798
TTDR00740	Name	Acylamino-acid-releasing enzyme
TTDR00740	Type of target	Research target
TTDR00740	Synonyms	AARE
TTDR00740	Synonyms	APH
TTDR00740	Synonyms	Acyl-peptide hydrolase
TTDR00740	Synonyms	Acylaminoacyl-peptidase
TTDR00740	Synonyms	Acylpeptide hydrolase
TTDR00740	Synonyms	DNF15S2 protein
TTDR00740	Synonyms	OPH
TTDR00740	Synonyms	Oxidized protein hydrolase
TTDR00740	Disease	Cognitive deficits
TTDR00740	Function	This enzyme catalyzes the hydrolysis of the n-terminal peptide bond of an n-acet
TTDR00740	Sequence	MERQVLLSEPEEAAALYRGLSRQPALSAACLGPEVTTQYGGQYRTVHTEWTQRDLERMENIRFCRQYLVFHDGDSVVFAG
TTDR00740	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00740	EC Number	EC 3.4.19.1
TTDR00741	UniProt ID	P22681
TTDR00741	Name	Signal transduction protein CBL
TTDR00741	Type of target	Research target
TTDR00741	Synonyms	C-Cbl
TTDR00741	Synonyms	Casitas B-lineage lymphoma proto-oncogene
TTDR00741	Synonyms	Proto-oncogene c-CBL
TTDR00741	Disease	Malignancies
TTDR00741	Function	Participates in signal transduction in hematopoietic cells. Adapter protein that
TTDR00741	Sequence	MAGNVKKSSGAGGGSGSGGSGSGGLIGLMKDAFQPHHHHHHHLSPHPPGTVDKKMVEKCWKLMDKVVRLCQNPKLALKNS
TTDR00741	PDB Structure	1B47; 1FBV; 1YVH; 2CBL; 2JUJ; 2K4D; 2OO9; 2Y1M; 2Y1N; 3BUM; 3BUN; 3BUO; 3BUW; 3B
TTDR00741	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00741	Pathway	Chronic myeloid leukemia
TTDR00741	Pathway	ErbB signaling pathway
TTDR00741	Pathway	Insulin signaling pathway
TTDR00741	Pathway	Jak-STAT signaling pathway
TTDR00741	Pathway	Pathways in cancer
TTDR00741	Pathway	T cell receptor signaling pathway
TTDR00741	Pathway	Ubiquitin mediated proteolysis
TTDR00741	EC Number	EC 6.3.2.-
TTDR00742	UniProt ID	Q16853
TTDR00742	Name	Membrane copper amine oxidase
TTDR00742	Type of target	Research target
TTDR00742	Synonyms	HPAO
TTDR00742	Synonyms	VAP-1
TTDR00742	Synonyms	Vascular adhesion protein-1
TTDR00742	Disease	Inflammation
TTDR00742	Function	Cell adhesion protein that participate in lymphocyte recirculation by mediating
TTDR00742	Sequence	MNQKTILVLLILAVITIFALVCVLLVGRGGDGGEPSQLPHCPSVSPSAQPWTHPGQSQLFADLSREELTAVMRFLTQRLG
TTDR00742	PDB Structure	1PU4; 1US1; 2C10; 2C11; 2Y73; 2Y74; 3ALA
TTDR00742	BioChemical Class	Oxidoreductases acting on the CH-NH2 group of donors
TTDR00742	Pathway	Alkaloid biosynthesis II
TTDR00742	Pathway	Glycine, serine and threonine metabolism
TTDR00742	Pathway	Metabolic pathways
TTDR00742	Pathway	Phenylalanine metabolism
TTDR00742	Pathway	Tyrosine metabolism
TTDR00742	Pathway	beta-Alanine metabolism
TTDR00742	EC Number	EC 1.4.3.6
TTDR00742	Related US Patent	6,624,202
TTDR00742	Inhibitor	2,6-DICHLORO-N-IMIDAZOLIDIN-2-YLIDENEANILINE
TTDR00742	Inhibitor	6-hydroxydopa quinone
TTDR00743	UniProt ID	P09341
TTDR00743	Name	Cytokine growth-related oncogene-alpha
TTDR00743	Type of target	Research target
TTDR00743	Synonyms	CXCL1
TTDR00743	Synonyms	GRO-a protein
TTDR00743	Synonyms	GRO-alpha
TTDR00743	Synonyms	GRO-alpha(1-73)
TTDR00743	Synonyms	Growth regulated protein
TTDR00743	Synonyms	MGSA
TTDR00743	Synonyms	Macrophage Inflammatory Protein-2
TTDR00743	Synonyms	Melanoma growth stimulatory activity
TTDR00743	Synonyms	NAP-3
TTDR00743	Synonyms	Neutrophil-activating protein 3
TTDR00743	Disease	Nasal polyposis
TTDR00743	Function	Has chemotactic activity for neutrophils. May play a role in inflammation and ex
TTDR00743	Sequence	MARAALSAAPSNPRLLRVALLLLLLVAAGRRAAGASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKN
TTDR00743	PDB Structure	1MGS; 1MSG; 1MSH; 1ROD
TTDR00743	BioChemical Class	Growth factor
TTDR00743	Pathway	Chemokine signaling pathway
TTDR00743	Pathway	Cytokine-cytokine receptor interaction
TTDR00743	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR00744	UniProt ID	P23771
TTDR00744	Name	Trans-acting T-cell specific transcription factor GATA-3
TTDR00744	Type of target	Research target
TTDR00744	Synonyms	GATA-3
TTDR00744	Disease	Allergic rhinitis, unspecified
TTDR00744	Function	Transcriptional activator which binds to the enhancer of the t cell receptor alp
TTDR00744	Sequence	MEVTADQPRWVSHHHPAVLNGQHPDTHHPGLSHSYMDAAQYPLPEEVDVLFNIDGQGNHVPPYYGNSVRATVQRYPPTHH
TTDR00744	PDB Structure	4HC7; 4HC9; 4HCA
TTDR00744	BioChemical Class	Zinc-finger
TTDR00745	UniProt ID	Q15109
TTDR00745	Name	Advanced glycosylation end product-specific receptor
TTDR00745	Type of target	Clinical trial target
TTDR00745	Synonyms	RAGE
TTDR00745	Synonyms	RAGESEC
TTDR00745	Synonyms	Receptor for advanced glycosylation end products
TTDR00745	Disease	Amyloidosis
TTDR00745	Function	Mediates interactions of advanced glycosylation end products (age). These are no
TTDR00745	Sequence	MAAGTAVGAWVLVLSLWGAVVGAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLP
TTDR00745	PDB Structure	1PWI; 2BJP; 2E5E; 2ENS; 2L7U; 2LE9; 2LMB; 3CJJ; 3O3U; 3S58; 3S59
TTDR00745	BioChemical Class	Transmembrane protein
TTDR00746	UniProt ID	P26276
TTDR00746	Name	Phosphomannomutase/phosphoglucomutase
TTDR00746	Type of target	Research target
TTDR00746	Synonyms	PMM / PGM
TTDR00746	Synonyms	PMM/PGM
TTDR00746	Disease	P. aeruginosa infections
TTDR00746	Function	The phosphomannomutase activity produces a precursor for alginate polymerization
TTDR00746	Sequence	MSTAKAPTLPASIFRAYDIRGVVGDTLTAETAYWIGRAIGSESLARGEPCVAVGRDGRLSGPELVKQLIQGLVDCGCQVS
TTDR00746	PDB Structure	1K2Y; 1K35; 1P5D; 1P5G; 1PCJ; 1PCM; 2FKF; 2FKM; 2H4L; 2H5A; 3BKQ; 3C04; 3RSM
TTDR00746	BioChemical Class	Intramolecular transferases
TTDR00746	Pathway	Amino sugar and nucleotide sugar metabolism
TTDR00746	Pathway	Fructose and mannose metabolism
TTDR00746	Pathway	Galactose metabolism
TTDR00746	Pathway	Glycolysis / Gluconeogenesis
TTDR00746	Pathway	Metabolic pathways
TTDR00746	Pathway	Pentose phosphate pathway
TTDR00746	Pathway	Starch and sucrose metabolism
TTDR00746	Pathway	Streptomycin biosynthesis
TTDR00746	EC Number	EC 5.4.2.2
TTDR00746	EC Number	EC 5.4.2.8
TTDR00746	Inhibitor	Alpha-D-Glucose-1-Phosphate
TTDR00746	Inhibitor	Alpha-D-Glucose-6-Phosphate
TTDR00746	Inhibitor	Alpha-D-Mannose-6-Phosphate
TTDR00746	Inhibitor	D-Mannose 1-Phosphate
TTDR00746	Inhibitor	Phosphonoserine
TTDR00747	UniProt ID	P24232
TTDR00747	Name	Flavohemoglobin
TTDR00747	Type of target	Research target
TTDR00747	Synonyms	Dihydropteridine reductase
TTDR00747	Synonyms	Ferrisiderophore reductase B
TTDR00747	Synonyms	HMP
TTDR00747	Synonyms	Hemoglobin-like protein
TTDR00747	Synonyms	NO oxygenase
TTDR00747	Synonyms	NOD
TTDR00747	Synonyms	Nitric oxide dioxygenase
TTDR00747	Disease	Microbial infections
TTDR00747	Function	Possesses dihydropteridine reductase activity. Also has nitric oxide dioxygenase
TTDR00747	Sequence	MLDAQTIATVKATIPLLVETGPKLTAHFYDRMFTHNPELKEIFNMSNQRNGDQREALFNAIAAYASNIENLPALLPAVEK
TTDR00747	PDB Structure	1GVH
TTDR00747	BioChemical Class	Oxidoreductases acting on paired donors
TTDR00747	EC Number	EC 1.14.12.17
TTDR00747	EC Number	EC 1.5.1.34
TTDR00747	EC Number	EC 1.6.99.7
TTDR00747	Inhibitor	2-(N-Morpholino)-Ethanesulfonic Acid
TTDR00747	Inhibitor	Flavin-Adenine Dinucleotide
TTDR00747	Inhibitor	Heme
TTDR00747	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00748	UniProt ID	P26281
TTDR00748	Name	2-amino-4-hydroxy-6- hydroxymethyldihydropteridine pyrophosphokinase
TTDR00748	Type of target	Research target
TTDR00748	Synonyms	6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase
TTDR00748	Synonyms	7,8- dihydro-6-hydroxymethylpterin-pyrophosphokinase
TTDR00748	Synonyms	7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase
TTDR00748	Synonyms	HPPK
TTDR00748	Synonyms	PPPK
TTDR00748	Disease	Infections
TTDR00748	Disease	Microbial infections
TTDR00748	Disease	Parasitic diseases
TTDR00748	Sequence	MTVAYIAIGSNLASPLEQVNAALKALGDIPESHILTVSSFYRTPPLGPQDQPDYLNAAVALETSLAPEELLNHTQRIELQ
TTDR00748	PDB Structure	1DY3; 1EQ0; 1EQM; 1EX8; 1F9H; 1G4C; 1HKA; 1HQ2; 1IM6; 1KBR; 1Q0N; 1RAO; 1RB0; 1R
TTDR00748	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00748	Pathway	Folate biosynthesis
TTDR00748	Pathway	Metabolic pathways
TTDR00748	EC Number	EC 2.7.6.3
TTDR00748	Inhibitor	6-Hydroxymethyl-7,8-Dihydropterin
TTDR00748	Inhibitor	6-Hydroxymethylpterin
TTDR00748	Inhibitor	Acetate Ion
TTDR00748	Inhibitor	Adenosine-5'-Diphosphate
TTDR00748	Inhibitor	Alpha,Beta-Methyleneadenosine-5'-Triphosphate
TTDR00748	Inhibitor	P(1)-(6-Hydroxymethylpterin)-P(2)-(5'-adenosyl)diphosphate
TTDR00748	Inhibitor	P(1)-(6-Hydroxymethylpterin)-P(4)-(5'-adenosyl)tetraphosphate
TTDR00748	Inhibitor	[Pterin-6-Yl Methanyl]-Phosphonophosphate
TTDR00749	Name	G-quadruplex DNA
TTDR00749	Type of target	Research target
TTDR00749	Disease	Cancer, unspecific
TTDR00750	UniProt ID	P43357
TTDR00750	Name	Melanoma-associated antigen 3
TTDR00750	Type of target	Clinical trial target
TTDR00750	Synonyms	Antigen MZ2-D
TTDR00750	Synonyms	MAGE-3 antigen
TTDR00750	Synonyms	MAGE-A3
TTDR00750	Synonyms	MAGE-A3 antigen
TTDR00750	Synonyms	Melanoma antigen 3
TTDR00750	Synonyms	Melanoma associated antigen-A3
TTDR00750	Disease	Head and neck squamous cell carcinomas
TTDR00750	Disease	Intrahepatic cholangiocarcinoma
TTDR00750	Disease	Nonsmall cell lung cancer
TTDR00750	Function	Not known, though may play a role in embryonal development and tumor transformat
TTDR00750	Sequence	MPLEQRSQHCKPEEGLEARGEALGLVGAQAPATEEQEAASSSSTLVEVTLGEVPAAESPDPPQSPQGASSLPTTMNYPLW
TTDR00750	PDB Structure	1QEW
TTDR00751	UniProt ID	P21926
TTDR00751	Name	CD9 antigen
TTDR00751	Type of target	Research target
TTDR00751	Synonyms	CD9
TTDR00751	Synonyms	Leukocyte antigen MIC3
TTDR00751	Synonyms	MRP-1
TTDR00751	Synonyms	Motility-related protein
TTDR00751	Synonyms	P24
TTDR00751	Disease	Angiogenesis in metastatic and atherosclerotic processes
TTDR00751	Function	Involved in platelet activation and aggregation.
TTDR00751	Sequence	MPVKGGTKCIKYLLFGFNFIFWLAGIAVLAIGLWLRFDSQTKSIFEQETNNNNSSFYTGVYILIGAGALMMLVGFLGCCG
TTDR00751	BioChemical Class	Transmembrane protein
TTDR00751	Pathway	Hematopoietic cell lineage
TTDR00752	UniProt ID	O35713
TTDR00752	Name	Myelin-associated/oligodendrocyte basic protein
TTDR00752	Type of target	Research target
TTDR00752	Synonyms	MOBP
TTDR00752	Synonyms	Mus musculus adult male cerebellum cDNA, RIKEN full-length enriched library, clo
TTDR00752	Synonyms	Mus musculus adult male hippocampus cDNA, RIKEN full-length enriched library, cl
TTDR00752	Synonyms	Mus musculus adult male hippocampus cDNA, RIKEN full-length enriched library, cl
TTDR00752	Synonyms	Myelin oligodendrocytic basic protein
TTDR00752	Disease	Multiple sclerosis
TTDR00752	Sequence	MSQKMAKEGPRLSKNQKFSEHFSIHCCPPFTFLNSKREIVDRKYSICKSGCFYQKKEEDWICCACQKTSRRATSPQRPKH
TTDR00753	UniProt ID	P17169
TTDR00753	Name	Glucosamine-6-phosphate synthase
TTDR00753	Type of target	Research target
TTDR00753	Synonyms	D-fructose-6-phosphate amidotransferase
TTDR00753	Synonyms	GFAT
TTDR00753	Synonyms	Glucosamine--fructose-6-phosphate aminotransferase
TTDR00753	Synonyms	Hexosephosphate aminotransferase
TTDR00753	Synonyms	L-glutamine-D-fructose-6-phosphate amidotransferase
TTDR00753	Disease	Bacterial infections
TTDR00753	Disease	Fungal diseases
TTDR00753	Function	Catalyzes the first step in hexosamine metabolism, converting fructose-6p into g
TTDR00753	Sequence	MCGIVGAIAQRDVAEILLEGLRRLEYRGYDSAGLAVVDAEGHMTRLRRLGKVQMLAQAAEEHPLHGGTGIAHTRWATHGE
TTDR00753	PDB Structure	1JXA; 1MOQ; 1MOR; 1MOS; 1XFF; 1XFG; 2J6H; 2VF4; 2VF5; 3OOJ; 4AMV
TTDR00753	BioChemical Class	Transferases transferring nitrogenous groups
TTDR00753	Pathway	Alanine, aspartate and glutamate metabolism
TTDR00753	Pathway	Amino sugar and nucleotide sugar metabolism
TTDR00753	Pathway	Aminosugars metabolism
TTDR00753	Pathway	Metabolic pathways
TTDR00753	EC Number	EC 2.6.1.16
TTDR00753	Inhibitor	2-(N-Morpholino)-Ethanesulfonic Acid
TTDR00753	Inhibitor	2-Deoxy-2-Amino Glucitol-6-Phosphate
TTDR00753	Inhibitor	2-Methyl-2,4-Pentanediol
TTDR00753	Inhibitor	Acetate Ion
TTDR00753	Inhibitor	Alpha-D-Glucose-6-Phosphate
TTDR00753	Inhibitor	Glucosamine 6-Phosphate
TTDR00753	Inhibitor	Glucose-6-Phosphate
TTDR00753	Inhibitor	Glutamine Hydroxamate
TTDR00754	UniProt ID	Q9UNH0
TTDR00754	Name	Mitotic checkpoint protein
TTDR00754	Type of target	Research target
TTDR00754	Synonyms	MAD1 (Mitotic arrest deficient, yeast, homolog)-like 1
TTDR00754	Synonyms	Mitotic checkpoint gene hMAD1
TTDR00754	Disease	Lung cancer
TTDR00754	Sequence	MEDLGENTMVLSTLRSLNNFISQRVEGGSGLDISTSAPGSLQMQYQQSMQLEERAEQIRSKSHLIQVEREKMQMELSHKR
TTDR00754	PDB Structure	1GO4; 4DZO
TTDR00754	Pathway	Cell cycle
TTDR00755	UniProt ID	O00222
TTDR00755	Name	Metabotropic glutamate receptor 8
TTDR00755	Type of target	Research target
TTDR00755	Synonyms	Glutamate receptor mGLU8
TTDR00755	Synonyms	MGLUR8
TTDR00755	Synonyms	MGluR8a
TTDR00755	Disease	Analgesics
TTDR00755	Disease	Epilepsy
TTDR00755	Disease	Pain
TTDR00755	Function	Receptor for glutamate. The activity of this receptor is mediated by a g-protein
TTDR00755	Sequence	MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGGLFPVHAKGERGVPCGELKKEKGIHRLEAML
TTDR00755	BioChemical Class	G-protein coupled receptor (metabotropic glutamate family)
TTDR00755	Pathway	Neuroactive ligand-receptor interaction
TTDR00755	Target Validation	TTDR00755
TTDR00755	Inhibitor	2-Amino-4-phosphono-butyric acid
TTDR00755	Inhibitor	GLUTAMATE
TTDR00755	Inhibitor	L-1-amino-4-phosphonobutanoic acid
TTDR00755	Inhibitor	QUISQUALATE
TTDR00755	Agonist	(R,S)-4-phosphonophenylglycine
TTDR00756	UniProt ID	Q92826
TTDR00756	Name	Homeobox protein Hox-B13
TTDR00756	Type of target	Research target
TTDR00756	Synonyms	Hoxb-13
TTDR00756	Disease	Advanced Prostate cancer
TTDR00756	Function	Sequence-specific transcription factor which is part of a developmental regulato
TTDR00756	Sequence	MEPGNYATLDGAKDIEGLLGAGGGRNLVAHSPLTSHPAAPTLMPAVNYAPLDLPGSAEPPKQCHPCPGVPQGTSPAPVPY
TTDR00756	PDB Structure	2CRA
TTDR00757	Name	Fatty-acyl-CoA synthase
TTDR00757	Type of target	Research target
TTDR00757	Synonyms	Fatty acyl-CoA synthetase enzyme
TTDR00757	Synonyms	Yeast fatty acid synthase
TTDR00757	Disease	Malaria
TTDR00757	EC Number	EC 2.3.1.86
TTDR00758	UniProt ID	Q968X7
TTDR00758	Name	Pyruvate:ferredoxin oxidoreductase
TTDR00758	Type of target	Research target
TTDR00758	Synonyms	CpPNO
TTDR00758	Synonyms	PFOR
TTDR00758	Synonyms	Pyruvate:NADP+ oxidoreductase
TTDR00758	Disease	Anaerobic pathogens
TTDR00758	Function	May have an important role in respiratory metabolism. Cryptosporidium have a rel
TTDR00758	Sequence	MGEKEIVDGCVAACHIAYACSEVAFTYPITPSSTISEVADSWMSRGRRNIFDQVVSVVEMQSEMGSAGALHGSLSVGCST
TTDR00758	BioChemical Class	Oxidoreductases acting on the aldehyde or oxo group of donors
TTDR00758	EC Number	EC 1.2.1.51
TTDR00759	UniProt ID	P12955
TTDR00759	Name	Xaa-Pro dipeptidase
TTDR00759	Type of target	Research target
TTDR00759	Synonyms	Imidodipeptidase
TTDR00759	Synonyms	Prolidase
TTDR00759	Synonyms	Proline dipeptidase
TTDR00759	Synonyms	X-Pro dipeptidase
TTDR00759	Disease	Neoplastic diseases
TTDR00759	Function	Splits dipeptides with a prolyl or hydroxyprolyl residue in the carboxyl termina
TTDR00759	Sequence	MAAATGPSFWLGNETLKVPLALFALNRQRLCERLRKNPAVQAGSIVVLQGGEETQRYCTDTGVLFRQESFFHWAFGVTEP
TTDR00759	PDB Structure	2IW2; 2OKN
TTDR00759	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00759	EC Number	EC 3.4.13.9
TTDR00761	UniProt ID	O61142
TTDR00761	Name	Subtilisin-like protease
TTDR00761	Type of target	Research target
TTDR00761	Synonyms	PfSUB-1
TTDR00761	Synonyms	Subtilisin-like protein
TTDR00761	Disease	Malaria
TTDR00761	Sequence	MMLNKKVVALCTLTLHLFCIFLCLGKEVRSEENGKIQDDAKKIVSELRFLEKVEDVIEKSNIGGNEVDADENSFNPDTEV
TTDR00761	BioChemical Class	Protease
TTDR00762	UniProt ID	P07639
TTDR00762	Name	3-dehydroquinate synthase
TTDR00762	Type of target	Research target
TTDR00762	Synonyms	AROB
TTDR00762	Synonyms	Dehydroquinate synthase
TTDR00762	Disease	Bacterial infections
TTDR00762	Disease	Fungal diseases
TTDR00762	Sequence	MERIVVTLGERSYPITIASGLFNEPASFLPLKSGEQVMLVTNETLAPLYLDKVRGVLEQAGVNVDSVILPDGEQYKSLAV
TTDR00762	BioChemical Class	Carbon-oxygen lyases
TTDR00762	Pathway	Metabolic pathways
TTDR00762	Pathway	Phenylalanine, tyrosine and tryptophan biosynthesis
TTDR00762	EC Number	EC 4.2.3.4
TTDR00762	Inhibitor	Carbaphosphonate
TTDR00762	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00763	UniProt ID	P51685
TTDR00763	Name	C-C chemokine receptor type 8
TTDR00763	Type of target	Research target
TTDR00763	Synonyms	C-C CKR-8
TTDR00763	Synonyms	CC-CKR-8
TTDR00763	Synonyms	CC-chemokine receptor CHEMR1
TTDR00763	Synonyms	CCR-8
TTDR00763	Synonyms	CKR-L1
TTDR00763	Synonyms	CMKBRL2
TTDR00763	Synonyms	Chemokine receptor CCR8
TTDR00763	Synonyms	Chemokine receptor-like 1
TTDR00763	Synonyms	GPR-CY6
TTDR00763	Synonyms	GPRCY6
TTDR00763	Synonyms	TER1
TTDR00763	Disease	Allergic diseases
TTDR00763	Function	Receptor for the chemokines scya1/i-309, scya4/mip-1- beta and scya17/tarc. May
TTDR00763	Sequence	MDYTLDLSVTTVTDYYYPDIFSSPCDAELIQTNGKLLLAVFYCLLFVFSLLGNSLVILVLVVCKKLRSITDVYLLNLALS
TTDR00763	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00763	Pathway	Chemokine signaling pathway
TTDR00763	Pathway	Cytokine-cytokine receptor interaction
TTDR00763	Target Validation	TTDR00763
TTDR00763	Inhibitor	N-(4-phenylsulfamoyl-naphthalen-1-yl)-benzamide
TTDR00763	Inhibitor	N-{4-[(benzylamino)sulfonyl]-1-naphthyl}benzamide
TTDR00763	Ligand	I-309
TTDR00764	UniProt ID	O39166
TTDR00764	Name	Haemagglutinin
TTDR00764	Type of target	Research target
TTDR00764	Disease	Influenza A virus infections
TTDR00764	Function	Hemagglutinin is responsible for attaching the virus to cell receptors and for i
TTDR00764	Sequence	MKAKLLVLLCAFTATYADTICIGYHANNSTDTVDTVLEKNVTVTHSVNLLEDSHNGKLCRLKGTAPLQLGNCSVAGWILG
TTDR00764	BioChemical Class	Transmembrane protein
TTDR00765	UniProt ID	P16422
TTDR00765	Name	Tumor-associated calcium signal transducer 1
TTDR00765	Type of target	Research target
TTDR00765	Synonyms	Adenocarcinoma-associated antigen
TTDR00765	Synonyms	Cell surface glycoprotein Trop-1
TTDR00765	Synonyms	EGP
TTDR00765	Synonyms	Epithelial cell surface antigen
TTDR00765	Synonyms	Epithelial glycoprotein
TTDR00765	Synonyms	Gastrointestinal carcinoma antigen GA733
TTDR00765	Synonyms	KS 1/4 antigen
TTDR00765	Synonyms	KSA
TTDR00765	Synonyms	Major gastrointestinal tumor-associated protein GA733-2
TTDR00765	Disease	Colorectal cancer
TTDR00765	Function	Ga733 tumor-associated antigen gene family may function as growth factor recepto
TTDR00765	Sequence	MAPPQVLAFGLLLAAATATFAAAQEECVCENYKLAVNCFVNNNRQCQCTSVGAQNTVICSKLAAKCLVMKAEMNGSKLGR
TTDR00765	BioChemical Class	Transmembrane protein
TTDR00766	UniProt ID	P35755
TTDR00766	Name	Iron-transporter ferric ion-binding protein
TTDR00766	Type of target	Research target
TTDR00766	Synonyms	FBP
TTDR00766	Synonyms	Fe(+3)Iron-utilization periplasmic protein precursor-binding protein
TTDR00766	Synonyms	Fe(3+)-binding protein
TTDR00766	Synonyms	Iron-regulated 40 kDa protein
TTDR00766	Synonyms	MIRP
TTDR00766	Synonyms	Major ferric iron binding protein
TTDR00766	Disease	Bacterial infections
TTDR00766	Function	Part of the abc transporter complex fbpabc (tc 3.a.1.10.1) involved in ferric ca
TTDR00766	Sequence	MQFKHFKLATLAAALAFSANSFADITVYNGQHKEAATAVAKAFEQETGIKVTLNSGKSEQLAGQLKEEGDKTPADVFYTE
TTDR00766	PDB Structure	1D9V; 1MRP; 1NNF; 1QVS; 1QW0; 2O68; 2O69; 2O6A; 3KN7; 3KN8; 3OD7; 3ODB
TTDR00766	BioChemical Class	Ion transport
TTDR00766	Pathway	ABC transporters
TTDR00767	UniProt ID	O96438
TTDR00767	Name	Tryparedoxin
TTDR00767	Type of target	Research target
TTDR00767	Disease	Trypanosomiasis
TTDR00767	Sequence	MSGLDKYLPGIEKLRRGDGEVEVKSLAGKLVFFYFSASWCPPCRGFTPQLIEFYDKFHESKNFEVVFCTWDEEEDGFAGY
TTDR00767	PDB Structure	1EWX; 1EZK; 1O7U; 1O85; 1O8W; 1O8X; 1OKD; 1QK8
TTDR00769	UniProt ID	O91466
TTDR00769	UniProt ID	Q7M469
TTDR00769	Name	Cysteine proteinase
TTDR00769	Type of target	Research target
TTDR00769	Synonyms	CP
TTDR00769	Synonyms	V-cath
TTDR00769	Synonyms	Viral cathepsin
TTDR00769	Disease	Malaria
TTDR00769	Disease	Parasitic diseases
TTDR00769	Function	May play a role in degradation of infected larvae to facilitate horizontal trans
TTDR00769	Sequence	MTKLLNFVILASVLTVTAHALTYDLNNSDELFKNFAIKYNKTYVSDEERAIKLENFKNNLKMINEKNMASKYAVFDINEY
TTDR00769	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00769	EC Number	EC 3.4.22.50
TTDR00769	Related US Patent	6,329,377
TTDR00769	Related US Patent	6,342,531
TTDR00769	Related US Patent	6,468,977
TTDR00769	Related US Patent	6,500,802
TTDR00769	Related US Patent	6,569,847
TTDR00769	Inhibitor	E-64
TTDR00771	UniProt ID	P23415
TTDR00771	Name	Glycine receptor alpha-1 chain
TTDR00771	Type of target	Research target
TTDR00771	Synonyms	Glycine receptor 48 kDa subunit
TTDR00771	Synonyms	Strychnine binding subunit
TTDR00771	Synonyms	Strychnine-insensitive glycine receptor
TTDR00771	Disease	Convulsions
TTDR00771	Disease	Depression
TTDR00771	Function	The glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine
TTDR00771	Sequence	MYSFNTLRLYLWETIVFFSLAASKEAEAARSAPKPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVSCNIFINSFGSIA
TTDR00771	PDB Structure	1MOT; 1VRY
TTDR00771	BioChemical Class	Chloride channel
TTDR00771	Pathway	Neuroactive ligand-receptor interaction
TTDR00771	Target Validation	TTDR00771
TTDR00771	Inhibitor	10-methoxy-ginkgolide C
TTDR00771	Inhibitor	3,14-DIDEHYDROGINKGOLIDE A
TTDR00771	Inhibitor	3-demethoxy-3-D-lyxopyranosylaminothiocolchicine
TTDR00771	Inhibitor	3-demethoxy-3-D-mannopyranosylaminothiocolchicine
TTDR00771	Inhibitor	3-demethoxy-3-D-xylopyranosylaminothiocolchicine
TTDR00771	Inhibitor	3-demethoxy-3-L-fucopyranosylaminothiocolchicine
TTDR00771	Inhibitor	3-demethoxy-3D-glucopyranosylaminothiocolchicine
TTDR00771	Inhibitor	D-Serine
TTDR00771	Inhibitor	GINKGOLIDE A
TTDR00771	Inhibitor	GINKOLIDE B
TTDR00771	Inhibitor	STRYCHNINE
TTDR00771	Inhibitor	THIOCOLCHICOSIDE
TTDR00771	Inhibitor	ginkgolide C
TTDR00771	Inhibitor	ginkgolide J
TTDR00771	Inhibitor	ginkgolide M
TTDR00773	UniProt ID	P43358
TTDR00773	Name	Melanoma-associated antigen 4
TTDR00773	Type of target	Research target
TTDR00773	Synonyms	MAGE-4 antigen
TTDR00773	Synonyms	MAGE-4 protein
TTDR00773	Synonyms	MAGE-41
TTDR00773	Synonyms	MAGE-X2
TTDR00773	Disease	Cancer, unspecific
TTDR00773	Function	Not known, though may play a role in embryonal development and tumor transformat
TTDR00773	Sequence	MSSEQKSQHCKPEEGVEAQEEALGLVGAQAPTTEEQEAAVSSSSPLVPGTLEEVPAAESAGPPQSPQGASALPTTISFTC
TTDR00773	PDB Structure	1I4F; 2WA0
TTDR00774	UniProt ID	P49915
TTDR00774	Name	GMP synthase [glutamine-hydrolyzing]
TTDR00774	Type of target	Research target
TTDR00774	Synonyms	GMP synthetase
TTDR00774	Synonyms	Glutamine amidotransferase
TTDR00774	Disease	Cancer, unspecific
TTDR00774	Function	Involved in the de novo synthesis of guanine nucleotides which are not only esse
TTDR00774	Sequence	MALCNGDSKLENAGGDLKDGHHHYEGAVVILDAGAQYGKVIDRRVRELFVQSEIFPLETPAFAIKEQGFRAIIISGGPNS
TTDR00774	PDB Structure	2VPI; 2VXO
TTDR00774	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00774	Pathway	Drug metabolism - other enzymes
TTDR00774	Pathway	Metabolic pathways
TTDR00774	Pathway	Purine metabolism
TTDR00774	EC Number	EC 6.3.5.2
TTDR00774	Inhibitor	2,3,4-tribromo-6-(2,4-dibromophenoxy)phenol
TTDR00774	Inhibitor	3,4,5-tribromo-2-(2', 4'-dibromo-phenoxy)phenol
TTDR00774	Inhibitor	3,5-dibromo-2-(2,4-dibromophenoxy)phenol
TTDR00774	Inhibitor	Decoyinine
TTDR00774	Inhibitor	Pyrophosphate 2-
TTDR00775	UniProt ID	P48649
TTDR00775	Name	Gamma crystallin M2
TTDR00775	Type of target	Research target
TTDR00775	Synonyms	GM2
TTDR00775	Synonyms	Gamma-M2
TTDR00775	Disease	Motor disorder
TTDR00775	Function	Crystallins are the dominant structural components of the vertebrate eye lens.
TTDR00775	Sequence	MGKVIFYEDRNFQGRHYECSSDCADLSPYFSRCNSIRVEGGCWVLYEKPNYMGYQYFLTRGEYPDYQRWMGFNDTIRSCR
TTDR00776	UniProt ID	P14672
TTDR00776	Name	Solute carrier family 2, facilitated glucose transporter, member 4
TTDR00776	Type of target	Research target
TTDR00776	Synonyms	Glucose transporter type 4, insulin-responsive
TTDR00776	Synonyms	Glut4 protein
TTDR00776	Disease	Noninsulin-dependent diabetes mellitus
TTDR00776	Function	Insulin-regulated facilitative glucose transporter.
TTDR00776	Sequence	MPSGFQQIGSEDGEPPQQRVTGTLVLAVFSAVLGSLQFGYNIGVINAPQKVIEQSYNETWLGRQGPEGPSSIPPGTLTTL
TTDR00776	BioChemical Class	Transmembrane protein
TTDR00776	Pathway	Adipocytokine signaling pathway
TTDR00776	Pathway	Insulin signaling pathway
TTDR00776	Pathway	Type II diabetes mellitus
TTDR00777	UniProt ID	P01303
TTDR00777	Name	Neuropeptide Y
TTDR00777	Type of target	Research target
TTDR00777	Synonyms	NPY
TTDR00777	Disease	Heart failure
TTDR00777	Disease	Hypertension
TTDR00777	Disease	Metabolic disorder, unspecified
TTDR00777	Disease	Noninsulin-dependent diabetes mellitus
TTDR00777	Disease	Obesity
TTDR00777	Function	Npy is implicated in the control of feeding and in secretion of gonadotrophin-re
TTDR00777	Sequence	MLGNKRLGLSGLTLALSLLVCLGALAEAYPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRYGKRSSPETLISDLLMR
TTDR00777	PDB Structure	1QFA; 1RON
TTDR00777	Pathway	Adipocytokine signaling pathway
TTDR00777	Related US Patent	6,177,429
TTDR00777	Related US Patent	6,197,822
TTDR00777	Related US Patent	6,407,120
TTDR00777	Related US Patent	6,432,960
TTDR00777	Related US Patent	6,444,675
TTDR00777	Related US Patent	6,479,482
TTDR00777	Related US Patent	6,511,984
TTDR00777	Related US Patent	6,596,724
TTDR00777	Inhibitor	Alpha-Aminoisobutyric Acid
TTDR00777	Inhibitor	L-Tyrosinamide
TTDR00778	UniProt ID	P04324
TTDR00778	Name	Negative factor
TTDR00778	Type of target	Research target
TTDR00778	Synonyms	27 kDa protein
TTDR00778	Synonyms	3'ORF
TTDR00778	Synonyms	F-protein
TTDR00778	Synonyms	Nef protein
TTDR00778	Disease	Human immunodeficiency virus [HIV] disease
TTDR00778	Function	Nef has gtpase, gtp-binding and autophosphorylating activities. It seems to down
TTDR00778	Sequence	MGGKWSKSSVVGWPAVRERMRRAEPAADGVGAASRDLEKHGAITSSNTAANNAACAWLEAQEEEKVGFPVTPQVPLRPMT
TTDR00778	PDB Structure	1QA4; 1QA5; 1ZEC
TTDR00778	BioChemical Class	Cell membrane protein
TTDR00778	Inhibitor	MYRISTIC ACID
TTDR00779	UniProt ID	Q05084
TTDR00779	Name	69 kDa islet cell autoantigen
TTDR00779	Type of target	Research target
TTDR00779	Synonyms	ICA69
TTDR00779	Synonyms	ICAp69
TTDR00779	Synonyms	Islet cell autoantigen 1
TTDR00779	Synonyms	Islet cell autoantigen p69
TTDR00779	Synonyms	P69
TTDR00779	Disease	Insulin-dependent diabetes mellitus
TTDR00779	Sequence	MSGHKCSYPWDLQDRYAQDKSVVNKMQQKYWETKQAFIKATGKKEDEHVVASDADLDAKLELFHSIQRTCLDLSKAIVLY
TTDR00779	Pathway	Type I diabetes mellitus
TTDR00780	UniProt ID	Q8JIN2
TTDR00780	Name	Interleukin-8 receptor
TTDR00780	Type of target	Research target
TTDR00780	Synonyms	IL-8R
TTDR00780	Disease	Inflammatory diseases
TTDR00780	Disease	Psoriasis
TTDR00780	Sequence	MSIIFEFSDNFYDLLNESTNNNLTLIIDPSKLICELKPLEPTAAVTLCVLLIAIFLLAIPGNLLVGWVISTSKQNLTPSD
TTDR00780	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00780	Related US Patent	6,221,889
TTDR00780	Related US Patent	6,297,265
TTDR00780	Related US Patent	6,316,478
TTDR00780	Related US Patent	6,440,993
TTDR00780	Related US Patent	6,500,863
TTDR00780	Related US Patent	6,548,499
TTDR00780	Related US Patent	6,566,387
TTDR00780	Related US Patent	6,579,880
TTDR00780	Related US Patent	6,605,633
TTDR00780	Related US Patent	6,608,077
TTDR00780	Related US Patent	6,653,347
TTDR00780	Related US Patent	6,664,259
TTDR00780	Related US Patent	6,680,317
TTDR00781	Name	Guanosine phosphotransferase
TTDR00781	Type of target	Research target
TTDR00781	Disease	Parasitic diseases
TTDR00783	UniProt ID	Q9XZT6
TTDR00783	Name	Deoxyribonucleoside phosphotransferase
TTDR00783	Type of target	Research target
TTDR00783	Synonyms	Deoxyribonucleoside kinase
TTDR00783	Synonyms	Dm-Dnk
TTDR00783	Synonyms	Multispecific deoxynucleoside kinase
TTDR00783	Disease	Trichomoniasis
TTDR00783	Sequence	MAEAASCARKGTKYAEGTQPFTVLIEGNIGSGKTTYLNHFEKYKNDICLLTEPVEKWRNVNGVNLLELMYKDPKKWAMPF
TTDR00783	PDB Structure	1J90; 1OE0; 1OT3; 1ZM7; 1ZMX; 2JCS; 2JJ8; 2VP0; 2VP2; 2VP4; 2VP5; 2VP6; 2VP9; 2V
TTDR00783	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00783	EC Number	EC 2.7.1.145
TTDR00783	Target Validation	TTDR00783
TTDR00783	Inhibitor	1-[(Z)-4-(triphenylmethoxy)-2-butenyl]thymine
TTDR00783	Inhibitor	1-[5-(triphenylmethoxy)pentyl]thymine
TTDR00783	Inhibitor	1-[6-(triphenylmethoxy)hexyl]thymine
TTDR00784	UniProt ID	P15144
TTDR00784	Name	Aminopeptidase N
TTDR00784	Type of target	Research target
TTDR00784	Synonyms	Alanyl aminopeptidase
TTDR00784	Synonyms	Aminopeptidase M
TTDR00784	Synonyms	Gp150
TTDR00784	Synonyms	HAPN
TTDR00784	Synonyms	Microsomal aminopeptidase
TTDR00784	Synonyms	Myeloid plasma membrane glycoprotein CD13
TTDR00784	Disease	Coronaviruses infections
TTDR00784	Disease	Severe acute respiratory syndrome
TTDR00784	Disease	Tumors
TTDR00784	Function	Broad specificity aminopeptidase. Plays a role in the final digestion of peptide
TTDR00784	Sequence	MAKGFYISKSLGILGILLGVAAVCTIIALSVVYSQEKNKNANSSPVASTTPSASATTNPASATTLDQSKAWNRYRLPNTL
TTDR00784	PDB Structure	4FYQ; 4FYR; 4FYS; 4FYT
TTDR00784	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00784	Pathway	Glutathione metabolism
TTDR00784	Pathway	Hematopoietic cell lineage
TTDR00784	Pathway	Metabolic pathways
TTDR00784	Pathway	Renin-angiotensin system
TTDR00784	EC Number	EC 3.4.11.2
TTDR00784	Target Validation	TTDR00784
TTDR00784	Inhibitor	(1-Amino-2-phenyl-ethyl)-phosphinic acid
TTDR00784	Inhibitor	(1-Amino-3-methyl-butyl)-phosphinic acid
TTDR00784	Inhibitor	(1-Amino-3-methylsulfanyl-propyl)-phosphinic acid
TTDR00784	Inhibitor	(1-Amino-3-phenyl-propyl)-phosphinic acid
TTDR00784	Inhibitor	(1-Amino-ethyl)-phosphinic acid
TTDR00784	Inhibitor	(Amino-phenyl-methyl)-phosphinic acid
TTDR00784	Inhibitor	(S)-2-Amino-2-phenyl-ethanethiol
TTDR00784	Inhibitor	(S)-2-Amino-3-phenyl-propane-1-thiol
TTDR00784	Inhibitor	(S)-2-Amino-4-methyl-pentane-1-thiol
TTDR00784	Inhibitor	(S)-2-Amino-4-methylsulfanyl-butane-1-thiol
TTDR00784	Inhibitor	(S)-2-Amino-4-phenyl-butane-1-thiol
TTDR00784	Inhibitor	(S)-2-Amino-propane-1-thiol
TTDR00784	Inhibitor	1-aminobutylphosphonic acid
TTDR00784	Inhibitor	1-aminohexylphosphonic acid
TTDR00784	Inhibitor	1-aminohexylphosphonic acid monophenyl ester
TTDR00784	Inhibitor	1-aminopentylphosphonic acid monophenyl ester
TTDR00784	Inhibitor	2-Cinnamamido-N1-hydroxy-N4-octylsuccinamide
TTDR00784	Inhibitor	2-Cinnamamido-N1-hydroxy-N4-pentylsuccinamide
TTDR00784	Inhibitor	2-Cinnamamido-N4-hexyl-N1-hydroxysuccinamide
TTDR00784	Inhibitor	2-amino-N1-benzyl-N3-hydroxymalonamide
TTDR00784	Inhibitor	2-benzyl-N1-hydroxy-N3-(3-phenylpropyl)malonamide
TTDR00784	Inhibitor	2-benzyl-N1-hydroxy-N3-(4-phenylbutyl)malonamide
TTDR00784	Inhibitor	2-benzyl-N1-hydroxy-N3-phenethylmalonamide
TTDR00784	Inhibitor	Angiotensin IV
TTDR00784	Inhibitor	KELATORPHAN
TTDR00784	Inhibitor	N-Hydroxy-2-(naphthalen-2-ylsulfanyl)-acetamide
TTDR00784	Inhibitor	N-biphenyl-3-ylmethyl-N'-hydroxy-malonamide
TTDR00784	Inhibitor	N1,2-dibenzyl-N3-hydroxy-N1-phenethylmalonamide
TTDR00784	Inhibitor	N1,2-dibenzyl-N3-hydroxymalonamide
TTDR00784	Inhibitor	N1-(3,3-diphenylpropyl)-N3-hydroxymalonamide
TTDR00784	Inhibitor	N1-(3-phenoxybenzyl)-N3-hydroxymalonamide
TTDR00784	Inhibitor	N1-(4-chlorobenzyl)-2-amino-N3-hydroxymalonamide
TTDR00784	Inhibitor	N1-(4-chlorobenzyl)-2-benzyl-N3-hydroxymalonamide
TTDR00784	Inhibitor	N1-(4-fluorobenzyl)-2-benzyl-N3-hydroxymalonamide
TTDR00784	Inhibitor	N1-benzyl-N3-hydroxy-2-isobutylmalonamide
TTDR00784	Inhibitor	N1-hydroxy-2-isobutyl-N3-phenethylmalonamide
TTDR00784	Inhibitor	N4-Butyl-2-cinnamamido-N1-hydroxysuccinamide
TTDR00784	Inhibitor	[(125)I] RB129
TTDR00785	UniProt ID	P24199
TTDR00785	UniProt ID	P71684
TTDR00785	Name	3,4-dihydroxy-2-butanone-4-phosphate synthase
TTDR00785	Type of target	Research target
TTDR00785	Synonyms	DHBP synthase
TTDR00785	Synonyms	RibB
TTDR00785	Disease	Microbial infections
TTDR00785	Sequence	MTRLDSVERAVADIAAGKAVIVIDDEDRENEGDLIFAAEKATPEMVAFMVRYTSGYLCVPLDGAICDRLGLLPMYAVNQD
TTDR00785	PDB Structure	1G57; 1G58; 1IEZ
TTDR00786	UniProt ID	P24864
TTDR00786	Name	G1/S-specific cyclin E1
TTDR00786	Type of target	Research target
TTDR00786	Synonyms	Cyclin E
TTDR00786	Synonyms	G1/S-specific cyclin E
TTDR00786	Disease	Hepatocellular carcinoma
TTDR00786	Function	Essential for the control of the cell cycle at the g1/s (start) transition.
TTDR00786	Sequence	MPRERRERDAKERDTMKEDGGAEFSARSRKRKANVTVFLQDPDEEMAKIDRTARDQCGSQPWDNNAVCADPCSLIPTPDK
TTDR00786	PDB Structure	1W98
TTDR00786	Pathway	Cell cycle
TTDR00786	Pathway	Pathways in cancer
TTDR00786	Pathway	Prostate cancer
TTDR00786	Pathway	Small cell lung cancer
TTDR00786	Pathway	p53 signaling pathway
TTDR00786	Target Validation	TTDR00786
TTDR00786	Inhibitor	(2'Z,3'E)-5-Chloro-5'-chloro-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Chloro-5'-fluoro-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Chloro-5'-hydroxy-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Chloro-5'-methyl-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-chloro-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-fluoro-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-hydroxy-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-methoxy-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Fluoro-5'-methyl-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Nitro-5'-chloro-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Nitro-5'-fluoro-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Nitro-5'-hydroxy-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Nitro-5'-methoxy-indirubin-3'-oxime
TTDR00786	Inhibitor	(2'Z,3'E)-5-Nitro-5'-methyl-indirubin-3'-oxime
TTDR00786	Inhibitor	2-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol
TTDR00786	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDR00786	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDR00786	Inhibitor	3-((3,5-diamino-1H-pyrazol-4-yl)diazenyl)phenol
TTDR00786	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDR00786	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDR00786	Inhibitor	4-(7-Butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)-phenol
TTDR00786	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDR00786	Inhibitor	5-nitroindirubin-3'-oxime
TTDR00786	Inhibitor	BMS-536924
TTDR00786	Inhibitor	PD-0183812
TTDR00787	Name	Endothelium-derived hyperpolarizing factor
TTDR00787	Type of target	Research target
TTDR00787	Synonyms	EDHF
TTDR00787	Disease	Erectile dysfunction
TTDR00788	Name	Fibroblast-specific protein-1
TTDR00788	Type of target	Research target
TTDR00788	Synonyms	FSP1
TTDR00788	Disease	Breast cancer
TTDR00789	UniProt ID	P05109
TTDR00789	Name	Calgranulin A
TTDR00789	Type of target	Research target
TTDR00789	Synonyms	CFAG
TTDR00789	Synonyms	Calprotectin L1L subunit
TTDR00789	Synonyms	Cystic fibrosis antigen
TTDR00789	Synonyms	Leukocyte L1 complex light chain
TTDR00789	Synonyms	MRP-8
TTDR00789	Synonyms	MRP8
TTDR00789	Synonyms	Migration inhibitory factor-related protein 8
TTDR00789	Synonyms	Myeloid-related protein 8
TTDR00789	Synonyms	P8
TTDR00789	Synonyms	S100 calcium-binding protein A8
TTDR00789	Synonyms	Urinary stone protein band A
TTDR00789	Disease	Inflammatory arthritis
TTDR00789	Function	Expressed by macrophages in chronic inflammations. Also expressed in epithelial
TTDR00789	Sequence	MLTELEKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETECPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMGV
TTDR00789	PDB Structure	1MR8; 1XK4; 4GGF
TTDR00790	UniProt ID	P06702
TTDR00790	Name	Calgranulin B
TTDR00790	Type of target	Research target
TTDR00790	Synonyms	Calprotectin L1H subunit
TTDR00790	Synonyms	Leukocyte L1 complex heavy chain
TTDR00790	Synonyms	MRP-14
TTDR00790	Synonyms	MRP14
TTDR00790	Synonyms	Migration inhibitory factor-related protein 14
TTDR00790	Synonyms	Myeloid-related protein 14
TTDR00790	Synonyms	P14
TTDR00790	Synonyms	S100 calcium-binding protein A9
TTDR00790	Disease	Inflammatory arthritis
TTDR00790	Function	Expressed by macrophages in acutely inflammated tissues and in chronic inflammat
TTDR00790	Sequence	MTCKMSQLERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFI
TTDR00790	PDB Structure	1IRJ; 1XK4; 4GGF
TTDR00792	UniProt ID	O75293
TTDR00792	Name	Growth arrest and DNA-damage-inducible protein GADD45 beta
TTDR00792	Type of target	Research target
TTDR00792	Synonyms	DNA damage-inducible gene 45beta
TTDR00792	Synonyms	GADD45beta
TTDR00792	Synonyms	Myeloid differentiation primary response protein MyD118
TTDR00792	Synonyms	Negative growth-regulatory protein MyD118
TTDR00792	Disease	Hepatocellular carcinoma
TTDR00792	Function	Involved in the regulation of growth and apoptosis. Mediates activation of stres
TTDR00792	Sequence	MTLEELVACDNAAQKMQTVTAAVEELLVAAQRQDRLTVGVYESAKLMNVDPDSVVLCLLAIDEEEEDDIALQIHFTLIQS
TTDR00792	Pathway	Cell cycle
TTDR00792	Pathway	MAPK signaling pathway
TTDR00792	Pathway	p53 signaling pathway
TTDR00793	UniProt ID	Q15072
TTDR00793	Name	Zinc finger protein OZF
TTDR00793	Type of target	Research target
TTDR00793	Synonyms	ZNF146
TTDR00793	Disease	Colorectal cancer
TTDR00793	Sequence	MSHLSQQRIYSGENPFACKVCGKVFSHKSNLTEHEHFHTREKPFECNECGKAFSQKQYVIKHQNTHTGEKLFECNECGKS
TTDR00793	BioChemical Class	Zinc-finger
TTDR00794	UniProt ID	Q15746
TTDR00794	Name	Myosin light chain kinase, smooth muscle and non-muscle isozymes
TTDR00794	Type of target	Research target
TTDR00794	Synonyms	210,000 molecular weight myosin light chain kinase
TTDR00794	Synonyms	EC mlck
TTDR00794	Synonyms	Endothelial cell (EC) MLCK isoform
TTDR00794	Synonyms	MLCK
TTDR00794	Synonyms	MLCK210
TTDR00794	Disease	Lung injury
TTDR00794	Function	Calcium/calmodulin-dependent enzyme responsible for smooth muscle contraction vi
TTDR00794	Sequence	MGDVKLVASSHISKTSLSVDPSRVDSMPLTEAPAFILPPRNLCIKEGATAKFEGRVRGYPEPQVTWHRNGQPITSGGRFL
TTDR00794	PDB Structure	2CQV; 2K0F; 2YR3
TTDR00794	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00794	Pathway	Calcium signaling pathway
TTDR00794	Pathway	Focal adhesion
TTDR00794	Pathway	Regulation of actin cytoskeleton
TTDR00794	Pathway	Vascular smooth muscle contraction
TTDR00794	EC Number	EC 2.7.1.117
TTDR00794	Related US Patent	6,642,227
TTDR00795	UniProt ID	Q9BY76
TTDR00795	Name	Angiopoietin-related protein 4
TTDR00795	Type of target	Research target
TTDR00795	Synonyms	ANGPTL4
TTDR00795	Synonyms	Angiopoietin-like 4
TTDR00795	Synonyms	Angiopoietin-like protein PP1158
TTDR00795	Synonyms	HFARP
TTDR00795	Synonyms	Hepatic fibrinogen/angiopoietin-related protein
TTDR00795	Disease	Ischemic and solid tumor
TTDR00795	Function	May exert a protective function on endothelial cells through an endocrine action
TTDR00795	Sequence	MSGAPTAGAALMLCAATAVLLSAQGGPVQSKSPRFASWDEMNVLAHGLLQLGQGLREHAERTRSQLSALERRLSACGSAC
TTDR00795	Pathway	PPAR signaling pathway
TTDR00796	UniProt ID	Q9H3M7
TTDR00796	Name	VDUP1 protein
TTDR00796	Type of target	Research target
TTDR00796	Synonyms	VDUP1
TTDR00796	Synonyms	Vitamin D(3) up-regulating protein-1
TTDR00796	Disease	Melanoma
TTDR00796	Sequence	MVMFKKIKSFEVVFNDPEKVYGSGEKVAGRVIVEVCEVTRVKAVRILACGVAKVLWMQGSQQCKQTSEYLRYEDTLLLED
TTDR00796	PDB Structure	4GEI; 4GEJ
TTDR00797	UniProt ID	O60993
TTDR00797	UniProt ID	Q9GT49
TTDR00797	Name	Trypanothione synthetase
TTDR00797	Type of target	Research target
TTDR00797	Synonyms	Cf-TS
TTDR00797	Disease	Chagas' disease
TTDR00797	Disease	Parasitic diseases
TTDR00797	Function	Conjugates glutathione (gamma-glu-cys-gly) and glutathionylspermidine to form tr
TTDR00797	Sequence	MASAERVPVSFNKPGRVPFGEVQGYAPGHIPAYSNKHDHFFSGERSIDDNVFCGFKYQCVEFARRWLLERKGLVLPDVNW
TTDR00797	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00797	Pathway	Glutathione metabolism
TTDR00797	Pathway	Metabolic pathways
TTDR00797	EC Number	EC 6.3.1.9
TTDR00798	Name	Calprotectin
TTDR00798	Type of target	Research target
TTDR00798	Synonyms	CFAG
TTDR00798	Synonyms	Calprotectin L1L subunit
TTDR00798	Synonyms	Cystic fibrosis antigen
TTDR00798	Synonyms	Cytosolic protein complex L1
TTDR00798	Synonyms	L1 antigen
TTDR00798	Synonyms	L1 protein
TTDR00798	Synonyms	Leucocyte protein L1
TTDR00798	Synonyms	Leukocyte L1 complex light chain
TTDR00798	Synonyms	MRP-8
TTDR00798	Synonyms	MRP-8/MRP-14
TTDR00798	Synonyms	MRP8/MRP14 complex
TTDR00798	Synonyms	Migration inhibitory factor-related protein 8
TTDR00798	Synonyms	P8
TTDR00798	Synonyms	S100 calcium-binding protein A8
TTDR00798	Synonyms	S100A9/S100A8
TTDR00798	Synonyms	Urinary stone protein band A
TTDR00798	Disease	Inflammation
TTDR00798	Function	Expressed by macrophages in chronic inflammations. Also expressed in epithelial
TTDR00799	UniProt ID	Q15848
TTDR00799	Name	Adiponectin
TTDR00799	Type of target	Research target
TTDR00799	Synonyms	30 kDa adipocyte complement-related protein
TTDR00799	Synonyms	ACRP30
TTDR00799	Synonyms	Adipocyte, C1q and collagen domain containing protein
TTDR00799	Synonyms	Adipose most abundant gene transcript 1
TTDR00799	Synonyms	ApM-1
TTDR00799	Synonyms	Gelatin-binding protein
TTDR00799	Disease	Atherosclerotic cardiovascular disease
TTDR00799	Disease	Dyslipidemia
TTDR00799	Function	Important negative regulator in hematopoiesis and immune systems; may be involve
TTDR00799	Sequence	MLLLGAVLLLLALPGHDQETTTQGPGVLLPLPKGACTGWMAGIPGHPGHNGAPGRDGRDGTPGEKGEKGDPGLIGPKGDI
TTDR00799	PDB Structure	4DOU
TTDR00799	Pathway	Adipocytokine signaling pathway
TTDR00799	Pathway	PPAR signaling pathway
TTDR00799	Pathway	Type II diabetes mellitus
TTDR00800	UniProt ID	P28688
TTDR00800	Name	Polyphosphate kinase
TTDR00800	Type of target	Research target
TTDR00800	Synonyms	ATP-polyphosphate phosphotransferase
TTDR00800	Synonyms	PPK
TTDR00800	Synonyms	Polyphosphoric acid kinase
TTDR00800	Disease	Bacterial infections
TTDR00800	Function	Catalyzes the reversible transfer of the terminal phosphate of atp to form a lon
TTDR00800	Sequence	MGQEKLYIEKELSWLSFNERVLQEAADKSNPLIERMRFLGIYSNNLDEFYKVRFAELKRRIIISEEQGSNSHSRHLLGKI
TTDR00800	PDB Structure	1XDO; 1XDP
TTDR00800	EC Number	EC 2.7.4.1
TTDR00801	Name	Glycine receptor
TTDR00801	Type of target	Research target
TTDR00801	Synonyms	Strychnine-insensitive Glycine receptor
TTDR00801	Disease	Convulsions
TTDR00801	Disease	Depression
TTDR00801	Related US Patent	6,251,903
TTDR00802	UniProt ID	Q13258
TTDR00802	Name	Prostaglandin D2 receptor
TTDR00802	Type of target	Discontinued target
TTDR00802	Synonyms	PGD receptor
TTDR00802	Synonyms	Prostanoid DP receptor
TTDR00802	Disease	Allergic diseases
TTDR00802	Function	Receptor for prostaglandin d2 (pgd2). The activity of this receptor is mainly me
TTDR00802	Sequence	MKSPFYRCQNTTSVEKGNSAVMGGVLFSTGLLGNLLALGLLARSGLGWCSRRPLRPLPSVFYMLVCGLTVTDLLGKCLLS
TTDR00802	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00802	Pathway	Neuroactive ligand-receptor interaction
TTDR00802	Related US Patent	6,384,075
TTDR00802	Related US Patent	6,498,190
TTDR00802	Related US Patent	6,506,789
TTDR00802	Related US Patent	6,693,203
TTDR00802	Target Validation	TTDR00802
TTDR00802	Drug(s)	Laropiprant+niacin
TTDR00802	Drug(s)	S-555739
TTDR00802	Inhibitor	DIASTEREOMER 2
TTDR00802	Inhibitor	DINOPROST
TTDR00802	Inhibitor	LAROPIPRANT
TTDR00802	Antagonist	Laropiprant+niacin
TTDR00802	Antagonist	S-555739
TTDR00802	Antagonist	S-5751
TTDR00803	UniProt ID	P80511
TTDR00803	Name	Calgranulin D
TTDR00803	Type of target	Research target
TTDR00803	Synonyms	CAAF1
TTDR00803	Synonyms	CAGC
TTDR00803	Synonyms	CGRP
TTDR00803	Synonyms	Calcium-binding protein in amniotic fluid 1
TTDR00803	Synonyms	Neutrophil S100 protein
TTDR00803	Synonyms	P6
TTDR00803	Synonyms	S100A12
TTDR00803	Disease	Chronic airway inflammation
TTDR00803	Disease	Chronic arthritis
TTDR00803	Function	Calcitermin possesses antifungal activity against c.albicans and is also active
TTDR00803	Sequence	MTKLEEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAI
TTDR00803	PDB Structure	1E8A; 1GQM; 1ODB; 2WC8; 2WCB; 2WCE; 2WCF
TTDR00804	UniProt ID	P17931
TTDR00804	Name	Galectin-3
TTDR00804	Type of target	Research target
TTDR00804	Synonyms	35 kDa lectin
TTDR00804	Synonyms	Beta-galactoside-binding protein LGALS3
TTDR00804	Synonyms	CBP 35
TTDR00804	Synonyms	Carbohydrate binding protein 35
TTDR00804	Synonyms	GALBP
TTDR00804	Synonyms	Galactose-specific lectin 3
TTDR00804	Synonyms	Galactoside-binding protein
TTDR00804	Synonyms	IgE-binding protein
TTDR00804	Synonyms	L-31
TTDR00804	Synonyms	Laminin-binding protein
TTDR00804	Synonyms	Lectin L-29
TTDR00804	Synonyms	Mac-2 antigen
TTDR00804	Disease	Nonsmall cell lung cancer
TTDR00804	Function	Galactose-specific lectin which binds ige.
TTDR00804	Sequence	MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYP
TTDR00804	PDB Structure	1A3K; 1KJL; 1KJR; 2NMN; 2NMO; 2NN8; 2XG3; 3AYA; 3AYC; 3AYD; 3AYE; 3T1L; 3T1M; 3Z
TTDR00804	Inhibitor	2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide
TTDR00804	Inhibitor	PFFFFF
TTDR00805	UniProt ID	P35790
TTDR00805	Name	Choline kinase
TTDR00805	Type of target	Research target
TTDR00805	Synonyms	CHETK-alpha
TTDR00805	Synonyms	CK
TTDR00805	Synonyms	ChoK
TTDR00805	Disease	Cancer, unspecific
TTDR00805	Disease	Proliferative diseases
TTDR00805	Disease	Ras-dependent tumourigenesis
TTDR00805	Function	May have a regulatory role in phosphatidylcholine synthesis.
TTDR00805	Sequence	MKTKFCTGGEAEPSPLGLLLSCGSGSAAPAPGVGQQRDAASDLESKQLGGQQPPLALPPPPPLPLPLPLPQPPPPQPPAD
TTDR00805	PDB Structure	2CKO; 2CKP; 2CKQ; 2I7Q; 3F2R; 3G15; 3ZM9; 4DA5
TTDR00805	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00805	Pathway	Glycerophospholipid metabolism
TTDR00805	Pathway	Metabolic pathways
TTDR00805	EC Number	EC 2.7.1.32
TTDR00805	Target Validation	TTDR00805
TTDR00805	QSAR Model	TTDR00805
TTDR00805	Inhibitor	Bispyridinium compounds 87-89
TTDR00805	Inhibitor	Bisquinolinium derivative
TTDR00805	Inhibitor	Hemicholinium-3
TTDR00805	Inhibitor	Trispyridinium compounds 91-95
TTDR00806	UniProt ID	P78352
TTDR00806	Name	Presynaptic density protein 95
TTDR00806	Type of target	Research target
TTDR00806	Synonyms	Discs, large homolog 4
TTDR00806	Synonyms	PSD-95
TTDR00806	Synonyms	Postsynaptic density-95
TTDR00806	Disease	Analgesics
TTDR00806	Disease	Chronic neuropathic pain
TTDR00806	Disease	Opioid dependence
TTDR00806	Function	Interacts with the cytoplasmic tail of nmda receptor subunits. May be involved i
TTDR00806	Sequence	MDCLCIVTTKKYRYQDEDTPPLEHSPAHLPNQANSPPVIVNTDTLEAPGYELQVNGTEGEMEYEEITLERGNSGLGFSIA
TTDR00806	PDB Structure	1KEF; 3I4W; 3K82; 3ZRT
TTDR00806	BioChemical Class	Cell membrane protein
TTDR00806	Target Validation	TTDR00806
TTDR00806	Inhibitor	2-Methyl-2,4-Pentanediol
TTDR00806	Inhibitor	FETAV
TTDR00806	Inhibitor	Guanosine-5'-Monophosphate
TTDR00806	Inhibitor	KSG-LDTKNYKQTSV
TTDR00806	Inhibitor	KSG-YEKLSSIESDV
TTDR00806	Inhibitor	N-(3,4-Dichlorophenyl)propyl-ETAV
TTDR00806	Inhibitor	N-(3,4-Difluorophenyl)propyl-ETAV
TTDR00806	Inhibitor	N-(Naphthalene-2-yl)ethyl-ETAV
TTDR00806	Inhibitor	N-Benzyl-ETAV
TTDR00806	Inhibitor	N-Butyl-ETAV
TTDR00806	Inhibitor	N-Cyclohexylethyl-ETAV
TTDR00806	Inhibitor	N-Cyclohexylmethyl-ETAV
TTDR00806	Inhibitor	N-Ethyl-ETAV
TTDR00806	Inhibitor	N-Methyl-ETAV
TTDR00806	Inhibitor	N-Phenylethyl-ETAV
TTDR00806	Inhibitor	N-Phenylpropyl-ETAV
TTDR00806	Inhibitor	N-Propyl-ETAV
TTDR00806	Inhibitor	YGRKKRRQRRR-KLSSIESDV
TTDR00807	UniProt ID	P43121
TTDR00807	Name	Cell surface glycoprotein MUC18
TTDR00807	Type of target	Research target
TTDR00807	Synonyms	CD146
TTDR00807	Synonyms	CD146 antigen
TTDR00807	Synonyms	Melanoma adhesion molecule
TTDR00807	Synonyms	Melanoma-associated antigen A32
TTDR00807	Synonyms	Melanoma-associated antigen MUC18
TTDR00807	Synonyms	S-endo 1 endothelial-associated antigen
TTDR00807	Disease	Angiogenesis
TTDR00807	Disease	Tumors
TTDR00807	Function	Could be an adhesion molecule active in neural crest cells during embryonic deve
TTDR00807	Sequence	MGLPRLVCAFLLAACCCCPRVAGVPGEAEQPAPELVEVEVGSTALLKCGLSQSQGNLSHVDWFSVHKEKRTLIFRVRQGQ
TTDR00807	BioChemical Class	Transmembrane protein
TTDR00808	UniProt ID	P48061
TTDR00808	Name	Stromal cell-derived factor 1
TTDR00808	Type of target	Research target
TTDR00808	Synonyms	CXCL12
TTDR00808	Synonyms	HIRH
TTDR00808	Synonyms	PBSF
TTDR00808	Synonyms	Pre-B cell growth stimulating factor
TTDR00808	Synonyms	SDF-1
TTDR00808	Disease	Breast cancer
TTDR00808	Disease	Ovarian cancer
TTDR00808	Function	Chemoattractant active on t-lymphocytes, monocytes, but not neutrophils.
TTDR00808	Sequence	MNAKVVVVLVLVLTALCLSDGKPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQ
TTDR00808	PDB Structure	1A15; 1QG7; 1SDF; 1VMC; 2J7Z; 2K01; 2K03; 2K04; 2K05; 2KEC; 2KED; 2KEE; 2KOL; 2N
TTDR00808	BioChemical Class	Growth factor
TTDR00808	Pathway	Axon guidance
TTDR00808	Pathway	Chemokine signaling pathway
TTDR00808	Pathway	Cytokine-cytokine receptor interaction
TTDR00808	Pathway	Leukocyte transendothelial migration
TTDR00809	UniProt ID	P43246
TTDR00809	Name	DNA mismatch repair protein MSH2
TTDR00809	Type of target	Research target
TTDR00809	Synonyms	Mismatch repair gene Msh2
TTDR00809	Disease	Huntington's disease
TTDR00809	Function	Involved in postreplication mismatch repair. Binds specifically to dna containin
TTDR00809	Sequence	MAVQPKETLQLESAAEVGFVRFFQGMPEKPTTTVRLFDRGDFYTAHGEDALLAAREVFKTQGVIKYMGPAGAKNLQSVVL
TTDR00809	PDB Structure	2O8B; 2O8C; 2O8D; 2O8E; 2O8F; 3THW; 3THX; 3THY; 3THZ
TTDR00809	BioChemical Class	DNA repair
TTDR00809	Pathway	Colorectal cancer
TTDR00809	Pathway	Mismatch repair
TTDR00809	Pathway	Pathways in cancer
TTDR00810	UniProt ID	Q02363
TTDR00810	Name	DNA-binding protein inhibitor ID-2
TTDR00810	Type of target	Research target
TTDR00810	Synonyms	Id2
TTDR00810	Disease	Allergic diseases
TTDR00810	Function	Id (inhibitor of dna binding) hlh proteins lack a basic dna-binding domain but a
TTDR00810	Sequence	MKAFSPVRSVRKNSLSDHSLGISRSKTPVDDPMSLLYNMNDCYSKLKELVPSIPQNKKVSKMEILQHVIDYILDLQIALD
TTDR00810	PDB Structure	4AYA
TTDR00810	Pathway	TGF-beta signaling pathway
TTDR00811	UniProt ID	P51659
TTDR00811	Name	Estradiol 17 beta-dehydrogenase 4
TTDR00811	Type of target	Research target
TTDR00811	Synonyms	17 beta-hydroxysteroid dehydrogenase type 4
TTDR00811	Synonyms	17-beta-HSD 4
TTDR00811	Synonyms	17-beta-hydroxysteroid dehydrogenase 4
TTDR00811	Synonyms	D-bifunctional protein
TTDR00811	Synonyms	DBP
TTDR00811	Synonyms	MFE-2
TTDR00811	Disease	Stiff-man syndrome
TTDR00811	Function	Bifunctional enzyme acting on the peroxisomal beta- oxidation pathway for fatty
TTDR00811	Sequence	MGSPLRFDGRVVLVTGAGAGLGRAYALAFAERGALVVVNDLGGDFKGVGKGSLAADKVVEEIRRRGGKAVANYDSVEEGE
TTDR00811	PDB Structure	1IKT; 1S9C; 1ZBQ
TTDR00811	Pathway	Metabolic pathways
TTDR00811	Pathway	Primary bile acid biosynthesis
TTDR00811	EC Number	EC 1.1.1.62
TTDR00811	Inhibitor	3r-Hydroxydecanoyl-Coa
TTDR00811	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00812	UniProt ID	Q13613
TTDR00812	Name	Myotubularin-related protein 1
TTDR00812	Type of target	Research target
TTDR00812	Synonyms	MTMR1
TTDR00812	Disease	Myotonic dystrophy
TTDR00812	Function	Not known, could be a tyrosine-phosphatase.
TTDR00812	Sequence	MDRPAAAAAAGCEGGGGPNPGPAGGRRPPRAAGGATAGSRQPSVETLDSPTGSHVEWCKQLIAATISSQISGSVTSENVS
TTDR00812	BioChemical Class	Hydrolases acting on ester bonds
TTDR00812	Pathway	Aminosugars metabolism
TTDR00812	Pathway	Fructose and mannose metabolism
TTDR00812	Pathway	Metabolic pathways
TTDR00812	Pathway	Riboflavin metabolism
TTDR00812	Pathway	Thiamine metabolism
TTDR00813	UniProt ID	O60603
TTDR00813	Name	Toll-like receptor 2
TTDR00813	Type of target	Research target
TTDR00813	Synonyms	TLR2
TTDR00813	Disease	Skin diseases
TTDR00813	Function	Cooperates with ly96 to mediate the innate immune response to bacterial lipoprot
TTDR00813	Sequence	MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQA
TTDR00813	PDB Structure	1FYW; 1FYX; 1O77; 2Z7X; 2Z80
TTDR00813	BioChemical Class	Transmembrane protein
TTDR00813	Pathway	Toll-like receptor signaling pathway
TTDR00813	Inhibitor	S-(Dimethylarsenic)Cysteine
TTDR00814	UniProt ID	Q13309
TTDR00814	Name	S-phase kinase-associated protein 2
TTDR00814	Type of target	Research target
TTDR00814	Synonyms	Cyclin A/CDK2-associated p45
TTDR00814	Synonyms	Cyclin A/CDK2-associated protein p45
TTDR00814	Synonyms	F-box protein Skp2
TTDR00814	Synonyms	F-box/LRR-repeat protein 1
TTDR00814	Synonyms	P45skp2
TTDR00814	Synonyms	Skp2
TTDR00814	Disease	Gastric carcinoma
TTDR00814	Disease	Small cell lung cancer
TTDR00814	Disease	Squamous cell carcinoma
TTDR00814	Function	Substrate recognition component of the scf (skp1-cul1-f- box protein) e3 ubiquit
TTDR00814	Sequence	MHRKHLQEIPDLSSNVATSFTWGWDSSKTSELLSGMGVSALEKEEPDSENIPQELLSNLGHPESPPRKRLKSKGSDKDFV
TTDR00814	PDB Structure	1FQV; 1FS1; 1FS2; 1LDK; 2ASS; 2AST
TTDR00814	Pathway	Cell cycle
TTDR00814	Pathway	Pathways in cancer
TTDR00814	Pathway	Small cell lung cancer
TTDR00814	Pathway	Ubiquitin mediated proteolysis
TTDR00815	UniProt ID	Q99988
TTDR00815	Name	Growth/differentiation factor 15
TTDR00815	Type of target	Research target
TTDR00815	Synonyms	GDF-15
TTDR00815	Synonyms	MIC-1
TTDR00815	Synonyms	Macrophage inhibitory cytokine 1
TTDR00815	Synonyms	Macrophage inhibitory cytokine-1
TTDR00815	Synonyms	NRG-1
TTDR00815	Synonyms	NSAID-regulated protein 1
TTDR00815	Synonyms	Placental TGF-beta
TTDR00815	Synonyms	Placental bone morphogenic protein
TTDR00815	Synonyms	Prostate differentiation factor
TTDR00815	Disease	Cardiovascular disease, unspecified
TTDR00815	Sequence	MPGQELRTVNGSQMLLVLLVLSWLPHGGALSLAEASRASFPGPSELHTEDSRFRELRKRYEDLLTRLRANQSWEDSNTDL
TTDR00815	BioChemical Class	Growth factor
TTDR00816	UniProt ID	P24555
TTDR00816	Name	Protease II
TTDR00816	Type of target	Research target
TTDR00816	Synonyms	Oligopeptidase B
TTDR00816	Disease	Microbial infections
TTDR00816	Function	Cleaves peptide bonds on the c-terminal side of lysyl and argininyl residues.
TTDR00816	Sequence	MLPKAARIPHAMTLHGDTRIDNYYWLRDDTRSQPEVLDYLQQENSYGHRVMASQQALQDRILKEIIDRIPQREVSAPYIK
TTDR00816	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00816	EC Number	EC 3.4.21.83
TTDR00817	UniProt ID	Q15466
TTDR00817	Name	Orphan nuclear receptor SHP
TTDR00817	Type of target	Research target
TTDR00817	Synonyms	SHP
TTDR00817	Synonyms	Short heterodimer partner
TTDR00817	Synonyms	Small heterodimer partner
TTDR00817	Disease	Endometrial cancer
TTDR00817	Function	May be a negative regulator of receptor-dependent signaling pathways. Specifical
TTDR00817	Sequence	MSTSQPGACPCQGAASRPAILYALLSSSLKAVPRPRSRCLCRQHRPVQLCAPHRTCREALDVLAKTVAFLRNLPSFWQLP
TTDR00817	PDB Structure	1YUC; 2Q3Y; 2Z4J; 4DOR
TTDR00818	UniProt ID	Q9PY17
TTDR00818	Name	Nucleocapsid protein, NCP7, NC71
TTDR00818	Type of target	Research target
TTDR00818	Synonyms	HIV-1 nucleocapsid protein NCp7
TTDR00818	Synonyms	NCp7
TTDR00818	Disease	Human immunodeficiency virus [HIV] disease
TTDR00818	Sequence	MQRGNFRNQRKMVKCFNCGKEGHTARNCRAPRKKGCWKCGKEGHQMKDCTERQANFLGKIWPSYKGRPGNF
TTDR00819	UniProt ID	Q92940
TTDR00819	Name	Mothers against decapentaplegic homolog 3
TTDR00819	Type of target	Research target
TTDR00819	Synonyms	HMAD-3
TTDR00819	Synonyms	HSMAD3
TTDR00819	Synonyms	JV15-2
TTDR00819	Synonyms	MMad3
TTDR00819	Synonyms	Mad3
TTDR00819	Synonyms	Mothers against DPP homolog 3
TTDR00819	Synonyms	SMAD 3
TTDR00819	Synonyms	Smad3
TTDR00819	Synonyms	TGF-beta response effector Smad3
TTDR00819	Disease	Lung fibrosis
TTDR00819	Function	Transcriptional modulator activated by tgf-beta (transforming growth factor) and
TTDR00819	Sequence	MSSILPFTPPIVKRLLGWKKGEQNGQEEKWCEKAVKSLVKKLKKTGQLDELEKAITTQNVNTKCITIPRSLDGRLQVSHR
TTDR00819	PDB Structure	1MHD; 1MJS; 1MK2; 1OZJ; 1U7F
TTDR00819	Target Validation	TTDR00819
TTDR00819	Inhibitor	ELLAGIC ACID
TTDR00819	Inhibitor	FLUORESCEIN
TTDR00819	Inhibitor	GNF-PF-2272
TTDR00820	UniProt ID	O95389
TTDR00820	Name	WNT1 inducible signaling pathway protein 3 variant
TTDR00820	Type of target	Research target
TTDR00820	Synonyms	UNQ462/PRO790
TTDR00820	Synonyms	WISP-3
TTDR00820	Synonyms	WNT1 inducible signaling pathway protein 3
TTDR00820	Disease	Colorectal cancer
TTDR00820	Function	Appears to be required for normal postnatal skeletal growth and cartilage homeos
TTDR00820	Sequence	MQGLLFSTLLLAGLAQFCCRVQGTGPLDTTPEGRPGEVSDAPQRKQFCHWPCKCPQQKPRCPPGVSLVRDGCGCCKICAK
TTDR00820	BioChemical Class	Growth factor
TTDR00821	UniProt ID	Q14831
TTDR00821	Name	Metabotropic glutamate receptor 7
TTDR00821	Type of target	Research target
TTDR00821	Disease	Convulsions
TTDR00821	Function	Receptor for glutamate. The activity of this receptor is mediated by a g-protein
TTDR00821	Sequence	MVQLRKLLRVLTLMKFPCCVLEVLLCALAAAARGQEMYAPHSIRIEGDVTLGGLFPVHAKGPSGVPCGDIKRENGIHRLE
TTDR00821	PDB Structure	3MQ4
TTDR00821	BioChemical Class	G-protein coupled receptor (metabotropic glutamate family)
TTDR00821	Pathway	Neuroactive ligand-receptor interaction
TTDR00821	Target Validation	TTDR00821
TTDR00821	Inhibitor	QUISQUALATE
TTDR00822	UniProt ID	P42773
TTDR00822	Name	Cyclin-dependent kinase 6 inhibitor
TTDR00822	Type of target	Research target
TTDR00822	Synonyms	Cyclin-dependent kinase 4 inhibitor C
TTDR00822	Synonyms	P18 INK4c protein
TTDR00822	Synonyms	P18(INK4c)
TTDR00822	Synonyms	P18(INK4c) protein
TTDR00822	Synonyms	P18-INK4c
TTDR00822	Synonyms	P18-INK6
TTDR00822	Disease	Autoimmune diseases
TTDR00822	Function	Interacts strongly with cdk6, weakly with cdk4. Inhibits cell growth and prolife
TTDR00822	Sequence	MAEPWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKLGNPEIARRLLLRGANPDLKDRTGFAVIHDAARA
TTDR00822	PDB Structure	1BU9; 1G3N; 1IHB; 1MX2; 1MX4; 1MX6
TTDR00822	Pathway	Cell cycle
TTDR00823	UniProt ID	O14793
TTDR00823	Name	Growth/differentiation factor 8
TTDR00823	Type of target	Clinical trial target
TTDR00823	Synonyms	GDF-8
TTDR00823	Synonyms	Myostatin
TTDR00823	Disease	Cachexia
TTDR00823	Disease	Endocrine disorder
TTDR00823	Disease	Immune disease
TTDR00823	Disease	Metabolic disorder, unspecified
TTDR00823	Disease	Muscular atrophy
TTDR00823	Disease	Sarcopenia
TTDR00823	Disease	Skeletal muscle wasting
TTDR00823	Function	Acts specifically as a negative regulator of skeletal muscle growth.
TTDR00823	Sequence	MQKLQLCVYIYLFMLIVAGPVDLNENSEQKENVEKEGLCNACTWRQNTKSSRIEAIKIQILSKLRLETAPNISKDVIRQL
TTDR00823	BioChemical Class	Growth factor
TTDR00824	UniProt ID	P29120
TTDR00824	Name	Neuroendocrine convertase 1
TTDR00824	Type of target	Research target
TTDR00824	Synonyms	NEC 1
TTDR00824	Synonyms	PC1
TTDR00824	Synonyms	Prohormone convertase 1
TTDR00824	Synonyms	Proprotein convertase 1
TTDR00824	Synonyms	Subtilisin-like proprotein convertase
TTDR00824	Disease	Cancer, unspecific
TTDR00824	Disease	Malignant gliomas
TTDR00824	Function	Involved in the processing of hormone and other protein precursors at sites comp
TTDR00824	Sequence	MERRAWSLQCTAFVLFCAWCALNSAKAKRQFVNEWAAEIPGGPEAASAIAEELGYDLLGQIGSLENHYLFKHKNHPRRSR
TTDR00824	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00824	EC Number	EC 3.4.21.93
TTDR00824	Target Validation	TTDR00824
TTDR00824	Inhibitor	phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide
TTDR00825	UniProt ID	P16519
TTDR00825	Name	Neuroendocrine convertase 2
TTDR00825	Type of target	Research target
TTDR00825	Synonyms	KEX2-like endoprotease 2
TTDR00825	Synonyms	NEC 2
TTDR00825	Synonyms	PC2
TTDR00825	Synonyms	Prohormone convertase 2
TTDR00825	Synonyms	Proprotein convertase 2
TTDR00825	Synonyms	Subtilisin-like proprotein convertase
TTDR00825	Disease	Cancer, unspecific
TTDR00825	Disease	Malignant gliomas
TTDR00825	Function	Involved in the processing of hormone and other protein precursors at sites comp
TTDR00825	Sequence	MKGGCVSQWKAAAGFLFCVMVFASAERPVFTNHFLVELHKGGEDKARQVAAEHGFGVRKLPFAEGLYHFYHNGLAKAKRR
TTDR00825	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00825	EC Number	EC 3.4.21.94
TTDR00825	Target Validation	TTDR00825
TTDR00825	Inhibitor	phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide
TTDR00826	UniProt ID	O74271
TTDR00826	Name	Histidine kinase
TTDR00826	Type of target	Research target
TTDR00826	Synonyms	COS-l
TTDR00826	Disease	Fungal diseases
TTDR00826	Sequence	MNPTKKPRLSPMQPSVFEILNDPELYSQHCHSLRETLLDHFNHQATLIDTYEHELEKSKNANKAFQQALSEIGTVVISVA
TTDR00826	EC Number	EC 2.7.3.-
TTDR00827	UniProt ID	Q92210
TTDR00827	Name	Phosphoribosylaminoimidazole carboxylase
TTDR00827	Type of target	Research target
TTDR00827	Synonyms	ADE2
TTDR00827	Synonyms	AIR carboxylase
TTDR00827	Synonyms	AIRC
TTDR00827	Disease	Fungal diseases
TTDR00827	Sequence	MDSKTVGILGGGQLGRMIVEAAHRLNIKTVILDAAKSPAKQINALDDHVDGSFTNYDSIVKLAEKADVLTVEIEHVDVDA
TTDR00827	BioChemical Class	Carbon-carbon lyases
TTDR00827	EC Number	EC 4.1.1.21
TTDR00828	UniProt ID	P24855
TTDR00828	Name	Deoxyribonuclease I
TTDR00828	Type of target	Research target
TTDR00828	Synonyms	Alkaline deoxyribonuclease
TTDR00828	Synonyms	DNase I
TTDR00828	Synonyms	Dornase alfa
TTDR00828	Synonyms	Herpesvirus alkaline DNase
TTDR00828	Synonyms	Herpesvirus alkaline deoxyribonuclease
TTDR00828	Disease	Herpes virus infection
TTDR00828	Function	Among other functions, seems to be involved in cell death by apoptosis. Binds sp
TTDR00828	Sequence	MRGMKLLGALLALAALLQGAVSLKIAAFNIQTFGETKMSNATLVSYIVQILSRYDIALVQEVRDSHLTAVGKLLDNLNQD
TTDR00828	PDB Structure	4AWN
TTDR00828	BioChemical Class	Hydrolases acting on ester bonds
TTDR00828	EC Number	EC 3.1.21.1
TTDR00828	Inhibitor	Alpha-D-Mannose
TTDR00829	UniProt ID	Q16658
TTDR00829	Name	Fascin
TTDR00829	Type of target	Research target
TTDR00829	Synonyms	55 kDa actin bundling protein
TTDR00829	Synonyms	P55
TTDR00829	Synonyms	Singed-like protein
TTDR00829	Disease	Ovarian cancer
TTDR00829	Function	Organizes filamentous actin into bundles with a minimum of 4.1:1 actin/fascin ra
TTDR00829	Sequence	MTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTC
TTDR00829	PDB Structure	1DFC; 3LLP; 3O8K; 3P53; 4GOV; 4GOY; 4GP0; 4GP3
TTDR00830	UniProt ID	P33151
TTDR00830	Name	Vascular endothelial-cadherin
TTDR00830	Type of target	Research target
TTDR00830	Synonyms	7B4 antigen
TTDR00830	Synonyms	CD144 antigen
TTDR00830	Synonyms	Cadherin-5
TTDR00830	Synonyms	VE-cad
TTDR00830	Synonyms	VE-cadherin
TTDR00830	Disease	Tumor angiogenesis and metastasis
TTDR00830	Function	Cadherins are calcium dependent cell adhesion proteins. They preferentially inte
TTDR00830	Sequence	MQRLMMLLATSGACLGLLAVAAVAAAGANPAQRDTHSLLPTHRRQKRDWIWNQMHIDEEKNTSLPHHVGKIKSSVSRKNA
TTDR00830	BioChemical Class	Transmembrane protein
TTDR00830	Pathway	Cell adhesion molecules (CAMs)
TTDR00830	Pathway	Leukocyte transendothelial migration
TTDR00831	UniProt ID	P08519
TTDR00831	Name	Apolipoprotein(a)
TTDR00831	Type of target	Clinical trial target
TTDR00831	Synonyms	Apo(a)
TTDR00831	Synonyms	Lipoprotein(a)
TTDR00831	Synonyms	Lp(a)
TTDR00831	Disease	Cardiovascular disease, unspecified
TTDR00831	Disease	Neurodegenerative diseases
TTDR00831	Function	Apo(a) is the main constituent of lipoprotein(a) (lp(a)). It has serine proteina
TTDR00831	Sequence	MEHKEVVLLLLLFLKSAAPEQSHVVQDCYHGDGQSYRGTYSTTVTGRTCQAWSSMTPHQHNRTTENYPNAGLIMNYCRNP
TTDR00831	PDB Structure	1I71; 1JFN; 1KIV; 2FEB; 3KIV; 4KIV
TTDR00831	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00831	EC Number	EC 3.4.21.-
TTDR00832	UniProt ID	Q9H255
TTDR00832	Name	Olfactory receptor 51E2
TTDR00832	Type of target	Research target
TTDR00832	Synonyms	HPRAJ
TTDR00832	Synonyms	PSGR
TTDR00832	Synonyms	Prostate specific G-protein coupled receptor
TTDR00832	Disease	Prostate cancer
TTDR00832	Function	Putative odorant receptor.
TTDR00832	Sequence	MSSCNFTHATFVLIGIPGLEKAHFWVGFPLLSMYVVAMFGNCIVVFIVRTERSLHAPMYLFLCMLAAIDLALSTSTMPKI
TTDR00832	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR00832	Pathway	Olfactory transduction
TTDR00833	UniProt ID	O15116
TTDR00833	Name	U6 snRNA-associated Sm-like protein LSm1
TTDR00833	Type of target	Research target
TTDR00833	Synonyms	CaSm
TTDR00833	Synonyms	Cancer-associated Sm-like
TTDR00833	Synonyms	Cancer-associated Sm-like (CaSm) oncogene
TTDR00833	Synonyms	Small nuclear ribonuclear CaSm
TTDR00833	Disease	Pancreatic cancer
TTDR00833	Function	Binds specifically to the 3'-terminal u-tract of u6 snrna.
TTDR00833	Sequence	MNYMPGTASLIEDIDKKHLVLLRDGRTLIGFLRSIDQFANLVLHQTVERIHVGKKYGDIPRGIFVVRGENVVLLGEIDLE
TTDR00834	UniProt ID	P35318
TTDR00834	Name	ADM
TTDR00834	Type of target	Research target
TTDR00834	Synonyms	Adrenomedullin
TTDR00834	Synonyms	Proadrenomedullin N-20 terminal peptide
TTDR00834	Disease	Angiogenesis
TTDR00834	Disease	Cancer, unspecific
TTDR00834	Disease	Diabetic complications
TTDR00834	Disease	Tumors (androgen sensitive)
TTDR00834	Function	Am and pamp are potent hypotensive and vasodilatator agents. Numerous actions ha
TTDR00834	Sequence	MKLVSVALMYLGSLAFLGADTARLDVASEFRKKWNKWALSRGKRELRMSSSYPTGLADVKAGPAQTLIRPQDMKGASRSP
TTDR00834	PDB Structure	2FLY; 2L7S
TTDR00838	UniProt ID	O95186
TTDR00838	Name	Fatty acid transport protein
TTDR00838	Type of target	Research target
TTDR00838	Synonyms	FATP1
TTDR00838	Synonyms	FATP4
TTDR00838	Synonyms	Fatty acid transport protein 1
TTDR00838	Synonyms	Fatty acid transport protein 4
TTDR00838	Synonyms	Long-chain fatty acid transport protein 4
TTDR00838	Disease	Insulin resistance
TTDR00838	Disease	Noninsulin-dependent diabetes mellitus
TTDR00838	Disease	Obesity
TTDR00838	Sequence	MLLGASLVGVLLFSKLVLKLPWTQVGFSLLFLYLGSGGWRFIRVFIKTIRRDIFGGLVLLKVKAKVRQCLQERRTVPILF
TTDR00838	BioChemical Class	Ligases forming carbon-sulfur bonds
TTDR00838	Pathway	PPAR signaling pathway
TTDR00839	UniProt ID	Q9UVD0
TTDR00839	Name	Kexin-like serine endoprotease
TTDR00839	Type of target	Research target
TTDR00839	Synonyms	Serine endoprotease
TTDR00839	Synonyms	Serine endoprotease kexin
TTDR00839	Disease	P. carinii pneumonia
TTDR00839	Sequence	EPPAPPSQPEPPAPQPQPEPPAPPPQPEPPAPPPQPEPPAPPPQPEPPAPPSQPEPPAPPPQPEPPAPPPQPEPPAPPPK
TTDR00839	BioChemical Class	Protease
TTDR00839	EC Number	EC 3.4.21.61
TTDR00840	UniProt ID	P15407
TTDR00840	Name	Fos-related antigen 1
TTDR00840	Type of target	Research target
TTDR00840	Synonyms	Fra-1
TTDR00840	Disease	Pancreatic cancer
TTDR00840	Sequence	MFRDFGEPGPSSGNGGGYGGPAQPPAAAQAAQQKFHLVPSINTMSGSQELQWMVQPHFLGPSSYPRPLTYPQYSPPQPRP
TTDR00840	Pathway	Wnt signaling pathway
TTDR00841	UniProt ID	Q15717
TTDR00841	Name	Elav-like protein 1
TTDR00841	Type of target	Research target
TTDR00841	Synonyms	Hu-antigen R
TTDR00841	Synonyms	HuR
TTDR00841	Disease	Paraneoplastic encephalomyelitis
TTDR00841	Function	Binds avidly to the au-rich element in c-fos and interleukin-3 mrnas. In the cas
TTDR00841	Sequence	MSNGYEDHMAEDCRGDIGRTNLIVNYLPQNMTQDELRSLFSSIGEVESAKLIRDKVAGHSLGYGFVNYVTAKDAERAINT
TTDR00841	PDB Structure	3HI9; 4ED5; 4EGL; 4FXV
TTDR00842	UniProt ID	P41970
TTDR00842	Name	Ets-domain protein elk-3
TTDR00842	Type of target	Research target
TTDR00842	Synonyms	ETS-related protein ERP
TTDR00842	Synonyms	ETS-related protein NET
TTDR00842	Synonyms	SAP-2
TTDR00842	Synonyms	SAP2
TTDR00842	Synonyms	SRF accessory protein 2
TTDR00842	Disease	Candida vaginitis
TTDR00842	Function	May be a negative regulator of transcription but can activate transcription when
TTDR00842	Sequence	MESAITLWQFLLQLLLDQKHEHLICWTSNDGEFKLLKAEEVAKLWGLRKNKTNMNYDKLSRALRYYYDKNIIKKVIGQKF
TTDR00843	UniProt ID	O13430
TTDR00843	UniProt ID	P13639
TTDR00843	Name	Elongation factor 2
TTDR00843	Type of target	Research target
TTDR00843	Synonyms	EF2
TTDR00843	Disease	Fungal diseases
TTDR00843	Function	This protein promotes the gtp-dependent translocation of the nascent protein cha
TTDR00843	Sequence	MVAFTIEQIRGLMDKVTNVRNMSVIAHVDHGKSTLSDSLVQKAGIISAAKAGDARFMDTRKDEQERGITIKSTAISLYAS
TTDR00843	PDB Structure	3J3A
TTDR00843	EC Number	EC 3.6.5.3
TTDR00843	Inhibitor	Adenosine-5-Diphosphoribose
TTDR00843	Inhibitor	Diphthamide
TTDR00843	Inhibitor	Guanosine-5'-Diphosphate
TTDR00844	UniProt ID	P16150
TTDR00844	Name	Leukosialin
TTDR00844	Type of target	Research target
TTDR00844	Synonyms	CD43
TTDR00844	Synonyms	CD43 antigen
TTDR00844	Synonyms	GALGP
TTDR00844	Synonyms	Galactoglycoprotein
TTDR00844	Synonyms	Leucocyte sialoglycoprotein
TTDR00844	Synonyms	Sialophorin
TTDR00844	Disease	Atherosclerosis
TTDR00844	Disease	Inflammation
TTDR00844	Function	One of the major glycoproteins of thymocytes and t lymphocytes. Plays a role in
TTDR00844	Sequence	MATLLLLLGVLVVSPDALGSTTAVQTPTSGEPLVSTSEPLSSKMYTTSITSDPKADSTGDQTSALPPSTSINEGSPLWTS
TTDR00844	BioChemical Class	Transmembrane protein
TTDR00844	Pathway	Cell adhesion molecules (CAMs)
TTDR00845	UniProt ID	Q8IWM1
TTDR00845	Name	Protein tyrosine phosphatase
TTDR00845	Type of target	Research target
TTDR00845	Synonyms	PTPN
TTDR00845	Synonyms	PTPase
TTDR00845	Disease	Atherosclerosis
TTDR00845	Disease	Inflammation
TTDR00845	Disease	Tumor angiogenesis and metastasis
TTDR00845	Sequence	MAAGVLPQNEQPYSTLVNNSECVANMKGNLERPTPKYTKVGERLRHVIPGHMACSMACGGRACKYENPARWSEQEQAIKG
TTDR00845	BioChemical Class	Hydrolases acting on ester bonds
TTDR00845	EC Number	EC 3.1.3.48
TTDR00845	Inhibitor	Diamide
TTDR00845	Inhibitor	Pervanadate
TTDR00845	Inhibitor	Phenylarsine oxide
TTDR00846	UniProt ID	P52757
TTDR00846	Name	Beta-chimaerin
TTDR00846	Type of target	Research target
TTDR00846	Synonyms	Beta-chimerin
TTDR00846	Synonyms	Beta2-chimaerin
TTDR00846	Synonyms	Rho-GTPase-activating protein 3
TTDR00846	Disease	Phorbol ester tumor
TTDR00846	Function	Gtpase activating protein for p21-rac. Insufficient expression of beta-2 chimaer
TTDR00846	Sequence	MAASSNSSLSGSSVSSDAEEYQPPIWKSYLYQLQQEAPRPKRIICPREVENRPKYYGREFHGIISREQADELLGGVEGAY
TTDR00846	PDB Structure	1XA6
TTDR00846	BioChemical Class	Zinc-finger
TTDR00847	UniProt ID	P78536
TTDR00847	Name	ADAM 17
TTDR00847	Type of target	Research target
TTDR00847	Synonyms	A disintegrin and metalloproteinase domain 17
TTDR00847	Synonyms	CD156b antigen
TTDR00847	Synonyms	Snake venom-like protease
TTDR00847	Synonyms	TACE
TTDR00847	Synonyms	TNF alpha converting enzyme
TTDR00847	Synonyms	TNF-alpha convertase
TTDR00847	Synonyms	TNF-alpha converting enzyme
TTDR00847	Disease	Inflammatory bowel disease
TTDR00847	Disease	Inflammatory diseases
TTDR00847	Disease	Neuroimmunological diseases
TTDR00847	Function	Cleaves the membrane-bound precursor of tnf-alpha to its mature soluble form. Re
TTDR00847	Sequence	MRQSLLFLTSVVPFVLAPRPPDDPGFGPHQRLEKLDSLLSDYDILSLSNIQQHSVRKRDLQTSTHVETLLTFSALKRHFK
TTDR00847	PDB Structure	1BKC; 1ZXC; 2A8H; 2DDF; 2FV5; 2FV9; 2I47; 2M2F; 2OI0; 3B92; 3CKI; 3E8R; 3EDZ; 3E
TTDR00847	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00847	Pathway	Alzheimer's disease
TTDR00847	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR00847	Pathway	Notch signaling pathway
TTDR00847	EC Number	EC 3.4.24.86
TTDR00847	Related US Patent	6,200,996
TTDR00847	Related US Patent	6,225,311
TTDR00847	Related US Patent	6,277,885
TTDR00847	Related US Patent	6,288,086
TTDR00847	Related US Patent	6,313,128
TTDR00847	Related US Patent	6,326,516
TTDR00847	Related US Patent	6,331,563
TTDR00847	Related US Patent	6,340,694
TTDR00847	Related US Patent	6,342,508
TTDR00847	Related US Patent	6,358,980
TTDR00847	Related US Patent	6,387,901
TTDR00847	Related US Patent	6,441,023
TTDR00847	Related US Patent	6,444,704
TTDR00847	Related US Patent	6,462,073
TTDR00847	Related US Patent	6,498,167
TTDR00847	Related US Patent	6,534,491
TTDR00847	Related US Patent	6,548,524
TTDR00847	Related US Patent	6,716,833
TTDR00847	Target Validation	TTDR00847
TTDR00847	QSAR Model	TTDR00847
TTDR00847	Drug(s)	DPC-333
TTDR00847	Drug(s)	GW-3333
TTDR00847	Inhibitor	2-(4-bromophenylsulfonamido)-N-hydroxyacetamide
TTDR00847	Inhibitor	2-(biphenyl-4-ylsulfonamido)-N-hydroxyacetamide
TTDR00847	Inhibitor	Batimistat
TTDR00847	Inhibitor	CGS-27023A
TTDR00847	Inhibitor	CH4474
TTDR00847	Inhibitor	CIPEMASTAT
TTDR00847	Inhibitor	DPC-333
TTDR00847	Inhibitor	GW-3333
TTDR00847	Inhibitor	IK-682
TTDR00847	Inhibitor	IM-491
TTDR00847	Inhibitor	N-hydroxy-2-(4-methoxyphenylsulfonamido)acetamide
TTDR00847	Inhibitor	N-hydroxy-3-(2-oxo-2H-chromen-3-yl)propanamide
TTDR00847	Inhibitor	N-hydroxy-3-(6-methoxy-2-oxo-2H-chromen-3-yl)
TTDR00847	Inhibitor	PKF-241-466
TTDR00847	Inhibitor	PKF-242-484;TNF-484
TTDR00847	Inhibitor	SR-973
TTDR00847	Inhibitor	TMI-05
TTDR00848	UniProt ID	P49366
TTDR00848	Name	Deoxyhypusine synthase
TTDR00848	Type of target	Research target
TTDR00848	Synonyms	DHS
TTDR00848	Disease	Cancer, unspecific
TTDR00848	Function	Catalyzes the nad-dependent oxidative cleavage of spermidine and the subsequent
TTDR00848	Sequence	MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQD
TTDR00848	PDB Structure	1DHS; 1RLZ; 1ROZ; 1RQD
TTDR00848	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR00848	EC Number	EC 2.5.1.46
TTDR00848	Target Validation	TTDR00848
TTDR00848	Inhibitor	1-Guanidinium-7-Aminoheptane
TTDR00848	Inhibitor	GC7
TTDR00848	Inhibitor	N-guanyl-1,7-diaminoheptane
TTDR00848	Inhibitor	N1-guanyl-1,7-diaminoheptane
TTDR00848	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00849	UniProt ID	P31120
TTDR00849	Name	Lantibiotic mersacidin
TTDR00849	Type of target	Research target
TTDR00849	Synonyms	Mersacidin
TTDR00849	Synonyms	Protein mrsA
TTDR00849	Disease	Methicillin-resistant S. aureus infection
TTDR00849	Sequence	MSNRKYFGTDGIRGRVGDAPITPDFVLKLGWAAGKVLARHGSRKIIIGKDTRISGYMLESALEAGLAAAGLSALFTGPMP
TTDR00849	BioChemical Class	Intramolecular transferases
TTDR00849	Pathway	Amino sugar and nucleotide sugar metabolism
TTDR00849	Pathway	Aminosugars metabolism
TTDR00849	Pathway	Metabolic pathways
TTDR00849	Inhibitor	2,3-Didehydroalanine
TTDR00849	Inhibitor	2-Thioethenamine
TTDR00849	Inhibitor	Alpha-Aminobutyric Acid
TTDR00850	Name	Cd28 receptor
TTDR00850	Type of target	Research target
TTDR00850	Disease	Immunosuppression
TTDR00851	UniProt ID	Q9NRA7
TTDR00851	Name	Angiotensin converting enzyme-like protein
TTDR00851	Type of target	Research target
TTDR00851	Synonyms	ACE-related carboxypeptidase ACE2
TTDR00851	Synonyms	ACE2
TTDR00851	Synonyms	Angiotensin I converting enzyme (Peptidyl-dipeptidase A) 2
TTDR00851	Synonyms	Angiotensin converting enzyme 2
TTDR00851	Disease	Cardiovascular disease, unspecified
TTDR00851	Sequence	MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLA
TTDR00851	PDB Structure	1R42; 1R4L; 1XJP; 2AJF; 3D0G; 3D0H; 3D0I; 3KBH; 3SCI; 3SCJ
TTDR00851	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00851	Pathway	Renin-angiotensin system
TTDR00852	UniProt ID	P36956
TTDR00852	Name	Sterol regulatory element binding protein-1
TTDR00852	Type of target	Research target
TTDR00852	Synonyms	SREBP 1
TTDR00852	Synonyms	SREBP-1
TTDR00852	Synonyms	Sterol regulatory element-binding transcription factor 1
TTDR00852	Disease	Diabetic dyslipidemia
TTDR00852	Function	Transcriptional activator that binds to the sterol regulatory element 1 (sre-1)
TTDR00852	Sequence	MDEPPFSEAALEQALGEPCDLDAALLTDIEDMLQLINNQDSDFPGLFDPPYAGSGAGGTDPASPDTSSPGSLSPPPATLS
TTDR00852	PDB Structure	1AM9
TTDR00852	BioChemical Class	Transmembrane protein
TTDR00852	Pathway	Insulin signaling pathway
TTDR00853	UniProt ID	Q13855
TTDR00853	UniProt ID	Q86WA6
TTDR00853	Name	Biphenyl hydrolase-related protein
TTDR00853	Type of target	Research target
TTDR00853	Synonyms	BPHL
TTDR00853	Synonyms	Biphenyl hydrolase-like protein
TTDR00853	Synonyms	Biphenyl hydrolase-like protein (Serine hydrolase) (Breast epithelial mucin-asso
TTDR00853	Synonyms	Bph-rp
TTDR00853	Synonyms	Breast epithelial mucin-associated antigen
TTDR00853	Synonyms	DJ40E16.6.1
TTDR00853	Synonyms	MCNAA
TTDR00853	Synonyms	VACVase
TTDR00853	Disease	Herpes virus infection
TTDR00853	Function	Serine hydrolase that catalyzes the hydrolytic activation of amino acid ester pr
TTDR00853	Sequence	MVAVLGGRGVLRLRLLLSALKPGIHVPRAGPAAAFGTSVTSAKVAVNGVQLHYQQTGEGDHAVLLLPGMLGSGETDFGPQ
TTDR00853	PDB Structure	2OCG; 2OCI; 2OCK; 2OCL
TTDR00853	BioChemical Class	Hydrolases acting on ester bonds
TTDR00853	EC Number	EC 3.1.-.-
TTDR00853	Inhibitor	L-Tyrosinamide
TTDR00854	UniProt ID	Q9NNX6
TTDR00854	Name	Membrane-associated lectin type-C
TTDR00854	Type of target	Research target
TTDR00854	Synonyms	CD 209
TTDR00854	Synonyms	CD209
TTDR00854	Synonyms	DC-SIGN
TTDR00854	Synonyms	DC-SIGN1
TTDR00854	Synonyms	DC-specific ICAM-3 grabbing nonintegrin
TTDR00854	Synonyms	Dendritic cell-specific ICAM-3-grabbing nonintegrin 1
TTDR00854	Synonyms	MDC-SIGN1A type I isoform
TTDR00854	Synonyms	Probable mannose-binding C-type lectin DC-SIGN
TTDR00854	Synonyms	Surface C-type lectin DC-SIGN
TTDR00854	Disease	Cutaneous leishmaniasis
TTDR00854	Disease	Dengue virus infection
TTDR00854	Disease	Visceral leishmaniasis
TTDR00854	Sequence	MSDSKEPRLQQLGLLEEEQLRGLGFRQTRGYKSLAGCLGHGPLVLQLLSFTLLAGLLVQVSKVPSSISQEQSRQDAIYQN
TTDR00854	PDB Structure	1K9I; 1SL4; 1SL5; 2B6B; 2IT5; 2IT6; 2XR5; 2XR6
TTDR00854	BioChemical Class	Transmembrane protein
TTDR00854	Inhibitor	Alpha-D-Mannose
TTDR00854	Inhibitor	Fucose
TTDR00855	UniProt ID	Q9NYY1
TTDR00855	Name	Interleukin-20
TTDR00855	Type of target	Clinical trial target
TTDR00855	Synonyms	Four alpha helix cytokine ZCYTO10
TTDR00855	Synonyms	IL-20
TTDR00855	Synonyms	UNQ852/PRO1801
TTDR00855	Disease	Inflammatory skin disorder
TTDR00855	Function	Cytokine that may be involved in epidermal function and psoriasis. Acts through
TTDR00855	Sequence	MKASSLAFSLLSAAFYLLWTPSTGLKTLNLGSCVIATNLQEIRNGFSEIRGSVQAKDGNIDIRILRRTESLQDTKPANRC
TTDR00855	PDB Structure	4DOH
TTDR00855	Pathway	Cytokine-cytokine receptor interaction
TTDR00855	Pathway	Jak-STAT signaling pathway
TTDR00856	UniProt ID	O95633
TTDR00856	Name	Follistatin-related protein 3
TTDR00856	Type of target	Research target
TTDR00856	Synonyms	FLRG
TTDR00856	Synonyms	Follistatin-like 3
TTDR00856	Synonyms	Follistatin-related gene
TTDR00856	Synonyms	Follistatin-related gene protein
TTDR00856	Synonyms	UNQ674/PRO1308
TTDR00856	Disease	Malignant blood disorders
TTDR00856	Function	Binding protein for activin and bmp-2 (by similarity).
TTDR00856	Sequence	MRPGAPGPLWPLPWGALAWAVGFVSSMGSGNPAPGGVCWLQQGQEATCSLVLQTDVTRAECCASGNIDTAWSNLTHPGNK
TTDR00856	PDB Structure	2KCX; 3B4V; 3SEK
TTDR00857	Name	Coronavirus main proteinase
TTDR00857	Type of target	Research target
TTDR00857	Synonyms	3CLpro
TTDR00857	Synonyms	Rhinovirus 3Cpro
TTDR00857	Disease	Severe acute respiratory syndrome
TTDR00857	Related US Patent	6,355,807
TTDR00857	Related US Patent	6,528,252
TTDR00857	Inhibitor	Sabadinine
TTDR00858	UniProt ID	Q08881
TTDR00858	Name	Tyrosine-protein kinase itk/tsk
TTDR00858	Type of target	Research target
TTDR00858	Synonyms	ITK
TTDR00858	Synonyms	Inducible T cell kinase
TTDR00858	Synonyms	Kinase EMT
TTDR00858	Synonyms	T-cell-specific kinase
TTDR00858	Synonyms	Tyrosine kinase ITK
TTDR00858	Synonyms	Tyrosine-protein kinase Lyk
TTDR00858	Disease	Asthma
TTDR00858	Function	Plays a role in t cell proliferation and differentiation.
TTDR00858	Sequence	MNNFILLEEQLIKKSQQKRRTSPSNFKVRFFVLTKASLAYFEDRHGKKRTLKGSIELSRIKCVEIVKSDISIPCHYKYPF
TTDR00858	PDB Structure	1SM2; 1SNU; 1SNX; 2E6I; 2LMJ; 2YUQ; 3MIY; 3MJ1; 3MJ2; 3QGW; 3QGY; 3T9T; 3V5J; 3V
TTDR00858	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00858	Pathway	Chemokine signaling pathway
TTDR00858	Pathway	Leukocyte transendothelial migration
TTDR00858	Pathway	T cell receptor signaling pathway
TTDR00858	EC Number	EC 2.7.1.112
TTDR00858	Inhibitor	Staurosporine
TTDR00859	UniProt ID	P13423
TTDR00859	Name	Protective antigen
TTDR00859	Type of target	Successful target
TTDR00859	Synonyms	Anthrax toxins translocating protein
TTDR00859	Synonyms	Bacillus anthracis protective antigen
TTDR00859	Synonyms	PA
TTDR00859	Synonyms	PA-83
TTDR00859	Synonyms	PA83
TTDR00859	Disease	Anthrax infection
TTDR00859	Function	One of the three proteins composing the anthrax toxin, the agent which infects m
TTDR00859	Sequence	MKKRKVLIPLMALSTILVSSTGNLEVIQAEVKQENRLLNESESSSQGLLGYYFSDLNFQAPMVVTSSTTGDLSIPSSELE
TTDR00859	PDB Structure	1ACC; 1T6B; 1TX5; 1TZN; 1TZO; 1V36; 3ETB; 3INO; 3KWV; 3MHZ; 3Q8A; 3Q8B; 3Q8C; 3Q
TTDR00860	UniProt ID	Q13296
TTDR00860	Name	Mammaglobin A
TTDR00860	Type of target	Research target
TTDR00860	Synonyms	Mammaglobin 1
TTDR00860	Synonyms	Secretoglobin family 2A member 2
TTDR00860	Disease	Breast cancer
TTDR00860	Sequence	MKLLMVLMLAALSQHCYAGSGCPLLENVISKTINPQVSKTEYKELLQEFIDDNATTNAIDELKECFLNQTDETLSNVEVF
TTDR00861	UniProt ID	P78380
TTDR00861	Name	Lectin-like oxidized ldl receptor
TTDR00861	Type of target	Research target
TTDR00861	Synonyms	LOX-1
TTDR00861	Synonyms	LOX1
TTDR00861	Synonyms	Lectin-like oxidized LDL receptor-1
TTDR00861	Synonyms	Lectin-like oxidized low-density lipoprotein receptor-1
TTDR00861	Synonyms	Lectin-type oxidized LDL receptor
TTDR00861	Synonyms	Oxidised low density lipoprotein (Lectin-like) receptor 1
TTDR00861	Synonyms	Oxidized low-density lipoprotein receptor
TTDR00861	Disease	Endotoxin-induced inflammation
TTDR00861	Sequence	MTFDDLKIQTVKDQPDEKSNGKKAKGLQFLYSPWWCLAAATLGVLCLGLVVTIMVLGMQLSQVSDLLTQEQANLTHQKKK
TTDR00861	PDB Structure	1YPO; 1YPQ; 1YPU; 1YXJ; 1YXK; 3VLG
TTDR00861	BioChemical Class	Transmembrane protein
TTDR00861	Pathway	PPAR signaling pathway
TTDR00862	UniProt ID	P00353
TTDR00862	UniProt ID	P23247
TTDR00862	Name	Aspartate-semialdehyde dehydrogenase
TTDR00862	Type of target	Research target
TTDR00862	Synonyms	ASA dehydrogenase
TTDR00862	Synonyms	ASADH
TTDR00862	Synonyms	L-Aspartate-beta-semialdehyde dehydrogenase
TTDR00862	Disease	Bacterial infections
TTDR00862	Disease	Fungal diseases
TTDR00862	Sequence	MKNVGFIGWRGMVGSVLMQRMVEERDFDAIRPVFFSTSQLGQAAPSFGGTTGTLQDAFDLEALKALDIIVTCQGGDYTNE
TTDR00862	PDB Structure	2QZ9; 2R00
TTDR00862	BioChemical Class	Oxidoreductases acting on the aldehyde or oxo group of donors
TTDR00862	Pathway	Glycine, serine and threonine metabolism
TTDR00862	Pathway	Lysine biosynthesis
TTDR00862	Pathway	Metabolic pathways
TTDR00862	EC Number	EC 1.2.1.11
TTDR00862	Target Validation	TTDR00862
TTDR00862	Inhibitor	2'-Monophosphoadenosine 5'-Diphosphoribose
TTDR00862	Inhibitor	Aspartate Semialdehyde
TTDR00862	Inhibitor	Cacodylate Ion
TTDR00862	Inhibitor	S-sulpho-L-cysteine
TTDR00863	Name	Organic cation transporter 6
TTDR00863	Type of target	Research target
TTDR00863	Synonyms	37900
TTDR00863	Disease	Leukemia, unspecified
TTDR00864	UniProt ID	P43675
TTDR00864	UniProt ID	P90518
TTDR00864	Name	Glutathionylspermidine synthase
TTDR00864	Type of target	Research target
TTDR00864	Synonyms	GSP synthetase
TTDR00864	Synonyms	Glutathione:spermidine ligase [ADP-forming]
TTDR00864	Synonyms	Glutathionylspermidine synthetase
TTDR00864	Synonyms	GspS
TTDR00864	Disease	Bacterial infections
TTDR00864	Disease	Parasitic diseases
TTDR00864	Function	Conjugates glutathione (gamma-glu-cys-gly) and spermidine to form glutathionylsp
TTDR00864	Sequence	MSSLPHNHHYETHHRGTAEVPFDELIGVTPDGVPVISNGNEAHFSNLESITAACLPLSSFERKAPCKQPYRKMGVKWQCV
TTDR00864	PDB Structure	2IO7; 2IO8; 2IO9; 2IOA; 2IOB
TTDR00864	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00864	EC Number	EC 6.3.1.8
TTDR00865	UniProt ID	P07652
TTDR00865	UniProt ID	P47205
TTDR00865	Name	UDP-3-O-[3-hydroxymyristoyl] n-acetylglucosamine deacetylase
TTDR00865	Type of target	Research target
TTDR00865	Synonyms	EnvA protein
TTDR00865	Synonyms	LpxC
TTDR00865	Synonyms	UDP-3-O-acyl-GlcNAc deacetylase
TTDR00865	Disease	Bacterial infections
TTDR00865	Function	Involved in the biosynthesis of lipid a, a phosphorylated glycolipid that anchor
TTDR00865	Sequence	MIKQRTLKRIVQATGVGLHTGKKVTLTLRPAPANTGVIYRRTDLNPPVDFPADAKSVRDTMLCTCLVNEHDVRISTVEHL
TTDR00865	PDB Structure	2VES; 3P3E; 3U1Y; 3UHM; 4FW3; 4FW4; 4FW5; 4FW6; 4FW7; 4J3D
TTDR00865	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDR00865	Pathway	Lipopolysaccharide biosynthesis
TTDR00865	Pathway	Metabolic pathways
TTDR00865	EC Number	EC 3.5.1.-
TTDR00865	QSAR Model	TTDR00865
TTDR00865	Inhibitor	3-(heptyloxy)benzoic acid
TTDR00865	Inhibitor	BB-78484
TTDR00865	Inhibitor	BB-78485
TTDR00865	Inhibitor	Cacodylate Ion
TTDR00865	Inhibitor	MYRISTIC ACID
TTDR00865	Inhibitor	Palmitoleic Acid
TTDR00865	Inhibitor	Tu-514
TTDR00866	UniProt ID	P48449
TTDR00866	Name	Lanosterol synthase
TTDR00866	Type of target	Research target
TTDR00866	Synonyms	2,3-epoxysqualene--lanosterol cyclase
TTDR00866	Synonyms	OSC
TTDR00866	Synonyms	Oxidosqualene cyclase
TTDR00866	Synonyms	Oxidosqualene--lanosterol cyclase
TTDR00866	Disease	Hypercholesterolemia
TTDR00866	Function	Catalyzes the cyclization of (s)-2,3 oxidosqualene to lanosterol, a reaction tha
TTDR00866	Sequence	MTEGTCLRRRGGPYKTEPATDLGRWRLNCERGRQTWTYLQDERAGREQTGLEAYALGLDTKNYFKDLPKAHTAFEGALNG
TTDR00866	PDB Structure	1W6J; 1W6K
TTDR00866	BioChemical Class	Intramolecular transferases
TTDR00866	Pathway	Biosynthesis of steroids
TTDR00866	Pathway	Metabolic pathways
TTDR00866	EC Number	EC 5.4.99.7
TTDR00866	Target Validation	TTDR00866
TTDR00866	Inhibitor	B-Octylglucoside
TTDR00866	Inhibitor	Lanosterol
TTDR00866	Inhibitor	R048-8071
TTDR00866	Inhibitor	Ro48-8071
TTDR00866	Inhibitor	Tetradecane
TTDR00866	Inhibitor	[3-(Biphenyl-4-yloxy)-propyl]-dimethyl-amine
TTDR00867	UniProt ID	P22466
TTDR00867	Name	Galanin
TTDR00867	Type of target	Research target
TTDR00867	Disease	Anxiety disorder, unspecified
TTDR00867	Function	Contracts smooth muscle of the gastrointestinal and genitourinary tract, regulat
TTDR00867	Sequence	MARGSALLLASLLLAAALSASAGLWSPAKEKRGWTLNSAGYLLGPHAVGNHRSFSDKNGLTSKRELRPEDDMKPGSFDRS
TTDR00868	UniProt ID	P46531
TTDR00868	Name	Neurogenic locus notch homolog protein 1
TTDR00868	Type of target	Research target
TTDR00868	Synonyms	HN1
TTDR00868	Synonyms	Notch 1
TTDR00868	Synonyms	Notch1
TTDR00868	Synonyms	Translocation-associated notch protein TAN-1
TTDR00868	Disease	Immunodeficiency
TTDR00868	Function	Functions as a receptor for membrane-bound ligands jagged1, jagged2 and delta1 t
TTDR00868	Sequence	MPPLLAPLLCLALLPALAARGPRCSQPGETCLNGGKCEAANGTEACVCGGAFVGPRCQDPNPCLSTPCKNAGTCHVVDRR
TTDR00868	PDB Structure	1PB5; 1TOZ; 1YYH; 2F8X; 2F8Y; 2HE0; 2VJ3; 3ETO; 3I08; 3L95; 3NBN; 3V79
TTDR00868	BioChemical Class	Growth factor
TTDR00868	Pathway	Notch signaling pathway
TTDR00869	Name	ORF74 protein
TTDR00869	Type of target	Research target
TTDR00869	Synonyms	GCR ORF74
TTDR00869	Synonyms	Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74
TTDR00869	Disease	Kaposi's sarcoma
TTDR00870	UniProt ID	P40107
TTDR00870	UniProt ID	Q96WN8
TTDR00870	Name	GDP-mannose transporter
TTDR00870	Type of target	Research target
TTDR00870	Synonyms	Golgi GDP-mannose transporter
TTDR00870	Synonyms	VRG4 gene
TTDR00870	Disease	Fungal diseases
TTDR00870	Function	Involved in the import of gdp-mannose from the cytoplasm into the golgi lumen. D
TTDR00870	Sequence	MSELKTGHAGHNPWASVANSGPISILSYCGSSILMTVTNKFVVNLKDFNMNFVMLFVQSLVCTITLIILRILGYAKFRSL
TTDR00870	BioChemical Class	Transmembrane protein
TTDR00871	UniProt ID	P00935
TTDR00871	Name	Cystathionine gamma-synthase
TTDR00871	Type of target	Research target
TTDR00871	Synonyms	CGS
TTDR00871	Synonyms	O-succinylhomoserine (Thiol)-lyase
TTDR00871	Disease	Microbial infections
TTDR00871	Sequence	MTRKQATIAVRSGLNDDEQYGCVVPPIHLSSTYNFTGFNEPRAHDYSRRGNPTRDVVQRALAELEGGAGAVLTNTGMSAI
TTDR00871	PDB Structure	1CS1
TTDR00871	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR00871	Pathway	Cysteine metabolism
TTDR00871	Pathway	Metabolic pathways
TTDR00871	Pathway	Methionine metabolism
TTDR00871	Pathway	Selenoamino acid metabolism
TTDR00871	Pathway	Sulfur metabolism
TTDR00871	EC Number	EC 2.5.1.48
TTDR00871	Inhibitor	5-carboxymethylthio-3-(3'-chlorophenyl)-1,2,4-oxadiazol
TTDR00871	Inhibitor	N'-Pyridoxyl-Lysine-5'-Monophosphate
TTDR00872	Name	Riboflavin synthase
TTDR00872	Type of target	Research target
TTDR00872	Disease	Infections
TTDR00872	Disease	Microbial infections
TTDR00872	EC Number	EC 2.5.1.9
TTDR00873	UniProt ID	P23025
TTDR00873	Name	DNA-repair protein complementing xp-a cells
TTDR00873	Type of target	Research target
TTDR00873	Synonyms	XPA protein
TTDR00873	Disease	Cancer, unspecific
TTDR00873	Function	Involved in dna excision repair. Initiates repair by binding to damaged sites wi
TTDR00873	Sequence	MAAADGALPEAAALEQPAELPASVRASIERKRQRALMLRQARLAARPYSATAAAATGGMANVKAAPKIIDTGGGFILEEE
TTDR00873	PDB Structure	1D4U; 1XPA; 2JNW
TTDR00873	BioChemical Class	Zinc-finger
TTDR00873	Pathway	Nucleotide excision repair
TTDR00874	UniProt ID	P40126
TTDR00874	Name	Dopachrome tautomerase
TTDR00874	Type of target	Research target
TTDR00874	Synonyms	DCT
TTDR00874	Synonyms	DT
TTDR00874	Synonyms	Dopachrome delta-isomerase
TTDR00874	Synonyms	TRP-2
TTDR00874	Synonyms	TRP2
TTDR00874	Synonyms	Tyrosinase-related protein 2
TTDR00874	Synonyms	Tyrosinase-related protein-2
TTDR00874	Disease	Malignant gliomas
TTDR00874	Disease	Melanoma
TTDR00874	Disease	Tyrosinase-positive melanomas
TTDR00874	Function	Involved in regulating eumelanin and phaeomelanin levels.
TTDR00874	Sequence	MSPLWWGFLLSCLGCKILPGAQGQFPRVCMTVDSLVNKECCPRLGAESANVCGSQQGRGQCTEVRADTRPWSGPYILRNQ
TTDR00874	BioChemical Class	Intramolecular oxidoreductases
TTDR00874	EC Number	EC 5.3.3.12
TTDR00875	UniProt ID	P51858
TTDR00875	Name	Hepatoma derived growth factor
TTDR00875	Type of target	Research target
TTDR00875	Synonyms	HDGF
TTDR00875	Synonyms	HMG-1L2
TTDR00875	Synonyms	High-mobility group protein 1-like 2
TTDR00875	Disease	Cancer, unspecific
TTDR00875	Function	Heparin-binding protein, with mitogenic activity for fibroblasts.
TTDR00875	Sequence	MSRSNRQKEYKCGDLVFAKMKGYPHWPARIDEMPEAAVKSTANKYQVFFFGTHETAFLGPKDLFPYEESKEKFGKPNKRK
TTDR00875	PDB Structure	1RI0; 2NLU
TTDR00875	BioChemical Class	Growth factor
TTDR00876	UniProt ID	O60235
TTDR00876	Name	Airway trypsin-like protease
TTDR00876	Type of target	Research target
TTDR00876	Synonyms	HAT
TTDR00876	Synonyms	Human airway trypsin-like protease
TTDR00876	Disease	Chronic airway diseases
TTDR00876	Function	May play some biological role in the host defense system on the mucous membrane
TTDR00876	Sequence	MYRPARVTSTSRFLNPYVVCFIVVAGVVILAVTIALLVYFLAFDQKSYFYRSSFQLLNVEYNSQLNSPATQEYRTLSGRI
TTDR00876	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00876	EC Number	EC 3.4.21.-
TTDR00877	UniProt ID	Q7YRV3
TTDR00877	Name	Peroxysome proliferator-activated receptor gamma 2
TTDR00877	Type of target	Research target
TTDR00877	Synonyms	PPARG2
TTDR00877	Synonyms	PPARgamma 2
TTDR00877	Disease	Osteoporosis and other bone-related diseases
TTDR00877	Sequence	MGETLGDPLIDPESEPFAVTVSASTSQEITMVDTEMPFWPTNFGISSVDLSMMDDHSHAFDIKPFTTVDFSSISAPHYED
TTDR00878	UniProt ID	Q9UHC7
TTDR00878	Name	Makorin 1
TTDR00878	Type of target	Research target
TTDR00878	Synonyms	MKRN1
TTDR00878	Synonyms	Makorin ring finger protein-1 gene
TTDR00878	Disease	Polycystic kidney disease
TTDR00878	Sequence	MAEAATPGTTATTSGAGAAAATAAAASPTPIPTVTAPSLGAGGGGGGSDGSGGGWTKQVTCRYFMHGVCKEGDNCRYSHD
TTDR00878	BioChemical Class	Zinc-finger
TTDR00879	UniProt ID	Q00796
TTDR00879	Name	Sorbitol dehydrogenase
TTDR00879	Type of target	Research target
TTDR00879	Synonyms	L-iditol 2-dehydrogenase
TTDR00879	Synonyms	SDH
TTDR00879	Disease	Diabetic complications
TTDR00879	Disease	Myocardial ischemia
TTDR00879	Sequence	MAAAAKPNNLSLVVHGPGDLRLENYPIPEPGPNEVLLRMHSVGICGSDVHYWEYGRIGNFIVKKPMVLGHEASGTVEKVG
TTDR00879	PDB Structure	1PL6; 1PL7; 1PL8
TTDR00879	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00879	Pathway	Fructose and mannose metabolism
TTDR00879	EC Number	EC 1.1.1.14
TTDR00879	Related US Patent	6,414,149
TTDR00879	Related US Patent	6,544,998
TTDR00879	Related US Patent	6,602,875
TTDR00879	Related US Patent	6,660,740
TTDR00879	Inhibitor	CP-470,711
TTDR00879	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00879	Inhibitor	ZOPOLRESTAT
TTDR00880	UniProt ID	P13516
TTDR00880	Name	Acyl-CoA desaturase 1
TTDR00880	Type of target	Research target
TTDR00880	Synonyms	Delta(9)-desaturase 1
TTDR00880	Synonyms	Fatty acid desaturase 1
TTDR00880	Synonyms	SCD1
TTDR00880	Synonyms	Stearoyl-CoA desaturase 1
TTDR00880	Disease	Diabetes mellitus
TTDR00880	Function	Terminal component of the liver microsomal stearyl-coa desaturase system, that u
TTDR00880	Sequence	MPAHMLQEISSSYTTTTTITAPPSGNEREKVKTVPLHLEEDIRPEMKEDIHDPTYQDEEGPPPKLEYVWRNIILMVLLHL
TTDR00880	BioChemical Class	Oxidoreductases acting on paired donors
TTDR00880	Pathway	Biosynthesis of unsaturated fatty acids
TTDR00880	Pathway	PPAR signaling pathway
TTDR00880	EC Number	EC 1.14.19.1
TTDR00880	Target Validation	TTDR00880
TTDR00880	Inhibitor	2-(4-benzoylpiperazin-1-yl)thiazole-5-carboxamide
TTDR00880	Inhibitor	CVT-12012
TTDR00880	Inhibitor	MF-152
TTDR00880	Inhibitor	MF-438
TTDR00883	UniProt ID	Q9NQ66
TTDR00883	Name	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 1
TTDR00883	Type of target	Research target
TTDR00883	Synonyms	PLC-154
TTDR00883	Synonyms	PLC-I
TTDR00883	Synonyms	PLC-beta-1
TTDR00883	Synonyms	Phosphoinositide phospholipase C
TTDR00883	Synonyms	Phospholipase C-beta-1
TTDR00883	Synonyms	Phospholipase C-beta1
TTDR00883	Disease	Asthma
TTDR00883	Function	The production of the second messenger molecules diacylglycerol (dag) and inosit
TTDR00883	Sequence	MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDDDSTIVTPIILRTDPQGFFFYWTDQNKETELLDLSLVKDARCGRHAKA
TTDR00883	BioChemical Class	Hydrolases acting on ester bonds
TTDR00883	Pathway	Alzheimer's disease
TTDR00883	Pathway	Calcium signaling pathway
TTDR00883	Pathway	Chemokine signaling pathway
TTDR00883	Pathway	Gap junction
TTDR00883	Pathway	GnRH signaling pathway
TTDR00883	Pathway	Huntington's disease
TTDR00883	Pathway	Inositol phosphate metabolism
TTDR00883	Pathway	Long-term depression
TTDR00883	Pathway	Long-term potentiation
TTDR00883	Pathway	Melanogenesis
TTDR00883	Pathway	Metabolic pathways
TTDR00883	Pathway	Phosphatidylinositol signaling system
TTDR00883	Pathway	Vascular smooth muscle contraction
TTDR00883	Pathway	Wnt signaling pathway
TTDR00883	EC Number	EC 3.1.4.11
TTDR00884	UniProt ID	Q13882
TTDR00884	Name	Tyrosine-protein kinase 6
TTDR00884	Type of target	Research target
TTDR00884	Synonyms	BRK
TTDR00884	Synonyms	Breast tumor kinase
TTDR00884	Synonyms	Brk (PTK6)
TTDR00884	Synonyms	Tyrosine-protein kinase brk
TTDR00884	Disease	Breast cancer
TTDR00884	Disease	Cancer, unspecific
TTDR00884	Disease	Pancreatic cancer
TTDR00884	Disease	Prostate tumor
TTDR00884	Function	May function as an intracellular signal transducer in epithelial tissues. Overex
TTDR00884	Sequence	MVSRDQAHLGPKYVGLWDFKSRTDEELSFRAGDVFHVARKEEQWWWATLLDEAGGAVAQGYVPHNYLAERETVESEPWFF
TTDR00884	PDB Structure	1RJA; 2KGT
TTDR00884	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00884	EC Number	EC 2.7.1.112
TTDR00884	Inhibitor	PP2
TTDR00885	UniProt ID	Q14209
TTDR00885	Name	Transcription factor E2F2
TTDR00885	Type of target	Research target
TTDR00885	Synonyms	E2F-2
TTDR00885	Synonyms	E2F2
TTDR00885	Disease	Proliferative diseases
TTDR00885	Function	Transcription activator that binds dna cooperatively with dp proteins through th
TTDR00885	Sequence	MLQGPRALASAAGQTPKVVPAMSPTELWPSGLSSPQLCPATATYYTPLYPQTAPPAAAPGTCLDATPHGPEGQVVRCLPA
TTDR00885	PDB Structure	1N4M
TTDR00885	Pathway	Bladder cancer
TTDR00885	Pathway	Cell cycle
TTDR00885	Pathway	Chronic myeloid leukemia
TTDR00885	Pathway	Glioma
TTDR00885	Pathway	Melanoma
TTDR00885	Pathway	Non-small cell lung cancer
TTDR00885	Pathway	Pancreatic cancer
TTDR00885	Pathway	Pathways in cancer
TTDR00885	Pathway	Prostate cancer
TTDR00885	Pathway	Small cell lung cancer
TTDR00886	UniProt ID	P07858
TTDR00886	Name	Cathepsin B
TTDR00886	Type of target	Research target
TTDR00886	Synonyms	APP secretase
TTDR00886	Synonyms	APPS
TTDR00886	Synonyms	Cathepsin B1
TTDR00886	Synonyms	Cathepsin-B
TTDR00886	Synonyms	Cathepsins B
TTDR00886	Synonyms	Ctsb
TTDR00886	Disease	Acute otitis media
TTDR00886	Disease	Arthritis
TTDR00886	Disease	Ischemia
TTDR00886	Disease	Tumor angiogenesis
TTDR00886	Function	Thiol protease which is believed to participate in intracellular degradation and
TTDR00886	Sequence	MWQLWASLCCLLVLANARSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKL
TTDR00886	PDB Structure	1CSB; 1GMY; 1HUC; 1PBH; 2IPP; 2PBH; 3AI8; 3CBJ; 3CBK; 3K9M; 3PBH
TTDR00886	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00886	Pathway	Antigen processing and presentation
TTDR00886	Pathway	Lysosome
TTDR00886	EC Number	EC 3.4.22.1
TTDR00886	Related US Patent	6,313,119
TTDR00886	Related US Patent	6,420,364
TTDR00886	Related US Patent	6,436,925
TTDR00886	Related US Patent	6,455,502
TTDR00886	Related US Patent	6,476,026
TTDR00886	Related US Patent	6,492,362
TTDR00886	Related US Patent	6,525,036
TTDR00886	Related US Patent	6,525,052
TTDR00886	Related US Patent	6,576,630
TTDR00886	Related US Patent	6,593,327
TTDR00886	Related US Patent	6,608,057
TTDR00886	Related US Patent	6,635,621
TTDR00886	Related US Patent	6,649,642
TTDR00886	Target Validation	TTDR00886
TTDR00886	Inhibitor	(S)-1-benzylcyclopentyl 1-oxohexan-2-ylcarbamate
TTDR00886	Inhibitor	1-(phenyl(p-tolyl)methylene)thiosemicarbazide
TTDR00886	Inhibitor	2-Aminoethanimidic Acid
TTDR00886	Inhibitor	2-Pyridinethiol
TTDR00886	Inhibitor	3-Amino-4-Oxybenzyl-2-Butanone
TTDR00886	Inhibitor	3-Methylphenylalanine
TTDR00886	Inhibitor	Ac-hPhe-Leu-Ala-LeuVSMe
TTDR00886	Inhibitor	Ac-hPhe-Leu-Phe-LeuVSMe
TTDR00886	Inhibitor	Bis(3-bromophenyl)(4-hydroxy)thiosemicarbazone
TTDR00886	Inhibitor	Cbz-Ile-Leu-Ala-LeuVSMe
TTDR00886	Inhibitor	Cbz-Ile-t-ButylhomoGlu-Ala-LeuVSMe
TTDR00886	Inhibitor	Diphenylacetic Acid
TTDR00886	Inhibitor	GNF-PF-5434
TTDR00886	Inhibitor	Gold trichloride; sodium chloride
TTDR00886	Inhibitor	L-006235-1
TTDR00886	Inhibitor	L-873724
TTDR00886	Inhibitor	MDL-2170;MDL-28170
TTDR00886	Inhibitor	PEPSTATIN A
TTDR00886	Inhibitor	Z-Ala-Leu-His-Agly-Ile-Val-OMe
TTDR00886	Inhibitor	Z-Ala-Leu-Nal-Agly-Ile-Val-OMe
TTDR00886	Inhibitor	Z-Ala-Leu-Phe-Agly-Ile-Val-OMe
TTDR00886	Inhibitor	Z-Ala-Leu-Tyr(Me)-Agly-Ile-Val-OMe
TTDR00886	Inhibitor	Z-Ala-Leu-lle-Agly-Ile-Val-NHBzl
TTDR00886	Inhibitor	Z-Ala-Leu-lle-Agly-Ile-Val-OMe
TTDR00886	Inhibitor	Z-Arg-Leu-Val-Agly-Ala-Gly-NH2
TTDR00886	Inhibitor	Z-Arg-Leu-Val-Agly-Ile-Val-Trp-NH2
TTDR00886	Inhibitor	Z-Arg-Leu-Val-Agly-Ileu-Val-OMe
TTDR00886	Inhibitor	Z-Arg-Leu-Val-Agly-Trp-Val-Ala-NH2
TTDR00886	Inhibitor	Z-Arg-Leu-Val-Agly-Val-Ala-NH2
TTDR00886	Inhibitor	Z-leu-Val-Agly-Val-OBzl
TTDR00886	Inhibitor	[(3-Bromophenyl)-p-tolyl-ketone]thiosemicarbazone
TTDR00886	Inhibitor	pTosyl-Glu(OtBu)-Ala-LeuVSMe
TTDR00887	UniProt ID	O15519
TTDR00887	Name	CASP8 and FADD-like apoptosis regulator
TTDR00887	Type of target	Research target
TTDR00887	Synonyms	C-FLIP
TTDR00887	Synonyms	CASH
TTDR00887	Synonyms	CLARP
TTDR00887	Synonyms	Caspase homolog
TTDR00887	Synonyms	Caspase-eight-related protein
TTDR00887	Synonyms	Caspase-like apoptosis regulatory protein
TTDR00887	Synonyms	Casper
TTDR00887	Synonyms	Cellular FLICE-like inhibitory protein
TTDR00887	Synonyms	Cellular FLIP
TTDR00887	Synonyms	FADD-like antiapoptotic molecule 1
TTDR00887	Synonyms	FLICE-inhibitory protein
TTDR00887	Synonyms	Flame-1
TTDR00887	Synonyms	I-FLICE
TTDR00887	Synonyms	Inhibitor of FLICE
TTDR00887	Synonyms	MACH-related inducer of toxicity
TTDR00887	Synonyms	MRIT
TTDR00887	Synonyms	Usurpin
TTDR00887	Disease	Alzheimer's disease
TTDR00887	Disease	Cancer, unspecific
TTDR00887	Disease	Diabetes mellitus
TTDR00887	Disease	Multiple sclerosis
TTDR00887	Disease	Rheumatoid arthritis, unspecified
TTDR00887	Function	Apoptosis regulator protein which may function as a crucial link between cell su
TTDR00887	Sequence	MSAEVIHQVEEALDTDEKEMLLFLCRDVAIDVVPPNVRDLLDILRERGKLSVGDLAELLYRVRRFDLLKRILKMDRKAVE
TTDR00887	PDB Structure	3H11; 3H13
TTDR00887	Pathway	Apoptosis
TTDR00888	UniProt ID	O60565
TTDR00888	Name	Gremlin
TTDR00888	Type of target	Research target
TTDR00888	Synonyms	Cysteine knot superfamily 1, BMP antagonist 1
TTDR00888	Synonyms	DRM
TTDR00888	Synonyms	Proliferation-inducing gene 2
TTDR00888	Disease	Renal diseases
TTDR00888	Sequence	MSRTAYTVGALLLLLGTLLPAAEGKKKGSQGAIPPPDKAQHNDSEQTQSPQQPGSRNRGRGQGRGTAMPGEEVLESSQEA
TTDR00889	UniProt ID	Q9BZ11
TTDR00889	Name	ADAM 33
TTDR00889	Type of target	Research target
TTDR00889	Synonyms	A disintegrin and metalloproteinase domain 33
TTDR00889	Synonyms	ADAM33
TTDR00889	Synonyms	UNQ873/PRO1891
TTDR00889	Disease	Asthma
TTDR00889	Sequence	MGWRPRRARGTPLLLLLLLLLLWPVPGAGVLQGHIPGQPVTPHWVLDGQPWRTVSLEEPVSKPDMGLVALEAEGQELLLE
TTDR00889	PDB Structure	1R54; 1R55
TTDR00889	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00889	EC Number	EC 3.4.24.-
TTDR00889	Inhibitor	Alpha-D-Mannose
TTDR00890	UniProt ID	Q07108
TTDR00890	Name	Early activation antigen CD69
TTDR00890	Type of target	Research target
TTDR00890	Synonyms	AIM
TTDR00890	Synonyms	Activation inducer molecule
TTDR00890	Synonyms	BL-AC/P26
TTDR00890	Synonyms	CD69
TTDR00890	Synonyms	EA1
TTDR00890	Synonyms	Early T-cell activation antigen p60
TTDR00890	Synonyms	GP32/28
TTDR00890	Synonyms	Leu-23
TTDR00890	Synonyms	MLR-3
TTDR00890	Disease	Arthritis
TTDR00890	Function	Involved in lymphocyte proliferation and functions as a signal transmitting rece
TTDR00890	Sequence	MSSENCFVAENSSLHPESGQENDATSPHFSTRHEGSFQVPVLCAVMNVVFITILIIALIALSVGQYNCPGQYTFSMPSDS
TTDR00890	PDB Structure	1E87; 1E8I; 1FM5; 3CCK; 3HUP
TTDR00890	BioChemical Class	Transmembrane protein
TTDR00891	UniProt ID	Q13476
TTDR00891	Name	Kinase suppressor of ras-1
TTDR00891	Type of target	Research target
TTDR00891	Synonyms	KSR1
TTDR00891	Disease	Tumor angiogenesis
TTDR00891	Sequence	MDRAALRAAAMGEKKEGGGGGDAAEGGAGAAASRALQQCGQLQKLIDISIGSLRGLRTKCAVSNDLTQQEIRTLEAKLVR
TTDR00892	UniProt ID	Q99795
TTDR00892	Name	Cell surface A33 antigen
TTDR00892	Type of target	Research target
TTDR00892	Synonyms	A33 antigen
TTDR00892	Synonyms	A33 cognate antigen
TTDR00892	Disease	Colon cancer
TTDR00892	Disease	Gastrointestinal cancers
TTDR00892	Function	May play a role in cell-cell recognition and signaling.
TTDR00892	Sequence	MVGKMWPVLWTLCAVRVTVDAISVETPQDVLRASQGKSVTLPCTYHTSTSSREGLIQWDKLLLTHTERVVIWPFSNKNYI
TTDR00892	BioChemical Class	Transmembrane protein
TTDR00893	UniProt ID	O14543
TTDR00893	Name	Suppressor of cytokine signaling 3
TTDR00893	Type of target	Research target
TTDR00893	Synonyms	CIS-3
TTDR00893	Synonyms	Cytokine-inducible SH2 protein 3
TTDR00893	Synonyms	SOCS-3
TTDR00893	Synonyms	SOCS3
TTDR00893	Synonyms	SSI-3
TTDR00893	Synonyms	STAT induced STAT inhibitor 3
TTDR00893	Disease	Inflammatory diseases
TTDR00893	Function	Socs family proteins form part of a classical negative feedback system that regu
TTDR00893	Sequence	MVTHSKFPAAGMSRPLDTSLRLKTFSSKSEYQLVVNAVRKLQESGFYWSAVTGGEANLLLSAEPAGTFLIRDSSDQRHFF
TTDR00893	Pathway	Adipocytokine signaling pathway
TTDR00893	Pathway	Insulin signaling pathway
TTDR00893	Pathway	Jak-STAT signaling pathway
TTDR00893	Pathway	Type II diabetes mellitus
TTDR00893	Pathway	Ubiquitin mediated proteolysis
TTDR00894	UniProt ID	Q9Y4W7
TTDR00894	Name	Poly(ADP-ribose) glycohydrolase
TTDR00894	Type of target	Research target
TTDR00894	Synonyms	PARG
TTDR00894	Disease	Ischemia reperfusion injuries
TTDR00894	Disease	Septic shock-like syndrome induced by zymosan
TTDR00894	Sequence	MNAGPGCEPCTKRPRWGAATTSPAASDARSFPSRQRRVLDPKDAHVQFRVPPSSPACVPGRAGQHRGSATSLVFKQKTIT
TTDR00894	PDB Structure	4A0D; 4B1G; 4B1H; 4B1I; 4B1J
TTDR00894	BioChemical Class	Glycosylases
TTDR00894	Inhibitor	GPI 18214
TTDR00894	Inhibitor	N-bis-(3-phenyl-propyl)9-oxo-fluorene-2,7-diamide
TTDR00895	UniProt ID	P18843
TTDR00895	Name	NH(3)-dependent NAD(+) synthetase
TTDR00895	Type of target	Research target
TTDR00895	Synonyms	Diphosphopyridine nucleotide synthetase
TTDR00895	Synonyms	NAD synthase
TTDR00895	Synonyms	NAD synthetase
TTDR00895	Synonyms	NAD(+)-synthetase
TTDR00895	Synonyms	NAD+ synthase
TTDR00895	Synonyms	NAD+ synthetase
TTDR00895	Synonyms	NadE
TTDR00895	Synonyms	Nicotinamide adenine dinucleotide synthetase
TTDR00895	Synonyms	Nitrogen-regulatory protein
TTDR00895	Disease	Bacillus subtilis infections
TTDR00895	Disease	Bacterial infections
TTDR00895	Function	This nad synthase uses nh(3) in preference to glutamine.
TTDR00895	Sequence	MTLQQQIIKALGAKPQINAEEEIRRSVDFLKSYLQTYPFIKSLVLGISGGQDSTLAGKLCQMAINELRLETGNESLQFIA
TTDR00895	PDB Structure	1WXE; 1WXF; 1WXG; 1WXH; 1WXI
TTDR00895	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00895	Pathway	Metabolic pathways
TTDR00895	Pathway	Nicotinate and nicotinamide metabolism
TTDR00895	Pathway	Nitrogen metabolism
TTDR00895	EC Number	EC 6.3.1.5
TTDR00895	EC Number	EC 6.3.5.1
TTDR00895	Related US Patent	6,500,852
TTDR00895	Related US Patent	6,673,827
TTDR00895	Inhibitor	Alpha,Beta-Methyleneadenosine-5'-Triphosphate
TTDR00895	Inhibitor	Deamido-Nad+
TTDR00895	Inhibitor	Diphosphate
TTDR00895	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00895	Inhibitor	Pyrophosphate 2-
TTDR00897	UniProt ID	P52433
TTDR00897	Name	DNA-directed RNA polymerase II 19 kDa polypeptide
TTDR00897	Type of target	Research target
TTDR00897	Synonyms	HsRPB7
TTDR00897	Synonyms	Human RNA polymerase II seventh subunit
TTDR00897	Synonyms	RPB7
TTDR00897	Disease	Renal cell carcinoma
TTDR00897	Disease	Von Hippel-Lindau tumor (hereditary VHL disease)
TTDR00897	Function	Dna-dependent rna polymerase catalyzes the transcription of dna into rna using t
TTDR00897	Sequence	MFYHISLEHEILLHPRYFGPNLLNTVKQKLFTEVEGTCTGKYGFVIAVTTIDNIGAGVIQPGRGFVLYPVKYKAIVFRPF
TTDR00897	PDB Structure	2C35
TTDR00897	EC Number	EC 2.7.7.6
TTDR00898	UniProt ID	P15042
TTDR00898	Name	DNA ligase
TTDR00898	Type of target	Research target
TTDR00898	Synonyms	NAD+-dependent DNA ligase
TTDR00898	Synonyms	Polydeoxyribonucleotide synthase [NAD+]
TTDR00898	Disease	Bacterial infections
TTDR00898	Function	This protein catalyzes the formation of phosphodiester linkages between 5'-phosp
TTDR00898	Sequence	MESIEQQLTELRTTLRHHEYLYHVMDAPEIPDAEYDRLMRELRELETKHPELITPDSPTQRVGAAPLAAFSQIRHEVPML
TTDR00898	PDB Structure	2OWO; 4GLX
TTDR00898	BioChemical Class	Ligases forming phosphoric ester bonds
TTDR00898	Pathway	Base excision repair
TTDR00898	Pathway	DNA replication
TTDR00898	Pathway	Mismatch repair
TTDR00898	Pathway	Nucleotide excision repair
TTDR00898	EC Number	EC 6.5.1.2
TTDR00898	Target Validation	TTDR00898
TTDR00898	Inhibitor	(2-hydroxyphenyl)(4-hydroxyphenyl)methanone
TTDR00898	Inhibitor	2,3-dioxoindoline-7-carboxylic acid
TTDR00898	Inhibitor	3-amino-2-(benzylideneamino)-5-mercaptophenol
TTDR00898	Inhibitor	5-(methylthio)thiophene-2-carboxylic acid
TTDR00898	Inhibitor	7-(4-methoxyphenyl)pteridine-2,4-diol
TTDR00899	UniProt ID	Q86YT5
TTDR00899	Name	Na+-coupled citrate transporter protein
TTDR00899	Type of target	Research target
TTDR00899	Synonyms	Human sodium-coupled citrate transporter
TTDR00899	Synonyms	Na(+)-coupled citrate transporter
TTDR00899	Synonyms	NaCT
TTDR00899	Synonyms	Sodium-coupled citrate transporter
TTDR00899	Disease	Bipolar affective disorder
TTDR00899	Sequence	MASALSYVSKFKSFVILFVTPLLLLPLVILMPAKFVRCAYVIILMAIYWCTEVIPLAVTSLMPVLLFPLFQILDSRQVCV
TTDR00899	BioChemical Class	Ion transport
TTDR00900	UniProt ID	P55798
TTDR00900	Name	Serine/threonine protein phosphatase 1
TTDR00900	Type of target	Research target
TTDR00900	Synonyms	Nuclear PP1
TTDR00900	Synonyms	Nuclear protein phosphatase-1
TTDR00900	Synonyms	Protein phosphatase 1
TTDR00900	Disease	Human immunodeficiency virus [HIV] disease
TTDR00900	Function	Plays a key role in signaling protein misfolding via the cpxr/cpxa transducing s
TTDR00900	Sequence	MKQPAPVYQRIAGHQWRHIWLSGDIHGCLEQLRRKLWHCRFDPWRDLLISVGDVIDRGPQSLRCLQLLEQHWVCAVRGNH
TTDR00900	BioChemical Class	Hydrolases acting on ester bonds
TTDR00900	EC Number	EC 3.1.3.16
TTDR00901	UniProt ID	Q92905
TTDR00901	Name	JUN activation domain binding protein
TTDR00901	Type of target	Research target
TTDR00901	Synonyms	JAB1
TTDR00901	Synonyms	Jun activation domain-binding protein 1
TTDR00901	Disease	Breast cancer
TTDR00901	Sequence	MAASGSGMAQKTWELANNMQEAQSIDEIYKYDKKQQQEILAAKPWTKDHHYFKYCKISALALLKMVMHARSGGNLEVMGL
TTDR00901	PDB Structure	4F7O
TTDR00901	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00902	UniProt ID	Q13507
TTDR00902	Name	Short transient receptor potential channel 3
TTDR00902	Type of target	Research target
TTDR00902	Synonyms	Htrp-3
TTDR00902	Synonyms	Htrp3
TTDR00902	Synonyms	TrpC3
TTDR00902	Disease	Immune disease
TTDR00902	Function	Thought to form a receptor-activated non-selective calcium permeant cation chann
TTDR00902	Sequence	MEGSPSLRRMTVMREKGRRQAVRGPAFMFNDRGTSLTAEEERFLDAAEYGNIPVVRKMLEESKTLNVNCVDYMGQNALQL
TTDR00902	BioChemical Class	Calcium channel
TTDR00903	UniProt ID	P22001
TTDR00903	Name	Potassium voltage-gated channel subfamily A member 3
TTDR00903	Type of target	Research target
TTDR00903	Synonyms	HGK5
TTDR00903	Synonyms	HLK3
TTDR00903	Synonyms	HPCN3
TTDR00903	Synonyms	HuKIII
TTDR00903	Synonyms	Potassium channel Kv1.3
TTDR00903	Synonyms	Voltage-gated K(+) channel Kv1.3
TTDR00903	Synonyms	Voltage-gated Kv1.3 K(+) channel
TTDR00903	Synonyms	Voltage-gated potassium channel subunit Kv1.3
TTDR00903	Disease	Autoimmune diseases
TTDR00903	Disease	Immunosuppression
TTDR00903	Disease	Multiple Sclerosis
TTDR00903	Disease	T cell-mediated autoimmune diseases
TTDR00903	Function	Mediates the voltage-dependent potassium ion permeability of excitable membranes
TTDR00903	Sequence	MDERLSLLRSPPPPSARHRAHPPQRPASSGGAHTLVNHGYAEPAAGRELPPDMTVVPGDHLLEPEVADGGGAPPQGGCGG
TTDR00903	BioChemical Class	Voltage-gated channel
TTDR00903	Target Validation	TTDR00903
TTDR00903	Inhibitor	1-Benzyl-7-chloro-4-hexyloxy-quinolinium; bromide
TTDR00903	Inhibitor	2-Methoxy-N-(3-methyl-2-phenyl-butyl)-benzamide
TTDR00903	Inhibitor	4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one
TTDR00903	Inhibitor	5-(4-Phenylbutoxy)psoralen
TTDR00903	Inhibitor	CP-339818
TTDR00903	Inhibitor	Correloid
TTDR00903	Inhibitor	Correloid derivative
TTDR00903	Inhibitor	UK-78282
TTDR00903	Inhibitor	[1-Benzyl-1H-quinolin-(4E)-ylidene]-hexyl-amine
TTDR00903	Blocker	Psora-4
TTDR00905	UniProt ID	Q05086
TTDR00905	Name	Ubiquitin-protein ligase E3A
TTDR00905	Type of target	Research target
TTDR00905	Synonyms	E6AP
TTDR00905	Synonyms	E6AP ubiquitin-protein ligase
TTDR00905	Synonyms	Human papillomavirus E6-associated protein
TTDR00905	Synonyms	Oncogenic protein-associated protein E6-AP
TTDR00905	Disease	Human papillomavirus (HPV) positive cancers
TTDR00905	Function	Interacts with the e6 protein of the cancer-associated human papillomavirus type
TTDR00905	Sequence	MEKLHQCYWKSGEPQSDDIEASRMKRAAAKHLIERYYHQLTEGCGNEACTNEFCASCPTFLRMDNNAAAIKALELYKINA
TTDR00905	PDB Structure	1C4Z; 1D5F; 1EQX; 2KR1; 4GIZ
TTDR00905	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00905	Pathway	Ubiquitin mediated proteolysis
TTDR00905	EC Number	EC 6.3.2.-
TTDR00906	UniProt ID	O14795
TTDR00906	Name	Munc13
TTDR00906	Type of target	Research target
TTDR00906	Synonyms	Munc13-1
TTDR00906	Synonyms	Munc13-2
TTDR00906	Disease	Diabetes mellitus
TTDR00906	Sequence	MSLLCVRVKRAKFQGSPDKFNTYVTLKVQNVKSTTVAVRGDQPSWEQDFMFEISRLDLGLSVEVWNKGLIWDTMVGTVWI
TTDR00906	BioChemical Class	Zinc-finger
TTDR00907	UniProt ID	Q08752
TTDR00907	Name	40 kDa peptidyl-prolyl cis-trans isomerase
TTDR00907	Type of target	Research target
TTDR00907	Synonyms	CYP D
TTDR00907	Synonyms	CYP-40
TTDR00907	Synonyms	Cyclophilin D
TTDR00907	Synonyms	Cyclophilin-40
TTDR00907	Synonyms	Cyclophilin-related protein
TTDR00907	Synonyms	PPID
TTDR00907	Synonyms	PPIase
TTDR00907	Synonyms	Peptidylprolyl isomerase D
TTDR00907	Synonyms	Rotamase
TTDR00907	Disease	Neurodegenerative diseases
TTDR00907	Function	Ppiases accelerate the folding of proteins. It catalyzes the cis-trans isomeriza
TTDR00907	Sequence	MSHPSPQAKPSNPSNPRVFFDVDIGGERVGRIVLELFADIVPKTAENFRALCTGEKGIGHTTGKPLHFKGCPFHRIIKKF
TTDR00907	BioChemical Class	Cis-trans-Isomerases
TTDR00907	Pathway	Calcium signaling pathway
TTDR00907	Pathway	Huntington's disease
TTDR00907	Pathway	Parkinson's disease
TTDR00907	EC Number	EC 5.2.1.8
TTDR00908	Name	Gamma-aminobutyric acid C receptor
TTDR00908	Type of target	Research target
TTDR00908	Synonyms	GABA(C) receptor
TTDR00908	Synonyms	GABA-C receptor
TTDR00908	Disease	Cognitive deficits
TTDR00908	Disease	Sleeping sickness
TTDR00908	Disease	Visual disorders
TTDR00908	Antagonist	THIP
TTDR00909	UniProt ID	P51559
TTDR00909	UniProt ID	Q7Z0F0
TTDR00909	Name	Endoprotease bli-4
TTDR00909	Type of target	Research target
TTDR00909	Synonyms	Blisterase
TTDR00909	Synonyms	Blistered cuticle protein 4
TTDR00909	Disease	Helminth infection
TTDR00909	Function	The kex2/subtilisin-like proteinase activity of this enzyme is required for the
TTDR00909	Sequence	MRISIGRIAWQILAVLIAVAFTIEHDSICDESIGACGEPIHTVIRLAKRDDELARRIAADHDMHVKGDPFLDTHYFLYHS
TTDR00909	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00909	EC Number	EC 3.4.21.-
TTDR00909	Inhibitor	EDTA
TTDR00909	Inhibitor	Edetic acid
TTDR00910	UniProt ID	P52209
TTDR00910	Name	6-phosphogluconate dehydrogenase, decarboxylating
TTDR00910	Type of target	Research target
TTDR00910	Synonyms	6-phosphogluconate dehydrogenase
TTDR00910	Synonyms	6PGDH
TTDR00910	Disease	Trichomoniasis
TTDR00910	Disease	Trypanosomiasis
TTDR00910	Sequence	MAQADIALIGLAVMGQNLILNMNDHGFVVCAFNRTVSKVDDFLANEAKGTKVVGAQSLKEMVSKLKKPRRIILLVKAGQA
TTDR00910	PDB Structure	2JKV; 4GWG; 4GWK
TTDR00910	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR00910	Pathway	Glutathione metabolism
TTDR00910	Pathway	Metabolic pathways
TTDR00910	Pathway	Pentose phosphate pathway
TTDR00910	EC Number	EC 1.1.1.44
TTDR00910	Target Validation	TTDR00910
TTDR00910	Inhibitor	(2R)-2-Methyl-4,5-dideoxy
TTDR00910	Inhibitor	(2R)-2-methyl-4-deoxy and 2,4-dideoxy
TTDR00910	Inhibitor	4-phospho-D-erythronate
TTDR00910	Inhibitor	5-deoxy-5-phosphono-D-arabinonate
TTDR00910	Inhibitor	6-Phosphogluconic Acid
TTDR00910	Inhibitor	Pyrophosphate 2-
TTDR00911	Name	Oxysterols receptor LXR
TTDR00911	Type of target	Clinical trial target
TTDR00911	Synonyms	Liver x receptor
TTDR00911	Synonyms	Nuclear orphan receptor LXR
TTDR00911	Disease	Atherosclerosis
TTDR00911	Disease	Diabetes mellitus
TTDR00911	Disease	Dyslipidemia
TTDR00911	Disease	Low high density lipoprotein syndromes
TTDR00911	Drug(s)	BMS-779788
TTDR00911	Drug(s)	XL652/XL014
TTDR00911	Modulator	XL652/XL014
TTDR00911	Ligand	T0901317
TTDR00912	UniProt ID	O76070
TTDR00912	Name	Gamma-synuclein
TTDR00912	Type of target	Research target
TTDR00912	Synonyms	Breast cancer-specific gene 1 protein
TTDR00912	Synonyms	Persyn
TTDR00912	Synonyms	SR
TTDR00912	Synonyms	Synoretin
TTDR00912	Disease	Breast cancer
TTDR00912	Function	Plays a role in neurofilament network integrity. May be involved in modulating a
TTDR00912	Sequence	MDVFKKGFSIAKEGVVGAVEKTKQGVTEAAEKTKEGVMYVGAKTKENVVQSVTSVAEKTKEQANAVSEAVVSSVNTVATK
TTDR00913	UniProt ID	Q9NZ08
TTDR00913	Name	Adipocyte-derived leucine aminopeptidase
TTDR00913	Type of target	Research target
TTDR00913	Synonyms	A-LAP
TTDR00913	Synonyms	ALAP
TTDR00913	Synonyms	ARTS-1
TTDR00913	Synonyms	Aminopeptidase PILS
TTDR00913	Synonyms	PILS-AP
TTDR00913	Synonyms	Puromycin-insensitive leucyl-specific aminopeptidase
TTDR00913	Synonyms	Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator
TTDR00913	Disease	Hypertension
TTDR00913	Function	May play a role in the inactivation of peptide hormones. May be involved in the
TTDR00913	Sequence	MVFLPLKWSLATMSFLLSSLLALLTVSTPSWCQSTEASPKRSDGTPFPWNKIRLPEYVIPVHYDLLIHANLTTLTFWGTT
TTDR00913	PDB Structure	2YD0; 3MDJ; 3QNF; 3RJO
TTDR00913	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00913	EC Number	EC 3.4.11.-
TTDR00914	UniProt ID	Q29870
TTDR00914	Name	Human leukocyte antigen class II
TTDR00914	Type of target	Research target
TTDR00914	Synonyms	HLA class II
TTDR00914	Disease	Hematologic malignancies
TTDR00914	Disease	Lymphoma
TTDR00914	Sequence	MSWKMALQIPGGFWAAAVTVMLVMLSTPVAEARDFPKDFLVQFKGMCYFTNGTERVRGVARYIYNREEYGRFDSDVGEFQ
TTDR00915	UniProt ID	P55061
TTDR00915	Name	Bax inhibitor-1
TTDR00915	Type of target	Research target
TTDR00915	Synonyms	BI-1
TTDR00915	Synonyms	Testis enhanced gene transcript
TTDR00915	Disease	Prostate cancer
TTDR00915	Function	Suppressor of apoptosis.
TTDR00915	Sequence	MNIFDRKINFDALLKFSHITPSTQQHLKKVYASFALCMFVAAAGAYVHMVTHFIQAGLLSALGSLILMIWLMATPHSHET
TTDR00915	BioChemical Class	Transmembrane protein
TTDR00916	UniProt ID	O96935
TTDR00916	Name	M1-family aminopeptidase
TTDR00916	Type of target	Research target
TTDR00916	Synonyms	Pfa-M1
TTDR00916	Disease	Malaria
TTDR00916	Function	Displays aminopeptidase activity with a broad substrate specificity. Preferentia
TTDR00916	Sequence	MKLTKGCAYKYIIFTVLILANILYDNKKRCMIKKNLRISSCGIISRLLKSNSNYNSFNKNYNFTSAISELQFSNFWNLDI
TTDR00916	PDB Structure	3EBG; 3EBH; 3EBI; 3Q43; 3Q44; 3T8V; 4K5L; 4K5M; 4K5N; 4K5O; 4K5P
TTDR00916	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00916	EC Number	EC 3.4.11.-
TTDR00916	Target Validation	TTDR00916
TTDR00916	Inhibitor	EUPAFOLIN
TTDR00917	UniProt ID	Q05469
TTDR00917	Name	Hormone sensitive lipase
TTDR00917	Type of target	Research target
TTDR00917	Synonyms	HSL
TTDR00917	Disease	Lipid metabolic disorders
TTDR00917	Disease	Obesity
TTDR00917	Function	In adipose tissue and heart, it primarily hydrolyzes stored triglycerides to fre
TTDR00917	Sequence	MEPGSKSVSRSDWQPEPHQRPITPLEPGPEKTPIAQPESKTLQGSNTQQKPASNQRPLTQQETPAQHDAESQKEPRAQQK
TTDR00917	BioChemical Class	Hydrolases acting on ester bonds
TTDR00917	Pathway	Insulin signaling pathway
TTDR00917	EC Number	EC 3.1.1.-
TTDR00917	Target Validation	TTDR00917
TTDR00917	Inhibitor	2-(3-methoxybenzylthio)-2-phenylacetic acid
TTDR00917	Inhibitor	BENZYL BENZOATE
TTDR00917	Inhibitor	BIFENOX
TTDR00917	Inhibitor	ETHIOFENCARB
TTDR00917	Inhibitor	NCI-159878
TTDR00917	Inhibitor	NCI-58425
TTDR00917	Inhibitor	OXYBENZONE
TTDR00918	UniProt ID	Q9NQR9
TTDR00918	Name	Islet-specific glucose-6-phosphatase catalytic subunit-related protein
TTDR00918	Type of target	Research target
TTDR00918	Synonyms	IGRP
TTDR00918	Disease	Insulin-dependent diabetes mellitus
TTDR00918	Sequence	MDFLHRNGVLIIQHLQKDYRAYYTFLNFMSNVGDPRNIFFIYFPLCFQFNQTVGTKMIWVAVIGDWLNLIFKWILFGHRP
TTDR00918	BioChemical Class	Hydrolases acting on ester bonds
TTDR00918	Pathway	Adipocytokine signaling pathway
TTDR00918	Pathway	Galactose metabolism
TTDR00918	Pathway	Glycolysis / Gluconeogenesis
TTDR00918	Pathway	Insulin signaling pathway
TTDR00918	Pathway	Metabolic pathways
TTDR00918	Pathway	Starch and sucrose metabolism
TTDR00919	UniProt ID	P03230
TTDR00919	Name	Latent membrane protein 1
TTDR00919	Type of target	Research target
TTDR00919	Synonyms	LMP-1
TTDR00919	Synonyms	P63
TTDR00919	Synonyms	Protein p63
TTDR00919	Disease	Epstein-Barr virus (EBV)-associated malignancies
TTDR00919	Function	The latent membrane protein has transforming activity.
TTDR00919	Sequence	MEHDLERGPPGPRRPPRGPPLSSSLGLALLLLLLALLFWLYIVMSDWTGGALLVLYSFALMLIIIILIIFIFRRDLLCPL
TTDR00919	PDB Structure	1CZY
TTDR00919	BioChemical Class	Transmembrane protein
TTDR00920	UniProt ID	P78325
TTDR00920	Name	ADAM 8
TTDR00920	Type of target	Research target
TTDR00920	Synonyms	A disintegrin and metalloproteinase domain 8
TTDR00920	Synonyms	ADAM8
TTDR00920	Synonyms	CD156
TTDR00920	Synonyms	CD156a antigen
TTDR00920	Synonyms	Cell surface antigen MS2
TTDR00920	Disease	Allergy, unspecified
TTDR00920	Disease	Inflammation
TTDR00920	Function	Possible involvement in extravasation of leukocytes.
TTDR00920	Sequence	MRGLGLWLLGAMMLPAIAPSRPWALMEQYEVVLPRRLPGPRVRRALPSHLGLHPERVSYVLGATGHNFTLHLRKNRDLLG
TTDR00920	PDB Structure	4DD8
TTDR00920	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00920	EC Number	EC 3.4.24.-
TTDR00921	UniProt ID	P10147
TTDR00921	Name	Small inducible cytokine A3
TTDR00921	Type of target	Research target
TTDR00921	Synonyms	CCL3
TTDR00921	Synonyms	G0/G1 switch regulatory protein 19-1
TTDR00921	Synonyms	G0S19-1 protein
TTDR00921	Synonyms	MIP-1-alpha
TTDR00921	Synonyms	MNP
TTDR00921	Synonyms	Macrophage Inflammatory Protein-1alpha Nuclear Protein
TTDR00921	Synonyms	Macrophage inflammatory protein 1-alpha
TTDR00921	Synonyms	PAT 464.1
TTDR00921	Synonyms	SIS-beta
TTDR00921	Synonyms	Tonsillar lymphocyte LD78 alpha protein
TTDR00921	Disease	B-cell lymphoma
TTDR00921	Function	Monokine with inflammatory and chemokinetic properties. Binds to ccr1, ccr4 and
TTDR00921	Sequence	MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEW
TTDR00921	PDB Structure	1B50; 1B53; 2X69; 2X6G; 3FPU; 3H44; 3KBX; 3TN1
TTDR00921	Pathway	Chemokine signaling pathway
TTDR00921	Pathway	Cytokine-cytokine receptor interaction
TTDR00921	Pathway	Toll-like receptor signaling pathway
TTDR00922	UniProt ID	Q06609
TTDR00922	Name	DNA repair protein RAD51 homolog 1
TTDR00922	Type of target	Research target
TTDR00922	Synonyms	HRAD51
TTDR00922	Synonyms	HsRAD51
TTDR00922	Synonyms	RAD51
TTDR00922	Disease	Small cell lung cancer
TTDR00922	Function	May participate in a common dna damage response pathway associated with the acti
TTDR00922	Sequence	MAMQMQLEANADTSVEEESFGPQPISRLEQCGINANDVKKLEEAGFHTVEAVAYAPKKELINIKGISEAKADKILAEAAK
TTDR00922	PDB Structure	1B22; 1N0W
TTDR00922	BioChemical Class	DNA repair
TTDR00922	Pathway	Homologous recombination
TTDR00922	Pathway	Pancreatic cancer
TTDR00922	Pathway	Pathways in cancer
TTDR00922	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDR00924	UniProt ID	O15120
TTDR00924	Name	1-acyl-sn-glycerol-3-phosphate acyltransferase beta
TTDR00924	Type of target	Research target
TTDR00924	Synonyms	1-AGP acyltransferase 2
TTDR00924	Synonyms	1-AGPAT 2
TTDR00924	Synonyms	1-acylglycerol-3-phosphate O-acyltransferase 2
TTDR00924	Synonyms	LPAAT-beta
TTDR00924	Synonyms	Lysophosphatidic acid acyltransferase-beta
TTDR00924	Disease	Cancer, unspecific
TTDR00924	Function	Converts lysophosphatidic acid (lpa) into phosphatidic acid by incorporating acy
TTDR00924	Sequence	MELWPCLAAALLLLLLLVQLSRAAEFYAKVALYCALCFTVSAVASLVCLLRHGGRTVENMSIIGWFVRSFKYFYGLRFEV
TTDR00924	BioChemical Class	Acyltransferases
TTDR00924	Pathway	Ether lipid metabolism
TTDR00924	Pathway	Glycerolipid metabolism
TTDR00924	Pathway	Glycerophospholipid metabolism
TTDR00924	Pathway	Metabolic pathways
TTDR00924	EC Number	EC 2.3.1.51
TTDR00925	UniProt ID	P05230
TTDR00925	Name	Heparin-binding growth factor 1
TTDR00925	Type of target	Research target
TTDR00925	Synonyms	AFGF
TTDR00925	Synonyms	Acidic fibroblast growth factor
TTDR00925	Synonyms	Beta-endothelial cell growth factor
TTDR00925	Synonyms	ECGF-beta
TTDR00925	Synonyms	FGF1
TTDR00925	Synonyms	Fibroblast growth factor 1
TTDR00925	Synonyms	HBGF-1
TTDR00925	Disease	Hepatic fibrosis
TTDR00925	Function	The heparin-binding growth factors are angiogenic agents in vivo and are potent
TTDR00925	Sequence	MAEGEITTFTALTEKFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYL
TTDR00925	PDB Structure	1AXM; 1DJS; 1DZC; 1DZD; 1E0O; 1EVT; 1HKN; 1JQZ; 1JT3; 1JT4; 1JT5; 1JT7; 1JTC; 1J
TTDR00925	BioChemical Class	Growth factor
TTDR00925	Pathway	MAPK signaling pathway
TTDR00925	Pathway	Melanoma
TTDR00925	Pathway	Pathways in cancer
TTDR00925	Pathway	Regulation of actin cytoskeleton
TTDR00925	Related US Patent	6,485,920
TTDR00925	Inhibitor	5-AMINO-NAPHTALENE-2-MONOSULFONATE
TTDR00925	Inhibitor	Formic Acid
TTDR00925	Inhibitor	N,O6-Disulfo-Glucosamine
TTDR00925	Inhibitor	Naphthalene Trisulfonate
TTDR00925	Inhibitor	O2-Sulfo-Glucuronic Acid
TTDR00925	Inhibitor	Sucrose Octasulfate
TTDR00926	UniProt ID	P49765
TTDR00926	Name	Vascular endothelial growth factor B
TTDR00926	Type of target	Successful target
TTDR00926	Synonyms	VEGF related factor
TTDR00926	Synonyms	VEGF-B
TTDR00926	Synonyms	VRF
TTDR00926	Disease	Rheumatoid arthritis, unspecified
TTDR00926	Function	Growth factor for endothelial cells. Vegf-b167 binds heparin and neuropilin-1 wh
TTDR00926	Sequence	MSPLLRRLLLAALLQLAPAQAPVSQPDAPGHQRKVVSWIDVYTRATCQPREVVVPLTVELMGTVAKQLVPSCVTVQRCGG
TTDR00926	PDB Structure	2C7W; 2VWE; 2XAC
TTDR00926	BioChemical Class	Growth factor
TTDR00926	Pathway	Bladder cancer
TTDR00926	Pathway	Cytokine-cytokine receptor interaction
TTDR00926	Pathway	Focal adhesion
TTDR00926	Pathway	Pancreatic cancer
TTDR00926	Pathway	Pathways in cancer
TTDR00926	Pathway	Renal cell carcinoma
TTDR00926	Pathway	mTOR signaling pathway
TTDR00927	UniProt ID	Q9Y6Y9
TTDR00927	Name	Lymphocyte antigen 96
TTDR00927	Type of target	Research target
TTDR00927	Synonyms	ESOP-1
TTDR00927	Synonyms	MD-2
TTDR00927	Synonyms	MD-2 protein
TTDR00927	Disease	Endotoxin-mediated diseases
TTDR00927	Function	Cooperates with tlr4 in the innate immune response to bacterial lipopolysacchari
TTDR00927	Sequence	MLPFLFFSTLFSSIFTEAQKQYWVCNSSDASISYTYCDKMQYPISINVNPCIELKGSKGLLHIFYIPRRDLKQLYFNLYI
TTDR00927	PDB Structure	1T2Z; 2E56; 2E59; 2Z65; 3FXI; 3ULA; 4G8A
TTDR00927	Pathway	Pathogenic Escherichia coli infection
TTDR00927	Pathway	Toll-like receptor signaling pathway
TTDR00927	Inhibitor	3-Hydroxy-Myristic Acid
TTDR00927	Inhibitor	Lauric Acid
TTDR00927	Inhibitor	MYRISTIC ACID
TTDR00928	UniProt ID	P53779
TTDR00928	Name	Mitogen-activated protein kinase 10
TTDR00928	Type of target	Research target
TTDR00928	Synonyms	C-Jun N-terminal kinase 3
TTDR00928	Synonyms	JNK3
TTDR00928	Synonyms	MAP kinase p49 3F12
TTDR00928	Synonyms	Stress-activated protein kinase JNK3
TTDR00928	Disease	Ischemic stroke
TTDR00928	Disease	Neurological diseases
TTDR00928	Function	Responds to activation by environmental stress and pro- inflammatory cytokines b
TTDR00928	Sequence	MSLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCA
TTDR00928	PDB Structure	1JNK; 1PMN; 1PMQ; 1PMU; 1PMV; 2B1P; 2EXC; 2O0U; 2O2U; 2OK1; 2P33; 2R9S; 2WAJ; 2Z
TTDR00928	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00928	Pathway	Adipocytokine signaling pathway
TTDR00928	Pathway	Colorectal cancer
TTDR00928	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR00928	Pathway	ErbB signaling pathway
TTDR00928	Pathway	Fc epsilon RI signaling pathway
TTDR00928	Pathway	Focal adhesion
TTDR00928	Pathway	GnRH signaling pathway
TTDR00928	Pathway	Insulin signaling pathway
TTDR00928	Pathway	MAPK signaling pathway
TTDR00928	Pathway	Pancreatic cancer
TTDR00928	Pathway	Pathways in cancer
TTDR00928	Pathway	Toll-like receptor signaling pathway
TTDR00928	Pathway	Type II diabetes mellitus
TTDR00928	Pathway	Wnt signaling pathway
TTDR00928	EC Number	EC 2.7.1.37
TTDR00928	Target Validation	TTDR00928
TTDR00928	Inhibitor	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One
TTDR00928	Inhibitor	9-(4-Hydroxyphenyl)-2,7-Phenanthroline
TTDR00928	Inhibitor	AS-601245
TTDR00928	Inhibitor	N-(4-amino-5-cyano-6-ethoxypyridin-2-yl)acetamide
TTDR00928	Inhibitor	N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide
TTDR00928	Inhibitor	NSC-656158
TTDR00928	Inhibitor	Phenyl-(3-phenyl-1H-indazol-6-yl)-amine
TTDR00928	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDR00928	Inhibitor	SB-203580
TTDR00928	Inhibitor	SP-600125
TTDR00929	UniProt ID	O05891
TTDR00929	UniProt ID	P37345
TTDR00929	Name	Thymidine monophosphate kinase
TTDR00929	Type of target	Research target
TTDR00929	Synonyms	DTMP kinase
TTDR00929	Synonyms	Deoxythymidine 5'-monophosphate kinase
TTDR00929	Synonyms	TMPK
TTDR00929	Synonyms	Thymidine 5'-monophosphate kinase
TTDR00929	Synonyms	Thymidylate kinase
TTDR00929	Synonyms	Thymidylate monophosphate kinase
TTDR00929	Synonyms	Thymidylic acid kinase
TTDR00929	Synonyms	Thymidylic kinase
TTDR00929	Disease	Tuberculosis
TTDR00929	Function	Phosphorylation of dtmp to form dtdp in both de novo and salvage pathways of dtt
TTDR00929	Sequence	MLIAIEGVDGAGKRTLVEKLSGAFRAAGRSVATLAFPRYGQSVAADIAAEALHGEHGDLASSVYAMATLFALDRAGAVHT
TTDR00929	PDB Structure	1G3U; 1GSI; 1GTV; 1MRN; 1MRS; 1N5I; 1N5J; 1N5K; 1N5L; 1W2G; 1W2H
TTDR00929	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00929	Pathway	Metabolic pathways
TTDR00929	Pathway	Pyrimidine metabolism
TTDR00929	EC Number	EC 2.7.4.9
TTDR00929	Target Validation	TTDR00929
TTDR00929	Inhibitor	2',3'-Dideoxythymidine-5'-Monophosphate
TTDR00929	Inhibitor	3'-Azido-3'-Deoxythymidine-5'-Monophosphate
TTDR00929	Inhibitor	5'-amino-5'-deoxy-alpha-D-thymidine
TTDR00929	Inhibitor	5'-deoxythymidine
TTDR00929	Inhibitor	5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate
TTDR00929	Inhibitor	Acetate Ion
TTDR00929	Inhibitor	Adenosine-5'-Diphosphate
TTDR00929	Inhibitor	BROMODEOXYURIDINE
TTDR00929	Inhibitor	CHLORODEOXYURIDINE
TTDR00929	Inhibitor	Deoxythymidine
TTDR00929	Inhibitor	Diphosphate
TTDR00929	Inhibitor	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate
TTDR00929	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDR00929	Inhibitor	Thymidine-5'-Phosphate
TTDR00929	Inhibitor	Thymidine-5'-Triphosphate
TTDR00930	UniProt ID	O00329
TTDR00930	Name	Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, delta isoform
TTDR00930	Type of target	Clinical trial target
TTDR00930	Synonyms	P110delta
TTDR00930	Synonyms	PI3-kinase p110 subunit delta
TTDR00930	Synonyms	PI3K
TTDR00930	Synonyms	PI3K delta
TTDR00930	Synonyms	Phosphoinositide 3-kinase delta
TTDR00930	Synonyms	PtdIns-3-kinase p110
TTDR00930	Disease	Inflammatory diseases
TTDR00930	Sequence	MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQ
TTDR00930	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00930	Pathway	Acute myeloid leukemia
TTDR00930	Pathway	Apoptosis
TTDR00930	Pathway	B cell receptor signaling pathway
TTDR00930	Pathway	Chemokine signaling pathway
TTDR00930	Pathway	Chronic myeloid leukemia
TTDR00930	Pathway	Colorectal cancer
TTDR00930	Pathway	Endometrial cancer
TTDR00930	Pathway	ErbB signaling pathway
TTDR00930	Pathway	Fc epsilon RI signaling pathway
TTDR00930	Pathway	Focal adhesion
TTDR00930	Pathway	Glioma
TTDR00930	Pathway	Inositol phosphate metabolism
TTDR00930	Pathway	Insulin signaling pathway
TTDR00930	Pathway	Jak-STAT signaling pathway
TTDR00930	Pathway	Leukocyte transendothelial migration
TTDR00930	Pathway	Melanoma
TTDR00930	Pathway	Natural killer cell mediated cytotoxicity
TTDR00930	Pathway	Non-small cell lung cancer
TTDR00930	Pathway	Pancreatic cancer
TTDR00930	Pathway	Pathways in cancer
TTDR00930	Pathway	Phosphatidylinositol signaling system
TTDR00930	Pathway	Prostate cancer
TTDR00930	Pathway	Regulation of actin cytoskeleton
TTDR00930	Pathway	Renal cell carcinoma
TTDR00930	Pathway	Small cell lung cancer
TTDR00930	Pathway	T cell receptor signaling pathway
TTDR00930	Pathway	Toll-like receptor signaling pathway
TTDR00930	Pathway	Type II diabetes mellitus
TTDR00930	Pathway	VEGF signaling pathway
TTDR00930	Pathway	mTOR signaling pathway
TTDR00930	EC Number	EC 2.7.1.153
TTDR00930	Related US Patent	6,518,277
TTDR00930	Related US Patent	6,667,300
TTDR00930	Target Validation	TTDR00930
TTDR00930	Inhibitor	IC87114
TTDR00930	Inhibitor	IC980033
TTDR00930	Inhibitor	LY-292223
TTDR00930	Inhibitor	LY-293646
TTDR00930	Inhibitor	LY-294002
TTDR00930	Inhibitor	LY294002
TTDR00930	Inhibitor	Wortmannin
TTDR00931	UniProt ID	O36486
TTDR00931	Name	Putative NTPase/helicase protein
TTDR00931	Type of target	Research target
TTDR00931	Synonyms	NTPase/helicase
TTDR00931	Synonyms	Nucleotide triphosphatase/helicase
TTDR00931	Synonyms	RNA nucleoside triphosphatases (NTPase)/helicase
TTDR00931	Disease	Hepatitis C
TTDR00931	Disease	Severe acute respiratory syndrome
TTDR00931	Disease	Viral infection, unspecified
TTDR00931	Sequence	IPLERMRTGRHLVFCHSKAECERLAGQFSARGVNAIAYYGGKDSS
TTDR00931	Inhibitor	Ribavirin-TP
TTDR00932	UniProt ID	P24253
TTDR00932	Name	YihA
TTDR00932	Type of target	Research target
TTDR00932	Synonyms	Probable GTP-binding protein engB
TTDR00932	Disease	Bacterial infections
TTDR00932	Function	Necessary for normal cell division and for the maintenance of normal septation.
TTDR00932	Sequence	MTNLNYQQTHFVMSAPDIRHLPSDTGIEVAFAGRSNAGKSSALNTLTNQKSLARTSKTPGRTQLINLFEVADGKRLVDLP
TTDR00932	PDB Structure	1PUI
TTDR00932	Inhibitor	Guanosine-5'-Diphosphate
TTDR00932	Inhibitor	Guanosine-5'-Triphosphate
TTDR00933	Name	TNF receptor associated factor
TTDR00933	Type of target	Research target
TTDR00933	Synonyms	TNF-receptor-associated factor
TTDR00933	Synonyms	TRAF
TTDR00933	Disease	Autoimmune diseases
TTDR00933	Disease	Inflammatory diseases
TTDR00934	UniProt ID	Q02223
TTDR00934	Name	Tumor necrosis factor receptor superfamily member 17
TTDR00934	Type of target	Research target
TTDR00934	Synonyms	BCMA
TTDR00934	Disease	Multiple myeloma
TTDR00934	Function	Receptor for tnfsf13b/blys/baff and tnfsf13/april. Promotes b-cell survival and
TTDR00934	Sequence	MLQMAGQCSQNEYFDSLLHACIPCQLRCSSNTPPLTCQRYCNASVTNSVKGTNAILWTCLGLSLIISLAVFVLMFLLRKI
TTDR00934	PDB Structure	1OQD; 1XU2; 2KN1
TTDR00934	BioChemical Class	Transmembrane protein
TTDR00934	Pathway	Cytokine-cytokine receptor interaction
TTDR00935	UniProt ID	O14836
TTDR00935	Name	Tumor necrosis factor receptor superfamily member 13B
TTDR00935	Type of target	Research target
TTDR00935	Synonyms	TACI
TTDR00935	Disease	Multiple myeloma
TTDR00935	Function	Receptor for tnfsf13/april and tnfsf13b/tall1/baff/blys that binds both ligands
TTDR00935	Sequence	MSGLGRSRRGGRSRVDQEERFPQGLWTGVAMRSCPEEQYWDPLLGTCMSCKTICNHQSQRTCAAFCRSLSCRKEQGKFYD
TTDR00935	PDB Structure	1XU1; 1XUT
TTDR00935	BioChemical Class	Transmembrane protein
TTDR00935	Pathway	Cytokine-cytokine receptor interaction
TTDR00935	Pathway	Primary immunodeficiency
TTDR00936	UniProt ID	Q96RJ3
TTDR00936	Name	Tumor necrosis factor receptor superfamily member 13C
TTDR00936	Type of target	Research target
TTDR00936	Synonyms	B cell-activating factor receptor
TTDR00936	Synonyms	BAFF receptor
TTDR00936	Synonyms	BAFF-R
TTDR00936	Synonyms	BLyS receptor 3
TTDR00936	Disease	Multiple myeloma
TTDR00936	Function	B-cell receptor specific for tnfsf13b/tall1/baff/blys. Promotes the survival of
TTDR00936	Sequence	MRRGPRSLRGRDAPAPTPCVPAECFDLLVRHCVACGLLRTPRPKPAGASSPAPRTALQPQESVGAGAGEAALPLPGLLFG
TTDR00936	PDB Structure	1MPV; 1OQE; 1OSX; 1P0T; 2HFG
TTDR00936	BioChemical Class	Transmembrane protein
TTDR00936	Pathway	Cytokine-cytokine receptor interaction
TTDR00936	Pathway	Primary immunodeficiency
TTDR00937	UniProt ID	Q8CCS5
TTDR00937	Name	F-box and WD-40 domain protein 7
TTDR00937	Type of target	Research target
TTDR00937	Synonyms	F-box protein FBW7
TTDR00937	Synonyms	F-box protein Fbxw6
TTDR00937	Synonyms	F-box-WD40 repeat protein 6
TTDR00937	Synonyms	FBXW7
TTDR00937	Synonyms	SEL-10
TTDR00937	Disease	Pancreatic cancer
TTDR00937	Sequence	MRVCVPSSVLVLSCVCWCWGVLLPVPLPNLPFLACLSMSTLESVTYLPEKGLYCQRLPSSRTHGGTESLKGKNTENMGFY
TTDR00937	Pathway	Ubiquitin mediated proteolysis
TTDR00938	UniProt ID	P14598
TTDR00938	Name	Neutrophil cytosol factor 1
TTDR00938	Type of target	Research target
TTDR00938	Synonyms	47 kDa autosomal chronic granulomatous disease protein
TTDR00938	Synonyms	47 kDa neutrophil oxidase factor
TTDR00938	Synonyms	NCF-1
TTDR00938	Synonyms	NCF-47K
TTDR00938	Synonyms	NOXO2
TTDR00938	Synonyms	Neutrophil NADPH oxidase factor 1
TTDR00938	Synonyms	P47(phox) NAD(P)H oxidase
TTDR00938	Synonyms	P47-phox
TTDR00938	Disease	Atherosclerosis
TTDR00938	Disease	Cardiovascular disease, unspecified
TTDR00938	Disease	Hypertension
TTDR00938	Function	Ncf2, ncf1, and a membrane bound cytochrome b558 are required for activation of
TTDR00938	Sequence	MGDTFIRHIALLGFEKRFVPSQHYVYMFLVKWQDLSEKVVYRRFTEIYEFHKTLKEMFPIEAGAINPENRIIPHLPAPKW
TTDR00938	PDB Structure	1GD5; 1K4U; 1KQ6; 1NG2; 1O7K; 1OV3; 1UEC; 1W70; 1WLP
TTDR00938	Pathway	Chemokine signaling pathway
TTDR00938	Pathway	Leukocyte transendothelial migration
TTDR00939	Name	Toll-like receptor
TTDR00939	Type of target	Research target
TTDR00939	Disease	Allergy, unspecified
TTDR00939	Disease	Autoimmune diseases
TTDR00939	Disease	Cancer, unspecific
TTDR00939	Disease	Sepsis
TTDR00940	Name	Fc receptor
TTDR00940	Type of target	Research target
TTDR00940	Disease	Allergy, unspecified
TTDR00940	Disease	Autoimmune diseases
TTDR00940	Disease	Cancer, unspecific
TTDR00941	Name	SLC38
TTDR00941	Type of target	Research target
TTDR00941	Synonyms	Amino acids transporter NAT
TTDR00941	Synonyms	Solute carrier family 38
TTDR00941	Disease	Neoplasms
TTDR00943	UniProt ID	P10082
TTDR00943	Name	Peptide YY
TTDR00943	Type of target	Research target
TTDR00943	Synonyms	PYY
TTDR00943	Synonyms	PYY-I
TTDR00943	Synonyms	Peptide tyrosine tyrosine
TTDR00943	Disease	Obesity
TTDR00943	Function	This gut peptide inhibits exocrine pancreatic secretion, has a vasoconstrictory
TTDR00943	Sequence	MVFVRRPWPALTTVLLALLVCLGALVDAYPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRYGKRDGPDTLLSKTFFP
TTDR00943	PDB Structure	2DEZ; 2DF0; 2L60
TTDR00944	Name	High density lipoprotein
TTDR00944	Type of target	Research target
TTDR00944	Synonyms	HDL
TTDR00944	Disease	Atherosclerosis
TTDR00944	Disease	Atherosclerotic cardiovascular disease
TTDR00945	Name	Phosphoribosylaminoimidazolecarboxamide formyltransferase
TTDR00945	Type of target	Research target
TTDR00945	Synonyms	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase
TTDR00945	Synonyms	AICAR transformylase
TTDR00945	Synonyms	AICARFT
TTDR00945	Disease	Cancer, unspecific
TTDR00945	EC Number	EC 2.1.2.3
TTDR00945	Related US Patent	6,525,050
TTDR00945	Target Validation	TTDR00945
TTDR00945	Inhibitor	FAICAR
TTDR00945	Inhibitor	NSC-126445
TTDR00945	Inhibitor	NSC-26699
TTDR00945	Inhibitor	NSC-292213
TTDR00945	Inhibitor	NSC-30171
TTDR00945	Inhibitor	NSC-324572
TTDR00945	Inhibitor	NSC-37031
TTDR00945	Inhibitor	NSC-37173
TTDR00945	Inhibitor	NSC-45592
TTDR00945	Inhibitor	NSC-47729
TTDR00945	Inhibitor	NSC-58046
TTDR00945	Inhibitor	NSC-88915
TTDR00946	Name	Glycoprotein Ib-IX-V receptor
TTDR00946	Type of target	Research target
TTDR00946	Synonyms	GP Ib-IX-V
TTDR00946	Synonyms	Glycoprotein (GP) Ib-IX-V
TTDR00946	Synonyms	Glycoprotein Ib-IX-V
TTDR00946	Disease	Inflammation
TTDR00946	Disease	Thrombosis
TTDR00947	UniProt ID	P08709
TTDR00947	Name	Coagulation factor VII
TTDR00947	Type of target	Research target
TTDR00947	Synonyms	Eptacog alfa
TTDR00947	Synonyms	Factor VII
TTDR00947	Synonyms	Proconvertin
TTDR00947	Synonyms	SPCA
TTDR00947	Synonyms	Serum prothrombin conversion accelerator
TTDR00947	Disease	Coagulative disorders
TTDR00947	Function	Circulates in the blood in a zymogen form. Factor vii is converted to factor vii
TTDR00947	Sequence	MVSQALRLLCLLLGLQGCLAAGGVAKASGGETRDMPWKPGPHRVFVTQEEAHGVLHRRRRANAFLEELRPGSLERECKEE
TTDR00947	PDB Structure	1BF9; 1CVW; 1DAN; 1DVA; 1F7E; 1F7M; 1FAK; 1FF7; 1FFM; 1J9C; 1JBU; 1KLI; 1KLJ; 1N
TTDR00947	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00947	Pathway	Complement and coagulation cascades
TTDR00947	EC Number	EC 3.4.21.21
TTDR00947	Target Validation	TTDR00947
TTDR00947	Inhibitor	4-(3,4-Diethoxy-benzylamino)-benzamidine
TTDR00947	Inhibitor	4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine
TTDR00947	Inhibitor	Fucose
TTDR00948	Name	Protein phosphatase 1
TTDR00948	Type of target	Research target
TTDR00948	Synonyms	Nuclear protein phosphatase-1
TTDR00948	Synonyms	PP1
TTDR00948	Synonyms	Phosphatase-1
TTDR00948	Disease	Alzheimer's disease
TTDR00948	Disease	Cancer, unspecific
TTDR00948	Disease	Heart failure
TTDR00948	Disease	Human immunodeficiency virus [HIV] disease
TTDR00949	UniProt ID	Q90835
TTDR00949	Name	Elongation factor 1-alpha
TTDR00949	Type of target	Research target
TTDR00949	Synonyms	EF-1 alpha
TTDR00949	Synonyms	EF-1-alpha-1
TTDR00949	Synonyms	EF-Tu
TTDR00949	Synonyms	Elongation factor Tu
TTDR00949	Disease	Leishmania infections
TTDR00949	Function	This protein promotes the gtp-dependent binding of aminoacyl-trna to the a-site
TTDR00949	Sequence	MGKEKTHINIVVIGHVDSGKSTTTGHLIYKCGGIDKRTIEKFEKEAAEMGKGSFKYAWVLDKLKAERERGITIDISLWKF
TTDR00949	Inhibitor	Ge2270a
TTDR00949	Inhibitor	Guanosine-5'-Diphosphate
TTDR00950	UniProt ID	Q16719
TTDR00950	Name	Kynureninase
TTDR00950	Type of target	Research target
TTDR00950	Synonyms	L-kynurenine hydrolase
TTDR00950	Disease	AIDS related dementia
TTDR00950	Disease	Alzheimer's disease
TTDR00950	Disease	Huntington's disease
TTDR00950	Function	Catalyzes the cleavage of l-kynurenine (l-kyn) and l-3- hydroxykynurenine (l-3oh
TTDR00950	Sequence	MEPSSLELPADTVQRIAAELKCHPTDERVALHLDEEDKLRHFRECFYIPKIQDLPPVDLSLVNKDENAIYFLGNSLGLQP
TTDR00950	PDB Structure	2HZP; 3E9K
TTDR00950	EC Number	EC 3.7.1.3
TTDR00950	Inhibitor	3,6,9,12,15-Pentaoxaheptadecane
TTDR00950	Inhibitor	3-Hydroxyhippuric acid
TTDR00950	Inhibitor	3-hydroxydesaminokynurenine
TTDR00950	Inhibitor	3-methoxydesaminokynurenine
TTDR00951	Name	CAMP-specific 3',5'-cyclic phosphodiesterase 4
TTDR00951	Type of target	Research target
TTDR00951	Disease	Asthma
TTDR00952	UniProt ID	P02918
TTDR00952	UniProt ID	Q04707
TTDR00952	Name	Penicillin-binding protein 1A
TTDR00952	Type of target	Research target
TTDR00952	Synonyms	PBP 1a
TTDR00952	Synonyms	PBP-1a
TTDR00952	Synonyms	PBP1a
TTDR00952	Disease	Bacterial infections
TTDR00952	Function	Cell wall formation. Synthesis of cross-linked peptidoglycan from the lipid inte
TTDR00952	Sequence	MKFVKYFLILAVCCILLGAGSIYGLYRYIEPQLPDVATLKDVRLQIPMQIYSADGELIAQYGEKRRIPVTLDQIPPEMVK
TTDR00952	PDB Structure	2ZC5; 2ZC6
TTDR00952	BioChemical Class	Transmembrane protein
TTDR00952	Inhibitor	PCNOTAXIME GROUP
TTDR00952	Antagonist	Cephalosporin C
TTDR00953	UniProt ID	O00273
TTDR00953	Name	DNA fragmentation factor alpha subunit
TTDR00953	Type of target	Research target
TTDR00953	Synonyms	DFF-45
TTDR00953	Synonyms	DNA fragmentation factor 45 kDa subunit
TTDR00953	Synonyms	ICAD
TTDR00953	Synonyms	Inhibitor of CAD
TTDR00953	Synonyms	Inhibitor of caspase-3-activated Dnase
TTDR00953	Disease	Colon cancer
TTDR00953	Function	Inhibitor of the caspase-activated dnase (dff40).
TTDR00953	Sequence	MEVTGDAGVPESGEIRTLKPCLLRRNYSREQHGVAASCLEDLRSKACDILAIDKSLTPVTLVLAEDGTIVDDDDYFLCLP
TTDR00953	PDB Structure	1IBX; 1IYR; 1KOY
TTDR00953	Pathway	Apoptosis
TTDR00955	UniProt ID	P09622
TTDR00955	UniProt ID	P90597
TTDR00955	Name	Dihydrolipoamide dehydrogenase, mitochondrial
TTDR00955	Type of target	Research target
TTDR00955	Synonyms	Dihydrolipoamide dehydrogenase
TTDR00955	Synonyms	Glycine cleavage system L protein
TTDR00955	Synonyms	LipDH
TTDR00955	Synonyms	Lipoamide dehydrogenase
TTDR00955	Disease	Chagas' disease
TTDR00955	Function	Lipoamide dehydrogenase is a component of the glycine cleavage system as well as
TTDR00955	Sequence	MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTC
TTDR00955	PDB Structure	2QAE
TTDR00955	BioChemical Class	Oxidoreductases acting on a sulfur group of donors
TTDR00955	EC Number	EC 1.8.1.4
TTDR00955	Inhibitor	Flavin-Adenine Dinucleotide
TTDR00955	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00956	UniProt ID	P17812
TTDR00956	Name	CTP synthase
TTDR00956	Type of target	Research target
TTDR00956	Synonyms	CTP synthetase
TTDR00956	Synonyms	Cytidine 5'-triphosphate synthetase
TTDR00956	Synonyms	Cytidine triphosphate synthetase
TTDR00956	Synonyms	UTP--ammonia ligase
TTDR00956	Synonyms	UTP:ammonia ligase (ADP-forming)
TTDR00956	Synonyms	Uridine triphosphate aminase
TTDR00956	Disease	Acute T-lymphoid leukemia
TTDR00956	Disease	Acute non-lymphocytic leukaemia
TTDR00956	Disease	Malaria
TTDR00956	Disease	Sleeping sickness
TTDR00956	Disease	Tumors
TTDR00956	Disease	Viral infection, unspecified
TTDR00956	Function	Catalyzes the atp-dependent amination of utp to ctp with either l-glutamine or a
TTDR00956	Sequence	MKYILVTGGVISGIGKGIIASSVGTILKSCGLHVTSIKIDPYINIDAGTFSPYEHGEVFVLDDGGEVDLDLGNYERFLDI
TTDR00956	PDB Structure	2VO1
TTDR00956	BioChemical Class	Ligases forming carbon-nitrogen bonds
TTDR00956	Pathway	Metabolic pathways
TTDR00956	Pathway	Pyrimidine metabolism
TTDR00956	EC Number	EC 6.3.4.2
TTDR00956	Inhibitor	2-Methyl-2,4-Pentanediol
TTDR00956	Inhibitor	Acivicin
TTDR00956	Inhibitor	Carbodine
TTDR00956	Inhibitor	Cyclopentenylcytosine
TTDR00956	Inhibitor	Cyclopentylcytosine
TTDR00956	Inhibitor	Cylopentenyl cytosine
TTDR00956	Inhibitor	DON
TTDR00957	UniProt ID	P23526
TTDR00957	Name	Adenosylhomocysteinase
TTDR00957	Type of target	Research target
TTDR00957	Synonyms	AdoHcyase
TTDR00957	Synonyms	S-adenosyl-L-homocysteine hydrolase
TTDR00957	Synonyms	SAH hydrolase
TTDR00957	Disease	Viral infection, unspecified
TTDR00957	Function	Adenosylhomocysteine is a competitive inhibitor of s-adenosyl-l-methionine-depen
TTDR00957	Sequence	MSDKLPYKVADIGLAAWGRKALDIAENEMPGLMRMRERYSASKPLKGARIAGCLHMTVETAVLIETLVTLGAEVQWSSCN
TTDR00957	PDB Structure	1A7A; 1LI4; 3NJ4
TTDR00957	BioChemical Class	Hydrolases acting on ether bonds
TTDR00957	Pathway	Metabolic pathways
TTDR00957	Pathway	Methionine metabolism
TTDR00957	Pathway	Selenoamino acid metabolism
TTDR00957	EC Number	EC 3.3.1.1
TTDR00957	Target Validation	TTDR00957
TTDR00957	Inhibitor	3'-Oxo-Adenosine
TTDR00957	Inhibitor	4(Z)-(5'-Deoxyadenosin-5'-ylidene)butanoic acid
TTDR00957	Inhibitor	5'-S-ethyl-5'-thioadenosine
TTDR00957	Inhibitor	5'-deoxy-5'-ureidoadenosine
TTDR00957	Inhibitor	5(E)-(5'-Deoxyadenosin-5'-ylidene)pentanoic acid
TTDR00957	Inhibitor	5-methylenearisteromycin
TTDR00957	Inhibitor	ARISTEROMYCIN
TTDR00957	Inhibitor	D-Eritadenine
TTDR00957	Inhibitor	ERITADENINE
TTDR00957	Inhibitor	FLUORO-NEPLANOCIN A
TTDR00957	Inhibitor	Isopropyl Alcohol
TTDR00957	Inhibitor	NORARISTEROMYCIN
TTDR00957	Inhibitor	Neplanocin A
TTDR00957	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR00958	Name	Purine nucleoside kinase
TTDR00958	Type of target	Research target
TTDR00958	Synonyms	Diphosphate-dependent nucleoside kinase
TTDR00958	Synonyms	Diphosphate-purine nucleoside kinase
TTDR00958	Synonyms	Pyrophosphate-dependent nucleoside kinase
TTDR00958	Synonyms	Pyrophosphate-purine nucleoside kinase
TTDR00958	Disease	Trypanosomatid infections
TTDR00958	EC Number	EC 2.7.1.143
TTDR00959	UniProt ID	Q13126
TTDR00959	Name	5'-methylthioadenosine phosphorylase
TTDR00959	Type of target	Research target
TTDR00959	Synonyms	MTA phosphorylase
TTDR00959	Synonyms	MTAP
TTDR00959	Synonyms	MTAPase
TTDR00959	Synonyms	Methylthioadenosine phosphorylase
TTDR00959	Disease	T cell leukemias
TTDR00959	Function	Plays a major role in polyamine metabolism and is important for the salvage of b
TTDR00959	Sequence	MASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWA
TTDR00959	PDB Structure	1CB0; 1CG6; 1K27; 1SD1; 1SD2; 3LN5; 3OZC; 3OZD; 3OZE
TTDR00959	BioChemical Class	Glycosyltransferases
TTDR00959	Pathway	Metabolic pathways
TTDR00959	Pathway	Methionine metabolism
TTDR00959	EC Number	EC 2.4.2.28
TTDR00959	Inhibitor	5'-Deoxy-5'-(Methylthio)-Tubercidin
TTDR00959	Inhibitor	5'-Deoxy-5'-Methylthioadenosine
TTDR00959	Inhibitor	Formycin
TTDR00960	Name	Caspase
TTDR00960	Type of target	Research target
TTDR00960	Disease	Heart failure
TTDR00960	EC Number	EC 3.4.22.-
TTDR00960	Related US Patent	6,355,619
TTDR00960	Related US Patent	6,462,041
TTDR00960	Related US Patent	6,566,338
TTDR00960	Related US Patent	6,613,762
TTDR00960	Related US Patent	6,620,782
TTDR00960	Target Validation	TTDR00960
TTDR00960	Inhibitor	Ac-DEVD-CHO
TTDR00960	Inhibitor	IDN-1965
TTDR00960	Inhibitor	isoquinoline-1,3,4(2H)-trione
TTDR00961	Name	Calcitonin gene-related peptide receptor
TTDR00961	Type of target	Research target
TTDR00961	Synonyms	CGRP receptor
TTDR00961	Disease	Migraine
TTDR00961	Disease	Primary headache disorders
TTDR00961	Related US Patent	6,344,438
TTDR00961	Related US Patent	6,521,609
TTDR00962	UniProt ID	Q14061
TTDR00962	Name	Cytochrome c oxidase copper chaperone
TTDR00962	Type of target	Research target
TTDR00962	Synonyms	CCO assembly protein COX17
TTDR00962	Synonyms	COX17
TTDR00962	Synonyms	Cytochrome c oxidase assembly protein COX17
TTDR00962	Disease	Nonsmall cell lung cancer
TTDR00962	Function	Copper chaperone for cytochrome c oxidase (cox). Binds two copper ions and deliv
TTDR00962	Sequence	MPGLVDSNPAPPESQEKKPLKPCCACPETKKARDACIIEKGEEHCGHLIEAHKECMRALGFKI
TTDR00962	PDB Structure	2L0Y; 2LGQ; 2RN9; 2RNB
TTDR00962	Pathway	Metabolic pathways
TTDR00962	Pathway	Oxidative phosphorylation
TTDR00963	UniProt ID	P11166
TTDR00963	Name	Solute carrier family 2, facilitated glucose transporter, member 1
TTDR00963	Type of target	Research target
TTDR00963	Synonyms	GLUT1
TTDR00963	Synonyms	Glucose transporter type 1, erythrocyte/brain
TTDR00963	Synonyms	HepG2 glucose transporter
TTDR00963	Disease	Cervical cancer
TTDR00963	Function	Facilitative glucose transporter. This isoform may be responsible for constituti
TTDR00963	Sequence	MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTTLTTLWSLSVAIFSVGGMIGS
TTDR00963	PDB Structure	1SUK
TTDR00963	BioChemical Class	Transmembrane protein
TTDR00963	Pathway	Adipocytokine signaling pathway
TTDR00963	Pathway	Pathways in cancer
TTDR00963	Pathway	Renal cell carcinoma
TTDR00964	UniProt ID	P01121
TTDR00964	Name	Transforming protein RhoB
TTDR00964	Type of target	Research target
TTDR00964	Synonyms	RhoB
TTDR00964	Disease	Cancer, unspecific
TTDR00964	Disease	Diabetic retinopathy
TTDR00964	Disease	Macular degeneration
TTDR00964	Function	Regulates a signal transduction pathway linking plasma membrane receptors to the
TTDR00964	Sequence	MAAIRKKLVVVGDGACGKTCLLIVFSKDEFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVI
TTDR00964	PDB Structure	2FV8
TTDR00965	UniProt ID	Q14833
TTDR00965	Name	Metabotropic glutamate receptor 4
TTDR00965	Type of target	Research target
TTDR00965	Synonyms	Group III metabotropic glutamate receptor 4
TTDR00965	Synonyms	mGluR4
TTDR00965	Disease	Parkinson's disease
TTDR00965	Function	Receptor for glutamate. The activity of this receptor is mediated by a g-protein
TTDR00965	Sequence	MPGKRGLGWWWARLPLCLLLSLYGPWMPSSLGKPKGHPHMNSIRIDGDITLGGLFPVHGRGSEGKPCGELKKEKGIHRLE
TTDR00965	BioChemical Class	G-protein coupled receptor (metabotropic glutamate family)
TTDR00965	Pathway	Neuroactive ligand-receptor interaction
TTDR00965	Pathway	Taste transduction
TTDR00965	Target Validation	TTDR00965
TTDR00965	Inhibitor	(2S,1'R,2'S)-2-(2'-phosphonocyclopropyl)glycine
TTDR00965	Inhibitor	GLUTAMATE
TTDR00965	Inhibitor	L-1-amino-4-phosphonobutanoic acid
TTDR00966	UniProt ID	P08727
TTDR00966	Name	Keratin, type I cytoskeletal 19
TTDR00966	Type of target	Research target
TTDR00966	Synonyms	CK 19
TTDR00966	Synonyms	CK19
TTDR00966	Synonyms	Cytokeratin 19
TTDR00966	Synonyms	K19
TTDR00966	Disease	Hepatocellular carcinoma
TTDR00966	Sequence	MTSYSYRQSSATSSFGGLGGGSVRFGPGVAFRAPSIHGGSGGRGVSVSSARFVSSSSSGGYGGGYGGVLTASDGLLAGNE
TTDR00967	UniProt ID	P27695
TTDR00967	Name	DNA-(apurinic or apyrimidinic site) lyase
TTDR00967	Type of target	Research target
TTDR00967	Synonyms	AP endonuclease 1
TTDR00967	Synonyms	APE/ref-1
TTDR00967	Synonyms	APEN
TTDR00967	Synonyms	APEX nuclease
TTDR00967	Synonyms	Apurinic/apyrimidinic endonuclease/redox factor-1
TTDR00967	Synonyms	REF-1 protein
TTDR00967	Disease	Ovarian cancer
TTDR00967	Disease	Tumors
TTDR00967	Function	Repairs oxidative dna damages in vitro. May have a role in protection against ce
TTDR00967	Sequence	MPKRGKKGAVAEDGDELRTEPEAKKSKTAAKKNDKEAAGEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKG
TTDR00967	PDB Structure	1BIX; 1CQG; 1CQH; 1DE8; 1DE9; 1DEW; 1E9N; 1HD7; 2ISI; 2O3H; 3U8U; 4IEM
TTDR00967	BioChemical Class	Carbon-oxygen lyases
TTDR00967	Pathway	Base excision repair
TTDR00967	EC Number	EC 4.2.99.18
TTDR00968	UniProt ID	Q99683
TTDR00968	Name	Mitogen-activated protein kinase kinase kinase 5
TTDR00968	Type of target	Research target
TTDR00968	Synonyms	ASK-1
TTDR00968	Synonyms	ASK1
TTDR00968	Synonyms	Apoptosis signal-regulating kinase 1
TTDR00968	Synonyms	MAP3K5
TTDR00968	Synonyms	MAPK/ERK kinase kinase 5
TTDR00968	Synonyms	MEK kinase 5
TTDR00968	Synonyms	MEKK 5
TTDR00968	Disease	Cardiac diseases
TTDR00968	Disease	Malignant fibrous histiocytomas
TTDR00968	Function	Phosphorylates and activates two different subgroups of map kinase kinases, mkk4
TTDR00968	Sequence	MSTEADEGITFSVPPFAPSGFCTIPEGGICRRGGAAAVGEGEEHQLPPPPPGSFWNVESAAAPGIGCPAATSSSSATRGR
TTDR00968	PDB Structure	2CLQ; 3VW6
TTDR00968	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00968	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDR00968	Pathway	MAPK signaling pathway
TTDR00968	EC Number	EC 2.7.1.-
TTDR00969	UniProt ID	P06138
TTDR00969	UniProt ID	P45485
TTDR00969	UniProt ID	Q9ZHA4
TTDR00969	Name	Cell division protein FtsZ
TTDR00969	Type of target	Research target
TTDR00969	Synonyms	FtsZ
TTDR00969	Synonyms	FtsZ protein
TTDR00969	Synonyms	ftsZ;
TTDR00969	Disease	Bacterial infections
TTDR00969	Function	Essential cell division protein that forms a contractile ring structure (Z ring)
TTDR00969	Function	This protein is essential to the cell-division process. It seems to assemble int
TTDR00969	Sequence	MFEPMELTNDAVIKVIGVGGGGGNAVEHMVRERIEGVEFFAVNTDAQALRKTAVGQTIQIGSGITKGLGAGANPEVGRNA
TTDR00969	PDB Structure	1F47
TTDR00969	EC Number	EC 3.4.24.-
TTDR00969	Drug(s)	
TTDR00969	Inhibitor	5'-Guanosine-Diphosphate-Monothiophosphate
TTDR00969	Inhibitor	Guanosine-5'-Diphosphate
TTDR00969	Inhibitor	Phosphomethylphosphonic Acid Guanylate Ester
TTDR00970	UniProt ID	Q81099
TTDR00970	Name	DNA polymerase/reverse transcriptase
TTDR00970	Type of target	Clinical trial target
TTDR00970	Synonyms	HBV reverse transcriptase
TTDR00970	Synonyms	Hepatitis B Virus reverse transcriptase
TTDR00970	Disease	Hepatitis B
TTDR00970	Sequence	MPLSYQHFRKLLLLDDEAGPLEEELPRLADEGLNRRVAEDLNLGNLNVSIPWTHKVGNFTGLYSSTVPVLNPEWQTPSFP
TTDR00970	BioChemical Class	DNA-directed DNA polymerase
TTDR00970	Related US Patent	6,593,082
TTDR00970	Drug(s)	Clevudine
TTDR00970	Drug(s)	Emtricitabine
TTDR00970	Drug(s)	LB80380
TTDR00970	Drug(s)	MIV-210
TTDR00970	Inhibitor	Clevudine
TTDR00970	Inhibitor	Emtricitabine
TTDR00970	Inhibitor	LB80380
TTDR00970	Inhibitor	MIV-210
TTDR00971	UniProt ID	Q8N608
TTDR00971	Name	Similar to dipeptidyl aminopeptidase-like protein
TTDR00971	Type of target	Research target
TTDR00971	Synonyms	DPP10
TTDR00971	Synonyms	Dipeptidylpeptidase 10
TTDR00971	Disease	Asthma
TTDR00971	Sequence	MNQTASVSHHIKCQPSKTIKELGSNSPPQRNWKGIAIALLVILVVCSLITMSVILLTPDELTNSSETRLSLEDLFRKDFV
TTDR00971	BioChemical Class	Transmembrane protein
TTDR00972	UniProt ID	P23863
TTDR00972	UniProt ID	Q97PK6
TTDR00972	Name	Cytidylate kinase
TTDR00972	Type of target	Research target
TTDR00972	Synonyms	CK
TTDR00972	Synonyms	CMP kinase
TTDR00972	Synonyms	Cytidine monophosphate kinase
TTDR00972	Synonyms	MssA protein
TTDR00972	Synonyms	P25
TTDR00972	Synonyms	TIGR4
TTDR00972	Disease	Streptococcus pneumoniae infections
TTDR00972	Function	Atp, datp, and gtp are equally effective as phosphate donors. Cmp and dcmp are t
TTDR00972	Sequence	MTAIAPVITIDGPSGAGKGTLCKAMAEALQWHLLDSGAIYRVLALAALHHHVDVASEDALVPLASHLDVRFVSTNGNLEV
TTDR00972	PDB Structure	1Q3T
TTDR00972	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00972	Pathway	Metabolic pathways
TTDR00972	Pathway	Pyrimidine metabolism
TTDR00972	EC Number	EC 2.7.4.14
TTDR00972	Inhibitor	2',3'-Dideoxycytidine-5'-Monophosphate
TTDR00972	Inhibitor	Cytidine-5'-Diphosphate
TTDR00972	Inhibitor	Cytidine-5'-Monophosphate
TTDR00972	Inhibitor	Cytosine Arabinose-5'-Phosphate
TTDR00973	Name	Neuropeptide Y receptor
TTDR00973	Type of target	Research target
TTDR00973	Synonyms	NPY receptor
TTDR00973	Disease	Ovarian cancer
TTDR00973	Related US Patent	6,177,429
TTDR00973	Related US Patent	6,197,822
TTDR00973	Related US Patent	6,391,881
TTDR00973	Related US Patent	6,407,120
TTDR00973	Related US Patent	6,432,960
TTDR00973	Related US Patent	6,444,675
TTDR00973	Related US Patent	6,479,482
TTDR00973	Related US Patent	6,511,984
TTDR00973	Related US Patent	6,596,724
TTDR00973	Related US Patent	6,649,759
TTDR00975	UniProt ID	Q28773
TTDR00975	Name	Glandular kallikrein 1
TTDR00975	Type of target	Research target
TTDR00975	Synonyms	Glandular kallikrein
TTDR00975	Synonyms	Kidney/pancreas/salivary gland kallikrein
TTDR00975	Synonyms	Tissue kallikrein
TTDR00975	Disease	Asthma
TTDR00975	Disease	Pancreatitis
TTDR00975	Disease	Rheumatoid arthritis, unspecified
TTDR00975	Function	Glandular kallikreins cleave met-lys and arg-ser bonds in kininogen to release l
TTDR00975	Sequence	MWFLVLCLALSLGGTGAAPPIQSRIVGGWECSQPWQAALYHFSTFQCGGILVHPQWVLTAAHCIGDNYQLWLGRHNLFDD
TTDR00975	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00975	EC Number	EC 3.4.21.35
TTDR00975	Inhibitor	Alpha1-PI
TTDR00975	Inhibitor	SBTI
TTDR00976	UniProt ID	P40376
TTDR00976	Name	CAMP-dependent protein kinase, catalytic subunit
TTDR00976	Type of target	Research target
TTDR00976	Disease	Prostate cancer
TTDR00976	Sequence	MDTTAVASKGSTNVGSSTDTLSTSASLHPSMNAGSVNEYSEQQRHGTNSFNGKPSVHDSVGSDASVSNGHNNHNESSLWT
TTDR00976	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00976	EC Number	EC 2.7.1.37
TTDR00976	Related US Patent	6,495,558
TTDR00977	UniProt ID	P10644
TTDR00977	Name	CAMP-dependent protein kinase type I-alpha regulatory chain
TTDR00977	Type of target	Research target
TTDR00977	Synonyms	CAMP-dependent protein kinase (PKA)
TTDR00977	Synonyms	PKA RIalpha-subunit
TTDR00977	Synonyms	RIalpha subunit of cAMP-dependent protein kinase
TTDR00977	Synonyms	TSE1
TTDR00977	Synonyms	Tissue-specific extinguisher-1
TTDR00977	Disease	Cancer, unspecific
TTDR00977	Sequence	MESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKEEAKQIQNLQKAGTRTDSRED
TTDR00977	Pathway	Apoptosis
TTDR00977	Pathway	Insulin signaling pathway
TTDR00977	EC Number	EC 2.7.1.37
TTDR00977	Target Validation	TTDR00977
TTDR00977	Inhibitor	5-(2-methylpiperazin-1-ylsulfonyl)isoquinoline
TTDR00977	Inhibitor	AdcAhxArg4Lys(biotin)-PEG-OMe
TTDR00977	Inhibitor	AdcAhxArg4Lys-PEGOMe
TTDR00977	Inhibitor	AdcAhxArg4NH(CH2)6NH2
TTDR00977	Inhibitor	AdcAhxArg6
TTDR00977	Inhibitor	AdoC(Ahx)Arg6
TTDR00977	Inhibitor	AdoC(Aoc)Arg6
TTDR00977	Inhibitor	AdoC(Aun)Arg6
TTDR00977	Inhibitor	AdoC(Dpr)2AlaArg6
TTDR00977	Inhibitor	AdoC(GABA)Arg6
TTDR00977	Inhibitor	AdoC(beta-Ala)2AlaArg6
TTDR00977	Inhibitor	AdoC(beta-Ala)Arg6
TTDR00977	Inhibitor	AdoC(betaAsp)2AlaArg6
TTDR00977	Inhibitor	AdoCGlyArg6
TTDR00977	Inhibitor	Cyclic Adenosine Monophosphate
TTDR00977	Inhibitor	Cyclic Guanosine Monophosphate
TTDR00977	Inhibitor	RO-316233
TTDR00977	Inhibitor	Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate
TTDR00978	UniProt ID	P31323
TTDR00978	Name	CAMP-dependent protein kinase type II-beta regulatory chain
TTDR00978	Type of target	Research target
TTDR00978	Synonyms	PKA RIIbeta-subunit
TTDR00978	Synonyms	RIIbeta subunit of cAMP-dependent protein kinase
TTDR00978	Synonyms	Type RIIbeta regulatory subunit of protein kinase A
TTDR00978	Disease	Obesity
TTDR00978	Function	Type ii regulatory chains mediate membrane association by binding to anchorinG p
TTDR00978	Sequence	MSIEIPAGLTELLQGFTVEVLRHQPADLLEFALQHFTRLQQENERKGTARFGHEGRTWGDLGAAAGGGTPSKGVNFAEEP
TTDR00978	Pathway	Apoptosis
TTDR00978	Pathway	Insulin signaling pathway
TTDR00978	EC Number	EC 2.7.1.37
TTDR00978	Target Validation	TTDR00978
TTDR00978	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDR00978	Inhibitor	AdcAhxArg4Lys(biotin)-PEG-OMe
TTDR00978	Inhibitor	AdcAhxArg4Lys-PEGOMe
TTDR00978	Inhibitor	AdcAhxArg4NH(CH2)6NH2
TTDR00978	Inhibitor	AdcAhxArg6
TTDR00978	Inhibitor	AdoC(Ahx)Arg6
TTDR00978	Inhibitor	AdoC(Aoc)Arg6
TTDR00978	Inhibitor	AdoC(Aun)Arg6
TTDR00978	Inhibitor	AdoC(Dpr)2AlaArg6
TTDR00978	Inhibitor	AdoC(GABA)Arg6
TTDR00978	Inhibitor	AdoC(beta-Ala)2AlaArg6
TTDR00978	Inhibitor	AdoC(beta-Ala)Arg6
TTDR00978	Inhibitor	AdoC(betaAsp)2AlaArg6
TTDR00978	Inhibitor	AdoCGlyArg6
TTDR00978	Inhibitor	BALANOL
TTDR00978	Inhibitor	Cyclic Adenosine Monophosphate
TTDR00978	Inhibitor	Ro-4396686
TTDR00979	UniProt ID	P00936
TTDR00979	Name	Adenylate cyclase
TTDR00979	Type of target	Research target
TTDR00979	Synonyms	ATP pyrophosphate-lyase
TTDR00979	Synonyms	Adenylyl cyclase
TTDR00979	Disease	Heart failure
TTDR00979	Sequence	MYLYIETLKQRLDAINQLRVDRALAAMGPAFQQVYSLLPTLLHYHHPLMPGYLDGNVPKGICLYTPDETQRHYLNELELY
TTDR00979	BioChemical Class	Phosphorus-oxygen lyases
TTDR00979	Pathway	Purine metabolism
TTDR00979	EC Number	EC 4.6.1.1
TTDR00979	Target Validation	TTDR00979
TTDR00979	Inhibitor	2,3,17BETA-TRIHYDROXY-1,3,5(10)-ESTRATRIENE
TTDR00979	Inhibitor	2,5-didesoxy-3-ATP
TTDR00979	Inhibitor	2-hydroxy-17beta-estradiol
TTDR00979	Inhibitor	Adenosine-5'-Rp-Alpha-Thio-Triphosphate
TTDR00979	Inhibitor	Alpha,Beta-Methyleneadenosine-5'-Triphosphate
TTDR00979	Inhibitor	Colforsin
TTDR00979	Inhibitor	Cyclic Adenosine Monophosphate
TTDR00979	Inhibitor	DEOXYADENOSINE
TTDR00979	Inhibitor	N6-CYCLOPENTYLADENOSINE
TTDR00979	Inhibitor	NSC-270718
TTDR00979	Inhibitor	NSC-88915
TTDR00980	Name	28-kDa cysteine proteinase
TTDR00980	Type of target	Research target
TTDR00980	Synonyms	28 kDa cysteine protease
TTDR00980	Disease	Malaria
TTDR00981	UniProt ID	Q14210
TTDR00981	Name	Lymphocyte antigen Ly-6D
TTDR00981	Type of target	Research target
TTDR00981	Synonyms	Desmoglein III (dg4)
TTDR00981	Synonyms	E48 antigen
TTDR00981	Disease	Squamous cell carcinoma
TTDR00981	Function	May be involved in cell-cell adhesion and signal transduction.
TTDR00981	Sequence	MRTALLLLAALAVATGPALTLRCHVCTSSSNCKHSVVCPASSRFCKTTNTVEPLRGNLVKKDCAESCTPSYTLQGQVSSG
TTDR00981	BioChemical Class	Cell membrane protein
TTDR00982	UniProt ID	P25779
TTDR00982	Name	Cruzipain
TTDR00982	Type of target	Research target
TTDR00982	Synonyms	Congopain
TTDR00982	Synonyms	Cruzaine
TTDR00982	Synonyms	Cysteine proteinase cruzipain
TTDR00982	Synonyms	Major cysteine proteinase
TTDR00982	Disease	Chagas' disease
TTDR00982	Disease	Trypanolytic infections
TTDR00982	Sequence	MSGWARALLLAAVLVVMACLVPAATASLHAEETLTSQFAEFKQKHGRVYESAAEEAFRLSVFRENLFLARLHAAANPHAT
TTDR00982	PDB Structure	1AIM; 1EWL; 1EWM; 1EWO; 1EWP; 1F29; 1F2A; 1F2B; 1F2C; 1ME3; 1ME4; 1U9Q; 2AIM; 2O
TTDR00982	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR00982	EC Number	EC 3.4.22.51
TTDR00982	Target Validation	TTDR00982
TTDR00982	Inhibitor	(3Z)-1H-indole-2,3-dione 3-thiosemicarbazone
TTDR00982	Inhibitor	1-(1-(3-nitrophenyl)propylidene)thiosemicarbazide
TTDR00982	Inhibitor	1-(3,4-dihydronaphthalen-1-yl)ethanone
TTDR00982	Inhibitor	1-(3-Methoxy-benzyl)-5-methyl-1H-indole-2,3-dione
TTDR00982	Inhibitor	1-(bis(3-bromophenyl)methylene)thiosemicarbazide
TTDR00982	Inhibitor	2-(cycloheptylamino)-2-oxoethyl 2-aminonicotinate
TTDR00982	Inhibitor	2-(trifluoromethyl)benzaldehyde thiosemicarbazone
TTDR00982	Inhibitor	2-methoxy-1-naphthaldehyde thiosemicarbazone
TTDR00982	Inhibitor	3',4'-dichloroacetophenonethiosemicarbazone
TTDR00982	Inhibitor	3'-bromopropiophenonethiosemicarbazone
TTDR00982	Inhibitor	3,4-dichlorobenzaldehyde thiosemicarbazone
TTDR00982	Inhibitor	3,5-dichlorobenzaldehyde thiosemicarbazone
TTDR00982	Inhibitor	3-(trifluoromethyl)benzaldehyde thiosemicarbazone
TTDR00982	Inhibitor	3-amino-5-(furan-2-yl)biphenyl-2,4-dicarbonitrile
TTDR00982	Inhibitor	3-chloro-N-(4-(phenyldiazenyl)phenyl)benzamide
TTDR00982	Inhibitor	5-(3,4-dichlorophenyl)-1H-pyrazol-3-ol
TTDR00982	Inhibitor	5-(4-bromophenyl)-2-furaldehyde thiosemicarbazone
TTDR00982	Inhibitor	5-Chloro-1-(4-chloro-benzyl)-1H-indole-2,3-dione
TTDR00982	Inhibitor	Benzoyl-Arginine-Alanine-Methyl Ketone
TTDR00982	Inhibitor	GNF-PF-4478
TTDR00982	Inhibitor	K-777
TTDR00982	Inhibitor	L-755507
TTDR00982	Inhibitor	MANIDIPINE
TTDR00982	Inhibitor	N1,N4-bis(5-chloro-2-methylphenyl)succinamide
TTDR00982	Inhibitor	TRICLABENDAZOLE
TTDR00982	Inhibitor	VITAMIN K2
TTDR00982	Inhibitor	WRR-112
TTDR00982	Inhibitor	WRR-204
TTDR00982	Inhibitor	WRR-99
TTDR00982	Binder	Vinylsulphones
TTDR00983	UniProt ID	P36952
TTDR00983	Name	Maspin
TTDR00983	Type of target	Research target
TTDR00983	Synonyms	Protease inhibitor 5
TTDR00983	Disease	Breast cancer
TTDR00983	Function	Tumor suppressor. It blocks the growth, invasion, and metastatic properties of m
TTDR00983	Sequence	MDALQLANSAFAVDLFKQLCEKEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFENVKDVPFGFQTVTSDVNKL
TTDR00983	PDB Structure	1WZ9; 1XQG; 1XQJ; 1XU8
TTDR00983	Inhibitor	S,S-(2-Hydroxyethyl)Thiocysteine
TTDR00984	UniProt ID	Q9RGS8
TTDR00984	Name	Phosphatidylcholine-specific phospholipase C
TTDR00984	Type of target	Research target
TTDR00984	Synonyms	Lecithinase
TTDR00984	Synonyms	Non-hemolytic phospholipase C
TTDR00984	Synonyms	PC-PLC
TTDR00984	Synonyms	PLC-N
TTDR00984	Synonyms	Phosphatidylcholine cholinephosphohydrolase
TTDR00984	Synonyms	Phosphatidylcholine-hydrolyzing phospholipase C
TTDR00984	Disease	Inflammatory diseases
TTDR00984	Function	Hydrolyzes phosphatidylserine as well as phosphatidylcholine.
TTDR00984	Sequence	MTNQNRRDFLRLAAGTAGAAALQLFPPVIREALAIPANRRTGTIRDVEHIVILMQENRSFDHYFGKLRGVRGFGDPRPLA
TTDR00984	BioChemical Class	Hydrolases acting on ester bonds
TTDR00984	Pathway	Ether lipid metabolism
TTDR00984	Pathway	Glycerophospholipid metabolism
TTDR00984	Pathway	Inositol phosphate metabolism
TTDR00984	Pathway	Metabolic pathways
TTDR00984	EC Number	EC 3.1.4.3
TTDR00984	Inhibitor	D609
TTDR00985	UniProt ID	P50148
TTDR00985	Name	Guanine nucleotide-binding protein G(q), alpha subunit
TTDR00985	Type of target	Research target
TTDR00985	Synonyms	G alpha(q)
TTDR00985	Synonyms	G alphaq
TTDR00985	Disease	Myocardial infarction
TTDR00985	Disease	Stroke
TTDR00985	Disease	Unstable angina
TTDR00985	Function	Guanine nucleotide-bindinG proteins (G proteins) are involved as modulators or t
TTDR00985	Sequence	MTLESIMACCLSEEAKEARRINDEIERQLRRDKRDARRELKLLLLGTGESGKSTFIKQMRIIHGSGYSDEDKRGFTKLVY
TTDR00986	UniProt ID	P25685
TTDR00986	Name	Heat shock protein 40
TTDR00986	Type of target	Research target
TTDR00986	Synonyms	DnaJ homolog subfamily B member 1
TTDR00986	Synonyms	DnaJ protein homolog 1
TTDR00986	Synonyms	HDJ-1
TTDR00986	Synonyms	HSP40
TTDR00986	Synonyms	Heat shock 40 kDa protein 1
TTDR00986	Disease	Polyglutamine diseases
TTDR00986	Function	Interacts with hsp70 and can stimulate its atpase activity. Stimulates the assoc
TTDR00986	Sequence	MGKDYYQTLGLARGASDEEIKRAYRRQALRYHPDKNKEPGAEEKFKEIAEAYDVLSDPRKREIFDRYGEEGLKGSGPSGG
TTDR00986	PDB Structure	1HDJ; 2QLD; 3AGX; 3AGY; 3AGZ
TTDR00987	UniProt ID	O94759
TTDR00987	Name	Long transient receptor potential channel 2
TTDR00987	Type of target	Research target
TTDR00987	Synonyms	LTRPC7
TTDR00987	Synonyms	LTrpC2
TTDR00987	Synonyms	Transient receptor potential channel 7
TTDR00987	Synonyms	TrpC7
TTDR00987	Disease	Inflammatory diseases
TTDR00987	Function	May be a calcium channel.
TTDR00987	Sequence	MEPSALRKAGSEQEEGFEGLPRRVTDLGMVSNLRRSNSSLFKSWRLQCPFGNNDKQESLSSWIPENIKKKECVYFVESSK
TTDR00987	BioChemical Class	Hydrolases acting on acid anhydrides
TTDR00988	UniProt ID	Q9Y210
TTDR00988	Name	Short transient receptor potential channel 6
TTDR00988	Type of target	Research target
TTDR00988	Synonyms	STrpC6
TTDR00988	Synonyms	TRP6
TTDR00988	Disease	Inflammatory diseases
TTDR00988	Function	Thought to form a receptor-activated non-selective calcium permeant cation chann
TTDR00988	Sequence	MSQSPAFGPRRGSSPRGAAGAAARRNESQDYLLMDSELGEDGCPQAPLPCYGYYPCFRGSDNRLAHRRQTVLREKGRRLA
TTDR00988	BioChemical Class	Calcium channel
TTDR00989	UniProt ID	P42898
TTDR00989	Name	mRNA of Methylenetetrahydrofolate reductase
TTDR00989	Type of target	Research target
TTDR00989	Disease	Colon cancer
TTDR00989	Function	Catalyzes the conversion of 5,10- methylenetetrahydrofolate to 5-methyltetrahydr
TTDR00989	Sequence	MVNEARGNSSLNPCLEGSASSGSESSKDSSRCSTPGLDPERHERLREKMRRRLESGDKWFSLEFFPPRTAEGAVNLISRF
TTDR00989	BioChemical Class	Oxidoreductases acting on the CH-NH group of donors
TTDR00989	Pathway	Methane metabolism
TTDR00989	Pathway	One carbon pool by folate
TTDR00989	EC Number	EC 1.5.1.20
TTDR00989	Antisense	677T
TTDR00989	Antisense	EX5
TTDR00990	Name	T cell receptor beta chain
TTDR00990	Type of target	Research target
TTDR00990	Synonyms	TCR beta
TTDR00990	Disease	Acute myelogenous leukemia
TTDR00990	Disease	Aplastic anemia
TTDR00990	Disease	Lymphoma
TTDR00991	UniProt ID	Q02556
TTDR00991	Name	Interferon consensus sequence binding protein
TTDR00991	Type of target	Research target
TTDR00991	Synonyms	ICSBP
TTDR00991	Synonyms	IRF-8
TTDR00991	Disease	Chronic myelogenous leukemia
TTDR00991	Function	Specifically binds to the upstream regulatory region of type i ifn and ifn-induc
TTDR00991	Sequence	MCDRNGGRRLRQWLIEQIDSSMYPGLIWENEEKSMFRIPWKHAGKQDYNQEVDASIFKAWAVFKGKFKEGDKAEPATWKT
TTDR00992	UniProt ID	P12008
TTDR00992	UniProt ID	Q6BQN1
TTDR00992	UniProt ID	Q97Q57
TTDR00992	Name	Chorismate synthase
TTDR00992	Type of target	Research target
TTDR00992	Synonyms	5-enolpyruvylshikimate-3-phosphate phospholyase
TTDR00992	Synonyms	CS
TTDR00992	Disease	Bacterial infections
TTDR00992	Disease	Fungal diseases
TTDR00992	Disease	Parasitic diseases
TTDR00992	Sequence	MAGNTIGQLFRVTTFGESHGLALGCIVDGVPPGIPLTEADLQHDLDRRRPGTSRYTTQRREPDQVKILSGVFEGVTTGTS
TTDR00992	PDB Structure	1QXO
TTDR00992	BioChemical Class	Carbon-oxygen lyases
TTDR00992	Pathway	Metabolic pathways
TTDR00992	Pathway	Phenylalanine, tyrosine and tryptophan biosynthesis
TTDR00992	EC Number	EC 4.2.3.5
TTDR00992	Inhibitor	Cobalt Hexammine Ion
TTDR00992	Inhibitor	Riboflavin Monophosphate
TTDR00993	UniProt ID	Q9H479
TTDR00993	Name	Fructosamine-3-kinase
TTDR00993	Type of target	Research target
TTDR00993	Synonyms	F3K
TTDR00993	Disease	Diabetic complications
TTDR00993	Function	May initiate a process leading to the deglycation of fructoselysine and of glyca
TTDR00993	Sequence	MEQLLRAELRTATLRAFGGPGAGCISEGRAYDTDAGPVFVKVNRRTQARQMFEGEVASLEALRSTGLVRVPRPMKVIDLP
TTDR00993	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00994	UniProt ID	Q9UK79
TTDR00994	Name	Herstatin
TTDR00994	Type of target	Research target
TTDR00994	Synonyms	HER-2
TTDR00994	Synonyms	HER-2/NEU
TTDR00994	Disease	Bladder cancer
TTDR00994	Sequence	MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEV
TTDR00995	UniProt ID	P00354
TTDR00995	Name	Glyceraldehyde 3-phosphate dehydrogenase, muscle
TTDR00995	Type of target	Research target
TTDR00995	Synonyms	D-glyceraldehyde-3-phosphate dehydrogenase
TTDR00995	Synonyms	GAPDH
TTDR00995	Disease	Cancer, unspecific
TTDR00995	Sequence	MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQER
TTDR00995	PDB Structure	1U8F; 1ZNQ; 2FEH; 3GPD
TTDR00995	BioChemical Class	Oxidoreductases acting on the aldehyde or oxo group of donors
TTDR00995	Pathway	Alzheimer's disease
TTDR00995	Pathway	Glycolysis / Gluconeogenesis
TTDR00995	Pathway	Metabolic pathways
TTDR00995	EC Number	EC 1.2.1.12
TTDR00995	Binder	Saframycin A
TTDR00996	UniProt ID	P41732
TTDR00996	Name	Transmembrane 4 superfamily, member 2
TTDR00996	Type of target	Research target
TTDR00996	Synonyms	CD231 antigen
TTDR00996	Synonyms	Cell surface glycoprotein A15
TTDR00996	Synonyms	Membrane component, X chromosome, surface marker 1
TTDR00996	Synonyms	T-cell acute lymphoblastic leukemia associated antigen 1
TTDR00996	Synonyms	T-cell acute lymphoblastic leukemia-associated antigen 1
TTDR00996	Synonyms	TALLA-1
TTDR00996	Disease	Desmoplastic small round-cell tumor
TTDR00996	Sequence	MASRRMETKPVITCLKTLLIIYSFVFWITGVILLAVGVWGKLTLGTYISLIAENSTNAPYVLIGTGTTIVVFGLFGCFAT
TTDR00996	BioChemical Class	Transmembrane protein
TTDR00997	UniProt ID	Q25306
TTDR00997	Name	Guanine nucleotide-binding protein beta subunit-like protein
TTDR00997	Type of target	Research target
TTDR00997	Synonyms	LACK antigen
TTDR00997	Disease	Leishmania infections
TTDR00997	Sequence	MNYEGHLKGHRGWVTSLACPQQAGSYIKVVSTSRDGTVISWKANPDRHSVDSDYGLPNHRLEGHTGFVSCVSLAHATDYA
TTDR00998	UniProt ID	P36897
TTDR00998	Name	TGF-beta receptor type I
TTDR00998	Type of target	Clinical trial target
TTDR00998	Synonyms	ALK-5
TTDR00998	Synonyms	Activin receptor-like kinase 5
TTDR00998	Synonyms	SKR4
TTDR00998	Synonyms	Serine/threonine-protein kinase receptor R4
TTDR00998	Synonyms	TGF-beta type I receptor
TTDR00998	Synonyms	TGFR-1
TTDR00998	Synonyms	TbetaRI
TTDR00998	Synonyms	Type I TGFbeta receptor kinase
TTDR00998	Disease	Cancer, unspecific
TTDR00998	Disease	Fibrosis
TTDR00998	Function	Type i/type ii tgf-beta receptors form an heteromeric complex after binding tgf-
TTDR00998	Sequence	MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPR
TTDR00998	PDB Structure	1B6C; 1IAS; 1PY5; 1RW8; 1TBI; 1VJY; 2L5S; 2PJY; 2WOT; 2WOU; 2X7O; 3FAA; 3GXL; 3H
TTDR00998	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR00998	EC Number	EC 2.7.1.37
TTDR00998	Target Validation	TTDR00998
TTDR00998	Inhibitor	2-phenyl-N-(pyridin-4-yl)quinazolin-4-amine
TTDR00998	Inhibitor	4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline
TTDR00998	Inhibitor	4-Pyridin-2-yl-5-quinolin-2-yl-thiazol-2-ylamine
TTDR00998	Inhibitor	4-Pyridin-2-yl-5-quinolin-4-yl-thiazol-2-ylamine
TTDR00998	Inhibitor	4-Pyridin-3-yl-5-quinolin-4-yl-thiazol-2-ylamine
TTDR00998	Inhibitor	5''-Quinolin-4-yl-[2,4'']bithiazolyl-2''-ylamine
TTDR00998	Inhibitor	GW-788388
TTDR00998	Inhibitor	HTS-466284;LY-364947
TTDR00998	Inhibitor	IN-1130
TTDR00998	Inhibitor	IN-1166
TTDR00998	Inhibitor	Naphthyridine Inhibitor
TTDR00998	Inhibitor	SB-431542
TTDR00998	Inhibitor	SB-505124
TTDR00998	Inhibitor	SB-525334
TTDR00998	Inhibitor	TGF-beta receptor kinase inhibitor
TTDR00999	UniProt ID	P56279
TTDR00999	Name	T-cell leukemia/lymphoma protein 1A
TTDR00999	Type of target	Research target
TTDR00999	Synonyms	P14 TCL1 protein
TTDR00999	Synonyms	T-cell leukemia/lymphoma 1 oncogene
TTDR00999	Synonyms	TCL-1 protein
TTDR00999	Synonyms	TCL1
TTDR00999	Synonyms	TCL1 oncogene
TTDR00999	Disease	Cancer, unspecific
TTDR00999	Sequence	MAECPTLGEAVTDHPDRLWAWEKFVYLDEKQHAWLPLTIEIKDRLQLRVLLRREDVVLGRPMTPTQIGPSLLPIMWQLYP
TTDR00999	PDB Structure	1JSG
TTDR01000	Name	CFP32
TTDR01000	Type of target	Research target
TTDR01000	Disease	Tuberculosis
TTDR01001	UniProt ID	Q92911
TTDR01001	Name	Sodium/iodide cotransporter
TTDR01001	Type of target	Research target
TTDR01001	Synonyms	NIS
TTDR01001	Synonyms	Na(+)/I(-) cotransporter
TTDR01001	Synonyms	Na+/I-symporter
TTDR01001	Synonyms	Sodium-iodide symporter
TTDR01001	Synonyms	Sodium/iodide symporter
TTDR01001	Disease	Cancer, unspecific
TTDR01001	Function	Mediates iodide uptake in the thyroid gland.
TTDR01001	Sequence	MEAVETGERPTFGAWDYGVFALMLLVSTGIGLWVGLARGGQRSAEDFFTGGRRLAALPVGLSLSASFMSAVQVLGVPSEA
TTDR01001	BioChemical Class	Ion transport
TTDR01002	Name	Borna disease virus envelope glycoprotein
TTDR01002	Type of target	Research target
TTDR01002	Synonyms	BDV glycoprotein
TTDR01002	Synonyms	BDV-GP
TTDR01002	Disease	Borna disease
TTDR01003	UniProt ID	P01343
TTDR01003	Name	Insulin-like growth factor IA
TTDR01003	Type of target	Clinical trial target
TTDR01003	Synonyms	IGF-1
TTDR01003	Synonyms	IGF-IA
TTDR01003	Synonyms	Insulin-like growth factor-1
TTDR01003	Synonyms	Somatomedin C
TTDR01003	Disease	Cancer, unspecific
TTDR01003	Function	The insulin-like growth factors, isolated from plasma, are structurally and func
TTDR01003	Sequence	MGKISSLPTQLFKCCFCDFLKVKMHTMSSSHLFYLALCLLTFTSSATAGPETLCGAELVDALQFVCGDRGFYFNKPTGYG
TTDR01003	PDB Structure	1B9G; 1BQT; 1GF1; 1GZR; 1GZY; 1GZZ; 1H02; 1H59; 1IMX; 1PMX; 1TGR; 1WQJ; 2DSP; 2D
TTDR01003	BioChemical Class	Growth factor
TTDR01003	Pathway	Focal adhesion
TTDR01003	Pathway	Glioma
TTDR01003	Pathway	Long-term depression
TTDR01003	Pathway	Melanoma
TTDR01003	Pathway	Pathways in cancer
TTDR01003	Pathway	Prostate cancer
TTDR01003	Pathway	mTOR signaling pathway
TTDR01003	Pathway	p53 signaling pathway
TTDR01003	Related US Patent	6,645,775
TTDR01003	Related US Patent	6,677,305
TTDR01003	Related US Patent	6,680,298
TTDR01003	Drug(s)	MEDI-573
TTDR01003	Antibody	MEDI-573
TTDR01004	UniProt ID	P53396
TTDR01004	Name	ATP-citrate synthase
TTDR01004	Type of target	Research target
TTDR01004	Synonyms	ATP-citrate (pro-S-)-lyase
TTDR01004	Synonyms	ATP-citrate lyase
TTDR01004	Synonyms	Acly
TTDR01004	Synonyms	Citrate cleavage enzyme
TTDR01004	Disease	Hyperlipidemia
TTDR01004	Disease	Obesity
TTDR01004	Function	Atp citrate-lyase is the primary enzyme responsible for the synthesis of cytosol
TTDR01004	Sequence	MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDG
TTDR01004	PDB Structure	3MWD; 3MWE; 3PFF
TTDR01004	BioChemical Class	Acyltransferases
TTDR01004	Pathway	Citrate cycle (TCA cycle)
TTDR01004	Pathway	Metabolic pathways
TTDR01004	Pathway	Reductive carboxylate cycle (CO2 fixation)
TTDR01004	EC Number	EC 2.3.3.8
TTDR01004	Target Validation	TTDR01004
TTDR01004	Inhibitor	(-)-hydroxycitrate
TTDR01004	Inhibitor	(2S,3S)-3-Carboxy-2,3-dihydroxy-pentanedioic acid
TTDR01004	Inhibitor	SB-201076
TTDR01005	UniProt ID	Q99759
TTDR01005	Name	Mitogen-activated protein kinase kinase kinase 3
TTDR01005	Type of target	Research target
TTDR01005	Synonyms	MAPK/ERK kinase kinase 3
TTDR01005	Synonyms	MEK kinase 3
TTDR01005	Synonyms	MEKK 3
TTDR01005	Synonyms	MEKK3
TTDR01005	Disease	Cancer, unspecific
TTDR01005	Function	Preferentially activates p42/44 (erk2/erk1) map kinases.
TTDR01005	Sequence	MDEQEALNSIMNDLVALQMNRRHRMPGYETMKNKDTGHSNRQSDVRIKFEHNGERRIIAFSRPVKYEDVEHKVTTVFGQP
TTDR01005	PDB Structure	2C60; 2JRH; 2O2V; 2PPH
TTDR01005	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01005	Pathway	GnRH signaling pathway
TTDR01005	Pathway	MAPK signaling pathway
TTDR01005	EC Number	EC 2.7.1.-
TTDR01006	UniProt ID	P55211
TTDR01006	Name	Caspase-9
TTDR01006	Type of target	Research target
TTDR01006	Synonyms	APAF-3
TTDR01006	Synonyms	Apoptotic protease Mch-6
TTDR01006	Synonyms	Apoptotic protease activating factor 3
TTDR01006	Synonyms	CASP-9
TTDR01006	Synonyms	ICE-LAP6
TTDR01006	Synonyms	ICE-like apoptotic protease 6
TTDR01006	Disease	Amyotrophic lateral sclerosis
TTDR01006	Disease	Brain injury associated with seizures
TTDR01006	Function	Involved in the activation cascade of caspases responsible for apoptosis executi
TTDR01006	Sequence	MDEADRRLLRRCRLRLVEELQVDQLWDALLSRELFRPHMIEDIQRAGSGSRRDQARQLIIDLETRGSQALPLFISCLEDT
TTDR01006	PDB Structure	1JXQ; 1NW9; 2AR9; 3D9T; 3V3K; 3YGS
TTDR01006	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01006	Pathway	Alzheimer's disease
TTDR01006	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDR01006	Pathway	Apoptosis
TTDR01006	Pathway	Colorectal cancer
TTDR01006	Pathway	Endometrial cancer
TTDR01006	Pathway	Huntington's disease
TTDR01006	Pathway	Non-small cell lung cancer
TTDR01006	Pathway	Pancreatic cancer
TTDR01006	Pathway	Parkinson's disease
TTDR01006	Pathway	Pathways in cancer
TTDR01006	Pathway	Prostate cancer
TTDR01006	Pathway	Small cell lung cancer
TTDR01006	Pathway	VEGF signaling pathway
TTDR01006	Pathway	p53 signaling pathway
TTDR01006	EC Number	EC 3.4.22.-
TTDR01006	Related US Patent	6,632,962
TTDR01006	Inhibitor	Z-LEHD-fmk
TTDR01007	UniProt ID	P14923
TTDR01007	Name	Junction plakoglobin
TTDR01007	Type of target	Research target
TTDR01007	Synonyms	Plakoglobin
TTDR01007	Disease	Fibrosarcoma
TTDR01007	Function	Common junctional plaque protein. The membrane- associated plaques are architect
TTDR01007	Sequence	MEVMNLMEQPIKVTEWQQTYTYDSGIHSGANTCVPSVSSKGIMEEDEACGRQYTLKKTTTYTQGVPPSQGDLEYQMSTTA
TTDR01007	PDB Structure	3IFQ
TTDR01007	Pathway	Acute myeloid leukemia
TTDR01007	Pathway	Pathways in cancer
TTDR01008	UniProt ID	P12830
TTDR01008	Name	Epithelial-cadherin
TTDR01008	Type of target	Research target
TTDR01008	Synonyms	CAM 120/80
TTDR01008	Synonyms	CDH1
TTDR01008	Synonyms	Cadherin-1
TTDR01008	Synonyms	E-cadherin
TTDR01008	Synonyms	E-cadherin gene
TTDR01008	Synonyms	Uvomorulin
TTDR01008	Disease	Gastric cancer
TTDR01008	Function	Cadherins are calcium dependent cell adhesion proteins. They preferentially inte
TTDR01008	Sequence	MGPWSRSLSALLLLLQVSSWLCQEPEPCHPGFDAESYTFTVPRRHLERGRVLGRVNFEDCTGRQRTAYFSLDTRFKVGTD
TTDR01008	PDB Structure	1O6S; 2O72; 2OMT; 2OMU; 2OMV; 2OMX; 2OMY; 2OMZ; 3FF7; 3FF8; 3L6X; 3L6Y
TTDR01008	BioChemical Class	Transmembrane protein
TTDR01008	Pathway	Adherens junction
TTDR01008	Pathway	Bladder cancer
TTDR01008	Pathway	Cell adhesion molecules (CAMs)
TTDR01008	Pathway	Endometrial cancer
TTDR01008	Pathway	Melanoma
TTDR01008	Pathway	Pathogenic Escherichia coli infection
TTDR01008	Pathway	Pathways in cancer
TTDR01008	Pathway	Thyroid cancer
TTDR01010	UniProt ID	Q15726
TTDR01010	Name	Malignant melanoma metastasis-suppressor KiSS-1
TTDR01010	Type of target	Research target
TTDR01010	Synonyms	KiSS-1
TTDR01010	Disease	Human reproductive syndromes
TTDR01010	Function	Metastasis suppressor in malignant melanoma and in some human breast cancers. Ma
TTDR01010	Sequence	MNSLVSWQLLLFLCATHFGEPLEKVASVGNSRPTGQQLESLGLLAPGEQSLPCTERKPAATARLSRRGTSLSPPPESSGS
TTDR01011	UniProt ID	Q7RTX7
TTDR01011	Name	CatSper
TTDR01011	Type of target	Research target
TTDR01011	Synonyms	Putative ion channel CatSper
TTDR01011	Disease	Male infertility (asthenospermia)
TTDR01011	Sequence	MRDNEKAWWQQWTSHTGLEGWGGTQEDRMGFGGAVAALRGRPSPLQSTIHESYGRPEEQVLINRQEITNKADAWDMQEFI
TTDR01011	BioChemical Class	Voltage-gated channel
TTDR01012	UniProt ID	O53579
TTDR01012	Name	Polyketide synthase
TTDR01012	Type of target	Research target
TTDR01012	Synonyms	Pks13
TTDR01012	Disease	Corynebacterineae infections
TTDR01012	Sequence	MADVAESQENAPAERAELTVPEMRQWLRNWVGKAVGKAPDSIDESVPMVELGLSSRDAVAMAADIEDLTGVTLSVAVAFA
TTDR01012	PDB Structure	3TZW; 3TZX; 3TZY; 3TZZ
TTDR01013	UniProt ID	O60450
TTDR01013	Name	PDZ domain containing-protein
TTDR01013	Type of target	Research target
TTDR01013	Synonyms	Multi-PDZ domain containing adaptor protein
TTDR01013	Synonyms	PDZK1
TTDR01013	Disease	Cardiovascular disease, unspecified
TTDR01013	Sequence	MTSTFNPRECKLSKQEGQNYGFFLRIEKDTEGHLVRVVEKCSPAEKAGLQDGDRVLRINGVFVDKEEHMQVVDLVRKSGN
TTDR01013	PDB Structure	2EEI; 2EEJ; 2VSP; 3TMH
TTDR01014	UniProt ID	Q12908
TTDR01014	Name	Ileal sodium/bile acid cotransporter
TTDR01014	Type of target	Research target
TTDR01014	Synonyms	ASBT
TTDR01014	Synonyms	Apical sodium dependent bile acid transporter ASBT/IBAT
TTDR01014	Synonyms	Human ileal bile acid transporter gene ASBT
TTDR01014	Synonyms	ISBT
TTDR01014	Synonyms	Ileal Na(+)/bile acid cotransporter
TTDR01014	Synonyms	Ileal sodium-dependent bile acid transporter
TTDR01014	Synonyms	Na(+) dependent ileal bile acid transporter
TTDR01014	Synonyms	Na+ dependent ileal bile acid transporter
TTDR01014	Synonyms	SLC10A2
TTDR01014	Synonyms	Sodium/taurocholate cotransporting polypeptide, ileal
TTDR01014	Disease	Crohn's disease, unspecified
TTDR01014	Function	Plays a critical role in the sodium-dependent reabsorption of bile acids from th
TTDR01014	Sequence	MNDPNSCVDNATVCSGASCVVPESNFNNILSVVLSTVLTILLALVMFSMGCNVEIKKFLGHIKRPWGICVGFLCQFGIMP
TTDR01014	BioChemical Class	Ion transport
TTDR01014	Related US Patent	6,387,924
TTDR01015	UniProt ID	P13981
TTDR01015	Name	Arginine deiminase
TTDR01015	Type of target	Research target
TTDR01015	Synonyms	AD
TTDR01015	Synonyms	ADI
TTDR01015	Synonyms	Arginine dihydrolase
TTDR01015	Synonyms	L-arginine deiminase
TTDR01015	Disease	Microbial infections
TTDR01015	Disease	Parasitic diseases
TTDR01015	Sequence	MSTEKTKLGVHSEAGKLRKVMVCSPGLAHQRLTPSNCDELLFDDVIWVNQAKRDHFDFVTKMRERGIDVLEMHNLLTETI
TTDR01015	PDB Structure	1RXX; 2A9G; 2AAF; 2ABR; 2ACI
TTDR01015	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDR01015	Pathway	Arginine and proline metabolism
TTDR01015	Pathway	Metabolic pathways
TTDR01015	EC Number	EC 3.5.3.6
TTDR01016	UniProt ID	Q9NG20
TTDR01016	Name	Subtilisin-like protease 2
TTDR01016	Type of target	Research target
TTDR01016	Synonyms	Subtilisin-like protease SUB2
TTDR01016	Disease	Malaria
TTDR01016	Sequence	MLRTFYVLSLMLIEFILHNGQYNKHICSKNSKKYNFVGKKHRILVSDIEDRENHIEGIADIYKPIFNIYEISAEFHKKKN
TTDR01016	BioChemical Class	Protease
TTDR01017	Name	Development and differentiation enhancing factor-like 1
TTDR01017	Type of target	Research target
TTDR01017	Synonyms	130-kDa phosphatidylinositol 4,5-biphosphate-dependent ARF1 GTPase-activating pr
TTDR01017	Synonyms	ADP-ribosylation factor-directed GTPase-activating protein 1
TTDR01017	Synonyms	ARF GTPase-activating protein 1
TTDR01017	Synonyms	DDEFL1
TTDR01017	Synonyms	Development and differentiation-enhancing factor 1
TTDR01017	Synonyms	PIP2-dependent ARF1 GAP
TTDR01017	Synonyms	Q9ULH1
TTDR01017	Disease	Hepatocellular carcinoma
TTDR01018	UniProt ID	P23875
TTDR01018	UniProt ID	Q50452
TTDR01018	Name	Phosphopantetheine adenylyltransferase
TTDR01018	Type of target	Research target
TTDR01018	Synonyms	Dephospho-CoA pyrophosphorylase
TTDR01018	Synonyms	PPAT
TTDR01018	Synonyms	Pantetheine-phosphate adenylyltransferase
TTDR01018	Disease	Bacterial infections
TTDR01018	Function	Reversibly transfers an adenylyl group from atp to 4'- phosphopantetheine, yield
TTDR01018	Sequence	MQKRAIYPGTFDPITNGHIDIVTRATQMFDHVILAIAASPSKKPMFTLEERVALAQQATAHLGNVEVVGFSDLMANFARN
TTDR01018	PDB Structure	1B6T; 1GN8; 1H1T; 1QJC; 1TFU
TTDR01018	EC Number	EC 2.7.7.3
TTDR01018	Inhibitor	2-Methyl-2,4-Pentanediol
TTDR01018	Inhibitor	4'-Phosphopantetheine
TTDR01018	Inhibitor	Adenosine-5'-Diphosphate
TTDR01018	Inhibitor	Coenzyme A
TTDR01018	Inhibitor	Dephospho Coenzyme A
TTDR01019	UniProt ID	P07638
TTDR01019	UniProt ID	P22487
TTDR01019	Name	3-phosphoshikimate 1-carboxyvinyltransferase
TTDR01019	Type of target	Research target
TTDR01019	Synonyms	5-enolpyruvylshikimate-3-phosphate synthase
TTDR01019	Synonyms	EPSP synthase
TTDR01019	Synonyms	EPSPS
TTDR01019	Disease	Microbial infections
TTDR01019	Sequence	MESLTLQPIARVDGTINLPGSKSVSNRALLLAALAHGKTVLTNLLDSDDVRHMLNALTALGVSYTLSADRTRCEIIGNGG
TTDR01019	PDB Structure	2BJB; 2O0B; 2O0D; 2O0E; 2O0X; 2O0Z; 2O15
TTDR01019	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR01019	Pathway	Metabolic pathways
TTDR01019	Pathway	Phenylalanine, tyrosine and tryptophan biosynthesis
TTDR01019	EC Number	EC 2.5.1.19
TTDR01019	Inhibitor	Formic Acid
TTDR01019	Inhibitor	Glyphosate
TTDR01019	Inhibitor	Shikimate-3-Phosphate
TTDR01020	UniProt ID	O53774
TTDR01020	Name	27 kDa antigen Cfp30B
TTDR01020	Type of target	Research target
TTDR01020	Synonyms	32-kDa putative glyoxalase
TTDR01020	Synonyms	CFP32
TTDR01020	Synonyms	Rv0577
TTDR01020	Disease	Tuberculosis
TTDR01020	Sequence	MPKRSEYRQGTPNWVDLQTTDQSAAKKFYTSLFGWGYDDNPVPGGGGVYSMATLNGEAVAAIAPMPPGAPEGMPPIWNTY
TTDR01021	Name	88 kDa glycoprotein growth factor
TTDR01021	Type of target	Research target
TTDR01021	Synonyms	GP88
TTDR01021	Disease	Cancer, unspecific
TTDR01021	Related US Patent	6,670,183
TTDR01022	Name	AMP deaminase
TTDR01022	Type of target	Research target
TTDR01022	Synonyms	AMPDA
TTDR01022	Synonyms	Adenosine monophosphate deaminase
TTDR01022	Disease	Viral infection, unspecified
TTDR01022	EC Number	EC 3.5.4.6
TTDR01022	Related US Patent	6,300,328
TTDR01022	Inhibitor	Coformycin
TTDR01023	Name	Alpha v beta 5 integrin receptor
TTDR01023	Type of target	Research target
TTDR01023	Synonyms	Alpha V beta 5 vitronectin receptor
TTDR01023	Synonyms	Alpha v beta 5 integrin
TTDR01023	Synonyms	Integrin alpha(v) beta(5)
TTDR01023	Disease	Arteriosclerosis
TTDR01023	Disease	Cancer, unspecific
TTDR01023	Disease	Diabetic retinopathy
TTDR01023	Disease	Inflammation
TTDR01023	Disease	Ophthalmic diseases
TTDR01023	Disease	Osteoporosis, unspecified
TTDR01023	Disease	Restenosis
TTDR01023	Related US Patent	6,232,308
TTDR01023	Related US Patent	6,268,378
TTDR01023	Related US Patent	6,274,620
TTDR01023	Related US Patent	6,344,484
TTDR01023	Related US Patent	6,358,970
TTDR01023	Related US Patent	6,407,241
TTDR01023	Related US Patent	6,410,526
TTDR01023	Related US Patent	6,413,955
TTDR01023	Related US Patent	6,472,403
TTDR01023	Related US Patent	6,486,174
TTDR01023	Related US Patent	6,495,545
TTDR01023	Related US Patent	6,531,494
TTDR01023	Related US Patent	6,545,029
TTDR01023	Related US Patent	6,589,972
TTDR01023	Related US Patent	6,630,488
TTDR01023	Related US Patent	6,677,360
TTDR01023	Antagonist	Cilengitide
TTDR01024	Name	Anandamide amidase
TTDR01024	Type of target	Research target
TTDR01024	Synonyms	Anandamide synthase
TTDR01024	Synonyms	Arachidonylethanolamide synthase
TTDR01024	Disease	Analgesics
TTDR01024	Disease	Pain
TTDR01024	EC Number	EC 3.5.1.4
TTDR01024	Related US Patent	6,579,900
TTDR01025	UniProt ID	P10997
TTDR01025	Name	Islet amyloid polypeptide
TTDR01025	Type of target	Research target
TTDR01025	Synonyms	Amylin
TTDR01025	Synonyms	DAP
TTDR01025	Synonyms	Diabetes-associated peptide
TTDR01025	Synonyms	Insulinoma amyloid peptide
TTDR01025	Disease	Noninsulin-dependent diabetes mellitus
TTDR01025	Function	Selectively inhibits insulin-stimulated glucose utilization and glycogen deposit
TTDR01025	Sequence	MGILKLQVFLIVLSVALNHLKATPIESHQVEKRKCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTYGKRNAVEVLK
TTDR01025	PDB Structure	1KUW; 2G48; 2KB8; 2L86; 3FPO; 3FR1; 3FTH; 3FTK; 3FTL; 3FTR; 3G7V; 3G7W; 3HGZ
TTDR01025	Pathway	Maturity onset diabetes of the young
TTDR01025	Related US Patent	6,417,164
TTDR01026	Name	Angiotensin-(1-7) receptor
TTDR01026	Type of target	Research target
TTDR01026	Disease	Angina pectoris
TTDR01026	Disease	Cardiac hypertrophy
TTDR01026	Disease	Cardiac insufficiency
TTDR01026	Disease	Coronary heart disease
TTDR01026	Disease	Hypertension
TTDR01026	Related US Patent	6,235,766
TTDR01026	Related US Patent	6,429,222
TTDR01026	Related US Patent	6,538,144
TTDR01027	UniProt ID	P15917
TTDR01027	Name	Lethal factor
TTDR01027	Type of target	Research target
TTDR01027	Synonyms	ALF
TTDR01027	Synonyms	Anthrax lethal factor
TTDR01027	Synonyms	Anthrax lethal toxin endopeptidase component
TTDR01027	Synonyms	LF
TTDR01027	Disease	Anthrax infection
TTDR01027	Function	One of the three proteins composing the anthrax toxin, the agent which infects m
TTDR01027	Sequence	MNIKKEFIKVISMSCLVTAITLSGPVFIPLVQGAGGHGDVGMHVKEKEKNKDENKRKDEERNKTQEEHLKEIMKHIVKIE
TTDR01027	PDB Structure	1J7N; 1JKY; 1PWP; 1PWQ; 1PWU; 1PWV; 1PWW; 1YQY; 1ZXV; 2L0R; 3KWV; 4DV8
TTDR01027	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01027	EC Number	EC 3.4.24.83
TTDR01027	Related US Patent	6,436,933
TTDR01027	Target Validation	TTDR01027
TTDR01027	Inhibitor	3-(2,5-dimethyl-1H-pyrrol-1-yl)benzoic acid
TTDR01027	Inhibitor	CGS-27023A
TTDR01027	Inhibitor	GF-109203
TTDR01027	Inhibitor	GM6001
TTDR01027	Inhibitor	GNF-PF-600
TTDR01027	Inhibitor	N,N'-Bis(4-Amino-2-Methylquinolin-6-Yl)Urea
TTDR01027	Inhibitor	N,N-Dimethylsphingosine
TTDR01027	Inhibitor	N-(3,4,5-trihydroxyphenethyl)oleamide
TTDR01027	Inhibitor	N-(3,4-dihydroxybenzyl)oleamide
TTDR01027	Inhibitor	N-(Sulfanylacetyl)Tyrosylprolylmethioninamide
TTDR01027	Inhibitor	N-hydroxy-4-(2-oleamidoethyl)benzamide
TTDR01027	Inhibitor	N-hydroxy-4-(oleamidomethyl)benzamide
TTDR01027	Inhibitor	N-oleoyl-dopamine
TTDR01027	Inhibitor	NSC-622445
TTDR01028	UniProt ID	O15382
TTDR01028	UniProt ID	P54687
TTDR01028	Name	Branched chain amino acid-dependent aminotransferase
TTDR01028	Type of target	Research target
TTDR01028	Synonyms	BCAT
TTDR01028	Synonyms	BCAT(c)
TTDR01028	Synonyms	BCAT(m)
TTDR01028	Synonyms	Branched-chain amino acid aminotransferase
TTDR01028	Synonyms	ECA39 protein
TTDR01028	Synonyms	PP18
TTDR01028	Synonyms	Placental protein 18
TTDR01028	Disease	Anxiety disorder, unspecified
TTDR01028	Disease	Cerebral ischemia
TTDR01028	Disease	Hypoglycemia
TTDR01028	Disease	Stroke
TTDR01028	Sequence	MAAAALGQIWARKLLSVPWLLCGPRRYASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKTFTDHMLMVEWNDKGWGQPRI
TTDR01028	PDB Structure	2ABJ; 2COG; 2COI; 2COJ
TTDR01028	BioChemical Class	Transferases transferring nitrogenous groups
TTDR01028	Pathway	Metabolic pathways
TTDR01028	Pathway	Pantothenate and CoA biosynthesis
TTDR01028	Pathway	Valine, leucine and isoleucine biosynthesis
TTDR01028	Pathway	Valine, leucine and isoleucine degradation
TTDR01028	EC Number	EC 2.6.1.42
TTDR01028	Related US Patent	6,632,831
TTDR01028	Target Validation	TTDR01028
TTDR01028	Inhibitor	Alpha-ketoisovalerate
TTDR01028	Inhibitor	N'-(phenylsulfonyl)benzofuran-2-carbohydrazide
TTDR01028	Inhibitor	N'-(phenylsulfonyl)quinoline-6-carbohydrazide
TTDR01028	Inhibitor	N-[O-Phosphono-Pyridoxyl]-Isoleucine
TTDR01028	Inhibitor	Pyridoxamine-5'-Phosphate
TTDR01029	Name	CAMP-specific 3',5'-cyclic phosphodiesterase 7
TTDR01029	Type of target	Research target
TTDR01029	Synonyms	PDE-7
TTDR01029	Synonyms	PDE-VII
TTDR01029	Synonyms	PDE7
TTDR01029	Synonyms	Phosphosdiesterase-7
TTDR01029	Disease	Allergy, unspecified
TTDR01029	Disease	Asthma
TTDR01029	Disease	Inflammatory bowel disease
TTDR01029	Disease	Multiple sclerosis
TTDR01029	Disease	Osteoporosis, unspecified
TTDR01029	Disease	Psoriasis
TTDR01029	Disease	Rheumatoid arthritis, unspecified
TTDR01029	EC Number	EC 3.1.4.17
TTDR01029	Related US Patent	6,531,498
TTDR01029	Related US Patent	6,613,778
TTDR01029	Related US Patent	6,617,357
TTDR01029	Related US Patent	6,753,340
TTDR01030	UniProt ID	P16870
TTDR01030	Name	Carboxypeptidase H
TTDR01030	Type of target	Research target
TTDR01030	Synonyms	CPE
TTDR01030	Synonyms	CPH
TTDR01030	Synonyms	Carboxypeptidase E
TTDR01030	Synonyms	Enkephalin convertase
TTDR01030	Synonyms	Prohormone processing carboxypeptidase
TTDR01030	Disease	Cognitive deficits
TTDR01030	Disease	Neurological diseases
TTDR01030	Function	Removes residual c-terminal arg or lys remaining after initial endoprotease clea
TTDR01030	Sequence	MAGRGGSALLALCGALAACGWLLGAEAQEPGAPAAGMRRRRRLQQEDGISFEYHRYPELREALVSVWLQCTAISRIYTVG
TTDR01030	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01030	Pathway	Type I diabetes mellitus
TTDR01030	EC Number	EC 3.4.17.10
TTDR01030	Related US Patent	6,489,319
TTDR01031	UniProt ID	P07711
TTDR01031	Name	Cathepsin L
TTDR01031	Type of target	Research target
TTDR01031	Synonyms	MEP
TTDR01031	Synonyms	Major excreted protein
TTDR01031	Disease	Autoimmune diseases
TTDR01031	Disease	Melanoma
TTDR01031	Function	Important for the overall degradation of proteins in lysosomes.
TTDR01031	Sequence	MNPTLILAAFCLGIASATLTFDHSLEAQWTKWKAMHNRLYGMNEEGWRRAVWEKNMKMIELHNQEYREGKHSFTMAMNAF
TTDR01031	PDB Structure	1CJL; 1CS8; 1ICF; 1MHW; 2NQD; 2VHS; 2XU1; 2XU3; 2XU4; 2XU5; 2YJ2; 2YJ8; 2YJ9; 2Y
TTDR01031	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01031	Pathway	Antigen processing and presentation
TTDR01031	Pathway	Lysosome
TTDR01031	EC Number	EC 3.4.22.15
TTDR01031	Related US Patent	6,313,119
TTDR01031	Related US Patent	6,420,364
TTDR01031	Related US Patent	6,436,925
TTDR01031	Related US Patent	6,455,502
TTDR01031	Related US Patent	6,476,026
TTDR01031	Related US Patent	6,492,362
TTDR01031	Related US Patent	6,525,036
TTDR01031	Related US Patent	6,525,052
TTDR01031	Related US Patent	6,576,630
TTDR01031	Related US Patent	6,593,327
TTDR01031	Related US Patent	6,608,057
TTDR01031	Related US Patent	6,635,621
TTDR01031	Related US Patent	6,649,642
TTDR01031	Target Validation	TTDR01031
TTDR01031	Inhibitor	(3-Bromobenzoylpyridine)thiosemicarbazone
TTDR01031	Inhibitor	(S)-1-benzylcyclopentyl 1-oxohexan-2-ylcarbamate
TTDR01031	Inhibitor	(S)-tert-butyl 1-oxohexan-2-ylcarbamate
TTDR01031	Inhibitor	1-(1,3-diphenylpropylidene)thiosemicarbazide
TTDR01031	Inhibitor	1-(phenyl(p-tolyl)methylene)thiosemicarbazide
TTDR01031	Inhibitor	6-(benzylamino)-9-butyl-9H-purine-2-carbonitrile
TTDR01031	Inhibitor	9-benzyl-6-(benzylamino)-9H-purine-2-carbonitrile
TTDR01031	Inhibitor	BIPHENYL-4-YL-ACETALDEHYDE
TTDR01031	Inhibitor	BOCEPREVIR
TTDR01031	Inhibitor	Bis(3-Fluorophenyl)-ketone]thiosemicarbazone
TTDR01031	Inhibitor	Bis(3-bromophenyl)(4-hydroxy)thiosemicarbazone
TTDR01031	Inhibitor	Bis(3-bromophenyl)(5-hydroxy)thiosemicarbazone
TTDR01031	Inhibitor	Cysteinesulfonic Acid
TTDR01031	Inhibitor	L-006235-1
TTDR01031	Inhibitor	L-873724
TTDR01031	Inhibitor	MDL-2170;MDL-28170
TTDR01031	Inhibitor	N-(4-phenylbenzoyl)-phenylalanyl-glycine-nitrile
TTDR01031	Inhibitor	N-(benzyloxycarbonyl)-leucyl-glycine-nitrile
TTDR01031	Inhibitor	N-(tert-butoxycarbonyl)-isoleucyl-glycine-nitrile
TTDR01031	Inhibitor	N-(tert-butoxycarbonyl)-leucyl-glycine-nitrile
TTDR01031	Inhibitor	N-(tert-butoxycarbonyl)-methionyl-glycine-nitrile
TTDR01031	Inhibitor	N-(tert-butoxycarbonyl)-norleucyl-glycine-nitrile
TTDR01031	Inhibitor	N-(tert-butoxycarbonyl)-tyrosyl-glycine-nitrile
TTDR01031	Inhibitor	N-(tert-butoxycarbonyl)-valyl-glycine-nitrile
TTDR01031	Inhibitor	N-acetyl-phenylalanyl-glycine-nitrile
TTDR01031	Inhibitor	N-benzoyl-phenylalanyl-glycine-nitrile
TTDR01031	Inhibitor	PEPSTATIN A
TTDR01031	Inhibitor	[(3-Bromophenyl)-m-tolyl-ketone]thiosemicarbazone
TTDR01031	Inhibitor	[(3-Bromophenyl)-p-tolyl-ketone]thiosemicarbazone
TTDR01031	Inhibitor	[2-Phenylacetophenone]thiosemicarbazone
TTDR01032	UniProt ID	Q9UBX1
TTDR01032	Name	Cathepsin F
TTDR01032	Type of target	Research target
TTDR01032	Synonyms	CATSF
TTDR01032	Disease	Autoimmune diseases
TTDR01032	Function	Thiol protease which is believed to participate in intracellular degradation and
TTDR01032	Sequence	MAPWLQLLSLLGLLPGAVAAPAQPRAASFQAWGPPSPELLAPTRFALEMFNRGRAAGTRAVLGLVRGRVRRAGQGSLYSL
TTDR01032	PDB Structure	1D5U; 1M6D
TTDR01032	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01032	Pathway	Lysosome
TTDR01032	EC Number	EC 3.4.22.41
TTDR01032	Related US Patent	6,313,119
TTDR01032	Related US Patent	6,420,364
TTDR01032	Related US Patent	6,492,362
TTDR01032	Related US Patent	6,525,052
TTDR01032	Related US Patent	6,608,057
TTDR01032	Related US Patent	6,635,621
TTDR01032	Related US Patent	6,649,642
TTDR01032	Target Validation	TTDR01032
TTDR01032	Inhibitor	BENZOYL-TYROSINE-ALANINE-METHYL KETONE
TTDR01032	Inhibitor	BOCEPREVIR
TTDR01032	Inhibitor	Benzoyl-Arginine-Alanine-Methyl Ketone
TTDR01032	Inhibitor	HOMOPHENYLALANINYLMETHANE
TTDR01032	Inhibitor	WRR-112
TTDR01032	Inhibitor	WRR-99
TTDR01033	UniProt ID	P29144
TTDR01033	Name	Tripeptidyl-peptidase II
TTDR01033	Type of target	Clinical trial target
TTDR01033	Synonyms	CCK-inactivating peptidase tripeptidyl peptidase
TTDR01033	Synonyms	TPP II
TTDR01033	Synonyms	TPP-II
TTDR01033	Synonyms	Tripeptidyl aminopeptidase
TTDR01033	Disease	Eating disorders
TTDR01033	Disease	Obesity
TTDR01033	Disease	Psychiatric illness
TTDR01033	Sequence	MATAATEEPFPFHGLLPKKETGAASFLCRYPEYDGRGVLIAVLDTGVDPGAPGMQVTTDGKPKIVDIIDTTGSGDVNTAT
TTDR01033	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01033	EC Number	EC 3.4.14.10
TTDR01033	Related US Patent	6,335,360
TTDR01033	Target Validation	TTDR01033
TTDR01033	Drug(s)	UCL-2000 and butabindide
TTDR01033	Inhibitor	(2S)-aminobutyryl-(R)-pipecolinic acid amide
TTDR01033	Inhibitor	(2S)-aminobutyryl-L-prolinamide
TTDR01033	Inhibitor	(2S)-aminobutyryl-L-proline (R)-sec-butylamide
TTDR01033	Inhibitor	(2S)-aminobutyryl-L-proline isobutylamide
TTDR01033	Inhibitor	(2S)-aminobutyryl-L-proline n-butylamide
TTDR01033	Inhibitor	(2S)-aminobutyryl-L-proline n-pentylamide
TTDR01033	Inhibitor	(2S)-aminobutyryl-L-proline n-propylamide
TTDR01033	Inhibitor	(2S)-aminobutyryl-L-proline-(2S)-methylbutylamide
TTDR01033	Inhibitor	L-isoleucyl-L-prolinamide
TTDR01033	Inhibitor	L-leucyl-L-prolinamide
TTDR01033	Inhibitor	L-norleucyl-L-prolinamide
TTDR01033	Inhibitor	L-norvalyl-L-prolinamide
TTDR01033	Inhibitor	L-valyl-L-prolinamide
TTDR01033	Inhibitor	L-valyl-L-proline benzylamide
TTDR01033	Inhibitor	L-valyl-L-proline hexylamide
TTDR01033	Inhibitor	UCL-2000 and butabindide
TTDR01033	Inhibitor	alpha-methylalanyl-L-proline butylamide
TTDR01033	Multitarget	UCL-2000 and butabindide
TTDR01034	Name	Chlorine/potassium channel receptor
TTDR01034	Type of target	Research target
TTDR01034	Disease	Erythema
TTDR01034	Disease	Pruritus
TTDR01034	Disease	Skin itching
TTDR01034	Related US Patent	6,572,848
TTDR01035	UniProt ID	P13497
TTDR01035	Name	Bone morphogenetic protein 1
TTDR01035	Type of target	Research target
TTDR01035	Synonyms	BMP-1
TTDR01035	Synonyms	MTld
TTDR01035	Synonyms	Mammalian tolloid protein
TTDR01035	Synonyms	PCP
TTDR01035	Synonyms	Procollagen C-proteinase
TTDR01035	Disease	Fibrotic disease
TTDR01035	Function	Cleaves the c-terminal propeptides of procollagen i, ii and iii. Induces cartila
TTDR01035	Sequence	MPGVARLPLLLGLLLLPRPGRPLDLADYTYDLAEEDDSEPLNYKDPCKAAAFLGDIALDEEDLRAFQVQQAVDLRRHTAR
TTDR01035	PDB Structure	3EDG; 3EDH
TTDR01035	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01035	EC Number	EC 3.4.24.19
TTDR01035	Related US Patent	6,448,278
TTDR01035	Related US Patent	6,462,063
TTDR01035	Related US Patent	6,645,993
TTDR01035	Target Validation	TTDR01035
TTDR01035	Inhibitor	UK-383367
TTDR01036	Name	Creatine kinase
TTDR01036	Type of target	Research target
TTDR01036	Synonyms	Mitochondrial creatine kinase
TTDR01036	Disease	Angina pectoris
TTDR01036	Disease	Atherosclerosis
TTDR01036	Disease	Coronary atherosclerosis
TTDR01036	Disease	Myocardial infarction
TTDR01036	Disease	Stroke
TTDR01036	Disease	Thrombocytopenia
TTDR01036	Disease	Thrombosis
TTDR01036	EC Number	EC 2.7.3.2
TTDR01036	Related US Patent	6,444,695
TTDR01036	Inhibitor	5-(4'-benzoylbiphenyl-4-yl)-2-furoic acid
TTDR01036	Inhibitor	Iodoacetamide
TTDR01038	Name	Amiloride-sensitive sodium channel
TTDR01038	Type of target	Research target
TTDR01038	Synonyms	ENaC
TTDR01038	Synonyms	Epithelial Na+ channel
TTDR01038	Synonyms	Epithelial sodium channel
TTDR01038	Disease	Hypertension
TTDR01038	Related US Patent	6,586,416
TTDR01039	UniProt ID	Q02790
TTDR01039	Name	FK506-binding protein 4
TTDR01039	Type of target	Research target
TTDR01039	Synonyms	52 kDa FK506 binding protein
TTDR01039	Synonyms	FKBP-52
TTDR01039	Synonyms	FKBP52 protein
TTDR01039	Synonyms	FKBP59
TTDR01039	Synonyms	HBI
TTDR01039	Synonyms	HSP binding immunophilin
TTDR01039	Synonyms	P59 protein
TTDR01039	Synonyms	PPIase
TTDR01039	Synonyms	Peptidyl-prolyl cis-trans isomerase
TTDR01039	Synonyms	Rotamase
TTDR01039	Disease	Neurological diseases
TTDR01039	Function	Component of unactivated mammalian steroid receptor complexes that sediment at 8
TTDR01039	Sequence	MTAEEMKATESGAQSAPLPMEGVDISPKQDEGVLKVIKREGTGTEMPMIGDRVFVHYTGWLLDGTKFDSSLDRKDKFSFD
TTDR01039	PDB Structure	1N1A; 1P5Q; 1Q1C; 1QZ2; 4DRJ
TTDR01039	BioChemical Class	Cis-trans-Isomerases
TTDR01039	EC Number	EC 5.2.1.8
TTDR01039	Related US Patent	6,562,964
TTDR01041	Name	Fructosamine oxidase
TTDR01041	Type of target	Research target
TTDR01041	Disease	Diabetes mellitus
TTDR01041	Related US Patent	6,348,465
TTDR01041	Related US Patent	6,610,693
TTDR01042	UniProt ID	P31644
TTDR01042	Name	Gamma-aminobutyric-acid receptor alpha-5 subunit
TTDR01042	Type of target	Clinical trial target
TTDR01042	Synonyms	GABA-A alpha-5
TTDR01042	Synonyms	GABAA alpha 5
TTDR01042	Disease	Alzheimer's Disease
TTDR01042	Disease	Central nervous system diseases
TTDR01042	Disease	Cognitive deficits
TTDR01042	Disease	Delirium
TTDR01042	Disease	Dementia
TTDR01042	Function	Gaba, the major inhibitory neurotransmitter in the vertebrate brain, mediates ne
TTDR01042	Sequence	MDNGMFSGFIMIKNLLLFCISMNLSSHFGFSQMPTSSVKDETNDNITIFTRILDGLLDGYDNRLRPGLGERITQVRTDIY
TTDR01042	BioChemical Class	Chloride channel
TTDR01042	Pathway	Neuroactive ligand-receptor interaction
TTDR01042	Related US Patent	6,455,552
TTDR01042	Related US Patent	6,534,505
TTDR01042	Target Validation	TTDR01042
TTDR01042	Inhibitor	(2E,4S)-4-ammoniopent-2-enoate
TTDR01042	Inhibitor	(4R)-4-ammoniopentanoate
TTDR01042	Inhibitor	(4S)-4-ammoniopentanoate
TTDR01042	Inhibitor	3-(benzyloxy)-9H-pyrido[3,4-b]indole
TTDR01042	Inhibitor	3-(hexa-1,3-dienyloxy)-9H-pyrido[3,4-b]indole
TTDR01042	Inhibitor	3-(isopentyloxy)-9H-pyrido[3,4-b]indole
TTDR01042	Inhibitor	3-butoxy-9H-pyrido[3,4-b]indole
TTDR01042	Inhibitor	3-ethoxy-9H-pyrido[3,4-b]indole
TTDR01042	Inhibitor	3-isobutoxy-9H-pyrido[3,4-b]indole
TTDR01042	Inhibitor	3-propoxy-9H-pyrido[3,4-b]indole
TTDR01042	Inhibitor	5-[(1R)-1-ammonioethyl]isoxazol-3-olate
TTDR01042	Inhibitor	5-[(1S)-1-ammonioethyl]isoxazol-3-olate
TTDR01042	Inhibitor	AMENTOFLAVONE
TTDR01042	Inhibitor	Barbital
TTDR01042	Inhibitor	Barbituric acid derivative
TTDR01042	Inhibitor	CI-218872
TTDR01042	Inhibitor	Ethyl 9H-pyrido[3,4-b]indole-3-carboxylate
TTDR01042	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDR01042	Inhibitor	L-655708;NCGC00025115-02
TTDR01042	Inhibitor	Ro-151310
TTDR01042	Inhibitor	Ro-154513
TTDR01042	Inhibitor	Ro-4882224
TTDR01042	Inhibitor	Ro-4938581
TTDR01042	Inhibitor	TPA-023
TTDR01042	Inhibitor	beta-Carboline-3-carboxylic acid t-butyl ester
TTDR01042	Inhibitor	ethyl 6-iodo-9H-pyrido[3,4-b]indole-3-carboxylate
TTDR01042	Inhibitor	sec-butyl 9H-pyrido[3,4-b]indole-3-carboxylate
TTDR01044	UniProt ID	O43603
TTDR01044	Name	Galanin receptor type 2
TTDR01044	Type of target	Research target
TTDR01044	Synonyms	GAL2-R
TTDR01044	Synonyms	GALR2
TTDR01044	Disease	Alzheimer's disease
TTDR01044	Disease	Central nervous system diseases
TTDR01044	Disease	Cerebral hemorrhage
TTDR01044	Disease	Diabetes mellitus
TTDR01044	Disease	Diarrhea
TTDR01044	Disease	Eating disorders
TTDR01044	Disease	Obesity
TTDR01044	Function	Receptor for the hormone galanin and for galp. The activity of this receptor is
TTDR01044	Sequence	MNVSGCPGAGNASQAGGGGGWHPEAVIVPLLFALIFLVGTVGNTLVLAVLLRGGQAVSTTNLFILNLGVADLCFILCCVP
TTDR01044	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01044	Pathway	Neuroactive ligand-receptor interaction
TTDR01044	Related US Patent	6,407,136
TTDR01044	Target Validation	TTDR01044
TTDR01044	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-MPEG4)K
TTDR01044	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-decanoyl)K
TTDR01044	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-lauroyl)K
TTDR01044	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-myristoyl)K
TTDR01044	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-octanoyl)K
TTDR01044	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-palmitoyl)K
TTDR01044	Inhibitor	(Sar)WTLNSAGYLLGPKK(Lys-stearoyl)K
TTDR01044	Inhibitor	(Sar)WTLNSAGYLLGPKKKK
TTDR01044	Inhibitor	GALANIN
TTDR01044	Inhibitor	GALANTIDE
TTDR01044	Inhibitor	GWTLNSAGYLLGPHAV-NH2
TTDR01044	Inhibitor	GWTLNSAGYLLGPPPALALA-CONH2
TTDR01044	Inhibitor	GWTLNSAGYLLGPPPGFSPFR-CONH2
TTDR01044	Inhibitor	GWTLNSAGYLLGPRHYINLITRQRY-CONH2
TTDR01044	Inhibitor	GWTLNSAGYLLGPrPKPQQwFwLL-CONH2
TTDR01044	Inhibitor	Gal-B5
TTDR01044	Inhibitor	GalB2
TTDR01044	Inhibitor	GwTLNSAGYLLGPHAVGNHRSFSDKNGLTS-CONH2
TTDR01044	Inhibitor	WTLNSAGYLL-CONH2
TTDR01044	Inhibitor	WTLNSAGYLLGPHAVGNHPSFSDKNGLTS-CONH2
TTDR01044	Inhibitor	[N-Ac,des-Sar]Gal-B2
TTDR01044	Inhibitor	[N-Me,des-Sar]Gal-B2
TTDR01044	Inhibitor	[Sar1Ala]GAL-B2
TTDR01044	Inhibitor	[Sar1Gly]GAL-B2
TTDR01045	UniProt ID	O60755
TTDR01045	Name	Galanin receptor type 3
TTDR01045	Type of target	Research target
TTDR01045	Synonyms	GAL3-R
TTDR01045	Synonyms	GALR3
TTDR01045	Disease	Central nervous system diseases
TTDR01045	Disease	Eating disorders
TTDR01045	Disease	Obesity
TTDR01045	Function	Receptor for the hormone galanin.
TTDR01045	Sequence	MADAQNISLDSPGSVGAVAVPVVFALIFLLGTVGNGLVLAVLLQPGPSAWQEPGSTTDLFILNLAVADLCFILCCVPFQA
TTDR01045	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01045	Pathway	Neuroactive ligand-receptor interaction
TTDR01045	Related US Patent	6,407,136
TTDR01045	Target Validation	TTDR01045
TTDR01045	Inhibitor	(E)-3-(2,3-dichlorophenylimino)indolin-2-one
TTDR01045	Inhibitor	(E)-3-(4-chlorophenylimino)indolin-2-one
TTDR01048	UniProt ID	P01241
TTDR01048	Name	Somatotropin
TTDR01048	Type of target	Research target
TTDR01048	Synonyms	GH
TTDR01048	Synonyms	GH-N
TTDR01048	Synonyms	Growth hormone
TTDR01048	Synonyms	Growth hormone 1
TTDR01048	Synonyms	Pituitary growth hormone
TTDR01048	Disease	Nutritional disorders
TTDR01048	Disease	Skin diseases
TTDR01048	Function	Plays an important role in growth control. Its major role in stimulating body gr
TTDR01048	Sequence	MATGSRTSLLLAFGLLCLPWLQEGSAFPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCF
TTDR01048	PDB Structure	1A22; 1AXI; 1BP3; 1HGU; 1HUW; 1HWG; 1HWH; 1KF9; 3HHR
TTDR01048	Pathway	Cytokine-cytokine receptor interaction
TTDR01048	Pathway	Jak-STAT signaling pathway
TTDR01048	Pathway	Neuroactive ligand-receptor interaction
TTDR01048	Related US Patent	6,495,589
TTDR01049	Name	HIV-2 Protease
TTDR01049	Type of target	Research target
TTDR01049	Synonyms	HIV-2 Retropepsin
TTDR01049	Disease	Human immunodeficiency virus [HIV] disease
TTDR01049	EC Number	EC 3.4.23.47
TTDR01049	Related US Patent	6,455,587
TTDR01049	Related US Patent	6,506,786
TTDR01049	Related US Patent	6,528,532
TTDR01049	Related US Patent	6,608,100
TTDR01049	Related US Patent	6,610,689
TTDR01049	Related US Patent	6,613,743
TTDR01049	Related US Patent	6,613,764
TTDR01049	Related US Patent	6,617,350
TTDR01049	Related US Patent	6,632,816
TTDR01049	Related US Patent	6,673,821
TTDR01049	Related US Patent	6,677,367
TTDR01050	Name	HNEAA81 receptor
TTDR01050	Type of target	Research target
TTDR01050	Disease	Arthritis
TTDR01050	Disease	Cancer, unspecific
TTDR01050	Disease	Inflammation
TTDR01050	Disease	Ophthalmic diseases
TTDR01050	Related US Patent	6,358,695
TTDR01051	Name	Human rhinovirus 3C protease
TTDR01051	Type of target	Research target
TTDR01051	Synonyms	P3C
TTDR01051	Synonyms	Picornain 3C
TTDR01051	Synonyms	Protease 3C
TTDR01051	Disease	Human rhinovirus infection
TTDR01051	EC Number	EC 3.4.22.28
TTDR01051	Related US Patent	6,369,226
TTDR01052	Name	Homocitrate synthase
TTDR01052	Type of target	Research target
TTDR01052	Synonyms	2-hydroxybutane-1,2,4-tricarboxylate 2-oxoglutarate-lyase (CoA-acetylating)
TTDR01052	Synonyms	Acetyl-coenzyme A:2-ketoglutarate C-acetyl transferase
TTDR01052	Synonyms	Homocitrate synthetase
TTDR01052	Disease	Fungal diseases
TTDR01052	EC Number	EC 2.3.3.14
TTDR01052	Related US Patent	6,632,631
TTDR01053	Name	Insulin receptor kinase
TTDR01053	Type of target	Research target
TTDR01053	Synonyms	Insulin receptor tyrosine kinase
TTDR01053	Disease	Diabetes mellitus
TTDR01053	Disease	Hyperglycemia
TTDR01053	Disease	Hypertriglyceridemia
TTDR01053	Disease	Insulin resistance
TTDR01053	Disease	Ketoacidosis
TTDR01053	Disease	Lipodystrophy
TTDR01053	Related US Patent	6,528,037
TTDR01054	Name	Integrin receptor
TTDR01054	Type of target	Research target
TTDR01054	Disease	Arteriosclerosis
TTDR01054	Disease	Cardiac infarction
TTDR01054	Disease	Circulatory disorders
TTDR01054	Disease	Coronary heart disease
TTDR01054	Disease	Inflammatory diseases
TTDR01054	Disease	Osteoporosis, unspecified
TTDR01054	Disease	Skeletal disorders
TTDR01054	Disease	Thrombosis
TTDR01054	Related US Patent	6,326,403
TTDR01054	Related US Patent	6,444,680
TTDR01054	Related US Patent	6,552,079
TTDR01054	Related US Patent	6,610,826
TTDR01056	UniProt ID	O43614
TTDR01056	Name	Orexin receptor type 2
TTDR01056	Type of target	Research target
TTDR01056	Synonyms	HFGANP
TTDR01056	Synonyms	Hypocretin receptor type 2
TTDR01056	Synonyms	Orexin-2 receptor
TTDR01056	Synonyms	Ox2r
TTDR01056	Disease	Gastrointestinal motility disorders
TTDR01056	Disease	Nausea and vomiting
TTDR01056	Function	Nonselective, high-affinity receptor for both orexin-a and orexin-b neuropeptide
TTDR01056	Sequence	MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVW
TTDR01056	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01056	Pathway	Neuroactive ligand-receptor interaction
TTDR01056	Related US Patent	6,506,774
TTDR01056	Target Validation	TTDR01056
TTDR01056	Inhibitor	MK-4305
TTDR01057	UniProt ID	Q13751
TTDR01057	Name	Laminin beta-3 chain
TTDR01057	Type of target	Research target
TTDR01057	Synonyms	Kalinin B1 chain
TTDR01057	Synonyms	Laminin 5 beta 3
TTDR01057	Synonyms	Laminin B1k chain
TTDR01057	Synonyms	Laminin5beta3
TTDR01057	Disease	Cancer, unspecific
TTDR01057	Function	Binding to cells via a high affinity receptor, laminin is thought to mediate the
TTDR01057	Sequence	MRPFFLLCFALPGLLHAQQACSRGACYPPVGDLLVGRTRFLRASSTCGLTKPETYCTQYGEWQMKCCKCDSRQPHNYYSH
TTDR01057	Pathway	ECM-receptor interaction
TTDR01057	Pathway	Focal adhesion
TTDR01057	Pathway	Pathways in cancer
TTDR01057	Pathway	Small cell lung cancer
TTDR01057	Related US Patent	6,586,244
TTDR01059	UniProt ID	P21757
TTDR01059	Name	Macrophage scavenger receptor types I and II
TTDR01059	Type of target	Research target
TTDR01059	Synonyms	CD204 antigen
TTDR01059	Synonyms	Macrophage acetylated LDL receptor I and II
TTDR01059	Synonyms	Macrophage scavenger receptor
TTDR01059	Disease	Cardiovascular disease, unspecified
TTDR01059	Function	Membrane glycoproteins implicated in the pathologic deposition of cholesterol in
TTDR01059	Sequence	MEQWDHFHNQQEDTDSCSESVKFDARSMTALLPPNPKNSPSLQEKLKSFKAALIALYLLVFAVLIPLIGIVAAQLLKWET
TTDR01059	BioChemical Class	Transmembrane protein
TTDR01059	Related US Patent	6,255,298
TTDR01059	Related US Patent	6,458,845
TTDR01059	Inhibitor	Sodium; 2,4-bis-docosanoylamino-benzenesulfonate
TTDR01061	Name	Metabotropic glutamate receptor
TTDR01061	Type of target	Research target
TTDR01061	Synonyms	MGluR
TTDR01061	Disease	Alzheimer's disease
TTDR01061	Disease	Cognitive deficits
TTDR01061	Disease	Neurodegenerative diseases
TTDR01061	Disease	Neurological diseases
TTDR01061	Disease	Psychosis
TTDR01061	Disease	Schizophrenia
TTDR01061	Related US Patent	6,268,366
TTDR01061	Related US Patent	6,369,222
TTDR01061	Related US Patent	6,399,641
TTDR01061	Related US Patent	6,407,094
TTDR01061	Related US Patent	6,429,207
TTDR01061	Related US Patent	6,479,470
TTDR01061	Related US Patent	6,509,328
TTDR01061	Related US Patent	6,599,902
TTDR01061	Target Validation	TTDR01061
TTDR01061	Inhibitor	2S,4R-4-METHYLGLUTAMATE
TTDR01061	Inhibitor	Ethyl 2-amino-4,5-diphenylthiophene-3-carboxylate
TTDR01061	Inhibitor	QUISQUALATE
TTDR01062	UniProt ID	O14731
TTDR01062	Name	Membrane-associated kinase
TTDR01062	Type of target	Research target
TTDR01062	Synonyms	Myt1 kinase
TTDR01062	Disease	Cancer, unspecific
TTDR01062	Disease	Hyperproliferative disorders
TTDR01062	Sequence	MLERPPALAMPMPTEGTPPPLSGTPIPVPAYFRHAEPGFSLKRPRGLSRSLPPPPPAKGSIPISRLFPPRTPGWHQLQPR
TTDR01062	PDB Structure	3P1A
TTDR01062	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01062	Pathway	Cell cycle
TTDR01062	Related US Patent	6,391,894
TTDR01062	Related US Patent	6,448,272
TTDR01063	UniProt ID	P56192
TTDR01063	Name	Methionyl-tRNA synthetase
TTDR01063	Type of target	Research target
TTDR01063	Synonyms	MRS
TTDR01063	Synonyms	MetRS
TTDR01063	Synonyms	Methionine translase
TTDR01063	Synonyms	Methionine--tRNA ligase
TTDR01063	Synonyms	Methionine-tRNA ligase
TTDR01063	Synonyms	Methionyl t-RNA synthetase
TTDR01063	Synonyms	Methionyl-transfer RNA synthetase
TTDR01063	Synonyms	Methionyl-transfer ribonucleate synthetase
TTDR01063	Synonyms	Methionyl-transfer ribonucleic acid synthetase
TTDR01063	Disease	Bacterial infections
TTDR01063	Sequence	MRLFVSDGVPGCLPVLAAAGRARGRAEVLISTVGPEDCVVPFLTRPKVPVLQLDSGNYLFSTSAICRYFFLLSGWEQDDL
TTDR01063	PDB Structure	2DJV; 4BJV; 4BJW
TTDR01063	BioChemical Class	Ligases forming carbon-oxygen bonds
TTDR01063	Pathway	Aminoacyl-tRNA biosynthesis
TTDR01063	Pathway	Methionine metabolism
TTDR01063	Pathway	Selenoamino acid metabolism
TTDR01063	EC Number	EC 6.1.1.10
TTDR01063	Related US Patent	6,320,051
TTDR01063	Inhibitor	5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine
TTDR01063	Inhibitor	Difluoromethionine
TTDR01063	Inhibitor	Methionine Phosphinate
TTDR01063	Inhibitor	Methionine Phosphonate
TTDR01063	Inhibitor	Trifluoromethionine
TTDR01064	Name	Multidrug transporter
TTDR01064	Type of target	Research target
TTDR01064	Disease	Bacterial and fungal resistance
TTDR01064	Disease	Cancer, unspecific
TTDR01064	Related US Patent	6,362,229
TTDR01065	UniProt ID	Q9Y3Q0
TTDR01065	Name	N-acetylated-alpha-linked acidic dipeptidase II
TTDR01065	Type of target	Research target
TTDR01065	Synonyms	NAALAD2
TTDR01065	Synonyms	NAALADase II
TTDR01065	Disease	Cancer, unspecific
TTDR01065	Disease	Compulsive disorders
TTDR01065	Disease	Diabetic neuropathy
TTDR01065	Disease	Glaucoma
TTDR01065	Disease	Ischemia
TTDR01065	Disease	Prostate diseases
TTDR01065	Disease	Stroke
TTDR01065	Function	Has n-acetylated-alpha-linked-acidic dipeptidase (naaladase) activity. Also exhi
TTDR01065	Sequence	MAESRGRLYLWMCLAAALASFLMGFMVGWFIKPLKETTTSVRYHQSIRWKLVSEMKAENIKSFLRSFTKLPHLAGTEQNF
TTDR01065	PDB Structure	3FEC; 3FED; 3FEE; 3FF3
TTDR01065	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01065	EC Number	EC 3.4.17.21
TTDR01065	Related US Patent	6,376,478
TTDR01065	Related US Patent	6,479,470
TTDR01065	Related US Patent	6,528,499
TTDR01065	Related US Patent	6,586,623
TTDR01066	UniProt ID	P20916
TTDR01066	Name	Myelin-associated glycoprotein
TTDR01066	Type of target	Clinical trial target
TTDR01066	Synonyms	MAG
TTDR01066	Disease	Injury to nervous tissue or neurons
TTDR01066	Disease	Neurodegenerative diseases
TTDR01066	Function	Adhesion molecule in postnatal neural development that mediates sialic-acid depe
TTDR01066	Sequence	MIFLTALPLFWIMISASRGGHWGAWMPSSISAFEGTCVSIPCRFDFPDELRPAVVHGVWYFNSPYPKNYPPVVFKSRTQV
TTDR01066	BioChemical Class	Transmembrane protein
TTDR01066	Pathway	Cell adhesion molecules (CAMs)
TTDR01066	Related US Patent	6,399,577
TTDR01067	UniProt ID	O60906
TTDR01067	Name	Sphingomyelin phosphodiesterase 2
TTDR01067	Type of target	Research target
TTDR01067	Synonyms	Lyso-PAF-PLC
TTDR01067	Synonyms	Lyso-platelet activating factor-phospholipase C
TTDR01067	Synonyms	N-SMase
TTDR01067	Synonyms	NSMase
TTDR01067	Synonyms	Neutral sphingomyelinase
TTDR01067	Disease	Cancer, unspecific
TTDR01067	Disease	Inflammatory diseases
TTDR01067	Disease	Neurodegenerative diseases
TTDR01067	Function	Converts sphingomyelin to ceramide. Hydrolyze 1-acyl-2- lyso-sn-glycero-3-phosph
TTDR01067	Sequence	MKPNFSLRLRIFNLNCWGIPYLSKHRADRMRRLGDFLNQESFDLALLEEVWSEQDFQYLRQKLSPTYPAAHHFRSGIIGS
TTDR01067	BioChemical Class	Hydrolases acting on ester bonds
TTDR01067	Pathway	Metabolic pathways
TTDR01067	Pathway	Sphingolipid metabolism
TTDR01067	EC Number	EC 3.1.4.12
TTDR01067	Related US Patent	6,306,911
TTDR01068	Name	mRNA of PAI-1
TTDR01068	Type of target	Research target
TTDR01068	Disease	Angiitis
TTDR01068	Disease	Cirrhosis
TTDR01068	Disease	Glomerulonephritis
TTDR01068	Disease	Glomerulosclerosis
TTDR01068	Disease	Heart failure
TTDR01068	Disease	Interstitial fibrosis
TTDR01068	Disease	Pulmonary fibrosis
TTDR01068	Related US Patent	6,333,408
TTDR01068	siRNA	PAI-1 specific siRNA
TTDR01069	Name	Prostaglandin receptor
TTDR01069	Type of target	Research target
TTDR01069	Disease	Bone disorders
TTDR01069	Disease	Osteoporosis, unspecified
TTDR01069	Related US Patent	6,492,412
TTDR01069	Related US Patent	6,649,657
TTDR01070	Name	Geranylgeranyl transferase type I beta subunit
TTDR01070	Type of target	Research target
TTDR01070	Synonyms	GGTase-I-beta
TTDR01070	Synonyms	Type I protein geranyl-geranyltransferase beta subunit
TTDR01070	Disease	Myeloma disease
TTDR01070	Function	Catalyzes the transfer of a geranyl-geranyl moiety from geranyl-geranyl pyrophos
TTDR01070	EC Number	EC 2.5.1.59
TTDR01070	Target Validation	TTDR01070
TTDR01070	Inhibitor	A-313326
TTDR01070	Inhibitor	BMS-214662
TTDR01070	Inhibitor	L-745631
TTDR01070	Inhibitor	L-778123
TTDR01070	Inhibitor	PD-83176
TTDR01072	UniProt ID	Q12770
TTDR01072	Name	Sterol regulatory element binding protein cleavage-activating protein
TTDR01072	Type of target	Research target
TTDR01072	Synonyms	SCAP
TTDR01072	Synonyms	SREBP cleavage-activating protein
TTDR01072	Synonyms	SREBP-cleavage activating protein
TTDR01072	Disease	Atherosclerosis
TTDR01072	Disease	Coronary heart disease
TTDR01072	Disease	Hypercholesterolemia
TTDR01072	Disease	Hyperlipidemia
TTDR01072	Disease	Hyperlipoproteinemia
TTDR01072	Disease	Noninsulin-dependent diabetes mellitus
TTDR01072	Disease	Obesity
TTDR01072	Function	Sterol sensor. Necessary for the proteolytic activation of srebps by site-1 prot
TTDR01072	Sequence	MTLTERLREKISRAFYNHGLLCASYPIPIILFTGFCILACCYPLLKLPLPGTGPVEFTTPVKDYSPPPVDSDRKQGEPTE
TTDR01072	BioChemical Class	Transmembrane protein
TTDR01072	Related US Patent	6,673,555
TTDR01073	UniProt ID	P19793
TTDR01073	Name	Retinoic acid receptor RXR-alpha
TTDR01073	Type of target	Research target
TTDR01073	Synonyms	RXRalpha
TTDR01073	Disease	Prostate cancer
TTDR01073	Function	Nuclear hormone receptor. Involved in retinoic acid response pathway. Binds 9-ci
TTDR01073	Sequence	MDTKHFLPLDFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVP
TTDR01073	PDB Structure	1BY4; 1DSZ; 1FBY; 1FM6; 1FM9; 1G1U; 1G5Y; 1K74; 1LBD; 1MV9; 1MVC; 1MZN; 1R0N; 1R
TTDR01073	BioChemical Class	Zinc-finger
TTDR01073	Pathway	Adipocytokine signaling pathway
TTDR01073	Pathway	Non-small cell lung cancer
TTDR01073	Pathway	PPAR signaling pathway
TTDR01073	Pathway	Pathways in cancer
TTDR01073	Pathway	Small cell lung cancer
TTDR01073	Pathway	Thyroid cancer
TTDR01073	Target Validation	TTDR01073
TTDR01073	Inhibitor	(5BETA)-PREGNANE-3,20-DIONE
TTDR01073	Inhibitor	2-chloro-5-nitro-N-phenylbenzamide
TTDR01073	Inhibitor	AGN-34
TTDR01073	Inhibitor	tributylstannanyl
TTDR01074	Name	Retinoic acid receptor RXR-beta
TTDR01074	Type of target	Research target
TTDR01074	Disease	Breast fibrocystic disease and cancer
TTDR01074	Function	Involved in retinoic acid response pathway. Binds 9-cis retinoic acid (9c-ra).
TTDR01074	Target Validation	TTDR01074
TTDR01074	Inhibitor	AGN-34
TTDR01075	UniProt ID	P48443
TTDR01075	Name	Retinoic acid receptor RXR-gamma
TTDR01075	Type of target	Research target
TTDR01075	Disease	Cancer, unspecific
TTDR01075	Function	Involved in retinoic acid response pathway. Binds 9-cis retinoic acid (9c-ra).
TTDR01075	Sequence	MYGNYSHFMKFPAGYGGSPGHTGSTSMSPSAALSTGKPMDSHPSYTDTPVSAPRTLSAVGTPLNALGSPYRVITSAMGPP
TTDR01075	PDB Structure	2GL8
TTDR01075	BioChemical Class	Zinc-finger
TTDR01075	Target Validation	TTDR01075
TTDR01075	Inhibitor	AGN-34
TTDR01076	UniProt ID	P49356
TTDR01076	Name	Protein farnesyltransferase beta subunit
TTDR01076	Type of target	Research target
TTDR01076	Synonyms	CAAX farnesyltransferase beta subunit
TTDR01076	Synonyms	FTase-beta
TTDR01076	Synonyms	RAS proteins prenyltransferase beta
TTDR01076	Disease	Cancer, unspecific
TTDR01076	Function	Catalyzes the transfer of a farnesyl moiety from farnesyl pyrophosphate to a cys
TTDR01076	Sequence	MASPSSFTYYCPPSSSPVWSEPLYSLRPEHARERLQDDSVETVTSIEQAKVEEKIQEVFSSYKFNHLVPRLVLQREKHFH
TTDR01076	PDB Structure	1JCQ; 1LD7; 1LD8; 1MZC; 1S63; 1SA4; 1TN6; 2F0Y; 2H6F; 2H6G; 2H6H; 2H6I; 2IEJ; 3E
TTDR01076	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR01076	EC Number	EC 2.5.1.58
TTDR01076	Target Validation	TTDR01076
TTDR01076	Inhibitor	(Z)-2-Methyl-3-tetradecyl-but-2-enedioic acid
TTDR01076	Inhibitor	A-313326
TTDR01076	Inhibitor	ABT-839
TTDR01076	Inhibitor	ACTINOPLANIC ACID A
TTDR01076	Inhibitor	ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID
TTDR01076	Inhibitor	ARTEMINOLIDE
TTDR01076	Inhibitor	BMS-214662
TTDR01076	Inhibitor	BMS-316810
TTDR01076	Inhibitor	BMS-404683
TTDR01076	Inhibitor	CLAVARINONE
TTDR01076	Inhibitor	CYLINDROL A
TTDR01076	Inhibitor	FARNESYL
TTDR01076	Inhibitor	FARNESYL DIPHOSPHATE
TTDR01076	Inhibitor	FUSIDIENOL
TTDR01076	Inhibitor	GERANYLGERANYL DIPHOSPHATE
TTDR01076	Inhibitor	H-SMGLPCVVM-OH
TTDR01076	Inhibitor	L-731735
TTDR01076	Inhibitor	L-739749
TTDR01076	Inhibitor	L-739750
TTDR01076	Inhibitor	L-745631
TTDR01076	Inhibitor	L-778123
TTDR01076	Inhibitor	MANUMYCIN A
TTDR01076	Inhibitor	PB-27
TTDR01076	Inhibitor	PB-80
TTDR01076	Inhibitor	PB-81
TTDR01076	Inhibitor	PD-83176
TTDR01076	Inhibitor	PREUSSOMERIN
TTDR01076	Inhibitor	Prenyl pyrophosphate analogue
TTDR01076	Inhibitor	Pseudopeptide derivative
TTDR01076	Inhibitor	RPR-113829
TTDR01076	Inhibitor	RPR-114334
TTDR01076	Inhibitor	SCH-44342
TTDR01077	Name	Retinoic acid receptor gamma-1
TTDR01077	Type of target	Research target
TTDR01077	Disease	Breast fibrocystic disease and cancer
TTDR01077	Function	This is a receptor for retinoic acid. This metabolite has profound effects on ve
TTDR01077	Inhibitor	BMS184394
TTDR01077	Inhibitor	CD564
TTDR01077	Inhibitor	Dodecyl-Alpha-D-Maltoside
TTDR01077	Inhibitor	SR11254
TTDR01078	Name	Retinoic acid receptor gamma-2
TTDR01078	Type of target	Research target
TTDR01078	Disease	Breast fibrocystic disease and cancer
TTDR01078	Function	This is a receptor for retinoic acid. This metabolite has profound effects on ve
TTDR01079	Name	Pyruvate kinase
TTDR01079	Type of target	Research target
TTDR01079	Disease	Alzheimer's disease
TTDR01079	Disease	Cancer, unspecific
TTDR01079	Disease	Tumors
TTDR01079	EC Number	EC 2.7.1.40
TTDR01079	Related US Patent	6,534,501
TTDR01080	Name	Serine/threonine protein kinase
TTDR01080	Type of target	Research target
TTDR01080	Disease	Alzheimer's disease
TTDR01080	Disease	Atherosclerosis
TTDR01080	Disease	Cancer, unspecific
TTDR01080	Disease	Diabetes mellitus
TTDR01080	EC Number	EC 2.7.1.-
TTDR01080	Related US Patent	6,498,176
TTDR01080	Related US Patent	6,653,308
TTDR01081	Name	Protein kinase
TTDR01081	Type of target	Research target
TTDR01081	Disease	Cancer, unspecific
TTDR01081	Disease	Colonic polyps
TTDR01081	Disease	Osteoporosis, unspecified
TTDR01081	Disease	Polycystic kidney disease
TTDR01081	Related US Patent	6,514,972
TTDR01081	Related US Patent	6,521,618
TTDR01081	Related US Patent	6,573,293
TTDR01081	Related US Patent	6,610,688
TTDR01081	Related US Patent	6,638,929
TTDR01082	Name	Phenyl-protein transferase
TTDR01082	Type of target	Research target
TTDR01082	Disease	Cancer, unspecific
TTDR01082	Related US Patent	6,333,335
TTDR01082	Related US Patent	6,350,755
TTDR01082	Related US Patent	6,358,956
TTDR01082	Related US Patent	6,380,228
TTDR01082	Related US Patent	6,387,903
TTDR01082	Related US Patent	6,413,964
TTDR01082	Related US Patent	6,441,017
TTDR01082	Related US Patent	6,525,074
TTDR01082	Related US Patent	6,534,506
TTDR01082	Related US Patent	6,562,823
TTDR01082	Related US Patent	6,566,385
TTDR01082	Related US Patent	6,610,722
TTDR01083	UniProt ID	Q9UW83
TTDR01083	Name	Pyridoxin biosynthesis protein pyroA
TTDR01083	Type of target	Research target
TTDR01083	Synonyms	Pdx1 homolog
TTDR01083	Disease	Bacterial infections
TTDR01083	Sequence	MAATNGASNDFTVKAGLAQMLKGGVIMDVVNAEQARIAEEAGAAAVMALERVPADIRAQGGVARMSDPSMIKEIMEAVTI
TTDR01083	Pathway	Vitamin B6 metabolism
TTDR01084	UniProt ID	Q03148
TTDR01084	Name	Pyridoxin biosynthesis protein SNZ1
TTDR01084	Type of target	Research target
TTDR01084	Synonyms	P35
TTDR01084	Synonyms	PDX1 homolog 1
TTDR01084	Disease	Bacterial infections
TTDR01084	Function	May be involved in growth arrest and cellular response to nutrient limitation.
TTDR01084	Sequence	MTGEDFKIKSGLAQMLKGGVIMDVVTPEQAKIAEKSGACAVMALESIPADMRKSGKVCRMSDPKMIKDIMNSVSIPVMAK
TTDR01084	PDB Structure	3FEM; 3O05; 3O06; 3O07
TTDR01084	Pathway	Vitamin B6 metabolism
TTDR01085	UniProt ID	P47669
TTDR01085	UniProt ID	P56196
TTDR01085	UniProt ID	P75167
TTDR01085	Name	2,3-bisphosphoglycerate-independent phosphoglycerate mutase
TTDR01085	Type of target	Research target
TTDR01085	Synonyms	BPG-independent PGAM
TTDR01085	Synonyms	IPGM
TTDR01085	Synonyms	Phosphoglycerate mutase
TTDR01085	Synonyms	Phosphoglyceromutase
TTDR01085	Disease	Bacterial infections
TTDR01085	Function	Catalyzes the interconversion of 2-phosphoglycerate and 3-phosphoglycerate (by s
TTDR01085	Sequence	MHKKVLLAILDGYGISNAIYGNAVQNANTPMLDELINSYPCVLLDASGEAVGLPMGQIGNSEVGHLNIGAGRVVYTGLSL
TTDR01085	PDB Structure	1LNO
TTDR01085	BioChemical Class	Intramolecular transferases
TTDR01085	Pathway	Glycolysis / Gluconeogenesis
TTDR01085	Pathway	Metabolic pathways
TTDR01085	EC Number	EC 5.4.2.1
TTDR01085	Inhibitor	2-Phosphoglyceric Acid
TTDR01085	Inhibitor	3-Phosphoglyceric Acid
TTDR01085	Inhibitor	Clorsulon
TTDR01086	UniProt ID	P56070
TTDR01086	Name	Phosphoenolpyruvate synthase
TTDR01086	Type of target	Research target
TTDR01086	Synonyms	PEP synthase
TTDR01086	Synonyms	Pyruvate, water dikinase
TTDR01086	Synonyms	Pyruvate,water dikinase
TTDR01086	Disease	Bacterial infections
TTDR01086	Sequence	MRYIKFFKELNNKNVNLVGGKNASIGEMFQELVPIGIKVPDGFAITSEAYWYLLEQGGAKQKIIELLENVDATEIDVLKI
TTDR01086	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01086	Pathway	Metabolic pathways
TTDR01086	Pathway	Pyruvate metabolism
TTDR01086	Pathway	Reductive carboxylate cycle (CO2 fixation)
TTDR01086	EC Number	EC 2.7.9.2
TTDR01087	UniProt ID	O83650
TTDR01087	UniProt ID	Q9ZDF8
TTDR01087	Name	Lysyl-tRNA synthetase
TTDR01087	Type of target	Research target
TTDR01087	Synonyms	LysRS
TTDR01087	Synonyms	Lysine--tRNA ligase
TTDR01087	Disease	Bacterial infections
TTDR01087	Sequence	MSICEKSLHWADKVAHKIIKERADCDQYTCASGITPSGTVHIGNFREIISVDLVVRALRDQGKSVRFVHSWDDYDVFRRI
TTDR01087	BioChemical Class	Ligases forming carbon-oxygen bonds
TTDR01087	Pathway	Aminoacyl-tRNA biosynthesis
TTDR01087	EC Number	EC 6.1.1.6
TTDR01088	UniProt ID	Q39002
TTDR01088	UniProt ID	Q6MDZ0
TTDR01088	UniProt ID	Q8WH67
TTDR01088	Name	ATP/ADP translocase
TTDR01088	Type of target	Research target
TTDR01088	Synonyms	AATP1
TTDR01088	Disease	Bacterial infections
TTDR01088	Sequence	MEAVIQTRGLLSLPTKPIGVRSQLQPSHGLKQRLFAAKPRNLHGLSLSFNGHKKFQTFEPTLHGISISHKERSTEFICKA
TTDR01088	BioChemical Class	Transmembrane protein
TTDR01089	UniProt ID	P77898
TTDR01089	Name	Orotidine 5'-phosphate decarboxylase
TTDR01089	Type of target	Research target
TTDR01089	Synonyms	OMP decarboxylase
TTDR01089	Synonyms	OMPDCase
TTDR01089	Synonyms	OMPdecase
TTDR01089	Disease	Bacterial infections
TTDR01089	Sequence	MTGFGLRLAEAKARRGPLCLGIDPHPELLRGWDLATTADGLAAFCDICVRAFADFAVVKPQVAFFESYGAAGFAVLERTI
TTDR01089	EC Number	EC 4.1.1.23
TTDR01089	Target Validation	TTDR01089
TTDR01089	Inhibitor	6-Hydroxyuridine-5'-Phosphate
TTDR01089	Inhibitor	6-amino-uridine monophosphate
TTDR01089	Inhibitor	6-aza-uridine monophosphate
TTDR01089	Inhibitor	Uridine-5'-Monophosphate
TTDR01089	Inhibitor	xanthosine-5'-monophosphate disodium salt
TTDR01090	UniProt ID	O84620
TTDR01090	Name	Probable dihydroneopterin aldolase
TTDR01090	Type of target	Research target
TTDR01090	Synonyms	DHNA
TTDR01090	Synonyms	DhnA-type aldolase
TTDR01090	Disease	Bacterial infections
TTDR01090	Function	Catalyzes the conversion of 7,8-dihydroneopterin to 6- hydroxymethyl-7,8-dihydro
TTDR01090	Sequence	MLLYRLDIADFRVWVSIGVSEQERHYPQPVLVSLSLFFKEEPKACSTDKVSDSVCYAELVSLIEEVATNNPCALIERLAK
TTDR01090	BioChemical Class	Carbon-carbon lyases
TTDR01090	Pathway	Folate biosynthesis
TTDR01090	Pathway	Metabolic pathways
TTDR01090	EC Number	EC 4.1.2.25
TTDR01091	Name	ATP/ADP translocase
TTDR01091	Type of target	Research target
TTDR01091	Disease	Bacterial infections
TTDR01092	Name	ATP/ADP translocase
TTDR01092	Type of target	Research target
TTDR01092	Disease	Bacterial infections
TTDR01093	Name	mRNA of beta-arrestin
TTDR01093	Type of target	Research target
TTDR01093	Disease	Analgesics
TTDR01093	Disease	Neuropathic pain
TTDR01093	Antisense	Antisense oligonucleotides targeting beta-arrestin
TTDR01094	Name	mRNA of c-fos
TTDR01094	Type of target	Research target
TTDR01094	Disease	Clutamate neurotoxicity
TTDR01094	Antisense	ISIS 10639
TTDR01094	Antisense	c-fos antisense oligonucleotide
TTDR01095	Name	mRNA of CIRL-1
TTDR01095	Type of target	Research target
TTDR01095	Disease	Oxidative cell injury
TTDR01095	Antisense	Antisense oligonucleotides complementary to CIRL-1 mRNA
TTDR01096	Name	mRNA of CIRL-3
TTDR01096	Type of target	Research target
TTDR01096	Disease	Oxidative cell injury
TTDR01096	Antisense	Antisense oligonucleotides complementary to CIRL-3 mRNA
TTDR01097	Name	mRNA of Connexin 32
TTDR01097	Type of target	Research target
TTDR01097	Disease	Oxidative cell injury
TTDR01097	siRNA	sc-43076
TTDR01097	siRNA	sc-43077
TTDR01098	Name	mRNA of APP
TTDR01098	Type of target	Research target
TTDR01098	Disease	Alzheimer's disease
TTDR01098	Antisense	APP antisense oligonucleotides
TTDR01100	UniProt ID	Q9UBC3
TTDR01100	Name	DNA (cytosine-5)-methyltransferase 3B
TTDR01100	Type of target	Research target
TTDR01100	Synonyms	DNA MTase HsaIIIB
TTDR01100	Synonyms	DNA methyltransferase 3B
TTDR01100	Synonyms	DNA methyltransferase HsaIIIB
TTDR01100	Synonyms	Dnmt3b
TTDR01100	Synonyms	M.HsaIIIB
TTDR01100	Disease	Breast cancer
TTDR01100	Function	Required for genome wide de novo methylation and is essential for development. I
TTDR01100	Sequence	MKGDTRHLNGEEDAGGREDSILVNGACSDQSSDSPPILEAIRTPEIRGRRSSSRLSKREVSSLLSYTQDLTGDGDGEDGD
TTDR01100	PDB Structure	3FLG; 3QKJ
TTDR01100	BioChemical Class	Transferases transferring one-carbon groups
TTDR01100	Pathway	Metabolic pathways
TTDR01100	Pathway	Methionine metabolism
TTDR01100	EC Number	EC 2.1.1.37
TTDR01100	Target Validation	TTDR01100
TTDR01100	Inhibitor	(L-)-S-adenosyl-L-homocysteine
TTDR01100	Inhibitor	CURCUMIN
TTDR01100	Inhibitor	NSC-106084
TTDR01100	Inhibitor	NSC-137546
TTDR01100	Inhibitor	NSC-138419
TTDR01100	Inhibitor	NSC-154957
TTDR01100	Inhibitor	NSC-158324
TTDR01100	Inhibitor	NSC-319745
TTDR01100	Inhibitor	NSC-345763
TTDR01100	Inhibitor	NSC-348926
TTDR01100	Inhibitor	NSC-401077
TTDR01100	Inhibitor	NSC-54162
TTDR01100	Inhibitor	NSC-56071
TTDR01100	Inhibitor	NSC-57893
TTDR01100	Inhibitor	NSC-622444
TTDR01100	Inhibitor	NSC-622445
TTDR01100	Inhibitor	NSC-623548
TTDR01100	Inhibitor	S-Adenosylhomocysteine
TTDR01100	Inhibitor	S-tubercidinylhomocysteine
TTDR01101	UniProt ID	P01589
TTDR01101	Name	Interleukin-2 receptor alpha chain
TTDR01101	Type of target	Research target
TTDR01101	Synonyms	CD25 antigen
TTDR01101	Synonyms	IL-2 receptor alpha subunit
TTDR01101	Synonyms	P55
TTDR01101	Synonyms	TAC antigen
TTDR01101	Disease	Acute allograft rejection
TTDR01101	Function	Receptor for interleukin-2.
TTDR01101	Sequence	MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEGTMLNCECKRGFRRIKSGSLYMLCTGNSSHSSWDNQC
TTDR01101	PDB Structure	1ILM; 1ILN; 1Z92; 2B5I; 2ERJ; 3IU3; 3NFP
TTDR01101	BioChemical Class	Transmembrane protein
TTDR01101	Pathway	Cytokine-cytokine receptor interaction
TTDR01101	Pathway	Hematopoietic cell lineage
TTDR01101	Pathway	Jak-STAT signaling pathway
TTDR01101	Target Validation	TTDR01101
TTDR01101	Inhibitor	SP-4206
TTDR01102	UniProt ID	P08373
TTDR01102	UniProt ID	P61431
TTDR01102	Name	UDP-N-acetylenolpyruvylglucosamine reductase
TTDR01102	Type of target	Research target
TTDR01102	Synonyms	MurB
TTDR01102	Synonyms	UDP-N-acetylmuramate dehydrogenase
TTDR01102	Disease	Bacterial infections
TTDR01102	Function	Cell wall formation.
TTDR01102	Sequence	MNHSLKPWNTFGIDHNAQHIVCAEDEQQLLNAWQYATAEGQPVLILGEGSNVLFLEDYRGTVIINRIKGIEIHDEPDAWY
TTDR01102	PDB Structure	1HSK
TTDR01102	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR01102	Pathway	Amino sugar and nucleotide sugar metabolism
TTDR01102	Pathway	Aminosugars metabolism
TTDR01102	Pathway	Metabolic pathways
TTDR01102	EC Number	EC 1.1.1.158
TTDR01102	Inhibitor	Flavin-Adenine Dinucleotide
TTDR01103	UniProt ID	Q00613
TTDR01103	Name	Heat shock factor protein 1
TTDR01103	Type of target	Research target
TTDR01103	Synonyms	HSF 1
TTDR01103	Synonyms	HSF1
TTDR01103	Synonyms	HSTF 1
TTDR01103	Synonyms	Heat shock transcription factor 1
TTDR01103	Disease	Disease pathogenesis associated with abnormal ubiquitin-dependent proteasome fun
TTDR01103	Function	Dna-binding protein that specifically binds heat shock promoter elements (hse) a
TTDR01103	Sequence	MDLPVGPGAAGPSNVPAFLTKLWTLVSDPDTDALICWSPSGNSFHVFDQGQFAKEVLPKYFKHNNMASFVRQLNMYGFRK
TTDR01103	PDB Structure	2LDU
TTDR01104	UniProt ID	Q99665
TTDR01104	Name	Interleukin-12 receptor beta-2 chain
TTDR01104	Type of target	Research target
TTDR01104	Synonyms	IL-12 receptor beta-2
TTDR01104	Synonyms	IL-12R beta 2
TTDR01104	Synonyms	IL-12R-beta2
TTDR01104	Disease	Redirection of ongoing Th cell responses
TTDR01104	Function	Involved in il12 transduction. Binds to il12 with a low affinity.
TTDR01104	Sequence	MAHTFRGCSLAFMFIITWLLIKAKIDACKRGDVTVKPSHVILLGSTVNITCSLKPRQGCFHYSRRNKLILYKFDRRINFH
TTDR01104	BioChemical Class	Transmembrane protein
TTDR01104	Pathway	Cytokine-cytokine receptor interaction
TTDR01104	Pathway	Jak-STAT signaling pathway
TTDR01104	Related US Patent	6,338,848
TTDR01105	UniProt ID	P55075
TTDR01105	Name	Fibroblast growth factor-8
TTDR01105	Type of target	Research target
TTDR01105	Synonyms	AIGF
TTDR01105	Synonyms	Androgen-induced growth factor
TTDR01105	Synonyms	FGF-8
TTDR01105	Synonyms	HBGF-8
TTDR01105	Disease	Alzheimer's disease
TTDR01105	Disease	Amyotrophic lateral sclerosis
TTDR01105	Disease	Neuropathy
TTDR01105	Disease	Parkinson's disease
TTDR01105	Disease	Shionogi carcinoma
TTDR01105	Disease	Tumors (androgen sensitive)
TTDR01105	Function	Stimulates growth of the cells in an autocrine manner. Mediates hormonal action
TTDR01105	Sequence	MGSPRSALSCLLLHLLVLCLQAQEGPGRGPALGRELASLFRAGREPQGVSQQHVREQSLVTDQLSRRLIRTYQLYSRTSG
TTDR01105	PDB Structure	2FDB
TTDR01105	BioChemical Class	Growth factor
TTDR01105	Related US Patent	6,485,920
TTDR01106	UniProt ID	P51587
TTDR01106	Name	Breast cancer type 2 susceptibility protein
TTDR01106	Type of target	Research target
TTDR01106	Synonyms	BRCA2
TTDR01106	Disease	Breast cancer
TTDR01106	Disease	Ovarian cancer
TTDR01106	Function	May participate in a pathway associated with the activation of double-strand bre
TTDR01106	Sequence	MPIGSKERPTFFEIFKTRCNKADLGPISLNWFEELSSEAPPYNSEPAEESEHKNNNYEPNLFKTPQRKPSYNQLASTPII
TTDR01106	PDB Structure	1N0W; 3EU7
TTDR01106	BioChemical Class	DNA repair
TTDR01106	Pathway	Homologous recombination
TTDR01106	Pathway	Pancreatic cancer
TTDR01106	Pathway	Pathways in cancer
TTDR01107	UniProt ID	Q9NPI8
TTDR01107	Name	Fanconi anemia group F protein
TTDR01107	Type of target	Research target
TTDR01107	Synonyms	FANCF
TTDR01107	Disease	Head and neck Squamous cell carcinomas
TTDR01107	Disease	Lung Cancer
TTDR01107	Disease	Nonsmall cell lung cancer
TTDR01107	Disease	Oral cancer
TTDR01107	Disease	Ovarian cancer
TTDR01107	Function	Dna repair protein that may operate in a postreplication repair or a cell cycle
TTDR01107	Sequence	MESLLQHLDRFSELLAVSSTTYVSTWDPATVRRALQWARYLRHIHRRFGRHGPIRTALERRLHNQWRQEGGFGRGPVPGL
TTDR01107	PDB Structure	2IQC
TTDR01107	BioChemical Class	DNA repair
TTDR01108	UniProt ID	Q99836
TTDR01108	Name	Myeloid differentiation primary response protein MyD88
TTDR01108	Type of target	Research target
TTDR01108	Synonyms	MyD88
TTDR01108	Disease	Inflammatory joint diseases
TTDR01108	Disease	Rheumatoid arthritis, unspecified
TTDR01108	Disease	Sepsis
TTDR01108	Function	Adapter protein involved in the toll-like receptor and il-1 receptor signaling p
TTDR01108	Sequence	MAAGGPGAGSAAPVSSTSSLPLAALNMRVRRRLSLFLNVRTQVAADWTALAEEMDFEYLEIRQLETQADPTGRLLDAWQG
TTDR01108	PDB Structure	2JS7; 2Z5V; 3MOP; 4DOM; 4EO7
TTDR01108	Pathway	Apoptosis
TTDR01108	Pathway	Toll-like receptor signaling pathway
TTDR01109	UniProt ID	P18428
TTDR01109	Name	Lipopolysaccharide-binding protein
TTDR01109	Type of target	Research target
TTDR01109	Synonyms	Lipopolysaccharide binding protein
TTDR01109	Disease	Inflammatory diseases
TTDR01109	Function	Binds to the lipid a moiety of bacterial lipopolysaccharides (lps), a glycolipid
TTDR01109	Sequence	MGALARALPSILLALLLTSTPEALGANPGLVARITDKGLQYAAQEGLLALQSELLRITLPDFTGDLRIPHVGRGRYEFHS
TTDR01109	Pathway	Toll-like receptor signaling pathway
TTDR01110	UniProt ID	P33981
TTDR01110	Name	Dual specificity protein kinase TTK
TTDR01110	Type of target	Research target
TTDR01110	Synonyms	PYT
TTDR01110	Synonyms	TTK
TTDR01110	Synonyms	Tyrosine threonine kinase
TTDR01110	Disease	Cancer, unspecific
TTDR01110	Function	Phosphorylates proteins on serine, threonine, and tyrosine. Probably associated
TTDR01110	Sequence	MESEDLSGRELTIDSIMNKVRDIKNKFKNEDLTDELSLNKISADTTDNSGTVNQIMMMANNPEDWLSLLLKLEKNSVPLS
TTDR01110	PDB Structure	2X9E; 2ZMC; 2ZMD; 3CEK; 3DBQ; 3GFW; 3H9F; 3HMN; 3HMO; 3HMP; 3VQU; 4B94; 4BHZ; 4B
TTDR01110	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01110	EC Number	EC 2.7.1.-
TTDR01110	Inhibitor	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One
TTDR01111	Name	Abeta-binding alcohol dehydrogenase
TTDR01111	Type of target	Research target
TTDR01111	Synonyms	ABAD
TTDR01111	Synonyms	Enzyme A beta-binding alcohol dehydrogenase
TTDR01111	Disease	Alzheimer's disease
TTDR01112	UniProt ID	Q14242
TTDR01112	Name	P-selectin glycoprotein ligand 1
TTDR01112	Type of target	Research target
TTDR01112	Synonyms	CD162 antigen
TTDR01112	Synonyms	P-selectin glycoprotein ligand-1
TTDR01112	Synonyms	PSGL-1
TTDR01112	Synonyms	SPSGL-1
TTDR01112	Synonyms	Selectin P ligand
TTDR01112	Disease	Cutaneous vasculitis induced by immune complex deposition
TTDR01112	Disease	IC-mediated diseases
TTDR01112	Disease	Pulmonary fibrosis
TTDR01112	Function	Binds to p-, e- and l-selectins. The calcium-dependent high affinity interaction
TTDR01112	Sequence	MPLQLLLLLILLGPGNSLQLWDTWADEAEKALGPLLARDRRQATEYEYLDYDFLPETEPPEMLRNSTDTTPLTGPGTPES
TTDR01112	PDB Structure	1G1S
TTDR01112	BioChemical Class	Transmembrane protein
TTDR01112	Pathway	Cell adhesion molecules (CAMs)
TTDR01113	UniProt ID	Q9NR28
TTDR01113	Name	Diablo homolog, mitochondrial
TTDR01113	Type of target	Research target
TTDR01113	Synonyms	Direct IAP binding protein with low pI
TTDR01113	Synonyms	Second mitochondria-derived activator of caspase
TTDR01113	Synonyms	Smac
TTDR01113	Synonyms	Smac protein
TTDR01113	Disease	Cancer, unspecific
TTDR01113	Function	Promotes apoptosis by activating caspases in the cytochrome c/apaf-1/caspase-9 p
TTDR01113	Sequence	MAALKSWLSRSVTSFFRYRQCLCVPVVANFKKRCFSELIRPWHKTVTIGFGVTLCAVPIAQKSEPHSLSSEALMRRAVSL
TTDR01113	PDB Structure	1FEW; 1G3F; 1G73; 1TW6; 1XB0; 1XB1; 3D9U; 3UIH; 3UIJ
TTDR01114	UniProt ID	P52823
TTDR01114	Name	Stanniocalcin 1
TTDR01114	Type of target	Research target
TTDR01114	Synonyms	STC1
TTDR01114	Synonyms	Stanniocalcin-1
TTDR01114	Disease	Breast cancer
TTDR01114	Function	Stimulates renal phosphate reabsorption, and could therefore prevent hypercalcem
TTDR01114	Sequence	MLQNSAVLLVLVISASATHEAEQNDSVSPRKSRVAAQNSAEVVRCLNSALQVGCGAFACLENSTCDTDGMYDICKSFLYS
TTDR01115	Name	Cyclin E/cdk2
TTDR01115	Type of target	Research target
TTDR01115	Synonyms	Cyclin E-cdk2 complexes
TTDR01115	Disease	B-cell lymphoma
TTDR01116	UniProt ID	O75604
TTDR01116	Name	Ubiquitin carboxyl-terminal hydrolase 2
TTDR01116	Type of target	Research target
TTDR01116	Synonyms	41 kDa ubiquitin-specific protease
TTDR01116	Synonyms	Deubiquitinating enzyme 2
TTDR01116	Synonyms	USP2a
TTDR01116	Synonyms	Ubiquitin thiolesterase 2
TTDR01116	Synonyms	Ubiquitin-specific processing protease 2
TTDR01116	Synonyms	Ubiquitin-specific protease-2a
TTDR01116	Disease	Prostate cancer
TTDR01116	Sequence	MSQLSSTLKRYTESARYTDAHYAKSGYGAYTPSSYGANLAASLLEKEKLGFKPVPTSSFLTRPRTYGPSSLLDYDRGRPL
TTDR01116	PDB Structure	2HD5; 2IBI; 3NHE; 3V6C; 3V6E
TTDR01116	BioChemical Class	Hydrolases acting on ester bonds
TTDR01116	EC Number	EC 3.1.2.15
TTDR01117	UniProt ID	O75496
TTDR01117	Name	Geminin
TTDR01117	Type of target	Research target
TTDR01117	Disease	Tumors
TTDR01117	Function	Inhibits dna replication by preventing the incorporation of mcm complex into pre
TTDR01117	Sequence	MNPSMKQKQEEIKENIKNSSVPRRTLKMIQPSASGSLVGRENELSAGLSKRKHRNDHLTSTTSSPGVIVPESSENKNLGG
TTDR01117	PDB Structure	1T6F; 1UII; 2LP0; 2WVR
TTDR01118	UniProt ID	Q9NQB0
TTDR01118	Name	Transcription factor 7-like 2
TTDR01118	Type of target	Research target
TTDR01118	Synonyms	HMG box transcription factor 4
TTDR01118	Synonyms	HTCF-4
TTDR01118	Synonyms	T-cell transcription factor-4
TTDR01118	Synonyms	T-cell-specific transcription factor 4
TTDR01118	Synonyms	TCF-4
TTDR01118	Synonyms	TCF4
TTDR01118	Disease	Hepatocellular carcinoma
TTDR01118	Function	Participates in the wnt signaling pathway and modulates myc expression by bindin
TTDR01118	Sequence	MPQLNGGGGDDLGANDELISFKDEGEQEEKSSENSSAERDLADVKSSLVNESETNQNSSSDSEAERRPPPRSESFRDKSR
TTDR01118	PDB Structure	1JDH; 1JPW; 2GL7
TTDR01118	Pathway	Acute myeloid leukemia
TTDR01118	Pathway	Adherens junction
TTDR01118	Pathway	Basal cell carcinoma
TTDR01118	Pathway	Colorectal cancer
TTDR01118	Pathway	Endometrial cancer
TTDR01118	Pathway	Melanogenesis
TTDR01118	Pathway	Pathways in cancer
TTDR01118	Pathway	Prostate cancer
TTDR01118	Pathway	Thyroid cancer
TTDR01118	Pathway	Wnt signaling pathway
TTDR01119	UniProt ID	Q9H490
TTDR01119	Name	GPI transamidase component PIG-U
TTDR01119	Type of target	Research target
TTDR01119	Synonyms	CDC91-like 1 protein
TTDR01119	Synonyms	CDC91L1
TTDR01119	Synonyms	Cell division cycle protein 91-like 1
TTDR01119	Synonyms	PIG-U
TTDR01119	Synonyms	Phosphatidylinositol-glycan biosynthesis, class U protein
TTDR01119	Synonyms	UNQ3055/PRO9875
TTDR01119	Disease	Bladder cancer
TTDR01119	Function	May play a role in the biosynthesis of gpi anchors.
TTDR01119	Sequence	MAAPLVLVLVVAVTVRAALFRSSLAEFISERVEVVSPLSSWKRVVEGLSLLDLGVSPYSGAVFHETPLIIYLFHFLIDYA
TTDR01119	BioChemical Class	Transmembrane protein
TTDR01119	Pathway	Glycosylphosphatidylinositol(GPI)-anchor
TTDR01119	Pathway	Metabolic pathways
TTDR01120	UniProt ID	Q92876
TTDR01120	Name	Kallikrein 6
TTDR01120	Type of target	Research target
TTDR01120	Synonyms	K6
TTDR01120	Synonyms	MSP
TTDR01120	Synonyms	Neurosin
TTDR01120	Synonyms	Protease M
TTDR01120	Synonyms	SP59
TTDR01120	Synonyms	Zyme
TTDR01120	Disease	Inflammatory diseases
TTDR01120	Disease	Multiple sclerosis
TTDR01120	Sequence	MKKLMVVLSLIAAAWAEEQNKLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLRQR
TTDR01120	PDB Structure	1GVL; 1L2E; 1LO6; 3VFE; 4D8N
TTDR01120	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01120	EC Number	EC 3.4.21.-
TTDR01120	Inhibitor	Benzamidine
TTDR01121	UniProt ID	O95125
TTDR01121	Name	Zinc finger protein 202
TTDR01121	Type of target	Research target
TTDR01121	Synonyms	ZNF202
TTDR01121	Synonyms	Zinc finger protein ZNF202
TTDR01121	Disease	Atherosclerosis
TTDR01121	Disease	Lipid metabolic disorders
TTDR01121	Function	Transcriptional repressor that binds to elements found predominantly in genes th
TTDR01121	Sequence	MATAVEPEDQDLWEEEGILMVKLEDDFTCRPESVLQRDDPVLETSHQNFRRFRYQEAASPREALIRLRELCHQWLRPERR
TTDR01121	BioChemical Class	Zinc-finger
TTDR01122	UniProt ID	Q9JIW5
TTDR01122	Name	Mothers against decapentaplegic homolog 9
TTDR01122	Type of target	Research target
TTDR01122	Synonyms	Mothers against DPP homolog 9
TTDR01122	Synonyms	SMAD 8
TTDR01122	Synonyms	SMAD 9
TTDR01122	Synonyms	Smad8
TTDR01122	Synonyms	Smad9
TTDR01122	Disease	Breast cancer
TTDR01122	Disease	Colon cancer
TTDR01122	Function	Transcriptional modulator activated by bmp (bone morphogenetic proteins) type 1
TTDR01122	Sequence	MHPSTPISSLFSFTSPAVKRLLGWKQGDEEEKWAEKAVDSLVKKLKKKKGAMDELERALSCPGQPSKCVTIPRSLDGRLQ
TTDR01122	Pathway	TGF-beta signaling pathway
TTDR01123	UniProt ID	Q9Y6W8
TTDR01123	Name	Activation-inducible lymphocyte IMMUNOMEDIATORY molecule AILIM
TTDR01123	Type of target	Clinical trial target
TTDR01123	Synonyms	ICOS
TTDR01123	Synonyms	Inducible COSTIMULATOR precursor
TTDR01123	Synonyms	Inducible T-cell co-stimulator
TTDR01123	Synonyms	Inducible costimulator
TTDR01123	Disease	Inflammatory bowel disease
TTDR01123	Sequence	MKSGLWYFFLFCLRIKVLTGEINGSANYEMFIFHNGGVQILCKYPDIVQQFKMQLLKGGQILCDLTKTKGSGNTVSIKSL
TTDR01123	BioChemical Class	Transmembrane protein
TTDR01123	Pathway	Cell adhesion molecules (CAMs)
TTDR01123	Pathway	Primary immunodeficiency
TTDR01123	Pathway	T cell receptor signaling pathway
TTDR01124	UniProt ID	O14493
TTDR01124	Name	Claudin-4
TTDR01124	Type of target	Research target
TTDR01124	Synonyms	CPE-R
TTDR01124	Synonyms	CPE-receptor
TTDR01124	Synonyms	Claudin 4
TTDR01124	Synonyms	Clostridium perfringens enterotoxin receptor
TTDR01124	Synonyms	Williams-Beuren syndrome chromosome region 8 protein
TTDR01124	Disease	Pancreatic cancer
TTDR01124	Function	Component of tight junction (tj) strands.
TTDR01124	Sequence	MASMGLQVMGIALAVLGWLAVMLCCALPMWRVTAFIGSNIVTSQTIWEGLWMNCVVQSTGQMQCKVYDSLLALPQDLQAA
TTDR01124	BioChemical Class	Transmembrane protein
TTDR01124	Pathway	Cell adhesion molecules (CAMs)
TTDR01124	Pathway	Leukocyte transendothelial migration
TTDR01124	Pathway	Tight junction
TTDR01125	UniProt ID	P28799
TTDR01125	Name	Granulins
TTDR01125	Type of target	Research target
TTDR01125	Synonyms	Acrogranin
TTDR01125	Synonyms	Granulin-epithelin
TTDR01125	Synonyms	PC cell-derived growth factor
TTDR01125	Synonyms	PCDGF
TTDR01125	Synonyms	PEPI
TTDR01125	Synonyms	Proepithelin
TTDR01125	Synonyms	Progranulin
TTDR01125	Disease	Prostate cancer
TTDR01125	Function	Granulins have possible cytokine-like activity. They may play a role in inflamma
TTDR01125	Sequence	MWTLVSWVALTAGLVAGTRCPDGQFCPVACCLDPGGASYSCCRPLLDKWPTTLSRHLGGPCQVDAHCSAGHSCIFTVSGT
TTDR01125	PDB Structure	1G26; 2JYE; 2JYT; 2JYU; 2JYV
TTDR01126	UniProt ID	Q04864
TTDR01126	Name	C-Rel proto-oncogene protein
TTDR01126	Type of target	Research target
TTDR01126	Synonyms	C-Rel
TTDR01126	Disease	B-cell lymphoma
TTDR01126	Function	Proto-oncogene that may play a role in differentiation and lymphopoiesis.
TTDR01126	Sequence	MASGAYNPYIEIIEQPRQRGMRFRYKCEGRSAGSIPGEHSTDNNRTYPSIQIMNYYGKGKVRITLVTKNDPYKPHPHDLV
TTDR01127	Name	KSHV G protein-couple receptor
TTDR01127	Type of target	Research target
TTDR01127	Synonyms	Kaposi's sarcoma-associated virus G protein-couple receptor
TTDR01127	Synonyms	VGPCR
TTDR01127	Disease	KSHV-mediated disease
TTDR01127	Disease	Kaposi's sarcoma
TTDR01127	Disease	Primary effusion lymphoma
TTDR01128	UniProt ID	P40199
TTDR01128	Name	Carcinoembryonic antigen-related cell adhesion molecule 6
TTDR01128	Type of target	Research target
TTDR01128	Synonyms	CD66c antigen
TTDR01128	Synonyms	CEACAM6
TTDR01128	Synonyms	Nonspecific crossreacting antigen
TTDR01128	Synonyms	Normal cross-reacting antigen
TTDR01128	Disease	Pancreatic adenocarcinoma
TTDR01128	Disease	Pancreatic cancer
TTDR01128	Sequence	MGPPSAPPCRLHVPWKEVLLTASLLTFWNPPTTAKLTIESTPFNVAEGKEVLLLAHNLPQNRIGYSWYKGERVDGNSLIV
TTDR01128	BioChemical Class	Cell membrane protein
TTDR01129	UniProt ID	Q8IVN5
TTDR01129	Name	Protein tyrosine phosphatase short form
TTDR01129	Type of target	Research target
TTDR01129	Synonyms	Metastasis-associated phosphatase PRL-3
TTDR01129	Synonyms	PRL-3
TTDR01129	Disease	Cancer metastasis
TTDR01129	Disease	Colorectal cancer
TTDR01129	Sequence	MARMNRPAPVEVSYKHMRFLITHNPTNATLSTFIEDLKKYGATTVVRVCEVTYDKTPLEKDGITVVDWPFDDGAPPPGKV
TTDR01129	PDB Structure	1R6H; 1V3A
TTDR01129	BioChemical Class	Hydrolases acting on ester bonds
TTDR01129	Inhibitor	Sodium orthovanadate
TTDR01130	UniProt ID	Q08050
TTDR01130	Name	Forkhead box protein M1
TTDR01130	Type of target	Research target
TTDR01130	Synonyms	Forkhead Box (Fox) m1b
TTDR01130	Synonyms	Forkhead-related protein FKHL16
TTDR01130	Synonyms	Foxm1
TTDR01130	Synonyms	Foxm1b
TTDR01130	Synonyms	HFH-11
TTDR01130	Synonyms	HNF-3/fork-head homolog-11
TTDR01130	Synonyms	Hepatocyte nuclear factor 3 forkhead homolog 11
TTDR01130	Synonyms	M-phase phosphoprotein 2
TTDR01130	Synonyms	MPM-2 reactive phosphoprotein 2
TTDR01130	Synonyms	Transcription factor Trident
TTDR01130	Synonyms	Winged helix factor from INS-1 cells
TTDR01130	Disease	Hepatocellular carcinoma
TTDR01130	Function	Transcriptional activatory factor. May play a role in the control of cell prolif
TTDR01130	Sequence	MKTSPRRPLILKRRRLPLPVQNAPSETSEEEPKRSPAQQESNQAEASKEVAESNSCKFPAGIKIINHPTMPNTQVVAIPN
TTDR01130	PDB Structure	3G73
TTDR01130	Inhibitor	(D-Arg)(9)-p19(ARF) 26-44 peptide
TTDR01131	UniProt ID	Q14314
TTDR01131	Name	Fibroleukin
TTDR01131	Type of target	Research target
TTDR01131	Synonyms	Fibrinogen-like protein 2
TTDR01131	Synonyms	Hfgl2
TTDR01131	Synonyms	PT49
TTDR01131	Disease	Acute allograft rejection
TTDR01131	Function	May play a role in physiologic lymphocyte functions at mucosal sites.
TTDR01131	Sequence	MKLANWYWLSSAVLATYGFLVVANNETEEIKDERAKDVCPVRLESRGKCEEAGECPYQVSLPPLTIQLPKQFSRIEEVFK
TTDR01132	UniProt ID	O43826
TTDR01132	Name	Glucose 6-phosphate translocase
TTDR01132	Type of target	Research target
TTDR01132	Synonyms	Glucose 5-phosphate transporter
TTDR01132	Synonyms	Glucose-6-phosphate translocase
TTDR01132	Synonyms	PRO0685
TTDR01132	Synonyms	Solute carrier family 37 member 4
TTDR01132	Disease	Noninsulin-dependent diabetes mellitus
TTDR01132	Sequence	MAAQGYGYYRTVIFSAMFGGYSLYYFNRKTFSFVMPSLVEEIPLDKDDLGFITSSQSAAYAISKFVSGVLSDQMSARWLF
TTDR01132	BioChemical Class	Transmembrane protein
TTDR01132	Inhibitor	Chlorogenic acid
TTDR01132	Inhibitor	Kodaistatin A
TTDR01132	Inhibitor	Kodaistatin C
TTDR01132	Inhibitor	Mumbaistatin
TTDR01132	Inhibitor	S 0957
TTDR01132	Inhibitor	S 1743
TTDR01132	Inhibitor	S 3025
TTDR01132	Inhibitor	S-4048
TTDR01133	UniProt ID	P29323
TTDR01133	Name	Ephrin type-B receptor 2
TTDR01133	Type of target	Research target
TTDR01133	Synonyms	DRT
TTDR01133	Synonyms	ERK
TTDR01133	Synonyms	EphB2
TTDR01133	Synonyms	EphB2 receptor tyrosine kinase
TTDR01133	Synonyms	Receptor protein-tyrosine kinase HEK5
TTDR01133	Synonyms	Tyrosine-protein kinase receptor EPH-3
TTDR01133	Disease	Colorectal cancer
TTDR01133	Function	Receptor for members of the ephrin-b family.
TTDR01133	Sequence	MALRRLGAALLLLPLLAAVEETLMDSTTATAELGWMVHPPSGWEEVSGYDENMNTIRTYQVCNVFESSQNNWLRTKFIRR
TTDR01133	PDB Structure	1B4F; 1F0M; 2QBX
TTDR01133	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01133	Pathway	Axon guidance
TTDR01133	EC Number	EC 2.7.1.112
TTDR01133	Target Validation	TTDR01133
TTDR01133	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDR01133	Inhibitor	SNEWIQPRLPQH
TTDR01134	UniProt ID	Q14653
TTDR01134	Name	Interferon regulatory factor 3
TTDR01134	Type of target	Research target
TTDR01134	Synonyms	IRF3
TTDR01134	Disease	Septic shock
TTDR01134	Function	May activate transcription by complex formation with other transcriptional facto
TTDR01134	Sequence	MGTPKPRILPWLVSQLDLGQLEGVAWVNKSRTRFRIPWKHGLRQDAQQEDFGIFQAWAEATGAYVPGRDKPDLPTWKRNF
TTDR01134	PDB Structure	1J2F; 1QWT; 1T2K; 1ZOQ; 2O61; 2O6G; 2PI0; 3A77; 3QU6
TTDR01134	Pathway	Toll-like receptor signaling pathway
TTDR01134	Inhibitor	Piceatannol
TTDR01135	Name	NGEP
TTDR01135	Type of target	Research target
TTDR01135	Synonyms	NGEP-L
TTDR01135	Disease	Prostate cancer
TTDR01136	UniProt ID	O75832
TTDR01136	Name	26S proteasome non-ATPase regulatory subunit 10
TTDR01136	Type of target	Research target
TTDR01136	Synonyms	26S proteasome regulatory subunit p28
TTDR01136	Synonyms	Gankyrin
TTDR01136	Disease	Hepatocellular carcinoma
TTDR01136	Function	Acts as a regulatory subunit of the 26s proteasome which is involved in the atp-
TTDR01136	Sequence	MEGCVSNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIA
TTDR01136	PDB Structure	1QYM; 1TR4; 1UOH
TTDR01137	Name	17-beta-hydroxysteroid dehydrogenase 5
TTDR01137	Type of target	Research target
TTDR01137	Synonyms	17-beta-HSD 5
TTDR01137	Synonyms	17beta-HSD5
TTDR01137	Synonyms	HSD17B5
TTDR01137	Synonyms	Type 5 17beta-hydroxysteroid dehydrogenase
TTDR01137	Disease	Prostate cancer
TTDR01137	EC Number	EC 1.1.1.62
TTDR01138	UniProt ID	P35243
TTDR01138	Name	Recoverin
TTDR01138	Type of target	Research target
TTDR01138	Synonyms	CAR protein
TTDR01138	Synonyms	Cancer associated retinopathy protein
TTDR01138	Disease	Lung cancer
TTDR01138	Function	Seems to be implicated in the pathway from retinal rod guanylate cyclase to rhod
TTDR01138	Sequence	MGNSKSGALSKEILEELQLNTKFSEEELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGT
TTDR01138	PDB Structure	2D8N
TTDR01138	Inhibitor	MYRISTIC ACID
TTDR01139	UniProt ID	Q8IDQ9
TTDR01139	Name	Phosphoethanolamine N-methyltransferase
TTDR01139	Type of target	Research target
TTDR01139	Synonyms	Pfpmt
TTDR01139	Synonyms	Phosphoethanolamine methyltransferase
TTDR01139	Disease	Malaria
TTDR01139	Sequence	MTLIENLNSDKTFLENNQYTDEGVKVYEFIFGENYISSGGLEATKKILSDIELNENSKVLDIGSGLGGGCMYINEKYGAH
TTDR01139	BioChemical Class	Transferases transferring one-carbon groups
TTDR01139	Pathway	Glycerophospholipid metabolism
TTDR01140	Name	HIV-1 RNA
TTDR01140	Type of target	Research target
TTDR01140	Disease	Human immunodeficiency virus [HIV] disease
TTDR01141	UniProt ID	P09936
TTDR01141	Name	Ubiquitin carboxyl-terminal hydrolase isozyme L1
TTDR01141	Type of target	Research target
TTDR01141	Synonyms	Neuron cytoplasmic protein 9.5
TTDR01141	Synonyms	PGP 9.5
TTDR01141	Synonyms	PGP9.5
TTDR01141	Synonyms	UCH-L1
TTDR01141	Synonyms	UCHL1
TTDR01141	Synonyms	Ubiquitin carboxy-terminal hydrolase L1
TTDR01141	Synonyms	Ubiquitin thiolesterase L1
TTDR01141	Disease	Parkinson's disease
TTDR01141	Function	Ubiquitin-protein hydrolase is involved both in the processing of ubiquitin prec
TTDR01141	Sequence	MQLKPMEINPEMLNKVLSRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVY
TTDR01141	PDB Structure	2ETL; 2LEN; 3IFW; 3IRT; 3KVF; 3KW5; 4DM9
TTDR01141	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01141	Pathway	Parkinson's disease
TTDR01141	EC Number	EC 3.4.19.12
TTDR01142	UniProt ID	P78527
TTDR01142	Name	DNA-dependent protein kinase catalytic subunit
TTDR01142	Type of target	Research target
TTDR01142	Synonyms	DNA-PK
TTDR01142	Synonyms	DNA-PKcs
TTDR01142	Synonyms	DNA-dependent protein kinase
TTDR01142	Synonyms	DNPK1
TTDR01142	Synonyms	P460
TTDR01142	Disease	Leukemia, unspecified
TTDR01142	Function	Ser/thr kinase involved in dna double-stranded break repair, v(d)j recombination
TTDR01142	Sequence	MAGSGAGVRCSLLRLQETLSAADRCGAALAGHQLIRGLGQECVLSSSPAVLALQTSLVFSRDFGLLVFVRKSLNSIEFRE
TTDR01142	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01142	Pathway	Cell cycle
TTDR01142	Pathway	Non-homologous end-joining
TTDR01142	EC Number	EC 2.7.1.37
TTDR01142	Target Validation	TTDR01142
TTDR01142	Inhibitor	1-Morpholin-4-yl-benzo[f]chromen-3-one
TTDR01142	Inhibitor	2-(1H-indol-5-yl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(2-Fluoro-phenyl)-benzo[h]chromen-4-one
TTDR01142	Inhibitor	2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one
TTDR01142	Inhibitor	2-(2-aminophenyl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(2-methoxyphenyl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(3-Fluoro-phenyl)-benzo[h]chromen-4-one
TTDR01142	Inhibitor	2-(3-acetylphenyl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(3-methoxyphenyl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(4-Amino-phenyl)-benzo[h]chromen-4-one
TTDR01142	Inhibitor	2-(4-chlorophenyl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(4-fluorophenyl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(4-methoxyphenyl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(benzofuran-2-yl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(furan-2-yl)-6-morpholino-4H-pyran-4-one
TTDR01142	Inhibitor	2-(piperidin-1-yl)-4H-benzo[h]chromen-4-one
TTDR01142	Inhibitor	2-Morpholin-4-yl-6-phenyl-chromen-4-one
TTDR01142	Inhibitor	2-Morpholin-4-yl-benzo[h]chromene-4-thione
TTDR01142	Inhibitor	2-Morpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one
TTDR01142	Inhibitor	2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one
TTDR01142	Inhibitor	2-Pyridin-3-yl-benzo[h]chromen-4-one
TTDR01142	Inhibitor	2-Pyrrolidin-1-yl-benzo[h]chromen-4-one
TTDR01142	Inhibitor	2-Thiomorpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one
TTDR01142	Inhibitor	2-[1,4]Oxazepan-4-yl-benzo[h]chromen-4-one
TTDR01142	Inhibitor	2-biphenyl-4-yl-6-morpholin-4-yl-pyran-4-one
TTDR01142	Inhibitor	2-dibenzofuran-4-yl-6-morpholin-4-yl-pyran-4-one
TTDR01142	Inhibitor	2-morpholin-4-yl-6-phenyl-4H-thiopyran-4-one
TTDR01142	Inhibitor	2-morpholin-4-yl-8-naphthalen-2-ylchromen-4-one
TTDR01142	Inhibitor	2-morpholin-4-yl-8-phenoxathiin-4-ylchromen-4-one
TTDR01142	Inhibitor	2-morpholin-4-yl-8-styrylchromen-4-one
TTDR01142	Inhibitor	2-morpholin-4-yl-8-thiophen-2-ylchromen-4-one
TTDR01142	Inhibitor	2-morpholin-4-yl-8-thiophen-3-ylchromen-4-one
TTDR01142	Inhibitor	2-morpholino-4H-benzo[g]chromen-4-one
TTDR01142	Inhibitor	2-morpholino-6-(naphthalen-1-yl)-4H-chromen-4-one
TTDR01142	Inhibitor	2-morpholino-6-(naphthalen-1-yl)-4H-pyran-4-one
TTDR01142	Inhibitor	2-morpholino-6-(naphthalen-2-yl)-4H-pyran-4-one
TTDR01142	Inhibitor	2-morpholino-6-(quinolin-8-yl)-4H-pyran-4-one
TTDR01142	Inhibitor	2-morpholino-6-(thianthren-1-yl)-4H-chromen-4-one
TTDR01142	Inhibitor	2-morpholino-6-(thiophen-2-yl)-4H-pyran-4-one
TTDR01142	Inhibitor	2-morpholino-6-(thiophen-3-yl)-4H-pyran-4-one
TTDR01142	Inhibitor	2-morpholino-6-phenyl-4H-pyran-4-one
TTDR01142	Inhibitor	2-morpholino-6-styryl-4H-pyran-4-one
TTDR01142	Inhibitor	2-morpholinobenzo[h]quinolin-4(1H)-one
TTDR01142	Inhibitor	2-thiomorpholino-4H-benzo[h]chromen-4-one
TTDR01142	Inhibitor	3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzaldehyde
TTDR01142	Inhibitor	3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzoic acid
TTDR01142	Inhibitor	3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzonitrile
TTDR01142	Inhibitor	3-morpholino-1H-benzo[f]chromen-1-one
TTDR01142	Inhibitor	4-(6-morpholino-4-oxo-4H-pyran-2-yl)benzonitrile
TTDR01142	Inhibitor	4-Morpholin-4-yl-benzo[g]chromen-2-one
TTDR01142	Inhibitor	4-Morpholin-4-yl-benzo[h]chromen-2-one
TTDR01142	Inhibitor	4-Morpholin-4-yl-chromen-2-one
TTDR01142	Inhibitor	4-Piperidin-1-yl-chromen-2-one
TTDR01142	Inhibitor	4-Thiomorpholin-4-yl-benzo[g]chromen-2-one
TTDR01142	Inhibitor	4-morpholino-6-phenyl-2H-pyran-2-one
TTDR01142	Inhibitor	6-(2-acetylphenyl)-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	6-(3-hydroxyphenyl)-2-morpholino-4H-chromen-4-one
TTDR01142	Inhibitor	6-(4-chlorophenyl)-2-morpholin-4-ylpyridin-4-ol
TTDR01142	Inhibitor	6-(4-chlorophenyl)-4-morpholino-2H-pyran-2-one
TTDR01142	Inhibitor	6-(4-fluorostyryl)-2-morpholino-4H-chromen-4-one
TTDR01142	Inhibitor	6-(4-hydroxyphenyl)-2-morpholino-4H-chromen-4-one
TTDR01142	Inhibitor	6-(4-methoxyphenyl)-4-morpholino-2H-pyran-2-one
TTDR01142	Inhibitor	6-Chloro-4-morpholin-4-yl-chromen-2-one
TTDR01142	Inhibitor	6-Methoxy-4-morpholin-4-yl-chromen-2-one
TTDR01142	Inhibitor	6-Methyl-4-morpholin-4-yl-chromen-2-one
TTDR01142	Inhibitor	6-biphenyl-2-yl-2-morpholin-4-yl-chromen-4-one
TTDR01142	Inhibitor	6-isopropyl-2-morpholin-4-yl-4H-thiopyran-4-one
TTDR01142	Inhibitor	6-tert-Butyl-2-morpholin-4-yl-4H-thiopyran-4-one
TTDR01142	Inhibitor	7-Methoxy-2-morpholin-4-yl-chromen-4-one
TTDR01142	Inhibitor	7-Methoxy-4-morpholin-4-yl-chromen-2-one
TTDR01142	Inhibitor	7-benzoyloxy-2-(morpholin-4-yl)-chromen-4-one
TTDR01142	Inhibitor	7-benzyloxy-2-(morpholin-4-yl)-chromen-4-one
TTDR01142	Inhibitor	7-ethyloxyethoxy-2-morpholin-4-yl-chromen-4-one
TTDR01142	Inhibitor	7-hydroxy-2-(morpholin-4-yl)chromen-4-one
TTDR01142	Inhibitor	7-phenylethoxy-2-morpholin-4-yl-chromen-4-one
TTDR01142	Inhibitor	7-phenyloxyethoxy-2-morpholin-4-yl-chromen-4-one
TTDR01142	Inhibitor	7-propoxy-2-(morpholin-4-yl)-chromen-4-one
TTDR01142	Inhibitor	8-(1H-indol-5-yl)-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	8-(2-acetylphenyl)-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	8-(3-hydroxyphenyl)-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	8-(4-acetylphenyl)-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	8-(4-chlorophenyl)-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	8-(4-hydroxyphenyl)-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	8-Methoxy-2-morpholin-4-yl-chromen-4-one
TTDR01142	Inhibitor	8-Methoxy-4-morpholin-4-yl-chromen-2-one
TTDR01142	Inhibitor	8-Methyl-2-morpholin-4-yl-chromen-4-one
TTDR01142	Inhibitor	8-Methyl-4-morpholin-4-yl-chromen-2-one
TTDR01142	Inhibitor	8-Phenyl-2-piperidin-1-yl-chromen-4-one
TTDR01142	Inhibitor	8-Phenyl-2-thiomorpholin-4-yl-chromen-4-one
TTDR01142	Inhibitor	8-biphenyl-2-yl-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	8-dibenzofuran-4-yl-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	8-furan-2-yl-2-morpholin-4-ylchromen-4-one
TTDR01142	Inhibitor	ALPHA-NAPHTHOFLAVONE
TTDR01142	Inhibitor	KU-55933
TTDR01142	Inhibitor	LY-292223
TTDR01142	Inhibitor	LY-293646
TTDR01142	Inhibitor	LY-294002
TTDR01142	Inhibitor	NU-7432;NU-7441
TTDR01142	Inhibitor	NU7026
TTDR01143	UniProt ID	P60472
TTDR01143	Name	Undecaprenyl pyrophosphate synthetase
TTDR01143	Type of target	Research target
TTDR01143	Synonyms	Di-trans-poly-cis-decaprenylcistransferase
TTDR01143	Synonyms	UDS
TTDR01143	Synonyms	UPP synthase
TTDR01143	Synonyms	UPP synthetase
TTDR01143	Synonyms	Undecaprenyl diphosphate  synthase
TTDR01143	Synonyms	Undecaprenyl diphosphate synthase
TTDR01143	Disease	Microbial infections
TTDR01143	Function	Generates undecaprenyl pyrophosphate (upp) from isopentenyl pyrophosphate (ipp).
TTDR01143	Sequence	MMLSATQPLSEKLPAHGCRHVAIIMDGNGRWAKKQGKIRAFGHKAGAKSVRRAVSFAANNGIEALTLYAFSSENWNRPAQ
TTDR01143	PDB Structure	1JP3; 1UEH; 1V7U; 1X06; 1X07; 1X08; 1X09; 2E98; 2E99; 2E9A; 2E9C; 2E9D; 3QAS; 3S
TTDR01143	BioChemical Class	Transferases transferring alkyl or aryl groups
TTDR01143	Pathway	Terpenoid biosynthesis
TTDR01143	EC Number	EC 2.5.1.31
TTDR01143	Inhibitor	E-pentenylbutanedioic acid 32
TTDR01143	Inhibitor	FARNESYL DIPHOSPHATE
TTDR01143	Inhibitor	FARNESYL THIOPYROPHOSPHATE
TTDR01143	Inhibitor	ISOPENTENYL PYROPHOSPHATE
TTDR01144	UniProt ID	Q16542
TTDR01144	Name	Interleukin 11 receptor
TTDR01144	Type of target	Research target
TTDR01144	Synonyms	IL-11 receptor alpha
TTDR01144	Synonyms	IL-11Ralpha
TTDR01144	Disease	Prostate cancer
TTDR01144	Sequence	MSSSCSGLSRVLVAVATALVSASSPCPQAWGPPGVQYGQPGRSVKLCCPGVTAGDPVSWFRDGEPKLLQGPDSGLGHELV
TTDR01144	Pathway	Cytokine-cytokine receptor interaction
TTDR01144	Pathway	Hematopoietic cell lineage
TTDR01144	Pathway	Jak-STAT signaling pathway
TTDR01145	Name	TRNA-dependent amidotransferase
TTDR01145	Type of target	Research target
TTDR01145	Synonyms	AdT
TTDR01145	Disease	Bacterial infections
TTDR01147	UniProt ID	P02786
TTDR01147	Name	Transferrin receptor protein 1
TTDR01147	Type of target	Research target
TTDR01147	Synonyms	CD71 antigen
TTDR01147	Synonyms	P90
TTDR01147	Synonyms	T9
TTDR01147	Synonyms	TFRC
TTDR01147	Synonyms	TR
TTDR01147	Synonyms	TfR
TTDR01147	Synonyms	TfR1
TTDR01147	Synonyms	Trfr
TTDR01147	Disease	Solid tumor
TTDR01147	Function	Cellular uptake of iron occurs via receptor-mediated endocytosis of ligand-occup
TTDR01147	Sequence	MMDQARSAFSNLFGGEPLSYTRFSLARQVDGDNSHVEMKLAVDEEENADNNTKANVTKPKRCSGSICYGTIAVIVFFLIG
TTDR01147	PDB Structure	1CX8; 1DE4; 1SUV; 2NSU; 3KAS; 3S9L; 3S9M; 3S9N
TTDR01147	BioChemical Class	Transmembrane protein
TTDR01147	Pathway	Hematopoietic cell lineage
TTDR01148	UniProt ID	P02788
TTDR01148	Name	Lactotransferrin
TTDR01148	Type of target	Research target
TTDR01148	Synonyms	Lactoferrin
TTDR01148	Disease	Osteoporosis and other bone-related diseases
TTDR01148	Function	Transferrins are iron binding transport proteins which can bind two atoms of fer
TTDR01148	Sequence	MKLVFLVLLFLGALGLCLAGRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQAIAENRADAVTLDG
TTDR01148	PDB Structure	1B0L; 1BKA; 1CB6; 1DSN; 1EH3; 1FCK; 1H43; 1H44; 1H45; 1HSE; 1L5T; 1LCF; 1LCT; 1L
TTDR01148	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01148	Inhibitor	3h-Indole-5,6-Diol
TTDR01148	Inhibitor	Alpha-D-Fucose
TTDR01148	Inhibitor	Alpha-D-Mannose
TTDR01148	Inhibitor	Fucose
TTDR01148	Inhibitor	Lauric Acid
TTDR01148	Inhibitor	Nimesulide
TTDR01148	Inhibitor	Nitrilotriacetic Acid
TTDR01148	Inhibitor	Oxalate Ion
TTDR01148	Inhibitor	parecoxib
TTDR01149	UniProt ID	P23471
TTDR01149	Name	Receptor-type protein-tyrosine phosphatase zeta
TTDR01149	Type of target	Research target
TTDR01149	Synonyms	R-PTP-zeta
TTDR01149	Synonyms	Receptor protein tyrosine phosphatase zeta
TTDR01149	Disease	Glioblastoma multiforme
TTDR01149	Function	May be involved in the regulation of specific developmental processes in the cns
TTDR01149	Sequence	MRILKRFLACIQLLCVCRLDWANGYYRQQRKLVEEIGWSYTGALNQKNWGKKYPTCNSPKQSPINIDEDLTQVNVNLKKL
TTDR01149	PDB Structure	3JXF; 3S97
TTDR01149	BioChemical Class	Hydrolases acting on ester bonds
TTDR01149	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR01149	EC Number	EC 3.1.3.48
TTDR01150	UniProt ID	Q9BYZ8
TTDR01150	Name	Regenerating gene type IV
TTDR01150	Type of target	Research target
TTDR01150	Synonyms	Gastrointestinal secretory protein GISP
TTDR01150	Synonyms	REG-like protein
TTDR01150	Synonyms	REGIV
TTDR01150	Synonyms	Regenerating islet-derived family, member 4
TTDR01150	Disease	Gastric cancer
TTDR01150	Sequence	MASRSMRLLLLLSCLAKTGVLGDIIMRPSCAPGWFYHKSNCYGYFRKLRNWSDAELECQSYGNGAHLASILSLKEASTIA
TTDR01150	PDB Structure	2KV3
TTDR01151	Name	Heat shock protein 20
TTDR01151	Type of target	Research target
TTDR01151	Synonyms	Heat-Shock Protein Hsp20
TTDR01151	Synonyms	Hsp20
TTDR01151	Disease	Heart failure
TTDR01152	UniProt ID	Q69128
TTDR01152	Name	Epstein-Barr virus (Strain FF41) nuclear antigen gene
TTDR01152	Type of target	Research target
TTDR01152	Synonyms	EBNA1
TTDR01152	Synonyms	Epstein-Barr virus nuclear antigen 1
TTDR01152	Disease	EBV-related cancers
TTDR01152	Sequence	MSDEGPGTGPGNGLGEKGDTSGPEGSGGSGPQRRGGDNHGRGRGRGRGRGGGRPGAPG
TTDR01153	UniProt ID	P01024
TTDR01153	Name	Complement C3
TTDR01153	Type of target	Research target
TTDR01153	Synonyms	C3
TTDR01153	Disease	Hypertension
TTDR01153	Function	C3 plays a central role in the activation of the complement system. Its processi
TTDR01153	Sequence	MGPTSGPSLLLLLLTHLPLALGSPMYSIITPNILRLESEETMVLEAHDAQGDVPVTVTVHDFPGKKLVLSSEKTVLTPAT
TTDR01153	PDB Structure	1C3D; 1GHQ; 1W2S; 2A73; 2A74; 2GOX; 2HR0; 2I07; 2ICE; 2ICF; 2NOJ; 2QKI; 2WII; 2W
TTDR01153	Pathway	Complement and coagulation cascades
TTDR01153	Pathway	Systemic lupus erythematosus
TTDR01153	Target Validation	TTDR01153
TTDR01153	Inhibitor	Ac-ICV(1MeW)QDWGAHRCT-NH2
TTDR01153	Inhibitor	Ac-ICV(2Nal)QDWGAHRCT-NH2
TTDR01153	Inhibitor	Ac-ICV(5MeW)QDWGAHRCT-NH2
TTDR01153	Inhibitor	Ac-ICV(5fW)QDWGAHRCT-NH2
TTDR01153	Inhibitor	Ac-ICVWQD(5fW)GAHRCT-NH2
TTDR01153	Inhibitor	Ac-ICVWQDWGAHRCT-NH2
TTDR01153	Inhibitor	Ac-I[CV(1Nal)QDWGAHRC]T
TTDR01153	Inhibitor	Ac-I[CV(2Igl)QDWGAHRC]T
TTDR01153	Inhibitor	Ac-I[CV(2Igl)QDWGAHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CV(2Nal)QDWGAHRC]T
TTDR01153	Inhibitor	Ac-I[CV(2Nal)QDWGAHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CV(Bpa)QDWGAHRC]T
TTDR01153	Inhibitor	Ac-I[CV(Bpa)QDWGAHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CV(Bta)QDWGAHRC]T
TTDR01153	Inhibitor	Ac-I[CV(Bta)QDWGAHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CV(Dht)QDWGAHRC]T
TTDR01153	Inhibitor	Ac-I[CV(Yphs)QDWGAHRC]I-NH2
TTDR01153	Inhibitor	Ac-I[CVFQDWGHHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CVHQDWGHHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CVSQDWGHHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CVTQDWGHHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CVVQDWGAHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CVWQDWG(Abu)HRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CVWQDWGAHRC]T
TTDR01153	Inhibitor	Ac-I[CVWQDWGAHRC]dT
TTDR01153	Inhibitor	Ac-I[CVWQDWGHHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CVWQDWGWHRC]T-NH2
TTDR01153	Inhibitor	Ac-I[CVYQDWGAHRC]T-NH2
TTDR01153	Inhibitor	S-Hydroxycysteine
TTDR01154	UniProt ID	Q12884
TTDR01154	Name	Seprase
TTDR01154	Type of target	Research target
TTDR01154	Synonyms	170-kDa melanoma membrane-bound gelatinase
TTDR01154	Synonyms	APCE
TTDR01154	Synonyms	Antiplasmin-cleaving enzyme
TTDR01154	Synonyms	Fibroblast activation protein alpha
TTDR01154	Synonyms	Integral membrane serine protease
TTDR01154	Disease	Atherogenesis
TTDR01154	Disease	Inflammatory diseases
TTDR01154	Disease	Thrombosis
TTDR01154	Function	May have a role in tissue remodeling during development and wound healing, and m
TTDR01154	Sequence	MKTWVKIVFGVATSAVLALLVMCIVLRPSRVHNSEENTMRALTLKDILNGTFSYKTFFPNWISGQEYLHQSADNNIVLYN
TTDR01154	PDB Structure	1Z68
TTDR01154	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01154	EC Number	EC 3.4.21.-
TTDR01154	Target Validation	TTDR01154
TTDR01154	Inhibitor	N-alkyl Gly-boro-Pro derivative
TTDR01154	Inhibitor	PF-00734200
TTDR01155	UniProt ID	P13385
TTDR01155	Name	Teratocarcinoma-derived growth factor 1
TTDR01155	Type of target	Research target
TTDR01155	Synonyms	CRGF
TTDR01155	Synonyms	Cripto
TTDR01155	Synonyms	Cripto-1 growth factor
TTDR01155	Synonyms	Epidermal growth factor-like cripto protein CR1
TTDR01155	Synonyms	TDGF1
TTDR01155	Disease	Cancer, unspecific
TTDR01155	Function	Could play a role in the determination of the epiblastic cells that subsequently
TTDR01155	Sequence	MDCRKMARFSYSVIWIMAISKVFELGLVAGLGHQEFARPSRGYLAFRDDSIWPQEEPAIRPRSSQRVPPMGIQHSKELNR
TTDR01155	BioChemical Class	Growth factor
TTDR01156	UniProt ID	Q92769
TTDR01156	Name	Histone deacetylase 2
TTDR01156	Type of target	Research target
TTDR01156	Synonyms	HDAC2
TTDR01156	Disease	Colon cancer
TTDR01156	Function	Responsible for the deacetylation of lysine residues on the n-terminal part of t
TTDR01156	Sequence	MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSI
TTDR01156	PDB Structure	3MAX
TTDR01156	BioChemical Class	Hydrolases acting on carbon-nitrogen bonds
TTDR01156	Pathway	Cell cycle
TTDR01156	Pathway	Chronic myeloid leukemia
TTDR01156	Pathway	Huntington's disease
TTDR01156	Pathway	Notch signaling pathway
TTDR01156	Pathway	Pathways in cancer
TTDR01156	Target Validation	TTDR01156
TTDR01156	QSAR Model	TTDR01156
TTDR01156	Inhibitor	(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one
TTDR01156	Inhibitor	1,1,1-Trifluoro-8-(4-phenoxy-phenoxy)-octan-2-one
TTDR01156	Inhibitor	1,1,1-Trifluoro-8-phenoxy-octan-2-one
TTDR01156	Inhibitor	2-(allyloxy)-N8-hydroxy-N1-phenyloctanediamide
TTDR01156	Inhibitor	2-(benzyloxy)-N7-hydroxy-N1-phenylheptanediamide
TTDR01156	Inhibitor	2-(methylsulfonylthio)ethyl 2-propylpentanoate
TTDR01156	Inhibitor	4-Benzoylamino-N-hydroxy-benzamide
TTDR01156	Inhibitor	4-Butyrylamino-N-hydroxy-benzamide
TTDR01156	Inhibitor	4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDR01156	Inhibitor	4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide
TTDR01156	Inhibitor	4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDR01156	Inhibitor	4-Phenylbutyrohydroxamic acid
TTDR01156	Inhibitor	5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide
TTDR01156	Inhibitor	5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione
TTDR01156	Inhibitor	5-(Biphenyl-4-yl)-pentanoic acid N-hydroxyamide
TTDR01156	Inhibitor	5-Mercapto-pentanoic acid phenylamide
TTDR01156	Inhibitor	6-(2-Bromo-acetylamino)-hexanoic acid phenylamide
TTDR01156	Inhibitor	6-Mercapto-hexanoic acid phenylamide
TTDR01156	Inhibitor	6-Phenoxy-hexane-1-thiol
TTDR01156	Inhibitor	6-benzenesulfinylhexanoic acid hydroxamide
TTDR01156	Inhibitor	6-benzenesulfonylhexanoic acid hydroxamide
TTDR01156	Inhibitor	6-phenylsulfanylhexanoic acid hydroxamide
TTDR01156	Inhibitor	7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01156	Inhibitor	7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one
TTDR01156	Inhibitor	7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01156	Inhibitor	7-(Biphenyl-4-yloxy)-heptanoic acid hydroxyamide
TTDR01156	Inhibitor	7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01156	Inhibitor	7-Biphenyl-4-yl-heptanoic acid hydroxyamide
TTDR01156	Inhibitor	7-Mercapto-heptanoic acid benzothiazol-2-ylamide
TTDR01156	Inhibitor	7-Mercapto-heptanoic acid biphenyl-3-ylamide
TTDR01156	Inhibitor	7-Mercapto-heptanoic acid biphenyl-4-ylamide
TTDR01156	Inhibitor	7-Mercapto-heptanoic acid phenylamide
TTDR01156	Inhibitor	7-Mercapto-heptanoic acid pyridin-3-ylamide
TTDR01156	Inhibitor	7-Mercapto-heptanoic acid quinolin-3-ylamide
TTDR01156	Inhibitor	7-Phenoxy-heptanoic acid hydroxyamide
TTDR01156	Inhibitor	8-(Biphenyl-3-yloxy)-1,1,1-trifluoro-octan-2-one
TTDR01156	Inhibitor	8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one
TTDR01156	Inhibitor	8-(Biphenyl-4-yloxy)-2-oxo-octanoic acid
TTDR01156	Inhibitor	8-Mercapto-octanoic acid phenylamide
TTDR01156	Inhibitor	8-Oxo-8-phenyl-octanoic acid
TTDR01156	Inhibitor	8-Oxo-8-phenyl-octanoic acid hydroxyamide
TTDR01156	Inhibitor	8-Phenyl-octanoic acid hydroxyamide
TTDR01156	Inhibitor	9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide
TTDR01156	Inhibitor	9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one
TTDR01156	Inhibitor	CI-994
TTDR01156	Inhibitor	Cyclostellettamine derivative
TTDR01156	Inhibitor	DEPUDECIN
TTDR01156	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide
TTDR01156	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-succinamide
TTDR01156	Inhibitor	N-(2-amino-5-(benzofuran-2-yl)phenyl)benzamide
TTDR01156	Inhibitor	N-(2-amino-5-(furan-2-yl)phenyl)benzamide
TTDR01156	Inhibitor	N-(2-amino-5-(furan-3-yl)phenyl)benzamide
TTDR01156	Inhibitor	N-(2-amino-5-(pyridin-4-yl)phenyl)benzamide
TTDR01156	Inhibitor	N-(2-amino-5-(thiazol-2-yl)phenyl)benzamide
TTDR01156	Inhibitor	N-(2-amino-5-(thiophen-2-yl)phenyl)nicotinamide
TTDR01156	Inhibitor	N-(2-aminophenyl)-4-methoxybenzamide
TTDR01156	Inhibitor	N-(2-aminophenyl)benzamide
TTDR01156	Inhibitor	N-(2-aminophenyl)nicotinamide
TTDR01156	Inhibitor	N-(2-aminophenyl)quinoxaline-6-carboxamide
TTDR01156	Inhibitor	N-(3'-acetyl-4-aminobiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(4'-acetyl-4-aminobiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(4-amino-3'-methoxybiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(4-amino-3'-methylbiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(4-amino-4'-bromobiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(4-amino-4'-fluorobiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(4-amino-4'-methoxybiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(4-amino-4'-vinylbiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(4-aminobiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(4-aminobiphenyl-3-yl)nicotinamide
TTDR01156	Inhibitor	N-(4-hydroxybiphenyl-3-yl)benzamide
TTDR01156	Inhibitor	N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide
TTDR01156	Inhibitor	N-(6-Hydroxycarbamoyl-hexyl)-benzamide
TTDR01156	Inhibitor	N-(6-Mercapto-hexyl)-benzamide
TTDR01156	Inhibitor	N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide
TTDR01156	Inhibitor	N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide
TTDR01156	Inhibitor	N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide
TTDR01156	Inhibitor	N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide
TTDR01156	Inhibitor	N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide
TTDR01156	Inhibitor	N-Hydroxy-4-(pentanoylamino-methyl)-benzamide
TTDR01156	Inhibitor	N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide
TTDR01156	Inhibitor	N-Hydroxy-4-phenylacetylamino-benzamide
TTDR01156	Inhibitor	N-Hydroxy-E-3-(4'-chlorobiphenyl-4-yl)-acrylamide
TTDR01156	Inhibitor	N-Hydroxy-E-3-(4'-cyanobiphenyl-4-yl)-acrylamide
TTDR01156	Inhibitor	N-Hydroxy-E-3-(biphenyl-4-yl)-acrylamide
TTDR01156	Inhibitor	N-hydroxy-4-(3-phenylpropanamido)benzamide
TTDR01156	Inhibitor	N7-hydroxy-2-methoxy-N1-phenylheptanediamide
TTDR01156	Inhibitor	N7-hydroxy-N1-phenyl-2-propoxyheptanediamide
TTDR01156	Inhibitor	N8,2-dihydroxy-N1-phenyloctanediamide
TTDR01156	Inhibitor	N8-hydroxy-2-methoxy-N1-phenyloctanediamide
TTDR01156	Inhibitor	Octanedioic acid bis-hydroxyamide
TTDR01156	Inhibitor	Octanedioic acid hydroxyamide pyridin-2-ylamide
TTDR01156	Inhibitor	Octanedioic acid hydroxyamide pyridin-4-ylamide
TTDR01156	Inhibitor	PSAMMAPLIN A
TTDR01156	Inhibitor	ST-2986
TTDR01156	Inhibitor	ST-2987
TTDR01156	Inhibitor	Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester
TTDR01157	UniProt ID	Q9HX21
TTDR01157	Name	Probable nicotinate-nucleotide adenylyltransferase
TTDR01157	Type of target	Research target
TTDR01157	Synonyms	Deamido-NAD(+) diphosphorylase
TTDR01157	Synonyms	Deamido-NAD(+) pyrophosphorylase
TTDR01157	Synonyms	NaMN AT
TTDR01157	Synonyms	NaMN adenylyltransferase
TTDR01157	Synonyms	NaMN-Atase
TTDR01157	Synonyms	Nicotinate mononucleotide adenylyltransferase
TTDR01157	Synonyms	Nicotinate-nucleotide adenylyltransferase
TTDR01157	Synonyms	Nicotinic acid mononucleotide adenylyltransferase
TTDR01157	Disease	Bacterial infections
TTDR01157	Function	Catalyzes the reversible adenylation of nicotinate mononucleotide (namn) to nico
TTDR01157	Sequence	MGKRIGLFGGTFDPVHIGHMRSAVEMAEQFALDELRLLPNARPPHRETPQVSAAQRLAMVERAVAGVERLTVDPRELQRD
TTDR01157	PDB Structure	1YUL; 1YUM; 1YUN
TTDR01157	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01157	Pathway	Metabolic pathways
TTDR01157	Pathway	Nicotinate and nicotinamide metabolism
TTDR01157	EC Number	EC 2.7.7.18
TTDR01157	Inhibitor	Deamido-Nad+
TTDR01157	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR01158	UniProt ID	P31268
TTDR01158	Name	Homeobox protein Hox-A7
TTDR01158	Type of target	Research target
TTDR01158	Synonyms	Hox 1.1
TTDR01158	Synonyms	Hox-1A
TTDR01158	Synonyms	HoxA7
TTDR01158	Disease	Myeloid leukemia
TTDR01158	Function	Sequence-specific transcription factor which is part of a developmental regulato
TTDR01158	Sequence	MSSSYYVNALFSKYTAGTSLFQNAEPTSCSFAPNSQRSGYGAGAGAFASTVPGLYNVNSPLYQSPFASGYGLGADAYGNL
TTDR01159	UniProt ID	Q07954
TTDR01159	Name	Low-density lipoprotein receptor-related protein 1
TTDR01159	Type of target	Research target
TTDR01159	Synonyms	A2MR
TTDR01159	Synonyms	APOER
TTDR01159	Synonyms	Alpha-2-macroglobulin receptor
TTDR01159	Synonyms	Apolipoprotein E receptor
TTDR01159	Synonyms	CD91
TTDR01159	Synonyms	LRP
TTDR01159	Synonyms	LRP1
TTDR01159	Disease	Proliferative vitreoretinopathy
TTDR01159	Function	Involved in the plasma clearance of chylomicron remnants and activated alpha 2-m
TTDR01159	Sequence	MLTPPLLLLLPLLSALVAAAIDAPKTCSPKQFACRDQITCISKGWRCDGERDCPDGSDEAPEICPQSKAQRCQPNEHNCL
TTDR01159	PDB Structure	1CR8; 1D2L; 1J8E; 2FYJ; 2FYL; 2KNX; 2KNY
TTDR01159	BioChemical Class	Growth factor
TTDR01159	Pathway	Alzheimer's disease
TTDR01160	UniProt ID	Q9HBA0
TTDR01160	Name	Transient receptor potential cation channel subfamily V member 4
TTDR01160	Type of target	Research target
TTDR01160	Synonyms	OTRPC4
TTDR01160	Synonyms	Osm-9-like TRP channel 4
TTDR01160	Synonyms	TRP12
TTDR01160	Synonyms	Transient receptor potential protein 12
TTDR01160	Synonyms	TrpV4
TTDR01160	Synonyms	VR-OAC
TTDR01160	Synonyms	VRL-2
TTDR01160	Synonyms	VRL2
TTDR01160	Synonyms	VROAC
TTDR01160	Synonyms	Vanilloid receptor-like channel 2
TTDR01160	Synonyms	Vanilloid receptor-like protein 2
TTDR01160	Synonyms	Vanilloid receptor-related osmotically-activated channel
TTDR01160	Disease	Analgesics
TTDR01160	Disease	Neuropathic pain
TTDR01160	PDB Structure	4DX1; 4DX2
TTDR01160	Target Validation	TTDR01160
TTDR01160	Inhibitor	4-Pyridin-2-yl-piperazine-1-carboxylic acid amide
TTDR01160	Inhibitor	CAPSAZEPINE
TTDR01160	Inhibitor	IODORESINIFERATOXIN
TTDR01160	Inhibitor	MK-056
TTDR01160	Inhibitor	Pyrrolidin-1-yl-thiourea
TTDR01160	Inhibitor	SC-0030;SC0030
TTDR01161	UniProt ID	Q8MTU2
TTDR01161	Name	Toxopain-1
TTDR01161	Type of target	Research target
TTDR01161	Synonyms	Cysteine proteinase
TTDR01161	Disease	Parasitic diseases
TTDR01161	Sequence	MEGRKSFRVLGTPLPFAALAAILLLGCMYTRAAGTPDDSLFPLSEDTSVDPRESFSAEDVLNAFVSPESVESLFDSIVAE
TTDR01161	BioChemical Class	Protease
TTDR01162	Name	mRNA of platelet-derived growth factor receptor beta subunit
TTDR01162	Type of target	Research target
TTDR01162	Synonyms	mRNA of PDGFR-beta
TTDR01162	Disease	Liver fibrosis
TTDR01162	Antisense	Antisense PDGFR-beta
TTDR01163	Name	GABA transporter-3
TTDR01163	Type of target	Research target
TTDR01163	Synonyms	GABA transporter 3
TTDR01163	Synonyms	GABA transporter type 3
TTDR01163	Synonyms	GAT-3
TTDR01163	Synonyms	Gamma-aminobutyric acid transporter 3
TTDR01163	Disease	Neurological diseases
TTDR01163	Target Validation	TTDR01163
TTDR01163	Inhibitor	2,4-Diamino-butyric acid(GABA)
TTDR01163	Inhibitor	4-Hydroxy-piperidine-3-carboxylic acid
TTDR01163	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDR01163	Inhibitor	NIPECOTIC ACID
TTDR01163	Blocker	Beta-Alanine
TTDR01164	UniProt ID	Q8NBP7
TTDR01164	Name	Proprotein convertase subtilisin/kexin type 9
TTDR01164	Type of target	Clinical trial target
TTDR01164	Synonyms	NARC-1
TTDR01164	Synonyms	Neural apoptosis-regulated convertase 1
TTDR01164	Synonyms	Proprotein convertase PC9
TTDR01164	Synonyms	Subtilisin/kexin-like protease PC9
TTDR01164	Disease	Dyslipidemia
TTDR01164	Function	May be implicated in the differentiation of cortical neurons and may play a role
TTDR01164	Sequence	MGTVSSRRSWWPLPLLLLLLLLLGPAGARAQEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVV
TTDR01164	PDB Structure	2P4E; 2PMW; 2QTW; 2W2M; 2W2N; 2W2O; 2W2P; 2W2Q; 2XTJ; 3BPS; 3GCW; 3GCX; 3H42; 3M
TTDR01164	EC Number	EC 3.4.21.-
TTDR01164	Drug(s)	ALN-PCS01
TTDR01164	Drug(s)	AMG 145
TTDR01164	Drug(s)	PCSK9 inhibitor
TTDR01164	Drug(s)	SPC5001
TTDR01164	Inhibitor	ALN-PCS01
TTDR01164	Inhibitor	PCSK9 inhibitor
TTDR01164	Inhibitor	SPC5001
TTDR01165	UniProt ID	P25105
TTDR01165	Name	Platelet-activating factor receptor
TTDR01165	Type of target	Research target
TTDR01165	Synonyms	PAF-R
TTDR01165	Disease	Ocular allergy
TTDR01165	Function	Receptor for platelet activating factor, a chemotactic phospholipid mediator tha
TTDR01165	Sequence	MEPHDSSHMDSEFRYTLFPIVYSIIFVLGVIANGYVLWVFARLYPCKKFNEIKIFMVNLTMADMLFLITLPLWIVYYQNQ
TTDR01165	PDB Structure	2B0X
TTDR01165	Pathway	Calcium signaling pathway
TTDR01165	Pathway	Neuroactive ligand-receptor interaction
TTDR01165	Target Validation	TTDR01165
TTDR01165	Drug(s)	Apafant
TTDR01165	Inhibitor	L-652731
TTDR01165	Inhibitor	L-659989
TTDR01165	Inhibitor	L-680573;MK-287
TTDR01165	Inhibitor	RUPATADINE
TTDR01165	Inhibitor	Ro-24-0238
TTDR01165	Inhibitor	SCH-37370
TTDR01165	Inhibitor	SDZ-64-412
TTDR01165	Inhibitor	VERAGUENSIN
TTDR01165	Antagonist	Apafant
TTDR01166	UniProt ID	P08004
TTDR01166	Name	Chitin synthase 1
TTDR01166	Type of target	Research target
TTDR01166	Synonyms	Chitin-UDP acetyl-glucosaminyl transferase 1
TTDR01166	Disease	Fungal diseases
TTDR01166	Function	Septum formation and repair, especially under certain adverse conditions.
TTDR01166	Sequence	MSDQNNRSRNEYHSNRKNEPSYELQNAHSGLFHSSNEELTNRNQRYTNQNASMGSFTPVQSLQFPEQSQQTNMLYNGDDG
TTDR01166	Pathway	Amino sugar and nucleotide sugar metabolism
TTDR01166	EC Number	EC 2.4.1.16
TTDR01166	Target Validation	TTDR01166
TTDR01166	Drug(s)	Chitin synthase inhibitor
TTDR01166	Inhibitor	Chitin synthase inhibitor
TTDR01166	Inhibitor	NIKKOMYCIN
TTDR01167	UniProt ID	Q9UBN7
TTDR01167	Name	Histone deacetylase 6
TTDR01167	Type of target	Research target
TTDR01167	Synonyms	HD6
TTDR01167	Disease	Multiple myeloma
TTDR01167	Function	Responsible for the deacetylation of lysine residues on the N-terminal part of t
TTDR01167	Sequence	MTSTGQDSTTTRQRRSRQNPQSPPQDSSVTSKRNIKKGAVPRSIPNLAEVKKKGKMKKLGQAMEEDLIVGLQGMDLNLEA
TTDR01167	PDB Structure	3C5K; 3GV4; 3PHD
TTDR01167	EC Number	EC 3.5.1.98
TTDR01167	Target Validation	TTDR01167
TTDR01167	QSAR Model	TTDR01167
TTDR01167	Inhibitor	(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one
TTDR01167	Inhibitor	(S)-2-Amino-N-cyclopentyl-7-mercaptoheptanamide
TTDR01167	Inhibitor	2-(methylsulfonylthio)ethyl 2-propylpentanoate
TTDR01167	Inhibitor	4-Benzoylamino-N-hydroxy-benzamide
TTDR01167	Inhibitor	4-Butyrylamino-N-hydroxy-benzamide
TTDR01167	Inhibitor	4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDR01167	Inhibitor	4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide
TTDR01167	Inhibitor	4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDR01167	Inhibitor	4-Phenylbutyrohydroxamic acid
TTDR01167	Inhibitor	5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide
TTDR01167	Inhibitor	5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione
TTDR01167	Inhibitor	5-Mercapto-pentanoic acid phenylamide
TTDR01167	Inhibitor	6-(2-Bromo-acetylamino)-hexanoic acid phenylamide
TTDR01167	Inhibitor	6-(9H-carbazol-9-yl)-N-hydroxyhexanamide
TTDR01167	Inhibitor	6-Mercapto-hexanoic acid phenylamide
TTDR01167	Inhibitor	6-Phenoxy-hexane-1-thiol
TTDR01167	Inhibitor	6-benzenesulfinylhexanoic acid hydroxamide
TTDR01167	Inhibitor	6-benzenesulfonylhexanoic acid hydroxamide
TTDR01167	Inhibitor	6-phenylsulfanylhexanoic acid hydroxamide
TTDR01167	Inhibitor	7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01167	Inhibitor	7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one
TTDR01167	Inhibitor	7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01167	Inhibitor	7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01167	Inhibitor	7-Mercapto-heptanoic acid benzothiazol-2-ylamide
TTDR01167	Inhibitor	7-Mercapto-heptanoic acid biphenyl-3-ylamide
TTDR01167	Inhibitor	7-Mercapto-heptanoic acid biphenyl-4-ylamide
TTDR01167	Inhibitor	7-Mercapto-heptanoic acid phenylamide
TTDR01167	Inhibitor	7-Mercapto-heptanoic acid pyridin-3-ylamide
TTDR01167	Inhibitor	7-Mercapto-heptanoic acid quinolin-3-ylamide
TTDR01167	Inhibitor	7-mercapto-N-(4-phenylthiazol-2-yl)heptanamide
TTDR01167	Inhibitor	8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one
TTDR01167	Inhibitor	8-Mercapto-octanoic acid phenylamide
TTDR01167	Inhibitor	8-Oxo-8-phenyl-octanoic acid
TTDR01167	Inhibitor	8-Oxo-8-phenyl-octanoic acid hydroxyamide
TTDR01167	Inhibitor	9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide
TTDR01167	Inhibitor	9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one
TTDR01167	Inhibitor	Cyclostellettamine derivative
TTDR01167	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide
TTDR01167	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-succinamide
TTDR01167	Inhibitor	N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide
TTDR01167	Inhibitor	N-(6-Hydroxycarbamoyl-hexyl)-benzamide
TTDR01167	Inhibitor	N-(6-Mercapto-hexyl)-benzamide
TTDR01167	Inhibitor	N-(biphenyl-3-yl)-6-(sulfamoylamino)hexanamide
TTDR01167	Inhibitor	N-(quinolin-3-yl)-6-(sulfamoylamino)hexanamide
TTDR01167	Inhibitor	N-(quinolin-6-yl)-6-(sulfamoylamino)hexanamide
TTDR01167	Inhibitor	N-(quinolin-8-yl)-6-(sulfamoylamino)hexanamide
TTDR01167	Inhibitor	N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide
TTDR01167	Inhibitor	N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide
TTDR01167	Inhibitor	N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide
TTDR01167	Inhibitor	N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide
TTDR01167	Inhibitor	N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide
TTDR01167	Inhibitor	N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide
TTDR01167	Inhibitor	N-Hydroxy-4-(pentanoylamino-methyl)-benzamide
TTDR01167	Inhibitor	N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide
TTDR01167	Inhibitor	N-Hydroxy-4-phenylacetylamino-benzamide
TTDR01167	Inhibitor	N-[5-(Formyl-hydroxy-amino)-pentyl]-benzamide
TTDR01167	Inhibitor	N-phenyl-6-(sulfamoylamino)hexanamide
TTDR01167	Inhibitor	N1-(biphenyl-3-yl)-N8-hydroxyoctanediamide
TTDR01167	Inhibitor	N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide
TTDR01167	Inhibitor	N1-hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide
TTDR01167	Inhibitor	NILTUBACIN
TTDR01167	Inhibitor	Octanedioic acid bis-hydroxyamide
TTDR01167	Inhibitor	Octanedioic acid hydroxyamide pyridin-2-ylamide
TTDR01167	Inhibitor	Octanedioic acid hydroxyamide pyridin-4-ylamide
TTDR01167	Inhibitor	PSAMMAPLIN A
TTDR01167	Inhibitor	ST-2741
TTDR01167	Inhibitor	ST-2986
TTDR01167	Inhibitor	ST-2987
TTDR01167	Inhibitor	ST-3050
TTDR01167	Inhibitor	Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester
TTDR01167	Inhibitor	Tubacin
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ph4-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ph5-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Phe-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Phg-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ser(Bzl)-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-Aib-L-Ser-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-L-2MePhe-L-Ala-D-Pro-)
TTDR01167	Inhibitor	cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-)
TTDR01168	UniProt ID	Q9S400
TTDR01168	Name	3-phosphoshikimate 1-carboxyvinyltransferase
TTDR01168	Type of target	Research target
TTDR01168	Synonyms	5-enolpyruvylshikimate-3-phosphate synthase
TTDR01168	Synonyms	EPSP synthase
TTDR01168	Synonyms	EPSPS
TTDR01168	Disease	Malaria
TTDR01168	Sequence	MKLKTNIRHLHGSIRVPGDKSISHRSIIFGSLAEGETKVYDILRGEDVLSTMQVFRDLGVEIEDKDGVITIQGVGMAGLK
TTDR01168	PDB Structure	1RF4; 1RF5; 1RF6
TTDR01168	Pathway	Metabolic pathways
TTDR01168	Pathway	Phenylalanine, tyrosine and tryptophan biosynthesis
TTDR01168	EC Number	EC 2.5.1.19
TTDR01168	Inhibitor	Formic Acid
TTDR01168	Inhibitor	Glyphosate
TTDR01168	Inhibitor	Shikimate-3-Phosphate
TTDR01169	UniProt ID	P0AFI2
TTDR01169	Name	DNA topoisomerase 4 subunit A
TTDR01169	Type of target	Research target
TTDR01169	Synonyms	Topoisomerase IV subunit A
TTDR01169	Disease	Bacterial infections
TTDR01169	Function	Topoisomerase IV is essential for chromosome segregation. It has relaxation of s
TTDR01169	Sequence	MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDS
TTDR01169	PDB Structure	1ZVT; 1ZVU
TTDR01169	EC Number	EC 5.99.1.-
TTDR01169	Target Validation	TTDR01169
TTDR01169	Inhibitor	A-62824
TTDR01169	Binder	CBR-2092
TTDR01170	UniProt ID	P05107
TTDR01170	Name	Integrin beta-2
TTDR01170	Type of target	Research target
TTDR01170	Synonyms	CD18
TTDR01170	Synonyms	Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta
TTDR01170	Synonyms	Complement receptor C3 subunit beta
TTDR01170	Disease	Ischemic stroke
TTDR01170	Function	Integrin alpha-L/beta-2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. Integri
TTDR01170	Sequence	MLGLRPPLLALVGLLSLGCVLSQECTKFKVSSCRECIESGPGCTWCQKLNFTGPGDPDSIRCDTRPQLLMRGCAADDIMD
TTDR01170	PDB Structure	1JX3; 1L3Y; 1YUK; 2JF1; 2P26; 2P28; 2V7D; 3K6S; 3K71; 3K72
TTDR01170	Pathway	Cell adhesion molecules (CAMs)
TTDR01170	Pathway	Leukocyte transendothelial migration
TTDR01170	Pathway	Natural killer cell mediated cytotoxicity
TTDR01170	Pathway	Regulation of actin cytoskeleton
TTDR01170	Target Validation	TTDR01170
TTDR01170	Inhibitor	A-286982
TTDR01170	Inhibitor	BMS-587101;BMS-688521
TTDR01170	Antagonist	UK-279,276
TTDR01171	Name	Hypoxia-inducible gene DDIT4
TTDR01171	Type of target	Research target
TTDR01171	Disease	Diabetic macular oedema
TTDR01171	siRNA	PF-04523655
TTDR01172	Name	mRNA of thymidylate synthase
TTDR01172	Type of target	Research target
TTDR01172	Disease	Cancer
TTDR01172	Antisense	TS antisense + 5-FU
TTDR01172	Antisense	TS antisense + raltitrexed
TTDR01173	Name	mRNA of MCL-1
TTDR01173	Type of target	Research target
TTDR01173	Disease	Systemic mastocytosis
TTDR01173	Antisense	MCL-1-specific antisense oligonucleotide + Imatinib (STI571)
TTDR01173	Antisense	MCL-1-specific antisense oligonucleotide + midostaurin(PKC412)
TTDR01173	Antisense	MCL-1-specific antisense oligonucleotide + nilotinib (AMN107)
TTDR01174	Name	mRNA of Tumour protein p53
TTDR01174	Type of target	Clinical trial target
TTDR01174	Disease	Acute kidney injury
TTDR01174	Drug(s)	OPI-1002
TTDR01174	siRNA	OPI-1002
TTDR01174	siRNA	QPI-1002
TTDR01175	Name	mRNA of HIV-1 Gag
TTDR01175	Type of target	Research target
TTDR01175	Disease	AIDS
TTDR01175	Drug(s)	Gem 92
TTDR01175	Antisense	Gem 92
TTDR01176	Name	Respiratory syncytial virus genomic RNA
TTDR01176	Type of target	Research target
TTDR01176	Disease	Upper and lower respiratory tract disease
TTDR01176	Antisense	RBI034 (2-5A antisense compound) + Ribavirin
TTDR01177	UniProt ID	P47869
TTDR01177	Name	Gamma-aminobutyric-acid receptor alpha-2 subunit
TTDR01177	Type of target	Research target
TTDR01177	Synonyms	GABA(A)Gamma-aminobutyric-acid receptor alpha-2 subunit precursor receptor
TTDR01177	Synonyms	GABA-A receptor alpha 2
TTDR01177	Disease	Anxiety disorder, unspecified
TTDR01177	Disease	Disorders of initiating and maintaining sleep [insomnias]
TTDR01177	Function	GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates ne
TTDR01177	Sequence	MKTKLNIYNMQFLLFVFLVWDPARLVLANIQEDEAKNNITIFTRILDRLLDGYDNRLRPGLGDSITEVFTNIYVTSFGPV
TTDR01177	BioChemical Class	Chloride channel
TTDR01177	Pathway	Neuroactive ligand-receptor interaction
TTDR01177	Related US Patent	6,399,608
TTDR01177	Target Validation	TTDR01177
TTDR01177	Inhibitor	(2E,4S)-4-ammoniopent-2-enoate
TTDR01177	Inhibitor	(4R)-4-ammoniopentanoate
TTDR01177	Inhibitor	(4S)-4-ammoniopentanoate
TTDR01177	Inhibitor	3-(benzyloxy)-9H-pyrido[3,4-b]indole
TTDR01177	Inhibitor	3-(hexa-1,3-dienyloxy)-9H-pyrido[3,4-b]indole
TTDR01177	Inhibitor	3-(isopentyloxy)-9H-pyrido[3,4-b]indole
TTDR01177	Inhibitor	3-Ethoxy-9H-beta-carboline
TTDR01177	Inhibitor	3-butoxy-9H-pyrido[3,4-b]indole
TTDR01177	Inhibitor	3-ethoxy-9H-pyrido[3,4-b]indole
TTDR01177	Inhibitor	3-isobutoxy-9H-pyrido[3,4-b]indole
TTDR01177	Inhibitor	3-propoxy-9H-pyrido[3,4-b]indole
TTDR01177	Inhibitor	5-[(1R)-1-ammonioethyl]isoxazol-3-olate
TTDR01177	Inhibitor	5-[(1S)-1-ammonioethyl]isoxazol-3-olate
TTDR01177	Inhibitor	AMENTOFLAVONE
TTDR01177	Inhibitor	Barbital
TTDR01177	Inhibitor	Barbituric acid derivative
TTDR01177	Inhibitor	CGS-17867A
TTDR01177	Inhibitor	CI-218872
TTDR01177	Inhibitor	Ethyl 9H-pyrido[3,4-b]indole-3-carboxylate
TTDR01177	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDR01177	Inhibitor	L-655708;NCGC00025115-02
TTDR01177	Inhibitor	RY-066
TTDR01177	Inhibitor	Ro-151310
TTDR01177	Inhibitor	Ro-154513
TTDR01177	Inhibitor	Ro-4882224
TTDR01177	Inhibitor	Ro-4938581
TTDR01177	Inhibitor	TPA-023
TTDR01177	Inhibitor	beta-Carboline-3-carboxylic acid t-butyl ester
TTDR01177	Inhibitor	ethyl 6-iodo-9H-pyrido[3,4-b]indole-3-carboxylate
TTDR01177	Inhibitor	sec-butyl 9H-pyrido[3,4-b]indole-3-carboxylate
TTDR01178	UniProt ID	P34903
TTDR01178	Name	Gamma-aminobutyric-acid receptor alpha-3 subunit
TTDR01178	Type of target	Research target
TTDR01178	Synonyms	GABA(A)Gamma-aminobutyric-acid receptor alpha-3 subunit precursor receptor
TTDR01178	Synonyms	GABA-A receptor alpha 3
TTDR01178	Disease	Anxiety disorder, unspecified
TTDR01178	Disease	Disorders of initiating and maintaining sleep [insomnias]
TTDR01178	Function	GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates ne
TTDR01178	Sequence	MIITQTSHCYMTSLGILFLINILPGTTGQGESRRQEPGDFVKQDIGGLSPKHAPDIPDDSTDNITIFTRILDRLLDGYDN
TTDR01178	BioChemical Class	Chloride channel
TTDR01178	Pathway	Neuroactive ligand-receptor interaction
TTDR01178	Related US Patent	6,399,608
TTDR01178	Target Validation	TTDR01178
TTDR01178	QSAR Model	TTDR01178
TTDR01178	Inhibitor	(2E,4S)-4-ammoniopent-2-enoate
TTDR01178	Inhibitor	(4R)-4-ammoniopentanoate
TTDR01178	Inhibitor	(4S)-4-ammoniopentanoate
TTDR01178	Inhibitor	3-(benzyloxy)-9H-pyrido[3,4-b]indole
TTDR01178	Inhibitor	3-(hexa-1,3-dienyloxy)-9H-pyrido[3,4-b]indole
TTDR01178	Inhibitor	3-(isopentyloxy)-9H-pyrido[3,4-b]indole
TTDR01178	Inhibitor	3-butoxy-9H-pyrido[3,4-b]indole
TTDR01178	Inhibitor	3-ethoxy-9H-pyrido[3,4-b]indole
TTDR01178	Inhibitor	3-isobutoxy-9H-pyrido[3,4-b]indole
TTDR01178	Inhibitor	3-propoxy-9H-pyrido[3,4-b]indole
TTDR01178	Inhibitor	5-[(1R)-1-ammonioethyl]isoxazol-3-olate
TTDR01178	Inhibitor	5-[(1S)-1-ammonioethyl]isoxazol-3-olate
TTDR01178	Inhibitor	6-benzyl-3-ethoxycarbonyl-4-quinolone
TTDR01178	Inhibitor	6-bromo-3-ethoxycarbonyl-4-quinolone
TTDR01178	Inhibitor	6-ethyl-3-(3-methylbutoxycarbonyl)-4-quinolone
TTDR01178	Inhibitor	AMENTOFLAVONE
TTDR01178	Inhibitor	Barbital
TTDR01178	Inhibitor	Barbituric acid derivative
TTDR01178	Inhibitor	CI-218872
TTDR01178	Inhibitor	Ethyl 9H-pyrido[3,4-b]indole-3-carboxylate
TTDR01178	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDR01178	Inhibitor	L-655708;NCGC00025115-02
TTDR01178	Inhibitor	RY-066
TTDR01178	Inhibitor	Ro-151310
TTDR01178	Inhibitor	Ro-154513
TTDR01178	Inhibitor	Ro-4882224
TTDR01178	Inhibitor	Ro-4938581
TTDR01178	Inhibitor	TPA-023
TTDR01178	Inhibitor	beta-Carboline-3-carboxylic acid t-butyl ester
TTDR01178	Inhibitor	ethyl 6-iodo-9H-pyrido[3,4-b]indole-3-carboxylate
TTDR01178	Inhibitor	sec-butyl 9H-pyrido[3,4-b]indole-3-carboxylate
TTDR01179	UniProt ID	P30531
TTDR01179	Name	Sodium- and chloride-dependent GABA transporter 1
TTDR01179	Type of target	Research target
TTDR01179	Synonyms	GABA transporter 1
TTDR01179	Disease	Convulsions
TTDR01179	Disease	Psychosis
TTDR01179	Function	Terminates the action of GABA by its high affinity sodium-dependent reuptake int
TTDR01179	Sequence	MATNGSKVADGQISTEVSEAPVANDKPKTLVVKVQKKAADLPDRDTWKGRFDFLMSCVGYAIGLGNVWRFPYLCGKNGGG
TTDR01179	BioChemical Class	Transmembrane protein
TTDR01179	Target Validation	TTDR01179
TTDR01179	Inhibitor	(R)-Piperidine-3-carboxylic acid
TTDR01179	Inhibitor	(S)-Piperidine-3-carboxylic acid
TTDR01179	Inhibitor	2,4-Diamino-butyric acid(GABA)
TTDR01179	Inhibitor	4-Hydroxy-piperidine-3-carboxylic acid
TTDR01179	Inhibitor	GAMMA-AMINO-BUTANOIC ACID
TTDR01179	Inhibitor	NIPECOTIC ACID
TTDR01180	UniProt ID	P18825
TTDR01180	Name	Alpha-2C adrenergic receptor
TTDR01180	Type of target	Research target
TTDR01180	Synonyms	Alpha-2C adrenoceptor
TTDR01180	Synonyms	Alpha-2C adrenoreceptor
TTDR01180	Synonyms	Subtype C4
TTDR01180	Disease	Neuropsychiatric disorders
TTDR01180	Disease	Raynaud's syndrome
TTDR01180	Function	Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of ade
TTDR01180	Sequence	MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSR
TTDR01180	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01180	Pathway	Neuroactive ligand-receptor interaction
TTDR01180	Related US Patent	6,593,324
TTDR01180	Target Validation	TTDR01180
TTDR01180	Inhibitor	(+/-)-nantenine
TTDR01180	Inhibitor	(1,2,3,4-Tetrahydro-isoquinolin-3-yl)-methanol
TTDR01180	Inhibitor	(1H-Benzoimidazol-5-yl)-(1H-imidazol-2-yl)-amine
TTDR01180	Inhibitor	(1H-Imidazol-2-yl)-quinoxalin-6-yl-amine
TTDR01180	Inhibitor	(2,6-Dichloro-phenyl)-(1H-imidazol-2-yl)-amine
TTDR01180	Inhibitor	(2-Bromo-phenyl)-(1H-imidazol-2-yl)-amine
TTDR01180	Inhibitor	(2-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine
TTDR01180	Inhibitor	(3-Ethyl-indol-1-yl)-propyl-pyridin-4-yl-amine
TTDR01180	Inhibitor	(3-Methyl-indol-1-yl)-propyl-pyridin-4-yl-amine
TTDR01180	Inhibitor	(R)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline
TTDR01180	Inhibitor	(S)-3-Methyl-1,2,3,4-tetrahydro-isoquinoline
TTDR01180	Inhibitor	1,2,3,4,4a,5,10,10a-Octahydro-benzo[g]quinoline
TTDR01180	Inhibitor	1,2,3,4,5,6-Hexahydro-benzo[c]azocine
TTDR01180	Inhibitor	1,2,3,4-Tetrahydro-benzo[h]isoquinolin-8-ol
TTDR01180	Inhibitor	1,2,3,4-Tetrahydro-isoquinolin-7-ol
TTDR01180	Inhibitor	1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole
TTDR01180	Inhibitor	1,2,3,4-tetrahydroisoquinoline
TTDR01180	Inhibitor	1-((S)-2-aminopropyl)-1H-indazol-6-ol
TTDR01180	Inhibitor	2,3,4,5-Tetrahydro-1H-benzo[c]azepine
TTDR01180	Inhibitor	2,3,4,5-Tetrahydro-1H-benzo[e][1,4]diazepine
TTDR01180	Inhibitor	2,3,4,5-Tetrahydro-benzo[f][1,4]oxazepine
TTDR01180	Inhibitor	2,3-Dihydro-1H-isoindole
TTDR01180	Inhibitor	2-Benzofuran-2-yl-4,5-dihydro-1H-imidazole
TTDR01180	Inhibitor	3-Fluoromethyl-1,2,3,4-tetrahydro-isoquinoline
TTDR01180	Inhibitor	3-Methoxymethyl-1,2,3,4-tetrahydro-isoquinoline
TTDR01180	Inhibitor	3-Methyl-1,2,3,4-tetrahydro-isoquinoline
TTDR01180	Inhibitor	4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole
TTDR01180	Inhibitor	4-(4-Methyl-indan-1-yl)-1H-imidazole
TTDR01180	Inhibitor	5-Aminomethyl-naphthalen-2-ol
TTDR01180	Inhibitor	6,7,8,9-Tetrahydro-5-thia-8-aza-benzocycloheptene
TTDR01180	Inhibitor	7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline
TTDR01180	Inhibitor	8-Methoxy-1,2,3,4-tetrahydro-benzo[h]isoquinoline
TTDR01180	Inhibitor	A-80426
TTDR01180	Inhibitor	Butyl-indol-1-yl-pyridin-4-yl-amine
TTDR01180	Inhibitor	C-(6-Methoxy-naphthalen-1-yl)-methylamine
TTDR01180	Inhibitor	C-Naphthalen-1-yl-methylamine
TTDR01180	Inhibitor	CONESSINE
TTDR01180	Inhibitor	Ethyl-indol-1-yl-pyridin-4-yl-amine
TTDR01180	Inhibitor	GNF-PF-2857
TTDR01180	Inhibitor	GNF-PF-3427
TTDR01180	Inhibitor	GNF-PF-3878
TTDR01180	Inhibitor	INDORAMIN
TTDR01180	Inhibitor	Indol-1-yl-methyl-pyridin-4-yl-amine
TTDR01180	Inhibitor	Indol-1-yl-prop-2-ynyl-pyridin-4-yl-amine
TTDR01180	Inhibitor	Indol-1-yl-propyl-pyridin-4-yl-amine
TTDR01180	Inhibitor	Indol-1-yl-pyridin-4-yl-amine
TTDR01180	Inhibitor	MAZAPERTINE
TTDR01180	Inhibitor	MEDETOMIDINE
TTDR01180	Inhibitor	METHYLNORADRENALINE
TTDR01180	Inhibitor	MEZILAMINE
TTDR01180	Inhibitor	MOXONIDINE
TTDR01180	Inhibitor	PIPEROXAN
TTDR01180	Inhibitor	R-226161
TTDR01180	Inhibitor	RX-821002
TTDR01180	Inhibitor	S-34324
TTDR01180	Inhibitor	SK&F-104078;SK-104078
TTDR01180	Inhibitor	SK&F-64139;SK-64139
TTDR01180	Inhibitor	SNAP-5089
TTDR01180	Inhibitor	SNAP-5150
TTDR01180	Inhibitor	TRACIZOLINE
TTDR01180	Inhibitor	TRAMAZOLINE
TTDR01180	Inhibitor	TRYPTOLINE
TTDR01180	Inhibitor	WB-4101
TTDR01180	Inhibitor	Yohimbine Hydrochloride
TTDR01180	Antagonist	ARC239
TTDR01180	Antagonist	Ciproxifan
TTDR01180	Antagonist	MK-912
TTDR01180	Agonist	Chloroethylclonidine
TTDR01181	UniProt ID	Q01680
TTDR01181	Name	Plasma membrane H(+)-ATPase
TTDR01181	Type of target	Research target
TTDR01181	Disease	Fungal diseases
TTDR01181	Sequence	DDIDALIDDLESQDGDQEDNIEDTEFQSQRQVPEELLATDTRIGLTSQEVINRRKKYGLNKMKEEKENMIIKFLMYFVGP
TTDR01182	UniProt ID	P18405
TTDR01182	Name	3-oxo-5-alpha-steroid 4-dehydrogenase 1
TTDR01182	Type of target	Research target
TTDR01182	Synonyms	5-alpha reductase 1
TTDR01182	Synonyms	S5AR
TTDR01182	Synonyms	SR type 1
TTDR01182	Synonyms	Steroid 5-alpha-reductase 1
TTDR01182	Disease	Acne
TTDR01182	Disease	Alopecia, unspecified
TTDR01182	Disease	Benign prostate hyperplasia
TTDR01182	Disease	Hirsutism
TTDR01182	Disease	Prostate cancer
TTDR01182	Function	Converts testosterone into 5-alpha-dihydrotestosterone and progesterone or corti
TTDR01182	Sequence	MATATGVAEERLLAALAYLQCAVGCAVFARNRQTNSVYGRHALPSHRLRVPARAAWVVQELPSLALPLYQYASESAPRLR
TTDR01182	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDR01182	Pathway	Androgen and estrogen metabolism
TTDR01182	EC Number	EC 1.3.99.5
TTDR01182	Related US Patent	6,552,034
TTDR01182	Related US Patent	6,555,549
TTDR01182	Target Validation	TTDR01182
TTDR01182	Inhibitor	(3-fluoro-4-(4-phenoxybenzoyl)phenyl)acetic acid
TTDR01182	Inhibitor	(3-methyl-4-(4-phenoxybenzoyl)phenyl)acetic acid
TTDR01182	Inhibitor	(E)-3-(4-(4-phenoxybenzoyl)phenyl)acrylic acid
TTDR01182	Inhibitor	1,2,5,6-tetrahydro pyrido[1,2-a]quinolin-3-one
TTDR01182	Inhibitor	1-Methyl-5-(4-phenylazo-phenyl)-piperidin-2-one
TTDR01182	Inhibitor	1-Methyl-5-phenyl-piperidin-2-one
TTDR01182	Inhibitor	19-nor-10-azasteroid skeleton
TTDR01182	Inhibitor	2,3,5,6-Tetrafluoro-4-pentafluorophenylazo-phenol
TTDR01182	Inhibitor	3,4,5,6-Tetrahydrobenzo[c]quinolizin-3-(4aH)-one
TTDR01182	Inhibitor	4,4'-dihydroxyoctafluoroazobenzene
TTDR01182	Inhibitor	4-(4-phenoxybenzoyl)benzoic acid
TTDR01182	Inhibitor	4-Methyl-5,6-dihydro-pyrido[1,2-a]quinolin-3-one
TTDR01182	Inhibitor	4-[4-(benzhydryloxy)benzoyl]benzoic acid
TTDR01182	Inhibitor	4-[4-benzyloxy)benzoyl]benzoic acid
TTDR01182	Inhibitor	5-(4-Chloro-phenyl)-1-methyl-piperidin-2-one
TTDR01182	Inhibitor	5-(4-Chloro-phenyl)-1-methyl-piperidine-2-thione
TTDR01182	Inhibitor	Bexlosteride;LY-191704
TTDR01182	Inhibitor	FK-143
TTDR01182	Inhibitor	LY-266111
TTDR01182	Inhibitor	MK-386
TTDR01182	Inhibitor	ONO-3805
TTDR01182	Inhibitor	{4-[4-(4-bromophenoxy)benzoyl]phenyl}acetic acid
TTDR01183	UniProt ID	P31213
TTDR01183	Name	3-oxo-5-alpha-steroid 4-dehydrogenase 2
TTDR01183	Type of target	Research target
TTDR01183	Synonyms	5 alpha-SR2
TTDR01183	Synonyms	5-alpha reductase 2
TTDR01183	Synonyms	SR type 2
TTDR01183	Synonyms	Steroid 5-alpha-reductase 2
TTDR01183	Synonyms	Type 2 steroid 5alpha-reductase (5alpha-R)
TTDR01183	Disease	Alopecia, unspecified
TTDR01183	Disease	Androgen-dependent diseases
TTDR01183	Disease	Benign prostate hyperplasia
TTDR01183	Disease	Prostate cancer
TTDR01183	Function	Converts testosterone into 5-alpha-dihydrotestosterone and progesterone or corti
TTDR01183	Sequence	MQVQCQQSPVLAGSATLVALGALALYVAKPSGYGKHTESLKPAATRLPARAAWFLQELPSFAVPAGILARQPLSLFGPPG
TTDR01183	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDR01183	Pathway	Androgen and estrogen metabolism
TTDR01183	Pathway	Prostate cancer
TTDR01183	EC Number	EC 1.3.99.5
TTDR01183	Related US Patent	6,355,649
TTDR01183	Related US Patent	6,552,034
TTDR01183	Related US Patent	6,555,549
TTDR01183	Target Validation	TTDR01183
TTDR01183	Inhibitor	(3-fluoro-4-(4-phenoxybenzoyl)phenyl)acetic acid
TTDR01183	Inhibitor	(3-methyl-4-(4-phenoxybenzoyl)phenyl)acetic acid
TTDR01183	Inhibitor	(E)-3-(4-(4-phenoxybenzoyl)phenyl)acrylic acid
TTDR01183	Inhibitor	19-nor-10-azasteroid skeleton
TTDR01183	Inhibitor	2,3,5,6-Tetrafluoro-4-pentafluorophenylazo-phenol
TTDR01183	Inhibitor	3-[4-(4-phenoxybenzoyl)phenyl]propanoic acid
TTDR01183	Inhibitor	4,4'-dihydroxyoctafluoroazobenzene
TTDR01183	Inhibitor	4-(4-phenoxybenzoyl)benzoic acid
TTDR01183	Inhibitor	4-(4-phenoxybenzoyl)phenylacetic acid
TTDR01183	Inhibitor	4-[3-(benzyloxy)benzoyl]benzoic acid
TTDR01183	Inhibitor	4-[4-(benzhydryloxy)benzoyl]benzoic acid
TTDR01183	Inhibitor	4-[4-(benzoylamino)benzoyl]benzoic acid
TTDR01183	Inhibitor	4-[4-(benzylamino)benzoyl]benzoic acid
TTDR01183	Inhibitor	4-[4-benzyloxy)benzoyl]benzoic acid
TTDR01183	Inhibitor	FK-143
TTDR01183	Inhibitor	ONO-3805
TTDR01183	Inhibitor	{4-[4-(4-bromophenoxy)benzoyl]phenyl}acetic acid
TTDR01184	UniProt ID	P77580
TTDR01184	Name	Acetaldehyde dehydrogenase
TTDR01184	Type of target	Research target
TTDR01184	Synonyms	Acetaldehyde dehydrogenase [acetylating]
TTDR01184	Disease	Alcoholism
TTDR01184	Sequence	MSKRKVAIIGSGNIGTDLMIKILRHGQHLEMAVMVGIDPQSDGLARARRMGVATTHEGVIGLMNMPEFADIDIVFDATSA
TTDR01184	BioChemical Class	Oxidoreductases acting on the aldehyde or oxo group of donors
TTDR01184	Pathway	Butanoate metabolism
TTDR01184	Pathway	Metabolic pathways
TTDR01184	Pathway	Pyruvate metabolism
TTDR01184	EC Number	EC 1.2.1.10
TTDR01184	Inhibitor	Calcium carbimide
TTDR01185	UniProt ID	P05091
TTDR01185	Name	Aldehyde dehydrogenase, mitochondrial
TTDR01185	Type of target	Research target
TTDR01185	Synonyms	ALDH class 2
TTDR01185	Synonyms	ALDH-E2
TTDR01185	Synonyms	ALDH2
TTDR01185	Synonyms	ALDHI
TTDR01185	Synonyms	Aldehyde dehydrogenase
TTDR01185	Synonyms	Human liver mitochondrial aldehyde dehydrogenase
TTDR01185	Synonyms	Mitochondrial aldehyde dehydrogenase
TTDR01185	Disease	Alcoholism
TTDR01185	Sequence	MLRAAARFGPRLGRRLLSAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAV
TTDR01185	PDB Structure	1CW3; 1NZW; 1NZX; 1NZZ; 1O00; 1O01; 1O02; 1O04; 1O05; 1ZUM; 2ONM; 2ONN; 2ONO; 2O
TTDR01185	BioChemical Class	Oxidoreductases acting on the aldehyde or oxo group of donors
TTDR01185	Pathway	3-Chloroacrylic acid degradation
TTDR01185	Pathway	Arginine and proline metabolism
TTDR01185	Pathway	Ascorbate and aldarate metabolism
TTDR01185	Pathway	Butanoate metabolism
TTDR01185	Pathway	Fatty acid metabolism
TTDR01185	Pathway	Glycerolipid metabolism
TTDR01185	Pathway	Glycolysis / Gluconeogenesis
TTDR01185	Pathway	Histidine metabolism
TTDR01185	Pathway	Limonene and pinene degradation
TTDR01185	Pathway	Lysine degradation
TTDR01185	Pathway	Metabolic pathways
TTDR01185	Pathway	Propanoate metabolism
TTDR01185	Pathway	Pyruvate metabolism
TTDR01185	Pathway	Tryptophan metabolism
TTDR01185	Pathway	Valine, leucine and isoleucine degradation
TTDR01185	Pathway	beta-Alanine metabolism
TTDR01185	EC Number	EC 1.2.1.3
TTDR01185	Target Validation	TTDR01185
TTDR01185	Inhibitor	Crotonaldehyde
TTDR01185	Inhibitor	Daidzin
TTDR01185	Inhibitor	ISOFORMONENTIN
TTDR01185	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR01186	UniProt ID	P17445
TTDR01186	UniProt ID	P72155
TTDR01186	Name	Betaine aldehyde dehydrogenase
TTDR01186	Type of target	Research target
TTDR01186	Synonyms	BADH
TTDR01186	Disease	Bacterial infections
TTDR01186	Function	This is a soluble nad-dependent betaine aldehyde- specific dehydrogenase.
TTDR01186	Sequence	MSRMAEQQLYIHGGYTSATSGRTFETINPANGNVLATVQAAGREDVDRAVKSAQQGQKIWASMTAMERSRILRRAVDILR
TTDR01186	BioChemical Class	Oxidoreductases acting on the aldehyde or oxo group of donors
TTDR01186	Pathway	Glycine, serine and threonine metabolism
TTDR01186	EC Number	EC 1.2.1.8
TTDR01187	UniProt ID	Q12882
TTDR01187	Name	Dihydropyrimidine dehydrogenase [NADP+]
TTDR01187	Type of target	Research target
TTDR01187	Synonyms	DHPDHase
TTDR01187	Synonyms	DPD
TTDR01187	Synonyms	DPYD
TTDR01187	Synonyms	Dihydropyrimidine dehydrogenase
TTDR01187	Synonyms	Dihydrothymine dehydrogenase
TTDR01187	Synonyms	Dihydrouracil dehydrogenase
TTDR01187	Disease	Lung cancer
TTDR01187	Function	Involved in pyrimidine base degradation and catalyzes the reduction of uracil an
TTDR01187	Sequence	MAPVLSKDSADIESILALNPRTQTHATLCSTSAKKLDKKHWKRNPDKNCFNCEKLENNFDDIKHTTLGERGALREAMRCL
TTDR01187	BioChemical Class	Oxidoreductases acting on the CH-CH group of donors
TTDR01187	Pathway	Drug metabolism - other enzymes
TTDR01187	Pathway	Pantothenate and CoA biosynthesis
TTDR01187	Pathway	Pyrimidine metabolism
TTDR01187	Pathway	beta-Alanine metabolism
TTDR01187	EC Number	EC 1.3.1.2
TTDR01187	Inhibitor	(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione
TTDR01187	Inhibitor	5-Fluorouracil
TTDR01187	Inhibitor	5-Iodouracil
TTDR01187	Inhibitor	6-Carboxymethyluracil
TTDR01187	Inhibitor	Flavin-Adenine Dinucleotide
TTDR01187	Inhibitor	Riboflavin Monophosphate
TTDR01187	Inhibitor	Uracil
TTDR01188	Name	Corticosteroid receptor
TTDR01188	Type of target	Research target
TTDR01188	Disease	Affective disorders
TTDR01189	Name	Corticosteroid receptor type I
TTDR01189	Type of target	Research target
TTDR01189	Disease	Endocrine disorder
TTDR01190	Name	Corticosteroid receptor type II
TTDR01190	Type of target	Research target
TTDR01190	Disease	Endocrine disorder
TTDR01191	UniProt ID	P10826
TTDR01191	Name	Retinoic acid receptor beta
TTDR01191	Type of target	Research target
TTDR01191	Synonyms	HBV-activated protein
TTDR01191	Synonyms	RAR-beta
TTDR01191	Synonyms	RAR-epsilon
TTDR01191	Disease	Pancreatic cancer
TTDR01191	Function	This is a receptor for retinoic acid. This metabolite has profound effects on ve
TTDR01191	Sequence	MTTSGHACPVPAVNGHMTHYPATPYPLLFPPVIGGLSLPPLHGLHGHPPPSGCSTPSPATIETQSTSSEELVPSPPSPLP
TTDR01191	PDB Structure	1HRA; 1XAP; 4DM6; 4DM8
TTDR01191	BioChemical Class	Zinc-finger
TTDR01191	Inhibitor	TTNPB
TTDR01192	UniProt ID	Q02880
TTDR01192	Name	DNA topoisomerase II, beta isozyme
TTDR01192	Type of target	Research target
TTDR01192	Synonyms	TOP2beta
TTDR01192	Synonyms	Topo IIbeta
TTDR01192	Disease	Cancer, unspecific
TTDR01192	Function	Control of topological states of dna by transient breakage and subsequent rejoin
TTDR01192	Sequence	MAKSGGCGAGAGVGGGNGALTWVTLFDQNNAAKKEESETANKNDSSKKLSVERVYQKKTQLEHILLRPDTYIGSVEPLTQ
TTDR01192	PDB Structure	3QX3
TTDR01192	BioChemical Class	Isomerases
TTDR01192	Target Validation	TTDR01192
TTDR01192	Inhibitor	3'-THIO-THYMIDINE-5'-PHOSPHATE
TTDR01192	Inhibitor	A-62176
TTDR01192	Inhibitor	Icrf-187
TTDR01192	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDR01193	UniProt ID	Q9H3N8
TTDR01193	Name	Histamine H4 receptor
TTDR01193	Type of target	Research target
TTDR01193	Synonyms	AXOR35
TTDR01193	Synonyms	G protein-coupled receptor 105
TTDR01193	Synonyms	GPCR105
TTDR01193	Synonyms	GPRv53
TTDR01193	Synonyms	H4 receptor
TTDR01193	Synonyms	HH4R
TTDR01193	Synonyms	SP9144
TTDR01193	Disease	Allergic diseases
TTDR01193	Disease	Allergy, unspecified
TTDR01193	Disease	Asthma
TTDR01193	Function	The H4 subclass of histamine receptors could mediate the histamine signals in pe
TTDR01193	Sequence	MPDTNSTINLSLSTRVTLAFFMSLVAFAIMLGNALVILAFVVDKNLRHRSSYFFLNLAISDFFVGVISIPLYIPHTLFEW
TTDR01193	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01193	Pathway	Neuroactive ligand-receptor interaction
TTDR01193	Target Validation	TTDR01193
TTDR01193	QSAR Model	TTDR01193
TTDR01193	Inhibitor	(1H-indol-2-yl)(piperazin-1-yl)methanone
TTDR01193	Inhibitor	(R)-(-)-alpha-methylhistamine
TTDR01193	Inhibitor	(R)-3-(1H-imidazol-4-yl)propyl sec-butylcarbamate
TTDR01193	Inhibitor	4-(2-(4-tert-butylphenylthio)ethyl)-1H-imidazole
TTDR01193	Inhibitor	6-(4-Methylpiperazin-1-yl)-9H-purin-2-amine
TTDR01193	Inhibitor	6-(4-Methylpiperazin-1-yl)pyrimidine-2,4-diamine
TTDR01193	Inhibitor	6-(4-methylpiperazin-1-yl)-9Hpurine
TTDR01193	Inhibitor	9-benzyl-6-(4-methylpiperazin-1-yl)-9H-purine
TTDR01193	Inhibitor	A-846714
TTDR01193	Inhibitor	A-943931
TTDR01193	Inhibitor	IODOPHENPROPIT
TTDR01193	Inhibitor	JNJ-7777120
TTDR01193	Antagonist	Thioperamide
TTDR01193	Agonist	Clobenpropit
TTDR01193	Agonist	Imetit
TTDR01193	Agonist	N-alpha-methyl histamine
TTDR01193	Agonist	R-alpha-methyl histamine
TTDR01194	UniProt ID	P30939
TTDR01194	Name	5-hydroxytryptamine 1F receptor
TTDR01194	Type of target	Research target
TTDR01194	Synonyms	5-HT-1F
TTDR01194	Synonyms	5-HT1F receptor
TTDR01194	Synonyms	Serotonin receptor
TTDR01194	Synonyms	Serotonin receptor 1F
TTDR01194	Disease	Migraine
TTDR01194	Function	This is one of the several different receptors for 5- hydroxytryptamine (seroton
TTDR01194	Sequence	MDFLNSSDQNLTSEELLNRMPSKILVSLTLSGLALMTTTINSLVIAAIIVTRKLHHPANYLICSLAVTDFLVAVLVMPFS
TTDR01194	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01194	Pathway	Neuroactive ligand-receptor interaction
TTDR01194	Related US Patent	6,358,972
TTDR01194	Related US Patent	6,608,079
TTDR01194	Target Validation	TTDR01194
TTDR01194	Inhibitor	LY-334370
TTDR01194	Inhibitor	WAY-466
TTDR01194	Agonist	LY344864
TTDR01195	Name	Serotonin transporter
TTDR01195	Type of target	Research target
TTDR01195	Synonyms	5-HTT
TTDR01195	Disease	Depression
TTDR01195	Target Validation	TTDR01195
TTDR01195	Inhibitor	(2R,3R)-iodoreboxetine
TTDR01195	Inhibitor	(2R,3S)-2-[(2-Iodophenoxy)phenylmethyl]morpholine
TTDR01195	Inhibitor	(2R,3S)-2-[(3-Iodophenoxy)phenylmethyl]morpholine
TTDR01195	Inhibitor	(2R,3S)-2-[(4-Iodophenoxy)phenylmethyl]morpholine
TTDR01195	Inhibitor	(2S,3S)-iodoreboxetine
TTDR01195	Inhibitor	(R)-DULOXETINE
TTDR01195	Inhibitor	(cis)-1,6-diphenyl-3-aza-bicyclo[3.1.0]hexane
TTDR01195	Inhibitor	1-(3,4-Dichloro-phenyl)-3-diethylamino-indan-5-ol
TTDR01195	Inhibitor	1-(3,4-Dichloro-phenyl)-3-methylamino-indan-5-ol
TTDR01195	Inhibitor	1-(3,4-dichlorophenyl)-3-aza-bicyclo[3.1.0]hexane
TTDR01195	Inhibitor	1-(4-Benzylsulfanyl-phenyl)-propylamine
TTDR01195	Inhibitor	1-(benzofuran-2-yl)-3-aza-bicyclo[3.1.0]hexane
TTDR01195	Inhibitor	1-(naphthalen-2-yl)-3-aza-bicyclo[3.1.0]hexane
TTDR01195	Inhibitor	1-(thiophen-2-yl)-3-aza-bicyclo[3.1.0]hexane
TTDR01195	Inhibitor	1-Biphenyl-4-yl-3-aza-bicyclo[3.1.0]hexane
TTDR01195	Inhibitor	1-Methyl-2-(4-phenylsulfanyl-phenyl)-ethylamine
TTDR01195	Inhibitor	1-Methyl-4-p-tolyl-piperidine-4-carbonitrile
TTDR01195	Inhibitor	1-benzylpiperidine hydrochloride
TTDR01195	Inhibitor	1-fluoro-5-phenyl-3-aza-bicyclo[3.1.0]hexane
TTDR01195	Inhibitor	1-phenyl-3-aza-bicyclo[3.1.0]hexane
TTDR01195	Inhibitor	10R-hydroxylobel-7-ene
TTDR01195	Inhibitor	10R-hydroxylobelane
TTDR01195	Inhibitor	10S-hydroxylobel-7-ene
TTDR01195	Inhibitor	10S-hydroxylobelane
TTDR01195	Inhibitor	1S,2R-milnacipran
TTDR01195	Inhibitor	2-(3-Methyl-piperazin-1-yl)-6-nitro-quinoline
TTDR01195	Inhibitor	2-Amino-1-(4-ethylthiophenyl)butane
TTDR01195	Inhibitor	2-Amino-1-(4-ethylthiophenyl)propane
TTDR01195	Inhibitor	2-Amino-1-(4-methylthiophenyl)butane
TTDR01195	Inhibitor	2-Amino-1-(4-methylthiophenyl)propane
TTDR01195	Inhibitor	2-N,N-Dimethylamino-1-(4-methylthiophenyl)propane
TTDR01195	Inhibitor	2-N-(Isopropyl)amino-1-(4-methylthiophenyl)butane
TTDR01195	Inhibitor	2-N-(n-Propyl)amino-1-(4-methylthiophenyl)butane
TTDR01195	Inhibitor	2-N-Allylamino-1-(4-methylthiophenyl)propan
TTDR01195	Inhibitor	2-N-Cyclopropylamino-1-(4-methylthiophenyl)butane
TTDR01195	Inhibitor	2-N-Ethylamino-1-(4-ethylthiophenyl)butane
TTDR01195	Inhibitor	2-N-Ethylamino-1-(4-ethylthiophenyl)propane
TTDR01195	Inhibitor	2-N-Ethylamino-1-(4-methylthiophenyl)butane
TTDR01195	Inhibitor	2-N-Ethylamino-1-(4-methylthiophenyl)propane
TTDR01195	Inhibitor	2-N-Hydroxyamino-1-(4-ethylthiophenyl)butane
TTDR01195	Inhibitor	2-N-Hydroxyamino-1-(4-ethylthiophenyl)propane
TTDR01195	Inhibitor	2-N-Hydroxyamino-1-(4-methylthiophenyl)butane
TTDR01195	Inhibitor	2-N-Hydroxyamino-1-(4-methylthiophenyl)propane
TTDR01195	Inhibitor	2-N-Methoxyamino-1-(4-methylthiophenyl)propane
TTDR01195	Inhibitor	2-N-Methylamino-1-(4-ethylthiophenyl)propane
TTDR01195	Inhibitor	2-N-Methylamino-1-(4-methylthiophenyl)butane
TTDR01195	Inhibitor	2-N-Methylamino-1-(4-methylthiophenyl)propane
TTDR01195	Inhibitor	2-N-Propargylamino-1-(4-methylthiophenyl)butane
TTDR01195	Inhibitor	2-N-Propargylamino-1-(4-methylthiophenyl)propane
TTDR01195	Inhibitor	2-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole
TTDR01195	Inhibitor	2-[1,4]Diazepan-1-yl-6-nitro-quinoline
TTDR01195	Inhibitor	3-(3,4-dichlorophenyl)-2-nortropene
TTDR01195	Inhibitor	3-(4-Chlorophenyl)-2-nortropene
TTDR01195	Inhibitor	3-(4-Fluorophenyl)-2-nortropene
TTDR01195	Inhibitor	3-(4-Trifluoromethylphenyl)-2-nortropene
TTDR01195	Inhibitor	3-Bromo-6-nitro-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	3-Phenyl-2-nortropene
TTDR01195	Inhibitor	3-alpha-Phenylmethoxy-3-beta-phenyl-nortropane
TTDR01195	Inhibitor	3-p-Tolyl-8-aza-bicyclo[3.2.1]octane
TTDR01195	Inhibitor	3alpha-(bis-chloro-phenylmethoxy)tropane
TTDR01195	Inhibitor	4-Allyl-6-nitro-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	4-Benzyl-6-nitro-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	4-Bromo-6-nitro-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	4-Chloro-6-nitro-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	4-Furan-2-yl-6-nitro-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	4-Iodo-6-nitro-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	6,6-dimethyl-1-phenyl-3-aza-bicyclo[3.1.0]hexane
TTDR01195	Inhibitor	6,8-Dinitro-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	6-(3-aza-bicyclo[3.1.0]hexan-1-yl)quinoline
TTDR01195	Inhibitor	6-Bromo-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	6-Chloro-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	6-Iodo-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	6-Nitro-2-piperazin-1-yl-4-vinyl-quinoline
TTDR01195	Inhibitor	6-Nitro-4-phenyl-2-piperazin-1-yl-quinoline
TTDR01195	Inhibitor	6-nitroquipazine
TTDR01195	Inhibitor	8-Methyl-3-p-tolyl-8-aza-bicyclo[3.2.1]octane
TTDR01195	Inhibitor	8R-hydroxylobel-9-ene
TTDR01195	Inhibitor	8R-hydroxylobelane
TTDR01195	Inhibitor	8S-hydroxylobel-9-ene
TTDR01195	Inhibitor	8S-hydroxylobelane
TTDR01195	Inhibitor	A-80426
TTDR01195	Inhibitor	COCAINE.HCL
TTDR01195	Inhibitor	Cyclohexyl-(3,4-dichloro-phenyl)-acetonitrile
TTDR01195	Inhibitor	Cyclopentyl-(3,4-dichloro-phenyl)-acetonitrile
TTDR01195	Inhibitor	D-166A
TTDR01195	Inhibitor	D-211A
TTDR01195	Inhibitor	D-211B
TTDR01195	Inhibitor	D-254C
TTDR01195	Inhibitor	D-257A
TTDR01195	Inhibitor	D-257C
TTDR01195	Inhibitor	DIFLUOROBENZTROPINE
TTDR01195	Inhibitor	FLUOXETINE HYDROCHLORIDE
TTDR01195	Inhibitor	GBR-12909
TTDR01195	Inhibitor	Irindalone
TTDR01195	Inhibitor	METHYLENEDIOXYAMPHETAMINE
TTDR01195	Inhibitor	METHYLENEDIOXYMETHAMPHETAMINE
TTDR01195	Inhibitor	N*1*-(6-Nitro-quinolin-2-yl)-ethane-1,2-diamine
TTDR01195	Inhibitor	NISOXETINE
TTDR01195	Inhibitor	QUIPAZINE
TTDR01195	Inhibitor	TEFLUDAZINE
TTDR01195	Inhibitor	WIN-35065
TTDR01195	Inhibitor	WIN-35065-2
TTDR01195	Inhibitor	WIN_35428
TTDR01195	Inhibitor	ZIMELIDINE
TTDR01195	Inhibitor	[3-(3,4-Dichloro-phenyl)-indan-1-yl]-methyl-amine
TTDR01195	Inhibitor	erythro-3,4-dichloromethylphenidate hydrochloride
TTDR01195	Inhibitor	para-Methoxyamphetamine
TTDR01195	Inhibitor	para-chloroamphetamine
TTDR01195	Inhibitor	threo-1-aza-5-phenyl[4.4.0]decane hydrochloride
TTDR01195	Inhibitor	threo-3,4-dichlororitalinol hydrochloride
TTDR01196	Name	P2Y purinoceptor
TTDR01196	Type of target	Research target
TTDR01196	Synonyms	ADP receptor
TTDR01196	Synonyms	Adenosine 5'-Diphosphate Receptor
TTDR01196	Synonyms	Adenosine diphosphate (ADP) receptor
TTDR01196	Synonyms	P2Y receptor
TTDR01196	Synonyms	Platelet adenosine diphosphate receptor
TTDR01196	Disease	Diabetes mellitus
TTDR01196	Disease	Liver fibrosis
TTDR01196	Disease	Thrombosis
TTDR01196	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01196	Related US Patent	6,555,675
TTDR01196	Related US Patent	6,559,148
TTDR01196	Related US Patent	6,624,150
TTDR01196	Related US Patent	6,689,786
TTDR01196	Agonist	Adenosine-5'-O-(2-thiodiphosphate)
TTDR01197	UniProt ID	P34981
TTDR01197	Name	Thyrotropin-releasing hormone receptor
TTDR01197	Type of target	Research target
TTDR01197	Synonyms	TRH-R
TTDR01197	Synonyms	Thyroliberin receptor
TTDR01197	Disease	Alcohol dependence
TTDR01197	Disease	Anxiety disorder, unspecified
TTDR01197	Function	Receptor for thyrotropin-releasing hormone. This receptor is mediated by G prote
TTDR01197	Sequence	MENETVSELNQTQLQPRAVVALEYQVVTILLVLIICGLGIVGNIMVVLVVMRTKHMRTPTNCYLVSLAVADLMVLVAAGL
TTDR01197	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01197	Pathway	Calcium signaling pathway
TTDR01197	Pathway	Neuroactive ligand-receptor interaction
TTDR01197	Target Validation	TTDR01197
TTDR01197	QSAR Model	TTDR01197
TTDR01197	Inhibitor	CORYMBONE B
TTDR01197	Inhibitor	PROTIRELIN
TTDR01198	UniProt ID	Q9NPC2
TTDR01198	Name	Potassium channel subfamily K member 9
TTDR01198	Type of target	Research target
TTDR01198	Synonyms	Acid-sensitive potassium channel protein TASK-3
TTDR01198	Synonyms	TWIK-related acid-sensitive K+ channel 3
TTDR01198	Synonyms	Two pore potassium channel KT3.2
TTDR01198	Disease	Cancer, unspecific
TTDR01198	Function	Ph-dependent, voltage-insensitive, background potassium channel protein.
TTDR01198	Sequence	MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKF
TTDR01198	PDB Structure	3P1N; 3P1O; 3P1P; 3P1Q; 3P1R; 3P1S; 3SMK; 3SML; 3SMM; 3SMN; 3SMO; 3SPR; 3UX0; 4F
TTDR01198	BioChemical Class	Voltage-gated channel
TTDR01199	UniProt ID	Q9UHW9
TTDR01199	Name	K-Cl cotransporter 3
TTDR01199	Type of target	Research target
TTDR01199	Synonyms	Electroneutral potassium-chloride cotransporter 3
TTDR01199	Disease	Hypertension
TTDR01199	Function	Mediates electroneutral potassium-chloride cotransport. May be activated by cell
TTDR01199	Sequence	MHPPETTTKMASVRFMVTPTKIDDIPGLSDTSPDLSSRSSSRVRFSSRESVPETSRSEPMSEMSGATTSLATVALDPPSD
TTDR01199	BioChemical Class	Ion transport
TTDR01200	UniProt ID	Q9UPY5
TTDR01200	Name	Cystine/glutamate transporter
TTDR01200	Type of target	Research target
TTDR01200	Synonyms	Amino acid transport system XCT
TTDR01200	Synonyms	Calcium channel blocker resistance protein CCBR1
TTDR01200	Synonyms	X(c)- plasma membrane cystine transporter
TTDR01200	Synonyms	X(c)-cystine transporter
TTDR01200	Synonyms	XCT
TTDR01200	Disease	Lymphoma
TTDR01200	Function	Sodium-independent, high-affinity exchange of anionic amino acids with high spec
TTDR01200	Sequence	MVRKPVVSTISKGGYLQGNVNGRLPSLGNKEPPGQEKVQLKRKVTLLRGVSIIIGTIIGAGIFISPKGVLQNTGSVGMSL
TTDR01200	BioChemical Class	Transmembrane protein
TTDR01201	UniProt ID	O00764
TTDR01201	Name	Pyridoxal kinase
TTDR01201	Type of target	Research target
TTDR01201	Synonyms	Pyridoxine kinase
TTDR01201	Disease	Asthma
TTDR01201	Disease	Korsakov's alcoholic psychosis
TTDR01201	Disease	Vitamin B6 deficiency
TTDR01201	Function	Required for synthesis of pyridoxal-5-phosphate from vitamin B6.
TTDR01201	Sequence	MEEECRVLSIQSHVIRGYVGNRAATFPLQVLGFEIDAVNSVQFSNHTGYAHWKGQVLNSDELQELYEGLRLNNMNKYDYV
TTDR01201	PDB Structure	2AJP; 2F7K; 2YXT; 2YXU; 3FHX; 3FHY; 3KEU; 4EN4; 4EOH
TTDR01201	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01201	Pathway	Metabolic pathways
TTDR01201	Pathway	Vitamin B6 metabolism
TTDR01201	EC Number	EC 2.7.1.35
TTDR01201	Inhibitor	Adenosine-5'-Diphosphate
TTDR01201	Inhibitor	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate
TTDR01202	UniProt ID	O14732
TTDR01202	Name	Inositol-1(or 4)-monophosphatase
TTDR01202	Type of target	Research target
TTDR01202	Synonyms	IMP
TTDR01202	Synonyms	IMPase
TTDR01202	Synonyms	Inositol monophosphatase
TTDR01202	Synonyms	Lithium-sensitive myo-inositol monophosphatase A1
TTDR01202	Synonyms	Myo-inositol monophosphatase: IMP.18p
TTDR01202	Synonyms	Myo-inositol-1-phosphate phosphohydrolase
TTDR01202	Disease	Bipolar affective disorder
TTDR01202	Function	Responsible for the provision of inositol required for synthesis of phosphatidyl
TTDR01202	Sequence	MKPSGEDQAALAAGPWEECFQAAVQLALRAGQIIRKALTEEKRVSTKTSAADLVTETDHLVEDLIISELRERFPSHRFIA
TTDR01202	PDB Structure	2CZH; 2CZI; 2CZK; 2DDK; 2FVZ
TTDR01202	BioChemical Class	Hydrolases acting on ester bonds
TTDR01202	Pathway	Inositol phosphate metabolism
TTDR01202	Pathway	Metabolic pathways
TTDR01202	Pathway	Phosphatidylinositol signaling system
TTDR01202	EC Number	EC 3.1.3.25
TTDR01202	Inhibitor	L-Myo-Inositol-1-Phosphate
TTDR01203	UniProt ID	P34913
TTDR01203	Name	Soluble epoxide hydrolase
TTDR01203	Type of target	Clinical trial target
TTDR01203	Synonyms	CEH
TTDR01203	Synonyms	Cytosolic epoxide hydrolase
TTDR01203	Synonyms	Epoxide Hydrolase
TTDR01203	Synonyms	Epoxide hydratase
TTDR01203	Synonyms	SEH
TTDR01203	Disease	Cardiovascular disease, unspecified
TTDR01203	Disease	Hypertension
TTDR01203	Disease	Renal diseases
TTDR01203	Function	This enzyme acts on epoxides (alkene oxides, oxiranes) and arene oxides. plays a
TTDR01203	Sequence	MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKV
TTDR01203	PDB Structure	1S8O; 1VJ5; 1ZD2; 1ZD3; 1ZD4; 1ZD5; 3ANS; 3ANT; 3I1Y; 3I28; 3KOO; 3OTQ; 3PDC; 4H
TTDR01203	BioChemical Class	Hydrolases acting on ether bonds
TTDR01203	Pathway	Arachidonic acid metabolism
TTDR01203	Pathway	Metabolic pathways
TTDR01203	Pathway	Tetrachloroethene degradation
TTDR01203	EC Number	EC 3.3.2.3
TTDR01203	Related US Patent	6,531,506
TTDR01203	Target Validation	TTDR01203
TTDR01203	Inhibitor	1,3-DIPHENYLUREA
TTDR01203	Inhibitor	1-(1-Adamantyl)-3-(1-propionylpiperidin-4-yl)urea
TTDR01203	Inhibitor	1-(1-Propionylpiperidin-4-yl)-3-m-tolylurea
TTDR01203	Inhibitor	1-(1-Propionylpiperidin-4-yl)-3-o-tolylurea
TTDR01203	Inhibitor	1-(1-Propionylpiperidin-4-yl)-3-p-tolylurea
TTDR01203	Inhibitor	1-(3-(3-morpholinopropoxy)phenyl)-3-phenylurea
TTDR01203	Inhibitor	1-(3-Chloro-phenyl)-3-(4-hydroxy-decyl)-urea
TTDR01203	Inhibitor	1-(3-Chloro-phenyl)-3-cyclohexyl-urea
TTDR01203	Inhibitor	1-(4-(3-morpholinopropoxy)phenyl)-3-phenylurea
TTDR01203	Inhibitor	1-Adamantan-1-yl-3-(2-hydroxy-phenyl)-urea
TTDR01203	Inhibitor	1-Adamantan-1-yl-3-(2-methoxy-phenyl)-urea
TTDR01203	Inhibitor	1-Adamantan-1-yl-3-(3-hydroxy-phenyl)-urea
TTDR01203	Inhibitor	1-Adamantan-1-yl-3-(3-methoxy-phenyl)-urea
TTDR01203	Inhibitor	1-Adamantan-1-yl-3-(4-hydroxy-decyl)-urea
TTDR01203	Inhibitor	1-Adamantan-1-yl-3-(4-hydroxy-phenyl)-urea
TTDR01203	Inhibitor	1-Adamantan-1-yl-3-(4-methoxy-phenyl)-urea
TTDR01203	Inhibitor	1-Adamantan-1-yl-3-decyl-urea
TTDR01203	Inhibitor	1-Adamantan-1-yl-3-phenyl-urea
TTDR01203	Inhibitor	1-Cycloheptyl-3-(1-propionylpiperidin-4-yl)urea
TTDR01203	Inhibitor	1-Cyclohexyl-3-(1-propionylpiperidin-4-yl)urea
TTDR01203	Inhibitor	1-Cyclohexyl-3-(4-methoxy-phenyl)-urea
TTDR01203	Inhibitor	1-Cyclohexyl-3-phenethyl-urea
TTDR01203	Inhibitor	1-Cyclohexyl-3-phenyl-urea
TTDR01203	Inhibitor	1-Octyl-3-(1-propionylpiperidin-4-yl)urea
TTDR01203	Inhibitor	1-Phenyl-3-(1-propionylpiperidin-4-yl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-((R)-1-phenyl-ethyl)-urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(1-benzyl-piperidin-4-yl)-urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(1-butyl-piperidin-4-yl)-urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(1-ethyl-piperidin-4-yl)-urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(1-propyl-piperidin-4-yl)-urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(2-heptyloxyethyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(2-hydroxyethyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(3-hexyloxypropyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(3-hydroxypropyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(4-hydroxybutyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(4-pentyloxybutyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(4-pentyloxycylclohexyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(5-butoxypentyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(5-hydroxypentyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(6-hydroxyhexyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-(6-propyloxyhexyl)urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-[4-(4-fluorophenoxy)butyl]urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-piperidin-4-yl-urea
TTDR01203	Inhibitor	1-adamantan-1-yl-3-piperidin-4-ylmethyl-urea
TTDR01203	Inhibitor	12-(3-Adamantan-1-yl-ureido)-dodeca noic acid
TTDR01203	Inhibitor	12-(3-n-Hexylureido)dodec-8(Z)-enoic acid
TTDR01203	Inhibitor	12-(3-n-Pentylureidooxy)dodec-8(Z)-enoic acid
TTDR01203	Inhibitor	13-(3-Pentyluredo)tridec-8(Z)-enoic acid
TTDR01203	Inhibitor	13-(3-n-Pentylthioureido)tridec-8(Z)-enoic Acid
TTDR01203	Inhibitor	13-(3-n-Pentylureido)tridec-5(Z)-enoic acid
TTDR01203	Inhibitor	13-(3-n-Pentylureido)tridec-8(E)-enoic acid
TTDR01203	Inhibitor	13-(3-n-Pentylureido)tridec-8-ynoic acid
TTDR01203	Inhibitor	13-(5-n-Pentylfuran-2-yl)tridec-8(Z)-enoic acid
TTDR01203	Inhibitor	13-(N-Isopropylheptanamido)tridec-8(Z)-enoic acid
TTDR01203	Inhibitor	13-(N-Methyl-n-heptnamido)tridec-8(Z)-enoic acid
TTDR01203	Inhibitor	13-(n-Pentylcarbamoyloxy)tridec-8(Z)-enoic acid
TTDR01203	Inhibitor	13-n-Heptanamidotridec-5-ynoic acid
TTDR01203	Inhibitor	13-n-Heptanamidotridec-8(Z)-enoic acid
TTDR01203	Inhibitor	14-(n-Hexylamino)-14-oxotetradec-8(Z)-enoic acid
TTDR01203	Inhibitor	16-(3-Ethylureido)hexadec-11(Z)-enoic acid
TTDR01203	Inhibitor	2-Adamantan-1-yl-N-decyl-acetamide
TTDR01203	Inhibitor	2-Cyclohexyl-N-(4-methoxy-phenyl)-acetamide
TTDR01203	Inhibitor	2-Cyclohexyl-N-phenethyl-acetamide
TTDR01203	Inhibitor	2-Cyclohexyl-N-phenyl-acetamide
TTDR01203	Inhibitor	3-(3-Adamantan-1-yl-ureido)-benzoic acid
TTDR01203	Inhibitor	4,4-Diphenyl-N-(pyridin-3-yl)-butyramide
TTDR01203	Inhibitor	4-(3-Adamantan-1-yl-ureido)-benzoic acid
TTDR01203	Inhibitor	4-(3-cyclohexylureido)butanoic acid
TTDR01203	Inhibitor	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID
TTDR01203	Inhibitor	6-amino-N-(2,4-dichlorobenzyl)nicotinamide
TTDR01203	Inhibitor	6-amino-N-(3,3-diphenylpropyl)nicotinamide
TTDR01203	Inhibitor	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID
TTDR01203	Inhibitor	9-(3-n-Pentylureido)non-4(Z)-enoic acid
TTDR01203	Inhibitor	9-(3-n-Pentylureido)non-4-ynoic acid
TTDR01203	Inhibitor	Dodecanoic acid adamantan-1-ylamide
TTDR01203	Inhibitor	Methyl 14-(3-n-butylureido)tetradec-8(Z)-enoate
TTDR01203	Inhibitor	N,N'-dicyclohexyl-urea
TTDR01203	Inhibitor	N-(1-acetylpiperidin-4-yl)-N'-(adamant-1-yl)urea
TTDR01203	Inhibitor	N-(3,3-Diphenyl-propyl)-2-pyridine-3-ylacetamide
TTDR01203	Inhibitor	N-(3,3-Diphenyl-propyl)-isonicotinamide
TTDR01203	Inhibitor	N-(3,3-diphenyl-propyl)-nicotinamide
TTDR01203	Inhibitor	N-(3-Chloro-phenyl)-2-cyclohexyl-acetamide
TTDR01203	Inhibitor	N-(3-Phenyl-propyl)-nicotinamide
TTDR01203	Inhibitor	N-(4,4-Diphenyl-butyl)-nicotinamide
TTDR01203	Inhibitor	N-(biphenyl-3-yl)benzo[d]isoxazol-3-amine
TTDR01203	Inhibitor	N-(biphenyl-4-yl)benzo[d]isoxazol-3-amine
TTDR01203	Inhibitor	N-(naphthalen-1-yl)benzo[d]isoxazol-3-amine
TTDR01203	Inhibitor	N-(naphthalen-2-yl)benzo[d]isoxazol-3-amine
TTDR01203	Inhibitor	N-Cyclohexyl-2-(4-methoxy-phenyl)-acetamide
TTDR01203	Inhibitor	N-Cyclohexyl-2-phenyl-acetamide
TTDR01203	Inhibitor	N-Cyclohexyl-4-phenyl-butyramide
TTDR01203	Inhibitor	N-Cyclohexyl-N'-(4-Iodophenyl)Urea
TTDR01203	Inhibitor	N-Cyclohexyl-N'-(Propyl)Phenyl Urea
TTDR01203	Inhibitor	N-Cyclohexyl-N'-Decylurea
TTDR01203	Inhibitor	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE
TTDR01203	Inhibitor	N-[3,3-Bis-(4-fluorophenyl)-propyl]-benzamide
TTDR01203	Inhibitor	N-[3,3-Bis-(4-fluorophenyl)-propyl]-nicotinamide
TTDR01203	Inhibitor	N-adamantyl-N'-cyclohexylurea
TTDR01203	Inhibitor	N-benzyl-6-(3,3,3-trifluoropropoxy)nicotinamide
TTDR01203	Inhibitor	[4-(3-Adamantan-1-yl-ureido)-phenyl]-acetic acid
TTDR01203	Inhibitor	cis-1-adamantan-1-yl-3-(4-hydroxycyclohexyl)urea
TTDR01203	Inhibitor	cis-1-adamantan-1-yl-3-(4-methoxycyclohexyl)urea
TTDR01203	Inhibitor	methyl 4-(3-cyclohexylureido)butanoate
TTDR01203	Inhibitor	methyl 6-(3-cyclohexylureido)hexanoate
TTDR01203	Inhibitor	trans,trans-1,3-bis-(4-hydroxycyclohexyl)urea
TTDR01204	Name	Carboxypeptidase A
TTDR01204	Type of target	Research target
TTDR01204	Disease	Arthritis
TTDR01204	Disease	Cancer, unspecific
TTDR01204	Disease	Heart disease, unspecified
TTDR01204	EC Number	EC 3.4.17.-
TTDR01204	Target Validation	TTDR01204
TTDR01204	Inhibitor	DL-benzylsuccinic acid
TTDR01204	Inhibitor	SQ-14603
TTDR01205	Name	Leukotriene E4 receptor
TTDR01205	Type of target	Research target
TTDR01205	Disease	Asthma
TTDR01205	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01205	Pathway	Calcium signaling pathway
TTDR01205	Pathway	Neuroactive ligand-receptor interaction
TTDR01206	UniProt ID	O14920
TTDR01206	Name	Inhibitor of nuclear factor kappa B kinase beta subunit
TTDR01206	Type of target	Research target
TTDR01206	Synonyms	I-kappa-B kinase 2
TTDR01206	Synonyms	I-kappa-B-kinase beta
TTDR01206	Synonyms	IKK-2
TTDR01206	Synonyms	IKK-B
TTDR01206	Synonyms	IKK-beta
TTDR01206	Synonyms	IKK2
TTDR01206	Synonyms	IKKbeta
TTDR01206	Synonyms	IkBKB
TTDR01206	Synonyms	IkappaB kinase 2
TTDR01206	Synonyms	IkappaB kinase beta
TTDR01206	Synonyms	Inhibitory kappa B kinase b
TTDR01206	Synonyms	NFKBIKB
TTDR01206	Synonyms	Nuclear factor NF-kappa-B inhibitor kinase beta
TTDR01206	Disease	Asthma
TTDR01206	Disease	Autoimmune diseases
TTDR01206	Disease	Fibrosing alveolitis
TTDR01206	Disease	Inflammation
TTDR01206	Disease	Inflammatory lung disease
TTDR01206	Disease	Rheumatoid arthritis, unspecified
TTDR01206	Disease	Transplant failure or rejection
TTDR01206	Function	Phosphorylates inhibitors of nf-kappa-b thus leading to the dissociation of the
TTDR01206	Sequence	MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVP
TTDR01206	PDB Structure	3BRT; 3BRV
TTDR01206	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01206	Pathway	Acute myeloid leukemia
TTDR01206	Pathway	Adipocytokine signaling pathway
TTDR01206	Pathway	Apoptosis
TTDR01206	Pathway	B cell receptor signaling pathway
TTDR01206	Pathway	Chemokine signaling pathway
TTDR01206	Pathway	Chronic myeloid leukemia
TTDR01206	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR01206	Pathway	Insulin signaling pathway
TTDR01206	Pathway	MAPK signaling pathway
TTDR01206	Pathway	Pancreatic cancer
TTDR01206	Pathway	Pathways in cancer
TTDR01206	Pathway	Prostate cancer
TTDR01206	Pathway	Small cell lung cancer
TTDR01206	Pathway	T cell receptor signaling pathway
TTDR01206	Pathway	Toll-like receptor signaling pathway
TTDR01206	Pathway	Type II diabetes mellitus
TTDR01206	EC Number	EC 2.7.1.-
TTDR01206	EC Number	EC 2.7.1.37
TTDR01206	Target Validation	TTDR01206
TTDR01206	Inhibitor	2-amino-5-phenylthiophene-3-carboxamide
TTDR01206	Inhibitor	2-amino-quinoline-3-carboxylic acid amide
TTDR01206	Inhibitor	3-amino-5-(4-chlorophenyl)thiophene-2-carboxamide
TTDR01206	Inhibitor	3-amino-benzo[b]thiophene-2-carboxylic acid amide
TTDR01206	Inhibitor	4-amino-biphenyl-3-carboxylic acid amide
TTDR01206	Inhibitor	5-Bromo-6-methoxy-9H-beta-carboline
TTDR01206	Inhibitor	5-amino-2-p-tolyl-oxazole-4-carboxylic acid amide
TTDR01206	Inhibitor	5-amino-2-phenyl-oxazole-4-carboxylic acid amide
TTDR01206	Inhibitor	6-phenyl-thieno[3,2-d]pyrimidin-4-ylamine
TTDR01206	Inhibitor	PF-228
TTDR01206	Inhibitor	Parthenolide
TTDR01206	Inhibitor	SC-514
TTDR01206	Inhibitor	Staurosporine
TTDR01207	Name	Endothelin receptor
TTDR01207	Type of target	Research target
TTDR01207	Disease	Diabetes mellitus
TTDR01207	Disease	Hypertension
TTDR01207	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01207	Pathway	Calcium signaling pathway
TTDR01207	Pathway	Neuroactive ligand-receptor interaction
TTDR01207	Pathway	Vascular smooth muscle contraction
TTDR01207	Related US Patent	6,197,800
TTDR01207	Related US Patent	6,274,737
TTDR01207	Related US Patent	6,306,852
TTDR01207	Related US Patent	6,384,070
TTDR01207	Related US Patent	6,448,260
TTDR01207	Related US Patent	6,462,194
TTDR01207	Related US Patent	6,482,956
TTDR01207	Related US Patent	6,545,031
TTDR01207	Related US Patent	6,620,826
TTDR01207	Related US Patent	6,638,937
TTDR01207	Related US Patent	6,673,824
TTDR01208	Name	RNase P RNA
TTDR01208	Type of target	Research target
TTDR01208	Disease	Bacterial infections
TTDR01208	Binder	Neomycin B
TTDR01209	UniProt ID	P71485
TTDR01209	Name	Probable arabinosyltransferase A
TTDR01209	Type of target	Research target
TTDR01209	Synonyms	Arabinosyltransferase A
TTDR01209	Synonyms	EmbA
TTDR01209	Disease	Bacterial infections
TTDR01209	Function	Arabinosyl transferase responsible for the polymerization of arabinose into the
TTDR01209	Sequence	MPHDGKQRSQRIPRSVAAVAGIAGLLLCLAVPLLPVRQTTATVLWPQGTVDGHVSQITAPLVSGAPRALDISIPCPAVAT
TTDR01209	BioChemical Class	Glycosyltransferases
TTDR01210	UniProt ID	P71486
TTDR01210	Name	Probable arabinosyltransferase B
TTDR01210	Type of target	Research target
TTDR01210	Synonyms	Arabinosyltransferase B
TTDR01210	Synonyms	EmbB
TTDR01210	Disease	Bacterial infections
TTDR01210	Function	Arabinosyl transferase responsible for the polymerization of arabinose into the
TTDR01210	Sequence	MSVSTVGGDVRVTRWVATIAGLIGFVLSVATPLLPVVQTTATLNWPQGGQLNSVTAPLISLTPVDLTATVPCSLVRDLPP
TTDR01210	BioChemical Class	Glycosyltransferases
TTDR01211	UniProt ID	P96848
TTDR01211	Name	Arylamine N-acetyltransferase
TTDR01211	Type of target	Research target
TTDR01211	Synonyms	Arylamine acetylase
TTDR01211	Synonyms	NAT
TTDR01211	Disease	Bacterial infections
TTDR01211	Disease	Tuberculosis
TTDR01211	Function	Could have a role in acetylating, and hence inactivating, the antitubercular dru
TTDR01211	Sequence	MALDLTAYFDRINYRGATDPTLDVLQDLVTVHSRTIPFENLDPLLGVPVDDLSPQALADKLVLRRRGGYCFEHNGLMGYV
TTDR01211	EC Number	EC 2.3.1.5
TTDR01211	Target Validation	TTDR01211
TTDR01211	Inhibitor	(Z)-5-Benzylidene-2-thioxothiazolidin-4-one
TTDR01211	Inhibitor	(Z)-5-Butylidene-2-thioxothiazolidin-4-one
TTDR01211	Inhibitor	(Z)-5-Decylidene-2-thioxothiazolidin-4-one
TTDR01211	Inhibitor	(Z)-5-Hexylidene-2-thioxothiazolidin-4-one
TTDR01211	Inhibitor	(Z)-5-Octylidene-2-thioxothiazolidin-4-one
TTDR01212	UniProt ID	O69476
TTDR01212	UniProt ID	P25715
TTDR01212	UniProt ID	Q10501
TTDR01212	Name	Malonyl-CoA:acyl carrier protein transacylase
TTDR01212	Type of target	Research target
TTDR01212	Synonyms	MCAT
TTDR01212	Synonyms	MCT
TTDR01212	Synonyms	Malonyl CoA : holo-ACP transacylase
TTDR01212	Synonyms	Malonyl CoA-acyl carrier protein transacylase
TTDR01212	Synonyms	Malonyl coenzyme A:acyl carrier protein transacylase
TTDR01212	Synonyms	Malonyl-CoA:ACP transacylase
TTDR01212	Synonyms	MtfabD
TTDR01212	Disease	Bacterial infections
TTDR01212	Disease	Tuberculosis
TTDR01212	Sequence	MIALLAPGQGSQTEGMLSPWLGLPGAADQIATWSKASGLDLVRLGTTASTEEITDTAVAQPLIVATTLLAHQELAKHALF
TTDR01212	PDB Structure	1MLA; 2G1H; 2G2O; 2G2Y; 2G2Z; 2QC3; 2QJ3
TTDR01212	Pathway	Fatty acid biosynthesis
TTDR01212	Pathway	Metabolic pathways
TTDR01212	EC Number	EC 2.3.1.39
TTDR01213	Name	DNA helicase
TTDR01213	Type of target	Research target
TTDR01213	Disease	Breast cancer
TTDR01214	UniProt ID	P29317
TTDR01214	Name	Ephrin type-A receptor 2
TTDR01214	Type of target	Research target
TTDR01214	Synonyms	EphA2 receptor
TTDR01214	Synonyms	Epithelial cell kinase
TTDR01214	Synonyms	Tyrosine-protein kinase receptor ECK
TTDR01214	Disease	Breast cancer
TTDR01214	Disease	Cancer, unspecific
TTDR01214	Disease	HCV infection
TTDR01214	Disease	Pancreatic cancer
TTDR01214	Function	Receptor for members of the ephrin-a family. Binds to Ephrin-A1, -A3, -A4 and -A
TTDR01214	Sequence	MELQAARACFALLWGCALAAAAAAQGKEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNW
TTDR01214	PDB Structure	1MQB; 2E8N; 2K9Y; 2KSO; 2X10; 2X11; 3C8X; 3CZU; 3FL7; 3HEI; 3HPN; 3KKA; 3MBW; 3M
TTDR01214	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01214	Pathway	Axon guidance
TTDR01214	EC Number	EC 2.7.1.112
TTDR01214	Inhibitor	Phosphoaminophosphonic Acid-Adenylate Ester
TTDR01215	Name	Microtubular protein
TTDR01215	Type of target	Successful target
TTDR01215	Synonyms	Microtubule protein
TTDR01215	Disease	Cancer, unspecific
TTDR01215	Binder	Costunolide
TTDR01216	UniProt ID	P01127
TTDR01216	UniProt ID	P04085
TTDR01216	Name	Platelet-derived growth factor
TTDR01216	Type of target	Research target
TTDR01216	Synonyms	C-SIS oncogene
TTDR01216	Synonyms	PDGF
TTDR01216	Synonyms	Platelet derived growth factor
TTDR01216	Disease	Cancer, unspecific
TTDR01216	Sequence	MNRCWALFLSLCCYLRLVSAEGDPIPEELYEMLSDHSIRSFDDLQRLLHGDPGEEDGAELDLNMTRSHSGGELESLARGR
TTDR01216	PDB Structure	3MJK
TTDR01216	BioChemical Class	Growth factor
TTDR01216	Pathway	Cytokine-cytokine receptor interaction
TTDR01216	Pathway	Focal adhesion
TTDR01216	Pathway	Gap junction
TTDR01216	Pathway	Glioma
TTDR01216	Pathway	MAPK signaling pathway
TTDR01216	Pathway	Melanoma
TTDR01216	Pathway	Pathways in cancer
TTDR01216	Pathway	Prostate cancer
TTDR01216	Pathway	Regulation of actin cytoskeleton
TTDR01216	Pathway	Renal cell carcinoma
TTDR01216	Aptamer	SU6668
TTDR01217	UniProt ID	P09619
TTDR01217	Name	Beta platelet-derived growth factor receptor
TTDR01217	Type of target	Research target
TTDR01217	Synonyms	Beta-PDGFR
TTDR01217	Synonyms	CD140b antigen
TTDR01217	Synonyms	PDGF-R-beta
TTDR01217	Synonyms	Platelet-derived growth factor receptor beta
TTDR01217	Disease	Chronic myeloproliferative diseases
TTDR01217	Disease	Ewing's sarcoma
TTDR01217	Function	Receptor that binds specifically to pdgfb and has a tyrosine-protein kinase acti
TTDR01217	Sequence	MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGT
TTDR01217	PDB Structure	1GQ5; 1H9O; 1LWP; 2L6W; 3MJG
TTDR01217	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01217	Pathway	Calcium signaling pathway
TTDR01217	Pathway	Colorectal cancer
TTDR01217	Pathway	Cytokine-cytokine receptor interaction
TTDR01217	Pathway	Focal adhesion
TTDR01217	Pathway	Gap junction
TTDR01217	Pathway	Glioma
TTDR01217	Pathway	MAPK signaling pathway
TTDR01217	Pathway	Melanoma
TTDR01217	Pathway	Pathways in cancer
TTDR01217	Pathway	Prostate cancer
TTDR01217	Pathway	Regulation of actin cytoskeleton
TTDR01217	EC Number	EC 2.7.1.112
TTDR01217	Target Validation	TTDR01217
TTDR01217	Inhibitor	(1H-indol-2-yl)(5-methoxy-1H-indol-2-yl)methanone
TTDR01217	Inhibitor	(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone
TTDR01217	Inhibitor	(1H-indol-2-yl)(6-methoxy-1H-indol-2-yl)methanone
TTDR01217	Inhibitor	(2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine
TTDR01217	Inhibitor	(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone
TTDR01217	Inhibitor	(5-hydroxy-1H-indol-2-yl)(1H-indol-2-yl)methanone
TTDR01217	Inhibitor	(benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone
TTDR01217	Inhibitor	1-Phenyl-1H-benzoimidazol-5-ol
TTDR01217	Inhibitor	1-Phenyl-1H-benzoimidazole
TTDR01217	Inhibitor	2-(1H-indazol-3-yl)-1H-benzo[d]imidazole
TTDR01217	Inhibitor	3-((E)-Styryl)-quinoline
TTDR01217	Inhibitor	3-(1H-Indol-3-yl)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-(1H-Indol-3-yl)-quinoline
TTDR01217	Inhibitor	3-(2-Cyclohexyl-ethyl)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-(3,4-Dichloro-phenyl)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-(3,4-Difluoro-phenyl)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-(3,4-Dimethoxy-phenyl)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-(3-Fluoro-phenyl)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-(4-Fluoro-phenyl)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-(4-dimethylamino-benzylidenyl)-2-indolinone
TTDR01217	Inhibitor	3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenol
TTDR01217	Inhibitor	3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenylamine
TTDR01217	Inhibitor	3-Benzimidazol-2-ylhydroquinolin-2-one
TTDR01217	Inhibitor	3-Benzyloxy-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-Cyclohexylethynyl-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-Cyclopent-1-enyl-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-Cyclopentyl-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	3-Pyridin-3-yl-quinoline-6,7-diol
TTDR01217	Inhibitor	3-Pyridin-4-yl-quinolin-7-ol
TTDR01217	Inhibitor	3-Pyridin-4-yl-quinoline
TTDR01217	Inhibitor	3-Pyridin-4-yl-quinoline-5,7-diol
TTDR01217	Inhibitor	3-Thiophen-3-yl-quinoline
TTDR01217	Inhibitor	4-(2,3-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	4-(3,4-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	4-(3,5-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinazoline
TTDR01217	Inhibitor	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	4-(3-Ethoxy-phenoxy)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	4-(3-Ethyl-phenoxy)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	4-(3-Fluoro-phenoxy)-6,7-dimethoxy-quinoline
TTDR01217	Inhibitor	4-(5-Methoxy-benzoimidazol-1-yl)-phenylamine
TTDR01217	Inhibitor	4-(6,7-Dimethoxy-quinolin-3-yl)-benzoic acid
TTDR01217	Inhibitor	4-(6,7-Dimethoxy-quinolin-3-yl)-phenol
TTDR01217	Inhibitor	4-Benzoimidazol-1-yl-phenylamine
TTDR01217	Inhibitor	5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline
TTDR01217	Inhibitor	5,7-Dimethoxy-3-pyridin-4-yl-quinoline
TTDR01217	Inhibitor	5,7-Dimethoxy-3-thiophen-3-yl-quinoline
TTDR01217	Inhibitor	5,7-Dimethyl-3-thiophen-3-yl-quinoline
TTDR01217	Inhibitor	5-(6,7-Dimethoxy-quinolin-3-yl)-1H-pyridin-2-one
TTDR01217	Inhibitor	5-Methoxy-1-phenyl-1H-benzoimidazole
TTDR01217	Inhibitor	6,7-Dichloro-3-thiophen-3-yl-quinoline
TTDR01217	Inhibitor	6,7-Difluoro-3-thiophen-3-yl-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-((E)-styryl)-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-(3-methoxy-phenyl)-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-(4-methoxy-phenyl)-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-(4-nitro-phenyl)-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-p-tolyl-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-phenyl-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-phenylethynyl-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-pyridin-3-yl-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-pyridin-4-yl-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-3-thiophen-2-yl-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-4-(2-methoxy-phenoxy)-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-4-(3-methoxy-phenoxy)-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-4-(3-nitro-phenoxy)-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-4-(4-methoxy-phenoxy)-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-4-m-tolyloxy-quinoline
TTDR01217	Inhibitor	6,7-Dimethoxy-4-phenoxy-quinoline
TTDR01217	Inhibitor	6-Methoxy-3-pyridin-4-yl-quinoline
TTDR01217	Inhibitor	6-Methoxy-3-thiophen-3-yl-quinoline
TTDR01217	Inhibitor	7-Chloro-3-pyridin-4-yl-quinoline
TTDR01217	Inhibitor	7-Fluoro-3-thiophen-3-yl-quinoline
TTDR01217	Inhibitor	7-Methoxy-3-pyridin-4-yl-quinoline
TTDR01217	Inhibitor	7-Methoxy-3-thiophen-3-yl-quinoline
TTDR01217	Inhibitor	7-Thiophen-3-yl-[1,3]dioxolo[4,5-g]quinoline
TTDR01217	Inhibitor	AG1295
TTDR01217	Inhibitor	BMS-536924
TTDR01217	Inhibitor	Benzyl-(6,7-dimethoxy-quinolin-3-yl)-amine
TTDR01217	Inhibitor	Bis-(5-hydroxy-1H-indol-2-yl)-methanone
TTDR01217	Inhibitor	JNJ-10198409
TTDR01217	Inhibitor	PD-0166326;PD-166326
TTDR01217	Inhibitor	PD-0173952
TTDR01217	Inhibitor	PD-0173955;PD-17395
TTDR01217	Inhibitor	PD-0173956
TTDR01217	Inhibitor	PD-0173958
TTDR01217	Inhibitor	PD-0179483
TTDR01217	Inhibitor	PD-0180970
TTDR01217	Inhibitor	PD-173074
TTDR01217	Inhibitor	RG-13022
TTDR01217	Inhibitor	RPR-101511
TTDR01217	Inhibitor	RPR-108514A
TTDR01217	Inhibitor	Ro-4396686
TTDR01217	Inhibitor	SEMAXINIB
TTDR01217	Inhibitor	SU-11652
TTDR01217	Inhibitor	TG-100435
TTDR01217	Inhibitor	bis(5-acetoxybenzo[b]furan-2-yl)methanone
TTDR01217	Inhibitor	bis(5-aminobenzo[b]furan-2-yl)methanone
TTDR01217	Inhibitor	bis(5-hydroxybenzo[b]furan-2-yl)methanone
TTDR01217	Inhibitor	bis(5-methoxybenzo[b]furan-2-yl)methanone
TTDR01217	Inhibitor	bis(6-hydroxybenzo[b]furan-2-yl)methanone
TTDR01217	Inhibitor	bis(benzo[b]furan-2-yl)methanone
TTDR01217	Inhibitor	di(1H-indol-2-yl)methanone
TTDR01218	UniProt ID	Q16189
TTDR01218	Name	BCR/ABL protein
TTDR01218	Type of target	Research target
TTDR01218	Synonyms	BCR-ABL tyrosine kinase
TTDR01218	Synonyms	BCR/ABL FUSION GENE
TTDR01218	Synonyms	Bcr-Abl
TTDR01218	Synonyms	Bcr-abl oncogene
TTDR01218	Disease	Cancer, unspecific
TTDR01218	Disease	Chronic myelogenous leukemia
TTDR01218	Disease	Chronic myeloid leukemia
TTDR01218	Sequence	IPLTINKEDDESPGLYGFLNVIVHSATGFKQSSSEKLRVLGYNHNG
TTDR01218	EC Number	EC 2.7.1.112
TTDR01218	Inhibitor	PD180970
TTDR01218	Inhibitor	STI571
TTDR01219	Name	FIP1L1-PDGFRalpha kinase
TTDR01219	Type of target	Research target
TTDR01219	Synonyms	FIP1L1-PDGFRA fusion gene
TTDR01219	Synonyms	FIP1L1-PDGFRalpha
TTDR01219	Disease	Chronic eosinophilic leukemia
TTDR01219	Disease	Hypereosinophilic syndrome
TTDR01220	UniProt ID	Q9NYX4
TTDR01220	Name	D1 dopamine receptor-interacting protein calcyon
TTDR01220	Type of target	Research target
TTDR01220	Disease	Cocaine dependence
TTDR01220	Disease	Erectile dysfunction
TTDR01220	Disease	Neuroleptic malignant syndrome
TTDR01220	Disease	Respiratory diseases
TTDR01220	Disease	Treatment-refractory psychoses
TTDR01220	Function	May have a role in potentiating calcium ion-dependent signaling.
TTDR01220	Sequence	MVKLGCSFSGKPGKDPGDQDGAAMDSVPLISPLDISQLQPPLPDQVVIKTQTEYQLSSPDQQNFPDLEGQRLNCSHPEEG
TTDR01220	BioChemical Class	Transmembrane protein
TTDR01220	Activator	A 77636
TTDR01220	Activator	Apomorphine SL
TTDR01220	Activator	Indolophenanthridine
TTDR01220	Activator	SKF 38393
TTDR01221	Name	Growth-arrest-specific protein 6
TTDR01221	Type of target	Research target
TTDR01221	Synonyms	Gas6SV
TTDR01221	Synonyms	Growth potentiating factor-encoding gene gas6
TTDR01221	Disease	Endocrine disorder
TTDR01222	UniProt ID	Q02809
TTDR01222	Name	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1
TTDR01222	Type of target	Research target
TTDR01222	Synonyms	LH
TTDR01222	Synonyms	LH1
TTDR01222	Synonyms	Lysyl hydroxylase
TTDR01222	Synonyms	Lysyl hydroxylase 1
TTDR01222	Synonyms	Peptidyllysine, 2-oxoglutarate:oxygen 5-oxidoreductase
TTDR01222	Disease	Excessive collagen deposition
TTDR01222	Disease	Proliferative vitreoretinopathy
TTDR01222	Function	Forms hydroxylysine residues in -xaa-lys-gly- sequences in collagens. These hydr
TTDR01222	Sequence	MRPLLLLALLGWLLLAEAKGDAKPEDNLLVLTVATKETEGFRRFKRSAQFFNYKIQALGLGEDWNVEKGTSAGGGQKVRL
TTDR01222	BioChemical Class	Oxidoreductases acting on paired donors
TTDR01222	Pathway	Lysine degradation
TTDR01222	EC Number	EC 1.14.11.4
TTDR01222	Activator	Ascorbate
TTDR01223	UniProt ID	Q09163
TTDR01223	Name	Preadipocyte factor
TTDR01223	Type of target	Research target
TTDR01223	Synonyms	Pref-1
TTDR01223	Disease	Eye inflammation
TTDR01223	Sequence	MIATGALLRVLLLLLAFGHSTYGAECDPPCDPQYGFCEADNVCRCHVGWEGPLCDKCVTAPGCVNGVCKEPWQCICKDGW
TTDR01223	PDB Structure	1EDM
TTDR01224	UniProt ID	P00915
TTDR01224	Name	Carbonic anhydrase I
TTDR01224	Type of target	Research target
TTDR01224	Synonyms	CA-I
TTDR01224	Synonyms	Carbonate dehydratase I
TTDR01224	Synonyms	Carbonic anhydrase B
TTDR01224	Disease	Glaucoma
TTDR01224	Disease	Hypertension
TTDR01224	Disease	Pancreatic cancer
TTDR01224	Function	Reversible hydration of carbon dioxide.
TTDR01224	Sequence	MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVL
TTDR01224	PDB Structure	1AZM; 1BZM; 1CRM; 1CZM; 1HCB; 1HUG; 1HUH; 1J9W; 1JV0; 2CAB; 2FOY; 2FW4; 2IT4; 2N
TTDR01224	BioChemical Class	Carbon-oxygen lyases
TTDR01224	Pathway	Nitrogen metabolism
TTDR01224	EC Number	EC 4.2.1.1
TTDR01224	Target Validation	TTDR01224
TTDR01224	QSAR Model	TTDR01224
TTDR01224	Inhibitor	2,4-dichloro-5-sulfamoylbenzoic acid
TTDR01224	Inhibitor	2-(biphenyl-4-yl)vinylboronic acid
TTDR01224	Inhibitor	2-Hydroxycinnamic acid
TTDR01224	Inhibitor	2-oxo-2H-thiochromene-3-carboxylic acid
TTDR01224	Inhibitor	3-phenylprop-1-enylboronic acid
TTDR01224	Inhibitor	4-azidobenzenesulfonamide
TTDR01224	Inhibitor	4-bromophenylboronic acid
TTDR01224	Inhibitor	4-butylphenylboronic acid
TTDR01224	Inhibitor	4-ethynyl benzene sulfonamide
TTDR01224	Inhibitor	4-methoxyphenylboronic acid
TTDR01224	Inhibitor	4-methylstyrylboronic acid
TTDR01224	Inhibitor	4-nitrophenyl phosphate
TTDR01224	Inhibitor	4-phenoxyphenylboronic acid
TTDR01224	Inhibitor	6-methoxy-2-oxo-2H-chromene-3-carboxylic acid
TTDR01224	Inhibitor	Aminobenzolamide derivative
TTDR01224	Inhibitor	Azide
TTDR01224	Inhibitor	BENZENESULFONAMIDE
TTDR01224	Inhibitor	BENZOLAMIDE
TTDR01224	Inhibitor	CATECHIN
TTDR01224	Inhibitor	CHLORIDE
TTDR01224	Inhibitor	COUMARIN
TTDR01224	Inhibitor	COUMATE
TTDR01224	Inhibitor	CURCUMIN
TTDR01224	Inhibitor	CYANATE
TTDR01224	Inhibitor	Cynooxide anion
TTDR01224	Inhibitor	Ditiocarb sodium
TTDR01224	Inhibitor	ELLAGIC ACID
TTDR01224	Inhibitor	EMATE
TTDR01224	Inhibitor	FERULIC ACID
TTDR01224	Inhibitor	GALLICACID
TTDR01224	Inhibitor	HERNIARIN
TTDR01224	Inhibitor	HYDROSULFIDE
TTDR01224	Inhibitor	INDISULAM
TTDR01224	Inhibitor	IODIDE
TTDR01224	Inhibitor	Indan-5-sulfonic acid amide
TTDR01224	Inhibitor	N-(prop-2-ynyl)-4-sulfamoylbenzamide
TTDR01224	Inhibitor	N-hydroxysulfamide
TTDR01224	Inhibitor	N-hydroxysulfonamides
TTDR01224	Inhibitor	N-unsubstituted carbamate esters
TTDR01224	Inhibitor	NITRATE
TTDR01224	Inhibitor	NSC-654077
TTDR01224	Inhibitor	PARABEN
TTDR01224	Inhibitor	PARAOXON
TTDR01224	Inhibitor	PHENOL
TTDR01224	Inhibitor	PHENYLDIFLUOROMETHANESULFONAMIDE
TTDR01224	Inhibitor	PHENYLMETHANESULFONAMIDE
TTDR01224	Inhibitor	PHENYLSULFAMATE
TTDR01224	Inhibitor	Phenyl Boronic acid
TTDR01224	Inhibitor	SACCHARIN
TTDR01224	Inhibitor	SALICYLATE
TTDR01224	Inhibitor	SULFAMATE
TTDR01224	Inhibitor	SULFAMIDE
TTDR01224	Inhibitor	SULFATE
TTDR01224	Inhibitor	Sulfenamido-sulfonamides
TTDR01224	Inhibitor	Syringic Acid
TTDR01224	Inhibitor	Thioureido sulfonamide
TTDR01224	Inhibitor	[Au(CN)2]-
TTDR01224	Inhibitor	[Cu(CN)2]-
TTDR01224	Inhibitor	beta-naphthylboronic acid
TTDR01224	Inhibitor	biphenylboronic acid
TTDR01224	Inhibitor	decyl sulfamate
TTDR01224	Inhibitor	hexane-1,6-diamine
TTDR01224	Inhibitor	octyl sulfamate
TTDR01224	Inhibitor	p-Coumaric Acid
TTDR01224	Inhibitor	pentane-1,5-diamine
TTDR01224	Inhibitor	phenethylboronic acid
TTDR01224	Inhibitor	phenoxyarsonous acid
TTDR01224	Inhibitor	prop-2-ynyl 4-sulfamoylbenzoate
TTDR01224	Inhibitor	sodium trithiocarbonate
TTDR01224	Inhibitor	styrylboronic acid
TTDR01224	Inhibitor	sulfanilamide derivative
TTDR01225	Name	HIV aspartyl protease
TTDR01225	Type of target	Research target
TTDR01225	Synonyms	HIV aspartyl protease
TTDR01225	Synonyms	HIV proteinase
TTDR01225	Synonyms	Retroproteinase
TTDR01225	Disease	Human immunodeficiency virus [HIV] disease
TTDR01225	Disease	Retrovirus infections
TTDR01225	EC Number	EC 3.4.23.16
TTDR01225	Related US Patent	6,214,861
TTDR01225	Related US Patent	6,281,367
TTDR01225	Related US Patent	6,313,117
TTDR01225	Related US Patent	6,316,496
TTDR01225	Related US Patent	6,316,625
TTDR01225	Related US Patent	6,319,946
TTDR01225	Related US Patent	6,329,524
TTDR01225	Related US Patent	6,335,460
TTDR01225	Related US Patent	6,372,905
TTDR01225	Related US Patent	6,380,188
TTDR01225	Related US Patent	6,380,400
TTDR01225	Related US Patent	6,384,036
TTDR01225	Related US Patent	6,388,132
TTDR01225	Related US Patent	6,391,919
TTDR01225	Related US Patent	6,392,067
TTDR01225	Related US Patent	6,403,585
TTDR01225	Related US Patent	6,403,799
TTDR01225	Related US Patent	6,407,134
TTDR01225	Related US Patent	6,407,285
TTDR01225	Related US Patent	6,417,387
TTDR01225	Related US Patent	6,440,659
TTDR01225	Related US Patent	6,444,678
TTDR01225	Related US Patent	6,451,999
TTDR01225	Related US Patent	6,458,785
TTDR01225	Related US Patent	6,465,661
TTDR01225	Related US Patent	6,469,207
TTDR01225	Related US Patent	6,472,404
TTDR01225	Related US Patent	6,472,407
TTDR01225	Related US Patent	6,472,534
TTDR01225	Related US Patent	6,489,364
TTDR01225	Related US Patent	6,500,832
TTDR01225	Related US Patent	6,506,759
TTDR01225	Related US Patent	6,512,006
TTDR01225	Related US Patent	6,512,135
TTDR01225	Related US Patent	6,515,024
TTDR01225	Related US Patent	6,515,162
TTDR01225	Related US Patent	6,525,215
TTDR01225	Related US Patent	6,528,252
TTDR01225	Related US Patent	6,528,510
TTDR01225	Related US Patent	6,534,493
TTDR01225	Related US Patent	6,538,006
TTDR01225	Related US Patent	6,552,203
TTDR01225	Related US Patent	6,555,558
TTDR01225	Related US Patent	6,559,137
TTDR01225	Related US Patent	6,562,848
TTDR01225	Related US Patent	6,569,882
TTDR01225	Related US Patent	6,570,027
TTDR01225	Related US Patent	6,605,721
TTDR01225	Related US Patent	6,632,826
TTDR01225	Related US Patent	6,646,010
TTDR01225	Related US Patent	6,649,651
TTDR01225	Related US Patent	6,649,761
TTDR01225	Related US Patent	6,656,965
TTDR01225	Related US Patent	6,667,307
TTDR01225	Related US Patent	6,673,822
TTDR01226	UniProt ID	Q9UID5
TTDR01226	Name	DNA-dependent DNA polymerase
TTDR01226	Type of target	Research target
TTDR01226	Disease	Human immunodeficiency virus [HIV] disease
TTDR01226	Sequence	ARVVYGDTDSMFVLLKGATKEQSFKIGQEIAEAVTATNPKPVKLKFEKVYLPCVLQTKKRYVGYMYETLDQKDPVFDAKG
TTDR01227	UniProt ID	P10828
TTDR01227	Name	Thyroid hormone receptor beta-1
TTDR01227	Type of target	Clinical trial target
TTDR01227	Disease	Hyperlipidemia
TTDR01227	Disease	Obesity
TTDR01227	Disease	Thyroid hormone resistance syndrome
TTDR01227	Disease	Thyrotoxicosis [hyperthyroidism]
TTDR01227	Function	High affinity receptor for triiodothyronine.
TTDR01227	Sequence	MTPNSMTENGLTAWDKPKHCPDREHDWKLVGMSEACLHRKSHSERRSTLKNEQSSPHLIQTTWTSSIFHLDHDDVNDQSV
TTDR01227	PDB Structure	1BSX; 1N46; 1NAX; 1NQ0; 1NQ1; 1NQ2; 1NUO; 1Q4X; 1R6G; 1XZX; 1Y0X; 2J4A; 2NLL; 2P
TTDR01227	BioChemical Class	Zinc-finger
TTDR01227	Pathway	Neuroactive ligand-receptor interaction
TTDR01227	Target Validation	TTDR01227
TTDR01227	Inhibitor	(3,5-Dibromo-4-butoxy-phenyl)-acetic acid
TTDR01227	Inhibitor	(3,5-Dibromo-4-hexyloxy-phenyl)-acetic acid
TTDR01227	Inhibitor	(3,5-Dibromo-4-pentyloxy-phenyl)-acetic acid
TTDR01227	Inhibitor	(4-hexylphenyl)(oxiran-2-yl)methanone
TTDR01227	Inhibitor	(E)-1-(4-heptylphenyl)but-2-en-1-one
TTDR01227	Inhibitor	(Z)-4-(4-hexylphenylamino)-4-oxobut-2-enoic acid
TTDR01227	Inhibitor	1-(4-(Hexyloxy)phenyl)-3-morpholinopropan-1-one
TTDR01227	Inhibitor	1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE
TTDR01227	Inhibitor	1-(4-heptylphenyl)prop-2-en-1-one
TTDR01227	Inhibitor	1-(4-hexylphenyl)-3-(propylamino)propan-1-one
TTDR01227	Inhibitor	1-(4-hexylphenyl)-3-morpholinopropan-1-one
TTDR01227	Inhibitor	1-(4-octylphenyl)prop-2-en-1-one
TTDR01227	Inhibitor	2-hexylphenyl acrylate
TTDR01227	Inhibitor	3-(3,5-Dibromo-4-hexyloxy-phenyl)-propionic acid
TTDR01227	Inhibitor	3-(4-(benzyloxy)-3,5-dibromophenyl)propanoic acid
TTDR01227	Inhibitor	3-(dibutylamino)-1-(4-hexylphenyl)propan-1-one
TTDR01227	Inhibitor	3-(dimethylamino)-1-(4-heptylphenyl)propan-1-one
TTDR01227	Inhibitor	3-(dimethylamino)-1-(4-hexylphenyl)propan-1-one
TTDR01227	Inhibitor	3-bromo-1-(4-hexylphenyl)propan-1-one
TTDR01227	Inhibitor	4-(3-(Dimethylamino)propanoyl)-N-hexylbenzamide
TTDR01227	Inhibitor	4-(4-hexylphenyl)-4-oxobut-2-enoic acid
TTDR01227	Inhibitor	4-hexylphenyl propiolate
TTDR01227	Inhibitor	Cacodylate Ion
TTDR01227	Inhibitor	Detrothyronine
TTDR01227	Inhibitor	GC-24
TTDR01227	Inhibitor	MB-07344
TTDR01227	Agonist	GC-1
TTDR01228	Name	Sulfonylurea receptor 2B
TTDR01228	Type of target	Research target
TTDR01228	Disease	Hypertension
TTDR01229	UniProt ID	P21589
TTDR01229	Name	5'-Nucleotidase
TTDR01229	Type of target	Research target
TTDR01229	Synonyms	5'-NT
TTDR01229	Synonyms	CD73 antigen
TTDR01229	Synonyms	Ecto-5'-nucleotidase
TTDR01229	Disease	Immune disease
TTDR01229	Function	Hydrolyzes extracellular nucleotides into membrane permeable nucleosides.
TTDR01229	Sequence	MCPRAARAPATLLLALGAVLWPAAGAWELTILHTNDVHSRLEQTSEDSSKCVNASRCMGGVARLFTKVQQIRRAEPNVLL
TTDR01229	PDB Structure	4H1S; 4H1Y; 4H2B; 4H2F; 4H2G; 4H2I
TTDR01229	BioChemical Class	Hydrolases acting on ester bonds
TTDR01229	Pathway	Metabolic pathways
TTDR01229	Pathway	Nicotinate and nicotinamide metabolism
TTDR01229	Pathway	Purine metabolism
TTDR01229	Pathway	Pyrimidine metabolism
TTDR01229	EC Number	EC 3.1.3.5
TTDR01229	Target Validation	TTDR01229
TTDR01229	Inhibitor	PSB-0952
TTDR01229	Inhibitor	PSB-0963
TTDR01229	Inhibitor	RB 2
TTDR01229	Inhibitor	acid blue 25
TTDR01230	UniProt ID	P00156
TTDR01230	UniProt ID	Q02768
TTDR01230	Name	Cytochrome B
TTDR01230	Type of target	Research target
TTDR01230	Synonyms	Cyb
TTDR01230	Disease	Malaria
TTDR01230	Function	Component of the ubiquinol-cytochrome c reductase complex (complex iii or cytoch
TTDR01230	Sequence	MTPMRKINPLMKLINHSFIDLPTPSNISAWWNFGSLLGACLILQITTGLFLAMHYSPDASTAFSSIAHITRDVNYGWIIR
TTDR01230	BioChemical Class	Transmembrane protein
TTDR01230	Inhibitor	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE
TTDR01230	Inhibitor	5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE
TTDR01230	Inhibitor	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole
TTDR01230	Inhibitor	B-2-Octylglucoside
TTDR01230	Inhibitor	B-Octylglucoside
TTDR01230	Inhibitor	FAMOXADONE
TTDR01230	Inhibitor	UBIQUINONE-2
TTDR01231	Name	Haem polymerase
TTDR01231	Type of target	Research target
TTDR01231	Synonyms	Heme polymerase
TTDR01231	Disease	Malaria
TTDR01232	UniProt ID	O15770
TTDR01232	UniProt ID	P00390
TTDR01232	Name	Glutathione reductase, mitochondrial
TTDR01232	Type of target	Research target
TTDR01232	Synonyms	GR
TTDR01232	Synonyms	GRase
TTDR01232	Synonyms	Glutathione reductase
TTDR01232	Disease	Malaria
TTDR01232	Disease	Parasitic diseases
TTDR01232	Function	Maintain high levels of reduced glutathione in the cytosol.
TTDR01232	Sequence	MALLPRALSAGAGPSWRRAARAFRGFLLLLPEPAALTRALSRAMACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASA
TTDR01232	PDB Structure	1ALG; 1BWC; 1DNC; 1GRA; 1GRB; 1GRE; 1GRF; 1GRG; 1GRH; 1GRT; 1GSN; 1K4Q; 1XAN; 2A
TTDR01232	BioChemical Class	Oxidoreductases acting on a sulfur group of donors
TTDR01232	Pathway	Glutathione metabolism
TTDR01232	EC Number	EC 1.8.1.7
TTDR01232	Target Validation	TTDR01232
TTDR01232	Inhibitor	1-(2'-chlorophenyl)penta-1,4-dien-3-one
TTDR01232	Inhibitor	2,4,6 trinitrobenzene sulfonate 1,3-bis (2-chlorethyl)-1-nitrosourea
TTDR01232	Inhibitor	3,6-Dihydroxy-Xanthene-9-Propionic Acid
TTDR01232	Inhibitor	3,7-Bis-dimethylamino-phenothiazin-5-ylium
TTDR01232	Inhibitor	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol
TTDR01232	Inhibitor	3-Sulfinoalanine
TTDR01232	Inhibitor	4-nitrobenzo[c][1,2,5]thiadiazole
TTDR01232	Inhibitor	Flavin-Adenine Dinucleotide
TTDR01232	Inhibitor	Glutathionylspermidine Disulfide
TTDR01232	Inhibitor	Meta-Nitro-Tyrosine
TTDR01232	Inhibitor	Methylene blue
TTDR01232	Inhibitor	Nicotinamide-Adenine-Dinucleotide
TTDR01232	Inhibitor	Oxidized Glutathione Disulfide
TTDR01232	Inhibitor	Oxidized glutathione
TTDR01232	Inhibitor	trans-(1S(R),2S(R))-2-Hydroxycyclooctyl nitrate
TTDR01232	Inhibitor	trans-(R(S))-2-Hydroxy-1-phenylethyl nitrate
TTDR01233	UniProt ID	P00750
TTDR01233	Name	Tissue-type plasminogen activator
TTDR01233	Type of target	Research target
TTDR01233	Synonyms	Alteplase
TTDR01233	Synonyms	Reteplase
TTDR01233	Synonyms	T-PA
TTDR01233	Synonyms	T-plasminogen activator
TTDR01233	Synonyms	TPA
TTDR01233	Disease	Neurological diseases
TTDR01233	Function	Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzi
TTDR01233	Sequence	MDAMKRGLCCVLLLCGAVFVSPSQEIHARFRRGARSYQVICRDEKTQMIYQQHQSWLRPVLRSNRVEYCWCNSGRAQCHS
TTDR01233	PDB Structure	1A5H; 1BDA; 1PK2; 1PML; 1RTF; 1TPG; 1TPK; 1TPM; 1TPN
TTDR01233	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01233	Pathway	Complement and coagulation cascades
TTDR01233	EC Number	EC 3.4.21.68
TTDR01233	Related US Patent	6,541,452
TTDR01233	Target Validation	TTDR01233
TTDR01233	Inhibitor	1-guanidino-N-phenyl-7-isoquinolinesulphonamide
TTDR01233	Inhibitor	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine
TTDR01233	Inhibitor	5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID
TTDR01233	Inhibitor	6-Amino Hexanoic Acid
TTDR01233	Inhibitor	BMS-344577
TTDR01233	Inhibitor	N-(4-Chloro-7-p-tolyl-isoquinolin-1-yl)-guanidine
TTDR01233	Inhibitor	N-(4-Phenyl-pyridin-2-yl)-guanidine
TTDR01233	Inhibitor	N-(5-Benzyloxy-isoquinolin-1-yl)-guanidine
TTDR01233	Inhibitor	N-(7-Benzyloxy-isoquinolin-1-yl)-guanidine
TTDR01234	UniProt ID	P09919
TTDR01234	Name	Granulocyte colony-stimulating factor
TTDR01234	Type of target	Research target
TTDR01234	Synonyms	G-CSF
TTDR01234	Synonyms	Lenograstim
TTDR01234	Synonyms	Pluripoietin
TTDR01234	Disease	Neutropenia
TTDR01234	Function	Granulocyte/macrophage colony-stimulating factors are cytokines that act in hema
TTDR01234	Sequence	MAGPATQSPMKLMALQLLLWHSALWTVQEATPLGPASSLPQSFLLKCLEQVRKIQGDGAALQEKLVSECATYKLCHPEEL
TTDR01234	PDB Structure	1CD9; 1GNC; 1PGR; 1RHG; 2D9Q
TTDR01234	BioChemical Class	Growth factor
TTDR01234	Pathway	Cytokine-cytokine receptor interaction
TTDR01234	Pathway	Hematopoietic cell lineage
TTDR01234	Pathway	Jak-STAT signaling pathway
TTDR01235	Name	Catecholamine uptake
TTDR01235	Type of target	Research target
TTDR01235	Disease	Obesity
TTDR01235	Inhibitor	Metanephrine
TTDR01236	UniProt ID	Q09428
TTDR01236	Name	Sulfonylurea receptor 1
TTDR01236	Type of target	Research target
TTDR01236	Synonyms	SUR1
TTDR01236	Disease	Obesity
TTDR01236	Function	Putative subunit of the beta-cell atp-sensitive potassium channel (katp) and reg
TTDR01236	Sequence	MPLAFCGSENHSAAYRVDQGVLNNGCFVDALNVVPHVFLLFITFPILFIGWGSQSSKVHIHHSTWLHFPGHNLRWILTFM
TTDR01236	BioChemical Class	ABC transporter
TTDR01236	Pathway	ABC transporters
TTDR01236	Pathway	Type II diabetes mellitus
TTDR01236	Related US Patent	6,242,200
TTDR01236	Inhibitor	HBR-985
TTDR01236	Inhibitor	HMR-1883
TTDR01237	UniProt ID	P04156
TTDR01237	Name	Major prion protein
TTDR01237	Type of target	Research target
TTDR01237	Synonyms	ASCR
TTDR01237	Synonyms	CD230 antigen
TTDR01237	Synonyms	PRNP
TTDR01237	Synonyms	PrP
TTDR01237	Synonyms	PrP27-30
TTDR01237	Synonyms	PrP33-35C
TTDR01237	Synonyms	Prion protein
TTDR01237	Synonyms	Prion protein PrP(C)
TTDR01237	Disease	Prion diseases
TTDR01237	Function	The physiological function of prp is not known.
TTDR01237	Sequence	MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGG
TTDR01237	PDB Structure	1E1G; 1E1J; 1E1P; 1E1S; 1E1U; 1E1W; 1FKC; 1FO7; 1H0L; 1HJM; 1HJN; 1I4M; 1OEH; 1O
TTDR01237	BioChemical Class	Cell membrane protein
TTDR01237	Antibody	Anti-PrP antibodies
TTDR01238	UniProt ID	P20333
TTDR01238	Name	Tumor necrosis factor receptor superfamily member 1B
TTDR01238	Type of target	Research target
TTDR01238	Synonyms	CD120b
TTDR01238	Synonyms	Cytokine response modifying protein B
TTDR01238	Synonyms	P75
TTDR01238	Synonyms	P80
TTDR01238	Synonyms	TNF-R2
TTDR01238	Synonyms	Tumor necrosis factor receptor 2
TTDR01238	Synonyms	Tumor necrosis factor receptor II
TTDR01238	Disease	Rheumatoid arthritis, unspecified
TTDR01238	Function	Receptor with high affinity for tnfsf2/tnf-alpha and approximately 5-fold lower
TTDR01238	Sequence	MAPVAVWAALAVGLELWAAAHALPAQVAFTPYAPEPGSTCRLREYYDQTAQMCCSKCSPGQHAKVFCTKTSDTVCDSCED
TTDR01238	PDB Structure	1CA9; 3ALQ
TTDR01238	BioChemical Class	Transmembrane protein
TTDR01238	Pathway	Adipocytokine signaling pathway
TTDR01238	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDR01238	Pathway	Cytokine-cytokine receptor interaction
TTDR01239	Name	Cholinergic receptor
TTDR01239	Type of target	Research target
TTDR01239	Disease	Muscle contraction
TTDR01239	Disease	Schizophrenia
TTDR01239	Antagonist	Cisatracurium
TTDR01240	UniProt ID	P22102
TTDR01240	Name	Glycinamide ribonucleotide formyltransferase
TTDR01240	Type of target	Research target
TTDR01240	Synonyms	5'-phosphoribosylglycinamide transformylase
TTDR01240	Synonyms	GAR transformylase
TTDR01240	Synonyms	GARFT
TTDR01240	Synonyms	GART
TTDR01240	Synonyms	Glycinamide ribonucleotide transformylase
TTDR01240	Synonyms	Phosphoribosylglycinamide formyltransferase
TTDR01240	Disease	Solid tumor
TTDR01240	Sequence	MAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAA
TTDR01240	PDB Structure	1MEJ; 1MEN; 1MEO; 1NJS; 1RBM; 1RBQ; 1RBY; 1RBZ; 1RC0; 1RC1; 1ZLX; 1ZLY; 2QK4; 2V
TTDR01240	Pathway	Metabolic pathways
TTDR01240	Pathway	One carbon pool by folate
TTDR01240	Pathway	Purine metabolism
TTDR01240	EC Number	EC 2.1.2.2
TTDR01240	Target Validation	TTDR01240
TTDR01240	Inhibitor	(10r)-10-Formyl-5,8,10-Trideazafolic Acid
TTDR01240	Inhibitor	10-CF3C(OH)2-DDACTHF
TTDR01240	Inhibitor	10-Formyl-5,8,10-Trideazafolic Acid
TTDR01240	Inhibitor	10-trifluoroacetyl-DDACTHF
TTDR01240	Inhibitor	AG2034
TTDR01240	Inhibitor	DDATHF
TTDR01240	Inhibitor	DIDEAZAFOLATE
TTDR01240	Inhibitor	Glycinamide Ribonucleotide
TTDR01240	Inhibitor	LOMETREXOL
TTDR01240	Inhibitor	LY309887
TTDR01240	Inhibitor	dideazaacyclotetrahydrofolic acid
TTDR01241	Name	Tyrosine kinase
TTDR01241	Type of target	Research target
TTDR01241	Synonyms	PTK
TTDR01241	Synonyms	Protein-tyrosine kinase
TTDR01241	Synonyms	Tyrosine kinase
TTDR01241	Disease	Solid tumors
TTDR01241	EC Number	EC 2.7.1.112
TTDR01241	Related US Patent	6,239,133
TTDR01241	Related US Patent	6,245,759
TTDR01241	Related US Patent	6,306,874
TTDR01241	Related US Patent	6,313,138
TTDR01241	Related US Patent	6,344,455
TTDR01241	Related US Patent	6,350,754
TTDR01241	Related US Patent	6,355,636
TTDR01241	Related US Patent	6,420,382
TTDR01241	Related US Patent	6,479,512
TTDR01241	Related US Patent	6,489,328
TTDR01241	Related US Patent	6,498,176
TTDR01241	Related US Patent	6,506,769
TTDR01241	Related US Patent	6,518,316
TTDR01241	Related US Patent	6,541,504
TTDR01241	Related US Patent	6,544,988
TTDR01241	Related US Patent	6,548,496
TTDR01241	Related US Patent	6,559,173
TTDR01241	Related US Patent	6,562,818
TTDR01241	Related US Patent	6,579,897
TTDR01241	Related US Patent	6,586,423
TTDR01241	Related US Patent	6,586,424
TTDR01241	Related US Patent	6,596,746
TTDR01241	Related US Patent	6,602,863
TTDR01241	Related US Patent	6,608,048
TTDR01241	Related US Patent	6,630,489
TTDR01241	Related US Patent	6,653,308
TTDR01241	Related US Patent	6,656,940
TTDR01241	Related US Patent	6,747,025
TTDR01241	Inhibitor	PKI166
TTDR01242	Name	Fibrin
TTDR01242	Type of target	Research target
TTDR01242	Disease	Myocardial infarction
TTDR01242	Disease	Thrombosis
TTDR01243	UniProt ID	Q59571
TTDR01243	Name	Cytochrome p450 121
TTDR01243	Type of target	Research target
TTDR01243	Synonyms	CYP121
TTDR01243	Synonyms	P450 MT2
TTDR01243	Disease	Tuberculosis
TTDR01243	Sequence	MTATVLLEVPFSARGDRIPDAVAELRTREPIRKVRTITGAEAWLVSSYALCTQVLEDRRFSMKETAAAGAPRLNALTVPP
TTDR01243	PDB Structure	1N40; 1N4G; 2IJ5; 2IJ7; 3CXV; 3CXX; 3CXY; 3CXZ
TTDR01243	EC Number	EC 1.14.-.-
TTDR01243	Inhibitor	4-Iodopyrazole
TTDR01243	Inhibitor	Heme
TTDR01244	Name	24:1 cis-5 elongase
TTDR01244	Type of target	Research target
TTDR01244	Disease	Tuberculosis
TTDR01245	UniProt ID	Q10524
TTDR01245	Name	3-oxoacyl-[acyl-carrier-protein] synthase 1
TTDR01245	Type of target	Research target
TTDR01245	Synonyms	Beta-ketoacyl-ACP synthase 1
TTDR01245	Synonyms	KAS 1
TTDR01245	Disease	Bacterial infections
TTDR01245	Disease	Tuberculosis
TTDR01245	Function	Catalyzes the condensation reaction of fatty acid synthesis by the addition to a
TTDR01245	Sequence	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRM
TTDR01245	EC Number	EC 2.3.1.41
TTDR01245	Inhibitor	2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE
TTDR01245	Inhibitor	Caprylic acid
TTDR01245	Inhibitor	Decanoic Acid
TTDR01245	Inhibitor	Lauric Acid
TTDR01246	UniProt ID	Q04760
TTDR01246	Name	Lactoylglutathione lyase
TTDR01246	Type of target	Research target
TTDR01246	Synonyms	Aldoketomutase
TTDR01246	Synonyms	Glx I
TTDR01246	Synonyms	GlxI
TTDR01246	Synonyms	Glyoxalase I
TTDR01246	Synonyms	Ketone-aldehyde mutase
TTDR01246	Synonyms	Methylglyoxalase
TTDR01246	Synonyms	S-D-lactoylglutathione methylglyoxal lyase
TTDR01246	Disease	Tumors
TTDR01246	Function	Catalyzes the conversion of hemimercaptal, formed from methylglyoxal and glutath
TTDR01246	Sequence	MAEPQPPSGGLTDEAALSCCSDADPSTKDFLLQQTMLRVKDPKKSLDFYTRVLGMTLIQKCDFPIMKFSLYFLAYEDKND
TTDR01246	PDB Structure	1BH5; 1FRO; 1QIN; 1QIP; 3VW9
TTDR01246	BioChemical Class	Carbon-sulfur lyases
TTDR01246	Pathway	Pyruvate metabolism
TTDR01246	EC Number	EC 4.4.1.5
TTDR01246	Target Validation	TTDR01246
TTDR01246	Inhibitor	2-Sulfhydryl-Ethanol
TTDR01246	Inhibitor	BAICALEIN
TTDR01246	Inhibitor	CYANIDIN
TTDR01246	Inhibitor	DELPHINIDIN CHLORIDE
TTDR01246	Inhibitor	KAEMPFEROL
TTDR01246	Inhibitor	NARINGENIN
TTDR01246	Inhibitor	PELARGONIDIN CHLORIDE
TTDR01246	Inhibitor	S-(N-4bromophenyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-(N-4chlorophenyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione
TTDR01246	Inhibitor	S-(N-butyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-(N-ethyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-(N-heptyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-(N-hexyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-(N-methyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-(N-pentyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-(N-phenyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-(N-propyl-N-hydroxycarbamoyl)glutathione
TTDR01246	Inhibitor	S-Benzyl-Glutathione
TTDR01246	Inhibitor	S-Hexylglutathione
TTDR01246	Inhibitor	S-P-Nitrobenzyloxycarbonylglutathione
TTDR01246	Inhibitor	S-p-bromobenzyl glutatione
TTDR01247	UniProt ID	P41146
TTDR01247	Name	Nociceptin receptor
TTDR01247	Type of target	Research target
TTDR01247	Synonyms	KOR-3
TTDR01247	Synonyms	Kappa-type 3 opioid receptor
TTDR01247	Synonyms	OP(4)
TTDR01247	Synonyms	ORL-1
TTDR01247	Synonyms	ORL-1 receptor
TTDR01247	Synonyms	Opioid receptor 4
TTDR01247	Synonyms	Opioid receptor like-1 receptor
TTDR01247	Synonyms	Opioid-receptor-like 1
TTDR01247	Synonyms	Orphanin FQ receptor
TTDR01247	Disease	Analgesics
TTDR01247	Disease	Anorexia nervosa
TTDR01247	Disease	Anxiety disorder, unspecified
TTDR01247	Disease	Cerebral ischemia
TTDR01247	Disease	Depression
TTDR01247	Disease	Drug dependence
TTDR01247	Disease	Epilepsy
TTDR01247	Disease	Erectile dysfunction
TTDR01247	Disease	Hypertension
TTDR01247	Disease	Neurogenic bladder
TTDR01247	Disease	Neuropathic pain
TTDR01247	Disease	Pain, unspecified
TTDR01247	Function	Receptor for the neuropeptide nocipeptin/orphanin fq. Has a potential role in mo
TTDR01247	Sequence	MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHT
TTDR01247	PDB Structure	4EA3
TTDR01247	BioChemical Class	G-protein coupled receptor (rhodopsin family)
TTDR01247	Pathway	Neuroactive ligand-receptor interaction
TTDR01247	Related US Patent	6,340,681
TTDR01247	Related US Patent	6,410,561
TTDR01247	Related US Patent	6,423,725
TTDR01247	Target Validation	TTDR01247
TTDR01247	Inhibitor	[Asp6,Lys10]N/OFQ(1-13)NH2
TTDR01247	Inhibitor	cyclo [Asp6,Lys10]N/OFQ(1-13)NH2
TTDR01247	Inhibitor	1-(1,2-diphenylethyl)-4-phenylpiperidin-4-ol
TTDR01247	Inhibitor	1-(2-ethoxy-1-phenylethyl)-4-phenylpiperidin-4-ol
TTDR01247	Inhibitor	1-(3,3-diphenylpropyl)-4-phenylpiperidin-4-ol
TTDR01247	Inhibitor	1-(dio-tolylmethyl)-4-phenylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(2-fluorophenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(2-methoxyphenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(3-fluorophenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(3-methoxyphenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(3-phenylpropyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(4-bromophenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(4-butylphenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(4-chlorophenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(4-ethylphenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(4-fluorophenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(4-methoxyphenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(4-propylphenyl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(benzyloxy)-4-phenylpiperidine
TTDR01247	Inhibitor	1-benzhydryl-4-(furan-2-yl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(pyridin-2-yl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-(thiophen-2-yl)piperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-benzylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-butylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-cyclohexylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-cyclopropylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-ethoxy-4-phenylpiperidine
TTDR01247	Inhibitor	1-benzhydryl-4-hexylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-isopropylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-m-tolylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-methoxy-4-phenylpiperidine
TTDR01247	Inhibitor	1-benzhydryl-4-o-tolylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-p-tolylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-phenyl-4-propoxypiperidine
TTDR01247	Inhibitor	1-benzhydryl-4-phenylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzhydryl-4-tert-butylpiperidin-4-ol
TTDR01247	Inhibitor	1-benzyl-4-phenylpiperidin-4-ol
TTDR01247	Inhibitor	2,2-diMeBut-RYYRIK-NH2
TTDR01247	Inhibitor	2-MePen-RYYRIK-NH2
TTDR01247	Inhibitor	3-(1-benzylpiperidin-4-yl)-5-chloro-1H-indole
TTDR01247	Inhibitor	4-(2-(aminomethyl)phenyl)-1-benzylpiperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(1-phenylbutyl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(1-phenylethyl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(1-phenylheptyl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(1-phenylhexyl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(1-phenylpentyl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(1-phenylpropan-2-yl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(1-phenylpropyl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(3-phenylpropyl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(phenyl(m-tolyl)methyl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(phenyl(o-tolyl)methyl)piperidin-4-ol
TTDR01247	Inhibitor	4-phenyl-1-(phenyl(p-tolyl)methyl)piperidin-4-ol
TTDR01247	Inhibitor	Ac-Phe-[Orn-Pro-cha-Trp-Arg]
TTDR01247	Inhibitor	Ac-RYYRIK-GGG-K-(NH2)-YAFGYPS-GG
TTDR01247	Inhibitor	Ac-RYYRIK-GGG-K-(NH2)-YRFB-GGGGG
TTDR01247	Inhibitor	Ac-RYYRIK-K-(NH2)-YAFGYPS
TTDR01247	Inhibitor	Ac-RYYRIK-K-(NH2)-YRFB
TTDR01247	Inhibitor	Ac-RYYRIK-NH2
TTDR01247	Inhibitor	Ada-RYYRIK-NH2
TTDR01247	Inhibitor	Bu-RYYRIK-NH2
TTDR01247	Inhibitor	Bz--RYYRIK-NH2
TTDR01247	Inhibitor	CFGGFTCARKSARK
TTDR01247	Inhibitor	CFGGFTGARKCARK
TTDR01247	Inhibitor	EtBut-RYYRIK-NH2
TTDR01247	Inhibitor	F-G-G-F-T-G-A-R-K-S-A-R-K-L-Aib-N-Q-CONH2
TTDR01247	Inhibitor	F-G-G-F-T-G-A-R-K-S-A-R-K-L-Aib-N-Q-COOH
TTDR01247	Inhibitor	F-G-G-F-T-G-A-R-K-S-A-R-K-L-MeA-N-Q-CONH2
TTDR01247	Inhibitor	F-G-G-F-T-G-A-R-K-S-A-R-K-L-MeA-N-Q-COOH
TTDR01247	Inhibitor	F-G-G-F-T-G-A-R-K-S-Aib-R-K-L-A-N-Q-CONH2
TTDR01247	Inhibitor	F-G-G-F-T-G-A-R-K-S-Aib-R-K-L-A-N-Q-COOH
TTDR01247	Inhibitor	F-G-G-F-T-G-A-R-K-S-MeA-R-K-L-A-N-Q-CONH2
TTDR01247	Inhibitor	F-G-G-F-T-G-A-R-K-S-MeA-R-K-L-A-N-Q-COOH
TTDR01247	Inhibitor	F-G-G-F-T-G-Aib-R-K-S-A-R-K-L-A-N-Q-CONH2
TTDR01247	Inhibitor	F-G-G-F-T-G-Aib-R-K-S-A-R-K-L-A-N-Q-COOH
TTDR01247	Inhibitor	F-G-G-F-T-G-Aib-R-K-S-Aib-R-K-L-A-N-Q-CONH2
TTDR01247	Inhibitor	F-G-G-F-T-G-MeA-R-K-S-A-R-K-L-A-N-Q-CONH2
TTDR01247	Inhibitor	F-G-G-F-T-G-MeA-R-K-S-A-R-K-L-A-N-Q-COOH
TTDR01247	Inhibitor	FGGFTCARKCARK
TTDR01247	Inhibitor	FGGFTGARKCARKC
TTDR01247	Inhibitor	FGGFTGARKRKRKLANQ
TTDR01247	Inhibitor	FGGFTGARKSARK
TTDR01247	Inhibitor	FGGFTGARKSARKAANQ
TTDR01247	Inhibitor	FGGFTGARKSARKFANQ
TTDR01247	Inhibitor	FGGFTGARKSARKKANQ
TTDR01247	Inhibitor	FGGFTGARKSARKKKNQ
TTDR01247	Inhibitor	FGGFTGARKSARKKRNQ
TTDR01247	Inhibitor	FGGFTGARKSARKKWNQ
TTDR01247	Inhibitor	FGGFTGARKSARKL
TTDR01247	Inhibitor	FGGFTGARKSARKLADE
TTDR01247	Inhibitor	FGGFTGARKSARKLARK
TTDR01247	Inhibitor	FGGFTGARKSARKLFNQ
TTDR01247	Inhibitor	FGGFTGARKSARKLKNQ
TTDR01247	Inhibitor	FGGFTGARKSARKLLNQ
TTDR01247	Inhibitor	FGGFTGARKSARKLRNQ
TTDR01247	Inhibitor	FGGFTGARKSARKLVNQ
TTDR01247	Inhibitor	FGGFTGARKSARKLWNQ
TTDR01247	Inhibitor	FGGFTGARKSARKLYNQ
TTDR01247	Inhibitor	FGGFTGARKSARKRANQ
TTDR01247	Inhibitor	FGGFTGARKSARKRKNQ
TTDR01247	Inhibitor	FGGFTGARKSARKRKRK
TTDR01247	Inhibitor	FGGFTGARKSARKRRNQ
TTDR01247	Inhibitor	FGGFTGARKSARKRWNQ
TTDR01247	Inhibitor	FGGFTGARKSARKVANQ
TTDR01247	Inhibitor	FGGFTGARKSARKWANQ
TTDR01247	Inhibitor	FGGFTGARKSARKWKNQ
TTDR01247	Inhibitor	FGGFTGARKSARKWRNQ
TTDR01247	Inhibitor	FGGFTGARKSARKYANQ
TTDR01247	Inhibitor	FGGFTGCRKSARKC
TTDR01247	Inhibitor	FGGFTGCRKSCRK
TTDR01247	Inhibitor	FGGFTRKRKSARKLANQ
TTDR01247	Inhibitor	FLUPERAMIDE
TTDR01247	Inhibitor	For-RYYRIK-NH2
TTDR01247	Inhibitor	H-RYYRIK-NH2
TTDR01247	Inhibitor	Hex-RYYRIK-NH2
TTDR01247	Inhibitor	MeBut-RYYRIK-NH2
TTDR01247	Inhibitor	NOCICEPTIN
TTDR01247	Inhibitor	Piv-RYYRIK-NH2
TTDR01247	Inhibitor	Pr-RYYRIK-NH2
TTDR01247	Inhibitor	Va-RYYRIK-NH2
TTDR01247	Inhibitor	[D-Asp7,Lys10]N/OFQ(1-13)NH2
TTDR01247	Inhibitor	cyclo[Cys6,Cys10]N/OFQ(1-13)NH2
TTDR01247	Inhibitor	cyclo[Cys7,Cys10]N/OFQ(1-13)NH2
TTDR01247	Inhibitor	cyclo[DAsp7,Lys10]N/OFQ(1-13)NH2
TTDR01247	Inhibitor	isoBu-RYYRIK-NH2
TTDR01247	Inhibitor	isoVa-RYYRIK-NH2
TTDR01247	Inhibitor	t-BuAc-RYYRIK-NH2
TTDR01247	Antagonist	J-113397
TTDR01247	Antagonist	JTC-801
TTDR01247	Antagonist	[Nphe(1)]-nociceptin (1-13)-NH(2)
TTDR01247	Agonist	Etorphine
TTDR01247	Agonist	Ro-64-6198
TTDR01247	Aptamer	NOX 2137a/b
TTDR01247	Aptamer	NOX 2149
TTDR01248	UniProt ID	P51606
TTDR01248	Name	N-acylglucosamine 2-epimerase
TTDR01248	Type of target	Research target
TTDR01248	Synonyms	AGE
TTDR01248	Synonyms	GlcNAc 2-epimerase
TTDR01248	Synonyms	N-acetyl-D-glucosamine 2-epimerase
TTDR01248	Synonyms	RENBP
TTDR01248	Synonyms	Renin-binding protein
TTDR01248	Synonyms	RnBP
TTDR01248	Disease	Osteoarthritis
TTDR01248	Function	Catalyzes the interconversion of n-acetylglucosamine to n-acetylmannosamine. Bin
TTDR01248	Sequence	MEKERETLQAWKERVGQELDRVVAFWMEHSHDQEHGGFFTCLGREGRVYDDLKYVWLQGRQVWMYCRLYRTFERFRHAQL
TTDR01248	BioChemical Class	Racemases and Epimerases
TTDR01248	EC Number	EC 5.1.3.8
TTDR01249	UniProt ID	Q96GD0
TTDR01249	Name	Pyridoxal phosphate phosphatase
TTDR01249	Type of target	Research target
TTDR01249	Synonyms	PDXP
TTDR01249	Synonyms	PLP
TTDR01249	Synonyms	PLP phosphatase
TTDR01249	Synonyms	PLPP
TTDR01249	Disease	Korsakov's alcoholic psychosis
TTDR01249	Disease	Vitamin B6 deficiency
TTDR01249	Function	Pyridoxal phosphate phosphatase. Has some activity towards pyridoxal 5'-phosphat
TTDR01249	Sequence	MARCERLRGAALRDVLGRAQGVLFDCDGVLWNGERAVPGAPELLERLARAGKAALFVSNNSRRARPELALRFARLGFGGL
TTDR01249	PDB Structure	2CFR; 2CFS; 2CFT; 2OYC; 2P27; 2P69
TTDR01249	BioChemical Class	Hydrolases acting on ester bonds
TTDR01249	Pathway	Metabolic pathways
TTDR01249	EC Number	EC 3.1.3.74
TTDR01250	UniProt ID	O00141
TTDR01250	Name	Serine/threonine-protein kinase Sgk1
TTDR01250	Type of target	Research target
TTDR01250	Synonyms	Serum/glucocorticoid-regulated kinase 1
TTDR01250	Disease	Leukemia, Myeloid
TTDR01250	Disease	Myelodysplastic Syndrome
TTDR01250	Disease	Solid tumors
TTDR01250	Sequence	MTVKTEAAKGTLTYSRMRGMVAILIAFMKQRRMGLNDFIQKIANNSYACKHPEVQSILKISQPQEPELMNANPSPPPSPS
TTDR01250	PDB Structure	2R5T; 3HDM; 3HDN
TTDR01250	EC Number	EC 2.7.11.1
TTDR01250	Target Validation	TTDR01250
TTDR01250	Inhibitor	4,5,6,7-tetrabromobenzotriazole
TTDR01250	Inhibitor	CGP-57380
TTDR01250	Inhibitor	CI-1040;PD-18435;PD-184352
TTDR01250	Inhibitor	GF-109203
TTDR01250	Inhibitor	Go-6976
TTDR01250	Inhibitor	KN-62
TTDR01250	Inhibitor	LY-294002
TTDR01250	Inhibitor	PD-98059
TTDR01250	Inhibitor	RO-316233
TTDR01250	Inhibitor	Riboflavin Monophosphate
TTDR01250	Inhibitor	SB-202190
TTDR01250	Inhibitor	SB-203580
TTDR01250	Inhibitor	U-0126
TTDR01251	UniProt ID	O43915
TTDR01251	Name	Vascular endothelial growth factor D
TTDR01251	Type of target	Research target
TTDR01251	Synonyms	FIGF
TTDR01251	Synonyms	VEGF-D
TTDR01251	Synonyms	c-fos-induced growth factor
TTDR01251	Disease	Cancer/Tumors (Unspecified)
TTDR01251	Disease	Macular Degeneration
TTDR01251	Disease	Solid tumors
TTDR01251	Sequence	MYREWVVVNVFMMLYVQLVQGSSNEHGPVKRSSQSTLERSEQQIRAASSLEELLRITHSEDWKLWRCRLRLKSFTSMDSR
TTDR01251	PDB Structure	2XV7
TTDR01251	Pathway	Bladder cancer
TTDR01251	Pathway	Cytokine-cytokine receptor interaction
TTDR01251	Pathway	Focal adhesion
TTDR01251	Pathway	Pancreatic cancer
TTDR01251	Pathway	Pathways in cancer
TTDR01251	Pathway	Renal cell carcinoma
TTDR01251	Pathway	mTOR signaling pathway
TTDR01252	UniProt ID	P24347
TTDR01252	Name	Stromelysin-3
TTDR01252	Type of target	Research target
TTDR01252	Synonyms	MMP-11
TTDR01252	Synonyms	Matrix metalloproteinase-11
TTDR01252	Synonyms	SL-3
TTDR01252	Synonyms	ST3
TTDR01252	Synonyms	ST3/MMP11
TTDR01252	Synonyms	STR-3
TTDR01252	Synonyms	Stromelysin-3 (ST3) gene
TTDR01252	Disease	Cancer, unspecific
TTDR01252	Disease	Nonsmall cell lung cancer
TTDR01252	Disease	Oral cancer
TTDR01252	Disease	Osteoarthritis
TTDR01252	Function	May play an important role in the progression of epithelial malignancies.
TTDR01252	Sequence	MAPAAWLRSAAARALLPPMLLLLLQPPPLLARALPPDVHHLHAERRGPQPWHAALPSSPAPAPATQEAPRPASSLRPPRC
TTDR01252	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01252	EC Number	EC 3.4.24.-
TTDR01252	Related US Patent	6,630,501
TTDR01253	UniProt ID	Q8IZS8
TTDR01253	Name	Voltage-dependent calcium channel subunit alpha-2/delta-3
TTDR01253	Type of target	Research target
TTDR01253	Synonyms	CACNA2D3
TTDR01253	Synonyms	Voltage-dependent calcium channel subunit alpha-2-3
TTDR01253	Synonyms	Voltage-dependent calcium channel subunit delta-3
TTDR01253	Synonyms	Voltage-gated calcium channel subunit alpha-2/delta-3
TTDR01253	Disease	Analgesics
TTDR01253	Disease	Pain, unspecific
TTDR01253	Function	The alpha-2/delta subunit of voltage-dependent calcium channels regulates calciu
TTDR01253	Sequence	MAGPGSPRRASRGASALLAAALLYAALGDVVRSEQQIPLSVVKLWASAFGGEIKSIAAKYSGSQLLQKKYKEYEKDVAIE
TTDR01253	BioChemical Class	Voltage-gated channel
TTDR01253	Target Validation	TTDR01253
TTDR01253	Inhibitor	3-Aminomethyl-5-methyl-hexanoic acid
TTDR01253	Inhibitor	PD-144550
TTDR01254	UniProt ID	Q9UI33
TTDR01254	Name	Voltage-gated sodium channel subunit alpha Nav1.9
TTDR01254	Type of target	Research target
TTDR01254	Synonyms	PN5
TTDR01254	Synonyms	Peripheral nerve sodium channel 5
TTDR01254	Synonyms	SCN11A
TTDR01254	Synonyms	SCN12A
TTDR01254	Synonyms	SNS2
TTDR01254	Synonyms	Sensory neuron sodium channel 2
TTDR01254	Synonyms	Sodium channel protein type 11 subunit alpha
TTDR01254	Synonyms	Sodium channel protein type XI subunit alpha
TTDR01254	Synonyms	hNaN
TTDR01254	Disease	Analgesics
TTDR01254	Disease	Pain, unspecific
TTDR01254	Function	This protein mediates the voltage-dependent sodium ion permeability of excitable
TTDR01254	Sequence	MDDRCYPVIFPDERNFRPFTSDSLAAIEKRIAIQKEKKKSKDQTGEVPQPRPQLDLKASRKLPKLYGDIPRELIGKPLED
TTDR01254	PDB Structure	1BYY
TTDR01254	BioChemical Class	Voltage-gated channel
TTDR01254	Inhibitor	PD-32577
TTDR01255	UniProt ID	Q9NY46
TTDR01255	Name	Voltage-gated sodium channel subunit alpha Nav1.3
TTDR01255	Type of target	Research target
TTDR01255	Synonyms	KIAA1356
TTDR01255	Synonyms	NAC3
TTDR01255	Synonyms	SCN3A
TTDR01255	Synonyms	Sodium channel protein type 3 subunit alpha
TTDR01255	Synonyms	Sodium channel protein type III subunit alpha
TTDR01255	Synonyms	Sodium channel protein, brain III subunit alpha
TTDR01255	Synonyms	Voltage-gated sodium channel subtype III
TTDR01255	Disease	Analgesics
TTDR01255	Disease	Pain, unspecific
TTDR01255	Function	Mediates the voltage-dependent sodium ion permeability of excitable membranes. A
TTDR01255	Sequence	MAQALLVPPGPESFRLFTRESLAAIEKRAAEEKAKKPKKEQDNDDENKPKPNSDLEAGKNLPFIYGDIPPEMVSEPLEDL
TTDR01255	PDB Structure	1BYY
TTDR01255	BioChemical Class	Voltage-gated channel
TTDR01255	Target Validation	TTDR01255
TTDR01255	Inhibitor	2-(1-Pentyl-hexyl)-4-phenyl-1H-imidazole
TTDR01255	Inhibitor	2-Hexyl-4-(4-isobutyl-phenyl)-1H-imidazole
TTDR01255	Inhibitor	2-Hydroxy-2-phenyl-nonanoic acid amide
TTDR01255	Inhibitor	4-Biphenyl-4-yl-2-(1-pentyl-hexyl)-1H-imidazole
TTDR01255	Inhibitor	4-Biphenyl-4-yl-2-(1-propyl-butyl)-1H-imidazole
TTDR01255	Inhibitor	4-Biphenyl-4-yl-2-cyclohexylmethyl-1H-imidazole
TTDR01255	Inhibitor	4-Biphenyl-4-yl-2-hexyl-1H-imidazole
TTDR01255	Inhibitor	4-Biphenyl-4-yl-2-methyl-1H-imidazole
TTDR01255	Inhibitor	5-Ethyl-3-methyl-5-phenyl-oxazolidine-2,4-dione
TTDR01255	Inhibitor	5-Heptyl-5-phenyl-imidazolidine-2,4-dione
TTDR01255	Inhibitor	5-Hexyl-5-phenyl-imidazolidine-2,4-dione
TTDR01255	Inhibitor	5-Nonyl-5-phenyl-imidazolidine-2,4-dione
TTDR01255	Inhibitor	BW-202W92
TTDR01255	Inhibitor	CCNCSSKWCRDHSRCC
TTDR01255	Inhibitor	L-741742
TTDR01255	Inhibitor	LIDOFLAZINE
TTDR01255	Inhibitor	LIFARIZINE
TTDR01255	Inhibitor	LUBELUZOLE
TTDR01255	Inhibitor	PD-85639
TTDR01255	Inhibitor	SIPATRIGINE
TTDR01255	Inhibitor	U-92032
TTDR01256	UniProt ID	P78348
TTDR01256	Name	Acid-sensing ion channel ASIC1a/ASIC1b
TTDR01256	Type of target	Research target
TTDR01256	Synonyms	ACCN2
TTDR01256	Synonyms	ASIC1
TTDR01256	Synonyms	Acid-sensing ion channel 1
TTDR01256	Synonyms	Amiloride-sensitive cation channel 2, neuronal
TTDR01256	Synonyms	BNaC2
TTDR01256	Synonyms	Brain sodium channel 2
TTDR01256	Disease	Analgesics
TTDR01256	Disease	Pain, unspecific
TTDR01256	Function	Cation channel with high affinity for sodium, which is gated by extracellular pr
TTDR01256	Sequence	MELKAEEEEVGGVQPVSIQAFASSSTLHGLAHIFSYERLSLKRALWALCFLGSLAVLLCVCTERVQYYFHYHHVTKLDEV
TTDR01256	Blocker	PcTx1
TTDR01257	UniProt ID	Q9UHC3
TTDR01257	Name	Acid-sensing ion channel ASIC3
TTDR01257	Type of target	Research target
TTDR01257	Synonyms	ACCN3
TTDR01257	Synonyms	ASIC3
TTDR01257	Synonyms	Acid-sensing ion channel 3
TTDR01257	Synonyms	Amiloride-sensitive cation channel 3
TTDR01257	Synonyms	Neuronal amiloride-sensitive cation channel 3
TTDR01257	Synonyms	SLNAC1
TTDR01257	Synonyms	TNAC1
TTDR01257	Synonyms	Testis sodium channel 1
TTDR01257	Synonyms	hASIC3
TTDR01257	Synonyms	hTNaC1
TTDR01257	Disease	Analgesics
TTDR01257	Disease	Pain, unspecific
TTDR01257	Function	Cation channel with high affinity for sodium, which is gated by extracellular pr
TTDR01257	Sequence	MKPTSGPEEARRPASDIRVFASNCSMHGLGHVFGPGSLSLRRGMWAAAVVLSVATFLYQVAERVRYYREFHHQTALDERE
TTDR01257	Blocker	APETX2
TTDR01258	UniProt ID	Q8NET8
TTDR01258	Name	Transient receptor potential cation channel subfamily V member 3
TTDR01258	Type of target	Clinical trial target
TTDR01258	Synonyms	TrpV3
TTDR01258	Synonyms	VRL-3
TTDR01258	Synonyms	Vanilloid receptor-like 3
TTDR01258	Disease	Analgesics
TTDR01258	Disease	Pain, unspecific
TTDR01258	Function	Putative receptor-activated non-selective calcium permeant cation channel. It is
TTDR01258	Sequence	MKAHPKEMVPLMGKRVAAPSGNPAILPEKRPAEITPTKKSAHFFLEIEGFEPNPTVAKTSPPVFSKPMDSNIRQCISGNC
TTDR01259	UniProt ID	Q05586
TTDR01259	Name	Glutamate [NMDA] receptor subunit zeta-1
TTDR01259	Type of target	Research target
TTDR01259	Synonyms	GRIN1
TTDR01259	Synonyms	N-methyl-D-aspartate receptor subunit NR1
TTDR01259	Synonyms	NMDAR1
TTDR01259	Disease	Analgesics
TTDR01259	Disease	Pain, unspecific
TTDR01259	Function	NMDA receptor subtype of glutamate-gated ion channels with high calcium permeabi
TTDR01259	Sequence	MSTMRLLTLALLFSCSVARAACDPKIVNIGAVLSTRKHEQMFREAVNQANKRHGSWKIQLNATSVTHKPNAIQMALSVCE
TTDR01259	PDB Structure	2NR1; 3BYA
TTDR01259	BioChemical Class	Ion transport
TTDR01259	Pathway	Alzheimer's disease
TTDR01259	Pathway	Amyotrophic lateral sclerosis (ALS)
TTDR01259	Pathway	Calcium signaling pathway
TTDR01259	Pathway	Huntington's disease
TTDR01259	Pathway	Long-term potentiation
TTDR01259	Pathway	Neuroactive ligand-receptor interaction
TTDR01259	Target Validation	TTDR01259
TTDR01259	Inhibitor	(D)-Ala-Pro-Glu
TTDR01259	Inhibitor	(R)-2-Amino-5-phosphono-pentanoic acid
TTDR01259	Inhibitor	(R)-2-Amino-7-phosphono-heptanoic acid
TTDR01259	Inhibitor	(R)-4-Amino-Isoxazolidin-3-One
TTDR01259	Inhibitor	2-(4-Phenoxy-benzyl)-1H-benzoimidazole
TTDR01259	Inhibitor	2-(4-Phenoxy-benzyl)-3H-benzoimidazol-4-ol
TTDR01259	Inhibitor	2-(4-Phenoxy-benzyl)-3H-benzoimidazol-5-ol
TTDR01259	Inhibitor	2-(4-Phenoxy-benzyl)-3H-benzoimidazol-5-ylamine
TTDR01259	Inhibitor	2-Methylamino-succinic acid(NMDA)
TTDR01259	Inhibitor	2-Pyridin-4-yl-1,2,3,4-tetrahydro-isoquinoline
TTDR01259	Inhibitor	3-Benzoyl-7-chloro-4-hydroxy-1H-quinolin-2-one
TTDR01259	Inhibitor	3-Carbamoyl-6-chloro-1H-indole-2-carboxylic acid
TTDR01259	Inhibitor	3-Hydroxy-1H-benzo[b]azepine-2,5-dione
TTDR01259	Inhibitor	3-Hydroxy-6-methyl-1H-benzo[b]azepine-2,5-dione
TTDR01259	Inhibitor	3-Hydroxy-7-nitro-1H-benzo[b]azepine-2,5-dione
TTDR01259	Inhibitor	3-Hydroxy-8-methyl-1H-benzo[b]azepine-2,5-dione
TTDR01259	Inhibitor	3-phenyl-4-hydroxyquinolin-2(1H)-one
TTDR01259	Inhibitor	4,5,7-Trichloro-3-hydroxy-1H-quinolin-2-one
TTDR01259	Inhibitor	4,6-Dichloro-1H-indole-2-carboxylic acid
TTDR01259	Inhibitor	4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinoline
TTDR01259	Inhibitor	4-Benzyl-1-(2-phenoxy-ethyl)-piperidine
TTDR01259	Inhibitor	4-Benzyl-1-phenethyl-piperidine; hydrochloride
TTDR01259	Inhibitor	4-Bromo-3-hydroxy-1H-quinolin-2-one
TTDR01259	Inhibitor	4-Bromo-5,7-dichloro-3-hydroxy-1H-quinolin-2-one
TTDR01259	Inhibitor	4-Chloro-3-hydroxy-1H-quinolin-2-one
TTDR01259	Inhibitor	4-Phosphonomethyl-piperidine-2-carboxylic acid
TTDR01259	Inhibitor	4-[2-(3-Phenyl-propylamino)-ethyl]-phenol
TTDR01259	Inhibitor	4-[2-(4-Benzyl-piperidin-1-yl)-ethoxy]-phenol
TTDR01259	Inhibitor	4-[2-(4-Phenyl-butoxy)-ethyl]-phenol
TTDR01259	Inhibitor	4-[2-(4-Phenyl-butylamino)-ethyl]-phenol
TTDR01259	Inhibitor	4-[2-(4-Phenyl-piperidin-1-yl)-ethoxy]-phenol
TTDR01259	Inhibitor	4-[2-(5-Phenyl-pentylamino)-ethyl]-phenol
TTDR01259	Inhibitor	4-[2-(6-Phenyl-hexylamino)-ethyl]-phenol
TTDR01259	Inhibitor	4-[3-(4-Phenyl-butylamino)-propyl]-phenol
TTDR01259	Inhibitor	4-[3-(5-Phenyl-pentylamino)-propyl]-phenol
TTDR01259	Inhibitor	4-hydroxy-5-phenylthieno[2,3-b]pyridin-6(7H)-one
TTDR01259	Inhibitor	4-{2-[Ethyl-(4-phenyl-butyl)-amino]-ethyl}-phenol
TTDR01259	Inhibitor	5,6,7-Trichloro-1,4-dihydro-quinoxaline-2,3-dione
TTDR01259	Inhibitor	5,7-Dibromo-1,4-dihydro-quinoxaline-2,3-dione
TTDR01259	Inhibitor	5,7-Dichloro-1,4-dihydro-quinoxaline-2,3-dione
TTDR01259	Inhibitor	5,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione
TTDR01259	Inhibitor	5,7-Dichloro-4-hydroxy-3-phenyl-1H-quinolin-2-one
TTDR01259	Inhibitor	5,7-Dinitro-1,4-dihydro-quinoxaline-2,3-dione
TTDR01259	Inhibitor	6,7-Dichloro-1,4-dihydro-quinoxaline-2,3-dione
TTDR01259	Inhibitor	6,7-Dichloro-3-hydroxy-1H-quinazoline-2,4-dione
TTDR01259	Inhibitor	6-Chloro-1,4-dihydro-quinoxaline-2,3-dione
TTDR01259	Inhibitor	6-Methoxy-2-(4-phenoxy-benzyl)-1H-benzoimidazole
TTDR01259	Inhibitor	6-Nitro-1,4-dihydro-quinoxaline-2,3-dione
TTDR01259	Inhibitor	6-Nitro-2-(4-phenoxy-benzyl)-1H-benzoimidazole
TTDR01259	Inhibitor	7-Chloro-3-nitro-3,4-dihydro-1H-quinolin-2-one
TTDR01259	Inhibitor	7-chloro-3-hydroxyquinazoline-2,4-dione
TTDR01259	Inhibitor	8-Bromo-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDR01259	Inhibitor	8-Chloro-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDR01259	Inhibitor	8-Ethyl-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDR01259	Inhibitor	8-Fluoro-3-hydroxy-1H-benzo[b]azepine-2,5-dione
TTDR01259	Inhibitor	AM-92016
TTDR01259	Inhibitor	AP-7
TTDR01259	Inhibitor	Ala-Pro-Glu
TTDR01259	Inhibitor	CI-1041
TTDR01259	Inhibitor	Cycloleucine
TTDR01259	Inhibitor	D-Serine
TTDR01259	Inhibitor	DITOLYLGUANIDINE
TTDR01259	Inhibitor	DIZOCILPINE
TTDR01259	Inhibitor	DNQX
TTDR01259	Inhibitor	Dcka, 5,7-Dichlorokynurenic Acid
TTDR01259	Inhibitor	ELIPRODIL
TTDR01259	Inhibitor	GLUTAMATE
TTDR01259	Inhibitor	Gly-Amp-Glu
TTDR01259	Inhibitor	Gly-Hyp-Glu
TTDR01259	Inhibitor	Gly-Pip-Glu
TTDR01259	Inhibitor	Gly-b7Pro-Glu
TTDR01259	Inhibitor	H-Gly-D-dmP-Glu-OH
TTDR01259	Inhibitor	H-Gly-PMe-Glu-OH
TTDR01259	Inhibitor	H-Gly-dmP-Glu-OH
TTDR01259	Inhibitor	L-687414
TTDR01259	Inhibitor	L-695902
TTDR01259	Inhibitor	L-698532
TTDR01259	Inhibitor	L-701324
TTDR01259	Inhibitor	MDL-105519
TTDR01259	Inhibitor	N,N'-Bis-(4-butoxy-phenyl)-guanidine
TTDR01259	Inhibitor	N,N'-Bis-(4-butyl-phenyl)-guanidine
TTDR01259	Inhibitor	N,N'-Bis-(4-ethyl-phenyl)-guanidine
TTDR01259	Inhibitor	N,N'-Bis-(4-hexyl-phenyl)-guanidine
TTDR01259	Inhibitor	N,N'-Bis-(4-isopropyl-phenyl)-guanidine
TTDR01259	Inhibitor	N,N'-Bis-(4-sec-butyl-phenyl)-guanidine
TTDR01259	Inhibitor	N-(2-methoxybenzyl)cinnamamidine
TTDR01259	Inhibitor	NBQX
TTDR01259	Inhibitor	Nle-Pro-Glu
TTDR01259	Inhibitor	PHENCYCLIDINE
TTDR01259	Inhibitor	Phe-Pro-Glu
TTDR01259	Inhibitor	Phenethyl-(3-phenyl-propyl)-amine
TTDR01259	Inhibitor	Phenethyl-(4-phenyl-butyl)-amine
TTDR01259	Inhibitor	RPR-104632
TTDR01259	Inhibitor	RPR-118723
TTDR01259	Inhibitor	SPERMINE
TTDR01259	Inhibitor	TRANSTORINE
TTDR01259	Inhibitor	YM-90K
TTDR01259	Inhibitor	benzyl 4-aminobutyl(3-aminopropyl)carbamate
TTDR01260	UniProt ID	P30532
TTDR01260	Name	Neuronal acetylcholine receptor subunit alpha-5
TTDR01260	Type of target	Research target
TTDR01260	Synonyms	CHRNA5
TTDR01260	Synonyms	NACHRA5
TTDR01260	Disease	Analgesics
TTDR01260	Disease	Pain, unspecific
TTDR01260	Function	After binding acetylcholine, the AChR responds by an extensive change in conform
TTDR01260	Sequence	MAARGSGPRALRLLLLVQLVAGRCGLAGAAGGAQRGLSEPSSIAKHEDSLLKDLFQDYERWVRPVEHLNDKIKIKFGLAI
TTDR01261	UniProt ID	Q99571
TTDR01261	Name	P2X purinoceptor 4
TTDR01261	Type of target	Research target
TTDR01261	Synonyms	ATP receptor
TTDR01261	Synonyms	P2RX4
TTDR01261	Synonyms	P2X4
TTDR01261	Synonyms	Purinergic receptor
TTDR01261	Disease	Analgesics
TTDR01261	Disease	Pain, unspecific
TTDR01261	Function	Receptor for ATP that acts as a ligand gated ion channel. This receptor is insen
TTDR01261	Sequence	MAGCCAALAAFLFEYDTPRIVLIRSRKVGLMNRAVQLLILAYVIGWVFVWEKGYQETDSVVSSVTTKVKGVAVTNTSKLG
TTDR01261	Pathway	Calcium signaling pathway
TTDR01261	Pathway	Neuroactive ligand-receptor interaction
TTDR01261	Target Validation	TTDR01261
TTDR01261	Inhibitor	MRS-2160
TTDR01262	UniProt ID	Q6QWE0
TTDR01262	Name	Cyclooxygenase-3
TTDR01262	Type of target	Research target
TTDR01262	Synonyms	COX-3
TTDR01262	Synonyms	Cyclo-oxygenase 3
TTDR01262	Disease	Analgesics
TTDR01262	Disease	Chronic inflammatory diseases
TTDR01262	Disease	Inflammation
TTDR01262	Disease	Pain, unspecified
TTDR01262	Sequence	MSRESDPSGAPTRPGIRWPAGGALNVRLNSLFPLQEGVSRSSFPCCCSCCCSHHPRYCSQMLGYPHQSIPVVTIHARTRV
TTDR01262	BioChemical Class	Oxidoreductases acting on paired donors
TTDR01262	Inhibitor	Dipyrone
TTDR01262	Inhibitor	Phenacetin
TTDR01262	Inhibitor	Phenazone
TTDR01263	UniProt ID	Q06124
TTDR01263	Name	Protein-tyrosine phosphatase, non-receptor type 11
TTDR01263	Type of target	Research target
TTDR01263	Synonyms	PTP-1D
TTDR01263	Synonyms	PTP-2C
TTDR01263	Synonyms	Protein-tyrosine phosphatase 2C
TTDR01263	Synonyms	Protein-tyrosine phosphatase SHP2
TTDR01263	Synonyms	SH-PTP2
TTDR01263	Synonyms	SH-PTP3
TTDR01263	Synonyms	SHP-2
TTDR01263	Synonyms	SHP2
TTDR01263	Disease	Cancer, unspecific
TTDR01263	Disease	Multiple myeloma
TTDR01263	Disease	Solid tumors
TTDR01263	Function	This ptpase activity may directly link growth factor receptors and other signali
TTDR01263	Sequence	MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQY
TTDR01263	PDB Structure	2SHP; 3B7O; 3MOW; 3O5X; 3TKZ; 3TL0; 4DGP; 4DGX
TTDR01263	BioChemical Class	Hydrolases acting on ester bonds
TTDR01263	Pathway	Adipocytokine signaling pathway
TTDR01263	Pathway	Chronic myeloid leukemia
TTDR01263	Pathway	Epithelial cell signaling in Helicobacter pylori
TTDR01263	Pathway	Jak-STAT signaling pathway
TTDR01263	Pathway	Leukocyte transendothelial migration
TTDR01263	Pathway	Natural killer cell mediated cytotoxicity
TTDR01263	Pathway	Renal cell carcinoma
TTDR01263	EC Number	EC 3.1.3.48
TTDR01263	Target Validation	TTDR01263
TTDR01263	Inhibitor	Dodecane-Trimethylamine
TTDR01263	Inhibitor	NSC-87877
TTDR01264	UniProt ID	P78552
TTDR01264	Name	Interleukin-13 receptor alpha-1 chain
TTDR01264	Type of target	Research target
TTDR01264	Synonyms	CD213a1 antigen
TTDR01264	Synonyms	IL-13R alpha-1 chain
TTDR01264	Synonyms	IL-13R-alpha-1
TTDR01264	Synonyms	IL-13RA-1
TTDR01264	Disease	Glioblastoma multiforme
TTDR01264	Function	Binds il13 with a low affinity. Together with il4r-alpha can form a functional r
TTDR01264	Sequence	MEWPARLCGLWALLLCAGGGGGGGGAAPTETQPPVTNLSVSVENLCTVIWTWNPPEGASSNCSLWYFSHFGDKQDKKIAP
TTDR01264	PDB Structure	3BPN; 3BPO; 4HWB
TTDR01264	BioChemical Class	Transmembrane protein
TTDR01264	Pathway	Cytokine-cytokine receptor interaction
TTDR01264	Pathway	Jak-STAT signaling pathway
TTDR01265	UniProt ID	P21860
TTDR01265	Name	Receptor protein-tyrosine kinase erbB-3
TTDR01265	Type of target	Clinical trial target
TTDR01265	Synonyms	C-erbB-3 protein
TTDR01265	Synonyms	C-erbB3
TTDR01265	Synonyms	Tyrosine kinase-type cell surface receptor HER3
TTDR01265	Disease	Advanced nonsmall cell lung cancer
TTDR01265	Disease	Lung adenocarcinomas
TTDR01265	Function	Binds and is activated by neuregulins and ntak.
TTDR01265	Sequence	MRANDALQVLGLLFSLARGSEVGNSQAVCPGTLNGLSVTGDAENQYQTLYKLYERCEVVMGNLEIVLTGHNADLSFLQWI
TTDR01265	PDB Structure	1M6B; 2L9U; 3KEX; 3LMG; 3P11
TTDR01265	BioChemical Class	Transferases transferring phosphorus-containing groups
TTDR01265	Pathway	Calcium signaling pathway
TTDR01265	Pathway	ErbB signaling pathway
TTDR01265	EC Number	EC 2.7.1.112
TTDR01265	Drug(s)	AMG888/U3-1287
TTDR01265	Drug(s)	Anti-HER3/EGFR DAF
TTDR01265	Drug(s)	MEHD7945A
TTDR01265	Drug(s)	RG7116
TTDR01265	Drug(s)	RG7597
TTDR01265	Drug(s)	SAR256212
TTDR01265	Drug(s)	U3-1287
TTDR01265	Antibody	Anti-HER3/EGFR DAF
TTDR01265	Antibody	MM-111
TTDR01265	Multitarget	Anti-HER3/EGFR DAF
TTDR01266	UniProt ID	P22894
TTDR01266	Name	Neutrophil collagenase
TTDR01266	Type of target	Successful target
TTDR01266	Synonyms	MMP-8
TTDR01266	Synonyms	Matrix metalloproteinase-8
TTDR01266	Synonyms	PMNL collagenase
TTDR01266	Synonyms	PMNL-CL
TTDR01266	Disease	Inflammatory diseases
TTDR01266	Disease	Osteoarthritis
TTDR01266	Disease	Osteoporosis, unspecified
TTDR01266	Disease	Rheumatoid arthritis, unspecified
TTDR01266	Disease	Tumors
TTDR01266	Function	Can degrade fibrillar type i, ii, and iii collagens.
TTDR01266	Sequence	MFSLKTLPFLLLLHVQISKAFPVSSKEKNTKTVQDYLEKFYQLPSNQYQSTRKNGTNVIVEKLKEMQRFFGLNVTGKPNE
TTDR01266	PDB Structure	1A85; 1A86; 1BZS; 1I73; 1I76; 1JAN; 1JAO; 1JAP; 1JAQ; 1JH1; 1JJ9; 1KBC; 1MMB; 1M
TTDR01266	BioChemical Class	Hydrolases acting on peptide bonds (Peptidases)
TTDR01266	EC Number	EC 3.4.24.34
TTDR01266	Related US Patent	6,310,084
TTDR01266	Target Validation	TTDR01266
TTDR01266	QSAR Model	TTDR01266
TTDR01266	Drug(s)	Doxycycline
TTDR01266	Inhibitor	1-Hydroxyamine-2-Isobutylmalonic Acid
TTDR01266	Inhibitor	2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide
TTDR01266	Inhibitor	2-(biphenyl-4-ylsulfonamido)pentanedioic acid
TTDR01266	Inhibitor	2-HYDROXYCARBAMOYL-4-METHYL-PENTANOIC ACID
TTDR01266	Inhibitor	2-Thiomethyl-3-Phenylpropanoic Acid
TTDR01266	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-cyclohexanethiol
TTDR01266	Inhibitor	3-(4-Methoxy-benzenesulfonyl)-propane-1-thiol
TTDR01266	Inhibitor	3-(4-Phenoxy-benzenesulfonyl)-cyclohexanethiol
TTDR01266	Inhibitor	3-(4-Phenoxy-benzenesulfonyl)-propane-1-thiol
TTDR01266	Inhibitor	3-AMINO-AZACYCLOTRIDECAN-2-ONE
TTDR01266	Inhibitor	4-amino-3-(4-(hexyloxy)phenyl)-4-oxobutanoic acid
TTDR01266	Inhibitor	BB-1101
TTDR01266	Inhibitor	Batimastat
TTDR01266	Inhibitor	CGS-27023A
TTDR01266	Inhibitor	CIPEMASTAT
TTDR01266	Inhibitor	Doxycycline
TTDR01266	Inhibitor	Glycinamid
TTDR01266	Inhibitor	IK-682
TTDR01266	Inhibitor	ILOMASTAT
TTDR01266	Inhibitor	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID
TTDR01266	Inhibitor	N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide
TTDR01266	Inhibitor	Ro-32-3555
TTDR01266	Inhibitor	Ro-37-9790
TTDR01266	Inhibitor	SC-44463
TTDR01266	Inhibitor	[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid
TTDR01267	UniProt ID	P13613
TTDR01267	Name	Beta-lactoglobulin-1
TTDR01267	Type of target	Research target
TTDR01267	Synonyms	Beta-LG-1
TTDR01267	Synonyms	Beta-lactoglobulin I, major monomeric
TTDR01267	Disease	Rheumatoid arthritis
TTDR01267	Function	Primary component of whey, it binds retinol and is probably involved in the tran
TTDR01267	Sequence	TNIPQTMQDLDLQEVAGKWHSVAMAASDISLLDSEEAPLRVYIEKLRPTPEDNLEIILREGENKGCAEKKIFAEKTESPA
TTDR01268	Name	mRNA of Huntingtin protein
TTDR01268	Type of target	Research target
TTDR01268	Disease	Hepatitis C
TTDR01268	Drug(s)	ALN-HTT
TTDR01268	Drug(s)	Huntingtin gene antisense
TTDR01268	Antisense	Huntingtin gene antisense
TTDR01268	RNAi	ALN-HTT
TTDR01269	UniProt ID	P80365
TTDR01269	Name	Corticosteroid 11-beta-dehydrogenase, isozyme 2
TTDR01269	Type of target	Research target
TTDR01269	Synonyms	11 beta-HSD2
TTDR01269	Synonyms	11 beta-hydroxysteroid dehydrogenase type 2
TTDR01269	Synonyms	11-DH2
TTDR01269	Synonyms	11-beta-HSD2
TTDR01269	Synonyms	11-beta-hydroxysteroid dehydrogenase type 2
TTDR01269	Synonyms	NAD-dependent 11-beta-hydroxysteroid dehydrogenase
TTDR01269	Disease	Tumors
TTDR01269	Function	Catalyzes the conversion of cortisol to the inactive metabolite cortisone. modul
TTDR01269	Sequence	MERWPWPSGGAWLLVAARALLQLLRSDLRLGRPLLAALALLAALDWLCQRLLPPPAALAVLAAAGWIALSRLARPQRLPV
TTDR01269	BioChemical Class	Oxidoreductases acting on the CH-OH group of donors
TTDR01269	Pathway	Androgen and estrogen metabolism
TTDR01269	Pathway	C21-Steroid hormone metabolism
TTDR01269	Pathway	Metabolic pathways
TTDR01269	EC Number	EC 1.1.1.-
TTDR01269	EC Number	EC 1.1.1.146
TTDR01269	Target Validation	TTDR01269
TTDR01269	Inhibitor	11-keto-beta-boswellicacid
TTDR01269	Inhibitor	3-acetyl-11-keto-beta-boswellic acid
TTDR01269	Inhibitor	Ganoderic acid A
TTDR01269	Inhibitor	Glycyrrhetinic acid
TTDR01269	Inhibitor	glycyrrhizic acid
TTDR01270	UniProt ID	Q14654
TTDR01270	Name	ATP-sensitive inward rectifier potassium channel 11
TTDR01270	Type of target	Research target
TTDR01270	Synonyms	IKATP
TTDR01270	Synonyms	Inward rectifier K+ channel Kir6.2
TTDR01270	Synonyms	KATP channel (Kir6.2/SUR2A)
TTDR01270	Synonyms	Potassium channel, inwardly rectifying, subfamily J, member 11
TTDR01270	Disease	Noninsulin-dependent diabetes mellitus
TTDR01270	Function	This receptor is controlled by G proteins. Inward rectifier potassium channels a
TTDR01270	Sequence	MLSRKGIIPEEYVLTRLAEDPAEPRYRARQRRARFVSKKGNCNVAHKNIREQGRFLQDVFTTLVDLKWPHTLLIFTMSFL
TTDR01270	BioChemical Class	Voltage-gated channel
TTDR01270	Target Validation	TTDR01270
TTDR01270	Drug(s)	Iptakalim
TTDR01270	Inhibitor	HBR-985
TTDR01270	Inhibitor	HMR-1883
TTDR01270	Opener	Iptakalim
TTDR01271	Name	Serine protease
TTDR01271	Type of target	Clinical trial target
TTDR01271	Disease	Asthma
TTDR01271	Disease	Cardiovascular disease, unspecified
TTDR01271	Disease	Chronic tendon injury
TTDR01271	Disease	Hypotension
TTDR01271	Disease	Thrombosis
TTDR01271	Related US Patent	6,262,069
TTDR01271	Related US Patent	6,294,181
TTDR01271	Related US Patent	6,329,377
TTDR01271	Related US Patent	6,344,450
TTDR01271	Related US Patent	6,420,438
TTDR01271	Related US Patent	6,489,308
TTDR01271	Related US Patent	6,538,017
TTDR01271	Target Validation	TTDR01271
TTDR01271	Drug(s)	ONO-5046
TTDR01271	Drug(s)	VT-111
TTDR01271	Inhibitor	Camostat
TTDR01271	Inhibitor	Gabexate
TTDR01271	Inhibitor	Nafamostat
TTDR01271	Inhibitor	ONO-5046
TTDR01271	Inhibitor	VT-111
TTDR01272	Name	Hepatitis C Virus RNA-dependent RNA Polymerase
TTDR01272	Type of target	Discontinued target
TTDR01272	Disease	Cancer, unspecific
TTDR01272	Disease	Viral infection, unspecified
TTDR01272	Target Validation	TTDR01272
TTDR01272	Drug(s)	A-837093
TTDR01272	Drug(s)	AG-021541
TTDR01272	Inhibitor	A-837093
TTDR01272	Inhibitor	AG-021541
TTDR01273	UniProt ID	O75469
TTDR01273	Name	Pregnane X receptor
TTDR01273	Type of target	Research target
TTDR01273	Synonyms	Orphan nuclear receptor PAR1
TTDR01273	Synonyms	SXR
TTDR01273	Synonyms	Steroid and xenobiotic receptor
TTDR01273	Disease	Anxiety disorder, unspecified
TTDR01273	Disease	Depression
TTDR01273	Disease	Eye inflammation
TTDR01273	Disease	Multiple Sclerosis
TTDR01273	Function	Orphan receptor; Its natural ligand is probably pregnane. Binds to a response el
TTDR01273	Sequence	MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATGYHFNVMTCEGCKGFFRRAMKRNARLRCPFR
TTDR01273	PDB Structure	1ILG; 1ILH; 1M13; 1NRL; 1SKX; 2O9I; 2QNV; 3CTB; 3HVL; 3R8D
TTDR01273	BioChemical Class	Zinc-finger
TTDR01273	Target Validation	TTDR01273
TTDR01273	Inhibitor	SR12813
TTDR01273	Inhibitor	WAY-214950
TTDR01273	Inhibitor	WAY-252623
TTDR01273	Ligand	Hyperforin
TTDR01273	Ligand	Pregnenolone-16alpha-carbonitrile (PCN)
TTDR01274	Name	Acid-sensing ion channel
TTDR01274	Type of target	Research target
TTDR01274	Disease	Pain, CNS diseases
TTDR01275	Name	Activin
TTDR01275	Type of target	Research target
TTDR01275	Disease	Osteoporosis
TTDR01276	Name	AP endonuclease APE1
TTDR01276	Type of target	Research target
TTDR01276	Disease	Melanoma,  glioma
TTDR01276	Inhibitor	1,3-bis(1,3-benzothiazol-2-ylthio)acetone
TTDR01276	Inhibitor	3-benzofuran-2-yl-2-benzothiazol-2-yl-3-oxo-propanenitrile
TTDR01276	Inhibitor	5-fluoro-1H-indole-2-carboxylic acid
TTDR01277	Name	Apelin receptor
TTDR01277	Type of target	Research target
TTDR01277	Disease	Calcified aortic valve disease
TTDR01278	Name	Aquaporin 3
TTDR01278	Type of target	Research target
TTDR01278	Disease	Squamous cell carcinoma
TTDR01279	Name	Astrocyte glutamine synthetase
TTDR01279	Type of target	Research target
TTDR01279	Disease	Hyperammonemic syndromes
TTDR01280	Name	Beta2-microglobulin
TTDR01280	Type of target	Research target
TTDR01280	Disease	Ovarian cancer
TTDR01281	Name	CCCH tandem zinc finger protein ZFP36L1
TTDR01281	Type of target	Research target
TTDR01281	Disease	Chronic myeloproliferative disorders
TTDR01282	Name	CCN1
TTDR01282	Type of target	Research target
TTDR01282	Disease	Pancreatic cancer
TTDR01283	Name	CD147
TTDR01283	Type of target	Research target
TTDR01283	Disease	Inflammation
TTDR01284	Name	CD248
TTDR01284	Type of target	Research target
TTDR01284	Disease	Arthritis
TTDR01285	Name	Cell division cycle 7 kinase
TTDR01285	Type of target	Research target
TTDR01285	Disease	Solid tumors, hematologic malignancies
TTDR01285	Inhibitor	BMS-863233
TTDR01285	Inhibitor	NMS-1116354
TTDR01286	Name	Chondroitin sulfate proteoglycan 4
TTDR01286	Type of target	Research target
TTDR01286	Disease	Triple-Negative Breast Cancer
TTDR01287	Name	Dickkopf-1
TTDR01287	Type of target	Research target
TTDR01287	Disease	Myeloma bone disease
TTDR01288	Name	Dynactin-Associated Protein
TTDR01288	Type of target	Research target
TTDR01288	Disease	Cancer
TTDR01289	Name	Echinoderm microtubule-associated protein-like 4
TTDR01289	Type of target	Research target
TTDR01289	Disease	NonCSmall-Cell Lung Cancer
TTDR01290	Name	Elongation factor 1A
TTDR01290	Type of target	Research target
TTDR01290	Disease	Melanomas
TTDR01290	Inhibitor	Narciclasine
TTDR01291	Name	Entamoeba histolytica cysteine proteinase EhCP4
TTDR01291	Type of target	Research target
TTDR01291	Disease	Amebiasis induced by E. histolytica
TTDR01291	Inhibitor	WRR605
TTDR01292	Name	Eukaryotic translation initiation factor 5A-1
TTDR01292	Type of target	Research target
TTDR01292	Disease	Diabetic inflammation
TTDR01293	Name	Ferritin
TTDR01293	Type of target	Research target
TTDR01293	Disease	Opioid-induced neuropathology
TTDR01294	Name	Forkhead box O
TTDR01294	Type of target	Research target
TTDR01294	Disease	Diabetes, cancer
TTDR01295	Name	G protein-coupled estrogen receptor 1
TTDR01295	Type of target	Research target
TTDR01295	Disease	ER-positive Breast Cancer
TTDR01296	Name	G Protein-Coupled Receptor 87
TTDR01296	Type of target	Research target
TTDR01296	Disease	Cancer
TTDR01297	Name	GlgE
TTDR01297	Type of target	Research target
TTDR01297	Disease	Tuberculosis
TTDR01298	Name	Gli1
TTDR01298	Type of target	Research target
TTDR01298	Disease	Brain gliomas
TTDR01299	Name	Heat shock protein 47
TTDR01299	Type of target	Research target
TTDR01299	Disease	Inflammatory bowel disease
TTDR01300	Name	Helicobacter pylori  Heat-shock protein A
TTDR01300	Type of target	Research target
TTDR01300	Disease	Ulcer induced by H. pylori infection
TTDR01301	Name	Histone H2A
TTDR01301	Type of target	Research target
TTDR01301	Disease	Breast cancer
TTDR01302	Name	Interleukin-2-inducible T cell kinase
TTDR01302	Type of target	Research target
TTDR01302	Disease	Inflammatory disorders
TTDR01302	Inhibitor	BMS-488516
TTDR01302	Inhibitor	BMS-509744
TTDR01302	Inhibitor	Biaryl thiophenes
TTDR01303	Name	Liver receptor homologue-1
TTDR01303	Type of target	Research target
TTDR01303	Disease	Cancer
TTDR01304	Name	MicroRNA miR-191
TTDR01304	Type of target	Research target
TTDR01304	Disease	Hepatocellular carcinoma
TTDR01304	Antisense	AntiCmiR-191 2-MOECmodified oligonucleotide AGCTGCTTTTGGGATTCCGTTG
TTDR01305	Name	Mitochondrial Na+/Ca2+ exchanger
TTDR01305	Type of target	Research target
TTDR01305	Disease	Neurodegenerative diseases
TTDR01305	Inhibitor	CGP37157
TTDR01306	Name	Mitochondrial/Cell-Surface Protein p32/gC1qR
TTDR01306	Type of target	Research target
TTDR01306	Disease	Breast cancer
TTDR01306	Antibody	Anti-p32 human monoclonal antibody 2.15
TTDR01307	Name	Olfactomedin 4
TTDR01307	Type of target	Research target
TTDR01307	Disease	Myeloid leukemia
TTDR01308	Name	Orphan G protein-coupled receptor Gpr88
TTDR01308	Type of target	Research target
TTDR01308	Disease	Psychiatric disorders
TTDR01309	Name	Periostin
TTDR01309	Type of target	Research target
TTDR01309	Disease	Ovarian cancer
TTDR01310	Name	Phosphodiesterase 8
TTDR01310	Type of target	Research target
TTDR01310	Disease	Inflammatory disorders associated with the vascular recruitment of activated T c
TTDR01310	Inhibitor	PF-4957325-00
TTDR01311	Name	Pituitary adenylate cyclase-activating polypeptide type I receptor
TTDR01311	Type of target	Research target
TTDR01311	Disease	Migraine
TTDR01312	Name	Plasmodium Dihydroorotate Dehydrogenase
TTDR01312	Type of target	Research target
TTDR01312	Disease	Malaria
TTDR01312	Inhibitor	DSM1
TTDR01312	Inhibitor	DSM2
TTDR01313	Name	Plasmodium falciparum plasmepsin V
TTDR01313	Type of target	Research target
TTDR01313	Disease	Malaria
TTDR01314	Name	Prolyl hydroxylase domain 2
TTDR01314	Type of target	Research target
TTDR01314	Disease	Cancer
TTDR01315	Name	Prostaglandin E receptor EP4
TTDR01315	Type of target	Research target
TTDR01315	Disease	Prostate Cancer
TTDR01316	Name	Prostate apoptosis response-4
TTDR01316	Type of target	Research target
TTDR01316	Disease	Pancreatic cancer
TTDR01317	Name	Protein kinase D
TTDR01317	Type of target	Research target
TTDR01317	Disease	Cancer
TTDR01317	Inhibitor	BPKDi
TTDR01317	Inhibitor	CID755673
TTDR01317	Inhibitor	CRT0066101
TTDR01317	Inhibitor	G?6976
TTDR01317	Inhibitor	K252a
TTDR01317	Inhibitor	Staurosporine
TTDR01318	Name	Pseudomonas aeruginosa  KerV
TTDR01318	Type of target	Research target
TTDR01318	Disease	Bacterial infections
TTDR01319	Name	Rabl3
TTDR01319	Type of target	Research target
TTDR01319	Disease	Cancer
TTDR01320	Name	Receptor protein tyrosine kinase TYRO3
TTDR01320	Type of target	Research target
TTDR01320	Disease	Melanoma
TTDR01321	Name	Roundabout homolog 1
TTDR01321	Type of target	Research target
TTDR01321	Disease	Choroidal or retinal angiogenesis
TTDR01322	Name	Salmonella enterica 27-kDa outer membrane protein T2544
TTDR01322	Type of target	Research target
TTDR01322	Disease	Bacterial infections
TTDR01323	Name	Salt inducible kinase 2
TTDR01323	Type of target	Research target
TTDR01323	Disease	Ovarian cancer
TTDR01324	Name	Serine Racemase
TTDR01324	Type of target	Research target
TTDR01324	Disease	Neurodegenerations, epilepsy, neuropathic pain, drug addiction, and schizophreni
TTDR01324	Inhibitor	L-erythro-3-hydroxyaspartate
TTDR01324	Inhibitor	Malonic acid
TTDR01325	Name	Serine/threonine-protein kinase Nek6
TTDR01325	Type of target	Research target
TTDR01325	Disease	Cancer
TTDR01326	Name	Small conductance calcium-activated potassium channel
TTDR01326	Type of target	Research target
TTDR01326	Disease	Parkinson's disease
TTDR01327	Name	Sprouty 1
TTDR01327	Type of target	Research target
TTDR01327	Disease	Cancer
TTDR01328	Name	Ste20-Related Proline/Alanine-Rich Kinase
TTDR01328	Type of target	Research target
TTDR01328	Disease	Hypertension
TTDR01329	Name	Transient receptor potential channel TRPM2
TTDR01329	Type of target	Research target
TTDR01329	Disease	Prostate cancer
TTDR01330	Name	TRESK background K(+) channel
TTDR01330	Type of target	Research target
TTDR01330	Disease	T-cell mediated immune dysfunction
TTDR01330	Activator	Calcineurin
TTDR01331	Name	Tryptophan hydroxylase
TTDR01331	Type of target	Research target
TTDR01331	Disease	Depressive disorders
TTDR01332	Name	Tyrosine kinase non-receptor 2
TTDR01332	Type of target	Research target
TTDR01332	Disease	Ewing's sarcoma
TTDR01333	Name	Ubiquitin-activating enzyme E1
TTDR01333	Type of target	Research target
TTDR01333	Disease	Leukemia
TTDR01333	Inhibitor	PYZD-4409
TTDR01334	Name	Ubiquitin-activating enzyme E2
TTDR01334	Type of target	Research target
TTDR01334	Disease	Multiple myeloma
TTDR01334	Inhibitor	PYZD-4409
TTDR01335	Name	Western equine encephalitis virus envelope protein E1
TTDR01335	Type of target	Research target
TTDR01335	Disease	Viral infections
TTDR01335	Antibody	HAd5-vectored E1 vaccine Ad5-E1
TTDR01336	Name	WNT1-inducible-signaling pathway protein 1
TTDR01336	Type of target	Research target
TTDR01336	Disease	Osteoarthritis
TTDR01337	Name	Histone Deacetylase 8
TTDR01337	Type of target	Research target
TTDR01337	Disease	Not Available
TTDR01337	Target Validation	TTDR01337
TTDR01337	QSAR Model	TTDR01337
TTDR01337	Inhibitor	(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one
TTDR01337	Inhibitor	2-(methylsulfonylthio)ethyl 2-propylpentanoate
TTDR01337	Inhibitor	4-Benzoylamino-N-hydroxy-benzamide
TTDR01337	Inhibitor	4-Butyrylamino-N-hydroxy-benzamide
TTDR01337	Inhibitor	4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDR01337	Inhibitor	4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide
TTDR01337	Inhibitor	4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDR01337	Inhibitor	4-Phenylbutyrohydroxamic acid
TTDR01337	Inhibitor	5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide
TTDR01337	Inhibitor	5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione
TTDR01337	Inhibitor	5-Mercapto-pentanoic acid phenylamide
TTDR01337	Inhibitor	6-(2-Bromo-acetylamino)-hexanoic acid phenylamide
TTDR01337	Inhibitor	6-(2-mercaptoacetamido)-N-phenylhexanamide
TTDR01337	Inhibitor	6-Mercapto-hexanoic acid phenylamide
TTDR01337	Inhibitor	6-Phenoxy-hexane-1-thiol
TTDR01337	Inhibitor	6-benzenesulfinylhexanoic acid hydroxamide
TTDR01337	Inhibitor	6-benzenesulfonylhexanoic acid hydroxamide
TTDR01337	Inhibitor	6-phenylsulfanylhexanoic acid hydroxamide
TTDR01337	Inhibitor	7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01337	Inhibitor	7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one
TTDR01337	Inhibitor	7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01337	Inhibitor	7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01337	Inhibitor	7-Mercapto-heptanoic acid benzothiazol-2-ylamide
TTDR01337	Inhibitor	7-Mercapto-heptanoic acid biphenyl-3-ylamide
TTDR01337	Inhibitor	7-Mercapto-heptanoic acid biphenyl-4-ylamide
TTDR01337	Inhibitor	7-Mercapto-heptanoic acid phenylamide
TTDR01337	Inhibitor	7-Mercapto-heptanoic acid pyridin-3-ylamide
TTDR01337	Inhibitor	7-Mercapto-heptanoic acid quinolin-3-ylamide
TTDR01337	Inhibitor	8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one
TTDR01337	Inhibitor	8-Mercapto-octanoic acid phenylamide
TTDR01337	Inhibitor	8-Oxo-8-phenyl-octanoic acid
TTDR01337	Inhibitor	9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide
TTDR01337	Inhibitor	9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one
TTDR01337	Inhibitor	9-mercapto-8-oxo-N-phenylnonanamide
TTDR01337	Inhibitor	Azithromycin-N-benzyltriazolylhexahydroxamic Acid
TTDR01337	Inhibitor	Azithromycin-N-benzyltriazolylnonahydroxamic Acid
TTDR01337	Inhibitor	Azithromycin-N-benzyltriazolyloctahydroxamic Acid
TTDR01337	Inhibitor	Azithromycinarylalkylhydroxamic Acid
TTDR01337	Inhibitor	Cyclostellettamine derivative
TTDR01337	Inhibitor	Desclasinose Azithromycinarylalkyl Hydroxamate
TTDR01337	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide
TTDR01337	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-succinamide
TTDR01337	Inhibitor	N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide
TTDR01337	Inhibitor	N-(6-Hydroxycarbamoyl-hexyl)-benzamide
TTDR01337	Inhibitor	N-(6-Mercapto-hexyl)-benzamide
TTDR01337	Inhibitor	N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide
TTDR01337	Inhibitor	N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide
TTDR01337	Inhibitor	N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide
TTDR01337	Inhibitor	N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide
TTDR01337	Inhibitor	N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide
TTDR01337	Inhibitor	N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide
TTDR01337	Inhibitor	N-Hydroxy-4-(pentanoylamino-methyl)-benzamide
TTDR01337	Inhibitor	N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide
TTDR01337	Inhibitor	N-Hydroxy-4-phenylacetylamino-benzamide
TTDR01337	Inhibitor	N-hydroxy-1-naphthamide
TTDR01337	Inhibitor	N-hydroxy-3-(naphthalen-1-yl)acrylamide
TTDR01337	Inhibitor	N-hydroxy-3-phenoxybenzamide
TTDR01337	Inhibitor	N-hydroxy-4-(naphthalen-1-yl)benzamide
TTDR01337	Inhibitor	NILTUBACIN
TTDR01337	Inhibitor	Octanedioic acid hydroxyamide pyridin-2-ylamide
TTDR01337	Inhibitor	Octanedioic acid hydroxyamide pyridin-4-ylamide
TTDR01337	Inhibitor	PSAMMAPLIN A
TTDR01337	Inhibitor	S-2,9-dioxo-9-(phenylamino)nonyl ethanethioate
TTDR01337	Inhibitor	ST-2986
TTDR01337	Inhibitor	ST-2987
TTDR01337	Inhibitor	ST-3050
TTDR01337	Inhibitor	Suberohydroxamic acid
TTDR01337	Inhibitor	Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester
TTDR01338	Name	Histone Deacetylase 10
TTDR01338	Type of target	Research target
TTDR01338	Disease	Not Available
TTDR01338	Target Validation	TTDR01338
TTDR01338	QSAR Model	TTDR01338
TTDR01338	Inhibitor	(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one
TTDR01338	Inhibitor	2-(methylsulfonylthio)ethyl 2-propylpentanoate
TTDR01338	Inhibitor	4-Benzoylamino-N-hydroxy-benzamide
TTDR01338	Inhibitor	4-Butyrylamino-N-hydroxy-benzamide
TTDR01338	Inhibitor	4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDR01338	Inhibitor	4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide
TTDR01338	Inhibitor	4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide
TTDR01338	Inhibitor	5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide
TTDR01338	Inhibitor	5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione
TTDR01338	Inhibitor	5-Mercapto-pentanoic acid phenylamide
TTDR01338	Inhibitor	6-(2-Bromo-acetylamino)-hexanoic acid phenylamide
TTDR01338	Inhibitor	6-Mercapto-hexanoic acid phenylamide
TTDR01338	Inhibitor	6-Phenoxy-hexane-1-thiol
TTDR01338	Inhibitor	6-benzenesulfinylhexanoic acid hydroxamide
TTDR01338	Inhibitor	6-benzenesulfonylhexanoic acid hydroxamide
TTDR01338	Inhibitor	6-phenylsulfanylhexanoic acid hydroxamide
TTDR01338	Inhibitor	7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01338	Inhibitor	7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one
TTDR01338	Inhibitor	7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01338	Inhibitor	7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one
TTDR01338	Inhibitor	7-Mercapto-heptanoic acid benzothiazol-2-ylamide
TTDR01338	Inhibitor	7-Mercapto-heptanoic acid biphenyl-3-ylamide
TTDR01338	Inhibitor	7-Mercapto-heptanoic acid biphenyl-4-ylamide
TTDR01338	Inhibitor	7-Mercapto-heptanoic acid phenylamide
TTDR01338	Inhibitor	7-Mercapto-heptanoic acid pyridin-3-ylamide
TTDR01338	Inhibitor	7-Mercapto-heptanoic acid quinolin-3-ylamide
TTDR01338	Inhibitor	8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one
TTDR01338	Inhibitor	8-Mercapto-octanoic acid phenylamide
TTDR01338	Inhibitor	8-Oxo-8-phenyl-octanoic acid
TTDR01338	Inhibitor	9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide
TTDR01338	Inhibitor	9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one
TTDR01338	Inhibitor	Cyclostellettamine derivative
TTDR01338	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide
TTDR01338	Inhibitor	N-(2-Mercapto-ethyl)-N'-phenyl-succinamide
TTDR01338	Inhibitor	N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide
TTDR01338	Inhibitor	N-(6-Hydroxycarbamoyl-hexyl)-benzamide
TTDR01338	Inhibitor	N-(6-Mercapto-hexyl)-benzamide
TTDR01338	Inhibitor	N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide
TTDR01338	Inhibitor	N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide
TTDR01338	Inhibitor	N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide
TTDR01338	Inhibitor	N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide
TTDR01338	Inhibitor	N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide
TTDR01338	Inhibitor	N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide
TTDR01338	Inhibitor	N-Hydroxy-4-(pentanoylamino-methyl)-benzamide
TTDR01338	Inhibitor	N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide
TTDR01338	Inhibitor	N-Hydroxy-4-phenylacetylamino-benzamide
TTDR01338	Inhibitor	Octanedioic acid hydroxyamide pyridin-2-ylamide
TTDR01338	Inhibitor	Octanedioic acid hydroxyamide pyridin-4-ylamide
TTDR01338	Inhibitor	PSAMMAPLIN A
TTDR01338	Inhibitor	ST-2986
TTDR01338	Inhibitor	ST-2987
TTDR01338	Inhibitor	ST-3050
TTDR01338	Inhibitor	Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester
TTDR01339	Name	3-Hydroxy-anthranilic Acid Dioxygenase (3-HAO)
TTDR01339	Type of target	Research target
TTDR01339	Disease	Not Available
TTDR01339	QSAR Model	TTDR01339
TTDR01340	UniProt ID	O00308
TTDR01340	Name	mRNA of Ubiquitin Protein Ligase WWP2
TTDR01340	Type of target	Research target
TTDR01340	Disease	Not Available
TTDR01340	Antisense	ISIS 103669
TTDR01340	Antisense	ISIS 103671
TTDR01340	Antisense	ISIS 103701
TTDR01340	Antisense	ISIS 103708
TTDR01340	Antisense	ISIS 103736
TTDR01340	Antisense	ISIS 103747
TTDR01340	Antisense	ISIS 103752
TTDR01340	Antisense	ISIS 103771
TTDR01340	Antisense	ISIS 103803
TTDR01340	Antisense	ISIS 103806
TTDR01340	Antisense	ISIS 103819
TTDR01341	UniProt ID	O00716
TTDR01341	Name	mRNA of human E2F transcription factor 3
TTDR01341	Type of target	Research target
TTDR01341	Disease	Not Available
TTDR01341	Antisense	ISIS 114170
TTDR01341	Antisense	ISIS 114184
TTDR01341	Antisense	ISIS 114197
TTDR01341	Antisense	ISIS 114232
TTDR01342	UniProt ID	O14672
TTDR01342	Name	mRNA of Human ADAM10
TTDR01342	Type of target	Research target
TTDR01342	Disease	Not Available
TTDR01342	PDB Structure	1M1I
TTDR01342	Target Validation	TTDR01342
TTDR01342	Inhibitor	CGS-27023A
TTDR01342	Antisense	ISIS 100742
TTDR01342	Antisense	ISIS 100743
TTDR01342	Antisense	ISIS 100748
TTDR01342	Antisense	ISIS 100749
TTDR01342	Antisense	ISIS 100750
TTDR01343	UniProt ID	O15105
TTDR01343	Name	mRNA of Smad7
TTDR01343	Type of target	Research target
TTDR01343	Disease	Not Available
TTDR01343	PDB Structure	2DJY; 2KXQ; 2LTV; 2LTW; 2LTX; 2LTY; 2LTZ
TTDR01343	Antisense	ISIS 28465
TTDR01343	Antisense	ISIS 28466
TTDR01343	Antisense	ISIS 28472
TTDR01343	Antisense	ISIS 28477
TTDR01344	UniProt ID	O15111
TTDR01344	Name	mRNA of Inhibitor-kappa B Kinase-alpha
TTDR01344	Type of target	Research target
TTDR01344	Disease	Not Available
TTDR01344	PDB Structure	3BRT
TTDR01344	Target Validation	TTDR01344
TTDR01344	Inhibitor	5-Bromo-6-methoxy-9H-beta-carboline
TTDR01344	Inhibitor	N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide
TTDR01344	Antisense	ISIS 23544
TTDR01344	Antisense	ISIS 23559
TTDR01345	UniProt ID	O15530
TTDR01345	Name	mRNA of PDK-1 (also known as PDPK-1, 3-phosphoinositide-dependent protein kinase
TTDR01345	Type of target	Research target
TTDR01345	Disease	Not Available
TTDR01345	PDB Structure	1H1W; 1OKY; 1OKZ; 1UU3; 1UU7; 1UU8; 1UU9; 1UVR; 1W1D; 1W1G; 1W1H; 1Z5M; 2BIY; 2P
TTDR01345	Target Validation	TTDR01345
TTDR01345	Inhibitor	(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one
TTDR01345	Inhibitor	BX-201
TTDR01345	Inhibitor	BX-517
TTDR01345	Inhibitor	NU-6102
TTDR01345	Inhibitor	SU-6689
TTDR01345	Antisense	ISIS 29219
TTDR01345	Antisense	ISIS 29223
TTDR01345	Antisense	ISIS 29224
TTDR01345	Antisense	ISIS 29232
TTDR01345	Antisense	ISIS 29233
TTDR01345	Antisense	ISIS 29234
TTDR01345	Antisense	ISIS 29236
TTDR01345	Antisense	ISIS 29237
TTDR01345	Antisense	ISIS 29239
TTDR01345	Antisense	ISIS 29243
TTDR01345	Antisense	ISIS 29244
TTDR01345	Antisense	ISIS 29246
TTDR01345	Antisense	ISIS 29255
TTDR01345	Antisense	ISIS 29256
TTDR01345	Antisense	ISIS 29257
TTDR01345	Antisense	ISIS 29469
TTDR01345	Antisense	ISIS 29470
TTDR01345	Antisense	ISIS 29471
TTDR01345	Antisense	ISIS 29475
TTDR01345	Antisense	ISIS 29477
TTDR01346	UniProt ID	O43353
TTDR01346	Name	mRNA of human RIP2
TTDR01346	Type of target	Research target
TTDR01346	Disease	Not Available
TTDR01346	Target Validation	TTDR01346
TTDR01346	Inhibitor	AG-1879
TTDR01346	Inhibitor	NM-PP1
TTDR01346	Inhibitor	SB-203580
TTDR01346	Antisense	ISIS 104211
TTDR01346	Antisense	ISIS 104253
TTDR01346	Antisense	ISIS 104254
TTDR01346	Antisense	ISIS 104255
TTDR01346	Antisense	ISIS 104256
TTDR01346	Antisense	ISIS 104257
TTDR01346	Antisense	ISIS 104258
TTDR01347	UniProt ID	O43541
TTDR01347	Name	mRNA of MADH6
TTDR01347	Type of target	Research target
TTDR01347	Disease	Not Available
TTDR01347	Antisense	ISIS 101952
TTDR01347	Antisense	ISIS 101960
TTDR01347	Antisense	ISIS 101983
TTDR01347	Antisense	ISIS 101984
TTDR01347	Antisense	ISIS 101985
TTDR01347	Antisense	ISIS 101986
TTDR01347	Antisense	ISIS 101987
TTDR01347	Antisense	ISIS 101995
TTDR01347	Antisense	ISIS 101996
TTDR01347	Antisense	ISIS 101997
TTDR01347	Antisense	ISIS 101998
TTDR01348	UniProt ID	O56140
TTDR01348	Name	mRNA of influenza A hemagglutinin
TTDR01348	Type of target	Research target
TTDR01348	Disease	Not Available
TTDR01348	Antisense	ISIS 3306
TTDR01349	UniProt ID	O56266
TTDR01349	Name	mRNA of Influenza polymerase 3
TTDR01349	Type of target	Research target
TTDR01349	Disease	Not Available
TTDR01349	Antisense	ISIS 3303
TTDR01350	UniProt ID	O70632
TTDR01350	Name	mRNA of influenza A matrix protein
TTDR01350	Type of target	Research target
TTDR01350	Disease	Not Available
TTDR01350	PDB Structure	2KAD; 2KQT; 3C9J; 3LBW
TTDR01350	Antisense	ISIS 3309
TTDR01351	UniProt ID	O75362
TTDR01351	Name	mRNA of human zinc finger protein-217
TTDR01351	Type of target	Research target
TTDR01351	Disease	Not Available
TTDR01351	PDB Structure	2HU2; 3UK3; 4F2J; 4IS1
TTDR01351	Antisense	ISIS 114527
TTDR01351	Antisense	ISIS 114530
TTDR01351	Antisense	ISIS 114531
TTDR01351	Antisense	ISIS 114532
TTDR01351	Antisense	ISIS 114537
TTDR01351	Antisense	ISIS 114559
TTDR01351	Antisense	ISIS 114563
TTDR01351	Antisense	ISIS 14548
TTDR01352	UniProt ID	O75907
TTDR01352	Name	mRNA of mouse diacylglycerol acyltransferase 1
TTDR01352	Type of target	Research target
TTDR01352	Disease	Not Available
TTDR01352	Antisense	ISIS 191729
TTDR01352	Antisense	ISIS 191731
TTDR01352	Antisense	ISIS 191755
TTDR01352	Antisense	ISIS 191756
TTDR01352	Antisense	ISIS 191759
TTDR01352	Antisense	ISIS 191761
TTDR01353	UniProt ID	O75908
TTDR01353	Name	mRNA of human acyl CoA cholesterol acyl-transferase-2
TTDR01353	Type of target	Research target
TTDR01353	Disease	Not Available
TTDR01353	Target Validation	TTDR01353
TTDR01353	Inhibitor	PYRIPYROPENE A
TTDR01353	Inhibitor	oleic acid anilide
TTDR01353	Antisense	ISIS 140148
TTDR01353	Antisense	ISIS 140153
TTDR01353	Antisense	ISIS 140157
TTDR01353	Antisense	ISIS 140158
TTDR01353	Antisense	ISIS 140161
TTDR01354	UniProt ID	O92784
TTDR01354	Name	mRNA of influenza A nucleoprotein
TTDR01354	Type of target	Research target
TTDR01354	Disease	Not Available
TTDR01354	Antisense	ISIS 3307
TTDR01355	UniProt ID	P00441
TTDR01355	Name	mRNA of human superoxide dismutase 1
TTDR01355	Type of target	Research target
TTDR01355	Disease	Not Available
TTDR01355	PDB Structure	1AZV; 1BA9; 1DSW; 1FUN; 1HL4; 1HL5; 1KMG; 1L3N; 1MFM; 1N18; 1N19; 1OEZ; 1OZT; 1O
TTDR01355	Antisense	ISIS 150450
TTDR01355	Antisense	ISIS 150451
TTDR01355	Antisense	ISIS 150452
TTDR01355	Antisense	ISIS 150453
TTDR01355	Antisense	ISIS 150454
TTDR01355	Antisense	ISIS 150463
TTDR01355	Antisense	ISIS 150464
TTDR01356	UniProt ID	P01112
TTDR01356	Name	mRNA of H-ras
TTDR01356	Type of target	Research target
TTDR01356	Disease	Not Available
TTDR01356	PDB Structure	121P; 1AA9; 1AGP; 1BKD; 1CLU; 1CRP; 1CRQ; 1CRR; 1CTQ; 1GNP; 1GNQ; 1GNR; 1HE8; 1I
TTDR01356	Antisense	ISIS 13920
TTDR01356	Antisense	ISIS 2502
TTDR01356	Antisense	ISIS 2503
TTDR01356	Antisense	ISIS 6186
TTDR01357	UniProt ID	P02647
TTDR01357	Name	mRNA of human apolipoprotein A
TTDR01357	Type of target	Research target
TTDR01357	Disease	Not Available
TTDR01357	PDB Structure	1AV1; 1GW3; 1GW4; 1ODP; 1ODQ; 1ODR; 2A01; 3J00; 3K2S; 3R2P
TTDR01357	Antisense	ISIS 144368
TTDR01357	Antisense	ISIS 144379
TTDR01357	Antisense	ISIS 144396
TTDR01358	UniProt ID	P02741
TTDR01358	Name	mRNA of human C-reactive protein
TTDR01358	Type of target	Research target
TTDR01358	Disease	Not Available
TTDR01358	PDB Structure	1B09; 1CRV; 1GNH; 1LJ7; 3L2Y; 3PVN; 3PVO
TTDR01358	Antisense	ISIS 133712
TTDR01358	Antisense	ISIS 133726
TTDR01358	Antisense	ISIS 140180
TTDR01358	Antisense	ISIS 329956
TTDR01358	Antisense	ISIS 330012
TTDR01358	Antisense	ISIS 330031
TTDR01359	UniProt ID	P03122
TTDR01359	Name	mRNA of BPV-1 E2
TTDR01359	Type of target	Research target
TTDR01359	Disease	Not Available
TTDR01359	PDB Structure	1DBD; 1JJH; 2BOP; 2JEU; 2JEX
TTDR01359	Antisense	ISIS 1751
TTDR01359	Antisense	ISIS 1753
TTDR01359	Antisense	ISIS 2324
TTDR01360	UniProt ID	P04114
TTDR01360	Name	mRNA of human apolipoprotein B
TTDR01360	Type of target	Research target
TTDR01360	Disease	Not Available
TTDR01360	Antisense	ISIS 147483
TTDR01360	Antisense	ISIS 147764
TTDR01360	Antisense	ISIS 147788
TTDR01361	UniProt ID	P04626
TTDR01361	Name	mRNA of HER2
TTDR01361	Type of target	Research target
TTDR01361	Disease	Not Available
TTDR01361	PDB Structure	1MFG; 1MFL; 1MW4; 1N8Z; 1OVC; 1QR1; 1S78; 2A91; 2JWA; 2KS1; 2L4K; 3BE1; 3H3B; 3M
TTDR01361	Target Validation	TTDR01361
TTDR01361	Inhibitor	(1-Benzyl-1H-indol-5-yl)-quinazolin-4-yl-amine
TTDR01361	Inhibitor	17-allylamino-17-desmethoxy-geldanamycin
TTDR01361	Inhibitor	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione
TTDR01361	Inhibitor	3,4-diphenyl-1H-pyrrole-2,5-dione
TTDR01361	Inhibitor	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione
TTDR01361	Inhibitor	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione
TTDR01361	Inhibitor	4-(3-phenoxylphenyl)-5-cyano-2H-1,2,3-triazole
TTDR01361	Inhibitor	4-(4-bromophenyl)-5-cyano-2H-1,2,3-triazole
TTDR01361	Inhibitor	4-(4-chlorophenyl)-5-cyano-2H-1,2,3-triazole
TTDR01361	Inhibitor	4-(4-isopropylphenyl)-5-cyano-2H-1,2,3-triazole
TTDR01361	Inhibitor	4-(Bis(2-chloroethyl)amino)-N-p-tolylbenzamide
TTDR01361	Inhibitor	AG-213
TTDR01361	Inhibitor	BMS-536924
TTDR01361	Inhibitor	CL-387785
TTDR01361	Inhibitor	Lapatinib ditosylate
TTDR01361	Inhibitor	N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide
TTDR01361	Inhibitor	NERATINIB
TTDR01361	Inhibitor	PD-168393
TTDR01361	Inhibitor	geldanamycin-estradiol hybrid
TTDR01361	Antisense	ISIS 12882
TTDR01361	Antisense	ISIS 12883
TTDR01361	Antisense	ISIS 12884
TTDR01361	Antisense	ISIS 9002
TTDR01361	Antisense	ISIS 9003
TTDR01361	Antisense	ISIS 9005
TTDR01362	UniProt ID	P05106
TTDR01362	Name	mRNA of integrin beta 3
TTDR01362	Type of target	Research target
TTDR01362	Disease	Not Available
TTDR01362	PDB Structure	1JV2; 1KUP; 1KUZ; 1L5G; 1M1X; 1M8O; 1MK7; 1MK9; 1RN0; 1S4X; 1TYE; 1U8C; 2INI; 2K
TTDR01362	Target Validation	TTDR01362
TTDR01362	Inhibitor	3-(3-(benzamido)-5-nitrobenzamido)propanoic acid
TTDR01362	Inhibitor	3-(3-(carbamoyl)benzamido)-3-phenylpropanoic acid
TTDR01362	Inhibitor	3-(3-(carbamoyl)benzamido)propanoic acid
TTDR01362	Inhibitor	Ac-Asp-Arg-Leu-Asp-Ser-OH
TTDR01362	Inhibitor	AcDRGDS
TTDR01362	Inhibitor	CYCLORGDFV
TTDR01362	Inhibitor	DMP-728
TTDR01362	Inhibitor	DMP-757
TTDR01362	Inhibitor	DMP-802
TTDR01362	Inhibitor	ELAROFIBAN
TTDR01362	Inhibitor	E[c(RGDyK)]2
TTDR01362	Inhibitor	E[c(RGDyK)]2-PTX conjugate
TTDR01362	Inhibitor	FK-633
TTDR01362	Inhibitor	GR-144053;GR-144053F
TTDR01362	Inhibitor	Gantofiban
TTDR01362	Inhibitor	Gly-Arg-Gly-Asp-Ser
TTDR01362	Inhibitor	Gly-Arg-Gly-Asp-Ser-Pro-Lys
TTDR01362	Inhibitor	ISONIPECOTAMIDE
TTDR01362	Inhibitor	L-703014
TTDR01362	Inhibitor	L-709780
TTDR01362	Inhibitor	L-734115
TTDR01362	Inhibitor	L-734217
TTDR01362	Inhibitor	L-738167
TTDR01362	Inhibitor	L-739758
TTDR01362	Inhibitor	L-746233
TTDR01362	Inhibitor	L-750034
TTDR01362	Inhibitor	L-756568
TTDR01362	Inhibitor	L-767679
TTDR01362	Inhibitor	LAMIFIBAN
TTDR01362	Inhibitor	LOTRAFIBAN
TTDR01362	Inhibitor	MK-852
TTDR01362	Inhibitor	N-(3,5-dichlorophenyl)imidodicarbonimidic diamide
TTDR01362	Inhibitor	ORBOFIBAN
TTDR01362	Inhibitor	RGDechi
TTDR01362	Inhibitor	RO-44-3888
TTDR01362	Inhibitor	ROXIFIBAN
TTDR01362	Inhibitor	RWJ-53419
TTDR01362	Inhibitor	Ro-43-5054
TTDR01362	Inhibitor	Ro-43-8857
TTDR01362	Inhibitor	SB-207043
TTDR01362	Inhibitor	SB-208651
TTDR01362	Inhibitor	SB-223245
TTDR01362	Inhibitor	SB-265123
TTDR01362	Inhibitor	SC-47643
TTDR01362	Inhibitor	SC-54701A
TTDR01362	Inhibitor	SIBRAFIBAN
TTDR01362	Inhibitor	SKF-106760
TTDR01362	Inhibitor	SKF-107260
TTDR01362	Inhibitor	ST-1646
TTDR01362	Inhibitor	XEMILOFIBAN
TTDR01362	Inhibitor	ZD-2486
TTDR01362	Inhibitor	c(-GRGDfL-)
TTDR01362	Inhibitor	c(Arg-Gly-Asp-D-Phe-Val)
TTDR01362	Inhibitor	c(RGDfF)
TTDR01362	Inhibitor	c(RGDfMeF)
TTDR01362	Inhibitor	c(RGDfV)
TTDR01362	Inhibitor	c-[-Arg-Gly-Asp-Acpca30-]
TTDR01362	Inhibitor	c-[-Arg-Gly-Asp-Acpca31-]
TTDR01362	Inhibitor	c-[-Arg-Gly-Asp-Acpca32-]
TTDR01362	Inhibitor	c-[-Arg-Gly-Asp-Acpca33-]
TTDR01362	Inhibitor	c[-Arg-Gly-Asp-Acpca19-]
TTDR01362	Inhibitor	c[-Arg-Gly-Asp-Acpca20-]
TTDR01362	Inhibitor	c[-Arg-Gly-Asp-Acpca21-]
TTDR01362	Inhibitor	c[-Arg-Gly-Asp-Acpca22-]
TTDR01362	Inhibitor	c[-Arg-Gly-Asp-Acpca34-]
TTDR01362	Inhibitor	c[-Arg-Gly-Asp-Acpca35-]
TTDR01362	Inhibitor	c[-Arg-Gly-Asp-Acpca36-]
TTDR01362	Inhibitor	c[RGD-(R)-alpha-TfmfV]
TTDR01362	Inhibitor	c[RGD-(S)-alpha-TfmfV]
TTDR01362	Inhibitor	c[RGDf-(R)-N-Me-alpha-TfmF]
TTDR01362	Inhibitor	c[RGDf-(R)-alpha-TfmF]
TTDR01362	Inhibitor	c[RGDf-(R)-alpha-TfmV]
TTDR01362	Inhibitor	c[RGDf-(S)-N-Me-alpha-TfmF]
TTDR01362	Inhibitor	c[RGDf-(S)-alpha-TfmF]
TTDR01362	Inhibitor	c[RGDf-(S)-alpha-TfmV]
TTDR01362	Inhibitor	c[RGDf-(S,R)-alpha-Dfm-F]
TTDR01362	Inhibitor	cyclo(RGDfV) (control)
TTDR01362	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp21-]
TTDR01362	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp22-]
TTDR01362	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp23-]
TTDR01362	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp24-]
TTDR01362	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp25-]
TTDR01362	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp26-]
TTDR01362	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp27-]
TTDR01362	Inhibitor	cyclo-[-Arg-Gly-Asp-Amp28-]
TTDR01362	Inhibitor	cyclo[RGDfK(cypate)]
TTDR01362	Inhibitor	cypate-[(RGD)2-NH2]1
TTDR01362	Inhibitor	cypate-[(RGD)2-NH2]2
TTDR01362	Inhibitor	cypate-[(RGD)3-NH2]1
TTDR01362	Inhibitor	cypate-[(RGD)3-NH2]2
TTDR01362	Inhibitor	cypate-[(RGD)4-NH2]1
TTDR01362	Inhibitor	cypate-[(RGD)4-NH2]2
TTDR01362	Antisense	ISIS 196103
TTDR01362	Antisense	ISIS 25237
TTDR01363	UniProt ID	P05412
TTDR01363	Name	mRNA of c-jun
TTDR01363	Type of target	Research target
TTDR01363	Disease	Not Available
TTDR01363	PDB Structure	1A02; 1FOS; 1JNM; 1JUN; 1S9K; 1T2K
TTDR01363	Target Validation	TTDR01363
TTDR01363	Inhibitor	DCB-3503
TTDR01363	Inhibitor	TYLOPHORININE
TTDR01363	Inhibitor	[(R)-(+)-deoxytylophorinidine
TTDR01363	Antisense	ISIS 10582
TTDR01364	UniProt ID	P06463
TTDR01364	Name	mRNA of HPV-18 E6 (start codon regions)
TTDR01364	Type of target	Research target
TTDR01364	Disease	Not Available
TTDR01364	PDB Structure	2I04; 2I0I; 2I0L
TTDR01364	Antisense	ISIS 2490
TTDR01365	UniProt ID	P06788
TTDR01365	Name	mRNA of HPV-18 E7 (start codon regions)
TTDR01365	Type of target	Research target
TTDR01365	Disease	Not Available
TTDR01365	Antisense	ISIS 2491
TTDR01366	UniProt ID	P06790
TTDR01366	Name	mRNA of HPV E2 transactivator protein
TTDR01366	Type of target	Research target
TTDR01366	Disease	Not Available
TTDR01366	PDB Structure	1F9F; 1JJ4; 1QQH; 1TUE
TTDR01366	Antisense	ISIS 2105
TTDR01367	UniProt ID	P08546
TTDR01367	Name	mRNA of HCMV DNA polymerase
TTDR01367	Type of target	Research target
TTDR01367	Disease	Not Available
TTDR01367	PDB Structure	1YYP
TTDR01367	Antisense	ISIS 2922
TTDR01368	UniProt ID	P09651
TTDR01368	Name	mRNA of hnRNP A1
TTDR01368	Type of target	Research target
TTDR01368	Disease	Not Available
TTDR01368	PDB Structure	1HA1; 1L3K; 1PGZ; 1PO6; 1U1K; 1U1L; 1U1M; 1U1N; 1U1O; 1U1P; 1U1Q; 1U1R; 1UP1; 2H
TTDR01368	Antisense	ISIS 111992
TTDR01368	Antisense	ISIS 111993
TTDR01368	Antisense	ISIS 111997
TTDR01368	Antisense	ISIS 112000
TTDR01368	Antisense	ISIS 112001
TTDR01368	Antisense	ISIS 112002
TTDR01368	Antisense	ISIS 112003
TTDR01368	Antisense	ISIS 112004
TTDR01368	Antisense	ISIS 112005
TTDR01368	Antisense	ISIS 112019
TTDR01368	Antisense	ISIS 112020
TTDR01368	Antisense	ISIS 112021
TTDR01368	Antisense	ISIS 112022
TTDR01368	Antisense	ISIS 112023
TTDR01368	Antisense	ISIS 112024
TTDR01369	UniProt ID	P09917
TTDR01369	Name	mRNA of human 5-lipoxygenase
TTDR01369	Type of target	Research target
TTDR01369	Disease	Not Available
TTDR01369	PDB Structure	2ABV; 3O8Y; 3V92; 3V98; 3V99
TTDR01369	Target Validation	TTDR01369
TTDR01369	Inhibitor	(+)-3,3'-bisdemethyltanegool
TTDR01369	Inhibitor	(-)-3,3'-bisdemethylpinoresinol
TTDR01369	Inhibitor	(-)-pinoresinol
TTDR01369	Inhibitor	(-)-zileuton
TTDR01369	Inhibitor	(N-(3-phenoxycinnamyl)-acetohydroxamic acid
TTDR01369	Inhibitor	1-(4-methoxyphenyl)-3-(1,3,4-thiadiazol-2-yl)urea
TTDR01369	Inhibitor	1-(4-methoxyphenyl)-3-(4-methylthiazol-2-yl)urea
TTDR01369	Inhibitor	1-(4-methoxyphenyl)-3-(5-methylthiazol-2-yl)urea
TTDR01369	Inhibitor	2,4'-Diacetoxy-5,3'-di-(2-propenyl)-biphenyl
TTDR01369	Inhibitor	2,4'-Dimethoxy-5,3'-di-(2-propenyl)-biphenyl
TTDR01369	Inhibitor	2,4,5-Triarylimidazole analogue
TTDR01369	Inhibitor	2-(4-methoxyphenyl)-N-(thiazol-2-yl)acetamide
TTDR01369	Inhibitor	2-(benzyloxy)naphthalene
TTDR01369	Inhibitor	2-phenyl-N-(1,3,4-thiadiazol-2-yl)acetamide
TTDR01369	Inhibitor	2-phenyl-N-(thiazol-2-yl)acetamide
TTDR01369	Inhibitor	3,4,5-trimethoxy-N-(thiazol-2-yl)benzamide
TTDR01369	Inhibitor	3-methoxy-N-(1,3,4-thiadiazol-2-yl)benzamide
TTDR01369	Inhibitor	3-methoxy-N-(4-methylthiazol-2-yl)benzamide
TTDR01369	Inhibitor	4'-Methoxy-5,3'-dipropyl-biphenyl-2ol
TTDR01369	Inhibitor	4-(dimethylamino)-N-(thiazol-2-yl)benzamide
TTDR01369	Inhibitor	4-methoxy-N-(thiazol-2-yl)benzamide
TTDR01369	Inhibitor	5,3'-Dipropyl-biphenyl-2,4'-diol
TTDR01369	Inhibitor	CMI-977
TTDR01369	Inhibitor	HONOKIOL
TTDR01369	Inhibitor	ISAINDIGOTONE
TTDR01369	Inhibitor	JASPAQUINOL
TTDR01369	Inhibitor	KAEMPFEROL
TTDR01369	Inhibitor	L-689065
TTDR01369	Inhibitor	L-702-539
TTDR01369	Inhibitor	L-746530
TTDR01369	Inhibitor	METHYLHONOKIOL
TTDR01369	Inhibitor	Methyl 2-(Benzylamino)-1H-indole-3-carboxylate
TTDR01369	Inhibitor	Methyl 2-(Diallylamino)-1H-indole-3-carboxylate
TTDR01369	Inhibitor	N-(1,3,4-thiadiazol-2-yl)benzamide
TTDR01369	Inhibitor	N-(3-phenoxycinnamyl)-N-hydroxyacetamide
TTDR01369	Inhibitor	N-(4-methylthiazol-2-yl)-2-phenylacetamide
TTDR01369	Inhibitor	N-(4-methylthiazol-2-yl)benzamide
TTDR01369	Inhibitor	N-(5-methylthiazol-2-yl)-2-phenylacetamide
TTDR01369	Inhibitor	N-(5-methylthiazol-2-yl)benzamide
TTDR01369	Inhibitor	N-(thiazol-2-yl)benzamide
TTDR01369	Inhibitor	N-hydroxy-N-[1-(4-isobutylphenyl)ethyl]urea
TTDR01369	Inhibitor	N-hydroxycarbamate derivative
TTDR01369	Inhibitor	PD-169316
TTDR01369	Inhibitor	PUUPEHEDIONE
TTDR01369	Inhibitor	PUUPEHENONE
TTDR01369	Inhibitor	SB-202190
TTDR01369	Inhibitor	SB-203580
TTDR01369	Inhibitor	TEBUFELONE
TTDR01369	Inhibitor	ZD-2138
TTDR01369	Inhibitor	isojaspic acid
TTDR01369	Inhibitor	jaspic acid
TTDR01369	Antisense	ISIS 1820
TTDR01369	Antisense	ISIS 1821
TTDR01369	Antisense	ISIS 1822
TTDR01369	Antisense	ISIS 1827
TTDR01369	Antisense	ISIS 1831
TTDR01369	Antisense	ISIS 2177
TTDR01370	UniProt ID	P10398
TTDR01370	Name	mRNA of A-Raf
TTDR01370	Type of target	Research target
TTDR01370	Disease	Not Available
TTDR01370	PDB Structure	1WXM
TTDR01370	Antisense	ISIS 10228
TTDR01370	Antisense	ISIS 9060
TTDR01370	Antisense	ISIS 9061
TTDR01370	Antisense	ISIS 9062
TTDR01370	Antisense	ISIS 9063
TTDR01370	Antisense	ISIS 9064
TTDR01370	Antisense	ISIS 9065
TTDR01370	Antisense	ISIS 9066
TTDR01370	Antisense	ISIS 9067
TTDR01370	Antisense	ISIS 9068
TTDR01370	Antisense	ISIS 9069
TTDR01370	Antisense	ISIS 9070
TTDR01370	Antisense	ISIS 9071
TTDR01371	UniProt ID	P13612
TTDR01371	Name	mRNA of integrin alpha-4
TTDR01371	Type of target	Research target
TTDR01371	Disease	Not Available
TTDR01371	PDB Structure	3V4P; 3V4V
TTDR01371	Target Validation	TTDR01371
TTDR01371	Inhibitor	MK-0668
TTDR01371	Inhibitor	TR-14035
TTDR01371	Antisense	ISIS 24448
TTDR01371	Antisense	ISIS 24453
TTDR01371	Antisense	ISIS 24454
TTDR01371	Antisense	ISIS 24475
TTDR01371	Antisense	ISIS 24477
TTDR01372	UniProt ID	P14174
TTDR01372	Name	mRNA of human Macrophage migration inhibitory factor
TTDR01372	Type of target	Research target
TTDR01372	Disease	Not Available
TTDR01372	PDB Structure	1CA7; 1CGQ; 1GCZ; 1GD0; 1GIF; 1LJT; 1MIF; 1P1G; 2OOH; 2OOW; 2OOZ; 3B9S; 3CE4; 3D
TTDR01372	Target Validation	TTDR01372
TTDR01372	Inhibitor	1-(2-chlorophenyl)-3-(pyridin-2-yl)thiourea
TTDR01372	Inhibitor	1-phenyl-3-(1,3,4-thiadiazol-2-yl)thiourea
TTDR01372	Inhibitor	2-(4-hydroxystyryl)quinolin-8-ol
TTDR01372	Inhibitor	3,3,3-tris(4-chlorophenyl)propanoic acid
TTDR01372	Inhibitor	3-(1H-pyrazol-3-yl)benzoic acid
TTDR01372	Inhibitor	3-acetyl-7-hydroxy-2H-chromen-2-one
TTDR01372	Inhibitor	3-benzyl-5-fluorobenzo[d]oxazol-2(3H)-one
TTDR01372	Inhibitor	3-benzyl-5-methylbenzo[d]oxazol-2(3H)-one
TTDR01372	Inhibitor	3-benzyl-6-methylbenzo[d]oxazol-2(3H)-one
TTDR01372	Inhibitor	4-((pyridin-4-ylthio)methyl)benzene-1,2-diol
TTDR01372	Inhibitor	4-(4-benzyl-1H-1,2,3-triazol-1-yl)phenol
TTDR01372	Inhibitor	4-iodo-6-phenylpyrimidine
TTDR01372	Inhibitor	6-phenylpyridazin-3-yl thiophene-2-carboxylate
TTDR01372	Inhibitor	7-hydroxy-3-phenyl-2H-chromen-2-one
TTDR01372	Inhibitor	N-(2-bromobenzoyloxy)-4-chlorobenzamide
TTDR01372	Inhibitor	S-benzo[d]oxazol-2-yl O-butyl carbonothioate
TTDR01372	Inhibitor	benzofuran-2-yl(indolin-1-yl)methanone
TTDR01372	Inhibitor	ethyl 7-hydroxy-2-oxo-2H-chromene-3-carboxylate
TTDR01372	Antisense	ISIS 112580
TTDR01372	Antisense	ISIS 112590
TTDR01372	Antisense	ISIS 112592
TTDR01372	Antisense	ISIS 112599
TTDR01372	Antisense	ISIS 112690
TTDR01372	Antisense	ISIS 112694
TTDR01372	Antisense	ISIS 112696
TTDR01372	Antisense	ISIS 112699
TTDR01372	Antisense	ISIS 112711
TTDR01372	Antisense	ISIS 112724
TTDR01373	UniProt ID	P15056
TTDR01373	Name	mRNA of B-Raf
TTDR01373	Type of target	Research target
TTDR01373	Disease	Not Available
TTDR01373	PDB Structure	1UWH; 1UWJ; 2FB8; 2L05; 3C4C; 3D4Q; 3IDP; 3II5; 3NY5; 3OG7; 3PPJ; 3PPK; 3PRF; 3P
TTDR01373	Target Validation	TTDR01373
TTDR01373	Inhibitor	2-(Benzylamino)-6-(3-acetamidophenyl)pyrazine
TTDR01373	Inhibitor	2-(Phenylamino)-6-(3-acetamidophenyl)pyrazine
TTDR01373	Inhibitor	BIRB796
TTDR01373	Inhibitor	GW-5074
TTDR01373	Inhibitor	L-779450
TTDR01373	Inhibitor	ZM-336372
TTDR01373	Inhibitor	pyrazolo[1,5-a]pyrimidine-3-carboxylate
TTDR01373	Antisense	ISIS 13727
TTDR01373	Antisense	ISIS 13730
TTDR01373	Antisense	ISIS 13740
TTDR01373	Antisense	ISIS 13741
TTDR01373	Antisense	ISIS 13743
TTDR01373	Antisense	ISIS 14144
TTDR01374	UniProt ID	P16581
TTDR01374	Name	mRNA of E-selectin
TTDR01374	Type of target	Research target
TTDR01374	Disease	Not Available
TTDR01374	PDB Structure	1ESL; 1G1T; 1KJA
TTDR01374	Antisense	ISIS 11929
TTDR01374	Antisense	ISIS 2674
TTDR01374	Antisense	ISIS 2678
TTDR01374	Antisense	ISIS 2686
TTDR01374	Antisense	ISIS 4719
TTDR01374	Antisense	ISIS 4729
TTDR01374	Antisense	ISIS 4730
TTDR01374	Antisense	ISIS 4756
TTDR01374	Antisense	ISIS 4759
TTDR01374	Antisense	ISIS 4764
TTDR01374	Antisense	ISIS 9984
TTDR01375	UniProt ID	P17612
TTDR01375	Name	mRNA of PKA Catalytic Subunit C-alpha
TTDR01375	Type of target	Research target
TTDR01375	Disease	Not Available
TTDR01375	PDB Structure	2GU8; 3AGL; 3AGM; 3AMA; 3AMB; 3L9L; 3L9M; 3L9N; 3MVJ; 3NX8; 3OOG; 3OVV; 3OWP; 3O
TTDR01375	Target Validation	TTDR01375
TTDR01375	Inhibitor	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol
TTDR01375	Inhibitor	BALANOL
TTDR01375	Inhibitor	NM-PP1
TTDR01375	Inhibitor	Ro-4396686
TTDR01375	Antisense	ISIS 102450
TTDR01375	Antisense	ISIS 102454
TTDR01375	Antisense	ISIS 102458
TTDR01375	Antisense	ISIS 102462
TTDR01375	Antisense	ISIS 102466
TTDR01375	Antisense	ISIS 102478
TTDR01375	Antisense	ISIS 102482
TTDR01375	Antisense	ISIS 102486
TTDR01375	Antisense	ISIS 102490
TTDR01375	Antisense	ISIS 102558
TTDR01375	Antisense	ISIS 102563
TTDR01375	Antisense	ISIS 102584
TTDR01375	Antisense	ISIS 102599
TTDR01375	Antisense	ISIS 102604
TTDR01375	Antisense	ISIS 102609
TTDR01375	Antisense	ISIS 102614
TTDR01375	Antisense	ISIS 102619
TTDR01375	Antisense	ISIS 102624
TTDR01375	Antisense	ISIS 102629
TTDR01375	Antisense	ISIS 102633
TTDR01375	Antisense	ISIS 102660
TTDR01375	Antisense	ISIS 102664
TTDR01375	Antisense	ISIS 102668
TTDR01375	Antisense	ISIS 102676
TTDR01376	UniProt ID	P17676
TTDR01376	Name	mRNA of human C/EBP beta
TTDR01376	Type of target	Research target
TTDR01376	Disease	Not Available
TTDR01376	PDB Structure	1GTW; 1GU4; 1GU5; 1H88; 1H89; 1H8A; 1HJB; 1IO4; 2E42; 2E43
TTDR01376	Antisense	ISIS 116505
TTDR01376	Antisense	ISIS 116507
TTDR01376	Antisense	ISIS 116508
TTDR01377	UniProt ID	P19320
TTDR01377	Name	mRNA of human VCAM-1
TTDR01377	Type of target	Research target
TTDR01377	Disease	Not Available
TTDR01377	PDB Structure	1IJ9; 1VCA; 1VSC
TTDR01377	Inhibitor	SYMBIOPOLYOL
TTDR01377	Antisense	ISIS 3792
TTDR01377	Antisense	ISIS 3801
TTDR01377	Antisense	ISIS 3804
TTDR01377	Antisense	ISIS 3805
TTDR01377	Antisense	ISIS 5874
TTDR01377	Antisense	ISIS 5875
TTDR01377	Antisense	ISIS 5876
TTDR01377	Antisense	ISIS 5884
TTDR01378	UniProt ID	P19338
TTDR01378	Name	mRNA of Nucleolin
TTDR01378	Type of target	Research target
TTDR01378	Disease	Not Available
TTDR01378	PDB Structure	2FC8; 2FC9; 2KRR
TTDR01378	Antisense	ISIS 110064
TTDR01378	Antisense	ISIS 110065
TTDR01378	Antisense	ISIS 110066
TTDR01378	Antisense	ISIS 110067
TTDR01378	Antisense	ISIS 110068
TTDR01378	Antisense	ISIS 110073
TTDR01378	Antisense	ISIS 110074
TTDR01379	UniProt ID	P24723
TTDR01379	Name	mRNA of human PKC-eta
TTDR01379	Type of target	Research target
TTDR01379	Disease	Not Available
TTDR01379	PDB Structure	2FK9; 3TXO
TTDR01379	Target Validation	TTDR01379
TTDR01379	Inhibitor	8-Octyl-benzolactam-V9
TTDR01379	Inhibitor	BALANOL
TTDR01379	Inhibitor	GSK-690693
TTDR01379	Inhibitor	LY-326449
TTDR01379	Inhibitor	PROSTRATIN
TTDR01379	Antisense	ISIS 6431
TTDR01379	Antisense	ISIS 6432
TTDR01379	Antisense	ISIS 6434
TTDR01379	Antisense	ISIS 6435
TTDR01379	Antisense	ISIS 6442
TTDR01379	Antisense	ISIS 6443
TTDR01379	Antisense	ISIS 6445
TTDR01379	Antisense	ISIS 6553
TTDR01379	Antisense	ISIS 6581
TTDR01379	Antisense	ISIS 6603
TTDR01380	UniProt ID	P25445
TTDR01380	Name	mRNA of Human Fas
TTDR01380	Type of target	Research target
TTDR01380	Disease	Not Available
TTDR01380	PDB Structure	1BZI; 1DDF; 3EWT; 3EZQ; 3THM; 3TJE
TTDR01380	Antisense	ISIS 17020
TTDR01381	UniProt ID	P25942
TTDR01381	Name	mRNA of CD40
TTDR01381	Type of target	Research target
TTDR01381	Disease	Not Available
TTDR01381	PDB Structure	1CDF; 1CZZ; 1D00; 1FLL; 1LB6; 3QD6
TTDR01381	Antisense	ISIS 19211
TTDR01381	Antisense	ISIS 19212
TTDR01381	Antisense	ISIS 19213
TTDR01381	Antisense	ISIS 19217
TTDR01381	Antisense	ISIS 19218
TTDR01381	Antisense	ISIS 19219
TTDR01381	Antisense	ISIS 19220
TTDR01381	Antisense	ISIS 19221
TTDR01382	UniProt ID	P26664
TTDR01382	Name	mRNA of HCV core protein
TTDR01382	Type of target	Research target
TTDR01382	Disease	Not Available
TTDR01382	PDB Structure	1RTL; 2A4G; 2GVF; 3EYD; 3HKW; 3KN2; 3QGH; 3QGI; 3RC4; 3RC5
TTDR01382	Antisense	ISIS 11155
TTDR01383	UniProt ID	P29992
TTDR01383	Name	mRNA of G-alpha-11
TTDR01383	Type of target	Research target
TTDR01383	Disease	Not Available
TTDR01383	Antisense	ISIS 20577
TTDR01383	Antisense	ISIS 20579
TTDR01383	Antisense	ISIS 20585
TTDR01383	Antisense	ISIS 20586
TTDR01383	Antisense	ISIS 20990
TTDR01383	Antisense	ISIS 20993
TTDR01383	Antisense	ISIS 20994
TTDR01383	Antisense	ISIS 20995
TTDR01384	UniProt ID	P33681
TTDR01384	Name	mRNA of B7 protein (translation initiation codon region)
TTDR01384	Type of target	Research target
TTDR01384	Disease	Not Available
TTDR01384	PDB Structure	1DR9; 1I8L
TTDR01384	Antisense	ISIS 13805
TTDR01384	Antisense	ISIS 13812
TTDR01385	UniProt ID	P36507
TTDR01385	Name	mRNA of MEK2
TTDR01385	Type of target	Research target
TTDR01385	Disease	Not Available
TTDR01385	PDB Structure	1S9I; 4H3Q
TTDR01385	Target Validation	TTDR01385
TTDR01385	Inhibitor	AZD-0530
TTDR01385	Inhibitor	U-0126
TTDR01385	Antisense	ISIS 25073
TTDR01385	Antisense	ISIS 25074
TTDR01385	Antisense	ISIS 25075
TTDR01385	Antisense	ISIS 25078
TTDR01385	Antisense	ISIS 25079
TTDR01385	Antisense	ISIS 25080
TTDR01385	Antisense	ISIS 25081
TTDR01385	Antisense	ISIS 25082
TTDR01385	Antisense	ISIS 25113
TTDR01385	Antisense	ISIS 25114
TTDR01385	Antisense	ISIS 25115
TTDR01385	Antisense	ISIS 25116
TTDR01385	Antisense	ISIS 25117
TTDR01385	Antisense	ISIS 25118
TTDR01385	Antisense	ISIS 25123
TTDR01385	Antisense	ISIS 25124
TTDR01385	Antisense	ISIS 25125
TTDR01385	Antisense	ISIS 25126
TTDR01385	Antisense	ISIS 25127
TTDR01385	Antisense	ISIS 25128
TTDR01386	UniProt ID	P37231
TTDR01386	Name	mRNA of PPAR-gamma
TTDR01386	Type of target	Research target
TTDR01386	Disease	Not Available
TTDR01386	PDB Structure	1FM6; 1FM9; 1I7I; 1K74; 1KNU; 1NYX; 1PRG; 1RDT; 1WM0; 1ZEO; 1ZGY; 2ATH; 2F4B; 2F
TTDR01386	Target Validation	TTDR01386
TTDR01386	Inhibitor	(9Z,12E)-12-nitrooctadeca-9,12-dienoic acid
TTDR01386	Inhibitor	(E)-10-Nitrohexadec-9-enoic Acid
TTDR01386	Inhibitor	(E)-10-nitrooctadec-9-enoic acid
TTDR01386	Inhibitor	(E)-12-Nitrooctadec-12-enoic Acid
TTDR01386	Inhibitor	(E)-13-Nitrooctadec-12-enoic Acid
TTDR01386	Inhibitor	(E)-5-Nitrooctadec-5-enoic Acid
TTDR01386	Inhibitor	(E)-6-Nitrooctadec-5-enoic Acid
TTDR01386	Inhibitor	(E)-9-Nitrohexadec-9-enoicAcid
TTDR01386	Inhibitor	(E)-9-nitrooctadec-9-enoic acid
TTDR01386	Inhibitor	2-chloro-5-nitro-N-(pyridin-4-yl)benzamide
TTDR01386	Inhibitor	BRL-48482
TTDR01386	Inhibitor	CHLOROCYCLINONE A
TTDR01386	Inhibitor	CHLOROCYCLINONE B
TTDR01386	Inhibitor	CHLOROCYCLINONE C
TTDR01386	Inhibitor	CHLOROCYCLINONE D
TTDR01386	Inhibitor	FARGLITAZAR
TTDR01386	Inhibitor	GNF-PF-2893
TTDR01386	Inhibitor	GNF-PF-3037
TTDR01386	Inhibitor	GW-9662
TTDR01386	Inhibitor	KRP-297
TTDR01386	Inhibitor	L-165461
TTDR01386	Inhibitor	L-796449
TTDR01386	Inhibitor	L-Tryptophan-L-2-aminoadipic acid
TTDR01386	Inhibitor	L-Tryptophan-L-arginine
TTDR01386	Inhibitor	L-Tryptophan-L-asparagine
TTDR01386	Inhibitor	L-Tryptophan-L-aspartic acid
TTDR01386	Inhibitor	L-Tryptophan-L-glutamine
TTDR01386	Inhibitor	L-Tryptophan-L-leucine
TTDR01386	Inhibitor	METAGLIDASEN
TTDR01386	Inhibitor	MURAGLITAZAR
TTDR01386	Inhibitor	PD-068235
TTDR01386	Inhibitor	PLOGLITAZONE
TTDR01386	Inhibitor	Ragaglitazar
TTDR01386	Inhibitor	SB-213068
TTDR01386	Inhibitor	TESAGLITAZAR
TTDR01386	Antisense	ISIS 105987
TTDR01386	Antisense	ISIS 105989
TTDR01386	Antisense	ISIS 105990
TTDR01386	Antisense	ISIS 106008
TTDR01387	UniProt ID	P40763
TTDR01387	Name	mRNA of STAT3
TTDR01387	Type of target	Research target
TTDR01387	Disease	Not Available
TTDR01387	Drug(s)	ISIS-STAT3
TTDR01387	Antisense	ISIS 113176
TTDR01387	Antisense	ISIS 113187
TTDR01387	Antisense	ISIS 113209
TTDR01387	Antisense	ISIS 113210
TTDR01387	Antisense	ISIS 17148
TTDR01387	Antisense	ISIS 17152
TTDR01387	Antisense	ISIS-STAT3
TTDR01388	UniProt ID	P41279
TTDR01388	Name	mRNA of human cot oncogene
TTDR01388	Type of target	Research target
TTDR01388	Disease	Not Available
TTDR01388	Target Validation	TTDR01388
TTDR01388	Inhibitor	8-chloro-quinoline-3-carbonitrile
TTDR01388	Antisense	ISIS 116359
TTDR01388	Antisense	ISIS 116360
TTDR01388	Antisense	ISIS 116361
TTDR01388	Antisense	ISIS 116362
TTDR01388	Antisense	ISIS 116363
TTDR01388	Antisense	ISIS 116414
TTDR01389	UniProt ID	P42081
TTDR01389	Name	mRNA of CD86
TTDR01389	Type of target	Research target
TTDR01389	Disease	Not Available
TTDR01389	PDB Structure	1I85; 1NCN
TTDR01389	Antisense	ISIS 10373
TTDR01389	Antisense	ISIS 113131
TTDR01389	Antisense	ISIS 9133
TTDR01389	Antisense	ISIS 9139
TTDR01390	UniProt ID	P42338
TTDR01390	Name	mRNA of PI3K p110 beta
TTDR01390	Type of target	Research target
TTDR01390	Disease	Not Available
TTDR01390	Target Validation	TTDR01390
TTDR01390	Inhibitor	3-(4-morpholinothieno[3,2-d]pyrimidin-2-yl)phenol
TTDR01390	Inhibitor	LY-292223
TTDR01390	Inhibitor	LY-293646
TTDR01390	Inhibitor	LY-294002
TTDR01390	Antisense	ISIS 31963
TTDR01390	Antisense	ISIS 31982
TTDR01390	Antisense	ISIS 31996
TTDR01390	Antisense	ISIS 32000
TTDR01390	Antisense	ISIS 32002
TTDR01390	Antisense	ISIS 32003
TTDR01390	Antisense	ISIS 32004
TTDR01390	Antisense	ISIS 32005
TTDR01390	Antisense	ISIS 32006
TTDR01390	Antisense	ISIS 32008
TTDR01390	Antisense	ISIS 32010
TTDR01390	Antisense	ISIS 32014
TTDR01390	Antisense	ISIS 32015
TTDR01390	Antisense	ISIS 32020
TTDR01390	Antisense	ISIS 32021
TTDR01390	Antisense	ISIS 32024
TTDR01390	Antisense	ISIS 32028
TTDR01390	Antisense	ISIS 32035
TTDR01390	Antisense	ISIS 32039
TTDR01391	UniProt ID	P45984
TTDR01391	Name	mRNA of human Jun-N-terminal kinase-2 (JNK2)
TTDR01391	Type of target	Research target
TTDR01391	Disease	Not Available
TTDR01391	PDB Structure	3E7O; 3NPC
TTDR01391	Target Validation	TTDR01391
TTDR01391	Inhibitor	AS-601245
TTDR01391	Inhibitor	BIRB796
TTDR01391	Inhibitor	IN-1166
TTDR01391	Inhibitor	N-(4-amino-5-cyano-6-ethoxypyridin-2-yl)acetamide
TTDR01391	Inhibitor	N-(4-amino-5-cyano-6-phenylpyridin-2-yl)acetamide
TTDR01391	Inhibitor	N-(4-amino-6-butoxy-5-cyanopyridin-2-yl)acetamide
TTDR01391	Inhibitor	SB-203580
TTDR01391	Inhibitor	SP-600125
TTDR01391	Antisense	ISIS 18078
TTDR01392	UniProt ID	P46087
TTDR01392	Name	mRNA of P120
TTDR01392	Type of target	Research target
TTDR01392	Disease	Not Available
TTDR01392	Antisense	ISIS 6739
TTDR01392	Antisense	ISIS 6748
TTDR01392	Antisense	ISIS 6755
TTDR01392	Antisense	ISIS 6756
TTDR01393	UniProt ID	P48023
TTDR01393	Name	mRNA of Human FasL
TTDR01393	Type of target	Research target
TTDR01393	Disease	Not Available
TTDR01393	PDB Structure	1BZI
TTDR01393	Antisense	ISIS 16179
TTDR01394	UniProt ID	P49840
TTDR01394	Name	mRNA of human glycogen synthase kinase 3 alpha
TTDR01394	Type of target	Research target
TTDR01394	Disease	Not Available
TTDR01394	PDB Structure	2DFM
TTDR01394	Target Validation	TTDR01394
TTDR01394	Inhibitor	LEUCETTAMINE B
TTDR01394	Antisense	ISIS 116625
TTDR01394	Antisense	ISIS 116631
TTDR01394	Antisense	ISIS 116632
TTDR01394	Antisense	ISIS 116648
TTDR01394	Antisense	ISIS 116654
TTDR01394	Antisense	ISIS 116670
TTDR01395	UniProt ID	P52732
TTDR01395	Name	mRNA of kinesin-like 1
TTDR01395	Type of target	Research target
TTDR01395	Disease	Not Available
TTDR01395	PDB Structure	1II6; 1Q0B; 1X88; 1YRS; 2FKY; 2FL2; 2FL6; 2FME; 2G1Q; 2GM1; 2IEH; 2PG2; 2Q2Y; 2Q
TTDR01395	Target Validation	TTDR01395
TTDR01395	Inhibitor	(S)-dimethylenastron
TTDR01395	Inhibitor	(S)-enastron
TTDR01395	Inhibitor	1-(7-methyl-9H-carbazol-3-yl)ethanone
TTDR01395	Inhibitor	1-(trifluoromethyl)-9H-carbazole
TTDR01395	Inhibitor	1-tert-butyl-9H-carbazole
TTDR01395	Inhibitor	11H-benzo[a]carbazole
TTDR01395	Inhibitor	2,3,4,11-tetrahydro-1H-benzo[a]carbazole
TTDR01395	Inhibitor	2-(difluoromethyl)-9H-carbazole
TTDR01395	Inhibitor	2-(trifluoromethoxy)-9H-carbazole
TTDR01395	Inhibitor	2-(trifluoromethyl)-9H-carbazole
TTDR01395	Inhibitor	2-ethyl-9H-carbazole
TTDR01395	Inhibitor	2-isopropyl-9H-carbazole
TTDR01395	Inhibitor	2-methyl-6-(trifluoromethyl)-9H-carbazole
TTDR01395	Inhibitor	2-methyl-9H-carbazole
TTDR01395	Inhibitor	2-tert-butoxy-9H-carbazole
TTDR01395	Inhibitor	2-tert-butyl-7-(trifluoromethyl)-9H-carbazole
TTDR01395	Inhibitor	2-tert-butyl-9H-carbazole
TTDR01395	Inhibitor	3-(trifluoromethyl)-9H-carbazole
TTDR01395	Inhibitor	3-methyl-6-(trifluoromethyl)-9H-carbazole
TTDR01395	Inhibitor	3-tert-butyl-9H-carbazole
TTDR01395	Inhibitor	4'-(trifluoromethyl)-4-biphenylol
TTDR01395	Inhibitor	4'-(trifluoromethyl)-4-biphenylsulfonamide
TTDR01395	Inhibitor	4'-(trifluoromethyl)-4-biphenylyl carbamate
TTDR01395	Inhibitor	4'-(trifluoromethyl)-4-biphenylyl sulfamate
TTDR01395	Inhibitor	4'-trifluoromethyl-biphenyl-4-ylamine
TTDR01395	Inhibitor	4-(trifluoromethyl)biphenyl
TTDR01395	Inhibitor	6-fluoro-2-methyl-9H-carbazole
TTDR01395	Inhibitor	7-tert-butyl-9H-carbazole-3-carboxylic acid
TTDR01395	Inhibitor	9-methyl-2-(trifluoromethyl)-9H-carbazole
TTDR01395	Inhibitor	9H-carbazole-2-carbaldehyde
TTDR01395	Inhibitor	9H-carbazole-3-carbaldehyde
TTDR01395	Inhibitor	EMD-534085
TTDR01395	Inhibitor	N-(4'-bromo-3,3'-difluoro-4-biphenylyl)urea
TTDR01395	Inhibitor	N-(4'-chloro-4-biphenylyl)methanesulfonamide
TTDR01395	Inhibitor	N-(4'-isopropyl-4-biphenylyl)urea
TTDR01395	Inhibitor	N-(4'-methyl-4-biphenylyl)urea
TTDR01395	Inhibitor	N-(4'-t-butyl-4-biphenylyl)urea
TTDR01395	Inhibitor	N-[3'-(trifluoromethyl)-4-biphenylyl]urea
TTDR01395	Inhibitor	N-[4'-(ethylsulfonyl)-3-fluoro-4-biphenylyl]urea
TTDR01395	Inhibitor	N-[4'-(trifluoromethyl)-4-biphenylyl]sulfamide
TTDR01395	Inhibitor	N-[4'-(trifluoromethyl)-4-biphenylyl]thiourea
TTDR01395	Inhibitor	N-[4'-(trifluoromethyl)-4-biphenylyl]urea
TTDR01395	Inhibitor	N-[4-(1,3-benzodioxol-5-yl)phenyl]sulfamide
TTDR01395	Inhibitor	N-{4'-[(trifluoromethyl)sulfonyl]-4-biphenyl}urea
TTDR01395	Inhibitor	N-{4'-[(trifluoromethyl)thio]-4-biphenyl}urea
TTDR01395	Inhibitor	SB-731489
TTDR01395	Inhibitor	adociasulfate-2
TTDR01395	Inhibitor	methyl 7-tert-butyl-9H-carbazole-3-carboxylate
TTDR01395	Inhibitor	methyl 9H-carbazole-2-carboxylate
TTDR01395	Inhibitor	methyl[4'-(trifluoromethyl)-4-biphenylyl]amine
TTDR01395	Antisense	ISIS 183881
TTDR01395	Antisense	ISIS 183882
TTDR01395	Antisense	ISIS 183883
TTDR01395	Antisense	ISIS 183897
TTDR01395	Antisense	ISIS 183901
TTDR01395	Antisense	ISIS 183910
TTDR01395	Antisense	ISIS 183911
TTDR01395	Antisense	ISIS 183912
TTDR01396	UniProt ID	P55212
TTDR01396	Name	mRNA of human caspase 6
TTDR01396	Type of target	Research target
TTDR01396	Disease	Not Available
TTDR01396	PDB Structure	1MI9; 2WDP; 3K7E; 3NKF; 3NR2; 3OD5; 3P45; 3P4U; 3QNW; 3S70; 3S8E; 3V6L; 3V6M; 4E
TTDR01396	Target Validation	TTDR01396
TTDR01396	Inhibitor	Ac-VEID-CHO
TTDR01396	Inhibitor	isoquinoline-1,3,4(2H)-trione
TTDR01396	Antisense	ISIS 134499
TTDR01396	Antisense	ISIS 134524
TTDR01396	Antisense	ISIS 134528
TTDR01396	Antisense	ISIS 134532
TTDR01396	Antisense	ISIS 134563
TTDR01396	Antisense	ISIS 134564
TTDR01396	Antisense	ISIS 134565
TTDR01396	Antisense	ISIS 134566
TTDR01396	Antisense	ISIS 134583
TTDR01396	Antisense	ISIS 134601
TTDR01396	Antisense	ISIS 134602
TTDR01396	Antisense	ISIS 134603
TTDR01396	Antisense	ISIS 134604
TTDR01396	Antisense	ISIS 134605
TTDR01396	Antisense	ISIS 134606
TTDR01396	Antisense	ISIS 134607
TTDR01396	Antisense	ISIS 134608
TTDR01396	Antisense	ISIS 134609
TTDR01397	UniProt ID	P60484
TTDR01397	Name	mRNA of PTEN
TTDR01397	Type of target	Research target
TTDR01397	Disease	Not Available
TTDR01397	PDB Structure	1D5R; 2KYL
TTDR01397	Antisense	ISIS 116847
TTDR01398	UniProt ID	P61586
TTDR01398	Name	mRNA of RhoA
TTDR01398	Type of target	Research target
TTDR01398	Disease	Not Available
TTDR01398	PDB Structure	1A2B; 1CC0; 1CXZ; 1DPF; 1FTN; 1KMQ; 1LB1; 1OW3; 1S1C; 1TX4; 1X86; 1XCG; 2RGN; 3K
TTDR01398	Antisense	ISIS 25544
TTDR01398	Antisense	ISIS 25547
TTDR01398	Antisense	ISIS 25549
TTDR01398	Antisense	ISIS 25551
TTDR01398	Antisense	ISIS 25552
TTDR01398	Antisense	ISIS 25554
TTDR01398	Antisense	ISIS 25563
TTDR01398	Antisense	ISIS 25564
TTDR01398	Antisense	ISIS 25565
TTDR01398	Antisense	ISIS 25566
TTDR01398	Antisense	ISIS 25567
TTDR01399	UniProt ID	Q00987
TTDR01399	Name	mRNA of Human mdm2
TTDR01399	Type of target	Research target
TTDR01399	Disease	Not Available
TTDR01399	PDB Structure	1RV1; 1T4E; 1T4F; 1YCR; 1Z1M; 2AXI; 2C6A; 2C6B; 2F1Y; 2FOP; 2GV2; 2HDP; 2LZG; 2V
TTDR01399	Target Validation	TTDR01399
TTDR01399	Inhibitor	NSC-66811
TTDR01399	Inhibitor	NU-8231
TTDR01399	Inhibitor	NUTLIN-3
TTDR01399	Inhibitor	PLSQETFSDLWKLLPEN-NH2
TTDR01399	Antisense	ISIS 16507
TTDR01399	Antisense	ISIS 16518
TTDR01400	UniProt ID	Q01094
TTDR01400	Name	mRNA of human E2F transcription factor 1
TTDR01400	Type of target	Research target
TTDR01400	Disease	Not Available
TTDR01400	PDB Structure	1H24; 1O9K; 2AZE
TTDR01400	Antisense	ISIS 113019
TTDR01400	Antisense	ISIS 113020
TTDR01400	Antisense	ISIS 113021
TTDR01400	Antisense	ISIS 113022
TTDR01400	Antisense	ISIS 113048
TTDR01401	UniProt ID	Q02156
TTDR01401	Name	mRNA of PKC-epsilon
TTDR01401	Type of target	Research target
TTDR01401	Disease	Not Available
TTDR01401	PDB Structure	2WH0
TTDR01401	Target Validation	TTDR01401
TTDR01401	Inhibitor	8-Octyl-benzolactam-V9
TTDR01401	Inhibitor	BALANOL
TTDR01401	Inhibitor	GF-109203
TTDR01401	Inhibitor	GSK-690693
TTDR01401	Inhibitor	PROSTRATIN
TTDR01401	Inhibitor	RO-316233
TTDR01401	Antisense	ISIS 7942
TTDR01401	Antisense	ISIS 7948
TTDR01402	UniProt ID	Q04759
TTDR01402	Name	mRNA of Protein kinase C-theta
TTDR01402	Type of target	Research target
TTDR01402	Disease	Not Available
TTDR01402	PDB Structure	1XJD; 2ENJ; 2ENN; 2ENZ; 2JED
TTDR01402	Target Validation	TTDR01402
TTDR01402	Inhibitor	4-(1H-indol-5-ylamino)-5-styrylnicotinonitrile
TTDR01402	Inhibitor	4-(1H-indol-5-yloxy)-5-styrylnicotinonitrile
TTDR01402	Inhibitor	4-(1H-indol-6-ylamino)-5-styrylnicotinonitrile
TTDR01402	Inhibitor	4-(3H-indol-4-ylamino)-5-styrylnicotinonitrile
TTDR01402	Inhibitor	8-Octyl-benzolactam-V9
TTDR01402	Inhibitor	GSK-690693
TTDR01402	Inhibitor	PROSTRATIN
TTDR01402	Antisense	ISIS 109351
TTDR01402	Antisense	ISIS 109352
TTDR01402	Antisense	ISIS 109353
TTDR01402	Antisense	ISIS 109354
TTDR01402	Antisense	ISIS 109355
TTDR01403	UniProt ID	Q05513
TTDR01403	Name	mRNA of PKC-zeta
TTDR01403	Type of target	Research target
TTDR01403	Disease	Not Available
TTDR01403	Target Validation	TTDR01403
TTDR01403	Inhibitor	BALANOL
TTDR01403	Inhibitor	LY-326449
TTDR01403	Antisense	ISIS 9007
TTDR01403	Antisense	ISIS 9008
TTDR01403	Antisense	ISIS 9022
TTDR01403	Antisense	ISIS 9023
TTDR01403	Antisense	ISIS 9025
TTDR01404	UniProt ID	Q05655
TTDR01404	Name	mRNA of PKC-delta
TTDR01404	Type of target	Research target
TTDR01404	Disease	Not Available
TTDR01404	PDB Structure	1YRK; 2YUU
TTDR01404	Target Validation	TTDR01404
TTDR01404	Inhibitor	8-Octyl-benzolactam-V9
TTDR01404	Inhibitor	BALANOL
TTDR01404	Inhibitor	BRYOSTATIN
TTDR01404	Inhibitor	Dicarba-Closo-Dodecaborane analogue
TTDR01404	Inhibitor	GF-109203
TTDR01404	Inhibitor	GSK-690693
TTDR01404	Inhibitor	LY-326449
TTDR01404	Inhibitor	PROSTRATIN
TTDR01404	Inhibitor	diheptan-3-yl 5-(hydroxymethyl)isophthalate
TTDR01404	Inhibitor	dihexan-3-yl 5-(hydroxymethyl)isophthalate
TTDR01404	Antisense	ISIS 10303
TTDR01404	Antisense	ISIS 10310
TTDR01404	Antisense	ISIS 10311
TTDR01404	Antisense	ISIS 17252
TTDR01405	UniProt ID	Q07817
TTDR01405	Name	mRNA of Bcl-x
TTDR01405	Type of target	Research target
TTDR01405	Disease	Not Available
TTDR01405	PDB Structure	1BXL; 1G5J; 1LXL; 1MAZ; 1R2D; 1R2E; 1R2G; 1R2H; 1R2I; 1YSG; 1YSI; 1YSN; 2B48; 2L
TTDR01405	Target Validation	TTDR01405
TTDR01405	Inhibitor	4,5-dibenzylbenzene-1,2-diol
TTDR01405	Inhibitor	PURPUROGALLIN
TTDR01405	Inhibitor	QEDIIRNIARHLAQVGDSMDR
TTDR01405	Inhibitor	TW-37
TTDR01405	Antisense	ISIS 11219
TTDR01405	Antisense	ISIS 11220
TTDR01405	Antisense	ISIS 11221
TTDR01405	Antisense	ISIS 11223
TTDR01405	Antisense	ISIS 11224
TTDR01405	Antisense	ISIS 15998
TTDR01405	Antisense	ISIS 15999
TTDR01405	Antisense	ISIS 16005
TTDR01405	Antisense	ISIS 16009
TTDR01405	Antisense	ISIS 16010
TTDR01406	UniProt ID	Q12778
TTDR01406	Name	mRNA of human forkhead box O1A
TTDR01406	Type of target	Research target
TTDR01406	Disease	Not Available
TTDR01406	PDB Structure	3CO6; 3CO7; 3COA
TTDR01406	Antisense	ISIS 188755
TTDR01406	Antisense	ISIS 188757
TTDR01406	Antisense	ISIS 188759
TTDR01406	Antisense	ISIS 188761
TTDR01406	Antisense	ISIS 188763
TTDR01406	Antisense	ISIS 188778
TTDR01406	Antisense	ISIS 188780
TTDR01406	Antisense	ISIS 188781
TTDR01406	Antisense	ISIS 188782
TTDR01407	UniProt ID	Q12923
TTDR01407	Name	mRNA of Human FAP-1
TTDR01407	Type of target	Research target
TTDR01407	Disease	Not Available
TTDR01407	PDB Structure	1D5G; 1Q7X; 1WCH; 3LNX; 3LNY; 3PDZ
TTDR01407	Antisense	ISIS 18473
TTDR01408	UniProt ID	Q13202
TTDR01408	Name	mRNA of Dual specific phosphatase 8
TTDR01408	Type of target	Research target
TTDR01408	Disease	Not Available
TTDR01408	Antisense	ISIS 103375
TTDR01408	Antisense	ISIS 103386
TTDR01408	Antisense	ISIS 103387
TTDR01409	UniProt ID	Q13233
TTDR01409	Name	mRNA of MEKK1
TTDR01409	Type of target	Research target
TTDR01409	Disease	Not Available
TTDR01409	Antisense	ISIS 100913
TTDR01409	Antisense	ISIS 100929
TTDR01409	Antisense	ISIS 100935
TTDR01409	Antisense	ISIS 100939
TTDR01410	UniProt ID	Q13489
TTDR01410	Name	mRNA of Apoptosis-2
TTDR01410	Type of target	Research target
TTDR01410	Disease	Not Available
TTDR01410	PDB Structure	2UVL; 3EB5; 3EB6; 3M0A; 3M0D
TTDR01410	Target Validation	TTDR01410
TTDR01410	Inhibitor	SM-122
TTDR01410	Inhibitor	SM-131
TTDR01410	Inhibitor	SM-337
TTDR01410	Antisense	ISIS 23412
TTDR01410	Antisense	ISIS 23414
TTDR01410	Antisense	ISIS 23416
TTDR01410	Antisense	ISIS 23452
TTDR01410	Antisense	ISIS 23454
TTDR01410	Antisense	ISIS 23459
TTDR01411	UniProt ID	Q13542
TTDR01411	Name	mRNA of eIF4E-BP2
TTDR01411	Type of target	Clinical trial target
TTDR01411	Disease	Cancers
TTDR01411	PDB Structure	3AM7
TTDR01411	Drug(s)	ISIS-EIF4E
TTDR01411	Antisense	ISIS 232828
TTDR01411	Antisense	ISIS 347573
TTDR01411	Antisense	ISIS 347577
TTDR01411	Antisense	ISIS-EIF4E
TTDR01412	UniProt ID	Q13772
TTDR01412	Name	mRNA of human ARA70
TTDR01412	Type of target	Research target
TTDR01412	Disease	Not Available
TTDR01412	PDB Structure	1T5Z
TTDR01412	Antisense	ISIS 114371
TTDR01412	Antisense	ISIS 114372
TTDR01412	Antisense	ISIS 114388
TTDR01412	Antisense	ISIS 114390
TTDR01412	Antisense	ISIS 114397
TTDR01412	Antisense	ISIS 114399
TTDR01412	Antisense	ISIS 114404
TTDR01412	Antisense	ISIS 114442
TTDR01413	UniProt ID	Q14790
TTDR01413	Name	mRNA of Caspase 8
TTDR01413	Type of target	Research target
TTDR01413	Disease	Not Available
TTDR01413	PDB Structure	1F9E; 1I4E; 1QDU; 1QTN; 2C2Z; 2FUN; 2K7Z; 2Y1L; 3H11; 3KJN; 3KJQ; 4JJ7
TTDR01413	Target Validation	TTDR01413
TTDR01413	Inhibitor	Ac-IETD-CHO
TTDR01413	Inhibitor	PRALNACASAN
TTDR01413	Inhibitor	isoquinoline-1,3,4(2H)-trione
TTDR01413	Antisense	ISIS 107612
TTDR01413	Antisense	ISIS 107642
TTDR01413	Antisense	ISIS 107652
TTDR01413	Antisense	ISIS 107676
TTDR01413	Antisense	ISIS 107681
TTDR01414	UniProt ID	Q15303
TTDR01414	Name	mRNA of HER4
TTDR01414	Type of target	Research target
TTDR01414	Disease	Not Available
TTDR01414	PDB Structure	2AHX; 2L2T; 2LCX; 2R4B; 3BBT; 3BBW; 3BCE; 3U2P; 3U7U; 3U9U
TTDR01414	Target Validation	TTDR01414
TTDR01414	Inhibitor	CL-387785
TTDR01414	Antisense	ISIS 19634
TTDR01414	Antisense	ISIS 19639
TTDR01414	Antisense	ISIS 19647
TTDR01414	Antisense	ISIS 19649
TTDR01414	Antisense	ISIS 19650
TTDR01414	Antisense	ISIS 19651
TTDR01414	Antisense	ISIS 19657
TTDR01414	Antisense	ISIS 19658
TTDR01414	Antisense	ISIS 19659
TTDR01414	Antisense	ISIS 19675
TTDR01414	Antisense	ISIS 19676
TTDR01414	Antisense	ISIS 19677
TTDR01415	UniProt ID	Q15797
TTDR01415	Name	mRNA of Smad
TTDR01415	Type of target	Research target
TTDR01415	Disease	Not Available
TTDR01415	PDB Structure	1KHU; 2LAW; 2LAX; 2LAY; 2LAZ; 2LB0; 2LB1
TTDR01415	Antisense	ISIS 28405
TTDR01415	Antisense	ISIS 28407
TTDR01415	Antisense	ISIS 28425
TTDR01416	UniProt ID	Q16665
TTDR01416	Name	mRNA of HIF1-alpha
TTDR01416	Type of target	Research target
TTDR01416	Disease	Not Available
TTDR01416	PDB Structure	1D7G; 1H2K; 1H2L; 1H2M; 1L3E; 1L8C; 1LM8; 1LQB; 2ILM; 3HQR; 3HQU; 4AJY; 4H6J
TTDR01416	Target Validation	TTDR01416
TTDR01416	Inhibitor	(5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol
TTDR01416	Antisense	ISIS 175510
TTDR01416	Antisense	ISIS 298697
TTDR01416	Antisense	ISIS 298699
TTDR01416	Antisense	ISIS 298700
TTDR01416	Antisense	ISIS 298701
TTDR01416	Antisense	ISIS 298702
TTDR01416	Antisense	ISIS 298711
TTDR01416	Antisense	ISIS 298712
TTDR01416	Antisense	ISIS 298743
TTDR01416	Antisense	ISIS 298744
TTDR01416	Antisense	ISIS 298745
TTDR01416	Antisense	ISIS 298746
TTDR01417	UniProt ID	Q16690
TTDR01417	Name	mRNA of human dual specific phosphatase 5
TTDR01417	Type of target	Research target
TTDR01417	Disease	Not Available
TTDR01417	PDB Structure	2G6Z
TTDR01417	Antisense	ISIS 133206
TTDR01417	Antisense	ISIS 133207
TTDR01417	Antisense	ISIS 133208
TTDR01417	Antisense	ISIS 133211
TTDR01417	Antisense	ISIS 133242
TTDR01417	Antisense	ISIS 133243
TTDR01417	Antisense	ISIS 133244
TTDR01417	Antisense	ISIS 133245
TTDR01418	UniProt ID	Q6ZWJ1
TTDR01418	Name	mRNA of Human Syntaxin 4 Interacting Protein
TTDR01418	Type of target	Research target
TTDR01418	Disease	Not Available
TTDR01418	PDB Structure	2YSG
TTDR01418	Antisense	ISIS 119262
TTDR01418	Antisense	ISIS 119263
TTDR01418	Antisense	ISIS 119264
TTDR01418	Antisense	ISIS 119281
TTDR01418	Antisense	ISIS 119282
TTDR01418	Antisense	ISIS 119283
TTDR01418	Antisense	ISIS 119284
TTDR01418	Antisense	ISIS 119285
TTDR01418	Antisense	ISIS 119286
TTDR01419	UniProt ID	Q7Z5L6
TTDR01419	Name	mRNA of human E2A-Pbx1
TTDR01419	Type of target	Research target
TTDR01419	Disease	Not Available
TTDR01419	Antisense	ISIS 16108
TTDR01419	Antisense	ISIS 16112
TTDR01419	Antisense	ISIS 16121
TTDR01419	Antisense	ISIS 16123
TTDR01419	Antisense	ISIS 16124
TTDR01420	UniProt ID	Q96GD4
TTDR01420	Name	mRNA of Aurora B
TTDR01420	Type of target	Research target
TTDR01420	Disease	Not Available
TTDR01420	PDB Structure	4AF3
TTDR01420	Target Validation	TTDR01420
TTDR01420	Inhibitor	4-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine
TTDR01420	Inhibitor	4-(4'-Benzamidoanilino)-6,7-dimethoxyquinazoline
TTDR01420	Inhibitor	6-bromoindirubin-3-oxime
TTDR01420	Inhibitor	7-bromoindirubin-3-oxime
TTDR01420	Inhibitor	7-chloroindirubin-3-oxime
TTDR01420	Inhibitor	7-fluoroindirubin-3-acetoxime
TTDR01420	Inhibitor	7-fluoroindirubin-3-oxime
TTDR01420	Inhibitor	7-iodoindirubin-3-oxime
TTDR01420	Inhibitor	AZD-1152-HQPA;Barasertib
TTDR01420	Inhibitor	CGP-57380
TTDR01420	Inhibitor	GSK-1070916
TTDR01420	Inhibitor	HESPERADIN
TTDR01420	Inhibitor	PHA-680632
TTDR01420	Inhibitor	SU 6656
TTDR01420	Inhibitor	indirubin-3-acetoxime
TTDR01420	Inhibitor	indirubin-3-methoxime
TTDR01420	Inhibitor	indirubin-3-oxime
TTDR01420	Antisense	ISIS 173813
TTDR01420	Antisense	ISIS 173831
TTDR01420	Antisense	ISIS 173840
TTDR01420	Antisense	ISIS 173848
TTDR01421	UniProt ID	Q99418
TTDR01421	Name	mRNA of cytohesin-2
TTDR01421	Type of target	Research target
TTDR01421	Disease	Not Available
TTDR01421	PDB Structure	1PBV; 1R8M; 1R8Q; 1R8S; 1S9D
TTDR01421	Antisense	ISIS 111084
TTDR01421	Antisense	ISIS 111085
TTDR01421	Antisense	ISIS 111086
TTDR01421	Antisense	ISIS 111105
TTDR01421	Antisense	ISIS 111117
TTDR01421	Antisense	ISIS 111118
TTDR01421	Antisense	ISIS 111119
TTDR01421	Antisense	ISIS 111120
TTDR01421	Antisense	ISIS 111121
TTDR01422	UniProt ID	Q99759
TTDR01422	Name	mRNA of human MEKK3
TTDR01422	Type of target	Research target
TTDR01422	Disease	Not Available
TTDR01422	PDB Structure	2C60; 2JRH; 2O2V; 2PPH
TTDR01422	Antisense	ISIS 122970
TTDR01422	Antisense	ISIS 122971
TTDR01422	Antisense	ISIS 122974
TTDR01422	Antisense	ISIS 122975
TTDR01422	Antisense	ISIS 122976
TTDR01422	Antisense	ISIS 122984
TTDR01422	Antisense	ISIS 122985
TTDR01422	Antisense	ISIS 122986
TTDR01422	Antisense	ISIS 122990
TTDR01422	Antisense	ISIS 122991
TTDR01423	UniProt ID	Q99814
TTDR01423	Name	mRNA of HIF2-alpha
TTDR01423	Type of target	Clinical trial target
TTDR01423	Disease	Solid tumors
TTDR01423	PDB Structure	1P97; 2A24; 3F1N; 3F1O; 3F1P; 3H7W; 3H82; 4GHI; 4GS9
TTDR01423	Drug(s)	EZN-2968
TTDR01423	Antisense	EZN-2968
TTDR01423	Antisense	ISIS 222001
TTDR01423	Antisense	ISIS 222035
TTDR01423	Antisense	ISIS 222039
TTDR01423	Antisense	ISIS 222041
TTDR01423	Antisense	ISIS 222043
TTDR01424	UniProt ID	Q99956
TTDR01424	Name	mRNA of Dual specific phosphatase 9
TTDR01424	Type of target	Research target
TTDR01424	Disease	Not Available
TTDR01424	PDB Structure	2HXP; 3LJ8
TTDR01424	Antisense	ISIS 103471
TTDR01424	Antisense	ISIS 103473
TTDR01424	Antisense	ISIS 103486
TTDR01424	Antisense	ISIS 103489
TTDR01425	UniProt ID	Q9H0M0
TTDR01425	Name	mRNA of Ubiquitin Protein Ligase WWP1
TTDR01425	Type of target	Research target
TTDR01425	Disease	Not Available
TTDR01425	PDB Structure	1ND7; 2OP7
TTDR01425	Antisense	ISIS 103582
TTDR01425	Antisense	ISIS 103601
TTDR01425	Antisense	ISIS 103612
TTDR01425	Antisense	ISIS 103613
TTDR01425	Antisense	ISIS 103615
TTDR01425	Antisense	ISIS 103616
TTDR01425	Antisense	ISIS 103619
TTDR01425	Antisense	ISIS 103620
TTDR01425	Antisense	ISIS 103621
TTDR01425	Antisense	ISIS 103622
TTDR01425	Antisense	ISIS 103624
TTDR01425	Antisense	ISIS 103629
TTDR01425	Antisense	ISIS 103631
TTDR01425	Antisense	ISIS 103635
TTDR01426	UniProt ID	Q9NWZ3
TTDR01426	Name	mRNA of human IL-1 receptor-associated kinase-4
TTDR01426	Type of target	Research target
TTDR01426	Disease	Not Available
TTDR01426	PDB Structure	2NRU; 2NRY; 2O8Y; 2OIB; 2OIC; 2OID; 3MOP
TTDR01426	Target Validation	TTDR01426
TTDR01426	Inhibitor	N-(1H-benzo[d]imidazol-2-yl)-3-cyanobenzamide
TTDR01426	Inhibitor	N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide
TTDR01426	Antisense	ISIS 156449
TTDR01426	Antisense	ISIS 156451
TTDR01426	Antisense	ISIS 156452
TTDR01426	Antisense	ISIS 156453
TTDR01426	Antisense	ISIS 156471
TTDR01426	Antisense	ISIS 156472
TTDR01426	Antisense	ISIS 156473
TTDR01426	Antisense	ISIS 156474
TTDR01426	Antisense	ISIS 156475
TTDR01427	UniProt ID	Q9UPY3
TTDR01427	Name	mRNA of human helicase-moi
TTDR01427	Type of target	Research target
TTDR01427	Disease	Not Available
TTDR01427	PDB Structure	2EB1
TTDR01427	Antisense	ISIS 138612
TTDR01427	Antisense	ISIS 138613
TTDR01427	Antisense	ISIS 138616
TTDR01427	Antisense	ISIS 138647
TTDR01427	Antisense	ISIS 138648
TTDR01427	Antisense	ISIS 138649
TTDR01427	Antisense	ISIS 138678
TTDR01428	UniProt ID	Q9W7Y7
TTDR01428	Name	mRNA of influenza A neuraminidase
TTDR01428	Type of target	Research target
TTDR01428	Disease	Not Available
TTDR01428	Antisense	ISIS 3308
TTDR01429	UniProt ID	Q9WLS3
TTDR01429	Name	mRNA of influenza A polymerase 1
TTDR01429	Type of target	Research target
TTDR01429	Disease	Not Available
TTDR01429	PDB Structure	3CM8
TTDR01429	Antisense	ISIS 3304
TTDR01430	UniProt ID	Q9Y219
TTDR01430	Name	mRNA of human Jagged2
TTDR01430	Type of target	Research target
TTDR01430	Disease	Not Available
TTDR01430	Antisense	ISIS 148715
TTDR01431	UniProt ID	Q9Y243
TTDR01431	Name	mRNA of AkT-3
TTDR01431	Type of target	Research target
TTDR01431	Disease	Not Available
TTDR01431	PDB Structure	2X18
TTDR01431	Target Validation	TTDR01431
TTDR01431	Inhibitor	GSK-690693
TTDR01431	Inhibitor	SB-747651A
TTDR01431	Antisense	ISIS 29112
TTDR01431	Antisense	ISIS 29135
TTDR01431	Antisense	ISIS 29136
TTDR01431	Antisense	ISIS 29137
TTDR01431	Antisense	ISIS 29138
TTDR01431	Antisense	ISIS 29139
TTDR01431	Antisense	ISIS 29154
TTDR01431	Antisense	ISIS 29155
TTDR01431	Antisense	ISIS 29156
TTDR01431	Antisense	ISIS 29159
TTDR01431	Antisense	ISIS 29160
TTDR01431	Antisense	ISIS 29161
TTDR01431	Antisense	ISIS 29176
TTDR01431	Antisense	ISIS 29177
TTDR01431	Antisense	ISIS 29178
TTDR01431	Antisense	ISIS 29200
TTDR01431	Antisense	ISIS 29201
TTDR01431	Antisense	ISIS 29202
TTDR01432	UniProt ID	Q9Y2U5
TTDR01432	Name	mRNA of human MEKK2
TTDR01432	Type of target	Research target
TTDR01432	Disease	Not Available
TTDR01432	PDB Structure	2CU1; 2NPT
TTDR01432	Antisense	ISIS 113858
TTDR01432	Antisense	ISIS 113871
TTDR01432	Antisense	ISIS 113872
TTDR01432	Antisense	ISIS 113873
TTDR01432	Antisense	ISIS 113874
TTDR01432	Antisense	ISIS 113902
TTDR01432	Antisense	ISIS 113903
TTDR01432	Antisense	ISIS 113904
TTDR01432	Antisense	ISIS 113905
TTDR01432	Antisense	ISIS 113906
TTDR01432	Antisense	ISIS 113907
TTDR01432	Antisense	ISIS 113908
TTDR01432	Antisense	ISIS 113909
TTDR01433	UniProt ID	Q9Y490
TTDR01433	Name	mRNA of Talin
TTDR01433	Type of target	Research target
TTDR01433	Disease	Not Available
TTDR01433	PDB Structure	1SYQ; 4DJ9
TTDR01433	Antisense	ISIS 109110
TTDR01433	Antisense	ISIS 109111
TTDR01433	Antisense	ISIS 109112
TTDR01433	Antisense	ISIS 109113
TTDR01433	Antisense	ISIS 109114
TTDR01433	Antisense	ISIS 109115
TTDR01433	Antisense	ISIS 109116
TTDR01434	UniProt ID	Q9Y6Q6
TTDR01434	Name	mRNA of RANK
TTDR01434	Type of target	Research target
TTDR01434	Disease	Not Available
TTDR01434	Antisense	ISIS 109490
TTDR01434	Antisense	ISIS 109491
TTDR01434	Antisense	ISIS 109502
TTDR01434	Antisense	ISIS 109524
TTDR01434	Antisense	ISIS 109525
TTDR01434	Antisense	ISIS 109526
TTDR01435	Name	Sigma 2-type opioid receptor
TTDR01435	Type of target	Research target
TTDR01435	Disease	Melanoma, prostate cancer, pancreatic cancer
TTDR01435	QSAR Model	TTDR01435
TTDR01435	Drug(s)	ANAVEX 1007
TTDR01435	Agonist	ANAVEX 1007
TTDR01435	Multitarget	ANAVEX 1007
TTDR01436	UniProt ID	P04150
TTDR01436	Name	mRNA of glucocorticoid receptor
TTDR01436	Type of target	Research target
TTDR01436	Synonyms	mRNA of GR
TTDR01436	Synonyms	mRNA of GRL
TTDR01436	Synonyms	mRNA of NR3C1
TTDR01436	Synonyms	mRNA of Nuclear receptor subfamily 3 group C member 1
TTDR01436	Disease	Type 2 Diabetes
TTDR01436	Function	Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription
TTDR01436	Sequence	MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAVASQSDSKQRRLLVDFPKGSVSNAQQPDLSK
TTDR01436	PDB Structure	1M2Z; 1NHZ; 1P93; 3BQD; 3CLD; 3E7C; 3H52; 3K22; 3K23; 4HN5; 4HN6
TTDR01436	Target Validation	TTDR01436
TTDR01436	Drug(s)	ISIS-GCCR
TTDR01436	Inhibitor	1-(2,3-DICHLOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETH
TTDR01436	Inhibitor	1-(3-CHLORO-4-FLUOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-Y
TTDR01436	Inhibitor	1-Methoxy-6-phenyl-6H-benzo[c]chromen-8-ylamine
TTDR01436	Inhibitor	1-Methoxy-6-phenyl-6H-benzo[c]chromene
TTDR01436	Inhibitor	2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL
TTDR01436	Inhibitor	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one
TTDR01436	Inhibitor	A-348441
TTDR01436	Inhibitor	AL-43
TTDR01436	Inhibitor	CP-394531
TTDR01436	Inhibitor	CP-409069
TTDR01436	Inhibitor	DI-O-METHYLENDIANDRIN A
TTDR01436	Inhibitor	ENDIANDRIN A
TTDR01436	Inhibitor	EPIERENONE
TTDR01436	Inhibitor	LG-120838
TTDR01436	Inhibitor	LGD-5552
TTDR01436	Inhibitor	Methanesulfonamide derivative
TTDR01436	Inhibitor	ONAPRISTONE
TTDR01436	Inhibitor	OXDEX
TTDR01436	Inhibitor	RU-43044
TTDR01436	Inhibitor	WAY-214950
TTDR01436	Inhibitor	WAY-252623
TTDR01436	Antisense	ISIS-GCCR
TTDR01437	UniProt ID	P18031
TTDR01437	Name	mRNA of Protein tyrosine phosphatase-1B
TTDR01437	Type of target	Research target
TTDR01437	Synonyms	mRNA of PTP-1B
TTDR01437	Synonyms	mRNA of PTPN1
TTDR01437	Synonyms	mRNA of Protein-tyrosine phosphatase 1B
TTDR01437	Synonyms	mRNA of Tyrosine-protein phosphatase non-receptor type 1
TTDR01437	Disease	Type 2 Diabetes
TTDR01437	Function	May play an important role in CKII- and p60c-src-induced signal transduction cas
TTDR01437	Sequence	MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRS
TTDR01437	PDB Structure	1A5Y; 1AAX; 1BZC; 1BZH; 1BZJ; 1C83; 1C84; 1C85; 1C86; 1C87; 1C88; 1ECV; 1EEN; 1E
TTDR01437	Target Validation	TTDR01437
TTDR01437	Drug(s)	ISIS-PTP1B
TTDR01437	Inhibitor	1,2,3,4,6-penta-O-galloyl-D-glucopyranose
TTDR01437	Inhibitor	1,2-NAPHTHOQUINONE
TTDR01437	Inhibitor	16-alphaH,17-isovaleryloxy-ent-kauran-19-oic acid
TTDR01437	Inhibitor	18alpha-Glycyrrhetic acid
TTDR01437	Inhibitor	18beta-Glycyrrhetic acid
TTDR01437	Inhibitor	19alpha,24-dihydroxyurs-12-en-3-on-28-oic acid
TTDR01437	Inhibitor	24-hydroxyursolic acid
TTDR01437	Inhibitor	3,9-Dihydroxy-4-prenyl-[6aR;11aR]pterocarpan
TTDR01437	Inhibitor	3-(4,5-Bis-biphenyl-4-yl-1H-imidazol-2-yl)-phenol
TTDR01437	Inhibitor	3-epi-masilinic acid
TTDR01437	Inhibitor	3-isopropyl-4-(phenylthio)naphthalene-1,2-dione
TTDR01437	Inhibitor	3-oxoolean-12-en-27-oic acid
TTDR01437	Inhibitor	3alpha,24-dihydroxyolean-12-en-27-oic acid
TTDR01437	Inhibitor	3beta,6beta-dihydroxyolean-12-en-27-oic acid
TTDR01437	Inhibitor	3beta-acetoxyolean-12-en-27-oic acid
TTDR01437	Inhibitor	3beta-hydroxyolean-12-en-27-oic acid
TTDR01437	Inhibitor	3beta-hydroxyurs-12-en-27-oic acid
TTDR01437	Inhibitor	4'-((2-butylbenzofuran-3-yl)methyl)biphenyl-4-ol
TTDR01437	Inhibitor	4'-(2-butylbenzofuran-3-yl)biphenyl-4-ol
TTDR01437	Inhibitor	4-(p-toluidino)-3-isopropylnaphthalene-1,2-dione
TTDR01437	Inhibitor	5-deoxyabyssinin II
TTDR01437	Inhibitor	ALBAFURAN A
TTDR01437	Inhibitor	BURTTINONE
TTDR01437	Inhibitor	CAULERPIN
TTDR01437	Inhibitor	CHROMOTROPATE
TTDR01437	Inhibitor	DYSIDINE
TTDR01437	Inhibitor	ERTIPROTAFIB
TTDR01437	Inhibitor	ERYBREADIN B
TTDR01437	Inhibitor	ERYTHRIBYSSIN A
TTDR01437	Inhibitor	EVANS BLUE
TTDR01437	Inhibitor	Erybreadin C
TTDR01437	Inhibitor	Erybreadin D
TTDR01437	Inhibitor	Erysubin E
TTDR01437	Inhibitor	FOLITENOL
TTDR01437	Inhibitor	FORMYLCHROMONE
TTDR01437	Inhibitor	Kuwanon L
TTDR01437	Inhibitor	LICOAGROCHACONE A
TTDR01437	Inhibitor	LICOAGROCHALCONE A
TTDR01437	Inhibitor	MASLINIC ACID
TTDR01437	Inhibitor	Mulberrofuran C
TTDR01437	Inhibitor	NEORAUTENOL
TTDR01437	Inhibitor	OHIOENSIN A
TTDR01437	Inhibitor	OLEANOLIC_ACID
TTDR01437	Inhibitor	PHELLIGRIDIN I
TTDR01437	Inhibitor	RK-682
TTDR01437	Inhibitor	SIGMOIDIN A
TTDR01437	Inhibitor	SIGMOIDIN B
TTDR01437	Inhibitor	Sanggenon C
TTDR01437	Inhibitor	Sanggenon G
TTDR01437	Inhibitor	TRYPAN BLUE
TTDR01437	Inhibitor	URSOLIC ACID
TTDR01437	Inhibitor	USIMINE A
TTDR01437	Inhibitor	USNIC ACID
TTDR01437	Inhibitor	UVAOL
TTDR01437	Inhibitor	abyssinin I
TTDR01437	Inhibitor	abyssinin II
TTDR01437	Inhibitor	abyssinoflavanone VI
TTDR01437	Inhibitor	abyssinoflavanone VII
TTDR01437	Inhibitor	abyssinone-IV
TTDR01437	Inhibitor	abyssinone-VI-4-O-methyl ether
TTDR01437	Inhibitor	augustic acid
TTDR01437	Inhibitor	isochroman mono-carboxylic acid
TTDR01437	Inhibitor	isoxazolecarboxylic acid
TTDR01437	Inhibitor	kuwanon J
TTDR01437	Inhibitor	kuwanon R
TTDR01437	Inhibitor	kuwanon V
TTDR01437	Inhibitor	methyl 3beta-hydroxyolean-12-en-28-oate
TTDR01437	Inhibitor	methyl3beta-hydroxyolean-12-en-27-oate
TTDR01437	Inhibitor	mulberrofuran D
TTDR01437	Inhibitor	mulberrofuran W
TTDR01437	Inhibitor	ohioensin C
TTDR01437	Inhibitor	ohioensin F
TTDR01437	Inhibitor	ohioensin G
TTDR01437	Inhibitor	oleanonic acid
TTDR01437	Inhibitor	oxalylaminobenzoic acid
TTDR01437	Inhibitor	pomolic acid
TTDR01437	Inhibitor	rotungenic acid
TTDR01437	Inhibitor	sigmoidin F
TTDR01437	Inhibitor	spathodic acid
TTDR01437	Antisense	ISIS-PTP1B
TTDR01438	UniProt ID	P22455
TTDR01438	Name	mRNA of FGFR4
TTDR01438	Type of target	Research target
TTDR01438	Synonyms	mRNA of CD334
TTDR01438	Synonyms	mRNA of FGFR-4
TTDR01438	Synonyms	mRNA of Fibroblast growth factor receptor 4
TTDR01438	Disease	Obesity
TTDR01438	Function	Receptor for acidic fibroblast growth factor. Does not bind to basic fibroblast
TTDR01438	Sequence	MRLLLALLGVLLSVPGPPVLSLEASEEVELEPCLAPSLEQQEQELTVALGQPVRLCCGRAERGGHWYKEGSRLAPAGRVR
TTDR01438	PDB Structure	1QCT
TTDR01438	Target Validation	TTDR01438
TTDR01438	Drug(s)	ISIS-FGFR4
TTDR01438	Inhibitor	PD-0183812
TTDR01438	Inhibitor	PD-173074
TTDR01438	Inhibitor	Ro-4396686
TTDR01438	Antisense	ISIS-FGFR4
TTDR01439	UniProt ID	Q8NBP7
TTDR01439	Name	mRNA of proprotein convertase subtilisin/kexin type 9
TTDR01439	Type of target	Clinical trial target
TTDR01439	Synonyms	mRNA of NARC-1
TTDR01439	Synonyms	mRNA of Neural apoptosis-regulated convertase 1
TTDR01439	Synonyms	mRNA of PC9
TTDR01439	Synonyms	mRNA of PCSK9
TTDR01439	Synonyms	mRNA of Proprotein convertase 9
TTDR01439	Synonyms	mRNA of Subtilisin/kexin-like protease PC9
TTDR01439	Disease	Coronary Artery Disease
TTDR01439	Disease	Hypercholesterolemia
TTDR01439	Function	May be implicated in the differentiation of cortical neurons and may play a role
TTDR01439	Sequence	MGTVSSRRSWWPLPLLLLLLLLLGPAGARAQEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVV
TTDR01439	PDB Structure	2P4E; 2PMW; 2QTW; 2W2M; 2W2N; 2W2O; 2W2P; 2W2Q; 2XTJ; 3BPS; 3GCW; 3GCX; 3H42; 3M
TTDR01439	Drug(s)	ALN-PCS
TTDR01439	Drug(s)	BMS-PCSK9
TTDR01439	Drug(s)	MPSK3169A
TTDR01439	Drug(s)	RG7652
TTDR01439	Drug(s)	SAR236553
TTDR01439	Antisense	BMS-PCSK9
TTDR01439	RNAi	ALN-PCS
TTDR01440	UniProt ID	Q8TDU6
TTDR01440	Name	TGR5
TTDR01440	Type of target	Research target
TTDR01440	Synonyms	BG37
TTDR01440	Synonyms	G-protein coupled bile acid receptor 1
TTDR01440	Synonyms	G-protein coupled receptor GPCR19
TTDR01440	Synonyms	GPBAR1
TTDR01440	Synonyms	M-BAR
TTDR01440	Synonyms	Membrane-type receptor for bile acids
TTDR01440	Synonyms	hBG37
TTDR01440	Synonyms	hGPCR19
TTDR01440	Disease	Type 2 Diabetes
TTDR01440	Function	Receptor for bile acid. Bile acid-binding induces its internalization, activatio
TTDR01440	Sequence	MTPNSTGEVPSPIPKGALGLSLALASLIITANLLLALGIAWDRRLRSPPAGCFFLSLLLAGLLTGLALPTLPGLWNQSRR
TTDR01440	Target Validation	TTDR01440
TTDR01440	Drug(s)	XL475
TTDR01440	Inhibitor	bile acid
TTDR01440	Agonist	XL475
TTDR01441	UniProt ID	P0A0J7
TTDR01441	Name	Staphylococcus aureus Quinolone resistance protein norA
TTDR01441	Type of target	Research target
TTDR01441	Synonyms	norA
TTDR01441	Disease	Bacterial infection
TTDR01441	Function	Involved in quinolone resistance. May constitute a membrane-associated active ef
TTDR01441	Sequence	MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGTLADKLGKKLIICIGLILFSV
TTDR01441	QSAR Model	TTDR01441
TTDR01442	UniProt ID	P04167
TTDR01442	Name	Cytochrome P450 2B2
TTDR01442	Type of target	Research target
TTDR01442	Synonyms	CYPIIB2
TTDR01442	Synonyms	Cyp2b-2
TTDR01442	Synonyms	Cyp2b2
TTDR01442	Synonyms	Cytochrome P450 PB4
TTDR01442	Synonyms	Cytochrome P450E
TTDR01442	Disease	Hypothalamic-pituitary ACTH function
TTDR01442	Function	Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsome
TTDR01442	Sequence	MEPSILLLLALLVGFLLLLVRGHPKSRGNFPPGPRPLPLLGNLLQLDRGGLLNSFMQLREKYGDVFTVHLGPRPVVMLCG
TTDR01442	QSAR Model	TTDR01442
TTDR01443	UniProt ID	P11509
TTDR01443	Name	Cytochrome P450 2A6
TTDR01443	Type of target	Research target
TTDR01443	Synonyms	CYP2A3
TTDR01443	Synonyms	CYP2A6
TTDR01443	Synonyms	CYPIIA6
TTDR01443	Synonyms	Coumarin 7-hydroxylase
TTDR01443	Synonyms	Cytochrome P450 IIA3
TTDR01443	Synonyms	Cytochrome P450(I)
TTDR01443	Disease	Hypothalamic-pituitary ACTH function
TTDR01443	Function	Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of
TTDR01443	Sequence	MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVV
TTDR01443	PDB Structure	1Z10; 1Z11; 2FDU; 2FDV; 2FDW; 2FDY; 3EBS; 3T3Q; 3T3R; 4EJJ
TTDR01443	QSAR Model	TTDR01443
TTDR01444	UniProt ID	P20813
TTDR01444	Name	Cytochrome P450 2B6
TTDR01444	Type of target	Research target
TTDR01444	Synonyms	CYP2B6
TTDR01444	Synonyms	CYPIIB6
TTDR01444	Synonyms	Cytochrome P450 IIB1
TTDR01444	Disease	Hypothalamic-pituitary ACTH function
TTDR01444	Function	Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsome
TTDR01444	Sequence	MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCG
TTDR01444	PDB Structure	3IBD; 3QOA; 3QU8; 3UA5
TTDR01444	QSAR Model	TTDR01444
TTDR01445	UniProt ID	P20852
TTDR01445	Name	Cytochrome P450 2A5
TTDR01445	Type of target	Research target
TTDR01445	Synonyms	CYPIIA5
TTDR01445	Synonyms	Coumarin 7-hydroxylase
TTDR01445	Synonyms	Cyp2a-5
TTDR01445	Synonyms	Cyp2a5
TTDR01445	Synonyms	Cytochrome P450-15-COH
TTDR01445	Synonyms	Cytochrome P450-IIA3.2
TTDR01445	Disease	Hypothalamic-pituitary ACTH function
TTDR01445	Function	Exhibits a high coumarin 7-hydroxylase activity.
TTDR01445	Sequence	MLTSGLLLVAAVAFLSVLVLMSVWKQRKLSGKLPPGPTPLPFIGNFLQLNTEQMYNSLMKISQRYGPVFTIYLGPRRIVV
TTDR01445	QSAR Model	TTDR01445
TTDR01446	UniProt ID	Q9X721
TTDR01446	Name	Clostridium histolyticum Collagenase
TTDR01446	Type of target	Research target
TTDR01446	Synonyms	colG
TTDR01446	Disease	Bacterial infection
TTDR01446	Sequence	MKKNILKILMDSYSKESKIQTVRRVTSVSLLAVYLTMNTSSLVLAKPIENTNDTSIKNVEKLRNAPNEENSKKVEDSKND
TTDR01446	PDB Structure	2Y3U; 2Y50; 2Y6I; 2Y72; 3JQU; 3JS7; 4AQO; 4ARE; 4HPK
TTDR01446	QSAR Model	TTDR01446
